Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 144.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 150.2;Distal enterocytes: 71.3;Enteroendocrine cells: 116.5;Hepatocytes: 337.9;Paneth cells: 83.8;Proximal enterocytes: 147.5;Proximal tubular cells: 118.4"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"CACO-2: 23.5;Hep G2: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	23.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	12.5	144.0	0.0	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	10.3	0.1	0.0	0.0	0.0	0.0	26.8	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	60.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	150.2	0.0	3.7	2.1	0.0	0.0	71.3	9.8	1.2	0.0	0.0	0.0	0.6	116.5	5.3	0.4	11.4	0.0	0.0	0.0	0.0	0.0	0.0	6.1	337.9	0.0	0.0	0.3	52.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	83.8	0.0	0.0	0.1	147.5	118.4	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	35.1	0.1
AAMDC	"C11orf67, CK067, FLJ21035, PTD015"	ENSG00000087884	"Adipogenesis associated Mth938 domain containing"	Q9H7C9	11	77821109-77918432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 656.7"	"Cell type enhanced"	"Detected in all"		"Theca cells: 385.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 143.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 280.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA037918, HPA037919"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA037918: AB_2675737, HPA037919: AB_2675738"	"unprognostic (3.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (6.02e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.84e-2)"	75.8	180.9	30.1	13.0	35.8	21.0	62.5	35.2	42.6	51.0	31.4	66.6	37.4	41.4	27.9	24.6	47.5	23.4	178.9	30.5	31.7	56.0	57.9	46.9	13.8	37.2	34.4	56.7	34.4	27.4	28.6	21.7	35.9	46.0	29.2	20.1	36.6	34.6	656.7	55.4	47.5	40.2	31.9	31.7	62.4	42.2	34.3	23.7	42.2	173.0	13.6	48.1	42.7	42.7	30.3	24.3	37.2	26.5	106.0	73.3	10.0	49.2	33.4	43.8	54.1	280.1	44.6	20.3	46.5	83.0	43.2	16.9	56.4	32.9	51.9	47.1	45.3	19.5	43.5	52.4	52.2	11.2	17.1	98.3	22.2	46.0	24.2	40.2	131.3	27.0	23.1	32.0	93.2	35.6	23.8	44.3	17.3	84.5	41.4	22.3	63.6	19.6	58.2	18.1	13.1	49.2	62.4	26.7	36.0	55.1	41.2	21.1	138.2	45.5	24.7	87.5	16.5	34.2	58.4	37.8	17.7	18.0	26.2	143.1	28.9	33.3	14.6	17.7	18.8	18.3	28.4	24.2	32.6	25.2	24.8	18.4	16.9	35.9	17.5	33.8	47.3	16.3	30.1	35.8	35.2	42.6	30.5	31.7	37.2	34.4	35.9	31.9	34.3	42.7	68.4	83.3	25.4	19.6	10.0	64.2	82.7	51.0	24.5	10.0	58.7	67.2	114.1	62.9	42.5	79.1	4.2	29.1	11.8	70.2	144.8	60.0	100.1	37.7	27.8	55.7	22.7	19.1	6.9	73.1	43.1	64.5	39.3	35.8	41.2	53.4	93.9	122.2	46.9	11.8	8.9	48.7	44.7	29.9	35.9	36.3	68.3	22.5	83.6	8.4	56.2	101.3	16.5	18.1	24.8	70.2	132.2	64.3	10.2	46.6	160.3	200.8	50.1	13.9	46.0	53.5	65.8	154.0	85.4	29.2	100.7	15.7	14.8	385.5	61.0	71.2
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122064583-122144308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Hepatocytes: 113.9;Oligodendrocyte precursor cells: 106.1;Oligodendrocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.5;NTERA-2: 55.3;SuSa: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		Yes	No		19000		"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	9.7	5.9	10.0	1.8	12.2	0.2	8.4	10.3	14.4	8.2	15.5	5.2	0.9	9.5	7.5	3.2	11.7	2.1	9.2	9.4	10.6	13.9	44.3	6.3	1.4	11.6	11.0	25.2	4.8	7.1	3.5	3.2	11.4	5.4	1.4	3.7	3.5	4.8	8.6	2.8	3.6	4.4	10.1	2.9	5.5	2.2	11.0	1.5	4.7	6.2	1.4	6.9	6.2	11.8	0.1	0.0	21.9	41.5	27.3	13.5	9.4	5.4	8.0	7.3	9.1	12.6	0.1	0.0	0.2	6.6	8.3	4.1	33.5	16.8	9.6	0.0	12.2	9.4	4.3	12.5	22.0	0.0	2.9	12.2	0.5	9.2	7.1	18.9	19.8	12.1	2.7	15.5	5.1	0.1	0.9	0.0	55.3	0.1	1.7	11.8	16.3	0.3	5.3	2.4	2.7	0.7	1.5	0.0	5.3	37.8	0.5	0.0	8.1	13.6	3.4	7.0	8.3	3.5	3.0	0.0	4.9	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	12.2	10.3	14.4	9.4	10.6	11.6	11.0	11.4	10.1	11.0	11.8	16.0	9.6	37.8	145.9	2.1	6.2	9.0	2.8	14.8	7.0	8.7	6.3	9.7	14.3	5.6	14.7	16.7	11.6	1.5	0.6	0.0	2.7	12.2	4.1	24.0	11.7	3.0	5.2	5.0	1.8	3.3	14.4	5.6	7.7	3.8	18.1	24.7	113.9	1.5	11.8	4.4	2.6	2.0	2.2	2.5	7.4	19.0	1.4	12.4	35.6	0.0	8.9	0.0	106.1	132.5	2.3	2.5	24.5	1.6	4.7	5.4	8.6	0.9	3.3	19.7	38.9	15.8	12.4	2.4	7.8	4.7	5.1	2.1	8.0	1.9	4.8
AATF	"BFR2, CHE-1, CHE1, DED"	ENSG00000275700	"Apoptosis antagonizing transcription factor"	Q9NY61	17	36948925-37056871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004940, HPA075963"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA004940: AB_1078075, HPA075963: "	"unprognostic (1.10e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.21e-3)"	29.8	24.4	22.2	26.3	25.6	34.7	26.6	23.6	24.9	24.6	19.8	28.3	18.5	25.6	17.5	24.4	24.7	15.4	26.1	21.0	23.2	22.1	22.5	23.4	34.1	24.0	23.4	29.5	37.5	20.3	15.9	23.2	24.5	20.3	24.0	17.3	21.0	24.1	40.8	37.1	24.2	24.5	22.8	27.1	30.0	22.9	23.5	35.3	20.4	14.2	39.2	31.2	23.4	26.8	107.2	174.2	37.0	73.8	49.3	57.0	67.3	61.2	50.4	76.0	67.3	120.3	74.3	178.2	79.5	60.5	123.4	89.9	141.8	80.0	102.6	83.4	97.3	77.1	65.6	85.8	59.4	121.9	73.4	49.5	138.7	98.4	88.4	68.2	56.6	92.3	114.4	51.7	68.6	81.6	162.4	105.0	46.0	62.8	63.3	104.0	96.7	105.6	62.6	93.7	79.0	33.8	90.9	40.8	95.5	79.6	69.6	72.3	50.4	58.1	96.2	122.5	211.9	61.3	83.1	124.2	72.2	101.9	107.1	48.9	55.2	90.2	60.0	74.0	59.6	46.8	53.9	64.0	51.0	51.0	48.1	47.7	67.5	58.1	77.7	45.5	75.7	57.2	22.2	25.6	23.6	24.9	21.0	23.2	24.0	23.4	24.5	22.8	23.5	26.8	24.5	22.4	34.6	25.1	41.2	43.7	46.3	39.7	29.6	13.4	14.7	13.1	17.8	32.9	37.8	25.8	22.9	72.9	48.5	26.4	9.8	41.6	32.0	23.4	22.9	30.1	16.1	33.7	28.5	48.1	59.8	30.3	23.0	22.0	47.5	37.4	14.6	16.9	46.8	18.5	24.6	26.4	6.1	33.9	30.3	62.0	23.6	33.4	28.4	30.0	54.9	34.3	53.5	29.1	57.7	51.1	26.3	23.3	38.4	52.1	48.8	52.0	31.1	24.0	32.9	32.3	39.0	52.5	40.8	28.2	43.9	163.9	44.3	27.4	31.9	43.6
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781006-104928155	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Translocase	"Atherosclerosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Hepatocytes: 175.5;Kupffer cells: 169.1;Langerhans cells: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 13.1;neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 34.1;U-87 MG: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057283, CAB069889"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Vesicles"		"CAB069889: AB_10002789, HPA057283: AB_2683396"	"unprognostic (1.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.22e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.57e-1)"	24.7	36.5	12.0	11.0	29.1	20.7	13.3	14.4	12.5	7.4	4.1	16.3	4.5	5.6	8.2	4.9	8.0	15.0	4.6	10.4	13.7	7.2	38.7	12.3	8.9	19.5	26.2	8.9	4.0	1.8	2.5	22.7	19.0	4.1	9.9	3.7	5.7	5.0	10.9	13.4	8.1	7.6	16.4	7.1	6.7	3.6	27.3	11.0	5.1	3.4	5.4	19.7	7.6	20.7	0.0	5.6	4.6	0.0	13.1	4.9	4.1	5.9	22.6	1.9	2.1	0.8	0.8	8.2	6.4	5.9	21.7	0.0	2.5	0.3	1.7	0.0	0.0	0.9	1.9	20.3	23.5	0.0	13.8	34.1	1.5	22.7	0.4	21.6	2.2	0.7	0.0	20.2	0.5	0.8	5.2	11.1	6.5	1.2	1.7	0.1	0.0	0.4	3.7	3.9	0.7	0.2	6.2	1.0	1.2	8.7	0.1	4.1	2.1	6.0	0.4	8.0	6.5	7.9	4.0	4.8	79.0	0.0	0.1	2.4	0.8	13.1	0.1	1.0	0.2	1.2	0.3	0.0	0.2	1.5	0.6	0.0	10.6	0.1	1.7	0.1	0.1	0.2	12.0	29.1	14.4	12.5	10.4	13.7	19.5	26.2	19.0	16.4	27.3	20.7	35.8	105.8	9.3	71.5	21.1	29.7	5.9	6.3	61.5	18.4	4.6	7.0	8.9	22.8	11.7	11.0	47.9	31.1	2.4	8.4	0.0	4.5	1.9	17.1	76.0	18.7	9.1	1.3	8.1	1.5	6.9	44.0	14.3	29.4	46.9	3.6	31.4	175.5	75.0	0.0	22.5	2.2	8.2	169.1	109.5	2.5	31.1	74.8	26.6	38.4	6.4	0.5	0.0	57.8	7.7	4.9	5.0	28.2	2.2	2.6	0.1	18.0	8.4	6.7	46.0	24.3	23.4	1.0	1.8	17.1	19.5	8.9	6.5	39.5	3.2	13.3
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.2"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 427.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.6;SCLC-21H: 45.9;T-47d: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.8	8.7	19.1	3.0	20.8	0.7	6.7	10.2	25.5	3.0	0.0	7.9	2.0	3.7	3.5	2.9	4.4	2.7	6.1	23.4	17.1	6.5	1.1	91.2	3.7	20.1	15.8	3.4	13.1	11.2	11.1	4.3	22.2	4.9	1.2	7.4	9.1	4.3	6.2	4.3	3.9	4.6	11.1	3.4	4.9	8.9	19.1	11.3	24.6	3.8	6.5	4.5	2.2	19.7	0.7	21.6	4.1	33.1	0.8	0.0	0.3	5.8	1.4	2.3	2.4	3.0	3.4	0.2	8.4	2.7	2.1	0.6	19.2	0.3	0.8	34.6	12.9	2.2	2.5	0.5	2.9	0.4	3.6	0.3	0.5	0.3	1.1	13.4	32.4	0.2	24.0	0.0	0.1	29.3	0.1	2.4	4.4	5.2	10.4	5.4	0.7	3.8	18.7	0.7	45.9	33.0	4.1	23.4	0.6	1.6	76.5	2.0	9.3	0.2	1.1	9.0	9.8	6.1	2.9	0.1	4.7	11.7	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.1	19.1	20.8	10.2	25.5	23.4	17.1	20.1	15.8	22.2	11.1	19.1	19.7	4.3	70.5	427.4	30.0	1.1	0.6	0.5	0.2	2.2	20.7	8.4	6.7	6.7	4.3	9.5	18.4	12.5	0.0	2.1	0.3	0.0	5.7	7.7	1.3	0.3	6.3	5.4	0.0	60.3	3.8	0.0	2.7	0.0	2.9	29.7	7.7	5.3	0.7	1.0	18.5	58.6	0.8	4.1	1.2	1.8	3.8	1.8	3.1	1.8	13.1	2.2	7.1	2.1	32.2	37.2	1.9	0.4	3.4	3.6	1.5	0.4	2.0	2.4	12.5	6.6	7.2	2.9	5.1	15.0	1.2	1.6	0.0	3.9	1.3	0.4	0.2
ABCA5	EST90625	ENSG00000154265	"ATP binding cassette subfamily A member 5"	Q8WWZ7	17	69244311-69327244	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022032, HPA062904"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA022032: AB_1844427, HPA062904: AB_2732692"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.17e-2)"	"unprognostic (8.05e-4)"	"unprognostic (3.05e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.52e-2)"	7.6	7.7	4.0	2.9	4.2	6.4	12.2	25.9	9.8	7.9	10.2	9.4	9.5	5.4	7.0	7.0	6.1	4.2	4.7	5.4	9.9	7.0	21.4	3.9	3.4	6.6	3.8	5.7	17.9	11.4	12.5	3.4	7.3	6.0	10.0	27.3	6.7	6.3	33.4	23.6	13.6	3.1	5.3	3.9	8.6	9.1	7.0	5.8	7.4	13.8	3.9	3.5	6.9	6.8	5.1	2.3	1.8	2.8	8.7	6.3	0.6	5.1	5.6	5.3	7.8	0.7	1.8	0.0	2.7	4.5	4.2	7.3	1.2	4.3	5.9	0.1	3.4	0.0	6.0	3.4	11.6	0.0	3.1	6.2	5.2	2.2	6.0	1.1	11.7	1.8	0.0	1.9	0.5	4.3	3.2	0.0	1.8	1.9	3.4	0.4	0.1	0.4	1.0	8.3	10.0	1.5	18.6	8.4	5.0	1.6	8.7	3.2	8.6	6.0	1.7	5.6	1.1	10.3	0.3	0.4	2.4	0.0	5.5	0.3	0.3	2.1	1.3	0.0	1.8	1.1	1.7	1.5	0.2	2.3	0.9	1.4	0.9	1.5	0.0	1.8	1.2	0.6	4.0	4.2	25.9	9.8	5.4	9.9	6.6	3.8	7.3	5.3	7.0	6.8	17.7	19.2	20.3	14.4	12.5	65.4	34.9	35.1	31.3	122.3	33.9	42.8	26.4	30.0	27.8	38.6	116.7	17.3	17.7	126.7	5.9	15.6	18.9	38.6	17.4	18.3	112.7	8.4	143.1	9.8	6.0	33.1	32.6	61.8	14.0	90.3	17.2	94.4	7.4	106.0	184.6	73.7	32.6	3.7	24.4	14.4	63.6	7.0	101.4	20.6	29.9	45.6	11.3	79.9	105.3	9.3	45.6	45.9	23.4	32.1	151.1	9.4	66.0	113.4	92.1	28.7	30.3	200.8	78.1	33.8	53.6	23.7	18.2	80.7	30.4	41.8
ABCA6	EST155051	ENSG00000154262	"ATP binding cassette subfamily A member 6"	Q8N139	17	69078702-69141895	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 77.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.5;Fibroblasts: 117.6;Hepatocytes: 110.3;Inhibitory neurons: 77.8;Leydig cells: 51.3;Microglial cells: 93.7;Theca cells: 45.4"	"Cancer enriched"	"Detected in some"	7	"liver cancer: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 39.9;ASC TERT1: 56.0;HSkMC: 25.3;HUVEC TERT2: 54.8;RT4: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA064878, HPA067180"			Enhanced	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA064878: AB_2685380, HPA067180: AB_2685797"	"unprognostic (7.76e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.82e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.35e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.96e-4)"	"unprognostic (1.61e-4)"	"unprognostic (2.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.69e-1)"	23.3	5.5	1.3	2.6	5.5	0.0	15.9	5.1	3.2	10.5	3.1	8.0	2.2	5.9	2.8	5.9	11.3	10.1	17.5	1.1	4.1	3.6	77.9	10.9	5.0	14.3	3.0	29.8	2.3	1.3	2.1	2.1	9.4	2.9	4.4	0.8	9.0	2.0	5.4	6.6	5.5	3.7	7.1	1.5	5.7	1.8	3.4	1.4	8.6	11.7	3.2	14.2	8.9	21.3	0.0	0.0	0.0	0.0	39.9	56.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	25.3	0.1	3.2	0.9	1.5	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	5.5	5.1	3.2	1.1	4.1	14.3	3.0	9.4	7.1	3.4	21.3	12.5	0.0	0.0	2.9	2.0	3.1	1.5	0.4	4.0	11.6	1.8	2.2	6.0	4.3	0.9	3.7	6.2	0.0	1.7	1.8	0.0	0.5	3.3	0.7	5.1	3.2	2.4	2.7	62.5	0.2	0.0	117.6	2.0	2.5	0.0	4.0	3.3	110.3	1.6	0.0	77.8	0.7	0.0	2.5	42.1	2.7	51.3	20.3	5.4	93.7	0.7	3.2	0.0	4.5	33.4	0.4	1.1	12.0	1.2	0.1	0.5	0.9	0.7	13.3	0.0	20.0	14.3	2.0	0.9	1.4	2.8	0.0	1.2	45.4	0.3	0.5
ABCA8	KIAA0822	ENSG00000141338	"ATP binding cassette subfamily A member 8"	O94911	17	68867289-68955392	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 231.5;Granulosa cells: 117.3;Leydig cells: 502.6;Microglial cells: 162.1;Oligodendrocytes: 406.6;Skeletal myocytes: 216.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 31.9;ASC TERT1: 69.6;HSkMC: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044914	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA044914: AB_10964859"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.14e-3)"	39.1	30.5	12.6	2.8	28.1	0.0	21.3	21.0	18.3	10.0	9.6	16.4	6.2	11.9	15.6	7.6	23.7	16.9	42.1	13.6	16.1	9.5	33.7	18.2	1.1	28.2	19.8	51.5	5.7	3.8	11.1	9.0	29.0	9.5	16.9	9.2	14.8	8.6	12.3	6.2	11.8	6.6	20.7	12.4	14.3	19.5	18.4	4.5	17.0	26.7	3.0	16.3	14.6	58.1	0.0	0.0	3.9	0.0	31.9	69.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	12.0	0.0	0.0	53.5	0.0	0.8	0.0	0.4	6.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	28.1	21.0	18.3	13.6	16.1	28.2	19.8	29.0	20.7	18.4	58.1	22.6	51.3	1.1	0.7	0.0	6.0	1.8	0.0	2.8	5.0	0.7	1.0	18.8	0.0	4.3	0.0	2.1	0.2	0.3	0.0	0.0	0.0	4.8	0.4	14.0	6.8	0.0	0.0	0.5	0.0	0.1	231.5	3.1	0.3	1.3	117.3	5.7	48.1	1.1	5.0	0.6	0.0	0.0	1.9	9.4	19.4	502.6	2.6	1.8	162.1	0.0	100.3	0.0	0.5	406.6	0.0	0.0	70.3	1.9	0.4	0.0	0.1	0.0	3.3	39.5	216.6	44.5	5.1	1.7	2.5	4.7	0.3	2.1	60.9	0.0	0.4
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503017-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 101.7;intestine: 70.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 95.8;Distal enterocytes: 109.9;Microglial cells: 570.6;Paneth cells: 106.2;Proximal enterocytes: 204.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 27.2;NK-cell: 17.9"	"Group enriched"	"Detected in many"	9	"NK-cells: 17.9;T-cells: 27.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 67.3;HEK 293: 20.4;HEL: 37.7;Hep G2: 18.5;RPTEC TERT1: 24.2;SH-SY5Y: 78.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	101.7	14.1	3.9	13.6	1.9	3.6	13.7	17.6	6.4	5.3	16.6	26.4	11.0	3.6	3.1	5.0	15.5	1.9	15.3	15.6	33.7	28.0	6.4	3.2	17.6	14.4	2.2	2.0	1.4	0.5	2.3	19.7	4.2	18.2	2.2	1.2	3.1	0.2	1.5	70.7	9.8	15.1	4.2	2.1	0.9	19.3	2.7	1.9	1.4	3.5	3.6	1.7	14.3	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.1	4.3	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	20.4	37.7	4.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	24.2	0.2	0.9	78.9	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	4.0	0.0	0.9	7.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	11.1	0.0	27.2	0.8	2.7	6.8	0.0	2.5	1.7	6.6	0.2	17.9	0.0	0.1	0.0	2.5	14.1	13.6	13.7	17.6	15.3	15.6	17.6	14.4	19.7	15.1	19.3	14.3	17.1	0.0	3.0	3.9	9.9	0.8	0.1	0.0	1.2	1.9	0.4	3.9	3.0	95.8	0.6	49.7	0.0	5.8	24.7	109.9	5.9	13.8	27.3	0.6	0.6	52.9	0.0	7.8	16.1	1.9	0.2	3.7	0.0	0.7	3.8	0.3	2.5	38.4	0.4	0.0	11.4	15.8	0.0	0.6	1.2	3.8	0.9	1.6	0.0	570.6	0.2	0.2	32.0	6.0	3.2	8.1	106.2	0.0	4.6	0.2	204.6	57.7	0.7	1.1	0.0	0.4	1.3	0.4	0.9	0.2	0.6	9.9	24.5	0.1	19.9	0.3
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168915498-169031324	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 80.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 41.7;Alveolar cells type 2: 44.1;Club cells: 19.3;Early spermatids: 16.5;granulocytes: 24.0;Hepatocytes: 20.4"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.6;RT4: 1.6;TIME: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.5	0.0	0.3	0.1	0.3	0.0	0.6	0.3	0.5	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	80.8	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.0	6.2	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.4	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.2	0.2	1.0	0.6	0.5	0.3	0.2	0.3	0.0	41.7	44.1	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	19.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	16.5	0.1	0.0	1.8	0.0	2.7	0.8	0.0	0.0	6.6	0.0	0.0	24.0	0.0	0.0	20.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	9.1	0.0	3.8	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.6
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401696-87480435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 123.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 256.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.4;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.1"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.9;WM-115: 25.7"	"Low region specificity"	"Detected in many"							"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.7	7.4	0.8	2.5	0.6	0.9	0.5	0.6	0.9	0.3	0.4	1.1	0.4	0.2	0.6	0.6	0.2	0.8	6.6	0.8	0.6	0.6	123.2	0.2	5.9	0.9	0.6	0.4	0.1	0.0	0.2	0.2	1.0	0.5	1.2	0.4	0.6	0.4	7.5	1.4	2.1	0.3	0.6	5.0	0.6	1.0	0.7	0.7	0.5	4.8	5.2	1.2	0.5	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	12.9	0.0	0.6	2.6	0.5	0.2	0.6	0.0	0.2	1.7	0.1	0.0	0.0	0.0	3.2	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.8	0.6	0.6	0.9	0.8	0.6	0.9	0.6	1.0	0.6	0.7	0.7	1.3	0.0	0.5	0.3	22.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.8	0.0	1.1	0.1	0.2	0.0	0.1	0.6	0.2	0.2	1.0	0.0	0.4	0.6	0.0	0.3	2.0	0.0	0.2	0.0	0.0	3.3	256.1	0.5	38.7	1.8	0.0	0.0	5.0	1.2	0.4	0.0	1.0	10.6	3.7	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.4	0.3	0.0	0.5	0.7	0.0	0.2	0.0	0.6	1.2	1.2	0.2	0.0	0.4	0.1	0.7	0.0	0.2	0.0
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209772-219218994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.2	8.7	4.3	3.4	3.9	10.4	7.6	3.2	4.6	7.7	4.4	6.5	6.9	8.4	8.2	11.4	9.6	7.1	8.5	4.0	5.1	5.2	15.9	5.9	1.9	4.4	4.2	12.9	5.7	4.8	6.0	3.1	6.2	8.0	3.3	3.0	6.2	8.6	30.4	6.8	6.3	7.9	4.1	3.9	7.9	18.0	5.7	2.6	10.7	9.8	2.9	14.9	7.9	5.0	0.3	22.9	4.7	28.8	30.8	11.1	27.6	8.5	7.9	9.2	9.2	35.5	5.0	0.3	42.8	8.6	5.0	49.1	0.6	3.6	3.0	15.0	4.7	36.3	24.9	65.8	37.0	0.0	12.0	16.3	4.2	6.2	0.1	13.9	16.3	4.8	31.4	4.4	6.3	12.0	2.3	0.1	7.2	53.6	9.2	12.3	14.3	1.6	5.1	0.4	16.6	17.8	17.6	41.4	18.7	17.4	12.4	0.8	7.5	12.5	0.5	16.9	10.3	11.2	9.6	0.1	14.0	0.4	17.0	0.7	0.4	0.0	0.7	0.4	0.2	1.0	0.5	0.2	0.3	0.8	1.2	0.8	0.0	0.4	0.3	2.3	0.5	1.0	4.3	3.9	3.2	4.6	4.0	5.1	4.4	4.2	6.2	4.1	5.7	5.0	0.2	0.0	0.0	14.7	0.3	0.3	0.0	0.5	1.2	1.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.8	1.2	0.3	0.6	0.4	0.0	1.3	12.9	0.0	0.1	0.7	5.1	0.2	0.0	0.5	0.0	0.4	0.1	0.0	10.9	0.3	0.0	0.3	0.4	1.0	0.3	0.3	0.0	3.7	0.0	0.3	0.0	13.6	5.6	0.3	0.0	0.4	0.5	0.0	0.5	0.2	2.2	0.8	0.0	0.4	0.3	1.0	0.3	2.8	0.3	0.3	0.1	0.4	0.2	0.1
ABCB8	"EST328128, M-ABC1, MABC1, MITOSUR"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	10.3	20.4	9.3	8.4	10.3	8.1	8.6	9.7	13.7	16.6	11.3	12.1	10.9	14.9	7.9	18.3	11.0	6.0	13.2	9.5	8.6	15.0	22.3	10.8	7.5	11.5	10.3	11.6	10.0	11.5	19.6	8.4	12.2	11.0	5.3	8.7	8.9	6.6	7.9	10.6	11.3	7.1	8.3	11.2	12.2	12.4	11.1	7.2	15.6	5.8	6.2	8.9	10.6	14.3	26.1	40.1	10.1	32.3	15.8	9.2	20.0	13.6	13.8	20.6	21.9	16.1	42.7	13.8	17.7	14.4	25.2	27.1	15.0	28.1	9.3	17.2	16.5	10.9	16.2	19.7	10.3	8.5	25.9	15.7	20.8	25.1	10.3	7.8	21.4	29.5	57.8	18.3	16.1	58.4	32.3	15.9	6.9	19.6	45.8	14.8	6.4	49.0	14.2	10.9	9.8	19.6	14.5	40.4	13.0	7.9	15.6	11.0	13.3	19.3	5.1	14.1	20.6	18.7	9.8	9.8	27.6	19.9	20.2	11.8	3.2	2.5	4.9	4.7	3.4	2.8	3.4	3.9	4.3	2.1	3.1	4.4	0.7	3.0	3.3	7.1	3.8	2.8	9.3	10.3	9.7	13.7	9.5	8.6	11.5	10.3	12.2	8.3	11.1	14.3	7.3	12.8	1.1	16.6	12.1	3.7	6.6	10.6	6.2	24.9	6.4	4.7	7.0	7.2	7.2	11.0	37.5	36.2	12.0	28.5	3.9	15.9	3.1	14.8	12.8	4.8	0.0	13.7	15.9	20.0	22.5	9.8	36.7	12.1	49.6	57.8	6.1	25.2	28.0	30.3	17.8	14.0	18.3	6.0	3.9	2.8	6.5	8.2	8.8	2.8	9.7	9.0	17.5	7.1	11.8	21.5	8.5	12.4	22.9	7.0	20.6	14.3	8.8	36.6	26.3	8.9	9.5	9.9	13.5	12.0	7.4	81.8	11.3	28.1	18.7	7.6
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184017939	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 167.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 196.0;Inhibitory neurons: 122.8;Rod photoreceptor cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	15.4	23.2	42.5	16.3	44.2	22.4	13.1	48.4	50.0	30.9	167.1	24.4	10.8	21.6	10.4	44.5	16.1	17.9	47.2	45.5	43.6	41.6	7.9	15.6	13.1	44.0	39.5	23.4	13.0	24.0	41.7	17.2	44.7	27.8	22.1	126.2	18.4	13.7	117.5	24.1	23.2	16.1	34.0	37.1	82.3	16.5	46.3	15.3	13.8	40.3	11.8	34.8	35.2	43.2	21.5	11.5	25.9	30.8	25.7	28.3	40.0	16.8	13.3	14.8	16.2	17.9	15.8	22.5	38.6	16.2	22.6	83.3	32.1	18.6	19.3	24.4	31.1	48.1	32.5	18.0	10.3	14.8	36.5	45.6	18.3	15.9	10.6	30.3	17.8	65.6	45.6	30.8	25.7	56.7	40.7	17.1	26.7	38.4	21.7	28.1	8.7	13.4	54.4	136.4	46.6	27.8	17.1	93.5	29.3	33.3	56.6	4.9	20.4	17.4	16.6	22.3	23.8	11.7	24.3	21.1	12.5	29.2	17.9	11.7	4.6	8.3	6.9	2.2	4.4	3.1	3.8	3.1	3.6	4.5	4.3	6.0	16.4	5.6	4.2	1.3	5.7	4.5	42.5	44.2	48.4	50.0	45.5	43.6	44.0	39.5	44.7	34.0	46.3	43.2	8.3	9.6	5.3	39.2	6.4	8.9	14.4	18.3	35.3	39.1	10.5	11.3	37.2	2.8	37.2	44.1	196.0	3.2	7.7	23.3	7.9	5.7	6.0	10.4	18.0	9.5	59.3	21.2	101.3	4.5	5.0	12.5	91.3	20.8	5.1	31.0	6.8	3.3	49.7	33.7	122.8	6.4	20.3	32.7	6.5	3.5	8.1	29.3	12.4	32.8	8.3	13.8	9.2	82.4	62.7	7.9	20.2	7.9	7.5	9.3	5.1	4.8	44.9	121.1	0.0	27.4	15.4	6.8	18.8	41.3	12.1	4.5	8.6	14.9	7.5	61.5
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16149565-16223522	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 134.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 31.5;Distal tubular cells: 45.0;Hepatocytes: 77.9;Proximal enterocytes: 33.7;Proximal tubular cells: 151.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 16.7;renal cancer: 5.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 68.4"	"Not detected"	"Not detected"							HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	5.6	3.6	0.7	0.3	0.7	0.7	3.8	0.7	1.1	1.0	0.8	5.7	13.2	0.3	0.6	0.3	1.5	2.9	2.6	0.7	0.7	27.4	134.2	7.4	0.0	0.8	0.9	1.0	17.2	2.1	0.9	0.2	0.8	2.9	2.8	0.3	12.7	1.0	4.6	0.4	7.9	0.3	0.7	0.7	6.4	0.4	0.8	0.0	5.6	0.1	0.0	0.4	0.7	0.7	0.0	1.5	0.7	0.0	0.0	0.8	1.8	0.0	0.4	1.0	1.6	7.1	2.3	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.6	0.0	0.7	1.8	0.2	68.4	0.4	0.0	0.0	2.7	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	1.0	0.0	0.8	0.1	0.3	8.4	5.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.7	1.1	0.7	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.3	28.9	31.5	2.9	1.9	0.1	0.5	3.2	0.0	1.0	4.3	3.6	3.3	18.6	8.7	9.2	0.0	0.0	0.0	13.7	45.0	2.2	0.5	4.8	1.0	0.8	3.0	2.7	1.0	7.9	0.0	1.7	13.3	1.0	1.3	1.9	1.8	77.9	1.0	0.0	1.1	10.9	0.0	3.5	0.0	0.7	1.5	1.8	1.8	3.7	3.1	1.5	0.0	1.0	0.4	2.2	8.1	5.7	0.3	2.0	33.7	151.1	25.4	0.6	0.0	0.3	1.2	0.4	0.3	0.2	0.9	0.0	1.4	1.8	11.9	0.7
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797389-21942529	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 60.3;Astrocytes: 72.1;Hepatocytes: 99.4;Sertoli cells: 131.5;Smooth muscle cells: 140.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.9;BJ hTERT+: 14.0;CACO-2: 20.8;HSkMC: 27.1;U-138 MG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	27.4	5.9	4.5	3.4	5.4	1.7	9.2	3.1	9.2	8.2	11.6	7.4	4.0	19.1	8.3	6.2	12.3	11.7	28.3	5.4	3.6	6.6	45.2	7.7	3.5	4.8	7.4	10.9	3.5	1.9	2.2	3.6	3.7	7.9	1.8	3.2	4.5	9.9	41.9	4.2	3.1	21.0	3.4	4.4	8.1	1.2	5.1	1.8	6.3	30.3	1.5	5.3	5.1	7.2	0.9	0.2	11.9	0.3	24.9	11.0	0.3	6.1	14.0	7.0	3.5	20.8	1.0	0.5	1.2	0.6	0.8	0.3	0.0	0.0	7.2	0.3	0.2	0.5	0.8	0.3	0.1	0.5	0.6	27.1	0.0	6.7	2.5	0.4	0.0	0.4	0.3	1.2	0.3	1.4	0.2	0.4	1.4	1.2	0.6	0.5	0.3	0.3	0.0	1.2	0.4	1.7	0.4	0.5	0.2	1.7	1.2	0.3	0.3	27.0	1.9	2.2	8.7	1.1	1.3	0.4	6.7	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.5	5.4	3.1	9.2	5.4	3.6	4.8	7.4	3.7	3.4	5.1	7.2	33.8	35.3	60.3	72.1	0.2	3.4	1.5	5.0	0.6	0.8	0.5	0.8	38.2	0.0	25.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.8	20.6	19.7	0.0	0.0	17.2	0.2	0.1	26.2	1.1	0.6	24.0	0.0	7.1	99.4	0.1	1.7	1.0	0.0	0.0	2.4	5.9	0.1	0.3	2.5	10.6	2.8	0.0	15.9	0.0	1.5	1.4	0.1	0.0	0.4	0.0	0.5	0.0	0.1	20.4	1.2	131.5	11.1	140.7	0.4	1.6	1.1	2.3	0.3	2.5	0.2	0.0	2.2
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090150-88231628	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 88.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 106.7;Extravillous trophoblasts: 81.7;Hofbauer cells: 137.4;Microglial cells: 185.5;Proximal enterocytes: 216.6"	"Cancer enhanced"	"Detected in many"		"glioma: 9.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 43.5;BEWO: 75.8;MCF7: 26.2;OE19: 58.6;RPMI-8226: 38.9;SuSa: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.3	4.0	30.8	1.0	29.1	2.3	4.0	30.0	33.1	22.1	17.4	15.7	48.2	23.1	6.8	2.3	9.8	5.1	2.9	25.4	32.3	3.5	36.0	5.1	1.2	40.1	31.3	8.3	0.8	4.4	8.9	11.7	40.1	7.1	13.9	2.5	5.0	33.8	0.3	0.6	88.3	19.8	31.1	1.4	1.9	3.0	40.0	1.3	6.4	0.9	2.0	2.3	4.0	31.9	1.7	43.5	11.9	0.0	0.4	0.0	75.8	1.9	1.3	2.1	3.5	9.8	0.5	0.0	0.4	0.3	5.4	13.2	0.4	1.2	3.1	13.2	1.9	0.6	0.3	13.0	0.0	0.6	0.1	0.2	5.1	4.8	0.3	1.2	4.1	1.0	1.1	0.0	1.3	26.2	6.3	0.2	4.1	58.6	0.0	3.2	0.0	38.9	0.1	9.5	0.2	0.5	8.9	0.9	1.2	26.1	0.3	0.1	0.0	1.7	1.6	0.4	0.2	11.9	4.7	0.0	3.1	0.0	1.8	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.2	0.2	0.0	0.5	0.2	0.1	0.0	1.1	0.1	0.2	0.8	0.2	30.8	29.1	30.0	33.1	25.4	32.3	40.1	31.3	40.1	31.1	40.0	31.9	9.4	3.2	1.1	3.9	0.9	3.8	0.3	0.0	0.0	0.4	24.3	1.9	1.6	1.5	0.2	0.0	0.0	16.8	0.6	106.7	1.9	0.0	3.3	0.4	3.8	45.8	3.0	20.6	1.1	0.2	81.7	2.4	0.5	0.5	5.7	0.2	31.4	23.4	137.4	0.0	0.7	12.0	0.0	1.3	2.5	1.2	1.2	2.8	5.4	185.5	0.1	0.7	2.1	11.1	0.9	0.1	44.3	0.4	2.0	0.2	216.6	7.6	0.8	0.9	0.0	0.4	4.3	1.0	4.3	1.1	0.4	37.6	1.0	4.3	6.1	0.2
ABHD12B	"BEM46L3, C14orf29"	ENSG00000131969	"Abhydrolase domain containing 12B"	Q7Z5M8	14	50872053-50904970	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 6.8;retina: 15.6;skin 1: 10.5"	"Cell type enriched"	"Detected in some"	7	"Muller glia cells: 188.1"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.0;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"thalamus: 2.1"	"Low region specificity"	"Detected in many"			HPA002873	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"		"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA002873: AB_2220573"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.99e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.31e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.68e-1)"	0.5	0.0	2.7	0.1	6.5	1.6	1.3	0.0	2.6	0.0	0.9	0.7	0.0	0.3	0.0	0.2	1.0	0.1	0.1	1.4	1.7	0.2	0.0	0.3	0.1	0.2	5.0	0.0	0.0	0.2	0.1	0.1	1.4	0.0	1.0	15.6	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.6	6.8	0.3	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.7	6.5	0.0	2.6	1.4	1.7	0.2	5.0	1.4	0.0	6.8	1.0	2.4	0.0	0.0	0.3	0.1	0.4	0.1	1.5	0.0	3.4	0.1	0.1	1.9	0.0	5.0	1.8	2.1	0.1	0.0	2.2	0.0	0.0	7.7	2.5	0.2	0.7	0.0	0.0	9.9	0.0	0.0	0.7	0.0	0.6	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.0	4.1	0.0	0.0	5.8	1.2	0.1	0.0	0.0	0.0	188.1	0.0	1.0	4.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	26.4	18.1	0.0	0.1	1.2	0.3	0.2	0.0	1.4	0.3	0.1	0.0	1.8	0.2
ABHD14B	"CIB, MGC15429"	ENSG00000114779	"Abhydrolase domain containing 14B"	Q96IU4	3	51968510-51983409	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 313.2;Proximal tubular cells: 265.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 190.8"	"Low region specificity"	"Detected in all"							"HPA036444, HPA036642"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		2100000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036444: AB_10672221, HPA036642: AB_10672225"	"unprognostic (8.97e-2)"	"prognostic favorable (6.92e-5)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.42e-5)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.35e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.70e-2)"	69.2	81.9	21.3	26.1	22.3	37.4	66.0	21.4	25.3	49.7	29.9	60.0	81.5	39.3	44.7	46.1	58.3	35.2	31.0	20.2	21.4	97.3	155.6	37.8	48.3	22.2	22.2	51.2	65.2	51.3	36.5	15.4	22.7	48.5	55.3	40.4	64.8	36.6	25.1	42.7	74.8	26.9	22.4	47.1	51.0	9.6	22.9	39.0	57.1	22.6	43.1	47.9	42.9	22.3	37.6	32.9	2.7	37.3	100.6	91.3	9.2	14.5	18.4	27.2	32.5	25.3	72.6	41.7	11.4	54.2	12.6	18.5	23.5	22.2	21.0	57.6	27.2	66.6	30.6	106.6	55.3	37.8	64.9	115.1	74.4	27.8	36.9	41.9	34.0	64.2	39.1	66.8	55.8	40.5	16.8	29.9	3.5	43.6	88.5	42.1	5.2	190.8	51.8	16.7	15.2	16.6	37.3	68.0	121.8	5.7	97.7	25.8	31.5	13.8	64.8	32.3	8.7	82.1	41.6	17.4	30.4	118.9	24.8	41.7	24.3	10.9	42.2	19.9	63.3	58.3	53.0	52.0	38.1	42.9	52.4	49.2	1.9	24.5	12.9	28.4	42.4	37.5	21.3	22.3	21.4	25.3	20.2	21.4	22.2	22.2	22.7	22.4	22.9	22.3	40.4	6.4	26.2	7.8	69.4	30.2	62.4	68.5	38.1	12.7	88.1	81.0	4.7	72.9	28.7	69.9	14.6	16.7	50.7	79.6	146.8	34.8	1.4	19.6	22.4	36.8	75.9	41.2	10.1	46.8	19.0	43.4	35.2	20.9	50.8	14.8	39.7	122.1	55.4	8.4	10.8	97.1	42.7	60.7	36.3	2.4	65.0	39.0	55.2	14.0	37.7	14.8	50.4	4.5	9.4	30.0	74.5	46.6	37.4	39.6	313.2	265.3	25.2	39.9	39.5	34.7	35.6	0.4	3.9	57.1	30.4	11.8	63.9	47.7	127.9	64.4
ABHD15		ENSG00000168792	"Abhydrolase domain containing 15"	Q6UXT9	17	29560547-29567037	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 26.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 79.4;Hepatocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 18.3;MAIT T-cell: 6.6;NK-cell: 10.8;plasmacytoid DC: 23.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA014470	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA014470: AB_1852993"	"unprognostic (1.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.45e-2)"	19.2	3.8	3.6	6.2	4.0	8.2	10.6	3.8	3.3	4.6	3.8	7.3	11.2	4.5	3.3	4.7	4.7	5.2	4.9	3.1	4.1	8.9	26.2	6.0	9.1	4.9	4.2	2.9	8.1	7.9	9.1	4.5	4.7	4.7	6.5	1.6	5.1	3.8	2.6	4.6	11.2	4.0	4.2	9.9	8.3	1.8	4.3	4.6	5.8	3.8	8.1	5.6	4.6	4.9	5.8	22.1	2.7	7.7	29.0	12.6	11.3	7.8	8.6	7.6	6.9	5.1	2.9	8.6	5.6	8.4	13.4	15.6	9.7	3.3	4.2	26.5	7.3	3.5	11.0	6.5	8.8	9.0	15.4	9.4	8.9	7.3	1.4	5.6	5.6	5.0	4.6	8.0	4.1	7.8	8.5	10.4	0.6	19.5	6.5	19.7	10.5	20.0	13.7	8.8	1.9	3.1	11.7	5.2	3.1	2.9	13.2	20.5	6.9	4.4	5.5	11.1	7.0	13.3	9.6	4.4	8.8	5.6	9.6	18.3	0.6	2.8	2.6	0.3	6.6	1.4	1.4	2.2	1.5	2.5	0.4	1.3	0.6	10.8	0.2	23.6	1.2	1.1	3.6	4.0	3.8	3.3	3.1	4.1	4.9	4.2	4.7	4.2	4.3	4.9	2.4	3.2	4.1	2.6	11.7	1.3	1.1	2.5	2.2	0.1	3.8	2.4	3.0	2.8	4.3	7.3	0.0	1.5	79.4	12.0	0.0	3.0	0.3	4.7	3.1	2.9	7.2	7.0	0.3	7.6	1.4	4.0	2.0	5.1	2.5	2.9	4.2	30.2	7.2	1.7	0.5	6.1	2.0	6.7	8.4	0.7	4.7	9.5	5.4	2.8	5.6	1.1	15.5	0.5	1.2	5.6	2.5	4.5	5.2	1.5	17.7	5.6	5.2	0.9	0.0	3.5	1.9	0.8	0.6	2.0	2.4	0.3	11.8	4.5	7.4	1.2
ABHD16B	"C20orf135, dJ591C20.1"	ENSG00000183260	"Abhydrolase domain containing 16B"	Q9H3Z7	20	63861498-63862988	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 15.9"	"Group enriched"	"Detected in some"	77	"Early spermatids: 131.8;Late spermatids: 270.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.0;PC-3: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059272, HPA075886"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA059272: AB_2683963, HPA075886: "																		2.1	1.5	2.2	2.5	1.6	1.0	0.1	1.7	3.0	0.2	0.8	0.8	1.8	1.0	0.0	0.4	0.2	0.4	1.0	1.7	2.1	1.0	0.3	1.0	1.7	2.0	2.2	0.9	2.1	0.0	0.1	0.6	2.3	1.3	0.0	0.3	1.6	0.0	1.6	1.1	1.6	0.0	1.3	3.6	2.3	15.9	4.6	0.0	0.4	0.0	0.0	0.1	0.2	2.1	4.9	3.2	0.6	1.2	0.0	0.0	7.2	5.7	0.0	0.1	0.0	16.0	6.3	4.5	4.6	0.0	1.4	12.6	0.0	0.0	0.0	3.1	3.8	2.9	6.7	11.8	0.0	1.7	7.9	0.0	0.0	0.0	0.0	0.3	0.0	3.4	5.6	5.2	0.0	8.5	2.7	4.8	1.3	0.6	18.8	5.8	0.7	1.7	0.0	3.3	2.2	1.9	5.4	3.1	0.8	0.2	6.3	0.8	1.9	3.3	5.8	1.7	2.4	4.2	2.6	2.9	2.4	1.8	2.4	0.1	0.7	2.7	0.7	0.4	0.4	0.3	0.2	0.5	0.6	0.6	0.5	0.4	0.2	0.2	0.3	0.6	0.8	0.8	2.2	1.6	1.7	3.0	1.7	2.1	2.0	2.2	2.3	1.3	4.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	131.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	270.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2, acylglycerol lipase"	P08910	15	89087459-89202355	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.8;Hepatocytes: 402.5;Late spermatids: 462.1;Oligodendrocyte precursor cells: 421.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 69.8;neutrophil: 52.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HEL: 340.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	18.5	36.3	20.0	20.2	20.9	34.9	22.5	40.2	27.2	19.5	130.3	21.1	47.9	20.7	56.1	17.4	23.4	47.2	36.1	29.0	20.3	22.4	137.6	45.3	14.7	13.3	32.4	24.5	57.9	18.4	14.0	11.1	13.5	44.2	18.9	14.5	12.7	18.6	21.8	13.1	35.9	22.4	11.0	24.6	72.9	52.0	24.2	15.5	17.1	46.3	16.1	31.1	9.6	16.4	33.0	62.3	14.7	16.3	29.2	39.0	8.2	21.4	62.5	19.8	18.6	15.7	55.3	9.4	23.9	27.4	54.1	42.6	32.4	26.4	28.0	48.1	15.8	340.5	14.0	12.8	14.8	24.2	74.4	20.1	18.6	70.1	45.5	33.7	25.3	20.7	30.3	27.4	56.3	13.3	15.0	5.8	6.6	76.9	18.1	20.7	32.2	71.9	27.0	51.5	25.2	39.0	41.4	19.4	34.4	13.5	21.7	18.6	38.6	70.9	23.7	24.2	55.8	23.5	49.3	10.9	58.2	21.5	55.4	8.4	13.4	69.8	3.5	11.3	2.1	2.4	3.2	3.4	7.1	2.2	3.2	3.2	52.2	11.2	17.8	5.7	8.7	6.9	20.0	20.9	40.2	27.2	29.0	20.3	13.3	32.4	13.5	11.0	24.2	16.4	43.4	96.1	118.1	87.5	10.7	18.6	47.3	27.0	7.4	25.5	26.6	17.8	52.0	130.1	82.1	42.3	18.8	4.6	53.7	65.9	1.9	48.9	331.8	28.3	36.8	27.7	48.7	40.8	103.6	85.2	7.7	26.6	103.0	25.9	60.7	18.5	21.0	402.5	40.8	20.2	114.7	58.7	87.5	59.2	26.6	462.1	32.9	67.3	58.7	46.9	46.4	45.5	36.0	421.2	54.4	106.4	38.0	59.8	27.4	171.1	53.1	18.0	158.0	14.7	78.9	36.1	53.4	119.8	13.2	20.8	17.5	2.6	24.5	35.2	38.7	117.5
ABHD3	LABH3	ENSG00000158201	"Abhydrolase domain containing 3, phospholipase"	Q8WU67	18	21650901-21704780	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 187.7;Paneth cells: 126.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 209.6;RPMI-8226: 233.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010729	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA010729: AB_1844449"	"unprognostic (1.46e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.21e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.58e-2)"	17.1	7.3	13.3	25.2	13.8	17.6	15.7	16.8	21.9	12.6	23.2	63.5	44.1	8.1	9.1	18.1	12.0	20.8	7.5	13.2	14.0	14.5	39.3	15.7	29.8	14.2	15.6	12.5	12.3	16.0	11.4	19.8	16.2	11.1	65.7	5.8	14.5	6.2	14.4	6.3	56.3	9.7	13.2	24.0	35.6	6.3	16.2	21.4	22.9	7.9	25.8	15.3	12.8	15.9	29.0	20.6	19.8	12.7	12.3	8.2	0.1	18.6	7.6	13.1	17.6	21.6	29.1	82.3	33.2	6.2	58.6	93.6	32.5	15.3	18.1	52.1	21.9	9.0	35.7	37.5	18.7	39.6	28.9	7.3	17.7	19.2	8.8	6.5	8.7	28.0	23.4	47.9	11.6	11.7	38.5	43.6	9.7	92.1	47.8	209.6	15.0	233.5	36.4	27.6	16.6	7.5	42.5	37.6	11.2	21.3	11.7	68.9	6.9	12.7	18.2	22.6	29.3	53.1	37.5	84.9	16.1	50.9	29.4	89.3	24.7	29.3	25.3	44.4	19.8	16.2	22.7	24.8	15.2	12.6	18.2	23.2	81.6	18.6	61.8	10.2	44.9	24.3	13.3	13.8	16.8	21.9	13.2	14.0	14.2	15.6	16.2	13.2	16.2	15.9	8.4	9.6	9.3	42.4	22.8	33.4	40.8	21.6	18.2	14.3	12.9	6.2	4.6	40.0	25.4	3.7	47.9	30.6	24.4	187.7	1.9	52.9	4.1	32.6	9.9	9.5	36.4	10.3	27.2	27.5	22.7	10.6	32.1	49.4	11.4	1.2	10.4	31.6	68.5	0.0	30.9	57.9	52.9	31.9	47.2	1.5	7.5	26.4	32.0	33.7	29.6	7.8	26.8	17.1	10.7	51.1	126.6	6.4	45.5	32.0	93.8	8.8	40.8	15.7	13.1	6.8	13.2	4.1	9.7	22.4	15.2	94.3	38.3	5.4	36.8	36.8
ABHD4	FLJ12816	ENSG00000100439	"Abhydrolase domain containing 4, N-acyl phospholipase B"	Q8TB40	14	22598237-22613215	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 35.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 35.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 121.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000600	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA000600: AB_1078081"	"unprognostic (5.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.03e-2)"	22.8	28.7	21.6	7.3	23.6	12.6	17.5	22.3	22.4	25.9	27.7	19.2	15.0	26.3	27.4	38.3	15.4	24.7	20.5	21.0	24.5	25.3	22.6	17.6	8.0	27.8	24.5	15.9	14.5	22.8	12.8	17.9	23.3	19.3	13.8	21.7	16.5	33.7	25.5	18.9	17.9	24.5	22.5	14.8	24.9	36.8	24.2	10.1	21.6	27.2	14.8	24.8	26.2	26.0	23.4	38.5	15.5	14.2	121.8	44.0	14.9	10.3	52.2	25.3	46.8	23.5	36.4	2.2	26.7	45.2	27.2	44.5	9.9	26.6	20.6	17.3	3.5	8.7	28.1	77.9	55.6	1.4	30.3	56.1	20.6	33.2	28.2	52.7	26.4	16.0	6.5	41.1	23.5	12.8	0.7	1.3	18.8	94.4	27.7	6.5	13.8	9.8	29.6	24.6	1.0	3.1	69.1	24.3	27.2	30.6	9.5	2.6	18.8	11.0	14.9	18.0	4.1	44.1	25.3	0.8	8.2	1.8	8.9	35.4	6.3	10.2	8.2	4.7	6.8	5.5	5.4	5.5	4.2	3.1	1.7	3.5	25.7	7.3	4.6	0.6	3.4	5.6	21.6	23.6	22.3	22.4	21.0	24.5	27.8	24.5	23.3	22.5	24.2	26.0	5.0	12.8	5.6	2.6	4.7	3.2	7.0	5.2	7.4	3.5	6.2	6.6	6.7	11.5	3.4	3.7	4.2	6.1	4.8	9.8	9.8	13.3	3.1	8.3	6.0	6.5	6.0	4.4	1.1	11.7	2.3	5.2	16.3	12.5	5.1	5.2	9.3	10.3	7.8	8.4	1.2	6.8	4.1	6.9	1.7	4.7	5.6	4.6	1.8	1.0	9.4	6.9	5.2	4.0	3.7	9.8	9.3	8.2	12.4	9.5	13.3	4.7	2.6	3.2	6.6	3.1	6.0	0.7	0.5	13.2	2.7	26.8	5.0	9.7	3.3	11.7
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 67.8;neutrophil: 42.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 67.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favorable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	38.8	12.5	6.7	8.5	8.6	39.6	27.9	10.5	8.9	9.8	6.0	12.3	9.9	5.7	4.1	31.1	5.1	11.6	13.4	6.8	7.4	12.0	21.7	16.4	3.4	9.2	8.2	4.6	16.0	12.2	5.6	10.2	9.1	7.1	7.5	6.3	27.4	8.4	15.0	38.0	10.5	9.3	9.3	9.4	12.1	10.8	8.4	6.8	15.5	18.5	7.9	16.7	16.9	11.9	18.9	6.8	8.2	9.7	32.0	12.8	17.1	77.4	27.1	18.8	14.9	9.4	6.4	16.2	10.9	23.2	15.8	5.8	16.5	18.5	22.6	58.4	13.2	36.6	24.4	7.5	15.7	9.2	13.2	13.0	64.6	31.3	28.5	18.8	33.3	10.8	23.9	14.2	46.9	11.0	7.6	6.9	22.8	16.7	20.4	3.1	24.1	8.6	27.9	40.4	10.6	13.6	36.9	20.5	9.8	9.8	18.9	8.9	19.3	18.1	13.6	35.0	34.5	11.1	34.0	7.7	20.3	17.3	16.0	67.8	14.7	9.5	2.3	7.9	1.7	3.5	1.7	2.7	6.8	4.0	1.6	2.5	42.5	2.0	5.7	1.9	4.8	5.3	6.7	8.6	10.5	8.9	6.8	7.4	9.2	8.2	9.1	9.3	8.4	11.9	117.5	25.6	51.8	12.7	44.8	39.9	27.5	25.9	88.8	11.9	149.9	116.2	10.3	14.3	49.6	27.6	27.1	16.7	80.3	65.0	33.2	57.5	19.5	47.5	49.0	34.6	36.2	69.0	24.1	61.5	24.9	53.7	67.8	114.0	16.5	8.8	18.2	12.7	18.0	3.3	24.1	23.7	34.6	44.1	17.4	17.1	5.3	79.8	7.2	11.2	35.9	11.0	12.3	18.1	28.8	75.2	49.8	5.7	41.8	25.5	98.5	39.8	19.1	17.4	0.0	32.0	46.4	47.3	41.9	111.7	40.9	205.4	42.6	15.2	21.9	71.6
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6, acylglycerol lipase"	Q9BV23	3	58237532-58295693	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 60.6;Oligodendrocytes: 88.6;Proximal enterocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	12.2	12.9	24.0	6.4	33.9	0.9	8.9	34.1	32.4	4.4	19.4	12.7	39.5	6.1	14.7	6.4	9.1	5.8	5.7	31.6	26.9	35.6	64.9	8.5	8.0	31.7	32.3	5.0	2.7	8.9	16.6	6.4	31.7	5.5	11.1	9.2	4.0	14.3	4.6	25.5	52.3	9.2	28.8	35.0	12.9	3.9	35.5	5.5	9.1	5.4	7.6	5.8	5.9	49.8	3.5	12.0	1.8	8.5	23.2	4.2	21.2	8.9	8.1	9.2	12.5	6.9	4.8	6.6	0.8	4.7	28.5	9.9	8.3	3.9	8.4	11.3	4.2	5.7	8.1	9.7	7.8	1.7	28.1	3.9	18.4	8.8	3.8	10.6	5.0	10.6	6.8	15.0	7.2	2.6	11.7	0.7	6.1	28.5	27.3	4.2	3.8	14.8	14.5	4.8	10.8	4.4	9.9	5.1	19.0	3.7	3.6	4.5	5.8	6.6	7.0	16.6	10.8	4.2	13.5	0.3	17.1	16.9	9.3	0.0	2.2	1.7	1.6	7.4	1.5	3.6	0.9	1.9	3.7	2.5	0.9	1.1	0.0	0.7	5.2	5.4	1.2	1.0	24.0	33.9	34.1	32.4	31.6	26.9	31.7	32.3	31.7	28.8	35.5	49.8	27.1	0.0	1.8	11.4	13.6	8.7	3.0	2.7	6.2	13.3	2.1	1.5	5.6	5.7	4.9	3.7	4.2	2.0	7.7	11.2	1.9	3.0	1.0	9.8	7.9	14.1	0.0	5.7	33.6	1.9	0.9	2.9	7.7	1.5	11.4	10.1	21.4	60.6	8.9	15.2	34.3	4.0	0.0	16.7	20.0	0.7	6.8	12.1	3.6	11.2	11.5	11.2	6.2	37.7	88.6	1.9	1.4	8.2	2.0	1.8	55.1	17.4	13.8	3.3	0.0	2.9	3.9	0.5	2.2	6.9	24.6	0.5	5.1	16.0	5.8	2.0
ABHD8	"FLJ11743, MGC14280, MGC2512"	ENSG00000127220	"Abhydrolase domain containing 8"	Q96I13	19	17292131-17310236	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 146.2;Horizontal cells: 72.3;Late spermatids: 314.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 53.9;U-266/70: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037658, HPA058209"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA037658: AB_10672602, HPA058209: AB_2683638"	"unprognostic (4.71e-3)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (7.45e-3)"	"unprognostic (7.09e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.77e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.24e-2)"	7.4	26.0	32.3	3.9	37.2	4.5	8.8	20.6	57.8	12.0	14.3	16.7	2.7	11.5	1.7	5.7	11.2	2.9	12.4	36.3	23.8	11.6	28.2	9.6	4.5	19.2	26.5	14.2	11.6	8.9	24.6	5.6	19.5	14.6	0.6	6.1	10.5	6.7	13.8	11.3	7.8	2.7	16.1	11.4	11.1	45.7	30.0	4.7	12.1	3.9	2.2	10.2	8.8	27.0	22.5	6.4	3.2	12.6	4.1	1.4	34.2	4.5	6.0	4.8	6.1	5.6	15.0	1.6	6.1	3.5	7.4	3.1	3.2	7.8	1.0	26.6	21.1	7.3	9.6	9.7	13.4	0.5	9.9	3.8	4.7	8.2	1.0	7.4	3.5	12.5	6.6	12.4	1.9	1.2	9.0	1.3	6.0	3.8	53.9	13.3	9.9	6.5	4.3	2.1	3.9	21.3	10.0	3.3	14.6	2.8	13.6	12.6	2.1	4.4	9.6	22.7	8.1	40.6	33.0	7.9	14.9	8.7	4.1	0.0	2.4	3.0	1.1	1.9	0.7	0.3	1.6	0.9	2.9	0.5	1.3	1.2	1.3	1.7	1.9	1.3	1.2	1.0	32.3	37.2	20.6	57.8	36.3	23.8	19.2	26.5	19.5	16.1	30.0	27.0	5.9	0.0	1.3	20.9	5.0	3.8	4.7	8.0	8.6	56.9	9.6	14.4	2.0	7.2	4.8	7.3	18.8	20.6	4.0	0.8	7.9	13.1	146.2	3.0	3.7	4.3	7.2	0.8	22.7	8.5	9.0	7.7	2.6	2.5	4.5	12.3	4.2	13.5	22.5	72.3	19.4	3.3	12.2	8.1	6.9	314.2	12.5	11.1	1.8	8.4	18.4	36.1	7.2	2.5	1.4	8.4	4.3	25.6	9.2	6.3	0.4	9.7	1.7	38.2	6.6	13.6	5.6	64.3	1.5	3.0	4.1	24.8	4.8	10.8	1.3	4.3
ABI2	"ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2"	ENSG00000138443	"Abl interactor 2"	Q9NYB9	2	203328280-203447728	"Predicted intracellular proteins"	"Host-virus interaction, Neurogenesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070567	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"HPA070567: AB_2686281"	"unprognostic (5.26e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-3)"	"unprognostic (7.05e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	10.5	13.2	31.0	9.5	41.9	3.3	15.2	22.9	38.4	19.0	10.0	18.7	5.7	28.0	18.7	11.9	22.5	13.4	32.7	40.4	33.0	20.9	7.4	16.1	8.2	16.3	24.1	27.9	7.5	20.4	20.5	19.4	17.3	18.7	10.7	30.0	8.6	23.0	7.4	7.6	8.9	25.2	21.3	12.9	9.3	27.5	36.0	22.2	26.5	15.8	8.7	14.6	11.9	22.5	19.3	29.4	102.5	64.4	23.9	40.5	22.6	33.0	29.0	27.9	32.2	27.3	35.5	0.0	22.0	39.0	38.8	20.9	47.1	34.6	54.8	9.5	27.4	47.9	30.9	21.4	36.3	20.6	21.1	28.8	16.5	51.2	39.5	80.5	52.6	54.1	34.7	41.8	49.7	35.0	52.8	20.4	53.5	18.2	64.8	34.5	51.4	3.5	29.3	19.6	43.2	55.3	6.2	19.2	37.4	76.8	25.0	23.9	39.9	50.4	43.0	27.8	36.2	29.3	28.7	26.6	54.7	8.5	33.2	0.2	1.4	0.0	3.3	1.6	3.6	1.4	3.7	3.7	4.0	1.3	4.4	3.9	0.2	3.9	3.8	12.7	4.4	3.2	31.0	41.9	22.9	38.4	40.4	33.0	16.3	24.1	17.3	21.3	36.0	22.5	39.7	54.5	26.5	123.4	14.7	30.1	55.7	37.7	34.1	111.9	39.5	38.7	56.7	28.6	32.8	53.3	162.6	23.7	33.1	10.1	33.2	24.3	128.2	62.3	68.4	43.6	49.2	30.3	201.3	13.1	15.7	54.1	25.0	72.3	15.8	100.0	65.7	12.3	16.7	102.6	128.6	10.9	20.3	11.4	62.3	81.6	46.6	22.1	49.8	57.1	18.6	67.6	26.8	114.1	94.2	15.5	19.4	63.2	18.3	44.2	11.1	38.5	83.1	89.6	26.3	70.5	67.9	89.0	52.4	22.0	26.1	19.7	21.7	69.9	17.0	37.5
ABITRAM	"C9orf6, CG-8, FAM206A, FLJ20457, Simiate"	ENSG00000119328	"Actin binding transcription modulator"	Q9NX38	9	108934400-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.7;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 10.6;Fibroblasts: 4.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035917, HPA035918"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	14.2	11.9	17.2	10.0	18.7	15.6	17.2	16.8	21.9	12.5	18.7	14.9	14.4	13.6	25.1	16.4	21.5	10.9	15.8	17.7	17.3	13.6	14.6	12.7	9.0	16.8	17.1	13.5	13.3	23.2	13.9	12.5	17.2	12.1	16.2	24.7	15.3	14.2	13.2	24.5	13.1	12.5	17.5	8.5	14.5	20.2	17.5	11.9	19.0	11.8	12.0	11.9	11.4	18.3	18.5	19.8	19.5	23.4	36.2	44.6	28.1	17.1	20.0	17.0	13.9	29.5	9.7	17.0	9.8	16.6	22.3	41.3	17.2	18.3	16.0	10.4	17.6	10.5	25.8	27.0	30.7	40.4	13.3	25.3	33.6	20.7	47.6	20.9	23.7	26.1	39.7	16.6	20.3	53.0	28.9	16.3	22.6	55.9	28.7	13.9	33.9	18.9	22.5	19.2	26.7	13.7	27.0	23.3	30.1	20.0	31.6	21.4	14.9	9.2	16.9	39.3	21.7	14.7	38.5	12.6	30.1	15.6	13.4	38.8	31.2	31.0	14.8	33.4	22.6	16.5	23.1	19.6	35.5	10.8	22.9	17.6	37.4	21.1	34.6	37.0	21.1	20.1	17.2	18.7	16.8	21.9	17.7	17.3	16.8	17.1	17.2	17.5	17.5	18.3	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	6.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	10.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713016-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 71.2;Oligodendrocytes: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (4.82e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	50.9	30.7	27.4	25.3	38.9	23.4	45.8	33.6	31.4	60.5	40.4	96.4	23.1	63.0	11.6	33.8	55.6	35.7	36.1	26.6	28.3	23.1	17.5	37.3	16.3	39.3	38.5	56.0	24.9	32.5	34.9	26.5	35.8	43.5	26.7	14.2	32.4	33.6	29.4	36.3	45.2	41.2	31.3	23.3	51.6	20.1	34.9	22.4	46.7	30.8	15.4	79.3	42.7	41.3	22.5	48.3	53.6	62.9	76.5	93.3	18.8	38.8	60.4	44.8	38.1	36.4	28.3	32.3	22.3	52.0	47.6	42.5	23.5	36.0	30.7	20.6	16.3	23.7	84.1	33.4	51.8	36.5	32.3	68.8	37.2	80.6	50.0	64.1	61.0	47.9	135.8	26.5	54.9	42.0	49.2	30.5	57.9	34.3	33.8	55.9	67.9	35.9	45.0	25.7	47.9	60.1	66.1	23.5	29.2	31.0	46.2	33.1	71.1	170.7	44.1	66.3	62.6	8.4	20.3	47.9	72.1	27.6	55.1	0.0	0.7	0.3	0.6	0.4	0.8	1.3	0.6	0.6	0.7	0.4	0.6	0.5	0.0	0.8	1.9	1.0	0.3	0.6	27.4	38.9	33.6	31.4	26.6	28.3	39.3	38.5	35.8	31.3	34.9	41.3	16.2	9.6	13.6	54.9	4.7	9.2	7.3	9.8	5.2	8.2	11.6	10.2	6.2	7.2	7.2	14.7	12.5	13.6	12.1	21.2	1.9	14.4	5.9	8.6	29.7	18.1	22.1	4.6	52.5	11.1	4.3	36.7	5.6	12.4	2.5	22.1	20.3	15.9	16.6	10.1	63.7	17.5	6.1	16.4	11.7	8.8	28.0	10.2	5.4	71.2	6.6	19.2	6.2	66.9	116.0	17.9	18.3	25.6	5.6	8.6	11.6	10.3	7.8	9.1	19.7	29.5	19.8	16.9	16.5	6.6	6.8	15.2	7.9	20.1	21.4	7.2
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099330-179229684	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 166.8;Langerhans cells: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 73.5;TIME: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001866, CAB017106, HPA072754"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212"	"unprognostic (3.05e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.45e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (8.40e-4)"	9.3	3.2	5.9	4.9	6.7	2.7	5.7	6.1	6.1	5.4	2.0	4.6	2.8	3.7	2.7	2.5	3.2	11.8	3.9	7.4	5.0	3.6	2.7	6.5	2.7	3.8	4.4	3.5	5.7	4.2	3.8	4.1	3.9	3.5	3.3	9.2	3.5	2.6	3.1	4.2	3.2	4.5	3.0	2.7	3.7	4.4	5.6	4.1	3.8	4.2	2.5	6.4	4.0	4.8	24.2	13.1	8.7	5.8	7.3	16.8	5.3	26.3	21.6	31.9	23.1	9.9	7.2	13.7	18.9	19.2	21.7	11.0	12.6	9.1	44.6	8.5	11.4	6.7	12.4	4.9	13.3	7.5	2.1	15.6	11.6	45.3	73.5	13.9	36.2	7.0	16.1	3.8	42.6	6.5	5.9	4.0	8.3	5.0	4.3	8.6	14.4	6.5	10.8	4.0	5.2	11.9	22.0	7.0	53.8	13.2	6.2	6.4	70.7	33.3	24.5	15.7	42.8	7.0	9.3	14.1	15.6	4.0	32.4	1.4	0.3	0.0	0.5	0.1	0.2	0.5	0.3	0.3	0.2	0.7	0.4	0.5	0.6	0.5	0.1	0.5	0.2	0.1	5.9	6.7	6.1	6.1	7.4	5.0	3.8	4.4	3.9	3.0	5.6	4.8	33.5	22.4	24.0	44.1	14.4	46.9	43.6	16.3	12.5	40.0	18.7	9.5	8.9	22.8	10.8	11.0	166.8	9.3	7.7	15.5	11.7	14.3	15.6	12.3	23.4	67.2	27.0	9.9	81.6	13.9	8.2	67.6	10.2	21.5	17.1	19.5	31.1	15.3	22.9	25.2	62.0	11.0	10.2	34.9	188.1	32.2	15.2	67.7	69.4	45.0	13.9	11.3	8.2	72.4	57.1	45.5	16.0	13.5	10.3	42.6	9.9	9.4	11.0	35.7	6.6	32.3	30.5	17.8	30.5	11.5	38.4	10.4	12.4	11.6	14.9	25.3
ABLIM2	KIAA1808	ENSG00000163995	"Actin binding LIM protein family member 2"	Q6H8Q1	4	7965310-8158832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 204.8;tongue: 73.5"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 93.2;Inhibitory neurons: 67.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 13.8;SiHa: 5.9;U-2197: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035808	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Nucleoplasm	"HPA035808: AB_10601962"	"unprognostic (7.57e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.45e-2)"	7.3	4.0	2.7	1.6	11.0	0.1	5.1	0.0	9.9	2.5	0.0	2.3	0.5	1.2	0.7	13.1	1.8	1.3	7.1	2.7	10.4	7.0	0.9	3.3	1.0	1.4	0.0	0.6	3.4	1.3	6.8	0.6	1.1	1.5	1.7	5.0	5.4	0.5	204.8	6.9	1.6	1.9	0.0	20.5	1.4	1.0	1.4	1.7	3.0	73.5	2.2	1.9	4.1	0.0	1.1	0.0	0.2	1.6	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.0	1.5	3.1	0.3	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.1	1.1	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.7	2.1	0.1	0.0	1.2	2.9	0.9	0.2	1.0	0.7	0.2	0.0	13.8	1.0	5.9	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.4	20.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.7	11.0	0.0	9.9	2.7	10.4	1.4	0.0	1.1	0.0	1.4	0.0	4.4	0.0	1.1	9.4	0.5	2.5	0.1	0.1	0.6	6.4	0.4	0.3	4.7	1.5	0.3	3.7	0.0	0.0	0.6	7.9	0.0	3.5	2.2	5.2	0.7	3.5	10.7	0.0	93.2	4.3	0.6	0.9	2.6	0.2	2.5	0.5	0.7	0.4	0.1	11.8	67.6	3.8	0.0	0.6	0.7	5.1	0.0	0.3	0.0	2.8	0.0	3.1	0.0	16.1	17.6	3.5	5.1	3.8	0.1	0.3	14.3	0.6	1.7	3.2	6.6	7.0	3.5	0.2	2.0	2.0	6.3	0.0	0.7	4.0	5.8	0.3
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 197.6;Cardiomyocytes: 61.7;Hepatocytes: 116.0;Oligodendrocyte precursor cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 75.3;HHSteC: 77.6;HSkMC: 89.4;hTERT-HME1: 90.9;hTERT-RPE1: 76.2;TIME: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		30000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	68.4	7.4	19.2	3.8	18.0	0.5	57.6	49.7	19.1	12.5	6.8	11.1	2.7	10.4	6.3	33.2	14.4	7.1	87.8	20.4	26.7	19.8	115.8	20.0	5.3	37.2	25.2	3.9	2.7	59.6	6.8	34.4	28.7	9.1	5.0	28.6	6.5	8.2	45.8	8.3	7.8	10.6	34.0	8.7	5.4	2.0	29.9	2.2	9.2	38.7	4.5	14.1	17.7	30.2	23.6	4.8	0.0	0.2	39.6	75.3	0.1	16.1	44.8	9.1	15.8	0.1	16.2	0.0	2.7	20.5	47.9	0.5	0.1	18.9	17.7	0.1	0.2	0.0	1.4	0.6	77.6	0.0	0.1	89.4	5.1	32.5	90.9	76.2	41.1	0.0	0.0	7.2	54.8	9.2	0.0	0.0	0.2	1.5	63.0	0.0	0.1	0.0	50.3	16.0	6.3	0.1	3.3	1.1	8.7	1.2	1.5	0.1	103.9	18.9	4.2	19.9	27.7	0.1	0.0	0.0	33.5	0.0	55.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	2.7	19.2	18.0	49.7	19.1	20.4	26.7	37.2	25.2	28.7	34.0	29.9	30.2	197.6	0.0	3.7	21.5	1.3	1.5	1.2	2.6	0.6	2.5	7.6	3.9	61.7	18.6	5.3	0.0	0.0	0.2	0.3	0.0	5.9	8.7	3.0	0.5	2.5	39.6	0.0	0.0	31.0	3.5	0.7	9.4	3.6	2.5	1.3	0.0	34.2	116.0	12.3	28.6	33.7	0.0	8.2	13.5	1.1	0.5	0.3	8.5	5.4	21.5	0.9	19.3	0.0	63.8	25.6	22.5	0.0	0.7	0.1	2.5	0.0	23.5	4.9	25.1	0.0	7.4	7.7	1.7	2.7	2.0	1.6	0.4	0.7	0.5	0.0	22.2
ABR	MDB	ENSG00000159842	"ABR activator of RhoGEF and GTPase"	Q12979	17	1003518-1229738	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 171.7;Late spermatids: 164.0;Microglial cells: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 31.3;hTERT-RPE1: 38.6;LHCN-M2: 24.6;RPMI-8226: 21.5;TIME: 41.3;U-251 MG: 42.0;U-698: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053618, HPA054824"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA053618: AB_2682208, HPA054824: AB_2682616"	"unprognostic (1.69e-1)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.20e-3)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.74e-2)"	22.7	21.7	4.5	5.5	3.1	1.3	20.0	1.2	6.0	27.0	0.0	58.9	1.9	28.5	0.1	42.0	22.9	0.6	40.5	5.1	1.7	9.7	3.0	28.5	1.0	4.2	5.0	14.7	8.6	1.2	22.4	1.6	7.3	18.2	7.0	1.2	28.1	0.4	9.0	25.0	40.5	8.1	6.9	21.0	19.5	13.9	6.7	4.8	10.5	0.0	5.7	22.0	24.7	12.3	1.0	1.3	0.3	0.1	1.3	0.2	1.7	0.2	0.3	0.1	0.0	0.6	0.0	31.3	0.7	0.3	1.7	0.1	4.0	0.1	0.9	11.8	14.5	0.0	0.4	0.1	0.8	2.7	9.5	0.4	0.0	0.3	12.7	38.6	0.0	0.0	0.1	0.0	24.6	1.2	0.1	3.4	0.2	0.7	0.2	0.2	0.0	21.5	0.2	0.4	0.3	0.6	0.1	0.0	1.8	0.1	11.5	3.0	41.3	0.3	0.4	3.0	42.0	0.1	0.6	29.5	1.9	5.1	0.8	9.0	0.2	0.6	0.1	0.5	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.5	0.0	4.5	3.1	1.2	6.0	5.1	1.7	4.2	5.0	7.3	6.9	6.7	12.3	20.0	32.1	24.6	171.7	9.6	17.1	18.2	19.0	11.4	75.5	11.3	8.3	23.7	22.8	21.0	1.8	2.1	2.4	13.3	61.0	0.0	17.7	37.0	14.3	6.1	22.1	15.0	2.5	80.5	6.3	3.0	13.7	18.8	9.7	19.6	16.3	18.2	0.6	30.4	11.8	67.6	37.2	16.2	31.9	49.4	164.0	13.7	31.0	19.6	146.1	25.5	25.8	34.0	41.7	5.2	48.3	38.4	9.4	4.2	21.8	36.8	7.9	26.7	20.0	39.5	19.9	25.3	2.7	8.3	22.3	16.9	2.2	15.5	0.6	53.2	25.1
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028745-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 440.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 501.5;NB-4: 530.8;U-937: 515.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		9200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	20.1	9.6	16.8	73.7	16.2	87.7	44.9	13.5	20.8	20.7	14.7	95.0	74.1	22.0	136.0	42.0	12.4	36.0	13.3	18.6	15.7	50.0	60.7	31.2	123.1	14.7	14.6	4.1	16.1	49.1	14.4	29.1	16.2	16.3	86.5	5.4	40.8	12.2	3.0	38.8	74.4	23.5	14.9	73.9	34.4	32.3	16.4	139.6	42.4	7.5	87.9	79.6	17.1	16.0	76.8	40.7	100.7	94.8	39.7	62.2	110.6	59.7	42.9	44.5	91.2	91.2	87.4	0.4	105.8	59.8	189.5	112.9	90.4	130.0	51.9	204.4	167.4	297.8	20.7	31.6	57.6	501.5	130.5	55.9	108.2	59.9	49.1	79.4	237.5	204.9	38.4	100.4	129.5	162.7	314.2	530.8	120.9	119.1	78.5	199.8	62.3	23.8	121.7	225.0	225.4	24.8	40.5	112.3	194.5	141.9	45.1	369.8	175.7	28.2	24.0	58.9	107.7	54.1	169.2	20.9	35.7	515.5	84.2	232.3	178.0	114.2	161.1	334.3	252.2	93.8	259.3	208.2	193.9	96.9	250.9	235.9	48.8	152.1	514.5	215.9	260.2	347.8	16.8	16.2	13.5	20.8	18.6	15.7	14.7	14.6	16.2	14.9	16.4	16.0	54.2	19.2	22.2	2.0	87.1	139.6	71.4	195.2	108.1	0.3	86.6	67.8	3.8	27.1	126.2	44.1	0.0	77.1	151.3	304.5	60.7	145.3	4.8	85.8	20.1	55.0	43.1	75.7	12.8	145.0	207.7	23.5	55.5	129.0	79.4	59.9	53.6	254.3	353.1	0.0	9.1	116.8	162.8	286.1	133.9	13.7	4.7	187.6	87.2	5.6	167.9	49.8	189.5	1.0	1.0	167.4	250.6	12.8	121.0	47.9	247.5	440.3	74.1	1.3	32.9	7.2	37.3	3.6	7.7	116.6	90.1	48.6	198.5	17.7	123.6	133.8
ABTB2	"ABTB2A, BTBD22, DKFZP586C1619"	ENSG00000166016	"Ankyrin repeat and BTB domain containing 2"	Q8N961	11	34150987-34358010	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 126.2;Syncytiotrophoblasts: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"eosinophil: 5.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.6;granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020065, HPA030699"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA020065: AB_1844459, HPA030699: AB_2673576"	"unprognostic (3.00e-1)"	"prognostic unfavorable (5.70e-5)"	"unprognostic (2.61e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.58e-2)"	2.3	13.0	7.9	2.0	12.6	2.5	2.0	18.1	6.7	8.1	1.2	3.4	8.8	6.1	4.4	4.1	4.6	2.1	12.8	5.3	8.5	9.4	11.6	2.9	2.1	24.1	16.3	2.5	2.3	0.5	3.5	3.2	16.7	4.9	2.5	2.6	6.7	4.3	16.9	6.8	7.0	2.5	12.7	0.9	2.5	2.7	15.9	2.4	2.0	7.2	2.0	3.6	5.6	20.3	5.6	16.2	6.4	1.8	1.7	0.1	6.4	3.2	2.5	2.8	5.3	4.0	4.0	0.2	5.3	4.1	16.5	10.5	3.6	3.7	2.3	0.2	8.8	0.1	9.8	17.4	1.0	8.9	1.2	0.9	2.0	5.6	2.4	10.1	0.0	0.7	1.9	0.5	1.8	13.8	0.3	10.7	8.0	8.1	8.8	1.7	3.8	6.3	10.0	13.0	8.1	6.6	8.1	24.6	6.5	4.2	5.3	3.8	0.9	3.1	0.5	9.8	5.8	0.9	0.4	0.1	7.1	2.5	9.7	0.0	0.1	5.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	7.9	12.6	18.1	6.7	5.3	8.5	24.1	16.3	16.7	12.7	15.9	20.3	0.7	0.0	2.3	18.9	1.1	4.7	3.2	1.3	1.2	2.1	3.0	3.3	10.0	2.8	1.1	12.9	0.0	2.7	2.5	12.2	5.9	4.6	1.2	3.4	4.5	0.9	7.2	0.0	4.0	4.5	1.1	5.8	4.6	10.7	1.3	0.3	0.0	6.8	0.8	0.0	8.9	2.3	4.1	0.8	6.1	0.3	1.2	1.2	1.8	6.5	9.3	7.5	0.0	50.3	126.2	10.5	9.1	6.0	2.1	9.3	15.5	2.0	0.3	0.6	0.0	4.3	2.4	0.5	1.1	1.0	4.8	28.3	2.9	0.4	2.9	7.5
AC003006.1		ENSG00000269026	"Novel protein"		19	57682045-57753575	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.2;RT4: 1.0;U-266/84: 2.1"									HPA068553			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"		"Cluster 16: U-266 - Nucleosome"		Nucleoplasm		"HPA068553: AB_2686002"	"unprognostic (2.74e-1)"				"unprognostic (1.47e-1)"					"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.61e-1)"		"unprognostic (4.82e-2)"	"unprognostic (1.46e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.2	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.9	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.3	0.4	0.1	0.3	0.1	0.3	0.2	0.1	0.4	1.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC004593.2		ENSG00000285162	"Chimerin 2"		7	29122340-29514667	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 3.3"	"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	6	"cerebellum: 3.3"	"Group enriched"	"Detected in some"	32	"classical monocyte: 4.1;intermediate monocyte: 3.4;myeloid DC: 4.3;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	42	"dendritic cells: 4.3;monocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.0;HaCaT: 1.1;U-266/84: 1.4"									HPA019026			Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"		"Cluster 16: U-266 - Nucleosome"		Nucleoplasm	"Nuclear bodies"	"HPA019026: "																		0.0	0.1	0.2	0.1	0.2	0.1	0.0	3.3	0.3	0.0	0.4	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.5	0.2	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0		0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.5	0.8	0.2	0.0	0.4	0.0	0.0	0.0		0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.8	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.3	0.8	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.5	0.0	4.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	1.9	0.2	0.2	3.3	0.3	0.1	0.5	0.2	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC005726.1		ENSG00000258472	"Novel protein"		17	28455752-28614185	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 13.2;Club cells: 5.6;granulocytes: 6.3;Proximal tubular cells: 20.4;Respiratory ciliated cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"									HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA					"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: AB_2679710"	"unprognostic (1.26e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (7.25e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.58e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.49e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	9.6	13.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.3	2.4	0.0	0.0	5.6	3.7	0.0	1.7	0.5	0.0	1.9	1.2	0.0	1.7	2.4	1.4	0.0	0.0	0.0	2.0	0.8	1.6	0.0	3.2	6.3	2.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	20.4	5.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.3	1.1	1.2	0.0	0.0
AC005833.1		ENSG00000255639	"Novel protein"		12	4649101-4774184	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"intestine: 23.1;tongue: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA012638, HPA042268, HPA073212"	Supported		Approved	Nucleoplasm,Mitochondria		No	NA			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Mitochondria"		"HPA012638: AB_2294503, HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-2)"			"unprognostic (5.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.10e-1)"			"unprognostic (1.31e-1)"	"unprognostic (6.29e-3)"		"unprognostic (2.94e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.16e-1)"	2.1	1.3	1.1	3.8	1.4	2.0	2.6	1.3	1.6	1.9	0.9	14.6	14.2	1.2	1.0	2.2	1.7	1.3	7.0	1.2	1.3	6.8	6.4	1.4	1.7	1.3	1.3	1.0	0.5	7.0		1.9	1.4	1.8	23.1	0.7	2.5	2.4	2.2	1.0	14.5	3.2	1.3	1.3	2.6	3.4	1.3	2.9	1.6	18.4	3.4	2.8		1.5	4.4	7.0	5.1	3.4	3.4	3.5	11.8	3.7	5.2	10.4	8.6	13.6	7.6	8.8	1.0	5.7	6.5	6.0	9.3	6.4	11.9	8.9	5.0	10.0	7.4	8.9	7.1	9.6	3.0	5.0	6.0	5.6	10.2	4.0	10.6	5.9	7.0	19.9	7.8	5.0	3.6	3.3	16.5	10.2	2.2	6.5	9.6	6.0	8.6	8.2	2.7	2.3	5.3	9.5	4.6	11.7	1.8	3.0	5.1	4.7	9.5	2.5	8.3	1.3	4.6	10.6	3.5	4.5	4.5	3.6	7.4	2.6	5.2	7.4	5.9	6.0	4.9	5.7	9.6	3.9	4.1	4.0	0.3	5.6	6.9	8.7	6.7	14.7	1.1	1.4	1.3	1.6	1.2	1.3	1.3	1.3	1.4	1.3	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC006059.2		ENSG00000280571	"Novel protein"		3	42705756-42804518	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	6	"brain: 2.2;retina: 7.6"	"Cell type enriched"	"Detected in single"	4	"Alveolar cells type 1: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047429			Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA047429: AB_2680043"	"unprognostic (1.72e-1)"	"unprognostic (4.20e-1)"			"unprognostic (8.65e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.02e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.72e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.09e-3)"		"unprognostic (2.99e-2)"	"unprognostic (3.01e-2)"	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.1	0.0		0.0	0.7	0.0	0.0	7.6	0.1	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0		2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.2	0.6	0.4	0.7	0.7	0.6	0.7	0.7	0.5	2.2	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC007325.2		ENSG00000277196	"Proline dehydrogenase 1, mitochondrial"		Unmapped	138082-161852	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"brain: 113.8;choroid plexus: 218.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 5.9;Distal tubular cells: 7.9;Endometrial ciliated cells: 2.5;Proximal enterocytes: 5.6;Squamous epithelial cells: 2.3"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"OE19: 345.1;RPTEC TERT1: 183.1"									HPA020361	Uncertain		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA					"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"																		2.2	0.6	83.9	0.8	83.5	0.7	3.3	75.2	113.8	1.0	218.6	1.1	28.9	0.5	0.1	6.8	1.4	0.4	9.5	90.0	76.6	12.3	6.0	18.8	1.0	87.3	82.6	0.0	0.1	0.1		0.9	72.0	0.9	1.4	1.9	0.7	2.4	10.2	32.6	33.2	0.2	74.5	0.7	0.8	1.9	85.0	5.6	4.5	24.0	6.4	1.9		72.3	0.0	8.3	0.3	2.5	5.0	0.0	1.6	0.0	0.0	0.0	0.0	5.3	1.8	0.0	0.5	0.0	0.2	10.0	18.8	0.5	0.0	0.0	0.7	0.0	0.2	0.9	3.6	0.0	0.1	0.4	18.5	0.0	1.0	0.0	0.0	0.3	0.0	0.1	0.0	1.5	0.2	0.0	17.5	345.1	0.0	0.1	0.1	0.0	183.1	0.7	0.4	0.5	0.0	6.9	1.5	18.8	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.9	83.5	75.2	113.8	90.0	76.6	87.3	82.6	72.0	74.5	85.0	72.3	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	2.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.2	0.1
AC008758.5		ENSG00000268870	"Novel zinc finger protein"		19	12391949-12441082	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 4.4;RT4: 4.9"									"HPA003150, HPA018683"	Uncertain		Uncertain	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 30: Non-specific - Translation"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"		Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"																		0.6	0.1	0.2	0.6	0.3	0.2	0.8	0.5	0.6	0.4	0.3	0.8	0.5	0.6	0.2	0.0	0.3	0.1	0.0	0.1	0.3	0.6	0.6	0.4	0.6	0.3	0.2	0.6	0.2	0.6	0.0	0.8	0.5	0.5	0.8	0.5	0.4	0.4	0.7	0.2	0.3	0.2	0.3	0.6	0.7	0.6	0.3	0.9	0.5	0.0	0.5	0.2	0.1	0.4	1.6	0.0	1.1	1.8	0.1	0.2	2.9	1.2	0.2	0.1	0.5	1.7	0.0	1.4	2.6	0.7	0.6	0.5	0.0	0.4	0.5	0.0	0.9	2.3	0.0	3.2	0.0	2.1	3.1	0.0	0.8	1.1	0.0	0.0	1.0	1.7	1.5	0.0	0.2	0.3	3.3	0.5	1.1	1.9	0.3	0.5	4.4	0.0	0.3	4.9	0.2	0.9	1.1	0.6	0.0	1.6	2.1	2.5	0.3	1.2	0.7	2.5	0.5	0.2	1.5	1.6	0.5	0.9	1.2	0.3	0.5	0.4	0.8	0.1	1.4	1.5	1.6	1.3	0.9	0.9	1.4	0.3	0.2	0.7	0.1	0.2	1.1	0.6	0.2	0.3	0.5	0.6	0.1	0.3	0.3	0.2	0.5	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC008770.2		ENSG00000267179	"Novel protein"		19	11925075-11979290	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"									HPA047845	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"		"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (2.46e-3)"	"unprognostic (9.75e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.13e-2)"	0.1	0.2	0.1	0.3	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.2	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.3	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.4	0.2	0.2	0.2	0.6	0.1	0.2	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.9	0.3	0.4	0.1	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.7	0.2	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	1.1	0.5	0.5	0.1	0.5	0.0	0.4	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.3	0.3	0.2	0.1	0.4	0.2	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
AC011455.2		ENSG00000269547	"Novel protein"		19	38915404-38949855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"A549: 1.0"									"HPA052730, HPA056957"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA					"Cluster 6: T47d - Mammary gland"		"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"										"unprognostic (6.10e-2)"			"unprognostic (3.79e-2)"					0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012184.2		ENSG00000260537	"Novel protein, DDX19B and DDX19A readthrough"		16	70299194-70372582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 34.2;U-698: 35.1"									"HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA046380: AB_2679645, HPA066668: "																		3.3	1.8	0.0	4.3	0.0	4.5	1.3	0.0	0.2	0.5	0.0	3.1	4.0	0.5	0.0	4.0	0.5	2.8	4.6	0.0	0.0	2.3	1.9	1.2	4.0	0.0	0.0	0.2	6.3	1.5	0.0	1.2	0.0	0.9	2.6	0.7	2.1	0.2	6.0	3.8	2.8	1.0	0.0	1.1	3.0	0.0	0.0	1.3	3.1	2.1	5.8	4.3	0.7	0.0	2.2	7.6	5.5	14.4	0.0	6.4	12.7	6.6	7.9	11.8	12.6	14.0	19.2	13.1	8.7	6.4	1.4	7.2	0.0	5.0	6.6	3.9	9.6	8.7	4.5	0.9	7.3	12.2	6.2	4.3	1.1	11.5	0.0	2.3	7.7	3.3	5.3	3.5	4.8	4.8	0.1	0.0	6.7	0.6	1.8	34.2	2.7	22.9	3.6	9.2	7.3	8.1	18.1	3.2	3.2	0.9	5.4	3.0	7.8	8.1	7.6	3.2	4.8	11.0	8.0	35.1	1.0	9.0	13.8	22.4	16.1	11.6	15.5	19.8	12.8	10.4	13.3	15.3	18.2	11.5	11.3	11.3	2.2	15.9	14.8	3.8	22.1	14.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012213.5		ENSG00000285982	"Novel protein"		8	103398658-103501895	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"retina: 6.8"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.8;SCLC-21H: 17.6"									HPA024763			Approved	Nucleoplasm,Mitochondria		NA	NA					"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria	Nucleoplasm	"HPA024763: "																		0.3	2.7	2.1	1.3	2.3	2.7	0.6	4.8	2.6	0.9	0.9	0.7	0.7	1.0	0.8	1.2	0.8	1.3	0.8	1.9	2.9	0.5	0.6	0.6	1.2	2.3	2.1	0.9	0.9	0.6		1.1	2.5	1.6	1.6	6.8	1.1	0.7	0.4	2.0	1.3	1.5	0.8	0.6	1.5	4.9	2.2	0.2	2.9	0.1	1.3	0.9		2.0	0.2	0.8	5.8	0.6	0.0	0.7	0.4	0.2	0.2	0.5	0.9	0.6	0.6	0.0	0.2	1.0	1.1	0.8	0.7	1.7	0.5	0.2	0.2	0.6	1.3	0.2	0.0	0.6	0.4	1.6	1.4	0.2	0.9	3.9	0.3	1.3	0.3	2.2	0.2	0.2	1.2	0.3	2.5	0.6	0.2	0.2	0.8	0.2	0.8	2.9	17.6	2.6	0.0	0.4	0.6	2.4	0.5	0.1	0.4	1.2	0.4	0.1	0.5	0.6	0.6	0.3	0.8	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.3	4.8	2.6	1.9	2.9	2.3	2.1	2.5	0.8	2.2	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012254.6		ENSG00000288607	"Elongin A3 family member B"	Q3SY89	18	47022287-47023927	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	34	"brain: 3.4;choroid plexus: 3.4"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	2.0	0.0	2.7	0.0	0.0	0.9	1.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	3.4	3.2	0.0	0.0	0.0		0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0		2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.7	0.9	1.3	1.1	1.1	3.4	3.2	2.7	1.8	2.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012254.7		ENSG00000288631	"Elongin A3"	Q8NG57	18	47028202-47029842	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"brain: 3.9;choroid plexus: 4.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	2.0	0.0	2.8	0.0	0.0	1.5	1.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	3.9	3.8	0.0	0.0	0.0		0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0		1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.8	1.5	1.8	1.6	1.9	3.9	3.8	2.7	1.1	3.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC013489.1		ENSG00000173867	"Novel transcript"		15	88459501-88546585	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"granulocytes: 1.3;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA048873: AB_2680541"	"unprognostic (3.32e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.47e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	0.4	0.4	0.6	0.2	0.6	0.4	1.1	0.7	0.7	0.4	0.9	0.5	0.3	2.2	1.0	0.3	1.0	0.5	0.8	0.5	0.9	0.7	0.8	0.5	0.4	0.6	0.6	2.2	1.0	0.7		0.5	0.7	0.6	0.6	1.3	0.4	0.7	1.4	0.3	0.4	0.9	0.6	0.7	0.4	0.4	0.7	0.5	0.7	1.2	0.5	0.3		0.8	0.3	0.6	0.5	0.8	1.2	0.6	0.6	1.0	0.7	1.0	0.7	0.6	1.1	0.9	0.7	1.2	0.7	0.6	2.1	0.6	0.9	0.3	1.0	1.0	0.5	0.8	0.4	0.8	0.7	1.0	1.1	0.7	0.8	0.4	0.5	1.2	1.0	0.9	0.1	0.4	1.0	0.5	0.6	0.7	0.2	0.4	0.7	1.2	0.6	0.8	0.6	0.4	0.9	0.4	1.4	1.0	0.7	1.5	0.8	0.7	0.5	0.9	0.9	0.5	0.9	0.6	0.9	0.7	0.5	0.0	0.5	0.3	0.7	0.9	0.8	0.9	0.9	0.8	0.8	0.7	1.0	1.1	0.0	0.9	0.6	0.6	0.8	0.9	0.6	0.6	0.7	0.7	0.5	0.9	0.6	0.6	0.7	0.6	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC020907.6		ENSG00000285526	"Novel protein"		19	35106510-35124297	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 3.3;choroid plexus: 3.1;salivary gland: 7.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 3.9;Club cells: 1.3;Respiratory ciliated cells: 2.9"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"SCLC-21H: 6.2;WM-115: 8.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"spinal cord: 3.8"	HPA010856	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA					"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"																		0.0	0.0	2.4	0.0	3.1	0.0	0.4	2.7	3.2	1.4	3.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	2.4	0.0	0.1	0.0	0.0	2.9	2.7	0.0	1.8	0.0		0.2	2.6	0.3	0.0	0.2	7.3	0.1	0.0	1.6	0.0	0.0	2.3	0.0	0.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0		3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	3.1	2.7	3.2	2.2	2.4	2.9	2.7	2.6	2.3	2.6	3.3	0.0	6.4	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC058822.1		ENSG00000282278	"Novel FIP1L1-PDGFRA fusion protein"		4	53377839-54295272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.7;BJ hTERT+: 10.2;fHDF/TERT166: 17.2;HSkMC: 9.8;U-138 MG: 5.4;U-2197: 7.7"									HPA058202			Supported	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA058202: AB_2683636"																		0.9	0.0	1.0	2.0	1.5	0.0	0.0	0.4	1.7	0.3	1.5	0.4	0.5	0.3	0.0	1.3	0.1	0.4	1.6	0.9	0.7	0.3	0.3	0.8	0.0	1.6	0.7	1.2	0.8	0.0	0.0	1.2	1.3	0.2	0.0	0.8	0.0	0.0	0.3	0.0	1.0	0.9	0.5	0.2	0.8	2.2	0.5	0.1	0.0	2.0	0.1	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.8	4.7	0.0	1.5	10.2	0.0	0.1	0.9	0.0	0.0	0.0	17.2	0.0	0.0	1.5	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.8	0.0	3.8	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.1	5.4	0.1	7.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.5	0.4	1.7	0.9	0.7	1.6	0.7	1.3	0.5	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC073610.1		ENSG00000272822	"Novel protein"		12	48903503-48957365	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.7;hTERT-RPE1: 4.4"									HPA068942			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA068942: AB_2732124"	"unprognostic (7.48e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.01e-12)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.06e-2)"	0.8	0.3	0.9	0.0	1.3	0.1	0.6	0.1	1.9	0.9	0.0	0.9	0.0	0.8	0.5	0.3	0.8	0.6	1.0	1.1	0.6	0.3	0.6	1.1	0.4	0.0	0.0	0.8	0.6	0.0	0.8	0.1	0.1	0.6	0.2	1.4	0.4	0.2	0.4	0.7	0.2	0.9	0.0	0.3	0.4	1.1	1.0	0.2	0.3	0.8	0.2	0.6	0.5	0.1	0.5	0.2	2.1	1.6	2.2	0.9	0.0	0.9	4.7	1.2	0.5	0.0	0.6	0.6	1.3	0.8	1.4	0.1	0.8	0.0	1.2	2.8	0.3	0.6	0.3	0.0	1.5	0.0	0.6	0.2	1.1	0.3	0.7	4.4	0.5	1.1	0.0	0.8	0.7	0.2	0.3	0.5	0.0	1.2	0.6	1.3	0.3	0.1	0.1	0.1	0.9	0.3	0.5	0.4	0.4	0.4	0.1	0.3	2.4	0.4	0.3	0.3	0.3	1.1	0.1	0.4	1.0	0.6	0.2	0.3	0.3	0.1	0.6	0.1	0.7	0.2	0.2	0.5	0.2	0.2	0.6	0.6	0.2	0.3	0.1	0.5	0.2	0.7	0.9	1.3	0.1	1.9	1.1	0.6	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
AC073896.1		ENSG00000144785	"Novel protein"		12	56285916-56316059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"pancreas: 18.8;salivary gland: 19.4"	"Cell type enhanced"	"Detected in single"		"Club cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA038466, HPA068007"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 4: Stomach - Digestion"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Centriolar satellite"		"HPA038466: AB_10672646, HPA068007: "	"unprognostic (3.07e-2)"	"unprognostic (9.89e-3)"	"unprognostic (8.23e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.63e-1)"		"unprognostic (2.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.26e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.93e-1)"	7.0	5.7	1.5	3.5	1.5	5.1	3.9	1.5	5.3	1.7	2.6	8.9	9.8	1.2	0.3	3.0	3.3	5.9	1.4	1.7	1.2	3.0	4.7	1.8	2.2	1.6	1.4	3.7	18.8	3.7	0.3	4.4	1.6	2.5	0.3	0.7	19.4	6.6	1.5	1.0	5.6	0.9	1.3	4.2	7.0	2.0	1.6	3.3	3.3	1.4	0.9	2.6	0.3	2.2	22.0	38.1	5.4	23.4	17.4	12.6	37.7	42.5	42.1	33.2	23.4	43.2	22.7	15.8	61.9	17.7	18.8	49.0	9.9	15.3	3.8	30.6	18.4	0.8	22.8	42.6	37.6	15.5	45.4	24.5	23.3	18.3	1.1	19.8	29.0	43.8	19.2	18.5	5.1	36.9	11.0	24.7	37.5	19.1	97.7	50.3	21.2	29.2	0.3	3.4	30.6	29.1	26.1	25.8	26.9	0.6	20.9	84.8	20.6	30.1	15.6	18.8	37.4	29.4	62.0	17.1	41.4	27.0	41.3	31.5	41.3	19.4	40.8	36.4	41.6	65.1	35.5	43.2	50.3	51.9	40.9	38.7	6.9	41.7	22.1	59.5	39.6	70.1	1.5	1.5	1.5	5.3	1.7	1.2	1.6	1.4	1.6	1.3	1.6	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
AC087721.2		ENSG00000285920	"Novel protein"		15	41284007-41380996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 5.3;Club cells: 5.6;granulocytes: 3.8;Respiratory ciliated cells: 2.9"					"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											"HPA042904, HPA074847"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"																		0.8	1.5	0.3	1.8	0.2	2.9	1.3	2.1	1.0	1.0	0.1	1.8	1.7	0.9	0.3	1.6	0.7	1.1	0.8	0.1	0.3	1.1	1.7	1.0	2.4	0.4	0.6	1.5	0.6	0.9		1.3	0.5	0.7	1.9	1.8	0.6	1.1	3.1	1.0	1.4	1.1	0.2	1.6	1.2	2.9	0.6	2.6	0.7	1.9	2.5	1.5		0.4	3.7	1.2	6.6	5.5	2.5	3.7	3.4	3.8	2.9	4.8	4.7	2.0	4.1	2.8	4.0	2.2	4.4	8.7	10.1	5.3	4.1	7.2	3.6	9.4	3.8	3.6	2.0	14.2	8.2	2.1	3.3	3.3	8.8	1.9	4.7	10.6	8.7	11.0	4.3	1.8	5.5	4.5	6.9	9.2	5.5	7.6	5.0	4.3	4.6	4.0	6.6	6.0	6.6	3.9	2.6	7.0	6.6	8.5	4.3	2.8	5.5	3.2	5.8	5.6	10.7	9.4	2.4	8.7	5.6	0.1	0.4	1.0	0.2	0.4	0.3	0.4	0.5	0.4	0.6	0.3	0.2	0.2	0.1	0.3	0.5	0.9	0.9	0.5	0.3	0.2	2.1	1.0	0.1	0.3	0.4	0.6	0.5	0.2	0.6	0.4	0.0	6.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
AC090373.2		ENSG00000288616	"Elongin A3 family member D"	A6NLF2	18	46962768-46964408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	37	"brain: 3.4;choroid plexus: 4.0"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	1.4	0.0	2.2	0.0	0.0	1.2	1.4	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	3.4	1.9	0.0	0.0	0.0		0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0		1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	1.2	1.4	1.0	0.9	3.4	1.9	2.4	0.8	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC093668.1		ENSG00000270249	"Novel protein"		7	102541501-102592444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.1;hTERT-RPE1: 1.0;Karpas-707: 1.0"									HPA046970			Uncertain	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA046970: AB_2679882"																		0.3	0.4	0.2	0.4	0.4	0.4	0.3	1.1	1.4	0.6	0.3	0.6	1.0	0.5	1.0	0.2	0.5	0.0	0.3	0.6	0.4	0.5	0.0	0.4	0.3	0.4	0.4	0.4	0.5	2.1	1.2	0.2	0.7	0.3	0.3	1.8	0.4	0.1	2.1	0.9	0.6	0.0	0.1	0.7	0.6	0.1	0.4	0.3	0.2	0.4	0.1	0.3	0.4	1.2	0.0	0.0	0.3	0.0	0.0	1.1	0.1	0.2	0.2	0.2	0.0	0.0	0.7	0.7	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	1.0	0.0	0.1	0.9	0.4	0.1	0.8	0.3	0.4	0.0	0.1	0.1	0.3	0.5	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.1	0.1	0.3	0.0	0.0	0.3	0.2	1.4	0.4	1.8	2.0	1.8	1.4	0.8	1.3	2.4	1.4	0.6	0.3	0.4	1.6	2.8	0.6	0.2	0.4	1.1	1.4	0.6	0.4	0.4	0.4	0.7	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC097634.4		ENSG00000285708	"Novel protein"		3	70959226-71754229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"basal ganglia: 102.6"					HPA003876	Uncertain		Approved	Nucleoplasm		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA003876: AB_1078907"																		0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC116366.1		ENSG00000283782	"Novel protein"		5	132410832-132646079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.0;Breast glandular cells: 6.0;Endometrial ciliated cells: 11.7;Endometrial stromal cells: 10.9;Glandular and luminal cells: 22.2"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA052291	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"		"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA052291: AB_2681786"																		4.0	3.4	2.5	3.6	2.4	2.0	4.1	3.3	2.9	4.3	2.7	3.7	4.9	3.1	3.3	2.0	3.8	3.5	3.6	2.5	3.3	4.2	4.7	4.4	4.7	3.1	3.0	6.2	1.1	4.3		2.6	3.1	3.8	4.0	2.2	2.8	4.3	3.8	1.8	4.0	3.0	3.2	4.7	3.9	1.9	2.9	6.2	3.2	5.8	5.0	2.8		3.0	3.7	0.2	0.9	2.2	8.0	7.0	5.3	4.0	3.1	6.0	5.7	0.2	7.9	3.7	2.3	3.9	10.2	2.4	2.5	0.9	3.1	7.3	1.2	4.4	0.9	0.5	12.6	2.3	3.1	4.9	1.3	4.1	4.5	6.7	4.7	4.0	0.5	8.6	6.7	0.1	8.6	3.0	1.6	2.2	1.3	7.9	3.2	11.4	1.4	0.3	1.9	1.4	2.0	1.6	3.2	2.6	0.2	3.7	4.4	2.9	1.9	2.0	2.0	12.5	6.7	3.0	3.6	9.0	1.5	2.7	1.1	4.4	4.7	1.9	2.7	3.0	2.6	3.5	0.6	2.9	2.9	3.4	2.7	3.4	1.9	2.0	3.3	2.2	2.5	2.4	3.3	2.9	2.5	3.3	3.1	3.0	3.1	3.2	2.9	3.0	9.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.7	0.0	11.7	10.9	3.1	0.0	0.0	0.0	0.5	0.0	2.5	0.0	22.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	3.0	1.1	0.0	0.0
AC127029.3		ENSG00000285947	"Novel protein"		17	63917203-63931385	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 14.0;naive B-cell: 18.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 18.4"	"Cell line enhanced"	"Detected in single"		"U-698: 2.2"									"HPA009178, HPA043715"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"		"Cluster 27: U-698-M & Daudi - Adaptive immune response"		"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA009178: AB_1078483, HPA043715: AB_2678632"																		0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	2.2	0.4	14.0	0.7	0.3	0.5	18.4	0.4	0.2	0.0	0.5	3.8	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC138696.1		ENSG00000264668	"Novel protein"		8	143247110-143276403	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.7;MOLT-4: 1.2"									"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"		"Cluster 34: Mesenchymal cell lines - ECM organization"		"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (2.24e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-3)"		"unprognostic (1.87e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.80e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.06e-1)"	0.3	0.3	0.2	0.0	0.3	0.0	0.2	0.1	0.5	0.3	0.0	0.4	0.1	0.6	0.0	0.1	0.7	0.0	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.2	0.4	0.4	0.6	0.1	0.2	0.0	0.3	0.3	0.0	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.2	0.1	0.3	0.2	0.3	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.5	0.0	0.0	0.3	1.7	0.1	0.1	0.5	1.1	0.6	0.2	0.0	0.7	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	1.0	0.4	0.0	0.3	0.2	0.3	0.4	0.0	0.0	0.0	0.0	1.2	0.0	1.1	0.1	0.3	0.6	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.2	1.1	0.0	0.8	0.2	0.5	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.5	0.3	0.3	0.2	0.4	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC138894.1		ENSG00000261832	"Novel protein"		16	28456371-28492098	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 3.3;Distal tubular cells: 1.9;Respiratory ciliated cells: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA053611	Uncertain		Approved	Nucleoplasm		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.93e-3)"	"unprognostic (8.88e-3)"	"unprognostic (4.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.82e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.74e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.3	6.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.6	0.0	0.0	0.9	0.1	0.0	1.9	0.4	0.0	0.6	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.6	1.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0
AC138969.1		ENSG00000183889	"Novel member of the nuclear pore complex interacting protein NPIP gene family"		16	16317444-16350590	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.6;Club cells: 4.3;granulocytes: 8.8;Respiratory ciliated cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 234.1"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.91e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.45e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.04e-6)"	"unprognostic (6.04e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.22e-3)"	97.7	91.8	210.7	20.9	215.1	43.4	93.2	264.9	292.8	115.3	185.9	152.7	18.7	108.3	87.1	88.8	130.4	52.5	101.0	212.4	210.2	76.7	99.9	89.4	35.2	217.5	201.8	171.4	117.5	41.9	232.0	21.5	218.9	122.2	55.9	63.7	69.1	44.0	121.5	116.4	87.3	63.1	186.1	96.8	92.5	116.9	203.7	37.2	105.5	49.6	41.8	116.6	103.2	214.5	30.3	20.9	57.7	54.3	80.8	75.8	40.6	61.1	30.1	31.8	41.7	14.6	18.0	24.5	55.3	67.3	25.5	53.1	36.9	25.4	47.7	9.9	34.8	58.3	167.0	99.7	83.0	37.1	234.1	70.8	158.4	49.6	82.6	61.3	20.7	45.3	21.6	81.4	47.0	50.8	59.2	135.2	26.7	27.9	14.5	69.9	23.8	25.0	50.5	100.5	36.0	36.7	29.8	44.2	107.5	41.6	47.2	108.9	14.1	49.0	29.3	30.3	23.2	36.7	73.4	49.3	28.2	39.2	25.8	0.0	0.2	0.1	0.7	0.0	0.2	1.3	0.6	0.7	0.0	0.3	0.4	0.1	0.0	0.0	0.2	0.2	0.4	0.2	210.7	215.1	264.9	292.8	212.4	210.2	217.5	201.8	218.9	186.1	203.7	214.5	0.4	3.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	4.3	0.0	0.0	0.8	0.4	0.0	0.0	1.0	0.0	0.9	1.3	1.6	0.0	0.0	0.0	1.3	0.6	1.3	0.0	0.7	8.8	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225266	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 850.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		98000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	197.9	405.2	120.1	78.7	131.0	103.5	142.9	128.4	126.7	110.5	170.6	157.3	306.2	98.5	44.4	181.0	94.0	92.6	576.8	117.8	125.0	215.3	517.4	106.7	52.0	127.5	125.3	80.9	236.5	159.6	189.6	112.0	124.8	133.2	131.6	34.9	158.5	113.9	850.4	135.7	270.6	110.6	118.2	132.2	186.4	75.9	132.0	83.4	159.3	817.1	82.9	137.1	115.3	122.7	193.7	162.5	65.8	92.4	271.2	99.2	135.9	156.5	169.0	136.9	84.5	67.2	155.3	90.4	109.0	260.0	49.7	147.9	43.8	135.5	119.6	295.9	47.1	50.6	120.9	101.1	131.2	49.0	129.5	112.5	122.0	114.7	178.5	212.6	124.8	111.3	73.3	110.2	222.7	65.3	49.6	68.4	34.3	178.4	91.9	70.4	78.3	227.2	305.1	155.0	19.1	47.3	206.8	224.8	110.8	60.6	102.8	74.9	151.5	127.5	101.6	75.9	149.9	104.5	59.1	5.2	230.7	85.7	94.9	24.2	96.1	121.3	39.1	57.8	35.7	25.2	32.5	43.8	99.9	24.6	23.7	29.1	20.2	37.8	39.3	80.4	31.8	79.4	120.1	131.0	128.4	126.7	117.8	125.0	127.5	125.3	124.8	118.2	132.0	122.7	109.9	60.9	81.9	143.3	72.3	87.3	336.0	322.4	91.6	42.0	157.7	104.5	451.4	138.7	206.7	202.3	62.6	482.9	87.7	484.2	185.9	310.8	133.0	87.2	52.7	77.4	179.3	65.2	40.9	77.0	197.8	118.6	406.7	88.5	88.4	121.1	53.6	365.4	182.4	33.7	33.4	251.8	233.9	67.9	94.6	249.9	124.5	101.5	81.8	34.7	274.9	40.7	73.2	23.1	24.5	106.1	388.9	132.8	172.3	369.0	489.8	345.8	144.1	41.3	105.2	88.3	147.4	114.3	47.8	113.8	87.5	663.3	75.5	169.2	316.8	367.5
ACAP3	"CENTB5, KIAA1716"	ENSG00000131584	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 3"	Q96P50	1	1292390-1309609	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 148.3;Cone photoreceptor cells: 104.3;Rod photoreceptor cells: 201.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049317, HPA058381"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Golgi apparatus"	"HPA049317: AB_2680710, HPA058381: AB_2683699"	"unprognostic (5.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	14.1	17.1	40.9	2.9	48.0	9.0	10.1	46.1	62.4	23.0	27.9	21.2	6.0	16.3	2.5	32.4	14.2	3.5	26.7	47.7	32.9	17.3	20.6	12.8	3.1	35.1	33.6	16.4	13.3	2.7	40.2	2.9	34.0	17.3	2.1	12.1	14.5	5.0	17.4	33.5	13.7	3.7	35.0	16.3	16.4	6.5	41.7	4.8	10.7	5.7	2.3	19.6	25.3	43.9	9.7	10.5	5.2	8.5	11.8	8.1	5.2	23.7	7.6	6.7	5.0	13.2	8.1	10.5	12.1	13.2	6.7	22.0	4.7	6.3	1.7	11.8	21.1	4.5	43.7	25.2	8.3	9.1	10.8	6.0	5.0	5.7	3.5	6.4	3.2	12.7	12.5	14.2	7.6	12.9	19.1	13.9	5.1	12.8	24.6	18.7	10.9	40.7	4.1	5.1	36.4	25.9	14.1	9.2	22.8	4.4	9.4	7.1	10.7	12.4	8.9	10.3	8.4	11.5	8.6	9.0	17.0	23.6	5.5	0.0	0.2	0.3	0.2	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.1	40.9	48.0	46.1	62.4	47.7	32.9	35.1	33.6	34.0	35.0	41.7	43.9	10.0	0.0	4.7	20.5	11.0	32.1	5.8	7.0	12.5	148.3	15.4	11.9	23.4	14.3	5.6	1.8	104.3	9.0	9.3	22.2	3.9	9.4	3.5	4.3	18.3	8.8	32.3	12.6	48.2	5.1	8.8	16.0	39.3	8.0	0.0	8.2	13.2	17.3	7.2	53.8	31.7	14.4	8.2	17.9	15.5	9.0	15.2	11.2	8.8	15.0	11.9	18.9	12.3	80.9	44.4	12.7	13.7	13.2	11.1	6.1	12.6	7.8	6.9	201.6	6.6	12.9	15.2	3.9	15.2	23.5	34.2	10.1	10.4	12.2	16.8	9.9
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159762045-159779112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 231.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 262.1;Early spermatids: 187.0;Exocrine glandular cells: 176.6;Hepatocytes: 214.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	10.9	21.6	22.2	18.5	24.4	22.4	23.6	30.2	30.0	12.8	20.1	38.5	31.2	10.9	40.0	32.6	11.4	10.6	9.4	22.7	27.6	27.0	231.3	20.2	25.0	39.4	26.3	17.3	9.4	12.5	3.2	11.8	39.1	35.6	33.8	19.5	15.5	9.3	4.9	18.1	17.9	15.8	24.8	9.7	19.5	28.6	24.4	39.4	9.0	7.1	36.7	13.7	9.1	28.1	70.1	58.8	451.9	160.8	57.2	111.6	14.4	57.4	70.5	141.8	244.5	234.0	87.1	55.9	29.0	48.7	458.2	64.5	174.8	465.8	166.7	35.2	174.4	127.4	97.2	418.8	62.0	81.4	35.8	62.2	40.1	231.1	92.9	21.4	68.8	160.1	139.9	104.3	85.5	113.0	137.0	154.0	142.8	65.5	41.7	83.9	94.4	173.1	377.2	93.7	107.8	63.2	67.5	43.3	26.2	18.5	83.4	157.3	39.2	50.3	45.7	72.1	154.0	47.7	89.0	142.0	15.7	151.2	77.1	30.1	24.9	46.7	47.9	33.9	47.3	46.6	54.1	47.8	34.7	51.4	53.3	43.2	11.0	41.3	23.6	30.4	79.0	46.2	22.2	24.4	30.2	30.0	22.7	27.6	39.4	26.3	39.1	24.8	24.4	28.1	11.8	12.8	45.4	15.3	25.8	26.1	32.4	262.1	22.2	19.4	33.4	24.5	1.2	42.9	115.5	20.2	2.1	53.7	28.6	34.7	70.5	78.8	187.0	14.3	9.9	18.8	17.2	38.5	14.3	176.6	97.0	21.6	9.7	25.9	13.3	47.7	16.1	214.8	58.1	13.5	14.7	23.6	83.4	14.8	29.8	128.8	13.7	25.7	30.2	1.0	58.9	22.5	30.9	13.0	17.5	65.6	28.8	19.2	25.5	38.7	15.4	50.0	30.1	24.7	0.0	25.1	44.9	28.5	45.6	43.0	21.0	35.2	31.0	102.5	33.0	38.9
ACBD4	FLJ13322	ENSG00000181513	"Acyl-CoA binding domain containing 4"	Q8NC06	17	45132600-45144181	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.0"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051772	Approved		Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Vesicles"		"HPA051772: AB_2681603"	"unprognostic (1.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (4.76e-4)"	"unprognostic (2.27e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.53e-4)"	11.1	17.2	14.4	6.3	14.1	4.1	12.9	13.9	16.6	19.1	13.1	21.2	29.9	14.4	4.0	7.1	22.3	6.6	11.8	13.4	13.9	24.6	93.0	9.6	9.9	14.2	14.0	19.3	20.0	14.5	15.8	4.3	13.4	21.6	5.7	10.3	14.1	12.2	6.8	9.0	25.9	5.7	14.5	16.2	14.7	4.2	14.2	5.4	21.1	5.1	6.4	15.7	13.6	13.2	7.9	15.4	1.9	4.2	3.5	6.4	5.1	2.9	6.1	4.7	9.2	6.0	10.8	8.4	7.4	4.3	2.8	7.3	2.6	4.8	1.9	12.2	5.9	4.2	11.3	12.0	7.5	1.6	11.1	6.4	4.6	1.7	2.4	16.1	4.6	7.7	2.7	13.1	2.3	5.3	6.0	2.1	0.3	8.3	4.2	4.8	0.5	18.8	11.8	5.1	3.1	1.4	2.1	3.1	8.9	1.0	20.1	3.0	1.7	1.2	3.6	1.8	1.8	20.4	5.9	2.6	6.8	2.1	2.0	4.4	2.3	3.5	2.9	2.6	3.2	3.7	3.4	3.2	2.0	5.0	3.7	4.3	0.5	4.0	1.7	1.3	4.3	3.2	14.4	14.1	13.9	16.6	13.4	13.9	14.2	14.0	13.4	14.5	14.2	13.2	5.7	3.2	3.0	12.4	7.8	1.9	5.9	3.9	2.8	16.6	7.4	6.9	9.7	14.3	2.6	3.7	22.9	6.3	5.9	9.6	7.9	7.3	1.4	2.0	2.7	5.3	6.0	2.1	7.2	7.1	1.3	7.3	4.6	3.6	8.2	7.4	5.0	21.8	5.3	11.8	8.5	7.8	6.1	1.9	2.6	5.0	6.8	3.1	3.6	2.8	4.5	14.7	5.2	4.5	1.9	5.6	12.5	7.5	5.2	3.1	56.8	25.6	2.6	16.8	6.6	8.7	7.7	2.5	5.2	3.1	1.8	6.3	6.4	4.4	9.1	2.8
ACBD6	MGC2404	ENSG00000230124	"Acyl-CoA binding domain containing 6"	Q9BR61	1	180269653-180502954	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028179, HPA028457"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA028179: AB_10601788, HPA028457: "	"unprognostic (3.12e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-1)"	19.5	19.0	11.5	15.0	11.3	25.9	18.4	14.9	13.8	20.5	10.7	21.1	15.2	21.5	15.1	15.1	17.7	17.7	22.3	10.6	12.3	17.7	15.5	15.2	19.0	10.7	10.5	24.7	19.5	25.0	14.4	28.2	10.7	16.4	13.6	7.2	17.3	17.4	24.0	20.7	13.8	18.5	10.3	17.8	15.4	33.0	11.1	20.5	20.0	20.6	18.1	19.5	17.3	13.5	69.4	56.4	47.6	33.2	33.9	57.4	91.1	31.3	69.7	57.6	52.0	80.1	52.8	60.0	62.2	35.3	27.5	47.0	36.2	62.7	38.3	44.5	56.8	48.3	51.9	48.2	82.2	85.5	41.2	51.1	89.5	35.9	59.0	52.4	66.2	49.9	74.5	48.9	48.4	70.7	68.1	84.1	47.8	53.2	20.3	67.3	38.0	119.4	51.4	40.8	68.0	86.0	44.4	74.6	44.9	48.6	75.6	65.4	50.4	40.8	45.3	49.5	71.0	88.1	55.7	137.4	43.4	50.7	47.7	3.1	13.1	4.4	13.6	20.0	15.4	18.1	11.6	11.8	22.0	11.6	13.9	16.3	0.9	27.3	16.3	17.7	11.7	12.2	11.5	11.3	14.9	13.8	10.6	12.3	10.7	10.5	10.7	10.3	11.1	13.5	31.5	32.1	33.0	60.4	32.7	21.3	29.9	38.7	42.7	64.2	23.6	33.3	42.3	21.5	35.4	16.5	39.6	165.0	38.7	3.8	41.1	43.7	106.9	22.2	38.0	31.9	19.4	25.0	124.9	41.6	41.7	35.6	19.9	23.3	20.2	52.2	23.9	13.4	44.6	52.2	118.1	15.7	34.6	17.8	18.6	59.2	51.3	25.0	37.4	60.9	30.0	37.8	26.8	98.0	109.3	36.2	12.9	50.8	48.4	27.2	19.6	51.2	27.4	6.6	59.2	38.4	53.4	143.6	64.6	40.5	22.4	84.4	29.4	63.2	19.2	24.8
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		30000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	41.5	57.7	58.3	35.0	60.2	66.7	36.6	64.3	64.6	46.1	62.7	42.6	28.6	41.5	30.1	50.9	39.3	24.3	44.1	57.5	63.4	51.3	47.5	33.8	45.2	60.9	60.6	48.7	45.1	41.4	48.5	37.2	59.9	45.8	33.2	39.0	39.1	27.8	53.0	39.5	46.0	38.9	55.7	66.4	45.3	47.6	61.6	52.8	47.1	36.5	47.4	41.9	41.3	64.4	77.1	77.6	120.0	97.7	73.3	58.5	120.2	83.8	58.8	98.9	80.0	103.8	87.8	141.8	48.4	69.7	65.0	82.6	167.4	95.6	100.7	100.2	74.3	124.5	82.9	144.8	41.8	136.6	106.4	69.0	58.0	101.5	84.8	81.0	87.9	103.4	117.2	55.1	75.7	96.5	156.1	134.6	135.1	84.6	73.3	139.7	93.0	75.8	82.9	133.3	79.7	58.6	111.2	71.7	69.1	86.7	59.2	109.0	90.7	67.3	67.3	64.7	78.5	57.9	70.2	144.0	59.9	101.8	74.8	5.3	4.0	5.1	4.2	3.5	3.2	3.8	2.9	3.2	3.4	5.4	3.8	3.7	10.8	7.5	3.2	5.5	3.5	2.6	58.3	60.2	64.3	64.6	57.5	63.4	60.9	60.6	59.9	55.7	61.6	64.4	49.8	70.5	123.0	44.4	61.6	37.3	30.2	52.7	64.9	38.1	43.4	40.8	67.9	32.9	67.2	35.0	27.1	58.0	65.0	64.4	17.6	53.4	42.5	70.5	97.6	55.5	58.3	76.2	41.0	49.3	66.8	60.3	85.1	90.1	130.6	79.4	35.0	28.8	47.1	15.2	43.6	50.1	42.7	38.1	40.8	10.9	46.0	52.5	26.6	44.0	53.4	26.1	54.6	45.8	65.6	59.4	49.7	38.4	65.4	43.5	37.7	21.6	82.6	43.3	6.6	52.4	66.9	42.1	39.2	58.5	46.5	69.2	65.2	86.1	55.8	38.4
ACKR2	"CCBP2, CCR10, CCR9, CMKBR9, D6"	ENSG00000144648	"Atypical chemokine receptor 2"	O00590	3	42804752-42887974	"G-protein coupled receptors, Predicted membrane proteins"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 9.4;placenta: 16.0"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 33.0;Extravillous trophoblasts: 106.2;Syncytiotrophoblasts: 73.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.9;NK-cell: 1.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.9;NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 51.2;HEL: 17.1;SK-BR-3: 28.0;U-937: 10.7"	"Group enriched"	"Detected in many"	5	"amygdala: 2.2;basal ganglia: 7.9;cerebral cortex: 4.9;hippocampal formation: 2.4"	"Low region specificity"	"Detected in all"			"HPA013819, HPA073493"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Vesicles, Cytosol"	Nucleoplasm	"HPA013819: AB_1846126, HPA073493: AB_2686610"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.13e-4)"	"unprognostic (5.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.58e-3)"	"unprognostic (6.09e-2)"	6.7	1.0	1.5	1.0	1.0	0.7	2.8	1.5	1.3	1.7	0.9	1.9	0.9	0.9	2.8	1.6	2.3	1.3	1.3	1.0	0.5	1.5	9.4	1.6	1.1	1.4	1.4	0.4	0.9	0.4	0.5	16.0	1.3	0.6	2.1	0.7	2.2	0.4	0.6	2.6	1.1	1.1	0.6	0.7	1.1	0.8	1.1	0.4	2.9	0.9	2.1	1.8	2.3	1.3	0.1	0.0	0.2	0.4	2.4	0.2	51.2	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.1	0.1	0.2	0.4	0.0	0.2	0.1	0.1	0.2	17.1	0.4	3.1	0.1	0.2	1.9	0.5	0.5	0.0	0.1	0.0	0.1	0.5	2.2	0.4	0.3	0.3	0.0	0.2	0.1	0.7	0.2	0.1	0.0	0.1	0.7	7.5	0.3	0.1	1.3	28.0	0.1	2.9	2.8	0.3	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	10.7	0.1	0.4	0.1	3.9	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.1	0.4	1.1	0.3	0.1	0.0	0.1	1.5	1.0	1.5	1.3	1.0	0.5	1.4	1.4	1.3	0.6	1.1	1.3	1.0	0.0	0.0	9.8	0.1	0.1	0.1	0.3	0.0	0.7	1.2	0.3	0.8	1.5	3.3	0.0	2.1	33.0	0.3	3.0	1.9	0.1	3.0	3.7	0.8	3.3	1.8	0.0	2.0	0.0	106.2	2.1	0.0	5.9	2.5	2.5	4.6	7.0	5.3	1.7	1.2	0.6	0.0	0.6	0.4	1.8	0.3	0.4	0.0	5.6	0.1	2.6	0.0	1.0	4.5	0.8	0.5	1.2	0.1	0.4	1.6	0.5	3.4	1.0	0.0	0.4	0.3	4.8	5.4	0.0	0.0	73.6	0.5	0.5	1.1	0.6
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866917-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	64.9	30.2	24.0	43.9	27.2	34.7	46.7	33.6	55.5	33.2	22.5	35.4	49.3	34.4	34.7	30.5	36.0	31.1	27.1	24.7	66.5	47.5	27.5	35.3	42.7	80.3	48.6	21.3	46.3	37.4	22.4	42.4	76.5	62.6	35.7	23.2	39.1	28.5	15.3	28.9	43.7	42.5	34.2	39.1	38.9	32.2	43.1	48.4	30.8	14.9	40.3	36.7	29.2	43.7	127.1	423.2	194.8	168.8	296.1	274.4	178.3	174.0	188.0	213.7	266.3	217.9	141.8	204.7	108.8	245.2	200.6	197.2	253.9	298.0	177.8	184.9	243.0	117.3	228.3	227.5	136.9	191.9	147.1	219.8	88.3	376.9	75.6	140.0	228.7	155.0	147.4	158.5	180.4	130.0	317.8	107.6	127.6	84.8	75.7	205.2	236.2	262.2	221.0	222.4	364.7	200.2	124.5	382.8	133.7	167.6	229.4	181.0	248.4	165.7	135.5	169.0	291.0	91.9	127.0	193.0	280.3	145.7	137.5	32.2	29.2	36.5	30.9	30.9	29.1	21.6	24.4	27.7	33.0	18.3	18.1	20.3	14.6	24.0	39.8	19.1	34.3	33.8	24.0	27.2	33.6	55.5	24.7	66.5	80.3	48.6	76.5	34.2	43.1	43.7	28.2	28.9	26.2	12.4	20.5	25.0	10.0	25.4	12.5	12.1	38.6	21.6	12.6	31.5	21.0	23.9	4.2	22.6	25.9	26.7	11.7	33.8	73.3	31.6	35.3	33.4	65.9	34.3	10.9	33.6	46.5	28.9	23.4	29.2	15.2	28.7	41.4	53.0	31.0	18.5	14.7	54.0	20.3	39.0	25.9	17.5	61.8	27.6	32.0	16.9	42.9	7.6	25.7	11.6	13.6	42.9	16.2	51.1	17.4	35.9	40.4	87.0	31.1	9.4	13.1	17.6	25.7	17.9	36.0	21.6	33.0	22.2	25.1	49.0	22.2	15.5
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81329996-81394179	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 100.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 36.2"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA037723			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Nucleoplasm, Cytokinetic bridge"	"HPA037723: AB_10672606"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	2.7	100.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.5	0.3	0.5	0.3	0.3	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	8.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	36.2	0.5	0.0	1.2	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	3.4	4.2	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6393767	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 128.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 137.2;Late spermatids: 160.8;Proximal enterocytes: 179.4;Proximal tubular cells: 253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"NK-cell: 40.2;plasmacytoid DC: 35.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 35.7;NK-cells: 40.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		26000	"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	11.3	20.4	72.8	18.7	72.8	14.7	9.9	56.2	108.2	17.8	16.7	32.7	55.1	18.2	5.5	35.0	11.0	8.2	17.3	75.1	107.2	47.8	22.0	17.9	22.4	96.1	88.5	11.2	9.0	3.8	65.1	10.4	128.7	12.9	21.4	24.5	11.9	6.9	5.2	27.1	56.1	23.5	46.9	20.7	19.2	38.1	83.9	28.3	6.1	4.7	19.4	18.0	23.5	68.4	117.6	100.0	96.6	104.6	21.7	35.6	36.4	98.6	50.6	142.7	85.1	347.7	37.0	142.4	70.6	80.4	110.3	113.0	156.9	263.2	53.2	126.0	136.7	75.2	74.4	124.9	88.7	88.8	59.9	32.1	49.6	118.2	139.2	38.1	81.2	174.8	62.3	29.8	76.8	136.6	187.0	94.0	48.5	116.9	228.2	219.9	110.6	95.6	80.9	44.2	52.6	149.1	88.9	134.5	317.9	47.3	47.9	41.2	133.0	129.1	75.4	129.6	158.9	24.9	110.6	202.1	81.8	153.7	80.3	0.0	0.3	0.2	7.3	1.2	1.8	2.1	5.8	6.2	5.4	0.7	2.0	3.9	0.7	40.2	0.9	35.7	8.2	5.3	72.8	72.8	56.2	108.2	75.1	107.2	96.1	88.5	128.7	46.9	83.9	68.4	3.4	6.4	16.4	9.4	4.9	31.7	16.5	24.2	12.5	46.8	4.1	7.5	9.8	8.6	14.9	9.2	10.4	20.9	14.4	45.4	15.6	22.7	95.5	4.0	6.1	19.1	4.8	26.5	38.6	7.2	29.7	11.5	19.9	7.6	137.2	13.2	8.6	16.8	30.1	47.1	38.9	110.2	36.7	4.8	85.9	160.8	3.7	13.4	39.2	5.6	15.7	12.8	8.2	22.6	21.0	23.2	41.8	7.2	9.3	9.5	179.4	253.7	7.1	24.4	0.0	6.7	17.6	37.8	28.0	26.2	29.5	17.2	21.7	13.7	51.3	19.6
ACOT9	"ACATE2, CGI-16, MT-ACT48"	ENSG00000123130	"Acyl-CoA thioesterase 9"	Q9Y305	X	23701055-23766475	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035533	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		7600	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035533: AB_10696506"	"unprognostic (5.69e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	24.1	18.8	8.0	19.5	7.5	15.8	19.8	7.5	9.5	17.7	10.3	22.0	15.5	22.5	8.4	12.1	17.3	13.6	49.3	7.2	9.1	15.5	14.5	26.1	12.7	8.0	7.5	15.1	14.0	11.7	8.8	17.8	8.6	16.1	16.4	9.6	18.6	22.1	27.6	12.5	15.8	32.3	6.9	18.4	17.7	6.2	8.5	6.3	17.4	14.2	12.5	21.3	14.7	7.5	81.5	54.0	23.1	51.4	37.2	42.0	11.7	62.7	54.3	60.7	58.4	48.5	71.4	4.1	39.1	70.5	81.8	48.3	29.6	79.9	84.2	18.8	44.6	27.4	55.0	35.6	49.9	10.8	33.3	37.5	53.6	71.5	80.5	39.6	90.3	0.6	17.7	26.7	66.7	28.4	15.2	26.1	33.9	31.8	65.3	15.7	87.6	34.4	72.8	29.8	4.5	22.1	68.4	28.3	41.6	85.5	31.9	14.0	84.7	50.7	33.8	73.3	34.7	6.4	16.1	0.5	37.4	10.5	43.6	24.7	30.2	22.2	10.2	43.5	14.1	11.1	12.6	11.3	32.4	9.9	4.0	9.4	15.8	12.3	56.2	5.4	20.8	18.6	8.0	7.5	7.5	9.5	7.2	9.1	8.0	7.5	8.6	6.9	8.5	7.5	34.6	48.1	27.3	12.1	23.0	20.1	45.9	51.8	7.4	5.3	5.6	6.7	44.3	18.6	36.8	16.5	25.0	4.0	21.5	9.7	5.9	59.6	0.8	20.8	22.9	38.7	2.4	11.2	6.1	52.5	11.4	33.4	16.8	21.6	37.3	14.8	32.9	11.8	42.4	5.0	8.6	10.3	16.2	37.1	95.4	0.4	18.0	57.3	33.8	13.1	192.3	11.9	19.6	4.5	3.1	83.4	15.0	25.6	27.7	52.4	14.6	30.3	38.0	9.9	26.3	35.2	65.1	1.6	10.4	3.5	10.7	3.0	21.2	30.4	11.2	38.2
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 1061.1;Late spermatids: 2128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	41.2	104.0	43.1	45.5	47.6	91.9	64.7	43.9	54.0	43.4	63.9	61.4	64.0	46.6	69.3	43.3	57.9	45.4	57.3	49.4	47.1	78.1	106.4	46.8	66.2	43.4	44.2	59.2	94.1	73.9	59.2	61.7	44.3	52.1	64.7	72.7	71.1	44.2	76.6	41.3	60.7	41.5	44.9	44.7	67.1	46.1	45.3	66.2	63.7	74.9	61.9	47.5	36.4	50.2	78.3	112.5	177.4	97.4	76.1	77.1	142.2	92.6	97.7	91.9	80.8	151.7	78.5	48.8	70.7	85.1	114.6	76.5	169.4	97.0	82.3	118.7	157.9	142.3	99.0	348.5	105.7	162.5	80.4	78.7	90.5	81.9	102.3	95.5	105.8	176.9	145.1	95.1	110.9	103.1	178.5	161.3	214.1	204.7	111.7	118.2	176.1	114.5	144.2	110.5	191.6	191.3	56.0	137.6	196.3	115.0	82.1	89.8	88.9	101.3	65.2	84.0	142.6	123.8	261.2	150.4	120.0	138.9	123.7	65.4	61.6	57.2	88.8	75.2	118.1	106.6	100.4	103.2	57.3	97.2	118.1	115.2	10.9	121.5	80.2	65.3	117.6	115.0	43.1	47.6	43.9	54.0	49.4	47.1	43.4	44.2	44.3	44.9	45.3	50.2	62.5	44.8	96.7	9.1	102.6	79.2	105.3	173.4	51.8	53.1	118.8	130.0	84.9	131.5	119.6	68.0	8.4	207.1	101.3	81.9	270.1	226.7	1061.1	113.1	56.2	70.6	82.5	291.5	20.4	169.0	279.7	74.2	54.6	85.5	70.3	95.9	56.0	115.8	141.1	28.6	21.0	125.1	126.1	72.0	66.3	2128.2	94.4	74.6	81.8	16.9	117.8	92.2	152.4	19.6	26.0	174.4	109.2	92.2	106.4	187.0	174.2	306.6	128.1	56.9	92.1	42.5	87.0	122.6	137.4	87.4	91.2	187.7	86.0	124.4	143.9	148.3
ACRBP	"CT23, OY-TES-1, SP32"	ENSG00000111644	"Acrosin binding protein"	Q8NEB7	12	6638075-6647433	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"testis: 283.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1097.8;Late spermatids: 723.5;Macrophages: 220.0;Spermatocytes: 387.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.5;intermediate monocyte: 15.8;myeloid DC: 17.7;non-classical monocyte: 31.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 17.7;monocytes: 31.0"	"Cell line enhanced"	"Detected in some"		"HEL: 5.3;HMC-1: 6.7;U-266/70: 15.0;U-266/84: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039081, HPA039082"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted in male reproductive system"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA039081: AB_10670920, HPA039082: AB_10671036"	"unprognostic (7.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-4)"	2.2	0.9	0.9	3.8	1.3	10.7	1.1	1.9	1.4	1.9	1.1	2.9	8.4	1.4	14.2	0.9	2.1	4.1	0.6	0.9	1.0	1.8	2.2	2.8	5.5	1.3	1.2	0.7	2.9	0.3	0.9	2.3	1.3	2.0	2.1	1.8	1.3	1.1	0.4	1.7	8.1	2.1	1.1	9.2	1.9	283.5	1.2	3.0	13.8	0.4	3.6	2.4	0.9	1.5	0.2	0.1	0.8	2.5	0.8	1.2	1.3	0.0	0.0	0.1	0.1	0.0	1.8	0.3	0.8	0.2	0.1	0.0	0.4	0.0	0.2	0.8	0.0	5.3	0.6	0.0	1.8	0.1	6.7	0.1	3.3	0.9	0.1	0.6	0.6	1.7	3.5	0.0	0.1	0.3	0.2	1.9	1.5	4.3	0.0	0.3	0.1	0.3	0.5	0.1	1.0	0.3	0.0	0.7	1.1	1.2	0.0	1.9	0.7	0.1	0.8	0.5	0.0	15.0	10.5	0.5	0.5	2.0	0.0	1.5	12.5	1.2	0.2	15.8	0.0	1.3	0.0	0.0	17.7	1.9	0.2	0.1	2.6	0.7	31.0	4.5	0.0	10.6	0.9	1.3	1.9	1.4	0.9	1.0	1.3	1.2	1.3	1.1	1.2	1.5	0.3	0.0	1.3	0.7	1.5	0.1	0.1	0.0	1.2	1.7	0.5	0.5	1.0	0.0	0.1	0.0	0.0	0.1	1.9	0.9	0.0	0.2	1097.8	0.7	0.5	1.5	0.0	5.7	0.2	0.5	0.3	0.5	0.0	0.8	6.3	0.4	1.8	0.3	9.8	0.0	0.3	0.8	0.0	20.5	3.4	723.5	8.1	220.0	0.0	1.0	7.6	1.1	10.3	0.0	0.4	0.1	1.6	4.5	0.5	0.0	7.6	1.1	0.2	1.3	6.6	0.3	0.2	387.5	7.5	0.3	0.0	0.1	1.0	0.4	1.1	0.1
ACSF2	"ACSMW, FLJ20920"	ENSG00000167107	"Acyl-CoA synthetase family member 2"	Q96CM8	17	50426158-50474845	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 142.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 85.8;Proximal enterocytes: 78.2;Proximal tubular cells: 128.4;Syncytiotrophoblasts: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 97.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024693	Enhanced		Uncertain	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Microtubules, Cytosol"		"HPA024693: AB_2671654"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.49e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.45e-2)"	"prognostic favorable (2.41e-4)"	24.8	71.9	7.6	5.7	8.5	3.3	21.0	7.7	10.1	18.9	8.6	26.9	22.1	6.7	15.8	7.7	9.7	10.8	25.9	7.1	7.0	142.1	36.4	17.8	8.5	8.5	7.3	19.3	6.8	9.9	2.9	15.4	8.0	15.0	17.5	1.1	15.8	16.0	41.3	22.5	20.2	5.4	8.2	8.4	18.8	4.9	7.9	5.6	42.5	25.8	8.2	17.8	13.4	7.7	24.8	8.1	6.6	15.8	68.1	12.1	38.1	5.9	8.6	12.6	24.5	32.1	47.2	15.7	12.6	7.3	11.5	14.7	4.7	29.2	15.3	19.5	11.2	27.3	3.9	58.5	11.4	3.3	24.3	54.9	44.4	15.8	2.1	45.4	17.4	20.3	3.2	8.8	13.7	31.3	8.8	11.1	1.1	47.5	11.9	20.6	4.8	41.2	4.2	97.2	21.6	11.3	11.8	17.3	12.3	13.7	15.5	22.8	12.7	22.5	6.8	3.5	1.9	15.4	3.1	8.2	9.3	17.1	1.4	0.0	2.9	15.3	2.0	7.7	1.7	8.6	1.5	2.1	16.1	2.0	0.7	0.9	0.5	1.6	7.0	6.3	5.5	2.7	7.6	8.5	7.7	10.1	7.1	7.0	8.5	7.3	8.0	8.2	7.9	7.7	3.2	28.9	24.3	27.1	7.3	6.0	23.3	17.0	25.0	0.0	20.8	16.0	25.9	11.5	19.9	3.7	0.0	85.8	1.7	59.5	11.7	13.5	0.4	4.9	3.5	4.9	10.2	1.3	0.3	4.3	11.7	6.5	21.9	7.7	22.2	24.5	4.2	44.4	21.9	0.0	0.3	20.6	2.0	9.8	11.0	1.6	26.8	11.0	3.6	17.8	12.7	6.1	5.2	3.5	0.5	5.7	53.1	14.3	2.6	3.5	78.2	128.4	14.6	0.2	0.0	2.7	5.9	0.2	2.2	5.4	7.0	81.0	4.1	12.1	25.8	14.0
ACSF3		ENSG00000176715	"Acyl-CoA synthetase family member 3"	Q4G176	16	89088375-89164121	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 242.9;U-698: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008322			Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA008322: AB_1845294"	"unprognostic (1.94e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.76e-5)"	"unprognostic (3.36e-2)"	"prognostic favorable (5.97e-6)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.00e-3)"	8.9	20.5	8.0	15.9	8.2	11.6	9.4	9.9	11.4	9.2	9.6	17.1	30.7	9.6	9.7	10.5	9.5	9.7	9.8	8.0	7.1	11.6	19.2	7.9	21.7	9.1	8.2	8.9	15.6	18.5	7.7	6.1	9.3	8.6	11.4	5.9	13.2	6.5	13.1	10.5	26.4	7.8	7.1	13.3	12.6	7.8	10.6	37.6	9.8	16.5	13.9	10.2	8.7	12.0	12.8	17.8	8.4	14.4	14.5	13.3	19.6	16.5	6.1	16.2	10.4	16.2	20.9	33.2	21.5	14.2	10.5	20.9	8.6	19.4	10.0	12.3	20.6	25.8	16.6	23.8	35.2	8.1	13.3	19.4	22.0	12.4	18.1	18.5	11.7	242.9	36.4	10.1	9.0	32.7	45.6	25.7	9.8	24.8	30.0	53.2	7.2	14.1	15.9	17.2	20.6	15.3	26.6	6.8	26.2	13.5	23.1	28.6	11.6	17.3	12.8	10.2	12.5	11.7	17.3	113.0	15.4	29.8	14.5	7.0	23.0	17.2	22.7	22.8	25.2	29.8	18.5	16.5	21.7	20.6	19.5	17.4	9.0	10.8	21.3	24.6	19.6	17.9	8.0	8.2	9.9	11.4	8.0	7.1	9.1	8.2	9.3	7.1	10.6	12.0	9.2	0.0	11.4	9.4	22.5	3.2	7.6	11.9	4.0	20.2	8.5	7.5	9.1	11.5	15.5	5.5	31.3	11.9	17.5	29.9	15.6	16.1	13.8	10.3	9.3	10.3	16.8	14.3	10.1	10.7	3.8	9.3	17.3	8.1	2.5	44.7	7.9	12.5	18.6	21.9	9.5	19.4	28.5	19.5	14.2	20.4	12.2	14.0	7.2	14.0	18.6	9.3	13.4	9.0	11.2	16.3	20.8	10.1	21.2	8.9	54.7	13.5	10.0	19.0	39.5	11.1	9.7	8.8	8.5	8.2	4.5	7.3	17.0	20.1	31.1	7.4
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 217.8;intestine: 418.0;liver: 165.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.9;Endometrial ciliated cells: 159.9;Glandular and luminal cells: 292.3;Proximal enterocytes: 462.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 87.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 138.8;RT4: 143.3;U-937: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	23.8	4.2	13.1	29.0	12.6	16.2	21.3	13.0	15.5	51.4	10.4	111.7	358.9	30.3	217.8	7.9	45.0	21.5	9.4	12.1	13.4	9.0	165.5	35.6	28.0	14.4	13.1	17.0	5.5	2.2	2.6	8.6	14.9	12.3	116.6	1.5	5.5	20.3	3.9	3.4	418.0	15.5	14.0	25.7	44.2	9.6	15.3	16.4	7.2	8.8	28.0	76.3	7.6	13.2	38.6	0.9	0.7	0.1	2.5	0.4	3.3	1.1	7.3	0.3	0.6	34.8	138.8	46.7	8.4	1.9	6.8	0.3	0.0	0.2	0.8	39.4	0.0	36.5	1.3	60.9	8.8	57.3	59.2	5.9	0.0	0.8	0.0	2.7	2.8	0.0	0.1	20.6	0.1	0.0	0.1	26.3	0.1	32.2	1.3	12.9	0.2	28.6	3.8	143.3	0.1	0.9	55.8	21.0	0.1	0.1	0.1	31.7	40.5	0.5	0.4	2.2	2.5	14.8	0.1	22.6	1.2	70.5	0.1	27.4	15.1	27.5	25.2	27.9	24.9	16.3	20.4	27.8	31.1	13.1	13.8	21.4	3.9	26.1	27.7	9.8	41.5	21.1	13.1	12.6	13.0	15.5	12.1	13.4	14.4	13.1	14.9	14.0	15.3	13.2	23.4	12.8	51.3	0.0	20.1	3.8	10.3	10.7	8.6	0.1	7.0	4.6	1.7	12.8	23.6	0.0	4.2	1.8	10.5	164.9	0.0	13.3	92.6	159.9	37.6	24.7	40.8	10.7	1.3	6.4	2.6	5.7	41.8	292.3	17.2	0.5	16.1	88.6	18.9	0.0	1.1	79.0	0.0	22.4	57.8	42.6	15.8	24.9	3.6	17.8	11.5	0.1	16.5	1.0	1.0	48.0	122.4	12.0	20.3	7.1	462.5	0.2	8.2	1.2	0.0	0.8	3.3	4.0	1.9	3.3	1.7	0.7	24.0	6.4	103.3	50.0
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562886-179588407	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 243.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	19.7	20.4	8.3	23.5	9.8	17.8	33.0	10.1	12.4	24.6	11.0	31.1	24.7	27.6	25.9	25.3	25.0	15.6	18.6	7.9	9.5	22.3	21.8	19.0	32.0	10.4	9.8	31.9	20.6	24.3	13.1	23.5	10.8	21.3	37.8	16.3	21.3	21.4	12.3	26.8	23.8	26.3	9.4	19.9	22.3	62.5	8.9	46.0	20.5	13.9	41.4	24.8	20.7	11.9	196.4	59.5	142.2	75.7	53.4	58.0	111.7	78.1	60.2	142.3	119.8	126.6	94.8	154.0	136.8	73.5	164.7	88.7	126.3	95.7	174.6	156.7	105.0	125.5	58.2	101.9	61.0	157.4	75.2	40.7	96.1	91.5	76.6	44.5	82.5	90.7	100.1	85.1	103.6	135.6	140.1	96.8	127.6	178.0	129.5	128.7	118.0	284.4	113.4	76.2	116.9	83.2	119.1	118.5	125.2	71.2	231.5	128.8	62.5	101.0	87.1	104.1	237.8	54.6	86.5	231.3	55.6	165.0	113.5	5.7	19.3	14.7	24.5	25.5	32.4	29.2	27.8	28.5	34.1	24.1	30.2	31.3	2.6	26.7	30.1	19.3	39.1	24.3	8.3	9.8	10.1	12.4	7.9	9.5	10.4	9.8	10.8	9.4	8.9	11.9	31.1	22.4	23.1	6.2	27.1	47.2	48.0	60.4	29.0	6.1	24.5	23.9	6.7	30.0	38.1	27.6	8.4	51.2	21.6	13.4	35.2	51.1	53.5	27.1	28.8	26.7	30.5	62.3	2.8	44.7	67.5	28.1	23.4	20.8	14.5	31.0	13.6	16.8	34.9	0.0	3.8	26.7	48.8	17.1	18.7	17.7	32.3	15.4	30.2	3.7	27.1	16.7	18.6	6.6	19.0	38.8	18.8	30.1	25.8	45.4	18.2	25.8	35.6	14.9	26.3	25.0	49.0	243.2	92.1	42.7	45.9	30.6	21.6	35.1	40.4	38.5
ACTR8	"ARP8, INO80N"	ENSG00000113812	"Actin related protein 8"	Q9H981	3	53867066-53882152	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.3;Late spermatids: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 56.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA065236: AB_2685442"	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favorable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	8.4	6.8	7.8	9.8	8.6	9.4	9.3	10.5	9.0	9.2	13.0	9.3	7.4	9.8	9.0	9.2	9.0	8.1	18.5	8.3	9.3	13.0	8.7	9.2	13.9	8.6	9.6	10.3	9.4	14.7	7.2	11.0	8.5	9.0	12.0	7.6	8.8	8.6	9.0	9.2	7.2	11.0	8.8	9.4	9.6	21.5	9.3	13.4	12.1	12.6	14.8	11.5	7.3	9.6	11.9	14.4	27.5	22.9	22.2	27.6	20.6	27.4	34.8	36.3	28.7	22.6	14.1	36.1	7.9	37.9	26.7	9.9	21.0	18.8	34.1	14.7	8.7	35.2	21.9	24.3	26.1	38.6	30.8	21.8	19.1	37.6	23.4	28.0	28.4	18.9	16.4	12.2	37.0	13.8	12.9	23.0	25.7	17.0	22.7	16.8	17.3	21.8	27.5	32.7	8.1	23.5	17.8	15.4	16.1	25.9	9.9	21.1	19.7	27.5	17.8	25.6	25.2	33.9	46.4	36.3	20.4	27.7	17.6	56.2	8.2	10.5	9.2	12.0	9.2	9.8	8.5	8.8	10.7	6.1	8.9	9.6	4.3	15.1	7.4	7.8	15.0	8.0	7.8	8.6	10.5	9.0	8.3	9.3	8.6	9.6	8.5	8.8	9.3	9.6	6.3	3.2	7.7	6.5	9.4	7.8	6.0	12.3	5.7	6.8	5.4	5.1	19.5	10.0	8.6	3.7	4.2	12.7	11.6	5.7	21.5	15.1	44.3	5.9	12.0	8.8	10.8	7.8	7.1	15.6	11.3	7.8	12.2	7.6	5.7	10.9	8.2	5.4	11.5	1.7	8.5	10.6	12.2	7.6	6.9	85.9	10.8	10.0	5.4	4.7	11.9	7.6	13.4	8.0	6.2	15.5	3.5	9.8	13.6	6.3	5.9	24.1	5.0	5.3	0.0	5.5	20.8	27.6	20.3	7.3	6.5	10.3	11.5	13.5	6.3	6.5
ACTRT3	ARPM1	ENSG00000184378	"Actin related protein T3"	Q9BYD9	3	169766921-169769561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 47.5"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 1021.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.1;HSkMC: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA035817, HPA035818"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA035817: AB_10671938, HPA035818: AB_2674801"	"unprognostic (2.35e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.22e-1)"	1.6	0.9	1.7	0.7	2.1	0.4	1.1	2.6	4.5	1.4	2.0	0.9	1.1	1.1	0.8	1.0	2.0	0.9	1.2	2.2	2.0	2.4	2.7	1.1	0.8	2.1	3.5	1.6	0.6	1.2	1.3	1.0	2.2	1.2	0.8	0.8	0.6	1.9	0.7	0.4	0.8	1.6	1.8	0.4	1.2	47.5	2.5	0.8	1.5	0.7	0.9	1.7	0.7	2.6	4.0	2.5	0.2	1.1	18.1	5.5	0.0	4.7	3.0	3.1	2.6	0.0	5.2	0.0	6.5	5.9	2.0	2.5	1.5	2.5	3.3	2.9	1.7	9.3	1.9	0.5	3.0	1.1	0.9	11.8	0.6	3.8	0.7	2.0	5.8	0.9	0.0	0.0	5.7	2.0	0.2	0.1	4.5	3.5	5.3	0.6	0.0	0.1	3.3	1.0	3.1	2.1	5.9	1.4	0.1	0.6	2.5	4.1	2.4	0.0	0.0	2.5	0.0	0.4	0.2	0.2	1.1	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.9	0.3	0.0	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.7	2.1	2.6	4.5	2.2	2.0	2.1	3.5	2.2	1.8	2.5	2.6	0.9	0.0	1.5	0.3	0.1	0.4	1.3	1.6	1.2	1.6	0.4	0.4	0.7	0.0	2.0	0.0	2.1	1.7	0.1	0.2	1.9	2.3	1021.8	1.1	0.6	1.8	0.0	0.4	0.2	2.1	1.3	1.7	0.5	0.9	1.3	1.3	2.2	2.1	1.5	3.3	0.2	1.3	0.0	0.8	0.7	161.0	9.6	2.2	1.8	0.0	0.0	1.5	0.0	0.0	0.0	2.1	0.1	5.7	0.2	0.7	0.5	2.8	2.1	1.3	13.1	1.1	1.4	24.6	4.6	1.2	0.0	0.8	1.3	3.8	1.2	0.4
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053237-75069483	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034944	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		89000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favorable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	13.7	38.4	46.2	15.2	48.6	21.1	22.1	49.9	65.5	17.3	50.8	21.5	15.6	14.4	36.7	20.8	29.6	10.2	17.0	45.0	54.0	29.1	9.6	19.7	27.7	50.7	49.7	13.6	12.4	21.1	36.5	15.3	51.8	17.3	26.9	44.0	15.8	15.0	34.0	35.0	21.1	15.6	46.6	16.5	19.3	26.9	50.4	39.7	30.1	21.1	28.1	16.1	17.6	56.0	78.9	43.1	60.9	37.4	24.5	26.6	32.6	44.7	17.2	45.5	63.5	42.8	86.9	86.5	26.4	18.2	25.7	68.1	39.9	19.1	73.8	127.8	49.3	57.6	123.6	32.1	14.3	36.6	56.8	14.9	27.7	61.5	30.0	28.8	60.0	80.9	45.2	103.0	60.0	52.3	82.7	67.7	18.6	67.6	40.8	64.7	80.8	41.2	62.2	39.0	112.0	44.5	29.5	20.8	74.2	29.1	44.5	35.4	27.3	29.5	55.6	61.3	48.4	23.8	52.4	94.6	46.1	42.5	32.8	5.3	2.8	17.5	10.9	6.2	12.7	13.7	18.3	12.9	5.1	14.1	15.4	14.5	1.2	14.0	10.5	10.3	24.6	6.7	46.2	48.6	49.9	65.5	45.0	54.0	50.7	49.7	51.8	46.6	50.4	56.0	18.5	6.4	9.1	17.0	18.2	28.7	44.4	54.1	30.1	38.6	20.8	24.0	21.2	31.5	28.9	66.2	12.5	27.3	18.7	24.5	39.2	20.6	31.6	89.2	18.4	26.5	30.1	47.5	17.8	18.7	33.7	22.7	13.7	17.8	12.0	19.8	10.4	5.7	22.3	43.7	25.0	25.2	73.2	6.6	11.7	11.0	16.8	12.3	39.2	15.9	10.1	23.2	16.5	16.1	44.4	20.2	20.6	16.6	16.9	20.2	16.7	22.3	137.9	32.4	26.3	11.1	31.5	89.8	14.1	23.8	24.0	13.7	22.3	20.4	33.8	34.4
ACYP2		ENSG00000170634	"Acylphosphatase 2"	P14621	2	53970838-54305300	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.4;tongue: 163.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 162.6;Excitatory neurons: 158.8;Oligodendrocytes: 180.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035301	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035301: AB_10670291"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.90e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.24e-2)"	19.5	42.8	64.9	5.4	72.9	7.1	15.7	74.8	85.4	10.6	61.5	14.3	7.4	11.5	12.8	10.4	11.6	8.5	63.4	63.9	72.8	14.5	28.0	10.6	10.9	69.5	68.8	9.3	12.7	13.6	26.2	6.5	70.3	14.4	5.3	24.1	15.2	9.2	207.4	9.9	9.0	7.9	70.4	12.7	12.9	10.2	70.4	10.7	12.6	163.2	8.4	14.0	10.7	76.9	11.7	5.9	6.0	4.4	23.7	17.3	3.7	11.5	9.7	8.3	7.3	1.5	7.1	21.5	33.0	12.6	7.8	8.5	3.3	10.8	7.4	14.4	13.1	13.4	6.3	16.3	8.5	12.7	6.3	13.6	19.3	5.6	9.5	15.2	3.9	9.8	5.5	11.5	17.9	7.6	7.5	17.0	5.9	8.4	6.7	5.4	4.7	12.2	18.8	10.6	17.6	10.0	17.4	10.0	5.7	1.9	3.4	13.2	10.9	11.5	10.6	3.5	11.1	21.4	12.5	10.2	16.3	24.3	12.4	41.2	14.0	26.1	16.9	13.0	15.4	29.0	16.6	16.1	20.3	26.9	20.1	16.4	11.5	18.6	13.5	33.4	16.3	11.3	64.9	72.9	74.8	85.4	63.9	72.8	69.5	68.8	70.3	70.4	70.4	76.9	21.7	16.0	17.9	84.9	30.6	20.5	41.9	52.8	18.8	15.5	49.7	65.7	162.6	34.3	32.0	18.4	10.4	13.6	27.9	24.5	62.6	24.3	86.8	29.5	23.6	23.1	30.6	14.5	158.8	38.1	6.1	21.0	26.0	19.5	19.7	17.6	30.7	74.2	31.9	28.6	134.1	21.9	36.7	40.0	28.5	64.7	13.4	25.4	23.2	59.0	26.1	90.1	24.7	67.8	180.1	29.9	18.8	30.9	36.4	27.4	29.1	55.6	32.2	31.6	52.6	30.8	30.0	22.9	9.8	28.9	21.3	10.3	22.7	29.7	18.6	45.0
ADAL		ENSG00000168803	"Adenosine deaminase like"	Q6DHV7	15	43330672-43354569	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 81.3;Rod photoreceptor cells: 84.8;Spermatocytes: 99.5;Spermatogonia: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039879, HPA048175, HPA058795"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear speckles, Vesicles"	"HPA039879: , HPA048175: AB_2680298, HPA058795: "	"unprognostic (1.65e-2)"	"unprognostic (1.53e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (7.64e-9)"	"unprognostic (2.37e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.44e-2)"	6.2	6.6	6.7	4.2	7.1	4.4	5.9	7.6	9.6	3.6	10.2	5.7	5.8	4.3	8.4	4.1	3.3	3.8	20.9	6.3	7.4	11.9	8.2	3.5	4.8	6.7	7.2	3.6	3.6	10.4	6.1	2.7	7.0	6.2	4.8	21.2	4.2	6.4	20.4	2.6	4.6	4.7	6.9	3.8	4.0	11.1	7.1	5.4	10.9	23.4	4.8	4.6	3.0	7.4	6.8	3.4	13.3	15.1	5.5	7.1	6.3	8.1	8.2	12.6	19.3	14.2	3.5	8.0	13.0	8.9	16.7	7.5	0.0	5.7	10.8	8.5	8.0	19.0	23.1	12.0	6.9	0.0	14.8	9.1	10.3	8.5	8.7	8.1	2.7	19.4	21.1	16.2	13.2	4.6	12.3	9.7	5.5	7.8	4.6	15.9	19.9	12.7	11.0	4.1	16.3	11.6	13.1	11.7	12.4	7.2	12.5	12.5	3.7	21.9	10.6	16.6	16.5	16.6	29.9	3.4	12.2	21.2	18.1	5.9	1.4	3.8	2.4	2.0	1.8	2.0	2.2	1.9	2.0	1.6	2.3	2.9	1.1	2.3	1.9	2.9	4.5	1.3	6.7	7.1	7.6	9.6	6.3	7.4	6.7	7.2	7.0	6.9	7.1	7.4	5.9	9.6	10.3	32.7	10.0	7.0	7.4	9.3	7.4	40.7	9.2	9.9	51.2	10.0	6.9	18.4	81.3	7.1	13.3	7.0	58.7	8.9	17.6	10.6	10.3	8.2	7.7	19.1	24.4	8.5	7.0	10.4	5.1	6.8	7.6	15.7	11.0	30.8	8.9	42.1	26.7	7.2	10.2	8.8	7.0	12.7	9.6	8.9	8.8	10.3	5.4	35.5	24.7	19.1	18.3	5.7	1.3	8.6	6.9	7.1	13.0	29.0	10.9	84.8	6.6	11.6	7.3	99.5	82.5	8.8	4.4	2.6	7.0	12.6	11.6	4.4
ADAM32		ENSG00000197140	"ADAM metallopeptidase domain 32"	Q8TC27	8	39106990-39284917	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 27.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 189.0;Excitatory neurons: 37.3;Late spermatids: 50.5;Spermatocytes: 99.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.0;MCF7: 1.1;U-2 OS: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA044156, HPA062151"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA044156: AB_10796798, HPA062151: AB_2684699"	"unprognostic (2.13e-1)"	"unprognostic (6.92e-2)"	"unprognostic (4.63e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-7)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.34e-3)"	"unprognostic (7.82e-2)"	1.0	1.0	1.0	0.2	0.9	0.4	1.0	3.2	1.5	0.6	0.0	0.5	0.0	0.4	0.6	0.2	0.5	0.4	0.7	0.9	1.3	0.2	0.0	0.3	0.1	0.1	0.5	0.6	1.8	0.0	0.4	0.1	0.4	0.6	0.4	0.9	0.5	0.3	0.2	0.7	0.2	0.1	0.1	0.7	0.3	27.4	1.0	0.0	0.3	0.1	0.1	0.5	0.4	1.3	0.2	0.4	0.0	0.2	0.6	0.0	0.0	0.4	0.1	0.4	0.2	0.1	0.9	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.2	0.5	1.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.7	1.3	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	1.0	0.9	3.2	1.5	0.9	1.3	0.1	0.5	0.4	0.1	1.0	1.3	1.0	0.0	0.0	11.8	0.0	0.9	1.1	0.7	0.6	8.2	2.5	2.3	1.7	1.5	0.4	1.8	18.8	0.3	0.1	0.4	0.0	0.4	189.0	5.7	3.6	1.0	4.2	0.0	37.3	1.3	0.2	2.4	0.0	9.8	0.0	3.3	0.7	0.4	0.5	0.0	29.8	1.1	0.0	0.0	1.0	50.5	2.8	0.6	0.0	9.4	0.1	1.0	0.0	18.6	17.6	2.8	0.1	3.0	0.1	1.7	0.0	0.2	1.4	3.8	0.0	3.4	0.9	99.9	2.9	0.5	0.0	0.1	0.2	3.7	1.4	1.5
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;ovary: 10.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 7.3;Excitatory neurons: 44.7;Fibroblasts: 13.7;Granulosa cells: 22.2;Theca cells: 15.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 3.9;SuSa: 3.5;U-2197: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	5.4	0.2	1.4	0.4	1.9	0.5	0.7	17.0	2.6	1.4	0.0	0.7	0.6	1.3	1.6	1.5	0.7	6.4	0.2	3.4	0.0	3.5	0.4	0.7	0.2	0.2	0.2	10.4	4.5	0.1	0.0	0.2	0.7	0.1	0.3	1.2	0.2	0.5	0.2	0.4	0.5	1.1	0.0	0.2	0.2	0.4	0.0	0.2	0.3	0.2	0.1	1.0	0.6	1.8	1.7	1.7	1.7	0.1	0.1	0.3	0.2	0.0	0.0	0.4	0.5	0.0	1.4	0.1	2.1	0.0	3.0	0.1	0.0	0.0	0.4	0.1	0.9	0.3	2.8	0.0	0.0	0.2	0.0	0.0	0.0	3.9	0.1	0.5	0.0	0.3	0.6	0.4	0.7	0.0	0.4	0.2	1.1	0.0	1.6	0.4	2.2	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	3.5	0.1	0.1	0.1	2.1	3.0	5.8	1.4	0.9	0.3	0.1	3.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	1.9	17.0	2.6	3.4	0.0	0.2	0.2	0.7	0.0	0.0	1.8	0.7	0.0	0.6	2.6	0.0	0.0	0.0	0.0	0.6	2.0	0.7	0.4	0.5	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	5.0	0.1	0.0	0.0	44.7	0.0	0.0	13.7	0.5	0.5	0.0	22.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	6.9	1.6	0.1	0.0	0.0	0.0	0.0	0.1	15.9	0.0	0.0
ADAMTS17	"FLJ16363, FLJ32769"	ENSG00000140470	"ADAM metallopeptidase with thrombospondin type 1 motif 17"	Q8TE56	15	99971437-100342005	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Deafness, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.7"	"Group enriched"	"Detected in many"	8	"Astrocytes: 116.9;Early spermatids: 108.4;Inhibitory neurons: 275.7;Late spermatids: 91.0;Oligodendrocyte precursor cells: 337.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 6.4;JURKAT: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062487			Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA				"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA062487: AB_2684780"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.43e-2)"	0.8	1.2	1.6	0.5	1.1	0.6	0.6	0.3	2.7	1.4	6.0	0.9	0.6	1.2	0.6	2.1	1.8	0.3	1.3	1.3	0.6	1.1	7.5	1.5	0.5	1.2	0.7	1.7	5.0	0.2	1.2	0.5	0.8	1.0	0.4	0.7	2.6	0.5	5.6	2.2	1.2	0.5	0.7	0.9	1.0	2.7	1.0	10.7	0.7	0.1	0.5	1.6	1.4	1.1	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.2	0.3	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.7	2.0	0.5	0.2	0.9	1.0	0.0	0.3	2.3	0.0	0.2	1.7	0.2	0.2	2.2	2.7	0.4	0.0	0.2	0.3	0.0	0.6	0.6	0.0	0.2	0.0	0.0	0.0	0.4	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.3	2.7	1.3	0.6	1.2	0.7	0.8	0.7	1.0	1.1	0.7	0.0	0.0	116.9	0.3	1.0	0.9	0.1	3.4	0.8	1.5	1.3	4.3	1.5	0.9	0.0	0.0	0.1	2.6	0.4	1.9	0.1	108.4	1.2	2.8	0.9	0.0	0.0	8.2	0.9	0.0	1.6	5.1	1.8	0.0	0.1	0.4	4.4	8.2	21.9	275.7	0.7	0.0	0.6	0.3	91.0	2.1	0.4	0.0	22.5	0.0	1.3	1.0	337.3	9.5	0.3	0.2	0.0	0.8	1.6	0.5	0.1	0.0	0.7	0.0	3.2	0.9	1.7	1.9	2.1	0.6	0.1	3.7	2.5	0.4	0.9
ADAMTS5	"ADAMTS11, ADMP-2"	ENSG00000154736	"ADAM metallopeptidase with thrombospondin type 1 motif 5"	Q9UNA0	21	26917922-26967088	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 26.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 38.2;Endometrial stromal cells: 72.1;Fibroblasts: 88.6;Leydig cells: 62.7;Skeletal myocytes: 110.2;Smooth muscle cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 31.6;ASC TERT1: 13.9;fHDF/TERT166: 11.9;RH-30: 33.1;U-87 MG: 13.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA005661, CAB025996, HPA030906, HPA030908"	Approved		Supported	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		28000		"Cluster 5: Breast - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655"	"unprognostic (1.97e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.38e-8)"	"unprognostic (1.11e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.15e-1)"	17.5	0.8	0.3	1.0	0.6	0.0	10.8	3.3	0.3	8.8	2.6	2.7	0.8	12.5	2.4	1.6	4.2	1.6	3.3	0.5	0.9	2.5	1.4	1.0	0.6	1.4	0.9	16.6	0.4	1.5	0.4	26.2	0.9	3.0	1.3	0.6	2.0	1.8	2.0	4.2	3.4	7.5	1.5	7.7	2.2	0.8	0.4	0.3	6.8	3.7	0.1	4.2	3.6	1.2	0.0	0.0	0.0	0.0	31.6	13.9	0.0	1.7	0.2	1.4	0.6	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	2.3	0.0	1.3	0.0	0.3	0.0	3.5	0.1	0.0	8.0	0.0	1.1	0.2	0.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.1	0.0	3.4	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	8.3	0.4	1.9	0.9	0.0	0.0	0.0	13.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	3.3	0.3	0.5	0.9	1.4	0.9	0.9	1.5	0.4	1.2	24.3	0.0	0.5	0.3	0.1	2.9	0.2	0.4	0.0	9.8	1.5	38.2	2.7	0.0	0.6	3.7	0.0	1.1	0.3	0.0	0.0	0.0	6.4	2.0	72.1	10.6	1.8	0.0	0.5	0.2	1.6	88.6	0.0	1.3	0.0	3.0	3.3	0.0	1.9	0.0	11.6	0.0	0.0	0.0	4.6	1.0	62.7	1.4	3.6	3.7	4.0	0.1	0.0	12.5	0.2	0.0	0.0	9.1	0.0	0.3	0.0	2.2	0.0	0.2	13.1	110.2	44.9	0.3	0.9	0.4	3.0	2.7	0.8	20.0	0.0	0.1
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase RNA specific"	P55265	1	154581695-154628013	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	41.9	44.7	30.4	57.2	29.9	47.1	41.1	18.0	35.1	49.4	16.3	42.9	46.4	50.2	26.3	37.9	50.3	45.6	36.1	31.5	40.0	51.7	56.1	54.6	66.1	32.1	33.8	54.9	40.6	62.8	53.9	46.5	34.8	42.8	44.4	47.9	59.4	43.0	18.8	39.9	52.8	56.6	39.2	73.5	40.3	34.4	37.8	85.2	47.1	27.6	65.0	50.5	40.0	25.5	93.2	103.1	84.4	104.8	87.4	88.5	97.8	59.5	132.7	209.8	183.4	87.8	85.3	162.6	97.7	98.7	112.4	85.4	111.9	115.5	109.8	159.1	52.3	84.9	66.2	48.4	96.7	122.8	83.8	86.2	84.7	100.4	104.1	81.2	104.5	112.4	82.4	111.6	72.0	107.8	165.0	43.3	139.7	125.5	74.6	140.1	74.2	131.2	67.6	106.1	84.8	100.2	104.4	167.9	126.2	128.1	113.4	148.2	94.3	67.5	68.5	58.8	71.5	132.9	179.0	177.6	70.2	78.4	81.0	7.8	8.1	15.0	10.8	9.9	10.2	9.0	10.6	11.2	7.8	5.8	9.8	10.0	29.1	8.6	9.4	6.3	9.1	7.4	30.4	29.9	18.0	35.1	31.5	40.0	32.1	33.8	34.8	39.2	37.8	25.5	73.3	83.3	51.2	37.5	80.5	33.3	39.4	39.9	32.5	94.5	43.6	36.6	22.1	45.8	44.0	47.8	95.9	41.2	103.0	73.3	9.8	49.2	4.2	48.9	61.0	86.7	63.1	45.2	44.8	66.9	57.8	49.1	56.6	52.4	62.1	88.6	84.9	93.8	53.5	168.2	53.2	53.9	34.6	104.1	43.9	13.1	73.7	78.0	19.6	32.8	110.2	37.9	126.7	38.2	39.7	69.6	62.7	59.0	87.5	61.1	86.7	42.5	50.0	80.2	52.6	40.1	45.2	11.4	35.0	37.9	40.3	31.5	85.6	66.5	56.2	53.8
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase RNA specific B1"	P78563	21	45073853-45226560	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 62.9;Excitatory neurons: 54.1;Horizontal cells: 69.0;Inhibitory neurons: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 65.8;HHSteC: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	15.4	7.0	14.9	10.3	13.2	5.2	11.4	39.1	26.5	14.7	29.6	35.7	3.0	23.0	6.3	7.4	13.6	8.1	10.1	20.0	17.9	9.5	7.0	35.2	13.4	30.6	17.2	7.8	6.1	9.3	6.1	12.3	30.8	17.9	4.8	28.6	6.8	8.1	13.6	15.9	10.8	11.7	8.7	16.1	19.0	4.5	22.7	5.7	6.6	11.8	8.7	60.4	11.9	12.7	7.0	1.0	5.3	6.2	6.3	4.3	7.2	4.6	7.6	14.4	9.0	10.9	1.1	2.2	12.1	22.6	7.9	0.6	7.8	19.1	15.9	1.7	7.0	15.2	65.8	7.2	65.7	10.5	7.2	23.7	8.1	5.1	14.9	5.4	15.4	20.4	3.5	0.8	42.2	5.1	6.8	10.0	8.6	3.4	10.1	2.0	5.0	7.1	3.2	2.3	30.6	8.2	36.4	1.6	11.6	8.5	3.5	8.2	16.3	4.7	5.7	19.4	17.5	6.6	3.1	1.8	4.3	24.1	25.8	0.7	0.0	2.4	0.4	0.2	0.8	1.0	1.1	0.7	0.0	2.6	0.7	0.6	0.1	0.3	0.2	1.0	0.8	0.2	14.9	13.2	39.1	26.5	20.0	17.9	30.6	17.2	30.8	8.7	22.7	12.7	29.0	0.0	1.1	10.7	12.0	11.1	2.9	3.4	2.8	62.9	6.2	7.1	21.6	1.5	1.9	0.0	12.5	0.5	5.9	0.9	0.0	1.3	2.7	1.6	8.8	21.2	0.0	2.1	54.1	0.5	1.2	9.4	2.6	1.6	8.2	5.5	14.3	6.3	5.9	69.0	85.7	0.9	0.0	3.4	4.9	2.9	3.7	3.2	5.4	37.5	5.0	34.2	2.1	16.1	4.8	1.0	0.1	5.7	4.0	5.5	0.3	2.7	0.7	16.0	0.0	32.9	12.7	11.4	17.7	1.5	7.2	1.0	13.7	1.4	1.2	2.3
ADAT1		ENSG00000065457	"Adenosine deaminase tRNA specific 1"	Q9BUB4	16	75596868-75623300	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 101.9;Late spermatids: 213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040713, HPA040903"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA040713: AB_10795371, HPA040903: AB_10794071"	"unprognostic (7.71e-3)"	"unprognostic (5.35e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.27e-2)"	13.8	16.4	11.0	9.5	11.1	7.8	14.1	11.5	15.1	12.0	10.5	11.6	5.1	14.0	12.7	11.7	11.8	6.6	11.5	10.8	10.5	19.8	18.5	12.8	10.8	11.5	11.2	10.3	12.6	14.6	14.2	7.3	11.7	15.3	9.1	9.6	12.1	8.6	9.5	14.1	14.0	6.0	10.6	20.4	12.0	26.9	11.5	11.8	14.8	5.2	8.7	13.1	11.6	13.0	14.7	23.1	15.0	15.5	26.4	20.3	11.5	20.2	21.0	26.1	17.7	15.4	22.4	15.7	19.8	20.6	14.0	17.6	16.4	25.0	24.6	11.7	8.6	8.8	16.0	13.3	21.2	19.6	19.6	21.7	23.8	42.7	32.1	7.5	23.1	24.7	13.7	7.6	21.2	35.9	18.8	14.3	12.2	19.8	10.7	23.6	12.1	21.5	24.6	22.0	18.1	18.6	47.8	12.2	11.2	15.0	24.6	9.3	16.3	32.4	14.6	17.1	16.9	15.1	24.3	58.9	16.3	15.6	28.5	8.5	4.3	11.5	8.5	6.4	11.3	7.9	7.3	11.3	5.8	7.3	4.5	6.3	4.9	10.8	9.9	4.6	9.0	6.2	11.0	11.1	11.5	15.1	10.8	10.5	11.5	11.2	11.7	10.6	11.5	13.0	9.9	9.6	5.8	2.3	11.6	4.6	5.9	5.7	6.8	13.5	10.7	6.6	5.6	11.5	6.6	7.3	27.1	11.8	9.8	6.8	17.6	8.6	101.9	11.8	8.2	11.9	14.4	16.0	6.0	7.6	8.9	6.4	8.6	10.5	8.2	12.6	6.1	10.5	10.3	13.5	6.4	4.7	10.2	14.4	10.6	213.0	9.9	10.2	3.6	2.8	12.8	7.8	15.5	3.0	8.0	9.8	3.3	7.9	8.1	8.3	6.9	11.3	9.9	21.6	6.6	6.8	7.0	17.5	13.4	8.4	5.4	9.7	14.8	12.9	9.1	7.6
ADAT2	"DEADC1, dJ20N2.1, TAD2"	ENSG00000189007	"Adenosine deaminase tRNA specific 2"	Q7Z6V5	6	143422832-143450695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035479	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA035479: AB_10611672"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.28e-5)"	"unprognostic (4.88e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.08e-2)"	6.8	8.8	1.4	3.1	1.3	5.4	6.3	1.9	1.5	6.3	1.8	7.8	3.1	4.8	1.4	10.3	6.1	1.2	3.4	1.3	1.2	7.7	12.0	8.5	4.2	1.2	1.2	5.8	10.5	1.5	6.6	1.1	1.3	7.3	4.1	1.4	5.4	1.1	3.1	8.9	8.8	1.7	1.0	10.7	8.9	2.8	1.5	1.9	8.6	0.7	3.5	6.5	7.9	1.4	1.8	1.6	2.2	7.2	1.7	5.3	2.7	2.6	1.1	1.6	2.2	4.0	4.4	7.0	2.7	1.7	1.7	5.8	4.3	4.1	3.4	3.5	9.2	10.4	7.3	8.3	2.1	15.0	4.6	2.4	6.0	3.2	6.3	1.8	3.7	6.5	11.3	5.4	2.7	2.5	6.0	7.6	2.5	2.6	2.8	7.0	5.7	5.6	3.0	1.9	4.7	3.1	2.1	6.0	1.8	1.2	2.4	5.0	3.4	2.6	1.9	5.6	4.8	5.9	4.2	4.9	2.7	13.0	2.8	0.0	0.2	0.0	0.6	0.3	0.8	0.5	0.5	0.5	0.6	0.3	0.7	1.0	0.1	0.4	0.0	0.6	1.3	0.4	1.4	1.3	1.9	1.5	1.3	1.2	1.2	1.2	1.3	1.0	1.5	1.4	4.6	6.4	12.9	8.8	6.9	6.6	4.3	4.1	6.2	3.7	5.6	6.3	4.0	5.7	4.1	1.8	0.0	2.4	11.9	4.3	3.9	5.6	1.2	2.7	11.1	4.8	4.2	14.9	11.2	4.1	2.6	5.3	12.2	5.9	7.6	7.1	3.9	5.2	4.9	1.7	10.4	6.0	4.1	4.3	6.1	1.6	6.8	5.3	5.4	7.5	2.1	1.9	8.2	12.5	4.2	6.6	2.4	3.4	4.2	6.8	1.6	1.4	2.1	4.3	0.0	5.1	5.1	2.4	5.6	9.8	9.2	0.8	8.9	6.2	8.8	4.5
ADAT3	TAD3	ENSG00000213638	"Adenosine deaminase tRNA specific 3"		19	1905399-1913447	"Human disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 9.1;Gastric mucus-secreting cells: 8.2;Squamous epithelial cells: 13.7;Suprabasal keratinocytes: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 13.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA058899	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA058899: AB_2683847"	"unprognostic (1.79e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.43e-2)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.55e-3)"	3.3	4.6	1.6	0.8	3.1	0.7	3.1	2.8	2.6	4.2	1.2	7.7	7.5	3.5	0.2	10.6	3.7	0.2	2.8	1.1	1.4	7.9	5.4	3.7	0.5	5.6	3.1	3.1	6.3	0.1	3.3	0.2	4.0	6.4	0.7	0.0	8.1	0.4	1.9	13.9	6.6	0.1	3.1	6.1	4.7	2.9	3.3	0.1	4.5	0.2	0.3	2.8	5.3	6.1	4.9	1.2	0.7	1.0	0.4	0.0	5.9	1.7	0.3	0.6	0.9	1.9	1.5	2.8	0.7	0.2	0.3	3.1	0.2	0.2	0.0	6.9	12.5	0.7	3.7	2.5	0.2	1.3	8.8	0.0	0.2	0.8	0.0	0.1	0.6	0.8	8.1	1.5	0.4	1.0	2.3	4.2	6.5	0.2	8.4	7.6	1.1	4.8	0.7	1.2	2.6	6.4	2.1	5.0	2.5	0.3	3.9	1.0	1.6	0.6	2.8	2.4	3.7	2.7	2.6	2.5	0.5	1.3	1.6	0.2	1.2	0.0	1.3	0.7	1.4	0.9	2.0	2.3	1.7	2.5	1.4	2.3	0.3	4.1	1.1	13.2	2.6	0.8	1.6	3.1	2.8	2.6	1.1	1.4	5.6	3.1	4.0	3.1	3.3	6.1	1.1	0.0	1.5	0.0	2.9	6.1	1.0	1.0	9.1	0.0	4.0	1.8	0.6	1.5	0.5	0.0	0.0	1.8	5.5	4.1	1.9	1.5	0.1	6.3	1.2	1.4	1.2	0.4	0.0	0.7	2.4	1.6	8.2	3.1	0.0	0.5	2.2	0.8	1.8	0.0	0.0	1.1	0.0	1.4	3.1	0.6	0.0	2.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	4.3	0.7	6.4	0.3	4.2	4.0	2.3	0.0	0.0	0.8	1.2	0.8	3.1	13.7	11.1	4.5	3.6	0.8	1.7	1.2
ADCK1	FLJ39600	ENSG00000063761	"AarF domain containing kinase 1"	Q86TW2	14	77800109-77935014	"Enzymes, Predicted secreted proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 20.9;Oligodendrocytes: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051012, HPA055014"	Uncertain		Uncertain	Nucleoplasm	"Secreted - unknown location"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA051012: AB_2681310, HPA055014: AB_2682672"	"unprognostic (6.36e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic favorable (4.11e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.82e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.57e-2)"	"unprognostic (4.06e-1)"	4.4	8.1	7.3	3.7	7.8	5.3	4.2	7.3	10.3	4.3	8.2	6.7	7.4	4.8	5.1	6.1	4.4	3.8	9.0	7.8	7.2	7.0	8.6	4.0	4.1	7.8	7.4	4.7	6.7	6.5	8.3	5.1	8.2	6.5	5.8	3.8	6.7	5.4	8.9	6.3	5.6	6.4	7.1	7.3	6.1	4.6	7.9	5.2	5.9	5.2	4.8	5.1	4.0	10.2	5.5	9.1	4.4	17.4	13.0	6.5	6.2	5.7	7.9	4.5	5.6	4.7	12.4	12.0	8.5	9.5	7.5	10.2	27.0	9.3	2.9	6.3	9.1	2.8	4.9	7.5	12.2	4.5	6.6	7.7	16.2	1.9	5.7	4.4	7.1	10.1	11.4	7.4	5.9	24.5	5.8	7.6	9.6	17.5	10.2	9.1	0.7	9.0	6.6	13.9	10.4	6.0	10.6	14.7	5.9	6.8	20.9	9.4	6.8	4.6	3.4	8.9	4.6	6.4	7.7	6.3	6.6	7.7	5.8	1.3	4.0	1.4	4.2	6.0	2.9	1.4	1.6	2.4	7.4	3.0	1.9	3.4	0.3	3.2	2.5	5.5	3.1	2.5	7.3	7.8	7.3	10.3	7.8	7.2	7.8	7.4	8.2	7.1	7.9	10.2	1.9	0.0	3.7	10.1	1.8	0.9	1.8	3.9	2.8	5.9	2.9	3.0	5.7	4.3	2.8	0.0	20.9	8.2	4.2	4.0	3.9	4.4	1.5	2.0	2.4	1.4	1.8	2.1	10.3	5.1	4.2	2.4	6.6	2.4	1.3	5.0	1.8	6.6	9.6	8.4	11.7	4.0	4.1	4.4	1.5	0.8	1.5	5.1	0.0	5.6	2.5	4.0	3.1	11.6	29.0	2.8	1.3	1.9	3.2	1.5	3.0	3.8	2.4	9.3	0.0	2.1	1.6	1.8	9.9	4.3	1.4	5.3	2.2	4.6	5.4	1.2
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;Rod photoreceptor cells: 624.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	104.4	70.0	96.4	60.7	119.7	65.9	89.1	86.7	117.7	96.5	46.4	127.9	65.5	121.4	57.9	71.9	96.3	69.0	111.2	99.2	90.9	74.1	53.7	93.5	65.3	91.5	100.4	129.5	56.4	67.5	70.1	66.0	92.3	86.1	62.7	269.1	61.9	107.3	166.3	69.4	92.3	110.2	76.0	88.9	84.3	53.2	113.2	76.0	71.7	115.0	62.1	115.3	82.9	116.2	74.7	61.2	142.0	73.8	205.8	152.6	53.2	123.2	146.9	125.6	105.3	90.5	91.8	38.7	63.0	212.3	146.6	46.6	107.5	103.4	104.3	49.9	49.4	109.5	50.4	87.9	100.4	65.8	74.7	151.6	95.2	110.4	44.0	130.1	158.5	71.9	116.0	90.8	145.1	43.7	203.7	91.6	80.0	67.9	85.7	89.1	78.6	45.7	91.2	162.2	84.8	110.0	88.9	35.8	76.9	107.0	84.2	61.7	193.4	102.1	52.4	84.7	103.0	72.5	63.3	48.9	98.2	80.4	100.9	20.1	7.6	35.5	19.1	7.3	17.6	23.8	10.6	16.3	12.0	31.2	9.8	11.8	10.5	27.2	11.4	25.4	14.8	16.0	96.4	119.7	86.7	117.7	99.2	90.9	91.5	100.4	92.3	76.0	113.2	116.2	89.3	70.5	45.4	141.3	66.5	26.9	29.8	33.0	27.9	99.5	41.2	41.5	78.0	40.0	46.3	60.7	402.4	35.5	84.0	51.3	15.6	37.3	48.5	43.9	61.2	89.4	57.7	57.9	85.7	45.8	32.5	72.9	39.8	58.1	37.3	53.0	84.3	41.8	41.8	111.0	83.2	39.3	28.5	51.6	42.2	35.9	77.6	47.4	35.6	72.1	58.3	233.8	120.5	68.9	178.6	53.2	39.4	121.9	49.7	35.8	48.6	44.6	40.4	624.3	98.6	58.4	73.1	45.3	33.2	30.5	36.7	36.5	55.6	80.7	45.1	33.0
ADD2	ADDB	ENSG00000075340	"Adducin 2"	P35612	2	70607618-70768225	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 66.5;brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.7;Erythroid cells: 74.1;Excitatory neurons: 70.1;Horizontal cells: 139.7;Inhibitory neurons: 51.8;Late spermatids: 62.4"	"Group enriched"	"Detected in many"	5	"glioma: 5.2;testis cancer: 11.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.2;non-classical monocyte: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 33.9;JURKAT: 33.1;K-562: 46.5;NTERA-2: 86.7;RPMI-8226: 41.7;SCLC-21H: 42.8;U-251 MG: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009796, HPA034509, HPA034510"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.47e-7)"	"unprognostic (2.81e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-3)"	1.8	1.7	19.5	1.9	21.0	66.5	0.9	14.6	52.8	0.7	0.0	0.9	0.1	0.5	0.3	1.4	0.7	0.3	0.9	18.7	10.8	0.4	0.2	0.9	2.5	14.0	0.2	0.2	1.7	0.2	4.0	0.7	9.5	0.5	0.3	16.0	0.2	0.2	0.8	0.3	0.9	1.0	0.0	1.2	0.3	2.8	0.9	0.7	1.4	1.0	2.2	0.5	0.6	9.6	17.6	20.5	0.8	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	2.7	12.3	0.0	33.9	0.0	0.0	0.1	20.1	1.7	0.2	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	8.0	0.0	33.1	46.5	0.0	0.0	0.1	0.2	1.6	86.7	0.0	0.4	0.0	0.5	41.7	5.7	0.0	42.8	19.3	21.6	0.1	0.1	9.4	0.1	10.7	0.8	0.2	0.9	0.0	47.1	14.1	17.0	0.0	0.7	7.1	7.9	0.0	0.0	0.0	0.0	1.2	0.0	2.2	0.0	0.0	0.0	1.7	0.8	0.4	0.0	0.0	2.3	0.0	0.0	0.3	19.5	21.0	14.6	52.8	18.7	10.8	14.0	0.2	9.5	0.0	0.9	9.6	2.8	0.0	0.5	1.0	4.2	0.1	0.3	0.0	0.0	23.3	0.2	0.0	2.5	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.1	31.7	0.1	0.2	3.9	0.0	74.1	70.1	1.1	0.2	1.0	1.1	0.1	0.0	0.0	2.9	0.0	0.2	139.7	51.8	0.0	0.0	1.0	0.4	62.4	0.9	0.6	1.8	2.8	0.8	0.8	0.0	17.6	1.8	0.3	0.0	0.7	0.1	0.6	0.0	0.0	0.0	8.7	0.0	0.6	0.3	3.5	6.8	0.0	0.1	0.3	0.5	1.5	0.0	1.3
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598967-146815462	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5;choroid plexus: 6.0;fallopian tube: 7.5;testis: 26.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 305.4;Endometrial ciliated cells: 57.1;Late spermatids: 74.8;Respiratory ciliated cells: 92.5;Spermatocytes: 68.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"HDLM-2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria		No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA036340: AB_2675071, HPA036341: AB_10672241"	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.3	0.1	0.4	6.0	0.3	0.0	0.1	0.2	0.0	7.5	0.0	0.0	0.8	0.8	0.0	0.0	1.4	0.0	5.5	3.8	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	26.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.3	0.1	0.8	0.8	5.5	3.8	2.4	3.0	1.0	1.0	0.0	3.2	1.5	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.0	9.5	0.0	4.2	0.0	0.0	0.4	0.0	0.0	305.4	57.1	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	2.0	0.0	1.9	74.8	2.8	0.4	0.0	1.0	0.0	0.2	0.0	0.5	0.2	0.0	0.3	2.6	0.0	0.1	0.0	0.1	92.5	0.1	0.0	0.0	0.9	68.4	3.3	0.0	0.0	0.0	0.1	0.0	0.7	0.0
ADGRD1	"DKFZp434B1272, GPR133, PGR25"	ENSG00000111452	"Adhesion G protein-coupled receptor D1"	Q6QNK2	12	130953907-131141469	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.4"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 22.4;Alveolar cells type 2: 30.5;Cardiomyocytes: 47.0;Early spermatids: 16.2;Endometrial stromal cells: 50.2;Fibroblasts: 32.7;Late spermatids: 21.4;Leydig cells: 13.7;Microglial cells: 25.3;Peritubular cells: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.0;intermediate monocyte: 2.3;myeloid DC: 1.1;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;monocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"BJ: 4.1;fHDF/TERT166: 4.7;HeLa: 7.6;HHSteC: 4.9;HMC-1: 13.0;U-2 OS: 6.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.1"	"Low region specificity"	"Detected in all"			"HPA042395, HPA076279"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA042395: AB_10796906, HPA076279: "	"unprognostic (3.21e-1)"	"unprognostic (1.49e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.79e-5)"	"unprognostic (1.31e-3)"	"unprognostic (4.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-3)"	26.4	1.9	1.9	1.3	2.0	0.3	10.3	1.2	2.5	20.6	1.0	10.6	1.9	15.4	7.3	6.9	17.7	12.9	62.4	1.4	3.2	3.4	10.3	35.6	0.4	2.0	2.6	17.9	12.0	0.3	6.3	25.7	2.2	15.3	1.8	0.8	2.9	1.0	7.3	7.0	12.1	7.1	2.0	2.3	20.7	7.5	3.6	0.4	11.2	8.5	1.0	40.3	16.3	1.7	0.0	0.7	0.0	2.0	0.0	0.0	0.1	4.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.6	0.0	4.9	0.0	13.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.8	0.0	0.1	0.2	2.1	0.5	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.4	6.1	1.5	0.1	0.1	1.7	0.8	0.1	0.0	0.0	0.0	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.8	1.9	2.0	1.2	2.5	1.4	3.2	2.0	2.6	2.2	2.0	3.6	1.7	2.0	22.4	30.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	47.0	0.0	5.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	16.2	1.3	50.2	3.4	0.0	0.0	1.1	0.4	0.6	32.7	0.5	1.0	1.3	0.3	1.8	3.6	2.3	0.0	1.4	0.0	0.0	1.5	0.0	21.4	13.7	1.5	0.0	25.3	3.5	0.0	0.0	0.0	0.1	0.3	0.0	15.8	0.0	0.0	0.0	0.1	2.2	0.7	6.6	2.2	3.5	4.3	6.5	0.1	0.0	1.0	0.6	0.2	0.1	0.3
ADGRG5	"GPR114, PGR27"	ENSG00000159618	"Adhesion G protein-coupled receptor G5"	Q8IZF4	16	57542643-57591681	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 3.9;lymphoid tissue: 10.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 32.0;Microglial cells: 11.2;NK-cells: 43.3;Plasma cells: 16.4;T-cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 125.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 39.4;OE19: 13.2;RPMI-8226: 6.2;THP-1: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007133	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA007133: AB_1849253"	"unprognostic (6.11e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.09e-4)"	"unprognostic (3.80e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.69e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.32e-3)"	0.3	0.3	0.3	5.0	0.2	1.4	0.7	0.2	0.2	0.2	0.1	1.7	3.7	0.3	0.1	0.6	0.5	0.1	0.0	0.3	0.4	0.0	0.2	0.9	10.5	0.8	0.4	0.0	0.0	0.1	0.2	0.0	0.6	0.3	1.3	0.0	1.3	0.3	0.1	0.1	3.9	0.3	0.6	5.8	0.4	0.4	0.4	1.6	0.3	0.0	10.5	1.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	3.6	3.6	13.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.1	125.9	33.3	0.1	16.9	12.0	4.8	19.1	2.4	8.6	1.2	11.2	0.5	29.9	0.1	68.8	0.2	9.0	0.3	0.2	0.2	0.2	0.3	0.4	0.8	0.4	0.6	0.6	0.4	0.3	0.3	0.0	1.3	0.3	5.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.2	32.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.6	0.0	0.3	0.0	3.2	0.0	11.2	1.7	0.0	43.3	0.0	0.3	0.0	0.0	0.0	16.4	0.1	2.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	7.1	0.0	0.7	0.0
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 5151.4"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 975.2"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		20000000	"Cluster 34: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	2.1	0.8	0.5	0.4	0.4	0.4	4.3	1.2	1.0	1.5	0.0	0.6	164.1	0.2	0.5	0.8	0.3	0.4	0.2	0.4	0.7	1.5	5151.4	0.2	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.3	0.6	0.8	2.6	0.5	0.6	0.9	22.9	0.1	0.0	0.6	0.6	1.0	0.5	0.0	0.4	2.1	0.1	0.3	3.4	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.4	22.2	0.0	1.6	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.8	0.0	0.1	0.1	0.5	0.3	0.0	0.1	0.1	1.6	0.5	0.0	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.0	0.4	0.4	0.6	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.2	1.0	0.4	0.7	0.1	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.0	26.9	0.7	0.6	1.1	0.0	45.5	0.1	0.6	0.0	1.0	0.0	0.3	0.0	0.0	16.1	975.2	0.0	0.0	0.0	1.1	0.0	27.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.8	0.0
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497366-3519531	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 590.7"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 888.3;Hepatocytes: 1234.6;Proximal tubular cells: 1546.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	55.1	76.9	31.1	28.0	32.6	31.7	50.4	31.7	42.1	54.2	43.3	58.3	105.2	45.6	43.3	48.2	45.2	66.7	146.4	32.0	31.0	200.2	590.7	44.6	30.1	33.0	32.2	50.0	34.9	49.6	33.5	41.3	33.6	101.1	52.3	17.1	53.6	55.9	121.1	35.7	68.9	37.9	31.6	57.2	82.4	16.7	31.6	26.9	36.5	56.0	34.5	57.9	36.5	34.7	46.5	64.5	55.9	50.2	187.5	85.0	91.9	95.6	124.1	102.7	74.5	86.9	59.2	22.1	143.4	109.5	21.4	45.1	62.9	49.0	59.2	39.5	131.4	67.6	42.2	184.1	165.4	71.2	151.3	91.4	72.3	55.0	63.7	45.3	75.8	36.1	51.8	45.3	87.4	137.8	25.6	147.1	44.4	131.9	86.4	27.1	31.3	128.2	90.2	83.3	57.0	54.0	53.0	75.0	37.2	36.8	55.6	95.5	54.1	75.9	29.0	35.9	56.6	35.4	91.6	88.7	58.6	115.5	41.0	87.6	134.3	336.9	28.5	126.5	31.8	66.8	67.4	26.7	127.7	53.4	79.3	25.6	59.4	54.5	117.4	186.3	67.4	189.0	31.1	32.6	31.7	42.1	32.0	31.0	33.0	32.2	33.6	31.6	31.6	34.7	44.8	67.3	111.1	25.1	73.1	76.0	154.5	107.8	92.2	9.2	103.0	88.9	275.8	338.8	109.5	152.6	14.6	395.0	80.6	140.1	888.3	157.2	8.8	65.9	116.3	61.6	57.2	123.1	9.4	87.2	247.1	129.1	66.3	116.3	41.8	75.1	207.8	1234.6	263.2	8.4	15.0	146.1	236.0	168.8	67.6	23.8	137.0	90.0	204.5	7.5	108.2	197.2	40.2	5.5	19.0	79.7	272.5	210.3	97.4	143.6	409.8	1546.8	38.0	15.3	164.3	45.5	109.3	5.3	11.3	113.6	76.9	381.4	53.0	120.8	147.2	156.9
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968432-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1238.9"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 12067.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 847.5;PC-3: 680.7;RT4: 1035.2"					"Low region specificity"	"Detected in all"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA026810: AB_2672003"																		1238.9	58.8	253.4	50.9	238.3	1.0	246.1	221.8	380.1	201.9	226.1	114.2	476.9	114.1	49.1	114.2	235.9	46.7	90.6	251.6	278.5	147.2	82.5	209.5	15.5	259.4	237.0	252.6	73.2	26.9	55.1	28.4	241.8	312.5	48.1	29.0	296.8	233.8	87.5	115.6	491.6	75.8	239.8	73.6	75.2	27.2	242.7	25.8	116.6	131.9	44.7	242.9	171.1	247.4	259.8	4.9	0.1	0.1	123.3	224.9	16.1	97.0	166.9	1.7	0.4	6.5	29.5	0.0	3.4	209.9	8.4	847.5	0.0	39.7	1.0	9.1	0.0	0.0	22.5	1.8	19.9	0.2	3.4	1.9	132.0	0.6	70.1	6.7	50.4	3.6	0.3	36.3	4.0	130.4	0.6	6.5	0.0	6.4	680.7	0.5	0.0	3.4	14.6	1035.2	11.8	3.0	36.0	222.0	1.7	0.0	270.7	2.7	132.6	3.4	17.4	13.2	0.6	4.0	3.3	0.4	6.3	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	2.5	1.9	0.0	0.0	0.0	0.0	0.5	0.3	253.4	238.3	221.8	380.1	251.6	278.5	259.4	237.0	241.8	239.8	242.7	247.4	1215.2	1842.9	476.5	3.9	15.0	528.4	141.9	309.7	39.9	5.4	651.4	253.2	0.0	58.6	614.4	187.6	2.1	299.2	14.3	658.7	1352.0	29.9	9.6	55.7	63.9	944.9	30.0	37.5	0.1	272.1	16.9	508.0	121.3	195.1	48.9	11.7	1691.7	257.4	26.4	0.0	0.3	418.7	128.1	17.3	492.0	48.4	1309.5	25.3	610.1	10.3	99.9	703.9	0.0	1.0	0.2	336.8	1115.3	469.8	3.4	481.9	12067.2	1144.8	88.2	16.5	1472.6	705.4	2422.0	3.2	6.2	35.0	438.6	166.8	40.7	2.4	443.5	1160.7
ADK	AK	ENSG00000156110	"Adenosine kinase"	P55263	10	74151202-74709963	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 151.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 245.3;Inhibitory neurons: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032876, HPA038391, HPA038409, HPA075222"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		920000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: "	"unprognostic (1.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.93e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.95e-2)"	23.9	15.5	13.0	16.9	18.7	28.6	27.4	13.5	17.7	17.5	11.6	17.9	16.9	10.8	16.5	47.3	16.5	11.4	27.2	13.9	15.2	35.8	151.2	24.4	22.8	14.0	15.0	8.3	18.8	44.2	14.9	26.6	16.5	14.9	19.5	16.1	20.0	16.0	41.5	33.9	12.4	14.8	14.2	15.0	12.1	15.5	14.1	27.0	38.2	47.1	34.5	24.5	24.7	15.8	177.3	37.4	37.2	50.5	37.1	54.7	88.2	140.8	105.4	103.8	114.5	114.0	172.6	86.3	34.2	57.7	51.3	151.1	44.1	150.1	167.0	59.1	51.3	55.6	59.8	122.8	41.7	87.6	22.5	51.1	95.5	77.4	191.7	79.0	91.2	38.7	41.8	28.4	78.8	101.7	102.5	129.0	9.9	80.0	276.3	100.6	63.7	69.4	117.1	92.7	29.5	33.8	63.6	239.7	49.5	34.7	159.7	69.3	82.8	34.3	67.0	93.2	123.0	40.5	48.3	98.1	65.0	127.6	22.1	2.3	34.2	4.1	12.9	65.5	29.9	103.7	28.2	24.1	83.1	155.0	21.3	19.2	11.1	20.7	80.4	57.6	55.7	36.3	13.0	18.7	13.5	17.7	13.9	15.2	14.0	15.0	16.5	14.2	14.1	15.8	9.8	83.3	75.8	136.5	84.2	94.2	73.5	102.0	105.9	16.3	26.2	26.0	67.8	38.6	72.4	31.3	56.3	136.7	25.9	11.0	92.0	83.2	80.7	40.6	18.8	14.9	10.8	27.7	245.3	67.5	139.5	27.0	23.0	55.6	21.5	9.7	17.2	130.1	39.3	11.8	287.7	12.1	44.7	25.2	50.0	26.9	16.8	33.7	48.0	198.6	44.1	14.1	11.3	140.8	165.4	62.7	10.4	12.0	39.1	92.1	5.0	64.5	33.5	25.0	6.6	20.4	26.0	17.4	14.3	96.7	97.0	107.3	32.7	17.0	20.5	66.3
ADNP	"ADNP1, KIAA0784"	ENSG00000101126	"Activity dependent neuroprotector homeobox"	Q9H2P0	20	50888916-50931437	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006371	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006371: AB_1078105"	"unprognostic (3.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.68e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-1)"	21.1	22.3	31.9	20.2	33.1	25.3	32.6	37.5	40.0	26.6	30.6	23.3	20.1	31.4	42.1	23.9	29.4	22.3	19.4	32.1	32.7	24.9	25.4	24.0	28.9	30.8	31.7	39.3	21.8	36.1	20.5	25.3	30.7	28.6	24.1	43.6	21.9	29.9	35.7	27.9	22.8	29.7	31.2	25.0	26.7	36.6	35.1	44.8	29.6	28.4	35.6	26.7	23.9	36.9	51.2	50.9	103.2	53.7	51.3	47.3	38.8	41.2	48.1	79.0	55.8	80.4	42.3	74.0	51.7	52.9	41.9	62.1	86.6	85.1	89.5	32.6	30.8	54.2	58.1	64.0	48.9	87.7	41.2	47.1	101.3	47.8	85.7	61.2	56.7	46.2	66.7	47.2	51.6	61.6	76.4	61.4	45.5	52.7	42.8	76.2	54.4	55.5	50.9	77.2	81.2	61.9	92.7	138.0	73.6	65.8	62.7	82.5	44.7	68.6	69.4	49.0	45.8	36.3	39.2	104.0	42.2	50.5	47.3	38.5	23.8	22.3	40.5	37.4	42.7	26.0	44.6	36.9	28.3	29.8	43.8	58.4	12.3	31.4	52.8	58.2	32.8	22.5	31.9	33.1	37.5	40.0	32.1	32.7	30.8	31.7	30.7	31.2	35.1	36.9	45.5	9.6	24.4	85.5	31.1	60.0	32.9	22.9	26.7	41.3	46.9	39.2	38.0	38.6	26.4	14.7	25.0	31.4	55.4	25.6	17.6	22.2	26.3	50.0	59.9	33.4	37.1	26.9	75.6	21.9	20.3	32.8	25.0	61.3	17.2	72.5	27.1	29.5	22.5	38.7	93.5	29.3	18.3	27.4	41.0	38.8	31.4	28.9	40.9	77.8	26.7	25.0	20.6	124.1	122.7	28.5	21.1	39.9	27.0	36.1	22.1	23.2	22.0	37.1	39.5	45.9	41.2	27.9	35.2	31.2	52.0	22.2	36.6	42.8	33.7	39.8
ADPRH	ARH1	ENSG00000144843	"ADP-ribosylarginine hydrolase"	P54922	3	119579268-119589945	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.9;HEL: 17.1;HMC-1: 18.5;Karpas-707: 25.3;U-266/70: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001701, HPA036961"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear membrane"	Nucleoplasm	"CAB001701: , HPA036961: AB_2675405"	"prognostic favorable (2.42e-4)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.60e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.35e-2)"	10.6	6.2	3.0	7.3	3.3	3.4	7.9	3.3	4.2	6.9	9.2	5.5	2.3	6.0	4.9	4.0	4.2	6.9	8.5	2.9	3.5	4.9	3.1	13.5	11.0	4.6	3.4	1.9	6.7	8.0	2.0	11.3	4.4	6.1	4.1	6.6	5.1	9.3	11.8	2.6	5.4	9.2	4.2	11.9	3.9	2.4	4.6	5.9	5.8	9.9	13.0	6.5	3.4	4.9	2.4	3.0	0.7	0.0	2.4	2.7	0.0	2.1	0.4	1.8	2.3	0.9	2.0	0.6	0.9	3.2	0.1	0.2	2.0	0.0	1.7	23.9	0.2	17.1	0.4	0.0	3.9	0.1	18.5	4.0	0.1	0.9	0.1	0.8	7.3	0.0	1.6	25.3	11.0	0.7	0.0	4.1	6.9	0.2	5.8	0.0	8.2	1.1	1.0	0.9	0.5	0.1	0.0	0.1	6.4	1.0	4.4	10.6	6.0	0.0	1.1	4.6	0.4	24.5	5.8	0.1	3.0	0.0	4.6	13.9	18.7	19.1	0.8	17.2	0.8	11.0	1.9	1.7	11.2	6.8	0.2	0.7	0.6	5.3	13.9	9.8	14.3	7.5	3.0	3.3	3.3	4.2	2.9	3.5	4.6	3.4	4.4	4.2	4.6	4.9	12.6	9.6	8.6	0.3	5.0	0.8	0.7	0.4	0.0	0.5	1.5	1.9	4.7	2.8	2.7	3.7	4.2	5.8	5.0	0.3	1.9	3.6	0.7	0.2	0.9	9.9	0.0	2.7	0.1	3.2	3.8	2.1	2.6	0.5	10.8	2.5	7.1	1.6	9.4	0.0	0.2	0.2	2.0	12.2	11.1	0.5	0.3	14.8	1.8	4.7	10.2	0.8	4.1	0.0	0.6	2.1	0.5	3.0	3.9	0.7	0.0	1.3	2.1	4.3	0.0	3.6	3.9	0.4	0.6	0.1	0.9	11.8	1.2	0.7	0.2	0.2
ADPRHL1	ARH2	ENSG00000153531	"ADP-ribosylhydrolase like 1"	Q8NDY3	13	113399610-113453524	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	36	"heart muscle: 384.9;skeletal muscle: 332.6;tongue: 243.0"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 148.6;Skeletal myocytes: 53.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 20.8;T-47d: 37.7"	"Region enhanced"	"Detected in single"		"cerebellum: 2.3"					"HPA066478, HPA072123"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA066478: AB_2685673, HPA072123: "	"unprognostic (3.03e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.02e-1)"	3.0	3.9	3.0	0.8	3.1	0.5	3.5	1.9	6.2	1.9	5.8	3.1	4.3	1.7	1.0	7.9	8.2	3.3	384.9	3.3	2.8	1.3	2.2	1.3	0.8	3.6	2.7	2.1	6.7	0.7	4.1	1.9	3.5	4.3	2.5	1.1	8.7	0.8	332.6	4.2	4.1	0.9	1.9	1.4	6.4	2.7	4.2	1.5	1.2	243.0	0.4	1.7	1.5	4.7	5.9	13.9	1.4	4.3	4.3	6.9	3.8	2.3	1.0	0.7	0.5	3.9	14.3	2.1	8.1	2.5	4.0	3.2	5.4	0.3	0.6	2.1	2.3	6.1	3.3	1.1	1.4	0.4	2.5	2.4	3.3	4.5	0.6	0.6	0.1	5.1	1.8	0.6	5.7	12.9	1.0	3.6	3.1	15.3	7.3	9.4	3.6	5.5	1.5	0.6	20.8	4.8	1.5	6.8	1.8	1.6	37.7	0.8	0.5	0.2	2.6	6.3	0.8	2.1	1.8	6.9	4.1	1.1	3.0	0.1	0.2	0.0	0.0	0.3	0.4	0.4	0.1	0.5	0.6	0.1	0.3	0.3	0.3	0.2	0.3	0.1	0.3	0.2	3.0	3.1	1.9	6.2	3.3	2.8	3.6	2.7	3.5	1.9	4.2	4.7	1.3	0.0	4.6	4.9	0.5	1.3	2.3	1.0	2.8	1.6	5.5	5.2	148.6	0.0	3.0	0.0	0.0	3.6	0.4	3.2	0.0	3.6	1.4	16.6	8.1	2.8	4.2	0.0	5.4	3.2	2.5	6.8	2.6	12.4	0.0	0.6	1.1	1.0	0.6	1.7	4.0	4.8	0.0	0.6	0.3	3.8	0.0	1.3	1.8	1.0	0.1	2.6	0.0	1.5	2.3	1.2	7.4	1.5	0.1	2.0	7.8	0.5	5.9	1.7	0.0	53.7	2.8	1.8	2.7	2.0	2.6	2.5	0.8	4.2	3.2	3.2
ADPRS	"ADPRHL2, ARH3, FLJ20446"	ENSG00000116863	"ADP-ribosylserine hydrolase"	Q9NX46	1	36088892-36093932	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 79.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 51.6;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026641, HPA027104, HPA027141"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		54000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619"	"unprognostic (3.22e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (3.71e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.74e-2)"	19.0	36.7	28.4	16.0	30.0	19.7	18.5	31.3	30.3	20.7	33.4	19.6	15.6	17.6	15.0	36.1	33.5	13.3	20.7	28.6	29.1	27.7	22.4	20.6	21.5	32.5	29.7	19.7	17.9	17.6	17.7	20.8	31.2	19.9	12.4	9.1	20.9	16.3	34.4	34.1	16.8	16.4	31.9	23.1	17.6	28.7	29.7	20.9	19.4	21.8	20.2	21.3	22.2	33.9	54.3	22.4	26.2	37.2	23.6	17.1	37.3	39.4	32.9	62.1	60.9	26.8	47.7	38.4	37.5	39.5	32.0	32.9	33.4	60.5	37.0	27.7	41.8	34.9	27.0	36.3	44.4	40.2	19.9	20.3	45.4	56.5	24.5	47.2	39.9	36.2	30.8	30.9	29.6	26.0	40.9	60.5	56.5	31.8	46.0	32.9	27.6	38.8	56.5	43.8	32.1	50.8	28.9	29.9	65.9	34.4	30.9	34.3	27.6	35.7	37.0	50.1	53.0	39.8	41.2	34.2	51.7	39.6	22.4	40.6	58.3	65.8	43.4	74.1	41.5	43.5	47.6	50.8	71.4	51.5	47.7	40.3	57.1	47.9	77.7	44.8	43.4	57.8	28.4	30.0	31.3	30.3	28.6	29.1	32.5	29.7	31.2	31.9	29.7	33.9	3.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	79.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	40.7	6.4	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	70.6	1.3	0.0	0.0	0.0
ADRA1A	"ADRA1C, ADRA1L1"	ENSG00000120907	"Adrenoceptor alpha 1A"	P35348	8	26748150-26867278	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.6;liver: 60.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 105.4;Early spermatids: 51.3;Inhibitory neurons: 123.2;Late spermatids: 28.3;Oligodendrocyte precursor cells: 114.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.9;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029678, HPA029679, HPA076693"	Approved	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 15: Liver - Metabolism"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Vesicles"	"HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: "	"unprognostic (1.27e-1)"		"unprognostic (1.68e-2)"		"unprognostic (1.99e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.04e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.30e-1)"	21.8	0.5	13.3	1.1	11.1	0.0	3.6	3.0	22.6	0.7	0.0	1.4	0.9	1.4	0.6	0.8	0.2	0.3	7.6	42.6	20.8	0.7	60.1	3.9	1.7	9.3	4.9	0.9	0.0	0.0	0.1	0.0	9.5	12.4	0.5	0.3	6.2	13.5	0.2	0.6	1.1	2.9	1.5	9.2	0.9	0.1	4.2	0.1	0.1	1.4	0.4	0.4	0.3	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	11.1	3.0	22.6	42.6	20.8	9.3	4.9	9.5	1.5	4.2	6.9	0.0	0.0	0.0	105.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.3	0.0	0.0	0.1	0.0	0.0	15.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	16.2	0.0	0.0	123.2	0.0	0.0	0.0	0.5	28.3	0.6	0.0	0.0	9.4	0.0	0.0	0.0	114.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
ADRM1	"ARM1, GP110, Rpn13"	ENSG00000130706	"Adhesion regulating molecule 1"	Q16186	20	62302093-62308862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 369.5"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 1655.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 727.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042266	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		28000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042266: AB_10794044"	"unprognostic (5.49e-2)"	"unprognostic (5.14e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.47e-2)"	76.9	92.7	44.9	53.4	45.6	78.0	68.3	48.7	63.7	57.8	38.1	78.7	52.0	80.6	14.6	99.0	58.4	33.5	109.0	44.0	48.4	65.1	119.5	67.3	54.2	52.0	45.7	44.5	83.2	23.5	52.6	39.6	51.0	59.5	16.1	11.9	61.3	35.1	369.5	93.9	63.4	23.3	44.4	83.2	68.6	128.5	47.3	38.9	51.7	66.9	29.7	73.0	64.4	46.4	219.9	241.8	66.8	142.6	62.5	45.8	178.1	138.9	95.4	260.1	104.0	727.1	227.8	117.4	250.3	82.1	148.3	243.6	84.3	209.9	79.8	136.7	170.1	284.4	177.4	392.0	105.6	149.3	261.1	57.0	126.3	170.9	67.7	43.4	101.4	113.0	211.4	125.6	61.7	296.1	187.5	290.8	225.1	106.6	354.0	149.2	115.5	186.7	71.3	163.9	118.5	146.5	151.5	241.7	174.0	44.9	168.1	163.3	149.4	258.5	274.4	252.4	289.1	261.5	223.4	158.6	272.6	148.7	192.3	195.4	208.7	233.5	200.4	262.1	179.9	260.2	180.8	192.9	219.2	265.2	132.4	151.4	200.2	184.8	227.8	205.6	265.8	260.8	44.9	45.6	48.7	63.7	44.0	48.4	52.0	45.7	51.0	44.4	47.3	46.4	91.4	35.3	25.2	7.5	91.3	148.2	115.6	275.4	98.4	34.7	62.0	62.0	19.4	52.9	119.3	66.2	18.8	230.4	83.3	156.4	115.4	186.9	359.1	61.7	43.9	105.6	57.8	74.3	5.2	211.3	173.6	73.3	51.0	56.9	42.5	55.8	87.1	101.7	150.2	33.7	4.9	87.1	156.6	77.6	154.2	1655.0	72.4	89.8	97.8	3.7	126.5	73.0	83.4	4.0	8.5	247.5	129.7	86.9	118.2	145.7	118.6	139.0	96.2	31.7	65.7	49.9	177.0	135.2	204.2	108.0	148.0	423.0	86.1	57.5	95.2	144.6
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104345-44114562	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 103.0;Fibroblasts: 263.2;Leydig cells: 151.6;Peritubular cells: 508.9;Smooth muscle cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.1;BJ: 193.0;BJ hTERT+: 126.0;fHDF/TERT166: 208.9;JURKAT: 145.0;WM-115: 117.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 57.6"	"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2700000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	190.5	59.9	45.0	59.8	56.0	10.6	153.0	38.6	44.8	312.1	28.0	95.3	19.2	268.8	59.6	65.7	199.8	155.9	156.7	47.3	92.9	68.7	20.3	166.0	45.5	114.7	81.5	253.7	28.9	10.1	43.3	89.0	79.6	112.1	25.0	1.3	50.7	213.5	21.3	84.8	79.1	119.3	74.3	54.4	71.2	40.4	52.1	73.3	83.7	14.1	16.7	138.7	198.0	66.6	0.6	0.0	44.5	0.1	141.1	49.6	1.0	193.0	126.0	21.6	4.5	0.0	0.1	5.3	20.9	208.9	0.2	0.1	2.4	3.5	9.1	0.6	0.0	13.3	0.1	0.0	39.6	0.1	0.3	75.8	0.0	72.9	0.1	1.1	9.7	145.0	8.3	0.3	0.0	0.2	86.9	16.1	19.1	0.0	0.4	71.3	1.7	1.7	5.0	0.0	4.9	25.3	0.1	0.3	85.9	41.9	0.4	14.4	34.1	0.0	86.2	0.5	0.3	1.0	0.9	102.8	0.4	0.2	117.9	0.0	0.0	0.0	0.3	0.0	0.2	1.5	0.2	0.0	0.0	1.4	0.9	0.5	0.0	0.1	0.0	7.6	0.0	0.3	45.0	56.0	38.6	44.8	47.3	92.9	114.7	81.5	79.6	74.3	52.1	66.6	23.6	0.0	2.5	32.3	11.8	34.5	5.7	1.3	1.8	0.8	2.0	14.6	26.4	1.5	1.4	7.3	0.0	2.0	22.7	0.0	0.0	0.9	3.1	3.3	103.0	18.0	0.0	1.3	0.1	0.0	3.3	263.2	8.6	2.9	2.5	33.3	30.4	0.6	3.6	0.0	0.3	0.0	0.0	1.8	42.0	18.0	151.6	3.2	85.4	17.8	1.0	0.2	1.0	6.0	0.3	0.4	0.0	508.9	9.7	16.9	0.0	2.2	2.2	0.8	39.5	23.6	173.4	4.0	4.6	1.5	27.4	3.4	4.8	28.7	0.0	2.4
AEBP2	MGC17922	ENSG00000139154	"AE binding protein 2"	Q6ZN18	12	19404045-19720801	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020893, HPA022282"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA020893: AB_2670528, HPA022282: AB_2670931"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	19.0	27.2	9.9	20.0	11.6	20.5	23.5	13.0	16.5	25.8	12.5	18.8	16.3	34.0	20.2	35.1	28.0	21.8	17.8	17.7	7.2	27.8	20.3	20.7	27.7	1.9	6.7	35.1	17.5	29.9	8.9	44.1	2.0	24.8	20.6	27.7	19.3	30.7	13.6	29.4	16.7	31.1	0.3	23.1	16.1	20.8	11.8	29.2	30.8	19.8	32.3	25.0	18.2	14.7	32.4	42.4	42.6	20.1	31.1	38.6	95.2	29.9	34.1	43.5	45.7	48.0	54.5	51.0	24.3	41.4	27.6	38.0	93.7	34.6	69.1	149.4	30.6	46.7	60.8	30.0	36.4	60.1	30.8	36.2	36.3	35.6	52.8	52.0	35.6	34.8	25.2	1.4	41.2	38.5	63.0	71.7	82.6	26.6	18.9	50.3	82.3	35.9	32.2	68.2	10.0	23.4	60.6	25.7	29.8	91.3	32.8	35.0	40.5	40.7	30.9	12.8	44.9	14.0	24.9	106.0	30.3	25.1	29.2	4.3	2.5	2.5	4.2	2.7	4.4	2.2	4.4	3.6	2.0	2.8	3.7	5.8	2.7	6.0	2.2	2.6	4.5	1.2	9.9	11.6	13.0	16.5	17.7	7.2	1.9	6.7	2.0	0.3	11.8	14.7	23.9	25.6	14.3	31.6	20.5	75.2	25.1	15.5	53.5	29.8	22.0	13.3	22.1	12.8	24.2	12.9	43.8	60.3	24.3	9.5	17.6	12.3	1.3	31.1	31.5	22.2	22.7	11.6	57.2	12.2	24.8	28.3	14.3	28.8	27.8	17.7	14.3	12.9	15.4	52.2	59.4	11.2	4.1	17.0	47.9	2.3	24.5	17.8	28.4	30.0	17.7	21.5	14.4	42.3	51.6	11.5	10.3	29.0	18.3	24.5	9.0	18.3	26.1	16.1	19.7	46.7	40.1	16.2	26.3	51.0	76.0	83.0	28.1	34.2	10.7	28.2
AEN	"FLJ12484, FLJ12562, ISG20L1"	ENSG00000181026	"Apoptosis enhancing nuclease"	Q8WTP8	15	88621337-88632281	"Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 62.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 38.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048599			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"	"Nuclear membrane"	"HPA048599: AB_2756313"	"unprognostic (8.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.52e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.00e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.10e-2)"	9.1	12.2	6.8	10.7	7.1	17.7	6.0	6.6	6.8	6.8	7.0	8.4	5.1	7.6	9.6	9.6	7.0	12.5	7.3	6.3	11.5	9.0	13.5	10.1	12.8	8.6	7.7	8.0	20.9	4.4	22.4	6.9	7.7	12.1	8.6	1.0	8.3	8.2	15.1	7.2	9.1	10.1	8.1	15.2	13.2	9.8	9.5	10.7	10.3	3.7	11.9	11.5	5.9	7.7	14.9	64.5	39.6	34.2	17.4	20.7	83.7	51.5	46.8	39.1	47.8	53.8	28.2	63.6	16.1	28.3	35.0	20.9	148.0	42.1	32.6	15.7	58.2	34.0	26.4	89.9	42.0	28.5	32.8	25.6	36.4	48.5	39.7	14.0	33.0	20.6	54.6	35.2	48.3	34.4	35.5	24.0	96.0	30.8	36.9	45.4	28.2	46.9	16.5	31.9	31.1	28.5	20.8	23.7	40.1	90.7	19.7	32.0	29.9	39.5	55.1	16.2	70.5	67.0	48.5	54.7	36.0	31.5	79.1	0.0	2.3	0.8	6.2	3.7	12.0	10.9	10.8	8.4	5.2	10.3	11.6	10.6	0.6	3.9	4.9	3.1	19.6	9.2	6.8	7.1	6.6	6.8	6.3	11.5	8.6	7.7	7.7	8.1	9.5	7.7	6.9	6.4	8.1	4.2	21.0	18.6	25.8	6.2	12.0	1.2	21.4	15.4	3.9	8.6	12.9	1.8	0.0	4.7	8.4	5.6	3.9	11.4	23.6	22.5	5.3	7.6	9.0	11.8	20.5	7.6	16.3	9.0	11.7	17.7	2.5	12.3	2.5	6.3	4.5	1.7	16.0	9.9	26.4	4.7	26.4	62.7	4.4	7.8	14.2	3.7	14.2	3.1	9.2	9.0	2.5	11.5	6.2	2.6	26.9	27.8	2.3	5.5	5.4	0.9	13.1	12.0	11.6	10.2	18.2	10.9	28.3	6.2	14.9	6.8	9.7	25.4
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Alveolar cells type 1: 169.9;Breast glandular cells: 119.1;Endometrial ciliated cells: 194.3;Glandular and luminal cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924"	"prognostic unfavorable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	39.7	15.0	25.1	23.1	34.8	5.5	49.5	27.2	27.9	46.0	35.1	55.3	53.1	35.8	39.8	126.3	63.8	33.6	47.3	21.0	29.7	45.0	66.8	57.0	10.9	30.2	30.0	31.2	61.2	32.8	38.3	44.9	29.5	47.0	62.7	47.1	79.0	28.6	34.0	54.7	71.1	23.9	12.3	34.2	50.6	31.3	31.2	7.3	51.4	28.4	27.3	29.2	61.8	35.3	67.7	20.7	141.2	50.8	13.5	11.3	104.8	26.8	13.7	22.7	27.9	88.8	41.1	12.0	48.3	16.3	35.5	31.8	59.2	55.1	40.3	76.1	61.1	0.4	9.1	67.9	20.3	7.7	30.8	8.0	36.2	38.1	89.0	36.1	42.8	25.6	137.4	45.5	14.9	29.2	0.8	0.6	34.7	95.6	9.5	43.6	37.1	51.2	41.3	32.5	65.1	39.6	27.2	101.7	40.5	131.1	12.2	2.8	62.9	10.6	50.5	45.7	44.9	0.8	59.3	24.5	31.4	15.4	93.7	0.0	0.1	0.0	0.3	0.1	0.2	1.1	0.3	0.1	0.2	0.7	0.0	0.1	0.9	0.0	0.1	0.0	0.2	0.0	25.1	34.8	27.2	27.9	21.0	29.7	30.2	30.0	29.5	12.3	31.2	35.3	173.8	169.9	89.3	0.0	6.4	0.0	0.0	0.0	0.0	0.0	119.1	83.3	0.0	0.0	40.9	95.6	0.0	30.6	4.7	0.0	21.5	70.1	0.0	194.3	42.0	36.3	0.0	0.0	0.0	39.4	35.0	20.5	0.0	273.4	8.8	65.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	10.9	0.0	0.0	0.0	0.0	65.7	0.0	0.0	4.5	0.0	0.0	35.0	46.7	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	42.1	5.6	13.2	0.0	0.0
AFF1	"AF-4, AF4, MLLT2, PBM1"	ENSG00000172493	"AF4/FMR2 family member 1"	P51825	4	86935002-87141054	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 225.2;Microglial cells: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069947			Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Mitochondria"		"HPA069947: AB_2686219"	"unprognostic (1.01e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-2)"	33.2	18.0	10.7	18.1	11.8	35.0	22.8	8.1	13.0	24.8	51.4	25.9	18.2	25.6	11.8	19.1	21.4	19.6	19.6	10.2	10.0	32.8	24.8	20.7	16.3	16.3	9.8	28.8	28.2	31.8	12.5	26.8	11.8	18.2	22.5	63.6	24.0	22.8	55.6	23.4	19.4	31.9	9.1	19.4	19.0	6.9	14.2	22.8	54.9	41.8	13.4	18.5	19.0	12.0	15.3	13.5	11.3	12.0	18.3	21.6	15.9	15.1	22.2	11.3	16.7	14.7	27.8	17.3	20.2	18.7	14.4	6.8	18.0	22.8	15.7	29.8	7.2	36.0	38.3	12.3	14.1	35.0	27.4	17.7	16.1	19.4	17.0	16.4	42.1	14.1	22.5	47.5	4.8	4.1	31.6	10.1	15.0	25.6	4.8	24.7	6.7	22.2	33.1	14.5	25.6	4.7	23.1	15.0	7.2	23.5	9.0	28.9	21.3	20.9	18.8	12.9	8.5	41.0	24.8	29.6	17.1	39.5	7.7	5.4	7.4	17.6	8.8	5.4	9.8	12.0	11.8	8.9	8.5	14.5	6.0	5.8	28.4	7.7	3.3	20.7	11.3	4.2	10.7	11.8	8.1	13.0	10.2	10.0	16.3	9.8	11.8	9.1	14.2	12.0	88.0	41.7	55.6	125.7	29.3	24.1	20.2	17.8	33.6	41.7	20.6	11.6	119.8	40.0	28.4	92.0	225.2	1.4	29.1	40.7	3.9	11.9	7.2	32.4	39.1	50.2	32.3	54.5	69.2	12.6	4.2	36.3	42.8	46.2	25.2	40.3	65.0	34.2	13.0	18.5	47.5	35.8	16.2	41.7	32.8	9.3	29.2	34.8	23.2	202.4	16.5	21.4	16.5	74.4	84.0	13.1	31.4	28.6	53.9	21.9	29.8	50.3	36.0	147.2	26.3	41.9	31.2	3.8	11.3	45.3	31.7	32.8	26.4	13.3	29.0	15.8
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100192428	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 154.9;Excitatory neurons: 491.3;Inhibitory neurons: 300.7;Oligodendrocyte precursor cells: 211.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 11.4;prostate cancer: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 31.0;naive B-cell: 44.2;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in many"	17	"B-cells: 44.2;dendritic cells: 23.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 51.1;U-698: 56.5"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: AB_2682133"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.3	1.6	3.1	6.2	3.9	11.2	11.6	17.4	13.2	3.5	0.0	5.1	1.1	7.7	0.8	3.5	4.5	2.2	4.3	9.7	5.0	1.4	1.7	6.5	14.2	2.2	0.0	6.3	0.4	0.1	4.4	6.2	1.8	16.2	2.2	4.2	1.9	2.5	0.7	0.9	6.0	5.9	0.0	7.3	4.6	5.4	0.0	7.7	1.2	0.7	12.2	6.7	2.2	9.8	0.2	0.0	18.0	6.4	0.0	0.6	0.0	2.8	0.7	5.6	1.9	0.0	0.0	51.1	0.1	3.8	12.4	0.2	0.5	0.0	4.0	14.3	6.3	0.0	0.0	0.0	0.4	0.2	12.4	0.8	0.0	12.8	0.2	13.8	0.0	2.2	0.3	0.1	0.0	0.1	4.3	0.3	1.8	0.0	3.2	7.5	0.0	0.3	0.0	0.0	17.4	6.5	0.0	0.3	11.0	1.5	17.9	16.5	6.7	19.1	3.4	0.5	2.9	0.8	0.1	56.5	15.9	1.5	2.0	0.6	0.5	0.1	0.0	0.5	0.3	31.0	0.2	0.0	5.1	44.2	1.9	0.0	0.0	1.0	0.4	23.9	0.0	0.8	3.1	3.9	17.4	13.2	9.7	5.0	2.2	0.0	1.8	0.0	0.0	9.8	1.2	6.4	40.9	41.8	154.9	1.8	0.4	0.0	1.8	21.8	78.9	37.7	11.1	0.0	3.7	0.0	12.5	0.4	32.8	0.1	0.0	0.0	33.9	0.9	19.8	6.0	22.9	3.4	491.3	0.0	0.2	13.5	1.1	1.1	0.0	31.6	0.7	1.2	1.8	47.1	300.7	0.5	0.0	9.2	18.2	38.5	10.8	16.5	14.2	66.5	5.2	6.8	0.0	211.6	46.7	0.0	0.1	21.1	0.8	14.3	0.1	1.9	0.0	1.7	0.0	1.1	8.5	10.5	9.8	0.0	1.3	0.1	6.1	5.7	0.6	0.3
AFF4	"AF5Q31, MCEF"	ENSG00000072364	"AF4/FMR2 family member 4"	Q9UHB7	5	132875395-132963634	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023690, HPA029634"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA023690: AB_1844633, HPA029634: AB_2673129"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (1.69e-1)"	21.4	28.2	10.9	16.9	13.3	43.4	22.8	20.2	15.3	20.3	9.9	18.5	14.4	26.7	18.2	26.8	16.4	26.0	16.5	11.3	18.7	24.3	21.1	19.7	15.4	11.5	16.1	28.9	24.9	36.3	19.5	20.5	10.6	25.1	17.6	47.3	19.1	21.3	25.4	18.5	15.0	23.6	7.8	16.8	25.1	18.0	19.0	19.0	33.2	25.6	17.1	23.1	19.3	15.6	42.5	33.5	45.2	50.3	34.1	40.9	35.3	44.8	47.9	40.4	51.2	49.8	27.2	21.5	51.7	59.2	49.0	20.8	36.8	55.5	67.3	15.4	23.7	26.6	44.6	17.8	43.6	9.4	26.5	48.2	36.2	70.2	70.7	43.5	39.4	19.2	19.4	17.7	51.2	16.0	26.1	10.0	17.4	12.6	13.6	17.3	44.1	8.1	35.0	58.8	35.2	37.0	50.9	12.3	50.4	62.0	26.2	15.0	55.9	48.3	40.8	43.0	48.2	24.3	45.3	19.3	45.2	17.2	33.7	13.0	1.8	3.2	4.0	1.5	3.0	6.2	3.7	2.8	2.2	6.3	3.8	3.3	4.1	3.0	4.1	4.1	1.9	1.3	10.9	13.3	20.2	15.3	11.3	18.7	11.5	16.1	10.6	7.8	19.0	15.6	134.3	80.1	43.9	62.3	98.7	79.7	79.8	52.0	140.0	74.8	94.1	76.7	65.2	57.2	70.8	58.8	158.4	36.4	75.9	69.9	7.9	51.1	244.1	136.4	147.8	79.3	97.6	29.2	99.5	46.2	47.8	98.0	197.2	229.0	43.1	222.1	54.3	25.2	41.9	79.1	85.1	59.1	50.8	62.3	123.7	200.5	69.3	100.9	69.4	60.9	41.6	61.9	39.1	73.9	106.0	75.8	65.5	67.4	93.0	97.3	56.1	35.7	53.2	135.1	78.9	126.5	103.8	34.2	21.5	130.6	86.5	69.9	68.9	89.6	47.2	120.0
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 219.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 16.4;Excitatory neurons: 22.2;Inhibitory neurons: 12.3;NK-cells: 17.5;Sertoli cells: 32.9;Smooth muscle cells: 16.2;T-cells: 16.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 219.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.3;Karpas-707: 39.8;RH-30: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	6.3	2.5	85.4	10.0	69.0	14.5	1.8	0.6	219.9	0.8	0.0	2.2	2.9	2.0	0.3	2.3	1.0	4.3	23.5	162.1	0.0	0.8	1.1	3.4	16.9	0.0	0.0	1.5	3.7	1.8	7.5	2.5	0.0	1.9	1.5	4.6	2.3	0.8	15.1	3.2	5.8	1.0	0.0	11.4	3.3	1.0	0.0	15.0	2.5	9.9	11.3	3.2	1.0	38.7	7.3	10.5	19.8	5.8	0.0	0.0	11.3	4.8	0.9	0.1	0.5	1.2	6.6	18.4	1.5	0.0	3.6	4.4	0.1	0.2	0.0	20.3	3.1	20.5	1.6	3.4	0.1	21.2	40.3	0.0	0.0	0.1	0.1	8.4	0.0	21.3	0.0	39.8	0.0	12.6	37.4	13.5	3.2	2.3	10.6	15.5	98.8	13.4	0.0	6.0	5.6	20.5	2.6	3.6	4.3	0.1	2.6	14.8	11.2	5.5	9.0	10.5	3.6	16.8	10.9	9.4	9.8	13.9	9.4	3.8	0.5	0.6	2.7	0.8	2.9	1.2	2.8	3.0	0.8	0.8	1.1	1.7	3.8	1.4	0.4	0.8	4.2	1.1	85.4	69.0	0.6	219.9	162.1	0.0	0.0	0.0	0.0	0.0	0.0	38.7	3.6	3.2	1.1	0.0	5.7	0.0	0.3	0.0	0.0	10.0	0.8	0.5	5.8	1.5	0.6	0.0	0.0	0.1	16.4	0.2	0.0	0.1	0.4	0.1	0.7	4.2	0.0	2.1	22.2	0.0	0.2	0.9	2.0	0.2	2.5	0.0	1.1	0.1	1.3	8.4	12.3	0.5	0.0	2.2	1.1	1.1	0.0	3.0	0.0	1.9	3.9	0.5	17.5	5.0	1.2	0.1	0.1	0.7	11.4	0.3	0.3	0.1	0.0	2.3	32.9	2.2	16.2	0.8	0.4	0.2	0.4	0.0	16.4	0.3	0.2	0.0
AGFG2	"HRBL, RABR"	ENSG00000106351	"ArfGAP with FG repeats 2"	O95081	7	100539203-100568220	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"salivary gland: 289.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 34.3;Hepatic stellate cells: 57.5;Hepatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019689, HPA073562"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Nucleoplasm	"HPA019689: AB_1855074, HPA073562: "	"unprognostic (7.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.03e-6)"	"unprognostic (7.83e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.90e-3)"	"unprognostic (9.31e-2)"	12.8	35.6	16.7	5.1	20.1	5.0	11.2	10.8	15.8	11.6	6.8	18.9	10.3	21.9	5.3	30.8	16.4	11.1	9.8	22.0	14.7	14.0	53.9	7.8	9.0	19.4	12.0	30.2	18.8	7.4	17.7	2.2	14.1	13.3	9.9	2.2	289.4	13.4	6.2	26.0	13.4	7.6	11.1	29.1	13.5	12.1	15.5	4.4	10.7	5.6	6.4	11.7	12.5	12.3	10.8	17.2	2.2	5.1	15.1	7.8	3.0	5.1	13.6	7.9	8.2	15.1	9.6	6.8	16.5	6.0	34.8	8.8	2.4	5.2	3.5	24.1	6.7	2.1	8.3	33.1	6.1	2.2	11.7	13.0	3.9	6.4	7.1	4.9	21.6	4.4	6.4	9.2	6.5	9.5	8.8	8.0	1.5	30.0	7.1	4.3	2.5	6.1	4.6	5.7	3.1	3.8	9.9	14.0	4.6	3.4	4.0	3.0	5.5	9.8	6.7	24.5	5.4	5.6	31.4	2.6	7.4	6.5	5.7	2.2	0.0	2.2	1.7	0.2	1.5	0.3	1.7	2.0	0.1	0.6	0.5	0.7	0.4	0.5	0.0	0.4	1.4	0.6	16.7	20.1	10.8	15.8	22.0	14.7	19.4	12.0	14.1	11.1	15.5	12.3	16.9	0.0	3.9	15.0	3.2	2.0	7.4	2.3	8.6	1.6	4.3	3.6	9.1	34.3	3.1	25.8	2.1	1.8	4.9	25.8	11.7	13.4	1.7	2.8	3.2	13.4	26.5	5.9	6.2	11.6	1.6	3.6	10.2	4.2	2.5	7.2	57.5	37.0	1.5	3.3	4.8	12.0	2.0	5.4	3.1	2.3	5.6	1.3	3.6	3.7	7.1	4.0	7.2	3.0	2.5	7.2	9.6	9.1	7.3	3.6	11.1	2.8	1.0	1.7	13.1	1.5	5.6	14.5	14.5	9.2	5.4	0.8	12.6	6.8	15.2	6.9
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850361-99924023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 257.6;tongue: 212.0"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 160.5;Theca cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		450000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	11.9	6.7	4.1	7.1	4.9	6.1	9.1	6.9	5.6	6.1	6.0	10.0	8.8	7.3	7.6	16.4	5.4	5.2	22.8	3.7	5.1	13.3	42.8	5.9	7.3	4.7	5.6	5.9	4.3	17.6	4.5	11.7	4.4	13.8	10.6	23.3	7.7	9.6	257.6	5.3	7.1	9.7	4.9	8.0	7.7	4.7	4.8	7.9	10.5	212.0	8.5	8.9	5.0	5.6	20.4	5.9	7.0	11.4	11.0	10.4	23.4	6.3	9.2	5.5	9.8	22.3	6.8	26.4	11.7	10.8	4.9	11.3	40.5	12.4	10.2	14.2	12.9	15.5	18.9	12.4	7.3	13.7	8.9	12.8	7.9	7.5	6.2	7.5	8.5	9.2	26.3	2.0	5.5	6.2	16.3	4.3	10.9	8.9	7.7	0.0	2.3	1.3	16.3	26.7	17.2	12.1	18.2	17.3	9.9	12.8	12.6	9.0	9.4	6.6	9.3	8.9	6.3	7.3	6.1	30.5	11.7	3.6	3.5	0.0	0.4	1.4	1.5	0.6	1.4	1.0	1.1	1.0	0.9	1.0	1.1	1.1	0.5	2.4	0.3	0.8	1.3	0.8	4.1	4.9	6.9	5.6	3.7	5.1	4.7	5.6	4.4	4.9	4.8	5.6	12.8	22.4	26.8	96.6	28.5	10.6	18.1	24.6	18.2	34.6	18.8	18.0	119.6	18.6	25.8	16.5	54.2	107.9	18.8	23.2	23.5	13.7	1.2	18.8	23.6	13.9	16.8	15.6	45.6	12.9	20.3	28.5	31.1	18.6	10.8	45.0	14.6	111.0	17.9	52.2	56.0	15.8	12.2	19.1	8.8	2.5	10.2	13.5	16.0	23.4	14.1	160.5	21.6	36.2	34.4	17.7	14.3	21.4	20.4	13.0	15.2	19.2	26.0	46.9	6.6	41.4	18.4	8.7	11.9	40.0	9.2	29.1	25.7	159.1	23.5	20.1
AGO3	"EIF2C3, FLJ12765, hAGO3"	ENSG00000126070	"Argonaute RISC catalytic component 3"	Q9H9G7	1	35930718-36072500	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 155.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048342, HPA067849, HPA075436"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750"	"unprognostic (4.10e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.39e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.81e-1)"	3.6	2.8	4.5	2.6	8.4	7.4	2.9	6.9	6.9	3.3	7.4	3.0	1.4	2.9	3.2	2.7	2.7	1.9	3.4	4.6	6.9	2.5	4.3	3.5	3.0	8.5	7.2	3.7	2.9	3.3	6.2	3.5	7.4	3.2	2.0	5.1	2.5	2.2	3.2	3.8	2.5	2.7	6.8	2.8	2.8	5.6	8.0	3.3	3.2	4.4	3.1	3.0	3.0	14.0	6.6	4.4	5.5	4.4	7.5	4.6	6.7	5.2	5.4	7.9	8.4	4.9	7.2	7.2	6.5	5.4	9.1	5.3	5.9	3.8	10.5	9.9	3.7	8.8	8.3	3.7	4.0	8.5	7.2	2.2	3.4	11.4	7.2	3.1	6.8	7.4	9.8	10.2	7.0	2.5	6.5	4.6	9.6	3.4	7.8	7.5	7.4	7.1	2.5	6.2	6.7	4.2	9.4	2.3	3.3	8.3	3.5	3.5	5.4	5.5	13.9	4.9	6.4	5.6	10.5	9.9	2.8	5.4	5.4	9.8	4.3	13.2	4.9	4.1	3.1	6.5	3.1	3.4	4.8	6.4	4.4	4.3	13.0	5.4	6.1	4.2	3.4	2.3	4.5	8.4	6.9	6.9	4.6	6.9	8.5	7.2	7.4	6.8	8.0	14.0	32.2	86.6	43.2	80.6	32.6	38.7	35.9	17.8	35.3	69.1	26.1	17.8	19.1	17.2	23.0	25.8	112.6	11.8	36.6	13.2	0.0	15.8	56.0	26.6	43.0	33.8	46.7	18.7	103.8	12.2	14.8	42.3	19.9	35.6	55.9	31.6	36.8	24.7	16.4	42.1	101.1	16.0	20.3	31.7	45.1	76.7	37.9	29.7	23.2	70.3	36.9	35.2	27.8	141.8	155.9	17.3	9.1	41.3	24.7	41.1	15.0	8.8	17.5	89.6	19.7	64.4	29.9	37.5	22.1	20.0	33.5	12.9	35.3	31.0	17.5	27.9
AHCYL2	"IRBIT2, KIAA0828, long-IRBIT"	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"choroid plexus: 488.0;intestine: 177.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 567.4;Distal enterocytes: 334.0;Excitatory neurons: 131.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 235.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 40: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	7.1	10.2	25.4	15.6	35.9	3.2	8.4	27.2	34.4	10.6	488.0	157.4	57.8	9.1	7.2	9.6	7.4	55.8	4.6	47.3	32.5	28.5	7.7	65.8	10.8	30.3	28.1	11.4	13.7	19.2	21.3	12.1	22.5	9.3	177.4	57.8	30.6	7.0	37.3	24.3	38.6	11.8	27.8	7.0	41.9	10.5	39.0	9.4	42.6	27.7	9.4	16.1	7.6	25.2	8.7	13.5	25.4	15.3	6.8	9.9	5.4	6.8	9.4	7.5	6.6	7.9	5.7	5.3	6.9	7.4	15.9	6.0	12.8	10.7	8.3	235.7	16.0	12.4	14.5	6.4	4.0	9.3	15.4	9.1	13.5	6.0	9.1	12.7	15.1	10.1	5.8	28.7	9.9	8.2	13.7	12.1	12.7	8.6	9.5	9.0	6.9	14.4	15.0	11.5	11.6	7.3	15.5	6.5	9.3	21.0	6.1	6.6	8.6	6.4	3.6	16.9	7.2	12.0	14.6	7.2	16.4	9.8	9.9	0.1	0.4	0.7	0.3	0.9	0.4	0.3	0.5	0.2	0.4	0.1	0.4	0.1	0.1	1.3	0.4	0.1	1.8	0.2	25.4	35.9	27.2	34.4	47.3	32.5	30.3	28.1	22.5	27.8	39.0	25.2	4.7	60.9	98.6	567.4	9.3	15.6	5.1	7.2	31.3	10.8	4.8	4.3	7.3	18.6	16.4	5.5	6.2	12.5	2.2	334.0	11.7	4.5	61.7	5.9	5.3	5.2	9.1	3.4	131.2	5.3	2.9	3.6	30.1	8.7	5.7	6.0	5.7	6.0	4.7	5.0	115.5	32.9	6.1	10.0	6.1	30.6	4.1	7.3	24.9	99.3	7.7	91.0	2.1	127.2	77.5	6.2	71.8	6.8	7.4	6.2	27.0	17.1	8.7	5.9	6.6	5.1	4.3	5.1	2.3	17.8	9.8	15.2	7.3	8.3	46.1	15.1
AHDC1	"DJ159A19.3, RP1-159A19.1"	ENSG00000126705	"AT-hook DNA binding motif containing 1"	Q5TGY3	1	27534035-27604431	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 31.3"	"Low region specificity"	"Detected in all"							"HPA028648, HPA028685, HPA028691"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781"	"unprognostic (1.96e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (4.43e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (5.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	12.3	24.3	10.6	3.8	8.4	2.5	12.6	12.5	11.3	23.5	0.0	16.2	2.6	26.8	2.2	35.8	19.5	3.4	18.2	9.1	8.1	11.5	7.6	12.0	3.2	5.5	9.2	22.7	8.5	2.0	18.7	4.6	3.8	12.0	1.1	2.7	16.8	6.9	30.3	31.2	7.8	5.2	3.2	16.6	11.3	9.7	9.0	6.3	20.9	15.5	2.0	15.2	24.2	5.1	10.5	9.5	13.0	6.9	4.1	6.7	13.2	9.6	6.8	6.5	5.3	3.7	9.5	1.6	6.9	6.5	3.9	10.3	1.4	12.5	1.9	3.9	5.0	8.3	9.0	5.0	3.8	2.2	4.1	6.3	5.0	4.6	2.9	6.7	3.4	4.8	10.0	1.1	11.1	5.1	7.2	11.8	9.5	2.6	11.5	31.3	15.7	0.8	4.4	1.4	22.3	8.6	6.8	10.8	2.7	4.4	5.3	1.9	6.6	11.2	9.2	8.4	3.0	3.3	2.4	1.6	9.5	6.5	6.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.1	10.6	8.4	12.5	11.3	9.1	8.1	5.5	9.2	3.8	3.2	9.0	5.1	20.3	6.4	5.2	39.2	5.8	49.5	9.1	25.3	41.5	33.4	37.9	44.4	14.5	4.3	14.4	18.4	0.0	11.5	23.0	10.3	3.9	10.4	0.8	13.2	33.0	19.7	9.7	3.4	26.4	13.7	4.3	24.5	15.8	14.1	0.0	5.5	17.2	11.7	14.2	35.3	19.9	5.5	6.1	3.5	24.8	4.1	51.9	5.8	16.0	16.9	3.6	12.8	14.4	21.6	8.1	16.2	4.5	63.6	5.6	11.6	4.3	4.3	17.7	2.0	39.5	46.2	20.9	4.6	6.8	61.6	56.1	5.6	10.5	67.5	6.6	13.6
AHR	bHLHe76	ENSG00000106546	"Aryl hydrocarbon receptor"	P35869	7	16916359-17346152	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Cancer-related genes, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 262.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 71.0;hTERT-HME1: 73.8;OE19: 61.2;RT4: 63.2"									"CAB005072, HPA029722, HPA029723"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.45e-2)"	22.3	15.0	1.4	25.8	2.7	44.1	19.5	1.4	2.8	14.5	2.3	13.7	16.4	8.8	7.0	17.4	10.5	33.7	9.5	1.9	1.3	7.1	45.0	37.6	15.4	5.4	1.9	6.9	5.8	6.6	3.0	17.7	3.9	11.0	16.3	4.0	10.5	11.2	2.2	22.0	14.5	15.2	2.8	18.7	25.2	2.9	2.7	9.7	12.7	6.5	19.8	49.5	15.0	5.8	8.2	6.6	2.6	0.0	19.2	13.1	1.2	16.5	23.9	7.5	10.8	8.2	17.5	0.0	5.0	24.4	29.7	21.8	1.6	15.1	19.7	0.4	3.6	4.8	8.1	7.3	35.5	8.1	11.5	18.1	71.0	28.8	73.8	33.8	25.3	0.0	0.7	0.2	34.3	4.2	0.0	12.6	2.1	61.2	10.3	0.0	0.0	0.3	23.5	63.2	2.4	0.0	12.4	13.0	12.5	19.0	9.4	2.7	4.3	3.1	0.1	40.7	0.0	3.3	0.1	0.0	51.6	30.6	51.9	0.8	5.6	4.2	0.5	2.6	0.7	0.6	1.7	1.0	6.9	0.7	0.9	0.7	0.6	2.1	1.0	1.6	2.1	1.7	1.4	2.7	1.4	2.8	1.9	1.3	5.4	1.9	3.9	2.8	2.7	5.8	78.3	150.6	76.2	1.6	15.2	75.3	47.6	67.9	104.2	37.0	23.4	30.0	14.7	34.3	84.9	7.3	8.4	3.3	13.6	23.9	0.0	19.3	6.2	39.1	8.4	78.1	5.4	8.6	18.0	15.7	1.8	57.0	56.1	78.8	133.1	0.6	52.1	48.3	24.4	43.7	39.2	12.9	30.5	88.4	262.6	3.2	3.7	107.1	71.2	8.4	70.1	0.9	5.2	1.5	40.6	33.3	19.8	2.6	16.7	48.6	9.9	6.8	51.3	6.1	6.6	14.8	37.8	2.8	2.2	38.3	89.2	21.5	54.7	3.3	19.3	116.1
AHRR	"AHH, AHHR, bHLHe77, KIAA1234"	ENSG00000063438	"Aryl-hydrocarbon receptor repressor"	A9YTQ3	5	321759-438291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 46.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 299.1;Late spermatids: 168.8;Spermatocytes: 123.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 59.6;HMC-1: 76.8;NB-4: 91.1;WM-115: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA021483			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA021483: AB_1855110"	"unprognostic (2.06e-4)"	"unprognostic (3.48e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.33e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-6)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.55e-2)"	1.4	0.7	2.2	0.6	1.8	0.4	0.8	0.0	6.0	3.8	1.1	2.1	0.7	1.6	0.5	2.2	0.7	1.2	0.5	5.0	1.7	1.6	0.7	2.2	0.4	0.4	0.7	2.6	0.6	0.1	1.5	2.0	0.0	1.0	1.1	0.1	0.7	0.1	0.5	5.9	1.9	0.3	0.0	5.7	1.1	46.4	2.6	0.2	1.4	0.0	0.4	3.4	2.2	0.0	0.4	5.8	1.4	1.0	6.1	11.9	11.0	22.5	30.0	10.7	18.4	0.6	6.7	0.6	10.1	38.6	2.2	0.5	0.9	0.5	5.1	1.2	2.8	8.6	59.6	0.9	3.5	1.6	76.8	1.4	0.8	7.3	1.3	17.3	3.4	0.8	1.0	0.6	11.8	0.7	0.3	91.1	0.5	2.6	8.9	1.3	0.5	0.4	0.5	0.2	10.0	0.4	27.6	3.7	14.7	0.1	0.5	36.4	6.1	20.5	1.6	21.5	0.4	2.6	3.6	0.8	8.3	0.8	53.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	1.8	0.0	6.0	5.0	1.7	0.4	0.7	0.0	0.0	2.6	0.0	0.6	0.0	0.0	2.0	0.2	2.2	0.0	0.1	0.0	0.4	0.2	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	299.1	0.3	0.8	3.6	0.0	0.0	11.1	0.2	5.8	2.7	0.5	0.7	0.0	0.3	0.0	0.0	0.8	0.0	9.5	0.1	0.0	0.0	9.7	168.8	3.4	1.5	19.6	3.7	5.7	0.2	0.0	3.5	2.9	0.2	0.0	1.2	0.1	0.3	0.1	0.1	0.2	0.2	6.6	0.0	3.0	123.7	6.9	0.1	1.4	0.8	1.2	0.7	0.1	0.2
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.5;lymphoid tissue: 50.3"	"Group enriched"	"Detected in some"	4	"B-cells: 64.2;Early spermatids: 24.0;Late spermatids: 33.3;Plasma cells: 40.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 15.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"memory B-cell: 143.8;naive B-cell: 63.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 143.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 94.6;HDLM-2: 132.5;Karpas-707: 50.4;U-266/70: 41.7;U-266/84: 34.2;U-87 MG: 38.6"	"Low region specificity"	"Detected in many"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: AB_2676925"	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	1.2	0.6	0.9	21.6	0.6	1.2	0.9	0.9	0.9	0.6	8.1	2.4	1.8	0.4	0.3	1.6	0.4	2.3	0.3	0.8	0.6	0.5	1.7	1.7	50.3	1.3	0.9	0.2	0.4	0.0	9.8	0.9	1.1	0.9	2.2	0.4	1.3	0.1	0.3	0.6	15.5	0.8	0.8	24.9	3.2	2.5	0.8	4.1	0.7	1.0	49.4	14.0	0.5	0.7	15.8	0.0	0.9	0.0	0.0	12.5	0.0	0.0	1.6	1.1	1.0	0.0	0.0	94.6	0.1	0.0	0.1	0.1	0.0	0.0	1.0	132.5	0.0	3.3	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	50.4	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	0.0	8.9	0.0	8.3	8.6	0.0	0.2	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.1	17.9	0.3	41.7	34.2	0.8	38.6	3.4	6.7	20.7	8.2	0.0	2.0	7.0	5.4	143.8	5.3	3.5	4.2	63.7	0.5	1.3	16.3	0.0	8.2	0.0	11.9	5.0	0.9	0.6	0.9	0.9	0.8	0.6	1.3	0.9	1.1	0.8	0.8	0.7	0.4	0.0	0.0	0.0	64.2	0.0	0.1	0.2	0.0	0.7	0.1	0.3	0.3	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	24.0	0.0	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.4	0.0	0.0	3.2	1.9	33.3	0.3	3.2	3.6	0.0	4.0	0.3	0.0	0.5	0.0	0.1	0.1	0.7	40.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.7	0.4	1.4	0.0	0.0	10.0	0.0	0.0	0.4
AIPL1	LCA4	ENSG00000129221	"Aryl hydrocarbon receptor interacting protein like 1"	Q9NZN9	17	6393693-6435199	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1012	"retina: 836.0"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 1926.4"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;OE19: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026578	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA026578: AB_2671905"		"unprognostic (2.42e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.68e-3)"		"unprognostic (3.24e-1)"		"unprognostic (1.13e-3)"				"unprognostic (3.76e-1)"	"unprognostic (5.35e-2)"			0.0	0.0	0.2	0.1	0.3	0.7	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	836.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	2.8	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.3	0.1	0.8	0.2	0.1	0.3	0.0	0.3	0.6	0.0	3.2	1.1	0.0	0.0	0.8	1.0	0.0	0.0	139.2	0.1	0.0	0.6	0.0	1.4	0.0	412.8	0.1	0.1	0.2	0.0	0.0	7.8	0.4	0.2	8.5	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.4	0.0	0.1	1.4	0.0	0.1	65.6	0.2	0.2	0.0	0.3	1.1	1.3	0.0	0.3	1.8	0.0	0.0	256.1	0.0	0.5	0.1	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1926.4	0.0	1.8	0.3	0.4	0.2	0.0	0.4	0.3	0.4	0.1	0.0	1.7
AJUBA	"JUB, MGC15563"	ENSG00000129474	"Ajuba LIM protein"	Q96IF1	14	22971177-22982551	"Cancer-related genes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 61.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 47.5;Basal squamous epithelial cells: 35.3;Pancreatic endocrine cells: 33.8;Prostatic glandular cells: 34.2;Sertoli cells: 32.9;Suprabasal keratinocytes: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 217.0;hTCEpi: 222.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006171	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Golgi apparatus"		"HPA006171: AB_1852044"	"unprognostic (1.15e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.07e-1)"	4.8	3.0	2.3	1.4	1.8	0.5	6.7	2.0	2.2	14.4	9.2	3.2	1.5	12.1	8.5	18.3	7.5	4.9	6.3	2.2	1.5	17.7	43.4	15.2	2.6	2.5	2.1	12.2	11.6	7.2	2.0	19.3	1.6	10.6	2.5	3.7	8.2	15.9	1.9	61.7	1.9	8.4	2.2	3.8	4.2	5.5	1.9	8.2	10.9	2.3	5.5	7.6	15.5	2.7	46.9	54.1	71.0	27.6	6.8	12.2	57.4	44.9	58.5	102.6	91.4	116.0	47.3	1.2	45.5	92.9	70.8	146.2	54.9	217.0	124.6	4.5	5.0	3.5	90.8	131.4	78.9	4.9	3.1	38.9	222.3	42.9	164.3	72.7	40.0	8.3	1.9	2.8	96.2	37.3	4.5	5.7	4.5	86.6	73.9	12.7	59.0	1.2	103.9	71.3	0.2	6.2	135.5	39.4	8.8	57.4	55.3	4.5	36.1	44.2	88.4	7.3	43.6	0.4	1.3	0.5	7.0	4.2	20.6	0.7	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.5	0.1	0.2	0.3	0.2	0.5	0.5	0.2	0.2	0.0	0.1	2.3	1.8	2.0	2.2	2.2	1.5	2.5	2.1	1.6	2.2	1.9	2.7	2.1	19.2	6.4	0.7	0.0	47.5	13.0	27.6	35.3	0.1	3.7	9.7	4.5	20.0	10.2	7.3	0.0	10.0	0.1	0.3	5.9	14.3	5.8	13.0	2.5	4.0	0.0	0.0	0.0	14.9	9.8	3.4	0.0	4.4	0.0	12.8	2.5	17.1	1.7	0.0	0.0	0.4	2.0	0.0	2.2	5.0	3.7	0.6	3.6	0.0	0.0	8.1	0.0	0.5	0.0	33.8	0.1	0.7	1.2	34.2	0.3	21.0	8.3	0.2	32.9	2.7	14.0	7.0	2.7	14.2	49.6	4.0	0.5	1.6	0.8	18.0
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 76.3;Respiratory ciliated cells: 152.0;Spermatocytes: 174.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.6"	"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	3.5	3.1	8.1	3.3	9.9	3.7	4.8	13.5	17.2	3.5	10.9	4.6	3.6	4.3	7.6	4.3	7.9	3.5	4.9	6.4	11.0	5.3	3.1	4.1	4.2	8.8	10.7	3.6	3.4	9.2	7.7	3.1	9.5	3.9	4.5	14.1	5.1	3.9	4.8	3.9	3.6	3.9	10.7	4.0	4.5	16.6	8.7	7.6	6.9	3.5	3.6	3.4	3.2	13.4	2.3	1.6	6.6	11.5	6.1	3.7	4.8	3.5	4.3	3.6	4.9	2.6	4.6	4.9	1.7	3.4	7.9	3.7	1.9	3.9	7.6	10.2	4.0	3.8	3.8	2.6	4.8	4.4	2.3	3.1	7.3	6.6	8.6	8.8	4.2	7.2	3.6	4.0	2.7	4.7	4.1	3.2	1.5	5.1	2.5	5.5	3.7	4.7	5.0	4.3	7.8	6.4	4.2	3.9	5.9	3.7	5.1	5.8	5.2	3.1	2.2	5.1	2.3	2.0	1.8	2.8	6.8	5.9	2.0	17.1	2.8	7.1	5.1	1.5	4.4	13.1	4.9	6.2	2.1	10.8	6.2	5.4	5.6	5.6	4.8	3.1	3.9	1.6	8.1	9.9	13.5	17.2	6.4	11.0	8.8	10.7	9.5	10.7	8.7	13.4	13.3	28.9	17.2	21.2	13.6	2.7	7.7	14.7	3.4	18.3	10.4	6.7	18.9	5.7	19.9	9.2	14.6	3.4	8.6	13.1	0.0	9.1	70.9	76.3	5.4	10.0	19.8	4.2	34.8	4.5	1.5	6.0	12.2	7.3	22.1	10.6	8.9	2.1	3.6	20.2	37.0	15.5	14.2	5.3	3.9	41.7	7.5	5.6	5.4	25.3	5.0	12.6	18.6	22.6	46.9	7.4	8.9	6.4	5.5	5.6	22.9	6.8	152.0	50.7	26.3	9.1	6.9	174.3	34.1	4.0	2.6	5.6	10.3	4.7	11.4	7.9
AKAP5	"AKAP75, AKAP79"	ENSG00000179841	"A-kinase anchoring protein 5"	P24588	14	64465499-64474503	"Plasma proteins, Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 13.5;intestine: 3.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 15.6;Excitatory neurons: 17.2;granulocytes: 67.6;Intestinal goblet cells: 28.7;NK-cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"amygdala: 5.3;basal ganglia: 13.5;cerebral cortex: 8.5;hippocampal formation: 7.7"	"Immune cell enriched"	"Detected in single"	8	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.9"	"Group enriched"	"Detected in all"	5	"amygdala: 27.6;basal ganglia: 79.0;cerebral cortex: 29.4;hippocampal formation: 30.8"	"Group enriched"	"Detected in all"	5	"amygdala: 24.3;basal ganglia: 79.9;cerebral cortex: 44.9;hippocampal formation: 43.7"	"CAB004308, HPA053891"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"CAB004308: AB_626655, HPA053891: AB_2682294"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.44e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.49e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.45e-2)"	0.3	0.3	5.3	1.4	13.5	0.6	0.5	0.0	8.5	0.4	0.0	3.7	0.5	1.3	0.1	0.5	0.5	0.9	0.2	7.7	0.0	1.3	0.8	1.8	1.9	0.0	0.1	0.4	0.2	0.4	1.0	1.1	0.0	0.4	3.8	0.6	0.3	0.4	0.2	0.5	1.4	1.3	0.0	1.2	0.5	0.3	0.0	0.9	0.5	0.0	1.6	0.6	0.3	0.3	1.3	1.0	1.3	0.8	0.4	0.1	4.2	0.9	0.4	1.2	1.5	10.9	3.3	1.0	2.0	0.7	0.1	0.4	2.8	0.2	1.1	2.0	2.4	3.3	2.0	0.9	0.1	0.4	0.4	0.4	0.1	0.8	0.0	2.1	0.4	2.4	0.4	0.7	0.7	0.8	2.7	0.2	1.0	0.1	0.5	3.3	0.5	0.2	1.9	1.2	3.3	1.4	1.1	0.1	0.2	3.8	1.0	0.2	0.6	1.4	4.2	0.1	1.7	2.2	2.6	2.4	0.9	0.4	0.2	3.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.0	5.3	13.5	0.0	8.5	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	6.4	2.4	1.6	2.8	0.9	1.3	0.5	1.2	7.4	1.8	1.4	1.6	1.5	0.2	0.0	8.4	0.6	15.6	5.1	0.0	0.6	2.6	0.5	1.4	1.9	0.0	2.7	17.2	0.2	1.9	2.1	0.5	1.0	67.6	0.9	0.4	0.7	0.5	8.4	5.5	28.7	0.0	0.3	2.9	0.9	0.0	1.2	1.8	0.0	0.3	0.9	16.5	3.0	1.6	0.8	2.2	0.0	6.4	1.2	0.8	1.4	0.2	7.7	0.0	2.2	0.8	0.5	4.9	0.1	0.9	0.7	12.4	0.3	6.2	0.9
AKAP8	"AKAP95, DKFZp586B1222"	ENSG00000105127	"A-kinase anchoring protein 8"	O43823	19	15353385-15379815	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004776	Supported		Supported	Nucleoplasm		NA	NA		10000	"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004776: AB_1078122"	"unprognostic (9.04e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.17e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.78e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.57e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.83e-2)"	13.6	10.4	0.1	1.5	0.1	3.1	12.3	0.2	1.0	10.2	0.1	11.7	5.4	12.3	0.0	11.6	11.0	0.0	10.0	0.1	0.1	8.8	12.5	10.3	0.3	0.1	0.1	10.9	10.5	1.5	7.5	0.4	0.1	9.5	0.1	0.3	11.2	1.1	23.0	14.6	12.8	0.4	0.0	13.3	10.7	7.4	0.1	1.8	10.1	2.5	0.2	10.7	10.2	0.1	18.2	12.2	8.4	5.6	2.6	2.3	12.2	10.1	7.1	7.2	7.2	19.4	10.6	19.9	10.2	8.9	6.8	8.5	5.1	12.3	0.4	17.9	12.8	21.1	11.7	18.8	4.3	28.0	8.0	4.5	2.7	7.8	0.0	0.6	7.3	11.5	15.1	6.4	2.3	23.7	15.1	5.7	17.8	9.7	15.8	12.1	12.3	16.8	0.0	22.5	10.5	11.4	13.0	9.9	8.9	1.5	4.3	2.2	18.8	12.4	10.1	7.0	21.0	12.9	12.8	21.0	9.8	10.4	11.5	0.0	4.4	0.9	4.4	4.6	4.7	3.8	4.0	4.8	6.5	4.2	2.9	3.6	0.3	4.1	6.3	4.4	5.6	3.0	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	25.6	12.8	28.1	17.0	24.6	19.2	21.0	14.5	19.9	14.7	16.0	14.7	18.0	10.0	22.3	12.9	27.1	30.0	25.9	26.0	5.9	18.9	3.6	22.8	24.1	20.9	10.8	28.2	14.4	21.6	23.9	17.6	20.9	39.9	30.4	14.3	10.4	13.8	13.1	21.9	14.0	21.9	2.0	13.5	16.1	2.7	19.0	19.8	12.4	10.3	21.3	16.5	12.3	12.1	15.3	18.6	13.1	13.9	25.6	16.7	14.8	9.7	22.1	19.5	6.6	26.3	22.5	19.6	23.2	21.3	16.1	40.2	25.6	15.4	22.6	20.9
AKIP1	"BCA3, C11orf17"	ENSG00000166452	"A-kinase interacting protein 1"	Q9NQ31	11	8911139-8920084	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061391			Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA061391: AB_2684499"	"unprognostic (7.79e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (5.15e-4)"	"unprognostic (6.58e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.24e-9)"	"unprognostic (1.03e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.77e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.88e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.19e-1)"	16.0	33.0	21.3	12.4	21.6	11.0	14.9	20.8	21.9	22.1	21.4	22.2	13.7	22.7	17.3	22.4	19.2	13.5	27.1	21.2	22.8	22.7	15.5	17.2	11.3	21.8	24.6	19.6	13.0	13.9	18.7	16.0	21.9	17.3	11.3	16.4	14.6	14.9	37.7	10.3	14.2	14.9	22.4	25.5	16.7	17.6	22.2	16.0	18.6	22.1	9.1	18.8	17.3	22.7	81.5	73.2	31.1	30.4	29.2	37.0	25.0	58.6	45.6	35.0	33.4	39.2	48.1	14.7	45.2	42.5	36.9	53.4	15.6	28.3	24.2	72.4	40.3	25.1	39.7	34.9	34.3	33.6	29.1	31.7	37.8	17.2	62.9	26.8	32.2	29.0	52.2	15.3	65.3	26.6	27.3	31.2	26.3	39.3	54.6	28.5	22.9	18.7	35.7	33.4	22.0	21.6	67.2	29.3	31.7	20.1	33.7	27.6	53.1	49.0	44.5	84.2	56.7	23.0	63.0	3.6	51.0	40.5	52.6	3.1	31.5	1.4	15.3	29.0	16.1	9.2	17.8	17.4	41.1	8.5	11.9	21.0	1.9	13.1	14.5	43.7	58.8	18.1	21.3	21.6	20.8	21.9	21.2	22.8	21.8	24.6	21.9	22.4	22.2	22.7	16.1	19.2	9.9	6.8	7.8	10.7	15.1	54.0	16.5	15.9	13.2	17.0	11.7	20.0	22.2	20.2	10.4	40.9	12.5	7.0	25.4	41.4	54.6	7.6	20.6	24.5	2.4	15.3	8.3	36.0	41.5	22.0	9.2	10.7	49.4	25.9	22.9	15.2	65.9	25.2	10.3	9.8	75.3	25.5	17.3	28.0	22.1	25.6	16.0	8.4	33.4	32.3	7.2	9.5	5.2	33.1	18.6	48.2	9.0	8.3	11.5	21.0	15.7	15.5	19.7	15.4	22.2	39.8	35.1	18.5	7.1	11.8	14.7	48.9	13.7	11.8
AKIRIN1	"C1orf108, FLJ12666"	ENSG00000174574	"Akirin 1"	Q9H9L7	1	38991276-39006059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 1546.1;Late spermatids: 1455.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051871	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA051871: AB_2681646"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.77e-3)"	"unprognostic (5.17e-2)"	46.0	29.9	37.5	33.5	41.3	77.2	23.1	41.8	43.8	21.9	41.3	35.1	24.2	28.7	42.3	29.2	25.0	41.8	38.5	38.6	47.4	42.9	53.2	30.0	42.3	45.9	45.1	19.6	27.7	43.2	40.0	26.5	47.2	36.3	36.2	37.5	24.4	35.8	30.1	17.3	26.8	41.9	42.4	31.7	33.3	83.2	49.8	41.5	36.1	30.4	42.1	41.2	18.6	48.1	61.4	28.0	117.3	96.9	56.3	66.2	83.8	70.0	73.1	69.2	70.1	73.2	49.5	48.3	63.3	67.1	49.6	41.8	114.7	62.8	110.8	72.2	58.3	142.7	41.6	92.5	74.2	137.5	75.3	68.5	80.5	90.4	73.6	61.6	64.9	61.8	99.0	46.6	87.8	25.2	58.5	60.2	248.2	45.9	47.1	92.4	85.4	48.2	77.7	73.9	81.3	55.2	77.8	41.4	160.1	182.8	37.9	70.6	58.3	42.3	68.4	46.2	72.1	67.1	92.5	102.6	72.7	80.4	73.3	35.7	39.3	83.7	33.4	33.9	50.6	33.7	54.4	51.7	55.4	30.2	63.3	42.0	102.8	72.0	38.8	41.7	54.7	53.1	37.5	41.3	41.8	43.8	38.6	47.4	45.9	45.1	47.2	42.4	49.8	48.1	48.5	64.1	43.9	25.1	83.8	137.9	77.1	34.0	56.9	48.1	69.0	48.6	45.1	31.5	40.1	38.6	47.9	72.9	111.6	48.6	93.9	45.6	1546.1	108.2	56.7	43.5	94.8	57.9	32.9	40.5	76.9	49.9	37.2	93.9	47.6	55.1	35.0	37.3	45.5	55.5	26.6	49.6	36.7	39.9	109.9	1455.5	44.1	65.2	42.7	16.9	85.1	52.1	42.2	23.6	73.2	50.5	37.2	45.5	53.2	67.8	23.9	41.8	38.9	45.0	52.6	61.3	77.5	77.3	103.9	43.4	138.5	167.5	99.9	34.0	41.8	81.4
AKIRIN2	"C6orf166, dJ486L4.2, FLJ10342"	ENSG00000135334	"Akirin 2"	Q53H80	6	87674860-87702233	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA064239			Supported	Nucleoplasm		No	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA064239: AB_2685222"	"unprognostic (9.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.62e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	32.9	37.1	29.0	23.8	32.5	70.5	26.0	26.5	37.6	22.7	27.8	19.8	12.7	24.6	23.7	33.2	22.6	15.3	30.9	34.0	34.0	20.8	31.2	33.2	28.4	26.9	28.8	25.6	13.2	17.8	23.4	18.5	26.4	17.0	12.5	29.7	24.5	11.7	97.4	22.9	22.9	16.4	29.5	49.0	16.8	24.1	35.7	31.2	17.2	42.6	30.3	23.2	25.0	30.9	23.9	24.7	71.0	40.1	43.1	29.6	41.4	41.1	25.7	33.2	32.3	39.7	18.0	62.2	44.1	42.1	55.1	36.2	39.1	29.6	37.9	79.2	48.5	36.3	21.8	89.7	47.1	31.4	30.2	34.6	29.9	41.0	40.2	32.5	36.6	24.3	71.2	42.2	43.5	30.7	9.9	64.9	51.0	20.3	38.1	38.7	50.2	25.7	41.7	20.8	53.0	50.3	24.9	14.8	44.2	40.1	17.9	73.9	47.6	27.5	18.8	23.5	54.6	40.9	48.4	38.8	30.4	40.2	45.1	76.1	57.8	64.8	28.1	73.2	29.2	41.6	27.4	27.6	55.0	32.6	21.4	23.1	144.4	36.6	75.6	75.1	39.1	35.0	29.0	32.5	26.5	37.6	34.0	34.0	26.9	28.8	26.4	29.5	35.7	30.9	49.9	25.6	19.8	10.4	88.2	96.5	192.2	101.9	80.8	13.0	31.8	28.8	22.5	35.8	43.7	18.4	8.4	45.1	94.4	17.1	45.0	30.9	58.0	44.9	34.3	45.6	12.1	45.4	15.6	14.7	71.0	51.1	16.3	39.9	33.6	47.2	44.6	29.9	77.0	11.8	14.8	10.9	69.2	104.4	167.0	100.9	35.8	142.8	74.7	19.7	46.7	80.5	33.0	17.6	15.1	29.6	21.7	28.2	69.4	119.7	19.0	53.5	17.9	17.0	6.6	62.2	39.9	70.6	63.0	92.6	92.9	136.5	99.5	54.2	12.6	191.0
AKNA	KIAA1968	ENSG00000106948	"AT-hook transcription factor"	Q7Z591	9	114334156-114394405	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 110.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 148.0;dendritic cells: 240.0;NK-cells: 265.7;Plasma cells: 137.3;Rod photoreceptor cells: 140.1;T-cells: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 108.4;MOLT-4: 98.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052367, HPA063993"			Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Centrosome"		"HPA052367: AB_2681801, HPA063993: AB_2685169"	"unprognostic (5.19e-3)"	"prognostic favorable (1.22e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.12e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.29e-4)"	23.3	8.5	13.1	54.5	14.3	50.6	18.9	12.9	14.9	49.6	21.0	20.5	16.2	37.2	5.8	8.8	37.4	14.6	8.4	11.1	14.5	10.3	19.2	32.0	82.4	22.7	21.2	28.0	10.4	2.9	11.4	8.5	17.2	16.9	11.9	36.0	9.2	11.0	3.0	7.7	52.5	22.6	16.3	110.6	21.4	7.8	15.2	75.2	11.5	3.6	61.6	17.6	18.3	14.1	4.7	4.8	5.9	3.7	36.9	4.4	25.1	5.0	6.2	4.8	4.0	7.8	4.9	57.9	4.7	4.3	8.2	10.7	3.7	1.4	1.3	108.4	2.3	6.0	2.4	5.6	42.2	57.5	59.5	8.0	8.1	4.0	3.8	6.7	8.7	49.9	5.3	61.9	2.0	7.5	98.0	63.2	20.1	10.2	5.8	60.4	1.0	12.8	40.3	2.3	2.7	5.2	1.3	4.0	13.4	6.3	11.5	29.2	14.2	2.2	4.8	0.8	4.2	12.5	15.4	47.0	2.8	27.6	2.2	11.5	7.9	12.6	18.9	5.7	14.8	7.6	10.3	16.9	5.0	7.9	9.0	12.1	19.6	14.6	5.5	10.5	8.7	10.3	13.1	14.3	12.9	14.9	11.1	14.5	22.7	21.2	17.2	16.3	15.2	14.1	13.5	12.8	22.8	2.6	76.0	5.2	6.9	1.6	6.2	36.4	7.4	5.3	4.1	4.3	8.3	23.9	148.0	9.5	240.0	9.5	0.0	3.7	17.5	34.8	14.4	9.7	12.7	34.3	2.6	8.1	6.2	8.8	17.9	12.4	33.5	16.6	12.1	9.6	18.2	5.0	8.4	18.9	2.0	59.1	31.5	26.2	14.6	43.0	5.4	19.7	67.2	7.0	265.7	20.1	4.9	5.4	9.2	6.8	137.3	7.8	12.6	0.9	40.7	140.1	0.0	5.8	13.6	1.1	0.9	1.9	3.4	3.4	145.7	2.8	13.4	9.3
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 872.9;Proximal tubular cells: 1215.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	68.8	72.7	37.6	73.4	41.4	48.6	123.1	41.3	38.9	84.0	49.1	106.6	188.7	59.9	90.7	151.9	88.9	61.7	67.6	37.2	41.0	323.5	323.7	75.8	97.3	44.0	39.3	61.8	158.1	60.8	99.4	63.9	44.1	75.9	115.4	23.2	123.0	60.0	46.5	73.5	171.6	79.0	43.3	92.5	112.9	21.1	44.4	77.3	80.7	42.6	117.0	72.3	70.9	53.2	74.3	94.5	91.2	73.7	173.1	124.8	67.9	78.3	178.0	68.8	133.5	40.1	50.3	179.5	68.5	86.2	71.6	94.5	94.0	118.3	60.0	74.3	92.6	101.2	82.2	167.8	152.0	132.4	102.7	140.2	104.7	87.0	157.4	123.4	154.7	125.1	59.4	131.2	77.1	49.1	147.3	61.2	106.0	219.4	68.2	170.1	119.5	211.9	185.5	89.3	117.5	65.3	71.8	271.1	108.5	113.2	80.3	72.3	97.2	30.2	72.0	113.1	54.2	97.0	140.5	87.6	59.1	168.7	26.6	141.8	229.5	45.4	65.3	224.5	71.6	99.8	59.6	63.5	196.8	108.9	51.4	52.4	11.1	66.1	174.8	170.0	81.9	182.7	37.6	41.4	41.3	38.9	37.2	41.0	44.0	39.3	44.1	43.3	44.4	53.2	53.0	48.1	57.3	7.2	96.6	49.2	99.3	210.0	87.6	21.2	121.0	94.7	46.1	95.8	173.8	79.1	37.5	115.2	45.1	113.7	181.9	195.9	5.4	48.7	49.1	58.6	118.4	48.0	8.3	156.5	142.1	82.0	135.5	54.7	112.1	59.2	78.1	294.5	399.3	16.8	7.1	201.9	118.0	141.8	153.7	9.6	68.3	142.1	81.8	20.6	140.3	33.6	49.4	9.0	16.2	123.6	199.9	56.1	187.2	115.1	872.9	1215.0	131.6	38.0	6.6	40.3	132.5	5.9	32.2	158.5	47.0	67.9	49.5	59.0	198.5	129.6
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442356-134459284	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"adrenal gland: 3039.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 649.2;Cytotrophoblasts: 1105.1;Extravillous trophoblasts: 1284.9;Ionocytes: 697.8;Syncytiotrophoblasts: 2022.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 1667.3;BJ hTERT+: 3096.2;RPTEC TERT1: 1447.8;U-87 MG: 1343.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	65.1	3039.1	83.1	38.4	89.3	21.9	52.3	91.8	97.4	41.4	80.9	40.1	20.5	42.4	44.0	28.2	38.7	40.2	208.2	84.1	92.5	218.0	19.3	55.0	74.6	101.6	96.9	60.5	34.4	111.2	76.5	203.7	104.9	34.4	30.9	36.5	41.9	332.7	330.0	26.6	50.8	39.6	91.4	62.8	51.4	44.9	88.7	54.9	44.3	396.9	62.5	67.3	35.0	101.4	184.2	1667.3	186.5	261.4	785.9	212.3	494.6	177.2	3096.2	259.3	335.0	75.8	170.6	0.0	79.2	301.5	1143.3	78.6	204.0	175.3	206.6	65.2	168.2	93.4	225.0	230.1	1117.9	0.1	0.8	196.9	133.4	367.6	98.3	252.8	370.3	181.1	0.1	62.4	292.4	3.5	283.3	131.0	309.2	13.9	1.8	292.9	116.5	138.8	1447.8	915.5	137.1	301.6	1261.5	1.5	134.3	121.3	0.6	140.6	289.6	254.5	116.0	22.7	195.6	168.2	196.9	470.0	1343.5	0.7	153.0	125.7	106.4	5.6	147.6	72.3	135.2	133.0	124.7	144.5	145.3	121.7	162.9	156.7	8.5	119.7	39.2	20.4	94.9	230.2	83.1	89.3	91.8	97.4	84.1	92.5	101.6	96.9	104.9	91.4	88.7	101.4	34.1	12.8	19.4	9.1	50.3	20.6	55.3	66.1	20.5	36.2	11.7	27.9	202.4	25.8	26.4	649.2	8.4	1105.1	35.1	2.3	164.4	112.7	5.0	6.1	20.9	50.9	31.0	20.2	10.5	41.5	1284.9	100.3	20.4	5.9	53.8	59.8	82.1	2.6	394.1	72.3	18.7	15.1	697.8	172.8	53.9	14.5	79.2	127.7	30.2	14.0	76.3	49.3	66.9	5.5	12.4	51.0	4.5	77.5	72.6	25.6	0.3	60.2	24.9	24.1	59.2	98.9	54.5	22.6	100.2	10.5	11.6	2022.4	49.9	70.5	6.7	54.2
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 341.5;liver: 481.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	341.5	20.8	9.8	10.0	11.6	1.0	205.6	10.7	12.9	17.4	8.1	37.1	29.6	5.6	3.3	202.5	8.6	98.1	83.8	7.2	16.6	43.0	481.9	23.5	2.1	18.7	13.7	10.4	11.8	1.1	8.1	0.8	17.1	11.7	13.3	15.2	116.5	12.9	286.9	42.5	33.7	9.2	11.5	2.1	137.0	11.8	16.8	4.4	38.3	36.5	9.3	253.9	47.0	9.7	0.0	2054.8	2.4	214.1	2439.5	83.4	0.1	0.7	8.6	0.9	2.0	8.1	0.2	0.4	11.5	14.2	10.0	57.8	0.2	10.7	1.2	0.6	0.2	0.7	516.4	3926.2	4.6	0.4	0.9	218.3	126.4	10.5	10.4	0.7	0.9	0.3	81.9	0.3	20.4	3.3	0.2	0.0	0.7	2684.9	0.8	0.3	0.6	34.6	19.0	1178.9	1.2	0.4	21.2	0.3	0.1	0.4	0.5	4.0	8.6	5.1	1.8	74.6	0.8	0.6	0.6	0.3	25.9	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	11.6	10.7	12.9	7.2	16.6	18.7	13.7	17.1	11.5	16.8	9.7	15.2	12.8	2.8	0.0	0.9	11.9	9.5	141.7	20.5	1.9	0.8	1.4	5.5	102.9	128.8	0.0	0.0	0.0	0.0	10.3	0.0	18.3	17.3	0.7	0.5	7.5	1.8	8.0	2.6	103.3	0.1	44.2	133.5	0.8	0.0	0.1	10.8	397.4	0.1	3.3	4.2	5.4	46.8	12.0	7.8	7.8	79.2	1.0	8.8	19.7	0.6	39.6	0.0	5.5	0.3	90.0	6.6	78.6	0.8	23.7	15.9	3.6	40.3	3.0	0.0	5.3	13.9	0.2	0.3	112.9	13.5	0.0	1.3	0.4	8.5	271.9
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 441.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 83.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 244.0;gdT-cell: 102.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 244.0;T-cells: 102.6"	"Cell line enhanced"	"Detected in many"		"A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	164.4	50.2	31.1	25.4	34.6	42.3	115.2	32.1	42.4	21.9	30.2	185.9	441.3	25.9	4.4	53.2	42.1	261.1	42.9	31.5	35.6	177.7	268.0	48.3	7.6	30.3	33.9	17.8	36.4	22.5	10.4	4.7	32.3	10.3	98.0	19.1	40.5	19.4	116.9	27.0	270.9	39.2	30.3	3.8	237.4	10.0	31.5	37.4	26.4	34.8	6.6	84.7	22.2	31.1	0.1	1615.1	1.1	413.0	811.9	292.2	1.0	0.0	21.4	0.4	1.4	47.6	24.5	0.2	78.7	19.4	45.0	11.5	1.5	28.8	1.1	3.0	0.5	3.2	438.4	699.6	4.3	0.7	0.2	160.9	57.1	20.0	0.7	25.8	28.1	3.4	10.8	0.0	42.6	3.8	9.8	2.6	0.7	3025.3	4.3	3.3	9.6	43.7	149.0	639.2	1.0	2.9	232.2	0.0	0.3	0.9	0.5	0.2	221.7	5.2	4.7	87.8	3.1	0.7	0.7	0.3	45.8	62.8	4.4	244.0	2.9	4.8	102.6	0.9	6.9	0.0	19.0	18.7	2.1	0.5	11.6	8.9	7.3	21.1	1.4	39.6	21.4	42.4	31.1	34.6	32.1	42.4	31.5	35.6	30.3	33.9	32.3	30.3	31.5	31.1	144.2	44.8	5.3	4.9	4.3	12.0	3.7	393.1	2.8	2.0	15.8	5.5	3.9	0.0	172.9	36.8	0.0	0.4	64.4	133.8	43.0	114.6	3.3	67.5	4.5	67.5	19.2	34.9	2.5	722.5	0.0	44.3	158.0	66.4	5.7	0.1	0.0	0.0	1.6	1.7	3.2	65.9	61.1	0.0	14.0	4.9	78.3	14.8	21.4	7.5	4.1	132.7	202.9	14.6	0.0	266.1	219.6	106.8	3.1	1.3	576.9	601.8	112.8	5.3	26.3	15.5	20.3	0.5	4.3	20.2	10.7	0.0	14.4	7.8	196.9	46.4
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 717.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	41.8	0.0	0.0	0.0	0.3	717.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138118305	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"liver: 426.9"	"Group enriched"	"Detected in some"	31	"Early spermatids: 65.4;Hepatocytes: 110.3;Late spermatids: 126.1"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		61000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	426.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	110.3	0.4	0.0	0.2	0.2	0.0	3.2	0.4	126.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	1.6	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2
AKR1E2	"AKR1CL2, AKRDC1, htAKR, HTSP1, MGC10612"	ENSG00000165568	"Aldo-keto reductase family 1 member E2"	Q96JD6	10	4786629-4848062	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 19.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 153.8;Late spermatids: 174.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 12.3;RT4: 10.4;U-2197: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037821, HPA037822"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA037821: AB_2675687, HPA037822: AB_10671722"	"unprognostic (2.33e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.62e-4)"	"unprognostic (5.62e-2)"	2.0	0.8	1.7	0.7	1.8	2.1	3.1	1.5	2.3	1.8	0.0	1.3	1.4	1.1	0.9	1.4	1.0	1.3	1.9	2.0	2.4	0.9	0.5	2.0	0.8	1.6	2.0	0.7	2.1	1.0	0.5	1.8	2.7	0.9	1.2	3.5	1.1	1.8	1.5	1.2	1.0	2.1	0.5	1.2	1.5	19.0	1.6	0.7	3.3	0.8	0.5	1.1	1.3	1.6	0.5	5.9	2.2	1.0	0.0	0.0	0.1	2.3	0.2	0.1	0.1	9.0	0.8	0.0	0.0	6.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	1.1	6.2	1.1	0.0	0.0	6.5	12.3	5.6	0.0	0.0	5.4	0.7	0.0	2.2	6.9	4.4	0.0	0.0	0.0	1.6	10.4	0.0	4.8	8.2	2.4	4.7	2.4	4.6	2.6	4.1	0.0	2.0	19.5	0.0	2.8	0.0	0.0	0.1	0.0	1.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.7	1.8	1.5	2.3	2.0	2.4	1.6	2.0	2.7	0.5	1.6	1.6	0.9	0.0	0.0	1.6	0.2	0.0	0.1	0.5	0.6	0.2	1.1	0.6	0.8	0.0	0.6	1.8	0.0	0.1	0.1	0.0	0.0	0.3	153.8	0.5	0.7	1.4	0.0	1.3	7.1	0.0	0.0	2.2	0.0	0.6	0.0	0.6	2.2	0.0	1.2	1.7	8.9	0.1	0.0	0.6	0.6	174.2	2.8	0.8	3.6	5.6	0.6	0.3	0.0	9.0	0.0	0.1	0.1	1.5	0.0	0.2	0.0	0.5	0.3	1.2	0.0	0.8	1.2	32.0	10.0	0.7	0.1	0.0	0.2	0.2	0.1	0.5
AKT1	"AKT, PKB, PRKBA, RAC, RAC-alpha"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 61.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 558.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	71.5	102.7	45.9	57.7	45.5	51.2	61.2	43.7	53.2	52.0	50.4	85.0	50.8	59.5	23.2	70.7	53.7	50.0	105.9	45.2	44.3	54.3	97.3	69.2	51.9	50.5	45.7	43.7	94.3	53.0	35.9	55.4	45.0	67.2	39.6	25.1	67.7	73.0	58.1	45.0	53.3	63.4	47.4	63.7	77.8	23.9	48.0	52.4	52.3	64.9	40.3	72.6	48.4	43.3	77.3	150.5	124.6	186.9	95.2	97.7	136.9	142.3	171.5	204.6	163.6	96.8	92.8	91.2	105.5	196.6	102.8	99.4	89.5	131.9	90.1	214.3	36.2	70.6	90.4	103.2	104.6	117.5	178.0	140.0	109.1	102.9	68.1	98.2	154.4	87.5	62.1	102.2	134.1	558.3	145.3	146.8	32.6	153.5	107.2	137.5	111.9	60.5	94.8	189.5	141.2	117.2	117.3	152.2	88.9	56.8	195.7	170.2	123.5	133.2	63.2	192.3	145.1	105.4	52.6	80.7	113.7	96.7	162.0	6.4	9.9	61.5	10.0	10.3	7.2	5.5	8.7	11.4	7.0	7.2	4.6	10.1	22.6	11.0	12.4	10.0	9.0	6.3	45.9	45.5	43.7	53.2	45.2	44.3	50.5	45.7	45.0	47.4	48.0	43.3	45.8	16.0	27.4	16.6	13.7	12.4	20.0	17.3	15.9	26.3	58.0	39.9	16.1	32.9	17.7	22.0	12.5	19.4	54.2	40.9	13.7	23.6	1.9	17.9	28.1	27.5	30.0	11.3	8.2	35.2	31.8	24.0	26.0	24.8	2.5	40.4	23.2	42.9	23.2	42.1	13.0	37.3	22.4	23.3	21.4	3.3	28.6	28.0	10.6	6.5	23.1	51.2	24.7	8.0	9.6	53.3	22.1	30.9	10.3	38.8	23.5	17.9	14.2	26.6	26.3	24.9	29.1	1.8	5.3	16.2	13.9	23.4	23.3	34.0	33.7	33.4
AKT2	PKBβ	ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: AB_2685278"	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"	62.8	40.0	31.7	37.3	31.3	48.4	38.6	58.3	40.0	49.8	55.1	42.3	24.5	43.5	49.4	42.5	46.1	25.1	40.8	31.5	24.5	52.2	59.2	30.7	38.1	32.0	26.0	53.9	41.9	58.5	47.8	27.6	26.3	41.2	23.3	41.2	32.5	45.0	101.3	39.4	35.6	34.2	22.1	38.1	33.1	29.7	28.0	53.4	100.1	118.7	37.0	39.8	41.5	35.2	66.2	160.1	63.1	61.5	72.0	88.9	32.5	41.7	63.5	87.6	77.9	71.8	60.8	67.4	36.8	96.3	37.2	28.2	66.8	90.0	56.1	62.5	74.3	43.4	116.5	44.7	45.8	50.7	50.5	82.7	53.6	58.6	56.4	71.9	19.0	73.0	57.3	67.5	49.8	54.6	81.1	24.7	31.7	73.7	41.5	54.2	32.1	48.5	68.3	105.7	82.7	49.8	43.3	75.0	35.0	62.5	59.8	64.9	18.8	52.7	51.5	47.3	67.6	61.5	59.0	56.4	52.6	59.7	44.3	5.7	2.6	2.1	2.2	1.2	2.2	1.9	1.8	1.5	1.7	2.9	1.7	2.6	4.0	1.7	1.6	4.9	1.6	1.7	31.7	31.3	58.3	40.0	31.5	24.5	32.0	26.0	26.3	22.1	28.0	35.2	18.1	16.0	15.9	51.2	33.0	23.8	23.9	20.9	26.2	67.6	25.3	23.9	31.2	30.0	18.1	60.7	41.7	31.3	26.0	23.7	21.5	19.7	5.5	26.2	26.7	17.4	19.2	19.1	30.4	30.4	25.2	27.9	20.9	25.8	14.0	44.2	13.9	87.5	22.3	60.6	25.3	20.1	22.4	23.2	17.5	10.5	42.9	20.0	23.2	23.4	21.7	46.2	50.4	41.7	40.6	24.8	16.9	26.7	30.4	29.7	21.8	24.8	24.9	97.4	19.7	29.3	25.0	14.8	15.6	31.1	27.4	38.7	23.1	56.9	23.3	29.4
AL031681.2		ENSG00000288000	"Novel protein"		20	43458054-43541881	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059648			Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA							Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA059648: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL031777.2		ENSG00000282988	"Novel protein"		6	26195595-26199293	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.1;Extravillous trophoblasts: 6.7;Hofbauer cells: 9.1;Syncytiotrophoblasts: 20.7"					"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 16.9;neutrophil: 30.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 30.6"	"Cell line enhanced"	"Detected in some"		"K-562: 6.9;SiHa: 7.7;T-47d: 4.6;U-2 OS: 5.1;U-266/70: 9.3;U-266/84: 5.6"									HPA041189	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA041189: AB_2677357"																		0.6	0.3	0.5	0.2	0.6	1.5	1.1	1.3	1.2	2.0	1.6	0.7	0.3	0.1	0.0	3.4	0.4	0.1	0.4	0.6	0.5	0.8	1.9	2.2	0.3	1.2	0.8	0.4	0.1	0.1	0.3	0.3	1.1	2.5	0.3	0.1	0.5	0.0	0.0	0.8	0.6	0.1	1.0	2.0	0.5	0.7	1.0	0.8	0.4	0.0	0.1	0.4	2.4	1.4	0.2	0.7	0.2	0.7	1.5	0.1	0.5	0.6	0.1	1.2	0.4	0.2	0.5	0.1	2.0	0.1	0.5	1.4	0.1	0.0	0.2	2.6	0.2	0.4	2.1	0.3	0.1	0.1	0.9	1.0	0.0	0.1	0.3	0.2	0.0	0.6	6.9	1.5	0.0	1.0	0.1	0.4	0.2	2.6	1.6	0.2	0.1	3.0	0.0	0.0	0.6	0.2	7.7	0.5	0.3	0.3	4.6	0.0	0.0	0.7	5.1	0.0	0.0	9.3	5.6	0.7	0.0	1.9	0.7	16.9	0.6	5.1	1.6	0.7	3.6	2.1	0.8	1.1	2.3	4.7	0.8	0.5	30.6	0.9	1.5	5.2	2.3	1.1	0.5	0.6	1.3	1.2	0.6	0.5	1.2	0.8	1.1	1.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0
AL035461.3		ENSG00000286235	"Novel protein"		20	5950949-6039856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.0"									"HPA045141, HPA066433"			Approved	Nucleoplasm,Cytosol		NA	NA					"Cluster 37: Hep G2 - Hepatocyte cell processes"		Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "																		0.9	0.9	0.1	1.0	0.1	0.4	2.6	0.1	0.3	1.8	0.1	1.5	1.4	1.3	1.5	1.4	1.3	0.8	1.5	0.1	0.1	1.5	1.1	1.2	1.4	0.1	0.1	1.6	0.8	1.4		1.8	0.1	1.7	2.6	2.2	0.5	1.5	0.3	0.7	1.6	2.1	0.1	0.9	1.0	2.0	0.1	2.3	1.2	2.9	2.4	1.0		0.1	0.5	5.4	5.0	2.4	5.4	4.7	0.7	1.2	4.5	4.3	4.7	7.3	3.0	1.6	0.1	3.7	3.2	0.4	8.4	6.6	7.1	0.3	0.0	7.2	2.5	18.0	0.8	2.4	1.1	2.8	1.7	4.1	4.0	3.7	2.4	3.0	0.4	2.0	5.2	2.0	3.5	0.7	2.7	6.9	0.1	2.2	3.2	1.8	4.0	4.9	2.6	2.1	0.0	10.8	1.2	6.7	1.4	5.6	0.0	1.6	0.8	0.8	1.2	0.1	0.2	0.9	1.4	4.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL133500.1		ENSG00000285547	"Novel protein"		X	72301691-72572843	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	6	"epididymis: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;SH-SY5Y: 1.4"									"HPA048560, HPA049051"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"		"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA048560: AB_2680442, HPA049051: AB_2680612"																		0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1		0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2		0.0	0.1	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.6	0.6	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.2	0.0	0.1	0.1	0.5	1.2	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.1	0.6	0.0	0.1	0.2	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL139260.3		ENSG00000274944	"Novel protein"		1	38864501-38881617	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 5.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.7;Endometrial ciliated cells: 1.3;Glandular and luminal cells: 2.1;Respiratory ciliated cells: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA041188, HPA078331"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (8.00e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-3)"	"unprognostic (4.27e-4)"	"unprognostic (4.64e-7)"	"unprognostic (2.59e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.54e-3)"	"unprognostic (6.09e-6)"	"unprognostic (1.30e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-3)"	1.4	2.0	0.0	0.9	0.0	0.4	0.4	0.0	0.9	0.5	0.0	2.7	1.7	0.3	0.0	2.7	0.7	0.2	0.4	0.0	0.0	1.1	1.8	0.4	2.5	0.0	0.0	0.4	0.5	0.0	0.9	0.6	0.0	0.7	1.6	0.0	2.4	0.0	0.3	1.5	1.2	0.0	0.0	1.2	1.6	5.1	0.0	0.4	0.6	0.0	0.5	0.9	1.0	0.0	16.7	1.3	3.7	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	8.0	17.5	2.8	14.5	0.0	0.3	11.1	0.0	0.0	0.0	9.2	2.3	1.4	2.7	2.2	0.0	19.3	5.4	0.0	0.0	0.8	0.5	1.2	0.9	0.0	6.4	4.7	1.1	4.1	8.7	20.6	7.7	8.5	9.8	9.8	7.7	17.9	0.0	8.6	7.0	3.6	9.2	7.5	2.1	3.1	5.0	6.1	6.8	2.2	7.6	7.7	16.0	1.8	17.3	12.9	8.2	7.5	2.2	0.0	0.4	0.0	0.0	0.5	0.2	1.2	0.0	0.1	1.7	1.3	0.1	0.0	0.9	0.0	1.4	3.1	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AL139300.1		ENSG00000256500	"Novel protein"		14	103562962-103685924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.7;tongue: 16.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;granulocytes: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA044617, HPA052450"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044617: AB_2679024, HPA052450: AB_2681838"					"unprognostic (1.56e-1)"													4.3	2.6	0.9	2.9	1.0	0.8	1.3	0.9	5.2	1.2	0.2	1.4	0.0	0.8	0.2	1.6	0.9	0.1	12.8	1.4	1.6	0.5	0.5	1.0	1.6	1.0	1.7	1.0	2.5	7.5	3.8	0.1	1.6	1.4	0.0	3.5	1.6	1.1	31.7	0.6	0.7	3.1	0.7	0.4	0.7	9.4	1.1	2.9	0.1	16.5	1.7	3.4	0.5	1.2	8.1	15.9	18.5	0.6	8.2	7.8	5.6	25.7	19.7	29.3	17.0	9.5	12.1	22.0	17.2	19.2	19.3	5.5	12.4	13.3	17.4	6.7	0.0	8.7	6.1	8.7	9.7	10.8	3.4	8.6	0.6	13.5	11.0	14.5	15.2	13.7	11.6	3.4	21.4	15.4	18.9	1.2	12.1	19.5	13.9	7.7	12.1	11.4	13.6	9.0	22.1	12.2	14.6	5.7	12.1	6.2	13.0	6.6	8.4	11.3	9.2	16.9	10.4	6.4	8.6	25.6	19.6	3.4	9.8	0.2	0.8	1.1	0.5	1.3	0.7	0.3	0.7	0.9	0.4	1.3	1.0	0.4	0.7	0.6	1.6	1.5	1.4	0.3	0.9	1.0	0.9	5.2	1.4	1.6	1.0	1.7	1.6	0.7	1.1	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL162417.1		ENSG00000285245	"Novel protein"		9	133098121-133163914	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in single"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.0;REH: 1.1;TIME: 1.1"									HPA025961	Uncertain		Uncertain	Nucleoplasm		NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"		Nucleoplasm		"HPA025961: AB_2671795"																		0.1	0.2	0.0	0.2	0.2	0.4	0.0	0.4	0.3	0.1	0.8	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.7	0.8	1.0	0.6	0.2		0.1	0.8	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.5	0.3	0.1	0.1	0.0	0.7	0.0	0.1	0.6	0.0	0.3		0.3	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.6	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.3	0.1	0.3	0.7	0.8	0.8	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL358113.1		ENSG00000285130	"Novel protein"		9	69035747-69255187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.6;Endometrial ciliated cells: 3.8;Glandular and luminal cells: 3.8;Respiratory ciliated cells: 1.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"									"HPA001813, HPA068304, HPA070714"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"		"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161"																		0.0	0.3	0.1	0.4	0.1	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.6	0.0		0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0		0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.7	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.8	0.5	0.1	0.1	0.1	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	3.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.8	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
AL512785.2		ENSG00000254706	"Novel protein"		1	162365407-162383531	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.6;HEL: 12.0"	"Low region specificity"	"Detected in all"							"HPA052251, HPA074060"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"		Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"unprognostic (1.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.50e-1)"		"unprognostic (9.12e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.57e-1)"		"unprognostic (3.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.61e-3)"	"unprognostic (6.07e-2)"		"unprognostic (1.19e-2)"	"unprognostic (6.10e-2)"	1.1	0.6	0.5	0.3	1.2	1.2	1.8	2.3	0.6	1.9	3.5	2.1	2.1	0.9	0.0	1.0	1.2	2.4	0.7	0.6	1.4	1.2	2.7	1.0	0.2	3.8	1.6	0.3	3.2	1.0	0.4	0.7	2.5	1.1	0.5	0.0	5.0	3.9	0.2	1.1	1.4	0.7	2.6	0.1	2.1	1.5	1.4	0.2	0.1	0.2	0.1	0.7	0.3	4.1	7.6	0.0	4.0	4.4	0.2	0.0	0.0	0.8	0.5	0.4	0.0	1.7	2.6	0.0	5.8	0.0	1.5	3.0	0.4	0.5	0.0	0.1	3.9	12.0	0.0	2.8	0.1	0.2	0.0	0.8	0.2	0.0	0.5	0.7	1.5	0.9	1.2	0.2	0.2	2.7	0.4	0.0	3.5	2.1	3.0	0.3	0.1	0.0	1.4	2.7	1.7	1.9	2.6	0.4	1.9	0.5	4.3	0.0	2.1	0.1	1.0	0.1	1.8	5.8	0.0	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	2.3	0.6	0.6	1.4	3.8	1.6	2.5	2.6	1.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 720.5;liver: 548.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 243.1;Syncytiotrophoblasts: 309.2;Theca cells: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 233.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 233.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	34.5	720.5	24.8	23.9	25.1	176.7	28.7	37.9	82.5	20.5	35.7	43.6	44.9	19.0	28.1	36.4	15.3	32.7	116.2	26.6	28.1	45.7	548.8	47.8	22.9	27.2	25.4	17.1	19.6	60.3	15.7	36.8	33.2	23.1	41.6	20.6	42.8	27.2	110.9	24.3	39.3	23.9	24.9	19.5	45.9	18.6	31.8	23.5	22.1	106.6	28.2	73.8	23.5	28.3	36.2	55.0	38.0	35.4	57.9	43.1	103.1	51.8	47.7	67.6	65.3	73.6	66.2	33.6	12.7	36.4	137.0	20.9	55.1	42.6	54.7	65.9	21.6	43.2	41.2	56.4	81.8	70.8	83.0	54.0	39.1	107.7	35.7	25.0	62.8	57.7	25.8	27.0	62.4	29.5	33.9	107.3	33.0	41.1	93.4	20.0	23.9	53.3	59.8	213.9	20.2	13.3	83.9	40.9	47.2	30.5	23.5	99.9	45.7	37.6	37.1	78.5	76.2	39.5	73.8	50.5	42.1	75.5	61.1	233.9	33.4	103.2	22.9	42.9	37.4	23.1	23.9	26.0	29.8	21.5	21.1	23.3	49.6	30.9	39.0	17.1	35.7	25.1	24.8	25.1	37.9	82.5	26.6	28.1	27.2	25.4	33.2	24.9	31.8	28.3	28.4	35.3	60.3	5.2	14.9	17.3	17.2	36.1	15.9	16.6	28.6	19.6	107.5	25.8	37.7	23.9	4.2	81.9	25.1	68.5	56.7	35.5	10.2	20.2	9.3	27.6	34.6	11.2	6.2	31.3	28.2	19.6	42.3	25.3	95.4	13.1	18.5	243.1	69.1	11.8	6.2	24.3	34.6	13.0	20.8	4.1	13.4	36.4	5.4	8.4	49.1	9.7	11.3	4.0	8.4	42.3	28.1	16.6	14.0	16.0	35.6	36.1	40.6	9.2	13.1	9.1	27.5	25.5	22.3	21.4	16.2	309.2	25.1	187.2	24.3	26.4
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 134.5;urinary bladder: 125.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 175.4;Endometrial stromal cells: 247.9;Leydig cells: 194.5;Prostatic glandular cells: 580.3;Urothelial cells: 468.7"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 80.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 363.3;HaCaT: 441.7;HBEC3-KT: 1096.9;hTERT-RPE1: 347.7;U-2197: 619.0;U-87 MG: 484.7;WM-115: 516.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"olfactory bulb: 4.5;spinal cord: 15.8"	"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	83.7	11.4	3.0	41.5	2.7	0.6	30.5	4.7	5.2	37.1	16.2	16.6	15.0	8.2	30.3	28.7	24.9	17.0	12.4	3.1	1.9	8.2	5.3	9.8	3.0	4.8	3.4	6.1	15.0	9.0	7.5	8.4	2.6	134.5	8.9	0.3	93.7	49.3	5.9	3.9	25.2	40.8	2.8	3.1	12.8	16.6	3.3	1.6	2.5	6.9	15.7	125.1	22.3	3.9	363.3	43.5	0.6	0.7	75.0	32.8	1.4	3.2	3.2	1.9	0.8	1.0	285.8	2.6	4.7	97.1	55.7	441.7	8.8	1096.9	6.7	0.1	2.0	1.7	20.1	0.3	25.5	1.4	1.9	23.5	29.8	24.4	4.5	347.7	4.0	0.0	0.7	2.4	1.8	3.8	0.2	1.2	9.0	9.6	316.3	0.7	4.2	2.3	0.2	283.6	0.3	25.4	113.9	94.9	33.3	3.6	9.3	3.2	58.3	0.3	1.0	619.0	14.2	0.7	3.4	1.5	484.7	0.2	516.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	2.7	4.7	5.2	3.1	1.9	4.8	3.4	2.6	2.8	3.3	3.9	10.0	16.0	6.3	0.3	0.5	0.6	175.4	70.5	4.6	0.0	64.6	18.9	2.0	1.5	141.6	103.0	0.0	9.6	0.9	1.0	3.9	70.5	1.2	20.6	247.9	11.6	3.5	0.0	2.9	1.4	0.5	48.9	1.1	11.7	5.7	0.0	1.8	0.1	1.2	0.0	2.3	2.1	30.5	0.0	1.3	8.5	194.5	3.3	0.0	1.0	0.6	0.0	0.0	36.7	4.6	29.4	0.0	135.4	0.0	580.3	0.1	0.7	78.7	0.0	13.1	20.4	11.5	0.5	0.9	2.9	1.6	4.9	2.0	1.5	0.8	468.7
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392702-38398661	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 172.7;smooth muscle: 128.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 85.8;Ductal cells: 64.1;Hepatocytes: 128.1;Proximal tubular cells: 165.0;Theca cells: 91.7;Undifferentiated cells: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 183.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	21.2	10.4	3.2	31.4	3.2	2.9	8.9	4.1	4.0	8.5	6.4	61.5	22.9	57.7	5.7	32.7	34.9	29.0	14.7	2.7	4.8	59.2	172.7	7.3	5.1	3.5	3.3	12.6	11.3	8.5	2.5	5.2	4.3	36.9	35.5	1.5	11.1	54.5	55.8	6.3	24.8	128.0	3.4	7.2	28.2	8.3	4.0	5.1	15.4	35.9	5.6	85.1	10.5	4.1	72.2	65.5	19.8	31.8	27.6	32.5	15.8	33.6	16.9	27.8	28.3	44.2	13.7	45.2	19.7	47.4	42.0	10.0	66.0	71.4	27.4	50.8	28.5	22.4	44.7	132.2	20.0	36.0	24.0	39.0	15.3	22.6	19.5	56.6	26.8	10.6	65.6	42.8	42.8	27.3	0.1	14.4	59.1	183.3	29.0	14.9	119.9	34.5	25.1	31.7	43.3	19.9	25.7	16.7	19.4	20.6	15.9	27.9	18.2	31.9	52.4	26.9	42.5	6.5	13.2	17.8	16.4	36.0	22.1	0.3	4.2	0.2	6.7	9.2	9.6	5.5	6.5	6.1	9.5	2.6	5.1	6.2	1.0	8.0	11.9	1.2	5.0	5.3	3.2	3.2	4.1	4.0	2.7	4.8	3.5	3.3	4.3	3.4	4.0	4.1	3.3	9.6	1.7	0.0	3.7	1.0	5.7	9.4	2.2	1.2	3.7	4.2	6.6	85.8	3.8	16.5	2.1	2.0	1.2	12.8	17.6	64.1	0.6	2.3	6.4	4.7	15.6	12.8	0.5	6.9	46.6	6.6	8.2	3.4	8.9	12.8	8.9	128.1	7.2	0.0	1.1	25.5	6.1	4.1	2.4	2.2	6.5	4.2	0.0	0.0	5.5	2.1	0.0	0.5	0.5	15.0	7.7	6.8	3.7	6.1	10.3	165.0	0.3	0.7	0.0	6.0	16.1	0.6	0.8	2.1	1.0	1.8	3.3	91.7	71.7	2.8
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 496.1;salivary gland: 128.0;stomach 1: 224.8"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 389.5;Basal squamous epithelial cells: 274.3;Club cells: 150.1;Gastric mucus-secreting cells: 437.9;Respiratory ciliated cells: 412.7;Squamous epithelial cells: 342.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.4;lung cancer: 60.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"A549: 5094.7;OE19: 6071.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		52000	"Cluster 22: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	1.7	1.0	0.4	1.3	0.7	0.1	3.2	0.3	0.4	6.7	17.5	4.5	6.2	0.3	0.2	496.1	5.5	10.3	0.3	1.0	0.4	1.3	1.9	10.9	0.5	0.6	2.1	0.4	0.5	0.0	0.9	0.0	0.5	1.9	3.3	0.1	128.0	1.5	1.3	72.6	3.5	0.4	0.9	0.9	224.8	1.6	1.3	0.6	0.5	0.3	33.7	6.2	22.3	0.9	0.1	5094.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	10.7	246.5	0.0	2.7	0.5	2.0	29.3	0.7	12.8	0.0	0.0	0.8	0.1	116.6	1.0	0.3	0.1	0.5	0.0	14.9	0.5	0.4	0.2	0.5	0.0	0.0	0.0	0.0	9.7	0.1	0.3	0.4	6071.6	19.8	0.0	0.0	0.0	0.0	87.0	0.2	0.6	24.8	0.0	0.0	0.2	0.2	0.9	0.6	0.3	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.4	1.0	0.4	0.6	2.1	0.5	0.9	1.3	0.9	0.7	3.2	5.5	0.0	0.7	44.1	46.8	389.5	274.3	0.0	0.1	1.5	0.4	2.8	150.1	0.0	0.0	0.0	0.0	5.1	0.0	1.4	1.5	12.4	0.2	1.3	1.8	0.0	0.1	0.5	0.0	1.6	437.9	0.8	2.5	0.3	1.4	3.2	0.2	0.0	0.0	4.8	83.4	0.3	1.8	5.2	0.9	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	9.5	4.7	1.9	3.2	5.8	3.4	5.0	412.7	0.2	0.0	1.7	20.1	1.7	8.6	342.2	32.0	0.0	0.5	0.2	8.4	64.3
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917393-134950115	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"kidney: 72.2;liver: 247.2"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 142.5;Proximal tubular cells: 136.9"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;Hep G2: 2.9;K-562: 3.0;RPTEC TERT1: 3.3;U-266/70: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		110000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	1.3	1.3	6.4	0.7	7.1	2.4	1.2	6.9	9.8	1.5	2.2	3.3	0.8	1.2	2.1	0.8	1.0	0.9	0.7	6.5	3.8	72.2	247.2	0.9	0.6	5.3	4.4	0.5	0.9	0.4	0.8	0.5	6.2	1.7	0.8	2.8	0.8	0.8	3.6	1.7	1.1	0.9	3.1	1.3	1.2	0.5	5.4	0.7	0.6	0.3	0.6	1.9	0.9	8.3	0.1	0.5	0.8	0.5	0.2	0.1	0.6	0.2	0.2	0.0	0.5	0.2	0.3	0.1	0.2	0.0	0.1	0.6	0.6	0.0	0.4	0.6	2.9	2.0	2.1	2.9	0.3	0.8	1.0	0.8	0.9	0.2	0.4	0.6	0.2	0.8	3.0	1.1	0.1	0.0	0.9	1.0	0.2	0.2	0.3	0.0	0.2	0.2	3.3	0.4	0.8	0.2	0.1	0.0	0.5	0.2	0.3	0.2	0.2	0.2	1.6	0.6	0.8	2.8	1.0	0.5	0.3	0.7	0.2	2.5	0.3	0.3	0.4	0.1	0.1	0.4	0.4	0.2	0.0	0.4	0.3	0.3	0.8	0.8	0.1	0.4	0.5	0.3	6.4	7.1	6.9	9.8	6.5	3.8	5.3	4.4	6.2	3.1	5.4	8.3	0.3	3.2	0.6	3.6	0.8	0.0	0.2	0.2	0.0	2.6	0.7	0.9	0.6	1.5	0.7	31.3	0.0	0.2	0.3	0.1	19.6	0.2	0.1	0.4	0.4	0.7	0.0	0.0	14.3	0.0	1.7	0.4	0.0	1.6	0.0	0.5	2.5	142.5	0.1	3.3	12.9	0.1	0.0	2.5	0.3	0.0	0.0	0.8	0.0	1.0	0.7	0.3	0.0	3.0	9.6	0.0	0.1	0.0	0.3	0.1	0.0	136.9	0.0	1.8	0.0	1.2	0.5	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.2	0.1
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28576948	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1384.6;choroid plexus: 589.6;retina: 1183.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.5;Horizontal cells: 274.2;Muller glia cells: 127.1;Proximal enterocytes: 120.0;Rod photoreceptor cells: 348.5"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 250.9;U-266/70: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		150000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	87.0	24.3	953.6	12.7	909.7	23.6	42.5	1238.3	1162.3	39.3	589.6	18.5	18.7	17.9	10.9	40.8	14.3	10.9	285.5	955.7	958.0	16.8	98.3	13.7	19.3	1297.5	962.6	39.1	4.9	12.1	30.6	4.1	1384.6	18.9	14.7	1183.1	19.9	15.8	4.8	74.5	43.9	12.4	926.9	24.4	23.3	14.2	1090.2	9.6	7.4	8.1	30.5	19.0	47.0	886.1	29.9	2.1	13.7	55.7	29.9	32.9	2.9	16.7	37.7	12.9	76.0	17.9	3.0	14.9	17.3	15.5	3.3	36.9	10.3	102.3	23.4	12.4	8.9	28.3	11.6	30.4	25.8	10.0	29.2	27.8	13.9	1.5	24.0	1.7	5.3	29.7	19.3	71.9	10.7	15.1	11.9	32.0	20.8	6.7	15.3	9.5	1.6	250.9	1.9	4.3	36.2	61.9	9.1	67.3	0.5	20.8	36.6	21.2	3.5	1.2	5.3	2.1	2.4	161.0	51.4	10.9	105.2	28.0	1.9	0.5	7.4	3.0	21.6	8.7	30.6	24.0	29.5	17.8	9.4	25.1	37.7	28.4	18.0	29.4	5.3	4.6	40.9	19.0	953.6	909.7	1238.3	1162.3	955.7	958.0	1297.5	962.6	1384.6	926.9	1090.2	886.1	4.2	0.0	15.8	97.6	9.8	7.5	20.3	80.5	8.6	112.5	9.0	11.0	22.1	11.5	29.3	7.3	106.3	1.1	9.5	31.7	3.9	21.9	0.9	1.0	3.0	11.3	21.6	3.2	19.2	10.2	6.5	5.8	6.6	1.2	13.3	4.9	14.3	93.1	5.4	274.2	41.3	12.9	28.5	4.4	5.3	1.3	9.3	3.1	24.9	21.5	34.1	127.1	12.3	26.7	16.8	12.4	12.4	10.1	2.6	6.1	120.0	2.1	11.8	348.5	13.1	6.4	10.1	0.3	3.2	7.9	10.9	1.5	17.0	11.7	5.1	7.8
ALG14	MGC19780	ENSG00000172339	"ALG14 UDP-N-acetylglucosaminyltransferase subunit"	Q96F25	1	94974405-95072951	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031829	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli	Nucleoplasm	"HPA031829: AB_2674062"	"unprognostic (7.79e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.93e-1)"	1.2	2.5	1.5	0.8	1.7	0.9	1.3	2.2	1.9	1.0	1.7	1.6	1.8	0.8	2.3	1.0	0.8	1.2	0.9	1.6	1.4	1.5	2.1	0.7	0.8	1.7	1.4	0.9	1.8	1.6	1.0	0.8	1.5	0.9	1.7	1.4	1.8	0.8	1.5	0.9	1.3	0.8	1.2	0.8	1.1	1.1	1.7	0.7	1.7	0.5	0.8	0.9	0.7	2.2	2.5	1.6	1.3	1.2	1.0	1.7	1.1	1.8	1.9	1.8	1.5	1.8	0.8	1.3	1.8	2.2	2.2	1.7	1.5	1.7	2.2	2.8	2.5	0.7	1.6	2.9	1.6	1.7	0.4	1.9	1.7	1.4	1.3	1.4	1.6	1.7	1.4	1.6	1.8	1.2	1.9	1.1	0.8	2.5	2.2	1.2	2.6	1.4	2.1	1.4	1.1	1.5	1.0	3.4	3.2	0.9	1.5	1.5	1.2	1.1	1.3	2.0	3.9	1.0	1.0	1.1	0.8	0.8	0.9	1.3	1.0	0.3	0.8	1.3	0.7	1.6	0.9	1.0	1.5	1.4	0.8	0.9	0.8	0.9	0.6	1.9	1.3	0.6	1.5	1.7	2.2	1.9	1.6	1.4	1.7	1.4	1.5	1.2	1.7	2.2	11.8	0.0	12.2	14.0	13.1	11.7	11.4	30.5	19.4	16.9	13.8	15.2	7.7	10.0	20.3	16.5	6.2	34.6	10.5	25.7	19.6	24.9	10.0	12.2	19.6	10.1	4.2	13.0	24.6	53.7	25.9	18.9	11.2	13.3	1.3	14.7	11.7	32.4	18.9	8.4	22.4	12.9	18.3	8.4	8.9	8.4	14.3	8.6	32.0	14.0	10.3	30.9	3.1	14.6	35.4	23.6	22.6	10.1	41.6	8.9	22.1	40.0	12.7	14.4	32.9	17.1	15.2	36.1	23.0	19.0	8.7	25.2	5.6	39.9	26.9	12.9
ALG8	MGC2840	ENSG00000159063	"ALG8 alpha-1,3-glucosyltransferase"	Q9BVK2	11	78095244-78139660	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051898	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA051898: AB_2681656"	"unprognostic (1.37e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.38e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.37e-2)"	22.8	33.0	12.7	13.4	14.3	9.2	25.6	13.9	16.4	18.7	15.4	17.5	13.3	15.9	33.2	19.0	18.8	12.0	17.9	12.9	13.3	24.9	47.1	15.0	14.6	14.1	13.1	22.1	23.8	23.7	19.8	18.7	13.8	19.1	21.8	10.4	21.7	18.0	12.1	16.6	15.5	16.4	13.5	18.3	20.2	43.5	13.1	17.8	22.4	8.9	19.8	18.4	16.0	15.2	27.8	74.4	62.8	56.6	63.7	42.5	37.6	38.6	57.8	68.6	67.4	127.9	102.0	61.4	74.5	51.5	92.3	86.5	87.0	56.5	111.9	46.3	50.8	74.3	56.5	62.2	38.9	71.8	39.6	34.4	36.4	81.8	37.9	37.5	50.3	58.0	98.2	65.8	97.7	38.6	53.3	61.9	81.9	200.5	38.1	63.6	32.6	168.3	70.0	40.4	20.2	44.8	62.0	102.2	29.4	65.6	106.5	50.8	32.0	43.5	50.6	102.5	35.1	46.6	88.0	80.3	26.7	71.4	84.4	1.2	30.0	5.4	25.1	34.5	29.1	37.2	25.5	25.7	34.2	31.3	29.7	26.2	2.6	29.1	39.9	33.1	22.5	27.6	12.7	14.3	13.9	16.4	12.9	13.3	14.1	13.1	13.8	13.5	13.1	15.2	11.9	12.8	11.6	12.4	21.0	10.5	23.3	49.6	26.2	14.7	18.3	16.3	6.9	20.0	35.2	20.2	18.8	53.8	9.1	7.0	5.9	24.4	18.9	11.0	16.9	17.2	7.8	9.9	21.3	25.4	59.5	19.4	11.7	13.8	11.4	36.4	9.3	40.2	31.4	16.8	18.0	15.9	32.6	17.0	10.8	14.0	18.0	15.3	26.6	12.2	12.3	8.2	21.6	13.0	20.7	17.7	6.4	15.8	43.1	16.9	7.7	15.8	21.7	13.5	0.0	14.2	19.6	105.0	37.8	20.9	8.9	32.7	15.2	16.9	16.8	15.2
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708023	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: AB_2678803, HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	2.7	2.7	2.8	1.8	3.2	1.2	3.5	3.9	3.5	3.4	2.7	2.8	2.5	2.3	2.1	2.6	2.9	2.2	4.1	3.0	3.5	3.0	3.6	2.2	3.5	2.8	3.2	2.9	2.6	3.3	1.5	3.9	2.9	3.1	3.4	2.9	2.1	3.1	5.7	2.6	2.1	2.9	3.0	2.3	2.5	3.0	3.2	4.4	3.1	7.4	4.1	3.1	2.2	3.3	5.2	7.5	6.0	4.1	6.3	6.8	7.4	5.3	6.8	11.3	12.7	7.7	3.1	7.9	2.9	4.8	5.3	4.5	13.2	5.7	13.2	5.4	5.1	4.2	4.0	6.4	8.9	4.5	2.6	5.8	9.2	6.6	10.5	5.0	9.4	6.1	6.6	4.4	6.1	8.1	6.0	5.7	6.6	7.7	9.6	6.0	6.0	5.3	6.4	4.5	7.6	5.7	4.3	4.5	5.7	4.9	10.9	4.5	4.3	4.7	4.7	5.2	4.3	5.4	9.4	7.6	3.2	6.3	4.7	10.7	3.0	1.4	2.9	3.5	2.4	3.4	2.7	2.8	3.0	2.7	2.8	2.2	0.8	3.6	2.4	1.6	3.3	2.2	2.8	3.2	3.9	3.5	3.0	3.5	2.8	3.2	2.9	3.0	3.2	3.3	6.5	0.0	3.9	13.1	7.3	8.4	5.7	6.2	6.8	4.1	5.4	4.4	7.5	1.5	4.5	1.8	2.1	9.9	3.5	4.2	9.8	6.2	4.8	4.4	4.5	5.7	2.4	4.2	15.9	7.0	8.8	5.5	2.6	3.8	9.5	6.1	2.2	3.9	7.6	0.0	15.8	4.9	6.1	5.2	5.0	4.2	6.5	7.7	5.4	5.6	6.6	7.8	4.1	16.1	19.4	6.8	1.5	5.3	4.9	4.5	7.0	6.5	5.5	5.3	6.6	4.2	5.6	21.1	15.9	4.4	5.4	12.2	5.6	5.1	4.8	3.7
ALKBH2	"ABH2, MGC90512"	ENSG00000189046	"AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase"	Q6NS38	12	109088188-109093631	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011198, HPA045392, HPA051976"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680"	"prognostic favorable (6.67e-5)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (8.67e-4)"	22.1	14.7	17.0	13.1	18.8	8.5	22.3	17.9	18.5	19.9	15.0	16.7	7.9	21.6	9.3	18.0	20.4	8.2	14.6	17.1	18.1	15.2	31.8	12.3	16.8	18.5	18.3	21.8	19.1	6.1	9.8	7.2	18.6	15.4	9.1	4.5	15.6	11.3	25.3	27.7	15.0	13.8	17.7	15.1	16.8	11.3	18.1	11.3	15.1	12.1	14.0	19.1	18.6	20.8	35.1	58.6	33.0	74.1	22.7	30.3	52.2	22.9	15.2	23.7	26.7	62.3	24.6	53.5	22.1	13.3	11.1	25.1	55.9	23.0	13.8	48.0	50.0	26.8	35.3	57.9	30.1	37.2	23.9	31.4	48.9	22.2	56.5	28.7	9.1	50.5	40.3	31.0	16.3	61.6	34.8	74.5	45.6	36.6	59.1	30.4	32.0	57.7	31.5	48.1	33.8	58.0	24.2	77.4	50.9	12.3	47.5	22.1	9.6	26.0	28.5	25.0	34.1	43.1	54.6	119.2	22.4	31.8	42.7	2.9	8.1	1.4	12.4	11.2	21.8	27.4	18.4	17.5	8.5	27.6	27.1	16.2	1.5	16.7	7.6	21.6	15.8	10.4	17.0	18.8	17.9	18.5	17.1	18.1	18.5	18.3	18.6	17.7	18.1	20.8	23.7	9.6	6.3	4.2	15.9	50.9	52.2	19.4	42.1	3.6	25.2	44.3	6.2	12.8	16.3	9.2	2.1	17.5	12.5	3.1	15.6	26.5	12.2	7.2	27.9	17.3	8.4	10.9	3.5	24.0	25.0	20.6	14.3	8.6	6.3	9.5	6.1	21.4	9.8	5.0	3.6	11.6	18.3	8.2	11.7	5.4	26.8	6.8	26.6	3.7	4.9	11.2	7.2	6.0	7.6	24.1	5.1	17.3	13.1	46.7	7.4	20.2	10.0	7.4	0.0	44.5	26.0	7.9	32.0	35.9	60.0	5.1	12.6	24.5	14.8	25.3
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutarate dependent dioxygenase"	Q96Q83	11	43880811-43920274	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 90.9;Late spermatids: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: AB_2679671"	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	20.6	15.7	14.6	9.1	16.0	7.9	20.6	18.3	20.9	21.3	15.7	18.3	10.9	20.5	24.7	18.5	19.5	9.2	15.3	15.3	15.4	16.7	18.5	13.2	13.8	15.5	15.2	22.9	23.6	16.9	18.2	7.3	15.3	21.9	12.8	17.0	19.3	13.5	35.2	23.4	15.9	13.6	15.3	19.6	20.0	20.4	15.2	15.9	15.3	25.8	14.6	19.2	19.9	17.6	15.8	26.0	10.7	0.0	20.3	26.1	0.0	19.5	42.0	36.9	34.7	10.7	12.0	2.6	12.2	28.7	20.5	21.3	14.6	32.3	33.1	0.0	49.6	23.7	17.1	27.4	51.9	44.5	30.5	27.8	55.7	17.0	81.4	15.2	26.5	44.7	33.9	25.9	18.3	18.4	38.6	21.9	20.6	16.2	38.5	11.6	23.8	30.3	21.3	23.2	20.3	16.1	15.7	22.6	37.1	9.7	32.9	26.3	20.6	21.6	12.5	35.7	28.0	23.1	25.1	26.3	31.3	18.3	17.6	34.4	16.4	9.4	19.8	18.4	19.3	18.6	20.9	18.2	23.5	21.8	24.8	22.9	2.9	24.6	29.4	20.9	21.3	17.4	14.6	16.0	18.3	20.9	15.3	15.4	15.5	15.2	15.3	15.3	15.2	17.6	12.0	16.0	10.9	15.0	12.6	10.3	8.8	16.5	10.8	11.5	10.9	12.8	6.8	14.3	13.3	16.5	4.2	3.4	13.7	9.8	31.3	24.6	90.9	6.3	7.3	14.6	9.5	9.9	15.8	32.6	4.6	14.0	10.2	4.8	7.6	12.5	13.2	12.9	19.0	10.1	15.8	11.3	6.1	11.2	7.0	103.3	16.1	13.1	17.8	3.7	14.1	20.4	22.6	13.0	16.1	27.7	8.6	10.5	12.4	9.3	15.5	17.1	14.0	13.0	6.6	9.9	15.3	29.3	12.6	20.6	7.1	2.2	12.7	15.7	12.5	8.3
ALKBH5	"FLJ20308, OFOXD1"	ENSG00000091542	"AlkB homolog 5, RNA demethylase"	Q6P6C2	17	18183078-18209954	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 236.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007196	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA007196: AB_1850461"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.68e-3)"	"prognostic unfavorable (5.69e-4)"	33.4	40.1	23.7	21.4	21.8	32.6	29.2	18.1	23.5	34.2	17.8	51.1	22.3	45.3	5.2	25.9	43.1	21.6	68.6	20.4	23.4	29.9	33.6	28.8	25.1	23.2	23.7	33.5	36.0	26.6	39.8	17.4	29.5	31.7	10.6	26.5	36.4	25.1	236.6	28.1	31.0	22.0	19.3	26.8	33.6	51.3	26.7	22.2	29.8	98.7	15.8	43.0	29.6	27.4	90.3	86.4	27.8	47.0	37.0	25.0	30.1	41.1	41.8	56.8	51.5	96.1	19.9	53.9	65.4	35.9	29.4	56.2	40.9	33.6	26.8	71.3	74.0	35.4	47.7	41.8	32.5	27.4	53.0	24.3	23.1	41.8	24.7	33.9	31.8	35.3	45.0	20.4	29.8	60.6	60.1	28.6	24.9	28.3	44.4	57.6	56.0	89.0	14.4	31.0	32.5	47.6	44.8	27.2	41.7	90.9	31.4	20.9	38.3	55.8	44.1	87.8	78.0	32.0	25.1	32.2	100.6	38.8	39.0	3.6	7.4	20.4	13.0	7.8	11.9	6.8	13.3	16.1	9.0	10.0	9.5	9.5	4.3	7.2	11.6	5.7	7.4	6.7	23.7	21.8	18.1	23.5	20.4	23.4	23.2	23.7	29.5	19.3	26.7	27.4	37.2	35.3	33.3	17.9	41.1	64.6	29.0	26.8	19.4	80.3	48.7	40.3	93.5	28.6	24.4	27.6	39.6	33.0	59.0	44.9	84.1	27.4	58.9	53.9	36.5	36.6	60.9	24.0	17.0	31.4	44.8	42.4	18.3	36.7	40.7	25.2	35.7	65.2	33.5	119.5	18.1	45.0	22.4	45.3	56.9	42.5	41.0	36.4	49.8	7.5	36.3	76.3	57.7	9.0	24.0	32.8	38.7	51.9	21.1	35.3	47.6	115.2	46.4	58.9	19.7	39.4	47.3	118.7	117.3	20.3	56.0	31.5	48.3	32.7	39.1	28.6
ALKBH6	MGC15677	ENSG00000239382	"AlkB homolog 6"	Q3KRA9	19	36009120-36014239	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073835, HPA074340"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	"Focal adhesion sites"	"HPA073835: AB_2686637, HPA074340: AB_2686680"	"unprognostic (1.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.86e-5)"	"unprognostic (6.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (8.78e-4)"	"unprognostic (1.77e-2)"	"unprognostic (2.31e-5)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.05e-3)"	5.4	8.4	9.3	3.1	8.3	3.3	5.3	9.7	12.4	6.6	6.9	9.8	2.9	7.6	2.3	7.6	6.7	2.1	6.8	9.3	12.3	7.2	11.5	5.5	4.3	15.7	10.3	5.6	4.4	4.7	9.9	2.7	15.0	7.6	1.9	2.7	6.1	4.0	6.4	6.3	7.3	3.7	8.3	7.9	7.8	4.5	12.7	4.1	6.6	3.9	3.8	7.9	6.0	10.6	12.5	13.1	4.9	7.2	7.4	4.5	8.2	12.1	8.0	13.9	14.0	5.4	6.4	10.8	18.8	6.7	7.2	4.9	5.1	14.0	7.2	17.2	9.4	6.2	5.1	5.9	8.4	5.4	18.3	6.8	9.9	11.5	3.9	4.8	9.5	16.2	9.9	8.0	7.5	13.1	13.1	7.0	3.8	12.8	8.3	8.4	6.7	7.9	10.3	5.5	5.9	6.0	8.2	9.8	10.8	6.8	7.8	12.1	4.1	7.2	10.5	16.6	12.0	14.9	9.6	7.8	15.5	6.1	7.8	58.5	18.2	47.8	26.2	26.0	20.4	32.9	23.8	25.4	16.0	24.6	20.2	19.3	16.0	28.8	20.7	22.7	34.4	16.0	9.3	8.3	9.7	12.4	9.3	12.3	15.7	10.3	15.0	8.3	12.7	10.6	6.1	3.2	1.7	6.8	16.5	6.8	11.1	4.5	9.1	5.6	8.0	6.5	2.0	10.0	3.3	18.4	0.0	17.7	13.1	9.5	5.9	10.4	7.6	6.8	5.0	5.9	13.1	14.5	8.1	9.2	15.8	8.1	14.3	6.3	0.0	7.1	7.9	12.7	11.0	10.1	7.2	11.9	2.0	5.3	7.7	5.4	11.1	9.1	8.8	3.7	15.2	5.5	23.7	2.0	6.5	13.3	13.6	4.5	12.1	7.1	7.8	11.8	2.3	3.3	6.6	4.1	10.1	3.6	2.4	8.7	5.1	19.0	15.5	6.4	9.5	9.5
ALKBH8	"MGC10235, TRM9, TRMT9A"	ENSG00000137760	"AlkB homolog 8, tRNA methyltransferase"	Q96BT7	11	107502727-107565742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, RNA-binding, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 25.2;Inhibitory neurons: 27.4;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038724, HPA038725, HPA061514"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"	Nucleoplasm	"HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547"	"unprognostic (2.66e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.01e-1)"	3.1	2.9	2.4	4.0	3.0	3.3	5.0	2.6	2.8	2.9	1.7	3.0	3.2	3.8	3.2	3.1	2.9	2.8	3.8	2.4	2.6	3.9	4.5	3.6	6.0	2.2	2.6	4.4	2.3	4.1	1.7	3.3	2.5	3.5	3.6	3.3	2.9	3.3	5.1	4.6	2.6	3.6	2.2	4.6	3.3	2.8	2.3	4.6	5.2	4.7	5.9	3.5	2.8	2.3	5.4	6.5	6.6	7.2	3.6	7.9	5.4	10.2	7.5	7.4	8.0	12.1	9.7	12.6	5.8	10.0	10.2	9.6	9.9	8.5	9.6	11.4	6.6	10.6	2.5	5.6	5.3	13.7	12.6	4.9	9.2	9.5	12.0	3.8	9.3	9.9	15.2	4.1	5.9	4.9	12.4	6.8	8.7	10.5	10.6	11.1	10.2	8.7	5.9	5.8	6.0	6.7	5.9	4.4	4.5	4.0	7.2	4.1	8.8	16.1	9.6	5.3	12.9	3.8	4.3	9.7	4.5	9.0	16.1	0.0	1.1	0.3	2.2	2.1	2.1	0.9	1.6	1.9	1.7	1.9	3.0	2.6	0.0	2.8	1.5	1.0	1.8	1.1	2.4	3.0	2.6	2.8	2.4	2.6	2.2	2.6	2.5	2.2	2.3	2.3	4.4	0.0	5.3	4.6	8.5	2.0	1.7	1.5	7.4	5.7	3.2	3.0	11.2	5.7	3.5	1.8	6.2	2.3	3.0	1.3	0.0	1.9	0.4	2.4	4.6	4.2	1.2	4.6	25.2	3.3	2.7	4.3	7.7	2.3	10.1	5.1	2.9	6.6	2.8	1.7	27.4	2.8	2.0	3.8	2.2	0.2	2.8	4.1	3.6	14.0	4.7	3.0	3.1	23.1	14.3	2.7	5.2	4.1	3.8	1.3	1.3	3.6	0.8	3.8	0.0	4.0	3.0	1.8	3.2	6.9	4.1	0.8	6.6	5.2	3.5	0.6
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 72.8;lymphoid tissue: 93.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 63.7;granulocytes: 201.3;Hofbauer cells: 85.0;Kupffer cells: 78.5;Macrophages: 86.5;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 13.9;Daudi: 40.9;HMC-1: 24.0;U-266/70: 30.8;U-698: 11.0"	"Region enriched"	"Detected in single"	4	"white matter: 2.9"	"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"	16.8	8.4	1.4	8.4	1.1	31.1	12.7	2.8	2.9	6.1	1.0	11.0	3.0	6.9	0.3	10.7	11.1	3.4	6.7	1.2	1.8	8.3	5.5	72.8	6.7	4.1	2.5	2.6	23.2	0.9	3.2	3.6	2.7	11.8	2.3	0.1	14.1	1.5	2.1	5.6	35.8	4.9	2.5	93.9	9.3	2.1	2.2	2.6	4.7	3.7	8.9	40.0	7.9	4.2	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	7.4	40.9	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	8.6	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	2.7	0.0	5.2	0.7	0.0	0.0	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.2	0.0	0.0	30.8	2.8	11.0	0.0	0.1	0.0	462.5	225.6	317.6	0.3	198.4	0.6	133.9	5.3	1.7	119.7	98.5	0.7	0.5	457.8	0.2	210.5	2.4	1.2	136.1	1.4	1.1	2.8	2.9	1.2	1.8	4.1	2.5	2.7	2.5	2.2	4.2	0.7	16.0	38.4	1.3	63.7	1.1	7.3	0.2	1.2	1.3	7.3	4.3	2.2	12.8	9.5	9.2	2.1	0.7	1.7	1.7	0.0	20.9	0.5	0.7	0.5	3.0	7.1	1.7	2.8	21.6	2.0	1.7	13.7	4.4	201.3	2.2	3.6	1.1	85.0	0.0	1.1	2.0	14.2	78.5	17.8	1.1	0.3	86.5	0.0	47.8	59.5	0.7	4.1	4.0	1.4	18.4	0.6	0.0	13.8	4.0	9.4	0.2	2.6	0.3	13.1	0.3	1.1	0.3	1.1	9.2	1.4	4.1	5.9	0.7	3.2	45.3
ALPK3	"KIAA1330, MAK, Midori"	ENSG00000136383	"Alpha kinase 3"	Q96L96	15	84817356-84873479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 62.7;skeletal muscle: 195.8;tongue: 59.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 64.1;Exocrine glandular cells: 20.5;Skeletal myocytes: 51.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;HDLM-2: 10.7;HUVEC TERT2: 15.5;LHCN-M2: 21.2;NTERA-2: 12.9;RH-30: 37.7;THP-1: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA026558	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA026558: AB_1844774"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.95e-7)"	"unprognostic (1.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.87e-2)"	12.5	9.6	1.2	0.9	1.6	0.1	4.4	1.0	2.2	2.2	9.3	7.5	0.6	1.5	5.4	3.0	1.7	1.8	62.7	1.3	3.8	13.5	5.9	5.5	0.6	2.2	3.4	0.8	7.7	11.2	26.1	2.5	4.5	2.4	0.8	2.5	2.6	1.3	195.8	1.0	2.1	3.1	1.6	0.5	5.2	0.9	3.9	0.6	3.6	59.1	0.4	3.6	1.4	1.1	1.8	0.1	0.1	0.2	0.3	0.1	14.3	0.0	0.0	0.0	0.1	0.1	6.3	0.0	0.4	0.0	0.1	1.1	0.0	0.0	0.1	10.7	1.7	1.8	0.3	0.0	0.2	0.0	0.1	1.3	0.2	0.0	0.0	0.1	15.5	0.1	0.0	0.1	21.2	0.9	0.0	0.2	12.9	0.3	0.1	0.0	37.7	0.2	0.0	4.0	0.0	0.2	0.0	2.0	0.1	1.9	0.1	9.6	0.3	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	1.0	2.2	1.3	3.8	2.2	3.4	4.5	1.6	3.9	1.1	3.3	6.4	2.7	2.6	0.2	0.9	0.1	0.6	1.2	4.1	1.3	0.8	64.1	17.2	2.4	9.2	16.7	0.3	0.2	0.5	0.0	2.9	0.3	11.5	1.0	8.7	9.1	0.0	3.0	20.5	0.7	3.8	0.5	8.9	1.3	8.7	1.8	1.7	10.2	0.0	3.4	0.3	0.0	0.3	12.0	0.0	0.0	5.2	3.6	9.4	4.7	1.0	1.0	0.5	0.3	10.4	1.2	0.0	1.5	0.7	0.1	2.2	4.2	3.4	0.0	51.9	8.4	0.5	3.2	0.2	0.1	0.7	0.5	0.2	0.3	1.6
ALX1	CART1	ENSG00000180318	"ALX homeobox 1"	Q15699	12	85280220-85301784	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 3.9;kidney: 6.1"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 32.0"	"Cancer enriched"	"Detected in some"	10	"melanoma: 16.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 10.4;HEK 293: 23.3;HUVEC TERT2: 17.2;SK-MEL-30: 29.5;THP-1: 18.0;WM-115: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001598, HPA018905"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Golgi apparatus"	"HPA001598: AB_1078400, HPA018905: AB_1844783"	"unprognostic (4.92e-3)"	"unprognostic (8.09e-2)"		"unprognostic (1.09e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.24e-2)"		"unprognostic (2.05e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-5)"		"unprognostic (8.97e-2)"		"unprognostic (1.43e-1)"	0.2	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.3	1.0	0.4	0.0	0.0	0.7	3.9	0.0	2.3	0.0	0.0	0.2	0.3	6.1	0.0	0.0	0.0	0.2	0.2	1.6	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.2	1.9	0.9	0.0	1.6	0.0	0.3	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.8	0.0	0.4	0.3	0.2	0.0	6.0	0.0	0.0	0.7	0.7	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	3.6	0.0	10.4	0.5	0.0	0.0	23.3	0.0	4.1	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.0	9.3	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.7	5.8	0.0	0.0	29.5	4.1	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	2.2	0.2	1.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0
ALX4	"FPP, KIAA1788, PFM, PFM2"	ENSG00000052850	"ALX homeobox 4"	Q9H161	11	44260440-44310139	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 1.8;choroid plexus: 1.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.4;Fibroblasts: 4.3;Leydig cells: 4.7;Microglial cells: 6.5;Skeletal myocytes: 5.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;BJ: 3.4;HAP1: 4.7;HEK 293: 4.8;HEL: 6.8;K-562: 3.2;SiHa: 7.0"	"Region enriched"	"Detected in some"	8	"olfactory bulb: 9.0"	"Region enriched"	"Detected in single"	31	"olfactory bulb: 9.0"	HPA001903			Supported	Nucleoplasm		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA001903: AB_2666495"	"unprognostic (7.56e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.63e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.34e-6)"	"unprognostic (3.62e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.03e-1)"	0.4	0.0	0.1	0.0	0.1	0.0	1.8	0.1	0.4	0.4	1.9	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.7	0.0	1.0	0.9	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	4.0	0.0	0.0	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	1.0	4.8	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.1	1.3	20.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.6	4.7	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.9"	"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HEK 293: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Uncertain	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA					"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMD1	SAMDC	ENSG00000123505	"Adenosylmethionine decarboxylase 1"	P17707	6	110874770-110898879	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 202.9"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 70.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029281, HPA029282"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA029281: AB_10600101, HPA029282: AB_10599965"	"prognostic unfavorable (3.87e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.71e-2)"	31.8	28.3	35.0	34.7	44.9	89.9	33.9	39.6	56.1	32.8	32.0	36.9	29.2	35.5	25.7	56.0	25.6	33.3	40.2	37.5	38.2	48.6	33.6	33.4	39.9	45.6	38.5	30.0	39.7	40.3	26.0	59.9	42.2	202.9	36.5	35.9	37.4	34.5	26.7	26.9	26.5	35.4	45.5	27.3	31.2	31.9	37.6	40.5	46.2	50.2	50.3	37.4	25.8	67.1	85.8	57.4	68.6	130.6	101.1	63.9	89.8	119.9	131.8	91.4	106.7	92.2	52.3	149.7	56.7	76.7	97.0	57.4	163.9	108.6	125.1	88.5	94.6	155.4	47.5	96.5	60.2	135.7	88.9	43.4	98.0	63.4	126.4	31.8	81.0	75.4	118.2	126.8	156.3	51.8	181.9	103.3	84.7	84.1	51.9	98.5	68.9	89.3	103.9	112.9	87.4	62.2	73.2	91.7	110.7	55.5	59.5	114.9	53.8	60.5	45.7	325.0	131.5	34.4	59.7	152.8	69.6	106.7	79.4	42.9	23.9	37.7	17.4	28.9	20.2	14.5	17.4	20.3	31.5	14.8	20.4	20.8	102.6	15.5	37.3	13.9	22.5	17.0	35.0	44.9	39.6	56.1	37.5	38.2	45.6	38.5	42.2	45.5	37.6	67.1	169.5	38.5	92.5	23.2	164.8	315.3	241.5	49.5	262.4	101.4	178.5	151.1	95.7	125.8	82.7	55.2	60.5	44.5	208.7	144.1	146.8	67.2	31.8	145.0	106.2	104.4	124.4	184.1	39.2	70.0	152.0	132.1	96.4	214.8	93.9	36.9	53.6	59.3	77.0	77.4	37.9	108.2	28.5	109.1	244.2	53.6	43.8	176.7	131.6	23.4	92.0	303.7	60.8	36.7	111.6	87.6	95.9	50.0	118.9	379.4	66.2	89.9	29.3	105.6	19.7	170.5	124.9	93.0	76.7	246.4	288.1	54.6	184.6	45.7	128.8	147.7
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7;skeletal muscle: 27.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 132.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.8	11.7	8.2	6.5	11.2	6.1	0.4	5.5	11.8	0.3	6.9	1.4	5.1	3.0	0.4	2.6	0.7	1.7	1.7	7.6	6.9	5.8	60.7	2.3	4.4	15.5	8.6	1.4	3.3	0.7	0.5	2.0	9.5	2.8	0.2	1.8	2.0	0.2	27.3	5.8	5.0	0.6	2.7	5.9	4.8	13.1	8.0	0.6	0.9	0.9	0.4	0.3	0.2	15.4	46.6	9.5	0.8	5.8	0.0	0.0	10.0	1.5	0.5	0.7	1.4	3.9	5.8	4.0	4.2	0.0	2.6	8.2	0.3	0.0	0.3	16.0	1.7	4.2	7.9	9.4	0.0	5.9	47.7	0.0	0.4	0.8	0.1	0.2	0.3	3.9	2.7	61.2	0.0	6.8	3.7	10.8	4.4	1.8	2.2	7.8	0.3	5.3	0.0	4.3	4.9	6.9	40.5	46.1	5.2	0.2	4.6	8.4	0.0	5.8	19.1	8.0	5.4	49.1	62.8	6.3	3.8	12.2	6.9	0.2	0.6	1.7	0.5	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.4	0.4	2.3	1.8	0.2	0.1	0.5	8.2	11.2	5.5	11.8	7.6	6.9	15.5	8.6	9.5	2.7	8.0	15.4	1.1	0.0	0.5	0.3	2.0	0.4	0.2	0.0	0.0	0.1	1.1	1.0	0.6	1.5	0.6	3.7	0.0	0.9	1.7	0.0	3.9	0.2	0.9	0.1	0.0	0.8	1.8	8.0	0.7	1.1	0.1	0.1	0.0	0.0	0.0	0.2	8.6	132.5	4.4	1.7	0.3	0.1	0.0	5.7	1.3	0.1	0.3	1.8	3.6	0.0	0.7	1.8	2.1	4.0	2.0	0.2	0.0	0.0	0.7	0.0	0.4	31.0	0.0	0.0	0.0	0.8	0.0	1.5	1.9	0.0	0.3	0.3	1.4	0.3	0.4	0.1
AMER3	"FAM123C, FLJ38377"	ENSG00000178171	"APC membrane recruitment protein 3"	Q8N944	2	130755540-130768134	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 14.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.2;Enteroendocrine cells: 15.1;Excitatory neurons: 6.6;Horizontal cells: 3.3;Inhibitory neurons: 5.7;Rod photoreceptor cells: 4.9"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA045593, HPA054230"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA045593: AB_10965021, HPA054230: AB_2682423"	"unprognostic (6.68e-2)"		"unprognostic (3.73e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.83e-1)"					"unprognostic (2.71e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.46e-3)"		0.0	0.6	4.0	0.0	4.5	0.1	0.0	14.6	8.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.2	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.9	0.0	2.8	0.0	1.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	4.5	14.6	8.1	3.7	3.2	1.2	0.2	1.0	0.0	1.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 41.5;ovary: 33.1"	"Group enriched"	"Detected in some"	4	"granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HEL: 40.1;K-562: 22.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 9.4"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.6	41.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.5	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.2	33.1	12.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.2	0.1	0.1	0.0	0.0	5.7	0.7	9.1	0.5	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	40.1	0.0	0.8	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	3.5	2.6	0.0	0.1	1.5	0.0	4.2	0.1	2.1	0.1	2.7	0.0	0.1	26.0	36.1	11.4	0.3	0.1	0.0	0.0	0.0	0.0	1.2	0.0	2.5	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.3	0.0	0.0	0.3	0.8	94.9	0.1	0.0
AMIGO1	"AMIGO, KIAA1163"	ENSG00000181754	"Adhesion molecule with Ig like domain 1"	Q86WK6	1	109504178-109509738	"Predicted membrane proteins, Transporters"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.6;Excitatory neurons: 9.6;Inhibitory neurons: 15.9;Rod photoreceptor cells: 9.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046152	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear bodies"		"HPA046152: AB_2679559"	"unprognostic (1.35e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.16e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	3.8	10.7	12.7	2.7	13.8	0.4	3.2	11.7	20.0	3.6	8.2	6.9	2.1	4.3	11.7	2.8	3.3	2.8	8.6	14.3	12.6	5.2	2.8	4.6	4.1	11.5	10.7	8.8	6.8	12.4	7.4	1.9	12.5	6.3	2.4	23.4	7.6	7.7	19.3	2.4	3.8	4.5	7.9	3.3	4.6	2.9	12.6	2.7	6.5	11.9	3.3	3.9	2.8	11.8	2.3	1.1	2.4	8.3	3.0	1.3	2.9	3.6	2.0	4.4	2.1	0.5	0.1	0.1	1.0	2.5	1.0	1.2	6.5	0.2	3.7	0.9	0.5	0.0	1.6	0.7	2.5	1.9	4.6	0.6	2.8	1.5	0.0	0.4	1.1	1.3	1.9	0.0	0.1	4.1	0.4	3.9	1.3	2.0	2.5	0.6	0.0	0.3	5.1	1.1	8.1	2.7	0.9	11.0	3.2	1.0	3.2	2.8	1.0	0.1	4.8	3.0	1.5	0.2	0.0	0.0	1.6	0.0	2.4	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.9	1.1	0.0	0.0	2.3	1.7	0.0	0.9	0.0	0.0	0.7	0.4	12.7	13.8	11.7	20.0	14.3	12.6	11.5	10.7	12.5	7.9	12.6	11.8	0.6	3.2	2.0	5.9	0.2	0.6	0.4	0.3	0.6	33.6	2.4	1.4	8.9	1.5	0.3	3.7	4.2	1.3	0.6	1.5	0.0	1.2	0.0	0.4	0.4	1.6	4.8	0.0	9.6	0.9	0.2	1.9	0.0	0.7	0.0	1.4	1.1	1.0	0.2	5.0	15.9	1.0	2.0	0.6	0.0	0.1	2.1	0.2	0.0	2.8	0.8	6.7	0.0	3.0	2.1	0.8	1.6	5.7	0.1	1.1	2.3	0.8	0.1	9.4	0.0	4.3	1.5	1.2	1.4	0.2	0.4	0.3	1.8	0.9	1.5	0.3
AMMECR1		ENSG00000101935	"AMMECR nuclear protein 1"	Q9Y4X0	X	110194186-110440318	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 83.1;Excitatory neurons: 92.8;Inhibitory neurons: 108.7;Rod photoreceptor cells: 87.3;Syncytiotrophoblasts: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000590, HPA051762"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Mitochondria	"HPA000590: AB_2666037, HPA051762: AB_2681596"	"unprognostic (7.77e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (6.55e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (6.62e-5)"	"unprognostic (3.61e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (7.82e-2)"	3.6	2.9	1.7	3.7	1.7	13.4	3.4	1.8	2.0	2.9	8.5	3.7	3.1	2.3	2.1	7.9	3.3	2.3	1.1	1.5	1.7	3.4	3.3	2.8	4.2	1.3	1.3	5.5	2.0	2.2	2.0	7.0	1.2	2.2	3.9	14.5	2.8	1.9	1.3	7.4	3.3	2.9	1.0	3.7	3.7	1.6	1.7	4.5	2.4	1.7	5.7	4.8	4.5	1.5	20.3	9.8	7.1	3.4	7.9	11.8	7.8	13.8	12.3	11.1	16.2	15.9	14.4	12.0	6.4	18.4	9.0	9.5	22.7	15.7	11.3	8.4	10.1	16.7	21.7	3.3	19.9	13.5	6.7	6.6	27.3	12.7	22.6	6.0	8.9	5.9	47.1	34.8	8.5	17.2	6.5	4.8	32.6	17.4	19.1	13.7	7.6	21.2	18.8	16.8	11.3	5.3	23.2	22.7	19.9	8.5	5.6	13.3	4.1	7.6	4.6	22.8	12.6	7.1	8.6	18.9	11.6	27.5	25.9	0.6	0.9	0.8	1.6	0.6	2.1	1.6	3.2	2.6	1.5	2.2	2.1	1.9	0.4	0.6	2.7	0.6	2.3	1.0	1.7	1.7	1.8	2.0	1.5	1.7	1.3	1.3	1.2	1.0	1.7	1.5	4.4	0.0	9.8	17.9	11.5	9.6	3.9	10.5	5.7	35.3	7.5	4.4	4.2	8.6	8.9	3.7	52.1	27.2	9.5	8.9	23.5	9.2	0.5	10.5	7.7	9.6	15.0	83.1	92.8	12.0	9.9	12.8	13.7	13.4	2.5	14.4	19.6	8.4	7.1	1.7	108.7	11.2	12.2	7.6	3.1	2.1	12.8	7.3	3.6	21.5	9.4	7.1	14.4	35.7	19.2	11.5	3.7	17.3	8.0	9.1	10.3	10.2	10.4	87.3	13.1	6.7	8.4	2.2	6.9	17.4	26.7	86.5	13.0	34.7	10.5	15.7
AMMECR1L	MGC4268	ENSG00000144233	"AMMECR1 like"	Q6DCA0	2	127861630-127885967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000590, HPA057234"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Cytosol	"HPA000590: AB_2666037, HPA057234: AB_2683376"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.92e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (8.91e-2)"	12.4	10.1	3.1	3.4	3.3	2.4	10.9	3.2	3.8	12.1	2.6	9.9	4.5	12.1	2.4	10.0	11.5	5.0	9.4	3.2	3.4	9.2	12.7	8.9	3.7	3.4	3.3	10.8	10.5	8.5	7.2	7.4	3.3	9.7	4.6	2.3	8.9	5.7	8.3	11.4	9.4	7.3	2.9	10.1	9.6	12.7	3.8	5.4	9.0	7.9	5.1	9.4	11.4	3.2	8.0	5.6	16.4	12.3	15.7	12.0	11.1	10.0	14.4	13.6	14.6	15.0	7.4	6.5	6.6	18.2	6.0	7.7	17.2	10.5	17.9	13.1	9.8	5.7	5.4	11.2	18.3	9.7	9.6	15.6	21.9	18.8	18.4	12.6	19.1	9.5	8.3	5.4	14.6	4.7	10.3	2.7	11.3	9.7	14.1	11.0	15.7	4.7	10.1	3.7	11.0	11.9	12.9	16.2	27.0	14.1	7.0	8.6	13.4	16.6	9.0	5.4	8.5	5.6	11.1	7.6	7.7	7.7	12.5	0.5	1.2	3.8	1.5	1.3	2.0	1.4	1.6	1.5	1.7	1.6	1.4	1.1	1.8	1.6	1.6	1.8	1.4	1.3	3.1	3.3	3.2	3.8	3.2	3.4	3.4	3.3	3.3	2.9	3.8	3.2	9.8	19.2	8.1	5.9	7.2	18.0	8.6	4.8	9.6	5.3	14.5	9.7	12.0	10.0	9.2	3.7	6.2	5.9	7.1	8.6	0.0	6.2	11.4	11.8	27.0	10.4	5.4	5.0	10.4	5.8	7.7	11.1	10.2	12.6	7.0	10.2	8.2	16.2	4.6	1.7	9.2	9.4	2.0	7.5	6.6	15.1	6.8	5.8	5.4	8.4	4.4	4.2	3.1	7.5	10.8	9.2	6.7	8.2	12.2	14.8	5.5	4.6	14.7	6.0	0.0	15.4	11.8	6.6	9.8	13.2	15.8	7.7	7.0	6.4	9.3	13.9
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 145.6;tongue: 53.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.5;Collecting duct cells: 29.5;Cytotrophoblasts: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 22.5;HAP1: 25.1;OE19: 21.2;SuSa: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Cell Junctions"	Nucleoplasm	"HPA067290: AB_2685819, HPA067853: AB_2732773"	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	4.3	1.6	29.0	1.3	24.7	0.3	6.5	23.4	21.9	9.2	0.6	3.5	2.9	4.9	145.6	4.0	12.2	2.8	4.0	23.7	31.6	10.4	2.1	2.7	0.8	32.8	34.4	5.7	2.3	14.3	7.2	20.7	24.1	6.3	4.3	1.7	6.9	25.7	39.0	2.3	3.7	3.2	20.6	1.5	3.0	2.3	36.4	4.4	3.8	53.5	1.0	2.8	4.1	18.2	4.3	0.0	22.5	1.0	0.5	0.5	8.8	0.7	0.0	0.0	0.0	10.5	0.8	0.5	4.7	3.5	0.0	8.4	25.1	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.2	0.0	1.1	0.2	0.0	5.1	0.6	4.9	0.2	0.4	0.0	0.0	0.6	0.4	6.8	0.3	10.5	21.2	0.1	8.4	6.6	0.1	11.2	11.0	0.0	8.0	0.1	0.0	9.8	34.9	0.8	0.2	0.1	2.9	6.8	0.0	9.4	0.7	0.0	0.0	1.0	0.1	6.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	29.0	24.7	23.4	21.9	23.7	31.6	32.8	34.4	24.1	20.6	36.4	18.2	2.2	3.2	2.0	57.5	0.9	1.8	2.7	2.5	2.8	1.1	9.7	6.9	2.0	1.5	7.2	29.5	0.0	46.2	1.1	4.9	1.9	5.1	0.2	7.2	6.3	3.7	15.8	0.4	8.9	1.9	3.8	7.2	4.1	7.1	0.0	1.5	4.2	4.0	6.2	0.0	2.0	7.2	6.1	1.6	2.1	0.5	6.8	1.0	3.6	17.8	1.7	4.9	4.1	2.0	3.5	3.2	5.6	6.4	0.0	6.6	4.7	16.8	10.1	0.5	6.6	3.9	4.0	0.4	3.2	3.0	1.1	15.9	0.9	0.8	7.3	2.5
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416778-49422685	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.4;Proximal enterocytes: 33.3;Undifferentiated cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.1;Hep G2: 47.5;NTERA-2: 8.0;SH-SY5Y: 14.9;SuSa: 9.0"									HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	12.8	9.8	1.2	10.3	8.8	5.6	10.7	11.7	11.8	13.1	12.2	13.8	6.8	8.2	3.5	10.1	5.8	21.6	9.4	9.6	23.2	49.1	5.4	2.1	9.8	10.2	12.5	19.5	14.2	11.9	2.3	9.8	11.3	11.8	6.5	10.6	8.5	3.1	4.8	12.1	3.7	9.9	6.3	11.1	3.0	10.0	3.8	5.8	4.2	1.5	8.0	6.4	9.9	0.1	0.7	1.4	0.4	0.6	0.0	17.1	0.0	0.4	0.1	0.3	0.5	0.6	0.0	0.2	0.4	0.0	0.3	0.1	0.7	0.1	0.3	0.0	0.0	0.5	47.5	1.8	0.0	0.0	0.6	1.8	0.0	0.7	1.3	0.6	0.2	0.0	0.0	0.2	0.4	0.1	0.1	8.0	0.0	0.2	0.0	0.5	1.0	0.8	0.4	0.0	14.9	0.2	0.0	1.1	9.0	0.1	0.3	0.6	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	3.2	0.0	1.7	0.0	0.5	0.0	0.0	4.2	0.2	1.2	0.9	0.1	7.9	0.5	0.3	0.0	1.3	9.8	10.3	10.7	11.7	9.4	9.6	9.8	10.2	9.8	9.9	10.0	9.9	1.2	3.2	9.2	11.4	3.6	2.8	12.1	3.1	3.4	17.4	1.2	1.3	21.8	14.3	6.3	0.0	20.9	25.6	1.4	13.8	0.0	0.8	2.5	0.7	1.6	3.2	12.7	8.8	8.7	0.7	8.8	4.5	15.8	1.0	7.6	2.0	3.9	42.4	5.0	8.4	8.5	18.4	2.0	3.8	2.9	1.6	10.5	2.6	5.4	7.5	1.8	26.0	7.2	6.0	6.6	0.6	18.9	6.4	1.1	6.7	33.3	1.1	6.6	19.3	6.6	5.2	3.1	1.9	0.3	2.2	2.7	10.3	3.8	1.0	31.6	10.9
AMZ2		ENSG00000196704	"Archaelysin family metallopeptidase 2"	Q86W34	17	68205481-68257712	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 477.3;Early spermatids: 736.8;Late spermatids: 1665.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023299, HPA052406"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023299: AB_2226909, HPA052406: AB_2681818"	"unprognostic (3.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.62e-2)"	52.3	51.8	54.5	32.6	66.4	36.4	45.0	57.1	87.2	41.2	50.0	57.8	26.2	44.5	53.4	38.4	52.5	37.9	77.0	59.5	56.6	59.2	38.1	32.9	54.0	58.8	56.7	48.7	45.3	64.4	59.1	29.5	58.0	41.6	32.9	78.5	40.0	51.2	95.6	43.1	36.9	41.7	55.3	43.3	39.7	194.4	60.0	53.2	53.3	86.8	51.7	48.5	36.5	61.4	94.6	98.9	87.5	72.9	65.6	113.4	140.0	71.0	88.3	116.1	93.7	42.3	60.4	142.6	74.9	104.8	107.0	46.0	68.6	198.5	154.0	50.2	67.7	52.8	38.6	83.1	124.9	49.8	86.9	96.9	213.9	107.5	206.2	113.0	118.9	121.7	54.6	86.5	150.9	67.3	110.2	45.4	43.5	51.1	98.5	41.3	238.9	106.7	71.2	50.1	85.7	67.2	64.8	125.5	130.9	184.6	100.7	33.5	65.2	143.8	72.0	55.8	74.8	121.9	121.9	255.7	105.1	69.0	79.1	76.6	25.2	35.3	34.8	30.3	46.2	30.7	43.2	46.0	30.3	41.3	37.8	40.4	45.1	63.7	40.9	28.1	58.3	36.9	54.5	66.4	57.1	87.2	59.5	56.6	58.8	56.7	58.0	55.3	60.0	61.4	18.5	12.8	15.6	477.3	38.7	18.6	31.6	58.4	30.1	13.8	29.7	34.3	81.4	21.5	32.8	23.9	8.4	64.0	58.0	9.4	109.5	28.8	736.8	28.4	17.2	24.4	21.1	21.0	36.4	26.0	66.9	28.2	14.8	18.5	34.1	28.9	21.4	15.5	41.8	18.5	30.0	16.7	40.7	26.1	71.0	1665.0	36.1	39.0	56.9	27.2	46.4	65.7	69.0	56.8	47.7	25.4	10.8	32.7	46.2	17.7	15.2	69.0	61.8	12.8	19.7	26.5	26.8	274.4	59.4	26.4	22.6	34.2	49.3	26.1	15.1	24.5
ANAPC10	"APC10, DKFZP564L0562, DOC1"	ENSG00000164162	"Anaphase promoting complex subunit 10"	Q9UM13	4	144831908-145098541	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044547	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA044547: AB_2678979"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.55e-2)"	11.4	9.4	7.7	6.1	8.2	10.1	14.3	9.6	11.2	11.0	7.9	9.1	4.4	11.6	13.3	7.7	10.7	7.7	13.9	7.9	8.5	12.9	13.6	9.8	10.3	8.3	8.9	11.9	7.5	9.0	7.5	12.3	8.3	8.9	9.8	9.2	8.1	9.2	14.9	8.2	6.6	11.8	8.5	8.4	7.4	19.0	8.4	13.8	11.8	15.1	10.7	11.0	9.0	9.1	14.3	7.8	20.0	7.8	19.5	21.2	13.0	17.1	16.9	21.6	15.7	18.9	18.6	19.6	11.1	11.8	15.6	8.4	17.6	22.6	23.1	19.0	14.0	12.1	6.0	15.6	24.5	23.9	13.7	17.2	15.9	17.7	28.8	18.0	17.1	23.0	32.2	28.2	22.8	10.3	40.5	29.1	14.1	17.0	15.7	20.5	15.5	11.8	24.1	9.0	14.0	10.4	11.1	10.4	23.1	18.6	9.4	19.7	15.6	14.7	8.9	13.7	21.7	22.3	25.2	31.3	19.2	30.2	18.7	25.5	7.8	9.7	13.0	10.3	13.4	15.1	13.5	13.2	11.5	12.4	13.4	13.7	2.2	16.4	9.6	15.6	18.1	7.4	7.7	8.2	9.6	11.2	7.9	8.5	8.3	8.9	8.3	8.5	8.4	9.1	30.7	12.8	17.0	31.3	16.7	16.3	22.0	61.6	10.8	9.9	16.9	26.0	14.8	4.3	34.3	14.7	0.0	38.9	20.2	7.6	46.9	25.8	83.3	26.4	21.0	22.2	3.0	8.6	61.2	26.1	35.8	20.7	9.2	15.6	26.0	15.3	19.6	15.6	35.1	5.0	58.0	13.0	40.7	12.7	18.2	22.8	33.8	17.6	10.6	36.5	27.8	19.0	22.6	55.8	62.3	27.3	15.5	27.1	10.5	26.9	14.3	49.8	27.6	9.8	32.9	21.0	36.2	126.8	41.5	14.2	19.9	29.6	19.5	26.1	13.7	29.4
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1161.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	112.1	120.5	104.8	52.1	108.6	109.3	103.4	110.9	149.5	85.9	100.7	126.0	61.0	86.4	39.0	125.8	80.3	58.0	231.3	106.4	106.8	127.3	185.7	89.3	73.0	110.0	105.1	76.4	108.1	59.0	92.0	54.8	105.0	105.7	27.3	19.3	117.6	42.0	272.8	99.7	83.4	36.5	110.4	86.7	117.9	189.7	113.0	50.1	90.6	126.5	34.0	95.9	94.7	118.1	262.4	605.0	139.0	209.7	118.7	132.8	164.3	123.4	100.6	111.4	127.1	248.6	226.9	82.1	133.3	114.4	121.8	148.9	58.1	166.4	40.5	122.5	437.1	126.8	257.9	379.0	131.3	95.3	103.6	145.6	151.8	120.4	98.2	73.4	184.9	111.9	173.7	233.8	120.8	474.1	225.5	150.6	131.2	259.2	448.7	92.3	136.2	168.0	104.9	229.3	175.8	282.6	133.5	205.7	253.8	96.7	254.1	222.7	108.4	215.0	169.5	229.4	234.1	110.5	52.1	107.0	228.7	144.5	177.7	495.1	419.8	418.8	229.7	359.9	218.7	309.0	232.0	252.9	348.0	296.2	223.0	212.3	212.1	258.5	345.4	581.1	297.9	506.0	104.8	108.6	110.9	149.5	106.4	106.8	110.0	105.1	105.0	110.4	113.0	118.1	137.2	128.2	157.2	11.4	110.5	148.6	215.0	406.1	145.7	59.5	272.5	332.7	360.2	201.6	272.3	198.6	20.9	467.8	119.5	239.6	522.3	260.6	451.9	157.0	151.3	152.9	190.3	201.6	9.8	337.7	524.6	182.9	124.4	169.5	108.3	158.3	159.2	496.4	448.2	33.7	10.2	272.6	319.4	174.6	194.3	1161.0	181.7	170.1	261.5	13.1	251.4	227.7	176.1	7.1	17.0	324.3	274.0	164.7	226.8	334.2	290.7	548.0	199.8	78.9	105.2	115.9	245.0	435.8	252.5	257.4	186.7	508.7	117.3	156.0	271.4	307.0
ANAPC15	"APC15, C11orf51, DKFZP564M082, HSPC020"	ENSG00000110200	"Anaphase promoting complex subunit 15"	P60006	11	72106378-72112780	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036596	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA036596: AB_10671961"	"unprognostic (1.17e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (9.18e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.08e-2)"	28.9	44.2	47.0	30.0	47.5	95.9	30.0	47.8	61.1	24.3	45.8	67.1	30.7	43.4	38.3	53.2	30.4	18.3	62.2	47.2	47.7	48.8	44.0	30.0	43.5	46.4	46.8	22.4	39.2	25.4	32.8	19.2	47.2	52.0	40.6	42.8	39.9	38.8	95.2	39.6	40.1	31.9	46.4	41.2	46.5	72.0	46.3	72.6	44.7	64.3	44.3	41.6	29.5	49.0	74.0	109.4	87.5	55.8	25.5	41.2	41.4	77.1	70.1	121.3	80.2	128.8	78.4	98.8	72.9	110.3	59.0	122.6	133.4	144.0	113.9	64.0	63.3	113.1	124.9	84.5	30.2	110.8	101.3	43.2	56.2	68.9	91.6	45.4	80.7	136.7	83.3	66.6	80.0	127.2	214.5	102.9	70.9	155.3	62.3	89.6	217.4	67.2	106.1	50.5	61.9	53.8	79.0	76.5	127.0	46.8	89.6	58.6	73.4	55.5	72.9	110.5	82.8	68.0	71.5	125.3	34.0	87.8	31.7	29.7	168.5	136.3	73.3	114.2	78.0	94.5	93.4	86.3	148.8	71.4	110.9	101.5	68.4	72.4	107.4	119.1	153.0	124.1	47.0	47.5	47.8	61.1	47.2	47.7	46.4	46.8	47.2	46.4	46.3	49.0	20.1	16.0	16.5	2.9	36.1	41.8	71.2	83.5	44.3	32.9	43.2	55.6	3.9	12.8	50.6	23.9	27.1	84.7	40.5	82.9	123.3	49.4	15.4	38.8	21.3	22.8	49.6	34.1	7.1	102.7	78.8	18.3	36.7	27.8	30.4	27.2	15.0	44.1	82.8	13.5	7.3	66.2	61.1	48.5	47.5	13.4	6.8	48.0	26.6	1.0	58.8	44.1	36.0	5.5	5.2	53.1	61.4	23.0	47.1	43.8	56.2	123.6	45.6	43.3	19.7	16.0	35.3	115.9	139.9	53.8	41.1	46.7	41.1	32.3	71.5	61.7
ANAPC2	"APC2, KIAA1406"	ENSG00000176248	"Anaphase promoting complex subunit 2"	Q9UJX6	9	137174784-137188560	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018692, HPA066539"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB018692: AB_2258285, HPA066539: AB_2685688"	"unprognostic (5.20e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.43e-2)"	"prognostic favorable (8.91e-5)"	"unprognostic (2.29e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.41e-2)"	"prognostic favorable (3.67e-4)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.46e-2)"	"unprognostic (9.88e-2)"	14.4	17.7	8.8	11.3	9.6	15.0	15.8	8.9	13.4	15.2	8.6	14.4	11.9	15.8	3.1	15.8	14.7	8.6	15.6	9.7	8.1	14.2	20.2	13.1	14.5	11.5	9.1	15.2	20.7	7.4	13.8	7.2	10.2	17.5	3.1	4.3	18.2	8.9	18.9	19.2	16.5	5.3	8.1	19.9	17.0	25.5	8.8	10.2	15.5	8.3	6.1	13.8	13.4	12.9	20.9	45.6	10.7	17.5	12.6	7.5	33.5	18.5	11.5	16.9	12.8	27.8	20.9	22.4	21.3	12.3	15.8	41.9	12.9	13.8	2.5	28.9	22.5	13.3	55.1	24.9	14.9	20.7	22.1	15.0	10.9	11.3	6.1	8.3	20.8	20.7	20.3	26.4	8.0	58.2	24.7	28.7	21.6	27.4	34.6	29.3	26.5	41.4	13.1	18.1	14.1	21.3	28.2	36.5	11.9	5.1	39.2	27.8	22.4	24.8	19.8	30.1	16.7	12.9	20.5	24.5	20.1	14.1	18.3	0.3	0.6	0.1	0.5	0.6	0.3	0.3	0.3	0.4	0.5	0.2	0.3	0.4	0.2	0.3	0.9	0.6	0.3	1.1	8.8	9.6	8.9	13.4	9.7	8.1	11.5	9.1	10.2	8.1	8.8	12.9	9.3	0.0	0.5	6.2	12.2	9.3	7.9	14.2	6.2	5.7	13.0	12.6	3.2	11.5	11.5	11.0	4.2	25.9	11.1	19.0	13.7	10.0	40.5	4.2	4.0	9.0	10.2	9.5	2.4	10.9	11.1	9.0	27.0	5.0	11.4	8.5	12.1	11.1	15.6	1.7	2.5	19.1	12.2	8.8	7.8	58.4	11.1	7.6	14.2	1.0	13.9	3.7	6.2	1.5	4.3	8.6	8.0	9.4	15.3	6.8	21.2	15.8	10.2	4.7	0.0	9.8	17.4	40.5	26.4	11.9	9.5	24.5	9.4	5.9	15.4	7.1
ANAPC5	APC5	ENSG00000089053	"Anaphase promoting complex subunit 5"	Q9UJX4	12	121308245-121399896	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039457, HPA039801"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA039457: AB_10795676, HPA039801: AB_2676687"	"unprognostic (3.41e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.35e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (2.31e-5)"	"unprognostic (1.63e-1)"	"unprognostic (6.91e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.93e-3)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (2.01e-9)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.28e-1)"	47.8	48.9	32.2	38.7	38.0	55.0	49.6	34.6	39.8	48.6	36.0	42.7	36.3	45.7	41.6	43.5	53.7	33.0	40.9	33.0	32.3	38.1	52.1	34.4	56.9	34.0	34.3	41.9	76.3	41.4	50.2	35.8	37.3	37.1	47.4	17.6	51.7	37.3	90.5	48.5	42.1	42.2	34.6	50.8	52.6	28.3	33.6	61.9	43.9	61.1	64.7	41.3	39.5	47.3	92.0	123.5	56.4	38.9	98.1	108.1	97.7	86.8	100.2	100.6	89.8	101.9	46.7	124.1	85.0	128.2	40.5	76.7	131.5	86.6	79.8	105.9	139.1	113.7	74.0	114.1	106.5	167.8	108.5	108.3	80.5	101.3	82.6	93.0	129.2	107.0	144.6	74.2	81.4	130.1	141.9	161.6	89.8	91.4	132.1	126.2	82.1	162.6	73.0	92.9	71.1	70.5	127.7	54.2	87.5	63.8	128.9	157.8	80.5	67.1	47.7	43.3	71.5	92.1	97.6	143.1	88.3	123.7	84.0	51.2	67.2	59.9	52.1	71.0	66.2	64.5	60.8	66.3	80.0	52.9	60.1	57.4	15.6	79.0	63.5	52.4	86.1	99.4	32.2	38.0	34.6	39.8	33.0	32.3	34.0	34.3	37.3	34.6	33.6	47.3	60.3	41.7	64.8	34.6	85.6	65.6	65.0	61.3	68.9	61.7	60.3	55.2	48.0	44.3	68.2	55.2	56.3	90.5	81.4	45.8	70.5	61.0	22.4	72.9	74.8	60.2	85.1	89.6	56.8	88.3	105.2	71.9	58.6	41.5	68.4	76.9	46.8	62.7	55.1	77.4	57.6	55.9	63.1	54.1	50.4	36.6	80.2	78.0	48.0	30.0	94.4	43.2	141.1	45.8	184.3	68.7	42.7	63.6	151.2	53.2	61.3	75.9	93.8	59.7	52.6	59.9	65.0	54.1	89.2	75.5	64.8	82.0	79.6	103.6	71.2	53.3
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	14.4	19.0	11.8	14.0	14.3	12.6	15.7	12.7	16.1	20.1	11.8	18.8	10.6	21.4	16.7	36.2	18.0	11.4	22.7	13.0	12.9	18.6	13.3	13.7	18.0	12.3	11.7	16.7	14.1	24.9	14.7	8.5	12.4	18.5	16.2	13.2	20.5	17.5	33.8	18.0	14.5	21.1	12.4	16.6	15.7	30.1	12.1	24.0	20.2	24.9	20.7	19.0	24.8	12.8	49.7	66.8	47.8	40.9	48.8	24.6	27.4	33.9	30.6	61.1	42.2	68.5	30.8	78.6	33.5	45.8	35.2	49.1	71.8	46.5	61.8	42.0	57.8	69.3	46.0	57.3	35.5	62.5	31.6	27.0	32.7	53.0	35.0	43.6	60.1	55.2	110.7	16.4	48.7	53.0	95.6	46.7	42.0	48.1	57.6	72.8	47.2	93.1	41.4	62.5	61.8	35.4	53.2	41.2	57.3	41.9	87.1	56.0	38.2	36.3	34.1	32.6	40.6	27.4	59.5	105.6	40.5	52.6	42.9	20.2	12.1	20.5	18.2	17.2	21.7	14.3	19.6	17.7	20.1	18.7	16.1	17.5	9.3	24.3	15.9	10.9	26.1	14.4	11.8	14.3	12.7	16.1	13.0	12.9	12.3	11.7	12.4	12.4	12.1	12.8	13.1	16.0	18.4	17.6	12.9	10.1	19.6	16.5	13.1	18.5	12.8	11.6	17.5	10.0	22.6	12.9	20.9	12.4	10.7	9.2	11.7	16.9	7.6	22.8	18.6	15.7	10.8	33.6	28.1	15.2	10.1	16.9	16.3	15.3	15.8	42.5	11.7	13.4	22.4	21.9	22.6	10.8	32.6	17.9	6.6	12.7	18.3	12.5	17.8	13.1	14.7	16.1	11.3	22.6	29.3	16.2	8.9	21.8	11.4	20.0	7.3	15.0	18.4	22.9	13.1	15.9	16.2	74.1	42.2	38.3	13.4	7.3	14.0	32.4	14.9	17.5
ANGEL1	"Ccr4e, KIAA0759"	ENSG00000013523	"Angel homolog 1"	Q9UNK9	14	76786009-76826246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.3;Late spermatids: 75.1;Oligodendrocyte precursor cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000948	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA000948: AB_2227189"	"unprognostic (4.81e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (9.24e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (5.46e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.32e-2)"	11.3	18.5	18.3	11.8	19.7	6.8	12.7	16.7	21.2	12.8	15.6	10.0	9.2	14.8	23.8	7.0	12.2	11.4	15.7	19.2	21.1	11.6	19.3	14.0	12.2	22.5	19.6	19.3	50.8	17.2	21.1	10.4	21.5	9.3	10.9	26.4	15.8	8.4	12.2	6.4	10.3	12.3	18.1	29.3	15.8	52.4	20.1	8.1	13.7	9.8	10.9	9.5	8.5	23.8	13.1	14.0	15.2	13.6	12.2	11.1	14.1	7.7	11.0	7.8	9.9	13.5	18.2	23.8	11.1	6.7	10.6	16.2	14.6	13.7	13.1	10.1	13.1	14.8	9.7	10.3	7.9	7.8	8.7	11.8	16.8	7.3	14.5	11.3	20.0	24.8	14.5	6.2	8.2	25.3	14.0	11.6	17.5	20.7	18.4	17.0	10.4	14.1	11.8	18.4	21.5	9.6	11.6	15.8	7.1	13.8	31.1	8.4	9.6	9.1	8.0	6.9	6.4	15.9	12.9	14.7	7.7	13.7	11.8	0.8	4.8	1.6	5.9	5.5	7.2	6.8	5.3	5.6	7.5	5.5	7.5	5.6	1.4	5.5	7.1	4.9	4.5	5.9	18.3	19.7	16.7	21.2	19.2	21.1	22.5	19.6	21.5	18.1	20.1	23.8	7.4	6.4	10.5	17.6	4.7	1.1	1.8	1.5	2.2	2.4	5.7	5.0	6.7	5.7	2.2	3.7	10.4	1.5	1.5	2.1	0.0	3.3	64.3	3.7	3.9	10.0	4.2	4.2	18.3	3.2	2.8	4.3	1.5	3.3	1.3	15.9	7.1	9.5	7.2	0.0	19.7	4.4	4.1	5.7	2.0	75.1	2.1	5.5	1.8	23.4	1.4	4.9	1.0	64.8	30.2	2.5	1.0	4.9	8.9	3.4	1.7	1.3	1.4	8.9	6.6	5.1	2.4	15.9	4.9	2.8	0.4	1.2	3.0	12.9	4.6	1.5
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015867	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavorable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.20e-4)"	7.5	6.6	13.1	6.9	14.9	6.4	10.4	11.1	14.7	7.9	9.2	6.6	5.2	8.6	8.1	5.9	7.4	6.1	5.8	12.8	11.1	7.7	8.0	6.6	10.5	10.6	10.8	10.8	6.7	7.8	6.2	6.5	10.1	8.2	6.4	9.2	6.0	6.2	7.3	9.1	7.2	7.1	10.1	9.8	6.3	5.5	13.1	10.2	8.1	7.1	9.2	7.1	6.3	11.6	12.2	9.6	15.2	13.2	11.5	16.8	13.6	9.8	16.3	15.4	15.3	6.3	8.9	11.8	8.8	9.7	8.5	9.4	17.8	9.4	15.5	22.3	10.6	11.9	7.4	6.3	12.5	11.8	13.6	10.4	11.9	12.1	12.2	13.1	13.2	10.4	13.9	11.8	18.0	4.0	13.6	7.9	36.4	6.6	6.8	6.9	27.4	12.4	12.1	8.2	7.5	21.7	11.9	15.7	18.3	16.2	12.2	8.6	9.8	12.7	6.7	15.7	15.1	8.6	8.9	7.9	14.2	8.7	11.9	6.6	4.4	5.9	5.1	4.3	6.5	5.7	6.4	5.4	5.5	3.5	6.7	5.7	2.7	10.9	3.5	3.3	8.9	5.2	13.1	14.9	11.1	14.7	12.8	11.1	10.6	10.8	10.1	10.1	13.1	11.6	23.1	48.1	9.8	26.8	23.8	6.9	8.5	11.7	12.5	21.2	14.6	10.2	15.2	17.2	14.5	12.9	10.4	14.8	26.2	7.6	11.7	10.3	1.5	11.3	19.8	15.9	6.7	18.1	33.2	10.5	15.0	18.0	14.3	11.7	17.1	28.8	16.1	12.5	11.8	28.6	26.3	8.4	14.2	20.4	10.5	2.6	15.5	17.1	3.6	30.0	17.3	11.6	16.5	30.2	49.3	10.2	6.4	13.9	24.2	10.8	10.7	16.9	22.5	17.8	19.7	21.7	16.1	9.5	16.6	12.7	7.0	10.9	25.8	17.9	8.0	7.4
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374370	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 195.8;breast: 165.0;liver: 183.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 318.9;Hepatocytes: 148.4;Pancreatic endocrine cells: 230.4;Proximal enterocytes: 146.3;Skeletal myocytes: 198.3"	"Cancer enriched"	"Detected in all"	4	"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.6;HBEC3-KT: 226.5;LHCN-M2: 60.9;TIME: 114.6;U-138 MG: 65.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	7750000	3100000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"		"CAB033770: AB_2057427, HPA007879: AB_1078158"	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	195.8	23.0	25.2	15.4	31.8	1.4	165.0	26.2	32.6	18.8	14.0	25.6	11.5	6.8	0.1	41.2	7.9	9.4	45.4	27.7	27.0	51.9	183.7	46.6	2.0	30.1	37.6	9.1	70.8	1.0	16.1	18.3	27.2	30.4	0.9	3.2	19.1	2.6	24.8	30.2	28.0	6.0	27.3	13.1	21.7	6.7	33.8	0.7	34.1	6.2	2.8	26.6	32.1	33.7	0.1	2.2	1.2	3.3	54.6	12.0	0.7	4.4	0.5	0.7	0.2	0.0	20.9	0.2	30.6	8.8	4.5	3.0	0.0	226.5	0.4	1.9	0.4	0.3	0.9	0.9	1.2	0.1	0.2	5.6	1.0	34.0	0.7	6.2	17.4	0.6	1.1	0.5	60.9	1.8	0.2	2.1	0.3	0.0	1.8	1.3	0.1	1.0	11.1	4.0	0.2	0.5	26.2	2.7	4.3	1.5	6.8	0.4	114.6	65.1	0.3	33.3	0.0	0.3	0.1	0.2	44.9	0.0	12.4	3.3	0.1	0.4	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.3	0.0	0.1	0.2	0.1	25.2	31.8	26.2	32.6	27.7	27.0	30.1	37.6	27.2	27.3	33.8	33.7	53.5	38.5	5.8	128.0	1.2	14.0	39.8	318.9	17.1	0.2	71.8	49.0	5.3	1.5	85.7	14.7	0.0	7.4	2.5	17.1	0.0	107.1	0.7	4.2	6.9	28.9	0.0	0.0	0.4	18.0	111.2	89.1	46.9	13.8	2.5	1.5	17.9	148.4	8.3	0.0	0.6	14.2	16.2	1.6	10.3	2.2	88.0	5.0	8.8	2.8	2.0	2.7	0.0	1.0	4.5	230.4	8.4	131.7	1.0	38.3	146.3	4.5	19.0	0.1	32.9	198.3	121.5	0.0	3.1	21.8	11.5	40.1	2.3	20.7	6.7	77.7
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 409.8"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 151.2"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"Hep G2: 37.0;MCF7: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	836000	350000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	35.7	0.8	1.1	0.2	1.0	0.1	22.5	0.1	1.7	1.2	0.0	1.4	0.4	0.9	1.6	0.3	0.8	0.4	1.8	0.9	0.6	4.0	409.8	0.4	0.1	0.7	0.6	1.1	0.9	0.0	0.3	0.1	0.5	0.8	0.0	0.1	1.3	0.1	0.8	0.9	1.2	0.1	0.3	0.4	0.7	0.5	1.1	0.0	1.0	0.0	0.0	1.1	1.0	0.9	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	1.3	37.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	21.2	0.0	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.0	0.3	0.0	0.3	0.4	0.9	0.0	0.4	0.6	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.1	1.7	0.9	0.6	0.7	0.6	0.5	0.3	1.1	0.9	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.4	0.2	0.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	2.7	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	4.6	151.2	0.1	0.0	0.0	0.0	0.0	4.4	0.0	1.9	0.9	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.0	0.1
ANKAR	FLJ25415	ENSG00000151687	"Ankyrin and armadillo repeat containing"	Q7Z5J8	2	189674290-189761193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 5.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.9;Early spermatids: 88.8;Inhibitory neurons: 60.6;Oligodendrocyte precursor cells: 87.0;Oligodendrocytes: 80.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036168	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centriolar satellite"	Nucleoplasm	"HPA036168: AB_10673345"	"unprognostic (2.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	0.2	0.4	0.2	0.2	0.3	0.2	0.4	1.0	0.3	0.2	1.4	0.2	0.2	0.4	0.6	0.2	0.3	0.3	0.1	0.2	0.3	0.2	0.4	0.3	0.5	0.3	0.3	0.3	0.5	0.6	0.1	0.3	0.3	0.5	0.4	0.6	0.5	0.2	0.1	0.3	0.3	0.2	0.2	0.4	0.5	5.8	0.3	0.1	0.5	0.0	0.3	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.4	0.6	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.6	10.5	3.2	8.2	82.9	13.4	1.3	7.2	2.5	5.2	12.6	4.1	3.8	4.7	4.3	2.8	11.0	14.6	1.2	8.1	3.3	1.9	3.3	88.8	2.8	8.4	8.9	0.0	10.1	46.0	4.3	1.1	9.7	13.3	2.8	0.0	8.4	7.1	2.4	2.4	3.3	60.6	5.7	2.0	1.9	4.9	46.1	21.8	5.6	7.2	47.8	3.4	6.1	13.4	87.0	80.5	4.5	5.6	13.9	5.1	4.1	4.8	2.7	1.5	46.2	6.6	15.8	8.4	20.3	11.1	5.2	1.3	0.1	9.6	4.8	4.2	4.1
ANKDD1A	FLJ25870	ENSG00000166839	"Ankyrin repeat and death domain containing 1A"	Q495B1	15	64911902-64958691	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 209.6;Leydig cells: 61.8;Peritubular cells: 78.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.1;RT4: 17.7;U-266/84: 25.4"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 13.8"	HPA040757	Approved		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA040757: AB_10960566"	"unprognostic (3.72e-4)"	"unprognostic (1.86e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.25e-2)"	"unprognostic (4.78e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.11e-3)"	"unprognostic (5.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.64e-2)"	3.6	9.0	5.1	2.6	4.5	2.7	1.5	2.0	5.4	2.3	0.1	1.3	1.2	2.2	1.9	3.6	4.0	2.9	2.2	3.8	2.5	0.8	0.4	2.6	4.8	4.7	2.7	3.8	4.4	4.4	1.2	1.6	2.2	2.3	0.4	2.8	2.4	2.1	1.2	3.3	1.8	1.6	2.1	10.7	1.7	3.6	3.5	0.8	2.6	0.1	1.3	3.0	2.0	2.5	1.2	3.7	1.6	1.6	2.7	2.1	6.9	1.6	4.4	1.7	2.5	2.1	1.7	1.6	1.9	3.8	1.4	1.3	3.7	0.3	1.4	0.7	1.1	1.5	4.6	1.5	2.0	1.2	2.5	1.6	0.5	1.1	0.6	0.9	1.2	1.7	0.3	24.1	0.5	3.5	0.6	2.6	2.2	0.6	1.7	0.8	1.0	12.1	0.2	17.7	3.2	4.5	1.0	1.2	1.8	1.5	1.2	1.5	1.8	3.2	3.3	2.8	1.6	6.4	25.4	1.2	3.6	3.0	1.0	0.5	0.4	0.0	1.0	0.9	0.3	0.4	0.5	1.4	0.7	0.3	0.3	0.4	0.7	3.1	0.9	0.0	2.1	0.4	5.1	4.5	2.0	5.4	3.8	2.5	4.7	2.7	2.2	2.1	3.5	2.5	8.0	0.0	1.3	209.6	1.5	5.6	4.2	1.1	4.0	11.2	0.7	1.0	1.4	1.5	1.3	0.0	12.5	3.1	3.8	0.1	0.0	0.9	1.1	1.7	9.6	12.7	1.2	0.0	37.7	2.3	5.6	6.5	0.0	3.6	5.7	1.1	5.3	0.0	5.4	3.3	24.6	0.0	2.0	6.0	25.4	4.1	61.8	7.1	10.6	19.7	1.1	28.9	5.2	30.2	10.7	2.8	0.1	78.6	6.2	2.7	0.0	0.3	0.2	8.2	13.1	11.8	7.1	2.6	1.3	0.8	3.7	2.2	3.0	3.3	0.1	5.2
ANKFN1	FLJ38335	ENSG00000153930	"Ankyrin repeat and fibronectin type III domain containing 1"	Q8N957	17	55882301-56511659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.3;cervix: 9.2;fallopian tube: 5.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 138.4;Excitatory neurons: 27.2;Inhibitory neurons: 86.6;Oligodendrocyte precursor cells: 70.9;Respiratory ciliated cells: 31.0"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.8;MOLT-4: 15.4;T-47d: 5.0;U-2197: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021566, HPA022538, HPA048953"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane"	"HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: "	"unprognostic (6.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.38e-5)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.44e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-2)"	0.7	0.2	5.3	0.0	3.6	0.0	0.3	3.6	1.8	9.2	0.6	0.1	0.1	0.1	0.9	0.2	5.3	0.2	0.0	3.1	8.4	0.1	0.0	0.7	0.0	7.5	11.3	0.0	0.0	0.0	0.3	0.8	6.2	0.2	0.1	0.2	0.2	0.1	0.0	2.2	0.1	0.0	7.7	0.0	0.3	1.7	9.7	0.6	0.1	0.0	0.0	1.0	0.9	3.0	0.0	0.0	0.1	0.0	1.1	0.1	0.3	0.0	2.5	0.1	0.2	0.0	0.0	0.2	0.2	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.1	0.4	15.4	0.0	0.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.5	0.0	0.2	0.0	5.0	0.0	0.0	0.0	0.3	4.8	0.0	1.3	0.2	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.6	3.6	1.8	3.1	8.4	7.5	11.3	6.2	7.7	9.7	3.0	0.0	0.0	1.1	138.4	0.0	0.5	0.1	0.6	0.0	0.0	0.3	0.1	0.6	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	18.7	16.9	1.2	0.3	0.0	0.0	27.2	0.0	0.9	1.1	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	86.6	2.4	0.0	0.0	0.7	8.6	0.6	0.0	1.8	11.2	0.0	0.3	0.0	70.9	3.0	0.0	0.1	0.0	0.0	0.3	0.2	0.1	31.0	0.1	6.6	0.0	0.5	6.4	2.7	0.0	0.4	2.9	0.0	0.0	0.1	1.4
ANKLE1	"ANKRD41, FLJ39369, LEMD6"	ENSG00000160117	"Ankyrin repeat and LEM domain containing 1"	Q8NAG6	19	17281645-17287646	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.6;brain: 8.8"	"Cell type enriched"	"Detected in some"	10	"Erythroid cells: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 77.2;HL-60: 34.6;NB-4: 41.7;U-937: 57.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026789, HPA073498"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA026789: AB_10611675, HPA073498: AB_2686612"	"unprognostic (5.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (4.86e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.89e-4)"	"unprognostic (5.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.30e-2)"	0.7	0.9	4.5	2.3	2.7	25.6	0.6	8.8	5.5	0.7	0.6	0.5	0.9	1.0	1.2	0.7	0.6	0.7	1.0	3.2	2.3	0.4	0.6	0.8	4.1	1.6	1.4	1.5	1.7	0.4	0.5	1.2	1.7	0.7	0.5	3.6	1.5	0.6	0.3	2.4	0.8	0.8	0.4	2.2	0.8	1.5	3.3	1.3	0.9	0.5	3.1	0.7	0.4	2.7	0.9	0.8	3.7	1.7	0.4	0.6	3.2	1.1	0.3	0.6	0.6	17.1	1.5	77.2	0.7	0.5	0.6	1.5	28.4	0.4	0.6	22.3	3.4	29.1	13.1	0.6	0.3	34.6	12.5	0.3	1.0	2.7	0.2	0.9	0.6	6.4	4.2	9.2	0.4	0.9	24.2	41.7	10.2	0.3	2.6	17.3	1.0	8.7	0.4	1.7	1.2	7.1	6.8	0.9	0.7	1.5	0.6	20.1	1.4	1.0	1.2	1.4	1.0	1.3	0.9	27.8	0.7	57.2	1.3	0.9	0.9	0.6	0.5	1.9	0.3	1.6	0.4	0.5	1.1	0.9	0.5	0.4	1.5	0.3	1.4	0.9	0.4	0.6	4.5	2.7	8.8	5.5	3.2	2.3	1.6	1.4	1.7	0.4	3.3	2.7	0.4	0.0	0.5	0.7	1.1	0.8	0.8	0.3	0.0	1.9	0.5	0.6	0.8	0.0	0.1	0.0	0.0	1.6	0.4	0.4	0.0	0.2	0.3	0.2	0.4	0.4	0.0	70.7	1.4	0.2	0.7	0.6	0.0	0.8	1.3	1.1	0.0	0.1	0.8	0.0	1.6	0.5	0.0	0.9	1.3	0.0	1.8	1.1	0.0	1.0	3.0	0.5	1.0	1.0	1.6	0.3	0.1	1.5	0.9	0.5	0.0	0.1	0.9	1.5	6.6	0.6	0.4	0.5	1.0	0.0	0.4	0.4	0.5	0.3	0.3	0.2
ANKMY1	"FLJ20499, ZMYND13"	ENSG00000144504	"Ankyrin repeat and MYND domain containing 1"	Q9P2S6	2	240479422-240569209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 187.5;Late spermatids: 213.1;Respiratory ciliated cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026620, HPA048869"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026620: AB_1844834, HPA048869: "	"unprognostic (2.89e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.46e-1)"	"unprognostic (3.97e-5)"	"unprognostic (8.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.59e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.20e-4)"	4.9	4.4	6.4	5.7	7.6	12.5	6.3	6.0	7.3	7.5	6.1	6.0	6.5	5.4	8.7	5.8	24.6	4.7	3.4	5.4	4.9	5.0	6.2	6.9	9.0	8.1	12.3	7.4	8.6	6.2	4.5	3.9	8.0	6.6	5.5	3.8	5.1	5.2	3.5	8.2	7.2	3.0	8.0	8.2	9.6	67.9	7.1	7.1	6.5	2.1	6.7	5.7	6.4	11.1	7.0	15.2	3.2	6.0	2.9	4.1	13.4	3.3	5.0	2.7	3.6	4.9	14.2	7.0	0.6	3.7	4.1	7.6	6.2	7.8	3.2	12.9	5.2	13.9	8.6	13.0	2.4	7.8	12.8	6.6	18.7	2.5	17.7	8.2	2.8	11.0	13.2	8.8	4.6	6.7	7.2	12.8	2.7	12.1	9.0	20.1	9.8	11.1	4.1	15.0	7.5	5.6	2.7	7.2	10.0	3.9	6.2	11.9	3.6	10.0	3.3	4.0	5.9	20.0	5.5	7.0	5.7	11.8	7.9	0.0	2.1	4.5	4.6	1.8	2.7	2.8	2.8	2.9	2.7	4.1	4.1	3.0	0.9	1.3	2.3	1.8	0.9	2.4	6.4	7.6	6.0	7.3	5.4	4.9	8.1	12.3	8.0	8.0	7.1	11.1	3.0	0.0	8.1	23.8	7.2	0.9	1.8	5.3	13.1	3.5	4.3	3.7	2.2	1.5	10.1	3.7	4.2	3.0	8.1	4.8	1.9	2.7	187.5	40.8	3.6	3.5	4.2	6.5	17.0	4.3	1.7	2.8	16.8	4.5	5.7	4.8	2.9	6.4	2.7	3.3	25.4	4.5	6.1	7.6	2.0	213.1	4.1	6.7	0.0	38.4	5.5	2.6	7.2	21.1	42.9	3.2	2.2	3.0	3.4	2.8	5.7	2.9	62.6	4.0	0.0	2.2	3.5	28.8	8.9	5.0	2.3	2.9	8.6	2.9	4.7	2.0
ANKMY2	"DKFZP564O043, ZMYND20"	ENSG00000106524	"Ankyrin repeat and MYND domain containing 2"	Q8IV38	7	16599779-16645817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067100			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA067100: AB_2685777"	"unprognostic (3.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (5.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.85e-2)"	11.1	10.9	13.1	7.1	16.8	14.4	14.4	13.4	19.0	14.0	14.7	17.0	15.2	13.2	12.1	11.6	15.7	13.6	39.1	17.3	13.0	16.1	11.1	11.8	9.6	11.8	11.4	25.6	11.9	15.4	11.7	9.2	11.2	13.4	17.0	23.4	13.2	18.5	23.5	10.8	17.3	11.7	11.9	10.5	24.8	9.6	12.0	13.2	21.8	23.3	9.1	14.4	11.3	14.0	20.9	17.0	23.2	22.6	21.5	22.2	12.8	24.2	29.7	18.3	28.4	30.0	30.9	4.2	28.5	26.4	38.3	21.0	15.4	9.6	27.7	9.1	12.0	37.8	20.2	13.4	13.8	28.5	13.5	19.8	4.9	19.3	19.0	25.5	16.8	26.2	41.0	6.5	26.5	5.6	12.5	19.4	15.9	62.5	22.2	20.2	21.0	9.7	28.6	17.2	15.0	8.6	16.0	11.9	10.0	21.2	14.1	24.5	10.2	14.4	12.5	31.8	17.2	24.6	19.6	6.6	21.8	23.1	22.9	30.1	4.0	17.5	11.6	5.0	11.0	7.9	9.4	11.8	6.0	7.9	7.7	9.2	3.0	13.6	11.8	5.7	10.6	6.6	13.1	16.8	13.4	19.0	17.3	13.0	11.8	11.4	11.2	11.9	12.0	14.0	6.8	3.2	15.1	17.3	6.5	4.7	8.6	9.1	7.4	17.3	7.3	10.9	37.9	10.0	15.1	11.0	6.2	13.6	10.3	13.6	21.5	8.0	42.5	7.9	5.5	7.3	19.2	15.8	57.3	8.9	11.7	13.6	20.9	4.9	6.3	14.7	4.6	5.6	9.5	8.4	36.5	14.2	10.2	7.4	6.7	31.0	12.8	7.4	14.2	15.9	6.1	19.6	8.2	22.6	19.2	5.2	11.7	13.5	8.1	4.1	19.9	12.9	28.8	19.6	26.3	6.3	12.1	9.8	4.0	6.7	4.1	17.0	8.7	15.7	14.1	6.1
ANKRA2		ENSG00000164331	"Ankyrin repeat family A member 2"	Q9H9E1	5	73552190-73565667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003968, HPA065263"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA003968: , HPA065263: AB_2685449"	"unprognostic (1.75e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.13e-3)"	7.8	11.3	4.6	5.7	5.1	14.0	10.1	5.7	5.4	9.4	5.2	8.9	9.6	12.4	13.1	7.5	11.4	9.7	8.2	4.2	5.1	5.9	10.8	7.0	9.9	5.0	4.9	14.1	8.3	8.0	7.5	10.0	5.3	12.4	10.4	9.9	10.9	8.4	7.6	9.1	9.6	8.3	5.1	8.8	10.0	6.7	5.2	10.0	14.3	6.6	8.1	7.4	7.7	6.2	6.6	4.5	6.6	7.5	12.3	19.3	20.6	9.0	13.2	7.6	11.0	1.4	9.4	6.2	7.0	8.8	7.3	4.5	3.1	15.4	10.9	11.9	5.5	5.4	3.6	6.5	9.6	3.1	9.3	19.8	21.0	9.1	9.2	13.6	8.7	6.7	5.3	9.9	8.6	3.8	5.6	8.5	3.9	2.5	3.7	3.5	7.1	8.7	5.6	8.2	9.0	6.9	6.9	5.3	11.0	10.2	8.2	5.0	11.2	3.0	3.4	4.9	6.3	19.7	15.1	5.3	7.5	5.1	8.8	19.9	5.1	11.2	7.6	4.5	9.3	9.9	8.9	10.7	4.6	8.0	13.3	12.4	8.4	7.3	7.8	5.3	11.5	6.8	4.6	5.1	5.7	5.4	4.2	5.1	5.0	4.9	5.3	5.1	5.2	6.2	10.7	3.2	11.5	10.4	23.5	15.8	30.1	29.8	26.2	26.2	20.7	15.9	8.9	31.5	22.7	18.4	10.4	26.3	27.1	16.0	27.4	14.1	1.3	18.1	11.0	12.8	24.1	21.5	10.0	16.6	22.2	13.8	10.7	13.4	19.0	18.8	15.7	23.8	10.5	23.5	12.9	22.6	36.7	18.5	6.7	2.2	32.6	11.1	12.4	16.9	15.1	16.2	17.5	21.1	22.3	16.9	20.0	29.0	14.6	25.7	21.5	18.0	21.4	21.2	26.3	11.3	17.8	25.6	15.9	16.0	12.4	48.8	20.4	16.3	17.0	36.8
ANKRD1	"ALRP, C-193, CARP, CVARP, MCARP"	ENSG00000148677	"Ankyrin repeat domain 1"	Q15327	10	90912096-90921087	"Metabolic proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"heart muscle: 6540.8"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 13820.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 474.5;EFO-21: 1248.9;hTERT-RPE1: 679.8;LHCN-M2: 1573.6;SuSa: 469.1;TIME: 2206.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038736	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA038736: AB_2676184"	"unprognostic (2.45e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.39e-1)"	"unprognostic (9.14e-3)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.72e-5)"	"unprognostic (3.40e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.16e-3)"	0.9	0.7	0.0	0.4	0.0	0.0	1.8	0.2	0.3	0.6	0.6	0.7	0.0	0.4	0.0	0.6	0.1	1.3	6540.8	0.0	0.2	0.7	1.6	48.6	2.5	0.0	0.2	0.7	4.8	0.2	1.1	4.2	0.0	6.8	0.0	0.0	8.7	0.1	571.0	2.3	0.6	2.1	0.0	0.5	1.0	0.9	0.8	1.5	1.7	20.5	0.0	1.2	0.5	0.1	37.2	10.8	6.6	0.3	5.8	6.7	0.5	21.5	2.2	6.0	10.8	474.5	17.9	0.3	1248.9	1.8	48.5	13.3	2.3	3.1	15.7	1.4	1.2	0.2	2.9	148.5	27.7	0.0	0.0	44.2	0.1	9.5	21.6	679.8	437.8	0.0	0.3	0.0	1573.6	0.4	0.0	0.0	1.3	2.7	0.3	0.0	104.3	0.0	3.9	0.5	0.1	0.0	0.3	0.4	1.2	469.1	0.3	1.9	2206.7	4.1	163.9	3.2	175.0	0.0	1.2	3.0	0.9	0.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.1	0.0	913.5	42.0	0.0	0.0	0.0	3.5	18.5	0.0	0.0	0.0	0.0	13820.4	7.2	6.6	0.0	0.0	0.6	0.0	0.0	0.0	66.3	5.7	9.4	0.2	83.6	0.0	0.0	0.0	0.2	0.2	243.5	0.0	4.6	3.8	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.0	0.0	74.5	100.9	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1
ANKRD10	FLJ20093	ENSG00000088448	"Ankyrin repeat domain 10"	Q9NXR5	13	110878540-110915069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034211, HPA038878, HPA038879"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB034211: AB_2058024, HPA038878: AB_2676252, HPA038879: AB_2676253"	"unprognostic (3.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.97e-3)"	"unprognostic (9.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.25e-6)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.41e-6)"	78.2	60.3	61.9	42.2	69.8	88.7	75.6	65.9	85.2	109.1	71.4	97.2	43.8	87.4	89.9	37.6	90.7	53.5	74.3	62.6	68.8	93.9	84.1	91.7	63.3	72.5	65.8	99.6	94.9	25.5	97.5	36.4	75.5	108.1	50.2	77.6	70.3	42.4	176.6	48.9	88.1	49.0	66.3	138.9	75.0	40.8	67.7	52.4	82.1	73.4	50.4	79.2	68.3	80.1	36.1	29.6	66.7	56.2	50.2	48.4	29.6	24.0	50.0	23.5	28.9	31.0	68.8	49.5	51.1	18.2	38.2	81.1	29.2	22.6	31.7	119.1	43.2	59.0	73.3	64.9	20.0	85.9	49.4	46.2	33.7	16.5	24.4	49.1	32.1	48.8	26.4	33.1	64.2	10.8	49.9	95.3	37.0	79.1	18.3	76.0	24.5	49.6	64.9	39.4	53.2	39.7	18.2	31.7	39.9	49.7	22.7	108.0	28.0	27.6	23.0	13.7	24.7	40.8	46.9	28.9	51.7	41.5	44.2	39.0	25.8	22.7	30.4	21.1	26.3	42.9	29.2	25.3	33.8	44.7	30.9	33.7	16.1	31.8	22.3	31.5	39.9	26.8	61.9	69.8	65.9	85.2	62.6	68.8	72.5	65.8	75.5	66.3	67.7	80.1	77.6	16.0	65.4	83.6	69.3	94.3	39.0	25.9	129.1	33.3	72.2	55.0	32.0	45.8	45.3	38.6	54.2	45.1	54.4	43.4	19.6	52.1	8.5	59.0	79.2	83.3	41.9	30.3	118.7	49.2	51.8	78.3	51.5	105.4	30.4	65.3	40.7	48.8	46.6	32.0	105.8	55.2	57.0	46.5	99.7	7.3	39.1	60.4	72.9	145.2	44.7	28.6	35.0	158.3	203.6	38.7	46.2	51.6	58.5	62.5	40.9	45.1	40.8	55.4	52.6	105.6	88.8	28.0	23.6	44.3	77.7	38.9	58.9	44.9	59.6	53.2
ANKRD11	"LZ16, T13"	ENSG00000167522	"Ankyrin repeat domain 11"	Q6UB99	16	89267630-89490561	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019288, HPA041593, HPA049470"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780"	"unprognostic (7.31e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.16e-1)"	24.2	21.1	33.1	26.0	29.3	53.9	14.5	23.2	39.1	18.0	18.7	17.6	21.4	22.0	12.8	22.5	18.4	18.6	22.3	36.8	22.1	15.7	12.2	18.9	26.3	29.8	25.7	29.2	26.6	24.7	24.1	17.9	25.3	16.1	13.6	14.1	20.1	17.0	24.8	35.0	21.0	14.5	19.2	26.6	21.7	18.4	26.7	24.9	19.4	15.0	19.0	19.3	16.5	28.8	55.5	67.9	66.8	51.5	40.3	41.4	64.5	61.7	41.1	36.5	25.8	79.7	57.8	51.0	41.6	44.9	41.1	54.6	46.0	56.8	41.2	25.5	55.3	40.3	49.3	64.7	60.8	30.0	44.0	46.4	56.4	47.9	61.5	52.8	44.4	84.1	88.4	39.6	46.5	52.5	50.1	75.2	58.8	28.7	61.9	101.6	77.0	43.3	38.0	45.7	39.1	47.9	89.0	18.5	65.1	33.9	43.3	46.6	83.2	76.4	71.4	42.9	68.7	71.5	27.1	62.9	61.6	48.6	42.2	7.6	2.9	3.0	2.7	3.1	3.1	2.6	3.1	3.3	1.6	3.0	2.7	2.4	8.5	7.1	5.1	5.4	3.3	1.5	33.1	29.3	23.2	39.1	36.8	22.1	29.8	25.7	25.3	19.2	26.7	28.8	133.0	131.4	103.0	94.7	136.3	116.5	150.3	49.5	91.6	181.3	57.4	65.8	233.3	84.4	52.5	71.7	158.4	42.7	203.7	109.7	31.3	80.1	118.5	200.9	162.6	135.4	106.9	58.5	122.1	72.7	36.3	118.2	96.8	312.8	55.7	164.5	80.7	69.4	48.4	156.5	97.7	89.8	30.5	63.5	117.9	39.5	103.8	112.0	48.0	119.0	110.9	83.1	146.2	117.1	110.0	122.4	66.9	106.1	143.3	147.6	64.6	35.1	45.6	112.9	39.5	148.3	126.3	92.2	98.9	102.6	122.2	38.7	133.8	137.4	87.3	179.0
ANKRD12	"FLJ20053, GAC-1, KIAA0874"	ENSG00000101745	"Ankyrin repeat domain 12"	Q6UB98	18	9136228-9285985	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 106.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040705	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA040705: AB_10673301"	"unprognostic (2.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.03e-2)"	15.8	9.3	17.1	20.5	21.4	20.5	13.7	59.9	26.0	11.1	2.2	13.0	12.9	11.8	9.5	14.4	6.2	14.6	11.9	13.9	18.4	13.0	13.8	11.5	22.4	11.2	13.4	14.1	11.9	10.5	5.9	14.1	13.2	12.2	12.0	29.8	12.3	10.6	26.7	20.2	13.4	9.1	10.4	19.9	14.5	27.7	15.8	11.4	16.4	12.3	18.5	13.5	8.0	32.3	10.1	6.7	9.0	6.0	14.2	14.5	7.3	15.3	14.2	5.4	7.4	6.1	7.6	13.9	8.7	10.6	16.4	9.1	6.8	6.0	14.5	14.8	8.1	6.4	4.7	9.0	10.5	15.0	19.7	7.6	13.1	7.7	12.4	12.2	9.2	8.0	14.7	106.4	13.2	5.7	10.1	10.2	3.4	24.7	6.8	9.0	12.6	51.1	7.1	15.8	20.9	7.7	15.0	7.4	11.1	8.0	9.2	12.4	19.9	39.5	18.1	32.1	14.4	30.8	52.0	25.9	19.4	7.9	15.2	102.0	26.4	85.1	42.4	24.1	47.9	63.6	54.9	42.0	19.2	56.2	55.9	43.4	157.3	30.4	37.2	60.6	44.0	18.3	17.1	21.4	59.9	26.0	13.9	18.4	11.2	13.4	13.2	10.4	15.8	32.3	235.1	278.9	261.5	198.5	246.9	108.2	205.9	83.3	116.7	301.0	87.5	108.5	138.6	94.4	137.7	68.0	523.3	46.3	267.2	163.1	19.6	99.7	204.9	144.3	91.9	136.8	92.7	90.7	172.1	83.5	41.1	126.8	64.2	292.9	187.2	76.3	121.7	74.0	67.8	286.0	218.1	90.4	107.8	99.7	126.2	230.9	134.8	149.3	90.7	161.1	178.2	125.5	244.1	184.5	347.4	93.0	147.1	141.4	210.1	196.8	126.1	37.0	88.5	315.4	111.7	173.2	150.0	239.5	152.8	70.9	96.0	78.1	298.3	63.0	71.0	170.7
ANKRD13D		ENSG00000172932	"Ankyrin repeat domain 13D"	Q6ZTN6	11	67289300-67302485	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 63.9;SK-MEL-30: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039950	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA039950: AB_10796337"	"unprognostic (1.10e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (5.73e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.74e-2)"	12.0	14.7	13.3	6.8	14.3	0.3	11.4	10.9	20.7	19.5	10.8	13.8	3.1	12.5	2.9	24.4	15.3	7.9	12.0	16.5	12.9	16.2	8.9	13.8	15.0	13.8	11.7	14.1	9.5	6.0	28.9	5.2	15.1	23.8	2.3	2.0	14.4	7.3	3.7	15.0	13.8	6.5	10.2	39.2	12.8	12.1	15.8	10.0	11.2	3.8	5.7	17.5	20.5	19.6	9.7	7.2	5.8	12.3	10.9	10.1	3.8	7.0	8.4	7.2	5.6	6.4	10.1	11.6	12.4	5.6	10.7	12.4	4.5	8.6	1.0	19.9	5.3	11.6	11.3	4.3	16.8	14.0	27.8	10.4	11.8	6.2	6.8	14.1	9.5	9.2	6.3	12.4	8.0	14.1	18.0	63.9	2.5	19.8	10.1	28.5	4.9	9.9	13.6	6.0	6.0	9.8	7.0	16.7	57.0	4.5	14.3	33.1	7.7	7.1	6.1	7.9	8.2	9.8	9.4	5.6	17.4	21.4	8.2	6.6	0.6	5.7	2.0	2.1	1.3	0.8	1.5	2.8	1.2	0.5	0.5	3.2	1.9	3.1	1.4	1.8	1.6	1.2	13.3	14.3	10.9	20.7	16.5	12.9	13.8	11.7	15.1	10.2	15.8	19.6	23.2	0.0	18.8	18.9	22.2	14.1	11.7	15.4	17.6	61.1	21.5	20.8	7.0	8.6	14.5	16.5	75.0	8.3	73.6	7.5	1.9	8.3	18.0	27.7	19.7	17.9	10.8	8.2	29.8	6.9	9.0	15.7	20.4	18.0	25.3	25.7	22.1	3.0	20.0	42.1	29.7	7.9	18.3	52.0	21.4	6.0	22.1	45.8	12.4	18.7	49.7	20.8	49.4	17.6	18.4	9.9	4.6	17.0	30.7	19.9	2.3	2.6	30.4	51.7	13.1	13.6	18.5	3.1	8.1	19.3	25.1	7.5	49.9	28.9	8.4	19.8
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 337.8;Inhibitory neurons: 315.8;Oligodendrocyte precursor cells: 275.0;Oligodendrocytes: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: AB_2685106"	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	13.7	13.5	15.6	13.6	16.7	9.2	20.0	23.1	20.4	16.8	16.8	15.8	14.8	14.7	18.5	14.5	18.2	12.4	14.5	16.2	21.1	19.6	20.6	14.2	15.1	15.7	15.9	17.8	18.0	24.5	14.4	19.0	16.0	15.1	19.0	36.0	16.7	13.7	23.2	17.2	15.2	16.4	12.3	15.1	15.7	11.1	18.5	27.2	17.9	26.1	17.7	17.7	12.8	20.1	25.6	27.7	43.1	34.2	47.4	41.5	23.5	36.9	43.1	32.5	31.1	33.9	32.8	69.2	29.9	38.0	17.1	20.9	54.4	32.6	44.6	27.1	23.1	47.1	29.5	49.4	25.4	62.2	27.9	35.2	34.8	46.6	36.9	33.6	43.8	27.9	67.2	24.8	39.4	23.7	51.3	22.1	28.0	33.0	27.6	40.5	47.3	28.8	34.5	38.1	41.6	28.2	35.7	39.7	18.9	33.5	21.3	24.3	53.2	34.0	32.6	30.8	29.3	20.5	11.1	51.5	27.6	26.8	35.6	1.6	1.7	1.8	3.0	1.1	1.5	1.8	1.8	2.0	1.4	2.6	1.7	2.0	1.9	5.6	1.3	4.4	1.2	1.1	15.6	16.7	23.1	20.4	16.2	21.1	15.7	15.9	16.0	12.3	18.5	20.1	42.9	48.1	52.9	194.9	30.9	76.1	36.9	33.9	67.2	57.2	38.6	31.2	82.2	35.8	45.5	40.5	123.0	31.8	40.0	52.8	7.9	30.9	12.7	46.0	57.9	52.2	45.1	36.1	337.8	28.9	24.6	44.8	51.5	60.8	31.6	53.4	43.9	49.7	27.3	69.0	315.8	45.6	26.4	31.2	34.7	5.5	35.1	35.0	28.4	181.8	34.8	30.5	50.4	275.0	296.5	30.2	25.7	37.6	44.2	52.8	39.4	25.4	30.5	84.1	19.7	58.5	48.5	28.1	30.8	64.9	81.3	33.8	32.4	47.6	48.3	48.4
ANKRD22	MGC22805	ENSG00000152766	"Ankyrin repeat domain 22"	Q5VYY1	10	88819896-88851844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.8;skin 1: 30.9;stomach 1: 46.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 37.2;Distal enterocytes: 38.2;Gastric mucus-secreting cells: 49.5;Paneth cells: 51.5;Squamous epithelial cells: 35.8;Suprabasal keratinocytes: 102.9;Urothelial cells: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.4"	"Group enriched"	"Detected in many"	14	"granulocytes: 6.4;monocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"A-431: 8.6;CAPAN-2: 26.1;HL-60: 9.4;NB-4: 8.7;OE19: 20.9;RT4: 16.4;T-47d: 12.2;U-937: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA012922	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA012922: AB_1844838"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-3)"	"unprognostic (9.73e-3)"	"prognostic favorable (8.73e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.21e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (1.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.01e-3)"	0.2	0.3	0.6	9.5	0.7	5.4	2.6	0.5	0.9	7.6	0.4	7.2	2.7	0.2	0.3	33.8	0.3	3.2	0.1	0.5	0.7	4.7	2.0	1.5	4.2	1.3	0.8	0.3	12.9	0.8	0.3	0.2	1.1	2.5	7.1	0.1	4.9	0.1	0.1	30.9	2.1	1.6	0.6	6.4	46.3	0.1	0.7	5.5	0.1	0.0	7.8	4.8	13.9	0.9	8.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.1	0.0	0.0	6.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.4	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.6	8.7	0.0	20.9	0.1	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	1.3	0.0	0.0	12.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.9	0.0	0.0	2.1	1.1	0.0	3.1	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	6.4	0.2	0.6	0.2	0.0	0.6	0.6	0.7	0.5	0.9	0.5	0.7	1.3	0.8	1.1	0.6	0.7	0.9	0.0	0.0	3.7	0.0	1.0	37.2	18.6	7.6	1.8	0.0	1.5	0.9	0.2	5.7	4.5	7.3	0.0	0.0	0.0	38.2	0.0	3.2	0.0	0.9	0.5	0.3	1.8	0.4	0.0	5.9	0.0	0.6	49.5	4.8	0.0	0.0	0.0	0.6	2.2	0.0	0.0	14.9	16.2	9.3	3.1	0.2	0.3	8.5	1.8	0.0	2.2	0.0	0.0	0.0	0.0	5.7	51.5	0.0	0.2	10.1	0.6	0.0	1.7	0.0	0.0	0.1	0.3	0.1	0.2	35.8	102.9	0.0	0.8	0.1	25.7	30.3
ANKRD23	"DARP, FLJ32449, MARP3"	ENSG00000163126	"Ankyrin repeat domain 23"	Q86SG2	2	96824526-96857934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"skeletal muscle: 1438.6;tongue: 448.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 5.0;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 5.2;Skeletal myocytes: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Karpas-707: 38.5"	"Low region specificity"	"Detected in many"							HPA036201	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA036201: AB_10673347"	"unprognostic (2.48e-1)"	"unprognostic (7.83e-4)"	"unprognostic (4.93e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.81e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-6)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.70e-4)"	0.8	0.9	1.6	0.4	2.1	0.7	1.2	2.2	2.1	1.4	0.6	1.3	0.8	1.8	0.0	6.0	2.5	0.2	24.2	1.5	1.4	0.7	2.2	1.0	0.6	2.5	1.6	1.7	1.6	0.3	10.4	0.2	1.8	5.3	0.1	0.1	18.5	0.3	1438.6	2.5	1.3	0.2	1.5	2.3	0.7	0.7	1.9	0.6	1.1	448.6	0.4	1.2	1.1	2.3	0.5	0.7	0.4	0.8	0.0	0.2	1.1	0.3	0.1	0.2	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.3	0.3	0.3	0.2	1.1	1.0	0.5	0.8	0.2	0.1	0.8	1.8	0.3	0.3	0.6	0.0	0.2	0.1	1.5	0.9	38.5	0.3	0.9	0.5	0.8	0.4	0.1	0.3	1.4	0.0	5.0	0.2	0.9	1.4	0.2	0.3	0.7	0.0	0.2	1.1	0.0	0.3	0.5	0.6	0.7	0.1	1.7	0.7	0.3	0.4	1.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	2.1	2.2	2.1	1.5	1.4	2.5	1.6	1.8	1.5	1.9	2.3	1.1	0.0	1.1	2.0	0.5	0.8	0.5	0.4	0.6	2.6	0.8	2.3	5.0	0.0	1.5	0.0	2.1	0.4	2.1	0.9	0.0	0.3	3.3	1.3	1.9	0.8	0.0	0.4	2.8	1.1	0.2	1.3	0.5	0.7	1.3	1.1	1.4	1.2	0.2	1.7	2.7	1.0	0.0	0.6	0.3	1.8	1.5	0.6	0.0	1.0	0.2	1.1	1.0	0.5	2.9	0.1	0.3	3.0	0.4	0.3	0.6	0.2	7.4	5.2	0.0	6.1	1.6	1.3	0.4	0.4	1.3	0.3	1.1	0.7	0.9	0.2
ANKRD29	FLJ25053	ENSG00000154065	"Ankyrin repeat domain 29"	Q8N6D5	18	23598926-23662911	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 163.8;Alveolar cells type 1: 218.0;Cone photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.7;BJ hTERT+: 16.6;hTCEpi: 16.2;PC-3: 15.5;U-2197: 20.5;U-87 MG: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041272, HPA049419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA041272: AB_2677387, HPA049419: AB_2680757"	"unprognostic (4.52e-3)"	"unprognostic (8.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (1.92e-5)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.98e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.54e-1)"	"prognostic favorable (7.20e-5)"	"unprognostic (1.10e-2)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.64e-5)"	17.8	7.2	14.1	3.6	6.4	0.2	15.8	9.1	13.5	12.9	10.7	4.7	1.5	15.7	5.3	9.4	13.8	5.6	6.8	13.5	10.4	3.6	1.9	31.3	20.1	11.6	14.8	14.5	1.0	24.8	8.1	0.1	11.5	8.3	2.2	4.9	7.5	8.8	4.4	4.4	6.6	11.7	6.8	2.6	15.1	3.7	9.4	3.8	3.3	3.9	14.3	6.6	13.0	10.1	2.4	6.7	0.0	0.0	1.6	16.7	0.1	6.6	16.6	2.6	3.3	3.0	0.6	0.0	0.9	3.2	12.9	3.4	0.0	8.7	0.6	0.2	5.9	0.0	4.3	0.2	0.3	0.0	0.5	4.4	16.2	2.6	4.4	2.4	1.7	0.0	0.0	0.4	4.4	0.7	0.0	0.0	1.2	5.7	15.5	0.0	0.4	1.5	4.1	2.4	1.0	8.0	1.7	0.3	0.1	0.3	1.9	0.1	3.9	0.4	2.3	20.5	6.0	0.0	0.0	0.0	21.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	14.1	6.4	9.1	13.5	13.5	10.4	11.6	14.8	11.5	6.8	9.4	10.1	163.8	218.0	38.7	27.4	0.2	5.1	10.1	5.0	5.2	6.0	5.1	16.6	9.7	8.6	6.3	1.8	66.7	0.0	1.1	0.3	5.9	2.5	40.0	10.2	18.7	39.0	1.8	0.4	22.1	1.1	0.0	6.6	25.5	0.8	3.8	9.7	15.4	0.9	2.3	42.1	27.6	1.7	0.0	0.8	3.3	25.2	7.2	3.6	7.2	22.5	0.2	1.3	0.0	8.5	1.3	11.4	1.2	20.3	1.5	5.1	11.5	10.1	1.6	4.3	13.1	12.1	40.6	2.3	2.6	20.1	2.8	0.0	0.8	21.5	2.5	3.6
ANKRD31	FLJ40191	ENSG00000145700	"Ankyrin repeat domain 31"	Q8N7Z5	5	75068275-75236911	"Predicted intracellular proteins"	"DNA recombination, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 4.9"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 148.9;Spermatogonia: 37.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA038028, HPA057566"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles,Centrosome		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Nucleoli, Vesicles"	"HPA038028: AB_10672615, HPA057566: AB_2683470"	"unprognostic (1.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-1)"	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	4.9	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.1	0.1	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.2	0.2	0.1	0.3	0.1	0.0	0.5	5.2	0.4	0.4	0.4	0.5	0.6	3.3	0.8	1.1	1.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.3	3.6	2.8	0.8	0.1	0.0	0.8	5.8	0.2	0.6	0.4	4.1	0.4	12.0	0.5	0.4	0.0	0.1	1.7	5.4	0.0	0.0	0.0	0.0	4.7	1.5	0.1	0.0	1.0	0.1	1.3	0.0	3.0	5.6	0.1	0.1	0.4	1.3	0.0	0.1	0.3	1.2	2.2	13.1	0.6	0.4	148.9	37.7	0.4	0.1	0.3	1.1	0.7	0.1	0.2
ANKRD34B	DP58	ENSG00000189127	"Ankyrin repeat domain 34B"	A5PLL1	5	80556755-80570280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"brain: 40.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.0;Collecting duct cells: 3.7;Enteroendocrine cells: 1.8;Inhibitory neurons: 6.0;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.3"	"Region enhanced"	"Detected in many"		"thalamus: 40.7"	"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.8"	"Cell line enriched"	"Detected in some"	29	"RPTEC TERT1: 97.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043327	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA043327: AB_10794180"	"unprognostic (1.05e-1)"	"unprognostic (4.16e-6)"		"unprognostic (2.07e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.03e-1)"		"unprognostic (8.25e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.94e-2)"	0.0	0.0	2.8	0.4	15.8	1.7	0.0	3.4	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	7.4	0.7	0.0	0.1	0.9	4.0	2.4	0.0	0.0	0.1	0.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.0	0.2	40.7	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	97.9	0.1	0.3	0.4	0.0	0.3	0.0	0.1	3.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	2.8	15.8	3.4	3.6	1.1	7.4	4.0	2.4	2.0	1.6	40.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.0	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.1	1.8	0.0	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	6.0	0.0	0.0	1.2	0.0	0.7	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 60.8"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 56.4;Fibroblasts: 31.2;Leydig cells: 36.4;Muller glia cells: 57.7;Peritubular cells: 50.8;Skeletal myocytes: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.6;THP-1: 6.8;TIME: 8.4;U-87 MG: 8.3;U-937: 7.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA035453: AB_10672864"	"prognostic favorable (9.35e-4)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	4.0	1.3	8.2	1.1	7.9	0.3	4.6	7.6	9.7	20.6	6.4	6.0	0.5	5.8	1.4	24.7	6.6	1.3	2.9	7.5	8.6	0.8	2.5	2.3	0.4	8.7	9.5	4.4	0.7	0.0	2.0	0.1	8.5	6.6	0.8	1.3	11.4	2.7	8.2	60.8	2.5	2.1	8.4	0.5	3.9	1.6	9.0	0.5	1.7	3.8	6.7	7.3	20.6	7.6	0.1	0.0	0.0	0.0	2.2	9.6	0.2	1.4	3.6	0.4	1.2	0.4	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.1	2.9	0.1	3.3	0.4	0.3	0.0	0.1	0.4	0.0	0.0	0.0	2.2	0.0	0.0	3.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.3	7.5	0.0	0.0	2.1	0.0	0.7	0.8	0.1	0.0	0.3	1.1	0.3	0.0	0.2	0.7	0.1	0.7	0.2	0.5	0.7	0.7	8.2	7.9	7.6	9.7	7.5	8.6	8.7	9.5	8.5	8.4	9.0	7.6	1.6	0.0	0.0	6.8	0.3	4.6	16.8	10.2	0.0	1.1	6.3	13.5	1.5	2.8	9.5	1.8	0.0	0.1	2.2	0.0	0.0	0.0	3.5	56.4	10.9	1.3	0.0	2.7	5.6	0.4	0.1	31.2	0.5	17.2	19.1	0.0	2.2	13.9	11.0	0.0	2.1	0.0	14.2	1.2	4.6	5.9	36.4	1.1	5.4	1.0	1.1	57.7	5.2	3.0	0.6	0.1	0.0	50.8	0.4	5.3	0.0	0.1	9.8	2.7	0.0	29.5	6.4	0.1	1.0	10.4	12.4	0.3	5.5	1.1	0.0	13.6
ANKRD36	UNQ2430	ENSG00000135976	"Ankyrin repeat domain 36"	A6QL64	2	97113153-97264521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.0;retina: 20.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 240.8;Inhibitory neurons: 255.3;Oligodendrocyte precursor cells: 155.3;Oligodendrocytes: 217.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (4.24e-3)"	"unprognostic (7.59e-2)"	"unprognostic (6.15e-3)"	"unprognostic (9.86e-2)"	"unprognostic (9.83e-3)"	"unprognostic (5.25e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.75e-1)"	1.8	1.6	5.8	2.7	8.3	11.8	3.2	25.0	7.8	2.2	0.3	1.8	1.8	3.6	4.2	1.0	2.1	1.9	1.3	5.3	4.0	0.9	0.6	2.4	2.9	7.1	2.0	4.5	1.8	1.8	1.9	1.3	8.2	2.3	2.6	20.3	2.1	1.4	0.7	3.2	1.8	2.3	1.5	3.3	2.8	7.1	6.2	3.1	2.1	0.5	2.2	1.4	1.8	9.5	4.4	1.4	3.9	2.4	0.9	2.1	1.5	2.1	1.3	1.5	1.5	1.3	2.3	5.5	1.0	1.4	1.2	2.9	1.4	1.9	1.3	2.9	2.4	4.7	6.4	2.4	0.4	3.8	1.9	1.4	0.9	1.2	1.9	2.2	2.9	8.9	3.6	10.1	0.8	1.0	4.4	4.4	0.9	0.4	2.8	5.0	1.9	2.2	0.8	2.3	3.3	2.2	2.3	1.3	0.7	1.5	1.4	1.9	3.9	4.2	3.8	4.1	2.3	6.5	2.8	5.1	2.2	4.5	1.0	9.2	2.2	3.1	7.2	1.0	7.4	9.2	7.1	6.1	0.9	8.1	7.2	7.5	3.3	4.9	2.3	10.1	6.6	2.0	5.8	8.3	25.0	7.8	5.3	4.0	7.1	2.0	8.2	1.5	6.2	9.5	16.9	44.8	27.4	85.5	27.8	15.7	8.4	28.2	14.2	51.0	9.0	11.2	26.2	2.8	31.5	7.3	75.0	1.4	38.2	4.9	0.0	7.1	70.7	39.6	22.2	19.3	13.8	14.3	240.8	18.6	5.6	19.5	84.6	19.3	26.6	39.4	11.7	1.1	5.1	21.9	255.3	10.5	12.2	3.8	26.2	14.3	26.1	10.2	39.2	46.9	6.1	9.3	26.8	155.3	217.7	9.5	3.6	18.0	56.3	5.9	2.2	2.7	43.2	65.0	0.0	36.4	20.7	123.4	22.1	9.8	9.2	0.4	39.6	9.1	8.1	14.1
ANKRD36B	"FLJ21281, KIAA1641"	ENSG00000196912	"Ankyrin repeat domain 36B"	Q8N2N9	2	97492663-97589965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 73.4;Oligodendrocytes: 71.1;Plasma cells: 81.7;Spermatocytes: 76.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.03e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.20e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.13e-6)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.71e-3)"	"unprognostic (6.98e-2)"	4.4	1.8	3.0	1.6	4.8	21.5	4.7	13.7	5.8	4.7	0.0	3.2	1.0	4.1	2.3	1.8	5.0	1.7	2.7	3.1	2.5	2.4	1.1	3.0	2.6	4.7	1.2	5.3	6.1	1.0	2.9	0.8	5.3	3.4	2.8	10.1	4.3	1.4	1.3	4.1	3.5	2.8	1.0	3.1	3.2	13.1	4.1	2.9	2.7	0.2	1.9	3.1	3.1	7.2	2.9	1.4	1.4	1.7	1.1	2.8	1.8	1.5	1.2	1.0	1.1	1.8	3.2	4.7	1.1	1.5	1.0	0.4	1.1	1.1	1.1	1.5	2.2	3.6	3.5	1.3	0.8	2.6	1.6	1.5	1.5	1.5	2.4	2.8	1.4	7.1	3.8	5.0	1.2	0.5	3.0	3.3	0.9	0.5	1.4	3.2	0.6	0.7	1.4	2.1	1.8	2.3	1.2	0.7	0.9	3.1	1.6	2.0	2.6	1.5	1.8	2.5	2.8	3.9	5.7	3.3	1.9	3.9	1.3	1.9	0.1	0.2	0.6	0.1	0.6	0.6	0.8	0.5	0.1	1.0	0.9	0.6	0.1	0.8	0.0	0.8	0.4	0.1	3.0	4.8	13.7	5.8	3.1	2.5	4.7	1.2	5.3	1.0	4.1	7.2	14.6	12.8	15.0	27.1	28.3	0.0	6.9	0.0	20.5	36.7	5.4	7.4	15.4	5.7	17.3	9.2	20.9	1.4	15.4	5.9	0.0	9.4	48.9	29.6	10.1	12.5	14.4	16.4	68.5	14.0	3.9	11.4	73.4	14.1	22.8	23.4	4.2	0.7	3.4	16.8	68.7	12.6	0.0	1.2	0.0	7.3	12.8	9.5	0.0	19.7	7.3	6.8	12.3	42.3	71.1	9.7	3.6	7.5	81.7	5.0	2.5	1.3	16.8	34.1	6.6	25.2	9.9	76.4	11.1	24.0	0.0	0.1	35.2	7.1	6.7	12.4
ANKRD36C	DKFZp667P0924	ENSG00000174501	"Ankyrin repeat domain 36C"	Q5JPF3	2	95836919-95991831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 615.1;Gastric mucus-secreting cells: 498.9;Inhibitory neurons: 290.7;Pancreatic endocrine cells: 311.5;Urothelial cells: 411.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 30.9"									"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.35e-6)"	"unprognostic (9.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	2.0	1.5	5.3	2.1	9.3	16.3	6.1	24.0	8.9	2.6	1.5	2.8	1.2	3.8	2.3	2.3	3.1	4.8	1.4	4.2	9.3	1.2	0.6	2.6	3.5	9.4	5.9	6.0	1.8	1.6	1.6	1.5	11.3	1.9	2.6	10.6	14.6	1.5	0.7	3.6	1.6	1.9	2.6	2.9	5.4	12.0	9.7	6.5	1.6	0.9	2.9	3.2	1.9	25.8	8.4	1.6	3.3	2.3	2.1	5.7	1.3	1.9	1.4	2.5	3.3	1.9	1.9	8.3	2.5	1.4	2.5	1.9	3.0	1.5	3.2	4.8	4.1	3.2	4.5	2.4	0.5	9.9	2.4	1.7	1.2	2.0	1.0	2.5	4.3	11.7	3.3	10.2	2.8	1.2	7.7	3.7	0.7	0.4	30.9	4.0	2.5	3.3	1.3	1.6	3.0	2.7	1.3	2.1	1.3	1.2	1.0	2.3	4.8	3.1	3.4	2.4	2.4	3.8	3.4	8.9	0.9	6.7	1.3	48.0	3.3	2.8	20.8	0.5	13.4	17.1	16.7	13.9	2.5	19.5	14.5	14.2	0.2	12.6	1.0	35.0	15.6	1.3	5.3	9.3	24.0	8.9	4.2	9.3	9.4	5.9	11.3	2.6	9.7	25.8	32.3	38.5	19.9	123.1	26.9	10.7	53.4	33.6	11.4	84.4	38.4	20.8	29.1	4.3	91.0	9.2	79.2	0.3	47.2	23.5	0.0	226.3	118.4	42.6	28.7	25.8	21.0	27.1	227.9	615.1	0.8	26.3	498.9	25.8	34.1	41.3	15.4	1.5	8.3	33.7	290.7	70.2	12.2	7.0	14.7	17.7	32.6	15.9	14.2	46.9	27.4	15.8	50.4	147.8	177.7	311.5	8.4	36.5	48.7	145.8	7.7	0.9	82.3	72.9	19.7	56.1	31.0	178.7	22.4	7.7	7.4	0.3	47.5	13.1	22.0	411.9
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 93.7"	"Cell type enhanced"	"Detected in all"		"Club cells: 257.6;Endometrial ciliated cells: 271.9;Respiratory ciliated cells: 263.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: AB_2683614"	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	16.9	10.3	30.7	4.3	31.7	3.3	13.4	32.2	58.7	36.6	45.2	11.2	7.8	6.1	3.7	69.5	11.7	6.7	27.4	31.5	31.9	14.3	26.2	9.9	4.1	33.7	32.9	29.1	17.5	1.4	21.8	15.1	32.1	35.2	9.5	93.7	31.2	5.7	30.2	14.9	6.4	4.4	33.9	7.1	9.0	11.2	34.7	5.1	23.9	13.3	7.5	10.8	29.6	32.4	12.6	1.6	1.1	5.4	7.4	4.5	4.9	4.8	3.7	3.7	6.8	2.9	3.4	4.3	2.4	8.4	6.4	4.3	6.5	6.2	4.2	12.4	0.7	2.8	5.8	8.3	3.3	2.4	7.6	1.2	6.4	3.0	3.6	23.8	3.9	2.9	5.0	8.2	9.4	2.6	2.6	12.1	1.7	1.1	8.3	0.5	1.5	13.4	4.5	1.1	7.2	12.9	3.7	4.1	14.4	4.6	4.1	2.3	5.1	6.6	5.0	4.2	5.1	13.3	5.2	2.2	20.9	2.8	6.9	0.5	3.3	8.3	4.1	3.2	3.9	6.8	3.6	6.7	2.0	6.9	2.4	3.4	1.2	3.9	3.3	3.4	4.5	2.5	30.7	31.7	32.2	58.7	31.5	31.9	33.7	32.9	32.1	33.9	34.7	32.4	39.3	22.4	28.7	9.1	104.2	59.4	41.8	197.9	42.7	29.9	66.9	92.3	1.8	11.5	257.6	9.2	29.2	25.0	69.8	93.8	25.4	25.2	6.2	271.9	18.9	44.7	119.9	8.4	8.0	23.3	43.0	28.6	142.2	96.5	61.7	7.7	12.1	25.8	15.4	10.1	7.9	186.6	89.5	8.1	170.2	3.2	9.3	53.3	142.3	12.2	17.7	99.8	1.0	4.0	4.6	32.3	53.3	11.7	223.5	38.5	60.9	31.5	263.3	115.2	6.6	27.3	38.7	32.1	28.4	54.0	48.2	84.4	65.8	7.4	50.8	20.2
ANKRD39	MGC41816	ENSG00000213337	"Ankyrin repeat domain 39"	Q53RE8	2	96836611-96858016	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 263.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042678	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA042678: AB_10794532"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (9.53e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.12e-3)"	"prognostic favorable (6.12e-5)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (6.78e-9)"	"unprognostic (3.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.21e-4)"	6.8	14.1	13.1	7.2	13.4	10.5	7.3	15.9	18.7	6.9	8.9	11.0	8.3	10.2	2.9	7.5	10.2	5.9	14.9	13.2	13.2	7.9	14.8	6.2	11.0	13.0	12.5	6.6	8.3	12.3	16.0	5.5	13.4	8.2	4.0	5.3	7.4	6.8	7.9	8.7	7.4	6.2	12.3	9.7	8.3	4.1	12.5	7.4	5.8	4.5	6.5	8.5	6.8	14.5	24.0	15.7	8.8	19.2	2.9	5.7	21.1	18.1	8.4	22.5	17.3	38.8	9.9	15.2	26.4	13.2	17.7	10.3	11.2	17.3	5.0	17.6	34.1	11.0	14.4	53.5	14.8	24.9	25.6	11.0	10.2	20.5	7.9	8.4	16.3	31.1	23.5	263.1	8.4	37.9	23.3	19.5	11.1	8.1	35.8	17.8	6.2	85.3	11.8	12.3	20.3	13.3	13.1	30.6	23.7	8.0	9.3	13.5	8.2	14.0	13.8	16.0	32.5	13.4	16.2	25.3	14.0	28.5	14.9	20.1	16.0	13.4	44.4	20.8	37.7	41.6	43.6	39.3	16.6	33.2	24.0	29.2	8.3	37.6	23.5	70.4	71.0	21.1	13.1	13.4	15.9	18.7	13.2	13.2	13.0	12.5	13.4	12.3	12.5	14.5	14.0	6.4	8.9	2.6	16.9	9.4	17.2	25.7	9.1	25.2	14.9	23.2	19.5	18.6	17.6	9.2	4.2	44.9	28.1	15.1	25.4	28.8	6.1	18.1	18.7	12.9	18.6	13.5	4.6	32.0	38.6	14.9	11.7	11.8	12.7	12.7	10.8	32.0	31.6	33.7	5.3	19.9	18.3	11.1	10.4	2.9	12.5	13.8	28.4	1.0	9.3	15.9	37.0	4.5	5.9	41.3	11.3	14.7	26.2	12.5	23.4	29.4	35.0	29.8	26.3	24.9	18.8	13.6	14.3	18.9	17.8	21.6	24.4	33.5	16.9	15.7
ANKRD42	"FLJ37874, PPP1R79, SARP"	ENSG00000137494	"Ankyrin repeat domain 42"	Q8N9B4	11	83193712-83260694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 170.5;Late spermatids: 63.2;Respiratory ciliated cells: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039917	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039917: AB_10672894"	"unprognostic (6.59e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.12e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.90e-1)"	5.2	13.3	8.0	5.2	8.9	9.0	6.0	4.3	11.8	7.4	15.8	5.8	5.2	6.0	19.7	4.8	15.8	7.6	5.3	11.6	14.3	11.1	4.7	6.6	3.8	10.0	9.2	8.7	5.9	12.3	13.1	3.9	7.9	7.2	4.2	17.8	6.0	7.4	2.7	5.5	4.9	5.3	7.6	4.5	6.2	37.2	10.7	2.8	11.8	2.2	4.1	7.3	5.5	8.2	5.6	9.7	4.7	9.5	14.3	15.0	4.1	11.4	8.8	6.7	4.1	5.9	6.8	2.2	14.1	10.3	13.4	11.9	5.0	7.8	5.5	3.2	3.7	4.0	14.5	4.0	10.0	11.6	9.0	8.9	8.8	17.0	8.9	12.3	7.0	4.0	12.0	2.0	9.8	7.9	1.7	12.2	3.9	8.8	6.1	2.7	6.5	2.8	21.8	6.6	3.7	4.9	14.9	9.2	2.9	6.1	13.9	6.2	10.2	10.2	7.1	37.1	5.4	2.9	7.1	4.5	7.9	6.7	4.3	5.7	2.6	3.2	2.9	3.0	1.9	5.0	2.5	2.9	3.5	3.8	1.2	2.0	2.0	4.4	8.0	1.4	1.1	1.7	8.0	8.9	4.3	11.8	11.6	14.3	10.0	9.2	7.9	7.6	10.7	8.2	7.6	9.6	16.0	7.5	8.5	11.2	21.5	6.5	4.0	3.9	11.9	9.8	7.8	8.6	8.0	7.3	39.6	3.1	7.1	5.2	9.8	7.7	170.5	53.1	21.9	8.5	3.0	2.1	33.3	6.7	3.3	13.0	7.7	15.4	13.9	7.8	9.3	4.8	5.0	1.7	27.3	3.1	12.2	7.2	9.9	63.2	8.7	8.8	7.2	7.5	7.3	7.4	2.1	4.5	2.9	5.7	4.9	10.5	4.7	10.6	5.8	14.8	61.6	22.4	13.1	16.6	9.0	55.5	17.3	4.7	15.3	5.5	9.1	14.5	3.9	11.5
ANKRD49	"FGIF, FLJ20189, GBIF"	ENSG00000168876	"Ankyrin repeat domain 49"	Q8WVL7	11	94493979-94499578	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040273, HPA048137"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA040273: AB_10674991, HPA048137: AB_2680279"	"unprognostic (1.52e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.46e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.21e-3)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (6.32e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.40e-2)"	"prognostic favorable (6.16e-4)"	7.8	6.8	8.3	12.7	8.9	25.2	13.1	11.1	11.4	9.7	8.2	10.8	11.4	10.4	18.3	9.5	8.5	8.4	5.3	8.3	8.4	7.8	8.6	7.5	20.8	8.2	7.7	12.6	13.4	9.3	8.9	12.1	8.0	10.9	13.6	11.8	10.7	10.8	5.8	10.2	16.2	8.8	7.8	15.6	12.7	5.4	9.3	17.1	14.2	7.3	20.8	7.9	8.5	9.5	8.9	4.4	11.0	9.4	10.2	12.0	13.5	13.3	12.0	14.9	17.1	20.7	18.4	23.4	20.9	8.5	12.5	20.5	14.0	9.8	12.2	17.9	12.1	18.9	16.8	7.8	11.1	17.8	15.8	9.1	23.1	10.7	14.9	10.4	11.3	20.9	18.4	14.4	9.4	6.1	19.8	32.8	6.3	17.5	9.8	14.9	11.3	12.0	12.9	9.2	10.5	10.9	10.2	9.8	8.7	18.4	18.0	12.9	7.5	13.0	9.3	13.8	7.2	7.6	20.0	24.6	4.4	21.8	7.4	77.8	23.1	23.9	21.9	19.5	23.7	34.1	23.4	19.4	18.4	28.8	28.4	25.9	42.7	27.2	15.8	30.5	31.4	17.8	8.3	8.9	11.1	11.4	8.3	8.4	8.2	7.7	8.0	7.8	9.3	9.5	20.5	12.8	9.3	11.1	43.2	5.6	10.0	15.1	14.2	16.3	14.0	11.3	9.1	24.3	15.4	25.8	14.6	31.1	36.1	27.8	21.5	20.3	10.1	11.9	18.1	15.4	13.3	40.0	11.1	23.0	13.8	16.5	27.0	15.1	21.5	18.7	16.4	18.8	14.3	11.8	9.5	23.6	8.2	28.5	8.4	3.7	35.8	18.5	10.6	8.4	28.1	21.8	57.7	5.5	12.7	22.8	35.2	23.7	28.0	11.3	45.3	19.3	8.1	14.4	26.3	11.3	18.4	21.0	19.9	11.6	6.8	28.0	36.5	9.8	22.0	5.8
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664048-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 56.8;HUVEC TERT2: 58.2;TIME: 147.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	6.0	2.6	3.2	4.2	4.5	4.5	5.7	1.3	3.1	11.4	2.6	4.7	3.1	7.6	2.5	6.4	2.8	8.5	5.0	3.7	6.2	4.4	5.8	9.6	2.3	4.3	4.2	6.5	3.3	5.7	1.0	14.8	3.8	8.9	5.6	1.8	3.9	6.2	1.4	11.0	3.9	8.9	2.1	3.1	7.4	15.1	7.2	4.6	7.4	3.6	1.9	14.2	5.6	2.0	6.3	11.6	32.0	14.9	25.0	15.8	3.2	15.9	13.4	8.1	5.2	5.0	8.1	0.0	4.8	22.8	7.3	5.7	21.3	12.3	14.1	0.0	4.6	5.3	15.3	5.0	17.8	8.8	6.6	16.0	16.4	12.8	56.8	15.2	58.2	5.7	9.6	11.0	15.5	14.3	11.1	3.2	6.7	9.2	16.9	9.0	9.9	1.4	10.2	25.7	9.2	11.5	11.0	6.9	12.9	13.3	7.4	7.4	147.7	17.1	13.3	8.5	13.8	8.0	0.1	2.1	7.8	3.7	20.0	0.0	0.5	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.0	0.1	3.2	4.5	1.3	3.1	3.7	6.2	4.3	4.2	3.8	2.1	7.2	2.0	18.3	32.1	24.6	10.7	0.9	40.4	21.7	17.9	24.5	2.8	12.2	7.1	9.0	12.8	12.5	5.5	0.0	2.9	2.7	7.3	0.0	9.3	41.0	6.6	14.2	21.5	8.4	5.0	15.1	20.1	29.0	16.5	11.7	7.7	5.1	20.4	29.6	8.8	5.3	21.9	42.2	3.7	18.3	13.4	13.0	55.6	6.8	12.6	10.6	30.9	12.8	2.7	0.0	30.7	13.4	15.1	2.8	12.0	0.6	11.7	3.7	4.7	11.0	0.9	0.0	10.9	17.5	17.2	11.2	33.0	30.7	4.1	1.2	33.7	5.3	18.0
ANKRD52	"FLJ34236, PP6-ARS-C"	ENSG00000139645	"Ankyrin repeat domain 52"	Q8NB46	12	56237807-56258384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043815	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA043815: AB_10961762"	"unprognostic (6.25e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (6.31e-2)"	8.4	21.5	10.9	9.8	11.3	9.6	8.7	9.3	12.9	11.9	4.9	12.3	8.4	12.4	5.7	10.5	11.0	6.1	12.9	9.6	13.3	11.6	7.9	9.4	9.2	17.7	16.2	12.9	12.9	19.8	13.2	7.1	21.4	11.2	8.1	9.6	10.9	7.9	25.0	11.2	12.8	11.0	9.2	10.9	10.5	7.4	15.4	8.8	11.2	17.0	9.6	12.0	9.8	10.3	24.7	58.5	25.9	47.4	20.7	16.2	18.2	48.1	20.9	42.1	18.9	39.0	13.4	26.1	29.9	47.3	14.8	31.5	29.0	21.0	24.2	25.3	29.1	46.9	38.6	15.0	14.3	37.3	26.2	16.7	23.2	39.0	19.7	30.9	24.8	21.1	19.6	13.8	40.1	34.2	30.0	12.3	10.9	16.1	27.4	23.4	17.8	10.4	27.7	30.0	19.6	17.8	52.2	33.1	18.9	19.9	26.5	14.3	34.4	43.4	38.1	24.7	30.4	12.7	18.0	12.4	45.0	12.2	29.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	11.3	9.3	12.9	9.6	13.3	17.7	16.2	21.4	9.2	15.4	10.3	4.1	6.4	5.3	9.1	7.8	11.2	3.6	8.4	10.2	5.0	9.1	6.9	6.7	4.3	4.3	12.9	27.1	5.8	7.9	12.6	0.0	10.4	0.5	5.8	9.7	5.7	9.6	5.5	12.8	9.5	7.4	5.4	8.2	9.0	1.3	8.6	6.8	6.5	7.0	8.4	12.5	6.6	20.3	7.1	7.5	1.1	6.2	4.8	10.6	7.5	4.6	3.4	7.2	7.5	8.4	15.7	7.0	4.9	8.7	5.7	9.2	6.4	4.2	6.0	0.0	5.6	7.6	6.4	8.8	10.0	10.9	3.7	6.0	5.5	8.9	4.4
ANKRD54	LIAR	ENSG00000100124	"Ankyrin repeat domain 54"	Q6NXT1	22	37830855-37849327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071287	Approved		Approved	Nucleoplasm,Microtubules,Midbody		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Microtubules, Midbody"	Nucleoplasm	"HPA071287: AB_2686380"	"unprognostic (5.36e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.38e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-3)"	8.6	18.7	22.4	5.9	20.8	6.9	9.1	22.6	23.3	13.0	28.7	16.4	7.1	12.9	7.8	14.0	23.8	6.3	12.4	23.0	26.2	14.9	15.6	8.4	6.4	22.6	24.7	17.8	18.1	11.7	19.2	5.4	21.6	13.7	6.6	6.3	13.9	11.0	12.6	11.3	8.9	9.5	22.0	9.2	10.9	30.9	26.1	10.4	13.8	8.7	7.2	14.0	10.9	20.3	18.5	18.6	15.4	23.0	19.9	11.3	8.1	24.8	19.2	41.1	25.2	11.8	7.3	17.8	10.1	16.5	13.3	16.4	19.5	14.1	19.9	14.2	39.5	9.3	17.3	28.3	17.7	17.8	20.8	10.1	14.2	22.6	13.3	10.3	25.5	13.1	11.9	12.7	19.1	19.8	17.6	21.1	4.4	24.5	16.5	20.2	18.3	11.3	23.2	6.4	26.4	14.1	20.7	18.8	30.8	7.0	19.3	28.0	15.1	24.5	25.6	12.9	18.6	13.3	11.7	14.3	20.1	15.1	17.9	3.5	4.5	2.2	5.4	5.5	5.4	3.9	5.1	4.0	5.7	5.2	5.3	2.6	2.7	10.2	9.3	5.3	2.4	3.3	22.4	20.8	22.6	23.3	23.0	26.2	22.6	24.7	21.6	22.0	26.1	20.3	8.4	12.8	14.5	11.8	14.4	15.8	11.0	12.4	12.0	18.3	16.9	15.6	8.1	24.3	12.2	18.4	29.2	20.9	14.0	19.9	39.2	17.1	6.4	47.8	12.6	10.9	9.0	12.8	9.4	14.7	17.7	12.3	12.2	8.5	9.5	23.3	13.6	12.0	13.2	26.9	9.4	14.3	12.2	12.5	10.7	7.7	18.0	8.8	10.6	2.8	9.2	18.5	17.5	13.6	8.6	11.3	15.3	21.4	8.4	11.4	19.2	22.0	48.2	23.2	6.6	13.1	13.4	65.6	42.1	12.7	17.6	16.8	13.3	25.4	20.7	9.9
ANKRD55	FLJ11795	ENSG00000164512	"Ankyrin repeat domain 55"	Q3KP44	5	56099680-56233330	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.3;liver: 3.1;lymphoid tissue: 3.6;testis: 9.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 161.3;Hepatic stellate cells: 41.7;Inhibitory neurons: 103.5;Late spermatids: 29.1;Spermatocytes: 59.3"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 22.9;eosinophil: 20.7;naive CD4 T-cell: 19.8"	"Group enriched"	"Detected in many"	74	"granulocytes: 22.9;T-cells: 19.8"	"Group enriched"	"Detected in some"	6	"HEL: 34.4;HMC-1: 17.1;NB-4: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051049, HPA061649"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA051049: AB_2681326, HPA061649: "	"unprognostic (1.00e-4)"	"unprognostic (1.58e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.19e-6)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.01e-1)"	0.4	0.1	2.2	0.7	3.0	0.7	0.1	0.0	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.1	0.9	8.3	0.4	3.1	0.3	3.6	4.1	4.6	0.1	0.0	0.0	0.2	0.6	5.2	0.0	0.2	0.4	1.0	0.0	0.0	0.4	1.3	0.1	3.3	1.6	0.3	9.8	7.8	3.2	0.2	0.0	2.0	0.3	0.1	0.9	0.2	0.3	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.2	1.3	0.0	1.6	17.1	0.0	0.1	0.0	0.0	0.1	4.2	0.1	2.9	1.1	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	1.7	0.0	2.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	2.0	0.4	22.9	0.2	20.7	0.1	0.1	0.0	0.0	4.3	0.0	0.1	0.0	19.8	0.8	2.0	0.0	0.1	0.0	1.0	2.8	2.2	3.0	0.0	2.4	0.9	8.3	4.1	4.6	5.2	3.3	7.8	0.9	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	161.3	0.4	0.8	2.2	0.0	0.0	1.3	0.2	0.3	0.6	0.5	7.5	2.5	0.1	41.7	0.6	0.7	0.0	103.5	0.0	0.0	3.2	1.9	29.1	0.6	1.4	1.8	1.0	0.9	0.9	3.1	18.6	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	59.3	0.6	0.0	0.0	1.2	3.9	0.5	0.0	0.2
ANKRD61		ENSG00000157999	"Ankyrin repeat domain 61"	A6NGH8	7	6031376-6036552	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"bone marrow: 6.1;testis: 5.6"	"Group enriched"	"Detected in some"	21	"Early spermatids: 58.5;Late spermatids: 23.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029511, HPA050732"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA029511: AB_10602430, HPA050732: "	"unprognostic (1.40e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-1)"	0.4	0.4	0.2	0.6	0.3	6.1	0.5	1.2	0.4	0.4	0.8	0.4	0.5	0.4	0.0	0.3	0.4	0.2	0.4	0.1	0.4	0.2	0.4	0.4	0.8	0.4	0.3	0.5	0.7	0.0	0.4	0.4	0.6	0.3	0.0	0.7	0.6	0.0	0.5	1.2	0.6	0.1	0.1	0.7	0.6	5.6	0.5	0.1	0.6	0.2	0.0	0.3	0.4	1.1	1.4	3.4	1.2	1.7	0.2	0.1	1.6	0.9	0.2	0.3	0.3	1.7	3.5	0.7	0.3	0.1	1.6	1.3	0.6	0.0	0.3	0.2	0.4	1.0	9.3	0.2	0.1	1.0	1.5	0.2	0.7	0.3	0.6	0.8	0.3	1.1	1.2	1.0	0.4	2.3	0.2	1.1	0.6	0.3	0.4	1.0	0.3	0.2	0.3	1.7	0.8	1.5	0.9	1.0	0.1	1.7	1.7	0.6	0.7	1.4	2.9	1.7	1.0	0.9	1.1	0.5	0.4	0.9	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.2	0.4	0.1	0.4	0.4	0.3	0.6	0.1	0.5	1.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	58.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	23.9	0.0	0.2	0.0	0.0	0.2	0.0	1.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD62	DKFZp779B1634	ENSG00000181626	"Ankyrin repeat domain 62"	A6NC57	18	12093843-12129764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 1.1;pancreas: 1.0;testis: 1.6"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 92.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059835	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies,Actin filaments"		NA	NA				"Cluster 22: Non-specific - Unknown function"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Actin filaments"	"HPA059835: AB_2684136"	"unprognostic (2.45e-2)"	"unprognostic (1.18e-1)"		"unprognostic (2.37e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.98e-1)"		"unprognostic (6.61e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-3)"	"unprognostic (8.70e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.4	0.0	0.6	0.0	0.7	0.0	0.0	0.4	0.1	0.0	1.3	0.3	0.1	0.4	0.3	0.0	0.0	1.7	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.2	0.1	0.2	0.5	0.0	0.0	16.5	1.7	0.6	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.6	0.8	2.6	0.6	0.2	0.0	1.0	0.0	0.1	1.0	1.0	0.2	0.5	1.1	0.4	0.0	0.8	0.2	0.0	0.0	0.9	0.0	1.3	0.3	92.8	15.8	0.5	1.1	0.0	0.2	0.1	0.2	0.5
ANKRD65		ENSG00000235098	"Ankyrin repeat domain 65"	E5RJM6	1	1418420-1421769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 65.0;Glandular and luminal cells: 88.4;Respiratory ciliated cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"myeloid DC: 3.5;plasmacytoid DC: 7.8"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 7.8"	"Group enriched"	"Detected in some"	8	"Hep G2: 35.9;RT4: 34.5;SCLC-21H: 46.3"	"Not detected"	"Not detected"							HPA065720	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA065720: AB_2685545"	"unprognostic (2.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.64e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.76e-2)"	6.0	1.0	24.6	3.2	29.5	0.2	10.3	25.6	25.9	8.8	18.5	14.2	2.3	7.6	5.9	15.6	36.7	2.9	4.1	22.0	25.2	6.0	1.5	11.2	9.1	31.0	28.5	8.5	15.2	1.4	2.3	6.9	29.4	19.9	1.7	2.5	16.1	21.9	3.1	7.0	6.3	4.0	24.0	1.6	9.9	7.3	25.7	7.8	4.3	3.3	7.2	21.1	9.4	34.8	1.0	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.5	0.9	0.0	4.5	0.3	4.3	0.0	0.5	0.4	0.0	0.0	35.9	0.8	0.1	0.0	0.4	5.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.2	0.1	0.0	0.3	4.6	0.0	0.0	34.5	46.3	0.5	0.2	0.0	0.1	0.4	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.3	0.0	0.3	0.0	0.0	0.0	7.8	0.0	0.2	24.6	29.5	25.6	25.9	22.0	25.2	31.0	28.5	29.4	24.0	25.7	34.8	11.8	22.4	29.0	5.5	0.1	2.2	12.9	14.1	13.1	8.5	5.9	32.5	0.7	14.3	20.1	1.8	0.0	26.0	0.0	0.0	9.8	19.0	0.0	65.0	20.5	11.7	1.8	2.7	4.4	30.7	0.8	13.3	3.1	88.4	8.8	2.9	1.4	0.8	2.2	8.4	2.0	0.0	14.2	1.0	3.3	0.9	20.8	1.5	3.6	1.0	1.2	16.6	0.0	3.5	20.5	11.0	0.1	29.0	0.1	6.3	0.0	0.5	51.8	3.1	0.0	25.7	3.6	0.3	0.3	10.7	3.1	16.8	1.1	0.7	0.0	10.8
ANKRD7	TSA806	ENSG00000106013	"Ankyrin repeat domain 7"	Q92527	7	118214669-118496171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	431	"testis: 860.1"	"Group enriched"	"Detected in some"	61	"Early spermatids: 3367.0;Late spermatids: 861.1;Spermatocytes: 3073.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;JURKAT: 4.6;SCLC-21H: 7.8;U-266/70: 9.8;WM-115: 3.1"									"HPA043489, HPA052941"			Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA043489: AB_10959304, HPA052941: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-4)"		"unprognostic (3.13e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.49e-2)"		"unprognostic (1.69e-1)"	"unprognostic (5.51e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.57e-4)"	"unprognostic (3.32e-2)"	0.1	0.5	0.3	0.1	0.4	0.0	0.5	0.0	0.7	0.3	0.1	0.2	0.5	0.1	1.9	0.1	0.4	0.1	0.3	0.4	1.0	0.7	0.2	0.1	0.2	0.6	0.7	0.2	0.7	0.1	0.7	0.0	0.9	0.6	0.1	0.3	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.1	860.1	1.1	0.1	0.9	0.1	0.2	0.1	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.3	1.2	0.0	2.3	0.0	0.0	0.2	0.1	1.2	0.8	0.0	0.0	0.0	1.4	0.0	0.0	1.7	0.3	0.5	0.0	0.3	0.0	4.6	0.0	1.7	1.1	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	2.0	0.0	0.0	1.5	0.0	0.0	1.0	0.3	0.0	0.8	0.2	0.0	9.8	0.5	0.4	1.4	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.7	0.4	1.0	0.6	0.7	0.9	0.1	1.1	0.5	0.3	0.0	0.0	0.3	0.3	0.0	0.3	0.4	0.0	0.9	0.1	0.3	0.5	1.5	0.1	0.0	0.0	0.1	0.0	0.1	5.9	0.2	3367.0	0.5	0.3	1.6	0.0	0.4	2.8	0.2	0.1	0.2	0.0	0.0	0.0	1.2	0.4	0.0	0.1	3.3	2.8	0.0	0.0	0.0	0.0	861.1	39.4	2.7	1.8	1.0	0.0	1.8	0.0	0.0	1.0	0.1	0.0	29.3	0.1	0.1	0.0	2.0	0.2	0.0	26.3	0.2	0.2	3073.6	29.9	0.0	0.1	0.0	0.1	2.5	0.0	0.1
ANKS1A	"ANKS1, KIAA0229"	ENSG00000064999	"Ankyrin repeat and sterile alpha motif domain containing 1A"	Q92625	6	34889255-35091406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.0;Inhibitory neurons: 160.5;Microglial cells: 168.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036768, HPA036769"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		17000	"Cluster 14: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA036768: AB_10670923, HPA036769: AB_10672473"	"unprognostic (3.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.79e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (1.18e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.80e-2)"	15.0	19.1	15.2	8.0	13.9	5.7	15.0	16.4	15.8	10.9	13.8	29.0	10.5	10.7	7.4	15.4	20.1	10.0	18.6	12.7	13.4	13.1	10.7	18.8	9.3	15.6	17.0	17.4	9.4	16.4	8.4	27.8	17.4	11.7	9.0	22.9	9.2	15.4	20.1	15.6	14.3	14.3	14.0	23.0	14.8	16.5	22.1	7.6	13.8	9.5	5.7	27.2	13.1	11.9	15.4	7.3	14.8	14.2	6.5	6.4	22.3	6.0	6.7	7.2	8.7	18.4	9.7	10.4	10.0	6.4	13.1	15.7	17.4	17.6	8.3	8.0	21.9	7.3	9.2	13.7	4.0	11.8	6.7	7.4	14.9	9.3	12.3	7.7	15.9	10.7	12.6	4.4	6.4	10.0	7.4	12.8	10.7	20.3	8.4	8.9	8.3	10.6	14.5	27.9	58.5	14.8	10.3	14.1	43.7	18.1	11.1	13.0	13.9	7.3	9.2	7.6	8.9	6.7	10.9	5.5	5.6	16.8	20.3	0.0	0.6	0.5	0.2	0.9	0.4	0.4	0.2	0.4	0.5	0.1	0.3	0.2	1.1	0.2	1.5	1.1	0.3	0.4	15.2	13.9	16.4	15.8	12.7	13.4	15.6	17.0	17.4	14.0	22.1	11.9	48.2	80.1	11.4	54.2	4.4	12.1	9.1	4.2	4.0	28.8	11.3	14.4	25.3	11.5	8.3	12.9	64.6	8.9	5.5	17.2	0.0	7.3	12.7	32.1	7.4	31.7	13.2	5.7	94.0	5.9	7.5	10.0	13.3	35.6	2.5	17.2	47.5	6.6	11.9	8.4	160.5	11.0	18.3	29.2	10.9	11.3	12.8	18.9	5.4	168.6	8.1	21.7	10.3	90.5	75.9	10.2	7.6	30.1	6.4	13.3	10.0	7.0	29.0	45.4	19.7	10.3	13.5	6.9	5.9	8.5	20.5	12.4	4.8	5.9	9.2	14.9
ANKS1B	"AIDA-1, ANKS2, cajalin-2, EB-1"	ENSG00000185046	"Ankyrin repeat and sterile alpha motif domain containing 1B"	Q7Z6G8	12	98726457-99984654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 77.0;skeletal muscle: 34.2"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 2224.0;Inhibitory neurons: 1545.5;Oligodendrocyte precursor cells: 1318.0;Oligodendrocytes: 1000.1"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;ASC TERT1: 5.8;SCLC-21H: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078230	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane, Centrosome"	"HPA078230: "	"unprognostic (5.50e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.97e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.75e-3)"	1.6	3.6	36.2	0.7	50.4	0.1	2.7	40.2	77.0	2.9	0.0	4.0	0.5	2.3	1.4	2.9	3.6	1.2	1.4	51.8	5.2	4.6	1.1	1.0	0.6	0.0	7.9	8.9	1.1	0.8	10.1	1.8	2.0	3.1	1.0	6.2	3.1	2.7	34.2	1.0	1.1	2.3	0.4	1.1	1.4	7.6	13.8	1.0	5.6	1.8	0.3	2.1	1.7	71.6	0.2	2.2	10.3	2.4	4.0	5.8	0.5	0.0	1.1	0.7	0.8	0.2	0.7	0.8	0.4	1.5	3.1	0.4	0.1	0.0	0.2	1.2	0.7	0.1	0.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.7	0.1	0.6	0.4	0.5	2.9	0.0	1.9	0.7	0.0	0.2	0.1	0.0	11.1	1.1	0.9	3.2	1.2	0.8	3.7	0.1	0.1	0.9	0.9	0.6	0.6	0.0	0.7	0.5	0.9	0.2	0.9	3.7	0.6	1.1	0.7	1.0	1.1	0.9	1.3	0.7	0.6	0.9	1.0	1.0	1.9	1.5	1.6	1.2	4.3	0.6	36.2	50.4	40.2	77.0	51.8	5.2	0.0	7.9	2.0	0.4	13.8	71.6	0.5	3.2	3.9	228.8	0.8	1.1	1.1	0.2	4.6	32.9	6.3	2.4	2.4	0.0	1.3	9.2	18.8	0.4	0.5	0.0	0.0	0.5	142.2	2.6	0.8	0.8	0.0	0.0	2224.0	0.0	0.3	5.7	1.1	0.9	1.3	0.3	0.4	0.5	0.6	30.3	1545.5	0.0	0.0	0.0	1.9	92.0	1.2	0.4	5.4	84.3	0.2	1.7	1.0	1318.0	1000.1	0.0	1.1	6.0	0.3	0.5	0.0	5.0	3.1	3.4	6.6	12.1	1.8	31.8	3.9	2.6	1.4	0.8	2.1	0.5	0.1	0.6
ANKS3	"FLJ32345, FLJ32767, KIAA1977"	ENSG00000168096	"Ankyrin repeat and sterile alpha motif domain containing 3"	Q6ZW76	16	4696510-4734378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Rod photoreceptor cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041409, HPA041482"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA041409: AB_10794375, HPA041482: AB_10795594"	"unprognostic (3.02e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-3)"	5.1	4.9	5.5	2.4	5.6	1.9	4.6	6.1	7.9	7.3	5.3	8.7	2.6	6.3	1.5	3.9	6.8	2.9	4.9	5.3	5.7	7.9	5.0	4.6	3.0	5.4	5.4	8.7	5.5	2.8	7.2	2.4	5.7	6.9	1.2	2.5	6.5	4.0	6.5	4.3	4.1	2.8	5.1	4.3	4.9	5.0	5.5	2.0	6.2	3.3	2.0	6.9	5.7	6.0	2.5	29.4	3.7	8.3	7.1	5.8	8.6	11.0	8.9	10.0	8.9	15.3	6.1	5.5	13.4	7.4	3.9	4.9	8.2	6.0	4.4	7.2	15.6	5.2	14.6	3.8	7.7	2.8	4.3	3.7	6.2	9.6	9.2	6.0	1.9	3.6	12.4	1.7	5.9	9.3	5.5	10.3	10.0	3.7	5.4	8.6	9.3	10.0	7.6	3.1	12.1	11.6	5.7	8.3	4.7	2.1	8.2	3.6	3.4	7.3	9.9	13.7	5.7	8.6	16.4	8.6	4.0	2.8	8.5	0.0	0.4	0.0	0.8	0.5	1.2	1.2	1.0	0.7	0.8	1.3	1.5	0.9	0.0	0.6	0.6	2.2	0.7	0.5	5.5	5.6	6.1	7.9	5.3	5.7	5.4	5.4	5.7	5.1	5.5	6.0	9.0	6.4	14.3	18.3	9.9	7.6	13.2	12.9	8.0	42.9	11.6	11.0	4.9	14.3	11.7	22.0	110.5	12.6	9.9	9.8	19.6	16.5	6.1	10.1	15.1	9.4	9.0	5.5	28.8	8.6	8.5	13.1	13.7	6.8	0.0	21.4	14.6	8.1	8.1	50.5	27.7	13.6	14.2	4.4	4.3	6.4	27.1	4.9	10.6	6.5	12.5	12.5	20.6	17.1	21.2	13.3	13.3	28.2	7.5	16.1	8.8	16.1	15.1	92.2	6.6	13.8	12.3	29.1	25.4	6.0	9.7	6.7	10.6	19.1	12.8	6.2
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233699-21253850	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 12.3;kidney: 5.9;liver: 13.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 63.4;Enteroendocrine cells: 25.1;Hepatocytes: 28.0;Intestinal goblet cells: 40.0;Paneth cells: 38.2;Proximal enterocytes: 113.0;Proximal tubular cells: 37.5;Undifferentiated cells: 24.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Region enriched"	"Detected in single"	8	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;HDLM-2: 3.4;Hep G2: 8.2;OE19: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043523, HPA061125"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687, HPA061125: "	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.0	0.0	0.1	0.6	0.2	0.1	0.0	2.1	0.2	0.0	0.0	8.9	9.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	5.9	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	7.1	0.2	0.0	0.0	0.7	0.1	12.3	0.2	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.8	2.8	0.6	1.8	0.0	0.0	0.0	63.4	0.0	0.2	0.8	0.3	0.1	0.3	25.1	0.0	1.3	1.7	0.0	0.2	0.0	0.1	1.3	0.0	0.4	28.0	0.0	0.0	0.2	40.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.3	38.2	0.0	0.0	0.5	113.0	37.5	0.0	0.3	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.1	0.6	0.0	24.7	0.4
ANKS6	"ANKRD14, FLJ36928, NPHP16, SAMD6"	ENSG00000165138	"Ankyrin repeat and sterile alpha motif domain containing 6"	Q68DC2	9	98731329-98796965	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.8;Inhibitory neurons: 48.6;Oligodendrocytes: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA008355	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA008355: AB_2058277"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.31e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.94e-2)"	"prognostic favorable (3.44e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.68e-1)"	5.7	4.8	8.0	3.2	8.8	1.5	4.7	14.3	10.0	9.5	7.6	10.5	4.2	8.9	4.9	8.7	10.2	3.3	3.9	8.1	7.7	9.4	2.7	6.6	2.4	12.5	8.9	10.3	12.8	5.5	4.8	2.0	12.4	5.5	4.9	2.2	5.4	2.3	3.7	5.3	7.7	4.9	8.2	3.2	11.5	5.7	10.1	2.6	13.6	1.0	2.9	8.7	5.2	9.7	8.2	12.3	10.9	19.3	9.0	7.3	7.4	5.9	10.0	6.5	7.7	6.7	5.8	15.2	4.4	8.4	9.2	23.9	8.1	9.9	3.4	21.2	8.3	3.6	7.7	2.9	8.8	2.0	2.3	8.9	12.0	8.7	8.9	7.9	7.4	13.8	26.0	3.5	5.0	13.5	0.9	3.9	17.3	36.3	12.2	10.2	26.8	1.2	11.7	5.1	7.1	8.1	2.5	14.2	6.7	8.8	0.0	4.1	7.6	6.5	7.2	18.4	5.8	6.8	12.1	2.4	9.4	6.8	9.8	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	8.0	8.8	14.3	10.0	8.1	7.7	12.5	8.9	12.4	8.2	10.1	9.7	3.5	6.4	10.5	16.0	2.4	1.8	0.9	8.2	5.2	12.0	1.5	2.2	4.4	10.0	7.7	12.9	8.4	3.1	1.5	5.1	3.9	4.2	3.0	3.7	5.3	3.2	4.9	0.8	52.8	8.9	2.7	4.9	7.7	3.9	1.3	6.2	1.8	1.7	1.9	0.0	48.6	7.1	0.0	1.3	0.9	5.8	2.8	0.9	0.0	9.4	0.7	1.9	2.1	14.1	54.2	9.3	3.1	4.5	1.4	3.9	4.8	5.9	11.1	0.8	0.0	2.7	3.2	3.8	5.9	5.6	1.1	1.1	2.4	6.2	10.4	2.9
ANKZF1	"FLJ10415, Vms1, ZNF744"	ENSG00000163516	"Ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1"	Q9H8Y5	2	219229783-219236679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035208	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035208: AB_10602229"	"unprognostic (5.23e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.27e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.95e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (3.87e-2)"	"unprognostic (9.68e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-3)"	9.1	9.2	7.8	8.8	8.6	7.8	10.8	9.9	9.8	13.8	9.6	13.1	9.6	10.1	3.2	15.2	13.5	6.1	14.1	7.9	8.0	13.9	14.4	10.7	13.7	10.1	8.5	16.0	15.6	6.4	12.5	5.9	9.3	15.1	5.2	8.2	15.3	5.6	16.9	17.3	15.2	4.6	7.9	18.1	14.2	7.9	8.7	11.9	11.9	8.1	8.3	12.4	15.0	10.5	31.6	6.1	8.1	11.8	10.6	8.8	32.5	10.1	10.0	13.6	17.2	14.9	13.2	6.6	18.0	4.3	15.3	22.7	10.5	17.5	10.0	13.9	11.0	14.6	19.1	13.9	10.6	9.6	13.7	8.9	33.1	10.1	15.9	22.6	9.4	17.0	24.8	14.9	6.9	13.6	14.1	24.1	13.5	13.7	10.9	14.3	9.9	21.4	7.6	7.9	10.3	10.5	11.9	23.9	19.8	19.5	6.4	23.7	10.3	11.4	8.7	10.1	13.3	31.6	19.9	12.9	19.4	13.8	5.1	9.9	9.1	11.0	16.1	9.0	17.4	13.0	16.3	16.2	9.4	13.3	19.0	18.0	12.3	24.4	14.0	9.8	17.1	13.6	7.8	8.6	9.9	9.8	7.9	8.0	10.1	8.5	9.3	7.9	8.7	10.5	10.2	16.0	17.2	24.2	28.0	9.3	14.5	28.9	9.6	39.8	14.4	13.6	9.2	11.5	24.8	12.9	31.3	10.5	32.7	17.3	13.7	20.5	4.4	28.2	9.7	11.8	9.6	19.6	19.0	12.6	27.2	8.9	17.9	13.0	21.6	21.4	8.6	13.1	7.7	32.0	21.0	19.1	20.3	8.2	5.3	4.0	23.9	10.9	10.6	6.5	15.6	18.0	43.3	13.6	25.3	14.2	16.0	16.6	17.7	13.6	25.2	16.5	65.1	55.4	6.6	13.2	12.8	10.1	17.0	8.3	9.9	11.6	30.0	21.3	17.6	11.1
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389821-36453791	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 266.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 156.4;Oligodendrocytes: 441.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HBF TERT88: 655.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175"	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (5.97e-7)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.2	0.7	59.8	5.2	134.5	36.4	2.0	125.1	72.7	1.8	18.4	6.0	4.4	1.8	0.2	10.4	0.9	2.1	0.8	59.3	83.6	0.4	1.2	1.4	6.7	162.3	106.5	0.9	0.6	0.2	0.2	8.9	160.2	0.9	8.0	0.3	1.7	0.4	0.3	13.6	4.3	14.9	99.2	1.2	4.8	12.4	102.3	16.0	0.8	0.3	9.5	3.2	3.2	266.0	476.1	96.5	79.3	61.0	10.7	26.9	85.6	292.5	169.3	344.4	256.0	66.4	142.7	23.9	82.1	148.6	182.8	237.0	63.4	170.7	655.4	16.1	46.0	32.7	104.8	55.8	1.7	47.3	36.7	6.0	7.7	225.3	147.2	40.8	109.3	31.2	69.6	48.8	284.4	71.0	40.0	54.8	88.5	71.9	102.3	29.1	238.2	15.9	76.5	76.5	33.5	39.5	154.1	175.8	26.1	109.6	119.0	53.6	104.5	214.2	239.0	127.6	346.6	20.1	34.2	43.2	72.9	74.9	460.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.3	59.8	134.5	125.1	72.7	59.3	83.6	162.3	106.5	160.2	99.2	102.3	266.0	0.4	0.0	1.1	2.3	1.0	14.1	1.9	8.3	7.4	0.0	1.9	2.0	0.6	0.0	3.2	0.0	0.0	13.8	1.1	2.8	0.0	0.7	156.4	18.9	3.2	1.9	0.0	35.3	3.4	0.2	23.2	6.9	10.2	12.8	0.0	15.4	1.1	0.5	9.8	0.0	5.7	3.4	6.1	1.6	5.9	53.3	1.2	2.7	0.0	0.0	0.0	0.0	0.0	1.5	441.3	0.6	0.1	0.0	8.8	1.6	0.8	0.3	10.4	0.0	0.0	0.4	5.2	20.0	17.7	27.1	9.2	2.9	2.6	1.7	6.0	3.3
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 181.7;salivary gland: 180.5;seminal vesicle: 209.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 70.2;Early spermatids: 54.9;Hepatocytes: 141.3;Late spermatids: 75.1;Sertoli cells: 46.0;Smooth muscle cells: 52.5;Suprabasal keratinocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 140.2;CAPAN-2: 207.9;HaCaT: 254.0;OE19: 182.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 6.6"	"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	16.3	2.2	0.3	3.6	1.6	0.1	86.8	0.8	1.3	46.7	0.1	14.3	3.6	40.0	181.7	12.7	59.1	54.4	21.9	0.5	0.1	6.4	108.5	16.1	3.4	1.0	0.2	2.9	9.1	48.0	4.4	5.2	1.1	17.1	11.0	0.9	180.5	209.2	12.7	97.4	4.6	30.1	0.2	1.2	48.3	10.4	0.1	1.5	35.4	33.0	4.0	6.7	12.8	0.5	140.2	5.3	0.3	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	207.9	0.0	2.5	0.0	0.3	254.0	0.0	0.7	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.0	1.0	0.5	0.3	1.1	182.2	19.6	0.3	0.0	0.7	0.0	0.2	7.3	0.2	0.1	43.1	0.8	1.4	16.2	0.5	0.5	0.3	1.1	0.0	3.5	0.1	0.3	0.2	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.8	1.3	0.5	0.1	1.0	0.2	1.1	0.2	0.1	0.5	7.2	0.0	0.0	0.7	0.4	17.7	21.5	4.2	0.0	0.0	30.5	70.2	3.5	17.2	2.0	0.0	0.0	1.3	0.2	0.4	0.0	4.1	54.9	10.0	27.5	5.6	0.0	2.7	0.7	0.0	0.6	4.2	36.7	18.5	4.5	0.0	3.3	141.3	0.2	0.0	20.4	13.3	0.0	1.6	3.0	75.1	1.8	0.7	5.4	2.8	0.0	0.8	0.0	1.5	0.7	1.0	0.5	1.5	0.3	22.6	0.0	0.7	0.3	0.4	46.0	1.1	52.5	1.4	2.3	1.4	46.7	4.1	0.7	0.1	0.4	20.9
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"retina: 226.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 81.3;Early spermatids: 57.3;Late spermatids: 283.2;Microglial cells: 143.4;Rod photoreceptor cells: 179.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;HUVEC TERT2: 9.5;U-2 OS: 24.1"	"Region enriched"	"Detected in many"	4	"basal ganglia: 19.6"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	8.8	0.3	3.8	0.4	4.4	0.0	6.6	2.2	3.3	4.3	5.0	1.9	0.7	1.8	1.4	1.7	3.2	1.1	8.0	2.5	2.4	1.2	0.2	7.2	0.1	3.2	3.2	1.5	0.9	1.3	0.6	4.1	3.4	2.5	0.6	226.0	1.3	1.0	2.0	1.1	1.7	1.5	3.0	3.4	2.2	10.1	3.9	0.3	2.4	4.4	0.2	2.4	3.5	2.8	2.5	0.0	4.4	0.0	0.0	0.2	2.0	0.0	9.6	0.5	1.0	0.0	0.2	0.2	0.3	0.0	0.1	0.3	0.0	0.1	0.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	1.9	0.0	1.0	0.0	0.0	4.6	2.3	0.0	1.9	0.0	1.0	0.1	0.1	0.0	0.0	2.3	1.6	0.0	3.9	1.3	0.0	0.2	0.0	24.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.8	4.4	2.2	3.3	2.5	2.4	3.2	3.2	3.4	3.0	3.9	2.8	9.7	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.6	11.5	0.3	0.1	1.9	0.0	0.0	0.0	81.3	1.4	0.0	0.0	0.0	0.0	57.3	0.4	0.4	9.1	0.0	0.0	1.7	0.0	2.0	0.3	0.0	0.5	0.0	0.0	4.6	0.0	0.2	10.1	2.0	0.0	0.0	0.0	0.0	283.2	0.3	0.1	0.0	143.4	0.0	13.0	0.0	31.2	9.9	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	179.9	0.0	1.3	0.6	1.4	1.8	0.0	0.1	2.5	0.0	0.2	0.2	0.0
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		770000	"Cluster 52: Eosinophils - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	50.8	34.7	50.2	87.3	60.5	137.0	71.6	62.3	59.1	54.0	33.3	81.0	70.8	59.1	50.7	65.8	75.1	59.8	127.9	48.8	57.3	75.1	76.4	71.0	156.2	60.0	56.5	57.8	53.7	61.4	27.5	101.5	65.4	75.4	89.0	106.0	54.0	66.8	62.4	36.1	76.9	57.0	62.7	85.5	78.9	20.8	54.3	203.0	73.6	64.5	141.2	76.4	43.6	71.0	196.4	234.7	303.2	263.2	104.2	90.9	200.5	101.0	134.3	193.5	161.8	195.3	358.0	629.8	184.5	114.5	114.2	279.9	709.5	206.6	230.8	286.6	241.2	478.6	192.7	247.8	64.5	380.8	247.4	72.9	143.1	106.3	210.2	126.6	285.9	300.0	354.5	239.1	168.2	136.1	386.1	311.6	270.1	192.5	118.2	531.7	280.7	375.3	170.5	304.5	399.8	247.8	153.7	170.8	282.7	301.1	227.2	491.4	129.0	199.0	313.5	139.3	275.2	143.8	433.9	733.8	132.2	632.1	186.7	12.9	26.4	44.9	16.8	30.6	14.2	18.7	13.8	17.8	30.0	17.9	16.5	14.9	27.2	28.8	27.5	26.8	17.2	16.0	50.2	60.5	62.3	59.1	48.8	57.3	60.0	56.5	65.4	62.7	54.3	71.0	100.2	109.0	118.0	20.2	98.1	64.7	67.7	147.0	91.0	92.2	57.3	70.6	80.0	60.1	105.4	69.9	35.5	258.2	119.7	57.1	107.6	112.5	6.7	61.2	67.7	91.8	78.5	144.2	16.8	96.1	172.4	57.5	69.3	70.1	92.4	63.6	78.1	81.8	194.1	65.6	17.4	92.1	114.0	150.1	112.6	6.3	34.8	111.6	78.2	37.5	158.9	103.7	84.5	15.6	55.4	79.8	57.0	29.7	92.6	59.7	99.3	148.0	113.7	87.2	26.3	49.9	75.1	8.8	18.2	86.4	34.9	232.5	99.5	82.5	94.7	52.0
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983341-98015943	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		570000	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	144.0	77.1	134.8	124.0	155.9	365.7	138.6	134.0	187.6	161.6	112.0	145.5	95.1	116.2	104.7	140.9	127.2	60.4	92.3	113.7	150.0	100.2	103.5	122.4	222.6	171.4	149.8	168.5	156.4	68.7	68.1	110.5	158.5	98.6	118.7	46.2	110.6	71.4	109.6	148.0	127.3	78.0	155.6	123.8	131.9	59.6	142.6	271.5	96.9	50.6	248.4	132.5	146.6	173.4	659.7	347.4	378.6	318.4	208.1	365.2	344.4	332.6	292.4	349.2	291.9	438.3	313.1	798.2	194.2	224.6	266.3	423.9	516.1	375.2	397.1	523.0	290.9	692.4	289.1	478.4	266.9	1201.9	386.8	278.7	268.8	280.9	574.0	283.2	307.9	701.5	1359.2	548.8	272.6	875.7	913.5	1062.0	148.2	638.8	341.2	537.8	589.5	381.7	228.8	269.9	304.2	265.8	390.4	376.2	364.5	185.3	213.2	444.0	377.0	226.5	367.3	288.3	355.5	493.2	601.3	469.1	209.7	472.7	432.1	91.3	83.6	118.8	65.2	95.5	89.3	106.1	122.5	92.8	100.5	93.0	143.8	112.1	34.2	74.1	149.7	96.4	162.5	85.3	134.8	155.9	134.0	187.6	113.7	150.0	171.4	149.8	158.5	155.6	142.6	173.4	127.9	86.6	101.8	7.8	227.7	180.7	201.3	180.0	208.9	61.1	100.4	126.0	85.8	112.9	120.7	75.4	25.0	345.5	159.5	159.1	97.8	144.9	114.9	73.8	176.3	146.9	149.9	709.4	5.8	171.6	537.9	121.9	123.3	117.5	119.7	247.9	159.5	96.6	284.7	119.5	6.2	242.2	75.3	310.6	152.0	95.2	146.3	222.5	128.1	14.0	263.5	68.9	149.3	8.0	18.8	137.1	151.1	145.2	266.5	260.6	177.7	101.9	56.3	42.1	151.2	113.4	189.4	204.3	339.0	243.0	154.1	333.1	217.6	188.9	302.7	234.1
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472559-48473622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Smooth muscle cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA						"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: AB_2684947, HPA067561: AB_2685861"		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 222.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		280000	"Cluster 44: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	20.0	30.4	36.1	38.9	37.8	75.7	18.1	54.9	45.0	20.5	30.4	19.9	22.5	26.3	34.4	18.7	21.2	20.2	35.1	32.8	39.9	30.8	29.0	23.0	71.0	43.5	41.5	23.3	8.9	33.1	16.4	21.6	40.5	16.2	18.2	98.6	12.9	24.5	49.8	21.6	25.7	21.0	39.7	33.1	17.3	10.3	40.7	88.2	30.5	26.0	62.2	21.8	16.2	35.6	224.0	141.7	289.7	144.0	22.3	32.7	109.8	117.7	66.6	111.8	106.0	105.6	154.0	405.1	101.8	68.3	66.3	76.6	164.9	73.6	158.4	466.1	101.3	280.7	175.6	153.2	21.1	572.0	136.6	26.8	11.9	104.1	95.4	54.8	84.6	193.3	274.8	231.2	103.6	232.3	231.5	148.3	292.5	72.9	64.8	245.4	161.2	214.1	80.2	88.8	94.5	161.2	245.4	39.6	70.7	127.5	105.3	287.7	87.4	56.7	158.4	59.1	239.1	297.6	325.6	388.7	64.5	403.6	105.5	56.6	20.8	35.9	35.0	15.6	53.2	54.5	46.4	38.5	17.4	39.5	32.6	40.7	14.7	31.5	20.3	12.2	56.2	36.5	36.1	37.8	54.9	45.0	32.8	39.9	43.5	41.5	40.5	39.7	40.7	35.6	48.7	12.8	84.0	16.3	88.9	97.3	37.6	36.8	40.5	117.5	33.8	37.7	99.9	24.3	32.8	73.5	33.3	58.4	98.2	12.1	86.1	36.4	1.4	52.5	64.0	52.3	14.4	222.5	7.9	26.5	133.1	57.6	20.9	41.9	63.3	28.4	39.7	59.0	52.3	63.9	9.9	19.9	28.5	48.0	108.9	1.9	30.4	54.3	67.6	6.5	57.0	134.3	60.8	3.0	6.6	27.0	14.2	33.4	116.3	21.6	20.4	58.6	59.6	135.1	26.3	56.8	75.1	12.4	22.7	55.2	98.5	40.6	108.9	27.9	37.8	25.8
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151865-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 7527.7"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 3632.9;Syncytiotrophoblasts: 7071.8;Urothelial cells: 4808.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 2816.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	Yes		3000000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.57e-5)"	"prognostic unfavorable (6.19e-6)"	719.8	60.3	27.5	268.3	35.1	2132.2	442.6	24.8	44.4	952.0	32.8	152.7	64.1	116.2	58.6	7527.7	264.6	329.4	145.3	28.4	53.4	67.9	54.7	470.4	67.9	55.5	46.4	109.4	61.8	28.2	98.1	559.4	36.5	165.3	103.2	6.5	1547.5	154.9	47.6	213.8	88.7	261.5	40.4	79.6	90.2	17.9	45.9	109.9	206.8	89.1	1485.5	386.3	1536.1	43.2	960.2	1485.7	65.8	68.4	905.8	855.6	4.2	1614.6	1008.5	656.3	441.9	43.5	841.0	2.2	520.1	1426.5	1441.9	1147.7	142.6	984.1	516.8	541.6	10.3	73.2	398.5	1.4	719.4	160.9	34.7	495.7	800.6	664.7	1294.6	604.0	947.8	85.4	309.3	39.5	822.6	4.3	287.0	87.7	82.6	379.7	597.6	0.9	369.1	3.2	1495.9	200.4	1.0	0.7	556.6	14.7	377.9	862.7	3.5	24.3	1176.2	761.8	478.9	1058.2	845.1	6.8	2.0	3.6	1757.9	147.8	1171.2	2816.9	1237.6	2227.6	744.1	328.7	757.0	13.7	662.7	664.5	1513.3	3.3	190.7	348.5	128.4	443.6	324.0	53.2	134.5	2021.5	27.5	35.1	24.8	44.4	28.4	53.4	55.5	46.4	36.5	40.4	45.9	43.2	447.4	583.3	415.2	1.6	39.0	846.7	2486.8	2417.6	1748.3	0.1	225.0	417.1	22.5	58.6	2214.7	62.5	0.0	1543.4	602.1	32.2	0.0	167.4	8.2	2037.4	241.6	362.2	5.3	81.2	3.7	23.1	1747.7	732.0	86.6	1993.5	2550.6	0.1	136.7	6.5	593.8	0.0	0.1	20.8	1330.6	545.0	1190.3	7.3	222.4	901.7	307.7	29.0	575.0	0.2	319.3	0.5	0.6	733.2	5.5	9.4	140.4	1552.2	0.1	5.7	1996.9	0.0	65.7	728.2	413.3	2.3	4.0	3632.9	597.7	7071.8	1348.3	3.0	12.6	4808.1
ANXA10	ANX14	ENSG00000109511	"Annexin A10"	Q9UJ72	4	168092537-168187736	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 486.3"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 172.6;Gastric mucus-secreting cells: 667.7;Pancreatic endocrine cells: 315.0"	"Group enriched"	"Detected in many"	5	"pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"OE19: 284.8;PC-3: 125.5;RT4: 172.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005469, HPA074650"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nucleoli"	Vesicles	"HPA005469: AB_1844849, HPA074650: "	"unprognostic (2.29e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.29e-2)"	"prognostic favorable (3.64e-6)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-1)"	"unprognostic (8.61e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-3)"	"unprognostic (8.41e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.89e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	19.6	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	486.3	0.9	0.0	0.0	0.0	0.0	0.0	89.6	0.1	0.0	0.0	4.6	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.4	0.1	9.7	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	284.8	125.5	0.0	0.6	0.0	0.0	172.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	1.5	0.0	0.5	15.5	0.0	0.4	0.1	0.0	0.2	7.2	3.2	0.0	2.1	0.0	0.0	0.1	0.0	21.1	11.0	0.1	0.1	0.3	0.0	2.7	0.2	172.6	0.0	0.4	667.7	0.1	0.0	0.0	1.8	72.6	0.0	0.0	0.2	0.5	0.0	2.8	0.0	0.8	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.5	0.0	315.0	1.1	0.0	1.4	0.6	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.1	14.7
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 443.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		210000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	139.9	29.5	39.0	99.4	40.6	192.9	107.6	27.5	46.8	86.6	52.8	130.3	138.0	74.3	107.5	210.2	109.0	84.8	236.2	47.3	29.0	144.7	47.7	109.5	81.2	26.4	26.6	78.2	95.4	81.8	27.2	91.1	23.9	100.3	120.7	4.8	94.1	81.8	188.9	75.6	137.2	86.0	25.4	76.2	139.3	24.5	24.6	100.2	61.4	166.2	101.7	148.1	102.8	30.4	221.7	195.7	10.4	53.9	220.2	201.1	119.6	149.5	397.3	95.7	98.8	168.7	338.2	13.1	113.6	236.7	8.1	277.7	44.6	136.2	54.2	384.3	76.0	84.4	98.9	131.5	129.4	92.0	212.3	222.9	74.6	57.8	39.4	178.9	143.9	117.9	82.1	163.7	76.8	127.3	119.8	200.9	19.6	211.5	367.7	91.7	14.9	344.0	155.1	191.8	5.1	37.9	65.0	269.9	156.4	83.4	80.6	120.6	160.0	68.7	101.4	157.6	84.4	91.7	145.6	96.0	66.6	155.4	47.4	130.8	66.8	443.8	72.9	52.4	75.0	64.9	92.5	100.5	49.4	54.2	83.7	74.4	231.8	61.3	59.1	78.5	126.5	85.4	39.0	40.6	27.5	46.8	47.3	29.0	26.4	26.6	23.9	25.4	24.6	30.4	150.5	96.1	78.4	17.3	101.4	51.2	266.4	219.4	92.8	1.6	58.8	50.4	293.3	203.0	227.1	220.7	0.0	271.7	137.1	457.7	332.6	429.2	4.5	180.6	49.7	82.7	77.5	29.9	29.5	352.5	309.8	113.1	175.8	265.7	116.1	81.4	91.4	40.8	228.1	3.3	15.5	186.9	97.6	149.7	167.4	9.6	92.9	155.0	90.7	24.4	208.2	38.9	159.6	3.0	2.3	420.6	461.0	92.6	98.2	414.9	367.7	156.8	229.0	2.8	92.1	56.4	137.9	2.8	51.5	98.4	42.1	185.5	131.9	50.8	227.8	581.4
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737402	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 144.3;intestine: 293.6"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 180.1;Enteroendocrine cells: 44.9;Intestinal goblet cells: 161.1;Paneth cells: 58.1;Proximal enterocytes: 125.2;Undifferentiated cells: 38.5"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A549: 27.8;HDLM-2: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.0	1.1	1.6	2.6	0.0	0.4	2.6	2.2	0.4	1.1	21.6	293.6	1.5	2.2	0.2	58.4	144.3	0.1	1.1	1.5	7.0	20.2	0.2	0.2	4.1	2.9	0.4	0.4	0.0	0.0	0.0	3.3	0.5	36.1	4.3	0.1	24.3	0.0	0.1	219.5	2.9	3.3	0.0	0.8	4.2	2.1	0.1	0.0	0.0	0.0	0.5	0.1	5.3	0.0	27.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	14.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.0	0.0	1.7	1.6	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.6	2.6	2.2	1.1	1.5	4.1	2.9	3.3	3.3	2.1	5.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.2	0.1	1.1	0.4	180.1	0.0	0.0	0.0	0.0	0.0	6.2	3.9	1.4	1.1	4.5	3.6	0.2	44.9	2.7	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.2	0.0	1.0	161.1	0.0	0.0	0.0	1.4	1.2	0.3	0.0	0.0	0.0	0.3	0.0	0.5	1.2	0.1	58.1	0.0	0.0	0.0	125.2	27.6	2.9	10.9	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.4	0.1	38.5	0.1
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039233-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.2;B-cells: 23.8;dendritic cells: 36.4;Endothelial cells: 24.8;Hepatic stellate cells: 38.2;NK-cells: 47.4;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5"	"Group enriched"	"Detected in all"	6	"B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3"	"Cell line enhanced"	"Detected in many"		"HSkMC: 27.7;JURKAT: 33.1;MOLT-4: 30.0;REH: 30.9;U-937: 117.7"									HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	4.7	1.3	3.2	12.1	3.2	19.8	3.9	3.0	3.8	3.5	3.5	2.5	3.3	2.4	1.7	1.8	3.3	3.5	2.9	2.8	2.9	2.0	1.3	4.6	26.1	3.4	3.3	1.2	0.8	0.6	1.1	3.2	3.2	2.7	2.7	0.1	1.7	1.2	2.5	2.1	8.2	2.1	3.5	15.8	3.3	1.5	3.3	25.2	2.7	3.0	17.2	3.2	3.8	4.0	2.1	2.1	1.6	1.2	2.6	8.0	0.4	0.5	0.3	0.5	0.6	3.9	1.9	6.8	6.5	1.6	2.2	0.8	5.0	0.5	0.5	13.3	4.0	2.2	5.9	1.8	4.1	2.6	0.8	27.7	0.2	2.4	0.2	0.1	16.2	33.1	1.5	8.9	2.1	3.1	30.0	4.1	0.0	1.7	14.8	30.9	3.6	3.9	0.7	1.1	5.7	0.0	2.7	0.7	0.7	0.2	0.7	4.9	9.9	0.5	0.0	0.8	2.5	4.4	6.7	3.3	3.6	117.7	1.4	5.6	3.5	1.7	53.9	2.5	63.5	34.3	56.1	59.9	3.5	32.9	96.3	72.1	3.2	24.8	8.1	5.2	66.5	26.6	3.2	3.2	3.0	3.8	2.8	2.9	3.4	3.3	3.2	3.5	3.3	4.0	32.2	0.0	9.9	0.0	23.8	3.7	1.4	0.3	2.2	0.1	1.9	2.2	1.3	4.3	1.5	0.0	0.0	0.4	36.4	0.5	0.0	0.1	4.0	1.1	5.0	24.8	1.8	8.2	0.0	0.0	1.1	7.2	1.5	0.8	15.2	4.1	38.2	1.4	8.7	0.0	0.0	0.1	2.0	18.2	5.6	1.5	1.5	7.5	7.2	0.0	7.1	0.2	47.4	0.0	0.0	0.1	0.0	0.4	7.8	1.2	1.0	0.4	2.0	0.0	0.0	3.4	3.7	0.7	1.6	1.2	2.3	0.4	66.0	0.3	0.5	1.4
ANXA7	ANX7	ENSG00000138279	"Annexin A7"	P20073	10	73375101-73414076	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 693.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004312, HPA064290"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA		290000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"CAB004312: AB_626681, HPA064290: AB_2685233"	"unprognostic (1.48e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.06e-2)"	79.0	72.1	60.1	58.6	61.1	85.2	75.5	55.9	67.8	69.9	57.1	64.3	39.4	57.6	80.5	69.3	57.0	51.8	113.4	62.6	64.8	116.4	126.0	60.4	60.8	55.4	57.0	67.1	55.9	240.7	55.6	57.2	58.1	69.2	74.4	32.3	70.2	70.6	200.1	61.2	44.9	68.4	60.8	53.4	51.7	26.3	62.5	55.4	83.1	139.6	84.1	75.2	57.4	63.9	143.4	101.4	38.8	95.3	148.9	145.2	84.3	93.2	244.7	119.9	100.6	149.2	164.8	56.6	92.2	177.2	78.8	116.9	73.2	110.9	118.1	140.8	54.5	80.4	46.5	133.9	130.6	115.7	35.4	90.8	105.7	149.2	265.1	104.7	108.0	60.8	106.2	156.4	154.4	114.5	66.1	74.4	43.5	85.1	693.9	53.9	110.1	103.4	209.3	86.5	30.9	42.8	105.1	239.4	90.3	54.3	149.7	61.0	100.8	48.5	87.9	148.1	122.5	100.5	153.2	79.5	114.4	147.4	38.4	188.6	98.1	129.8	57.5	74.9	78.9	96.5	88.8	72.2	101.3	75.1	80.0	71.4	98.0	97.2	77.5	43.2	127.8	137.2	60.1	61.1	55.9	67.8	62.6	64.8	55.4	57.0	58.1	60.8	62.5	63.9	85.0	67.3	61.8	24.8	68.4	86.2	137.9	189.8	40.9	33.0	56.7	40.9	131.9	62.9	120.6	93.8	14.6	210.6	61.2	76.2	193.7	167.2	9.7	82.9	43.8	82.4	191.8	119.3	44.8	150.9	112.0	85.3	51.5	60.4	108.3	69.0	56.4	122.7	119.9	10.1	50.7	82.8	193.3	83.0	87.3	6.5	137.0	91.4	85.4	15.0	301.5	66.4	36.0	26.7	46.2	133.1	47.5	174.5	73.0	125.3	57.9	262.8	161.1	26.3	26.3	82.1	92.9	24.0	42.3	72.5	92.5	177.3	78.4	46.9	76.9	146.1
ANXA8	ANX8	ENSG00000265190	"Annexin A8"	P13928	10	47460162-47484158	"Predicted intracellular proteins"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.6;skin 1: 266.2;vagina: 110.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 99.3;Astrocytes: 38.8;Club cells: 40.7;Excitatory neurons: 47.8;Fibroblasts: 34.5;Inhibitory neurons: 41.0;Microglial cells: 35.6;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 48.1;Squamous epithelial cells: 63.6"	"Group enriched"	"Detected in many"	4	"cervical cancer: 14.3;head and neck cancer: 16.1;lung cancer: 4.3;urothelial cancer: 11.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 394.3;HBEC3-KT: 622.3;hTCEpi: 357.6;hTERT-HME1: 134.2;RT4: 159.6"									"HPA045246, HPA047451"			Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (8.32e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (5.94e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.55e-15)"	"unprognostic (1.04e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	73.3	0.7	0.5	0.1	0.5	0.7	11.7	0.7	1.1	49.6	0.6	0.5	0.0	0.1	1.0	217.6	3.7	0.4	4.4	0.6	0.3	0.0	1.8	13.1	0.0	1.0	0.8	1.3	0.3	0.0	0.3	30.9	0.8	12.4	0.1	0.0	47.3	9.8	0.4	266.2	0.2	0.0	0.6	0.2	0.4	0.8	1.5	4.8	0.2	0.2	46.6	66.4	110.7	0.9	123.4	16.2	0.0	0.0	0.0	0.0	33.7	2.3	0.3	0.0	0.0	8.7	35.0	0.0	2.5	1.0	1.8	394.3	0.0	622.3	0.0	27.9	0.0	0.0	39.6	0.0	26.2	0.0	1.3	0.2	357.6	0.2	134.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.2	0.1	4.0	0.0	0.0	0.5	0.0	0.0	159.6	0.0	0.0	56.4	16.4	0.3	8.7	0.1	3.5	0.0	0.0	39.5	0.7	2.4	0.2	0.1	0.2	4.4	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.5	0.7	1.1	0.6	0.3	1.0	0.8	0.8	0.6	1.5	0.9	0.1	99.3	7.3	38.8	0.0	1.1	10.3	1.6	2.8	0.0	4.9	3.4	2.6	7.2	40.7	3.7	0.0	14.7	0.1	1.0	0.0	3.1	0.6	2.1	0.0	0.5	0.0	0.0	47.8	0.4	6.7	34.5	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.0	41.0	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.0	35.6	0.1	0.0	0.0	50.8	48.1	17.3	0.0	0.0	0.0	8.5	1.5	0.0	14.2	0.0	0.0	0.0	0.6	0.2	1.4	63.6	2.0	6.2	0.3	0.1	0.2	17.2
ANXA8L1	"ANXA8L2, bA145E20.2, bA301J7.3"	ENSG00000264230	"Annexin A8 like 1"	Q5VT79	10	46375627-46391784	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 195.2;skin 1: 325.4;vagina: 100.5"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 118.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.2;head and neck cancer: 5.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 374.5;HBEC3-KT: 485.0;hTCEpi: 140.1;SiHa: 116.6"									"HPA045246, HPA047451"			Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (3.67e-3)"	"unprognostic (4.56e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.94e-3)"	"unprognostic (8.33e-5)"	"unprognostic (3.43e-1)"	"unprognostic (8.26e-10)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	39.8	0.2	0.0	0.0	0.0	1.2	21.9	0.0	0.1	45.2	0.0	0.3	0.0	0.1	0.0	195.2	6.1	0.1	2.9	0.0	0.0	0.0	1.1	16.5	0.0	0.0	0.0	0.9	0.3	0.0	0.2	24.1	0.0	6.8	0.0	0.0	40.8	4.5	1.1	325.4	0.1	0.0	0.0	0.1	0.3	0.8	0.0	4.3	0.1	0.0	35.1	37.4	100.5	0.0	70.1	18.2	0.0	0.0	0.0	0.0	24.8	0.9	0.1	0.0	0.0	1.9	12.6	0.0	0.6	0.3	0.5	374.5	0.0	485.0	0.0	28.9	0.0	0.0	33.3	0.0	9.3	0.0	0.7	0.0	140.1	0.2	58.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	70.2	0.2	0.7	0.0	0.0	0.8	0.0	0.0	76.0	0.1	0.0	116.6	12.0	0.0	7.2	0.0	0.7	0.0	0.1	12.2	0.1	0.3	0.0	0.1	0.0	2.8	0.1	0.2	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	1.1	0.0	0.0	0.0	3.0	0.2	11.4	1.6	2.3	2.4	3.7	18.6	19.9	0.0	0.0	14.8	0.0	3.0	0.0	0.7	0.4	1.0	0.0	0.9	0.0	0.0	0.0	0.2	11.4	12.8	5.6	0.1	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.7	1.4	0.0	1.2	2.5	5.2	0.0	10.9	0.2	13.1	0.0	1.5	0.3	2.4	118.7	1.1	6.3	0.6	0.0	0.2	5.9
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 subunit alpha 2"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		10000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: AB_2678283"	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	20.1	18.0	3.5	1.3	5.1	4.5	16.6	10.8	9.9	20.3	1.4	23.0	5.4	17.9	1.5	12.7	18.1	2.0	19.1	5.5	3.5	34.4	29.9	18.9	3.2	0.9	2.1	17.5	25.3	3.7	25.6	5.2	3.0	20.3	4.9	5.8	14.6	4.0	14.1	14.5	19.6	5.6	0.0	57.6	20.6	15.5	3.3	3.8	13.9	1.6	2.5	19.0	15.7	1.4	7.5	2.9	3.7	10.7	13.8	14.2	9.1	10.2	3.3	6.0	4.9	1.3	7.3	7.4	8.7	12.3	5.7	8.9	8.9	5.6	3.9	5.5	23.2	2.1	10.4	3.9	5.3	2.8	4.9	16.8	6.1	3.1	6.1	14.8	8.5	5.0	5.9	4.7	6.3	0.4	2.6	3.2	2.0	9.1	17.9	4.2	2.6	8.1	9.2	6.2	12.3	10.0	11.4	9.2	1.7	6.3	5.4	0.8	13.3	1.9	2.3	2.8	5.2	4.3	3.9	5.3	4.0	3.7	3.1	1.5	1.7	1.5	1.1	1.7	0.5	0.5	1.1	0.6	1.4	1.0	1.1	1.2	2.1	1.1	1.4	1.3	2.1	0.6	3.5	5.1	10.8	9.9	5.5	3.5	0.9	2.1	3.0	0.0	3.3	1.4	38.1	38.5	21.8	29.4	14.3	14.3	12.4	13.3	7.4	50.9	27.2	23.0	12.9	21.5	15.9	62.5	60.5	42.1	17.3	45.3	39.2	37.5	46.7	64.0	44.6	36.6	35.2	27.1	37.2	18.0	45.2	28.7	16.3	86.7	27.3	31.0	80.3	59.8	82.8	101.0	36.4	32.3	18.3	104.7	26.9	28.3	34.5	51.8	8.8	41.2	31.2	30.4	39.1	23.1	21.9	25.8	24.2	27.8	13.6	16.9	43.5	70.4	23.5	69.2	26.3	20.7	22.6	72.7	28.0	11.2	11.4	28.5	19.7	30.5	37.0	11.5
AP3B1	"ADTB3A, HPS2"	ENSG00000132842	"Adaptor related protein complex 3 subunit beta 1"	O00203	5	78002326-78294698	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038737, HPA045458"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		38000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA038737: AB_10670788, HPA045458: AB_2679333"	"unprognostic (9.14e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.37e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (7.97e-6)"	"unprognostic (1.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.39e-2)"	21.5	21.5	21.1	19.6	26.1	21.9	21.3	22.3	26.4	20.7	23.0	24.1	19.8	17.8	53.9	30.8	15.8	15.9	19.0	19.6	23.4	30.3	15.9	17.2	22.5	23.4	24.4	13.0	24.9	29.3	40.4	19.6	24.5	16.9	28.3	8.8	26.4	16.4	15.8	22.5	20.8	20.5	23.3	21.6	23.0	13.2	23.6	23.2	27.2	13.0	24.8	20.1	21.9	26.5	51.3	40.3	45.4	63.1	53.2	64.5	39.5	56.3	66.1	50.1	67.5	31.4	44.1	53.7	32.5	69.4	41.7	36.6	45.0	94.1	62.7	61.7	31.7	37.4	33.9	55.5	31.1	33.7	47.1	46.2	34.0	42.3	42.5	47.7	64.1	10.9	27.3	34.3	86.9	31.6	43.4	52.2	24.1	37.4	23.9	45.2	80.2	74.4	72.7	47.5	16.0	25.7	52.3	33.7	49.7	37.1	40.9	55.6	65.0	37.4	29.1	45.4	57.4	26.3	43.3	36.3	48.5	48.5	48.4	18.3	12.6	11.3	9.6	12.5	10.6	31.3	8.0	10.0	17.2	40.1	6.6	8.8	15.4	9.6	17.3	14.2	10.4	8.1	21.1	26.1	22.3	26.4	19.6	23.4	23.4	24.4	24.5	23.3	23.6	26.5	31.6	44.8	33.7	82.3	59.0	15.8	22.1	28.1	22.8	16.2	18.8	14.1	29.0	10.0	37.5	31.3	22.9	30.9	37.1	36.9	25.4	35.8	12.0	27.7	38.8	33.3	19.2	27.3	59.7	38.0	38.7	32.0	35.2	40.8	32.9	26.1	23.2	17.0	39.5	20.2	57.3	34.1	26.4	41.9	24.8	20.2	15.8	47.3	26.6	118.0	66.5	21.5	32.0	86.5	231.0	43.5	25.0	16.6	44.0	20.7	30.0	27.2	29.8	27.5	26.3	36.2	28.5	16.1	10.1	28.9	23.4	29.8	39.9	31.2	28.0	22.2
AP3B2	NAPTB	ENSG00000103723	"Adaptor related protein complex 3 subunit beta 2"	Q13367	15	82659281-82710112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.7;pituitary gland: 18.8;retina: 33.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 27.1;Excitatory neurons: 61.7;Inhibitory neurons: 56.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 22.8;Rod photoreceptor cells: 58.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.5;NTERA-2: 9.5;RT4: 17.3;SCLC-21H: 29.0;SH-SY5Y: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039467, HPA039818"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039467: AB_10795143, HPA039818: AB_10795299"	"unprognostic (3.17e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.48e-6)"	"unprognostic (8.44e-2)"	"unprognostic (7.62e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.43e-2)"	0.7	4.5	15.3	0.9	18.6	1.1	1.4	15.5	20.7	0.9	0.0	1.1	0.7	1.1	2.3	0.7	0.9	0.4	0.2	19.6	5.5	0.6	0.2	0.3	0.5	15.6	5.4	1.2	2.1	12.7	18.8	0.6	13.2	1.4	0.6	33.0	0.9	1.4	0.3	0.9	0.9	1.3	1.1	0.7	1.1	6.2	4.7	1.0	2.1	0.4	1.3	0.8	0.6	11.3	0.2	0.4	9.5	3.2	1.6	0.2	5.7	0.5	0.0	0.8	0.2	0.4	0.4	0.8	4.9	0.2	1.8	0.9	1.0	0.0	0.2	3.2	0.7	0.3	0.4	0.2	0.3	0.4	1.8	1.0	1.1	0.1	0.7	0.1	0.0	2.8	1.0	0.7	0.1	2.5	0.3	0.5	9.5	0.1	0.1	0.3	0.0	0.2	0.0	17.3	29.0	17.5	3.2	1.4	2.4	1.0	0.2	1.9	0.2	0.3	0.9	0.4	1.3	1.6	8.8	0.7	2.2	0.5	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.3	0.2	0.9	0.1	0.1	0.4	0.0	0.1	15.3	18.6	15.5	20.7	19.6	5.5	15.6	5.4	13.2	1.1	4.7	11.3	0.1	0.0	1.1	20.9	0.1	0.4	2.1	0.6	1.2	18.4	1.5	2.3	0.8	0.0	0.1	0.0	27.1	0.1	0.2	0.1	0.0	0.2	8.0	0.2	0.6	0.1	13.9	0.0	61.7	0.4	0.1	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	13.5	56.9	0.5	6.1	0.0	0.6	5.4	0.9	0.1	0.0	4.7	0.0	4.1	0.0	44.7	22.8	0.0	0.1	0.4	1.2	0.7	0.0	0.4	0.0	58.6	0.0	1.3	0.7	9.8	3.1	0.7	0.1	0.0	0.1	0.2	0.0	0.6
AP5B1	"AP-5, DKFZp761E198, PP1030"	ENSG00000254470	"Adaptor related protein complex 5 subunit beta 1"	Q2VPB7	11	65773898-65780976	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 44.0"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"neutrophil: 25.0"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 25.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065739, HPA067880"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Golgi apparatus"	"HPA065739: AB_2685550, HPA067880: AB_2685914"	"unprognostic (3.64e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.67e-1)"	8.3	4.8	3.2	6.9	2.6	44.0	6.6	5.8	3.6	5.4	1.3	6.0	5.7	7.1	2.0	10.2	5.2	3.1	5.0	3.6	1.2	5.7	5.8	8.7	4.7	3.9	1.5	2.9	10.3	6.4	3.5	3.8	3.0	5.0	3.0	2.5	7.0	4.5	9.6	9.1	6.8	3.2	1.1	10.0	6.0	2.5	1.8	4.8	4.9	3.4	4.3	6.6	5.1	1.6	12.8	9.8	2.8	14.3	8.6	4.1	16.4	5.3	6.2	6.1	4.7	7.7	6.0	7.8	9.4	6.3	12.4	15.8	8.7	4.3	2.9	12.1	10.1	7.0	12.0	3.8	5.8	9.9	13.3	7.0	10.1	4.0	2.9	6.0	5.2	13.6	15.6	9.7	3.6	9.2	5.5	10.5	4.6	4.4	10.1	17.3	0.5	16.8	5.9	15.8	2.7	5.4	4.1	2.6	26.0	3.7	4.4	14.1	7.6	10.2	8.6	13.6	6.0	10.0	11.2	8.1	7.5	8.5	10.5	1.1	1.7	0.6	0.5	1.0	0.2	0.3	0.2	0.2	0.5	0.3	0.3	0.2	25.0	0.4	1.3	0.3	0.2	0.8	3.2	2.6	5.8	3.6	3.6	1.2	3.9	1.5	3.0	1.1	1.8	1.6	2.0	0.0	8.8	6.2	3.9	2.4	12.3	4.3	7.4	5.0	4.2	2.0	1.6	2.8	3.7	7.3	14.6	7.6	5.9	12.8	1.9	8.9	1.4	6.3	2.9	3.0	3.0	0.0	3.6	13.6	18.2	2.9	6.6	10.7	2.5	5.3	1.4	7.1	14.0	11.8	3.2	3.8	6.1	12.4	2.1	0.7	0.6	11.6	7.2	3.7	17.8	3.0	6.2	1.0	2.2	9.4	6.9	3.8	3.6	5.6	10.1	8.8	2.9	8.0	0.0	3.7	3.0	0.6	4.7	6.0	2.3	34.9	4.3	2.0	4.5	10.0
AP5S1	"C20orf29, FLJ11168"	ENSG00000125843	"Adaptor related protein complex 5 subunit sigma 1"	Q9NUS5	20	3820524-3828838	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034200, HPA043533, HPA048244"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328"	"unprognostic (1.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.91e-2)"	"unprognostic (5.15e-3)"	"unprognostic (8.17e-2)"	"prognostic favorable (5.53e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.09e-3)"	"unprognostic (5.08e-2)"	6.0	11.5	7.1	5.5	7.7	7.4	5.8	6.4	8.2	4.8	8.1	6.2	6.3	5.7	3.0	7.4	4.7	4.6	11.3	7.3	6.7	9.4	14.6	5.4	5.5	6.8	6.5	5.8	7.5	7.8	7.5	5.4	6.5	6.9	4.4	3.4	8.7	3.6	19.2	5.3	6.4	3.9	6.3	8.2	6.4	11.2	6.6	4.3	9.4	10.0	3.8	5.4	5.1	6.5	18.1	33.8	4.6	3.1	6.2	8.0	5.7	10.8	8.6	10.4	8.3	28.5	18.9	10.4	11.3	11.4	19.7	15.9	3.9	17.4	3.6	5.7	10.9	17.3	10.1	25.3	10.7	12.0	10.0	13.7	9.7	13.0	10.3	7.0	12.4	12.4	12.4	19.8	14.0	29.4	28.0	10.5	4.2	13.0	27.3	11.7	7.8	10.8	11.8	14.4	14.2	5.7	10.6	32.4	18.2	3.1	15.9	5.9	16.9	21.7	10.3	11.3	20.6	10.6	12.6	5.7	7.5	10.6	19.0	2.2	7.5	4.6	10.2	11.9	7.8	5.4	8.5	8.4	9.9	7.0	7.8	7.3	1.7	6.2	6.7	7.7	9.9	6.5	7.1	7.7	6.4	8.2	7.3	6.7	6.8	6.5	6.5	6.3	6.6	6.5	4.0	0.0	10.6	2.3	5.9	1.7	4.4	8.0	7.4	15.3	4.9	4.3	11.2	11.5	5.9	3.7	10.4	19.4	3.8	8.4	11.7	11.1	3.7	5.1	6.2	8.6	12.6	9.9	1.9	12.7	13.3	6.8	14.8	5.2	14.0	6.6	6.1	9.4	15.5	25.2	2.1	7.3	8.2	6.9	2.0	3.6	5.9	7.3	5.4	4.7	11.0	12.8	8.2	2.5	1.7	10.2	8.8	4.1	8.6	3.6	11.2	8.5	4.5	20.8	13.1	5.8	4.5	19.4	10.9	6.8	1.0	18.5	6.2	10.9	7.4	3.0
AP5Z1	"KIAA0415, SPG48, zeta"	ENSG00000242802	"Adaptor related protein complex 5 subunit zeta 1"	O43299	7	4775615-4794397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035693	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"	Nucleoplasm	"HPA035693: AB_10960687"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.01e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.19e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.22e-1)"	14.8	18.5	7.0	0.7	7.1	1.5	11.8	7.3	10.0	12.4	5.8	13.2	1.1	13.4	1.0	11.0	11.0	0.8	7.7	6.9	5.7	9.2	9.2	12.9	1.8	8.3	6.5	11.8	9.9	0.7	9.8	1.1	7.4	11.7	0.4	0.6	12.4	0.7	8.5	21.8	15.5	0.4	5.9	22.9	12.0	8.6	7.4	0.9	11.2	0.2	0.6	13.4	10.9	7.3	2.8	4.2	0.7	2.4	1.0	0.9	4.3	1.3	1.9	2.0	1.7	5.2	3.5	1.6	1.8	0.9	5.1	5.4	0.7	0.5	0.6	1.8	3.5	2.4	4.5	4.6	3.0	2.5	5.1	2.2	1.6	1.8	1.3	0.7	0.5	2.2	3.4	1.1	1.2	7.7	0.3	15.0	5.9	0.3	4.3	2.9	2.6	4.8	1.0	4.4	1.7	3.0	1.8	8.7	6.4	0.5	6.4	8.9	3.8	2.3	4.4	6.5	1.7	8.5	7.4	2.3	1.7	5.6	3.6	1.9	2.3	2.9	2.4	2.8	1.4	1.9	1.8	2.4	1.2	1.8	2.5	2.2	2.2	2.4	2.5	2.4	1.8	1.3	7.0	7.1	7.3	10.0	6.9	5.7	8.3	6.5	7.4	5.9	7.4	7.3	12.4	9.6	15.0	7.5	18.2	6.9	2.9	8.8	8.0	10.5	5.7	5.8	4.3	15.7	6.6	11.0	4.2	11.5	20.3	20.1	0.0	14.1	2.2	9.9	10.1	11.6	12.0	5.0	12.4	13.6	7.7	9.9	21.4	16.4	17.1	14.3	12.5	8.1	28.7	18.5	10.7	15.1	10.2	12.3	10.7	1.5	13.4	16.3	14.2	13.1	23.4	8.2	21.6	10.6	12.6	20.6	15.9	10.9	19.8	4.9	14.7	6.8	8.3	9.4	0.0	5.8	9.5	8.1	10.8	7.6	11.1	16.6	15.6	12.6	14.1	3.8
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645290-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.0"	"Cell type enhanced"	"Detected in many"		"monocytes: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 71.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	4.5	2.8	2.4	8.9	2.8	32.0	5.0	2.5	2.7	5.5	1.2	8.5	5.1	5.5	3.5	3.2	4.0	7.3	2.6	2.8	1.3	3.7	4.7	6.7	9.4	2.3	1.2	7.7	4.0	2.8	3.1	7.6	2.2	3.9	9.6	5.8	4.6	3.4	3.4	5.7	7.1	5.0	1.9	9.7	6.6	3.1	2.2	7.7	4.7	3.1	8.8	5.8	3.9	4.3	6.8	8.7	30.3	11.6	9.4	18.2	8.3	17.3	12.1	11.7	11.6	6.3	4.8	9.8	4.5	12.7	4.4	11.3	20.2	11.4	13.9	7.3	8.0	18.5	9.6	7.7	3.5	18.6	22.7	7.5	3.5	12.1	5.5	14.1	19.6	7.3	9.1	5.2	18.7	1.8	9.4	19.0	8.1	7.5	5.8	11.9	22.8	3.1	7.1	11.5	4.1	7.4	13.5	5.3	4.6	18.6	9.2	25.7	17.7	7.5	6.6	9.0	5.4	3.5	7.1	11.5	3.3	25.4	11.5	16.8	18.1	17.0	4.0	8.0	3.1	5.5	2.8	2.3	14.3	6.2	2.9	1.9	71.1	2.9	8.5	10.4	2.1	3.9	2.4	2.8	2.5	2.7	2.8	1.3	2.3	1.2	2.2	1.9	2.2	4.3	11.7	12.8	8.2	10.4	13.8	3.8	5.7	8.7	8.6	5.8	6.4	6.5	1.5	1.5	7.8	7.3	14.6	3.8	21.4	22.3	0.0	9.4	0.7	5.9	11.6	11.1	12.0	7.6	12.8	8.0	8.0	9.1	14.8	8.7	6.3	18.6	13.2	6.7	12.3	5.0	13.8	18.9	4.1	34.7	25.3	1.3	5.9	34.1	10.6	30.9	54.6	2.7	20.6	14.1	11.2	19.7	20.3	5.3	8.9	8.7	9.2	2.7	8.9	9.8	0.0	6.9	8.1	6.9	10.0	8.7	3.3	1.9	14.6	4.3	13.3	15.0
APC	"DP2, DP2.5, DP3, PPP1R46"	ENSG00000134982	"APC regulator of WNT signaling pathway"	P25054	5	112707498-112846239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 536.4;Bipolar cells: 196.9;Excitatory neurons: 165.8;Inhibitory neurons: 236.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013349, HPA013362"	Supported		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA013349: AB_1844913, HPA013362: "	"unprognostic (4.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	6.9	4.6	28.4	6.2	26.0	9.1	5.7	23.1	31.0	5.7	0.1	6.7	6.2	5.6	3.3	7.7	4.3	4.9	7.2	52.8	27.4	6.2	5.7	6.2	5.6	32.1	30.7	6.6	4.1	8.5	3.9	5.1	39.0	5.2	6.2	20.0	3.8	4.1	8.5	5.7	8.5	7.5	16.0	6.1	5.0	5.1	37.9	8.5	5.9	11.8	5.9	5.4	3.6	20.9	11.3	10.1	16.8	12.2	13.4	11.3	6.7	17.9	8.5	9.7	11.5	8.2	8.9	22.0	17.0	23.1	15.5	9.0	17.4	14.6	15.9	13.2	12.2	16.8	14.9	6.2	6.6	8.4	8.6	9.3	9.8	16.6	10.8	6.8	13.6	10.2	20.9	7.2	14.3	7.8	9.6	4.2	6.0	6.1	3.6	8.1	20.8	10.7	8.9	14.1	17.0	10.1	16.9	6.5	7.1	6.8	9.1	6.7	22.8	19.6	9.5	19.5	13.6	5.6	9.5	8.2	10.8	15.3	11.2	11.8	2.5	4.9	2.9	1.3	2.4	2.8	1.5	1.9	2.1	3.1	2.4	2.4	11.4	2.9	2.4	2.7	1.5	1.0	28.4	26.0	23.1	31.0	52.8	27.4	32.1	30.7	39.0	16.0	37.9	20.9	40.6	51.3	23.6	536.4	21.9	11.2	8.9	10.1	19.9	196.9	13.1	14.9	56.6	18.6	20.1	0.0	66.7	5.4	28.9	28.6	0.0	18.7	10.5	20.1	27.6	31.2	27.5	17.4	165.8	19.5	6.5	25.9	19.4	29.7	19.0	28.7	26.7	13.9	16.3	79.1	236.4	17.2	2.0	18.9	12.4	5.5	17.7	27.8	17.8	85.3	30.7	23.4	23.7	196.6	150.8	20.3	34.7	19.5	22.9	10.4	37.2	5.1	18.0	41.5	39.5	44.1	34.0	19.2	30.4	26.5	11.6	2.9	22.4	27.1	16.0	8.9
APEX1	"APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1"	ENSG00000100823	"Apurinic/apyrimidinic endodeoxyribonuclease 1"	P27695	14	20455191-20457772	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000956, HPA002564, CAB004294, CAB047307"	Supported		Supported	Nucleoplasm		Yes	No		330000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174"	"unprognostic (2.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (4.21e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.08e-2)"	83.9	103.6	56.9	82.8	58.1	154.9	103.2	60.0	67.5	80.4	57.9	89.1	107.5	97.2	66.5	80.5	99.1	79.7	76.6	57.5	60.3	82.8	104.6	61.0	112.4	58.9	58.3	146.3	92.2	88.3	39.3	57.3	59.5	69.3	92.7	52.9	66.0	80.2	102.9	83.4	73.0	95.7	59.5	68.9	85.4	21.5	60.1	125.0	93.2	71.9	121.2	103.8	65.8	62.6	249.3	296.8	267.8	247.2	180.9	259.3	226.5	227.3	245.7	333.3	287.4	216.9	240.7	477.9	198.4	176.4	178.1	262.5	317.5	242.1	304.8	214.7	135.9	195.5	162.8	368.9	189.5	623.1	193.2	270.6	261.6	217.6	212.6	267.2	282.3	193.9	228.4	153.6	270.7	240.0	404.7	264.7	260.3	282.4	269.5	441.5	297.7	200.8	281.7	327.1	315.2	201.8	248.5	305.2	253.1	185.0	186.4	276.7	186.0	175.0	292.8	177.9	216.6	203.1	375.8	327.7	77.8	390.7	224.7	0.9	106.7	7.5	79.6	93.4	108.4	154.8	98.9	95.4	208.6	140.5	133.1	117.7	6.8	97.6	60.1	235.6	65.8	200.3	56.9	58.1	60.0	67.5	57.5	60.3	58.9	58.3	59.5	59.5	60.1	62.6	63.8	64.1	57.6	11.8	120.3	106.4	101.1	192.9	136.1	57.5	131.3	136.8	50.1	111.5	117.1	68.0	41.7	200.1	114.1	32.4	150.6	152.7	19.9	65.0	161.1	75.6	120.0	135.6	20.6	104.5	212.6	88.7	72.9	82.0	81.6	165.5	42.1	70.8	175.6	28.6	19.5	85.4	138.4	96.7	89.4	5.8	80.5	95.2	64.0	11.2	121.9	77.4	75.2	22.6	19.4	78.2	73.1	64.3	71.1	60.4	66.2	170.1	64.6	51.6	52.6	87.5	174.2	8.5	43.0	106.4	97.0	101.5	75.1	198.4	157.6	76.8
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000363-55009057	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: AB_2680448"	"unprognostic (2.90e-2)"	"prognostic favorable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.63e-4)"	7.2	8.9	6.1	8.8	6.3	10.0	7.2	6.0	6.6	7.6	6.5	8.9	8.9	7.4	8.5	15.5	7.3	6.3	9.0	5.9	6.4	10.8	11.0	7.2	11.3	6.4	6.3	9.6	7.4	7.1	7.0	9.0	6.3	7.8	10.5	2.3	7.0	6.6	7.5	12.2	9.1	7.0	6.3	11.2	7.9	4.1	6.6	10.9	6.3	7.3	13.5	10.2	9.4	6.7	36.9	32.4	12.5	18.3	17.9	11.9	21.3	14.8	19.8	28.0	27.2	17.8	30.0	24.1	22.7	14.0	33.0	26.9	29.1	28.2	21.0	19.7	22.1	29.4	31.6	18.3	11.5	18.3	26.6	11.8	22.6	39.6	14.2	13.2	22.6	25.3	15.4	15.9	21.2	35.7	24.9	23.8	25.0	17.4	38.6	21.8	20.8	26.4	15.2	18.1	11.6	12.7	28.0	33.4	14.7	28.5	26.4	14.1	13.1	16.6	23.9	33.7	19.6	16.4	22.9	19.9	17.7	30.9	20.1	16.2	11.5	13.1	10.2	14.4	8.6	8.2	9.6	10.2	13.7	8.5	8.5	8.4	4.1	42.0	13.4	7.4	11.6	10.1	6.1	6.3	6.0	6.6	5.9	6.4	6.4	6.3	6.3	6.3	6.6	6.7	6.1	3.2	11.8	1.6	12.7	12.9	12.5	20.1	6.8	3.6	7.2	7.1	5.9	15.7	14.9	11.0	0.0	52.7	7.1	17.9	15.6	31.5	0.3	6.0	5.7	11.5	6.1	31.5	0.8	15.1	35.3	7.6	10.2	9.7	8.8	13.1	10.4	11.4	24.2	6.7	0.7	10.1	10.2	10.9	11.1	1.1	5.9	12.0	0.0	1.9	21.7	5.2	16.5	1.0	1.9	20.5	19.1	8.6	9.8	10.5	16.6	21.6	11.8	2.1	19.7	4.4	6.9	1.4	10.6	13.8	12.6	47.6	11.6	12.4	13.7	13.2
APIP	"APIP2, CGI-29, Mmrp19"	ENSG00000149089	"APAF1 interacting protein"	Q96GX9	11	34853094-34916379	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021188, HPA024131"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		52000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA021188: AB_10610977, HPA024131: AB_10602171"	"unprognostic (2.80e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.58e-2)"	30.4	25.4	14.7	20.7	17.1	14.4	20.7	17.3	17.1	18.0	14.2	19.9	13.6	15.0	15.0	13.8	17.2	18.5	20.0	13.9	16.3	27.0	19.4	21.2	20.2	18.7	16.4	12.3	17.2	15.8	9.1	13.3	18.4	16.8	19.5	16.8	31.7	23.6	65.6	10.0	16.3	12.3	17.1	15.5	18.8	10.7	16.0	31.3	24.6	38.3	16.3	19.1	9.6	20.9	25.1	27.3	33.5	8.3	27.7	26.8	14.5	36.8	38.0	38.9	44.4	15.6	21.3	77.1	21.7	15.5	40.3	28.8	56.1	24.9	53.3	49.9	56.3	39.5	27.8	42.6	41.2	111.3	28.9	23.6	20.6	22.1	40.7	19.1	29.8	49.8	94.2	45.2	27.6	24.2	59.7	57.7	25.1	39.6	61.7	36.4	89.1	29.6	46.8	36.3	28.5	13.6	45.0	37.2	50.2	17.4	38.9	34.3	24.1	29.2	26.9	68.1	9.0	43.9	36.1	89.4	32.2	27.3	37.2	11.3	27.3	25.4	17.2	30.0	21.3	24.5	21.1	18.8	42.7	24.3	21.4	18.3	6.7	31.4	36.8	27.2	27.2	18.4	14.7	17.1	17.3	17.1	13.9	16.3	18.7	16.4	18.4	17.1	16.0	20.9	24.7	35.3	30.1	42.4	27.9	25.0	37.5	62.7	19.4	28.8	73.8	36.2	23.1	37.1	63.0	18.4	4.2	37.2	25.5	49.5	187.9	30.2	8.0	33.4	23.9	22.8	35.5	42.5	28.4	32.4	23.4	24.4	29.6	24.8	20.3	22.0	21.0	26.0	76.5	18.5	35.2	41.3	87.5	47.1	31.8	8.3	23.9	47.6	21.4	17.8	59.4	23.1	25.7	51.3	108.8	25.4	28.4	24.8	44.2	33.0	35.0	101.7	56.8	21.6	39.5	37.8	30.1	32.4	22.3	31.4	26.3	26.4	25.8	27.1	50.1	50.4
APLF	"C2orf13, MGC47799, Xip1, ZCCHH1"	ENSG00000169621	"Aprataxin and PNKP like factor"	Q8IW19	2	68467572-68655862	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 103.7;Late spermatids: 164.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029396, HPA034642, HPA034643"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA029396: AB_10610285, HPA034642: AB_2674259, HPA034643: AB_10602431"	"unprognostic (9.37e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.29e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.39e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.44e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.85e-3)"	1.2	1.1	2.0	0.8	3.2	0.7	1.4	0.1	2.2	1.1	0.0	1.1	0.6	1.3	1.0	1.5	0.5	1.0	0.9	2.7	1.9	0.9	1.5	0.9	1.2	0.7	2.2	0.9	0.6	0.9	0.4	1.8	1.0	1.1	0.8	0.4	1.1	1.3	1.1	2.3	0.5	1.1	0.9	0.8	0.7	1.0	1.5	0.8	1.1	1.3	1.2	1.0	1.4	3.2	1.8	0.3	1.7	1.8	3.4	4.4	1.0	1.7	3.6	1.1	1.4	0.7	1.1	3.4	1.1	1.7	2.2	0.5	0.3	2.7	2.7	2.9	0.4	2.5	0.1	0.4	1.5	0.8	2.4	2.4	2.2	1.7	2.5	2.2	0.8	1.7	0.2	2.8	1.2	0.2	1.3	3.1	1.1	1.8	0.9	1.5	0.6	1.6	2.4	1.0	0.4	1.1	1.8	0.0	1.7	2.6	0.0	0.6	1.2	3.4	0.6	1.5	1.3	2.0	0.9	2.4	1.5	0.8	2.0	7.0	0.5	1.9	0.4	0.7	0.6	0.6	0.8	0.7	0.8	0.5	0.8	0.4	0.0	1.0	0.6	0.7	1.4	0.5	2.0	3.2	0.1	2.2	2.7	1.9	0.7	2.2	1.0	0.9	1.5	3.2	3.6	3.2	2.6	14.0	3.1	2.4	2.4	4.4	8.0	0.5	2.4	3.6	3.5	0.0	2.9	0.0	2.1	6.3	2.6	0.3	0.0	3.5	103.7	1.4	4.0	3.1	3.5	3.4	21.8	1.9	2.2	3.2	4.6	1.7	0.0	3.9	2.2	1.2	2.2	3.3	3.2	0.7	2.0	1.9	2.6	164.1	4.4	2.3	0.0	9.4	4.2	0.5	3.1	22.6	29.0	1.4	0.5	1.9	6.4	2.8	0.2	2.2	1.3	0.2	0.0	4.8	4.7	7.7	4.8	5.0	3.3	4.9	1.8	2.2	0.7	1.5
APLP1	APLP	ENSG00000105290	"Amyloid beta precursor like protein 1"	P51693	19	35867899-35879792	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Endocytosis"	Heparin-binding	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 1201.6"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 147.1;Horizontal cells: 161.5;Oligodendrocytes: 461.3"	"Cancer enhanced"	"Detected in many"		"glioma: 63.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 81.6;AN3-CA: 162.9;HMC-1: 76.0;SCLC-21H: 87.2;SH-SY5Y: 89.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028970, HPA028971"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		6400000	"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA028970: AB_2672847, HPA028971: AB_10601334"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.36e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (7.32e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-11)"	"unprognostic (1.38e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (2.65e-5)"	3.0	31.5	417.1	3.1	718.0	0.4	1.4	680.9	552.4	3.1	218.6	4.4	1.8	3.1	1.3	1.5	2.7	5.5	10.8	438.3	465.8	4.9	0.6	1.9	1.4	783.2	627.4	1.4	75.0	22.3	151.4	0.9	710.7	2.1	2.2	56.3	1.8	1.9	0.5	1.1	2.1	3.2	605.9	0.5	28.1	13.1	598.3	0.8	1.5	0.5	1.5	1.2	2.1	1201.6	4.4	40.0	81.6	162.9	7.1	3.2	10.4	5.6	3.5	7.8	1.1	7.3	6.3	0.8	66.5	21.0	27.7	2.2	26.1	2.6	5.2	48.9	3.7	0.3	10.6	5.2	2.0	0.2	76.0	3.6	1.8	3.2	0.1	28.8	3.1	6.1	2.7	1.2	25.0	8.3	0.2	0.3	3.9	16.5	16.5	7.2	0.4	1.1	1.4	1.1	87.2	89.3	23.1	3.8	0.8	23.9	20.8	4.3	1.3	61.3	28.8	32.9	4.3	2.4	1.6	0.3	42.3	1.1	33.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	417.1	718.0	680.9	552.4	438.3	465.8	783.2	627.4	710.7	605.9	598.3	1201.6	2.5	6.4	0.0	12.4	0.6	1.3	2.6	0.7	1.2	147.1	0.4	1.1	6.2	1.5	0.2	0.0	12.5	0.3	0.3	0.4	0.0	2.0	27.6	1.3	1.2	2.8	34.9	0.0	55.5	4.2	6.4	2.8	10.2	3.2	0.0	0.1	0.7	0.4	0.4	161.5	46.8	1.1	2.0	0.3	1.6	15.8	1.2	1.1	5.4	12.2	0.0	14.6	0.0	19.1	461.3	3.1	0.1	0.0	0.4	1.9	0.0	0.1	0.2	38.6	0.0	1.9	1.8	14.5	28.7	0.1	0.6	0.4	0.5	0.1	0.2	1.3
APOBEC3A	"ARP3, PHRBN"	ENSG00000128383	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3A"	P31941	22	38952741-38992778	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 93.9;lymphoid tissue: 48.3;urinary bladder: 24.4"	"Cell type enriched"	"Detected in many"	4	"Urothelial cells: 426.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 11.3;head and neck cancer: 15.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 1014.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 1014.5"	"Not detected"	"Not detected"											"HPA043237, HPA056980, HPA066719"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (6.45e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-3)"	"unprognostic (9.01e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.91e-1)"	7.9	0.4	0.5	20.9	0.5	93.9	0.8	0.7	1.1	2.2	0.8	1.5	1.4	0.4	0.3	12.2	4.2	6.3	1.4	0.9	0.5	0.7	2.0	13.4	1.1	0.6	0.4	0.2	1.5	0.4	0.3	3.5	0.7	0.4	0.6	0.2	6.7	0.3	0.5	0.6	0.8	1.7	0.3	48.3	1.1	0.2	0.5	2.4	1.0	3.7	21.1	24.4	10.3	1.0	0.1	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.6	0.3	34.7	223.9	8.4	0.7	1014.5	1.5	3.1	0.6	0.7	10.4	0.8	0.7	0.7	121.7	0.9	298.5	1.3	1.0	149.1	0.5	0.5	0.7	1.1	0.9	0.5	0.6	0.4	0.7	0.3	0.5	1.0	0.7	28.9	33.6	0.0	0.5	1.3	16.0	1.8	0.0	0.6	0.7	0.3	0.1	0.0	24.1	1.8	4.2	0.3	0.2	17.5	0.0	0.1	0.6	0.5	0.2	1.4	0.0	8.0	0.0	0.2	0.3	6.3	0.0	0.6	25.9	0.3	0.7	0.4	14.9	0.0	0.0	0.0	2.0	18.8	41.4	0.1	0.3	91.3	16.0	0.0	17.9	0.8	2.1	0.0	0.0	1.3	27.4	0.4	15.6	6.7	4.5	0.2	10.7	0.8	0.0	1.0	1.2	0.1	0.4	48.7	6.8	0.3	3.1	0.2	1.7	426.0
APOBEC3B	"FLJ21201, PHRBNL"	ENSG00000179750	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3B"	Q9UH17	22	38982347-38992804	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.4;intestine: 12.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 11.8;Ductal cells: 14.7;Erythroid cells: 14.1;Plasma cells: 26.2;Urothelial cells: 11.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 256.0;Karpas-707: 283.6"									"HPA056980, HPA066719"			Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (2.92e-2)"	"prognostic favorable (2.58e-5)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.47e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-1)"	0.9	1.2	0.1	5.7	0.1	28.4	2.0	0.1	0.2	1.2	0.1	12.1	7.3	1.0	0.4	3.0	0.7	1.1	0.8	0.1	0.1	2.7	1.1	1.9	5.9	0.1	0.1	0.7	3.3	1.2	0.2	1.6	0.1	0.4	12.0	0.3	2.8	0.2	0.4	2.1	4.3	1.4	0.1	6.4	4.1	0.3	0.2	2.5	1.3	0.2	8.6	7.6	1.5	0.2	256.0	28.0	10.5	68.1	1.5	6.0	18.6	23.0	19.7	43.0	56.5	54.7	46.6	3.0	20.4	22.9	63.0	108.2	1.3	4.5	43.1	92.1	2.5	72.5	5.6	14.0	0.7	61.7	43.0	2.3	0.5	45.1	2.2	8.9	17.0	0.0	41.6	283.6	68.1	6.9	0.2	35.3	0.3	24.6	25.2	1.8	105.0	95.6	9.1	42.2	1.8	0.0	0.0	0.3	16.0	1.8	33.0	18.1	10.2	48.0	81.9	7.5	0.7	62.8	18.0	0.3	34.4	68.2	100.7	0.4	1.0	0.0	0.2	4.9	0.0	7.2	0.5	0.3	0.6	3.1	0.0	0.3	1.4	1.7	1.7	0.0	2.8	3.5	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	1.7	0.0	2.2	5.4	3.2	11.8	0.6	0.0	1.5	0.5	0.3	0.0	8.1	0.0	0.0	1.0	0.4	4.6	0.0	14.7	0.0	5.9	0.6	0.2	0.0	14.1	0.0	1.8	1.8	0.8	3.1	5.3	0.0	0.8	0.4	0.0	2.1	0.0	0.0	0.4	10.2	1.2	6.3	0.0	0.0	2.3	7.2	0.0	1.4	0.0	0.0	0.0	0.0	6.0	9.9	0.0	26.2	1.4	0.4	0.3	9.3	0.0	0.0	0.0	0.9	0.0	0.0	4.2	3.3	0.8	0.5	0.1	1.6	11.4
APOBEC3F	"ARP8, BK150C2.4.MRNA, KA6"	ENSG00000128394	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3F"	Q8IUX4	22	39040604-39055972	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.9"									HPA073637			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA073637: "	"unprognostic (1.38e-3)"	"unprognostic (1.28e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (8.28e-4)"	2.2	6.3	2.2	9.2	2.1	3.3	2.5	2.2	2.7	4.0	3.4	3.5	3.7	4.1	6.3	2.4	8.3	3.5	5.5	2.0	2.2	3.4	2.9	3.4	15.7	3.1	2.6	8.8	3.0	5.2	3.4	2.2	2.8	4.8	2.8	1.1	4.9	5.2	0.6	1.6	3.8	4.5	2.3	11.9	4.8	8.2	2.5	5.3	3.0	1.3	14.5	4.5	3.2	2.9	4.9	4.2	1.8	6.2	4.9	7.1	2.2	4.2	6.9	8.8	14.0	3.9	9.1	12.9	4.1	8.9	7.7	6.5	1.7	6.0	3.8	11.7	5.3	16.5	0.5	2.5	8.6	3.6	7.0	9.5	3.0	5.0	1.5	5.1	8.5	3.5	1.3	19.9	4.8	3.9	4.0	2.7	0.8	0.5	0.7	6.1	0.7	2.5	8.1	6.6	0.9	1.5	4.7	1.2	2.5	3.5	4.7	1.9	2.3	2.0	5.0	0.4	2.0	3.4	1.7	0.5	5.6	1.9	3.1	3.2	4.7	9.4	8.5	9.1	9.8	27.7	5.6	9.0	6.0	34.2	3.4	5.6	3.1	14.6	14.5	4.6	8.4	7.4	2.2	2.1	2.2	2.7	2.0	2.2	3.1	2.6	2.8	2.3	2.5	2.9	1.6	0.0	0.5	0.0	9.8	0.9	4.9	6.3	2.2	0.0	2.1	2.2	5.9	8.6	4.2	0.0	0.0	2.0	7.6	0.8	1.9	7.4	2.4	4.8	3.8	2.6	1.2	2.1	0.1	3.9	1.4	2.9	2.6	3.6	2.5	11.0	3.6	1.6	5.9	0.0	0.0	2.2	4.1	2.2	1.4	5.2	5.0	2.8	5.4	2.8	5.3	2.2	8.2	0.5	0.0	4.8	3.6	6.4	9.6	4.5	0.5	5.3	4.6	0.2	0.0	1.0	2.6	0.3	0.4	1.6	0.9	1.6	5.4	7.8	1.5	5.9
APOBEC3G	"bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019"	ENSG00000239713	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3G"	Q9HC16	22	39077067-39087743	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 45.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 145.4;monocytes: 69.1;NK-cells: 251.3;Plasma cells: 69.5;T-cells: 120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.0;Daudi: 38.3;HDLM-2: 31.8;Karpas-707: 44.2"									"HPA001812, HPA073637"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA001812: AB_1078175, HPA073637: "	"prognostic favorable (4.78e-4)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.18e-3)"	"prognostic favorable (6.03e-5)"	"unprognostic (2.37e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.13e-3)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (8.66e-13)"	"unprognostic (3.41e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.91e-2)"	"prognostic favorable (6.30e-4)"	5.5	8.1	3.3	21.7	3.2	15.9	8.6	3.4	4.6	7.7	2.9	7.6	5.5	10.3	10.4	6.1	21.1	11.1	4.3	3.0	4.0	4.1	5.7	14.5	45.9	3.9	3.7	22.7	1.7	4.8	3.5	5.0	3.9	7.8	9.4	1.4	8.5	22.4	1.2	1.6	9.6	9.6	4.0	28.2	10.0	20.1	3.4	25.9	5.8	2.7	35.1	15.7	6.4	4.5	4.5	0.1	0.0	0.0	5.0	9.7	0.3	1.0	16.8	19.9	30.0	1.6	22.6	38.3	0.5	7.3	11.6	0.1	0.2	1.3	6.0	31.8	0.1	23.1	0.0	0.2	21.8	7.1	10.1	14.3	0.5	10.9	2.4	0.0	2.4	1.2	1.9	44.2	3.1	0.0	7.6	7.7	0.6	0.0	1.7	15.3	0.0	25.8	0.0	19.6	0.0	0.0	0.5	0.0	2.0	1.7	0.0	13.2	0.0	2.8	0.2	0.0	0.0	0.0	3.5	0.5	3.2	6.9	5.0	30.7	42.3	28.7	363.8	98.1	207.6	84.9	108.8	281.7	52.4	66.1	34.3	160.2	34.8	232.2	123.0	28.1	92.3	297.8	3.3	3.2	3.4	4.6	3.0	4.0	3.9	3.7	3.9	4.0	3.4	4.5	8.4	3.2	8.9	1.0	55.7	1.8	15.5	27.0	4.6	0.4	3.0	6.6	3.7	7.2	14.4	0.0	2.1	3.9	145.4	0.6	5.9	11.7	47.2	5.7	6.4	8.9	6.0	8.6	0.1	2.3	1.1	10.0	2.0	3.9	12.6	62.5	11.4	0.9	30.6	0.0	0.1	1.9	10.2	20.4	9.8	13.7	19.0	21.3	7.2	3.7	69.1	8.1	251.3	0.5	0.0	2.2	1.8	9.1	69.5	16.0	0.1	2.1	12.1	1.2	19.7	4.7	10.1	1.3	1.6	2.0	1.3	1.0	120.5	20.3	1.5	18.0
APOBEC3H	ARP10	ENSG00000100298	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3H"	Q6NTF7	22	39097224-39104067	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.6;dendritic cells: 9.6;Hofbauer cells: 4.9;monocytes: 10.5;NK-cells: 6.2;T-cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.2;MAIT T-cell: 9.4;memory CD4 T-cell: 12.1;memory CD8 T-cell: 19.4;naive CD8 T-cell: 8.9;NK-cell: 19.7;T-reg: 11.9"	"Group enriched"	"Detected in many"	13	"NK-cells: 19.7;T-cells: 23.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HDLM-2: 2.7;Karpas-707: 6.9;U-266/70: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021492, HPA058565"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA021492: AB_10964888, HPA058565: "	"unprognostic (7.09e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.81e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.73e-12)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (8.43e-7)"	0.7	0.8	0.3	2.3	0.5	3.6	0.6	1.0	0.7	0.7	0.0	1.8	0.5	0.8	3.6	1.1	1.3	1.6	0.5	0.3	0.3	0.8	0.6	2.4	3.8	0.7	0.4	0.5	0.3	0.6	0.7	1.0	0.6	0.7	3.3	0.6	0.9	1.5	0.6	0.5	1.2	1.2	0.2	3.1	0.9	1.6	0.5	2.9	0.7	0.0	2.1	1.4	0.6	0.5	0.0	0.5	0.0	0.0	0.0	0.2	2.0	0.0	0.1	0.2	0.0	0.0	0.2	2.8	1.0	0.3	0.0	0.1	0.0	0.6	0.0	2.7	0.3	0.7	0.1	0.0	0.2	0.0	2.0	1.8	1.6	0.2	0.2	0.2	0.0	0.1	0.0	6.9	0.9	0.9	1.4	0.2	0.0	0.0	0.0	1.6	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	4.8	0.7	0.2	0.2	1.2	0.1	0.1	0.3	0.0	23.2	0.5	9.4	1.4	12.1	19.4	0.2	0.4	0.6	8.9	0.0	19.7	1.6	0.0	11.9	4.7	0.3	0.5	1.0	0.7	0.3	0.3	0.7	0.4	0.6	0.2	0.5	0.5	0.4	0.0	4.2	0.0	1.6	0.1	0.6	0.9	1.2	0.0	0.2	0.3	0.1	0.0	2.4	0.0	0.0	6.6	9.6	0.1	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.3	0.0	0.6	0.1	0.5	0.1	3.8	0.1	0.4	0.2	4.9	0.0	0.2	0.0	2.0	1.0	0.6	0.5	0.0	1.0	0.0	0.0	10.5	0.0	6.2	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.9	0.1	0.2	0.2	0.0	1.5	20.8	0.0	0.0	0.5
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 27649.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 84691.9"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 107.3;Hep G2: 296.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	45000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			4.1	1.2	0.0	1.0	0.0	0.0	2.5	0.0	0.1	0.4	0.0	7.2	907.0	0.5	0.0	1.1	1.9	0.0	1.6	0.0	0.0	18.2	27649.0	1.4	0.9	0.0	0.0	0.8	2.4	0.0	0.8	0.9	0.0	0.6	0.0	0.0	0.6	0.0	0.6	1.2	1106.7	0.5	0.0	8.0	1.5	1.0	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.1	107.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	296.2	0.0	10.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	2.3	0.2	0.0	0.0	0.0	6.3	3.9	0.0	0.1	1.1	3.8	4.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	3.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	674.9	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	4.2	0.0	0.0	39.7	0.0	823.7	0.0	0.4	1.5	0.1	0.0	0.0	0.0	0.3	707.9	84691.9	1.1	0.0	0.0	264.5	0.0	1107.4	0.0	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.0	0.0	0.0	0.0	10473.3	121.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	39.8	0.0	135.5	0.0
APOL6	"APOL-VI, APOLVI"	ENSG00000221963	"Apolipoprotein L6"	Q9BWW8	22	35648446-35668404	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.9;NK-cells: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB028574, HPA029165, HPA029167"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832"	"unprognostic (7.25e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.76e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (6.61e-4)"	23.4	7.3	4.1	15.8	4.3	16.1	10.0	3.4	4.0	6.8	3.3	13.2	19.2	5.5	5.5	5.9	6.6	9.1	4.2	3.9	5.1	6.4	46.5	15.5	15.5	8.7	5.0	12.2	2.9	2.6	2.4	7.8	5.8	7.9	11.8	2.6	14.0	5.1	3.1	4.5	19.7	7.4	6.7	18.2	14.0	2.3	4.9	10.1	8.5	3.9	10.4	13.2	3.7	5.4	12.8	4.1	0.3	1.5	30.1	15.0	17.3	5.3	14.2	17.3	21.7	2.0	14.2	17.7	2.6	14.0	12.6	16.2	0.1	8.6	4.5	33.6	0.1	7.4	2.6	4.0	23.7	10.4	12.4	19.3	5.7	5.9	3.3	3.9	3.6	8.0	0.8	31.2	3.2	1.3	14.6	3.2	0.5	0.9	5.3	6.1	6.8	8.7	7.6	28.9	0.4	0.2	8.5	7.2	10.0	1.1	1.2	12.1	3.9	4.3	2.6	3.0	2.8	16.4	14.2	1.7	8.1	16.2	6.1	7.5	4.8	2.6	7.3	7.6	6.1	1.0	4.8	5.8	2.4	0.7	4.6	5.3	7.5	5.0	8.5	0.3	5.5	4.2	4.1	4.3	3.4	4.0	3.9	5.1	8.7	5.0	5.8	6.7	4.9	5.4	58.6	70.5	34.3	6.8	15.7	8.0	10.8	14.7	13.6	0.2	16.8	10.8	7.3	34.3	38.6	12.9	0.0	8.3	79.1	101.1	9.8	33.6	10.5	18.4	48.9	33.4	47.3	11.6	0.2	41.9	35.6	33.4	41.8	17.2	36.8	12.2	39.3	135.9	34.9	0.0	1.3	55.3	20.3	58.1	19.9	7.4	26.1	50.5	8.8	17.8	68.5	3.8	126.7	9.5	2.1	45.7	43.7	18.8	51.0	43.2	88.6	31.6	47.4	0.0	0.0	25.3	22.0	0.5	0.2	15.6	5.3	2.5	67.7	6.0	35.9	62.0
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 124.5"	"Cell type enriched"	"Detected in many"	4	"Adipocytes: 781.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 24.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 36.7;HDLM-2: 19.3;hTERT-RPE1: 15.1"	"Group enriched"	"Detected in all"	4	"basal ganglia: 5.7;olfactory bulb: 20.1"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Approved	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA052462: AB_2681841, HPA058882: AB_2683844"	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	124.5	15.6	35.2	15.4	28.7	0.3	90.6	29.8	41.8	43.8	22.5	12.4	3.9	15.7	2.3	35.3	30.5	34.4	55.8	26.9	30.7	20.0	17.7	17.1	5.6	37.6	34.0	6.9	24.0	28.0	10.5	86.6	38.1	12.8	12.0	5.8	10.3	5.6	34.3	18.4	10.7	52.5	30.3	6.1	12.1	3.0	43.6	10.6	64.8	28.8	3.3	28.3	18.1	29.3	6.4	0.2	36.7	1.2	1.1	2.1	0.3	6.0	9.9	6.0	8.7	2.4	6.5	2.0	0.5	2.3	2.1	2.0	1.4	0.3	10.1	19.3	1.4	0.5	2.0	0.0	2.2	1.0	0.6	1.4	1.7	2.1	4.7	15.1	4.6	3.5	0.5	2.5	3.1	1.3	1.0	1.1	0.2	1.5	1.1	2.9	0.8	0.9	0.7	0.6	3.1	3.4	5.7	0.5	13.6	0.6	0.2	3.1	5.6	1.3	2.0	8.1	5.5	1.8	0.9	1.4	2.0	4.0	6.9	2.2	0.3	0.2	0.3	0.1	0.4	1.0	0.7	0.5	0.2	0.8	0.5	0.3	1.6	0.3	0.2	0.6	1.1	0.1	35.2	28.7	29.8	41.8	26.9	30.7	37.6	34.0	38.1	30.3	43.6	29.3	781.6	6.4	5.3	17.3	15.9	18.1	2.5	1.4	6.8	4.4	5.4	5.8	11.9	4.3	5.9	0.0	4.2	2.9	13.3	5.3	0.0	1.1	2.9	0.7	7.2	169.4	3.6	18.9	5.3	0.4	1.4	25.0	1.1	1.3	7.6	5.8	62.4	3.8	6.6	3.3	7.0	6.3	2.0	14.2	27.1	2.1	4.4	6.6	28.4	32.8	5.9	39.6	29.9	5.0	28.5	1.2	0.6	0.4	5.7	2.9	2.3	0.5	5.4	4.8	111.7	17.5	193.5	5.5	1.0	2.3	15.5	1.0	18.3	1.1	9.3	3.7
APPBP2	"Hs.84084, KIAA0228, PAT1"	ENSG00000062725	"Amyloid beta precursor protein binding protein 2"	Q92624	17	60443158-60526242	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 391.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 110.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066852, HPA078370"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA066852: , HPA078370: "	"unprognostic (1.43e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.93e-2)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (7.67e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.90e-3)"	"unprognostic (6.87e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.36e-2)"	14.9	11.2	13.6	10.2	15.3	4.1	11.3	14.9	15.4	11.7	11.9	10.4	7.3	12.8	9.5	10.3	10.0	11.6	7.0	12.0	14.1	13.1	11.0	9.5	8.7	12.6	13.6	19.6	11.5	14.4	8.0	12.2	13.8	13.7	9.1	17.3	8.5	10.1	9.4	8.7	7.2	11.8	14.6	12.0	10.8	23.5	14.4	10.3	12.8	9.8	8.2	10.0	8.8	22.0	16.5	21.9	22.6	19.0	23.7	24.7	12.6	25.4	17.5	13.9	17.6	10.7	14.0	17.0	41.7	21.4	24.0	13.8	16.2	8.8	24.4	15.3	12.4	21.6	20.1	22.5	25.2	18.1	23.1	24.4	11.4	14.6	14.1	21.6	21.9	10.5	16.5	19.3	20.4	110.4	25.5	9.2	5.0	17.9	9.7	16.8	37.8	20.0	21.5	26.7	24.6	21.0	22.0	3.7	18.2	12.5	30.4	12.3	28.4	31.1	37.6	21.7	19.5	20.5	70.8	14.3	20.6	10.5	22.4	13.8	9.5	12.0	7.4	7.1	8.4	7.2	8.7	8.2	9.3	9.7	11.8	8.9	11.9	12.5	12.2	5.6	9.3	7.5	13.6	15.3	14.9	15.4	12.0	14.1	12.6	13.6	13.8	14.6	14.4	22.0	32.8	28.9	24.0	55.5	20.9	18.0	15.6	18.6	21.6	59.4	18.8	15.0	27.3	20.0	20.8	14.7	18.8	27.4	24.0	17.0	19.6	19.7	391.3	21.3	33.6	29.3	33.0	5.9	57.8	16.6	8.9	30.1	13.7	27.3	22.9	40.6	40.0	21.7	19.8	37.0	65.4	22.1	20.3	19.4	14.9	126.2	35.4	17.7	17.8	44.0	22.5	44.4	16.5	55.8	132.0	16.9	13.2	39.1	17.1	24.7	15.9	30.2	19.5	34.9	39.5	32.1	31.6	56.3	33.3	15.3	18.5	63.2	20.8	42.0	20.4	18.1
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811937	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	118.5	161.2	30.1	73.6	30.1	103.1	112.3	32.0	39.5	109.6	39.3	121.0	72.2	81.2	25.5	231.1	87.6	31.4	70.2	29.9	32.0	128.7	190.4	85.8	83.8	32.9	31.3	73.3	169.4	66.1	64.9	37.0	32.1	113.6	40.2	5.1	119.8	44.6	62.7	240.1	106.8	29.8	33.7	128.6	131.8	35.2	35.1	77.2	96.9	23.8	64.5	95.7	153.7	35.7	157.9	228.3	44.9	200.4	54.2	106.0	232.2	117.1	105.0	136.0	52.6	237.6	189.0	145.5	221.9	68.4	65.0	165.3	74.8	195.4	27.5	102.9	417.7	124.3	106.5	253.0	168.1	87.4	97.7	113.1	207.6	109.0	139.4	63.7	172.6	244.6	266.6	107.9	71.4	586.0	242.1	254.7	169.4	169.5	288.8	259.2	69.2	351.5	156.3	107.0	218.2	132.4	223.5	130.7	131.2	41.9	427.9	171.1	111.4	122.5	104.9	99.5	118.0	205.9	186.5	408.8	179.9	228.4	110.5	77.7	544.5	202.8	474.5	473.5	631.7	501.1	612.0	510.3	562.4	517.3	557.8	475.3	31.8	501.8	322.1	731.6	551.8	998.0	30.1	30.1	32.0	39.5	29.9	32.0	32.9	31.3	32.1	33.7	35.1	35.7	146.5	115.4	147.4	5.9	247.0	319.0	320.0	375.7	207.7	19.9	346.2	479.7	46.9	230.2	206.8	92.0	6.2	265.0	262.3	273.1	406.9	404.3	11.8	124.6	180.3	163.1	210.8	150.6	5.1	442.6	401.5	170.3	192.7	148.4	131.9	154.9	147.8	309.6	348.0	15.2	4.4	386.4	160.7	253.9	336.1	35.4	239.9	214.6	297.1	3.7	449.4	78.7	355.3	2.5	7.2	392.3	228.3	135.4	171.6	404.3	349.2	647.9	125.5	20.4	39.5	135.6	186.5	18.4	126.9	358.8	494.7	172.7	285.7	339.5	426.7	385.2
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32886601-33025130	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	9.7	14.8	14.6	7.0	14.8	11.0	10.4	14.8	20.2	9.1	13.9	10.2	8.6	8.6	7.6	14.7	8.9	4.9	9.9	14.8	15.0	13.6	15.6	9.3	8.1	14.7	14.6	8.5	9.6	12.1	7.6	7.8	15.0	9.6	11.2	8.0	9.0	6.6	9.8	15.3	8.3	8.6	14.2	8.9	9.7	14.7	15.2	9.3	7.0	6.9	11.0	10.4	9.6	15.0	36.2	26.1	18.4	17.1	19.0	17.4	25.6	24.8	26.0	28.7	31.5	35.1	12.7	27.8	14.6	21.1	18.4	19.4	33.7	32.8	35.1	39.2	11.2	17.9	32.5	37.8	24.4	29.4	15.1	23.8	36.3	32.5	37.9	16.9	26.8	20.2	27.0	24.2	26.0	15.6	24.4	43.2	33.5	24.4	29.0	21.2	14.4	21.5	25.2	21.2	15.6	11.1	21.4	18.0	15.5	17.9	23.0	11.4	17.7	16.2	21.1	29.9	25.0	11.1	21.2	27.5	23.4	23.8	13.2	3.3	14.7	13.4	12.2	15.6	15.2	16.3	12.8	14.6	17.6	16.1	16.0	12.1	5.9	23.1	21.7	15.2	17.3	16.1	14.6	14.8	14.8	20.2	14.8	15.0	14.7	14.6	15.0	14.2	15.2	15.0	14.8	19.2	29.0	31.3	16.9	16.7	23.1	32.9	22.2	15.2	17.9	17.0	14.9	21.5	23.1	9.2	10.4	27.7	15.1	12.6	29.4	25.3	55.6	19.7	18.3	13.3	16.8	20.0	27.3	28.2	27.7	15.6	19.4	18.1	16.5	17.8	8.9	21.4	18.8	13.5	29.0	15.3	34.6	14.7	9.9	48.7	13.4	15.0	14.2	15.9	19.3	18.3	15.5	23.6	43.0	31.9	6.8	10.5	28.3	24.0	13.9	31.7	25.4	16.6	13.1	13.5	20.2	42.2	26.9	25.8	21.2	27.9	15.9	20.5	16.3	23.1
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610356	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.6;liver: 16.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 42.0;Hepatocytes: 35.9;Late spermatids: 65.0;Muller glia cells: 30.7;Proximal enterocytes: 33.2;Spermatocytes: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;GAMG: 12.3;Hep G2: 13.6;OE19: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	13.2	3.4	0.7	3.0	0.6	1.2	4.6	3.3	0.8	1.0	2.3	28.6	0.8	1.0	0.4	0.8	1.2	0.8	2.6	3.4	6.0	16.1	0.5	0.8	3.3	3.1	6.0	4.0	0.5	1.5	0.8	3.5	4.0	2.1	5.6	0.7	0.4	0.9	0.9	25.3	0.4	2.7	0.9	2.4	8.1	3.0	0.1	1.5	0.2	0.1	0.8	0.6	3.0	1.0	3.4	1.4	2.2	3.1	0.8	1.3	1.6	0.8	1.6	0.7	8.2	1.6	1.6	0.7	0.8	12.3	0.9	0.6	0.1	0.8	4.7	1.2	1.3	1.3	13.6	1.0	2.8	1.4	0.8	0.3	0.9	0.2	1.9	0.3	0.4	0.9	1.0	1.9	1.7	0.9	2.0	1.4	7.8	3.1	1.3	3.3	0.6	0.9	1.2	1.3	0.9	2.1	0.5	0.8	1.1	1.5	0.3	0.9	1.2	3.7	2.4	1.0	1.0	0.8	1.3	0.4	0.2	1.8	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.2	0.4	0.0	0.5	0.6	0.2	0.0	0.7	0.0	0.0	0.0	0.2	3.4	3.0	4.6	3.3	2.6	3.4	3.3	3.1	3.5	2.7	3.0	3.0	0.6	0.0	0.0	3.9	0.8	0.1	0.9	0.4	1.8	7.5	2.1	1.3	0.7	7.2	0.2	1.8	0.0	7.5	0.6	10.8	0.0	1.1	42.0	1.2	0.8	0.5	4.2	0.0	13.5	4.0	11.4	1.5	3.6	0.8	4.5	17.1	0.4	35.9	1.2	0.0	14.6	2.9	0.0	0.6	0.4	65.0	15.5	0.5	1.8	1.0	0.0	30.7	0.0	9.0	9.9	2.5	5.5	11.3	0.3	1.4	33.2	19.9	0.2	5.0	0.0	0.5	1.2	56.0	6.4	0.4	0.1	15.9	0.7	21.4	6.4	0.4
AQR	"fSAP164, IBP160, KIAA0560"	ENSG00000021776	"Aquarius intron-binding spliceosomal factor"	O60306	15	34851782-34969742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040624, HPA055647"			Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040624: AB_2677050, HPA055647: AB_2682874"	"unprognostic (1.73e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.13e-2)"	3.7	3.9	4.5	3.4	5.7	4.0	5.9	7.8	5.2	5.7	3.9	4.2	3.4	4.5	4.1	3.5	4.4	3.1	2.7	4.7	5.0	5.2	4.0	3.6	4.2	4.1	4.7	5.0	4.1	5.2	2.5	4.4	4.5	4.0	4.2	8.0	3.3	3.7	2.8	4.2	3.6	3.8	4.5	4.7	3.8	5.6	4.9	7.0	5.4	3.5	4.7	4.0	3.5	5.8	5.3	13.5	8.7	9.3	11.6	10.7	4.5	6.4	8.1	8.3	7.4	6.1	3.2	4.3	4.0	10.8	5.4	8.2	14.8	9.1	9.1	6.1	6.0	13.8	11.4	5.6	6.6	11.3	6.2	8.4	5.9	6.5	6.9	7.7	7.1	3.3	9.9	4.2	8.3	3.6	6.6	7.5	8.7	12.2	5.5	8.9	15.0	4.3	8.3	9.2	9.5	7.4	10.3	9.7	2.3	7.6	6.9	8.7	9.3	6.1	3.4	4.3	5.7	5.0	6.6	8.5	7.7	9.6	6.3	3.6	2.0	1.2	2.6	2.2	2.3	1.6	2.3	2.6	1.7	2.3	2.3	2.6	1.0	2.1	1.4	2.3	2.0	1.4	4.5	5.7	7.8	5.2	4.7	5.0	4.1	4.7	4.5	4.5	4.9	5.8	27.0	12.8	26.0	45.4	27.9	9.6	13.7	17.0	15.4	28.6	19.9	15.6	14.7	17.2	28.1	14.7	114.7	16.4	31.4	18.2	3.9	13.4	38.2	20.6	26.7	24.1	13.2	21.0	39.8	14.3	14.4	18.6	20.4	22.1	24.1	28.8	31.1	18.5	14.9	25.2	44.0	19.1	12.2	18.6	5.1	8.4	20.8	21.8	16.0	29.0	27.9	14.3	22.6	42.3	42.2	18.5	12.1	18.4	22.9	18.8	17.4	12.9	27.1	41.1	6.6	42.8	16.9	19.4	22.2	22.4	9.7	13.3	27.0	46.5	21.6	13.5
ARAP1	CENTD2	ENSG00000186635	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1"	Q96P48	11	72685069-72793599	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020703, HPA070383"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		36000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"CAB020703: , HPA070383: AB_2686262"	"unprognostic (3.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (4.01e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.41e-4)"	"unprognostic (7.56e-3)"	41.5	63.5	40.0	58.6	48.6	97.5	33.4	37.9	50.4	44.1	62.9	35.5	29.6	38.9	14.0	37.7	48.3	44.2	42.9	42.2	38.5	47.8	40.2	71.8	53.4	50.6	42.3	49.4	37.1	20.4	48.9	35.5	45.9	44.9	18.2	8.6	33.3	25.7	20.1	47.1	43.3	28.7	40.1	117.5	31.3	16.4	50.8	32.2	46.6	20.1	25.2	39.7	37.5	56.8	19.7	41.9	15.2	18.5	63.4	42.9	23.1	26.2	46.5	29.8	29.3	56.0	50.8	42.9	51.3	44.4	40.7	64.5	23.2	64.4	12.5	50.9	28.4	36.6	40.3	81.9	43.7	25.1	98.7	47.5	65.4	48.7	23.4	36.2	33.2	31.3	31.5	17.4	13.9	40.3	38.9	89.3	9.5	35.1	25.9	36.8	23.2	21.3	27.5	61.1	15.7	32.0	19.1	27.9	84.8	19.5	25.1	56.8	37.5	41.0	28.5	42.8	16.4	27.4	14.3	23.0	21.8	37.4	22.3	19.3	24.8	30.7	8.9	39.4	5.2	6.6	5.9	6.8	15.9	4.7	4.5	5.4	50.8	13.4	51.3	5.3	6.7	17.6	40.0	48.6	37.9	50.4	42.2	38.5	50.6	42.3	45.9	40.1	50.8	56.8	8.9	28.9	32.3	33.6	16.1	7.4	7.5	14.3	15.4	4.3	8.7	7.9	2.6	7.2	9.0	16.5	33.3	9.2	18.3	16.5	9.8	13.5	50.1	14.1	11.7	7.8	23.3	9.9	7.7	7.5	8.9	22.4	16.3	9.1	10.8	36.9	9.7	10.8	43.0	0.0	7.0	12.8	12.2	45.6	25.1	6.4	20.8	57.3	8.8	30.0	29.0	7.4	21.6	17.6	31.5	12.1	10.9	15.1	12.3	4.8	20.9	5.3	20.2	2.8	0.0	8.6	8.8	0.4	2.8	10.8	5.4	4.9	12.4	10.5	15.1	7.4
ARFGEF1	"ARFGEP1, BIG1, DKFZP434L057, p200"	ENSG00000066777	"ADP ribosylation factor guanine nucleotide exchange factor 1"	Q9Y6D6	8	67173511-67343781	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023399, HPA023822"	Supported	Supported	Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA023399: AB_1844981, HPA023822: AB_1844982"	"prognostic unfavorable (8.76e-4)"	"unprognostic (1.62e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.52e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.61e-2)"	11.4	10.3	5.6	14.6	5.3	27.5	13.6	8.2	6.8	14.2	10.1	19.2	16.9	10.5	11.0	15.2	11.8	12.5	9.6	4.6	5.5	22.8	15.2	13.8	15.4	6.2	6.5	10.3	17.5	28.0	5.4	14.4	6.7	13.0	17.2	36.5	14.8	12.1	12.8	13.7	17.5	10.8	5.2	13.8	19.6	28.3	6.4	22.2	22.4	14.0	17.2	19.7	7.9	7.3	31.8	20.4	19.3	7.3	21.9	29.8	22.5	21.4	24.3	21.7	22.0	12.6	30.0	23.9	8.9	27.6	26.2	22.2	23.5	30.4	26.6	28.3	16.0	40.2	12.0	13.5	18.6	20.9	37.3	18.4	21.6	19.2	31.8	22.3	31.5	24.6	24.5	25.3	25.5	7.2	48.1	9.7	42.5	34.5	18.5	22.4	13.9	4.8	35.8	58.2	7.6	14.9	14.1	33.9	19.5	29.5	58.5	18.3	38.6	14.4	19.3	19.5	16.4	20.4	22.6	17.5	23.6	20.8	14.2	6.1	1.6	4.3	2.8	2.3	3.6	1.2	1.8	2.3	1.6	1.3	3.0	2.6	5.1	2.5	0.9	2.2	3.9	0.9	5.6	5.3	8.2	6.8	4.6	5.5	6.2	6.5	6.7	5.2	6.4	7.3	38.5	44.8	23.1	73.1	32.7	23.7	34.0	23.8	19.9	36.8	32.7	18.9	33.1	18.6	31.9	38.6	139.7	20.0	47.0	43.2	11.7	29.7	25.4	42.5	34.7	28.5	29.4	16.2	119.0	25.6	15.4	22.9	57.6	53.0	15.2	40.0	23.2	19.6	15.8	43.7	146.3	27.9	14.2	31.3	20.4	36.0	40.0	35.2	17.8	105.9	47.1	22.9	46.4	151.8	126.6	40.1	25.7	30.1	29.8	38.2	30.8	24.7	33.9	100.8	6.6	23.6	26.5	69.4	50.7	26.0	29.5	24.9	42.4	32.1	28.0	60.4
ARFIP1	HSU52521	ENSG00000164144	"ADP ribosylation factor interacting protein 1"	P53367	4	152779937-152918463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005080, HPA037375, HPA063759"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.49e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (2.83e-10)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.22e-3)"	16.8	14.8	7.9	15.8	8.7	3.7	23.4	9.9	10.8	22.5	9.9	28.1	23.2	21.7	20.5	20.9	18.5	19.9	10.2	7.3	9.3	19.8	15.4	16.8	15.1	9.3	8.0	17.6	10.5	22.4	10.5	18.0	9.5	21.1	27.8	20.2	13.7	17.2	6.6	17.3	21.3	19.8	9.4	18.3	22.7	12.1	8.3	12.0	20.1	10.4	14.8	23.5	15.2	11.4	25.8	18.4	25.1	25.7	37.2	37.9	30.6	29.5	40.5	28.7	26.9	21.3	51.3	20.6	9.9	40.5	22.7	18.1	26.3	29.1	35.3	16.9	16.2	20.0	18.0	20.5	26.1	38.2	41.7	26.6	30.9	24.8	23.8	30.7	26.4	11.8	23.5	43.3	39.8	28.6	22.7	19.8	21.8	29.9	18.5	12.6	14.7	19.2	50.7	32.1	32.8	26.0	22.1	40.7	30.2	23.5	37.7	19.6	17.3	27.8	20.1	26.8	21.4	48.2	42.8	28.1	35.3	38.2	40.0	31.5	27.3	42.2	14.5	31.1	14.6	19.0	11.2	12.2	24.8	17.7	8.7	11.8	81.6	29.1	30.7	3.1	18.5	18.7	7.9	8.7	9.9	10.8	7.3	9.3	9.3	8.0	9.5	9.4	8.3	11.4	28.5	6.4	31.8	40.5	20.3	29.6	18.4	30.7	34.1	17.2	26.2	19.7	10.2	20.0	29.1	38.6	0.0	28.6	15.6	40.9	27.4	27.4	46.3	42.2	33.0	23.8	38.9	12.0	44.5	18.3	27.0	28.8	40.2	50.7	22.8	14.2	17.2	19.8	22.1	18.5	42.8	39.1	34.6	23.8	18.0	21.6	22.4	24.5	21.4	89.9	19.5	35.9	23.7	76.4	75.6	24.4	28.2	21.8	11.8	23.6	23.8	34.2	31.9	24.2	32.9	20.6	27.8	31.7	29.5	31.9	34.0	43.9	17.7	89.2	31.7	30.3
ARFIP2	POR1	ENSG00000132254	"ADP ribosylation factor interacting protein 2"	P53365	11	6474683-6481479	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB032985, HPA038156"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus"		"CAB032985: AB_2058811, HPA038156: AB_10697243"	"unprognostic (2.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (8.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.48e-3)"	19.8	29.3	31.7	18.6	32.3	22.8	50.7	32.5	35.2	36.3	36.2	36.8	32.9	27.2	34.0	31.4	39.3	23.9	17.9	32.1	31.4	27.0	34.6	24.4	22.4	31.2	31.4	29.4	49.4	46.4	40.7	29.7	31.9	46.6	48.1	28.3	57.7	28.2	15.2	32.8	30.7	27.4	30.9	20.7	50.4	18.3	31.8	25.7	36.9	16.1	32.0	29.2	24.4	33.1	50.4	64.8	38.9	38.5	59.1	53.9	56.1	40.3	107.0	86.2	101.8	62.1	80.3	39.9	16.5	79.3	49.8	68.0	49.4	84.1	70.0	30.9	86.5	22.3	87.7	60.4	71.3	36.2	42.8	60.0	65.7	43.0	98.3	64.2	55.9	38.3	35.3	45.0	55.8	98.9	41.9	41.6	67.2	119.0	71.9	31.7	22.6	37.1	61.9	50.4	50.8	63.2	48.7	204.9	25.9	36.3	86.9	33.0	36.8	35.4	35.7	39.1	30.3	67.3	32.5	24.3	65.4	22.0	43.9	13.0	15.6	9.9	17.9	10.9	17.8	12.1	16.7	14.5	21.3	13.8	16.7	17.1	6.1	21.1	6.7	16.6	18.9	13.9	31.7	32.3	32.5	35.2	32.1	31.4	31.2	31.4	31.9	30.9	31.8	33.1	14.8	6.4	6.4	4.6	20.7	28.0	49.3	48.9	16.5	32.6	59.8	45.1	4.3	40.0	30.5	12.9	29.2	80.1	24.3	56.0	58.7	62.7	31.7	28.1	20.1	19.6	63.0	21.8	8.4	85.4	65.8	23.1	62.2	37.2	31.8	30.3	20.3	21.1	28.1	21.9	7.8	126.6	32.6	10.1	16.4	43.3	20.5	14.4	24.9	5.6	25.2	35.4	18.6	6.6	7.6	59.9	63.4	24.5	28.0	73.3	65.2	34.4	34.7	32.3	26.3	21.6	23.3	41.0	26.2	26.2	32.1	112.5	16.9	40.9	52.6	64.7
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568137	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: AB_2683236"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (7.34e-5)"	35.0	25.5	17.9	4.5	18.4	11.0	36.3	19.5	25.2	43.7	13.5	41.2	3.5	43.1	6.2	30.8	47.0	2.9	31.1	17.8	16.4	28.2	22.9	46.3	6.7	15.2	15.6	50.4	29.3	3.7	34.1	6.1	15.3	34.7	4.7	8.6	35.1	4.5	28.4	32.1	42.6	6.3	15.3	40.8	38.2	23.7	16.2	7.0	36.3	7.5	5.7	35.6	37.6	18.2	10.5	9.4	26.0	6.4	9.0	4.6	9.1	10.2	6.5	9.1	6.6	16.8	8.3	21.5	6.1	9.2	8.4	6.9	17.4	9.9	11.4	24.5	12.3	18.8	9.2	11.6	9.3	36.0	8.2	5.0	6.8	6.9	7.2	9.2	8.1	13.0	13.4	11.4	11.4	7.7	16.4	13.9	18.6	23.6	4.0	17.3	19.7	8.9	10.6	7.3	7.0	13.8	9.9	12.7	6.1	17.6	5.8	27.0	9.2	7.5	6.2	5.9	10.0	11.1	14.2	27.4	10.6	15.6	6.7	44.6	24.2	17.2	15.4	17.7	14.1	30.2	13.5	12.1	17.1	32.4	15.3	14.6	45.7	18.8	14.8	34.2	15.7	12.8	17.9	18.4	19.5	25.2	17.8	16.4	15.2	15.6	15.3	15.3	16.2	18.2	342.0	141.1	230.6	198.8	242.0	261.7	268.5	179.3	186.1	222.7	153.9	104.0	88.3	90.1	204.9	114.0	135.5	141.9	329.3	195.3	99.7	120.7	42.0	201.2	308.3	298.1	187.7	160.3	208.8	113.2	137.7	204.7	355.7	290.6	168.7	331.2	280.2	81.5	101.3	304.5	155.6	218.5	148.5	90.7	186.2	34.0	255.1	142.1	128.1	161.1	182.1	223.3	301.8	200.6	367.2	145.0	173.8	217.7	194.9	251.0	153.7	58.6	190.7	271.2	216.9	179.6	196.8	199.8	125.9	164.1	262.3	185.2	257.8	280.7	193.1	316.0
ARHGAP10	"FLJ20896, FLJ41791, GRAF2"	ENSG00000071205	"Rho GTPase activating protein 10"	A1A4S6	4	147732063-148072776	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 137.6;Oligodendrocyte precursor cells: 124.7;Peritubular cells: 121.1;Rod photoreceptor cells: 132.9;Sertoli cells: 144.7;Smooth muscle cells: 107.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 80.2"	HPA039589			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039589: "	"unprognostic (8.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-2)"	"prognostic favorable (8.15e-5)"	"prognostic unfavorable (6.26e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.09e-2)"	35.0	11.4	4.6	7.0	6.3	3.3	22.6	2.0	7.1	35.1	9.8	47.0	4.9	16.9	9.8	35.7	35.1	13.0	38.7	6.0	2.6	9.7	7.9	15.1	5.8	3.1	4.7	33.4	9.2	16.0	6.2	10.7	3.5	26.0	8.0	14.4	11.1	20.0	38.6	22.2	16.6	13.3	3.6	9.8	26.3	11.8	5.5	11.3	16.9	33.1	6.7	44.2	30.8	4.1	21.0	8.3	4.4	9.2	33.2	45.1	46.0	28.3	23.5	17.9	13.8	21.6	11.8	0.0	4.7	24.4	15.0	10.1	16.4	23.4	21.5	11.4	10.9	7.2	6.2	0.7	51.2	7.1	8.0	23.4	17.9	22.3	19.0	22.7	22.0	6.0	1.0	38.3	32.3	25.5	4.5	0.0	4.1	13.9	4.0	8.1	12.7	24.5	12.3	19.0	10.7	5.1	7.4	29.6	7.9	19.0	3.7	0.6	21.9	16.8	12.9	10.3	13.8	14.2	1.8	0.1	25.5	0.9	15.1	0.0	1.7	16.7	5.3	0.1	10.5	0.0	4.1	6.2	3.0	0.0	1.2	6.0	0.2	5.3	0.1	0.1	5.4	2.4	4.6	6.3	2.0	7.1	6.0	2.6	3.1	4.7	3.5	3.6	5.5	4.1	18.5	3.2	4.1	5.5	1.5	14.4	7.9	7.0	16.5	7.1	13.0	15.4	64.8	5.7	3.5	1.8	43.8	29.0	11.1	0.2	0.0	5.8	13.6	16.3	83.5	11.8	0.0	1.3	63.3	16.0	48.2	45.6	11.2	31.8	1.3	21.7	4.2	13.0	20.9	3.3	26.7	0.4	0.0	6.2	33.7	10.2	137.6	24.2	5.4	46.9	58.4	8.2	8.2	124.7	2.1	14.0	0.1	121.1	3.2	4.5	0.8	15.0	1.3	132.9	144.7	22.7	107.3	4.7	13.3	15.7	10.2	12.7	16.0	9.1	1.1	3.1
ARHGAP15	BM046	ENSG00000075884	"Rho GTPase activating protein 15"	Q53QZ3	2	143091362-143768352	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 79.8;lymphoid tissue: 75.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 126.3;Early spermatids: 132.3;granulocytes: 88.5;Microglial cells: 250.1;NK-cells: 89.6;T-cells: 149.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 59.4;HEL: 75.8;HL-60: 124.3;MOLT-4: 82.0;NB-4: 100.4;THP-1: 131.0;U-698: 89.5;U-937: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032125			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA		38000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA032125: AB_10671370"	"unprognostic (1.59e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.62e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.95e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.94e-2)"	6.9	5.9	1.4	27.1	1.3	79.8	7.6	2.3	2.3	4.1	1.9	7.3	6.8	2.6	9.7	4.0	2.8	11.4	5.6	1.2	2.2	4.4	10.2	9.8	59.3	3.0	1.9	1.8	1.3	1.7	1.0	4.0	2.7	4.3	7.7	1.3	4.2	5.1	1.2	2.0	15.1	3.9	1.9	44.9	7.5	7.4	2.1	75.2	4.5	2.2	46.3	11.4	4.3	4.0	0.3	0.1	4.9	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	59.4	0.2	0.1	0.1	0.1	0.2	0.1	0.3	14.6	0.0	75.8	0.5	0.1	0.0	124.3	1.2	0.0	0.0	0.2	0.2	0.1	0.0	47.0	0.3	4.4	0.0	0.1	82.0	100.4	0.3	0.0	0.1	44.7	0.6	22.7	0.0	0.1	0.2	0.4	0.3	0.2	1.0	0.1	4.5	131.0	0.6	0.4	1.2	0.1	0.2	1.0	0.3	89.5	0.7	63.9	3.9	181.8	32.0	140.1	97.7	34.3	161.6	94.3	172.8	125.7	56.3	86.2	119.0	101.7	207.2	121.4	40.5	54.3	147.7	99.9	1.4	1.3	2.3	2.3	1.2	2.2	3.0	1.9	2.7	1.9	2.1	4.0	8.2	0.0	9.6	2.0	126.3	5.6	0.1	0.0	0.0	0.3	1.8	2.0	3.9	1.5	2.5	0.0	0.0	0.2	78.9	0.3	0.0	0.1	132.3	1.8	2.3	4.3	0.0	26.3	12.2	0.0	0.3	9.7	8.6	3.5	88.5	0.0	8.6	0.8	21.3	1.7	6.8	0.0	0.0	39.9	30.9	17.5	14.9	43.0	8.8	250.1	34.9	0.4	89.6	20.6	3.2	0.0	0.0	3.4	65.8	0.2	0.0	0.7	2.2	0.3	46.0	2.7	31.6	68.4	1.2	0.4	4.5	0.3	149.2	0.1	0.2	0.2
ARHGAP22	RhoGAP2	ENSG00000128805	"Rho GTPase activating protein 22"	Q7Z5H3	10	48446036-48656265	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 122.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 200.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 68.8;LHCN-M2: 64.8;TIME: 66.2;U-87 MG: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020696, HPA040391, HPA064439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266"	"unprognostic (1.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (7.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.66e-2)"	2.6	1.9	12.0	3.0	15.7	1.4	1.6	17.6	14.5	1.6	7.7	2.0	0.6	1.1	0.7	1.4	1.8	1.8	4.4	11.9	12.7	1.3	0.8	2.0	2.7	22.6	17.0	4.8	1.7	0.9	2.0	0.8	20.1	3.3	1.0	0.4	2.0	1.1	1.9	2.2	1.6	1.4	16.9	2.8	1.2	4.8	17.0	2.8	6.6	1.6	2.2	2.1	2.2	22.2	6.2	1.4	0.4	0.0	5.1	20.8	4.3	31.9	15.1	3.0	4.1	7.0	0.9	0.0	1.2	13.1	2.1	12.4	0.4	11.2	5.4	0.6	11.5	18.2	0.2	0.1	2.7	2.0	2.0	5.0	11.2	37.1	3.0	68.8	20.6	0.0	17.4	3.0	64.8	0.2	0.2	0.1	7.2	0.0	0.5	0.1	0.0	7.9	6.5	0.7	1.1	6.4	1.5	0.1	0.6	0.6	0.4	0.3	66.2	30.1	0.4	3.8	23.8	0.0	0.0	0.0	82.5	0.3	4.9	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	12.0	15.7	17.6	14.5	11.9	12.7	22.6	17.0	20.1	16.9	17.0	22.2	0.9	0.0	1.7	4.2	2.9	3.4	4.1	6.8	4.6	1.1	0.8	3.0	2.9	1.5	2.9	0.0	2.1	11.6	3.2	0.2	0.0	2.8	53.6	0.7	1.6	2.4	0.0	10.9	51.7	4.4	0.7	6.5	0.5	1.0	0.0	4.4	1.8	0.0	10.3	0.0	29.8	0.3	2.0	7.6	14.2	122.7	2.8	15.6	1.8	227.7	14.8	1.8	0.0	141.8	200.8	2.5	0.0	6.0	0.5	1.9	0.0	0.2	3.8	1.4	0.0	1.6	4.2	1.6	4.3	0.4	0.6	1.0	0.7	10.6	0.1	0.6
ARHGAP23	KIAA1501	ENSG00000275832	"Rho GTPase activating protein 23"	Q9P227	17	38419280-38512385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 97.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 59.4;Hepatic stellate cells: 46.1;Oligodendrocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 296.7;RT4: 115.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019818, HPA047291"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA019818: AB_1844993, HPA047291: AB_2680012"	"unprognostic (3.35e-1)"	"unprognostic (5.11e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.50e-3)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.38e-5)"	"unprognostic (8.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.25e-1)"	25.6	13.8	36.2	8.3	66.2	10.7	18.8	47.2	54.6	25.9	5.5	22.8	3.0	28.4	3.7	60.8	18.4	7.8	27.3	34.4	37.5	11.8	2.9	28.0	4.1	63.7	59.6	18.1	3.5	3.1	6.2	19.4	54.1	19.9	2.8	8.5	12.8	12.5	10.6	61.1	10.4	11.6	43.0	30.7	13.4	16.1	66.1	5.4	9.5	5.8	11.0	36.3	29.5	97.8	32.5	17.2	15.2	5.1	9.5	31.1	19.6	44.8	49.5	37.7	21.8	56.8	55.1	0.7	35.2	102.5	18.7	296.7	1.7	62.3	26.6	3.5	3.3	0.0	55.1	0.4	47.2	3.0	0.3	18.8	11.8	27.7	17.3	31.0	39.4	6.0	0.6	8.3	21.6	0.0	10.2	6.3	9.0	1.2	6.3	17.0	33.0	10.4	16.0	115.7	3.7	8.8	26.9	0.1	0.3	21.2	6.7	7.9	57.7	62.6	22.9	12.9	12.1	6.5	7.3	1.9	16.3	8.1	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	66.2	47.2	54.6	34.4	37.5	63.7	59.6	54.1	43.0	66.1	97.8	27.2	12.8	1.5	23.8	0.7	9.9	17.5	10.6	9.1	59.4	1.7	3.9	20.4	1.5	13.2	3.7	0.0	27.0	0.2	0.1	0.0	2.9	7.6	8.5	10.0	34.9	0.0	4.0	9.3	1.4	3.1	11.6	3.1	5.7	0.0	4.9	46.1	0.5	5.1	26.9	16.2	0.4	2.0	2.5	4.2	21.0	9.0	1.2	1.8	9.4	0.2	9.6	0.0	20.1	129.2	7.0	0.1	7.2	1.7	15.4	0.0	0.2	8.3	3.4	0.0	10.9	7.6	13.5	2.7	27.5	25.9	16.6	1.8	1.3	0.3	42.2
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 72.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.7;granulocytes: 210.8;Microglial cells: 88.1;NK-cells: 103.0;T-cells: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 657.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 66.7;HMC-1: 256.1;NB-4: 47.3;U-266/70: 50.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Vesicles"		"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"	11.1	5.2	5.2	38.8	5.4	37.4	8.0	5.6	7.9	6.0	5.1	7.2	6.2	6.7	22.7	4.3	4.7	11.7	6.7	5.2	5.6	7.1	10.1	21.3	71.4	7.6	6.0	16.7	2.1	2.3	3.5	10.7	6.7	5.0	9.6	0.6	5.1	3.8	3.2	6.2	23.3	8.3	7.1	72.8	8.8	2.5	7.0	27.3	5.1	8.4	67.3	11.9	4.7	8.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	20.8	0.5	0.0	0.1	2.5	0.0	20.5	0.0	2.3	0.0	66.7	0.0	0.0	1.0	14.8	256.1	0.2	2.4	0.4	8.1	0.0	0.0	22.2	0.4	23.6	0.0	0.0	17.2	47.3	1.2	0.2	0.0	18.7	4.3	0.8	0.0	5.4	4.1	0.6	0.2	0.0	1.4	1.4	0.0	12.3	3.5	0.1	0.9	0.1	0.5	50.8	29.0	16.8	0.2	33.3	0.3	234.8	60.8	528.7	171.3	75.9	107.0	156.4	76.2	150.0	37.4	100.8	54.2	95.2	657.3	170.6	94.8	52.3	102.0	132.0	5.2	5.4	5.6	7.9	5.2	5.6	7.6	6.0	6.7	7.1	7.0	8.4	14.1	3.2	15.0	0.3	88.7	5.6	12.4	2.9	5.7	0.8	0.7	6.1	1.4	1.5	2.0	0.0	0.0	0.5	35.1	0.1	1.9	0.1	1.8	0.7	0.6	16.6	3.0	11.6	15.5	0.2	0.4	3.5	2.0	0.4	210.8	0.1	15.4	1.0	48.6	0.0	0.9	0.5	2.0	27.3	12.8	3.6	1.5	22.6	1.8	88.1	40.9	0.5	103.0	0.5	0.9	0.0	0.1	2.6	34.7	1.2	0.0	0.2	5.2	0.2	6.6	0.8	2.1	0.6	1.3	2.5	1.4	0.3	53.7	1.8	0.2	2.5
ARHGAP27	"CAMGAP1, FLJ43547, SH3D20, SH3P20"	ENSG00000159314	"Rho GTPase activating protein 27"	Q6ZUM4	17	45393902-45434421	"Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 99.1;Paneth cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.7;OE19: 20.5;RT4: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023919, HPA053053"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA023919: AB_2059402, HPA053053: AB_2682027"	"unprognostic (9.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (3.21e-4)"	16.2	7.3	4.3	8.6	6.7	11.6	15.8	4.0	4.8	27.1	3.1	39.6	10.5	8.7	1.7	98.0	11.7	3.2	22.7	3.7	4.0	20.4	6.5	28.4	9.1	5.4	4.5	3.6	7.7	3.1	10.4	4.0	4.7	17.0	8.9	0.5	37.7	1.5	4.4	27.3	51.6	2.4	4.4	63.0	12.7	8.9	5.5	6.3	16.7	1.8	6.7	17.6	44.2	4.3	6.1	6.0	0.1	1.7	0.8	0.4	16.7	0.0	0.3	0.4	0.1	5.3	11.9	5.5	11.4	0.4	2.6	3.8	0.8	1.1	0.2	11.3	3.7	0.3	2.7	3.5	0.1	0.0	15.7	0.8	4.7	0.0	1.7	0.5	3.6	5.9	1.5	9.8	0.5	4.2	5.3	1.9	0.3	20.5	4.9	4.4	0.2	1.9	3.9	26.1	0.8	0.5	0.7	5.0	0.3	2.0	3.9	10.2	5.6	0.0	1.4	0.1	0.5	12.0	8.4	1.2	0.3	1.5	0.1	1.0	5.2	4.4	2.4	8.6	1.5	3.6	1.5	2.7	4.3	2.7	1.2	1.3	10.0	1.8	11.4	7.2	2.1	4.0	4.3	6.7	4.0	4.8	3.7	4.0	5.4	4.5	4.7	4.4	5.5	4.3	19.9	6.4	17.8	2.9	23.1	10.3	15.2	9.3	2.8	3.3	11.4	7.4	10.6	15.7	13.0	18.4	4.2	7.7	38.0	99.1	3.9	6.0	1.1	11.0	2.5	20.8	19.2	1.7	3.6	3.4	11.5	3.1	31.6	18.4	4.5	0.5	17.5	2.1	15.0	1.7	8.8	34.2	10.2	47.1	13.4	1.1	0.3	33.1	7.2	19.7	26.0	1.6	23.7	3.0	2.5	19.1	79.6	0.0	15.9	28.3	57.0	6.4	11.7	1.6	0.0	3.0	2.9	6.7	2.0	9.7	8.7	14.1	14.2	1.0	43.4	57.4
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 440.8;Endothelial cells: 298.6;Prostatic glandular cells: 593.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A-431: 118.8;hTERT-HME1: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	32.9	3.7	7.0	2.8	5.5	0.1	30.3	22.5	8.0	8.8	7.3	9.4	2.1	7.4	5.3	4.5	10.2	6.5	19.2	4.6	5.5	23.7	16.8	27.1	4.9	6.8	6.1	10.2	7.4	6.5	6.2	17.4	7.1	11.2	3.2	14.9	12.1	7.0	11.6	14.7	6.4	5.6	6.4	21.7	10.4	5.8	8.6	3.0	22.8	12.7	2.8	8.0	9.3	5.1	118.8	4.8	7.0	0.1	26.7	57.5	24.5	38.6	62.9	31.0	45.1	13.7	5.4	0.0	85.2	76.5	36.3	24.8	0.2	27.4	63.9	0.1	4.1	0.4	6.6	7.6	2.7	0.0	0.0	11.7	5.4	23.7	100.9	36.4	88.0	0.1	0.0	0.0	32.1	4.7	2.2	0.1	9.0	0.6	82.1	1.4	5.6	0.0	82.7	10.8	0.1	1.5	24.1	20.5	2.0	26.5	5.6	0.4	84.2	20.0	26.2	29.7	32.3	0.1	0.1	0.2	3.7	0.0	0.9	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	5.5	22.5	8.0	4.6	5.5	6.8	6.1	7.1	6.4	8.6	5.1	440.8	51.3	18.4	26.4	2.9	23.5	239.2	31.7	4.6	16.0	87.3	46.1	26.0	31.5	39.6	130.6	18.8	29.5	2.0	0.9	54.8	83.5	94.1	36.9	11.4	298.6	0.0	3.2	11.3	17.2	102.6	63.6	20.9	106.2	3.8	13.8	177.1	56.1	3.0	92.5	24.1	1.0	6.1	13.6	17.9	24.4	24.5	6.2	26.6	208.9	2.5	94.2	0.0	2.0	3.5	55.7	0.1	21.8	0.1	593.9	0.1	78.1	12.5	81.2	190.7	58.2	127.8	80.3	116.5	1.7	17.2	14.1	4.1	11.1	1.6	146.9
ARHGAP32	"GC-GAP, GRIT, KIAA0712, MGC1892, RICS"	ENSG00000134909	"Rho GTPase activating protein 32"	A7KAX9	11	128965060-129279324	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 240.6;Excitatory neurons: 403.4;Inhibitory neurons: 239.7;Oligodendrocyte precursor cells: 170.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 26.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 36.6;RT4: 39.5;SK-BR-3: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038382, HPA038389, HPA061505"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544"	"unprognostic (1.17e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (1.47e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.64e-2)"	4.7	7.5	2.6	3.4	8.2	2.1	10.3	0.0	26.6	11.9	0.0	14.1	21.1	8.1	9.0	26.3	13.3	7.6	4.3	15.1	0.0	7.0	5.0	5.8	1.6	0.0	0.0	10.9	15.2	10.7	6.1	8.6	0.0	6.4	15.8	33.5	15.8	4.2	7.6	20.1	20.6	5.9	0.0	3.0	12.0	10.7	0.0	10.5	3.8	4.3	6.9	9.4	17.1	5.1	12.2	6.4	19.7	0.1	6.3	6.3	14.2	4.5	6.3	2.8	3.4	14.9	24.7	0.1	6.7	8.7	14.1	27.2	9.0	11.4	5.4	0.0	3.1	0.2	3.4	5.6	3.1	0.0	0.0	6.1	14.4	2.7	16.3	6.2	3.5	10.2	0.6	0.2	4.9	9.5	10.2	0.2	5.4	36.6	6.8	24.9	5.9	2.5	3.0	39.5	19.3	7.9	6.8	42.3	8.0	7.5	21.9	3.9	6.6	9.9	5.2	5.9	8.9	0.3	0.0	0.1	4.3	27.4	6.4	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.7	0.1	0.3	0.1	0.1	2.6	8.2	0.0	26.6	15.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.3	6.4	16.8	240.6	3.4	18.2	12.7	29.1	16.5	31.6	36.5	17.1	4.3	14.3	46.6	11.0	123.0	23.1	4.8	48.7	1.9	8.3	19.0	27.7	10.0	5.6	40.7	2.5	403.4	27.2	4.2	14.1	35.2	25.4	1.3	9.8	5.0	16.2	6.5	18.5	239.7	61.9	20.3	4.1	4.2	12.3	6.8	5.7	16.0	103.0	2.9	113.6	0.0	170.9	95.0	24.5	44.2	13.2	1.5	22.7	52.7	9.9	61.6	37.9	19.7	19.4	9.5	8.6	9.6	55.4	31.1	28.5	2.0	4.0	54.0	59.5
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058346-131089885	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"adrenal gland: 105.4;brain: 144.3;pituitary gland: 176.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast glandular cells: 2.7;Oligodendrocyte precursor cells: 1.0;Skeletal myocytes: 1.5"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	161	"SH-SY5Y: 176.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 89.4"	"Low region specificity"	"Detected in many"			"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		0.2	105.4	20.1	0.0	3.7	0.0	1.4	0.8	3.2	1.6	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	13.5	132.5	0.0	0.0	0.0	0.0	35.0	46.1	0.0	0.0	0.0	176.9	0.1	144.3	0.2	0.1	0.0	0.2	0.0	6.6	0.1	0.0	0.0	4.7	0.0	0.1	0.8	52.1	0.4	0.1	1.1	0.0	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	176.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	3.7	0.8	3.2	13.5	132.5	35.0	46.1	144.3	4.7	52.1	10.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ARHGAP39	"CrGAP, KIAA1688, Vilse"	ENSG00000147799	"Rho GTPase activating protein 39"	Q9C0H5	8	144529179-144605816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.3;Endometrial ciliated cells: 31.4;Excitatory neurons: 41.7;Inhibitory neurons: 33.1;Oligodendrocytes: 30.8;Respiratory ciliated cells: 27.6;Rod photoreceptor cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044491			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Nucleoplasm, Microtubules, Cytokinetic bridge"	"HPA044491: AB_10794775"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-7)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.97e-2)"	1.6	3.9	4.3	0.8	5.2	0.0	3.4	2.3	9.4	4.9	1.2	4.5	1.7	2.8	0.8	5.0	8.2	0.7	1.9	8.5	2.3	4.9	1.6	2.7	0.3	8.4	5.9	2.6	5.2	1.3	9.9	0.7	5.5	4.2	0.6	3.1	3.5	1.4	0.7	5.2	2.7	0.5	4.7	1.3	2.0	21.8	3.5	0.7	7.5	0.1	0.1	1.9	3.1	9.5	8.3	8.1	3.8	5.8	0.7	0.6	7.2	2.1	0.7	2.6	1.6	5.2	4.8	0.8	5.4	0.8	2.7	7.0	1.8	2.0	0.5	0.0	7.2	0.1	5.8	3.4	1.3	0.0	0.8	0.5	3.2	3.3	1.4	1.3	0.8	0.4	7.7	0.0	1.1	13.4	4.6	0.0	4.0	3.4	11.4	4.3	3.0	3.2	2.1	4.1	10.9	7.7	6.2	2.1	3.8	1.4	9.0	1.2	2.0	1.9	0.1	6.6	4.5	0.0	0.1	0.3	3.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.2	2.3	9.4	8.5	2.3	8.4	5.9	5.5	4.7	3.5	9.5	0.8	3.2	2.3	34.3	0.6	3.7	0.6	1.9	2.2	7.2	5.0	3.3	1.6	0.0	2.8	3.7	20.9	0.6	0.1	7.5	0.0	2.4	3.9	31.4	2.8	1.1	0.0	0.0	41.7	2.5	0.9	1.2	1.1	6.0	0.0	6.0	0.7	1.4	0.5	3.3	33.1	4.2	4.1	0.0	0.4	3.1	2.1	0.2	5.4	1.0	0.0	3.6	0.0	15.6	30.8	1.4	7.9	8.2	0.0	1.0	3.3	1.5	27.6	24.5	6.6	2.5	2.1	8.5	11.2	2.1	3.0	0.5	0.3	3.1	5.2	0.7
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"breast: 32.4;epididymis: 35.7;esophagus: 28.7;skin 1: 45.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 14.7;Breast myoepithelial cells: 8.6;Club cells: 4.3;Collecting duct cells: 3.7;Early spermatids: 7.2;Late spermatids: 4.3;Respiratory ciliated cells: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.3;HBEC3-KT: 13.6;RPTEC TERT1: 11.7;SK-BR-3: 12.7;T-47d: 15.4"	"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		No	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.1	0.0	0.3	0.0	1.3	0.0	32.4	0.1	0.6	3.2	0.2	0.0	1.7	0.7	35.7	28.7	0.1	0.1	0.0	0.2	0.3	5.6	0.1	0.8	0.0	0.3	1.8	0.0	0.3	0.0	0.0	0.0	0.8	4.6	0.0	0.0	3.6	7.9	0.4	45.3	0.0	0.0	0.2	0.0	4.6	2.7	0.6	0.0	0.9	0.0	3.7	3.2	7.4	0.2	4.5	0.0	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.0	0.1	0.2	0.9	0.0	3.6	0.0	0.0	0.0	0.0	13.6	0.2	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	12.7	0.0	1.6	15.4	0.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.6	0.2	0.3	0.3	1.8	0.8	0.2	0.6	0.2	0.1	0.0	1.5	0.7	0.0	0.3	0.0	1.8	0.0	0.0	14.7	8.6	0.1	0.0	4.3	3.7	0.0	0.0	0.2	0.0	0.0	0.0	7.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.4	3.4	0.0	0.0	0.0	0.3	0.7	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3
ARHGEF10	"Gef10, KIAA0294"	ENSG00000104728	"Rho guanine nucleotide exchange factor 10"	O15013	8	1823926-1958641	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.1;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 158.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024649	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA024649: AB_1845002"	"unprognostic (2.51e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.46e-2)"	19.2	10.1	9.3	2.3	9.9	0.4	15.2	9.3	9.6	14.7	9.3	19.1	0.5	18.7	2.7	5.5	15.0	1.9	18.3	9.0	8.9	12.4	3.4	27.9	1.6	9.7	9.8	13.5	6.6	1.1	7.3	3.0	10.3	12.8	1.6	1.9	12.1	3.1	4.0	13.3	9.3	4.7	8.8	6.9	14.2	24.3	9.1	2.1	12.9	1.1	1.1	12.3	13.4	11.7	7.1	7.6	7.7	4.0	6.8	7.4	1.9	9.4	6.9	6.5	7.8	2.5	3.2	0.0	1.0	11.7	11.1	5.3	8.4	10.9	8.8	0.0	3.0	3.2	8.6	0.0	6.0	0.0	2.1	6.5	6.2	7.7	6.1	10.0	11.8	2.5	3.1	0.0	8.0	3.8	5.8	1.1	6.6	5.3	4.2	0.3	8.6	0.0	6.2	2.7	1.5	1.6	5.7	0.2	5.3	9.4	3.1	2.1	13.2	5.9	3.8	0.1	8.4	0.0	2.9	0.1	6.0	8.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.3	9.9	9.3	9.6	9.0	8.9	9.7	9.8	10.3	8.8	9.1	11.7	11.7	3.2	4.1	90.1	0.9	38.4	13.4	8.1	5.7	7.7	7.8	6.3	13.3	15.7	5.0	7.3	10.4	0.6	2.6	1.4	0.0	7.5	17.8	3.3	11.4	27.7	1.2	3.6	17.3	2.0	1.6	30.0	4.1	6.9	0.0	11.3	13.9	1.2	1.7	21.9	16.3	4.5	8.2	1.6	9.4	20.5	35.1	2.1	23.2	50.6	0.3	10.1	4.1	69.9	158.9	12.4	0.3	26.4	2.3	22.6	0.7	0.8	2.8	9.2	0.0	22.6	14.2	54.9	38.3	1.4	15.2	0.3	2.1	7.7	2.4	6.3
ARHGEF11	"GTRAP48, KIAA0380, PDZ-RHOGEF"	ENSG00000132694	"Rho guanine nucleotide exchange factor 11"	O15085	1	156934840-157045742	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 68.6;Cone photoreceptor cells: 93.8;Excitatory neurons: 102.4;Inhibitory neurons: 122.5;Oligodendrocyte precursor cells: 78.4;Rod photoreceptor cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"WM-115: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011026, HPA012037, HPA014658"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428"	"unprognostic (2.19e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.30e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.73e-2)"	10.9	10.9	10.3	9.5	8.6	4.3	8.1	4.1	22.6	10.0	0.8	12.3	13.1	12.0	9.6	11.5	10.3	10.2	12.1	9.4	10.2	7.2	6.3	11.4	5.3	12.7	11.1	13.2	9.9	25.0	12.2	11.1	12.0	9.2	11.2	17.6	8.6	11.6	12.3	10.0	14.9	13.3	4.0	9.3	10.7	19.2	16.9	3.6	13.0	11.2	5.7	10.4	8.1	11.1	13.5	26.6	22.0	16.9	28.5	14.6	25.0	13.4	19.4	20.0	14.6	17.9	14.0	1.8	22.6	23.0	15.3	14.4	15.0	13.5	10.8	19.6	9.3	6.7	15.9	11.5	16.4	13.7	23.0	22.7	14.4	18.3	14.2	14.9	14.5	5.7	11.1	1.2	13.3	17.4	3.5	7.2	27.6	21.0	16.0	0.5	10.9	7.4	9.5	21.9	4.2	25.1	28.3	22.6	23.3	18.8	20.3	30.3	22.4	20.6	12.9	18.3	13.7	18.7	12.2	1.3	13.1	1.8	69.7	0.0	0.4	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.9	0.0	0.4	0.0	0.0	0.2	10.3	8.6	4.1	22.6	9.4	10.2	12.7	11.1	12.0	4.0	16.9	11.1	6.2	3.2	4.2	68.6	0.5	1.1	2.8	0.4	0.0	48.0	5.0	5.8	15.3	7.2	1.6	1.8	93.8	1.8	0.0	26.0	1.9	1.1	8.6	7.7	10.9	5.0	5.4	0.4	102.4	1.6	0.6	5.5	10.2	7.8	8.9	6.6	5.3	5.2	4.0	21.9	122.5	7.3	0.0	8.8	3.9	10.5	4.7	7.1	1.8	37.5	6.8	9.7	0.0	78.4	47.2	1.2	10.8	4.5	2.9	4.0	10.6	1.3	1.4	58.7	0.0	6.7	6.9	3.1	4.8	1.8	2.0	1.5	0.9	9.2	9.8	3.3
ARHGEF12	"KIAA0382, LARG"	ENSG00000196914	"Rho guanine nucleotide exchange factor 12"	Q9NZN5	11	120336413-120489937	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018911, CAB025581"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB025581: , HPA018911: AB_1845003"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.91e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (5.43e-6)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	25.6	30.6	27.2	14.3	26.9	11.4	31.9	26.8	32.1	32.9	26.4	27.6	25.0	27.8	25.4	27.6	29.3	28.4	40.3	30.9	23.0	67.4	66.4	36.7	11.9	17.8	25.6	25.2	26.1	68.4	14.6	42.9	17.3	26.5	29.1	47.7	25.0	30.9	32.2	49.5	25.5	30.3	20.1	21.5	32.2	9.7	35.9	13.5	51.5	31.8	18.7	28.7	22.0	19.3	38.1	31.6	41.9	39.8	55.0	54.5	16.7	43.8	49.8	26.1	33.1	37.5	27.2	3.2	51.7	79.8	46.6	27.5	54.1	56.0	51.3	31.1	25.8	61.8	34.0	29.2	49.2	0.1	43.7	52.4	39.7	57.8	63.8	58.0	80.7	32.7	52.4	122.5	67.0	26.6	0.1	0.1	11.4	49.3	26.1	13.4	47.4	11.9	65.1	66.1	30.0	36.4	61.5	51.0	16.2	25.0	43.1	5.1	80.1	57.2	24.2	37.6	32.4	35.1	15.4	20.2	23.6	7.9	44.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	27.2	26.9	26.8	32.1	30.9	23.0	17.8	25.6	17.3	20.1	35.9	19.3	86.2	73.7	88.4	274.9	8.6	90.5	69.1	47.2	42.1	134.6	55.1	26.9	87.6	68.6	57.8	97.5	185.6	16.7	11.5	59.7	35.2	45.6	6.4	61.4	55.7	94.0	37.8	69.7	239.0	50.9	10.4	44.0	34.7	140.3	11.4	44.9	85.6	118.3	7.3	90.9	192.4	39.6	18.3	31.2	25.6	14.8	29.8	18.2	51.6	118.0	8.7	41.0	13.4	143.2	55.0	53.5	52.1	33.4	9.3	85.6	48.1	76.3	48.7	80.9	26.3	58.4	60.3	16.3	13.8	55.3	85.1	28.7	16.1	43.1	41.3	99.1
ARHGEF26	"DKFZP434D146, SGEF"	ENSG00000114790	"Rho guanine nucleotide exchange factor 26"	Q96DR7	3	154121003-154257827	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 339.7;Astrocytes: 248.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017722, HPA049195"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017722: AB_1856800, HPA049195: AB_2680671"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.55e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.42e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.01e-5)"	"unprognostic (1.44e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.53e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.24e-3)"	8.0	2.1	5.8	1.8	5.7	0.3	6.0	4.1	5.3	5.0	7.7	18.3	7.3	4.3	1.2	7.4	6.2	5.5	3.2	4.6	5.0	1.7	15.5	16.3	0.3	5.9	7.3	3.9	6.0	9.9	1.7	3.4	5.8	3.4	2.6	7.1	3.1	4.8	0.4	6.2	6.6	7.1	5.4	0.8	8.7	5.1	6.1	0.8	3.1	1.4	0.9	5.1	6.4	4.8	8.5	3.7	10.6	6.8	5.1	1.4	0.3	0.3	0.0	3.1	4.3	6.5	0.8	5.0	0.5	0.6	4.9	8.9	6.7	4.4	3.9	0.0	8.8	0.1	2.6	1.5	4.7	1.6	0.2	1.3	0.4	4.0	0.5	1.8	0.6	5.4	0.0	0.0	2.0	8.1	2.0	0.1	6.7	2.4	3.0	0.0	12.9	0.0	0.7	4.1	3.2	1.1	1.7	14.4	1.5	4.6	10.1	0.5	0.0	1.1	5.3	0.1	26.6	4.5	0.7	0.0	2.5	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.7	4.1	5.3	4.6	5.0	5.9	7.3	5.8	5.4	6.1	4.8	5.0	339.7	26.8	248.8	1.7	19.5	9.0	2.7	17.6	11.6	54.2	6.6	1.8	20.0	10.8	3.7	4.2	1.8	4.3	1.5	0.0	2.2	11.9	4.7	4.5	4.3	0.0	2.7	4.2	2.5	1.1	12.0	14.3	2.1	5.1	3.6	8.6	60.8	0.6	5.0	10.1	7.9	6.1	2.5	3.4	3.4	10.5	1.3	3.6	7.5	2.7	58.1	12.3	41.7	5.1	2.0	6.9	18.8	0.7	7.5	21.4	0.1	14.9	47.8	0.0	14.1	3.7	4.7	37.0	11.7	23.7	6.2	4.7	2.5	8.1	5.7
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889875-38975454	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.8;Excitatory neurons: 15.2;Late spermatids: 26.8;Spermatocytes: 34.7;Spermatogonia: 35.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.6"	"Group enriched"	"Detected in some"	4	"BEWO: 5.6;HeLa: 2.6;SiHa: 7.2"	"Region enriched"	"Detected in many"	32	"cerebellum: 280.4"	"Region enriched"	"Detected in all"	6	"cerebellum: 23.1"	"HPA034661, HPA041051"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Vesicles	"Nucleoplasm, Cytosol"	"HPA034661: AB_10669679, HPA041051: AB_2677274"	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.4	2.1	4.9	0.6	5.2	0.0	0.9	22.6	5.8	1.5	4.4	1.0	0.1	1.5	2.6	0.4	1.4	0.8	0.5	4.9	4.1	0.9	0.2	0.7	0.3	4.1	5.4	3.5	0.4	0.7	3.4	0.5	4.0	0.9	0.3	4.0	0.5	0.7	0.3	0.8	0.4	0.5	3.1	0.3	0.5	5.7	7.2	0.1	1.1	0.0	0.2	0.7	0.7	5.0	0.2	0.0	0.2	0.1	0.1	0.1	5.6	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.1	2.6	0.1	0.4	0.2	0.1	0.5	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.3	0.3	0.2	7.2	0.3	0.0	0.6	0.0	0.2	0.4	0.1	0.9	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.2	3.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.9	5.2	22.6	5.8	4.9	4.1	4.1	5.4	4.0	3.1	7.2	5.0	0.4	0.0	1.5	7.8	0.1	0.0	0.1	0.0	0.6	2.5	0.3	0.6	0.8	1.5	0.6	0.0	0.0	1.1	0.0	0.1	0.0	0.1	34.8	1.8	1.2	0.4	0.0	2.7	15.2	0.0	1.9	1.2	0.0	0.2	0.0	1.4	0.0	0.2	1.0	0.0	11.4	0.4	0.0	0.0	0.0	26.8	1.2	0.2	0.0	1.9	0.1	3.6	0.0	5.5	3.4	0.0	0.0	3.4	0.0	0.1	0.0	0.4	3.9	2.9	0.0	0.3	1.5	34.7	35.6	0.1	0.1	0.5	0.0	2.0	0.1	0.2
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 7.8;pancreas: 6.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 48.5;Breast glandular cells: 17.9;Respiratory ciliated cells: 31.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.8;RPTEC TERT1: 14.3;SK-BR-3: 8.0;T-47d: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Centrosome	"HPA036510: AB_10672357, HPA045484: AB_2679345"	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	7.8	0.0	0.0	2.5	0.0	2.6	1.9	0.2	5.5	0.1	0.6	3.2	0.0	0.0	0.0	3.9	0.1	3.6	0.0	0.0	0.0	0.0	6.5	0.0	2.0	0.0	0.0	5.7	4.2	0.0	4.9	0.4	0.3	0.5	2.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	48.5	0.0	0.2	0.0	1.1	1.1	0.0	0.0	17.9	6.1	1.8	4.3	12.6	12.9	0.0	0.2	0.2	9.8	9.8	6.8	1.9	12.6	0.5	0.3	8.4	0.0	0.3	5.8	0.1	0.3	9.2	7.8	0.0	0.0	0.0	0.1	0.1	0.0	0.3	14.8	10.2	0.0	0.2	0.4	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.1	2.4	6.4	0.0	0.1	9.4	4.8	0.5	31.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.4	0.8
ARHGEF5	"GEF5, P60, TIM, TIM1"	ENSG00000050327	"Rho guanine nucleotide exchange factor 5"	Q12774	7	144355288-144380632	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 47.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 61.7;Glandular and luminal cells: 47.4;Paneth cells: 53.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 29.4;CAPAN-2: 21.9;HaCaT: 16.7;hTCEpi: 18.0;RPTEC TERT1: 17.5;WM-115: 17.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA020980, HPA029504, HPA044188, HPA045619, HPA045699"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423"	"unprognostic (1.45e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.95e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (3.28e-7)"	"unprognostic (4.67e-2)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.76e-2)"	5.1	2.6	1.8	1.6	2.4	2.4	12.3	1.5	1.7	11.5	5.7	16.4	10.1	3.4	6.9	36.6	4.7	4.7	3.5	0.9	1.8	20.9	14.4	8.4	2.2	2.1	2.7	5.6	19.0	7.3	9.5	3.2	1.8	14.7	5.6	1.8	18.1	2.0	0.7	47.1	13.1	1.2	1.3	3.8	13.8	2.0	2.0	1.8	24.0	0.2	3.1	5.3	17.6	1.4	29.4	3.3	0.0	0.0	0.0	0.0	8.7	3.8	2.3	1.5	1.9	11.5	21.9	0.1	10.3	0.9	0.3	16.7	0.0	10.6	1.5	0.1	3.8	0.0	4.2	0.8	3.1	0.0	0.0	5.5	18.0	0.7	9.9	4.8	0.1	0.0	0.0	0.0	1.5	9.7	0.1	0.0	4.5	7.9	5.2	1.1	0.0	0.4	17.5	1.3	0.1	0.1	11.5	13.4	5.1	2.3	6.8	0.3	0.2	0.5	0.8	0.0	0.1	0.0	0.1	0.1	0.6	0.0	17.7	0.0	0.0	0.0	0.3	0.0	0.4	0.8	0.8	0.7	0.0	0.9	0.9	0.2	0.3	0.0	0.0	0.0	1.5	0.1	1.8	2.4	1.5	1.7	0.9	1.8	2.1	2.7	1.8	1.3	2.0	1.4	3.0	6.4	14.8	0.3	2.3	18.5	37.3	9.4	26.2	0.0	17.5	18.7	1.4	11.5	12.1	22.0	4.2	11.8	1.4	61.7	5.9	14.8	2.3	28.9	5.5	1.6	9.6	2.7	0.0	16.5	15.2	3.6	37.2	47.4	0.0	4.0	1.8	7.5	1.8	0.0	0.0	24.0	6.1	0.3	1.9	0.6	1.5	1.2	5.4	0.0	0.0	2.7	0.0	0.5	0.1	27.7	53.7	1.5	3.1	14.3	42.0	5.4	13.5	3.1	0.0	1.1	1.8	0.7	1.5	28.7	16.8	14.2	2.5	1.1	23.5	33.6
ARID1A	"B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1"	ENSG00000117713	"AT-rich interaction domain 1A"	O14497	1	26693236-26782104	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005456, CAB016334"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB016334: AB_673396, HPA005456: AB_1078205"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.54e-2)"	16.4	16.3	10.1	22.7	9.4	37.0	16.4	12.9	24.3	16.2	0.0	18.0	15.4	20.4	15.8	22.2	18.3	14.0	17.4	6.3	35.8	13.3	16.8	16.8	25.8	20.8	6.8	20.8	23.2	19.3	14.3	18.6	9.9	15.1	15.3	20.1	19.3	14.4	21.6	20.5	20.3	17.5	3.0	24.3	19.5	16.7	17.9	46.4	22.6	17.6	23.7	18.4	17.8	9.0	53.2	49.5	68.6	71.5	19.6	18.5	32.3	24.4	21.1	32.7	23.0	36.3	34.1	74.3	20.7	31.8	20.7	31.6	60.3	26.9	37.9	92.7	22.6	63.6	33.0	24.7	16.1	95.2	19.6	21.7	18.8	38.7	27.5	18.2	28.6	52.5	77.7	81.1	21.5	25.1	80.1	36.8	72.4	34.5	22.9	82.2	45.3	42.1	20.3	35.3	62.9	50.7	42.7	35.7	29.0	37.8	10.6	53.4	50.6	34.9	33.5	32.4	39.9	38.0	54.9	34.1	21.2	59.8	31.5	0.2	1.5	1.5	1.6	1.2	2.1	1.8	1.3	2.1	1.4	1.6	1.7	1.9	3.3	2.1	1.3	2.4	0.7	1.9	10.1	9.4	12.9	24.3	6.3	35.8	20.8	6.8	9.9	3.0	17.9	9.0	49.9	60.9	40.4	99.9	66.6	73.4	21.0	32.5	90.0	68.0	77.2	61.5	33.0	38.6	35.9	38.6	52.1	36.5	56.1	46.5	1.9	35.3	23.3	48.8	59.3	46.3	47.5	56.6	47.1	37.6	40.2	35.9	35.7	72.3	61.2	68.4	49.6	65.6	51.0	74.0	59.8	50.2	28.5	89.0	47.5	9.0	38.5	73.2	40.9	89.9	86.4	30.8	53.5	78.9	116.1	49.7	36.4	41.8	48.5	50.0	32.4	16.7	36.1	42.3	52.6	38.2	47.3	44.1	52.2	101.8	94.3	36.7	57.0	45.8	52.1	43.2
ARID1B	"6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R"	ENSG00000049618	"AT-rich interaction domain 1B"	Q8NFD5	6	156776020-157210779	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 404.3;Inhibitory neurons: 475.4;Microglial cells: 327.0;Oligodendrocyte precursor cells: 417.7;Oligodendrocytes: 503.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016511, HPA075291"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016511: AB_1845008, HPA075291: AB_2686743"	"prognostic unfavorable (1.04e-4)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-1)"	15.2	12.0	14.6	14.5	13.4	28.7	15.6	29.0	16.0	19.0	2.2	15.9	14.2	17.0	11.3	15.7	18.6	14.4	14.4	20.4	10.1	13.2	9.7	14.6	18.2	13.4	10.9	27.5	17.1	28.2	12.2	11.7	11.1	14.6	12.1	11.7	20.4	12.7	33.6	23.2	15.3	15.8	7.3	18.4	12.5	9.8	12.5	25.4	22.0	25.4	18.8	17.4	17.4	17.2	13.0	19.4	29.6	41.2	24.7	21.5	20.4	14.6	18.6	18.1	18.0	17.7	20.0	43.0	8.1	23.9	22.4	16.5	25.2	23.3	18.1	40.4	18.1	30.6	19.6	22.1	17.1	25.3	21.8	25.5	18.4	27.1	24.6	20.4	25.6	26.8	35.8	32.3	13.2	15.9	29.1	30.5	15.3	18.3	10.5	66.3	12.7	22.9	12.7	24.3	28.0	34.7	28.3	29.4	15.8	15.7	19.6	40.2	26.4	23.4	23.6	22.0	27.5	21.8	18.2	52.7	19.7	30.3	32.0	5.0	2.3	2.3	4.1	1.9	3.7	5.3	3.5	2.8	1.8	6.9	2.9	4.1	4.2	2.4	2.1	9.4	3.7	1.2	14.6	13.4	29.0	16.0	20.4	10.1	13.4	10.9	11.1	7.3	12.5	17.2	85.7	48.1	51.8	282.7	83.3	47.5	22.3	22.3	41.5	36.0	70.9	44.4	36.9	27.1	32.6	126.9	29.2	14.7	103.7	21.8	7.9	40.8	15.0	70.8	124.5	43.9	40.8	37.8	404.3	34.5	7.5	49.9	31.1	78.0	38.7	137.1	33.9	27.3	14.1	47.1	475.4	33.7	20.3	32.6	36.1	19.4	56.8	49.1	30.2	327.0	59.4	21.9	24.7	417.7	503.7	46.6	26.9	62.8	70.2	28.1	26.8	18.4	29.5	29.6	46.0	43.1	56.7	8.0	12.2	39.7	55.7	17.5	51.9	72.9	36.3	27.1
ARID2	"BAF200, DKFZp686G052, FLJ30619, KIAA1557"	ENSG00000189079	"AT-rich interaction domain 2"	Q68CP9	12	45729706-45908040	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 525.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063044			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA063044: AB_2684929"	"unprognostic (8.41e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.15e-2)"	"prognostic favorable (5.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (9.71e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.53e-2)"	6.4	5.2	4.6	6.7	7.8	12.6	7.5	13.8	6.9	8.5	10.2	6.8	5.0	6.9	6.5	8.4	6.4	5.4	6.0	5.0	7.3	6.3	5.4	7.8	7.5	7.8	6.4	8.3	7.2	11.7	5.0	7.2	7.6	7.4	6.0	13.2	6.7	6.2	5.9	10.0	6.6	6.1	6.0	6.9	6.2	26.1	6.2	18.7	8.8	7.7	8.9	6.8	8.0	9.8	10.3	14.5	25.3	11.1	10.5	7.3	13.7	7.0	9.9	9.6	8.9	20.7	10.4	19.8	12.7	9.8	7.0	12.1	20.6	11.8	13.6	8.8	9.8	26.1	15.9	10.1	7.2	20.7	11.5	6.0	8.8	12.1	19.1	13.4	10.0	29.1	22.4	19.9	8.6	13.4	29.9	14.7	15.1	0.0	7.7	22.9	18.0	19.0	9.1	16.9	13.6	17.4	11.4	13.0	11.1	14.5	20.0	40.8	11.8	10.3	12.3	7.0	9.2	13.2	11.8	53.6	7.9	53.2	7.4	9.4	1.1	2.7	2.4	1.3	2.5	1.0	2.1	2.5	1.5	1.1	2.0	1.9	1.4	2.1	3.4	3.3	2.0	0.9	4.6	7.8	13.8	6.9	5.0	7.3	7.8	6.4	7.6	6.0	6.2	9.8	23.3	28.9	28.4	110.4	30.8	33.8	14.4	16.3	36.5	51.6	21.7	15.4	15.6	14.3	17.3	29.5	68.8	15.5	49.0	21.3	7.9	13.2	525.4	23.2	23.8	21.1	21.0	35.1	56.7	10.0	10.5	22.0	24.5	27.7	22.1	29.3	19.2	17.3	11.2	32.0	60.3	19.0	22.4	29.8	36.7	149.3	24.8	25.6	14.2	128.4	22.4	19.9	45.3	144.3	157.9	18.8	24.6	22.6	33.8	23.7	19.1	7.4	15.4	66.2	26.3	27.0	27.2	80.2	17.0	39.3	41.3	23.4	34.8	16.4	17.9	21.0
ARID3A	"BRIGHT, DRIL1"	ENSG00000116017	"AT-rich interaction domain 3A"	Q99856	19	925781-975939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 23.4;testis: 17.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 191.8;Extravillous trophoblasts: 492.4;Langerhans cells: 163.7;Syncytiotrophoblasts: 518.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 206.5;CACO-2: 72.3;Hep G2: 65.8;K-562: 95.6;THP-1: 66.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004793, HPA076330"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA004793: AB_1847870, HPA076330: AB_2732309"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-2)"	3.4	1.8	2.3	4.9	1.6	10.3	2.2	3.4	3.8	2.5	2.7	2.4	3.2	2.2	0.7	3.0	2.3	0.8	1.9	1.9	1.2	3.9	2.1	4.4	3.5	2.0	1.6	1.2	3.1	2.1	3.3	23.4	2.1	1.9	1.2	0.8	2.0	0.7	1.7	3.1	3.6	1.3	1.7	6.6	2.6	17.0	2.2	2.5	1.6	1.1	2.7	2.2	3.0	1.8	3.8	5.0	17.2	4.3	7.2	5.4	206.5	16.5	10.7	8.8	5.8	72.3	0.6	1.6	3.8	5.6	2.2	1.5	7.0	3.9	3.8	22.5	5.0	7.2	6.5	65.8	3.1	25.1	17.8	7.7	5.5	5.5	1.4	1.4	2.9	5.7	95.6	20.3	2.6	5.8	9.8	28.5	16.6	2.6	1.0	21.9	5.4	13.9	1.1	3.7	8.3	15.8	5.3	4.3	3.1	37.7	7.6	66.7	4.9	5.8	7.8	8.4	1.9	47.0	45.3	12.5	3.8	14.5	4.0	0.7	1.6	1.1	0.3	1.4	0.3	0.9	0.2	0.3	1.0	0.6	0.3	0.1	4.1	1.3	2.1	6.4	0.2	0.7	2.3	1.6	3.4	3.8	1.9	1.2	2.0	1.6	2.1	1.7	2.2	1.8	4.7	6.4	2.8	2.9	30.2	14.8	8.0	8.9	9.6	8.4	7.4	7.5	8.0	0.0	2.4	14.7	8.4	191.8	56.0	4.0	9.8	5.7	41.3	14.8	19.0	14.1	46.9	9.9	8.5	3.3	492.4	18.9	5.1	15.2	3.8	11.4	11.4	7.6	98.2	6.7	8.0	11.3	4.1	41.0	163.7	4.7	7.2	41.0	16.0	24.4	60.4	2.2	13.4	6.6	2.7	14.3	0.3	6.4	50.9	6.9	10.8	5.7	1.1	4.4	0.0	3.2	10.5	2.9	9.9	8.1	15.3	518.3	10.7	8.2	5.5	2.1
ARID3B	"BDP, DRIL2"	ENSG00000179361	"AT-rich interaction domain 3B"	Q8IVW6	15	74541206-74598131	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Early spermatids: 45.4;Glandular and luminal cells: 45.6;Late spermatids: 65.8;Rod photoreceptor cells: 50.8;Syncytiotrophoblasts: 64.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 10.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 87.8;SuSa: 95.4;U-266/70: 53.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 28.8"	HPA050320	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050320: AB_2681085"	"unprognostic (2.97e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.20e-1)"	2.8	2.4	3.1	6.1	2.4	24.6	2.6	5.2	3.4	3.3	6.6	4.9	4.4	2.3	1.9	6.2	2.5	2.4	2.3	3.3	4.4	3.6	4.0	7.3	7.2	2.9	3.4	1.5	5.7	1.7	6.2	15.7	2.9	4.6	4.0	18.7	3.8	1.7	3.4	3.2	7.0	1.6	2.3	9.5	7.1	22.1	3.7	6.0	3.8	2.2	6.3	3.2	3.9	2.8	7.6	3.1	40.7	8.9	1.5	0.8	43.8	1.8	2.0	2.5	2.7	49.9	3.6	0.7	2.0	1.9	14.3	9.0	49.8	6.8	2.2	47.7	11.6	29.5	6.0	13.7	1.0	4.7	18.5	1.0	3.0	4.2	4.3	2.0	4.3	11.7	26.1	16.8	0.7	1.8	12.9	15.7	87.8	3.2	2.7	5.7	1.6	12.1	2.4	7.9	10.4	18.4	2.2	4.5	8.8	95.4	5.8	8.5	2.7	3.4	4.3	2.7	5.6	53.0	36.1	5.3	1.8	7.3	1.3	2.6	1.9	7.0	5.0	1.5	3.0	3.1	2.9	3.8	1.4	1.4	2.2	2.9	13.0	4.0	2.0	1.9	4.4	3.4	3.1	2.4	5.2	3.4	3.3	4.4	2.9	3.4	2.9	2.3	3.7	2.8	3.5	3.2	5.6	10.7	11.8	5.2	5.2	3.5	3.4	23.9	4.4	2.3	1.2	4.3	1.9	0.0	43.8	36.0	10.2	10.2	0.0	2.5	45.4	20.5	4.4	4.8	5.4	9.7	7.3	3.5	20.6	2.3	8.6	45.6	2.5	4.2	4.2	2.5	8.3	11.8	7.8	6.0	0.0	8.7	9.1	65.8	2.8	9.5	3.6	5.6	6.4	5.9	18.6	5.5	7.8	7.6	8.4	3.0	19.2	7.8	7.0	1.7	3.8	50.8	0.0	1.5	1.8	17.2	19.4	10.4	3.3	64.0	12.8	5.5	4.0	8.0
ARID4A	"RBBP1, RBP-1, RBP1"	ENSG00000032219	"AT-rich interaction domain 4A"	P29374	14	58298504-58373887	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048899			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA048899: "	"unprognostic (1.57e-1)"	"unprognostic (9.39e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.70e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.52e-2)"	9.8	6.9	8.6	11.1	9.2	34.7	9.1	14.8	10.0	8.6	8.9	7.7	8.8	9.5	6.8	7.4	6.8	9.0	8.7	8.0	11.7	9.4	18.7	10.3	14.9	7.9	7.7	12.5	7.4	9.8	5.4	9.8	7.6	8.6	8.8	14.0	6.7	7.6	5.4	8.7	9.1	8.2	6.8	14.0	8.9	6.9	12.3	14.5	10.6	6.3	11.2	8.4	7.5	10.7	8.5	7.0	19.2	9.5	9.3	11.2	9.7	9.9	8.4	6.6	10.4	8.3	13.1	20.4	10.3	8.4	6.3	9.6	8.6	4.8	9.6	14.3	5.5	9.2	8.2	8.0	5.6	19.7	12.8	8.4	5.2	6.4	6.6	10.5	10.6	11.6	10.7	16.3	7.1	11.5	14.3	17.7	3.8	8.2	8.7	14.5	16.6	6.1	7.1	14.9	16.5	14.3	16.9	8.4	12.0	9.4	14.3	17.8	15.3	11.2	8.7	9.1	4.6	5.3	4.2	18.3	6.7	12.3	5.8	65.8	19.5	59.1	20.6	20.1	23.3	31.5	25.3	22.1	14.9	42.3	27.0	26.5	109.4	29.1	40.8	19.8	19.8	10.1	8.6	9.2	14.8	10.0	8.0	11.7	7.9	7.7	7.6	6.8	12.3	10.7	57.7	83.3	100.9	68.9	73.5	38.4	21.2	22.1	64.3	111.0	29.5	35.8	55.0	24.3	32.3	27.6	52.1	19.9	74.0	33.0	19.6	23.3	18.2	40.5	37.6	47.1	22.8	45.8	94.2	21.7	21.3	40.1	26.0	52.6	65.2	39.9	37.5	41.9	34.7	112.7	78.6	35.5	20.3	47.7	49.5	8.8	36.4	59.3	26.6	63.7	75.8	63.9	49.4	86.5	91.4	24.9	38.6	36.1	55.1	20.9	43.4	14.9	11.2	64.2	19.7	40.0	43.0	38.6	33.8	55.4	33.4	20.4	77.0	34.1	32.9	17.7
ARID4B	"BCAA, BRCAA1, RBP1L1, SAP180"	ENSG00000054267	"AT-rich interaction domain 4B"	Q4LE39	1	235131634-235328219	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 486.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027205, HPA027333"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	Nucleoplasm	"HPA027205: , HPA027333: AB_1845013"	"unprognostic (2.62e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.84e-3)"	11.3	10.9	9.6	14.1	11.2	33.0	13.5	12.8	13.0	15.0	7.8	10.2	8.1	15.9	14.4	9.8	10.9	13.2	7.4	8.4	9.5	10.6	11.9	12.0	21.0	10.4	10.5	17.2	11.4	13.6	10.9	12.7	10.8	14.3	9.1	14.6	11.5	10.8	9.0	9.0	10.3	10.2	9.9	18.4	13.2	17.1	9.6	21.4	16.9	9.8	17.0	12.9	10.6	13.0	15.8	10.5	18.0	16.5	15.3	15.5	17.5	17.6	15.1	11.3	10.9	12.2	16.9	18.1	19.9	12.0	8.7	13.4	16.4	7.4	17.8	23.5	17.3	14.7	14.7	10.9	11.9	15.8	21.0	10.8	10.4	13.5	12.7	16.1	18.2	11.4	19.3	25.4	11.9	7.5	21.9	15.3	18.9	12.1	8.2	9.4	13.4	15.3	14.1	13.2	15.9	22.4	22.1	20.3	18.3	6.2	19.1	27.4	21.6	14.4	11.5	18.2	17.7	25.1	22.1	18.2	9.8	11.9	19.4	61.7	13.7	41.1	29.9	15.0	27.5	32.2	31.6	26.0	13.8	34.0	31.2	26.7	72.5	33.8	25.6	23.6	28.3	12.6	9.6	11.2	12.8	13.0	8.4	9.5	10.4	10.5	10.8	9.9	9.6	13.0	156.8	102.5	106.8	107.7	150.1	124.3	83.8	61.2	103.0	125.5	86.2	78.5	77.4	47.1	91.7	31.3	120.9	64.0	218.9	47.9	19.6	76.4	334.7	119.3	127.9	128.9	90.1	45.2	157.0	47.9	70.2	101.6	59.1	169.2	110.1	78.0	67.8	27.6	44.4	112.7	158.4	53.2	65.1	61.2	127.6	486.5	101.2	97.3	83.6	107.7	122.8	67.7	204.9	144.8	304.2	68.6	57.3	77.5	104.1	108.7	48.3	20.6	82.3	150.7	46.0	130.2	121.4	236.7	161.9	66.5	106.4	156.7	209.8	84.8	44.7	149.6
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552634	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 137.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 295.3;RPMI-8226: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favorable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	32.6	4.5	8.1	19.5	8.9	11.8	38.8	8.7	11.1	18.5	7.7	25.9	5.0	25.2	2.0	7.8	24.1	12.3	28.8	7.8	8.7	12.3	8.5	48.1	19.0	14.3	10.8	10.8	6.9	2.2	9.3	9.6	11.5	23.2	2.3	2.2	10.2	2.6	23.5	11.3	19.8	7.3	10.6	22.8	14.6	5.6	10.2	10.3	13.0	2.3	9.9	19.9	15.4	9.6	3.4	1.9	1.6	5.4	2.7	3.0	7.5	5.1	17.2	6.1	5.3	3.1	0.9	1.1	3.8	2.9	9.1	4.6	1.4	0.3	2.1	295.3	4.1	6.9	1.1	5.8	3.4	4.7	4.9	2.1	5.7	5.0	0.9	5.3	5.4	8.1	5.4	38.5	2.4	2.9	8.7	16.1	3.3	1.5	0.2	12.2	11.3	117.5	0.7	2.5	2.2	1.1	0.5	0.6	4.3	1.3	0.2	10.0	6.0	5.4	6.7	6.2	4.6	24.7	21.5	3.1	3.0	11.1	4.9	10.5	7.9	32.8	15.3	6.9	14.9	5.9	13.1	14.6	10.3	6.5	14.1	14.4	21.5	27.5	5.5	18.4	16.0	14.9	8.1	8.9	8.7	11.1	7.8	8.7	14.3	10.8	11.5	10.6	10.2	9.6	97.1	3.2	18.3	3.9	59.9	52.4	46.5	17.0	5.7	24.8	80.3	44.7	14.7	8.6	14.7	3.7	31.3	4.9	121.1	10.8	3.9	33.7	14.2	16.7	26.8	82.2	0.0	3.4	1.5	30.9	9.0	41.2	11.2	32.4	61.9	2.1	38.6	28.7	72.6	0.0	1.6	10.7	20.3	41.5	137.1	36.7	3.7	61.6	58.7	15.9	66.6	6.5	123.6	3.5	1.3	29.1	23.9	6.4	54.5	28.2	0.6	10.6	8.3	25.7	46.0	49.1	120.1	3.2	17.9	1.1	32.5	4.0	98.2	2.1	7.8	26.9
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901684-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 968.2;Syncytiotrophoblasts: 920.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 115.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	50.0	8.1	2.9	21.2	5.8	6.9	34.3	3.2	11.3	37.2	20.7	17.5	10.2	39.0	4.6	20.2	20.6	39.3	18.3	4.4	1.6	21.4	8.3	18.3	18.8	7.8	6.9	17.5	6.2	13.3	10.0	21.0	11.4	18.3	11.7	4.1	15.8	10.2	87.2	18.1	14.2	42.5	0.9	16.9	11.5	6.9	9.0	13.1	7.8	11.9	16.7	30.9	19.6	9.7	2.2	0.9	6.0	14.7	13.0	34.0	1.2	42.9	115.2	29.9	23.3	52.7	2.3	3.9	10.1	41.4	4.3	14.3	20.6	6.5	36.0	13.7	6.1	2.1	10.4	13.5	23.9	0.6	25.2	43.3	3.4	17.6	20.2	26.2	3.9	7.5	1.9	5.7	9.9	7.7	14.4	1.1	1.1	10.2	13.5	17.7	9.8	1.1	20.1	23.9	3.3	4.4	19.2	10.6	12.8	13.1	8.7	0.7	3.3	16.5	22.0	25.1	10.9	0.4	0.0	11.4	14.3	0.8	5.4	9.6	1.2	0.8	13.3	2.8	1.8	37.5	19.7	11.8	2.2	41.2	12.8	8.4	2.2	12.3	8.2	1.0	30.9	5.4	2.9	5.8	3.2	11.3	4.4	1.6	7.8	6.9	11.4	0.9	9.0	9.7	86.2	131.4	70.7	54.5	199.8	968.2	453.9	111.3	105.9	54.4	112.8	96.6	72.8	27.1	96.3	51.5	0.0	187.8	89.1	7.5	99.7	56.1	31.7	164.7	231.0	134.1	36.4	5.2	167.8	14.6	150.7	343.6	21.4	457.7	24.6	37.6	119.2	7.4	51.0	74.0	181.9	18.7	22.4	44.1	162.4	20.1	151.6	43.6	138.7	34.7	39.0	17.2	58.7	74.4	155.8	41.1	25.2	60.5	234.5	193.7	5.4	304.8	38.4	3.6	131.5	496.3	463.9	8.2	5.8	65.7	477.8	920.4	178.2	24.3	41.7	233.9
ARIH1	"ARI, HARI, HHARI, UBCH7BP"	ENSG00000166233	"Ariadne RBR E3 ubiquitin protein ligase 1"	Q9Y4X5	15	72474330-72602987	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.8;testis: 42.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003295	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003295: AB_1845017"	"unprognostic (3.31e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.96e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.70e-2)"	8.5	7.9	2.5	10.1	3.9	16.5	6.0	7.0	5.8	6.4	7.1	8.2	9.5	7.5	3.2	6.8	5.4	4.4	11.4	4.4	4.0	5.2	6.2	7.3	4.9	3.4	2.7	9.0	6.6	3.9	5.9	6.5	3.6	5.8	3.3	10.4	4.3	4.8	47.8	7.6	7.4	6.3	3.0	6.0	6.3	42.5	3.8	3.9	5.0	8.5	4.1	7.6	6.5	4.3	17.6	18.0	17.5	10.2	8.9	6.2	20.6	19.3	7.0	8.6	5.9	18.3	14.6	17.2	28.4	8.3	30.3	24.8	18.1	10.1	4.8	30.6	12.4	13.0	22.5	12.4	6.3	19.6	14.4	7.4	3.4	9.5	12.2	8.2	6.4	12.4	13.8	19.7	8.5	11.5	18.9	7.5	18.9	6.3	6.5	21.4	21.3	9.8	4.8	29.0	16.3	18.4	25.1	11.2	31.4	23.0	9.0	22.0	16.7	14.1	19.6	54.8	27.4	20.7	45.2	20.6	9.2	17.5	15.2	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.3	0.3	0.2	0.6	0.4	0.4	1.0	0.6	0.2	0.3	0.8	0.1	2.5	3.9	7.0	5.8	4.4	4.0	3.4	2.7	3.6	3.0	3.8	4.3	79.5	19.2	37.7	88.5	64.0	66.3	52.7	13.3	76.2	63.3	74.9	53.3	46.9	30.0	25.7	18.4	91.8	18.4	83.3	32.9	3.9	18.4	110.3	108.7	84.8	50.7	46.5	24.8	141.6	18.9	21.8	43.3	63.7	148.4	43.2	43.7	40.0	28.5	19.0	62.2	152.0	31.2	8.2	30.5	42.1	55.4	28.6	67.5	16.0	104.0	24.2	25.7	27.8	129.7	135.1	24.7	19.1	27.4	60.9	55.8	20.8	13.9	33.0	58.8	19.7	96.8	59.9	45.3	32.1	68.8	59.8	40.8	68.3	36.8	27.0	63.7
ARIH2	TRIAD1	ENSG00000177479	"Ariadne RBR E3 ubiquitin protein ligase 2"	O95376	3	48918821-48986382	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067381, HPA069715, HPA070963"			Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329"	"unprognostic (7.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (5.01e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (1.15e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.39e-2)"	20.6	22.9	21.4	16.0	24.5	23.0	19.8	24.2	23.7	21.4	24.7	29.4	11.7	24.5	33.8	19.5	21.3	15.0	53.9	21.3	23.4	22.7	21.3	19.7	20.7	22.9	22.9	20.7	24.1	24.4	26.0	18.4	23.8	23.1	17.7	32.4	18.6	21.9	100.4	16.5	21.2	24.4	22.0	24.3	22.5	27.0	22.8	26.1	22.0	79.6	21.4	23.6	17.4	27.7	40.4	39.6	37.6	53.2	54.3	29.7	52.4	46.3	53.5	56.5	62.1	42.0	35.0	84.1	21.4	49.8	82.0	23.5	77.9	47.2	68.7	57.0	48.1	85.3	51.7	34.5	48.9	63.4	39.5	31.9	70.2	70.9	94.9	32.2	43.1	38.3	68.4	54.6	50.7	27.8	65.4	25.8	64.3	43.3	59.5	23.5	42.8	70.2	32.9	54.1	16.4	44.8	47.7	56.1	45.0	44.1	28.6	43.8	41.4	34.1	49.4	52.5	74.0	72.8	148.1	103.3	37.3	51.9	43.7	53.1	34.6	39.9	44.2	32.2	30.5	28.8	28.2	37.1	32.3	34.2	29.2	37.3	25.6	25.8	20.9	29.9	35.5	39.3	21.4	24.5	24.2	23.7	21.3	23.4	22.9	22.9	23.8	22.0	22.8	27.7	37.0	35.3	31.4	54.9	50.2	50.9	51.5	27.3	68.3	57.0	35.5	35.3	74.6	32.9	44.0	29.5	87.6	36.4	76.0	31.3	29.4	33.8	15.3	33.5	48.3	38.4	16.7	76.2	50.0	43.2	36.2	40.1	42.3	38.1	45.5	42.3	28.5	44.6	26.6	57.2	59.1	26.2	14.2	32.8	35.7	11.3	41.7	44.6	30.2	38.4	45.2	42.2	95.8	42.3	128.6	42.1	23.0	43.2	85.0	78.9	20.8	34.3	30.6	82.5	26.3	51.5	48.6	165.7	89.7	59.4	54.0	53.4	66.8	37.7	31.6	67.0
ARL14EP	"ARF7EP, C11orf46, FLJ38968"	ENSG00000152219	"ADP ribosylation factor like GTPase 14 effector protein"	Q8N8R7	11	30323104-30338223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039634, HPA048127"	Approved		Supported	"Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA039634: AB_2676606, HPA048127: AB_2680277"	"prognostic favorable (2.50e-5)"	"unprognostic (8.93e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (2.50e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.76e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (7.49e-4)"	13.9	22.5	13.5	13.2	15.6	8.0	20.0	15.9	17.3	17.0	14.9	11.8	9.5	18.9	23.2	11.6	16.4	13.1	22.9	15.7	14.2	17.4	19.7	10.9	22.5	12.4	13.3	20.5	12.9	26.1	12.0	11.5	12.1	19.7	10.8	15.9	19.1	19.9	20.6	12.6	9.7	14.5	13.9	20.8	15.7	14.6	13.3	15.6	24.7	20.8	21.4	14.5	8.1	13.8	10.8	15.4	16.9	14.8	27.1	29.2	8.5	20.8	26.0	18.4	20.2	8.5	4.1	43.8	13.9	15.0	20.5	17.8	24.8	17.5	25.9	35.2	30.7	13.3	12.0	15.0	42.6	24.0	14.7	30.5	34.7	8.7	32.8	26.7	20.6	17.9	21.4	23.2	32.5	10.4	21.9	19.6	19.6	24.1	21.3	18.8	41.2	18.0	24.7	14.8	19.2	20.4	16.2	21.4	25.8	15.0	22.8	13.4	18.1	20.8	11.2	41.7	20.1	36.0	21.9	28.5	20.0	14.8	20.4	12.7	19.2	6.4	23.3	20.0	55.5	35.9	28.2	25.9	26.3	28.9	25.7	25.0	3.5	52.9	15.5	18.9	20.3	23.1	13.5	15.6	15.9	17.3	15.7	14.2	12.4	13.3	12.1	13.9	13.3	13.8	27.3	28.9	33.6	14.4	39.7	12.4	46.6	35.1	8.0	34.0	19.9	30.4	68.1	24.3	23.8	25.8	14.6	19.1	29.2	5.9	76.3	27.3	130.1	25.8	41.0	29.2	14.5	13.2	31.1	22.5	12.7	33.4	12.8	19.0	27.8	33.5	15.4	29.8	25.7	32.0	26.4	11.7	32.6	27.1	29.3	66.3	27.4	28.4	26.6	18.7	45.4	36.1	38.1	27.6	19.9	21.9	8.4	25.2	25.4	46.0	9.4	42.1	27.5	32.4	13.1	33.1	29.8	111.4	37.6	13.8	11.1	11.1	29.6	33.0	12.6	28.4
ARL2	ARFL2	ENSG00000213465	"ADP ribosylation factor like GTPase 2"	P36404	11	65014160-65022184	"FDA approved drug targets, Predicted intracellular proteins"	"Cell cycle"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 430.8;Late spermatids: 1125.1;Proximal tubular cells: 505.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044610	Supported		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol"	"HPA044610: AB_10964207"	"unprognostic (9.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-3)"	"unprognostic (6.43e-2)"	"unprognostic (6.87e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.24e-2)"	124.8	93.7	161.5	40.6	190.2	51.3	112.0	172.4	200.2	106.3	132.3	123.1	52.7	121.2	28.2	67.2	94.6	48.0	169.1	157.0	168.7	138.5	22.5	90.4	37.7	171.5	167.9	95.7	75.3	65.3	68.5	56.1	167.2	84.7	32.9	43.5	67.9	66.6	214.2	95.8	73.4	60.9	171.4	63.4	85.2	116.1	167.4	33.5	85.7	158.1	29.0	112.2	93.5	184.4	162.0	257.0	76.5	115.8	207.4	156.5	70.5	82.5	181.7	111.2	109.1	72.8	110.0	62.1	144.5	112.7	168.1	101.4	82.9	140.0	53.1	65.5	130.6	61.9	109.2	111.9	157.8	77.9	54.9	123.7	114.6	92.6	204.4	160.5	150.4	74.0	152.8	110.1	76.4	194.1	63.1	174.5	120.3	77.7	208.6	33.4	81.6	152.9	120.9	70.6	143.3	79.3	66.4	67.6	225.8	74.4	72.3	94.3	109.2	205.9	68.6	164.7	82.1	37.9	57.6	38.5	97.2	112.5	171.3	46.5	78.2	72.5	120.4	80.2	130.9	163.1	110.0	116.9	101.7	149.0	123.5	137.2	10.2	83.3	48.2	140.1	79.0	136.9	161.5	190.2	172.4	200.2	157.0	168.7	171.5	167.9	167.2	171.4	167.4	184.4	179.1	22.4	43.6	0.0	42.7	81.4	94.4	118.4	63.7	70.2	66.8	83.9	103.2	51.5	66.4	82.8	29.2	179.7	40.0	110.0	268.0	142.0	430.8	42.2	59.0	148.0	83.3	69.4	0.0	76.0	193.5	107.0	29.6	50.7	95.7	71.5	137.4	19.7	98.3	69.0	0.0	68.4	83.4	49.7	73.5	1125.1	71.7	49.5	177.9	0.0	100.6	208.4	55.6	0.0	0.0	68.3	115.7	71.1	16.5	79.9	162.4	505.5	47.0	48.9	65.7	74.2	109.7	126.5	79.4	56.3	82.8	107.3	40.0	65.7	98.0	75.9
ARL2BP	"BART, BART1, RP66"	ENSG00000102931	"ADP ribosylation factor like GTPase 2 binding protein"	Q9Y2Y0	16	57245259-57253635	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 264.6;Late spermatids: 503.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043066, HPA048440"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA043066: AB_2678302, HPA048440: AB_2680393"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (2.38e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.78e-2)"	48.5	42.6	49.8	30.1	51.6	35.7	37.4	51.1	58.1	35.5	51.9	36.0	20.8	45.0	34.8	49.6	44.1	36.2	54.4	51.5	52.2	44.0	32.7	44.5	37.7	50.1	51.9	50.6	29.6	48.0	27.6	37.4	51.6	34.9	36.0	37.2	25.4	46.0	31.8	31.3	24.8	59.3	51.1	49.4	27.5	57.1	51.6	44.8	29.9	46.1	46.3	39.9	29.9	52.1	74.2	49.4	93.3	48.7	82.6	106.0	23.2	91.2	105.4	104.2	65.9	37.4	28.9	61.9	104.0	126.3	48.8	48.5	60.3	74.0	97.8	28.5	57.8	54.9	36.3	64.2	112.3	50.8	113.6	91.6	94.8	75.4	103.3	77.4	127.5	46.7	42.5	23.3	73.0	28.7	52.3	63.9	32.7	25.7	98.7	71.3	91.7	120.8	113.8	26.4	29.2	61.1	140.1	66.1	82.8	58.1	48.8	66.6	114.6	61.2	37.8	53.3	70.8	58.8	49.6	58.9	79.8	33.2	60.2	35.5	46.1	27.3	40.5	45.3	42.3	37.6	36.7	44.1	56.5	29.8	49.5	42.0	7.6	63.6	51.3	16.3	33.7	55.1	49.8	51.6	51.1	58.1	51.5	52.2	50.1	51.9	51.6	51.1	51.6	52.1	60.3	51.3	27.4	9.8	47.0	36.7	43.3	57.0	42.7	44.4	30.6	27.8	0.2	40.0	28.7	36.8	4.2	51.0	50.5	23.4	76.3	46.2	264.6	49.2	57.8	63.7	26.4	105.7	20.6	58.0	30.2	66.6	30.1	58.7	74.3	105.7	62.8	34.3	63.3	55.5	22.5	21.5	46.8	52.8	36.5	503.7	82.3	42.2	48.0	7.5	71.2	66.0	66.9	42.7	33.9	44.6	18.5	109.1	50.3	24.0	23.2	65.8	32.9	38.0	13.1	39.7	45.5	122.2	51.8	66.8	37.1	22.3	60.8	170.2	23.6	22.6
ARL3	ARFL3	ENSG00000138175	"ADP ribosylation factor like GTPase 3"	P36405	10	102673731-102714397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 96.3"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 289.1;Rod photoreceptor cells: 318.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036292, HPA063596"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		44000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 46: Photoreceptor cells - Phototransduction"	Centrosome	Nucleoplasm	"HPA036292: AB_10673618, HPA063596: AB_2685053"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.99e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.71e-6)"	"unprognostic (5.62e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-1)"	8.1	8.9	20.2	4.2	21.3	1.7	8.1	20.8	25.1	12.4	19.1	11.3	4.2	11.5	10.6	4.6	15.2	5.2	13.5	20.8	19.5	15.4	5.2	8.3	3.6	19.3	19.1	16.8	6.4	19.8	21.0	4.9	19.7	8.7	4.6	96.3	6.3	9.0	5.6	7.2	6.1	8.7	18.5	4.5	8.8	11.0	20.5	5.7	11.4	5.9	4.7	9.8	8.3	19.5	14.7	25.0	33.6	24.7	15.2	22.7	5.9	11.4	17.3	13.6	14.7	8.7	7.4	6.1	10.8	18.5	16.4	10.7	12.7	15.3	16.9	16.1	13.4	9.9	16.9	8.3	16.4	4.6	9.5	11.5	12.6	18.8	11.0	36.1	15.8	12.0	4.5	6.0	23.0	15.1	9.5	7.3	13.0	9.2	9.8	7.9	24.8	5.4	18.1	7.7	11.8	25.7	8.7	1.8	14.1	18.5	45.1	4.6	9.1	9.2	12.9	18.9	16.0	4.2	8.9	11.3	24.4	13.6	8.1	2.0	7.2	2.6	3.7	6.1	9.4	4.5	6.5	5.5	7.1	3.9	3.9	4.7	13.4	4.4	5.4	5.2	4.9	5.4	20.2	21.3	20.8	25.1	20.8	19.5	19.3	19.1	19.7	18.5	20.5	19.5	46.0	54.5	39.3	47.7	16.7	32.1	70.4	144.3	29.0	167.6	48.2	57.5	135.5	31.5	85.8	62.5	116.7	45.5	12.1	9.4	234.8	70.7	46.5	250.5	85.2	41.6	74.8	9.4	30.8	43.6	37.8	61.7	19.4	84.6	33.0	94.1	43.9	25.5	64.7	97.6	37.6	31.6	73.2	16.4	33.6	25.8	60.6	26.8	76.5	13.1	67.3	289.1	13.4	31.7	23.4	31.1	13.5	104.2	18.6	54.2	23.1	225.8	268.3	318.6	26.3	50.8	122.0	145.6	43.4	11.9	31.7	32.3	20.8	58.6	25.4	50.5
ARL4A	ARL4	ENSG00000122644	"ADP ribosylation factor like GTPase 4A"	P40617	7	12686856-12690958	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 191.1"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1523.0;Late spermatids: 3892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 261.3;K-562: 328.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064513			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064513: AB_2685276"	"unprognostic (8.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.94e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.42e-3)"	"unprognostic (9.49e-3)"	31.6	7.9	17.1	16.8	20.1	98.4	55.3	14.3	25.8	38.0	22.5	40.7	29.9	16.8	13.8	60.0	27.7	19.2	15.5	23.0	15.4	8.9	15.6	19.4	18.6	14.4	14.3	8.0	7.2	5.3	9.2	23.6	14.5	21.0	34.7	6.7	86.6	16.5	9.1	88.5	62.7	25.1	14.7	21.0	24.5	191.1	15.4	22.7	19.2	8.7	15.9	21.4	63.8	18.6	45.0	46.7	121.5	261.3	19.3	31.8	0.3	17.9	16.2	28.7	17.2	41.6	32.9	0.3	7.5	25.4	73.4	12.6	27.3	22.6	28.9	9.8	20.4	9.2	61.7	39.3	39.8	39.6	16.0	14.3	88.3	16.7	74.2	18.1	69.0	17.7	328.1	42.5	29.4	19.3	2.2	55.6	44.2	129.2	53.1	0.0	42.4	20.8	37.8	21.3	22.3	20.8	29.5	31.1	6.3	31.3	15.3	32.0	24.3	11.5	40.6	43.5	73.1	19.4	27.2	10.3	29.7	16.5	46.4	8.1	14.8	0.7	11.3	25.7	31.7	41.0	26.8	17.7	14.4	44.7	12.9	10.8	2.2	13.0	32.1	12.8	17.8	13.6	17.1	20.1	14.3	25.8	23.0	15.4	14.4	14.3	14.5	14.7	15.4	18.6	134.0	22.4	20.3	1.0	96.9	339.7	179.1	144.5	70.0	20.9	217.9	230.0	15.8	64.3	86.6	20.2	85.5	152.9	61.0	236.6	27.4	47.8	1523.0	179.1	41.5	162.5	62.6	249.9	11.6	29.6	18.7	46.1	63.2	86.5	80.5	27.7	157.1	21.7	59.5	3.3	3.4	107.1	337.7	168.2	171.1	3892.8	69.0	170.9	120.9	17.8	38.7	11.0	3.1	36.7	8.7	55.3	118.0	26.7	24.4	53.4	641.5	14.6	102.5	125.9	13.1	59.5	55.3	564.1	57.5	134.9	234.7	444.0	98.0	32.4	124.2	89.1
ARL6IP4	"SFRS20, SR-25, SRp25, SRrp37"	ENSG00000182196	"ADP ribosylation factor like GTPase 6 interacting protein 4"	Q66PJ3	12	122980060-122982913	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052098	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA052098: AB_2681724"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.04e-3)"	"unprognostic (6.48e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.03e-5)"	"unprognostic (4.01e-2)"	"unprognostic (8.41e-8)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.43e-2)"	"prognostic favorable (1.08e-4)"	134.0	168.4	158.3	88.5	152.0	162.6	130.6	147.5	178.3	135.7	143.1	177.2	108.8	117.1	63.7	118.3	120.5	74.9	190.3	148.9	151.2	159.1	207.4	106.9	117.9	157.2	157.9	142.4	192.6	109.3	120.4	67.3	156.4	131.4	59.2	44.1	151.8	92.6	373.4	118.0	116.0	64.1	149.0	135.5	161.1	91.3	158.1	100.6	114.8	174.0	82.5	145.8	117.5	161.1	233.9	248.5	160.3	108.3	110.3	144.7	125.7	131.0	156.0	192.5	145.4	123.9	96.2	220.5	160.3	166.8	90.1	120.3	129.1	212.6	85.2	197.1	134.8	367.3	227.3	246.5	211.4	202.8	155.6	151.0	168.3	148.4	193.7	210.1	214.8	174.6	166.4	104.3	156.2	274.1	237.5	367.4	126.5	140.1	156.0	178.1	175.9	262.6	168.2	195.1	155.1	185.2	123.7	204.3	314.5	69.6	268.4	259.5	194.5	110.7	202.4	106.6	166.1	221.6	115.0	255.4	159.9	233.8	141.6	182.2	250.1	266.6	194.6	327.5	209.3	241.1	231.4	217.0	315.8	233.8	219.7	198.4	68.5	216.9	385.2	215.0	272.3	298.5	158.3	152.0	147.5	178.3	148.9	151.2	157.2	157.9	156.4	149.0	158.1	161.1	239.4	93.0	127.9	33.6	228.0	204.4	313.8	271.4	156.5	111.1	309.0	379.5	0.0	207.3	146.2	211.5	43.8	282.2	262.0	361.9	516.5	306.3	200.5	141.3	168.6	218.7	223.3	147.5	27.1	635.5	261.0	197.4	171.8	112.1	167.1	273.3	240.2	465.6	386.5	97.6	26.5	332.6	170.9	401.4	412.8	380.8	222.4	270.7	377.1	23.4	477.6	231.0	324.4	18.6	26.4	395.6	332.8	180.9	241.6	337.3	706.6	814.9	135.8	125.5	177.5	215.3	242.7	189.1	164.2	188.8	203.3	240.2	228.5	353.8	331.7	370.1
ARMC12	"C6orf81, FLJ25390"	ENSG00000157343	"Armadillo repeat containing 12"	Q5T9G4	6	35737032-35749079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 64.2"	"Group enriched"	"Detected in some"	96	"Early spermatids: 503.3;Late spermatids: 1116.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.9;HSkMC: 6.1;MOLT-4: 4.8;U-698: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030895, HPA075457, HPA075777"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA030895: AB_10602114, HPA075457: , HPA075777: "	"unprognostic (1.94e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.52e-2)"	"unprognostic (6.36e-4)"	"unprognostic (8.99e-2)"	"unprognostic (1.17e-12)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.09e-1)"	1.6	1.7	4.4	0.6	4.4	0.9	1.5	4.0	5.3	2.5	5.1	1.5	0.0	1.7	5.8	0.8	2.8	0.7	0.7	4.3	4.5	1.5	4.5	1.2	1.3	4.6	5.1	3.0	1.3	0.5	11.2	0.2	4.6	3.6	0.3	1.3	0.6	0.8	1.9	1.1	1.7	0.7	4.3	2.8	1.2	64.2	4.3	3.0	2.4	0.5	0.7	1.1	1.7	4.5	0.0	0.3	2.1	2.7	4.9	2.3	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.5	0.1	0.1	0.8	0.1	0.6	0.1	0.1	1.2	0.6	0.3	0.1	0.0	2.4	0.0	0.0	6.1	1.5	0.1	0.9	2.5	0.5	2.0	0.0	3.2	0.8	0.3	4.8	0.6	0.4	0.0	0.1	2.2	0.0	0.0	0.5	0.0	0.6	2.0	0.0	0.0	0.4	1.0	1.4	0.2	0.0	0.4	0.2	0.1	0.0	0.7	0.2	5.4	0.2	2.8	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.2	0.9	0.0	0.0	0.0	0.8	0.0	0.1	4.4	4.4	4.0	5.3	4.3	4.5	4.6	5.1	4.6	4.3	4.3	4.5	0.8	0.0	0.0	4.6	0.1	0.9	1.9	0.2	1.2	0.0	0.3	0.4	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	503.3	0.4	0.4	0.8	0.0	0.4	0.3	0.0	0.0	0.6	0.0	0.3	0.0	2.4	0.4	2.8	0.0	0.0	0.5	0.2	0.0	1.2	0.8	1116.3	8.4	1.3	0.0	0.0	0.1	0.8	0.0	0.5	0.3	0.0	0.0	4.1	0.0	0.7	0.2	0.3	0.2	0.2	0.0	0.5	0.4	8.1	6.0	0.7	0.1	0.0	0.3	0.2	0.2	0.4
ARMC2	"bA787I22.1, DKFZp434P0714"	ENSG00000118690	"Armadillo repeat containing 2"	Q8NEN0	6	108848416-108974476	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 80.0;Early spermatids: 117.7;Excitatory neurons: 86.1;Inhibitory neurons: 69.3;Late spermatids: 145.3;Respiratory ciliated cells: 61.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025809, HPA053696"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA025809: AB_1845032, HPA053696: AB_2682233"	"unprognostic (4.42e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.19e-5)"	"unprognostic (7.55e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.38e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	5.3	3.8	3.8	3.9	7.8	8.8	7.0	0.9	6.8	6.6	31.8	2.9	1.8	7.5	7.6	3.4	20.4	5.2	9.3	3.0	2.3	3.6	2.6	8.6	4.2	2.7	5.9	5.4	2.4	9.4	6.7	6.9	1.2	3.9	4.6	26.7	3.4	4.7	4.0	5.2	3.4	4.1	1.1	5.9	5.0	33.4	7.6	3.8	10.6	1.3	4.2	2.4	2.7	3.6	3.5	2.1	10.1	6.5	4.9	5.9	2.2	2.1	2.9	5.3	7.0	3.2	3.0	5.5	2.6	3.4	8.1	3.0	5.6	4.2	9.1	1.5	4.9	5.1	5.2	3.4	2.6	8.0	2.2	6.8	5.8	6.1	1.7	7.1	5.0	16.6	2.2	8.4	5.5	2.7	7.0	7.3	3.2	3.4	2.6	7.8	8.3	4.3	4.9	4.1	14.0	5.2	7.3	1.8	5.1	5.6	3.7	4.1	2.5	4.4	2.3	3.8	2.9	3.8	5.5	4.7	7.6	5.5	5.6	3.7	2.1	0.6	2.0	3.0	1.8	0.8	1.5	2.2	1.7	1.9	0.9	2.2	6.0	2.9	2.4	2.8	4.7	1.0	3.8	7.8	0.9	6.8	3.0	2.3	2.7	5.9	1.2	1.1	7.6	3.6	2.0	9.6	3.7	80.0	3.4	1.0	1.1	1.9	0.6	2.0	1.2	1.5	6.8	1.5	10.9	0.0	0.0	1.5	2.9	0.3	0.0	1.2	117.7	33.0	2.7	2.2	1.8	2.1	86.1	1.0	2.1	3.0	1.5	1.8	0.0	2.8	0.7	0.3	3.9	1.7	69.3	0.4	4.1	4.4	0.4	145.3	6.8	3.1	5.4	11.2	0.5	1.7	3.1	35.7	24.4	0.7	0.0	10.1	5.9	0.6	0.4	1.8	61.8	4.9	0.0	4.2	4.2	41.5	6.3	1.9	1.4	0.5	5.1	2.5	0.6	0.7
ARMC5	FLJ13063	ENSG00000140691	"Armadillo repeat containing 5"	Q96C12	16	31458080-31467166	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041524, HPA063706"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA041524: AB_10796676, HPA063706: AB_2685098"	"unprognostic (1.37e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.14e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.97e-6)"	"unprognostic (4.70e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	6.3	7.9	9.0	3.4	9.2	21.4	4.3	8.9	11.7	6.0	7.0	5.8	4.6	6.9	0.9	9.9	5.6	2.0	6.5	9.2	8.1	8.7	24.6	4.6	3.2	12.3	9.4	6.8	6.4	3.0	9.0	2.1	12.4	7.7	0.9	2.4	5.3	2.2	16.0	8.5	7.0	1.7	9.1	8.8	6.8	6.8	9.2	2.9	9.7	3.9	1.3	5.6	6.6	10.5	5.0	7.6	3.3	4.8	2.0	1.5	8.4	6.5	2.8	3.6	3.0	7.2	5.0	4.9	13.3	3.5	3.6	7.5	3.9	5.7	0.7	6.8	9.9	2.2	12.4	16.7	4.0	14.9	14.3	3.7	6.3	3.6	1.0	4.2	5.5	8.0	11.2	11.5	2.5	12.2	5.6	59.5	5.3	2.2	5.0	10.0	4.7	18.2	2.9	5.6	10.7	9.4	5.9	7.8	4.6	2.0	5.1	17.6	10.9	7.8	5.7	3.2	5.4	10.4	9.8	3.0	5.1	12.2	5.7	2.9	2.3	0.7	3.2	1.1	2.7	2.7	2.5	2.6	3.0	2.2	2.2	2.6	1.3	7.1	1.3	7.2	3.2	2.6	9.0	9.2	8.9	11.7	9.2	8.1	12.3	9.4	12.4	9.1	9.2	10.5	8.7	6.4	14.3	4.2	6.2	6.5	9.2	8.7	9.1	6.0	6.3	5.0	5.8	11.5	8.2	0.0	6.2	7.5	7.6	11.1	3.9	5.0	1.2	5.2	8.6	10.8	7.8	8.2	4.3	4.4	5.4	6.1	6.6	7.6	9.5	6.7	8.9	28.7	6.1	13.5	4.0	8.7	6.1	3.7	4.0	0.6	4.4	6.7	1.8	2.8	3.9	7.2	6.2	2.0	4.6	4.4	3.8	5.7	8.0	6.9	9.2	4.6	3.4	5.9	0.0	8.7	6.6	5.5	8.0	9.6	6.3	11.5	7.6	6.1	7.7	6.1
ARMC8	"DKFZP434A043, GID5, HSPC056, VID28"	ENSG00000114098	"Armadillo repeat containing 8"	Q8IUR7	3	138187248-138298384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036996, HPA044869"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA036996: AB_10672786, HPA044869: AB_2679123"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (3.51e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.18e-1)"	20.8	14.3	14.6	18.0	16.6	60.6	16.4	41.2	18.5	14.7	25.6	16.8	12.0	17.6	12.2	21.0	15.7	15.3	17.4	13.3	16.9	18.9	16.9	16.3	21.2	16.0	15.8	16.0	14.2	21.3	12.3	19.8	17.5	16.5	18.3	26.2	12.5	17.5	38.7	12.8	13.5	24.4	15.9	15.9	15.4	18.4	16.7	22.2	21.3	34.8	22.9	22.2	13.4	19.4	46.2	22.0	28.5	23.2	35.2	30.7	37.9	34.8	33.4	46.7	45.3	34.3	23.7	43.2	35.0	30.2	54.6	23.5	37.1	33.9	57.4	29.3	25.7	77.2	14.3	23.9	44.3	60.6	82.5	46.2	21.2	30.0	42.9	25.4	37.0	37.0	29.3	23.8	58.6	40.5	42.7	28.6	39.2	34.8	19.1	33.0	45.7	34.6	30.7	42.3	33.0	24.0	50.0	17.2	29.1	36.8	33.8	31.6	40.4	24.8	20.2	33.1	25.9	45.0	37.5	65.2	22.4	28.4	25.2	79.7	39.7	74.8	38.6	43.5	44.6	48.8	35.2	41.1	45.9	43.3	41.1	40.6	27.9	48.8	46.0	20.3	50.4	37.4	14.6	16.6	41.2	18.5	13.3	16.9	16.0	15.8	17.5	15.9	16.7	19.4	25.0	28.9	14.1	56.2	38.2	31.0	31.9	29.0	25.0	34.9	17.7	14.9	23.1	24.3	27.2	12.9	33.3	29.9	35.6	25.1	11.7	20.2	7.3	16.2	22.3	23.4	23.4	59.6	101.9	14.6	27.6	23.4	31.1	19.5	35.4	24.1	24.3	24.6	22.5	43.7	93.6	16.9	30.5	32.7	39.2	7.3	30.4	35.2	19.6	70.3	27.2	25.0	39.1	128.2	120.8	14.8	17.2	22.2	26.8	28.1	17.0	26.1	17.4	47.0	13.1	30.2	31.5	43.4	32.2	22.3	28.4	34.1	30.9	19.6	17.4	28.3
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing X-linked 1"	Q9P291	X	101550547-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 74.9;ASC TERT1: 66.9;BJ hTERT+ SV40 Large T+ RasG12V: 78.2;LHCN-M2: 70.7;RH-30: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000268, HPA005685, CAB020695"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	"Nucleoplasm, Cytosol"	"CAB020695: , HPA000268: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	24.4	34.0	16.8	8.8	18.4	3.1	21.9	14.9	21.9	32.3	18.2	31.4	7.0	30.4	21.2	11.4	25.2	17.5	32.8	18.0	19.5	13.7	4.0	16.5	5.5	16.2	17.9	48.3	12.8	16.9	25.9	14.9	18.8	24.3	7.6	12.0	14.1	23.0	27.7	10.9	12.0	21.2	15.6	14.1	14.8	5.9	17.7	6.3	16.4	25.5	3.4	23.2	21.7	17.9	2.1	0.6	16.0	0.0	74.9	66.9	0.2	25.5	49.7	31.4	78.2	0.0	0.4	0.0	21.3	39.3	34.2	2.1	0.0	3.7	17.7	0.1	0.0	14.9	5.1	0.0	39.6	0.0	0.2	56.5	4.8	23.8	0.0	25.9	19.2	0.0	0.3	0.3	70.7	1.0	0.0	0.1	23.1	0.0	0.2	0.0	87.8	0.1	21.6	0.0	15.8	13.1	0.0	0.3	45.9	4.4	2.5	11.0	25.6	18.9	10.0	55.5	0.3	0.0	0.3	0.0	18.6	0.0	12.1	0.0	3.3	0.4	0.0	3.1	0.5	0.0	0.4	0.3	7.7	0.2	1.1	2.7	0.1	1.8	0.9	4.0	0.8	1.6	16.8	18.4	14.9	21.9	18.0	19.5	16.2	17.9	18.8	15.6	17.7	17.9	27.6	25.6	7.4	8.5	0.7	33.1	22.9	5.0	18.2	32.2	19.1	17.4	59.7	7.2	4.1	23.9	6.2	1.6	3.7	0.6	13.7	21.1	0.3	10.4	23.2	29.9	5.4	4.2	9.5	7.1	2.6	53.2	9.2	11.2	24.1	20.0	20.7	0.8	27.9	21.9	11.8	2.2	2.0	9.5	33.4	2.0	47.2	17.5	58.7	4.7	5.7	36.0	0.0	11.1	8.4	5.6	0.1	44.4	0.4	20.6	0.6	13.6	3.6	13.9	46.0	60.6	39.9	1.6	0.7	3.8	21.7	2.6	2.3	35.6	2.5	7.5
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing X-linked 2"	Q7L311	X	101655281-101659850	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 154.8"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 59.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 164.1;NTERA-2: 117.2;SuSa: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	17.0	46.2	28.7	11.5	29.1	0.5	17.6	22.8	29.7	36.9	26.5	25.4	5.4	30.6	154.8	9.2	28.8	20.6	33.2	29.1	31.6	28.3	3.2	16.8	8.5	25.9	26.2	47.8	18.9	71.2	78.3	26.3	27.5	28.3	7.9	15.3	44.5	67.9	6.2	6.5	13.0	32.3	23.4	21.3	16.3	5.8	28.1	7.7	59.7	7.5	6.5	26.9	20.1	25.4	0.0	0.0	50.8	0.4	43.6	39.4	0.4	56.0	70.4	1.4	1.4	0.0	21.8	0.0	0.0	74.6	0.0	1.5	0.0	1.3	0.6	0.0	2.0	0.2	60.9	0.0	46.4	0.4	0.1	63.7	17.6	43.5	0.4	68.3	59.7	0.0	0.2	0.3	164.1	0.0	0.0	0.6	117.2	3.4	0.3	14.5	88.9	0.3	2.8	0.0	20.4	36.6	0.0	0.2	1.7	90.3	25.9	0.1	13.0	61.9	65.1	38.8	0.4	0.0	0.0	0.2	55.7	0.1	1.2	0.0	0.4	0.0	1.0	0.9	0.4	2.8	0.9	0.9	0.7	4.0	2.4	2.5	0.0	2.8	0.6	0.9	0.7	1.1	28.7	29.1	22.8	29.7	29.1	31.6	25.9	26.2	27.5	23.4	28.1	25.4	10.4	16.0	6.4	8.5	8.2	4.2	16.4	5.8	21.1	12.5	18.0	20.8	28.7	5.7	11.4	33.1	8.4	1.2	2.4	0.1	3.9	9.6	0.2	11.2	23.4	13.3	9.1	3.2	15.4	2.0	0.7	28.4	4.6	15.2	2.5	18.1	19.2	0.7	3.8	1.7	14.3	3.0	2.0	2.4	6.5	1.3	24.2	7.4	5.4	11.2	7.1	9.3	0.0	16.1	14.0	2.2	0.1	24.5	2.8	16.5	0.3	4.3	4.9	11.3	59.2	31.8	23.9	1.4	1.9	3.8	3.0	5.1	2.5	4.6	1.6	7.2
ARMCX3	"ALEX3, GASP6"	ENSG00000102401	"Armadillo repeat containing X-linked 3"	Q9UH62	X	101622797-101627843	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000325, HPA000967, HPA001530"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349"	"unprognostic (1.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.23e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-2)"	34.9	58.9	30.8	24.4	33.0	14.7	32.2	35.4	35.7	45.0	27.6	31.5	20.2	40.9	105.3	18.1	27.7	34.0	51.0	34.1	38.7	37.2	24.6	29.5	21.8	34.5	33.7	38.3	57.4	103.6	47.7	45.4	34.8	44.5	21.8	19.0	59.6	46.7	30.7	11.9	21.5	36.3	35.4	41.3	29.7	12.9	35.5	20.1	49.9	63.6	21.5	31.9	22.5	37.7	26.4	18.8	48.8	23.9	109.4	118.3	10.0	56.5	54.3	23.2	68.3	20.7	21.5	9.5	31.7	64.7	50.8	5.0	34.9	20.2	28.7	21.6	23.2	18.7	64.9	30.2	85.2	18.2	41.5	67.0	27.4	30.9	30.3	65.1	47.6	11.6	15.2	78.9	67.4	10.9	15.0	0.8	24.4	49.5	4.3	19.1	62.2	8.9	36.0	10.1	22.1	18.9	28.3	1.5	63.9	67.7	19.2	19.0	67.5	29.8	18.9	70.8	11.2	69.7	20.9	0.1	50.4	14.5	25.5	43.6	15.3	13.6	14.6	15.8	18.3	15.0	14.0	12.4	15.8	9.8	15.2	10.6	5.6	13.7	16.8	25.8	9.0	14.4	30.8	33.0	35.4	35.7	34.1	38.7	34.5	33.7	34.8	35.4	35.5	37.7	67.4	44.8	36.1	16.3	61.1	37.9	81.2	40.6	42.7	63.1	70.9	42.3	114.6	50.1	48.4	75.4	58.4	55.3	61.1	20.4	37.2	53.9	0.6	42.2	80.9	69.2	82.4	25.6	35.9	30.6	27.4	85.8	33.1	78.8	79.1	45.5	58.2	48.6	50.7	62.2	41.8	67.6	40.7	52.5	84.9	2.8	64.7	72.3	97.8	18.7	27.2	86.6	34.0	28.6	31.0	30.6	22.1	72.6	122.6	75.2	20.1	43.1	25.1	13.3	32.9	57.1	73.2	2.5	0.4	24.6	21.5	114.9	58.0	70.2	32.1	81.2
ARMCX4	"CXorf35, GASP4, MGC40053"	ENSG00000196440	"Armadillo repeat containing X-linked 4"	Q5H9R4	X	101418287-101533459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.6;Excitatory neurons: 59.1;Inhibitory neurons: 87.5;Microglial cells: 63.7;Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 75.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000429, HPA051930"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Vesicles	"HPA000429: AB_1078210, HPA051930: AB_2681665"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.81e-3)"	"unprognostic (7.28e-2)"	"unprognostic (3.67e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.29e-1)"	"prognostic favorable (8.20e-5)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.92e-2)"	2.1	4.0	1.8	1.1	2.1	0.7	2.7	1.4	2.0	2.8	0.0	2.5	0.9	3.6	2.5	1.0	3.0	1.3	1.8	2.0	3.0	2.4	1.0	1.8	0.9	1.8	2.1	7.1	2.0	4.5	4.5	1.7	2.1	3.6	1.6	1.6	1.9	4.7	1.9	2.1	2.1	2.6	1.1	1.7	1.8	0.9	2.2	0.9	2.7	1.0	0.8	2.3	1.8	2.3	2.4	0.6	7.9	0.0	3.7	3.9	0.8	5.5	4.3	4.4	8.5	1.9	0.7	0.0	2.1	8.2	0.1	0.9	0.0	0.1	7.2	0.0	0.9	0.6	2.5	0.0	2.2	0.0	3.0	2.4	0.4	9.6	0.0	0.0	7.8	0.0	0.0	0.7	2.0	0.0	0.3	0.3	5.8	0.8	0.0	0.4	6.5	0.0	1.1	1.4	5.3	4.9	0.8	0.0	3.0	1.3	0.6	1.2	2.9	2.0	1.2	6.1	0.0	0.0	0.0	0.0	3.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.4	2.0	2.0	3.0	1.8	2.1	2.1	1.1	2.2	2.3	8.7	3.2	6.8	66.6	2.2	2.4	7.7	1.7	5.7	24.5	9.1	7.1	10.5	2.8	7.9	27.6	8.4	1.7	2.6	2.3	17.6	2.7	0.2	5.6	8.9	8.0	3.0	1.3	59.1	2.3	0.7	11.0	2.0	8.3	3.8	13.3	5.3	2.5	2.3	23.5	87.5	2.3	6.1	3.8	5.1	0.7	10.5	2.4	17.8	63.7	2.8	11.6	4.1	78.4	75.6	2.0	3.9	12.4	2.2	5.3	4.7	4.8	9.8	7.8	0.0	8.1	10.9	1.3	1.3	1.8	3.4	1.5	2.2	8.4	4.0	4.5
ARMCX5-GPRASP2		ENSG00000286237	"ARMCX5-GPRASP2 readthrough"		X	102712495-102753530	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	470	"Astrocytes: 29.7;Excitatory neurons: 67.9;Inhibitory neurons: 74.3;Microglial cells: 24.4;Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 35.6"					"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9"									HPA000887			Uncertain	Nucleoplasm,Cytosol		NA	NA					"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA000887: AB_2666130"																		0.1	0.6	0.6	0.0	0.6	0.0	0.2	1.2	1.2	0.4	0.0	0.1	0.0	0.7	0.6	0.3	0.6	0.3	0.6	0.4	0.7	0.2	0.0	0.2	0.0	0.7	0.5	1.2	0.2	0.6		0.2	0.8	0.4	0.2	0.9	0.2	0.7	0.2	0.2	0.1	0.6	0.2	0.1	0.1	0.1	0.2	0.2	0.6	0.6	0.1	0.1		0.8	0.1	0.4	2.9	0.7	1.2	0.7	0.4	0.3	0.5	0.3	0.9	0.0	0.0	0.0	0.1	0.2	1.0	0.1	1.6	0.0	0.2	0.0	0.9	0.0	1.0	0.2	0.1	0.0	0.5	0.5	0.5	0.3	0.0	1.1	0.5	0.1	0.0	0.0	0.8	0.0	0.5	0.1	0.7	0.4	0.7	0.3	0.8	0.0	0.0	0.2	0.4	0.6	0.5	0.1	0.1	0.6	0.2	0.1	0.2	0.4	0.6	0.5	0.3	0.0	0.1	0.0	1.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	1.2	1.2	0.4	0.7	0.7	0.5	0.8	0.2	0.2	0.8	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	50.3	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARMCX6	"FLJ20811, GASP10"	ENSG00000198960	"Armadillo repeat containing X-linked 6"	Q7L4S7	X	101615118-101618001	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043030, HPA048125"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nucleoplasm, Nuclear membrane"	"HPA043030: AB_2678277, HPA048125: AB_2680275"	"unprognostic (1.20e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.38e-2)"	9.4	14.6	11.8	9.6	12.1	8.2	11.7	13.0	13.8	14.2	11.9	11.1	6.2	15.8	22.7	9.3	12.6	10.5	15.3	11.7	12.7	13.0	7.6	9.6	12.8	13.9	12.6	19.1	17.4	26.3	17.1	15.7	13.5	13.7	8.1	5.3	24.5	18.3	6.7	10.7	9.0	14.8	12.9	19.2	9.5	4.4	12.4	13.8	14.2	8.3	13.8	11.2	11.3	14.6	13.7	15.7	24.2	13.8	48.4	28.6	4.8	28.0	27.0	24.5	47.5	9.4	12.8	14.4	28.0	26.4	25.5	13.9	23.8	11.3	19.1	12.6	14.4	13.5	22.6	12.8	22.2	13.4	16.4	17.9	11.3	15.1	7.8	34.3	25.4	7.4	11.3	18.0	37.3	33.0	19.8	0.2	17.5	17.7	3.1	20.0	32.5	5.5	17.7	1.8	13.3	12.5	16.4	0.1	21.0	18.3	11.4	6.4	19.8	29.7	13.4	41.8	6.6	22.1	12.6	0.0	8.9	3.5	9.9	11.3	3.7	6.1	5.8	6.7	7.5	13.2	6.1	6.4	7.6	9.0	7.3	6.9	0.4	8.3	5.1	13.2	3.6	6.2	11.8	12.1	13.0	13.8	11.7	12.7	13.9	12.6	13.5	12.9	12.4	14.6	23.9	9.6	9.1	5.2	28.5	13.4	14.4	28.3	26.2	5.5	39.3	44.4	9.7	14.3	16.3	31.3	16.7	37.8	40.6	2.2	23.5	44.2	0.6	21.9	23.7	27.2	16.4	13.0	1.9	27.7	17.3	24.6	19.9	38.0	14.5	30.2	25.4	15.7	67.9	10.1	3.3	14.2	16.2	29.0	32.3	2.2	18.6	40.8	37.4	5.6	28.5	30.3	36.0	8.5	4.9	26.5	11.2	19.9	23.8	18.3	7.6	25.0	5.5	4.6	26.3	13.1	22.4	2.6	2.3	32.7	16.1	34.5	26.0	29.5	11.7	20.8
ARMT1	"C6orf211, FLJ12910"	ENSG00000146476	"Acidic residue methyltransferase 1"	Q9H993	6	151452258-151470101	"Predicted intracellular proteins"	"DNA damage"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003004, HPA005819"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		410000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA003004: AB_1078358, HPA005819: AB_1845741"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.22e-1)"	17.1	16.0	8.5	15.3	9.5	5.5	25.0	9.6	12.2	16.1	8.3	16.6	18.9	16.0	16.1	12.0	12.6	11.3	16.8	8.6	10.0	41.5	37.6	19.5	21.0	9.0	9.1	11.9	6.8	11.6	5.3	22.2	9.1	12.2	17.6	16.4	7.6	11.1	19.0	8.8	14.5	14.9	9.6	12.8	14.1	14.1	9.8	15.6	27.7	22.6	18.5	17.3	8.1	9.0	24.6	18.4	37.9	34.2	30.3	47.4	60.9	44.8	39.1	36.9	48.4	47.8	19.7	36.2	29.5	31.8	33.7	24.2	112.7	33.5	61.7	40.6	34.9	26.0	21.7	55.9	37.8	50.1	31.7	38.2	23.3	49.3	29.2	30.6	52.8	27.0	38.5	44.3	46.4	101.8	31.7	47.4	64.4	23.7	15.3	41.0	32.7	28.6	112.6	31.2	15.6	10.2	37.5	34.9	23.8	67.4	98.9	38.6	44.6	17.9	25.0	66.8	36.3	21.1	28.5	43.7	31.7	60.7	21.6	53.8	26.9	52.0	13.5	34.5	18.1	17.5	17.4	14.5	22.9	14.7	15.9	14.8	22.1	21.0	33.4	8.5	25.1	21.1	8.5	9.5	9.6	12.2	8.6	10.0	9.0	9.1	9.1	9.6	9.8	9.0	16.3	25.6	40.4	6.5	13.2	0.0	8.4	0.0	11.4	10.0	33.5	16.3	18.6	14.3	6.2	23.9	8.4	31.7	12.6	10.6	45.0	19.5	1.4	19.4	29.3	10.6	4.9	6.5	11.4	17.8	39.0	14.2	12.2	23.3	3.8	7.7	15.4	48.7	35.4	8.4	9.8	8.9	0.0	34.0	0.0	3.1	19.3	23.6	0.0	5.6	36.0	17.3	18.6	6.6	8.9	19.5	7.2	14.7	15.2	5.4	18.6	79.3	10.9	20.9	0.0	6.7	14.3	25.2	14.8	11.1	0.0	36.0	14.0	15.5	10.7	9.6
ARNT	"bHLHe2, HIF-1beta"	ENSG00000143437	"Aryl hydrocarbon receptor nuclear translocator"	P27540	1	150809713-150876708	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"U-698: 397.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001759, CAB004318"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nuclear bodies"		"CAB004318: AB_626698, HPA001759: AB_1078213"	"unprognostic (1.81e-1)"	"unprognostic (8.14e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.27e-3)"	"unprognostic (5.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.67e-1)"	"unprognostic (6.45e-2)"	"unprognostic (6.92e-2)"	25.8	20.4	9.6	18.1	9.6	17.1	22.7	16.2	12.2	31.8	16.5	19.5	15.0	27.4	14.8	19.2	25.0	20.5	20.7	8.9	10.7	17.8	42.9	24.7	17.5	10.4	9.5	37.7	28.6	19.6	12.5	31.2	10.2	16.3	21.2	39.1	15.5	17.6	32.3	23.9	17.0	29.0	8.0	19.5	19.0	17.3	10.9	20.4	19.6	28.1	22.4	21.3	24.0	11.2	17.1	17.2	25.6	19.5	53.4	50.9	34.2	19.0	36.9	25.2	22.7	15.1	17.0	18.3	16.5	34.0	12.4	19.1	24.2	21.3	21.9	29.3	13.8	21.4	28.7	17.6	31.0	26.4	24.7	39.9	20.0	30.7	26.9	30.6	31.3	24.4	27.9	34.9	26.3	33.8	21.1	15.0	21.2	30.9	13.0	26.1	30.8	25.5	20.6	17.4	17.6	25.1	36.6	25.3	15.2	34.4	32.6	59.4	22.6	20.9	18.8	16.8	16.8	39.8	30.8	397.5	25.5	0.9	14.4	46.6	23.6	21.2	12.1	21.6	11.1	8.7	10.0	11.7	18.7	8.7	9.5	9.8	11.9	12.0	23.4	7.8	11.1	16.2	9.6	9.6	16.2	12.2	8.9	10.7	10.4	9.5	10.2	8.0	10.9	11.2	14.8	12.8	10.3	28.1	14.9	14.1	9.9	11.0	8.0	23.6	10.2	6.9	12.8	24.3	11.6	11.0	54.2	24.5	12.6	13.3	3.9	11.2	5.0	10.3	23.3	14.8	20.4	16.6	41.6	9.7	37.1	25.4	8.6	20.6	3.8	17.1	30.0	47.7	20.3	6.7	47.5	16.5	8.2	39.1	20.1	4.3	32.3	20.0	10.6	39.4	27.9	7.9	13.4	41.7	50.9	9.6	8.1	32.7	13.0	8.8	10.1	13.1	9.7	38.3	13.1	17.0	19.4	18.4	16.7	11.0	15.3	29.6	12.7	20.7	9.0	10.0
ARNT2	"bHLHe1, KIAA0307"	ENSG00000172379	"Aryl hydrocarbon receptor nuclear translocator 2"	Q9HBZ2	15	80404350-80597933	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 128.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 209.6;Excitatory neurons: 204.7;Inhibitory neurons: 301.5;Microglial cells: 98.4;Oligodendrocyte precursor cells: 232.7;Oligodendrocytes: 136.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 28.4;BJ hTERT+ SV40 Large T+ RasG12V: 28.2;hTERT-RPE1: 29.7;LHCN-M2: 26.0;SK-MEL-30: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001056, CAB005081"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB005081: AB_2243005, HPA001056: AB_1845042"	"unprognostic (2.04e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.46e-6)"	"unprognostic (2.20e-1)"	"prognostic favorable (7.51e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.62e-2)"	2.2	2.1	94.4	2.1	100.6	0.4	1.4	47.8	111.7	5.6	29.8	5.8	1.7	5.9	8.2	2.0	5.3	2.5	4.1	128.0	64.2	21.7	0.4	5.0	2.3	61.8	70.5	10.7	3.4	6.4	11.5	1.1	53.6	5.5	2.1	8.1	1.2	5.0	9.7	2.1	2.7	3.9	60.2	3.5	4.1	9.9	84.0	2.2	7.0	6.0	3.0	4.3	2.0	66.7	0.4	16.1	28.4	0.0	0.1	3.6	0.1	12.2	17.3	13.9	28.2	0.0	0.0	0.0	3.0	14.7	7.2	0.4	10.5	0.6	17.7	0.0	2.9	0.5	0.0	1.0	0.9	0.0	7.2	13.2	0.5	6.1	0.3	29.7	0.0	0.0	0.0	0.1	26.0	14.0	0.0	0.0	5.7	0.0	0.2	0.0	0.3	0.0	6.0	20.5	14.9	20.6	1.5	0.2	30.8	1.8	0.6	0.0	0.0	22.2	4.4	0.6	14.7	0.0	0.0	0.0	8.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.4	100.6	47.8	111.7	128.0	64.2	61.8	70.5	53.6	60.2	84.0	66.7	0.1	0.0	2.3	209.6	0.0	1.3	1.2	1.5	4.0	17.0	3.2	3.4	7.6	2.8	4.7	3.7	8.4	0.2	0.1	0.2	13.7	6.0	36.7	8.5	2.7	1.8	22.9	0.0	204.7	0.2	3.6	2.7	3.1	4.4	2.5	5.7	0.4	0.0	0.2	1.7	301.5	2.6	8.2	0.0	1.6	39.8	0.6	0.4	7.2	98.4	0.1	5.9	2.1	232.7	136.9	2.4	2.3	3.0	0.0	2.2	0.3	1.0	1.6	9.3	6.6	2.6	2.5	2.1	3.0	0.5	0.3	2.7	0.6	1.9	1.3	1.4
ARNTL	"bHLHe5, BMAL1, JAP3, MOP3, PASD3"	ENSG00000133794	"Aryl hydrocarbon receptor nuclear translocator like"	O00327	11	13276652-13387266	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 63.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 11.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045962, HPA050938"	Supported		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB045962: AB_11124144, HPA050938: AB_2681282"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.08e-2)"	15.0	13.3	3.2	5.1	4.8	7.4	14.1	4.8	8.3	10.5	3.2	12.4	5.2	11.6	1.6	10.5	11.5	4.0	9.5	5.5	1.9	7.2	19.4	15.0	5.8	1.6	2.6	19.7	10.3	1.5	12.3	4.4	2.2	8.5	4.1	23.4	12.7	3.4	27.0	17.6	12.4	5.6	1.9	11.6	10.9	10.9	4.4	14.1	18.9	8.2	6.4	9.3	11.5	7.4	8.2	9.0	7.5	4.0	15.0	9.0	5.7	9.5	8.1	8.6	9.7	3.7	10.9	0.1	2.6	5.2	10.4	3.4	5.3	10.3	7.7	13.6	6.3	3.9	6.6	1.8	23.7	1.8	16.2	10.1	21.3	3.7	14.1	5.9	6.2	12.6	2.5	14.9	6.9	4.7	4.7	0.9	1.6	5.4	4.3	5.1	11.4	3.4	5.7	1.8	1.2	12.2	6.1	0.7	7.6	7.1	5.7	7.0	11.5	6.2	6.8	20.3	5.5	4.1	12.0	0.0	6.4	4.1	8.3	4.3	8.3	17.9	18.1	9.0	25.2	2.6	16.8	15.6	8.4	3.1	9.4	11.1	24.5	14.1	8.9	1.1	11.1	10.7	3.2	4.8	4.8	8.3	5.5	1.9	1.6	2.6	2.2	1.9	4.4	7.4	4.9	25.6	21.0	49.9	9.0	30.8	13.4	7.3	10.2	28.3	6.1	5.0	8.8	10.0	11.1	1.8	16.7	17.6	34.8	8.6	17.6	6.8	1.5	6.1	14.2	6.6	1.2	3.0	63.6	6.4	2.2	10.3	11.7	12.9	2.5	6.9	10.8	22.9	8.2	30.3	30.5	4.6	4.1	14.0	12.3	4.2	12.8	11.9	3.6	18.7	13.1	18.8	32.0	34.2	11.9	8.3	9.3	19.9	11.5	8.0	13.5	11.3	5.3	30.9	13.1	6.6	10.7	4.7	5.4	9.4	32.4	6.3	33.0	4.7	4.5	12.0
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.1;lymphoid tissue: 22.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 45.6;Excitatory neurons: 78.8;Pancreatic endocrine cells: 86.9;Prostatic glandular cells: 109.0;Urothelial cells: 128.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.4"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 121.9;U-2197: 159.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli"		"HPA059074: AB_2683897"	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.0	1.0	1.3	10.0	6.4	2.3	2.1	0.0	3.6	5.8	0.0	2.5	2.8	1.2	0.2	28.1	0.9	3.6	0.8	2.8	1.6	1.1	4.7	2.3	5.2	0.0	0.5	0.2	1.3	1.5	0.8	2.8	0.0	1.1	3.2	0.4	7.2	0.6	0.2	7.6	2.6	4.6	0.0	1.0	10.9	2.7	0.6	4.4	0.6	0.8	22.2	14.7	11.9	2.2	76.0	19.2	4.2	1.6	3.6	11.0	58.3	26.3	34.5	16.8	26.2	18.2	57.4	0.6	14.4	12.6	51.9	30.6	12.3	92.1	42.7	121.9	15.7	14.6	11.7	15.2	4.8	29.6	6.1	4.0	8.1	58.8	45.6	28.9	80.0	17.7	7.5	29.8	19.6	9.2	16.2	16.2	32.1	25.7	65.8	29.8	68.2	4.7	14.1	42.8	13.6	2.2	13.5	2.1	0.4	10.0	2.9	9.7	54.6	54.2	31.4	159.5	110.0	4.4	8.4	0.1	46.5	23.5	10.9	1.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.5	0.0	1.3	6.4	0.0	3.6	2.8	1.6	0.0	0.5	0.0	0.0	0.6	2.2	2.1	3.2	1.3	1.3	0.4	0.8	45.6	8.6	1.2	0.9	1.6	0.8	0.9	11.5	7.5	9.2	0.0	1.9	0.3	1.5	0.0	22.1	3.8	7.9	0.7	6.9	1.2	3.4	78.8	27.4	4.0	3.2	28.1	11.8	0.0	5.3	2.5	3.5	1.4	0.0	24.8	3.3	2.0	2.5	5.4	4.4	0.0	2.9	1.8	7.5	15.7	0.0	0.0	8.5	2.3	86.9	1.4	0.0	3.4	109.0	1.7	0.6	2.7	0.1	0.0	1.7	3.6	3.1	4.7	6.6	2.3	4.2	1.3	0.2	2.1	128.2
ARPC2	"ARC34, p34-Arc"	ENSG00000163466	"Actin related protein 2/3 complex subunit 2"	O15144	2	218217141-218254356	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001994, HPA008352, HPA052703"	Approved		Supported	Nucleoplasm		NA	NA		6600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"CAB001994: , HPA008352: AB_1854887, HPA052703: "	"unprognostic (7.42e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.41e-2)"	205.4	121.8	114.0	361.4	125.6	544.1	163.5	109.4	130.8	163.1	117.4	252.8	200.3	153.3	161.8	460.5	146.3	211.3	167.3	135.2	123.1	155.0	152.8	259.7	505.2	115.1	114.7	121.3	122.1	115.4	94.7	295.0	116.4	132.1	274.8	77.4	163.6	176.0	385.3	293.4	226.5	291.2	117.8	294.6	251.5	149.7	118.2	298.3	115.3	250.8	626.0	402.0	231.7	125.4	438.3	188.3	264.1	198.0	346.6	463.6	489.4	680.5	640.7	551.2	549.5	588.6	452.0	358.6	347.6	764.7	396.8	492.3	362.6	985.4	645.4	284.2	296.5	362.1	279.0	325.8	386.8	764.2	968.9	310.2	784.1	552.0	454.6	515.1	731.3	294.1	179.5	681.4	858.6	304.3	416.8	888.6	310.8	500.8	201.1	307.2	235.0	488.7	556.8	787.8	156.3	278.8	246.7	265.8	590.0	544.4	192.7	689.2	642.1	709.5	268.1	321.9	507.8	359.8	418.8	624.7	515.1	472.9	548.2	1728.0	1318.5	1975.5	930.7	1773.7	626.1	785.9	720.7	913.6	1330.1	658.5	505.7	750.0	2200.3	698.9	2060.4	734.3	1039.0	2503.2	114.0	125.6	109.4	130.8	135.2	123.1	115.1	114.7	116.4	117.8	118.2	125.4	334.8	285.2	326.6	21.2	506.7	928.5	691.0	1140.2	425.2	89.8	150.3	189.7	145.3	200.1	465.4	172.9	56.3	944.5	902.3	595.0	342.4	585.8	604.0	220.6	288.5	363.5	319.7	144.9	48.5	658.7	1509.4	301.7	242.6	222.4	414.5	600.6	281.3	98.4	1094.0	58.9	33.1	329.4	364.2	779.9	1321.0	759.3	214.0	896.1	414.4	53.4	1721.9	175.3	1336.7	30.7	33.7	919.8	604.5	326.5	529.9	762.7	510.9	342.8	249.6	95.3	302.4	131.6	571.2	324.4	227.9	645.2	970.6	1045.8	694.1	285.6	337.6	1126.5
ARPC3	"ARC21, p21-Arc"	ENSG00000111229	"Actin related protein 2/3 complex subunit 3"	O15145	12	110434823-110450422	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006550	Approved		Uncertain	Nucleoplasm		NA	NA		3800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA006550: AB_1854869"	"unprognostic (1.83e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.15e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (9.96e-2)"	"prognostic unfavorable (2.22e-11)"	"unprognostic (3.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.79e-3)"	196.5	205.3	160.2	365.7	167.7	774.3	213.5	160.2	228.2	205.5	165.9	324.0	259.5	151.6	298.3	367.1	162.2	253.1	153.0	167.3	171.5	241.6	262.4	264.7	578.8	172.9	166.9	107.2	171.6	174.8	163.6	276.6	170.8	166.9	344.1	60.4	205.0	152.1	106.7	156.5	258.2	206.6	169.4	366.3	263.3	106.9	165.1	343.3	184.2	102.5	573.7	355.8	206.5	180.5	452.0	360.8	307.0	196.4	318.3	600.2	411.5	476.0	550.1	594.6	578.6	392.9	350.1	654.7	359.3	559.7	354.4	340.1	343.9	520.7	647.7	377.7	415.6	562.1	146.6	385.1	519.7	565.6	842.4	422.6	555.3	375.3	347.8	736.2	756.3	434.5	366.2	170.3	746.3	365.6	661.6	1390.3	302.7	525.8	428.6	510.9	181.5	559.4	1050.5	581.0	346.6	342.2	334.0	464.7	427.1	453.8	757.8	933.8	630.0	350.5	195.7	312.9	349.9	332.7	507.0	914.8	458.0	568.1	425.1	1313.6	1022.6	1660.3	352.4	1182.3	322.2	692.3	361.1	398.7	987.2	604.5	267.0	349.5	1607.5	418.3	1417.4	632.7	619.8	1547.5	160.2	167.7	160.2	228.2	167.3	171.5	172.9	166.9	170.8	169.4	165.1	180.5	316.2	189.1	239.5	16.6	619.4	159.5	315.8	810.1	145.1	36.1	222.3	252.2	52.2	208.8	555.8	268.5	12.5	538.2	582.4	473.2	579.2	636.3	131.2	373.6	241.1	269.0	274.1	244.0	32.4	535.1	824.0	199.0	190.6	459.6	491.8	245.8	227.7	165.5	1432.0	53.8	25.1	538.9	537.1	918.9	781.2	45.3	172.4	935.9	240.1	45.9	1221.8	184.1	545.8	23.6	41.6	630.2	665.2	157.6	352.5	313.5	422.2	777.0	407.3	35.6	249.8	108.4	329.6	209.8	200.1	365.5	171.9	721.6	462.6	323.3	401.1	629.3
ARRB1	ARR1	ENSG00000137486	"Arrestin beta 1"	P49407	11	75260122-75351705	"Predicted intracellular proteins, Transporters"	"Protein transport, Transcription, Transcription regulation, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 136.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 42.5;granulocytes: 49.5;monocytes: 136.8"	"Cell line enhanced"	"Detected in many"		"HEL: 168.9;RH-30: 114.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003763, HPA049318, HPA070249"	Approved		Supported	Nucleoplasm		NA	NA		1500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB003763: AB_562248, HPA049318: AB_2680711, HPA070249: AB_2732151"	"unprognostic (3.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	30.7	7.1	49.7	21.9	49.4	15.7	24.1	28.3	49.5	10.0	0.0	26.4	21.9	10.2	6.1	19.0	15.9	12.9	17.6	54.3	43.6	14.2	10.1	53.0	15.3	41.1	55.6	16.2	24.5	3.8	4.1	25.1	49.4	16.3	22.5	5.3	12.7	9.7	11.4	16.8	27.2	21.8	23.2	40.1	33.9	4.3	49.9	9.9	8.8	10.9	10.3	16.5	11.0	36.7	5.1	23.6	24.2	12.0	20.2	17.6	48.8	5.0	17.2	6.2	4.3	34.5	23.9	2.0	58.9	4.5	4.7	1.1	9.5	0.1	2.4	0.2	5.5	168.9	3.3	20.6	5.5	5.1	63.9	8.9	1.2	10.3	0.0	7.4	70.4	6.1	83.5	0.2	12.2	14.1	3.1	58.4	17.8	76.9	7.1	18.8	114.4	6.8	26.8	20.4	12.5	13.5	8.7	61.7	15.0	49.3	44.8	27.6	61.0	4.7	5.9	19.3	0.6	0.1	0.1	0.1	3.5	78.0	5.8	33.7	65.7	45.9	11.6	106.5	4.3	0.4	5.5	6.6	42.5	0.2	5.0	6.6	49.5	14.8	136.8	0.9	5.7	41.1	49.7	49.4	28.3	49.5	54.3	43.6	41.1	55.6	49.4	23.2	49.9	36.7	24.2	28.9	14.8	52.2	1.9	1.9	2.0	1.9	2.8	3.1	9.0	14.7	4.6	8.6	5.8	3.7	6.2	41.7	10.7	38.5	1.9	5.0	2.6	0.8	4.3	19.4	5.4	10.3	35.6	8.4	4.1	9.1	17.3	0.9	23.5	2.3	25.7	2.1	39.6	0.0	48.9	11.1	8.2	55.2	17.9	21.4	15.8	31.2	3.6	55.3	42.1	0.2	29.9	8.0	23.9	9.2	19.1	16.6	1.0	3.6	29.9	0.2	4.7	1.1	13.1	4.5	7.7	0.2	0.8	1.0	3.0	33.7	5.9	9.4	20.0	2.8
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710596-4721499	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 263.6;lymphoid tissue: 168.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 262.0;Kupffer cells: 242.5;Langerhans cells: 164.2;Macrophages: 226.4;monocytes: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 195.8;HMC-1: 315.9;NB-4: 199.2;U-937: 279.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075177			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA075177: "	"unprognostic (1.12e-1)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	48.6	39.7	54.4	110.0	53.8	263.6	26.1	48.2	62.2	19.3	49.1	29.5	50.5	17.4	10.8	15.1	29.0	31.4	25.0	63.8	67.7	25.2	35.6	94.8	59.4	61.6	58.3	17.5	19.4	16.4	24.9	35.5	59.5	19.5	27.6	16.9	20.9	11.7	12.7	14.6	51.1	29.6	55.4	168.3	35.0	7.2	59.5	45.2	15.8	18.1	38.0	41.6	17.6	66.5	17.3	88.7	34.7	32.9	6.8	9.5	18.6	13.7	18.0	38.4	48.0	31.0	14.2	49.1	12.2	10.3	18.3	28.5	58.0	18.4	39.4	116.6	85.0	195.8	46.8	55.6	10.2	89.2	315.9	8.8	23.5	47.9	18.7	24.9	29.6	89.1	13.5	46.4	8.9	30.5	87.9	199.2	18.9	44.9	18.4	104.3	31.0	53.8	13.2	9.2	36.0	49.2	30.8	50.8	23.6	14.2	24.6	40.0	26.1	14.3	29.1	25.1	51.5	19.8	28.6	27.6	37.9	279.4	21.6	116.2	145.5	269.7	49.1	151.1	35.1	10.1	31.1	51.3	84.9	9.0	29.3	38.7	250.6	29.9	168.6	20.7	28.8	93.5	54.4	53.8	48.2	62.2	63.8	67.7	61.6	58.3	59.5	55.4	59.5	66.5	7.7	22.4	32.3	5.5	26.4	11.5	7.7	16.6	3.4	20.5	9.6	12.3	8.3	14.3	47.9	3.7	2.1	7.5	83.8	7.4	15.6	11.2	0.6	1.5	3.6	10.1	8.4	33.9	20.4	7.3	12.0	8.7	19.4	1.8	94.9	7.8	19.2	12.4	262.0	21.9	18.2	17.0	50.8	242.5	164.2	3.5	5.0	226.4	10.6	42.2	311.3	5.8	89.6	7.1	8.4	6.3	22.0	4.9	23.4	4.4	35.5	17.5	24.4	8.7	19.7	10.9	8.5	1.1	13.1	6.8	8.4	6.0	77.2	3.5	11.4	11.7
ARRDC2	"CLONE24945, PP2703"	ENSG00000105643	"Arrestin domain containing 2"	Q8TBH0	19	18001132-18014102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 204.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 114.2;B-cells: 80.3;Cholangiocytes: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 57.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053788, HPA074216"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA053788: AB_2682262, HPA074216: "	"unprognostic (8.10e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.20e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.81e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.87e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.91e-4)"	"prognostic favorable (2.92e-4)"	65.8	10.7	50.9	23.7	61.3	80.0	49.8	52.9	67.2	31.7	34.2	30.8	12.2	22.8	7.7	22.1	27.7	22.8	34.4	43.2	48.4	32.9	20.4	75.0	38.7	64.7	61.1	13.7	16.5	71.6	17.2	14.4	58.0	33.6	12.1	1.3	44.2	18.8	204.8	30.7	43.4	11.1	50.4	58.4	27.7	5.2	53.1	24.8	44.0	49.3	35.0	32.6	32.0	81.3	12.1	21.2	0.4	10.6	8.5	7.8	8.4	6.8	19.3	5.6	5.5	4.8	22.9	22.1	18.9	5.8	9.1	7.9	8.4	6.2	4.4	14.5	12.3	16.8	18.0	6.8	7.8	12.9	24.0	8.4	9.6	6.5	9.9	10.5	9.6	13.9	19.7	0.6	5.4	18.4	9.8	35.6	2.7	26.4	34.9	57.7	0.2	16.8	8.1	11.0	5.0	5.2	11.1	11.0	11.5	1.7	6.7	32.5	21.1	9.7	7.5	32.9	8.6	1.6	0.1	24.8	15.5	48.6	7.7	3.7	5.8	3.6	3.6	4.8	2.5	3.4	6.1	4.6	3.0	5.3	14.1	7.5	2.3	6.6	5.7	1.8	5.1	4.4	50.9	61.3	52.9	67.2	43.2	48.4	64.7	61.1	58.0	50.4	53.1	81.3	114.2	16.0	15.5	1.6	80.3	6.4	19.8	14.0	13.1	0.4	16.7	11.0	7.3	64.3	15.8	9.2	0.0	0.7	47.7	12.7	1.9	10.8	0.8	10.7	13.0	29.9	18.5	44.6	3.8	6.2	7.8	9.2	23.4	29.8	26.6	3.3	17.2	7.0	17.9	0.0	0.5	12.3	16.2	31.0	58.7	1.2	4.7	50.3	5.4	9.4	14.5	1.1	13.4	0.5	20.0	15.4	9.4	7.5	13.6	24.9	3.5	0.5	15.9	0.4	13.1	14.0	15.9	0.5	3.9	7.6	7.1	1.2	38.6	5.0	5.6	26.7
ARSK	"DKFZp313G1735, TSULF"	ENSG00000164291	"Arylsulfatase family member K"	Q6UWY0	5	95555101-95605102	"Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 19.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042384	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA042384: AB_10795703"	"unprognostic (9.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-2)"	3.0	3.7	2.1	2.2	2.3	2.3	3.3	2.8	3.0	3.8	2.1	2.7	2.2	3.6	4.2	2.9	3.2	3.1	2.6	2.4	2.1	5.4	3.7	2.9	2.7	1.9	1.9	5.8	4.9	19.1	2.6	5.5	2.3	4.9	2.5	3.6	2.8	4.9	2.3	3.3	2.2	3.0	1.7	2.4	4.2	1.6	2.6	3.7	5.0	2.7	2.0	3.2	3.3	2.2	5.1	3.2	6.6	6.6	32.4	16.8	9.5	15.9	9.2	6.1	12.4	3.9	7.8	6.9	8.1	5.5	10.9	4.6	5.8	10.1	13.3	7.4	8.5	5.5	7.7	6.7	9.4	3.1	4.4	12.4	8.9	9.2	5.9	12.8	10.0	9.3	5.6	7.4	13.7	2.5	8.5	5.9	8.6	1.6	15.3	5.2	10.6	11.0	14.1	1.2	4.7	4.8	9.7	3.1	10.0	9.1	8.9	3.2	18.1	9.6	7.8	15.0	9.9	6.2	11.2	8.4	9.6	8.0	36.5	12.9	1.1	2.1	4.0	1.2	4.7	4.9	4.7	5.4	0.6	5.0	7.0	5.2	0.9	3.3	0.7	2.2	3.9	1.8	2.1	2.3	2.8	3.0	2.4	2.1	1.9	1.9	2.3	1.7	2.6	2.2	6.8	3.2	2.2	9.1	6.6	4.5	6.8	7.4	5.7	7.3	4.4	7.2	4.6	1.5	3.7	7.3	12.5	11.8	6.6	1.9	3.9	4.1	9.2	7.1	10.3	6.2	3.0	10.1	11.0	2.5	47.4	13.6	2.0	5.7	22.9	8.1	6.8	16.5	4.6	10.1	9.7	2.0	10.2	3.2	5.4	2.9	10.8	4.9	5.4	7.5	5.1	12.7	14.4	7.1	10.0	2.6	3.2	11.7	7.1	3.9	3.2	4.8	6.8	10.4	0.0	10.2	10.9	7.4	8.6	5.1	7.0	5.1	9.8	11.8	3.4	2.1
ASAP3	"CENTB6, DDEFL1, FLJ20199, UPLC1"	ENSG00000088280	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 3"	Q8TDY4	1	23428563-23484568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.9;Extravillous trophoblasts: 43.3;Granulosa cells: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 31.8;ASC TERT1: 29.9;HSkMC: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020537, HPA020546"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	Nucleoplasm	"HPA020537: AB_2670467, HPA020546: AB_2670470"	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (3.87e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (5.12e-5)"	"unprognostic (3.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.27e-2)"	24.1	39.1	11.5	3.2	11.6	0.1	21.9	12.5	12.4	32.6	10.0	18.4	1.6	18.6	4.2	32.3	24.3	5.1	30.1	10.5	11.2	21.4	19.8	15.9	1.6	14.5	12.7	58.3	22.2	11.7	18.6	8.0	13.2	31.0	5.2	3.0	38.0	8.0	42.9	52.9	11.0	5.9	12.7	5.0	25.4	18.2	13.4	1.0	29.0	11.7	4.2	21.3	33.4	12.1	1.8	1.8	17.6	11.6	31.8	29.9	21.6	3.2	3.8	4.9	6.3	1.3	0.1	9.2	3.7	6.3	2.9	8.4	12.2	2.9	2.8	0.4	1.6	0.5	4.8	11.8	17.1	0.0	0.9	38.4	4.4	7.9	7.1	14.6	3.9	1.3	6.4	0.0	3.1	3.9	1.3	0.1	3.0	5.0	4.2	4.9	1.9	0.0	3.4	3.7	0.6	6.0	14.1	3.5	3.5	8.7	13.2	0.1	1.4	2.1	5.2	5.9	0.2	3.9	4.2	1.1	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.5	11.6	12.5	12.4	10.5	11.2	14.5	12.7	13.2	12.7	13.4	12.1	4.5	9.6	6.7	35.9	0.3	2.0	1.5	2.0	2.8	1.1	6.3	3.7	15.5	0.0	4.1	3.7	0.0	2.1	0.0	6.7	3.9	5.8	5.1	2.4	7.3	6.6	1.2	0.0	7.6	6.1	43.3	12.2	10.2	4.4	1.3	28.3	3.9	4.0	1.8	0.0	4.9	8.5	2.0	0.0	1.3	8.1	12.5	0.4	0.0	7.5	0.1	8.3	0.0	18.1	4.2	2.5	2.1	13.5	0.2	2.4	0.8	5.4	4.3	0.6	0.0	2.0	3.4	8.2	11.8	3.7	4.3	1.4	0.2	15.9	5.2	2.1
ASB1	ASB-1	ENSG00000065802	"Ankyrin repeat and SOCS box containing 1"	Q9Y576	2	238426742-238452250	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003508	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA003508: AB_1845065"	"unprognostic (1.02e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (4.04e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-1)"	6.6	5.5	19.1	7.3	18.8	2.9	5.3	14.6	18.1	8.9	9.7	10.1	3.9	10.7	3.7	5.0	8.6	5.3	16.2	17.0	18.6	6.2	6.4	6.4	8.0	18.1	20.0	10.2	5.9	8.4	7.6	3.2	19.5	7.5	4.7	5.5	5.4	7.9	21.1	5.7	8.3	8.1	18.9	7.8	8.0	10.7	19.3	6.7	5.8	23.3	8.5	8.1	6.5	17.1	11.1	15.7	21.2	17.0	13.3	14.0	17.1	29.9	19.8	17.7	19.8	7.7	7.7	9.6	4.0	28.2	39.3	12.0	21.1	47.7	27.7	24.3	17.2	12.1	15.2	19.3	31.1	16.8	15.5	15.0	21.7	51.7	69.7	27.8	7.7	16.7	25.9	6.3	32.9	7.6	9.2	17.8	22.6	9.7	13.2	13.3	43.1	6.4	12.9	15.1	17.1	23.2	9.4	6.9	15.7	12.7	5.2	17.9	16.6	31.8	20.6	25.1	59.9	22.8	15.2	16.5	50.2	5.3	16.2	0.0	0.5	1.0	4.2	0.7	2.2	4.3	3.0	4.1	0.6	2.1	2.5	3.0	0.2	2.1	0.4	2.8	4.1	1.3	19.1	18.8	14.6	18.1	17.0	18.6	18.1	20.0	19.5	18.9	19.3	17.1	2.3	9.6	3.7	7.8	12.2	7.9	27.5	16.4	7.4	10.0	7.4	7.1	45.3	15.7	11.3	9.2	4.2	12.3	12.8	5.2	1.9	15.8	35.2	9.8	8.1	4.0	12.7	19.1	6.1	21.0	28.6	15.0	14.8	4.6	15.9	7.6	5.0	12.5	23.7	10.1	6.1	6.6	10.2	9.5	4.3	19.5	7.8	10.4	7.2	3.7	12.3	9.8	11.3	6.6	8.5	30.4	16.3	14.7	18.5	20.1	8.4	11.3	18.4	6.5	26.3	10.6	16.0	52.1	37.4	7.2	6.8	5.7	13.9	9.9	7.1	15.4
ASB13	"FLJ13134, MGC19879"	ENSG00000196372	"Ankyrin repeat and SOCS box containing 13"	Q8WXK3	10	5638867-5666595	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 45.0;Hepatocytes: 55.9;Proximal enterocytes: 41.1;Proximal tubular cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 13.6;monocytes: 12.9;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 66.7;RPMI-8226: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048293, HPA061742"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Golgi apparatus"		"HPA048293: AB_2680344, HPA061742: AB_2684599"	"unprognostic (3.64e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	11.2	19.7	4.9	7.2	4.9	3.5	15.9	6.3	7.0	10.1	5.5	14.4	25.4	9.2	1.8	10.3	12.8	7.6	8.9	3.7	4.5	21.3	44.0	6.5	18.2	5.9	5.9	14.8	10.7	4.8	8.2	3.3	5.9	9.6	6.6	6.7	8.9	6.5	11.9	11.9	25.4	5.7	5.2	9.7	8.7	3.3	8.4	3.8	6.2	10.1	12.9	11.7	9.1	4.8	10.6	13.7	5.5	24.6	21.5	5.8	9.5	1.9	4.1	6.1	7.0	11.4	19.4	66.7	16.2	3.9	2.2	17.3	12.2	13.6	0.8	3.4	24.0	10.0	7.7	8.5	14.4	8.5	0.9	9.6	20.7	3.2	5.3	6.1	5.0	18.0	12.1	1.3	1.7	7.6	11.0	7.8	12.0	28.6	8.0	4.5	0.8	68.8	7.9	16.3	11.5	27.2	12.9	8.7	21.5	1.6	25.9	10.6	2.1	3.5	6.2	14.6	5.7	3.6	8.6	44.0	10.8	22.9	2.8	0.0	12.9	0.3	1.5	8.3	2.6	1.8	3.9	1.7	13.6	2.4	4.1	2.0	0.4	1.2	6.6	0.4	1.2	7.5	4.9	4.9	6.3	7.0	3.7	4.5	5.9	5.9	5.9	5.2	8.4	4.8	4.7	0.0	5.8	9.1	1.7	1.7	1.9	2.5	2.2	45.0	8.8	7.4	7.8	8.6	4.7	1.8	18.8	5.8	0.4	21.3	5.9	5.3	2.7	3.2	7.9	5.3	4.2	1.7	6.7	4.5	1.6	9.1	1.5	2.3	3.8	20.1	5.3	55.9	7.0	16.8	13.3	5.7	4.1	12.6	2.6	0.7	13.4	7.3	8.8	6.5	7.0	8.5	0.0	7.1	8.1	4.5	12.6	21.4	0.4	3.3	41.1	39.5	4.9	14.2	6.6	7.2	10.7	0.2	1.6	5.7	1.7	2.1	2.1	16.5	12.4	1.5
ASB2	ASB-2	ENSG00000100628	"Ankyrin repeat and SOCS box containing 2"	Q96Q27	14	93934166-93976739	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 522.2;tongue: 157.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 51.1;Early spermatids: 26.4;Late spermatids: 29.9;Skeletal myocytes: 27.6;T-cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 50.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 50.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 12.8;RPMI-8226: 12.4;SK-MEL-30: 5.9;U-266/70: 42.1;U-266/84: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001546			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA001546: AB_1078224"	"unprognostic (5.65e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.62e-6)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.49e-7)"	"unprognostic (2.51e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.27e-1)"	2.9	0.8	0.8	5.6	2.1	0.5	1.5	0.0	1.9	12.0	0.0	66.5	4.0	31.6	0.3	4.0	26.6	0.5	78.5	0.6	0.0	0.5	0.5	3.0	7.4	0.1	0.0	2.9	0.3	0.2	0.2	0.2	0.3	14.4	0.4	0.0	6.6	0.9	522.2	2.3	18.3	1.6	0.0	4.2	17.2	0.4	0.3	0.4	1.2	157.6	3.2	30.4	8.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.4	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.0	12.4	0.0	0.2	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.9	0.0	0.0	0.0	0.2	0.0	42.1	8.6	1.7	0.5	2.6	0.5	0.0	0.2	50.8	1.9	2.7	0.3	1.9	1.7	3.8	4.2	0.4	0.2	0.5	0.1	0.0	7.8	0.4	2.3	1.3	0.8	2.1	0.0	1.9	0.6	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.0	0.3	3.3	0.4	0.1	8.4	0.0	0.2	0.2	0.9	51.1	0.0	2.9	0.0	0.0	0.1	3.0	0.0	0.0	1.4	26.4	1.7	0.3	0.5	0.0	2.7	4.7	0.0	0.5	1.9	1.1	2.5	0.0	0.0	0.0	0.0	0.6	0.0	1.9	0.0	0.0	0.0	0.3	29.9	0.3	5.3	1.8	1.9	5.8	0.8	2.1	0.0	0.7	0.2	0.0	0.4	10.7	0.1	0.0	0.0	0.4	1.1	0.0	27.6	5.0	0.8	8.4	0.1	0.1	2.9	14.5	0.1	0.1	0.3
ASB7		ENSG00000183475	"Ankyrin repeat and SOCS box containing 7"	Q9H672	15	100602589-100651701	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003300	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA003300: AB_1845071"	"unprognostic (1.38e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.91e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	4.6	3.6	4.2	4.5	4.7	12.8	5.1	4.9	4.6	5.2	5.6	6.8	4.6	5.3	6.5	4.6	5.7	3.8	3.9	4.2	4.1	6.7	6.8	4.9	6.3	4.5	4.3	5.7	3.5	6.7	3.1	4.3	4.2	4.7	6.3	4.9	4.5	4.3	3.1	4.4	4.4	6.0	4.2	5.9	4.3	6.8	4.9	7.0	6.2	4.7	6.3	5.1	3.5	5.0	6.7	14.5	6.6	7.9	8.6	9.2	7.5	7.2	13.0	11.8	12.3	8.8	13.2	10.9	6.4	9.2	11.6	14.5	9.2	9.4	12.2	7.6	9.8	14.4	9.0	8.8	13.0	8.6	12.3	8.9	10.3	9.6	15.8	11.4	11.0	11.7	8.6	8.9	6.8	7.2	6.7	8.7	6.3	14.9	6.9	9.0	14.1	9.2	11.8	14.8	6.5	9.2	11.1	10.8	15.0	12.5	7.6	10.7	8.4	10.3	9.5	7.3	10.2	10.6	23.5	10.4	8.0	7.8	8.3	1.2	5.8	10.2	5.2	4.7	4.2	4.3	4.5	6.4	5.1	4.2	6.2	4.4	5.2	4.3	3.1	3.3	5.7	4.8	4.2	4.7	4.9	4.6	4.2	4.1	4.5	4.3	4.2	4.2	4.9	5.0	4.6	0.0	5.4	14.7	6.6	6.5	2.3	3.5	13.1	4.9	6.2	4.1	3.4	12.8	6.4	3.7	6.2	3.8	9.9	12.9	1.9	5.7	4.0	8.1	8.3	6.7	8.4	3.0	20.6	4.9	3.0	4.0	7.1	8.1	10.8	7.3	4.2	8.0	6.0	13.5	15.0	6.2	4.1	7.8	4.3	2.1	5.0	5.2	3.6	20.6	7.8	3.1	6.2	16.6	17.4	6.5	9.7	5.3	4.9	5.5	5.4	7.1	10.3	5.0	0.0	4.3	4.3	9.9	8.2	10.8	4.5	5.9	8.2	6.7	5.8	5.6
ASCC1	"ASC1p50, CGI-18, Em:AC022392.3, p50"	ENSG00000138303	"Activating signal cointegrator 1 complex subunit 1"	Q8N9N2	10	72096032-72217134	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038038, HPA057567"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA038038: AB_10674544, HPA057567: "	"unprognostic (1.96e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.22e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.64e-2)"	19.0	24.9	18.3	13.9	23.5	7.3	16.4	22.4	24.5	16.1	18.8	14.4	9.0	17.1	16.4	14.3	15.3	13.7	24.8	17.2	20.7	15.2	21.6	13.5	18.5	23.4	20.6	17.9	22.7	14.2	11.9	13.0	23.6	11.9	9.9	15.7	12.8	14.5	29.7	17.1	14.6	12.4	21.7	17.1	14.4	18.4	20.4	22.3	13.4	17.3	16.8	15.7	13.6	30.4	29.3	40.3	25.8	58.1	34.0	37.9	21.1	18.0	33.5	26.5	30.7	31.4	105.3	37.0	35.6	26.3	17.9	38.4	21.1	30.6	26.5	27.2	20.1	24.1	29.1	36.4	32.7	25.2	24.1	33.3	68.9	26.7	45.0	38.1	36.4	40.4	34.8	51.8	35.0	25.7	34.2	36.1	15.7	18.8	8.8	20.1	21.1	27.4	49.8	21.0	27.1	16.9	26.1	65.7	49.4	23.9	21.7	18.5	32.0	15.2	27.1	11.6	19.4	28.4	40.4	45.5	24.6	55.9	10.8	20.4	19.0	35.0	16.5	20.3	17.0	31.4	19.4	17.7	21.0	32.5	27.2	25.8	12.5	26.6	15.4	28.9	29.2	19.0	18.3	23.5	22.4	24.5	17.2	20.7	23.4	20.6	23.6	21.7	20.4	30.4	16.7	9.6	5.8	25.5	20.5	6.2	14.0	22.8	9.6	12.9	9.0	6.3	23.6	10.0	13.4	12.9	14.6	17.7	18.6	4.7	23.5	20.4	27.5	12.1	13.8	13.9	3.6	11.1	33.1	20.0	19.5	16.5	6.6	12.1	12.7	12.6	10.4	22.0	18.2	25.2	42.9	5.2	16.2	24.1	8.7	14.2	20.5	12.7	19.6	27.2	21.4	19.9	16.5	35.7	52.8	14.7	8.4	20.7	14.5	8.0	9.5	11.4	9.8	14.3	13.1	10.8	15.9	27.8	28.2	10.9	7.0	15.2	17.9	18.9	6.5	9.2
ASCC2	"ASC1p100, DKFZp586O0223, FLJ21588"	ENSG00000100325	"Activating signal cointegrator 1 complex subunit 2"	Q9H1I8	22	29788609-29838304	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 155.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001439, HPA052879"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA001439: AB_1078229, HPA052879: AB_2732577"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.97e-3)"	"unprognostic (5.19e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.05e-3)"	26.6	31.3	11.4	22.7	12.7	53.7	24.9	12.6	13.7	23.7	16.7	24.5	23.7	21.0	16.1	42.0	19.9	17.1	22.8	11.6	11.9	19.8	35.8	22.1	24.5	13.5	12.9	19.9	23.5	21.8	26.7	21.8	13.2	27.1	24.6	8.4	29.8	18.0	43.5	30.1	23.1	19.2	12.9	29.4	37.0	24.5	12.5	29.6	28.3	32.3	34.0	26.8	27.5	13.3	46.9	26.8	28.4	38.7	41.6	36.7	40.7	47.6	36.3	48.4	48.1	31.5	24.7	46.5	33.4	46.2	30.7	55.5	36.8	54.0	40.5	59.8	64.3	39.9	33.0	38.0	52.1	72.3	115.6	39.6	48.2	55.0	50.0	28.4	42.9	30.7	41.8	43.7	44.3	57.8	44.5	37.9	20.7	65.6	36.0	53.0	34.9	48.6	29.6	76.1	43.8	38.5	44.3	48.2	35.4	28.8	34.3	37.4	42.8	67.1	11.3	41.2	47.9	51.9	42.8	54.4	39.2	39.9	49.5	44.7	29.8	53.6	32.1	49.2	28.4	18.8	23.6	26.9	37.7	15.0	24.1	24.6	9.2	33.7	43.9	21.7	30.3	20.0	11.4	12.7	12.6	13.7	11.6	11.9	13.5	12.9	13.2	12.9	12.5	13.3	27.7	19.2	14.7	18.6	35.8	30.0	25.2	38.1	13.1	9.4	23.3	12.3	19.1	31.5	33.3	40.5	4.2	46.3	40.5	38.8	11.7	25.4	110.2	14.0	28.1	20.7	15.5	116.0	13.5	24.9	63.3	22.9	69.8	20.0	34.9	24.3	22.9	25.7	30.6	5.0	13.8	23.2	44.7	29.2	37.3	155.2	31.1	29.1	28.4	11.2	27.9	12.2	56.7	15.6	16.3	27.7	34.0	24.8	32.4	16.2	46.8	18.2	24.4	13.6	19.7	19.6	19.7	48.4	22.5	35.0	39.2	44.3	34.9	27.8	23.9	34.2
ASCL1	"ASH1, bHLHa46, HASH1"	ENSG00000139352	"Achaete-scute family bHLH transcription factor 1"	P50553	12	102957674-102960513	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;choroid plexus: 13.7;liver: 11.1;pituitary gland: 30.1"	"Group enriched"	"Detected in some"	5	"Astrocytes: 17.0;Enteroendocrine cells: 36.4;Oligodendrocyte precursor cells: 42.7"	"Group enriched"	"Detected in many"	6	"glioma: 21.4;lung cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"SCLC-21H: 53.7;SH-SY5Y: 29.0"	"Low region specificity"	"Detected in all"							"HPA029217, HPA076307"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA029217: AB_10669595, HPA076307: "	"unprognostic (7.92e-2)"	"unprognostic (4.37e-3)"		"unprognostic (4.55e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.52e-2)"	0.0	1.1	18.7	0.0	18.3	0.0	0.0	18.9	23.0	0.5	13.7	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.0	18.2	16.8	0.0	11.1	0.5	0.5	20.1	18.1	0.4	0.2	0.0	30.1	0.0	18.5	0.3	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	1.2	0.1	18.7	5.5	0.1	0.0	0.0	0.0	0.3	19.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	29.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	18.3	18.9	23.0	18.2	16.8	20.1	18.1	18.5	19.9	18.7	19.4	0.1	0.0	0.0	17.0	0.3	0.0	0.3	0.0	0.0	4.3	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	36.4	0.0	1.7	0.0	0.0	0.2	4.6	0.1	0.0	0.0	0.0	1.8	0.1	5.0	4.1	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	2.4	0.0	42.7	0.3	0.2	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4
ASF1A	"CIA, DKFZP547E2110"	ENSG00000111875	"Anti-silencing function 1A histone chaperone"	Q9Y294	6	118894152-118909171	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030502, HPA071495"			Enhanced	Nucleoplasm		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA030502: AB_2673504, HPA071495: AB_2686404"	"unprognostic (7.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.02e-7)"	"unprognostic (8.28e-2)"	"unprognostic (8.42e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.95e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.09e-3)"	7.4	10.2	13.0	8.7	14.4	8.3	12.5	14.8	17.1	8.5	11.2	9.4	7.7	10.6	13.0	8.9	10.5	7.9	13.3	12.4	14.2	12.6	12.0	13.4	16.0	13.6	13.7	17.5	9.4	15.8	6.3	8.2	14.0	9.8	10.9	11.5	10.7	11.0	16.6	11.6	8.8	7.4	14.5	11.5	10.9	9.7	13.9	24.4	15.1	16.1	15.1	9.4	6.7	15.7	14.7	9.2	31.2	21.2	26.0	15.2	25.3	19.3	18.8	24.3	27.2	11.7	12.2	24.0	30.8	13.7	21.5	15.3	27.2	24.7	30.8	17.5	25.4	35.1	20.7	72.9	18.5	60.6	17.4	13.8	24.3	21.2	32.0	32.6	32.9	75.2	55.2	61.9	28.9	15.7	70.8	47.4	12.9	21.6	30.5	38.7	13.1	30.1	32.7	18.4	20.1	15.8	19.6	19.4	23.3	9.8	11.4	55.3	29.1	11.3	17.0	16.1	30.1	19.4	34.5	35.6	29.7	47.5	25.0	18.8	15.4	32.9	40.3	17.1	56.5	35.7	64.0	51.8	34.1	24.7	69.0	56.8	2.7	34.3	23.1	26.1	83.9	47.4	13.0	14.4	14.8	17.1	12.4	14.2	13.6	13.7	14.0	14.5	13.9	15.7	16.0	16.0	22.6	11.1	24.7	29.4	14.8	36.7	28.5	16.7	14.0	19.2	27.1	18.6	23.0	9.2	4.2	67.5	19.8	11.6	62.6	33.9	40.9	10.2	13.9	23.3	29.5	82.1	5.8	23.5	71.5	24.0	17.9	9.1	22.8	39.9	17.2	15.1	24.6	25.2	6.3	12.4	10.2	16.3	16.7	10.8	25.4	16.5	16.0	9.4	24.9	27.8	24.7	9.0	10.0	20.7	10.1	23.3	22.7	10.9	11.5	27.2	21.2	13.7	13.1	17.0	37.2	32.7	48.0	20.8	33.0	46.7	49.1	28.1	17.5	12.5
ASF1B	FLJ10604	ENSG00000105011	"Anti-silencing function 1B histone chaperone"	Q9NVP2	19	14119512-14136613	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.2;testis: 32.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.1;Early spermatids: 36.4;Erythroid cells: 43.6;Extravillous trophoblasts: 35.4;Spermatocytes: 73.2;Spermatogonia: 87.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 60.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 60.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA054036, HPA069385"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054036: AB_2682350, HPA069385: "	"unprognostic (3.14e-1)"	"prognostic favorable (4.45e-5)"	"unprognostic (2.41e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (8.48e-3)"	"prognostic unfavorable (2.22e-16)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.31e-2)"	0.9	1.4	0.2	5.6	0.3	11.7	1.3	0.3	0.2	2.2	0.1	7.4	5.3	1.0	0.1	10.3	0.7	0.7	0.7	0.1	0.2	1.0	1.3	2.1	12.5	0.3	0.2	0.7	0.7	0.3	0.7	3.6	0.3	0.8	7.7	0.0	1.9	0.3	0.5	3.2	6.0	2.0	0.2	6.7	3.2	32.0	0.3	23.2	0.6	0.4	14.7	1.8	3.2	0.3	64.6	25.3	37.7	28.9	3.8	3.6	16.2	33.1	28.3	63.8	79.5	26.5	31.6	59.1	30.0	17.5	26.5	38.0	41.8	24.1	49.7	54.0	26.9	55.5	48.7	18.6	0.2	39.0	35.1	0.7	1.7	35.8	12.4	7.2	25.1	44.1	50.2	83.8	31.8	75.7	80.8	34.3	17.3	69.1	56.7	77.0	56.0	51.6	20.1	28.3	46.0	16.5	39.8	29.2	17.4	10.3	22.1	41.5	10.6	36.0	21.6	91.0	56.6	43.2	46.5	80.3	28.0	71.9	36.1	0.7	6.2	1.5	1.7	8.0	0.9	1.1	1.5	2.0	1.2	0.9	0.9	1.7	60.1	1.7	8.5	0.5	5.1	3.2	0.2	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.3	0.2	0.3	0.3	1.0	0.0	0.6	0.3	5.6	2.5	2.4	4.5	1.2	0.1	4.8	8.5	1.2	1.5	1.1	0.0	0.0	36.1	3.8	11.7	0.0	1.0	36.4	2.1	1.3	2.1	1.2	43.6	0.5	1.2	35.4	4.1	23.4	2.3	4.5	9.2	0.4	0.3	21.5	0.0	0.4	9.9	8.2	5.6	5.6	29.1	0.0	5.0	1.8	1.0	2.1	0.3	4.1	0.0	0.5	1.1	2.2	0.7	20.1	1.0	2.4	0.3	0.2	0.9	0.0	1.1	3.3	73.2	87.8	8.3	1.1	10.4	5.3	3.0	20.9	2.4
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155563162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	14.1	12.8	21.3	8.5	23.4	11.9	16.8	27.0	25.7	14.4	14.8	13.0	9.7	14.4	20.8	9.2	11.4	9.0	12.6	23.8	19.2	13.9	10.0	10.3	10.9	18.7	19.8	21.3	9.9	18.2	8.4	10.3	18.9	15.7	11.5	26.2	14.8	15.4	30.3	20.4	10.2	12.7	19.3	10.5	11.9	6.8	20.7	12.1	15.8	24.3	9.7	11.7	10.0	23.4	17.2	12.3	9.5	9.4	28.0	22.8	9.6	14.7	13.5	8.3	6.5	10.5	12.3	5.4	14.2	17.0	5.4	19.2	13.6	12.6	13.6	7.6	8.9	8.0	13.2	9.8	14.5	8.8	6.6	16.2	18.0	13.6	15.0	17.1	11.0	6.0	12.3	8.3	18.8	19.0	6.4	8.8	8.3	28.8	13.1	6.1	18.5	10.4	18.6	16.0	9.1	14.3	20.1	25.9	12.9	9.3	16.6	26.6	17.4	13.6	15.8	13.4	17.9	8.0	5.3	8.9	10.7	9.1	13.1	1.0	0.4	0.8	0.7	0.2	0.5	0.9	0.5	0.5	0.2	0.8	0.8	0.5	1.0	0.6	0.1	0.7	0.9	0.2	21.3	23.4	27.0	25.7	23.8	19.2	18.7	19.8	18.9	19.3	20.7	23.4	96.5	60.9	103.2	171.7	108.3	103.9	97.4	52.9	109.3	147.6	75.9	58.3	107.8	50.1	82.7	51.5	202.3	53.6	83.3	76.2	17.6	41.5	25.9	72.0	107.4	77.6	67.5	46.7	220.6	39.8	25.2	93.7	101.4	87.9	81.1	72.3	63.1	39.0	24.6	114.4	211.8	59.0	26.4	42.1	106.9	22.8	102.2	69.1	53.4	203.3	85.2	68.4	89.6	190.5	265.0	37.5	64.8	118.8	110.1	112.0	68.9	31.0	47.1	116.7	98.6	134.4	104.6	85.6	56.1	80.9	112.0	76.2	98.7	87.3	60.2	111.6
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like, histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105493-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	28.9	18.9	19.7	17.9	20.3	31.6	21.4	19.2	21.5	19.9	14.7	22.5	18.2	22.0	17.1	23.8	20.1	17.4	21.3	20.2	17.4	23.3	23.6	18.5	27.9	16.7	16.1	26.2	17.7	24.8	12.0	22.1	16.7	19.9	22.3	21.7	20.6	21.0	32.4	20.4	18.3	24.2	16.5	18.9	22.1	41.3	19.0	33.6	21.1	27.7	28.3	18.5	16.1	18.1	45.6	23.3	39.8	39.8	26.3	34.0	49.8	44.1	45.7	53.5	47.0	24.9	21.1	51.4	38.2	37.1	27.2	27.5	49.0	24.8	50.4	20.3	22.4	200.3	22.9	51.7	39.4	32.0	41.3	28.6	22.9	25.0	27.7	28.1	43.9	48.0	138.2	40.0	53.7	26.1	91.9	40.7	51.7	39.3	15.6	38.2	42.9	23.4	28.9	33.1	18.3	32.4	33.5	22.5	38.4	37.1	27.4	40.4	33.5	35.3	35.0	50.4	37.6	37.8	48.7	44.9	35.2	44.7	49.7	39.9	23.0	55.9	16.8	26.8	18.1	19.6	18.8	20.0	27.7	19.2	19.3	18.4	19.2	26.1	25.8	15.8	21.3	21.6	19.7	20.3	19.2	21.5	20.2	17.4	16.7	16.1	16.7	16.5	19.0	18.1	11.1	12.8	15.8	18.3	14.3	6.9	9.3	13.3	10.8	12.9	9.6	8.0	18.1	8.6	15.9	12.9	10.4	37.0	15.9	11.5	7.9	21.2	10.8	12.7	13.2	14.0	10.8	62.1	19.7	28.7	37.2	17.3	8.6	10.8	19.6	38.2	12.8	11.9	24.2	6.7	21.4	11.6	12.2	17.2	5.7	13.0	23.3	17.0	23.2	15.9	29.2	17.8	19.6	17.6	16.5	21.3	8.9	20.7	8.4	6.2	12.8	17.1	18.0	15.5	13.1	14.6	20.7	69.6	33.9	11.6	6.8	30.9	11.9	37.3	10.9	7.4
ASIC3	"ACCN3, DRASIC, TNaC1"	ENSG00000213199	"Acid sensing ion channel subunit 3"	Q9UHC3	7	151048292-151052756	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 12.5;Early spermatids: 15.6;Granulosa cells: 14.8;Late spermatids: 61.0;Spermatocytes: 10.3"	"Group enriched"	"Detected in many"	4	"glioma: 3.1;testis cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 16.7;U-266/84: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049155, HPA054805"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA049155: AB_2680657, HPA054805: AB_2732588"	"unprognostic (8.71e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.45e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-12)"	"unprognostic (1.49e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.31e-3)"	2.8	2.1	8.2	0.3	9.0	0.6	2.7	11.7	10.9	13.3	6.7	7.9	1.1	7.7	1.5	1.9	7.2	0.7	10.9	7.9	8.8	4.8	4.0	3.2	0.8	9.3	7.9	6.4	2.1	0.5	18.1	0.6	10.3	5.3	0.6	8.7	1.6	0.4	6.0	2.9	4.1	0.8	7.0	2.8	3.8	19.9	8.6	0.6	4.1	0.9	0.7	3.1	4.3	11.5	1.5	4.0	1.7	2.7	3.7	0.0	7.4	0.4	0.2	0.3	0.5	0.8	1.9	0.9	0.4	0.2	1.8	2.4	1.0	0.0	0.7	8.9	4.5	1.7	3.4	0.0	0.0	0.1	3.9	0.9	0.7	0.2	0.0	2.9	0.1	1.1	4.2	6.8	0.5	6.3	0.3	0.4	1.8	0.1	3.3	3.1	1.7	0.5	0.3	1.4	2.3	8.2	0.6	0.5	4.3	4.9	1.8	0.4	0.1	1.4	2.1	4.3	1.1	16.7	10.2	0.1	2.3	5.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	9.0	11.7	10.9	7.9	8.8	9.3	7.9	10.3	7.0	8.6	11.5	0.4	0.0	0.5	2.9	0.5	0.6	0.0	0.2	0.0	9.7	0.6	0.6	2.1	0.0	0.2	0.0	12.5	0.2	0.3	0.6	0.0	0.2	15.6	0.9	1.1	0.3	0.0	0.0	3.4	0.4	0.2	0.3	0.5	0.8	8.9	14.8	0.0	0.9	0.6	6.7	4.2	0.1	0.0	0.6	0.9	61.0	1.5	0.4	0.0	0.0	0.6	1.6	0.0	1.5	5.1	0.4	0.0	1.9	0.1	0.3	0.2	0.2	0.6	4.9	0.0	0.7	0.4	10.3	5.6	0.0	0.9	0.7	0.3	0.2	0.2	0.2
ASPDH		ENSG00000204653	"Aspartate dehydrogenase domain containing"	A6ND91	19	50511600-50514690	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.1;kidney: 39.0;liver: 132.4"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 135.8;Proximal tubular cells: 487.2"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 24.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.6;MOLT-4: 16.5;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042631, HPA042654"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		200000		"Cluster 15: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA042631: AB_10794530, HPA042654: AB_10794383"	"unprognostic (5.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.97e-3)"	"unprognostic (6.13e-3)"	"unprognostic (5.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.70e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.99e-3)"	0.5	2.5	18.1	0.9	20.9	0.5	0.0	23.7	40.1	0.0	7.3	0.2	6.6	0.2	0.0	0.3	0.0	1.7	0.3	19.8	17.3	39.0	132.4	0.2	0.9	17.0	17.5	0.0	0.8	0.0	19.6	0.0	16.8	0.3	0.0	5.4	1.6	0.0	0.3	1.1	2.5	0.0	13.4	0.6	0.3	0.2	22.9	2.4	0.9	0.0	0.0	0.1	0.1	21.9	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	13.6	0.0	0.7	3.8	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	1.7	0.0	1.6	16.5	0.1	0.0	0.6	0.2	0.4	0.3	1.1	0.0	0.2	1.7	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	3.6	0.8	1.8	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	20.9	23.7	40.1	19.8	17.3	17.0	17.5	16.8	13.4	22.9	21.9	0.0	0.0	0.0	3.3	2.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.4	1.5	0.0	9.2	4.2	0.0	0.0	0.1	45.0	0.0	0.7	0.0	0.0	0.1	7.1	10.7	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	135.8	0.0	0.0	4.4	0.1	0.0	1.9	0.0	2.5	0.0	3.4	0.0	2.8	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	8.8	487.2	0.0	4.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 95.3;smooth muscle: 110.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 67.2;Fibroblasts: 94.6;Microglial cells: 24.4;Sertoli cells: 39.5;Smooth muscle cells: 73.5;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 51.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;BJ hTERT+: 5.7;HHSteC: 23.2;HSkMC: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007894, HPA008435, HPA024230"	Approved		Uncertain	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		2100000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	29.6	7.6	1.2	5.7	1.7	0.1	11.8	2.3	2.0	40.9	0.9	25.5	9.6	69.6	9.7	10.1	16.9	65.9	95.3	1.2	1.2	11.2	41.1	14.3	3.0	1.3	1.2	7.1	13.4	3.8	2.5	4.3	1.6	4.7	11.3	0.2	3.2	11.7	7.8	12.1	17.6	110.5	1.0	2.3	12.0	1.2	1.8	2.5	11.1	19.8	5.5	13.4	5.0	1.7	0.1	0.0	0.0	0.0	1.4	16.0	0.2	2.6	5.7	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	23.2	0.2	0.0	4.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	1.2	1.7	2.3	2.0	1.2	1.2	1.3	1.2	1.6	1.0	1.8	1.7	12.9	0.0	1.1	0.3	0.1	67.2	0.1	0.0	0.0	0.4	0.4	0.1	8.5	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	4.2	6.8	0.0	0.0	2.0	0.0	0.1	94.6	0.5	0.2	1.3	0.1	13.9	0.4	0.2	0.0	1.7	0.0	0.0	0.0	13.5	0.6	5.9	0.8	14.2	24.4	0.0	0.1	0.0	1.5	1.1	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.7	0.6	39.5	4.3	73.5	0.0	0.1	0.3	27.0	0.0	1.7	0.3	0.0	0.0
ASPSCR1	"ASPL, ASPS, TUG, UBXD9, UBXN9"	ENSG00000169696	"ASPSCR1 tether for SLC2A4, UBX domain containing"	Q9BZE9	17	81976807-82017406	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"Hep G2: 298.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026749	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA026749: AB_1845114"	"unprognostic (5.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.01e-2)"	16.5	20.4	16.6	8.4	17.0	15.0	16.9	16.5	20.4	16.2	17.7	16.0	13.6	15.6	7.9	16.8	14.0	7.7	26.1	16.2	15.5	27.3	57.9	17.3	12.2	20.1	16.6	13.4	22.8	14.8	30.6	12.9	18.3	21.6	4.6	5.7	18.3	6.7	44.3	20.5	18.1	5.2	14.7	20.7	22.7	30.0	17.2	8.3	25.9	5.8	6.4	16.0	14.2	21.5	19.3	33.3	13.0	17.9	7.5	9.3	55.4	17.7	12.6	19.3	19.5	20.3	21.3	19.2	18.1	12.4	16.3	9.8	12.0	13.1	6.2	12.9	41.0	21.4	28.7	298.1	25.5	19.1	29.9	10.9	13.9	9.5	6.6	10.0	19.5	16.0	22.0	25.0	11.6	65.0	16.9	41.8	15.5	32.8	23.5	19.2	18.7	39.4	18.0	17.0	32.4	34.8	14.6	42.2	35.2	12.3	27.2	41.4	16.6	35.7	24.5	26.4	22.8	20.2	12.5	21.6	19.2	19.3	21.3	24.0	11.7	8.6	6.6	8.0	3.7	9.0	10.0	8.8	14.7	9.0	7.7	5.8	2.7	8.0	10.4	9.3	5.3	5.6	16.6	17.0	16.5	20.4	16.2	15.5	20.1	16.6	18.3	14.7	17.2	21.5	13.9	9.6	44.7	19.9	24.1	13.4	23.7	24.4	23.3	23.3	19.6	15.6	13.6	27.1	19.8	14.7	41.7	73.7	25.8	29.3	39.2	24.2	49.1	16.2	14.9	16.1	25.0	17.9	12.4	26.2	222.6	17.5	46.9	20.1	21.5	31.0	12.8	56.1	44.7	50.5	12.1	31.5	20.3	26.7	18.6	96.0	11.8	21.7	19.6	1.9	23.8	57.8	19.6	10.6	14.1	17.6	25.8	17.7	27.3	24.9	42.5	58.3	18.5	39.4	13.1	14.7	37.4	41.7	51.0	20.3	14.3	59.4	18.4	23.6	33.3	23.1
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase and isoaspartyl peptidase 1"	Q7L266	11	62337448-62393412	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.7;cervix: 121.7;testis: 100.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 372.5;Endometrial ciliated cells: 414.6;Glandular and luminal cells: 437.1;Late spermatids: 597.6;Proximal tubular cells: 214.1;Spermatocytes: 534.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 277.9;eosinophil: 269.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 277.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 85.2;HAP1: 83.9;SCLC-21H: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favorable (6.14e-4)"	"prognostic favorable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favorable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	13.8	3.7	94.2	6.5	95.4	14.4	12.0	92.5	103.5	121.7	71.7	14.2	6.8	26.4	3.1	2.1	68.1	11.2	6.2	87.1	93.3	42.5	10.2	25.8	5.6	87.5	102.7	1.8	13.4	2.3	21.2	3.2	87.6	23.8	17.1	17.8	13.2	7.2	7.3	2.9	9.5	4.4	83.4	4.7	15.1	100.5	112.7	10.3	6.7	3.0	4.7	4.3	2.0	90.0	2.4	19.5	20.9	27.2	0.1	0.0	16.4	2.3	0.8	3.6	3.5	32.0	8.5	1.9	85.2	0.3	9.3	1.8	83.9	0.7	4.2	2.6	34.4	1.2	28.1	23.5	0.6	24.0	30.8	0.8	0.2	1.6	0.4	1.3	39.4	47.8	24.5	21.5	0.9	37.5	65.3	15.9	28.5	13.6	15.2	26.1	12.5	11.8	73.3	5.9	112.3	16.1	16.4	28.2	14.4	21.2	15.0	12.1	2.0	0.4	15.4	1.2	9.5	32.8	33.6	3.0	0.8	12.3	9.7	277.9	68.6	269.5	2.8	50.8	1.9	2.4	1.0	3.3	39.7	1.5	2.3	3.4	16.3	11.5	38.5	7.2	0.8	24.2	94.2	95.4	92.5	103.5	87.1	93.3	87.5	102.7	87.6	83.4	112.7	90.0	29.2	6.4	27.8	56.8	5.2	3.4	2.5	2.2	0.6	24.4	13.8	6.6	2.4	42.9	4.1	22.0	33.3	2.3	3.2	14.0	133.1	30.3	372.5	414.6	39.9	31.2	47.2	14.1	13.9	22.3	2.4	4.0	19.9	437.1	80.9	16.6	49.2	3.7	25.0	16.8	18.6	67.4	6.1	11.4	6.4	597.6	8.7	26.9	1.8	9.4	10.5	80.8	4.1	15.1	22.0	7.8	7.5	7.2	13.9	35.4	2.9	214.1	5.4	37.1	13.1	7.7	6.1	534.3	48.6	0.1	1.3	0.8	7.8	10.8	36.0	15.9
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444961-130501274	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 1284.8;liver: 2037.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 398.7;Hepatocytes: 1062.0;Proximal enterocytes: 618.2;Proximal tubular cells: 1408.9;Urothelial cells: 413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 893.9;HaCaT: 850.4;hTCEpi: 817.8;RPMI-8226: 1444.5;THP-1: 1061.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		6400000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	215.0	146.8	29.6	51.3	29.7	0.2	168.2	25.0	31.0	67.0	61.7	157.2	124.5	111.3	124.8	51.1	166.3	110.2	66.5	31.5	38.3	1284.8	2037.7	52.9	7.5	40.2	42.2	57.2	68.4	11.4	45.0	50.6	51.7	56.2	167.9	6.9	119.4	132.6	74.4	131.3	194.8	61.2	28.4	20.0	53.2	35.9	38.4	7.8	92.3	71.4	15.6	288.7	66.6	25.3	124.5	11.9	13.7	23.1	88.4	223.1	43.6	146.2	893.9	28.2	85.5	52.5	34.0	0.4	95.9	300.2	8.2	850.4	59.9	5.2	19.5	21.7	27.1	0.3	18.3	137.3	305.4	18.3	1.6	148.2	817.8	45.4	81.2	0.3	1.1	384.0	5.3	530.6	28.8	619.8	7.2	262.7	19.2	635.9	26.7	1.7	15.4	1444.5	78.8	61.3	342.4	5.8	515.4	534.7	41.5	53.5	366.1	1061.5	0.4	11.3	68.3	2.3	13.0	88.1	91.5	32.1	219.0	137.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	29.6	29.7	25.0	31.0	31.5	38.3	40.2	42.2	51.7	28.4	38.4	25.3	72.1	25.6	28.6	2.6	21.3	70.5	55.7	179.8	53.5	0.1	23.7	17.3	5.4	138.7	104.4	47.8	0.0	178.5	0.4	398.7	133.1	116.5	1.2	4.7	30.5	68.0	12.0	93.7	2.2	110.5	8.9	21.5	20.4	6.2	5.7	55.5	65.7	1062.0	14.7	0.0	8.0	186.8	24.4	40.1	6.5	7.8	31.1	8.0	3.6	7.5	1.6	10.6	0.0	0.0	0.2	70.8	310.4	124.8	11.7	104.0	618.2	1408.9	32.7	0.4	0.0	18.7	13.4	1.4	2.6	23.5	17.5	144.1	11.5	62.0	165.6	413.2
ASTN2	KIAA0634	ENSG00000148219	"Astrotactin 2"	O75129	9	116423112-117415070	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 354.6;Excitatory neurons: 370.0;Inhibitory neurons: 1011.0;Late spermatids: 228.2;Oligodendrocyte precursor cells: 900.3;Oligodendrocytes: 225.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027035	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA027035: AB_1845122"	"unprognostic (3.25e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.93e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	3.3	9.8	26.1	2.7	26.3	3.6	4.3	39.0	36.0	5.3	9.0	5.2	3.4	3.2	3.9	2.2	8.0	2.5	22.5	27.0	25.8	5.5	4.1	2.2	2.4	29.3	36.2	2.8	6.7	3.1	11.6	1.8	28.7	25.2	3.2	13.4	5.8	11.3	7.3	2.4	4.1	2.8	21.4	2.4	5.6	17.6	35.0	6.0	1.8	5.6	1.8	3.2	3.5	39.2	3.7	12.0	4.3	7.1	7.6	7.0	15.4	5.7	2.3	2.5	2.8	8.1	4.4	8.8	6.1	3.8	9.3	1.3	11.5	0.6	3.1	4.8	2.9	3.1	5.8	17.0	3.0	1.8	6.2	9.5	1.1	7.8	0.7	5.4	1.8	10.5	3.9	5.9	7.9	3.8	4.1	1.4	13.2	10.6	6.4	4.9	27.5	2.5	8.0	12.3	6.3	37.9	6.8	2.0	4.8	14.5	15.5	1.3	3.5	5.9	9.1	5.6	4.9	9.0	5.0	8.3	10.5	2.0	25.8	2.5	0.4	0.5	2.8	0.3	3.6	1.5	3.1	2.4	0.2	1.6	3.0	2.5	1.9	5.9	0.6	0.9	8.8	1.0	26.1	26.3	39.0	36.0	27.0	25.8	29.3	36.2	28.7	21.4	35.0	39.2	0.6	6.4	8.9	354.6	1.1	1.3	3.2	0.4	1.2	4.9	4.2	4.8	22.7	2.8	5.0	1.8	10.4	0.4	1.0	0.4	3.9	0.8	122.5	4.7	5.5	1.3	12.6	0.4	370.0	1.1	0.4	4.9	4.1	0.7	6.3	37.0	0.7	2.9	3.2	10.1	1011.0	1.0	0.0	0.0	1.6	228.2	2.8	1.0	0.0	36.5	0.2	3.0	0.0	900.3	225.9	0.5	2.1	5.7	3.6	11.7	5.7	6.9	11.7	5.1	0.0	1.9	2.0	7.7	13.2	0.3	0.6	0.3	3.8	1.9	1.8	2.2
ASXL1	KIAA0978	ENSG00000171456	"ASXL transcriptional regulator 1"	Q8IXJ9	20	32358330-32439319	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor"	"Cancer-related genes, Craniosynostosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064156			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA064156: AB_2685200"	"unprognostic (1.49e-1)"	"unprognostic (5.97e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (6.69e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (2.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.06e-1)"	31.6	24.6	13.4	18.1	14.4	36.9	30.5	15.0	14.4	30.6	20.2	31.6	12.2	26.8	15.6	17.2	28.6	13.7	21.8	14.1	15.6	28.7	32.8	36.0	24.0	15.8	14.2	32.3	32.9	13.1	19.2	17.3	13.8	24.8	13.2	19.7	21.0	13.3	30.1	23.2	27.8	18.4	13.8	35.0	24.7	37.2	15.1	27.4	32.0	16.4	25.0	26.4	24.2	17.1	59.2	33.6	52.7	28.2	23.6	28.6	45.6	35.4	33.0	64.1	48.6	99.8	35.2	54.4	24.5	47.3	62.2	39.5	45.3	37.8	53.2	70.6	24.1	88.9	53.6	55.7	21.6	38.5	36.1	32.4	25.1	46.1	35.6	33.3	37.4	45.3	45.2	29.1	31.9	18.4	51.7	30.3	12.9	27.7	38.9	30.8	62.1	24.8	27.1	28.4	23.7	38.2	68.9	23.5	31.7	27.9	32.7	27.0	39.9	69.1	59.4	32.3	43.2	33.9	38.6	39.3	34.0	100.2	27.8	0.1	0.6	1.0	2.6	0.5	2.5	4.8	3.6	3.9	0.8	3.3	3.5	4.0	0.5	1.5	0.6	2.7	9.0	1.5	13.4	14.4	15.0	14.4	14.1	15.6	15.8	14.2	13.8	13.8	15.1	17.1	92.3	51.3	35.5	54.9	63.3	40.0	51.8	8.6	50.7	21.4	52.9	48.6	19.8	15.7	17.9	27.6	52.1	18.0	55.2	18.8	25.4	13.5	97.8	59.4	80.1	65.6	7.2	40.8	61.4	12.6	16.5	49.8	30.5	86.2	18.3	57.7	41.0	34.7	21.3	18.5	80.3	14.1	16.2	21.2	42.2	84.9	25.4	33.5	78.2	75.9	16.7	11.6	20.6	78.4	125.9	15.6	13.7	14.7	94.6	49.6	29.9	31.7	20.8	30.7	6.6	96.7	62.7	31.0	16.1	34.6	30.5	5.9	67.2	36.4	17.5	40.5
ASXL2	"ASXH2, FLJ10898, KIAA1685"	ENSG00000143970	"ASXL transcriptional regulator 2"	Q76L83	2	25733753-25878487	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034646, HPA058040"			Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA034646: AB_2674261, HPA058040: AB_2683586"	"unprognostic (4.78e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.68e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.75e-2)"	6.8	6.2	3.8	9.5	5.1	8.3	7.2	4.8	3.9	8.2	4.5	9.1	6.4	7.1	5.0	7.7	7.2	6.8	7.1	3.5	7.7	8.7	6.1	6.9	11.1	7.5	5.0	6.6	7.7	14.1	3.5	7.1	7.5	6.3	8.9	8.8	6.6	6.3	8.0	7.6	7.1	8.2	3.6	9.9	7.8	17.7	6.3	13.9	10.5	7.3	10.5	7.5	4.2	6.4	25.1	23.1	11.0	7.8	9.8	13.7	12.9	16.0	19.0	12.4	10.5	19.4	12.6	14.8	9.7	13.9	13.8	14.1	21.1	14.9	16.9	22.5	10.2	32.9	20.1	16.6	8.3	42.2	25.1	6.8	15.2	17.9	15.3	10.4	15.2	8.8	29.0	12.2	12.5	9.2	15.5	9.2	14.4	13.2	9.4	15.4	48.2	11.4	10.7	30.1	11.3	12.5	22.2	13.9	13.5	10.4	8.9	12.3	31.4	16.6	22.0	15.9	22.4	26.8	39.8	41.0	15.5	27.4	13.2	1.7	2.7	4.2	2.7	1.4	2.3	2.2	1.9	1.9	1.5	2.0	2.2	2.5	6.0	1.2	3.3	2.3	2.2	0.8	3.8	5.1	4.8	3.9	3.5	7.7	7.5	5.0	7.5	3.6	6.3	6.4	16.1	25.6	24.1	54.2	25.9	32.4	8.9	15.9	29.0	22.3	19.1	10.8	27.0	14.3	19.1	9.2	25.0	10.2	22.5	20.1	15.6	15.7	48.9	25.8	20.4	22.0	10.3	33.6	62.5	14.4	9.4	17.3	24.5	19.8	23.5	12.6	28.5	12.6	18.2	25.2	47.6	16.8	18.3	25.7	23.6	26.9	19.6	25.2	23.2	68.4	34.4	12.4	12.3	46.3	72.8	18.4	14.2	13.2	29.8	13.4	12.4	14.3	41.3	24.9	39.5	20.6	16.8	34.4	26.6	29.7	41.1	14.6	45.0	17.2	19.7	19.3
ASZ1	"ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3"	ENSG00000154438	"Ankyrin repeat, SAM and basic leucine zipper domain containing 1"	Q8WWH4	7	117363222-117428123	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 10.7"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 89.0;Spermatogonia: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020558	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA020558: AB_1845123"								"unprognostic (4.30e-1)"				"unprognostic (1.87e-1)"			"unprognostic (1.42e-1)"			0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	6.6	0.2	0.0	89.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ATAD2	"ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000"	ENSG00000156802	"ATPase family AAA domain containing 2"	Q6PL18	8	123319850-123416350	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 79.1;Spermatocytes: 106.0;Spermatogonia: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 294.4"					"Low region specificity"	"Detected in all"			"HPA029424, CAB056158"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB056158: AB_2665580, HPA029424: AB_10611680"	"unprognostic (1.56e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.02e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.33e-15)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.17e-2)"	2.9	3.4	3.8	7.7	3.6	26.5	6.8	2.6	3.9	12.8	2.0	5.3	5.0	4.3	3.8	6.8	3.4	3.2	5.8	3.2	4.5	1.4	9.9	4.1	14.4	2.9	3.8	7.0	3.3	1.9	3.9	4.8	2.6	10.3	6.9	1.4	4.3	4.7	9.3	6.8	5.2	4.1	2.8	4.9	4.7	18.9	5.1	28.3	3.9	3.2	12.8	4.8	3.9	2.8	103.7	39.6	55.0	19.0	9.7	12.3	24.3	79.2	27.2	66.8	73.9	30.1	43.8	67.2	23.6	25.2	26.5	48.3	74.2	25.6	106.1	94.3	39.0	121.2	41.0	61.4	3.8	44.6	57.4	4.1	3.8	63.6	21.0	14.3	20.7	38.6	57.7	66.4	50.4	107.1	129.5	32.8	10.0	77.8	38.4	66.5	65.6	36.4	23.8	46.7	70.2	30.5	114.4	294.4	20.8	22.1	60.2	41.2	13.0	50.4	69.3	40.2	96.6	21.2	40.7	60.8	32.9	72.9	40.4	5.3	0.8	3.3	1.6	0.8	2.2	2.6	2.3	2.7	1.4	1.5	1.5	1.7	0.2	2.5	1.9	0.1	4.6	1.0	3.8	3.6	2.6	3.9	3.2	4.5	2.9	3.8	2.6	2.8	5.1	2.8	4.8	6.4	11.0	9.4	18.5	15.8	27.9	9.1	14.2	2.8	17.3	21.2	27.3	2.8	10.2	3.7	4.2	14.9	15.3	9.0	1.9	3.5	54.9	7.9	17.3	9.6	1.2	79.1	25.6	2.2	26.2	17.1	13.3	17.5	14.5	37.9	7.1	16.3	11.2	1.7	16.4	13.1	4.1	8.2	6.9	24.4	7.5	11.7	1.8	14.0	6.3	6.3	17.5	11.6	2.8	3.5	4.3	13.9	34.0	20.7	3.1	1.0	5.4	1.9	0.0	9.5	17.5	106.0	82.4	23.7	12.1	13.5	22.8	3.7	14.6	24.5
ATAD2B	KIAA1240	ENSG00000119778	"ATPase family AAA domain containing 2B"	Q9ULI0	2	23748664-23927123	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.0;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 143.7;Oligodendrocytes: 125.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034555	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA034555: AB_10601665"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.93e-3)"	"unprognostic (5.57e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.14e-2)"	"unprognostic (7.56e-3)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.46e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.98e-1)"	4.8	3.1	4.9	5.9	6.1	9.8	4.5	8.1	5.5	5.9	11.0	4.2	5.1	4.9	2.6	6.0	4.6	3.5	3.7	4.0	6.1	3.7	4.1	4.8	7.3	6.5	5.7	5.8	4.3	3.3	4.1	4.0	5.7	4.3	4.3	9.4	4.8	2.3	4.4	8.3	5.2	2.8	4.8	5.1	3.9	4.3	5.9	10.3	5.2	2.8	6.5	4.0	6.6	7.7	4.1	3.4	11.0	5.0	3.1	3.4	8.5	2.7	2.2	3.5	2.4	5.5	2.0	13.4	2.4	2.5	1.6	5.3	8.6	3.0	2.9	8.8	4.1	11.3	4.5	6.6	3.4	10.2	8.1	2.7	5.2	2.1	3.4	2.9	4.8	7.4	12.2	5.8	2.7	7.0	9.5	11.9	6.5	6.8	1.9	10.8	11.8	3.1	3.8	9.1	5.1	8.4	7.4	9.0	4.2	6.0	4.4	10.0	4.6	3.5	4.0	3.0	3.2	6.0	2.9	10.0	1.9	11.5	3.3	15.8	7.9	5.1	3.9	4.7	4.4	8.5	3.6	3.5	7.6	6.4	5.2	4.2	12.0	6.0	6.2	11.0	3.4	1.8	4.9	6.1	8.1	5.5	4.0	6.1	6.5	5.7	5.7	4.8	5.9	7.7	18.4	3.2	16.0	93.0	26.1	10.7	7.7	6.4	13.1	27.6	9.5	7.1	11.3	10.0	12.2	9.2	47.9	8.4	33.8	15.2	0.0	7.7	60.2	10.1	20.1	14.6	15.6	11.1	60.3	12.2	7.4	14.7	19.9	17.0	13.3	21.2	11.7	10.7	8.2	10.1	95.5	11.0	10.2	14.4	17.6	36.1	12.5	23.8	3.6	85.3	30.9	13.0	22.6	143.7	125.3	8.9	18.6	10.9	14.0	10.8	17.2	2.4	8.5	45.4	6.6	19.1	13.5	23.5	16.8	20.0	17.5	10.9	22.6	13.1	11.3	16.5
ATAD5	"C17orf41, ELG1, FLJ12735, FRAG1"	ENSG00000176208	"ATPase family AAA domain containing 5"	Q96QE3	17	30831966-30895869	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 59.3;Spermatocytes: 73.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA066823			Approved	"Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol"	"Intracellular and membrane"	Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA066823: "	"unprognostic (3.12e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.19e-3)"	"unprognostic (6.30e-10)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.38e-1)"	0.7	0.4	0.3	2.1	0.2	12.3	1.2	2.6	0.5	0.8	0.1	1.2	1.4	1.0	0.4	1.3	0.7	0.5	0.4	0.3	0.2	0.4	0.5	0.8	3.6	0.2	0.1	0.9	0.5	0.3	0.5	1.4	0.3	0.6	1.6	2.5	0.7	0.4	0.4	2.5	1.4	0.6	0.1	1.4	1.1	2.0	0.3	5.3	0.6	0.1	2.9	0.6	0.9	0.6	7.2	6.0	14.0	13.3	0.3	1.4	5.5	6.3	3.2	6.9	9.8	6.6	5.1	19.5	5.9	2.9	4.7	13.0	9.1	4.7	12.4	4.4	7.9	11.7	8.0	4.6	0.2	23.1	9.2	0.6	0.6	10.1	3.5	1.4	3.6	18.7	18.7	15.9	4.6	4.2	26.1	11.5	8.2	5.3	2.9	17.6	26.4	9.3	1.8	7.6	8.1	7.2	7.0	4.0	3.7	7.6	7.6	10.2	2.8	8.3	11.3	12.0	11.4	5.2	5.9	24.0	3.6	10.7	8.4	0.4	0.2	0.3	0.3	0.3	0.2	0.3	0.1	0.2	0.1	0.4	0.2	0.2	0.6	0.6	0.1	0.5	0.3	0.1	0.3	0.2	2.6	0.5	0.3	0.2	0.2	0.1	0.3	0.1	0.3	0.6	4.3	3.2	4.1	6.8	9.9	4.7	3.1	2.6	3.4	19.3	4.7	5.1	2.7	0.0	2.6	3.7	0.0	21.7	10.7	6.6	0.0	4.1	13.9	4.4	8.5	5.4	0.0	59.3	20.4	2.9	21.1	5.4	9.7	5.1	3.8	32.6	2.9	0.7	8.7	11.8	17.4	8.6	2.0	2.8	7.4	7.8	3.7	5.7	7.2	11.2	10.0	2.9	12.3	16.6	14.9	4.0	2.4	2.2	24.4	2.4	2.3	0.5	2.7	21.3	0.0	7.4	6.5	73.3	34.5	9.3	4.5	7.9	10.5	8.4	13.0	2.3
ATE1		ENSG00000107669	"Arginyltransferase 1"	O95260	10	121740424-121928492	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 220.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038444, HPA057549"	Approved		Supported	Nucleoplasm		NA	NA		83000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA038444: AB_10672745, HPA057549: AB_2683463"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-1)"	10.1	11.7	8.1	8.5	8.5	7.4	10.4	7.3	9.2	12.1	17.3	13.5	11.4	10.6	8.4	10.7	9.0	10.4	22.2	8.4	11.0	18.2	18.2	9.5	9.5	6.7	7.3	10.0	6.2	15.4	4.8	11.0	7.5	12.7	14.6	15.6	7.8	10.0	18.3	6.7	11.1	11.7	7.4	10.4	8.8	13.3	10.6	13.0	16.0	15.4	10.6	12.7	6.6	8.7	13.0	19.5	15.4	15.0	15.1	16.8	12.3	12.0	24.0	13.1	13.2	23.6	19.1	16.1	9.5	14.3	8.8	16.1	14.5	14.2	16.3	20.3	13.1	5.8	8.8	31.1	15.5	26.7	13.4	11.9	15.2	13.8	32.0	19.3	18.7	9.0	7.8	29.4	14.5	7.9	14.0	15.2	7.5	19.6	11.4	13.1	18.1	10.6	23.4	11.2	4.8	19.4	17.2	12.9	28.2	11.3	8.9	9.2	19.2	8.2	7.0	12.5	21.1	28.0	33.6	12.0	12.6	20.6	7.4	12.8	3.8	6.1	5.3	4.5	6.3	4.5	5.0	5.3	3.4	4.2	5.5	5.6	2.3	5.1	3.5	4.8	6.7	4.0	8.1	8.5	7.3	9.2	8.4	11.0	6.7	7.3	7.5	7.4	10.6	8.7	23.0	9.6	22.0	76.4	17.3	8.4	12.8	9.4	24.5	31.3	17.5	14.6	75.6	11.5	12.7	20.2	12.5	7.2	20.9	42.8	17.6	11.3	6.5	15.8	19.4	19.3	22.1	16.2	100.5	13.3	10.5	25.0	29.6	16.4	12.6	13.5	20.0	26.6	10.0	23.5	93.8	17.7	10.2	14.8	7.2	7.7	20.5	23.6	14.2	74.0	12.8	21.7	27.8	137.7	220.4	15.6	18.3	25.9	24.8	21.0	19.5	39.4	11.5	35.8	0.0	23.4	21.1	26.9	40.2	30.7	17.5	8.6	17.9	29.1	16.8	16.6
ATF1	TREB36	ENSG00000123268	"Activating transcription factor 1"	P18846	12	50763710-50821162	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016222, HPA055069, HPA055406"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB016222: AB_2290030, HPA055069: AB_2682688, HPA055406: AB_2682807"	"unprognostic (1.71e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.65e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.94e-2)"	"unprognostic (4.31e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.27e-1)"	"unprognostic (8.75e-2)"	13.8	21.2	4.9	15.8	5.1	14.8	16.8	14.2	7.1	16.7	8.2	18.0	16.0	18.2	13.7	17.0	17.8	16.5	14.6	4.8	7.9	17.4	20.8	15.8	21.5	5.3	5.8	23.1	9.1	19.8	10.1	16.7	5.4	14.3	18.6	11.9	14.5	13.5	32.4	10.4	14.7	16.7	5.4	17.9	14.3	8.6	6.6	29.2	22.7	23.7	21.5	16.5	12.9	6.9	28.6	20.4	21.0	21.4	29.0	30.4	52.2	29.5	50.7	45.7	35.8	41.7	43.7	38.7	47.6	34.5	20.0	22.8	24.9	30.6	47.6	39.0	25.8	42.8	43.1	22.6	56.5	62.3	39.6	33.7	45.7	32.8	52.8	47.6	22.5	27.1	53.2	36.2	33.9	42.4	39.6	37.3	30.0	33.0	32.1	37.5	32.3	45.9	33.6	19.5	27.9	14.9	61.8	26.5	44.7	28.5	37.3	37.6	16.1	32.1	38.2	26.4	24.1	20.2	25.8	63.6	30.9	33.9	15.3	6.6	17.9	42.7	20.2	18.8	23.1	20.2	21.7	24.1	21.1	21.7	26.4	20.4	11.2	20.8	12.7	9.6	28.8	19.1	4.9	5.1	14.2	7.1	4.8	7.9	5.3	5.8	5.4	5.4	6.6	6.9	25.5	54.5	18.5	22.2	41.5	75.3	48.4	34.8	52.3	12.1	26.0	18.5	14.6	15.7	26.7	12.9	0.0	34.6	25.4	23.4	52.8	24.9	9.2	24.6	20.8	23.8	6.0	46.7	25.8	21.1	77.1	33.1	14.3	21.0	10.1	14.1	20.0	16.2	27.5	13.5	29.2	18.7	24.4	25.2	48.4	5.9	32.0	24.2	23.2	16.9	24.6	14.2	27.8	12.5	25.3	22.8	17.9	27.8	22.1	43.7	20.7	34.6	19.9	7.2	39.5	34.1	33.7	10.9	10.3	30.3	54.6	80.6	38.4	20.4	22.8	36.9
ATF2	"CRE-BP1, CREB2, HB16, TREB7"	ENSG00000115966	"Activating transcription factor 2"	P15336	2	175072250-175168382	"Predicted intracellular proteins, Transcription factors"	"DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003769, HPA022134"	Supported	Supported	Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB003769: AB_562241, HPA022134: AB_1845138"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.21e-3)"	"unprognostic (6.70e-2)"	16.8	20.2	15.6	15.2	17.6	16.4	19.5	23.3	25.7	25.7	4.1	15.1	13.0	21.8	21.6	14.3	18.9	17.8	12.1	19.3	15.5	22.5	27.8	15.4	19.7	16.2	14.9	26.0	18.9	24.0	13.9	20.4	17.2	18.3	15.7	21.8	17.9	17.7	12.5	10.0	13.6	18.1	12.3	17.6	14.3	21.0	13.3	30.2	32.3	23.1	21.1	18.8	13.0	19.8	14.1	12.1	35.1	23.4	30.6	32.3	16.1	22.3	38.1	26.6	38.1	26.6	25.4	21.1	23.9	26.6	31.2	13.3	26.9	13.5	41.2	26.6	15.6	29.3	19.8	58.3	34.4	27.8	29.7	24.4	29.8	34.4	40.5	35.0	37.0	19.4	24.4	31.6	30.1	10.5	45.2	34.4	32.7	23.6	27.2	38.3	16.1	32.5	39.1	11.8	29.3	23.9	27.9	8.6	33.0	28.2	19.3	30.4	23.5	30.8	16.1	16.9	13.6	30.3	48.9	26.9	24.2	26.0	21.2	35.5	16.9	20.1	20.1	15.1	24.3	16.6	17.0	20.9	21.9	14.1	19.6	21.5	10.8	19.8	19.1	12.1	24.4	18.0	15.6	17.6	23.3	25.7	19.3	15.5	16.2	14.9	17.2	12.3	13.3	19.8	43.4	16.0	13.2	47.7	33.5	33.0	15.4	15.6	52.9	22.7	34.0	24.4	22.5	20.0	15.5	23.9	10.4	14.1	37.4	16.5	13.7	12.1	115.4	19.5	30.5	33.8	16.3	20.8	86.6	7.0	13.0	32.2	18.3	28.4	29.8	27.1	17.2	27.0	18.9	40.4	71.3	14.4	18.3	23.3	30.2	153.0	32.6	23.6	30.2	54.4	20.4	32.3	24.7	75.9	84.9	11.9	9.1	28.6	38.8	15.6	11.5	21.6	19.3	27.3	13.1	31.5	33.9	36.3	17.6	30.4	25.3	6.3	32.9	23.7	16.1	13.6
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1462.0;Endometrial ciliated cells: 1049.4;Glandular and luminal cells: 1429.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.4;intermediate monocyte: 4.0;myeloid DC: 1.6;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	15	"dendritic cells: 1.6;granulocytes: 6.4;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 131.5;HDLM-2: 100.4;SuSa: 155.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 9.3"	HPA001562	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	176.1	82.8	14.2	63.3	17.7	45.3	97.6	16.5	18.7	106.2	17.1	66.6	21.0	108.6	9.3	128.4	122.6	135.0	113.7	14.4	20.2	98.1	139.9	116.0	20.8	21.1	16.7	40.2	67.2	48.8	45.0	66.3	17.2	116.3	60.0	16.2	33.1	24.1	30.7	154.9	45.6	313.0	15.4	24.4	104.8	3.9	18.8	84.5	181.1	30.0	3.1	281.2	55.2	25.0	21.1	1.2	40.7	8.7	3.9	10.4	131.5	14.7	11.9	12.5	29.8	27.7	15.5	0.4	6.5	0.9	68.0	11.6	24.6	4.0	20.5	100.4	24.6	1.6	11.6	10.0	72.9	9.0	22.7	18.3	65.3	34.9	80.4	2.4	2.6	23.9	10.0	77.0	1.9	2.8	27.5	5.9	29.2	11.5	9.2	8.1	27.1	18.4	1.8	3.0	18.3	18.4	19.1	34.2	59.0	155.0	19.9	6.5	2.4	3.6	19.5	12.3	6.7	60.4	27.9	7.4	11.9	4.8	10.8	6.4	0.7	0.0	0.3	4.0	0.3	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.2	0.0	6.3	0.8	0.0	0.7	14.2	17.7	16.5	18.7	14.4	20.2	21.1	16.7	17.2	15.4	18.8	25.0	568.2	423.1	146.5	1.6	55.3	202.8	866.2	236.1	1462.0	4.4	753.9	510.9	689.3	92.9	136.0	55.2	0.0	178.9	100.3	611.7	1.9	186.2	3.7	1049.4	318.2	176.2	889.6	2.7	2.6	122.7	330.8	452.6	966.9	1429.3	78.6	5.6	30.7	25.8	103.7	1.7	2.4	758.4	114.0	29.8	282.8	2.8	17.4	351.8	174.3	3.7	32.3	39.9	0.0	1.5	10.8	185.7	484.8	1.2	161.0	457.5	421.3	3.3	133.2	5.3	98.6	279.4	573.7	2.2	3.1	474.6	202.7	420.6	97.1	5.8	349.6	263.6
ATF5		ENSG00000169136	"Activating transcription factor 5"	Q9Y2D1	19	49928702-49933935	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"liver: 2479.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1412.6"	"Cancer enriched"	"Detected in all"	7	"liver cancer: 200.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 24.0;intermediate monocyte: 22.4;myeloid DC: 14.3;plasmacytoid DC: 38.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 38.5;monocytes: 24.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 313.2;Karpas-707: 523.4;THP-1: 452.4;U-266/84: 715.6;U-698: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Cytosol	"HPA030187: AB_10601666"	"unprognostic (2.09e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.38e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (3.39e-7)"	"unprognostic (3.06e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	40.7	61.4	11.7	31.7	11.6	21.4	35.6	10.7	15.2	14.9	9.3	19.6	28.3	16.2	9.8	18.0	22.9	14.4	17.3	12.2	14.7	26.1	2479.9	17.0	23.3	14.5	17.0	14.1	29.1	10.0	14.7	12.3	15.7	23.2	10.3	12.5	21.1	10.3	30.6	17.7	23.2	10.2	13.6	27.3	24.5	44.3	12.4	13.1	118.7	9.5	20.0	24.4	14.3	15.3	68.5	47.3	17.8	12.0	18.3	15.5	17.8	48.6	40.8	49.4	30.2	35.7	36.5	60.7	24.3	28.6	34.0	24.2	22.7	20.0	23.5	313.2	22.6	41.7	14.8	27.4	12.5	162.7	113.6	108.3	31.5	36.5	8.5	12.2	21.4	132.6	38.1	523.4	24.7	64.3	23.5	35.9	8.8	18.6	62.6	194.2	19.1	24.9	56.6	90.9	28.2	20.1	113.2	47.8	34.9	6.6	39.2	452.4	36.6	95.5	61.3	11.3	49.8	13.8	715.6	316.2	75.1	63.6	36.4	0.4	24.0	1.0	1.4	22.4	2.0	1.6	1.4	1.7	14.3	0.8	1.2	1.8	3.6	3.2	6.0	38.5	1.9	4.7	11.7	11.6	10.7	15.2	12.2	14.7	14.5	17.0	15.7	13.6	12.4	15.3	16.3	12.8	11.9	2.6	41.7	22.6	12.3	11.1	39.9	3.8	31.9	29.3	7.4	38.6	9.4	16.5	6.2	33.9	23.5	22.0	13.7	13.1	260.8	36.5	17.4	21.1	21.5	64.2	1.2	29.8	19.4	27.3	34.1	35.3	6.3	27.1	40.0	1412.6	82.5	92.5	1.8	21.0	2.0	59.4	172.3	134.3	13.4	51.2	40.9	2.8	259.9	17.4	8.2	0.5	1.6	20.0	20.6	16.6	118.1	24.8	49.0	47.9	9.6	7.5	13.1	18.0	24.2	15.0	11.3	37.7	24.0	35.6	15.1	23.4	23.4	18.4
ATF6B	"CREBL1, G13"	ENSG00000213676	"Activating transcription factor 6 beta"	Q99941	6	32115264-32128253	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046871	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA		46000000	"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA046871: AB_10963542"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-2)"	35.0	40.8	7.3	7.4	7.4	29.4	40.3	6.6	9.9	50.2	3.9	46.3	11.9	46.0	16.7	56.6	45.6	11.5	31.2	7.9	9.1	36.7	35.1	35.6	14.2	7.7	7.7	57.1	43.4	14.1	43.0	8.8	7.6	43.7	14.0	8.1	44.9	6.3	22.4	53.3	46.9	8.9	7.1	60.0	45.4	29.3	7.4	16.7	51.1	5.0	17.0	44.3	47.0	7.1	2.5	6.3	18.1	29.7	17.8	18.9	11.5	9.8	13.3	13.7	20.8	25.2	20.9	30.4	26.8	60.1	14.5	17.0	23.5	37.2	8.1	18.3	34.5	11.2	36.1	24.7	28.9	2.9	40.0	17.2	16.1	5.4	31.4	25.5	44.0	47.9	38.0	32.9	39.9	18.3	25.5	17.4	5.1	20.8	5.4	7.5	7.6	20.7	17.5	6.3	1.8	6.4	35.2	13.9	40.5	5.0	39.5	12.5	17.1	3.6	13.0	13.7	15.6	33.8	20.4	17.0	15.5	18.5	21.9	4.2	1.1	0.7	1.9	1.7	1.5	1.6	1.0	0.9	2.3	1.1	0.6	1.4	0.9	2.5	1.5	1.4	1.7	2.2	7.3	7.4	6.6	9.9	7.9	9.1	7.7	7.7	7.6	7.1	7.4	7.1	39.1	12.8	15.2	31.6	72.7	24.9	37.6	83.0	33.6	89.3	31.8	26.0	2.0	50.1	53.1	55.2	95.9	88.4	64.9	52.9	5.9	48.1	3.3	22.0	24.5	40.3	53.5	39.8	29.5	42.8	50.2	29.8	39.8	27.8	16.5	148.5	43.5	18.5	52.8	43.7	29.9	53.9	79.3	55.4	40.5	8.9	70.8	42.0	32.0	28.1	65.4	35.0	124.6	21.6	24.1	37.2	58.6	51.9	40.3	30.6	64.3	14.6	43.5	98.0	59.2	30.5	29.8	64.3	58.6	36.1	25.3	89.2	58.6	49.5	55.7	39.8
ATF7	ATFA	ENSG00000170653	"Activating transcription factor 7"	P17544	12	53507856-53626410	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 141.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003384	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.59e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.28e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.17e-1)"	26.4	13.2	12.4	18.1	19.6	15.4	23.9	26.1	16.7	21.1	11.5	21.9	12.6	24.4	14.5	22.4	17.8	18.1	20.6	15.1	15.5	17.4	14.6	20.2	13.2	20.8	16.9	24.6	18.4	14.2	11.5	18.3	21.8	19.0	21.1	15.3	24.2	14.6	30.5	24.6	14.0	25.9	14.8	14.3	18.0	12.6	18.2	16.4	16.4	22.2	15.7	19.9	20.9	29.1	16.6	32.1	16.6	18.2	30.8	39.1	10.8	19.6	20.1	21.3	14.2	23.0	25.2	25.8	25.4	24.2	8.7	20.2	13.0	21.7	19.2	25.2	16.7	22.6	37.4	24.8	20.7	29.0	16.1	30.7	28.1	26.5	29.9	35.3	42.6	14.0	26.0	23.2	32.1	30.9	17.6	20.2	16.3	18.7	17.4	22.9	19.7	24.9	32.3	21.2	13.8	14.6	29.9	21.7	30.8	16.0	29.2	17.6	31.4	25.2	17.7	20.2	17.9	11.4	14.6	16.2	20.6	27.1	23.6	15.3	13.8	13.8	7.4	19.1	7.6	10.5	10.1	7.5	10.8	11.5	7.2	8.6	8.6	14.2	14.1	7.5	10.4	8.8	12.4	19.6	26.1	16.7	15.1	15.5	20.8	16.9	21.8	14.8	18.2	29.1	30.5	12.8	17.3	83.2	16.3	22.2	24.0	35.9	25.6	9.4	33.3	31.1	18.2	22.8	23.4	14.7	25.0	22.2	14.0	21.4	37.2	30.3	32.2	16.5	23.1	25.4	18.6	13.2	29.0	31.6	25.0	23.8	17.3	22.5	28.6	25.0	28.9	14.7	25.3	10.1	29.7	20.3	24.4	24.1	23.1	35.8	27.1	24.9	24.9	55.3	24.0	23.9	17.5	40.7	141.9	27.5	13.8	24.5	12.5	25.0	17.9	46.0	17.0	10.9	26.3	25.6	27.5	9.9	17.9	34.1	28.8	27.9	17.3	20.2	18.4	28.9
ATF7-NPFF		ENSG00000267281	"ATF7-NPFF readthrough"		12	53506688-53625979	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 1.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"A549: 1.4"									HPA003384	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (1.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.37e-4)"	"unprognostic (6.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.91e-2)"	"unprognostic (2.26e-7)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.77e-3)"	0.1	0.0	0.1	0.0	0.5	0.3	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.2	0.0	0.5	0.2	0.2	0.0	1.0	0.2	1.4	0.0	0.1	0.5	0.7	0.0	0.0	0.4	0.5	0.1	0.1	0.2	0.5	0.1	0.0	0.0	0.4	0.1	0.3	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.7	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.8	0.5	0.1	0.6	0.7	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.7	0.0	0.0	0.4	0.1	0.1	0.1	0.5	1.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.8	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ATF7IP	"FLJ10688, p621"	ENSG00000171681	"Activating transcription factor 7 interacting protein"	Q6VMQ6	12	14365632-14502935	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016578, HPA023505"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"		"HPA016578: AB_1845147, HPA023505: AB_1845148"	"unprognostic (2.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.48e-2)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.88e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.78e-2)"	12.4	10.4	12.1	16.8	18.8	30.9	14.7	32.8	11.7	12.8	21.7	11.2	8.3	15.6	13.7	14.3	13.4	11.8	16.3	9.9	14.1	11.0	14.4	13.3	28.2	16.9	15.5	17.9	11.5	17.2	8.5	14.2	15.8	13.4	13.0	17.1	20.6	12.0	16.4	16.7	11.9	16.4	11.2	20.8	14.2	33.8	18.8	32.5	21.7	21.2	28.1	12.6	11.4	21.3	23.2	13.8	54.3	31.7	27.9	35.2	11.4	24.4	13.7	18.8	28.6	31.4	23.9	38.5	16.2	16.6	34.3	23.0	34.3	22.4	42.3	27.5	20.1	25.8	23.3	6.5	16.6	17.7	15.1	19.0	18.3	23.2	23.9	29.3	41.5	13.6	15.6	19.7	29.9	21.7	25.5	15.4	35.1	11.9	12.7	52.3	60.3	21.0	16.2	44.6	17.4	14.2	27.7	16.0	15.4	44.0	16.2	20.5	19.2	26.3	16.7	14.9	20.3	13.2	13.9	53.1	16.7	16.5	29.0	29.2	11.6	19.4	16.2	8.3	16.8	23.1	13.6	16.0	9.8	30.9	10.9	15.5	17.8	11.4	14.2	12.9	18.7	11.0	12.1	18.8	32.8	11.7	9.9	14.1	16.9	15.5	15.8	11.2	18.8	21.3	46.6	67.3	42.5	67.9	121.2	6.6	12.8	9.7	75.1	50.2	31.6	24.6	73.0	20.0	26.6	35.0	68.8	17.2	112.1	13.2	7.9	16.6	79.6	31.1	34.7	40.3	28.1	55.1	62.6	12.2	10.9	32.0	41.8	31.9	25.9	34.8	30.0	31.3	20.5	63.9	73.9	19.6	10.2	48.4	11.2	19.6	29.2	46.3	5.4	107.7	47.9	23.5	64.9	136.7	147.9	14.5	13.5	29.3	85.9	13.6	12.0	16.4	24.3	39.8	13.1	40.0	33.3	42.4	25.0	62.7	6.7	15.5	98.5	35.1	18.3	12.1
ATG10	"APG10L, DKFZP586I0418, FLJ13954"	ENSG00000152348	"Autophagy related 10"	Q9H0Y0	5	81972023-82276857	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044163	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	Nucleoplasm	"HPA044163: AB_2678842"	"unprognostic (1.20e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.43e-1)"	4.0	5.4	4.8	4.1	4.9	5.6	7.0	8.3	5.7	3.5	7.9	5.5	3.3	4.6	7.8	4.9	4.2	4.3	4.6	5.0	4.7	5.7	6.5	3.7	3.5	5.0	4.5	3.2	4.4	11.6	4.0	4.7	5.0	5.6	6.1	3.5	3.7	5.6	7.2	6.6	3.3	5.5	4.6	4.1	4.4	10.4	5.0	7.8	7.1	3.1	4.3	4.0	3.9	8.0	4.7	12.6	7.9	23.0	5.3	10.0	20.1	5.4	4.4	3.9	6.0	3.7	16.7	8.4	4.4	8.8	29.7	2.5	5.9	12.2	5.1	14.4	4.2	9.2	11.4	4.0	5.0	4.8	7.3	9.3	8.2	5.7	4.7	6.0	7.4	17.7	11.3	6.8	14.4	9.5	11.0	5.2	11.0	3.5	8.2	8.0	11.5	20.1	10.0	6.7	11.8	16.9	8.8	4.9	10.0	13.6	9.4	8.9	6.0	7.0	6.6	3.8	11.5	9.4	17.0	11.5	9.8	11.4	11.7	2.7	5.7	8.5	5.1	5.8	4.8	3.6	4.5	4.8	7.5	4.5	4.2	5.2	7.4	6.5	4.3	5.6	5.0	4.1	4.8	4.9	8.3	5.7	5.0	4.7	5.0	4.5	5.0	4.6	5.0	8.0	8.1	16.0	15.6	69.2	9.3	24.9	17.4	16.3	14.2	16.3	15.6	14.4	9.3	12.8	16.7	12.9	10.4	25.5	9.7	8.2	15.6	15.7	67.6	7.7	11.4	13.0	9.6	14.5	56.4	18.4	46.3	15.1	6.6	9.7	11.4	22.1	10.0	12.8	18.3	18.5	52.2	7.8	4.1	14.1	28.4	96.6	6.8	12.3	32.0	57.1	17.2	12.5	15.5	67.8	76.5	15.2	9.9	10.1	10.1	12.0	8.5	18.8	8.8	15.2	0.0	18.2	13.6	54.1	22.9	13.8	32.0	21.1	14.3	15.6	11.5	14.0
ATG12	"APG12, APG12L"	ENSG00000145782	"Autophagy related 12"	O94817	5	115828200-115841837	"Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013272, HPA068989"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB013272: AB_2533272, HPA068989: "	"unprognostic (2.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (5.11e-2)"	15.5	10.5	12.3	10.7	12.7	11.3	10.2	12.9	16.9	12.0	10.5	10.4	11.6	10.8	11.9	11.3	9.8	11.6	9.7	12.6	13.3	7.1	18.4	10.4	13.6	13.2	13.2	12.0	9.5	7.4	8.7	13.6	13.7	10.8	11.1	9.6	7.9	10.9	11.1	9.0	11.9	12.7	12.7	11.2	8.8	9.4	12.8	14.0	8.6	12.6	11.6	11.8	8.8	15.0	20.7	10.9	26.3	24.1	42.9	57.4	20.0	34.9	38.3	22.6	36.5	15.8	16.5	17.8	14.5	32.1	35.3	11.3	20.5	29.4	36.4	93.2	20.2	11.5	13.0	14.8	33.7	12.8	22.0	43.0	31.5	25.1	29.6	26.3	27.6	19.0	16.8	24.4	43.5	13.5	27.2	20.2	17.9	15.7	23.6	19.8	25.4	25.7	15.7	13.7	25.8	27.6	37.3	14.7	36.6	20.0	20.3	19.2	28.3	41.3	18.9	38.2	36.0	18.7	31.5	28.9	37.7	27.2	39.6	15.4	11.5	19.3	11.8	13.6	16.5	12.3	14.3	11.7	10.3	12.2	14.6	14.1	20.9	14.4	17.4	13.8	12.3	11.0	12.3	12.7	12.9	16.9	12.6	13.3	13.2	13.2	13.7	12.7	12.8	15.0	52.5	44.8	41.0	17.0	82.8	85.8	65.4	81.6	44.3	42.3	46.8	36.1	45.2	38.6	56.9	25.8	77.2	61.8	92.3	50.3	37.2	60.6	28.7	49.0	60.7	55.1	41.8	23.8	28.5	81.6	134.1	75.2	36.2	55.8	96.9	48.8	47.5	57.9	68.2	30.3	26.5	54.5	59.0	72.1	69.8	14.9	64.0	53.7	53.4	19.7	76.8	34.1	99.9	26.7	35.5	105.5	45.8	53.8	50.1	68.4	56.3	44.3	49.7	59.2	26.3	39.5	50.5	50.0	45.1	40.0	84.7	88.7	78.8	45.1	46.0	78.1
ATG13	KIAA0652	ENSG00000175224	"Autophagy related 13"	O75143	11	46617527-46674818	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Autophagy		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039350			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039350: AB_10673142"	"unprognostic (3.66e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.47e-1)"	32.3	39.7	55.9	26.1	67.6	60.5	30.1	49.4	63.7	30.6	46.1	26.5	29.3	28.2	32.2	32.0	32.1	29.6	36.8	55.2	51.8	28.7	43.9	25.3	31.5	60.2	59.4	29.7	44.6	37.5	57.7	21.9	61.8	31.1	24.1	48.4	35.9	25.5	34.5	39.6	28.0	24.8	51.8	36.4	36.4	82.0	59.6	40.6	36.8	33.4	33.6	27.4	29.1	87.9	32.8	58.5	44.1	26.1	60.2	70.0	44.5	37.5	65.4	45.0	57.0	40.2	31.7	30.2	25.6	56.5	58.1	38.8	42.7	50.3	45.2	57.9	81.1	32.8	39.7	71.2	67.4	44.1	54.1	84.9	59.0	31.0	67.9	63.9	45.0	69.4	57.8	66.8	40.8	48.8	44.0	65.1	55.0	59.5	49.9	41.4	57.0	53.7	29.9	34.5	41.6	42.1	51.2	40.6	55.4	42.1	58.0	89.5	44.6	54.7	33.3	51.1	41.2	61.1	73.8	38.6	67.8	39.3	40.9	41.7	36.1	48.5	35.1	42.6	27.9	27.1	31.2	27.8	35.0	21.7	26.4	29.2	67.7	31.5	35.1	25.6	44.7	39.9	55.9	67.6	49.4	63.7	55.2	51.8	60.2	59.4	61.8	51.8	59.6	87.9	10.6	16.0	16.2	14.7	16.9	9.3	12.0	9.0	13.1	22.7	16.7	12.3	13.2	8.6	12.0	12.9	39.6	9.9	25.4	24.5	7.9	18.9	42.7	30.0	17.3	12.7	18.0	28.2	23.4	32.3	22.4	14.8	20.9	46.1	8.8	22.5	13.2	22.5	15.1	33.7	25.7	22.6	14.2	19.1	9.8	46.8	11.5	15.7	12.4	15.0	22.8	16.3	19.6	25.1	61.0	30.4	12.9	11.3	36.6	19.9	19.5	13.5	9.4	32.2	13.1	16.9	19.9	46.3	16.3	15.8	11.5	26.4	18.0	9.8	11.9	24.3
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814406-72843674	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 136.8;lymphoid tissue: 129.0"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 45.4;neutrophil: 59.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	20.2	18.1	18.1	33.0	19.2	136.8	14.9	20.2	24.1	21.6	16.2	20.4	10.8	14.6	7.5	26.1	22.1	18.9	20.8	18.0	16.0	20.1	18.5	41.2	34.3	18.9	17.7	23.4	15.1	6.3	13.7	10.2	18.0	14.4	17.0	2.9	13.6	8.2	7.7	72.9	34.0	15.0	15.3	129.0	17.7	6.5	21.1	9.7	15.9	7.4	25.2	18.9	22.2	20.9	2.7	2.5	7.5	5.9	8.7	7.2	4.6	6.1	5.9	2.9	4.4	3.1	6.4	18.3	4.0	7.7	5.3	5.2	0.9	20.1	5.0	14.2	3.0	14.5	14.4	5.1	6.4	18.8	58.2	6.9	2.7	6.6	8.0	32.2	9.0	32.7	1.9	24.1	3.4	9.1	22.5	32.0	1.1	12.0	2.9	10.6	5.5	8.6	9.7	9.2	5.5	4.4	2.6	13.2	5.8	5.9	6.6	25.5	12.6	7.9	2.9	14.4	5.0	11.0	2.9	8.1	3.5	16.4	4.5	5.9	16.3	45.4	2.7	9.3	2.7	2.6	3.9	5.4	10.9	4.6	2.2	2.6	59.6	5.2	11.8	1.7	4.0	4.0	18.1	19.2	20.2	24.1	18.0	16.0	18.9	17.7	18.0	15.3	21.1	20.9	19.5	6.4	14.4	11.4	37.6	16.7	5.1	6.1	10.2	3.6	8.7	9.0	5.0	4.3	6.2	5.5	2.1	9.6	29.0	13.0	0.0	5.0	0.8	8.9	12.0	12.7	13.1	9.9	14.0	1.0	3.7	7.1	17.9	7.9	22.9	10.6	18.9	3.8	16.2	5.0	11.1	9.1	8.2	48.5	18.1	2.1	10.2	45.7	3.6	23.4	39.2	4.4	30.9	18.1	9.7	2.7	59.1	7.9	17.3	2.5	8.3	2.5	8.1	3.5	0.0	8.8	11.4	4.9	13.4	15.7	17.3	12.3	21.3	7.2	14.0	6.0
ATG2A	KIAA0404	ENSG00000110046	"Autophagy related 2A"	Q2TAZ0	11	64894546-64917211	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 16.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038715	Uncertain		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"HPA038715: AB_10673474"	"unprognostic (3.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (4.79e-5)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	16.4	20.1	11.4	6.5	10.9	60.2	16.9	8.6	40.1	19.9	11.4	18.9	7.5	18.2	1.8	15.7	19.2	4.2	18.4	11.5	9.8	22.0	59.2	24.2	6.1	13.9	12.3	24.9	22.7	4.9	21.6	4.9	12.7	21.6	2.6	1.9	15.2	5.7	26.7	34.9	21.4	3.3	9.0	25.7	23.2	15.3	11.4	5.4	19.3	4.4	3.3	17.7	15.6	10.4	13.2	12.6	4.4	12.0	5.7	4.0	12.3	7.1	10.3	9.4	6.8	11.0	9.9	9.3	14.7	6.0	12.0	10.8	4.5	8.3	2.5	9.1	15.7	8.7	19.1	10.0	8.4	6.5	18.2	10.9	7.1	11.8	6.3	5.4	7.9	9.5	16.1	7.3	4.1	21.3	7.8	21.9	5.1	3.5	14.3	8.6	7.1	13.5	5.0	10.9	16.5	6.7	10.6	14.6	13.3	3.3	14.3	8.1	10.1	9.0	8.6	18.3	5.3	14.7	5.5	6.5	13.0	5.2	5.6	3.0	2.0	2.2	2.5	2.1	2.1	0.8	1.7	2.2	1.4	0.9	1.3	2.4	16.9	1.8	1.7	2.4	0.9	1.2	11.4	10.9	8.6	40.1	11.5	9.8	13.9	12.3	12.7	9.0	11.4	10.4	9.8	9.6	16.2	20.2	17.0	28.9	8.7	35.7	16.5	16.6	15.8	10.3	8.1	7.2	17.6	9.2	33.3	12.7	40.1	38.8	1.9	10.2	2.5	12.4	9.2	10.2	35.9	16.2	7.6	10.3	5.3	12.6	16.8	24.4	9.5	15.4	7.9	23.2	10.9	13.5	8.4	17.6	24.4	20.1	19.9	3.6	12.8	24.2	30.2	5.6	11.9	12.3	19.6	6.6	7.1	14.9	21.7	10.1	27.3	12.2	26.8	6.6	13.3	26.0	13.1	11.6	10.6	9.0	6.2	16.3	38.4	66.9	40.2	27.2	19.0	15.9
ATG4B	"APG4B, AUTL1, DKFZp586D1822, KIAA0943"	ENSG00000168397	"Autophagy related 4B cysteine peptidase"	Q9Y4P1	2	241637213-241673857	"Enzymes, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037195, HPA069803"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB037195: AB_1078237, HPA069803: AB_2686200"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.60e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (9.64e-4)"	12.0	17.5	21.4	8.1	21.7	14.7	13.2	20.9	24.7	18.0	20.1	19.7	11.4	16.8	5.3	16.2	16.8	7.6	18.4	21.6	23.0	19.7	18.0	12.4	13.2	23.0	21.4	16.5	16.4	12.1	21.5	7.2	23.6	22.6	5.4	8.5	14.4	9.6	18.7	16.7	18.3	6.7	20.7	19.9	16.1	19.7	22.4	16.1	18.7	7.6	7.8	16.3	14.6	21.5	8.8	15.6	16.9	13.5	15.8	10.5	29.5	23.8	9.8	16.5	12.4	15.0	9.8	7.4	7.2	11.8	10.5	16.5	16.0	20.3	3.8	18.8	31.8	19.6	14.1	40.2	20.1	13.6	12.0	13.8	15.0	9.0	7.1	16.8	11.0	44.3	23.4	5.1	8.6	32.6	33.4	36.9	30.9	23.8	25.9	51.3	25.1	16.2	11.4	14.9	26.2	21.3	17.5	13.9	27.8	14.1	15.5	24.6	15.4	7.1	12.0	14.8	13.3	21.1	17.0	34.6	18.8	21.4	17.6	3.9	17.9	19.2	18.5	15.6	15.9	15.8	14.2	15.6	20.4	16.5	18.0	12.8	12.8	11.8	18.9	17.0	20.4	16.8	21.4	21.7	20.9	24.7	21.6	23.0	23.0	21.4	23.6	20.7	22.4	21.5	23.2	32.1	33.8	41.1	25.6	24.3	27.2	41.3	25.0	22.2	24.4	21.8	16.2	25.8	29.9	27.6	33.3	35.8	33.5	61.8	19.6	37.5	18.1	28.6	21.9	25.3	35.9	31.8	38.5	40.2	28.5	22.6	40.8	43.3	19.0	36.5	20.3	27.9	33.4	42.1	33.8	36.4	42.7	28.5	34.5	25.9	22.1	30.7	28.4	31.9	51.2	24.5	41.2	20.1	41.0	41.5	41.5	24.8	28.6	35.6	70.5	25.1	26.7	26.8	19.7	22.7	22.8	58.3	63.3	19.9	25.4	53.9	29.4	27.6	35.6	32.5
ATG4C	"APG4C, AUTL1, AUTL3, FLJ14867"	ENSG00000125703	"Autophagy related 4C cysteine peptidase"	Q96DT6	1	62784132-62865516	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 60.8"	"Cell type enriched"	"Detected in all"	7	"Oligodendrocytes: 449.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007049	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA007049: AB_1845159"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (9.83e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	7.9	8.0	23.3	10.3	41.1	5.8	7.8	25.0	24.0	8.5	6.3	8.4	6.7	8.0	5.9	7.2	6.5	8.8	6.0	19.7	25.0	11.2	11.1	8.1	13.3	28.5	29.9	8.3	7.5	10.8	3.3	12.8	29.3	6.5	8.7	6.6	9.8	6.2	5.2	5.5	6.6	9.4	23.7	12.1	7.7	8.1	26.5	13.7	9.9	5.2	10.9	8.3	3.9	60.8	11.5	8.9	13.5	11.9	17.4	18.5	13.5	16.6	11.3	15.7	17.5	6.5	8.8	23.9	12.5	8.5	18.3	8.6	16.1	12.7	22.5	18.0	15.0	27.2	9.3	8.7	12.4	22.2	17.4	15.5	8.9	16.7	7.9	15.1	19.1	26.3	23.4	19.1	13.4	5.4	22.5	8.5	19.8	16.2	14.5	26.5	32.2	17.2	11.2	8.1	18.2	9.1	11.0	20.6	22.1	23.2	10.0	10.3	7.6	12.5	12.2	21.3	18.4	16.3	24.0	20.0	14.3	21.5	15.4	32.6	17.4	14.1	7.2	14.1	10.1	34.3	10.2	8.9	31.9	30.8	14.1	12.0	2.5	12.5	8.6	19.0	9.8	11.5	23.3	41.1	25.0	24.0	19.7	25.0	28.5	29.9	29.3	23.7	26.5	60.8	12.6	6.4	10.6	50.3	29.7	5.0	6.2	9.9	6.8	5.2	5.8	5.8	10.0	5.7	9.7	7.3	2.1	37.7	14.1	3.7	19.6	7.2	8.1	5.5	10.2	12.8	6.0	15.8	42.0	8.1	30.7	12.2	8.2	4.9	12.0	7.8	12.8	10.0	36.5	5.0	40.8	4.3	4.1	17.9	7.3	3.0	8.7	25.1	8.8	58.1	29.7	10.5	9.2	57.8	449.9	4.8	4.2	9.8	24.2	3.5	4.8	24.8	4.8	5.2	6.6	8.3	8.3	37.2	14.6	6.6	4.0	29.0	9.2	9.1	6.6	3.6
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 103.9;Proximal enterocytes: 109.3;Spermatocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 57.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA067683: AB_2685886"	"unprognostic (2.85e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.39e-7)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	7.3	15.6	4.2	7.3	4.7	33.2	7.4	8.3	8.6	9.4	8.2	22.3	21.8	8.1	1.6	27.3	7.6	3.9	23.2	4.5	4.0	20.8	13.2	10.6	8.3	5.2	4.7	9.5	16.3	10.7	16.6	4.9	5.3	14.0	5.2	2.5	16.6	4.4	36.9	24.6	23.2	2.1	3.1	17.0	13.7	24.5	5.4	12.0	13.4	10.8	4.6	9.7	15.0	6.1	13.8	8.7	11.7	16.5	2.1	1.8	9.9	9.2	7.8	11.1	12.2	14.9	4.3	9.2	16.2	0.9	8.6	20.8	7.3	6.8	1.4	10.4	23.5	23.1	22.3	8.2	7.4	9.4	22.1	1.8	14.2	9.8	3.4	2.8	3.3	18.1	17.8	19.8	3.6	21.9	27.6	57.8	18.9	6.1	29.0	20.0	8.2	15.1	6.4	17.8	45.3	17.8	12.6	22.6	11.3	2.1	14.0	21.6	6.4	16.8	11.0	34.7	20.4	19.2	15.4	10.8	14.4	18.0	19.5	1.6	0.8	3.7	1.1	1.0	1.5	1.0	1.3	1.2	0.6	0.4	1.2	1.7	0.2	1.3	0.4	4.2	2.2	0.8	4.2	4.7	8.3	8.6	4.5	4.0	5.2	4.7	5.3	3.1	5.4	6.1	6.3	9.6	6.6	9.1	14.4	30.5	19.8	14.9	24.5	14.9	14.1	10.2	0.5	14.3	8.1	1.8	14.6	27.9	38.7	103.9	13.7	16.1	83.6	9.6	5.5	5.3	22.2	43.6	8.4	16.5	6.7	8.2	26.5	10.1	7.0	10.9	6.1	11.9	13.4	28.6	9.1	38.5	20.3	15.0	12.1	16.3	8.7	10.0	12.4	4.7	15.7	11.8	22.6	4.5	8.4	20.5	72.4	4.5	17.6	21.6	109.3	25.4	5.2	20.1	13.1	9.1	14.2	100.7	21.2	33.4	31.3	36.5	19.6	10.6	33.2	36.4
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Excitatory neurons: 178.7;Inhibitory neurons: 176.4;Late spermatids: 119.1;Microglial cells: 132.1;Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 60.1;classical monocyte: 136.6;eosinophil: 88.4;intermediate monocyte: 79.4;myeloid DC: 82.4;neutrophil: 107.4;non-classical monocyte: 60.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 82.4;granulocytes: 107.4;monocytes: 136.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		33000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	16.8	13.5	11.2	25.0	13.1	47.6	18.0	7.3	21.8	14.5	17.0	17.3	13.0	14.9	16.7	16.7	18.7	16.6	10.8	12.4	9.5	13.7	13.2	20.9	23.9	15.0	15.0	12.2	10.9	21.2	7.5	21.0	13.1	11.6	19.2	10.3	12.2	11.9	13.0	18.0	13.8	20.0	12.4	16.4	14.4	22.5	15.4	13.1	13.0	13.5	25.0	20.3	12.0	21.3	48.5	37.1	16.7	9.2	28.0	36.7	80.4	44.5	56.8	43.1	49.9	16.0	42.5	22.1	26.5	39.2	45.1	14.5	18.3	62.0	73.8	19.8	23.5	16.0	33.6	19.6	36.9	46.8	50.8	38.0	28.2	83.6	52.0	45.4	60.5	14.0	24.1	17.9	60.6	31.3	13.7	21.3	13.0	22.2	47.9	17.1	19.6	19.9	32.5	34.2	14.6	14.5	31.6	26.4	17.5	20.1	28.8	44.7	42.5	36.0	25.7	23.6	63.2	11.1	31.8	38.1	57.8	43.1	49.9	60.1	136.6	88.4	15.9	79.4	12.3	13.0	12.9	15.1	82.4	12.3	11.7	13.7	107.4	21.3	60.8	14.7	12.4	56.8	11.2	13.1	7.3	21.8	12.4	9.5	15.0	15.0	13.1	12.4	15.4	21.3	6.4	0.0	9.8	160.0	11.4	11.1	7.3	21.6	9.6	18.1	7.4	3.6	4.2	4.3	12.5	7.3	18.8	16.5	7.9	8.3	7.9	12.3	44.2	10.6	9.5	14.6	11.4	9.5	178.7	12.9	16.8	11.0	10.7	13.2	14.7	12.4	19.6	9.0	57.6	20.2	176.4	7.6	22.4	25.8	12.1	119.1	10.2	28.8	3.6	132.1	30.6	8.1	13.4	99.0	137.2	17.4	7.3	9.8	10.8	6.4	8.4	6.8	16.5	12.5	6.6	11.7	10.6	22.4	11.9	9.8	7.7	19.2	10.1	9.9	7.6	7.4
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222832-108369102	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 210.6;NK-cells: 339.8;Oligodendrocytes: 217.6;Rod photoreceptor cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	6.2	7.4	8.2	17.5	15.0	16.2	8.5	17.0	12.3	8.7	16.1	6.7	5.2	10.0	9.9	4.0	7.5	8.2	7.0	7.3	11.3	5.8	7.8	7.6	33.7	15.8	13.1	15.8	14.8	9.3	12.1	8.0	17.0	6.3	7.0	20.6	11.4	6.1	4.4	7.5	12.6	6.9	10.3	22.2	8.6	5.2	12.7	18.2	8.8	6.0	25.9	7.1	6.9	28.8	4.3	6.8	14.8	7.6	20.2	29.1	3.1	10.9	13.5	6.4	11.3	7.1	10.3	18.3	14.0	10.2	9.6	7.7	11.6	10.8	9.0	12.3	5.7	15.2	8.7	10.2	10.5	16.4	17.0	18.3	6.3	10.0	21.2	15.2	14.1	16.5	12.4	9.9	14.3	3.4	10.6	18.5	9.8	8.6	7.4	9.7	9.7	24.9	8.1	7.5	9.0	10.5	11.1	4.7	20.6	13.2	9.3	10.1	23.7	15.8	8.4	7.3	9.0	6.2	7.0	78.3	7.0	19.0	18.8	21.3	5.5	4.0	16.5	5.7	11.1	11.6	11.7	12.5	2.6	13.0	21.1	20.4	9.9	9.7	13.3	6.2	6.1	5.3	8.2	15.0	17.0	12.3	7.3	11.3	15.8	13.1	17.0	10.3	12.7	28.8	23.7	38.5	20.8	62.7	146.4	12.6	17.5	21.1	28.5	111.0	19.6	14.2	39.9	12.8	19.5	22.0	210.6	16.9	140.2	4.2	5.9	9.9	19.2	14.4	52.1	25.9	20.4	39.1	70.2	12.3	13.2	39.0	12.8	20.9	13.3	45.9	32.9	23.3	29.1	60.6	82.8	14.9	26.4	96.4	34.0	5.1	39.4	69.2	26.6	178.9	63.2	27.3	339.8	85.5	217.6	7.6	7.6	27.8	96.5	9.1	8.9	11.1	16.0	200.1	26.3	41.4	29.2	31.5	37.4	15.8	12.4	4.2	147.7	52.3	11.5	10.2
ATN1	"B37, D12S755E, DRPLA"	ENSG00000111676	"Atrophin 1"	P54259	12	6924463-6942321	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031619	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031619: AB_10601667"	"unprognostic (3.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (1.44e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.35e-2)"	125.2	148.3	71.7	33.7	60.1	6.9	120.6	94.2	120.0	143.8	14.5	155.4	36.3	146.4	25.5	71.9	148.9	43.2	94.2	66.8	75.7	95.5	42.7	109.0	20.4	81.3	70.6	234.6	79.6	56.7	188.9	43.8	60.0	117.6	21.1	58.8	89.8	59.5	81.9	79.2	82.0	49.4	41.2	74.2	100.4	33.3	71.5	16.3	189.0	34.4	14.0	122.2	108.8	67.4	56.4	72.1	75.9	154.7	69.6	61.7	126.3	65.5	55.4	65.1	45.8	73.6	65.6	15.2	20.4	80.8	54.1	36.8	46.2	63.8	33.3	178.0	46.3	70.6	71.7	35.6	108.3	14.6	103.8	101.8	46.1	82.4	63.6	112.5	64.4	22.4	61.1	29.9	58.2	81.2	31.9	13.5	156.0	26.2	30.1	65.9	40.6	11.2	48.3	78.3	23.4	75.3	66.5	77.2	47.1	73.6	29.5	40.3	85.2	76.7	97.9	61.1	102.2	22.7	8.1	10.7	60.1	18.7	82.3	0.5	0.1	0.7	0.6	0.0	0.5	0.7	0.2	0.3	0.1	0.5	0.3	0.4	0.0	0.1	0.0	0.5	0.3	0.2	71.7	60.1	94.2	120.0	66.8	75.7	81.3	70.6	60.0	41.2	71.5	67.4	66.3	16.0	17.2	76.4	9.1	30.2	13.5	22.9	30.1	26.6	51.5	57.4	16.4	24.3	20.4	29.5	18.8	27.4	11.4	37.4	15.6	20.5	2.3	39.9	61.2	40.7	21.7	4.8	23.8	30.3	15.3	30.9	34.7	51.7	10.1	37.1	39.7	8.0	11.9	25.2	29.7	23.0	8.2	10.9	21.0	3.5	63.6	13.7	21.4	23.4	4.8	17.3	3.1	17.6	18.2	29.9	25.3	52.6	9.5	17.4	24.2	12.1	15.4	23.9	19.7	29.4	39.5	9.7	7.7	22.1	24.9	37.1	10.9	26.2	20.4	17.9
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"intestine: 20.0"	"Cell type enriched"	"Detected in some"	30	"Intestinal goblet cells: 226.1"	"Cancer enriched"	"Detected in some"	4	"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049400			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA049400: "			"prognostic favorable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.1	20.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	226.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0
ATOH8	"bHLHa21, FLJ14708, HATH6"	ENSG00000168874	"Atonal bHLH transcription factor 8"	Q96SQ7	2	85751344-85791383	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 123.8;Endothelial cells: 41.7;Hepatocytes: 39.1;Muller glia cells: 32.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.2;fHDF/TERT166: 6.8;hTERT-RPE1: 5.0;RH-30: 9.5;RT4: 5.6;TIME: 7.9;U-2197: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028406			Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA028406: AB_2672587"	"unprognostic (7.70e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.32e-2)"	"prognostic favorable (3.80e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-2)"	33.8	1.8	2.1	0.3	2.2	0.0	29.9	2.7	1.6	20.9	0.5	8.8	0.2	25.9	0.2	5.6	19.4	0.4	30.6	1.5	5.1	7.3	25.1	25.6	0.8	5.7	4.9	15.0	4.2	0.2	5.4	0.3	5.3	17.4	0.4	0.6	5.2	1.9	54.7	19.9	8.9	1.3	1.6	12.2	9.4	2.1	3.1	0.2	48.5	2.0	0.1	21.7	20.6	3.3	0.0	1.1	4.1	6.2	3.0	0.4	0.0	3.4	0.5	0.8	0.3	0.0	0.0	0.0	1.1	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.1	1.6	0.0	0.0	2.1	0.0	0.0	0.0	5.0	0.6	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	9.5	0.0	0.0	5.6	3.0	1.4	0.6	0.0	0.6	0.0	0.0	0.0	7.9	1.2	0.0	5.5	0.0	0.0	0.0	0.0	0.8	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.2	2.7	1.6	1.5	5.1	5.7	4.9	5.3	1.6	3.1	3.3	123.8	9.6	18.3	10.7	0.3	2.5	8.5	11.8	0.6	0.4	0.5	0.8	13.2	5.7	17.5	1.8	0.0	0.1	0.1	1.1	0.0	11.9	13.6	5.9	5.7	41.7	4.2	0.0	0.3	2.3	0.6	11.4	1.1	20.5	1.3	5.3	5.7	39.1	3.2	0.0	0.3	2.2	6.1	3.1	4.0	25.9	3.4	4.3	1.8	5.6	0.6	32.3	0.0	14.6	3.1	1.0	5.5	0.4	0.0	4.5	0.0	0.6	2.4	1.3	0.0	12.2	11.6	3.0	2.7	0.2	1.4	0.3	0.5	0.1	1.0	2.3
ATOX1	HAH1	ENSG00000177556	"Antioxidant 1 copper chaperone"	O00244	5	151742316-151772532	"Predicted intracellular proteins"	"Copper transport, Ion transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 932.7;Proximal tubular cells: 1449.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055036			Approved	"Nucleoplasm,Plasma membrane"		NA	NA		790000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane"	"HPA055036: "	"unprognostic (5.55e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.53e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.72e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-1)"	102.0	136.9	173.3	65.9	183.6	73.8	100.1	180.8	201.1	84.4	181.9	84.7	81.8	73.7	98.0	112.1	64.6	63.6	107.4	170.0	189.7	217.1	260.9	80.3	142.9	181.9	184.7	57.8	57.1	180.6	81.2	69.8	183.6	100.2	64.3	24.9	93.0	74.6	53.6	102.8	83.0	75.9	184.9	124.4	76.1	72.9	185.6	82.6	119.3	39.5	128.2	91.7	84.2	192.8	112.0	181.9	104.4	73.1	275.1	224.2	136.6	197.7	225.8	197.2	267.3	248.2	235.8	224.9	233.3	345.7	437.1	102.4	129.2	502.5	161.3	143.9	220.3	98.7	118.4	255.1	254.1	137.5	108.5	291.3	105.0	246.0	161.1	144.7	295.3	138.5	83.4	642.7	305.1	276.6	102.3	304.0	59.8	249.8	382.3	61.4	120.0	350.0	190.6	98.1	136.2	80.0	169.3	476.6	763.4	117.2	234.2	165.3	328.5	201.0	159.4	246.9	345.9	522.6	513.4	136.2	271.7	92.3	846.1	154.6	207.9	199.4	75.1	247.6	69.0	98.6	67.3	66.2	171.3	68.3	53.0	58.0	155.3	97.0	177.2	217.8	103.5	117.3	173.3	183.6	180.8	201.1	170.0	189.7	181.9	184.7	183.6	184.9	185.6	192.8	209.1	57.7	56.6	8.1	93.2	67.7	79.8	204.5	70.0	22.7	250.1	246.5	112.1	165.8	102.2	211.5	14.6	146.0	65.6	213.6	541.9	207.6	178.9	121.1	171.1	183.2	150.7	104.1	6.4	159.1	218.7	127.3	96.8	135.3	73.0	117.8	236.7	932.7	671.2	25.2	9.1	171.1	164.8	221.4	166.0	321.1	83.0	230.4	238.3	4.7	436.7	185.7	88.6	5.5	22.7	318.1	238.7	103.4	170.4	124.2	727.0	1449.1	108.5	24.9	92.1	69.0	235.2	81.9	156.0	153.1	106.4	118.8	55.4	96.6	152.7	122.2
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485275-47593486	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	12	"basophil: 84.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 84.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 41.6"					"Low region specificity"	"Detected in all"			HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	4.9	6.0	2.6	5.0	2.9	1.3	4.2	1.9	2.7	7.0	15.9	3.7	3.9	7.4	7.2	10.2	4.7	7.4	4.2	1.8	4.1	10.2	2.4	6.1	6.2	3.1	3.7	8.1	4.5	10.4	3.1	14.9	2.9	4.6	3.8	4.1	3.4	6.4	1.0	9.9	4.5	9.7	2.4	10.0	5.1	2.0	5.0	4.5	9.1	2.7	7.9	7.3	6.5	2.9	2.6	1.8	4.0	2.8	11.1	12.0	0.7	17.9	21.5	8.4	15.1	9.4	15.4	8.1	6.5	29.1	14.3	4.6	41.6	15.0	12.9	3.2	3.2	6.5	2.8	0.5	9.8	2.1	3.9	10.3	11.2	16.4	10.9	27.5	14.4	4.0	0.1	4.3	23.2	1.0	4.4	1.2	1.4	0.0	2.2	4.9	9.0	0.1	15.0	3.1	2.6	4.9	8.4	2.1	5.2	8.7	3.8	2.1	21.9	20.7	4.1	1.9	7.8	1.9	1.5	0.0	10.2	11.9	6.8	84.3	3.1	0.4	1.1	5.0	1.9	2.7	0.5	0.8	4.0	6.7	0.1	0.9	1.5	2.3	6.9	2.4	0.8	1.6	2.6	2.9	1.9	2.7	1.8	4.1	3.1	3.7	2.9	2.4	5.0	2.9	22.9	9.6	7.5	39.2	27.8	19.2	9.2	21.9	23.9	12.2	6.7	8.4	4.9	4.3	8.5	16.5	31.3	48.5	17.1	1.6	1.9	5.5	4.4	4.8	29.5	16.1	9.6	4.0	25.7	4.6	11.0	22.4	14.3	7.0	2.5	21.3	18.2	6.6	13.0	13.5	42.8	4.6	18.3	21.7	7.9	1.5	62.1	17.7	7.2	47.8	15.7	21.9	15.5	52.3	24.1	2.7	3.4	25.2	23.0	5.7	1.9	9.2	6.2	9.2	26.3	12.8	23.6	0.6	2.8	35.4	27.0	176.8	15.5	51.7	4.1	8.1
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193398967-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 64.5;parathyroid gland: 58.4;thyroid gland: 51.9"	"Group enriched"	"Detected in many"	4	"Astrocytes: 409.4;Oligodendrocyte precursor cells: 163.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051932			Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.1	0.3	19.5	0.2	20.9	0.2	22.7	18.1	20.1	2.8	28.2	2.0	0.3	0.1	64.5	20.1	2.4	4.6	0.1	18.0	17.0	0.7	0.6	27.3	0.4	18.5	21.5	0.3	5.3	58.4	4.8	0.1	17.9	0.1	3.4	2.5	7.2	2.4	0.5	16.9	0.3	0.1	15.2	0.3	9.6	0.5	21.6	0.3	51.9	0.0	4.8	0.1	6.7	15.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.5	20.9	18.1	20.1	18.0	17.0	18.5	21.5	17.9	15.2	21.6	15.8	0.2	64.1	30.5	409.4	1.1	0.1	0.0	1.7	0.0	1.6	6.1	3.6	0.4	11.5	15.3	0.0	0.0	1.2	0.5	1.6	0.0	3.3	0.4	4.0	0.7	0.1	0.0	0.0	5.8	0.2	0.1	0.2	17.3	6.4	1.3	0.3	1.4	0.1	0.2	1.7	10.9	1.9	0.0	0.3	0.5	1.0	0.0	0.5	1.8	13.1	0.0	0.5	0.0	163.3	20.6	1.3	1.7	0.4	0.2	0.0	0.0	0.4	8.5	1.0	0.0	0.1	0.2	0.7	1.5	2.2	1.6	0.7	0.9	0.1	2.2	0.1
ATP13A5	FLJ16025	ENSG00000187527	"ATPase 13A5"	Q4VNC0	3	193274789-193378820	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"breast: 17.3;choroid plexus: 38.5;salivary gland: 11.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 37.9;Oligodendrocyte precursor cells: 26.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA031771, HPA031772, HPA031774"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	Nucleoplasm	"HPA031771: AB_2674038, HPA031772: , HPA031774: AB_2674039"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-4)"		"unprognostic (2.06e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.93e-1)"		"unprognostic (1.67e-4)"	"unprognostic (3.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.14e-2)"		"unprognostic (1.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.10e-2)"		0.0	0.1	2.3	0.0	1.9	0.2	17.3	1.5	2.7	0.0	38.5	0.0	0.0	0.1	0.8	0.7	0.1	0.0	0.2	3.1	1.8	0.2	0.0	0.5	0.1	1.6	2.3	0.2	0.1	0.2	0.3	0.0	1.5	0.0	0.0	0.8	11.7	0.0	1.3	3.9	0.0	0.0	0.8	0.0	1.6	0.4	2.4	0.0	1.3	0.1	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	2.3	1.9	1.5	2.7	3.1	1.8	1.6	2.3	1.5	0.8	2.4	1.8	0.1	0.0	0.5	37.9	0.0	0.0	0.0	0.3	0.0	0.0	5.8	5.8	0.7	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.5	0.1	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.4	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.9	0.0	0.0	0.0	26.2	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747033-113812056	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 463.7;Late spermatids: 870.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 79.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 38.8;granulocytes: 79.2;monocytes: 37.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	18.1	32.2	40.1	21.6	46.4	16.6	24.5	14.7	53.0	25.3	62.4	22.1	18.5	14.2	15.1	22.7	19.0	20.9	9.0	47.5	58.5	92.7	36.4	24.5	25.1	39.6	23.0	11.3	20.9	60.1	17.1	24.5	39.0	20.9	22.5	58.7	37.5	14.9	7.9	25.0	15.9	15.8	16.9	26.5	22.1	18.1	28.4	22.9	40.8	11.0	28.0	19.6	14.2	21.9	61.7	27.4	33.9	29.7	70.0	30.9	36.0	32.7	49.4	33.7	46.1	52.4	48.3	50.4	75.5	48.0	37.3	39.1	77.5	43.2	43.8	23.1	21.4	44.8	39.3	40.6	57.6	33.2	50.0	42.0	29.1	43.7	30.2	52.0	55.7	25.1	52.0	37.0	50.5	40.5	24.4	14.9	42.8	42.9	34.3	20.8	24.6	57.4	92.5	58.0	65.4	24.1	57.3	38.6	44.9	46.4	58.5	26.6	51.4	31.1	23.1	21.7	19.8	38.4	44.5	46.2	61.1	41.2	35.3	26.8	37.0	12.8	6.3	27.7	5.9	8.2	5.6	6.0	38.8	6.8	5.4	6.2	79.2	9.2	23.9	10.8	8.1	16.7	40.1	46.4	14.7	53.0	47.5	58.5	39.6	23.0	39.0	16.9	28.4	21.9	18.8	28.9	35.0	43.4	24.2	30.3	15.9	30.3	23.9	94.1	27.9	17.1	10.4	31.5	32.9	99.3	41.7	22.0	20.8	38.3	82.2	29.5	463.7	41.7	24.5	26.8	55.8	49.6	119.4	27.5	22.6	17.9	20.9	100.6	10.8	19.4	36.0	74.3	74.3	101.0	107.7	25.4	197.4	104.7	73.3	870.3	18.0	70.9	46.2	34.7	82.8	45.6	11.3	54.3	53.2	27.1	30.5	23.0	23.6	25.6	24.1	80.8	38.3	44.4	6.6	15.3	21.6	28.7	15.7	40.8	47.9	43.9	19.0	25.8	27.2	26.8
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935900-70965431	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 127.4;salivary gland: 139.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	2.2	0.5	0.5	0.2	0.3	0.0	11.8	0.7	0.9	31.1	0.0	0.6	0.5	1.4	1.2	1.6	12.8	0.2	1.1	0.2	0.0	127.4	0.2	1.7	0.5	0.1	0.0	1.2	3.3	0.8	4.2	17.9	0.1	2.0	0.1	3.9	139.8	1.4	0.5	32.5	0.6	0.8	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.2	0.0	0.6	0.8	0.3	0.4	0.3	0.6	1.3	2.6	3.1	21.6	0.4	0.2	0.0	0.0	0.1	2.0	0.1	0.2	1.2	0.0	20.3	0.7	0.0	0.0	0.5	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.3	3.1	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.3	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.2	0.5	1.5	0.7	49.2	0.1	2.7	0.6	0.0	0.4	0.6	0.2	0.9	0.5	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.7	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	3.2	0.0	0.3	0.0	0.1	1.3	1.7	0.0	0.9	5.6	3.7	0.4	0.0	13.9	0.0	8.4	197.3	0.1	0.6	49.0	0.1	1.5	0.0	0.1	1.1	0.0	0.0	1.0	0.6	38.3	3.8	0.0	0.1	0.0	0.0	0.0	0.1	11.7	1.7	0.4	0.0	321.4	0.0	0.3	0.1	0.0	0.1	30.2	0.0	0.0	0.5	1.0	1.0	0.1	0.4	0.0	1.2	0.0	0.6	0.3	0.2	2.6	3.8	0.0	1.1	1.0	0.4	1.2	0.0	0.4	64.9	0.1	0.1	0.1	0.6
ATP6V1C1	"ATP6C, ATP6D, VATC, Vma5"	ENSG00000155097	"ATPase H+ transporting V1 subunit C1"	P21283	8	103021063-103073051	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 162.7;Late spermatids: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023943, HPA057297"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023943: AB_1845197, HPA057297: AB_2683402"	"unprognostic (5.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.29e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.83e-1)"	23.8	32.2	31.6	23.8	36.8	9.7	21.6	18.7	38.2	17.8	20.7	15.4	16.1	19.0	14.2	15.6	16.8	19.8	30.1	39.4	28.9	51.7	27.5	18.6	26.2	25.4	24.5	17.7	18.8	39.0	22.2	30.2	31.5	18.3	18.8	36.7	15.3	16.1	17.2	11.9	17.8	20.6	20.2	19.9	17.4	20.9	25.5	21.9	37.8	24.3	24.5	25.2	14.0	26.3	68.4	38.6	20.2	15.6	54.6	39.3	27.7	49.0	49.7	60.6	68.9	30.4	76.7	41.2	58.2	40.8	97.5	29.6	42.4	41.0	87.8	30.3	26.4	39.2	28.0	35.8	59.5	20.8	52.5	28.8	55.4	77.4	36.2	35.6	43.9	28.7	54.6	37.3	71.4	32.1	46.2	16.7	19.1	67.9	37.6	24.6	36.0	36.4	70.3	48.8	28.5	22.6	26.9	26.9	102.0	40.5	58.9	27.8	44.4	33.2	36.1	74.3	35.0	45.1	17.7	42.1	60.2	47.2	33.2	16.8	30.5	38.1	15.1	44.9	17.2	18.7	12.7	15.1	29.0	18.7	14.4	16.0	50.2	18.7	42.7	15.8	23.1	21.1	31.6	36.8	18.7	38.2	39.4	28.9	25.4	24.5	31.5	20.2	25.5	26.3	31.3	32.1	26.4	38.2	22.9	34.9	33.1	31.2	21.1	32.3	21.9	20.6	43.3	15.7	26.5	31.3	16.7	35.4	15.5	14.7	64.6	36.9	162.7	18.3	19.5	25.5	15.6	33.6	64.9	31.5	35.6	28.4	12.2	16.4	24.1	14.0	17.5	19.0	101.8	37.0	56.6	12.4	46.8	47.6	99.6	166.9	24.2	62.8	19.6	36.5	34.3	34.5	14.4	39.2	44.7	30.4	18.2	18.4	25.1	34.7	19.2	139.1	41.2	25.3	19.7	20.7	45.5	11.1	23.4	19.5	32.8	74.8	18.5	17.4	13.5	27.4
ATP6V1D	"ATP6M, VATD, VMA8"	ENSG00000100554	"ATPase H+ transporting V1 subunit D"	Q9Y5K8	14	67294371-67360265	"Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 365.9;Proximal tubular cells: 365.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031515, HPA057316"	Enhanced		Approved	Nucleoplasm		Yes	No		19000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA031515: AB_10600785, HPA057316: AB_2683409"	"unprognostic (1.10e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.60e-13)"	"unprognostic (2.78e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.44e-2)"	43.4	116.2	98.0	32.2	103.2	28.8	43.8	91.8	119.7	40.3	101.8	52.9	40.4	34.3	72.5	96.7	48.1	38.7	136.6	107.2	103.5	129.8	51.7	37.5	33.3	96.1	98.4	26.1	36.2	88.8	65.8	43.4	106.7	55.7	57.5	78.0	45.1	49.8	78.5	40.4	41.7	46.4	95.1	24.3	43.8	42.5	99.7	52.4	89.5	108.5	46.3	54.5	54.1	99.6	242.5	64.7	96.2	62.4	80.2	82.8	73.5	199.1	109.4	145.8	109.1	76.2	85.2	24.8	73.9	155.1	105.3	89.2	72.6	117.9	195.7	82.5	50.8	23.4	74.5	51.0	144.0	24.9	64.8	65.1	77.7	105.4	73.1	131.4	97.6	58.6	50.2	55.3	206.6	78.5	66.5	46.2	60.7	104.6	83.3	48.8	84.2	32.8	171.2	104.3	120.2	49.8	122.9	65.4	145.6	96.2	98.3	53.4	123.8	162.4	121.6	77.6	120.1	55.8	46.1	33.4	150.2	44.1	96.1	106.7	77.5	92.8	48.5	78.8	40.8	39.9	53.2	52.7	83.4	42.0	41.6	41.7	94.0	48.9	83.5	73.9	78.8	65.0	98.0	103.2	91.8	119.7	107.2	103.5	96.1	98.4	106.7	95.1	99.7	99.6	31.3	54.5	63.0	13.4	27.6	96.2	66.6	112.3	26.2	60.0	44.8	41.8	160.8	55.8	85.0	82.8	54.2	92.3	51.4	91.6	365.9	125.9	190.3	120.8	44.1	40.7	54.4	78.1	22.7	48.9	85.5	51.5	42.3	71.8	41.2	39.8	27.5	45.8	132.0	87.5	21.0	49.4	175.0	44.6	61.0	97.9	32.9	62.2	80.0	6.5	58.5	89.4	47.4	9.5	22.1	121.5	78.7	50.8	21.3	65.9	80.9	365.5	184.1	94.2	13.1	44.5	64.1	100.1	61.5	78.4	138.4	205.9	40.8	71.6	40.6	113.8
ATP6V1E1	"ATP6E, ATP6E2, ATP6V1E, P31, Vma4"	ENSG00000131100	"ATPase H+ transporting V1 subunit E1"	P36543	22	17592136-17628749	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 461.8;Proximal tubular cells: 411.3;Syncytiotrophoblasts: 479.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009528, CAB018699, HPA029196"	Enhanced		Approved	Nucleoplasm		NA	NA		34000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944"	"unprognostic (1.53e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (4.18e-4)"	"prognostic favorable (7.66e-8)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.75e-1)"	119.5	165.0	209.8	68.3	220.9	90.4	109.5	214.3	287.3	101.7	200.4	128.9	56.6	112.2	135.8	117.2	96.0	84.7	224.9	231.8	226.9	230.5	85.6	110.3	88.6	220.3	202.3	81.9	59.5	239.9	117.1	113.8	230.8	95.0	99.7	128.4	83.7	126.4	232.8	120.3	83.1	121.0	215.9	99.0	101.8	67.3	218.1	108.2	100.8	178.6	109.5	114.5	97.6	245.6	121.8	108.6	96.4	94.3	314.4	169.6	106.0	159.3	212.0	198.7	228.0	137.3	97.5	76.1	132.8	215.0	251.8	187.9	152.8	140.2	174.9	145.9	173.3	137.1	97.5	182.7	459.9	159.8	226.5	212.9	267.7	192.4	138.7	220.9	170.2	95.0	174.8	150.3	341.9	127.4	136.5	114.5	71.0	269.6	152.6	80.3	140.7	45.7	331.6	189.0	70.3	122.7	146.0	101.0	358.9	187.0	98.6	180.4	146.3	137.5	72.6	174.0	119.2	145.7	275.5	96.3	221.2	76.7	189.3	178.1	106.3	184.7	64.0	100.9	63.0	78.7	64.7	61.5	83.6	59.8	60.8	63.7	137.6	76.0	120.5	81.2	97.7	112.8	209.8	220.9	214.3	287.3	231.8	226.9	220.3	202.3	230.8	215.9	218.1	245.6	66.5	76.9	83.4	13.4	47.1	41.9	77.6	121.8	19.9	54.6	33.9	34.8	126.8	74.4	83.9	138.0	27.1	235.1	63.8	105.2	461.8	143.8	7.6	74.3	56.9	69.3	41.9	49.4	24.9	119.7	143.9	60.8	40.8	79.2	90.5	41.6	72.5	46.8	186.8	53.8	24.4	54.0	116.0	75.1	52.1	17.9	94.1	91.9	80.0	15.0	144.1	94.1	85.5	13.0	31.9	154.7	104.7	97.8	38.3	60.1	65.4	411.3	78.8	50.4	59.2	39.0	74.5	71.7	74.7	34.3	51.6	479.1	54.6	57.6	40.1	93.1
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587706-114598915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		96000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	79.5	140.2	70.5	80.5	71.1	131.4	108.4	74.0	101.1	85.0	85.0	70.5	59.4	92.4	177.3	132.5	71.3	64.6	93.0	72.1	79.4	138.1	125.9	84.9	115.4	75.4	79.1	106.2	72.5	172.9	135.1	91.2	80.2	132.7	65.5	91.2	111.9	55.1	124.0	98.1	69.2	60.6	71.5	93.9	121.1	75.4	75.6	104.2	99.2	113.0	100.8	106.8	94.0	75.4	83.6	71.0	153.2	38.8	111.0	84.5	148.3	125.2	86.6	88.5	63.4	92.3	94.8	74.2	106.8	80.0	183.2	179.0	105.6	84.6	79.3	63.2	73.8	72.3	84.4	143.4	156.8	173.1	135.1	105.2	227.9	72.7	87.3	104.1	91.0	123.1	136.0	164.4	131.6	159.0	164.6	113.6	187.0	222.2	126.8	159.0	95.0	126.7	195.2	128.4	113.8	156.3	159.7	284.0	487.6	143.9	235.0	202.5	118.9	80.1	68.9	132.3	142.0	213.6	474.5	139.6	106.8	97.2	112.0	490.1	327.8	495.0	212.6	331.2	264.9	549.6	288.8	255.8	255.0	501.7	374.7	305.5	405.4	255.4	348.4	401.5	398.9	756.7	70.5	71.1	74.0	101.1	72.1	79.4	75.4	79.1	80.2	71.5	75.6	75.4	230.6	160.3	176.6	19.6	353.9	519.0	492.9	1068.9	277.7	170.5	470.4	494.1	151.6	163.0	629.7	331.1	41.7	346.1	268.2	198.5	970.5	374.1	85.7	381.6	223.8	227.7	360.7	157.6	35.0	263.6	336.5	247.0	231.4	594.9	267.4	156.8	219.2	337.1	548.1	164.9	37.4	346.8	1133.2	350.1	517.8	60.3	306.0	382.4	494.5	20.6	699.7	360.9	261.6	20.1	22.9	430.5	218.1	250.9	255.0	686.5	176.7	1021.5	426.3	158.6	236.7	155.6	393.0	400.6	326.7	361.4	576.7	757.4	304.0	280.3	201.6	852.2
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25371974-26025851	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 21.6;pituitary gland: 15.2;retina: 17.2"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 518.7;Inhibitory neurons: 727.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.9;JURKAT: 9.8;MOLT-4: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: AB_2676809"	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	0.1	2.1	5.5	0.3	6.7	0.0	0.6	8.0	21.6	0.2	0.0	0.4	0.3	0.6	1.8	0.0	0.0	0.1	0.1	8.7	19.3	0.3	0.0	0.8	0.6	12.8	4.6	0.2	0.6	0.0	15.2	0.2	12.1	0.1	0.2	17.2	0.1	0.0	0.3	0.1	0.3	0.1	0.2	0.3	0.6	2.9	6.6	1.0	0.1	0.1	0.2	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	19.9	0.1	0.0	0.0	0.0	0.6	0.5	9.8	0.0	0.0	1.7	0.1	3.9	0.0	2.0	0.0	0.7	0.0	2.7	0.9	0.2	0.0	3.2	0.0	0.2	0.2	0.1	0.2	0.0	0.4	0.2	0.0	1.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.2	0.1	5.5	6.7	8.0	21.6	8.7	19.3	12.8	4.6	12.1	0.2	6.6	6.8	0.7	0.0	12.2	9.4	0.8	1.0	0.2	0.3	0.0	21.5	1.5	0.3	2.5	1.5	0.4	0.0	95.9	1.5	0.4	0.0	0.0	0.3	39.0	1.2	23.6	2.6	0.0	0.8	518.7	0.0	0.4	1.7	1.1	0.9	5.1	3.7	0.0	0.0	3.2	21.9	727.7	0.0	0.0	0.0	0.7	30.3	0.9	0.3	0.0	9.4	0.0	7.2	1.0	88.4	24.7	0.0	0.0	1.2	0.1	0.2	0.0	1.3	0.3	91.6	13.1	0.3	0.8	19.8	12.5	0.0	0.4	1.1	1.8	10.1	0.1	0.1
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 279.7;Intestinal goblet cells: 180.5;Paneth cells: 116.7;Undifferentiated cells: 185.7;Urothelial cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 90.2;RT4: 168.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	9.1	5.4	1.3	8.5	2.0	1.2	9.5	3.6	3.9	16.3	3.0	76.2	30.3	5.9	3.5	14.8	10.6	18.0	4.4	1.7	1.1	6.6	7.7	8.3	2.2	2.1	1.1	2.1	23.3	9.7	2.7	6.9	2.0	17.6	61.7	0.6	20.6	11.5	1.9	8.4	38.2	8.3	1.0	4.6	46.1	0.6	1.9	1.5	22.0	1.8	3.6	30.0	13.0	3.0	32.0	10.7	0.1	0.6	10.5	19.2	11.9	62.6	63.6	67.4	40.4	8.0	24.3	1.5	19.3	90.2	22.3	44.9	0.2	13.9	64.3	0.2	1.1	0.2	2.6	2.5	2.2	0.4	0.6	2.9	12.6	20.8	34.0	39.5	33.0	0.3	0.3	0.7	34.1	15.6	0.1	0.3	0.3	35.5	3.3	0.3	0.2	0.0	7.9	168.1	0.8	0.7	1.3	32.5	0.1	0.5	10.3	0.6	35.3	48.3	2.0	7.7	14.2	0.4	0.4	0.5	1.1	0.4	2.8	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.0	0.2	0.1	0.0	0.0	1.3	2.0	3.6	3.9	1.7	1.1	2.1	1.1	2.0	1.0	1.9	3.0	25.9	19.2	27.0	11.1	4.1	7.8	66.7	20.6	10.2	0.7	28.4	10.4	5.4	27.1	48.9	40.5	0.0	25.6	0.6	279.7	0.0	27.0	2.8	26.3	4.0	30.8	68.4	0.4	61.2	53.1	2.7	7.1	98.4	40.1	4.5	0.9	33.2	19.1	2.4	6.7	11.7	180.5	22.4	2.8	4.0	0.4	0.3	1.0	7.2	37.5	0.9	0.1	0.0	20.6	10.7	38.5	116.7	0.0	0.9	70.8	58.2	0.2	44.7	1.2	13.1	2.8	20.7	0.3	1.5	28.0	16.3	10.9	1.7	2.3	185.7	119.2
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"bone marrow: 78.1"	"Cell type enriched"	"Detected in many"	6	"Microglial cells: 248.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.2;NK-cell: 11.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.2;NK-cells: 11.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040254	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	2.3	2.5	2.4	78.1	0.7	3.5	6.5	1.5	3.0	1.1	0.7	6.4	4.2	0.5	3.1	2.2	0.4	4.5	2.9	1.2	1.6	1.1	1.0	2.5	2.6	0.4	0.5	0.2	0.3	3.5	2.8	0.6	1.7	0.1	0.5	0.8	0.1	0.3	1.3	3.1	3.1	2.6	0.6	0.4	2.4	0.5	0.1	0.1	1.0	1.4	0.4	4.9	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.5	0.5	0.2	0.0	0.2	12.2	0.0	7.3	1.7	0.1	0.0	13.6	40.2	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	19.2	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.1	1.2	0.0	0.0	0.1	0.0	26.7	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	1.3	103.7	0.0	15.2	2.0	3.8	0.4	1.2	0.1	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.8	11.0	0.4	0.0	0.0	0.9	2.3	2.4	3.5	6.5	4.5	2.9	2.5	2.6	2.8	3.1	2.4	4.9	1.7	0.0	1.9	1.6	0.8	1.5	0.1	0.2	0.6	0.6	0.2	0.6	1.3	0.0	0.1	0.0	0.0	5.4	12.5	0.3	0.0	0.0	27.6	0.3	1.7	1.0	0.0	12.2	20.3	0.0	1.8	8.1	3.1	0.2	19.7	0.0	1.1	3.7	16.4	0.0	17.5	0.3	2.0	37.0	17.7	25.3	1.8	27.0	1.8	248.3	6.3	0.5	15.5	1.0	2.1	0.0	0.1	0.7	4.8	2.3	0.7	1.2	0.7	0.2	0.0	1.0	7.0	0.5	0.6	0.6	0.3	2.9	13.4	1.1	0.2	0.3
ATPSCKMT	"FAM173B, JS-2"	ENSG00000150756	"ATP synthase c subunit lysine N-methyltransferase"	Q6P4H8	5	10225507-10249897	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.1;Cytotrophoblasts: 5.9;Extravillous trophoblasts: 4.1;Fibroblasts: 2.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 2.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SiHa: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074513			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"HPA074513: AB_2686698"	"prognostic unfavorable (1.32e-6)"	"unprognostic (8.87e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.20e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.03e-1)"	8.5	10.3	12.4	5.4	13.0	3.9	6.6	13.5	15.5	5.7	13.8	7.4	6.1	6.9	9.1	5.8	6.5	7.2	6.9	11.7	14.3	9.0	9.9	5.1	7.8	13.2	13.6	6.3	5.1	17.1	9.9	4.1	13.2	8.8	8.7	5.0	7.4	8.3	6.7	5.8	5.6	7.5	12.0	4.5	6.2	5.7	13.4	6.9	8.8	7.4	6.8	7.1	5.3	14.8	14.1	13.3	13.9	13.8	12.7	9.8	4.8	20.4	9.2	9.2	8.0	14.1	21.0	16.8	35.2	13.0	27.7	9.6	19.6	17.0	15.8	30.9	13.2	14.5	47.6	11.4	9.7	22.8	16.5	9.1	18.3	17.4	5.5	11.8	19.7	17.8	19.9	18.0	26.6	11.9	11.6	20.2	9.1	29.9	17.4	15.8	9.7	15.9	24.6	16.5	11.1	10.9	69.3	24.5	12.2	10.5	25.7	23.2	11.2	22.4	13.9	14.2	14.9	11.9	14.5	19.7	14.1	25.3	9.0	3.2	5.8	8.1	4.3	6.7	5.3	3.8	4.2	5.5	5.8	2.6	4.1	5.4	2.2	3.8	5.5	2.1	5.4	2.6	12.4	13.0	13.5	15.5	11.7	14.3	13.2	13.6	13.2	12.0	13.4	14.8	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	5.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449007-142578733	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.0;Inhibitory neurons: 94.4;Microglial cells: 73.1;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	3.0	8.6	0.7	4.1	1.1	1.2	3.2	0.9	1.4	3.8	3.7	2.7	1.7	3.3	2.3	3.1	3.3	3.4	2.3	1.2	1.9	3.7	3.6	2.9	4.8	1.5	1.2	2.7	3.8	5.2	3.7	3.1	1.4	3.0	2.9	2.9	3.5	2.5	2.9	2.7	3.1	3.2	1.0	4.2	2.8	5.2	1.2	4.9	5.0	1.4	4.6	4.1	2.7	1.2	28.6	13.2	7.1	7.0	9.6	13.6	8.8	14.8	8.4	10.1	9.7	6.4	6.8	19.9	14.6	10.1	14.6	16.1	10.9	12.8	15.0	7.5	7.9	11.9	8.2	4.1	4.2	20.5	5.3	9.8	4.8	9.5	10.3	5.8	11.6	8.7	8.2	7.5	9.6	7.5	13.9	2.6	7.3	15.6	9.6	11.8	12.5	13.5	6.3	11.1	5.2	5.1	28.6	8.3	8.0	7.8	12.0	5.4	14.6	10.5	4.9	12.3	15.2	10.8	7.4	18.5	13.8	6.5	8.5	0.0	0.3	0.0	0.5	0.4	1.0	0.1	0.3	0.5	0.7	0.3	0.4	0.4	0.0	1.3	0.2	0.2	0.4	0.2	0.7	1.1	0.9	1.4	1.2	1.9	1.5	1.2	1.4	1.0	1.2	1.2	11.5	6.4	10.6	39.2	22.4	4.0	7.2	8.8	14.2	14.1	9.2	6.5	7.6	5.7	10.1	3.7	37.5	7.7	14.9	3.5	0.0	5.9	16.4	18.8	18.6	10.2	7.7	14.5	93.0	4.9	3.6	8.3	14.8	10.3	1.3	16.3	7.9	7.3	6.4	8.4	94.4	4.8	14.2	9.4	4.0	8.7	6.5	12.8	10.6	73.1	12.0	6.0	9.2	65.4	71.9	6.4	1.8	7.2	23.1	8.1	1.9	6.5	25.4	23.6	0.0	14.6	9.8	50.1	18.5	14.7	4.5	5.1	15.1	13.8	7.6	6.1
ATRIP	"FLJ12343, MGC20625, MGC21482, MGC26740"	ENSG00000164053	"ATR interacting protein"	Q8WXE1	3	48446710-48467645	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 14.9"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033109, HPA047590"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB033109: AB_634993, HPA047590: AB_2680094"	"unprognostic (5.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"unprognostic (4.72e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.66e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.52e-2)"	3.8	2.6	2.0	3.7	2.1	5.0	3.8	3.9	2.3	3.9	2.2	3.1	2.4	3.4	1.4	3.7	3.0	2.0	2.4	2.0	1.7	3.1	2.5	3.6	3.6	2.0	1.9	3.6	2.7	4.0	1.8	3.2	1.9	3.0	3.5	2.7	2.5	3.6	4.7	4.4	2.6	3.0	1.6	3.0	2.8	14.9	2.0	4.9	5.4	3.0	4.9	3.3	3.5	2.3	8.7	3.7	9.7	7.4	5.6	9.5	10.2	13.1	6.0	15.7	12.8	5.1	6.3	19.3	5.9	5.4	7.3	9.2	10.9	10.2	15.1	11.5	5.6	14.9	19.1	3.7	3.2	15.0	9.7	3.8	3.1	8.5	4.0	3.5	7.0	7.1	12.0	9.6	14.7	4.9	12.6	5.4	7.5	4.4	10.5	8.5	8.7	13.7	5.3	4.3	4.7	6.9	10.4	10.5	3.9	8.5	8.8	5.7	8.1	10.7	7.0	13.0	15.3	11.6	20.0	13.6	5.7	11.2	6.0	0.2	0.7	0.0	1.1	0.3	0.1	0.3	0.9	0.5	0.5	0.2	0.7	1.0	0.5	0.5	0.6	1.1	1.2	0.7	2.0	2.1	3.9	2.3	2.0	1.7	2.0	1.9	1.9	1.6	2.0	2.3	4.3	0.0	1.5	2.0	0.9	2.9	0.0	0.9	0.0	1.0	4.1	4.7	1.6	0.0	2.0	0.0	2.1	0.2	4.4	2.4	0.0	3.6	0.0	3.8	6.4	2.3	0.0	0.4	3.2	3.9	0.1	2.2	1.5	5.8	0.0	5.5	0.0	0.0	0.1	1.7	3.2	1.7	2.0	0.0	0.5	0.0	0.0	2.5	0.0	1.9	1.6	0.5	3.1	2.0	3.3	4.1	1.1	0.0	0.7	0.0	0.0	2.1	3.6	2.1	0.0	0.0	4.5	0.0	0.0	0.0	3.8	0.1	2.2	4.2	1.3	0.0
ATRNL1	"ALP, FLJ45344, KIAA0534"	ENSG00000107518	"Attractin like 1"	Q5VV63	10	115093365-115948999	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 91.1"	"Group enriched"	"Detected in many"	13	"Excitatory neurons: 2134.6;Inhibitory neurons: 1473.4;Oligodendrocyte precursor cells: 1456.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 91.1;white matter: 58.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.4;RH-30: 18.4;U-266/70: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038070			Approved	Nucleoplasm,Mitochondria		NA	NA		160000000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Mitochondria"		"HPA038070: AB_10697237"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.08e-3)"	0.7	10.7	3.8	0.2	9.5	0.0	1.0	0.0	91.1	0.9	0.0	2.4	0.3	6.2	0.3	0.5	1.0	0.2	1.8	18.3	0.0	2.8	1.5	0.1	0.4	0.0	0.2	9.7	1.3	2.1	5.8	1.9	1.0	3.1	0.2	6.3	1.0	3.8	2.8	0.2	0.8	5.8	0.0	0.3	0.4	12.6	0.0	0.4	1.0	0.0	0.4	0.6	1.0	58.7	0.0	0.6	6.3	21.4	0.0	0.0	0.0	0.1	0.6	3.9	4.6	0.2	0.2	0.0	1.5	0.5	5.1	0.0	1.6	0.0	4.0	0.1	4.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	6.4	0.0	11.3	0.0	5.3	10.4	0.2	9.9	0.0	9.1	0.0	0.1	7.5	18.4	11.4	3.9	0.0	3.6	10.5	0.0	0.1	0.4	4.3	1.8	0.0	0.0	0.0	2.7	0.1	3.3	14.2	0.0	4.6	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.5	0.0	91.1	18.3	0.0	0.0	0.2	1.0	0.0	0.0	58.7	0.0	0.0	0.0	55.8	0.8	0.6	0.1	0.8	0.6	35.4	2.1	0.5	2.5	0.0	0.1	0.0	2.1	0.1	0.2	0.2	0.0	0.7	45.6	0.8	1.5	1.5	0.0	0.0	2134.6	0.4	0.0	5.3	0.0	1.8	0.0	24.9	21.0	0.1	3.0	10.1	1473.4	0.0	0.0	1.9	0.4	47.8	1.5	0.3	0.0	128.4	0.0	4.3	0.0	1456.7	34.2	0.3	0.0	0.7	0.0	0.1	0.0	0.5	0.1	4.7	0.0	2.4	2.6	46.6	11.5	0.0	0.1	0.3	0.1	53.1	0.0	0.1
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 582.5;Inhibitory neurons: 519.0;Oligodendrocyte precursor cells: 318.2;Oligodendrocytes: 466.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 14.4"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: AB_2686306"	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	4.1	4.0	3.2	5.9	5.3	2.6	4.1	0.0	14.4	8.4	0.0	8.8	3.8	10.9	4.3	5.0	6.2	5.7	5.8	8.4	0.0	4.1	4.7	6.9	4.2	0.0	1.3	5.4	4.8	5.5	6.5	4.9	0.0	7.4	3.8	13.9	4.6	6.2	14.6	5.7	4.8	7.5	0.0	5.7	5.3	3.0	3.9	2.6	6.1	14.8	3.1	6.7	6.6	0.8	4.5	2.6	0.9	0.0	4.4	5.9	5.8	4.8	11.2	2.9	3.3	2.8	2.8	0.2	6.3	9.3	3.7	4.2	0.3	3.0	4.2	2.6	4.7	0.7	4.4	9.0	7.0	4.2	7.0	4.6	5.7	6.1	5.1	11.2	5.9	0.9	0.0	5.3	2.4	2.3	0.3	4.8	0.9	1.4	4.3	0.3	5.8	4.0	4.0	7.6	0.3	2.5	4.4	5.5	9.1	8.4	3.6	7.2	9.1	4.0	6.1	4.8	4.4	30.7	19.2	0.2	2.6	4.3	10.0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.5	0.7	0.2	0.0	0.0	0.4	1.3	0.0	0.2	0.1	0.4	0.3	3.2	5.3	0.0	14.4	8.4	0.0	0.0	1.3	0.0	0.0	3.9	0.8	16.0	48.1	25.9	206.3	20.7	91.4	72.2	22.8	48.9	39.8	20.7	14.4	35.9	25.8	26.0	11.0	100.1	0.6	48.4	23.6	7.9	16.7	4.3	80.5	144.4	21.7	1.2	5.7	582.5	8.5	4.0	32.9	22.4	75.8	38.7	67.4	17.2	25.2	22.4	38.7	519.0	16.5	2.0	39.6	79.1	3.3	10.5	41.7	32.0	217.4	42.3	24.1	33.0	318.2	466.8	32.3	16.3	28.2	82.6	56.6	13.9	8.8	33.2	99.9	52.6	19.0	41.6	1.0	6.9	60.9	48.7	0.4	61.5	6.4	7.7	63.8
ATXN1L	BOAT1	ENSG00000224470	"Ataxin 1 like"	P0C7T5	16	71845976-71885268	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 263.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062596, HPA062789"			Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA062596: AB_2684802, HPA062789: AB_2684868"	"unprognostic (1.51e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.33e-8)"	"unprognostic (1.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (8.42e-4)"	14.0	8.0	11.5	9.9	12.7	39.5	10.9	9.0	9.7	11.1	5.6	10.4	8.2	12.3	7.3	9.7	10.9	9.0	9.5	9.3	9.4	18.7	6.6	12.0	10.0	10.9	11.7	12.7	12.5	16.5	5.2	10.8	10.3	8.1	9.2	8.0	9.4	10.4	10.4	12.1	9.4	12.9	10.3	11.8	10.0	12.2	12.5	12.8	11.9	13.7	10.5	8.9	7.4	11.9	11.8	15.7	15.7	11.5	18.1	8.9	18.4	9.8	10.8	17.4	13.2	22.6	12.9	13.2	15.0	15.4	8.0	20.3	13.4	14.9	18.9	3.6	11.9	9.7	17.7	15.9	13.5	11.9	19.0	12.8	18.6	19.8	14.2	11.4	16.0	17.0	11.1	10.2	10.4	33.6	20.2	11.7	14.3	9.3	7.4	21.4	15.9	15.8	12.1	16.4	8.3	14.2	19.5	10.2	11.9	16.4	16.0	12.5	19.4	19.0	19.9	12.1	13.3	23.0	20.8	30.7	11.8	7.9	16.3	0.6	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.4	0.2	0.2	0.5	0.5	0.4	0.4	0.2	0.1	0.7	0.3	11.5	12.7	9.0	9.7	9.3	9.4	10.9	11.7	10.3	10.3	12.5	11.9	11.1	0.0	10.6	4.2	14.9	22.8	15.3	11.4	14.2	11.2	16.0	10.2	15.7	14.3	9.5	14.7	14.6	8.3	19.9	15.2	17.6	11.9	44.2	19.1	15.0	14.2	7.8	5.7	6.8	11.8	7.9	11.0	5.6	35.4	12.7	8.0	14.3	12.3	8.5	15.2	5.7	8.7	8.2	14.3	25.2	263.0	14.9	11.8	12.4	5.6	16.9	6.3	29.9	3.5	9.1	14.4	19.6	12.8	16.0	18.3	13.3	15.8	9.9	17.2	13.1	15.5	14.3	22.4	21.1	13.1	24.9	11.5	15.8	8.0	10.6	28.4
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106621	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124"	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	9.0	5.9	3.8	5.7	4.2	9.9	6.8	4.9	5.0	7.5	3.3	7.3	3.7	6.4	4.3	10.3	6.0	6.5	5.3	3.6	5.0	5.6	9.6	6.8	7.7	6.2	5.7	7.1	4.5	6.4	4.0	7.0	6.2	6.0	6.8	3.9	5.8	5.5	3.3	12.9	4.8	8.6	4.3	5.6	5.2	9.3	4.3	8.0	5.9	5.9	9.8	9.0	8.0	4.9	8.6	16.7	14.6	13.6	20.9	20.1	28.4	9.7	15.4	11.9	16.5	12.3	23.2	17.6	18.5	15.8	14.1	14.6	11.6	21.0	26.3	20.0	3.5	7.4	8.0	18.2	17.3	13.5	12.6	16.5	18.1	20.9	21.8	15.9	18.7	19.4	10.1	12.5	18.2	33.1	14.0	11.9	10.4	28.5	13.6	11.0	27.0	9.9	15.3	19.4	5.3	8.8	23.1	9.5	13.3	19.6	18.1	9.1	10.0	11.7	17.0	7.5	5.2	10.8	19.8	16.2	8.3	12.9	6.9	13.5	14.3	10.8	6.1	16.5	7.4	7.7	7.0	6.9	16.2	10.6	7.8	8.8	12.2	8.7	23.0	9.3	8.1	6.3	3.8	4.2	4.9	5.0	3.6	5.0	6.2	5.7	6.2	4.3	4.3	4.9	55.0	16.0	12.4	33.6	27.6	25.4	28.6	29.8	19.4	35.4	16.9	18.4	19.3	15.7	20.0	42.3	50.1	20.3	31.5	13.8	15.6	25.8	19.8	20.3	34.9	53.0	16.1	30.3	36.1	17.3	29.8	34.6	18.3	22.5	24.6	25.9	49.6	21.1	22.4	26.9	28.6	16.4	12.2	35.1	27.2	26.8	67.7	30.0	23.2	28.1	48.0	20.4	29.9	39.2	51.5	19.6	16.1	65.1	20.1	31.9	16.6	17.7	16.0	46.7	46.0	51.9	38.2	39.1	57.2	21.6	30.3	25.3	28.8	24.8	18.9	28.2
ATXN7	"ADCAII, OPCA3, SCA7, SGF73"	ENSG00000163635	"Ataxin 7"	O15265	3	63863155-64003462	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034989			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA034989: AB_10602596"	"unprognostic (1.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (9.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.45e-2)"	7.5	6.3	4.5	11.4	4.1	24.4	7.1	4.9	4.4	7.4	0.2	6.9	8.0	8.6	4.7	8.7	6.3	9.6	5.8	3.1	3.7	7.1	8.4	9.0	12.7	3.4	3.3	8.0	21.0	10.9	2.3	8.3	2.7	6.7	8.8	16.3	7.8	5.2	7.1	9.3	9.2	7.9	0.7	10.6	8.4	15.0	3.1	16.5	7.5	8.7	11.7	7.4	4.4	3.2	8.4	5.7	8.1	7.2	8.5	11.3	9.5	6.5	9.0	11.1	10.5	8.9	8.7	12.5	3.1	9.0	12.5	6.5	9.6	9.1	11.9	22.8	4.9	16.1	10.7	4.2	6.4	8.5	17.7	7.9	9.0	15.7	17.7	9.0	8.4	13.3	6.3	26.2	7.7	25.8	12.7	6.8	5.5	5.7	3.0	9.1	7.1	10.1	6.1	11.0	3.1	5.6	13.2	9.4	10.8	6.4	5.1	12.2	11.9	11.4	12.0	12.7	12.9	12.9	13.2	10.3	10.3	11.6	9.4	15.8	1.1	2.1	3.7	1.0	3.3	1.0	6.2	4.0	0.8	2.4	6.2	4.1	4.5	3.5	0.7	1.5	6.2	1.3	4.5	4.1	4.9	4.4	3.1	3.7	3.4	3.3	2.7	0.7	3.1	3.2	2.4	9.6	9.1	34.6	17.0	43.6	24.9	17.6	29.6	73.2	3.4	1.7	10.5	35.8	17.9	5.5	102.2	14.1	21.5	38.3	0.0	2.8	17.1	3.3	1.5	16.1	26.4	29.5	81.2	4.2	13.6	16.6	18.8	3.5	14.7	1.2	26.7	22.8	14.2	25.2	67.0	19.7	24.4	34.6	30.3	9.5	12.8	20.1	12.4	64.6	33.5	24.5	54.6	60.3	46.7	2.5	28.5	13.2	14.8	26.1	28.1	0.7	27.4	70.8	0.0	39.2	15.6	14.8	15.6	25.6	46.2	61.2	41.5	1.6	20.1	38.6
ATXN7L1	"ATXN7L4, KIAA1218, MGC33190"	ENSG00000146776	"Ataxin 7 like 1"	Q9ULK2	7	105604772-105876599	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.7;Early spermatids: 93.4;Excitatory neurons: 107.3;Inhibitory neurons: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021448	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA021448: AB_1845213"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.01e-1)"	5.0	4.3	2.8	4.4	3.0	4.3	4.5	5.0	4.3	6.6	0.6	5.3	4.1	4.7	4.5	4.1	5.8	4.3	2.6	2.8	1.3	7.3	6.3	4.0	6.4	1.6	1.7	6.5	3.2	4.9	3.3	5.7	1.5	4.7	5.9	2.0	5.8	3.8	2.3	5.9	5.0	4.1	0.1	5.7	4.8	10.2	1.8	10.1	5.0	3.1	5.9	4.5	5.2	2.7	3.2	4.3	9.0	4.2	5.5	6.5	2.8	5.7	5.6	5.0	4.6	4.2	6.1	1.3	4.3	6.1	4.4	3.0	5.1	5.9	3.7	18.0	3.3	4.3	3.2	4.1	3.3	7.1	13.9	4.5	4.7	3.3	3.3	3.7	4.6	3.0	5.2	2.8	4.2	7.7	3.9	4.3	16.7	9.0	4.3	3.8	3.0	1.0	3.8	3.2	5.6	3.7	4.0	8.0	7.9	8.9	4.1	7.2	11.5	7.8	3.5	6.5	2.2	0.6	0.0	0.1	4.8	10.9	8.0	2.3	3.8	4.2	2.4	4.4	1.8	3.5	6.5	5.6	2.9	3.5	6.9	3.9	1.3	4.4	2.8	1.9	14.3	3.3	2.8	3.0	5.0	4.3	2.8	1.3	1.6	1.7	1.5	0.1	1.8	2.7	8.3	0.0	3.9	60.7	8.0	5.1	5.4	4.9	6.2	7.8	5.2	3.9	2.4	4.3	3.6	5.5	2.1	6.3	16.8	11.3	5.9	3.9	93.4	13.1	6.4	5.2	5.4	9.4	107.3	2.6	3.6	5.9	11.2	7.9	5.1	7.9	6.4	17.0	7.5	8.4	96.3	8.5	2.0	11.6	6.1	56.6	6.5	9.3	8.8	55.3	10.8	2.0	19.6	46.8	51.3	4.2	11.0	4.5	7.4	4.6	43.7	42.6	14.9	1.0	6.6	7.5	6.4	20.9	2.5	7.0	4.0	5.3	13.3	7.7	9.4	3.7
ATXN7L3B	lnc-SCA7	ENSG00000253719	"Ataxin 7 like 3B"	Q96GX2	12	74537835-74545430	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056612			Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA056612: AB_2683190"	"unprognostic (3.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.68e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.81e-3)"	"unprognostic (7.12e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.25e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.15e-2)"	13.8	18.5	27.5	15.2	28.2	20.1	22.2	26.2	30.7	18.2	25.5	17.3	20.3	21.1	25.0	13.9	33.2	14.2	17.9	28.9	32.0	23.6	20.5	16.6	21.0	25.6	27.2	32.3	22.9	25.9	15.9	22.8	28.8	22.3	19.1	46.3	23.3	21.1	20.9	17.9	18.9	18.0	25.3	19.1	38.3	8.8	30.7	30.5	24.5	20.9	22.8	14.1	12.0	27.4	21.5	16.6	54.3	34.6	33.6	31.4	23.2	20.1	20.0	23.3	18.1	19.3	11.6	31.0	15.6	20.0	15.6	21.1	28.4	19.4	19.2	28.8	22.3	41.5	17.3	29.4	32.0	41.6	8.4	36.4	44.3	17.9	29.2	40.6	27.3	35.5	52.1	15.2	19.3	31.0	46.2	29.5	31.0	29.4	15.8	35.7	29.4	28.1	21.5	34.8	85.1	53.7	22.7	26.6	32.6	35.0	62.8	26.9	23.6	22.3	19.5	13.4	12.7	18.0	18.0	39.9	9.6	15.0	22.8	17.3	9.5	12.7	5.1	8.9	6.2	4.2	7.7	5.7	8.9	4.8	13.1	7.4	2.7	8.4	12.1	4.9	6.1	9.1	27.5	28.2	26.2	30.7	28.9	32.0	25.6	27.2	28.8	25.3	30.7	27.4	40.1	73.7	46.3	10.1	33.4	18.4	42.1	25.2	56.9	87.9	40.6	44.7	53.0	41.5	48.3	38.6	33.3	58.7	54.8	33.1	31.3	39.6	0.7	76.1	67.5	39.9	36.2	36.2	17.2	32.8	34.0	41.7	98.4	37.5	46.2	35.8	27.8	27.5	22.9	52.2	18.2	38.7	10.2	23.9	10.7	2.0	37.6	25.9	21.4	13.1	32.9	104.5	62.8	9.5	17.9	61.8	23.4	37.6	27.6	47.3	23.3	39.8	113.5	80.8	19.7	58.8	81.5	11.6	15.8	37.0	22.9	45.0	37.5	46.7	35.8	37.9
AUP1		ENSG00000115307	"AUP1 lipid droplet regulating VLDL assembly factor"	Q9Y679	2	74526645-74529760	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007674	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA007674: AB_1078251"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (2.97e-9)"	"unprognostic (9.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.96e-2)"	48.0	42.2	68.0	44.4	69.0	78.8	52.6	71.0	85.8	56.0	72.1	76.9	70.6	38.7	78.6	49.9	45.3	46.0	38.4	67.6	71.0	48.8	106.9	48.7	41.3	73.0	69.6	38.1	127.3	77.6	2.1	60.6	69.7	38.9	81.0	32.4	89.1	46.3	57.7	42.3	68.5	55.8	70.5	39.5	56.7	24.5	70.1	42.5	50.9	66.6	51.5	69.6	20.7	72.1	114.2	133.4	55.3	87.5	183.1	107.7	124.9	89.1	152.6	122.3	77.3	196.9	130.6	126.4	61.9	126.5	210.3	143.4	140.4	115.1	98.5	100.1	128.7	153.6	71.2	180.7	181.5	97.8	127.9	128.5	256.7	174.4	198.6	101.1	117.3	105.1	202.2	164.5	134.0	124.6	79.0	200.6	111.4	298.3	111.9	95.3	150.0	270.3	139.3	90.9	80.7	79.6	65.2	200.4	162.2	70.8	90.2	156.7	59.3	162.9	97.2	50.6	146.8	87.9	88.1	120.4	129.6	155.9	184.9	113.8	132.9	108.9	81.9	169.3	89.6	90.6	81.0	82.0	124.6	113.9	72.9	75.8	68.8	85.3	144.7	118.3	107.9	132.2	68.0	69.0	71.0	85.8	67.6	71.0	73.0	69.6	69.7	70.5	70.1	72.1	64.8	67.3	44.6	22.5	97.3	73.2	120.7	161.1	80.8	31.7	71.4	59.6	34.9	74.4	108.1	68.0	14.6	140.0	86.6	150.4	23.5	125.2	24.3	36.2	50.1	74.9	73.8	72.4	17.7	208.7	217.3	73.0	121.8	58.7	89.9	57.3	50.0	114.3	161.8	37.0	16.1	127.7	136.3	83.5	95.5	29.7	44.4	95.2	97.8	17.8	67.2	74.5	72.1	14.6	23.4	153.1	141.3	38.0	229.9	141.1	196.0	59.6	46.6	43.2	59.2	60.0	104.2	85.9	64.6	95.7	78.7	223.8	77.6	68.4	134.2	143.9
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.1;testis: 30.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB001454, HPA002636"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Mitotic spindle, Cytosol"	"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	1.3	2.3	1.3	10.4	1.6	15.3	2.2	2.4	1.4	1.4	0.6	10.8	11.7	1.5	0.8	7.5	1.2	2.0	5.3	0.8	1.0	2.3	5.0	2.2	20.9	1.7	1.2	8.4	2.0	1.8	0.6	8.1	1.4	1.1	12.9	3.0	1.9	1.3	8.7	3.5	9.3	4.9	1.3	5.2	4.9	30.8	1.6	20.2	1.4	8.2	22.1	2.9	2.6	1.3	179.9	127.2	84.5	61.2	4.9	10.8	106.3	145.2	66.8	339.7	142.9	361.4	124.8	58.4	96.2	59.2	176.2	142.2	152.4	96.4	360.0	52.4	57.5	102.6	128.9	229.8	2.8	140.4	140.4	5.1	10.1	117.3	104.5	26.7	80.7	93.2	121.8	45.3	146.9	182.1	85.3	108.9	78.3	145.6	129.8	62.9	163.4	65.9	56.0	46.8	73.9	39.6	200.5	228.8	94.2	77.3	137.9	86.1	47.1	149.7	145.3	83.0	208.6	62.3	78.9	100.5	80.5	80.9	127.0	0.2	3.5	4.3	1.2	5.9	1.8	2.5	2.0	1.1	3.7	0.8	0.9	0.9	2.3	1.4	3.4	0.8	4.7	1.7	1.3	1.6	2.4	1.4	0.8	1.0	1.7	1.2	1.4	1.3	1.6	1.3	2.5	0.0	2.8	0.3	7.4	1.1	1.2	5.6	0.6	1.0	4.3	6.2	5.6	1.5	2.3	3.7	2.1	34.5	8.3	8.3	1.9	4.0	33.9	2.0	2.3	3.1	6.0	81.6	1.1	4.9	67.1	7.0	13.7	3.4	54.1	12.3	3.6	2.6	17.5	1.7	1.5	10.8	2.0	3.5	7.6	16.3	1.5	11.7	0.0	1.0	12.0	3.7	3.1	1.0	2.0	5.2	2.8	0.4	10.1	2.0	5.1	4.2	1.5	2.7	6.6	2.2	7.7	168.2	30.8	8.3	1.1	8.2	8.0	8.7	15.5	1.5
AURKAIP1	"AIP, AKIP, FLJ20608"	ENSG00000175756	"Aurora kinase A interacting protein 1"	Q9NWT8	1	1373730-1375495	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1314.3;Late spermatids: 3668.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031821	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA031821: AB_10601458"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.31e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.34e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.84e-1)"	98.0	129.1	116.2	43.4	117.6	51.5	90.0	125.2	142.4	64.9	130.2	110.5	71.7	70.0	23.5	118.0	64.1	26.1	260.8	113.4	116.3	151.8	215.8	67.2	41.4	125.6	116.8	58.2	120.1	73.4	92.3	35.8	116.1	85.9	27.5	23.6	88.2	38.7	281.3	91.0	85.6	22.4	116.9	85.8	121.4	300.6	128.4	37.9	83.1	171.3	27.2	87.2	72.9	118.4	197.8	116.9	62.9	113.6	54.6	68.2	115.7	116.8	76.8	180.7	127.6	206.3	177.5	103.2	169.3	79.6	90.7	142.4	86.5	154.6	51.9	124.7	245.8	83.6	156.1	194.0	106.7	109.0	109.0	90.4	68.6	127.1	51.3	52.8	99.2	96.3	167.2	138.5	106.6	150.3	134.7	386.9	119.1	123.2	329.1	154.8	77.5	222.7	145.9	51.6	200.7	150.6	83.7	288.4	295.1	38.1	125.0	250.7	75.5	111.3	144.4	134.1	175.7	179.1	177.0	223.4	155.3	159.2	77.1	279.1	231.8	266.6	171.6	200.3	162.7	190.6	178.4	181.7	207.4	202.7	166.6	161.1	291.7	142.4	177.7	294.0	230.1	225.6	116.2	117.6	125.2	142.4	113.4	116.3	125.6	116.8	116.1	116.9	128.4	118.4	118.9	48.1	73.5	18.9	137.4	162.3	166.4	271.4	87.0	109.8	228.1	240.2	231.3	180.1	149.6	165.5	64.6	384.1	134.7	642.0	677.0	310.2	1314.3	145.6	119.3	127.6	203.9	125.2	11.2	418.4	458.6	121.0	178.4	141.8	87.5	144.6	121.1	390.5	294.6	104.3	12.8	415.1	238.0	154.8	175.5	3668.5	136.1	149.7	217.1	5.6	208.1	299.8	166.9	13.0	17.9	425.2	484.3	118.5	240.5	272.5	607.4	780.2	142.2	124.5	157.8	104.4	152.4	572.4	149.2	190.4	197.6	438.1	116.3	181.0	414.3	270.1
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.1;lymphoid tissue: 60.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.5;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.3;white matter: 4.0"	"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.1	1.2	0.1	14.2	0.2	44.1	1.7	0.2	0.2	3.0	0.1	11.1	12.1	1.6	0.4	18.6	0.6	1.5	0.7	0.1	0.2	0.9	2.0	2.5	36.7	0.1	0.3	0.5	0.6	0.3	0.2	8.2	0.3	0.8	11.0	0.0	2.7	0.3	5.5	9.3	11.6	3.2	0.0	12.0	4.6	1.2	0.4	60.1	0.6	0.0	36.6	3.5	5.9	0.2	196.5	130.9	191.1	93.0	4.2	6.5	73.4	91.7	49.5	186.2	170.6	171.5	57.4	193.3	46.2	37.0	77.0	139.8	140.1	62.6	153.7	84.9	231.3	115.7	78.3	146.1	0.7	62.2	109.2	3.5	2.9	109.4	67.7	18.5	86.5	123.6	73.3	73.4	82.9	92.9	225.1	87.4	119.6	63.9	57.6	149.8	176.1	80.5	41.2	38.2	41.2	59.1	81.7	36.5	61.2	56.5	63.5	41.4	33.9	74.3	75.6	67.6	243.3	53.2	37.7	147.9	35.7	92.9	153.4	0.0	0.4	0.6	0.5	0.3	0.1	1.1	1.3	2.1	0.5	2.5	0.1	0.7	0.9	0.3	0.2	0.2	7.9	0.9	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.3	0.0	0.5	0.0	7.6	4.5	1.8	6.1	0.6	0.0	1.8	2.2	1.4	0.0	2.6	0.0	0.0	40.5	1.8	13.2	0.0	0.4	0.1	0.5	1.6	3.1	0.0	59.3	0.0	0.0	89.1	5.7	6.1	2.1	4.5	24.7	6.1	0.7	29.4	0.0	0.0	10.8	0.0	5.7	7.3	0.2	0.6	5.1	1.8	0.0	0.9	0.0	3.1	0.0	0.1	0.3	2.8	0.0	15.4	1.2	1.5	0.1	0.2	0.0	0.0	0.1	4.8	1.6	7.2	11.8	2.4	9.0	4.3	1.0	22.0	2.8
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"Activator of transcription and developmental regulator AUTS2"	Q8WXX7	7	69598296-70793506	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 598.7;Excitatory neurons: 871.5;Inhibitory neurons: 1405.7;Microglial cells: 583.7;Oligodendrocytes: 1231.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 8.1;naive B-cell: 9.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 82.8;REH: 84.1;SCLC-21H: 112.5;T-47d: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	8.7	5.2	50.4	9.1	41.1	8.5	17.2	10.6	19.0	7.9	0.0	11.3	6.8	7.4	6.2	11.5	7.0	13.3	5.5	21.8	32.0	13.9	20.2	10.8	4.8	40.6	25.9	14.6	5.7	11.3	9.7	4.1	23.0	11.3	10.0	11.0	48.2	5.7	15.2	20.5	15.6	7.5	14.0	6.5	10.5	7.9	37.3	10.7	5.8	5.2	6.3	10.5	10.5	8.7	0.3	7.5	82.8	4.3	5.4	3.2	0.9	5.2	0.0	0.4	0.5	29.1	0.3	13.0	1.9	5.0	0.5	27.1	10.0	11.5	2.3	60.5	22.4	6.2	7.8	0.3	2.4	0.1	0.4	8.6	15.2	12.5	3.1	3.0	0.0	13.5	0.6	6.5	7.2	4.8	1.2	2.4	59.0	18.9	0.1	84.1	40.0	39.8	0.0	12.5	112.5	61.3	5.3	9.2	0.2	35.4	80.0	0.1	0.0	0.3	27.1	8.8	52.6	0.2	0.2	43.1	0.1	0.2	0.2	1.0	0.2	0.1	1.4	0.1	1.9	8.1	0.9	1.4	0.6	9.4	0.1	0.8	0.4	1.5	0.1	2.8	0.2	0.6	50.4	41.1	10.6	19.0	21.8	32.0	40.6	25.9	23.0	14.0	37.3	8.7	13.7	19.2	38.2	598.7	19.9	28.6	21.1	25.0	34.7	37.2	72.9	41.5	20.8	11.5	22.2	9.2	16.7	1.2	103.2	23.5	5.9	13.1	31.8	11.5	36.0	15.9	28.9	5.2	871.5	1.3	0.1	19.3	4.1	11.0	0.0	44.4	12.1	28.8	0.8	63.9	1405.7	23.4	38.7	2.6	17.1	27.7	15.8	5.5	17.8	583.7	0.8	11.2	25.7	292.0	1231.2	3.9	15.3	14.7	37.7	32.6	15.3	12.4	20.3	20.7	26.3	13.7	17.2	10.1	16.9	20.3	16.1	1.4	35.5	10.4	25.3	26.6
AVPI1	"PP5395, VIP32, VIT32"	ENSG00000119986	"Arginine vasopressin induced 1"	Q5T686	10	97677424-97687241	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 100.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 246.7;Granulosa cells: 385.5;Langerhans cells: 326.1;Late spermatids: 278.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 119.7;HHSteC: 119.1;hTCEpi: 230.5;SK-MEL-30: 194.5;U-2197: 134.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037649	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA037649: AB_10671879"	"unprognostic (4.57e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-2)"	"unprognostic (7.34e-3)"	"unprognostic (8.56e-3)"	"unprognostic (2.29e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.83e-3)"	32.1	41.5	18.5	6.5	25.4	5.0	21.2	21.9	23.2	38.1	16.2	24.6	14.0	11.2	4.7	26.2	18.9	10.4	22.4	18.3	19.8	12.1	46.9	22.5	2.4	23.7	20.2	85.6	9.4	5.6	19.2	16.9	21.9	26.3	18.9	25.5	22.7	16.6	12.5	100.7	15.6	5.3	22.4	20.8	30.5	16.0	20.8	2.0	9.1	3.9	4.4	25.5	46.0	29.5	38.8	99.8	0.5	14.3	20.2	9.1	20.0	18.5	100.7	25.0	37.5	18.8	47.2	0.8	13.0	10.5	18.0	40.0	7.6	32.3	9.4	1.0	8.9	2.6	119.7	52.6	119.1	2.6	3.0	14.6	230.5	18.7	49.1	22.8	3.4	3.6	5.7	2.0	14.0	33.4	1.7	3.1	3.5	10.6	9.3	1.3	11.3	1.5	24.9	20.9	1.7	4.0	63.9	22.7	194.5	3.2	17.2	3.1	5.5	5.9	11.7	134.4	4.6	4.4	3.3	0.8	22.2	8.1	3.8	0.0	6.2	2.3	4.2	5.7	2.0	2.8	2.8	3.1	11.1	2.0	3.0	3.7	0.5	2.0	0.5	2.3	2.6	2.9	18.5	25.4	21.9	23.2	18.3	19.8	23.7	20.2	21.9	22.4	20.8	29.5	6.3	19.2	19.0	0.7	8.0	96.0	87.6	246.7	145.1	9.6	13.6	16.8	9.7	52.9	63.4	38.6	6.2	149.6	15.4	137.5	43.0	18.8	60.9	33.2	17.1	11.4	31.8	2.1	3.6	24.1	64.8	23.4	58.1	57.9	6.3	385.5	34.2	42.4	41.8	13.5	4.3	70.4	48.8	21.7	326.1	278.5	10.2	49.6	83.6	0.0	6.4	128.2	2.1	0.5	4.4	43.3	100.6	14.7	5.9	55.2	109.0	11.2	16.7	14.6	6.6	10.2	19.3	3.5	4.9	68.0	108.4	194.7	19.0	10.9	100.6	106.3
AXIN2	"DKFZp781B0869, MGC126582"	ENSG00000168646	"Axin 2"	Q9Y2T1	17	65528563-65561648	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.7;Extravillous trophoblasts: 102.6"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 33.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 27.2;CACO-2: 52.3;Hep G2: 78.8;OE19: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012283, CAB017783"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB012283: AB_2290204, CAB017783: "	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.48e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.84e-3)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.25e-1)"	8.7	10.9	6.8	5.4	6.9	0.9	5.3	7.9	7.9	17.2	5.5	12.3	7.1	23.9	5.9	5.9	19.8	6.6	8.0	9.4	6.2	3.7	2.7	17.0	3.5	8.5	7.9	15.0	4.2	4.2	6.2	18.4	5.3	14.0	14.6	3.4	5.2	8.9	14.6	14.9	7.4	17.3	7.3	7.4	13.6	6.7	11.0	17.3	12.3	7.8	2.7	11.4	8.0	5.6	0.0	13.9	27.2	0.5	9.6	4.1	12.0	0.4	1.3	0.9	1.7	52.3	5.0	1.0	1.7	8.0	1.0	0.4	5.7	0.1	1.9	2.4	3.1	0.0	2.4	78.8	1.0	0.1	0.1	2.4	2.1	2.2	0.6	1.6	2.4	5.1	0.2	1.2	1.4	0.3	13.9	0.1	5.3	86.9	0.6	9.9	1.6	0.1	2.6	0.3	8.4	5.5	0.5	0.3	4.8	20.0	1.0	0.3	6.3	5.3	9.6	7.6	1.7	0.1	3.0	3.8	2.5	0.6	2.6	3.2	0.0	0.0	0.1	0.0	0.4	0.5	1.1	0.2	0.0	1.8	2.3	0.4	0.0	1.0	0.0	0.0	0.0	0.3	6.8	6.9	7.9	7.9	9.4	6.2	8.5	7.9	5.3	7.3	11.0	5.6	2.4	0.0	9.0	9.8	1.0	11.2	2.2	1.0	11.4	3.7	5.2	8.1	8.7	1.5	8.1	0.0	4.2	18.1	0.7	15.2	0.0	1.4	33.7	7.8	15.1	5.3	5.4	0.0	8.4	0.9	102.6	10.3	5.6	16.5	0.0	3.1	1.1	2.0	3.8	1.7	8.7	17.4	0.0	0.0	7.5	17.5	6.5	0.6	17.8	9.4	1.0	3.3	0.0	8.0	2.0	0.8	18.9	10.9	0.9	2.9	1.9	0.9	1.3	2.5	13.1	1.6	10.6	6.2	12.9	3.3	5.5	14.2	4.6	3.6	19.8	1.3
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976042	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 2809.6;salivary gland: 3847.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	74000000000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	128.6	3.9	17.1	2.7	28.8	0.4	1061.4	23.1	18.8	3.4	16.0	6.7	30.9	1.5	2.5	22.0	3.0	38.7	114.7	14.9	22.2	326.8	2809.6	14.8	0.4	20.2	23.3	6.0	752.1	0.1	1.3	0.5	27.1	1051.4	4.2	3.6	3847.3	40.2	1.7	206.8	28.6	0.3	14.0	1.4	315.2	25.9	21.4	0.8	1.9	2.3	1.5	5.8	7.5	24.5	0.2	0.0	0.0	0.0	11.3	0.0	5.5	0.0	0.0	0.0	0.0	0.1	4.0	14.2	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.3	0.1	56.6	4.9	1.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.3	29.9	0.0	0.0	0.0	5.1	0.2	158.9	0.0	0.0	1.7	130.4	0.0	0.0	0.0	2.0	1.0	25.4	13.0	0.0	41.8	0.0	0.0	0.5	0.1	1.8	0.9	1.9	0.8	0.4	0.0	0.5	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	28.8	23.1	18.8	14.9	22.2	20.2	23.3	27.1	14.0	21.4	24.5	9.9	22.4	276.8	0.0	14.7	4.2	422.1	25.3	0.0	0.0	1315.5	704.8	115.9	451.8	63.0	5.5	2.1	0.0	10.4	5.5	46.9	11.7	1.9	1.4	1.2	14.2	12.4	85.5	0.1	254.2	0.0	7.7	94.8	5.5	3.8	1.2	65.3	4270.8	0.0	0.0	0.1	13.1	901.3	93.1	0.7	4.2	0.9	14.8	62.2	1.0	2.0	23.7	0.0	7.5	7.3	221.5	6.4	0.0	0.3	1691.9	15.3	596.1	6.3	0.3	0.0	0.0	11.9	7.4	0.4	9.9	9.7	0.0	12.3	0.1	12.6	674.2
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369499-382117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;ovary: 27.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.2;Bipolar cells: 23.8;Excitatory neurons: 31.2;Horizontal cells: 33.7;Inhibitory neurons: 32.3;Muller glia cells: 45.6;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 35.4;NTERA-2: 32.0;SCLC-21H: 39.5;SH-SY5Y: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043276, HPA053126"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	No				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cytosol"	Vesicles	"HPA043276: , HPA053126: AB_2682049"	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	0.9	0.6	23.1	0.9	17.2	0.0	3.3	5.1	33.3	17.2	0.0	5.9	0.6	14.1	0.6	2.3	11.9	0.5	1.6	23.8	12.9	1.0	0.3	0.5	0.3	19.3	20.7	27.8	1.1	2.6	17.9	0.0	14.9	6.3	0.2	5.3	2.0	1.2	0.0	2.1	2.9	1.0	8.4	0.3	2.1	1.5	15.1	0.3	0.5	0.0	0.3	1.8	6.3	13.4	0.0	4.8	35.4	20.4	0.0	0.1	8.4	6.5	1.7	2.9	0.8	3.7	0.0	0.0	4.8	0.7	5.6	1.4	4.8	8.5	0.8	0.0	12.3	0.0	13.4	11.4	0.4	0.0	8.7	0.6	5.0	0.2	3.8	12.7	0.4	1.9	11.5	0.0	0.0	10.8	0.4	0.0	32.0	0.6	14.0	0.0	0.0	4.9	0.4	0.0	39.5	47.6	2.4	1.7	0.5	3.7	14.0	0.0	9.0	2.0	11.1	3.5	0.4	0.1	1.7	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	17.2	5.1	33.3	23.8	12.9	19.3	20.7	14.9	8.4	15.1	13.4	0.1	0.0	0.0	133.2	0.2	0.8	1.5	1.4	0.6	23.8	6.5	8.9	12.5	0.0	0.1	1.8	4.2	0.1	0.3	0.1	0.0	1.3	0.0	0.6	7.1	0.6	1.8	0.0	31.2	0.0	0.0	2.4	0.0	1.1	0.0	6.9	0.0	0.0	0.2	33.7	32.3	0.1	2.0	0.0	0.0	0.0	3.1	0.1	3.6	2.8	0.2	45.6	0.0	28.1	32.5	0.2	0.0	1.2	0.0	2.6	0.0	0.0	0.1	8.6	0.0	0.0	3.3	0.1	0.2	0.1	0.3	0.3	0.1	0.6	0.5	0.4
BAALC		ENSG00000164929	"BAALC binder of MAP3K1 and KLF4"	Q8WXS3	8	103140713-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 300.9;choroid plexus: 108.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 67.8;Astrocytes: 198.2;Excitatory neurons: 131.4;Inhibitory neurons: 62.3;Muller glia cells: 132.4;Oligodendrocyte precursor cells: 125.7"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"NK-cell: 3.7"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"AF22: 51.7;BJ hTERT+: 18.1;SCLC-21H: 27.9;SH-SY5Y: 20.5;U-87 MG: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: AB_2685971"	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	9.3	15.6	196.7	2.1	209.2	3.4	7.0	182.2	226.6	1.6	108.2	3.1	0.9	1.7	0.4	0.7	3.8	1.6	3.1	201.1	206.8	4.3	2.9	7.3	1.4	240.0	237.4	3.3	2.1	0.4	25.9	5.3	219.5	1.1	1.6	19.4	1.0	0.9	2.0	2.0	2.7	1.8	229.2	14.5	2.4	1.3	300.9	0.6	4.5	1.4	0.8	2.5	1.4	205.3	0.5	3.0	51.7	0.5	0.5	14.9	0.0	2.6	18.1	0.1	0.2	0.5	0.1	0.2	0.5	10.1	0.2	0.8	0.9	0.1	0.1	0.1	3.1	0.5	0.8	0.1	1.2	0.0	1.1	3.0	2.9	0.6	0.0	2.7	0.4	0.1	0.0	0.4	0.1	0.4	0.0	0.2	1.3	0.4	1.0	0.2	0.3	1.2	0.0	0.1	27.9	20.5	0.6	0.0	0.1	4.5	0.2	0.3	3.0	16.0	1.0	0.4	1.0	0.0	0.2	0.2	75.7	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	196.7	209.2	182.2	226.6	201.1	206.8	240.0	237.4	219.5	229.2	300.9	205.3	67.8	0.0	1.8	198.2	0.3	5.5	0.7	4.5	0.6	2.1	2.0	1.1	0.8	17.2	5.9	0.0	0.0	0.1	2.1	0.3	7.9	32.0	2.9	15.6	2.3	33.4	17.8	6.1	131.4	25.6	0.1	1.6	0.0	34.0	0.0	0.0	23.6	0.8	0.9	0.0	62.3	3.4	22.4	1.3	6.2	8.7	1.5	2.1	14.2	18.7	4.6	132.4	2.1	125.7	46.1	4.1	1.2	0.0	0.8	0.8	0.1	0.1	21.7	3.3	0.0	2.1	8.1	0.1	0.1	0.3	4.0	0.0	1.3	0.3	0.1	1.1
BABAM1	"C19orf62, FLJ20571, HSPC142, MERIT40, NBA1"	ENSG00000105393	"BRISC and BRCA1 A complex member 1"	Q9NWV8	19	17267376-17281249	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054386, HPA068786, HPA077609"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 47: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: "	"unprognostic (5.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.74e-2)"	45.8	54.1	51.9	40.0	55.4	70.4	46.8	44.7	66.7	49.9	39.4	60.6	41.6	50.3	28.7	48.3	44.5	28.9	72.1	58.3	53.9	53.3	55.3	42.8	55.4	50.4	51.5	44.2	49.9	46.8	32.2	46.7	54.1	48.0	36.3	26.4	50.2	37.1	134.1	46.1	50.6	37.3	44.0	60.7	54.2	41.6	51.4	51.3	37.3	96.9	51.3	49.2	43.4	54.7	126.8	69.5	68.8	66.0	72.9	51.9	154.9	73.5	96.0	143.2	142.1	78.2	146.5	87.8	172.1	102.2	64.9	61.2	79.7	102.2	89.1	127.5	130.9	78.6	91.6	99.0	60.4	142.4	96.0	79.6	68.3	96.4	56.1	79.3	122.5	123.9	132.9	101.1	103.3	104.1	138.7	135.8	182.0	106.3	147.0	95.5	92.2	119.4	104.1	62.1	66.3	120.3	90.5	92.8	84.6	77.2	81.4	115.2	91.7	87.8	55.7	108.8	124.3	133.1	172.5	119.7	125.6	187.0	85.5	201.3	154.3	167.7	132.9	148.1	128.3	141.9	121.7	129.2	161.3	143.4	111.8	109.9	37.9	114.3	147.8	134.3	180.2	214.1	51.9	55.4	44.7	66.7	58.3	53.9	50.4	51.5	54.1	44.0	51.4	54.7	40.8	12.8	29.7	11.1	45.0	34.9	41.5	63.4	19.4	21.9	53.9	60.7	37.8	41.5	44.9	35.0	14.6	172.4	51.0	51.1	101.8	70.1	65.8	18.4	30.4	39.9	43.8	78.5	18.6	72.4	155.4	41.4	26.0	28.1	46.3	54.3	40.0	50.4	98.7	16.8	16.2	60.6	48.8	46.8	45.6	106.3	36.7	43.2	65.8	8.4	80.4	35.3	68.0	8.5	12.3	69.8	63.8	44.4	51.7	44.6	68.1	89.3	23.5	18.5	39.5	34.7	52.5	57.8	74.2	27.9	41.3	158.0	46.4	43.0	64.7	45.5
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.4;Late spermatids: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 150.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 150.2;monocytes: 51.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA034949: AB_2674376"	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	15.8	12.1	12.3	27.8	13.3	89.4	13.3	27.6	16.0	18.1	9.9	13.4	17.4	19.8	9.7	23.0	9.1	26.1	13.2	10.5	19.5	16.0	30.5	21.4	16.9	23.0	28.4	11.6	17.2	8.3	3.3	50.6	31.0	13.3	13.2	12.0	17.4	8.6	26.3	23.3	17.4	15.9	14.2	20.7	13.5	27.3	16.6	14.2	12.6	12.8	14.8	29.8	13.1	12.3	21.5	8.6	26.1	6.8	20.2	57.7	16.3	23.0	55.0	21.8	24.3	18.1	28.9	25.5	18.0	21.1	22.7	11.1	15.7	30.9	38.6	21.3	13.3	78.7	18.9	18.6	26.8	22.8	28.1	30.3	46.4	42.8	63.4	25.7	11.7	13.9	40.6	129.7	30.2	7.6	19.5	13.0	40.3	8.4	8.9	19.8	61.8	33.1	11.5	16.8	10.8	12.2	12.6	23.5	29.0	26.0	17.1	27.1	29.6	21.3	29.4	23.1	11.8	74.9	51.9	26.9	17.3	27.8	64.9	72.4	51.1	38.6	5.0	40.1	4.1	10.3	8.3	4.3	24.9	13.7	11.9	6.0	150.2	7.1	46.0	6.0	14.8	15.3	12.3	13.3	27.6	16.0	10.5	19.5	23.0	28.4	31.0	14.2	16.6	12.3	31.9	28.9	15.3	12.1	90.6	59.0	53.2	17.9	19.4	16.6	18.3	15.1	20.7	15.7	23.1	14.7	18.8	13.7	33.0	30.7	7.9	19.8	164.4	32.2	45.9	26.0	30.9	33.0	5.1	16.6	15.7	31.3	30.5	64.1	48.6	13.6	22.1	20.9	22.0	13.5	36.9	24.7	12.2	57.1	113.8	422.4	13.4	113.8	21.4	68.4	109.1	10.2	24.7	33.7	25.0	28.2	38.2	14.3	87.8	50.7	25.5	12.8	15.7	12.6	32.9	54.7	36.6	31.5	28.4	34.7	58.1	39.7	31.3	17.4	11.7	48.4
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926528-90296908	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 17.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 81.3;B-cells: 93.1;Excitatory neurons: 95.2;Horizontal cells: 198.5;Inhibitory neurons: 293.9;Oligodendrocyte precursor cells: 169.9;Oligodendrocytes: 253.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Daudi: 139.5;U-698: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	1.3	0.8	2.0	4.9	3.7	11.7	1.7	3.2	4.0	1.9	0.1	0.9	0.3	2.6	0.6	0.6	1.1	0.9	1.2	2.3	3.3	0.6	2.5	2.4	17.0	4.9	2.9	3.3	1.6	1.6	0.6	1.0	3.2	1.3	0.5	1.3	1.3	0.8	3.2	2.2	2.7	1.1	1.9	4.4	0.6	1.7	2.7	12.3	0.6	2.3	12.8	1.4	1.3	7.7	1.0	0.1	5.1	0.5	0.2	0.0	0.8	0.0	0.2	0.1	0.6	0.0	0.2	139.5	0.2	0.0	0.1	0.1	0.8	1.7	0.4	0.0	1.7	0.0	0.1	0.0	0.0	0.2	0.4	1.1	0.4	0.1	3.0	0.0	0.1	8.6	5.8	11.6	0.0	0.4	3.0	0.0	1.4	0.0	1.1	19.3	3.6	2.5	0.0	0.3	4.5	12.8	0.5	0.1	0.9	1.7	0.2	0.1	0.4	0.0	1.9	0.0	0.1	8.9	0.4	78.8	0.6	1.4	1.0	2.4	0.0	0.8	0.3	0.0	0.8	2.5	0.8	0.7	0.2	14.1	3.6	2.5	0.0	1.7	0.0	0.2	0.1	0.5	2.0	3.7	3.2	4.0	2.3	3.3	4.9	2.9	3.2	1.9	2.7	7.7	4.0	0.0	0.5	81.3	93.1	7.5	11.4	1.7	15.9	5.9	5.4	7.7	2.2	0.0	2.2	3.7	41.7	0.2	10.2	0.1	0.0	6.2	19.9	2.9	7.2	2.9	0.0	2.5	95.2	2.8	0.3	8.4	1.5	11.4	0.0	0.7	2.2	3.1	0.5	198.5	293.9	0.2	0.0	0.3	11.8	10.6	5.9	3.0	3.6	38.4	2.5	0.7	20.6	169.9	253.9	3.4	0.0	4.5	7.6	20.0	0.0	0.3	0.7	1.8	0.0	13.5	4.2	0.1	2.4	3.8	7.7	0.0	23.6	0.5	0.1	3.5
BAG1		ENSG00000107262	"BAG cochaperone 1"	Q99933	9	33247820-33264720	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1043.2;Late spermatids: 2944.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 437.5;NB-4: 417.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002486, HPA018121, HPA073236"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB002486: AB_563422, HPA018121: AB_1845255, HPA073236: "	"unprognostic (4.49e-3)"	"unprognostic (4.52e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.22e-16)"	"unprognostic (4.45e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-2)"	79.7	76.3	96.6	36.3	106.7	85.0	72.3	102.2	112.3	65.0	106.0	122.5	59.3	59.8	53.9	103.2	54.8	39.1	192.9	86.4	102.8	151.6	83.4	82.5	35.5	107.4	105.2	45.6	91.7	139.6	99.3	47.1	98.8	88.0	75.4	82.2	97.4	68.4	297.7	113.8	66.1	42.7	100.2	66.0	102.5	87.9	104.3	45.1	71.6	206.1	55.2	121.5	78.8	101.6	56.0	56.1	46.8	103.3	69.9	40.9	63.6	46.5	64.6	68.4	69.8	39.7	54.1	181.2	33.6	46.6	24.5	69.8	54.8	37.9	45.0	96.5	52.1	90.2	437.5	62.5	58.9	210.1	110.0	41.5	205.6	32.3	76.8	32.2	82.4	48.0	108.7	92.1	57.8	89.7	152.4	417.0	90.8	73.9	81.2	78.7	63.7	119.6	87.1	164.8	149.1	88.5	192.7	176.9	46.0	18.7	80.5	261.8	44.1	30.5	37.8	89.9	78.0	74.9	125.3	100.4	25.5	114.1	17.7	29.1	20.7	57.9	10.0	22.2	9.0	14.7	11.2	11.9	26.1	25.6	15.7	9.1	10.2	15.3	22.3	33.9	15.2	10.2	96.6	106.7	102.2	112.3	86.4	102.8	107.4	105.2	98.8	100.2	104.3	101.6	107.7	89.8	67.5	5.2	69.4	429.9	279.4	193.3	172.4	84.0	134.1	123.6	144.4	127.2	157.0	218.8	58.4	154.7	113.7	211.4	397.2	135.6	1043.2	109.3	72.2	86.6	198.1	259.1	5.9	189.0	59.9	79.4	104.5	193.3	41.9	36.7	66.8	72.8	104.9	38.7	7.1	287.8	170.9	86.4	162.7	2944.9	85.7	93.9	163.7	2.8	81.0	123.9	88.6	4.5	9.7	131.1	259.2	88.8	110.3	505.4	247.9	286.1	71.8	131.3	98.6	98.5	109.9	87.9	64.4	261.1	561.5	245.9	69.6	103.7	222.4	531.4
BAG6	"BAT3, D6S52E, G3, Scythe"	ENSG00000204463	"BAG cochaperone 6"	P46379	6	31639028-31652705	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 261.8;Late spermatids: 483.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020704, HPA045116, HPA053291"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		26000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103"	"unprognostic (7.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.16e-2)"	70.1	77.3	10.4	18.1	11.5	24.1	67.7	11.9	10.8	68.0	23.3	69.2	38.1	72.2	26.3	73.6	67.0	15.2	96.3	11.3	12.3	58.1	65.4	71.3	24.6	12.9	11.8	76.0	64.1	23.9	65.4	21.8	13.3	62.2	24.8	16.0	70.7	12.3	204.6	84.2	76.4	17.4	10.0	76.4	65.3	136.8	13.4	23.1	74.6	51.8	28.0	69.8	64.7	12.5	28.3	47.3	63.7	63.0	28.7	47.8	49.0	33.1	34.1	49.1	42.5	121.2	26.5	44.0	98.2	101.2	72.1	22.3	17.3	110.7	19.1	45.4	139.8	62.2	18.8	77.5	42.5	47.4	125.6	37.2	52.8	27.0	24.0	52.9	47.9	76.3	85.7	46.1	82.6	34.4	25.4	46.7	20.1	16.7	23.8	37.0	26.3	52.1	38.3	31.2	29.4	41.6	22.7	27.3	42.0	16.8	112.6	91.2	31.8	57.8	40.0	28.2	53.6	59.9	87.0	88.4	56.0	45.8	40.2	3.3	2.5	2.8	2.2	3.0	1.7	1.4	1.0	1.1	2.2	1.3	1.2	1.4	1.5	1.6	3.4	1.6	0.9	1.9	10.4	11.5	11.9	10.8	11.3	12.3	12.9	11.8	13.3	10.0	13.4	12.5	39.0	48.1	39.9	11.1	39.0	32.1	39.0	44.5	23.3	28.4	34.5	30.2	77.7	42.9	51.3	36.8	18.8	62.2	33.0	82.4	31.3	66.0	261.8	39.1	22.4	40.8	76.7	52.2	7.6	50.0	67.1	38.4	40.8	34.1	48.2	41.4	38.6	45.4	55.9	50.5	8.6	56.4	61.1	39.9	29.9	483.4	33.2	40.5	28.4	12.2	38.5	34.0	44.3	5.0	10.8	64.0	63.4	39.5	51.6	35.0	105.6	47.9	54.6	48.3	39.5	35.4	65.8	115.0	87.9	33.3	35.5	119.4	34.8	31.7	68.8	40.1
BAHD1	KIAA0945	ENSG00000140320	"Bromo adjacent homology domain containing 1"	Q8TBE0	15	40439721-40468236	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041196			Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA041196: AB_10803999"	"prognostic unfavorable (1.55e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.81e-2)"	"prognostic favorable (1.29e-10)"	"unprognostic (4.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	9.6	21.9	10.8	8.0	11.5	8.1	9.2	8.6	10.5	11.0	9.9	12.3	9.1	12.5	10.2	12.0	13.6	6.3	14.3	11.9	9.8	14.2	11.6	12.5	9.8	10.3	9.5	21.4	13.8	13.0	13.3	8.7	9.4	10.3	5.8	5.2	12.6	10.2	12.6	11.0	12.0	7.2	9.1	12.6	12.7	18.6	10.9	11.6	16.5	7.6	9.1	12.3	9.1	10.1	16.9	8.5	14.7	24.5	11.7	9.1	32.0	13.3	9.5	14.4	14.0	23.1	7.9	12.5	17.6	12.0	17.6	32.6	24.2	10.1	8.0	24.2	15.2	32.9	13.2	11.5	11.1	14.4	24.0	12.0	10.2	8.8	8.7	12.8	12.5	15.8	32.8	10.4	8.6	16.0	16.2	21.8	14.6	19.7	15.6	27.3	16.6	10.4	15.9	19.7	23.0	13.9	8.2	42.8	9.7	9.1	34.4	23.1	14.8	15.6	17.4	22.4	14.1	15.5	18.4	14.2	16.3	22.1	10.7	0.6	0.3	1.4	1.3	0.6	0.6	0.5	0.9	0.7	0.3	0.7	1.2	1.0	0.3	1.4	1.2	0.6	0.3	0.4	10.8	11.5	8.6	10.5	11.9	9.8	10.3	9.5	9.4	9.1	10.9	10.1	9.7	19.2	7.0	7.8	4.9	8.3	3.7	4.1	6.8	3.9	11.4	9.4	11.7	5.7	7.7	11.0	2.1	5.5	5.6	20.7	1.9	5.4	1.0	6.1	4.9	8.4	7.8	2.5	10.3	7.4	7.3	4.7	2.0	8.4	8.9	5.6	9.7	12.0	5.7	16.8	8.1	7.4	2.0	12.0	4.6	2.7	10.2	5.4	0.0	7.5	6.7	5.2	10.3	9.0	8.9	6.7	8.9	5.7	1.6	5.3	11.6	5.0	5.0	4.7	6.6	6.1	5.5	6.3	10.9	6.9	7.7	4.1	5.8	7.6	8.0	4.9
BANF1	BAF	ENSG00000175334	"BAF nuclear assembly factor 1"	O75531	11	66002228-66004149	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032896, HPA039242"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB032896: AB_2061090, HPA039242: AB_2676409"	"unprognostic (1.69e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.16e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.57e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	116.4	149.0	252.8	144.8	256.8	127.2	151.4	261.0	312.9	135.4	248.4	153.7	107.2	168.0	248.5	136.0	279.6	100.9	272.2	249.9	259.6	115.6	174.0	111.3	178.5	258.4	254.4	207.6	132.5	148.8	69.0	120.8	261.1	139.2	155.9	98.7	148.2	169.7	582.1	121.0	105.0	190.0	258.5	116.0	92.7	111.1	254.8	220.7	164.6	394.8	211.9	140.6	82.4	274.5	665.5	712.0	452.8	427.9	237.7	306.5	220.5	364.7	349.4	715.9	447.0	415.3	496.1	606.5	651.8	503.3	544.0	433.5	641.7	600.1	559.1	476.4	411.5	699.5	431.3	537.0	296.0	503.4	480.4	292.5	404.6	453.8	418.1	404.6	494.6	526.5	552.5	459.6	687.5	1196.3	607.7	1023.8	494.7	410.4	525.6	507.0	447.1	1297.4	647.9	361.7	362.9	458.0	399.1	636.4	469.4	352.9	698.8	378.6	350.4	535.8	574.2	601.8	515.8	313.6	680.4	771.1	442.7	420.2	485.5	112.7	231.7	82.2	165.2	239.1	159.1	243.7	139.0	160.5	252.9	234.6	166.0	174.4	28.7	219.7	266.2	238.2	125.5	324.0	252.8	256.8	261.0	312.9	249.9	259.6	258.4	254.4	261.1	258.5	254.8	274.5	135.8	54.5	41.9	11.4	112.7	126.8	154.6	301.2	142.9	52.8	164.8	230.0	32.1	102.9	153.6	196.8	25.0	296.5	101.4	70.7	326.8	196.8	17.1	164.8	147.2	126.5	142.8	144.5	12.3	177.3	346.6	126.6	86.6	116.2	140.2	199.7	79.9	130.8	324.5	50.5	13.4	171.4	223.8	80.6	169.8	41.9	142.0	124.7	186.7	8.4	155.9	123.8	186.4	9.0	22.2	170.3	107.1	123.8	110.8	126.8	77.4	251.5	187.7	57.8	72.3	123.9	145.5	250.2	325.1	227.0	118.1	174.7	104.9	172.6	196.2	148.9
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.2;lymphoid tissue: 96.4"	"Cell type enriched"	"Detected in many"	10	"B-cells: 455.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"memory B-cell: 310.4;naive B-cell: 253.0"	"Lineage enriched"	"Detected in many"	16	"B-cells: 310.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.6;HEL: 10.6;HL-60: 9.6;U-266/70: 31.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	8.5	3.6	0.6	35.1	0.6	6.2	2.2	1.5	0.9	2.3	0.2	2.8	2.4	0.8	3.2	0.8	2.3	3.0	0.7	0.5	0.7	3.2	0.3	8.1	82.2	0.8	0.8	0.1	0.5	0.4	1.5	0.8	0.9	5.8	3.3	0.2	2.4	4.7	0.1	0.7	24.2	1.0	0.9	56.1	7.4	3.0	1.0	9.7	12.9	0.2	96.4	7.6	0.7	0.6	0.0	3.0	0.0	0.0	3.4	1.4	0.1	0.1	0.1	0.4	0.6	0.1	4.6	13.6	1.2	0.0	0.0	0.2	0.1	1.5	0.4	0.0	0.0	10.6	2.6	0.0	0.1	9.6	0.0	0.6	0.4	0.0	0.0	1.2	0.1	0.0	0.1	4.0	0.6	0.5	0.0	0.6	0.0	0.4	5.7	0.2	0.6	0.0	0.4	6.1	2.6	0.0	0.3	0.2	0.0	0.1	0.5	2.5	1.3	0.0	0.6	0.0	0.0	31.0	0.0	2.2	0.1	5.3	0.0	10.8	1.7	19.7	0.4	0.5	0.1	310.4	0.1	0.2	10.5	253.0	0.1	0.1	0.9	1.5	0.2	5.2	0.2	11.3	0.6	0.6	1.5	0.9	0.5	0.7	0.8	0.8	0.9	0.9	1.0	0.6	3.5	44.8	27.1	6.8	455.9	0.1	2.2	0.5	0.0	0.2	1.7	0.4	0.5	0.0	10.0	3.7	0.0	2.1	5.8	0.0	0.0	0.2	2.8	13.1	1.0	1.3	0.0	6.1	7.3	0.2	0.6	1.4	6.1	15.2	1.3	0.1	0.0	0.1	1.5	0.0	1.6	0.4	2.0	2.9	25.1	2.0	0.0	13.0	5.4	4.7	2.8	1.8	1.0	1.0	1.3	4.1	1.3	0.4	13.7	4.4	0.2	4.2	2.2	0.1	0.0	0.1	0.8	1.9	5.6	0.8	1.1	0.3	12.9	2.1	1.1	4.3
BANP	"BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1"	ENSG00000172530	"BTG3 associated nuclear protein"	Q8N9N5	16	87949244-88077318	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047164	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA047164: AB_2679964"	"unprognostic (1.82e-1)"	"unprognostic (7.84e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.89e-2)"	8.8	9.3	8.1	9.5	8.8	12.1	7.8	16.0	9.5	10.2	11.3	8.8	5.1	9.6	3.3	7.5	9.6	4.9	8.0	9.1	8.9	9.0	13.9	7.4	9.6	10.6	9.0	12.3	8.7	6.2	9.9	7.7	9.8	8.1	3.6	6.4	7.9	5.1	10.2	8.0	8.7	4.3	7.3	12.1	7.5	11.0	10.3	10.4	8.0	5.1	6.4	9.3	8.3	12.1	12.5	19.7	9.6	14.4	8.4	10.1	32.2	14.8	7.4	14.3	9.7	21.6	17.0	16.8	19.6	3.5	13.0	14.2	14.4	6.7	5.2	13.1	15.5	10.5	12.9	18.0	7.1	11.2	8.3	3.0	10.7	8.8	6.3	12.9	8.9	10.9	17.9	9.3	8.8	14.5	15.5	14.6	16.5	9.7	23.6	16.4	11.1	12.4	8.5	5.9	14.2	11.7	18.8	11.0	13.8	14.1	13.5	14.3	11.0	15.4	10.7	9.1	14.8	7.6	13.9	25.7	9.2	17.2	15.1	22.9	19.9	40.7	22.2	18.2	18.7	25.1	23.5	19.9	24.7	21.5	24.9	22.3	64.5	24.5	22.5	29.7	23.0	19.5	8.1	8.8	16.0	9.5	9.1	8.9	10.6	9.0	9.8	7.3	10.3	12.1	12.0	9.6	8.3	15.0	28.6	14.9	11.8	7.4	6.2	14.2	14.1	13.2	5.8	10.0	5.1	16.5	4.2	19.4	42.2	9.2	3.9	12.5	5.8	10.7	9.7	13.6	12.1	4.4	32.7	8.0	27.3	16.3	4.1	13.4	8.2	17.9	5.3	10.3	12.4	26.9	28.3	8.9	2.0	11.1	48.3	8.2	10.8	22.6	19.6	20.6	16.0	11.6	22.6	23.1	28.6	11.0	8.6	10.9	21.2	16.2	10.0	7.8	6.3	17.2	13.1	10.8	22.7	33.7	22.7	6.2	21.3	56.6	19.1	10.2	8.9	17.2
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401008-52410008	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850"	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favorable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	45.2	63.5	97.6	25.0	99.2	73.9	42.9	78.9	135.5	39.1	71.4	47.7	21.6	40.5	23.1	59.3	36.0	25.7	57.0	114.1	83.3	57.3	65.2	46.0	29.4	81.2	85.7	43.9	52.7	40.2	36.9	24.6	81.7	50.0	24.1	20.1	43.0	22.5	74.7	73.4	43.4	23.8	79.9	54.2	48.1	140.0	89.2	33.1	49.1	43.5	27.9	44.6	41.7	90.5	39.1	43.1	52.2	44.8	50.1	31.4	59.3	37.8	50.1	62.4	48.0	52.5	35.8	55.7	18.3	54.7	69.3	31.4	55.7	63.0	37.9	55.1	51.4	68.6	94.4	53.2	45.7	65.6	58.5	48.0	80.1	68.5	36.1	33.3	50.3	107.7	59.9	48.3	44.5	33.7	79.1	89.5	58.0	31.0	52.8	33.7	41.7	55.8	37.4	61.2	19.8	63.6	46.1	13.7	56.9	29.2	37.7	90.6	52.5	54.1	49.3	66.0	70.9	71.7	101.6	81.2	58.5	68.2	66.1	2.9	3.2	5.4	5.4	2.8	2.6	3.2	4.3	4.4	2.2	4.1	3.1	4.0	7.4	2.2	2.2	5.6	4.2	2.7	97.6	99.2	78.9	135.5	114.1	83.3	81.2	85.7	81.7	79.9	89.2	90.5	13.5	0.0	16.0	8.1	12.2	31.6	10.5	13.2	23.3	16.6	16.4	12.6	23.6	11.5	10.2	25.8	0.0	14.0	17.7	23.2	11.7	13.5	103.4	9.2	12.4	14.7	10.8	8.2	7.5	16.7	15.8	13.6	14.8	13.6	21.0	18.1	14.6	29.2	12.6	10.1	7.7	16.6	6.1	17.4	10.7	48.0	10.2	12.0	12.4	5.6	15.2	16.1	16.5	7.1	6.7	15.8	16.5	11.7	16.2	11.7	13.3	18.5	8.2	12.3	19.7	14.7	14.2	37.8	13.9	23.0	23.4	12.0	12.2	15.9	19.8	9.6
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809683	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 68.6;Basal prostatic cells: 62.2;Suprabasal keratinocytes: 74.4;Urothelial cells: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119"	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	1.8	0.6	3.0	2.7	4.6	11.4	2.9	2.2	2.7	3.1	0.2	2.9	2.3	3.3	2.6	5.1	1.9	2.0	1.5	2.3	4.1	0.8	1.0	2.5	5.5	3.8	3.2	2.3	1.6	2.3	1.2	2.3	3.9	2.9	3.6	2.0	1.9	3.6	4.2	8.8	2.1	3.9	3.9	2.6	1.9	6.6	4.1	7.0	1.4	2.3	6.6	2.1	3.8	4.2	12.3	8.8	20.2	9.3	2.7	4.0	12.0	17.3	10.6	17.8	21.8	12.0	12.2	12.6	7.6	8.5	9.5	12.7	16.5	10.5	22.7	11.5	6.4	12.5	13.8	8.7	0.9	13.9	12.7	4.7	1.1	15.0	8.1	4.5	6.1	14.7	7.9	36.0	13.7	10.7	27.9	12.5	14.3	7.9	3.7	24.7	19.8	11.2	3.9	14.0	5.8	8.8	15.0	14.7	5.3	10.9	16.3	13.4	4.7	18.0	14.0	11.7	13.6	10.2	12.6	28.0	7.6	11.3	13.4	3.9	2.0	5.8	4.6	4.0	3.2	9.7	5.4	5.5	3.6	8.2	2.4	4.0	0.3	7.3	3.8	6.9	17.1	2.3	3.0	4.6	2.2	2.7	2.3	4.1	3.8	3.2	3.9	3.9	4.1	4.2	12.3	6.4	2.2	14.7	13.0	68.6	62.2	13.0	14.2	3.3	9.9	14.1	17.4	17.2	12.7	9.2	0.0	18.2	11.3	8.2	3.9	8.0	9.2	13.3	11.9	9.6	1.2	34.5	5.5	6.9	16.0	10.0	10.2	18.0	15.2	28.2	10.0	4.2	12.5	1.7	15.4	13.1	8.2	10.1	12.2	5.7	6.2	11.2	3.6	15.9	16.6	4.4	9.2	19.6	31.7	6.5	6.5	10.1	22.0	22.9	3.2	0.7	12.3	6.8	19.7	15.4	16.9	27.6	43.4	28.6	74.4	5.1	13.4	10.5	14.7	67.2
BARX1		ENSG00000131668	"BARX homeobox 1"	Q9HBU1	9	93951627-93955355	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"stomach 1: 166.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Early spermatids: 2.6;Fibroblasts: 2.9;Smooth muscle cells: 1.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 29.5;HMC-1: 69.8;NTERA-2: 20.7;THP-1: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055858			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Vesicles	"HPA055858: AB_2682947"	"unprognostic (6.19e-4)"	"unprognostic (4.81e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.16e-6)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.23e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.68e-13)"	"unprognostic (7.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.16e-2)"	17.1	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.9	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.6	15.1	1.5	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	166.5	3.9	0.0	0.0	1.0	0.5	0.4	0.0	0.0	0.0	0.0	2.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.6	0.0	4.3	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	20.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	5.8	0.0	28.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.9	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375848-129452279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 158.0;salivary gland: 131.4;vagina: 72.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 128.5;Breast glandular cells: 50.4;Squamous epithelial cells: 136.4;Suprabasal keratinocytes: 82.5;Urothelial cells: 84.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 163.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.8;hippocampal formation: 1.7"	"CAB033311, HPA064966, HPA068414"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.06e-4)"	0.3	0.0	0.1	1.3	0.3	0.0	14.9	1.1	0.3	24.2	5.5	7.0	17.9	0.1	0.2	158.0	16.7	4.7	0.2	0.3	0.4	5.4	0.0	0.3	0.7	3.0	1.6	0.0	10.3	0.3	1.7	3.6	3.2	4.8	4.9	0.2	131.4	0.6	2.2	34.8	13.0	0.2	1.8	0.0	6.4	2.4	0.4	0.4	0.3	39.3	8.8	0.4	72.2	2.9	23.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.3	0.0	1.0	20.9	0.0	5.1	0.0	163.7	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.1	0.0	3.9	0.0	6.2	0.0	0.0	0.0	20.6	0.9	0.0	0.0	39.8	0.0	0.3	0.2	0.0	0.0	19.4	0.1	0.4	3.8	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.1	0.3	0.3	0.4	3.0	1.6	3.2	1.8	0.4	2.9	0.2	0.0	1.1	0.3	0.5	43.1	128.5	8.7	3.4	0.6	50.4	16.9	0.5	4.3	8.0	0.0	0.0	13.4	0.8	29.4	7.9	23.7	7.2	11.3	0.6	1.2	1.8	0.0	1.8	0.7	5.8	2.7	6.6	4.6	0.0	0.0	0.0	0.2	1.9	0.0	0.3	13.4	0.0	0.3	2.2	1.6	0.0	0.7	10.6	0.0	0.1	0.7	0.0	0.0	0.3	6.2	29.8	0.4	0.9	25.6	34.0	3.4	11.8	0.3	0.0	0.6	1.7	0.1	5.3	136.4	82.5	4.2	1.7	0.0	19.4	84.8
BATF	"B-ATF, BATF1, SFA-2"	ENSG00000156127	"Basic leucine zipper ATF-like transcription factor"	Q16520	14	75522455-75546993	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.7;lymphoid tissue: 30.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 105.4;Breast myoepithelial cells: 73.9;granulocytes: 243.7;NK-cells: 103.0;T-cells: 116.5;Urothelial cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"T-cells: 130.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 368.9;MCF7: 134.7;RT4: 83.3;SK-BR-3: 64.8;U-937: 101.6"	"Not detected"	"Not detected"							"HPA059588, HPA064962"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA059588: AB_2684074, HPA064962: AB_2685392"	"unprognostic (3.33e-3)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (8.30e-4)"	"prognostic favorable (5.35e-6)"	"unprognostic (3.02e-2)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (3.74e-9)"	"unprognostic (4.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (4.30e-4)"	5.5	1.3	1.0	20.5	1.8	21.7	7.8	1.0	1.4	2.2	1.1	3.0	2.6	1.3	1.1	2.9	1.9	5.8	2.4	1.0	1.2	1.4	2.9	8.0	30.6	1.5	1.4	0.5	0.9	8.0	0.5	4.1	1.7	5.5	1.4	0.0	6.5	1.8	0.4	2.9	9.7	2.3	1.2	26.9	7.8	0.6	2.2	7.2	1.9	1.0	20.4	18.2	2.9	1.5	4.7	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	368.9	0.0	7.5	0.0	1.6	11.5	10.0	36.3	0.1	0.0	0.0	0.0	0.0	0.0	8.1	2.0	10.3	0.0	134.7	4.7	30.8	0.2	54.9	0.0	1.1	0.0	6.3	0.0	83.3	0.1	0.0	0.0	64.8	2.7	0.0	6.1	18.7	0.0	0.0	0.0	4.4	0.3	32.8	36.9	0.3	0.0	101.6	0.1	3.6	25.5	8.2	55.0	13.7	43.4	21.3	59.7	74.2	25.2	17.5	23.1	50.4	14.4	21.3	13.2	2.9	130.3	27.8	1.0	1.8	1.0	1.4	1.0	1.2	1.5	1.4	1.7	1.2	2.2	1.5	2.9	9.6	29.3	0.0	17.1	5.4	50.8	5.7	0.6	0.0	105.4	73.9	0.3	1.5	13.5	3.7	0.0	0.4	36.9	0.0	0.0	0.8	0.5	0.9	0.6	5.0	0.0	7.2	0.2	2.5	0.4	4.4	10.2	1.9	243.7	0.0	2.5	0.7	61.3	0.0	0.1	0.0	34.6	15.4	10.7	0.6	0.0	21.7	5.4	1.0	16.7	0.0	103.0	0.0	0.1	11.0	0.1	0.0	29.9	22.1	0.0	0.2	12.8	0.0	0.0	1.0	2.0	0.0	0.1	0.4	3.4	1.1	116.5	0.2	0.5	74.3
BATF3	"JDP1, JUNDM1, SNFT"	ENSG00000123685	"Basic leucine zipper ATF-like transcription factor 3"	Q9NR55	1	212686417-212699840	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 41.0;Langerhans cells: 50.4;Macrophages: 24.4;monocytes: 65.7;Smooth muscle cells: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 65.9;myeloid DC: 55.3;non-classical monocyte: 99.3"	"Group enriched"	"Detected in many"	34	"dendritic cells: 55.3;monocytes: 99.3"	"Cell line enriched"	"Detected in many"	11	"HDLM-2: 497.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA075858			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA075858: "	"unprognostic (3.87e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.43e-10)"	"unprognostic (9.88e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.08e-2)"	5.9	1.1	1.9	3.6	2.9	3.0	3.0	1.4	2.8	1.8	9.1	1.7	0.6	1.3	0.0	1.1	2.0	2.0	2.1	2.2	1.9	5.1	1.1	5.8	5.9	1.8	1.8	0.6	1.7	0.4	0.9	2.5	1.9	1.8	0.6	0.0	0.9	0.4	0.5	0.9	2.3	1.8	2.3	7.3	1.5	0.5	1.7	4.2	1.6	0.6	2.6	4.9	1.4	2.0	2.4	6.6	0.7	0.0	0.2	3.1	4.3	2.3	7.4	6.5	7.0	0.0	1.7	0.0	0.9	0.4	10.6	0.0	7.0	1.1	4.5	497.4	12.5	0.1	1.9	0.0	1.2	22.6	3.9	0.5	0.0	12.5	1.8	1.0	0.1	43.5	1.1	6.5	1.3	0.0	17.8	9.3	2.7	0.0	8.4	3.5	2.4	0.3	6.0	0.0	1.4	0.9	1.6	0.0	0.5	2.3	0.0	17.8	0.0	2.7	11.1	0.5	13.4	0.5	1.4	2.7	8.7	21.3	6.2	0.0	13.6	0.0	0.0	65.9	0.0	0.7	0.2	0.3	55.3	0.0	0.0	0.0	2.2	1.5	99.3	0.2	1.8	8.8	1.9	2.9	1.4	2.8	2.2	1.9	1.8	1.8	1.9	2.3	1.7	2.0	9.6	3.2	0.6	0.3	2.4	5.7	2.3	0.9	0.0	0.2	5.2	5.5	0.5	0.0	1.6	0.0	0.0	2.1	0.7	0.0	0.0	0.7	0.7	1.5	3.1	8.2	0.0	0.4	4.5	0.4	41.0	6.8	0.0	2.3	5.1	1.0	6.1	0.4	5.8	0.0	0.6	0.1	0.0	14.4	50.4	0.8	0.9	24.4	1.8	7.5	65.7	0.1	0.0	0.5	0.9	1.1	0.0	0.0	0.0	18.9	0.0	0.4	2.7	0.4	0.0	5.2	20.0	1.0	4.1	0.1	2.8	4.5	1.9	0.1	0.0	1.4
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440406-73522293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA058068"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB037081: AB_477637, CAB037158: AB_477636, HPA058068: "	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	22.6	19.4	24.1	22.1	28.3	24.7	16.7	28.6	25.2	22.5	21.5	23.0	16.0	24.4	17.7	18.0	19.3	16.0	19.6	21.9	26.9	16.8	24.1	20.3	27.9	25.1	26.5	30.8	21.0	27.6	19.2	22.7	24.7	22.6	20.5	28.3	17.1	25.4	28.0	14.2	18.2	24.7	23.8	23.4	18.9	17.3	25.5	40.6	23.8	30.7	29.6	21.9	17.5	29.1	75.6	76.1	102.5	115.3	52.0	55.1	34.1	71.7	54.7	67.4	70.5	62.4	55.6	141.6	16.3	64.1	102.6	51.7	126.1	47.7	100.9	80.3	63.8	84.4	89.3	54.3	57.9	128.8	68.5	39.6	45.5	83.2	101.6	50.4	54.5	75.9	149.9	86.4	76.7	71.7	132.8	59.1	66.7	57.6	56.2	133.1	89.9	94.5	38.5	58.2	102.4	87.2	102.1	112.4	59.8	87.1	69.1	63.6	64.4	116.1	66.5	70.6	123.2	49.7	84.7	235.7	65.9	119.1	107.7	4.0	1.5	1.0	3.0	1.1	2.6	1.2	2.3	2.2	1.1	2.5	1.7	1.9	1.1	2.8	0.8	3.1	2.5	0.9	24.1	28.3	28.6	25.2	21.9	26.9	25.1	26.5	24.7	23.8	25.5	29.1	46.3	76.9	129.8	28.7	52.8	29.8	34.5	16.7	38.1	69.9	28.1	24.6	81.7	27.1	59.0	20.2	43.8	57.3	50.4	33.1	7.9	35.5	8.4	47.4	72.2	53.5	34.7	89.8	35.0	23.1	59.6	58.7	34.7	52.6	51.8	59.5	34.6	59.1	33.0	60.6	35.3	34.6	22.4	33.4	24.8	12.5	61.2	38.7	12.4	34.7	47.3	54.4	61.8	28.6	43.9	26.5	13.6	76.3	65.3	40.5	25.2	12.9	49.2	53.8	32.9	67.1	57.5	75.7	127.0	47.0	25.3	34.6	56.5	46.1	43.3	35.2
BAZ2B	WALp4	ENSG00000123636	"Bromodomain adjacent to zinc finger domain 2B"	Q9UIF8	2	159318979-159616569	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 477.3;Oligodendrocytes: 604.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 115.8;neutrophil: 213.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 213.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019819, HPA059292"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA019819: AB_1845282, HPA059292: AB_2683968"	"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.14e-2)"	20.6	23.8	23.0	18.1	43.7	36.7	22.1	57.4	26.8	23.8	3.6	18.2	17.1	33.6	19.7	22.1	24.4	26.1	18.4	21.8	41.4	17.3	16.8	24.7	14.7	45.3	29.1	42.4	19.3	24.6	17.5	20.5	47.7	18.4	16.4	52.0	23.4	19.8	18.4	17.5	18.5	23.5	26.0	20.9	17.0	26.4	43.7	21.5	25.4	22.3	13.6	20.9	14.7	75.3	7.4	14.7	48.4	29.4	14.2	22.8	8.4	15.3	18.7	8.2	9.6	22.1	19.9	12.4	25.8	15.0	8.4	16.6	19.4	20.7	13.0	4.5	11.1	24.7	26.9	3.1	9.3	16.3	17.0	18.0	22.2	20.6	22.2	30.4	42.5	8.3	25.7	2.3	13.1	9.1	5.6	10.5	16.1	1.5	12.4	13.1	15.7	8.8	16.4	26.2	32.1	27.9	30.3	3.7	18.5	25.0	5.8	46.7	42.6	14.9	30.1	6.5	10.3	9.0	1.0	14.0	14.1	17.5	10.0	115.8	27.4	36.4	10.1	12.0	8.3	6.5	6.1	10.5	17.7	9.6	4.1	6.6	213.2	19.7	11.3	24.5	7.1	6.0	23.0	43.7	57.4	26.8	21.8	41.4	45.3	29.1	47.7	26.0	43.7	75.3	105.3	99.3	148.0	477.3	34.3	32.6	70.1	35.8	66.0	91.8	56.4	38.9	60.8	61.5	71.5	68.0	310.6	18.5	40.1	45.4	9.8	55.5	158.0	69.8	63.9	82.5	99.9	42.1	180.4	38.9	7.2	54.9	59.7	118.9	73.9	71.9	71.0	29.4	25.5	94.2	177.3	52.1	36.7	58.0	37.1	35.4	59.4	76.6	14.2	289.5	81.4	87.3	41.2	300.6	604.3	54.3	55.5	35.0	42.2	50.0	51.7	12.4	73.3	332.3	13.1	74.9	54.1	98.2	20.7	49.6	37.5	26.7	38.9	83.2	48.6	91.6
BBOF1	"C14orf45, CCDC176, FBB10"	ENSG00000119636	"Basal body orientation factor 1"	Q8ND07	14	74019349-74082863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 239.3;Endometrial ciliated cells: 166.4;Late spermatids: 111.3;Respiratory ciliated cells: 177.8;Spermatocytes: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003090, HPA003136, HPA075108"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: "	"unprognostic (1.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.71e-2)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.04e-3)"	4.9	2.8	5.8	2.3	6.3	6.5	7.3	5.5	9.0	6.5	15.9	7.1	2.0	7.1	14.6	5.2	22.5	5.7	4.4	6.3	5.8	9.7	2.2	6.8	1.7	9.7	9.8	5.1	2.8	5.0	10.7	2.4	8.3	5.5	3.5	24.3	3.8	7.1	2.3	3.1	2.4	5.5	8.0	1.4	3.4	38.6	6.2	2.8	13.2	3.3	2.1	5.0	3.1	6.6	5.4	3.1	1.3	8.7	5.7	12.5	1.1	4.6	6.5	4.6	4.3	1.1	3.7	5.3	1.2	5.7	2.0	1.3	1.8	0.8	5.2	0.8	1.0	0.6	3.1	1.2	4.8	2.7	0.3	6.1	4.2	10.3	1.3	7.3	1.7	9.7	2.9	0.9	3.4	4.3	8.5	1.3	0.4	0.5	2.1	3.0	3.4	0.9	7.9	1.4	5.2	3.3	9.0	3.6	2.6	1.3	9.2	0.2	3.8	5.7	4.0	7.6	1.3	1.9	4.9	3.3	16.7	0.3	1.6	1.1	0.0	0.1	1.5	0.0	1.8	0.5	1.4	1.0	0.1	0.6	1.9	1.5	1.0	1.1	0.0	2.4	0.3	1.2	5.8	6.3	5.5	9.0	6.3	5.8	9.7	9.8	8.3	8.0	6.2	6.6	3.8	12.8	8.1	0.0	1.4	0.0	3.8	0.0	4.0	7.8	15.8	8.0	0.0	7.2	30.3	3.7	29.2	1.8	3.9	1.8	15.6	9.0	239.3	166.4	15.1	3.1	2.4	39.6	0.0	3.5	2.6	7.4	2.0	18.2	1.3	4.3	3.6	4.5	2.3	6.7	0.0	2.7	0.0	1.6	0.0	111.3	10.8	3.9	0.0	0.0	0.8	5.7	4.1	0.0	0.0	3.0	0.2	6.0	0.7	2.5	1.0	23.5	177.8	29.9	0.0	4.3	4.0	149.2	14.7	1.3	0.0	1.0	2.3	4.1	0.9	3.4
BBX	"HBP2, HSPC339, MDS001"	ENSG00000114439	"BBX high mobility group box domain containing"	Q8WY36	3	107522936-107811339	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1071.7;Late spermatids: 571.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006049, HPA050646"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA006049: AB_2667504, HPA050646: AB_2681200"	"unprognostic (7.57e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	13.9	25.0	19.3	12.8	39.0	18.5	14.5	23.7	22.2	17.2	18.7	11.5	9.5	19.0	38.6	12.9	16.8	16.7	16.5	17.0	29.4	19.5	10.2	13.3	13.9	31.0	26.3	27.0	12.3	46.4	10.2	24.2	32.8	22.7	9.3	20.0	13.4	31.6	6.7	8.1	9.1	16.5	25.6	18.9	12.1	58.1	28.5	16.4	26.2	16.2	13.7	14.6	8.7	59.9	40.0	39.7	31.1	47.0	26.5	35.1	25.5	38.6	36.5	33.2	35.4	4.4	31.4	20.2	46.5	23.4	37.5	26.9	34.4	44.2	45.7	29.0	16.3	31.9	30.0	9.4	31.1	43.3	18.2	31.6	31.3	32.5	62.4	44.5	26.2	23.8	14.9	29.6	27.7	13.5	25.2	4.6	15.5	0.4	30.2	35.8	30.1	22.9	20.8	32.2	22.5	22.0	69.0	6.3	31.5	30.7	25.4	8.6	38.3	38.7	30.7	15.3	26.8	12.9	10.3	25.0	36.9	21.4	23.2	76.0	19.9	50.4	47.0	20.8	54.4	75.9	42.2	48.3	28.3	75.0	52.5	43.3	32.0	58.0	42.7	36.2	30.8	27.7	19.3	39.0	23.7	22.2	17.0	29.4	31.0	26.3	32.8	25.6	28.5	59.9	76.9	64.1	84.1	106.7	123.0	85.1	145.6	103.3	80.8	92.8	72.7	79.4	112.7	85.8	72.5	95.6	64.6	208.2	87.7	18.1	49.0	92.9	1071.7	76.8	62.1	78.4	66.4	51.7	96.3	73.8	92.1	86.2	40.8	88.0	32.3	151.7	66.4	30.8	47.9	171.6	78.4	41.4	114.0	62.2	73.0	571.4	156.3	70.7	67.6	112.4	48.2	149.9	101.0	163.3	323.2	65.4	37.8	206.1	66.4	115.7	19.7	112.8	60.9	64.5	144.7	108.5	114.9	94.1	159.0	59.0	75.6	198.4	100.8	107.1	39.3	128.9
BCAT2	"BCAM, BCT2"	ENSG00000105552	"Branched chain amino acid transaminase 2"	O15382	19	48795062-48811029	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 254.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054091	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		25000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA054091: AB_2682374"	"unprognostic (2.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.50e-3)"	27.2	85.4	27.5	11.4	27.8	6.1	25.2	34.6	34.5	29.7	72.3	38.8	14.8	27.0	5.3	33.7	30.2	10.7	63.4	29.0	26.5	40.5	22.1	30.4	14.0	28.2	29.7	53.3	76.7	20.1	30.7	12.4	27.8	38.4	17.4	5.6	29.1	17.0	58.7	28.0	23.7	13.5	26.1	19.7	66.4	20.2	30.8	12.0	28.9	29.4	16.5	56.6	29.0	29.2	62.9	73.3	19.3	40.6	78.1	26.3	34.2	27.3	13.8	32.7	31.7	74.5	37.4	73.3	30.2	24.3	10.1	28.8	29.8	47.4	16.5	46.0	76.0	27.0	32.7	5.0	75.3	36.9	24.2	38.5	29.8	24.2	35.0	31.8	45.5	55.3	34.9	43.8	12.2	74.8	50.4	38.9	16.9	98.5	35.7	75.2	33.1	80.8	30.8	254.3	102.6	29.4	41.0	66.7	20.7	13.3	42.3	17.9	25.9	31.5	30.3	37.6	34.3	40.8	58.4	35.8	17.2	56.7	21.0	0.0	14.4	3.0	14.3	16.1	20.1	23.5	17.5	18.8	25.6	20.3	15.7	14.1	0.6	14.8	6.2	28.9	24.9	12.3	27.5	27.8	34.6	34.5	29.0	26.5	28.2	29.7	27.8	26.1	30.8	29.2	13.1	28.9	44.8	59.7	14.1	6.0	28.3	32.3	14.2	10.4	23.5	17.9	25.5	31.5	20.6	12.9	20.9	67.6	11.0	28.8	72.4	38.6	8.0	16.2	22.4	13.5	19.9	6.3	11.2	21.3	25.2	15.3	32.6	23.8	23.5	18.3	12.8	11.2	26.2	1.7	10.6	30.4	38.7	7.9	10.5	10.2	17.4	7.5	24.9	8.4	21.6	7.3	7.2	9.0	11.2	15.8	17.7	30.1	15.1	16.1	13.9	39.4	13.2	13.4	19.7	9.9	17.3	8.0	19.5	32.6	7.1	45.8	9.5	21.9	33.9	47.7
BCCIP	"BCCIPalpha, TOK-1"	ENSG00000107949	"BRCA2 and CDKN1A interacting protein"	Q9P287	10	125823546-125853695	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038011			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA038011: AB_2675784"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	40.0	35.1	37.7	38.3	39.1	62.4	52.4	41.1	43.4	31.4	42.3	37.6	32.3	31.0	54.6	38.5	33.0	26.6	48.0	37.5	38.7	55.3	67.9	27.2	49.3	38.3	38.3	42.8	47.1	41.6	24.8	32.5	39.2	42.4	41.1	55.7	58.2	28.6	77.5	31.8	31.7	31.4	38.7	29.8	42.8	48.3	39.0	50.0	39.8	63.6	48.7	55.9	30.1	40.8	225.6	114.4	126.9	141.3	70.9	77.2	105.9	117.9	112.1	142.3	131.2	188.2	146.4	156.6	72.1	108.6	107.1	121.4	219.3	167.0	197.6	145.3	148.5	157.9	97.5	210.0	89.4	219.7	96.1	79.9	98.7	170.1	178.3	108.0	137.7	145.1	177.7	78.1	122.5	134.7	142.7	220.4	98.2	188.0	170.2	134.7	133.5	94.3	126.6	106.0	67.2	68.5	88.1	142.4	149.9	102.7	76.9	96.3	93.0	65.9	116.9	98.2	215.9	79.3	94.9	233.0	129.7	112.5	52.0	30.3	68.3	41.1	56.2	86.6	77.8	76.8	63.7	61.9	75.2	71.4	71.1	64.4	11.2	68.2	94.3	65.0	75.6	48.1	37.7	39.1	41.1	43.4	37.5	38.7	38.3	38.3	39.2	38.7	39.0	40.8	21.6	64.1	67.9	16.6	46.9	66.9	59.3	60.6	58.1	24.2	32.2	27.3	80.4	28.6	67.0	23.9	22.9	41.4	28.2	16.7	78.2	52.7	14.7	37.6	36.6	30.4	25.8	47.3	21.3	44.1	38.0	43.2	40.2	33.2	27.1	33.6	23.2	50.4	35.8	16.8	21.0	23.1	42.7	28.9	22.2	9.4	37.0	29.3	23.2	11.2	36.2	30.2	28.8	22.1	25.7	45.1	19.6	31.2	57.7	51.9	22.7	62.4	74.7	25.1	26.3	47.5	37.5	105.3	117.2	57.8	52.1	33.8	38.6	28.3	33.3	55.5
BCDIN3D		ENSG00000186666	"BCDIN3 domain containing RNA methyltransferase"	Q7Z5W3	12	49836043-49843106	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 22.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039911	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"HPA039911: AB_10673021"	"unprognostic (2.21e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.96e-3)"	"prognostic favorable (3.24e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.62e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (2.31e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.06e-4)"	2.0	2.9	5.4	2.8	5.5	1.1	4.0	6.0	6.8	2.9	5.3	2.3	2.4	2.5	3.7	2.7	3.9	2.4	2.6	5.4	5.2	3.3	3.7	2.1	4.8	5.5	5.2	3.8	3.5	4.3	2.2	2.3	5.5	3.8	2.8	2.6	4.2	2.7	22.1	3.8	2.8	2.6	5.3	3.2	3.1	2.5	5.3	4.2	3.9	3.0	4.2	2.4	1.9	6.4	2.8	4.0	3.8	5.8	8.0	4.7	3.8	3.9	5.1	4.1	4.2	2.1	7.0	2.5	4.2	1.8	3.0	3.4	3.9	2.3	2.2	8.7	5.1	3.3	3.1	1.3	6.3	4.0	3.3	2.5	9.2	2.9	4.1	5.1	1.9	5.3	6.4	6.7	2.6	7.2	4.5	6.4	3.8	6.3	7.1	4.7	3.6	5.0	4.0	2.6	5.2	7.2	4.6	7.4	5.7	3.0	8.9	4.4	2.1	3.2	2.4	5.0	2.1	6.3	5.7	4.8	3.5	2.9	2.2	4.0	3.0	1.6	4.5	4.0	6.0	6.7	5.7	4.4	3.2	5.7	6.4	5.9	2.4	4.4	4.2	1.7	5.3	3.0	5.4	5.5	6.0	6.8	5.4	5.2	5.5	5.2	5.5	5.3	5.3	6.4	4.0	32.1	25.0	2.9	9.4	2.2	7.3	7.6	5.2	6.8	7.4	6.7	2.4	5.7	10.2	1.8	0.0	12.6	4.8	3.6	13.7	10.1	1.7	5.9	6.0	4.6	1.8	9.5	3.3	9.8	7.4	6.8	5.1	5.0	10.8	4.6	3.9	7.7	5.8	5.0	5.2	5.6	6.1	4.1	1.2	0.9	8.4	4.3	0.0	2.8	3.1	7.2	13.4	4.0	11.0	6.4	4.8	6.4	4.9	5.7	6.9	8.7	14.2	6.2	0.0	4.7	4.5	11.8	8.7	5.1	3.1	7.7	9.1	6.8	5.1	2.8
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 296.5;Early spermatids: 110.9;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 98.5;Oligodendrocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoplasm,Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	19.7	10.7	7.3	7.6	8.3	8.2	22.3	11.5	7.8	11.7	11.6	22.5	11.5	9.2	7.1	10.3	11.5	7.8	18.8	8.8	7.0	31.8	78.4	7.3	8.8	10.7	9.2	14.6	12.9	19.7	7.2	4.8	13.1	15.9	20.7	7.9	26.6	11.3	10.9	8.5	12.4	9.4	11.8	6.3	17.6	13.1	8.7	9.1	15.5	15.3	9.1	11.2	7.6	16.0	13.8	5.1	18.8	25.3	18.6	16.1	14.9	9.7	19.8	15.4	21.0	8.3	18.5	38.9	10.1	23.1	18.0	13.6	10.6	12.7	21.5	48.8	15.6	19.4	12.6	11.3	20.7	27.7	8.3	15.6	12.8	10.7	13.3	13.8	18.6	29.8	16.6	33.8	35.0	7.6	10.3	16.3	14.0	30.1	6.5	25.5	58.3	33.8	43.2	20.7	12.6	17.8	16.2	13.4	9.9	20.6	17.3	21.1	8.0	9.2	6.3	8.5	13.0	24.0	25.2	12.9	11.3	20.4	14.2	3.4	4.2	1.0	10.1	5.1	13.3	10.6	8.3	8.5	8.3	12.7	11.0	11.6	0.8	17.4	5.9	12.9	20.3	6.1	7.3	8.3	11.5	7.8	8.8	7.0	10.7	9.2	13.1	11.8	8.7	16.0	8.4	9.6	21.0	296.5	11.5	8.5	12.5	21.1	15.9	7.8	19.6	14.7	29.3	8.6	18.0	5.5	2.1	17.0	9.1	17.5	27.4	8.2	110.9	8.3	10.3	8.0	12.0	10.3	72.0	10.4	8.3	13.7	15.3	17.6	16.5	19.2	11.0	66.5	12.2	3.3	94.9	31.3	10.2	9.1	9.0	13.7	8.7	5.4	16.0	59.0	7.3	15.5	10.3	98.5	101.7	5.4	10.4	8.6	8.4	6.2	11.5	33.1	13.5	8.7	6.6	11.1	9.4	15.2	5.6	20.1	12.4	10.4	9.9	15.5	17.4	10.9
BCL11A	"BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856"	ENSG00000119866	"BAF chromatin remodeling complex subunit BCL11A"	Q9H165	2	60450520-60554467	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.8;lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 149.0;Basal squamous epithelial cells: 118.4;dendritic cells: 140.3;Excitatory neurons: 180.8;Inhibitory neurons: 153.2;Squamous epithelial cells: 120.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 312.7;naive B-cell: 415.7;plasmacytoid DC: 899.0"	"Group enriched"	"Detected in all"	15	"B-cells: 415.7;dendritic cells: 899.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 51.1;MOLT-4: 49.0;REH: 48.3;U-698: 106.7;U-937: 34.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 52.5;cerebral cortex: 82.3;hippocampal formation: 69.2;olfactory bulb: 66.7"	"CAB014891, HPA029003, HPA075941"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB014891: , HPA029003: AB_2672863, HPA075941: "	"unprognostic (4.10e-3)"	"unprognostic (6.72e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.37e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.27e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.99e-2)"	0.7	2.1	31.4	11.3	34.7	25.3	7.1	10.5	47.8	5.2	9.7	18.4	9.7	2.1	1.4	18.4	5.7	2.5	8.0	38.7	15.5	1.0	0.5	2.1	29.2	31.6	15.3	0.6	10.8	1.7	3.0	0.9	31.0	7.8	6.1	1.7	13.8	1.9	1.7	33.2	13.9	3.4	15.9	19.6	4.8	2.0	15.9	33.9	2.3	0.2	40.9	3.3	11.5	38.7	0.6	0.0	4.2	0.1	0.8	0.8	0.3	1.5	0.0	0.1	0.0	0.0	0.2	51.1	0.2	0.2	0.0	10.5	15.4	7.4	0.2	0.9	15.2	0.1	0.6	0.2	0.0	18.7	0.1	1.7	4.1	0.0	2.5	4.0	2.6	17.1	0.8	0.3	0.1	0.1	49.0	19.9	28.6	7.7	0.2	48.3	1.3	19.7	0.0	0.9	20.1	4.8	0.3	0.4	0.3	8.0	0.3	9.1	1.0	0.3	11.6	0.3	0.1	0.8	0.2	106.7	0.1	34.0	1.6	4.5	23.8	5.1	0.5	44.1	1.1	312.7	0.5	0.5	89.9	415.7	1.3	1.1	11.0	8.4	33.7	899.0	1.1	11.4	31.4	34.7	10.5	47.8	38.7	15.5	31.6	15.3	31.0	15.9	15.9	38.7	0.6	0.0	7.4	3.6	149.0	46.3	16.0	34.0	118.4	2.5	31.6	28.6	18.2	4.3	11.7	1.8	0.0	0.6	140.3	7.5	5.9	9.5	12.0	3.9	2.0	1.4	19.8	69.6	180.8	6.4	0.5	3.6	5.1	4.8	10.1	67.4	0.7	0.1	43.2	52.2	153.2	13.6	6.1	7.0	86.1	5.0	0.3	20.5	16.0	11.2	16.0	0.3	0.0	3.5	4.6	4.7	12.5	0.0	6.0	11.7	16.2	0.5	5.5	0.3	0.0	0.2	2.0	2.9	6.9	120.3	69.9	0.8	4.6	1.0	28.9	5.8
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"BAF chromatin remodeling complex subunit BCL11B"	Q9C0K0	14	99169287-99272197	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9"	"Group enriched"	"Detected in many"	8	"gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"JURKAT: 38.3;MOLT-4: 47.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 64.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 30.0"	HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.4	0.3	8.0	5.1	21.2	4.9	1.1	0.0	17.2	0.9	0.0	1.2	2.0	0.2	0.5	4.3	0.3	0.9	0.1	18.9	1.1	0.3	0.4	1.1	10.2	0.3	0.8	0.2	0.1	0.0	0.2	0.1	0.0	0.5	1.4	0.0	1.7	0.3	0.2	15.0	3.5	0.2	1.5	4.4	1.9	0.5	2.0	36.6	0.8	0.0	7.5	1.3	2.9	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.0	0.0	38.3	0.0	4.1	0.0	2.8	47.3	0.8	0.5	3.6	0.0	7.0	0.0	0.0	0.0	2.6	3.7	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.2	0.0	2.6	0.1	0.0	2.0	0.7	0.0	0.0	0.0	0.1	2.0	0.0	1.8	0.0	2.8	2.4	0.0	0.0	4.6	3.1	0.0	0.3	0.0	0.0	2.0	0.8	8.0	21.2	0.0	17.2	18.9	1.1	0.3	0.8	0.0	1.5	2.0	3.9	1.3	3.2	0.0	1.3	6.4	62.8	1.6	6.3	73.4	0.4	4.3	4.4	3.8	4.3	1.3	0.0	0.0	0.1	44.2	3.8	1.9	0.2	0.2	0.2	0.2	1.2	1.2	5.3	57.5	0.5	0.0	3.3	2.0	0.3	5.1	0.2	3.3	0.3	0.3	0.0	105.7	4.9	2.0	1.0	11.4	0.4	0.6	4.0	5.4	1.0	4.9	0.0	51.5	32.2	2.0	1.1	5.4	0.0	24.4	0.6	10.1	0.5	0.3	0.1	0.0	0.5	1.9	1.6	5.8	42.7	71.3	0.0	133.4	0.1	9.7	0.6
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2 apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 271.6;Inhibitory neurons: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"B-cells: 5.4;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.8	1.9	5.5	10.2	7.8	5.0	9.6	4.7	3.4	10.7	0.0	6.2	4.4	11.6	2.9	5.9	11.8	6.5	5.3	2.9	6.6	6.7	2.1	3.7	14.7	11.2	7.9	14.5	3.1	13.0	4.7	4.6	7.5	6.4	5.5	2.1	3.7	7.0	16.5	4.8	8.1	6.6	7.9	17.9	3.8	1.5	8.2	18.3	24.0	8.8	14.6	5.4	7.7	5.7	1.7	0.3	6.8	5.9	6.7	1.3	2.4	1.0	0.7	2.4	2.0	3.5	0.4	0.3	1.1	0.9	4.7	0.4	6.7	0.9	1.5	44.2	1.6	0.5	2.0	0.7	2.0	43.7	5.6	1.7	0.8	3.3	5.8	1.1	0.7	4.3	0.8	72.9	2.2	1.4	9.8	10.7	1.5	0.8	1.3	39.5	1.9	26.5	7.4	8.5	7.2	6.4	0.3	0.3	8.5	1.4	0.3	29.9	0.3	9.9	3.3	0.9	5.1	217.4	40.1	2.9	1.9	24.9	6.0	0.3	0.0	0.0	1.9	0.0	7.6	5.4	6.3	3.4	0.1	3.1	3.3	3.2	0.0	0.2	0.3	0.2	8.5	1.3	5.5	7.8	4.7	3.4	2.9	6.6	11.2	7.9	7.5	7.9	8.2	5.7	7.1	0.0	1.1	271.6	84.9	19.5	33.6	1.6	13.6	1.9	39.7	19.7	17.4	18.6	2.4	7.3	0.0	14.0	39.9	2.7	15.6	3.7	0.4	9.8	9.8	5.9	5.4	3.8	60.7	0.0	0.7	15.8	5.6	24.9	15.8	38.8	3.9	1.2	9.4	0.0	102.3	10.5	24.4	15.0	29.6	1.9	8.7	29.0	46.2	88.1	19.7	18.8	18.6	76.4	56.7	0.2	5.9	13.9	50.1	41.6	0.9	18.0	0.1	0.6	26.3	48.8	19.7	0.3	1.3	6.2	17.6	49.1	76.1	24.1	9.8	76.2
BCL2L2	"BCL-W, KIAA0271, PPP1R51"	ENSG00000129473	"BCL2 like 2"	Q92843	14	23298790-23311751	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB040539, HPA048740"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB040539: , HPA048740: "	"unprognostic (8.23e-3)"	"unprognostic (9.85e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.99e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.60e-2)"	"unprognostic (5.38e-2)"	48.5	36.6	102.4	26.0	95.3	13.9	35.6	83.7	112.4	30.2	61.8	86.9	28.5	43.0	30.5	46.8	35.4	24.7	37.3	89.8	88.8	35.0	20.9	34.6	13.9	94.8	94.0	31.8	53.3	52.9	38.1	23.8	91.7	47.4	31.8	51.9	52.2	45.5	24.2	46.5	34.3	41.5	101.0	20.5	54.2	25.1	108.3	10.7	38.5	19.9	16.4	55.6	34.9	92.4	24.1	23.0	25.6	19.0	43.4	39.2	19.3	43.9	28.5	21.8	24.9	16.3	42.6	16.8	14.2	26.6	27.4	43.9	15.9	28.1	29.4	8.9	12.7	18.4	44.4	30.3	26.6	20.7	30.0	30.3	54.0	17.6	27.1	30.6	18.6	2.9	17.3	18.0	27.8	17.8	1.6	14.5	8.0	33.4	41.3	12.8	28.1	8.2	19.7	45.5	31.7	18.0	20.8	31.3	31.2	15.6	20.6	15.5	37.1	35.1	24.8	27.6	23.1	22.0	12.7	2.2	21.6	16.0	43.5	0.0	0.4	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.3	102.4	95.3	83.7	112.4	89.8	88.8	94.8	94.0	91.7	101.0	108.3	92.4	9.2	9.6	13.1	0.0	2.6	8.7	9.5	12.7	5.7	20.0	11.0	8.0	28.9	4.3	13.6	5.5	25.0	5.3	3.5	16.8	13.7	8.0	20.1	11.1	10.4	10.8	18.6	2.1	0.0	18.3	4.0	10.4	9.7	12.1	5.7	12.0	11.4	7.2	5.5	20.2	0.0	16.8	6.1	8.4	4.0	6.1	11.1	5.5	7.2	0.0	7.5	7.4	2.1	0.0	0.0	25.5	11.0	21.4	4.5	17.2	16.3	9.2	12.2	12.7	6.6	12.6	15.5	0.5	0.9	10.8	11.1	5.6	1.5	8.9	10.5	17.6
BCL2L2-PABPN1		ENSG00000258643	"BCL2L2-PABPN1 readthrough"	Q92843	14	23306833-23326175	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Excitatory neurons: 10.9;Inhibitory neurons: 14.4;Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 13.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA000637, HPA048740"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553, HPA048740: "	"unprognostic (1.32e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-3)"	"unprognostic (9.82e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.05e-6)"	"unprognostic (4.39e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.84e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.72e-7)"	"unprognostic (3.13e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.95e-2)"	8.2	4.1	8.8	4.2	10.8	10.7	9.6	7.2	20.6	10.9	1.3	17.2	10.4	8.3	2.0	11.6	10.8	10.9	7.2	9.8	8.3	3.5	4.2	7.3	4.3	8.7	9.3	4.6	12.4	8.0	7.1	10.9	9.0	12.1	6.3	5.6	24.9	22.1	4.8	11.0	8.8	7.7	10.1	6.0	10.3	12.5	11.7	1.2	8.7	0.9	4.1	13.4	7.5	15.8	11.4	18.0	15.2	31.3	15.3	29.3	14.0	13.4	27.3	39.8	44.2	10.1	38.0	3.5	4.0	21.2	22.5	24.2	16.9	21.4	17.9	8.5	21.6	4.7	11.2	26.0	14.5	10.0	29.7	37.4	29.7	17.6	6.1	27.3	14.7	0.2	8.2	8.2	19.3	18.1	0.4	7.5	17.3	10.3	18.2	7.9	4.0	5.9	10.3	10.1	16.0	10.0	9.8	22.6	15.2	10.8	8.7	8.2	15.4	18.7	8.4	17.1	12.8	4.9	6.6	1.1	25.2	10.5	19.4	0.8	2.5	0.1	0.1	1.2	0.0	0.5	0.0	0.0	0.8	1.0	0.1	0.0	0.5	1.6	1.4	0.4	0.0	0.6	8.8	10.8	7.2	20.6	9.8	8.3	8.7	9.3	9.0	10.1	11.7	15.8	0.0	3.2	3.9	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	10.9	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.8	0.0	0.0	0.0	16.6	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
BCL3	"BCL4, D19S37"	ENSG00000069399	"BCL3 transcription coactivator"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 172.4;Squamous epithelial cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.5;neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.3;Karpas-707: 54.1;SiHa: 69.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: AB_2680074"	"prognostic favorable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	65.1	43.6	6.7	25.0	6.3	54.0	37.2	6.4	7.8	26.8	7.9	39.7	32.2	26.8	1.7	67.5	35.9	13.4	36.3	5.9	7.2	56.6	161.8	87.3	11.6	11.6	7.8	23.7	37.4	3.1	25.2	7.9	8.1	43.4	9.3	1.3	40.9	8.9	17.8	28.3	44.2	11.7	8.0	58.7	35.9	9.6	8.5	6.6	36.8	4.9	12.7	37.6	37.7	6.4	9.8	33.5	0.7	17.5	6.1	12.6	1.7	5.8	6.3	3.7	5.3	6.9	17.8	9.5	13.4	11.5	18.5	10.5	2.4	9.9	2.3	67.3	0.6	1.1	18.9	9.3	14.6	0.7	28.2	22.5	7.8	8.1	9.9	16.6	10.0	0.0	1.2	54.1	2.2	8.4	0.0	7.4	0.9	15.1	12.8	4.3	6.5	3.4	16.5	19.9	0.0	0.9	69.7	35.7	1.9	1.1	12.7	7.6	16.8	11.8	11.6	18.5	2.2	50.1	21.4	10.1	22.1	1.2	9.2	0.4	2.7	5.5	0.8	1.8	1.1	1.5	1.0	1.3	2.6	1.3	0.5	0.7	19.8	2.3	1.1	3.1	1.7	1.0	6.7	6.3	6.4	7.8	5.9	7.2	11.6	7.8	8.1	8.0	8.5	6.4	56.3	19.2	51.3	2.6	43.9	46.7	38.8	22.4	172.4	2.3	106.8	62.0	3.0	42.9	28.6	12.9	0.0	0.6	33.4	60.6	9.8	31.8	11.8	49.4	34.2	76.3	21.5	4.2	0.5	68.7	6.8	47.8	128.0	70.0	38.0	1.4	38.9	35.5	16.1	8.4	0.8	56.2	8.2	30.5	110.8	2.7	13.4	86.6	40.9	1.0	28.4	2.2	2.1	0.0	0.1	43.0	40.0	4.5	100.4	58.9	56.6	17.7	20.5	0.6	6.6	43.3	40.1	0.5	2.0	146.0	61.1	1.4	46.2	0.3	34.5	51.2
BCL6	"BCL5, BCL6A, LAZ3, ZBTB27, ZNF51"	ENSG00000113916	"BCL6 transcription repressor"	P41182	3	187721377-187745725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Immunity, Inflammatory response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 485.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"neutrophil: 269.1;non-classical monocyte: 76.4"	"Group enriched"	"Detected in all"	7	"granulocytes: 269.1;monocytes: 76.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 166.4;HSkMC: 113.9;U-698: 231.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000307, HPA004899, HPA050645"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199"	"unprognostic (5.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.62e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.27e-9)"	"unprognostic (5.22e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.58e-2)"	143.0	49.4	54.3	53.9	53.4	123.7	126.9	85.9	57.9	100.0	35.0	87.1	7.5	68.1	16.4	44.6	140.7	45.6	72.1	50.9	68.7	37.0	65.3	110.5	56.0	104.1	69.4	65.6	49.2	11.3	44.8	15.3	74.2	57.5	10.3	34.2	70.3	22.2	485.9	160.7	34.4	43.0	55.9	106.3	58.4	18.6	69.0	43.2	50.4	96.6	47.7	90.6	81.5	64.1	5.1	13.8	14.4	3.2	98.1	78.0	14.9	16.5	39.2	18.4	19.4	9.4	7.6	166.4	11.5	21.0	11.7	7.7	4.4	10.6	15.3	33.8	5.1	0.2	6.7	22.5	51.5	2.1	0.9	113.9	68.8	22.7	32.9	60.1	10.2	4.2	1.6	27.6	18.2	5.7	5.5	1.3	1.4	3.0	10.3	45.4	7.0	0.8	13.6	23.2	3.1	0.2	18.8	8.1	11.0	30.2	35.3	5.9	21.2	43.7	7.1	16.6	7.5	21.2	7.2	231.6	24.2	6.0	31.7	8.8	33.0	18.9	5.5	37.3	5.4	6.6	3.4	5.0	24.6	15.3	2.1	2.3	269.1	3.9	76.4	4.0	3.1	30.7	54.3	53.4	85.9	57.9	50.9	68.7	104.1	69.4	74.2	55.9	69.0	64.1	35.7	19.2	67.4	66.0	22.7	47.3	14.7	18.8	205.5	10.9	55.3	54.6	71.4	14.3	28.9	16.5	20.9	1.4	36.0	3.5	0.0	12.2	13.3	36.2	26.7	25.0	4.8	3.2	7.6	12.5	2.7	57.3	12.2	51.4	11.4	9.4	15.0	51.2	11.9	0.0	19.6	2.3	16.2	67.5	74.4	8.6	28.9	48.1	35.6	7.5	16.8	39.1	1.0	50.8	7.8	7.9	0.3	18.8	14.2	27.9	1.2	1.5	29.5	9.7	32.9	77.0	84.9	0.4	1.2	72.4	61.5	4.1	30.0	10.3	2.8	29.7
BCL6B	"BAZF, ZBTB28, ZNF62"	ENSG00000161940	"BCL6B transcription repressor"	Q8N143	17	7023050-7030290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 37.8;Endothelial cells: 45.0;Hepatic stellate cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 53.2;HUVEC TERT2: 96.2;TIME: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059147, HPA075112"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA059147: AB_2683928, HPA075112: AB_2732279"	"unprognostic (5.61e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (8.56e-5)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.26e-2)"	29.8	5.6	8.1	5.7	7.0	0.1	15.4	6.2	9.2	5.7	4.4	4.4	3.2	7.7	0.7	3.8	5.1	13.4	23.3	6.5	6.9	13.4	4.0	28.9	5.5	7.8	7.1	2.9	3.8	3.1	5.5	19.9	7.3	4.5	2.2	0.6	4.0	3.5	11.5	4.4	4.9	7.7	6.6	13.0	4.3	2.0	10.1	2.0	12.0	14.7	2.1	7.9	4.8	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	18.2	0.0	0.0	0.5	0.0	53.2	0.0	0.0	0.0	0.1	0.0	96.2	0.2	3.4	0.4	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	38.2	0.8	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.2	9.2	6.5	6.9	7.8	7.1	7.3	6.6	10.1	6.7	37.8	3.2	4.2	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	45.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	23.6	0.2	0.1	0.0	0.0	0.2	0.0	1.9	2.3	0.0	0.0	0.3	3.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.2	0.0	0.9	0.8	0.6	1.5	0.4	1.3	0.1	0.2	0.9	0.0	0.5
BCL7A	BCL7	ENSG00000110987	"BAF chromatin remodeling complex subunit BCL7A"	Q4VC05	12	122019422-122062044	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.9;Horizontal cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 1.0;naive B-cell: 2.1;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	14	"B-cells: 2.1;dendritic cells: 2.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 71.9;MOLT-4: 71.4;U-698: 95.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019762	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"		"HPA019762: AB_10962489"	"unprognostic (3.27e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (5.18e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.86e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.51e-2)"	3.1	2.8	9.2	5.2	10.8	9.8	5.7	8.9	11.2	5.1	0.0	4.0	2.5	4.5	6.7	2.8	8.4	2.4	7.6	9.6	3.2	9.1	4.9	3.9	16.2	3.5	4.7	3.7	9.1	9.1	5.2	1.9	3.3	5.1	2.9	4.1	7.0	5.9	11.5	8.2	3.0	3.3	2.9	5.8	3.8	2.2	4.5	24.7	9.0	8.9	15.4	4.8	4.8	9.1	6.0	6.2	29.9	17.9	2.2	1.1	6.0	3.2	3.1	5.3	4.9	3.2	2.4	71.9	9.2	2.7	2.7	8.8	22.7	16.4	5.3	0.0	25.0	3.5	0.4	5.5	6.5	13.8	8.1	4.7	21.3	3.9	26.7	8.1	7.7	42.3	18.3	0.0	4.3	10.7	71.4	1.3	10.7	9.7	11.0	33.2	8.5	1.2	13.4	14.3	26.5	28.9	3.4	0.8	13.1	7.7	17.4	13.6	6.9	0.7	5.1	10.0	6.1	9.4	5.4	95.8	2.1	9.3	6.7	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.3	2.1	0.1	0.1	0.1	0.0	0.0	2.8	0.0	0.1	9.2	10.8	8.9	11.2	9.6	3.2	3.5	4.7	3.3	2.9	4.5	9.1	4.6	22.4	9.2	8.5	51.6	35.9	77.9	26.5	22.8	41.8	32.7	33.5	28.6	42.9	19.0	38.6	18.8	1.5	38.1	5.9	58.7	33.5	6.9	39.3	10.9	5.6	21.5	18.7	15.9	10.9	0.9	11.9	7.1	26.8	10.8	16.6	5.3	18.6	4.2	107.7	19.9	8.6	16.2	2.2	14.3	18.7	14.0	9.8	12.4	1.9	6.2	5.5	1.0	13.6	16.2	10.0	6.9	7.9	6.8	29.9	1.6	31.3	20.7	14.0	6.6	34.7	16.6	0.7	7.7	5.3	30.1	0.5	3.2	42.9	11.7	32.3
BCL7B		ENSG00000106635	"BAF chromatin remodeling complex subunit BCL7B"	Q9BQE9	7	73536356-73557690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Wnt signaling pathway"		"Allergen, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049943, HPA058069"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA049943: AB_2680963, HPA058069: AB_2683594"	"unprognostic (2.79e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.32e-1)"	35.6	23.8	34.9	18.7	35.0	90.0	18.5	28.1	43.5	16.3	28.3	32.6	21.8	15.5	17.4	27.5	16.6	22.5	49.5	36.5	34.1	21.9	25.1	27.4	24.4	30.6	31.2	9.0	25.6	30.3	20.9	21.7	29.7	17.8	16.4	17.7	16.0	23.5	66.0	11.1	23.6	29.8	28.3	23.0	20.6	20.5	33.4	22.4	22.1	55.8	19.4	33.4	11.4	34.3	67.8	46.9	26.7	47.8	21.5	34.0	27.1	56.1	58.9	58.0	52.9	52.0	73.8	56.7	14.0	58.7	84.7	30.4	19.4	45.7	42.7	73.9	27.5	31.5	28.7	28.0	61.3	54.3	85.3	22.8	45.0	59.5	58.7	23.9	38.4	31.7	50.6	65.0	41.6	79.5	93.0	71.2	46.5	43.0	67.7	49.2	28.6	67.6	46.5	51.8	59.7	57.9	49.6	85.0	62.3	11.3	53.0	73.3	39.6	69.8	44.7	47.9	84.1	37.0	35.9	105.2	68.7	82.8	89.0	13.7	13.3	19.7	11.4	15.8	13.8	11.7	13.1	15.3	13.5	17.6	13.7	11.1	6.5	21.2	20.3	15.9	11.4	8.3	34.9	35.0	28.1	43.5	36.5	34.1	30.6	31.2	29.7	28.3	33.4	34.3	50.4	32.1	20.7	6.8	59.8	64.6	81.9	18.7	39.3	27.5	37.4	32.1	29.5	24.3	17.5	16.5	6.2	72.5	55.9	63.3	54.8	46.7	8.0	35.4	16.8	37.3	34.6	17.9	10.3	45.8	43.6	30.4	21.9	31.6	32.4	21.5	34.2	18.1	51.0	42.1	8.8	40.6	32.6	37.5	46.4	6.7	25.7	48.3	32.0	6.5	41.1	32.4	62.8	6.0	10.0	67.9	58.3	30.5	35.7	61.6	50.4	47.0	15.7	21.8	46.0	52.4	46.7	64.1	71.6	28.7	57.7	101.8	58.3	27.3	37.6	74.1
BCL7C		ENSG00000099385	"BAF chromatin remodeling complex subunit BCL7C"	Q8WUZ0	16	30833626-30894302	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018676, HPA052654"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA018676: AB_1845322, HPA052654: AB_2681903"	"unprognostic (2.27e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.18e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.85e-1)"	30.2	18.5	41.9	22.2	43.8	40.7	28.8	42.9	52.2	35.4	38.3	32.2	22.3	27.2	14.9	25.8	28.1	21.4	32.6	39.1	42.9	39.4	19.0	20.8	27.6	46.2	44.2	40.5	23.2	20.6	21.3	18.0	45.8	27.3	15.6	7.9	33.2	35.0	34.8	32.1	25.0	23.2	42.4	23.6	23.9	24.5	43.7	19.5	24.6	25.5	21.3	30.2	27.2	42.8	84.3	51.4	46.4	132.7	34.5	52.3	32.4	54.8	51.9	65.1	47.2	47.2	54.4	1.8	79.9	69.1	35.7	44.7	22.9	58.0	26.0	53.0	101.2	18.5	37.8	77.0	49.1	34.3	42.5	60.1	58.5	43.3	22.4	27.6	65.9	37.1	46.2	27.5	54.1	120.3	35.9	103.4	26.8	48.7	84.5	74.0	48.7	66.8	38.2	30.1	30.8	52.5	56.2	51.8	42.5	22.7	83.8	53.8	35.4	85.8	81.0	52.0	53.3	28.2	25.9	37.2	57.2	61.1	61.3	8.1	4.6	8.0	7.7	3.1	8.8	9.0	6.7	9.5	4.3	5.8	5.4	6.5	2.9	2.9	3.4	5.7	7.3	2.4	41.9	43.8	42.9	52.2	39.1	42.9	46.2	44.2	45.8	42.4	43.7	42.8	76.4	12.8	11.4	21.9	31.5	39.6	80.5	21.9	37.5	11.4	67.7	100.5	17.2	47.1	14.0	71.7	6.2	54.3	66.8	45.5	217.2	36.2	21.5	37.2	49.4	52.8	37.3	33.4	7.6	35.5	58.5	67.7	23.9	42.5	2.5	55.9	51.4	26.5	57.1	13.5	20.8	42.8	16.2	38.6	49.1	26.9	55.9	39.5	55.2	16.9	65.6	49.1	64.9	22.1	21.4	48.1	25.2	51.6	17.2	51.4	42.0	78.0	8.8	13.8	19.7	47.3	88.9	5.7	3.5	53.3	42.6	25.0	56.4	49.4	64.3	77.1
BCL9		ENSG00000116128	"BCL9 transcription coactivator"	O00512	1	147541501-147626216	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Oligodendrocyte precursor cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020274	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA020274: AB_2670400"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	3.7	6.2	6.1	4.5	5.6	3.2	3.9	7.6	5.8	10.8	1.1	8.6	4.8	14.4	13.7	4.9	16.4	4.6	7.7	5.6	7.1	6.8	3.5	4.5	3.9	6.0	5.2	14.6	5.0	10.8	7.2	4.1	4.1	9.1	6.9	7.4	7.5	11.1	8.1	7.1	4.7	13.9	4.1	3.1	6.2	5.5	4.9	11.1	6.8	6.2	4.4	7.1	6.5	4.8	5.5	5.3	36.4	27.2	4.1	4.8	7.1	4.4	6.9	4.7	4.6	6.9	8.1	5.2	9.6	4.1	7.9	4.3	23.3	8.0	4.4	12.4	6.5	2.5	5.7	4.6	3.5	1.6	7.2	4.8	6.7	5.6	4.1	8.4	7.4	16.8	4.9	8.3	4.2	12.4	13.1	1.2	43.2	11.0	11.5	13.8	9.2	10.1	18.4	6.0	10.0	21.4	4.9	9.0	8.6	33.3	11.4	2.5	5.5	3.3	15.5	9.4	7.1	36.6	10.0	9.7	8.4	1.4	16.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.2	6.1	5.6	7.6	5.8	5.6	7.1	6.0	5.2	4.1	4.1	4.9	4.8	4.6	0.0	2.2	39.5	2.1	3.1	6.0	2.8	14.8	12.1	10.1	5.0	7.4	7.2	2.9	12.9	2.1	2.1	1.2	3.2	11.7	4.4	10.5	21.0	17.5	4.1	28.3	0.0	12.9	4.7	2.5	7.5	2.6	24.6	8.8	12.8	5.7	3.7	1.3	6.7	20.7	7.9	4.1	1.9	1.4	5.3	9.6	1.9	0.0	8.4	1.1	4.8	4.1	31.2	24.2	4.5	1.4	7.9	4.4	6.1	1.3	7.0	4.8	3.1	0.0	6.8	7.3	4.0	8.6	9.7	3.7	2.1	3.6	4.8	6.6	3.3
BCL9L	"B9L, Bcl9-2, DLNB11"	ENSG00000186174	"BCL9 like"	Q86UU0	11	118893875-118925608	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049370, HPA053421"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA049370: AB_2680732, HPA053421: AB_2682145"	"unprognostic (1.67e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.90e-3)"	24.3	24.8	5.7	24.1	4.6	20.5	21.1	17.7	6.7	28.5	4.7	23.8	17.4	32.3	4.7	26.4	29.6	18.1	20.9	4.9	1.2	12.1	10.8	24.4	19.5	3.3	3.7	29.4	21.3	8.5	7.8	24.4	1.3	18.1	5.4	2.9	25.9	16.6	29.0	30.8	19.8	17.7	1.1	19.6	18.5	6.4	5.3	13.7	16.8	12.3	12.8	24.6	24.8	1.8	40.5	71.6	10.2	18.5	32.2	30.8	64.3	54.6	41.4	16.9	9.9	77.0	78.2	11.0	70.8	57.4	68.7	76.0	5.0	99.9	4.4	13.4	2.6	10.9	41.2	26.8	36.1	3.7	10.0	39.2	60.8	20.3	40.5	32.5	15.1	6.4	14.3	12.4	11.9	67.2	8.2	3.1	12.1	24.1	40.8	17.2	4.3	7.4	17.5	27.6	5.5	8.1	76.7	114.2	10.3	18.0	90.3	4.5	51.1	53.7	40.7	16.4	46.9	2.6	0.1	3.3	29.0	12.5	31.3	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.0	0.2	5.7	4.6	17.7	6.7	4.9	1.2	3.3	3.7	1.3	1.1	5.3	1.8	16.3	16.0	11.5	9.1	18.3	38.7	9.3	18.5	13.1	20.0	23.8	16.5	2.4	15.7	14.1	7.3	4.2	12.7	42.2	10.9	0.0	14.0	0.1	36.6	31.5	12.3	5.4	1.3	3.9	15.1	8.4	14.1	13.3	61.9	2.5	12.2	11.4	9.7	4.4	13.5	4.8	5.4	4.1	6.1	11.6	0.5	14.6	8.0	7.2	12.2	16.5	5.5	32.0	5.0	1.1	29.3	7.4	14.3	14.8	23.5	10.8	3.3	14.0	3.1	26.3	12.4	26.4	0.6	1.4	34.7	45.3	35.4	33.0	8.6	6.8	11.1
BCLAF3	CXorf23	ENSG00000173681	"BCLAF1 and THRAP3 family member 3"	A2AJT9	X	19912860-19970298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Alveolar cells type 2: 17.0;Granulosa cells: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027215	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA027215: AB_1847358"	"unprognostic (2.46e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.30e-2)"	"prognostic favorable (5.56e-4)"	4.6	3.0	3.5	3.8	4.0	3.6	5.2	10.2	3.8	4.7	2.0	5.2	3.4	5.5	8.3	3.5	4.0	4.2	3.4	4.0	3.1	4.3	2.7	4.5	4.3	3.4	3.4	5.0	3.4	5.7	3.4	3.3	3.6	5.0	5.9	6.4	3.4	5.1	4.5	6.0	4.4	4.0	2.6	4.1	3.9	2.6	5.0	5.3	4.7	5.2	4.2	4.2	4.1	5.0	4.8	3.8	5.1	8.7	4.5	6.3	2.8	4.4	3.7	2.8	3.9	3.4	5.0	4.9	2.6	5.2	4.9	3.5	4.6	3.3	5.3	3.2	3.7	3.1	4.3	3.4	6.3	4.4	5.3	5.7	5.0	3.1	4.2	6.5	3.2	3.9	2.3	11.5	3.2	3.6	3.1	2.9	4.5	4.5	4.8	1.3	5.1	6.7	7.3	4.7	3.1	4.8	5.6	4.6	4.5	9.5	5.5	3.9	6.0	4.7	2.3	11.4	3.3	3.6	3.0	4.0	4.0	2.4	4.1	1.8	0.3	0.6	0.4	0.4	0.5	0.4	0.3	0.4	0.2	0.8	0.3	0.4	1.5	0.4	0.4	0.7	0.2	0.1	3.5	4.0	10.2	3.8	4.0	3.1	3.4	3.4	3.6	2.6	5.0	5.0	10.8	16.0	17.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	8.8	8.1	0.0	0.0	7.4	9.2	0.0	4.5	8.9	0.0	1.9	6.1	0.0	8.2	9.4	3.4	0.0	0.0	0.0	3.6	3.5	5.0	0.0	10.9	6.3	12.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	6.1	0.0	0.0	3.6	0.0	0.0	6.2	4.4	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	4.5	3.9	7.4	0.0	0.0
BCOR	"FLJ20285, KIAA1575"	ENSG00000183337	"BCL6 corepressor"	Q6W2J9	X	40049815-40177329	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA056308, HPA073591"			Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA056308: AB_2683095, HPA073591: AB_2732227"	"unprognostic (2.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (3.82e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.83e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.55e-1)"	10.2	14.0	2.4	8.3	3.8	22.2	10.0	3.0	3.7	11.5	3.8	14.7	8.8	11.0	5.4	14.4	10.9	7.5	14.0	1.9	2.9	12.9	14.6	12.3	15.0	4.5	3.3	20.0	13.9	14.0	12.0	12.3	2.8	12.5	6.8	14.2	11.9	8.4	20.6	14.7	11.2	8.7	2.0	10.7	12.2	9.0	3.8	25.8	15.6	7.2	12.5	10.9	11.4	5.1	35.5	21.9	45.1	50.5	4.7	3.3	7.8	11.4	18.6	14.4	11.7	8.9	13.5	31.3	13.3	21.7	8.9	31.0	70.8	9.3	12.0	56.0	67.4	36.2	31.8	31.7	7.6	28.7	19.3	5.6	12.0	16.7	7.0	20.0	19.8	20.2	94.7	74.3	14.8	17.9	65.8	27.2	43.4	14.2	33.9	32.3	47.5	36.2	17.3	20.8	32.5	57.6	25.5	20.5	15.5	18.9	22.8	51.5	16.8	15.5	18.5	23.1	12.8	39.1	36.1	33.8	13.1	23.5	24.6	4.6	3.1	2.1	3.8	3.6	2.7	1.9	2.5	2.4	4.5	2.5	2.1	2.3	0.5	3.3	3.9	1.4	2.7	8.8	2.4	3.8	3.0	3.7	1.9	2.9	4.5	3.3	2.8	2.0	3.8	5.1	20.3	22.4	24.5	24.2	16.8	14.7	4.7	8.0	33.6	35.7	10.4	13.1	9.2	10.0	5.9	11.0	12.5	4.5	20.6	6.4	1.9	5.4	2.1	24.1	8.6	15.9	16.3	20.4	21.6	10.5	6.3	11.9	11.7	25.6	24.6	12.8	16.4	10.7	7.5	15.2	20.4	11.4	10.2	8.4	25.6	2.4	10.5	11.5	5.4	27.2	12.0	7.6	7.2	27.6	31.3	6.4	3.9	7.9	16.9	7.6	6.5	4.1	7.1	23.8	0.0	16.4	17.4	2.0	13.2	21.0	13.9	2.1	21.1	6.4	8.8	2.8
BCORL1	"CXorf10, FLJ11362"	ENSG00000085185	"BCL6 corepressor like 1"	Q5H9F3	X	129981107-130058071	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Syncytiotrophoblasts: 93.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.6;HAP1: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031775, HPA031777, HPA068568"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Plasma membrane"	"HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007"	"unprognostic (8.07e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (2.20e-5)"	"unprognostic (4.58e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.41e-2)"	3.5	3.1	2.4	2.6	2.5	5.6	2.1	4.5	2.6	3.5	0.4	2.9	2.6	4.5	2.2	2.6	4.3	2.0	2.8	2.4	2.7	2.6	2.0	2.9	1.7	2.9	2.1	5.5	4.5	5.8	2.6	11.3	1.9	3.2	2.0	2.0	3.3	3.7	3.3	2.9	2.8	4.3	1.4	2.8	2.2	6.5	2.1	2.3	4.5	3.3	1.7	2.6	2.6	1.9	3.4	8.0	18.7	29.6	10.6	8.0	5.3	4.5	5.2	5.7	6.5	9.6	2.2	1.5	9.9	8.8	5.5	2.0	44.2	1.8	5.2	3.4	6.7	16.2	3.9	3.1	5.2	3.8	4.8	4.9	3.6	11.0	0.6	8.3	6.8	5.2	7.7	16.4	3.6	1.9	6.0	11.3	5.2	2.6	5.9	12.6	7.5	2.2	3.0	0.4	3.2	10.9	2.3	0.7	3.0	9.4	6.7	5.9	5.9	4.5	6.0	5.7	4.5	5.1	10.1	2.5	2.9	7.8	2.2	0.0	0.3	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.0	0.2	2.4	2.5	4.5	2.6	2.4	2.7	2.9	2.1	1.9	1.4	2.1	1.9	5.4	0.0	2.8	6.8	2.9	11.9	2.8	2.2	10.8	1.7	12.5	7.5	7.1	4.3	1.9	7.3	0.0	14.1	6.1	3.7	0.0	3.0	0.5	3.7	7.0	7.9	12.0	2.5	4.6	1.1	4.8	6.9	2.6	4.7	7.0	4.3	4.6	2.8	3.2	8.4	4.4	2.4	2.0	2.2	5.9	1.2	4.7	2.7	7.2	5.6	3.0	2.3	4.1	4.5	8.5	2.6	1.9	3.8	3.2	3.8	4.2	2.3	2.9	1.3	6.6	8.0	6.1	3.4	6.9	9.2	11.5	93.4	4.9	0.9	3.6	2.8
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR activator of RhoGEF and GTPase"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.15e-10)"	"unprognostic (1.47e-1)"	"unprognostic (7.10e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.43e-2)"	19.4	11.1	34.3	11.0	65.7	34.6	17.4	15.9	30.7	14.3	10.6	11.7	10.0	12.3	16.1	24.5	12.1	9.3	12.2	45.0	22.2	21.1	13.8	18.6	13.7	27.1	26.5	9.4	14.6	20.6	25.0	10.3	24.1	11.8	7.6	7.4	18.3	10.1	5.8	23.5	10.2	8.8	20.9	11.4	16.1	11.0	35.0	14.7	19.7	5.7	10.8	15.3	14.3	14.1	47.6	20.1	30.3	31.2	17.7	12.1	45.6	16.8	15.7	15.2	12.2	35.6	18.7	32.9	30.5	14.4	14.7	47.6	3.6	46.8	4.3	63.3	32.3	28.8	27.7	28.6	22.9	26.9	14.6	10.2	31.1	22.8	19.8	27.0	53.6	23.3	112.5	15.1	7.0	31.3	25.4	21.4	25.8	37.4	19.5	32.9	12.4	21.7	23.7	29.6	27.7	26.3	30.7	26.1	12.6	19.3	16.6	21.7	61.4	9.1	1.0	14.9	14.0	3.4	14.8	11.7	23.4	20.1	14.3	0.0	0.5	0.0	3.1	0.2	1.1	0.6	1.5	1.6	0.4	0.6	1.3	1.7	0.5	1.5	0.5	0.4	0.8	1.4	34.3	65.7	15.9	30.7	45.0	22.2	27.1	26.5	24.1	20.9	35.0	14.1	19.3	9.6	11.5	51.2	4.5	15.4	11.9	18.2	6.2	22.9	17.1	9.9	7.5	17.2	20.9	18.4	22.9	14.0	23.9	17.7	9.8	14.4	5.6	22.1	8.0	27.8	19.9	5.5	24.6	16.6	6.8	7.1	11.7	31.4	10.8	9.9	70.6	22.1	7.2	23.5	20.7	13.9	12.2	9.3	11.1	13.5	8.7	9.2	5.4	18.7	6.6	13.2	15.5	32.2	7.0	27.7	8.1	5.7	10.7	11.8	10.7	18.2	12.5	9.4	0.0	4.0	6.8	2.7	7.3	9.3	15.8	10.8	10.3	10.0	13.7	13.3
BDP1	"HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR"	ENSG00000145734	"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB"	A6H8Y1	5	71455651-71567820	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064166, HPA077984"			Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA064166: , HPA077984: "	"unprognostic (4.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.86e-2)"	2.5	2.7	0.5	1.3	0.6	0.9	3.4	0.8	1.7	1.8	0.2	0.9	0.0	1.2	0.0	0.8	1.2	2.0	0.7	0.5	0.5	2.7	1.6	1.4	1.2	0.5	0.5	1.8	4.0	0.3	0.3	1.4	0.5	1.5	2.3	5.8	0.8	1.9	2.2	1.9	0.8	2.0	0.5	0.7	1.0	0.9	0.4	2.3	2.8	3.5	1.6	0.9	0.6	0.9	1.3	2.1	10.1	3.1	1.6	5.0	7.7	0.2	0.1	2.4	0.0	0.7	1.0	0.5	9.4	4.0	11.0	0.0	3.2	0.2	11.0	0.0	0.0	1.6	7.0	3.1	4.2	4.4	0.4	0.0	0.1	0.9	5.9	5.4	7.9	0.0	12.7	0.7	5.0	3.9	0.0	1.2	0.0	1.0	7.7	10.5	1.3	7.9	4.4	6.6	1.2	7.3	0.2	2.1	6.4	7.2	0.0	0.0	16.1	5.6	0.9	3.6	0.5	3.4	8.5	0.1	0.0	3.8	8.6	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.6	0.8	1.7	0.5	0.5	0.5	0.5	0.5	0.5	0.4	0.9	69.5	60.9	96.2	52.5	79.7	44.5	63.7	26.9	55.8	78.2	57.9	55.8	110.7	38.6	57.3	35.0	102.2	37.9	101.1	38.7	1.9	48.1	37.8	88.7	109.5	71.7	58.6	59.7	116.7	36.3	50.2	57.0	57.1	127.3	58.2	66.0	28.9	32.0	31.7	94.2	96.4	39.3	24.4	27.7	36.9	21.1	58.7	53.3	28.4	57.1	62.3	41.7	76.2	57.3	86.8	52.2	26.0	54.5	72.3	57.9	18.5	10.9	39.9	125.1	52.6	104.3	74.0	85.8	60.4	60.0	43.3	48.2	86.3	69.0	50.0	64.5
BEAN1	SCA31	ENSG00000166546	"Brain expressed associated with NEDD4 1"	Q3B7T3	16	66427295-66493529	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.8;Early spermatids: 10.7;Excitatory neurons: 9.9;Extravillous trophoblasts: 10.9;Inhibitory neurons: 7.7;Late spermatids: 13.6;Oligodendrocyte precursor cells: 7.5;Spermatocytes: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.2;BEWO: 4.2;RPTEC TERT1: 9.1;U-87 MG: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053851	Uncertain		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Centrosome	"HPA053851: AB_2682280"	"unprognostic (1.92e-1)"	"unprognostic (5.79e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.18e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-2)"	0.7	0.3	1.3	0.3	1.2	0.8	0.6	2.4	4.1	0.8	0.0	0.6	0.2	0.8	0.3	0.6	1.1	0.4	0.9	2.4	0.7	0.5	0.7	0.6	0.2	5.1	1.6	0.9	0.5	0.6	0.3	1.5	5.0	0.4	0.2	1.7	0.5	0.1	1.0	0.9	0.4	0.2	0.7	0.4	0.4	1.1	3.0	0.0	0.7	0.1	0.2	0.6	0.6	1.7	0.5	0.8	0.8	9.2	0.1	0.1	4.2	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.4	0.6	0.0	0.0	0.3	1.6	0.4	0.1	1.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.4	0.0	0.1	0.3	9.1	0.3	0.0	0.1	0.1	0.1	1.4	0.5	0.1	0.0	0.1	0.2	2.0	0.0	0.3	0.3	0.0	0.0	4.8	0.1	1.0	0.2	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.1	0.0	0.9	0.0	0.0	1.3	1.2	2.4	4.1	2.4	0.7	5.1	1.6	5.0	0.7	3.0	1.7	0.1	0.0	0.0	2.0	0.0	0.1	0.3	0.2	0.0	0.6	0.2	0.6	1.4	0.0	0.2	0.0	0.0	5.8	0.0	0.1	0.0	0.4	10.7	0.2	0.2	0.4	0.0	0.0	9.9	0.0	10.9	0.4	0.0	0.2	0.0	0.3	0.7	0.0	1.0	0.0	7.7	0.0	0.0	0.8	0.4	13.6	0.3	0.1	3.6	3.7	0.0	0.0	1.0	7.5	2.6	1.7	0.0	2.2	0.0	1.7	0.0	0.1	0.1	1.4	0.0	0.2	0.3	6.6	0.3	0.0	0.1	2.9	0.1	0.5	0.0	0.8
BEGAIN	KIAA1446	ENSG00000183092	"Brain enriched guanylate kinase associated"	Q9BUH8	14	100537147-100587413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;pancreas: 23.8;pituitary gland: 19.6"	"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 143.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Group enriched"	"Detected in some"	7	"HeLa: 56.6;SH-SY5Y: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002899			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA002899: AB_1078277"	"unprognostic (2.98e-4)"	"unprognostic (2.75e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.77e-3)"	"unprognostic (1.93e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.60e-1)"	1.9	3.2	15.3	0.4	14.9	4.0	1.7	16.4	27.2	3.4	0.0	1.2	2.6	2.4	0.8	1.0	6.0	1.2	2.6	22.0	5.1	1.0	0.7	1.4	0.5	6.4	1.5	4.8	23.8	4.6	19.6	1.6	6.6	4.1	0.2	2.1	1.5	1.3	0.7	1.2	2.7	0.8	1.0	5.8	1.2	2.8	3.2	1.0	1.0	0.1	0.5	1.5	1.3	11.9	0.8	3.3	1.8	11.1	0.0	0.0	0.3	0.3	0.0	0.5	0.1	0.0	1.1	0.3	0.5	0.5	2.5	0.4	0.5	0.0	0.0	0.0	1.1	5.1	56.6	0.0	0.1	0.2	0.3	0.3	0.2	0.9	1.2	0.0	0.1	0.7	0.6	0.1	0.0	4.4	0.4	1.6	1.3	0.3	1.9	0.1	0.3	7.0	0.0	0.2	2.9	129.7	3.0	0.1	3.0	0.0	0.9	13.7	0.0	0.4	3.8	0.1	0.0	0.0	0.0	0.2	9.2	2.5	0.3	0.8	0.1	3.4	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.0	0.1	15.3	14.9	16.4	27.2	22.0	5.1	6.4	1.5	6.6	1.0	3.2	11.9	0.8	0.0	0.6	18.6	0.3	2.4	1.8	0.3	0.0	3.7	0.5	1.1	2.3	0.0	0.7	0.0	0.0	0.1	0.2	0.3	0.0	1.4	0.4	0.1	0.1	0.6	0.0	0.0	18.4	8.0	0.2	1.5	0.0	0.1	9.5	0.1	1.4	0.0	0.3	143.0	10.9	0.0	0.0	0.0	0.8	0.8	1.8	0.3	1.8	4.7	1.1	0.8	0.0	15.6	0.8	2.9	1.1	6.8	0.3	1.6	2.7	0.1	0.1	2.3	0.0	1.7	0.7	0.9	1.5	0.3	2.0	0.1	0.3	0.4	0.4	0.4
BEND3	KIAA1553	ENSG00000178409	"BEN domain containing 3"	Q5T5X7	6	107065182-107115515	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Late spermatids: 6.9"	"Cancer enriched"	"Detected in all"	4	"testis cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA017891, HPA062067"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA017891: AB_2064595, HPA062067: AB_2684675"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.37e-8)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-1)"	0.8	0.7	1.0	0.9	0.8	0.9	0.7	2.1	0.9	0.7	0.4	1.5	1.2	0.8	1.0	0.9	0.9	0.6	1.0	0.7	0.7	1.2	0.7	0.9	0.8	0.7	0.7	0.7	1.5	0.6	0.8	0.5	0.7	1.0	1.5	0.8	1.5	0.4	1.2	0.6	1.1	0.7	0.8	0.6	2.0	1.8	1.0	1.0	0.8	0.6	0.8	0.7	0.5	0.9	2.9	4.0	11.3	6.4	1.3	0.9	9.3	1.1	1.4	1.4	1.6	4.7	2.1	8.6	2.8	3.0	2.6	2.8	12.2	6.3	2.3	3.4	6.1	2.2	3.1	5.2	1.0	6.1	2.9	2.4	2.6	2.2	3.1	1.0	1.9	4.0	6.7	3.4	1.9	5.8	5.3	4.7	15.9	7.4	2.5	7.3	3.2	5.7	2.4	8.6	11.3	5.5	3.6	6.0	2.2	5.7	3.6	4.9	2.2	4.1	3.7	1.8	5.5	2.3	3.4	8.7	1.3	4.7	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	2.1	0.9	0.7	0.7	0.7	0.7	0.7	0.8	1.0	0.9	1.3	3.2	2.7	1.3	0.7	2.9	1.1	0.8	1.8	1.0	1.3	0.8	3.0	4.3	1.8	0.0	6.2	1.1	0.8	0.6	0.0	1.0	5.8	1.3	1.8	1.2	1.2	0.8	1.2	1.8	1.2	1.2	2.6	1.5	0.0	1.9	0.0	0.5	0.6	0.0	2.1	2.4	0.0	1.0	1.2	6.9	0.9	1.0	0.0	1.0	0.1	0.5	0.0	3.0	1.6	1.4	0.8	0.0	1.6	1.6	0.5	0.9	1.1	1.5	0.0	2.1	2.5	0.7	2.5	1.8	3.0	0.8	1.1	0.5	3.3	0.9
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110853-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;prostate: 3.3;testis: 9.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 8.1;Inhibitory neurons: 6.2;Muller glia cells: 10.7;Spermatogonia: 38.3"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 33.2;HEK 293: 7.9;HEL: 21.1;MOLT-4: 13.1;SuSa: 15.4;U-698: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.0	0.0	0.7	1.1	0.7	0.8	0.0	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.3	1.1	0.0	0.1	0.2	2.1	1.2	3.6	0.1	0.0	0.0	1.0	0.3	2.8	3.3	0.2	1.1	0.0	0.0	0.0	0.0	1.2	0.1	0.1	1.2	0.2	9.4	0.7	1.1	0.0	0.0	1.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	33.2	0.0	0.0	0.0	7.9	21.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	7.0	0.0	0.1	0.0	0.0	13.1	0.0	6.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	4.7	0.8	0.0	0.0	0.0	15.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	1.3	1.3	1.1	1.2	3.6	2.8	0.1	0.7	0.4	0.4	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	0.0	3.4	4.4	0.0	0.0	0.3	0.0	0.0	0.0	4.8	2.5	0.0	0.0	3.3	6.2	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.1	10.7	0.0	3.5	0.2	0.0	0.0	0.0	3.9	1.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.6	38.3	0.0	0.0	0.0	1.5	2.2	0.0	0.0
BEND6	"bA203B9.1, C6orf65, FLJ30162"	ENSG00000151917	"BEN domain containing 6"	Q5SZJ8	6	56955107-57027346	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.9;retina: 11.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.6;Excitatory neurons: 87.3;Horizontal cells: 42.1;Inhibitory neurons: 118.6;Oligodendrocyte precursor cells: 49.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 8.8"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 8.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 28.8;fHDF/TERT166: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031605, HPA052973"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA031605: AB_10602395, HPA052973: AB_2682002"	"unprognostic (4.27e-1)"	"unprognostic (7.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.18e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.84e-6)"	"unprognostic (9.27e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.98e-3)"	1.2	2.1	12.1	1.5	14.2	0.7	0.6	30.5	30.9	4.0	2.9	1.4	0.5	2.8	0.7	1.2	1.0	3.8	2.4	12.6	16.0	0.6	0.2	0.6	0.9	19.5	16.0	2.0	0.4	0.7	1.7	2.0	20.4	2.4	1.5	11.8	0.5	2.4	3.9	1.0	0.7	3.6	12.1	0.8	0.8	1.0	15.7	1.1	0.8	0.6	0.8	2.8	1.7	21.7	5.4	2.2	1.3	0.6	17.6	28.8	4.9	16.1	15.6	7.1	8.2	0.2	2.4	0.1	5.2	28.7	9.9	0.7	1.8	0.8	8.7	2.4	1.0	3.6	7.5	0.4	4.7	10.3	0.2	12.7	4.5	9.8	4.3	11.9	4.7	13.3	4.6	9.2	14.3	5.5	6.2	2.5	4.4	0.3	1.3	0.1	0.2	2.6	2.6	5.4	6.1	6.2	10.8	1.3	1.4	6.1	0.3	5.9	6.1	21.5	0.7	14.5	3.6	12.6	15.2	4.3	12.6	6.5	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	8.8	0.0	0.1	12.1	14.2	30.5	30.9	12.6	16.0	19.5	16.0	20.4	12.1	15.7	21.7	0.4	0.0	0.0	16.6	0.3	0.9	0.2	0.2	0.0	82.6	0.2	1.1	3.6	0.0	0.7	0.0	4.2	0.5	10.8	0.0	0.0	0.2	0.6	0.5	11.9	0.2	0.0	0.0	87.3	0.4	1.6	5.6	0.0	0.5	0.0	13.5	1.1	0.0	0.1	42.1	118.6	0.0	0.0	0.0	4.0	0.8	1.8	1.1	3.6	13.1	0.3	4.9	0.0	49.8	22.9	0.6	0.0	3.0	0.0	0.4	0.0	1.0	0.0	4.8	0.0	8.7	2.7	0.7	5.8	0.2	1.0	0.0	0.1	4.4	0.0	0.1
BEND7	"C10orf30, FLJ40283"	ENSG00000165626	"BEN domain containing 7"	Q8N7W2	10	13438484-13528974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 167.3;Late spermatids: 268.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;hTERT-RPE1: 17.3"									HPA037835	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center, Vesicles"		"HPA037835: AB_10669722"	"unprognostic (6.22e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.20e-3)"	8.0	6.0	4.7	2.4	4.9	0.7	9.4	6.5	4.7	7.4	4.9	11.2	16.5	7.3	13.6	2.2	12.4	6.5	7.4	5.0	4.9	18.5	9.0	9.1	1.1	5.1	5.9	8.3	12.1	14.8	10.3	4.3	5.9	5.7	6.6	15.4	15.1	6.5	16.4	3.2	19.3	6.1	4.7	3.0	11.2	16.3	5.6	0.5	23.5	13.3	1.0	6.8	4.4	4.4	9.9	5.9	6.0	2.2	0.1	0.0	8.7	3.8	0.1	9.3	5.6	2.4	17.5	0.0	5.1	7.3	5.2	0.4	9.8	2.1	8.3	0.0	8.7	0.0	0.0	11.4	3.9	0.0	0.0	0.2	5.7	1.2	0.0	17.3	10.3	1.4	4.3	0.0	9.3	4.0	0.1	0.0	1.8	0.0	1.0	0.0	4.4	0.0	8.0	1.3	0.4	4.7	10.7	0.0	0.1	9.1	0.1	4.7	9.2	1.1	13.8	11.6	4.8	0.0	0.0	0.0	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.7	4.9	6.5	4.7	5.0	4.9	5.1	5.9	5.9	4.7	5.6	4.4	33.6	22.4	11.6	23.5	1.9	3.4	23.6	1.1	1.8	14.4	15.4	11.4	11.0	22.8	9.8	20.2	8.4	3.0	2.6	13.2	3.9	13.0	167.3	25.0	5.8	16.7	7.8	0.0	7.5	16.5	2.9	8.0	9.7	36.2	6.3	14.7	22.5	9.6	3.0	1.7	10.2	8.5	6.1	9.4	1.9	268.7	5.0	2.5	3.6	24.4	4.5	20.3	12.3	47.7	0.7	21.8	9.5	6.0	0.5	23.9	45.2	52.0	9.7	32.2	0.0	14.1	8.4	21.5	20.0	3.3	1.8	2.5	3.5	3.4	10.3	36.1
BET1L	"GOLIM3, GS15"	ENSG00000177951	"Bet1 golgi vesicular membrane trafficking protein like"	Q9NYM9	11	167784-207428	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039819	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA039819: AB_10673020"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.49e-2)"	36.2	38.2	26.8	29.4	28.2	18.0	35.5	26.5	27.6	43.2	33.2	37.0	29.1	37.0	37.3	30.1	38.8	27.5	34.3	25.6	27.1	40.4	53.5	35.4	32.9	31.0	28.5	53.6	79.9	39.9	56.0	29.8	28.0	43.4	29.8	17.1	52.9	41.6	22.5	36.1	39.4	31.3	27.5	39.4	43.1	33.0	27.5	28.2	37.5	23.4	35.7	37.4	33.2	30.1	46.2	37.6	22.0	27.3	66.5	58.3	31.8	48.1	62.8	50.6	51.5	47.3	43.4	40.5	22.9	87.7	36.4	42.1	25.6	44.0	38.3	31.6	27.7	37.5	21.5	48.2	61.4	43.2	70.2	66.2	58.1	29.8	79.6	58.7	34.7	28.2	55.7	41.3	32.7	25.0	31.7	27.3	33.6	66.8	42.3	32.6	32.6	27.7	41.8	20.3	23.9	29.0	42.9	68.5	47.7	31.5	35.2	33.6	38.6	39.0	18.0	16.0	24.0	72.2	35.9	35.6	52.7	35.6	36.4	58.5	19.0	66.0	28.4	27.5	34.1	31.9	32.5	29.1	19.0	25.0	37.4	29.6	43.5	27.9	25.8	22.1	27.4	32.5	26.8	28.2	26.5	27.6	25.6	27.1	31.0	28.5	28.0	27.5	27.5	30.1	9.8	12.8	17.0	3.9	23.0	9.3	16.8	12.8	16.5	6.8	21.3	19.0	14.5	15.7	10.7	14.7	8.4	15.8	16.9	24.4	21.5	12.8	58.8	8.6	13.2	10.6	7.8	12.0	3.6	23.4	28.2	19.4	20.9	10.1	38.0	10.2	18.2	39.3	22.7	3.3	4.4	23.1	14.2	16.4	12.7	142.9	22.1	18.4	7.2	2.8	14.8	9.1	10.3	4.0	4.7	18.6	26.1	18.8	68.3	29.2	39.2	28.7	12.6	10.4	6.6	12.8	15.9	47.2	21.8	11.9	11.6	26.3	19.4	8.9	17.1	29.3
BEX4	"BEXL1, FLJ10097"	ENSG00000102409	"Brain expressed X-linked 4"	Q9NWD9	X	103215108-103217246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 309.3;Syncytiotrophoblasts: 364.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 162.5;HMC-1: 188.1;K-562: 232.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045105, HPA051935"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA045105: AB_10966792, HPA051935: AB_2681667"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.03e-1)"	"unprognostic (6.33e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.54e-14)"	"unprognostic (1.62e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.33e-2)"	32.2	99.9	186.5	24.8	187.5	71.4	56.3	173.4	225.0	53.0	154.9	63.6	17.0	70.3	265.9	48.0	65.7	40.2	101.9	188.8	209.2	97.6	13.5	44.0	32.9	185.7	185.7	102.6	34.7	126.0	134.0	60.6	184.6	80.2	26.4	92.0	74.6	83.1	6.8	26.6	32.2	56.4	183.7	68.7	36.2	46.1	195.1	57.0	131.1	13.6	34.8	46.6	44.3	188.2	0.0	0.2	96.4	0.0	24.1	16.6	86.5	23.2	19.8	42.6	77.7	0.0	1.4	0.3	38.1	16.2	36.0	0.7	39.1	5.3	46.8	0.1	36.8	162.5	0.0	0.1	73.7	123.0	188.1	62.3	12.9	22.3	0.0	47.3	50.2	62.2	232.5	0.5	13.1	0.5	86.4	1.0	117.0	0.0	6.9	0.2	28.0	0.6	39.1	2.4	71.7	109.3	8.1	1.5	5.1	93.0	3.9	1.3	1.3	5.5	34.3	0.8	0.3	12.5	6.0	0.2	16.0	0.0	4.9	118.6	23.1	42.3	31.6	30.0	26.5	37.6	38.2	32.0	51.3	33.7	65.5	52.2	5.2	100.5	26.4	79.0	40.3	43.9	186.5	187.5	173.4	225.0	188.8	209.2	185.7	185.7	184.6	183.7	195.1	188.2	45.7	35.3	40.4	25.5	38.7	27.3	133.8	86.0	87.0	174.9	99.0	105.4	81.3	81.5	64.0	99.3	25.0	309.3	47.5	6.8	299.3	66.4	4.7	31.2	35.5	59.2	63.1	35.1	70.0	13.7	156.0	65.1	19.4	38.1	109.2	147.8	73.2	0.7	88.3	222.1	69.6	37.2	52.9	55.5	53.2	12.9	63.3	68.9	115.6	22.5	118.4	217.8	34.0	34.2	64.3	10.8	23.3	61.3	22.2	118.1	8.1	186.5	33.2	81.0	52.6	64.4	57.4	27.4	14.3	42.5	24.2	364.3	37.2	115.0	28.7	111.7
BHLHA15	"BHLHB8, MIST1"	ENSG00000180535	"Basic helix-loop-helix family member a15"	Q7RTS1	7	98211439-98215457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"pancreas: 502.8;salivary gland: 145.9"	"Cell type enriched"	"Detected in single"	25	"Plasma cells: 12.6"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 16.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Karpas-707: 53.5;RPMI-8226: 72.0;U-266/70: 67.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034083, HPA047834"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Golgi apparatus"		"CAB034083: AB_2065216, HPA047834: AB_2680172"	"unprognostic (2.80e-2)"	"unprognostic (9.45e-3)"	"unprognostic (8.10e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.10e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.70e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.25e-3)"	0.1	0.1	0.8	3.6	0.6	0.3	1.5	0.1	2.0	1.9	0.1	4.0	4.0	0.1	0.8	0.9	0.1	0.7	0.2	1.3	0.9	0.6	5.2	0.9	3.8	0.6	0.5	0.4	502.8	0.1	1.5	0.1	0.6	8.5	1.5	0.0	145.9	3.9	0.2	0.6	3.4	0.0	1.0	5.0	31.3	0.2	1.5	0.7	1.9	0.0	4.7	2.5	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.3	0.1	0.8	0.9	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.6	6.7	5.9	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.2	0.0	0.0	53.5	0.0	0.9	0.0	0.0	0.8	6.2	0.8	0.4	0.0	72.0	0.3	0.0	4.3	1.2	0.0	11.2	0.0	0.0	0.7	0.1	0.0	0.0	0.7	0.1	0.1	67.6	5.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.6	0.1	2.0	1.3	0.9	0.6	0.5	0.6	1.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
BHLHB9	"GASP3, KIAA1701, p60TRP"	ENSG00000198908	"Basic helix-loop-helix family member b9"	Q6PI77	X	102720688-102753540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.6;Inhibitory neurons: 28.5;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA000887			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA000887: AB_2666130"	"unprognostic (4.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.42e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.40e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.74e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (8.88e-2)"	1.6	3.0	6.6	0.8	7.6	1.7	1.9	5.0	7.1	3.6	2.3	2.5	1.2	3.6	2.6	1.2	2.2	1.4	2.4	7.4	8.8	3.4	2.1	1.3	0.8	6.8	4.8	4.4	1.8	3.4	4.5	2.6	7.1	3.6	1.3	6.9	2.0	3.9	3.0	1.7	1.3	3.5	5.1	1.4	1.4	2.5	7.2	2.4	3.2	2.4	1.0	2.4	2.3	5.3	0.4	3.1	8.6	2.6	2.4	1.4	4.1	2.8	3.7	4.7	8.6	2.9	2.0	0.0	2.9	3.3	2.3	2.3	4.7	3.4	5.4	0.0	2.8	0.9	1.8	0.4	5.5	0.6	0.6	3.1	2.4	1.9	0.3	3.5	4.6	0.1	2.6	3.1	3.6	1.9	1.9	0.2	6.0	0.8	1.9	0.9	2.5	0.0	3.2	5.0	4.6	4.1	2.8	0.8	0.2	3.4	2.7	1.5	4.9	0.8	2.8	1.4	2.6	1.6	4.2	0.0	2.0	0.5	1.7	0.4	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.6	0.0	0.1	0.3	0.5	0.2	1.7	0.0	0.0	0.5	0.1	6.6	7.6	5.0	7.1	7.4	8.8	6.8	4.8	7.1	5.1	7.2	5.3	3.4	6.4	1.5	12.1	0.6	1.8	1.2	0.7	4.6	11.3	1.9	1.7	6.9	2.8	1.0	3.7	12.5	4.3	0.5	0.7	7.9	1.2	0.2	1.2	5.3	3.5	4.8	0.8	24.6	0.8	0.8	5.4	0.5	1.0	0.0	7.3	3.9	1.4	1.4	3.3	28.5	0.7	0.0	1.3	0.0	0.9	2.8	0.2	0.0	1.9	0.7	12.5	2.1	17.6	16.9	0.4	0.5	2.6	0.1	1.4	0.8	1.9	0.3	5.8	6.6	3.7	2.8	9.1	7.5	2.1	1.1	1.4	1.6	3.6	1.1	0.6
BHLHE22	"Beta3, BHLHB5, CAGL85, TNRC20"	ENSG00000180828	"Basic helix-loop-helix family member e22"	Q8NFJ8	8	64580365-64583627	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 23.2"	"Cell type enriched"	"Detected in some"	14	"Bipolar cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"THP-1: 78.4"	"Group enriched"	"Detected in all"	5	"amygdala: 30.7;cerebellum: 30.7;cerebral cortex: 22.7;hippocampal formation: 46.3;white matter: 13.1"					"HPA064128, HPA064872, HPA067500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.28e-5)"	"unprognostic (7.22e-3)"	"unprognostic (6.47e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.86e-7)"	"unprognostic (3.20e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.86e-1)"	2.0	0.5	8.9	1.4	6.6	0.0	1.5	12.1	22.4	2.3	0.4	1.3	0.4	0.3	0.1	0.9	0.8	0.4	0.3	23.2	1.5	0.2	0.5	2.0	0.7	5.5	1.5	0.2	0.7	0.1	1.4	0.0	2.6	0.4	0.5	4.4	0.5	2.3	0.1	0.8	1.4	0.4	1.4	1.4	0.5	0.2	1.1	0.3	0.7	0.0	0.6	1.2	2.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	78.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.6	12.1	22.4	23.2	1.5	5.5	1.5	2.6	1.4	1.1	1.8	0.3	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	64.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.0	3.4	0.2	0.0	0.0	0.6	1.5	0.0	1.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.2	2.9	0.0	0.4	0.1	1.6	0.0	0.1	0.0	0.0	0.0
BHLHE41	"BHLHB3, DEC2, SHARP-1, SHARP1"	ENSG00000123095	"Basic helix-loop-helix family member e41"	Q9C0J9	12	26120030-26125037	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 122.4;skeletal muscle: 92.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 347.5;Cone photoreceptor cells: 183.5;Horizontal cells: 250.7;Muller glia cells: 239.8;Rod photoreceptor cells: 309.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 78.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 92.4;RT4: 126.6;U-266/70: 52.6;U-87 MG: 44.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056035, HPA077617"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Vesicles	"HPA056035: AB_2683017, HPA077617: "	"unprognostic (1.57e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (5.23e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.61e-3)"	"prognostic favorable (1.09e-4)"	10.6	14.6	35.4	7.4	46.7	0.5	13.6	52.5	35.2	38.8	11.8	9.5	2.7	8.1	19.3	3.2	45.5	18.3	20.0	30.5	39.5	3.8	0.7	11.6	7.9	58.1	48.7	12.9	7.7	6.5	16.7	10.5	62.3	9.7	11.1	122.4	18.4	14.0	92.5	5.6	6.3	4.1	60.2	9.1	4.9	4.3	49.8	6.3	57.8	12.9	17.9	21.3	9.9	67.1	11.4	0.1	0.3	0.0	20.4	9.4	4.7	2.2	3.8	0.4	1.4	0.0	13.4	0.0	1.9	4.4	31.4	11.3	0.4	1.9	1.1	0.1	1.7	1.0	0.2	0.0	0.9	5.7	0.3	1.5	1.1	7.8	15.0	92.4	0.0	0.1	0.0	39.6	2.4	1.3	0.0	3.9	10.4	3.7	7.8	0.0	1.9	31.6	4.9	126.6	0.2	0.2	1.4	0.6	29.7	0.6	0.0	0.2	6.7	7.1	8.2	0.8	5.9	52.6	32.3	0.1	44.9	4.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.4	46.7	52.5	35.2	30.5	39.5	58.1	48.7	62.3	60.2	49.8	67.1	1.6	0.0	1.1	46.0	25.0	6.0	59.8	34.1	10.8	347.5	9.2	56.0	46.7	37.1	11.2	29.5	183.5	26.6	0.2	55.0	0.0	40.6	0.6	78.5	27.1	12.0	13.1	0.0	10.1	21.9	3.6	22.7	3.1	60.8	5.7	0.2	2.5	0.1	91.1	250.7	12.4	4.4	0.0	4.0	4.4	1.3	30.1	39.8	14.2	120.9	27.4	239.8	0.0	22.1	56.2	21.9	12.0	26.7	61.8	49.0	0.4	2.3	34.8	309.5	6.6	13.0	7.5	0.5	3.7	3.5	3.3	7.1	2.4	2.3	5.0	83.8
BICDL1	"BICDR-1, CCDC64, FLJ26450"	ENSG00000135127	"BICD family like cargo adaptor 1"	Q6ZP65	12	119989869-120094494	"Predicted intracellular proteins"	"Neurogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 128.7;pituitary gland: 80.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 12.9;dendritic cells: 13.7;Distal tubular cells: 23.5;Plasma cells: 12.8;Proximal tubular cells: 27.3;T-cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 48.9;MCF7: 27.7;OE19: 25.2;SCLC-21H: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061116	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	Vesicles	"HPA061116: AB_2684433"	"unprognostic (2.17e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-2)"	"unprognostic (6.81e-4)"	"prognostic favorable (3.15e-4)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (3.93e-5)"	"prognostic favorable (1.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-1)"	24.8	2.7	7.6	10.8	8.8	3.0	2.9	5.4	13.3	7.4	0.2	3.2	4.0	0.7	37.5	35.8	4.2	4.1	2.9	7.6	10.9	128.7	5.6	6.0	23.8	5.6	3.4	1.1	7.7	2.5	80.2	1.1	5.6	4.9	3.1	67.6	8.3	1.0	0.4	64.2	7.3	0.6	2.6	7.1	20.9	40.8	6.9	18.2	24.4	0.0	15.5	3.1	21.5	6.6	3.5	10.6	0.6	0.0	0.9	0.0	12.6	0.0	0.0	0.0	0.0	9.5	5.9	16.8	4.4	0.0	9.1	7.9	1.3	1.6	0.0	1.2	1.7	0.1	4.7	18.3	0.0	2.1	17.1	0.0	48.9	0.0	0.6	0.0	0.0	14.1	0.5	2.1	0.0	27.7	12.3	0.2	21.1	25.2	5.0	1.3	0.9	4.5	6.2	8.4	30.8	2.2	3.6	9.7	2.6	5.1	22.4	8.3	0.0	0.1	2.9	0.0	0.2	4.2	17.1	6.5	0.6	2.4	1.7	0.3	0.0	0.0	1.2	0.0	0.4	0.1	1.2	1.0	0.0	0.1	0.9	0.7	0.0	0.0	0.3	0.0	0.2	0.2	7.6	8.8	5.4	13.3	7.6	10.9	5.6	3.4	5.6	2.6	6.9	6.6	0.6	0.0	1.3	0.0	6.8	0.0	0.0	0.0	0.0	0.0	2.8	2.2	0.0	0.0	1.3	12.9	0.0	1.0	13.7	0.0	23.5	1.1	0.0	3.1	1.0	0.1	0.0	0.0	0.0	3.5	0.6	2.7	0.0	7.7	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	12.8	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	17.6	0.7	0.0	0.0
BICRA	GLTSCR1	ENSG00000063169	"BRD4 interacting chromatin remodeling complex associated protein"	Q9NZM4	19	47608196-47703277	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.5;Breast myoepithelial cells: 6.1;Collecting duct cells: 7.3;Endometrial stromal cells: 6.4;Glandular and luminal cells: 6.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056211	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA056211: AB_2683068"	"unprognostic (2.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.58e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (8.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.21e-3)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (9.72e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (9.34e-4)"	6.7	5.0	1.6	5.0	2.1	5.3	6.9	4.3	3.6	9.6	0.9	9.1	6.5	10.6	1.6	6.9	9.1	2.4	6.2	3.6	1.1	3.9	4.9	7.0	3.9	1.9	0.5	8.6	4.4	4.0	5.6	4.8	1.0	8.2	3.6	4.2	7.0	4.1	13.7	9.9	7.3	5.3	0.0	6.1	6.3	3.0	2.2	5.6	7.5	5.5	3.5	8.6	8.3	5.5	6.8	6.6	12.3	9.5	6.0	6.1	7.0	5.8	4.9	6.4	4.3	7.3	3.5	7.3	3.0	6.7	5.4	6.9	7.7	4.1	6.4	7.5	6.5	4.3	5.3	3.1	7.7	5.1	7.5	5.2	5.6	7.0	6.3	5.3	6.5	6.2	6.7	8.4	3.9	4.8	9.1	16.3	8.6	8.7	5.4	9.7	4.2	2.1	2.5	4.6	7.4	9.6	14.4	8.3	3.7	10.0	3.4	4.0	8.1	5.3	10.8	4.4	7.9	6.8	11.8	7.1	1.2	3.6	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.6	2.1	4.3	3.6	3.6	1.1	1.9	0.5	1.0	0.0	2.2	5.5	5.1	9.6	6.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	5.2	6.1	0.0	0.0	0.6	7.3	0.0	4.3	3.8	0.0	0.0	3.2	0.0	4.9	6.4	2.0	0.0	0.0	0.0	3.8	3.9	1.6	0.0	6.0	1.3	4.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	5.5	2.0	3.3	0.0	0.0
BICRAL	"GLTSCR1L, KIAA0240"	ENSG00000112624	"BRD4 interacting chromatin remodeling complex associated protein like"	Q6AI39	6	42746958-42868560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 10.3;Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.4;Breast glandular cells: 10.2;Breast myoepithelial cells: 9.1;dendritic cells: 11.6;Endometrial stromal cells: 9.6;Glandular and luminal cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029390, HPA029391"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA029390: AB_10599730, HPA029391: AB_10599949"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.74e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.54e-2)"	8.5	5.7	4.5	8.3	4.4	7.7	9.5	15.9	6.9	9.4	1.1	7.6	6.1	11.3	7.7	6.5	10.2	7.2	7.0	4.2	5.0	6.1	5.7	7.8	12.2	4.8	4.0	16.2	7.0	10.4	5.8	5.2	5.1	9.2	9.5	14.3	8.3	8.1	8.0	8.7	6.7	9.6	2.9	9.8	7.5	5.0	4.0	11.6	11.3	9.4	12.2	7.7	7.3	7.4	6.2	4.9	4.3	6.9	8.7	10.0	3.7	5.4	5.6	4.7	3.6	2.2	4.4	14.4	4.8	9.1	7.2	4.8	4.2	5.6	7.7	10.8	2.7	10.1	4.9	6.3	4.6	8.6	8.8	6.2	10.6	4.6	8.4	8.9	4.9	8.4	9.8	12.5	5.6	7.4	1.4	4.9	4.8	24.3	3.0	8.9	2.5	14.3	4.8	4.0	14.6	7.8	6.1	8.7	6.1	4.1	7.6	10.0	5.7	6.5	6.4	4.3	5.4	11.3	7.0	21.6	3.9	10.8	4.7	2.3	0.5	2.8	2.2	0.4	1.9	1.2	1.3	2.1	0.4	1.3	1.2	1.6	3.7	1.6	0.8	0.7	1.6	0.6	4.5	4.4	15.9	6.9	4.2	5.0	4.8	4.0	5.1	2.9	4.0	7.4	10.3	9.6	9.4	0.0	4.2	0.0	0.0	0.0	0.0	0.0	10.2	9.1	0.0	0.0	4.3	3.7	0.0	2.3	11.6	0.0	0.0	3.8	0.0	6.2	9.6	3.1	0.0	0.0	0.0	3.8	2.1	3.9	0.0	9.8	1.3	8.4	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	3.5	0.0	0.0	4.3	2.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.4	5.0	5.2	0.0	0.0
BIRC2	"API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48"	ENSG00000110330	"Baculoviral IAP repeat containing 2"	Q13490	11	102347211-102378670	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005513, CAB020661"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"CAB020661: , HPA005513: AB_1846746"	"unprognostic (1.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.64e-2)"	23.2	27.6	18.4	25.8	19.6	36.4	28.2	20.0	23.4	27.5	22.5	27.2	23.6	25.7	30.2	18.1	19.7	24.8	23.6	17.9	19.9	28.8	44.3	22.6	34.5	19.7	19.4	21.8	33.7	20.4	18.8	29.4	19.8	21.4	26.0	22.2	21.1	16.1	29.7	18.2	25.2	21.6	20.1	26.7	23.5	24.6	18.8	50.6	22.2	32.9	27.1	30.4	20.4	24.9	34.0	24.7	37.3	29.3	46.1	63.3	23.9	128.3	48.8	71.9	43.4	30.9	81.7	37.1	123.5	59.2	40.3	36.7	24.5	33.8	85.7	50.0	12.6	37.2	17.6	37.8	46.9	22.9	23.0	40.8	64.4	41.2	52.3	66.2	50.1	22.2	34.4	0.2	131.0	10.9	24.3	20.1	18.1	40.1	23.7	11.9	48.4	24.9	55.4	38.5	15.5	20.3	44.7	26.9	40.7	56.7	42.5	27.3	82.7	150.7	34.4	46.2	84.2	14.9	21.9	25.0	32.6	28.2	112.5	97.2	43.3	104.4	22.9	42.2	18.9	15.7	21.5	21.3	33.8	15.1	27.4	27.7	67.6	34.3	46.7	20.4	33.2	27.5	18.4	19.6	20.0	23.4	17.9	19.9	19.7	19.4	19.8	20.1	18.8	24.9	61.8	41.7	41.1	17.0	52.6	67.2	109.2	53.6	39.9	24.4	52.3	52.8	58.6	67.2	49.5	64.4	29.2	38.4	77.9	85.7	43.0	49.8	20.8	63.2	54.0	51.0	48.5	80.0	22.4	73.7	27.8	55.9	28.5	85.7	62.7	43.7	59.3	182.1	41.5	20.2	21.7	54.3	46.8	84.3	71.5	11.2	36.4	71.1	51.6	26.2	81.2	34.3	55.6	21.6	33.1	54.5	71.1	29.0	49.2	75.0	82.1	110.1	56.6	31.0	26.3	45.7	48.9	44.7	42.4	28.4	62.8	35.2	57.1	36.4	44.2	82.5
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 89.0;lymphoid tissue: 141.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 554.8;Langerhans cells: 1400.9;monocytes: 1117.0;Proximal enterocytes: 817.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 209.0;naive B-cell: 159.9"	"Group enriched"	"Detected in all"	13	"B-cells: 209.0;T-cells: 83.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 146.5;Daudi: 140.7;EFO-21: 74.3;HDLM-2: 140.1;hTERT-HME1: 140.2;U-266/70: 89.2;U-266/84: 85.8"	"Low region specificity"	"Detected in all"							HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favorable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	9.0	14.7	2.7	104.8	2.9	26.3	18.4	1.6	3.4	19.1	3.4	24.9	26.6	10.5	3.7	16.0	8.5	51.0	7.7	2.8	3.5	12.6	26.3	24.6	141.5	2.6	2.7	6.6	12.0	4.3	3.6	5.3	2.3	10.6	24.7	0.6	12.7	11.4	2.7	8.1	89.0	10.7	2.5	73.2	54.3	8.2	2.7	59.2	3.9	4.3	134.4	46.9	4.8	3.6	26.4	24.5	0.2	0.4	0.7	3.9	2.4	2.5	17.5	3.3	3.7	4.6	146.5	140.7	74.3	1.4	22.8	13.0	0.1	4.6	7.8	140.1	0.3	0.5	7.3	1.4	30.7	2.4	3.7	3.5	18.1	8.4	140.2	4.9	0.4	10.2	0.5	0.0	3.0	0.1	8.3	1.3	0.3	14.2	1.0	0.1	0.8	6.8	34.3	12.9	0.1	0.3	2.1	2.1	1.8	0.5	6.4	1.8	7.5	25.6	3.4	1.4	28.3	89.2	85.8	48.8	4.0	7.4	3.0	8.6	3.9	2.2	5.8	10.1	9.8	209.0	41.7	14.1	3.6	159.9	28.4	8.3	2.6	9.9	11.0	1.7	83.6	11.9	2.7	2.9	1.6	3.4	2.8	3.5	2.6	2.7	2.3	2.5	2.7	3.6	41.2	144.2	70.8	0.0	420.1	101.2	324.9	267.2	51.2	0.3	26.6	22.9	12.5	134.4	146.9	40.5	0.0	2.0	71.2	142.4	7.9	230.3	1.8	231.3	16.8	101.4	15.0	23.6	1.1	179.7	0.5	63.4	184.5	289.4	554.8	1.8	6.4	4.4	11.7	0.0	3.2	38.0	75.3	25.4	1400.9	2.1	5.0	170.0	192.1	2.8	1117.0	0.5	14.4	0.0	0.4	207.4	281.1	2.2	288.4	455.1	817.3	19.5	88.1	0.0	0.0	60.8	90.9	0.7	0.5	31.8	84.5	0.5	278.0	0.7	49.4	193.3
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240495	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 6.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 12.4;Extravillous trophoblasts: 16.5;Hofbauer cells: 75.8;Melanocytes: 26.6;Muller glia cells: 54.2"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 196.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Centrosome, Cytosol"	"HPA047850: AB_2680181, HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	0.8	0.8	0.7	0.3	0.4	0.1	0.4	0.3	1.3	1.7	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.7	0.9	0.9	0.3	1.1	1.3	0.8	0.7	0.1	0.0	0.0	0.3	6.5	1.1	0.1	0.0	0.6	0.2	0.0	0.0	2.4	0.2	0.0	0.7	0.9	0.1	0.1	1.2	0.0	0.2	0.0	0.2	0.2	0.7	1.5	0.3	4.3	0.1	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	6.6	1.1	0.0	17.8	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	20.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	196.8	4.4	1.3	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.2	0.0	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.3	1.3	0.7	0.9	0.8	0.7	1.1	0.7	1.2	1.5	0.3	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	1.8	0.0	12.4	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.6	16.5	0.7	0.0	0.0	2.5	0.1	0.0	0.0	75.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.7	26.6	0.0	0.0	54.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0
BIVM	FLJ20159	ENSG00000134897	"Basic, immunoglobulin-like variable motif containing"	Q86UB2	13	102799119-102841533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA050126	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"HPA050126: AB_2681027"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.89e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-2)"	7.4	7.1	8.2	3.6	8.6	3.6	8.8	10.9	10.6	8.6	7.6	7.1	6.3	9.2	11.5	5.5	7.7	6.9	19.4	8.3	7.8	16.3	18.8	6.7	4.5	7.5	7.9	9.2	10.4	9.1	8.9	7.7	7.7	7.8	8.2	9.0	6.1	7.6	17.8	7.2	6.3	8.9	6.8	7.4	8.6	2.3	8.5	10.4	8.0	18.9	4.3	7.4	6.5	9.1	16.8	4.6	19.9	18.7	24.2	37.4	4.1	19.3	23.9	14.5	16.5	6.1	7.7	0.1	8.2	22.1	10.3	11.5	17.9	16.3	17.5	17.1	16.3	14.7	14.2	8.8	19.5	16.8	22.2	28.2	18.8	7.9	20.5	25.4	20.2	22.7	14.4	0.0	25.7	3.7	19.3	16.1	4.3	24.1	12.9	0.0	9.0	6.4	50.0	7.2	23.8	21.1	8.5	9.2	12.3	7.2	13.3	22.7	12.9	13.0	4.3	9.4	11.8	12.5	5.6	0.1	21.2	0.0	25.9	5.5	0.4	1.1	2.2	0.2	5.2	0.5	1.4	2.9	1.6	0.5	0.7	1.4	0.3	7.6	0.0	0.4	1.0	1.0	8.2	8.6	10.9	10.6	8.3	7.8	7.5	7.9	7.7	6.8	8.5	9.1	9.3	9.6	12.8	2.9	2.6	3.7	3.8	7.0	11.4	19.0	7.7	6.1	30.7	21.5	11.2	18.4	14.6	7.1	3.8	5.6	29.4	6.5	0.5	5.1	11.8	11.0	21.8	9.2	13.9	5.5	7.8	11.8	6.1	4.9	6.3	15.2	17.2	34.0	7.0	23.5	16.8	15.3	6.1	5.0	3.4	0.4	13.7	3.3	3.6	4.7	2.4	8.1	5.2	9.0	6.3	4.1	9.3	11.3	4.5	4.9	9.7	30.8	8.9	12.4	19.7	10.4	9.8	2.0	12.6	11.4	4.8	2.5	8.1	10.3	15.2	3.4
BIVM-ERCC5		ENSG00000270181	"BIVM-ERCC5 readthrough"		13	102799110-102875994	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.3;Club cells: 2.5;Excitatory neurons: 6.4;granulocytes: 2.5;Inhibitory neurons: 7.5;Oligodendrocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.3;HMC-1: 1.3;hTERT-RPE1: 1.3;RPTEC TERT1: 2.5;SK-MEL-30: 1.4"									"HPA045845, HPA050126, HPA050374"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106"													"unprognostic (6.01e-2)"					10.2	9.5	0.2	0.1	0.0	0.0	9.5	0.4	0.2	10.1	0.0	9.9	0.0	9.7	0.0	8.7	8.6	0.3	8.6	0.1	0.0	9.7	12.4	9.1	0.0	0.0	0.2	10.5	11.7	0.1	9.3	0.0	0.0	8.8	0.2	0.2	9.3	0.0	12.5	9.7	9.9	0.1	0.0	9.4	9.4	3.2	0.1	0.0	9.9	0.0	0.0	9.2	9.2	0.3	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.4	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.2	1.3	0.9	0.6	0.7	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.3	0.5	1.3	0.3	0.5	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.5	0.5	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	2.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.4	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564599	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 39.1;lymphoid tissue: 46.7"	"Cell type enriched"	"Detected in some"	11	"B-cells: 116.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 183.4;naive B-cell: 131.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 183.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 106.6;REH: 29.9;RPMI-8226: 38.5;U-698: 48.6;U-87 MG: 22.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB005093, HPA069571"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.1	0.0	9.1	0.0	2.6	0.2	0.0	0.0	0.0	0.0	2.6	0.5	0.1	0.0	1.2	0.2	0.5	0.1	0.0	0.0	1.2	0.7	0.8	29.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.0	0.7	0.0	0.3	0.0	39.1	0.1	0.0	46.7	2.1	0.1	0.0	2.5	1.2	0.0	27.9	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	29.9	0.0	38.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	5.4	10.2	48.6	22.7	0.0	0.0	0.2	0.1	0.2	2.0	0.0	37.9	183.4	1.4	4.6	0.1	131.5	0.9	0.4	0.7	0.1	0.1	17.5	1.8	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	116.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.1	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	4.0	0.1	0.1	0.0
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"BLM RecQ like helicase"	P54132	15	90717346-90816166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	0.3	0.2	0.9	3.6	1.1	5.7	0.5	2.3	0.9	0.1	0.3	1.4	1.0	0.4	0.4	0.6	0.3	0.3	0.3	0.8	1.1	0.1	0.1	0.4	6.4	1.2	1.4	0.1	0.2	0.0	0.6	1.2	1.1	0.1	1.7	2.4	7.8	0.0	0.5	0.4	1.6	0.4	1.0	1.6	1.1	2.2	0.9	7.9	0.3	0.1	6.2	1.0	0.2	1.0	13.0	14.4	20.4	12.6	0.1	0.9	14.6	9.4	3.2	11.1	13.4	11.7	10.1	35.1	5.9	2.6	14.1	20.4	25.7	7.1	15.1	19.1	20.5	36.4	14.8	3.9	0.0	33.7	17.3	0.3	0.1	10.6	4.7	1.3	7.9	16.9	32.7	9.9	11.0	7.4	28.3	14.5	22.2	24.9	4.2	25.4	39.1	14.7	2.3	18.9	14.6	14.7	8.5	11.5	4.8	18.1	7.2	23.4	3.7	8.6	13.6	9.6	21.0	6.4	30.4	39.5	5.6	25.8	15.7	1.7	0.6	2.6	1.6	0.8	2.6	4.6	1.4	2.1	0.7	2.3	1.0	1.1	0.7	3.1	1.0	0.7	3.2	0.9	0.9	1.1	2.3	0.9	0.8	1.1	1.2	1.4	1.1	1.0	0.9	1.0	0.9	3.2	8.9	1.0	12.9	0.3	0.5	0.5	0.6	3.6	1.3	1.0	7.9	0.0	4.2	0.0	2.1	5.5	6.9	2.2	1.9	1.0	2.7	1.3	1.3	2.0	0.0	18.3	0.7	0.7	6.8	1.8	3.6	1.7	13.3	8.1	2.2	0.6	5.7	0.0	8.6	1.3	0.0	7.7	1.3	1.6	0.0	7.7	0.0	7.5	2.7	1.7	10.3	58.3	2.6	1.2	0.3	0.4	20.6	0.7	0.2	0.0	5.4	7.1	0.0	0.9	1.7	17.1	12.9	2.2	0.6	1.0	10.2	0.7	4.0	0.4
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248203-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 130.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		42000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	20.6	13.5	13.4	18.2	15.0	18.1	20.4	15.9	17.6	19.1	14.5	18.8	12.4	21.2	21.1	28.3	14.7	18.4	15.6	13.5	15.2	22.0	14.0	16.0	26.0	15.6	14.1	13.9	26.8	21.7	9.7	27.4	15.4	14.4	15.4	14.7	15.6	14.4	28.8	130.3	18.3	22.4	14.7	20.6	16.2	15.9	14.2	36.3	16.5	19.0	26.9	17.9	21.5	16.2	40.3	62.9	61.5	41.6	40.6	43.8	27.8	36.5	24.0	59.1	50.8	93.2	11.9	119.5	63.3	31.1	26.1	27.1	135.5	52.8	50.1	31.5	101.4	73.5	54.6	80.0	58.3	136.1	43.2	50.5	3.5	46.5	26.5	47.1	87.2	98.2	157.9	47.6	24.6	31.0	168.1	98.6	57.2	0.0	29.2	143.0	154.5	78.9	46.8	35.6	135.1	48.4	32.6	63.2	42.2	106.6	42.9	68.5	54.5	35.0	69.2	16.0	66.0	55.8	124.1	159.3	26.7	0.2	47.6	0.0	8.8	1.5	15.3	6.2	25.3	6.5	18.2	20.2	10.1	7.3	16.4	17.8	1.2	16.3	3.3	10.1	20.0	9.9	13.4	15.0	15.9	17.6	13.5	15.2	15.6	14.1	15.4	14.7	14.2	16.2	21.0	3.2	12.6	13.4	8.8	15.9	16.7	10.6	19.4	20.2	10.3	6.6	17.8	12.8	4.0	11.0	12.5	49.6	15.6	7.6	7.9	17.4	8.4	7.4	28.2	24.0	18.0	22.5	19.0	14.2	38.0	18.3	11.2	7.0	43.8	30.5	25.7	6.9	25.0	13.5	20.9	8.4	6.1	18.9	7.1	6.6	16.1	13.0	10.6	18.7	12.2	9.9	22.6	29.1	22.6	7.2	9.6	24.8	20.0	13.0	11.5	20.0	5.5	15.7	6.6	12.9	19.7	14.9	29.1	24.0	12.6	27.5	20.9	34.8	11.5	7.6
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465764	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 625.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 3131.8;Hofbauer cells: 1099.2;Proximal enterocytes: 864.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 465.2"	"Group enriched"	"Detected in all"	7	"dendritic cells: 343.3;monocytes: 465.2"	"Cell line enhanced"	"Detected in many"		"A549: 506.6;K-562: 506.8;OE19: 451.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	115.7	76.8	46.6	48.2	46.9	625.2	93.8	49.4	61.0	86.2	52.1	78.5	75.1	59.0	20.5	188.8	69.3	50.9	125.6	44.5	48.0	103.1	266.2	102.8	58.9	56.0	48.6	66.7	73.2	46.1	25.2	52.1	58.5	74.3	30.3	5.5	89.4	42.2	210.4	83.9	72.2	31.7	49.8	166.7	138.4	10.2	52.3	27.5	64.5	94.1	25.3	81.0	96.5	53.4	227.9	506.6	7.3	77.7	73.7	70.2	57.3	28.0	88.7	39.3	75.4	103.4	203.8	74.3	212.3	56.3	126.8	73.1	30.4	64.6	10.5	123.8	20.0	114.9	73.4	62.4	169.8	1.6	32.2	69.2	119.4	52.4	34.2	40.1	41.8	27.4	506.8	137.0	51.0	359.2	6.1	7.2	1.9	451.4	133.8	54.0	23.4	120.3	50.9	146.5	0.4	10.5	84.5	224.5	84.4	13.2	221.5	17.6	39.2	99.4	103.9	156.4	15.9	71.7	92.1	28.5	259.1	46.2	39.0	45.5	465.2	18.0	29.2	220.9	27.0	58.2	24.3	24.5	343.3	37.5	24.7	19.3	58.4	27.4	117.7	75.8	37.3	259.4	46.6	46.9	49.4	61.0	44.5	48.0	56.0	48.6	58.5	49.8	52.3	53.4	74.6	221.2	164.5	9.4	34.4	129.4	348.5	337.9	103.6	11.2	93.8	143.0	130.5	164.5	184.2	97.5	6.2	84.9	39.5	343.6	266.1	234.2	10.0	56.5	46.3	51.1	44.9	3131.8	5.2	267.3	94.7	112.5	280.3	83.1	43.1	31.0	57.1	680.8	1099.2	10.1	5.1	223.5	158.7	627.7	165.4	23.6	124.2	286.7	144.1	13.1	219.8	88.0	32.0	2.0	5.6	260.4	464.0	94.0	25.7	229.7	864.3	488.3	139.1	13.5	32.9	65.4	146.0	2.6	4.0	160.3	130.4	74.7	34.5	34.7	191.0	260.5
BLZF1	JEM-1	ENSG00000117475	"Basic leucine zipper nuclear factor 1"	Q9H2G9	1	169367970-169396540	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 85.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025703, HPA027331, HPA067113"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781"	"unprognostic (5.25e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-3)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (3.28e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.18e-1)"	14.9	13.1	8.2	12.5	10.3	25.6	19.4	11.3	10.3	14.6	9.4	13.9	12.3	15.6	14.3	32.4	11.3	16.3	16.0	8.9	9.0	17.0	14.9	13.0	11.8	9.9	9.4	14.5	9.5	15.1	8.7	18.2	9.7	15.6	15.6	22.8	12.7	16.0	11.3	18.0	12.7	17.9	9.7	12.5	13.1	35.0	9.3	13.7	18.7	11.0	16.2	16.6	14.7	14.3	52.8	16.6	16.5	13.6	24.9	37.6	26.2	46.6	32.0	48.1	52.5	19.5	33.3	7.5	26.8	31.6	30.7	38.6	16.6	30.3	37.4	16.8	16.1	13.7	20.0	13.6	26.4	27.2	18.9	27.6	36.9	35.8	31.7	27.3	25.1	14.9	25.6	20.0	46.0	10.8	12.1	12.7	19.9	38.2	25.2	6.8	26.0	16.6	48.1	17.5	9.3	30.6	30.3	41.3	36.9	28.3	44.8	20.4	30.5	28.9	22.5	26.7	39.6	20.4	26.1	19.5	22.1	11.7	44.6	85.6	12.2	51.5	12.2	16.2	16.0	11.3	15.0	14.1	10.8	10.4	13.2	14.4	25.1	19.8	15.8	8.2	23.9	10.9	8.2	10.3	11.3	10.3	8.9	9.0	9.9	9.4	9.7	9.7	9.3	14.3	14.7	22.4	16.4	34.9	11.7	18.4	46.7	22.6	16.5	14.3	18.0	12.1	29.6	11.5	24.4	11.0	14.6	18.3	15.2	18.2	23.5	24.2	131.4	28.0	18.6	11.9	12.6	16.0	30.2	13.2	17.3	18.7	22.4	28.5	26.0	12.3	12.5	4.8	14.3	33.7	32.8	11.7	14.2	10.7	6.8	72.8	14.6	11.6	14.2	17.8	10.3	21.2	17.5	30.2	57.8	36.7	11.6	17.7	13.9	17.0	15.4	22.4	31.6	27.9	0.0	23.0	21.7	84.9	25.8	16.7	15.6	20.1	18.8	17.1	11.6	65.3
BMERB1	"C16orf45, FLJ32618"	ENSG00000166780	"BMERB domain containing 1"	Q96MC5	16	15434475-15625028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 57.0"	"Cancer enhanced"	"Detected in all"		"glioma: 30.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 8.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 101.8;U-2197: 81.3;U-87 MG: 124.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041114, HPA063757"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA041114: AB_10794542, HPA063757: "	"unprognostic (1.02e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.28e-2)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.79e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	30.9	15.4	90.3	10.5	111.6	1.1	21.6	67.4	112.7	46.0	48.2	46.1	8.3	40.5	19.7	21.4	38.4	23.9	47.3	107.0	87.2	23.1	21.8	13.4	6.4	123.0	74.0	40.9	18.6	3.9	40.8	1.3	118.5	32.4	9.3	40.6	12.6	27.6	86.9	13.0	19.1	35.6	69.6	9.2	21.6	40.3	80.5	4.0	13.5	41.3	4.0	44.4	25.3	96.2	1.4	31.5	12.8	1.5	56.7	50.7	0.3	18.1	62.6	15.5	8.4	0.0	0.9	0.1	4.0	101.8	37.5	0.2	4.1	5.3	7.9	0.4	0.7	6.7	11.9	1.5	19.4	0.1	13.6	24.5	5.2	33.8	0.5	25.8	25.2	14.5	0.4	0.5	24.2	21.6	5.1	0.9	17.2	0.4	10.7	1.0	16.3	0.1	8.8	4.6	26.2	27.6	0.9	8.3	5.5	2.1	0.4	0.4	8.9	34.2	17.6	81.3	9.4	5.7	12.5	0.2	124.3	0.2	7.1	0.1	0.1	0.1	8.7	0.0	1.7	2.1	2.0	5.2	0.5	1.3	1.5	2.8	0.6	0.2	0.1	0.2	2.6	1.1	90.3	111.6	67.4	112.7	107.0	87.2	123.0	74.0	118.5	69.6	80.5	96.2	7.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0
BMF	FLJ00065	ENSG00000104081	"Bcl2 modifying factor"	Q96LC9	15	40087890-40108892	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.0"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 14.9;Exocrine glandular cells: 15.1;Kupffer cells: 18.7;Langerhans cells: 12.8;monocytes: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 43.3;HMC-1: 44.2;hTERT-RPE1: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010120	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA010120: AB_1845385"	"unprognostic (2.94e-1)"	"unprognostic (4.92e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.83e-4)"	"prognostic unfavorable (6.32e-4)"	"unprognostic (1.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.06e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.35e-2)"	3.7	2.9	1.9	12.6	1.8	33.0	5.7	2.2	3.0	9.6	3.9	10.1	21.2	15.8	7.2	2.9	11.9	12.2	5.3	1.2	3.5	10.7	3.4	12.8	13.7	4.3	3.0	14.1	7.7	6.0	2.7	6.4	4.1	6.0	8.4	3.0	10.4	4.7	5.1	5.3	23.6	10.1	3.4	18.9	10.1	2.1	5.0	76.0	17.1	5.3	23.5	7.5	3.8	6.4	1.0	1.4	22.9	5.1	0.6	0.9	15.5	0.1	3.6	0.4	1.1	23.6	1.7	6.8	7.3	1.0	7.0	4.9	5.7	0.1	0.1	16.0	4.7	3.5	43.3	5.5	2.1	0.6	44.2	11.3	1.3	0.4	0.4	57.0	6.0	5.0	1.9	2.9	2.0	1.3	2.3	17.6	6.2	11.8	0.8	4.3	5.2	20.4	1.0	5.4	12.1	9.8	4.4	11.6	10.6	24.3	6.9	13.8	4.6	0.8	3.1	0.7	0.3	28.1	28.4	4.3	1.6	3.3	2.7	0.0	2.6	2.4	0.1	2.9	0.2	2.9	0.2	0.8	1.6	0.9	0.4	0.0	3.2	0.0	4.0	2.0	0.7	0.7	1.9	1.8	2.2	3.0	1.2	3.5	4.3	3.0	4.1	3.4	5.0	6.4	2.3	3.2	2.2	0.3	7.3	1.1	0.9	1.0	1.2	0.2	2.1	1.3	1.6	4.3	5.0	0.0	0.0	1.4	0.7	7.9	0.0	14.9	1.3	5.9	1.2	3.8	1.2	3.2	0.1	15.1	1.3	2.3	1.5	8.5	0.0	0.8	1.4	1.0	8.4	0.0	0.8	1.1	6.1	18.7	12.8	0.5	1.8	8.8	0.0	3.7	14.2	0.3	0.0	0.5	0.5	10.9	1.2	0.7	7.0	1.7	9.6	2.4	1.0	0.8	0.0	1.3	1.3	0.4	1.4	0.9	0.6	1.8	3.5	0.2	1.2	1.0
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321099-22331484	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 134.0;Late spermatids: 165.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 508.3;U-937: 583.9"									"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	29.0	31.1	26.6	25.1	35.1	21.9	36.0	29.9	42.4	27.6	28.2	26.2	19.7	30.7	29.7	21.9	22.6	23.9	20.5	25.0	27.8	26.0	35.6	23.4	27.7	29.5	30.1	21.7	25.7	56.9	25.0	28.7	31.6	33.7	21.5	40.4	19.9	26.1	44.4	14.4	20.8	36.2	29.9	36.2	22.5	35.3	28.1	24.9	23.9	35.5	27.0	23.8	14.8	45.4	74.9	36.1	41.2	12.7	68.9	54.6	40.5	49.7	22.2	37.3	43.5	37.6	93.4	38.1	32.8	45.6	42.2	26.1	59.1	35.0	45.4	508.3	72.8	104.7	28.7	42.9	41.1	39.8	55.7	35.5	58.8	41.2	45.3	47.0	26.2	62.1	105.4	63.3	48.6	30.2	106.9	11.4	9.3	36.3	83.4	79.6	57.1	37.3	35.3	25.2	33.8	66.0	32.7	42.5	57.3	17.8	38.5	153.8	56.4	41.4	122.6	99.6	67.6	76.1	110.8	83.1	59.5	583.9	27.4	15.1	1.3	2.5	5.2	3.0	7.0	4.4	5.3	5.0	0.9	2.2	4.4	4.3	0.6	5.2	2.1	1.6	4.1	2.0	26.6	35.1	29.9	42.4	25.0	27.8	29.5	30.1	31.6	29.9	28.1	45.4	18.9	25.6	24.0	0.0	23.1	15.9	20.5	12.4	22.8	20.9	24.4	20.3	19.0	22.8	19.8	12.9	8.4	12.7	14.2	5.6	13.7	16.3	134.0	12.1	25.3	24.0	13.2	19.1	0.0	18.2	22.2	19.8	7.7	9.8	12.0	12.6	28.5	30.7	9.9	30.3	0.0	9.9	14.2	19.7	25.6	165.1	36.1	13.8	37.4	0.0	17.5	13.9	15.5	0.0	0.0	22.9	7.3	36.5	33.9	29.1	4.6	13.0	16.9	15.2	19.7	26.5	28.6	19.8	22.2	11.2	14.6	6.7	22.4	17.0	10.3	20.4
BMP7	OP-1	ENSG00000101144	"Bone morphogenetic protein 7"	P18075	20	57168753-57266641	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;choroid plexus: 43.8;thyroid gland: 45.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Basal squamous epithelial cells: 51.8;Cytotrophoblasts: 137.4;Oligodendrocyte precursor cells: 74.4;Squamous epithelial cells: 44.2;Syncytiotrophoblasts: 56.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 172.1;MCF7: 202.3;OE19: 94.4;RPMI-8226: 77.8;SK-BR-3: 128.4;U-698: 237.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057757			Approved	Nucleoplasm,Nucleoli,Vesicles	"Secreted to blood"	NA	NA	248000			"Cluster 27: Brain & Skin - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA057757: AB_2683518"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-3)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.59e-1)"	1.5	6.5	33.1	1.9	34.6	0.0	1.3	37.2	27.9	8.5	43.8	2.9	2.2	1.2	17.2	23.9	9.5	0.4	13.8	35.6	28.5	6.3	0.0	1.6	1.0	36.2	36.3	0.2	0.5	0.0	2.7	25.7	34.7	5.9	1.7	5.3	3.9	9.2	0.3	22.5	1.9	0.3	32.8	0.6	3.6	0.7	39.7	3.8	45.9	0.0	2.1	6.8	13.0	42.8	0.3	0.7	23.4	5.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	20.0	6.8	172.1	41.3	0.0	8.7	48.3	5.2	0.0	0.0	0.4	17.2	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	202.3	0.0	0.1	12.3	94.4	0.0	0.1	0.1	77.8	0.0	0.2	0.4	17.8	5.5	128.4	0.5	15.2	0.9	0.4	0.4	0.1	10.9	0.0	0.1	0.2	0.3	237.6	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	34.6	37.2	27.9	35.6	28.5	36.2	36.3	34.7	32.8	39.7	42.8	0.6	6.4	2.2	74.1	0.4	13.8	13.4	12.9	51.8	4.7	0.9	4.6	15.1	0.0	4.2	1.8	0.0	137.4	0.1	0.2	0.0	0.0	5.3	1.7	2.4	1.2	2.4	0.0	0.9	0.0	21.0	13.5	2.0	2.5	21.6	0.1	0.0	0.0	11.0	1.7	4.7	1.5	6.1	0.0	1.9	4.9	0.3	0.4	3.6	2.8	0.1	38.4	0.0	74.4	8.7	0.0	0.3	0.4	2.5	6.6	0.2	2.2	1.9	2.4	0.0	1.3	0.8	1.8	3.4	44.2	9.7	56.9	0.9	0.7	1.5	18.1
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	"Bone morphogenetic protein receptor type 2"	Q13873	2	202376327-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.2;Inhibitory neurons: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA017385: AB_1845397, HPA049014: AB_2680599"	"unprognostic (2.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	18.5	21.6	8.2	10.9	14.1	2.2	13.2	3.2	16.8	22.6	0.3	13.6	8.5	20.0	11.3	12.4	14.9	17.3	21.5	16.0	14.8	17.4	15.6	29.1	7.2	6.2	7.7	16.8	10.4	17.5	8.5	34.0	10.0	17.1	13.0	26.7	11.0	13.9	10.9	10.9	8.6	24.3	3.9	13.1	11.7	11.3	10.6	9.0	18.2	23.1	9.4	20.6	12.4	5.9	13.3	12.3	12.6	19.7	34.2	31.9	23.8	27.2	28.3	23.6	23.9	10.8	19.6	4.7	30.7	58.2	19.9	24.5	16.8	21.4	41.6	13.8	11.2	14.2	12.6	16.8	22.7	4.0	10.7	24.2	21.5	17.1	22.8	40.6	73.9	5.6	9.3	22.5	33.8	24.8	3.4	3.6	6.9	6.6	11.1	9.1	24.3	7.1	21.3	27.9	12.6	12.7	28.9	17.7	32.7	32.0	13.2	9.5	75.9	48.0	24.4	16.3	16.7	3.1	4.1	1.3	11.3	9.0	13.9	0.1	0.6	0.2	0.9	0.5	0.6	0.3	0.3	0.5	0.6	0.4	0.7	0.3	0.1	0.3	0.9	0.7	1.0	0.3	8.2	14.1	3.2	16.8	16.0	14.8	6.2	7.7	10.0	3.9	10.6	5.9	116.9	105.8	40.3	104.5	15.2	33.4	18.0	34.9	13.6	54.3	29.2	29.7	55.5	15.7	38.8	20.2	81.3	16.9	17.8	25.2	1.9	27.2	2.8	23.1	54.5	152.2	25.1	6.9	202.2	28.1	22.6	47.7	16.8	36.4	23.5	155.1	143.1	19.9	18.7	35.3	190.2	16.3	20.3	24.2	31.7	4.6	33.8	23.5	42.7	170.5	20.2	39.9	16.5	152.8	55.1	46.8	21.1	42.9	9.5	23.9	16.4	12.4	28.0	31.7	65.7	48.8	62.4	33.2	25.0	21.2	35.9	20.0	13.1	0.8	15.5	24.8
BMS1	"BMS1L, KIAA0187"	ENSG00000165733	"BMS1 ribosome biogenesis factor"	Q14692	10	42782795-42834937	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"		"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036589, HPA043081"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Mitotic chromosome"		"HPA036589: AB_10601460, HPA043081: AB_2678305"	"unprognostic (1.46e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.82e-2)"	8.1	8.3	6.5	8.9	7.2	10.7	8.5	8.6	8.2	8.2	8.5	7.7	6.3	8.2	6.8	9.6	7.3	5.1	9.0	6.1	7.8	8.1	8.1	7.6	10.0	7.4	7.8	8.4	8.8	11.4	7.6	8.2	7.7	7.3	7.9	6.5	8.8	6.9	17.7	10.2	7.8	7.7	6.5	8.7	7.4	8.1	7.0	9.6	7.2	13.4	10.8	10.1	8.3	7.2	32.0	26.7	25.3	29.0	18.8	15.5	24.5	26.1	27.5	30.3	25.9	37.1	24.4	16.9	18.1	22.7	17.0	27.3	42.0	33.8	39.4	24.7	29.3	22.7	20.7	31.9	16.2	61.7	20.4	13.9	16.9	32.7	31.5	16.9	23.2	19.4	40.4	17.7	21.8	27.1	34.6	20.3	32.3	22.0	28.0	31.3	26.7	18.1	16.8	27.7	19.3	20.4	22.9	25.1	21.7	26.2	30.6	17.6	28.3	14.0	50.7	28.4	43.2	14.1	18.7	48.5	20.5	44.9	11.0	3.8	4.6	2.7	7.2	8.2	8.5	8.7	8.9	7.9	7.5	6.1	9.6	8.3	0.6	6.1	7.1	3.9	6.9	5.3	6.5	7.2	8.6	8.2	6.1	7.8	7.4	7.8	7.7	6.5	7.0	7.2	25.6	32.1	33.1	19.6	29.7	22.9	33.9	28.4	14.2	20.7	18.8	17.1	48.0	20.0	37.4	23.9	10.4	27.7	23.6	10.2	21.5	32.3	14.6	28.8	34.5	31.3	16.8	19.5	31.4	34.9	30.0	26.4	16.3	30.0	22.1	36.8	21.4	18.6	19.7	21.9	28.8	11.5	22.4	15.3	22.6	12.1	23.6	19.9	33.8	10.3	35.2	12.8	24.7	20.1	24.0	38.2	8.9	16.6	31.3	32.2	8.8	30.1	49.5	28.7	19.7	35.3	31.4	40.3	56.1	17.1	25.4	24.9	25.3	33.5	18.7	41.4
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"epididymis: 102.6"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 28.2;Hepatic stellate cells: 93.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	77	"granulocytes: 7.6"	"Cell line enriched"	"Detected in some"	119	"HUVEC TERT2: 353.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	7.7	0.3	0.3	1.7	0.5	7.1	4.9	0.3	0.6	1.7	1.1	3.8	4.4	2.3	102.6	2.3	2.6	2.6	8.8	0.3	0.3	0.6	0.7	3.0	1.5	0.3	0.4	0.9	0.9	0.3	0.2	4.7	0.3	0.9	2.4	0.0	1.1	0.9	1.3	1.6	4.8	2.6	0.3	2.2	1.4	0.2	0.4	0.7	2.0	2.2	0.4	2.6	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	353.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.4	14.1	0.0	1.1	1.3	0.0	0.4	0.7	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.2	0.0	28.2	4.2	3.2	1.3	0.2	0.0	1.1	4.6	0.2	0.0	0.1	93.9	0.7	0.1	0.0	1.2	0.1	2.0	0.0	1.1	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.8	0.0	0.0	0.3	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.4	0.4
BNC1	"BNC, HsT19447"	ENSG00000169594	"Basonuclin 1"	Q01954	15	83255903-83284714	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.0;esophagus: 12.5;testis: 30.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 88.6;Early spermatids: 45.5;Late spermatids: 103.4;Suprabasal keratinocytes: 58.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 51.1;HBEC3-KT: 116.6;hTCEpi: 128.1;hTERT-HME1: 123.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063183, HPA066947, HPA077428"			Enhanced	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345"	"unprognostic (1.86e-3)"	"unprognostic (1.08e-1)"		"unprognostic (7.89e-3)"	"unprognostic (5.55e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.89e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (8.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.01e-2)"	15.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	3.1	0.0	0.1	0.0	0.0	8.1	12.5	0.9	0.1	1.4	0.2	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.7	0.0	1.0	0.0	1.8	0.0	0.2	0.0	0.1	2.0	0.2	0.0	9.3	0.0	0.0	0.0	0.0	0.1	30.8	0.3	4.2	0.1	0.3	2.1	0.3	6.5	0.4	25.9	0.1	0.0	0.0	4.2	6.4	0.0	2.0	0.3	21.9	30.3	0.0	0.5	0.0	1.0	13.8	0.0	51.1	2.7	116.6	39.3	0.0	0.2	0.0	0.0	0.0	32.6	0.0	0.0	5.6	128.1	19.6	123.8	4.5	21.7	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	4.6	0.0	0.0	0.0	11.6	0.0	0.0	14.2	0.0	0.0	40.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	88.6	14.8	15.5	14.8	0.0	0.0	0.1	0.4	1.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	6.9	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	5.5	103.4	0.6	0.1	8.8	1.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.7	0.0	1.2	0.0	0.1	1.7	0.0	0.0	2.7	0.6	22.2	6.5	21.7	58.4	0.0	0.0	0.0	0.0	4.8
BNC2	"BSN2, FLJ20043"	ENSG00000173068	"Basonuclin 2"	Q6ZN30	9	16409503-16870843	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.9;ovary: 31.7;smooth muscle: 31.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.7;Leydig cells: 90.1;Microglial cells: 230.5;Peritubular cells: 67.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"gdT-cell: 2.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HSkMC: 31.9;Karpas-707: 40.4;RPMI-8226: 28.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA018525, HPA059419"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA018525: AB_1845402, HPA059419: AB_2732637"	"unprognostic (2.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.14e-3)"	5.6	1.0	1.4	3.7	2.5	0.7	3.3	2.3	4.4	12.1	8.2	10.1	1.3	26.9	2.1	4.6	18.4	7.2	2.9	2.6	2.7	6.4	0.3	3.1	0.8	4.7	6.0	31.7	0.5	2.9	1.7	3.4	3.9	3.7	3.0	0.8	1.3	4.8	3.5	3.4	3.3	31.7	3.5	0.7	3.0	6.9	4.7	2.5	2.1	1.9	1.1	6.3	5.8	4.9	0.3	1.7	1.2	0.1	17.5	21.1	2.7	11.4	19.5	7.8	6.4	0.1	0.0	0.0	3.7	7.8	5.8	0.1	5.1	0.0	7.9	0.2	2.0	0.1	5.3	0.0	13.4	0.1	0.5	31.9	0.0	16.6	0.1	13.7	18.0	0.0	0.0	40.4	11.1	0.0	0.0	2.8	6.6	0.1	10.2	0.0	12.5	28.0	6.0	0.3	0.2	1.0	0.1	0.1	18.6	8.3	0.1	0.0	17.7	18.6	13.5	15.1	20.9	0.2	0.0	0.1	7.6	2.5	2.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.5	1.4	2.5	2.3	4.4	2.6	2.7	4.7	6.0	3.9	3.5	4.7	4.9	5.5	0.0	2.2	46.7	0.0	10.1	0.6	0.0	33.6	8.2	0.2	0.4	4.8	0.0	0.6	0.0	0.0	3.2	10.7	0.1	0.0	1.0	7.2	2.2	9.1	10.5	0.0	0.0	1.6	0.4	1.2	38.6	3.1	2.0	22.2	25.1	10.4	0.3	7.3	0.0	1.9	1.1	6.1	1.6	2.3	4.5	90.1	4.2	10.6	230.5	0.1	2.6	30.9	1.0	1.6	0.1	0.0	67.7	3.9	0.7	5.7	35.5	0.7	0.3	6.6	31.5	5.1	0.9	13.5	5.7	5.5	1.2	3.1	36.5	1.8	0.1
BOC	CDON2	ENSG00000144857	"BOC cell adhesion associated, oncogene regulated"	Q9BWV1	3	113211003-113287459	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025806	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	No		7900000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies, Plasma membrane"	Nucleoplasm	"CAB025806: "	"unprognostic (6.89e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.03e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (4.89e-4)"	"unprognostic (8.66e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.18e-5)"	41.6	5.8	15.8	10.4	15.5	0.2	29.8	13.1	12.1	26.0	33.2	49.1	4.9	46.6	10.1	24.9	63.2	19.3	14.3	17.1	15.2	9.7	1.0	6.6	3.6	53.2	30.1	35.2	16.1	2.7	20.8	2.2	23.2	33.8	4.6	3.2	23.8	21.3	6.3	34.9	18.3	32.6	32.3	4.6	19.0	5.0	26.3	5.7	24.6	9.0	3.1	32.5	25.8	23.4	0.0	7.6	27.6	79.2	113.6	6.0	0.9	12.8	41.9	3.2	2.7	0.0	0.0	0.1	7.8	21.8	1.7	0.0	5.6	2.7	1.1	0.0	3.4	0.0	2.3	0.0	0.6	0.3	0.2	19.7	1.8	1.7	0.2	25.7	0.0	0.0	0.1	0.0	0.6	2.1	0.2	1.4	7.0	0.0	6.9	0.2	12.3	0.0	0.7	0.1	8.2	11.7	0.1	0.5	0.3	8.1	3.4	0.4	0.0	4.5	7.3	0.1	4.2	0.0	0.0	0.0	9.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	15.5	13.1	12.1	17.1	15.2	53.2	30.1	23.2	32.3	26.3	23.4	9.6	0.0	0.5	71.8	0.0	21.2	3.1	3.6	112.1	0.6	3.7	17.3	1.1	1.5	0.7	5.5	0.0	4.8	0.2	0.0	0.0	0.1	1.4	12.6	10.5	5.6	1.8	0.0	8.8	0.0	4.3	55.4	0.5	11.7	0.0	5.7	3.3	0.1	0.8	0.0	2.5	0.0	0.0	0.3	5.5	3.3	84.8	1.0	10.6	6.5	0.0	12.2	0.0	24.1	0.7	0.3	0.0	47.8	0.6	3.3	0.0	0.0	0.3	0.5	0.0	18.0	13.5	1.5	3.2	11.5	11.1	1.9	0.8	1.1	0.0	0.9
BOD1L1	"BOD1L, FAM44A, FLJ33215, KIAA1327"	ENSG00000038219	"Biorientation of chromosomes in cell division 1 like 1"	Q8NFC6	4	13568738-13627725	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036943, HPA037362, HPA041290"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.15e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (3.48e-6)"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.60e-2)"	15.9	10.6	11.8	17.6	12.8	41.6	16.2	17.5	15.0	14.3	10.1	16.1	10.8	16.6	16.8	12.8	14.8	12.4	11.9	11.2	14.4	13.5	11.1	12.9	21.8	13.5	12.3	23.0	13.7	22.6	9.1	16.6	13.1	12.3	12.5	22.0	14.5	12.7	11.3	17.7	18.8	11.8	10.6	21.9	14.2	16.7	12.9	25.3	13.7	14.1	20.8	12.7	14.0	15.7	17.6	23.2	22.7	16.3	27.0	28.4	17.4	20.0	21.0	16.3	18.1	17.6	18.7	23.6	8.9	22.0	30.2	11.7	18.7	19.9	31.2	16.3	10.7	33.2	31.0	21.6	16.6	50.5	26.4	22.9	22.1	33.7	25.9	22.3	17.0	16.4	23.8	27.4	20.6	10.5	26.2	33.4	29.2	11.3	19.9	19.8	33.6	9.6	30.6	17.5	13.5	24.6	22.0	7.7	18.2	24.3	9.1	19.3	38.9	25.1	13.2	15.6	26.7	32.3	20.3	29.0	24.6	23.4	20.3	2.5	1.1	2.3	1.1	1.1	0.9	1.3	0.7	0.8	0.7	1.5	1.0	0.8	9.2	0.6	0.7	1.9	0.7	0.4	11.8	12.8	17.5	15.0	11.2	14.4	13.5	12.3	13.1	10.6	12.9	15.7	113.2	83.3	95.8	72.1	93.7	26.3	22.6	17.4	33.0	170.8	39.6	67.8	88.5	51.5	49.7	36.8	89.6	16.5	105.8	31.0	3.9	30.2	20.8	135.4	108.7	68.7	34.7	57.4	56.1	25.3	18.6	60.0	29.6	193.7	63.3	110.1	41.0	32.7	21.5	161.5	62.8	29.1	6.1	41.5	29.0	17.6	50.4	70.9	24.9	56.2	64.1	87.6	57.7	57.8	96.5	33.2	23.8	57.9	68.4	24.8	22.4	7.6	40.0	198.3	46.0	103.4	78.8	83.1	32.1	29.7	28.8	18.6	73.5	106.7	24.3	27.4
BOLA2	"BOLA2A, My016"	ENSG00000183336	"BolA family member 2"	Q9H3K6	16	29443056-29454964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.7;Erythroid cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 24.7;HEK 293: 32.4;Hep G2: 22.1;MCF7: 33.7"									"HPA045380, HPA046696"	Supported		Uncertain	Nucleoplasm		NA	NA		390000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA045380: AB_2679301, HPA046696: AB_2679757"																		6.6	8.0	0.3	0.8	0.4	2.6	5.8	0.3	0.7	4.6	0.3	9.2	2.4	3.9	0.0	10.2	3.9	0.5	7.0	0.3	0.3	8.6	7.6	6.7	2.0	0.4	0.3	2.2	5.3	0.3	7.9	0.4	0.3	5.1	0.1	0.0	6.6	0.2	6.4	6.6	9.0	0.1	0.3	12.2	8.0	13.2	0.3	0.2	4.9	0.0	0.3	6.6	6.1	0.4	7.0	24.7	0.7	1.3	0.5	0.8	9.2	1.9	0.8	2.3	2.5	12.5	3.2	4.4	9.2	0.2	2.6	4.5	0.4	1.6	0.1	10.2	32.4	8.2	9.4	22.1	1.2	2.8	5.9	0.4	0.7	2.8	0.1	0.2	1.9	11.2	2.6	1.2	0.4	33.7	3.4	6.7	2.9	0.2	18.6	8.0	2.9	8.6	0.5	5.5	3.7	3.3	2.2	4.3	2.0	0.0	1.9	1.3	3.3	5.8	1.6	4.1	3.4	8.4	8.7	7.6	4.2	6.4	3.5	6.0	7.1	7.2	5.0	9.8	6.1	15.3	6.2	6.7	4.4	12.4	5.3	5.3	1.6	4.6	8.2	10.6	8.3	8.8	0.3	0.4	0.3	0.7	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.4	0.4	0.0	2.7	0.3	0.7	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.0	0.0	0.3	1.0	0.7	0.0	0.4	0.5	0.4	0.6	0.2	0.0	2.7	0.9	0.8	0.2	0.4	0.0	0.8	1.3	0.4	0.0	0.4	0.2	0.0	1.0	0.3	0.0	0.6	0.0	0.6	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.5	0.6	0.6	0.4	0.0	0.3	0.4	0.8	0.1	0.7	0.0	0.0	0.5	0.4	0.2	0.4	0.5	0.3	0.3	0.8	0.1	0.3	0.3
BOLA2B		ENSG00000169627	"BolA family member 2B"	Q9H3K6	16	30192932-30194306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 107.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045380, HPA046696"	Supported		Uncertain	Nucleoplasm		NA	NA		390000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA045380: AB_2679301, HPA046696: AB_2679757"	"unprognostic (2.49e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.02e-3)"	"unprognostic (9.80e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.29e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.91e-3)"	29.1	29.5	84.0	63.6	88.0	98.6	36.8	90.5	115.2	26.3	87.1	84.4	76.2	15.4	30.8	41.3	18.1	26.3	32.4	84.3	88.7	36.4	24.6	27.4	76.7	90.6	87.3	13.7	46.9	69.3	28.6	31.6	88.5	20.6	48.5	8.6	43.4	18.1	44.8	29.5	56.4	21.3	85.2	48.2	54.6	28.2	86.1	58.8	16.9	60.1	59.1	61.1	22.8	91.9	277.0	624.3	120.0	300.3	66.6	93.3	224.4	103.3	111.9	161.0	201.1	317.6	309.1	104.5	304.9	86.7	212.3	174.0	129.9	272.4	63.5	257.0	1029.1	229.0	322.0	937.7	158.6	190.2	270.7	79.6	186.6	307.1	168.3	43.6	204.0	365.9	161.2	359.9	139.3	875.3	292.5	379.3	362.2	275.3	651.2	382.2	143.2	699.6	219.4	272.7	305.0	310.0	59.5	558.5	143.8	42.3	227.1	174.4	112.0	173.6	144.4	259.4	276.8	458.9	353.3	302.1	253.4	303.2	277.1	130.8	178.0	156.5	193.4	226.7	196.8	313.6	191.2	204.6	156.7	245.1	144.6	185.2	31.8	160.2	213.7	254.6	254.0	195.8	84.0	88.0	90.5	115.2	84.3	88.7	90.6	87.3	88.5	85.2	86.1	91.9	4.4	16.0	19.2	0.0	11.7	6.2	3.2	7.5	6.2	0.9	18.3	16.0	107.5	22.8	24.6	23.9	2.1	7.5	11.3	35.7	46.9	14.4	27.8	8.3	4.4	12.6	28.9	5.2	0.0	24.5	5.7	14.1	11.2	8.3	30.3	2.4	16.4	27.1	11.3	1.7	0.0	22.8	8.2	22.0	8.0	31.6	2.5	12.0	7.2	0.0	12.3	7.3	14.4	0.0	0.0	29.6	25.2	1.5	11.0	3.9	51.4	32.7	24.7	2.3	6.6	2.4	11.0	5.7	8.0	5.6	11.2	3.8	14.5	2.7	23.7	4.1
BOP1	KIAA0124	ENSG00000261236	"BOP1 ribosomal biogenesis factor"	Q14137	8	144262045-144291438	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 223.5"	"Low region specificity"	"Detected in all"							"HPA047869, HPA066764"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA047869: AB_2680193, HPA066764: AB_2685716"	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	18.1	17.8	6.8	8.8	6.9	9.7	16.3	7.7	10.9	16.1	3.5	17.3	5.6	18.2	1.0	26.0	13.2	2.8	24.4	7.6	5.5	16.7	21.5	13.3	8.0	7.1	6.0	11.1	32.0	5.6	16.9	3.7	6.5	15.3	1.9	1.1	13.2	3.1	76.6	21.4	14.9	3.1	4.7	20.4	15.4	20.1	6.2	5.4	17.0	8.1	3.6	19.3	16.5	6.1	45.0	87.4	11.8	50.6	6.4	7.7	41.4	30.5	6.5	30.3	19.1	66.3	25.4	54.1	50.1	11.6	11.5	34.9	21.2	36.2	6.9	47.8	82.5	68.4	54.4	49.7	15.1	30.8	35.6	15.5	17.0	25.2	22.1	5.7	18.8	48.3	70.1	18.1	11.9	112.8	82.4	37.6	28.3	45.1	223.5	61.4	17.6	82.2	12.5	30.1	64.7	25.8	32.5	41.9	20.3	5.5	30.6	27.7	36.6	27.8	83.3	37.1	88.5	16.5	11.7	45.6	20.3	48.6	36.7	0.0	2.2	1.3	1.9	2.3	2.1	2.5	2.2	2.5	3.0	1.8	2.0	1.8	0.1	1.8	2.0	2.0	2.0	1.2	6.8	6.9	7.7	10.9	7.6	5.5	7.1	6.0	6.5	4.7	6.2	6.1	12.8	9.6	5.1	3.9	16.7	0.5	18.7	0.0	13.1	9.8	12.7	13.8	7.2	10.0	3.7	11.0	0.0	25.2	20.9	18.7	5.9	25.8	11.2	7.5	10.7	12.0	26.9	22.1	4.4	21.7	45.3	13.2	17.3	8.3	10.2	13.5	4.6	14.8	21.5	15.2	3.5	11.5	0.0	11.1	0.0	24.3	10.5	12.8	0.0	1.0	16.2	16.7	18.6	5.0	2.8	26.4	11.3	9.8	25.4	39.5	11.3	17.2	1.5	4.6	13.1	12.9	15.1	13.9	53.4	25.7	0.1	17.8	11.8	29.6	31.8	14.3
BORA	"C13orf34, FLJ22624"	ENSG00000136122	"BORA aurora kinase A activator"	Q6PGQ7	13	72727749-72756198	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 13.5;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040866	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA040866: AB_10794868"	"unprognostic (9.93e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.32e-12)"	"unprognostic (7.04e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.28e-2)"	1.6	1.3	1.2	4.3	1.2	6.0	2.4	1.4	1.7	1.6	1.9	4.2	4.3	1.3	1.5	3.5	1.4	1.3	1.0	1.2	1.3	1.8	1.7	1.8	7.6	1.6	1.3	1.2	1.7	0.5	1.9	2.3	1.5	1.8	5.0	3.5	1.9	1.0	1.1	4.2	3.5	1.7	1.1	4.2	3.2	4.0	1.4	8.1	1.9	0.9	6.8	2.2	2.2	1.5	32.5	8.5	19.6	14.7	2.4	2.4	11.6	9.8	8.6	17.9	18.1	20.6	17.2	23.8	6.4	6.4	10.3	15.0	17.1	11.5	22.1	20.9	12.3	28.7	11.4	15.8	1.7	54.2	17.1	1.9	2.6	8.9	15.1	5.0	14.6	22.8	12.7	10.7	14.6	9.8	20.8	21.8	10.8	36.8	6.0	16.4	12.3	10.6	6.5	10.0	6.9	7.0	12.0	12.8	10.2	15.0	6.4	24.6	4.8	5.8	9.7	8.3	16.3	6.9	7.0	14.8	16.3	24.8	13.9	1.3	1.1	0.5	1.9	1.9	2.3	1.6	1.8	2.0	1.9	1.9	1.6	2.5	0.1	1.8	1.2	1.4	1.9	1.1	1.2	1.2	1.4	1.7	1.2	1.3	1.6	1.3	1.5	1.1	1.4	1.5	1.6	3.2	2.8	3.6	5.4	0.6	1.3	2.2	3.4	1.7	1.4	1.3	0.3	1.5	2.1	1.8	2.1	7.5	3.9	3.1	0.0	1.9	12.6	2.2	2.3	1.4	0.0	13.5	4.3	2.6	11.5	1.7	3.6	2.4	1.3	5.1	1.8	0.4	4.6	8.4	3.1	2.7	0.0	2.8	1.5	2.7	0.9	2.8	0.0	3.7	3.5	1.1	4.1	2.5	7.3	1.7	2.2	1.2	5.2	1.2	3.2	0.8	2.7	2.3	13.1	1.6	1.5	11.8	4.3	3.4	1.1	2.9	4.1	1.5	5.8	1.4
BORCS8	MEF2BNB	ENSG00000254901	"BLOC-1 related complex subunit 8"	Q96FH0	19	19176903-19192591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045700	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"HPA045700: AB_10968570"	"unprognostic (4.23e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.82e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.00e-2)"	12.7	12.4	27.2	11.9	27.1	15.9	8.4	27.1	34.7	6.1	25.3	9.7	11.0	6.5	6.4	11.7	10.8	7.6	17.4	27.2	29.7	13.4	10.7	10.5	12.5	28.0	27.7	5.3	11.0	15.9	20.3	7.6	28.8	10.0	8.7	5.5	9.9	7.9	14.3	8.7	8.1	8.8	25.4	10.1	9.8	8.6	27.2	12.2	12.5	18.0	8.7	10.8	6.3	28.4	21.9	15.4	13.5	14.4	17.8	8.7	22.5	22.4	16.3	25.9	25.7	17.9	26.1	12.9	36.6	22.1	19.1	12.9	12.9	28.5	9.9	12.6	18.9	11.1	23.0	18.0	14.8	17.4	17.8	13.6	15.0	23.2	9.2	11.0	29.7	19.0	26.1	21.1	28.5	38.6	25.7	14.5	9.8	23.3	18.7	10.3	9.9	18.7	27.3	17.1	26.2	14.5	22.4	17.0	15.9	10.0	20.8	17.3	17.0	14.1	14.9	32.5	34.3	15.7	15.3	15.3	16.8	14.0	27.8	45.3	32.4	57.2	14.5	44.9	12.5	27.0	15.4	14.6	22.2	19.6	12.9	13.2	79.9	14.9	45.9	30.1	19.7	20.0	27.2	27.1	27.1	34.7	27.2	29.7	28.0	27.7	28.8	25.4	27.2	28.4	16.6	12.8	21.6	0.0	13.6	0.0	15.4	0.0	5.2	17.0	19.6	18.5	0.0	25.8	7.4	14.7	10.4	31.8	22.5	11.6	43.0	38.0	5.0	25.4	12.1	12.3	10.9	10.8	0.0	32.7	34.9	11.1	13.3	15.7	10.1	11.6	12.1	16.6	41.0	18.5	0.0	9.3	0.0	23.4	0.0	5.2	7.8	24.0	0.0	0.0	37.1	13.2	15.5	0.0	0.0	42.4	9.5	6.8	15.3	14.7	25.6	40.8	13.1	18.3	0.0	11.6	15.0	33.8	23.9	7.4	0.0	39.5	14.0	18.6	9.5	17.2
BORCS8-MEF2B	MEF2BNB-MEF2B	ENSG00000064489	"BORCS8-MEF2B readthrough"		19	19145569-19192158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 2.2;dendritic cells: 1.4;Gastric mucus-secreting cells: 1.5;Late spermatids: 1.1;Plasma cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.0;U-266/70: 3.1"									HPA004734	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"		"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (2.74e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.29e-2)"	0.2	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.6	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.6	0.2	0.2	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.6	0.2	0.2	0.1	0.3	0.2	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.1	0.1	0.7	0.2	0.1	0.1	0.4	0.3	0.4	0.0	1.4	0.3	0.1	0.0	0.5	0.5	0.2	0.1	0.2	0.1	0.5	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.9	0.1	2.0	0.5	0.2	1.3	0.1	0.6	0.0	0.7	0.7	0.1	0.0	0.1	1.6	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.0	1.5	0.0	3.1	0.6	1.7	0.3	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.1	1.4	0.8	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.2	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.5	0.0	1.2	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.6	0.0
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646811-134679816	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 87.3"	"Group enriched"	"Detected in all"	4	"Distal tubular cells: 129.1;Erythroid cells: 456.6;Syncytiotrophoblasts: 368.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 118.2;RT4: 186.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA		81000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favorable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favorable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	11.4	12.6	16.3	9.1	17.1	87.3	12.4	17.9	20.5	12.5	15.8	12.9	8.4	9.6	18.5	26.9	8.5	12.9	13.5	16.5	19.0	35.1	13.1	14.0	11.1	17.9	17.8	7.1	8.4	35.3	18.1	47.0	18.2	13.5	10.0	19.9	17.8	17.9	37.8	10.7	8.0	12.1	19.6	12.5	11.9	14.7	17.7	16.3	11.9	27.0	26.2	39.0	17.2	18.5	14.0	16.3	21.7	29.6	24.3	14.4	21.9	41.3	49.9	15.7	23.2	6.5	18.5	17.1	12.0	23.2	30.9	11.2	23.3	22.7	27.6	118.2	19.9	9.8	15.4	7.8	16.7	18.8	12.4	14.2	20.0	29.7	16.0	24.0	58.0	20.8	28.8	20.9	37.8	6.6	30.7	26.0	22.7	27.7	15.3	23.2	15.5	12.4	36.1	186.8	18.7	31.1	19.3	23.1	21.7	23.1	15.1	11.8	44.7	25.1	6.0	33.7	33.9	33.9	41.2	21.5	43.3	17.7	43.7	61.1	16.4	48.9	23.3	22.2	16.7	19.3	15.0	20.7	17.5	18.9	20.7	21.1	30.2	18.5	23.0	11.4	21.1	23.6	16.3	17.1	17.9	20.5	16.5	19.0	17.9	17.8	18.2	19.6	17.7	18.5	17.6	9.6	25.5	6.5	15.7	39.0	18.5	60.6	10.8	19.2	15.9	18.7	25.0	18.6	52.3	27.6	2.1	44.5	43.0	5.0	129.1	45.9	3.4	10.0	7.0	18.8	13.1	456.6	8.0	18.2	32.7	17.0	4.1	8.5	24.7	6.6	10.0	4.7	15.1	20.2	9.3	4.6	36.7	11.7	10.5	7.2	10.2	11.8	23.2	5.6	15.7	25.6	47.4	7.5	11.6	49.0	4.6	12.0	14.2	26.0	5.5	68.8	50.5	13.5	6.6	12.0	22.1	33.9	21.8	13.5	13.2	368.9	25.0	7.8	4.8	19.2
BPNT2	"FLJ20421, gPAPP, IMPA3, IMPAD1"	ENSG00000104331	"3'(2'), 5'-bisphosphate nucleotidase 2"	Q9NX62	8	56957931-56993867	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.6;Cardiomyocytes: 53.8;Cytotrophoblasts: 18.0;dendritic cells: 16.2;Extravillous trophoblasts: 91.8;Hofbauer cells: 26.6;Syncytiotrophoblasts: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		480000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	37.6	37.3	14.8	16.1	19.9	12.4	19.3	19.2	19.8	25.5	8.9	17.4	13.3	21.9	16.2	19.1	13.4	16.5	29.4	16.0	17.9	23.4	36.2	17.2	12.3	17.2	17.6	11.8	19.6	35.6	13.7	24.9	17.7	31.0	17.6	19.7	21.9	23.6	37.4	14.3	12.7	25.7	15.3	15.5	16.9	16.5	18.0	15.4	27.1	30.1	13.3	22.4	12.2	29.3	42.4	34.5	26.0	26.9	78.2	53.3	35.7	62.9	60.9	44.1	38.3	17.4	29.2	26.3	47.0	67.3	31.2	33.7	31.8	42.5	65.0	36.4	22.7	51.4	23.0	31.2	48.5	33.0	35.1	43.2	41.6	39.7	63.9	40.8	59.5	24.3	22.5	46.1	48.9	22.1	40.6	19.8	19.2	48.1	12.7	27.9	23.4	29.7	46.0	24.9	10.1	28.1	35.3	42.9	36.3	27.1	38.4	23.9	50.1	59.3	34.2	59.2	45.8	47.5	42.5	27.8	81.0	27.0	37.3	1.8	0.9	0.5	0.9	0.6	0.7	0.7	0.6	0.5	0.7	0.9	0.6	1.1	2.5	3.2	2.6	1.0	0.4	0.3	14.8	19.9	19.2	19.8	16.0	17.9	17.2	17.6	17.7	15.3	18.0	29.3	22.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	18.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	91.8	14.4	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	33.8	1.8	0.0	0.0	0.0
BPTF	"FAC1, FALZ, NURF301"	ENSG00000171634	"Bromodomain PHD finger transcription factor"	Q12830	17	67825503-67984378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029069, HPA048289"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029069: AB_10602597, HPA048289: AB_2680342"	"unprognostic (1.22e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	25.5	23.7	24.1	25.4	29.5	32.0	25.5	88.1	26.3	30.3	10.9	27.9	15.7	27.9	28.7	26.6	29.6	19.1	20.7	21.0	38.2	27.9	20.7	22.6	43.7	26.4	21.9	38.1	22.9	27.4	34.6	22.2	24.3	25.2	22.2	44.0	25.2	16.7	25.9	37.5	28.5	19.6	17.6	31.4	23.6	32.1	22.6	52.9	27.4	22.3	39.2	24.4	27.7	34.3	42.2	52.8	76.3	38.7	41.6	39.0	42.2	32.0	29.4	37.1	31.8	49.6	29.0	167.7	22.4	35.4	28.5	32.2	74.4	34.5	60.0	24.2	72.5	64.9	50.4	68.8	19.8	97.3	49.9	28.6	37.3	36.9	27.6	34.0	70.2	52.9	75.1	46.1	32.3	64.0	99.1	47.3	58.9	37.9	47.8	70.3	91.0	33.6	32.5	50.6	56.5	65.6	42.8	117.4	46.4	91.4	49.1	53.7	49.6	56.2	43.7	20.7	39.7	39.3	42.0	97.9	26.9	45.1	22.0	20.3	4.2	8.5	7.2	2.4	5.7	6.2	5.9	5.7	3.0	11.8	6.1	6.3	9.2	10.7	5.7	10.9	4.5	1.6	24.1	29.5	88.1	26.3	21.0	38.2	26.4	21.9	24.3	17.6	22.6	34.3	118.7	115.4	148.2	192.3	130.9	75.2	55.3	37.8	87.0	216.8	76.2	78.5	136.0	61.5	92.0	58.8	143.9	39.4	170.3	64.1	7.9	63.8	26.6	147.7	174.5	108.1	126.1	114.6	124.4	63.1	30.8	94.8	88.2	165.9	121.4	124.9	71.0	46.4	42.2	198.5	136.4	68.9	48.8	56.3	54.4	25.7	108.7	84.7	64.0	109.6	88.0	129.3	146.2	231.8	262.7	65.4	64.5	111.3	129.2	62.1	37.7	17.4	80.8	202.6	65.7	167.3	92.3	144.9	101.3	82.6	75.6	38.7	128.8	126.6	85.8	60.7
BRAT1	"BAAT1, C7orf27, MGC22916"	ENSG00000106009	"BRCA1 associated ATM activator 1"	Q6PJG6	7	2537810-2555694	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029455, HPA076508"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029455: AB_10600761, HPA076508: AB_2686803"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.04e-3)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (5.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (8.88e-2)"	"unprognostic (3.71e-2)"	17.4	31.0	10.7	6.8	10.9	7.9	17.8	10.4	14.3	22.5	9.6	16.2	8.8	19.4	2.2	15.1	19.2	3.7	14.5	10.4	11.2	15.2	20.7	12.2	7.2	13.5	11.4	21.6	20.2	5.2	19.8	4.5	10.1	24.5	1.3	0.9	17.4	6.6	14.8	21.6	16.6	2.5	10.6	21.1	19.6	31.5	11.2	5.0	18.7	3.7	2.1	17.6	18.8	10.5	35.1	31.1	7.5	27.2	6.8	6.3	24.5	11.7	6.5	10.1	8.5	22.5	21.5	26.3	18.1	7.8	19.4	35.1	8.8	13.7	1.6	10.4	44.4	12.2	23.5	14.3	8.7	16.5	18.2	10.6	9.5	10.2	3.0	5.8	11.4	20.2	39.1	9.6	7.1	50.0	11.8	77.9	35.3	8.8	47.0	28.6	21.9	25.5	6.5	11.3	19.5	30.2	17.1	29.8	12.9	3.5	26.5	33.4	11.8	13.8	43.3	28.5	23.2	20.7	17.3	19.0	15.2	32.8	33.2	5.1	30.8	17.5	21.9	28.2	19.3	18.6	19.8	22.6	32.4	15.2	16.3	17.9	25.4	15.9	27.1	22.7	18.4	22.8	10.7	10.9	10.4	14.3	10.4	11.2	13.5	11.4	10.1	10.6	11.2	10.5	10.1	12.8	6.4	19.9	11.1	7.8	17.5	22.6	16.5	12.8	11.3	8.9	6.8	15.7	14.8	9.2	12.5	21.1	15.0	14.8	15.6	10.6	20.8	7.1	12.3	13.0	11.4	10.3	14.2	13.8	12.9	12.8	26.0	7.5	14.0	34.9	15.4	15.3	34.2	3.3	16.2	14.8	8.2	13.1	6.7	9.4	22.7	13.3	7.2	12.2	17.6	14.4	9.2	13.6	11.3	12.0	12.1	22.2	14.4	9.1	15.0	16.6	8.1	11.9	6.6	9.4	10.7	28.8	39.5	8.0	6.8	14.6	11.9	31.7	17.9	7.6
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1 DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 42.5;Granulosa cells: 38.2;Spermatocytes: 105.8;Spermatogonia: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 6.8;classical monocyte: 14.7;intermediate monocyte: 4.7;myeloid DC: 10.9;neutrophil: 11.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 10.9;granulocytes: 11.3;monocytes: 14.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611"	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	3.1	1.8	4.2	7.5	7.2	13.0	3.6	4.7	5.2	2.7	2.7	6.8	3.2	3.1	2.2	4.0	3.7	1.9	3.0	3.6	4.1	2.0	5.6	3.2	10.3	5.6	5.0	2.8	2.8	5.9	2.8	3.8	6.0	2.4	7.4	8.2	3.2	1.6	4.2	6.0	5.1	3.9	3.7	3.9	3.6	13.0	5.5	14.5	7.8	3.7	11.2	2.8	2.4	10.8	44.1	69.1	37.8	30.1	6.0	13.4	36.6	50.6	21.5	41.9	39.3	42.3	33.4	100.8	9.1	19.0	49.0	49.5	51.9	28.3	69.5	46.9	38.0	48.1	54.0	37.1	1.3	86.0	39.9	3.8	4.5	63.1	20.0	10.6	22.3	46.6	73.7	42.2	39.7	30.0	72.0	27.8	20.5	29.1	18.7	49.0	79.8	40.8	15.4	42.1	25.8	27.4	38.8	12.5	19.4	25.5	33.9	39.6	13.8	37.2	29.6	49.0	53.2	20.1	51.2	75.5	29.6	49.6	39.4	6.8	14.7	2.2	1.5	4.7	1.5	1.2	1.5	1.2	10.9	2.1	1.3	1.5	11.3	1.5	2.0	1.7	0.5	17.5	4.2	7.2	4.7	5.2	3.6	4.1	5.6	5.0	6.0	3.7	5.5	10.8	5.0	0.0	2.8	9.4	5.8	2.9	4.5	1.9	1.2	10.3	4.4	5.2	10.1	5.7	3.5	1.8	22.9	12.8	8.1	6.2	0.0	3.0	11.9	14.0	6.3	4.7	0.0	42.5	3.0	1.1	18.2	7.4	6.1	4.2	8.2	38.2	5.3	18.3	10.1	11.8	4.4	7.5	0.0	3.9	2.8	8.0	2.5	6.4	0.0	4.7	4.9	2.4	5.2	3.0	18.7	1.7	2.4	1.5	16.6	2.3	1.1	1.0	10.0	22.8	6.6	13.7	5.5	105.8	73.5	8.2	2.3	4.0	4.7	9.7	12.7	3.4
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2 DNA repair associated"	P51587	13	32315086-32400268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 3.1;testis: 2.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 115.4;Spermatogonia: 85.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA026815	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.0	1.3	0.0	5.8	0.5	0.0	0.0	0.2	0.2	0.7	0.5	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.3	2.1	0.1	0.1	0.1	0.1	0.0	0.0	1.0	0.1	0.1	0.8	0.0	0.2	0.0	0.0	0.7	0.5	0.3	0.1	0.9	0.6	2.7	0.2	3.1	0.2	0.0	2.0	0.5	0.2	0.1	4.7	4.0	6.0	5.0	0.6	1.4	7.0	4.8	3.1	5.5	5.0	10.6	6.0	15.9	3.2	2.1	7.6	6.1	5.5	2.9	10.5	10.5	3.1	10.3	2.5	3.5	0.1	15.4	4.9	0.2	0.0	10.3	6.9	0.4	4.5	8.1	7.0	5.5	6.4	5.1	11.8	8.3	8.3	4.9	2.3	11.4	17.3	3.0	1.4	5.4	2.4	4.6	5.9	2.4	2.2	2.2	2.9	7.3	1.3	6.3	6.8	7.0	6.7	2.0	3.3	8.0	2.7	5.7	5.8	0.0	0.3	1.5	0.5	0.7	0.1	1.7	0.4	0.4	0.3	2.2	0.5	0.4	0.8	0.5	0.8	3.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	4.4	9.6	2.6	0.0	12.4	2.5	3.3	2.5	2.2	0.0	4.3	3.3	1.9	0.0	1.8	0.0	0.0	14.1	10.5	4.8	0.0	2.5	5.2	4.4	6.3	5.5	1.2	29.5	0.7	1.6	12.7	5.8	10.7	4.6	3.8	26.9	1.4	0.8	9.5	0.0	0.5	4.4	0.0	7.5	11.0	4.4	2.1	14.4	3.6	4.7	20.1	0.3	0.0	0.0	0.6	1.2	1.8	1.2	27.8	1.2	1.0	0.6	2.9	0.0	13.1	8.3	5.3	115.4	85.6	8.0	1.3	5.5	7.9	4.2	7.8	2.3
BRCC3	"BRCC36, C6.1A, CXorf53"	ENSG00000185515	"BRCA1/BRCA2-containing complex subunit 3"	P46736	X	155071420-155123077	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Metalloprotease, Protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048737			Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA048737: AB_2680504"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.90e-1)"	9.9	12.9	6.8	12.1	6.6	15.6	15.8	9.2	7.7	12.8	6.8	22.3	19.3	9.2	18.5	18.4	11.6	8.4	11.2	6.6	7.0	17.8	13.8	9.8	15.4	5.9	7.1	8.1	11.4	14.7	5.2	14.0	6.7	14.6	23.3	12.9	18.5	10.9	17.8	11.1	16.9	10.6	5.4	11.0	15.6	2.3	7.4	13.4	15.2	17.6	15.5	12.6	6.3	6.6	95.6	45.1	24.4	19.6	20.9	17.7	37.9	35.9	25.8	24.1	52.3	44.0	40.1	84.1	62.8	22.1	36.1	36.3	54.4	33.6	38.0	45.4	42.1	17.7	76.1	41.4	15.8	62.8	25.5	17.3	16.9	35.1	28.5	23.1	30.1	32.2	27.4	24.9	24.6	33.6	25.8	28.8	22.3	101.9	41.9	36.2	43.3	42.0	36.8	36.5	38.0	17.3	25.6	43.6	27.3	31.5	25.2	33.7	31.5	20.4	32.1	27.6	53.8	30.0	56.1	114.5	28.2	61.5	25.3	36.8	18.8	34.0	20.0	22.9	23.4	17.6	19.3	18.2	21.2	16.7	14.8	16.6	10.5	28.4	24.1	13.3	25.4	16.9	6.8	6.6	9.2	7.7	6.6	7.0	5.9	7.1	6.7	5.4	7.4	6.6	12.0	32.1	23.3	16.6	14.0	5.5	7.0	13.8	6.8	13.0	15.0	14.0	27.2	10.0	28.5	7.3	14.6	26.7	17.6	25.5	19.6	22.9	0.6	13.8	13.7	10.6	9.6	17.1	31.9	19.8	26.6	11.3	12.8	15.9	26.6	13.7	8.6	8.6	17.4	8.4	35.2	22.6	16.2	9.5	7.0	1.3	5.9	14.5	5.4	15.9	22.3	12.9	20.6	26.7	29.2	14.7	16.8	12.0	21.1	10.3	16.3	18.0	25.1	14.5	19.7	12.6	22.9	1.2	1.3	26.2	6.5	13.5	14.9	18.3	27.3	8.3
BRD4	"CAP, HUNK1, HUNKI, MCAP"	ENSG00000141867	"Bromodomain containing 4"	O60885	19	15235519-15332545	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015055, HPA061646, CAB068177, CAB068178"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB068177: AB_2665685, CAB068178: AB_2665686, HPA015055: AB_1845435, HPA061646: AB_2684575"	"unprognostic (2.83e-3)"	"unprognostic (2.39e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.53e-3)"	"unprognostic (3.03e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.98e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	24.4	24.4	16.1	23.3	16.1	24.3	23.8	8.5	34.0	26.9	3.2	26.1	14.1	25.9	8.3	27.7	23.5	12.9	30.6	14.5	17.3	24.4	32.7	27.7	20.8	11.5	12.8	30.2	26.8	13.4	20.9	29.4	9.2	24.8	8.5	12.1	22.9	13.6	62.7	33.7	25.5	13.2	2.8	28.7	22.4	24.7	10.3	16.9	24.1	19.1	15.8	25.2	26.7	15.2	46.7	49.1	31.0	58.6	26.4	20.1	32.5	32.5	29.3	28.3	29.6	47.1	71.4	58.5	48.4	36.5	27.6	47.1	30.8	32.4	24.0	51.3	21.4	58.0	41.1	43.7	42.2	53.2	59.7	29.4	34.6	35.2	68.7	18.1	26.1	41.5	91.7	62.7	18.3	55.5	53.6	41.6	58.5	23.4	54.2	63.8	32.5	37.5	22.3	48.8	35.3	31.1	44.7	34.5	40.5	24.4	33.7	38.3	45.0	72.5	32.6	63.3	53.0	43.9	39.0	25.7	39.7	47.0	58.5	3.4	2.2	2.2	2.1	2.8	1.6	3.6	1.8	1.8	1.4	4.3	1.8	1.7	6.5	3.1	2.8	2.6	1.5	1.6	16.1	16.1	8.5	34.0	14.5	17.3	11.5	12.8	9.2	2.8	10.3	15.2	85.9	64.1	52.7	26.8	97.9	117.6	118.4	33.9	80.8	67.0	71.8	54.7	79.5	58.6	33.9	25.8	83.4	219.8	91.6	93.9	25.4	53.6	130.3	83.1	102.6	84.7	113.9	117.0	46.3	67.1	72.4	75.9	56.1	128.2	36.7	95.2	64.6	84.9	60.5	79.1	44.2	71.5	16.2	83.4	101.0	249.3	77.3	87.7	44.4	48.7	72.8	37.0	63.8	28.6	39.3	65.3	62.6	79.7	77.4	137.3	50.7	35.2	30.2	84.2	72.3	103.1	92.0	52.6	48.8	84.7	143.2	254.3	77.4	65.9	71.8	147.0
BRD7	"BP75, CELTIX1"	ENSG00000166164	"Bromodomain containing 7"	Q9NPI1	16	50313487-50368988	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042389, CAB046458, HPA060171"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214"	"unprognostic (2.10e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (2.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.34e-2)"	32.6	34.1	50.8	33.6	55.8	65.9	36.0	53.4	69.4	36.0	49.2	42.8	31.1	36.8	47.0	49.3	34.3	26.7	36.4	49.5	55.3	40.3	30.6	35.3	46.6	55.4	53.4	33.3	47.8	56.0	30.8	43.1	54.8	32.7	38.5	49.6	35.0	33.1	54.4	43.4	35.1	34.5	52.4	37.4	39.5	57.0	53.3	57.2	40.1	44.3	50.0	35.5	35.6	57.6	78.4	67.8	116.4	69.7	48.2	47.7	76.6	62.8	61.7	96.9	43.8	114.3	77.5	116.1	64.2	56.0	60.4	70.7	107.6	63.3	111.1	53.2	89.1	79.0	54.2	159.2	56.7	110.0	83.5	34.9	93.2	49.9	85.5	58.8	65.6	113.0	115.8	36.2	59.9	51.0	125.2	147.0	91.5	82.0	63.5	151.8	109.2	84.8	85.6	54.5	90.0	73.1	76.3	73.2	53.6	99.0	43.9	98.5	66.8	61.3	74.4	51.0	62.0	17.0	7.1	196.9	48.1	78.5	62.2	6.2	5.1	7.6	6.4	4.4	4.9	6.1	6.4	6.0	4.1	6.2	7.1	8.7	2.9	9.8	4.1	8.5	6.9	3.0	50.8	55.8	53.4	69.4	49.5	55.3	55.4	53.4	54.8	52.4	53.3	57.6	73.7	38.5	64.4	16.0	54.6	50.7	41.1	16.9	20.5	89.0	63.4	63.8	35.7	52.9	29.6	49.7	66.7	70.6	124.6	51.1	107.6	22.3	47.4	75.1	62.9	42.0	36.0	76.4	14.6	23.0	49.5	41.3	40.2	89.1	15.2	84.3	38.6	45.8	29.9	90.9	15.8	46.6	20.3	40.3	24.5	22.5	32.6	45.9	26.6	17.8	38.4	81.2	82.4	30.2	32.7	23.9	36.4	28.2	74.2	62.2	32.0	72.3	36.7	120.6	52.6	78.4	46.5	203.6	157.2	44.8	63.2	72.4	55.7	59.3	46.1	66.6
BRD8	"p120, SMAP"	ENSG00000112983	"Bromodomain containing 8"	Q9H0E9	5	138139770-138178953	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 120.8;Spermatocytes: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001841	Supported		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Mitochondria	"HPA001841: AB_1845438"	"unprognostic (1.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (1.73e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-2)"	21.8	21.5	23.4	15.4	24.2	22.4	25.1	27.4	28.5	30.1	21.5	30.5	15.5	28.4	41.3	23.5	26.6	16.4	19.5	22.0	23.4	25.0	25.4	19.5	20.6	21.5	21.1	32.7	30.6	26.2	46.6	24.9	22.2	27.3	24.8	38.7	25.1	23.9	27.8	23.6	23.3	25.1	20.8	27.6	24.9	83.1	22.7	38.0	34.3	25.1	22.1	24.3	24.8	29.6	28.7	36.8	63.1	101.8	45.0	42.0	57.0	43.4	47.9	61.6	64.4	55.4	62.6	28.6	42.2	40.3	62.9	32.9	67.4	41.5	65.9	50.3	50.1	38.5	93.6	38.0	25.0	23.6	39.2	31.4	27.2	48.7	44.1	49.3	39.7	52.2	35.2	35.8	41.3	31.8	48.4	37.6	28.6	32.9	18.8	46.4	52.2	35.1	41.4	41.3	55.7	27.9	51.9	22.4	40.1	85.0	38.5	43.2	25.0	30.2	34.7	21.2	38.1	31.5	37.9	39.1	23.1	34.7	28.5	16.2	10.8	14.1	14.6	8.0	15.8	10.7	12.7	13.2	12.0	11.0	15.9	16.0	20.2	23.8	8.8	8.4	13.0	9.8	23.4	24.2	27.4	28.5	22.0	23.4	21.5	21.1	22.2	20.8	22.7	29.6	21.0	25.6	38.3	28.1	17.8	6.9	10.6	16.4	31.9	33.7	19.8	20.3	44.8	14.3	27.0	27.6	37.5	27.7	19.0	17.0	19.6	19.5	120.8	30.1	51.1	24.3	31.2	26.5	26.2	12.4	13.2	32.5	20.9	29.7	24.0	43.2	13.6	17.2	11.9	30.3	23.7	23.3	14.2	14.8	9.8	43.9	31.4	14.3	24.9	12.2	31.3	27.1	19.6	27.6	30.8	16.0	16.8	24.0	21.8	18.1	15.4	22.4	29.0	34.9	26.3	23.2	31.7	226.9	65.0	23.2	7.0	25.3	19.1	41.9	18.6	10.1
BRD9	FLJ13441	ENSG00000028310	"Bromodomain containing 9"	Q9H8M2	5	850291-892801	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 110.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021465, HPA023197"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021465: AB_1845441, HPA023197: AB_2671106"	"unprognostic (3.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-3)"	"unprognostic (4.61e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (5.88e-7)"	"unprognostic (6.28e-2)"	"unprognostic (7.53e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (2.37e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.02e-2)"	7.7	7.4	14.3	9.1	14.2	8.1	8.5	13.0	15.0	6.9	12.6	7.3	6.8	8.6	7.3	6.6	7.4	5.9	10.5	13.2	12.7	5.8	5.5	7.8	10.0	15.0	14.1	8.8	8.7	9.0	4.5	6.9	13.5	6.6	7.0	3.6	8.8	8.2	16.9	6.8	7.6	7.9	13.5	8.0	7.9	7.5	15.1	13.2	8.0	9.9	8.5	8.6	6.0	14.7	14.4	14.2	27.5	28.6	11.7	23.7	32.5	28.2	19.4	29.7	23.5	26.6	19.5	17.9	46.0	30.4	33.3	14.1	20.4	27.7	27.5	110.2	17.0	22.2	37.0	17.9	23.7	34.0	20.3	17.7	9.9	20.8	19.0	22.1	29.6	34.2	29.5	12.8	25.4	22.9	40.0	32.1	18.5	15.0	22.4	26.9	16.4	16.5	17.2	21.5	16.8	29.7	56.3	19.1	13.4	14.9	17.1	43.1	28.7	24.2	18.8	12.4	29.3	23.3	10.0	32.5	22.7	35.5	32.3	7.0	3.3	3.7	3.0	1.5	4.0	4.9	4.2	4.5	3.0	6.0	3.8	3.2	2.0	4.2	2.9	3.1	5.2	1.4	14.3	14.2	13.0	15.0	13.2	12.7	15.0	14.1	13.5	13.5	15.1	14.7	36.8	19.2	14.4	13.1	32.1	25.4	18.2	12.5	39.3	70.2	23.5	21.7	25.2	25.8	13.8	23.9	45.9	17.1	39.5	33.9	23.5	23.4	93.5	46.7	80.7	25.0	16.3	21.0	9.3	20.0	30.3	24.0	42.8	52.7	19.0	40.9	27.8	22.2	21.0	101.0	8.2	33.9	4.1	25.4	14.9	56.8	22.7	25.3	14.2	6.5	31.3	29.1	42.2	9.0	11.8	31.1	27.4	19.5	44.8	20.6	21.3	18.7	7.7	87.8	26.3	28.5	25.0	49.2	68.2	32.0	20.3	19.7	47.8	27.1	27.6	16.5
BRF1	"BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90"	ENSG00000185024	"BRF1 RNA polymerase III transcription initiation factor subunit"	Q92994	14	105209286-105315589	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051918, HPA074990"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA051918: AB_2681663, HPA074990: "	"unprognostic (1.98e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.52e-4)"	"unprognostic (2.67e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.25e-6)"	"unprognostic (8.83e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.52e-1)"	10.5	11.4	19.7	5.5	22.2	6.5	10.5	23.1	23.6	12.5	12.9	11.1	7.6	12.1	4.2	10.4	12.8	6.0	12.2	17.1	19.2	11.6	13.1	8.4	8.1	31.8	24.9	13.0	15.1	10.3	20.4	6.0	29.7	12.0	4.2	7.5	10.1	6.3	17.7	11.2	10.3	4.6	18.7	12.6	11.2	14.6	25.4	7.3	10.5	9.6	5.8	11.5	9.9	37.4	12.6	28.0	11.8	25.3	10.3	11.4	11.9	17.4	11.2	15.4	12.2	20.2	18.8	9.4	16.9	12.0	7.5	24.2	14.4	11.7	8.4	25.2	14.2	11.5	15.1	9.9	11.5	13.7	24.3	11.3	10.1	9.3	11.5	7.8	11.3	19.7	13.1	7.5	7.6	40.9	16.2	17.1	8.6	20.7	27.7	28.2	8.1	9.6	7.6	29.9	37.5	27.8	18.4	14.0	16.0	5.4	33.4	18.9	16.8	12.1	9.6	22.7	14.2	13.8	11.5	8.9	14.5	11.3	16.9	0.4	1.2	2.0	1.6	1.0	1.1	1.5	1.1	1.6	1.2	1.4	1.4	1.3	0.5	2.5	4.0	3.1	1.6	1.6	19.7	22.2	23.1	23.6	17.1	19.2	31.8	24.9	29.7	18.7	25.4	37.4	11.5	3.2	5.9	17.6	11.4	7.5	7.1	4.5	8.6	18.8	10.7	9.0	8.5	2.8	6.3	3.7	16.7	11.4	15.5	16.2	3.9	5.8	2.3	26.5	10.9	9.5	9.6	6.3	18.3	7.1	8.9	7.7	14.8	16.5	2.5	16.0	8.9	11.3	7.2	30.3	20.8	11.7	4.1	6.7	10.3	1.4	6.5	7.8	8.8	10.3	5.3	7.1	4.1	15.1	34.2	4.8	6.5	4.5	13.4	7.7	8.9	6.1	12.4	20.0	0.0	9.6	8.2	9.2	12.7	7.7	8.8	9.3	11.6	13.2	12.5	5.1
BRI3BP	"BNAS1, HCCR-2, HCCRBP-3, KG19"	ENSG00000184992	"BRI3 binding protein"	Q8WY22	12	124993645-125031231	"Predicted membrane proteins, Transporters"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 20.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 174.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 114.9;U-698: 161.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014957	Approved		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA014957: AB_1845447"	"unprognostic (1.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.44e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.55e-1)"	3.3	2.0	9.2	8.9	10.7	5.5	5.5	8.2	10.7	3.0	7.1	15.5	20.8	2.1	2.2	6.8	4.1	4.8	2.5	9.2	7.9	6.9	4.8	2.8	13.8	9.6	9.7	1.5	5.1	9.1	2.1	2.1	10.2	2.9	15.3	10.0	2.5	2.2	1.7	5.5	18.8	2.6	9.1	5.9	8.2	1.8	9.1	7.0	4.4	2.1	16.2	2.5	2.6	9.4	34.1	43.8	13.8	12.5	10.9	5.6	24.1	22.2	4.6	13.7	7.1	36.1	22.3	114.9	27.8	5.0	8.9	38.7	30.7	17.3	10.9	26.9	25.5	58.4	16.9	24.8	2.2	86.8	72.2	2.5	9.9	15.0	7.1	5.3	5.1	41.0	23.5	8.0	12.0	31.3	45.1	33.3	9.9	29.9	17.3	30.2	23.0	30.7	17.3	46.8	19.0	13.2	27.6	26.9	9.2	4.6	48.8	60.8	5.9	13.0	16.2	12.5	23.4	26.9	49.7	161.8	11.9	28.7	29.1	4.2	2.2	13.1	0.8	1.6	0.8	1.4	0.6	0.7	1.7	1.5	0.5	0.7	2.2	0.9	1.2	4.2	0.7	0.6	9.2	10.7	8.2	10.7	9.2	7.9	9.6	9.7	10.2	9.1	9.1	9.4	3.4	9.6	10.4	13.4	23.6	12.2	9.1	8.2	5.2	37.1	14.9	6.3	7.2	31.5	9.2	9.2	14.6	15.4	24.3	65.5	3.9	9.1	25.6	16.1	7.2	5.1	7.8	21.5	32.6	10.4	24.0	7.1	32.1	18.0	18.4	7.2	4.2	27.4	19.8	25.2	43.8	42.8	8.2	31.5	26.1	174.4	1.2	23.6	10.6	11.2	28.8	12.1	9.2	11.1	23.4	17.1	43.3	4.1	39.5	9.6	60.2	12.7	15.0	27.9	0.0	9.2	6.9	1.1	11.5	20.7	18.3	5.2	11.5	6.8	72.6	9.7
BRICD5	"C16orf79, MGC21830"	ENSG00000182685	"BRICHOS domain containing 5"	Q6PL45	16	2209253-2211950	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.8;Cone photoreceptor cells: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 18.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"spinal cord: 3.1"	HPA063522			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Actin filaments"	Nucleoplasm	"HPA063522: AB_2685029"	"prognostic favorable (9.74e-4)"	"unprognostic (7.12e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.34e-3)"	"unprognostic (7.56e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (8.06e-5)"	5.0	6.6	9.7	3.3	10.4	3.0	5.8	25.5	18.7	9.3	6.1	9.7	4.7	8.2	1.3	4.2	8.6	1.9	15.9	9.3	9.9	19.1	7.9	10.2	4.3	11.4	9.0	7.0	5.5	1.4	14.3	2.6	10.8	11.0	0.6	4.6	5.9	2.5	11.1	4.7	10.4	1.2	6.8	16.7	7.4	17.5	10.1	2.2	23.3	1.6	1.3	8.9	6.0	10.6	3.3	6.3	7.5	4.7	1.2	1.1	15.6	3.1	0.4	1.8	2.6	8.3	8.0	1.6	2.0	0.6	1.9	8.6	1.1	1.1	1.1	6.0	3.4	2.1	18.4	2.0	0.7	0.7	4.7	1.6	2.3	2.5	0.6	2.2	0.9	6.9	2.3	4.3	0.4	8.6	5.1	12.8	8.4	0.7	3.7	16.8	5.6	5.9	2.0	2.5	5.8	5.5	2.9	3.6	3.1	3.0	3.4	4.4	2.3	8.0	6.6	6.7	2.7	13.5	6.6	4.7	1.5	5.0	3.8	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	9.7	10.4	25.5	18.7	9.3	9.9	11.4	9.0	10.8	6.8	10.1	10.6	2.4	3.2	4.4	10.4	1.6	0.4	0.4	1.1	0.0	11.8	1.8	1.5	0.5	0.0	0.7	5.5	25.0	2.0	1.3	2.4	0.0	0.9	2.4	0.9	1.1	2.2	1.2	2.1	5.7	0.6	0.9	1.1	4.1	1.5	4.5	4.8	1.1	1.2	1.2	5.0	5.5	1.0	2.0	1.9	2.0	10.2	1.2	2.8	1.8	2.8	2.5	4.5	4.1	3.5	5.2	1.0	0.8	2.6	1.5	0.9	1.9	0.6	3.4	10.9	0.0	1.2	1.3	4.0	1.9	0.4	1.1	0.8	1.7	1.6	3.1	0.3
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61679139-61863528	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;lymphoid tissue: 5.9;testis: 7.0"	"Group enriched"	"Detected in many"	12	"Early spermatids: 186.2;Late spermatids: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear membrane"		"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	0.3	0.3	0.8	1.7	0.6	7.2	0.9	1.3	0.9	0.4	0.0	1.7	2.0	0.8	0.4	1.5	0.3	0.6	0.1	0.5	0.2	0.3	1.6	0.4	2.8	0.3	0.0	1.1	0.3	0.1	0.0	0.8	0.4	0.4	1.9	0.5	0.4	0.2	0.1	2.0	1.9	0.9	0.0	0.7	0.9	7.0	0.2	5.9	0.3	0.1	3.3	0.7	0.6	0.8	26.6	9.4	25.0	14.1	0.9	2.1	5.5	23.6	13.3	24.6	31.8	9.5	8.0	14.9	5.2	4.9	7.7	9.2	12.8	4.5	33.3	3.8	15.8	15.5	14.4	10.5	0.2	20.3	8.8	0.6	0.4	20.2	5.1	3.4	5.0	14.8	11.6	10.5	14.4	88.9	32.5	6.7	5.3	5.9	7.3	19.7	50.1	7.1	3.0	12.8	10.0	24.2	9.4	3.0	3.3	9.1	8.3	7.3	4.5	36.9	26.5	13.5	26.6	6.3	13.3	16.6	7.3	9.3	8.8	1.0	0.1	0.4	0.1	0.0	0.1	0.5	0.3	0.1	0.1	0.6	0.4	0.2	0.3	0.1	0.1	0.1	1.0	0.1	0.8	0.6	1.3	0.9	0.5	0.2	0.3	0.0	0.4	0.0	0.2	0.8	0.2	0.0	0.5	1.0	1.6	2.3	1.3	0.8	0.6	0.3	1.1	1.8	0.6	0.0	4.0	0.0	0.0	2.0	2.0	1.8	0.0	0.3	186.2	0.7	1.7	0.8	0.0	7.4	4.6	0.2	3.0	2.0	2.0	1.6	0.0	15.5	0.4	3.4	1.7	0.0	3.3	1.8	0.0	0.8	1.1	194.1	1.2	1.0	3.6	2.8	0.6	0.2	1.0	1.5	1.0	0.8	0.1	1.2	4.8	0.4	1.4	0.2	0.8	0.2	0.0	2.5	1.8	12.1	6.0	2.9	0.4	0.3	2.3	2.1	4.7	0.7
BRME1	"C19orf57, MEIOK21, MGC11271"	ENSG00000132016	"Break repair meiotic recombinase recruitment factor 1"	Q0VDD7	19	13882348-13906452	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 18.2"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044012, HPA054615"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA044012: AB_10964782, HPA054615: AB_2682543"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (2.12e-1)"	"prognostic favorable (5.14e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.60e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-4)"	"unprognostic (1.21e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.73e-2)"	1.4	0.8	1.9	0.8	2.0	1.9	2.3	3.8	2.8	3.3	1.4	3.7	3.2	1.3	1.4	6.0	2.3	0.4	0.8	1.9	1.5	1.3	1.9	1.1	0.7	2.2	1.7	2.3	6.9	0.6	1.4	0.4	2.0	2.4	1.2	1.7	2.4	0.7	0.9	6.1	5.6	0.5	1.5	1.2	1.7	18.2	1.7	0.4	1.2	0.2	0.8	1.7	4.5	2.7	5.9	0.1	4.3	2.4	1.2	0.2	2.8	1.6	0.6	1.9	1.8	3.7	0.8	6.5	8.9	0.7	1.1	2.9	1.3	0.5	0.6	1.0	2.8	2.8	2.7	0.1	0.3	1.4	5.9	0.2	0.4	1.2	0.2	0.3	0.4	3.5	1.9	2.5	0.6	1.9	5.3	3.0	0.6	2.0	4.4	5.8	1.6	0.3	0.7	1.4	3.8	1.4	6.3	1.1	1.8	0.3	1.2	1.3	0.0	3.5	1.9	8.0	0.4	4.5	1.0	3.5	2.1	4.5	5.5	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.2	1.9	2.0	3.8	2.8	1.9	1.5	2.2	1.7	2.0	1.5	1.7	2.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0
BRMS1L	"BRMS1, FLJ39177, MGC11296"	ENSG00000100916	"BRMS1 like transcriptional repressor"	Q5PSV4	14	35826338-35932325	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046623	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA046623: AB_2679724"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.56e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.04e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.55e-5)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (6.87e-6)"	6.2	10.1	8.3	3.8	9.0	2.6	6.2	7.6	11.2	6.0	5.4	5.1	3.2	6.3	5.5	6.4	5.1	4.2	11.6	8.9	7.8	8.9	6.1	4.8	3.0	7.4	8.2	7.2	3.0	9.8	4.4	7.3	7.9	6.5	3.6	8.2	4.2	6.2	13.6	5.9	3.1	7.0	7.7	3.5	4.3	5.3	8.2	3.5	7.2	13.7	3.9	5.8	5.4	9.4	10.1	10.1	17.1	9.9	15.2	19.1	25.5	10.3	9.9	15.7	15.3	6.5	8.3	8.1	10.3	14.4	7.4	12.6	13.7	18.7	22.3	9.0	16.8	7.4	10.1	28.6	10.7	3.7	5.9	13.4	12.5	12.1	10.2	8.2	11.4	4.7	3.6	6.3	17.7	13.5	4.3	6.0	6.8	14.2	14.8	4.4	19.1	6.2	12.7	11.4	5.1	13.1	12.0	13.7	12.2	13.0	15.7	5.2	7.0	14.9	9.1	8.6	10.2	5.8	8.2	5.0	3.7	8.1	9.2	0.0	0.5	0.3	1.0	1.2	0.8	0.7	1.0	1.3	0.3	0.5	1.4	1.2	0.0	0.4	1.4	0.9	1.4	0.7	8.3	9.0	7.6	11.2	8.9	7.8	7.4	8.2	7.9	7.7	8.2	9.4	11.6	9.6	13.9	13.7	10.5	18.6	10.2	10.4	19.9	18.5	8.4	7.1	19.2	2.8	10.6	7.3	4.2	19.3	15.7	2.3	7.9	4.9	3.5	6.7	13.0	11.2	4.8	1.3	21.2	6.9	15.4	15.3	6.1	6.3	14.7	6.9	6.8	6.3	5.1	16.8	22.3	3.8	12.2	2.8	9.5	3.2	11.1	3.9	8.8	6.5	6.6	21.4	3.1	20.6	26.2	4.4	3.0	9.8	8.8	14.0	1.7	19.2	6.7	17.5	19.7	17.5	20.0	6.5	16.6	12.6	16.2	22.4	11.4	11.8	3.7	7.1
BROX	"C1orf58, FLJ32421"	ENSG00000162819	"BRO1 domain and CAAX motif containing"	Q5VW32	1	222712553-222735196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		270000	"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA031445: AB_10602697"	"unprognostic (1.27e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.50e-2)"	17.4	14.5	19.3	18.1	21.9	40.8	23.3	21.0	21.6	17.5	14.1	25.9	21.6	17.3	15.3	27.7	18.5	19.2	16.5	16.6	20.7	22.3	16.9	20.1	19.0	23.2	18.2	21.6	14.8	26.2	8.9	20.5	23.3	17.3	24.9	16.3	16.6	17.8	26.7	23.2	27.5	17.7	22.7	20.9	24.9	12.8	20.2	14.4	26.5	20.5	22.1	16.4	13.5	33.6	56.6	34.2	20.1	17.5	28.6	30.2	38.8	38.2	47.6	30.6	34.8	19.0	71.6	18.7	44.1	47.2	16.5	48.2	22.9	36.5	46.1	23.2	20.4	28.2	34.8	19.2	32.2	32.2	25.4	26.8	34.8	38.4	44.8	34.5	28.3	11.9	43.0	24.8	38.0	17.4	13.7	16.7	25.3	46.0	39.8	14.4	61.2	42.3	36.3	55.6	22.5	35.3	41.7	46.3	28.8	18.9	57.1	32.5	40.7	42.1	23.9	43.6	43.5	18.4	33.8	16.7	34.0	26.8	39.0	75.4	28.0	36.6	21.3	42.1	24.1	15.9	27.0	21.8	26.1	14.4	17.8	22.6	52.7	28.4	44.1	14.4	27.2	18.6	19.3	21.9	21.0	21.6	16.6	20.7	23.2	18.2	23.3	22.7	20.2	33.6	35.7	73.7	46.5	15.7	30.4	48.6	32.3	32.2	27.3	16.3	42.1	23.9	35.9	30.0	38.3	51.5	8.4	29.7	49.1	56.2	56.7	40.0	20.8	43.2	30.9	29.0	31.8	73.0	17.1	32.5	32.6	29.7	35.7	54.2	16.4	26.3	31.8	28.4	36.6	35.3	20.1	50.1	32.6	65.5	33.1	23.7	24.2	50.8	49.8	12.2	52.4	31.0	42.2	25.1	27.3	54.5	44.6	32.0	23.2	47.8	48.4	58.8	67.8	20.8	52.6	27.4	26.8	29.9	27.4	40.4	46.7	51.6	40.5	35.1	41.0	56.4
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	6.6	11.9	3.5	7.6	4.3	12.1	8.4	9.0	5.4	8.4	0.1	13.1	11.7	11.9	6.1	7.9	8.8	8.6	7.3	5.5	1.9	11.8	6.9	7.4	6.2	0.6	1.4	11.9	18.0	14.5	4.4	7.5	0.7	9.6	12.9	6.4	15.7	10.9	12.1	12.6	13.8	10.2	0.3	9.0	10.7	19.9	2.1	9.4	12.1	12.2	6.2	7.4	4.7	4.0	10.6	10.0	24.6	19.4	13.3	11.2	21.0	15.6	16.3	21.5	16.9	29.4	9.8	16.3	16.4	15.4	27.0	10.0	21.8	11.2	18.8	15.6	13.5	11.5	9.3	17.6	14.0	9.1	15.5	14.4	9.4	25.6	12.8	15.6	16.3	7.7	24.5	14.6	11.9	15.0	10.4	3.9	12.4	12.9	8.5	29.9	10.1	5.1	6.9	21.4	35.0	11.0	12.7	13.8	12.9	15.1	15.4	24.6	17.2	22.3	18.9	6.1	18.3	12.0	16.8	12.1	3.7	14.1	26.9	0.7	0.0	0.3	0.4	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.1	3.5	4.3	9.0	5.4	5.5	1.9	0.6	1.4	0.7	0.3	2.1	4.0	5.7	6.4	12.7	8.8	5.6	9.6	7.2	4.6	9.6	9.0	21.1	11.7	13.7	10.0	7.3	5.5	6.2	4.8	9.7	28.1	0.0	6.6	15.3	7.3	10.9	7.2	19.7	5.7	16.6	10.8	4.1	9.8	10.2	12.7	2.5	16.6	9.7	18.2	4.5	0.0	11.4	27.5	6.1	5.7	6.6	14.0	11.1	4.9	7.2	6.5	5.4	6.1	9.2	13.6	11.0	11.2	13.6	9.4	10.5	11.3	21.5	13.5	4.5	7.2	0.0	11.1	8.0	25.7	17.5	7.3	11.4	8.2	6.3	14.2	16.2	10.2
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312562	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 141.8;pituitary gland: 53.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.8;Excitatory neurons: 30.1;Horizontal cells: 38.7;Inhibitory neurons: 27.6;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 29.4;Proximal enterocytes: 23.6"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 56.4;SH-SY5Y: 51.8;WM-115: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.5	12.0	75.0	3.7	90.1	0.5	2.6	47.5	141.8	5.9	0.0	11.8	3.8	8.3	4.0	3.2	5.4	4.4	12.8	103.2	66.1	2.4	0.7	1.9	2.7	70.4	54.8	5.5	2.8	16.9	53.0	1.1	66.8	8.3	1.6	20.4	2.3	5.0	0.7	1.5	4.7	5.6	32.9	1.8	4.9	11.4	74.1	2.3	3.1	1.4	1.4	6.3	4.6	105.5	0.8	2.8	33.2	17.6	0.1	1.4	0.3	5.9	7.7	7.1	10.3	13.1	5.9	7.0	3.7	6.2	6.6	0.3	7.0	0.3	6.6	33.3	28.0	4.6	4.0	1.4	7.0	1.5	12.8	4.6	0.6	7.3	0.0	27.4	0.3	17.9	6.6	40.8	6.5	1.9	9.0	1.7	24.9	0.7	2.3	20.4	8.5	1.1	0.5	0.0	56.4	51.8	0.1	1.0	12.8	9.2	2.9	3.8	0.0	13.7	15.2	7.7	10.8	37.9	28.0	16.6	13.8	3.1	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	90.1	47.5	141.8	103.2	66.1	70.4	54.8	66.8	32.9	74.1	105.5	0.3	0.0	1.3	9.4	5.2	0.1	1.0	0.1	1.2	34.8	0.9	2.2	1.2	0.0	0.6	1.8	2.1	0.0	1.2	10.4	0.0	0.4	1.2	0.3	3.8	0.9	3.5	0.0	30.1	0.0	0.0	1.2	0.5	0.3	0.0	2.3	0.0	0.0	1.6	38.7	27.6	1.6	0.0	6.6	0.4	0.3	0.6	1.0	0.0	1.0	2.3	4.1	3.1	17.1	29.4	0.5	0.1	4.9	9.8	1.0	23.6	0.9	0.2	10.1	0.0	0.6	2.1	3.9	7.0	0.0	0.0	0.0	1.1	2.8	1.9	0.2
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	13.6	18.8	35.7	10.2	37.5	18.6	17.5	40.9	37.3	12.9	27.2	12.5	9.7	14.5	22.6	11.9	13.1	11.0	15.5	37.6	32.9	15.7	25.8	13.2	15.7	23.4	27.5	17.7	19.9	13.1	13.3	17.4	24.8	14.3	12.3	38.6	11.7	11.5	21.9	14.6	11.4	11.1	27.2	10.9	12.1	21.0	40.4	14.9	19.7	24.0	15.0	12.5	12.5	34.4	19.3	7.8	18.6	9.5	10.4	17.2	17.9	11.0	12.7	8.5	9.7	7.1	12.5	59.8	11.0	15.0	9.9	9.1	17.5	12.3	12.9	14.8	14.2	40.9	13.6	12.3	13.7	23.4	11.1	11.2	19.0	11.2	29.0	18.1	11.9	38.7	32.4	30.7	11.5	13.4	15.8	26.8	19.5	23.1	10.7	28.5	14.4	19.4	9.5	12.2	13.9	18.0	23.8	25.0	15.7	6.2	20.7	31.8	14.3	10.6	5.2	6.2	8.1	32.7	24.5	30.1	12.5	24.3	8.7	3.5	4.2	9.7	8.0	5.0	6.1	7.3	6.8	8.3	5.8	4.8	8.2	6.8	4.3	8.4	3.1	5.4	8.5	3.4	35.7	37.5	40.9	37.3	37.6	32.9	23.4	27.5	24.8	27.2	40.4	34.4	42.5	48.1	49.9	147.6	46.1	63.2	43.8	26.6	52.9	65.5	43.2	24.9	59.0	34.3	39.2	18.4	116.7	64.6	45.0	40.1	45.0	28.9	53.5	46.0	48.2	41.6	35.4	37.6	213.9	34.5	45.2	43.3	57.6	54.8	32.9	42.7	32.2	41.1	24.8	74.0	190.0	34.7	48.8	36.8	52.2	20.7	43.2	35.0	30.2	127.4	37.5	43.1	51.5	170.9	201.9	37.8	34.1	44.8	63.2	63.0	39.2	33.1	48.3	109.1	26.3	47.8	41.4	86.1	81.9	52.8	70.3	99.9	51.1	51.1	36.6	67.1
BRWD3	"FLJ38568, MRX93"	ENSG00000165288	"Bromodomain and WD repeat domain containing 3"	Q6RI45	X	80669503-80809877	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 69.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012802	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA012802: AB_2066662"	"unprognostic (1.13e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.17e-3)"	"unprognostic (7.04e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-1)"	3.2	2.2	1.5	4.0	2.2	5.1	3.1	6.0	1.8	3.0	1.2	3.0	3.6	3.0	2.5	4.4	3.2	2.4	1.9	1.6	2.4	2.2	3.1	3.4	4.3	1.6	2.3	4.5	3.1	2.0	3.1	3.6	1.7	2.3	3.2	5.8	3.3	1.9	1.4	6.1	4.1	1.9	1.6	3.9	3.1	3.9	2.4	5.2	3.5	1.7	3.9	2.8	3.5	2.0	4.4	4.6	7.1	4.6	2.8	3.4	5.0	2.5	2.1	3.1	4.2	2.2	5.9	4.7	5.7	2.3	3.8	7.7	10.7	4.2	4.2	4.0	4.5	9.6	7.8	3.3	2.1	5.5	6.2	2.3	2.9	3.5	4.9	4.6	4.8	4.1	7.1	11.5	3.7	0.8	3.3	5.6	10.6	4.8	1.9	2.8	12.2	2.9	3.8	3.7	1.6	4.0	6.1	3.3	2.7	12.9	1.5	5.5	4.4	3.7	4.5	3.4	2.7	5.1	5.7	5.4	3.0	11.0	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	1.5	2.2	6.0	1.8	1.6	2.4	1.6	2.3	1.7	1.6	2.4	2.0	16.1	12.8	13.4	48.3	14.5	17.5	8.0	8.6	13.6	27.7	9.7	6.2	8.2	15.7	15.4	5.5	16.7	5.7	13.1	13.8	0.0	6.5	2.8	11.5	15.6	13.3	7.2	12.0	47.0	6.0	7.7	10.5	21.9	16.6	11.4	22.4	8.2	5.6	5.5	62.2	54.2	10.8	2.0	13.2	17.7	3.7	9.9	19.7	1.8	45.9	17.5	8.1	6.2	69.4	53.5	8.8	22.4	10.1	13.5	13.0	17.1	4.0	12.7	20.8	6.6	14.3	11.9	6.7	9.6	16.8	20.9	7.7	15.1	12.7	12.1	19.2
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 447.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 61.9;Ductal cells: 66.8;Exocrine glandular cells: 65.8;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"A-431: 41.8;CAPAN-2: 25.9;MCF7: 62.0;OE19: 70.9;RPMI-8226: 32.3;SK-BR-3: 29.9;T-47d: 30.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.8"	"HPA042889, HPA077485"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Cytosol	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.3	3.1	3.7	2.6	11.3	5.9	14.6	5.9	4.2	6.5	1.2	12.0	8.8	1.1	10.9	30.1	4.4	4.4	1.5	2.5	3.0	14.4	0.8	5.6	0.8	2.1	4.8	0.0	41.7	447.2	8.3	1.7	1.7	5.0	11.0	6.9	81.6	4.5	0.0	26.3	7.0	0.7	1.7	0.5	24.7	2.8	5.9	1.8	30.3	0.1	3.1	3.0	7.6	2.5	41.8	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	8.6	25.9	0.0	0.4	0.0	0.0	3.6	0.4	0.0	0.0	4.6	3.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.8	0.3	0.0	0.0	62.0	0.7	0.0	1.0	70.9	0.0	0.9	0.0	32.3	4.0	8.8	13.7	0.0	0.0	29.9	0.0	1.7	30.3	4.3	0.0	0.0	0.0	0.1	0.0	9.7	13.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	3.7	11.3	5.9	4.2	2.5	3.0	2.1	4.8	1.7	1.7	5.9	2.5	0.3	6.4	6.9	0.0	2.5	1.0	2.0	4.4	0.0	1.8	61.9	31.2	2.8	17.2	9.5	27.6	6.2	9.2	9.9	20.8	39.2	66.8	0.5	11.3	1.6	0.9	20.4	15.6	1.0	65.8	1.1	0.7	21.4	17.3	3.8	1.5	0.0	0.8	1.4	0.0	3.2	19.1	12.2	0.3	0.3	0.6	0.0	0.5	10.6	0.0	1.0	0.8	3.1	0.5	0.2	48.6	14.5	0.0	2.5	13.8	13.5	21.2	9.7	12.1	0.0	0.0	1.7	0.6	4.3	26.4	14.2	6.7	1.3	0.1	24.9	17.7
BTAF1	"MOT1, TAF-172, TAF(II)170, TAF172, TAFII170"	ENSG00000095564	"B-TFIID TATA-box binding protein associated factor 1"	O14981	10	91923770-92030325	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070682			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"HPA070682: AB_2686294"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (2.72e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	20.4	13.2	5.2	20.1	7.3	32.1	19.2	8.5	8.6	18.4	5.9	20.4	16.2	20.7	21.1	17.2	23.4	15.2	14.4	6.1	5.5	11.8	15.4	19.1	32.0	6.1	5.3	25.4	18.1	14.7	13.3	13.7	6.0	16.8	15.9	34.3	19.2	12.7	14.8	50.4	22.0	14.0	5.9	22.0	18.4	17.9	5.8	21.7	17.3	9.2	25.5	20.1	19.9	10.4	28.9	13.8	31.7	38.7	16.5	25.8	15.8	16.5	19.6	16.0	23.7	19.1	17.2	30.8	10.3	16.3	9.9	30.4	21.5	14.6	23.8	21.2	23.2	21.9	35.7	20.0	16.8	33.3	22.0	18.4	18.5	24.3	35.1	34.3	15.6	25.9	18.2	34.5	16.6	12.6	25.8	21.0	14.4	8.3	10.8	20.6	19.7	14.5	14.9	17.5	12.2	14.3	15.8	8.0	20.3	20.8	16.2	21.9	16.9	14.3	11.4	19.5	23.7	39.7	19.6	24.9	22.4	30.1	3.8	4.4	2.7	1.5	2.5	1.9	2.2	2.5	1.9	1.8	2.1	3.1	2.3	1.8	1.9	2.2	3.6	4.9	1.6	1.4	5.2	7.3	8.5	8.6	6.1	5.5	6.1	5.3	6.0	5.9	5.8	10.4	18.3	19.2	31.5	58.4	29.5	21.7	12.1	7.3	21.6	26.7	16.2	11.9	13.6	7.2	14.6	20.2	45.9	6.6	34.8	7.9	1.9	6.8	12.9	33.3	28.0	15.6	16.2	13.9	78.5	6.6	9.8	17.3	35.2	46.6	24.1	22.4	8.9	8.7	7.1	18.5	66.4	7.1	6.1	9.7	19.8	5.1	11.8	27.1	5.4	67.5	16.4	13.9	14.4	68.3	91.5	6.7	6.3	11.7	52.1	15.7	9.6	3.3	24.9	35.5	6.6	25.7	22.8	24.7	12.2	20.4	29.8	14.6	24.7	11.4	9.3	16.4
BTBD1		ENSG00000064726	"BTB domain containing 1"	Q9H0C5	15	83016423-83067252	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 325.0;tongue: 230.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024263, HPA067671"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA024263: , HPA067671: AB_2685882"	"unprognostic (1.63e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.21e-7)"	"unprognostic (8.94e-3)"	"unprognostic (8.27e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	36.8	26.7	39.8	24.9	41.0	36.3	28.8	40.4	48.1	24.8	26.2	33.4	32.5	24.2	25.7	30.4	31.5	28.7	107.2	41.3	43.8	37.8	34.3	23.9	36.7	40.7	41.4	23.6	17.2	46.4	22.1	24.1	38.5	30.1	35.5	28.4	21.0	24.0	325.0	16.5	29.9	26.5	44.4	25.9	23.9	58.4	46.8	35.5	37.1	230.8	34.2	36.2	18.2	46.0	45.8	43.1	37.3	37.0	57.5	98.2	19.5	64.9	88.0	54.8	60.6	27.4	46.4	91.0	78.4	73.2	45.6	56.4	82.7	52.0	64.4	73.4	67.1	77.7	62.6	39.6	67.6	74.2	82.9	80.6	45.8	37.2	55.4	71.0	82.0	35.2	70.2	49.9	117.2	24.1	55.8	38.5	52.2	39.9	47.0	57.1	94.4	45.5	55.0	106.7	64.9	46.6	75.1	61.6	111.2	50.7	46.5	61.6	82.9	61.9	46.1	86.0	91.2	50.6	84.0	88.4	66.7	123.6	43.8	1.3	2.9	5.7	3.1	3.2	2.7	2.7	2.9	4.0	5.2	3.4	3.2	3.2	1.6	2.4	4.2	2.2	3.0	1.3	39.8	41.0	40.4	48.1	41.3	43.8	40.7	41.4	38.5	44.4	46.8	46.0	24.2	16.0	5.8	30.7	22.0	15.2	13.7	9.6	13.6	9.4	11.4	6.9	84.9	8.6	18.1	11.0	6.2	8.4	23.6	20.8	17.6	14.2	35.8	19.9	16.6	16.8	23.3	18.7	36.0	10.5	13.5	15.8	18.8	14.5	17.7	11.0	17.2	11.0	18.0	11.8	38.4	10.8	14.2	23.6	24.6	24.5	8.7	21.2	12.4	37.5	22.8	11.1	9.2	32.2	28.6	15.1	19.8	11.3	22.6	11.8	15.8	15.7	24.7	8.6	6.6	21.0	15.3	46.2	14.9	16.0	12.1	8.1	18.8	22.0	18.4	18.7
BTBD10	"GMRP-1, GMRP1, MGC13007"	ENSG00000148925	"BTB domain containing 10"	Q9BSF8	11	13388008-13463297	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 116.5;Spermatocytes: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046777	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA046777: AB_2679801"	"unprognostic (2.38e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.27e-1)"	13.8	12.2	19.8	13.6	30.9	13.4	13.3	18.8	27.9	15.0	3.2	18.1	13.1	16.5	12.0	28.6	11.8	15.2	17.7	25.9	18.6	11.4	9.8	13.0	15.7	12.0	15.7	14.1	8.7	13.2	14.1	17.4	16.2	15.0	20.3	18.8	10.8	17.4	14.6	13.1	11.7	21.1	10.0	12.6	17.7	38.3	14.5	18.5	13.6	18.4	17.4	27.1	17.8	22.2	55.9	40.2	34.3	23.2	30.4	29.5	43.5	57.5	33.3	43.5	39.4	37.7	64.0	38.1	27.1	42.2	43.9	44.0	26.3	61.4	50.8	38.7	27.1	20.7	13.9	22.5	46.9	27.6	45.4	25.3	68.0	25.2	57.3	33.0	89.1	26.8	11.8	38.2	46.0	33.7	28.3	15.2	14.9	50.0	34.9	24.8	29.4	23.8	69.7	44.3	14.8	20.9	34.4	27.5	20.5	38.9	19.7	14.7	81.7	44.7	37.2	43.4	33.6	14.2	52.6	25.5	30.6	23.6	38.9	41.1	24.8	38.2	18.1	39.7	21.7	18.4	17.1	20.1	29.2	17.2	19.1	19.3	64.9	25.7	50.5	12.7	23.6	18.3	19.8	30.9	18.8	27.9	25.9	18.6	12.0	15.7	16.2	10.0	14.5	22.2	20.5	16.0	7.0	35.9	16.9	28.2	40.7	27.0	15.9	13.9	9.6	8.6	14.0	12.8	19.7	5.5	4.2	24.3	18.1	15.7	5.9	31.8	95.7	14.3	12.5	22.6	16.3	9.0	116.5	25.2	54.3	15.3	27.5	19.1	22.8	11.1	11.7	5.9	22.9	8.4	74.2	14.2	28.5	16.4	13.0	26.3	9.9	13.0	17.8	38.4	22.2	9.9	18.6	61.9	62.4	50.2	14.2	18.4	12.0	30.1	8.7	10.5	19.9	14.1	6.6	13.4	20.6	121.3	59.7	27.8	35.8	62.1	17.8	9.2	13.3	64.6
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318421-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 100.3"	"Cell type enriched"	"Detected in many"	9	"Inhibitory neurons: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.0;Hep G2: 13.6;MOLT-4: 17.9;PC-3: 12.3;RT4: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA055898: AB_2682964, HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.4	0.7	7.2	2.7	4.3	4.4	2.9	5.5	10.9	8.1	5.9	0.6	0.7	0.9	1.2	29.4	0.3	0.9	0.6	2.9	13.2	4.2	1.1	0.6	2.9	24.3	16.0	0.1	0.8	100.3	3.5	2.0	24.4	3.4	0.6	1.9	5.6	1.3	0.5	11.1	1.4	0.5	11.4	1.4	0.6	0.7	21.7	17.2	18.9	0.2	3.3	1.7	11.1	5.3	0.1	25.0	5.0	0.0	1.8	0.5	0.0	0.6	0.0	0.2	0.0	0.3	4.0	0.0	6.1	0.1	2.4	9.2	5.1	9.5	0.3	0.0	1.6	0.0	0.1	13.6	0.0	0.2	0.1	2.0	4.0	0.0	2.9	3.8	0.7	10.5	0.0	0.0	0.2	0.9	17.9	2.0	5.3	0.5	12.3	0.0	8.1	0.0	0.0	11.4	6.8	2.5	0.0	0.2	0.0	0.4	0.5	0.7	1.0	0.1	0.2	0.0	2.0	0.1	0.0	0.1	6.4	2.6	0.0	0.9	0.4	0.5	1.0	0.1	3.5	0.0	1.1	0.6	0.7	0.1	1.4	1.3	1.3	0.1	0.3	0.1	0.6	0.6	7.2	4.3	5.5	10.9	2.9	13.2	24.3	16.0	24.4	11.4	21.7	5.3	0.3	0.0	0.0	17.3	0.3	5.2	3.7	2.5	6.8	3.5	0.7	3.2	2.9	0.0	3.0	0.0	0.0	0.2	1.2	0.0	0.0	0.8	0.0	1.2	1.9	0.3	3.5	1.3	8.7	0.0	0.0	1.5	0.0	2.3	0.0	0.0	0.0	0.9	0.3	1.7	266.4	0.4	0.0	0.6	4.3	0.0	0.6	1.7	0.0	1.0	1.8	0.2	3.1	12.5	1.9	0.3	0.0	4.1	0.7	2.8	0.2	0.9	0.3	0.4	0.0	0.0	1.1	0.1	0.2	27.5	7.7	0.4	4.5	3.4	0.4	3.4
BTBD18		ENSG00000233436	"BTB domain containing 18"	B2RXH4	11	57743514-57751781	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 3.1;testis: 2.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.7;Cone photoreceptor cells: 4.2;Rod photoreceptor cells: 1.6;Spermatocytes: 5.5;Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049325	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA049325: AB_2680713"	"unprognostic (6.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.69e-3)"	"unprognostic (4.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.17e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.88e-1)"	0.0	0.0	0.1	0.0	0.3	0.4	0.0	3.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.3	3.1	0.9	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.4	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	5.5	3.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
BTBD6	BDPL	ENSG00000184887	"BTB domain containing 6"	Q96KE9	14	105248490-105251093	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031355	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031355: AB_10611812"	"prognostic favorable (1.11e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.25e-4)"	"unprognostic (8.48e-3)"	"prognostic favorable (6.51e-5)"	"unprognostic (6.55e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.86e-2)"	"unprognostic (9.85e-2)"	69.4	26.3	52.1	20.4	52.6	28.2	56.6	48.3	60.3	32.6	48.1	43.8	28.8	31.4	28.1	50.9	30.8	20.5	52.1	54.2	51.7	34.5	44.2	34.7	22.0	49.7	51.0	36.7	13.2	12.6	39.9	15.6	49.9	43.6	23.1	14.6	42.8	23.5	169.4	48.5	39.5	18.8	48.4	31.4	46.9	79.3	52.1	18.4	30.4	144.6	19.0	38.9	37.7	51.3	50.8	39.8	21.4	56.8	66.8	46.2	0.1	45.6	41.1	69.2	46.9	31.3	45.2	15.9	27.4	67.0	14.5	66.2	41.3	43.9	34.0	41.2	33.5	11.7	58.6	0.0	45.6	35.8	21.7	48.3	59.6	31.9	25.7	26.9	55.9	52.2	0.0	0.3	37.3	71.8	37.8	14.5	9.1	47.6	67.6	40.3	0.1	14.9	26.5	55.0	34.8	14.8	42.9	34.3	35.0	14.7	69.9	45.3	37.9	55.5	1.5	82.1	57.8	10.2	14.7	7.8	57.2	16.4	44.1	0.5	0.6	2.9	2.3	1.0	2.2	1.3	2.4	2.3	0.7	0.7	1.8	1.2	0.3	0.4	0.8	1.5	5.3	0.6	52.1	52.6	48.3	60.3	54.2	51.7	49.7	51.0	49.9	48.4	52.1	51.3	31.5	25.6	24.3	3.9	5.4	11.7	25.7	6.5	6.2	23.1	24.0	23.4	22.0	14.3	15.3	11.0	6.2	2.8	25.3	31.0	21.5	5.7	15.0	25.6	19.5	17.8	20.4	5.2	12.4	0.0	3.8	17.3	10.2	34.9	24.7	22.2	17.9	15.4	7.8	20.2	12.5	31.2	10.2	9.8	10.0	35.2	9.3	10.3	12.4	8.4	3.6	19.1	5.2	5.0	3.7	1.0	11.6	7.5	7.6	16.3	20.5	11.6	15.5	18.8	13.1	15.7	13.0	7.8	8.3	9.6	12.6	2.2	16.4	15.2	21.9	19.5
BTBD8		ENSG00000189195	"BTB domain containing 8"	"Q5XKL5, Q9UPP5"	1	92080305-92184725	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 13.4;retina: 18.0;testis: 5.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 21.9;Inhibitory neurons: 38.3;Oligodendrocyte precursor cells: 29.7;Oligodendrocytes: 46.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024216, HPA035311"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA024216: AB_1852385, HPA035311: AB_10671933"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.04e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.15e-1)"	0.9	1.5	2.6	0.5	4.5	0.1	1.2	6.6	13.4	0.7	0.0	0.8	0.5	1.3	1.1	0.4	1.5	0.8	0.9	5.9	0.9	0.9	0.5	1.1	0.5	0.1	1.8	2.0	0.5	1.5	0.3	0.9	3.1	1.2	0.8	18.0	0.4	1.0	0.4	0.4	0.7	0.6	0.4	0.5	0.9	5.1	2.1	0.7	1.6	0.7	0.3	0.8	0.2	7.1	1.3	0.8	0.6	0.0	1.1	3.5	2.8	0.6	1.1	0.6	0.7	0.3	0.9	0.4	2.2	0.7	2.5	0.3	0.5	1.2	1.1	1.2	0.7	1.2	0.3	0.4	0.1	0.5	0.5	2.3	1.0	0.4	0.7	2.3	0.7	1.0	1.1	0.3	1.0	0.9	0.3	0.4	0.7	1.6	0.7	0.9	0.5	0.1	0.9	0.9	0.3	0.3	1.0	0.5	0.5	1.1	0.9	0.8	0.6	0.6	0.5	0.3	0.2	1.0	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.6	4.5	6.6	13.4	5.9	0.9	0.1	1.8	3.1	0.4	2.1	7.1	5.9	0.0	4.1	19.9	0.9	0.4	1.0	0.3	0.0	9.5	6.0	2.7	0.7	2.8	3.6	5.5	6.2	2.4	2.5	1.2	1.9	4.7	7.6	10.3	5.9	2.8	0.0	2.5	21.9	2.9	1.2	3.7	2.0	8.1	0.0	13.8	1.4	1.1	0.7	3.3	38.3	2.4	6.1	1.5	0.6	1.7	5.9	1.8	1.8	10.3	2.6	4.7	5.2	29.7	46.0	3.8	4.4	3.8	2.1	1.7	3.1	1.7	4.3	15.3	0.0	2.4	2.8	8.1	9.0	0.6	0.6	1.4	2.0	9.4	2.0	1.4
BTBD9	"dJ322I12.1, KIAA1880"	ENSG00000183826	"BTB domain containing 9"	Q96Q07	6	38168451-38640148	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Astrocytes: 191.3;Excitatory neurons: 390.4;Inhibitory neurons: 257.0;Microglial cells: 142.4;Oligodendrocyte precursor cells: 193.5;Oligodendrocytes: 218.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041930	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA041930: AB_10795270"	"unprognostic (4.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.64e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.76e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (4.20e-13)"	"unprognostic (1.35e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.15e-2)"	4.2	4.7	13.1	4.3	13.2	8.3	3.8	1.8	22.6	3.8	10.1	5.1	5.2	5.2	4.4	5.6	8.7	5.8	8.3	18.8	4.2	6.2	3.2	9.2	4.7	3.0	7.8	8.1	3.5	13.7	4.3	4.3	4.1	5.2	5.6	7.1	4.5	4.1	7.8	5.2	7.2	5.0	0.7	4.8	4.7	8.1	7.5	3.7	6.7	6.7	4.4	4.7	3.5	10.7	5.4	4.7	6.8	8.5	4.6	6.7	5.4	5.3	7.4	5.4	6.3	6.2	3.1	3.1	3.7	8.2	7.3	3.5	3.2	6.7	5.9	7.4	7.0	6.9	5.1	2.5	4.0	6.5	13.4	5.2	6.0	7.4	7.9	4.9	9.3	4.8	3.2	5.2	5.6	3.4	4.6	2.7	2.0	4.9	3.6	3.0	4.7	6.1	5.1	12.3	10.2	5.8	4.5	5.7	5.2	4.6	5.8	5.3	7.0	5.6	3.7	6.6	5.5	3.3	2.5	3.7	4.9	4.4	6.6	12.3	1.8	3.2	2.4	2.6	3.3	2.6	2.4	2.2	1.7	3.7	3.0	2.7	4.5	3.3	4.0	2.6	4.1	1.9	13.1	13.2	1.8	22.6	18.8	4.2	3.0	7.8	4.1	0.7	7.5	10.7	3.9	3.2	17.9	191.3	14.2	4.6	2.2	2.9	4.6	11.5	3.6	2.9	11.8	8.6	6.7	9.2	8.4	2.7	7.3	15.5	5.9	4.6	17.5	12.8	5.3	4.1	4.9	1.3	390.4	5.8	1.5	4.6	10.2	8.1	0.0	5.5	7.5	3.0	2.6	5.0	257.0	3.9	6.1	3.5	3.0	24.6	3.1	5.6	1.8	142.4	1.5	5.9	2.1	193.5	218.3	5.5	5.0	3.4	10.4	2.1	13.1	6.8	8.7	5.6	0.0	5.4	6.1	3.1	2.9	4.4	5.8	4.7	11.1	3.7	6.0	3.2
BTF3L4	MGC23908	ENSG00000134717	"Basic transcription factor 3 like 4"	Q96K17	1	52056199-52090716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067026	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		59000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA067026: AB_2685765"	"unprognostic (6.12e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (6.73e-8)"	"unprognostic (8.85e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.56e-2)"	44.6	51.9	28.4	30.3	29.3	61.0	43.6	28.8	36.1	31.4	28.3	25.1	14.5	36.4	30.7	36.0	36.5	23.9	40.1	28.8	33.0	35.0	40.9	26.3	36.6	31.0	31.2	52.9	38.3	42.1	31.0	37.4	31.6	29.2	23.6	31.4	29.9	24.5	70.1	35.9	18.6	34.8	30.3	28.1	27.6	34.0	31.8	49.2	43.1	59.0	40.8	42.3	29.9	39.7	99.8	23.7	113.5	59.6	60.4	76.4	117.3	96.1	96.3	108.0	115.2	43.8	50.8	92.3	93.9	68.3	127.1	56.6	111.1	75.0	137.0	64.4	77.7	105.8	41.0	65.5	163.8	118.2	70.0	79.2	101.0	100.2	140.1	89.1	86.9	75.1	81.5	57.0	98.0	42.1	82.6	69.9	202.7	76.7	51.2	53.6	132.1	109.8	105.3	78.6	89.1	100.6	112.5	102.8	141.7	124.8	92.8	124.8	64.0	60.5	65.4	78.4	114.8	98.9	176.3	89.4	52.2	90.0	77.9	70.3	74.2	70.9	29.7	78.9	40.2	49.9	42.8	31.0	72.9	49.7	49.1	38.2	31.6	49.7	70.9	34.3	62.6	64.3	28.4	29.3	28.8	36.1	28.8	33.0	31.0	31.2	31.6	30.3	31.8	39.7	60.4	35.3	22.3	17.0	76.0	107.7	91.7	153.6	65.4	43.6	81.2	75.6	44.7	52.9	82.2	69.9	33.3	111.1	45.9	18.7	168.3	106.0	115.3	82.9	83.6	55.1	52.2	114.9	30.8	80.1	137.6	77.2	44.4	73.3	22.8	128.2	56.0	81.0	129.3	38.7	32.9	33.8	120.1	127.8	92.9	25.4	72.4	87.4	78.2	27.2	86.5	62.0	49.4	29.7	39.5	72.7	26.3	55.7	58.7	135.9	23.4	162.9	75.7	33.2	59.2	73.7	106.3	97.1	31.1	108.5	160.3	145.8	56.0	114.9	34.8	106.7
BTG1	APRO2	ENSG00000133639	"BTG anti-proliferation factor 1"	P62324	12	92140278-92145846	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2751.6;Langerhans cells: 2893.3;Suprabasal keratinocytes: 3004.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 33.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA005972			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA005972: AB_1078303"	"prognostic favorable (4.36e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (9.81e-2)"	91.5	36.9	1.9	19.8	2.0	93.9	80.1	33.5	4.1	62.3	1.4	38.9	8.5	45.6	1.5	29.5	55.9	7.1	45.2	2.5	4.6	52.4	69.7	55.5	23.8	3.6	2.6	45.6	63.7	8.3	26.2	6.2	3.7	40.5	4.8	5.2	30.5	4.5	20.5	120.6	58.4	8.2	3.5	92.2	39.3	12.4	3.1	20.1	21.9	3.7	18.2	38.5	60.1	3.0	5.7	5.4	3.5	0.9	13.4	16.9	3.2	8.0	6.3	2.3	2.3	2.4	1.6	5.7	1.5	3.3	3.5	3.9	1.6	3.0	2.2	9.8	8.8	0.8	2.9	1.3	15.0	3.7	1.9	14.1	11.9	4.5	11.7	8.5	5.0	2.4	4.6	7.1	3.4	3.7	5.5	9.4	2.2	3.0	11.0	15.2	2.4	1.5	5.5	6.5	3.4	7.8	6.1	4.4	17.3	2.1	21.5	7.7	2.6	3.9	1.3	3.6	3.7	14.0	6.3	8.9	3.1	2.4	4.6	36.2	21.8	151.8	22.8	16.2	27.8	92.4	47.3	40.7	9.2	105.5	133.1	53.6	75.9	68.8	22.8	8.0	66.8	51.3	1.9	2.0	33.5	4.1	2.5	4.6	3.6	2.6	3.7	3.5	3.1	3.0	1186.6	96.1	185.4	12.1	2512.8	2751.6	1030.9	206.6	912.9	592.7	607.5	573.8	119.5	1009.4	140.4	174.7	196.0	412.8	1907.2	672.9	320.8	388.1	411.8	216.7	258.8	709.0	452.4	230.7	7.9	255.8	416.3	529.1	406.7	264.7	286.6	197.4	339.1	274.9	361.4	424.0	20.6	373.8	193.3	564.3	2893.3	213.7	287.1	1251.4	983.6	31.9	1241.2	877.6	1354.3	22.1	8.4	364.4	668.7	241.9	758.5	791.3	667.9	162.6	53.0	377.2	539.0	870.7	723.5	130.1	101.5	508.7	3004.2	1342.7	2354.0	786.4	410.9	1513.3
BTG2	"APRO1, MGC126063, MGC126064, PC3, TIS21"	ENSG00000159388	"BTG anti-proliferation factor 2"	P78543	1	203305491-203309602	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Enteroendocrine cells: 965.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 161.8;HMC-1: 160.8;RT4: 131.3;U-266/70: 259.8;U-266/84: 141.2"	"Low region specificity"	"Detected in all"							HPA002355	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"HPA002355: AB_1078304"	"prognostic favorable (8.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.86e-3)"	274.5	244.6	38.3	124.3	40.7	309.3	118.8	58.4	45.0	101.7	36.7	231.5	88.5	91.9	41.5	313.4	355.0	157.8	256.3	35.1	49.0	132.2	20.8	105.0	122.0	61.8	42.1	554.9	488.9	37.4	209.2	106.7	43.6	265.9	205.7	152.6	75.1	182.9	210.7	134.4	111.1	213.7	49.3	107.1	244.5	10.2	42.4	334.6	201.2	287.1	132.3	279.9	79.1	42.1	4.3	6.1	10.9	4.5	13.4	9.8	92.9	11.2	21.4	2.8	10.5	8.8	1.6	161.8	7.8	3.5	1.8	69.5	39.6	42.6	5.2	10.8	20.3	84.5	12.3	18.4	29.5	0.4	160.8	10.1	76.7	10.3	18.7	9.5	57.6	8.2	40.6	106.9	28.1	3.6	18.1	5.4	4.9	1.7	1.2	11.4	36.5	84.3	5.3	131.3	1.9	11.3	8.6	3.6	1.4	80.0	9.0	10.1	14.3	0.3	18.2	2.9	0.6	259.8	141.2	103.4	2.2	4.1	6.3	8.4	19.7	23.1	10.0	27.1	14.8	29.9	10.9	10.2	11.5	29.0	17.5	12.6	77.1	12.7	35.6	38.6	11.2	19.7	38.3	40.7	58.4	45.0	35.1	49.0	61.8	42.1	43.6	49.3	42.4	42.1	555.8	157.0	241.8	6.5	330.1	230.2	464.4	311.4	548.7	25.4	355.1	276.7	274.8	48.6	128.5	187.6	29.2	50.0	343.9	345.8	15.6	113.2	1.4	336.7	211.7	196.4	965.1	127.6	2.9	163.7	16.6	352.8	562.2	643.2	369.3	40.6	148.2	6.5	120.1	3.3	2.0	617.1	264.5	98.8	183.6	3.1	72.7	227.0	120.9	25.3	47.5	478.8	58.7	4.5	10.4	55.9	399.9	55.3	725.2	230.1	397.5	13.9	88.5	38.9	124.9	537.5	305.0	1.8	1.7	343.8	447.9	138.0	300.8	278.6	360.7	211.8
BTRC	"beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1"	ENSG00000166167	"Beta-transducin repeat containing E3 ubiquitin protein ligase"	Q9Y297	10	101354033-101557321	"Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 109.7;Excitatory neurons: 154.0;Inhibitory neurons: 144.4;Oligodendrocyte precursor cells: 183.5;Oligodendrocytes: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031156, CAB032986"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB032986: AB_2243598, HPA031156: AB_2673764"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.23e-1)"	5.2	9.2	16.3	3.8	19.3	2.8	8.5	8.9	17.4	6.8	7.8	6.3	3.9	6.1	10.5	8.4	7.7	5.8	14.6	18.9	16.3	8.0	6.4	4.9	4.2	10.7	12.6	11.0	6.5	13.1	9.4	7.9	13.7	8.8	4.7	21.6	6.9	5.9	12.2	6.8	4.7	7.1	10.0	6.5	5.7	13.8	16.3	6.4	8.5	12.1	5.6	6.4	6.7	13.7	8.7	13.0	17.2	20.0	16.1	14.1	6.3	12.0	18.4	11.8	10.0	9.0	6.5	13.8	11.8	9.9	12.3	12.9	14.1	13.0	11.7	9.5	11.5	10.1	8.0	11.5	8.9	14.9	5.7	9.0	14.7	10.4	18.4	22.4	15.3	12.7	11.0	4.5	12.0	7.2	9.8	7.5	7.8	9.0	9.9	12.4	24.6	2.8	10.3	5.4	12.9	11.2	8.1	3.5	11.3	19.2	9.2	5.1	12.7	6.1	10.3	8.6	8.5	7.5	18.2	8.7	6.4	7.3	3.9	1.8	1.7	1.8	2.9	1.5	2.8	2.5	3.0	2.5	2.3	2.1	3.4	2.8	1.1	2.5	1.6	1.1	2.8	1.6	16.3	19.3	8.9	17.4	18.9	16.3	10.7	12.6	13.7	10.0	16.3	13.7	8.6	3.2	9.4	109.7	6.9	5.6	4.1	6.9	12.5	32.5	10.0	7.4	28.0	8.6	10.6	3.7	29.2	11.5	6.1	5.0	7.9	9.7	41.9	11.7	12.4	9.0	3.0	20.6	154.0	7.2	7.2	10.3	3.6	10.6	13.9	10.1	6.4	6.7	5.9	16.8	144.4	4.9	6.1	3.5	2.5	21.6	9.0	5.0	1.8	69.3	4.6	13.6	8.2	183.5	148.0	7.9	3.2	10.5	6.3	6.6	5.5	9.4	13.0	26.0	6.6	8.3	7.6	33.8	18.3	7.4	7.1	12.4	8.2	5.9	4.8	6.2
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637528-110678063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 11.9;lymphoid tissue: 27.5;testis: 30.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 24.8;Granulosa cells: 66.1;Plasma cells: 35.2;Spermatocytes: 85.6;Spermatogonia: 20.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 221.5"	"Region enhanced"	"Detected in single"		"white matter: 1.7"	"Not detected"	"Not detected"			HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	0.5	0.4	0.1	8.4	0.3	11.9	1.2	0.1	0.1	0.9	0.0	4.3	4.0	1.0	3.5	4.7	0.5	0.9	0.6	0.1	0.1	0.3	0.6	1.2	15.9	0.1	0.6	0.4	0.2	0.7	0.0	3.2	0.3	0.3	5.7	0.1	0.9	0.1	0.1	2.7	3.5	2.2	0.0	5.6	1.9	30.3	0.4	27.5	0.4	0.2	17.0	2.4	1.6	0.3	96.0	29.4	68.5	46.8	3.8	5.3	38.8	50.9	32.9	85.6	62.3	58.3	55.0	64.7	30.9	30.1	80.1	43.2	93.9	35.0	105.7	51.4	45.6	221.5	26.2	50.6	0.8	63.5	57.0	1.7	2.8	65.2	33.1	12.7	49.8	73.2	96.8	126.5	76.8	33.7	126.3	39.0	71.2	39.4	55.3	69.3	64.2	102.7	18.3	27.0	48.3	21.4	34.2	31.4	27.2	44.1	24.0	60.6	19.1	39.7	57.5	28.8	69.0	67.3	65.5	75.4	24.2	48.6	69.8	1.1	0.0	0.2	0.2	0.0	0.3	0.5	0.9	0.5	0.1	0.5	0.6	0.4	0.0	0.5	0.0	0.9	1.5	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.3	0.0	0.4	0.3	0.2	0.0	1.5	0.0	5.5	0.5	0.5	2.0	0.6	0.0	0.9	0.8	1.1	0.0	1.6	0.0	0.0	5.8	2.5	2.4	0.0	0.3	13.5	4.5	1.5	1.1	0.0	24.8	0.2	0.0	9.8	2.2	2.0	2.2	0.0	66.1	1.8	0.3	8.1	0.0	0.2	3.1	4.1	1.6	1.4	7.5	0.3	2.0	0.0	0.0	0.6	0.0	0.0	0.5	1.0	0.1	0.0	0.4	35.2	0.5	0.3	0.1	1.8	0.0	6.6	0.2	3.7	85.6	20.0	4.0	0.4	0.7	2.9	0.5	5.9	0.9
BUB3	BUB3L	ENSG00000154473	"BUB3 mitotic checkpoint protein"	O43684	10	123154402-123170467	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003601, CAB037075"	Supported		Supported	Nucleoplasm		NA	Yes		39000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB037075: AB_1078310, HPA003601: AB_1078309"	"unprognostic (7.82e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (9.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.93e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (4.45e-5)"	"unprognostic (6.04e-3)"	"unprognostic (9.41e-2)"	"unprognostic (6.30e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (8.80e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.71e-2)"	36.6	49.8	27.3	63.3	34.5	102.9	41.1	35.0	35.0	36.0	30.7	49.0	42.2	35.7	35.2	56.6	37.6	35.8	28.0	31.9	36.4	32.6	34.9	33.5	99.9	34.1	50.6	42.9	30.1	32.6	36.0	38.2	39.6	30.6	49.1	25.5	39.5	28.8	36.9	44.1	47.7	36.4	35.7	52.9	38.4	58.5	33.0	100.6	37.4	33.5	87.2	49.5	40.4	48.6	309.8	302.5	190.4	211.5	105.4	100.3	166.2	316.2	329.5	340.3	268.8	266.3	203.2	275.9	116.3	145.2	163.6	195.9	285.1	343.0	349.9	228.8	294.2	173.0	355.1	291.8	110.1	338.1	206.8	86.5	132.9	307.9	382.4	182.1	232.7	228.9	216.1	266.7	308.4	264.1	281.8	206.9	117.6	159.0	293.0	378.6	96.2	175.7	156.3	333.1	141.4	143.1	179.2	116.6	151.9	77.5	135.0	173.4	188.5	262.4	163.9	167.6	473.8	143.0	220.6	433.9	143.0	333.2	113.2	200.3	113.2	165.7	246.0	122.2	224.1	216.7	223.0	251.0	119.1	209.7	237.9	249.3	56.1	241.6	112.3	127.6	366.9	294.0	27.3	34.5	35.0	35.0	31.9	36.4	34.1	50.6	39.6	35.7	33.0	48.6	55.8	25.6	36.5	15.3	99.7	130.5	65.5	154.6	73.4	30.8	53.4	48.8	39.2	44.3	66.9	38.6	10.4	108.1	119.0	37.1	70.5	68.8	160.8	26.1	41.4	62.1	40.7	93.6	14.4	58.9	136.5	62.6	34.7	28.1	50.7	56.3	45.0	43.0	80.7	10.1	12.9	57.3	118.0	58.1	68.6	159.3	45.1	53.1	96.0	16.9	140.4	55.7	97.9	21.6	35.9	64.1	40.2	46.3	107.1	64.7	44.5	78.4	51.2	25.1	105.2	42.2	70.6	199.8	145.4	86.3	133.3	65.0	150.3	84.1	67.8	62.9
BUD13	"Cwc26, fSAP71, MGC13125"	ENSG00000137656	"BUD13 homolog"	Q9BRD0	11	116748170-116772987	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038340, HPA038341"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038340: AB_2675967, HPA038341: AB_10671528"	"unprognostic (1.89e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.07e-5)"	"unprognostic (1.77e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-1)"	10.8	7.5	7.4	12.2	8.9	12.7	13.5	10.5	9.3	11.8	8.5	11.9	11.0	15.4	10.5	11.4	13.7	8.1	8.0	7.3	8.8	9.1	9.7	12.2	16.4	8.6	8.1	16.0	11.3	10.5	8.0	11.0	8.8	10.2	13.4	10.6	10.1	10.6	12.3	11.2	12.8	12.8	7.7	12.7	11.3	21.6	8.5	25.5	12.0	14.0	18.8	11.0	11.2	10.4	22.4	12.0	33.3	20.1	10.4	12.5	16.6	21.6	23.9	24.3	23.5	28.6	33.0	47.1	26.8	17.9	25.4	30.7	27.2	16.8	26.6	27.8	11.1	55.1	8.8	21.8	12.7	46.9	31.6	11.3	19.2	20.6	20.8	15.6	24.0	46.1	36.0	22.8	20.2	17.7	57.5	41.0	20.0	31.6	19.0	42.9	28.6	36.3	17.0	25.5	19.7	26.2	25.3	18.3	10.0	21.0	25.1	30.6	13.7	27.7	17.5	14.3	29.0	9.3	12.4	39.1	9.0	42.6	25.3	15.8	7.6	20.2	10.0	7.8	10.8	10.4	8.6	7.9	8.2	7.4	9.5	8.1	9.1	7.5	8.7	7.2	8.1	5.7	7.4	8.9	10.5	9.3	7.3	8.8	8.6	8.1	8.8	7.7	8.5	10.4	11.7	9.6	5.6	6.2	14.3	7.6	10.8	7.1	11.4	6.8	6.6	6.0	4.9	2.8	6.5	9.2	12.5	9.2	9.5	11.7	7.9	8.5	13.5	10.4	8.7	8.5	9.6	17.7	7.2	8.1	10.5	7.8	7.1	9.3	11.4	9.6	7.1	8.0	8.2	3.3	6.8	6.9	2.0	12.0	6.7	5.3	9.0	7.8	7.2	3.7	9.4	7.3	26.8	9.0	11.2	6.4	8.5	10.9	16.6	6.4	15.4	5.8	10.9	7.3	6.6	8.5	7.7	51.2	21.8	11.0	4.8	9.9	13.1	7.9	11.3	7.0
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23 rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 119.9;Endometrial ciliated cells: 133.6;Exocrine glandular cells: 140.8;Pancreatic endocrine cells: 126.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 712.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA052185: AB_2681753"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	39.8	49.2	34.5	40.0	36.7	58.7	43.4	36.4	39.8	36.3	41.0	48.6	47.0	38.6	72.3	41.7	58.9	34.5	87.9	36.1	39.0	53.3	47.2	38.5	52.6	37.0	36.1	37.8	70.8	49.2	45.1	30.7	36.3	37.8	47.7	20.3	55.9	42.2	128.0	43.8	40.3	41.4	36.4	42.1	44.9	130.0	36.6	44.7	56.5	78.4	51.7	51.9	32.8	38.5	142.1	151.8	53.6	429.2	72.0	64.2	91.1	95.1	83.3	118.5	96.1	211.4	182.6	163.6	48.9	99.5	204.0	97.0	124.8	91.0	108.4	116.6	147.1	72.0	174.8	86.7	91.2	200.3	98.8	57.3	102.2	103.2	93.9	59.7	77.4	130.3	285.4	288.9	103.7	219.6	128.0	277.8	130.2	317.8	172.2	110.5	106.8	712.0	132.5	100.2	163.4	124.4	126.3	329.2	146.5	53.0	207.9	159.0	85.2	101.8	130.3	130.0	208.3	99.5	192.6	275.5	232.3	155.6	218.0	54.8	64.9	60.6	112.0	74.2	124.9	175.3	127.1	122.5	122.9	153.5	132.8	121.5	11.9	125.4	68.0	190.9	150.6	132.6	34.5	36.7	36.4	39.8	36.1	39.0	37.0	36.1	36.3	36.4	36.6	38.5	67.0	44.8	64.5	0.0	26.5	0.0	0.0	0.0	0.0	0.0	75.4	85.7	0.0	0.0	42.7	46.0	0.0	75.7	64.1	0.0	97.8	119.9	0.0	133.6	51.2	28.6	0.0	0.0	0.0	140.8	82.7	24.5	0.0	79.6	46.7	49.2	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	21.2	0.0	0.0	0.0	0.0	126.0	0.0	0.0	16.5	0.0	0.0	103.5	78.7	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	106.7	28.1	73.0	0.0	0.0
BUD31	"Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W"	ENSG00000106245	"BUD31 homolog"	P41223	7	99408641-99419616	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028943	Approved		Approved	Nucleoplasm,Microtubules,Centrosome		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Microtubules, Centrosome"	"HPA028943: AB_10602396"	"unprognostic (1.68e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.71e-1)"	48.2	47.1	51.3	32.6	51.0	91.7	45.9	54.5	59.7	37.8	52.3	46.4	32.0	38.1	35.4	49.6	39.9	32.2	39.6	51.9	51.8	65.5	42.9	43.4	45.5	51.4	51.3	39.0	33.9	41.1	54.0	33.9	51.6	42.3	25.7	14.8	37.9	30.8	31.6	40.8	35.2	29.2	51.5	40.9	44.0	68.4	55.0	41.1	41.2	25.1	35.8	40.3	40.7	53.2	111.2	123.9	67.5	153.9	67.3	75.0	67.0	103.7	96.7	113.4	124.1	148.5	104.5	83.7	122.7	98.3	123.8	65.5	76.0	92.9	93.8	102.3	106.9	61.1	83.1	98.2	139.4	106.0	78.2	73.8	112.1	104.1	195.1	66.4	89.8	87.6	151.7	182.3	106.2	283.9	143.3	281.2	152.2	114.6	156.8	73.2	69.5	145.7	100.7	85.6	120.3	145.8	101.8	114.9	216.8	43.8	72.2	129.0	74.8	108.1	138.5	216.8	163.6	115.0	207.2	220.9	94.9	153.6	199.4	390.7	206.8	516.9	175.8	232.0	164.7	226.1	165.5	171.2	175.9	223.9	140.0	145.7	451.2	203.7	252.6	171.2	215.7	360.5	51.3	51.0	54.5	59.7	51.9	51.8	51.4	51.3	51.6	51.5	55.0	53.2	103.2	83.3	81.2	3.6	88.1	192.7	142.3	192.7	103.6	32.8	94.8	134.1	12.8	68.6	110.5	92.0	10.4	169.9	118.5	157.7	238.7	169.9	173.1	137.3	91.7	98.1	146.8	85.2	5.7	187.1	163.0	97.9	65.2	111.9	91.2	79.6	86.0	84.3	151.5	16.8	5.6	187.2	111.9	89.2	125.1	121.3	82.0	90.8	136.9	5.6	148.5	103.5	116.4	5.0	6.8	248.1	153.8	74.1	68.4	153.9	155.4	242.3	171.2	40.1	59.2	77.4	144.3	298.2	135.7	99.1	183.8	182.4	112.0	86.9	132.3	174.8
BX664615.2		ENSG00000283886		Q8NFD4	9	39816599-39874562	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HDLM-2: 4.8;SCLC-21H: 6.2;SH-SY5Y: 4.5;SiHa: 4.1;WM-115: 8.8"									HPA021733			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"		"Cluster 7: SCLC-21H - Neuronal signaling"		Nucleoplasm	Cytosol	"HPA021733: AB_10602499"																		0.4	2.6	1.2	1.6	1.3	0.4	0.7	1.3	2.3	1.4	1.4	0.3	0.4	1.1	1.1	1.2	0.9	1.2	3.5	1.3	1.4	3.8	1.6	0.8	1.4	1.4	1.5	2.2	1.9	1.4		0.1	1.3	1.0	0.2	5.4	2.1	0.7	0.3	2.4	0.9	0.4	1.1	0.8	0.6	0.4	1.4	0.5	5.4	0.1	0.1	1.0		1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.1	0.1	0.1	6.0	0.0	1.3	0.0	0.0	0.0	0.0	1.0	0.0	4.8	1.3	0.0	2.9	0.0	0.1	0.9	0.1	0.3	3.9	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.4	0.7	6.2	4.5	4.1	2.3	0.2	0.0	0.5	0.0	3.0	0.2	0.4	1.6	0.0	0.0	1.6	2.2	0.0	0.0	8.8	0.9	0.0	0.7	1.0	0.6	0.7	0.7	0.7	0.8	0.6	1.6	0.6	0.8	0.0	0.5	0.4	0.7	0.5	0.2	1.2	1.3	1.3	2.3	1.3	1.4	1.4	1.5	1.3	1.1	1.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921499-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	10.7	10.1	6.0	8.2	6.1	7.4	8.8	5.7	6.2	6.4	5.8	6.8	4.7	8.2	5.4	9.2	8.5	5.4	7.2	6.1	6.7	6.5	10.7	5.1	8.4	6.0	6.7	8.1	11.6	6.5	3.6	10.0	6.9	6.8	7.0	2.5	4.8	6.5	20.1	8.0	4.0	11.9	5.9	5.8	5.5	7.9	6.6	12.2	5.2	10.8	13.2	15.4	5.9	6.2	50.6	52.1	30.2	54.2	21.8	25.5	59.7	44.0	21.6	66.7	48.9	72.1	15.7	78.2	43.9	32.9	51.9	34.3	91.6	61.0	58.0	30.1	89.2	72.7	37.3	81.5	38.6	58.8	36.0	30.1	39.5	67.2	62.1	16.9	50.5	47.3	96.1	26.0	48.7	70.8	74.2	68.3	29.0	162.4	50.9	77.9	38.2	57.3	45.2	37.9	65.6	37.4	30.0	37.8	58.2	26.3	38.0	58.6	39.3	49.0	53.5	31.4	77.2	24.6	33.0	185.8	14.5	57.9	49.9	0.0	3.8	0.7	4.3	3.9	5.9	3.8	2.5	3.5	6.0	5.5	1.6	3.3	0.5	6.1	3.0	9.2	3.3	2.3	6.0	6.1	5.7	6.2	6.1	6.7	6.0	6.7	6.9	5.9	6.6	6.2	6.4	0.0	3.9	0.7	6.7	31.0	34.5	19.2	8.6	2.8	8.6	8.5	2.8	5.7	9.5	1.8	4.2	22.1	4.8	4.6	3.9	21.4	10.4	7.9	12.1	10.9	5.4	6.3	2.8	17.5	24.4	11.4	4.6	9.8	2.5	11.4	3.9	6.8	12.0	0.0	2.5	6.5	12.2	1.0	7.3	6.8	8.1	5.1	8.8	1.9	6.6	4.4	9.2	4.0	2.8	23.5	2.9	7.2	4.9	26.2	2.2	10.5	5.1	3.4	6.6	16.1	13.8	10.8	25.7	14.0	25.3	29.1	4.1	18.2	11.4	32.2
C10orf62	bA548K23.1	ENSG00000203942	"Chromosome 10 open reading frame 62"	Q5T681	10	97589721-97590934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	155	"testis: 277.9"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 9848.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA072947	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Vesicles"	"HPA072947: AB_2686562"		"unprognostic (3.66e-2)"		"unprognostic (3.97e-2)"	"unprognostic (2.81e-1)"		"unprognostic (5.36e-2)"		"unprognostic (3.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.63e-2)"		"unprognostic (2.53e-2)"	"unprognostic (2.04e-2)"				0.0	0.2	0.3	0.0	0.8	0.0	0.2	1.4	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.5	0.7	0.7	0.0	0.0	0.9	1.0	0.0	0.3	0.1	0.2	0.0	0.9	0.3	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.5	0.0	0.0	277.9	0.8	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.4	0.4	0.3	0.5	0.9	1.0	0.9	0.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1711.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9848.3	39.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.3	0.0	0.0	6.6	0.0	0.0	40.7	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C10orf71	FLJ45913	ENSG00000177354	"Chromosome 10 open reading frame 71"	Q711Q0	10	49299170-49327492	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 280.2;tongue: 81.9"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 56.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"K-562: 6.9;RH-30: 9.9"	"Not detected"	"Not detected"							HPA057556			Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Mitochondria	"HPA057556: AB_2683467"				"unprognostic (1.25e-2)"		"unprognostic (3.97e-2)"		"unprognostic (4.16e-2)"		"unprognostic (5.58e-2)"		"unprognostic (1.66e-1)"		"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	44.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.3	21.9	0.0	0.0	0.1	1.3	0.0	0.0	1.2	0.0	280.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126798708	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 112.1"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 819.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 118.8;U-2197: 36.1;U-266/84: 27.2;U-87 MG: 37.0;WM-115: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	0.7	0.0	30.4	0.1	74.4	0.0	4.7	41.9	47.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	29.9	37.4	0.3	0.1	0.0	0.0	60.4	53.8	0.1	0.2	0.0	0.3	0.3	57.0	0.0	0.1	0.0	10.6	0.0	0.1	1.1	0.1	0.0	29.8	0.0	0.0	6.5	68.0	1.1	0.3	0.4	0.7	0.0	0.0	112.1	0.3	0.1	0.0	0.0	0.8	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	2.3	0.0	1.6	0.0	0.9	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.0	118.8	0.0	0.0	0.2	0.0	4.7	0.0	36.1	0.7	0.0	27.2	0.0	37.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	74.4	41.9	47.7	29.9	37.4	60.4	53.8	57.0	29.8	68.0	112.1	0.2	0.0	0.0	24.5	0.1	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	120.5	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	142.7	0.3	0.0	0.0	3.7	0.0	0.0	0.0	181.0	819.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	1.3	0.5	0.0	0.0	4.2	0.1	0.0	0.0	0.0
C11orf1	FLJ23499	ENSG00000137720	"Chromosome 11 open reading frame 1"	Q9H5F2	11	111878935-111885975	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 402.4;Late spermatids: 1147.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038410, HPA057519"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038410: AB_10672591, HPA057519: AB_2683454"	"unprognostic (1.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.86e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.08e-1)"	21.5	37.0	25.9	10.4	29.0	18.1	49.2	26.4	36.1	20.5	24.6	26.3	20.4	17.2	64.2	24.0	28.6	19.6	33.0	26.1	27.5	70.3	54.9	16.3	15.1	26.1	26.7	28.0	48.0	39.9	28.4	9.4	26.5	27.4	26.4	22.3	33.0	26.8	16.2	34.8	21.4	14.9	25.7	11.6	30.6	61.2	27.1	20.3	41.1	21.1	17.8	22.7	18.4	27.0	25.1	31.9	40.3	44.6	45.6	34.3	42.0	13.5	34.2	10.9	13.8	54.5	45.6	91.9	63.5	23.2	31.4	28.9	16.5	50.2	17.0	40.6	23.4	30.9	6.9	42.0	28.6	45.7	20.9	63.8	76.9	39.0	74.4	48.4	13.5	96.2	45.3	66.8	36.9	25.0	62.2	70.8	46.3	86.8	48.0	31.5	42.0	127.6	69.4	46.0	36.3	34.1	8.7	31.5	31.3	38.4	63.1	31.8	11.7	40.2	28.8	17.6	19.1	38.8	61.2	136.7	20.3	53.1	24.9	6.5	7.4	9.0	13.0	14.6	24.9	26.0	22.0	17.0	11.1	17.7	34.5	26.5	1.7	16.7	10.1	32.8	17.6	10.2	25.9	29.0	26.4	36.1	26.1	27.5	26.1	26.7	26.5	25.7	27.1	27.0	14.3	25.6	19.8	3.6	22.6	23.7	67.5	60.6	71.2	8.6	56.5	79.6	57.6	28.6	43.4	35.0	6.2	28.9	17.3	15.1	201.5	21.8	402.4	30.5	17.3	15.3	26.4	26.3	3.5	27.2	22.5	16.5	22.4	22.6	29.2	23.3	11.0	43.4	23.0	15.2	4.7	39.8	28.5	7.9	11.4	1147.2	27.4	14.3	24.9	3.7	19.3	43.5	20.6	1.0	3.7	18.9	22.3	24.5	41.9	36.4	40.6	197.9	44.4	15.5	19.7	10.8	17.0	54.4	30.9	53.4	29.5	21.1	22.6	49.2	44.4	72.7
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295628-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"bone marrow: 50.4;heart muscle: 20.0;lymphoid tissue: 14.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 68.1;dendritic cells: 29.4;Macrophages: 20.3;monocytes: 28.4;NK-cells: 47.4;T-cells: 16.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 51.7;HL-60: 19.7;NB-4: 18.4;THP-1: 12.7;U-937: 22.2"									HPA037607	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.4	0.6	0.3	7.1	0.4	50.4	0.6	0.4	0.4	1.6	0.2	0.9	0.6	0.6	0.3	0.6	0.7	2.1	20.0	0.3	0.3	0.7	1.3	4.7	14.0	1.1	0.5	0.2	0.4	0.1	0.3	0.6	0.8	0.6	1.3	0.0	1.5	0.4	1.0	1.3	3.5	1.0	0.6	14.9	2.6	0.3	0.4	3.6	0.9	0.2	7.3	1.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	51.7	0.1	0.1	0.5	19.7	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	22.2	0.0	80.3	14.9	45.8	23.8	31.4	16.1	4.7	7.8	18.8	17.1	5.8	11.6	16.3	12.6	23.9	58.4	1.7	6.1	16.5	0.3	0.4	0.4	0.4	0.3	0.3	1.1	0.5	0.8	0.6	0.4	1.0	0.2	0.0	4.2	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.1	0.3	68.1	2.8	0.0	0.0	0.0	0.1	29.4	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	13.9	0.0	0.0	0.2	1.7	0.5	0.0	15.8	0.0	2.5	0.0	3.7	0.0	0.0	0.0	0.0	12.5	15.5	0.0	0.0	20.3	1.8	0.0	28.4	0.0	47.4	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.4	0.0	16.0	0.0	0.0	0.0
C11orf24	DM4E3	ENSG00000171067	"Chromosome 11 open reading frame 24"	Q96F05	11	68261338-68272001	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 107.7;Proximal enterocytes: 162.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 222.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012411, HPA012748"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012411: , HPA012748: AB_1845526"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.91e-2)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.60e-9)"	"unprognostic (2.18e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.67e-3)"	25.0	17.6	8.9	20.7	12.2	4.7	21.0	12.1	12.7	23.3	8.2	29.2	53.8	39.2	7.3	15.5	22.2	17.6	31.5	9.7	10.5	17.0	87.4	24.1	15.5	14.4	11.6	19.3	27.3	7.3	14.5	16.1	12.5	22.9	17.4	3.0	34.0	17.6	13.7	15.4	59.4	32.6	11.0	20.8	23.6	14.6	12.8	6.4	17.0	15.2	16.7	22.3	19.4	15.2	44.8	45.5	26.4	51.6	62.1	62.5	29.7	105.4	67.5	51.8	53.1	96.2	26.9	20.1	31.7	131.3	47.2	49.4	39.1	47.4	33.2	22.1	23.1	21.4	44.8	65.3	50.1	18.3	68.7	52.1	34.6	78.8	32.0	31.0	21.2	10.6	37.9	32.2	44.6	55.7	4.5	26.4	44.2	72.1	53.8	8.2	44.8	104.1	23.9	21.1	17.3	31.8	33.3	27.1	222.8	21.8	25.6	15.3	23.3	80.8	50.2	103.3	47.3	39.4	41.4	18.8	65.1	14.1	79.9	16.7	12.1	12.6	14.0	19.0	9.4	26.7	7.9	8.9	19.5	35.7	7.3	7.7	1.8	9.9	14.1	26.7	8.4	12.6	8.9	12.2	12.1	12.7	9.7	10.5	14.4	11.6	12.5	11.0	12.8	15.2	6.8	9.6	3.6	3.3	25.5	14.0	12.2	11.7	9.6	4.8	8.2	8.9	10.4	11.5	6.9	9.2	2.1	11.9	12.4	36.2	1.9	21.9	3.5	5.3	17.8	6.6	4.8	9.1	4.1	31.5	30.7	21.1	18.3	6.8	45.0	5.0	9.3	107.7	15.8	0.0	4.2	50.0	6.1	12.9	23.5	7.1	14.0	12.3	28.4	5.6	14.9	6.8	18.6	6.6	8.5	26.9	16.6	16.1	67.0	13.0	162.5	10.6	9.4	2.9	13.1	11.2	20.2	20.7	27.1	9.6	11.2	10.5	6.5	9.6	15.5	10.6
C11orf53	MGC50104	ENSG00000150750	"Chromosome 11 open reading frame 53"	Q8IXP5	11	111245726-111286401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 3.4;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 14.3;Early spermatids: 38.1;Exocrine glandular cells: 56.6;Late spermatids: 12.4;Respiratory ciliated cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"OE19: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA056128, HPA073101"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Vesicles	"HPA056128: AB_2683046, HPA073101: "	"unprognostic (3.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.84e-2)"		"unprognostic (1.94e-1)"		"unprognostic (8.07e-3)"		"unprognostic (5.60e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.50e-1)"		"unprognostic (9.95e-2)"	"unprognostic (8.66e-2)"		"unprognostic (3.52e-2)"	0.9	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	1.4	0.9	0.9	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.6	1.3	0.4	0.7	0.0	0.3	1.0	0.0	2.1	0.0	1.8	0.0	1.2	0.0	0.0	0.0	3.4	5.5	0.0	0.4	0.0	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.0	0.0	0.1	0.1	14.3	3.3	0.0	0.0	0.0	0.1	1.5	0.0	1.9	38.1	0.0	1.4	0.0	7.7	0.0	0.1	56.6	0.1	1.9	3.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	3.0	8.2	0.0	0.0	12.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.2	0.3	4.0	0.0	9.9	0.0	0.0	0.1	0.6	1.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	4.4
C11orf54	PTD012	ENSG00000182919	"Chromosome 11 open reading frame 54"	Q9H0W9	11	93741591-93764749	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 569.9;liver: 258.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 370.4;Proximal tubular cells: 1136.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040088, HPA040511"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		1300000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"	Nucleoplasm	"HPA040088: AB_10795518, HPA040511: AB_10795369"	"unprognostic (3.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (5.06e-6)"	"unprognostic (2.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.53e-3)"	20.1	24.6	10.2	19.1	16.4	7.4	31.4	15.2	14.8	20.7	18.0	40.8	53.0	21.7	19.6	17.6	32.3	47.2	21.5	9.5	14.8	569.9	258.8	30.3	21.5	18.3	12.9	30.1	51.6	20.9	16.7	25.3	16.5	39.6	43.8	20.7	28.9	25.0	41.8	21.2	51.5	20.8	13.0	17.3	37.9	19.8	12.9	28.1	35.9	54.7	23.4	17.0	12.9	25.2	9.4	13.5	30.9	18.3	23.5	26.8	36.1	13.8	23.6	13.8	19.0	5.6	52.9	39.4	85.5	25.6	14.4	22.2	37.5	10.0	19.4	39.9	11.4	21.7	34.9	26.5	27.7	20.7	11.0	24.7	17.0	24.7	16.6	34.8	21.6	26.2	29.6	26.6	12.8	8.0	33.0	23.7	10.5	64.9	22.1	31.4	40.8	62.2	74.6	19.6	15.2	20.2	23.0	28.2	27.7	22.7	65.9	13.4	13.5	13.0	10.0	22.5	6.6	12.0	38.2	37.8	9.8	29.2	23.3	75.0	30.0	74.0	21.7	21.5	22.3	27.1	22.1	24.7	23.0	23.0	27.0	23.7	100.9	24.8	19.0	31.9	31.5	18.8	10.2	16.4	15.2	14.8	9.5	14.8	18.3	12.9	16.5	13.0	12.9	25.2	25.1	64.1	54.7	28.1	27.4	5.5	10.6	18.4	21.1	18.0	21.6	14.6	34.7	190.1	33.5	47.8	16.7	51.4	21.6	53.6	178.1	17.4	14.4	34.2	20.5	18.3	22.2	23.1	23.7	13.9	14.8	23.9	32.6	43.6	15.2	40.2	29.6	370.4	17.5	15.2	27.8	37.1	28.5	29.2	7.2	6.4	25.7	22.2	8.8	15.9	18.2	17.0	10.3	25.6	37.8	13.1	38.4	23.0	25.7	29.0	75.0	1136.3	36.2	19.7	6.6	28.9	17.0	38.6	17.4	17.6	9.9	62.0	21.1	16.3	35.6	22.9
C11orf58	SMAP	ENSG00000110696	"Chromosome 11 open reading frame 58"	O00193	11	16613132-16758340	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036591, HPA076406"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"	Nucleoplasm	"HPA036591: AB_10669909, HPA076406: AB_2686798"	"unprognostic (8.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (1.30e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.45e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-1)"	142.2	135.1	52.2	129.5	57.8	128.3	94.5	55.3	79.7	91.5	66.5	101.8	89.9	136.1	73.8	172.3	128.0	115.6	159.9	52.0	62.7	114.9	132.9	102.9	162.9	57.6	56.0	172.0	127.8	115.1	78.7	123.9	61.3	111.7	71.7	94.2	128.6	85.3	212.2	99.8	96.5	113.8	56.8	125.8	111.7	89.6	55.4	138.2	162.1	109.6	127.9	125.1	81.3	69.1	416.1	362.9	390.3	197.0	199.5	162.3	272.8	419.2	213.0	276.2	245.5	348.0	397.7	383.1	315.2	253.7	311.4	242.3	275.0	206.9	232.8	485.8	289.9	342.7	286.8	310.1	243.4	492.8	276.2	182.3	230.6	168.9	336.6	209.7	178.4	232.6	435.2	246.5	191.1	247.8	506.5	211.7	291.1	212.7	197.6	404.3	413.6	196.0	158.6	248.7	269.8	267.4	372.4	273.4	501.4	225.0	244.4	315.7	359.5	336.7	268.2	407.1	388.0	164.0	648.6	525.2	297.2	275.3	326.1	587.6	390.4	552.8	407.8	451.9	482.3	621.9	451.4	435.0	429.7	578.9	506.9	440.6	186.9	433.9	490.1	544.7	522.0	896.2	52.2	57.8	55.3	79.7	52.0	62.7	57.6	56.0	61.3	56.8	55.4	69.1	188.3	246.8	222.5	41.8	219.8	257.1	275.3	379.8	167.9	169.5	170.9	168.4	206.4	178.7	259.1	200.5	150.1	312.2	242.8	65.6	428.4	249.7	65.6	204.2	202.0	217.3	159.2	213.7	72.5	228.1	346.8	258.2	73.4	139.8	237.3	151.3	175.6	163.8	227.0	143.0	68.6	133.2	299.1	164.3	261.0	34.3	205.9	180.1	229.5	45.0	249.9	230.5	248.2	61.3	63.5	232.3	104.3	204.2	183.0	324.1	103.4	364.6	237.0	215.7	157.8	164.9	246.8	331.6	245.7	142.5	276.6	453.5	217.3	188.2	118.7	296.6
C11orf68	"BLES03, P5326"	ENSG00000175573	"Chromosome 11 open reading frame 68"	Q9H3H3	11	65916810-65919062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045938	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA045938: AB_10961633"	"unprognostic (3.18e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.50e-3)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.18e-1)"	36.0	29.3	68.1	14.9	70.3	10.1	33.5	74.7	82.3	50.4	59.4	50.1	17.2	56.1	39.0	29.7	40.5	20.7	50.7	71.0	65.1	31.2	28.0	31.9	24.8	69.0	67.0	43.4	27.2	25.6	24.0	23.4	67.6	42.6	15.7	12.5	30.9	31.7	81.1	32.8	31.0	27.0	66.3	41.6	32.8	53.9	67.9	29.1	32.6	51.4	21.3	45.9	39.5	71.4	76.4	33.6	20.4	22.2	70.0	67.3	17.6	59.7	90.2	74.3	45.2	12.6	83.9	15.6	40.6	89.5	118.6	24.0	15.9	36.6	39.8	24.2	16.1	18.5	23.4	33.2	55.7	14.9	23.7	62.9	53.8	53.9	58.9	76.6	56.1	26.1	25.1	37.7	136.2	34.5	19.7	35.9	20.5	16.5	165.8	28.8	23.1	44.4	39.6	14.5	13.9	21.6	23.1	30.1	59.8	21.0	39.0	14.0	61.4	118.0	57.9	162.1	30.9	25.3	11.9	13.1	69.8	11.1	94.1	6.8	2.5	3.7	5.3	3.9	3.8	3.0	3.4	4.4	2.0	5.3	5.2	5.2	9.1	3.8	2.1	2.7	4.2	2.2	68.1	70.3	74.7	82.3	71.0	65.1	69.0	67.0	67.6	66.3	67.9	71.4	17.8	16.0	5.1	6.5	7.3	15.3	32.9	4.2	6.8	11.4	14.7	22.5	16.6	14.3	2.3	16.5	10.4	16.4	14.5	10.8	7.9	14.5	7.9	8.1	17.8	13.8	4.8	2.1	7.9	11.7	16.5	18.5	7.1	11.8	3.8	12.9	18.2	10.5	14.2	16.8	7.5	13.1	4.1	13.9	7.5	24.5	21.5	8.7	10.6	7.5	14.1	26.7	22.6	4.5	8.6	19.3	3.4	35.3	3.6	23.2	11.8	5.4	1.9	9.9	19.7	13.5	16.4	15.0	17.1	6.2	12.8	21.9	8.3	23.3	9.2	31.3
C11orf71	FLJ20010	ENSG00000180425	"Chromosome 11 open reading frame 71"	Q6IPW1	11	114391443-114400511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 139.0"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2360.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063943, HPA074787"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA063943: AB_2685157, HPA074787: AB_2686712"	"unprognostic (1.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (7.35e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (7.01e-9)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.17e-2)"	5.8	10.7	11.8	5.1	13.7	3.7	7.6	12.3	13.8	5.5	10.8	6.9	7.6	5.1	22.6	4.3	7.1	4.4	9.3	11.7	13.9	13.9	22.1	5.9	6.7	14.0	16.7	7.2	8.7	8.9	13.4	3.7	13.2	8.5	6.2	15.9	9.8	5.7	15.0	9.4	7.5	2.9	12.2	9.4	7.3	139.0	12.7	8.9	12.4	15.2	4.7	4.6	4.1	16.0	1.2	3.9	4.2	13.6	6.2	3.6	2.9	0.6	1.7	1.7	1.5	3.0	23.6	6.8	7.8	1.0	8.1	6.3	2.8	2.9	2.1	7.5	1.6	5.1	3.2	6.9	5.9	3.0	5.5	5.9	3.2	2.2	6.7	1.9	2.1	10.8	5.1	6.0	3.2	5.5	5.5	4.6	2.2	5.5	2.5	3.9	3.4	17.3	3.8	3.0	11.6	4.6	15.3	1.8	2.4	4.4	11.5	1.6	2.1	0.4	5.9	4.6	1.2	5.8	10.1	5.2	0.9	6.9	1.7	15.9	15.4	10.3	8.8	9.8	5.5	5.9	5.7	6.0	9.3	8.3	9.5	9.9	12.3	12.1	11.9	12.0	7.1	10.1	11.8	13.7	12.3	13.8	11.7	13.9	14.0	16.7	13.2	12.2	12.7	16.0	12.7	3.2	13.4	5.2	8.0	2.7	15.7	6.3	8.6	10.3	18.3	15.9	19.0	0.0	6.2	5.5	4.2	16.1	6.4	15.0	82.2	15.7	589.6	21.2	8.1	8.7	18.1	7.2	4.7	18.9	3.4	9.5	18.8	12.8	6.3	14.1	0.0	0.0	11.5	13.5	5.6	16.7	10.2	0.0	4.1	2360.8	13.1	13.6	5.4	2.8	11.2	31.5	7.2	4.0	18.5	10.5	15.5	9.1	17.2	9.2	33.0	78.6	18.9	14.1	6.6	7.6	8.0	70.6	9.9	10.4	2.6	14.6	7.4	19.6	12.7	11.4
C11orf96	AG2	ENSG00000187479	"Chromosome 11 open reading frame 96"	Q7Z7L8	11	43925342-43943878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 750.2;ovary: 721.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 796.5;Endometrial stromal cells: 906.3;Fibroblasts: 801.3;Granulosa cells: 982.4;Peritubular cells: 474.3;Smooth muscle cells: 1942.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"SH-SY5Y: 197.7"	"Low region specificity"	"Detected in all"							HPA038843	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA038843: AB_10673296"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.42e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.19e-2)"	478.3	199.0	28.7	39.2	24.3	4.9	203.5	26.1	34.2	305.0	18.4	151.0	19.7	283.4	8.7	44.8	750.2	61.1	269.3	24.8	44.4	226.8	179.2	377.9	6.8	93.8	42.4	721.3	60.7	3.2	126.5	15.4	38.5	157.3	8.4	1.3	22.2	14.3	110.8	97.2	130.3	28.4	35.1	54.4	240.2	67.8	44.5	5.0	119.4	10.3	0.7	176.3	148.1	21.0	0.0	0.0	0.0	0.0	4.0	2.0	1.1	0.3	1.3	0.0	0.1	0.1	0.0	0.0	0.5	0.5	2.1	0.1	0.4	0.0	0.0	0.0	2.9	6.2	0.1	0.0	0.8	0.5	0.6	0.3	0.1	1.4	0.0	0.0	1.2	2.1	2.3	0.0	0.0	0.0	2.4	2.7	1.7	0.0	0.9	10.3	0.7	4.7	0.0	0.0	2.2	197.7	0.0	0.0	19.4	5.5	0.0	2.3	2.7	9.2	3.8	2.3	0.2	22.5	0.2	3.2	7.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	24.3	26.1	34.2	24.8	44.4	93.8	42.4	38.5	35.1	44.5	21.0	796.5	6.4	139.9	0.0	1.9	92.9	15.2	1.6	5.2	15.4	8.2	13.7	6.0	0.0	1.9	0.0	2.1	1.5	13.7	0.3	0.0	4.5	4.3	34.1	906.3	260.3	0.0	2.7	0.0	0.6	4.4	801.3	4.1	183.3	13.9	982.4	172.7	6.4	3.8	1.7	0.0	0.2	0.0	8.4	171.8	13.9	215.6	27.1	174.3	0.0	0.1	2.7	0.0	0.0	0.0	1.9	0.0	474.3	9.4	73.6	0.0	0.0	0.9	9.3	302.4	173.2	1942.9	2.1	1.5	6.5	88.5	3.1	14.2	243.9	0.1	50.5
C12orf45	MGC40397	ENSG00000151131	"Chromosome 12 open reading frame 45"	Q8N5I9	12	104986316-105074197	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 462.1"	"Lineage enriched"	"Detected in all"	13	"dendritic cells: 462.1"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038722	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA038722: AB_10673118"	"unprognostic (1.27e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.58e-10)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.19e-2)"	11.9	8.5	11.8	10.5	12.0	12.2	10.5	15.8	21.0	12.0	6.9	9.7	10.1	8.3	5.9	10.3	7.4	4.3	9.5	10.8	9.1	9.0	14.6	7.2	11.1	7.0	6.7	8.9	24.7	2.4	7.8	4.4	8.4	9.7	7.5	4.5	14.7	4.2	7.5	10.5	7.8	6.4	4.4	11.4	15.1	6.4	10.9	9.2	11.0	2.1	11.0	9.5	10.3	13.3	23.3	32.4	15.3	39.2	12.7	13.0	70.9	20.6	5.2	12.2	6.8	32.8	11.4	44.2	20.1	9.3	30.5	15.2	12.9	31.1	13.5	12.6	22.9	29.5	14.9	45.4	18.4	44.4	22.1	19.1	12.9	18.5	19.7	20.4	20.0	36.4	24.7	11.1	12.0	38.5	29.2	75.3	29.9	34.6	46.2	39.0	18.6	99.9	16.9	29.9	19.5	14.2	20.0	41.9	32.7	27.8	34.8	17.8	9.9	30.2	20.1	26.3	31.6	23.2	28.5	47.5	14.1	30.7	29.2	8.3	34.0	0.6	13.6	30.7	17.1	34.6	18.1	17.3	106.0	25.4	18.6	17.9	3.3	27.8	17.2	462.1	32.9	21.0	11.8	12.0	15.8	21.0	10.8	9.1	7.0	6.7	8.4	4.4	10.9	13.3	15.7	6.4	33.4	1.3	30.4	39.0	44.2	52.8	23.3	11.5	23.4	31.8	37.9	20.0	39.9	33.1	25.0	34.7	66.9	15.8	27.4	27.2	20.8	33.8	25.0	18.0	12.5	12.4	3.8	55.3	63.7	23.0	15.8	40.7	20.3	17.5	11.0	48.2	37.7	3.3	4.2	20.5	30.5	24.2	69.6	10.6	15.2	37.8	39.2	1.0	42.0	18.9	9.2	2.5	4.0	39.0	14.5	10.1	65.8	39.2	12.8	43.7	25.9	11.9	0.0	22.3	24.9	15.9	31.3	19.2	32.7	22.0	23.4	18.1	28.4	39.3
C12orf60	MGC47869	ENSG00000182993	"Chromosome 12 open reading frame 60"	Q5U649	12	14803666-14906586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.7"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 452.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA043911			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA043911: AB_10963941"	"unprognostic (3.71e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.09e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-2)"	0.8	4.7	0.9	0.5	1.2	0.8	0.7	1.1	1.5	0.6	1.6	0.5	0.1	0.4	1.4	0.4	1.4	0.8	3.3	0.9	1.1	2.6	6.0	0.9	1.8	1.2	1.2	0.5	0.9	1.1	0.6	0.7	1.2	0.9	0.4	6.4	0.8	0.5	1.3	0.5	0.5	0.2	1.2	3.3	0.8	14.7	1.2	0.7	1.3	0.8	1.0	0.5	0.4	1.5	1.8	1.9	1.9	5.5	2.0	1.4	1.7	1.3	0.7	1.3	1.6	0.8	1.9	1.5	1.5	0.4	2.0	2.0	2.1	4.3	1.8	3.6	2.2	1.2	0.5	1.3	1.7	1.8	0.6	0.7	2.6	1.3	2.9	1.8	2.6	2.5	2.0	0.3	1.9	0.6	0.7	1.1	6.6	2.7	1.1	2.2	3.3	2.3	2.5	0.5	1.4	1.7	2.8	0.7	2.6	5.6	2.2	0.8	2.0	1.2	1.3	0.9	1.5	0.9	0.7	5.1	1.5	1.7	1.7	0.1	0.5	1.7	0.9	0.6	1.5	1.6	0.7	1.3	0.5	1.0	1.8	1.5	0.1	1.6	0.3	0.4	1.6	0.4	0.9	1.2	1.1	1.5	0.9	1.1	1.2	1.2	1.2	1.2	1.2	1.5	0.9	0.0	0.0	6.8	3.3	0.3	0.5	3.9	0.0	4.0	1.2	1.7	3.6	0.0	3.0	5.5	20.9	1.8	0.9	0.3	7.9	1.8	452.6	3.6	0.6	1.8	0.0	11.6	3.1	1.1	1.6	2.2	0.0	1.1	0.0	1.0	0.0	1.1	1.3	1.7	3.7	0.4	8.2	0.9	0.8	72.6	3.1	1.0	0.0	1.0	2.8	2.8	5.2	10.6	10.8	0.8	0.2	2.6	1.2	0.5	0.3	3.4	8.0	17.0	19.7	2.0	1.6	31.9	8.9	0.2	1.0	0.3	2.8	0.5	0.5	0.3
C12orf65	"FLJ38663, SPG55"	ENSG00000130921	"Chromosome 12 open reading frame 65"	Q9H3J6	12	123233385-123258079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 60.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057595	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA057595: "	"unprognostic (9.07e-3)"	"unprognostic (1.51e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (4.29e-9)"	"unprognostic (9.33e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.83e-3)"	"prognostic favorable (7.82e-5)"	7.3	12.6	16.2	10.2	16.1	9.0	8.0	23.0	19.6	13.0	13.5	10.9	11.4	12.1	13.8	9.5	11.4	8.2	15.0	16.0	13.2	12.6	14.5	8.9	18.2	12.6	12.3	17.2	8.5	10.2	19.7	7.3	14.9	13.7	8.2	15.7	16.2	9.0	13.0	13.8	11.3	7.0	8.8	12.8	10.6	16.7	14.8	60.0	12.3	12.5	13.4	10.3	11.0	18.3	28.4	20.5	20.8	39.1	12.0	11.1	13.7	22.3	16.5	25.1	18.0	21.8	15.8	36.1	20.3	8.4	23.5	20.4	25.7	12.5	25.0	29.2	22.5	44.0	20.7	18.6	26.1	20.4	19.7	14.2	33.2	18.9	35.1	37.0	17.0	53.6	45.6	13.4	16.7	12.3	46.2	39.3	13.7	25.6	31.7	35.7	25.9	33.5	22.8	13.0	40.7	18.2	24.0	8.8	23.4	16.5	18.3	24.7	14.8	23.1	27.3	23.3	24.4	22.7	28.3	32.6	17.1	26.2	28.1	85.3	12.9	50.6	53.9	14.9	67.6	83.9	72.3	71.9	21.7	73.5	96.6	78.2	11.8	63.3	16.3	36.6	73.1	33.5	16.2	16.1	23.0	19.6	16.0	13.2	12.6	12.3	14.9	8.8	14.8	18.3	46.0	41.7	47.7	9.8	54.3	45.4	36.7	29.4	59.2	34.5	23.3	50.0	52.7	14.3	18.0	25.8	14.6	41.1	56.2	16.4	60.7	20.7	22.9	12.2	24.2	27.9	9.6	37.0	13.7	10.8	22.8	41.3	23.0	11.2	15.2	24.1	18.5	33.5	14.3	45.4	15.9	20.7	28.5	9.2	24.2	6.2	37.9	19.7	24.9	7.5	26.3	35.7	44.3	14.6	10.4	13.6	17.4	42.2	42.2	22.8	19.9	39.3	14.8	36.6	13.1	42.7	33.1	115.2	59.7	40.6	36.1	10.8	63.0	43.3	20.8	8.0
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 4.8;salivary gland: 4.6;testis: 10.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 92.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	16	"hypothalamus: 2.9;thalamus: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No				"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	0.3	1.8	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.8	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.1	0.1	1.2	0.0	0.5	4.8	0.0	0.0	1.1	0.0	2.7	4.6	0.1	3.0	0.0	0.1	0.1	0.0	0.0	0.3	10.8	2.4	0.1	0.2	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	6.2	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.7	0.0	0.1	0.0	28.3	0.0	0.0	2.0	0.0	23.9	0.3	3.0	0.0	1.4	0.0	6.2	0.0	0.4	1.7	0.1	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	12.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.9	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.9	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	1.0	0.0	12.3	0.0	1.0	0.7	0.0	0.0	0.7	0.0	0.8	0.0	0.0	1.2	1.1	0.0	10.0	0.2	92.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
C14orf93	"FLJ12154, RTFC"	ENSG00000100802	"Chromosome 14 open reading frame 93"	Q9H972	14	22985894-23010166	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002569	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"HPA002569: AB_1078334"	"prognostic favorable (5.05e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.11e-2)"	8.3	4.8	6.5	5.7	7.7	12.6	8.2	6.7	7.0	11.2	8.5	8.8	7.4	8.7	11.4	7.4	9.5	9.2	5.6	6.2	7.3	11.1	8.9	6.7	10.1	7.7	7.2	10.3	9.6	8.3	6.5	5.0	7.5	9.6	9.6	4.4	8.0	5.7	6.7	18.3	8.1	6.8	6.7	10.6	8.3	4.0	7.2	15.7	11.5	7.9	10.5	8.6	8.3	9.5	5.7	10.5	8.8	12.3	13.9	30.8	12.2	6.6	10.2	5.1	6.7	6.6	16.5	16.0	6.1	6.0	7.2	11.8	5.4	16.6	4.7	6.3	3.8	10.1	14.0	15.3	12.1	7.4	8.3	22.4	12.8	7.6	9.6	18.5	9.6	10.1	11.1	3.4	5.3	16.3	9.5	13.6	3.0	12.3	7.3	15.1	8.4	9.8	6.7	8.6	31.8	13.8	8.8	8.4	9.0	9.4	13.0	12.8	5.5	9.6	12.7	4.3	6.7	11.9	3.6	11.0	6.6	9.1	10.0	12.2	7.7	22.9	8.1	7.4	7.2	10.4	6.5	8.5	9.1	10.0	9.8	9.4	11.2	10.4	13.0	6.3	13.4	7.1	6.5	7.7	6.7	7.0	6.2	7.3	7.7	7.2	7.5	6.7	7.2	9.5	3.1	9.6	1.1	14.7	8.7	3.1	4.1	4.6	10.2	1.4	4.0	4.1	3.3	1.5	2.6	0.0	4.2	4.3	7.8	3.7	7.9	3.9	0.8	3.3	2.6	3.3	15.7	6.5	3.4	3.0	5.7	3.9	7.7	3.0	7.0	4.7	1.4	1.5	3.8	0.0	3.4	6.3	4.1	5.5	2.5	1.5	4.4	3.4	5.4	9.4	1.9	4.1	7.2	7.1	9.9	3.1	7.3	4.1	5.2	1.9	4.6	3.6	4.6	2.0	6.6	3.8	3.7	2.9	8.2	5.3	1.6	3.0	5.2	4.1	5.1	2.5
C15orf40	MGC29937	ENSG00000169609	"Chromosome 15 open reading frame 40"	Q8WUR7	15	82988441-83011641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041947, HPA042980"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA041947: , HPA042980: AB_10964298"	"unprognostic (8.30e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.55e-3)"	"unprognostic (7.71e-2)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.51e-2)"	13.4	13.5	8.3	10.1	8.1	13.9	13.2	12.4	10.8	11.0	6.1	12.4	13.7	9.2	19.8	12.1	9.0	6.5	8.1	8.1	6.7	19.1	13.0	8.2	13.5	8.1	6.3	10.5	12.4	9.7	9.3	7.6	7.6	9.4	8.2	10.2	12.4	5.8	12.4	14.7	12.9	6.1	4.2	11.9	11.2	13.9	7.0	10.7	10.3	6.7	11.2	10.1	10.7	15.3	16.8	19.7	12.8	17.4	15.9	14.4	11.6	10.1	16.0	9.7	10.9	13.7	26.6	16.6	13.4	7.6	23.8	29.5	28.5	20.2	10.9	32.1	19.0	15.7	26.4	15.9	15.3	26.6	15.6	12.1	28.8	16.1	18.1	12.8	16.8	43.6	22.1	26.6	9.3	15.7	22.6	14.3	21.4	23.8	12.5	30.5	17.3	22.7	16.7	23.5	29.7	18.2	26.0	20.4	40.8	16.2	23.3	15.4	10.4	20.0	29.1	15.5	17.7	25.4	42.0	31.8	26.0	26.4	22.4	58.0	20.9	31.2	28.1	22.0	31.4	46.7	29.7	29.5	21.2	38.8	34.7	29.9	20.6	42.2	21.4	29.6	41.1	20.5	8.3	8.1	12.4	10.8	8.1	6.7	8.1	6.3	7.6	4.2	7.0	15.3	27.3	28.9	32.5	16.6	41.1	12.0	27.8	45.2	51.2	28.9	33.6	41.0	11.6	38.6	46.2	25.8	12.5	46.6	22.3	42.3	93.9	47.3	36.7	30.0	21.1	27.2	28.8	32.4	11.6	56.1	30.0	29.9	32.1	19.0	27.8	33.7	26.0	37.7	30.0	30.3	14.3	26.4	34.6	28.4	12.0	30.8	33.2	28.0	26.6	8.4	42.7	32.1	63.8	11.6	19.9	62.7	29.6	36.1	41.2	26.7	77.6	127.3	51.2	30.1	19.7	28.6	25.9	107.3	66.8	46.5	15.3	35.6	39.3	39.9	29.9	26.3
C15orf65	FLJ27352	ENSG00000261652	"Chromosome 15 open reading frame 65"	H3BRN8	15	55408495-55418798	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 168.5;Endometrial ciliated cells: 79.4;Respiratory ciliated cells: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 13.2;SK-MEL-30: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA067189: AB_2685800"	"unprognostic (2.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (3.18e-7)"	"unprognostic (1.59e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	1.3	2.1	2.8	0.5	3.0	0.6	3.2	2.6	3.4	4.3	5.3	4.0	1.8	1.9	6.0	0.8	7.9	3.1	5.6	2.8	3.1	7.2	1.3	2.3	1.1	3.6	3.5	1.2	8.5	4.6	8.9	0.5	3.4	3.3	3.6	7.5	9.0	2.7	6.9	1.4	1.6	2.1	3.1	1.2	6.3	9.0	3.0	1.5	4.0	2.8	1.1	1.6	1.1	2.9	0.9	1.3	2.7	1.7	4.0	5.8	0.4	1.5	2.2	1.2	2.5	0.0	1.5	1.2	4.0	5.1	3.2	1.2	0.0	2.5	0.4	2.5	1.8	1.2	9.3	0.4	7.6	2.8	1.5	1.9	13.2	3.8	1.0	6.9	2.4	0.0	2.3	4.0	5.8	2.1	0.1	7.6	0.7	4.8	3.0	0.5	0.0	10.5	7.0	0.0	7.7	4.3	1.9	3.2	13.0	1.1	6.4	2.7	1.8	2.1	0.9	2.0	0.7	1.8	4.8	1.0	5.9	6.7	1.1	4.7	0.4	1.7	0.2	0.7	0.0	0.9	0.0	0.3	0.3	0.8	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	2.8	3.0	2.6	3.4	2.8	3.1	3.6	3.5	3.4	3.1	3.0	2.9	3.3	3.2	1.1	4.6	3.3	1.3	3.7	13.1	2.2	1.7	8.6	10.8	7.8	5.7	8.0	5.5	0.0	1.1	0.5	6.7	17.6	8.8	168.5	79.4	4.1	3.9	3.6	0.4	4.0	11.0	1.5	3.6	5.1	7.2	4.5	1.9	4.6	1.7	2.9	3.3	2.7	18.8	14.2	1.9	1.9	17.0	4.4	1.0	3.6	1.0	0.8	5.1	0.0	1.0	0.9	6.6	16.8	5.7	2.6	4.8	1.9	22.5	47.5	8.2	6.6	3.2	3.4	23.9	3.6	0.8	1.7	0.0	1.0	4.2	4.8	2.1
C16orf46	FLJ32702	ENSG00000166455	"Chromosome 16 open reading frame 46"	Q6P387	16	81053497-81077267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.7;Late spermatids: 112.4;Respiratory ciliated cells: 31.8;Spermatocytes: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041136, HPA041379"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041136: AB_10795535, HPA041379: AB_10794666"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.53e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.72e-2)"	0.5	0.5	1.9	0.4	1.9	0.6	0.8	1.6	2.8	0.7	4.0	0.3	0.2	0.7	1.2	0.3	2.7	0.4	0.3	2.2	2.1	1.0	1.0	0.4	0.1	2.0	2.2	0.4	0.7	0.5	1.8	0.7	2.1	0.9	0.2	1.3	0.4	0.4	0.7	0.1	0.2	0.4	1.9	0.2	0.3	5.9	2.1	0.2	2.8	0.3	0.2	0.6	0.4	2.4	1.2	0.2	0.4	0.2	2.0	0.4	1.1	0.2	1.5	0.8	0.5	0.2	1.7	0.3	0.7	0.3	1.0	0.4	0.4	0.8	1.5	0.3	0.3	0.3	0.9	1.1	1.2	0.4	0.9	0.8	0.6	2.0	1.2	0.9	0.7	0.6	0.8	0.6	0.6	0.9	0.1	2.4	0.5	0.4	0.2	0.9	0.1	0.2	1.4	0.7	0.6	0.5	1.7	0.5	0.3	0.7	0.5	0.6	0.6	0.4	0.2	0.3	0.3	0.6	1.0	0.7	0.7	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	1.6	2.8	2.2	2.1	2.0	2.2	2.1	1.9	2.1	2.4	1.0	0.0	2.3	11.4	0.5	1.9	8.9	6.4	2.2	2.3	5.7	3.2	2.3	4.3	4.6	0.0	4.2	8.2	0.3	0.6	5.9	1.2	94.7	17.3	2.0	1.7	1.2	0.4	12.1	0.4	15.8	2.1	0.5	1.7	0.0	0.3	1.1	3.3	3.3	0.0	9.0	1.7	8.2	0.6	1.0	112.4	8.1	1.5	5.4	1.0	0.3	5.6	1.0	7.1	16.3	0.5	0.6	7.5	0.5	7.5	0.1	3.9	31.8	8.1	0.0	3.1	2.0	32.7	6.8	0.8	2.7	6.3	0.7	0.8	0.8	5.0
C16orf72	"FLJ41272, PRO0149"	ENSG00000182831	"Chromosome 16 open reading frame 72"	Q14CZ0	16	9091644-9121635	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 106.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 643.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041568, HPA067492"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA041568: AB_10796677, HPA067492: AB_2685850"	"unprognostic (3.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.74e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.64e-3)"	"unprognostic (6.51e-2)"	20.0	17.4	15.7	18.2	17.8	106.1	17.2	14.9	20.3	15.9	14.0	14.9	14.8	15.2	17.3	19.6	12.8	19.0	15.8	18.8	16.7	18.6	26.8	17.5	20.1	14.1	15.8	14.2	18.6	22.3	9.8	17.1	14.9	15.9	15.0	20.8	14.2	14.7	32.4	17.0	13.6	16.8	13.8	20.9	15.8	17.3	16.8	19.4	18.8	27.8	22.0	17.8	15.2	16.8	17.3	18.9	29.6	27.1	34.4	26.7	15.5	33.2	27.6	18.8	19.3	15.9	22.0	30.8	18.6	38.6	14.8	19.8	27.5	29.4	39.2	20.3	15.4	20.7	27.2	33.6	44.4	26.3	23.2	40.7	45.3	31.5	44.7	30.1	33.1	31.7	31.6	45.7	33.6	24.9	23.5	23.3	36.1	17.7	16.5	39.6	36.1	33.1	24.6	31.3	19.1	21.4	39.9	27.8	35.1	27.4	32.1	26.6	38.3	36.6	24.0	47.6	21.7	51.7	48.0	42.5	32.6	23.2	30.3	5.5	2.8	3.2	3.7	3.1	4.2	2.5	3.1	2.6	2.2	3.0	3.5	3.2	10.9	2.3	3.4	2.8	2.7	1.7	15.7	17.8	14.9	20.3	18.8	16.7	14.1	15.8	14.9	13.8	16.8	16.8	65.3	48.1	37.2	17.6	47.5	76.9	45.4	13.0	78.6	43.6	81.6	53.8	39.3	35.8	19.1	22.0	87.6	29.6	76.0	45.8	19.6	28.1	210.0	75.7	75.1	52.5	48.2	21.7	27.6	29.4	35.7	42.9	35.2	115.7	18.3	51.9	38.6	59.5	32.5	43.7	28.2	35.1	8.2	83.8	65.6	643.5	24.5	83.5	32.0	28.1	49.0	41.8	33.0	24.6	33.3	38.9	37.7	27.1	59.2	52.0	44.5	36.8	15.9	51.2	32.9	78.0	56.3	41.5	22.3	84.5	64.4	57.1	58.8	35.3	34.9	70.1
C16orf87		ENSG00000155330	"Chromosome 16 open reading frame 87"	Q6PH81	16	46796603-46831180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 129.3;Spermatocytes: 194.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041179	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041179: AB_10795002"	"unprognostic (2.44e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (7.95e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.13e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.84e-2)"	3.7	4.7	2.3	3.3	3.1	11.9	3.4	1.4	3.1	3.9	2.0	4.1	2.7	4.1	1.6	4.6	3.3	2.6	6.2	2.5	1.7	7.5	13.1	4.0	6.1	0.8	1.1	3.1	2.5	5.3	3.9	3.6	0.8	2.9	2.3	2.4	3.3	1.9	13.7	3.7	4.7	2.9	0.7	3.9	2.9	18.4	1.7	3.7	2.9	7.5	4.0	4.2	3.3	2.1	8.2	3.2	14.3	7.7	3.0	3.4	12.1	8.3	6.3	6.2	3.3	5.4	6.1	10.0	9.7	4.7	4.5	5.3	13.2	3.8	7.3	9.9	8.0	6.9	6.1	6.8	6.2	8.3	11.3	4.1	4.1	8.0	7.9	10.3	4.4	13.7	6.9	2.1	7.3	4.6	11.5	11.2	11.2	5.2	5.4	19.3	15.0	8.3	10.6	4.0	7.5	7.5	9.8	9.6	4.8	25.7	5.1	12.5	7.0	7.0	6.6	7.5	4.4	9.7	10.2	29.7	2.7	6.8	7.0	2.6	6.4	8.1	4.6	8.8	2.4	11.9	6.3	5.6	9.7	7.4	5.5	4.0	0.9	3.3	8.2	5.3	13.6	4.0	2.3	3.1	1.4	3.1	2.5	1.7	0.8	1.1	0.8	0.7	1.7	2.1	13.9	16.0	11.5	9.4	26.0	47.2	16.9	19.2	61.5	8.9	17.1	17.8	38.2	21.5	11.6	16.5	22.9	68.9	15.5	6.7	31.3	20.4	45.1	28.0	35.1	16.0	19.1	14.1	28.2	12.2	53.4	21.8	9.7	30.8	14.0	20.6	15.0	40.7	22.7	30.3	14.5	12.4	22.4	23.9	71.5	25.9	17.1	27.8	33.8	9.4	23.9	24.2	13.4	24.6	9.8	12.4	7.5	14.3	27.9	24.4	32.9	129.3	6.0	10.5	32.9	15.3	26.5	194.6	93.2	42.8	41.9	34.3	22.0	13.7	14.0	16.0
C17orf100	LOC388327	ENSG00000256806	"Chromosome 17 open reading frame 100"	A8MU93	17	6651762-6693202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.9;Late spermatids: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.0;SH-SY5Y: 9.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA046824			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA046824: AB_2679825"	"unprognostic (9.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.16e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-2)"	"unprognostic (9.44e-2)"	"unprognostic (7.65e-2)"	0.9	1.6	4.1	1.7	4.9	0.5	1.5	3.3	4.8	1.9	2.2	1.6	3.0	1.6	2.2	4.3	2.0	1.1	0.6	3.5	4.5	2.4	3.6	1.2	3.2	3.2	3.7	1.3	4.5	3.5	9.5	0.8	3.2	2.5	1.5	5.3	2.8	1.0	0.6	7.3	3.0	0.8	3.4	2.9	2.4	5.5	4.1	1.7	3.3	0.8	1.2	1.9	2.3	3.9	1.1	2.1	4.6	1.5	0.7	1.3	2.2	0.6	3.4	1.4	2.7	3.2	1.5	1.3	2.3	1.1	3.6	4.1	0.9	2.2	2.0	5.6	6.3	1.2	2.4	10.0	1.6	0.2	3.2	1.8	2.1	0.7	1.5	4.1	0.8	6.7	1.6	1.2	1.8	2.4	1.4	2.1	0.6	1.9	1.4	2.6	0.8	2.0	2.9	1.0	4.8	9.4	2.9	0.3	3.4	1.4	2.5	0.3	1.3	1.3	2.6	0.8	1.1	1.7	1.2	0.8	1.1	0.4	3.1	3.9	0.9	4.0	1.2	1.3	1.6	2.3	2.2	1.4	1.6	2.5	2.5	1.4	0.8	1.4	1.3	0.5	1.5	0.9	4.1	4.9	3.3	4.8	3.5	4.5	3.2	3.7	3.2	3.4	4.1	3.9	1.7	0.0	1.7	0.0	3.2	2.8	5.4	4.8	8.0	3.8	4.9	5.0	0.4	0.0	4.9	0.0	2.1	1.7	0.6	3.8	1.9	4.1	32.9	3.0	3.0	1.8	7.7	1.3	1.4	3.2	1.8	1.6	4.1	2.9	8.9	4.7	0.0	0.0	1.2	1.7	1.4	7.1	10.2	0.0	1.3	48.7	0.9	0.7	1.8	1.0	1.2	5.1	1.0	1.5	2.2	3.3	2.6	1.9	0.9	4.5	9.0	2.1	2.4	5.8	6.6	1.9	3.0	16.4	4.6	7.0	3.0	1.5	1.7	3.8	3.9	5.1
C17orf107		ENSG00000205710	"Chromosome 17 open reading frame 107"	Q6ZR85	17	4899418-4902934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 16.6;pituitary gland: 27.0"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 288.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.0"	"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.6;HMC-1: 3.2;hTCEpi: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069713	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA069713: AB_2686181"	"prognostic favorable (5.06e-5)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.12e-1)"	2.2	1.8	1.3	1.1	0.9	2.1	2.0	9.0	3.6	2.1	0.0	0.9	1.0	1.5	3.4	1.1	1.8	1.5	16.6	1.7	3.5	2.9	5.6	2.0	0.5	1.3	0.2	4.2	5.0	3.6	27.0	0.6	0.7	3.4	0.4	1.7	13.2	1.9	0.5	3.5	1.0	0.4	0.0	2.0	3.3	4.6	1.6	0.3	1.3	0.0	0.6	1.0	1.6	1.0	0.3	0.4	0.5	0.1	1.0	0.8	0.7	1.9	0.2	0.1	0.3	0.3	0.3	0.2	0.3	2.6	0.0	0.7	0.0	0.2	0.1	0.0	0.4	0.8	0.4	0.4	1.4	0.0	3.2	0.8	3.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.9	0.4	0.1	0.1	1.4	0.1	0.1	0.0	0.2	0.2	1.0	0.1	0.2	0.3	0.5	0.2	0.1	0.3	0.2	0.2	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.0	0.0	0.0	0.1	1.3	0.9	9.0	3.6	1.7	3.5	1.3	0.2	0.7	0.0	1.6	1.0	1.7	0.0	1.3	1.6	9.7	1.8	2.8	0.4	6.8	1.2	3.5	1.7	14.4	0.0	1.1	0.0	0.0	0.4	4.5	0.1	1.9	0.4	53.3	0.8	0.4	1.5	0.0	0.0	0.7	1.3	2.3	2.3	2.0	1.2	11.4	0.9	0.4	3.1	1.0	5.0	0.8	1.5	2.0	1.9	10.7	288.4	1.5	6.3	1.8	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.0	1.2	8.1	2.3	0.2	1.9	0.6	0.8	0.0	0.5	2.0	1.5	1.2	1.2	1.3	5.2	4.0	1.1	0.2	1.1
C17orf49	"BAP18, HEPIS, MGC49942"	ENSG00000258315	"Chromosome 17 open reading frame 49"	Q8IXM2	17	7014495-7017525	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 62.0;Smooth muscle cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA022961, HPA024457"	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.09e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-9)"	"unprognostic (5.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.62e-2)"	62.3	42.6	54.9	61.5	54.6	122.1	55.5	55.6	60.4	42.1	49.3	37.8	34.9	36.0	53.1	52.8	49.3	38.2	53.1	53.7	55.4	47.2	47.1	55.3	97.5	54.6	54.0	35.6	50.8	37.7	40.1	36.9	54.1	35.3	42.3	39.2	42.2	26.8	69.6	63.1	37.0	34.0	54.6	73.0	35.5	28.2	57.2	97.6	52.9	55.1	105.4	53.9	39.5	55.9	68.2	88.3	136.8	106.6	95.4	134.5	47.0	36.1	58.7	70.8	57.5	43.6	54.5	64.6	97.1	86.8	23.0	55.1	34.5	69.8	53.7	227.6	91.6	58.4	27.9	85.3	71.6	37.7	74.8	85.4	92.4	52.9	106.0	50.7	112.0	51.6	21.9	179.3	87.5	77.7	62.3	125.1	45.9	77.1	51.2	38.3	40.0	95.1	80.9	44.6	37.2	105.3	63.4	32.3	67.5	49.1	41.0	47.9	61.7	40.8	50.3	69.7	93.5	63.8	39.5	22.5	63.6	55.6	59.9	259.3	159.7	157.7	190.8	225.8	122.3	238.7	195.9	193.8	251.3	221.0	128.9	143.0	148.1	391.4	177.4	346.7	215.3	193.1	54.9	54.6	55.6	60.4	53.7	55.4	54.6	54.0	54.1	54.6	57.2	55.9	9.6	3.2	10.3	0.0	18.2	10.5	5.9	8.2	13.1	1.2	8.9	11.2	1.1	2.8	7.2	1.8	0.0	10.9	18.1	8.2	17.6	17.7	0.2	2.3	4.1	12.3	30.6	8.6	0.0	23.1	16.5	6.0	2.6	4.2	18.9	3.1	9.3	2.1	11.1	0.0	0.0	12.5	14.2	7.8	32.3	1.4	4.1	12.0	24.9	0.0	62.0	2.1	16.5	0.0	0.0	24.2	14.3	1.5	14.1	6.6	8.8	6.0	4.1	3.5	6.6	6.1	41.9	5.4	18.5	11.9	11.8	10.4	17.6	3.3	14.0	6.2
C17orf50		ENSG00000270806	"Chromosome 17 open reading frame 50"	Q8WW18	17	35760887-35765079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"testis: 105.6"	"Group enriched"	"Detected in some"	45	"Early spermatids: 769.0;Late spermatids: 1197.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HaCaT: 3.7;MOLT-4: 1.0"	"Not detected"	"Not detected"							"HPA043184, HPA063464"			Supported	Nucleoplasm		Yes	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA043184: AB_2678358, HPA063464: "	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.12e-3)"		"unprognostic (2.04e-2)"		"unprognostic (1.97e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.54e-2)"	0.1	0.1	1.2	0.0	0.9	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.8	0.7	0.1	0.0	0.1	0.0	0.4	0.7	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	105.6	0.6	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.8	0.7	0.4	0.0	0.7	1.2	1.4	0.0	0.1	0.0	1.4	0.0	0.2	1.2	0.9	0.0	1.0	0.8	0.7	0.4	0.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.4	0.5	0.6	0.3	0.0	0.1	9.2	0.0	0.0	0.2	0.4	0.0	0.0	769.0	1.8	0.0	0.5	1.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	2.0	0.0	0.0	1197.7	8.4	0.4	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.2	5.7	0.0	0.1	0.4	1.0	1.5	0.2	6.6	0.0	0.2	21.8	7.2	0.0	0.0	0.0	0.1	0.1	0.5	0.1
C17orf64		ENSG00000141371	"Chromosome 17 open reading frame 64"	Q86WR6	17	60392429-60431426	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	173	"testis: 135.3"	"Group enriched"	"Detected in some"	25	"Early spermatids: 1057.0;Late spermatids: 524.2;Spermatocytes: 287.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.5;granulocytes: 1.0"	"Cell line enriched"	"Detected in some"	4	"MCF7: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044415	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA044415: AB_10797148"	"unprognostic (3.00e-1)"	"unprognostic (2.60e-2)"		"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.30e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.46e-2)"	0.3	0.1	0.3	0.0	0.1	0.6	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.3	0.0	0.1	0.1	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.1	135.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	5.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.2	1.0	0.0	0.0	2.5	0.0	0.0	0.3	0.1	0.2	0.7	0.2	0.4	0.6	0.4	0.4	0.2	0.4	0.6	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1057.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	524.2	9.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	287.9	24.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0
C17orf80	"FLJ20721, HLC-8, MIG3, SPEP1"	ENSG00000141219	"Chromosome 17 open reading frame 80"	Q9BSJ5	17	73232233-73248947	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 170.0;Late spermatids: 100.8;Spermatocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012896	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA012896: AB_1850766"	"unprognostic (9.22e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.43e-4)"	"unprognostic (5.55e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.37e-1)"	8.6	10.1	10.0	9.5	10.1	3.1	11.2	12.7	12.1	11.9	9.2	11.6	10.5	14.5	9.7	8.8	12.2	8.9	15.8	9.7	10.2	12.7	9.9	9.2	13.7	8.3	9.2	17.2	9.3	16.6	10.6	12.5	8.4	12.6	10.0	23.3	10.8	11.9	24.6	8.7	9.8	12.8	9.0	10.8	10.3	39.7	9.6	17.9	16.1	21.8	12.2	9.1	6.9	9.9	20.0	20.6	28.1	17.2	20.2	17.2	27.2	25.6	22.2	35.6	33.6	19.7	16.1	37.7	17.8	13.2	24.2	19.5	39.4	14.7	41.4	13.8	26.8	34.6	21.5	23.3	17.6	37.0	19.7	13.5	18.1	23.8	19.5	17.8	30.9	25.1	38.3	21.9	24.0	11.5	43.1	17.5	22.3	22.1	22.1	25.7	77.2	19.3	18.4	14.9	34.3	30.8	13.7	24.7	30.0	44.0	27.1	23.0	17.1	37.1	34.0	12.1	24.8	24.7	31.9	35.8	14.9	16.5	24.1	17.3	3.3	4.8	6.6	4.0	6.6	4.9	4.9	5.9	3.8	4.7	4.5	6.6	1.6	4.4	4.4	5.8	7.2	3.4	10.0	10.1	12.7	12.1	9.7	10.2	8.3	9.2	8.4	9.0	9.6	9.9	10.3	6.4	15.1	10.7	6.4	5.0	2.1	3.0	8.6	10.3	6.1	7.2	20.2	5.7	7.9	5.5	20.9	9.5	14.9	4.6	9.8	6.1	170.0	8.9	12.3	11.0	5.4	1.3	10.8	3.8	5.8	9.6	5.6	7.0	7.6	11.8	5.0	4.6	5.0	8.4	10.9	3.8	6.1	5.1	2.6	100.8	5.3	4.8	1.8	9.4	5.9	10.6	4.1	10.1	9.0	4.5	5.1	7.5	5.9	2.1	6.6	7.5	15.8	15.8	0.0	10.5	7.7	67.1	13.6	7.1	4.4	16.8	5.5	17.9	4.8	1.4
C18orf25	"Ark2N, ARKL1, MGC12909, RNF111L1"	ENSG00000152242	"Chromosome 18 open reading frame 25"	Q96B23	18	46173553-46266992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051314, HPA051899"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA051314: AB_2681438, HPA051899: AB_2681657"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.46e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.97e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	8.5	6.9	9.0	8.9	8.9	34.1	10.4	12.3	10.3	11.9	18.1	8.1	7.7	9.2	7.9	37.5	9.6	6.5	15.8	8.0	8.2	8.8	8.1	9.6	12.1	10.2	12.9	9.2	6.0	18.8	6.2	8.2	11.2	8.3	9.2	27.6	13.3	7.5	23.3	13.2	8.9	9.4	7.4	11.1	8.7	12.0	10.2	15.0	11.9	16.0	15.4	9.8	16.4	9.1	18.4	17.9	14.8	16.9	10.4	9.3	19.0	26.0	13.8	27.3	23.1	13.9	20.5	14.0	24.1	17.7	9.8	40.9	27.7	17.7	29.5	23.5	8.9	12.4	16.0	10.6	17.9	23.5	16.0	8.7	20.2	31.9	26.3	15.9	11.0	12.9	14.1	16.3	15.3	13.7	17.9	11.9	13.2	6.3	7.0	16.0	17.6	20.7	26.1	32.5	20.7	10.8	19.1	13.4	13.7	17.9	8.8	14.3	16.0	24.7	17.6	6.0	24.3	21.3	19.7	22.3	12.8	24.4	27.0	4.9	8.9	18.6	6.3	9.9	11.2	6.9	12.3	9.6	8.8	9.0	8.6	6.8	22.7	3.5	14.3	12.6	8.7	6.9	9.0	8.9	12.3	10.3	8.0	8.2	10.2	12.9	11.2	7.4	10.2	9.1	18.4	12.8	9.1	16.0	19.2	25.2	10.4	11.5	11.4	14.5	13.4	9.9	30.4	5.7	9.5	14.7	20.9	8.1	26.1	15.1	1.9	9.1	2.4	42.1	14.4	16.2	12.0	16.8	62.5	6.5	10.5	12.1	13.7	39.2	15.2	9.9	11.7	13.0	9.1	13.5	45.2	10.0	6.1	13.1	18.0	3.5	8.1	12.9	7.2	22.5	11.1	12.4	9.2	25.6	25.9	20.4	10.1	10.5	16.5	13.0	9.2	7.6	16.9	30.6	19.7	14.8	11.8	20.6	14.9	14.2	31.8	24.4	18.6	6.6	10.1	23.3
C18orf32	FLJ23458	ENSG00000177576	"Chromosome 18 open reading frame 32"	Q8TCD1	18	49477243-49487252	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 238.5;Late spermatids: 233.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040921	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	Vesicles	Nucleoplasm	"HPA040921: AB_10795423"	"unprognostic (5.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.76e-2)"	"prognostic favorable (8.89e-9)"	"unprognostic (1.02e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.36e-2)"	41.5	66.7	10.8	5.6	13.8	6.8	39.8	15.3	20.0	34.9	8.3	46.0	6.1	35.6	5.6	32.3	34.5	6.6	59.3	11.3	13.5	79.6	86.8	46.5	7.9	14.8	13.0	38.8	47.0	18.5	67.9	6.9	14.0	39.4	10.2	24.6	43.7	8.4	37.9	27.8	39.9	7.3	13.4	39.2	58.1	40.9	13.1	8.5	43.9	7.2	10.4	38.8	32.6	18.7	4.3	3.2	14.4	13.3	12.3	8.8	8.6	5.5	7.6	6.0	6.8	0.5	3.7	4.9	8.6	7.9	9.0	11.1	5.1	10.6	12.6	11.3	4.1	4.2	2.3	5.4	11.2	5.1	11.2	9.9	21.0	5.0	6.1	16.0	12.2	10.1	4.1	11.4	9.9	1.9	4.6	2.5	4.7	4.9	5.9	4.0	3.6	3.8	7.1	5.0	10.7	12.3	5.1	3.4	4.4	19.8	3.1	2.3	13.1	9.6	5.0	1.7	6.9	13.4	24.1	9.1	5.2	5.9	7.1	27.4	8.4	25.8	8.4	8.8	8.7	8.9	6.9	7.7	6.6	7.4	6.6	8.4	41.4	6.2	11.3	9.5	8.2	10.3	10.8	13.8	15.3	20.0	11.3	13.5	14.8	13.0	14.0	13.4	13.1	18.7	20.2	44.8	29.2	0.0	50.8	5.5	4.6	21.2	39.3	35.0	26.2	15.0	5.5	31.5	22.4	23.9	43.8	22.9	33.8	92.9	39.2	87.5	238.5	38.1	21.0	17.5	95.5	20.2	0.0	82.7	17.7	28.7	63.2	30.3	45.6	5.3	23.6	40.4	22.1	18.5	0.0	57.3	32.6	38.0	12.0	233.1	17.1	48.1	23.2	0.0	73.9	41.4	34.0	0.0	0.0	92.3	77.5	10.1	83.0	5.6	92.7	57.2	42.4	36.3	19.7	10.3	22.7	12.7	13.9	58.4	7.7	38.7	43.4	4.5	40.8	5.2
C18orf54	"LAS2, MGC33382"	ENSG00000166845	"Chromosome 18 open reading frame 54"	Q8IYD9	18	54357906-54385218	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 17.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 100.0;Extravillous trophoblasts: 24.0;Late spermatids: 29.7;Oligodendrocytes: 23.0;Spermatocytes: 38.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040704			Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA040704: AB_10959454"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.29e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.60e-6)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.06e-5)"	"unprognostic (2.29e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.05e-2)"	2.1	0.6	1.7	2.3	3.5	1.3	1.1	2.6	2.4	1.9	0.6	1.4	0.8	2.3	0.4	1.0	0.9	1.1	0.9	1.5	2.4	0.8	0.4	1.3	3.0	3.4	2.7	1.4	0.2	0.6	0.2	3.1	3.3	0.6	1.3	1.2	0.4	0.8	0.3	1.0	0.8	1.8	2.3	1.7	0.8	17.3	2.6	3.5	0.9	1.2	2.7	1.0	1.0	5.0	10.2	6.6	22.8	11.7	5.8	10.0	8.2	16.0	6.8	15.5	19.6	4.4	5.2	6.9	4.3	5.6	6.4	9.7	16.9	9.3	20.1	26.5	5.2	7.8	7.2	6.1	1.3	9.4	8.0	3.4	1.8	20.9	10.6	6.7	21.6	9.6	7.8	15.6	22.6	3.8	9.7	4.7	12.5	1.6	11.2	7.7	18.3	5.3	7.1	6.9	14.4	7.8	7.0	2.6	4.2	11.7	4.7	6.8	17.5	32.0	13.3	5.3	8.8	9.8	11.8	10.6	8.1	14.5	22.4	0.5	0.2	0.0	0.4	0.3	0.3	0.3	0.3	0.2	0.2	0.4	0.3	0.3	0.0	0.2	1.8	0.1	0.7	0.2	1.7	3.5	2.6	2.4	1.5	2.4	3.4	2.7	3.3	2.3	2.6	5.0	3.9	0.0	0.6	1.6	1.1	0.4	0.7	0.8	0.0	2.2	0.9	0.9	1.5	0.0	0.2	1.8	0.0	0.9	2.3	0.6	0.0	0.2	100.0	1.4	2.3	3.2	0.0	11.2	0.6	0.2	24.0	2.9	0.5	0.8	0.0	14.2	3.6	0.3	2.5	0.0	0.7	0.4	0.0	3.1	2.1	29.7	1.5	1.7	1.8	3.7	1.3	2.4	3.1	4.5	23.0	0.4	0.9	0.7	1.9	0.5	0.2	0.3	0.3	0.9	0.0	2.1	3.0	38.4	14.5	0.8	0.4	2.1	1.2	0.9	1.7	0.8
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304164-38305006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 515.3;skin 1: 331.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2060.3;Pancreatic endocrine cells: 2590.4;Paneth cells: 1697.3;Proximal enterocytes: 1756.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"myeloid DC: 22.2"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 22.2"	"Cell line enhanced"	"Detected in many"		"A-431: 745.5;A549: 1228.0;CAPAN-2: 767.1;HBEC3-KT: 744.6;hTCEpi: 799.2;OE19: 678.3;PC-3: 659.8"	"Not detected"	"Not detected"							"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	43.1	5.0	2.8	17.6	3.1	3.6	25.5	2.9	4.4	82.4	2.9	187.5	186.7	6.1	0.6	515.3	91.5	49.5	32.9	2.3	2.6	28.2	1.3	91.3	0.9	3.1	3.0	4.6	8.9	0.5	12.7	7.9	3.4	26.2	104.1	0.1	123.3	18.3	3.9	331.1	189.5	4.0	2.5	10.7	151.5	1.5	3.8	4.1	18.9	4.3	30.8	102.2	224.3	2.5	745.5	1228.0	0.0	0.6	0.0	0.0	1.2	1.0	0.0	0.0	0.0	77.1	767.1	0.0	394.2	0.0	0.7	300.1	0.0	744.6	0.0	0.4	0.5	0.4	244.2	20.0	5.4	0.0	0.2	0.0	799.2	0.3	493.3	3.3	10.2	0.9	0.4	0.5	0.8	220.4	0.1	1.9	0.4	678.3	659.8	0.2	0.2	2.8	469.5	255.2	0.8	0.8	416.6	340.8	0.8	1.6	103.7	2.3	141.6	0.5	201.9	0.7	2.8	0.7	2.4	3.7	0.1	0.2	0.2	2.1	0.6	2.2	0.2	0.0	0.4	0.1	0.5	0.1	22.2	1.4	0.7	0.3	1.0	0.4	0.1	1.8	0.0	18.2	2.8	3.1	2.9	4.4	2.3	2.6	3.1	3.0	3.4	2.5	3.8	2.5	29.1	535.2	172.9	0.0	5.4	225.3	28.4	508.7	436.5	0.0	32.5	25.5	2.4	267.4	418.0	55.2	0.0	8.6	1.7	2060.3	1.9	207.7	0.7	144.3	26.0	18.4	76.1	3.6	0.1	753.8	1.3	44.7	353.7	273.2	38.2	3.7	3.6	0.4	1.3	0.0	0.0	842.0	99.7	1.4	15.1	5.1	4.1	32.9	1.8	0.0	4.9	0.0	0.0	0.0	0.0	2590.4	1697.3	0.0	5.7	35.7	1756.4	51.7	212.5	0.0	0.0	0.4	14.3	1.8	1.9	629.0	348.4	3.1	7.9	0.0	691.9	188.4
C19orf44	FLJ21742	ENSG00000105072	"Chromosome 19 open reading frame 44"	Q9H6X5	19	16496394-16521352	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 46.7;Late spermatids: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041683, HPA049414"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA041683: AB_10793929, HPA049414: AB_2680754"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.19e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.02e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-1)"	3.2	2.7	3.9	1.8	4.1	3.2	3.4	3.7	5.4	5.7	5.9	5.3	1.9	4.9	2.8	2.8	6.0	3.7	3.3	3.9	4.2	4.5	2.7	2.6	2.2	4.7	5.0	8.1	4.1	5.6	5.2	2.1	3.5	4.8	1.5	3.7	5.8	4.4	4.6	4.3	2.3	3.4	2.9	2.4	3.3	14.5	4.1	3.5	4.8	2.7	1.9	4.4	3.7	3.8	4.7	4.9	5.1	6.4	3.3	6.1	5.4	3.6	3.5	4.5	6.6	3.0	6.5	3.6	6.9	2.9	3.0	3.9	3.9	3.1	3.4	2.5	10.0	1.4	8.0	4.6	4.4	2.0	2.2	3.3	3.1	5.7	4.3	8.8	2.5	5.5	5.7	1.5	2.9	6.6	3.6	5.7	3.0	6.3	7.3	3.5	2.3	5.9	4.7	1.8	5.9	3.2	4.1	5.6	3.3	4.4	5.7	2.9	4.4	6.2	3.5	5.9	5.7	4.3	3.3	2.5	4.6	2.0	5.4	3.5	0.5	0.1	0.5	0.3	0.1	1.5	0.6	0.2	0.2	1.1	0.6	1.0	1.0	0.3	0.8	0.4	0.2	0.4	3.9	4.1	3.7	5.4	3.9	4.2	4.7	5.0	3.5	2.9	4.1	3.8	1.7	0.0	5.6	9.4	2.5	0.4	1.0	1.3	1.2	3.4	2.1	2.3	3.7	2.8	4.8	7.3	12.5	1.9	1.1	0.8	0.0	1.8	46.7	9.9	6.0	2.5	7.2	2.1	3.9	1.2	1.8	3.1	2.6	5.4	0.0	6.7	1.4	1.7	0.8	0.0	4.8	1.6	0.0	0.6	1.0	72.6	3.1	0.9	0.0	5.6	1.3	2.7	0.0	0.5	2.9	1.1	1.6	5.3	1.2	0.7	0.4	3.4	6.6	8.4	0.0	3.7	2.9	10.9	2.1	1.6	0.4	0.5	0.9	4.1	1.2	0.3
C19orf47	FLJ36888	ENSG00000160392	"Chromosome 19 open reading frame 47"	Q8N9M1	19	40319536-40348527	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"heart muscle: 90.0;skeletal muscle: 259.4;tongue: 139.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 45.2;Late spermatids: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 29.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041843, HPA046309"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA041843: AB_10959886, HPA046309: AB_10960266"	"prognostic favorable (6.50e-4)"	"unprognostic (1.35e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.28e-2)"	6.7	5.9	16.0	6.6	16.1	8.3	8.3	11.6	14.7	8.6	1.8	7.6	5.6	7.7	4.0	12.6	6.0	3.5	90.0	12.2	10.0	5.8	7.7	6.4	7.6	15.4	15.0	6.7	5.2	6.6	7.5	6.5	14.0	8.8	2.9	2.5	10.5	6.4	259.4	12.3	6.0	3.9	13.1	7.4	6.2	26.5	13.9	7.3	6.9	139.1	4.4	8.5	8.7	17.1	20.3	30.5	12.7	13.8	7.4	6.6	17.4	20.6	9.3	19.1	22.9	25.5	8.3	23.5	11.1	9.7	10.0	9.9	15.5	18.9	7.9	29.1	19.1	19.3	18.2	19.6	5.5	19.5	11.9	6.6	11.0	25.6	9.0	5.1	11.7	21.5	24.0	13.4	15.9	19.9	29.4	11.0	8.2	16.2	11.5	28.8	20.7	11.8	6.1	17.6	16.2	13.2	22.1	20.5	8.1	7.4	12.2	15.9	15.7	23.7	16.6	16.2	28.4	16.0	24.2	24.1	10.1	18.6	16.7	29.0	2.2	6.6	1.6	2.0	2.0	2.0	3.0	2.7	2.1	2.5	2.0	1.4	7.3	2.5	2.3	2.1	2.3	2.1	16.0	16.1	11.6	14.7	12.2	10.0	15.4	15.0	14.0	13.1	13.9	17.1	2.6	3.2	2.8	9.1	2.6	4.8	3.2	2.6	4.0	3.1	4.9	5.0	45.2	2.8	2.3	0.0	2.1	11.0	1.5	3.6	0.0	3.5	12.5	2.5	2.3	4.3	3.6	1.7	19.2	4.7	13.8	6.2	2.6	2.7	4.5	3.6	5.7	5.0	6.6	3.3	15.4	3.4	0.0	6.2	4.1	27.4	1.8	2.8	5.4	8.4	3.3	2.9	3.1	9.5	11.2	4.4	1.4	6.8	6.5	2.0	2.8	2.8	1.3	2.0	6.6	7.1	3.8	18.2	6.3	4.1	7.0	15.9	3.3	1.4	2.4	1.8
C19orf53	"HSPC023, LYDG10"	ENSG00000104979	"Chromosome 19 open reading frame 53"	Q9UNZ5	19	13774456-13778773	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059928, HPA061291"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA059928: AB_2684165, HPA061291: AB_2684469"	"unprognostic (3.94e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.85e-2)"	95.6	117.7	154.3	52.1	157.8	80.4	88.9	161.0	209.6	97.0	148.4	94.3	45.4	91.6	85.6	92.3	87.6	49.8	155.6	154.4	163.8	124.4	111.0	80.1	76.9	159.4	159.9	111.7	95.5	92.8	111.6	40.2	157.8	98.8	41.6	35.7	76.9	52.8	167.6	95.2	72.4	63.0	157.5	82.1	91.2	51.6	158.0	101.5	90.4	107.2	70.8	88.6	82.6	157.3	176.4	249.9	123.0	98.9	169.6	191.1	80.1	167.0	145.5	201.0	200.7	235.8	83.5	95.4	198.2	202.4	146.6	90.1	111.6	250.1	102.7	113.5	362.3	90.1	254.6	260.5	174.9	140.7	109.4	237.8	174.7	188.1	105.9	129.0	171.0	136.6	140.9	154.2	157.9	406.2	193.6	145.9	152.6	133.8	441.8	105.7	94.9	160.5	177.1	221.3	108.6	132.4	115.1	130.8	172.5	89.2	120.0	139.0	118.4	221.9	89.2	239.4	227.5	172.3	240.3	144.4	132.3	157.6	121.8	264.1	220.1	275.7	211.0	238.2	240.4	333.2	270.7	248.4	202.2	321.1	318.1	289.7	107.1	184.7	214.3	289.4	337.9	496.3	154.3	157.8	161.0	209.6	154.4	163.8	159.4	159.9	157.8	157.5	158.0	157.3	167.0	115.4	97.8	13.7	205.2	291.1	260.1	349.2	147.4	50.5	258.7	352.9	263.3	213.1	207.8	268.5	22.9	218.6	176.5	230.1	628.0	242.5	176.8	229.3	189.8	194.4	227.3	174.0	10.5	335.2	406.3	184.4	109.6	233.0	128.7	132.4	179.9	367.5	368.2	35.3	10.2	254.3	236.0	247.1	287.1	621.4	218.7	187.5	231.3	5.6	338.9	220.3	260.6	6.6	18.8	269.6	272.8	182.4	164.1	360.5	353.9	820.0	189.3	65.9	92.1	138.5	206.0	102.6	137.0	187.7	348.5	213.0	216.0	169.8	257.5	345.2
C19orf67		ENSG00000188032	"Chromosome 19 open reading frame 67"	A6NJJ6	19	14081624-14085875	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	27	"testis: 6.6"	"Group enriched"	"Detected in some"	28	"Early spermatids: 30.0;Late spermatids: 28.2;Spermatocytes: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046351			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA046351: "	"unprognostic (1.21e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.45e-4)"	"unprognostic (1.25e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.76e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.94e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.5	30.0	0.4	0.2	0.1	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	28.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.1	9.9	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.2
C19orf73	FLJ10490	ENSG00000221916	"Chromosome 19 open reading frame 73"	Q9NVV2	19	49118402-49119143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.5"									HPA062719	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA062719: AB_2684847"	"unprognostic (3.02e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (3.05e-1)"	"unprognostic (9.00e-5)"	"unprognostic (1.19e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.13e-3)"	0.9	1.3	3.7	0.4	3.9	0.1	1.5	5.8	4.6	0.7	2.3	1.7	2.1	1.0	1.3	2.0	0.5	0.3	1.7	4.2	3.7	1.7	3.4	1.0	0.2	4.1	3.7	0.2	4.8	0.8	3.8	0.2	3.9	1.5	0.7	1.0	2.5	0.4	1.8	2.5	1.5	0.2	3.9	1.8	1.4	1.3	3.9	0.6	1.9	0.9	0.3	0.7	1.2	4.5	1.7	2.1	0.8	4.0	1.3	0.2	0.9	0.5	0.3	0.8	0.6	0.1	0.9	1.2	0.4	0.3	1.2	1.1	1.0	0.1	0.1	2.4	8.5	1.1	1.6	1.4	1.3	0.0	0.4	0.1	2.7	0.6	2.2	0.6	0.1	4.2	2.0	2.0	0.4	1.8	1.4	1.3	0.6	1.8	0.4	1.2	1.6	1.6	1.5	0.7	4.2	1.9	0.8	1.0	1.6	0.5	1.0	0.4	0.8	1.0	1.8	0.3	0.4	1.2	2.5	1.4	0.7	1.5	1.2	0.0	2.0	0.4	1.6	1.3	2.7	1.5	1.2	1.5	3.4	4.4	2.4	1.8	0.0	5.0	2.8	2.7	1.2	1.5	3.7	3.9	5.8	4.6	4.2	3.7	4.1	3.7	3.9	3.9	3.9	4.5	1.6	0.0	0.0	1.3	2.8	2.2	10.3	2.9	4.0	3.9	6.1	6.1	0.7	4.3	2.6	3.7	0.0	1.0	1.0	3.5	3.9	2.6	0.5	1.4	1.1	1.7	3.0	5.7	1.3	2.0	0.9	1.3	3.1	1.0	0.0	0.3	2.2	7.2	1.3	1.7	1.4	4.8	10.2	0.8	0.6	0.7	0.0	1.5	3.6	0.0	0.9	6.9	4.1	1.5	3.0	1.7	1.9	1.5	3.3	8.6	5.0	8.9	2.5	4.8	0.0	1.1	1.6	0.7	4.9	5.4	2.6	0.4	1.7	2.6	5.0	4.1
C1D	"LRP1, Rrp47, SUN-CoR, SUNCOR"	ENSG00000197223	"C1D nuclear receptor corepressor"	Q13901	2	68041130-68110948	"Predicted intracellular proteins"	"Apoptosis, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037413, HPA037588"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA037413: AB_2675463, HPA037588: AB_10672907"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.01e-1)"	21.7	25.3	11.6	17.0	11.8	48.1	21.4	11.9	19.0	19.9	12.8	19.1	16.6	20.0	17.0	19.3	18.3	14.7	22.2	12.0	12.8	31.5	33.4	19.0	21.4	11.3	11.8	19.3	15.8	24.0	15.3	17.5	11.6	19.5	14.7	16.6	18.7	15.5	46.9	17.5	18.5	13.7	12.0	21.7	21.4	14.8	12.0	17.5	19.6	31.9	16.5	17.4	28.2	13.9	36.6	20.3	22.0	21.0	22.2	27.0	29.6	48.7	28.1	29.3	22.4	40.8	45.0	45.2	27.2	28.9	28.1	18.0	24.7	20.4	43.1	43.0	36.6	43.5	17.6	46.3	22.3	68.1	54.4	25.0	32.4	22.1	20.9	36.3	22.0	41.4	44.8	41.1	26.6	22.2	51.3	69.6	25.4	29.8	24.4	29.6	28.3	39.9	28.2	29.2	20.5	25.4	15.1	30.0	51.6	26.7	22.2	41.2	30.9	27.9	34.5	34.0	38.9	38.0	40.8	58.6	38.9	41.3	34.2	45.3	17.6	43.7	19.0	23.3	22.5	24.2	22.0	16.6	20.6	21.3	23.4	24.3	34.9	30.3	25.2	19.2	25.3	15.2	11.6	11.8	11.9	19.0	12.0	12.8	11.3	11.8	11.6	12.0	12.0	13.9	65.2	76.9	47.9	13.1	70.7	85.0	83.2	132.8	33.6	34.3	52.9	58.4	36.5	64.3	86.3	64.4	22.9	98.9	76.2	48.1	234.8	83.4	52.4	53.7	47.2	42.9	51.6	121.2	17.7	59.4	82.7	60.2	44.9	46.6	44.3	32.8	43.5	81.7	87.5	35.3	15.9	42.6	109.9	61.9	46.1	21.7	55.6	66.9	56.9	8.4	80.1	57.4	88.6	14.1	21.9	65.6	63.3	59.0	58.5	78.1	57.0	251.4	95.4	36.8	98.6	54.2	65.3	164.5	100.3	44.5	86.2	107.8	62.9	52.2	32.8	109.0
C1orf100		ENSG00000173728	"Chromosome 1 open reading frame 100"	Q5SVJ3	1	244352635-244389663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 35.0"	"Group enriched"	"Detected in some"	151	"Early spermatids: 1207.7;Late spermatids: 851.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	41	"K-562: 5.9"	"Not detected"	"Not detected"							"HPA031179, HPA031180"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA031179: AB_10599995, HPA031180: AB_10599026"	"unprognostic (9.84e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.37e-2)"	"unprognostic (9.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.45e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-5)"	"unprognostic (1.85e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-4)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1207.7	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	851.9	5.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf109	FLJ20508	ENSG00000116922	"Chromosome 1 open reading frame 109"	Q9NX04	1	37681570-37692249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 50.2;Suprabasal keratinocytes: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027110, HPA027127"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA027110: AB_10611813, HPA027127: AB_1845628"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.13e-3)"	"prognostic unfavorable (1.76e-7)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.69e-1)"	8.8	10.7	7.7	7.3	6.8	8.0	9.7	7.1	7.5	8.9	5.9	7.2	8.2	10.2	10.0	10.1	9.8	6.9	8.3	7.0	7.5	9.2	7.8	5.5	11.9	7.0	8.1	13.4	14.6	15.0	6.1	10.4	7.6	10.6	5.6	5.3	12.3	10.1	9.7	10.5	5.7	8.2	7.9	7.7	6.9	8.3	10.3	9.1	11.4	10.0	9.7	8.1	7.9	8.2	17.7	20.1	16.9	27.8	14.5	10.4	38.5	20.9	14.7	30.7	22.6	30.8	20.8	25.0	24.4	9.2	14.2	25.3	31.5	21.2	31.3	40.3	35.1	28.3	20.7	19.5	27.9	31.6	18.0	14.2	25.7	30.4	39.8	13.4	15.7	21.6	57.2	29.5	17.7	12.1	30.9	13.9	52.9	18.1	38.0	30.2	35.4	69.0	16.4	14.9	50.8	24.4	18.4	27.9	43.1	16.9	15.7	13.9	10.6	30.7	19.3	25.0	40.8	24.0	29.0	52.0	15.4	30.4	33.0	3.5	9.7	6.9	18.9	7.9	29.9	21.2	22.8	18.3	11.6	18.7	28.8	25.0	1.9	24.8	8.8	54.1	12.5	15.0	7.7	6.8	7.1	7.5	7.0	7.5	7.0	8.1	7.6	7.9	10.3	8.2	10.9	6.4	7.9	4.2	12.9	50.2	24.1	5.9	22.8	10.1	15.6	15.1	5.5	5.7	10.8	3.7	10.4	14.9	12.2	6.7	13.7	10.5	1.5	5.8	12.8	11.5	4.2	45.3	9.5	7.3	14.0	14.4	6.1	6.2	11.4	9.6	6.4	6.6	5.4	16.8	7.2	5.1	8.2	4.4	9.0	1.0	9.9	4.8	12.4	4.7	7.3	10.4	17.5	5.0	5.0	10.2	8.1	13.9	10.9	21.3	5.5	8.9	5.6	14.6	0.0	17.5	8.5	25.7	25.5	15.5	62.1	7.9	12.0	11.9	8.3	13.2
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 115.0;lymphoid tissue: 134.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 182.3;Hofbauer cells: 195.3;Kupffer cells: 797.4;Langerhans cells: 226.7;Macrophages: 413.5;monocytes: 278.6;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"HDLM-2: 141.3;HL-60: 70.4;NB-4: 40.3;THP-1: 55.2;U-937: 117.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA026988	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	45.4	23.6	16.3	70.8	16.2	115.0	22.3	17.2	29.0	13.2	19.6	15.8	7.3	11.5	6.3	9.8	22.5	31.2	18.1	16.3	18.4	12.5	41.9	85.7	70.4	20.6	17.3	9.4	9.4	4.8	9.1	15.2	19.7	11.7	17.9	9.5	11.2	6.6	10.1	7.8	21.2	37.6	16.7	134.5	12.5	7.6	23.3	27.7	10.0	7.4	55.9	25.1	10.8	21.4	0.3	0.1	0.5	1.1	0.4	0.6	0.6	0.9	0.1	0.3	0.3	0.2	0.4	0.5	0.5	0.2	0.1	0.2	0.8	0.5	0.6	141.3	0.4	0.4	0.5	0.0	0.4	70.4	11.1	0.0	2.6	0.8	0.9	1.0	2.0	0.7	0.5	0.4	0.5	0.5	0.6	40.3	0.2	0.7	0.8	0.1	0.7	0.1	0.3	0.1	0.5	0.2	0.5	0.6	0.8	0.6	0.3	55.2	0.0	0.8	1.0	0.7	0.6	0.6	0.1	0.6	0.3	117.9	1.2	1114.1	1026.8	1294.8	166.6	1529.2	47.6	231.0	206.5	97.3	1021.6	296.4	318.0	193.6	143.3	536.7	1173.4	302.8	66.7	1189.5	16.3	16.2	17.2	29.0	16.3	18.4	20.6	17.3	19.7	16.7	23.3	21.4	4.4	22.4	43.9	8.1	84.1	7.9	0.7	0.4	0.6	4.0	2.2	5.2	3.8	10.0	4.5	7.3	2.1	1.0	103.4	0.6	0.0	0.2	36.7	0.8	0.9	8.1	1.8	23.5	9.2	0.2	2.0	3.2	0.5	1.0	182.3	0.9	15.7	8.9	195.3	0.0	13.0	0.0	0.0	797.4	226.7	90.7	2.8	413.5	12.4	12.2	278.6	0.2	355.3	6.0	7.7	0.2	0.0	0.7	4.2	0.8	0.9	1.0	0.9	4.2	32.9	2.4	2.9	2.4	2.0	0.2	6.5	1.6	59.8	0.3	0.7	0.3
C1orf174	RP13-531C17.2	ENSG00000198912	"Chromosome 1 open reading frame 174"	Q8IYL3	1	3889125-3900293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008270, HPA065778"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA008270: AB_1845633, HPA065778: AB_2685557"	"unprognostic (4.91e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (7.24e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-2)"	11.6	12.1	8.7	10.2	9.0	13.4	11.2	9.0	10.1	10.7	9.9	13.4	6.8	11.8	9.4	13.8	10.8	8.5	10.9	9.3	9.0	13.4	18.5	10.3	11.4	9.0	8.8	11.0	14.4	6.9	7.5	10.3	9.4	10.3	6.5	4.3	11.1	6.9	15.5	9.9	12.2	7.8	9.4	15.4	12.2	13.2	8.8	13.9	11.5	14.0	11.9	12.2	11.0	9.4	27.6	15.5	23.2	22.0	20.3	12.1	15.6	23.6	13.7	21.8	22.1	24.4	43.4	21.5	28.8	18.7	31.1	27.7	27.6	17.5	23.5	39.3	25.4	56.6	14.2	33.8	11.8	39.9	29.1	13.1	9.9	24.2	15.3	17.3	18.6	27.3	45.9	22.2	14.8	21.8	44.4	30.2	28.6	36.2	32.4	32.7	42.2	20.6	15.1	16.4	23.6	19.1	22.2	30.5	35.7	23.4	14.3	24.8	20.4	29.9	23.9	52.4	25.1	7.2	7.8	39.7	15.5	42.4	10.9	61.5	26.5	50.8	43.7	50.7	38.5	25.2	29.7	34.0	31.8	23.8	27.4	35.4	22.6	29.6	33.5	17.4	32.9	23.9	8.7	9.0	9.0	10.1	9.3	9.0	9.0	8.8	9.4	9.4	8.8	9.4	20.7	9.6	7.7	4.6	21.1	21.9	13.1	17.6	19.9	11.9	15.6	12.8	3.9	22.8	15.6	5.5	8.4	59.8	46.2	11.6	27.4	22.4	114.8	14.7	16.0	16.8	11.4	28.2	5.1	19.6	61.9	16.1	14.8	13.3	36.8	21.6	13.9	15.7	31.5	11.8	7.2	15.6	16.2	17.3	14.5	20.5	17.1	20.7	14.2	4.7	20.4	13.3	50.4	6.6	13.2	17.7	15.2	19.2	17.4	18.9	15.1	20.9	11.7	12.6	13.1	16.5	17.4	32.3	32.6	21.8	17.6	26.7	24.7	21.7	19.8	12.1
C1orf189		ENSG00000163263	"Chromosome 1 open reading frame 189"	Q5VU69	1	154199085-154206333	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 30.5;testis: 19.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 88.7;Endometrial ciliated cells: 30.7;Late spermatids: 19.6;Respiratory ciliated cells: 25.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045779			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Golgi apparatus, Plasma membrane"		"HPA045779: AB_2679448"	"unprognostic (8.23e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.01e-3)"	"unprognostic (2.50e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.36e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.05e-2)"	0.1	0.0	0.2	0.1	0.3	0.5	0.1	0.4	0.4	1.6	0.6	0.0	0.0	0.5	0.3	0.1	30.5	0.0	0.1	0.3	0.4	0.1	0.3	1.8	0.1	1.6	3.4	0.1	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.1	0.0	0.9	0.0	0.1	19.7	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.4	0.2	0.3	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.4	0.2	0.4	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.5	0.1	0.1	0.5	0.2	0.5	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.3	0.0	0.4	0.2	0.2	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.4	0.4	0.3	0.4	1.6	3.4	1.2	0.9	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.7	30.7	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	19.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	25.1	0.0	0.0	0.0	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
C1orf21	PIG13	ENSG00000116667	"Chromosome 1 open reading frame 21"	Q9H246	1	184387029-184629019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 52.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 305.1;Syncytiotrophoblasts: 284.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 3.9;memory CD8 T-cell: 2.0;naive CD8 T-cell: 1.8;NK-cell: 2.6"	"Group enriched"	"Detected in many"	13	"NK-cells: 2.6;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 12.3;HSkMC: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026831	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA026831: AB_1845636"	"unprognostic (8.27e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (3.35e-8)"	"unprognostic (1.81e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.60e-2)"	9.8	13.2	7.4	1.3	11.8	0.5	13.4	8.3	12.4	15.5	0.0	14.6	3.0	13.0	6.8	8.2	12.8	2.8	12.7	10.6	3.8	3.3	5.6	7.9	0.8	7.4	2.7	11.3	3.4	2.5	4.7	1.9	7.7	14.1	5.0	7.4	4.6	6.8	52.6	16.5	11.9	3.8	3.2	5.5	9.7	1.6	6.1	1.5	3.4	20.6	1.0	15.7	15.0	5.5	0.2	0.1	3.8	0.2	5.9	6.0	5.0	1.7	1.7	1.0	0.6	0.0	0.0	0.0	0.0	2.5	0.3	1.1	1.6	1.7	0.9	12.3	3.9	0.0	0.8	0.0	2.3	1.2	0.6	8.7	4.0	1.2	0.9	4.4	1.4	2.8	0.0	3.5	1.4	1.3	1.4	0.3	4.4	2.0	0.3	1.9	2.5	2.1	0.0	0.8	1.6	6.0	1.0	0.7	3.5	2.2	0.1	0.1	1.7	2.2	0.8	4.2	2.3	7.2	4.1	0.0	3.7	1.8	2.4	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.5	2.0	0.2	0.0	0.2	1.8	0.0	2.6	0.0	0.1	0.0	0.9	7.4	11.8	8.3	12.4	10.6	3.8	7.4	2.7	7.7	3.2	6.1	5.5	107.5	38.5	113.0	201.4	1.2	152.6	234.9	29.6	82.6	23.4	87.9	63.6	90.7	25.8	38.1	1.8	0.0	119.3	99.8	149.9	7.9	6.7	47.0	11.0	89.3	98.4	19.2	14.5	144.2	19.6	99.3	91.8	7.1	21.7	10.1	11.2	101.4	83.7	40.9	26.9	165.9	66.3	24.4	8.8	31.5	37.8	76.4	9.5	64.0	16.9	19.7	42.9	141.1	305.1	3.6	14.1	203.3	19.2	20.2	105.7	193.6	12.3	17.5	9.5	19.7	108.8	48.2	3.4	17.3	76.3	145.6	284.6	32.2	32.8	76.4	181.7
C1orf216	FLJ38984	ENSG00000142686	"Chromosome 1 open reading frame 216"	Q8TAB5	1	35713877-35718894	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.8"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028299, HPA031343"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA028299: AB_10601122, HPA031343: AB_2673834"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (7.68e-10)"	"unprognostic (3.31e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.93e-2)"	10.5	10.6	35.8	6.1	39.1	4.5	7.6	25.1	47.8	10.7	15.8	17.3	3.5	13.2	11.3	5.6	9.1	7.6	11.7	42.6	37.0	4.7	5.3	9.9	7.3	31.6	27.5	8.2	4.4	7.0	9.3	4.7	33.3	8.7	5.3	28.8	5.2	9.9	15.6	7.7	7.9	16.0	27.3	8.8	7.1	9.8	33.4	4.8	6.0	14.7	7.0	10.7	7.9	37.9	7.7	17.6	8.6	12.5	43.5	31.7	6.3	21.1	25.9	31.9	30.3	10.7	16.3	8.3	15.2	32.5	26.0	7.1	24.1	14.6	27.5	31.4	10.3	57.8	27.6	2.9	16.5	28.1	36.6	32.9	18.2	22.8	7.4	23.6	21.2	6.3	23.4	25.6	34.9	12.9	10.5	24.8	13.6	8.4	14.9	7.0	11.5	8.2	11.0	9.0	12.7	12.4	20.3	4.1	44.1	5.3	8.2	12.6	24.8	25.6	19.5	19.0	22.2	7.6	20.3	6.0	25.6	27.6	40.9	0.0	2.7	0.1	4.3	2.8	1.3	2.0	3.3	5.3	2.5	1.5	0.8	3.1	0.0	0.6	2.1	0.5	1.2	2.9	35.8	39.1	25.1	47.8	42.6	37.0	31.6	27.5	33.3	27.3	33.4	37.9	4.9	0.0	2.2	5.9	2.3	6.0	3.5	2.9	0.6	19.6	3.6	2.5	7.1	0.0	1.5	1.8	14.6	2.5	7.1	0.1	0.0	6.0	14.8	1.0	3.7	6.1	1.8	7.8	17.6	2.7	1.5	7.3	1.1	1.6	4.5	5.2	6.4	2.3	7.9	23.5	15.0	0.3	2.0	4.8	6.1	8.5	8.4	5.0	16.0	9.4	6.9	21.0	10.3	7.1	8.7	2.0	0.1	20.7	2.7	1.7	0.1	0.8	0.3	31.8	0.0	6.8	7.8	11.2	5.2	0.2	4.5	1.1	6.2	4.7	0.7	1.5
C1orf226	FLJ13137	ENSG00000239887	"Chromosome 1 open reading frame 226"	A1L170	1	162378841-162386812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 21.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 29.2;Early spermatids: 22.7;Hepatocytes: 30.0;Late spermatids: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 14.0;HEL: 18.4;OE19: 16.0"					"Low region specificity"	"Detected in all"			"HPA052251, HPA074060"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"prognostic favorable (2.60e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.71e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-3)"	"prognostic favorable (4.44e-5)"	"unprognostic (9.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.13e-4)"	1.9	9.6	3.5	1.1	3.6	2.0	8.1	4.6	3.1	3.8	5.1	9.3	5.6	2.4	2.4	4.1	3.2	3.4	3.4	3.7	5.1	11.3	21.9	2.5	0.4	7.2	4.0	1.2	3.7	4.0	9.9	2.4	5.3	4.8	9.7	7.0	8.5	7.7	0.6	5.2	7.9	2.4	5.8	0.6	8.7	4.0	3.5	0.4	0.8	0.6	1.5	2.5	2.2	7.3	14.0	0.9	13.1	8.9	0.4	0.0	0.2	0.9	1.4	0.8	0.5	2.0	7.2	0.0	9.5	0.3	4.7	10.3	3.7	0.9	0.7	0.1	4.4	18.4	0.8	10.2	0.3	0.0	0.0	1.4	1.1	0.0	0.5	3.9	3.2	2.3	1.7	0.1	0.2	5.6	0.5	0.0	6.3	16.0	7.5	0.3	2.2	0.0	12.1	7.0	5.9	3.7	4.6	1.6	3.1	5.3	5.7	0.9	3.1	0.1	1.4	0.1	4.0	6.3	0.0	0.0	2.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	4.6	3.1	3.7	5.1	7.2	4.0	5.3	5.8	3.5	7.3	2.5	3.2	2.6	0.3	0.1	0.8	1.7	1.1	0.6	0.8	10.3	14.9	3.4	4.3	2.4	14.7	29.2	0.1	0.1	11.6	0.0	0.9	22.7	2.6	1.1	2.2	2.4	0.0	2.8	2.3	0.1	0.7	0.0	4.2	0.0	3.4	4.2	30.0	0.1	6.7	1.8	11.6	4.1	1.0	0.7	38.4	2.1	0.1	0.0	3.7	0.0	5.0	0.0	6.6	3.7	1.7	3.6	1.9	0.0	2.6	7.7	0.2	2.7	0.4	0.0	0.2	0.6	1.1	0.9	0.6	1.4	0.1	0.3	0.5	7.1	2.5
C1orf52	"FLJ44982, gm117"	ENSG00000162642	"Chromosome 1 open reading frame 52"	Q8N6N3	1	85249953-85259672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036072, HPA061790"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA036072: AB_10602696, HPA061790: AB_2684610"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (5.37e-5)"	"unprognostic (6.67e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.93e-4)"	"prognostic unfavorable (1.17e-7)"	"unprognostic (8.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.14e-1)"	"unprognostic (2.05e-2)"	15.1	11.0	11.7	10.3	15.0	23.0	13.4	9.4	16.7	13.8	5.5	14.2	6.3	11.7	7.5	13.1	12.5	6.7	14.8	17.7	10.6	12.2	15.2	14.0	15.2	10.7	11.8	13.0	13.0	5.3	13.3	12.2	11.0	12.5	6.5	10.7	9.2	7.3	16.3	12.2	11.4	5.2	8.8	14.8	12.0	15.9	11.5	9.7	11.5	9.9	8.5	12.9	13.1	16.2	25.6	12.1	17.3	15.6	18.6	14.4	21.4	20.4	10.6	26.2	23.2	17.2	13.1	20.0	17.2	22.5	14.7	16.1	42.4	12.3	13.0	26.1	25.4	32.2	19.5	15.5	11.3	28.0	14.2	9.4	17.8	24.1	11.9	13.0	9.7	35.2	35.9	23.6	13.0	7.3	27.3	13.8	63.7	12.0	9.8	28.3	18.5	10.8	14.2	7.0	7.3	16.4	5.0	16.3	20.7	17.4	8.8	57.7	16.6	10.6	19.5	27.2	32.8	22.6	46.2	28.3	8.9	21.7	12.9	17.6	18.4	30.0	19.5	28.6	21.1	35.5	18.1	17.2	24.7	19.6	27.5	26.4	30.1	19.7	24.0	26.8	17.3	22.3	11.7	15.0	9.4	16.7	17.7	10.6	10.7	11.8	11.0	8.8	11.5	16.2	46.7	44.8	34.3	31.3	48.4	145.4	55.0	60.0	56.9	23.5	51.9	50.3	24.3	21.5	46.0	16.5	22.9	61.3	56.3	23.4	19.6	33.3	69.0	36.3	36.1	40.7	38.8	29.0	37.4	27.5	61.1	46.9	23.4	40.9	51.3	25.4	29.6	16.6	37.1	15.2	21.7	25.1	77.3	28.9	81.6	16.8	36.7	32.5	32.0	21.5	25.4	30.8	38.1	23.1	58.6	37.9	24.6	24.5	42.7	53.0	25.9	19.7	34.0	27.1	39.5	27.7	45.6	92.5	67.3	63.9	128.9	67.9	53.4	27.5	24.7	71.5
C1orf94	MGC15882	ENSG00000142698	"Chromosome 1 open reading frame 94"	Q6P1W5	1	34166883-34219131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 19.6"	"Group enriched"	"Detected in some"	28	"Early spermatids: 65.2;Late spermatids: 27.9;Spermatocytes: 34.6"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 17.0;U-87 MG: 48.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045805			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA045805: AB_10969626"					"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"				"unprognostic (9.77e-2)"	"unprognostic (4.09e-2)"			"unprognostic (1.65e-2)"	"unprognostic (2.31e-1)"			0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	19.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	1.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.5	0.4	0.8	0.5	0.5	0.5	0.8	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	65.2	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	34.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1QTNF1	"CTRP1, FLJ90694, GIP, ZSIG37"	ENSG00000173918	"C1q and TNF related 1"	Q9BXJ1	17	79022814-79049788	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 214.2;heart muscle: 319.1"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 120.0;Sertoli cells: 105.2;Smooth muscle cells: 105.8;Syncytiotrophoblasts: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.5;BJ hTERT+: 72.9;HHSteC: 112.3;HSkMC: 61.3;U-87 MG: 66.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025429, HPA051101"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	314000000	40000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"CAB025429: , HPA051101: AB_2681343"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.81e-3)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (1.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.95e-2)"	214.2	75.3	9.5	14.8	15.2	0.5	156.0	16.1	13.3	50.2	45.3	38.3	4.6	45.1	6.5	18.9	63.5	24.3	319.1	9.1	18.2	25.3	45.7	44.4	14.0	18.3	25.4	70.5	14.9	13.5	17.5	42.2	18.0	57.1	6.3	0.9	34.9	44.0	27.0	38.6	29.3	13.3	14.1	35.7	25.0	5.4	21.9	5.1	115.0	21.3	6.6	34.7	42.3	13.2	0.1	32.3	0.3	0.1	313.5	27.1	0.2	13.6	72.9	7.0	11.9	2.7	14.0	0.1	1.5	5.1	18.1	0.7	1.0	0.5	5.0	0.1	3.5	0.2	11.7	1.5	112.3	0.1	0.2	61.3	0.2	14.5	0.8	9.3	8.8	1.6	0.1	0.3	1.6	0.1	0.3	0.2	3.0	3.7	27.9	0.1	22.3	0.4	0.0	0.4	1.3	5.3	9.2	1.8	32.7	1.2	0.0	0.0	1.4	32.6	0.8	4.0	4.8	0.3	0.1	0.1	66.2	0.2	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.5	15.2	16.1	13.3	9.1	18.2	18.3	25.4	18.0	14.1	21.9	13.2	36.1	0.0	0.6	4.9	0.4	6.5	0.7	12.3	0.6	0.1	9.2	1.8	10.8	5.7	0.5	1.8	0.0	21.5	0.4	3.2	0.0	19.5	0.1	0.6	17.9	38.3	4.8	2.7	0.2	5.9	1.5	23.6	2.6	0.6	0.0	25.3	120.0	1.9	2.6	0.0	0.9	6.3	2.0	7.5	11.3	0.7	10.5	1.1	3.6	5.6	10.9	0.5	0.0	0.5	0.3	3.7	3.1	3.4	0.1	1.8	0.9	0.2	0.3	0.5	105.2	12.7	105.8	0.0	0.7	0.4	4.5	47.3	0.8	18.1	5.2	0.6
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180166-37199385	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.7;placenta: 29.6"	"Cell type enriched"	"Detected in many"	11	"Extravillous trophoblasts: 398.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 114.2;RT4: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"	No	No	354000000		"Cluster 48: NK-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA002042: AB_1078342"	"unprognostic (9.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.61e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.52e-2)"	4.9	6.7	4.4	6.6	4.5	1.6	4.0	4.3	5.3	11.1	4.3	5.5	1.6	31.7	1.4	2.7	7.0	8.8	3.7	4.5	4.3	7.4	13.0	5.2	5.1	5.1	4.5	5.5	3.5	2.2	2.5	29.6	4.8	6.8	3.6	0.5	3.2	2.9	1.5	5.0	5.4	8.2	4.4	6.5	3.5	6.2	4.8	2.4	3.8	0.7	2.3	5.6	4.3	6.3	17.7	20.5	10.7	3.6	1.8	21.3	32.6	3.4	6.8	2.8	2.0	3.8	24.7	0.1	14.1	6.0	1.5	34.9	0.4	8.4	1.2	4.9	2.6	2.8	8.3	3.8	7.1	0.1	2.3	29.2	4.9	2.3	0.6	7.3	25.5	0.8	0.1	7.7	1.1	114.2	0.0	0.5	7.1	2.5	0.3	0.2	0.1	2.8	24.5	50.7	1.8	14.6	1.0	19.7	2.8	5.5	7.0	0.5	9.4	1.1	5.6	0.4	0.1	15.5	0.4	0.1	2.1	2.0	3.2	0.4	0.1	0.5	0.2	0.2	0.2	0.2	0.4	0.3	0.1	0.7	0.9	0.7	0.5	1.5	0.1	0.3	1.4	0.3	4.4	4.5	4.3	5.3	4.5	4.3	5.1	4.5	4.8	4.4	4.8	6.3	3.2	0.0	0.0	13.7	2.9	1.5	2.1	1.9	0.6	1.0	8.6	4.2	1.8	1.5	2.2	1.8	0.0	8.1	1.5	7.9	1.9	3.4	2.0	4.8	30.8	6.8	0.0	0.8	3.3	1.1	398.9	7.6	2.0	9.6	1.3	19.8	10.0	7.2	9.3	0.0	4.3	3.1	0.0	1.9	1.4	8.9	0.6	1.2	5.4	3.7	1.1	4.5	1.0	4.0	7.8	2.7	2.8	0.4	3.4	0.8	2.0	1.6	2.7	0.9	0.0	2.2	7.5	7.2	4.5	1.0	0.3	34.5	3.1	7.6	4.4	1.5
C1R		ENSG00000159403	"Complement C1r"		12	7080214-7092540	"Human disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"liver: 1425.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 442.3;Fibroblasts: 684.4;Hepatocytes: 1444.2;Leydig cells: 1142.6;Peritubular cells: 388.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1089.8;ASC TERT1: 546.0;BJ hTERT+: 461.9;BJ hTERT+ SV40 Large T+ RasG12V: 303.4;HSkMC: 672.1"	"Low region specificity"	"Detected in many"							"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA001251: AB_2666252, HPA001551: AB_10754818"	"unprognostic (1.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (1.94e-14)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.59e-2)"	540.6	203.6	15.8	122.4	15.9	1.1	400.6	15.9	23.3	470.5	21.7	277.3	38.3	353.8	80.8	119.0	526.3	279.1	458.7	15.4	19.6	148.9	1425.6	340.3	72.4	23.4	19.9	644.3	88.0	11.0	63.9	52.4	18.4	205.2	100.9	5.8	158.3	87.0	69.4	177.7	228.1	157.7	18.1	192.1	242.7	46.7	18.1	34.7	223.4	74.2	75.3	468.4	394.3	18.0	1.2	8.9	0.9	9.1	1089.8	546.0	0.4	108.9	461.9	143.0	303.4	1.4	2.4	0.5	4.5	108.8	11.8	2.3	11.8	5.5	18.3	18.3	1.1	0.5	4.1	3.6	226.5	0.8	2.3	672.1	3.2	74.7	4.7	121.0	2.9	0.5	0.3	20.5	21.2	0.1	8.0	0.8	3.1	0.1	0.9	8.6	3.8	0.8	0.9	5.5	0.4	2.3	95.1	3.7	2.8	1.3	0.2	0.2	0.4	38.3	6.3	152.1	0.8	1.1	3.0	0.2	53.1	1.0	5.4	0.0	0.0	0.6	0.3	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.6	0.6	0.5	0.8	0.0	0.0	0.3	0.1	15.8	15.9	15.9	23.3	15.4	19.6	23.4	19.9	18.4	18.1	18.1	18.0	45.4	22.4	90.5	3.6	7.1	54.7	58.8	76.6	33.6	0.3	5.9	30.9	20.8	183.0	22.9	18.4	2.1	4.1	1.8	0.7	3.9	280.8	4.6	13.3	442.3	45.4	0.0	40.6	0.9	44.5	3.7	684.4	16.3	11.6	10.1	24.9	114.9	1444.2	11.2	0.0	0.3	0.7	0.0	40.9	66.9	29.2	1142.6	7.0	53.4	13.1	1.6	16.0	0.0	2.5	0.1	51.1	1.3	388.1	6.2	17.7	0.3	6.1	5.3	1.4	170.9	87.5	140.4	6.8	6.7	5.6	40.1	5.2	11.5	15.2	0.7	11.2
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 2915.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 687.0;Hepatocytes: 2795.1;Leydig cells: 1193.2;Peritubular cells: 640.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 276.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 769.5;ASC TERT1: 1012.7;BJ hTERT+: 336.1;HSkMC: 540.2"	"Not detected"	"Not detected"							"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	416.4	136.1	26.4	207.7	28.5	1.7	252.5	27.1	43.1	309.2	36.7	192.4	84.6	209.0	147.2	152.9	315.4	543.8	191.5	25.4	34.8	60.2	2915.2	224.9	209.2	44.3	31.7	485.9	62.1	21.8	33.1	52.9	31.2	174.4	215.2	9.7	96.9	139.1	57.0	104.1	154.2	251.8	30.9	168.5	150.1	90.0	30.9	88.1	139.0	154.7	192.5	455.7	189.8	31.3	0.2	18.6	1.2	10.2	769.5	1012.7	4.5	143.3	336.1	74.7	135.7	0.9	2.0	0.5	19.7	179.6	20.2	1.1	0.3	2.1	6.7	0.7	0.7	0.5	5.6	48.2	230.3	1.8	0.9	540.2	2.8	60.2	4.4	94.2	0.1	0.2	0.4	0.1	9.9	0.0	0.4	1.6	10.3	0.0	0.6	0.2	1.1	1.5	3.1	2.5	0.8	0.9	86.6	1.8	2.1	17.4	0.1	0.0	0.5	34.2	2.6	133.8	0.2	0.6	0.5	0.8	73.6	1.2	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	26.4	28.5	27.1	43.1	25.4	34.8	44.3	31.7	31.2	30.9	30.9	31.3	37.6	16.0	41.0	9.4	5.7	76.2	18.9	22.2	23.9	0.9	4.5	15.4	21.5	171.6	15.5	3.7	0.0	3.7	0.7	0.1	1.9	285.2	6.6	8.7	272.4	30.6	0.0	112.2	2.9	42.9	2.5	687.0	11.2	7.3	5.1	25.7	93.5	2795.1	8.1	5.0	1.7	0.0	2.0	62.8	103.7	29.9	1193.2	6.4	88.9	19.7	1.0	15.2	0.0	1.5	0.6	31.7	0.1	640.1	1.8	9.7	0.0	7.1	4.6	1.1	138.1	34.9	127.6	6.3	5.3	6.3	53.8	2.6	12.8	30.7	0.2	5.2
C20orf173	dJ477O4.4	ENSG00000125975	"Chromosome 20 open reading frame 173"	Q96LM9	20	35523186-35529652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 35.5"	"Group enriched"	"Detected in some"	76	"Early spermatids: 473.3;Late spermatids: 156.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA076859			Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA076859: "										"unprognostic (1.90e-1)"				"unprognostic (1.03e-1)"				0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	473.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	156.5	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C20orf27	FLJ20550	ENSG00000101220	"Chromosome 20 open reading frame 27"	Q9GZN8	20	3753508-3767781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 178.7;Hofbauer cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 144.6;intermediate monocyte: 249.1;myeloid DC: 199.4;non-classical monocyte: 235.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 199.4;monocytes: 249.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		140000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA047483: AB_2680064"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (8.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	55.8	24.0	48.8	20.4	125.4	103.6	45.2	44.7	70.9	39.5	33.7	117.3	17.0	42.5	8.7	29.6	51.8	25.5	27.9	45.6	63.3	25.7	24.7	20.8	24.5	52.9	59.3	66.3	23.6	9.4	23.3	8.9	67.5	24.2	7.8	4.9	15.7	10.9	22.4	26.9	33.9	14.1	43.8	45.5	86.8	22.7	59.5	11.0	23.4	11.5	9.8	73.9	26.3	40.7	172.9	177.7	24.4	106.1	49.5	28.1	42.7	45.5	25.1	70.4	50.3	120.5	61.6	111.1	41.4	48.2	94.7	140.9	65.7	101.9	24.9	26.1	138.3	63.2	35.9	212.6	36.2	88.2	24.7	41.0	41.8	93.3	46.1	24.2	48.2	72.9	114.6	59.8	37.3	240.2	107.6	186.3	114.9	107.0	248.4	86.6	67.9	123.7	43.9	62.0	121.8	56.6	41.2	155.3	85.1	10.4	36.9	96.8	35.9	104.8	73.8	171.6	129.6	50.5	93.2	80.7	31.5	161.2	53.9	1.3	144.6	2.3	28.7	249.1	42.1	38.7	33.6	38.6	199.4	36.2	37.6	37.5	5.4	32.5	235.3	38.7	34.2	87.4	48.8	125.4	44.7	70.9	45.6	63.3	52.9	59.3	67.5	43.8	59.5	40.7	54.0	0.0	3.3	3.3	26.5	24.2	23.0	26.8	35.3	9.7	28.2	45.7	3.7	8.6	7.4	11.0	2.1	17.5	15.8	10.2	29.4	32.6	21.8	13.8	178.7	28.7	15.7	99.1	6.0	30.0	49.2	27.1	14.3	7.5	22.9	45.0	19.6	17.9	142.9	1.7	9.5	15.9	16.2	119.0	53.1	15.3	32.6	92.2	37.4	5.6	97.4	24.6	15.5	3.5	2.1	34.7	14.6	24.8	20.2	46.6	19.3	32.4	2.7	13.6	65.7	17.1	98.8	27.3	39.1	34.8	32.8	7.3	24.1	69.7	33.0	22.7
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.4;pituitary gland: 20.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 141.9;Enteroendocrine cells: 69.4;Erythroid cells: 80.2;Respiratory ciliated cells: 164.1;Spermatocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"REH: 62.0"	"Not detected"	"Not detected"							"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.5	1.7	1.9	3.6	2.4	13.1	2.0	2.6	2.3	3.5	3.0	3.2	4.7	2.0	0.7	3.9	26.4	1.0	1.3	1.8	1.9	1.5	1.7	4.8	6.3	2.8	4.6	2.6	2.5	1.2	20.7	2.0	2.0	2.9	2.6	2.5	2.3	1.5	1.7	5.3	4.4	1.3	1.8	3.4	3.5	7.1	2.5	12.8	2.1	0.7	3.8	2.1	2.7	3.2	26.0	11.6	30.2	19.0	2.9	4.0	16.7	15.7	5.7	10.8	10.5	5.4	18.6	18.6	3.8	4.4	12.5	20.3	8.1	6.7	3.2	19.9	17.8	29.9	35.2	3.1	0.7	8.6	16.6	1.7	1.4	7.7	1.9	4.0	6.8	45.4	17.4	48.1	8.9	10.6	42.7	11.6	13.0	7.2	5.7	62.0	13.6	16.6	3.4	4.8	24.7	15.4	11.7	8.3	3.7	6.4	20.5	17.1	4.7	6.6	18.4	6.6	9.6	19.3	9.3	8.8	11.6	37.1	17.4	4.4	0.2	0.6	0.4	0.1	0.2	0.1	0.5	0.6	0.0	0.9	0.9	0.7	0.3	0.3	0.1	1.0	0.8	0.5	1.9	2.4	2.6	2.3	1.8	1.9	2.8	4.6	2.0	1.8	2.5	3.2	2.1	3.2	2.6	4.2	3.1	0.9	1.6	7.0	2.8	19.5	6.2	8.8	3.0	0.0	16.6	1.8	27.1	7.7	9.4	13.9	0.0	1.7	17.3	141.9	7.7	2.3	69.4	80.2	2.7	1.0	5.9	5.9	11.7	4.5	2.5	21.4	2.2	1.5	4.0	5.0	2.5	12.8	14.2	1.6	1.9	32.5	5.3	6.2	0.0	0.0	1.3	5.9	5.2	1.5	4.2	1.2	4.1	2.6	4.8	2.0	3.0	0.7	164.1	28.2	0.0	2.6	5.5	80.8	45.3	8.5	1.4	1.4	3.7	3.9	16.8	0.9
C22orf23	"EVG1, FLJ32787, LOC84645"	ENSG00000128346	"Chromosome 22 open reading frame 23"	Q9BZE7	22	37943050-37953669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 95.5"	"Group enriched"	"Detected in some"	7	"Early spermatids: 292.5;Late spermatids: 312.9;Spermatocytes: 241.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.8;U-138 MG: 31.4;U-87 MG: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000650			Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA000650: AB_2732391"	"unprognostic (6.09e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.42e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.80e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.46e-2)"	2.9	2.6	3.9	5.6	8.8	3.0	0.8	9.5	5.1	1.7	4.7	3.4	2.9	8.3	1.3	14.0	12.4	6.4	5.1	4.7	7.7	2.3	0.4	5.0	3.6	12.8	10.4	2.5	8.6	1.1	4.8	5.3	11.0	5.0	0.1	3.5	10.3	0.2	5.7	26.0	3.8	0.1	8.2	2.3	9.0	95.5	9.7	0.2	8.2	0.0	0.1	6.2	1.2	16.1	6.6	5.3	11.1	10.3	0.2	0.4	13.7	18.4	0.5	0.5	0.7	6.3	5.9	3.5	5.0	0.4	11.7	31.8	0.4	0.1	0.6	6.7	13.4	2.0	4.6	4.3	0.5	5.4	4.4	0.4	0.2	2.2	0.2	15.4	0.1	2.6	2.3	2.0	0.1	4.1	0.3	3.2	1.6	6.6	4.6	6.0	16.1	1.3	0.1	29.4	5.6	4.0	8.2	3.2	10.3	17.5	3.6	7.3	27.8	31.4	10.2	25.1	10.0	4.6	2.0	1.6	46.9	2.5	18.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	8.8	9.5	5.1	4.7	7.7	12.8	10.4	11.0	8.2	9.7	16.1	0.2	0.0	2.4	1.3	0.0	0.3	0.1	1.8	0.0	0.2	0.3	0.8	0.1	1.5	1.9	0.0	0.0	0.1	0.1	0.1	1.9	0.4	292.5	16.8	0.6	0.6	0.0	0.0	0.5	0.4	0.1	0.5	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	312.9	6.8	0.5	0.0	1.0	0.0	2.2	0.0	1.0	5.6	0.3	0.0	5.3	0.0	0.1	0.0	1.8	37.8	1.2	0.0	0.5	0.4	241.3	5.2	0.0	0.0	0.0	0.2	0.3	0.0	0.1
C2CD2	"C21orf25, C21orf258, DKFZP586F0422, TMEM24L"	ENSG00000157617	"C2 calcium dependent domain containing 2"	Q9Y426	21	41885112-41954018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 126.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 51.6;Cone photoreceptor cells: 83.4;Granulosa cells: 100.0;Theca cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 79.1;SK-BR-3: 44.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030922, HPA030924"	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA030922: AB_2673660, HPA030924: AB_10669873"	"unprognostic (3.02e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (7.68e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.48e-1)"	39.9	126.3	18.6	8.3	18.0	1.3	23.3	18.4	19.8	12.0	16.9	12.9	4.9	8.3	8.4	10.7	9.4	8.3	7.5	16.4	18.6	10.1	8.6	7.9	9.7	21.8	20.9	18.9	11.3	29.2	7.2	5.2	20.2	17.3	5.8	24.6	10.8	11.5	2.8	15.6	9.0	7.8	20.5	41.4	11.7	3.3	23.4	6.7	8.5	4.1	7.9	12.8	11.4	26.1	13.4	5.5	3.9	8.9	79.1	21.7	15.1	9.3	14.4	5.7	5.2	8.7	15.0	0.2	5.0	18.0	14.0	1.5	13.9	9.7	7.2	0.9	6.2	2.3	7.1	7.1	10.6	1.0	0.0	14.0	8.9	30.3	11.7	12.5	27.1	0.7	8.4	0.1	15.3	1.2	1.9	2.7	21.4	5.7	18.7	1.4	5.7	8.0	8.5	27.8	6.3	2.8	10.1	44.6	8.1	7.6	11.7	5.9	9.3	13.5	1.9	4.5	7.6	5.0	7.9	1.1	39.2	7.7	2.8	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.1	0.5	0.3	0.1	0.3	0.1	0.0	0.3	0.1	18.6	18.0	18.4	19.8	16.4	18.6	21.8	20.9	20.2	20.5	23.4	26.1	24.8	3.2	15.5	20.5	4.4	4.1	9.1	7.6	15.9	51.6	8.2	7.0	3.1	8.6	8.3	3.7	83.4	12.8	4.4	3.4	0.0	5.6	0.3	6.0	6.7	19.3	4.9	5.9	20.3	8.5	4.8	11.9	17.9	8.3	0.0	100.0	46.1	5.2	3.6	1.7	14.4	6.9	6.1	7.0	10.5	0.2	3.7	5.6	1.8	24.4	2.5	3.6	3.1	11.6	18.8	8.1	5.0	2.2	8.1	15.9	3.0	2.5	7.7	36.9	13.1	7.4	17.9	0.1	3.0	14.3	2.6	9.3	2.8	82.4	6.9	16.6
C2CD3	DKFZP586P0123	ENSG00000168014	"C2 domain containing 3 centriole elongation regulator"	Q4AC94	11	74012718-74171210	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Alveolar cells type 2: 114.6;Excitatory neurons: 57.4;Respiratory ciliated cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 17.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 60.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038552, HPA038553, HPA040433"	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Centrosome"		"HPA038552: AB_10669542, HPA038553: AB_2676080, HPA040433: AB_2676981"	"unprognostic (3.94e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.48e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.92e-1)"	3.9	4.7	15.4	5.1	14.8	9.9	3.7	21.7	22.9	4.2	16.7	4.0	3.9	4.8	4.5	3.9	7.8	3.7	2.9	18.5	14.4	4.9	5.8	4.2	5.0	16.9	13.8	4.7	2.2	6.2	3.7	5.9	15.3	4.3	5.2	8.2	4.3	3.5	3.5	6.0	4.2	4.2	11.2	5.9	4.3	11.0	15.8	7.7	7.0	3.4	5.4	3.9	2.7	19.4	9.3	14.3	11.7	14.3	5.2	4.8	5.6	13.7	8.8	16.0	13.0	24.4	7.4	9.0	9.2	5.2	15.5	13.9	14.7	3.8	19.3	12.4	7.0	12.4	21.3	10.8	8.8	12.0	16.9	4.8	4.8	13.4	9.7	5.1	9.0	11.1	14.2	15.7	13.3	7.7	14.1	8.3	9.4	17.8	7.7	14.3	60.4	9.0	4.6	13.0	15.6	9.2	22.4	8.4	21.2	11.9	16.5	7.8	12.7	10.3	17.0	10.1	11.0	11.7	8.5	26.1	4.0	6.0	11.1	17.8	2.0	3.0	2.2	2.3	2.0	2.3	1.4	1.8	1.3	4.4	2.1	2.1	12.6	2.9	4.7	2.0	1.0	0.7	15.4	14.8	21.7	22.9	18.5	14.4	16.9	13.8	15.3	11.2	15.8	19.4	6.5	70.5	114.6	28.1	10.5	5.2	3.6	4.8	9.6	8.7	6.2	5.8	5.1	4.3	36.0	9.2	4.2	3.8	5.6	7.6	0.0	4.0	33.0	18.4	9.4	9.8	7.7	12.2	57.4	2.6	2.9	9.6	15.3	8.9	36.6	8.5	5.0	3.0	5.0	11.8	52.1	5.0	4.1	7.6	6.6	24.7	4.4	12.7	7.2	26.2	4.9	4.8	10.3	37.7	38.5	3.8	2.8	6.4	9.5	3.4	3.4	1.8	57.1	14.8	6.6	7.2	5.2	11.1	6.9	6.4	4.5	2.3	14.0	5.4	5.4	4.7
C2CD4A	"FAM148A, NLF1"	ENSG00000198535	"C2 calcium dependent domain containing 4A"	Q8NCU7	15	62066977-62070917	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 5.1;pituitary gland: 13.5"	"Cell type enriched"	"Detected in many"	5	"Glandular and luminal cells: 107.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"OE19: 34.4;RPTEC TERT1: 29.9"									HPA078864			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA078864: "	"unprognostic (3.85e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-3)"	"unprognostic (5.49e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.72e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.35e-1)"	0.2	0.4	0.2	0.6	0.2	0.2	0.2	0.2	2.2	0.7	0.3	0.5	1.0	1.3	0.0	0.1	0.0	0.4	0.1	0.2	2.5	5.1	2.4	0.5	0.2	1.0	0.8	0.1	4.0	0.0	13.5	0.1	0.7	0.6	0.6	0.2	1.2	0.1	0.3	0.5	0.5	0.0	0.1	0.1	2.0	0.1	0.3	2.1	0.1	0.0	0.5	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	34.4	0.2	0.1	0.0	0.2	29.9	0.7	1.3	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.2	2.2	0.2	2.5	1.0	0.8	0.7	0.1	0.3	0.1	0.6	0.0	0.0	0.3	0.3	0.5	1.8	3.8	0.0	0.9	4.3	6.2	1.4	0.0	2.7	0.0	0.0	0.0	0.0	1.2	1.9	2.8	0.0	11.7	14.6	3.9	20.8	0.0	0.0	6.6	0.0	1.2	3.6	107.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.2	14.2	0.0	0.8	0.0	0.0	0.8	0.0	0.0	1.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.8	2.2	0.3	0.0	1.1	0.2	0.0	1.0	1.4	0.0	0.0	0.0	1.1	0.0	1.1	0.1	1.0	1.1
C2orf16	DKFZp434G118	ENSG00000221843	"Chromosome 2 open reading frame 16"	Q68DN1	2	27537386-27582721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 21.4"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 94.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.4;SiHa: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052136, HPA056962"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA052136: AB_2681742, HPA056962: AB_2683290"	"unprognostic (4.32e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.79e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.53e-3)"	0.1	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.2	0.2	0.3	0.1	0.2	0.2	1.2	0.1	0.1	0.3	0.1	0.5	0.3	0.0	0.5	0.0	0.3	0.2	0.0	1.5	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.4	21.4	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.2	0.6	0.6	0.9	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.8	0.3	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.6	0.1	1.2	0.5	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.5	0.8	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.5	0.2	0.0	0.6	2.4	0.4	1.8	0.4	0.2	0.1	0.4	0.4	1.1	0.5	0.8	0.3	0.4	0.1	0.0	0.7	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	94.1	0.3	0.2	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	14.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C2orf42	FLJ20558	ENSG00000115998	"Chromosome 2 open reading frame 42"	Q9NWW7	2	70149885-70248615	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 262.9;Late spermatids: 98.5;Spermatocytes: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031840, HPA031841, HPA031842"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA031840: AB_2674066, HPA031841: AB_10601124, HPA031842: AB_2674068"	"unprognostic (8.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.73e-1)"	"prognostic favorable (5.94e-5)"	"unprognostic (4.66e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.49e-3)"	6.5	7.3	11.2	5.9	12.7	4.8	6.4	16.3	12.5	7.8	10.6	6.5	4.4	8.5	10.9	6.4	11.2	7.5	5.8	10.4	11.7	8.4	15.4	6.0	12.4	10.8	11.5	10.2	6.7	11.5	7.8	8.0	11.5	6.7	5.2	7.5	6.4	7.2	6.7	6.7	6.3	7.5	10.9	8.8	6.1	59.0	11.9	10.1	8.2	8.4	11.6	8.2	6.2	16.1	5.9	9.6	8.9	8.1	17.9	10.4	10.1	13.9	9.4	11.0	9.4	7.8	5.1	7.5	7.9	8.3	18.0	8.0	9.4	7.9	12.2	13.1	8.3	8.8	6.8	7.7	15.9	7.3	8.6	12.5	14.1	10.5	13.3	12.0	10.8	9.4	7.5	27.6	14.7	4.6	9.4	10.7	6.4	9.9	10.6	8.8	12.1	13.8	9.0	6.8	7.4	7.5	7.5	11.6	14.4	6.2	5.2	8.9	8.5	9.8	6.7	9.1	11.4	15.1	16.2	7.5	7.6	11.8	8.9	2.3	7.7	9.9	12.1	7.2	15.5	14.2	12.2	14.7	7.9	13.0	13.9	14.9	8.3	21.9	7.8	7.0	15.5	10.9	11.2	12.7	16.3	12.5	10.4	11.7	10.8	11.5	11.5	10.9	11.9	16.1	4.0	0.0	2.2	7.8	8.9	2.5	3.4	3.7	5.7	5.8	4.0	5.0	2.8	1.5	2.8	5.5	0.0	8.8	6.1	4.2	7.9	4.5	262.9	3.8	3.3	3.6	1.2	4.0	9.2	2.4	4.0	4.4	3.6	2.8	2.5	5.0	6.4	6.9	4.3	0.0	8.9	2.1	2.0	4.7	3.1	98.5	7.5	3.6	3.6	2.8	3.1	9.0	9.2	8.0	12.3	2.0	3.1	7.9	8.4	2.9	3.3	6.4	6.6	4.1	0.0	4.2	3.8	63.1	12.0	3.5	4.3	9.6	5.3	4.3	2.5	2.0
C2orf49	"asw, MGC5509"	ENSG00000135974	"Chromosome 2 open reading frame 49"	Q9BVC5	2	105337532-105349211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043846, HPA060814"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Mitochondria	"HPA043846: AB_2678698, HPA060814: AB_2684372"	"unprognostic (4.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (6.51e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.04e-2)"	11.3	9.3	9.6	10.6	11.9	19.3	11.1	12.0	12.9	12.5	6.2	9.1	9.4	14.6	7.8	11.8	12.4	9.5	15.3	8.9	10.7	8.7	10.1	8.6	12.6	11.2	11.5	19.9	11.0	10.5	5.5	12.0	11.3	11.3	9.9	24.9	9.1	11.0	19.9	9.5	10.1	12.2	10.2	11.1	13.8	13.0	10.6	16.0	12.6	21.0	13.3	11.3	10.5	13.8	20.0	13.9	17.2	17.5	19.4	23.6	30.7	19.6	20.6	17.0	23.3	30.7	19.5	23.3	23.9	17.1	45.6	18.7	23.9	16.7	22.2	30.6	18.1	25.3	11.6	23.8	23.6	21.3	20.1	17.1	28.7	24.0	21.6	24.3	15.8	18.1	35.9	18.7	24.3	15.4	25.9	24.5	22.6	13.5	16.8	17.1	25.4	27.1	19.2	18.9	20.3	16.2	17.3	15.5	23.8	19.2	15.2	23.8	25.4	17.9	25.1	13.0	16.1	23.6	20.5	24.6	18.1	21.3	17.6	15.4	13.2	12.0	9.0	8.3	8.9	14.5	10.1	9.0	9.2	17.6	11.0	9.3	17.8	9.2	11.9	19.1	12.7	6.7	9.6	11.9	12.0	12.9	8.9	10.7	11.2	11.5	11.3	10.2	10.6	13.8	27.0	16.0	14.3	7.5	26.3	29.1	13.4	21.8	15.4	37.1	24.8	22.9	30.9	18.6	22.0	25.8	29.2	21.2	31.6	16.5	25.4	22.9	40.6	43.1	34.7	19.3	11.3	21.2	10.8	18.2	26.5	22.8	12.8	33.9	16.5	18.1	19.6	22.4	16.1	23.5	11.2	22.5	12.2	18.5	13.5	35.8	27.7	15.5	7.2	10.3	21.1	39.6	28.8	7.1	15.8	21.0	17.5	29.0	19.0	16.2	21.8	22.3	36.1	44.3	19.7	17.3	19.8	45.8	28.1	13.7	24.7	36.8	22.4	16.6	14.8	15.8
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"		2	196804417-196809355	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.9;brain: 5.1;pituitary gland: 3.7"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 36.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 9.0;RT4: 2.2;TIME: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA020869	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	2.8	3.9	2.1	0.2	1.8	0.1	0.4	1.4	2.2	0.0	1.7	0.3	0.0	0.1	0.4	0.2	0.6	0.3	0.5	2.0	4.2	0.2	0.1	0.3	0.0	2.3	5.1	0.3	0.4	0.1	3.7	0.0	2.9	0.3	0.1	1.8	0.1	0.1	0.0	1.2	0.3	0.0	1.5	0.1	0.2	1.5	2.8	0.1	0.1	0.0	0.1	0.3	0.2	1.6	0.0	0.1	0.2	0.8	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.4	9.0	0.3	0.1	0.0	0.1	0.8	0.2	1.2	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.4	2.2	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.1	2.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.8	1.4	2.2	2.0	4.2	2.3	5.1	2.9	1.5	2.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1
C2orf68		ENSG00000168887	"Chromosome 2 open reading frame 68"	Q2NKX9	2	85605254-85612066	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051143	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane, Mitochondria"	Nucleoli	"HPA051143: AB_2681360"	"unprognostic (1.71e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.76e-6)"	"unprognostic (4.24e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.81e-3)"	11.0	9.4	8.8	10.0	11.6	10.5	12.6	15.4	9.9	18.7	10.7	13.6	11.0	15.7	12.2	12.1	15.2	6.6	12.3	8.6	9.4	12.8	11.7	14.0	14.2	11.7	10.8	20.4	17.2	8.5	14.0	12.5	11.0	16.4	10.9	20.0	16.4	10.7	21.8	16.3	16.6	9.9	9.8	16.9	14.3	9.5	10.2	13.7	16.3	9.8	13.9	13.6	15.4	15.2	8.8	7.9	15.7	11.5	14.2	7.6	10.2	4.3	5.6	6.7	8.7	7.1	10.6	12.4	6.0	7.3	6.0	10.4	7.9	7.5	7.2	6.8	19.1	21.1	13.8	8.5	11.2	12.3	11.4	11.3	9.7	4.4	12.7	10.6	10.1	14.7	10.7	12.4	6.3	9.3	13.3	13.4	6.9	10.2	7.3	14.8	27.8	11.5	8.5	10.1	19.8	14.2	6.5	8.5	9.0	8.7	9.1	6.5	7.0	4.8	12.8	5.9	4.2	17.9	11.8	10.8	7.2	12.9	6.0	32.7	30.5	59.0	22.4	21.8	21.3	14.6	21.1	21.0	22.4	20.7	30.5	28.2	49.2	31.2	27.0	15.2	17.7	16.7	8.8	11.6	15.4	9.9	8.6	9.4	11.7	10.8	11.0	9.8	10.2	15.2	8.2	64.1	63.1	15.0	18.6	5.9	18.2	10.0	9.6	17.4	16.0	12.3	10.7	37.1	24.3	35.0	35.5	47.2	24.4	24.6	17.6	17.9	4.8	9.4	8.7	13.9	19.2	19.5	2.7	19.8	17.7	12.9	17.9	9.6	34.7	15.6	17.9	25.3	23.3	25.2	6.8	16.9	12.2	34.9	14.3	12.8	24.2	26.0	14.2	15.0	31.4	12.3	38.1	10.1	16.9	19.4	14.0	13.5	13.6	14.4	32.7	26.6	21.0	27.0	19.7	13.7	8.5	37.2	20.1	27.4	9.8	24.9	18.1	10.0	15.8	19.2
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037523-231049719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 14.6;liver: 18.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.2;Cholangiocytes: 47.1;Hepatocytes: 129.1;Oligodendrocyte precursor cells: 45.8;Paneth cells: 51.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;CACO-2: 2.2;EFO-21: 3.3;OE19: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"		"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	0.0	0.0	6.7	0.0	8.2	0.0	0.3	4.3	8.8	0.0	0.0	3.0	0.6	0.0	0.1	0.0	0.0	0.4	0.0	8.7	6.2	0.2	18.7	0.1	0.0	8.4	12.1	0.0	1.4	0.2	1.1	0.9	6.0	0.5	0.7	0.0	0.1	0.0	0.0	0.1	1.1	0.0	5.8	0.0	1.5	0.1	14.6	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.5	0.4	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	4.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.1	1.0	0.5	0.5	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.2	4.3	8.8	8.7	6.2	8.4	12.1	6.0	5.8	14.6	6.1	0.0	0.0	0.0	163.2	0.5	0.1	0.1	0.0	0.0	1.9	5.9	6.0	0.5	47.1	0.0	0.0	0.0	1.8	0.2	32.8	1.9	3.9	13.6	0.1	0.2	0.2	4.9	10.7	33.4	2.0	11.9	0.2	4.6	0.1	0.0	0.1	3.6	129.1	0.6	0.0	15.0	14.8	0.0	2.9	0.0	30.8	0.3	0.2	1.8	6.5	0.0	15.7	0.0	45.8	20.1	0.8	51.3	4.1	0.2	0.7	10.7	1.8	0.0	0.3	0.0	0.0	0.1	0.5	0.9	0.0	0.0	5.2	0.3	0.0	28.8	0.3
C2orf81	"hCG40743, LOC388963"	ENSG00000284308	"Chromosome 2 open reading frame 81"	A6NN90	2	74414176-74421591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.6;Late spermatids: 31.4;Respiratory ciliated cells: 25.7;Spermatocytes: 20.1"					"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 13.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 15.1;RPMI-8226: 14.5;SCLC-21H: 17.8;SH-SY5Y: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049564, HPA054835"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA049564: , HPA054835: AB_2682620"																		2.1	1.5	3.4	1.7	3.9	0.5	2.6	3.7	4.7	5.7	10.0	3.1	1.1	4.9	0.8	1.1	17.7	2.4	2.0	4.4	4.2	5.1	0.7	3.8	2.6	6.1	6.3	4.0	2.2	5.5	17.6	0.6	3.7	5.0	0.4	3.0	2.1	2.5	0.7	1.6	2.5	0.9	4.6	3.7	2.1	27.3	3.6	2.2	3.7	0.5	0.8	3.1	2.5	3.5	4.4	8.0	2.4	8.6	2.6	2.2	0.8	0.6	2.6	0.7	0.8	0.2	4.9	10.5	1.8	1.3	2.1	1.6	0.2	2.1	0.8	5.9	0.4	1.1	0.5	0.0	1.3	2.1	2.1	1.3	5.2	1.0	1.0	3.0	0.1	5.6	0.2	1.6	1.3	15.1	2.7	5.5	4.6	2.4	1.7	1.4	0.8	14.5	3.2	1.9	17.8	19.3	2.4	3.9	1.3	0.3	3.7	1.9	0.0	0.9	3.8	2.7	2.2	3.7	7.4	3.4	5.2	2.0	1.8	0.1	1.9	0.0	0.6	2.0	0.3	6.6	0.7	0.8	6.3	5.8	3.3	1.6	0.1	3.0	1.5	13.3	0.7	1.3	3.4	3.9	3.7	4.7	4.4	4.2	6.1	6.3	3.7	4.6	3.6	3.5	1.7	0.0	2.4	0.0	0.8	0.6	1.0	2.9	1.8	0.9	1.9	4.7	1.4	4.3	3.6	3.7	0.0	0.0	2.9	0.7	5.9	3.2	45.6	11.7	1.9	2.1	7.2	0.0	1.1	2.2	0.0	4.1	0.5	3.1	0.0	1.1	4.2	0.0	0.0	3.3	0.9	1.7	4.1	1.9	3.4	31.4	3.4	1.1	3.6	1.0	6.1	6.1	1.0	1.0	0.2	2.6	0.3	7.5	0.2	0.7	0.4	5.9	25.7	3.9	6.6	2.4	3.9	20.1	1.5	0.1	0.9	0.0	0.6	1.2	1.2	0.3
C3orf38	MGC26717	ENSG00000179021	"Chromosome 3 open reading frame 38"	Q5JPI3	3	88149959-88168729	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 341.2;Late spermatids: 312.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 147.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034736, HPA034737"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034736: AB_2674307, HPA034737: AB_10671505"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (9.28e-3)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.67e-2)"	10.2	8.8	7.1	11.1	9.2	42.1	12.4	11.2	11.5	10.7	6.8	11.1	9.7	9.1	10.9	12.1	10.6	9.7	9.9	7.8	8.6	10.4	14.1	10.1	17.7	8.0	7.5	11.6	7.8	10.7	4.8	12.4	8.6	10.1	11.0	7.7	8.8	9.5	8.0	8.2	10.0	10.9	8.7	13.2	10.4	32.8	7.8	20.9	12.0	10.8	18.4	12.5	5.2	12.8	16.6	17.4	32.5	17.7	22.5	19.8	15.0	26.3	31.5	38.6	51.9	19.5	22.5	22.8	23.1	24.5	18.4	11.8	23.7	19.2	33.1	40.1	11.7	27.1	12.3	16.9	30.8	37.9	22.5	27.7	20.1	26.1	21.8	25.2	23.1	23.7	18.0	25.1	43.4	19.4	38.3	16.9	40.0	31.0	18.8	23.9	11.4	21.5	25.7	22.6	10.1	14.6	24.1	14.2	42.2	26.2	25.5	30.0	20.6	24.2	25.7	147.7	29.8	22.6	36.2	33.0	18.8	29.8	23.0	47.8	22.3	24.1	16.8	32.4	21.4	26.0	15.3	17.2	23.5	22.3	15.1	15.6	9.7	23.4	27.4	16.2	20.5	21.6	7.1	9.2	11.2	11.5	7.8	8.6	8.0	7.5	8.6	8.7	7.8	12.8	13.3	19.2	7.5	5.9	30.9	11.7	18.8	19.9	14.2	21.6	11.0	9.5	6.9	8.6	16.7	5.5	22.9	21.6	24.4	13.9	19.6	16.7	341.2	14.4	13.3	10.8	16.2	23.5	9.7	13.7	22.7	17.3	11.7	10.2	14.0	14.2	11.4	7.5	26.7	6.7	9.1	13.3	14.2	23.9	25.1	312.0	16.4	24.0	16.0	6.5	28.0	23.2	23.7	10.1	15.0	15.3	19.3	15.1	17.5	18.6	16.1	14.5	21.2	24.8	13.1	14.9	16.6	75.7	12.2	14.9	14.1	25.6	24.6	18.1	11.1	22.5
C3orf52	"FLJ23186, TTMP"	ENSG00000114529	"Chromosome 3 open reading frame 52"	Q5BVD1	3	112086335-112131004	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 17.4;skin 1: 26.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 129.6;Pancreatic endocrine cells: 82.8;Prostatic glandular cells: 75.6;Syncytiotrophoblasts: 75.0;Urothelial cells: 132.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.4;U-698: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007678, HPA008119, HPA011968"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826"	"unprognostic (8.86e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.49e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-6)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.59e-2)"	1.2	1.0	0.1	1.2	0.2	0.6	2.7	0.2	0.3	0.7	0.2	7.5	3.3	0.9	0.0	2.6	0.7	5.0	4.0	0.2	0.1	4.8	0.3	3.8	1.2	0.0	0.1	0.2	17.4	0.0	2.0	3.3	0.1	1.7	13.7	0.1	3.8	3.4	0.5	26.3	5.2	0.9	0.1	0.7	13.7	0.9	0.3	6.6	7.6	0.1	2.0	5.8	1.6	0.1	11.0	2.0	4.2	0.0	0.6	0.0	1.8	15.5	6.7	10.1	11.3	26.4	10.1	0.4	1.9	3.1	4.4	8.7	6.1	0.3	19.4	0.0	2.8	7.9	1.8	1.9	4.6	0.0	0.1	0.6	8.7	5.2	15.0	5.4	2.2	0.0	2.8	2.8	7.5	1.7	0.3	0.0	12.3	7.9	0.6	0.3	13.2	0.0	18.1	16.5	0.5	0.9	2.4	5.2	6.3	6.8	9.5	0.0	5.8	3.6	5.5	0.0	0.0	3.9	0.0	30.1	2.7	0.1	3.6	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.8	16.0	10.0	0.3	1.6	32.5	129.6	10.0	45.5	0.0	14.8	3.3	2.1	4.3	19.3	18.4	0.0	18.1	0.7	30.4	0.0	26.3	24.2	24.8	3.1	3.5	11.9	0.0	3.2	35.9	25.6	4.7	64.2	44.1	0.0	0.4	0.4	0.0	1.9	0.0	0.6	56.6	8.2	0.3	2.7	23.3	0.3	1.0	1.8	1.0	2.6	0.0	0.0	0.5	0.3	82.8	30.7	0.4	4.6	75.6	7.8	2.1	14.8	0.0	0.0	4.6	4.7	3.2	5.3	44.0	33.5	75.0	2.0	3.0	8.9	132.5
C3orf56	FLJ40141	ENSG00000214324	"Chromosome 3 open reading frame 56"	Q8N813	3	127193131-127198185	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	15	"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA055395			Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Centrosome, Cytosol"	"HPA055395: "															"unprognostic (1.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C4orf46	"LOC201725, RCDG1"	ENSG00000205208	"Chromosome 4 open reading frame 46"	Q504U0	4	158666675-158672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047287, HPA052670"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA047287: AB_2680011, HPA052670: "	"unprognostic (2.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.06e-3)"	2.5	2.4	1.9	4.1	2.4	14.5	2.9	2.4	2.8	2.7	1.3	3.3	3.0	5.0	2.1	2.9	2.4	2.8	3.7	1.9	1.9	1.9	1.5	2.6	6.0	2.3	2.2	4.2	2.4	1.7	1.1	4.5	2.3	2.4	4.2	9.4	1.7	2.2	2.1	2.9	2.8	4.0	2.1	3.2	2.6	12.8	2.0	10.2	4.3	6.0	5.4	2.6	2.0	2.9	16.6	9.9	23.7	35.0	10.3	10.6	11.8	27.5	18.9	31.5	27.4	8.9	14.6	29.3	4.3	14.0	11.6	9.0	20.6	14.2	40.3	40.5	10.7	44.5	10.4	11.9	3.5	33.9	23.7	6.2	5.0	25.6	11.2	10.4	22.7	29.3	19.7	72.1	43.2	8.9	65.8	29.7	16.3	10.6	13.0	47.0	13.5	13.0	9.6	8.1	12.8	38.5	12.1	10.9	10.1	11.9	9.3	26.9	12.0	48.0	22.1	27.0	23.2	16.5	22.3	37.0	12.1	29.8	18.9	2.4	1.9	1.7	1.9	1.6	1.4	1.7	1.5	1.9	2.1	1.4	2.1	2.3	0.6	3.4	2.2	1.8	1.8	1.3	1.9	2.4	2.4	2.8	1.9	1.9	2.3	2.2	2.3	2.1	2.0	2.9	10.3	3.2	1.8	1.3	7.8	24.1	5.1	5.8	14.2	7.5	6.5	5.2	7.6	1.5	3.2	1.8	4.2	9.8	8.2	2.9	7.9	3.6	0.8	7.6	10.8	6.9	7.7	11.2	1.2	3.0	11.8	14.5	4.6	15.0	7.0	8.7	5.0	2.0	9.7	10.1	1.8	5.1	6.1	10.3	25.8	1.8	4.7	7.6	19.6	0.0	18.9	6.5	5.2	1.0	6.2	3.8	3.1	6.0	18.1	6.6	3.2	2.8	3.3	28.2	6.6	7.7	10.6	49.1	15.2	30.1	15.6	3.3	9.6	2.5	5.8	7.2
C5orf24	FLJ37562	ENSG00000181904	"Chromosome 5 open reading frame 24"	Q7Z6I8	5	134845680-134859735	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057749, HPA062502"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA057749: AB_2683515, HPA062502: AB_2684785"	"unprognostic (8.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.33e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.45e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (4.75e-2)"	24.1	25.9	17.3	17.8	20.7	24.9	20.2	26.3	31.2	20.2	16.2	21.2	22.1	28.9	15.8	21.0	17.5	21.3	19.5	18.4	18.3	41.0	43.2	22.9	16.3	19.5	18.7	20.0	13.2	26.8	15.4	28.6	18.9	21.5	18.4	19.3	18.3	18.3	21.5	19.1	17.1	26.7	19.8	16.7	16.1	12.4	18.7	15.0	29.8	26.6	14.6	22.1	16.8	23.4	26.0	21.5	43.8	63.7	53.0	62.3	15.7	54.7	38.5	29.6	35.3	28.7	29.0	24.0	46.4	39.1	37.6	17.3	25.0	37.9	51.3	18.0	35.3	27.1	50.4	33.9	40.1	11.8	30.8	51.6	45.0	42.9	48.9	59.5	55.2	39.5	19.0	29.1	64.7	14.8	26.0	20.4	9.8	16.1	21.8	29.4	41.6	27.4	75.4	23.9	27.0	51.5	56.7	15.0	82.2	19.4	30.8	38.1	61.4	59.4	25.7	43.8	39.5	30.3	23.2	30.3	43.6	33.2	44.9	4.5	9.0	9.6	5.5	6.9	4.4	6.7	3.7	4.5	7.8	6.4	6.9	4.3	1.7	5.5	5.7	10.5	4.9	4.2	17.3	20.7	26.3	31.2	18.4	18.3	19.5	18.7	18.9	19.8	18.7	23.4	71.8	86.6	34.1	21.2	44.1	43.1	34.7	50.0	56.9	47.2	64.3	56.8	33.2	64.3	34.8	106.7	37.5	33.4	45.9	26.4	58.7	52.0	18.6	33.0	85.6	83.6	53.9	45.0	31.1	43.7	35.4	60.1	27.0	48.2	21.5	48.0	78.1	94.4	32.2	69.0	33.9	32.4	28.5	33.6	47.9	10.8	70.5	33.3	64.0	22.5	40.3	28.2	68.0	22.6	44.3	83.9	34.7	71.5	32.3	44.7	42.4	132.8	29.1	45.9	72.3	61.3	88.0	66.9	44.6	67.8	49.3	22.2	37.6	34.6	35.0	25.0
C5orf51	LOC285636	ENSG00000205765	"Chromosome 5 open reading frame 51"	A6NDU8	5	41904188-41921636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 34.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043779, HPA063816"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA043779: AB_2678666, HPA063816: AB_2685130"	"unprognostic (6.64e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.93e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.67e-2)"	11.0	8.7	10.4	9.8	13.2	2.7	11.5	12.6	14.3	9.9	6.0	8.0	7.8	10.2	15.3	10.8	7.9	8.8	9.6	10.1	12.3	10.9	10.4	7.9	10.5	12.4	12.4	15.5	8.8	15.3	5.0	12.9	12.4	11.5	9.0	15.6	8.9	10.5	4.5	9.1	7.8	12.2	12.0	9.8	7.5	7.1	12.0	15.9	13.7	7.5	10.6	10.5	7.4	16.7	14.8	11.2	22.3	46.9	44.7	35.0	24.3	17.1	29.6	23.7	25.2	11.3	14.9	15.9	20.7	19.2	41.3	9.4	29.8	16.2	34.2	21.4	9.1	15.4	33.0	17.0	54.0	19.8	11.2	34.2	23.0	27.9	31.9	15.1	20.8	19.0	27.8	26.5	25.4	15.5	18.7	20.2	22.4	9.0	6.0	16.2	31.0	24.7	15.9	14.1	13.5	21.2	54.9	25.9	29.0	19.9	28.9	20.0	15.1	28.0	16.7	21.5	16.8	13.3	23.2	15.7	31.2	34.1	20.4	34.3	8.0	7.8	4.9	6.2	6.4	5.6	5.7	5.4	7.8	5.8	7.6	5.2	5.3	6.5	9.2	4.5	4.4	9.8	10.4	13.2	12.6	14.3	10.1	12.3	12.4	12.4	12.4	12.0	12.0	16.7	13.3	32.1	11.5	12.7	16.6	9.9	8.7	10.4	21.6	11.5	13.9	12.4	14.5	8.6	9.5	14.7	6.2	12.5	10.4	7.1	9.8	12.0	13.1	8.1	14.4	11.9	10.8	14.1	11.8	7.6	12.4	19.2	11.2	10.0	5.1	10.3	10.4	20.2	15.0	8.4	13.8	9.1	6.1	17.6	7.9	11.8	9.0	13.0	7.2	4.7	13.8	18.6	10.3	16.6	20.9	8.1	7.3	7.9	11.0	11.6	5.7	12.8	9.6	11.2	13.1	12.8	16.5	9.0	8.3	30.1	13.2	16.8	10.6	9.0	7.1	9.9
C6orf163		ENSG00000203872	"Chromosome 6 open reading frame 163"	Q5TEZ5	6	87344813-87365463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 180.7;Late spermatids: 267.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"basal ganglia: 1.5"	"Low region specificity"	"Detected in all"			"HPA044797, HPA052927"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA044797: AB_10962365, HPA052927: AB_2681990"	"unprognostic (4.98e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.96e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.60e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	0.6	0.6	1.1	0.3	0.7	2.3	0.9	0.5	1.6	1.0	1.4	0.8	0.1	0.9	1.4	0.4	1.5	0.4	0.8	1.1	0.3	0.8	0.7	0.4	0.7	0.7	0.4	1.1	0.8	0.7	1.2	0.4	0.7	0.9	0.8	1.2	0.9	0.3	1.2	1.6	0.8	0.4	0.0	1.2	0.6	7.7	0.8	0.5	0.8	0.6	0.6	0.5	0.5	1.4	0.0	0.2	1.0	1.6	0.1	1.1	1.3	0.0	0.0	0.2	0.3	0.4	0.3	0.6	0.1	0.1	0.6	0.3	0.4	0.9	0.0	0.6	0.7	0.8	0.4	0.3	0.0	0.4	0.2	0.5	0.5	0.3	0.3	0.4	0.2	0.6	1.3	0.5	0.1	0.2	0.1	0.5	0.2	0.0	0.0	1.4	0.3	0.0	0.7	1.0	0.8	0.4	0.1	0.2	0.5	1.0	0.2	0.4	0.3	0.6	0.5	0.3	0.5	0.2	0.3	0.1	0.0	0.8	0.4	0.2	0.1	0.0	0.4	0.1	0.2	0.2	0.3	0.2	0.1	0.2	0.3	0.3	0.8	0.2	0.2	0.0	0.2	0.1	1.1	0.7	0.5	1.6	1.1	0.3	0.7	0.4	0.7	0.0	0.8	1.4	0.7	0.0	0.5	28.4	0.4	0.4	0.5	0.5	0.0	0.6	0.5	0.3	2.5	1.5	0.2	0.0	0.0	0.6	0.3	0.6	0.0	0.3	180.7	1.8	1.2	1.3	0.0	1.3	31.4	0.0	0.4	0.5	1.5	0.4	0.0	1.6	0.4	0.5	0.2	0.0	25.1	0.4	0.0	0.8	0.0	267.1	2.5	0.4	1.8	12.2	0.2	0.2	0.0	14.1	16.0	0.1	0.2	1.9	0.5	0.4	0.4	0.5	1.1	0.5	6.6	1.4	0.9	2.3	1.8	0.2	0.1	0.8	0.7	1.6	0.2	0.4
C7orf25	MGC2821	ENSG00000136197	"Chromosome 7 open reading frame 25"	Q9BPX7	7	42908726-42912305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Cone photoreceptor cells: 4.2;Excitatory neurons: 4.6;Inhibitory neurons: 4.7;Oligodendrocytes: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 36.6"	"Lineage enriched"	"Detected in all"	15	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020120, HPA049635"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA020120: AB_1845755, HPA049635: AB_2680837"	"unprognostic (6.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.23e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.05e-3)"	1.5	1.6	2.4	0.6	2.9	0.7	2.0	2.6	4.5	1.6	1.7	1.6	0.5	1.7	3.2	1.6	2.0	1.9	2.1	2.8	3.2	2.7	1.6	1.5	1.6	3.4	3.0	2.2	1.7	3.1	1.4	2.0	3.5	2.6	1.0	1.9	1.6	2.8	1.7	1.4	1.2	1.9	1.9	1.8	1.9	3.7	2.7	1.6	2.7	1.9	1.2	1.2	0.9	4.5	2.7	8.5	2.2	3.7	2.9	2.0	2.5	5.9	2.0	3.4	3.0	4.9	3.9	7.4	3.7	5.2	4.3	4.1	1.7	5.0	4.2	3.3	7.3	4.0	8.2	3.2	6.2	3.2	2.2	2.9	3.4	3.3	3.3	1.4	2.6	4.8	5.0	1.5	3.3	6.1	1.7	2.5	3.0	1.7	9.8	1.7	2.8	3.7	2.1	6.9	2.8	3.9	8.3	2.9	2.7	3.3	3.3	2.1	7.3	3.6	3.8	4.3	3.3	4.0	9.1	2.2	3.7	3.5	8.3	36.6	1.6	15.7	1.5	2.0	2.3	2.2	1.0	1.5	1.0	1.6	1.6	1.7	8.8	2.2	2.3	0.8	0.8	1.1	2.4	2.9	2.6	4.5	2.8	3.2	3.4	3.0	3.5	1.9	2.7	4.5	0.4	0.0	1.1	2.3	0.7	0.3	0.4	0.1	0.6	0.9	0.4	0.5	0.6	0.0	0.1	3.7	4.2	0.7	0.3	0.1	1.9	0.9	0.1	0.4	0.6	0.7	0.0	0.4	4.6	1.1	0.4	0.6	0.0	0.2	0.0	0.6	1.1	0.5	0.2	0.0	4.7	0.2	0.0	0.0	0.4	0.3	0.6	1.2	0.0	2.8	0.3	0.7	2.1	3.0	7.9	0.9	0.3	0.7	0.2	0.3	0.7	1.5	1.0	0.4	0.0	0.3	0.8	1.7	1.3	0.4	0.4	0.8	0.5	1.0	0.2	0.1
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590021-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: AB_2678218, HPA052175: AB_2681750"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	18.1	18.9	16.9	12.2	18.2	21.3	18.9	15.9	18.5	23.0	15.0	21.6	12.6	23.3	6.5	16.5	22.2	9.3	17.6	16.3	16.2	19.6	21.5	17.2	17.3	18.8	17.2	19.9	21.7	10.1	17.0	7.2	16.9	22.9	7.1	3.8	16.6	9.8	21.9	21.4	18.6	11.1	16.0	27.2	20.0	17.3	17.3	18.5	19.0	10.2	10.9	20.9	17.1	20.4	21.5	17.6	12.0	28.5	19.3	10.7	15.8	12.6	10.9	17.8	10.9	16.5	8.7	25.2	16.0	9.4	33.7	23.3	16.2	11.5	8.1	9.9	23.3	9.4	11.5	17.6	22.5	22.7	29.0	12.4	17.0	10.7	11.2	9.4	19.6	26.7	25.1	18.6	10.7	36.1	19.9	46.9	24.0	10.6	23.2	40.1	9.5	21.5	11.6	18.5	15.7	29.2	12.2	39.9	17.3	12.5	18.3	33.8	14.2	14.7	48.2	16.3	27.9	22.5	23.8	23.8	9.9	24.9	44.3	0.5	1.5	2.2	2.0	1.5	2.6	1.7	2.4	2.6	1.1	1.6	2.4	2.0	1.4	1.6	1.6	2.9	2.7	0.9	16.9	18.2	15.9	18.5	16.3	16.2	18.8	17.2	16.9	16.0	17.3	20.4	12.9	9.6	8.6	11.1	13.7	15.2	8.8	4.6	13.1	7.1	14.2	14.5	6.0	12.8	6.1	1.8	6.2	11.6	23.6	11.8	0.0	8.9	8.2	9.9	12.6	12.8	12.6	4.2	9.5	10.2	10.6	11.2	10.7	8.9	1.3	16.0	12.5	7.4	13.4	5.0	8.3	12.5	8.2	11.3	10.2	3.5	8.1	12.9	7.2	7.5	8.4	6.7	18.6	9.5	13.2	10.2	9.8	8.6	10.9	10.9	8.5	8.0	5.3	6.5	6.6	12.0	14.5	11.9	13.5	11.7	12.8	9.7	17.5	14.0	11.6	7.6
C7orf31		ENSG00000153790	"Chromosome 7 open reading frame 31"	Q8N865	7	25134692-25180356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 65.6"	"Group enriched"	"Detected in many"	17	"Early spermatids: 423.9;Late spermatids: 881.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 19.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA020346			Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA020346: AB_1845758"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.12e-3)"	"unprognostic (8.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.15e-2)"	3.1	7.8	1.4	3.2	2.1	1.9	2.9	3.2	2.0	3.4	1.7	6.8	4.4	3.8	1.7	2.5	3.5	2.5	2.2	1.4	2.3	2.8	1.3	2.6	3.3	2.3	1.5	5.4	2.1	3.9	2.2	1.3	2.1	2.8	4.6	2.7	3.5	2.5	0.9	2.3	3.9	3.0	1.7	4.0	4.5	65.6	1.9	4.3	4.1	1.1	3.9	3.8	2.8	2.4	3.2	2.1	5.2	5.4	2.0	0.9	2.5	1.3	4.7	3.7	5.5	4.4	3.0	8.1	2.0	2.6	16.5	1.2	5.3	1.5	4.0	3.8	5.1	4.1	0.3	5.8	4.4	7.0	8.5	3.2	4.6	3.0	0.8	2.8	0.7	6.9	5.7	4.7	1.3	0.0	5.5	7.5	2.1	6.4	2.3	8.7	5.5	1.3	2.7	3.8	1.3	4.1	1.2	5.2	5.1	6.7	0.9	9.2	0.9	2.6	6.6	0.1	2.2	19.3	7.0	11.6	0.7	5.7	10.4	0.4	0.4	0.8	0.6	0.2	0.7	1.0	0.3	0.4	0.6	0.6	0.9	0.7	0.0	1.0	0.3	1.9	1.0	0.3	1.4	2.1	3.2	2.0	1.4	2.3	2.3	1.5	2.1	1.7	1.9	2.4	2.6	0.0	5.0	2.6	8.4	1.1	2.4	0.8	2.8	1.1	1.6	1.8	1.6	4.3	0.3	0.0	0.0	3.4	7.0	6.5	3.9	1.9	423.9	0.9	1.9	2.5	4.2	3.0	0.8	3.9	2.9	2.5	4.6	1.2	0.0	3.4	2.2	0.8	2.5	0.0	1.2	3.5	0.0	6.1	3.1	881.6	7.2	3.8	3.6	7.5	6.1	7.7	13.4	0.5	4.3	3.9	6.1	5.3	8.9	1.3	2.2	0.8	3.2	0.8	0.0	3.0	2.8	37.3	15.2	2.5	0.6	2.3	6.6	2.4	7.0	1.3
C7orf50	"MGC11257, YCR016W"	ENSG00000146540	"Chromosome 7 open reading frame 50"	Q9BRJ6	7	996986-1138260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 295.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052281	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA052281: AB_2681784"	"unprognostic (1.64e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	42.3	40.6	74.8	17.5	70.8	13.4	43.2	63.1	103.3	53.3	58.8	74.1	15.4	55.8	12.6	46.7	56.2	12.9	96.1	71.5	64.8	79.1	59.2	45.5	16.8	73.4	66.2	69.8	108.5	19.7	140.0	16.7	65.0	66.0	8.8	8.8	41.2	32.3	70.0	32.9	35.1	15.1	67.5	39.5	60.4	38.6	75.2	11.1	74.7	22.5	10.9	64.1	41.4	65.3	167.9	104.8	34.5	105.2	18.2	25.8	72.2	73.3	35.6	63.8	54.0	74.3	69.9	49.9	47.1	47.4	80.9	104.1	41.6	88.6	12.6	47.7	84.0	45.8	75.1	102.6	73.7	58.7	30.2	37.0	69.3	59.6	54.4	28.0	44.1	41.5	82.7	46.5	29.0	241.6	27.3	156.3	84.2	74.8	153.7	79.4	12.8	83.0	30.2	45.6	78.7	112.8	60.2	70.6	103.9	22.7	169.7	106.6	51.6	36.9	162.9	110.9	97.5	39.3	57.2	45.8	74.1	96.0	119.0	18.1	129.4	400.1	97.1	136.4	69.4	123.7	79.1	82.6	208.0	165.6	59.9	69.8	15.1	44.8	134.1	60.5	104.9	116.7	74.8	70.8	63.1	103.3	71.5	64.8	73.4	66.2	65.0	67.5	75.2	65.3	42.9	35.3	57.2	16.0	115.8	23.2	43.4	81.6	12.5	74.0	89.2	80.9	72.2	44.3	55.9	66.2	18.8	73.5	42.2	40.5	295.4	89.2	8.5	55.9	30.9	44.3	90.8	21.2	34.1	85.5	78.6	51.6	27.0	37.5	55.8	88.1	37.5	37.7	163.1	57.2	30.8	64.6	73.2	67.5	71.0	7.5	37.0	68.8	71.2	15.9	108.9	140.2	66.9	20.6	17.5	64.2	27.0	44.4	52.4	52.4	9.9	152.0	54.4	73.3	26.3	30.8	73.0	20.4	42.8	34.2	24.4	46.5	60.4	48.0	62.2	39.0
C8orf33	FLJ20989	ENSG00000182307	"Chromosome 8 open reading frame 33"	Q9H7E9	8	145052465-145066685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 180.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024812, HPA026104"	Approved		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA024812: AB_10599490, HPA026104: AB_10600875"	"prognostic unfavorable (2.77e-4)"	"unprognostic (6.51e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (4.75e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.37e-1)"	16.5	42.1	32.3	13.1	32.1	18.2	24.8	33.5	41.7	17.7	28.3	21.7	13.1	20.4	27.1	19.5	22.8	16.5	22.3	32.0	33.1	18.7	17.1	15.0	18.2	33.3	34.3	40.7	20.8	34.0	5.6	21.1	32.8	18.8	33.4	24.6	16.4	24.2	16.9	17.4	10.2	19.6	32.4	12.2	11.5	13.1	32.7	19.3	33.2	26.0	18.4	18.8	8.9	33.3	28.3	32.7	45.8	22.7	51.3	35.5	17.2	16.6	41.7	42.0	23.3	9.2	39.2	30.3	55.3	40.5	19.5	22.4	67.5	41.2	45.3	15.0	48.4	38.1	32.1	11.5	53.1	30.6	15.1	41.0	60.4	43.0	96.8	34.5	28.1	44.9	75.4	26.3	46.1	42.4	86.3	12.3	31.8	89.1	55.2	51.2	14.9	46.6	44.1	16.3	44.1	39.1	44.3	39.3	39.0	26.1	41.1	29.1	13.8	27.5	37.3	24.2	37.8	21.7	16.9	72.2	65.9	47.0	55.1	1.0	13.7	8.7	16.3	17.4	18.4	13.4	16.2	17.8	19.6	13.3	21.3	15.6	1.4	28.2	16.0	18.4	12.6	16.3	32.3	32.1	33.5	41.7	32.0	33.1	33.3	34.3	32.8	32.4	32.7	33.3	67.8	28.9	27.2	4.9	34.8	44.4	32.8	31.9	24.5	48.3	52.8	47.9	18.4	45.8	33.8	25.8	31.3	36.9	45.3	180.5	62.6	79.5	5.6	49.9	55.1	50.2	35.3	17.5	5.7	64.9	40.2	41.7	20.9	53.0	21.5	58.5	37.1	66.8	28.7	50.5	6.0	36.4	14.2	21.5	21.2	5.6	37.9	23.0	16.0	7.5	32.3	61.2	45.3	4.0	6.0	55.3	37.7	38.7	20.4	48.1	22.1	66.1	26.6	54.5	26.3	32.8	37.9	26.2	34.8	25.4	42.9	24.9	23.6	94.9	53.0	28.5
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330955-68819023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;fallopian tube: 9.1;parathyroid gland: 7.4"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 396.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.3;HEK 293: 2.3;LHCN-M2: 2.7;RH-30: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA044420: AB_10963791, HPA053065: AB_2682030"	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	2.7	0.3	4.0	0.2	5.4	0.5	0.7	3.6	3.9	2.1	2.0	0.2	0.2	0.6	0.6	1.0	9.1	0.6	0.7	6.2	3.8	0.4	0.2	2.5	0.2	6.4	10.2	0.4	1.1	7.4	1.7	0.3	4.6	2.1	0.3	1.0	0.6	1.0	0.3	0.9	0.2	0.1	4.0	0.2	0.8	0.7	6.7	0.8	0.4	0.9	0.2	0.4	0.2	6.1	0.1	0.0	0.3	0.1	0.6	1.0	0.1	0.9	2.3	0.3	0.3	0.1	0.2	0.1	0.3	0.5	0.1	0.1	0.1	0.3	0.1	0.0	2.3	0.3	0.5	0.2	0.1	0.0	0.2	0.1	0.3	0.4	0.8	0.1	0.0	0.3	0.1	0.4	2.7	0.3	0.0	0.2	1.0	0.0	0.0	0.1	2.7	0.0	0.2	0.2	0.5	0.0	0.1	0.1	0.0	0.2	1.4	0.1	0.0	0.4	0.2	1.6	0.0	0.4	0.0	0.0	0.1	0.1	0.4	0.5	0.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.3	0.2	0.3	0.5	0.2	0.1	0.4	0.1	0.1	4.0	5.4	3.6	3.9	6.2	3.8	6.4	10.2	4.6	4.0	6.7	6.1	0.2	16.0	18.7	9.4	0.0	1.7	0.8	0.2	0.0	1.5	0.2	0.0	1.2	0.0	3.9	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.5	26.4	0.7	0.5	0.0	0.0	79.2	0.0	0.3	1.9	0.0	4.3	1.3	0.1	0.0	0.0	0.3	0.0	396.6	0.1	0.0	0.0	1.2	1.3	0.3	0.4	1.8	3.7	0.1	0.0	0.0	9.5	10.1	0.5	0.0	0.4	0.0	0.8	0.0	0.0	20.8	0.7	0.0	0.6	1.7	0.6	0.4	0.1	0.9	0.4	0.4	0.2	0.0	0.4
C8orf44-SGK3		ENSG00000288602	"C8orf44-SGK3 readthrough"		8	66667596-66860472	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Astrocytes: 17.3;Excitatory neurons: 23.5;Inhibitory neurons: 17.5;Microglial cells: 11.2;Oligodendrocyte precursor cells: 15.6;Oligodendrocytes: 18.0"					"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006699, HPA027146"	Approved		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"		"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"																		4.1	3.1	5.2	3.1	5.5	6.1	6.3	5.3	7.2	4.5	3.5	3.5	2.8	5.6	11.5	2.1	7.3	3.7	4.4	5.1	6.3	4.2	3.1	3.4	5.7	4.6	4.8	7.9	2.2	2.9		3.8	4.7	5.1	5.8	9.1	4.2	6.1	4.1	6.9	2.6	4.9	3.9	5.1	4.3	6.6	4.8	5.7	7.6	3.7	5.4	2.6		7.5	6.9	2.4	3.5	2.6	5.8	7.0	1.7	2.3	4.3	5.2	5.8	2.8	8.7	9.8	1.3	5.3	4.1	4.4	5.5	3.1	8.2	8.5	8.3	9.3	7.2	5.5	4.6	5.3	6.0	9.2	9.1	3.3	7.3	9.0	5.3	10.7	9.7	5.6	4.8	2.1	4.6	3.7	3.5	6.6	3.8	3.7	2.4	2.4	5.0	2.0	3.4	3.8	2.9	1.3	3.9	5.3	7.0	3.5	5.1	2.6	2.5	2.2	2.2	5.7	3.8	4.8	4.7	6.0	1.4	31.0	9.8	6.2	4.0	4.1	4.9	7.6	4.5	5.1	7.2	6.1	7.0	5.0	6.9	5.2	2.7	6.9	7.0	4.2	5.2	5.5	5.3	7.2	5.1	6.3	4.6	4.8	4.7	3.9	4.8	7.5	0.0	0.0	0.0	17.3	0.9	0.0	0.0	0.1	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	23.5	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	11.2	0.1	0.5	0.0	15.6	18.0	0.0	1.1	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	1.4	0.1	0.0	0.6	0.0	0.0	0.0
C8orf48	FLJ25402	ENSG00000164743	"Chromosome 8 open reading frame 48"	Q96LL4	8	13566869-13568288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 33.3;Late spermatids: 51.9;Spermatocytes: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.5;U-87 MG: 11.5;WM-115: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026107, HPA027440"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA026107: AB_10600765, HPA027440: AB_10601678"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.07e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.84e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-3)"	"unprognostic (7.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.70e-2)"	1.1	0.2	1.1	0.6	2.2	0.0	1.8	1.3	1.6	1.3	0.2	0.5	0.4	1.1	2.9	0.6	1.8	1.2	1.3	1.2	1.2	1.2	0.8	1.2	0.4	2.2	1.5	0.6	0.4	0.3	0.5	0.6	2.6	0.2	0.4	4.8	0.4	0.4	0.1	1.3	0.4	0.9	1.2	0.2	0.9	7.0	1.7	0.2	4.4	0.4	0.2	0.8	0.3	2.9	0.0	0.1	1.8	0.0	6.0	6.0	0.0	5.5	6.1	2.9	4.9	0.0	0.0	0.0	0.0	2.9	13.5	0.6	0.2	1.1	5.7	0.0	0.6	0.6	0.0	0.0	2.1	0.0	0.9	1.9	3.6	3.9	1.0	0.7	3.8	0.0	0.1	0.0	7.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	3.2	0.0	0.2	6.3	2.0	0.0	0.0	1.7	5.1	4.9	6.0	5.0	0.0	0.0	0.0	11.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.2	1.3	1.6	1.2	1.2	2.2	1.5	2.6	1.2	1.7	2.9	1.0	0.0	0.0	2.0	0.0	1.0	0.0	1.0	0.0	0.2	0.9	0.8	0.3	0.0	0.9	0.0	2.1	0.0	0.0	0.1	0.0	2.7	33.3	1.8	3.0	0.7	0.0	0.0	0.6	1.1	0.0	2.7	0.0	0.2	0.0	0.3	1.1	0.5	0.1	0.0	0.3	0.0	2.0	0.0	0.0	51.9	5.0	0.2	5.4	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.0	3.0	0.0	0.0	0.0	3.6	1.9	4.3	6.6	1.2	4.5	18.2	2.3	0.8	0.4	0.0	0.1	3.4	0.0	0.1
C8orf74		ENSG00000171060	"Chromosome 8 open reading frame 74"	Q6P047	8	10672628-10700590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	171	"testis: 17.0"	"Group enriched"	"Detected in some"	90	"Early spermatids: 186.5;Late spermatids: 392.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027986	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA027986: AB_10600762"		"unprognostic (4.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.68e-2)"		"unprognostic (5.54e-2)"		"unprognostic (2.37e-2)"			"unprognostic (1.56e-4)"			"unprognostic (6.82e-2)"			"unprognostic (2.20e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	186.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	392.8	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C8orf76	FLJ14825	ENSG00000189376	"Chromosome 8 open reading frame 76"	Q96K31	8	123219967-123241377	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 136.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 164.9"									HPA023708	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"prognostic unfavorable (9.95e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.71e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.95e-11)"	"unprognostic (1.54e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.71e-2)"	10.5	14.1	12.0	9.5	12.8	12.6	10.8	13.3	15.0	9.3	13.3	10.8	9.4	7.7	11.4	15.4	8.9	8.7	13.0	12.0	12.6	9.2	18.4	9.4	14.1	12.3	12.5	8.3	10.8	7.7	17.3	12.2	12.4	10.5	11.8	11.0	12.5	8.1	15.2	8.4	11.1	7.8	12.7	14.3	10.0	7.3	12.6	13.9	9.8	7.9	13.9	10.5	10.3	13.4	24.7	22.4	20.3	14.3	19.5	17.8	13.9	22.7	22.0	26.0	26.1	20.5	17.5	16.8	24.4	21.9	19.4	18.4	22.9	12.4	29.3	27.0	31.9	19.7	10.1	28.0	35.0	10.5	15.6	13.1	23.3	23.3	19.4	15.2	23.4	25.9	28.6	12.8	21.9	72.3	30.7	23.1	16.6	59.4	37.6	16.1	10.4	19.3	22.4	20.1	26.7	24.8	22.7	164.9	25.0	20.6	20.2	24.7	12.9	14.8	28.3	16.1	19.0	16.8	19.8	18.2	15.9	23.7	16.3	19.9	18.3	28.3	13.6	21.4	14.4	11.7	14.8	17.6	19.2	14.8	14.0	14.1	10.9	15.0	18.1	16.8	21.3	13.2	12.0	12.8	13.3	15.0	12.0	12.6	12.3	12.5	12.4	12.7	12.6	13.4	12.4	12.8	2.0	7.2	17.7	13.5	17.8	29.0	17.1	8.2	13.8	13.8	5.9	7.2	25.4	1.8	10.4	27.4	23.4	21.3	5.9	16.4	5.1	10.7	15.4	11.7	24.7	8.6	6.8	11.8	31.5	15.1	8.2	11.5	22.2	10.8	8.9	11.1	22.6	136.3	8.2	12.5	32.6	14.5	17.7	4.0	12.8	16.3	14.2	3.7	21.7	12.9	20.6	3.5	8.8	14.8	13.8	7.5	19.1	21.6	19.4	11.2	48.3	7.7	19.7	11.5	28.7	14.4	17.1	12.6	11.5	40.2	18.1	8.8	15.7	39.9
C8orf82	MGC70857	ENSG00000213563	"Chromosome 8 open reading frame 82"	Q6P1X6	8	144525733-144529132	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 138.9;Proximal tubular cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"PC-3: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034331	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB034331: AB_1565393"	"unprognostic (3.56e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.60e-2)"	"unprognostic (6.31e-3)"	"unprognostic (1.95e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.09e-2)"	"prognostic favorable (1.70e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.87e-3)"	10.6	14.6	9.0	4.5	8.6	2.8	11.4	11.1	10.5	14.7	4.2	14.1	11.1	11.8	2.6	16.7	11.9	3.8	17.0	8.2	7.5	16.2	35.6	8.6	3.8	9.4	8.1	15.1	13.2	6.6	12.2	3.3	8.6	26.3	3.8	4.6	11.6	5.5	12.0	9.1	11.7	2.8	7.2	9.9	12.3	7.4	8.4	4.5	12.6	3.5	2.4	15.0	11.8	11.5	6.8	16.8	9.8	7.9	4.0	3.4	8.2	7.2	3.9	3.9	3.9	8.3	11.2	11.9	11.4	4.5	3.3	8.1	2.2	2.5	1.4	9.0	25.7	23.0	10.4	15.6	4.2	3.5	10.8	5.1	5.5	2.5	2.5	6.4	2.7	6.6	19.1	5.9	2.9	35.7	8.9	14.2	5.3	10.1	46.6	9.9	3.3	5.8	6.1	10.1	33.3	27.3	11.0	7.8	7.1	3.3	14.3	7.1	14.6	7.5	28.7	8.4	5.3	4.2	2.8	9.8	9.9	4.3	7.3	0.1	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.0	9.0	8.6	11.1	10.5	8.2	7.5	9.4	8.1	8.6	7.2	8.4	11.5	12.2	3.2	6.9	0.3	12.9	15.9	49.6	1.9	23.3	30.4	39.6	38.6	17.9	18.6	1.9	16.5	14.6	33.4	13.0	46.3	138.9	5.8	16.8	10.3	22.1	12.3	34.2	14.9	0.1	7.7	35.1	18.5	19.4	26.0	5.7	16.3	9.7	69.8	18.6	28.6	0.1	31.9	2.0	16.1	16.1	21.4	24.2	15.2	33.8	0.0	7.5	28.0	13.4	0.0	0.1	6.7	22.1	20.3	16.3	55.6	35.4	99.1	0.4	35.8	32.9	21.1	23.0	24.4	18.8	36.9	20.9	25.2	13.1	34.5	34.6	43.3
C9orf116	"MGC29761, PIERCE1, RbEST47"	ENSG00000160345	"Chromosome 9 open reading frame 116"	Q5BN46	9	135495181-135501734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 97.2;testis: 62.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 520.9;Endometrial ciliated cells: 442.5;Late spermatids: 579.4;Respiratory ciliated cells: 610.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 41.3;T-47d: 41.9;U-2197: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021439, HPA065287"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA021439: AB_1845799, HPA065287: AB_2732732"	"unprognostic (9.02e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (3.53e-5)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	2.6	16.3	11.9	0.8	12.8	0.9	3.1	10.7	13.0	5.5	24.5	2.1	1.0	4.2	25.7	1.9	97.2	2.8	2.0	14.0	13.6	9.5	3.5	9.2	0.7	15.8	19.7	2.8	6.5	6.8	16.9	1.5	15.9	4.2	1.2	10.1	3.4	6.3	1.5	1.8	1.4	1.2	15.4	1.9	3.1	62.5	14.5	0.6	8.1	0.9	1.2	2.7	1.5	13.0	11.0	18.7	8.1	12.7	3.5	7.4	1.6	7.3	5.1	8.7	5.9	7.1	10.9	1.9	9.5	4.9	4.7	7.4	9.1	4.1	7.4	0.5	8.0	0.0	21.0	22.1	9.7	1.5	5.0	5.2	3.2	4.4	1.4	7.1	4.2	8.6	10.3	1.4	4.2	41.3	5.7	1.9	17.1	17.2	21.5	8.7	3.9	6.9	21.0	7.7	7.9	8.3	10.3	4.4	1.2	3.7	41.9	1.8	2.1	5.0	6.5	42.9	2.9	4.7	12.6	1.8	14.7	0.7	1.5	0.0	0.8	0.0	0.5	0.5	1.2	0.2	0.4	0.4	0.3	0.4	0.7	0.5	0.0	0.6	0.1	0.1	0.5	0.3	11.9	12.8	10.7	13.0	14.0	13.6	15.8	19.7	15.9	15.4	14.5	13.0	1.2	9.6	7.8	2.3	1.9	0.9	1.8	39.7	2.2	5.0	11.7	9.8	1.7	15.7	46.3	14.7	14.6	11.5	0.7	0.5	11.7	26.0	520.9	442.5	6.6	2.1	1.2	1.3	2.1	7.8	3.4	5.2	4.6	23.9	1.3	12.0	0.7	1.6	3.6	3.3	2.2	1.0	38.7	1.2	1.4	579.4	8.1	1.3	0.0	0.0	2.0	13.2	0.0	1.0	0.2	6.9	1.7	7.5	3.6	2.4	1.3	58.8	610.3	19.9	0.0	1.4	15.0	133.8	20.0	1.3	0.3	4.5	1.6	41.4	1.7	3.1
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.6;salivary gland: 25.4;stomach 1: 32.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.4;Intestinal goblet cells: 139.7;Ionocytes: 40.7;Paneth cells: 40.0;Undifferentiated cells: 79.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 149.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA050769	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.1	0.0	0.5	2.1	0.4	0.0	12.4	0.2	0.4	10.4	0.1	32.8	19.0	2.3	0.0	3.0	3.7	5.5	0.0	0.4	0.1	0.2	0.8	5.8	0.0	0.6	0.4	0.0	5.1	0.0	0.1	0.0	0.6	17.0	41.6	0.0	25.4	1.4	0.0	5.4	15.1	1.2	0.2	0.1	32.9	0.0	0.5	0.1	0.1	0.0	0.2	1.2	0.4	0.6	0.0	1.3	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	149.2	0.2	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.0	9.3	0.0	0.0	18.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.4	0.1	0.6	0.4	0.6	0.2	0.5	0.6	0.4	9.6	16.3	0.3	0.2	0.3	3.4	5.9	6.2	0.0	20.5	10.8	0.1	20.0	14.5	0.0	0.0	0.0	0.1	35.4	0.0	6.0	0.0	4.0	2.0	0.5	25.9	0.0	0.1	11.1	0.0	0.2	25.0	13.9	0.0	0.0	0.0	3.3	0.1	0.0	0.1	139.7	40.7	0.0	1.0	0.0	0.0	0.6	10.6	0.0	0.0	0.0	0.0	0.0	0.1	3.9	40.0	0.0	0.0	12.4	4.4	0.0	5.2	0.0	0.0	0.4	0.9	0.0	0.0	10.9	0.4	0.0	0.4	0.0	79.8	5.5
C9orf153	bA507D14.1	ENSG00000187753	"Chromosome 9 open reading frame 153"	Q5TBE3	9	86220265-86259657	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 20.8"	"Group enriched"	"Detected in some"	26	"Early spermatids: 268.6;Late spermatids: 244.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.3"	"Not detected"	"Not detected"							HPA079466			Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies, Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA079466: "	"unprognostic (2.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.30e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.01e-6)"	"unprognostic (9.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.10e-1)"	0.1	0.4	0.3	0.4	0.2	2.6	0.2	1.4	0.9	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.2	0.5	0.5	0.6	0.2	0.1	0.1	0.0	0.9	0.6	0.1	0.1	0.6	0.2	0.2	0.0	0.3	0.2	0.1	0.0	0.2	0.3	20.8	0.5	0.1	0.2	0.1	0.0	0.0	0.0	1.3	0.2	0.8	0.0	0.4	0.0	0.4	0.3	0.2	0.0	0.0	0.2	0.0	0.6	0.8	0.2	0.2	0.5	0.2	0.0	0.0	0.1	0.1	0.3	0.0	1.3	0.2	0.1	0.2	0.2	0.1	0.6	0.1	0.0	0.0	0.3	0.9	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.7	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.6	0.1	0.2	0.4	0.1	0.3	0.0	0.1	0.4	0.8	1.6	0.2	0.3	0.6	0.1	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.5	0.3	0.2	0.2	0.1	1.5	0.3	0.2	1.4	0.9	0.2	0.2	0.5	0.6	0.6	0.0	0.5	1.3	0.3	0.0	0.0	9.8	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	268.6	0.4	0.5	0.7	0.0	0.0	4.8	0.0	0.1	0.4	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.4	244.8	2.8	0.1	1.8	1.0	0.1	0.4	2.1	6.6	9.7	0.1	0.0	0.7	0.4	0.3	0.0	0.1	0.0	0.1	0.0	1.3	0.7	1.8	1.9	0.0	0.1	0.1	0.2	0.3	0.1	0.2
C9orf24	"bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1"	ENSG00000164972	"Chromosome 9 open reading frame 24"	Q8NCR6	9	34379019-34397810	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 39.2;choroid plexus: 105.6;fallopian tube: 108.7;testis: 90.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 744.6;Endometrial ciliated cells: 841.0;Late spermatids: 3115.3;Respiratory ciliated cells: 1312.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053008	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA053008: AB_2682015"	"unprognostic (3.62e-3)"	"unprognostic (9.06e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.90e-2)"	1.2	0.6	20.6	0.3	26.6	0.0	0.7	19.5	29.8	7.8	105.6	3.2	1.9	0.7	0.0	0.4	108.7	0.3	17.5	20.8	22.8	3.4	0.3	18.4	0.2	35.9	39.2	0.4	0.9	0.1	10.6	0.2	29.8	1.6	0.7	1.2	1.9	0.4	1.4	0.6	5.4	0.5	33.0	0.2	1.4	90.6	22.3	0.3	0.6	1.7	0.3	0.9	0.4	25.5	0.2	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.3	0.4	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.3	0.0	0.4	1.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.2	0.6	0.4	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.8	0.3	0.0	0.2	0.0	0.0	0.4	0.1	20.6	26.6	19.5	29.8	20.8	22.8	35.9	39.2	29.8	33.0	22.3	25.5	0.4	6.4	15.1	11.4	0.3	2.2	3.3	67.3	2.2	1.4	1.6	1.8	37.0	1.5	116.4	7.3	0.0	0.6	0.1	11.3	72.4	1.1	744.6	841.0	6.1	2.1	12.1	0.0	11.3	1.5	0.3	3.5	0.5	9.8	8.8	0.2	1.4	4.1	0.4	0.0	12.6	13.4	81.4	1.0	1.0	3115.3	10.5	2.7	0.0	1.0	0.0	2.2	1.0	4.0	5.4	0.2	7.3	7.2	0.5	4.5	142.5	13.7	1312.6	0.9	32.9	0.5	25.5	21.0	6.9	0.4	1.0	0.5	1.6	0.0	20.5	2.4
C9orf40	FLJ10110	ENSG00000135045	"Chromosome 9 open reading frame 40"	Q8IXQ3	9	74946583-74952912	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.9;Cardiomyocytes: 45.0;Erythroid cells: 39.2;Spermatocytes: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042167	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		230000	"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Cytosol"	Centrosome	"HPA042167: AB_10797382"	"unprognostic (2.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.15e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	4.9	2.1	6.9	4.3	6.8	6.2	4.4	6.8	9.6	4.2	4.5	5.8	8.4	3.7	1.5	3.9	3.1	1.6	2.9	7.1	7.2	2.6	3.1	2.1	4.7	7.4	6.9	2.6	2.3	2.9	3.1	3.7	7.2	2.7	5.1	7.9	2.2	2.4	3.1	2.2	11.3	2.7	7.3	3.9	2.6	11.8	6.8	4.3	2.1	2.5	4.7	4.2	4.2	8.4	29.6	6.3	16.3	6.6	6.5	8.2	30.2	23.0	7.1	15.7	16.8	1.8	9.0	26.5	6.7	5.8	26.2	8.6	12.9	1.3	24.9	36.0	19.9	14.1	11.2	11.3	5.2	17.2	21.5	4.1	8.5	8.7	6.2	6.3	4.9	19.1	20.3	17.5	20.7	8.3	30.3	19.9	19.2	15.4	19.2	28.0	12.8	6.5	6.7	7.1	17.7	7.8	10.1	8.5	7.3	14.3	10.3	13.1	6.4	14.1	15.9	19.5	20.4	33.2	26.7	17.0	10.7	19.0	15.5	0.6	0.1	2.1	0.3	0.1	0.1	0.8	0.3	0.3	0.1	0.5	0.7	0.4	0.1	0.0	0.2	0.3	0.4	0.1	6.9	6.8	6.8	9.6	7.1	7.2	7.4	6.9	7.2	7.3	6.8	8.4	29.9	3.2	0.5	2.3	5.8	2.4	4.4	1.1	3.4	9.7	6.0	6.2	45.0	0.0	0.6	3.7	8.4	20.9	3.2	13.4	1.9	3.3	12.0	2.9	6.2	12.1	1.2	39.2	5.8	3.1	24.9	5.9	2.6	6.4	0.0	3.1	8.2	3.8	11.3	1.7	4.6	7.9	0.0	4.2	3.7	2.9	4.4	3.5	1.8	6.5	2.6	4.8	2.1	1.5	4.0	2.5	7.3	5.3	4.2	5.4	20.3	2.2	1.0	16.4	0.0	3.8	5.8	42.2	10.6	7.1	5.3	12.3	4.8	9.2	17.0	3.9
C9orf78	"CSU2, HCA59, HSPC220"	ENSG00000136819	"Chromosome 9 open reading frame 78"	Q9NZ63	9	129827290-129835863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 414.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021216, HPA021232, HPA021242"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838"	"unprognostic (1.00e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (3.49e-7)"	"unprognostic (5.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	38.4	36.9	53.7	33.4	55.5	113.6	35.7	53.8	62.3	35.3	49.7	41.7	27.2	36.1	35.4	36.9	32.4	31.3	37.5	54.0	55.4	47.8	61.0	29.7	49.6	55.5	55.3	36.3	38.2	29.2	29.4	27.9	54.8	35.5	33.5	20.7	35.5	30.8	67.6	40.9	37.1	29.1	54.4	37.3	36.5	33.2	56.5	60.5	37.9	36.5	44.4	40.9	34.3	56.3	36.0	36.3	36.9	59.8	66.4	44.4	44.4	51.7	41.0	44.7	32.5	37.0	38.3	57.9	41.6	60.5	72.6	71.8	52.8	41.9	36.9	57.2	37.8	92.1	63.6	40.8	42.7	131.5	91.1	39.2	78.2	56.5	47.9	44.2	42.9	242.6	235.4	68.3	57.3	87.4	175.0	160.3	53.2	143.9	81.4	47.8	57.1	117.8	46.3	24.9	31.6	60.0	76.2	73.0	63.3	35.8	63.9	88.6	47.2	68.5	50.1	68.2	63.6	30.2	94.6	89.9	57.1	105.1	57.3	164.4	82.1	219.5	150.2	131.0	150.4	105.3	156.0	164.3	69.7	106.5	174.8	159.8	63.8	147.9	172.7	82.7	184.6	138.6	53.7	55.5	53.8	62.3	54.0	55.4	55.5	55.3	54.8	54.4	56.5	56.3	55.7	89.8	84.6	7.8	93.9	78.1	64.8	60.2	55.2	39.8	57.3	58.5	55.5	57.2	81.6	57.0	37.5	71.9	160.1	60.7	125.2	65.1	58.8	46.7	57.7	58.4	84.4	414.9	12.5	89.6	78.3	55.4	39.3	41.1	134.1	34.8	45.7	83.3	66.3	32.0	12.8	64.5	109.9	66.6	78.2	17.7	59.0	75.0	72.9	8.4	102.6	62.3	178.2	5.0	9.9	65.7	44.0	60.9	73.9	68.4	102.8	183.4	72.8	35.1	78.9	59.9	68.0	119.8	117.7	63.2	85.0	67.6	172.4	45.3	58.0	55.9
C9orf85	MGC61599	ENSG00000155621	"Chromosome 9 open reading frame 85"	Q96MD7	9	71911510-71986054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 112.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050767, HPA076627"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA050767: AB_2681229, HPA076627: "	"unprognostic (7.81e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.18e-2)"	7.5	6.6	7.5	6.4	9.0	6.0	8.9	8.2	7.8	9.2	5.0	7.8	11.9	7.3	5.7	9.9	6.5	6.8	6.2	7.0	7.2	7.1	7.9	5.0	8.7	8.5	7.6	9.5	7.8	4.9	5.9	8.4	8.2	7.2	7.5	6.3	8.9	5.0	8.7	11.2	8.2	6.3	6.5	6.7	6.8	5.4	8.2	8.5	8.5	8.4	8.0	9.8	8.4	12.9	11.6	7.5	12.6	10.4	12.7	23.4	12.8	13.8	22.0	11.1	11.0	1.5	6.4	18.5	6.9	12.1	11.7	20.1	13.4	13.6	15.4	12.9	6.5	11.3	10.3	9.5	13.9	16.7	8.5	19.2	18.2	11.4	25.2	17.5	13.8	17.1	13.8	11.8	14.5	5.7	20.4	11.8	11.6	17.8	17.6	11.6	22.4	0.5	16.3	16.7	10.1	13.9	7.0	17.8	25.0	13.8	6.0	9.6	12.1	10.2	13.3	23.7	10.6	12.0	21.7	8.5	14.0	12.6	6.5	15.1	6.6	10.6	9.9	7.5	10.5	8.7	8.4	8.5	7.3	8.6	10.2	10.8	7.6	13.0	6.8	10.5	8.4	7.4	7.5	9.0	8.2	7.8	7.0	7.2	8.5	7.6	8.2	6.5	8.2	12.9	19.2	6.4	17.0	35.6	15.7	7.6	13.6	12.8	25.6	10.9	13.9	22.9	14.0	8.6	12.6	5.5	8.4	20.3	18.4	25.2	21.5	14.2	10.8	9.4	19.7	15.0	6.6	8.2	27.4	19.9	19.0	14.1	19.9	10.8	18.4	13.7	18.5	9.7	14.8	5.0	19.2	23.4	10.2	16.1	8.9	7.5	20.8	15.2	3.6	24.4	17.7	12.5	33.0	44.2	112.1	17.8	30.6	13.2	9.5	12.7	29.3	22.8	8.4	13.0	13.1	19.3	17.3	20.6	14.6	23.2	9.8	10.8	16.2	21.9	16.8	27.0
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 14.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Proximal enterocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 15.6;OE19: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA		27000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	1.8	2.1	1.2	1.2	1.2	0.3	2.3	1.4	1.3	2.1	0.7	2.5	12.0	0.9	0.6	5.0	1.1	5.4	3.6	1.0	1.7	5.7	3.7	2.4	0.6	0.9	1.5	1.1	1.1	9.0	2.9	0.3	0.8	1.2	3.0	2.3	4.8	0.7	0.4	5.6	14.6	0.8	0.6	0.7	5.9	0.7	1.1	0.7	5.0	0.3	2.9	2.1	2.5	1.3	0.2	0.4	0.8	0.1	0.5	0.6	0.4	1.0	1.1	0.1	2.9	7.2	5.4	0.4	0.5	1.2	6.0	2.3	2.2	2.9	0.2	1.6	0.9	15.6	2.0	6.7	1.4	0.2	0.6	2.2	0.5	0.2	1.2	1.8	1.6	0.6	4.0	2.9	2.6	0.0	0.3	0.2	0.4	30.6	0.4	0.2	2.2	0.1	8.1	0.3	0.2	0.0	0.5	0.0	1.6	1.0	0.5	0.8	1.5	2.8	3.9	0.1	1.6	1.1	0.6	1.9	5.7	2.2	2.6	0.7	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	1.2	1.2	1.4	1.3	1.0	1.7	0.9	1.5	0.8	0.6	1.1	1.3	1.7	3.2	12.4	7.2	2.9	1.8	2.7	2.7	3.4	1.8	7.0	4.7	6.4	4.3	10.5	12.9	33.3	0.3	2.1	12.3	9.8	4.0	11.3	4.7	2.5	2.7	4.8	3.2	12.2	1.6	0.3	2.9	9.7	7.7	0.0	0.3	8.6	5.8	1.1	0.0	13.7	4.3	2.0	2.5	3.3	13.1	0.0	3.0	5.4	1.9	1.0	1.9	8.2	16.1	4.4	4.4	4.3	0.0	6.9	1.9	52.6	21.0	9.5	5.1	0.0	8.1	1.9	1.3	2.1	9.1	3.1	0.3	2.2	1.0	5.4	2.4
CABCOCO1	"bA63A2.1, C10orf107, Em:AC022398.2, MGC44593"	ENSG00000183346	"Ciliary associated calcium binding coiled-coil 1"	Q8IVU9	10	61662929-61766766	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.6;testis: 15.5"	"Group enriched"	"Detected in some"	10	"Endometrial ciliated cells: 60.4;Respiratory ciliated cells: 88.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"MOLT-4: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome	"Nucleoplasm, Cytosol"	"HPA041398: AB_10794374"	"unprognostic (1.89e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.79e-4)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.52e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.33e-2)"	1.0	0.5	4.2	0.2	4.2	0.0	1.2	3.5	3.9	4.2	5.9	1.2	0.3	3.5	0.5	0.3	26.6	0.8	0.2	4.4	4.6	1.8	0.3	4.1	0.0	6.8	8.9	0.2	0.5	2.9	4.2	0.8	7.2	4.1	0.6	0.9	1.0	2.5	0.1	0.3	0.5	0.7	8.3	1.0	0.5	15.5	4.0	0.1	0.7	0.0	0.1	0.4	0.6	7.8	0.0	0.2	0.1	0.0	0.0	2.5	0.0	0.4	1.7	0.3	0.6	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.9	0.5	0.1	0.0	0.1	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	5.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	3.5	3.9	4.4	4.6	6.8	8.9	7.2	8.3	4.0	7.8	1.9	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.0	0.0	7.4	3.7	0.0	0.3	0.0	0.0	0.0	0.8	0.0	60.4	4.1	0.4	0.0	0.0	0.0	0.2	0.2	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	88.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.2	1.2	0.0	0.0
CABIN1	"KIAA0330, PPP3IN"	ENSG00000099991	"Calcineurin binding protein 1"	Q9Y6J0	22	24011192-24178628	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043296	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA043296: AB_10794657"	"unprognostic (8.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (9.57e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.94e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-3)"	"unprognostic (7.79e-2)"	27.2	28.7	28.9	15.5	29.1	30.9	24.3	33.3	40.9	33.3	32.6	37.0	13.6	32.4	8.7	23.4	35.9	10.1	30.9	28.8	25.6	36.0	28.2	28.5	19.6	28.0	27.5	27.3	28.1	15.6	46.2	8.2	28.1	34.0	8.4	13.3	22.1	14.1	17.4	24.7	33.1	11.0	23.1	37.2	31.9	34.4	29.2	19.5	50.3	7.0	10.0	29.7	27.1	28.9	24.7	17.7	23.6	20.8	20.9	24.1	33.3	20.4	17.5	16.0	18.1	22.0	11.9	28.6	11.0	20.5	20.8	23.1	28.4	18.5	14.2	48.3	27.8	24.6	21.1	46.8	9.9	57.1	25.6	20.5	11.6	19.6	14.7	19.2	27.1	25.1	52.1	15.2	9.2	32.0	27.1	62.1	14.7	34.5	12.6	26.3	17.3	36.0	14.6	24.8	30.2	25.9	25.2	17.4	26.1	21.3	15.6	25.6	22.3	37.0	28.6	14.3	14.9	26.5	17.1	16.9	17.3	27.3	15.8	7.2	3.9	15.5	5.7	2.7	6.3	2.5	4.3	7.5	2.6	4.1	5.2	4.8	17.4	5.4	1.9	3.0	3.7	2.5	28.9	29.1	33.3	40.9	28.8	25.6	28.0	27.5	28.1	23.1	29.2	28.9	14.5	22.4	37.5	37.5	22.7	8.3	8.9	11.0	13.1	33.3	14.2	10.8	18.5	4.3	9.1	9.2	89.6	17.4	24.6	19.9	7.9	11.6	16.6	43.6	19.6	15.1	14.8	18.3	54.2	9.7	6.9	16.4	29.6	26.8	17.7	21.1	13.2	9.4	21.7	33.7	39.4	13.0	20.3	12.6	16.2	16.0	21.5	16.1	10.6	20.6	19.2	14.5	44.3	21.1	35.9	10.8	6.6	19.9	24.4	7.1	8.8	7.9	24.4	50.1	19.7	14.6	32.6	60.7	41.6	13.6	9.5	22.4	36.5	18.4	13.8	7.3
CABLES1	"FLJ35924, HsT2563"	ENSG00000134508	"Cdk5 and Abl enzyme substrate 1"	Q8TDN4	18	23134564-23260467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 70.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 258.2;Glandular and luminal cells: 54.3;Oligodendrocyte precursor cells: 163.3"	"Cancer enriched"	"Detected in all"	5	"melanoma: 38.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 154.3;U-266/70: 216.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073649			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"HPA073649: AB_2732233"	"unprognostic (1.27e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.71e-6)"	"unprognostic (1.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.81e-2)"	17.1	3.3	63.9	2.1	67.9	2.6	13.8	36.8	54.8	6.9	17.1	5.2	7.5	9.4	3.2	6.9	10.9	5.2	4.6	44.9	53.5	13.1	9.9	21.5	2.8	39.6	59.0	3.7	3.0	21.9	4.0	10.4	40.8	3.7	5.1	8.0	22.3	4.5	1.5	17.2	6.7	6.6	31.2	3.7	14.5	3.5	70.2	4.9	15.0	1.8	2.3	5.4	7.8	33.3	13.1	14.4	11.8	0.9	7.1	0.3	20.4	3.1	17.3	4.2	2.5	9.5	23.0	0.7	13.3	14.9	42.3	11.4	9.0	2.3	3.2	0.3	19.4	1.0	38.7	37.1	6.2	2.5	1.0	4.2	2.1	5.3	6.1	26.8	47.1	2.3	0.5	16.2	11.7	30.2	0.1	8.8	7.5	64.5	46.6	3.1	42.2	50.6	21.2	31.5	11.2	8.2	26.1	32.5	154.3	8.3	52.4	7.2	79.3	47.9	0.5	1.6	3.8	216.0	88.9	27.4	0.2	19.2	16.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	63.9	67.9	36.8	54.8	44.9	53.5	39.6	59.0	40.8	31.2	70.2	33.3	2.9	22.4	27.4	258.2	3.8	5.1	2.0	1.4	5.2	4.1	9.2	6.7	1.4	7.2	2.3	3.7	29.2	0.9	1.3	8.5	1.9	1.1	2.0	11.6	4.4	6.0	3.5	1.3	19.2	2.3	1.1	4.1	10.2	54.3	0.0	14.8	25.0	9.3	16.6	0.0	22.2	4.6	0.0	3.5	3.1	3.5	0.0	4.7	28.4	41.2	0.0	1.4	0.0	163.3	1.4	2.4	5.2	6.0	3.6	0.6	6.7	14.3	1.8	18.7	0.0	5.0	2.1	0.2	3.2	1.6	6.7	0.3	1.4	0.5	2.1	2.2
CABLES2	"C20orf150, dJ908M14.2, ik3-2"	ENSG00000149679	"Cdk5 and Abl enzyme substrate 2"	Q9BTV7	20	62388632-62407285	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 51.3;Late spermatids: 25.6;Spermatocytes: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052138			Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear bodies"	"Nucleoplasm, Cell Junctions"	"HPA052138: AB_2681743"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.26e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.37e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.94e-2)"	2.4	3.0	6.8	4.2	7.2	8.1	2.8	11.5	9.1	3.9	3.5	4.4	2.9	3.5	2.6	3.2	4.8	2.2	10.6	7.1	7.4	2.6	4.0	2.9	5.1	7.9	6.6	4.3	3.2	3.9	5.9	2.8	7.8	4.3	3.2	5.6	3.3	3.1	5.8	4.3	4.4	3.3	5.9	4.2	4.0	31.0	7.5	5.3	5.1	4.1	4.4	3.7	3.3	7.2	16.3	12.0	20.4	20.9	3.1	4.4	2.8	9.2	8.9	24.8	11.4	43.6	9.1	16.3	7.6	5.9	33.9	10.1	12.6	6.0	9.6	7.3	6.9	19.0	6.3	10.6	5.5	7.8	9.4	2.7	6.7	7.1	2.6	4.4	5.8	20.8	4.9	13.9	5.6	20.0	20.6	6.2	6.8	16.4	13.7	28.1	17.2	7.1	3.7	10.6	11.1	16.8	13.3	17.4	3.6	7.6	11.9	11.7	6.0	22.7	6.8	30.3	9.5	13.3	11.7	19.4	20.4	8.8	12.1	0.0	0.2	0.0	0.7	0.3	0.4	0.5	0.4	0.5	0.3	0.2	0.2	0.3	0.2	0.4	0.3	0.2	1.3	0.1	6.8	7.2	11.5	9.1	7.1	7.4	7.9	6.6	7.8	5.9	7.5	7.2	1.5	3.2	1.7	2.0	2.1	0.9	0.5	1.7	2.8	6.0	2.9	2.4	10.7	2.8	2.5	0.0	4.2	1.3	3.1	3.5	1.9	2.2	51.3	1.1	1.2	1.6	3.5	1.7	4.4	2.4	0.7	2.6	3.6	2.2	0.0	5.3	2.2	1.4	2.1	13.5	5.2	4.1	0.0	1.6	3.0	25.6	1.8	2.0	0.0	1.0	1.0	1.9	1.0	3.5	3.3	2.1	2.3	3.4	2.5	0.7	1.8	0.7	0.2	3.4	0.0	3.0	1.3	21.8	6.9	1.3	2.0	2.3	2.0	1.0	2.8	0.6
CABYR	"CBP86, CT88, FSP-2"	ENSG00000154040	"Calcium binding tyrosine phosphorylation regulated"	O75952	18	24138987-24161600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	28	"testis: 303.5"	"Group enriched"	"Detected in many"	18	"Early spermatids: 2505.6;Late spermatids: 3543.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.8;memory B-cell: 4.7;naive B-cell: 5.0;neutrophil: 1.9"	"Group enriched"	"Detected in many"	6	"B-cells: 5.0;granulocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 26.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040703, HPA047801"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA040703: AB_2677087, HPA047801: AB_2680159"	"unprognostic (1.18e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	1.5	3.3	5.4	1.2	6.6	1.1	5.2	3.7	9.4	6.8	10.9	1.2	1.0	2.9	2.0	1.7	3.6	1.8	0.9	7.5	8.0	0.8	1.1	1.0	1.2	6.5	4.2	1.7	0.7	0.4	8.3	0.9	7.0	2.3	1.1	5.7	2.1	1.5	1.0	2.1	1.1	3.6	3.7	1.2	1.5	303.5	5.2	1.5	1.0	0.1	1.0	2.4	1.4	10.5	4.9	11.9	3.4	1.7	3.4	9.1	14.7	8.2	5.4	10.2	10.6	2.5	9.2	0.2	6.8	12.6	0.5	4.5	3.4	6.9	10.7	0.6	5.6	0.3	6.9	2.3	4.8	0.4	0.5	11.2	11.1	12.7	3.3	4.8	2.9	0.6	0.0	0.3	2.6	1.4	0.1	0.4	11.3	0.5	7.4	0.7	0.4	0.2	4.2	5.5	7.2	8.3	26.8	5.2	0.5	2.0	11.3	1.2	1.7	0.8	2.3	3.4	0.2	0.3	0.3	0.1	4.7	0.9	0.5	4.8	0.3	0.6	0.2	0.2	0.1	4.7	0.3	0.3	0.1	5.0	0.3	0.6	1.9	0.8	0.4	0.4	0.2	0.4	5.4	6.6	3.7	9.4	7.5	8.0	6.5	4.2	7.0	3.7	5.2	10.5	1.1	0.0	0.0	1.6	1.0	0.3	0.9	7.2	1.2	2.0	3.1	7.1	0.8	0.0	1.9	0.0	2.1	0.2	0.3	2.2	0.0	0.8	2505.6	76.2	3.3	2.0	0.0	0.4	10.7	0.2	0.5	0.9	0.0	5.1	0.0	0.9	0.4	0.0	0.6	0.0	9.9	1.9	6.1	0.0	0.7	3543.7	23.3	2.4	1.8	2.8	0.0	0.0	1.0	7.5	12.6	0.4	1.3	21.8	0.0	0.1	0.2	0.1	2.8	2.1	19.7	0.7	2.0	166.3	19.1	0.5	0.0	0.0	0.5	0.9	0.4	0.3
CACFD1	"C9orf7, D9S2135, flower"	ENSG00000160325	"Calcium channel flower domain containing 1"	Q9UGQ2	9	133459965-133470848	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 75.5;Gastric mucus-secreting cells: 67.2;Hepatocytes: 47.9;Paneth cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.8"	"Group enriched"	"Detected in many"	4	"B-cells: 2.0;granulocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"T-47d: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015280			Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA015280: AB_1845833"	"unprognostic (3.15e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.83e-8)"	"unprognostic (5.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.99e-3)"	5.1	11.3	6.4	1.9	6.2	2.4	7.0	8.2	6.9	9.5	6.9	19.9	5.8	9.9	5.3	9.9	9.3	4.5	11.2	5.8	6.0	28.2	58.6	12.8	1.5	7.5	6.1	10.7	18.9	7.9	19.0	1.2	6.0	13.3	2.8	2.1	15.8	4.0	9.0	5.4	14.9	2.4	5.9	7.3	28.4	23.9	6.5	0.9	17.4	1.8	1.7	11.8	6.9	7.8	0.4	2.1	4.3	2.7	0.8	0.1	2.5	2.0	2.9	1.5	0.3	5.7	4.8	0.2	4.2	2.0	2.6	1.2	2.2	1.6	0.0	1.1	1.4	0.6	4.8	2.5	2.5	0.0	0.6	0.0	3.2	1.3	1.0	4.8	1.8	1.1	0.8	1.8	2.4	3.7	0.3	0.7	3.4	3.3	1.5	1.4	0.6	9.3	2.9	1.7	4.9	9.1	2.5	5.6	0.9	2.6	9.5	1.6	0.4	3.5	2.2	0.6	0.1	3.4	4.8	2.4	1.1	0.3	1.1	3.8	0.5	1.6	0.2	0.0	0.0	2.0	0.1	0.4	0.4	0.7	0.1	0.5	0.0	0.6	0.2	0.2	0.2	0.1	6.4	6.2	8.2	6.9	5.8	6.0	7.5	6.1	6.0	5.9	6.5	7.8	1.7	19.2	19.6	3.3	5.5	2.8	5.5	5.0	3.4	4.6	13.0	8.9	9.8	21.5	8.8	20.2	12.5	1.9	1.0	75.5	3.9	22.0	13.4	9.8	5.4	3.8	29.2	0.0	5.8	33.1	3.3	4.0	67.2	15.1	4.5	5.9	5.3	47.9	3.6	3.3	4.8	43.1	10.2	5.6	2.2	8.1	8.1	2.1	5.4	1.9	5.9	6.7	2.1	4.5	4.7	26.2	53.2	7.5	3.9	7.0	31.7	16.5	5.2	9.8	0.0	3.4	4.4	13.7	14.7	2.9	1.6	2.9	1.9	2.9	24.5	6.2
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"	Q5VU97	1	64470129-64693058	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Astrocytes: 283.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 41.3;NTERA-2: 56.5;SuSa: 35.4;U-2197: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA		310000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	11.1	13.1	17.5	2.0	18.7	0.1	11.8	6.4	11.3	11.9	22.8	2.9	1.5	10.8	9.1	3.7	14.4	4.5	4.0	14.9	12.9	6.3	1.8	9.0	1.9	12.0	18.1	22.6	7.3	6.9	9.1	10.2	10.9	8.2	2.7	6.4	8.2	7.6	2.9	7.7	3.5	9.6	8.6	4.5	6.7	2.3	18.9	5.1	6.4	5.4	1.6	6.0	10.6	5.7	0.3	1.7	41.3	6.1	16.1	5.6	0.0	5.9	7.8	10.0	9.7	24.8	0.2	0.0	16.8	9.7	8.0	3.1	23.4	5.0	10.4	4.6	12.2	8.9	2.9	0.0	0.0	3.8	0.1	5.0	3.4	1.2	6.2	6.0	5.7	6.0	0.0	0.0	0.0	0.7	0.8	0.0	56.5	0.3	4.2	5.2	4.2	0.0	0.0	1.3	2.1	23.5	12.7	0.0	5.2	35.4	1.7	0.5	3.7	1.0	7.3	29.1	5.3	0.0	0.0	0.0	1.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.5	18.7	6.4	11.3	14.9	12.9	12.0	18.1	10.9	8.6	18.9	5.7	25.2	6.4	49.9	283.7	0.1	17.3	7.5	6.1	6.8	15.5	8.3	7.0	1.3	0.0	11.5	3.7	0.0	0.0	0.2	0.1	0.0	2.3	9.5	14.0	8.1	20.2	0.0	0.0	19.4	2.7	0.1	11.1	5.6	16.9	2.5	26.0	4.2	1.3	0.2	0.0	6.9	0.2	4.1	0.3	6.1	4.1	14.3	0.8	1.8	24.4	0.2	6.4	0.0	57.8	1.8	1.2	0.1	3.0	0.0	2.0	0.5	4.2	10.2	1.3	6.6	25.2	6.4	0.5	0.8	2.9	14.8	0.0	0.9	0.8	0.5	5.1
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153106-1221771	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 107.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.8;Late spermatids: 15.5;Peritubular cells: 25.9;Sertoli cells: 26.3;Smooth muscle cells: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.9;AN3-CA: 25.4;MCF7: 48.3;OE19: 16.0;T-47d: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039125	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (1.66e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.93e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.55e-2)"	13.6	28.0	13.6	5.2	24.5	0.1	7.6	2.1	12.1	26.3	0.0	107.7	6.4	57.3	2.6	7.1	37.8	10.3	9.3	11.0	8.1	14.1	13.4	11.8	0.7	3.0	3.8	80.1	4.6	3.6	45.9	2.1	2.9	28.0	2.4	1.8	1.9	27.5	6.2	19.4	22.3	15.6	3.7	0.7	27.5	19.4	13.5	0.5	11.0	3.0	0.2	57.0	17.1	0.2	0.0	17.9	3.0	25.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	10.4	0.1	0.0	11.0	3.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.0	3.0	4.9	0.0	0.0	48.3	0.0	0.0	9.4	16.0	3.6	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.9	1.0	13.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	24.5	2.1	12.1	11.0	8.1	3.0	3.8	2.9	3.7	13.5	0.2	1.3	0.0	0.0	1.0	0.0	1.5	0.1	0.0	0.0	22.8	0.3	0.1	2.7	4.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.7	7.2	0.2	5.3	2.2	10.8	0.0	2.6	0.0	0.1	1.3	0.5	0.2	4.5	0.0	0.4	7.8	0.1	0.0	0.7	1.0	2.0	0.0	0.3	15.5	8.4	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.1	0.4	0.4	25.9	0.0	7.2	0.0	0.7	0.0	1.5	26.3	0.4	22.4	3.4	5.1	0.0	3.4	0.0	0.2	0.3	0.1	1.3
CACNA2D3	HSA272268	ENSG00000157445	"Calcium voltage-gated channel auxiliary subunit alpha2delta 3"	Q8IZS8	3	54122547-55074557	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8;skeletal muscle: 9.9;tongue: 10.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.9;Excitatory neurons: 828.3;Inhibitory neurons: 456.4;Oligodendrocyte precursor cells: 317.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.1;HAP1: 1.9;HeLa: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030849			Uncertain	Nucleoplasm		NA	NA		69000		"Cluster 47: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA030849: "	"unprognostic (6.92e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-5)"	"unprognostic (5.53e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.84e-3)"	"unprognostic (7.22e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.95e-2)"	0.2	4.1	8.8	0.1	11.6	0.0	0.2	0.0	15.8	0.3	0.0	0.7	0.1	0.1	1.3	0.5	0.4	0.2	2.6	9.4	8.4	1.3	0.0	0.5	0.5	2.1	10.2	2.5	0.0	0.3	0.8	0.5	1.3	1.0	0.3	2.9	0.4	1.5	9.9	0.1	0.3	0.6	0.0	0.2	0.4	1.4	3.5	0.1	0.4	10.7	0.5	0.1	0.4	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.1	0.1	9.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	11.6	0.0	15.8	9.4	8.4	2.1	10.2	1.3	0.0	3.5	9.9	0.5	0.0	0.0	160.9	0.6	0.3	0.4	0.2	7.4	10.8	0.2	0.5	30.2	0.0	0.7	0.0	8.4	9.9	5.5	0.1	7.9	0.0	83.4	0.9	0.8	0.6	0.0	1.3	828.3	0.6	3.2	3.4	1.5	1.8	0.0	1.1	0.4	0.0	5.9	0.0	456.4	0.0	2.0	8.9	2.7	56.1	2.8	11.0	0.0	97.4	22.2	5.0	0.0	317.7	11.3	1.2	0.0	1.5	0.1	0.4	0.0	0.2	0.8	1.4	6.6	1.7	1.9	5.7	2.9	3.4	0.1	68.0	0.7	0.8	0.0	0.4
CACTIN	"C19orf29, fSAPc, NY-REN-24"	ENSG00000105298	"Cactin, spliceosome C complex subunit"	Q8WUQ7	19	3610645-3626815	"Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042504, HPA042548"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA042504: AB_10797501, HPA042548: AB_10794760"	"unprognostic (1.18e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (3.69e-5)"	"unprognostic (5.93e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.55e-3)"	14.6	14.2	20.6	7.8	19.6	10.0	14.8	19.4	24.0	15.7	16.6	15.4	6.2	16.7	2.6	15.4	16.8	3.0	16.3	20.3	18.8	17.0	19.9	12.3	7.6	21.1	19.6	24.7	17.3	4.2	13.3	4.6	19.1	17.2	3.2	4.6	13.2	4.2	19.4	17.8	15.2	2.9	18.5	18.4	15.8	18.2	19.8	8.7	15.3	6.1	4.4	16.5	14.6	20.1	22.2	12.5	10.3	17.9	7.4	7.2	15.6	15.4	6.3	9.1	10.2	12.5	9.7	18.4	12.9	9.7	10.6	20.4	10.8	12.9	5.5	18.7	14.8	11.4	19.2	15.1	10.3	15.7	15.9	7.1	12.2	8.4	5.8	5.4	13.2	15.6	25.9	19.8	4.9	13.3	28.0	13.5	22.0	13.4	14.8	29.4	13.5	17.5	8.5	11.0	14.2	19.9	17.4	12.1	13.3	5.5	9.8	17.7	17.2	12.3	15.5	27.0	27.4	30.3	21.6	20.7	15.2	24.8	16.8	0.0	0.4	0.0	1.2	1.0	0.4	0.6	0.5	0.5	0.3	0.6	0.6	0.8	0.2	0.3	0.1	1.4	0.5	0.4	20.6	19.6	19.4	24.0	20.3	18.8	21.1	19.6	19.1	18.5	19.8	20.1	7.4	0.0	2.7	5.9	6.3	6.0	4.1	2.8	5.7	5.1	6.9	7.1	3.1	5.7	2.2	1.8	2.1	3.6	7.2	6.9	0.0	5.1	3.3	6.7	5.8	5.3	1.2	7.4	3.9	4.9	5.2	5.1	9.2	7.4	4.5	8.5	3.3	4.8	5.1	0.0	4.1	5.8	2.0	3.9	6.5	4.5	5.9	5.3	1.8	3.7	6.1	6.0	8.2	2.5	5.8	5.2	4.4	5.7	6.0	6.0	3.6	3.1	2.4	6.2	0.0	7.2	6.4	10.8	8.8	7.9	8.0	3.3	5.6	7.6	6.1	3.6
CACUL1	"C10orf46, CAC1, FLJ40409, MGC33215"	ENSG00000151893	"CDK2 associated cullin domain 1"	Q86Y37	10	118674167-118755249	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 237.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050611			Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA050611: AB_2797238"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.75e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.54e-1)"	6.3	6.9	6.3	4.0	6.6	11.6	7.7	4.8	6.2	6.0	4.6	7.5	4.5	7.3	7.0	7.3	5.7	3.9	5.8	6.8	7.4	5.0	6.6	7.3	4.1	5.2	5.9	5.1	5.5	7.2	5.0	6.4	6.5	5.3	5.3	5.5	5.3	5.4	10.5	6.0	5.0	6.1	5.0	5.8	6.1	6.6	7.8	5.4	5.2	10.6	5.2	8.3	6.1	5.4	14.8	8.6	6.4	11.8	15.0	10.2	6.6	6.2	17.2	8.9	11.2	9.6	12.3	10.5	4.6	10.3	7.3	12.8	13.0	11.1	11.8	4.2	7.1	9.7	8.5	11.9	9.9	8.9	6.1	8.2	12.2	11.5	17.2	13.4	10.2	11.5	4.8	10.5	10.5	11.4	8.5	14.1	6.2	6.3	4.5	4.8	26.7	6.5	13.0	11.2	3.4	10.8	6.0	15.0	20.4	6.9	8.4	7.2	9.7	6.1	6.9	7.7	10.7	9.1	10.4	7.2	7.9	17.2	3.8	25.3	9.0	16.9	5.2	15.6	5.1	4.0	4.9	5.1	8.2	4.0	5.4	6.4	20.3	4.4	17.1	3.9	4.1	5.2	6.3	6.6	4.8	6.2	6.8	7.4	5.2	5.9	6.5	5.0	7.8	5.4	29.6	60.9	21.7	58.8	42.7	74.8	30.5	38.5	50.1	33.6	58.3	34.9	44.8	45.8	27.8	36.8	73.0	73.4	39.2	32.5	23.5	52.4	237.7	53.3	24.7	36.8	68.6	37.0	65.8	59.4	33.4	34.7	18.8	46.9	15.8	68.7	33.2	27.4	46.5	92.5	64.7	34.0	34.6	77.6	127.6	36.1	29.5	56.7	28.4	49.6	59.4	40.9	34.0	40.2	62.5	50.0	26.5	24.0	24.4	56.5	28.2	43.2	36.7	50.1	13.1	52.1	32.3	81.4	83.8	43.2	78.8	102.3	32.8	29.0	41.7	74.7
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175012027	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 191.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		560000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: AB_2683318"	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	26.5	22.6	60.7	25.5	63.4	33.8	20.6	66.8	191.9	21.8	48.5	25.6	15.9	19.1	24.4	23.8	17.4	14.7	26.8	66.3	65.6	27.2	25.7	23.7	32.7	60.8	61.8	34.8	15.9	20.5	26.9	22.8	66.8	15.3	20.7	52.5	17.5	18.5	37.7	17.4	19.1	16.4	57.8	24.1	20.3	30.5	58.7	27.9	14.9	27.4	28.9	28.0	20.4	71.9	127.7	85.6	124.0	53.1	40.2	44.8	79.5	94.7	55.6	119.8	86.8	88.9	76.9	132.8	96.0	67.5	85.8	67.3	155.0	69.4	122.7	70.6	92.4	99.6	80.8	96.3	30.1	135.4	59.9	30.3	42.2	98.7	58.8	62.0	85.5	117.0	203.7	72.2	87.0	47.4	208.2	121.5	118.0	189.1	39.4	93.6	87.9	152.5	85.4	99.8	84.9	81.4	64.7	111.0	106.3	165.7	86.8	116.6	44.9	67.9	73.3	96.0	153.8	68.6	211.5	301.8	57.1	117.1	80.6	34.0	25.5	27.9	29.4	41.7	35.4	43.0	42.0	36.2	32.3	33.7	44.6	39.9	14.6	43.7	54.9	28.3	48.7	46.1	60.7	63.4	66.8	191.9	66.3	65.6	60.8	61.8	66.8	57.8	58.7	71.9	70.6	86.6	41.9	13.1	82.1	117.0	183.6	102.2	63.7	57.7	61.8	79.0	108.1	40.0	62.7	35.0	62.6	238.8	68.7	66.2	152.6	96.8	102.2	124.5	67.6	80.0	119.6	113.0	22.4	95.0	304.1	92.8	36.7	167.3	92.0	52.8	44.3	39.4	196.3	30.3	24.1	101.6	67.1	56.0	188.2	30.6	86.0	110.9	108.5	13.1	231.0	77.8	60.8	8.5	28.0	106.9	58.4	73.7	90.7	115.4	80.7	171.4	78.0	84.0	32.9	57.6	108.4	186.7	139.9	88.7	85.7	143.5	188.0	76.5	139.1	106.9
CADM4	"IGSF4C, Necl-4, SynCAM4, TSLL2"	ENSG00000105767	"Cell adhesion molecule 4"	Q8NFZ8	19	43622368-43639850	"Predicted membrane proteins"	"Cell adhesion"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 186.0;choroid plexus: 108.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 42.3;Oligodendrocytes: 50.8;Proximal tubular cells: 31.2"	"Cancer enhanced"	"Detected in all"		"glioma: 108.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 1.5"	"Cell line enriched"	"Detected in many"	5	"WM-115: 557.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012612	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		8200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear membrane"	Nucleoplasm	"HPA012612: AB_1851530"	"unprognostic (8.80e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.81e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.39e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.93e-2)"	3.6	23.3	142.5	4.6	165.9	0.6	8.8	166.7	144.2	14.3	108.6	26.5	3.6	14.3	8.7	20.8	5.9	4.8	12.1	133.9	154.4	18.9	6.0	3.8	2.0	158.6	165.0	13.1	15.7	38.1	31.6	0.8	152.7	19.8	3.2	14.5	19.8	14.2	7.6	20.1	7.6	9.1	147.7	2.1	15.1	4.7	163.9	2.9	4.7	2.4	4.5	8.7	14.7	186.0	45.2	12.9	67.3	88.8	0.3	1.4	3.8	2.1	3.6	6.2	9.1	19.4	7.7	0.3	16.2	0.7	3.8	10.5	15.1	9.1	7.5	0.4	11.9	0.4	3.1	28.7	7.9	0.1	6.9	2.7	19.5	32.3	1.2	31.5	4.2	3.9	4.7	0.7	0.7	6.7	6.7	0.9	7.4	9.4	4.4	36.3	0.9	4.3	9.0	9.3	7.8	43.2	4.7	13.7	17.9	10.0	10.1	2.1	1.9	0.9	101.8	0.8	4.4	6.4	4.4	0.3	4.8	0.9	557.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	142.5	165.9	166.7	144.2	133.9	154.4	158.6	165.0	152.7	147.7	163.9	186.0	0.8	0.0	1.7	23.5	1.0	5.0	19.1	7.6	9.1	17.5	8.5	11.8	3.5	4.3	5.4	7.3	2.1	0.2	5.7	0.4	5.9	10.6	21.3	2.5	3.8	2.9	0.0	0.0	11.4	3.2	0.1	1.7	4.1	5.3	0.0	15.5	4.6	3.2	0.4	20.2	22.0	0.4	12.2	0.0	8.2	21.8	0.3	1.1	14.2	3.7	0.1	21.4	0.0	42.3	50.8	3.5	0.0	1.5	2.3	26.3	0.0	31.2	3.3	4.0	0.0	1.9	8.7	0.7	0.7	6.7	8.5	0.0	1.0	1.5	1.2	13.4
CADPS2	CAPS2	ENSG00000081803	"Calcium dependent secretion activator 2"	Q86UW7	7	122318411-122886759	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 682.7;Microglial cells: 180.8;Oligodendrocyte precursor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 96.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 43.5;Karpas-707: 56.3;OE19: 63.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 159.9"	HPA056398			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"HPA056398: AB_2683117"	"unprognostic (1.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.67e-3)"	"unprognostic (8.69e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (9.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-2)"	10.3	21.1	9.2	4.5	16.3	0.1	18.3	96.2	30.9	29.8	5.8	10.7	12.6	35.0	30.3	4.5	11.0	15.6	10.2	14.2	14.4	38.3	13.2	18.0	3.5	4.9	40.1	9.9	26.0	12.0	13.8	6.0	7.9	19.4	10.7	7.2	48.3	18.5	2.4	4.0	10.0	21.7	6.2	6.7	20.0	4.0	17.4	4.9	18.3	7.8	3.8	9.3	8.5	18.7	0.0	0.1	3.4	0.0	5.1	5.2	0.3	0.5	13.5	2.9	13.4	0.1	12.6	0.0	0.0	6.4	0.4	0.1	0.4	1.9	1.3	0.0	11.1	4.4	0.1	25.1	16.9	0.0	0.2	5.5	2.4	2.3	1.7	11.8	43.5	0.0	0.0	56.3	0.2	30.9	0.0	0.1	12.6	63.6	21.4	0.0	0.0	23.2	0.6	14.3	20.5	0.0	0.6	24.4	1.2	3.2	9.5	0.1	12.5	4.7	3.1	0.1	8.9	16.8	0.7	0.0	18.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	16.3	96.2	30.9	14.2	14.4	4.9	40.1	7.9	6.2	17.4	18.7	29.3	9.6	43.9	85.2	3.1	2.2	7.9	7.3	10.2	0.6	36.7	22.4	12.9	11.5	14.4	40.5	0.0	0.4	0.5	4.3	17.6	4.4	8.5	4.8	13.5	24.7	4.8	0.0	682.7	11.1	0.5	13.0	42.3	11.2	1.3	10.1	14.3	12.5	0.4	3.3	14.2	13.2	10.2	3.1	1.4	6.8	9.6	0.6	3.6	180.8	0.0	27.2	0.0	111.1	11.0	4.8	3.7	10.1	15.7	13.4	5.7	7.9	9.4	1.5	0.0	6.9	6.2	0.7	4.2	6.2	1.4	0.3	0.7	11.3	8.0	8.5
CALHM2	FAM26B	ENSG00000138172	"Calcium homeostasis modulator family member 2"	Q9HA72	10	103446786-103452402	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 75.1;Fibroblasts: 38.2;Hepatic stellate cells: 48.2;Hofbauer cells: 53.7;Leydig cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 45.1;BJ: 37.7;BJ hTERT+: 37.5;fHDF/TERT166: 43.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014706	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA014706: AB_2243916"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (8.59e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.74e-1)"	49.7	18.5	7.2	12.5	6.5	2.1	38.9	6.3	9.0	54.4	7.0	18.4	6.5	58.1	5.5	12.2	43.3	21.6	34.2	7.0	7.3	10.7	4.5	23.2	13.7	8.0	6.4	48.1	7.1	3.1	7.3	10.0	7.8	21.1	4.3	0.4	14.9	10.6	9.7	17.9	19.6	15.9	7.7	35.3	13.8	11.5	8.0	5.6	21.6	11.1	6.1	33.9	39.3	7.9	11.0	7.5	1.8	2.4	27.3	45.1	9.1	37.7	37.5	11.2	15.7	3.3	5.3	3.3	4.2	43.2	0.7	5.0	3.8	0.0	2.1	0.4	21.5	7.8	2.5	0.6	12.4	1.3	0.7	15.6	0.0	3.3	0.1	20.8	13.5	8.3	1.8	19.8	7.5	25.0	3.0	3.7	4.8	2.3	6.7	9.2	3.0	7.5	1.0	0.9	5.3	2.3	1.5	6.2	2.1	0.8	1.2	2.5	24.5	3.6	4.4	12.6	2.7	3.0	7.6	3.8	31.0	24.0	0.8	70.0	91.9	1.8	83.7	178.4	69.6	27.7	56.5	69.7	152.1	7.3	10.8	42.3	3.6	62.9	214.6	17.8	82.7	85.6	7.2	6.5	6.3	9.0	7.0	7.3	8.0	6.4	7.8	7.7	8.0	7.9	18.2	3.2	0.6	1.0	4.9	5.4	2.9	0.6	4.0	0.1	3.4	4.4	3.3	1.5	0.0	3.7	0.0	3.1	11.3	0.1	0.0	4.2	1.0	1.4	19.8	25.5	1.2	5.7	2.3	0.2	75.1	38.2	1.5	2.1	8.8	11.4	48.2	0.6	53.7	0.0	0.5	0.1	2.0	28.8	18.8	2.5	45.7	21.5	8.8	2.8	17.3	0.2	33.0	1.0	0.2	0.1	0.1	16.1	3.1	0.8	0.0	0.3	0.0	0.1	19.7	16.8	27.9	0.8	0.9	0.8	3.8	19.2	19.4	6.0	0.0	1.0
CALHM3	"bA225H22.7, FAM26A"	ENSG00000183128	"Calcium homeostasis modulator 3"	Q86XJ0	10	103472804-103479240	"Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Taste, Transport"	"Ion channel"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.2;Early spermatids: 2.2;Extravillous trophoblasts: 6.7;Late spermatids: 2.0;Syncytiotrophoblasts: 1.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"U-266/84: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018205	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"		"Cluster 16: U-266 - Nucleosome"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA018205: AB_2069267"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.06e-1)"		"unprognostic (1.25e-2)"		"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.44e-1)"		"unprognostic (4.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.53e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.3	2.6	0.3	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	14.3	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0
CALML4	"MGC4809, NY-BR-20"	ENSG00000129007	"Calmodulin like 4"	Q96GE6	15	68190705-68206079	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 91.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 49.2;Gastric mucus-secreting cells: 31.6;Paneth cells: 39.3;Proximal enterocytes: 36.2;Respiratory ciliated cells: 107.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 184.3;non-classical monocyte: 216.9"	"Lineage enriched"	"Detected in many"	7	"monocytes: 216.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051109	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA051109: AB_2681346"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.97e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.24e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	5.2	5.1	2.9	14.5	2.9	4.5	3.1	3.9	3.8	9.2	12.6	70.1	91.9	3.3	1.4	2.1	19.3	18.7	1.2	3.1	2.7	29.1	15.0	5.1	3.9	2.8	2.7	1.7	7.0	0.9	3.5	5.4	2.9	6.2	64.7	4.3	2.2	4.4	3.4	4.8	76.0	7.3	2.4	5.9	15.6	3.3	3.0	4.5	1.6	0.7	4.0	3.5	2.3	3.3	3.4	11.6	7.9	4.8	1.6	1.7	5.7	2.2	2.3	4.8	3.0	22.1	29.8	3.7	3.0	1.9	3.7	15.1	18.2	2.8	2.0	3.3	16.9	6.7	21.6	7.9	3.5	5.8	14.7	1.6	4.4	1.8	3.4	3.0	5.9	10.8	6.2	3.9	0.7	10.2	14.5	12.6	8.5	24.1	3.4	30.1	8.1	8.2	1.3	6.0	4.4	4.3	3.5	3.2	9.9	3.1	2.8	12.6	3.5	5.0	4.5	9.2	8.7	14.4	9.4	10.0	3.3	14.9	2.2	0.1	43.7	0.2	0.1	184.3	0.6	0.6	0.6	0.2	29.1	0.1	0.5	0.3	21.3	0.0	216.9	1.4	0.4	18.3	2.9	2.9	3.9	3.8	3.1	2.7	2.8	2.7	2.9	2.4	3.0	3.3	1.3	0.0	1.5	3.3	0.7	1.5	0.8	2.8	1.8	11.1	0.4	0.1	0.3	12.8	15.8	3.7	0.0	0.5	0.3	49.2	0.0	2.5	6.5	9.4	0.6	6.4	7.7	1.3	3.8	4.3	0.5	3.2	31.6	0.4	0.0	0.4	5.0	8.1	3.9	8.4	4.0	17.1	0.0	11.7	1.5	0.5	3.7	8.1	0.0	4.7	3.9	2.0	2.1	3.0	3.4	3.0	39.3	6.8	2.4	1.1	36.2	25.4	107.8	3.1	0.0	1.1	0.7	0.0	0.4	1.3	2.0	0.1	1.2	0.1	21.1	1.1
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349547-12835545	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 57.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 167.4;Cone photoreceptor cells: 392.0;Excitatory neurons: 416.9;Inhibitory neurons: 233.6;Microglial cells: 168.6;Rod photoreceptor cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 14.9;basal ganglia: 16.7;cerebral cortex: 35.6;hippocampal formation: 29.6;white matter: 14.5"	"Immune cell enhanced"	"Detected in all"		"eosinophil: 75.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 75.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 113.8;U-266/70: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	6.6	4.8	14.9	8.4	16.7	6.8	4.3	4.5	35.6	7.4	1.1	11.4	3.5	3.2	2.8	8.6	3.8	5.9	14.6	29.6	0.6	2.6	8.2	7.5	9.6	3.7	0.1	2.7	16.9	0.9	2.8	2.9	0.0	4.7	12.4	57.9	4.3	7.0	1.5	18.5	6.3	5.2	0.7	10.9	3.1	6.1	1.3	23.5	13.0	2.3	12.6	7.1	9.2	14.5	0.3	6.1	6.8	0.3	4.0	1.4	0.4	0.9	2.2	1.4	2.0	8.6	4.8	3.4	0.7	0.6	3.4	3.2	8.4	1.2	1.1	113.8	4.1	13.6	19.4	0.4	1.1	0.3	11.8	0.2	5.2	2.7	0.2	14.6	0.8	7.2	0.4	0.4	1.7	7.2	26.9	5.6	4.6	0.0	2.7	20.2	3.7	6.4	0.2	6.5	10.4	4.8	13.2	4.9	0.0	0.9	3.4	3.3	0.3	5.6	8.1	18.1	4.0	50.3	16.8	11.3	8.2	8.8	0.1	19.5	4.9	75.1	3.8	7.1	3.9	12.1	3.3	4.8	9.3	14.7	3.8	2.6	29.8	3.1	8.7	2.8	1.1	3.4	14.9	16.7	4.5	35.6	29.6	0.6	3.7	0.1	0.0	0.7	1.3	14.5	12.5	3.2	25.2	130.6	68.0	22.9	8.6	26.3	13.1	167.4	3.4	1.7	17.1	12.8	36.6	1.8	392.0	0.2	22.1	36.7	0.0	9.0	20.4	3.6	4.0	13.7	16.1	7.6	416.9	22.0	0.9	30.4	2.0	2.0	23.4	2.0	15.0	13.7	16.0	45.4	233.6	27.4	10.2	50.1	61.2	9.2	23.6	36.2	3.6	168.6	34.8	24.2	30.9	111.6	7.2	10.5	42.8	60.9	23.9	4.9	2.0	1.2	27.5	214.2	26.3	7.2	10.2	4.8	11.0	24.6	41.2	0.3	21.6	8.7	33.2	20.9
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261553	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 104.3;pancreas: 33.6;pituitary gland: 39.6"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 62.2;Inhibitory neurons: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 21.2;REH: 33.4;SCLC-21H: 33.2;U-138 MG: 32.1"	"Low region specificity"	"Detected in all"							"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Centrosome"		"HPA050835: AB_2681253, HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favorable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	0.1	14.6	60.0	0.2	29.5	0.0	0.1	45.8	49.8	0.1	0.0	0.6	0.2	0.2	0.0	0.1	0.1	0.1	0.1	36.0	69.1	0.2	0.7	0.1	0.0	95.7	70.7	0.1	33.6	0.8	39.6	0.1	79.5	0.3	0.0	5.5	0.2	0.1	0.0	0.2	0.2	0.1	50.7	0.1	0.5	0.2	104.3	0.0	0.1	0.0	0.0	0.1	0.1	29.7	21.2	0.5	3.2	1.7	0.5	0.5	2.2	0.5	6.2	4.0	4.1	1.2	1.1	2.0	5.4	0.3	13.0	2.8	1.1	0.7	2.2	16.1	1.4	0.7	0.5	0.9	0.1	1.4	3.0	0.5	1.0	0.6	2.8	1.4	0.0	0.9	0.3	7.5	0.6	14.5	0.4	1.1	13.3	1.5	8.4	33.4	9.4	3.2	0.9	5.0	33.2	7.3	3.9	1.7	0.3	0.3	13.3	0.2	0.2	32.1	15.0	4.3	6.7	4.1	8.1	6.8	8.1	3.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.0	29.5	45.8	49.8	36.0	69.1	95.7	70.7	79.5	50.7	104.3	29.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.2	0.3	0.5	0.4	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.4	0.2	3.6	0.0	7.8	4.3	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.8	0.0	62.2	45.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	2.8	0.0	2.0	0.0	7.5	2.0	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	7.2	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1
CAMK4	"CaMK-GR, CaMKIV"	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 70.4;lymphoid tissue: 55.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 70.9;Early spermatids: 306.2;Excitatory neurons: 212.2;Inhibitory neurons: 131.8;Late spermatids: 108.4;Oligodendrocyte precursor cells: 133.2;T-cells: 83.3"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"basal ganglia: 30.6;cerebellum: 70.4"	"Group enriched"	"Detected in many"	4	"MAIT T-cell: 24.3;memory CD4 T-cell: 17.3;memory CD8 T-cell: 13.5;naive CD4 T-cell: 33.1;naive CD8 T-cell: 18.5;T-reg: 21.3"	"Lineage enriched"	"Detected in many"	23	"T-cells: 33.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.9;JURKAT: 61.3;MOLT-4: 27.9;SH-SY5Y: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	0.4	3.8	5.0	4.4	30.6	3.1	0.4	70.4	8.2	0.9	0.0	1.3	1.4	0.6	0.3	0.7	0.3	1.5	0.1	7.6	0.0	0.7	1.4	1.1	8.1	0.0	0.4	0.6	0.4	0.0	0.6	0.2	1.4	3.4	1.4	4.7	0.4	1.4	0.1	0.1	2.3	0.8	0.0	2.6	1.5	9.4	0.8	55.4	0.2	0.0	5.2	1.7	0.4	0.0	0.0	0.0	3.1	2.1	0.6	2.3	0.0	0.8	6.8	8.0	7.8	0.0	0.1	0.0	4.0	0.4	5.4	0.3	6.8	0.8	5.8	88.9	5.2	1.3	2.8	0.0	0.2	0.6	0.3	0.3	0.0	16.8	1.7	4.9	1.4	61.3	0.0	3.3	0.4	0.0	27.9	0.0	4.1	0.0	0.2	4.0	5.0	0.2	2.9	0.1	18.8	33.5	1.2	0.0	5.6	0.2	0.1	0.5	0.1	16.3	9.5	0.1	14.7	2.6	0.3	0.0	8.0	0.0	6.3	0.1	0.0	0.0	4.8	0.0	24.3	1.3	17.3	13.5	0.0	0.3	33.1	18.5	0.9	1.4	0.0	0.1	21.3	5.5	5.0	30.6	70.4	8.2	7.6	0.0	0.0	0.4	1.4	0.0	0.8	0.0	1.8	0.0	1.1	57.8	9.4	1.1	0.3	1.3	8.6	70.9	0.6	0.6	5.3	0.0	0.0	0.0	0.0	0.1	3.1	0.1	0.0	0.1	306.2	0.2	1.6	1.1	0.0	0.0	212.2	0.0	0.2	4.6	3.6	0.4	4.5	0.3	0.7	0.3	0.2	0.0	131.8	0.8	0.0	1.3	2.1	108.4	4.1	2.0	0.0	12.2	2.7	2.8	1.0	133.2	5.4	1.2	0.0	1.5	11.5	0.5	0.0	0.1	0.1	4.3	0.0	0.6	3.8	30.3	6.2	2.4	1.0	0.0	83.3	0.1	0.0	0.3
CAMKMT	"C2orf34, CLNMT"	ENSG00000143919	"Calmodulin-lysine N-methyltransferase"	Q7Z624	2	44361947-44772592	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 155.1;Excitatory neurons: 88.7;Inhibitory neurons: 93.7;Microglial cells: 114.3;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067912			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA067912: AB_2685922"	"unprognostic (2.28e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.57e-2)"	4.2	5.3	15.9	3.9	21.1	10.2	5.3	19.4	21.1	5.9	17.8	7.0	5.3	4.1	6.5	6.1	4.9	5.7	5.0	15.5	17.1	7.5	4.8	3.9	5.4	17.7	16.4	3.9	9.8	9.8	5.6	3.3	17.3	3.5	6.8	8.5	4.8	3.9	7.8	5.8	5.7	3.9	15.5	3.7	5.8	13.2	17.9	6.2	7.3	3.3	5.4	4.5	4.7	20.4	10.2	6.2	7.4	6.8	8.0	8.1	15.0	7.4	6.0	4.3	5.5	11.9	9.0	9.6	8.6	5.6	5.3	8.3	10.6	13.2	7.6	35.2	13.3	14.2	12.1	22.4	3.1	9.4	9.5	2.6	8.0	5.9	10.9	6.1	6.4	9.9	10.4	17.1	7.1	10.9	17.6	19.1	13.9	24.6	6.1	10.3	8.3	19.4	20.8	11.6	14.0	13.4	7.6	24.1	9.2	7.0	8.8	7.7	7.6	5.5	6.4	6.1	5.9	13.3	11.5	18.2	6.1	16.5	3.9	13.1	8.2	6.2	11.1	6.9	11.5	20.9	11.2	9.7	9.7	14.7	16.9	13.4	5.2	8.7	8.4	10.1	18.3	6.9	15.9	21.1	19.4	21.1	15.5	17.1	17.7	16.4	17.3	15.5	17.9	20.4	5.4	6.4	3.1	155.1	11.0	5.2	7.9	10.9	9.1	5.3	6.6	5.2	2.2	10.0	5.5	9.2	0.0	3.3	6.9	4.5	23.5	13.3	74.3	8.2	7.2	4.0	0.0	13.3	88.7	15.6	4.5	6.2	11.7	10.0	5.7	2.0	3.3	6.3	5.8	1.7	93.7	5.5	20.3	1.9	4.9	39.0	8.1	4.3	10.6	114.3	6.4	20.3	13.4	121.2	211.7	8.6	8.3	5.7	13.3	5.8	7.2	14.5	7.4	3.0	0.0	3.6	5.0	35.5	5.8	10.7	7.4	2.6	9.2	7.9	8.1	6.0
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49869935	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 91.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.2;Early spermatids: 6.3;Excitatory neurons: 32.7;Inhibitory neurons: 27.0;Late spermatids: 7.8"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.6;CACO-2: 6.1;HAP1: 10.3;NTERA-2: 34.1;RPMI-8226: 6.9;SCLC-21H: 17.7;SH-SY5Y: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	0.0	0.8	66.5	0.0	91.8	0.0	0.0	0.0	84.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.3	19.0	0.1	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.1	0.1	0.0	12.9	0.0	0.1	2.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.2	7.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.1	0.9	0.2	34.1	0.0	0.2	1.3	0.0	6.9	0.0	0.0	17.7	8.3	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.5	91.8	0.0	84.9	73.3	19.0	0.2	8.7	0.0	12.9	37.2	39.2	0.0	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	12.2	0.1	0.1	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	1.2	0.0	32.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	27.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	4.7	0.0	0.2	0.0	2.5	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.3	0.0	0.0	0.1	0.0
CAMLG	"CAML, GET2"	ENSG00000164615	"Calcium modulating ligand"	P49069	5	134738495-134752157	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 845.6;Late spermatids: 1655.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052636, HPA056472"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA052636: AB_2681893, HPA056472: AB_2683143"	"unprognostic (9.23e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.16e-1)"	52.3	37.2	50.6	17.5	52.1	31.7	42.1	50.7	69.4	57.0	48.2	54.8	34.4	45.8	48.2	29.5	45.3	27.4	26.9	52.3	55.9	29.7	29.3	28.6	26.2	51.9	53.8	68.6	30.7	27.0	43.1	17.9	54.3	34.9	15.9	29.1	29.0	31.8	60.4	36.7	30.4	28.5	52.8	26.1	36.5	51.3	52.1	25.8	27.0	35.6	25.3	44.2	41.1	53.3	27.5	22.2	33.0	64.1	76.3	118.3	14.4	39.0	55.8	26.8	52.8	38.9	40.1	113.9	56.2	27.5	42.7	34.2	29.2	46.9	35.0	54.3	54.5	29.9	33.2	32.8	56.3	13.7	89.2	96.9	49.5	35.1	57.9	92.3	54.8	49.0	18.6	47.1	39.9	31.2	43.1	58.2	17.1	34.7	21.5	46.2	40.7	44.3	46.0	26.4	52.2	36.9	27.1	15.3	97.1	40.8	48.4	33.9	53.2	24.5	16.4	40.2	35.2	45.8	55.1	42.5	46.2	48.5	14.8	62.0	26.4	60.7	30.5	31.8	41.1	43.5	43.5	38.4	29.1	39.5	45.0	44.2	47.9	31.4	44.6	26.1	52.6	31.6	50.6	52.1	50.7	69.4	52.3	55.9	51.9	53.8	54.3	52.8	52.1	53.3	86.8	38.5	36.4	13.7	92.9	167.1	107.0	113.6	157.1	80.5	121.9	124.7	45.1	100.1	68.9	42.3	25.0	50.3	93.3	42.8	92.0	63.9	845.6	57.6	116.4	99.5	62.4	76.6	29.4	90.9	62.5	107.4	32.6	61.7	123.4	66.6	102.4	69.1	69.9	55.5	32.0	69.4	107.8	111.5	130.8	1655.8	168.0	76.6	96.0	10.3	126.9	127.7	90.6	15.1	18.6	67.5	58.0	132.4	55.2	148.6	158.2	199.1	51.3	71.4	98.6	119.5	109.7	241.5	68.6	119.3	201.6	73.2	101.6	67.9	90.9	107.9
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595863-7618304	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 62.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 40.0;Gastric mucus-secreting cells: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.7;Hep G2: 15.6;MCF7: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Centrosome"		"HPA043830: AB_10795879, HPA062149: AB_2684698"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.4	3.3	3.2	0.8	4.4	0.0	5.3	2.5	9.0	7.7	0.1	10.3	14.9	0.5	2.3	24.8	3.1	1.6	0.4	4.2	0.7	12.0	24.3	4.6	0.2	2.5	0.0	0.5	20.6	2.7	8.2	0.4	0.4	10.2	2.4	3.2	18.1	4.5	0.2	62.7	11.5	0.1	0.0	0.6	15.5	13.0	0.2	0.5	11.1	0.0	1.1	3.6	13.4	2.4	11.2	1.8	0.3	0.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	26.7	5.8	3.1	4.5	0.0	1.2	9.7	4.3	2.8	0.0	2.0	10.1	0.0	0.5	15.6	0.0	0.0	4.4	0.0	5.5	0.0	0.4	0.4	0.0	4.5	0.9	0.0	0.0	13.0	0.2	0.2	6.6	8.4	4.7	0.7	0.0	3.7	1.9	6.0	8.2	8.7	1.3	12.5	0.0	1.6	10.4	1.7	0.0	0.0	2.0	0.0	0.4	5.0	1.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	2.5	9.0	4.2	0.7	2.5	0.0	0.4	0.0	0.2	2.4	0.2	9.6	19.2	3.3	1.1	9.8	2.7	2.4	3.4	22.7	19.3	12.1	1.5	20.0	5.3	9.2	0.0	0.5	0.2	40.0	3.9	5.7	4.4	9.6	1.4	1.5	13.1	0.0	9.1	11.8	0.7	0.2	38.7	13.5	5.7	8.6	0.4	24.8	0.2	10.1	10.1	22.4	0.0	1.9	1.2	2.9	1.5	1.0	0.0	1.9	0.0	1.5	0.0	4.5	0.6	13.1	28.4	0.0	0.6	6.2	29.2	15.6	2.9	13.4	0.0	0.0	1.1	0.4	2.8	9.8	18.9	0.5	0.9	1.5	18.4	8.0
CAMTA2	KIAA0909	ENSG00000108509	"Calmodulin binding transcription activator 2"	O94983	17	4967992-4987675	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027835, HPA051147"			Supported	"Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Vesicles, Actin filaments, Mitochondria, Cytosol"	"HPA027835: , HPA051147: AB_2681362"	"unprognostic (2.82e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.08e-2)"	"prognostic favorable (6.00e-8)"	"unprognostic (3.42e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.19e-1)"	15.8	15.6	10.7	13.6	15.9	10.3	15.0	5.2	36.7	14.8	0.0	19.6	10.3	17.0	4.4	14.4	14.4	8.7	17.7	24.2	3.4	16.0	12.9	18.4	9.7	10.0	4.4	14.8	17.5	19.2	26.0	7.4	8.5	15.1	10.8	10.7	13.9	11.6	38.0	17.4	19.0	14.2	0.5	21.6	18.6	14.5	7.3	10.4	17.0	27.5	9.5	16.0	13.0	18.4	13.2	23.2	4.2	6.1	27.8	19.0	8.6	12.4	13.8	11.6	10.1	5.9	3.6	15.5	11.9	19.7	9.8	13.1	16.2	19.5	6.6	21.8	20.7	9.8	13.3	6.6	15.9	5.8	40.4	13.4	24.0	10.8	17.1	14.0	19.6	11.8	16.2	13.9	11.0	8.8	10.3	3.7	0.6	15.6	9.5	8.9	4.8	6.1	13.1	13.8	5.8	5.1	7.8	14.1	3.8	7.2	12.6	5.6	25.6	9.1	5.3	9.8	20.6	6.8	8.0	5.6	22.4	11.5	9.2	0.5	1.2	0.9	1.3	1.6	1.0	0.6	0.6	1.2	0.7	0.4	0.8	1.0	3.0	0.6	4.9	1.1	0.5	1.4	10.7	15.9	5.2	36.7	24.2	3.4	10.0	4.4	8.5	0.5	7.3	18.4	15.2	3.2	11.3	11.4	9.2	6.9	3.7	11.6	8.6	14.7	11.9	8.9	8.0	12.8	6.9	11.0	10.4	5.9	9.0	16.1	1.9	7.9	30.1	5.9	12.6	10.0	11.4	7.4	17.9	11.2	9.6	12.3	20.4	11.6	13.3	14.7	16.8	15.3	8.5	35.3	15.7	13.9	20.3	16.7	10.2	54.3	10.2	13.1	3.6	4.7	14.9	6.5	12.3	9.0	9.5	10.6	13.9	9.4	9.0	6.3	20.1	15.4	6.1	11.2	13.1	7.9	14.8	7.2	6.9	8.8	10.4	12.4	11.4	14.4	12.2	4.1
CAND1	"DKFZp434M1414, KIAA0829, TIP120, TIP120A"	ENSG00000111530	"Cullin associated and neddylation dissociated 1"	Q86VP6	12	67269358-67319953	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055748, HPA062833, HPA069053"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		5900000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074"	"unprognostic (1.50e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	18.4	23.1	19.6	19.9	21.4	22.6	25.9	25.3	21.8	21.4	15.9	19.8	19.5	21.2	27.8	22.5	19.2	18.3	12.6	20.9	21.7	24.3	27.4	16.8	27.5	18.8	19.0	25.0	18.7	28.3	19.3	23.2	21.2	22.4	20.6	37.5	16.5	20.0	9.9	29.3	18.5	21.6	19.5	19.1	18.2	27.8	19.5	38.8	26.0	11.4	30.8	23.3	19.3	19.5	62.1	62.6	93.1	66.6	69.7	54.3	62.4	60.2	51.6	62.0	54.2	58.4	34.5	132.9	51.0	60.6	38.9	57.8	101.1	68.3	70.6	50.8	60.5	75.1	46.5	55.7	45.7	89.5	40.9	51.5	51.0	56.8	51.9	75.8	58.7	63.9	60.4	72.3	67.7	61.0	81.6	60.3	98.8	47.4	43.1	78.4	79.8	56.3	57.3	103.9	95.2	47.3	74.9	68.0	49.9	77.8	73.2	40.7	50.3	49.0	31.5	34.1	46.1	23.5	31.1	111.5	58.3	52.2	51.4	9.3	6.4	7.4	14.0	7.4	17.0	10.9	16.8	15.3	10.0	14.7	17.7	14.9	2.7	19.0	14.0	8.6	19.3	5.7	19.6	21.4	25.3	21.8	20.9	21.7	18.8	19.0	21.2	19.5	19.5	19.5	37.6	60.9	36.3	38.5	61.2	58.1	50.2	51.6	57.5	92.4	51.4	40.6	17.0	42.9	42.0	44.1	116.7	37.4	61.5	47.3	13.7	30.7	3.9	45.2	53.9	44.6	45.4	34.9	48.8	28.6	42.7	47.7	41.3	51.1	7.6	71.0	40.4	49.8	31.3	87.5	61.7	50.4	34.6	42.4	52.4	11.0	69.0	35.9	33.8	32.8	54.6	53.8	48.4	49.8	63.5	35.2	28.6	60.9	55.1	56.6	59.8	32.3	55.3	115.3	26.3	52.1	50.7	82.5	47.7	47.1	63.9	44.6	59.3	66.4	46.5	64.2
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393505-17557790	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 577.1;tongue: 313.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.5;Excitatory neurons: 158.1;Inhibitory neurons: 137.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 26.1;basal ganglia: 40.9;cerebral cortex: 87.2;hippocampal formation: 50.2;white matter: 32.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 101.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	17.8	11.6	26.1	7.6	40.9	0.0	10.7	0.9	87.2	15.4	2.9	32.6	4.1	28.5	17.8	21.7	16.8	11.4	113.6	50.2	11.1	8.7	4.5	4.7	1.7	3.2	3.8	4.5	4.2	7.5	5.1	8.8	2.7	25.1	9.6	9.1	7.7	30.7	577.1	2.6	8.9	42.7	0.0	3.1	9.8	1.5	9.1	3.1	5.5	313.0	2.3	14.5	6.4	32.3	15.5	24.6	44.4	55.1	0.3	0.1	10.4	52.3	42.7	46.6	43.0	8.1	6.9	0.0	48.9	62.1	60.5	8.2	21.3	20.9	66.8	0.1	7.9	0.0	15.4	26.5	4.3	0.0	0.0	3.5	9.9	23.1	10.3	72.3	2.2	0.0	0.0	0.1	101.6	25.2	0.0	0.0	17.0	0.8	15.6	5.2	59.1	1.1	23.6	6.4	6.1	10.9	19.0	59.2	31.3	82.8	65.0	11.2	0.2	36.6	31.6	1.0	47.6	0.0	0.0	0.2	11.7	0.1	48.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	40.9	0.9	87.2	50.2	11.1	3.2	3.8	2.7	0.0	9.1	32.3	2.0	3.2	1.5	9.8	0.0	1.9	4.3	6.2	5.7	16.4	10.2	8.4	126.5	4.3	5.4	1.8	4.2	16.5	0.0	1.9	3.9	2.7	0.1	13.9	13.7	2.7	6.0	0.0	158.1	0.7	12.2	7.9	0.0	5.8	0.0	22.8	3.9	2.4	2.2	8.4	137.2	1.3	2.0	0.0	2.2	0.0	0.6	0.3	0.0	10.3	0.0	6.3	0.0	16.6	7.2	3.7	1.9	4.9	0.0	1.9	0.0	16.7	33.9	2.2	32.9	25.5	43.4	0.1	3.2	2.1	0.9	37.5	0.3	0.3	1.6	0.6
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394753-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 548.8;Hofbauer cells: 1107.4;Macrophages: 432.1;monocytes: 432.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1136.5;classical monocyte: 1139.3;eosinophil: 712.7;intermediate monocyte: 431.6;memory B-cell: 575.6;myeloid DC: 1363.2;naive B-cell: 516.8;NK-cell: 605.5;plasmacytoid DC: 959.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 563.6;HMC-1: 972.7;SK-MEL-30: 722.2;THP-1: 513.5;U-937: 569.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm		Yes	No		5400000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	92.4	26.3	42.8	82.4	44.2	159.3	94.9	46.3	79.6	119.1	37.5	56.9	30.3	50.0	46.2	289.5	48.7	44.4	19.2	41.7	51.1	201.1	8.9	175.7	117.9	60.2	46.3	19.7	44.9	151.7	27.2	26.1	57.2	76.5	42.9	4.2	111.8	38.0	16.5	219.9	54.2	24.5	57.5	46.2	94.4	26.0	66.1	58.0	162.3	5.8	109.5	97.1	174.8	79.4	165.5	75.9	0.7	6.9	50.2	102.8	83.7	59.6	6.1	51.2	49.8	9.4	563.6	28.1	96.6	116.0	64.0	181.1	0.2	113.7	23.0	142.0	4.4	74.3	128.0	29.3	40.6	44.8	972.7	93.8	80.5	53.8	70.3	3.6	37.5	143.8	8.2	60.1	38.1	150.1	101.3	414.8	23.2	166.5	112.8	87.3	13.3	11.8	220.6	77.7	0.8	1.4	86.9	128.4	722.2	44.2	40.0	513.5	148.7	111.6	26.8	4.6	2.4	1.4	6.2	10.3	259.5	569.5	1.5	1136.5	1139.3	712.7	12.2	431.6	39.2	575.6	107.8	41.1	1363.2	516.8	30.5	13.9	162.9	605.5	131.3	959.7	122.1	977.9	42.8	44.2	46.3	79.6	41.7	51.1	60.2	46.3	57.2	57.5	66.1	79.4	6.6	19.2	24.5	3.3	84.7	121.2	167.5	265.0	60.9	0.8	86.8	70.4	1.3	51.5	119.6	316.3	0.0	34.3	91.5	211.0	211.3	113.8	4.1	33.0	10.3	16.2	28.8	16.0	0.2	91.5	324.0	34.7	124.9	63.9	548.8	1.2	3.6	1.1	1107.4	1.7	0.2	55.9	50.8	141.6	337.2	15.2	46.9	432.1	147.7	1.0	432.4	43.6	11.3	0.5	0.1	405.8	205.4	22.6	17.2	106.0	74.1	168.5	48.8	1.7	13.1	2.0	54.0	9.6	33.1	167.4	169.5	35.7	101.9	0.9	83.9	253.1
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586734-240617705	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: AB_2683037"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favorable (8.47e-5)"	"prognostic unfavorable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	10.0	18.6	16.8	6.8	16.2	7.9	9.6	21.0	25.0	11.8	16.5	12.7	13.1	10.7	3.7	14.5	13.7	6.1	24.6	17.9	14.0	23.8	14.7	12.2	10.6	15.6	15.8	13.3	12.6	5.3	18.1	4.5	15.4	14.9	7.1	10.6	10.2	5.3	5.8	12.1	14.0	2.8	12.6	29.8	15.8	17.0	16.7	6.4	13.2	2.8	5.4	11.1	10.0	16.8	8.0	11.2	11.2	9.5	4.5	3.6	19.7	9.9	4.1	6.5	5.9	8.7	18.7	5.9	3.5	3.6	8.9	12.7	3.0	6.6	3.3	23.0	19.8	10.9	20.4	16.0	7.1	7.1	15.3	2.6	4.8	6.7	2.7	6.7	5.2	16.8	12.5	7.3	2.8	7.1	16.2	27.5	17.4	9.5	8.1	15.5	8.1	13.1	9.9	9.8	28.1	22.0	6.3	9.3	13.8	3.5	4.8	9.3	8.6	11.0	9.7	9.5	11.8	16.3	4.2	10.7	10.4	12.8	11.0	1.5	0.9	1.8	1.0	0.6	0.3	1.0	0.6	1.1	0.4	1.1	0.7	0.9	4.1	3.0	0.6	1.2	1.3	0.4	16.8	16.2	21.0	25.0	17.9	14.0	15.6	15.8	15.4	12.6	16.7	16.8	8.9	3.2	6.0	19.6	7.5	4.6	7.2	3.8	6.2	14.9	6.2	5.3	9.5	12.8	4.8	9.2	14.6	5.4	14.2	7.2	7.9	13.0	1.9	14.7	5.7	7.0	11.3	1.7	9.5	9.1	5.2	5.3	4.6	13.8	22.9	11.3	7.5	3.0	6.7	48.8	9.0	6.3	8.2	5.3	1.7	2.6	9.0	7.8	1.8	7.5	7.7	13.4	8.2	7.5	7.2	13.8	4.6	9.4	7.4	10.1	9.9	6.2	9.4	18.6	0.0	5.6	7.6	12.6	7.7	3.7	5.3	5.5	11.3	9.0	6.4	6.9
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"gallbladder: 22.8;liver: 24.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 41.4;Cholangiocytes: 41.5;NK-cells: 39.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"basophil: 59.3;NK-cell: 25.5"	"Group enriched"	"Detected in many"	9	"granulocytes: 59.3;NK-cells: 25.5"	"Cell line enriched"	"Detected in some"	14	"HMC-1: 35.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 3.0"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Focal adhesion sites"	Nucleoplasm	"HPA053322: AB_2682111"	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.5	0.2	0.4	1.3	0.4	0.5	0.6	0.3	0.7	5.3	0.3	1.1	2.6	1.1	0.7	1.0	2.9	22.8	1.1	0.3	0.7	3.5	24.8	2.5	2.2	0.5	0.4	0.3	1.9	0.5	0.3	0.2	0.7	0.4	1.0	0.0	5.3	1.2	0.4	4.0	1.0	0.8	0.3	1.9	2.0	0.5	0.7	1.3	0.3	0.0	2.8	0.5	0.9	0.4	0.2	1.4	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.0	0.1	2.4	0.1	0.6	0.0	0.0	0.3	1.0	0.0	0.6	0.0	0.1	0.0	0.2	0.7	0.7	0.0	0.0	35.1	0.6	2.0	0.2	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.4	0.7	0.6	0.0	0.1	0.0	0.5	59.3	0.1	3.6	4.4	0.0	4.4	2.6	1.3	2.4	0.1	3.8	0.0	1.1	0.7	25.5	0.0	0.0	1.0	1.2	0.4	0.4	0.3	0.7	0.3	0.7	0.5	0.4	0.7	0.3	0.7	0.4	2.5	12.8	41.4	0.7	14.8	9.4	9.2	16.5	4.0	1.6	3.3	4.6	0.9	41.5	8.5	5.5	0.0	1.7	17.7	4.3	0.0	11.6	0.8	7.8	2.8	2.6	3.6	1.3	0.5	7.2	9.4	1.1	8.6	21.2	5.1	0.9	2.5	16.1	1.0	0.0	0.2	21.4	10.2	1.3	3.3	0.6	0.6	1.4	3.6	1.0	1.0	1.4	39.1	0.0	0.3	5.4	6.0	0.4	9.8	5.4	9.7	21.7	10.0	0.6	0.0	2.3	3.0	0.3	2.4	3.4	9.5	2.9	19.1	2.2	15.7	4.8
CAPN13	FLJ23523	ENSG00000162949	"Calpain 13"	Q6MZZ7	2	30722771-30820542	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.2;stomach 1: 28.5"	"Cell type enhanced"	"Detected in many"		"Club cells: 76.6;Gastric mucus-secreting cells: 50.0;Proximal enterocytes: 35.2;Undifferentiated cells: 18.1;Urothelial cells: 19.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RT4: 9.3;SK-BR-3: 21.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029496, HPA029497, HPA030034"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281"	"unprognostic (7.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.28e-3)"	0.0	0.0	0.8	0.0	1.4	0.0	7.2	0.9	1.3	9.7	1.0	11.4	20.8	0.2	0.3	0.9	1.1	2.8	0.0	0.7	0.8	2.5	0.2	7.2	0.0	1.1	1.3	0.0	3.6	0.4	0.2	0.0	1.0	3.8	24.6	0.0	1.2	0.1	0.0	0.2	29.2	0.2	1.0	0.1	28.5	0.1	1.1	0.0	0.0	0.0	0.6	4.1	0.5	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	9.3	0.1	0.4	0.0	21.9	0.0	0.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.9	1.3	0.7	0.8	1.1	1.3	1.0	1.0	1.1	2.3	0.0	6.4	3.1	0.3	0.0	0.0	10.2	3.5	4.0	0.0	4.2	1.8	1.3	0.0	76.6	1.8	0.0	0.0	0.0	16.9	0.0	1.3	0.8	2.0	0.0	0.1	15.0	0.0	0.3	5.3	0.0	0.6	50.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	1.5	12.0	6.1	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.4	1.9	6.2	0.0	0.0	2.7	35.2	0.2	12.4	0.0	0.0	0.0	6.1	0.0	0.1	1.4	0.0	0.0	0.1	0.0	18.1	19.4
CAPN15	SOLH	ENSG00000103326	"Calpain 15"	O75808	16	527712-554636	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 4.7;neutrophil: 16.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011960	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA011960: AB_10610556"	"unprognostic (4.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.54e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.23e-3)"	13.0	12.0	3.6	7.2	2.5	8.1	10.8	11.6	6.2	12.2	0.2	20.2	16.3	13.4	0.4	18.5	13.2	1.6	11.2	3.2	0.2	18.4	17.2	15.3	5.1	4.1	1.0	13.2	24.8	2.2	15.2	2.6	1.4	12.3	2.3	1.1	12.6	2.8	14.9	22.3	22.7	1.2	0.2	21.2	16.5	18.7	2.1	2.8	11.7	0.9	2.5	12.5	12.8	0.8	16.8	21.5	3.0	9.3	1.7	3.4	46.2	17.5	4.6	4.9	3.3	28.2	12.1	24.0	16.3	3.2	5.0	21.9	2.0	6.9	1.8	25.2	37.1	20.2	25.7	17.6	7.3	23.8	27.3	3.9	4.0	4.9	2.2	2.9	5.3	14.7	37.6	7.1	1.6	25.9	27.1	26.0	26.7	8.6	20.2	46.5	8.7	24.2	3.3	11.0	19.6	17.8	11.7	16.2	10.2	1.8	13.3	24.7	26.2	15.3	21.4	15.7	22.0	18.2	11.0	21.3	6.7	13.8	9.7	4.7	1.3	0.8	0.3	0.8	0.1	0.4	0.1	0.4	0.3	2.3	0.1	0.2	16.2	1.1	1.3	0.5	0.2	0.3	3.6	2.5	11.6	6.2	3.2	0.2	4.1	1.0	1.4	0.2	2.1	0.8	7.6	3.2	8.4	10.1	5.9	8.9	5.7	6.2	3.4	12.1	7.6	6.6	3.1	8.6	5.6	7.3	16.7	3.7	22.3	54.3	1.9	6.2	16.5	6.1	8.9	8.7	4.2	1.7	10.6	15.7	4.4	6.9	20.4	13.3	7.0	10.8	8.9	16.5	6.8	20.2	11.3	26.9	8.2	12.0	6.8	6.2	7.5	8.2	1.8	7.5	6.5	9.1	23.7	10.6	7.8	14.3	37.1	4.5	5.8	13.4	33.1	5.7	4.6	11.2	0.0	10.2	5.2	5.3	7.4	5.8	8.0	2.5	9.2	9.6	25.9	11.6
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066961-77126155	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 60.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 170.3;Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 89.8;Paneth cells: 72.6;Proximal enterocytes: 75.6;Undifferentiated cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	6.7	12.2	8.5	10.9	7.9	2.7	4.9	6.4	8.6	13.5	3.5	60.5	60.7	10.0	5.7	31.6	10.8	36.3	7.2	8.5	8.7	15.1	52.1	4.8	1.9	11.7	8.2	13.2	5.6	1.0	5.1	2.8	12.5	16.0	49.9	3.8	7.7	8.9	1.6	3.1	52.4	11.3	9.9	3.5	47.9	21.5	7.9	2.8	4.7	1.7	2.7	15.4	10.5	8.1	0.8	12.5	8.6	7.8	32.0	30.4	0.7	11.8	22.9	13.4	10.0	6.9	3.6	0.4	7.7	24.5	14.4	0.5	3.8	1.0	6.4	0.5	0.8	2.1	0.5	0.9	7.9	0.2	0.4	16.1	1.4	22.6	5.2	18.8	14.4	5.1	0.2	0.0	26.9	19.9	1.8	0.3	6.6	106.6	9.3	2.0	27.0	0.4	4.6	16.4	0.5	13.5	1.0	2.7	5.9	5.7	1.7	0.1	23.9	25.4	12.3	34.8	1.3	0.8	1.7	0.1	13.1	0.3	5.7	0.0	0.2	0.0	1.3	0.3	0.1	0.0	0.1	0.5	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.0	0.7	8.5	7.9	6.4	8.6	8.5	8.7	11.7	8.2	12.5	9.9	7.9	8.1	1.6	0.0	0.5	4.2	1.0	1.7	0.3	2.2	0.0	3.1	0.5	1.8	1.7	24.3	10.3	23.9	0.0	0.1	3.4	170.3	1.9	10.3	1.1	1.9	5.9	2.4	22.3	5.7	4.6	32.7	0.4	7.6	80.0	3.5	0.0	10.2	2.9	40.4	0.9	1.7	6.7	89.8	10.2	1.6	1.8	1.3	12.5	1.2	7.2	1.0	0.3	5.8	5.2	11.6	0.7	22.4	72.6	4.5	0.9	2.0	75.6	9.9	11.1	2.1	0.0	8.3	4.1	0.5	2.3	2.5	0.9	0.0	1.5	5.3	69.2	2.4
CAPN6	"CalpM, CANPX, CAPNX"	ENSG00000077274	"Calpain 6"	Q9Y6Q1	X	111245099-111270483	"Cancer-related genes, Enzymes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 212.7;placenta: 83.1;seminal vesicle: 72.4"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 198.5;Syncytiotrophoblasts: 140.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 25.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.8;NTERA-2: 16.3;SuSa: 14.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 9.6"	HPA040259			Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA040259: "	"unprognostic (1.27e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.12e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.02e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.30e-2)"	2.1	0.0	0.0	7.2	0.0	0.0	12.7	0.0	0.0	11.9	0.0	5.6	1.8	22.5	212.7	2.3	3.2	8.4	0.3	0.0	0.0	11.5	0.3	0.5	2.8	0.0	0.0	2.6	7.5	0.1	0.2	83.1	0.0	10.6	8.6	0.0	14.1	72.4	3.0	1.0	1.7	8.2	0.0	1.7	12.9	2.0	0.0	1.8	1.5	9.0	4.7	3.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	16.3	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.3	0.4	0.3	0.0	14.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.1	0.0	1.2	0.0	0.6	2.0	0.3	7.2	0.0	7.3	0.0	39.9	0.1	0.1	3.9	8.3	0.0	18.0	4.3	0.4	0.0	0.0	0.0	0.7	198.5	12.9	6.6	40.1	0.0	0.0	0.0	0.0	7.6	0.0	0.1	1.2	0.0	0.0	0.3	0.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	22.2	0.1	0.4	0.0	0.2	0.0	0.0	0.0	1.0	0.5	0.1	0.1	0.9	0.0	140.5	0.3	0.9	0.5	0.3
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665723	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"stomach 1: 291.1"	"Cell type enriched"	"Detected in many"	6	"Gastric mucus-secreting cells: 910.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 125.9;RT4: 76.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: AB_2686646"	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.3	0.2	4.7	6.3	1.0	0.1	14.9	0.1	1.7	1.1	2.3	23.6	8.0	0.1	11.1	0.6	1.3	14.3	0.0	2.3	3.6	1.7	0.3	21.3	0.1	2.7	1.5	0.2	2.9	0.0	0.1	0.3	1.1	2.9	33.0	0.3	8.5	1.4	0.8	2.3	4.6	1.1	2.0	0.3	291.1	0.6	1.8	0.0	0.2	0.0	0.3	12.3	0.7	2.5	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.8	0.0	4.6	0.0	0.1	0.0	0.2	8.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.2	125.9	3.8	0.1	0.0	0.0	1.3	76.8	1.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	4.7	1.0	0.1	1.7	2.3	3.6	2.7	1.5	1.1	2.0	1.8	2.5	0.4	28.9	131.7	1.6	1.8	0.1	6.5	1.9	0.0	0.0	19.9	7.9	2.6	10.0	55.9	25.8	0.0	0.2	0.2	90.9	0.0	3.8	2.3	2.0	0.3	0.7	3.0	0.0	0.6	21.6	0.0	0.3	910.8	2.1	10.8	5.2	0.0	0.3	0.6	0.0	0.1	61.9	4.1	0.0	0.8	6.7	1.8	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	36.1	42.6	3.4	3.5	4.0	2.1	1.5	15.0	0.0	0.0	0.3	0.8	0.4	1.0	0.0	0.0	0.1	1.4	2.9	21.2	31.2
CAPNS1	"30K, CANP, CANPS, CAPN4, CDPS"	ENSG00000126247	"Calpain small subunit 1"	P04632	19	36139953-36150353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006872	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		9000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006872: AB_1078382"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-2)"	425.4	357.9	363.0	171.4	374.4	235.7	371.7	359.4	507.1	368.1	353.9	371.4	263.2	303.5	193.8	761.7	306.6	197.8	692.5	379.8	411.1	488.5	273.5	396.7	167.4	401.0	392.3	267.6	250.9	330.9	317.9	147.3	401.0	357.0	287.6	136.2	374.9	281.4	491.3	211.9	341.4	290.0	356.5	363.6	311.1	273.6	400.3	200.8	329.9	373.4	275.1	354.8	402.5	384.1	395.2	977.6	240.0	342.7	566.3	683.0	48.2	315.8	673.4	631.3	488.1	223.3	572.2	141.9	463.7	1067.5	225.6	207.0	291.3	780.8	514.7	592.4	142.9	166.0	259.7	373.0	655.0	166.7	393.9	740.8	477.9	411.1	577.5	767.3	699.8	173.5	204.4	554.4	978.6	522.7	295.4	301.4	137.9	754.6	490.6	156.5	194.7	262.3	1208.8	368.7	159.1	199.4	385.1	532.0	155.5	279.4	308.6	261.4	460.6	555.5	424.3	188.1	318.7	198.4	277.6	126.8	630.4	225.9	480.8	24.8	50.1	22.6	44.4	75.6	28.5	29.4	30.9	36.4	46.1	32.3	18.7	25.2	25.2	24.6	83.4	58.7	34.7	21.1	363.0	374.4	359.4	507.1	379.8	411.1	401.0	392.3	401.0	356.5	400.3	384.1	172.7	125.0	98.6	10.4	49.3	30.7	76.2	69.1	29.6	21.1	91.7	75.1	149.5	130.1	85.9	163.7	0.0	74.9	107.1	250.1	62.6	226.3	102.9	168.5	118.3	136.6	107.8	47.3	13.4	251.3	87.8	83.3	66.8	234.4	63.4	84.7	157.1	78.4	155.1	16.8	11.9	220.3	52.9	244.6	86.9	230.2	93.2	130.5	39.2	15.9	208.4	78.2	109.2	6.6	21.9	254.2	187.5	76.0	50.2	98.0	243.5	135.3	74.6	33.1	46.0	64.3	92.9	120.1	6.5	109.1	28.8	70.1	62.8	132.2	165.6	112.4
CAPRIN2	"C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140"	ENSG00000110888	"Caprin family member 2"	Q6IMN6	12	30709552-30754951	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.8;Inhibitory neurons: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039746	Supported		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	"Nucleoplasm, Centrosome"	"HPA039746: AB_10672902"	"unprognostic (7.45e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (8.36e-4)"	4.2	6.1	11.7	4.0	12.1	8.5	3.7	11.3	20.3	5.7	3.2	6.3	2.8	6.3	7.4	2.9	5.1	4.4	13.5	10.7	37.4	5.7	5.6	4.7	4.3	20.5	8.8	7.3	5.8	9.4	10.0	3.0	16.3	5.6	4.0	18.0	3.2	6.9	6.0	8.0	4.9	6.1	3.8	6.1	5.5	17.4	12.7	3.6	5.0	5.0	3.6	6.0	4.3	12.1	7.4	5.1	9.4	7.9	9.1	9.5	5.7	13.4	11.2	5.7	7.7	2.8	4.6	4.3	11.5	14.1	11.3	5.8	5.0	22.0	10.3	6.5	5.6	18.0	9.5	10.4	5.1	2.9	1.8	11.1	8.4	18.2	14.6	23.6	13.0	7.7	1.1	4.3	13.6	1.4	3.7	4.6	11.0	3.9	15.2	1.6	14.1	2.1	2.5	26.1	11.7	7.1	5.0	3.6	5.6	22.3	3.2	0.9	17.8	11.0	6.0	33.5	24.9	8.1	6.1	4.1	13.2	0.9	7.3	6.2	0.8	0.7	2.4	0.3	2.9	2.6	1.5	2.6	0.4	2.1	1.7	1.6	0.1	1.7	0.4	2.4	1.1	0.6	11.7	12.1	11.3	20.3	10.7	37.4	20.5	8.8	16.3	3.8	12.7	12.1	9.8	22.4	27.7	45.1	9.0	7.1	4.9	3.8	7.4	28.9	6.4	9.1	28.7	0.0	6.3	3.7	22.9	8.6	14.7	5.3	9.8	5.6	17.2	21.8	12.2	11.6	16.7	23.5	73.8	11.2	1.7	12.2	11.2	10.0	22.1	19.6	7.9	8.0	9.6	11.8	68.5	5.0	0.0	7.8	4.4	13.7	6.8	6.7	3.6	12.2	4.5	10.5	11.3	49.3	19.4	33.9	2.2	8.6	8.8	2.5	4.5	11.9	13.0	34.2	6.6	13.2	11.3	8.2	33.5	9.2	4.5	12.3	11.8	9.8	3.9	3.3
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine	Q13938	19	5912339-5916211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 334.8"	"Group enriched"	"Detected in many"	6	"Endometrial ciliated cells: 2622.9;Respiratory ciliated cells: 1557.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 19.4;SK-BR-3: 65.1;U-266/70: 19.8"					"Low region specificity"	"Detected in all"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favorable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	12.2	25.9	37.5	10.9	35.1	10.0	11.6	55.0	30.1	47.2	55.4	16.1	6.9	21.7	4.6	12.9	334.8	11.2	13.5	40.2	69.6	38.3	21.5	49.5	12.2	72.6	105.3	13.8	24.0	3.3	27.9	9.3	85.7	40.4	2.8	2.2	24.9	30.9	4.3	16.2	18.7	2.3	60.9	25.2	37.5	6.4	50.0	5.7	30.8	1.1	4.2	44.2	13.7	66.1	2.2	2.3	0.9	6.3	2.1	3.2	4.0	0.7	0.7	0.3	0.6	1.5	13.8	0.9	4.0	1.5	0.7	2.3	0.1	0.6	0.0	4.7	1.9	0.8	4.8	4.7	2.5	0.8	3.5	4.1	4.2	0.4	0.8	4.0	1.0	4.7	0.7	5.4	0.7	4.4	2.4	4.0	0.7	19.4	12.6	3.1	0.3	4.7	1.8	6.2	1.0	4.9	1.0	65.1	6.6	2.0	4.3	4.7	1.5	0.6	0.4	4.6	17.1	19.8	6.5	1.1	7.7	1.8	2.8	0.4	0.7	0.3	1.7	0.6	0.9	0.9	1.0	1.3	0.8	1.8	0.8	0.7	0.7	1.8	0.4	1.5	1.0	0.8	37.5	35.1	55.0	30.1	40.2	69.6	72.6	105.3	85.7	60.9	50.0	66.1	5.3	12.8	16.5	11.1	3.3	4.8	32.1	122.8	1.8	2.5	8.9	8.8	2.2	0.0	161.5	121.4	4.2	24.3	7.4	5.3	35.2	34.7	6.5	2622.9	48.3	5.5	19.2	0.4	2.6	5.9	22.8	12.9	33.6	330.8	6.3	8.1	0.0	0.0	5.2	6.7	3.2	25.1	197.4	0.0	5.9	5.7	4.7	6.6	10.6	6.5	3.0	7.7	9.2	3.5	12.9	36.9	3.3	4.9	3.8	20.4	4.2	4.5	1557.4	4.2	6.6	3.5	42.7	0.4	0.6	0.9	4.1	20.5	9.2	3.3	9.3	128.6
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 11.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 85.5;Excitatory neurons: 133.8;Inhibitory neurons: 95.8;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 102.6;Respiratory ciliated cells: 77.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039542, HPA040004"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles,Centrosome		Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Vesicles, Centrosome"	"HPA039542: , HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	1.0	1.5	1.2	0.3	1.2	0.5	1.4	1.7	4.0	1.2	8.8	1.0	0.6	2.0	3.7	1.3	10.0	1.3	2.3	1.1	3.1	2.7	1.8	2.4	0.3	5.5	4.3	1.6	0.9	3.9	2.5	0.1	2.5	2.0	0.6	11.8	2.4	1.3	1.7	0.9	0.6	0.6	2.7	1.0	1.3	3.8	2.3	0.6	4.0	3.2	0.3	0.7	0.7	2.6	0.7	2.1	0.6	0.1	1.0	0.7	0.0	0.4	0.1	1.1	1.2	0.0	1.0	0.2	1.8	0.3	0.4	0.5	0.0	1.0	0.8	0.7	0.3	0.9	0.4	0.0	0.0	0.1	0.0	0.3	0.5	0.9	0.2	6.8	0.1	0.7	0.2	0.3	1.5	0.0	1.0	0.8	0.3	0.0	0.3	0.0	0.0	0.1	1.5	0.0	1.2	0.6	0.1	0.0	0.6	0.1	0.7	0.3	0.5	1.0	0.5	0.2	0.1	0.1	0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.0	1.2	1.2	1.7	4.0	1.1	3.1	5.5	4.3	2.5	2.7	2.3	2.6	3.3	9.6	2.8	85.5	1.7	1.8	2.6	2.9	7.4	1.5	3.1	3.0	8.2	1.5	11.5	5.5	4.2	1.2	0.9	0.4	5.9	1.1	35.8	24.3	2.1	2.3	0.0	4.6	133.8	1.7	0.6	4.8	4.6	0.9	0.0	6.0	3.3	2.4	0.5	1.7	95.8	1.3	2.0	1.6	1.7	14.9	6.2	1.3	0.0	46.9	0.1	6.7	2.1	117.1	102.6	0.6	0.3	7.2	2.5	1.0	0.5	3.5	77.2	22.4	0.0	3.8	3.8	8.5	1.6	4.1	0.6	0.3	1.6	3.3	0.8	0.6
CAPSL	MGC26610	ENSG00000152611	"Calcyphosine like"	Q8WWF8	5	35904288-35938779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"fallopian tube: 110.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 167.1;Endometrial ciliated cells: 400.1;Late spermatids: 148.9;Respiratory ciliated cells: 709.5"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 14.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.7;REH: 8.0;U-698: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046811, HPA058495"	Enhanced		Approved	Nucleoplasm,Microtubules		No	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Microtubules"		"HPA046811: AB_2679819, HPA058495: AB_2683735"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.20e-2)"		"unprognostic (7.35e-2)"		"unprognostic (1.29e-1)"	"unprognostic (1.92e-3)"	"unprognostic (4.42e-1)"	"unprognostic (3.62e-4)"		"unprognostic (1.46e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.52e-1)"	0.0	0.0	3.3	0.0	2.8	0.2	0.1	1.9	2.1	2.5	25.4	0.0	0.0	2.0	8.4	0.0	110.9	0.0	0.0	2.1	3.6	0.8	0.0	7.7	0.0	9.9	10.2	0.1	0.5	1.2	13.6	0.0	7.5	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	8.0	0.0	0.1	9.9	4.0	6.6	5.4	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	7.3	6.2	0.0	0.0	2.2	0.0	1.0	0.1	0.0	0.1	0.0	4.7	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.0	0.0	1.2	2.1	0.0	0.5	0.0	0.0	19.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	2.8	1.9	2.1	2.1	3.6	9.9	10.2	7.5	8.0	4.0	7.6	0.0	3.2	7.3	0.3	0.0	0.0	0.1	58.0	0.0	0.0	0.2	0.0	0.0	0.0	66.2	1.8	0.0	0.0	0.0	0.0	1.9	0.1	167.1	400.1	2.4	0.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	4.7	1.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	65.1	0.0	0.0	148.9	0.9	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.5	0.0	1.6	709.5	0.0	0.0	0.0	19.2	21.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line subunit beta"	P47756	1	19338775-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1188.8;Late spermatids: 3669.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		6600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	210.2	193.0	126.1	196.7	126.9	154.3	189.1	128.8	133.4	233.9	129.0	294.5	149.1	254.5	145.8	265.1	199.9	144.2	207.5	139.9	129.8	161.3	127.7	217.9	223.8	133.7	128.6	205.1	94.2	128.6	121.5	178.7	132.5	200.9	214.2	123.8	152.5	177.9	301.8	195.1	220.6	241.4	126.3	215.9	192.6	216.2	135.8	237.1	155.2	214.2	271.8	230.3	222.2	143.8	263.9	146.4	260.0	179.3	355.6	467.0	187.9	435.9	430.0	364.0	377.5	189.6	338.1	179.7	186.4	533.5	218.7	212.0	224.0	297.9	424.3	280.0	160.5	340.1	170.6	298.3	355.0	236.5	533.6	424.0	243.4	314.9	292.6	300.5	338.6	204.5	132.1	229.7	393.9	185.1	270.5	307.0	200.5	343.8	155.3	223.4	184.6	225.2	507.6	133.0	158.0	123.4	255.2	200.6	299.3	229.5	222.2	199.6	351.5	237.9	207.0	409.4	208.7	156.0	188.8	217.4	314.1	306.8	261.5	456.1	358.2	1077.5	304.0	542.3	265.0	266.1	318.5	329.4	362.3	203.7	263.5	293.7	576.3	196.7	703.0	199.1	404.2	597.6	126.1	126.9	128.8	133.4	139.9	129.8	133.7	128.6	132.5	126.3	135.8	143.8	197.7	99.3	68.9	52.9	160.3	156.3	282.8	263.0	103.6	93.9	106.9	117.7	87.6	112.9	143.5	101.2	41.7	338.0	247.5	301.7	297.4	322.1	1188.8	86.7	122.2	182.4	141.2	89.4	49.8	256.5	396.4	178.9	101.9	96.8	147.5	164.6	156.0	98.7	800.9	77.4	67.5	278.7	215.7	302.6	276.7	3669.8	232.7	311.2	144.1	124.6	561.5	151.1	338.8	42.7	64.9	349.6	295.2	302.4	103.4	206.8	235.6	251.2	122.6	93.2	243.3	97.8	262.6	119.0	81.5	150.3	182.7	342.2	268.2	197.9	193.8	280.5
CARD8	"CARDINAL, Dakar, KIAA0955, NDPP, TUCAN"	ENSG00000105483	"Caspase recruitment domain family member 8"	Q9Y2G2	19	48180770-48255946	"Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 114.4;HUVEC TERT2: 154.6;NB-4: 131.8;TIME: 148.6"									"HPA042071, HPA043513"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA042071: AB_2677831, HPA043513: AB_2678522"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (1.72e-5)"	27.7	8.7	7.8	29.1	9.6	23.7	17.1	9.0	8.7	13.1	11.0	11.2	12.7	10.9	7.8	8.2	8.9	14.4	12.9	7.5	9.3	8.9	12.4	19.1	38.2	10.8	9.6	8.5	11.5	9.7	5.8	23.6	10.6	7.1	11.9	5.4	8.0	7.8	16.3	7.7	14.7	15.9	9.8	38.8	13.8	10.6	11.5	31.3	13.0	20.1	36.9	15.4	7.7	11.1	13.4	31.1	28.1	9.1	10.0	15.3	10.9	12.4	15.6	19.0	29.1	10.8	20.1	28.7	15.8	11.9	12.8	8.2	16.9	9.2	17.1	43.8	14.9	114.4	17.0	21.6	11.8	59.2	87.3	11.2	7.0	10.8	11.7	16.5	154.6	28.6	16.8	32.5	15.6	9.5	24.4	131.8	7.1	27.9	7.8	40.9	13.4	7.1	11.2	17.1	9.7	14.6	20.4	14.2	18.5	13.6	8.9	52.2	148.6	11.3	14.3	5.0	21.2	28.9	78.3	18.0	5.2	42.1	21.2	104.9	45.8	76.8	29.2	63.5	33.8	30.7	29.4	34.4	39.9	31.2	27.4	29.5	167.3	28.1	68.2	27.9	45.0	32.2	7.8	9.6	9.0	8.7	7.5	9.3	10.8	9.6	10.6	9.8	11.5	11.1	115.7	3.2	29.2	11.4	38.9	9.3	4.9	6.5	2.2	8.9	11.4	8.3	9.9	12.8	8.6	12.9	12.5	26.9	50.9	5.1	5.9	7.9	25.3	5.8	10.3	68.6	5.4	36.2	2.0	10.8	11.2	12.1	7.1	6.7	34.1	25.6	73.5	25.9	41.9	6.7	2.7	7.4	6.1	79.5	30.9	59.3	7.8	61.6	21.4	55.3	47.6	4.2	79.3	13.6	17.3	11.2	6.7	7.9	40.1	3.5	9.7	11.7	9.3	3.4	6.6	11.2	11.3	19.6	14.2	6.5	7.1	15.5	55.6	8.6	7.0	3.4
CARM1	PRMT4	ENSG00000142453	"Coactivator associated arginine methyltransferase 1"	Q86X55	19	10871553-10923075	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 110.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032961, HPA043561, HPA048073, HPA069313"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		19000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: "	"unprognostic (9.46e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.18e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (7.88e-6)"	"unprognostic (1.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (8.37e-4)"	20.3	17.1	24.7	19.6	26.6	22.7	17.6	18.9	34.1	30.6	17.2	28.4	17.3	31.7	7.8	36.7	23.4	14.7	25.4	27.6	23.7	18.8	20.1	16.4	19.8	22.8	21.8	21.9	22.3	11.5	14.8	20.4	22.6	20.2	14.3	6.4	20.2	17.5	110.5	22.6	20.9	21.3	19.9	18.6	20.3	45.4	22.6	10.9	13.4	72.4	15.4	26.3	28.0	26.0	62.5	46.8	64.9	88.3	52.5	71.1	63.2	42.8	75.6	63.9	61.0	73.4	21.8	85.2	52.4	77.4	32.1	58.0	65.4	66.2	40.1	98.4	52.7	26.5	29.1	89.9	44.8	39.3	33.9	49.0	42.4	43.8	52.4	35.9	82.1	67.9	65.8	79.2	38.2	116.7	70.0	34.3	81.4	40.7	74.8	97.5	32.8	100.7	38.9	29.7	47.0	45.1	30.7	36.2	43.6	31.7	38.4	35.3	48.7	75.4	43.2	72.3	54.0	75.0	64.1	77.2	51.1	63.8	35.3	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.1	0.5	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.1	24.7	26.6	18.9	34.1	27.6	23.7	22.8	21.8	22.6	19.9	22.6	26.0	12.9	9.6	12.2	7.2	11.6	7.8	5.9	4.1	12.0	36.4	14.0	13.7	1.1	14.3	6.5	9.2	52.1	18.5	6.4	42.3	7.9	13.4	32.7	20.1	30.8	12.7	27.6	30.7	12.9	19.7	33.1	13.8	13.7	25.4	1.3	17.8	12.8	27.8	26.7	45.4	10.6	24.9	4.1	20.0	10.9	23.5	28.3	14.8	5.4	5.6	23.9	8.7	4.1	10.6	5.8	24.8	27.2	19.2	11.7	14.1	22.6	9.2	7.4	21.1	6.6	19.6	13.0	23.8	17.5	25.7	7.0	12.0	6.5	6.6	25.7	11.8
CARS2	FLJ12118	ENSG00000134905	"Cysteinyl-tRNA synthetase 2, mitochondrial"	Q9HA77	13	110641412-110713603	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 204.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041776	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA041776: AB_2677666"	"unprognostic (2.34e-3)"	"unprognostic (9.50e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.71e-2)"	18.3	24.4	8.8	18.9	9.3	28.4	15.0	16.3	13.3	20.3	15.8	20.8	17.5	16.0	13.7	18.6	16.4	11.1	25.9	9.7	9.3	15.4	19.9	16.7	19.3	9.0	9.3	15.3	15.8	15.0	17.6	12.1	9.7	15.2	13.8	9.2	18.9	12.3	45.8	17.6	18.5	12.6	9.2	17.8	17.2	11.2	9.7	12.9	14.3	26.7	14.1	17.7	15.9	10.5	116.0	37.7	21.2	52.6	55.7	51.7	28.7	49.9	45.7	49.6	60.6	53.5	50.7	53.5	68.4	55.4	75.6	61.0	36.6	63.8	40.2	49.2	58.5	33.5	79.6	63.8	58.5	83.0	39.3	66.7	50.7	43.3	51.8	35.5	36.0	40.9	23.2	16.6	71.2	27.2	37.5	27.6	18.4	88.9	36.8	54.2	15.6	22.3	54.2	33.4	37.7	28.9	40.7	62.0	61.1	22.7	29.8	94.0	32.5	41.8	15.6	53.2	51.6	29.0	35.8	32.4	204.5	50.1	41.9	0.0	2.9	0.4	1.1	3.3	1.2	1.8	0.3	0.4	2.4	0.8	1.1	0.5	1.7	0.4	4.6	2.0	0.4	1.1	8.8	9.3	16.3	13.3	9.7	9.3	9.0	9.3	9.7	9.2	9.7	10.5	18.2	9.6	15.9	24.5	24.4	12.9	24.2	10.3	8.6	21.4	21.8	23.4	39.3	18.6	9.5	27.6	25.0	26.7	28.2	17.6	50.9	17.7	66.5	24.1	21.7	13.6	18.7	10.7	29.2	4.7	29.1	21.6	18.8	27.3	16.5	45.3	9.3	26.6	26.9	23.5	25.1	17.7	12.2	31.2	9.0	221.4	20.5	32.8	12.4	24.4	51.4	24.3	14.4	14.1	26.6	12.1	10.8	18.0	18.6	18.2	23.0	38.1	10.6	25.9	6.6	29.2	24.7	8.6	7.5	22.3	13.5	16.8	19.8	44.2	28.5	17.6
CASD1	"C7orf12, FLJ21213, FLJ21879"	ENSG00000127995	"CAS1 domain containing 1"	Q96PB1	7	94509219-94557019	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.7;Inhibitory neurons: 108.5;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044404	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA044404: AB_10964353"	"unprognostic (4.02e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.04e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.83e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.59e-3)"	11.1	25.3	11.4	9.6	14.0	6.0	15.7	11.1	12.9	11.3	4.8	16.5	6.5	14.1	14.6	6.3	11.0	10.0	17.1	14.9	17.4	12.4	9.0	11.3	12.5	8.8	10.7	16.4	9.8	13.8	8.7	12.3	12.9	13.9	19.3	22.1	20.3	9.4	14.1	3.8	6.1	11.0	11.3	10.6	7.3	13.1	14.6	11.2	16.0	19.6	10.8	9.1	4.3	14.0	5.5	10.4	34.7	12.9	10.4	12.3	5.9	7.2	12.8	7.9	10.2	6.5	13.2	13.9	18.5	9.8	14.1	3.0	8.8	2.5	15.4	22.2	7.1	12.3	8.5	11.9	8.8	20.5	0.0	11.4	9.2	7.2	10.3	15.4	12.6	16.0	6.7	29.3	19.6	8.0	28.5	11.6	17.7	7.7	8.2	19.3	28.0	10.8	15.9	14.9	13.1	44.5	11.4	20.7	7.4	24.9	5.4	12.8	6.7	19.6	15.5	16.2	10.6	28.0	28.1	28.5	10.7	4.7	12.9	0.0	0.2	0.0	0.6	0.2	1.6	0.6	0.9	0.8	0.4	0.5	0.9	0.7	0.0	0.6	0.2	0.3	0.6	0.2	11.4	14.0	11.1	12.9	14.9	17.4	8.8	10.7	12.9	11.3	14.6	14.0	26.2	28.9	26.3	76.0	15.4	4.6	5.8	5.8	4.0	56.4	14.4	12.8	21.1	17.2	12.8	20.2	18.8	14.2	14.6	29.7	3.9	5.1	3.4	18.0	13.1	16.4	7.2	4.6	93.7	5.6	5.7	14.6	5.1	9.9	10.2	23.7	16.1	13.3	8.8	67.3	108.5	30.2	2.0	9.8	5.5	7.0	11.5	10.8	24.9	61.8	7.1	23.3	10.3	122.6	170.3	6.8	11.8	9.8	9.2	10.0	0.6	10.8	18.1	31.4	19.7	41.2	12.2	9.6	12.8	4.7	4.5	16.8	12.2	25.8	19.5	4.5
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 135.8;Oligodendrocyte precursor cells: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 47.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 47.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	10.2	11.1	13.6	11.9	12.9	7.3	15.7	12.3	11.1	11.6	12.4	25.3	32.1	11.1	9.4	13.7	10.5	18.5	6.8	14.2	17.1	16.4	13.4	12.2	12.5	13.2	19.4	13.5	12.8	11.8	6.3	16.3	15.7	10.6	27.3	19.8	13.2	8.3	5.0	9.3	31.9	12.0	15.4	12.4	19.8	3.6	25.2	15.4	10.6	6.1	10.4	15.3	8.8	18.0	27.4	32.5	31.4	19.1	21.6	18.6	10.9	23.2	18.7	13.2	12.3	72.3	42.6	0.4	12.0	29.3	23.8	52.3	35.2	23.2	22.8	25.4	20.9	0.6	27.7	26.2	22.1	4.4	3.6	19.8	63.2	25.1	30.1	27.5	11.6	15.3	2.2	21.3	30.2	30.9	8.4	2.2	29.7	37.6	22.6	12.7	79.8	13.2	31.2	54.8	29.7	15.6	43.7	17.7	13.9	52.7	19.0	0.8	14.2	24.4	25.8	22.1	13.3	7.6	5.2	9.5	24.4	3.1	16.9	47.1	1.5	8.7	0.8	1.1	0.8	0.7	0.9	1.3	0.4	0.9	1.2	1.1	1.7	4.3	0.7	0.5	4.5	0.6	13.6	12.9	12.3	11.1	14.2	17.1	13.2	19.4	15.7	15.4	25.2	18.0	13.0	12.8	20.4	101.9	8.8	32.6	42.7	11.1	8.0	42.2	23.7	16.5	7.8	8.6	14.6	7.3	22.9	2.0	12.1	25.8	50.9	13.7	0.9	9.6	24.1	16.0	13.8	0.8	96.6	14.5	0.7	18.8	18.8	11.9	0.0	17.4	8.9	15.0	21.3	50.5	135.8	28.7	14.2	2.8	21.5	1.0	9.9	10.7	10.6	60.0	2.5	9.3	0.0	447.8	59.7	22.1	24.1	9.4	7.0	16.4	35.2	20.9	15.7	25.7	19.7	38.2	20.6	2.9	2.1	13.9	32.5	1.6	26.5	47.7	41.8	33.2
CASKIN1	"ANKS5A, KIAA1306"	ENSG00000167971	"CASK interacting protein 1"	Q8WXD9	16	2177180-2196605	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 45.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 39.5;Bipolar cells: 22.9;Excitatory neurons: 20.8;Horizontal cells: 42.1;Inhibitory neurons: 26.4;Muller glia cells: 20.2;Oligodendrocyte precursor cells: 28.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.8;HDLM-2: 14.7;HEK 293: 3.2;SCLC-21H: 6.4;SH-SY5Y: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055990, HPA076882, CAB079050"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"CAB079050: , HPA055990: AB_2682997, HPA076882: "	"unprognostic (4.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.21e-4)"	"unprognostic (2.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.39e-1)"	0.1	0.2	15.1	0.0	16.6	0.0	0.4	0.4	45.8	0.6	0.0	0.4	0.0	0.4	0.0	0.1	0.3	0.0	3.0	22.5	6.4	0.2	0.0	0.0	0.0	23.9	8.0	0.5	0.5	0.9	3.9	0.0	14.9	0.5	0.0	2.1	0.6	0.1	0.1	1.0	0.1	0.0	0.2	0.0	0.1	1.2	19.3	0.0	0.7	0.0	0.0	0.0	0.3	11.0	0.0	0.4	1.6	3.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.3	0.0	14.7	3.2	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.9	0.1	0.0	1.1	0.0	0.8	0.6	0.0	0.0	0.8	0.0	0.3	0.1	0.0	6.4	3.1	0.1	0.2	0.2	0.1	0.8	0.4	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	16.6	0.4	45.8	22.5	6.4	23.9	8.0	14.9	0.2	19.3	11.0	0.0	0.0	0.0	39.5	0.1	0.4	0.2	0.6	1.2	22.9	1.2	1.3	3.5	0.0	0.1	0.0	8.4	0.0	0.2	0.4	0.0	0.1	0.0	0.6	1.1	0.3	0.0	0.0	20.8	0.2	0.2	0.3	0.0	0.9	0.0	0.4	0.0	0.0	0.1	42.1	26.4	0.1	0.0	0.0	0.3	0.1	0.3	0.1	0.0	4.7	0.0	20.2	0.0	28.6	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	6.4	0.0	0.1	0.1	0.4	1.6	0.4	0.4	0.1	0.1	0.1	0.0	0.1
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 126.0;lymphoid tissue: 91.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 125.3;Langerhans cells: 120.7;Macrophages: 136.6;monocytes: 185.6;Proximal enterocytes: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 112.7;HBEC3-KT: 53.8;HHSteC: 58.2;U-937: 136.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 18.4"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	20.4	10.5	8.7	59.1	8.8	36.3	21.9	9.3	14.6	11.9	9.8	47.7	124.6	8.7	12.0	27.2	12.3	27.4	12.2	8.5	9.6	13.3	21.6	48.3	52.1	11.2	9.4	11.7	6.4	2.7	5.0	30.0	11.1	13.0	49.7	1.1	20.8	12.5	6.2	30.9	126.0	20.8	10.7	91.0	22.5	2.4	10.7	23.2	7.8	7.3	35.5	35.7	19.4	11.9	1.3	0.3	0.0	5.3	5.8	12.1	1.0	5.7	112.7	14.0	38.5	0.2	0.7	18.7	2.3	6.6	25.7	8.1	0.0	53.8	3.3	12.3	0.0	0.9	0.7	1.3	58.2	22.1	0.2	20.9	37.4	11.4	30.3	36.2	6.1	0.3	0.2	0.0	3.4	0.0	0.6	30.7	0.0	0.1	0.3	18.1	0.4	14.9	0.3	8.9	0.4	0.4	16.9	1.1	26.2	0.1	1.2	50.1	7.2	12.8	0.6	1.2	1.6	0.1	5.4	0.1	8.1	136.2	2.7	83.8	246.1	134.9	132.9	359.9	178.5	40.2	92.7	115.8	220.2	35.5	50.2	82.7	220.0	63.0	383.0	7.7	129.0	213.3	8.7	8.8	9.3	14.6	8.5	9.6	11.2	9.4	11.1	10.7	10.7	11.9	26.3	19.2	30.0	0.0	27.2	26.0	42.5	91.5	14.2	0.1	5.8	23.0	2.9	8.6	37.7	11.0	0.0	2.1	34.1	33.1	1.9	23.3	0.2	5.8	2.5	24.0	6.0	10.3	0.2	12.9	1.3	17.8	11.7	3.4	15.8	0.2	22.9	3.1	96.5	0.0	0.0	50.6	14.2	125.3	120.7	1.3	3.4	136.6	5.4	12.2	185.6	0.1	64.9	0.0	0.1	5.3	73.4	3.4	20.0	8.7	116.0	2.2	28.4	0.2	0.0	1.0	8.1	0.0	0.1	17.9	22.3	1.1	58.4	3.3	90.5	43.6
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049480-15058293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skin 1: 486.0"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 96.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 49.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		3600000		"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.6	0.0	0.1	0.0	0.4	0.4	7.8	0.4	0.2	3.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.8	0.0	0.1	1.1	4.2	1.4	486.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.0	0.0	0.0	19.9	1.0	1.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.3	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	19.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	96.0	0.7	0.1	0.0	0.0	0.8
CASP2	"ICH1, MGC2181, NEDD2, PPP1R57"	ENSG00000106144	"Caspase 2"	P42575	7	143288215-143307696	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012175, HPA050678"	Approved		Approved	Nucleoplasm		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB012175: , HPA050678: AB_2681214"	"unprognostic (6.96e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (2.74e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.64e-1)"	10.3	6.6	6.0	13.9	6.7	40.2	10.5	7.8	6.7	11.8	6.7	11.1	10.7	10.2	9.6	15.3	10.3	7.0	8.4	5.9	6.2	9.1	6.4	10.4	22.0	7.2	6.4	9.3	8.4	11.1	5.3	12.4	7.7	7.6	12.7	7.7	11.9	6.3	3.9	17.4	15.4	9.4	5.9	19.0	9.6	9.1	6.9	27.5	8.8	5.0	27.1	7.5	11.2	10.0	27.5	25.4	28.8	51.0	15.1	17.5	15.4	27.7	13.0	25.4	27.8	26.0	31.3	52.0	25.9	18.4	19.4	27.3	29.4	22.6	34.0	45.8	22.5	31.2	40.4	18.3	8.4	60.7	37.4	13.0	18.1	31.0	11.0	11.3	22.0	41.3	26.3	32.6	27.5	27.5	109.1	64.4	36.5	27.4	26.3	79.1	14.6	32.6	15.1	23.3	31.5	34.2	54.8	24.3	17.3	19.6	26.3	23.4	24.1	22.5	15.5	40.7	28.1	27.0	28.5	59.4	24.9	72.6	41.1	69.2	17.9	17.2	24.5	21.7	24.2	25.7	33.3	25.3	17.3	28.8	24.3	28.3	21.7	24.2	34.1	21.1	38.9	15.3	6.0	6.7	7.8	6.7	5.9	6.2	7.2	6.4	7.7	5.9	6.9	10.0	14.1	9.6	8.3	4.2	17.4	15.2	7.0	9.4	6.2	4.8	19.0	13.5	6.2	17.2	7.0	7.3	8.4	20.0	19.3	8.7	3.9	8.1	36.6	10.8	17.9	16.4	10.7	9.7	11.2	7.7	14.6	9.3	8.2	20.1	10.1	22.7	18.2	7.2	10.1	6.7	8.8	11.5	0.0	16.9	23.3	51.0	11.8	12.2	21.4	4.7	20.8	4.4	13.4	4.5	22.4	9.4	5.9	8.2	13.0	5.8	9.1	4.2	4.9	15.4	0.0	8.3	10.9	13.7	25.9	16.1	13.8	5.7	16.7	9.3	15.5	7.0
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 571.0;eosinophil: 408.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 571.0"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		94000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	16.3	12.1	11.3	26.6	10.9	32.8	16.3	18.6	11.4	12.7	10.0	34.2	54.1	12.7	12.9	27.7	9.2	19.9	14.7	10.8	12.2	8.5	22.0	12.8	43.4	10.8	11.5	8.9	13.4	9.0	8.8	26.1	11.4	11.3	33.9	12.7	13.2	10.6	13.9	16.1	41.8	15.3	11.6	23.0	31.2	9.3	11.3	39.0	10.6	14.1	41.9	24.4	12.0	13.0	31.0	16.7	65.3	31.6	39.4	52.2	37.6	90.2	67.7	61.9	35.4	30.7	25.2	42.4	13.9	44.1	29.2	25.5	52.1	32.1	69.7	109.9	28.7	68.2	12.9	71.4	47.3	55.9	62.3	71.7	38.3	39.3	31.4	44.4	77.6	43.1	57.2	259.8	64.5	13.2	89.1	51.8	65.1	33.7	20.9	63.6	30.8	41.2	52.9	49.3	37.1	40.5	39.1	35.1	52.1	64.3	19.2	35.9	54.1	28.2	25.9	21.1	42.4	118.9	121.6	29.2	34.2	38.5	40.9	571.0	26.1	408.6	32.1	43.3	34.4	26.0	29.5	46.3	33.3	18.6	22.2	32.8	35.6	62.0	71.0	26.5	64.1	47.5	11.3	10.9	18.6	11.4	10.8	12.2	10.8	11.5	11.4	11.6	11.3	13.0	28.6	19.2	15.8	26.4	32.3	48.7	22.2	34.1	35.9	18.6	21.7	17.0	17.5	5.7	36.3	12.9	0.0	46.9	54.8	37.4	13.7	18.4	9.6	24.9	17.1	26.6	18.0	62.3	9.6	23.7	33.6	19.5	24.5	24.9	17.7	24.8	21.0	15.3	23.9	13.5	12.6	37.6	44.7	27.0	17.4	4.0	7.5	33.3	30.2	13.1	41.5	15.4	37.0	11.1	18.4	25.0	18.8	7.5	118.6	20.1	26.6	8.4	30.4	11.3	13.1	19.0	20.8	7.9	16.4	34.6	28.6	51.4	43.8	23.1	24.4	36.7
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (9.93e-4)"	6.5	6.7	3.9	8.4	4.0	10.8	10.5	4.3	5.4	7.6	4.0	35.3	40.8	7.7	5.1	7.4	7.6	9.3	5.6	3.8	4.0	11.5	18.1	7.8	9.6	3.7	3.7	8.3	13.3	4.8	4.2	4.8	3.8	9.1	31.5	3.0	8.6	6.5	3.3	10.7	36.8	7.4	3.8	8.0	15.8	1.8	3.7	11.5	8.5	2.4	7.7	8.1	7.0	4.3	26.6	8.4	16.5	14.8	11.0	11.2	24.3	15.3	9.2	12.4	13.4	13.8	50.3	2.7	16.4	14.7	17.3	12.1	19.7	21.8	8.4	43.5	13.0	22.8	7.1	12.9	9.4	23.5	15.7	12.6	15.1	12.4	2.8	17.1	22.9	30.1	29.9	76.1	19.2	13.7	62.0	14.4	12.7	17.1	16.1	20.5	10.8	13.3	39.6	24.8	17.2	13.2	15.0	25.7	8.8	19.6	11.0	8.0	20.3	12.8	14.6	6.6	16.7	11.4	23.0	2.8	17.1	26.9	7.1	16.3	6.9	8.9	6.3	6.9	7.0	6.1	23.8	12.3	8.8	8.6	28.0	16.1	1.4	7.5	11.2	11.6	24.8	9.4	3.9	4.0	4.3	5.4	3.8	4.0	3.7	3.7	3.8	3.8	3.7	4.3	10.5	16.0	14.6	5.2	7.7	10.8	10.2	26.7	12.0	6.9	23.6	16.0	4.1	28.6	23.2	20.2	6.2	20.9	7.6	54.0	9.8	40.8	2.6	19.8	9.5	12.2	59.2	19.7	6.4	46.4	41.1	13.4	18.3	23.3	10.1	112.3	9.7	20.4	19.8	0.0	7.3	53.9	32.6	8.7	9.3	1.7	12.8	14.5	1.8	2.8	17.9	16.0	6.2	5.5	5.8	45.9	52.5	9.8	8.8	7.4	71.7	35.7	18.6	1.3	6.6	7.6	12.3	1.9	8.6	10.8	11.6	5.7	17.5	12.4	74.2	8.0
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 66.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.4;NK-cells: 132.8;Plasma cells: 73.4;T-cells: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	11.5	10.2	1.7	28.6	2.0	66.6	13.9	1.3	2.1	9.6	4.2	16.1	20.5	8.5	13.2	12.9	14.1	13.2	5.2	2.1	1.8	10.7	14.1	19.6	37.7	3.4	3.0	7.7	7.8	2.9	3.4	9.9	2.7	6.9	17.6	4.6	8.4	7.3	3.3	12.1	26.0	9.9	2.4	37.1	15.9	4.3	2.6	24.4	7.9	3.0	29.7	18.0	8.6	2.4	33.6	26.6	7.7	22.2	20.7	29.7	12.0	13.8	13.2	16.0	26.2	36.1	54.9	3.7	29.6	10.7	28.7	16.2	17.2	16.1	31.3	21.1	15.4	31.0	21.9	35.1	17.1	25.6	33.8	25.9	38.0	30.1	23.9	13.4	15.1	26.9	28.6	69.1	14.7	13.1	32.1	25.9	12.6	17.5	23.7	24.7	15.9	55.4	30.8	35.3	2.3	1.1	17.9	29.8	18.0	7.0	8.0	19.1	19.6	17.3	18.0	9.0	10.9	63.1	30.2	21.2	25.3	33.1	16.6	76.1	39.5	77.1	70.7	51.2	66.0	40.9	57.8	75.9	41.6	24.0	37.0	47.2	153.6	70.6	51.5	18.6	75.0	40.6	1.7	2.0	1.3	2.1	2.1	1.8	3.4	3.0	2.7	2.4	2.6	2.4	8.5	25.6	26.7	0.7	50.0	7.5	13.0	6.1	10.2	2.1	12.9	9.3	2.5	10.0	13.0	5.5	10.4	8.5	107.4	37.0	15.6	12.3	5.9	25.6	8.1	10.1	4.2	10.5	2.5	8.4	12.1	9.5	19.4	27.2	24.6	10.4	5.3	11.7	11.9	0.0	1.3	15.2	4.1	25.3	15.7	1.9	2.5	25.0	7.2	10.3	35.6	0.2	132.8	1.0	0.5	11.2	30.1	0.7	73.4	9.7	22.3	23.6	14.2	0.4	0.0	4.5	3.7	0.8	0.4	13.1	7.7	3.4	86.9	10.6	17.4	12.7
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190575-160201886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	64	"skeletal muscle: 4442.6;tongue: 1892.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 17.6;Rod photoreceptor cells: 25.2;Skeletal myocytes: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 19.3;HDLM-2: 38.5;RT4: 67.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		270000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	0.9	0.4	5.1	0.8	6.0	1.5	1.4	4.9	10.0	0.5	3.3	3.3	0.5	1.7	0.3	43.1	1.9	1.2	44.9	6.5	3.1	0.3	0.4	0.7	3.0	3.7	3.9	0.4	0.3	0.2	1.0	6.2	3.2	16.2	0.5	49.7	16.7	5.0	4442.6	1.0	1.9	7.4	3.1	1.3	0.8	5.7	3.6	0.5	0.6	1892.7	1.0	5.7	0.9	6.2	0.0	0.0	0.5	0.0	0.2	0.0	19.3	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	38.5	0.4	0.1	0.0	0.0	0.1	0.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.7	0.4	0.1	0.0	0.2	0.3	0.2	0.0	67.4	0.0	0.1	0.3	0.2	0.0	3.5	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.7	0.8	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.1	6.0	4.9	10.0	6.5	3.1	3.7	3.9	3.2	3.1	3.6	6.2	0.1	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	1.9	0.7	0.9	17.6	0.0	0.0	0.0	2.1	3.0	0.1	0.0	0.0	0.1	3.0	0.1	0.1	0.2	0.0	0.0	2.0	0.0	4.9	0.3	0.0	0.1	3.8	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.3	0.6	0.6	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	25.2	0.0	20.6	0.6	1.2	1.9	0.0	0.0	4.5	0.1	0.1	0.0	0.3
CASZ1	"castor, cst, FLJ20321, SRG, ZNF693"	ENSG00000130940	"Castor zinc finger 1"	Q86V15	1	10636604-10796650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 49.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 608.8;Horizontal cells: 138.0;Rod photoreceptor cells: 477.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 12.4;HDLM-2: 13.4;SCLC-21H: 19.8;SK-BR-3: 18.9"					"Low region specificity"	"Detected in some"			"HPA028222, HPA029927"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA028222: AB_10600106, HPA029927: AB_10601564"	"unprognostic (1.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.49e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.56e-1)"	2.1	2.0	0.6	2.2	0.8	4.6	7.0	0.1	1.1	5.9	2.4	20.6	12.0	7.8	0.8	15.3	5.6	2.7	20.1	0.2	1.2	7.4	2.7	11.3	1.3	1.0	0.7	0.9	6.0	0.2	2.1	1.7	0.8	18.2	3.3	35.1	19.9	5.8	34.4	49.0	11.6	3.3	2.3	2.2	17.3	1.7	0.9	1.3	3.4	5.8	1.9	10.7	11.6	0.1	12.4	1.0	2.2	2.2	0.0	0.0	0.5	0.4	0.1	0.4	0.4	2.6	2.8	0.5	2.5	0.5	1.0	10.5	2.3	2.4	0.2	13.4	4.1	0.8	2.0	2.8	0.3	1.4	3.8	0.1	8.7	0.1	0.8	0.0	0.4	1.9	0.0	0.0	0.1	6.6	0.7	8.9	0.2	6.4	0.6	1.0	1.5	0.1	2.0	5.0	19.8	1.8	3.2	18.9	0.3	0.8	10.1	1.3	0.1	0.0	1.6	1.0	0.2	0.0	0.0	1.3	0.1	3.8	0.2	0.6	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.4	0.6	0.8	0.0	0.1	0.6	0.8	0.1	1.1	0.2	1.2	1.0	0.7	0.8	2.3	0.9	0.1	12.9	28.9	21.7	1.6	6.1	33.0	20.1	21.2	30.7	12.7	57.9	30.4	25.2	17.2	17.8	14.7	608.8	0.7	15.3	60.4	3.9	14.1	0.6	41.8	5.6	14.4	41.3	1.3	1.6	8.9	1.2	2.3	57.6	66.7	4.5	4.5	5.0	5.1	1.1	138.0	0.9	39.1	16.2	0.3	5.1	1.6	0.0	1.8	1.8	1.9	6.7	28.4	9.2	0.5	0.3	18.1	40.8	6.8	6.1	33.4	46.3	1.1	41.2	477.7	0.0	6.8	5.1	2.5	3.5	31.0	61.2	0.7	7.6	1.5	27.1	27.6
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 31.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Gastric mucus-secreting cells: 27.0;Late spermatids: 49.2;Proximal enterocytes: 20.7;Spermatocytes: 28.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;HMC-1: 1.8;MCF7: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.2	0.1	0.5	0.1	0.8	0.3	0.4	0.8	0.9	0.4	0.2	0.2	0.4	0.2	0.7	0.2	0.5	0.1	0.1	0.4	0.5	0.2	0.2	0.3	0.3	0.7	2.8	0.4	0.2	0.2	0.2	0.1	0.7	0.4	0.2	0.2	0.3	0.2	0.2	1.0	0.3	0.1	0.4	0.2	0.2	31.3	0.8	0.2	0.5	0.0	0.2	0.1	0.2	1.1	0.0	0.1	0.0	0.6	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.7	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.7	0.1	0.1	0.0	0.5	0.8	0.8	0.9	0.4	0.5	0.7	2.8	0.7	0.4	0.8	1.1	4.9	0.0	2.7	2.6	3.6	2.5	2.4	1.0	4.6	1.3	4.8	8.0	3.0	1.5	0.6	1.8	0.0	1.7	5.1	10.1	0.0	1.0	29.4	4.9	4.4	2.7	1.8	3.2	4.3	0.7	0.3	3.0	27.0	8.8	1.3	2.0	2.5	0.3	3.2	1.7	3.8	3.9	2.0	1.2	3.1	49.2	1.8	3.3	0.0	1.9	3.9	1.9	10.3	3.0	17.0	0.4	5.6	2.2	2.2	1.9	20.7	0.9	1.3	1.4	0.0	5.3	3.7	28.9	3.7	4.9	1.8	1.4	3.4	1.9	3.5	1.8
CATSPERZ	"C11orf20, DKFZP566E164, TEX40"	ENSG00000219435	"Catsper channel auxiliary subunit zeta"	Q9NTU4	11	64300358-64304770	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	93	"testis: 586.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.1;Endometrial stromal cells: 12.7;Extravillous trophoblasts: 36.3;Syncytiotrophoblasts: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;CACO-2: 13.9;PC-3: 7.9;T-47d: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052822			Approved	Nucleoplasm		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA052822: AB_2797245"	"unprognostic (1.89e-1)"	"unprognostic (7.81e-2)"			"unprognostic (1.88e-1)"				"unprognostic (8.23e-2)"	"unprognostic (2.18e-1)"		"unprognostic (1.11e-1)"	"unprognostic (5.66e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.07e-2)"		"unprognostic (1.43e-1)"	0.4	0.2	4.0	0.1	4.1	0.0	0.6	5.9	6.3	1.0	2.1	0.3	0.1	0.5	0.0	0.4	0.2	0.6	0.1	4.5	3.1	0.5	0.3	0.5	0.1	3.5	3.1	0.1	0.6	0.6	0.1	0.8	3.1	0.8	0.3	0.4	0.2	0.0	0.2	1.2	0.2	0.0	2.6	0.1	0.3	586.3	3.5	0.0	1.0	0.1	0.0	0.3	0.3	4.0	0.0	3.5	0.3	0.1	0.4	0.8	4.8	0.0	0.3	0.0	0.0	13.9	2.8	0.1	0.2	0.1	0.1	3.1	2.6	0.4	0.1	0.0	0.0	1.3	0.1	0.9	0.1	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.1	0.0	1.4	0.6	0.2	0.6	0.0	0.6	0.9	4.0	7.9	1.5	0.0	1.8	3.9	1.2	0.1	0.8	1.4	0.4	0.2	0.2	6.6	0.3	0.2	0.2	0.0	1.8	0.0	0.4	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.1	5.9	6.3	4.5	3.1	3.5	3.1	3.1	2.6	3.5	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.5	12.7	0.2	0.0	0.0	0.0	0.5	36.3	0.3	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	0.0	0.1	0.0	0.0
CAVIN4	"cavin-4, MURC"	ENSG00000170681	"Caveolae associated protein 4"	Q5BKX8	9	100578079-100588389	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 276.1;tongue: 92.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.9;Granulosa cells: 1.8;Pancreatic endocrine cells: 1.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.9;SCLC-21H: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020973, HPA020987, HPA021021"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082"	"unprognostic (9.54e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.14e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.74e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.55e-3)"	0.2	0.1	1.6	0.2	2.9	0.1	0.1	2.0	5.6	0.4	0.4	0.4	0.0	0.5	0.1	4.3	0.1	0.3	45.9	1.7	2.5	0.2	0.2	0.4	0.1	2.7	2.7	0.2	0.1	0.0	0.2	0.3	2.7	4.5	0.1	0.3	2.4	0.1	276.1	0.2	0.1	0.3	1.8	0.1	0.3	3.7	2.7	0.4	0.5	92.4	0.1	0.3	0.2	3.5	0.5	0.3	6.1	2.2	1.4	2.0	4.3	1.1	0.9	0.8	1.0	0.0	0.4	0.2	0.3	0.6	2.1	0.3	3.1	0.1	1.7	1.4	2.0	0.1	1.0	0.0	0.4	0.2	0.4	5.0	0.3	0.8	0.5	1.5	1.1	1.5	0.2	0.2	3.9	0.1	1.8	0.3	8.9	1.0	0.7	2.6	5.8	0.0	0.8	0.3	13.2	3.4	0.2	0.2	1.1	4.1	0.1	0.2	1.1	1.5	1.2	1.0	1.0	0.3	1.1	0.6	1.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.9	2.0	5.6	1.7	2.5	2.7	2.7	2.7	1.8	2.7	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.7	0.0	1.2	1.8	0.3	0.0	0.0	0.0	0.5	0.4	0.5	0.0	1.9	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0
CBARP	"BARP, C19orf26, DOS, MGC40084"	ENSG00000099625	"CACN subunit beta associated regulatory protein"	Q8N350	19	1228287-1238027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.3;pituitary gland: 22.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 21.8;Early spermatids: 55.9;Late spermatids: 97.4;Spermatocytes: 54.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012777			Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA012777: AB_2067005"	"unprognostic (1.31e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-3)"	"unprognostic (3.03e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.42e-5)"	1.4	2.6	6.0	0.1	9.8	0.0	0.4	2.0	15.3	0.7	0.0	0.6	0.1	0.5	0.0	1.4	0.5	0.1	1.7	12.3	3.1	2.3	0.3	1.0	0.0	5.6	1.3	4.9	0.4	0.0	22.3	0.1	1.3	0.8	0.0	0.3	0.4	0.1	0.4	3.1	0.2	0.0	0.0	0.1	0.4	1.7	1.8	0.0	0.6	0.0	0.0	0.3	0.9	0.0	0.3	0.4	1.1	3.1	0.1	0.5	0.4	2.7	0.8	0.5	0.5	1.1	0.1	0.0	2.7	0.5	0.3	0.9	0.4	0.6	0.1	0.5	0.7	0.1	1.1	0.9	1.4	0.0	1.0	0.6	0.2	0.6	0.1	0.5	0.4	0.5	1.7	0.0	0.3	2.3	0.0	0.6	1.6	0.1	1.2	2.0	0.4	0.2	0.1	0.2	1.4	4.2	0.0	0.0	3.1	0.1	0.4	0.5	1.2	0.7	2.6	2.3	0.7	0.1	0.2	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	9.8	2.0	15.3	12.3	3.1	5.6	1.3	1.3	0.0	1.8	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	1.2	21.8	1.7	1.8	0.0	1.5	0.0	0.0	2.1	0.0	0.6	0.0	1.9	0.1	55.9	0.9	2.2	0.7	0.0	0.0	0.0	0.2	0.1	1.2	1.1	1.6	0.0	0.9	1.4	0.1	0.3	3.3	0.0	0.0	0.0	0.8	0.0	97.4	1.8	1.2	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	0.2	0.0	1.7	0.0	0.7	1.4	54.8	7.0	1.1	0.0	0.0	0.3	0.1	0.0	0.3
CBFA2T3	"ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4"	ENSG00000129993	"CBFA2/RUNX1 partner transcriptional co-repressor 3"	O75081	16	88874858-88977207	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8;lymphoid tissue: 29.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 24.8;B-cells: 26.2;dendritic cells: 25.7;Erythroid cells: 21.0;Intestinal goblet cells: 19.2;Langerhans cells: 23.3;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 35.8"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 64.2;K-562: 114.9;MCF7: 52.3;MOLT-4: 58.0;NB-4: 70.1;REH: 113.6;T-47d: 50.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059931, HPA062423, HPA065890"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575"	"unprognostic (2.47e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.04e-5)"	"unprognostic (2.18e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.35e-3)"	9.2	2.3	3.6	6.8	4.7	7.7	7.7	35.8	8.4	3.9	0.0	4.9	3.2	5.0	0.7	2.4	3.7	1.7	17.0	5.7	0.0	1.2	4.3	11.3	8.8	0.6	0.9	1.0	27.3	0.7	4.2	3.1	1.7	6.4	1.0	0.8	4.8	0.8	14.0	3.5	10.8	1.1	0.0	18.5	3.7	4.6	0.0	29.5	3.9	3.2	5.1	3.5	3.8	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	3.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.1	64.2	0.0	0.0	0.1	17.2	30.6	0.0	0.0	0.0	0.0	0.1	0.0	30.2	114.9	0.5	0.0	52.3	58.0	70.1	1.2	0.0	0.0	113.6	0.8	11.4	0.0	0.0	21.3	4.8	2.5	0.5	0.4	0.3	50.1	17.9	0.4	0.0	0.4	0.3	0.0	0.4	0.5	37.9	0.0	19.8	0.0	1.0	2.5	2.7	0.0	2.8	0.0	3.1	0.0	0.0	6.6	1.7	0.0	0.0	3.4	0.0	4.8	10.6	0.0	1.8	3.6	4.7	35.8	8.4	5.7	0.0	0.6	0.9	1.7	0.0	0.0	0.8	24.8	0.0	1.1	0.3	26.2	2.5	6.2	1.9	0.6	10.8	1.1	0.9	3.3	1.5	2.4	0.0	0.0	0.1	25.7	0.8	0.0	0.3	0.0	0.6	0.6	9.1	3.6	21.0	5.9	2.9	0.2	2.7	2.0	0.5	6.3	0.1	2.2	10.8	3.0	0.0	2.1	19.2	0.0	5.0	23.3	0.3	2.1	9.8	0.0	9.4	14.8	0.2	0.0	2.0	0.6	0.9	0.5	0.7	14.4	2.9	1.7	0.6	0.5	1.4	19.7	10.8	15.6	0.2	4.8	1.7	2.3	0.3	1.3	3.3	1.0	3.8
CBFB	PEBP2B	ENSG00000067955	"Core-binding factor subunit beta"	Q13951	16	67028984-67101058	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 243.7;U-698: 336.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038852	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA038852: AB_10795358"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (2.89e-8)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	18.2	11.7	5.7	17.3	12.0	11.8	16.5	9.3	7.3	19.2	6.0	11.4	5.5	15.4	2.7	23.3	16.6	5.2	18.0	7.1	8.1	16.4	14.2	18.1	16.3	13.9	9.3	17.3	14.7	9.8	15.0	7.3	11.5	14.5	3.5	3.8	21.3	4.8	38.6	17.4	14.5	4.9	8.6	18.0	15.1	6.9	9.5	13.4	15.9	10.5	12.1	15.2	20.3	17.2	54.8	43.7	14.8	40.6	8.7	12.2	54.0	76.1	23.6	43.6	30.0	79.1	51.0	106.3	81.2	39.7	16.3	53.7	30.7	22.6	29.2	63.3	48.3	67.2	27.3	38.0	17.8	77.7	171.3	18.2	11.1	51.3	30.4	10.2	25.4	42.2	104.9	28.9	20.8	44.5	115.8	28.9	25.5	16.4	74.1	243.7	92.7	73.4	15.5	43.2	37.9	31.5	166.2	11.0	37.6	10.4	15.4	28.6	87.1	70.8	70.2	34.6	79.6	76.8	147.8	336.8	50.2	50.7	65.0	29.2	7.6	6.3	6.0	9.5	6.5	6.2	5.5	6.4	10.2	7.2	5.0	3.9	4.1	18.2	5.6	2.3	6.0	5.6	5.7	12.0	9.3	7.3	7.1	8.1	13.9	9.3	11.5	8.6	9.5	17.2	20.1	9.6	20.2	37.2	38.2	56.2	42.2	18.0	27.9	5.8	27.8	14.7	19.8	21.5	18.8	40.5	12.5	15.8	30.0	11.9	27.4	17.6	6.1	23.8	16.0	26.1	19.0	18.5	11.5	28.0	32.1	28.7	16.8	29.8	27.8	34.2	28.5	15.8	37.9	10.1	16.5	12.8	22.4	41.9	66.8	7.6	23.9	39.1	51.6	53.4	25.0	13.2	44.3	97.5	99.8	74.1	6.8	21.1	38.3	50.5	6.9	11.6	20.8	15.3	13.1	21.6	21.0	17.4	19.1	32.2	63.1	17.0	48.6	11.2	11.8	62.0
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 113.7;Inhibitory neurons: 112.5;Oligodendrocyte precursor cells: 123.1;T-cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	17.3	5.8	5.6	6.7	4.6	11.9	11.0	17.4	5.9	6.8	5.8	6.3	6.2	6.3	4.3	3.5	8.8	8.4	12.2	5.2	7.3	4.3	4.4	9.9	14.5	4.4	5.3	10.0	3.6	2.3	3.8	6.5	5.7	4.7	5.1	9.2	6.7	2.3	7.8	6.8	8.2	3.0	2.0	8.5	8.3	6.4	6.5	4.3	9.1	5.1	6.9	10.0	6.5	4.0	2.4	3.2	10.7	5.4	11.8	12.1	6.8	7.6	4.0	2.3	3.7	4.1	2.6	5.2	5.4	4.2	3.6	3.9	1.5	1.4	2.8	3.8	4.0	2.8	16.1	2.7	17.7	2.0	2.0	11.9	4.3	6.2	16.7	8.5	7.9	5.2	3.0	15.5	5.0	2.8	2.9	1.3	3.6	2.9	4.4	6.1	3.1	0.9	5.9	10.2	8.2	8.9	9.5	1.1	11.9	7.3	2.4	4.3	4.8	32.0	2.6	4.5	2.0	8.8	0.7	8.3	8.6	1.7	2.1	0.7	1.4	2.8	8.9	0.9	7.9	2.1	4.6	5.1	1.3	4.8	3.9	7.0	1.0	10.2	2.0	3.1	5.7	1.7	5.6	4.6	17.4	5.9	5.2	7.3	4.4	5.3	5.7	2.0	6.5	4.0	26.0	16.0	6.1	57.8	43.1	10.8	6.9	35.6	25.6	42.6	12.0	9.7	43.7	2.8	13.7	12.9	27.1	10.1	113.7	12.8	5.9	8.4	34.1	20.9	47.0	34.0	12.6	10.8	48.9	7.8	83.2	55.2	43.8	26.4	8.8	21.3	33.2	8.1	13.9	3.3	112.5	18.8	6.1	13.5	17.1	14.4	7.5	14.6	16.0	74.9	9.0	7.5	59.8	123.1	100.3	15.5	8.6	10.9	53.1	8.9	17.6	3.9	20.2	28.9	6.6	23.6	28.9	11.1	13.3	10.3	7.0	45.4	111.5	5.5	9.9	7.0
CBLC	"CBL-3, CBL-SL, RNF57"	ENSG00000142273	"Cbl proto-oncogene C"	Q9ULV8	19	44777869-44800652	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.3;intestine: 50.9;skin 1: 42.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 108.6;Pancreatic endocrine cells: 95.0;Paneth cells: 108.1;Proximal enterocytes: 154.6;Undifferentiated cells: 67.1;Urothelial cells: 76.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 43.6;BEWO: 28.9;CACO-2: 28.3;CAPAN-2: 56.9;HaCaT: 41.0;HBEC3-KT: 34.8;hTCEpi: 26.0;OE19: 37.3;RT4: 34.7;SK-BR-3: 31.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB008087, HPA035266"	Approved		Approved	Nucleoplasm,Aggresome		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Aggresome	"CAB008087: AB_2228531, HPA035266: AB_2674542"	"unprognostic (1.58e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.11e-6)"	"unprognostic (3.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.21e-3)"	0.1	0.1	0.0	3.1	0.0	0.0	5.1	0.0	0.1	8.0	0.0	25.0	50.9	0.9	0.1	39.3	2.5	4.4	0.0	0.0	0.0	7.4	21.1	1.3	0.0	0.0	0.0	0.1	20.6	1.6	0.5	0.4	0.0	11.8	11.7	0.1	13.3	2.4	0.1	42.4	38.6	0.6	0.0	0.0	17.7	0.7	0.0	0.3	1.7	0.0	4.0	8.3	18.4	0.0	43.6	0.0	0.0	0.1	0.0	0.0	28.9	0.0	0.0	0.0	0.0	28.3	56.9	0.0	0.0	0.0	0.0	41.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.3	0.0	0.0	0.0	0.0	0.0	34.7	0.4	0.1	0.0	31.1	0.0	0.2	22.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.1	15.0	44.0	30.8	16.5	0.0	9.3	7.4	0.2	4.3	27.7	7.3	0.0	5.8	0.2	108.6	1.9	53.8	0.1	7.0	1.3	0.9	17.4	0.0	0.4	48.9	2.3	0.5	59.7	15.5	0.0	0.0	0.0	11.1	0.3	0.0	0.9	40.0	18.3	0.0	1.4	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.0	0.3	95.0	108.1	0.0	0.1	34.4	154.6	17.2	9.8	0.0	0.0	0.0	1.3	0.0	2.6	29.9	25.7	2.5	0.7	0.0	67.1	76.9
CBLN3		ENSG00000139899	"Cerebellin 3 precursor"	Q6UW01	14	24426545-24430954	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 93.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 3.0;Theca cells: 5.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	11	"cerebellum: 93.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.4;HDLM-2: 17.2;HSkMC: 23.3;Karpas-707: 18.3;U-266/70: 12.8"	"Region enriched"	"Detected in many"	25	"cerebellum: 429.5"	"Region enriched"	"Detected in many"	42	"cerebellum: 446.5"	HPA041266	Enhanced	Supported	Approved	Nucleoplasm	"Secreted in brain"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA041266: AB_10674430"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.39e-4)"	"unprognostic (5.39e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (6.20e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.02e-2)"	7.3	17.1	2.7	8.3	3.0	0.6	4.7	93.9	7.0	4.6	2.1	4.2	2.1	2.7	7.4	2.9	4.0	5.6	3.7	2.4	3.3	4.4	6.0	4.8	13.7	3.9	5.8	10.1	2.0	2.9	4.2	3.7	8.4	4.5	2.1	0.5	4.3	3.1	1.8	3.5	5.4	2.2	3.2	13.7	3.3	5.1	3.4	3.9	4.5	0.6	9.1	4.9	4.6	4.8	1.5	1.3	0.7	2.5	6.2	13.4	0.4	5.5	11.1	2.1	2.7	0.7	2.6	2.4	1.2	3.4	2.4	0.3	0.8	2.9	1.4	17.2	0.6	0.0	5.2	1.1	3.3	0.4	0.9	23.3	1.3	2.7	2.1	8.8	1.9	1.0	0.7	18.3	2.8	0.8	0.0	0.7	0.1	1.5	1.5	0.0	0.0	1.8	1.2	0.5	0.9	0.5	0.5	0.1	0.8	0.3	0.8	0.6	8.7	7.7	1.5	3.2	0.3	12.8	3.2	2.7	0.4	1.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.0	93.9	7.0	2.4	3.3	3.9	5.8	8.4	3.2	3.4	4.8	1.4	0.0	0.0	0.0	2.6	0.4	0.6	1.5	0.0	0.0	0.8	1.0	0.5	0.0	0.4	0.0	0.0	0.9	3.0	0.8	0.0	1.1	0.0	0.3	2.0	0.8	0.0	0.4	0.3	1.1	0.6	2.6	0.0	0.5	0.0	0.9	0.0	0.2	0.9	0.0	0.1	0.5	0.0	0.3	0.4	0.3	2.5	0.7	0.0	1.0	2.6	1.2	0.0	0.0	0.0	0.8	0.0	1.5	0.1	0.5	0.9	0.8	1.4	0.2	0.0	0.7	1.4	0.0	0.2	0.2	0.6	0.8	0.2	5.7	0.6	0.6
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 583.9"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 524.2;Distal tubular cells: 757.2;Proximal enterocytes: 1270.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018433, CAB034291"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		12000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 45: Intestine - Brush border"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB034291: AB_2070856, HPA018433: AB_1846109"	"prognostic favorable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favorable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	32.4	95.3	150.0	25.6	200.0	10.1	29.5	186.1	174.1	52.7	207.0	68.6	583.9	41.3	50.5	189.5	34.6	47.1	29.5	154.6	166.7	125.6	252.8	41.1	28.3	173.1	175.1	28.8	36.1	38.6	35.3	27.6	175.6	48.7	50.9	10.2	101.8	42.2	33.6	111.8	345.9	34.4	166.2	39.9	133.5	18.1	180.3	22.7	46.4	23.3	36.7	51.0	85.3	266.6	114.4	180.4	22.6	55.9	115.0	115.3	1.2	123.6	97.0	72.4	86.4	68.9	67.8	28.2	78.7	128.1	137.3	84.6	46.3	132.3	55.7	133.8	95.3	82.5	105.1	48.1	65.7	49.1	77.5	56.1	165.6	70.7	30.8	83.0	78.4	0.0	0.0	21.3	67.6	121.2	24.7	50.7	0.4	0.0	123.3	0.4	0.4	80.5	195.7	60.9	60.5	52.1	121.3	186.3	157.3	17.6	86.1	69.4	71.1	78.8	30.8	202.9	96.1	131.8	268.9	0.7	144.0	48.6	115.6	7.1	134.0	68.6	64.4	198.5	54.6	67.2	79.7	60.8	109.6	61.2	102.6	75.4	9.2	77.3	156.9	39.6	89.0	162.1	150.0	200.0	186.1	174.1	154.6	166.7	173.1	175.1	175.6	166.2	180.3	266.6	26.4	121.8	69.3	17.9	22.5	128.2	63.1	295.2	524.2	11.6	27.7	98.8	20.9	77.2	117.1	95.6	2.1	116.6	15.7	91.2	757.2	93.7	8.9	31.7	45.5	23.1	38.6	32.0	6.5	70.0	80.4	65.7	127.4	45.1	34.9	30.8	41.7	277.2	85.1	3.3	6.8	94.4	396.7	66.6	27.5	4.3	122.7	49.5	90.7	4.7	79.2	69.8	23.7	16.6	128.2	91.8	146.6	132.4	41.3	66.4	1270.3	326.0	121.2	8.3	26.3	51.3	90.7	5.8	17.4	403.5	123.6	89.2	30.7	55.6	145.8	55.0
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36135079-36146562	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 56.3;salivary gland: 41.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 102.5;Basal squamous epithelial cells: 107.0;Peritubular cells: 75.6;Squamous epithelial cells: 230.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"B-cells: 23.9;NK-cells: 11.5;T-cells: 33.7"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 64.9"	"Region enhanced"	"Detected in all"		"basal ganglia: 48.6"	"Low region specificity"	"Detected in many"			HPA018434	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	NA		2800000	"Cluster 30: Non-specific - Translation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	17.3	2.3	12.8	4.0	14.7	1.4	15.3	13.9	19.8	12.4	11.2	7.8	3.0	7.5	11.0	56.3	8.8	6.5	6.1	13.2	12.4	2.7	0.8	4.6	2.9	12.8	12.1	11.2	1.6	0.6	2.4	2.9	12.3	9.9	3.6	0.6	41.4	5.1	3.1	21.6	5.4	6.1	12.0	3.1	5.2	3.1	12.2	2.0	4.6	7.8	7.6	11.6	16.8	12.4	33.5	9.5	4.0	8.2	31.0	47.8	5.9	35.4	42.4	40.6	32.1	0.4	6.9	0.0	10.2	37.2	13.7	15.0	5.5	7.2	16.2	45.3	17.2	1.4	10.0	0.3	2.6	0.1	0.1	6.8	0.8	28.1	3.6	19.1	24.9	3.7	0.0	0.3	12.1	25.4	3.1	14.7	3.2	10.3	41.5	6.7	7.6	64.9	13.7	14.2	2.1	2.9	27.3	32.6	53.3	2.2	9.8	3.9	17.1	25.7	2.2	28.8	35.0	1.5	0.6	0.0	26.9	0.9	47.3	0.0	0.6	0.1	2.2	0.5	3.0	23.6	25.1	7.7	2.4	23.9	33.7	23.5	0.9	11.5	1.0	0.7	10.9	11.5	12.8	14.7	13.9	19.8	13.2	12.4	12.8	12.1	12.3	12.0	12.2	12.4	41.7	0.0	3.2	6.8	5.2	71.0	22.1	102.5	107.0	0.8	23.1	38.6	0.2	2.8	23.0	0.0	0.0	1.2	2.9	1.9	9.8	4.7	0.7	13.1	7.5	26.5	0.0	1.7	3.9	0.7	0.3	53.4	7.7	14.7	5.7	1.1	14.3	0.3	8.4	0.0	5.5	12.6	69.2	3.8	41.3	4.0	67.7	5.8	65.8	2.8	20.9	1.9	0.0	1.5	0.5	2.6	1.7	75.6	1.4	43.4	1.3	0.2	13.1	0.6	0.0	21.4	19.7	0.4	0.2	230.4	46.7	0.3	7.0	1.0	8.1	21.1
CBX1	"CBX, HP1-BETA, HP1Hs-beta, M31, MOD1"	ENSG00000108468	"Chromobox 1"	P83916	17	48070052-48101478	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 350.8;Spermatogonia: 304.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012265	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		120000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB012265: AB_297216"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.48e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.73e-2)"	30.9	31.4	60.3	35.5	59.9	16.5	37.2	61.6	73.2	53.6	54.5	40.7	19.0	66.5	47.9	36.8	40.2	27.9	32.1	59.8	63.9	37.9	21.6	26.9	35.0	63.2	59.7	77.5	22.3	43.8	34.8	34.7	64.0	38.0	33.1	59.5	29.7	47.1	68.4	28.8	24.0	55.6	64.9	33.7	26.6	69.1	60.3	73.6	39.5	46.0	46.9	36.4	37.9	67.3	217.3	121.1	392.4	185.6	78.0	69.3	217.7	197.0	95.1	188.0	200.6	319.2	84.5	148.4	204.5	155.6	144.8	85.3	146.3	124.6	329.2	273.8	118.1	119.8	121.1	119.3	47.5	115.5	71.9	49.8	68.4	140.3	178.3	144.7	157.1	176.6	152.0	67.2	153.8	135.7	325.9	79.8	150.6	118.8	156.9	241.8	322.7	95.8	110.3	121.7	138.5	345.6	135.0	44.6	75.5	281.8	211.0	82.5	110.7	260.2	238.9	112.0	201.1	94.0	227.9	140.4	71.4	50.4	119.0	5.1	12.2	16.0	12.4	12.7	10.0	16.1	11.2	10.4	9.9	15.7	11.5	9.7	33.6	9.5	9.3	10.6	12.4	5.9	60.3	59.9	61.6	73.2	59.8	63.9	63.2	59.7	64.0	64.9	60.3	67.3	32.9	67.3	27.6	7.8	31.4	43.6	30.5	46.1	36.5	46.9	48.0	54.7	70.9	18.6	33.6	42.3	20.9	66.4	27.5	19.2	35.2	68.7	26.8	40.8	78.9	40.2	40.3	34.3	13.0	29.7	86.6	61.5	10.2	39.6	39.9	65.3	30.0	15.6	69.6	50.5	15.5	27.3	42.7	33.5	24.5	59.5	80.2	26.7	40.9	7.5	47.7	106.6	42.2	12.5	13.7	34.7	12.9	91.7	20.0	51.1	9.6	30.9	32.2	36.3	39.5	33.3	71.8	350.8	304.0	26.7	36.2	27.8	25.6	35.8	28.6	20.1
CBX2	"CDCA6, MGC10561"	ENSG00000173894	"Chromobox 2"	Q14781	17	79778148-79787983	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.3;testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5;Granulosa cells: 10.4;Late spermatids: 39.1;Spermatogonia: 14.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 96.4;SK-BR-3: 134.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023083	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA023083: AB_2671063"	"unprognostic (1.37e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.25e-11)"	"unprognostic (1.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-8)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.07e-1)"	1.4	0.3	1.1	0.7	0.9	2.2	1.2	0.8	0.9	1.3	0.5	0.5	0.4	1.2	1.8	4.2	1.0	0.6	2.3	0.8	0.7	1.6	0.4	1.2	1.3	1.0	0.9	2.1	1.3	0.5	0.2	2.2	1.1	0.6	0.2	0.5	0.9	0.5	0.7	2.1	0.6	0.7	0.8	1.6	0.5	12.8	1.0	7.3	0.5	1.1	1.3	1.0	1.6	1.0	7.5	20.5	37.0	67.4	0.4	0.5	13.2	2.7	1.2	1.3	2.4	21.2	1.7	29.7	5.8	0.3	4.7	3.8	43.0	1.2	0.9	4.3	23.3	1.5	24.0	14.2	1.4	9.0	6.1	0.7	2.6	0.7	1.7	1.6	7.5	31.3	20.8	2.3	1.4	31.3	47.3	22.1	36.8	10.3	23.4	96.4	27.7	18.0	1.5	10.5	45.1	69.8	11.7	134.7	8.0	17.6	24.5	13.4	5.4	13.1	38.4	4.0	5.3	8.7	4.8	18.3	0.5	24.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.8	0.9	0.8	0.7	1.0	0.9	1.1	0.8	1.0	1.0	5.3	0.0	0.0	0.3	0.1	1.0	0.3	0.4	0.0	1.0	0.6	1.8	2.5	0.0	0.3	1.8	2.1	0.4	2.9	0.4	1.9	3.6	32.5	0.9	1.8	8.6	0.0	5.9	0.1	0.9	1.4	0.8	1.1	1.8	0.0	10.4	3.6	1.1	1.2	0.0	0.0	0.8	0.0	0.6	0.9	39.1	0.6	0.5	3.6	0.0	0.8	4.3	0.0	0.0	0.3	1.1	0.0	0.7	0.5	0.7	0.0	0.8	0.1	0.4	0.0	0.3	1.0	1.6	14.3	4.1	1.4	0.3	1.2	0.9	0.5	0.9
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213607	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes		180000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	76.2	93.0	55.5	99.2	57.8	168.8	98.5	58.8	74.1	65.0	56.6	75.3	105.8	76.7	79.7	63.9	62.9	58.5	64.2	54.2	63.2	87.6	84.9	62.1	145.7	60.2	61.0	79.5	56.3	51.5	40.5	88.8	60.7	56.6	87.2	122.7	61.3	59.8	87.2	54.7	99.0	65.9	60.2	82.0	61.7	99.6	58.2	190.4	55.3	68.6	140.4	84.1	55.7	63.6	365.4	156.3	330.0	332.2	115.0	205.8	257.8	275.9	209.1	205.2	207.2	185.8	296.8	544.1	218.7	183.9	440.6	283.0	275.7	231.2	332.1	151.8	209.1	312.8	201.0	208.5	126.1	508.3	294.7	153.9	197.5	163.2	231.2	253.9	281.7	343.2	506.1	263.9	351.7	207.5	489.4	625.9	424.4	311.3	225.1	313.6	303.9	452.3	303.8	201.4	401.1	448.2	230.5	482.6	274.9	345.3	412.4	455.1	212.0	186.0	340.5	222.1	376.8	394.6	596.5	929.3	163.2	422.3	864.3	135.7	85.9	137.7	77.3	116.3	96.9	86.8	114.4	96.1	89.1	77.7	118.4	119.6	92.6	99.2	123.2	72.4	148.3	87.2	55.5	57.8	58.8	74.1	54.2	63.2	60.2	61.0	60.7	60.2	58.2	63.6	139.1	109.0	98.4	16.3	158.5	143.6	93.3	128.0	105.3	101.8	223.8	181.0	124.1	133.0	119.7	64.4	77.2	176.3	138.7	111.2	140.8	167.6	162.2	132.4	215.4	142.6	110.2	306.6	27.4	141.4	362.1	123.6	81.1	129.0	222.0	166.2	145.3	289.2	143.1	50.5	26.8	156.6	107.8	254.9	200.0	41.9	136.4	157.6	104.9	15.0	183.3	155.9	166.9	23.1	35.8	166.3	103.8	98.2	129.1	135.1	112.6	187.4	107.3	132.1	78.9	60.0	110.1	274.5	388.6	112.5	107.8	270.8	155.2	133.1	205.9	110.9
CBX4	"hPC2, NBP16, PC2"	ENSG00000141582	"Chromobox 4"	O00257	17	79833156-79839440	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 130.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 110.8;SK-MEL-30: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008228, HPA012021"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"HPA008228: AB_1078413, HPA012021: AB_2668603"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (8.72e-8)"	"unprognostic (7.49e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-1)"	9.3	14.2	9.6	11.1	10.8	130.3	9.0	8.8	12.5	9.1	0.0	7.9	7.1	6.3	4.6	20.7	8.1	6.3	16.0	12.4	9.7	10.6	21.6	12.3	14.6	11.5	9.5	9.6	19.0	17.0	19.1	15.2	10.7	9.3	3.2	12.3	13.2	4.6	3.4	31.6	11.9	3.8	8.2	20.9	12.9	6.9	12.2	23.1	8.6	1.4	7.2	6.7	10.3	16.6	32.1	28.3	8.4	36.3	5.2	4.7	23.5	14.3	8.5	5.1	5.4	20.5	17.5	12.3	19.7	5.6	11.4	16.3	9.3	9.5	3.8	13.3	17.7	7.0	28.0	38.4	25.4	37.0	52.5	6.5	54.4	4.7	8.4	8.5	4.3	35.5	21.7	67.5	5.5	23.0	50.9	37.7	4.6	33.2	28.2	51.9	8.6	56.3	7.2	15.3	8.7	16.6	21.4	110.8	130.9	3.5	26.3	58.3	11.2	29.8	26.3	18.4	18.6	58.0	32.4	35.0	18.7	31.6	40.4	1.6	0.5	1.8	0.9	0.6	0.6	1.5	1.2	1.3	0.3	1.5	1.4	1.3	2.1	0.4	0.7	1.7	0.2	0.6	9.6	10.8	8.8	12.5	12.4	9.7	11.5	9.5	10.7	8.2	12.2	16.6	40.4	3.2	15.7	4.6	31.8	23.3	5.4	13.4	36.5	31.7	65.2	79.8	51.6	30.0	12.1	1.8	22.9	34.2	77.6	26.6	0.0	7.5	0.2	63.9	19.3	21.6	52.7	7.8	5.5	7.3	5.0	15.8	20.9	62.8	7.0	22.3	15.7	16.3	13.8	20.2	5.5	49.5	2.0	19.8	17.0	1.0	4.4	35.4	17.8	12.2	15.4	39.2	15.5	6.0	11.6	10.0	18.4	5.7	26.1	6.3	9.6	2.8	14.6	44.3	6.6	15.3	24.4	0.5	2.4	65.7	30.7	8.6	42.5	13.7	29.7	5.2
CBX5	"HP1, HP1-ALPHA, HP1Hs-alpha"	ENSG00000094916	"Chromobox 5"	P45973	12	54230942-54280133	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 102.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016699, CAB017548"	Enhanced		Enhanced	Nucleoplasm		NA	NA		22000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB017548: AB_2071368, HPA016699: AB_1850627"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.05e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.97e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.64e-2)"	8.1	14.0	20.9	12.6	22.4	17.2	13.8	14.1	19.8	10.9	102.6	10.5	7.5	9.7	15.0	9.4	16.0	8.9	20.8	19.3	37.3	17.2	8.0	9.5	18.8	18.7	25.7	18.3	9.9	25.6	19.8	12.3	22.3	11.5	10.9	22.9	8.6	11.8	13.8	17.3	8.7	10.8	24.4	10.7	10.3	25.4	39.1	31.0	23.9	7.7	21.5	7.1	8.4	28.8	33.1	96.3	147.9	68.5	19.3	41.4	34.2	50.1	35.8	41.5	42.8	37.8	102.8	91.0	65.3	49.7	49.4	27.1	106.1	31.2	70.2	144.7	23.1	80.1	108.4	13.5	15.0	42.8	32.8	20.6	20.6	71.0	62.1	46.8	46.4	82.6	92.8	87.4	69.2	57.4	137.2	44.8	118.6	13.9	11.5	133.9	82.7	50.6	43.1	30.0	73.9	113.5	93.6	21.0	10.7	58.0	80.6	71.5	61.4	69.3	59.5	26.6	59.8	22.0	25.9	169.4	44.3	43.0	74.3	1.0	5.4	4.7	6.8	6.0	5.5	11.7	7.3	6.5	9.3	14.3	7.2	6.7	0.8	7.7	8.1	21.8	10.0	4.3	20.9	22.4	14.1	19.8	19.3	37.3	18.7	25.7	22.3	24.4	39.1	28.8	39.4	38.5	50.5	33.3	46.5	46.3	42.6	46.5	40.9	120.5	59.6	55.4	138.2	55.8	47.0	82.8	45.9	58.2	32.1	25.9	105.7	61.7	117.4	53.9	58.9	49.1	27.0	102.2	28.4	59.7	56.5	69.0	22.4	37.0	30.9	81.3	38.6	37.5	38.7	183.4	38.9	37.6	48.8	22.9	35.8	58.3	64.7	25.9	35.6	23.4	44.5	68.6	36.0	46.3	40.0	45.4	14.1	80.5	49.2	41.4	11.6	63.2	79.3	64.1	32.9	70.2	67.9	221.4	80.1	40.8	32.7	26.1	40.5	83.5	44.1	29.8
CBX6		ENSG00000183741	"Chromobox 6"	O95503	22	38861422-38872249	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048653	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Mitochondria"		"HPA048653: AB_2680479"	"unprognostic (1.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.27e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-2)"	16.3	22.4	67.1	16.5	53.6	28.3	12.3	9.9	83.6	21.0	0.0	39.3	6.5	34.0	14.5	13.3	27.0	11.3	17.7	88.2	10.1	18.7	6.3	17.2	14.2	16.6	14.0	24.4	17.1	49.5	27.5	4.3	10.0	22.0	7.2	8.5	13.7	25.9	8.9	8.2	17.1	26.1	5.5	15.9	20.5	4.3	21.8	12.5	19.0	6.7	15.3	31.0	11.9	30.8	40.3	41.7	9.1	31.3	68.5	38.2	2.8	42.8	24.5	21.8	20.3	21.1	36.5	65.3	31.2	29.5	15.3	46.8	17.0	18.3	11.9	63.1	53.0	6.7	18.5	7.4	37.2	32.6	31.1	57.0	9.1	49.7	23.5	30.1	24.9	18.4	14.9	32.2	15.1	45.5	20.2	9.5	8.1	23.1	31.9	29.9	30.5	25.9	31.3	37.4	44.3	9.8	27.5	36.4	23.7	3.2	25.0	19.3	32.7	18.9	57.9	33.2	29.6	32.9	34.1	23.5	37.0	33.6	40.1	2.2	9.1	4.7	18.6	12.4	15.3	6.7	12.6	13.1	9.1	7.7	10.3	12.6	4.0	9.1	12.5	46.1	8.0	20.0	67.1	53.6	9.9	83.6	88.2	10.1	16.6	14.0	10.0	5.5	21.8	30.8	30.5	16.0	14.7	9.8	25.1	33.9	47.4	18.4	16.5	100.4	42.6	31.6	27.5	52.9	22.1	73.5	39.6	12.4	83.0	9.6	35.2	102.6	1.1	6.9	46.0	36.4	122.7	17.7	28.9	50.1	2.0	48.5	3.1	17.5	6.3	18.7	46.8	32.4	19.8	124.5	27.3	3.2	30.5	40.8	121.1	2.9	74.3	33.2	81.8	14.0	91.1	91.2	57.7	15.1	23.3	46.9	9.1	80.9	24.5	58.9	0.1	51.7	18.0	59.4	72.3	54.4	85.1	4.2	6.8	10.4	34.0	4.7	35.8	40.9	0.9	82.6
CBX7		ENSG00000100307	"Chromobox 7"	O95931	22	39120167-39152680	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 37.2;U-266/70: 30.7"	"Low region specificity"	"Detected in all"							"CAB011574, HPA048677, HPA056480"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB011574: AB_726005, HPA048677: AB_2680490, HPA056480: AB_2683146"	"prognostic favorable (6.18e-4)"	"prognostic favorable (3.63e-4)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.03e-3)"	"prognostic favorable (2.45e-5)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.63e-2)"	36.6	31.2	53.6	15.9	52.9	6.0	32.3	53.8	72.1	54.6	38.1	85.2	17.2	61.2	29.1	24.5	62.7	17.7	57.4	53.7	44.5	32.5	17.7	30.4	27.4	49.2	47.8	58.5	28.8	41.5	42.7	8.3	48.9	50.9	14.2	34.0	35.3	57.7	68.0	28.1	42.9	27.4	38.6	42.5	48.0	10.8	46.0	14.2	33.3	51.3	21.6	66.3	39.1	53.2	6.9	2.9	1.4	11.0	13.1	5.0	3.6	6.5	8.0	3.5	4.2	1.4	4.7	1.2	7.5	4.9	6.3	2.5	0.9	3.0	2.6	37.2	3.6	0.2	5.5	0.7	4.5	1.7	14.0	2.5	4.4	1.7	0.7	4.5	1.0	5.5	1.7	18.1	2.7	6.7	2.5	0.8	0.8	8.8	4.9	2.8	2.3	10.1	1.8	2.8	3.6	0.9	3.3	4.8	7.6	2.3	5.8	2.7	2.6	5.8	10.9	5.9	2.9	30.7	18.4	4.2	11.8	2.7	2.5	0.4	0.3	2.9	1.9	0.0	2.0	1.5	2.1	2.1	0.0	2.0	2.6	2.5	3.1	1.0	0.5	0.4	2.2	1.0	53.6	52.9	53.8	72.1	53.7	44.5	49.2	47.8	48.9	38.6	46.0	53.2	17.5	6.4	8.7	16.3	27.9	4.6	11.7	3.7	7.4	57.0	9.6	11.6	74.6	24.3	9.5	14.7	35.5	4.3	10.5	10.5	9.8	4.3	8.2	5.1	4.8	14.4	4.2	20.0	17.0	3.8	1.5	16.2	6.6	3.3	10.8	9.6	28.5	11.8	4.4	60.6	18.8	7.6	8.2	11.7	6.4	18.6	35.1	6.2	19.6	14.0	11.6	16.4	42.2	13.0	28.8	3.4	5.1	27.8	12.0	10.5	18.2	13.6	6.4	62.7	46.0	28.3	24.9	7.0	5.3	3.1	4.8	3.6	22.8	4.1	5.4	7.5
CBX8	"HPC3, PC3, RC1"	ENSG00000141570	"Chromobox 8"	Q9HC52	17	79792132-79801683	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031462	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA031462: AB_10601252"	"unprognostic (4.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.94e-6)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (3.84e-5)"	"unprognostic (4.74e-1)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (6.99e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.51e-1)"	"unprognostic (5.99e-2)"	4.3	3.3	1.9	2.5	1.8	2.1	3.3	1.9	1.8	3.3	1.9	2.5	2.9	2.4	10.9	2.9	8.5	1.9	3.8	1.6	1.9	7.3	5.6	3.2	3.1	2.0	1.9	2.1	3.6	6.6	7.6	2.5	2.1	2.2	0.7	4.5	2.5	2.0	2.4	2.9	2.7	1.1	1.4	3.0	2.8	10.9	2.3	3.8	3.0	0.8	2.0	2.0	1.8	2.9	12.4	24.9	6.5	23.7	3.5	2.2	8.0	6.2	4.4	5.2	3.6	13.6	6.2	9.1	17.1	3.5	4.6	11.6	8.5	1.9	2.3	7.0	11.9	3.3	13.9	14.8	4.1	13.8	27.4	1.9	3.8	3.3	0.9	5.2	1.1	10.7	8.2	4.0	1.6	15.2	15.7	20.3	2.7	9.0	13.4	14.5	5.8	16.9	4.1	8.5	9.5	19.3	8.9	28.2	14.8	2.3	14.8	17.7	2.8	10.9	15.0	4.4	9.9	11.3	4.8	6.0	6.8	13.5	6.2	0.9	5.0	15.0	3.2	6.8	1.1	4.5	1.8	1.9	5.7	1.8	1.7	1.7	6.3	3.3	7.3	4.6	1.9	2.0	1.9	1.8	1.9	1.8	1.6	1.9	2.0	1.9	2.1	1.4	2.3	2.9	2.3	0.0	0.5	0.7	2.8	1.8	1.2	4.4	4.0	5.3	2.7	2.2	4.1	8.6	2.3	3.7	8.4	7.1	4.1	3.9	0.0	4.6	2.8	15.6	4.9	2.1	9.1	0.0	0.2	5.4	2.8	2.4	5.6	5.2	5.7	2.3	0.7	2.5	5.0	8.4	0.3	7.1	2.0	2.2	1.0	0.4	0.9	2.3	1.8	0.0	1.9	7.2	2.1	0.0	1.0	4.4	5.1	2.2	2.7	0.9	4.3	2.3	5.4	11.0	0.0	0.6	3.9	6.2	11.5	3.8	1.1	2.5	3.4	4.0	4.7	0.4
CBY3		ENSG00000204659	"Chibby family member 3"	A6NI87	5	179678560-179681034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 15.4"	"Group enriched"	"Detected in some"	117	"Early spermatids: 211.1;Late spermatids: 351.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.3;HeLa: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA069037	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA069037: AB_2686069"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.68e-3)"	"unprognostic (7.69e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.10e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.76e-3)"	"unprognostic (7.85e-2)"	"unprognostic (5.04e-3)"	"unprognostic (4.98e-2)"	0.2	0.4	0.4	0.0	0.3	0.0	0.3	0.5	0.4	0.6	0.0	0.6	0.1	0.5	0.0	0.2	0.7	0.0	0.4	0.2	0.1	0.4	0.2	0.2	0.2	0.6	0.2	0.8	0.9	0.0	0.9	0.0	0.4	0.5	0.0	0.4	0.5	0.0	0.4	0.3	0.5	0.0	0.1	0.4	0.4	15.4	0.4	0.0	0.6	0.0	0.0	0.5	0.4	0.5	0.0	0.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.2	0.3	0.2	0.5	0.1	0.2	0.9	0.5	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.4	0.3	0.5	0.4	0.2	0.1	0.6	0.2	0.4	0.1	0.4	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	211.1	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	351.4	1.5	0.2	0.0	1.9	0.0	0.0	0.0	1.0	2.4	0.0	0.0	1.9	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CC2D1B	"Freud-2, KIAA1836"	ENSG00000154222	"Coiled-coil and C2 domain containing 1B"	Q5T0F9	1	52345723-52366205	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 10.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027500, HPA031426"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA027500: AB_10600693, HPA031426: AB_2673876"	"unprognostic (1.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (3.39e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.87e-1)"	13.4	15.0	14.5	8.7	18.0	5.0	12.6	17.3	15.9	10.4	13.5	13.0	8.0	11.0	9.2	16.7	10.0	7.0	13.3	13.1	16.0	18.9	17.2	17.8	12.1	19.1	17.7	13.3	15.6	10.2	19.5	7.5	18.6	13.7	6.5	4.0	12.7	7.1	29.1	12.0	15.0	5.5	17.4	17.9	12.8	16.7	17.1	11.0	17.7	11.7	9.7	12.2	12.0	19.5	12.4	17.2	7.8	12.2	28.1	10.7	18.3	15.6	27.3	19.9	15.0	11.5	10.1	7.7	12.9	18.2	43.6	8.3	10.1	21.6	9.0	14.2	11.1	8.5	13.6	9.7	22.6	11.8	19.8	15.9	19.3	22.2	16.9	19.3	12.4	12.2	14.7	8.2	22.2	8.5	12.4	9.7	15.2	12.5	19.2	7.9	14.7	11.3	21.0	17.2	8.5	8.0	15.2	22.7	22.7	20.0	8.0	17.4	14.9	22.9	12.6	12.6	17.9	11.7	11.5	9.9	30.3	12.7	28.8	10.4	1.1	2.8	2.3	0.6	1.9	1.7	1.8	1.8	1.1	1.2	1.4	2.0	1.6	1.9	0.5	1.1	1.6	1.3	14.5	18.0	17.3	15.9	13.1	16.0	19.1	17.7	18.6	17.4	17.1	19.5	6.7	9.6	13.4	4.6	7.5	3.2	3.3	3.4	5.2	5.6	3.9	2.7	5.6	4.3	7.6	11.0	0.0	9.0	9.0	10.2	3.9	10.0	3.7	6.7	4.1	5.8	6.0	2.5	4.6	12.7	10.3	3.9	14.8	9.6	15.8	6.7	9.7	8.2	11.6	1.7	4.6	5.7	2.0	6.9	1.5	2.4	3.4	8.0	1.8	2.8	5.9	6.5	8.2	2.0	5.9	12.2	9.1	6.4	6.7	3.8	8.6	5.3	5.4	4.9	0.0	5.1	4.1	16.6	8.8	4.9	3.1	15.7	8.9	5.8	4.9	3.5
CCAR1	"CARP-1, CARP1, FLJ10590"	ENSG00000060339	"Cell division cycle and apoptosis regulator 1"	Q8IX12	10	68721012-68792377	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007856, HPA048513"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA007856: AB_1078415, HPA048513: AB_2680424"	"unprognostic (1.71e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (2.89e-2)"	"unprognostic (3.21e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.41e-2)"	17.4	21.4	14.4	20.2	16.0	23.4	17.2	21.1	25.4	15.9	15.2	17.9	16.8	16.7	16.1	20.1	14.5	16.5	15.6	13.6	17.0	18.4	19.1	15.9	30.3	16.9	14.9	19.9	20.4	15.9	14.5	21.7	16.4	17.3	22.2	20.9	18.5	13.5	20.6	23.9	19.4	16.0	13.2	21.5	17.8	14.3	16.8	29.8	18.2	17.9	28.7	21.7	17.0	19.2	64.0	64.8	73.9	49.7	31.4	30.3	57.7	56.0	47.4	59.3	40.0	87.2	50.8	74.7	29.9	39.1	29.8	49.3	78.4	44.3	64.8	51.5	48.2	60.1	46.1	54.5	35.7	96.2	67.5	30.5	54.2	50.1	61.7	36.7	48.5	37.5	83.5	46.8	58.8	46.5	64.2	60.7	74.1	49.7	58.4	74.2	44.1	44.7	52.5	48.6	42.7	36.9	55.1	89.1	57.1	57.6	60.6	58.9	48.1	36.8	46.3	40.1	61.4	32.2	45.5	78.5	30.8	63.8	35.6	6.1	14.6	14.3	16.3	13.0	14.6	14.2	11.3	15.8	21.0	17.3	13.5	14.3	3.3	10.6	15.5	13.1	18.4	11.3	14.4	16.0	21.1	25.4	13.6	17.0	16.9	14.9	16.4	13.2	16.8	19.2	50.5	35.3	85.5	61.4	69.2	37.0	49.6	54.7	66.0	51.0	36.1	40.0	65.5	41.5	49.0	46.0	58.4	73.1	62.9	44.1	23.5	68.0	28.8	55.2	68.5	54.0	46.1	61.2	49.7	78.1	83.8	49.2	45.3	62.2	67.2	76.8	39.3	40.4	49.2	55.5	51.2	55.1	30.5	47.4	36.3	14.5	53.7	49.8	21.4	41.2	65.4	36.5	66.9	47.7	66.1	77.7	34.2	50.4	61.0	45.3	36.0	18.3	49.1	68.7	65.7	53.2	62.3	128.7	77.2	50.4	37.4	109.5	61.3	83.2	67.2	49.4
CCAR2	"DBC-1, DBC1, KIAA1967, NET35"	ENSG00000158941	"Cell cycle and apoptosis regulator 2"	Q8N163	8	22604632-22621514	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Metalloenzyme inhibitor, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019907, HPA019943, CAB072827, CAB072828"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		19000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nuclear bodies"		"CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454"	"unprognostic (3.42e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.77e-1)"	64.1	68.3	39.2	75.4	44.2	145.5	64.4	40.2	52.4	65.6	45.6	68.5	52.1	75.0	33.0	63.4	67.9	59.7	52.0	47.0	33.8	54.8	41.1	61.4	86.7	36.9	42.3	74.6	56.4	59.8	65.1	54.0	38.6	61.1	45.6	59.8	61.5	46.9	101.4	89.0	69.3	44.9	34.7	85.6	60.0	89.4	39.6	96.0	60.6	43.5	74.3	65.4	57.6	47.9	133.7	242.8	230.8	120.8	89.5	74.7	154.0	127.7	124.9	184.3	163.9	219.5	107.4	218.6	156.4	140.5	169.6	163.2	214.5	151.9	132.9	89.2	128.2	259.1	189.5	172.8	82.9	143.6	212.0	77.8	133.1	147.0	90.0	106.4	134.4	194.4	276.2	134.8	138.0	157.5	435.0	150.5	337.6	143.2	88.1	286.7	190.7	116.8	95.2	311.7	115.1	267.6	143.7	163.0	112.6	110.7	148.8	133.2	219.3	135.8	178.4	165.3	171.1	98.5	134.0	261.4	152.7	123.4	215.7	25.9	16.2	23.5	34.8	26.6	29.4	18.7	26.5	26.6	16.6	17.5	25.7	28.4	5.7	19.9	35.6	15.5	32.6	25.8	39.2	44.2	40.2	52.4	47.0	33.8	36.9	42.3	38.6	34.7	39.6	47.9	14.4	16.0	4.2	11.1	14.1	13.9	9.5	12.2	17.6	12.9	13.5	13.1	7.5	15.7	9.4	16.5	16.7	27.3	19.4	24.1	9.8	18.1	4.7	14.1	12.3	13.1	22.2	16.4	12.5	18.0	22.2	12.8	18.8	14.3	8.8	20.2	11.7	12.0	15.7	10.1	11.9	19.6	14.2	11.9	8.5	7.3	14.9	11.0	12.4	10.3	11.2	15.9	20.6	11.1	10.3	23.6	10.4	12.0	14.8	11.7	14.4	9.4	19.5	12.9	19.7	12.4	12.2	30.0	24.1	16.9	15.3	23.7	19.3	23.5	21.7	10.5
CCDC102A	MGC10992	ENSG00000135736	"Coiled-coil domain containing 102A"	Q96A19	16	57512181-57536571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040598, HPA040958"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA040598: AB_10794035, HPA040958: AB_10794156"	"unprognostic (3.46e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.40e-3)"	"unprognostic (4.08e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.42e-3)"	5.0	3.7	1.8	2.7	1.6	0.5	4.8	1.7	2.4	10.9	4.1	11.1	2.3	11.0	1.1	3.5	8.8	1.5	6.8	1.6	1.7	5.2	1.5	4.5	3.0	2.5	2.4	8.0	3.3	1.5	2.3	2.5	2.0	8.4	0.5	0.1	4.0	3.8	1.6	4.9	4.7	2.4	2.1	5.1	4.8	3.0	2.4	1.6	5.8	0.5	1.7	11.9	8.2	1.5	6.6	7.9	3.0	4.3	1.0	1.4	6.2	4.2	2.3	2.4	1.2	3.2	7.5	6.0	16.4	1.3	3.2	4.8	1.5	2.2	0.9	4.9	6.8	0.8	3.8	1.3	3.7	0.4	7.7	3.5	1.4	2.0	0.5	5.2	1.9	2.1	4.6	0.0	0.8	2.7	5.4	5.3	7.1	0.7	14.6	4.8	3.4	2.4	3.0	1.0	0.5	7.8	6.6	2.1	3.2	1.1	4.5	2.9	5.2	4.4	14.5	0.4	3.8	6.9	2.7	2.2	2.5	2.1	7.4	0.0	0.0	0.0	1.1	0.0	0.9	0.9	0.2	1.2	0.0	0.5	0.5	0.8	0.1	0.6	0.0	0.3	0.0	0.2	1.8	1.6	1.7	2.4	1.6	1.7	2.5	2.4	2.0	2.1	2.4	1.5	8.8	0.0	3.0	0.7	8.2	12.9	8.0	2.4	14.8	0.0	4.9	10.3	3.1	5.7	2.2	7.3	0.0	1.6	16.3	0.5	9.8	1.9	0.6	6.0	8.5	10.6	0.0	3.4	0.0	0.9	1.1	13.2	2.0	1.8	0.0	14.6	7.1	0.9	0.3	0.0	0.1	1.0	0.0	0.6	2.8	1.3	19.6	1.5	1.8	1.0	0.5	3.5	18.6	0.0	0.0	0.9	0.1	34.6	18.8	10.6	1.1	10.5	3.1	0.2	19.7	10.8	11.8	2.8	8.9	2.3	5.7	0.3	10.5	3.3	1.0	3.2
CCDC106	HSU79303	ENSG00000173581	"Coiled-coil domain containing 106"	Q9BWC9	19	55641062-55653161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 69.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 9.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041925, HPA043219"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA041925: AB_2677750, HPA043219: AB_2678368"	"unprognostic (5.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.74e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.28e-1)"	"prognostic favorable (7.54e-11)"	"unprognostic (5.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.26e-1)"	"unprognostic (8.69e-2)"	12.0	21.7	27.8	5.1	32.7	2.6	11.9	20.4	37.6	11.4	17.7	18.7	4.1	13.4	6.4	8.0	13.3	6.5	21.9	33.0	22.4	29.1	24.3	9.4	10.3	21.8	23.1	12.7	9.8	13.6	27.3	5.1	21.1	15.2	2.7	6.5	11.1	11.2	24.5	9.3	13.7	7.1	18.4	18.2	13.7	20.8	23.5	4.7	16.7	20.2	9.0	12.8	8.3	24.7	8.7	33.6	14.4	25.3	10.1	9.6	2.0	7.4	12.9	25.0	21.0	7.3	13.2	25.6	5.6	13.8	0.7	7.3	24.6	16.0	7.1	1.3	82.2	26.7	23.4	13.3	30.1	1.8	14.3	15.6	1.9	5.9	1.4	17.4	8.0	16.0	20.1	15.7	12.5	2.3	16.3	10.8	6.9	0.8	18.3	25.5	7.3	17.7	25.9	0.8	15.8	29.4	5.9	41.3	14.7	8.5	17.9	17.3	9.0	7.7	7.9	0.7	5.5	9.3	3.5	33.0	20.7	8.4	0.6	0.0	2.3	0.0	0.4	1.5	1.4	7.2	0.4	0.6	2.9	9.6	3.1	1.9	0.0	0.8	0.1	8.9	0.3	1.7	27.8	32.7	20.4	37.6	33.0	22.4	21.8	23.1	21.1	18.4	23.5	24.7	12.0	0.0	1.3	8.8	18.1	2.5	6.0	14.0	12.0	22.3	16.0	17.1	23.8	11.5	6.5	20.2	4.2	13.5	6.8	4.6	41.1	19.6	4.0	3.9	7.2	10.8	4.9	4.2	6.4	7.2	15.0	9.7	11.7	3.3	8.9	10.5	10.0	17.5	17.5	37.0	6.4	8.7	8.2	9.4	6.4	2.7	14.0	7.9	3.6	3.7	11.7	34.1	3.1	4.5	3.6	8.7	8.0	18.8	7.0	6.0	10.6	69.4	3.2	9.7	13.1	9.3	9.0	4.7	30.2	10.3	3.7	8.8	3.9	18.9	6.0	5.7
CCDC107	MGC31967	ENSG00000159884	"Coiled-coil domain containing 107"	Q8WV48	9	35658290-35661511	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016857, HPA050442"			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA016857: AB_10669751, HPA050442: AB_2681128"	"unprognostic (3.70e-3)"	"unprognostic (7.07e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.75e-2)"	91.6	61.0	35.1	19.1	34.6	7.8	75.3	37.4	40.6	48.5	36.0	117.8	19.2	74.2	31.1	25.1	60.6	15.3	90.3	34.5	35.3	37.7	50.3	43.6	15.4	35.5	35.7	32.3	62.7	12.8	33.0	13.9	36.0	55.9	16.8	13.9	26.6	29.2	64.4	32.5	47.1	28.2	34.7	41.2	74.4	17.1	37.3	26.0	31.4	22.4	14.4	76.6	39.1	35.0	17.9	15.7	12.8	16.3	63.3	40.3	7.4	29.5	26.4	18.5	17.2	7.2	5.2	11.5	12.8	38.9	47.6	5.9	9.6	14.2	13.6	34.4	15.3	5.5	25.1	18.3	15.0	8.5	20.1	24.1	16.6	19.8	15.3	34.4	13.1	19.2	7.2	21.7	23.4	11.6	9.5	12.6	9.5	12.6	48.2	13.7	2.9	9.3	62.8	9.6	8.4	14.0	15.2	21.1	15.4	9.5	11.1	10.4	16.7	29.5	16.3	21.6	27.3	9.6	15.4	23.1	54.6	13.5	26.2	33.3	39.3	20.1	128.7	43.2	168.8	79.5	111.6	113.8	45.0	79.5	53.2	74.2	7.8	69.3	25.9	123.8	140.8	75.1	35.1	34.6	37.4	40.6	34.5	35.3	35.5	35.7	36.0	34.7	37.3	35.0	68.7	67.3	25.0	11.1	104.8	70.2	38.0	76.9	8.6	31.9	39.2	65.3	0.7	60.1	48.4	82.8	8.4	15.0	175.2	143.9	17.6	74.1	7.6	33.5	34.1	36.1	88.1	15.8	8.6	140.2	66.2	60.0	121.8	30.5	34.3	24.4	53.9	77.3	90.9	32.0	10.2	100.5	69.2	46.9	185.9	28.3	59.4	82.0	113.8	13.1	43.5	57.2	133.9	7.5	10.8	86.7	108.6	102.3	53.3	45.3	146.7	66.9	48.2	34.1	118.3	33.7	135.3	37.9	63.1	17.8	66.9	13.8	132.7	44.9	51.7	29.5
CCDC110	"CT52, KM-HN-1, MGC33607"	ENSG00000168491	"Coiled-coil domain containing 110"	Q8TBZ0	4	185445182-185471752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pancreas: 30.7;testis: 100.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 796.2;Late spermatids: 175.5;Spermatocytes: 552.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.4;U-266/70: 5.3;U-266/84: 8.8;U-87 MG: 4.0"					"Low region specificity"	"Detected in many"			HPA078808			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA078808: "	"unprognostic (1.18e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.42e-2)"	"unprognostic (9.84e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.95e-5)"	"unprognostic (4.92e-2)"	"unprognostic (5.81e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.21e-2)"	0.6	1.0	1.8	1.0	3.4	0.0	3.6	2.6	2.1	2.6	1.6	1.8	0.9	1.4	5.1	1.8	2.9	1.2	1.1	1.2	1.2	2.5	0.8	0.9	1.2	2.0	1.6	4.5	30.7	2.0	2.9	0.8	2.4	2.2	1.9	7.9	6.2	2.0	2.1	1.1	0.8	1.4	0.8	0.6	2.5	100.0	1.7	0.4	7.7	0.9	0.7	1.3	0.5	0.9	0.4	0.0	0.2	0.1	2.2	2.4	0.1	0.0	0.0	0.0	0.2	0.0	1.7	2.7	0.3	0.0	2.3	0.3	1.7	0.0	0.2	1.0	1.7	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.0	1.0	0.0	1.4	0.8	0.7	0.2	0.2	2.9	0.7	0.0	0.0	0.2	0.3	1.3	0.1	0.0	0.4	0.6	0.0	8.4	1.5	0.0	0.9	0.7	0.4	3.8	0.0	0.5	0.3	0.7	0.1	0.1	5.3	8.8	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.4	2.6	2.1	1.2	1.2	2.0	1.6	2.4	0.8	1.7	0.9	0.4	0.0	0.0	0.7	0.9	0.3	0.4	0.3	1.8	0.5	2.9	4.7	4.2	0.0	0.0	1.8	0.0	0.1	0.0	0.3	1.9	2.6	796.2	1.8	0.2	1.2	0.0	0.0	3.5	3.5	0.1	2.1	0.5	1.0	0.0	0.2	2.2	0.5	0.1	0.0	1.3	1.1	4.1	0.0	0.3	175.5	7.2	0.9	3.6	1.9	0.1	3.1	1.0	0.5	1.8	2.2	0.3	6.0	9.3	0.4	0.0	2.3	4.4	5.3	0.0	1.7	2.5	552.8	6.1	1.5	0.4	0.0	0.3	0.7	1.1	0.1
CCDC112	MGC39633	ENSG00000164221	"Coiled-coil domain containing 112"	Q8NEF3	5	115267190-115296693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 113.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045120, HPA050621"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA045120: AB_2679222, HPA050621: AB_2681191"	"unprognostic (1.88e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-6)"	"unprognostic (4.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (7.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.10e-3)"	4.3	3.6	5.7	5.3	6.3	7.3	6.0	7.4	7.3	4.5	2.6	9.1	7.2	5.6	6.2	4.5	4.1	3.1	6.0	5.8	6.6	2.8	1.2	5.5	4.6	6.4	5.5	2.1	10.2	4.5	4.6	2.4	6.3	6.7	9.3	7.9	6.5	5.0	4.3	4.9	6.3	5.4	5.7	4.6	6.4	40.7	5.9	3.7	4.0	2.5	4.2	3.8	3.6	7.8	12.0	5.9	11.5	18.5	7.1	14.0	2.9	10.5	5.3	7.7	8.7	2.6	6.7	14.8	8.9	7.2	11.4	7.5	12.1	6.0	16.0	12.0	10.1	9.8	8.8	3.8	9.7	12.9	4.8	6.4	7.2	9.8	13.0	8.8	12.1	13.1	4.1	11.6	10.8	9.3	19.2	11.4	13.1	11.0	11.0	20.6	14.5	113.7	7.7	4.2	17.9	23.5	11.5	7.2	32.8	7.8	12.2	18.9	12.6	10.1	6.9	19.7	14.8	13.2	13.2	3.0	6.7	9.9	6.0	0.3	5.0	11.0	2.9	4.0	3.3	2.8	2.2	2.5	5.4	4.0	2.8	1.9	3.2	3.0	4.9	10.2	0.1	2.1	5.7	6.3	7.4	7.3	5.8	6.6	6.4	5.5	6.3	5.7	5.9	7.8	15.7	16.0	14.0	16.0	19.2	14.1	5.0	6.0	8.0	29.2	19.4	18.4	17.6	8.6	8.4	5.5	10.4	0.7	19.5	23.6	5.9	28.2	8.5	23.0	21.4	12.4	40.6	20.8	26.4	25.9	2.0	11.5	14.3	12.3	9.5	15.0	7.9	3.1	32.7	10.1	15.2	33.4	6.1	28.6	31.5	18.5	4.1	31.5	14.2	15.0	36.6	11.0	11.3	21.1	54.7	27.1	18.7	4.1	27.3	8.0	11.8	4.4	11.7	24.9	13.1	18.5	18.2	201.8	73.3	13.8	22.6	0.5	9.2	5.5	32.8	3.4
CCDC117	FLJ33814	ENSG00000159873	"Coiled-coil domain containing 117"	Q8IWD4	22	28772674-28789301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 104.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000826	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Microtubules, Cytosol"	"HPA000826: AB_1078417"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.61e-3)"	"unprognostic (9.07e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-3)"	"unprognostic (8.25e-2)"	9.5	10.2	11.8	12.7	12.7	21.8	11.9	15.7	22.8	14.2	13.4	11.2	11.8	11.5	8.0	8.2	9.1	9.5	7.9	11.6	12.5	9.8	24.2	9.4	18.2	11.6	11.8	12.5	9.4	12.6	6.7	19.1	11.5	9.8	11.2	10.6	18.3	9.3	16.9	8.2	9.4	9.7	11.8	12.6	10.0	36.6	13.1	17.9	10.9	20.7	20.3	10.6	7.5	17.6	19.9	16.0	32.2	31.7	20.6	18.0	25.5	19.7	23.9	33.4	29.2	24.6	9.4	61.7	8.6	18.0	14.2	20.2	47.8	7.8	31.6	33.6	31.4	25.2	17.3	36.6	14.1	40.6	30.9	12.2	16.8	19.3	11.9	14.9	23.5	20.0	36.0	26.6	15.2	25.6	24.1	32.8	26.4	35.3	7.7	48.1	50.8	27.0	14.9	7.6	12.3	16.4	30.4	28.0	12.7	38.0	34.9	17.4	13.7	41.7	28.3	13.3	15.3	61.7	68.9	51.2	14.6	21.9	18.1	13.5	14.6	15.3	10.0	13.2	10.2	10.0	8.3	9.8	14.6	12.4	14.5	11.8	6.7	25.3	12.9	12.7	11.6	14.9	11.8	12.7	15.7	22.8	11.6	12.5	11.6	11.8	11.5	11.8	13.1	17.6	11.1	22.4	14.3	4.2	18.3	10.6	14.4	4.3	6.2	7.7	21.9	14.2	10.4	15.7	8.5	14.7	14.6	16.5	20.4	13.2	7.9	9.9	104.0	20.7	32.5	15.5	20.4	17.4	6.6	10.0	17.8	14.3	6.6	31.0	17.2	11.9	10.8	42.3	9.3	3.3	7.1	12.3	4.1	18.9	19.0	38.2	12.8	15.4	17.8	7.5	14.7	6.2	21.6	4.5	12.8	9.7	8.9	7.9	26.4	22.6	9.0	12.5	13.8	15.2	0.0	9.6	16.1	49.5	48.5	9.5	10.9	24.6	14.7	9.0	12.4	22.3
CCDC12	MGC23918	ENSG00000160799	"Coiled-coil domain containing 12"	Q8WUD4	3	46921726-46982010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056814, HPA060530"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA056814: AB_2683241, HPA060530: AB_2684309"	"unprognostic (1.47e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.15e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.08e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.65e-2)"	39.1	55.5	40.1	38.3	40.7	57.9	40.2	41.8	45.3	48.4	39.2	44.4	39.7	45.2	22.1	75.2	33.4	22.1	53.5	39.8	40.4	53.3	46.1	39.4	51.0	40.9	40.0	40.4	40.9	33.7	35.2	26.7	40.7	38.4	21.3	19.1	42.3	22.9	80.6	72.5	42.8	21.1	40.7	48.9	46.9	30.1	40.9	41.4	43.2	30.1	33.4	39.2	55.6	41.4	63.7	52.5	60.4	31.7	33.4	27.1	46.5	63.1	32.1	46.6	34.0	68.5	53.5	123.9	56.1	38.2	66.3	35.1	51.6	58.6	19.6	122.3	39.3	136.0	77.8	104.6	45.5	147.1	93.1	37.2	54.6	59.2	52.2	36.9	45.7	78.0	148.3	59.6	23.1	77.0	114.6	139.0	78.7	62.5	42.9	48.0	46.9	79.6	49.2	65.5	32.0	62.1	77.0	62.8	62.7	26.7	47.8	143.9	94.6	31.1	61.4	63.5	101.4	77.5	185.8	155.1	43.5	102.2	45.6	50.0	132.0	122.0	139.3	142.8	109.8	209.7	106.6	122.8	126.9	222.4	90.8	107.3	40.4	123.7	155.8	202.1	148.8	118.9	40.1	40.7	41.8	45.3	39.8	40.4	40.9	40.0	40.7	40.7	40.9	41.4	58.0	80.1	54.7	15.0	119.1	79.2	146.0	146.6	73.4	53.4	55.9	47.1	53.3	82.9	97.4	80.9	54.2	137.0	132.2	137.2	111.6	103.7	4.3	64.4	54.8	66.1	79.1	38.7	15.9	124.8	112.5	53.5	85.6	89.4	82.4	52.4	55.6	54.1	100.0	58.9	14.6	104.4	87.5	70.8	75.6	9.8	58.4	58.6	46.2	16.9	112.7	68.8	213.1	15.1	21.0	103.5	132.4	48.2	73.9	124.1	147.7	90.5	71.1	90.7	39.5	82.8	55.6	21.7	57.5	97.1	108.8	166.9	98.6	82.0	112.6	209.0
CCDC122	FLJ31846	ENSG00000151773	"Coiled-coil domain containing 122"	Q5T0U0	13	43823909-43879740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 148.5;Spermatocytes: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034233, HPA054995, HPA061456"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"CAB034233: AB_2228702, HPA054995: AB_2682665, HPA061456: AB_2684527"	"unprognostic (1.74e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.75e-2)"	2.3	2.9	1.7	1.9	2.9	0.9	3.8	1.4	2.0	2.7	0.7	2.9	1.7	4.1	5.3	2.1	4.4	3.1	4.6	1.5	1.9	3.0	2.4	2.0	2.7	2.5	2.2	6.1	3.6	4.0	3.2	3.1	2.5	4.9	3.5	0.6	3.2	2.4	1.1	4.0	2.5	3.3	1.7	2.9	3.1	4.1	2.2	2.1	4.9	0.3	2.7	2.9	2.0	4.9	2.2	1.8	0.8	0.0	0.6	4.0	2.3	5.7	6.4	3.0	3.3	3.0	7.6	3.8	3.2	3.4	4.9	3.4	0.7	0.8	3.9	5.7	2.8	1.6	1.0	1.6	8.1	0.9	0.4	10.4	6.7	4.2	10.9	2.5	1.4	1.4	0.0	1.1	4.0	2.6	0.6	0.6	0.9	0.5	2.1	0.9	0.0	2.1	4.5	1.2	2.0	3.1	4.0	0.1	3.4	4.3	0.6	0.6	7.1	0.2	0.8	4.9	0.0	0.0	0.0	1.8	2.7	0.1	2.9	3.5	0.6	1.1	0.5	0.6	0.6	1.0	0.7	0.5	0.5	1.3	0.5	0.5	1.4	1.4	1.1	1.2	0.7	0.4	1.7	2.9	1.4	2.0	1.5	1.9	2.5	2.2	2.5	1.7	2.2	4.9	5.6	9.6	11.7	8.5	5.2	3.1	8.9	6.1	9.6	1.9	10.5	12.1	11.1	10.0	8.5	7.3	0.0	17.5	1.7	4.5	19.6	13.1	2.8	14.3	11.3	6.7	18.0	6.1	15.8	10.1	11.6	9.2	4.6	8.3	1.3	13.8	5.7	4.9	2.0	10.1	24.7	9.4	0.0	2.2	2.7	2.3	17.7	3.9	1.8	21.5	0.8	12.7	0.0	28.6	148.5	7.6	2.9	7.9	1.3	8.3	6.4	12.0	19.1	0.6	0.0	7.4	6.7	43.2	26.3	5.5	3.8	7.9	2.9	14.0	7.1	6.4
CCDC125	KENAE	ENSG00000183323	"Coiled-coil domain containing 125"	Q86Z20	5	69280175-69332809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 15.0;neutrophil: 11.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 15.0"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041878	Approved		Uncertain	"Nucleoplasm,Nuclear membrane,Intermediate filaments"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear membrane, Intermediate filaments"	Nucleoplasm	"HPA041878: AB_10796787"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (4.40e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (2.51e-4)"	3.3	3.9	2.3	2.9	2.4	10.9	7.0	2.6	2.8	2.8	2.7	4.8	4.9	2.7	2.6	4.5	3.6	3.3	2.1	2.1	2.5	3.8	12.9	3.3	2.9	2.7	2.7	3.0	5.1	3.2	4.3	3.9	3.2	6.9	5.6	3.2	6.6	1.9	2.0	3.8	5.4	1.3	2.0	3.5	5.9	1.4	2.5	2.4	2.9	1.1	2.4	3.2	2.9	3.5	3.1	5.0	0.9	14.0	1.6	0.9	17.9	1.8	2.6	1.2	0.7	4.4	15.3	5.5	10.4	2.1	1.1	3.9	10.3	5.3	1.1	19.4	8.1	3.5	7.5	8.6	4.2	3.9	1.9	5.5	2.6	5.7	1.7	2.8	2.0	6.6	10.6	2.3	1.1	12.5	4.9	6.1	0.2	3.9	3.2	7.2	0.0	7.4	6.7	3.5	5.8	3.6	3.7	8.2	2.8	0.2	27.0	3.9	2.3	1.1	2.0	3.4	2.9	10.8	17.8	2.0	3.5	20.5	0.5	6.9	1.0	15.0	1.1	1.0	0.9	1.1	0.9	0.8	1.7	0.8	0.8	0.5	11.4	1.1	2.8	1.3	0.7	0.9	2.3	2.4	2.6	2.8	2.1	2.5	2.7	2.7	3.2	2.0	2.5	3.5	4.7	25.6	20.4	21.9	5.7	1.0	4.0	8.5	7.4	4.7	13.4	10.3	5.9	7.2	16.8	1.8	2.1	34.2	4.4	11.0	5.9	13.7	0.9	31.6	5.6	3.4	1.2	9.2	17.2	12.2	8.5	5.5	28.5	15.1	15.8	9.9	1.8	17.9	6.1	3.3	16.7	14.1	10.2	4.1	2.7	1.9	2.1	8.7	1.8	17.8	7.8	4.5	5.2	16.1	13.4	8.6	17.1	2.2	6.9	5.5	9.6	8.9	60.7	7.4	0.0	5.3	4.7	1.8	3.1	8.5	1.0	12.4	5.2	14.1	7.9	4.8
CCDC127	FLJ25701	ENSG00000164366	"Coiled-coil domain containing 127"	Q96BQ5	5	196868-218153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045052	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045052: AB_10960630"	"prognostic unfavorable (7.01e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.04e-6)"	"unprognostic (2.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (2.42e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.87e-1)"	4.6	7.8	4.2	4.2	4.6	2.1	4.1	5.3	5.7	5.1	5.8	6.0	4.8	6.2	3.9	7.4	5.5	7.0	9.8	4.2	5.3	4.3	3.8	3.6	7.6	5.9	5.3	8.1	4.7	2.7	4.4	4.0	5.7	5.7	1.9	20.3	4.4	3.0	12.1	6.9	5.8	3.2	2.9	4.1	5.2	6.3	5.1	3.0	13.2	5.1	2.3	4.6	3.9	5.2	5.6	7.3	8.0	14.5	9.6	7.3	7.8	10.6	5.5	4.7	4.6	7.6	11.5	11.6	15.0	4.9	6.1	7.2	4.9	4.1	4.5	29.8	8.8	4.1	35.8	6.8	5.6	3.1	7.3	6.0	6.5	4.4	3.1	11.1	3.9	6.3	7.0	4.0	5.0	4.5	6.0	6.7	6.8	3.4	8.8	7.0	5.9	9.6	8.8	5.7	8.7	13.8	14.7	10.0	9.7	6.3	13.1	6.2	8.3	11.8	6.9	4.8	4.4	6.7	6.0	8.0	7.7	5.6	7.5	3.5	3.1	5.1	5.2	3.6	5.7	6.6	5.4	6.4	3.1	6.0	6.3	7.1	1.8	6.3	3.3	5.6	4.4	3.9	4.2	4.6	5.3	5.7	4.2	5.3	5.9	5.3	5.7	2.9	5.1	5.2	13.8	16.0	10.4	3.9	7.8	14.1	13.6	29.2	10.2	17.4	11.4	15.0	28.0	5.7	16.8	5.5	18.8	33.1	13.9	9.8	3.9	30.7	7.8	16.6	17.9	14.8	8.4	6.5	3.8	15.1	28.8	19.9	4.6	15.5	9.5	17.2	14.6	12.5	19.9	38.7	4.6	9.6	16.2	6.5	10.7	7.3	20.8	10.6	8.8	1.9	20.3	34.8	11.3	7.5	5.8	15.8	3.7	19.9	8.7	14.9	20.0	8.6	19.3	31.4	13.1	11.6	13.4	40.1	30.8	6.9	8.0	30.1	11.1	21.1	7.6	12.9
CCDC13	FLJ25467	ENSG00000244607	"Coiled-coil domain containing 13"	Q8IYE1	3	42705756-42773253	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 2.4;choroid plexus: 2.5;fallopian tube: 2.9;retina: 4.3;testis: 5.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 28.0;Distal tubular cells: 17.6;Early spermatids: 18.1;Endometrial ciliated cells: 23.3;Late spermatids: 18.4;Respiratory ciliated cells: 53.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047429			Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 49: Ciliated cells - Cilium organization"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA047429: AB_2680043"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.83e-7)"	"unprognostic (6.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (2.04e-2)"	0.2	0.1	1.0	0.0	1.9	0.0	0.1	1.1	1.4	0.5	2.5	0.3	0.0	0.2	0.3	0.1	2.9	0.0	0.4	1.1	0.9	0.4	0.8	0.8	0.0	1.9	2.1	0.0	0.2	0.0	0.7	0.0	1.6	0.3	0.1	4.3	0.1	0.0	0.3	0.0	0.2	0.0	1.5	0.1	0.3	5.9	1.4	0.0	0.6	0.0	0.0	0.2	0.2	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	1.1	1.4	1.1	0.9	1.9	2.1	1.6	1.5	1.4	2.4	0.3	0.0	0.6	7.2	0.4	1.0	0.4	2.8	0.6	28.0	0.8	0.5	1.2	1.5	5.6	3.7	4.2	0.1	0.3	0.9	17.6	0.9	18.1	23.3	2.1	0.6	0.0	0.0	6.0	0.2	0.5	0.8	0.0	1.1	1.3	0.2	0.4	0.4	2.6	0.0	4.0	0.4	0.0	1.6	2.8	18.4	1.5	1.4	1.8	3.7	2.7	1.8	1.0	2.0	4.6	0.2	2.4	0.7	0.0	1.0	0.0	4.6	53.4	5.4	0.0	0.0	1.7	13.3	3.7	0.1	1.1	0.0	0.5	1.0	0.1	0.7
CCDC138	FLJ32745	ENSG00000163006	"Coiled-coil domain containing 138"	Q96M89	2	108786757-108885477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 154.1;Excitatory neurons: 56.5;Inhibitory neurons: 58.9;Oligodendrocytes: 48.7;Respiratory ciliated cells: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049899, HPA054223"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA049899: AB_2680941, HPA054223: AB_2682420"	"unprognostic (2.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.24e-5)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.77e-2)"	"unprognostic (7.06e-4)"	"unprognostic (7.88e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.93e-2)"	1.0	0.9	2.0	2.0	1.8	3.5	2.4	4.8	3.1	1.3	2.1	1.9	1.0	2.1	1.3	2.1	4.3	1.8	0.7	2.4	2.3	1.7	2.8	1.3	4.5	2.6	2.4	1.6	1.7	0.7	0.8	1.3	2.4	1.4	2.3	2.3	1.3	0.7	1.0	2.4	1.7	1.5	2.0	1.2	1.8	10.9	2.0	6.4	0.8	0.7	3.8	1.6	1.3	3.0	14.7	6.7	22.4	11.6	1.8	2.0	14.2	6.3	2.0	14.6	10.6	21.8	8.4	35.2	9.2	2.0	7.3	12.2	16.3	8.5	13.0	8.2	21.0	16.3	11.6	18.2	2.2	22.4	2.3	1.4	2.5	17.2	5.1	2.2	7.7	15.0	31.4	15.8	7.5	8.2	32.2	15.3	33.3	8.0	6.9	21.1	21.2	21.3	8.1	11.5	15.7	15.3	13.6	7.3	11.1	13.6	7.8	10.7	4.9	9.2	16.2	6.0	13.5	4.9	12.2	36.4	3.8	17.2	9.3	2.6	0.5	0.8	1.1	1.2	2.2	3.0	1.5	2.3	0.5	3.2	2.2	2.6	0.3	2.0	0.4	4.8	2.4	1.2	2.0	1.8	4.8	3.1	2.4	2.3	2.6	2.4	2.4	2.0	2.0	3.0	2.4	0.0	3.3	14.7	7.9	2.4	3.5	4.5	6.8	7.3	3.6	3.9	1.4	2.8	9.6	1.8	8.4	5.2	13.6	0.9	1.9	3.7	154.1	38.9	7.0	2.7	5.4	5.9	56.5	1.4	5.5	6.3	8.6	7.3	4.5	6.7	1.1	2.4	2.2	6.7	58.9	2.5	2.0	1.6	1.5	34.0	3.7	3.9	1.8	10.3	1.3	1.8	6.2	19.1	48.7	3.3	0.5	1.9	14.4	1.1	0.7	1.7	43.8	7.0	0.0	5.0	3.5	29.5	20.1	7.0	2.8	1.4	5.9	5.5	2.9	2.3
CCDC141	"CAMDI, FLJ39502"	ENSG00000163492	"Coiled-coil domain containing 141"	Q6ZP82	2	178829757-179050086	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 74.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 29.5;Bipolar cells: 28.1;Cardiomyocytes: 118.2;Cholangiocytes: 27.1;Early spermatids: 37.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 15.0"	"Group enriched"	"Detected in many"	9	"B-cells: 8.1;T-cells: 15.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.6;Daudi: 3.0;HEL: 6.9;RH-30: 3.6;U-266/70: 4.3;U-698: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012718			Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA012718: AB_2072055"	"unprognostic (1.58e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (8.62e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.03e-3)"	"unprognostic (7.71e-8)"	"unprognostic (2.50e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-1)"	1.5	0.3	0.8	0.5	0.4	1.3	0.7	0.9	1.0	0.6	0.8	0.2	0.1	0.6	0.2	0.4	0.4	1.7	74.6	0.3	0.6	0.1	0.3	2.0	1.5	1.2	1.1	1.0	5.8	0.1	0.0	1.2	1.4	0.3	0.2	1.1	0.1	0.2	17.1	0.5	0.2	0.2	1.6	0.7	0.2	1.5	1.0	1.5	0.3	3.5	1.1	0.3	0.1	1.8	0.1	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.1	4.6	0.3	3.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	2.6	0.1	6.9	0.2	0.0	0.0	1.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.1	0.2	2.4	0.4	0.5	0.1	3.6	1.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.7	0.2	0.3	0.0	0.2	0.1	0.2	0.0	4.3	0.1	6.1	0.2	0.3	0.4	0.4	0.0	0.2	0.3	0.0	0.2	7.3	2.2	1.5	0.0	8.1	6.5	5.1	0.3	1.2	0.0	0.0	15.0	0.4	0.8	0.4	0.9	1.0	0.3	0.6	1.2	1.1	1.4	1.6	1.0	1.8	4.5	6.4	29.5	5.5	11.0	0.1	0.0	0.0	0.6	28.1	0.2	0.3	118.2	27.1	0.6	0.0	0.0	0.0	2.8	0.1	0.0	4.6	37.3	0.2	1.1	6.7	0.0	0.4	3.6	1.3	0.2	2.9	0.0	1.1	6.3	0.0	0.4	0.3	0.0	6.7	3.1	0.1	0.0	1.0	1.0	16.8	1.2	3.9	1.8	8.4	0.1	5.5	1.0	0.5	0.8	0.2	0.0	1.9	2.6	0.0	0.2	0.1	1.5	0.6	6.6	2.8	5.4	0.1	1.1	0.0	0.1	0.0	10.3	1.1	0.2	0.2
CCDC144A	"FLJ43983, KIAA0565"	ENSG00000170160	"Coiled-coil domain containing 144A"	A2RUR9	17	16689537-16777881	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 9.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Early spermatids: 59.1;Rod photoreceptor cells: 49.4;Spermatocytes: 165.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basal ganglia: 2.4;cerebellum: 7.6;cerebral cortex: 6.9;hippocampal formation: 4.9;white matter: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.5;TIME: 8.5"									"HPA022996, HPA047220, HPA047851, HPA066260"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 6: Brain - Smell perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: "	"unprognostic (8.54e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-1)"	1.3	1.3	0.6	2.1	2.4	4.2	1.5	7.6	6.9	1.1	0.0	1.7	0.7	3.5	2.5	0.8	1.6	1.2	1.2	4.9	0.0	0.5	1.1	1.3	1.7	0.8	0.0	4.5	2.7	0.4	1.6	2.7	0.8	1.5	0.9	7.4	1.2	1.0	1.0	2.5	1.0	1.6	0.0	1.8	1.5	9.1	0.0	3.3	0.8	2.3	1.2	1.6	0.9	3.9	0.5	3.4	0.8	2.1	3.0	9.5	0.4	0.2	0.0	0.2	0.2	4.4	0.1	0.5	2.8	6.2	0.2	5.3	4.4	0.3	0.2	3.2	0.2	0.4	0.5	0.3	0.2	0.7	2.7	1.7	0.1	2.1	0.2	0.9	0.1	0.1	0.4	0.3	2.0	0.1	0.0	1.1	0.6	0.9	0.4	1.4	0.2	0.1	0.1	4.1	1.1	1.2	0.6	0.2	1.2	1.5	3.4	0.1	8.5	0.7	0.4	4.6	1.4	5.7	6.3	0.2	0.3	6.2	1.6	0.2	0.1	0.0	0.5	0.1	0.3	0.2	0.5	0.3	0.1	0.1	0.9	0.5	0.2	0.2	0.4	0.2	0.5	0.0	0.6	2.4	7.6	6.9	4.9	0.0	0.8	0.0	0.8	0.0	0.0	3.9	5.9	0.0	14.9	15.7	3.1	4.0	6.4	1.9	0.0	40.8	4.5	2.5	2.8	2.8	2.9	0.0	54.2	4.9	6.4	1.7	0.0	1.8	59.1	8.0	25.8	9.1	1.2	1.7	21.2	0.0	7.1	9.7	2.0	10.4	26.0	6.2	3.6	2.0	4.2	33.7	19.8	2.4	2.0	6.8	7.7	6.5	7.2	6.3	5.4	1.0	3.6	7.1	6.2	17.1	4.0	1.7	3.8	9.1	1.7	8.6	1.2	1.1	3.9	49.4	6.6	11.7	10.2	165.9	36.1	0.2	3.7	1.9	6.9	22.2	2.1	4.6
CCDC148	MGC125588	ENSG00000153237	"Coiled-coil domain containing 148"	Q8NFR7	2	158171073-158456753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 3.0;testis: 3.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Early spermatids: 39.4;Excitatory neurons: 33.6;Inhibitory neurons: 53.0;Oligodendrocytes: 38.6;Respiratory ciliated cells: 34.1;Rod photoreceptor cells: 30.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;HBF TERT88: 1.8;RPTEC TERT1: 1.9;SCLC-21H: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042626	Uncertain		Uncertain	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA042626: AB_10806244"	"unprognostic (1.88e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.94e-4)"	"unprognostic (3.29e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (2.54e-4)"	"unprognostic (6.57e-3)"	0.2	0.3	0.5	0.0	0.6	0.0	1.0	0.9	0.4	0.7	3.0	0.0	0.0	0.4	1.2	0.1	1.8	0.3	0.1	0.5	0.4	2.4	0.1	0.4	0.0	0.9	0.7	0.7	0.2	2.5	1.0	0.0	0.6	0.3	0.0	2.0	0.6	0.4	0.0	0.2	0.0	0.1	0.5	0.0	0.1	3.4	0.5	0.0	1.0	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.4	0.7	0.0	0.0	0.0	0.5	0.0	0.5	1.1	0.5	2.7	0.0	0.1	0.4	0.2	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.9	0.2	2.0	0.1	0.3	0.2	0.2	0.6	1.2	0.1	0.0	0.2	0.4	0.1	0.1	0.3	0.6	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.9	0.4	0.5	0.4	0.9	0.7	0.6	0.5	0.5	0.3	1.1	0.0	1.5	13.4	0.2	0.0	2.6	4.2	1.2	10.9	3.8	4.6	3.0	0.0	3.0	7.3	56.3	0.0	0.0	0.0	13.7	5.5	39.4	15.2	0.6	1.5	0.0	0.0	33.6	2.0	0.0	0.6	0.0	2.8	0.0	1.3	1.1	1.3	0.1	5.0	53.0	0.0	10.2	0.3	0.0	7.7	0.9	1.0	0.0	5.6	0.8	6.0	0.0	19.6	38.6	2.6	0.0	1.9	0.0	1.2	0.0	6.4	34.1	30.8	6.6	1.6	0.7	22.6	4.0	0.6	0.4	0.0	0.2	1.3	0.1	1.7
CCDC150	FLJ39660	ENSG00000144395	"Coiled-coil domain containing 150"	Q8NCX0	2	196639554-196763490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.6;testis: 4.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.5;Granulosa cells: 16.5;Late spermatids: 20.9;Oligodendrocytes: 16.4;Spermatocytes: 32.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048104	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA048104: AB_2680264"	"unprognostic (1.92e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.58e-4)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.91e-4)"	"unprognostic (2.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.17e-3)"	"unprognostic (5.66e-4)"	"unprognostic (7.29e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.69e-5)"	0.1	0.0	0.2	0.2	0.2	0.6	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.6	1.2	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	4.9	0.2	1.0	0.0	0.0	0.1	0.0	0.0	0.2	1.0	0.3	4.4	2.8	0.1	0.3	1.9	1.0	0.5	0.7	1.9	1.5	0.9	0.6	0.5	0.7	0.6	1.3	1.7	0.8	1.9	4.2	2.4	1.4	2.4	2.5	0.0	0.9	0.6	0.0	0.1	1.0	0.5	0.2	0.5	1.5	2.0	1.8	0.5	0.5	0.8	1.3	2.6	0.3	1.0	1.8	0.6	0.6	0.3	0.4	4.6	0.9	0.7	0.4	0.2	2.2	0.7	0.5	0.9	1.5	1.4	1.4	0.9	0.8	0.8	1.4	0.5	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	1.5	3.2	1.7	2.3	1.0	1.5	2.2	0.2	0.0	3.6	0.6	1.3	1.5	1.5	0.1	0.0	2.1	2.2	0.7	1.4	1.9	0.3	54.5	2.1	1.7	2.6	0.0	2.1	1.1	0.4	2.0	2.3	1.5	3.8	3.8	16.5	1.4	3.8	1.3	1.7	3.0	1.4	0.0	1.3	2.5	20.9	1.5	1.3	7.2	0.0	0.5	1.1	2.1	2.0	16.4	0.4	1.2	1.9	2.4	1.3	0.7	12.5	2.5	1.3	0.0	4.0	2.3	32.2	14.8	2.0	1.0	0.7	1.2	2.8	1.7	1.3
CCDC152	LOC100129792	ENSG00000198865	"Coiled-coil domain containing 152"	Q4G0S7	5	42756818-42802439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 178.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 43.4;Spermatocytes: 103.0;Spermatogonia: 37.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 3.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 13.6;JURKAT: 13.3;U-2 OS: 23.5;U-266/84: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036240	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 62: Liver - Hemostasis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA036240: AB_10671242"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.25e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.14e-3)"	7.5	5.7	2.3	2.2	5.4	1.5	6.5	4.6	2.9	6.0	2.9	5.2	3.9	3.0	0.6	2.2	4.1	4.9	7.8	2.1	4.7	8.6	178.0	6.1	7.4	5.8	5.1	8.3	4.0	0.0	7.8	2.3	6.6	4.6	0.3	2.2	2.7	0.3	1.8	3.3	13.3	0.4	4.0	14.9	4.5	5.0	4.6	4.0	3.3	0.6	2.6	2.6	4.9	7.1	0.4	0.1	1.0	0.1	3.2	4.1	0.0	5.7	0.1	0.0	0.4	0.0	0.3	0.0	0.3	2.6	4.3	4.6	0.0	0.0	0.5	0.1	0.4	0.2	13.6	5.5	3.2	0.1	0.0	5.3	0.0	2.3	0.0	8.5	1.8	13.3	0.6	1.2	0.1	0.0	0.1	0.2	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.4	6.5	0.0	0.1	0.0	4.7	0.4	0.1	0.1	0.2	23.5	5.2	0.2	0.1	16.8	0.2	6.9	0.2	0.1	0.0	0.1	0.1	3.1	0.6	3.7	2.0	2.3	3.9	0.6	2.7	3.0	4.7	0.2	5.1	0.3	8.3	1.6	1.0	2.3	5.4	4.6	2.9	2.1	4.7	5.8	5.1	6.6	4.0	4.6	7.1	4.9	60.9	43.4	3.9	10.2	3.7	0.3	0.7	2.2	15.8	1.9	1.5	11.7	2.8	7.6	1.8	0.0	1.6	6.0	2.4	0.0	0.8	14.9	2.3	11.1	4.3	1.2	10.3	2.6	1.1	1.0	17.7	0.0	3.1	9.5	5.3	7.1	5.1	2.6	33.7	9.3	2.9	2.0	14.4	5.6	7.4	6.5	8.0	3.6	1.0	0.9	34.2	21.6	7.5	13.0	1.9	3.0	7.5	3.4	0.3	6.4	0.7	3.9	2.7	0.0	13.0	5.0	103.0	37.8	3.5	4.0	1.8	9.1	10.5	1.3	0.3
CCDC159		ENSG00000183401	"Coiled-coil domain containing 159"	P0C7I6	19	11344684-11354944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 275.7;Late spermatids: 277.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047126, HPA054655"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA047126: AB_10961722, HPA054655: AB_2682558"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (1.87e-7)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.40e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (9.46e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (8.62e-4)"	15.7	43.4	29.3	17.3	33.8	32.6	18.2	28.9	41.0	30.0	29.2	25.8	22.9	22.5	24.9	18.2	24.0	20.6	21.8	32.3	31.3	25.9	36.0	22.8	20.9	34.4	31.3	31.3	23.3	39.5	33.5	9.3	33.4	45.1	11.8	12.4	21.6	18.5	6.1	19.0	24.0	13.8	27.4	41.8	26.2	43.2	34.2	12.4	30.4	6.7	14.5	24.2	21.7	38.1	3.7	3.2	2.6	8.0	10.3	14.8	2.7	5.8	6.0	6.7	8.9	1.0	3.8	3.0	14.7	11.0	2.0	3.0	1.5	9.2	4.1	15.0	2.2	7.2	2.5	3.9	17.9	2.8	10.4	17.8	24.0	4.9	6.5	7.1	19.2	5.3	6.5	33.6	3.4	4.5	4.5	6.0	1.4	5.0	11.5	4.8	0.0	19.6	6.1	5.3	1.1	4.3	5.9	6.6	11.0	4.6	9.8	11.9	12.8	5.3	1.6	9.3	5.5	30.8	8.0	6.2	7.2	14.7	7.9	51.5	52.8	38.5	21.5	46.3	21.1	16.0	14.6	20.2	31.6	20.4	13.2	10.4	25.3	30.2	33.8	8.4	31.5	23.5	29.3	33.8	28.9	41.0	32.3	31.3	34.4	31.3	33.4	27.4	34.2	38.1	10.7	16.0	13.6	7.5	14.5	7.5	15.4	14.9	10.8	11.3	12.5	8.9	9.8	12.8	16.7	18.4	41.7	5.1	12.4	13.0	25.4	8.2	275.7	9.0	8.8	10.3	10.8	4.6	4.5	9.5	5.5	8.1	30.5	10.0	34.2	11.5	12.8	10.9	23.3	6.7	3.0	12.5	10.2	26.7	14.8	277.4	11.5	20.3	12.4	2.8	28.9	16.6	39.1	2.0	10.2	8.7	24.0	13.5	15.0	16.6	29.2	38.6	16.9	27.9	0.0	5.2	8.4	4.7	3.9	11.0	8.1	6.0	17.9	20.1	9.5	19.7
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553043-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 194.5;Excitatory neurons: 92.4;Inhibitory neurons: 70.6;Late spermatids: 172.4;Spermatocytes: 148.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.5;HEL: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	0.8	1.1	2.3	0.7	2.8	2.1	1.6	3.7	3.2	1.4	0.0	0.9	0.8	5.8	1.1	1.0	2.0	1.5	1.0	2.5	0.3	1.2	0.4	1.1	1.1	1.5	0.3	2.9	1.3	1.4	1.1	0.9	2.0	1.1	1.1	5.5	0.8	1.2	0.8	2.4	1.0	3.3	0.2	0.6	1.4	11.3	0.5	4.8	2.0	1.1	1.0	0.8	0.9	3.3	1.4	0.7	1.6	1.6	0.9	1.9	1.0	1.0	0.8	1.0	1.1	0.4	0.6	7.5	0.5	0.6	1.9	0.3	0.7	1.0	1.1	1.6	0.7	11.7	1.2	1.0	1.3	1.6	1.4	1.1	1.9	0.8	1.5	0.8	0.5	4.1	0.3	2.0	1.2	0.5	3.3	1.5	1.3	0.6	1.6	3.8	1.2	0.2	0.7	1.1	2.3	1.1	2.1	0.7	2.8	1.3	0.9	1.1	0.8	2.1	1.2	0.6	0.7	1.1	1.4	4.8	0.9	1.0	1.5	2.4	0.2	0.0	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	2.3	2.8	3.7	3.2	2.5	0.3	1.5	0.3	2.0	0.2	0.5	3.3	4.4	0.0	7.5	56.8	2.6	2.8	5.8	1.8	7.4	27.7	5.0	8.0	8.5	0.0	5.9	3.7	16.7	6.7	1.4	3.6	5.9	2.9	194.5	24.3	7.8	3.8	1.2	3.8	92.4	3.5	4.1	5.7	8.2	12.9	1.3	7.6	3.3	0.8	1.9	10.1	70.6	3.5	6.1	1.0	1.1	172.4	5.9	2.1	0.0	16.9	1.6	12.5	5.2	54.8	63.1	2.5	1.0	6.0	1.9	0.8	2.8	2.1	12.0	44.0	13.1	11.6	5.7	148.2	40.6	5.4	3.3	5.6	3.6	10.7	4.9	3.7
CCDC174	"C3orf19, FLJ33839"	ENSG00000154781	"Coiled-coil domain containing 174"	Q6PII3	3	14651746-14672659	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 152.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043468, HPA060129"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA043468: AB_2678493, HPA060129: AB_2684208"	"unprognostic (6.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.81e-5)"	9.5	7.0	7.7	7.0	8.5	17.2	9.2	8.8	8.5	10.9	6.8	9.8	9.4	10.4	7.5	8.9	9.4	6.8	8.2	7.7	8.0	8.9	8.7	7.1	9.6	8.1	8.4	14.7	10.1	11.9	8.6	8.6	8.1	9.7	7.3	6.7	8.6	8.0	11.1	9.7	9.5	7.9	7.5	10.6	10.3	9.1	8.2	11.6	9.0	10.7	10.2	9.6	9.5	9.6	6.2	6.7	10.0	10.7	13.6	11.1	25.3	8.1	11.6	10.0	7.8	7.5	7.0	12.8	5.8	7.2	6.8	5.3	7.3	6.8	7.8	9.7	8.9	13.0	8.1	8.1	19.7	12.9	14.5	12.9	17.0	13.5	16.5	14.0	8.6	13.4	13.2	11.4	7.6	10.9	13.6	11.3	13.5	10.1	10.9	10.1	9.3	10.6	10.4	10.8	4.8	13.1	9.5	7.4	13.4	11.6	11.2	18.1	8.0	8.0	7.8	7.4	9.5	15.0	14.3	14.7	8.0	9.8	11.1	25.4	10.7	22.2	12.9	11.3	15.2	17.4	16.1	15.1	9.7	16.4	17.4	13.8	20.5	18.8	12.2	10.9	12.5	10.0	7.7	8.5	8.8	8.5	7.7	8.0	8.1	8.4	8.1	7.5	8.2	9.6	29.5	9.6	34.5	11.4	48.0	16.2	31.3	38.0	26.7	32.8	25.0	28.4	37.0	32.9	35.7	12.9	20.9	32.1	42.3	27.3	56.7	34.7	152.5	27.3	35.4	31.0	18.5	43.4	12.8	34.9	25.2	33.7	20.4	34.7	52.0	22.0	38.6	29.3	26.5	15.2	16.6	34.1	32.6	27.2	16.5	59.1	33.5	30.5	14.2	5.6	45.2	22.2	34.0	11.1	15.8	38.2	34.9	40.3	34.9	28.8	36.8	46.4	31.1	24.9	32.9	28.4	37.2	78.7	33.5	19.9	13.5	65.7	41.6	23.5	23.1	31.8
CCDC175	C14orf38	ENSG00000151838	"Coiled-coil domain containing 175"	P0C221	14	59504539-59576812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 18.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 8.4;Early spermatids: 11.9;Excitatory neurons: 15.9;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 11.4;Spermatocytes: 17.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"cerebellum: 18.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004200	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA004200: AB_1078743"	"unprognostic (3.64e-3)"		"unprognostic (8.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"					"unprognostic (3.83e-1)"			"unprognostic (2.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.27e-1)"			0.0	0.0	0.1	0.0	0.2	0.1	0.0	18.4	0.5	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	18.4	0.5	0.0	0.2	0.7	0.8	0.8	0.4	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.6	0.0	8.4	0.0	0.0	1.1	0.0	0.0	11.9	5.0	0.1	0.0	0.0	1.7	15.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	1.5	4.8	0.0	0.3	0.0	0.0	0.1	1.5	0.0	5.0	3.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	7.4	11.4	0.0	0.4	0.3	17.7	4.4	0.0	0.0	0.0	0.0	0.1	2.4	0.1
CCDC18	NY-SAR-41	ENSG00000122483	"Coiled-coil domain containing 18"	Q5T9S5	1	93179919-93278730	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.6;lymphoid tissue: 8.9;testis: 9.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.5;Spermatocytes: 137.2;Spermatogonia: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028035	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA028035: AB_10601795"	"unprognostic (8.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.49e-4)"	"unprognostic (4.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.64e-13)"	"unprognostic (4.94e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	1.9	1.0	1.3	4.3	1.4	10.6	1.1	1.6	1.1	1.0	1.0	1.9	1.7	1.2	0.8	1.6	0.7	1.1	1.0	1.1	1.3	0.6	2.0	1.7	8.9	1.4	1.3	1.3	0.4	0.3	0.8	1.3	1.4	0.6	2.7	0.6	0.7	0.3	2.0	2.1	1.6	1.2	1.1	3.5	1.5	9.5	1.3	6.5	0.7	0.9	5.9	1.6	0.9	1.4	24.8	8.1	18.7	5.9	4.5	4.7	9.7	15.1	7.9	15.1	15.3	4.3	8.3	31.9	8.2	8.1	14.7	11.5	8.2	11.8	21.9	15.9	10.7	21.9	18.5	7.6	1.6	23.1	9.8	3.1	1.0	11.5	11.1	4.2	10.0	14.0	23.8	23.9	20.4	3.5	11.1	9.3	17.1	6.7	10.0	14.0	22.3	9.4	7.4	10.9	8.2	5.2	21.4	10.8	6.1	8.3	5.1	13.3	7.7	17.7	12.4	11.5	17.5	10.2	14.5	18.8	3.7	20.1	4.8	5.1	3.6	5.8	2.3	4.1	2.7	10.2	2.1	2.2	1.7	11.6	1.7	1.9	6.0	1.2	3.8	12.5	2.5	0.5	1.3	1.4	1.6	1.1	1.1	1.3	1.4	1.3	1.4	1.1	1.3	1.4	5.0	19.2	9.6	16.6	17.6	4.1	7.9	4.5	8.0	2.4	3.8	4.2	9.5	0.0	3.6	3.7	4.2	5.7	18.4	3.6	0.0	2.3	50.5	6.6	7.6	4.6	0.0	40.2	13.2	2.9	6.7	8.8	8.2	6.1	19.0	13.5	5.0	4.5	8.2	1.7	12.6	3.2	6.1	14.2	10.4	16.3	6.2	17.5	3.6	15.0	12.9	0.7	7.2	7.5	15.7	2.0	4.4	6.4	22.7	4.6	2.1	1.5	5.6	0.7	6.6	9.8	8.1	137.2	47.7	8.2	7.2	2.9	15.7	5.1	6.9	8.9
CCDC188		ENSG00000234409	"Coiled-coil domain containing 188"	H7C350	22	20148416-20151055	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 40.2"	"Group enriched"	"Detected in some"	89	"Early spermatids: 313.0;Late spermatids: 988.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in some"		"AF22: 4.0;SCLC-21H: 5.5;SH-SY5Y: 7.2;TIME: 3.1;U-2 OS: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049901			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA049901: AB_2680943"	"unprognostic (9.83e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-5)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-2)"	1.5	0.6	0.4	0.5	0.6	0.5	1.3	0.5	0.6	0.8	0.0	0.5	0.8	0.8	0.0	0.3	1.0	0.3	0.6	1.0	1.3	0.9	0.2	1.0	0.6	0.1	0.0	0.3	0.5	0.0	9.6	0.6	0.0	0.5	0.0	0.2	0.4	0.0	0.6	1.1	0.6	0.2	0.0	1.5	0.5	40.2	1.4	0.0	0.6	0.0	0.0	0.7	0.6	0.0	0.0	0.0	4.0	0.2	0.0	0.5	0.0	1.1	0.5	0.9	0.7	0.0	0.1	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	1.1	0.2	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.4	0.0	0.1	0.6	0.2	2.6	0.8	0.3	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	5.5	7.2	0.4	0.0	0.4	0.1	0.0	0.1	3.1	1.6	3.0	2.0	0.2	0.5	0.1	0.2	2.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.6	0.5	0.6	1.0	1.3	0.1	0.0	0.0	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.0	7.3	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	988.5	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	4.1	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CCDC198	"C14orf105, FLJ10650"	ENSG00000100557	"Coiled-coil domain containing 198"	Q9NVL8	14	57469300-57493867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 27.5;kidney: 97.3;liver: 36.8;pancreas: 34.0"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 57.0;Distal tubular cells: 68.4;Proximal tubular cells: 191.8"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 25.1"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"A549: 11.5;RPTEC TERT1: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029202			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA029202: AB_10600754"		"unprognostic (1.45e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.67e-2)"		"prognostic unfavorable (5.61e-4)"	"unprognostic (1.21e-1)"		"unprognostic (5.45e-3)"	"unprognostic (1.51e-1)"		"prognostic favorable (1.92e-4)"	"unprognostic (6.07e-2)"	"unprognostic (2.77e-1)"		"unprognostic (1.61e-3)"	0.1	0.1	0.5	0.5	0.7	0.6	0.0	1.0	0.6	1.3	0.0	0.2	1.5	0.5	1.9	0.1	27.5	16.8	0.2	0.4	0.4	97.3	36.8	0.1	0.1	0.7	0.5	0.1	34.0	0.0	0.0	0.0	0.8	0.1	0.1	0.1	0.0	1.5	0.2	0.6	0.2	0.0	0.4	0.1	0.4	0.1	0.8	0.0	0.2	0.0	0.0	0.2	0.0	1.6	0.0	11.5	0.0	0.0	0.0	0.6	0.2	0.1	0.1	0.0	0.0	1.1	0.9	0.1	2.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.2	0.2	0.0	0.2	0.1	0.0	0.2	34.3	0.4	0.1	0.0	0.1	0.1	0.0	0.3	0.2	0.5	0.3	0.4	0.5	0.1	0.0	0.3	0.3	0.3	1.6	0.4	0.0	1.7	0.3	0.2	0.7	0.1	0.9	0.6	1.4	1.0	0.0	1.2	1.2	1.9	1.5	1.0	0.3	0.5	2.2	1.9	0.5	0.7	1.0	0.6	0.4	0.4	0.7	0.5	0.8	0.4	0.8	1.6	0.0	3.2	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.1	0.0	68.4	22.2	0.0	19.7	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.1	0.0	0.0	191.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0
CCDC25	FLJ10853	ENSG00000147419	"Coiled-coil domain containing 25"	Q86WR0	8	27733316-27772653	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023256	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA023256: AB_2072067"	"unprognostic (1.43e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-2)"	"prognostic favorable (1.11e-7)"	"unprognostic (3.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-1)"	14.0	20.9	10.1	11.8	11.4	4.9	17.4	10.5	17.1	10.1	7.3	14.3	35.5	10.4	14.3	14.2	12.9	11.9	12.2	9.9	11.3	22.5	32.3	8.8	14.0	11.1	10.5	10.8	16.3	18.3	7.5	10.6	11.5	11.6	15.7	11.1	13.5	12.0	28.4	10.3	30.8	10.3	11.3	10.5	20.0	10.9	11.9	11.4	18.8	15.2	14.2	11.7	9.4	13.0	50.1	27.9	25.8	24.7	22.8	33.0	17.2	41.0	39.5	24.7	24.0	11.2	17.9	53.6	27.7	20.9	21.2	23.1	23.6	40.0	35.5	20.3	16.4	66.9	23.1	19.3	36.9	23.8	20.8	37.1	25.9	27.1	37.6	28.7	54.0	33.7	32.2	24.6	27.8	19.2	55.3	19.9	37.9	49.4	14.8	18.7	44.4	28.8	32.3	26.7	15.1	41.7	27.5	21.0	42.8	19.0	24.0	13.1	44.6	22.5	33.4	38.9	21.7	24.5	33.8	19.5	35.0	30.8	23.8	20.3	8.9	6.6	15.2	12.6	17.8	19.8	19.6	16.1	11.6	15.5	18.3	19.3	3.2	14.3	13.4	18.1	23.2	10.4	10.1	11.4	10.5	17.1	9.9	11.3	11.1	10.5	11.5	11.3	11.9	13.0	47.5	25.6	38.9	12.4	34.8	21.4	39.6	46.5	55.2	42.6	57.3	61.6	62.5	60.1	44.5	53.3	12.5	77.6	31.2	61.6	109.5	76.9	183.1	46.8	51.0	54.2	26.5	46.7	30.5	134.6	56.0	49.3	63.2	33.3	63.9	39.3	55.0	144.5	44.7	55.5	21.9	58.6	46.8	33.5	27.2	162.9	47.2	27.4	37.4	12.2	44.4	60.2	35.0	12.1	17.7	83.7	51.1	47.4	40.7	55.2	182.1	128.6	53.7	38.9	46.0	44.4	49.1	91.1	59.6	56.7	22.3	42.4	38.7	88.1	71.2	36.0
CCDC27	FLJ32825	ENSG00000162592	"Coiled-coil domain containing 27"	Q2M243	1	3746460-3771645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 16.9"	"Group enriched"	"Detected in some"	63	"Early spermatids: 87.6;Late spermatids: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 1.1"	HPA044395			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA044395: AB_10962987"	"unprognostic (1.36e-1)"	"unprognostic (6.67e-3)"		"unprognostic (3.23e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.28e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	27.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC28A	"C6orf80, CCRL1AP, DKFZp586D0623"	ENSG00000024862	"Coiled-coil domain containing 28A"		6	138773769-138793319	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055125	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Nucleoplasm	"HPA055125: AB_2682705"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.80e-1)"	"unprognostic (8.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.37e-2)"	21.8	48.4	41.8	19.6	42.5	40.1	28.1	38.4	48.7	23.8	47.1	23.8	30.4	16.7	38.1	16.4	35.8	23.8	19.1	43.8	43.2	59.9	67.8	26.2	35.4	38.5	38.8	21.8	35.5	53.0	29.5	32.1	39.3	25.0	24.3	25.6	52.3	20.2	15.7	18.0	30.7	15.9	37.8	29.8	29.3	23.8	41.1	46.5	54.2	21.3	33.6	26.2	17.2	39.0	7.2	12.9	9.5	17.4	17.5	24.4	19.4	11.7	20.3	15.2	24.6	11.1	14.1	31.1	22.3	11.8	21.3	12.3	15.6	16.2	24.4	35.9	35.7	25.3	16.3	22.1	27.6	43.8	25.6	15.7	20.2	10.9	32.0	31.0	25.1	43.1	25.8	42.2	17.1	15.9	36.3	58.0	8.9	28.9	13.2	21.7	9.5	29.2	18.3	10.6	11.8	18.4	15.6	13.8	34.9	18.6	6.7	47.6	19.5	11.9	13.5	22.3	18.0	55.8	53.0	23.1	12.7	27.1	10.6	137.8	91.6	120.6	84.5	96.5	76.4	107.1	88.4	92.8	102.1	106.6	101.5	93.3	249.6	115.8	85.0	90.0	159.8	93.6	41.8	42.5	38.4	48.7	43.8	43.2	38.5	38.8	39.3	37.8	41.1	39.0	24.5	32.1	35.4	12.7	36.5	13.4	25.0	36.9	29.0	16.0	24.6	25.1	11.0	24.3	31.6	36.8	18.8	82.7	42.7	31.7	123.3	19.3	146.8	83.5	11.4	20.7	24.7	39.2	25.6	31.6	49.2	23.2	16.3	15.6	43.1	25.3	29.3	50.8	38.0	10.1	22.3	30.6	38.7	41.5	31.5	99.9	16.8	36.1	32.0	3.7	39.5	24.6	42.2	5.5	17.9	16.8	35.9	15.1	29.7	31.2	81.0	130.9	89.0	14.2	13.1	14.0	15.8	48.6	27.2	15.5	14.9	108.9	35.4	18.1	23.1	36.2
CCDC3	DKFZp761F241	ENSG00000151468	"Coiled-coil domain containing 3"	Q9BQI4	10	12896625-13099652	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 132.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 50.1;Excitatory neurons: 100.2;Inhibitory neurons: 41.3;Peritubular cells: 60.5;Smooth muscle cells: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 10.4;HAP1: 19.1;HDLM-2: 32.4;hTERT-RPE1: 14.8;U-2 OS: 20.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 20.8"	HPA062425			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA062425: AB_2684759"	"unprognostic (2.26e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.54e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-2)"	91.8	11.0	32.9	5.9	35.2	0.1	37.2	17.9	40.2	48.1	17.8	10.1	6.6	25.0	41.3	60.4	56.7	70.7	21.9	37.1	20.1	19.0	20.6	21.0	12.4	18.6	19.1	86.2	6.5	4.9	10.2	22.2	19.6	35.2	7.4	1.6	7.1	22.0	30.7	132.2	14.3	24.2	19.8	24.7	13.1	11.6	21.7	42.0	20.0	13.3	4.2	23.2	27.4	30.5	0.0	0.2	1.7	9.4	0.0	0.0	0.1	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.7	0.0	10.4	1.9	19.1	3.6	0.6	32.4	8.1	0.0	0.2	0.0	0.7	0.0	0.0	2.3	2.3	0.4	0.0	14.8	0.9	0.8	0.0	0.2	1.0	0.2	0.0	5.4	1.5	0.0	0.1	0.0	4.1	0.3	0.0	0.0	3.6	1.6	7.0	1.0	0.0	4.4	0.0	0.0	0.0	0.0	20.0	1.2	0.3	0.0	0.0	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.9	35.2	17.9	40.2	37.1	20.1	18.6	19.1	19.6	19.8	21.7	30.5	12.4	0.0	0.0	10.1	0.1	50.1	6.4	26.3	13.6	1.2	0.9	4.7	7.9	1.5	2.1	0.0	0.0	0.3	1.3	0.1	1.9	0.0	0.2	0.1	0.7	27.2	0.0	0.0	100.2	0.0	0.2	16.0	0.5	0.4	0.0	16.4	8.2	0.2	0.3	0.0	41.3	0.1	0.0	0.0	6.4	1.5	22.4	0.6	14.2	3.7	0.0	0.3	0.0	22.6	23.2	0.1	2.5	60.5	0.0	3.0	0.3	0.4	1.1	2.1	32.9	7.9	119.4	0.0	5.7	2.1	37.2	0.3	1.0	6.0	0.3	1.3
CCDC51	FLJ12436	ENSG00000164051	"Coiled-coil domain containing 51"	Q96ER9	3	48432164-48440456	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010980, HPA011408"	Supported		Supported	Nucleoplasm,Centrosome,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Centrosome	"HPA010980: AB_1846155, HPA011408: AB_2072212"	"unprognostic (1.24e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	10.1	13.7	10.7	7.3	10.9	5.0	8.7	10.8	11.6	8.3	22.2	12.2	11.0	8.0	10.1	13.8	8.8	5.4	11.9	11.1	10.6	13.9	13.0	6.7	9.6	11.3	10.8	7.7	5.4	9.4	6.1	8.2	11.3	6.7	13.6	7.7	7.0	9.0	15.5	10.1	8.6	9.0	10.7	12.6	7.6	7.8	11.7	9.9	10.3	11.7	11.8	9.0	9.5	10.7	22.7	26.7	15.7	18.7	23.1	24.2	43.6	14.6	13.4	28.6	23.2	42.9	36.9	48.6	20.5	11.7	21.6	32.2	39.5	47.8	17.4	22.9	25.6	41.4	44.1	32.7	35.3	20.4	18.2	18.4	106.8	35.6	38.8	15.7	16.7	28.0	23.4	13.7	27.7	21.4	24.1	26.5	34.8	48.2	42.8	16.5	18.6	37.7	39.3	27.8	13.1	27.2	24.2	26.2	39.9	14.7	28.2	31.3	12.6	16.5	22.3	41.6	28.5	22.0	34.8	25.5	22.0	43.8	16.0	3.0	14.1	7.0	15.5	14.9	15.8	28.1	14.5	19.7	25.5	23.0	14.8	17.4	6.0	16.5	9.1	21.1	19.8	14.6	10.7	10.9	10.8	11.6	11.1	10.6	11.3	10.8	11.3	10.7	11.7	10.7	7.1	12.8	2.6	2.6	5.9	4.7	3.7	28.8	17.6	7.3	6.6	8.1	8.2	15.7	12.8	9.2	0.0	40.1	5.0	12.6	23.5	15.1	3.3	19.4	7.3	5.9	5.4	5.9	2.4	12.4	22.0	10.0	6.6	16.5	3.8	10.1	4.6	13.1	15.9	8.4	2.4	7.6	14.2	3.8	3.3	2.7	12.2	4.4	14.2	1.9	9.1	11.0	11.3	3.5	3.2	15.2	8.0	13.2	5.1	5.4	21.6	43.4	9.3	10.7	6.6	4.0	6.2	7.2	16.3	13.0	4.7	6.7	4.8	20.0	13.4	3.4
CCDC59	"BR22, HSPC128, TAP26"	ENSG00000133773	"Coiled-coil domain containing 59"	Q9P031	12	82223681-82358805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038555	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA038555: AB_10669543"	"unprognostic (1.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-2)"	12.9	6.3	7.1	5.2	7.4	40.3	10.9	7.8	10.3	9.2	3.7	10.0	4.2	9.2	10.9	10.6	10.0	7.0	9.0	7.1	6.5	6.5	9.7	8.0	8.8	7.4	6.1	11.3	7.8	9.6	6.7	9.6	7.0	7.0	7.5	4.7	6.7	6.7	16.0	8.5	6.0	8.0	6.1	6.3	7.4	12.3	6.9	12.5	8.6	19.3	11.1	11.1	8.7	10.2	27.2	22.9	18.9	16.0	22.5	20.1	33.1	24.0	28.5	43.4	35.3	52.9	16.0	31.0	12.0	26.0	29.9	18.3	95.3	46.7	36.4	35.7	51.3	34.3	15.1	34.6	66.7	40.3	15.7	36.1	39.0	43.5	55.9	34.6	35.9	55.8	62.8	17.1	26.9	50.6	39.6	57.1	30.4	25.6	54.4	28.4	31.9	27.6	23.4	28.4	33.8	16.4	27.4	15.6	34.6	23.1	32.3	55.0	17.6	18.0	16.3	15.1	45.7	22.7	30.2	66.2	15.7	32.8	29.0	25.9	9.2	18.3	10.7	12.6	22.0	16.4	19.0	20.9	9.9	24.1	22.2	18.7	22.3	14.9	19.0	21.4	29.5	5.9	7.1	7.4	7.8	10.3	7.1	6.5	7.4	6.1	7.0	6.1	6.9	10.2	76.6	67.3	56.3	10.1	81.7	85.8	129.9	84.9	65.4	33.7	57.3	80.1	44.3	40.0	66.5	44.1	22.9	80.0	88.2	33.1	129.1	48.7	125.8	63.1	71.5	62.0	35.8	41.2	9.4	57.5	88.3	61.5	29.6	85.0	78.6	45.8	64.2	53.9	56.8	43.7	9.9	62.5	50.8	70.9	53.8	28.4	53.4	62.0	48.0	5.6	66.9	47.2	64.9	12.1	17.2	54.8	44.0	53.8	54.7	88.1	56.1	93.0	51.5	40.6	19.7	118.1	57.8	204.9	135.2	57.6	89.9	146.8	95.6	43.5	56.7	100.6
CCDC61		ENSG00000104983	"Coiled-coil domain containing 61"	Q9Y6R9	19	45995461-46021318	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.5"	"Cell line enhanced"	"Detected in all"		"NB-4: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040325, HPA061548"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA040325: AB_10672970, HPA061548: AB_2684559"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.56e-1)"	"unprognostic (6.23e-3)"	"unprognostic (7.27e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.13e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.09e-1)"	9.3	11.2	6.9	8.0	8.1	5.9	9.3	13.7	11.2	11.6	4.8	11.1	7.9	10.0	7.2	10.4	16.2	5.0	8.4	7.8	5.4	12.2	12.5	8.6	11.0	6.6	5.1	12.5	10.3	9.9	13.3	5.9	5.4	11.2	4.9	1.6	9.0	8.0	5.6	12.7	10.3	5.1	4.0	13.9	11.0	24.9	5.3	9.7	12.4	4.1	6.9	11.2	10.0	7.8	13.9	10.0	5.2	9.0	9.6	7.0	7.9	9.8	5.0	5.8	9.7	6.1	12.0	8.7	4.7	6.9	8.0	11.6	5.7	13.1	4.3	16.6	5.4	9.3	8.6	10.1	10.6	8.9	12.2	7.6	17.9	5.0	10.4	9.9	11.7	16.3	10.5	17.5	7.5	4.4	20.4	57.2	1.9	14.9	4.3	13.7	1.7	14.1	9.5	11.4	5.6	5.1	9.7	12.5	7.6	5.1	5.3	12.7	10.0	4.2	1.7	2.0	11.2	10.6	5.5	8.9	9.4	9.8	7.1	6.5	0.4	0.4	0.9	0.4	0.5	0.8	0.5	0.5	0.2	1.2	0.6	0.5	1.3	0.3	0.5	0.3	0.5	0.2	6.9	8.1	13.7	11.2	7.8	5.4	6.6	5.1	5.4	4.0	5.3	7.8	8.8	0.0	4.4	4.6	7.0	6.2	7.1	1.1	4.6	4.3	4.3	5.3	6.0	4.3	3.0	11.0	0.0	11.2	5.1	11.9	9.8	1.6	3.4	9.0	5.7	5.3	3.6	2.1	4.0	2.0	8.5	6.4	12.8	5.6	0.0	11.8	4.2	4.4	8.0	3.3	4.1	8.6	0.0	5.3	2.7	1.6	5.3	5.5	3.6	1.9	2.3	3.3	2.1	1.5	2.6	1.8	5.8	5.7	6.1	4.3	6.6	8.4	3.5	1.9	6.6	4.6	6.0	13.9	6.2	6.4	5.3	7.8	7.3	9.8	10.9	4.3
CCDC62	"CT109, ERAP75, FLJ40344, TSP-NY"	ENSG00000130783	"Coiled-coil domain containing 62"	Q6P9F0	12	122774526-122827528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 70.0"	"Group enriched"	"Detected in some"	13	"Early spermatids: 259.2;Late spermatids: 75.0;Spermatocytes: 188.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039021, HPA058741"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"HPA039021: AB_10673604, HPA058741: AB_2683805"	"unprognostic (3.39e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-4)"	"unprognostic (5.23e-1)"	"unprognostic (6.39e-6)"	"unprognostic (2.78e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.25e-4)"	0.2	0.3	1.2	0.2	1.3	0.2	0.1	0.7	1.8	0.3	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	1.3	0.5	0.1	0.1	0.1	0.3	0.6	0.4	0.1	0.1	0.3	0.7	0.0	0.7	0.1	0.1	1.4	0.1	0.1	0.7	0.4	0.2	0.1	0.2	0.5	0.1	70.0	0.5	0.2	0.1	0.3	0.3	0.1	0.1	2.0	0.1	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.3	0.9	0.1	0.0	0.0	0.6	0.8	0.1	0.3	0.4	0.1	0.1	0.0	0.7	0.3	0.2	0.4	0.1	0.0	1.2	0.1	0.0	0.5	0.8	0.2	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.4	0.2	0.0	0.6	0.1	0.2	2.9	0.1	0.1	0.3	0.3	0.2	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.0	1.2	1.3	0.7	1.8	1.3	0.5	0.6	0.4	0.7	0.2	0.5	2.0	0.5	0.0	0.0	9.1	2.1	0.5	0.2	0.1	0.6	1.4	0.4	0.5	1.0	0.0	0.0	0.0	4.2	0.1	0.6	0.1	0.0	0.3	259.2	0.5	0.4	0.4	0.0	0.0	11.7	0.2	0.6	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.1	1.7	8.1	0.2	0.0	0.3	1.7	75.0	3.1	1.3	1.8	3.7	0.2	0.5	1.0	5.0	8.0	0.1	0.0	2.6	0.3	0.5	0.1	0.0	0.0	1.3	13.1	0.5	0.2	188.2	2.9	0.4	0.9	0.0	0.3	0.2	0.3	0.2
CCDC63	"FLJ35843, ODA5"	ENSG00000173093	"Coiled-coil domain containing 63"	Q8NA47	12	110846769-110907535	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.3"	"Group enriched"	"Detected in some"	32	"Early spermatids: 305.6;Late spermatids: 241.7"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"MCF7: 4.4"									HPA061568			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA061568: AB_2684561"					"unprognostic (1.98e-2)"	"unprognostic (1.05e-1)"		"unprognostic (1.17e-1)"	"unprognostic (2.65e-1)"					"unprognostic (5.59e-2)"	"unprognostic (1.09e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	305.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	241.7	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	4.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0
CCDC8	"3M3, DKFZp564K0322, PPP1R20"	ENSG00000169515	"Coiled-coil domain containing 8"	Q9H0W5	19	46410329-46413564	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 36.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 27.0;Distal tubular cells: 39.2;Granulosa cells: 25.7;Leydig cells: 70.8;Peritubular cells: 57.9;Theca cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 18.5;AN3-CA: 22.2;HSkMC: 19.6;K-562: 20.3;RH-30: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041993	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041993: AB_10795388"	"unprognostic (3.05e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.69e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (5.43e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.18e-3)"	4.1	16.3	4.1	2.7	3.8	0.7	8.8	3.9	2.6	13.9	7.5	3.3	0.9	13.9	10.5	1.3	22.9	4.2	24.7	3.6	3.9	11.2	0.7	4.4	0.9	5.2	7.4	36.8	13.6	9.1	12.9	6.7	5.3	6.4	1.2	1.3	10.8	7.5	2.1	3.1	2.2	6.5	4.8	2.3	2.2	5.9	4.2	5.6	9.0	2.4	0.8	7.5	7.3	4.4	1.9	0.1	18.5	22.2	4.8	6.0	8.9	9.6	0.0	2.1	0.9	0.1	0.1	0.2	12.5	7.6	0.4	0.2	0.1	15.0	1.0	0.0	9.4	0.0	0.2	1.0	16.0	0.1	0.1	19.6	0.0	5.2	15.2	0.3	0.1	0.1	20.3	0.0	6.8	0.0	0.0	1.3	13.3	0.0	0.0	0.7	24.8	0.0	16.1	0.1	2.9	0.1	0.1	0.1	0.1	14.2	0.1	4.7	1.7	1.2	4.9	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.1	3.8	3.9	2.6	3.6	3.9	5.2	7.4	5.3	4.8	4.2	4.4	0.7	0.0	1.1	1.3	0.0	0.9	6.5	1.5	0.0	0.4	1.8	19.3	27.0	7.2	4.0	11.0	0.0	7.5	0.1	0.0	39.2	14.8	0.4	15.0	13.9	1.2	0.0	0.0	0.0	1.1	10.0	17.3	0.0	3.9	1.3	25.7	1.1	0.0	1.7	0.0	0.0	0.0	2.0	0.0	0.9	2.9	70.8	0.6	1.8	1.0	0.0	14.6	0.0	1.5	0.1	3.6	0.0	57.9	0.0	3.7	0.0	1.2	2.4	0.5	13.1	12.3	8.3	0.4	5.5	0.0	0.1	2.1	0.2	32.7	0.0	0.8
CCDC82	FLJ23518	ENSG00000149231	"Coiled-coil domain containing 82"	Q8N4S0	11	96349241-96389956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 493.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038704, HPA070631"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA038704: AB_10674835, HPA070631: "	"unprognostic (3.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.94e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	22.2	15.1	16.5	19.6	19.7	17.1	17.6	32.0	26.6	15.9	8.7	18.1	13.0	18.4	13.9	10.4	15.9	16.8	13.7	17.4	24.6	16.6	22.1	17.9	23.4	18.2	16.5	18.3	13.8	11.8	18.2	17.4	19.5	13.0	13.3	43.2	12.8	15.8	14.3	14.3	16.9	13.8	12.4	20.3	16.7	23.7	17.9	22.3	17.9	14.9	20.1	16.7	14.5	31.1	12.9	17.9	52.4	21.0	35.9	30.0	20.8	47.0	28.0	29.9	42.4	31.1	41.3	26.1	42.8	23.1	50.5	29.1	17.5	14.7	42.5	44.5	11.7	49.1	42.7	26.0	25.6	41.5	33.2	18.3	9.2	58.9	22.8	28.0	35.9	25.3	31.4	28.1	40.5	1.1	34.9	40.2	12.0	21.6	12.7	23.7	44.2	21.0	22.6	32.9	9.6	22.7	26.6	2.7	23.0	35.5	5.0	19.5	42.6	50.1	28.1	43.7	25.3	9.5	29.9	36.0	16.2	30.7	38.6	59.4	12.5	25.1	23.7	15.2	24.5	22.5	24.7	23.6	14.0	19.3	26.9	25.5	17.9	35.7	16.2	18.7	28.5	17.9	16.5	19.7	32.0	26.6	17.4	24.6	18.2	16.5	19.5	12.4	17.9	31.1	57.9	19.2	31.4	30.7	32.9	30.5	27.0	31.5	19.4	58.9	14.0	18.5	37.2	18.6	28.9	31.3	100.1	16.6	55.1	10.7	27.4	34.6	493.8	57.6	37.0	53.6	19.8	16.4	67.0	17.5	20.5	44.9	13.7	26.4	40.4	36.4	38.6	32.1	25.2	32.0	67.0	9.0	24.4	27.4	38.4	76.8	43.8	32.5	26.6	23.4	37.2	41.6	42.2	54.3	119.7	32.3	12.2	42.9	27.2	14.5	8.8	40.1	71.8	50.6	32.9	45.4	48.4	85.4	57.0	13.0	20.5	8.2	40.7	24.9	10.3	18.7
CCDC83	"CT148, FLJ42119, KP-CoT-23, MGC34732"	ENSG00000150676	"Coiled-coil domain containing 83"	Q8IWF9	11	85855101-85920021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	115	"testis: 35.5"	"Group enriched"	"Detected in some"	46	"Early spermatids: 222.2;Late spermatids: 194.2;Spermatocytes: 160.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"MCF7: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039707, HPA039882"			Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039707: AB_10795259, HPA039882: AB_10795410"	"unprognostic (1.14e-1)"				"unprognostic (4.09e-1)"					"unprognostic (1.49e-2)"		"unprognostic (4.43e-2)"	"unprognostic (7.05e-6)"	"unprognostic (3.52e-1)"			"unprognostic (2.17e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.2	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	194.2	4.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC85C		ENSG00000205476	"Coiled-coil domain containing 85C"	A6NKD9	14	99500190-99604207	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058346, HPA061922"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Cell Junctions"	"Nucleoplasm, Nuclear bodies, Mitotic chromosome"	"HPA058346: AB_2683686, HPA061922: "	"unprognostic (7.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (5.70e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.68e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.68e-3)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.14e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.81e-3)"	5.2	22.0	26.4	4.3	32.9	9.7	7.1	72.9	27.1	5.8	20.6	31.3	18.7	15.4	14.3	28.3	11.3	5.4	19.6	24.8	20.9	14.4	18.2	8.1	2.5	30.8	24.1	5.1	18.5	16.4	17.0	8.6	27.0	15.0	11.1	34.7	26.4	16.2	20.7	19.4	17.7	13.1	24.5	3.6	19.2	8.5	28.6	5.0	9.3	5.6	7.5	16.1	8.9	21.0	48.4	43.4	52.7	31.7	0.7	0.2	48.9	16.0	16.2	31.4	18.1	52.9	49.8	0.3	61.7	18.2	8.6	63.3	39.2	38.4	19.5	79.2	23.3	2.5	43.6	36.1	4.2	0.5	4.9	0.1	19.9	9.0	25.9	18.6	9.9	27.9	11.8	7.2	3.9	80.3	21.8	6.6	19.3	55.4	44.7	32.1	22.1	10.8	22.3	18.8	26.0	32.6	40.7	21.5	9.5	19.9	46.9	9.8	22.6	6.2	51.5	22.4	16.2	11.2	15.8	0.4	1.0	4.3	4.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.4	0.1	26.4	32.9	72.9	27.1	24.8	20.9	30.8	24.1	27.0	24.5	28.6	21.0	8.5	22.4	5.6	15.7	6.7	8.8	8.7	4.0	13.6	35.2	12.1	9.3	3.0	5.7	7.3	1.8	62.6	6.3	3.9	21.2	0.0	7.6	3.1	18.8	8.1	9.2	9.6	3.4	2.8	9.4	4.5	6.2	17.3	35.6	6.3	14.1	5.3	16.7	1.8	1.7	5.4	9.6	6.1	1.6	1.2	2.1	0.6	5.0	8.8	4.7	0.4	30.6	1.0	1.5	11.7	17.4	13.2	0.7	10.4	11.0	23.3	6.5	3.0	51.7	0.0	5.7	4.1	1.4	3.5	20.4	14.1	4.9	8.3	2.3	13.0	12.0
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842113-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 377.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.36e-5)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	25.6	26.7	12.0	14.3	13.3	10.2	20.8	13.1	14.2	12.9	11.2	14.1	11.4	16.7	3.5	19.4	15.2	6.9	16.0	12.7	13.5	19.2	13.7	11.8	11.6	13.2	13.5	13.8	23.9	377.6	24.9	11.6	13.7	23.9	5.8	8.2	12.2	8.6	34.7	22.7	12.3	10.4	12.3	12.7	16.4	48.9	12.7	8.8	12.9	13.7	8.5	20.2	14.5	14.1	83.4	110.2	26.5	76.1	21.8	35.7	36.3	54.3	42.4	98.1	52.4	95.0	53.7	98.9	100.7	31.0	69.7	73.3	94.2	65.7	48.2	35.7	101.3	51.0	45.8	133.2	70.7	80.7	82.6	39.5	48.7	90.2	61.8	14.3	75.8	53.5	166.0	46.9	50.3	97.3	125.2	122.6	107.0	48.6	156.3	81.4	39.6	253.5	37.2	33.8	59.9	38.9	34.7	79.5	64.6	17.6	80.8	30.3	45.9	93.6	59.6	131.6	118.2	41.0	66.5	109.2	78.2	86.0	118.6	1.7	13.5	4.2	9.1	29.4	9.7	9.4	9.6	8.3	29.8	9.0	11.5	10.2	1.0	6.9	9.3	16.6	9.7	10.1	12.0	13.3	13.1	14.2	12.7	13.5	13.2	13.5	13.7	12.3	12.7	14.1	9.3	0.0	2.2	2.0	8.9	37.0	22.2	5.7	28.5	12.1	9.9	10.3	0.6	4.3	4.0	1.8	8.4	17.2	5.7	5.3	7.9	18.6	25.6	6.8	9.4	12.7	7.2	8.8	2.0	12.2	20.4	10.2	9.7	7.7	5.1	7.9	3.6	3.1	18.4	3.3	1.7	5.7	6.1	2.5	16.5	15.0	11.5	7.3	16.0	1.0	5.3	3.9	4.1	1.0	1.3	19.2	3.6	6.0	8.6	24.0	4.4	7.3	1.3	8.3	19.7	10.7	19.1	74.6	18.8	21.2	31.0	8.2	7.0	12.5	11.3	18.8
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340204-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.6;lymphoid tissue: 86.1"	"Cell type enhanced"	"Detected in many"		"NK-cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.7;HMC-1: 83.3;Karpas-707: 22.0;THP-1: 34.5;U-937: 25.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA026652	Approved		Supported	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	8.5	6.7	14.9	15.1	15.1	47.6	5.3	20.1	21.6	5.6	15.3	17.8	4.0	3.5	0.3	12.9	6.5	8.5	5.5	15.3	15.0	6.5	7.3	21.1	28.6	17.2	15.5	3.1	4.1	0.9	4.5	1.7	17.5	7.8	3.6	1.4	14.4	2.5	1.2	4.5	34.1	1.2	15.4	86.1	8.9	17.4	15.4	17.4	5.4	0.8	13.8	8.3	7.7	15.9	0.3	1.3	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	3.4	19.7	2.9	1.1	0.5	1.6	0.1	0.6	0.0	21.7	0.0	15.0	4.6	1.1	0.8	9.4	83.3	0.0	0.0	0.2	0.0	1.3	0.5	6.3	0.5	22.0	0.7	0.9	12.7	7.7	0.7	3.7	0.5	11.9	0.3	18.5	0.3	0.3	4.8	0.0	0.0	0.5	1.1	0.1	2.6	34.5	0.0	0.0	0.7	0.1	0.2	4.7	1.5	15.8	1.0	25.3	0.4	2.9	4.6	6.7	3.5	3.6	1.0	1.6	2.0	2.9	1.6	2.0	1.8	2.2	9.2	6.5	2.5	2.7	0.6	1.3	14.9	15.1	20.1	21.6	15.3	15.0	17.2	15.5	17.5	15.4	15.4	15.9	3.3	0.0	10.7	5.2	30.3	2.7	4.5	10.5	0.6	45.2	5.7	4.8	13.5	4.3	9.9	9.2	0.0	2.9	34.9	46.0	0.0	12.8	11.1	8.7	2.6	4.4	18.0	7.0	2.6	28.9	5.8	3.1	51.0	6.8	26.6	2.2	6.1	10.4	14.5	0.0	2.0	24.4	8.2	26.0	26.6	15.8	1.5	27.3	5.4	12.2	35.0	15.4	64.9	2.0	0.6	35.0	33.2	0.7	24.9	2.9	36.1	3.2	22.7	4.7	0.0	2.8	2.8	13.7	8.7	2.0	1.6	1.4	31.7	10.0	32.4	15.7
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Guanine-nucleotide releasing factor"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 80.1;NK-cells: 142.2;Plasma cells: 93.2;Respiratory ciliated cells: 112.5;T-cells: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 55.6;Karpas-707: 50.1;SCLC-21H: 53.6;U-266/70: 58.5;U-266/84: 76.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 37.0"	HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	4.5	1.4	5.9	19.4	23.9	31.2	6.9	3.2	7.1	4.0	2.5	9.4	13.3	3.1	1.6	12.5	12.2	6.2	4.0	3.6	3.9	6.8	3.6	9.7	33.9	5.6	6.7	1.0	8.3	5.3	5.2	2.4	4.6	9.4	7.0	1.0	10.1	3.9	2.3	7.0	11.7	2.3	4.3	21.7	12.4	8.0	7.8	20.4	2.5	2.7	20.4	8.1	7.6	3.2	8.5	6.9	7.5	9.5	0.0	0.0	34.9	0.0	0.0	0.0	0.0	6.8	13.4	45.1	6.1	0.0	0.4	0.4	11.3	6.4	0.0	28.8	4.7	10.0	4.8	9.9	0.7	23.0	8.4	0.0	11.4	0.0	0.0	0.7	8.6	55.6	11.2	50.1	0.1	24.9	24.2	29.6	7.1	6.2	11.5	19.5	0.2	14.2	2.6	10.2	53.6	11.6	4.6	16.9	4.6	5.6	10.2	20.7	2.6	0.0	0.2	0.1	0.1	58.5	76.2	22.8	0.0	20.1	0.1	7.8	3.3	1.3	9.4	1.9	8.8	2.5	6.0	9.2	1.8	2.1	3.8	5.8	2.3	4.0	3.0	2.0	10.7	4.1	5.9	23.9	3.2	7.1	3.6	3.9	5.6	6.7	4.6	4.3	7.8	3.2	26.6	3.2	28.8	7.8	54.1	9.3	15.9	19.0	27.9	0.0	15.3	7.6	19.8	10.0	22.1	14.7	0.0	3.6	80.1	29.6	0.0	4.4	9.6	62.6	1.4	17.3	23.9	20.6	7.1	5.9	2.2	4.2	20.4	12.1	2.5	1.3	20.3	1.6	6.3	0.0	2.5	15.3	22.4	21.0	12.4	18.7	4.1	18.9	1.8	9.4	20.1	8.0	142.2	8.0	5.2	7.8	18.2	3.0	93.2	16.8	13.1	13.2	112.5	0.1	0.0	2.9	4.4	4.7	17.4	31.2	9.5	1.8	89.2	3.3	19.4	19.8
CCDC89	FLJ38159	ENSG00000179071	"Coiled-coil domain containing 89"	Q8N998	11	85683848-85686195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 43.6"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 434.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.1;SCLC-21H: 3.9;U-2197: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040628	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA040628: AB_2677053"	"unprognostic (5.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-3)"	"unprognostic (7.75e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.52e-1)"	0.7	0.9	0.6	0.3	0.7	0.0	1.3	1.4	0.6	1.2	0.9	0.7	0.3	2.6	1.0	0.3	7.8	1.0	0.9	0.5	0.9	1.1	0.2	1.1	0.3	1.5	1.5	4.8	0.1	1.3	1.2	0.7	1.6	1.3	0.7	1.6	0.3	1.5	0.3	0.4	0.5	1.5	1.3	0.4	1.1	43.6	0.7	0.4	0.2	0.4	0.1	0.7	0.6	1.1	0.0	0.0	0.0	0.0	2.3	2.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.1	2.5	2.1	2.5	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.1	0.0	0.0	1.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.1	1.3	3.9	0.9	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.1	0.0	4.8	1.7	0.0	2.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.4	0.6	0.5	0.9	1.5	1.5	1.6	1.3	0.7	1.1	0.1	0.0	0.6	1.0	0.0	0.3	0.1	1.0	0.0	0.3	0.4	0.4	0.1	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.0	0.1	434.9	7.3	2.0	0.4	0.0	0.0	0.5	0.0	0.1	1.7	0.0	0.2	0.0	0.4	0.4	0.0	1.7	6.7	0.6	0.1	2.0	0.8	0.0	43.1	3.1	0.2	0.0	1.9	0.0	1.0	0.0	0.5	0.5	0.0	0.0	4.5	0.4	0.0	0.0	1.5	30.2	0.8	0.0	1.7	1.4	45.9	1.4	0.0	0.3	0.0	0.2	0.8	0.0	0.1
CCDC91	"DKFZp779L1558, FLJ11088, p56"	ENSG00000123106	"Coiled-coil domain containing 91"	Q7Z6B0	12	28133249-28581511	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	18	"Early spermatids: 2093.1;Late spermatids: 7910.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038169	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA038169: AB_10672506"	"unprognostic (6.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.98e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-1)"	17.5	18.3	15.0	13.0	15.8	12.3	16.1	23.2	29.3	11.5	3.5	14.4	12.1	17.8	17.3	14.3	12.3	14.6	30.9	16.6	12.3	20.2	14.3	12.0	16.4	20.7	13.8	17.7	27.1	30.8	12.1	8.5	20.7	15.1	12.6	27.1	13.6	14.0	41.6	10.2	13.1	13.0	11.1	13.6	17.1	34.5	14.6	21.7	24.6	21.7	13.7	16.6	10.5	20.7	21.2	14.8	13.4	0.4	13.6	12.6	25.1	17.5	18.5	15.1	19.3	8.4	27.6	11.0	14.7	20.9	9.0	23.7	12.3	28.2	22.6	29.7	10.2	36.2	29.4	7.7	21.3	35.0	17.1	12.5	27.6	15.0	43.7	28.5	12.3	19.2	33.4	36.0	14.6	7.6	34.8	29.7	27.5	16.2	13.5	21.1	38.7	18.3	24.6	14.3	11.3	20.4	32.7	10.9	55.4	36.4	21.3	27.3	9.3	31.8	22.1	31.5	10.3	44.4	52.5	30.1	27.6	28.0	18.4	21.8	2.3	3.6	5.1	4.5	6.7	6.7	6.5	7.4	3.4	5.2	7.6	7.0	0.7	7.1	5.9	4.1	8.4	3.4	15.0	15.8	23.2	29.3	16.6	12.3	20.7	13.8	20.7	11.1	14.6	20.7	23.4	38.5	41.0	129.3	47.2	34.9	37.4	49.5	34.7	61.5	42.1	36.8	80.8	20.0	40.8	22.0	45.9	14.0	48.4	26.0	43.0	46.2	2093.1	36.9	19.0	19.7	38.4	19.1	199.3	47.3	16.3	24.8	21.4	26.2	40.4	21.9	11.7	26.7	30.6	45.4	266.0	23.9	28.5	35.0	39.3	7910.6	57.8	39.0	37.4	135.9	35.7	52.0	53.5	152.8	221.0	33.8	25.0	51.9	34.2	33.6	25.5	35.0	54.5	74.9	39.5	28.6	31.7	72.0	39.0	19.9	40.5	16.0	50.6	28.5	18.3	33.6
CCDC92	FLJ22471	ENSG00000119242	"Coiled-coil domain containing 92"	Q53HC0	12	123918660-123972831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 89.2;Excitatory neurons: 123.0;Inhibitory neurons: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038560, HPA057580"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome	Nucleoplasm	"HPA038560: AB_10672717, HPA057580: AB_2683476"	"unprognostic (4.77e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.15e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.14e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	56.3	26.7	18.5	3.7	17.4	1.2	47.5	2.9	44.2	39.8	0.0	53.6	5.8	40.4	7.1	20.1	37.7	4.0	77.4	24.3	4.8	39.7	38.4	37.7	3.4	17.6	6.3	35.5	21.1	5.5	58.5	7.0	18.6	36.3	2.7	7.2	24.8	4.7	77.8	17.4	34.3	5.5	4.6	27.0	32.9	74.0	14.3	3.2	40.9	7.6	2.4	37.5	28.7	20.0	4.9	5.5	2.7	4.9	17.5	9.6	4.9	8.1	15.3	4.5	4.8	2.9	1.4	2.4	2.7	10.2	2.5	3.4	3.0	2.1	3.0	15.0	7.0	3.1	2.2	1.8	9.2	0.5	11.3	5.5	9.2	5.7	3.5	13.7	12.6	5.3	3.2	1.1	4.0	3.3	3.0	5.4	1.2	2.4	11.6	3.7	1.5	0.7	6.1	5.1	5.1	7.3	4.0	1.9	5.7	6.3	5.7	2.7	12.6	8.9	1.9	5.8	2.8	3.7	2.1	0.7	7.1	4.2	3.9	1.6	0.4	0.7	0.7	0.2	1.2	0.5	0.9	1.1	0.3	0.5	0.6	0.9	0.4	0.5	0.0	0.4	0.1	0.6	18.5	17.4	2.9	44.2	24.3	4.8	17.6	6.3	18.6	4.6	14.3	20.0	17.6	19.2	28.5	52.5	8.3	3.8	7.5	8.1	4.0	33.6	14.2	11.7	40.8	18.6	8.6	18.4	14.6	4.4	16.4	7.2	7.9	14.7	89.2	15.1	13.0	17.7	4.8	4.4	123.0	10.9	2.7	19.2	10.2	14.5	20.3	31.2	18.9	14.5	18.9	21.9	106.1	6.2	8.2	12.0	6.3	63.9	13.7	14.2	8.8	30.9	9.9	15.0	22.6	50.8	70.0	15.5	2.7	17.3	3.2	9.5	10.0	37.0	9.0	13.6	72.3	15.3	24.6	40.9	10.1	6.3	3.0	5.6	13.7	26.3	7.6	7.5
CCDC97	"FLJ40267, MGC20255"	ENSG00000142039	"Coiled-coil domain containing 97"	Q96F63	19	41310172-41324873	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043320, HPA043572"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043320: AB_10964344, HPA043572: AB_10962488"	"unprognostic (9.25e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"	14.6	12.9	19.0	17.8	21.3	23.0	14.3	17.7	17.7	20.3	14.4	14.0	14.2	17.3	23.4	20.2	21.9	12.3	15.6	16.5	18.2	12.0	11.8	14.3	23.8	23.5	20.2	24.0	17.7	15.8	13.7	10.5	19.9	16.2	11.2	10.7	18.0	14.6	30.6	20.2	16.6	14.2	18.1	20.0	15.7	32.1	20.4	21.9	16.3	20.5	22.2	14.8	17.2	20.5	25.2	54.1	28.2	32.9	36.2	28.7	20.3	16.6	13.4	25.7	21.9	32.4	23.6	23.9	17.4	13.9	17.3	16.7	38.8	33.1	19.5	44.1	37.6	21.9	25.5	21.5	27.5	36.6	45.3	28.1	41.7	30.0	25.0	21.1	18.0	25.8	28.5	44.4	24.9	18.3	33.6	8.9	13.2	30.5	19.3	37.5	22.4	17.5	23.7	47.3	25.1	22.2	37.0	40.3	16.5	18.6	27.5	27.6	21.6	22.1	22.0	11.5	27.8	45.3	42.2	22.7	21.0	26.7	30.0	9.4	7.2	8.5	12.0	7.6	13.4	9.1	8.1	8.7	5.8	10.0	8.7	7.8	11.9	10.4	12.6	6.3	7.2	8.1	19.0	21.3	17.7	17.7	16.5	18.2	23.5	20.2	19.9	18.1	20.4	20.5	7.3	12.8	6.7	5.2	22.3	4.6	11.4	11.3	6.2	11.8	11.2	8.8	6.7	7.2	8.9	9.2	12.5	11.1	23.9	13.5	7.9	13.1	3.7	9.3	8.6	8.4	11.5	7.8	4.1	26.1	4.5	10.0	15.3	9.8	16.5	11.2	9.7	6.5	15.3	10.1	4.7	12.1	18.3	10.0	7.9	8.4	12.8	12.3	1.8	3.7	16.1	7.1	25.7	1.0	6.6	20.5	5.9	11.3	18.6	10.0	16.7	9.3	12.2	8.5	0.0	13.1	8.5	22.5	12.9	10.8	5.8	18.3	20.1	7.2	10.7	13.3
CCDC9B	"C15orf52, FLJ43339"	ENSG00000188549	"Coiled-coil domain containing 9B"	Q6ZUT6	15	40331452-40340967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.0;Collecting duct cells: 20.2;Ductal cells: 30.0;Pancreatic endocrine cells: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 122.5;hTERT-RPE1: 110.8;WM-115: 138.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040484, HPA041834"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		77000	"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA040484: AB_10794742, HPA041834: AB_10795643"	"unprognostic (5.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.68e-2)"	4.9	10.3	9.5	7.7	13.1	2.8	8.1	10.9	10.7	12.0	15.0	73.4	9.9	23.9	7.3	33.2	10.8	12.0	53.0	9.0	12.7	10.2	5.0	12.3	3.3	13.1	12.6	4.0	25.3	11.3	10.2	3.9	12.7	16.2	12.5	4.3	28.3	22.7	67.4	15.4	18.1	24.2	11.6	5.6	22.3	8.3	12.7	1.3	45.2	65.1	5.9	25.9	16.7	12.6	50.0	6.8	0.0	0.4	1.1	4.6	2.5	14.8	14.6	16.1	15.6	0.5	44.7	0.3	20.1	47.8	58.6	122.5	0.2	40.4	15.1	0.0	0.3	14.9	64.4	4.7	8.5	0.2	2.8	5.7	9.0	6.9	20.3	110.8	11.6	0.8	0.1	0.7	27.9	0.0	0.5	0.0	0.2	23.1	12.7	0.0	4.2	0.2	48.0	2.8	0.1	3.6	8.8	19.1	8.4	0.2	1.9	2.3	62.1	29.7	47.2	7.9	39.8	0.0	0.1	0.6	36.2	2.8	138.3	4.3	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.5	0.4	0.1	0.2	0.0	0.2	9.5	13.1	10.9	10.7	9.0	12.7	13.1	12.6	12.7	11.6	12.7	12.6	2.7	12.8	10.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.5	3.0	0.0	0.0	1.3	20.2	0.0	0.0	0.2	0.0	1.9	30.0	0.0	1.8	0.4	0.6	0.0	0.0	0.0	3.7	0.1	0.6	0.0	2.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0
CCKAR		ENSG00000163394	"Cholecystokinin A receptor"	P32238	4	26481396-26490484	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.9;gallbladder: 29.2;stomach 1: 16.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Group enriched"	"Detected in some"	5	"hypothalamus: 5.1;midbrain: 6.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 7.2"	"Region enhanced"	"Detected in all"		"midbrain: 12.6"	HPA073900			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA073900: "	"unprognostic (7.48e-2)"				"unprognostic (3.70e-2)"	"unprognostic (7.13e-2)"					"unprognostic (3.08e-2)"	"unprognostic (3.36e-1)"		"unprognostic (3.79e-1)"				0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	29.2	0.0	0.6	5.1	0.1	0.0	0.0	0.0	0.8	6.9	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	16.5	0.1	1.1	0.3	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.4	0.6	5.1	0.8	6.9	0.6	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCM2L	"C20orf160, dJ310O13.5"	ENSG00000101331	"CCM2 like scaffold protein"	Q9NUG4	20	32010438-32032180	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 141.6"	"Cell type enriched"	"Detected in some"	5	"Theca cells: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HUVEC TERT2: 9.0;NTERA-2: 4.6;RH-30: 3.2;SCLC-21H: 7.7;TIME: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008434, HPA071063"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA008434: AB_1845671, HPA071063: AB_2686339"	"unprognostic (1.71e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	15.9	5.4	7.2	1.6	7.3	0.0	15.0	9.5	6.8	8.7	4.2	4.6	1.3	8.9	0.6	3.7	7.7	2.5	23.2	6.1	5.8	13.3	2.2	11.8	1.5	6.8	6.4	3.6	2.6	1.4	4.1	7.8	7.0	5.8	1.1	0.4	3.4	1.8	4.8	3.9	5.4	3.3	6.1	141.6	4.2	1.6	7.3	0.8	10.2	4.8	0.9	6.4	6.3	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.0	0.9	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.1	0.0	0.6	3.2	0.1	0.0	0.0	7.7	0.9	0.2	0.0	0.0	1.1	2.5	0.0	4.8	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	7.3	9.5	6.8	6.1	5.8	6.8	6.4	7.0	6.1	7.3	5.2	45.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.5	0.6	4.6	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.2	32.1	0.0	0.0	2.9	0.2	0.0	1.0	0.0	0.2	0.0	4.3	24.3	0.0	0.0	3.3	2.4	0.0	0.0	0.3	0.3	0.4	0.0	0.2	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.8	0.3	0.6	0.1	0.3	0.0	0.1	248.7	0.0	0.1
CCNA1	CT146	ENSG00000133101	"Cyclin A1"	P78396	13	36431520-36442870	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.2;testis: 81.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 162.4;Endometrial ciliated cells: 119.1;Late spermatids: 91.1;Spermatocytes: 285.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 20.7;head and neck cancer: 6.2;ovarian cancer: 18.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	103	"basophil: 49.2"	"Lineage enriched"	"Detected in single"	301	"granulocytes: 49.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 350.9;NB-4: 71.4;THP-1: 71.5;U-937: 90.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060646, HPA077614"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA060646: AB_2684336, HPA077614: "	"unprognostic (1.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.89e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.70e-4)"		"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.04e-6)"	"unprognostic (7.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-2)"	0.4	0.9	5.9	0.4	5.9	2.1	0.7	2.3	7.8	5.8	4.1	0.6	0.4	3.7	7.0	0.4	18.0	0.7	0.3	5.5	7.3	0.5	0.1	1.4	0.3	5.3	5.4	0.5	0.1	22.2	8.2	0.0	10.7	0.5	0.1	1.0	0.6	0.1	1.2	0.3	0.3	8.2	4.9	0.6	0.4	81.3	6.1	0.4	0.6	0.4	0.6	0.6	1.1	4.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	15.2	0.1	15.5	1.2	12.9	1.4	0.1	0.0	0.7	0.0	0.4	0.0	0.6	8.0	350.9	0.3	34.1	0.7	2.8	5.5	0.9	1.7	0.0	0.5	0.2	4.4	0.4	71.4	2.5	0.0	8.8	0.0	8.3	0.0	2.3	0.0	2.5	5.8	0.0	8.4	0.2	1.8	0.0	71.5	4.5	0.0	0.0	0.1	2.9	0.8	0.0	0.0	0.3	90.3	0.6	49.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.9	5.9	2.3	7.8	5.5	7.3	5.3	5.4	10.7	4.9	6.1	4.0	0.1	0.0	0.6	0.3	0.3	0.6	0.6	19.1	0.0	0.4	0.5	1.4	0.4	0.0	10.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	162.4	119.1	1.8	0.4	0.0	0.0	3.5	0.0	0.8	1.1	0.0	31.9	5.1	2.2	0.0	0.0	0.2	0.0	3.0	0.0	6.1	0.0	1.8	91.1	3.1	1.1	0.0	0.0	0.0	1.4	0.0	0.5	0.4	0.0	0.0	2.6	0.0	0.7	0.0	0.1	29.3	0.8	6.6	0.5	1.5	285.7	2.4	0.0	0.4	0.3	0.9	0.0	0.1	1.1
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823883	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.6;lymphoid tissue: 46.9;retina: 31.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 47.9;Erythroid cells: 102.1;Extravillous trophoblasts: 92.8;Plasma cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.4;white matter: 7.6"					"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	1.5	1.2	2.5	11.4	2.5	38.6	2.5	3.5	4.7	4.3	2.5	9.8	10.1	2.5	0.6	8.4	2.2	1.8	1.3	2.3	2.4	1.5	1.6	1.8	25.0	2.8	2.7	3.8	0.8	0.6	2.7	10.5	2.6	1.9	11.5	31.7	1.8	0.8	0.7	6.7	9.9	4.0	2.6	4.6	4.4	6.2	2.6	46.9	1.2	0.5	24.4	2.9	3.9	3.5	177.1	45.3	120.5	51.8	6.4	16.3	98.8	119.7	52.8	156.7	115.6	99.4	106.5	161.2	31.7	63.8	55.0	58.0	154.2	71.1	128.0	77.8	70.8	129.7	56.0	96.9	1.5	197.0	88.0	4.2	5.3	65.1	38.7	24.7	95.4	84.3	187.9	156.9	126.1	63.8	251.8	113.1	95.5	109.9	49.8	114.1	233.5	78.2	44.8	34.6	51.0	53.8	63.1	76.0	32.4	89.8	63.7	81.9	56.5	72.7	109.3	77.4	115.9	98.0	112.3	181.9	41.5	197.6	82.4	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.2	0.1	0.8	0.1	0.0	3.1	0.9	2.5	2.5	3.5	4.7	2.3	2.4	2.8	2.7	2.6	2.6	2.6	3.5	0.8	0.0	1.1	1.6	5.7	2.8	1.5	5.5	1.8	2.9	1.9	1.8	0.8	0.0	1.6	0.0	12.5	47.9	1.9	4.9	0.0	0.7	9.6	0.6	2.7	3.3	1.2	102.1	3.3	0.2	92.8	6.3	9.2	2.1	0.0	18.1	4.2	0.9	25.3	0.0	4.1	7.7	8.2	6.9	3.6	2.1	0.9	3.6	1.8	2.8	0.2	1.2	0.0	4.5	5.2	0.5	3.1	1.2	35.5	3.3	1.8	0.2	2.5	14.2	0.0	0.9	6.0	10.3	17.7	24.0	1.3	8.5	6.3	1.4	19.9	2.1
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542387-99568825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: AB_2686120"	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	31.3	32.5	15.9	27.4	17.0	33.0	47.4	26.1	19.3	29.8	26.8	30.9	42.8	21.9	58.7	41.3	18.9	42.1	23.6	17.3	17.9	54.3	74.6	25.1	39.6	17.0	16.9	16.7	62.6	47.3	22.2	35.7	17.0	34.6	30.3	27.0	70.4	23.2	22.1	32.5	35.0	21.9	17.0	24.1	41.6	17.1	18.1	32.1	60.6	17.7	43.3	34.6	19.7	18.0	86.9	29.8	45.8	99.2	39.3	53.7	126.9	61.4	78.3	75.9	97.9	118.2	53.2	177.2	69.1	51.5	69.8	60.5	72.2	91.1	109.7	45.1	91.2	101.6	44.4	97.7	67.6	118.6	35.3	51.5	55.4	55.9	67.3	52.0	82.2	102.3	151.6	62.9	68.3	53.8	43.7	98.5	64.1	53.5	47.4	75.8	76.7	71.2	105.3	101.2	72.5	43.8	35.6	67.1	69.5	65.5	46.5	117.8	60.6	38.4	51.2	47.0	92.8	42.9	69.7	134.1	69.0	87.9	55.8	40.9	20.7	16.2	21.2	22.1	39.8	29.7	25.5	20.9	23.4	25.3	27.4	21.7	3.3	28.2	16.7	23.0	29.6	30.7	15.9	17.0	26.1	19.3	17.3	17.9	17.0	16.9	17.0	17.0	18.1	18.0	37.1	44.8	32.8	25.5	58.3	75.1	99.3	58.0	50.7	42.8	60.0	31.0	16.1	81.5	57.5	23.9	22.9	110.3	45.0	32.2	84.1	127.2	45.1	36.7	27.3	46.3	43.6	23.3	64.2	186.9	93.3	33.2	38.2	43.1	32.4	31.1	36.4	53.0	41.1	25.2	56.6	38.2	67.1	37.0	52.8	45.5	22.4	32.8	58.7	24.4	41.2	64.6	40.2	52.8	40.5	133.7	27.1	25.2	120.5	158.8	37.8	128.4	37.4	42.2	19.7	26.9	40.2	62.3	21.4	60.0	67.5	176.4	38.7	42.8	46.3	147.0
CCND1	"BCL1, D11S287E, PRAD1, U21B31"	ENSG00000110092	"Cyclin D1"	P24385	11	69641156-69654474	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation"	"Cyclin, Repressor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 499.7;Ductal cells: 504.0;Pancreatic endocrine cells: 622.1;Urothelial cells: 412.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 874.2;WM-115: 1239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000024, HPA027802"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB000024: AB_563678, HPA027802: AB_2672390"	"unprognostic (4.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.57e-1)"	55.6	29.2	12.1	10.0	14.6	1.5	40.2	15.0	11.9	17.0	33.4	19.8	22.7	14.8	27.6	72.9	30.8	19.5	64.9	10.8	14.6	32.2	107.3	61.1	10.5	17.5	15.5	4.6	86.3	82.7	25.7	63.7	18.3	53.3	17.2	3.2	30.4	50.4	3.6	120.3	16.0	23.3	15.9	37.2	52.7	3.2	21.7	9.9	45.5	5.2	19.0	29.5	43.9	24.0	467.3	183.0	59.5	1.8	178.3	186.7	127.4	717.5	264.9	82.1	47.6	206.9	349.9	0.1	317.6	375.5	137.2	332.1	6.5	195.2	146.0	1.2	36.5	0.3	46.7	211.7	43.3	3.3	6.7	106.5	37.9	116.0	44.0	192.5	142.1	0.2	0.6	1.3	654.2	197.1	0.4	26.6	109.0	190.7	198.3	1.2	187.9	11.3	379.4	282.8	10.0	231.4	9.2	167.7	458.4	143.5	102.6	9.5	600.4	399.5	111.0	176.1	496.2	874.2	559.4	1.5	341.6	5.9	1239.0	0.2	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	1.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.1	14.6	15.0	11.9	10.8	14.6	17.5	15.5	18.3	15.9	21.7	24.0	84.6	182.7	115.6	0.3	8.3	202.5	234.7	499.7	133.1	2.3	163.4	140.0	80.0	92.9	271.6	125.0	2.1	10.9	2.4	44.8	31.3	504.0	0.4	104.2	23.5	141.0	56.5	2.5	0.5	142.6	1.2	67.6	127.4	199.5	29.1	0.0	98.2	165.2	75.0	0.0	2.2	42.6	75.3	18.8	61.9	2.0	4.1	23.6	51.6	17.8	2.4	79.1	0.0	49.8	0.3	622.1	118.0	57.6	0.5	262.0	19.4	57.1	85.9	3.1	131.5	13.0	184.8	0.5	23.4	292.3	351.1	2.5	8.8	3.4	82.2	412.6
CCND2		ENSG00000118971	"Cyclin D2"	P30279	12	4269771-4305353	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 354.3;Granulosa cells: 438.5;Langerhans cells: 255.3;Plasma cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 152.4;HBEC3-KT: 136.6;HDLM-2: 238.8;Karpas-707: 287.9;RH-30: 202.7;RPMI-8226: 114.2"									"HPA049138, HPA054196"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA049138: AB_2680650, HPA054196: AB_2682412"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.52e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (7.06e-2)"	20.0	52.6	5.4	8.7	12.9	20.3	13.0	0.0	13.5	26.9	0.0	40.8	17.4	26.1	7.5	12.2	22.1	2.7	51.9	14.4	1.1	9.7	1.9	17.2	5.3	9.6	0.2	14.2	24.5	9.9	23.5	12.9	2.7	20.7	10.4	0.7	10.8	9.1	1.8	12.6	25.9	9.8	7.8	19.7	12.7	4.0	0.0	3.2	20.3	0.0	5.1	26.5	19.9	4.5	0.0	0.0	152.4	0.0	10.1	0.4	0.0	0.0	0.0	0.0	0.0	62.8	0.0	0.0	0.4	0.0	0.0	16.2	0.1	136.6	0.0	238.8	2.5	0.7	0.0	0.0	0.0	57.0	12.6	23.8	2.4	0.0	97.0	0.0	0.0	0.8	17.0	287.9	6.8	0.0	0.0	52.8	50.8	0.0	0.0	0.0	202.7	114.2	0.0	8.1	0.0	0.0	0.0	0.0	0.0	89.6	0.0	0.0	4.2	0.0	39.3	0.0	0.0	1.4	60.7	0.0	0.0	32.3	0.0	6.6	0.4	4.7	11.1	0.0	17.1	3.1	16.3	13.8	0.4	1.7	10.4	12.1	1.1	9.4	0.0	1.1	13.6	6.8	5.4	12.9	0.0	13.5	14.4	1.1	9.6	0.2	2.7	7.8	0.0	4.5	23.9	60.9	46.6	10.1	82.9	106.8	23.9	73.4	174.2	7.6	3.4	41.8	354.3	2.8	37.4	12.9	0.0	4.0	128.7	37.5	0.0	3.1	0.8	3.3	110.8	35.7	64.8	37.2	54.1	68.3	2.7	123.6	4.6	3.6	55.8	438.5	19.6	2.2	13.0	3.3	55.2	147.7	12.2	11.9	255.3	3.3	52.5	39.3	39.2	19.7	9.8	170.0	89.6	55.3	4.0	20.7	49.4	124.1	371.2	35.8	34.4	1.4	10.3	6.5	26.3	21.4	112.6	0.8	5.1	50.9	39.6	6.3	122.6	41.5	159.7	8.4
CCND3		ENSG00000112576	"Cyclin D3"	P30281	6	41934934-42050357	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 256.6"	"Cell type enhanced"	"Detected in all"		"NK-cells: 555.1;Syncytiotrophoblasts: 236.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 696.3;REH: 651.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000116, HPA042871"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"CAB000116: , HPA042871: "	"unprognostic (4.53e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.08e-6)"	"unprognostic (2.11e-1)"	74.3	137.6	84.8	63.1	84.6	220.2	64.8	80.0	94.5	36.9	78.4	45.6	40.6	35.4	15.3	39.6	43.2	34.4	68.1	86.2	88.6	42.4	22.1	102.5	143.3	87.4	82.5	36.0	31.6	23.7	33.3	55.4	84.0	50.4	27.0	10.3	50.4	25.6	18.2	52.3	78.5	28.6	79.7	170.4	66.1	11.1	86.4	256.6	58.7	32.5	83.6	45.4	44.3	80.8	67.7	242.2	24.6	54.8	43.7	88.6	286.1	77.1	43.7	77.7	57.1	45.9	29.7	288.9	127.8	51.9	68.9	40.5	65.8	93.4	39.2	49.2	43.4	458.8	106.6	37.3	94.9	75.9	385.2	84.7	59.8	76.0	27.9	23.5	96.6	188.3	236.7	27.2	111.6	92.0	696.3	354.6	10.9	202.8	51.5	651.8	96.3	32.2	179.1	44.9	83.8	21.8	65.8	83.3	38.6	30.6	51.5	288.4	162.9	86.2	47.9	74.7	88.1	17.9	15.2	458.5	50.4	157.6	53.3	1281.3	246.3	725.1	390.4	294.4	276.5	127.1	266.4	318.1	343.3	180.8	306.4	328.3	339.3	333.2	405.6	221.4	193.0	635.4	84.8	84.6	80.0	94.5	86.2	88.6	87.4	82.5	84.0	79.7	86.4	80.8	102.2	60.9	67.9	31.0	102.9	27.0	95.8	52.3	48.9	19.6	49.9	45.1	26.2	64.3	27.8	20.2	6.2	201.0	227.3	66.4	29.4	20.3	12.8	12.1	10.8	68.3	9.6	133.6	37.1	24.3	82.4	32.3	19.9	11.2	26.6	7.7	70.6	7.2	45.3	11.8	23.7	19.5	50.8	115.7	51.7	9.4	41.3	152.2	37.4	47.8	79.0	40.8	555.1	18.1	9.3	29.9	30.5	51.9	48.7	40.3	18.6	19.8	22.5	16.2	46.0	19.2	31.9	4.3	6.3	21.7	22.6	236.6	195.0	141.6	32.7	52.8
CCNDBP1	"DIP1, GCIP, HHM"	ENSG00000166946	"Cyclin D1 binding protein 1"	O95273	15	43185118-43197177	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 20.0"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 362.7;Erythroid cells: 361.2;Syncytiotrophoblasts: 1055.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"HEL: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020664, HPA041065"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nuclear bodies"	"CAB020664: , HPA041065: AB_2677282"	"unprognostic (4.48e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.68e-2)"	3.2	1.4	2.3	1.3	2.1	20.0	2.1	3.8	2.6	1.4	1.9	1.7	1.5	1.4	2.1	1.2	2.0	1.0	1.3	2.0	2.4	1.5	1.7	2.7	2.2	2.4	2.3	0.7	1.3	1.1	1.2	1.4	2.5	1.3	1.9	1.8	1.5	1.1	1.7	2.8	2.6	1.2	1.8	2.6	2.1	0.9	2.6	1.5	1.7	1.2	1.9	1.7	1.1	2.4	0.2	0.2	0.4	0.2	1.3	0.8	0.4	0.3	1.6	0.3	0.3	0.4	0.3	0.5	0.4	1.1	0.1	0.5	1.1	0.5	0.2	0.7	1.1	13.5	0.6	0.5	0.9	0.7	0.7	1.5	1.2	0.1	0.2	1.3	1.0	0.2	0.8	0.4	0.4	0.0	0.4	1.4	0.9	0.5	0.3	0.4	0.5	1.2	1.7	0.6	0.6	0.9	0.5	0.4	0.3	0.5	0.0	1.1	1.2	0.2	0.1	1.0	0.2	1.4	0.6	0.1	1.3	1.4	0.4	21.8	1.9	5.6	5.1	3.7	5.4	4.7	5.5	5.2	1.8	5.3	5.6	5.9	6.2	4.8	9.5	3.0	8.4	1.8	2.3	2.1	3.8	2.6	2.0	2.4	2.4	2.3	2.5	1.8	2.6	2.4	59.8	48.1	54.9	11.1	81.8	34.7	55.7	83.3	25.0	28.9	38.0	40.9	52.6	40.0	78.6	29.5	20.9	362.7	92.0	63.6	90.1	64.0	24.2	61.6	33.8	45.2	46.2	361.2	20.7	59.3	82.1	55.9	45.3	37.0	57.0	40.2	53.6	31.0	85.4	45.4	17.8	47.7	154.6	83.5	36.2	12.6	47.2	57.1	64.0	11.2	137.8	55.9	74.2	9.5	23.4	68.6	55.8	29.3	54.2	42.1	85.8	47.5	128.0	66.0	46.0	35.2	49.4	124.3	61.6	27.8	40.3	1055.9	85.9	37.8	42.2	88.5
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811991-29824312	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8;placenta: 30.8"	"Cell type enriched"	"Detected in many"	14	"Extravillous trophoblasts: 1756.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"BEWO: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.2	5.7	1.9	4.3	2.1	35.8	0.8	2.8	2.7	1.0	0.9	3.9	3.0	1.4	0.6	4.4	0.9	1.0	2.3	2.0	2.5	1.0	0.7	1.1	6.1	2.0	2.1	0.8	1.8	2.8	0.9	30.8	2.0	1.0	4.7	2.0	1.5	1.4	2.1	4.1	2.5	2.2	1.7	4.2	2.1	12.1	2.5	4.5	1.6	1.8	7.8	3.0	1.8	2.3	15.6	31.8	24.3	34.0	5.2	6.0	293.1	24.7	5.3	10.8	13.2	33.0	31.2	13.3	55.9	11.1	14.0	4.9	28.8	12.8	15.2	41.9	17.7	11.2	30.0	34.5	4.1	44.0	28.7	6.2	7.1	14.8	1.9	3.4	13.3	13.2	45.6	5.8	16.8	24.4	24.5	13.0	40.1	36.2	7.2	36.2	28.6	10.1	8.4	24.6	20.5	17.4	35.4	42.7	3.9	35.4	9.5	32.7	8.0	25.0	92.8	14.9	16.9	24.1	18.2	91.6	13.8	5.6	13.7	0.0	0.0	0.0	0.1	0.5	0.3	0.6	0.1	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.3	0.1	1.9	2.1	2.8	2.7	2.0	2.5	2.0	2.1	2.0	1.7	2.5	2.3	3.1	0.0	0.6	0.7	4.8	4.8	1.5	0.3	2.2	2.9	8.2	11.3	3.1	0.0	1.4	0.0	0.0	122.4	3.7	3.5	0.0	0.4	14.6	7.5	4.1	1.9	3.0	30.7	2.9	0.7	1756.5	6.0	5.6	20.1	0.0	4.6	1.4	0.2	43.4	3.3	5.1	3.3	0.0	1.0	2.5	3.6	1.2	4.2	1.8	0.0	0.2	1.7	0.0	2.5	1.3	1.4	2.2	2.2	18.4	2.2	1.0	0.4	0.1	1.1	6.6	4.1	3.4	25.0	17.6	8.5	6.0	115.7	4.5	6.9	4.9	3.5
CCNG1	CCNG	ENSG00000113328	"Cyclin G1"	P51959	5	163437569-163446151	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 265.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB000350	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB000350: "	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.89e-2)"	51.2	48.8	21.0	30.4	23.0	38.3	67.2	22.9	25.8	63.4	27.8	68.0	137.2	50.5	73.4	47.8	61.8	56.7	50.4	19.1	23.4	123.5	129.6	33.4	49.0	24.7	21.6	112.0	74.4	39.7	14.6	54.0	25.0	71.4	87.0	21.3	56.3	55.7	163.6	23.5	109.1	52.3	23.5	35.5	57.3	20.7	21.7	50.3	62.4	120.6	47.0	59.7	33.8	28.6	54.9	59.8	246.6	138.8	207.9	397.3	258.2	74.1	181.2	73.8	165.2	130.4	109.4	134.1	73.7	100.1	121.7	22.2	137.2	185.0	107.9	63.7	171.9	106.6	71.7	230.0	226.4	49.9	68.9	433.8	105.6	73.3	75.1	221.5	241.1	88.3	92.3	92.8	253.4	33.8	89.6	66.5	113.3	40.1	52.7	74.6	120.7	75.2	179.5	209.4	57.6	65.6	0.4	30.5	154.0	155.2	115.5	155.8	140.5	47.6	101.0	40.8	66.2	81.5	34.2	87.7	84.3	81.4	80.6	44.5	25.6	31.0	35.8	36.1	53.9	55.4	63.2	49.3	59.6	33.9	84.5	72.0	10.9	40.7	36.7	22.6	80.9	63.9	21.0	23.0	22.9	25.8	19.1	23.4	24.7	21.6	25.0	23.5	21.7	28.6	20.8	25.6	20.0	7.5	67.3	57.2	94.7	64.7	103.0	12.4	64.4	33.0	52.9	77.2	39.7	36.8	0.0	138.7	49.8	48.2	162.4	73.0	8.1	30.6	27.5	43.5	71.0	96.3	8.4	119.0	107.7	57.1	110.6	46.1	43.7	108.8	61.1	51.7	60.0	15.2	8.8	113.2	44.7	74.8	70.5	6.1	75.8	60.8	37.4	15.0	52.0	29.9	54.6	4.5	12.7	91.1	80.2	72.2	63.5	107.2	223.4	265.9	11.2	10.8	39.5	42.4	73.4	8.8	12.1	61.5	44.2	97.3	76.4	81.5	182.7	104.3
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157207-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	HPA034684	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	46.4	23.6	15.5	35.6	18.2	88.0	81.5	64.3	20.8	39.6	8.3	33.5	28.0	39.2	26.7	136.0	18.8	32.8	14.9	17.5	11.4	71.0	11.0	26.3	73.5	13.5	14.7	37.4	14.7	46.3	8.8	64.6	13.5	78.1	34.4	81.2	34.3	31.4	12.3	29.2	25.1	33.8	13.1	48.1	25.4	11.2	15.2	67.3	53.2	34.4	73.5	53.5	37.1	19.2	30.9	3.9	66.5	35.5	43.1	54.9	45.0	25.4	72.6	19.4	36.0	4.6	43.8	61.7	40.0	23.7	18.4	21.7	17.6	83.8	37.2	43.2	11.8	5.2	18.1	9.1	22.4	9.3	62.1	46.9	40.8	9.1	19.9	64.6	29.4	35.9	3.0	36.7	36.0	12.0	42.9	19.7	6.8	15.0	4.1	24.3	64.8	4.1	121.9	84.1	17.7	56.1	30.0	46.7	18.0	39.4	34.9	13.8	27.6	26.3	26.0	19.1	4.2	26.9	21.9	43.8	18.4	14.4	13.4	14.8	1.7	21.0	0.9	2.7	2.1	3.2	1.3	1.0	1.9	6.3	1.0	0.6	8.0	2.1	3.1	2.8	6.1	0.8	15.5	18.2	64.3	20.8	17.5	11.4	13.5	14.7	13.5	13.1	15.2	19.2	25.0	12.8	12.3	14.7	55.8	37.1	29.0	27.8	113.8	112.4	101.1	53.6	4.7	8.6	25.4	55.2	22.9	29.7	35.5	57.6	86.1	33.7	0.8	50.4	44.6	35.7	16.7	1.7	13.8	19.6	98.7	61.5	18.3	107.7	39.3	20.3	35.3	3.9	32.3	25.2	26.7	38.0	50.8	45.3	56.7	2.3	27.7	35.8	56.9	10.3	61.8	28.4	17.5	17.1	13.9	49.2	24.6	27.4	20.5	74.3	29.6	70.9	15.3	46.8	65.7	61.3	41.5	9.2	10.1	40.8	26.7	15.7	31.1	17.1	16.1	57.8
CCNH	"CycH, p34, p37"	ENSG00000134480	"Cyclin H"	P51946	5	87318416-87412930	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.5;Plasma cells: 219.9;Spermatocytes: 202.6;T-cells: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019416, HPA044138"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB019416: AB_2259936, HPA044138: AB_2678828"	"unprognostic (5.65e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.01e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.93e-2)"	"unprognostic (6.43e-2)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.62e-2)"	36.6	26.6	6.9	18.8	7.6	38.3	29.0	15.6	10.9	19.4	6.9	16.0	17.6	14.9	24.2	17.7	17.6	24.6	22.0	8.7	9.0	24.5	37.5	25.8	24.1	7.7	6.3	26.9	23.0	29.9	27.1	15.6	6.9	26.5	19.9	11.4	20.4	18.4	29.1	15.4	16.6	15.6	7.1	18.4	17.6	54.1	6.7	36.8	26.9	22.6	25.9	27.3	18.3	10.3	62.6	26.6	27.1	18.1	39.3	27.5	28.1	44.4	54.8	73.8	101.2	46.7	35.0	40.5	15.8	66.4	77.7	31.1	32.5	67.5	68.4	42.9	39.9	73.1	44.8	46.4	69.3	61.9	57.6	37.0	25.4	38.6	93.8	37.8	65.6	38.7	50.0	70.7	61.7	35.1	42.4	49.5	11.6	15.7	99.4	34.5	63.3	60.9	62.5	32.8	27.8	18.1	23.3	21.7	53.8	16.3	51.7	46.8	45.6	70.9	29.3	41.9	39.4	25.1	23.9	63.4	45.6	55.7	33.6	49.3	37.7	58.8	26.4	47.2	37.4	36.7	35.4	34.8	44.5	32.0	34.4	36.2	28.0	35.4	50.2	26.1	44.8	36.9	6.9	7.6	15.6	10.9	8.7	9.0	7.7	6.3	6.9	7.1	6.7	10.3	67.5	35.3	33.7	15.0	111.2	37.3	64.3	55.1	40.5	29.0	30.1	24.3	13.2	20.0	37.7	18.4	16.7	21.0	154.2	14.7	41.1	40.1	281.5	28.0	25.2	37.6	24.0	33.7	28.3	34.5	25.6	52.5	41.3	24.2	57.1	19.9	30.0	19.9	45.3	18.5	43.7	15.2	36.7	67.9	73.4	41.4	29.5	125.2	48.0	20.6	25.5	44.9	41.2	20.1	23.5	31.1	15.8	25.2	219.9	31.7	27.0	53.8	34.4	32.9	52.6	43.3	120.0	202.6	48.3	22.3	34.5	30.1	207.8	35.7	19.4	41.0
CCNI	CCNI1	ENSG00000118816	"Cyclin I"	Q14094	4	77047155-77076309	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010206, HPA039853, HPA061470"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533"	"unprognostic (3.68e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.10e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	176.7	98.4	182.1	109.8	191.0	222.9	183.6	253.4	218.2	234.8	131.4	182.7	100.0	211.0	249.1	177.9	196.5	150.7	195.7	148.1	171.8	183.8	133.7	144.8	185.2	184.0	185.9	341.6	155.2	145.2	71.1	138.0	188.6	198.9	129.8	213.2	183.0	208.9	225.8	136.4	120.8	195.6	167.5	149.1	149.0	131.7	186.1	229.2	273.5	177.8	238.8	186.6	170.5	220.7	163.3	96.0	305.0	268.6	447.6	406.7	117.0	122.5	298.4	189.9	181.5	119.3	240.6	300.1	183.2	309.4	118.9	83.4	211.7	428.9	300.2	214.0	83.7	180.3	102.1	114.0	438.1	312.0	346.4	320.4	502.6	175.1	426.2	542.6	270.1	154.3	157.2	315.9	273.4	187.7	406.3	292.5	135.2	113.9	59.0	250.7	290.0	126.5	283.5	182.7	387.3	211.8	162.9	247.2	209.2	212.6	141.2	131.6	184.6	231.0	137.0	249.0	170.4	173.7	86.1	310.9	195.4	210.6	153.3	160.7	113.2	236.7	95.6	108.0	131.2	148.2	157.0	142.0	119.5	153.7	165.2	143.8	145.8	109.3	134.0	135.3	149.7	100.0	182.1	191.0	253.4	218.2	148.1	171.8	184.0	185.9	188.6	167.5	186.1	220.7	368.4	173.1	231.3	59.7	606.6	422.9	633.0	489.3	578.8	629.5	550.2	523.5	460.5	323.1	238.7	196.8	68.8	273.7	441.5	258.8	794.3	400.9	71.0	250.5	321.3	405.5	412.3	510.9	125.8	334.3	427.4	510.9	220.2	231.2	278.4	300.9	382.7	121.5	337.0	181.7	150.3	346.6	329.6	685.1	676.5	147.5	604.0	490.4	402.0	77.8	613.0	403.2	390.3	52.3	69.1	515.1	317.6	989.2	500.8	854.8	468.4	596.6	161.4	228.7	552.2	373.3	510.8	200.4	745.5	466.1	394.8	379.5	497.3	326.5	345.9	747.1
CCNI2	FLJ16793	ENSG00000205089	"Cyclin I family member 2"	Q6ZMN8	5	132747426-132754403	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;intestine: 3.6"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Gastric mucus-secreting cells: 7.1;Intestinal goblet cells: 3.5;Muller glia cells: 4.9;Plasma cells: 4.8;Undifferentiated cells: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"MOLT-4: 25.7"					"Low region specificity"	"Detected in all"			HPA056288	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA056288: AB_2683086"	"unprognostic (3.84e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.71e-7)"	"unprognostic (1.58e-1)"	0.2	0.3	1.2	0.9	1.9	0.1	0.2	1.3	1.5	0.5	0.0	2.6	3.6	0.1	0.3	0.1	0.3	0.4	0.3	0.9	0.8	3.1	0.0	0.5	0.8	2.2	1.3	0.2	1.2	0.0	0.6	0.1	1.6	0.9	2.7	1.1	2.6	1.3	0.3	0.3	2.1	0.1	0.9	0.4	2.4	0.7	1.5	1.5	0.4	0.0	0.9	0.9	0.2	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.4	0.0	0.6	25.7	0.1	0.4	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.3	1.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	4.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.8	0.1	1.2	1.9	1.3	1.5	0.9	0.8	2.2	1.3	1.6	0.9	1.5	4.3	0.2	0.0	0.5	0.0	0.9	0.1	0.4	0.8	0.0	0.1	0.4	0.1	0.6	0.0	0.4	0.0	0.0	0.4	0.1	3.4	3.9	0.4	2.2	0.4	0.0	0.1	1.2	0.0	0.6	1.5	0.2	0.3	7.1	0.5	1.3	0.0	0.0	0.0	0.1	1.7	0.5	3.5	0.0	0.0	0.0	2.1	0.3	0.4	0.0	0.0	0.0	4.9	0.0	1.0	2.4	1.5	2.3	0.0	4.8	0.6	1.8	0.3	1.0	0.2	0.0	0.1	0.2	0.2	0.7	0.0	0.1	0.0	1.9	0.1	4.2	0.6
CCNJ	"bA690P14.1, FLJ10895"	ENSG00000107443	"Cyclin J"	Q5T5M9	10	96043394-96060870	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 42.1;AN3-CA: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036531, HPA058151"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Golgi apparatus"		"HPA036531: AB_10696656, HPA058151: AB_2683623"	"unprognostic (1.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	3.6	4.5	1.9	4.2	2.4	11.5	3.9	2.9	2.1	3.3	1.7	3.3	4.4	4.3	3.1	2.7	2.8	3.8	2.2	1.7	2.5	2.6	2.5	3.1	4.9	2.5	2.2	2.8	4.3	5.0	2.1	3.5	2.4	3.3	3.6	4.0	2.7	3.1	3.8	2.9	3.6	3.4	2.1	5.0	2.8	4.2	2.4	4.0	3.2	4.0	3.9	4.4	1.8	2.6	9.0	6.6	42.1	42.2	4.2	3.1	6.1	5.6	5.9	7.7	6.9	17.2	3.7	12.3	6.4	5.4	6.5	5.2	27.4	5.9	10.0	6.1	11.8	12.0	5.2	26.0	9.7	12.0	5.4	5.7	8.2	7.5	17.3	7.6	18.8	11.0	17.6	0.2	4.9	8.6	20.9	14.8	23.6	0.8	6.0	24.3	2.0	0.9	9.4	8.1	6.4	22.2	6.2	1.8	12.6	14.1	10.1	13.7	9.1	4.8	11.1	5.6	13.1	2.5	1.0	11.5	5.8	20.5	3.3	0.1	1.7	0.5	0.9	1.4	1.2	0.7	0.8	0.4	2.9	0.7	1.1	1.1	0.1	0.4	1.3	0.6	0.7	0.9	1.9	2.4	2.9	2.1	1.7	2.5	2.5	2.2	2.4	2.1	2.4	2.6	2.6	6.4	3.1	2.3	3.3	1.9	3.1	1.3	2.8	5.1	3.1	2.0	4.0	1.5	2.4	5.5	14.6	1.5	2.1	3.4	3.9	2.9	3.7	2.6	4.8	4.8	4.2	4.2	4.2	2.7	3.0	3.2	2.0	2.5	0.0	4.6	10.4	1.4	3.6	1.7	5.8	3.5	2.0	6.5	4.6	7.6	1.8	5.0	1.8	1.9	2.8	3.1	1.0	5.5	3.7	4.0	1.5	1.9	1.9	4.0	1.4	2.1	4.3	3.2	0.0	4.1	4.0	10.1	6.9	2.3	1.4	1.1	2.2	3.1	3.2	2.9
CCNK	CPR4	ENSG00000090061	"Cyclin K"	O75909	14	99481169-99535044	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Cyclin	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 102.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000645, HPA077073"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA000645: AB_1078606, HPA077073: AB_2732331"	"unprognostic (8.07e-2)"	"unprognostic (9.32e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"unprognostic (9.22e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.78e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.21e-2)"	20.7	18.0	8.8	26.6	10.2	102.1	16.9	11.5	12.8	17.9	10.5	26.3	25.5	18.9	18.8	25.5	22.1	18.5	19.3	9.8	11.8	16.6	17.9	21.7	28.4	11.9	10.8	25.8	16.7	13.5	19.7	19.8	10.9	17.0	28.0	16.3	20.7	16.2	39.2	22.1	27.7	19.8	9.1	24.9	25.0	45.4	10.6	33.3	20.0	22.4	34.1	21.5	19.1	12.9	53.9	59.3	59.7	50.2	47.5	49.4	109.3	69.9	62.2	71.4	82.3	86.3	69.7	84.3	47.7	75.9	53.1	59.9	64.3	89.9	99.5	83.0	33.7	78.1	38.6	75.2	62.4	111.1	85.6	53.7	68.2	71.1	81.4	33.8	54.4	82.9	72.1	72.8	62.7	115.1	85.9	44.6	59.0	66.2	52.1	76.5	80.2	44.7	39.8	101.1	49.1	36.5	62.7	31.9	28.6	57.7	87.4	49.6	66.5	25.6	40.7	226.1	63.3	61.7	86.6	101.5	65.5	50.9	53.4	5.3	5.3	12.6	7.2	5.7	6.3	5.4	5.6	6.4	4.7	4.9	6.5	6.0	12.8	5.1	6.2	5.0	6.3	3.4	8.8	10.2	11.5	12.8	9.8	11.8	11.9	10.8	10.9	9.1	10.6	12.9	29.6	12.8	37.9	13.7	41.8	36.8	48.6	31.3	33.6	16.9	29.5	23.6	11.5	14.3	37.7	22.0	20.9	23.5	52.7	36.0	13.7	20.1	51.5	39.2	39.6	24.1	19.7	39.2	13.7	24.7	29.3	27.6	49.5	56.7	20.3	29.3	25.7	18.7	24.2	18.5	14.0	34.2	30.5	32.7	32.1	22.0	22.4	41.1	17.8	16.9	38.0	13.4	47.4	14.1	18.5	31.8	26.4	18.0	44.9	42.1	26.2	17.2	43.4	28.8	0.0	40.1	23.0	78.9	64.3	35.7	45.3	27.2	46.5	24.9	32.4	70.2
CCNL1	ania-6a	ENSG00000163660	"Cyclin L1"	Q9UK58	3	157146508-157160760	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Cyclin	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057911			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"HPA057911: AB_2683553"	"unprognostic (1.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-3)"	"unprognostic (7.50e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (3.71e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (6.96e-7)"	52.1	25.2	12.4	11.6	12.9	56.6	27.3	14.2	21.2	21.9	12.6	22.5	13.5	19.4	5.7	22.1	30.5	13.5	23.1	13.0	13.2	31.8	45.3	30.2	14.1	15.1	12.8	31.2	33.5	8.3	21.8	10.3	13.1	23.8	6.6	5.3	18.7	6.2	21.3	25.3	29.7	9.1	11.9	35.6	29.1	9.1	13.0	20.0	23.7	10.3	9.8	19.4	22.9	14.7	19.2	11.4	16.8	11.6	16.1	10.9	16.0	12.0	14.4	13.9	13.0	19.7	14.8	20.3	10.0	8.9	9.7	14.7	12.4	14.6	12.8	18.2	14.1	12.6	12.2	17.2	13.2	8.8	7.7	13.3	25.1	13.2	17.7	13.9	11.1	11.4	8.7	12.7	10.2	13.8	17.8	16.7	13.9	14.7	12.5	16.2	13.6	31.7	8.9	11.4	8.9	16.5	9.1	8.4	26.1	12.5	8.7	26.1	9.1	12.8	7.1	13.8	15.9	25.3	21.5	26.7	12.8	13.1	12.6	5.9	10.3	16.0	13.5	8.4	14.1	13.4	12.5	14.0	13.1	15.2	17.1	14.2	28.6	17.4	11.3	14.0	15.4	8.2	12.4	12.9	14.2	21.2	13.0	13.2	15.1	12.8	13.1	11.9	13.0	14.7	367.4	218.0	392.4	33.0	222.5	268.0	499.2	203.8	310.7	73.7	279.3	247.0	54.3	177.3	259.0	68.0	133.5	139.2	253.6	389.6	23.5	189.4	41.0	379.7	426.5	287.1	247.7	86.5	30.6	127.8	152.9	302.7	268.1	761.2	222.2	281.6	167.8	90.4	164.6	40.4	32.3	294.6	154.6	241.5	251.4	20.9	128.0	292.5	140.5	42.2	160.1	69.5	122.6	35.7	66.3	143.2	378.2	75.2	258.5	408.2	415.6	21.2	188.9	183.3	131.5	460.0	276.4	46.5	25.0	252.6	276.9	209.1	282.8	182.6	244.1	503.2
CCNL2	"ania-6b, CCNM, CCNS, HLA-ISO, PCEE, SB138"	ENSG00000221978	"Cyclin L2"	Q96S94	1	1385711-1399335	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053137	Supported		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053137: AB_2682053"	"unprognostic (3.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (4.61e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (1.46e-7)"	65.1	79.9	16.3	29.6	17.5	33.3	74.0	24.1	21.5	101.8	27.8	76.9	36.0	88.7	30.9	67.2	86.6	26.4	57.9	16.9	14.2	65.6	100.5	62.1	32.2	16.9	15.7	104.3	90.2	31.7	73.4	34.4	18.4	76.0	22.8	22.9	78.1	31.9	49.7	73.7	75.8	26.6	15.7	62.1	71.3	31.1	17.0	31.6	91.4	18.4	28.1	77.0	82.5	26.6	30.1	24.5	72.5	29.7	39.2	63.9	37.1	63.8	33.8	32.1	31.6	27.5	57.9	30.6	35.3	42.8	27.7	68.4	26.8	40.9	24.6	14.7	68.9	38.4	142.0	43.8	47.8	19.9	42.8	81.1	29.0	31.4	48.5	94.6	34.9	41.0	37.3	32.4	37.6	32.1	25.1	78.7	23.7	21.2	48.5	48.8	17.6	39.1	56.5	37.1	45.4	63.0	40.7	60.6	37.5	42.8	48.8	30.3	60.1	70.8	32.5	29.4	25.2	64.9	12.1	53.7	35.0	50.7	18.5	5.4	6.1	8.5	7.4	4.6	5.0	7.2	7.2	7.9	7.1	9.0	8.3	7.4	5.8	6.6	7.3	6.7	4.3	2.9	16.3	17.5	24.1	21.5	16.9	14.2	16.9	15.7	18.4	15.7	17.0	26.6	66.4	35.3	107.5	76.7	46.6	45.5	36.6	48.3	50.7	31.7	50.8	56.4	37.2	40.0	58.1	29.5	47.9	43.2	48.7	43.1	21.5	30.6	22.4	49.0	82.1	56.0	50.6	26.5	44.7	26.7	33.8	49.9	78.5	55.2	43.1	81.4	37.5	45.6	24.7	60.6	41.2	41.5	52.9	22.9	34.0	14.6	51.3	31.0	32.0	48.7	27.2	35.5	47.4	31.2	52.5	40.2	40.7	32.7	46.7	31.1	33.9	18.4	58.6	39.4	59.2	56.8	59.9	45.1	30.6	40.3	44.0	63.8	46.4	73.6	34.6	39.0
CCNQ	"CycM, FAM58A"	ENSG00000262919	"Cyclin Q"	Q8N1B3	X	153587925-153600045	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 72.4;Extravillous trophoblasts: 98.6;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050137, HPA059843"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA050137: AB_2681029, HPA059843: AB_2684140"	"unprognostic (3.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.50e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.25e-2)"	11.8	12.8	19.9	8.2	21.3	7.3	11.7	19.6	24.9	11.9	15.6	16.2	8.9	12.9	12.7	13.1	11.1	4.0	33.9	20.8	20.5	13.5	13.2	10.6	12.5	23.2	21.6	10.5	15.0	10.3	23.6	9.2	23.4	13.6	8.0	6.4	12.9	8.8	34.3	12.1	13.6	6.1	20.0	17.2	13.3	6.2	21.2	9.0	11.1	13.6	12.2	14.0	11.7	24.9	43.7	31.2	12.1	43.5	20.9	11.2	18.7	25.0	21.8	23.5	23.6	33.3	14.3	34.9	44.6	25.1	35.3	26.7	38.4	22.6	22.2	20.3	39.2	7.8	19.4	23.5	19.0	28.2	18.9	14.1	20.1	15.7	16.1	10.0	19.0	16.1	10.6	15.6	19.1	50.5	19.7	38.0	15.1	44.4	52.4	22.6	20.0	17.8	17.0	17.6	16.0	21.1	12.0	19.3	34.4	11.9	7.3	25.0	14.6	20.5	29.3	46.7	38.5	21.8	23.1	43.4	18.5	45.4	15.7	0.0	1.6	4.9	2.7	1.4	1.0	6.1	2.3	1.9	1.3	4.1	2.5	1.7	0.9	0.7	0.8	1.2	3.4	1.1	19.9	21.3	19.6	24.9	20.8	20.5	23.2	21.6	23.4	20.0	21.2	24.9	21.0	3.2	13.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	24.1	31.0	0.0	0.0	3.1	7.3	0.0	40.7	20.4	0.0	72.4	23.3	0.0	11.9	17.3	7.8	0.0	0.0	0.0	37.1	98.6	8.4	0.0	8.7	2.5	16.3	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	22.7	0.0	0.0	0.0	0.0	34.0	0.0	0.0	5.9	0.0	0.0	41.6	2.2	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	120.9	10.0	18.4	0.0	0.0
CCNT1	"CCNT, CYCT1, HIVE1"	ENSG00000129315	"Cyclin T1"	O60563	12	48688458-48716998	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004892, CAB009016, HPA072012"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: "	"unprognostic (1.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.78e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.92e-1)"	9.4	9.6	5.3	9.6	5.5	29.4	9.9	7.3	6.4	7.1	7.8	7.7	6.7	9.2	8.2	7.8	8.2	7.1	6.8	4.7	8.6	8.9	8.4	8.3	11.7	5.7	5.8	10.8	8.8	11.5	6.7	7.9	5.7	7.6	8.3	12.2	6.3	7.0	10.2	9.6	7.8	7.9	6.1	10.5	7.3	11.5	6.3	13.0	11.7	9.9	11.3	7.5	6.9	7.5	15.1	21.8	20.6	19.8	14.9	18.2	23.8	20.0	16.6	15.3	11.8	26.0	17.3	40.4	25.6	13.4	10.4	19.3	35.6	13.7	22.6	24.0	20.5	43.9	34.2	11.2	18.4	45.1	20.0	14.1	19.6	21.4	25.3	21.0	11.9	23.5	44.7	18.1	18.9	9.9	24.6	20.9	20.7	8.7	16.1	21.8	33.4	17.0	14.0	26.2	23.0	24.0	32.0	15.5	23.5	14.9	21.3	25.8	12.5	16.1	17.0	11.7	17.1	25.8	37.0	35.3	19.1	64.9	9.4	9.0	2.6	7.7	3.3	1.7	4.5	4.3	2.7	3.2	1.6	5.3	3.9	3.6	13.6	3.5	2.0	4.4	1.8	0.9	5.3	5.5	7.3	6.4	4.7	8.6	5.7	5.8	5.7	6.1	6.3	7.5	41.4	16.0	18.9	16.0	38.0	38.5	19.4	11.8	48.9	23.5	21.9	19.0	14.4	12.8	16.1	12.9	22.9	13.8	58.7	13.1	3.9	8.2	131.4	18.9	23.7	26.4	12.0	24.0	18.9	6.9	16.7	23.9	29.0	26.1	29.8	27.3	27.8	15.2	10.2	38.7	18.5	15.8	14.2	17.5	33.0	27.9	16.8	29.9	21.4	19.7	12.1	16.2	18.6	18.6	22.6	8.1	9.2	14.7	37.8	26.2	13.3	9.8	25.1	16.3	6.6	23.3	28.5	18.3	14.4	32.1	44.9	17.4	45.0	27.3	13.7	33.3
CCNT2		ENSG00000082258	"Cyclin T2"	O60583	2	134918235-134959342	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005559	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA005559: AB_1078608"	"unprognostic (2.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.44e-4)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (3.28e-4)"	13.4	12.1	10.1	12.2	10.2	29.0	15.6	13.7	12.4	16.4	10.6	13.0	13.4	13.5	14.8	12.8	14.0	9.4	11.7	9.9	10.8	10.9	18.3	14.9	15.5	10.4	10.0	17.4	19.8	15.0	15.1	12.0	10.8	13.5	12.1	19.0	13.0	10.7	10.3	15.4	14.4	8.5	11.1	15.6	14.8	12.3	10.5	14.4	14.5	9.7	14.1	15.0	16.3	14.4	9.0	4.4	28.0	10.5	13.6	13.7	21.3	12.2	9.9	11.2	13.9	11.9	10.1	14.6	8.9	10.0	5.4	11.4	17.0	9.1	16.3	7.9	11.5	15.8	11.9	16.9	13.3	14.3	13.4	12.6	17.6	11.1	13.5	14.4	16.8	10.8	13.4	14.6	13.2	6.1	16.0	21.2	22.8	7.4	9.0	15.2	10.0	11.7	17.4	24.4	19.1	15.8	8.9	10.3	14.2	20.3	10.8	17.3	15.3	14.4	15.9	6.2	9.0	10.2	6.7	15.1	9.0	11.2	12.5	3.8	1.6	2.0	1.7	2.0	2.1	1.6	1.9	2.1	2.1	1.2	3.3	2.6	2.1	2.8	1.0	1.9	2.6	1.3	10.1	10.2	13.7	12.4	9.9	10.8	10.4	10.0	10.8	11.1	10.5	14.4	27.1	25.6	26.0	49.6	38.0	15.0	28.8	17.9	26.7	34.7	21.6	15.4	23.5	14.3	21.8	14.7	33.3	11.9	35.3	22.4	7.9	16.2	5.5	20.2	30.2	21.5	18.5	20.0	73.6	14.9	9.6	23.7	46.9	33.1	11.4	31.1	18.9	20.9	10.1	42.1	70.1	16.4	6.1	15.7	22.1	14.6	14.0	25.2	8.8	52.5	23.6	12.9	19.6	76.9	81.8	14.2	19.0	22.2	26.5	35.4	19.1	7.0	12.4	34.5	19.7	17.7	24.2	17.7	23.6	25.3	18.2	13.7	29.0	25.2	17.1	50.5
CCSER2	"FAM190B, KIAA1128"	ENSG00000107771	"Coiled-coil serine rich protein 2"	Q9H7U1	10	84328586-84518521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	16	"Early spermatids: 1945.3;Late spermatids: 5466.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037481, HPA037482"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA037481: AB_10672385, HPA037482: AB_10671501"	"unprognostic (4.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.83e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.74e-2)"	20.1	10.0	22.4	9.4	22.1	9.6	13.7	28.6	23.1	18.4	15.8	20.7	11.5	18.9	15.3	27.8	10.2	12.2	55.7	22.4	28.3	11.6	12.7	16.5	12.1	31.0	25.1	13.6	11.8	11.4	6.6	10.7	32.2	14.6	12.2	18.5	9.5	15.5	66.2	13.3	11.3	24.7	25.4	10.3	10.8	63.1	31.0	16.3	24.5	62.9	11.3	16.5	11.0	26.8	17.1	13.0	15.2	33.7	21.4	35.1	10.7	20.2	33.1	12.3	23.8	7.4	17.7	11.4	12.9	37.1	19.7	14.2	11.5	12.8	18.4	37.5	7.2	4.1	5.8	9.3	20.1	6.1	8.3	17.4	18.1	19.8	62.2	31.5	33.7	21.0	5.4	33.6	22.2	10.6	10.6	4.3	6.6	5.9	10.3	10.6	7.8	4.2	11.0	17.8	4.6	8.4	11.1	7.3	34.7	20.9	13.4	3.0	30.5	36.7	16.6	18.2	21.5	33.5	12.2	9.0	23.7	7.7	16.2	4.9	4.3	7.7	19.4	3.9	19.8	7.5	14.3	18.2	4.1	6.9	12.8	13.8	5.9	20.3	3.2	6.2	9.6	8.5	22.4	22.1	28.6	23.1	22.4	28.3	31.0	25.1	32.2	25.4	31.0	26.8	50.9	41.7	40.8	120.2	28.8	35.3	57.8	28.1	22.8	87.0	43.7	43.1	218.6	12.8	32.6	16.5	31.3	24.9	101.2	16.1	37.2	31.3	1945.3	21.2	33.9	54.1	16.3	3.0	146.7	45.8	19.3	52.2	21.4	28.8	14.5	28.5	37.1	24.0	20.9	62.2	142.5	28.9	22.4	21.4	66.2	5466.2	51.6	29.2	26.6	124.6	39.5	58.5	81.4	209.6	222.3	34.1	13.8	59.8	42.1	55.4	49.6	26.1	22.0	55.9	13.1	61.8	65.3	103.6	84.0	36.4	47.0	68.4	90.4	30.0	21.4	67.2
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868085-61888671	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1700000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	66.4	67.0	60.4	59.9	62.6	64.9	90.2	67.1	114.9	68.4	66.7	65.1	45.8	68.7	50.8	75.6	74.4	43.1	67.0	62.3	65.7	73.5	63.7	48.7	81.4	63.9	62.6	109.3	95.3	62.8	45.9	65.8	66.1	57.8	58.9	56.8	53.7	57.5	96.7	66.4	48.5	72.0	70.4	55.3	64.5	77.6	66.0	83.3	65.3	74.0	92.0	68.4	61.2	80.0	274.5	313.6	203.1	190.1	166.2	251.5	342.5	244.6	174.3	345.6	230.4	550.5	193.2	437.9	239.7	176.5	354.6	192.4	405.8	313.9	362.3	216.0	398.9	280.4	149.4	347.7	149.3	347.8	179.1	215.0	214.4	278.8	287.2	259.5	293.3	220.0	406.5	137.2	297.5	246.4	299.6	451.2	365.3	364.2	276.0	336.9	319.2	297.4	237.5	186.2	177.6	148.8	177.2	221.9	324.5	235.7	161.9	245.6	185.2	190.6	275.5	143.3	400.1	205.3	297.3	739.8	188.9	391.7	255.7	58.2	60.7	25.0	83.2	88.9	106.9	93.6	87.1	100.8	100.4	88.6	112.9	112.2	8.4	107.5	103.3	64.3	100.7	125.2	60.4	62.6	67.1	114.9	62.3	65.7	63.9	62.6	66.1	70.4	66.0	80.0	111.8	73.7	54.3	20.9	125.4	152.6	350.8	206.6	136.1	52.9	131.3	136.4	47.7	82.9	116.7	73.5	14.6	256.5	106.5	52.8	135.0	156.0	250.0	111.9	117.2	118.0	140.6	156.9	28.0	130.6	284.9	114.9	67.8	92.8	95.8	148.2	95.3	79.4	163.5	32.0	31.3	105.9	175.0	105.0	112.4	72.1	88.3	110.2	94.3	30.0	125.8	64.9	71.1	26.7	40.8	143.9	61.4	97.8	111.9	200.3	67.9	165.2	143.1	63.3	92.1	117.2	297.8	338.8	153.2	151.2	151.3	180.6	146.6	173.7	138.2	203.8
CCT8	"C21orf112, Cctq, PRED71"	ENSG00000156261	"Chaperonin containing TCP1 subunit 8"	P50990	21	29055805-29073797	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018520, HPA021051, HPA029426"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796"	"unprognostic (3.41e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	72.7	125.0	62.5	99.1	67.0	99.5	100.4	70.3	84.0	78.5	78.0	87.9	77.9	74.8	88.2	83.7	80.9	64.3	116.3	66.9	74.7	102.7	92.7	70.1	140.8	64.5	65.3	88.0	95.3	100.0	40.6	107.0	69.0	77.1	102.1	71.3	70.7	72.5	121.1	75.0	78.6	85.5	66.7	88.9	68.8	79.1	68.7	141.2	78.5	145.2	154.3	122.3	50.3	66.1	437.4	243.1	319.4	233.3	220.4	302.3	350.9	340.5	219.1	386.2	317.5	548.6	269.0	858.8	229.1	237.1	466.8	174.4	632.2	391.7	441.1	364.0	348.1	1185.2	289.8	384.3	227.0	609.0	335.6	229.0	244.9	448.6	372.6	278.6	368.1	379.7	935.8	519.0	404.1	270.9	456.6	359.4	572.6	433.6	310.6	411.7	596.5	547.4	409.1	283.2	316.7	231.6	334.1	356.6	364.7	347.5	319.9	526.7	267.4	221.3	613.7	216.7	439.7	329.2	651.8	695.1	256.3	704.5	339.0	79.9	110.1	54.4	56.9	120.9	79.6	79.8	76.3	73.4	133.3	61.8	85.5	82.1	11.5	87.7	132.2	83.5	92.7	127.4	62.5	67.0	70.3	84.0	66.9	74.7	64.5	65.3	69.0	66.7	68.7	66.1	66.9	64.1	61.7	15.0	120.1	143.1	197.6	278.6	70.0	85.6	88.4	76.5	75.7	90.1	150.0	75.4	18.8	268.9	122.1	67.3	144.8	194.1	17.0	106.6	92.8	94.8	97.0	150.2	26.7	138.0	275.8	93.4	52.0	73.7	112.8	135.6	55.3	53.4	170.5	77.4	31.3	106.2	201.4	115.6	122.4	20.5	84.2	109.9	115.6	26.2	226.6	96.1	97.9	13.6	21.4	131.2	92.1	92.9	130.7	185.9	107.4	189.7	147.7	84.6	105.2	88.7	214.7	170.1	176.8	90.2	131.4	285.3	105.1	254.5	161.1	170.6
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.9;lymphoid tissue: 31.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 27.5;Breast myoepithelial cells: 20.3;Excitatory neurons: 18.9;Inhibitory neurons: 16.6;Melanocytes: 14.2;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 10.8;HDLM-2: 10.1;HUVEC TERT2: 10.6;TIME: 10.1;U-87 MG: 22.7"									HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA		660000		"Cluster 14: B-cells - Humoral immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 30: Mammary glandular cells - Lactation"	"Centrosome, Cytosol"	Nucleoplasm	"HPA015663: AB_2072575"	"unprognostic (1.25e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.26e-6)"	"unprognostic (8.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-1)"	7.5	2.0	0.6	6.4	0.7	0.1	3.7	0.4	1.4	2.0	1.3	14.6	8.6	0.9	0.6	3.0	0.7	4.2	1.3	0.6	0.5	0.7	2.6	2.7	8.0	1.7	1.3	0.3	0.4	0.3	0.5	10.6	1.8	0.5	21.9	1.8	0.8	1.2	0.4	0.6	18.5	3.2	1.2	31.8	4.5	4.1	3.6	4.6	0.7	0.9	6.3	6.1	0.3	1.0	0.2	0.5	0.3	0.0	1.1	0.4	0.0	1.0	2.1	0.2	0.9	0.0	1.7	0.0	0.4	1.0	10.8	0.0	0.0	1.4	1.6	10.1	0.0	0.0	0.6	1.6	0.0	0.7	0.1	0.3	0.0	0.3	3.9	0.7	10.6	0.0	0.2	5.6	6.3	0.0	0.0	8.1	0.2	0.0	0.0	1.9	1.8	2.2	0.0	0.0	1.4	6.5	5.1	8.0	0.0	0.4	0.0	6.6	10.1	3.5	3.2	0.3	0.0	0.1	0.1	0.0	22.7	0.5	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	1.4	0.6	0.5	1.7	1.3	1.8	1.2	3.6	1.0	4.1	0.0	0.0	2.6	0.3	1.3	0.0	1.1	0.0	2.5	27.5	20.3	0.7	0.0	2.1	0.0	4.2	0.1	0.5	0.4	0.0	0.0	3.1	0.0	0.1	2.5	0.0	0.0	18.9	1.4	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.4	9.1	0.0	16.6	0.1	4.1	4.1	5.2	1.5	0.0	6.4	14.2	7.5	0.2	1.1	0.0	4.5	2.4	3.3	2.6	0.0	1.2	0.0	0.0	0.1	1.2	2.1	19.7	2.1	10.5	3.4	0.8	0.1	1.3	0.3	0.3	0.0	0.1	0.1
CD180	"LY64, Ly78, RP105"	ENSG00000134061	"CD180 molecule"	Q99467	5	67179613-67196799	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 53.6;Hofbauer cells: 78.6;Kupffer cells: 23.5;Macrophages: 17.5;monocytes: 13.8;Plasma cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 77.0;naive B-cell: 78.9"	"Group enriched"	"Detected in many"	25	"B-cells: 78.9;dendritic cells: 23.5;monocytes: 34.5"	"Group enriched"	"Detected in some"	10	"Daudi: 45.2;Karpas-707: 41.1;U-266/70: 33.1;U-266/84: 49.0;U-698: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003740	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Mitotic spindle"		Yes	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nucleoli, Mitotic spindle"	"HPA003740: AB_1078450"	"unprognostic (9.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.85e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	1.6	0.7	0.7	9.7	0.7	2.4	6.7	0.6	1.2	0.5	0.4	2.1	2.0	0.5	0.2	0.4	0.4	1.6	0.4	0.8	0.7	0.3	2.5	1.6	23.2	1.5	1.5	0.2	0.3	0.2	0.1	3.2	2.0	0.5	2.7	0.3	1.1	0.4	0.1	0.2	3.9	1.8	1.0	12.9	2.2	0.4	1.8	2.5	0.3	0.2	23.3	3.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.6	0.2	33.1	49.0	12.3	0.0	2.7	0.0	0.3	11.8	0.9	0.0	20.4	0.0	77.0	0.1	0.1	22.1	78.9	0.0	0.0	0.9	1.8	34.5	23.5	0.1	8.5	0.7	0.7	0.6	1.2	0.8	0.7	1.5	1.5	2.0	1.0	1.8	2.1	0.1	0.0	0.5	0.3	53.6	0.4	0.1	0.0	0.0	0.1	1.8	1.1	0.7	1.5	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	2.2	0.1	0.0	0.6	0.0	1.7	0.0	0.2	0.3	0.4	0.0	0.1	2.5	0.0	0.0	0.3	78.6	0.0	0.0	0.0	0.0	23.5	8.0	1.0	0.0	17.5	0.0	1.9	13.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	39.6	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.7	2.2	0.0	0.1	0.1
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 249.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2"	"Group enriched"	"Detected in all"	10	"NK-cells: 1108.0;T-cells: 714.1"	"Group enriched"	"Detected in some"	25	"HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	4.6	4.6	0.6	51.3	0.7	11.4	7.6	0.6	1.0	5.8	0.8	13.9	17.2	3.7	2.8	8.4	4.2	16.8	2.6	0.5	0.8	2.5	7.8	21.0	119.6	1.7	0.7	2.8	2.9	0.9	0.7	1.0	1.1	5.2	16.0	0.0	8.6	2.3	1.4	3.5	28.4	4.4	1.0	44.1	24.1	1.8	1.0	249.8	3.8	1.7	79.1	20.8	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.1	0.0	0.4	0.0	0.0	0.0	0.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.1	0.5	0.0	0.0	166.9	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.4	0.0	11.3	5.2	1.6	421.8	3.7	403.1	3.8	610.2	714.1	95.4	2.5	316.3	486.2	14.1	1108.0	2.8	21.0	655.2	565.1	0.6	0.7	0.6	1.0	0.5	0.8	1.7	0.7	1.1	1.0	1.0	1.1	5.0	3.2	17.5	0.0	12.3	5.0	0.4	0.0	2.2	0.0	4.0	4.7	2.1	0.0	2.5	3.7	0.0	0.1	158.3	0.2	0.0	0.5	23.5	1.1	1.0	2.9	3.0	24.0	0.0	0.0	0.0	2.5	10.7	0.9	5.1	0.0	8.2	1.5	0.6	0.0	0.0	0.0	0.0	10.9	16.6	7.8	0.6	19.1	1.8	1.0	15.5	0.0	178.2	0.0	0.0	0.0	0.0	0.4	42.3	0.1	0.0	1.7	0.0	0.0	0.0	2.9	4.1	0.3	0.2	0.4	3.7	0.0	476.8	0.0	0.5	0.2
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 20.2;parathyroid gland: 62.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 52.1;Macrophages: 24.4;Microglial cells: 22.5;NK-cells: 90.6;Oligodendrocytes: 26.6;T-cells: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 29.7;T-cells: 36.6"	"Group enriched"	"Detected in some"	6	"HEL: 100.0;HMC-1: 42.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	No		20000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.1	0.6	1.1	5.7	6.4	4.4	1.5	1.5	2.4	1.1	0.0	1.8	2.3	1.3	0.5	1.6	1.3	3.0	0.5	0.7	2.0	1.5	4.2	4.2	9.7	3.1	3.3	0.9	0.5	62.4	0.6	0.5	3.2	1.0	2.4	1.4	1.5	0.4	0.7	0.3	3.1	1.6	2.2	20.2	3.2	1.2	5.5	6.4	0.7	0.6	7.1	3.1	0.4	3.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.4	0.2	5.3	0.1	100.0	0.3	0.1	0.0	0.7	42.6	0.0	1.1	0.2	0.6	0.2	0.0	0.9	0.3	9.3	0.4	0.0	0.8	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.8	0.3	0.1	0.2	11.5	0.4	0.0	0.3	0.2	0.5	0.3	0.1	1.2	36.6	1.0	13.4	0.8	28.8	22.5	2.9	0.1	15.8	17.3	1.6	29.7	1.3	0.1	11.3	13.2	1.1	6.4	1.5	2.4	0.7	2.0	3.1	3.3	3.2	2.2	5.5	3.2	0.6	3.2	3.6	3.3	3.2	0.0	0.3	0.0	0.0	3.4	0.5	0.8	2.5	0.0	0.7	0.0	0.0	0.1	52.1	0.2	0.0	0.0	8.4	0.9	1.7	1.0	0.0	3.2	4.6	0.4	0.0	1.3	3.1	0.5	13.9	1.3	3.3	0.4	1.6	0.0	3.1	0.1	0.0	16.7	2.7	8.2	0.9	24.4	0.0	22.5	14.7	0.8	90.6	2.0	26.6	0.2	0.1	0.7	13.4	0.3	0.0	0.3	1.5	3.6	0.0	1.8	0.6	0.4	0.8	0.0	0.4	0.0	43.2	0.5	0.1	0.2
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314494-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 237.3;breast: 155.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 155.4;Fibroblasts: 166.9;Leydig cells: 74.9;Smooth muscle cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive CD8 T-cell: 21.8"	"Lineage enriched"	"Detected in single"	144	"T-cells: 21.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 492.4;ASC TERT1: 481.9;BJ: 222.2;BJ hTERT+: 330.1;fHDF/TERT166: 451.1;HSkMC: 516.8;U-2197: 794.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		43000000	"Cluster 32: T-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA051856: AB_2681640"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (2.69e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-2)"	237.3	12.9	2.3	39.3	2.4	0.4	155.5	2.2	4.0	87.2	1.5	31.7	7.8	52.2	6.9	19.6	60.8	32.3	30.3	2.2	2.2	18.7	3.6	36.5	6.2	2.4	2.6	23.9	11.7	3.3	8.8	67.4	2.2	17.8	7.4	0.4	18.2	19.4	15.8	51.0	27.2	26.5	2.0	7.2	26.3	5.0	3.9	5.3	35.0	6.5	2.6	63.4	61.5	2.0	0.0	0.0	4.9	0.0	492.4	481.9	0.3	222.2	330.1	16.3	15.1	0.1	0.0	0.0	5.8	451.1	0.0	0.0	0.2	0.2	3.5	0.0	0.0	0.0	0.1	3.3	97.5	0.0	0.0	516.8	0.0	21.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.4	3.2	2.5	0.0	1.4	9.5	0.0	0.2	0.0	0.0	2.8	7.6	0.0	1.2	0.0	13.4	0.5	0.4	0.1	0.0	0.8	794.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	2.6	0.0	0.1	3.1	21.8	0.0	0.0	0.0	0.0	0.0	2.5	2.3	2.4	2.2	4.0	2.2	2.2	2.4	2.6	2.2	2.0	3.9	2.0	15.0	0.0	0.0	1.3	1.3	12.5	0.0	0.0	0.6	0.1	1.2	1.5	2.2	0.0	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.2	0.3	5.3	155.4	5.8	0.0	0.0	0.0	0.0	2.5	166.9	13.3	3.1	0.0	0.0	2.5	0.0	6.0	0.0	0.0	0.0	0.0	0.3	14.4	2.3	74.9	1.6	12.4	1.9	0.6	2.9	1.0	0.0	0.0	0.3	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.1	32.9	5.5	59.3	0.1	0.1	0.8	8.2	4.4	6.9	1.1	0.0	0.1
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 27.7;granulocytes: 28.4;Langerhans cells: 50.9;monocytes: 42.4;Syncytiotrophoblasts: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 89.6;HHSteC: 55.5;U-251 MG: 98.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003528, CAB076385"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB076385: AB_2687655, HPA003528: "	"prognostic favorable (8.89e-4)"	"unprognostic (4.54e-2)"	"prognostic favorable (1.64e-5)"	"unprognostic (1.27e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.67e-4)"	"unprognostic (7.39e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.02e-2)"	2.6	2.0	1.0	10.3	0.9	1.9	1.5	0.9	1.2	1.8	0.6	1.4	2.7	1.5	1.8	2.5	1.8	4.0	8.9	0.8	1.9	2.6	3.4	16.8	6.6	1.8	1.6	1.5	1.9	5.0	2.6	6.8	2.0	2.0	2.1	1.2	1.5	1.5	4.5	0.7	1.9	2.2	1.7	10.2	1.9	0.9	1.6	13.0	3.5	4.3	5.3	7.2	1.3	1.1	15.6	0.2	0.0	0.5	0.1	0.1	0.0	30.5	25.7	7.7	10.4	0.0	5.0	0.2	0.6	0.8	3.8	0.6	0.0	13.2	24.6	89.6	0.0	9.0	0.3	0.0	55.5	0.0	0.0	0.5	0.1	15.7	22.9	7.7	15.0	0.9	0.0	2.9	23.4	0.0	0.4	0.1	0.0	0.0	0.3	0.1	4.2	0.8	1.6	0.3	0.0	0.3	0.4	2.4	1.9	2.2	0.1	0.3	28.1	16.1	5.1	0.5	98.1	0.5	0.2	0.3	5.4	0.3	0.2	6.6	0.0	0.2	0.7	0.1	1.2	0.5	1.4	1.1	0.0	0.1	0.7	0.4	3.6	0.3	0.0	0.0	0.7	0.4	1.0	0.9	0.9	1.2	0.8	1.9	1.8	1.6	2.0	1.7	1.6	1.1	3.0	12.8	11.4	0.7	1.9	4.6	1.5	4.4	1.8	1.4	1.4	1.3	7.8	0.0	2.9	0.0	0.0	6.1	2.4	2.6	0.0	5.9	1.0	1.4	0.3	5.5	0.0	3.2	1.9	4.4	27.7	1.9	0.5	0.9	28.4	0.2	7.1	0.8	5.7	0.0	3.3	0.5	4.1	2.9	50.9	0.2	0.3	4.2	3.6	8.4	42.4	0.5	1.0	1.0	0.9	19.0	0.1	0.4	2.2	2.1	1.9	0.4	4.0	0.2	0.0	2.3	0.9	1.0	0.8	1.2	2.6	44.5	3.1	0.1	0.4	2.0
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.4;lymphoid tissue: 23.9"	"Group enriched"	"Detected in some"	6	"granulocytes: 76.0;Hofbauer cells: 78.8;Kupffer cells: 131.2;Langerhans cells: 41.4;Macrophages: 53.5;monocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 166.5;intermediate monocyte: 122.0;myeloid DC: 213.5;non-classical monocyte: 57.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 213.5;monocytes: 166.5"	"Cell line enhanced"	"Detected in some"		"HEL: 86.1;HL-60: 115.6;HMC-1: 82.4;NB-4: 55.2;RPMI-8226: 62.5;THP-1: 67.0;U-937: 84.1"									"CAB011442, HPA035832, HPA064807, CAB079996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		3400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane"		"CAB011442: , CAB079996: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	7.9	3.4	1.1	11.2	1.2	32.4	2.5	1.5	1.6	3.0	2.5	3.2	3.3	1.7	1.3	2.0	2.5	6.6	2.0	1.1	1.8	1.4	5.5	12.6	10.1	2.5	1.6	1.4	1.4	1.2	0.9	6.9	2.4	1.4	4.2	0.2	1.8	2.6	0.9	2.7	4.4	7.1	1.9	23.9	2.3	1.0	2.3	3.5	0.9	0.8	3.5	6.2	1.3	3.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	5.5	0.4	0.0	1.3	0.3	0.0	0.2	0.0	0.1	0.1	86.1	0.3	0.0	0.0	115.6	82.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	16.2	21.2	0.2	0.0	0.0	55.2	0.2	0.0	25.9	0.0	4.4	62.5	0.4	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	67.0	0.7	14.0	1.1	1.8	0.1	0.3	7.6	0.2	9.6	84.1	0.4	17.9	166.5	11.0	0.3	122.0	0.4	0.1	0.2	0.5	213.5	0.4	0.3	0.2	20.5	15.5	57.8	6.3	1.1	77.8	1.1	1.2	1.5	1.6	1.1	1.8	2.5	1.6	2.4	1.9	2.3	3.6	0.7	0.0	6.7	0.0	1.0	1.8	0.5	0.0	0.0	0.2	1.4	0.4	0.8	0.0	0.6	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.7	0.1	0.1	3.0	0.0	4.2	0.0	0.0	0.5	1.1	0.0	0.1	76.0	0.1	5.3	0.7	78.8	0.0	0.0	0.0	0.0	131.2	41.4	1.7	0.3	53.5	1.8	11.2	65.0	0.2	1.0	0.5	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.2	0.7	0.6	0.0	1.1	0.3	0.7	0.5	0.0	1.0	0.8	2.5	0.1	0.0	0.4
CD34		ENSG00000174059	"CD34 molecule"	P28906	1	207880972-207911402	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Adipocytes: 298.7;Endothelial cells: 292.4;Fibroblasts: 121.9;Hepatic stellate cells: 136.0;Leydig cells: 146.3;Peritubular cells: 123.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 64.3;MOLT-4: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000018, HPA036722, HPA036723"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		93000000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272"	"unprognostic (3.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (1.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.01e-2)"	202.7	28.5	29.2	13.9	28.8	5.7	122.3	27.3	34.2	95.4	21.0	54.2	13.5	71.6	42.3	28.9	82.8	54.3	153.2	25.1	27.5	49.4	5.6	69.1	18.1	29.8	29.5	35.4	18.9	21.8	10.1	219.5	30.8	36.2	19.3	2.3	37.4	33.2	58.5	67.5	39.3	75.5	24.8	21.7	34.4	20.2	32.9	19.0	79.5	68.2	17.1	74.0	61.6	28.0	0.0	0.0	0.2	0.0	3.2	0.3	0.2	0.4	2.4	0.7	1.7	0.0	0.0	0.0	6.2	0.7	0.2	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.7	64.3	1.1	0.0	0.0	1.7	0.0	66.5	0.3	0.5	0.0	0.0	0.1	3.7	0.0	0.3	0.0	0.1	0.2	0.0	0.6	0.1	0.4	2.3	0.0	9.9	0.2	2.8	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	29.2	28.8	27.3	34.2	25.1	27.5	29.8	29.5	30.8	24.8	32.9	28.0	298.7	3.2	7.8	1.6	1.0	16.7	0.2	0.3	4.6	0.6	2.1	3.0	21.9	2.8	0.1	3.7	2.1	0.2	1.5	0.0	0.0	0.5	11.6	1.0	5.2	292.4	0.0	22.3	0.2	0.2	0.3	121.9	0.5	1.0	1.3	0.1	136.0	0.6	0.4	0.0	0.1	0.0	0.0	1.2	21.8	5.0	146.3	2.4	17.8	33.7	0.3	0.2	0.0	0.5	0.3	0.2	0.0	123.0	1.6	0.3	0.0	0.1	0.0	0.2	6.6	7.7	15.2	1.0	2.0	1.5	12.9	0.1	2.2	4.0	0.0	0.3
CD70	"CD27L, CD27LG, TNFSF7"	ENSG00000125726	"CD70 molecule"	P32970	19	6583183-6604103	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	4	"monocytes: 239.4"	"Cancer enriched"	"Detected in many"	4	"renal cancer: 24.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 44.2"	"Group enriched"	"Detected in many"	35	"B-cells: 24.2;T-cells: 44.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 189.2;THP-1: 157.3;U-251 MG: 234.2;U-266/70: 399.5;U-266/84: 312.7;U-698: 138.1"	"Region enriched"	"Detected in single"	25	"cerebellum: 11.3"	"Low region specificity"	"Detected in all"			HPA046582			Uncertain	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA046582: "	"unprognostic (8.71e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (2.57e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	2.4	0.1	0.1	3.2	0.1	0.8	1.1	0.5	0.3	0.4	0.3	2.2	0.5	0.1	0.0	0.7	0.2	0.4	0.1	0.1	0.2	0.5	0.2	0.8	3.4	0.2	0.2	0.1	0.3	0.0	0.1	0.1	0.2	0.2	1.5	0.0	0.2	0.0	0.3	1.4	2.2	0.1	0.0	2.9	1.0	0.3	0.1	1.5	0.3	0.9	1.9	1.1	0.5	0.4	1.3	39.1	0.1	75.6	1.7	1.0	0.1	0.0	0.3	0.3	2.6	0.1	0.5	74.2	4.1	0.4	81.8	53.2	46.5	3.6	0.0	0.2	1.6	0.0	56.8	0.1	0.0	0.0	2.2	0.5	0.4	43.9	31.1	12.2	0.3	0.1	1.3	2.5	1.1	0.2	1.3	94.3	0.9	0.0	70.0	20.3	0.1	16.3	24.6	0.2	0.0	0.0	189.2	0.0	0.8	0.2	0.5	157.3	1.0	0.6	32.6	0.0	234.2	399.5	312.7	138.1	41.0	23.8	14.8	0.8	0.1	0.1	3.3	0.0	8.1	24.2	5.3	8.8	0.1	9.9	0.7	2.1	0.2	0.9	0.0	0.3	44.2	1.6	0.1	0.1	0.5	0.3	0.1	0.2	0.2	0.2	0.2	0.0	0.1	0.4	0.6	0.0	0.0	0.0	50.9	5.7	0.1	11.1	0.0	0.0	0.1	0.3	0.2	0.0	0.3	1.8	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.4	0.0	1.6	1.8	0.0	0.1	0.7	0.0	11.3	0.5	0.2	1.3	0.1	0.7	0.3	0.4	0.0	0.7	0.0	18.3	0.6	14.6	0.0	0.0	3.0	3.6	0.0	239.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	24.9	0.2	0.0	0.2	0.7	0.0	0.0	0.4	0.9	0.2	0.6	0.4	5.4	0.0	14.1	0.0	0.4	0.0
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609979-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 65.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 95.6;dendritic cells: 18.3;Hofbauer cells: 18.7;Kupffer cells: 25.6;Macrophages: 21.1;NK-cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"memory B-cell: 232.9;naive B-cell: 413.5"	"Lineage enriched"	"Detected in all"	20	"B-cells: 413.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.4;Karpas-707: 14.5;REH: 7.8;U-698: 44.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 4.1"	"Low region specificity"	"Detected in single"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"	4.5	2.3	1.9	20.6	2.0	6.7	1.7	2.0	3.3	1.4	4.2	1.9	1.3	1.0	4.8	0.6	1.2	4.1	0.7	1.8	1.8	2.2	6.0	2.8	65.0	2.8	1.8	0.8	2.2	1.1	2.5	3.3	2.4	1.5	1.3	0.4	1.6	0.7	0.6	2.0	8.4	1.6	1.9	53.6	2.6	0.8	3.3	6.9	2.4	0.0	50.2	4.2	0.9	2.3	0.1	0.0	0.6	0.5	0.9	5.2	0.1	0.3	0.1	0.4	0.7	0.0	0.2	21.4	0.1	0.3	0.1	0.0	0.0	0.1	0.5	1.8	0.4	0.6	0.2	0.0	0.5	0.3	4.1	1.5	0.0	0.2	0.4	0.9	0.0	4.9	0.0	14.5	1.1	0.0	0.3	2.7	0.2	0.0	0.1	7.8	0.0	5.5	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.3	0.2	0.2	0.1	0.7	0.2	0.2	0.0	0.3	0.3	44.4	0.8	0.5	0.0	0.6	2.0	0.3	3.1	3.5	4.3	232.9	1.5	2.2	20.2	413.5	0.7	2.4	1.4	10.6	0.5	11.0	1.7	14.8	1.9	2.0	2.0	3.3	1.8	1.8	2.8	1.8	2.4	1.9	3.3	2.3	0.7	0.0	0.6	5.9	95.6	1.0	0.5	0.9	0.6	0.0	1.3	1.3	1.1	1.5	0.4	3.7	0.0	0.2	18.3	0.7	0.0	0.8	0.2	0.4	0.6	0.9	1.8	2.7	1.0	0.7	0.3	0.9	1.1	0.4	0.0	0.8	0.7	0.2	18.7	0.0	1.2	0.2	0.0	25.6	14.6	0.3	0.9	21.1	0.0	0.0	3.0	0.6	19.6	2.0	4.4	1.1	0.0	0.4	2.7	0.5	0.6	0.7	1.3	0.7	0.0	0.5	0.9	1.1	1.7	0.2	1.1	0.3	5.9	0.5	0.4	0.4
CD79B	"B29, IGB"	ENSG00000007312	"CD79b molecule"	P40259	17	63928740-63932336	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 266.7"	"Cell type enriched"	"Detected in many"	4	"B-cells: 491.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"memory B-cell: 1132.1;naive B-cell: 1505.8"	"Lineage enriched"	"Detected in all"	5	"B-cells: 1505.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1060.0;REH: 350.2;U-698: 1475.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751, HPA044107"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: "	"unprognostic (3.90e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.22e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.75e-1)"	5.0	1.7	0.9	70.5	0.9	54.6	3.4	0.9	1.4	1.9	1.7	7.7	4.7	1.4	1.6	2.6	1.5	6.8	12.3	0.9	0.9	4.7	3.4	4.9	266.7	1.0	0.9	0.6	0.7	0.7	25.3	3.8	0.9	2.5	7.2	0.0	7.8	0.8	3.4	2.4	66.2	2.6	0.9	147.7	10.7	1.0	1.0	27.1	4.1	5.8	208.4	13.4	2.2	1.0	1.8	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	1060.0	7.8	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.0	2.7	0.0	0.4	0.6	0.6	0.5	0.0	0.0	0.1	0.0	0.0	1.2	0.4	1.2	56.9	0.0	0.0	0.6	23.0	0.3	0.0	0.0	350.2	0.9	4.4	0.0	0.0	0.5	0.0	1.7	0.0	0.7	5.8	0.0	16.2	1.7	0.1	3.7	0.3	0.6	51.3	54.4	1475.5	0.0	2.2	0.0	6.2	13.0	1.1	44.9	192.2	51.3	1132.1	57.1	30.1	47.0	1505.8	38.4	23.2	5.8	42.4	304.3	6.7	107.9	112.1	0.9	0.9	0.9	1.4	0.9	0.9	1.0	0.9	0.9	0.9	1.0	1.0	24.9	0.0	1.3	0.0	491.9	4.5	0.4	0.0	1.8	0.0	1.1	4.4	1.4	1.5	0.0	0.0	0.0	0.2	24.2	0.3	0.0	0.1	0.6	0.3	1.0	25.2	1.2	8.6	0.0	0.0	0.4	3.3	0.5	0.3	15.2	0.0	51.4	1.3	5.8	0.0	0.0	0.4	0.0	14.8	5.1	1.4	1.2	13.4	21.4	0.0	14.3	0.0	36.0	0.0	0.0	0.0	0.1	1.9	99.6	0.4	0.0	1.0	0.0	0.0	0.0	4.4	5.4	1.2	0.3	0.7	3.1	0.4	27.0	0.5	0.8	0.2
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20589086-20618903	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 193.5;esophagus: 87.1;liver: 86.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 364.9;Hepatocytes: 107.8;Pancreatic endocrine cells: 120.2;Paneth cells: 400.5;Proximal enterocytes: 137.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 1234.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1234.7"	"Cell line enhanced"	"Detected in many"		"A-431: 200.3;CAPAN-2: 141.9;HeLa: 207.1;PC-3: 107.0;SiHa: 249.9;U-937: 96.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA064202	Enhanced		Approved	Nucleoplasm		NA	NA		3700000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	7.1	3.0	8.0	9.6	8.1	193.5	3.7	8.3	10.6	19.7	7.4	23.7	6.4	5.3	5.5	87.1	6.4	4.3	6.7	7.9	8.3	14.0	86.7	7.1	1.5	9.0	8.2	1.5	0.8	3.2	1.2	10.8	9.5	4.3	27.8	0.5	15.0	3.1	1.7	17.1	16.3	11.3	8.3	23.4	2.1	1.0	8.9	2.0	4.5	6.4	4.4	5.5	38.5	8.7	200.3	21.4	0.0	0.0	0.2	5.5	0.0	16.7	4.3	4.1	16.2	1.0	141.9	0.0	8.1	30.8	8.7	63.9	4.5	46.8	10.7	0.1	3.9	0.0	207.1	34.4	1.4	0.0	0.0	8.8	8.9	31.4	0.0	0.5	2.7	0.0	0.0	0.0	1.6	0.2	0.0	1.0	0.1	24.7	107.0	0.0	0.1	3.4	1.5	0.0	0.1	0.0	249.9	0.0	0.3	2.2	0.0	4.3	3.4	0.2	8.3	18.5	1.2	0.0	0.1	0.0	2.4	96.9	0.0	216.2	207.2	471.1	0.5	124.7	0.8	0.1	0.4	0.9	12.7	0.2	0.3	0.4	1234.7	0.4	110.8	3.1	0.7	86.8	8.0	8.1	8.3	10.6	7.9	8.3	9.0	8.2	9.5	8.3	8.9	8.7	9.9	3.2	1.1	0.3	1.2	1.5	0.1	2.4	0.0	0.2	0.2	0.3	2.6	1.5	2.7	5.5	0.0	1.1	0.0	364.9	43.0	7.5	0.8	2.1	2.6	42.7	0.0	6.1	0.2	1.5	6.4	9.1	0.0	20.3	0.0	0.0	47.2	107.8	5.9	0.0	0.3	23.1	85.5	60.7	0.9	1.0	0.3	36.6	0.0	5.6	61.5	0.1	0.0	0.5	0.0	120.2	400.5	0.0	3.0	2.1	137.6	0.6	0.4	0.1	0.0	1.3	1.3	0.0	1.2	6.3	1.1	2.5	1.7	0.0	19.8	0.8
CDADC1	NYD-SP15	ENSG00000102543	"Cytidine and dCMP deaminase domain containing 1"	Q9BWV3	13	49247925-49293485	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 174.6;Late spermatids: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047615, HPA058314"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA047615: AB_2680104, HPA058314: AB_2683677"	"unprognostic (2.81e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (6.03e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.40e-2)"	"unprognostic (8.27e-3)"	5.0	6.8	4.9	2.3	4.5	6.3	4.2	5.8	6.5	4.0	5.8	4.7	3.1	3.8	5.1	3.2	4.2	2.7	4.3	4.5	5.5	9.5	8.1	3.5	3.1	4.9	5.4	4.5	2.7	5.5	3.2	2.0	5.1	3.9	3.2	5.2	3.4	4.4	4.4	2.2	3.0	3.7	4.7	4.1	3.9	7.9	5.6	4.3	9.4	5.2	2.6	3.5	3.6	5.4	2.1	2.6	2.2	2.7	10.8	5.9	1.1	5.0	3.1	2.5	2.6	2.6	1.7	2.9	1.0	2.2	2.4	3.6	4.6	2.2	3.2	6.3	3.7	3.3	2.5	2.7	4.7	6.3	1.7	4.1	5.5	2.3	3.0	4.4	3.7	5.6	2.1	2.1	3.2	0.7	6.0	5.1	0.8	3.6	2.2	4.0	2.4	2.9	3.6	0.7	1.3	1.1	3.4	2.1	2.9	1.4	1.5	5.4	2.8	1.3	2.4	3.5	2.4	0.6	2.4	1.8	1.1	7.2	3.7	9.9	1.1	0.9	1.4	0.9	1.5	0.4	1.0	1.9	0.8	0.6	0.9	1.3	1.2	1.2	1.8	0.8	1.6	0.9	4.9	4.5	5.8	6.5	4.5	5.5	4.9	5.4	5.1	4.7	5.6	5.4	12.4	6.4	12.4	9.4	6.6	8.0	7.3	10.7	11.4	12.7	8.5	9.7	15.0	5.7	8.6	18.4	12.5	4.6	19.1	4.7	9.8	5.3	174.6	12.6	14.6	8.7	6.7	10.3	16.0	10.7	10.9	17.1	6.6	6.0	24.7	10.0	11.7	11.5	6.2	3.3	21.4	6.9	4.1	9.1	8.3	77.7	15.8	9.9	7.2	3.7	5.4	25.9	9.2	14.1	12.4	6.7	5.7	14.3	10.6	7.3	7.9	25.4	18.9	12.2	0.0	15.3	17.8	39.3	15.5	7.7	5.4	2.5	14.1	17.2	6.0	5.7
CDC123	"C10orf7, D123"	ENSG00000151465	"Cell division cycle 123"	O75794	10	12195965-12250589	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037830, HPA057540"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA037830: AB_10671368, HPA057540: AB_2732614"	"unprognostic (5.35e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.16e-7)"	"unprognostic (2.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (5.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.19e-2)"	44.9	40.0	38.1	53.8	44.3	73.5	45.9	40.6	46.1	43.5	39.1	54.1	37.1	39.0	46.9	50.1	42.3	34.0	61.0	41.7	41.5	42.6	55.6	35.8	69.1	40.3	38.4	31.4	29.4	42.3	33.0	50.8	40.5	35.4	58.3	29.7	31.5	39.3	49.7	44.3	39.1	53.4	41.3	45.3	35.4	35.7	40.1	65.2	41.5	52.5	81.1	63.6	34.7	43.7	155.4	187.4	148.3	157.1	125.4	136.3	117.7	137.0	94.2	194.8	205.5	274.0	186.5	259.7	123.5	153.6	116.1	157.7	237.0	223.3	172.0	176.8	206.6	199.3	142.8	266.6	162.1	151.6	159.0	131.3	118.9	214.0	126.5	98.0	206.3	320.6	224.2	114.5	178.6	135.0	208.3	133.8	221.4	223.1	76.3	195.7	111.9	234.0	173.2	86.3	72.3	140.8	139.6	165.4	152.6	120.4	180.7	179.2	200.9	107.7	127.6	167.9	166.6	112.5	233.5	320.7	135.4	155.3	69.7	133.8	99.2	242.2	103.6	117.0	108.1	158.6	114.8	115.0	139.0	170.5	93.5	99.9	233.4	121.1	129.4	116.0	143.5	167.3	38.1	44.3	40.6	46.1	41.7	41.5	40.3	38.4	40.5	41.3	40.1	43.7	48.6	32.1	35.9	18.3	51.5	54.2	49.2	162.1	39.9	28.5	28.0	32.3	56.4	24.3	75.8	35.0	6.2	120.8	55.3	25.1	86.1	91.1	7.9	26.8	39.5	49.7	20.9	36.8	33.2	82.6	138.2	46.3	26.5	26.1	49.4	36.6	34.2	37.6	101.3	26.9	27.9	31.9	105.8	25.9	34.0	10.1	41.7	37.2	46.2	21.5	79.3	43.3	45.3	19.6	23.5	84.3	34.3	45.9	44.2	46.5	30.7	73.0	62.5	29.9	39.5	32.3	59.8	50.2	41.5	46.5	74.0	77.6	51.3	72.4	47.0	50.7
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDC14B	"Cdc14B1, Cdc14B2, CDC14B3, hCDC14B"	ENSG00000081377	"Cell division cycle 14B"	O60729	9	96490241-96619843	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.5;Excitatory neurons: 83.5;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 156.9;Oligodendrocytes: 273.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064747			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA064747: AB_2732719"	"unprognostic (5.69e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (2.97e-10)"	"unprognostic (2.01e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (7.40e-2)"	4.3	2.3	11.1	1.1	15.8	3.0	3.0	6.1	11.7	2.9	1.4	3.1	2.8	1.3	2.0	1.4	4.2	2.9	5.0	5.2	6.9	5.5	10.3	3.0	0.9	11.0	12.1	3.4	4.6	6.9	1.1	2.0	11.4	3.3	3.3	1.7	1.8	4.1	0.7	0.8	3.3	1.7	10.4	0.8	6.1	9.3	11.4	2.9	8.5	1.4	1.2	4.1	0.8	27.3	7.4	4.1	4.2	4.4	20.2	30.1	11.6	5.3	7.0	3.5	5.6	14.0	11.6	0.0	5.0	11.3	8.4	8.1	6.1	4.0	4.1	1.9	5.8	1.1	1.5	11.2	3.3	0.0	0.2	12.4	2.1	3.7	3.4	4.0	0.7	0.0	4.4	0.8	4.8	3.5	0.0	1.2	7.9	8.4	3.6	0.0	2.6	0.2	5.4	11.3	1.3	6.6	3.7	1.1	2.0	14.2	0.9	2.3	2.2	3.5	4.1	9.0	3.9	0.1	0.0	0.0	3.7	0.0	8.3	10.4	0.0	2.2	2.0	0.0	1.0	1.1	0.8	1.5	0.0	0.4	1.4	0.9	0.0	0.1	0.0	0.0	1.1	0.6	11.1	15.8	6.1	11.7	5.2	6.9	11.0	12.1	11.4	10.4	11.4	27.3	4.0	6.4	8.8	86.5	3.7	9.1	8.9	4.4	9.1	7.2	8.4	6.1	17.9	11.5	11.4	9.2	8.4	6.4	2.3	7.1	7.9	5.5	36.9	27.4	7.5	6.2	2.4	0.4	83.5	6.5	3.0	17.3	21.4	33.9	14.5	2.9	6.8	31.2	11.3	8.4	110.2	9.0	8.2	1.6	6.7	33.3	9.0	5.5	8.8	56.2	2.4	12.8	2.1	156.9	273.9	8.6	7.3	11.7	8.3	10.8	16.9	17.0	15.7	12.4	26.3	18.6	15.7	10.8	7.3	4.7	7.7	3.4	4.4	1.2	8.6	13.2
CDC14C	"CDC14B2, CDC14Bretro, CDC14CP, MGC26484"	ENSG00000218305	"Cell division cycle 14C"	A4D256	7	48919765-48927454	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 2.0;testis: 7.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA064747			Uncertain	Nucleoplasm		NA	NA						"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA064747: AB_2732719"					"unprognostic (1.95e-1)"									"unprognostic (1.75e-1)"				0.1	0.0	0.3	0.2	0.3	0.4	0.1	0.9	0.4	0.0	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.2	0.0		0.1	0.2	0.1	0.1	2.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.1	7.2	0.5	0.0	0.1	0.0	0.0	0.0		0.4	0.2	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.2	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.4	0.3	0.2	0.2	0.1	0.0	0.2	0.2	0.0	0.3	0.3	0.9	0.4	0.5	0.4	0.2	0.3	0.2	0.0	0.5	0.4	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358981-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 52.6;testis: 49.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.6	1.5	0.6	16.2	1.1	53.9	5.2	0.8	1.3	3.5	0.4	14.8	13.7	2.3	2.5	27.2	1.7	1.2	0.9	0.7	1.1	2.3	1.7	2.5	32.6	1.3	1.1	0.7	0.6	0.2	0.3	9.7	1.1	0.8	16.0	0.2	4.4	0.7	0.3	11.3	12.2	7.3	0.8	11.7	7.0	49.1	1.7	52.6	1.7	0.2	50.8	3.3	7.0	1.3	311.9	148.2	202.8	133.4	6.9	17.6	193.5	140.3	125.0	400.0	211.4	234.5	250.9	178.3	80.1	130.1	140.6	212.8	225.3	267.9	331.5	140.8	165.6	261.4	143.6	147.3	2.1	184.3	91.4	6.0	12.4	278.2	249.6	35.1	172.2	167.5	120.2	119.3	184.0	120.4	179.2	113.5	257.2	147.0	196.9	255.8	277.9	112.9	98.5	81.3	119.2	58.9	248.1	165.8	76.6	154.9	116.3	231.7	90.2	118.9	276.2	133.7	445.0	90.6	86.7	185.7	85.2	227.6	181.6	0.0	0.1	0.0	0.3	0.0	0.0	4.2	3.2	3.5	0.9	0.9	0.1	0.3	0.7	9.5	0.0	0.2	11.6	2.8	0.6	1.1	0.8	1.3	0.7	1.1	1.3	1.1	1.1	0.8	1.7	1.3	2.1	0.0	1.1	0.0	12.2	10.5	3.8	17.6	6.2	0.5	6.4	9.7	0.7	1.5	4.8	0.0	0.0	65.0	2.8	16.9	0.0	2.2	135.0	14.6	2.4	4.5	0.0	96.0	0.2	0.4	146.2	9.3	11.7	4.6	0.0	46.5	7.9	1.3	37.4	0.0	0.0	18.5	24.4	6.2	7.5	18.5	2.8	9.3	0.0	0.0	1.8	0.3	0.0	0.0	1.6	0.7	0.5	1.9	34.4	2.7	3.2	3.1	8.3	2.9	0.0	1.0	25.4	126.5	39.8	47.3	8.4	10.7	5.1	1.6	37.5	7.4
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188417	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;lymphoid tissue: 8.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.7	0.9	0.8	3.3	0.8	15.3	1.1	0.7	1.0	0.6	0.7	3.5	2.0	0.6	0.9	2.4	0.2	0.3	0.4	0.8	2.0	0.7	0.8	0.3	4.4	1.1	1.9	2.2	0.7	0.8	0.8	2.6	1.7	0.6	3.9	2.0	0.8	0.6	0.4	0.6	1.8	1.1	0.8	2.0	0.9	13.3	2.0	8.8	1.8	0.3	5.6	0.9	0.9	0.7	22.2	10.7	50.0	27.2	1.7	3.2	34.2	29.9	11.3	36.7	29.6	46.8	11.2	64.9	11.4	8.0	23.4	16.3	86.6	20.6	38.6	21.4	45.1	83.8	19.0	23.1	1.7	59.4	23.4	1.7	3.1	45.8	19.6	4.6	14.1	47.8	67.6	33.6	20.1	11.8	74.8	46.6	73.4	20.2	24.2	33.2	32.9	35.1	9.5	20.7	23.5	28.8	18.6	21.6	9.5	31.7	11.3	41.9	7.2	18.0	27.7	20.3	41.4	16.7	54.2	101.5	13.5	65.2	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.0	0.8	2.0	1.1	1.9	1.7	0.8	2.0	0.7	0.3	0.0	0.0	1.0	1.1	0.4	0.4	0.8	1.8	0.5	1.2	1.0	111.2	0.0	0.1	0.0	2.1	4.2	0.2	2.4	0.0	0.4	18.3	0.5	0.9	2.7	1.2	8.0	0.2	0.9	7.4	1.5	1.5	1.3	0.0	4.6	1.4	0.3	3.1	0.0	0.5	2.0	0.0	0.6	0.9	31.8	1.5	0.5	0.0	0.0	0.1	1.1	0.0	0.5	0.0	1.1	0.8	1.9	13.0	0.7	0.4	0.4	0.2	0.4	0.0	0.1	2.2	14.5	16.3	4.3	0.0	0.3	0.6	2.4	4.1	0.5
CDC26	"ANAPC12, APC12, C9orf17"	ENSG00000176386	"Cell division cycle 26"	Q8NHZ8	9	113255835-113275572	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044130	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044130: AB_10963690"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.79e-2)"	42.9	33.1	27.1	34.1	27.4	28.9	39.0	27.3	39.5	34.0	33.8	37.7	30.9	28.2	41.7	34.2	31.0	25.3	52.9	26.3	29.3	49.2	53.1	34.2	42.5	28.1	27.2	33.8	29.9	58.8	29.6	27.7	29.5	36.9	34.2	41.7	32.5	31.8	47.5	36.2	37.2	26.5	29.1	42.0	34.3	22.4	27.7	46.0	35.2	52.4	46.9	40.3	32.7	29.2	47.0	73.3	62.5	32.2	104.4	89.3	29.0	67.1	100.7	67.6	66.3	78.0	53.9	84.1	56.6	58.3	77.2	88.8	53.2	99.1	66.8	80.3	38.9	55.7	71.4	73.1	50.8	99.6	55.0	62.2	68.9	62.5	92.2	70.3	91.7	67.2	85.3	63.7	51.8	94.7	86.2	62.9	102.7	213.1	65.1	73.1	134.3	42.9	71.1	78.2	48.1	45.7	88.4	63.7	51.4	68.2	57.9	43.4	62.1	40.5	37.9	61.4	87.5	43.5	79.5	67.4	57.1	58.3	41.0	239.6	116.9	274.2	177.6	127.3	220.0	233.4	222.3	195.9	122.2	201.0	253.5	195.2	182.8	192.8	122.9	103.8	241.6	171.5	27.1	27.4	27.3	39.5	26.3	29.3	28.1	27.2	29.5	29.1	27.7	29.2	91.9	35.3	40.9	3.3	58.5	77.9	79.3	111.8	68.3	20.3	58.2	79.8	5.3	45.8	61.2	22.0	22.9	45.7	59.6	51.1	113.5	64.4	22.2	53.4	67.4	65.7	31.8	55.2	5.0	59.5	68.6	54.3	21.4	43.3	27.3	48.6	63.1	83.3	58.4	15.2	5.5	50.7	73.2	51.6	92.0	13.9	80.2	49.6	51.6	2.8	67.9	76.7	72.1	5.0	6.7	58.0	62.7	43.6	51.7	91.4	88.9	169.2	68.1	36.4	26.3	54.2	43.7	35.3	16.8	55.0	90.8	47.9	75.4	50.0	47.2	97.7
CDC27	"ANAPC3, APC3, D0S1430E, D17S978E, NUC2"	ENSG00000004897	"Cell division cycle 27"	P30260	17	47117703-47189422	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 149.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016315, HPA028129, HPA052399, HPA065835"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: "	"unprognostic (2.34e-2)"	"unprognostic (8.83e-3)"	"prognostic favorable (1.77e-4)"	"unprognostic (4.26e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.38e-4)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.39e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.66e-2)"	23.0	15.2	9.3	20.1	12.0	27.6	18.1	18.3	15.2	18.0	5.6	15.2	14.6	20.7	13.1	16.6	15.1	18.4	23.3	11.6	12.0	15.2	22.4	18.1	23.4	10.6	10.8	17.0	14.5	24.4	10.6	25.5	11.5	15.1	17.7	13.7	12.2	15.4	22.4	12.1	13.8	24.5	10.5	19.1	15.9	25.0	11.3	25.0	42.4	28.8	24.0	19.8	11.2	11.3	80.7	84.1	69.1	56.1	45.5	72.0	41.0	110.9	99.0	103.3	105.1	54.2	41.4	107.4	72.7	93.5	66.0	37.5	75.2	62.6	141.2	155.5	77.2	125.0	92.9	48.6	49.2	74.4	54.6	52.4	30.2	93.5	73.1	49.7	108.6	61.6	101.6	58.0	85.2	68.3	91.8	33.5	32.8	45.2	67.8	48.9	177.3	47.8	62.0	50.0	45.8	55.9	55.4	19.4	61.2	58.6	58.6	51.7	116.9	107.1	91.9	68.6	82.9	58.8	110.2	95.8	59.4	43.6	76.0	9.3	3.2	4.9	5.3	7.1	5.2	4.0	4.2	5.5	4.2	6.3	4.2	5.0	4.0	8.7	5.3	5.2	8.3	3.5	9.3	12.0	18.3	15.2	11.6	12.0	10.6	10.8	11.5	10.5	11.3	11.3	63.7	9.6	26.3	61.0	28.7	26.0	17.8	25.9	38.1	22.1	21.3	17.5	39.8	21.5	27.1	20.2	16.7	31.4	22.5	11.5	15.6	28.1	28.9	20.8	33.9	50.7	13.8	149.8	124.5	26.5	35.6	41.4	21.4	22.1	26.6	24.8	38.9	27.1	27.2	35.3	104.4	12.8	8.2	28.5	22.1	33.6	28.3	30.6	7.2	83.4	31.5	19.4	35.0	89.0	96.1	30.1	9.5	29.7	39.0	18.7	13.5	23.6	16.2	14.9	19.7	41.6	40.8	97.3	38.6	32.6	26.9	11.5	27.8	34.2	16.2	17.1
CDC34	"E2-CDC34, UBC3, UBE2R1"	ENSG00000099804	"Cell division cycle 34, ubiqiutin conjugating enzyme"	P49427	19	531760-542092	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 249.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002382, CAB005109, CAB047311, HPA074334"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370, HPA074334: "	"unprognostic (4.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.87e-3)"	"unprognostic (9.68e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.33e-2)"	35.1	36.7	52.0	13.3	51.2	34.5	34.2	51.5	63.0	36.9	47.5	62.5	17.8	33.5	14.1	40.5	33.6	10.1	80.0	52.7	48.7	32.1	88.0	32.1	12.5	51.0	50.7	35.6	58.5	18.7	43.4	29.2	50.8	36.9	11.5	28.2	34.2	19.3	105.0	51.8	27.6	18.5	48.2	31.0	38.6	100.2	52.7	16.4	26.7	63.2	9.7	43.7	34.2	52.7	54.8	54.6	66.4	54.7	29.2	28.4	68.5	47.8	36.1	50.2	51.9	86.1	32.8	29.5	49.3	34.1	30.1	36.9	52.1	40.2	25.0	49.2	146.0	27.8	35.5	94.5	73.6	39.0	32.4	36.4	58.9	42.2	43.6	38.8	60.6	41.2	120.3	57.5	33.8	80.7	53.3	53.6	85.3	39.4	51.7	49.1	35.1	51.2	38.0	32.4	87.2	65.9	41.5	42.1	85.2	53.2	34.0	57.4	50.5	36.5	43.7	86.2	65.2	57.7	47.3	40.1	50.0	55.6	38.8	3.2	2.5	4.7	1.6	2.7	1.1	2.3	2.1	2.9	2.0	1.0	1.6	1.6	8.2	1.2	3.5	1.6	2.5	1.0	52.0	51.2	51.5	63.0	52.7	48.7	51.0	50.7	50.8	48.2	52.7	52.7	39.4	0.0	5.4	21.9	11.4	46.8	17.5	5.4	16.5	35.5	43.4	47.1	27.7	27.1	3.5	14.7	25.0	44.3	30.9	47.4	13.7	24.9	63.9	29.6	28.3	27.7	13.2	77.7	8.3	20.5	55.4	21.4	16.8	42.3	0.0	28.1	15.7	41.1	27.9	16.8	6.3	34.0	14.2	14.5	38.6	249.4	18.0	20.6	19.6	2.8	15.1	68.9	20.6	6.6	12.9	45.0	27.0	15.1	25.0	34.8	25.9	18.9	5.5	44.3	13.1	22.6	34.9	22.4	54.6	15.2	54.7	63.1	22.0	27.1	23.7	27.9
CDC40	"EHB3, FLJ10564, PRP17, PRPF17"	ENSG00000168438	"Cell division cycle 40"	O60508	6	110180141-110254275	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046620			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA046620: AB_2679722"	"unprognostic (4.19e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.09e-1)"	11.1	14.7	6.9	13.3	10.3	38.2	13.6	6.5	10.9	11.3	7.3	11.1	11.1	11.7	10.4	10.7	11.0	10.4	10.5	10.2	6.1	16.3	16.9	11.0	19.6	4.7	5.0	16.1	12.4	14.0	9.4	9.9	5.0	12.5	12.1	14.8	11.0	9.4	11.6	10.6	11.0	10.1	5.2	16.0	11.4	11.8	5.2	18.6	15.9	11.6	18.6	12.6	8.5	9.2	11.3	10.4	18.2	31.8	18.3	18.8	14.8	21.5	26.4	21.3	26.9	22.8	11.3	37.8	23.7	19.2	22.7	15.8	28.2	17.5	30.1	30.5	21.3	31.0	14.4	12.4	24.2	40.2	39.8	17.1	16.4	22.5	18.1	15.9	21.6	24.3	31.5	22.0	21.3	11.0	29.9	14.9	18.1	15.1	11.2	26.0	21.4	13.1	15.5	23.6	19.4	19.1	15.8	13.8	15.9	16.6	12.8	38.1	24.5	11.5	11.4	27.3	24.1	11.0	15.9	33.8	18.6	33.2	17.4	28.6	18.7	20.4	13.8	20.3	13.7	29.5	13.7	14.3	15.9	28.3	16.2	14.1	20.8	16.5	23.4	24.9	16.8	10.2	6.9	10.3	6.5	10.9	10.2	6.1	4.7	5.0	5.0	5.2	5.2	9.2	38.9	32.1	37.6	18.3	85.7	26.4	26.2	43.1	36.5	94.4	32.2	32.8	21.5	30.0	37.5	27.6	43.8	32.9	79.2	20.9	56.7	35.8	257.8	34.6	48.4	35.5	26.4	44.2	65.4	37.3	30.9	35.8	35.2	30.4	49.4	43.0	38.9	56.6	37.8	94.2	25.6	29.8	22.4	44.9	28.6	84.6	67.4	49.6	10.6	24.4	76.0	46.1	57.7	27.2	43.6	28.5	28.9	45.1	27.8	23.4	29.1	74.0	31.0	84.0	78.9	38.2	39.3	20.9	22.5	37.6	27.1	28.7	59.0	70.6	35.5	22.4
CDC42EP1	"Borg5, CEP1, MSE55"	ENSG00000128283	"CDC42 effector protein 1"	Q00587	22	37560480-37569405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 245.6;Exocrine glandular cells: 226.0;Pancreatic endocrine cells: 266.2;Urothelial cells: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 7.3;intermediate monocyte: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006379, HPA076536"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA006379: AB_1078486, HPA076536: "	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.09e-3)"	76.3	91.2	55.7	16.7	107.5	1.6	58.0	89.9	73.3	68.2	17.6	43.7	31.1	70.7	4.1	93.1	61.0	40.8	53.8	55.9	67.3	50.2	133.1	65.2	11.3	102.8	104.5	60.9	161.6	16.5	18.8	31.8	97.4	41.5	14.4	2.6	102.7	23.9	13.1	71.2	32.7	19.6	70.2	26.2	155.9	23.6	87.5	2.7	33.7	11.1	10.4	38.4	69.6	151.5	125.2	35.4	15.1	67.9	23.7	40.2	73.3	69.9	41.0	78.9	54.3	87.8	15.9	0.2	24.2	81.4	25.4	95.0	17.8	35.1	26.0	15.5	60.7	0.5	33.9	53.6	167.7	0.3	0.6	74.9	52.1	65.0	61.5	63.1	59.2	0.1	78.9	0.7	33.0	42.6	0.3	0.5	13.6	96.5	79.6	0.4	27.5	2.4	27.9	1.9	0.4	2.6	51.2	112.3	112.4	20.6	50.3	11.0	91.6	163.9	98.2	80.0	98.6	0.2	0.8	0.3	65.3	0.7	135.6	0.4	7.3	0.0	0.1	1.9	0.1	0.0	0.1	0.1	2.4	0.3	0.0	0.2	0.2	0.4	0.1	0.3	0.0	3.4	55.7	107.5	89.9	73.3	55.9	67.3	102.8	104.5	97.4	70.2	87.5	151.5	62.4	6.4	19.5	2.3	1.8	46.9	87.2	51.4	21.1	0.1	59.2	31.8	3.5	134.4	41.1	12.9	0.0	98.2	2.0	41.6	1.9	245.6	3.7	4.3	20.0	54.7	11.5	0.0	0.1	226.0	110.3	32.1	133.0	9.0	2.5	1.7	69.7	35.6	13.2	1.7	0.2	66.6	30.5	5.9	29.3	1.7	39.4	5.3	21.4	4.7	8.9	12.8	0.0	2.0	42.7	266.2	45.8	35.3	0.6	122.4	17.5	11.4	14.7	0.3	39.5	22.8	49.5	2.0	0.6	55.9	52.0	112.2	2.2	7.0	61.1	161.3
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479457-19520612	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;lymphoid tissue: 20.4;testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Erythroid cells: 29.7;Spermatocytes: 72.3;Spermatogonia: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"K-562: 370.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.5	0.5	0.7	6.2	0.5	25.4	1.5	0.2	0.2	1.1	0.4	4.6	3.5	0.9	0.3	5.3	0.4	0.5	0.3	0.2	0.4	0.3	1.2	0.9	11.3	0.5	0.4	0.2	0.2	0.2	0.1	3.2	0.5	0.4	6.0	0.1	0.9	0.2	0.1	3.3	3.1	1.8	0.2	2.8	2.6	23.4	1.1	20.4	0.3	0.0	11.8	1.9	1.7	0.3	57.4	42.2	56.4	42.9	2.0	5.6	24.4	65.4	31.6	75.5	75.5	35.8	30.5	62.2	23.2	21.0	28.9	51.9	58.2	45.9	59.5	72.3	96.3	82.8	50.1	41.3	3.1	125.0	43.7	1.3	2.4	57.9	26.0	7.0	38.8	63.0	370.6	73.3	44.8	77.2	98.1	56.5	16.7	106.2	34.4	77.1	95.5	26.5	16.9	49.3	72.1	37.0	38.1	40.0	12.0	21.7	26.2	51.0	15.0	60.0	91.6	46.0	62.8	24.6	46.8	67.5	30.1	58.9	82.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.7	0.1	0.0	0.2	0.1	0.5	0.5	0.1	0.3	0.9	0.6	0.7	0.5	0.2	0.2	0.2	0.4	0.5	0.4	0.5	0.2	1.1	0.3	0.2	0.0	0.0	0.0	1.9	2.7	1.7	3.7	0.0	0.0	0.7	0.8	0.4	0.0	0.5	0.0	0.0	11.9	1.4	1.9	0.0	0.8	120.5	0.9	0.7	1.2	0.0	29.7	0.1	0.0	19.8	2.3	1.5	1.0	0.0	5.5	3.6	0.0	7.2	0.0	0.1	1.2	4.1	0.6	1.0	14.4	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.7	12.6	0.2	0.4	0.0	0.3	0.0	6.6	1.5	13.9	72.3	50.7	3.3	1.8	4.9	1.2	0.8	5.1	2.5
CDC5L	"CDC5, CEF1, hCDC5, PCDC5RP"	ENSG00000096401	"Cell division cycle 5 like"	Q99459	6	44387706-44450425	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 291.8;Late spermatids: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006302, HPA011361, CAB012275"	Supported		Supported	Nucleoplasm		NA	NA		22000	"Cluster 42: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379"	"unprognostic (2.67e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.01e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	11.5	11.9	6.7	10.7	7.1	21.3	13.5	10.1	9.4	10.3	7.0	10.5	9.4	12.0	13.2	10.9	9.7	8.7	13.8	7.3	7.0	10.5	18.7	9.6	13.4	6.7	6.8	14.0	10.1	19.8	5.7	12.0	7.1	11.8	11.3	13.2	9.7	9.4	17.8	8.5	9.4	11.7	6.9	10.5	9.7	13.2	6.9	15.3	10.8	22.5	14.1	12.1	8.1	8.7	43.0	16.5	39.8	32.5	16.0	20.7	22.5	30.6	23.8	37.9	41.5	21.7	14.4	40.8	24.8	24.7	30.8	26.6	41.8	24.2	56.4	34.5	37.6	54.5	15.4	28.1	14.6	41.3	28.2	15.9	20.9	37.0	31.9	21.7	25.0	20.7	42.6	23.3	34.7	29.0	38.4	28.1	28.0	103.5	15.1	29.6	45.7	26.4	21.5	25.2	43.8	38.0	24.7	16.5	33.3	25.4	23.2	39.6	23.0	32.4	32.8	25.5	43.7	19.9	25.8	73.8	20.9	35.3	33.2	20.2	13.1	17.5	10.4	15.7	11.8	9.9	10.0	11.7	13.0	11.3	10.7	10.4	19.9	14.8	18.1	11.2	14.6	8.5	6.7	7.1	10.1	9.4	7.3	7.0	6.7	6.8	7.1	6.9	6.9	8.7	57.3	73.7	50.3	14.7	48.5	44.2	69.2	58.0	55.8	36.4	26.7	29.5	82.2	30.0	80.5	23.9	31.3	57.5	58.2	26.8	39.2	53.4	291.8	63.7	64.2	51.5	36.1	48.1	20.6	55.2	49.4	52.2	28.5	72.1	71.0	58.8	26.7	44.7	45.3	32.0	34.7	40.7	52.9	38.6	29.8	285.9	61.5	53.1	19.6	18.7	74.3	65.8	45.3	14.1	33.0	47.8	34.5	55.3	37.7	49.0	18.6	28.6	78.6	38.1	65.7	67.9	76.2	48.2	98.7	35.6	38.4	71.7	46.8	59.8	40.8	62.5
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287879-40304657	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.2;lymphoid tissue: 17.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.2;Erythroid cells: 37.2;Extravillous trophoblasts: 34.6;Plasma cells: 31.6;Spermatocytes: 69.5;Spermatogonia: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.6;NK-cells: 1.5;T-cells: 2.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 500.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	2.1	1.9	0.5	13.7	0.8	27.2	3.4	0.2	1.9	3.2	0.0	8.4	7.5	2.2	1.1	5.7	1.0	2.8	0.6	1.1	0.1	0.5	3.0	1.4	16.4	0.1	0.0	0.9	1.9	0.8	0.5	9.3	0.3	1.1	8.7	0.5	1.3	1.2	0.3	2.8	6.7	3.7	0.0	3.7	3.6	10.1	0.2	16.7	1.7	0.5	17.1	4.3	1.8	0.6	155.1	119.0	115.1	86.5	6.7	12.7	118.0	159.9	49.0	149.2	166.5	135.8	64.9	123.9	99.6	35.9	85.9	214.0	112.2	76.2	148.9	64.5	98.4	96.2	122.3	134.6	4.4	133.3	55.1	4.7	8.1	156.4	107.1	14.8	46.9	84.2	183.0	109.0	71.9	95.8	199.3	43.3	101.6	96.9	48.7	145.0	286.8	119.9	30.3	184.8	85.6	76.9	146.9	500.3	55.4	100.3	100.8	120.0	34.7	95.5	146.3	170.8	196.1	46.1	103.6	222.8	84.6	93.9	109.2	0.1	0.1	0.0	0.8	0.0	0.5	0.4	0.6	1.1	0.7	0.3	0.4	1.1	0.1	1.5	0.0	3.6	2.4	0.6	0.5	0.8	0.2	1.9	1.1	0.1	0.1	0.0	0.3	0.0	0.2	0.6	2.2	0.0	2.0	0.7	4.9	4.2	1.1	3.7	3.4	0.2	2.1	2.2	0.9	1.5	1.3	0.0	0.0	23.2	2.3	7.8	0.0	1.3	2.2	1.3	2.9	2.1	0.0	37.2	2.0	0.6	34.6	5.6	3.6	5.1	0.0	8.1	1.1	0.9	8.3	0.0	0.7	6.1	0.0	1.3	2.1	1.0	2.8	1.5	0.0	0.0	0.0	0.4	2.1	0.0	0.2	1.5	3.0	0.7	31.6	1.3	0.8	0.2	0.2	0.3	13.1	0.6	4.6	69.5	57.2	9.1	1.6	16.7	3.3	1.9	9.3	2.4
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500851-91525764	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.8;Erythroid cells: 23.1;Spermatocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	1.9	2.7	3.6	6.0	3.8	13.8	2.1	6.3	4.8	2.1	1.6	3.0	3.1	1.8	1.7	3.5	1.3	1.7	1.4	3.8	3.4	4.3	1.5	4.2	9.3	2.9	3.7	2.5	1.6	0.8	4.0	5.9	3.1	1.9	4.6	14.1	1.7	1.4	0.5	5.1	3.7	2.4	2.8	12.1	1.8	16.9	3.2	10.9	1.7	0.5	9.4	2.4	2.3	3.5	32.0	9.4	59.1	17.3	1.4	7.6	18.8	12.0	9.1	22.6	24.3	19.6	10.8	22.5	16.1	7.7	19.8	13.7	39.8	13.5	29.4	36.8	34.3	33.7	27.9	9.5	2.1	37.0	11.9	4.2	4.0	21.0	11.9	4.1	8.9	30.9	44.8	31.4	15.2	11.8	31.5	33.5	48.9	17.2	21.6	38.9	49.5	14.5	10.2	24.0	44.7	18.6	37.5	10.2	21.6	14.3	9.8	18.2	7.3	25.8	22.7	20.6	17.9	11.6	15.6	57.9	9.4	36.0	9.4	0.0	1.0	0.0	3.8	0.7	3.2	0.9	2.8	3.5	2.3	0.9	1.5	3.0	0.1	1.6	0.2	1.4	4.6	1.4	3.6	3.8	6.3	4.8	3.8	3.4	2.9	3.7	3.1	2.8	3.2	3.5	1.9	0.0	1.1	3.3	3.2	5.9	1.2	2.7	3.4	8.2	14.4	1.4	2.1	0.0	1.3	1.8	0.0	8.2	4.1	0.6	3.9	1.5	37.8	1.1	4.9	4.1	0.0	23.1	18.3	2.6	6.3	3.1	2.6	1.9	4.5	15.4	4.2	0.2	2.7	3.3	19.6	1.8	6.1	2.2	2.9	18.7	0.9	1.6	3.6	5.6	2.1	1.6	6.2	16.6	3.1	1.2	1.7	0.7	7.1	0.9	0.5	0.4	2.0	5.1	6.6	1.5	4.1	30.5	21.4	4.3	3.7	2.2	5.3	7.6	3.6	1.0
CDC73	"C1orf28, FIHP, HRPT1, HRPT2, parafibromin"	ENSG00000134371	"Cell division cycle 73"	Q6P1J9	1	193121983-193254815	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002326, CAB016359, HPA069324"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB016359: AB_628102, HPA002326: , HPA069324: "	"unprognostic (4.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-3)"	"unprognostic (3.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.98e-3)"	11.3	9.5	5.8	7.3	6.9	8.9	10.7	6.1	7.3	11.1	4.5	10.2	5.6	10.3	8.5	8.4	7.2	5.9	9.6	4.6	8.1	10.4	9.2	7.9	7.5	6.9	7.2	11.5	6.4	12.9	5.6	9.4	7.9	15.1	9.0	10.1	7.7	9.7	12.2	7.0	7.7	10.3	7.9	8.6	7.0	5.9	6.5	10.6	13.1	5.6	7.9	9.7	8.5	8.3	9.3	2.4	16.6	11.5	18.3	18.9	4.9	6.7	16.1	19.5	16.4	6.5	12.3	10.5	5.2	20.4	8.8	10.7	16.8	14.9	24.7	6.1	4.1	7.3	8.1	7.2	16.1	16.0	11.6	13.7	16.0	14.9	17.7	20.6	17.8	11.1	8.1	14.2	28.8	3.5	13.9	9.2	11.9	21.9	2.5	10.6	7.0	15.0	26.6	8.2	3.9	12.3	8.6	26.8	22.3	21.0	18.3	14.0	9.2	19.3	2.2	16.4	12.6	12.2	7.2	7.6	11.9	10.2	30.1	2.2	0.5	0.7	0.8	1.0	1.2	0.9	1.1	0.6	0.6	0.5	1.4	1.2	0.3	1.3	0.8	1.0	0.9	0.4	5.8	6.9	6.1	7.3	4.6	8.1	6.9	7.2	7.9	7.9	6.5	8.3	44.5	35.3	25.4	54.5	44.9	37.2	35.6	38.4	36.5	30.4	24.4	21.8	44.5	25.8	27.2	33.1	35.5	25.0	48.0	18.2	33.2	37.5	19.7	24.6	39.6	38.0	11.4	40.8	71.9	32.2	42.0	39.1	28.1	30.8	41.1	17.6	25.4	17.2	31.6	21.9	76.4	15.8	34.6	27.4	49.1	8.5	33.5	38.3	28.4	54.4	46.0	35.2	41.2	78.4	112.3	35.5	16.9	36.1	50.3	34.9	19.2	36.3	20.6	36.7	26.3	49.0	48.3	55.6	33.0	36.8	34.9	38.0	44.4	30.3	18.6	27.9
CDCA2	"PPP1R81, Repo-Man"	ENSG00000184661	"Cell division cycle associated 2"	Q69YH5	8	25459199-25507911	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.5;lymphoid tissue: 11.4;testis: 19.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 23.3;Early spermatids: 49.9;Erythroid cells: 19.0;Late spermatids: 24.2;Spermatocytes: 66.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA026293, HPA030049"	Enhanced		Supported	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA026293: AB_1846384, HPA030049: AB_10600862"	"unprognostic (2.12e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (9.62e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.47e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.30e-14)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.30e-2)"	0.2	0.0	0.0	2.6	0.0	6.5	0.6	0.1	0.0	0.2	0.1	1.9	1.6	0.3	0.0	1.4	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.2	5.3	0.2	0.2	0.0	0.0	0.0	0.0	1.2	0.2	0.1	2.2	0.1	0.2	0.0	0.0	1.1	1.8	0.8	0.0	0.8	0.9	19.4	0.3	11.4	0.1	0.1	6.7	0.6	0.3	0.1	36.5	30.2	29.4	24.2	2.3	4.5	20.2	37.7	22.6	32.9	32.4	25.7	15.8	42.6	16.0	16.2	34.6	31.6	42.9	20.0	48.5	16.2	12.0	43.2	22.4	15.2	0.6	18.4	19.4	2.5	1.0	23.5	15.8	3.3	24.5	24.5	33.6	45.8	30.6	13.9	54.5	8.7	31.0	24.1	14.5	26.3	33.4	15.2	9.2	18.7	12.0	13.3	33.3	16.1	14.3	14.7	17.4	9.4	16.6	23.9	39.3	44.7	35.6	7.1	16.5	44.4	17.7	24.3	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	1.1	0.0	2.7	1.1	0.5	1.7	0.0	0.7	0.9	0.8	23.3	0.0	0.2	0.0	0.0	7.2	0.5	1.8	0.0	0.2	49.9	0.8	1.2	1.1	0.0	19.0	0.2	0.0	13.4	2.5	4.1	1.4	0.0	8.8	1.1	0.1	4.1	0.0	0.1	1.3	0.0	2.9	0.6	24.2	1.2	2.1	0.0	0.0	0.6	0.1	2.1	0.5	0.6	0.2	0.1	0.0	15.8	0.5	0.5	1.2	0.9	0.5	13.1	0.1	2.1	66.6	27.8	10.7	0.9	1.6	2.9	1.3	3.6	0.5
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 64.2;Cytotrophoblasts: 84.5;Extravillous trophoblasts: 154.5;Spermatogonia: 69.9;Suprabasal keratinocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064971			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA064971: AB_2685395"	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (4.19e-4)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	3.9	2.6	1.9	7.4	2.0	55.8	4.2	3.0	2.1	8.7	2.1	4.6	4.7	5.4	1.8	18.6	4.1	2.6	2.7	1.7	1.8	3.4	2.7	3.6	11.6	2.1	1.9	4.1	3.2	1.8	1.7	9.2	2.1	3.8	2.9	1.3	5.5	2.2	1.4	24.7	4.9	3.5	1.9	6.6	3.8	11.6	2.0	14.6	3.3	1.5	8.5	4.2	10.2	2.0	40.6	41.3	46.7	35.6	7.9	13.2	61.1	59.0	18.0	45.2	39.7	50.9	50.2	52.9	31.5	20.9	34.5	63.5	32.9	68.0	27.1	58.2	26.1	33.4	33.9	43.2	9.7	59.8	27.0	9.4	20.8	35.2	32.7	15.1	31.4	45.0	37.5	53.0	32.1	98.8	56.2	40.1	34.8	35.1	94.0	53.6	68.1	19.7	15.9	46.2	27.2	33.5	56.6	22.3	46.8	20.5	44.0	39.8	48.8	39.9	50.5	55.3	79.5	19.5	25.9	54.4	33.5	30.2	67.5	1.1	4.3	10.6	11.9	4.9	14.8	8.4	12.7	16.7	4.7	5.4	7.4	8.9	1.6	12.9	5.6	5.1	11.1	7.0	1.9	2.0	3.0	2.1	1.7	1.8	2.1	1.9	2.1	1.9	2.0	2.0	5.4	0.0	2.2	0.7	7.4	64.2	26.5	36.6	13.1	3.4	8.7	8.3	0.6	0.0	9.0	1.8	0.0	84.5	11.5	4.3	3.9	12.7	8.1	9.0	9.0	10.9	3.0	53.0	1.8	7.0	154.5	10.2	3.1	12.5	28.6	15.1	7.9	2.2	24.3	13.5	1.3	6.6	6.1	5.9	22.6	6.8	8.4	8.4	17.8	2.8	9.3	4.6	9.2	1.0	1.8	12.3	3.3	6.0	11.8	16.1	1.9	1.8	7.7	2.6	6.6	4.6	12.5	43.0	69.9	21.3	67.1	25.9	17.7	3.6	9.5	43.2
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.4;lymphoid tissue: 27.6;testis: 37.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.5;Extravillous trophoblasts: 38.3;Late spermatids: 116.9;Spermatocytes: 50.4;Spermatogonia: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NK-cell: 2.8;T-reg: 2.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.8;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			"HPA023691, HPA076007"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA023691: AB_1846392, HPA076007: "	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.4	1.2	1.3	10.5	1.3	53.4	2.0	0.8	1.8	1.9	0.9	6.8	5.8	1.3	0.3	9.3	0.9	0.9	0.9	1.5	0.9	0.9	1.3	1.9	17.0	1.6	1.3	0.6	0.7	0.4	0.5	6.5	1.6	0.8	7.7	0.5	1.4	0.5	0.6	4.2	5.8	3.1	0.8	6.6	3.1	37.8	1.8	27.6	0.6	0.4	16.2	2.2	2.8	1.3	131.7	74.9	67.2	57.3	4.5	7.3	57.8	92.7	37.4	103.6	81.5	77.7	75.4	121.3	52.3	29.4	120.8	87.9	110.3	49.5	98.6	122.0	52.2	107.7	54.4	64.1	0.4	116.8	81.8	2.5	4.5	96.3	44.0	10.8	32.6	138.4	126.6	206.6	63.5	109.2	164.7	116.9	107.8	63.0	92.4	140.4	76.8	111.9	21.2	49.6	89.1	68.4	59.3	80.7	62.8	41.6	104.7	54.7	19.9	92.7	97.2	99.5	101.7	106.9	187.8	195.4	37.2	69.5	97.4	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.5	0.3	0.4	0.5	0.0	0.3	0.0	2.8	0.3	0.3	2.0	0.7	1.3	1.3	0.8	1.8	1.5	0.9	1.6	1.3	1.6	0.8	1.8	1.3	0.9	0.0	0.5	0.0	4.6	3.8	1.2	1.3	0.6	0.6	2.3	4.4	1.0	0.0	0.8	0.0	2.1	19.7	2.2	4.6	1.9	0.8	56.5	1.1	1.5	2.3	0.0	21.8	1.1	0.8	38.3	3.5	3.1	1.5	3.8	14.5	1.1	0.0	11.7	1.7	0.6	4.7	2.0	2.8	1.5	116.9	2.8	1.7	0.0	1.0	2.1	0.9	2.1	0.0	0.6	0.6	0.1	1.5	16.2	1.1	1.1	0.6	0.4	0.2	0.0	0.5	2.7	50.4	31.1	7.1	1.0	3.7	4.2	1.9	9.4	1.6
CDCA7	"FLJ14736, JPO1"	ENSG00000144354	"Cell division cycle associated 7"	Q9BWT1	2	173354820-173368997	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.4;lymphoid tissue: 50.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 45.7;Intestinal goblet cells: 40.7;Leydig cells: 53.7;Undifferentiated cells: 124.2"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 43.3"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 279.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005565			Supported	Nucleoplasm,Cytosol		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA005565: AB_2078680"	"unprognostic (1.67e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.96e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.97e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.53e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.47e-2)"	1.7	0.3	0.7	13.1	0.6	23.0	2.4	0.5	0.7	12.6	6.5	25.5	30.7	13.8	3.3	10.1	3.8	1.5	0.8	0.7	1.2	0.5	0.3	1.6	37.5	0.7	0.9	1.1	1.7	0.3	0.1	7.4	0.7	3.0	29.5	0.4	2.5	1.2	3.1	11.7	32.4	3.4	0.7	2.4	14.3	6.0	1.2	50.1	0.5	0.8	41.2	2.8	6.7	1.0	44.2	33.3	76.4	83.3	3.6	14.0	79.9	26.0	9.2	60.3	67.2	51.6	54.4	122.1	32.2	15.8	23.5	45.0	122.4	46.6	87.0	59.2	67.4	27.6	24.6	66.0	3.8	181.2	25.1	11.4	3.9	32.8	27.3	7.8	28.0	158.1	67.4	27.2	17.7	35.4	279.7	181.7	90.4	103.4	22.7	194.4	58.2	77.3	29.5	38.2	22.3	39.2	40.8	13.4	22.0	67.9	0.3	70.5	13.0	39.3	16.8	12.9	48.5	7.4	17.1	173.0	24.4	99.8	34.0	0.0	0.5	0.0	1.1	0.0	0.4	1.9	3.0	5.9	3.5	0.3	0.2	1.0	0.2	3.2	0.0	0.5	7.9	2.3	0.7	0.6	0.5	0.7	0.7	1.2	0.7	0.9	0.7	0.7	1.2	1.0	1.0	0.0	0.6	0.7	3.0	20.3	14.9	3.3	14.8	0.0	2.6	6.5	1.1	0.0	0.3	0.0	0.0	45.7	1.6	17.1	0.0	0.2	0.9	3.2	33.0	3.4	12.2	33.6	0.1	0.2	29.9	4.1	22.4	6.8	0.0	18.5	0.0	0.2	10.4	0.0	10.5	40.7	4.1	1.0	4.4	2.2	53.7	2.3	3.6	0.0	1.2	0.7	0.0	0.5	0.1	1.0	11.1	34.6	3.8	5.3	11.9	0.0	0.1	0.0	0.0	1.1	7.2	13.8	28.9	21.8	15.9	10.1	9.1	2.7	124.2	3.8
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900899-21945903	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 51.0;Spermatogonia: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 101.0;naive B-cell: 124.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"olfactory bulb: 10.1"	"HPA027169, HPA074623"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	5.9	1.4	3.9	15.0	9.1	51.7	15.7	5.7	5.2	8.7	17.8	17.0	10.7	13.8	5.5	11.2	11.5	8.1	25.3	3.9	3.5	2.8	4.8	14.0	37.1	6.9	4.8	21.8	13.0	1.8	1.1	4.7	3.8	7.3	19.0	5.1	9.0	7.6	6.2	18.5	13.6	11.9	5.0	13.3	17.8	18.5	7.8	49.0	29.8	3.4	31.8	6.3	8.1	9.8	84.5	27.6	26.0	0.6	14.5	17.9	0.0	65.9	58.2	51.8	73.5	11.3	75.4	173.6	21.8	59.3	102.4	51.1	41.4	69.4	103.6	0.3	28.6	42.3	83.8	7.4	21.1	111.1	0.4	35.2	12.7	40.0	116.9	54.9	104.8	133.5	58.3	0.1	41.4	34.5	146.1	46.1	153.2	17.4	36.2	141.0	94.0	119.8	15.4	14.8	96.9	79.7	30.3	19.9	29.9	34.4	45.6	54.6	43.0	57.1	68.5	101.3	83.8	90.6	63.6	223.0	55.7	154.6	54.5	1.1	2.3	43.2	2.2	3.8	0.3	101.0	6.4	3.2	14.9	124.5	30.9	12.8	3.8	3.4	4.9	75.9	9.9	12.2	3.9	9.1	5.7	5.2	3.9	3.5	6.9	4.8	3.8	5.0	7.8	9.8	1.0	19.2	31.5	7.5	51.0	27.1	23.7	6.9	17.1	1.5	12.5	20.7	38.7	11.5	19.0	0.0	2.1	0.5	30.7	8.4	3.9	8.9	7.3	5.4	2.7	4.8	10.7	21.9	0.5	6.2	0.3	13.4	18.3	5.3	8.8	14.9	1.4	4.0	10.8	13.5	1.0	26.1	8.2	15.2	3.5	5.2	4.1	7.0	8.8	1.9	1.6	2.4	1.0	15.1	8.7	3.9	7.4	2.6	20.2	14.2	1.5	0.1	4.2	2.7	13.1	6.8	12.4	4.6	63.5	9.6	7.7	0.3	5.4	8.3	23.0	6.2
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692481-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.0	1.1	0.7	7.9	1.0	33.5	2.0	0.2	0.9	1.7	0.0	9.4	8.3	1.3	1.8	9.2	1.0	1.1	0.6	0.5	0.4	0.8	1.3	1.5	19.5	0.6	0.4	0.6	0.8	0.5	0.6	4.4	0.5	0.7	11.3	1.9	1.8	0.5	0.3	6.3	7.3	2.8	0.3	4.9	4.9	22.5	0.6	38.8	0.6	0.5	22.7	2.0	2.9	0.7	108.5	45.5	84.4	62.1	3.6	7.0	57.2	79.6	39.5	137.2	96.6	71.9	78.8	130.2	31.5	50.5	54.5	59.4	97.8	52.4	141.9	86.8	44.9	116.8	49.2	57.3	0.8	113.8	58.4	2.8	3.8	77.1	67.3	15.3	60.9	91.1	100.7	135.6	99.1	47.7	106.1	68.9	98.8	61.7	62.8	102.2	115.6	74.4	31.0	43.8	75.4	33.3	87.5	40.6	52.4	71.7	60.1	42.4	37.3	67.8	70.6	39.2	126.0	91.4	128.1	176.3	31.6	104.7	79.6	0.0	0.7	1.3	1.5	1.6	2.8	1.7	3.6	2.2	0.7	1.4	1.1	2.3	3.0	4.1	3.9	1.2	5.9	1.7	0.7	1.0	0.2	0.9	0.5	0.4	0.6	0.4	0.5	0.3	0.6	0.7	0.8	0.0	0.5	1.3	4.8	3.3	0.8	2.4	1.8	1.3	1.9	1.5	0.7	2.8	0.4	0.0	0.0	17.1	1.9	12.4	0.0	1.2	1.0	1.7	1.6	1.9	3.6	34.1	1.2	0.6	26.0	2.9	6.6	2.5	0.0	12.0	3.6	1.0	11.6	1.7	0.9	8.2	2.0	3.5	1.9	2.8	1.5	3.7	1.8	0.0	1.6	0.1	2.1	0.5	0.9	2.4	4.0	1.2	15.8	1.3	1.9	0.6	4.7	1.0	19.7	0.2	6.3	76.8	42.0	17.1	2.7	2.9	5.5	1.2	13.2	1.2
CDH10		ENSG00000040731	"Cadherin 10"	Q9Y6N8	5	24487100-24644978	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 13.0;prostate: 4.4"	"Group enriched"	"Detected in some"	20	"Astrocytes: 169.4;Excitatory neurons: 423.4;Inhibitory neurons: 216.9;Oligodendrocyte precursor cells: 488.6"	"Cancer enriched"	"Detected in some"	4	"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.1;HAP1: 4.6;hTERT-RPE1: 4.2;SuSa: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010651, HPA012085"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		270000		"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	Nucleoplasm	"HPA010651: AB_1078370, HPA012085: "	"unprognostic (4.31e-3)"			"unprognostic (2.77e-1)"	"unprognostic (1.88e-1)"			"unprognostic (3.66e-2)"		"unprognostic (4.48e-1)"	"unprognostic (6.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.59e-7)"	"unprognostic (1.65e-2)"	"unprognostic (1.41e-1)"		"unprognostic (8.74e-3)"	0.0	0.7	5.6	0.0	8.4	0.0	0.1	13.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	9.0	0.9	0.0	0.0	0.1	0.0	0.3	1.7	0.0	0.1	0.0	0.4	0.0	2.2	4.4	0.2	1.0	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.3	1.1	0.0	0.0	1.1	0.0	0.0	0.1	4.6	0.0	0.0	7.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	11.7	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.4	13.0	8.7	9.0	0.9	0.3	1.7	2.2	1.2	1.1	4.6	0.0	0.0	0.0	169.4	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.4	0.1	0.0	0.0	423.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	216.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.9	0.0	0.6	0.0	488.6	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127162-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 314.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 569.4;Enteroendocrine cells: 108.4;Intestinal goblet cells: 183.7;Paneth cells: 408.6;Proximal enterocytes: 336.9;Undifferentiated cells: 241.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 16.0"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 16.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 98.8;OE19: 430.1;U-266/70: 157.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA		7500000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.9	0.2	0.7	28.8	0.5	2.7	0.5	1.1	0.8	0.1	1.9	260.9	314.2	1.3	0.8	1.7	0.3	3.0	0.6	0.5	0.2	0.8	0.3	0.2	1.5	0.3	0.1	0.5	1.7	0.0	0.0	0.2	0.3	1.2	246.7	0.5	0.9	1.6	0.5	0.6	270.6	9.3	0.1	5.5	2.5	0.6	0.2	0.3	0.7	0.1	1.8	0.8	0.1	0.7	0.2	18.5	0.2	0.4	0.0	0.4	1.6	0.2	0.3	0.2	0.3	98.8	3.5	0.3	0.3	0.0	0.1	1.0	0.3	0.3	0.3	0.2	1.1	0.1	0.8	0.6	0.3	0.2	4.3	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.4	1.5	0.1	0.7	0.5	1.3	0.3	430.1	0.5	0.3	0.0	2.8	0.3	0.2	1.3	1.2	0.4	0.4	0.5	0.4	0.7	0.9	0.0	0.6	0.7	1.2	0.5	157.2	0.3	0.2	0.3	0.3	0.6	2.9	0.9	1.4	0.2	0.8	0.1	0.3	0.2	0.1	0.5	0.8	0.2	0.3	16.0	0.7	0.5	0.4	0.2	0.2	0.7	0.5	1.1	0.8	0.5	0.2	0.3	0.1	0.3	0.1	0.2	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	569.4	0.0	0.3	1.0	0.0	0.0	0.0	108.4	0.0	0.5	0.0	0.0	0.1	2.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	183.7	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	408.6	0.0	0.2	0.0	336.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.1	0.0	241.6	0.1
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404784	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 235.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 311.9;Endothelial cells: 206.1;Hepatic stellate cells: 185.6;Late spermatids: 84.6;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 752.5;TIME: 655.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA		1300000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	84.5	13.8	16.3	14.9	15.9	0.2	71.4	15.1	16.6	16.2	11.3	16.8	7.9	19.9	8.6	12.4	17.1	29.7	84.4	13.8	14.6	19.1	24.0	95.0	13.1	16.7	16.6	8.1	7.7	10.3	7.4	235.9	17.9	11.6	10.2	1.3	12.0	9.1	41.8	16.7	17.0	27.8	15.5	20.4	13.3	10.5	22.6	5.2	37.5	58.9	7.9	22.1	14.2	15.5	0.5	0.6	4.6	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	119.8	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	752.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	15.7	0.0	2.4	0.0	0.1	655.1	0.0	0.9	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	15.9	15.1	16.6	13.8	14.6	16.7	16.6	17.9	15.5	22.6	15.5	311.9	0.0	6.2	1.3	0.7	4.1	0.0	0.0	1.8	0.0	1.0	2.7	17.9	5.7	0.6	1.8	0.0	6.6	0.5	0.0	0.0	0.2	33.5	0.5	0.6	206.1	0.0	10.7	0.1	0.0	48.9	7.1	0.0	1.3	3.8	0.0	185.6	1.7	2.3	0.0	0.1	0.0	0.0	35.7	6.3	84.6	6.2	1.2	12.4	28.1	0.1	0.3	0.0	0.5	0.1	0.0	0.0	2.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.4	10.9	0.3	0.3	3.0	80.7	1.5	3.0	0.1	0.2
CDIN1	"C15orf41, FLJ22851, HH114, MGC11326"	ENSG00000186073	"CDAN1 interacting nuclease 1"	Q9Y2V0	15	36579626-36810248	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 78.6;tongue: 34.5"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 97.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061023	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA061023: AB_2684417"	"unprognostic (1.82e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-6)"	"unprognostic (1.22e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.58e-1)"	2.8	5.1	2.9	2.4	7.9	0.7	2.9	4.3	4.1	5.9	1.6	5.6	6.7	6.8	1.8	9.4	4.1	4.0	78.6	2.5	3.5	2.8	3.7	2.5	2.4	3.9	3.4	4.3	2.2	2.4	2.3	2.1	4.3	6.0	3.2	9.6	5.0	6.6	12.0	5.6	3.3	9.5	2.9	2.2	3.3	7.1	3.4	4.2	2.5	34.5	3.6	9.5	8.3	4.9	19.0	10.0	12.4	4.7	13.5	15.6	5.1	8.9	4.5	11.1	9.1	13.9	7.4	3.0	8.8	22.1	8.1	33.8	13.0	7.7	12.7	1.5	9.1	9.9	9.0	10.3	11.8	8.4	7.1	12.0	8.3	9.5	5.2	8.5	10.7	9.6	12.9	3.1	15.4	8.6	2.6	4.9	6.8	8.6	5.1	7.9	3.5	2.0	7.4	25.8	7.1	4.4	5.7	5.5	4.8	9.0	5.5	13.1	7.6	10.8	5.9	7.3	2.5	7.2	11.2	13.7	13.7	15.0	10.2	0.0	0.5	0.3	2.5	1.3	2.2	2.1	1.9	2.4	1.4	2.2	2.3	1.9	0.0	3.3	0.4	1.1	5.1	1.1	2.9	7.9	4.3	4.1	2.5	3.5	3.9	3.4	4.3	2.9	3.4	4.9	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.6	0.0	0.0	0.0	0.0	8.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	6.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	10.8	0.2	0.0	0.0	0.0
CDIP1	"C16orf5, CDIP, LITAFL"	ENSG00000089486	"Cell death inducing p53 target 1"	Q9H305	16	4510669-4538828	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 59.4;RPMI-8226: 68.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049352	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	Centrosome	Nucleoplasm	"HPA049352: AB_2680724"	"unprognostic (6.38e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (9.05e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.65e-2)"	19.6	43.2	27.2	5.0	30.0	2.1	18.4	21.2	65.1	26.8	0.0	24.6	14.5	30.0	1.0	22.3	24.6	7.9	57.3	26.6	21.3	49.7	44.1	14.5	5.4	22.3	21.3	34.0	37.9	7.1	65.2	5.3	25.4	25.3	2.5	6.9	14.0	10.9	41.1	17.9	26.0	7.0	15.0	20.1	21.5	28.7	29.3	11.5	24.2	8.4	4.0	20.3	20.1	36.2	10.6	3.6	14.0	3.0	1.7	0.0	0.4	14.9	2.3	11.5	10.6	22.6	2.2	0.7	12.2	10.8	4.6	0.8	12.8	41.9	3.0	27.6	25.8	40.7	12.9	59.4	10.5	20.5	21.0	10.5	44.7	10.2	3.4	3.4	9.6	13.1	1.2	9.1	14.5	1.3	15.0	19.2	19.9	10.6	10.1	50.1	12.8	68.3	3.0	0.5	27.9	13.6	24.2	1.4	16.6	7.2	4.4	13.4	0.8	5.5	16.3	7.7	0.7	27.5	29.1	37.9	0.5	16.7	4.7	4.5	5.8	14.4	11.7	9.0	6.9	6.4	4.1	7.3	5.7	5.7	9.0	6.8	5.0	12.0	17.7	6.6	7.0	5.9	27.2	30.0	21.2	65.1	26.6	21.3	22.3	21.3	25.4	15.0	29.3	36.2	27.1	16.0	7.0	28.7	19.4	29.6	21.5	25.4	38.1	63.5	7.7	14.4	26.5	7.2	9.0	16.5	12.5	1.8	16.3	12.1	52.8	13.0	90.9	1.5	18.7	20.3	9.6	7.2	23.5	9.2	1.6	15.4	7.7	2.9	22.9	11.3	25.7	18.5	19.6	70.7	26.4	6.1	14.2	12.2	11.7	25.4	18.0	17.5	14.2	8.4	7.1	41.4	45.3	9.5	14.7	8.2	13.2	16.6	24.1	13.3	39.6	65.0	0.9	16.1	6.6	8.4	11.3	21.1	27.7	15.2	14.9	6.7	22.9	13.7	6.7	11.5
CDIPT	"PIS, PIS1"	ENSG00000103502	"CDP-diacylglycerol--inositol 3-phosphatidyltransferase"	O14735	16	29858357-29863414	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056597	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane, Plasma membrane"		"HPA056597: AB_2683182"	"unprognostic (7.81e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (1.93e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.48e-1)"	93.8	101.7	75.1	32.1	73.8	26.8	81.0	79.0	86.2	84.5	64.2	104.7	39.0	91.1	31.1	61.1	76.2	51.7	105.4	73.6	76.2	80.6	114.5	65.1	36.1	78.4	74.6	109.6	86.8	87.9	68.7	42.3	78.9	78.1	24.4	34.0	67.2	55.5	49.7	82.8	69.6	38.9	69.1	66.3	89.1	43.9	73.6	40.6	69.1	43.9	24.8	89.7	73.6	70.1	40.0	85.6	23.7	47.3	125.8	86.3	70.5	71.0	76.6	47.9	47.4	50.5	75.1	26.9	125.2	80.3	42.2	62.0	38.7	44.5	21.3	67.5	85.3	19.5	61.4	74.1	87.7	28.5	47.2	148.0	77.2	64.3	29.7	75.8	60.9	49.9	29.5	67.1	44.0	127.7	40.3	56.2	55.5	42.2	65.7	74.8	29.5	78.7	63.7	38.1	96.4	53.8	36.9	76.1	55.7	41.2	57.5	74.8	52.8	70.3	22.1	58.0	35.8	51.4	62.1	19.3	77.2	46.0	43.4	11.7	8.2	28.9	8.5	6.2	5.7	6.5	7.9	9.1	3.8	6.4	7.7	7.2	20.6	11.4	7.9	8.1	12.0	3.8	75.1	73.8	79.0	86.2	73.6	76.2	78.4	74.6	78.9	69.1	73.6	70.1	54.7	25.6	28.3	10.4	25.1	41.3	41.4	22.9	30.1	53.4	42.1	49.7	57.9	41.5	15.4	46.0	45.9	120.6	31.9	57.5	41.1	72.0	54.0	18.1	30.4	48.0	37.3	22.7	16.4	71.8	127.3	59.3	19.4	29.6	13.4	30.7	46.1	41.7	65.0	58.9	19.3	30.6	10.2	41.8	21.3	12.8	76.7	33.3	23.2	11.2	45.2	57.7	36.0	9.0	11.5	44.9	37.9	61.7	31.7	38.9	87.9	34.5	15.1	56.3	46.0	24.4	44.6	10.2	14.7	32.3	50.7	73.2	30.5	34.1	34.8	39.3
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.2;lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.2;T-reg: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003387, CAB003799, CAB079974"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		51000	"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	3.8	1.8	0.9	17.0	1.0	53.2	7.4	0.9	1.5	5.2	0.9	17.6	16.3	7.1	12.2	17.5	3.7	4.3	1.4	0.9	1.0	3.1	3.2	4.7	40.6	1.2	1.2	2.3	0.8	2.5	4.1	19.4	1.1	1.7	20.8	1.3	3.2	5.2	1.4	13.2	14.5	8.0	0.9	9.0	10.1	25.1	1.4	74.0	3.6	2.2	47.5	7.1	6.9	1.0	249.9	93.5	241.1	96.0	15.4	23.6	99.0	183.8	132.7	218.8	209.0	218.9	213.7	226.2	69.6	50.6	79.6	149.9	166.2	106.8	225.8	162.3	121.1	119.4	84.4	128.1	2.8	184.5	117.6	4.7	10.4	142.1	137.0	49.6	133.3	146.2	185.1	270.3	246.9	66.3	234.0	131.1	106.6	149.3	193.1	199.7	224.5	111.3	84.3	81.4	112.7	98.7	123.5	184.9	96.3	130.0	199.9	111.5	55.4	92.8	197.9	99.1	255.8	104.9	180.8	205.6	79.9	203.5	117.6	0.0	0.0	0.0	0.3	0.1	0.2	0.5	0.7	1.3	0.3	0.4	0.2	0.7	0.0	3.2	0.1	0.9	3.4	0.9	0.9	1.0	0.9	1.5	0.9	1.0	1.2	1.2	1.1	0.9	1.4	1.0	7.7	0.0	3.2	0.3	7.1	39.8	5.4	29.9	2.8	1.1	5.3	6.1	0.8	0.0	10.2	18.4	0.0	80.9	3.6	8.9	3.9	0.8	18.7	10.8	6.2	10.5	3.0	209.6	0.4	0.0	144.6	13.3	13.3	9.4	0.0	51.5	7.5	1.3	57.2	0.0	0.2	14.6	30.5	20.5	18.1	10.4	2.1	16.5	1.8	1.9	1.0	1.0	3.1	0.0	0.1	0.4	0.7	0.7	32.1	4.3	2.2	3.0	17.6	0.7	0.0	0.5	24.6	110.0	39.6	33.8	18.6	22.0	10.3	2.1	26.6	10.4
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696354	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (3.63e-4)"	30.1	38.5	20.2	10.4	20.4	19.5	26.7	20.3	32.8	49.3	22.0	38.2	22.7	25.9	8.7	35.3	36.3	8.6	27.3	21.0	19.5	52.9	77.0	31.0	14.7	18.6	18.7	43.2	49.2	13.5	55.5	12.5	19.6	39.1	11.3	7.6	24.8	7.5	33.8	32.1	36.1	8.2	17.0	37.5	38.5	17.0	18.4	10.8	54.5	4.1	7.0	32.3	36.5	19.1	27.5	17.8	13.9	5.8	5.7	11.0	14.2	22.3	12.6	15.2	4.9	13.1	21.2	23.9	9.8	19.3	9.1	15.5	5.8	30.8	9.3	5.3	14.1	9.7	21.0	1.7	23.4	15.8	17.1	13.3	10.7	9.3	15.3	10.3	27.0	16.1	25.5	3.2	17.7	36.6	19.5	45.0	28.5	29.7	13.1	26.5	19.0	34.1	27.9	21.2	10.1	29.6	28.0	13.0	6.8	15.2	30.3	25.0	24.1	9.1	26.6	10.1	15.4	11.7	6.4	7.5	16.4	25.0	15.5	5.1	14.0	4.2	14.8	19.7	12.8	7.8	13.2	10.7	18.1	9.0	15.1	12.6	1.5	20.4	15.4	12.4	11.6	11.4	20.2	20.4	20.3	32.8	21.0	19.5	18.6	18.7	19.6	17.0	18.4	19.1	28.2	12.8	26.6	35.3	21.2	15.4	24.2	26.9	23.3	17.2	24.5	25.1	6.5	38.6	20.0	27.6	25.0	28.6	26.7	44.8	43.0	28.6	6.1	20.7	21.9	23.0	67.7	15.4	44.5	12.5	19.8	19.6	85.1	16.9	9.5	40.3	21.8	41.1	18.8	18.5	33.3	49.4	26.4	17.4	16.0	8.8	23.9	17.0	19.6	17.8	15.5	8.5	26.8	24.6	20.0	13.6	41.5	12.4	20.8	30.7	58.3	53.7	28.1	32.3	6.6	11.4	16.3	27.3	28.7	22.4	15.5	27.9	22.0	54.8	58.2	22.9
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461486-39564907	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 307.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	9.5	7.6	2.5	14.0	1.9	34.3	9.5	8.0	4.0	11.0	4.1	9.8	9.9	10.8	6.0	10.4	9.2	9.2	6.8	1.6	2.9	8.0	12.3	9.2	15.1	3.0	1.7	11.9	8.7	13.0	6.2	11.5	1.6	9.8	10.4	11.7	9.2	9.3	6.7	10.6	10.4	10.0	0.3	12.9	10.3	17.7	3.4	17.9	12.2	7.8	15.3	13.1	9.1	3.3	31.9	40.0	24.9	22.2	17.2	19.0	21.1	28.9	24.7	39.9	29.0	48.1	19.8	45.4	24.6	31.1	38.7	51.8	49.2	36.6	38.4	29.6	38.7	49.7	26.9	36.3	16.4	66.9	33.4	20.4	25.0	48.2	37.6	16.0	24.4	27.7	85.2	30.7	22.9	14.3	57.9	17.7	23.8	16.0	16.9	36.8	50.3	25.7	14.8	38.8	24.6	15.7	37.0	307.8	25.1	34.8	38.5	29.3	26.4	34.5	27.6	24.5	37.9	23.6	18.4	63.5	24.2	28.2	23.0	11.2	2.0	3.2	2.6	1.5	1.8	1.8	1.5	1.7	1.2	3.1	1.7	1.6	7.0	4.5	1.3	2.7	1.2	0.7	2.5	1.9	8.0	4.0	1.6	2.9	3.0	1.7	1.6	0.3	3.4	3.3	41.4	25.6	29.1	50.9	59.0	64.6	58.5	31.2	50.1	46.6	38.1	26.9	14.5	32.9	40.3	38.6	64.6	33.2	59.0	44.6	13.7	30.2	25.1	49.8	63.4	40.6	31.1	39.3	53.9	27.5	29.9	39.2	45.3	63.1	29.1	43.8	32.2	46.3	27.4	35.3	52.9	39.6	42.7	45.9	49.1	17.3	37.3	41.3	26.6	32.8	41.4	27.8	48.4	47.3	53.1	47.9	33.9	33.8	53.5	81.5	33.3	16.7	38.1	65.4	32.9	48.0	48.5	140.2	104.8	53.0	69.0	58.3	59.0	46.0	39.9	84.8
CDK14	"PFTAIRE1, PFTK1"	ENSG00000058091	"Cyclin dependent kinase 14"	O94921	7	90466424-91210590	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 545.4;Horizontal cells: 173.3;Inhibitory neurons: 426.8;Oligodendrocyte precursor cells: 320.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 9.0;memory B-cell: 8.5;naive B-cell: 4.8;neutrophil: 4.8"	"Group enriched"	"Detected in many"	10	"B-cells: 8.5;granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015267	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA015267: AB_1855249"	"prognostic favorable (5.86e-4)"	"unprognostic (3.96e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.39e-3)"	10.1	4.4	9.7	7.8	12.8	7.1	8.6	11.6	31.2	10.1	0.0	5.9	2.7	8.5	3.1	3.1	12.2	12.2	11.9	18.5	7.9	20.7	13.4	9.6	12.4	7.8	17.9	14.5	15.1	3.0	9.2	6.1	7.8	11.2	3.3	17.4	8.3	6.7	4.6	2.5	3.8	7.6	6.4	8.2	8.0	7.9	19.2	5.5	13.3	7.2	12.9	5.7	5.2	20.5	18.0	0.2	35.0	4.5	31.9	32.0	8.0	14.7	14.0	8.8	9.5	0.4	8.6	58.9	1.8	14.6	13.1	5.2	1.8	20.7	16.9	0.1	8.3	0.0	11.2	0.4	14.7	18.3	0.3	22.7	5.3	26.5	9.4	14.7	11.6	0.4	0.3	78.4	18.4	0.1	0.1	7.3	21.8	0.1	9.6	49.3	47.4	50.2	4.6	4.9	7.7	21.9	37.3	0.2	0.7	15.4	4.7	9.2	28.4	37.8	48.5	32.1	23.0	43.1	36.3	41.9	14.6	23.8	37.9	9.0	0.3	0.5	0.0	0.6	0.0	8.5	0.0	0.0	0.8	4.8	0.0	0.0	4.8	0.1	0.5	0.1	0.2	0.5	9.7	12.8	11.6	31.2	18.5	7.9	7.8	17.9	7.8	6.4	19.2	20.5	11.0	19.2	5.1	118.2	37.4	0.8	7.7	6.0	2.2	6.9	7.0	8.9	18.3	12.8	9.1	11.0	0.0	0.2	0.2	0.4	7.9	9.8	53.9	1.7	13.4	2.8	1.8	4.0	545.4	6.7	0.1	16.1	4.1	1.5	0.0	11.2	1.4	11.3	3.7	173.3	426.8	0.3	4.1	3.4	4.9	46.4	15.5	7.0	5.4	66.5	1.7	9.4	0.0	320.7	32.9	13.4	1.3	15.8	78.1	12.8	0.1	22.7	3.9	9.7	0.0	6.3	15.9	5.4	6.6	1.2	1.3	0.0	1.9	6.5	0.3	4.2
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 15.2;ovary: 6.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 27.1;granulocytes: 79.1;Late spermatids: 40.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.4"	"Group enriched"	"Detected in some"	28	"basophil: 1.8;eosinophil: 3.7"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.6;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 30.9;HMC-1: 58.4;LHCN-M2: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Golgi apparatus"	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	0.7	0.3	0.0	0.2	0.0	0.0	0.8	2.4	0.4	0.8	0.0	0.5	0.3	0.6	15.2	0.6	0.5	1.9	0.2	0.5	0.0	0.3	0.0	1.0	0.1	0.4	0.1	6.1	0.1	0.2	0.3	0.0	0.4	0.7	0.7	0.0	0.3	0.3	0.9	0.6	0.8	0.4	0.1	0.0	0.7	1.9	0.1	0.2	0.1	0.7	0.1	0.8	0.5	0.3	0.3	0.0	0.0	0.0	1.6	2.8	0.0	5.9	22.6	10.2	20.7	0.0	3.0	0.0	0.0	2.3	0.5	0.0	0.0	0.0	30.9	0.0	0.1	1.9	0.0	0.0	0.3	0.1	58.4	3.4	0.0	2.7	1.5	0.4	0.0	0.0	0.0	0.1	19.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.5	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.5	0.0	0.4	0.1	0.4	0.1	0.1	0.3	0.1	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.0	79.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	40.3	0.3	0.1	3.6	1.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.5	0.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 101.5;Oligodendrocytes: 259.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 134.8;TIME: 160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	21.4	11.2	26.3	18.9	45.9	48.1	18.4	23.0	34.7	13.2	8.3	17.0	11.9	26.2	9.1	14.6	13.9	16.2	11.4	36.7	28.6	11.6	16.3	20.6	21.7	23.2	23.0	15.7	10.5	10.6	8.0	31.8	23.0	14.0	12.2	19.3	8.7	11.1	8.8	11.0	11.5	29.5	27.4	21.8	10.5	26.6	28.5	24.8	11.6	12.3	22.2	17.1	12.8	54.0	15.4	12.5	32.5	8.9	15.9	41.2	24.1	34.8	46.9	29.1	27.2	7.7	8.8	22.7	23.0	24.5	15.6	13.8	19.8	20.9	39.5	24.9	15.5	32.7	8.5	10.9	34.4	17.9	18.4	30.0	21.3	43.0	77.1	51.8	134.8	18.9	24.7	18.1	66.8	9.5	17.0	28.1	14.4	7.6	22.8	29.2	18.0	19.8	35.1	12.7	17.1	11.7	19.9	18.4	25.9	24.7	14.0	15.7	160.5	25.6	10.0	13.8	18.7	26.0	21.1	24.1	9.6	7.6	19.2	66.7	6.4	17.1	22.2	9.3	24.0	17.5	17.9	25.1	10.0	16.6	25.0	21.7	23.2	31.4	9.0	7.3	15.8	16.6	26.3	45.9	23.0	34.7	36.7	28.6	23.2	23.0	23.0	27.4	28.5	54.0	58.1	16.0	6.5	54.5	37.3	26.8	10.7	8.6	19.4	11.8	13.8	9.8	11.9	7.2	10.3	9.2	16.7	12.0	64.4	7.2	0.0	4.9	3.3	17.6	10.0	51.7	15.0	17.9	101.5	3.6	27.9	24.0	21.4	17.2	18.3	8.9	34.2	10.8	12.1	5.0	59.2	7.9	4.1	14.5	20.7	4.1	9.9	16.7	17.8	64.6	8.6	22.6	32.0	52.3	259.2	7.4	3.4	9.4	64.7	12.5	6.5	8.6	15.4	9.6	6.6	22.7	22.0	8.8	21.6	24.2	25.9	13.7	63.2	10.7	6.0	15.1
CDK19	"bA346C16.3, CDC2L6, CDK11, KIAA1028"	ENSG00000155111	"Cyclin dependent kinase 19"	Q9BWU1	6	110609978-110815958	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.8"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 137.1;Oligodendrocyte precursor cells: 154.8;Oligodendrocytes: 476.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 23.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007053, HPA007062"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoplasm	"HPA007053: AB_1233803, HPA007062: "	"unprognostic (1.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (4.72e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.50e-3)"	6.2	3.4	22.7	7.2	32.1	11.7	6.4	17.9	29.0	6.6	7.5	6.9	5.3	10.2	3.8	8.2	5.4	8.3	4.4	20.8	19.3	6.4	5.0	6.7	9.4	28.8	24.7	9.8	3.9	6.5	2.3	11.5	22.7	26.7	6.4	8.8	4.4	5.9	3.3	8.5	6.7	7.3	19.4	8.0	7.1	18.5	26.9	13.6	6.1	5.4	9.2	5.3	6.6	40.8	5.7	6.1	21.8	26.4	11.1	15.6	10.8	18.8	19.4	6.7	8.8	7.6	6.4	14.7	6.5	13.2	13.9	3.2	8.0	3.9	15.4	18.2	4.5	26.0	8.8	8.9	6.8	10.5	18.2	10.7	8.6	9.7	14.1	17.0	6.8	12.3	7.6	20.2	14.5	9.7	14.3	15.0	2.0	8.1	4.1	14.8	11.3	5.8	7.8	11.0	10.6	19.8	14.4	11.3	17.0	7.2	3.9	37.1	7.7	14.2	7.6	29.6	11.4	2.1	3.2	12.8	15.6	13.7	14.9	2.1	1.2	0.9	0.4	0.7	0.4	0.6	0.3	0.3	1.0	0.6	0.2	0.3	4.6	0.7	0.4	0.5	0.4	0.3	22.7	32.1	17.9	29.0	20.8	19.3	28.8	24.7	22.7	19.4	26.9	40.8	15.9	3.2	17.8	50.6	19.2	9.8	14.4	6.7	12.0	19.2	14.6	9.4	8.2	18.6	8.7	16.5	16.7	7.0	17.8	27.0	1.9	10.5	102.3	13.7	16.5	13.6	12.6	21.6	85.3	4.7	18.4	12.0	13.7	25.6	7.0	23.0	20.0	12.2	16.4	23.5	51.5	13.5	8.2	33.9	19.9	137.1	10.8	22.1	26.6	62.8	19.6	33.9	22.6	154.8	476.3	7.0	20.0	16.1	5.9	30.0	16.1	7.7	6.9	13.9	6.6	11.2	12.3	56.6	15.8	20.3	16.2	7.9	13.3	10.1	13.8	11.1
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966781-55972789	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Extravillous trophoblasts: 84.7;Melanocytes: 87.2;Syncytiotrophoblasts: 170.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 540.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	15.3	9.2	3.5	16.3	3.4	36.0	14.2	3.6	4.9	13.4	6.4	12.5	9.8	13.7	6.3	14.9	13.7	10.8	10.9	3.5	3.8	14.7	16.2	22.9	21.6	4.7	4.0	16.3	10.0	7.9	4.9	47.3	4.1	12.6	14.9	6.5	10.9	14.3	7.0	22.7	12.3	19.5	4.2	14.5	12.2	6.6	4.1	37.2	9.6	8.1	24.8	18.1	12.9	3.9	81.7	39.1	93.6	52.4	19.2	24.9	172.2	98.9	53.5	123.3	114.8	89.4	76.3	77.5	70.9	37.9	46.4	50.8	73.4	44.9	126.8	86.9	68.0	89.0	65.0	34.6	6.3	70.4	61.4	12.6	10.9	83.8	29.1	36.1	63.1	76.8	85.6	68.0	88.3	60.8	149.9	61.7	36.9	55.8	60.7	143.7	86.2	57.1	36.5	77.1	37.4	48.1	114.1	41.7	540.3	54.9	88.9	51.1	34.5	82.9	76.3	65.0	71.0	37.4	46.3	95.5	47.4	51.1	74.2	3.6	2.6	2.2	4.7	2.7	4.6	6.5	2.1	3.5	1.9	3.7	2.0	3.7	1.2	3.4	1.2	7.9	5.4	3.3	3.5	3.4	3.6	4.9	3.5	3.8	4.7	4.0	4.1	4.2	4.1	3.9	17.9	16.0	4.8	1.3	7.3	28.0	23.9	6.2	12.5	0.0	14.5	8.9	3.1	11.5	7.6	1.8	0.0	92.8	7.1	3.7	1.9	11.5	0.6	7.4	6.5	18.2	5.4	14.7	0.1	5.7	84.7	15.7	9.2	13.0	10.8	12.0	10.4	9.1	13.3	1.7	0.1	7.2	6.1	4.7	43.8	0.8	14.9	4.9	87.2	1.9	28.4	4.2	5.2	0.0	0.5	12.3	1.5	4.5	11.8	13.4	2.8	4.5	4.4	3.6	0.0	10.1	11.6	3.1	7.4	14.5	31.4	170.7	9.6	4.8	9.7	19.3
CDK20	"CCRK, p42"	ENSG00000156345	"Cyclin dependent kinase 20"	Q8IZL9	9	87966441-87974753	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 21.9;Spermatocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.6"	"Group enriched"	"Detected in many"	7	"NK-cells: 3.6;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 18.2;THP-1: 29.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007666, HPA027379, HPA027401"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553"	"unprognostic (4.60e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.69e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (2.32e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.04e-2)"	"prognostic favorable (2.12e-5)"	"unprognostic (8.24e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.42e-2)"	2.9	14.8	8.8	1.5	9.8	1.0	3.1	5.5	9.5	7.2	11.1	6.4	3.5	5.7	3.8	2.3	13.3	3.5	3.4	10.0	10.6	8.3	3.3	3.0	1.2	6.4	6.8	7.8	6.1	8.4	12.7	1.8	6.9	5.2	2.2	8.4	3.3	5.5	1.0	3.3	4.8	3.6	6.1	1.4	4.4	15.9	10.9	1.3	5.3	1.3	0.5	7.6	3.7	7.1	3.1	3.6	3.2	9.5	2.6	3.5	1.2	2.7	5.4	7.7	6.9	1.1	4.6	0.0	3.7	4.6	13.0	3.7	0.0	2.8	3.2	7.3	3.2	0.0	1.9	0.0	9.2	3.7	4.4	2.6	5.5	12.0	5.1	5.9	0.0	6.7	0.4	0.0	2.2	9.1	2.2	1.2	2.4	7.2	1.1	0.0	0.0	0.1	9.6	2.8	18.2	5.2	2.9	3.9	4.9	1.1	3.9	29.8	0.0	3.4	1.3	0.6	3.0	4.2	4.6	0.0	11.7	2.4	3.5	0.0	0.3	0.2	0.6	0.4	0.3	0.0	1.4	1.0	0.3	0.0	2.3	1.6	0.0	3.6	0.3	0.3	1.5	0.6	8.8	9.8	5.5	9.5	10.0	10.6	6.4	6.8	6.9	6.1	10.9	7.1	0.3	3.2	4.4	5.2	0.2	2.2	2.3	2.2	5.7	6.1	3.0	3.2	2.0	2.8	4.0	1.8	2.1	4.6	0.8	5.8	1.9	5.2	6.3	15.8	6.7	0.8	0.0	0.8	8.3	1.5	2.3	3.4	4.1	5.8	1.3	4.0	0.7	0.8	0.9	8.4	6.7	2.8	4.1	0.0	0.2	4.3	4.4	1.1	0.0	1.0	0.3	5.0	2.1	3.0	2.9	1.4	1.6	6.8	0.3	3.0	7.3	6.3	21.9	15.0	6.6	1.1	3.2	30.2	3.4	0.8	2.3	4.0	1.1	11.6	3.4	1.2
CDK2AP1	"doc-1, DOC1, DORC1, p12DOC-1, ST19"	ENSG00000111328	"Cyclin dependent kinase 2 associated protein 1"	O14519	12	123250112-123272334	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 44.3;intermediate monocyte: 152.6;myeloid DC: 52.5;non-classical monocyte: 175.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 52.5;monocytes: 175.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019377, HPA057648, HPA068833"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB019377: , HPA057648: AB_2683488, HPA068833: AB_2686046"	"unprognostic (1.56e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.77e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (5.27e-7)"	"unprognostic (9.32e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.18e-1)"	96.1	82.8	239.4	62.7	255.4	70.6	105.0	270.5	285.1	114.8	199.5	111.8	40.1	111.9	127.7	115.1	81.5	87.7	95.1	238.3	272.2	82.2	56.7	78.3	51.0	296.1	256.0	56.0	53.2	72.3	88.8	64.4	288.2	103.5	63.1	43.4	158.8	97.7	91.5	68.1	53.9	120.3	292.7	48.6	84.9	69.1	260.8	86.0	61.4	109.9	56.5	124.9	105.3	288.3	125.7	172.4	451.1	481.5	352.6	443.9	81.8	399.1	369.6	311.1	234.7	131.0	117.5	0.1	174.9	611.4	115.9	111.3	484.0	261.3	256.1	77.6	120.7	66.4	98.0	208.4	192.0	104.9	68.7	282.8	267.0	180.2	116.9	283.4	449.4	151.0	90.6	0.5	594.9	244.3	140.3	170.2	296.1	154.9	129.2	528.7	193.0	54.0	259.7	295.2	416.7	496.5	290.9	141.5	412.0	119.4	272.5	104.3	273.2	286.5	149.1	172.9	267.6	21.0	41.6	116.1	156.6	48.9	640.9	15.9	44.3	21.3	0.5	152.6	1.9	0.9	0.5	0.9	52.5	0.1	0.3	0.5	1.5	1.3	175.4	4.2	0.4	29.7	239.4	255.4	270.5	285.1	238.3	272.2	296.1	256.0	288.2	292.7	260.8	288.3	10.4	28.9	39.7	32.0	3.0	1.3	1.5	8.7	18.2	0.3	6.9	8.8	1.8	8.6	21.7	12.9	0.0	1.6	1.4	12.3	1.9	24.0	30.7	8.0	31.6	14.0	7.7	13.7	12.2	16.7	3.3	13.8	19.9	7.6	19.0	3.2	16.4	6.9	6.0	3.3	5.0	16.7	4.1	26.0	4.9	131.8	13.4	18.8	3.6	14.0	11.4	19.4	1.0	17.1	25.0	24.3	12.5	14.3	2.8	0.4	5.4	3.4	12.5	0.3	0.0	3.2	10.3	1.4	8.1	46.9	2.8	1.4	1.9	1.0	16.2	0.9
CDK2AP2	"DOC-1R, p14"	ENSG00000167797	"Cyclin dependent kinase 2 associated protein 2"	O75956	11	67506497-67508649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038872, HPA047599"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA038872: , HPA047599: AB_10963069"	"unprognostic (2.44e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (8.80e-4)"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.73e-3)"	45.6	69.3	83.5	46.1	87.6	32.1	34.2	90.5	107.0	40.7	76.3	46.6	42.9	41.2	85.8	45.2	37.5	27.2	98.5	82.8	87.3	103.0	109.7	46.1	64.8	99.2	89.3	27.9	67.9	25.1	43.7	29.8	95.5	41.9	28.1	25.7	47.2	45.7	23.3	19.7	40.5	30.3	91.5	47.1	47.8	12.6	87.1	55.7	78.0	22.6	48.2	42.8	27.2	93.1	92.9	77.6	33.3	72.4	55.0	19.8	46.9	30.0	25.7	54.8	43.6	104.2	121.6	58.1	111.0	32.6	64.4	67.7	59.5	77.4	16.7	156.0	29.7	36.2	60.8	81.8	113.2	32.7	48.8	17.5	84.8	47.3	93.5	44.2	64.3	86.9	32.5	204.4	23.7	183.5	196.6	111.3	35.2	221.7	83.4	83.6	18.4	245.3	129.1	30.4	23.2	50.9	44.2	130.5	150.8	30.3	73.0	70.0	35.6	26.5	46.4	61.7	27.7	55.0	39.8	65.7	73.2	49.3	34.6	284.3	119.2	266.2	297.9	222.7	261.5	229.6	221.4	267.7	174.8	222.3	117.4	176.3	97.5	292.7	266.1	793.7	291.1	215.2	83.5	87.6	90.5	107.0	82.8	87.3	99.2	89.3	95.5	91.5	87.1	93.1	54.6	64.1	86.2	4.2	112.0	67.0	47.0	118.3	186.1	27.8	88.8	75.3	76.6	88.6	80.3	117.7	31.3	94.9	206.5	187.0	215.2	85.1	1.7	98.2	50.4	56.8	102.8	42.5	3.5	53.2	192.7	49.0	78.5	104.1	74.8	49.5	45.7	131.3	84.6	33.7	3.6	151.1	81.4	46.8	94.9	2.6	24.5	71.5	113.8	11.2	109.8	61.1	171.0	6.0	14.0	99.1	158.5	30.5	240.8	71.1	139.6	329.7	64.6	29.4	26.3	22.0	76.2	10.2	31.1	170.3	51.0	194.4	131.4	30.1	123.2	76.4
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"glioma: 175.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 2594.8;LHCN-M2: 2819.4;RH-30: 8902.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	69.7	87.8	35.0	52.8	37.9	72.0	76.6	37.7	36.9	84.3	35.9	62.6	40.2	97.4	64.2	57.2	69.4	57.1	58.9	33.6	37.1	58.5	51.5	58.0	66.8	37.1	36.9	97.3	70.9	63.5	67.7	52.4	36.8	52.7	63.3	14.5	54.4	54.1	48.2	58.9	47.2	80.4	37.3	51.5	54.8	24.1	37.3	67.6	66.0	52.7	70.6	71.6	60.7	37.6	207.1	235.7	295.7	268.0	253.7	220.7	210.4	116.1	347.9	468.5	385.7	338.2	189.1	297.4	200.2	173.6	293.2	158.0	396.3	2594.8	354.9	150.9	209.0	275.4	149.5	237.9	297.0	309.7	182.5	221.5	180.9	294.2	326.7	326.4	304.8	280.0	301.3	242.7	2819.4	304.9	296.7	256.5	347.0	208.0	249.8	267.3	8902.5	272.1	147.2	320.6	271.2	251.7	205.3	150.2	310.0	195.1	202.8	380.7	146.1	233.6	217.0	265.8	233.1	122.2	206.1	450.8	214.1	291.3	286.9	9.5	46.5	10.3	79.6	65.6	81.8	93.5	70.0	72.5	66.7	90.0	93.0	84.4	4.4	56.6	41.9	84.9	57.0	73.6	35.0	37.9	37.7	36.9	33.6	37.1	37.1	36.9	36.8	37.3	37.3	37.6	47.1	22.4	30.8	7.8	40.0	89.7	78.6	83.4	74.0	15.9	67.2	82.2	0.7	51.5	35.3	47.8	10.4	82.9	26.1	15.9	70.5	93.1	13.5	14.9	77.7	50.8	45.6	98.0	5.2	62.5	134.5	79.4	28.5	22.6	69.1	60.2	39.7	35.8	132.9	18.5	6.7	42.2	40.7	25.1	44.1	8.0	64.0	31.2	53.4	6.5	41.9	51.4	29.9	5.5	8.0	48.3	18.9	63.2	57.8	113.9	14.0	80.9	7.4	17.9	32.9	62.1	61.9	32.1	48.3	74.5	86.1	46.8	32.3	78.8	78.7	49.4
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053815-151057897	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	6.3	16.8	50.2	9.4	53.2	11.2	8.6	44.9	65.8	8.6	40.0	9.3	10.9	6.7	24.9	10.2	8.2	9.5	9.8	57.5	50.9	13.5	12.5	8.3	9.8	48.6	45.3	4.5	9.5	22.8	14.7	8.6	48.4	8.8	9.9	11.3	9.6	10.2	8.5	9.5	8.6	10.4	43.2	9.4	7.9	4.9	50.1	14.2	10.0	7.2	11.6	8.8	6.0	50.9	31.9	40.8	37.3	59.7	48.8	36.1	17.8	24.4	41.7	47.9	40.3	31.2	31.0	34.7	71.3	31.8	63.5	23.5	67.8	40.6	22.6	24.9	43.3	38.2	32.4	30.7	31.6	29.0	64.4	37.9	28.7	39.0	13.5	62.8	38.8	57.6	36.3	24.0	50.7	68.4	76.4	57.9	39.3	57.2	80.5	38.9	14.8	41.5	46.2	27.9	23.0	97.8	30.9	37.7	43.8	36.0	18.6	25.9	22.7	42.2	10.3	31.2	39.2	52.1	61.4	13.7	66.4	46.5	75.8	18.9	39.4	20.1	13.5	46.2	11.1	13.3	12.8	13.6	44.7	12.8	9.8	11.8	5.7	19.9	36.4	26.9	31.9	23.8	50.2	53.2	44.9	65.8	57.5	50.9	48.6	45.3	48.4	43.2	50.1	50.9	7.6	0.0	6.0	1.6	6.2	3.6	8.2	18.0	6.2	12.1	9.6	10.4	3.1	8.6	14.7	11.0	2.1	26.8	5.4	8.0	39.2	21.4	0.8	14.9	10.9	8.9	9.0	12.2	5.8	18.9	12.3	7.6	9.7	9.3	30.5	23.6	7.9	11.1	41.9	0.0	6.4	8.9	18.3	21.9	6.2	1.3	4.7	16.6	10.6	1.9	19.9	12.6	12.3	1.5	3.7	22.8	15.0	11.3	12.4	4.3	20.2	35.7	14.4	7.1	6.6	4.5	13.1	3.9	11.2	11.4	6.3	9.0	7.3	14.2	9.5	9.0
CDK5R1	"Nck5a, p35, p35nck5a"	ENSG00000176749	"Cyclin dependent kinase 5 regulatory subunit 1"	Q15078	17	32486993-32491253	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 63.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Early spermatids: 21.2;Excitatory neurons: 36.6;Inhibitory neurons: 31.6;Late spermatids: 18.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"SCLC-21H: 58.1;SH-SY5Y: 15.6;SK-MEL-30: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000252			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"HPA000252: AB_2665953"	"unprognostic (1.08e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.74e-5)"	"unprognostic (1.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.03e-1)"	0.8	2.8	37.8	7.1	50.8	5.4	1.2	11.0	63.5	1.5	0.0	0.9	1.4	0.9	0.2	7.5	0.7	0.9	1.1	53.4	21.1	0.8	1.0	0.8	13.9	3.2	10.5	2.6	1.4	0.7	6.9	0.6	4.5	0.6	0.8	10.4	1.1	0.5	2.3	1.9	3.6	0.6	3.5	12.1	1.6	7.2	21.7	4.2	0.5	0.8	14.1	0.8	3.1	34.2	3.9	2.2	9.8	3.1	1.1	1.8	1.1	2.4	1.4	2.9	3.7	5.7	0.9	1.9	2.2	2.0	2.4	1.8	3.8	2.4	3.8	0.7	7.3	0.7	1.1	2.3	0.5	1.3	1.9	1.1	5.8	2.9	2.4	1.1	2.1	6.9	3.9	2.2	6.2	1.6	3.4	1.5	6.2	1.4	2.1	2.9	5.9	7.1	1.4	1.7	58.1	15.6	2.3	1.3	43.8	1.4	2.5	4.4	2.2	4.0	5.9	1.6	6.3	1.1	1.5	1.9	3.4	5.6	9.7	0.0	0.3	0.4	0.8	0.3	0.6	0.2	1.1	0.4	0.0	0.1	1.5	0.9	1.2	0.2	0.1	0.6	0.1	0.6	37.8	50.8	11.0	63.5	53.4	21.1	3.2	10.5	4.5	3.5	21.7	34.2	1.7	0.0	1.5	6.5	13.1	1.5	0.5	1.0	7.4	15.9	3.7	2.3	3.6	0.0	0.8	0.0	45.9	0.6	10.1	0.3	0.0	0.2	21.2	1.1	1.3	1.2	0.0	0.0	36.6	0.6	0.3	1.2	0.5	1.5	0.0	1.6	0.7	0.7	0.9	1.7	31.6	1.4	2.0	3.5	0.5	18.9	0.0	1.3	3.6	2.8	2.0	18.4	10.3	9.5	11.9	1.2	1.2	0.7	0.9	1.2	0.4	1.5	1.0	6.3	0.0	2.9	3.1	6.7	4.3	8.8	1.3	1.1	7.1	1.9	1.1	0.5
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836573	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 215.9;Erythroid cells: 213.5;Late spermatids: 237.0;Oligodendrocytes: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 378.4;REH: 173.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	3.7	7.3	6.7	4.7	7.1	18.1	4.9	5.4	5.1	4.8	2.6	5.9	6.1	3.1	2.1	4.2	2.9	3.6	4.7	4.0	5.0	4.4	5.9	4.1	6.6	6.3	6.7	2.7	6.2	9.9	1.7	17.3	6.3	3.0	7.5	0.5	5.7	4.2	1.0	6.8	7.2	3.2	5.8	4.9	9.1	3.3	9.6	41.1	2.4	2.3	6.2	3.8	4.6	8.8	27.1	11.3	34.9	23.9	10.6	11.5	5.8	27.2	18.4	14.3	13.5	34.7	20.9	21.7	14.4	19.9	8.4	15.8	20.8	42.6	34.4	43.0	10.6	50.8	23.3	34.7	6.3	33.0	2.7	11.5	23.1	17.9	90.8	13.4	5.6	75.1	49.3	55.5	26.7	5.9	378.4	3.8	9.8	37.4	9.1	173.7	112.0	36.4	20.3	0.7	18.1	113.8	3.7	9.8	17.1	26.0	0.6	54.9	19.3	44.1	63.7	18.0	54.2	27.4	0.5	27.6	6.9	112.1	60.8	0.9	0.2	0.6	0.6	0.4	0.9	0.2	0.6	0.8	0.5	0.3	0.7	0.7	0.1	0.7	0.4	0.9	0.3	0.3	6.7	7.1	5.4	5.1	4.0	5.0	6.3	6.7	6.3	5.8	9.6	8.8	38.6	25.6	3.7	2.9	17.7	60.3	23.5	55.0	62.6	0.4	20.7	21.2	18.1	22.8	32.8	22.0	0.0	53.8	30.5	12.1	9.8	37.0	215.9	3.1	29.0	30.7	16.8	213.5	114.7	23.3	5.3	28.5	42.3	6.9	25.3	39.2	11.4	27.0	16.0	0.0	60.3	63.7	28.5	23.0	48.6	237.0	5.0	27.6	19.6	108.7	22.4	0.8	39.1	119.6	235.3	94.7	22.8	3.4	85.3	47.1	20.1	8.2	11.9	0.0	6.6	100.8	32.2	2.7	33.6	36.7	50.4	17.6	42.5	62.8	92.7	27.3
CDK7	"CAK, CAK1, CDKN7, MO15, STK1"	ENSG00000134058	"Cyclin dependent kinase 7"	P50613	5	69234795-69277430	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 121.0;Extravillous trophoblasts: 343.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 169.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004364, HPA007932, HPA008453, CAB079975"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Plasma membrane, Cytosol"	"CAB004364: AB_627243, CAB079975: , HPA007932: AB_1078492, HPA008453: "	"unprognostic (3.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (9.42e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-2)"	13.4	19.8	9.4	9.5	10.2	29.1	14.8	10.9	12.9	17.5	11.5	13.7	13.3	12.1	12.9	37.3	12.5	6.4	12.4	9.5	10.5	18.4	13.6	12.7	4.8	9.7	9.7	11.7	14.1	3.2	18.2	16.2	9.8	13.7	7.4	12.8	18.9	4.8	26.8	25.3	12.2	7.7	9.8	12.6	13.5	30.6	10.0	9.3	13.2	15.0	13.3	16.1	19.9	9.4	42.8	5.9	19.4	30.6	6.4	24.4	169.5	30.9	37.5	46.2	42.9	62.2	64.5	3.7	36.4	36.8	34.2	65.3	10.8	31.3	40.6	9.0	3.1	8.6	21.4	25.9	32.8	17.9	33.8	7.1	61.3	1.8	46.0	24.5	32.5	22.3	16.3	16.1	13.3	33.3	9.4	51.7	20.7	2.8	25.4	12.3	0.7	27.1	42.6	25.4	8.6	17.5	11.6	50.4	42.4	28.1	44.9	39.3	7.4	17.1	27.4	33.1	18.2	14.4	30.4	16.5	31.4	10.2	15.5	27.9	7.9	16.2	5.3	8.9	7.9	10.6	7.8	10.6	7.3	14.5	5.9	6.4	8.2	8.6	4.7	8.9	10.5	6.1	9.4	10.2	10.9	12.9	9.5	10.5	9.7	9.7	9.8	9.8	10.0	9.4	12.2	16.0	13.2	10.7	7.8	57.7	21.4	32.9	15.4	6.4	12.3	14.7	11.3	10.0	20.2	5.5	12.5	121.0	11.7	10.2	15.6	27.8	26.8	33.1	10.7	11.6	3.0	9.9	17.6	21.6	343.6	13.0	9.7	27.2	15.8	7.4	7.1	6.7	24.0	1.7	13.7	12.3	20.3	8.5	6.0	7.9	7.5	8.5	7.2	11.2	11.6	10.4	15.5	8.0	11.9	29.3	16.2	7.2	5.8	28.2	12.3	29.3	42.4	8.7	26.3	10.0	12.5	70.1	18.6	15.9	41.9	64.6	11.4	6.8	13.2	29.8
CDK8	K35	ENSG00000132964	"Cyclin dependent kinase 8"	P49336	13	26254104-26405238	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 118.7;Inhibitory neurons: 175.4;Late spermatids: 100.4;Oligodendrocyte precursor cells: 149.3;Oligodendrocytes: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044721			Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044721: AB_2679059"	"unprognostic (3.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.37e-2)"	4.4	2.9	2.2	3.5	2.5	3.2	3.0	7.6	3.0	2.9	1.2	10.5	7.7	4.0	3.2	5.1	2.5	3.9	4.1	3.0	2.7	5.1	5.7	2.9	3.1	2.7	3.0	2.5	7.1	5.1	2.1	5.9	2.4	3.5	6.0	8.5	4.6	6.9	5.0	3.1	7.5	6.6	2.1	2.5	5.0	9.7	2.6	5.9	3.4	5.2	4.1	6.2	2.5	2.1	10.1	8.4	16.5	16.4	8.3	10.2	10.3	19.6	13.2	13.8	10.0	23.8	13.6	10.7	8.3	9.8	11.6	12.2	18.7	12.9	17.2	25.8	10.3	20.5	6.4	8.2	5.8	32.3	11.4	7.5	12.2	10.7	17.3	7.8	10.2	18.1	32.1	0.0	12.5	10.7	25.2	15.1	13.2	15.5	9.9	15.4	15.9	7.6	8.2	9.2	13.6	8.6	8.1	15.1	13.9	12.7	5.5	14.6	10.5	8.8	11.3	16.1	10.4	7.8	15.2	19.3	5.5	13.2	10.7	0.1	0.2	1.0	0.2	0.4	0.4	0.2	0.3	0.4	0.4	0.4	0.4	0.3	0.0	0.2	0.3	0.2	0.2	0.2	2.2	2.5	7.6	3.0	3.0	2.7	2.7	3.0	2.4	2.1	2.6	2.1	6.5	9.6	4.4	63.6	11.2	19.8	7.7	5.9	8.6	20.5	6.4	5.0	5.9	10.0	6.8	1.8	25.0	8.2	9.5	11.7	9.8	8.9	66.4	7.8	7.7	6.6	8.4	9.9	118.7	8.2	9.7	9.4	14.3	7.4	0.0	8.9	6.8	8.0	8.0	18.5	175.4	7.6	10.2	9.1	11.3	100.4	7.8	7.9	8.8	58.1	8.4	7.7	6.2	149.3	91.9	11.5	10.9	8.2	14.4	14.9	18.0	15.3	5.3	17.3	6.6	67.6	10.9	32.9	18.3	12.8	23.9	9.7	10.8	11.2	11.7	16.2
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790792	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	44.6	60.8	44.3	23.7	43.7	47.0	40.3	40.8	53.8	55.5	35.4	49.3	19.7	49.3	21.1	35.4	65.6	23.7	40.4	50.8	42.0	44.5	65.1	47.2	35.1	44.7	44.1	88.5	44.4	19.2	67.0	18.7	41.1	44.1	12.2	11.1	29.7	23.3	28.3	38.7	40.9	19.1	42.7	65.6	37.4	44.3	42.1	31.9	42.1	17.1	20.9	38.9	40.5	44.4	22.5	40.5	24.9	27.6	27.6	21.4	32.1	22.9	33.3	23.4	20.9	30.3	25.0	39.5	25.7	26.0	32.1	44.2	16.5	37.3	8.9	34.8	19.0	37.1	45.2	25.3	40.2	36.3	56.5	37.9	44.5	24.8	27.7	30.0	48.5	34.8	32.6	51.7	21.2	60.1	39.5	54.5	55.0	34.3	41.9	112.2	21.2	57.0	34.2	24.9	24.5	29.2	34.5	35.8	20.9	19.3	45.0	33.9	56.4	27.8	30.9	24.1	22.3	92.5	76.4	34.7	26.1	24.4	25.9	4.1	3.7	5.8	10.3	5.1	10.1	3.6	5.7	8.3	4.8	6.6	6.3	7.9	5.4	22.4	7.5	9.9	4.4	3.6	44.3	43.7	40.8	53.8	50.8	42.0	44.7	44.1	41.1	42.7	42.1	44.4	43.1	12.8	12.4	39.8	27.1	24.1	27.6	15.8	18.8	13.9	17.9	10.9	14.1	20.0	10.8	11.0	2.1	22.5	28.5	17.1	15.6	31.3	4.4	26.4	22.7	35.6	19.2	15.4	18.1	37.2	22.3	23.0	24.5	25.3	25.3	18.1	33.5	26.4	23.3	25.2	17.0	12.7	8.2	18.8	23.4	6.2	19.6	24.2	16.0	22.5	44.7	17.5	33.0	12.5	16.8	32.9	13.7	31.2	22.2	28.9	14.5	16.7	20.4	7.9	0.0	21.6	22.1	8.9	22.9	19.9	22.0	51.3	24.7	54.5	13.7	31.4
CDKL1	KKIALRE	ENSG00000100490	"Cyclin dependent kinase like 1"	Q00532	14	50326265-50416461	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 23.4;Excitatory neurons: 46.2;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 25.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059605, HPA065919"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA059605: AB_2684080, HPA065919: AB_2685578"	"unprognostic (4.12e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (5.53e-8)"	"unprognostic (1.21e-1)"	"unprognostic (7.96e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.31e-3)"	13.5	3.6	3.4	4.9	4.4	3.6	3.5	1.4	9.0	13.9	3.7	8.8	13.2	13.9	3.2	5.2	15.4	5.2	2.3	5.5	2.3	19.4	1.6	6.5	6.5	2.0	2.1	13.8	1.3	1.2	0.6	6.5	2.9	5.9	6.6	20.2	2.8	9.0	7.1	13.5	6.9	8.5	2.9	7.0	4.9	2.0	1.8	1.9	7.9	1.0	2.6	6.9	6.6	8.1	7.7	4.9	3.5	4.3	5.3	6.1	2.3	2.2	3.2	1.9	2.0	4.0	5.9	6.1	2.8	3.2	3.2	5.9	0.8	0.3	1.9	8.9	3.1	12.2	4.6	3.9	6.2	9.7	5.3	1.5	3.0	3.2	8.0	2.4	6.7	10.3	3.3	4.8	1.1	2.5	2.8	4.7	1.9	2.6	3.9	3.3	3.8	3.1	5.3	6.6	4.6	3.4	4.2	18.3	2.1	1.3	2.4	6.2	4.0	6.7	4.1	7.1	5.0	2.4	1.8	2.9	1.7	8.7	7.6	3.2	1.4	2.6	3.5	1.4	3.1	2.6	2.3	3.2	0.8	3.0	1.9	1.9	0.7	2.3	0.2	0.8	2.4	1.3	3.4	4.4	1.4	9.0	5.5	2.3	2.0	2.1	2.9	2.9	1.8	8.1	3.2	19.2	9.9	6.5	3.0	3.1	4.1	0.2	3.4	0.7	0.4	0.5	0.5	0.0	2.6	11.0	0.0	0.1	2.3	7.2	5.9	1.4	0.4	23.4	9.6	3.3	1.8	6.1	46.2	1.8	0.1	7.6	1.1	4.9	1.3	3.2	6.4	0.3	0.4	0.0	20.6	2.1	2.0	0.9	1.5	1.5	9.0	1.5	0.0	7.5	0.8	0.9	2.1	46.8	25.4	1.9	4.8	3.4	0.2	3.1	4.9	8.0	20.4	0.7	0.0	4.0	4.6	0.0	0.3	4.7	2.7	0.3	4.2	3.6	5.2	2.2
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75576496-75630716	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;choroid plexus: 8.6;retina: 9.6;testis: 11.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 76.4;Early spermatids: 57.8;Excitatory neurons: 32.8;Inhibitory neurons: 40.9;Oligodendrocytes: 46.4;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;HHSteC: 1.9;RPTEC TERT1: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.1	1.0	6.3	0.3	6.7	0.0	0.3	4.1	8.3	0.6	8.6	0.7	0.1	0.6	0.9	0.8	1.6	0.4	0.3	6.5	6.1	5.9	0.0	4.7	0.3	6.0	4.8	1.6	0.5	2.5	1.5	0.0	6.5	0.6	0.9	9.6	0.3	0.6	0.0	0.2	0.1	0.4	4.9	0.1	0.6	11.6	5.8	0.0	3.1	0.0	0.6	0.2	0.3	8.3	2.1	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.8	1.0	0.9	0.1	0.5	0.0	0.3	0.0	1.0	0.2	0.0	0.2	0.9	0.1	1.5	0.0	0.1	0.0	1.9	0.0	0.0	0.6	1.0	0.1	0.3	0.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.2	0.1	1.1	0.9	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	6.7	4.1	8.3	6.5	6.1	6.0	4.8	6.5	4.9	5.8	8.3	0.2	25.6	76.4	5.9	0.4	0.1	0.5	0.6	0.6	17.7	0.7	3.0	0.9	1.5	4.7	9.2	4.2	0.1	0.3	3.0	7.9	1.9	57.8	11.6	1.4	0.2	1.8	0.0	32.8	0.2	0.6	1.2	1.1	2.5	1.3	1.0	0.4	0.0	0.1	10.1	40.9	2.3	0.0	0.0	0.4	20.7	1.8	0.5	1.8	3.7	0.0	11.6	0.0	5.5	46.4	0.1	1.0	1.2	0.3	0.2	0.0	29.5	18.6	20.2	0.0	0.4	1.1	101.7	4.1	0.8	0.3	0.3	2.7	0.2	2.7	0.2
CDKL3	NKIAMRE	ENSG00000006837	"Cyclin dependent kinase like 3"	Q8IVW4	5	134286350-134371047	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 342.0;Late spermatids: 295.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027751			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Vesicles"		"HPA027751: AB_10601256"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.47e-4)"	"unprognostic (2.82e-1)"	"unprognostic (9.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.43e-3)"	0.7	0.8	2.5	0.5	2.8	0.2	0.6	2.5	4.4	0.8	1.3	0.8	0.5	1.1	0.6	0.6	1.2	0.6	2.7	2.4	2.7	1.5	0.8	0.5	0.7	2.9	2.6	0.7	0.5	1.0	0.6	0.4	3.0	0.7	0.6	4.2	0.4	0.8	3.4	0.6	0.6	1.5	3.1	0.7	0.5	16.2	2.8	0.9	1.2	3.3	0.9	0.6	0.5	5.0	0.5	1.3	1.7	1.2	2.7	2.4	0.7	1.7	1.4	0.7	1.7	1.2	0.8	1.3	1.0	1.1	3.3	0.5	1.5	1.0	1.2	1.6	1.0	0.8	1.7	1.9	1.7	0.3	0.5	1.1	2.5	2.2	0.6	1.2	0.7	3.4	1.1	0.7	1.9	0.6	1.2	4.6	1.2	0.3	0.5	1.9	0.6	0.4	0.9	0.5	2.5	0.8	1.8	0.1	2.1	1.8	1.0	0.9	0.5	1.4	0.3	1.9	0.5	1.8	2.5	2.9	2.1	1.4	1.1	0.0	0.3	0.3	0.3	0.4	1.4	0.5	0.4	0.9	1.0	0.3	1.3	1.3	0.0	0.6	0.1	0.5	0.9	0.4	2.5	2.8	2.5	4.4	2.4	2.7	2.9	2.6	3.0	3.1	2.8	5.0	4.1	0.0	3.7	50.6	2.0	10.8	6.4	18.8	4.0	13.3	4.5	5.8	2.2	2.8	9.9	5.5	4.2	3.1	3.2	0.5	9.8	3.5	342.0	7.5	6.4	4.6	3.0	4.8	41.6	5.1	1.8	6.2	1.5	3.7	3.8	7.0	3.6	2.3	3.6	6.7	52.0	1.5	18.3	2.1	19.4	295.3	5.0	2.8	10.6	16.9	2.4	10.8	3.1	32.6	50.7	1.5	1.6	9.1	1.4	4.3	1.3	9.5	12.9	9.7	0.0	6.3	7.9	35.3	17.2	1.7	11.1	4.5	3.4	6.2	0.9	3.8
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 216.6;Horizontal cells: 80.8;Inhibitory neurons: 116.1;Oligodendrocytes: 79.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A549: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	2.0	1.6	4.9	1.1	6.7	2.5	2.5	0.0	11.7	3.9	0.0	1.9	0.9	2.6	1.9	3.5	1.7	1.8	3.8	6.8	0.0	3.5	1.2	4.6	0.8	0.0	2.5	3.8	2.4	2.4	1.7	3.2	0.0	3.6	1.2	12.2	2.2	2.3	1.7	2.2	0.9	2.5	0.0	1.2	2.4	7.1	5.7	1.7	3.0	2.0	1.1	2.7	3.4	5.4	1.1	10.0	2.6	2.2	2.4	3.6	1.7	1.7	3.0	2.0	2.5	3.3	1.5	1.5	0.3	1.0	4.5	0.5	3.2	1.8	4.3	0.4	1.7	0.1	5.5	2.1	1.1	0.2	0.7	1.7	1.9	5.4	4.9	1.3	1.0	1.6	0.2	1.5	2.7	1.0	0.6	0.8	5.2	0.9	2.3	0.6	3.0	0.1	1.8	7.1	0.5	3.2	2.7	0.9	1.5	4.4	1.3	0.4	6.2	2.5	1.7	5.5	1.3	0.3	0.1	0.3	1.4	0.4	3.0	5.7	0.5	1.1	0.3	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	2.0	0.2	0.3	0.5	0.1	0.1	4.9	6.7	0.0	11.7	6.8	0.0	0.0	2.5	0.0	0.0	5.7	5.4	9.4	25.6	24.8	37.5	2.8	0.9	10.7	0.7	4.6	19.0	7.9	6.3	12.9	5.7	5.3	7.3	33.3	27.4	3.8	1.3	7.9	7.7	34.3	6.5	8.4	6.3	2.4	2.7	216.6	9.6	3.1	7.4	7.7	7.9	1.3	3.9	6.1	3.4	4.2	80.8	116.1	1.6	2.0	4.4	0.5	55.3	5.9	4.9	0.0	34.7	4.6	23.5	0.0	41.7	79.7	8.2	0.8	5.3	4.3	16.2	0.6	8.9	4.0	20.4	32.9	7.2	8.4	5.8	10.1	4.2	1.3	47.3	2.3	5.7	1.8	22.9
CDKN1A	"CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1"	ENSG00000124762	"Cyclin dependent kinase inhibitor 1A"	P38936	6	36676460-36687337	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 74.5"	"Group enriched"	"Detected in many"	9	"B-cells: 20.7;dendritic cells: 21.5;monocytes: 74.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 798.5;HSkMC: 586.5;hTCEpi: 775.8;LHCN-M2: 604.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 76.0"	"Low region specificity"	"Detected in all"			"CAB000064, HPA005946, CAB069401"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477"	"unprognostic (7.99e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.14e-5)"	"unprognostic (1.57e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-2)"	"unprognostic (7.55e-3)"	"prognostic favorable (4.95e-5)"	"unprognostic (8.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-2)"	322.1	98.1	47.0	62.1	48.1	72.7	144.2	47.3	60.9	123.3	85.9	119.0	115.2	74.4	41.0	203.2	213.9	132.6	170.6	47.2	49.5	149.9	173.4	182.2	17.3	63.7	54.6	184.9	130.5	70.1	104.4	44.7	53.4	91.4	108.2	29.2	79.1	29.4	241.6	224.4	130.0	114.3	55.0	34.4	121.3	47.0	50.3	59.7	77.5	26.9	21.8	212.7	142.3	53.6	27.0	108.1	80.1	2.0	273.3	490.3	149.5	435.6	344.8	52.3	203.7	9.6	25.3	18.3	15.5	267.9	48.0	60.2	3.7	477.7	82.4	36.2	22.0	3.0	85.8	137.0	798.5	0.5	127.7	586.5	775.8	476.2	147.1	309.3	275.3	1.4	5.1	120.8	604.2	57.4	3.9	11.3	10.2	112.8	15.5	54.4	67.1	31.9	91.2	201.5	36.7	35.6	101.3	8.4	21.3	185.2	32.7	111.2	155.8	91.5	86.9	6.2	36.4	202.0	42.9	54.5	118.7	9.9	261.0	0.0	22.8	0.5	0.5	52.2	0.8	20.7	1.1	0.6	20.0	16.2	0.3	0.4	4.2	0.7	74.5	21.5	2.9	34.2	47.0	48.1	47.3	60.9	47.2	49.5	63.7	54.6	53.4	55.0	50.3	53.6	571.2	83.3	45.1	1.0	126.9	440.5	340.1	293.1	512.8	0.8	203.9	187.6	151.6	41.5	214.4	68.0	0.0	42.1	56.4	505.3	46.9	217.6	0.9	227.9	57.3	327.1	175.5	5.7	0.5	264.7	52.8	302.4	150.9	199.2	104.4	20.4	71.7	68.9	72.9	0.0	0.4	197.1	156.6	62.0	556.0	3.9	34.5	277.6	218.7	5.6	280.6	58.4	2.1	0.0	0.5	429.9	466.1	16.6	376.4	201.7	383.2	17.2	215.1	3.1	26.3	303.6	471.6	1.2	1.7	620.9	672.0	155.3	106.0	10.7	75.8	478.0
CDKN1B	"KIP1, P27KIP1"	ENSG00000111276	"Cyclin dependent kinase inhibitor 1B"	P46527	12	12715058-12722369	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003691, CAB021888, HPA059086"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB003691: AB_425362, CAB021888: , HPA059086: AB_2683900"	"unprognostic (5.67e-2)"	"unprognostic (9.76e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (6.90e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	53.4	44.7	53.6	40.1	70.6	68.1	50.2	73.4	81.3	55.3	43.1	43.9	44.5	41.0	24.5	29.1	47.3	24.6	32.9	47.9	58.9	30.2	35.2	38.9	55.3	58.6	58.3	66.1	23.9	34.4	24.4	41.0	61.2	35.9	32.5	55.3	36.3	33.4	81.4	45.4	40.7	24.8	55.1	55.1	30.0	25.8	58.3	71.8	33.7	63.4	39.9	32.0	44.5	91.2	37.1	16.6	94.5	16.6	32.0	18.0	46.1	31.5	53.8	46.0	56.4	47.7	40.4	0.3	12.5	19.6	16.6	34.2	44.9	16.7	41.1	62.4	31.5	28.8	46.5	53.2	42.5	24.5	18.6	19.8	35.3	15.2	44.0	107.8	27.8	54.5	31.5	101.6	16.6	45.9	32.7	35.3	38.0	32.1	16.8	25.2	30.9	63.1	22.5	38.6	35.6	58.4	48.9	34.8	65.8	33.7	18.6	54.6	19.1	22.6	34.9	20.7	33.3	86.1	59.4	33.2	28.2	36.6	22.5	6.2	3.8	8.6	5.9	3.5	6.1	6.8	7.7	7.2	3.6	5.0	8.0	6.1	20.9	7.3	5.5	3.9	12.3	4.0	53.6	70.6	73.4	81.3	47.9	58.9	58.6	58.3	61.2	55.1	58.3	91.2	64.2	44.8	29.3	6.2	126.2	52.6	20.7	21.0	115.5	45.6	39.5	30.1	39.1	21.5	27.1	9.2	27.1	42.9	92.5	32.3	15.6	10.8	70.0	31.2	35.8	51.1	45.7	70.5	8.1	9.3	47.6	39.3	25.5	34.3	31.0	21.3	47.2	30.7	26.8	10.1	13.4	41.4	24.4	55.3	66.0	67.7	55.9	65.1	74.7	23.4	31.6	182.9	60.8	6.0	29.5	10.1	21.3	26.7	121.2	30.3	33.4	16.9	36.4	29.4	92.1	20.2	53.5	7.7	10.8	102.3	52.6	39.0	166.1	20.9	41.9	22.7
CDKN1C	"BWCR, BWS, KIP2, P57"	ENSG00000129757	"Cyclin dependent kinase inhibitor 1C"	P49918	11	2883213-2885775	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 206.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 575.3;Extravillous trophoblasts: 1531.7;Syncytiotrophoblasts: 2241.2;Theca cells: 781.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 155.1;non-classical monocyte: 376.4"	"Lineage enriched"	"Detected in many"	14	"monocytes: 376.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.0;HeLa: 12.8;RPMI-8226: 18.7;SH-SY5Y: 33.0;SiHa: 25.2;SK-MEL-30: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002924	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA002924: AB_1079548"	"unprognostic (5.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.82e-3)"	"unprognostic (5.79e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	127.4	182.9	8.2	3.3	38.0	1.7	92.5	43.3	18.7	73.7	6.5	48.1	1.4	70.6	0.2	29.9	70.7	0.8	82.6	11.7	18.8	149.5	8.3	34.5	0.2	55.1	33.5	206.4	28.5	0.2	27.8	28.1	45.0	33.1	0.2	0.5	21.7	1.5	60.3	26.6	25.0	0.4	31.8	20.6	54.1	8.6	34.3	0.2	17.0	0.9	0.4	75.0	49.4	95.3	0.1	0.1	1.6	0.0	0.4	0.5	1.8	0.3	0.6	0.3	0.0	3.3	0.4	0.0	12.0	0.2	0.1	0.5	0.3	0.3	0.1	5.6	1.2	0.1	12.8	0.0	3.3	0.0	1.4	2.4	1.6	0.0	0.2	0.1	0.3	0.1	2.7	0.8	0.5	0.1	0.0	6.0	10.6	0.5	4.0	2.2	0.0	18.7	0.7	0.0	3.5	33.0	25.2	0.3	15.2	0.9	0.2	2.8	0.4	0.0	2.2	0.0	0.1	7.3	0.0	0.1	0.0	1.8	6.8	9.1	1.2	0.9	0.4	155.1	1.8	0.0	0.4	0.6	26.9	0.3	1.0	0.3	2.2	0.0	376.4	0.2	0.7	14.7	8.2	38.0	43.3	18.7	11.7	18.8	55.1	33.5	45.0	31.8	34.3	95.3	357.3	3.2	5.8	1.0	11.6	10.7	81.7	4.9	30.7	11.9	81.0	150.5	45.3	61.5	10.8	31.3	6.2	575.3	46.9	20.3	15.6	9.8	176.5	38.8	101.5	100.8	106.5	0.8	0.6	0.6	1531.7	141.0	17.9	56.2	0.0	31.2	74.6	4.0	91.0	8.4	1.2	25.0	12.2	23.5	23.2	276.4	74.3	54.9	35.6	4.7	14.1	68.3	0.0	3.5	65.7	4.3	4.2	44.4	12.9	64.6	4.0	78.5	7.5	27.4	32.9	238.3	71.4	2.1	3.5	17.3	11.8	2241.2	25.1	781.8	15.2	71.8
CDKN2AIP	"CARF, FLJ20036"	ENSG00000168564	"CDKN2A interacting protein"	Q9NXV6	4	183444635-183449064	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 207.0;Glandular and luminal cells: 333.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 161.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041397, HPA062142"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA041397: AB_10794297, HPA062142: AB_2684696"	"unprognostic (9.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.65e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.23e-2)"	11.7	11.7	10.1	11.9	10.7	38.0	15.5	13.4	13.4	12.8	9.9	14.3	19.0	15.7	12.3	22.2	11.8	12.9	10.3	9.8	10.4	18.3	17.5	11.2	19.8	10.2	10.2	22.6	18.5	15.4	11.4	13.9	10.1	12.8	13.6	13.1	12.8	13.0	9.0	12.0	17.3	9.7	10.9	14.3	17.8	20.1	10.8	24.0	13.5	14.2	18.8	11.8	12.3	12.3	14.4	8.1	23.2	16.8	19.0	14.0	17.7	23.9	19.9	23.9	16.0	11.9	13.5	47.1	4.9	16.1	10.0	11.3	21.0	17.3	25.1	19.4	12.6	49.7	39.4	15.9	14.8	37.3	19.5	16.3	15.6	14.3	18.7	12.6	19.1	18.0	25.1	50.4	16.5	7.8	41.6	30.5	17.0	5.5	16.2	36.1	11.2	19.5	161.1	13.5	23.9	20.7	17.2	72.0	29.9	14.9	10.5	32.0	11.0	8.5	12.3	7.9	19.6	24.4	10.9	25.0	13.3	31.4	13.9	61.0	8.0	18.6	14.4	9.7	14.9	12.2	17.4	15.4	7.7	14.1	22.6	20.8	9.7	15.0	10.3	5.2	19.2	14.6	10.1	10.7	13.4	13.4	9.8	10.4	10.2	10.2	10.1	10.9	10.8	12.3	49.6	16.0	33.1	3.6	58.9	35.9	38.5	9.1	130.3	21.2	35.5	40.1	18.9	17.2	24.2	16.5	10.4	21.8	51.8	36.4	17.6	12.5	150.8	207.0	48.9	33.5	30.4	32.0	5.8	15.5	14.7	38.8	62.2	333.9	62.1	29.7	16.4	13.5	15.7	21.9	5.8	25.5	20.3	12.6	24.2	70.5	21.1	25.7	21.4	7.5	13.2	24.3	22.6	7.5	9.9	17.6	21.1	17.3	47.2	31.5	37.8	13.1	28.8	21.2	13.1	60.8	37.5	36.6	40.3	124.7	39.8	18.7	55.3	22.4	33.3	60.9
CDKN2B	"CDK4I, INK4B, MTS2, P15, p15INK4b, TP15"	ENSG00000147883	"Cyclin dependent kinase inhibitor 2B"	P42772	9	22002903-22009305	"Human disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 36.2;intestine: 30.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 240.7;Pancreatic endocrine cells: 164.5;Proximal enterocytes: 139.0;Squamous epithelial cells: 142.0;Urothelial cells: 241.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 3.3;intermediate monocyte: 3.3;non-classical monocyte: 9.0"	"Lineage enriched"	"Detected in single"	17	"monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.1;HaCaT: 35.0;HeLa: 33.9;hTERT-RPE1: 60.1;SiHa: 48.0;SK-MEL-30: 35.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB000349, HPA052838, HPA063327"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB000349: , HPA052838: , HPA063327: AB_2684987"	"unprognostic (2.30e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.47e-6)"	"unprognostic (2.10e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (9.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.28e-2)"	18.7	1.9	2.0	2.9	1.8	0.4	8.6	1.1	1.9	9.6	9.1	22.4	21.7	3.8	0.6	36.2	1.7	2.4	1.0	1.6	2.2	1.2	1.2	12.6	1.1	2.7	1.5	0.9	1.2	3.3	3.5	2.3	2.3	3.6	19.7	2.8	6.7	4.7	7.2	12.9	30.9	2.1	1.7	4.6	6.0	5.3	2.4	0.8	1.1	1.1	8.1	7.9	20.2	2.4	0.0	0.0	0.3	2.1	28.2	38.1	0.7	1.8	0.0	4.6	12.6	3.6	10.3	0.0	3.4	2.3	0.0	35.0	0.8	6.9	5.5	2.6	9.7	0.0	33.9	1.5	14.4	1.1	6.1	8.1	0.0	6.5	25.8	60.1	4.4	0.0	0.0	17.1	7.3	2.8	0.0	0.1	1.7	1.7	19.5	0.0	2.4	0.7	10.0	0.0	5.4	0.1	48.0	11.5	35.7	25.8	3.0	0.0	14.8	0.0	0.7	0.1	0.0	13.5	8.4	0.1	0.0	1.0	0.0	0.0	3.3	0.0	0.1	3.3	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.1	0.0	0.0	9.0	0.0	0.0	1.0	2.0	1.8	1.1	1.9	1.6	2.2	2.7	1.5	2.3	1.7	2.4	2.4	3.5	67.3	6.7	0.3	2.9	5.4	27.0	40.5	5.7	3.2	6.4	9.8	3.1	1.5	37.5	5.5	0.0	1.2	3.2	240.7	0.0	57.7	11.3	31.8	7.5	4.1	7.7	0.0	0.1	38.2	0.8	11.5	30.5	37.2	0.0	0.4	1.8	0.1	1.2	0.0	0.5	31.6	14.2	17.6	3.8	2.7	0.6	5.6	3.6	2.8	3.2	4.8	0.0	1.0	0.5	164.5	75.6	1.2	2.1	65.3	139.0	0.1	17.9	7.2	0.0	2.7	8.9	13.8	3.5	142.0	24.2	3.1	2.9	1.2	23.3	241.6
CDKN2C	"INK4C, p18"	ENSG00000123080	"Cyclin dependent kinase inhibitor 2C"	P42773	1	50960745-50974634	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 98.4;lymphoid tissue: 96.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 73.5;Sertoli cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 273.1;U-937: 284.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005303, CAB018398, HPA019057, HPA019764"	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.70e-10)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.24e-1)"	98.4	23.2	21.6	9.1	23.6	36.0	30.6	22.6	31.4	17.5	20.3	19.3	13.4	20.4	11.8	11.1	15.2	15.5	24.2	21.6	23.0	10.4	7.2	9.9	22.5	23.0	22.4	47.6	17.4	19.9	7.8	7.3	24.0	9.9	12.6	7.8	8.8	24.9	20.5	18.9	14.2	22.2	21.2	11.1	7.4	5.2	22.2	96.2	9.7	8.6	23.4	13.1	16.3	30.3	67.6	32.9	5.9	99.6	108.0	16.4	1.5	61.8	76.2	121.8	107.8	1.8	25.7	140.3	58.5	63.5	41.6	8.2	71.4	9.8	63.4	78.4	90.7	102.5	254.6	21.5	5.5	74.0	42.8	5.6	1.9	32.8	14.6	45.6	32.7	115.0	45.0	0.0	76.2	22.0	91.1	40.4	0.1	31.6	71.3	108.6	86.8	0.4	42.9	34.1	49.6	114.3	88.1	67.5	23.6	0.6	31.3	273.1	21.6	130.8	44.1	76.3	0.9	128.1	131.9	113.2	0.0	284.5	118.3	22.4	3.7	17.9	7.3	2.2	8.4	4.9	10.8	9.7	9.3	4.3	6.0	5.8	0.4	10.5	0.9	11.5	22.0	5.6	21.6	23.6	22.6	31.4	21.6	23.0	23.0	22.4	24.0	21.2	22.2	30.3	9.5	0.0	3.9	2.0	5.6	10.1	2.6	8.1	23.9	8.2	3.8	29.5	14.3	5.7	6.1	3.7	16.7	4.9	11.3	2.8	17.6	6.3	4.9	1.1	18.2	8.1	8.4	73.5	0.6	3.4	12.1	31.0	3.1	1.2	16.5	12.6	20.3	8.8	28.3	5.0	0.6	10.2	14.2	20.5	16.0	7.1	39.4	11.0	7.2	1.9	17.1	26.9	17.5	2.0	3.3	3.1	10.2	47.8	14.0	1.8	24.6	40.8	3.2	9.9	85.5	38.9	26.7	32.0	15.0	22.0	11.2	1.9	18.2	28.6	9.1	1.2
CDKN2D	"INK4D, p19"	ENSG00000129355	"Cyclin dependent kinase inhibitor 2D"	P55273	19	10566460-10569059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 283.7"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 146.8;Erythroid cells: 116.6;Macrophages: 105.4;NK-cells: 155.5;Spermatocytes: 126.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 90.6;MOLT-4: 113.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011201, HPA043546"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"CAB011201: AB_261049, HPA043546: AB_2678545"	"unprognostic (3.08e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.55e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.90e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	13.7	9.8	61.0	13.3	64.9	283.7	9.5	43.9	86.9	9.4	37.3	14.2	6.3	7.0	3.1	14.3	11.0	6.4	18.8	64.8	59.7	11.3	7.1	30.8	23.9	53.8	51.5	7.1	5.8	3.3	15.7	8.2	59.9	8.0	5.6	16.3	7.3	4.1	19.7	18.1	14.5	7.8	46.1	42.4	9.4	38.6	57.6	78.0	6.2	15.9	16.1	11.2	12.9	57.4	30.8	4.8	15.1	10.0	8.0	12.2	3.8	19.8	23.2	21.4	18.8	6.1	7.3	8.5	6.4	21.1	21.6	6.4	5.2	5.1	7.7	34.3	12.6	90.6	5.8	10.2	9.2	9.2	70.2	5.1	16.2	11.0	8.2	17.7	6.1	52.6	3.8	72.3	21.5	4.3	113.9	48.3	3.0	23.4	22.7	18.4	14.7	5.1	9.7	2.6	21.3	11.2	14.0	10.4	15.2	2.8	9.4	24.0	4.7	25.2	12.9	42.1	30.1	44.9	16.5	15.8	26.7	15.5	18.4	143.5	17.7	79.7	30.2	23.2	24.2	56.7	24.9	34.1	17.4	50.0	23.3	27.4	139.9	41.1	35.6	51.0	22.5	31.8	61.0	64.9	43.9	86.9	64.8	59.7	53.8	51.5	59.9	46.1	57.6	57.4	35.2	6.4	7.0	4.6	65.2	23.2	13.7	17.1	38.7	32.4	11.1	15.2	9.2	5.7	8.2	5.5	12.5	4.8	146.8	11.8	9.8	7.7	21.2	26.9	10.2	29.3	7.2	116.6	18.5	4.9	8.4	11.0	3.6	16.7	21.0	4.8	26.7	3.8	10.4	47.1	14.8	6.4	36.7	42.2	47.7	13.7	7.2	105.4	30.2	1.9	46.4	22.2	155.5	1.0	8.2	14.2	9.4	6.0	9.2	11.4	5.0	5.1	10.9	37.1	19.7	8.3	25.8	126.0	83.7	38.6	33.1	4.9	63.4	4.5	6.9	23.8
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816659	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 506.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 329.4;Hepatocytes: 149.5;Leydig cells: 91.0;Syncytiotrophoblasts: 481.9;Theca cells: 104.7"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 48.1;ASC diff: 57.9;ASC TERT1: 22.3;GAMG: 17.2;HAP1: 17.1;NTERA-2: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA036573: AB_10696658, HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	119.3	18.1	26.1	3.3	28.2	0.2	35.9	24.6	31.2	9.5	109.8	4.8	0.7	8.3	140.3	3.5	13.7	10.5	26.1	28.3	30.7	3.1	506.7	11.7	6.6	23.6	26.2	25.8	14.2	0.7	20.7	35.2	25.6	9.1	1.8	15.9	7.2	72.8	8.5	3.0	4.0	6.2	25.6	3.7	4.1	15.6	26.7	1.3	9.6	19.9	3.1	8.1	5.7	25.6	0.0	0.0	48.1	0.0	57.9	22.3	0.2	1.4	0.4	4.6	4.5	0.0	0.0	0.0	0.0	0.6	17.2	0.1	17.1	0.0	6.6	0.1	8.5	1.7	0.0	1.4	0.2	0.1	0.0	8.5	0.0	0.7	0.0	1.2	6.3	0.0	0.0	0.0	5.5	0.0	1.2	0.2	17.8	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	11.0	0.1	0.0	0.0	4.0	0.0	5.4	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	26.1	28.2	24.6	31.2	28.3	30.7	23.6	26.2	25.6	25.6	26.7	25.6	4.1	0.0	1.3	6.8	0.7	0.8	0.8	0.0	0.6	27.3	1.0	7.1	3.4	0.0	0.0	1.8	6.2	329.4	0.3	0.0	0.0	9.9	6.0	0.3	7.1	3.1	1.8	2.7	12.2	0.2	17.0	27.8	0.0	0.3	0.0	7.5	33.9	149.5	23.4	1.7	16.4	0.0	0.0	5.7	1.6	15.0	91.0	0.6	1.8	1.0	0.6	31.4	0.0	5.5	3.1	0.3	0.0	37.6	0.0	0.9	0.0	2.0	0.0	3.8	13.1	7.3	3.9	1.6	1.4	0.5	1.3	481.9	0.9	104.7	0.0	0.1
CDPF1	"C22orf40, LOC150383"	ENSG00000205643	"Cysteine rich DPF motif domain containing 1"	Q6NVV7	22	46244011-46250311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018823	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Nucleoplasm	"HPA018823: AB_1853018"	"unprognostic (1.98e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (3.13e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.83e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	6.2	9.5	7.1	4.1	7.3	2.6	6.1	6.9	8.6	8.1	6.7	10.3	4.2	7.8	2.9	4.9	7.2	4.0	8.6	6.9	6.8	7.9	7.5	4.6	6.3	7.6	7.1	7.7	6.7	6.2	6.4	3.8	7.0	8.9	2.8	2.6	6.7	5.1	7.9	5.0	6.3	4.8	6.7	9.1	6.7	3.2	7.1	7.4	8.0	5.8	4.0	7.7	5.7	7.4	5.5	7.2	6.5	9.8	4.7	6.9	6.7	3.3	4.5	6.6	6.3	1.8	7.0	5.1	4.0	2.7	5.3	7.7	3.8	2.8	3.9	7.3	10.3	3.1	5.2	6.3	7.0	9.3	4.3	7.4	7.8	5.8	7.4	7.5	5.8	13.0	5.2	6.9	6.2	3.8	12.1	5.8	5.2	8.0	6.7	8.9	4.3	11.7	5.8	2.1	3.1	7.8	4.2	7.8	9.4	3.8	8.9	5.1	3.7	10.7	7.4	5.9	4.7	7.9	4.0	5.9	5.8	6.3	11.1	1.4	6.4	10.5	10.4	9.1	9.9	6.9	10.0	9.0	6.3	8.3	11.3	8.5	1.6	10.0	9.9	10.9	8.7	8.0	7.1	7.3	6.9	8.6	6.9	6.8	7.6	7.1	7.0	6.7	7.1	7.4	6.9	6.4	3.9	1.0	7.1	1.8	2.9	8.1	1.2	4.5	4.7	6.7	6.1	5.7	4.0	7.3	0.0	12.8	4.5	1.3	7.9	10.7	1.0	2.5	3.3	8.9	4.2	3.4	1.1	11.2	10.0	5.8	3.1	1.9	14.5	6.9	6.8	4.8	9.3	0.0	1.8	3.7	6.1	5.0	2.0	1.2	5.0	4.2	5.4	0.0	8.1	5.7	19.6	1.5	2.5	8.3	1.4	7.9	3.8	5.1	3.4	8.1	6.9	5.4	13.1	4.5	6.5	4.3	8.1	3.1	2.0	4.5	6.1	9.1	5.3	2.1
CDR1	"CDR, CDR34, CDR62A"	ENSG00000288642	"Cerebellar degeneration related protein 1"	P51861	X	140783578-140784366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1331	"brain: 44280.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 140.3;Horizontal cells: 35.3;Muller glia cells: 140.9;Rod photoreceptor cells: 34.1"					"Region enhanced"	"Detected in all"		"cerebellum: 44280.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.9;BJ: 16.0;MOLT-4: 10.6;U-87 MG: 61.7"	"Not detected"	"Not detected"							HPA073147			Approved	"Nucleoplasm,Golgi apparatus,Centrosome"		NA	NA					"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus, Centrosome"	Nucleoplasm	"HPA073147: AB_2686574"																		7.9	3.1	1936.4	0.7	9723.2	0.0	0.0	44280.9	11546.5	0.0	0.0	0.3	0.3	1.2	0.0	2.0	0.6	5.1	5.1	967.3	404.7	0.2	0.0	1.3	0.2	4300.7	2927.3	0.3	10.6	0.0		1.1	8854.8	0.4	0.0	20.8	1.4	0.0	0.4	33.2	0.3	0.0	1798.6	2.4	1.1	0.2	3637.0	0.0	2.2	0.0	0.0	1.7		21870.1	0.0	4.2	8.9	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	10.6	0.0	2.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	2.1	3.7	0.1	0.0	0.0	2.9	0.0	3.0	0.0	0.0	0.0	61.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1936.4	9723.2	44280.9	11546.5	967.3	404.7	4300.7	2927.3	8854.8	1798.6	3637.0	21870.1	0.1	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	140.3	0.3	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	1.1	0.0	0.0	0.4	0.0	0.0	4.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	35.3	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.2	0.0	0.0	0.0	140.9	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	34.1	0.0	1.6	1.2	0.0	0.0	0.1	3.1	0.0	0.1	0.1	0.0	0.1
CDR2	"CDR62, Yo"	ENSG00000140743	"Cerebellar degeneration related protein 2"	Q01850	16	22345936-22437165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 70.2;Spermatocytes: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 8.4;NK-cells: 2.5;T-cells: 6.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018151, HPA023870"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA018151: AB_1846457, HPA023870: AB_1846459"	"unprognostic (7.89e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.38e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.67e-3)"	19.1	12.0	9.5	19.0	17.7	23.9	14.6	13.6	10.9	18.8	32.0	22.5	28.6	17.8	10.3	12.1	15.9	22.2	14.3	9.8	9.5	25.0	22.9	21.6	25.4	8.6	7.6	14.9	13.9	13.2	21.8	15.0	8.5	20.7	19.3	74.0	15.7	23.1	5.9	10.6	22.1	27.2	5.0	18.7	17.5	62.0	10.5	28.2	49.0	5.6	19.3	29.2	14.0	8.3	38.9	26.8	22.8	24.2	55.2	47.4	23.9	36.4	57.0	36.7	48.4	35.3	25.9	33.3	19.3	62.4	22.2	36.5	49.2	20.8	43.0	26.2	25.1	25.3	29.4	111.0	63.4	27.6	49.6	35.6	18.8	36.2	40.3	46.3	46.2	42.6	25.1	53.3	35.4	28.0	27.8	20.0	32.4	32.3	22.0	40.1	29.4	49.5	45.7	24.8	17.5	12.5	24.8	51.9	36.4	25.7	15.4	13.7	31.9	36.2	22.9	34.5	32.9	27.6	49.7	46.9	23.8	27.1	31.7	8.4	0.8	1.2	1.6	0.7	3.6	0.9	5.3	3.4	0.9	0.6	4.1	3.5	0.7	2.5	0.9	1.1	6.5	1.7	9.5	17.7	13.6	10.9	9.8	9.5	8.6	7.6	8.5	5.0	10.5	8.3	18.2	3.2	5.1	3.6	8.7	34.0	17.3	4.3	15.4	8.9	27.4	9.1	3.5	10.0	7.0	9.2	14.6	1.7	12.7	22.0	1.9	8.7	36.7	6.9	10.0	13.9	6.6	17.2	8.0	7.1	10.8	19.6	19.4	12.0	0.0	9.6	10.0	9.5	9.4	8.4	10.5	16.1	6.1	5.0	11.5	8.8	6.8	7.4	10.6	2.8	4.0	10.1	4.1	3.5	2.2	13.8	12.2	10.9	24.9	19.4	22.4	12.4	4.9	70.2	6.6	9.7	15.8	50.9	16.1	8.7	24.3	1.4	25.8	2.7	7.8	14.8
CDRT1	"FBXW10B, FBXW10P1, HREP, SM25H2"	ENSG00000241322	"CMT1A duplicated region transcript 1"	O95170	17	15565483-15619704	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 8.5;testis: 12.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 22.9;Late spermatids: 11.8;Spermatocytes: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.6;HaCaT: 35.7;HeLa: 14.3;OE19: 9.3"									"HPA013332, HPA047457"			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA013332: AB_1848471, HPA047457: "	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (7.03e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.31e-8)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.86e-1)"	1.4	2.4	1.0	1.0	1.0	0.4	1.0	1.1	1.0	2.4	0.5	0.6	2.3	0.2	0.9	8.5	0.7	0.6	1.4	0.8	0.8	0.9	1.3	1.2	0.8	1.0	1.0	0.2	0.3	0.1	0.5	1.4	0.9	0.6	0.7	0.4	2.6	0.3	2.6	3.4	1.2	0.2	0.7	0.4	2.2	12.6	1.1	0.3	2.1	0.8	2.3	1.8	4.2	1.2	3.0	8.4	0.3	2.8	0.4	0.8	0.2	0.7	2.0	0.3	1.0	7.7	19.6	0.3	0.5	1.8	2.1	35.7	0.6	0.4	0.4	3.2	0.3	0.2	14.3	0.4	0.3	0.1	0.3	0.6	1.2	0.9	0.6	0.1	0.2	0.5	0.0	1.5	1.1	0.2	0.6	0.5	0.3	9.3	1.1	0.1	0.6	0.0	2.4	5.1	0.2	0.1	2.7	2.5	0.2	0.9	0.2	0.2	1.8	0.6	1.8	0.2	0.5	1.0	4.0	0.1	2.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	1.0	1.1	1.0	0.8	0.8	1.0	1.0	0.9	0.7	1.1	1.2	0.9	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	22.9	0.5	0.1	0.3	0.0	0.0	2.5	0.2	0.0	0.2	3.6	0.8	0.0	0.2	0.4	0.2	0.1	0.0	2.3	0.2	0.0	0.0	0.0	11.8	0.6	0.2	0.0	1.0	0.0	0.1	0.0	1.5	2.2	1.8	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.2	0.0	0.1	0.0	8.6	0.5	0.6	0.0	0.0	0.0	2.5	0.0	0.3
CDT1	"DUP, RIS2"	ENSG00000167513	"Chromatin licensing and DNA replication factor 1"	Q9H211	16	88803789-88809258	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 38.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 51.4;Erythroid cells: 71.3;Extravillous trophoblasts: 92.0;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 149.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA017224	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA017224: AB_1846468"	"unprognostic (1.33e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (3.44e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.69e-6)"	"unprognostic (7.72e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.54e-2)"	0.7	0.8	0.8	3.8	1.2	38.5	0.7	2.5	1.3	1.7	0.0	3.3	4.1	0.5	0.2	6.7	0.5	0.2	0.5	0.8	2.3	0.7	1.0	1.3	4.8	2.2	1.1	0.4	0.6	1.3	2.1	2.8	1.9	0.7	1.6	0.4	1.1	0.2	0.1	3.6	3.9	0.6	0.7	3.1	2.4	3.5	1.1	8.7	0.6	0.0	3.3	0.5	2.3	1.0	33.6	34.5	16.5	25.3	0.7	3.4	64.2	24.1	6.6	19.4	12.0	79.3	33.8	51.4	24.2	5.5	12.7	46.0	21.6	17.7	6.2	18.2	92.1	51.8	28.8	59.9	0.3	28.8	21.5	1.8	1.4	19.8	4.4	1.6	5.9	60.9	80.8	18.4	7.6	90.6	109.3	149.4	41.8	12.2	31.6	120.3	22.9	42.4	4.3	23.8	36.6	26.2	44.4	13.1	16.9	7.4	39.0	55.9	5.9	24.6	42.6	37.2	35.4	61.4	55.7	73.6	19.3	71.9	31.6	0.2	0.1	0.9	0.3	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.7	0.4	0.1	0.1	0.7	0.2	0.8	1.2	2.5	1.3	0.8	2.3	2.2	1.1	1.9	0.7	1.1	1.0	0.4	0.0	1.1	0.7	4.9	11.2	4.3	1.4	7.4	0.7	5.4	7.5	2.2	1.5	1.7	1.8	0.0	51.4	2.2	12.7	1.9	1.1	0.4	1.4	1.4	2.2	2.4	71.3	0.2	0.0	92.0	5.2	9.2	2.2	0.0	29.0	0.4	1.0	19.5	0.0	0.8	16.1	4.1	5.6	5.5	1.2	0.3	2.8	1.8	0.0	1.9	1.5	4.1	0.0	0.6	0.6	2.3	0.4	23.1	2.2	2.0	1.6	2.1	1.9	0.0	2.1	3.4	6.6	37.1	10.8	7.1	24.8	5.4	5.7	30.1	4.4
CDX2	CDX3	ENSG00000165556	"Caudal type homeobox 2"	Q99626	13	27960918-27969315	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 41.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 287.5;Intestinal goblet cells: 214.5;Paneth cells: 181.7;Proximal enterocytes: 226.9;Undifferentiated cells: 194.4"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 63.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 14.4;CAPAN-2: 4.8;HEK 293: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002221, HPA045669, HPA049580"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823"		"unprognostic (1.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.92e-1)"		"unprognostic (8.11e-3)"	"unprognostic (4.19e-6)"	"unprognostic (1.73e-4)"		"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.51e-2)"		"unprognostic (6.07e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.09e-1)"	0.1	0.0	0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	41.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	31.3	0.0	0.0	0.1	0.0	0.0	35.9	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	4.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.7	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	0.0	287.5	0.0	28.9	0.0	0.0	0.0	0.0	62.4	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	214.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.9	181.7	0.0	0.0	0.2	226.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.4	0.0	194.4	0.3
CDX4		ENSG00000131264	"Caudal type homeobox 4"	O14627	X	73447254-73455245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"skin 1: 1.1"	"Cell type enhanced"	"Detected in some"		"Spermatogonia: 1.2;Suprabasal keratinocytes: 1.1"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043714, HPA056528"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA043714: , HPA056528: AB_2683166"															"unprognostic (1.97e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0
CEACAM19	CEAL1	ENSG00000186567	"CEA cell adhesion molecule 19"	Q7Z692	19	44662278-44684359	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 7.9;Skeletal myocytes: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.2;RPTEC TERT1: 15.8;TIME: 20.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"HPA014462, HPA052865"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA014462: AB_2669006, HPA052865: AB_2681976"	"unprognostic (2.91e-1)"	"unprognostic (5.29e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.26e-9)"	"unprognostic (8.01e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-1)"	3.9	5.6	3.7	1.3	3.7	1.5	3.8	4.9	5.1	7.0	3.5	4.7	3.0	5.2	1.7	5.1	6.8	2.4	11.7	4.0	3.8	9.4	8.2	8.2	1.1	2.8	3.0	6.6	8.9	1.5	7.0	2.2	2.7	7.8	3.4	2.4	5.7	3.1	13.8	12.4	3.8	3.1	1.9	3.5	4.6	5.7	3.7	0.9	6.5	3.4	2.2	4.2	8.7	4.7	5.1	10.3	1.5	1.0	3.5	4.0	3.8	2.8	4.2	0.9	1.8	0.4	1.1	0.1	1.0	3.8	1.0	6.2	2.6	1.1	0.8	1.5	5.8	0.1	6.7	1.7	3.6	0.2	1.0	1.3	10.0	2.6	6.1	12.2	2.4	0.7	0.3	0.3	1.4	1.2	0.0	0.6	0.9	1.4	1.1	0.0	1.8	0.2	15.8	1.2	1.9	0.5	1.1	1.1	0.9	1.4	1.4	0.3	20.9	0.4	6.8	1.5	0.9	0.1	0.3	0.0	0.5	2.0	1.7	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.7	3.7	4.9	5.1	4.0	3.8	2.8	3.0	2.7	1.9	3.7	4.7	3.6	3.2	2.2	2.0	0.0	2.0	0.9	2.1	1.2	2.9	1.9	1.5	4.5	1.5	2.4	0.0	0.0	0.2	0.1	2.1	0.0	1.6	3.8	0.9	0.9	4.1	1.8	0.0	7.9	3.3	0.2	1.0	3.6	2.4	0.0	0.8	4.6	2.6	0.3	0.0	6.1	2.3	4.1	0.6	0.8	1.9	3.1	0.5	0.0	1.9	0.4	0.3	1.0	2.0	2.4	4.5	2.6	2.6	0.0	1.8	1.2	0.4	1.8	0.6	0.0	8.8	1.7	3.1	0.9	1.2	6.0	0.0	0.2	1.6	2.5	0.9
CEBPA	"C/EBP-alpha, CEBP"	ENSG00000245848	"CCAAT enhancer binding protein alpha"	P49715	19	33299934-33302534	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 98.7;liver: 194.7;skin 1: 118.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.6;Hepatocytes: 106.5;Hofbauer cells: 87.0;Suprabasal keratinocytes: 171.8;Syncytiotrophoblasts: 212.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 16.0;classical monocyte: 7.1;intermediate monocyte: 12.3;myeloid DC: 5.1;non-classical monocyte: 15.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 5.1;granulocytes: 16.0;monocytes: 15.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 196.9;Hep G2: 110.9;NB-4: 114.1;THP-1: 407.7;U-937: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052734, HPA065037, HPA067937"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927"	"unprognostic (1.80e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.95e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.72e-2)"	98.7	2.9	16.2	5.7	17.9	22.6	67.7	18.3	26.9	8.7	10.4	21.0	21.2	2.9	0.8	20.9	4.3	3.0	2.8	15.7	18.8	3.6	194.7	25.5	9.1	27.4	22.4	1.3	9.7	26.8	2.6	16.0	21.3	8.8	11.5	0.6	9.8	3.4	19.1	118.7	20.8	2.5	25.7	7.7	12.5	1.0	24.5	4.1	6.5	4.5	6.3	8.7	14.8	34.8	2.5	5.1	0.1	7.1	55.8	0.0	196.9	0.1	1.5	0.1	0.0	24.8	0.1	0.0	3.0	0.0	1.1	9.4	5.8	0.6	0.0	35.8	7.2	0.1	0.1	110.9	0.9	36.6	42.1	2.2	25.4	0.0	0.2	0.0	0.0	2.8	2.4	0.0	0.0	12.7	0.2	114.1	5.0	61.8	2.7	0.0	0.4	1.1	0.2	17.7	0.4	1.7	0.7	0.5	0.8	6.2	13.7	407.7	0.1	0.1	0.8	0.1	0.9	0.4	0.0	0.2	0.0	130.9	0.0	16.0	7.1	0.0	0.8	12.3	0.7	0.0	0.1	0.5	5.1	0.1	0.2	0.4	2.5	0.0	15.7	0.2	0.0	2.1	16.2	17.9	18.3	26.9	15.7	18.8	27.4	22.4	21.3	25.7	24.5	34.8	5.4	16.0	37.8	0.0	2.8	37.3	20.8	3.3	22.2	0.7	6.2	12.2	0.4	57.2	5.1	0.0	0.0	40.3	14.4	91.6	3.9	0.5	0.0	0.8	0.8	4.9	4.2	5.7	1.9	5.8	44.3	9.5	12.8	1.3	1.3	0.0	2.2	106.5	87.0	0.0	0.3	24.8	4.1	35.0	27.4	0.2	3.1	42.9	5.4	17.8	28.2	8.4	6.2	1.0	0.4	1.9	30.6	1.5	2.0	15.1	42.5	4.9	5.1	0.5	0.0	4.1	3.1	0.2	0.7	29.7	171.8	212.3	5.0	0.3	51.5	12.2
CEBPB	"C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5"	ENSG00000172216	"CCAAT enhancer binding protein beta"	P17676	20	50190830-50192668	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 765.6;Suprabasal keratinocytes: 800.1;Syncytiotrophoblasts: 1409.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 16.7;monocytes: 7.7"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 169.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004213, HPA061355, HPA062267"	Supported		Enhanced	Nucleoplasm		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.26e-3)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (2.44e-12)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.63e-2)"	160.7	125.5	26.6	63.9	29.4	43.2	86.5	24.4	29.8	95.5	36.7	60.0	13.1	72.4	5.8	43.2	94.9	27.6	59.3	29.7	32.4	39.3	228.7	139.5	11.2	34.8	36.4	89.6	35.6	10.8	28.4	37.8	29.2	60.3	7.1	4.6	49.1	12.3	202.2	99.1	43.4	15.5	35.7	93.1	57.7	9.0	33.3	6.3	57.5	44.3	7.3	64.9	67.2	31.5	26.4	11.8	1.3	13.9	63.7	24.9	112.7	34.9	54.6	23.5	20.7	12.0	23.9	17.1	64.5	14.5	115.4	35.3	3.7	34.2	15.9	12.5	8.3	5.2	15.0	17.8	78.3	8.7	32.9	26.7	88.5	29.9	52.9	49.0	3.3	17.4	25.4	31.0	15.0	9.9	4.1	19.0	7.3	24.8	33.6	12.3	3.4	20.1	7.9	6.3	6.7	4.4	28.9	70.7	169.6	7.4	18.8	48.1	4.5	48.6	37.2	42.1	34.0	64.6	29.5	15.9	88.7	19.6	21.6	8.6	3.5	12.5	0.5	6.8	0.1	0.6	0.4	0.6	1.5	0.3	0.4	0.2	16.7	0.5	7.7	0.0	0.3	0.8	26.6	29.4	24.4	29.8	29.7	32.4	34.8	36.4	29.2	35.7	33.3	31.5	83.3	35.3	67.6	16.3	64.2	724.2	371.8	48.3	241.9	3.9	244.6	244.5	48.7	130.1	35.6	46.0	0.0	185.0	208.1	83.4	31.3	32.9	9.9	305.3	417.4	74.9	66.7	33.9	18.4	13.2	681.2	605.1	102.4	410.5	51.4	10.8	94.9	402.7	345.7	3.3	8.6	102.5	24.4	500.4	438.5	10.6	129.5	765.6	217.1	37.5	159.0	87.6	61.8	0.5	1.8	19.2	60.9	96.3	102.7	346.5	61.9	74.2	29.8	5.6	157.8	466.2	356.7	1.1	13.3	162.1	800.1	1409.9	159.3	68.2	63.4	359.6
CEBPD	"C/EBP-delta, CELF, CRP3, NF-IL6-beta"	ENSG00000221869	"CCAAT enhancer binding protein delta"	P49716	8	47736913-47738164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1541.7;Basal prostatic cells: 1435.6;Basal squamous epithelial cells: 2487.0;Prostatic glandular cells: 1668.5;Skeletal myocytes: 1386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 54.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 54.9;monocytes: 19.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.9;HHSteC: 66.8;HSkMC: 66.7;NB-4: 148.7;SiHa: 58.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA067581			Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA067581: AB_2685865"	"prognostic favorable (2.28e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.87e-7)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.40e-2)"	251.6	72.0	33.4	62.1	35.2	34.3	168.0	37.2	42.0	99.7	43.9	143.5	26.7	82.8	2.7	85.4	192.0	14.7	136.9	35.8	63.6	106.9	207.8	157.5	8.7	81.5	49.3	265.3	81.9	7.6	117.4	50.0	49.5	151.1	12.1	16.9	89.3	19.4	133.0	106.9	79.6	21.6	46.5	109.7	116.3	14.3	47.4	18.5	103.5	21.6	6.6	168.1	139.9	44.6	9.5	7.4	0.3	0.1	41.5	43.2	51.9	24.1	18.7	6.8	14.4	14.8	14.8	0.1	17.3	6.6	5.8	9.9	1.7	12.9	2.1	0.1	3.9	0.5	6.0	6.3	66.8	4.1	0.0	66.7	33.7	1.6	16.0	4.3	1.4	0.4	4.1	7.3	2.5	2.9	0.1	148.7	2.8	6.2	2.5	0.1	5.1	0.5	20.6	7.8	2.8	1.0	58.7	7.7	6.3	2.6	6.4	33.5	6.2	1.5	3.9	15.6	1.5	0.1	0.1	0.1	7.9	0.1	0.3	2.3	19.9	10.6	2.1	8.4	6.2	0.1	0.3	1.2	7.4	0.6	0.0	0.0	54.9	3.7	3.2	0.2	0.3	2.8	33.4	35.2	37.2	42.0	35.8	63.6	81.5	49.3	49.5	46.5	47.4	44.6	1541.7	102.5	196.3	31.3	14.9	663.5	1435.6	98.7	2487.0	6.0	551.3	617.1	79.2	185.8	76.5	224.3	6.2	189.8	152.8	59.2	217.2	50.7	3.5	287.0	418.9	547.9	23.4	30.3	12.5	77.2	457.9	1377.3	387.3	621.0	5.1	96.4	269.5	157.7	220.3	1.7	2.5	44.3	42.7	520.1	502.0	21.5	435.5	912.6	268.6	29.0	163.5	321.9	150.4	6.0	0.5	53.2	58.4	144.8	34.9	1668.5	127.1	353.4	54.9	17.3	466.8	1386.3	1290.5	3.7	13.9	940.2	817.5	351.9	122.7	85.9	73.2	814.5
CEBPE	CRP1	ENSG00000092067	"CCAAT enhancer binding protein epsilon"	Q15744	14	23117306-23119255	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 51.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 6.6;Kupffer cells: 1.4;Macrophages: 2.3;monocytes: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	218	"eosinophil: 750.4"	"Lineage enriched"	"Detected in many"	250	"granulocytes: 750.4"	"Group enriched"	"Detected in some"	4	"HL-60: 233.8;NB-4: 122.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.1	0.0	0.1	1.6	0.1	51.8	0.0	0.0	0.2	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	3.2	0.3	0.1	3.4	0.8	0.0	0.3	0.5	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	233.8	39.6	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.9	122.5	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	26.3	0.0	0.5	3.0	750.4	0.0	0.6	0.1	0.5	1.0	0.4	1.5	0.5	1.8	1.5	3.4	0.0	0.3	1.5	0.0	1.8	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	6.6	0.0	0.0	0.0	0.0	1.4	0.6	0.1	0.0	2.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.1	0.0	0.0
CEBPG	"GPE1BP, IG/EBP-1"	ENSG00000153879	"CCAAT enhancer binding protein gamma"	P53567	19	33373685-33382686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012024	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA012024: AB_1846503"	"unprognostic (5.56e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.01e-2)"	19.1	8.8	16.0	14.2	16.9	15.4	15.1	17.6	23.8	11.0	12.4	30.2	34.1	12.0	9.1	20.1	11.9	11.4	14.8	15.6	19.3	12.9	34.6	16.0	12.4	17.0	17.6	5.3	28.3	15.1	11.0	16.8	17.6	12.0	28.8	17.3	13.5	9.4	47.4	27.7	35.3	14.6	18.7	9.7	18.8	12.5	19.0	14.1	25.7	44.2	13.8	16.3	14.2	18.4	33.4	29.7	30.9	31.0	14.8	21.6	41.8	24.8	22.1	21.9	26.4	35.3	14.4	54.0	19.1	11.8	26.2	16.6	54.8	25.0	37.5	91.7	23.3	29.1	15.6	34.5	49.3	49.1	31.0	28.6	121.0	27.7	86.7	11.1	27.7	45.1	39.3	49.7	17.9	20.4	33.0	25.7	17.5	94.2	18.2	35.1	21.0	22.5	12.4	19.9	61.1	37.2	25.8	26.7	61.3	22.6	22.7	96.8	26.7	22.2	26.3	23.8	39.6	28.4	27.0	32.4	23.4	53.2	31.4	7.5	9.7	4.4	3.6	11.8	4.3	4.6	4.9	5.6	10.3	3.7	5.2	5.0	0.8	3.0	19.1	3.2	6.0	5.6	16.0	16.9	17.6	23.8	15.6	19.3	17.0	17.6	17.6	18.7	19.0	18.4	61.3	19.2	13.2	2.6	30.5	124.3	95.8	51.5	67.7	11.3	32.8	31.9	15.1	48.6	29.6	14.7	8.4	42.6	27.6	160.5	19.6	37.0	90.3	43.2	14.9	50.4	35.3	22.3	11.7	54.1	71.5	26.1	34.1	26.6	26.0	9.5	31.4	66.2	45.6	3.3	8.3	81.8	34.6	35.4	65.1	74.5	6.8	34.4	28.4	10.3	63.9	27.7	28.8	6.0	3.9	75.8	107.7	9.1	30.5	70.2	115.7	30.4	49.4	12.9	6.6	24.7	31.5	76.4	45.2	57.8	155.7	74.8	29.4	5.1	67.8	120.4
CEBPZ	"CBF2, CTF2"	ENSG00000115816	"CCAAT enhancer binding protein zeta"	Q03701	2	37201612-37231596	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 282.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052065	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA052065: AB_2681715"	"unprognostic (1.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.13e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.01e-2)"	21.1	27.8	10.3	18.9	11.5	31.3	26.2	15.8	12.8	17.9	11.9	19.5	17.4	20.1	19.9	20.5	17.2	16.7	15.3	9.8	11.8	25.3	27.1	19.3	24.6	10.9	11.0	23.9	20.6	22.3	10.2	23.0	11.4	19.7	20.0	24.4	16.3	15.6	36.3	17.9	18.1	16.9	10.8	19.9	17.4	38.4	11.1	24.0	22.4	24.4	24.4	26.6	12.6	14.2	61.2	46.6	46.9	26.1	45.2	48.6	39.9	57.0	39.2	47.2	50.5	74.5	45.1	111.5	49.4	33.8	64.4	51.0	122.8	58.5	60.2	71.8	53.9	104.0	47.5	60.9	35.8	105.7	44.9	37.3	56.4	62.8	63.4	31.1	43.3	27.8	114.8	49.8	48.6	31.8	61.5	82.4	153.3	81.0	43.2	48.6	76.3	84.3	45.3	56.9	49.9	80.7	47.5	57.6	65.5	67.6	41.8	45.9	35.5	45.8	52.3	41.3	79.1	55.5	62.0	88.1	40.8	95.6	51.2	34.8	16.8	16.3	23.8	21.7	30.0	29.6	24.7	23.4	17.6	30.0	31.1	26.1	6.1	26.1	22.3	25.6	21.4	14.6	10.3	11.5	15.8	12.8	9.8	11.8	10.9	11.0	11.4	10.8	11.1	14.2	73.4	86.6	82.9	15.0	91.6	107.1	109.2	64.4	83.1	45.5	50.4	54.1	34.4	47.1	81.9	49.7	43.8	54.7	93.4	36.7	107.6	56.1	282.1	56.0	87.2	60.5	44.2	66.7	15.6	62.5	37.4	67.4	52.5	67.5	73.4	44.7	43.9	76.4	35.1	43.7	19.3	56.6	44.7	37.0	36.1	43.3	60.9	44.6	21.4	15.0	54.1	57.1	63.8	18.6	21.4	54.9	30.2	50.8	67.7	79.0	30.2	89.1	54.2	95.5	52.6	94.3	68.3	186.7	99.3	56.8	101.2	45.0	87.7	62.1	64.2	80.9
CEBPZOS	CEBPZ-AS1	ENSG00000218739	"CEBPZ opposite strand"	A8MTT3	2	37196488-37216193	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053866	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA053866: AB_2682283"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (3.46e-7)"	"unprognostic (3.69e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-2)"	22.3	46.5	23.6	15.0	24.7	25.4	22.4	26.4	32.7	23.9	25.6	28.8	23.8	23.4	38.5	24.3	23.9	17.7	42.5	26.4	24.9	35.9	27.9	17.8	22.7	24.7	24.0	28.3	22.9	24.9	31.1	22.0	24.8	29.9	22.6	28.1	26.1	18.2	53.4	23.9	22.5	20.2	23.1	20.6	24.5	22.7	24.5	18.3	26.0	37.3	19.6	24.0	22.0	27.9	59.9	19.4	41.1	32.9	42.5	47.0	39.4	43.2	39.3	27.2	19.8	18.5	26.4	20.7	22.9	42.8	36.2	33.7	22.4	32.9	33.4	55.3	47.1	56.2	21.6	29.0	38.2	70.5	29.4	49.6	44.0	37.1	42.1	36.7	44.3	21.4	42.6	28.9	45.3	11.9	17.2	67.6	60.2	47.6	29.5	51.4	55.8	47.2	48.6	15.9	43.4	42.6	33.4	54.0	43.5	22.1	23.9	41.2	39.0	29.1	35.9	43.2	38.1	53.0	0.5	44.1	54.0	41.2	42.5	32.4	23.0	21.2	27.3	26.4	32.2	34.1	31.1	29.2	22.8	26.9	38.5	34.9	8.8	23.2	20.6	49.2	23.5	22.3	23.6	24.7	26.4	32.7	26.4	24.9	24.7	24.0	24.8	23.1	24.5	27.9	46.6	54.5	40.9	13.7	37.7	0.0	51.6	0.0	51.2	46.5	37.6	38.9	43.0	27.1	21.1	38.6	18.8	83.0	43.6	25.7	92.0	46.8	76.0	59.1	35.7	27.9	17.5	30.1	14.7	33.7	50.7	35.6	41.3	41.4	17.1	30.3	27.5	27.4	44.5	32.0	19.5	32.6	0.0	27.7	0.0	18.2	47.2	34.7	0.0	18.7	39.9	59.8	46.4	13.6	27.1	41.8	31.0	44.4	30.4	38.9	54.2	92.1	27.0	56.2	46.0	31.0	33.0	115.8	58.8	48.5	0.0	69.1	37.8	33.4	33.1	41.6
CECR2	KIAA1740	ENSG00000099954	"CECR2 histone acetyl-lysine reader"	Q9BXF3	22	17359949-17558149	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;retina: 15.6;skeletal muscle: 21.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 109.4;Cone photoreceptor cells: 168.9;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 137.7;Rod photoreceptor cells: 94.1"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 14.4;K-562: 8.3;NTERA-2: 22.8;SCLC-21H: 10.1;SuSa: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002943	Approved		Approved	Nucleoplasm,Vesicles		No	No				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA002943: AB_1078496"	"unprognostic (2.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.92e-3)"	"unprognostic (7.48e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.13e-6)"	"unprognostic (1.13e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.94e-2)"	0.7	0.4	5.2	0.2	12.8	0.5	1.0	22.5	8.3	1.4	1.2	1.2	0.2	2.3	0.6	0.4	1.7	0.2	3.4	5.3	8.0	1.3	7.6	2.6	0.1	9.8	9.0	2.9	2.6	0.0	6.4	1.0	8.7	1.0	0.3	15.6	0.9	0.2	21.8	0.9	0.5	0.9	5.4	0.4	0.5	3.5	9.8	0.2	2.2	10.6	0.2	1.3	1.0	12.7	0.2	0.1	15.5	5.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.7	0.1	14.4	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	8.3	0.0	0.0	0.1	0.0	0.5	22.8	0.0	0.0	1.8	1.0	0.1	0.0	5.1	10.1	0.0	0.0	0.2	0.9	9.0	1.6	2.5	0.1	0.1	3.4	0.0	0.0	5.8	1.4	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	12.8	22.5	8.3	5.3	8.0	9.8	9.0	8.7	5.4	9.8	12.7	1.9	6.4	10.6	109.4	0.3	0.0	1.1	0.2	0.0	22.1	0.7	0.6	11.8	0.0	0.8	1.8	168.9	10.1	0.0	0.0	0.0	0.1	6.3	6.3	6.2	2.0	0.0	0.0	2.3	0.2	2.5	3.1	0.0	17.2	0.0	3.5	4.2	10.7	0.7	5.0	4.3	0.0	0.0	0.3	0.3	4.0	1.2	1.4	0.0	34.7	0.2	18.3	0.0	120.1	137.7	0.1	0.0	1.2	0.8	1.8	0.0	1.4	0.9	94.1	6.6	33.9	3.2	1.9	15.9	0.1	0.1	33.0	0.2	0.4	0.0	3.6
CELF1	"BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR"	ENSG00000149187	"CUGBP Elav-like family member 1"	Q92879	11	47465933-47565569	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016114, HPA044597, CAB069989"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012"	"unprognostic (1.05e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.34e-2)"	27.3	32.2	36.5	31.9	44.8	46.0	25.8	59.0	37.3	29.7	35.4	34.5	22.4	31.7	23.9	32.0	28.4	24.4	30.1	34.7	31.5	26.9	56.1	32.1	39.4	24.1	26.0	26.0	28.0	48.0	23.4	27.6	20.7	23.6	25.8	29.2	26.1	22.6	74.3	30.7	30.6	29.0	20.2	34.6	26.6	29.8	30.3	28.9	28.8	58.0	38.5	29.4	29.4	24.9	48.6	84.4	68.8	71.0	52.9	55.8	58.5	51.0	52.5	62.9	65.4	72.3	56.0	127.6	34.6	55.2	75.6	70.6	107.5	72.3	104.9	53.5	46.9	39.2	117.3	52.2	51.3	62.2	41.4	43.0	43.7	68.5	82.5	44.4	58.0	54.2	75.0	50.5	40.6	64.8	64.5	49.3	96.5	60.0	49.3	65.5	54.8	49.9	54.3	85.4	64.3	54.3	67.9	62.0	41.1	70.0	87.8	40.5	67.0	71.3	69.7	69.1	70.0	42.9	42.2	99.7	57.6	29.2	59.3	13.9	11.6	22.8	12.5	10.2	15.8	14.4	13.3	14.6	13.1	15.0	14.0	11.9	14.9	7.9	17.7	8.0	10.1	9.5	36.5	44.8	59.0	37.3	34.7	31.5	24.1	26.0	20.7	20.2	30.3	24.9	56.2	54.5	41.9	90.8	74.6	107.7	78.0	82.1	79.6	82.4	78.8	59.3	51.1	72.9	56.2	79.1	95.9	52.6	84.1	51.6	21.5	57.3	16.3	76.5	68.4	73.2	85.6	81.0	134.4	56.1	48.8	48.8	57.1	94.4	21.5	92.6	92.4	233.5	72.4	127.9	108.5	62.3	52.9	123.2	98.2	12.4	52.8	81.3	42.7	91.8	106.2	52.2	98.9	76.4	65.8	86.5	53.7	55.3	55.3	103.5	46.2	43.5	106.1	42.9	52.6	52.3	72.0	50.1	69.7	70.2	109.1	36.0	68.8	50.2	70.0	101.1
CELF2	"BRUNOL3, CUGBP2, Etr-3, NAPOR-2"	ENSG00000048740	"CUGBP Elav-like family member 2"	O95319	10	10798397-11336675	"Predicted intracellular proteins"	"mRNA processing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.0;Excitatory neurons: 1676.4;Inhibitory neurons: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 200.2;HMC-1: 186.2;REH: 86.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016395, HPA035813"	Enhanced		Supported	"Nucleoplasm,Vesicles,Midbody ring"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Midbody ring"	"CAB016395: AB_2086271, HPA035813: AB_2674797"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.45e-1)"	39.6	5.7	33.7	30.7	42.7	78.9	17.7	0.2	42.0	14.2	0.0	16.5	9.2	15.0	5.0	21.4	13.3	17.2	37.5	42.5	7.2	3.0	4.3	28.2	42.4	0.9	13.9	46.8	4.4	3.5	6.5	8.6	0.4	14.1	17.9	35.4	9.6	12.2	17.6	8.6	23.4	23.2	8.6	31.1	10.3	7.6	23.7	60.7	8.5	15.0	29.4	16.2	8.0	21.0	0.1	0.0	47.6	0.0	7.4	2.7	5.3	7.0	0.2	1.1	0.2	0.1	0.0	0.1	5.3	6.1	0.0	0.1	6.8	0.2	0.4	40.4	11.9	200.2	0.7	0.0	1.7	58.0	186.2	3.0	0.3	0.4	0.0	0.7	6.7	70.6	9.3	80.7	59.6	0.0	71.9	42.0	19.3	0.0	0.0	86.7	50.8	18.0	3.4	0.0	7.1	0.5	0.1	0.2	51.1	15.2	0.0	39.0	0.1	8.9	2.5	29.9	0.1	30.7	30.1	9.3	2.9	68.8	21.6	68.0	43.2	90.8	54.8	57.5	69.2	48.1	54.1	60.5	53.4	51.0	56.1	52.7	115.1	73.5	67.8	37.9	60.9	63.5	33.7	42.7	0.2	42.0	42.5	7.2	0.9	13.9	0.4	8.6	23.7	21.0	20.4	160.3	147.3	558.0	165.6	19.9	3.4	5.8	12.5	68.2	18.8	13.7	122.7	5.7	22.4	12.9	102.2	1.1	233.5	11.8	15.6	1.6	135.9	5.3	11.3	34.7	59.3	45.2	1676.4	2.1	0.9	106.0	11.2	17.0	128.5	0.7	13.2	5.1	90.0	134.6	576.9	37.5	24.4	261.4	134.3	110.3	111.6	192.9	115.6	376.6	263.6	90.5	256.4	324.7	21.6	1.5	16.9	89.5	124.3	10.1	2.4	1.0	5.8	99.2	52.6	117.6	33.7	4.1	11.5	5.7	14.5	1.9	232.5	8.5	23.8	2.4
CELF3	"BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4"	ENSG00000159409	"CUGBP Elav-like family member 3"	Q5SZQ8	1	151700058-151716803	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.7;pituitary gland: 109.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 101.4;Cone photoreceptor cells: 39.6;Enteroendocrine cells: 52.8;Excitatory neurons: 21.1;Horizontal cells: 20.2;Inhibitory neurons: 20.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.4;pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 42.1;SH-SY5Y: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006292	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA006292: AB_10602250"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.05e-2)"	0.1	11.2	41.9	0.2	41.1	0.3	0.0	22.1	70.7	0.0	0.0	2.1	3.0	0.0	0.0	0.0	0.8	0.0	0.1	48.5	37.5	0.1	0.0	0.1	0.0	8.6	16.4	0.0	6.1	0.0	109.0	0.1	10.9	0.1	0.7	23.6	0.0	0.0	0.0	0.1	2.1	0.2	5.2	0.0	4.9	3.1	28.5	0.0	0.1	0.0	0.0	0.1	0.2	20.5	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	42.1	29.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	41.1	22.1	70.7	48.5	37.5	8.6	16.4	10.9	5.2	28.5	20.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	101.4	0.0	0.0	0.9	0.0	0.0	0.0	39.6	0.1	0.0	0.3	0.0	0.0	13.1	0.3	0.0	0.0	52.8	0.0	21.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.2	20.4	1.5	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	6.0	0.7	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.0	5.5	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1
CELF4	BRUNOL4	ENSG00000101489	"CUGBP Elav-like family member 4"	Q9BZC1	18	37243040-37565827	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 122.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 126.4;Excitatory neurons: 197.7;Horizontal cells: 294.4;Inhibitory neurons: 197.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"SCLC-21H: 46.7;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013322, HPA037986"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA013322: , HPA037986: AB_10673035"	"unprognostic (7.87e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.42e-7)"	"unprognostic (2.95e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-3)"	"unprognostic (6.13e-2)"	0.6	11.5	102.9	1.1	104.8	0.3	0.4	59.5	122.2	0.3	11.1	1.9	0.8	0.4	0.6	0.5	0.4	1.2	1.0	96.4	81.2	1.5	0.3	0.6	0.8	58.3	69.7	1.3	3.9	0.3	28.4	0.8	71.4	0.8	0.4	21.4	1.7	0.2	11.0	1.3	1.2	0.5	34.6	1.1	1.7	3.6	57.4	0.0	1.5	0.2	0.1	0.2	0.5	94.4	0.1	0.1	0.7	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.3	1.0	0.0	0.2	0.6	0.1	0.0	0.0	0.8	0.4	0.0	1.8	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.8	0.0	0.3	0.1	0.5	1.7	0.0	0.3	0.1	0.0	2.1	0.0	0.1	46.7	11.7	1.1	0.3	0.1	0.3	0.2	0.1	0.0	1.4	0.7	0.3	0.2	2.9	0.5	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.9	104.8	59.5	122.2	96.4	81.2	58.3	69.7	71.4	34.6	57.4	94.4	0.2	0.0	0.0	22.5	0.8	0.4	1.4	0.9	0.0	126.4	0.4	0.5	1.9	0.0	0.3	0.0	41.7	0.3	0.1	0.2	0.0	0.4	46.9	0.7	0.9	4.1	12.7	0.0	197.7	1.1	0.3	1.2	2.0	1.2	0.0	1.8	0.7	0.0	8.6	294.4	197.5	2.5	6.1	0.0	0.0	22.6	0.6	0.3	0.0	14.0	0.0	7.3	0.0	19.1	12.3	2.6	0.2	5.3	0.0	2.7	4.4	6.7	0.3	22.0	0.0	4.3	8.2	12.6	7.6	0.0	0.6	0.3	0.3	1.5	3.5	1.2
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537620	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 31.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Basal respiratory cells: 28.1;Club cells: 31.1;Endometrial ciliated cells: 31.8;Glandular and luminal cells: 42.6;Respiratory ciliated cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"A549: 68.4;RPTEC TERT1: 48.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Enhanced	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		280000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA052976: AB_2682004, HPA060521: AB_2684303"	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	0.7	0.8	0.4	3.1	0.9	0.8	7.8	1.5	0.5	9.9	1.2	1.6	0.9	3.7	10.2	11.5	15.4	1.4	3.4	1.0	0.4	17.1	5.2	12.5	5.9	2.4	3.9	0.2	2.6	6.3	2.4	1.0	1.4	5.0	1.8	0.5	12.0	3.9	0.2	31.5	1.6	1.1	1.6	3.3	5.4	1.3	2.2	2.4	3.7	0.1	7.9	3.9	3.7	1.0	22.3	68.4	11.3	10.6	0.0	0.0	6.5	2.3	3.4	2.3	1.3	21.7	21.9	0.2	32.1	1.3	22.0	35.0	7.5	28.7	2.0	0.0	10.2	0.0	25.6	2.0	1.0	3.2	1.8	0.0	43.5	0.0	26.2	31.6	0.4	1.7	0.3	0.4	0.0	38.4	0.1	11.9	4.5	12.1	8.1	0.1	0.1	8.1	48.7	13.5	0.7	0.9	16.1	17.3	3.7	7.9	39.7	16.7	0.9	0.1	0.3	0.0	0.4	10.6	1.1	10.5	15.2	0.1	12.9	0.0	0.0	0.0	0.2	0.1	0.2	2.2	0.1	0.1	0.0	1.9	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.4	0.9	1.5	0.5	1.0	0.4	2.4	3.9	1.4	1.6	2.2	1.0	0.5	41.7	23.5	0.0	5.8	17.1	4.1	28.1	8.0	0.2	14.2	5.2	12.7	2.8	31.1	5.5	0.0	1.9	2.3	0.8	0.0	1.8	2.3	31.8	5.0	5.6	1.2	0.0	1.2	0.7	1.9	1.0	2.6	42.6	0.0	0.6	1.8	1.5	2.4	0.0	1.2	2.8	6.1	0.0	4.1	10.3	0.0	1.1	5.4	1.0	1.1	1.1	0.0	0.5	0.7	4.0	0.3	0.0	1.1	4.3	0.0	8.2	60.3	0.3	0.0	0.1	2.8	0.4	0.6	12.6	15.6	0.8	1.1	0.0	1.7	5.1
CEMP1	CP-23	ENSG00000205923	"Cementum protein 1"	Q6PRD7	16	2530035-2531417	"Metabolic proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.9;granulocytes: 1.3;Late spermatids: 8.3;Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	7	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.6;HEK 293: 6.6;REH: 4.2;T-47d: 3.5;U-937: 3.6"									"HPA057658, HPA075926"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA057658: AB_2683492, HPA075926: "																		7.4	14.4	0.7	0.9	1.0	0.2	6.7	0.1	1.0	7.7	0.6	8.0	0.2	5.8	0.0	7.1	4.2	1.5	6.0	0.7	0.4	19.4	11.2	6.2	3.5	0.9	0.5	5.8	5.4	0.3	7.0	0.1	0.6	8.2	0.0	0.6	7.3	0.4	3.4	7.2	10.9	0.0	0.6	16.5	6.4	4.1	0.5	0.1	8.0	0.0	0.0	7.0	6.1	0.5	0.0	0.0	0.7	4.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.2	6.6	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.6	1.0	0.0	0.0	0.9	0.0	1.5	0.5	1.2	4.2	0.2	0.0	0.0	1.5	2.2	1.2	0.6	3.1	1.0	0.2	3.5	0.6	0.2	1.1	0.5	1.2	0.9	0.0	1.4	1.5	0.8	3.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.0	0.1	1.0	0.7	0.4	0.9	0.5	0.6	0.6	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0
CENATAC	"CCDC84, DLNB14"	ENSG00000186166	"Centrosomal AT-AC splicing factor"	Q86UT8	11	118998138-119015793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.1;Cardiomyocytes: 8.5;Cytotrophoblasts: 15.3;dendritic cells: 12.1;Hofbauer cells: 9.2;Plasma cells: 8.1;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039906, HPA071715"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA039906: AB_2676740, HPA071715: AB_2686436"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (8.14e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	11.1	14.0	6.8	2.0	6.9	3.5	11.1	7.3	11.5	14.2	8.6	13.6	1.9	9.5	3.0	11.2	11.7	1.3	12.7	6.8	7.0	15.4	19.0	15.4	2.9	6.8	6.9	11.0	11.2	2.2	15.1	1.7	6.9	16.2	1.7	3.6	10.4	2.7	10.9	13.0	13.9	1.8	6.7	21.7	10.7	7.0	7.0	2.8	15.3	2.1	2.8	13.1	11.8	7.2	3.8	3.2	2.7	3.7	2.7	0.9	3.0	3.4	3.5	2.9	1.8	19.1	2.4	1.4	10.7	3.8	4.5	9.8	1.3	1.8	2.9	5.3	2.2	6.4	6.2	5.5	2.6	2.7	3.5	1.1	1.9	2.9	3.3	3.0	1.7	4.3	1.4	4.8	2.9	6.1	7.0	5.1	3.7	5.6	8.6	9.5	5.5	6.4	4.4	5.6	3.8	2.6	8.6	2.4	0.8	4.3	7.7	2.7	1.9	2.8	13.7	4.0	2.3	3.9	4.0	5.8	2.3	5.3	5.3	0.4	1.3	2.6	2.7	0.9	3.4	4.1	3.6	3.0	2.2	4.2	3.4	2.6	2.1	3.7	0.9	2.6	5.8	1.9	6.8	6.9	7.3	11.5	6.8	7.0	6.8	6.9	6.9	6.7	7.0	7.2	9.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	15.3	12.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.3	1.7	0.0	0.0	0.0
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.0;Extravillous trophoblasts: 33.2;Granulosa cells: 24.2;Plasma cells: 17.8;Spermatogonia: 28.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 24.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB008371: AB_591074, HPA073086: AB_2686569"	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (2.88e-8)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	0.2	0.3	0.0	4.0	0.0	3.7	0.4	0.1	0.1	0.5	0.0	2.9	4.1	0.7	0.0	3.7	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.4	7.3	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.1	2.6	0.0	0.6	0.0	0.0	3.6	2.9	0.9	0.0	2.0	1.6	2.2	0.1	13.3	0.1	0.0	8.4	0.7	1.1	0.0	86.4	21.0	34.9	19.3	2.4	4.5	24.3	26.2	22.2	37.3	31.5	15.4	30.0	25.7	16.2	10.4	45.7	25.6	28.9	15.3	37.7	77.3	25.6	44.0	11.0	28.6	0.8	26.7	49.0	0.4	1.6	16.1	24.4	6.7	22.1	33.7	36.7	58.5	32.5	30.1	39.0	42.2	26.6	35.3	34.3	45.4	53.6	30.8	17.5	5.5	27.5	26.7	25.7	32.7	23.6	12.9	18.2	27.2	12.6	23.9	54.2	27.9	46.4	51.5	53.5	107.3	11.1	54.7	46.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	5.2	6.2	0.7	1.9	1.8	0.0	2.0	2.5	2.7	0.0	0.5	0.0	0.0	15.3	1.0	2.3	0.0	0.5	0.6	1.6	1.6	1.5	4.2	45.0	0.1	0.2	33.2	4.9	2.6	3.0	0.0	24.2	3.9	0.6	15.7	0.0	0.1	6.6	0.0	2.9	2.8	0.1	0.9	4.4	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	1.4	0.0	17.8	2.1	0.8	0.2	0.1	0.0	0.0	0.6	3.9	16.1	28.6	12.5	5.3	3.4	3.4	1.5	11.1	2.0
CENPB		ENSG00000125817	"Centromere protein B"	P07199	20	3783851-3786740	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011626, HPA053507, HPA054405"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"	Nucleoplasm	"CAB011626: AB_726801, HPA053507: AB_2682173, HPA054405: AB_2682477"	"unprognostic (2.01e-1)"	"unprognostic (8.47e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (2.40e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.46e-1)"	45.2	39.8	115.4	20.4	120.8	14.9	40.3	97.8	109.8	41.1	68.0	56.9	21.4	45.5	11.0	42.2	36.2	15.3	54.8	89.6	91.8	40.4	42.3	36.0	17.5	121.9	113.7	36.6	40.7	26.1	29.6	15.3	108.2	40.0	12.6	3.9	35.0	24.1	95.0	53.7	34.9	19.4	119.6	35.9	44.3	10.8	111.8	17.7	35.0	43.2	13.7	48.2	33.9	133.5	111.9	140.4	27.1	58.1	56.2	44.4	17.4	78.2	56.4	49.1	39.5	57.5	78.1	38.7	24.0	72.9	77.0	88.3	21.7	88.9	24.6	55.5	37.1	82.3	51.5	51.4	65.2	27.0	26.7	50.5	46.9	70.5	45.0	38.5	42.5	49.2	53.9	23.8	42.4	183.2	81.1	61.8	34.0	62.7	165.4	66.8	3.6	28.3	52.2	67.6	66.2	49.4	64.7	89.7	62.4	12.2	56.7	59.1	73.2	84.9	45.8	74.1	121.3	28.5	44.1	22.5	29.8	95.2	56.9	0.0	1.7	0.6	1.9	1.7	1.3	1.0	1.3	1.2	1.3	1.4	1.1	1.4	0.2	1.7	1.1	1.7	0.4	1.1	115.4	120.8	97.8	109.8	89.6	91.8	121.9	113.7	108.2	119.6	111.8	133.5	30.2	6.4	19.5	2.3	6.8	13.9	5.7	11.2	15.9	18.3	23.8	23.1	16.5	30.0	11.6	14.7	10.4	6.2	17.2	48.0	3.9	18.9	1.2	12.7	21.5	24.7	20.4	12.0	2.6	29.8	7.9	14.6	15.8	18.1	7.6	24.0	17.9	25.6	22.7	21.9	4.5	27.1	6.1	25.7	12.3	7.5	21.8	15.3	17.8	3.7	17.3	31.1	12.3	1.5	3.8	31.0	25.4	25.9	5.7	12.5	28.4	8.7	10.8	13.0	13.1	22.4	21.9	1.1	1.5	17.4	14.1	4.5	11.8	46.5	26.9	7.4
CENPC	"CENP-C, CENPC1, hcp-4, MIF2"	ENSG00000145241	"Centromere protein C"	Q03188	4	67468762-67545503	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049740, HPA058252"			Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"HPA049740: , HPA058252: AB_2683654"	"unprognostic (4.35e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.31e-3)"	"unprognostic (7.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (6.40e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (3.22e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.32e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-3)"	1.5	1.6	2.5	1.0	3.2	3.6	3.3	5.6	2.6	2.8	0.2	2.0	1.1	3.1	2.3	1.5	2.9	1.1	1.5	2.2	2.0	2.0	1.4	1.5	1.8	1.3	1.8	5.6	3.8	1.5	2.5	1.3	1.7	2.9	1.2	2.7	2.0	1.6	1.1	2.3	1.8	1.5	1.3	2.0	2.1	1.7	1.7	2.0	3.1	1.1	1.5	2.0	2.3	2.8	0.4	0.5	1.6	0.9	1.9	1.1	0.9	0.6	0.5	0.7	0.5	0.7	1.3	2.7	0.8	0.8	0.2	0.8	2.2	0.9	1.2	0.8	0.4	2.1	0.9	0.9	0.6	3.9	0.8	1.4	0.3	0.5	1.3	1.2	0.4	1.8	3.0	1.6	1.1	0.7	5.3	3.5	1.8	0.8	0.3	2.4	4.0	0.9	1.0	0.8	2.8	1.3	1.2	2.5	0.7	1.6	0.7	1.3	0.4	1.0	0.5	0.7	0.5	1.3	0.5	2.7	1.1	2.2	0.6	0.5	0.2	0.5	0.7	0.4	0.3	0.8	0.8	0.9	0.2	1.1	1.2	0.9	0.2	0.5	0.2	0.4	0.4	0.2	2.5	3.2	5.6	2.6	2.2	2.0	1.3	1.8	1.7	1.3	1.7	2.8	53.1	32.1	35.5	38.8	68.4	15.2	25.3	17.7	35.9	53.7	26.0	32.3	24.3	18.6	31.6	16.5	14.6	20.2	75.0	17.7	11.7	13.5	4.1	21.0	39.0	33.7	13.1	31.7	58.5	16.7	12.9	41.3	35.7	25.1	26.6	39.8	23.2	14.1	12.8	52.2	57.0	18.4	18.3	16.7	7.9	5.5	34.8	26.7	16.0	31.9	27.4	31.6	60.8	46.3	74.6	14.6	13.0	25.6	89.1	15.3	24.2	20.4	27.2	29.0	19.7	54.1	34.2	47.2	44.4	34.7	9.2	18.3	69.8	43.3	16.4	23.9
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664571	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.8;lymphoid tissue: 33.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 84.4;Erythroid cells: 268.7;Extravillous trophoblasts: 78.8;Granulosa cells: 165.8;Spermatocytes: 107.5;Spermatogonia: 107.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	0.8	1.1	0.1	4.4	0.1	28.8	1.8	0.0	0.3	1.3	0.5	5.8	6.1	1.8	0.1	8.6	0.6	0.7	0.4	0.3	0.0	0.4	0.9	0.9	8.5	0.3	0.5	0.7	0.3	0.2	0.1	3.1	0.3	0.5	5.7	1.0	1.4	0.1	0.2	6.2	4.3	2.5	0.2	2.4	2.6	10.5	0.5	33.0	0.4	0.6	10.0	1.4	2.6	0.3	123.7	68.4	144.3	75.8	5.4	7.2	56.3	74.6	30.3	43.9	42.8	54.6	74.1	116.3	43.1	41.7	39.8	74.7	89.9	49.2	74.1	102.6	56.6	96.0	111.4	78.6	0.8	137.0	50.5	2.7	3.8	63.3	72.3	12.7	46.9	52.6	88.4	68.0	79.4	47.0	81.5	54.3	127.9	36.8	30.0	85.7	203.7	38.6	43.2	30.3	67.4	91.2	100.7	66.2	38.9	76.2	79.1	51.9	61.7	78.9	92.2	66.2	155.9	51.6	60.7	108.7	34.4	96.7	71.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.3	0.5	0.3	0.2	0.5	0.3	3.0	0.0	3.1	0.0	11.5	9.3	2.8	11.2	3.4	4.7	10.0	6.7	1.9	1.5	9.9	0.0	0.0	53.3	10.8	19.1	0.0	2.0	84.4	30.1	19.3	12.4	0.0	268.7	1.3	0.4	78.8	19.0	32.1	25.2	1.3	165.8	8.9	2.6	32.2	1.7	0.8	20.1	14.2	16.6	6.6	19.8	1.2	16.2	1.8	1.0	0.7	1.4	5.2	0.0	0.1	0.5	1.1	3.0	25.9	2.3	2.1	0.1	16.7	3.1	0.0	8.3	23.9	107.5	107.1	44.6	5.5	5.1	23.3	11.7	41.3	3.7
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189574-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.8;testis: 29.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 74.5;Spermatocytes: 222.7;Spermatogonia: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA036494	Approved		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.2	2.0	1.4	7.5	1.7	33.8	7.7	1.7	2.0	3.9	1.0	7.4	6.5	4.5	2.1	7.5	4.0	1.8	4.0	1.5	1.6	1.6	3.6	2.8	17.7	1.6	1.5	3.9	1.5	2.0	1.4	5.2	1.6	3.3	8.1	2.5	2.9	2.3	4.0	9.2	5.9	3.7	1.4	5.2	3.7	29.7	1.6	18.5	2.5	4.0	18.8	3.8	4.4	2.2	64.6	19.4	88.6	70.2	5.8	18.3	48.0	31.2	32.6	66.9	71.8	26.5	79.6	138.9	36.6	18.1	39.1	47.0	59.0	70.4	85.1	42.7	41.4	32.7	32.5	26.4	2.0	47.1	32.1	7.1	14.6	43.6	47.7	18.9	23.2	73.7	58.7	53.3	52.2	35.6	152.4	67.3	78.1	20.7	17.0	93.2	118.2	108.2	21.1	22.9	61.6	81.9	34.6	22.8	27.5	47.7	31.9	31.4	11.4	33.4	56.1	44.5	78.7	65.5	106.3	111.8	51.1	94.2	64.7	1.0	2.0	3.0	4.7	3.5	7.7	13.3	7.9	6.0	3.1	14.1	9.9	8.6	0.4	8.6	4.2	6.7	9.7	4.8	1.4	1.7	1.7	2.0	1.5	1.6	1.6	1.5	1.6	1.4	1.6	2.2	4.8	0.0	2.6	1.0	18.3	36.7	17.7	17.4	9.6	3.4	10.8	11.7	3.3	4.3	7.1	0.0	0.0	37.4	9.2	5.1	0.0	12.3	26.5	5.5	5.1	6.9	1.2	74.5	1.3	9.1	49.0	7.4	2.6	4.8	5.1	22.4	4.6	1.1	17.0	0.0	1.1	9.5	12.2	7.5	18.2	22.5	3.7	6.3	8.8	1.0	4.3	7.3	6.2	1.0	0.9	7.0	2.5	4.9	14.4	6.9	1.4	3.4	10.8	3.5	19.7	6.4	9.3	222.7	222.8	12.1	19.2	10.0	12.0	6.9	15.9	15.2
CENPN	"BM039, C16orf60, FLJ13607, FLJ22660"	ENSG00000166451	"Centromere protein N"	Q96H22	16	81006552-81033114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 37.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 64.2;Extravillous trophoblasts: 91.1;Spermatocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052870			Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA052870: AB_2681978"	"unprognostic (1.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.34e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.99e-2)"	5.1	5.0	3.2	7.9	4.0	37.4	3.6	3.1	4.9	2.8	2.1	8.0	7.8	2.3	3.1	7.5	1.6	3.1	5.7	3.3	3.1	5.4	9.0	3.3	11.0	3.8	4.0	1.5	5.2	8.6	1.6	8.9	3.4	18.7	7.6	1.4	2.5	2.7	4.5	3.8	6.4	6.4	2.7	4.3	5.2	11.2	3.9	18.1	2.8	2.6	12.0	6.0	2.8	5.8	86.2	81.0	64.9	58.4	16.9	15.1	82.6	97.5	59.3	137.0	59.6	150.8	64.6	48.1	52.4	48.9	62.7	69.9	53.1	61.5	172.9	29.3	47.9	43.0	63.3	100.9	9.6	64.6	80.4	14.0	6.6	123.3	40.8	18.0	62.6	59.1	83.6	65.9	66.9	160.1	78.0	79.6	69.7	37.2	45.4	90.9	64.5	51.3	22.5	58.6	43.2	38.9	140.3	31.8	40.1	38.9	76.2	34.0	38.5	97.7	101.1	66.8	96.8	46.4	112.1	186.8	45.8	43.7	85.8	0.9	1.4	2.4	2.1	2.8	2.0	1.6	2.7	1.5	6.6	5.9	1.3	1.5	1.7	3.6	3.1	2.2	7.9	2.0	3.2	4.0	3.1	4.9	3.3	3.1	3.8	4.0	3.4	2.7	3.9	5.8	2.8	0.0	4.8	1.0	10.2	24.0	15.7	9.6	14.8	1.0	6.0	7.0	4.8	5.7	5.8	3.7	0.0	47.1	10.0	7.4	0.0	5.7	41.8	4.5	3.8	5.8	1.2	64.2	1.9	6.5	91.1	9.7	11.7	6.4	6.3	13.2	6.8	6.3	27.2	0.0	1.1	12.8	12.2	9.7	20.2	40.9	2.8	10.4	7.2	1.0	4.4	0.8	0.0	0.5	6.1	5.1	4.0	3.4	34.7	13.6	5.1	8.8	1.8	0.4	0.0	7.1	10.0	52.3	39.1	32.7	16.3	27.2	10.9	6.3	22.0	16.6
CENPO	"CENP-O, MGC11266"	ENSG00000138092	"Centromere protein O"	Q9BU64	2	24793136-24822376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 11.2;Extravillous trophoblasts: 11.5;Spermatocytes: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046189			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA046189: AB_2679579"	"unprognostic (1.67e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.56e-2)"	"unprognostic (4.02e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.71e-13)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	5.2	4.0	3.5	3.5	3.3	9.2	4.6	2.9	4.1	4.0	2.3	3.3	3.2	3.1	0.8	4.5	3.0	1.5	2.8	3.7	3.5	2.9	2.6	3.6	4.9	3.7	3.4	4.5	1.9	1.6	3.6	3.2	3.5	3.1	3.7	1.4	2.5	1.1	3.0	3.8	3.9	2.2	3.2	4.3	2.7	8.3	3.8	11.4	3.4	2.0	5.8	2.5	3.7	3.1	31.1	36.4	40.7	21.7	4.8	7.3	22.7	36.8	21.7	51.0	38.7	46.2	15.5	21.4	4.2	22.8	29.8	16.3	40.6	14.0	34.1	28.1	21.1	34.3	23.9	31.0	2.4	28.7	24.4	3.6	2.5	51.5	11.4	9.3	24.0	25.4	40.3	23.8	31.8	21.8	39.2	20.6	29.3	21.0	22.8	31.0	53.4	11.5	12.9	18.6	27.0	29.3	22.1	16.9	7.9	18.5	16.3	11.8	15.4	46.9	42.8	15.9	41.6	14.5	20.1	42.8	14.5	27.5	36.4	0.0	0.3	0.0	1.0	0.2	0.4	0.4	0.4	0.5	0.4	0.3	0.3	0.7	0.1	0.7	0.3	1.1	0.7	0.3	3.5	3.3	2.9	4.1	3.7	3.5	3.7	3.4	3.5	3.2	3.8	3.1	0.7	3.2	2.2	4.2	1.5	1.1	0.7	1.3	2.2	0.9	1.9	1.4	6.5	0.0	1.2	3.7	0.0	3.9	1.9	3.0	1.9	1.5	3.9	1.5	2.2	2.0	0.0	11.2	5.3	1.3	11.5	2.4	6.6	1.5	1.3	6.5	1.8	0.9	4.9	1.7	4.9	1.6	0.0	1.6	1.1	9.6	0.3	1.1	1.8	3.7	1.2	1.6	1.0	2.0	2.5	1.1	0.5	1.2	8.6	0.5	1.8	1.7	0.7	0.7	0.0	1.1	3.3	11.7	9.5	3.3	1.4	2.9	1.4	2.8	2.7	0.9
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325953-92620529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 21.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 63.3;Excitatory neurons: 73.4;Inhibitory neurons: 70.5;Microglial cells: 94.6;Oligodendrocytes: 74.5;Suprabasal keratinocytes: 100.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Nucleoli	"HPA021787: AB_1846524, HPA058945: AB_2683860"	"unprognostic (5.48e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	3.4	3.0	1.7	3.5	2.1	12.3	3.0	5.6	2.1	3.8	0.8	2.4	2.8	2.9	0.7	4.4	2.0	2.8	2.8	2.0	1.5	2.0	1.8	1.9	5.6	1.7	1.4	2.2	2.1	2.4	1.8	3.1	2.0	2.3	2.7	2.4	2.2	1.5	9.0	21.4	1.9	3.0	1.0	2.7	1.8	4.5	1.8	7.1	1.4	4.5	6.4	2.3	4.0	1.8	14.2	8.7	12.0	8.8	4.9	5.3	11.7	14.6	8.2	17.9	14.3	4.0	7.9	18.5	6.7	4.7	16.5	16.8	11.6	8.0	16.6	26.3	15.1	18.6	7.2	5.7	2.6	38.2	17.0	5.8	4.5	17.3	11.1	2.5	9.2	17.5	20.8	25.2	13.8	9.0	53.4	11.6	10.1	26.6	17.9	17.9	20.3	20.0	2.7	14.1	27.8	9.6	16.8	10.5	5.4	8.7	5.6	11.4	4.4	17.4	8.7	26.6	21.2	16.7	21.6	23.9	19.5	18.9	16.1	1.8	1.8	2.6	2.6	6.4	4.7	4.6	3.0	2.3	2.3	3.6	2.7	2.7	0.5	3.5	3.3	3.0	3.5	2.0	1.7	2.1	5.6	2.1	2.0	1.5	1.7	1.4	2.0	1.0	1.8	1.8	3.7	0.0	0.5	17.3	4.5	63.3	4.0	4.5	5.2	6.2	4.0	2.7	2.1	2.8	1.3	0.0	8.4	6.2	3.3	1.6	1.9	1.7	17.5	2.4	4.2	4.4	1.2	11.2	73.4	2.3	9.2	5.8	5.6	2.3	0.0	6.4	2.5	0.9	17.1	1.7	70.5	1.5	0.0	2.1	11.7	4.7	4.4	4.0	14.2	94.6	0.5	2.8	1.0	38.2	74.5	1.1	0.4	4.9	11.9	2.8	0.4	1.8	0.3	7.8	6.6	20.8	9.2	30.2	16.2	9.8	100.9	3.8	3.6	4.4	2.6	2.7
CENPQ	"C6orf139, CENP-Q, FLJ10545"	ENSG00000031691	"Centromere protein Q"	Q7L2Z9	6	49463370-49493107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029043, HPA046634, HPA054965"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653"	"unprognostic (7.39e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.49e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.48e-3)"	"unprognostic (8.93e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.56e-1)"	4.8	4.7	4.7	5.4	5.8	4.9	5.4	5.8	6.9	3.1	3.8	3.9	2.8	4.7	3.0	4.3	4.0	3.5	6.4	4.2	5.1	3.8	4.4	3.8	7.0	5.8	5.2	6.2	2.5	3.6	2.3	5.9	6.0	4.5	4.7	4.2	2.8	3.3	5.0	4.0	3.3	4.4	5.3	4.7	3.8	6.0	4.8	9.4	3.7	8.4	8.4	3.7	3.3	7.6	35.3	9.7	30.1	18.9	8.0	12.4	26.4	44.6	25.5	41.9	58.4	11.9	13.8	23.7	21.7	12.7	32.8	12.5	15.8	16.2	61.6	25.9	22.0	17.5	14.6	19.2	3.4	37.4	21.2	5.7	8.7	51.5	17.9	10.7	15.5	20.4	27.3	22.9	31.4	10.2	26.4	17.6	18.8	30.6	8.7	18.8	35.6	25.8	12.3	14.3	16.2	16.0	21.0	12.4	23.9	29.6	15.9	33.8	9.2	32.3	25.2	25.7	40.4	10.4	28.9	21.4	21.9	27.8	32.0	2.2	1.2	4.1	2.0	1.4	2.0	4.4	2.1	2.3	1.3	4.5	2.3	2.3	0.9	2.4	1.8	2.7	3.2	1.2	4.7	5.8	5.8	6.9	4.2	5.1	5.8	5.2	6.0	5.3	4.8	7.6	8.6	0.0	2.7	7.2	9.5	8.7	9.9	10.4	8.6	6.3	4.1	4.7	6.2	4.3	5.2	7.3	2.1	17.3	8.7	4.2	7.9	7.8	1.3	8.8	5.6	8.0	2.4	5.9	3.0	7.9	30.8	9.3	6.6	5.4	4.5	6.3	14.3	3.4	10.1	6.7	3.1	3.7	2.0	11.4	6.0	2.3	8.7	5.9	3.6	11.2	7.6	14.5	13.4	6.6	13.5	7.8	8.0	10.9	7.5	5.4	1.7	4.4	9.4	5.1	6.6	15.2	6.5	17.7	34.6	6.5	7.0	12.4	5.9	4.2	5.9	6.2
CENPT	"C16orf56, CENP-T, FLJ13111"	ENSG00000102901	"Centromere protein T"	Q96BT3	16	67828157-67847811	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041220, HPA058036"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA041220: AB_2677367, HPA058036: AB_2683585"	"unprognostic (9.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.04e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (2.96e-4)"	"unprognostic (6.64e-3)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.74e-3)"	7.0	5.6	7.2	3.1	7.1	5.3	6.4	7.4	10.0	7.9	5.7	8.1	2.4	7.0	1.4	6.6	7.3	1.8	8.0	7.4	7.8	6.3	5.3	6.3	3.6	7.5	7.3	7.7	9.6	4.9	4.3	4.2	7.6	6.5	2.0	0.8	5.8	4.3	8.2	24.8	6.3	4.7	6.8	5.5	7.4	19.6	7.3	4.4	5.1	5.6	2.3	7.3	6.9	7.2	7.6	7.4	10.0	10.2	8.1	7.8	14.7	29.5	13.6	30.2	24.1	7.9	5.6	3.3	7.1	19.8	5.3	12.4	7.5	13.2	10.3	5.3	9.5	1.2	3.2	11.3	5.1	0.6	6.9	8.5	7.7	20.7	4.4	4.4	12.3	8.1	19.3	3.6	14.5	11.9	9.8	10.7	13.5	5.9	7.1	13.4	4.5	17.6	11.2	3.1	3.9	6.8	22.2	4.6	5.8	6.3	6.1	10.0	9.7	4.3	7.4	6.6	7.0	7.0	5.8	19.4	3.3	6.1	7.4	1.4	7.2	6.3	6.5	6.6	7.0	4.9	6.0	8.2	6.0	6.1	5.3	7.0	3.4	5.4	4.3	6.0	8.5	5.1	7.2	7.1	7.4	10.0	7.4	7.8	7.5	7.3	7.6	6.8	7.3	7.2	21.0	16.0	11.3	10.4	17.4	21.0	20.2	24.4	12.5	24.9	20.3	19.3	8.2	14.3	17.2	20.2	8.4	31.5	25.4	27.5	5.9	19.0	52.2	8.8	17.8	19.7	13.1	30.3	16.9	14.2	25.0	23.0	34.1	11.2	8.2	20.9	17.5	9.4	15.2	25.2	12.3	11.3	24.4	8.5	17.8	47.9	24.2	17.9	17.8	7.5	9.8	13.7	21.6	12.1	8.4	19.7	17.8	22.2	26.9	11.1	16.3	10.3	12.2	10.5	26.3	19.9	25.1	89.8	33.5	12.8	19.5	30.1	22.6	24.3	13.7	13.6
CENPU	"CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1"	ENSG00000151725	"Centromere protein U"	Q71F23	4	184694085-184734130	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.6;testis: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 489.7;Late spermatids: 900.3;Spermatocytes: 490.2;Spermatogonia: 215.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 20.7;eosinophil: 14.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 20.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 157.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022048			Supported	"Nucleoplasm,Centriolar satellite"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centriolar satellite"		"HPA022048: AB_1853985"	"unprognostic (1.47e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.34e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.11e-9)"	"unprognostic (2.19e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.46e-2)"	"unprognostic (2.74e-1)"	1.5	1.1	0.1	5.4	0.3	62.6	5.7	0.6	0.3	2.4	0.1	7.8	5.1	1.5	0.7	10.5	0.9	1.1	1.5	0.2	0.2	0.7	3.7	1.7	16.2	0.2	0.2	0.6	1.0	1.4	0.2	4.8	0.6	1.3	8.0	1.5	2.7	0.4	0.9	15.3	5.4	2.7	0.2	2.3	3.7	29.5	0.4	12.8	1.3	0.1	13.6	2.1	3.9	0.5	57.8	17.1	67.9	35.8	4.3	6.4	37.6	40.8	19.4	32.2	21.2	24.8	32.1	45.9	3.8	18.7	20.2	23.0	52.4	33.2	30.6	23.4	23.0	50.4	17.5	12.6	0.7	71.1	29.3	2.7	2.1	33.3	8.4	9.4	32.1	53.9	44.1	157.3	51.1	38.2	111.4	53.0	33.8	12.7	21.5	74.5	24.3	15.6	17.1	26.7	52.0	49.0	31.4	39.4	23.9	25.0	44.1	50.2	20.9	23.8	31.3	23.5	39.7	26.5	29.5	37.6	37.2	55.4	94.5	20.7	0.7	14.2	0.5	2.0	0.4	0.9	0.7	0.8	0.4	0.9	0.6	0.8	0.1	3.5	2.8	1.9	2.5	0.6	0.1	0.3	0.6	0.3	0.2	0.2	0.2	0.2	0.6	0.2	0.4	0.5	1.4	9.6	3.2	0.3	6.5	13.9	6.0	11.5	3.4	0.9	11.5	7.9	2.3	4.3	8.7	1.8	0.0	31.5	5.4	8.9	3.9	4.8	489.7	9.5	4.0	3.8	0.0	115.7	0.4	2.5	48.4	7.3	9.2	6.6	8.9	27.1	1.1	0.9	21.6	0.0	0.4	10.0	10.2	5.1	7.3	900.3	9.0	15.3	0.0	1.0	5.3	0.2	4.1	0.5	1.9	3.0	1.0	6.8	28.3	2.6	0.9	0.7	5.6	1.4	19.7	2.0	7.2	490.2	215.1	29.1	21.5	7.5	6.3	4.4	18.1	11.6
CENPV	"CENP-V, p30, PRR6"	ENSG00000166582	"Centromere protein V"	Q7Z7K6	17	16342534-16353656	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 100.4;Spermatogonia: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.3;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 106.4;JURKAT: 105.1;NTERA-2: 103.4"	"Low region specificity"	"Detected in all"							"HPA042529, HPA042616"	Enhanced		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Midbody, Cytosol"	"HPA042529: AB_10793882, HPA042616: AB_10794050"	"unprognostic (7.64e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.60e-3)"	4.0	4.7	11.7	0.6	11.3	5.1	4.6	9.3	11.7	4.4	7.1	9.1	9.8	5.9	3.5	0.5	6.6	1.3	5.6	11.9	13.2	3.4	10.7	2.6	1.2	11.6	11.0	6.2	4.0	3.9	7.0	1.2	10.0	3.1	8.0	4.0	1.5	4.0	21.1	0.8	10.6	4.0	11.6	1.1	13.2	10.3	11.4	17.1	2.4	9.5	1.2	4.2	1.7	11.9	10.7	20.4	106.4	53.4	3.0	2.7	18.2	8.7	8.6	26.5	20.0	20.5	4.7	42.5	17.0	6.5	4.9	3.2	69.3	0.6	16.8	0.0	85.9	10.1	5.0	41.1	29.2	10.1	0.0	7.6	2.8	31.6	18.7	3.0	15.2	105.1	17.4	0.0	8.0	1.8	80.2	34.2	103.4	69.1	0.0	57.1	4.1	4.9	6.1	15.4	56.8	43.9	22.2	0.3	5.2	48.6	0.3	24.8	1.0	0.0	8.6	1.2	0.0	0.0	0.0	24.9	0.0	14.0	0.6	0.0	0.0	1.3	0.1	0.0	0.0	1.4	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	11.7	11.3	9.3	11.7	11.9	13.2	11.6	11.0	10.0	11.6	11.4	11.9	13.3	0.0	2.7	3.9	13.7	1.0	29.7	0.5	4.6	40.0	22.5	31.6	4.2	30.0	4.4	1.8	4.2	19.6	19.6	43.0	31.3	7.5	16.3	2.6	32.4	5.0	39.4	12.6	18.9	23.3	22.1	9.2	59.1	2.7	5.7	39.7	1.8	50.1	6.0	11.8	21.8	63.0	0.0	1.4	0.7	9.0	8.7	4.6	8.8	3.7	2.0	45.9	13.4	19.6	11.7	17.8	83.9	11.7	10.7	38.0	100.4	43.5	2.5	15.0	26.3	4.2	17.9	81.6	124.2	2.5	2.6	6.4	10.7	8.7	78.9	45.0
CENPW	"C6orf173, CUG2"	ENSG00000203760	"Centromere protein W"	Q5EE01	6	126340115-126348875	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.6;testis: 39.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 329.7;Extravillous trophoblasts: 155.9;Spermatocytes: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA067285			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA067285: AB_2685818"	"unprognostic (3.51e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.26e-3)"	"unprognostic (9.61e-3)"	"unprognostic (3.78e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.11e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-1)"	8.2	4.3	2.5	12.8	2.3	50.6	6.6	2.0	3.5	14.4	1.4	15.0	8.3	21.6	7.0	23.1	9.2	5.4	1.7	4.2	2.0	3.4	3.6	4.9	15.5	1.9	2.0	4.1	2.1	2.8	2.5	7.8	1.7	6.3	17.5	1.6	8.5	4.4	3.0	8.3	10.8	16.1	1.9	6.8	6.3	39.5	2.0	27.4	2.5	1.9	20.5	6.6	10.9	2.4	73.4	49.0	94.7	82.9	10.3	10.4	81.2	60.0	43.6	81.3	98.3	148.0	50.1	86.8	48.8	38.3	128.7	88.0	78.0	94.3	114.6	94.0	140.2	84.7	141.4	166.3	3.4	123.8	59.1	6.4	10.0	69.1	51.2	23.1	88.3	116.8	144.1	56.5	69.6	119.3	103.1	204.4	60.5	64.0	74.3	107.7	63.2	62.6	38.0	33.0	99.1	44.0	50.8	46.5	67.4	76.9	43.7	119.5	48.0	76.6	78.3	104.6	163.7	36.9	72.7	156.8	45.9	147.0	92.8	3.2	16.9	2.3	2.0	20.3	0.6	6.0	4.4	4.3	15.9	3.5	3.4	2.7	2.9	6.9	14.1	18.9	12.0	5.9	2.5	2.3	2.0	3.5	4.2	2.0	1.9	2.0	1.7	1.9	2.0	2.4	2.5	0.0	2.6	1.0	18.6	38.0	13.4	54.3	6.2	1.3	10.3	18.7	0.3	11.5	29.4	1.8	2.1	52.2	6.1	23.5	5.9	16.6	329.7	18.0	26.5	11.0	7.8	75.1	23.7	17.9	155.9	25.1	17.3	12.7	13.4	31.4	10.8	6.0	63.6	3.3	22.0	27.1	42.7	15.6	40.1	39.3	19.3	19.3	8.8	1.0	12.6	3.1	3.1	1.0	2.4	17.2	10.6	9.1	38.6	24.7	18.1	1.6	7.0	1.4	0.0	6.4	18.1	148.3	83.8	60.9	29.0	21.2	8.6	11.4	51.7	35.8
CEP112	"CCDC46, MGC33887"	ENSG00000154240	"Centrosomal protein 112"	Q8N8E3	17	65635537-66192133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.0"	"Group enriched"	"Detected in many"	8	"Early spermatids: 1061.4;Late spermatids: 1606.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 32.0;RH-30: 75.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069724			Approved	"Nucleoplasm,Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Centrosome"	"Midbody ring, Cytosol"	"HPA069724: "	"unprognostic (9.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.48e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	11.3	3.9	5.0	2.7	5.4	1.7	9.5	7.1	5.8	8.3	11.9	7.8	2.0	8.5	8.2	4.3	8.3	7.0	8.0	7.4	5.1	5.6	3.2	7.4	2.5	5.8	5.7	8.2	4.6	8.7	8.3	7.2	4.2	7.2	3.1	25.4	3.0	7.9	8.8	3.3	2.9	8.0	3.4	8.8	4.2	49.0	5.5	2.8	7.1	14.0	1.7	5.4	5.9	3.4	5.0	10.5	13.3	3.8	6.9	14.0	0.4	4.5	7.7	5.5	5.0	1.5	2.0	1.6	4.3	9.8	15.5	0.6	2.9	2.9	7.8	2.6	4.8	0.3	4.7	1.9	2.9	0.6	0.2	8.4	4.8	5.2	1.6	11.0	16.8	2.7	0.3	5.0	32.0	0.7	5.3	0.4	1.3	1.1	4.4	1.5	75.9	0.4	6.0	0.3	3.5	7.4	4.7	0.5	3.6	11.4	3.8	0.4	7.9	14.3	8.2	3.9	6.7	2.3	2.1	0.2	4.4	0.2	5.3	1.3	0.4	0.4	0.3	0.2	0.6	0.3	0.8	0.3	0.2	0.8	0.5	0.3	1.3	0.8	0.2	1.4	0.5	0.1	5.0	5.4	7.1	5.8	7.4	5.1	5.8	5.7	4.2	3.4	5.5	3.4	39.7	9.6	35.8	83.6	1.1	2.5	2.9	2.2	2.2	36.7	2.7	5.5	28.3	4.3	15.3	1.8	20.9	0.7	0.8	1.5	1.9	7.4	1061.4	15.3	15.8	25.4	1.8	0.4	117.4	4.7	1.5	12.4	1.5	3.3	2.5	11.2	19.2	0.2	1.8	1.7	103.8	0.3	0.0	0.8	11.3	1606.0	24.8	2.3	14.2	99.3	0.0	14.7	1.0	29.7	6.6	4.4	0.5	19.9	0.4	1.5	0.0	4.3	23.7	154.3	13.1	43.7	12.5	40.6	16.5	2.4	1.6	0.1	2.5	3.1	1.5	1.3
CEP126	KIAA1377	ENSG00000110318	"Centrosomal protein 126"	Q9P2H0	11	101915010-102001062	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 143.7;Horizontal cells: 102.6;Respiratory ciliated cells: 138.5;Spermatocytes: 96.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 6.1;EFO-21: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038381, HPA038399"			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA038381: AB_10669780, HPA038399: AB_10670157"	"unprognostic (7.61e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.55e-4)"	"unprognostic (1.52e-2)"	"unprognostic (5.77e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.72e-3)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.30e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.99e-3)"	5.4	4.9	8.2	0.8	9.9	0.9	3.8	9.5	12.3	7.1	16.2	4.2	0.6	4.3	2.6	2.0	9.2	1.9	4.2	9.1	7.1	2.2	0.4	4.4	1.4	9.2	8.9	7.8	2.0	1.4	18.1	0.9	7.4	3.5	1.9	11.1	2.4	3.0	1.0	3.9	2.2	2.1	9.2	1.8	1.9	16.8	8.9	0.8	4.1	1.5	0.8	3.7	5.1	9.0	0.5	1.0	0.6	0.8	6.1	3.3	0.3	0.9	1.1	0.5	0.4	0.3	1.8	0.6	5.7	1.1	2.6	0.5	0.7	1.4	0.4	1.8	0.9	0.1	2.6	0.7	0.7	0.1	0.1	1.0	3.0	0.7	1.5	3.3	1.5	0.8	0.1	0.2	1.3	0.6	0.6	0.1	0.5	0.7	0.9	0.1	0.6	0.0	1.3	0.8	1.7	2.7	0.8	1.2	0.1	1.2	2.2	0.2	1.0	1.7	0.9	0.5	1.4	1.3	0.7	0.1	1.9	0.1	0.5	0.3	0.1	0.3	0.4	0.0	0.3	0.5	0.3	0.4	0.1	0.6	0.4	0.4	0.4	0.9	0.0	1.2	0.1	0.1	8.2	9.9	9.5	12.3	9.1	7.1	9.2	8.9	7.4	9.2	8.9	9.0	6.7	9.6	6.7	0.0	7.2	0.0	5.1	0.0	5.2	29.7	6.4	11.9	6.9	8.6	23.5	18.4	45.9	1.3	20.2	0.5	3.9	2.4	21.7	143.7	45.1	4.0	66.7	2.5	0.0	0.4	0.6	33.4	8.2	3.6	0.0	19.0	3.3	0.0	0.4	102.6	0.0	9.4	0.0	0.3	0.0	12.0	53.7	2.8	0.0	0.0	0.7	25.8	20.6	0.0	0.0	1.1	1.7	51.1	3.5	3.0	0.5	6.0	138.5	53.7	6.6	18.3	11.3	96.3	26.2	1.4	0.0	0.1	6.3	39.3	1.7	2.0
CEP152	"KIAA0912, MCPH9, SCKL5"	ENSG00000103995	"Centrosomal protein 152"	O94986	15	48712928-48811146	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 192.5;Late spermatids: 49.5;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039408	Approved		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome	Nucleoplasm	"HPA039408: AB_10795288"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.87e-4)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.25e-1)"	2.2	1.3	1.2	3.5	1.4	16.3	1.9	2.0	1.9	1.9	2.6	2.3	2.9	1.4	0.9	2.6	1.9	1.8	2.1	1.0	0.9	2.2	1.0	2.2	4.3	1.2	1.2	2.5	2.9	1.3	0.9	4.7	1.4	1.7	3.1	1.9	2.4	0.9	1.0	3.0	2.9	1.9	0.7	2.4	2.3	9.8	1.8	5.6	2.9	0.6	3.7	1.4	2.3	1.8	8.0	6.1	12.2	15.0	2.1	3.9	7.9	13.9	5.6	10.0	12.3	13.2	6.8	18.6	5.9	4.0	14.1	18.6	13.6	5.0	14.5	16.5	8.3	30.1	34.6	7.2	1.4	25.6	13.4	1.4	3.9	11.1	6.6	3.9	7.5	19.2	18.4	21.6	8.6	4.5	18.6	23.8	7.7	9.5	6.1	22.7	16.4	22.9	3.6	7.5	14.6	9.8	10.7	8.9	4.2	13.3	6.7	12.3	6.2	24.4	12.9	18.9	15.6	9.2	10.8	21.4	7.8	36.2	17.6	2.1	1.0	1.9	0.8	1.4	0.7	0.9	0.9	0.9	0.8	1.7	1.0	1.0	1.8	1.2	1.5	1.5	1.0	0.5	1.2	1.4	2.0	1.9	1.0	0.9	1.2	1.2	1.4	0.7	1.8	1.8	3.9	6.4	2.8	22.2	9.3	3.8	4.1	2.8	4.0	1.5	2.9	3.6	3.9	4.3	1.8	3.7	2.1	31.5	6.8	7.8	0.0	4.7	192.5	6.4	5.3	6.7	3.6	29.9	14.7	6.7	8.5	9.0	7.1	5.0	8.2	20.9	6.1	3.3	7.6	0.0	8.4	8.2	4.1	7.2	6.4	49.5	23.9	8.6	1.8	16.9	6.9	2.9	10.3	6.0	7.0	7.9	3.5	27.1	15.9	3.2	9.1	1.7	8.4	3.6	6.6	6.5	5.4	24.4	10.3	7.0	3.4	46.9	9.9	3.4	10.1	4.1
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227643	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.3;Oligodendrocytes: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	2.0	1.5	1.1	2.3	1.9	2.4	2.6	1.8	1.6	2.4	3.2	1.9	1.2	3.7	2.2	1.8	3.7	2.8	1.6	0.8	1.3	2.5	1.4	2.7	2.2	1.4	1.6	4.1	2.1	4.2	1.2	2.5	1.5	2.4	2.6	2.8	1.9	2.3	1.0	2.3	1.7	2.6	1.3	2.3	2.7	8.6	1.6	3.9	3.5	1.6	2.3	2.1	1.4	3.0	2.5	1.1	7.1	7.8	4.2	6.1	4.6	2.8	2.7	3.9	4.6	3.2	3.4	2.7	2.6	2.2	6.7	3.8	4.2	2.6	6.2	7.0	2.8	5.0	5.1	2.4	2.1	5.5	4.6	2.9	1.9	3.9	1.5	5.0	4.4	3.7	10.2	3.1	2.8	1.3	1.4	3.3	4.8	1.7	1.6	7.6	9.3	1.5	2.9	2.3	4.6	5.7	2.0	1.1	2.1	5.1	2.5	3.7	3.5	3.8	3.4	3.4	3.1	2.3	3.3	1.6	2.4	2.9	4.8	0.0	0.2	0.3	0.4	0.2	0.5	0.5	0.3	0.3	0.1	0.3	0.2	0.4	0.5	0.0	0.2	0.4	0.0	0.2	1.1	1.9	1.8	1.6	0.8	1.3	1.4	1.6	1.5	1.3	1.6	3.0	13.6	32.1	17.6	42.7	9.6	0.0	6.7	0.0	4.6	5.9	6.1	7.1	11.2	4.3	6.8	9.2	12.5	6.5	7.0	7.0	5.9	12.6	141.3	43.2	18.3	11.3	11.4	10.8	35.0	7.1	5.9	13.3	8.6	11.3	18.3	18.0	7.9	4.2	5.5	28.6	29.2	4.7	0.0	7.9	0.0	57.9	11.8	9.9	0.0	36.5	7.6	9.2	6.2	54.3	64.0	6.8	12.7	12.0	3.7	2.5	5.6	6.8	39.4	14.3	13.1	13.8	10.9	58.7	20.0	3.6	0.0	3.8	8.5	13.4	5.0	4.1
CEP164	"KIAA1052, NPHP15"	ENSG00000110274	"Centrosomal protein 164"	Q9UPV0	11	117314557-117413266	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis"		"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 454.5;Early spermatids: 241.0;Late spermatids: 291.7;Rod photoreceptor cells: 268.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037605, HPA037606"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Centrosome"		"HPA037605: AB_10672908, HPA037606: AB_10672498"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.93e-2)"	7.0	5.8	6.7	9.7	8.2	7.3	6.8	10.8	8.0	10.5	11.5	7.3	4.2	10.8	8.1	8.6	11.4	8.4	4.3	5.5	7.9	5.1	7.3	6.7	7.6	8.2	7.5	11.9	26.3	5.6	11.1	4.6	8.1	6.9	5.1	26.0	5.7	5.8	3.1	8.0	6.2	10.3	4.9	8.5	5.8	23.9	9.2	7.7	8.4	1.3	8.5	7.1	7.5	14.0	13.2	18.0	13.0	25.9	12.8	21.7	4.2	25.6	14.3	18.0	17.5	22.4	20.8	25.9	18.1	15.9	17.7	17.1	14.6	15.0	15.3	25.8	12.0	7.8	18.9	7.1	18.9	11.3	16.8	15.2	12.6	27.3	26.5	16.1	23.6	12.6	21.7	16.4	14.4	11.2	10.6	10.2	9.2	8.5	19.4	14.0	15.5	10.1	7.9	11.3	15.1	21.8	20.3	12.2	14.4	14.4	16.9	13.2	25.7	21.3	13.2	20.7	23.8	5.8	7.7	15.2	10.3	12.6	14.5	96.2	34.3	23.4	35.4	30.9	22.9	38.8	44.3	40.4	13.9	41.0	41.4	32.6	82.5	29.6	42.0	49.4	52.6	10.8	6.7	8.2	10.8	8.0	5.5	7.9	8.2	7.5	8.1	4.9	9.2	14.0	21.0	6.4	13.1	28.1	15.4	7.6	10.3	13.2	10.8	97.7	14.5	23.6	5.8	15.7	10.3	11.0	454.5	4.5	14.3	9.0	1.9	11.1	241.0	26.5	30.3	18.3	15.5	8.0	19.0	14.7	6.8	17.2	17.9	14.7	19.6	17.6	13.2	9.0	12.9	74.0	26.3	10.2	10.2	11.7	11.4	291.7	23.9	14.5	5.4	8.4	21.2	23.4	15.5	21.6	28.7	11.7	5.8	17.0	11.0	9.8	5.4	6.2	31.6	268.7	0.0	30.3	21.4	37.6	17.2	11.4	8.1	2.2	16.4	45.0	11.9	5.6
CEP63	FLJ13386	ENSG00000182923	"Centrosomal protein 63"	Q96MT8	3	134485721-134575017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Mitosis"		"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 139.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 179.4"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 179.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058154, HPA058313"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA058154: AB_2683624, HPA058313: "	"unprognostic (1.80e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	23.9	15.2	7.4	14.0	9.8	30.2	16.1	10.0	13.7	13.1	6.8	16.4	10.0	12.9	16.9	12.4	12.2	11.3	25.1	7.5	10.9	16.4	21.9	11.8	18.5	9.4	9.1	16.2	17.0	18.8	12.7	14.4	9.7	14.5	14.3	22.0	16.0	15.9	41.5	14.8	11.2	16.4	7.7	16.2	14.7	45.2	9.3	27.5	18.9	29.0	17.4	15.7	12.5	11.7	32.9	12.6	26.2	17.5	36.9	30.7	24.6	35.1	29.1	26.7	21.9	11.8	13.7	36.5	21.0	24.4	26.0	18.6	14.5	18.0	32.3	41.7	7.4	47.9	15.0	16.1	25.3	30.5	22.0	26.4	23.3	14.8	47.1	28.8	27.9	48.2	14.7	31.3	32.4	20.1	37.7	34.5	18.4	20.1	16.9	23.5	38.7	52.8	23.7	20.3	14.8	14.6	31.2	12.1	47.3	30.2	24.7	38.1	30.1	30.1	18.4	30.3	26.9	27.1	21.9	46.7	33.4	30.8	39.2	72.7	20.1	34.3	12.7	20.6	16.9	15.9	12.2	16.5	24.6	22.2	17.2	13.1	179.4	20.3	29.5	16.3	16.8	12.7	7.4	9.8	10.0	13.7	7.5	10.9	9.4	9.1	9.7	7.7	9.3	11.7	19.9	19.2	27.6	39.2	25.5	10.7	14.6	22.6	13.6	31.6	16.8	22.5	84.7	22.8	23.1	7.3	20.9	25.3	16.5	11.8	31.3	25.8	93.2	21.8	23.6	21.0	13.1	26.5	63.5	20.0	26.0	25.8	14.8	17.9	52.6	25.2	14.6	17.3	29.4	32.0	58.3	16.0	16.2	27.7	12.8	54.9	23.9	25.1	17.8	28.1	30.2	26.3	19.6	71.4	67.8	21.0	16.2	25.9	27.3	19.2	12.5	29.6	31.1	43.8	19.7	31.7	25.1	139.1	51.7	17.3	9.8	17.4	20.6	18.8	16.2	16.2
CEP68	KIAA0582	ENSG00000011523	"Centrosomal protein 68"	Q76N32	2	65056366-65087004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040493, HPA040620"	Enhanced		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Centriolar satellite"		"HPA040493: AB_10673411, HPA040620: AB_10794144"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.84e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.71e-1)"	15.9	5.8	11.2	6.9	11.3	4.6	14.1	13.8	11.6	15.3	8.5	12.1	5.5	16.9	6.1	9.8	13.7	10.1	13.9	12.3	9.5	7.1	2.6	7.8	10.0	10.5	9.2	21.6	9.1	9.9	5.9	10.2	10.9	11.0	7.0	7.4	10.7	12.3	26.7	11.8	7.5	14.3	8.1	9.2	8.1	6.0	10.1	10.6	9.6	27.7	8.5	10.3	10.5	11.0	3.9	6.9	13.2	9.7	11.6	13.0	24.2	3.7	6.5	5.6	4.9	5.4	3.4	6.6	4.5	6.7	5.7	5.3	8.7	5.6	5.8	8.0	7.5	9.0	2.5	6.5	3.2	5.1	6.1	12.3	7.8	5.1	7.1	9.8	16.1	13.5	8.4	20.7	7.1	4.5	8.6	9.4	13.3	7.1	5.5	8.9	15.9	7.8	5.0	5.1	23.1	15.7	7.3	5.3	7.9	8.0	3.1	3.3	6.4	5.2	7.1	8.2	3.7	22.4	6.5	15.3	2.8	3.9	6.4	0.9	1.3	0.3	2.3	2.5	2.6	2.6	5.4	4.3	3.5	3.6	8.3	5.2	1.1	4.4	5.0	7.2	4.4	2.5	11.2	11.3	13.8	11.6	12.3	9.5	10.5	9.2	10.9	8.1	10.1	11.0	72.0	28.9	10.9	17.9	13.2	7.1	14.2	15.5	22.2	26.7	11.8	13.6	16.7	8.6	15.5	9.2	25.0	15.4	15.4	3.6	9.8	10.3	3.7	11.2	22.2	47.1	13.1	7.2	28.8	21.4	7.5	17.8	9.2	19.8	6.3	24.9	28.5	6.9	9.4	23.5	31.6	5.8	8.2	7.2	14.4	6.2	37.9	18.9	7.2	22.5	18.4	15.5	8.2	22.6	21.2	8.9	4.3	27.1	6.9	8.9	2.8	9.0	15.0	21.3	32.9	30.5	18.5	11.6	23.9	10.1	5.8	34.1	16.1	9.9	11.2	7.3
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 222.5;Late spermatids: 299.3;Spermatocytes: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 2.8;MAIT T-cell: 3.3;memory B-cell: 1.7;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.1;naive CD8 T-cell: 4.0;NK-cell: 2.3;T-reg: 1.3"	"Group enriched"	"Detected in many"	10	"B-cells: 1.7;NK-cells: 2.3;T-cells: 4.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favorable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	7.5	12.0	20.1	6.3	20.9	5.9	13.3	24.1	22.3	30.6	16.2	17.6	56.2	20.9	21.6	12.0	30.6	13.1	15.8	18.1	25.4	21.4	29.4	14.7	5.5	22.1	21.8	18.5	24.1	21.8	15.6	3.9	21.8	21.0	18.1	35.8	8.7	21.7	18.0	6.8	19.0	11.7	20.5	6.1	13.1	69.0	23.9	42.4	39.2	20.8	6.9	12.1	11.7	22.7	53.7	11.1	25.3	30.8	15.2	16.9	23.5	10.4	19.4	14.0	20.5	15.5	27.9	12.5	24.0	19.2	53.1	23.0	23.2	20.6	31.1	22.2	15.3	35.7	26.0	20.1	24.2	1.6	12.5	92.3	11.7	10.6	26.2	37.0	20.5	40.1	26.6	40.5	23.1	20.1	38.4	2.1	15.0	13.9	24.6	41.7	32.9	32.3	26.9	23.8	30.7	19.8	54.5	12.7	60.8	28.4	64.3	17.7	12.1	10.3	19.0	21.3	12.9	37.2	22.1	42.6	22.9	3.3	35.7	0.2	0.0	0.1	2.8	0.1	3.3	1.7	2.1	2.3	0.0	1.4	4.1	4.0	0.2	2.3	0.0	0.1	1.3	1.2	20.1	20.9	24.1	22.3	18.1	25.4	22.1	21.8	21.8	20.5	23.9	22.7	7.0	32.1	69.3	44.1	4.8	9.7	46.3	14.0	22.2	15.8	11.8	9.8	34.3	22.8	27.4	20.2	35.5	8.1	4.6	10.5	72.4	24.9	222.5	114.0	14.9	7.7	15.6	13.7	51.8	17.6	4.4	11.8	16.3	52.6	20.8	21.9	6.1	14.7	2.4	21.9	48.5	11.1	8.2	0.3	3.0	299.3	9.9	2.3	10.6	19.7	0.6	26.4	2.1	60.8	30.5	12.7	8.1	12.8	9.2	29.5	3.3	21.1	34.5	31.1	6.6	17.5	12.4	163.6	9.5	18.6	8.1	9.6	8.9	9.5	23.9	28.6
CEP72	"FLJ10565, KIAA1519"	ENSG00000112877	"Centrosomal protein 72"	Q9P209	5	612340-667168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.3"	"Cell type enriched"	"Detected in many"	4	"Melanocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.6;NK-cells: 4.5;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.0;HeLa: 40.0"	"Region enriched"	"Detected in many"	8	"cerebellum: 14.1"	"Not detected"	"Not detected"			"HPA058235, HPA074879"	Approved		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Centrosome	"Nucleoplasm, Mitochondria"	"HPA058235: AB_2683649, HPA074879: AB_2686720"	"unprognostic (2.06e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.94e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.24e-2)"	1.1	0.9	1.3	1.9	1.2	3.1	1.4	1.5	1.3	1.6	0.8	1.2	1.4	1.3	1.0	2.2	1.6	1.5	0.9	1.4	0.6	1.4	2.1	1.4	2.7	0.7	0.8	2.8	1.9	1.2	1.5	0.7	0.8	1.3	0.8	1.1	1.7	0.8	0.7	2.4	1.6	0.9	0.6	1.8	1.8	7.3	0.9	3.0	1.8	0.6	1.4	1.2	1.7	1.8	7.5	11.9	10.6	15.0	0.9	1.0	19.1	3.2	1.4	7.1	6.2	10.8	11.2	8.8	8.2	1.4	13.2	7.1	7.5	5.4	2.8	46.0	11.8	9.7	40.0	4.3	1.3	11.3	6.3	1.1	2.3	6.1	4.1	1.4	2.8	17.0	10.1	10.1	3.5	5.7	17.1	9.8	7.0	6.4	11.1	12.8	6.1	12.2	2.3	5.8	8.1	6.2	23.3	7.6	2.0	3.3	7.6	8.7	0.9	6.8	9.9	6.5	4.6	6.3	6.4	8.8	4.2	15.7	7.3	0.0	0.3	0.3	1.3	0.1	1.7	1.4	1.1	1.2	0.1	1.6	1.6	1.6	0.0	4.5	0.6	0.4	1.5	0.8	1.3	1.2	1.5	1.3	1.4	0.6	0.7	0.8	0.8	0.6	0.9	1.8	0.7	3.2	1.5	1.3	2.9	5.7	0.9	2.4	0.6	2.5	1.1	1.8	2.2	2.8	1.0	0.0	0.0	1.2	1.1	1.1	0.0	2.5	4.0	2.4	1.5	1.1	0.0	4.2	2.5	0.9	5.1	1.0	3.6	1.9	0.0	3.8	0.4	1.7	1.4	3.3	1.3	0.7	4.1	0.8	2.9	2.2	1.2	0.7	135.2	1.0	1.4	0.9	2.1	2.0	3.9	2.3	0.5	2.6	4.7	1.1	0.1	0.5	3.4	2.0	0.0	1.3	1.1	30.7	10.1	2.8	3.7	1.6	1.9	0.9	1.3	2.5
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 551.5"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	26.1	8.9	249.9	12.3	411.3	2.5	24.5	248.6	378.3	42.4	140.1	20.9	7.9	35.0	9.7	13.1	23.4	31.2	34.0	261.5	322.7	25.9	3.7	16.9	4.1	344.1	349.4	31.2	30.1	31.0	106.4	49.4	323.9	27.9	7.7	1.0	21.4	22.8	7.0	15.0	12.3	47.4	224.7	10.9	15.8	11.1	386.4	2.4	23.4	7.0	3.9	29.9	30.8	551.5	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	249.9	411.3	248.6	378.3	261.5	322.7	344.1	349.4	323.9	224.7	386.4	551.5	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536672-181680665	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.1;retina: 16.6"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 43.5;Proximal tubular cells: 13.4;Respiratory ciliated cells: 38.7;Rod photoreceptor cells: 22.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	28	"SCLC-21H: 58.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 14.5"	"HPA035443, HPA035444, HPA043203"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"	1.2	0.5	0.3	0.2	0.6	0.0	1.0	9.7	0.4	3.1	6.0	2.3	0.2	0.8	0.3	0.5	7.8	0.7	0.5	0.8	0.6	8.0	1.3	5.1	0.9	1.8	2.0	0.3	0.7	0.6	0.7	0.1	1.8	1.0	0.3	16.6	1.0	0.2	0.4	0.4	6.8	0.2	1.8	17.1	1.2	0.5	0.4	0.4	0.9	0.3	1.9	1.3	1.2	1.8	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.4	0.0	0.3	0.2	0.0	0.3	2.0	0.0	0.4	0.3	0.4	0.0	0.0	0.6	0.5	0.1	0.3	0.6	0.0	0.5	0.9	0.3	0.7	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.8	0.4	0.0	0.4	1.2	0.0	0.0	0.9	0.0	58.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.1	0.8	0.0	0.0	0.3	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	9.7	0.4	0.8	0.6	1.8	2.0	1.8	1.8	0.4	1.8	0.0	3.2	0.5	0.3	0.0	0.0	0.1	1.0	0.0	0.5	0.0	0.0	0.7	1.5	4.9	0.0	18.8	0.0	1.5	0.0	9.8	0.0	4.6	43.5	0.7	0.3	1.8	0.0	6.8	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	2.0	0.0	0.0	2.8	0.0	0.3	0.0	0.0	0.1	2.5	0.0	0.5	0.2	0.0	0.0	0.0	0.4	0.0	2.7	13.4	38.7	22.8	0.0	0.2	0.5	0.4	0.9	0.0	0.0	0.0	0.6	0.0	1.2	0.0
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 55.1;skin 1: 64.0;vagina: 30.3"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 39.3;Early spermatids: 23.5;Late spermatids: 17.5;Spermatocytes: 28.2;Squamous epithelial cells: 48.3;Suprabasal keratinocytes: 50.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 65.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.1	0.0	0.1	0.0	0.2	0.2	3.3	0.3	0.2	15.1	0.0	0.0	0.0	0.0	0.5	55.1	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.6	0.0	0.1	8.4	0.1	0.6	64.0	0.1	0.0	0.0	0.1	0.1	18.3	0.2	0.4	0.1	0.0	16.0	0.3	30.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	1.3	0.0	18.9	5.0	3.9	39.3	0.4	0.1	0.3	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.5	0.2	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.1	17.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	2.0	1.4	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	28.2	0.7	48.3	50.2	0.0	0.1	0.0	0.0	6.0
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 71.3;Muller glia cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 55.1;NB-4: 99.8;U-937: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	13.6	13.0	31.8	10.0	38.9	3.4	31.1	26.6	37.1	35.9	18.7	17.7	6.3	21.5	61.5	64.3	21.3	11.2	14.8	35.3	25.2	27.8	57.7	19.4	19.9	36.9	30.5	22.0	89.1	29.0	22.2	1.9	30.8	32.9	3.9	36.9	55.0	17.6	3.1	47.7	15.2	12.0	26.8	17.7	26.8	11.5	30.7	13.1	51.9	5.3	20.4	18.4	32.7	44.0	0.4	2.1	2.1	25.0	0.8	0.2	1.7	3.1	8.4	3.7	1.7	19.5	1.7	40.0	27.4	0.0	9.6	13.6	16.4	0.4	1.7	35.5	12.4	7.6	0.1	55.1	31.6	0.0	21.3	12.3	20.7	8.8	18.9	10.5	0.3	17.7	5.9	1.2	0.0	0.8	2.6	99.8	25.4	0.2	8.7	49.1	0.8	3.0	6.3	0.0	9.3	12.2	4.3	0.7	14.5	16.7	18.8	8.8	0.2	2.9	7.8	18.6	0.1	24.5	21.1	32.0	0.1	61.9	2.8	12.3	7.1	27.4	7.5	3.9	5.7	19.8	4.3	4.6	4.1	17.7	3.9	3.8	22.4	22.4	2.4	3.9	5.5	5.8	31.8	38.9	26.6	37.1	35.3	25.2	36.9	30.5	30.8	26.8	30.7	44.0	3.2	6.4	10.7	27.1	31.2	18.0	13.2	12.0	15.4	24.5	47.0	28.8	4.1	22.8	22.2	1.8	18.8	3.4	17.2	0.2	7.9	20.0	1.7	7.9	11.2	8.6	23.9	4.0	38.3	30.5	0.9	15.7	3.1	7.6	12.7	14.4	8.2	71.3	16.4	11.8	24.4	1.3	8.2	7.1	7.2	7.3	14.3	6.7	26.6	16.9	19.6	150.3	27.8	47.7	48.1	9.4	2.5	16.1	12.4	40.6	0.4	44.6	27.8	29.5	6.6	6.9	13.8	1.0	1.6	20.6	25.9	2.9	15.7	2.7	2.5	11.9
CERT1	"CERT, COL4A3BP, GPBP, STARD11"	ENSG00000113163	"Ceramide transporter 1"	Q9Y5P4	5	75356345-75512138	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;Cardiomyocytes: 37.1;Cytotrophoblasts: 17.7;dendritic cells: 20.2;Extravillous trophoblasts: 16.8;Hofbauer cells: 36.8;Plasma cells: 12.4;Syncytiotrophoblasts: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 132.3;WM-115: 118.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035645, HPA042608"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	Nucleoplasm	"HPA035645: AB_10600700, HPA042608: AB_2678075"	"unprognostic (2.45e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.29e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.24e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.91e-1)"	38.1	26.1	12.4	16.5	16.1	27.2	17.6	18.0	15.4	33.9	14.0	20.8	18.7	20.6	15.1	24.9	22.4	23.3	20.8	14.0	15.1	27.9	31.2	24.3	20.3	14.7	17.5	23.1	16.4	26.1	8.0	22.9	16.7	24.3	19.6	18.2	14.0	19.9	28.9	18.7	21.1	18.3	14.7	25.3	23.5	28.8	15.5	21.2	49.9	28.3	22.7	23.7	16.0	17.6	44.9	22.7	21.6	19.0	132.3	36.6	29.0	24.8	30.8	18.8	24.8	34.4	25.3	21.5	52.3	26.9	25.8	26.7	33.4	34.4	28.6	27.1	15.2	18.2	24.4	18.4	33.6	18.2	20.1	27.9	23.8	22.3	24.9	30.5	22.1	28.3	33.0	32.0	25.0	23.0	21.6	13.2	27.9	10.2	16.8	18.0	28.5	20.2	30.5	54.0	16.4	16.5	31.6	21.6	31.8	45.4	21.3	30.5	30.1	12.6	15.1	22.8	20.3	29.1	41.6	24.8	21.4	30.7	118.2	9.6	19.8	16.0	8.2	22.4	7.8	9.1	8.3	7.7	14.5	9.1	7.7	7.8	29.6	7.8	25.4	8.3	13.0	9.0	12.4	16.1	18.0	15.4	14.0	15.1	14.7	17.5	16.7	14.7	15.5	17.6	23.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	17.7	20.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	16.8	10.5	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	27.8	3.8	0.0	0.0	0.0
CETN1	"CEN1, CETN"	ENSG00000177143	"Centrin 1"	Q12798	18	580380-582114	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1084	"testis: 134.3"	"Group enriched"	"Detected in some"	34	"Early spermatids: 930.9;Late spermatids: 435.6;Spermatocytes: 675.9"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001470, HPA028956, CAB037244, HPA069157"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB037244: AB_476871, HPA001470: , HPA028956: AB_10601798, HPA069157: "															"unprognostic (1.51e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	930.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	435.6	12.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	675.9	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CETN2	"CALT, CEN2"	ENSG00000147400	"Centrin 2"	P41208	X	152826994-152830757	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 243.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 639.9;Proximal tubular cells: 345.8;Respiratory ciliated cells: 1116.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001470, HPA028956"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA001470: , HPA028956: AB_10601798"	"unprognostic (3.32e-1)"	"prognostic favorable (7.54e-6)"	"unprognostic (7.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.73e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.20e-1)"	30.2	41.0	61.8	19.8	62.3	26.2	40.3	58.3	80.4	64.6	90.5	54.6	15.2	57.6	116.2	37.2	243.6	31.7	34.6	60.6	65.8	74.7	31.5	39.8	16.0	68.0	75.8	57.2	24.0	55.7	73.9	21.4	70.4	50.3	25.8	40.1	24.4	77.7	19.6	23.8	21.6	54.8	67.4	16.8	29.3	23.3	64.8	21.0	67.2	20.2	21.9	37.3	36.1	67.1	145.2	65.0	78.8	59.6	102.5	110.5	31.4	61.6	73.8	79.9	60.9	29.5	75.8	51.6	157.8	83.1	128.8	55.3	55.3	76.7	94.1	23.2	40.0	11.5	32.1	86.6	38.5	48.7	12.5	67.0	99.2	74.1	39.1	95.4	64.0	40.3	31.0	20.9	78.3	67.9	36.4	53.0	27.5	119.9	82.6	31.9	57.2	53.2	146.9	35.4	38.5	50.0	41.2	42.2	38.2	70.8	45.4	37.2	59.8	56.0	44.9	111.9	69.9	20.9	29.7	81.0	118.3	28.9	28.0	19.9	11.4	35.9	11.7	13.6	14.2	11.9	11.5	13.1	13.5	9.7	12.2	12.5	10.9	12.3	13.7	20.0	10.5	11.8	61.8	62.3	58.3	80.4	60.6	65.8	68.0	75.8	70.4	67.4	64.8	67.1	21.6	51.3	35.7	3.9	19.2	22.6	52.4	201.6	21.6	13.6	46.1	47.6	37.1	64.3	155.8	169.2	6.2	66.6	16.2	13.8	238.7	100.3	60.1	639.9	65.4	29.6	37.1	33.2	4.2	41.1	69.8	42.9	12.2	68.7	24.6	41.0	44.3	96.5	50.0	13.5	3.5	31.7	150.5	23.7	21.3	72.5	67.7	27.3	37.4	1.9	27.8	104.4	20.6	0.5	2.5	39.6	16.0	111.7	16.6	29.3	15.4	345.8	1116.5	29.4	19.7	22.7	64.2	76.5	70.4	33.7	30.5	41.5	19.7	51.8	29.2	42.4
CFAP20	"C16orf80, fSAP23, GTL3"	ENSG00000070761	"Cilia and flagella associated protein 20"	Q9Y6A4	16	58113592-58129381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 336.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018195	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA018195: AB_1850408"	"unprognostic (9.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.47e-1)"	20.3	23.8	34.9	15.6	36.9	26.0	20.9	35.2	37.9	20.7	33.8	16.8	17.3	20.1	23.1	18.9	36.2	18.0	43.1	35.5	38.2	20.6	33.8	20.5	25.5	33.3	35.0	31.3	14.6	34.7	30.9	30.2	35.1	18.6	16.1	28.5	17.5	17.8	12.1	20.8	16.6	17.5	37.8	18.1	16.4	30.8	35.8	39.3	26.5	20.0	21.9	18.1	17.8	38.1	58.1	45.6	75.5	40.9	27.6	22.0	59.2	53.7	37.4	83.3	53.7	73.3	61.4	60.1	75.5	36.4	37.8	58.0	70.7	53.3	82.2	34.5	75.0	34.1	25.3	97.7	32.1	51.7	64.9	24.9	36.3	53.1	47.9	31.8	51.6	92.5	57.2	28.0	66.3	43.7	147.4	104.2	69.5	39.7	91.6	141.5	94.3	56.7	46.8	35.6	68.7	61.2	95.7	36.9	54.0	51.8	32.0	63.3	36.1	51.0	67.0	56.3	62.1	33.7	33.5	115.1	33.3	53.5	70.0	88.6	29.6	52.9	46.4	30.2	45.5	55.0	48.1	49.6	33.9	49.7	64.0	54.3	24.8	66.6	31.1	56.8	94.9	52.5	34.9	36.9	35.2	37.9	35.5	38.2	33.3	35.0	35.1	37.8	35.8	38.1	70.9	12.8	20.3	10.4	21.8	0.0	38.5	0.0	60.3	28.7	28.7	50.9	51.7	30.0	16.1	20.2	33.3	101.9	29.3	7.4	56.7	36.7	336.7	60.1	29.2	58.7	24.3	19.1	7.3	16.5	75.3	40.8	18.8	22.0	12.6	22.5	30.4	35.7	35.1	18.5	7.7	19.6	0.0	11.4	0.0	137.7	33.8	17.4	0.0	3.7	17.4	32.3	23.7	16.6	21.0	22.6	17.2	31.2	19.1	30.8	23.5	34.7	33.5	38.8	19.7	60.9	30.3	109.7	30.3	35.6	0.0	65.9	31.6	38.5	17.2	19.5
CFAP206	"C6orf165, dJ382I10.1, FLJ25974"	ENSG00000272514	"Cilia and flagella associated protein 206"	Q8IYR0	6	87407972-87464465	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 22.3;testis: 59.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 300.7;Spermatocytes: 128.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.3;RPTEC TERT1: 2.6;T-47d: 4.5"									"HPA044891, HPA072261"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Cell Junctions"	"HPA044891: AB_10960832, HPA072261: AB_2686501"	"unprognostic (4.31e-1)"	"unprognostic (8.75e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.51e-2)"		"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.99e-3)"	"unprognostic (9.08e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	0.1	0.4	1.0	0.0	0.9	0.0	0.3	0.5	0.9	0.7	4.3	0.0	0.0	0.5	0.6	0.0	22.3	0.1	0.2	0.8	1.4	0.9	0.1	1.5	0.0	2.3	2.6	0.1	0.1	0.7	1.2	0.1	1.6	0.5	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.1	1.5	0.0	0.0	59.1	1.7	0.0	1.4	0.1	0.0	0.2	0.0	0.9	0.0	0.5	0.2	1.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.0	0.0	1.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.6	0.5	0.3	0.2	0.2	0.1	0.0	4.5	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.5	0.9	0.8	1.4	2.3	2.6	1.6	1.5	1.7	0.9	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	1.9	0.3	300.7	15.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.5	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	1.4	43.7	0.4	0.0	0.0	0.1	128.8	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
CFAP36	"BARTL1, CCDC104, MGC15407"	ENSG00000163001	"Cilia and flagella associated protein 36"	Q96G28	2	55519604-55545079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1342.4;Late spermatids: 262.5;Spermatocytes: 346.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008994, HPA017061"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies"	Cytosol	"HPA008994: AB_2275429, HPA017061: AB_1846129"	"unprognostic (8.11e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.66e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.96e-1)"	39.1	42.7	72.7	20.2	74.8	16.5	48.9	61.8	98.8	49.8	82.8	52.3	15.1	47.1	77.0	21.9	62.3	40.9	35.7	75.0	78.5	63.2	17.7	33.9	21.7	71.8	70.4	58.9	33.6	78.0	106.7	20.6	72.1	41.6	23.2	124.3	28.7	45.0	19.2	18.8	25.2	37.4	65.9	18.2	42.1	145.2	73.6	22.8	78.0	27.1	19.7	40.7	33.6	70.1	59.5	47.3	50.2	66.3	64.4	119.4	30.4	36.6	73.4	54.9	46.6	34.6	21.2	21.3	82.3	48.9	81.9	38.4	39.3	51.4	67.7	51.9	76.2	31.0	43.9	38.1	70.0	59.4	38.4	58.1	82.7	74.0	92.1	146.8	58.9	42.5	40.1	18.2	66.1	44.4	35.7	67.5	25.2	38.7	44.8	27.2	59.7	21.7	112.1	33.7	74.1	36.6	49.4	25.6	68.5	26.2	42.1	19.7	32.5	57.6	33.7	58.5	50.8	29.9	14.2	7.3	94.0	26.7	26.8	15.5	4.3	13.6	18.3	5.0	35.4	16.9	50.6	29.6	5.8	11.7	41.1	26.0	5.2	12.3	6.4	13.5	30.5	15.9	72.7	74.8	61.8	98.8	75.0	78.5	71.8	70.4	72.1	65.9	73.6	70.1	51.3	48.1	30.6	15.7	14.5	0.0	52.6	0.0	22.2	39.6	48.7	77.2	37.9	38.6	27.2	35.0	8.4	14.3	14.8	6.4	92.0	61.9	1342.4	184.4	51.8	42.9	17.0	21.0	51.6	60.7	27.0	44.7	21.9	36.3	39.1	27.1	42.1	10.7	23.6	23.5	41.1	12.2	0.0	8.7	0.0	262.5	75.2	12.8	0.0	14.0	16.9	145.0	16.5	21.6	13.3	37.0	11.5	67.7	11.4	41.3	7.6	146.9	99.1	92.4	59.2	43.0	43.4	346.0	29.8	16.1	0.0	7.8	24.7	36.0	9.9	35.6
CFAP45	"CCDC19, NESG1"	ENSG00000213085	"Cilia and flagella associated protein 45"	Q9UL16	1	159872364-159900165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 13.5;fallopian tube: 44.8;testis: 28.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 256.4;Endometrial ciliated cells: 98.2;Late spermatids: 57.4;Respiratory ciliated cells: 166.9;Spermatocytes: 43.7"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.0;HEL: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042204, HPA043618"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA042204: AB_10966555, HPA043618: AB_10959305"	"unprognostic (1.88e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-12)"	"unprognostic (2.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.65e-1)"	0.6	0.1	1.8	0.4	1.3	0.8	0.6	1.0	0.9	2.7	13.5	0.3	0.2	1.4	0.0	0.4	44.8	0.2	0.8	1.7	1.8	0.7	0.1	5.0	0.2	7.9	7.0	0.3	0.2	0.1	0.4	0.4	4.7	0.4	0.1	0.0	0.3	0.4	0.2	0.5	0.3	0.4	5.9	0.7	0.6	28.4	2.3	0.3	0.7	0.1	0.2	0.5	0.3	4.1	2.1	0.4	0.0	0.0	0.1	0.2	9.0	1.1	1.3	1.9	0.8	1.5	2.7	0.8	0.4	0.3	1.0	1.3	0.2	0.3	1.1	0.3	0.2	12.2	0.5	0.0	0.4	1.1	0.4	0.8	0.6	2.1	0.7	2.8	1.4	0.2	1.3	0.4	0.3	3.0	0.2	0.9	0.5	1.7	1.0	0.0	0.9	0.4	0.1	0.5	0.8	0.1	1.0	3.2	0.3	2.6	3.1	0.2	1.8	0.8	2.4	1.6	2.0	0.8	0.0	0.2	4.3	0.3	0.7	0.0	0.1	3.0	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.0	0.2	2.4	0.0	0.0	0.1	0.0	0.1	1.8	1.3	1.0	0.9	1.7	1.8	7.9	7.0	4.7	5.9	2.3	4.1	2.0	0.0	4.8	0.0	0.4	0.0	0.9	0.0	0.6	0.1	1.4	0.9	5.5	0.0	29.7	5.5	0.0	1.6	0.6	0.0	0.0	1.9	256.4	98.2	1.3	3.2	0.0	0.0	0.1	2.2	7.4	1.2	0.0	3.2	3.8	0.1	1.4	0.0	0.4	0.0	0.1	0.1	0.0	0.6	0.0	57.4	2.1	4.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	1.6	0.0	1.5	3.2	1.3	0.1	0.4	166.9	0.0	0.0	0.7	0.9	43.7	3.1	1.2	0.0	0.8	1.2	0.6	0.1	1.1
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.7;choroid plexus: 18.2;fallopian tube: 57.8"	"Group enriched"	"Detected in some"	6	"Early spermatids: 32.4;Endometrial ciliated cells: 99.6;Respiratory ciliated cells: 81.6;Spermatocytes: 33.9"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.5;glioma: 1.7;lung cancer: 0.6;ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;MCF7: 2.1;OE19: 2.7;REH: 1.4;T-47d: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023247, HPA030635"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA023247: AB_1858797, HPA030635: "	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.0	0.3	3.8	0.0	4.3	0.0	0.1	2.3	2.9	2.3	18.2	0.1	0.7	1.1	0.1	0.2	57.8	0.2	0.0	4.0	4.1	0.3	0.2	4.4	0.0	10.7	13.7	0.2	0.2	0.3	3.2	0.2	8.4	0.3	0.0	2.4	1.2	0.2	0.0	0.2	0.7	0.0	9.9	0.0	0.1	12.2	3.9	0.3	0.6	0.3	0.0	0.1	0.1	6.6	0.8	0.8	0.0	0.3	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.1	0.0	0.3	0.1	2.7	0.0	1.4	0.0	0.0	0.2	0.4	0.3	0.0	0.3	0.5	0.0	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	4.3	2.3	2.9	4.0	4.1	10.7	13.7	8.4	9.9	3.9	6.6	0.2	0.0	2.3	1.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.3	0.0	9.9	0.0	6.2	0.8	0.0	0.0	1.9	0.1	32.4	99.6	0.9	0.3	0.0	0.0	9.7	0.2	0.2	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	6.4	1.8	0.0	0.0	1.0	0.0	0.7	0.0	7.1	1.1	0.1	0.0	1.9	0.0	0.3	0.0	0.5	81.6	3.1	0.0	0.1	0.2	33.9	0.8	0.0	0.0	1.0	0.1	0.1	0.0	0.1
CFAP73	"CCDC42B, MIA2"	ENSG00000186710	"Cilia and flagella associated protein 73"	A6NFT4	12	113149858-113159276	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 21.6;choroid plexus: 28.1;fallopian tube: 42.2"	"Cell type enriched"	"Detected in some"	4	"Endometrial ciliated cells: 110.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;REH: 2.2;T-47d: 2.5;U-698: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048539	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA048539: AB_2680434"	"unprognostic (2.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.90e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.62e-4)"	"unprognostic (2.03e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.55e-2)"	0.2	0.4	3.2	0.4	2.8	2.1	0.3	1.1	1.0	3.8	28.1	0.3	0.3	0.5	0.3	0.5	42.2	0.2	0.2	5.5	5.8	1.7	0.5	7.1	0.7	17.9	21.6	0.4	0.4	0.1	1.2	0.0	11.3	0.6	0.0	0.2	2.3	0.7	0.3	4.7	0.5	0.0	15.0	0.6	4.0	0.5	4.6	0.0	0.8	0.0	1.2	0.2	0.2	3.4	0.2	0.0	0.2	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.3	2.0	4.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.2	1.7	0.1	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.7	0.2	0.7	0.3	0.8	0.1	2.2	0.0	0.3	0.5	0.5	0.4	0.1	0.0	0.6	0.0	0.2	2.5	0.0	0.1	0.1	0.7	0.2	0.1	0.4	0.1	9.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.8	1.1	1.0	5.5	5.8	17.9	21.6	11.3	15.0	4.6	3.4	0.0	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	6.2	3.7	0.0	0.1	0.1	0.2	0.0	0.0	0.4	110.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.6	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	23.3	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.2
CFDP1	"BCNT, CENP-29, CP27, p97, SWC5, Yeti"	ENSG00000153774	"Craniofacial development protein 1"	Q9UEE9	16	75293698-75433503	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 493.3;Paneth cells: 745.2;Proximal enterocytes: 612.2;Proximal tubular cells: 637.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041316, HPA048242"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA041316: AB_10794371, HPA048242: AB_2680327"	"unprognostic (1.45e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (5.81e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.25e-1)"	45.0	51.0	57.4	24.0	58.0	35.0	45.2	60.8	75.3	69.1	57.9	47.5	30.4	58.6	62.3	41.2	55.6	29.7	36.8	57.1	61.7	64.5	43.1	37.3	27.1	58.8	59.3	83.1	41.2	30.8	57.1	63.1	58.8	39.9	40.2	49.6	39.4	38.1	35.7	42.4	36.4	51.0	56.7	30.2	34.7	59.5	59.6	57.0	45.0	34.9	35.8	44.8	50.7	60.8	65.0	47.6	158.9	59.2	141.2	156.3	47.2	63.2	74.1	83.0	119.1	82.5	86.6	61.3	91.1	79.3	92.7	71.5	123.3	101.9	164.9	26.4	58.6	63.0	46.6	177.2	97.3	69.2	51.6	98.4	85.5	100.2	121.4	144.6	91.5	114.0	91.3	28.3	93.9	149.0	102.2	152.6	77.1	110.0	24.8	182.7	64.3	108.5	93.1	35.5	94.5	79.4	105.7	22.3	92.5	136.4	91.8	121.6	53.8	59.2	63.1	63.2	40.8	54.4	89.2	228.6	59.3	89.9	53.3	61.3	45.5	60.8	31.2	47.8	44.5	33.6	42.7	34.7	48.8	35.4	38.7	36.5	38.1	28.5	46.2	48.7	68.5	25.8	57.4	58.0	60.8	75.3	57.1	61.7	58.8	59.3	58.8	56.7	59.6	60.8	87.4	38.5	57.5	37.5	45.5	57.9	116.3	135.9	47.3	87.2	89.5	103.4	34.7	91.5	111.2	115.8	116.7	119.0	50.5	493.3	197.6	79.1	133.7	197.7	118.5	97.6	82.2	78.9	49.5	94.9	114.0	82.9	61.2	121.3	28.5	194.5	62.8	153.9	77.1	62.2	50.5	219.2	59.0	53.1	44.5	69.7	125.2	51.1	33.8	45.9	64.8	60.8	84.5	49.8	75.6	92.4	745.2	112.5	42.3	116.9	612.2	637.6	205.3	112.5	98.6	55.3	88.2	311.2	178.0	49.5	65.6	154.9	51.6	103.5	120.0	130.4
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34709113-34714823	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 372.8;skeletal muscle: 719.9;tongue: 686.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 522.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		47000000	"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (2.16e-5)"	48.7	52.5	71.7	28.6	98.7	18.1	24.6	90.3	116.1	39.8	53.9	92.5	14.3	73.4	19.5	69.0	42.6	24.1	372.8	69.4	85.0	31.4	125.9	24.9	10.7	85.7	83.6	41.2	9.4	24.4	10.9	35.3	88.7	75.4	28.1	41.0	17.1	107.3	719.9	8.2	24.0	115.0	74.7	12.7	36.1	21.7	81.2	10.4	29.4	686.4	9.9	56.8	24.3	130.5	87.1	77.7	49.5	32.0	51.1	185.6	27.9	146.6	170.5	145.6	151.4	61.9	38.5	30.6	58.5	245.2	104.9	17.1	107.4	32.5	268.6	4.2	45.0	6.6	87.4	144.5	81.6	8.2	5.3	139.3	12.4	122.2	67.7	96.8	145.9	4.5	9.9	26.8	186.9	25.5	6.3	4.3	16.3	15.4	118.9	5.4	158.1	4.7	55.1	17.7	10.3	41.7	96.6	21.5	51.2	36.2	47.8	7.5	124.6	140.9	93.0	66.1	72.9	34.3	22.8	11.7	51.7	11.4	34.5	1.8	1.0	1.3	1.9	1.0	3.1	4.9	2.2	2.1	1.6	3.0	1.7	1.8	0.3	1.8	0.4	1.6	2.1	0.9	71.7	98.7	90.3	116.1	69.4	85.0	85.7	83.6	88.7	74.7	81.2	130.5	39.6	105.8	41.6	6.2	17.0	20.0	88.6	31.3	23.9	62.8	19.6	16.6	522.2	22.8	26.3	22.0	20.9	32.2	11.5	0.9	60.7	45.2	2.6	40.3	60.5	45.1	9.5	11.4	9.6	39.7	60.5	69.9	6.1	56.2	5.7	25.8	47.2	112.0	15.6	77.4	14.2	2.4	57.0	15.7	14.4	10.1	57.2	10.6	30.2	11.2	5.7	112.9	15.5	8.0	93.8	24.7	4.0	98.6	60.4	84.0	1.0	101.9	24.7	57.8	32.9	83.9	115.8	49.3	51.9	16.1	19.5	21.3	21.1	47.9	4.6	58.5
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, cFLIP, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116154-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 609.9;Urothelial cells: 521.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 392.6"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 392.6"	"Cell line enhanced"	"Detected in all"		"U-266/70: 214.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	122.4	50.6	38.8	103.9	40.9	247.6	83.1	54.1	47.4	57.0	75.6	86.0	59.2	57.9	60.6	68.0	66.6	71.6	184.8	39.4	32.7	57.5	59.2	174.6	91.1	46.5	40.5	38.3	40.7	31.8	29.4	94.0	42.1	65.6	56.4	12.4	58.0	63.2	222.8	51.0	64.8	58.8	36.6	98.1	56.5	25.3	51.9	54.1	78.8	89.2	107.3	78.7	61.7	46.1	21.5	42.9	30.0	17.9	92.3	71.0	37.5	53.6	92.1	34.3	41.6	50.4	78.4	5.8	49.6	62.5	41.6	15.5	9.8	40.3	53.9	160.7	29.9	32.3	38.4	82.2	63.6	24.2	102.2	76.8	39.6	58.2	50.3	41.7	176.7	7.3	110.8	131.2	63.1	17.9	11.3	96.3	10.2	17.2	32.7	11.7	7.2	46.5	42.5	44.0	6.6	11.8	35.7	31.2	43.2	19.6	22.1	44.8	193.6	71.0	29.5	26.7	26.1	214.6	76.2	35.9	50.6	19.5	36.3	91.8	60.3	70.3	54.4	61.8	48.4	25.6	46.5	52.1	33.4	20.9	29.5	38.3	392.6	45.2	68.5	23.0	60.7	42.0	38.8	40.9	54.1	47.4	39.4	32.7	46.5	40.5	42.1	36.6	51.9	46.1	191.3	451.9	234.9	30.3	126.4	54.8	229.6	164.9	29.0	10.9	38.9	30.0	205.8	102.9	206.7	69.9	31.3	77.2	166.2	132.5	74.3	148.8	83.3	202.8	75.0	261.0	95.1	59.1	6.9	72.5	34.8	89.5	73.4	219.2	81.6	93.4	201.0	97.5	68.6	13.5	16.8	76.8	40.7	123.2	609.9	44.8	51.9	278.0	97.8	146.1	247.0	23.4	276.0	29.7	56.8	166.4	155.6	49.7	317.8	386.0	116.7	101.5	276.1	30.7	39.5	113.2	77.9	14.4	12.2	33.2	86.1	70.1	168.3	56.1	50.9	521.3
CGAS	"C6orf150, MB21D1"	ENSG00000164430	"Cyclic GMP-AMP synthase"	Q8N884	6	73413515-73452297	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.2;dendritic cells: 12.0;Glandular and luminal cells: 12.5;Hofbauer cells: 12.4;Macrophages: 10.0;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.1;RH-30: 43.8;RPMI-8226: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031700, HPA031702"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031700: AB_10601693, HPA031702: AB_2673999"	"unprognostic (2.49e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.27e-7)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-1)"	2.9	1.1	1.7	6.4	2.1	14.0	1.7	2.2	3.0	2.4	1.7	1.9	2.7	1.9	0.6	2.3	1.8	2.6	1.5	1.9	2.0	1.1	0.8	3.5	7.4	2.6	2.2	1.2	1.2	0.6	0.6	3.1	2.6	1.9	1.8	0.2	1.8	1.8	0.5	1.1	2.5	2.0	2.4	5.2	2.3	1.0	3.0	2.3	1.6	0.9	4.7	4.3	2.1	3.4	19.9	5.8	0.1	0.2	1.2	2.7	0.1	10.1	3.7	11.3	12.6	20.7	14.2	0.2	20.9	4.3	6.3	10.1	9.8	0.2	12.0	31.9	0.0	16.9	8.2	0.1	4.0	12.3	11.5	1.6	3.2	11.8	0.1	0.0	3.5	0.1	0.0	37.1	8.7	8.0	0.0	27.1	6.2	2.4	11.2	23.4	43.8	45.2	0.0	7.3	0.3	0.1	17.3	0.4	10.2	0.2	0.0	33.9	5.0	0.0	9.1	8.5	0.2	8.1	19.8	0.2	0.1	17.5	11.4	26.3	12.7	19.0	6.0	17.5	4.7	8.4	7.9	5.9	7.5	6.7	1.8	3.4	8.5	4.2	11.6	17.6	8.0	6.0	1.7	2.1	2.2	3.0	1.9	2.0	2.6	2.2	2.6	2.4	3.0	3.4	10.2	3.2	4.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	0.6	0.0	0.0	0.2	12.0	0.0	0.0	2.0	0.0	8.4	8.5	6.0	0.0	0.0	0.0	3.9	0.7	2.3	0.0	12.5	5.1	1.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	3.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.3	8.0	0.7	0.0	0.0
CGGBP1	"CGGBP, p20-CGGBP"	ENSG00000163320	"CGG triplet repeat binding protein 1"	Q9UFW8	3	88051944-88149885	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 528.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035568, HPA037017"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA035568: AB_10670022, HPA037017: AB_2675433"	"unprognostic (2.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.79e-4)"	40.2	31.0	22.2	45.8	25.5	75.7	36.9	26.5	29.8	39.9	27.1	32.8	35.6	45.3	32.7	35.6	33.5	37.3	35.9	23.5	27.3	40.2	41.3	39.5	65.2	23.0	22.9	56.2	37.9	44.4	23.2	42.0	23.3	35.5	39.6	48.8	35.2	35.3	37.6	28.1	37.6	44.3	24.4	52.7	33.7	32.5	23.6	85.3	47.0	47.4	61.9	35.7	27.7	34.9	37.4	64.1	109.3	77.4	92.8	78.1	34.5	81.9	71.4	82.0	97.9	46.7	56.4	81.9	52.7	74.7	63.0	30.2	91.4	63.2	103.2	126.0	46.5	132.3	66.0	47.4	79.7	86.3	93.8	74.4	53.8	95.0	118.7	99.2	85.1	99.0	58.2	87.5	89.5	62.9	136.5	59.5	58.1	62.5	59.0	83.6	106.9	58.0	56.0	66.3	22.0	66.6	66.9	35.6	179.1	79.6	57.5	95.6	81.5	98.8	72.5	528.4	81.8	64.0	83.2	90.5	73.1	81.5	84.9	107.9	42.7	81.2	44.2	45.7	43.8	45.0	39.6	46.4	40.6	47.6	46.6	39.6	77.0	47.4	51.6	34.0	48.9	44.7	22.2	25.5	26.5	29.8	23.5	27.3	23.0	22.9	23.3	24.4	23.6	34.9	65.1	51.3	48.0	32.3	75.1	53.2	65.7	45.6	60.9	35.8	59.8	45.3	45.9	42.9	47.8	40.5	16.7	55.0	66.0	49.0	66.5	39.0	21.0	37.8	64.5	63.0	41.9	107.5	40.6	42.0	63.6	57.5	50.4	46.8	46.9	61.1	74.6	55.1	41.2	67.3	35.6	38.3	38.7	56.2	72.8	36.3	69.6	58.7	40.9	42.2	52.4	70.6	53.5	62.8	91.1	52.8	43.9	50.0	63.7	63.0	41.1	65.1	25.3	32.9	65.7	63.3	79.0	94.1	47.9	52.5	50.0	83.9	80.5	31.8	36.0	72.7
CGRRF1	"CGR19, RNF197"	ENSG00000100532	"Cell growth regulator with ring finger domain 1"	Q99675	14	54509812-54539292	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.4;Spermatocytes: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002930	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA002930: AB_1078507"	"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (2.57e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.74e-1)"	9.9	9.2	20.5	3.9	21.1	7.9	11.9	22.2	25.8	9.6	21.2	11.7	5.3	11.0	13.8	5.9	11.2	5.9	12.3	20.2	21.2	14.5	7.8	7.5	6.0	21.2	21.4	10.0	13.1	12.8	12.7	7.0	21.2	11.3	6.9	13.6	8.5	10.9	19.3	4.2	8.5	8.6	22.1	8.5	9.7	22.3	20.9	5.6	12.7	12.5	5.3	10.1	7.5	22.3	10.4	8.6	9.7	8.6	16.7	10.6	7.3	9.5	10.2	14.6	15.2	8.7	11.7	5.9	11.9	8.2	15.8	9.1	10.8	8.4	18.5	11.9	8.7	8.3	1.7	10.6	20.1	4.6	4.4	10.9	16.7	11.0	18.1	9.6	10.6	9.3	3.3	7.6	13.6	19.0	4.9	7.2	6.0	9.5	15.3	10.8	12.3	2.9	11.8	13.3	6.4	6.3	8.3	3.9	16.1	8.7	11.3	4.2	9.3	18.2	14.3	7.2	8.7	5.0	6.4	8.5	10.0	5.6	12.0	61.9	12.4	22.6	19.1	15.4	18.7	18.2	19.9	20.2	10.4	19.4	20.0	18.6	12.5	20.3	19.0	9.0	22.3	19.7	20.5	21.1	22.2	25.8	20.2	21.2	21.2	21.4	21.2	22.1	20.9	22.3	20.3	9.6	11.5	21.5	22.6	7.6	17.4	26.7	16.5	18.6	18.3	18.7	22.1	14.3	17.3	16.5	10.4	14.7	21.8	17.5	23.5	21.6	145.4	13.7	15.1	20.3	10.7	4.2	14.2	16.9	11.5	22.3	5.6	13.1	29.2	12.7	18.9	10.6	17.0	11.8	13.8	9.1	28.5	14.8	10.3	41.5	16.8	24.8	16.0	12.2	15.5	29.4	16.5	17.1	24.3	17.7	13.1	22.6	11.5	16.8	15.6	27.3	22.6	15.9	19.7	17.0	25.0	112.2	36.0	10.0	3.4	12.0	24.0	12.3	11.0	14.0
CHAF1A	"CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150"	ENSG00000167670	"Chromatin assembly factor 1 subunit A"	Q13111	19	4402640-4445018	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 50.3;Spermatocytes: 94.3;Spermatogonia: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.7;granulocytes: 4.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB015186	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015186: AB_628065"	"unprognostic (1.91e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (2.49e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.89e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.54e-2)"	"prognostic favorable (4.15e-6)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.03e-2)"	4.9	4.4	3.5	9.7	3.0	31.4	4.8	5.6	6.6	4.7	1.3	6.9	6.5	3.9	2.0	10.2	4.0	2.7	3.9	3.7	3.0	2.4	4.1	4.0	13.4	3.4	3.1	3.7	3.9	3.3	3.7	6.2	3.0	5.8	6.6	3.4	5.5	3.0	12.2	10.8	6.7	4.1	2.4	6.9	5.1	14.5	3.1	16.3	2.9	4.1	10.5	4.7	5.6	4.1	65.8	44.0	71.8	45.3	7.0	8.5	36.7	61.2	24.8	50.5	56.7	53.5	22.8	100.4	24.7	19.6	28.6	50.3	61.6	41.5	59.8	58.1	67.2	62.9	69.4	42.7	3.5	73.7	48.8	4.8	8.6	41.5	17.7	9.4	24.0	54.9	76.8	88.0	31.3	37.8	119.2	40.7	80.1	33.5	35.6	87.2	56.8	57.2	13.1	76.7	50.6	39.2	41.6	29.1	24.5	45.2	25.7	53.9	17.5	41.3	35.9	71.1	74.9	43.7	71.0	96.3	34.7	92.8	49.9	3.8	2.3	4.7	0.5	2.3	0.4	1.6	0.6	0.1	2.1	1.0	0.5	0.4	1.2	1.2	0.4	15.7	0.9	0.9	3.5	3.0	5.6	6.6	3.7	3.0	3.4	3.1	3.0	2.4	3.1	4.1	2.3	0.0	3.9	2.0	12.5	9.7	4.6	3.5	6.2	12.1	5.1	3.6	5.7	1.5	2.6	5.5	2.1	25.3	17.3	13.9	1.9	8.5	6.7	5.3	4.2	4.6	1.8	50.3	4.1	6.7	37.9	6.1	10.7	6.5	2.5	19.3	3.3	4.8	12.1	1.7	3.6	10.7	0.0	4.8	21.4	6.7	3.1	11.8	1.8	1.9	11.5	5.2	5.2	2.5	2.9	6.8	1.7	3.8	32.5	4.1	4.6	1.8	5.0	8.4	32.9	5.7	5.5	94.3	103.8	18.7	14.9	14.6	7.7	9.4	14.6	5.9
CHAF1B	"CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7"	ENSG00000159259	"Chromatin assembly factor 1 subunit B"	Q13112	21	36385392-36419015	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 15.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021679, CAB033604"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB033604: AB_2229411, HPA021679: AB_1846621"	"unprognostic (2.28e-2)"	"prognostic favorable (5.44e-5)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (6.14e-6)"	"unprognostic (2.14e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.66e-6)"	"unprognostic (5.89e-2)"	"unprognostic (5.00e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.36e-1)"	1.3	0.6	1.5	2.4	1.2	6.9	2.6	2.2	1.5	1.3	0.3	1.9	1.6	1.7	1.5	2.5	1.3	0.9	0.6	1.6	0.7	1.3	0.7	1.0	3.0	0.6	0.4	1.4	3.3	1.6	1.0	1.1	0.7	1.6	2.1	1.7	3.0	0.9	15.6	2.7	1.9	1.5	0.1	1.3	1.2	4.2	0.8	4.1	0.9	1.8	3.5	1.0	1.5	1.0	25.5	15.0	25.3	14.4	1.9	5.0	13.8	17.6	10.1	21.4	22.2	17.1	13.3	19.9	7.6	9.2	21.7	8.2	26.3	11.7	17.2	20.2	20.5	30.9	15.5	12.2	1.3	19.8	14.4	3.1	2.8	20.0	8.6	4.1	10.2	24.1	27.3	18.0	11.0	17.7	31.0	11.5	17.6	23.0	10.8	45.0	13.6	11.4	7.5	12.4	15.2	12.6	27.0	20.3	9.8	10.1	15.9	13.4	6.3	17.2	8.5	15.4	20.8	13.1	26.0	23.1	11.0	21.5	22.3	1.5	0.2	0.3	1.4	0.1	1.2	1.0	1.0	1.0	0.3	1.1	0.6	1.0	1.2	1.7	0.2	0.4	2.2	0.7	1.5	1.2	2.2	1.5	1.6	0.7	0.6	0.4	0.7	0.1	0.8	1.0	1.3	0.0	2.7	2.0	1.8	2.8	6.2	3.7	5.2	1.6	2.8	3.4	1.3	2.8	3.4	3.7	0.0	7.6	2.5	1.7	0.0	7.3	9.1	2.5	1.2	2.5	0.0	10.7	4.4	2.2	9.7	2.6	4.1	2.4	2.5	9.4	1.4	0.5	4.5	1.7	3.1	2.3	10.2	0.9	1.6	6.7	0.6	1.2	5.4	1.9	1.5	1.5	5.2	1.0	2.5	2.2	0.2	0.0	4.4	4.6	0.4	0.3	3.1	2.6	6.6	3.4	2.5	14.4	11.8	7.4	2.4	2.5	2.4	0.5	4.7	3.4
CHAMP1	"C13orf8, CAMP, CHAMP, ZNF828"	ENSG00000198824	"Chromosome alignment maintaining phosphoprotein 1"	Q96JM3	13	114314482-114337626	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006623, HPA008900"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA006623: AB_1845548, HPA008900: AB_1845547"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-1)"	9.9	7.1	3.4	9.8	3.3	14.2	9.5	6.6	5.2	8.1	3.8	8.7	10.0	8.5	8.0	6.4	9.8	7.6	6.2	3.0	4.3	8.9	15.2	8.9	15.7	2.7	3.4	12.1	15.4	9.3	3.6	9.9	3.4	10.0	9.9	9.1	8.4	9.3	7.9	9.2	8.0	10.1	2.3	9.6	7.7	6.9	2.7	16.5	10.7	9.7	17.3	7.5	4.4	3.1	36.9	15.8	56.6	24.2	20.1	30.9	24.3	38.2	32.0	35.6	39.4	23.5	22.0	75.2	15.1	30.0	22.3	23.0	41.8	30.6	52.7	29.8	50.0	49.7	21.8	20.7	22.5	73.3	28.3	30.4	18.8	27.8	27.3	12.6	17.4	25.8	32.1	20.3	46.1	14.6	48.6	21.4	43.1	45.2	20.2	48.1	26.9	26.0	27.0	22.2	27.5	32.8	22.2	49.2	36.7	39.1	28.2	61.3	19.3	19.5	30.8	20.7	23.6	25.7	27.9	80.4	38.6	42.7	38.1	7.5	3.3	4.4	3.7	4.0	4.6	5.4	3.3	3.7	3.9	5.8	2.6	3.0	0.8	3.5	6.6	12.5	2.4	2.1	3.4	3.3	6.6	5.2	3.0	4.3	2.7	3.4	3.4	2.3	2.7	3.1	11.2	9.6	9.6	3.6	13.9	3.3	6.6	7.6	10.8	12.5	11.3	10.8	5.7	11.5	4.1	12.9	4.2	14.2	18.1	9.3	13.7	11.7	1.0	8.5	14.8	10.9	10.8	24.4	6.1	11.4	18.1	11.5	10.2	8.3	10.1	13.1	13.9	21.6	21.7	15.2	7.8	12.5	6.1	20.7	7.8	1.6	11.8	13.0	12.4	7.5	18.4	8.8	17.5	4.0	8.0	10.9	7.8	11.3	17.6	13.2	12.5	17.0	7.6	10.9	6.6	11.7	10.5	10.6	20.7	13.1	3.8	7.9	11.4	12.4	11.4	3.5
CHCHD1	"C10orf34, FLJ25854"	ENSG00000172586	"Coiled-coil-helix-coiled-coil-helix domain containing 1"	Q96BP2	10	73782047-73783652	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 561.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039046	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	"Nucleoli fibrillar center"	"HPA039046: AB_10673234"	"unprognostic (4.97e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.42e-4)"	30.1	53.2	38.7	29.3	39.1	26.7	34.4	40.0	45.1	25.4	41.9	38.1	40.0	25.9	52.0	49.8	25.6	18.5	52.9	38.9	39.6	55.9	54.7	25.6	36.4	38.8	38.5	24.1	31.3	42.8	31.0	29.2	39.2	36.7	29.0	21.9	45.6	21.9	64.2	29.9	35.1	19.1	39.3	40.3	37.6	24.8	39.4	34.6	31.9	50.6	30.8	27.7	30.1	40.1	115.8	87.6	70.8	98.3	57.0	56.6	71.1	58.3	70.7	59.8	80.0	78.6	99.3	56.9	63.3	52.9	60.1	77.9	69.8	79.8	46.9	87.6	132.4	42.7	73.2	119.6	68.6	65.8	65.7	52.3	96.3	51.5	33.0	87.4	83.9	78.8	67.0	61.7	78.3	117.3	82.1	146.5	66.3	109.6	561.7	77.3	53.9	72.6	97.5	63.0	34.2	67.4	36.0	246.2	127.3	56.8	138.0	92.5	47.2	35.7	79.7	60.2	102.4	61.5	70.7	91.2	83.4	133.7	28.5	44.2	51.3	32.5	36.1	54.9	43.9	62.6	43.7	43.5	52.5	50.8	36.1	36.9	21.2	36.6	45.6	75.1	65.2	35.8	38.7	39.1	40.0	45.1	38.9	39.6	38.8	38.5	39.2	39.3	39.4	40.1	45.0	41.7	48.4	5.2	50.7	35.1	34.4	117.2	29.0	27.0	68.7	74.4	77.3	47.1	84.4	60.7	22.9	151.6	49.3	112.1	199.6	80.8	73.3	99.0	64.1	44.5	61.8	61.2	8.6	88.3	166.3	38.2	41.8	75.8	29.8	63.9	51.4	132.5	139.7	20.2	8.0	106.2	122.1	61.2	35.6	16.3	56.5	52.7	40.9	5.6	82.5	76.8	51.5	5.5	9.6	96.4	96.4	55.3	53.3	55.3	101.0	243.3	99.0	35.3	52.6	36.1	52.4	70.1	48.7	71.2	43.5	128.1	41.6	83.9	98.4	54.9
CHD1		ENSG00000153922	"Chromodomain helicase DNA binding protein 1"	O14646	5	98853985-98929007	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022236	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA022236: AB_2670915"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (7.25e-6)"	"unprognostic (2.69e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.17e-1)"	14.7	10.3	6.9	17.8	7.3	69.6	9.2	17.9	14.1	8.0	8.8	10.5	9.8	12.7	7.0	7.9	8.1	15.0	5.4	6.1	8.3	8.3	13.2	9.4	13.7	9.7	7.7	14.1	10.0	9.4	4.8	14.2	8.8	8.2	10.3	14.9	5.4	7.1	9.7	6.2	9.5	9.0	7.4	15.7	8.2	18.1	7.3	49.6	8.8	9.0	13.8	12.4	5.9	9.3	23.0	20.7	47.5	32.3	15.7	16.1	41.3	23.2	15.1	18.4	23.8	25.9	17.3	19.3	22.0	13.5	29.8	18.6	37.6	25.6	38.2	30.5	28.2	34.2	25.8	19.8	17.3	33.3	25.5	14.0	10.2	32.0	32.2	12.5	22.6	62.0	42.0	28.9	18.7	18.5	66.4	14.4	32.0	7.2	24.8	55.7	33.2	29.2	16.0	21.6	22.1	18.9	29.8	15.4	37.9	24.6	15.0	22.6	25.7	39.3	21.2	24.9	41.6	20.0	22.6	40.0	21.5	32.6	24.2	13.1	7.1	10.1	5.4	6.6	6.9	9.4	5.1	5.3	6.5	8.3	7.0	5.6	14.4	7.4	6.8	4.7	5.9	2.0	6.9	7.3	17.9	14.1	6.1	8.3	9.7	7.7	8.8	7.4	7.3	9.3	87.2	48.1	72.2	35.3	145.3	155.5	99.0	26.6	115.5	39.3	85.9	56.1	29.9	22.8	57.4	36.8	43.8	53.9	203.6	64.0	7.9	36.5	101.0	84.3	114.3	79.5	31.8	40.8	50.9	32.0	38.4	104.6	50.0	107.3	89.2	45.2	40.0	30.6	35.6	33.7	59.8	31.2	16.2	65.8	145.9	19.8	32.3	169.7	67.6	90.9	89.1	20.5	59.8	66.4	72.1	35.3	51.4	19.2	121.0	82.6	28.1	15.5	45.3	49.5	46.0	173.8	113.5	67.1	54.6	74.1	188.5	90.3	148.2	49.9	39.4	75.4
CHD1L	ALC1	ENSG00000131778	"Chromodomain helicase DNA binding protein 1 like"	Q86WJ1	1	147242654-147295765	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027789, HPA028670"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027789: AB_10601099, HPA028670: AB_10601257"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.97e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.31e-9)"	"unprognostic (5.51e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.16e-1)"	14.4	14.9	19.2	11.9	20.4	17.1	14.6	20.0	28.0	14.6	17.8	16.4	14.4	19.1	9.4	12.7	17.3	6.7	10.8	18.6	18.9	16.5	33.7	17.5	13.1	19.7	19.6	10.9	13.1	19.8	20.1	9.4	19.3	16.4	15.1	4.9	11.6	8.9	12.8	14.4	19.3	16.1	20.3	27.1	15.8	19.5	20.0	14.9	10.6	11.2	11.1	13.1	11.7	20.9	40.0	34.0	28.0	21.2	25.1	21.4	29.6	38.7	31.4	30.4	29.1	30.6	29.2	49.9	15.4	33.9	21.9	37.7	31.2	35.3	30.6	53.6	40.6	43.8	27.5	87.0	31.5	58.9	24.0	25.6	15.1	30.2	31.1	27.9	34.1	51.5	56.0	19.8	44.3	42.2	39.8	43.1	46.9	80.0	47.4	48.8	35.1	41.1	32.2	30.7	16.6	36.4	32.4	39.2	30.8	46.3	21.7	99.3	34.5	19.2	33.2	18.2	49.0	14.9	22.4	37.9	46.7	19.6	33.3	11.3	8.7	3.2	8.7	7.9	8.1	11.7	7.4	6.6	20.3	14.2	6.9	7.9	0.4	10.0	9.2	17.5	5.4	8.2	19.2	20.4	20.0	28.0	18.6	18.9	19.7	19.6	19.3	20.3	20.0	20.9	7.7	12.8	15.6	45.7	27.1	11.5	10.0	8.8	15.9	7.2	12.5	8.5	6.5	11.5	16.4	5.5	6.2	21.7	17.1	15.4	21.5	10.0	21.2	6.4	12.5	11.1	9.0	43.7	48.3	8.2	19.1	12.6	21.4	9.8	21.5	25.1	5.3	33.7	21.8	1.7	40.8	16.7	16.2	16.1	20.7	25.6	7.2	25.5	16.0	36.5	15.9	14.5	12.3	60.8	80.7	10.3	14.4	11.3	14.4	10.8	13.0	12.9	16.1	9.3	6.6	11.9	12.5	38.3	27.4	20.9	10.4	11.8	13.4	18.8	19.7	9.1
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93027996	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060744: AB_2684353, HPA060960: AB_2684398"	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	13.9	12.3	22.7	20.7	25.5	73.5	20.4	42.0	32.7	15.7	32.0	15.2	14.8	19.4	29.1	14.6	16.2	15.6	12.0	21.3	24.7	16.9	15.4	21.6	26.4	29.0	23.3	26.1	19.6	18.2	16.6	20.5	24.5	20.4	14.8	30.8	21.2	13.4	17.4	18.8	18.7	13.3	22.1	23.3	17.7	20.8	25.9	27.0	26.3	14.7	25.4	13.7	16.1	27.6	21.3	11.6	30.6	13.6	17.9	45.3	23.0	19.4	20.0	13.0	16.1	14.5	27.4	5.2	16.1	17.3	22.1	31.1	17.6	19.5	18.0	0.1	10.6	25.3	26.1	12.9	24.6	27.1	19.0	28.7	23.0	15.5	31.1	26.8	22.4	36.7	26.8	57.1	19.9	13.1	14.2	14.0	19.5	10.5	12.6	19.9	27.6	28.4	13.3	28.5	16.8	18.1	34.2	12.3	25.9	30.6	14.1	22.6	36.2	10.7	13.9	9.3	12.8	53.4	23.2	21.6	15.9	15.9	9.4	35.9	10.8	27.7	22.1	6.6	21.8	48.7	21.5	20.5	7.4	39.6	30.1	22.1	53.7	20.6	13.4	27.9	24.9	10.9	22.7	25.5	42.0	32.7	21.3	24.7	29.0	23.3	24.5	22.1	25.9	27.6	59.3	70.5	176.3	182.2	137.8	164.3	112.3	102.3	153.7	71.4	62.6	46.5	42.3	37.1	137.3	46.0	91.8	30.7	116.3	59.6	3.9	36.1	56.5	96.9	61.7	58.6	59.3	65.4	161.5	38.3	28.5	64.5	96.4	189.8	99.3	70.7	25.0	34.9	24.8	57.2	146.2	54.9	91.6	55.1	297.4	39.2	34.8	89.5	96.0	119.9	50.7	34.2	48.4	140.8	155.9	64.2	61.6	37.6	133.0	110.0	39.9	11.5	93.9	82.2	32.9	52.7	64.4	15.3	14.7	125.2	180.7	60.5	153.2	42.9	51.5	143.6
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884796-7912760	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Supported	"Nucleoplasm,Nucleoli,Centriolar satellite"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Centriolar satellite"	"HPA043368: AB_2678448, HPA076524: AB_2686804"	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic favorable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	28.2	29.3	19.9	35.0	27.9	42.7	28.4	0.0	39.9	71.6	0.0	55.3	16.7	63.9	31.2	35.1	56.8	27.8	21.2	35.8	7.0	38.3	5.7	32.4	41.3	4.9	2.4	60.0	34.8	44.7	47.7	16.6	1.1	68.7	22.1	19.0	40.3	38.0	8.0	32.7	34.6	45.0	3.1	31.5	36.3	20.9	8.0	58.2	44.9	9.1	36.7	41.2	42.8	21.4	44.9	108.7	61.6	81.2	72.2	60.9	32.8	51.7	66.1	40.8	43.5	21.1	36.7	122.8	38.3	73.0	34.0	59.6	117.7	52.5	53.0	65.5	67.2	62.7	148.5	2.7	38.3	17.8	112.1	79.2	27.5	55.4	36.9	108.7	76.9	54.1	41.5	2.0	38.8	42.6	48.2	19.6	9.8	45.3	40.3	137.8	82.1	19.3	40.0	107.7	41.9	56.3	126.4	47.9	24.6	16.9	55.7	27.1	99.7	89.4	68.8	22.3	72.5	8.8	1.6	68.3	46.1	47.4	77.6	1.7	2.6	3.3	4.1	1.4	3.6	1.1	4.2	4.0	1.3	1.2	4.6	3.1	2.8	3.2	3.2	3.0	2.5	2.5	19.9	27.9	0.0	39.9	35.8	7.0	4.9	2.4	1.1	3.1	8.0	21.4	20.9	32.1	63.2	10.4	19.6	36.6	47.6	21.1	65.4	60.7	43.8	34.2	14.3	17.2	35.2	80.9	8.4	16.8	57.3	39.8	17.6	22.9	11.3	48.6	51.9	29.4	56.8	19.1	20.6	23.4	20.5	39.9	31.1	70.7	39.9	59.7	22.9	2.7	9.0	45.4	25.2	17.0	12.2	24.7	34.7	18.5	44.4	26.7	8.8	6.5	43.7	12.4	59.8	12.1	2.5	20.9	10.8	57.2	17.4	55.5	10.9	9.7	24.8	17.3	26.3	31.8	43.5	25.5	46.8	52.8	20.5	16.4	62.9	52.0	30.3	60.3
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA012008	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	34.5	45.6	22.9	38.6	30.7	44.4	31.9	24.6	30.1	39.4	20.6	45.7	26.5	47.8	44.9	35.4	37.7	31.1	41.4	19.7	26.1	39.3	31.6	35.3	46.3	27.3	29.2	40.9	37.7	58.3	33.5	42.2	28.0	28.4	35.4	44.9	33.8	44.1	50.0	45.8	35.5	49.9	22.6	39.0	38.5	34.2	29.6	90.7	54.6	38.7	56.6	42.2	34.4	27.4	86.7	79.7	187.6	72.1	76.6	84.7	110.4	92.9	93.4	102.3	93.5	130.6	66.6	184.9	36.0	107.5	66.1	76.0	179.1	104.5	135.7	139.9	92.7	258.5	122.0	83.3	67.1	207.2	119.1	82.9	51.7	99.1	68.7	128.2	122.2	101.6	209.0	91.0	98.7	111.8	196.6	67.8	184.7	82.5	72.7	166.4	114.9	103.6	64.2	101.6	88.8	114.6	121.1	136.0	92.9	205.4	61.3	121.3	114.4	103.4	217.4	76.3	111.5	144.0	91.8	230.2	68.7	125.8	79.5	12.3	6.8	8.7	9.3	7.7	9.6	8.8	8.4	9.3	6.9	11.3	10.6	10.3	10.8	12.2	8.0	14.4	15.9	5.6	22.9	30.7	24.6	30.1	19.7	26.1	27.3	29.2	28.0	22.6	29.6	27.4	68.2	60.9	119.7	56.2	82.8	68.6	47.4	42.4	76.2	109.9	77.5	61.2	132.9	58.6	67.2	88.3	70.9	48.2	106.0	58.1	13.7	84.6	76.4	128.1	153.3	78.9	97.1	64.4	26.1	71.9	46.1	67.7	47.9	123.7	85.9	73.0	56.0	69.2	69.0	139.7	21.4	66.6	54.9	51.9	78.3	59.1	65.9	68.9	48.0	25.3	66.7	71.4	56.7	24.6	55.5	95.8	36.4	74.4	69.0	49.4	45.8	38.3	82.1	57.8	52.6	112.1	98.1	102.6	111.6	78.9	67.6	68.0	85.1	83.7	72.1	47.4
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101787-6180321	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 59.0;pituitary gland: 57.3;testis: 31.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 84.3;Early spermatids: 217.8;Excitatory neurons: 80.4;Horizontal cells: 225.4;Inhibitory neurons: 56.2;Late spermatids: 113.2;Rod photoreceptor cells: 49.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 12.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	0.2	4.1	31.8	0.2	40.1	0.0	0.1	0.0	59.0	0.4	0.0	1.1	0.2	0.4	0.0	0.3	0.4	0.1	0.4	34.3	13.6	2.4	0.1	0.3	0.0	3.9	11.1	0.5	0.4	0.9	57.3	0.0	4.4	0.9	0.2	7.9	0.2	2.2	0.2	0.3	0.4	0.1	0.9	0.1	1.0	31.8	10.2	0.3	0.1	0.0	0.0	0.7	0.6	31.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	1.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	12.9	0.2	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	40.1	0.0	59.0	34.3	13.6	3.9	11.1	4.4	0.9	10.2	31.1	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.0	0.0	84.3	0.1	0.3	2.1	0.0	0.0	3.7	12.5	0.0	0.1	0.2	0.0	0.0	217.8	0.0	0.2	0.6	0.0	0.0	80.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	225.4	56.2	0.0	0.0	0.0	0.3	113.2	0.9	0.1	0.0	2.8	0.0	2.0	0.0	4.5	3.7	0.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	49.9	0.0	0.2	0.5	4.5	17.8	0.0	0.4	0.0	0.1	0.1	0.0	0.0
CHD6	"CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB"	ENSG00000124177	"Chromodomain helicase DNA binding protein 6"	Q8TD26	20	41402083-41618384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015543			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA015543: "	"unprognostic (5.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.72e-3)"	"prognostic favorable (3.42e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.12e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-2)"	7.2	7.7	10.2	6.9	11.4	13.5	12.4	17.5	13.0	9.5	6.0	7.1	4.0	12.7	12.4	6.1	10.0	7.2	8.0	8.5	13.1	7.2	6.8	7.5	8.4	11.7	10.9	16.2	8.1	16.2	7.9	8.4	14.2	12.2	6.1	15.7	8.4	9.3	5.5	8.7	6.1	8.9	7.3	8.2	7.4	7.1	11.0	17.2	13.6	7.8	8.2	8.1	8.8	12.9	8.4	9.8	20.6	9.2	11.5	11.7	13.3	7.2	14.8	12.6	15.2	13.5	6.7	10.0	12.7	12.4	14.2	12.2	12.9	12.4	14.3	3.2	6.3	13.7	9.1	13.2	6.5	10.9	6.6	11.8	11.3	9.2	10.1	13.5	11.0	13.7	11.0	10.4	9.9	23.3	17.3	11.8	6.8	5.2	16.5	13.2	24.2	7.1	7.9	19.3	18.6	12.8	22.1	5.8	14.2	14.9	9.9	8.1	12.7	19.8	9.6	10.0	6.3	9.9	8.6	12.8	8.7	5.2	6.2	20.2	6.0	7.5	8.1	6.1	8.2	8.5	7.0	6.9	5.2	10.6	9.4	8.0	0.9	10.2	10.0	11.4	6.0	2.4	10.2	11.4	17.5	13.0	8.5	13.1	11.7	10.9	14.2	7.3	11.0	12.9	42.2	48.1	30.8	148.2	42.8	18.1	38.6	30.3	37.0	140.4	39.5	34.7	56.6	30.0	34.4	22.0	93.8	34.2	53.3	14.5	21.5	24.4	14.5	50.3	65.3	36.5	60.6	19.6	143.2	15.8	28.2	33.8	19.9	76.0	21.5	65.1	34.2	21.1	16.5	151.4	179.0	35.9	42.7	27.7	44.7	20.3	49.7	27.5	17.8	87.1	40.8	62.2	39.1	182.9	160.6	15.4	16.0	45.5	32.3	30.3	4.1	13.9	35.6	133.8	19.7	71.0	44.4	20.6	61.9	21.8	17.2	32.7	45.5	40.4	24.5	32.9
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678740-60868028	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 241.8;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 255.7;Rod photoreceptor cells: 198.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 14.9;granulocytes: 17.6;T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"AF22: 51.5;SCLC-21H: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053075			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Nucleoli	"HPA053075: AB_2682035"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.6	1.9	10.3	3.9	17.2	22.1	3.5	71.5	11.0	2.0	2.5	4.6	4.6	2.2	2.2	4.9	2.3	1.9	3.8	9.4	11.5	3.8	3.2	4.6	5.8	19.7	17.2	1.0	4.4	5.3	6.1	4.3	18.8	2.7	4.0	23.7	3.9	1.7	10.4	5.2	6.4	1.7	11.4	5.6	3.5	2.9	15.6	2.6	4.1	4.1	5.7	3.4	3.2	17.7	8.0	4.0	51.5	9.2	0.1	0.0	16.2	0.4	0.1	1.8	1.6	10.0	7.3	15.5	0.9	0.1	2.3	4.8	26.7	7.9	1.6	5.9	14.3	36.5	7.0	13.2	2.1	11.1	6.5	1.0	5.9	0.0	8.5	3.1	7.7	12.5	2.7	13.4	1.2	8.3	17.5	12.7	35.4	8.1	1.8	36.0	12.1	5.0	4.1	9.1	46.9	23.2	1.4	5.9	14.9	18.0	10.5	10.5	9.0	0.5	8.3	0.5	4.3	14.2	8.7	23.7	3.0	1.2	13.4	14.9	0.4	17.6	3.2	0.2	4.1	10.1	3.6	1.1	0.1	14.9	6.6	2.4	9.3	0.0	0.8	0.8	0.3	0.6	10.3	17.2	71.5	11.0	9.4	11.5	19.7	17.2	18.8	11.4	15.6	17.7	35.9	32.1	17.5	68.6	64.3	30.3	35.9	10.8	9.6	36.3	16.6	14.6	35.8	27.1	20.7	16.5	241.8	8.2	17.4	31.8	1.9	17.7	15.9	34.0	4.1	40.5	87.3	3.8	6.8	11.3	8.6	6.4	28.5	37.6	41.0	39.8	21.4	12.6	14.9	70.7	17.8	39.9	32.6	10.8	10.4	8.9	0.9	13.6	21.4	118.0	13.9	121.3	15.5	298.6	255.7	16.9	27.4	0.4	29.1	42.9	17.4	5.4	20.4	198.5	0.0	49.7	9.8	8.0	12.9	25.5	32.4	6.2	21.4	3.0	34.1	35.8
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	12.5	11.9	11.2	13.5	12.5	35.3	14.8	16.3	13.2	12.4	10.5	14.0	9.4	14.8	11.1	14.9	12.9	10.1	12.0	11.1	12.2	11.7	9.6	13.7	18.0	11.4	11.6	17.1	13.6	22.3	13.1	11.7	11.1	13.2	12.3	14.8	13.6	12.1	15.7	22.3	14.7	14.8	11.5	15.8	14.2	12.9	12.5	25.4	14.8	12.7	17.5	12.8	12.9	13.6	31.2	39.6	43.6	20.7	27.7	23.6	24.9	24.4	28.4	36.5	35.4	35.0	26.3	51.4	14.8	33.1	28.4	37.2	54.9	35.1	46.0	39.3	24.2	46.3	27.6	43.5	25.7	64.6	40.4	32.8	27.2	40.9	29.7	28.6	33.4	40.2	32.4	26.7	28.0	33.9	46.1	26.0	33.4	30.9	34.3	42.0	32.9	17.4	27.3	57.9	30.9	30.7	37.5	29.8	21.8	39.7	20.7	30.5	36.4	29.2	23.0	17.8	29.1	30.3	38.4	50.3	12.1	23.2	29.6	9.1	3.8	9.8	5.5	3.8	6.4	4.2	4.9	5.6	2.7	11.2	5.0	4.4	7.9	7.8	6.7	6.1	4.7	2.7	11.2	12.5	16.3	13.2	11.1	12.2	11.4	11.6	11.1	11.5	12.5	13.6	27.6	38.5	56.3	27.4	32.2	12.6	11.3	15.9	23.3	33.3	21.9	22.6	19.6	24.3	32.6	33.1	27.1	14.7	40.0	16.8	1.9	21.8	3.4	32.5	37.9	25.5	27.1	27.8	41.0	23.6	12.3	24.0	27.5	39.5	28.4	41.7	13.9	14.9	17.5	23.5	40.2	16.0	8.2	20.1	9.3	4.1	16.1	25.3	10.6	20.6	27.1	18.9	32.0	29.7	33.1	26.5	13.9	17.7	32.4	16.1	12.0	7.4	28.8	24.3	0.0	32.1	26.2	29.2	25.1	24.6	16.6	12.3	31.4	34.1	16.8	12.7
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 502.5;Rod photoreceptor cells: 766.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420, HPA066155"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 14: REH - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	7.4	6.6	13.6	6.0	19.3	21.7	11.5	31.1	9.4	10.1	2.1	8.1	5.4	9.7	6.2	7.7	9.0	8.1	7.1	6.4	17.1	11.1	6.9	7.0	6.9	13.3	17.1	12.7	6.4	10.2	5.0	8.7	16.9	8.4	7.8	28.9	8.5	8.7	7.2	6.3	5.7	7.9	10.1	7.7	9.6	4.9	14.2	9.9	12.2	12.8	6.7	7.1	6.2	17.6	10.4	12.0	25.0	20.8	20.0	28.6	4.4	18.0	13.8	9.9	4.3	6.8	9.1	14.0	11.3	16.8	6.9	12.5	14.0	10.4	14.0	5.0	10.2	18.4	12.0	4.6	13.5	25.3	15.8	19.9	9.5	15.2	18.3	12.9	14.7	8.3	22.2	4.5	13.0	4.2	13.1	5.9	9.6	3.1	8.7	46.2	28.8	5.8	6.4	9.7	10.4	11.7	16.6	5.4	12.3	9.7	6.0	12.0	28.3	18.1	8.9	6.6	12.0	13.1	9.7	21.9	13.2	11.3	17.9	102.0	25.5	27.5	15.7	21.9	24.5	38.9	10.7	17.6	16.2	46.6	8.5	12.0	8.6	38.3	39.4	126.7	6.1	5.4	13.6	19.3	31.1	9.4	6.4	17.1	13.3	17.1	16.9	10.1	14.2	17.6	146.3	70.5	74.7	426.4	111.5	57.2	123.4	107.7	96.8	318.9	81.3	89.9	39.0	55.8	81.5	90.1	502.5	17.4	112.1	80.8	46.9	60.4	16.4	71.8	109.3	97.5	87.6	67.7	272.9	36.7	31.2	117.2	109.1	69.9	96.7	121.8	107.4	66.4	69.0	220.4	297.3	89.7	69.2	67.8	50.7	19.1	108.4	88.6	67.6	319.5	89.3	153.3	98.9	462.4	312.0	39.0	100.5	123.4	70.3	98.2	76.1	60.8	72.3	766.6	59.2	157.2	106.1	105.7	50.9	75.4	75.0	24.9	60.5	89.3	72.1	83.4
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625665-125676255	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.7;lymphoid tissue: 20.7;seminal vesicle: 29.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Erythroid cells: 34.5;Extravillous trophoblasts: 35.6;Spermatocytes: 48.9;Spermatogonia: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.7;T-cells: 6.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044364			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	1.6	1.3	0.7	8.2	1.0	25.7	2.6	0.6	1.3	1.7	0.5	7.9	6.8	1.7	6.7	4.1	1.1	1.7	0.9	0.7	0.9	2.2	2.1	1.3	14.9	0.7	0.8	1.8	2.0	13.2	1.7	4.8	0.8	1.6	8.7	0.7	1.5	29.8	0.6	3.6	7.3	3.4	0.6	2.2	2.6	8.9	1.2	20.7	1.0	1.3	13.9	3.3	2.1	0.8	48.5	37.0	81.1	47.4	13.5	28.9	35.7	61.1	28.7	41.6	40.1	88.0	100.3	120.7	63.5	24.9	53.7	52.6	54.2	33.2	50.1	81.4	24.8	224.2	27.2	44.7	4.3	121.1	39.6	15.7	6.0	47.6	36.0	19.9	44.7	84.1	117.3	102.7	51.4	23.8	181.3	65.0	86.1	77.1	33.2	104.7	74.4	67.2	37.9	63.2	50.5	53.6	45.2	35.4	15.2	57.3	93.9	40.6	28.4	51.0	47.3	29.6	60.8	21.9	45.4	187.5	20.5	86.6	67.6	1.7	0.2	0.0	0.4	0.1	0.2	0.7	1.6	0.4	0.6	0.3	0.4	0.3	1.1	0.3	0.1	0.7	6.2	0.4	0.7	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.8	0.6	1.2	0.8	1.1	3.2	0.5	1.6	5.5	6.2	3.9	5.8	5.2	1.7	3.9	6.0	4.6	32.9	4.1	7.3	0.0	17.3	6.0	4.5	3.9	3.4	7.8	5.5	8.0	3.5	1.8	34.5	3.3	1.1	35.6	5.3	6.1	9.9	0.0	21.1	3.6	1.2	11.1	0.0	2.5	9.2	2.0	0.0	5.2	3.1	1.5	3.2	0.0	2.8	3.2	2.8	3.1	1.5	1.6	2.9	3.9	1.2	17.7	3.1	8.0	9.4	2.5	1.7	0.0	3.1	7.8	48.9	49.8	9.5	4.8	7.8	5.1	4.8	16.7	3.0
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	4.5	6.2	2.4	8.8	2.5	15.4	5.8	2.4	3.7	5.0	2.8	8.8	6.3	4.1	7.3	7.2	3.7	4.7	4.2	2.3	2.8	4.5	6.3	4.4	12.1	2.6	2.6	8.2	2.3	1.3	2.7	7.8	2.8	4.1	10.9	0.4	3.2	3.8	1.3	6.7	7.0	4.8	2.6	6.7	4.1	8.5	2.8	9.4	3.3	1.1	12.0	6.8	5.0	2.9	30.7	9.7	31.1	32.4	10.1	42.7	18.7	15.2	19.9	18.7	27.8	29.1	21.8	36.3	13.0	11.5	21.6	32.1	42.7	29.0	25.0	24.6	31.2	45.3	25.5	46.2	9.4	33.4	38.0	18.6	13.5	25.0	23.0	14.1	25.4	29.4	30.5	33.9	19.8	39.2	24.6	61.5	40.6	41.3	21.6	52.6	18.2	42.7	17.1	11.2	17.8	9.7	16.7	31.4	17.4	22.8	22.6	32.2	7.8	17.1	19.4	14.3	9.1	21.8	28.3	65.4	17.1	34.9	21.0	9.9	4.0	1.2	1.1	8.1	2.4	11.9	2.1	2.1	8.2	7.8	4.0	2.6	0.6	3.4	4.1	6.1	2.8	3.6	2.4	2.5	2.4	3.7	2.3	2.8	2.6	2.6	2.8	2.6	2.8	2.9	2.3	9.6	4.8	2.9	5.5	6.4	5.3	8.3	8.6	1.1	3.2	3.9	1.8	0.0	5.0	1.8	0.0	15.4	1.1	3.8	0.0	1.8	7.0	2.9	10.1	3.0	1.2	11.2	2.9	1.4	13.6	12.4	5.1	7.0	3.8	7.4	2.5	1.3	9.7	0.0	1.2	5.3	8.2	2.4	8.5	1.2	6.2	5.1	1.8	2.8	3.9	0.8	6.2	0.0	1.0	1.0	4.7	4.5	11.4	2.7	3.0	3.9	2.9	1.1	0.0	10.2	3.0	6.7	31.2	8.3	2.3	3.4	3.3	5.7	10.0	4.5
CHID1	"FLJ42707, MGC3234, SI-CLP"	ENSG00000177830	"Chitinase domain containing 1"	Q9BWS9	11	867859-915058	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 404.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039374	Uncertain		Uncertain	"Nucleoplasm,Intermediate filaments"	"Intracellular and membrane"	No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Intermediate filaments"		"HPA039374: AB_10673609"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.96e-2)"	"prognostic favorable (6.76e-4)"	"unprognostic (4.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.89e-2)"	43.9	63.3	43.1	22.7	44.1	46.2	40.2	41.0	51.7	44.5	60.0	34.2	30.9	38.0	89.5	34.8	63.5	41.3	54.4	44.1	47.2	52.5	85.8	30.9	27.2	42.9	42.9	58.0	149.9	46.1	62.8	42.7	42.5	42.3	29.7	25.2	82.2	41.3	37.0	34.9	27.7	35.7	42.6	71.6	47.1	74.1	45.7	20.1	47.3	31.1	20.2	34.3	35.3	47.0	75.6	71.7	53.2	131.6	203.3	107.5	90.1	83.2	97.0	78.8	76.7	78.7	214.6	61.1	75.1	121.7	78.4	145.2	53.1	95.9	57.3	53.7	131.9	44.1	25.9	75.1	92.6	102.9	37.4	104.1	59.2	53.9	77.2	130.3	67.2	76.6	81.2	152.6	55.8	52.9	58.4	134.0	47.2	141.6	107.3	49.0	50.9	111.8	57.5	21.5	101.8	84.5	90.3	124.0	78.4	53.0	50.4	156.8	66.6	89.6	38.9	25.3	68.3	88.9	81.4	36.0	100.2	88.6	71.7	21.1	50.4	19.2	34.7	45.0	37.1	45.7	33.2	36.8	74.0	32.1	34.9	35.3	6.2	43.4	45.6	69.6	32.4	46.0	43.1	44.1	41.0	51.7	44.1	47.2	42.9	42.9	42.5	42.6	45.7	47.0	33.0	41.7	36.7	4.2	28.6	22.8	62.2	78.9	22.2	38.5	69.9	75.7	25.6	51.5	49.0	53.3	18.8	121.3	34.4	25.2	72.4	62.3	120.9	44.0	44.4	31.5	53.3	56.4	7.8	58.3	79.7	69.6	20.9	36.8	29.2	107.6	50.0	91.2	81.1	30.3	7.8	42.8	57.0	66.6	24.7	404.8	62.7	34.0	55.2	1.9	35.2	60.6	20.6	6.0	6.8	38.0	43.2	58.3	123.7	86.5	71.5	85.1	45.7	53.2	52.6	45.9	41.7	208.3	139.9	37.2	23.3	91.5	19.2	85.4	59.9	62.6
CHM	"DXS540, REP-1, TCD"	ENSG00000188419	"CHM Rab escort protein"	P24386	X	85861180-86047561	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003231, CAB016171"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB016171: AB_2229397, HPA003231: AB_1078518"	"unprognostic (6.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.40e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.60e-3)"	9.3	11.1	2.7	7.3	3.4	2.4	7.7	2.7	4.4	9.3	3.6	6.1	4.6	8.8	4.6	6.7	11.0	7.2	7.2	3.9	2.5	12.1	7.7	7.0	7.1	2.9	2.2	7.8	5.9	14.2	3.8	9.5	3.0	7.6	6.4	9.3	5.6	7.1	6.4	4.2	4.7	8.7	1.3	8.1	7.3	4.6	2.9	8.5	10.9	10.5	6.3	7.6	3.5	3.2	16.8	10.9	10.9	7.2	17.4	18.4	6.9	19.3	16.2	13.2	14.4	8.8	15.0	5.7	24.3	14.0	46.1	9.4	23.9	10.9	22.5	10.9	11.4	3.4	14.6	8.4	13.8	14.3	23.8	14.1	10.1	21.4	26.9	14.6	22.9	9.4	11.9	19.0	20.7	4.8	8.8	5.2	16.2	11.6	17.5	9.0	19.5	8.8	12.2	9.5	9.6	14.8	23.3	7.1	18.3	14.9	6.0	6.7	16.4	16.7	11.0	59.0	9.7	7.2	27.7	7.9	18.0	11.9	14.9	2.2	1.9	0.9	1.6	2.3	1.5	1.8	1.3	1.7	1.5	2.1	1.7	1.8	1.0	1.6	1.9	1.4	1.7	1.2	2.7	3.4	2.7	4.4	3.9	2.5	2.9	2.2	3.0	1.3	2.9	3.2	34.5	3.2	11.0	33.6	22.3	6.9	17.6	18.9	15.9	35.2	14.2	10.3	11.9	15.7	15.9	16.5	8.4	9.6	26.5	10.2	19.6	16.3	0.7	13.8	29.5	22.2	18.7	12.6	82.5	12.4	9.6	21.6	15.3	18.4	16.5	18.2	14.6	12.5	15.5	23.5	94.7	11.8	10.2	23.0	9.1	2.1	15.5	21.4	5.4	52.5	19.6	27.5	18.6	78.4	76.5	15.7	11.4	12.4	17.3	18.9	7.5	35.2	17.7	20.9	46.0	28.0	27.8	3.7	12.2	12.8	7.4	18.3	22.1	28.7	9.4	15.6
CHML	REP-2	ENSG00000203668	"CHM like Rab escort protein"	P26374	1	241628851-241640369	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029627, HPA029628, HPA062967"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.57e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (9.23e-5)"	"unprognostic (1.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.09e-1)"	2.7	1.8	0.7	3.5	1.5	7.5	3.6	0.0	3.6	3.1	0.0	3.0	2.2	4.2	2.7	3.3	2.8	3.2	3.0	1.5	0.2	2.9	2.4	3.8	3.7	0.1	1.0	7.4	2.0	4.1	1.5	11.4	0.0	1.9	3.4	3.3	2.3	1.5	2.6	3.2	2.8	3.2	0.0	3.9	3.1	6.1	1.7	6.4	4.4	3.4	3.0	2.1	2.3	1.5	31.3	9.5	14.6	11.7	4.3	12.8	28.4	12.1	6.0	10.3	7.0	17.5	5.6	8.6	18.1	8.1	8.4	6.3	20.6	13.1	19.0	16.5	19.2	11.3	39.4	12.3	8.7	27.2	14.0	10.7	5.8	13.6	14.0	7.2	8.2	22.7	31.0	10.2	12.3	12.2	18.1	18.1	19.4	11.8	30.6	27.3	18.0	28.8	10.4	19.2	18.6	30.6	15.2	11.5	13.3	14.2	13.5	17.4	16.7	20.9	40.8	10.6	23.3	11.9	31.2	9.0	20.3	16.0	33.0	1.1	0.2	0.1	0.1	0.3	0.1	0.3	0.0	0.0	0.2	0.3	0.3	0.2	0.0	0.1	0.2	0.7	0.0	0.0	0.7	1.5	0.0	3.6	1.5	0.2	0.1	1.0	0.0	0.0	1.7	1.5	14.0	48.1	7.0	0.0	17.2	8.5	6.1	3.8	3.4	3.6	9.9	11.7	19.6	4.3	7.9	0.0	0.0	23.5	26.4	6.2	5.9	14.8	12.3	14.4	15.1	8.1	6.7	10.3	0.0	21.3	26.7	6.5	6.6	34.8	3.8	21.3	4.2	2.1	7.1	5.0	0.0	4.2	6.1	17.6	31.0	30.9	10.5	34.7	17.8	0.0	18.6	3.1	4.1	0.0	0.0	22.5	4.3	18.0	5.8	3.9	4.3	2.2	2.0	4.7	13.1	11.4	20.7	9.0	12.6	7.6	7.2	20.1	5.8	9.9	5.0	4.3
CHMP1A	"CHMP1, KIAA0047, PCOLN3, PRSM1, Vps46A"	ENSG00000131165	"Charged multivesicular body protein 1A"	Q9HD42	16	89640816-89657738	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transcription, Transcription regulation, Transport"	Repressor	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA006776			Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Centrosome, Cytosol"		"HPA006776: AB_1078520"	"unprognostic (7.12e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.29e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.28e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.73e-1)"	30.3	31.2	46.3	21.1	44.5	31.4	29.4	41.2	53.4	34.3	36.9	42.7	37.8	35.8	17.0	65.4	31.6	24.8	33.1	46.8	42.7	36.6	30.6	28.7	27.5	45.3	44.3	25.0	25.7	30.4	24.8	24.7	44.0	33.5	23.0	5.4	31.8	22.1	50.0	48.7	42.5	22.4	44.3	31.6	34.0	37.3	45.7	30.5	28.3	25.9	24.3	35.6	36.9	44.2	70.5	66.3	29.5	46.2	42.2	38.2	75.3	53.0	54.3	79.3	38.7	97.1	111.5	37.7	53.2	70.1	52.9	88.3	52.6	69.7	36.7	34.2	82.7	31.0	23.4	108.5	57.8	23.0	31.7	54.7	75.6	74.6	33.8	42.7	41.2	46.2	69.9	18.2	45.6	141.4	55.1	88.3	58.1	78.6	63.5	60.1	58.3	39.8	60.4	43.0	52.7	70.8	103.5	34.3	38.1	27.5	117.6	48.5	63.1	52.7	61.6	65.3	45.8	52.1	59.1	51.1	88.1	54.9	62.5	66.7	51.6	108.9	54.4	62.7	42.0	36.3	43.6	50.1	44.2	33.4	27.5	33.4	86.0	49.8	82.3	49.4	58.5	64.1	46.3	44.5	41.2	53.4	46.8	42.7	45.3	44.3	44.0	44.3	45.7	44.2	31.1	32.1	23.6	17.3	27.5	23.8	24.5	28.8	13.1	24.6	33.9	27.6	16.8	28.6	26.6	31.3	8.4	57.7	43.2	147.3	37.2	55.3	56.4	27.2	26.3	28.3	44.3	16.2	8.8	59.5	74.4	26.9	36.2	35.0	27.9	33.0	23.2	31.1	47.6	43.7	7.9	57.7	30.5	30.4	23.8	125.5	20.5	28.3	23.2	11.2	62.8	36.3	43.3	11.1	9.5	84.7	121.6	24.0	14.8	31.7	109.6	40.9	22.4	20.5	26.3	17.1	27.1	45.4	33.3	26.3	32.5	66.2	28.6	28.8	58.2	36.5
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851413-11854444	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 361.4"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Midbody	Nucleoplasm	"HPA061997: AB_2684653, HPA062896: AB_2684898"	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favorable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	43.3	35.7	24.5	36.2	25.9	61.2	29.0	19.6	25.4	25.6	30.0	39.1	38.7	28.3	26.2	39.1	24.8	39.3	40.7	25.9	25.6	33.1	31.1	29.7	29.9	21.9	23.2	29.6	24.8	39.9	29.3	27.8	22.6	27.8	37.5	17.6	29.5	35.0	361.4	40.4	48.8	23.6	20.3	30.2	30.5	14.0	24.0	46.0	52.2	53.2	24.8	49.5	23.8	23.6	30.0	28.8	36.5	31.1	46.9	32.7	52.9	31.4	52.6	21.0	27.9	37.5	29.4	18.5	45.9	34.2	35.0	25.0	16.8	43.7	18.5	17.2	20.8	13.5	43.6	31.1	34.6	51.7	22.3	47.7	92.5	23.5	53.9	46.8	30.7	41.6	23.1	23.4	33.3	37.3	36.1	39.6	15.3	94.9	14.3	18.4	18.8	32.1	56.5	40.5	35.5	35.5	53.1	24.7	50.5	33.9	20.2	47.2	45.2	46.7	24.5	37.3	34.0	27.8	34.3	23.5	43.3	23.8	22.7	32.5	38.8	66.7	15.4	35.7	14.3	14.7	14.3	18.5	30.2	14.7	17.6	16.4	77.9	18.3	36.6	26.7	21.5	29.2	24.5	25.9	19.6	25.4	25.9	25.6	21.9	23.2	22.6	20.3	24.0	23.6	71.2	67.3	47.0	0.0	152.9	419.6	141.8	291.8	216.9	30.5	71.3	59.4	21.7	52.9	157.7	132.4	8.4	135.9	171.0	281.4	60.7	123.0	80.4	146.6	110.2	69.9	143.8	40.4	0.0	80.3	144.4	99.3	70.8	298.3	149.9	38.4	52.8	44.1	118.0	28.6	0.0	104.6	111.9	139.9	440.8	42.6	37.9	354.5	158.3	0.0	102.1	32.2	78.2	0.0	0.0	134.0	393.7	37.2	21.8	93.9	179.2	139.1	84.8	16.8	78.9	61.2	94.5	16.0	21.1	177.1	514.7	253.2	135.5	43.9	96.8	252.2
CHMP2A	"BC-2, CHMP2, VPS2, VPS2A"	ENSG00000130724	"Charged multivesicular body protein 2A"	O43633	19	58551566-58555105	"Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041153, HPA042031"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		230000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041153: AB_10964358, HPA042031: AB_10961727"	"unprognostic (1.80e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.71e-2)"	131.8	185.9	144.9	86.8	149.6	162.3	125.1	153.7	171.9	108.9	143.5	141.3	113.4	111.7	150.1	154.9	104.6	83.1	182.6	144.4	147.8	163.3	161.3	116.9	81.9	151.1	147.0	101.9	125.0	147.8	118.7	95.8	151.3	112.5	124.1	75.2	137.2	97.1	222.9	158.4	121.9	83.6	149.0	121.2	143.8	73.9	146.8	82.6	123.2	151.7	95.1	114.3	113.7	157.4	110.4	290.9	91.4	85.0	138.9	172.9	112.9	100.0	204.3	52.0	56.0	86.3	160.1	29.3	143.2	168.1	149.2	87.7	76.1	190.4	43.7	98.8	628.2	71.8	214.0	134.7	266.6	121.1	108.0	201.5	266.0	81.5	257.8	175.3	153.1	135.5	86.8	135.6	159.5	187.1	153.7	111.3	38.3	304.2	220.3	65.2	78.6	222.0	230.1	246.8	107.3	181.2	162.0	213.7	123.4	57.3	164.3	121.5	174.4	262.0	37.7	77.2	117.3	339.0	404.9	95.2	185.0	141.0	176.6	278.9	247.4	351.1	134.9	232.7	114.5	127.0	148.0	153.1	216.2	123.0	102.0	116.3	820.6	131.6	243.9	197.1	215.5	208.4	144.9	149.6	153.7	171.9	144.4	147.8	151.1	147.0	151.3	149.0	146.8	157.4	166.1	99.3	119.8	9.4	72.9	165.6	261.4	287.7	69.4	73.9	124.7	120.6	118.7	154.4	207.2	165.5	16.7	288.8	76.5	555.2	442.2	332.6	121.9	194.0	109.2	143.6	155.4	142.5	5.3	522.5	296.8	113.5	115.7	198.8	121.5	102.1	142.5	214.0	269.1	52.2	5.6	296.6	217.7	142.0	145.8	90.9	145.1	134.5	215.3	6.5	203.6	217.6	147.2	3.0	13.4	479.8	615.3	133.2	77.3	258.5	607.0	599.8	242.1	94.3	85.5	103.9	169.7	116.8	89.7	109.5	198.5	460.0	89.2	149.3	226.3	372.7
CHMP7	MGC29816	ENSG00000147457	"Charged multivesicular body protein 7"	Q8WUX9	8	23243637-23262000	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 32.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"B-cells: 35.7;T-cells: 76.3"	"Cell line enhanced"	"Detected in all"		"Daudi: 39.7;U-698: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036119	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA036119: AB_10673000"	"unprognostic (2.94e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.59e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.83e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.06e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.30e-1)"	4.6	5.9	2.3	19.5	2.4	9.8	4.5	3.6	3.2	5.1	1.4	6.0	4.0	6.2	1.4	4.8	4.9	3.4	3.9	2.3	2.9	3.4	3.5	4.7	32.8	3.4	2.0	4.4	2.7	2.7	3.6	2.1	3.5	4.1	3.4	2.2	5.2	3.6	7.0	4.6	14.7	2.6	1.9	16.9	5.8	4.8	2.9	31.0	4.4	3.9	27.7	5.6	4.7	4.8	6.2	8.6	4.6	7.8	4.2	4.0	5.2	5.0	3.6	7.2	6.1	9.6	4.8	39.7	6.0	3.7	6.9	5.9	4.3	6.3	2.9	10.6	7.4	8.4	11.5	4.9	3.6	2.4	11.4	3.4	4.2	7.0	1.9	4.1	6.0	16.7	9.3	5.6	4.2	6.0	7.3	9.3	7.1	5.9	6.5	2.8	3.7	5.5	3.7	8.0	5.6	5.5	3.9	5.9	2.3	2.5	6.2	4.5	6.7	8.9	5.7	6.7	4.0	15.1	8.5	47.2	6.6	6.6	6.6	1.2	4.8	5.0	6.3	4.8	12.7	35.7	41.3	19.0	3.7	35.6	76.3	45.2	4.3	5.4	3.5	3.0	46.8	32.7	2.3	2.4	3.6	3.2	2.3	2.9	3.4	2.0	3.5	1.9	2.9	4.8	8.6	6.4	7.9	7.2	48.6	13.6	15.8	12.1	12.5	11.9	11.3	10.9	13.2	11.5	11.8	14.7	4.2	15.8	12.7	16.9	19.6	19.7	43.5	5.5	11.3	12.1	13.8	8.6	9.3	15.8	18.8	11.1	11.7	10.2	12.0	13.1	6.4	7.0	15.9	13.5	11.4	13.1	14.2	7.5	7.7	13.7	9.9	13.1	16.0	1.9	17.3	20.6	21.6	3.5	9.5	20.5	12.4	10.5	24.0	15.9	16.0	18.8	7.1	10.6	6.6	10.1	13.1	15.7	16.8	9.2	10.7	20.7	25.7	10.1	10.8	19.6
CHN2	"ARHGAP3, RhoGAP3"	ENSG00000106069	"Chimerin 2"	P52757	7	29146569-29514328	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 101.0;intestine: 70.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 307.9;Early spermatids: 130.6;Excitatory neurons: 139.5;Late spermatids: 118.1;Microglial cells: 145.2;Oligodendrocytes: 496.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 37.4;HMC-1: 68.3"									"HPA018989, HPA019026"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA018989: AB_1846681, HPA019026: "	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.71e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.58e-3)"	4.6	6.3	19.0	5.3	33.0	2.2	3.4	101.0	37.5	10.2	12.4	8.5	70.1	4.1	2.3	2.6	8.0	7.0	11.7	22.2	27.1	13.1	37.9	5.6	3.1	30.4	26.5	20.2	25.1	0.5	3.4	10.8	33.2	8.0	9.8	51.5	2.7	4.1	4.7	1.9	57.9	4.3	24.2	8.2	6.6	2.5	25.4	3.8	7.8	1.4	2.5	6.3	3.2	59.6	0.3	0.8	3.0	0.0	0.0	0.0	19.0	0.0	0.0	0.7	0.0	10.4	2.9	0.9	6.0	0.2	1.2	5.2	10.1	0.1	0.0	18.1	3.8	37.4	1.7	18.4	0.2	0.0	68.3	0.0	6.4	0.0	0.7	0.0	3.5	5.9	1.5	0.5	0.0	0.4	11.2	0.4	1.2	6.8	3.4	0.8	0.0	2.0	18.2	12.0	18.3	1.4	3.9	5.8	10.2	10.7	0.7	2.0	0.4	1.0	0.3	0.1	0.4	3.6	15.2	0.0	0.3	2.2	1.2	4.4	11.6	0.1	2.8	12.7	1.9	0.3	0.4	2.1	10.1	0.1	0.4	1.1	0.5	9.6	7.3	1.1	0.0	3.6	19.0	33.0	101.0	37.5	22.2	27.1	30.4	26.5	33.2	24.2	25.4	59.6	3.3	6.4	3.6	5.5	2.0	2.7	0.8	0.2	0.6	307.9	0.3	0.3	14.1	5.7	2.0	3.7	43.8	24.6	6.1	15.3	0.0	0.5	130.6	8.8	0.3	8.5	39.4	9.5	139.5	2.1	33.5	3.8	12.2	2.7	23.5	2.2	3.9	84.4	18.5	6.7	28.8	24.0	2.0	29.0	33.1	118.1	5.0	20.5	17.8	145.2	29.3	11.7	22.6	10.1	496.8	0.2	14.3	4.9	1.3	1.0	107.8	2.3	7.6	15.9	0.0	5.4	1.1	2.6	6.2	0.2	0.6	16.4	14.4	0.7	23.6	1.1
CHP2		ENSG00000166869	"Calcineurin like EF-hand protein 2"	O43745	16	23755026-23758935	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"intestine: 305.0;skin 1: 149.7"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 345.0;Paneth cells: 274.0;Proximal enterocytes: 654.2;Undifferentiated cells: 205.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.3;hTERT-RPE1: 10.2;NB-4: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055198, CAB072806"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB072806: , HPA055198: "	"unprognostic (4.82e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.54e-1)"		"unprognostic (4.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.31e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.21e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.84e-2)"	"unprognostic (9.01e-2)"	0.4	0.2	1.1	3.8	1.1	2.2	4.3	3.6	1.3	14.0	0.0	146.7	305.0	0.9	1.1	0.6	0.9	0.4	0.4	0.7	1.6	4.1	0.7	0.6	0.8	0.5	0.1	0.4	0.5	0.1	0.0	1.4	0.9	3.8	147.4	1.3	0.8	4.5	1.2	149.7	250.5	6.5	0.1	0.3	1.1	7.3	0.9	0.5	0.6	0.2	0.4	9.0	4.2	2.9	1.0	2.2	0.5	0.6	1.2	1.3	1.2	2.9	1.1	0.3	1.0	0.5	2.3	0.4	0.9	2.5	1.2	1.4	0.4	2.9	0.6	0.7	0.2	0.5	4.1	1.6	1.7	0.3	0.7	0.9	0.8	2.5	7.3	10.2	1.1	0.3	1.2	1.0	1.2	0.1	0.1	8.7	0.3	0.5	2.1	0.2	0.1	1.4	1.1	0.7	0.6	0.7	0.8	0.2	0.0	0.6	0.2	0.2	1.3	0.5	0.6	0.7	0.1	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.1	0.1	0.0	0.0	1.1	1.1	3.6	1.3	0.7	1.6	0.5	0.1	0.9	0.1	0.9	2.9	0.0	0.0	0.0	0.0	0.0	10.3	8.7	6.1	0.0	0.0	0.0	0.1	0.1	0.0	24.4	1.8	0.0	0.9	0.0	345.0	0.0	0.0	0.6	1.3	0.5	0.2	9.1	0.0	0.0	0.0	4.1	0.2	0.0	3.6	4.5	0.7	0.0	0.0	0.1	0.0	0.0	70.0	12.2	0.0	1.6	0.5	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	274.0	0.0	0.0	2.5	654.2	12.9	4.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	67.5	0.7	0.2	0.2	205.4	29.9
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.7	31.7	9.5	17.4	9.3	23.1	13.6	3.8	12.9	14.6	13.5	17.4	13.0	19.5	10.3	14.0	14.6	15.1	19.8	9.6	11.6	14.9	20.4	17.6	16.6	11.1	8.7	14.0	26.2	13.2	43.7	16.1	10.0	19.1	9.0	2.9	22.2	12.9	8.1	14.7	18.9	14.9	5.4	28.9	20.1	9.6	10.5	10.9	17.6	5.0	10.7	16.7	13.6	6.7	27.9	22.3	14.7	43.1	50.0	49.2	22.2	57.3	88.4	30.5	37.1	14.9	46.1	8.4	98.7	91.6	41.5	34.3	6.5	40.8	13.1	32.1	20.3	8.9	25.4	21.0	46.7	18.2	70.9	75.8	22.7	28.9	10.3	63.1	48.6	13.8	8.6	23.7	49.2	45.7	17.0	70.6	19.7	11.6	25.6	15.8	8.7	28.1	29.6	21.7	15.9	28.1	30.7	29.8	15.2	11.0	11.6	29.4	66.9	33.6	5.6	45.2	49.3	43.3	6.8	12.3	122.3	23.9	46.6	0.9	4.4	6.2	4.0	3.6	3.7	1.9	2.1	3.6	4.7	2.0	1.4	1.6	7.2	2.0	3.9	6.9	2.4	3.3	9.5	9.3	3.8	12.9	9.6	11.6	11.1	8.7	10.0	5.4	10.5	6.7	8.3	9.6	11.8	2.3	11.2	4.6	6.6	15.1	6.2	8.8	10.5	5.6	1.9	10.0	11.7	11.0	4.2	11.5	23.4	21.3	1.9	12.4	0.6	6.5	11.0	8.9	8.4	8.6	6.1	16.8	16.3	13.3	18.8	9.0	6.3	14.6	12.5	9.6	12.6	25.2	5.0	12.0	14.2	10.9	6.8	1.0	17.1	11.1	7.2	3.7	11.0	5.3	11.3	5.5	1.8	17.7	17.4	15.1	26.5	11.5	8.5	3.5	8.8	7.4	19.7	7.8	14.6	5.0	3.1	6.6	4.4	10.3	13.0	15.8	9.8	10.5
CHRAC1	"CHRAC15, YCL1"	ENSG00000104472	"Chromatin accessibility complex subunit 1"	Q9NRG0	8	140511311-140517154	"Predicted intracellular proteins"		"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059008			Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA059008: AB_2683878"	"unprognostic (6.34e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (9.72e-4)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (4.19e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.49e-1)"	15.0	11.6	11.0	16.9	14.4	28.1	12.5	11.0	12.1	12.7	7.3	16.9	16.0	15.1	11.7	21.5	13.2	16.6	15.9	9.5	9.9	16.1	14.5	14.8	24.0	14.4	13.1	13.5	18.2	16.4	8.8	15.0	12.7	11.6	16.1	4.6	13.0	11.6	27.9	19.7	18.2	18.1	10.6	12.5	15.6	14.5	12.0	21.4	20.9	25.3	26.2	17.7	11.7	18.0	53.3	25.2	23.1	22.0	22.6	38.1	17.8	22.2	32.2	31.8	38.1	32.5	37.1	54.6	32.2	27.4	25.1	32.3	28.0	22.6	43.6	42.5	30.2	77.5	33.1	37.0	21.4	26.2	39.4	19.2	32.5	23.6	45.3	17.1	30.9	33.1	58.3	50.4	28.4	61.6	91.6	27.9	17.2	46.5	43.6	54.4	24.7	43.5	32.0	21.8	31.7	26.3	31.1	20.9	39.5	12.6	40.4	29.3	29.4	37.4	65.1	46.5	47.8	24.2	34.0	66.3	45.0	61.1	29.6	10.6	20.2	25.4	18.2	26.5	17.5	20.4	15.6	17.7	22.4	24.1	16.0	13.9	24.3	20.3	30.2	22.8	15.6	16.1	11.0	14.4	11.0	12.1	9.5	9.9	14.4	13.1	12.7	10.6	12.0	18.0	32.3	16.0	29.9	4.2	45.6	38.4	39.2	28.5	29.0	7.4	26.3	18.0	14.7	20.0	25.9	14.7	2.1	24.9	45.0	23.4	43.0	27.4	20.2	25.6	31.4	29.6	21.6	28.8	2.4	36.0	49.3	27.4	19.4	44.8	32.4	13.3	31.8	22.4	25.2	6.7	2.5	23.6	24.4	30.8	51.4	31.7	29.2	37.1	19.6	6.5	43.8	26.9	43.3	4.0	14.9	38.2	20.6	25.2	26.4	35.2	29.0	33.8	13.9	11.7	72.3	34.9	31.1	75.5	58.3	34.5	48.6	24.1	42.4	15.8	22.3	35.9
CHRM4		ENSG00000180720	"Cholinergic receptor muscarinic 4"	P08173	11	46385098-46386608	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 18.5;intestine: 6.8;lymphoid tissue: 15.9;testis: 5.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"basal ganglia: 18.5;cerebral cortex: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 3.4;SCLC-21H: 10.0;U-2 OS: 2.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 16.8"	"CAB022444, HPA072083"	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB022444: , HPA072083: "	"unprognostic (7.11e-2)"	"unprognostic (3.79e-1)"	"unprognostic (5.31e-2)"	"unprognostic (7.38e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.96e-3)"	"unprognostic (4.08e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.08e-2)"	0.1	0.5	1.6	0.2	18.5	1.7	0.1	0.0	4.6	0.1	0.0	1.5	3.2	0.1	0.0	0.0	0.1	0.0	0.1	1.8	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.2	1.2	0.0	0.0	0.0	0.1	2.4	0.1	0.0	0.0	2.0	6.8	0.1	0.0	15.9	0.6	5.0	1.7	2.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.2	0.0	0.1	0.0	2.1	0.0	0.1	0.1	0.1	1.0	0.1	0.2	0.2	0.0	1.8	0.1	1.3	0.1	0.0	1.6	0.2	0.4	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.7	0.2	0.1	0.4	0.1	0.1	0.0	3.4	0.0	0.0	0.1	10.0	0.2	0.2	0.0	0.1	0.2	0.1	1.7	0.0	0.3	2.8	0.0	0.0	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	18.5	0.0	4.6	1.8	0.1	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHRNA2		ENSG00000120903	"Cholinergic receptor nicotinic alpha 2 subunit"	Q15822	8	27459756-27479883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 72.1;prostate: 29.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.5;Inhibitory neurons: 14.8;Prostatic glandular cells: 2.4;Theca cells: 3.4"	"Cancer enriched"	"Detected in single"	421	"prostate cancer: 30.2"	"Region enhanced"	"Detected in many"		"thalamus: 72.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA048348			Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge"		Yes	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge"	"HPA048348: "	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"			"unprognostic (2.23e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.29e-3)"			"unprognostic (1.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.47e-1)"		0.0	0.5	15.8	0.2	5.5	0.9	1.4	38.1	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	8.0	0.0	0.0	0.2	0.1	15.7	21.5	0.0	0.2	0.0	0.3	0.0	3.5	29.0	0.0	3.7	0.0	0.0	0.1	0.2	0.2	0.0	2.3	0.1	0.0	0.0	72.1	2.9	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	15.8	5.5	38.1	2.9	0.7	8.0	15.7	21.5	3.5	2.3	72.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 57.6"	"Group enriched"	"Detected in some"	10	"Muller glia cells: 4.0;Skeletal myocytes: 4.4"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RH-30: 99.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: AB_2732603, HPA065404: AB_2732734"				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	6.3	0.7	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CHST2	C6ST	ENSG00000175040	"Carbohydrate sulfotransferase 2"	Q9Y4C5	3	143119771-143124014	"Metabolic proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 114.4;NK-cells: 233.8;Plasma cells: 79.3;Sertoli cells: 92.1;Theca cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.3;NK-cell: 4.9;non-classical monocyte: 11.4"	"Group enriched"	"Detected in many"	5	"monocytes: 11.4;NK-cells: 4.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 57.7;ASC TERT1: 58.8;HEL: 48.2;HHSteC: 118.4;HMC-1: 55.4;HSkMC: 62.3;U-266/70: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013620			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA013620: AB_2668861"	"unprognostic (1.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.75e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.34e-1)"	7.7	2.7	17.8	8.1	13.7	16.8	6.3	16.7	14.6	5.7	6.0	3.0	2.1	8.4	1.4	1.1	2.1	1.7	5.6	9.7	13.4	8.4	1.3	7.5	7.7	31.0	18.4	4.9	1.3	0.9	6.9	10.3	28.1	7.4	1.1	11.0	2.7	9.9	1.6	4.4	7.5	3.7	21.4	18.2	3.4	1.7	28.7	14.5	6.7	0.8	5.4	7.1	7.6	48.4	0.0	0.3	3.1	2.6	57.7	58.8	0.2	3.3	9.5	2.3	2.1	0.0	0.0	0.6	2.0	2.3	3.1	0.1	2.3	8.2	1.2	0.8	1.5	48.2	0.1	0.0	118.4	1.2	55.4	62.3	9.7	3.1	10.1	3.6	3.6	7.2	5.5	2.9	15.4	0.0	9.1	12.2	16.5	0.0	8.0	0.5	1.0	0.1	1.7	2.2	3.7	0.0	0.7	0.0	5.6	2.9	0.0	1.9	12.3	7.0	4.1	9.5	13.9	52.4	0.8	3.3	13.8	9.3	37.4	0.7	0.5	0.7	0.3	4.3	0.0	1.1	0.1	0.2	1.6	0.8	0.6	0.5	0.3	4.9	11.4	0.1	0.5	0.9	17.8	13.7	16.7	14.6	9.7	13.4	31.0	18.4	28.1	21.4	28.7	48.4	11.3	0.0	0.0	3.6	17.7	2.4	7.3	2.5	0.0	25.0	2.8	2.7	1.4	0.0	1.8	3.7	2.1	0.6	41.9	0.0	0.0	0.4	0.2	5.7	29.8	9.4	0.0	39.1	6.8	0.2	0.6	14.4	2.0	6.5	11.4	12.5	3.6	0.4	2.8	1.7	8.1	0.0	0.0	10.3	32.2	1.3	12.8	20.2	17.8	1.0	13.6	114.4	233.8	2.5	6.1	5.9	0.0	2.2	79.3	13.1	0.0	0.0	0.1	23.8	92.1	0.8	20.2	0.0	2.2	0.1	0.6	1.0	9.8	58.1	1.3	14.8
CHST7	"C6ST-2, C6ST2"	ENSG00000147119	"Carbohydrate sulfotransferase 7"	Q9NS84	X	46573765-46598496	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 35.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 45.4;monocytes: 55.5;Peritubular cells: 60.2;Sertoli cells: 52.6;Skeletal myocytes: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 18.5"	"Group enriched"	"Detected in many"	10	"granulocytes: 10.9;monocytes: 10.2;T-cells: 18.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 22.8;NTERA-2: 20.5;PC-3: 17.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003919, HPA030503"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		9800	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA003919: AB_10601258, HPA030503: "	"unprognostic (3.16e-1)"	"prognostic favorable (7.20e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.39e-2)"	13.2	3.4	5.4	1.7	7.3	2.5	7.5	6.4	7.0	11.2	3.7	3.7	0.8	5.8	0.4	2.5	4.9	1.9	17.4	5.4	7.1	4.0	7.5	3.6	1.8	6.1	7.3	35.3	2.0	1.2	4.2	2.0	6.0	4.1	0.8	0.9	3.5	1.4	4.4	7.3	4.0	1.4	4.7	10.2	3.4	2.1	8.0	1.4	5.8	3.9	0.7	4.5	7.7	4.0	5.5	4.7	3.9	3.5	10.8	7.5	0.2	7.6	5.4	2.0	2.6	1.2	2.1	0.0	22.8	3.1	1.3	4.1	3.8	1.3	1.7	3.2	8.1	1.1	0.3	4.1	16.6	1.9	0.1	2.5	1.1	3.8	3.1	3.4	6.2	2.5	0.0	4.7	1.5	2.6	0.7	2.4	20.5	0.4	17.0	3.6	3.2	10.3	5.5	0.2	8.8	3.4	1.1	0.2	0.9	9.6	1.3	0.4	1.4	6.1	0.6	3.3	3.5	11.0	2.4	1.7	6.8	0.1	0.4	2.4	2.2	0.7	1.5	7.1	1.4	1.2	5.8	2.8	1.2	0.6	1.2	1.1	10.9	0.6	10.2	0.8	18.5	1.9	5.4	7.3	6.4	7.0	5.4	7.1	6.1	7.3	6.0	4.7	8.0	4.0	33.8	0.0	3.1	22.9	2.5	12.4	2.0	4.8	1.2	0.8	2.2	3.7	7.4	10.0	2.6	1.8	0.0	5.3	11.5	1.7	1.9	2.8	0.0	3.6	20.8	16.3	0.0	0.0	0.9	2.5	4.3	23.6	0.0	1.6	0.0	19.7	15.7	4.5	11.5	3.3	4.1	2.9	0.0	14.2	45.4	0.3	19.0	14.1	14.2	4.7	55.5	5.2	4.1	13.0	1.0	1.8	1.5	60.2	4.7	6.7	0.7	2.1	1.9	0.8	52.6	43.1	11.2	0.5	1.3	1.3	13.2	1.4	9.9	11.4	0.9	3.3
CHTF18	"C16orf41, C321D2.4, CHL12, Ctf18"	ENSG00000127586	"Chromosome transmission fidelity factor 18"	Q8WVB6	16	788046-800737	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.1;Extravillous trophoblasts: 19.6;Granulosa cells: 22.0;Spermatogonia: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 48.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA040976, HPA056209"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA040976: AB_2677232, HPA056209: AB_2683066"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.80e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (1.43e-8)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (2.78e-4)"	2.7	2.2	0.7	1.1	0.5	6.8	3.2	0.7	1.5	4.3	0.0	3.3	1.9	3.2	0.0	5.1	3.2	0.6	1.8	0.7	0.4	2.6	2.4	2.8	1.4	0.5	0.3	4.8	2.8	0.1	2.5	1.2	0.5	3.4	0.3	0.3	2.7	0.6	2.0	4.0	4.0	0.3	0.1	5.7	3.0	11.7	0.5	1.8	3.1	0.3	0.3	3.1	3.7	0.4	14.4	7.0	5.5	4.5	0.5	0.4	48.3	8.9	2.4	4.4	3.0	12.5	10.8	16.1	8.9	1.5	2.3	15.7	1.2	6.8	0.0	9.2	20.1	7.1	8.6	6.4	0.0	4.4	13.4	0.2	0.8	4.2	2.2	0.6	3.7	16.4	10.9	5.2	1.1	27.7	17.4	16.6	7.2	3.3	8.3	31.1	14.0	21.2	1.5	4.1	7.2	9.2	6.4	14.1	4.8	0.6	10.3	10.8	2.4	6.5	23.5	11.8	12.2	12.3	4.3	9.1	2.0	6.5	11.5	2.5	0.2	0.0	0.7	1.0	0.4	0.1	0.3	0.6	0.4	0.2	0.4	0.1	0.1	0.7	0.6	0.2	0.4	0.2	0.7	0.5	0.7	1.5	0.7	0.4	0.5	0.3	0.5	0.1	0.5	0.4	4.3	3.2	4.2	2.6	3.5	5.4	3.3	2.7	5.7	23.1	4.1	5.5	4.6	0.0	3.0	1.8	2.1	15.2	4.3	7.1	1.9	2.9	1.2	4.2	4.9	2.4	6.6	14.3	2.3	3.9	19.6	3.9	10.2	8.8	4.5	22.0	3.3	2.4	6.4	6.7	1.8	5.3	0.0	2.6	5.8	1.3	1.8	2.9	0.0	2.8	0.3	2.4	2.1	1.5	2.8	1.8	1.0	1.5	5.7	1.4	0.9	1.0	2.5	7.0	0.0	3.2	3.5	13.6	21.2	4.5	2.0	8.6	3.4	5.0	7.4	3.2
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Component of inhibitor of nuclear factor kappa B kinase complex"	O15111	10	100188300-100229596	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	13.5	10.3	6.6	11.7	7.6	19.6	10.8	7.1	8.3	8.4	8.3	11.9	12.8	8.8	9.1	9.7	7.5	9.0	6.8	6.4	9.2	21.0	17.0	10.2	12.7	7.3	7.5	5.6	11.5	14.0	6.5	10.5	7.6	9.6	13.3	8.0	8.8	9.0	14.2	6.9	10.8	11.8	7.7	9.9	11.2	8.3	8.7	14.3	11.1	11.7	12.6	13.6	6.4	8.7	27.7	22.9	23.0	34.4	21.6	19.3	17.6	34.3	33.5	31.3	38.0	25.9	15.9	37.2	19.7	23.5	21.8	26.7	38.7	18.2	34.9	39.8	33.5	24.7	18.0	28.7	18.4	46.2	34.8	15.5	19.1	36.2	35.0	21.8	22.7	30.1	28.5	29.9	34.6	16.7	36.9	28.4	15.0	21.8	16.5	23.7	25.5	17.0	19.9	17.6	13.7	20.3	18.6	14.2	30.9	18.0	28.5	27.8	23.9	19.6	21.9	21.5	39.7	34.9	33.7	35.7	21.3	36.9	15.8	1.0	1.2	2.1	0.9	1.9	1.5	1.6	1.1	1.6	1.4	1.0	1.3	1.5	2.8	1.8	1.3	0.8	1.2	0.5	6.6	7.6	7.1	8.3	6.4	9.2	7.3	7.5	7.6	7.7	8.7	8.7	11.4	12.8	11.5	17.9	10.8	19.8	7.1	5.1	8.0	6.3	7.3	4.8	9.2	7.2	5.9	5.5	2.1	6.5	14.1	12.2	11.7	7.1	7.6	8.9	8.6	8.4	6.0	12.0	22.7	11.8	7.8	6.5	7.7	12.7	8.2	6.2	7.1	14.4	10.6	13.5	21.3	8.0	8.2	16.9	12.7	8.0	6.2	11.7	7.2	19.7	15.6	4.5	9.2	20.6	27.7	10.4	6.0	6.0	18.5	9.6	9.5	20.0	6.4	5.0	19.7	7.8	12.0	16.4	12.9	13.2	19.0	13.8	11.1	10.1	6.6	10.6
CIAO1	"CIA1, WDR39"	ENSG00000144021	"Cytosolic iron-sulfur assembly component 1"	O76071	2	96266159-96274173	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017882	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA017882: AB_1846738"	"unprognostic (2.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.15e-2)"	18.4	32.4	26.8	17.0	28.3	12.1	19.4	30.2	29.7	18.9	26.3	16.8	20.1	14.8	18.0	20.1	19.7	15.1	30.4	27.8	27.8	31.0	32.8	17.6	22.3	27.7	27.6	18.6	17.9	36.2	13.4	18.7	28.3	16.9	17.6	17.4	23.6	19.5	27.8	19.3	17.6	16.5	28.9	21.3	16.7	17.1	28.6	22.2	20.5	28.0	21.3	18.6	13.9	30.2	31.8	27.2	28.8	32.3	49.8	40.9	32.0	27.1	31.9	37.5	39.8	44.1	23.0	44.6	46.6	29.8	42.0	28.0	40.8	29.7	33.4	25.0	58.0	28.9	19.4	47.4	28.8	37.8	32.2	35.1	34.5	28.5	43.2	35.9	39.9	33.8	36.9	29.8	35.9	38.1	42.2	40.8	51.3	44.5	58.0	38.3	33.2	47.3	42.6	31.6	36.0	42.2	19.9	48.0	53.1	40.1	24.8	41.4	30.4	26.2	35.4	36.7	29.3	43.5	49.6	30.1	38.4	37.9	31.4	30.9	27.7	34.2	27.8	23.8	31.9	20.9	25.8	29.8	29.1	24.9	24.3	28.5	23.6	30.0	33.8	18.8	23.5	33.0	26.8	28.3	30.2	29.7	27.8	27.8	27.7	27.6	28.3	28.9	28.6	30.2	33.3	28.9	31.4	26.8	32.4	29.1	28.7	39.0	35.9	24.3	23.2	28.4	27.0	15.7	31.6	14.7	14.6	59.3	42.5	21.8	39.2	40.0	25.0	21.2	30.7	30.1	15.7	32.4	44.5	33.6	60.1	32.6	28.1	21.2	37.2	33.3	19.2	27.4	45.2	26.9	36.6	21.1	44.7	23.4	29.6	25.8	20.2	30.6	19.6	20.6	40.6	19.0	42.2	25.1	25.2	35.5	13.0	16.6	44.8	51.7	43.6	72.7	36.2	24.0	32.9	27.3	34.4	42.5	42.3	43.5	34.5	49.8	38.6	54.5	23.6	43.0
CIAO2A	"CIA2A, FAM96A, FLJ22875"	ENSG00000166797	"Cytosolic iron-sulfur assembly component 2A"	Q9H5X1	15	64072565-64093857	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 262.4"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 74.8;Cytotrophoblasts: 116.5;Extravillous trophoblasts: 100.6;Hofbauer cells: 218.2;Syncytiotrophoblasts: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA040459: AB_10796456, HPA063729: AB_2685105"	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	27.8	68.6	23.1	53.6	26.0	70.7	48.5	25.7	26.7	31.5	39.1	82.8	107.9	22.6	41.1	30.1	32.1	43.0	78.0	22.0	24.6	81.3	262.4	43.4	105.3	26.1	24.0	20.6	59.8	75.5	24.6	65.5	26.6	39.1	68.4	24.7	44.0	26.8	125.5	19.4	86.8	23.8	26.4	52.8	68.8	20.7	26.9	60.3	80.2	97.4	66.9	46.3	20.3	32.0	114.6	168.6	104.3	71.7	91.7	110.7	61.2	92.7	105.4	120.2	133.5	157.7	172.9	186.9	157.4	56.2	155.7	118.3	197.9	90.2	95.4	171.3	124.2	156.2	137.7	161.2	70.7	240.5	123.1	90.8	87.2	76.7	67.6	84.5	130.1	118.5	222.3	148.8	89.5	197.8	100.1	202.8	144.6	148.9	96.3	154.5	139.8	410.4	154.3	127.0	112.2	87.5	76.8	150.9	180.6	113.9	120.6	243.6	83.0	98.2	129.4	104.7	193.6	144.4	353.8	186.4	109.5	429.3	96.9	122.4	255.8	117.0	67.3	254.1	83.0	346.0	94.8	88.1	231.6	345.5	75.5	74.4	132.0	86.9	228.3	386.5	146.1	269.0	23.1	26.0	25.7	26.7	22.0	24.6	26.1	24.0	26.6	26.4	26.9	32.0	10.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	116.5	10.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	100.6	13.2	0.0	0.0	0.0	0.0	0.0	0.0	218.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	88.8	2.0	0.0	0.0	0.0
CIAO2B	"CGI-128, CIA2B, FAM96B, MIP18"	ENSG00000166595	"Cytosolic iron-sulfur assembly component 2B"	Q9Y3D0	16	66932065-66934423	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 143.6;Cytotrophoblasts: 204.8;Extravillous trophoblasts: 190.4;Hofbauer cells: 201.5;Syncytiotrophoblasts: 248.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041501, HPA041736"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA041501: AB_10795123, HPA041736: AB_10793932"	"unprognostic (2.49e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.12e-2)"	92.2	131.3	151.9	59.2	162.7	49.1	78.5	168.2	176.4	89.4	148.5	94.0	63.3	76.8	62.5	156.3	84.2	57.8	215.0	152.9	158.5	158.4	152.9	92.4	83.6	159.3	156.5	90.1	69.9	115.1	112.3	66.0	159.1	80.5	59.8	32.7	69.5	48.8	347.5	60.8	80.3	52.8	160.6	81.8	82.9	76.9	156.7	69.9	87.0	119.6	63.3	86.5	82.6	169.1	131.6	291.8	96.8	122.1	119.9	112.7	118.2	117.3	130.7	175.7	219.5	309.5	147.8	118.4	148.6	139.4	151.1	169.7	140.0	141.7	125.1	148.9	198.1	72.3	83.6	368.3	227.1	107.8	275.1	112.2	135.5	208.4	180.8	133.2	120.8	206.9	124.1	76.7	144.9	252.6	184.6	258.8	129.7	112.5	351.2	155.5	103.3	228.6	264.9	117.0	170.0	190.0	251.4	67.2	186.4	74.4	74.5	176.7	103.6	130.9	156.2	74.5	165.9	167.0	146.7	311.7	231.9	111.3	174.4	209.5	190.1	202.2	169.9	222.3	167.9	226.6	180.2	186.1	216.7	189.7	142.8	159.1	94.9	185.8	241.3	389.8	270.1	207.5	151.9	162.7	168.2	176.4	152.9	158.5	159.3	156.5	159.1	160.6	156.7	169.1	56.8	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.6	0.0	0.0	0.0	0.0	204.8	53.1	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	190.4	38.9	0.0	0.0	0.0	0.0	0.0	0.0	201.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	248.6	10.9	0.0	0.0	0.0
CIAPIN1	"Anamorsin, CIAE2"	ENSG00000005194	"Cytokine induced apoptosis inhibitor 1"	Q6FI81	16	57428187-57447420	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 259.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041350, HPA042182"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		21000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA041350: AB_10796665, HPA042182: AB_10794646"	"unprognostic (1.78e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.41e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.86e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.16e-1)"	19.1	32.8	22.1	19.7	22.3	20.6	18.9	23.2	26.8	16.3	26.3	29.4	21.3	16.3	15.5	30.2	16.1	16.6	38.7	22.5	23.8	30.8	27.3	19.9	24.2	24.3	23.2	12.9	19.6	37.4	17.7	31.6	23.8	18.0	25.9	20.9	19.7	16.3	41.3	28.3	20.9	22.0	20.7	21.6	22.3	68.0	25.1	31.0	18.4	38.4	34.3	24.3	20.2	21.8	51.8	77.8	80.4	61.4	46.5	31.8	67.5	52.7	51.2	102.6	48.1	87.6	40.3	55.0	75.8	46.9	32.4	95.9	113.2	82.2	86.5	32.7	68.2	71.4	63.6	91.6	74.6	88.2	67.7	48.8	88.7	74.9	94.5	40.5	101.9	69.3	101.4	30.7	60.9	51.5	81.1	71.1	100.8	60.3	114.8	146.0	93.6	112.7	69.6	57.7	68.7	85.8	126.4	86.2	56.6	64.6	61.7	76.5	63.2	42.3	52.1	42.4	64.7	76.8	113.4	175.0	51.1	78.9	68.0	53.6	80.5	54.2	74.2	79.2	68.1	65.7	60.8	78.4	94.6	72.6	128.5	115.1	19.8	91.1	64.7	79.8	74.5	153.8	22.1	22.3	23.2	26.8	22.5	23.8	24.3	23.2	23.8	20.7	25.1	21.8	25.3	16.0	22.0	7.8	16.0	14.3	13.9	59.4	8.6	29.2	17.5	18.3	36.1	20.0	28.4	22.0	10.4	90.4	21.8	17.0	39.2	55.4	19.3	14.4	19.1	28.5	18.6	21.9	15.7	51.8	50.0	19.2	19.4	15.1	10.8	28.1	17.9	20.3	40.0	23.5	16.4	17.8	52.9	13.9	13.2	33.6	14.0	17.4	24.9	7.5	42.9	27.9	23.7	11.1	10.6	54.6	23.9	20.7	14.4	23.2	25.5	37.4	14.1	17.8	39.5	11.8	21.3	259.9	69.8	23.2	15.9	106.2	19.3	43.4	28.0	15.2
CIART	"BC017397, C1orf51, CHRONO"	ENSG00000159208	"Circadian associated repressor of transcription"	Q8N365	1	150282543-150287093	"Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 30.7;Bipolar cells: 43.1;Cone photoreceptor cells: 102.2;Muller glia cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.2;memory CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.4;Karpas-707: 36.8;U-266/84: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027515, HPA054349"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA027515: AB_10600757, HPA054349: AB_2682457"	"unprognostic (1.77e-1)"	"unprognostic (5.63e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.42e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.34e-2)"	6.9	13.5	15.1	3.1	22.2	0.4	7.5	20.1	19.9	6.7	17.8	22.8	3.3	9.6	9.3	8.2	10.2	4.5	29.4	15.4	15.8	10.1	13.7	5.8	2.6	13.3	14.8	10.1	5.0	32.0	17.7	2.7	13.7	9.4	2.8	22.2	17.8	23.9	54.2	40.5	6.4	9.0	13.2	2.8	13.8	9.8	16.7	2.0	19.0	46.4	3.5	11.8	8.3	14.1	0.2	1.0	6.7	3.4	3.0	1.3	6.6	4.8	11.8	6.2	8.2	1.8	26.4	0.1	8.3	10.4	14.1	4.5	0.2	4.8	9.3	0.1	0.6	0.2	0.4	0.1	10.5	1.6	3.7	4.0	7.1	15.8	3.2	14.4	1.2	0.1	0.2	36.8	3.6	21.8	0.0	0.8	8.9	4.9	19.9	1.1	0.0	0.3	6.2	1.0	4.1	1.5	7.9	0.7	14.6	1.7	6.7	0.6	2.1	17.3	0.2	0.7	10.5	8.2	29.6	0.2	16.0	0.1	10.5	0.0	0.0	0.0	0.1	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.1	15.1	22.2	20.1	19.9	15.4	15.8	13.3	14.8	13.7	13.2	16.7	14.1	2.8	0.0	1.5	5.5	0.6	0.0	5.5	0.0	30.7	43.1	5.5	7.7	7.3	4.3	1.3	0.0	102.2	0.2	0.6	0.4	9.8	3.2	0.6	2.9	2.5	3.0	2.4	0.0	3.1	1.5	0.1	4.8	3.6	2.1	0.0	3.5	0.7	4.2	1.3	6.7	3.9	0.9	0.0	0.3	0.0	1.4	5.3	1.9	0.0	0.0	1.0	28.2	0.0	1.5	1.1	4.1	1.2	9.4	0.2	4.4	7.7	3.9	0.7	18.1	0.0	4.6	4.5	7.2	10.9	11.2	0.0	0.0	0.9	4.1	0.7	2.7
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1385.8;Respiratory ciliated cells: 1103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	65.6	163.6	65.4	79.7	69.2	205.5	67.4	67.8	76.5	93.8	96.7	147.9	130.1	44.6	88.1	127.3	146.6	77.4	101.9	62.7	68.8	220.1	195.7	86.7	97.0	70.1	70.3	43.9	214.1	98.3	93.0	38.0	68.7	127.6	138.1	29.1	116.6	72.7	58.8	40.4	128.5	45.3	69.3	117.0	99.3	113.8	69.2	64.4	89.1	42.3	120.9	93.7	68.3	69.3	119.5	261.4	23.8	83.7	98.7	102.7	38.9	123.8	107.2	99.6	87.2	104.7	207.4	34.7	129.7	144.0	125.7	124.2	48.0	141.8	54.0	81.9	114.2	77.5	182.3	175.9	96.2	155.2	71.4	72.2	84.9	91.9	64.6	113.7	129.1	83.7	105.8	53.5	76.4	233.3	118.4	179.4	36.7	223.9	134.0	66.1	62.8	139.7	256.1	199.4	18.7	22.8	168.7	136.5	135.7	41.5	105.3	93.3	81.7	109.6	77.0	132.0	153.2	73.0	122.0	40.3	176.1	174.9	47.8	168.9	201.8	271.3	226.9	248.9	188.0	476.4	269.9	249.4	224.4	418.0	221.5	218.0	118.2	205.7	230.0	149.7	245.8	399.6	65.4	69.2	67.8	76.5	62.7	68.8	70.1	70.3	68.7	69.3	69.2	69.3	77.4	89.8	104.2	14.7	203.7	85.7	253.6	520.1	84.8	12.0	152.0	118.5	86.9	128.7	469.1	183.9	10.4	106.7	198.7	670.9	453.9	372.1	380.8	480.8	101.3	83.9	97.1	62.3	7.7	662.9	117.6	96.5	149.9	222.8	138.8	66.9	79.6	230.1	209.0	3.3	6.6	379.5	463.9	102.5	148.0	1385.8	105.3	180.5	128.1	4.7	187.5	138.4	184.4	5.0	12.2	620.2	794.2	92.6	88.8	699.6	661.4	668.6	1103.6	25.5	39.5	62.3	140.4	160.3	69.0	218.1	67.3	66.1	227.5	91.8	315.5	577.8
CIC	KIAA0306	ENSG00000079432	"Capicua transcriptional repressor"	Q96RK0	19	42268537-42295797	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026388, HPA044341, HPA064725"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Vesicles	"CAB026388: , HPA044341: AB_2678901, HPA064725: AB_2685335"	"unprognostic (2.02e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.54e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.72e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.56e-1)"	41.9	41.5	43.3	23.4	36.1	31.8	42.7	40.7	47.4	53.8	2.3	45.6	15.6	62.3	8.7	34.3	49.1	16.1	35.4	36.3	27.7	41.7	44.6	40.8	24.2	39.5	27.8	70.1	39.4	12.2	58.7	12.6	35.7	40.5	5.8	13.5	35.4	18.7	45.2	47.2	36.9	16.0	17.4	46.9	38.6	74.6	29.4	21.0	44.3	15.3	13.5	39.6	37.5	32.5	31.8	56.7	26.4	34.4	16.6	30.7	10.7	22.8	22.5	22.9	20.9	18.5	21.4	26.7	20.8	21.8	19.6	16.6	14.6	38.9	7.6	61.9	19.6	22.2	44.7	23.0	20.1	11.8	50.9	36.7	25.5	24.4	15.5	24.8	19.2	15.9	21.8	52.5	13.3	31.9	25.1	25.6	16.2	12.6	5.8	21.5	21.2	14.3	20.5	25.3	33.6	27.1	23.7	15.7	21.6	8.3	18.3	25.8	27.5	52.0	43.7	15.9	33.2	41.0	29.8	18.1	37.9	19.4	32.6	0.0	0.5	0.1	0.7	0.8	0.5	0.5	0.3	0.5	0.5	0.6	0.2	0.4	1.1	0.2	0.6	0.6	0.1	0.6	43.3	36.1	40.7	47.4	36.3	27.7	39.5	27.8	35.7	17.4	29.4	32.5	27.8	0.0	3.0	15.7	13.7	25.9	12.8	16.2	27.9	38.3	20.7	16.9	7.8	21.5	7.1	9.2	20.9	6.9	9.1	14.2	3.9	13.4	5.1	14.6	14.9	20.3	14.8	8.4	8.0	15.3	5.1	11.2	17.9	22.3	12.0	11.1	13.9	19.2	11.9	42.1	9.0	10.1	10.2	18.0	23.6	3.3	21.8	15.3	24.9	7.5	13.0	18.4	8.2	4.0	10.3	16.9	11.2	18.0	10.4	11.3	10.6	6.2	8.0	18.8	26.3	19.9	17.6	19.4	20.2	16.5	19.5	13.0	13.2	14.2	10.6	11.9
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 48.8;Langerhans cells: 51.8;Macrophages: 43.8;Microglial cells: 42.2;monocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 29.1;eosinophil: 17.5;intermediate monocyte: 23.5;memory B-cell: 47.3;myeloid DC: 46.2;naive B-cell: 63.3;non-classical monocyte: 29.0;plasmacytoid DC: 48.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.1;REH: 89.5;U-266/70: 18.0;U-698: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	9.4	6.5	6.4	39.2	5.9	9.2	7.8	7.3	7.9	10.7	8.9	6.7	20.5	7.3	2.6	5.5	7.4	15.0	5.4	5.4	11.5	7.2	4.7	24.1	57.3	15.0	8.3	3.6	3.9	2.6	3.0	2.6	11.9	4.8	8.2	1.4	12.1	6.9	5.0	8.7	24.8	7.3	11.5	51.2	12.9	2.1	13.0	15.9	5.2	2.4	57.0	9.0	4.1	16.4	0.4	0.4	0.7	0.6	0.1	0.0	0.5	0.2	0.0	0.3	0.4	0.6	12.0	11.2	1.6	0.0	1.7	1.8	0.0	0.0	0.2	51.1	0.6	6.3	2.6	1.3	0.0	0.9	0.9	2.1	0.0	0.2	0.0	1.8	0.0	0.7	0.8	4.1	0.2	0.7	0.6	1.0	0.3	0.4	0.3	89.5	0.6	7.9	0.1	3.6	1.8	0.3	2.1	0.6	2.1	0.6	1.0	3.8	0.5	4.3	0.7	1.2	0.5	18.0	1.4	25.8	16.0	1.1	14.7	0.7	29.1	17.5	0.8	23.5	0.4	47.3	0.3	1.4	46.2	63.3	0.2	0.4	6.8	1.8	29.0	48.3	1.2	5.4	6.4	5.9	7.3	7.9	5.4	11.5	15.0	8.3	11.9	11.5	13.0	16.4	14.5	6.4	19.5	0.3	48.8	2.3	0.3	1.3	1.2	0.8	1.7	2.0	5.3	1.5	1.5	3.7	0.0	0.2	17.9	2.0	0.0	5.5	0.8	1.5	0.4	7.3	2.4	6.9	1.4	2.0	0.3	1.2	4.6	1.4	10.8	7.7	1.4	0.7	8.7	0.0	1.8	1.9	0.0	16.1	51.8	0.0	0.6	43.8	7.2	42.2	51.8	0.2	2.1	0.0	0.3	1.1	0.1	0.0	1.1	0.4	12.3	4.8	5.6	1.6	0.0	1.0	1.2	0.0	0.0	1.0	2.8	0.1	3.0	0.4	1.5	0.5
CIPC	KIAA1737	ENSG00000198894	"CLOCK interacting pacemaker"	Q9C0C6	14	77098126-77117287	"Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.1"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000644			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA000644: AB_1079206"	"unprognostic (3.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.77e-10)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-1)"	13.2	9.6	41.3	8.4	53.0	4.2	15.8	48.0	41.1	16.8	24.7	26.8	10.3	14.6	13.5	22.1	30.4	9.0	39.8	46.5	44.1	14.2	15.4	11.1	8.4	47.5	48.2	9.1	9.7	29.5	13.5	9.0	43.9	25.5	19.9	41.2	20.5	24.8	132.1	15.4	11.4	16.5	42.3	9.1	11.4	11.7	53.3	10.3	20.4	82.4	10.1	17.2	15.5	49.6	9.4	12.6	25.4	16.8	10.1	8.0	15.4	6.0	9.4	10.9	9.8	10.3	19.4	23.3	5.9	9.7	9.6	14.3	23.7	9.4	14.3	12.3	6.4	14.9	9.8	9.5	9.7	8.4	10.7	9.4	17.9	10.6	6.5	14.1	12.7	19.2	14.0	8.8	8.1	21.4	20.2	10.2	10.6	21.3	10.9	20.2	11.3	14.0	11.0	16.1	35.9	13.4	11.0	17.4	14.9	10.7	27.2	8.6	14.9	7.0	15.1	10.0	7.6	8.4	7.1	11.1	13.2	7.1	14.8	4.3	4.5	1.6	2.6	5.1	4.1	7.9	3.6	2.7	5.4	7.1	3.8	2.8	5.5	5.5	3.8	2.0	4.1	3.6	41.3	53.0	48.0	41.1	46.5	44.1	47.5	48.2	43.9	42.3	53.3	49.6	8.5	16.0	18.4	33.6	4.7	9.1	8.2	5.3	12.5	29.3	18.3	12.6	49.9	8.6	12.6	11.0	58.4	7.4	5.5	43.5	9.8	4.2	11.0	39.8	9.2	7.0	17.4	6.5	16.4	5.6	5.0	5.6	9.2	20.3	1.3	5.8	7.1	29.5	15.2	11.8	20.2	14.8	30.5	16.0	6.6	15.8	4.1	7.2	8.8	9.4	5.8	22.8	2.1	21.1	58.7	5.1	12.4	14.3	4.2	8.3	18.1	6.0	30.5	36.4	13.1	7.9	9.3	19.9	9.1	10.4	9.8	13.5	3.1	7.1	13.7	7.1
CIRBP	CIRP	ENSG00000099622	"Cold inducible RNA binding protein"	Q14011	19	1259384-1274880	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA060537			Supported	Nucleoplasm		NA	NA		240000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA060537: AB_2684314"	"unprognostic (2.77e-3)"	"prognostic favorable (3.63e-4)"	"unprognostic (9.80e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (6.43e-2)"	"unprognostic (2.29e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.65e-7)"	"unprognostic (1.04e-1)"	"unprognostic (5.76e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.49e-2)"	356.6	367.9	176.0	205.7	176.2	377.9	409.6	177.9	277.1	443.1	147.3	400.6	196.5	471.8	429.7	219.6	496.9	279.3	368.6	162.7	181.6	296.3	200.9	300.9	350.4	167.5	166.0	853.0	614.8	490.8	496.2	230.8	164.4	377.1	227.1	383.9	367.5	418.1	485.7	402.7	304.0	313.3	169.2	332.7	405.2	183.8	193.3	327.9	420.1	304.3	383.8	344.7	307.8	186.5	285.8	60.4	434.3	220.1	188.0	209.3	112.3	307.3	428.7	235.1	209.9	112.7	108.1	570.7	162.3	318.6	27.9	133.5	182.5	277.5	181.2	255.4	52.3	340.6	68.2	145.9	684.8	532.0	237.9	518.9	244.6	152.3	659.7	324.3	215.0	282.6	228.3	445.6	247.2	202.9	274.7	144.4	172.3	162.4	100.2	337.3	347.2	280.3	267.5	237.3	204.1	369.3	323.9	145.6	251.3	140.9	304.6	148.3	264.6	174.5	105.3	415.1	271.0	581.3	689.3	463.7	148.9	216.4	229.7	208.5	88.3	205.5	212.3	153.5	217.7	248.7	190.0	193.5	97.0	268.0	213.2	205.0	147.4	229.4	237.0	272.5	244.6	196.3	176.0	176.2	177.9	277.1	162.7	181.6	167.5	166.0	164.4	169.2	193.3	186.5	341.8	205.1	384.3	169.8	541.8	586.6	641.5	585.8	541.8	758.0	682.4	586.5	258.0	427.5	304.2	298.0	329.4	601.9	504.0	175.5	972.4	386.0	78.8	243.9	292.1	388.3	434.2	244.4	51.8	484.2	271.0	493.6	236.0	241.0	404.2	400.6	436.2	149.6	314.4	684.8	69.2	315.5	514.7	372.1	559.7	199.3	649.9	301.0	734.6	60.9	490.2	1307.9	563.4	90.0	157.2	348.7	281.7	499.5	477.5	434.5	399.6	635.6	295.8	712.7	374.7	956.8	488.0	228.5	504.5	327.6	556.8	737.4	482.5	586.9	270.5	378.6
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"epididymis: 1473.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 87.4;Breast myoepithelial cells: 47.6;Granulosa cells: 31.0;Late spermatids: 58.4;Paneth cells: 33.8"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 244.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Supported		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA049051: AB_2680612"	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (6.10e-4)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.99e-2)"	2.3	5.1	13.0	0.3	6.9	0.2	23.1	5.1	12.2	5.9	3.4	1.0	0.7	3.6	1473.6	0.3	1.5	0.0	0.7	6.7	56.2	5.1	0.4	0.6	0.3	8.5	8.8	1.5	1.5	0.0	209.9	0.0	24.5	11.2	0.2	4.5	0.8	3.0	0.4	0.6	1.0	8.1	4.3	0.4	1.0	199.9	30.6	0.2	8.0	0.4	0.1	0.5	1.0	6.2	0.4	0.3	2.2	57.1	2.5	0.0	2.1	0.0	0.5	0.4	0.3	0.1	0.6	0.0	0.2	0.0	0.6	0.0	20.5	1.4	0.1	6.1	8.0	0.9	0.4	0.0	0.0	0.2	10.4	1.1	0.8	0.5	1.0	0.2	0.2	0.2	2.5	0.0	0.4	0.8	0.2	4.4	3.3	0.0	3.6	0.1	3.6	3.2	0.1	0.4	25.8	12.5	0.4	5.1	244.4	0.2	1.4	1.0	0.0	0.2	1.9	0.4	0.8	0.2	0.5	0.2	0.5	0.4	5.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	6.9	5.1	12.2	6.7	56.2	8.5	8.8	24.5	4.3	30.6	6.2	2.2	0.0	0.0	0.0	0.0	0.1	1.0	0.4	0.0	5.6	87.4	47.6	0.4	1.5	0.1	3.7	6.2	0.1	0.3	0.3	0.0	0.1	20.4	0.5	0.8	1.0	1.2	0.0	0.7	0.8	0.1	0.7	0.0	0.3	0.0	31.0	0.4	0.1	0.1	0.0	1.5	0.2	0.0	0.0	0.7	58.4	7.5	0.8	3.6	1.9	0.1	1.7	0.0	0.0	0.1	0.4	33.8	3.0	0.0	19.3	0.7	0.3	0.0	3.8	13.1	1.2	3.2	12.6	6.8	0.0	0.0	0.0	0.1	0.5	0.5	1.0
CITED2	MRG1	ENSG00000164442	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2"	Q99967	6	139371807-139374648	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Stress response, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 685.3;Plasma cells: 619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 27.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 618.3;fHDF/TERT166: 1070.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016157, CAB069879"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB016157: AB_668099, CAB069879: AB_10003446"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.40e-4)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.03e-1)"	177.7	107.4	3.8	49.8	2.2	313.6	117.5	29.3	24.0	60.5	5.4	88.0	36.7	188.0	38.7	75.5	207.7	32.6	70.9	1.9	9.3	70.7	203.4	134.0	37.9	8.5	6.5	270.3	74.7	179.0	17.7	104.1	8.3	44.2	42.5	36.4	120.5	42.8	107.6	131.7	65.3	81.9	0.9	136.5	69.5	22.0	19.4	25.1	227.7	24.9	30.4	37.9	64.0	0.7	23.7	13.7	46.7	138.2	191.8	203.7	175.6	618.3	456.0	274.7	255.7	122.5	35.2	17.0	88.5	1070.3	58.5	28.0	14.2	14.5	192.4	467.0	45.8	346.9	76.0	10.1	157.1	103.1	36.5	164.6	64.4	121.3	91.4	177.9	51.2	10.1	132.9	80.1	359.2	51.0	17.5	128.3	43.8	15.0	21.2	24.7	34.2	152.3	131.7	52.5	51.8	0.8	45.2	167.6	21.2	106.8	72.3	348.3	283.6	219.9	69.5	66.4	35.0	23.4	22.6	26.3	68.0	86.9	15.8	3.1	8.2	27.7	3.4	4.6	5.0	1.2	5.4	4.9	3.6	3.1	4.7	2.4	4.0	3.0	6.6	1.6	3.6	3.3	3.8	2.2	29.3	24.0	1.9	9.3	8.5	6.5	8.3	0.9	19.4	0.7	157.1	115.4	272.8	3.6	138.8	35.8	111.5	12.7	347.8	30.6	164.4	180.0	114.1	80.1	36.5	103.0	12.5	173.1	156.5	159.6	185.9	20.5	1.5	122.6	131.7	68.9	99.7	274.3	6.9	14.9	685.3	200.3	121.8	262.3	46.9	133.9	61.1	65.5	372.6	30.3	22.2	111.6	20.3	124.4	67.7	7.7	99.4	188.9	83.6	9.4	44.2	51.9	55.6	1.0	1.3	23.1	97.7	60.9	619.4	46.6	88.8	121.0	27.4	52.5	98.6	107.9	179.1	1.8	20.8	200.8	33.8	269.3	291.8	272.9	112.6	38.4
CIZ1	"LSFR1, ZNF356"	ENSG00000148337	"CDKN1A interacting zinc finger protein 1"	Q9ULV3	9	128161251-128204383	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020380, HPA020387"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020380: , HPA020387: AB_2670425"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.13e-3)"	"unprognostic (8.05e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.47e-3)"	57.7	38.9	36.1	28.5	37.1	55.3	48.3	36.5	46.4	60.1	19.7	68.4	34.5	53.5	24.4	46.3	47.6	33.9	46.0	36.4	33.8	31.8	21.4	38.0	35.1	35.9	31.4	69.9	70.7	35.0	33.8	28.0	34.2	40.8	26.7	26.9	44.6	33.6	90.4	65.8	41.9	36.9	26.8	35.5	51.3	56.4	36.4	35.3	37.0	42.5	29.5	57.8	50.0	40.9	72.2	85.5	70.7	67.5	71.8	85.6	69.9	55.6	82.2	99.5	56.1	79.1	60.4	84.1	46.1	93.7	82.0	102.1	55.3	59.4	53.9	76.7	64.2	80.2	106.7	51.2	82.5	75.1	91.0	83.7	104.5	109.1	91.9	71.7	68.1	52.9	199.0	70.4	60.5	169.6	98.2	76.1	61.6	96.2	87.4	83.4	74.8	86.5	45.0	48.7	88.4	68.5	123.3	85.8	73.7	31.5	89.7	96.4	72.9	105.7	74.4	120.4	105.6	81.3	99.1	80.2	74.4	49.9	115.1	2.6	2.2	2.6	2.4	3.1	2.2	2.7	2.9	3.1	2.4	3.9	3.0	2.6	0.5	4.9	2.3	2.4	4.8	1.9	36.1	37.1	36.5	46.4	36.4	33.8	35.9	31.4	34.2	26.8	36.4	40.9	15.4	3.2	12.9	14.0	19.4	23.2	23.2	12.3	21.6	25.9	16.7	17.0	10.8	18.6	11.7	18.4	29.2	23.3	23.6	20.8	13.7	26.0	77.3	10.1	19.9	18.7	22.8	31.5	20.6	44.7	28.8	22.6	25.0	14.8	9.5	25.3	18.5	6.1	22.6	16.8	19.3	19.1	16.2	20.7	18.2	79.2	34.8	17.7	19.6	19.7	19.1	19.6	16.5	11.6	15.9	28.0	15.6	31.2	25.5	15.4	31.6	18.0	8.4	25.0	13.1	23.9	19.1	37.5	26.0	23.8	24.9	20.8	18.2	15.7	25.4	20.0
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979251	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 651.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.37e-1)"	59.0	31.9	15.0	33.6	15.8	117.7	67.8	16.4	19.8	44.3	15.0	49.4	40.8	35.0	36.8	61.6	40.9	22.2	35.5	15.4	16.2	37.9	73.3	29.0	71.3	17.5	15.8	31.7	22.4	35.5	18.4	50.6	17.7	26.1	50.5	6.0	28.4	32.9	14.5	51.2	44.3	34.8	17.4	37.0	35.5	48.6	15.7	88.7	30.1	23.5	74.1	30.1	42.6	18.8	459.2	616.5	455.9	245.3	66.9	68.1	361.4	209.1	166.8	463.4	367.8	599.9	653.4	433.8	345.9	143.2	251.2	410.6	468.0	305.2	428.7	392.9	293.9	294.6	249.9	426.5	19.4	359.7	257.9	39.8	132.2	391.4	532.8	91.5	232.5	298.2	486.6	566.8	353.9	452.8	337.3	273.9	575.3	442.1	547.6	334.8	373.6	554.3	165.6	164.2	184.3	463.9	313.6	292.0	347.3	530.2	391.6	492.9	126.0	282.5	292.4	237.0	505.3	348.9	734.7	617.0	179.6	300.1	399.8	2.2	13.0	6.9	19.8	82.0	24.4	74.2	28.0	27.1	22.1	70.4	34.0	32.8	1.7	28.7	105.4	92.6	33.3	28.1	15.0	15.8	16.4	19.8	15.4	16.2	17.5	15.8	17.7	17.4	15.7	18.8	31.7	12.8	33.3	1.3	46.5	217.6	101.3	170.6	74.0	3.4	90.6	140.5	9.2	87.2	63.1	29.5	0.0	224.0	40.7	48.3	80.3	93.0	15.8	43.1	24.6	51.9	20.4	140.1	0.8	112.1	651.8	84.6	20.9	28.3	21.0	66.7	29.6	89.8	132.1	1.7	0.8	57.4	120.1	46.0	121.0	21.7	76.1	37.4	113.8	0.0	41.3	20.7	20.6	0.5	3.5	119.0	41.7	45.9	38.4	130.2	63.1	87.5	52.1	3.0	19.7	50.6	53.0	124.7	151.0	74.9	203.6	131.9	40.7	27.2	80.0	99.5
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311195-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 177.3;testis: 186.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 474.6;Spermatocytes: 692.7;Spermatogonia: 503.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 187.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	13.6	82.9	9.6	38.5	10.0	177.3	20.1	11.9	26.9	10.1	11.8	44.1	43.3	13.0	8.8	53.2	12.1	18.7	10.3	12.7	10.3	35.6	31.2	24.0	102.8	10.5	10.1	9.4	4.2	19.8	4.8	44.3	11.0	15.0	41.0	27.9	10.8	17.8	9.4	19.9	33.1	17.6	10.6	32.6	20.4	186.3	10.8	121.1	12.8	4.8	84.7	26.5	19.9	11.3	685.9	570.1	342.6	230.6	98.7	89.1	249.5	396.1	211.4	428.1	340.0	236.1	328.6	504.9	228.4	149.1	761.4	466.5	415.5	305.1	488.2	398.1	335.5	257.5	378.9	637.5	42.4	531.7	281.2	33.0	69.2	307.2	269.1	162.9	403.2	409.1	313.2	430.6	556.0	509.1	420.7	928.3	501.6	795.5	521.5	358.4	376.4	303.7	342.8	153.5	288.4	171.7	328.7	314.9	324.5	318.4	379.7	304.2	231.4	184.1	350.3	449.6	588.2	345.9	759.2	415.3	271.3	303.1	268.5	40.8	19.5	44.1	22.6	26.5	25.3	61.3	30.4	21.9	22.5	44.7	16.3	21.8	14.5	40.9	14.8	187.9	62.7	23.6	9.6	10.0	11.9	26.9	12.7	10.3	10.5	10.1	11.0	10.6	10.8	11.3	138.6	38.5	103.9	0.3	175.7	280.2	92.1	126.1	259.0	4.1	107.2	169.0	61.3	5.7	49.9	14.7	0.0	231.1	201.1	79.4	23.5	20.1	37.3	149.7	66.4	66.1	122.3	266.9	1.2	11.2	379.4	63.1	74.9	250.2	145.0	144.7	29.3	25.0	184.6	0.0	1.9	164.9	111.9	40.5	474.6	77.0	25.7	164.3	140.5	1.9	31.0	26.1	28.8	1.0	1.1	31.1	67.1	16.6	89.3	72.1	37.6	209.7	32.8	7.3	46.0	75.2	206.5	692.7	503.6	197.5	299.1	199.5	156.0	70.3	162.7	102.1
CLASRP	"CLASP, SFRS16, SWAP2"	ENSG00000104859	"CLK4 associating serine/arginine rich protein"	Q8N2M8	19	45039045-45070956	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060469, HPA062455"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA060469: AB_2684289, HPA062455: AB_2684770"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.69e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.02e-5)"	12.0	8.7	6.3	6.4	7.5	19.5	12.3	6.3	11.2	12.7	3.9	12.7	6.9	12.5	2.6	14.0	13.8	2.8	9.0	6.4	7.0	9.8	11.1	12.0	7.5	9.1	8.6	15.6	15.6	4.6	13.4	4.1	9.2	13.2	3.2	2.6	11.1	4.3	12.3	15.2	13.3	4.0	7.7	14.1	13.4	14.6	8.5	6.2	13.1	3.1	5.4	11.3	12.5	11.7	18.5	25.8	10.4	7.7	3.3	5.1	23.0	15.7	5.8	11.6	11.7	12.2	17.1	28.7	11.7	6.1	4.6	19.9	15.7	11.7	5.1	14.5	23.8	17.0	15.0	15.3	7.6	11.4	22.4	6.5	6.4	7.9	13.9	5.6	8.0	19.0	27.6	15.9	4.1	18.6	30.9	38.2	14.4	11.9	14.8	24.4	11.6	22.0	7.9	18.2	12.0	18.6	12.6	11.9	12.3	5.6	15.2	24.9	12.3	11.5	14.4	9.7	24.0	23.1	20.0	25.3	8.0	18.4	9.6	0.4	2.2	3.7	2.3	1.7	2.0	4.0	1.4	2.4	2.0	3.4	1.9	1.7	5.5	1.8	2.0	3.2	1.1	1.4	6.3	7.5	6.3	11.2	6.4	7.0	9.1	8.6	9.2	7.7	8.5	11.7	16.1	3.2	3.2	28.1	39.0	23.3	25.5	19.5	46.1	25.3	22.7	16.9	4.7	18.6	10.9	16.5	16.7	24.3	24.7	31.7	5.9	12.2	19.2	12.2	16.0	14.6	9.6	17.5	25.2	15.1	32.9	16.9	67.2	18.7	12.7	22.9	15.4	15.0	17.4	20.2	21.5	27.1	14.2	18.5	21.7	10.2	21.8	21.2	3.6	18.7	19.6	19.7	15.5	13.0	65.1	15.0	40.0	17.7	35.0	25.2	30.6	7.0	8.5	29.6	32.9	21.1	18.5	76.7	33.9	29.8	21.6	36.3	20.9	17.6	25.6	21.6
CLBA1	C14orf79	ENSG00000140104	"Clathrin binding box of aftiphilin containing 1"	Q96F83	14	104985775-105010482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Endometrial ciliated cells: 29.9;Respiratory ciliated cells: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042052, HPA061117"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA042052: AB_2677822, HPA061117: AB_2684434"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	3.6	7.8	5.7	1.3	6.0	1.6	5.8	3.7	6.4	8.0	11.1	5.6	1.7	7.6	11.5	7.8	14.9	3.4	3.0	6.2	7.5	15.9	6.9	5.8	1.5	5.5	6.5	7.1	14.4	9.3	21.7	1.8	4.4	9.6	2.6	3.1	8.1	6.1	1.8	7.6	3.1	3.3	5.0	3.2	5.9	23.9	7.0	1.3	18.2	1.2	1.2	6.0	5.4	4.2	5.1	8.9	2.7	8.3	2.6	3.8	4.1	4.0	3.7	4.7	2.1	0.8	8.7	0.5	8.3	4.0	2.5	10.9	1.0	6.0	3.0	4.2	3.2	0.3	8.9	0.4	9.2	2.3	2.2	2.3	13.6	5.1	10.1	8.0	2.7	4.2	3.1	1.4	2.8	17.5	0.9	6.6	3.4	5.0	8.5	3.2	1.5	2.9	10.4	2.9	17.1	8.9	5.7	2.5	5.0	1.7	18.0	3.1	3.0	5.9	2.7	12.0	3.1	1.6	1.1	0.5	7.6	0.7	4.2	0.4	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.1	0.1	5.7	6.0	3.7	6.4	6.2	7.5	5.5	6.5	4.4	5.0	7.0	4.2	1.0	16.0	3.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	7.4	7.4	0.0	0.0	2.5	16.5	0.0	1.8	0.4	0.0	3.9	7.9	0.0	29.9	8.1	0.9	0.0	0.0	0.0	1.3	0.8	1.3	0.0	8.8	2.5	3.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	6.5	19.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.4	6.5	0.0	0.0
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424171-86456553	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 117.5;skin 1: 88.7;vagina: 53.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 47.4;Basal respiratory cells: 57.5;Basal squamous epithelial cells: 39.9;Club cells: 37.1;Early spermatids: 30.2;Squamous epithelial cells: 167.1;Suprabasal keratinocytes: 54.8;Urothelial cells: 52.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 146.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"hTCEpi: 210.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		96000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.8	0.1	0.2	0.1	0.6	0.0	4.6	0.4	0.5	22.8	0.1	0.6	0.2	0.0	0.5	117.5	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.7	0.4	2.4	0.7	0.0	13.2	0.2	0.2	88.7	0.8	0.0	0.4	0.0	0.1	0.6	0.3	1.0	0.0	0.0	26.0	21.2	53.1	1.0	0.0	0.0	0.0	0.0	0.6	3.0	38.9	1.7	2.7	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	0.0	33.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	210.8	1.0	10.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.9	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.4	0.5	0.2	0.3	0.4	0.3	0.4	0.4	0.3	1.0	0.0	0.0	0.0	0.7	0.0	47.4	13.1	57.5	39.9	0.0	7.7	2.8	0.4	0.0	37.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.3	4.1	0.0	3.1	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	2.5	2.1	0.3	0.0	8.0	0.0	0.0	0.0	0.6	0.2	0.0	167.1	54.8	0.1	0.5	0.0	0.1	52.9
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 373.9;intestine: 257.8"	"Group enriched"	"Detected in many"	6	"Distal enterocytes: 597.0;Paneth cells: 183.2;Squamous epithelial cells: 158.7;Urothelial cells: 176.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4;urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	1368	"RT4: 430.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	NA	NA		150000		"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Aggresome"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.6	0.0	6.3	13.9	9.4	0.0	2.2	6.7	8.0	44.6	3.2	257.8	0.1	0.1	0.1	373.9	0.2	0.2	0.1	6.2	6.6	0.1	0.1	0.0	0.0	10.9	7.0	0.0	0.1	0.0	0.5	0.0	8.7	2.5	143.5	0.0	23.1	0.2	0.1	17.1	29.1	2.9	7.1	0.1	0.6	0.3	8.0	0.1	0.0	0.0	30.1	99.3	66.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	430.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.4	6.7	8.0	6.2	6.6	10.9	7.0	8.7	7.1	8.0	12.7	0.1	0.0	0.0	0.0	2.9	3.3	40.3	6.5	2.8	0.0	1.9	1.8	0.4	0.0	17.5	1.8	0.0	0.0	0.2	597.0	0.0	0.0	0.4	7.3	0.1	0.3	8.3	0.0	0.1	0.0	0.0	0.4	0.0	3.5	8.9	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	183.2	0.0	1.2	9.7	4.7	0.0	1.9	0.0	0.0	0.0	0.4	0.1	0.0	158.7	11.9	0.0	1.5	0.0	12.0	176.9
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 114.7;gallbladder: 101.6;kidney: 165.2;seminal vesicle: 90.1"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 77.5;Exocrine glandular cells: 49.1;Hepatocytes: 25.9;Pancreatic endocrine cells: 30.9;Proximal enterocytes: 32.9;Proximal tubular cells: 153.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	5	"hippocampal formation: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 296.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;hippocampal formation: 9.5;pons and medulla: 10.3;thalamus: 8.9"	"Region enhanced"	"Detected in some"		"medulla oblongata: 1.7"	"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.7	3.0	0.1	2.2	0.1	0.1	0.6	1.6	0.5	0.0	114.7	2.1	21.0	0.1	33.7	0.1	0.3	101.6	0.0	8.4	0.0	165.2	44.2	1.3	0.0	0.2	0.2	0.0	13.2	0.0	0.2	0.0	0.1	1.2	4.5	0.7	0.1	90.1	0.2	0.3	24.5	0.2	0.0	0.0	7.7	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296.4	0.2	0.0	0.0	0.1	46.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.5	8.4	0.0	0.2	0.2	0.1	0.0	1.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	14.3	0.0	1.8	0.0	0.0	0.0	0.3	15.6	77.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	49.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.3	2.7	0.0	0.8	0.0	1.4	0.0	0.7	0.0	0.0	1.6	1.6	0.0	1.0	0.2	30.9	3.6	0.0	0.0	0.0	32.9	153.1	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.2	0.0
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"brain: 1093.8;choroid plexus: 316.7"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 575.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	53.6	42.6	477.0	40.7	757.5	49.1	48.8	696.1	804.5	59.0	316.7	58.3	36.5	58.8	43.1	77.8	46.7	50.6	57.6	483.5	577.6	39.2	50.0	46.9	54.7	851.3	670.8	63.9	23.6	32.6	28.2	73.8	837.8	49.5	46.9	46.5	29.8	51.9	43.6	64.8	42.2	63.5	643.7	44.0	37.4	106.6	638.3	44.7	40.5	68.9	54.9	64.0	65.8	1093.8	67.3	26.2	83.2	50.7	96.0	75.0	44.6	52.0	69.8	71.0	97.8	52.7	66.9	33.7	69.1	49.4	134.3	90.4	61.6	39.9	124.3	79.3	27.5	68.3	18.6	48.1	76.2	62.7	67.3	88.4	207.6	54.0	58.7	77.6	79.1	64.7	35.4	100.6	102.9	33.4	47.8	42.8	75.1	28.7	55.9	31.9	110.6	43.4	67.7	30.0	30.1	82.6	74.6	24.4	108.5	110.5	24.5	52.8	75.1	94.6	86.2	65.3	69.3	130.8	59.8	53.9	154.9	61.0	125.2	179.8	91.0	103.9	102.1	55.4	193.5	101.5	190.3	187.1	98.9	99.3	76.6	78.1	70.2	274.0	56.7	63.9	399.7	155.1	477.0	757.5	696.1	804.5	483.5	577.6	851.3	670.8	837.8	643.7	638.3	1093.8	83.3	35.3	36.6	17.9	72.1	144.0	131.7	122.3	87.0	20.1	43.6	45.3	53.8	17.2	71.4	27.6	25.0	52.0	72.8	16.9	29.4	21.2	105.3	21.1	47.7	70.8	28.7	65.4	25.1	16.2	160.6	86.6	30.1	41.7	36.8	25.2	61.4	19.4	35.6	15.2	23.6	19.6	89.5	29.2	168.1	76.7	51.6	46.9	113.8	20.6	42.3	28.1	38.1	30.7	575.2	30.3	16.8	46.6	131.7	98.1	34.6	23.3	27.5	35.0	52.6	53.2	128.4	182.4	55.3	90.1	196.5	95.8	147.1	22.8	17.5	121.9
CLDND2	MGC33839	ENSG00000160318	"Claudin domain containing 2"	Q8NHS1	19	51367098-51369003	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.9"	"Cell type enriched"	"Detected in many"	9	"Early spermatids: 344.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056971	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA056971: AB_2683294"	"unprognostic (2.86e-1)"	"unprognostic (4.29e-5)"	"unprognostic (2.29e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-9)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.70e-2)"	4.9	4.6	9.4	1.9	8.8	9.7	4.1	9.8	12.2	3.9	7.6	4.6	4.5	2.7	0.1	2.6	3.7	1.6	3.3	9.7	9.9	4.3	4.7	3.2	2.0	9.6	9.2	4.4	5.3	1.0	3.4	0.9	9.7	4.3	1.2	1.8	4.3	1.4	2.4	2.0	4.3	0.6	8.4	6.6	2.9	44.9	9.4	1.0	3.5	2.6	0.5	4.8	3.3	9.5	2.0	5.5	2.0	2.7	2.8	2.5	1.1	0.9	0.4	0.9	1.2	0.6	6.4	5.1	1.1	0.5	0.6	2.5	0.6	0.3	0.2	3.6	8.6	4.5	9.1	11.0	1.1	1.3	1.3	1.9	0.9	0.2	0.5	1.3	0.6	2.5	3.0	3.7	0.8	1.2	1.1	7.5	0.8	5.6	6.9	1.0	4.5	2.1	1.5	1.4	1.1	1.3	2.3	0.5	1.8	1.0	1.4	0.3	1.2	1.9	3.9	2.0	0.8	3.4	3.9	2.0	4.7	5.1	1.2	3.0	0.4	2.1	1.7	1.0	0.9	0.8	0.4	2.2	0.7	0.4	0.3	0.7	0.2	2.9	0.4	1.5	0.6	0.3	9.4	8.8	9.8	12.2	9.7	9.9	9.6	9.2	9.7	8.4	9.4	9.5	4.3	0.0	3.7	8.5	3.1	1.7	5.6	1.3	5.7	5.4	7.8	8.3	6.9	12.8	1.2	16.5	0.0	1.8	8.1	4.9	3.9	1.0	344.4	0.9	3.0	2.4	10.3	8.2	2.1	0.7	1.7	3.4	6.6	1.5	15.8	1.8	5.3	17.4	2.6	3.3	4.3	16.8	4.1	4.1	4.0	36.1	6.2	3.7	1.8	4.7	2.4	2.5	9.2	0.5	3.2	0.7	5.8	6.4	3.7	3.4	13.3	5.5	6.0	2.3	0.0	5.4	5.4	23.5	1.3	7.5	2.7	0.8	4.4	1.4	12.3	5.5
CLEC16A	"Gop-1, KIAA0350"	ENSG00000038532	"C-type lectin domain containing 16A"	Q2KHT3	16	10944564-11182186	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 130.9;Early spermatids: 118.7;Excitatory neurons: 93.3;Inhibitory neurons: 135.1;Late spermatids: 84.8;Oligodendrocyte precursor cells: 69.4;Oligodendrocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HDLM-2: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035814, HPA035815, HPA061385"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 43: Testis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: AB_2684498"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.92e-6)"	"unprognostic (2.69e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.03e-1)"	10.2	12.8	12.1	7.2	13.4	13.2	9.4	16.7	17.3	11.2	23.6	9.5	8.2	9.0	6.9	13.9	9.4	4.8	14.6	11.3	11.1	16.6	16.2	12.8	9.3	13.8	14.5	8.2	8.9	11.7	17.3	7.0	13.8	11.3	5.9	11.5	9.1	5.7	17.5	14.2	10.8	6.2	9.7	12.4	10.4	46.8	21.0	10.9	13.3	8.3	8.8	9.1	10.4	11.7	11.6	12.1	9.0	11.9	14.8	10.3	8.0	11.7	11.4	9.6	12.5	13.5	21.1	22.8	26.6	14.3	10.6	10.1	11.6	21.7	12.3	110.3	12.5	10.4	16.4	14.4	10.4	11.5	21.5	12.3	10.4	15.9	13.4	8.8	13.3	12.4	17.6	13.8	11.5	19.0	18.2	9.1	7.2	10.0	9.5	24.6	7.6	13.5	20.1	8.4	11.5	15.3	16.8	17.1	9.1	10.4	12.1	17.7	14.2	12.4	16.1	18.3	10.4	9.7	9.2	18.7	15.5	16.4	13.1	2.7	1.9	1.4	2.2	1.5	1.3	1.7	1.8	1.5	1.5	2.8	2.1	1.8	2.6	1.8	3.0	2.0	1.4	1.1	12.1	13.4	16.7	17.3	11.3	11.1	13.8	14.5	13.8	9.7	21.0	11.7	7.1	16.0	10.0	130.9	12.8	7.1	3.7	5.9	11.4	11.7	5.2	5.1	5.9	8.6	8.8	3.7	37.5	3.4	5.5	12.1	0.0	6.0	118.7	7.5	6.0	6.1	7.7	8.6	93.3	6.4	2.6	6.2	9.2	8.0	8.2	5.7	9.7	12.6	4.8	11.8	135.1	7.9	6.1	5.4	6.2	84.8	5.6	6.8	3.6	40.3	8.6	3.9	4.1	69.4	72.9	6.5	4.0	8.6	8.8	3.5	10.3	3.5	8.9	18.3	0.0	7.4	4.5	27.1	8.4	13.4	8.2	3.8	8.6	3.3	6.7	4.9
CLIC2	"CLCNL2, XAP121"	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.2;Alveolar cells type 1: 89.8;Alveolar cells type 2: 54.9;Endothelial cells: 60.4;Erythroid cells: 70.7;Kupffer cells: 73.5;Langerhans cells: 135.0;monocytes: 71.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 18.6;myeloid DC: 47.9;non-classical monocyte: 14.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 47.9;monocytes: 18.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 103.3;K-562: 60.4;Karpas-707: 53.4;RPMI-8226: 92.2"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	23.1	7.1	6.9	16.7	7.8	9.8	16.7	6.9	18.1	20.1	7.6	10.9	8.7	22.6	7.8	9.4	12.5	19.0	14.6	7.1	7.0	5.8	12.8	30.6	30.2	7.7	6.9	21.6	3.5	4.6	4.5	9.3	7.4	4.6	13.6	2.4	6.2	6.3	4.4	6.1	10.3	17.7	7.7	50.1	8.5	3.2	8.5	14.5	31.8	14.3	25.6	15.9	10.7	7.8	0.7	0.0	1.0	0.9	1.0	4.7	0.0	0.2	2.8	0.0	0.4	0.0	0.2	0.1	0.4	0.0	0.2	0.1	0.3	0.0	0.0	103.3	0.5	16.4	0.3	0.0	0.0	0.4	0.6	1.4	0.0	0.0	0.1	0.5	0.1	0.5	60.4	53.4	0.3	0.2	0.1	1.3	0.2	0.1	0.4	0.4	0.0	92.2	0.2	0.2	0.7	0.9	0.0	0.1	0.4	0.2	0.0	1.0	0.0	5.3	1.6	2.0	0.9	3.3	4.6	0.0	2.7	2.6	1.7	0.0	3.5	0.2	0.0	18.6	0.3	0.0	0.1	0.1	47.9	0.0	0.0	0.0	1.4	2.0	14.2	5.2	0.0	2.1	6.9	7.8	6.9	18.1	7.1	7.0	7.7	6.9	7.4	7.7	8.5	7.8	51.2	89.8	54.9	3.9	1.1	13.3	0.8	0.2	2.2	1.2	0.7	1.3	3.2	0.0	5.8	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.5	11.3	60.4	1.2	70.7	8.6	0.2	0.1	25.6	0.5	0.4	3.8	0.5	27.1	1.2	4.7	0.0	7.0	0.6	0.0	73.5	135.0	1.1	13.7	34.5	17.8	8.4	71.4	0.2	0.0	3.0	2.4	0.1	0.0	9.4	2.0	0.5	0.0	0.6	1.5	0.3	6.6	2.5	4.6	0.3	0.3	0.4	13.8	0.0	2.6	5.2	0.1	1.9
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859145	"Plasma proteins, Predicted intracellular proteins, Transporters"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 749.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 749.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		540000	"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.56e-1)"	28.6	34.4	10.3	42.8	11.9	101.1	31.4	10.6	14.8	36.4	17.7	53.9	68.3	26.4	54.2	72.0	37.8	61.4	34.2	11.8	12.7	70.4	89.5	36.3	49.4	11.8	11.9	26.9	49.3	113.2	17.8	47.1	11.4	29.5	53.4	16.0	50.8	42.4	53.1	39.7	55.7	31.9	11.0	31.0	69.2	20.3	12.4	50.7	56.0	41.0	73.8	64.5	38.8	11.4	65.6	91.7	64.3	59.8	86.3	71.0	91.6	89.7	87.5	83.4	115.9	128.7	100.0	121.3	100.3	82.6	112.0	95.8	87.1	100.4	120.7	57.9	70.4	80.6	80.4	65.2	85.5	112.9	105.6	52.5	75.6	94.7	105.6	53.6	80.0	69.6	70.6	66.1	69.9	56.7	88.7	60.5	67.8	63.6	93.9	78.8	96.9	103.0	84.8	115.4	56.6	62.1	64.5	111.7	87.4	81.2	76.4	78.0	83.7	74.6	56.3	69.5	89.4	76.1	77.9	154.4	61.0	126.2	67.5	749.5	46.5	179.7	43.6	49.2	75.2	47.5	41.4	43.7	62.7	46.2	35.9	38.8	17.6	58.6	53.4	48.5	66.2	53.1	10.3	11.9	10.6	14.8	11.8	12.7	11.8	11.9	11.4	11.0	12.4	11.4	68.6	60.9	132.9	25.1	76.0	57.1	83.7	69.4	80.2	21.6	74.4	44.2	103.9	105.8	137.8	68.0	8.4	45.1	73.8	73.5	95.9	93.4	4.1	116.5	82.4	52.8	54.5	54.9	31.9	64.0	71.9	71.8	119.3	141.9	84.7	40.2	21.0	86.8	30.5	11.8	29.0	78.9	38.7	42.9	87.8	5.6	47.2	73.0	35.6	28.1	94.1	25.5	73.2	39.2	31.4	53.7	62.6	28.6	158.3	92.5	50.3	94.5	148.5	19.0	39.5	67.2	61.9	44.2	40.2	156.3	78.3	68.3	65.5	82.0	99.0	271.5
CLK1		ENSG00000013441	"CDC like kinase 1"	P49759	2	200853009-200864744	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033141, HPA062405"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear membrane"		"CAB033141: AB_1121713, HPA062405: AB_2684753"	"unprognostic (9.79e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.19e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (2.28e-4)"	89.6	82.7	132.9	25.4	137.1	178.0	72.2	140.9	201.6	118.5	136.2	78.3	20.8	65.8	51.1	58.5	85.5	56.5	83.9	133.9	137.7	83.3	84.4	90.3	55.9	138.1	133.4	140.3	63.6	29.0	82.3	64.8	138.6	109.7	24.2	133.8	68.9	49.6	80.4	62.5	51.6	30.9	135.2	113.0	53.2	28.1	134.1	76.0	92.5	71.4	42.0	77.8	112.8	176.0	17.9	13.5	22.6	6.5	24.4	26.1	17.1	19.2	26.8	19.3	25.5	24.6	11.8	5.5	13.1	11.4	11.1	19.7	27.9	8.8	38.2	27.3	24.0	18.1	35.9	30.7	14.7	19.5	31.1	12.3	39.9	23.4	41.8	20.6	11.4	9.5	23.3	77.1	27.0	12.3	23.0	58.4	13.9	11.4	29.8	24.8	25.7	31.8	13.0	11.2	22.0	17.8	16.4	6.1	32.7	12.9	5.3	13.2	19.5	21.4	14.8	21.5	22.0	46.8	20.9	13.7	14.2	15.4	14.9	40.0	7.2	18.6	14.5	5.0	17.3	17.4	15.7	15.8	4.8	11.7	15.6	12.9	16.9	9.5	6.0	11.1	17.2	10.4	132.9	137.1	140.9	201.6	133.9	137.7	138.1	133.4	138.6	135.2	134.1	176.0	122.1	44.8	85.4	112.0	164.2	168.8	263.0	73.6	114.4	59.0	112.9	97.0	96.6	41.5	87.1	27.6	100.1	46.7	213.5	110.9	19.6	31.4	2.3	111.2	108.8	113.6	134.3	87.5	51.7	26.9	56.6	142.5	81.1	173.6	136.9	77.9	82.1	43.3	58.5	52.2	53.6	124.2	50.8	100.5	285.8	9.4	92.9	192.3	154.7	62.8	56.2	54.6	76.2	58.3	169.0	32.0	117.7	75.6	169.0	133.3	88.2	14.9	70.1	99.6	111.7	97.8	128.4	33.1	27.7	117.0	151.7	90.3	261.2	43.0	88.6	184.2
CLK2		ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nuclear bodies"	"HPA055366: AB_2682795, HPA059507: AB_2684044"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.43e-4)"	23.7	25.6	11.6	10.7	11.9	11.4	24.4	14.2	14.4	39.2	14.1	24.1	11.7	29.8	12.7	22.6	28.7	9.6	18.5	11.7	12.7	26.8	29.0	22.0	19.6	12.3	11.7	33.9	23.9	14.0	31.4	13.8	12.4	33.1	8.7	9.4	23.3	11.2	16.2	27.5	24.0	10.9	11.7	40.1	20.8	16.2	12.4	18.6	33.2	8.5	15.9	28.1	29.9	13.2	10.8	10.5	29.8	11.4	17.3	9.1	22.5	8.1	12.3	8.2	7.8	13.1	8.7	23.3	9.7	6.6	4.0	17.0	16.8	13.5	6.3	11.4	17.7	20.4	12.9	15.4	14.6	26.8	20.5	7.6	10.7	11.3	20.3	19.0	13.6	16.9	29.6	15.4	10.5	22.2	12.1	11.3	21.2	27.2	17.6	17.7	21.6	28.0	17.9	25.8	11.8	25.1	4.5	10.9	9.9	21.4	15.9	24.9	9.3	4.3	12.1	9.1	9.1	31.6	28.6	22.9	9.9	19.1	5.9	0.5	0.8	1.9	0.8	0.4	1.6	1.2	1.5	0.8	0.9	0.9	1.6	1.6	0.8	0.5	0.4	0.8	0.9	0.6	11.6	11.9	14.2	14.4	11.7	12.7	12.3	11.7	12.4	11.7	12.4	13.2	9.2	16.0	24.3	9.8	13.7	4.6	5.7	4.2	17.6	5.7	7.8	7.5	14.9	12.8	12.6	7.3	4.2	8.0	7.1	5.4	0.0	6.5	6.5	6.9	15.2	11.1	6.7	8.4	8.3	4.4	8.0	11.3	25.0	9.5	10.1	12.1	7.5	8.4	6.9	5.0	6.8	9.1	2.0	11.4	4.5	6.6	7.8	10.4	3.6	9.4	9.5	5.4	8.2	9.5	8.0	4.9	4.8	3.0	17.1	5.7	5.1	3.2	5.1	7.2	6.6	6.4	12.6	8.6	4.3	14.3	4.5	12.4	11.0	7.4	7.2	5.1
CLK3		ENSG00000179335	"CDC like kinase 3"	P49761	15	74598500-74645414	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046817	Approved		Supported	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA046817: AB_10964124"	"unprognostic (4.10e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (2.05e-6)"	"unprognostic (1.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.14e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-2)"	35.9	28.7	30.3	26.5	31.8	112.4	34.6	36.4	35.9	36.7	32.8	36.6	28.9	32.3	25.9	38.6	31.3	32.7	28.3	30.2	31.2	30.0	29.4	34.0	37.7	32.8	31.6	38.4	33.9	35.3	32.3	31.6	32.5	31.9	21.8	33.1	36.1	29.7	50.7	41.7	33.7	26.2	29.5	41.7	35.1	44.4	32.2	55.8	32.3	52.1	30.3	37.8	33.8	35.4	56.7	35.1	45.5	25.6	57.2	43.4	35.8	37.7	59.2	52.7	64.3	47.9	36.4	51.2	27.2	33.9	73.5	39.0	85.4	36.3	34.3	73.2	46.9	63.0	52.0	33.6	90.7	17.2	46.6	54.8	71.0	69.4	57.4	64.0	58.6	51.0	31.3	36.2	31.1	39.9	50.9	57.3	29.1	55.7	24.6	40.7	21.8	33.7	41.1	40.3	25.5	29.9	30.2	33.0	34.3	34.7	31.4	33.8	27.3	31.0	23.7	19.7	50.2	59.0	51.8	42.2	27.2	82.4	40.1	74.2	65.5	90.0	68.9	74.1	68.2	71.0	73.6	71.9	61.3	78.8	74.4	70.9	115.9	90.7	97.7	69.5	87.7	85.9	30.3	31.8	36.4	35.9	30.2	31.2	32.8	31.6	32.5	29.5	32.2	35.4	29.8	6.4	38.4	14.0	34.1	44.9	44.9	41.6	26.2	35.5	22.8	15.9	18.6	28.6	35.1	12.9	56.3	27.7	41.8	46.7	31.3	34.2	83.6	25.8	19.9	28.6	29.3	31.5	6.6	24.2	46.2	24.5	37.8	41.5	21.5	27.4	21.4	13.4	27.5	28.6	7.9	34.7	42.7	23.3	34.4	19.8	27.7	28.4	28.4	6.5	29.5	18.0	29.9	7.1	9.6	30.8	52.0	20.3	26.6	38.9	35.5	18.6	23.4	42.6	13.1	20.4	35.8	45.4	21.4	21.0	41.9	58.6	40.1	20.4	28.1	63.5
CLNS1A	"CLCI, ICln"	ENSG00000074201	"Chloride nucleotide-sensitive channel 1A"	P54105	11	77514936-77637794	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017840, HPA031707, HPA031708, HPA032045"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol		No	No		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nucleoplasm, Microtubules"	"CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123"	"unprognostic (1.30e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.12e-3)"	"unprognostic (5.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	53.1	88.7	86.1	63.1	91.8	72.3	79.9	89.3	92.7	62.2	82.0	72.7	49.7	63.5	99.6	85.3	74.8	53.2	76.4	79.9	94.1	59.6	105.6	45.7	99.5	88.0	86.6	103.3	90.0	60.2	54.0	65.6	89.8	61.2	77.5	97.0	58.2	57.5	98.4	54.0	53.6	56.8	90.5	61.9	65.7	45.7	87.9	102.8	79.0	100.7	105.4	74.6	61.0	94.8	138.4	134.7	216.6	160.7	157.1	224.8	86.8	119.1	181.3	189.0	168.9	326.5	190.0	308.6	194.5	144.6	148.1	162.8	263.0	245.6	227.2	178.6	160.1	301.9	161.7	188.8	132.5	451.8	134.1	182.9	278.9	165.9	311.7	185.5	217.4	187.1	404.8	91.9	186.6	205.0	299.2	364.5	205.7	458.8	243.9	161.5	419.8	332.7	136.7	191.9	219.0	250.1	158.2	177.7	112.1	155.2	241.8	195.8	144.4	138.7	171.2	274.4	116.8	184.3	276.6	330.1	55.0	166.9	114.4	48.1	100.6	39.1	61.1	107.1	68.9	96.5	76.1	66.3	138.7	99.5	91.1	77.8	7.1	101.2	93.6	85.3	72.8	105.7	86.1	91.8	89.3	92.7	79.9	94.1	88.0	86.6	89.8	90.5	87.9	94.8	47.9	16.0	20.3	14.7	91.6	82.7	107.0	248.2	116.7	67.2	75.4	78.6	71.6	71.4	102.6	58.8	50.1	132.9	70.0	27.4	84.1	76.4	17.0	45.1	57.4	53.1	31.8	123.6	21.7	87.5	145.9	72.5	43.8	34.5	78.0	117.0	57.5	62.2	91.1	58.9	24.3	65.3	87.5	108.7	99.3	13.6	87.7	74.9	76.5	10.3	153.8	221.9	57.7	17.6	24.9	65.4	54.3	68.4	64.8	108.2	79.3	97.6	71.6	60.3	52.6	61.8	54.5	116.0	109.4	128.0	86.1	80.6	69.2	126.7	112.5	103.9
CLOCK	"bHLHe8, KAT13D, KIAA0334"	ENSG00000134852	"Clock circadian regulator"	O15516	4	55427903-55546909	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001867, HPA027565"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA001867: AB_1078537, HPA027565: AB_1846975"	"unprognostic (1.30e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-2)"	5.5	6.1	3.7	4.2	4.2	1.3	5.9	8.9	5.4	8.0	5.5	5.1	4.9	6.9	5.7	9.2	5.3	4.3	7.5	4.7	5.3	6.5	5.5	4.6	2.9	2.8	3.7	6.2	5.1	10.3	5.5	5.5	3.3	6.2	5.7	11.6	4.6	6.1	9.8	6.8	5.6	7.1	3.8	4.5	6.9	14.1	3.8	3.0	10.1	9.2	3.7	5.6	6.8	5.0	20.0	9.1	7.5	11.6	11.8	11.5	3.6	18.7	16.4	12.9	12.7	5.1	14.8	5.1	9.9	22.8	10.3	15.9	9.5	15.4	23.2	6.9	3.1	4.4	9.4	6.7	10.3	7.0	4.7	6.7	15.8	18.8	18.7	10.4	13.1	4.6	10.1	10.1	21.3	10.6	4.0	4.1	5.0	16.3	9.4	2.5	8.7	3.3	11.0	10.9	7.6	6.2	13.5	16.7	8.9	6.2	5.7	4.2	17.1	18.4	19.5	6.0	26.6	9.1	7.5	3.1	15.6	5.8	14.6	0.0	0.7	0.2	0.7	0.7	1.3	0.4	0.9	0.8	1.1	0.7	0.4	0.6	0.2	0.9	0.7	0.5	0.9	0.4	3.7	4.2	8.9	5.4	4.7	5.3	2.8	3.7	3.3	3.8	3.8	5.0	32.2	41.7	27.7	49.3	15.2	31.1	21.8	28.5	27.9	63.4	21.5	14.9	55.2	14.3	27.4	14.7	43.8	11.3	11.9	21.5	1.9	13.6	34.5	34.2	39.9	32.1	39.7	3.8	95.9	16.5	6.8	28.0	25.0	32.0	3.8	16.6	28.9	27.7	11.6	33.7	114.6	18.5	18.3	17.0	26.1	16.9	23.9	16.9	10.6	70.3	14.0	26.7	19.6	82.0	93.1	28.3	13.2	36.1	18.5	34.0	29.6	19.7	25.2	41.4	13.1	36.5	28.2	64.9	72.5	55.1	37.5	5.2	14.0	21.7	15.6	51.6
CLP1	"hClp1, HEAB"	ENSG00000172409	"Cleavage factor polyribonucleotide kinase subunit 1"	Q92989	11	57648188-57661865	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057770	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA057770: AB_2683523"	"unprognostic (1.33e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.31e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.07e-1)"	8.9	7.4	3.1	10.1	3.6	26.1	9.2	3.9	4.4	7.1	4.4	9.0	8.7	7.7	7.6	9.2	7.3	5.9	6.5	3.3	3.3	8.0	10.1	7.3	10.8	3.3	3.1	6.8	7.4	6.8	4.4	9.2	3.7	5.6	8.6	3.2	6.7	7.1	8.2	9.0	8.4	8.9	3.4	10.0	8.1	8.4	3.3	11.2	7.2	9.3	13.1	8.6	5.0	3.7	21.2	22.2	21.0	21.6	22.3	14.4	19.7	21.4	23.2	30.1	25.8	21.4	18.4	35.1	24.3	18.9	24.2	25.9	29.2	34.5	34.2	24.3	18.0	19.4	13.5	21.7	17.7	28.5	22.2	17.4	24.0	26.9	18.6	11.9	27.7	17.4	30.4	11.9	24.9	14.8	21.8	32.9	31.8	24.3	22.2	21.7	32.1	37.5	16.5	15.0	11.1	22.3	19.1	17.2	28.7	21.7	32.7	23.2	20.0	16.0	21.7	27.7	15.9	18.6	26.4	39.3	17.3	16.3	17.3	31.2	19.0	20.0	15.9	16.4	18.9	15.6	14.1	16.4	19.0	14.3	16.4	14.9	21.7	13.6	15.9	10.8	16.2	12.3	3.1	3.6	3.9	4.4	3.3	3.3	3.3	3.1	3.7	3.4	3.3	3.7	6.1	9.6	5.1	1.0	8.5	19.4	10.7	13.4	16.5	4.3	6.0	6.2	2.4	7.2	10.5	0.0	6.2	16.5	12.7	4.8	9.8	12.9	32.5	6.7	5.7	7.3	2.4	12.2	1.9	11.7	13.9	7.4	3.1	7.1	8.2	4.9	4.2	3.5	11.0	5.0	1.8	3.2	8.2	6.0	6.9	4.1	5.6	5.8	8.8	1.0	15.0	3.3	7.2	2.5	1.4	9.8	4.7	8.6	5.9	4.7	6.2	10.1	6.4	3.1	6.6	10.4	6.9	9.4	12.0	9.3	14.5	13.5	9.7	6.5	4.6	7.8
CLPX		ENSG00000166855	"Caseinolytic mitochondrial matrix peptidase chaperone subunit X"	O76031	15	65148219-65185342	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 242.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040262, HPA048199"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA		65000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA040262: AB_10793961, HPA048199: AB_2680312"	"unprognostic (2.78e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.93e-9)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.50e-2)"	7.9	10.8	9.2	6.1	9.7	8.0	9.3	9.5	11.0	7.6	7.4	9.2	8.8	7.8	8.6	13.3	7.9	6.3	14.1	7.8	8.3	12.2	32.9	6.5	9.1	9.8	8.9	9.4	9.4	11.9	4.6	9.8	8.5	8.0	8.0	10.1	7.6	6.0	26.8	14.7	7.4	7.1	8.8	8.4	9.2	9.1	9.4	10.6	9.8	24.0	9.9	7.9	8.9	10.1	8.1	13.7	11.7	14.8	12.2	15.5	12.5	9.2	10.2	9.8	10.3	13.7	11.1	25.0	7.5	12.3	7.3	16.9	43.2	12.1	10.5	9.9	7.9	18.9	12.8	17.4	17.3	24.4	10.5	18.6	16.2	9.0	17.1	11.3	12.6	13.3	17.6	8.6	11.7	10.3	11.6	21.4	13.1	16.0	6.1	22.4	13.9	26.1	18.6	18.5	10.1	8.1	12.4	19.3	13.8	15.3	8.9	20.3	11.2	9.8	8.7	8.0	8.7	9.2	15.0	13.0	9.6	30.4	7.8	2.2	4.1	6.5	4.3	3.5	3.9	4.4	3.7	3.2	3.9	3.9	5.0	4.0	6.4	4.7	3.3	5.9	3.5	2.7	9.2	9.7	9.5	11.0	7.8	8.3	9.8	8.9	8.5	8.8	9.4	10.1	16.4	35.3	35.5	15.3	23.6	19.2	18.8	20.9	18.8	32.3	17.0	15.6	69.9	27.1	29.5	33.1	14.6	41.0	28.5	16.7	21.5	36.8	104.5	24.4	28.7	21.0	10.3	56.8	15.6	31.6	29.2	25.5	33.6	27.5	16.4	37.8	21.0	90.1	22.6	32.0	15.2	20.3	28.5	28.3	16.6	242.3	28.9	20.3	17.8	16.9	34.1	25.9	20.6	12.5	23.9	29.0	18.2	29.7	30.8	24.9	23.1	33.8	27.7	27.2	26.3	23.1	30.1	45.0	30.6	29.1	30.1	89.2	24.4	59.0	24.3	25.5
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769978	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low region specificity"	"Detected in many"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	0.5	0.2	0.7	3.2	0.6	11.3	0.5	0.6	1.4	0.2	0.4	1.4	1.0	0.4	0.7	0.9	0.2	0.3	0.1	1.3	0.3	0.2	0.5	0.4	4.9	0.4	0.4	0.1	0.1	0.2	0.0	1.5	0.6	0.2	2.0	6.8	0.2	0.1	0.6	1.2	1.0	0.9	0.2	1.3	0.9	5.7	0.6	7.9	0.2	0.0	5.2	0.6	0.4	0.9	22.0	17.5	37.8	19.9	2.6	4.8	14.1	43.6	12.0	31.0	41.3	27.9	19.6	45.7	13.9	11.8	22.7	21.4	37.1	14.9	48.1	31.6	16.8	64.5	38.1	12.6	0.1	54.0	36.8	1.0	0.6	53.8	3.7	3.7	16.9	27.1	44.2	30.8	30.3	14.1	56.9	13.1	36.0	14.9	12.2	36.0	57.0	13.8	6.4	35.3	14.0	16.2	37.7	11.6	7.4	25.6	10.0	21.1	12.5	44.6	33.8	27.6	49.3	11.1	29.1	47.1	14.1	37.4	37.0	1.1	0.3	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.2	1.0	0.5	0.2	0.2	0.3	0.3	0.7	0.6	0.6	1.4	1.3	0.3	0.4	0.4	0.6	0.2	0.6	0.9	2.6	0.0	0.5	0.3	6.5	5.6	5.7	4.4	1.2	9.4	2.9	3.8	1.4	2.8	2.7	0.0	12.5	19.7	4.6	12.8	0.0	1.6	7.9	1.0	3.6	3.6	1.2	55.6	1.6	0.6	41.1	5.2	4.6	3.3	1.3	12.0	2.2	0.4	16.9	1.7	1.5	9.4	2.0	3.0	8.2	6.1	2.5	5.8	3.6	0.0	9.1	9.4	4.1	0.0	0.6	1.4	9.5	0.4	32.5	1.8	0.4	0.2	0.0	101.0	6.6	5.3	8.7	281.1	263.3	5.8	2.0	10.4	7.2	1.2	12.0	3.9
CLUAP1	"CFAP22, FAP22, FLJ13297, IFT38, KIAA0643"	ENSG00000103351	"Clusterin associated protein 1"	Q96AJ1	16	3500976-3539048	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 215.5;Endometrial ciliated cells: 119.2;Respiratory ciliated cells: 181.3;Rod photoreceptor cells: 116.8;Spermatocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036976, HPA044191"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Vesicles	"HPA036976: AB_10602209, HPA044191: AB_2678852"	"unprognostic (1.78e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.12e-2)"	9.7	10.7	11.1	5.9	12.6	3.9	14.7	14.2	14.5	21.1	17.8	11.0	4.2	24.2	16.0	11.1	31.8	10.6	11.4	11.2	11.6	18.6	7.7	12.1	7.4	10.4	12.7	24.6	12.2	31.4	11.7	10.6	9.1	17.0	9.8	28.9	9.1	19.9	9.9	5.6	5.4	20.2	9.8	6.6	9.0	40.0	12.0	12.4	22.0	11.6	6.0	10.8	7.8	10.4	15.7	18.3	20.8	28.9	31.4	32.0	11.0	19.9	26.7	31.4	23.7	5.1	31.3	8.2	16.5	33.7	18.8	16.8	14.7	23.6	26.2	6.6	13.1	6.9	10.3	10.5	36.7	12.5	7.2	21.1	25.4	29.1	29.4	33.1	17.2	16.4	21.7	1.0	23.6	19.3	12.0	14.0	21.5	6.6	11.1	25.9	14.3	15.7	45.7	4.9	23.2	19.8	11.6	8.8	14.3	16.0	18.7	28.8	11.5	20.8	13.8	17.1	15.0	12.8	10.9	2.2	8.0	7.3	15.3	6.2	3.6	1.2	6.2	4.2	12.1	7.3	17.8	10.8	6.8	6.1	26.9	18.4	1.3	9.0	2.4	6.6	10.3	5.8	11.1	12.6	14.2	14.5	11.2	11.6	10.4	12.7	9.1	9.8	12.0	10.4	14.5	22.4	20.5	17.0	3.5	5.6	12.3	29.1	14.8	41.0	13.4	13.8	11.7	11.5	30.6	14.7	108.4	20.7	7.5	3.3	43.0	24.3	215.5	119.2	49.7	12.4	17.5	4.6	23.6	8.0	7.7	21.9	6.6	26.4	5.1	28.1	13.6	9.2	10.4	38.7	26.3	7.9	18.3	4.9	5.7	63.4	31.4	5.0	3.6	5.6	18.1	40.7	12.3	11.1	10.3	8.6	5.3	33.1	3.5	9.4	5.3	34.6	181.3	116.8	6.6	24.7	22.7	150.0	58.4	6.4	4.1	9.3	12.1	36.7	9.0	6.5
CMIP		ENSG00000153815	"C-Maf inducing protein"	Q8IY22	16	81444808-81711762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 180.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054424, HPA066710"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		83000	"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA054424: AB_2682484, HPA066710: AB_2685708"	"unprognostic (6.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.02e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (9.47e-7)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.59e-1)"	27.9	22.1	45.2	32.1	46.2	26.1	23.2	12.6	50.1	30.7	0.0	26.5	40.4	18.8	6.1	35.8	23.0	25.6	13.0	48.8	51.1	20.7	13.5	26.3	22.2	29.9	34.8	22.8	19.3	7.8	55.6	28.4	46.1	17.7	23.1	10.8	20.1	15.0	4.7	34.3	49.9	22.5	19.9	22.5	33.3	17.2	52.7	20.1	15.6	5.3	18.2	31.2	32.8	34.4	40.9	133.5	25.9	13.3	13.4	10.7	52.7	28.9	19.5	17.9	7.9	45.5	81.5	18.2	24.2	24.1	23.9	40.6	16.9	96.2	17.0	11.6	12.3	87.4	24.4	80.0	13.3	27.2	180.8	10.5	39.9	33.1	42.5	27.1	50.0	31.7	77.6	15.3	11.1	40.9	47.7	33.8	20.6	39.5	28.1	84.9	8.5	17.8	22.6	39.7	135.0	27.1	67.4	24.7	8.6	25.9	19.1	35.7	34.6	28.5	30.6	27.7	26.8	19.2	15.9	78.0	33.6	31.5	11.7	3.0	0.7	1.0	0.4	0.5	0.2	0.0	0.1	0.1	0.2	0.3	0.0	0.2	2.4	0.2	0.1	0.2	0.1	0.4	45.2	46.2	12.6	50.1	48.8	51.1	29.9	34.8	46.1	19.9	52.7	34.4	81.5	12.8	16.6	59.4	31.7	107.3	66.6	43.8	48.9	15.6	21.5	21.1	7.8	47.1	27.7	14.7	0.0	46.5	71.2	58.0	7.9	22.3	70.0	51.1	9.2	77.3	72.1	17.9	119.1	23.8	106.6	25.7	35.7	45.4	45.1	29.8	70.6	31.6	32.0	25.2	95.2	128.0	40.7	69.4	115.9	100.8	47.5	95.5	12.4	100.2	68.2	8.0	37.0	69.9	52.9	65.5	30.9	143.3	35.2	69.6	47.3	49.6	57.6	3.4	13.1	8.0	24.1	5.0	15.4	51.8	143.5	88.7	42.8	6.4	39.1	111.7
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		1400000	"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	88.2	45.2	47.0	64.2	50.6	53.1	102.2	51.9	73.1	74.8	49.8	134.1	163.9	44.2	42.2	108.2	35.2	88.5	63.3	44.5	56.9	78.7	217.2	63.8	71.8	52.6	52.4	38.1	90.9	57.7	32.9	48.8	54.2	95.0	141.0	29.2	157.4	50.7	71.1	65.1	152.5	56.0	52.6	58.0	109.0	17.5	52.3	61.7	92.0	73.9	87.9	80.6	63.8	55.3	124.9	68.4	86.6	77.9	154.6	179.3	122.5	216.4	129.8	128.6	129.9	61.3	84.1	183.4	108.6	147.9	120.5	82.7	64.8	112.1	174.9	279.5	52.7	142.9	91.0	106.7	100.8	206.2	100.2	101.2	132.7	107.5	119.7	121.1	135.2	67.4	137.3	143.5	169.8	45.9	168.2	96.8	55.1	162.9	93.6	103.4	149.8	138.5	126.5	134.9	78.3	41.3	155.0	177.7	128.9	113.7	44.2	121.0	127.7	159.6	92.7	154.5	180.8	103.8	154.3	124.4	126.3	125.3	111.7	43.3	12.8	24.2	16.1	14.0	20.7	13.6	18.0	20.0	13.5	14.3	16.9	16.4	5.3	19.4	17.0	11.4	20.9	15.6	47.0	50.6	51.9	73.1	44.5	56.9	52.6	52.4	54.2	52.6	52.3	55.3	101.7	70.5	54.4	14.4	148.1	175.5	125.3	88.9	102.4	34.2	167.8	67.7	48.9	147.3	87.0	75.4	16.7	82.3	117.9	280.0	174.1	186.8	1.6	56.2	63.3	83.8	117.5	126.0	28.5	181.6	133.0	91.2	125.4	98.2	94.0	39.7	88.5	235.9	75.9	43.7	30.2	326.6	91.6	122.0	265.0	5.0	59.4	107.1	254.3	31.9	100.5	66.9	124.6	20.6	25.0	146.8	168.6	70.0	119.8	203.5	234.6	254.5	112.3	31.1	85.5	75.9	95.8	14.0	29.8	167.0	195.1	118.3	160.5	49.0	240.2	250.8
CMPK2	"NDK, TYKi, UMP-CMPK2"	ENSG00000134326	"Cytidine/uridine monophosphate kinase 2"	Q5EBM0	2	6840570-6866635	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.6;salivary gland: 8.5"	"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 12.8;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HEL: 20.3;MOLT-4: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	Nucleoplasm	"HPA041430: AB_10796674"	"unprognostic (2.37e-1)"	"unprognostic (6.07e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.32e-2)"	2.1	1.4	1.7	1.4	2.8	6.4	1.8	0.7	1.8	1.4	1.7	1.3	1.6	0.9	0.3	0.7	0.7	0.8	2.1	1.2	1.9	1.1	0.9	2.8	1.3	6.0	3.0	0.4	1.3	0.9	1.1	1.6	3.2	0.7	0.6	0.1	8.5	0.7	1.1	0.4	2.2	0.9	10.6	3.5	2.9	2.0	2.0	1.9	1.2	1.6	0.7	0.9	0.6	1.5	0.3	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.2	12.8	11.9	0.0	1.4	3.1	0.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.2	20.3	0.0	0.0	0.0	0.6	1.8	0.1	0.0	0.2	0.0	0.0	0.0	2.0	5.8	0.1	0.0	0.1	11.8	3.6	0.3	0.0	1.0	3.6	0.0	0.0	0.0	0.4	0.4	0.5	0.2	0.0	1.9	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.0	0.0	3.6	0.8	3.1	1.6	4.9	0.3	3.9	0.2	1.1	0.2	0.2	1.1	0.1	0.2	0.3	1.1	0.5	2.0	0.1	0.4	0.7	1.7	2.8	0.7	1.8	1.2	1.9	6.0	3.0	3.2	10.6	2.0	1.5	20.8	3.2	7.5	0.0	1.9	0.4	0.9	0.5	0.0	1.5	1.7	1.3	1.6	0.0	0.5	1.8	0.0	3.0	3.4	10.0	1.9	2.6	4.0	5.4	0.8	11.7	7.2	86.3	1.9	6.6	2.9	2.7	11.2	1.0	2.5	1.7	7.1	1.4	19.5	0.0	2.5	2.5	0.0	12.3	2.8	1.6	1.5	11.3	0.0	9.4	11.9	5.3	3.1	1.5	0.2	6.2	8.4	5.7	2.1	1.0	8.4	0.7	4.1	0.2	0.0	2.2	2.0	2.7	4.4	0.7	0.4	0.8	4.5	1.6	1.6	2.0
CMSS1	"C3orf26, MGC4308"	ENSG00000184220	"Cms1 ribosomal small subunit homolog"	Q9BQ75	3	99817837-100181732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 215.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042820	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Nuclear membrane, Mitochondria"	"HPA042820: AB_10795763"	"unprognostic (1.50e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (5.92e-10)"	"unprognostic (1.50e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.04e-2)"	24.5	33.1	23.0	15.8	21.7	20.8	23.4	26.7	30.1	22.4	17.8	21.0	8.6	21.8	9.7	15.8	20.9	10.5	28.2	21.8	20.9	20.7	15.0	15.8	17.1	22.8	20.1	23.6	26.7	21.8	24.5	11.6	19.6	16.0	11.6	24.6	14.0	13.3	69.4	17.4	12.6	13.2	17.9	13.8	16.4	30.3	21.3	16.7	14.8	29.9	15.0	24.5	18.1	21.7	116.2	51.0	50.0	72.6	34.7	40.1	51.0	53.5	28.8	93.3	77.0	64.1	37.5	126.3	90.6	28.2	82.4	68.4	70.3	60.2	120.3	66.8	66.5	99.9	32.9	53.2	62.6	137.0	51.3	28.2	56.7	71.4	116.6	30.3	65.2	100.9	63.5	78.1	67.0	78.8	110.3	126.4	73.0	109.4	126.1	49.1	81.3	134.1	57.2	27.5	139.9	58.9	52.8	42.5	125.0	47.8	51.4	84.0	18.5	73.6	207.4	43.3	109.8	56.3	121.1	244.9	49.1	149.4	124.8	1.0	11.0	2.3	22.2	27.3	32.0	57.3	32.8	30.3	23.8	55.7	41.3	42.0	4.1	28.6	25.1	62.1	33.9	18.2	23.0	21.7	26.7	30.1	21.8	20.9	22.8	20.1	19.6	17.9	21.3	21.7	26.7	6.4	19.4	48.6	41.3	62.2	37.4	45.5	26.2	32.8	43.8	40.4	41.7	42.9	23.2	62.5	18.8	41.7	25.1	8.5	97.8	42.1	165.0	21.7	56.8	38.7	15.0	30.9	154.3	47.7	56.6	44.3	9.7	19.8	62.1	47.7	24.7	61.4	27.2	127.9	132.8	14.4	16.2	7.9	45.5	215.8	50.7	18.7	37.4	58.1	12.8	28.0	19.6	114.1	116.2	35.8	4.6	58.6	36.2	82.8	1.1	87.9	22.4	27.0	26.3	67.3	50.1	163.4	146.1	21.3	66.1	21.9	30.1	54.1	22.6	27.0
CMTM1	"CKLFH, CKLFH1a, CKLFSF1"	ENSG00000089505	"CKLF like MARVEL transmembrane domain containing 1"	Q8IZ96	16	66566393-66579137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 31.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 75.5;Late spermatids: 144.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 8.7;eosinophil: 6.2;neutrophil: 7.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"REH: 19.8"									"HPA013801, HPA017136"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA013801: AB_1846990, HPA017136: AB_1846992"	"unprognostic (2.37e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (2.47e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-1)"	1.0	1.1	1.0	2.5	1.0	0.3	0.5	1.5	1.8	1.1	0.0	1.3	2.0	1.5	0.4	0.7	1.1	1.7	0.6	0.9	2.7	0.9	0.5	1.2	1.6	2.1	0.9	1.8	0.6	1.1	0.8	1.2	1.8	0.7	0.5	0.9	1.0	0.5	0.4	0.9	1.5	0.6	0.2	3.2	1.2	31.3	1.5	2.6	0.9	0.5	1.0	0.9	0.8	1.7	5.1	7.8	1.4	6.4	2.7	2.5	1.4	6.5	3.0	5.1	5.2	1.6	3.3	2.3	3.3	1.9	1.6	3.9	2.2	0.4	2.7	8.8	1.5	0.9	3.7	1.7	1.2	4.7	5.6	2.2	0.6	4.6	0.5	7.7	2.7	4.6	4.2	3.1	2.2	1.9	8.9	4.5	1.1	0.7	2.8	19.8	16.3	5.5	4.5	2.3	3.6	4.8	9.0	0.7	2.2	0.2	2.3	3.3	6.6	8.9	14.1	5.5	2.8	3.1	8.3	8.7	4.3	6.3	10.7	8.7	1.7	6.2	1.4	0.5	1.2	0.1	0.4	0.7	1.6	0.2	0.4	0.4	7.0	1.2	1.1	0.5	0.5	1.0	1.0	1.0	1.5	1.8	0.9	2.7	2.1	0.9	1.8	0.2	1.5	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	75.5	0.0	0.1	0.2	0.0	2.7	0.0	0.2	0.2	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	144.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.1	26.5	0.4	0.0	0.3	0.1	0.4	0.1	0.0	0.1
CMTM3	"BNAS2, CKLFSF3, FLJ31762"	ENSG00000140931	"CKLF like MARVEL transmembrane domain containing 3"	Q96MX0	16	66603874-66613892	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 222.1;Granulosa cells: 140.8;Hofbauer cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 164.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013870, HPA072695"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA013870: AB_1847003, HPA072695: AB_2732210"	"unprognostic (1.59e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.65e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (4.42e-6)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	49.3	16.6	15.5	25.0	14.3	20.0	32.8	15.6	28.1	40.2	9.5	16.8	7.1	30.4	16.6	10.4	25.5	32.7	26.2	15.6	18.0	19.7	10.7	35.4	32.3	24.9	15.8	38.9	7.9	29.4	10.1	44.4	19.3	23.4	12.1	3.0	17.4	16.7	6.4	22.2	18.8	27.7	17.0	36.1	11.9	59.7	19.1	35.5	16.1	13.0	20.9	34.3	26.7	20.4	6.7	33.8	93.4	66.2	68.4	42.6	59.2	17.5	78.6	34.4	34.0	18.6	21.0	0.2	47.7	49.0	59.7	7.8	63.7	57.4	27.3	34.6	23.2	21.5	4.4	53.5	92.2	65.8	77.4	85.5	4.5	36.6	7.7	141.3	78.9	59.5	34.6	0.7	42.8	7.8	53.1	108.9	45.0	0.5	31.8	164.7	65.6	3.3	16.4	0.8	9.9	33.9	8.5	0.3	58.5	59.9	0.7	59.3	54.0	48.7	58.8	12.0	21.1	4.4	0.7	21.8	30.5	50.0	53.7	7.9	14.2	9.9	9.2	13.9	12.9	2.6	10.3	10.5	12.3	0.9	8.0	9.8	8.0	8.6	8.9	24.9	15.7	5.8	15.5	14.3	15.6	28.1	15.6	18.0	24.9	15.8	19.3	17.0	19.1	20.4	38.0	0.0	7.1	0.3	12.9	14.7	33.5	10.0	6.8	0.5	12.3	25.7	2.0	4.3	6.4	5.5	0.0	10.7	101.2	0.4	0.0	28.1	2.8	4.9	56.0	50.4	12.5	12.8	0.6	6.4	222.1	62.6	2.6	6.2	91.3	140.8	44.3	1.3	119.8	0.0	0.3	0.7	8.2	74.7	77.9	9.4	39.4	78.0	28.4	10.3	61.5	10.0	82.4	8.0	0.2	41.0	0.1	24.5	5.7	40.8	0.1	4.4	3.1	0.8	6.6	26.3	36.1	4.9	8.1	1.1	8.7	9.4	68.9	10.5	0.2	21.6
CMTM8	CKLFSF8	ENSG00000170293	"CKLF like MARVEL transmembrane domain containing 8"	Q8IZV2	3	32238679-32370321	"Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 47.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.7;Cytotrophoblasts: 107.6;Granulosa cells: 129.9;Syncytiotrophoblasts: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"BEWO: 208.4;SK-BR-3: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055077, HPA073258"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA055077: AB_2682691, HPA073258: AB_2686591"	"unprognostic (9.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	14.8	12.9	6.0	3.3	5.8	1.2	15.5	4.9	6.7	5.9	5.9	7.0	7.3	4.4	17.4	3.5	8.4	3.4	13.6	5.5	5.0	10.2	41.2	17.9	3.9	6.2	5.4	1.4	47.7	12.0	3.6	17.4	6.3	11.7	7.4	1.1	19.7	6.0	4.7	9.2	6.2	2.5	5.5	1.3	14.9	1.0	7.0	9.5	13.6	5.1	4.1	4.8	3.7	4.9	10.6	10.8	2.1	13.5	9.5	14.7	208.4	0.1	0.3	1.1	1.2	15.0	14.9	0.0	21.8	0.0	0.0	5.8	17.2	3.5	0.9	0.0	31.5	6.8	2.1	25.2	0.6	2.8	5.3	28.8	10.8	1.5	10.4	5.2	8.4	11.2	0.1	0.0	10.7	7.8	8.9	1.0	4.4	16.4	9.9	12.4	2.5	2.1	13.1	12.1	3.7	3.0	1.7	59.3	5.8	2.5	17.0	1.4	7.6	0.0	15.5	0.0	3.2	0.5	0.4	0.1	0.0	4.8	3.7	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	6.0	5.8	4.9	6.7	5.5	5.0	6.2	5.4	6.3	5.5	7.0	4.9	94.7	38.5	36.3	1.0	2.8	11.6	35.2	4.6	18.8	0.1	75.4	45.6	2.2	17.2	16.1	0.0	0.0	107.6	2.3	13.7	11.7	18.1	13.0	22.1	5.6	51.9	22.2	5.7	2.2	37.0	67.5	17.7	32.1	29.2	0.0	129.9	54.7	79.5	9.8	0.0	41.6	40.7	16.2	5.3	15.0	2.4	2.5	3.6	5.4	36.5	1.2	35.6	0.0	17.6	1.0	25.8	17.7	1.2	1.4	64.9	21.3	24.3	9.9	2.7	0.0	2.2	12.3	3.5	3.7	12.1	6.5	116.2	18.6	10.9	21.0	49.7
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	20.1	22.1	21.0	19.2	21.2	30.9	19.5	20.3	22.9	23.6	18.6	26.8	18.1	23.1	17.4	16.9	22.4	15.1	25.1	20.7	22.0	19.4	21.8	20.4	25.3	21.5	21.0	28.0	22.1	27.5	26.0	24.9	20.3	21.9	15.2	28.5	21.7	18.4	30.1	23.2	23.2	20.4	20.2	28.8	21.9	62.9	23.5	30.9	20.3	23.4	25.6	21.6	20.0	20.2	23.5	21.9	31.0	50.7	34.2	31.1	37.4	27.5	37.7	68.1	75.9	33.3	15.3	48.6	30.5	40.7	63.8	25.7	39.7	28.4	51.7	33.8	35.2	26.8	26.8	37.2	26.3	38.9	17.6	27.1	20.9	37.6	26.7	35.7	32.2	44.3	60.6	34.5	36.3	38.5	49.8	34.6	15.6	15.7	20.7	39.0	36.7	28.1	22.0	28.2	34.2	25.6	30.8	23.4	40.2	22.1	39.8	29.7	30.0	40.7	30.3	16.3	31.1	39.3	21.8	253.0	16.0	40.1	45.6	4.2	5.4	3.5	4.9	7.1	4.1	5.5	4.3	5.2	5.1	3.8	4.7	3.9	3.3	5.6	5.5	4.2	6.1	4.6	21.0	21.2	20.3	22.9	20.7	22.0	21.5	21.0	20.3	20.2	23.5	20.2	11.3	9.6	9.2	5.9	12.0	3.6	3.9	4.0	8.6	14.2	6.3	5.5	10.4	8.6	11.5	7.3	33.3	18.0	15.4	5.3	0.0	4.5	20.2	7.7	15.4	9.6	8.4	6.5	15.1	8.5	8.0	8.8	11.7	8.9	3.8	24.9	7.9	10.1	7.5	11.8	13.9	8.4	4.1	7.5	2.3	11.3	7.8	9.5	3.6	14.0	11.5	8.8	7.2	10.6	14.2	8.5	3.3	6.8	12.4	4.3	4.7	4.0	11.2	11.9	6.6	8.5	13.5	16.8	10.6	5.8	4.7	20.8	11.5	22.0	6.9	3.6
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129167827-129183922	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA063097: AB_2684939"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	292.7	308.2	175.2	181.1	184.0	254.1	274.6	198.6	211.3	295.9	175.7	314.1	198.5	285.8	197.6	264.6	275.7	195.1	487.2	170.6	184.3	231.6	433.7	258.3	251.0	182.7	175.1	385.8	307.4	277.9	169.5	214.3	187.1	256.6	219.0	231.8	250.8	282.4	1207.6	288.0	199.2	234.9	195.6	200.7	262.1	131.2	181.9	254.2	261.8	797.9	250.7	317.5	269.2	211.7	452.7	266.4	369.9	294.6	355.2	303.9	294.9	344.2	535.7	362.2	412.4	389.2	305.7	589.8	292.2	318.1	269.6	328.3	484.3	396.4	484.6	404.5	357.9	569.2	251.7	420.2	355.7	622.4	314.5	295.5	449.2	254.8	897.8	247.6	324.1	328.1	437.6	391.9	384.0	538.9	578.6	454.1	452.7	399.7	439.1	502.4	343.4	707.7	379.1	425.4	501.2	402.8	271.5	263.0	766.3	214.4	305.6	421.3	347.9	268.4	266.2	374.1	353.7	367.3	365.4	932.3	277.3	419.2	362.4	1077.7	810.5	930.9	551.8	596.8	699.0	691.0	658.8	595.3	552.8	603.8	700.3	610.5	1102.3	601.1	485.5	320.4	704.3	2029.8	175.2	184.0	198.6	211.3	170.6	184.3	182.7	175.1	187.1	195.6	181.9	211.7	253.7	259.6	263.9	27.1	292.8	524.7	417.0	262.9	259.6	153.7	177.5	272.5	608.0	141.5	235.1	79.1	33.3	252.3	188.1	143.9	373.7	226.9	36.0	141.4	195.1	267.5	171.3	246.5	28.2	290.7	396.6	309.4	142.8	172.8	314.5	173.0	167.0	138.5	246.5	92.5	33.7	178.6	140.4	194.4	463.0	42.9	316.0	232.4	318.4	35.6	392.7	350.3	236.9	32.6	42.8	230.1	158.0	319.7	311.7	405.1	196.5	237.4	164.8	153.8	263.0	343.6	571.0	305.2	271.5	286.5	586.7	291.7	304.2	277.7	213.6	376.2
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 334.7;Proximal enterocytes: 629.1;Proximal tubular cells: 487.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 458.7;RPMI-8226: 616.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	54.8	40.7	125.3	75.0	147.0	25.1	60.4	139.4	156.9	136.8	113.0	83.6	190.1	44.2	122.8	78.4	140.8	94.4	63.7	123.7	133.2	327.3	261.1	82.3	86.3	143.1	137.4	34.4	100.7	58.5	48.0	75.4	144.7	122.5	79.5	42.1	57.4	101.7	26.6	47.0	255.0	37.9	140.4	137.0	103.5	20.9	143.9	52.5	159.1	22.4	82.2	94.5	47.4	157.6	64.6	85.0	60.5	57.4	72.2	42.5	252.3	66.0	61.7	88.3	87.4	49.6	67.1	80.3	81.4	72.1	69.0	95.0	92.7	124.9	62.7	121.3	36.7	80.2	42.1	79.6	104.6	158.7	119.3	64.5	93.9	76.4	136.6	50.1	78.3	94.6	86.3	458.7	59.1	71.6	84.9	75.6	91.0	42.4	50.3	91.3	69.4	616.6	346.1	264.1	65.3	34.2	51.6	360.2	91.6	143.0	151.5	64.0	82.5	93.9	79.5	21.2	45.2	85.5	380.6	108.1	63.6	113.8	80.2	37.1	115.4	49.0	77.6	166.3	84.4	102.4	61.6	72.2	185.1	110.5	65.5	72.4	15.9	124.6	174.1	161.3	94.5	135.7	125.3	147.0	139.4	156.9	123.7	133.2	143.1	137.4	144.7	140.4	143.9	157.6	39.2	73.7	62.7	16.6	55.7	9.2	40.3	48.6	12.5	33.6	76.5	36.4	26.9	77.2	56.8	119.5	16.7	157.9	47.8	99.0	187.9	168.1	3.3	187.7	49.7	49.6	65.3	23.3	8.8	154.7	130.9	23.5	63.7	334.7	12.0	34.0	40.0	119.8	216.3	43.7	10.8	82.9	75.3	122.9	24.9	4.1	18.6	79.0	17.8	13.1	90.8	86.6	55.6	15.6	51.7	108.9	103.5	16.6	44.4	65.2	629.1	487.6	73.3	31.6	13.1	15.2	22.3	8.3	7.2	27.1	9.7	109.0	38.2	32.8	99.8	53.8
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel subunit alpha 1"	P29973	4	47935977-48016681	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 264.4"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 1139.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.2;RT4: 7.2;U-2 OS: 3.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 79: Retina - Phototransduction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	3.3	0.4	0.5	0.8	1.4	0.3	1.5	1.6	0.9	1.0	0.6	3.6	2.2	0.4	9.3	9.0	4.1	1.1	0.4	0.7	0.8	2.4	23.5	0.3	0.1	0.4	0.3	0.1	0.8	4.1	0.3	1.0	0.4	2.6	2.4	264.4	4.3	1.7	5.0	5.1	6.3	0.3	0.1	3.4	2.8	0.4	0.7	0.3	0.7	1.3	0.5	3.7	1.9	0.6	2.3	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	2.0	9.2	0.1	0.5	0.0	2.7	1.4	0.2	0.3	0.1	0.0	0.6	0.0	0.2	0.8	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.9	0.0	0.8	0.7	0.5	0.2	0.9	0.0	0.1	0.4	1.1	2.2	0.1	0.0	0.1	0.4	7.2	0.3	0.0	0.2	0.5	0.1	0.2	0.9	0.0	0.3	0.2	3.0	0.1	0.1	0.7	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.5	0.0	0.0	0.5	1.4	1.6	0.9	0.7	0.8	0.4	0.3	0.4	0.1	0.7	0.6	7.3	0.0	0.0	0.7	0.1	0.1	1.8	0.5	0.6	97.7	8.7	1.8	0.7	5.7	3.4	62.5	91.8	0.0	0.0	10.6	0.0	10.1	0.4	2.5	0.4	8.7	0.0	2.7	1.2	6.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	38.0	1.7	45.4	1.1	4.0	0.0	0.8	0.0	0.1	0.3	0.5	0.0	7.5	0.0	163.9	0.0	0.0	0.2	2.1	16.4	0.0	0.0	3.7	24.5	0.4	0.8	1139.7	0.0	0.6	17.1	0.6	1.3	10.3	2.7	0.3	0.2	0.1	4.7	35.1
CNGA4	"CNCA2, CNG5, CNGB2, OCNC2, OCNCb"	ENSG00000132259	"Cyclic nucleotide gated channel subunit alpha 4"	Q8IV77	11	6234765-6244479	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Olfaction, Sensory transduction, Transport"	"Ion channel, Ligand-gated ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 17.3;testis: 6.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.1;Early spermatids: 5.0;Endometrial ciliated cells: 2.7;Excitatory neurons: 3.0;Inhibitory neurons: 2.5;Late spermatids: 3.6;Oligodendrocytes: 3.1;Respiratory ciliated cells: 3.5"	"Cancer enriched"	"Detected in single"	6	"endometrial cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA074128			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"		"HPA074128: "	"unprognostic (1.11e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.69e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.55e-3)"	0.1	0.2	1.2	0.2	1.3	0.4	0.2	1.3	1.2	0.7	0.7	0.2	0.3	0.6	0.2	0.2	17.3	0.2	0.1	1.4	1.4	0.4	0.2	1.4	0.2	2.8	3.8	0.4	0.4	0.0	0.7	0.0	2.5	0.2	0.1	1.1	0.1	0.5	0.0	0.3	0.2	0.1	1.8	0.3	0.2	6.1	1.2	0.3	0.2	0.0	0.2	0.2	0.2	1.9	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	1.3	1.2	1.4	1.4	2.8	3.8	2.5	1.8	1.2	1.9	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	2.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CNN2		ENSG00000064666	"Calponin 2"	Q99439	19	1026586-1039068	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 274.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049095	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		8400000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA049095: AB_2680627"	"unprognostic (2.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.54e-1)"	76.7	22.1	6.3	149.8	7.9	208.8	82.1	9.0	11.2	88.2	30.3	64.1	25.6	118.0	20.0	131.7	88.7	78.8	60.2	6.1	6.7	65.0	42.9	152.2	184.2	9.5	7.7	164.7	69.2	8.6	22.4	37.8	9.6	84.1	33.6	7.5	89.4	68.4	8.1	76.5	64.8	56.0	7.9	154.0	75.1	12.1	9.0	52.2	79.0	7.7	169.9	86.4	79.7	13.3	230.7	75.6	206.9	257.3	104.5	196.9	162.6	204.3	221.8	249.2	192.5	263.0	191.8	151.2	203.9	367.9	58.9	221.3	123.9	324.1	164.7	104.7	10.6	109.6	122.0	205.9	415.0	97.4	230.1	337.2	150.9	158.1	118.5	405.6	142.9	110.1	64.0	225.2	206.0	44.0	8.9	91.5	256.2	184.0	35.0	52.8	72.5	170.9	247.5	265.9	0.5	14.8	252.6	34.3	27.5	149.6	247.6	163.6	349.4	134.8	140.0	210.0	208.9	105.2	86.8	297.8	79.6	117.7	220.9	560.2	142.2	631.5	243.1	180.6	393.5	231.0	301.6	324.2	217.5	201.9	250.1	252.0	845.4	213.8	209.4	96.7	347.3	393.3	6.3	7.9	9.0	11.2	6.1	6.7	9.5	7.7	9.6	7.9	9.0	13.3	10.3	60.9	60.6	0.0	140.4	97.6	274.2	142.9	178.2	1.2	36.5	66.4	6.1	15.7	78.4	36.8	10.4	12.0	66.4	47.0	62.6	63.6	0.5	29.1	52.9	26.3	15.4	44.1	0.1	138.6	99.8	50.4	49.5	40.0	59.5	44.3	37.9	29.8	54.9	0.0	0.1	51.2	42.7	87.9	103.1	1.8	8.1	90.7	14.2	2.8	129.9	0.9	91.6	0.0	0.6	186.9	27.1	76.8	85.8	60.9	3.3	5.9	37.8	7.5	32.9	10.4	70.6	1.7	3.8	135.0	87.8	11.4	160.8	1.7	32.1	170.9
CNOT10	"FLJ12890, FLJ13165"	ENSG00000182973	"CCR4-NOT transcription complex subunit 10"	Q9H9A5	3	32685145-32773875	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 181.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035614, HPA041450"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	Cytosol	"HPA035614: AB_10669975, HPA041450: AB_2677487"	"unprognostic (3.75e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.45e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.43e-1)"	8.4	7.8	5.9	11.4	6.5	17.4	12.6	7.8	7.1	10.9	7.2	11.6	9.8	10.7	11.5	9.8	14.1	8.7	7.7	5.7	6.7	10.6	12.5	9.8	14.6	6.1	5.8	12.2	9.4	13.0	10.3	8.5	6.2	9.1	13.8	6.5	8.5	7.5	9.5	13.2	10.6	10.1	6.1	14.5	9.1	39.8	6.3	19.7	12.3	5.8	16.5	9.8	8.7	7.5	24.4	26.7	27.2	25.9	12.9	14.8	181.2	20.1	20.0	28.0	31.3	20.5	20.5	39.6	13.0	14.4	18.1	20.9	32.5	26.5	27.8	34.5	33.3	51.0	23.2	20.0	37.6	42.3	18.9	10.9	23.3	30.9	40.4	18.7	23.2	36.4	54.1	30.1	16.6	20.1	38.0	20.4	41.2	28.0	25.3	37.9	18.5	39.8	18.0	28.1	15.5	29.9	29.5	41.1	24.4	19.3	40.0	47.4	14.3	17.3	24.6	23.0	33.7	30.8	67.8	39.6	17.7	31.7	21.4	18.5	12.0	17.7	11.4	17.1	12.4	15.3	18.6	13.7	15.1	17.4	18.1	16.0	9.6	10.2	25.2	8.4	16.0	12.3	5.9	6.5	7.8	7.1	5.7	6.7	6.1	5.8	6.2	6.1	6.3	7.5	11.6	16.0	22.8	28.4	19.6	10.5	7.2	13.0	9.1	16.8	9.4	9.0	13.2	14.3	15.3	14.7	33.3	14.8	21.0	15.3	5.9	12.9	60.3	23.4	12.9	14.1	15.6	21.2	37.7	13.5	17.1	12.0	15.3	14.1	10.8	17.2	12.8	9.8	11.9	15.2	36.5	10.6	10.2	18.8	14.3	34.3	9.6	14.5	12.4	20.6	37.2	7.4	10.3	29.1	35.3	11.7	16.4	10.5	17.5	6.6	15.2	7.0	29.9	20.9	6.6	14.9	12.5	63.0	33.1	10.2	14.5	8.2	20.1	17.8	14.4	7.3
CNOT11	"C2orf29, C40"	ENSG00000158435	"CCR4-NOT transcription complex subunit 11"	Q9UKZ1	2	101252886-101270316	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069823, HPA074943"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA069823: AB_2686209, HPA074943: "	"unprognostic (1.72e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (4.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.72e-3)"	15.7	20.3	16.7	26.3	17.5	34.7	19.1	18.4	21.1	22.6	20.6	31.4	33.1	19.8	24.8	36.4	20.9	25.0	37.7	17.3	17.8	27.9	30.8	19.7	37.7	17.6	17.2	14.1	30.9	21.9	14.5	34.1	17.8	20.0	36.1	16.1	24.8	19.1	33.0	25.3	31.5	20.8	17.6	29.8	30.3	29.5	17.8	31.8	17.3	26.4	40.9	24.3	20.2	18.7	42.6	29.1	46.2	64.1	38.2	46.0	137.4	43.1	54.6	52.5	55.4	64.2	47.8	75.0	49.7	39.1	66.1	50.6	56.0	51.7	63.4	51.4	47.6	62.6	32.1	96.6	42.5	76.2	59.5	36.5	46.3	37.7	40.0	43.1	59.7	41.8	71.1	44.4	48.0	44.5	74.8	82.0	58.0	67.5	40.6	47.5	50.3	58.1	72.3	79.4	69.1	44.1	26.1	76.6	72.4	52.6	48.5	69.2	40.3	40.7	47.2	35.4	36.4	63.2	63.5	58.8	45.0	84.4	48.6	9.6	2.0	3.9	3.1	2.9	2.1	2.0	3.2	3.8	1.7	3.1	3.0	4.1	7.9	1.2	2.8	2.6	4.5	1.3	16.7	17.5	18.4	21.1	17.3	17.8	17.6	17.2	17.8	17.6	17.8	18.7	13.4	6.4	13.4	11.1	17.3	11.7	24.7	13.8	14.2	10.7	18.1	10.7	27.8	28.6	14.6	40.5	14.6	65.8	21.1	32.1	31.3	52.1	8.7	53.3	14.0	19.1	10.8	9.4	12.5	41.3	52.6	12.9	25.0	41.8	6.3	13.8	16.8	32.1	23.0	6.7	12.5	26.2	12.2	17.9	8.9	9.3	9.6	16.8	5.4	14.0	29.3	19.9	21.6	9.5	18.2	43.6	18.6	12.0	25.6	32.7	24.6	34.8	24.1	11.3	39.5	10.6	22.4	34.1	15.7	26.9	12.8	57.6	22.1	30.0	25.7	39.3
CNOT2	"CDC36, NOT2, NOT2H"	ENSG00000111596	"CCR4-NOT transcription complex subunit 2"	Q9NZN8	12	70243002-70354993	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067711	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA067711: AB_2685893"	"unprognostic (5.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.23e-2)"	29.8	25.6	24.2	31.2	33.3	78.5	35.0	65.9	28.1	29.2	24.9	31.6	30.2	34.3	34.5	24.4	29.0	27.3	24.0	25.2	28.8	28.7	34.9	29.5	40.4	33.7	32.1	35.1	24.1	32.5	23.4	32.1	30.0	27.8	34.5	46.2	26.0	27.0	33.4	50.3	30.9	30.5	28.6	35.8	25.7	26.2	32.3	50.1	30.7	33.8	42.7	32.8	27.9	43.5	46.2	44.5	70.7	45.3	38.5	42.8	60.1	49.2	59.5	53.8	46.1	55.8	42.1	100.2	45.1	57.4	33.8	43.9	50.2	49.1	59.7	47.1	50.2	66.4	38.8	55.7	40.7	84.3	54.6	50.1	52.4	50.5	59.1	78.7	59.0	61.5	61.9	55.4	47.2	52.4	95.7	61.0	61.0	46.1	46.4	75.1	59.9	61.1	50.7	93.2	50.6	55.7	59.1	46.4	45.6	60.5	59.1	68.4	44.7	50.2	33.6	45.8	40.7	50.3	59.5	77.3	52.5	42.3	41.9	92.8	49.2	57.6	50.1	69.4	56.6	54.0	54.7	58.9	60.3	51.5	62.6	67.6	30.3	62.6	58.5	44.4	55.8	56.3	24.2	33.3	65.9	28.1	25.2	28.8	33.7	32.1	30.0	28.6	32.3	43.5	71.1	41.7	43.2	76.7	79.8	51.1	37.7	45.4	47.3	64.4	40.9	38.0	30.1	58.6	45.6	36.8	56.3	45.3	144.3	50.2	33.2	49.5	44.5	47.8	55.8	55.4	58.0	49.2	110.9	44.7	47.4	57.4	41.3	62.2	76.5	60.1	46.4	34.6	40.3	52.2	115.8	39.0	44.7	55.1	46.7	12.6	45.7	62.7	32.0	86.2	46.3	54.3	56.7	123.6	204.0	45.8	44.4	46.6	77.9	45.4	45.2	30.3	44.7	54.8	39.5	72.3	64.5	53.8	44.7	46.7	64.1	35.4	94.2	50.4	39.2	48.9
CNTD1	"CNTD, FLJ40137"	ENSG00000176563	"Cyclin N-terminal domain containing 1"	Q8N815	17	42798800-42811587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"testis: 42.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 70.5;Late spermatids: 124.8;Respiratory ciliated cells: 47.0;Spermatocytes: 150.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.9;ASC diff: 1.6;SiHa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072363			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA072363: "	"unprognostic (5.92e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.29e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.89e-7)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.81e-4)"	0.3	0.2	0.9	0.0	0.9	0.1	1.8	1.2	1.9	0.1	0.1	0.8	0.1	0.1	1.4	0.0	0.7	0.0	0.1	0.9	1.0	1.5	0.0	0.5	0.0	1.0	0.9	0.4	1.0	0.3	0.0	0.1	0.9	1.3	1.9	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.8	0.1	3.3	42.4	0.8	0.0	0.3	0.6	0.0	0.2	0.0	1.9	2.9	0.3	0.2	0.5	1.6	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.5	0.1	0.3	0.0	0.8	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.9	1.2	1.9	0.9	1.0	1.0	0.9	0.9	0.8	0.8	1.9	1.2	3.2	4.6	2.3	1.0	0.4	0.5	0.4	0.0	1.7	5.5	2.2	1.1	1.5	2.1	0.0	0.0	0.3	1.2	1.4	5.9	0.2	70.5	5.4	1.7	0.8	0.0	2.7	1.9	0.4	0.4	1.9	4.1	1.6	6.3	0.2	0.4	1.1	0.3	6.7	1.6	5.3	4.1	1.0	0.7	124.8	2.5	1.1	0.0	0.0	0.2	1.0	0.0	2.0	1.1	0.4	0.4	1.2	0.7	5.6	0.9	0.5	47.0	0.7	6.6	1.0	1.7	150.2	17.1	0.0	0.6	0.3	0.9	0.5	2.7	2.3
CNTLN	"bA340N12.1, C9orf101, C9orf39, FLJ20276"	ENSG00000044459	Centlein	Q9NXG0	9	17134982-17503923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Spermatocytes: 84.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.9"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"HEL: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007201, HPA036728, HPA036729"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Centrosome	"Nucleoplasm, Cytosol"	"HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240"	"unprognostic (1.97e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	4.4	2.4	2.3	2.1	2.4	7.3	3.5	7.7	2.2	5.0	3.3	4.5	1.2	7.1	2.4	2.7	4.3	4.2	2.3	1.7	2.6	2.4	10.5	2.8	2.7	2.7	3.1	8.8	1.7	4.4	2.2	3.6	3.0	2.7	2.2	2.1	1.6	3.2	1.6	1.9	2.2	4.5	2.6	3.9	1.9	5.2	2.5	2.8	3.1	2.5	1.6	3.5	3.5	2.8	8.3	5.6	12.1	6.8	5.8	13.6	0.4	9.5	6.3	7.0	9.5	0.4	2.7	6.0	1.5	6.6	7.5	0.3	14.1	3.9	10.9	0.3	4.9	35.5	11.7	2.0	6.4	4.9	7.4	8.6	2.0	5.8	5.7	6.5	10.0	2.2	1.3	1.1	11.3	0.6	4.0	7.8	9.4	1.4	10.3	5.8	11.2	3.0	4.1	2.0	7.6	7.9	11.6	0.2	3.0	4.8	2.3	12.3	7.5	9.5	3.7	10.4	8.3	4.7	6.1	0.1	4.4	6.1	4.4	0.2	1.3	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.1	0.5	3.9	0.7	0.1	0.2	2.3	2.4	7.7	2.2	1.7	2.6	2.7	3.1	3.0	2.6	2.5	2.8	32.0	6.4	17.6	59.7	1.6	8.8	13.7	6.1	13.1	12.3	3.6	5.8	13.4	7.2	3.4	9.2	0.0	2.5	1.1	2.4	5.9	10.1	16.3	23.4	30.7	24.9	2.4	17.1	20.3	12.0	5.2	29.2	4.1	17.0	7.6	42.4	20.0	38.8	18.4	20.2	37.2	5.9	4.1	40.3	11.6	8.8	45.7	24.0	8.8	91.8	31.0	21.4	1.0	70.4	29.6	4.0	0.8	30.9	1.8	3.8	5.3	8.5	6.7	8.1	13.1	34.2	21.3	84.3	48.9	5.3	5.5	1.0	1.7	31.6	5.5	6.3
CNTNAP1	"Caspr, CNTNAP, NRXN4, p190"	ENSG00000108797	"Contactin associated protein 1"	P78357	17	42682531-42699993	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 11.4;Bipolar cells: 15.6;Endometrial stromal cells: 15.5;Excitatory neurons: 45.6;Inhibitory neurons: 37.7"	"Cancer enhanced"	"Detected in all"		"glioma: 10.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.5;TIME: 68.5;U-138 MG: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011772	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA011772: AB_1079541"	"unprognostic (4.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.16e-14)"	"unprognostic (9.52e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.37e-3)"	7.1	3.6	27.5	5.6	30.8	0.6	5.0	13.5	46.7	12.0	0.0	23.8	1.8	21.8	6.1	2.2	14.0	6.3	8.2	29.5	15.7	6.4	1.5	6.9	2.4	21.6	15.4	15.7	11.5	0.6	19.3	4.5	19.1	7.2	3.9	11.3	2.9	6.5	3.7	2.2	6.0	25.9	8.1	4.9	9.8	3.3	18.8	1.2	4.9	2.5	2.4	8.0	8.5	29.4	4.1	5.4	13.2	4.2	20.0	40.4	0.8	25.6	43.5	18.2	16.5	0.5	1.0	0.1	1.3	27.7	18.6	4.8	6.4	2.0	14.2	9.0	2.1	0.0	24.0	6.4	9.8	0.2	0.4	39.7	0.1	17.5	3.5	29.1	23.3	0.2	1.2	7.6	7.1	0.7	0.1	3.8	4.7	0.3	5.5	0.7	1.4	2.0	4.8	0.0	2.4	7.7	7.6	0.1	4.7	12.0	4.1	2.3	68.5	76.2	12.5	18.0	7.0	8.5	5.7	0.2	21.4	1.7	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	27.5	30.8	13.5	46.7	29.5	15.7	21.6	15.4	19.1	8.1	18.8	29.4	1.0	0.0	4.1	11.4	0.5	0.5	0.2	0.4	1.2	15.6	0.2	0.1	1.3	0.0	0.7	0.0	4.2	0.0	0.1	0.1	0.0	0.0	0.9	3.2	15.5	1.2	0.0	0.0	45.6	0.0	0.0	4.2	0.5	1.0	0.0	0.1	1.8	0.0	0.1	1.7	37.7	0.1	0.0	0.0	0.8	0.3	1.5	0.2	0.0	6.5	0.8	0.9	0.0	7.5	5.2	0.1	0.1	0.7	0.4	0.3	0.0	0.1	1.6	3.0	6.6	1.1	6.3	1.4	1.1	0.3	0.3	0.3	0.6	0.2	0.1	0.2
CNTNAP5	"caspr5, FLJ31966"	ENSG00000155052	"Contactin associated protein family member 5"	Q8WYK1	2	124025287-124915287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 7.9"	"Group enriched"	"Detected in some"	49	"Excitatory neurons: 554.6;Inhibitory neurons: 906.4;Oligodendrocyte precursor cells: 760.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;SH-SY5Y: 2.6"					"Low region specificity"	"Detected in all"			"HPA069095, HPA069356"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA069095: AB_2686083, HPA069356: AB_2686127"				"unprognostic (6.32e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.23e-1)"		"unprognostic (2.25e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.62e-6)"	"unprognostic (3.65e-3)"	"unprognostic (5.32e-2)"		"unprognostic (9.58e-2)"	0.0	0.5	2.4	0.0	0.6	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	4.3	5.1	0.1	0.0	0.0	0.0	6.8	6.3	0.0	0.1	0.0	0.0	0.0	7.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	7.9	4.3	5.1	6.8	6.3	7.3	0.0	7.2	0.8	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.1	0.0	0.0	554.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	906.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.4	0.0	1.0	0.0	760.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
COA4	"CHCHD8, CMC3, E2IG2"	ENSG00000181924	"Cytochrome c oxidase assembly factor 4 homolog"	Q9NYJ1	11	73872667-73876901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040126	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA040126: AB_10795415"	"unprognostic (7.30e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.17e-2)"	45.1	96.2	46.9	36.8	52.5	25.4	39.0	51.6	52.0	37.1	46.2	44.5	49.0	35.8	32.5	48.0	40.2	40.3	63.1	46.0	49.4	70.4	99.7	31.3	47.3	51.0	50.4	37.8	46.5	49.6	34.2	37.6	51.0	45.1	42.2	15.7	42.7	36.2	72.2	33.1	49.6	32.4	50.6	37.1	41.6	31.6	50.3	32.3	55.7	55.9	36.0	54.6	37.4	56.9	106.4	201.9	80.2	119.0	70.6	86.6	79.3	107.4	75.5	126.0	107.2	147.4	132.5	91.3	214.7	90.2	99.9	105.7	124.2	146.1	98.3	120.6	115.1	156.3	118.1	141.8	130.5	107.2	115.0	109.4	136.1	207.0	136.6	70.9	120.0	87.0	135.3	87.5	118.3	210.8	83.7	168.1	104.3	422.7	205.9	96.2	174.3	244.0	137.5	101.3	72.5	121.3	99.0	110.7	295.3	78.8	162.3	108.0	83.8	102.8	91.7	212.9	142.8	103.3	125.1	313.1	57.0	132.0	121.4	18.5	49.6	12.7	35.9	52.2	47.0	58.1	42.0	37.8	61.1	48.5	44.6	48.2	3.4	43.1	51.4	80.2	47.7	38.6	46.9	52.5	51.6	52.0	46.0	49.4	51.0	50.4	51.0	50.6	50.3	56.9	48.9	35.3	36.0	6.8	48.6	53.5	75.7	89.7	47.8	19.5	64.3	86.1	66.7	85.8	55.5	55.2	22.9	168.8	36.7	97.8	129.1	89.2	37.3	77.2	90.9	49.7	72.6	68.3	3.6	94.9	111.3	54.2	69.3	72.0	62.1	83.9	33.2	184.1	97.5	18.5	5.8	98.6	28.5	44.8	34.2	13.3	55.0	44.7	28.4	2.8	55.2	67.5	49.4	8.5	18.8	98.2	85.1	38.4	47.3	139.5	174.2	266.2	47.1	18.5	6.6	81.6	51.0	78.7	34.2	86.3	51.3	122.3	39.9	150.7	121.2	98.7
COA6	C1orf31	ENSG00000168275	"Cytochrome c oxidase assembly factor 6"	Q5JTJ3	1	234373456-234385080	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028588	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA028588: AB_10601123"	"unprognostic (6.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.25e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.12e-4)"	23.5	34.2	38.2	21.6	44.0	17.1	21.1	35.7	45.1	15.2	37.0	30.4	44.8	15.1	32.2	31.9	15.3	16.2	41.0	39.7	36.4	44.8	36.7	15.3	30.9	35.5	35.9	15.9	25.8	26.4	16.4	14.2	37.6	22.6	25.6	16.3	24.3	13.2	101.4	16.1	31.2	14.0	36.2	21.2	27.7	9.0	36.2	25.8	17.2	60.9	21.2	21.8	19.4	39.1	69.6	87.2	31.0	35.2	31.7	62.3	98.2	49.9	29.7	51.0	47.8	67.6	90.2	68.4	90.0	28.6	95.7	86.6	48.6	61.4	40.5	86.0	207.1	30.9	92.8	181.4	121.9	77.0	57.6	41.4	80.8	67.2	51.6	44.5	63.9	75.0	153.4	60.2	56.2	37.1	73.7	148.0	76.2	155.5	41.0	43.0	37.1	135.6	65.0	64.6	55.0	39.9	48.5	84.7	162.1	19.7	75.2	130.0	48.9	60.2	50.2	81.7	151.7	71.2	149.8	86.0	46.2	120.3	110.3	59.4	70.3	23.2	40.0	68.2	39.0	65.4	63.3	49.7	76.3	43.4	65.0	49.2	18.8	44.9	59.0	52.2	85.9	48.6	38.2	44.0	35.7	45.1	39.7	36.4	35.5	35.9	37.6	36.2	36.2	39.1	31.2	9.6	24.0	5.9	29.6	57.2	50.2	80.7	34.1	13.6	35.6	57.0	88.1	30.0	51.1	47.8	4.2	50.8	21.1	61.4	103.7	55.2	4.2	63.3	32.9	27.8	22.2	33.7	19.0	69.4	79.2	31.0	31.1	40.9	22.2	35.4	26.7	52.4	84.3	11.8	13.6	64.2	52.9	37.7	32.3	4.9	26.1	39.6	30.2	5.6	45.5	28.1	28.8	9.0	5.9	62.7	42.0	28.2	24.3	77.0	83.4	131.3	64.0	17.8	19.7	22.8	31.9	23.7	26.9	57.9	58.7	43.6	30.6	63.5	72.4	81.8
COA7	"C1orf163, FLJ12439, RESA1, SELRC1"	ENSG00000162377	"Cytochrome c oxidase assembly factor 7 (putative)"	Q96BR5	1	52684449-52698347	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028154, HPA029926"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA028154: AB_10600656, HPA029926: AB_10602173"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	6.8	4.8	5.7	5.4	5.5	3.9	7.3	5.2	6.5	4.6	2.5	7.9	7.7	5.5	4.2	6.3	4.6	3.5	5.5	5.3	5.0	9.6	12.1	3.9	4.0	4.7	4.5	3.7	10.7	5.2	2.5	5.2	4.8	3.6	7.5	4.3	3.3	3.6	16.0	6.5	5.6	5.9	3.9	3.9	5.1	3.2	5.1	2.7	7.1	20.4	4.5	5.5	3.5	5.7	26.0	14.5	13.0	21.1	20.7	17.9	28.6	19.1	15.9	23.4	19.5	18.2	9.0	59.4	12.7	11.4	29.6	19.5	31.9	27.1	30.4	18.4	31.9	49.9	22.5	20.9	25.5	49.7	16.4	19.8	23.5	26.6	33.0	10.3	16.3	16.6	46.5	10.0	17.9	17.3	17.0	25.3	57.7	27.7	40.8	32.9	44.6	43.2	20.7	25.9	29.2	15.4	27.9	35.0	36.3	18.3	20.5	33.4	18.2	18.3	24.0	25.5	26.7	21.2	57.0	27.2	8.5	35.4	15.2	1.6	2.9	0.4	1.1	4.3	1.5	1.8	1.2	1.1	3.0	0.7	1.0	1.1	0.6	1.1	2.2	1.1	0.7	1.6	5.7	5.5	5.2	6.5	5.3	5.0	4.7	4.5	4.8	3.9	5.1	5.7	6.0	6.4	12.4	0.7	4.5	11.5	31.2	7.1	9.6	8.8	6.1	5.2	13.2	10.0	7.1	3.7	4.2	17.1	1.7	11.4	27.4	11.9	0.5	3.2	12.3	8.8	2.4	5.5	1.6	13.3	17.0	7.8	5.1	3.4	0.0	8.0	3.6	13.7	13.7	16.8	2.1	7.0	6.1	4.7	3.5	0.8	7.5	7.0	1.8	1.9	8.7	6.8	4.1	3.5	1.5	11.0	7.0	7.5	9.9	19.3	5.0	20.1	2.6	10.2	6.6	11.4	14.0	4.6	13.0	9.7	12.9	16.6	4.2	10.5	10.5	17.8
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536701	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: AB_2732585"	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	11.2	15.0	7.5	9.3	7.7	11.8	15.6	10.5	9.3	15.2	10.5	16.2	12.6	13.0	16.8	12.4	12.2	9.5	11.8	7.4	7.2	12.3	29.5	10.4	10.7	7.0	7.0	15.1	20.8	12.3	14.9	13.0	7.0	18.7	18.9	10.0	18.0	12.4	11.4	13.2	13.2	12.1	6.8	12.4	14.7	9.7	7.5	12.2	17.0	9.7	10.9	12.7	13.1	9.4	8.3	7.4	13.9	12.6	17.9	20.4	13.2	13.5	19.1	15.4	12.8	10.8	14.9	11.3	5.9	16.2	11.4	17.7	11.6	13.7	23.3	8.9	9.3	12.7	9.2	19.2	22.1	18.8	11.7	15.4	20.3	10.3	36.1	18.6	15.2	11.0	8.3	6.8	18.7	12.9	10.5	17.6	11.4	41.5	8.7	12.1	8.1	10.6	14.4	13.4	6.9	12.5	8.7	17.1	18.2	13.1	11.7	19.3	14.4	7.4	5.7	13.9	8.7	9.4	5.4	11.7	14.2	9.4	13.5	3.5	1.9	3.6	3.4	2.2	3.6	2.2	2.6	2.9	1.4	2.3	2.9	2.7	1.7	2.5	1.3	3.4	3.0	1.7	7.5	7.7	10.5	9.3	7.4	7.2	7.0	7.0	7.0	6.8	7.5	9.4	15.8	9.6	31.4	23.2	18.9	15.8	15.2	13.1	14.2	9.7	22.0	17.9	19.7	24.3	19.8	12.9	14.6	14.2	35.5	32.5	15.6	11.6	24.1	15.0	20.1	16.7	22.2	11.4	39.3	37.9	18.8	14.3	26.0	30.8	17.1	22.4	18.9	72.8	10.8	10.1	34.7	54.5	6.1	20.9	9.0	9.0	14.0	13.3	10.6	22.5	13.2	7.6	15.5	34.2	36.9	22.7	32.8	13.5	31.3	26.6	29.4	17.3	11.7	11.2	6.6	12.8	11.7	12.7	8.9	17.7	16.1	32.8	21.2	21.7	24.4	37.3
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201372-107564261	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 124.4;Excitatory neurons: 147.0;Inhibitory neurons: 196.1;Microglial cells: 147.1;Oligodendrocyte precursor cells: 136.7;Oligodendrocytes: 183.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: AB_2677564"	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (1.15e-1)"	11.4	12.1	6.7	9.5	7.7	14.2	10.8	7.7	8.5	20.4	8.1	12.0	9.3	17.1	10.0	12.8	9.0	12.9	19.7	7.1	7.5	9.7	6.8	10.2	9.5	7.0	7.5	12.4	14.7	19.4	10.2	10.5	7.6	17.8	12.4	11.8	22.8	11.0	14.0	12.9	10.1	14.4	6.3	9.0	11.7	8.6	7.5	6.2	20.3	15.4	10.4	10.5	16.7	9.4	39.3	14.9	16.1	15.1	14.7	16.2	12.6	27.0	28.2	11.7	20.5	12.0	17.5	7.9	14.9	27.0	26.5	15.5	10.7	16.0	18.2	23.5	9.6	8.7	9.9	15.1	17.4	18.8	19.0	15.4	15.3	20.4	24.0	32.1	31.7	17.1	16.6	25.1	21.5	18.5	19.2	17.8	5.9	30.0	19.1	6.8	13.6	18.6	13.6	17.9	7.6	21.8	16.6	27.2	31.2	23.8	6.2	12.2	36.6	12.6	16.0	39.7	17.2	16.3	16.9	17.3	24.2	21.0	33.9	9.4	6.6	7.5	6.1	7.6	8.4	6.0	7.7	6.9	5.4	5.8	6.4	6.4	3.4	5.1	9.3	3.7	6.5	5.9	6.7	7.7	7.7	8.5	7.1	7.5	7.0	7.5	7.6	6.3	7.5	9.4	14.8	3.2	15.5	124.4	21.7	12.2	15.0	11.1	24.5	23.2	10.0	7.7	27.6	7.2	16.5	14.7	33.3	10.2	16.5	15.8	1.9	10.5	22.6	11.8	21.8	11.0	10.3	5.9	147.0	10.9	8.5	14.4	14.8	19.8	3.8	12.3	9.7	5.8	11.3	11.8	196.1	36.2	18.3	14.8	12.3	22.1	11.8	15.3	12.4	147.1	15.7	9.0	11.3	136.7	183.2	10.8	10.1	12.4	20.7	20.6	14.5	6.5	16.3	17.4	26.3	15.4	10.2	18.2	14.0	19.0	13.4	10.5	18.9	7.5	14.9	16.1
COIL	"CLN80, p80-coilin"	ENSG00000121058	Coilin	P38432	17	56938199-56961050	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 98.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.2;Late spermatids: 591.1;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017524, HPA027885, HPA057480, CAB069400"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: "	"unprognostic (1.01e-2)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.71e-2)"	7.7	7.2	6.6	8.8	6.8	19.9	12.2	9.7	8.9	9.2	7.3	9.2	10.2	10.4	11.6	9.7	9.8	7.1	8.0	6.6	7.0	8.7	13.0	7.6	12.8	6.7	6.7	11.9	8.7	12.3	6.2	13.0	7.4	9.3	10.6	12.6	9.8	7.7	11.5	9.8	10.0	8.5	6.8	10.3	9.2	98.5	6.6	13.2	12.1	9.1	13.5	9.3	8.7	8.1	25.0	18.6	37.4	14.5	12.5	14.9	25.8	17.5	16.4	26.1	27.7	25.6	21.0	29.9	34.6	14.0	19.5	14.1	25.6	20.2	37.1	36.1	32.3	48.7	17.4	29.2	13.5	41.5	28.5	13.9	24.7	19.7	21.1	15.5	22.6	17.4	42.9	24.3	24.8	31.6	32.9	26.3	22.0	27.4	18.4	15.5	45.9	23.9	18.1	24.7	31.6	31.2	11.7	11.5	30.1	21.5	41.8	40.0	16.0	30.2	22.7	14.8	23.0	35.6	47.7	34.5	15.8	22.7	18.8	22.3	13.3	17.5	15.5	12.6	17.5	27.6	17.0	16.6	13.5	25.0	19.5	18.9	8.1	16.0	17.2	16.4	18.6	10.1	6.6	6.8	9.7	8.9	6.6	7.0	6.7	6.7	7.4	6.8	6.6	8.1	21.3	12.8	21.0	6.8	26.5	18.7	39.5	34.0	21.1	35.9	21.6	22.5	14.1	22.8	28.3	14.7	37.5	42.2	26.2	12.5	13.7	30.1	249.2	22.7	23.1	26.6	23.9	17.5	8.8	27.7	32.3	23.5	18.3	19.9	22.2	20.3	22.5	23.9	22.7	25.2	10.9	16.5	16.2	16.5	10.4	591.1	42.3	12.3	3.6	10.3	19.6	28.5	34.0	9.5	13.3	23.5	17.3	30.5	15.1	32.2	16.6	23.0	22.0	52.4	13.1	24.9	21.9	142.2	46.8	20.3	22.7	29.1	23.3	17.1	20.8	29.0
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535873	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 21.1;Excitatory neurons: 23.4;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 12.5;Respiratory ciliated cells: 16.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.3;U-266/70: 9.8;U-266/84: 2.8;WM-115: 4.9"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 3.6"	"Region enriched"	"Detected in some"	31	"spinal cord: 33.5"	"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	1.0	3.2	0.8	1.6	1.0	0.3	2.8	1.9	2.7	3.3	1.4	11.7	1.2	2.2	14.1	2.1	4.9	1.5	3.7	1.1	0.9	6.3	0.7	1.2	0.2	0.9	3.6	1.2	5.8	0.2	11.2	0.5	1.4	3.9	4.1	6.7	18.2	5.1	5.9	2.1	3.4	1.7	0.2	0.4	6.5	3.7	1.1	0.2	1.2	3.2	0.1	2.9	4.5	1.5	1.5	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.4	0.0	0.0	1.1	0.4	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.2	1.4	0.1	0.2	0.0	0.7	0.9	0.3	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.1	0.5	0.7	0.1	0.5	1.3	0.0	9.8	2.8	0.0	0.2	0.6	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.8	1.0	1.9	2.7	1.1	0.9	0.9	3.6	1.4	0.2	1.1	1.5	0.4	0.0	4.1	39.5	0.0	0.3	0.1	0.2	0.0	5.3	1.6	1.5	0.9	0.0	3.3	3.7	18.8	0.3	0.1	0.8	0.0	0.1	2.0	21.1	0.5	0.1	0.0	0.0	23.4	0.2	0.0	3.1	0.0	3.9	1.3	0.5	1.8	0.0	0.1	5.0	22.6	0.5	0.0	0.3	0.3	1.1	0.9	0.1	0.0	7.5	0.0	2.2	0.0	12.5	9.1	0.4	5.4	0.7	0.0	0.1	0.2	0.5	16.3	5.4	0.0	1.8	0.2	0.9	1.0	0.1	0.1	0.3	0.1	0.2	0.3	0.1
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972967-48004554	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, FDA approved drug targets, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 19.1;pituitary gland: 9.2;retina: 5.6;stomach 1: 12.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Enteroendocrine cells: 43.9;Late spermatids: 9.7;Muller glia cells: 22.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 156.3;HAP1: 98.9;HEK 293: 36.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002214, HPA055753"	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	No	NA		1400000		"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"CAB002214: AB_563666, HPA055753: AB_2682908"	"unprognostic (7.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.0	0.2	0.0	0.2	19.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.2	1.3	0.0	0.0	9.2	0.3	0.3	1.0	0.3	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.5	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.7	0.0	0.0	0.0	98.9	0.0	0.0	0.0	36.3	0.2	0.0	5.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	0.1	0.0	2.9	0.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	11.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.3	0.2	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.0	0.6	5.7	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	15.4	0.3	0.1	0.2	43.9	0.0	0.2	0.0	0.3	0.5	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	9.7	0.9	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	1.7	0.0	0.9	0.3	0.6	1.1	0.0	0.0	0.8	0.1	0.1	1.7	0.1
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300489-40317813	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease variant, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.2;pituitary gland: 108.1"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 295.4;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 128.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 3.2;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.2;granulocytes: 3.2"	"Group enriched"	"Detected in many"	4	"HDLM-2: 98.6;Hep G2: 27.6;HMC-1: 90.3;THP-1: 105.0"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA		510000	"Cluster 52: Eosinophils - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	Nucleoplasm	"HPA056316: AB_2683099, HPA075286: AB_2732288"	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	2.2	3.4	42.6	3.7	71.5	10.9	5.9	58.9	51.1	12.1	21.6	6.5	5.8	5.0	1.7	1.6	11.4	8.5	2.2	38.2	49.7	24.6	0.9	4.3	5.9	65.9	74.1	1.3	2.3	21.0	108.1	1.1	66.2	13.7	3.1	23.1	16.3	24.2	0.2	4.6	10.4	1.4	52.0	9.8	16.5	2.6	58.6	1.8	12.2	0.3	3.1	12.1	2.0	86.2	12.0	0.3	1.8	0.8	2.6	1.3	7.8	0.0	0.0	0.6	1.3	0.4	6.8	3.4	10.0	0.3	0.0	2.0	0.1	0.0	0.3	98.6	1.4	2.0	0.8	27.6	1.5	0.9	90.3	4.8	0.0	0.1	0.0	0.7	0.0	1.5	0.1	19.8	0.0	2.7	1.2	2.1	2.2	0.0	1.2	2.3	0.0	6.9	0.0	14.3	1.4	2.3	0.1	11.8	1.3	6.6	15.0	105.0	0.1	0.0	11.6	0.2	0.4	1.4	0.2	3.4	1.0	12.3	0.6	0.0	0.1	3.2	0.0	0.2	0.0	0.2	0.1	0.0	1.2	0.2	0.0	0.0	0.5	0.2	0.3	0.1	0.1	0.0	42.6	71.5	58.9	51.1	38.2	49.7	65.9	74.1	66.2	52.0	58.6	86.2	0.5	0.0	3.3	26.1	10.8	1.0	3.0	8.5	0.0	2.0	7.1	9.7	1.0	7.2	10.0	25.8	0.0	3.2	2.5	7.2	0.0	11.7	0.2	13.6	0.9	0.6	12.7	0.4	0.3	0.8	0.6	2.1	26.0	20.0	26.1	1.6	1.1	0.0	3.4	0.0	0.3	6.6	2.0	0.3	22.4	0.9	2.1	6.4	1.8	3.7	22.1	295.4	1.0	62.4	128.1	4.9	9.6	0.0	4.0	6.1	5.0	0.3	12.9	10.9	0.0	1.3	1.8	3.4	6.2	0.2	0.6	1.4	2.7	1.8	13.4	13.4
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.7;choroid plexus: 34.4;thyroid gland: 25.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 116.6;Late spermatids: 401.9;Muller glia cells: 95.8;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 68.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 30.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 143.4;Hep G2: 59.6;SK-MEL-30: 51.1;WM-115: 57.8"					"Low region specificity"	"Detected in all"			"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Intermediate filaments"	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	1.6	1.5	17.5	0.7	35.7	0.0	2.8	22.4	21.6	3.3	34.4	12.1	0.7	1.2	0.2	1.3	1.7	0.1	6.3	13.0	16.5	2.9	0.6	0.4	0.2	37.4	31.0	1.7	7.6	0.1	14.0	0.5	24.2	3.2	0.1	1.6	23.6	1.2	0.5	1.9	3.1	0.1	20.5	0.3	2.7	20.7	31.6	0.1	25.4	0.0	0.0	2.8	3.8	39.7	0.2	0.3	0.3	0.2	0.0	0.8	143.4	0.1	0.0	0.1	0.0	1.6	0.2	0.0	13.1	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.9	0.0	8.2	59.6	0.3	0.0	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.3	0.0	0.0	1.0	0.7	6.4	8.2	0.0	2.5	0.0	1.8	0.0	0.1	0.0	1.5	0.2	0.1	51.1	4.6	0.2	5.4	0.0	0.0	0.7	0.1	1.0	0.2	0.1	0.0	0.2	0.0	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	35.7	22.4	21.6	13.0	16.5	37.4	31.0	24.2	20.5	31.6	39.7	1.6	3.2	0.0	1.0	26.1	3.2	2.2	1.2	1.8	0.9	2.1	2.5	1.6	0.0	0.2	5.5	10.4	5.1	0.4	0.7	1.9	3.6	116.6	2.7	0.4	3.7	4.2	1.3	2.5	0.0	46.4	15.3	6.1	0.7	0.0	0.6	2.5	6.8	2.2	0.0	2.0	3.3	0.0	2.2	0.9	401.9	4.1	1.7	3.6	0.0	0.5	95.8	0.0	84.9	68.9	0.1	7.3	1.5	44.0	1.2	2.3	23.7	2.5	3.7	0.0	0.8	1.0	2.9	7.8	0.9	7.0	4.0	1.4	3.7	2.0	1.0
COLGALT2	"C1orf17, GLT25D2, KIAA0584"	ENSG00000198756	"Collagen beta(1-O)galactosyltransferase 2"	Q8IYK4	1	183929854-184037729	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 50.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.5;Excitatory neurons: 79.9;Inhibitory neurons: 71.5;Late spermatids: 76.2;Oligodendrocyte precursor cells: 115.1;Oligodendrocytes: 359.3"	"Cancer enhanced"	"Detected in many"		"glioma: 11.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"basophil: 11.1"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.1;OE19: 13.8;SK-MEL-30: 18.6;U-251 MG: 18.0;WM-115: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031749, HPA031750"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA031749: AB_10599298, HPA031750: AB_10611252"	"unprognostic (5.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-5)"	"unprognostic (2.08e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.13e-9)"	"unprognostic (1.53e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.80e-2)"	1.7	6.4	15.7	0.8	29.3	1.1	1.5	22.7	18.6	1.0	0.0	4.3	0.5	1.8	3.1	0.7	2.8	2.3	11.4	16.5	17.3	0.8	0.2	3.7	0.3	26.8	24.0	1.3	2.3	0.5	2.2	0.1	28.7	5.3	0.9	3.5	2.9	2.2	8.8	0.3	1.0	1.7	20.2	0.5	1.9	3.5	25.8	0.3	3.3	6.3	0.5	1.8	1.5	50.6	0.1	0.0	5.7	0.4	3.0	4.4	0.1	1.8	0.7	0.8	1.0	2.8	0.2	0.0	0.5	4.4	1.1	0.0	5.6	0.0	1.4	6.6	3.3	0.4	0.0	17.1	0.1	6.0	0.1	2.6	0.0	0.8	0.1	8.4	0.0	0.2	5.7	7.2	6.1	0.2	0.3	0.3	3.9	13.8	0.0	0.5	0.0	0.0	0.0	1.2	2.2	3.5	0.3	0.0	18.6	3.7	0.0	0.3	0.1	0.7	0.7	0.1	18.0	10.8	0.1	0.1	0.5	2.8	22.5	11.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	15.7	29.3	22.7	18.6	16.5	17.3	26.8	24.0	28.7	20.2	25.8	50.6	0.1	0.0	0.0	53.5	0.0	0.4	0.5	0.0	0.0	4.4	0.3	0.3	3.5	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.6	40.3	0.2	0.5	0.9	0.0	1.3	79.9	0.0	0.0	9.9	1.5	0.5	0.0	0.2	0.0	0.1	0.3	0.0	71.5	0.1	0.0	0.3	9.5	76.2	2.1	0.9	1.8	4.7	0.0	5.7	8.2	115.1	359.3	1.2	0.0	4.1	1.9	0.2	0.0	0.3	0.0	0.4	13.1	2.3	3.1	0.3	1.3	0.0	0.4	0.0	4.5	0.4	0.0	0.4
COMMD1	"C2orf5, MGC27155, MURR1"	ENSG00000173163	"Copper metabolism domain containing 1"	Q8N668	2	61888724-62147247	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034633, HPA049223"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA034633: AB_10601800, HPA049223: AB_2680680"	"unprognostic (6.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.93e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.77e-1)"	20.8	26.4	22.2	21.9	23.4	20.4	27.0	25.2	33.0	23.0	22.9	18.6	22.6	20.0	30.1	24.8	20.9	20.2	54.7	23.5	22.9	31.2	35.9	18.7	23.5	22.1	22.1	21.3	24.1	24.4	14.8	26.5	22.6	22.2	22.6	20.1	33.5	20.2	35.2	22.2	14.9	29.9	22.4	20.6	19.2	24.4	22.2	20.7	28.1	38.1	25.5	23.9	19.8	24.1	23.2	29.1	32.0	25.4	41.2	41.2	27.4	27.2	45.6	53.7	37.9	50.1	20.4	40.4	22.3	50.8	45.8	17.6	18.0	33.1	55.8	43.9	21.1	31.5	16.3	56.0	35.1	49.6	23.8	34.6	37.7	26.1	30.8	39.2	54.6	23.2	19.6	64.3	56.7	43.6	38.6	87.4	27.9	19.0	39.0	27.1	42.4	46.7	49.3	25.0	19.5	21.7	30.7	50.9	28.6	31.8	32.4	21.4	25.9	48.1	41.5	30.2	42.4	26.6	22.9	48.6	26.5	42.8	42.8	62.4	96.2	48.4	63.0	86.5	63.4	91.8	71.5	72.0	117.3	84.7	68.1	73.8	8.1	91.1	78.4	109.5	88.8	110.8	22.2	23.4	25.2	33.0	23.5	22.9	22.1	22.1	22.6	22.4	22.2	24.1	53.0	35.3	33.8	56.8	38.2	54.4	73.8	98.7	47.8	35.4	47.0	72.4	176.7	41.5	57.3	35.0	10.4	127.3	37.3	27.4	129.1	71.5	195.6	50.6	52.1	53.2	21.6	43.1	91.9	65.1	75.5	67.6	32.1	47.2	57.7	60.4	52.5	72.4	101.7	28.6	78.4	29.8	63.1	36.0	81.3	163.5	41.3	46.3	83.6	71.2	118.6	45.3	30.9	89.5	109.7	57.1	37.1	49.7	71.5	48.9	49.0	192.3	49.1	33.2	32.9	57.6	97.2	124.5	58.7	49.6	61.7	147.2	38.6	81.6	30.1	64.0
COMMD10	PTD002	ENSG00000145781	"COMM domain containing 10"	Q9Y6G5	5	116085016-116412762	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 184.6;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 236.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045441, HPA054156"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA045441: AB_10961905, HPA054156: "	"unprognostic (1.14e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.59e-1)"	19.4	24.1	12.5	14.2	12.4	14.9	23.1	12.8	15.9	19.2	14.4	17.0	13.0	16.7	32.2	15.6	12.9	17.3	31.3	11.7	13.3	35.4	24.6	13.9	22.1	12.8	13.2	13.9	24.1	25.4	14.3	19.6	13.4	20.7	20.1	17.1	30.7	17.0	14.3	9.6	13.8	19.6	13.5	18.6	16.3	8.1	13.2	16.3	27.4	17.5	20.3	18.0	13.6	14.7	34.7	36.7	37.5	20.0	27.3	37.1	40.2	26.5	30.0	37.5	31.0	29.2	43.7	17.9	29.0	37.9	75.0	18.6	20.8	42.6	56.9	49.3	14.6	22.1	10.7	22.9	30.8	17.5	37.1	23.7	28.7	22.4	29.2	31.1	37.9	25.2	13.6	12.1	50.2	24.2	32.9	41.9	32.7	26.8	16.9	30.9	40.1	51.2	54.7	21.8	20.2	26.0	31.3	30.5	39.7	28.1	34.6	64.1	20.9	31.5	38.5	15.3	46.0	11.9	16.3	45.8	32.1	63.2	36.5	13.6	24.6	18.3	9.9	29.7	13.7	16.2	12.9	12.8	32.7	11.3	12.5	13.0	4.7	22.7	31.0	24.9	15.3	18.9	12.5	12.4	12.8	15.9	11.7	13.3	12.8	13.2	13.4	13.5	13.2	14.7	25.7	9.6	20.0	97.3	36.7	22.2	30.4	54.0	17.6	15.7	28.1	18.3	48.9	11.5	29.5	23.9	6.2	44.9	16.9	11.5	92.0	26.2	1.9	15.8	22.2	24.0	10.7	18.5	84.8	15.1	53.4	25.0	27.0	22.8	46.3	22.5	26.4	15.1	48.7	16.8	90.5	25.1	46.8	28.7	38.4	3.7	21.1	33.1	32.0	184.6	27.1	30.2	15.5	142.7	236.7	17.1	17.2	20.3	30.6	33.1	17.3	101.3	10.4	20.9	0.0	13.4	22.4	8.7	15.6	20.5	25.1	49.5	28.4	36.3	25.5	32.0
COMMD3-BMI1		ENSG00000269897	"COMMD3-BMI1 readthrough"		10	22316388-22329542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"retina: 10.1;testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.3;MOLT-4: 12.7;U-937: 23.8"									"HPA030471, HPA030472, HPA036584"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"		"Nuclear bodies"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803"	"unprognostic (8.63e-2)"				"unprognostic (2.36e-2)"									"unprognostic (1.83e-2)"				0.9	2.2	0.4	1.0	1.4	0.3	0.8	1.0	1.9	1.5	0.8	0.8	0.6	0.4	0.0	1.8	1.3	0.2	3.0	0.3	1.6	0.4	0.5	0.9	1.0	1.3	0.7	0.6	0.8	0.4	0.1	0.7	0.9	0.5	0.2	10.1	1.8	2.7	6.4	0.7	0.8	0.3	0.4	0.9	1.1	6.7	1.3	2.0	0.4	2.3	1.5	1.0	0.8	2.0	2.1	6.4	3.9	0.2	2.5	2.3	0.4	0.9	1.3	1.4	5.8	7.8	1.2	1.9	0.8	3.0	5.1	1.1	2.8	2.2	1.3	23.3	2.4	5.4	1.5	0.0	1.7	0.6	3.0	2.9	3.2	3.3	0.1	4.3	1.6	8.3	1.4	2.8	0.8	0.0	12.7	0.9	0.4	3.9	2.1	1.7	3.1	1.7	0.5	1.9	0.4	2.7	5.5	1.1	0.2	1.4	0.0	4.7	6.8	2.3	3.9	1.3	0.7	4.9	0.9	3.5	1.2	23.8	0.0	7.4	2.1	3.0	3.4	2.4	3.7	7.5	3.2	4.1	2.2	7.3	2.4	1.8	0.7	4.9	1.3	0.3	6.5	4.9	0.4	1.4	1.0	1.9	0.3	1.6	1.3	0.7	0.9	0.4	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COMMD5	"FLJ13008, HCaRG, HT002"	ENSG00000170619	"COMM domain containing 5"	Q9GZQ3	8	144841042-144853736	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046905			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA046905: AB_2732535"	"unprognostic (2.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (5.05e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.24e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-3)"	17.0	22.9	16.6	11.9	17.0	21.2	15.7	18.1	19.7	14.9	15.6	15.6	12.1	16.1	9.7	20.1	14.2	11.3	18.9	16.2	16.3	18.7	23.2	15.1	16.2	18.1	16.9	12.8	16.7	14.5	17.7	11.0	17.5	16.4	6.8	3.8	15.5	10.7	18.2	16.8	14.9	8.8	17.3	21.9	16.4	11.2	17.2	11.3	16.4	11.4	10.6	15.9	14.3	18.7	32.8	38.3	17.9	24.2	21.8	17.4	16.0	18.5	19.7	30.9	24.2	23.0	25.1	22.3	40.4	22.6	17.9	21.7	22.5	30.6	13.2	29.6	31.7	47.1	35.3	38.8	28.8	16.0	39.6	23.1	27.6	21.2	15.7	15.0	24.2	7.9	34.2	39.8	25.2	59.4	14.6	16.8	27.1	45.6	75.3	18.8	20.4	34.8	30.2	28.3	41.6	36.6	30.9	18.5	27.4	11.9	36.3	29.7	22.4	23.1	45.9	33.3	36.8	16.6	19.2	21.3	32.5	29.7	30.5	66.1	84.3	76.6	55.8	72.4	49.8	60.7	42.4	54.9	74.2	54.1	41.6	46.7	52.3	69.2	47.0	26.8	71.2	70.1	16.6	17.0	18.1	19.7	16.2	16.3	18.1	16.9	17.5	17.3	17.2	18.7	27.8	12.8	15.0	8.5	27.5	27.8	20.4	46.4	11.4	12.3	22.8	23.9	10.9	21.5	25.0	16.5	12.5	35.8	39.0	26.4	39.2	46.4	3.5	19.6	16.4	27.6	19.9	14.1	6.2	40.1	23.8	22.7	13.7	18.6	24.8	15.6	25.7	19.0	70.0	11.8	7.7	16.8	34.6	31.4	27.6	2.5	18.6	34.2	26.6	5.6	37.2	22.3	38.1	6.6	9.5	50.0	18.4	23.3	20.3	42.7	29.8	44.6	28.2	15.2	13.1	16.0	24.6	12.1	17.2	18.4	30.0	33.1	27.0	28.7	18.9	28.5
COMMD8	FLJ20502	ENSG00000169019	"COMM domain containing 8"	Q9NX08	4	47450787-47463702	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 231.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035887	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA035887: AB_10600702"	"unprognostic (9.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (2.71e-5)"	"unprognostic (1.06e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.13e-2)"	13.4	15.5	9.7	20.3	9.8	21.4	13.6	10.0	14.6	11.8	13.0	17.7	18.4	10.4	22.6	24.1	11.3	13.7	27.2	9.5	12.2	45.3	12.7	13.5	30.4	9.9	10.3	10.2	10.4	26.8	13.4	19.0	10.0	10.6	18.1	13.5	8.4	10.0	8.8	17.5	19.0	15.0	10.4	18.1	14.3	24.1	10.3	21.6	21.3	12.6	25.4	16.8	11.8	10.3	32.6	17.6	15.2	7.8	31.6	44.8	21.1	47.8	31.5	30.7	41.5	29.9	37.4	51.7	39.0	45.3	69.4	17.0	49.4	39.1	55.0	30.8	22.1	29.8	17.7	23.2	43.0	73.6	36.8	38.7	51.6	29.2	32.3	28.5	39.5	33.7	22.5	20.6	75.8	18.1	44.1	59.4	10.4	21.8	22.8	21.8	34.7	11.2	88.1	26.3	29.8	15.2	19.9	16.1	39.6	26.5	29.5	48.0	32.7	43.6	41.8	39.2	57.9	21.6	27.6	42.1	47.3	95.2	32.2	114.3	58.2	68.9	44.6	80.4	48.1	48.1	40.5	44.9	74.0	43.4	37.5	43.2	29.0	57.4	89.4	34.3	51.2	71.4	9.7	9.8	10.0	14.6	9.5	12.2	9.9	10.3	10.0	10.4	10.3	10.3	31.3	22.4	16.5	3.3	41.6	22.6	11.4	60.5	21.6	18.2	12.8	16.6	46.1	18.6	32.6	29.5	4.2	86.6	39.1	20.9	107.6	42.8	68.4	43.0	21.6	26.7	21.0	14.5	5.5	46.3	116.3	28.6	16.8	19.2	33.0	11.3	22.5	12.7	90.9	6.7	7.3	19.4	42.7	54.4	42.1	18.9	54.3	50.7	12.4	4.7	82.0	37.2	72.1	2.5	5.3	25.1	23.8	40.6	22.9	8.6	28.0	231.8	57.4	23.8	19.7	16.9	29.9	141.5	59.0	37.3	30.0	105.8	53.9	36.9	28.8	10.2
COMMD9	"FLJ31106, HSPC166"	ENSG00000110442	"COMM domain containing 9"	Q9P000	11	36269284-36289449	"Predicted intracellular proteins"	"Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009142	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA009142: AB_1847105"	"unprognostic (1.56e-2)"	"unprognostic (4.75e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.15e-2)"	"prognostic favorable (8.54e-4)"	"unprognostic (4.94e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.08e-3)"	"unprognostic (7.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.88e-1)"	26.8	32.1	33.8	21.8	34.1	50.8	24.3	35.1	36.7	17.2	29.6	19.6	21.1	14.1	25.1	24.9	20.3	20.5	31.1	33.8	33.8	38.7	36.6	26.8	26.0	34.2	34.4	19.4	26.4	27.4	23.2	24.8	33.9	14.0	24.2	20.3	21.9	13.3	64.2	27.1	20.2	21.9	36.9	26.8	19.7	14.9	36.0	30.6	25.1	61.7	32.0	20.6	16.6	39.1	28.8	33.4	36.1	38.2	54.5	37.8	20.0	33.6	42.6	74.7	69.8	27.3	23.9	33.0	32.5	67.1	57.5	41.4	64.0	45.2	69.6	39.9	75.2	18.2	57.6	48.0	51.0	71.6	52.3	48.0	49.5	40.9	25.0	38.5	62.2	43.3	45.7	34.7	59.4	36.9	47.9	49.6	38.5	55.6	70.3	52.1	81.7	38.9	78.6	26.6	44.1	49.2	47.9	47.1	43.6	29.2	102.7	27.0	41.9	45.0	34.4	107.9	49.8	24.3	53.2	37.2	51.8	66.4	44.0	85.6	376.6	173.7	91.4	359.0	86.8	130.7	87.5	88.4	383.6	138.3	99.8	83.4	42.7	94.8	300.9	145.8	114.5	315.2	33.8	34.1	35.1	36.7	33.8	33.8	34.2	34.4	33.9	36.9	36.0	39.1	26.9	22.4	29.4	2.6	27.0	15.3	12.7	37.4	13.1	16.6	25.6	38.7	29.9	12.8	20.2	18.4	10.4	43.2	28.3	16.9	78.2	70.1	9.5	13.2	20.3	22.8	25.7	23.1	9.4	46.4	52.9	21.2	11.7	17.0	19.0	25.6	15.4	17.1	105.1	5.0	8.7	20.4	34.6	59.5	35.6	28.9	17.7	57.5	24.9	1.9	61.3	36.3	33.0	4.5	8.8	46.5	17.7	11.7	10.4	4.9	30.3	62.5	8.5	22.9	13.1	12.3	22.8	32.8	33.3	19.6	21.6	24.9	19.2	28.4	24.6	12.0
COPA	HEP-COP	ENSG00000122218	"COPI coat complex subunit alpha"	P53621	1	160288594-160343273	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	Hormone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028024	Supported		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		150000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA028024: AB_10603787"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	47.7	43.1	46.6	38.5	48.9	30.0	42.0	57.2	57.1	52.9	67.4	42.3	53.7	46.7	55.1	38.3	41.2	38.6	55.1	48.6	53.7	48.6	55.0	47.0	36.1	57.9	51.0	46.9	49.9	51.8	59.8	48.3	60.0	43.5	47.9	26.2	57.6	39.4	59.1	40.0	49.0	50.0	53.9	42.7	43.5	24.4	51.1	37.6	60.1	38.2	38.9	41.3	37.9	66.4	91.0	68.5	70.1	66.9	164.9	154.7	78.6	116.5	144.3	103.1	138.7	72.0	60.5	64.4	73.3	194.0	57.7	86.0	92.0	81.3	126.5	68.6	64.3	76.8	95.2	79.0	115.1	94.1	74.5	134.8	49.1	140.0	128.9	126.3	126.4	64.4	71.9	69.7	124.4	43.6	49.3	53.3	80.1	97.3	79.0	49.2	89.2	118.9	94.3	94.7	62.1	84.3	157.3	109.2	148.0	115.0	140.4	133.9	162.8	84.3	54.1	108.2	80.2	106.8	76.3	106.6	104.2	51.3	122.8	48.1	39.0	25.4	18.6	36.7	25.5	17.8	16.7	21.3	40.4	14.2	14.3	17.9	10.9	26.7	36.2	17.8	22.9	35.5	46.6	48.9	57.2	57.1	48.6	53.7	57.9	51.0	60.0	53.9	51.1	66.4	53.6	76.9	54.7	44.7	66.4	28.2	35.5	41.6	29.6	52.4	53.0	41.3	51.8	42.9	49.7	40.5	81.3	41.0	83.2	66.8	13.7	49.9	14.7	50.7	68.1	50.4	55.3	37.0	77.6	49.6	63.3	66.2	65.2	64.3	45.6	63.0	52.8	71.1	51.2	45.4	73.8	83.8	30.5	93.7	58.0	6.4	71.1	84.3	26.6	67.5	75.0	41.0	38.1	65.9	178.9	55.5	48.1	56.8	115.9	52.9	98.9	41.4	66.2	53.7	39.5	57.6	52.4	37.6	25.7	35.8	31.8	69.2	58.3	58.1	66.6	61.2
COPG1	COPG	ENSG00000181789	"COPI coat complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		57000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	84.7	111.0	66.6	59.0	68.2	59.4	79.8	69.5	80.7	100.4	93.0	107.6	86.7	75.5	157.4	86.8	70.0	53.8	95.5	70.3	73.7	82.7	149.5	84.4	54.8	74.3	71.5	77.9	162.4	96.3	139.0	81.9	77.4	107.7	109.8	33.4	130.7	72.7	75.7	74.4	86.7	72.2	66.4	81.9	114.0	46.5	73.2	53.5	83.3	43.2	67.1	67.2	72.2	73.2	167.8	83.2	119.1	104.0	272.8	219.0	126.9	266.3	251.8	179.5	225.2	153.9	101.2	91.1	150.8	380.7	145.6	98.4	99.5	157.2	193.6	112.0	41.4	151.9	103.2	252.6	247.9	116.4	156.4	230.9	135.6	143.8	235.0	196.1	164.3	68.9	54.2	213.6	219.2	253.4	68.7	117.7	71.3	243.6	100.9	73.3	111.8	178.3	227.3	136.7	74.1	86.1	204.2	150.3	255.9	129.8	167.1	167.6	223.9	96.9	91.7	207.2	104.2	165.7	86.1	158.9	236.4	86.9	190.0	79.1	49.9	37.2	44.1	59.2	53.6	24.9	39.8	43.9	57.0	26.9	30.0	36.2	37.2	57.0	57.3	52.2	43.8	56.2	66.6	68.2	69.5	80.7	70.3	73.7	74.3	71.5	77.4	66.4	73.2	73.2	16.6	16.0	31.5	7.8	19.2	8.8	16.9	35.4	12.0	9.2	18.9	8.6	23.3	17.2	34.6	27.6	4.2	55.6	19.7	77.0	43.0	44.5	10.4	26.2	27.7	22.8	38.6	22.9	14.1	46.5	63.1	32.5	53.0	36.9	15.2	28.6	28.9	56.5	39.0	5.0	14.8	75.1	22.4	31.2	14.8	4.7	41.0	21.6	23.2	7.5	36.5	12.7	18.6	4.5	11.8	40.8	44.6	31.2	68.4	24.4	64.5	39.5	32.6	7.1	19.7	20.2	33.3	24.3	17.0	16.4	10.2	72.2	19.4	27.7	44.6	20.6
COPRS	"C17orf79, COPR5, HSA272196, TTP1"	ENSG00000172301	"Coordinator of PRMT5 and differentiation stimulator"	Q9NQ92	17	31851871-31859291	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 253.2;Late spermatids: 288.9;Spermatocytes: 575.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052552	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA052552: AB_2681868"	"unprognostic (1.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.11e-2)"	51.1	46.5	127.4	20.1	130.0	14.2	49.8	124.6	172.8	42.8	129.5	99.0	16.0	43.4	117.6	26.4	51.7	32.0	66.1	128.7	136.2	55.8	68.1	33.9	21.0	123.6	126.7	51.7	41.9	49.0	67.4	19.7	128.8	60.2	27.4	56.0	35.4	46.3	53.5	30.3	31.1	44.4	123.3	25.1	51.6	241.4	131.2	13.2	63.2	53.3	27.8	57.1	33.3	124.1	101.5	132.9	64.4	66.6	104.3	99.5	45.2	109.7	140.3	125.8	127.8	83.4	27.0	53.0	58.8	135.1	245.0	58.5	116.0	67.6	142.3	18.7	153.8	15.4	79.7	99.5	105.5	53.2	43.4	64.2	87.4	169.3	92.4	135.7	68.6	75.2	75.0	46.9	139.6	89.9	79.6	170.7	49.1	65.2	62.8	61.8	120.8	104.4	74.5	62.8	58.4	44.2	65.9	32.6	107.1	56.1	104.4	57.9	37.0	327.8	85.9	116.6	156.3	76.2	77.2	58.3	170.8	50.1	44.9	1.8	2.0	0.0	0.6	2.0	1.6	1.9	0.5	0.1	2.6	3.6	0.3	0.3	0.6	0.0	0.9	1.0	0.8	0.3	127.4	130.0	124.6	172.8	128.7	136.2	123.6	126.7	128.8	123.3	131.2	124.1	54.2	22.4	8.3	13.7	20.9	34.4	69.0	15.3	29.6	43.1	79.2	88.4	78.9	68.6	13.4	86.5	10.4	31.9	10.7	12.1	225.0	99.6	253.2	142.2	38.5	53.5	19.7	18.7	14.6	80.8	54.9	65.7	14.3	40.5	3.8	39.9	62.4	95.4	87.6	26.9	14.8	15.9	40.7	30.3	34.7	288.9	62.4	36.5	58.7	7.5	47.9	136.3	9.2	3.5	9.2	70.7	8.4	65.1	27.4	127.4	6.4	212.0	55.8	43.0	19.7	46.9	63.5	575.6	63.8	21.4	31.7	27.4	11.2	49.6	21.3	39.6
COPS3	"CSN3, SGN3"	ENSG00000141030	"COP9 signalosome subunit 3"	Q9UNS2	17	17246616-17281273	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021997, HPA050557"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		38000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA021997: AB_1847152, HPA050557: AB_2681176"	"unprognostic (3.35e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (1.56e-4)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.03e-3)"	30.8	29.1	27.6	29.5	29.0	110.1	28.3	29.9	39.9	27.2	24.7	34.5	24.7	26.3	23.8	41.6	24.0	17.2	59.0	29.8	31.8	23.5	29.1	23.0	37.3	30.8	29.7	23.5	44.3	36.4	39.9	29.0	30.7	25.0	29.8	25.4	30.1	25.8	156.7	33.9	24.9	29.1	29.3	26.7	32.5	76.3	28.4	51.2	24.0	100.7	40.9	29.7	29.0	31.1	141.8	128.8	96.0	86.3	46.2	63.8	58.2	102.6	62.6	150.6	119.3	209.7	50.9	196.9	82.5	83.4	67.5	100.8	138.9	104.2	175.3	76.0	182.1	137.6	90.8	87.0	76.4	120.3	146.1	58.0	77.1	104.3	102.1	43.1	90.0	108.2	114.3	70.4	97.0	137.8	217.4	142.9	90.9	156.3	80.4	163.9	178.9	102.5	61.0	55.2	79.7	63.9	94.0	44.9	83.8	286.9	64.6	76.1	63.2	89.7	101.0	164.7	184.5	54.9	74.5	106.0	81.8	113.2	93.4	37.4	43.0	44.0	35.4	51.3	40.7	35.4	40.0	41.3	60.8	39.1	40.4	37.9	55.6	46.0	52.4	30.8	47.7	56.9	27.6	29.0	29.9	39.9	29.8	31.8	30.8	29.7	30.7	29.3	28.4	31.1	32.0	32.1	19.1	11.1	52.7	54.2	43.3	69.0	33.0	23.2	31.1	27.8	50.5	34.3	38.6	14.7	14.6	95.1	52.2	17.1	33.2	52.8	136.1	27.4	30.1	33.3	37.6	117.0	13.6	51.2	84.5	37.5	21.4	33.5	40.0	26.7	22.9	23.1	67.0	25.2	16.3	37.3	44.7	36.4	52.3	79.2	39.7	43.6	35.6	11.2	60.0	41.3	53.5	13.6	16.0	33.4	18.6	38.0	65.6	43.0	27.4	36.6	25.5	38.0	19.7	52.5	49.9	262.3	109.8	50.1	47.6	104.4	51.3	43.9	43.3	36.5
COPS5	"CSN5, JAB1, MOV-34, SGN5"	ENSG00000121022	"COP9 signalosome subunit 5"	Q92905	8	67043079-67083783	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 347.5;Late spermatids: 427.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004242, HPA004845, HPA051531"	Supported		Enhanced	Nucleoplasm		NA	NA		37000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-2)"	43.5	43.8	52.1	33.3	54.2	39.4	45.2	58.3	62.6	34.2	52.0	45.5	45.6	34.0	43.6	42.2	35.6	31.6	100.0	53.2	57.1	56.3	71.0	33.1	40.9	55.1	53.3	33.4	43.0	58.5	31.1	50.9	56.8	36.4	51.6	39.7	42.3	36.6	125.2	36.0	47.8	47.6	57.4	33.4	37.6	58.7	56.2	52.6	37.8	134.9	48.7	42.2	30.0	59.7	104.0	97.8	79.6	74.4	83.1	88.3	63.3	89.0	74.0	121.2	108.9	62.6	125.4	96.5	39.9	93.6	86.8	84.1	109.2	98.9	134.0	92.4	92.1	135.9	95.2	87.3	82.2	86.3	79.1	81.0	126.2	99.1	132.6	95.2	121.2	100.3	163.0	64.6	111.8	96.5	154.3	157.6	107.1	217.2	108.6	97.2	56.7	76.4	131.3	91.6	48.6	66.7	51.0	98.4	91.6	71.2	160.9	90.8	89.9	60.1	74.9	74.7	70.3	81.4	108.5	127.7	89.1	97.6	84.1	65.8	52.0	64.5	35.8	55.7	37.2	36.8	34.6	39.9	63.9	33.7	36.1	32.4	38.3	51.9	56.6	34.0	53.2	43.8	52.1	54.2	58.3	62.6	53.2	57.1	55.1	53.3	56.8	57.4	56.2	59.7	55.0	22.4	26.0	19.2	40.6	49.3	45.1	102.6	28.5	36.4	43.7	51.8	119.9	58.6	61.2	31.3	33.3	143.8	58.0	38.1	88.0	73.4	347.5	44.6	38.2	46.4	34.2	69.2	21.5	60.0	101.4	45.2	25.5	37.1	36.1	50.9	34.2	35.5	79.3	25.2	21.5	41.5	59.0	31.7	28.5	427.2	43.2	40.2	28.4	10.3	59.9	62.0	56.7	18.6	32.4	50.1	48.6	51.1	46.6	54.0	87.8	81.9	46.1	53.0	32.9	49.1	87.8	123.4	49.6	42.9	47.5	127.8	42.3	72.5	55.4	50.6
COPS6	"CSN6, MOV34-34KD"	ENSG00000168090	"COP9 signalosome subunit 6"	Q7L5N1	7	100088969-100092187	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044315	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA044315: AB_10959750"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-2)"	71.3	85.5	98.5	48.7	103.0	51.8	68.6	102.5	102.0	87.1	99.5	101.3	44.1	86.5	84.0	90.6	78.1	52.9	112.9	101.9	100.7	70.8	71.6	56.5	50.3	99.3	98.4	74.8	60.2	100.8	79.2	64.0	100.4	68.8	57.8	61.4	65.0	74.2	147.3	61.8	58.4	78.5	101.7	63.1	78.4	57.4	98.7	63.1	61.5	152.8	60.6	90.5	74.7	105.0	167.6	233.4	136.2	163.5	116.1	138.4	86.6	147.7	223.5	239.7	174.9	191.9	153.8	114.4	186.1	242.2	267.3	124.1	155.1	247.9	240.4	114.9	242.6	98.2	215.9	149.3	243.3	112.1	97.6	137.5	161.4	259.2	273.9	159.5	333.0	172.7	142.7	160.5	286.4	413.7	251.6	164.8	124.0	241.3	273.2	117.6	226.6	275.4	193.6	153.8	213.4	158.6	152.7	298.5	114.1	176.4	123.7	109.2	177.9	231.3	211.1	280.5	264.8	118.1	140.2	235.3	175.5	150.0	350.6	231.8	187.8	168.2	178.8	206.6	180.7	168.0	176.8	170.9	211.3	170.3	137.4	153.6	73.5	163.5	194.6	157.8	225.8	146.6	98.5	103.0	102.5	102.0	101.9	100.7	99.3	98.4	100.4	101.7	98.7	105.0	87.8	51.3	44.2	24.8	73.4	110.6	118.1	208.1	70.0	108.3	62.8	76.3	166.3	88.6	117.2	86.5	52.1	197.3	84.2	55.1	211.3	138.3	76.5	61.6	103.4	94.9	75.3	69.0	20.9	113.5	133.7	116.0	52.5	48.3	90.7	100.5	90.3	63.2	128.8	95.9	21.0	67.4	158.7	69.6	82.5	197.1	127.7	55.1	156.5	13.1	101.4	147.0	115.4	17.6	24.0	115.1	64.7	125.3	84.3	95.0	84.2	214.2	117.9	127.1	98.6	76.3	261.5	80.5	100.2	81.2	100.3	137.9	82.7	137.9	87.1	96.1
COPS7A	CSN7A	ENSG00000111652	"COP9 signalosome subunit 7A"	Q9UBW8	12	6724014-6731875	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026915	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		54000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA026915: AB_1847156"	"unprognostic (3.50e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	45.0	52.8	69.2	32.9	69.1	19.7	36.1	69.7	71.7	34.1	66.0	44.5	29.9	39.2	46.7	55.2	44.7	32.7	79.1	71.9	70.9	48.3	53.3	34.7	29.9	72.0	72.0	34.8	40.3	71.9	51.1	42.7	71.4	42.8	30.1	46.8	44.5	40.2	103.6	39.2	29.0	43.1	67.3	33.3	41.2	24.0	77.1	22.8	45.8	98.1	30.4	45.8	38.5	67.4	73.3	78.8	34.0	33.3	96.3	114.0	84.9	93.2	107.8	87.6	86.7	54.3	95.0	47.1	37.1	111.2	49.9	55.9	45.7	86.6	75.5	70.3	57.8	47.0	50.1	63.9	84.6	47.1	28.3	106.7	80.6	97.5	183.4	100.1	61.8	29.2	33.3	18.1	116.0	58.7	29.5	30.3	92.9	91.4	64.1	18.8	71.9	47.2	69.0	69.0	19.4	47.2	58.4	67.5	97.2	79.5	29.9	68.0	70.1	90.8	48.4	82.3	85.6	21.0	24.7	38.4	150.6	60.0	104.7	85.9	56.4	86.1	36.3	73.2	35.8	26.2	30.7	32.2	65.3	36.0	30.2	29.8	43.7	31.0	58.9	41.3	30.9	49.9	69.2	69.1	69.7	71.7	71.9	70.9	72.0	72.0	71.4	67.3	77.1	67.4	23.7	16.0	17.5	17.0	14.7	13.9	31.4	39.8	25.0	37.0	29.1	27.6	36.7	22.8	28.0	23.9	6.2	72.6	11.7	15.7	66.5	47.8	4.3	21.4	28.0	23.4	12.6	17.0	13.0	49.7	58.2	34.8	13.7	22.9	16.5	13.0	22.9	26.3	63.2	30.3	15.3	18.6	69.2	24.2	14.4	6.5	23.0	26.1	12.4	5.6	50.0	51.4	13.4	11.1	11.9	49.8	18.6	25.6	16.2	34.3	22.3	47.3	23.8	23.8	39.5	21.7	33.2	16.9	40.6	39.2	13.9	59.1	12.6	40.6	17.1	30.7
COPS7B	CSN7B	ENSG00000144524	"COP9 signalosome subunit 7B"	Q9H9Q2	2	231781671-231809254	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034675, HPA034676"	Uncertain		Supported	Nucleoplasm		NA	NA		44000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA034675: AB_10696360, HPA034676: AB_2674274"	"unprognostic (3.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (2.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.55e-3)"	10.8	15.6	16.5	11.3	17.6	11.7	11.3	16.3	26.3	16.7	14.3	15.1	6.9	14.2	10.6	12.7	15.1	8.1	10.8	17.0	16.4	11.9	14.6	11.6	17.8	16.0	17.4	13.8	11.5	19.8	15.5	15.0	17.3	14.9	15.1	9.4	14.1	14.9	13.6	17.0	13.3	16.7	16.2	17.5	15.9	20.5	16.8	22.9	13.9	12.8	22.3	13.9	13.8	18.4	24.8	20.9	31.7	33.5	22.1	27.8	33.9	19.8	18.6	31.5	37.3	35.9	26.6	23.4	21.2	24.3	38.1	19.5	45.6	36.1	46.8	40.3	42.3	46.2	17.9	51.4	23.8	49.1	25.0	19.4	36.2	35.2	25.8	28.6	36.4	58.2	51.7	18.6	30.2	31.8	49.7	40.0	48.5	24.8	22.0	54.6	38.8	25.6	24.2	21.1	34.2	28.5	18.6	15.8	35.4	44.9	20.1	39.6	23.6	22.9	22.1	26.8	27.7	29.9	26.9	65.0	22.0	34.2	23.4	12.6	8.4	4.6	12.3	9.9	12.1	13.3	9.6	11.4	12.5	13.3	13.1	9.4	1.8	15.8	13.7	9.8	10.5	11.5	16.5	17.6	16.3	26.3	17.0	16.4	16.0	17.4	17.3	16.2	16.8	18.4	10.6	16.0	11.3	28.1	17.1	12.4	12.2	24.0	18.2	13.8	16.7	16.5	6.7	10.0	15.2	16.5	10.4	24.2	19.7	8.6	13.7	14.1	54.6	10.7	10.1	11.1	23.3	7.6	14.8	9.3	20.5	12.3	9.7	9.0	5.7	18.1	14.6	7.9	15.1	13.5	14.3	15.7	18.3	12.7	9.7	14.9	18.0	10.1	12.4	14.0	18.6	9.5	35.0	18.1	17.8	13.7	9.5	20.3	13.5	12.5	10.4	9.9	11.4	18.3	13.1	8.3	13.5	43.3	61.4	16.5	8.1	17.8	16.5	21.1	14.3	12.1
COPS8	"COP9, CSN8, MGC1297, SGN8"	ENSG00000198612	"COP9 signalosome subunit 8"	Q99627	2	237085882-237100474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 451.5;U-138 MG: 536.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036485	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA036485: AB_10670720"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (1.34e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	51.2	47.8	58.1	36.0	62.8	41.2	42.0	61.2	67.3	42.8	54.9	36.3	17.0	44.1	38.1	26.8	37.4	42.4	83.7	64.5	76.1	51.9	34.4	29.4	32.5	59.4	59.4	48.2	22.6	64.1	37.5	43.7	62.4	34.1	24.7	91.8	27.7	35.9	172.9	30.4	23.8	54.1	62.2	24.1	30.3	47.2	64.0	48.7	37.2	118.1	32.9	52.0	32.5	63.2	58.9	48.6	103.5	51.8	289.5	226.1	69.2	100.7	99.0	100.3	110.7	31.9	57.9	39.9	37.6	110.0	159.5	43.3	102.4	136.1	138.8	94.9	66.2	58.0	57.5	113.8	199.4	76.3	33.3	376.9	153.0	101.2	451.5	124.6	119.4	84.7	81.9	37.4	320.9	55.7	94.7	77.7	91.7	63.0	70.2	71.7	123.3	79.9	124.7	46.4	50.8	87.3	60.3	51.2	155.4	82.4	59.5	61.4	127.4	536.9	91.1	106.1	110.7	71.1	64.0	127.9	167.4	46.0	138.7	59.1	45.2	56.1	57.1	53.3	70.9	68.3	60.4	65.8	55.7	56.9	58.3	60.7	14.1	72.2	58.0	40.2	70.7	70.5	58.1	62.8	61.2	67.3	64.5	76.1	59.4	59.4	62.4	62.2	64.0	63.2	46.8	32.1	24.4	13.1	38.5	75.5	50.0	97.1	39.9	55.2	32.3	26.8	114.2	31.5	44.4	33.1	27.1	61.6	32.5	12.5	142.8	65.1	34.7	45.0	41.2	52.2	21.0	39.6	20.6	40.8	79.3	85.7	23.0	28.7	42.6	38.9	38.9	23.5	61.0	35.3	20.1	16.5	95.6	29.6	59.3	21.1	72.7	24.2	126.3	11.2	44.6	98.2	39.1	15.1	20.6	52.6	16.7	75.6	44.4	44.9	22.6	96.9	55.3	63.0	59.2	44.7	69.8	98.1	116.1	33.6	64.5	44.5	44.5	50.0	21.0	41.8
COPS9	"CSNAP, MYEOV2"	ENSG00000172428	"COP9 signalosome subunit 9"	Q8WXC6	2	240126563-240136807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 340.8;Breast myoepithelial cells: 395.6;Distal tubular cells: 498.9;Exocrine glandular cells: 383.2;Pancreatic endocrine cells: 347.0;Proximal tubular cells: 720.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044845	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA044845: AB_10962975"	"unprognostic (6.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-2)"	141.9	129.3	373.7	62.2	373.1	80.5	139.6	386.7	485.1	118.8	367.8	164.4	73.5	97.0	142.5	167.4	93.3	59.3	245.9	386.8	372.6	176.8	93.3	92.1	88.4	373.9	376.2	105.7	183.9	72.3	168.3	50.2	375.8	129.9	52.1	50.3	124.6	69.2	282.2	142.7	99.4	59.3	376.9	113.7	149.6	105.2	384.0	74.9	119.2	131.2	58.0	115.3	125.4	396.2	151.7	200.3	154.5	162.4	209.0	169.6	142.0	213.7	147.0	136.5	173.9	146.2	131.7	41.4	62.5	196.0	218.1	118.9	138.4	197.5	94.0	177.6	510.6	125.0	182.8	458.8	166.1	126.7	112.4	201.1	159.9	102.0	126.3	126.1	203.2	207.8	147.3	87.0	201.8	324.3	204.2	391.0	235.5	188.5	433.3	158.3	207.2	129.3	172.4	256.1	178.7	178.8	112.1	150.7	243.1	118.5	139.0	242.2	165.7	179.5	203.1	231.3	206.9	177.4	166.2	220.1	223.8	148.6	180.9	514.1	298.1	415.1	292.3	315.9	293.1	322.9	298.6	301.0	287.2	237.6	260.5	294.1	106.3	259.4	330.2	364.2	386.0	415.1	373.7	373.1	386.7	485.1	386.8	372.6	373.9	376.2	375.8	376.9	384.0	396.2	187.9	128.2	121.1	0.0	41.2	0.0	0.0	0.0	0.0	0.0	340.8	395.6	0.0	0.0	55.7	275.8	0.0	175.1	117.0	0.0	498.9	220.7	0.0	182.6	190.7	75.6	0.0	0.0	0.0	383.2	193.7	82.8	0.0	193.1	61.8	174.9	0.0	0.0	322.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.4	0.0	0.0	145.3	0.0	0.0	0.0	0.0	347.0	0.0	0.0	18.6	0.0	0.0	720.0	67.1	0.0	0.0	0.0	93.1	0.0	0.0	0.0	0.0	132.4	69.8	129.2	0.0	0.0
COQ3	bA9819.1	ENSG00000132423	"Coenzyme Q3, methyltransferase"	Q9NZJ6	6	99369401-99394195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 51.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.8;Distal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031273, HPA031274"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA031273: AB_10611107, HPA031274: AB_10602176"	"unprognostic (1.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	6.4	10.1	13.4	5.2	14.3	4.6	8.6	14.7	18.0	5.6	13.7	10.7	8.2	5.2	7.6	9.3	5.1	3.5	30.9	13.8	13.9	12.7	15.1	3.5	5.6	13.8	14.0	6.8	6.6	14.2	8.5	3.0	13.9	7.7	12.5	11.9	9.6	8.4	37.3	6.9	6.6	6.3	13.7	6.4	7.4	3.0	13.8	7.9	5.2	51.1	7.1	6.8	6.5	13.7	20.2	11.4	13.5	19.2	8.6	9.6	18.4	17.0	10.5	25.2	29.0	15.9	8.5	19.6	11.1	12.8	16.3	18.3	22.7	26.6	30.6	21.0	29.1	24.1	15.5	17.1	11.3	35.0	9.0	6.1	16.0	14.9	14.9	5.5	15.6	23.8	37.2	14.5	13.6	19.8	15.5	29.0	16.4	19.7	21.7	7.5	13.8	26.1	19.9	17.3	21.0	11.2	11.8	18.0	22.9	9.0	22.1	22.8	5.6	10.9	16.0	17.0	26.4	5.1	10.0	30.9	14.0	33.6	16.4	14.1	2.9	2.4	5.0	6.9	5.8	5.6	6.4	8.1	7.3	2.5	10.5	7.8	0.4	10.1	6.1	4.9	5.2	4.7	13.4	14.3	14.7	18.0	13.8	13.9	13.8	14.0	13.9	13.7	13.8	13.7	4.7	3.2	3.7	6.5	3.9	4.5	6.8	26.1	7.4	8.1	5.0	6.3	42.8	5.7	11.2	3.7	0.0	14.0	2.2	3.7	33.2	11.5	0.5	3.5	4.9	5.5	0.0	8.2	10.6	10.5	13.3	5.9	3.6	2.6	1.3	6.6	3.3	8.6	6.8	6.7	13.2	7.3	24.4	1.3	3.5	0.3	8.1	2.4	5.4	1.0	2.0	13.2	4.1	4.5	7.6	9.2	5.8	6.0	4.7	2.4	5.2	12.0	4.9	8.7	6.6	6.5	10.6	3.6	10.9	8.0	4.3	6.3	3.7	11.1	9.8	4.7
COQ7	"CAT5, CLK-1"	ENSG00000167186	"Coenzyme Q7, hydroxylase"	Q99807	16	19067614-19080095	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubiquinone biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 40.4;neutrophil: 126.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 126.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067252, HPA071922"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Nucleoplasm	"HPA067252: AB_2685813, HPA071922: AB_2686473"	"unprognostic (1.37e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.23e-12)"	"unprognostic (2.19e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.27e-2)"	10.2	13.6	10.7	7.0	11.2	4.8	13.4	10.9	11.6	10.8	12.5	14.1	12.4	15.6	12.3	12.4	15.5	10.7	23.4	11.0	10.8	14.1	12.3	10.0	8.3	10.6	11.3	20.0	10.3	24.4	9.7	10.0	11.1	17.7	13.2	14.0	10.4	14.7	45.8	7.9	11.8	11.6	10.4	10.0	12.8	20.9	11.3	10.3	16.2	44.9	8.4	10.3	8.8	13.1	23.5	24.8	21.1	12.4	11.6	12.2	17.7	13.5	11.0	18.0	18.5	15.9	19.1	17.8	63.9	10.4	19.4	24.5	29.6	16.9	13.0	15.2	29.9	9.5	22.8	49.3	14.4	22.9	20.1	10.3	14.6	16.8	12.2	14.8	14.8	20.9	26.4	16.2	12.9	42.4	24.0	18.4	16.1	9.1	13.1	29.0	23.3	22.8	15.7	15.5	30.4	17.4	12.6	27.4	16.2	10.2	25.2	30.7	16.3	19.0	10.9	14.1	19.7	15.0	26.2	19.7	20.4	13.1	12.5	40.4	11.4	17.8	9.9	10.6	9.4	16.3	8.9	8.7	12.6	15.3	12.2	10.8	126.5	12.9	12.3	15.6	6.2	5.6	10.7	11.2	10.9	11.6	11.0	10.8	10.6	11.3	11.1	10.4	11.3	13.1	13.3	16.0	12.6	6.2	35.5	11.0	26.3	20.9	13.6	31.2	18.3	21.1	21.8	31.5	14.9	16.5	39.6	21.2	28.7	38.1	45.0	25.2	14.8	23.7	16.2	16.1	24.0	4.8	6.0	18.0	17.9	14.9	32.1	23.2	25.4	31.1	20.7	11.1	23.3	20.2	8.8	39.0	30.5	29.4	12.9	8.5	18.6	18.8	10.6	4.7	11.6	39.5	8.2	5.0	9.4	13.2	30.4	13.9	11.6	17.8	71.5	23.7	24.4	53.9	19.7	20.0	20.2	81.3	53.1	12.8	12.4	32.2	23.9	38.2	39.8	24.0
CORO7-PAM16		ENSG00000103426	"CORO7-PAM16 readthrough"		16	4340251-4420494	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Club cells: 2.5;Oligodendrocytes: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041657, HPA053586, HPA062721"	Uncertain		Approved	Nucleoplasm,Microtubules,Mitochondria		NA	NA						"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Mitochondria"	Microtubules	"HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849"	"unprognostic (2.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.11e-4)"	"unprognostic (4.39e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.85e-1)"	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.3	0.2	0.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COX15	CEMCOX2	ENSG00000014919	"Cytochrome c oxidase assembly homolog COX15"	Q7KZN9	10	99710868-99732127	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037727, HPA037728, HPA066096"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: AB_2685616"	"unprognostic (9.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.34e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.40e-2)"	15.0	31.2	12.9	9.7	13.3	6.6	13.8	12.9	16.4	16.7	14.3	17.1	12.6	15.6	14.2	18.8	15.2	10.4	21.3	12.7	12.7	21.1	23.4	11.4	13.7	12.4	12.9	19.0	16.2	14.6	16.2	10.8	13.0	14.5	16.0	15.3	14.2	11.0	34.5	14.7	15.6	10.9	12.7	17.8	16.2	12.0	13.6	13.4	13.6	27.2	16.1	19.6	15.0	14.1	22.7	50.3	19.6	42.9	28.4	22.4	15.9	16.9	22.1	25.0	23.9	37.6	30.2	42.8	26.6	15.4	15.6	32.1	44.2	25.7	26.5	19.2	21.0	25.1	23.5	39.6	30.0	33.5	22.3	23.3	23.9	27.7	40.9	36.6	26.3	36.1	27.3	29.6	24.2	24.8	24.7	27.6	21.0	22.1	22.0	30.2	29.5	27.9	24.8	16.6	16.7	26.4	29.9	16.6	29.5	15.7	61.2	13.2	22.1	12.4	17.1	18.7	25.6	25.2	36.2	28.5	22.7	53.2	10.7	19.6	12.8	12.4	7.4	15.2	8.8	12.7	8.6	8.4	13.9	11.3	8.6	8.9	7.9	8.7	18.5	5.7	9.9	9.7	12.9	13.3	12.9	16.4	12.7	12.7	12.4	12.9	13.0	12.7	13.6	14.1	11.4	22.4	8.4	32.0	14.1	6.1	10.3	13.2	12.0	14.7	14.2	11.2	25.2	14.3	15.9	14.7	10.4	23.7	9.0	16.5	29.4	17.6	1.9	14.0	15.4	10.8	17.5	9.4	18.7	15.8	20.7	9.6	11.7	14.6	2.5	21.5	7.9	27.2	17.4	13.5	23.7	13.4	6.1	27.4	8.6	1.9	10.5	14.7	12.4	12.2	18.5	13.4	13.4	16.6	26.1	13.2	11.9	10.1	9.0	7.5	16.5	24.5	27.7	15.5	0.0	11.0	9.4	10.1	9.5	12.2	9.2	22.7	10.3	35.8	16.6	9.3
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354719	"Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 90.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Late spermatids: 27.4;Respiratory ciliated cells: 12.6;Spermatocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 24.9;SCLC-21H: 10.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.7	0.1	0.3	1.0	0.2	1.1	0.9	1.0	0.5	0.4	0.4	6.7	0.2	0.2	1.2	1.2	0.7	0.2	0.1	0.3	0.3	0.8	0.1	0.3	0.2	0.3	0.5	0.5	0.2	0.0	0.9	0.2	0.4	0.7	4.8	0.4	1.4	0.2	0.3	2.5	0.3	0.2	0.1	0.3	0.2	90.5	0.3	3.3	0.1	0.0	1.9	0.5	0.9	0.6	3.1	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.2	24.9	0.1	0.2	0.3	0.3	1.8	0.7	0.2	0.2	0.9	0.7	0.0	2.0	0.1	0.3	0.2	1.8	0.2	2.7	0.5	0.6	1.7	0.0	0.1	0.4	0.2	0.0	0.6	0.1	0.2	0.6	2.6	0.5	0.1	0.0	0.2	0.1	0.4	10.1	0.3	0.4	0.1	0.0	0.6	0.4	0.0	0.5	0.2	0.5	0.1	0.3	1.6	1.4	0.1	0.1	0.3	0.1	0.8	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.2	0.2	1.5	0.5	0.2	0.4	0.2	0.3	0.3	0.2	1.0	0.5	0.3	0.3	0.3	0.5	0.4	0.1	0.3	0.6	0.2	0.0	0.5	0.0	0.0	0.5	0.7	3.5	1.2	2.4	0.9	1.3	0.6	0.0	2.1	0.0	4.2	0.5	1.8	8.0	0.0	0.5	36.0	1.3	0.5	0.2	1.2	0.0	0.0	0.6	0.3	0.6	0.0	0.8	0.0	0.2	0.0	0.0	0.1	3.3	0.1	1.3	4.1	0.0	0.0	27.4	0.6	0.3	0.0	0.0	0.0	1.4	2.1	0.0	0.1	9.6	4.1	0.0	0.3	0.7	3.4	0.1	12.6	5.4	0.0	0.4	0.5	61.1	1.7	0.3	0.4	0.4	0.6	0.1	6.5	2.3
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865296-148897203	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 112.0;lung: 86.3"	"Cell type enriched"	"Detected in some"	26	"granulocytes: 4422.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	1534	"basophil: 1115.4"	"Lineage enriched"	"Detected in single"	5518	"granulocytes: 1115.4"	"Cell line enriched"	"Detected in some"	45	"HEL: 303.3"	"Not detected"	"Not detected"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	18.2	2.6	0.0	19.9	0.4	25.7	20.9	0.0	0.0	59.4	0.3	39.2	27.3	26.1	19.3	41.1	6.6	112.0	6.2	0.0	0.0	3.3	2.7	86.3	11.2	0.0	0.0	0.9	21.0	2.8	0.9	1.7	0.0	18.5	56.6	0.0	12.1	15.1	1.6	17.7	45.9	25.7	0.0	1.1	45.3	3.8	0.0	14.9	0.9	10.2	15.1	54.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	303.3	0.0	0.0	0.2	0.2	6.7	0.2	0.0	0.1	0.3	0.5	3.8	0.0	0.1	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1115.4	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	163.9	0.0	0.5	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	16.0	0.0	1.6	0.0	3.5	0.5	0.0	4422.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	5.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	6.7	0.3	0.0	0.0	8.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	41.7	0.0	0.0	0.3
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.6;skin 1: 57.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 17.7;Basal respiratory cells: 23.7;Exocrine glandular cells: 54.1;Fibroblasts: 11.5;Suprabasal keratinocytes: 31.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 140.1;hTERT-RPE1: 261.0;LHCN-M2: 284.2;U-2 OS: 151.0;U-87 MG: 272.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	NA	Yes		390000		"Cluster 31: Skin - Epidermis development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (1.31e-4)"	5.0	4.4	0.4	0.4	0.4	0.1	3.5	0.5	1.7	15.3	0.5	0.0	0.0	0.2	0.3	21.6	0.4	0.1	1.1	0.6	2.1	0.6	0.1	0.4	0.2	1.1	0.7	0.1	12.7	0.0	0.5	2.0	1.1	0.2	0.0	0.2	6.7	0.0	0.3	57.1	0.2	0.8	0.6	3.3	0.4	0.3	1.2	0.8	0.0	0.0	0.9	0.0	12.6	1.1	95.3	5.0	0.3	0.3	0.7	1.5	0.1	74.6	140.1	74.9	18.5	0.7	8.1	0.1	14.3	31.9	75.2	5.5	0.0	41.3	76.7	0.4	0.3	0.0	33.3	2.1	1.8	0.3	0.2	1.0	65.2	6.7	9.4	261.0	0.3	0.1	0.0	0.2	284.2	0.2	0.0	0.0	0.8	0.4	11.1	0.3	75.4	0.1	34.5	4.0	0.2	0.0	49.9	23.3	0.5	28.0	0.5	0.4	57.3	18.1	151.0	6.2	7.4	0.2	0.2	0.1	272.7	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.5	1.7	0.6	2.1	1.1	0.7	1.1	0.6	1.2	1.1	0.0	3.2	0.5	0.0	0.0	17.7	0.5	23.7	0.6	0.0	4.2	2.8	0.3	0.0	8.5	0.0	0.0	5.6	0.1	0.0	0.0	0.5	0.4	0.4	0.2	0.3	0.0	0.0	0.4	54.1	1.2	11.5	0.0	2.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.3	3.6	1.0	0.6	0.0	0.0	0.0	0.5	7.9	0.0	0.0	0.0	0.9	0.0	0.1	2.9	0.0	0.0	1.3	0.4	0.1	0.7	10.0	31.0	9.4	0.1	0.0	0.0	1.6
CPA5		ENSG00000158525	"Carboxypeptidase A5"	Q8WXQ8	7	130344816-130368730	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 33.6"	"Group enriched"	"Detected in some"	23	"Early spermatids: 76.1;Late spermatids: 144.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 16.8;naive CD8 T-cell: 42.5;T-reg: 56.4"	"Lineage enriched"	"Detected in single"	102	"T-cells: 56.4"	"Cell line enhanced"	"Detected in some"		"RH-30: 7.3;RT4: 3.4;U-266/84: 6.0"	"Not detected"	"Not detected"							HPA020322			Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA020322: AB_10960562"	"unprognostic (2.44e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.88e-13)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.08e-2)"	0.3	0.2	0.3	0.1	0.2	0.2	0.1	0.2	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.2	0.0	0.0	1.9	0.3	0.4	0.0	0.5	0.0	1.2	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.2	1.0	0.7	0.0	0.2	1.8	0.0	33.6	0.5	2.2	0.3	0.0	0.9	0.6	0.0	0.4	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.3	2.1	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.0	0.0	1.2	0.5	0.5	0.8	0.3	0.0	0.0	0.0	0.7	0.0	0.9	0.9	0.0	0.6	0.0	1.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	7.3	0.2	1.0	3.4	0.9	0.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	6.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.6	0.0	16.8	8.6	0.0	0.0	4.2	42.5	0.0	0.0	0.0	0.0	56.4	5.8	0.3	0.2	0.2	1.0	0.4	0.5	0.3	0.4	0.4	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.0	0.0	1.8	0.0	3.1	0.0	0.0	0.0	0.1	76.1	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	144.1	0.9	0.1	0.0	0.0	0.9	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	3.8	2.6	0.0	0.0	4.7	4.0	0.0	0.0	0.1
CPD	GP180	ENSG00000108582	"Carboxypeptidase D"	O75976	17	30378927-30469989	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 25.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052796, HPA055465"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear speckles"		NA	NA		1700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nuclear speckles"	"Nuclear membrane"	"HPA052796: AB_2681953, HPA055465: AB_2682823"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.25e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.08e-1)"	25.9	7.4	10.8	19.7	13.1	32.2	20.5	15.4	25.6	40.9	9.4	18.0	20.3	15.8	13.2	12.1	23.0	31.8	9.1	11.8	13.0	19.7	25.4	18.2	7.9	19.5	13.3	7.8	15.7	28.5	6.1	30.3	17.8	16.8	20.1	14.9	44.8	11.2	8.1	8.2	19.8	23.3	18.3	9.3	37.3	41.3	13.5	8.3	57.6	14.0	9.9	18.3	7.1	28.0	39.4	58.9	50.0	51.6	51.0	95.9	18.0	53.1	77.2	36.0	43.9	69.6	24.9	5.1	65.8	61.3	45.6	27.6	32.7	67.1	60.3	18.7	46.7	11.2	32.5	43.2	61.8	73.8	28.3	172.3	29.4	46.2	44.3	59.7	74.3	16.5	22.1	56.1	29.2	7.7	23.9	20.3	14.1	89.8	13.4	22.6	57.8	15.3	67.3	44.2	12.5	31.5	63.4	54.0	27.6	58.0	51.2	50.4	89.2	35.7	23.3	56.2	51.3	22.5	50.0	16.1	45.6	47.2	30.9	4.5	7.7	8.4	4.1	3.6	4.5	0.2	2.1	3.5	4.4	0.4	1.6	2.0	25.0	2.7	3.2	0.5	1.5	3.6	10.8	13.1	15.4	25.6	11.8	13.0	19.5	13.3	17.8	18.3	13.5	28.0	124.4	32.1	23.9	28.4	7.5	22.0	34.2	99.2	21.6	30.8	34.9	18.8	13.7	155.8	129.5	29.5	45.9	24.8	35.9	37.8	1.9	32.4	96.1	21.9	24.9	51.9	32.3	15.6	62.9	24.8	11.1	25.6	72.4	35.2	24.1	21.6	56.0	93.9	15.9	47.1	57.1	69.0	85.5	31.2	20.4	56.0	16.8	33.7	30.2	90.9	32.9	13.4	29.9	45.8	164.5	32.8	26.4	16.1	38.1	58.5	50.1	18.5	84.2	33.8	0.0	21.3	23.4	31.0	21.0	21.1	18.6	24.1	35.6	14.2	34.4	50.7
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498547	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 643.3;retina: 741.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 727.4;Bipolar cells: 569.1;Cone photoreceptor cells: 621.3;Enteroendocrine cells: 587.4;Leydig cells: 500.8;Muller glia cells: 530.9;Peritubular cells: 621.0;Rod photoreceptor cells: 803.3;Sertoli cells: 854.6;Smooth muscle cells: 519.4"	"Cancer enhanced"	"Detected in all"		"glioma: 240.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 311.6;SCLC-21H: 418.2;SiHa: 629.0;SuSa: 342.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		600000		"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	138.1	151.7	554.8	20.5	593.0	1.8	97.5	550.9	604.0	53.9	311.9	44.6	22.0	67.7	404.6	74.8	88.6	65.7	100.7	584.3	643.3	68.4	26.7	50.1	37.5	417.0	494.2	104.0	170.4	89.9	328.4	7.7	456.2	295.1	36.8	741.7	104.5	84.7	56.2	45.1	30.7	83.3	448.3	11.6	80.2	146.2	578.2	68.8	179.7	47.5	35.2	33.8	73.4	446.2	0.2	8.4	54.4	10.5	41.4	4.5	2.4	0.1	21.5	8.1	16.5	0.0	0.5	0.0	15.8	0.6	1.9	1.2	20.4	4.4	4.7	0.3	78.6	0.0	21.6	311.6	3.0	0.3	0.5	102.3	21.5	0.3	0.4	104.0	0.2	0.0	0.1	2.1	11.2	15.4	0.4	2.7	34.4	0.2	12.1	0.3	0.2	1.1	0.7	3.4	418.2	138.0	629.0	77.9	0.0	342.6	46.7	1.9	0.0	16.7	42.5	1.5	1.5	23.5	0.6	2.2	15.5	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	554.8	593.0	550.9	604.0	584.3	643.3	417.0	494.2	456.2	448.3	578.2	446.2	87.1	0.0	5.6	727.4	0.6	26.1	81.7	10.3	66.0	569.1	25.6	52.1	54.5	54.3	5.0	22.0	621.3	0.6	1.4	2.9	0.0	19.7	6.7	2.2	12.1	130.4	587.4	2.7	234.8	1.8	0.3	249.0	31.6	1.3	0.0	8.6	274.2	15.1	1.0	70.7	129.0	16.2	38.7	5.4	41.2	23.3	500.8	6.3	87.2	94.6	1.0	530.9	0.0	211.6	23.0	12.4	3.7	621.0	0.7	434.6	10.2	12.7	1.2	803.3	854.6	14.1	519.4	19.7	13.3	14.0	20.9	0.8	5.5	15.4	4.0	18.9
CPEB1	"CPEB, FLJ13203"	ENSG00000214575	"Cytoplasmic polyadenylation element binding protein 1"	Q9BZB8	15	82543201-82648861	"Predicted intracellular proteins"	"mRNA processing, Translation regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.6;testis: 32.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.0;Inhibitory neurons: 44.3;Oligodendrocytes: 196.5;Spermatocytes: 34.1;Spermatogonia: 62.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 37.9;U-2197: 106.0;U-87 MG: 39.1"									HPA040396			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA040396: AB_2676960"	"unprognostic (3.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.50e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	2.8	5.0	10.4	1.3	18.6	0.2	2.5	20.3	18.6	9.3	4.5	6.8	1.2	4.2	7.9	3.6	8.3	4.0	2.9	12.7	17.0	1.2	0.2	1.6	0.5	21.3	21.7	14.3	1.3	0.8	21.8	0.3	24.0	2.3	2.4	4.5	1.5	3.7	2.4	1.9	2.5	3.4	15.0	0.6	2.5	32.4	20.4	0.4	2.3	10.5	0.5	7.7	6.1	33.6	0.1	3.6	0.3	0.4	2.6	0.2	0.1	2.8	0.3	1.8	1.4	0.2	0.1	0.0	6.3	1.1	19.5	0.1	5.1	0.0	0.4	0.0	4.2	0.1	0.1	0.1	1.8	0.1	2.3	1.4	0.0	3.5	0.0	0.2	0.0	7.6	8.9	0.2	1.3	0.2	0.6	0.1	8.2	0.1	1.0	0.0	0.2	0.1	0.0	0.1	10.5	2.4	9.2	0.5	37.9	11.2	0.1	1.1	0.1	18.9	7.5	106.0	6.0	5.3	14.3	1.4	39.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.4	18.6	20.3	18.6	12.7	17.0	21.3	21.7	24.0	15.0	20.4	33.6	0.3	0.0	0.0	19.6	0.1	0.8	0.3	0.0	0.0	11.5	0.6	0.3	1.9	0.0	0.0	0.0	10.4	0.0	0.1	0.1	0.0	0.1	12.6	0.5	1.4	0.2	0.0	0.0	70.0	0.0	0.0	5.9	0.5	0.1	1.3	0.3	0.4	0.0	0.3	11.8	44.3	0.0	0.0	0.0	0.8	20.0	4.1	0.4	5.4	10.3	0.1	5.2	0.0	10.1	196.5	0.1	0.0	2.2	0.2	0.5	0.0	0.4	2.2	4.3	6.6	1.9	1.8	34.1	62.3	0.0	0.6	0.1	0.4	0.0	0.0	0.1
CPEB3	KIAA0940	ENSG00000107864	"Cytoplasmic polyadenylation element binding protein 3"	Q8NE35	10	92046692-92291078	"Predicted intracellular proteins"	"Translation regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 32.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 176.0;Early spermatids: 226.2;Excitatory neurons: 233.7;Inhibitory neurons: 286.9;Late spermatids: 408.9;Oligodendrocyte precursor cells: 148.8;Oligodendrocytes: 128.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.1;U-266/70: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070942			Approved	"Nucleoplasm,Plasma membrane,Midbody,Cytosol"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane, Midbody"	"HPA070942: "	"unprognostic (4.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.95e-5)"	"prognostic favorable (5.06e-5)"	"unprognostic (4.09e-4)"	"unprognostic (2.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.84e-9)"	"unprognostic (3.33e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.40e-1)"	1.9	3.9	6.1	1.8	7.2	1.7	3.2	6.2	17.3	2.5	2.1	2.3	3.1	1.9	4.5	4.6	1.8	2.0	5.1	6.4	4.3	4.6	32.2	2.2	1.9	10.4	5.6	3.5	3.5	3.2	4.0	1.6	11.0	4.2	2.6	7.1	7.5	2.4	19.7	4.0	3.0	2.0	1.4	2.6	2.8	12.9	4.4	1.5	6.5	9.5	2.1	1.9	3.1	7.0	0.9	0.2	0.3	1.9	0.5	0.5	0.7	0.8	0.6	1.2	0.9	0.6	1.9	1.1	1.0	0.3	0.5	2.5	0.9	0.6	0.7	1.1	0.9	1.4	1.3	0.8	1.4	0.6	1.4	0.4	1.5	0.6	2.4	1.0	1.1	1.3	0.9	12.1	0.5	0.7	0.9	0.8	0.2	1.3	0.9	1.1	1.6	2.1	1.2	0.4	1.4	0.5	0.8	2.2	1.6	1.0	2.7	1.6	0.8	0.6	0.6	0.4	0.7	6.3	1.7	1.1	0.3	2.2	0.1	2.6	0.4	0.8	0.2	0.5	0.2	0.7	0.1	0.3	0.3	0.1	0.1	0.1	0.5	0.2	0.6	0.2	0.1	0.2	6.1	7.2	6.2	17.3	6.4	4.3	10.4	5.6	11.0	1.4	4.4	7.0	6.1	6.4	7.0	176.0	6.2	8.8	4.0	4.0	7.4	26.0	20.5	10.7	25.3	5.7	4.4	12.9	50.1	2.1	3.0	11.3	5.9	3.2	226.2	9.0	3.0	7.1	19.8	3.6	233.7	2.6	1.6	5.5	4.1	10.8	3.8	4.1	12.5	75.2	4.8	30.3	286.9	9.9	8.2	23.9	3.4	408.9	5.9	10.3	5.4	87.1	8.9	3.2	4.1	148.8	128.6	3.2	4.0	7.9	4.2	10.7	10.1	5.0	8.7	24.7	0.0	4.4	4.1	13.2	7.2	22.0	13.9	1.2	3.3	3.4	5.9	6.5
CPEB4	KIAA1673	ENSG00000113742	"Cytoplasmic polyadenylation element binding protein 4"	Q17RY0	5	173888349-173961980	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 112.1;U-266/84: 173.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038394			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA038394: AB_10671226"	"unprognostic (2.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (4.99e-8)"	"unprognostic (2.66e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.83e-2)"	20.0	66.2	22.4	17.8	29.4	72.0	17.3	44.7	29.3	17.4	44.2	12.8	13.7	12.7	6.9	30.8	10.4	20.0	46.6	23.7	24.8	50.7	79.1	16.6	12.5	20.6	27.8	10.7	36.6	73.1	12.3	18.3	22.7	12.2	13.0	41.7	23.0	15.4	62.1	12.0	15.1	16.3	23.0	14.7	19.2	15.7	26.3	9.4	33.4	62.5	16.3	22.2	8.8	32.4	12.6	18.4	9.2	5.4	14.0	8.5	16.0	21.5	20.2	7.6	9.3	16.1	8.5	15.9	16.0	12.0	24.5	1.0	7.4	12.6	12.0	32.3	8.4	11.0	42.2	10.9	30.5	4.5	19.4	13.2	24.9	19.6	29.3	32.5	8.5	6.7	33.8	35.5	17.6	8.8	3.7	3.5	4.8	5.3	17.9	3.5	8.5	50.7	10.8	21.6	9.8	10.6	2.5	29.6	39.0	13.7	20.9	7.7	22.6	12.8	6.9	6.5	15.1	112.1	173.8	8.6	28.8	8.1	15.9	0.4	1.1	1.2	0.7	1.1	1.0	1.2	0.9	0.6	0.5	0.9	0.9	0.5	5.7	0.5	1.5	0.5	0.9	0.6	22.4	29.4	44.7	29.3	23.7	24.8	20.6	27.8	22.7	23.0	26.3	32.4	66.1	76.9	34.3	270.3	39.6	42.4	14.0	23.0	23.3	163.8	80.2	30.0	221.8	97.2	55.2	53.3	135.5	11.5	36.9	68.2	23.5	31.5	67.6	104.4	38.6	54.3	62.7	244.4	190.4	26.5	5.8	26.1	59.1	133.7	90.0	7.6	59.6	144.1	69.2	146.4	163.2	26.8	52.9	109.9	95.8	47.8	8.7	87.5	74.7	61.8	50.8	108.6	18.6	322.2	237.5	43.8	59.4	21.4	174.8	43.3	39.4	81.5	74.9	131.3	0.0	49.2	47.7	55.9	19.9	45.6	51.3	62.0	26.9	36.6	21.3	64.4
CPED1	"C7orf58, FLJ21986"	ENSG00000106034	"Cadherin like and PC-esterase domain containing 1"	A4D0V7	7	120988697-121297442	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 78.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 48.4;Microglial cells: 229.5;Peritubular cells: 81.6;Theca cells: 94.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 10.8;intermediate monocyte: 11.3;myeloid DC: 25.2;non-classical monocyte: 7.6;plasmacytoid DC: 15.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 25.2;monocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 87.6;Hep G2: 51.6;K-562: 182.3;LHCN-M2: 60.0;U-138 MG: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012058	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA012058: AB_1845761"	"unprognostic (7.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.52e-3)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.28e-3)"	"unprognostic (5.05e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.54e-4)"	55.0	18.5	2.1	6.5	2.6	0.9	10.0	2.4	2.6	25.2	5.5	16.1	9.1	32.9	13.3	16.5	15.8	26.7	21.5	1.8	2.6	7.1	44.3	16.7	1.8	4.5	3.1	78.5	3.4	1.4	3.3	24.9	4.5	28.1	15.0	1.1	4.1	36.7	17.4	2.0	11.5	38.6	4.1	17.8	10.3	5.5	4.5	1.9	3.7	38.7	1.8	20.7	6.1	5.4	6.3	0.0	0.3	0.1	14.0	40.7	0.3	25.5	87.6	8.6	23.5	0.8	0.3	0.9	0.3	14.0	9.7	0.3	0.4	0.0	22.4	0.3	0.9	7.1	0.3	51.6	24.3	0.2	0.2	16.7	0.0	20.0	0.4	6.9	4.4	0.1	182.3	12.8	60.0	0.0	0.1	0.2	0.1	0.0	1.1	0.1	34.6	17.3	0.0	0.6	0.0	2.2	0.0	0.1	0.6	0.4	0.1	0.6	2.6	50.2	1.3	42.5	24.3	5.6	0.1	0.6	5.8	0.2	2.5	2.0	10.8	0.0	0.0	11.3	0.1	1.4	0.0	0.0	25.2	0.5	0.0	0.0	0.4	0.0	7.6	15.0	0.0	2.9	2.1	2.6	2.4	2.6	1.8	2.6	4.5	3.1	4.5	4.1	4.5	5.4	19.1	19.2	0.5	12.4	2.5	3.1	0.6	0.0	1.2	0.1	0.6	1.7	20.3	1.5	0.0	0.0	0.0	0.4	8.3	0.0	0.0	0.0	0.2	0.8	23.2	6.9	0.0	2.1	0.9	0.0	2.9	48.4	0.5	0.5	0.0	11.9	28.2	21.9	4.3	3.3	14.7	0.0	0.0	14.5	28.5	1.9	21.1	23.1	3.6	229.5	5.3	14.0	1.0	1.5	0.7	0.0	0.0	81.6	3.0	1.5	0.0	0.2	0.0	0.4	0.0	9.1	32.1	0.6	0.7	1.0	2.0	0.4	0.8	94.5	0.0	2.6
CPLANE2	"C1orf89, MGC10731, RSG1"	ENSG00000132881	"Ciliogenesis and planar polarity effector 2"	Q9BU20	1	16231692-16237183	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 7.3;Distal tubular cells: 3.9;Ductal cells: 2.4;Endometrial ciliated cells: 4.1;Extravillous trophoblasts: 2.3;Hofbauer cells: 2.4;Proximal tubular cells: 3.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028453	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028453: AB_10601692"	"unprognostic (7.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.45e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	2.0	5.9	9.7	2.3	9.2	3.8	2.1	4.7	8.8	3.2	3.3	3.2	2.5	4.5	1.4	5.2	6.7	2.3	4.8	9.1	12.7	4.2	3.2	2.3	2.9	9.2	10.9	5.6	4.9	6.2	6.5	1.8	10.2	3.0	1.9	2.3	4.9	4.0	1.9	4.4	2.4	1.7	5.9	3.7	3.9	6.3	12.8	2.9	6.1	1.7	2.4	4.0	2.4	3.5	4.5	12.1	3.6	12.0	2.4	4.3	3.3	5.0	3.2	4.0	1.7	4.4	6.7	9.7	9.7	2.8	7.8	3.6	6.6	6.4	0.4	14.7	5.6	4.8	11.1	0.9	5.9	3.2	8.4	2.3	5.4	4.6	4.1	4.0	3.8	7.3	17.8	3.7	3.3	5.5	3.5	2.4	0.9	4.8	4.7	8.8	0.4	7.8	3.4	2.8	8.7	5.8	1.9	3.0	4.7	2.7	9.0	3.0	3.8	1.1	1.9	2.3	1.6	10.1	4.1	5.7	3.1	7.0	6.7	0.0	0.5	1.9	2.2	1.6	2.8	1.2	1.3	0.6	1.0	1.3	1.3	0.9	0.4	1.4	1.1	0.3	1.5	0.6	9.7	9.2	4.7	8.8	9.1	12.7	9.2	10.9	10.2	5.9	12.8	3.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	7.3	0.0	2.0	0.7	0.0	3.9	2.4	0.0	4.1	0.9	0.3	0.0	0.0	0.0	0.9	2.3	0.4	0.0	1.5	0.0	1.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.4	1.4	0.0	0.0
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065876, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA065876: , HPA072634: AB_2686541"	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	61.0	47.9	15.5	50.5	15.2	70.9	58.5	14.5	17.5	68.7	17.0	65.4	32.5	74.1	58.5	58.7	62.4	48.3	38.4	15.2	15.8	44.1	38.7	59.6	52.3	16.9	14.6	64.7	48.4	38.6	52.1	69.8	15.4	52.3	47.4	17.7	51.6	41.9	43.7	63.4	62.9	70.3	14.5	78.3	51.0	25.5	14.9	82.8	60.2	33.6	81.8	64.4	59.8	19.6	264.1	202.5	112.0	47.3	14.3	18.6	85.4	123.9	219.8	295.0	192.1	590.5	111.2	181.6	115.8	185.3	251.6	98.1	88.1	233.7	182.8	34.7	65.7	459.1	149.9	440.5	131.9	151.5	61.9	121.6	235.8	118.1	139.0	178.9	188.1	183.9	61.4	90.3	144.0	142.9	226.0	201.9	27.8	264.2	187.6	159.1	334.0	125.4	119.9	183.9	78.9	87.9	277.2	129.6	188.1	31.1	134.3	148.8	123.6	306.6	56.4	101.3	131.6	61.5	66.9	126.9	222.7	81.8	69.6	53.6	102.9	180.5	119.3	100.5	164.8	120.8	115.2	112.5	143.7	113.8	111.3	113.6	140.4	206.7	98.8	78.0	153.7	164.5	15.5	15.2	14.5	17.5	15.2	15.8	16.9	14.6	15.4	14.5	14.9	19.6	47.0	19.2	37.3	33.6	55.2	55.1	71.8	82.3	44.9	34.6	40.2	46.0	15.7	32.9	56.5	25.8	20.9	125.1	73.4	26.8	25.4	72.7	39.6	23.3	44.1	53.2	33.6	42.5	37.2	37.8	76.7	56.2	25.0	28.3	48.2	59.9	34.6	23.3	62.4	21.9	33.7	30.8	81.4	43.0	79.6	9.6	54.7	45.5	48.0	30.0	85.0	24.8	62.8	32.6	39.4	44.2	34.0	61.7	60.2	78.6	38.2	34.8	33.9	18.1	46.0	47.0	55.0	13.1	22.9	41.4	49.0	106.3	77.0	65.9	41.2	71.7
CPNE2	CPN2	ENSG00000140848	"Copine 2"	Q96FN4	16	57092583-57148369	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 87.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 84.3;Hepatic stellate cells: 82.8;Oligodendrocytes: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041132	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA041132: AB_2677316"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	35.1	7.3	34.5	12.8	50.2	60.6	24.9	41.1	45.3	36.5	36.9	29.2	6.0	20.7	6.6	15.9	28.0	14.3	15.5	36.7	46.6	14.1	9.4	37.2	11.0	52.9	48.1	10.7	7.3	10.9	7.5	27.9	48.6	14.0	28.3	1.7	10.9	17.1	11.7	11.7	21.2	25.1	39.3	18.2	9.2	16.4	61.0	6.3	15.9	13.5	9.2	16.7	18.5	87.4	23.9	45.1	68.0	38.1	12.0	11.6	11.3	25.4	39.8	56.8	39.5	12.7	27.0	14.2	22.7	38.6	31.4	36.7	27.1	15.1	30.6	17.7	15.9	5.9	17.5	10.7	21.6	4.8	0.6	11.1	16.8	22.3	10.8	42.4	84.5	7.6	16.0	0.5	14.5	11.1	7.2	69.9	15.5	11.6	9.5	88.8	21.3	11.9	37.7	9.0	1.4	27.6	32.3	6.9	19.4	30.5	7.5	94.4	60.3	51.6	27.7	13.1	33.5	3.4	3.0	31.8	33.4	20.6	37.0	0.0	1.5	0.8	0.2	0.4	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.2	1.5	0.1	0.1	0.0	0.2	0.4	34.5	50.2	41.1	45.3	36.7	46.6	52.9	48.1	48.6	39.3	61.0	87.4	84.3	19.2	7.4	8.1	1.5	2.3	17.1	6.0	7.4	0.4	8.2	6.9	2.3	4.3	5.1	5.5	0.0	0.6	1.4	43.4	5.9	4.7	19.9	33.4	13.8	41.0	3.6	0.8	1.0	4.2	2.9	12.3	1.5	39.3	0.0	26.7	82.8	2.0	23.6	0.0	7.4	13.7	4.1	25.3	7.4	5.9	6.8	12.0	7.2	8.4	10.7	3.6	0.0	17.1	86.3	6.2	25.1	7.5	0.8	14.2	35.4	2.6	9.2	0.0	32.9	9.3	21.7	0.6	2.6	6.2	4.3	0.8	8.4	2.1	18.2	16.3
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514435-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 249.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		71000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	35.4	29.3	14.6	22.4	17.4	76.6	42.3	23.0	15.0	40.7	24.3	35.0	32.1	33.2	21.4	73.6	32.0	30.1	52.4	15.5	19.2	51.5	46.2	33.8	39.5	15.3	17.6	39.2	29.7	52.1	11.8	25.5	17.3	41.2	34.2	18.2	37.1	29.9	17.5	36.3	30.8	31.7	16.4	28.4	30.1	8.3	16.2	38.5	60.9	26.4	46.5	34.9	25.5	21.8	135.1	46.8	30.9	40.9	116.9	92.1	24.6	63.3	93.3	51.9	58.2	30.4	44.5	36.7	40.6	77.6	31.6	101.2	68.7	67.5	92.5	39.5	52.1	6.0	27.2	34.7	41.0	2.3	1.5	63.0	71.2	57.6	76.0	83.1	64.6	17.6	33.2	68.4	65.0	51.6	65.9	1.8	10.5	110.6	64.4	30.7	28.9	174.4	67.4	92.2	66.2	51.5	55.4	249.3	39.6	35.7	95.0	10.3	69.3	44.5	44.1	61.3	49.4	47.0	63.3	9.9	66.0	12.6	42.9	28.6	32.6	54.3	33.2	38.1	26.2	26.4	27.5	23.8	63.1	26.9	23.8	26.1	46.5	27.6	52.5	62.2	20.9	32.0	14.6	17.4	23.0	15.0	15.5	19.2	15.3	17.6	17.3	16.4	16.2	21.8	84.1	137.8	103.9	23.2	52.0	81.8	110.6	111.8	96.2	16.2	80.2	73.9	120.2	75.8	89.3	69.9	14.6	73.0	85.4	49.4	99.7	77.9	1.6	66.9	73.5	66.3	50.2	28.4	37.0	83.7	55.1	92.6	48.9	83.5	8.2	44.7	66.4	103.9	50.4	45.4	39.9	55.3	81.4	71.0	93.8	4.5	85.7	64.0	53.4	13.1	75.0	75.6	36.0	58.3	24.5	59.3	51.7	87.6	49.4	112.5	53.3	126.1	78.8	17.4	59.2	102.1	77.4	3.2	8.8	183.2	91.1	78.0	55.2	71.4	75.1	91.8
CPNE4	"COPN4, CPN4"	ENSG00000196353	"Copine 4"	Q96A23	3	131533555-132285410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.3;prostate: 25.3"	"Cell type enriched"	"Detected in some"	10	"Excitatory neurons: 351.2"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 22.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 34.3;cerebral cortex: 15.2;hippocampal formation: 16.8;thalamus: 12.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.2;AF22: 5.7;Karpas-707: 1.7;RT4: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA032036, HPA078300"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA032036: AB_10600898, HPA078300: AB_2732377"	"unprognostic (7.38e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.51e-1)"	0.6	0.5	4.8	0.1	34.3	0.0	0.2	0.0	15.2	0.2	0.0	0.3	0.7	0.2	0.6	0.3	0.4	0.0	0.9	16.8	3.7	1.0	0.1	0.4	0.0	0.0	4.2	0.0	0.2	1.9	3.0	0.0	0.1	25.3	0.2	2.0	0.4	3.7	0.0	0.2	0.5	0.3	0.5	0.8	0.5	1.4	12.1	0.0	0.3	0.1	0.0	0.1	0.4	1.2	0.0	6.2	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.8	0.4	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.8	0.4	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.7	1.4	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.8	34.3	0.0	15.2	16.8	3.7	0.0	4.2	0.1	0.5	12.1	1.2	0.9	0.0	0.0	8.8	0.0	0.3	0.4	0.1	0.0	0.8	0.0	0.0	17.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.6	0.1	0.6	4.9	0.0	351.2	0.0	0.0	0.6	3.6	0.6	0.0	0.2	0.0	0.0	0.1	1.7	33.0	0.1	0.0	0.0	0.3	5.6	0.3	1.1	0.0	8.4	0.6	0.3	0.0	8.5	7.1	0.1	0.0	0.0	0.0	17.0	0.0	2.6	0.3	0.6	0.0	0.0	0.4	1.4	1.1	0.3	0.1	0.0	0.0	0.1	0.0	0.9
CPSF1	CPSF160	ENSG00000071894	"Cleavage and polyadenylation specific factor 1"	Q10570	8	144393229-144409335	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065167, HPA068906"			Enhanced	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA065167: AB_2685426, HPA068906: AB_2686055"	"unprognostic (6.37e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.54e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.90e-2)"	"unprognostic (9.66e-3)"	39.1	52.0	16.2	11.0	16.6	20.4	45.5	15.9	23.3	53.5	16.2	54.8	27.4	48.8	3.8	49.2	49.1	9.0	44.9	15.9	14.9	52.2	76.3	43.3	12.3	16.8	14.9	56.6	88.6	6.1	78.0	6.8	17.1	61.7	4.2	5.2	49.6	7.6	41.0	55.3	68.1	5.7	14.6	70.5	68.9	132.0	15.6	15.0	52.9	5.2	6.8	41.2	44.0	16.2	21.4	29.4	26.3	27.7	13.8	11.0	25.7	19.6	12.4	15.8	16.3	29.8	27.0	24.6	18.7	14.8	10.7	19.1	14.9	16.7	4.4	22.2	43.0	48.3	37.4	48.6	11.7	18.6	28.8	12.1	6.9	14.5	8.5	9.5	21.2	40.1	41.1	20.4	8.0	90.7	48.8	38.6	15.9	17.9	41.0	34.7	10.6	19.9	17.0	31.1	21.3	21.1	25.4	15.7	14.8	7.4	27.9	20.5	18.4	10.8	41.3	23.9	22.3	12.1	10.2	23.3	14.6	31.0	13.1	3.8	5.1	3.3	4.8	6.1	5.1	4.0	5.2	5.1	5.7	4.8	4.5	4.3	0.9	4.0	6.2	2.6	6.7	4.2	16.2	16.6	15.9	23.3	15.9	14.9	16.8	14.9	17.1	14.6	15.6	16.2	10.1	16.0	22.5	10.1	9.5	10.1	4.0	6.6	6.2	9.6	15.1	16.9	8.3	20.0	10.7	9.2	12.5	10.1	14.5	26.4	1.9	9.5	19.5	9.6	7.8	11.7	13.1	15.8	9.4	11.5	11.5	10.7	21.9	11.8	14.0	20.7	8.9	8.1	15.1	8.4	6.9	28.6	8.2	12.4	12.4	40.4	14.0	11.7	14.2	3.7	11.9	5.0	10.3	5.5	6.5	10.5	8.8	16.1	17.9	4.1	24.0	6.2	11.7	14.4	6.6	7.7	9.0	36.5	23.1	12.2	12.4	7.3	11.5	7.6	30.3	4.3
CPSF2	"CPSF100, KIAA1367"	ENSG00000165934	"Cleavage and polyadenylation specific factor 2"	Q9P2I0	14	92121969-92172145	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024238	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Vesicles	"HPA024238: AB_1847200"	"unprognostic (2.31e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.78e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.90e-2)"	14.8	14.5	7.3	24.9	9.7	11.5	11.8	9.3	10.1	13.7	13.0	16.1	14.7	15.0	15.0	18.3	11.7	15.0	13.1	6.8	8.9	13.6	19.7	14.7	21.0	9.5	9.2	12.6	14.9	18.2	10.7	16.7	10.6	15.6	16.8	13.9	13.6	14.1	27.1	11.1	14.4	17.8	8.5	18.6	17.4	26.0	8.5	27.3	18.3	25.6	24.8	16.6	12.3	12.2	48.1	46.9	47.0	48.6	23.9	21.1	69.5	60.7	59.0	55.1	54.3	41.4	64.9	51.3	38.9	65.1	37.2	69.2	65.2	55.2	79.2	83.3	22.4	75.4	46.1	39.5	70.5	76.3	60.6	34.7	46.2	52.5	93.8	36.5	52.2	54.5	68.8	62.9	62.1	69.6	88.3	26.8	53.3	76.8	42.3	86.0	72.7	45.9	37.5	67.1	51.7	34.7	71.7	39.9	51.1	41.9	82.9	47.4	56.3	43.9	27.7	33.4	52.4	37.6	66.2	103.0	53.0	58.9	69.7	16.6	12.9	9.3	7.8	11.7	10.4	7.6	6.9	8.4	11.3	4.0	6.1	8.6	4.4	11.1	9.8	7.3	12.1	9.5	7.3	9.7	9.3	10.1	6.8	8.9	9.5	9.2	10.6	8.5	8.5	12.2	14.2	28.9	31.8	23.2	22.9	10.3	15.2	15.1	15.9	12.7	13.4	9.5	27.1	10.0	25.5	7.3	29.2	24.0	19.8	14.6	13.7	18.0	28.2	24.3	30.0	22.9	13.8	33.0	13.6	24.0	22.7	20.0	17.3	16.8	30.4	26.2	20.7	27.2	24.8	11.8	17.5	17.3	12.2	32.9	8.8	11.2	19.0	31.1	3.6	19.7	41.2	16.9	27.8	18.6	27.9	23.8	14.0	23.0	35.4	29.9	12.5	16.3	34.1	22.7	32.9	19.6	23.2	61.7	41.3	27.2	12.8	25.3	22.8	26.6	18.2	20.2
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457373	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Vesicles	"HPA049094: AB_2680626, HPA066470: AB_2685672"	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	20.4	19.0	31.4	13.8	30.8	20.1	19.2	29.9	35.1	18.7	23.6	16.7	14.0	16.8	11.7	20.4	15.7	11.3	17.4	30.1	30.4	17.3	20.2	15.4	23.7	35.5	31.6	18.8	29.9	8.3	18.4	16.7	32.1	19.1	10.7	7.2	19.8	12.3	36.1	20.4	16.1	11.1	30.4	22.0	20.0	32.0	32.3	16.1	13.9	18.0	19.9	16.0	17.4	30.4	40.0	33.9	55.4	44.9	22.4	25.5	66.8	25.8	31.5	38.8	50.5	56.0	52.0	56.4	34.2	25.2	48.2	34.0	39.1	40.5	35.4	41.9	41.6	27.0	41.4	54.4	117.2	49.4	33.3	46.8	34.0	40.7	60.4	28.1	35.8	40.1	70.8	64.8	36.2	95.6	99.6	88.9	51.3	53.0	47.7	40.8	37.0	66.8	24.2	36.1	43.3	50.6	29.4	60.9	61.6	58.2	25.3	51.8	20.0	36.5	50.1	64.3	50.0	59.9	68.6	83.3	28.1	48.1	44.1	1.2	3.4	2.6	3.3	3.0	4.4	8.2	5.0	6.1	4.1	8.4	6.3	5.6	1.3	4.4	2.1	5.4	8.2	3.0	31.4	30.8	29.9	35.1	30.1	30.4	35.5	31.6	32.1	30.4	32.3	30.4	11.6	6.4	8.9	6.2	11.2	8.8	16.4	10.6	9.6	4.6	11.9	10.3	10.4	14.3	8.6	1.8	10.4	55.9	17.7	8.7	15.6	15.6	3.0	4.9	9.3	11.0	7.7	15.6	10.7	17.1	33.1	12.7	5.1	5.3	12.7	27.0	8.2	8.2	21.5	6.7	14.7	10.6	14.2	10.1	13.5	7.8	27.4	8.7	8.8	5.6	18.5	10.7	14.4	6.0	8.1	13.9	6.0	17.3	14.7	28.6	10.1	20.2	4.3	6.9	19.7	23.7	16.4	20.9	19.8	9.3	9.2	45.4	10.7	25.1	12.6	14.9
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239569-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	23.8	26.3	14.4	35.8	13.9	71.9	23.8	30.5	16.8	27.5	1.8	24.0	26.2	28.4	38.6	27.8	25.3	18.3	21.5	14.5	18.0	20.8	20.6	22.5	46.9	6.1	5.6	40.5	23.9	28.3	26.5	25.0	8.4	23.1	24.8	43.5	26.0	20.2	27.9	24.6	25.4	23.7	8.2	27.1	26.6	22.3	12.6	43.6	26.6	17.0	40.8	25.6	25.2	12.3	97.5	80.3	115.7	81.7	43.8	49.7	87.1	62.7	74.1	87.3	82.0	83.8	64.8	153.6	62.6	63.9	48.5	89.2	114.5	73.7	92.3	101.4	78.1	124.3	85.7	97.1	65.4	170.1	87.1	60.0	57.2	70.4	28.7	58.2	68.3	90.6	130.1	159.6	73.3	112.9	159.9	110.3	112.3	80.4	67.8	159.9	91.6	108.2	68.9	113.4	97.0	85.4	83.7	77.7	88.9	68.8	93.2	118.5	79.1	65.4	80.0	62.6	104.5	101.9	88.5	190.9	53.1	97.5	85.9	44.3	26.0	29.9	27.9	32.6	29.5	32.8	30.8	29.1	39.0	28.9	23.4	28.2	7.7	30.2	28.7	27.8	47.2	19.7	14.4	13.9	30.5	16.8	14.5	18.0	6.1	5.6	8.4	8.2	12.6	12.3	29.1	12.8	24.9	53.2	49.9	76.0	46.7	55.7	43.3	56.5	30.0	24.5	31.7	30.0	39.9	18.4	37.5	64.6	51.1	22.5	37.2	59.6	18.7	35.6	40.2	35.0	52.5	47.1	97.6	56.8	85.7	36.6	33.6	37.9	34.9	54.0	23.6	23.0	39.5	89.2	115.4	32.6	75.3	29.3	39.7	19.8	56.8	37.1	24.9	53.4	53.5	37.8	45.3	137.2	126.0	61.1	23.3	53.0	56.3	37.4	25.4	26.6	28.0	45.8	39.5	37.4	56.0	68.1	69.4	43.9	59.1	51.2	38.5	54.1	36.2	51.5
CPSF7	"CFIM59, FLJ12529"	ENSG00000149532	"Cleavage and polyadenylation specific factor 7"	Q8N684	11	61402641-61430031	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041094	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA041094: AB_10794187"	"unprognostic (6.87e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (5.35e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.18e-2)"	43.2	44.1	39.1	36.0	40.7	55.0	44.2	40.0	48.4	55.2	39.8	48.9	32.0	54.8	44.1	46.6	55.1	27.3	39.5	37.9	41.3	44.2	62.8	38.0	43.3	38.1	41.0	55.6	49.2	35.0	79.1	37.8	39.1	47.3	34.3	40.7	41.4	34.7	68.0	52.3	49.0	43.7	33.9	57.4	47.3	42.0	39.3	57.8	58.9	48.1	43.7	47.4	45.7	44.3	72.5	71.0	98.0	78.2	52.0	45.8	68.7	58.9	56.2	76.7	58.4	83.7	60.6	107.7	61.4	63.6	65.0	87.4	94.7	67.4	93.1	71.8	48.4	90.9	95.8	68.0	52.5	111.4	77.9	48.7	54.3	81.3	118.4	46.7	52.8	69.1	111.2	67.1	56.2	87.7	110.5	90.9	96.2	50.5	55.6	102.8	77.1	88.9	57.8	87.9	66.3	67.6	78.2	68.4	74.3	59.7	94.4	47.6	53.2	84.4	71.6	79.0	61.4	92.0	116.5	122.4	49.3	53.2	63.0	15.1	5.6	7.1	8.1	6.0	8.7	6.9	6.4	8.4	7.6	6.5	7.0	7.2	9.8	6.7	4.6	6.4	4.8	5.7	39.1	40.7	40.0	48.4	37.9	41.3	38.1	41.0	39.1	33.9	39.3	44.3	23.3	35.3	21.2	56.8	29.0	23.2	18.4	15.5	26.7	21.4	26.1	24.9	11.4	11.5	16.0	16.5	39.6	26.7	29.4	22.6	17.6	15.7	41.8	17.1	21.7	22.6	22.2	20.0	29.8	13.8	17.5	20.7	22.4	21.3	23.5	26.6	22.9	27.2	19.6	32.0	31.0	21.9	16.2	31.0	19.0	29.1	27.4	23.4	3.6	37.5	39.7	24.2	22.6	31.7	39.8	19.5	13.6	25.2	28.6	25.0	22.3	14.3	19.9	21.7	39.5	28.8	22.6	37.5	27.1	25.0	26.3	27.5	22.1	17.7	23.0	23.0
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196792-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.2"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 85.1;Hepatocytes: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	12.9	14.3	6.6	9.4	8.2	5.4	13.6	7.9	7.3	10.3	16.8	35.4	32.4	6.8	10.5	14.2	10.5	9.5	19.5	6.1	7.1	35.1	91.2	11.5	10.6	8.1	7.5	10.2	21.7	27.3	6.7	18.0	8.0	12.2	32.8	7.1	14.6	11.7	17.3	6.7	24.9	11.4	7.7	8.7	18.4	12.9	9.0	10.2	12.5	33.1	13.2	11.1	4.5	8.9	16.0	8.3	17.2	17.8	14.6	11.3	17.5	9.8	13.2	17.5	17.5	8.6	14.5	28.9	14.6	9.2	20.1	19.1	35.1	25.1	15.1	17.0	16.0	21.8	9.9	6.4	25.9	15.9	19.5	23.0	23.2	13.8	11.1	18.6	15.4	26.5	20.9	9.9	13.1	12.8	10.7	13.0	29.8	38.4	20.0	13.2	16.2	34.4	22.9	22.0	25.3	14.4	22.1	30.3	39.7	36.6	32.3	32.2	8.7	8.4	6.1	16.5	8.5	26.3	19.8	16.2	11.6	20.6	12.4	5.6	14.1	14.6	7.2	20.0	8.1	5.3	6.3	8.4	17.9	7.4	10.5	7.2	5.3	6.9	20.5	8.9	9.9	10.3	6.6	8.2	7.9	7.3	6.1	7.1	8.1	7.5	8.0	7.7	9.0	8.9	5.0	12.8	24.1	4.2	7.8	1.8	5.2	20.5	5.2	6.0	7.5	7.0	18.1	15.7	11.4	11.0	14.6	85.1	4.5	49.3	25.4	12.9	1.1	10.9	8.1	5.9	14.5	9.4	1.5	10.5	20.3	7.2	18.3	10.3	2.5	12.7	8.9	88.8	26.3	15.2	2.0	26.6	16.2	15.1	7.2	2.8	6.8	10.5	7.2	1.9	20.2	11.6	6.2	2.5	4.5	10.5	25.6	5.3	9.1	4.9	38.6	41.0	7.6	11.0	6.6	7.5	8.4	49.9	31.3	13.8	2.6	54.6	6.9	25.6	29.5	5.7
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1189.7;vagina: 604.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 485.4;Breast glandular cells: 224.2;Club cells: 266.7;Squamous epithelial cells: 714.0;Urothelial cells: 506.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1592.5;MCF7: 625.9;T-47d: 1201.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 36.0"	HPA004135	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		76000	"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	Nucleoplasm	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	22.2	8.0	9.6	4.8	11.5	5.7	104.5	10.5	18.8	273.7	29.4	13.3	0.9	76.3	4.7	1189.7	83.1	18.2	5.5	10.7	12.8	12.0	2.3	6.4	3.9	8.0	8.2	6.2	3.4	55.1	43.5	40.5	7.8	34.8	4.8	4.5	93.5	57.1	5.0	179.0	3.9	57.0	7.4	7.9	5.6	5.3	12.0	15.5	14.5	1.8	76.2	81.2	604.9	10.1	103.4	5.4	115.3	1.6	147.1	218.0	0.4	215.4	1592.5	17.3	21.3	184.9	369.8	1.6	103.1	234.0	2.2	131.2	28.1	0.8	5.1	2.9	8.1	0.1	13.5	1.6	29.0	0.3	2.5	69.3	10.6	25.4	0.5	13.8	0.7	2.0	1.0	2.2	1.9	625.9	1.7	1.9	136.5	12.3	57.3	1.7	0.8	3.4	2.3	4.0	280.7	20.2	3.0	366.2	1.5	214.9	1201.3	0.7	0.2	4.2	63.1	35.5	13.4	9.8	23.8	1.3	28.6	1.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.6	11.5	10.5	18.8	10.7	12.8	8.0	8.2	7.8	7.4	12.0	10.1	7.0	0.0	2.6	1.3	1.8	65.0	131.2	485.4	104.2	1.8	224.2	96.8	0.7	1.5	266.7	16.5	2.1	53.9	4.9	0.9	0.0	12.6	2.2	18.0	51.9	10.3	0.0	0.0	3.1	5.2	6.2	168.4	1.1	29.3	0.0	0.5	6.4	0.2	10.0	0.0	1.8	0.9	40.7	0.0	55.4	1.0	19.9	3.9	62.2	0.0	0.0	1.0	0.0	1.5	0.3	18.1	0.2	37.6	0.2	194.9	0.1	0.3	28.2	0.6	0.0	4.3	40.0	2.0	6.1	714.0	190.7	18.1	7.6	4.8	1.7	506.4
CRACD	"CRAD, KIAA1211"	ENSG00000109265	"Capping protein inhibiting regulator of actin dynamics"	Q6ZU35	4	56049073-56328625	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;intestine: 19.7;testis: 29.6"	"Cell type enriched"	"Detected in single"	11	"Cardiomyocytes: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.7;SH-SY5Y: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043249, HPA048148"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		59000		"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Golgi apparatus"	"HPA043249: AB_2678388, HPA048148: AB_2680286"	"unprognostic (1.65e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.04e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.05e-6)"	"unprognostic (1.02e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.93e-1)"	0.5	2.3	6.6	3.1	9.6	3.9	0.3	8.7	5.6	1.6	0.0	9.5	13.8	3.5	4.2	0.5	2.9	11.3	0.8	5.7	12.8	0.7	0.6	1.0	2.2	18.8	13.3	1.2	1.8	6.3	0.9	0.6	19.1	1.7	8.1	4.1	1.0	3.5	0.0	0.5	19.7	4.4	8.7	2.5	2.7	29.6	11.9	0.6	0.1	0.2	1.9	1.3	1.2	6.2	0.0	2.9	11.2	0.9	0.3	0.0	4.1	0.1	0.4	0.5	1.2	3.4	0.4	10.2	0.3	0.0	9.1	0.0	9.6	0.2	0.3	0.9	5.6	5.7	5.1	0.5	1.6	4.8	0.8	0.4	0.2	0.0	0.1	3.6	5.3	9.1	0.0	9.8	0.1	1.4	7.1	0.4	6.0	8.7	7.2	6.8	6.1	0.2	0.1	2.6	26.7	56.7	1.0	0.3	6.9	9.4	2.4	0.5	2.1	0.3	2.8	0.7	2.6	9.7	6.9	0.1	2.8	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	9.6	8.7	5.6	5.7	12.8	18.8	13.3	19.1	8.7	11.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CRADD	RAIDD	ENSG00000169372	"CASP2 and RIPK1 domain containing adaptor with death domain"	P78560	12	93677375-93894840	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 161.3;Early spermatids: 164.5;Inhibitory neurons: 122.3;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 287.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005337	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"CAB005337: AB_2085481"	"unprognostic (1.07e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (9.65e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.10e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.18e-2)"	"prognostic favorable (4.04e-9)"	"unprognostic (2.57e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	10.0	19.3	9.1	5.0	10.5	9.3	11.2	9.9	9.1	12.8	12.8	13.6	16.9	13.0	12.6	13.0	9.9	10.4	41.2	8.7	10.1	17.9	37.3	9.9	7.3	9.7	9.9	10.3	12.7	18.6	15.3	7.2	9.8	11.4	8.2	12.8	11.0	8.9	28.2	11.4	18.0	8.2	8.7	10.4	12.9	13.7	10.0	13.3	9.6	30.0	6.2	12.7	11.3	10.3	7.8	17.4	8.4	9.6	11.8	21.2	10.6	8.8	10.7	7.6	8.9	16.4	3.2	13.9	5.3	10.2	5.8	8.0	9.3	11.5	9.3	14.7	12.3	7.4	7.0	12.2	12.2	6.8	6.8	19.8	17.4	12.2	9.5	8.0	9.3	15.2	21.3	6.4	9.1	12.6	10.1	12.3	10.6	8.9	13.2	16.8	4.3	19.3	7.4	5.7	12.9	12.5	12.0	11.7	21.3	8.1	20.5	13.2	10.0	17.5	8.7	8.4	9.0	15.0	8.7	12.9	8.2	10.0	8.4	62.7	11.6	45.5	23.8	14.7	21.1	15.1	16.5	24.8	9.7	13.5	17.6	13.0	33.9	20.6	23.2	13.1	20.9	12.0	9.1	10.5	9.9	9.1	8.7	10.1	9.7	9.9	9.8	8.7	10.0	10.3	7.8	9.6	6.3	161.3	7.8	7.4	9.3	21.1	6.2	6.4	8.9	7.2	38.7	7.2	18.0	7.3	8.4	14.5	9.0	19.1	23.5	16.8	164.5	11.8	8.7	11.9	7.8	9.1	62.8	22.4	12.7	10.3	10.2	6.7	4.5	3.7	10.0	41.9	11.5	23.5	122.3	14.6	26.4	10.6	6.1	35.2	17.7	16.0	3.6	96.5	9.5	16.9	15.5	174.4	287.2	19.5	19.8	23.7	8.4	10.1	58.5	63.1	20.0	15.5	6.6	15.0	11.4	25.6	11.7	10.1	8.1	10.8	10.2	8.3	13.9	10.1
CRAMP1	"CRAMP1L, KIAA1426"	ENSG00000007545	"Cramped chromatin regulator homolog 1"	Q96RY5	16	1612337-1677908	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041752	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA041752: AB_10796459"	"unprognostic (3.67e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.78e-4)"	"unprognostic (4.17e-2)"	"unprognostic (8.53e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.86e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	8.0	7.5	7.4	5.6	6.2	13.5	9.0	15.0	6.9	11.1	5.9	10.9	8.1	10.3	6.2	9.0	10.7	5.4	8.3	6.6	4.6	9.4	6.3	9.9	7.6	5.4	5.2	12.5	8.8	5.7	12.4	6.9	5.3	12.0	5.4	9.9	8.4	6.4	7.9	11.0	9.5	6.7	3.2	11.0	9.0	22.9	5.5	10.7	12.7	4.8	6.0	9.6	9.5	7.1	8.5	15.5	15.6	14.5	9.8	9.7	20.3	14.4	7.5	11.5	8.2	11.2	14.0	12.0	12.3	9.9	7.1	15.3	18.7	10.0	10.3	12.7	22.6	14.2	16.0	6.9	7.1	19.0	20.6	8.5	12.6	14.5	12.1	11.2	12.4	17.9	19.6	7.1	6.3	12.4	14.8	10.6	14.9	4.9	8.7	51.2	8.4	16.1	8.2	7.5	16.6	14.0	15.8	11.3	8.3	10.9	9.9	24.3	15.2	11.9	12.8	11.4	13.9	15.0	23.3	24.3	3.7	13.0	10.8	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.3	0.0	0.1	7.4	6.2	15.0	6.9	6.6	4.6	5.4	5.2	5.3	3.2	5.5	7.1	10.4	16.0	17.0	0.0	2.7	0.0	5.2	0.0	12.0	8.6	9.3	8.0	0.0	4.3	8.6	9.2	18.8	4.7	12.8	6.1	1.9	5.5	28.0	11.1	14.5	6.8	2.4	4.6	0.0	2.0	3.0	5.4	5.1	15.3	5.1	11.0	6.8	4.3	5.6	3.3	0.0	6.6	0.0	8.2	0.0	9.6	4.4	4.3	0.0	0.0	6.6	6.2	4.1	0.0	0.0	7.1	4.7	6.8	4.7	9.9	6.0	1.6	2.9	17.9	6.6	7.1	5.2	17.3	18.4	9.4	0.0	5.3	5.2	5.6	5.5	5.9
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094142-129111189	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 227.5;tongue: 201.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 181.2;Late spermatids: 521.8;Proximal enterocytes: 136.4;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		8100	"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	36.1	51.3	26.4	5.4	26.6	9.0	29.2	27.0	33.8	31.7	27.5	36.1	33.0	24.8	4.0	37.3	23.1	6.6	68.2	25.1	27.8	46.9	151.2	15.2	3.2	28.8	28.2	23.0	107.1	26.3	12.3	6.6	30.6	42.2	4.2	1.7	32.8	8.9	227.5	29.6	37.2	6.8	26.7	15.2	34.0	146.4	30.2	3.1	21.5	201.3	1.6	31.3	27.5	24.4	0.1	39.3	10.7	21.3	13.4	25.9	17.0	15.0	16.6	18.9	12.0	7.8	14.0	1.5	9.2	25.9	23.2	6.7	2.2	4.9	7.2	23.6	0.3	7.3	19.1	30.4	34.1	0.0	26.1	26.3	0.0	15.7	0.9	15.8	26.2	7.2	3.6	5.7	20.0	9.1	0.5	15.9	2.8	32.0	18.0	16.8	21.8	12.2	18.0	0.6	4.2	12.1	0.0	7.1	4.8	3.4	49.7	5.5	22.6	23.0	1.6	32.1	15.4	25.5	22.6	0.1	28.8	4.2	16.8	1.6	8.4	3.5	3.2	5.5	6.7	1.5	4.4	4.3	8.6	1.3	2.6	3.1	1.1	4.4	5.6	3.9	4.5	6.1	26.4	26.6	27.0	33.8	25.1	27.8	28.8	28.2	30.6	26.7	30.2	24.4	10.5	6.4	3.7	5.5	4.9	3.2	4.7	10.8	0.6	1.5	9.7	8.1	57.8	21.5	8.2	3.7	2.1	45.9	6.0	64.5	17.6	22.6	181.2	3.5	15.7	12.9	15.5	17.4	5.3	22.4	55.6	19.3	16.8	9.9	7.0	12.9	14.6	65.7	20.7	1.7	6.1	23.6	14.2	13.9	10.5	521.8	22.1	12.4	5.4	6.5	8.3	15.5	6.2	3.5	4.0	11.6	47.6	24.5	9.6	9.3	136.4	52.0	2.8	1.3	6.6	10.5	15.7	123.5	8.6	57.4	4.5	50.3	7.6	20.1	29.3	13.8
CRCP	"C17, CGRP-RCP, POLR3I, RCP, RCP9"	ENSG00000241258	"CGRP receptor component"	O75575	7	66114604-66154568	"Metabolic proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006883, HPA007216"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA006883: , HPA007216: AB_1856160"	"unprognostic (2.36e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.67e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.49e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.87e-2)"	"unprognostic (4.81e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.06e-1)"	13.5	15.3	10.8	13.8	11.4	37.5	17.6	12.7	14.1	14.7	11.2	18.3	16.8	14.7	11.3	20.0	17.3	13.1	17.5	11.3	13.7	16.5	26.5	14.5	16.4	11.6	12.2	16.9	20.6	21.2	11.1	13.7	14.1	17.3	19.6	14.2	16.1	15.8	14.8	16.1	14.7	18.2	11.3	17.4	17.9	8.3	13.9	15.2	20.0	13.6	16.6	16.6	14.4	12.4	44.0	26.9	19.5	26.4	27.0	33.7	19.0	29.9	31.9	43.7	33.7	43.5	34.6	40.6	35.7	29.0	37.0	32.4	26.7	35.9	46.1	26.0	27.3	23.1	19.1	20.9	19.4	47.6	32.6	27.0	30.9	38.3	71.6	27.8	23.7	23.1	49.3	28.8	30.0	35.0	36.7	37.7	39.8	58.7	33.6	38.4	30.1	37.8	27.8	40.5	46.1	60.3	34.3	95.2	29.2	22.8	73.6	24.0	27.6	63.4	33.6	36.5	56.3	35.4	70.0	54.3	35.9	36.8	51.6	25.9	12.0	20.4	17.6	11.1	17.1	14.4	15.4	14.9	9.1	13.4	14.5	17.3	20.9	10.9	17.0	12.0	16.0	12.0	10.8	11.4	12.7	14.1	11.3	13.7	11.6	12.2	14.1	11.3	13.9	12.4	24.8	28.9	32.5	12.1	30.4	13.4	22.2	13.9	24.5	29.9	19.7	19.2	25.7	12.8	23.0	16.5	22.9	12.6	47.8	15.5	35.2	21.3	4.4	27.7	30.3	18.1	16.1	12.2	19.5	24.8	11.8	20.5	27.5	29.4	34.1	22.8	9.7	25.2	12.1	30.3	20.5	15.4	8.2	13.6	9.2	4.3	18.6	17.7	16.0	12.2	20.6	23.0	22.6	12.5	17.2	29.8	10.2	22.2	26.5	26.2	10.5	17.6	32.8	25.8	6.6	27.2	18.5	24.5	16.7	20.9	14.8	11.5	27.3	28.6	14.7	32.1
CREB1		ENSG00000118260	"CAMP responsive element binding protein 1"	P16220	2	207529737-207605988	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Early spermatids: 417.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003803, HPA019150"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB003803: AB_562092, HPA019150: AB_1847220"	"unprognostic (1.20e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.45e-2)"	13.0	8.7	10.6	15.3	11.4	22.4	14.7	17.5	11.1	15.8	11.9	11.4	10.0	15.7	10.8	15.0	13.1	14.0	11.5	10.3	10.7	12.4	11.6	13.6	22.1	10.6	9.9	17.2	8.7	15.6	6.9	18.0	10.4	13.0	14.0	17.8	8.9	12.6	6.7	11.5	10.6	16.3	9.7	17.1	12.1	32.4	9.9	28.7	18.1	14.6	25.0	16.8	9.6	15.0	24.9	20.9	38.6	15.6	22.9	22.4	21.8	15.9	23.5	26.6	26.5	21.6	22.9	15.4	19.8	21.1	29.8	19.5	34.8	20.4	37.7	25.1	13.2	29.2	18.9	23.0	18.7	27.7	20.0	16.0	16.3	21.1	31.1	25.4	34.9	28.9	20.5	22.5	30.4	16.8	41.0	16.1	27.8	24.2	13.1	31.4	22.1	20.2	25.1	24.6	27.1	23.4	21.6	16.2	18.1	35.5	16.5	30.1	18.5	21.8	22.6	22.1	20.5	19.6	27.5	36.4	25.2	25.3	22.0	33.6	28.2	28.2	27.0	29.2	23.7	36.7	25.3	26.2	34.1	34.8	30.0	20.7	56.1	45.6	34.9	18.6	38.6	26.7	10.6	11.4	17.5	11.1	10.3	10.7	10.6	9.9	10.4	9.7	9.9	15.0	46.7	19.2	18.2	47.0	52.3	70.9	47.1	33.3	34.1	38.9	25.3	18.5	26.3	17.2	29.0	12.9	33.3	29.1	35.5	25.3	23.5	23.6	417.8	19.6	39.2	47.2	32.4	54.7	56.1	20.3	24.9	35.8	18.8	21.0	43.7	41.5	35.7	15.8	29.4	40.4	51.1	28.2	30.5	48.8	75.9	47.2	26.1	35.8	44.4	68.4	60.9	42.1	33.0	66.9	70.7	26.4	27.5	29.3	29.1	56.5	22.8	19.7	18.9	40.2	39.5	37.4	40.7	44.5	29.4	33.5	57.8	18.6	42.6	19.6	25.7	62.6
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002086	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 141.1;Syncytiotrophoblasts: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: AB_2669210"	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	20.7	29.7	8.3	18.5	13.9	23.8	22.8	8.3	12.2	30.3	46.5	22.4	22.3	33.9	26.8	15.0	22.6	15.0	25.9	8.1	9.6	19.6	12.5	19.3	12.8	13.2	10.8	29.0	30.1	59.5	25.1	39.4	12.1	21.6	17.6	5.0	28.7	23.2	6.1	8.7	22.9	29.2	9.6	13.0	17.4	9.0	16.1	10.0	65.3	9.4	20.4	19.5	19.9	17.3	13.1	19.9	37.6	0.6	62.9	61.7	28.1	65.1	104.0	44.4	44.7	27.5	11.7	2.6	16.8	71.1	24.1	6.9	21.9	47.1	86.9	19.1	10.8	83.4	26.7	67.6	41.4	25.3	115.5	25.4	29.2	56.0	65.3	45.5	59.7	6.5	43.8	37.4	52.9	23.5	8.0	31.6	13.6	17.9	13.7	17.5	19.8	22.1	35.3	13.2	9.4	22.3	21.1	54.0	29.1	21.7	7.9	18.9	63.1	59.5	8.7	72.3	24.2	43.9	16.2	16.9	70.9	71.3	135.0	10.4	5.5	6.0	7.3	3.0	9.8	3.9	5.4	8.2	5.7	3.9	2.0	3.4	2.0	7.2	1.6	11.9	12.5	3.2	8.3	13.9	8.3	12.2	8.1	9.6	13.2	10.8	12.1	9.6	16.1	17.3	30.6	6.4	25.9	18.6	27.3	12.2	9.7	18.9	8.0	12.0	32.0	25.4	17.5	21.5	34.9	23.9	10.4	62.6	39.5	24.7	13.7	10.2	56.3	18.1	86.6	31.6	15.7	12.0	7.5	17.6	93.0	49.6	16.3	42.4	49.4	27.8	29.6	24.3	56.3	15.2	10.6	21.0	20.3	34.9	25.6	18.7	61.8	30.7	26.6	63.7	21.4	5.4	40.2	55.8	48.0	14.4	18.2	103.0	141.1	35.1	66.2	7.9	22.4	12.3	39.5	62.3	50.2	3.4	7.4	9.5	7.1	144.5	26.6	11.1	17.0	44.0
CREB3L4	"AIbZIP, ATCE1, CREB3, CREB4, hJAL"	ENSG00000143578	"CAMP responsive element binding protein 3 like 4"	Q8TEY5	1	153967534-153974361	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 106.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 49.9;Breast myoepithelial cells: 40.1;Intestinal goblet cells: 56.9;Prostatic glandular cells: 49.3"	"Group enriched"	"Detected in all"	5	"breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 81.8;OE19: 82.7;SK-BR-3: 174.6;T-47d: 139.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA038122	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Nuclear membrane"	Mitochondria	"HPA038122: AB_10669516"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.13e-3)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.34e-3)"	6.3	8.5	3.5	4.5	3.8	7.6	48.2	4.6	4.7	30.5	4.4	11.5	11.4	12.9	13.0	8.2	19.2	6.7	5.0	3.3	3.5	10.5	14.0	5.8	5.9	3.9	4.1	17.4	13.2	6.7	6.1	6.3	3.7	106.2	15.2	4.9	43.9	7.6	5.6	10.2	9.0	5.7	3.9	7.5	29.3	5.3	3.6	12.0	11.3	5.3	7.4	6.8	6.9	4.7	7.5	10.6	9.8	10.9	6.9	10.0	24.7	6.2	7.2	8.3	7.3	5.1	31.0	13.9	31.7	2.6	6.1	12.0	14.5	9.7	4.5	11.4	5.9	10.3	11.7	8.9	5.6	4.9	8.5	10.9	9.2	7.9	17.9	7.5	7.4	16.5	8.1	16.9	3.8	81.8	9.3	3.8	6.7	82.7	12.7	20.9	10.3	26.1	9.0	5.3	18.5	20.1	6.6	174.6	16.8	12.8	139.9	14.9	4.5	2.5	7.3	5.2	4.9	31.4	17.3	10.6	5.3	8.5	8.2	1.5	2.9	2.2	3.4	1.2	4.5	4.5	1.9	2.4	5.0	4.8	1.8	3.5	0.1	9.4	1.7	5.7	1.8	2.5	3.5	3.8	4.6	4.7	3.3	3.5	3.9	4.1	3.7	3.9	3.6	4.7	7.2	6.4	13.1	3.6	6.2	2.9	13.1	10.1	6.8	5.3	49.9	40.1	2.0	7.2	20.3	1.8	2.1	12.9	5.6	3.6	9.8	14.0	0.4	10.6	5.2	6.9	9.0	8.6	0.4	13.3	17.0	4.8	10.7	13.5	5.7	8.7	4.2	14.2	5.4	0.0	0.4	56.9	6.1	7.5	2.0	0.6	7.2	5.1	5.4	0.0	2.8	6.6	8.2	1.5	2.2	7.9	4.3	2.2	5.3	49.3	4.0	4.1	16.6	8.8	19.7	3.1	5.0	7.4	10.6	6.3	3.0	4.2	4.5	7.6	10.9	7.0
CREB5	"CRE-BPA, H_GS165L15.1"	ENSG00000146592	"CAMP responsive element binding protein 5"	Q02930	7	28299321-28825894	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 165.7;Basal prostatic cells: 192.2;monocytes: 163.9;Oligodendrocyte precursor cells: 229.7;Oligodendrocytes: 734.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 198.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 198.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 62.5;Karpas-707: 25.0;U-2 OS: 25.7;U-2197: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050020, HPA061622"			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA050020: AB_2680993, HPA061622: AB_2684569"	"unprognostic (3.59e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	10.5	1.3	6.3	7.9	20.5	6.1	5.0	6.8	12.7	1.7	0.0	3.5	0.9	8.4	2.8	3.5	2.2	11.4	5.3	9.6	19.9	3.0	1.8	6.1	0.9	19.7	14.6	0.7	3.2	0.2	1.1	3.7	15.8	1.2	1.7	1.3	3.5	1.0	3.2	2.9	2.2	4.7	2.9	7.4	1.4	0.7	23.0	0.7	1.8	4.0	0.8	4.4	2.2	35.0	0.1	0.6	7.3	0.4	0.4	10.3	0.3	0.7	1.6	4.4	6.6	4.2	2.7	18.9	1.3	1.8	4.5	0.7	0.2	6.4	13.8	0.0	5.0	20.4	4.2	0.4	0.4	62.5	0.7	1.3	1.2	18.9	20.1	0.9	3.0	0.1	2.4	25.0	1.5	0.1	0.1	0.0	9.1	0.1	7.4	0.5	6.8	0.5	9.0	2.0	0.7	5.2	0.3	0.4	2.2	10.0	0.2	1.5	0.8	8.6	25.7	28.7	8.5	1.5	4.5	0.2	9.4	0.3	14.8	0.1	29.9	0.0	0.0	9.7	0.0	1.9	0.0	0.0	18.2	0.1	0.0	0.0	198.8	0.0	3.9	0.3	0.0	7.0	6.3	20.5	6.8	12.7	9.6	19.9	19.7	14.6	15.8	2.9	23.0	35.0	165.7	6.4	7.2	10.7	3.2	21.9	192.2	8.2	13.1	1.3	10.7	8.9	16.8	17.2	6.3	12.9	0.0	4.0	0.8	0.0	1.9	74.2	0.4	41.0	56.3	31.3	0.0	0.4	17.0	27.4	13.4	108.0	3.1	69.7	14.0	0.6	14.3	0.5	8.3	5.0	22.2	0.0	6.1	47.4	118.2	1.6	5.9	75.8	30.2	22.5	163.9	14.3	4.1	229.7	734.9	22.5	0.0	0.4	3.2	44.9	0.0	25.6	4.7	0.9	19.7	143.5	31.8	12.6	7.3	12.0	13.2	24.8	3.1	2.6	0.0	35.1
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880713	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	17.4	10.6	5.8	17.1	5.2	52.9	16.8	25.4	11.5	20.9	3.7	18.8	12.5	26.5	12.4	16.5	22.4	16.6	14.4	5.9	3.1	12.0	14.3	15.9	17.6	8.9	6.8	37.3	29.7	18.5	11.3	16.9	2.9	16.1	14.1	13.8	17.2	16.2	29.6	21.0	16.4	19.6	0.4	21.0	16.3	33.2	7.9	29.1	23.3	28.9	20.7	16.6	16.5	6.4	12.3	31.0	39.3	17.4	23.5	23.1	20.4	17.4	28.9	29.2	28.2	28.2	22.4	33.7	20.1	33.3	18.7	23.2	45.7	14.2	32.9	57.5	18.5	26.6	29.2	17.9	26.0	26.9	36.5	20.7	14.2	32.5	38.9	18.0	22.3	17.0	30.9	44.8	16.0	42.0	17.9	13.0	32.3	11.7	12.7	83.4	31.1	26.1	11.2	16.2	32.6	21.5	29.5	28.7	16.8	25.3	25.6	25.9	34.7	35.5	35.2	18.4	16.0	20.8	24.3	63.7	7.2	15.8	25.6	1.9	1.1	0.9	1.7	1.5	0.8	3.7	0.8	1.3	0.7	2.1	0.8	1.1	6.7	1.4	2.9	1.5	0.8	0.9	5.8	5.2	25.4	11.5	5.9	3.1	8.9	6.8	2.9	0.4	7.9	6.4	48.1	44.8	51.6	91.1	38.3	56.2	31.0	16.0	27.3	34.2	34.4	25.7	41.2	40.0	28.0	11.0	25.0	17.4	50.1	31.2	5.9	20.9	43.0	37.2	56.4	35.7	15.0	33.4	88.7	20.3	11.3	39.5	32.1	63.5	30.4	53.1	32.5	29.5	20.9	28.6	89.8	25.3	18.3	44.0	42.8	80.2	56.5	49.0	17.8	87.1	52.5	34.5	43.3	111.6	101.2	27.5	19.5	51.1	35.6	39.8	25.2	10.9	28.2	17.6	46.0	75.8	44.9	35.1	42.2	34.6	58.8	30.8	44.2	36.2	24.6	44.2
CREBL2		ENSG00000111269	"CAMP responsive element binding protein like 2"	O60519	12	12611827-12645108	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 130.6"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043738	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA043738: AB_10795041"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.53e-1)"	39.8	130.6	24.7	30.4	26.3	5.3	31.9	22.8	29.2	26.4	29.5	23.4	23.1	19.0	28.8	17.1	24.6	28.2	22.5	26.2	28.8	49.7	50.1	32.5	37.5	24.6	24.5	37.2	24.7	56.3	32.2	24.2	24.6	28.2	23.8	35.2	26.4	23.0	10.1	24.6	23.6	18.9	24.8	37.5	25.1	20.9	29.1	24.7	44.3	15.6	29.8	28.0	15.1	27.7	12.5	15.9	13.6	15.5	46.9	47.0	26.3	24.0	40.4	17.3	23.7	11.5	17.9	10.8	9.1	29.3	26.2	10.3	20.7	18.4	29.1	61.0	12.6	8.5	15.1	14.2	30.7	12.2	15.2	30.8	32.2	20.3	33.1	58.7	25.7	8.5	8.7	16.5	29.4	20.1	6.4	9.9	40.8	11.9	14.4	8.7	23.6	6.9	33.1	35.7	16.0	18.2	24.4	11.7	43.3	58.5	6.5	13.6	20.8	23.7	15.1	23.7	23.9	13.9	19.7	2.7	28.1	10.3	24.9	1.1	2.5	2.6	1.7	5.6	3.1	0.9	3.4	2.7	2.8	1.1	3.3	2.7	0.4	1.1	2.6	1.4	5.6	1.5	24.7	26.3	22.8	29.2	26.2	28.8	24.6	24.5	24.6	24.8	29.1	27.7	18.0	25.6	26.5	23.5	14.8	22.2	18.6	11.1	18.8	17.5	23.5	15.9	14.6	30.0	12.2	33.1	2.1	18.1	15.7	17.7	41.1	21.6	40.4	14.2	10.4	19.1	30.0	27.8	15.9	21.8	19.3	25.3	17.9	10.6	10.2	12.1	23.2	48.4	39.3	37.0	17.7	16.4	26.4	120.0	83.0	12.1	36.1	58.2	33.8	33.7	45.6	38.0	10.3	28.6	18.6	21.8	15.0	35.3	17.3	29.5	29.3	58.8	19.9	11.8	39.5	13.7	12.4	45.8	20.8	18.0	29.1	27.5	23.3	11.5	17.6	28.1
CREBRF	"C5orf41, LRF"	ENSG00000164463	"CREB3 regulatory factor"	Q8IUR6	5	173056352-173139284	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 21.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015329			Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA015329: AB_2669192"	"unprognostic (8.00e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (3.20e-7)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (9.30e-4)"	12.9	10.8	9.6	10.4	12.6	68.1	11.1	14.6	11.6	12.2	11.6	9.9	8.4	11.6	11.3	8.7	8.7	9.8	11.2	8.1	12.3	14.5	10.8	11.8	13.2	12.0	11.6	19.0	7.9	15.9	5.8	12.7	12.2	10.0	8.5	11.2	8.8	11.6	8.4	12.1	9.5	10.4	11.0	15.2	8.3	13.4	10.7	12.4	23.2	11.9	10.4	10.3	9.3	14.6	1.2	2.8	2.6	4.1	11.7	15.6	6.1	3.7	18.0	3.4	6.5	3.8	6.3	2.3	8.7	3.8	6.3	1.5	1.2	2.9	4.8	8.4	2.5	1.8	1.9	1.2	9.0	1.4	10.0	9.5	7.3	3.7	9.2	8.3	4.2	2.9	1.6	11.7	4.0	2.3	2.2	2.0	0.8	1.9	1.4	2.1	1.8	3.6	4.8	2.5	2.0	3.0	3.7	1.6	13.6	5.5	1.7	2.6	6.9	5.2	1.7	3.5	1.0	13.0	11.7	4.0	3.8	2.5	1.8	5.6	2.7	6.1	3.6	2.4	3.3	2.9	3.6	3.1	1.4	5.6	4.4	3.6	21.8	1.5	3.3	3.1	3.6	1.8	9.6	12.6	14.6	11.6	8.1	12.3	12.0	11.6	12.2	11.0	10.7	14.6	103.6	51.3	48.4	33.6	95.9	79.2	26.0	19.7	105.3	50.1	68.3	48.1	61.4	44.3	25.9	38.6	68.8	11.6	104.1	50.8	15.6	17.4	5.3	68.9	51.1	66.3	76.7	70.7	57.3	15.7	11.1	67.5	21.4	154.0	48.1	75.2	64.6	39.5	20.4	112.7	64.2	30.3	32.6	96.2	57.7	8.4	51.9	76.7	65.8	70.3	81.7	33.1	55.6	40.2	65.3	17.4	31.8	54.9	78.9	67.6	42.4	23.2	34.8	65.0	59.2	89.8	65.6	74.8	48.0	42.7	92.9	37.4	83.5	26.2	20.5	40.9
CREBZF	ZF	ENSG00000137504	"CREB/ATF bZIP transcription factor"	Q9NS37	11	85657990-85682908	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HeLa: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021526, HPA063652"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA021526: AB_2670738, HPA063652: AB_2685075"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.38e-3)"	17.1	12.4	9.8	12.9	11.1	9.7	16.8	18.3	15.4	15.9	11.3	12.8	14.1	21.3	12.2	10.1	15.1	10.3	8.2	10.1	9.9	8.8	10.8	15.4	18.7	10.6	10.0	21.7	14.8	11.8	8.7	13.2	11.1	12.9	13.7	27.9	16.4	10.2	9.9	17.2	16.4	10.3	10.5	17.2	12.7	6.1	10.3	13.6	16.3	6.8	15.3	12.1	14.9	13.5	5.6	12.4	18.4	7.6	8.4	8.8	13.7	9.8	6.0	8.4	11.0	15.6	22.5	16.4	9.1	5.8	22.1	19.6	12.7	6.2	14.1	9.3	11.9	14.9	53.1	7.2	5.7	14.1	8.0	7.8	12.2	8.5	11.8	11.5	5.3	10.8	11.7	18.6	10.1	7.9	12.0	27.5	6.8	16.3	8.7	19.2	15.7	10.1	9.2	10.7	14.5	12.4	12.6	19.3	4.2	11.6	20.8	20.8	6.3	17.4	10.7	24.3	11.0	6.4	7.6	16.8	4.1	10.4	10.9	0.3	0.1	0.1	0.4	0.1	0.7	0.2	0.3	0.3	0.2	0.2	0.4	0.4	0.2	0.4	0.3	0.2	0.6	0.1	9.8	11.1	18.3	15.4	10.1	9.9	10.6	10.0	11.1	10.5	10.3	13.5	30.3	19.2	21.5	58.1	41.9	41.3	21.6	12.4	31.3	97.5	35.1	20.6	13.9	17.2	17.9	22.0	91.8	16.9	53.1	30.0	9.8	13.2	34.5	27.6	31.1	25.1	39.4	30.1	57.6	8.6	14.9	34.7	46.9	34.0	22.2	64.3	23.2	29.5	9.9	90.9	60.7	23.8	10.2	19.2	27.3	16.6	30.7	15.6	33.8	25.3	24.8	47.9	46.4	56.8	114.5	9.2	22.8	33.4	39.1	29.5	29.8	8.0	22.5	113.5	13.1	34.6	30.9	27.4	11.4	27.7	41.3	14.4	43.0	51.9	25.7	26.5
CREM	hCREM-2	ENSG00000095794	"CAMP responsive element modulator"	Q03060	10	35126791-35212958	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 216.6"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 819.1;Early spermatids: 2013.6;Langerhans cells: 1094.0;Late spermatids: 814.3;T-cells: 612.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 103.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001818, CAB018352"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB018352: AB_673599, HPA001818: AB_1078566"	"unprognostic (1.78e-1)"	"unprognostic (6.26e-3)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (9.27e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (4.44e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.52e-1)"	54.9	137.4	31.9	51.0	34.3	22.0	27.1	31.3	39.2	26.4	38.6	24.5	8.9	30.3	11.4	17.6	29.2	44.5	50.5	33.6	42.9	58.8	60.5	30.5	17.6	36.7	35.5	60.6	16.0	24.5	59.5	100.3	36.0	32.0	13.6	23.5	13.4	23.3	30.0	9.0	15.9	24.5	34.1	25.3	20.7	216.6	35.8	29.3	22.3	31.3	16.9	60.5	19.1	33.5	24.8	39.0	32.3	33.2	22.2	23.0	32.2	31.8	24.8	19.6	27.0	4.6	10.2	42.0	30.2	18.7	21.2	5.6	28.0	20.8	28.5	103.8	20.6	14.9	25.7	18.6	26.5	3.6	15.2	20.4	25.9	38.3	11.7	17.2	55.3	31.1	44.3	16.9	30.4	20.0	26.1	10.8	9.6	9.2	88.6	16.0	16.9	7.8	34.8	9.7	7.5	20.4	15.1	13.1	88.7	36.5	7.2	11.0	74.0	14.9	19.1	41.4	21.3	7.4	10.9	14.6	35.6	33.1	13.0	5.3	3.5	11.5	11.5	5.5	14.6	7.0	12.6	10.4	4.1	6.8	9.0	10.4	9.7	10.2	4.2	12.4	16.2	8.5	31.9	34.3	31.3	39.2	33.6	42.9	36.7	35.5	36.0	34.1	35.8	33.5	98.7	19.2	47.9	42.7	301.8	143.4	58.0	30.9	18.8	18.3	32.1	32.4	62.3	20.0	33.2	165.5	6.2	98.7	819.1	16.8	97.8	40.6	2013.6	32.6	27.6	118.7	69.0	5.7	50.1	44.4	109.1	140.6	29.0	44.2	347.7	14.5	17.9	37.6	120.6	10.1	34.3	17.9	32.6	61.4	1094.0	814.3	26.1	286.1	247.3	30.0	187.4	39.0	65.9	113.1	34.9	30.6	19.7	32.7	109.4	49.5	15.3	64.2	46.1	19.5	46.0	45.5	232.8	464.7	156.8	15.9	108.4	230.0	612.4	46.4	13.6	52.7
CRIP2	"CRP2, ESP1"	ENSG00000182809	"Cysteine rich protein 2"	P52943	14	105472962-105480162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"heart muscle: 1113.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 459.4;Cardiomyocytes: 863.3;Endothelial cells: 510.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 52.1;memory CD4 T-cell: 80.4;naive B-cell: 109.9;T-reg: 115.6"	"Group enriched"	"Detected in all"	30	"B-cells: 109.9;T-cells: 115.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 321.9;MCF7: 306.5;SK-BR-3: 303.7;T-47d: 266.4;TIME: 259.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042664	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA		160000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA042664: AB_10797017"	"unprognostic (2.68e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.68e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.26e-3)"	177.6	44.7	160.4	31.3	172.0	1.5	162.5	137.7	259.5	101.6	124.2	101.9	27.0	138.1	36.4	127.3	130.0	47.9	1113.7	172.7	186.4	205.1	52.7	185.7	30.0	157.3	158.7	51.2	46.1	19.2	175.0	49.6	158.6	89.0	8.3	4.1	100.0	72.9	52.5	128.9	82.8	32.0	145.0	104.1	66.1	92.8	191.9	10.4	155.6	42.7	16.5	121.4	100.4	140.8	2.5	201.2	37.9	98.3	4.3	19.9	10.0	17.5	1.9	2.8	1.0	7.1	44.2	0.2	321.9	73.8	4.5	166.8	3.6	50.8	0.1	2.3	1.9	0.2	132.5	73.8	24.3	0.0	25.5	10.5	4.4	5.2	26.2	38.4	192.7	0.2	0.5	1.4	26.8	306.5	0.5	0.6	10.0	45.7	143.4	0.4	7.7	9.9	140.1	0.6	61.6	175.3	30.0	303.7	1.9	4.9	266.4	0.1	259.3	82.7	38.8	2.3	50.5	0.7	0.6	0.9	24.3	0.3	179.3	0.2	1.9	0.0	7.5	0.9	6.8	52.1	80.4	17.2	3.6	109.9	17.8	4.5	1.0	3.7	0.5	0.5	115.6	10.4	160.4	172.0	137.7	259.5	172.7	186.4	157.3	158.7	158.6	145.0	191.9	140.8	459.4	157.0	33.7	17.9	15.0	153.2	96.7	206.4	29.0	2.7	110.0	140.7	863.3	107.2	127.1	189.4	4.2	2.6	8.2	0.9	154.6	106.8	37.9	125.1	28.8	510.4	25.2	9.7	16.4	87.6	30.5	132.9	32.1	126.6	7.6	0.4	346.3	30.4	3.0	94.2	3.0	0.3	81.4	11.8	92.6	84.0	28.0	9.3	156.5	27.2	2.5	57.2	1.0	4.5	3.1	48.9	0.1	14.7	7.0	37.4	0.2	17.0	155.7	4.0	276.1	108.1	339.5	27.8	46.1	20.1	196.8	32.0	32.5	5.9	0.2	103.2
CRIPT	HSPC139	ENSG00000119878	"CXXC repeat containing interactor of PDZ3 domain"	Q9P021	2	46616416-46630176	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046080, HPA056765"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA046080: AB_2679529, HPA056765: AB_2683230"	"unprognostic (3.38e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.42e-2)"	7.0	7.7	4.7	2.2	4.6	6.0	6.6	7.6	6.0	5.9	5.3	7.2	3.0	5.9	5.5	6.3	5.5	1.8	11.9	4.8	4.1	7.2	6.1	4.3	3.3	5.5	4.3	7.2	5.4	2.7	6.0	2.1	5.0	5.6	2.8	10.7	7.0	1.9	12.3	6.1	5.6	2.2	3.6	4.7	6.3	5.8	4.6	2.4	4.7	2.8	3.1	6.3	6.3	7.8	3.8	2.5	2.3	2.4	2.7	2.9	3.4	2.7	1.8	1.7	1.7	2.9	2.7	2.9	5.7	2.9	2.4	2.6	2.3	2.4	3.3	4.4	2.6	3.6	3.4	3.8	3.1	2.8	2.2	3.3	2.9	2.4	1.7	3.2	2.7	1.6	3.7	3.4	2.1	2.4	1.9	3.5	3.0	3.6	2.5	1.7	4.6	4.4	3.2	2.7	4.2	6.7	3.1	2.4	3.2	2.3	2.0	2.1	3.5	2.7	2.6	2.7	3.0	3.7	3.1	2.8	4.1	3.1	2.3	6.3	2.6	3.8	2.9	2.3	2.6	3.6	3.0	2.6	2.1	3.5	3.0	2.9	5.8	3.0	2.4	3.2	3.6	1.9	4.7	4.6	7.6	6.0	4.8	4.1	5.5	4.3	5.0	3.6	4.6	7.8	28.6	19.2	13.7	19.2	34.5	43.1	65.5	71.3	28.5	28.9	56.5	54.4	60.4	45.8	51.8	31.3	25.0	56.7	48.4	38.5	68.4	64.5	41.8	46.4	33.7	29.5	65.1	91.8	22.5	39.8	81.4	35.1	20.4	37.7	28.5	28.3	38.6	57.5	48.1	16.8	25.7	39.9	42.7	38.9	30.2	15.9	36.4	29.3	30.2	20.6	48.7	40.4	51.5	44.2	31.2	67.6	58.4	25.6	46.2	58.6	81.0	102.6	48.7	51.2	19.7	26.0	48.0	56.0	49.6	39.1	53.0	95.6	35.8	26.2	32.6	74.9
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819985-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 137.3;Fibroblasts: 185.5;Leydig cells: 271.5;Peritubular cells: 265.9;Skeletal myocytes: 146.2;Smooth muscle cells: 341.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 87.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 87.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.7;BEWO: 69.2;HHSteC: 161.4;HSkMC: 68.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 15.6"	"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	No	219000000000		"Cluster 1: Neutrophils - Mixed function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA030054: AB_2732452, HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	113.4	29.0	3.3	46.6	4.9	8.1	64.2	3.9	4.6	112.9	2.6	88.9	10.8	115.7	20.3	39.9	129.0	104.0	36.6	3.7	5.2	40.9	17.1	92.7	7.3	5.9	5.5	80.7	23.5	2.5	19.3	122.7	5.9	98.9	18.1	2.4	18.1	27.7	15.0	36.7	58.5	95.0	4.4	24.9	65.9	21.5	4.3	8.2	47.9	12.2	3.7	119.9	69.8	5.7	0.9	2.2	0.6	6.0	43.7	16.2	69.2	34.5	30.4	27.2	19.1	4.7	2.9	0.1	3.0	30.5	8.0	1.0	0.1	0.1	27.3	0.0	0.2	0.5	0.9	0.1	161.4	0.0	0.3	68.0	0.1	8.0	0.1	9.0	0.2	0.0	0.3	0.3	3.1	1.4	0.3	1.7	2.0	4.6	2.0	0.1	0.3	0.4	0.2	5.5	6.7	0.5	8.1	3.5	0.7	9.4	13.7	0.9	3.8	0.4	1.8	28.3	1.0	0.4	0.1	5.8	0.2	0.5	4.1	14.8	20.2	0.7	0.0	1.2	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.0	87.2	0.0	0.0	0.1	0.0	4.2	3.3	4.9	3.9	4.6	3.7	5.2	5.9	5.5	5.9	4.4	4.3	5.7	5.9	3.2	2.3	0.7	0.7	46.1	8.6	0.6	9.6	0.5	3.9	7.6	8.6	2.8	1.6	0.0	0.0	7.4	0.8	1.8	0.0	1.4	12.6	7.0	137.3	21.7	3.0	0.0	2.2	0.5	42.4	185.5	27.0	6.3	7.0	11.5	38.6	0.8	4.7	1.7	1.5	4.1	0.0	36.6	39.6	19.6	271.5	14.8	48.0	9.4	41.5	5.1	3.1	54.3	0.6	0.9	0.3	265.9	0.9	17.1	0.2	0.1	0.9	0.7	92.1	146.2	341.2	1.0	1.9	3.7	42.8	9.0	5.4	5.7	2.2	6.5
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917407-20953747	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 344.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Cytosol	"HPA000532: AB_2666019, HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.7	14.8	34.5	18.4	34.9	53.7	16.3	34.6	35.7	17.5	26.0	18.4	22.0	19.4	13.0	26.6	20.4	14.3	25.1	33.7	33.5	17.1	27.3	20.7	25.5	36.8	37.0	27.4	23.5	19.1	16.1	25.9	34.0	16.5	19.6	22.4	14.8	19.0	54.3	24.9	19.7	19.5	38.8	22.4	14.7	13.3	38.9	33.3	14.8	43.0	27.6	18.9	18.4	36.0	43.9	25.8	56.7	44.8	37.5	23.9	61.0	29.0	35.5	43.7	49.1	42.8	19.2	56.1	22.9	30.8	30.0	54.8	67.2	46.3	51.7	47.7	65.5	77.7	28.6	47.3	37.4	83.5	38.0	24.3	60.3	38.1	64.6	35.7	39.1	44.3	344.9	44.8	35.7	41.2	49.0	39.0	44.8	45.5	27.7	62.7	89.9	13.5	29.2	37.8	36.5	46.9	48.6	42.4	36.4	67.7	36.4	45.9	31.9	69.0	77.8	26.2	37.2	42.7	44.4	64.1	51.1	34.8	43.3	16.2	15.0	22.1	18.5	13.9	19.3	12.1	16.2	18.4	16.5	11.4	19.7	18.9	15.9	12.9	26.1	8.3	14.4	21.2	34.5	34.9	34.6	35.7	33.7	33.5	36.8	37.0	34.0	38.8	38.9	36.0	11.8	9.6	17.8	17.3	18.6	54.2	13.5	15.2	29.6	17.8	19.7	14.2	23.1	7.2	12.2	5.5	14.6	19.6	26.4	19.6	1.9	7.7	30.4	19.3	15.3	15.0	20.4	28.6	23.9	8.6	42.4	16.5	10.2	18.4	1.3	15.8	20.7	25.0	17.5	18.5	18.6	19.9	8.2	19.5	20.8	52.5	15.2	15.2	24.9	9.4	19.0	17.5	21.6	16.6	25.0	11.2	11.8	15.4	14.1	19.0	18.5	10.7	14.8	13.2	13.1	15.7	12.1	12.7	11.0	40.2	60.4	27.2	17.8	12.7	18.5	18.6
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"liver: 9388.5"	"Group enriched"	"Detected in some"	16	"Ductal cells: 1087.7;Hepatocytes: 4142.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;HDLM-2: 6.3;U-2 OS: 4.5;U-266/84: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5200000000		"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	3.4	0.7	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.3	0.0	3.1	0.0	0.5	0.4	111.7	0.7	0.0	0.0	0.7	9388.5	0.5	0.1	0.0	0.0	0.4	118.5	0.0	0.3	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.3	0.6	0.5	0.0	0.0	6.1	0.4	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	6.3	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.8	0.0	11.7	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	118.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1087.7	1.4	0.0	0.1	6.3	0.0	163.2	0.0	63.2	0.0	0.0	0.0	0.2	0.0	0.0	89.6	4142.7	0.1	0.0	0.0	0.0	0.0	98.8	0.3	0.7	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0
CRPPA	"hCG_1745121, ISPD, Nip"	ENSG00000214960	"CDP-L-ribitol pyrophosphorylase A"	A4D126	7	16087525-16502504	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"choroid plexus: 27.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 8.0;Cytotrophoblasts: 3.5;Extravillous trophoblasts: 10.6;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	29	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"HEL: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053554			Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA053554: AB_2682185"	"unprognostic (4.65e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.38e-11)"	"unprognostic (4.01e-2)"	"unprognostic (1.78e-4)"	"unprognostic (6.26e-2)"	"unprognostic (2.79e-1)"	1.1	1.2	1.3	0.8	1.8	1.6	0.9	0.7	3.7	1.3	27.0	1.0	0.6	1.0	0.5	0.5	0.9	1.1	2.6	3.8	1.1	2.9	4.1	1.0	1.4	0.8	0.8	0.7	1.5	1.1	0.7	1.0	0.8	1.0	1.2	1.2	1.2	0.8	1.5	1.2	0.6	1.2	0.2	0.9	3.5	2.2	3.2	1.2	0.8	1.3	1.4	1.1	0.5	2.0	0.4	2.2	1.0	1.6	1.0	1.3	6.8	1.5	1.4	1.5	1.3	2.2	1.9	4.3	3.2	2.7	0.9	2.5	1.2	0.0	2.9	1.5	0.9	9.6	1.4	0.7	1.5	1.9	2.4	2.2	0.8	1.6	0.4	0.9	1.2	3.0	3.2	0.2	4.2	0.7	3.0	1.2	1.8	1.1	0.5	1.1	1.9	0.2	2.1	0.8	1.5	0.9	1.4	2.1	1.7	2.5	1.6	2.0	2.0	1.9	1.5	0.4	1.7	0.4	0.0	4.8	1.5	2.3	2.2	13.8	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.4	0.3	0.2	0.4	0.4	0.1	0.3	0.1	0.0	1.3	1.8	0.7	3.7	3.8	1.1	0.8	0.8	0.8	0.2	3.2	2.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	10.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0
CRTC1	"FLJ14027, KIAA0616, MECT1, TORC1"	ENSG00000105662	"CREB regulated transcription coactivator 1"	Q6UUV9	19	18683678-18782333	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 37.4;Horizontal cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	203	"amygdala: 14.2;basal ganglia: 11.4;cerebellum: 27.1;cerebral cortex: 24.3;hippocampal formation: 24.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022035, HPA063619"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane, Cytosol"	"HPA022035: AB_1847255, HPA063619: "	"unprognostic (5.95e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.94e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (1.80e-5)"	"unprognostic (3.37e-2)"	"prognostic favorable (3.83e-5)"	"unprognostic (6.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.03e-2)"	8.8	11.3	14.2	5.2	11.4	2.1	8.2	27.1	24.3	11.3	0.0	8.9	4.0	9.3	3.4	5.2	10.3	3.2	10.5	24.5	0.0	12.8	10.4	7.9	4.1	0.0	0.0	9.4	9.8	4.7	23.7	3.9	0.0	11.6	1.5	4.4	7.3	5.1	14.4	7.4	8.5	2.5	0.0	9.6	9.9	11.3	0.0	3.6	14.4	3.6	2.2	9.7	7.4	0.0	5.2	7.9	6.7	10.7	6.3	4.5	18.6	5.4	3.6	5.3	4.8	5.1	6.6	7.1	11.6	5.2	3.9	5.5	2.1	3.5	1.3	3.1	15.1	6.0	7.8	9.3	5.5	8.3	16.3	7.8	2.9	4.4	1.3	6.8	3.1	7.2	4.8	6.3	3.0	15.2	5.7	10.0	8.8	2.7	13.1	8.7	2.9	8.1	3.2	8.0	12.1	10.7	6.0	5.8	7.0	2.2	6.6	5.2	5.4	6.0	9.1	10.8	6.4	4.4	3.6	4.6	6.9	8.6	4.6	0.3	0.6	0.4	0.4	0.2	0.3	0.5	0.5	0.6	0.7	0.7	0.5	0.3	0.2	0.3	0.4	0.8	0.4	0.4	14.2	11.4	27.1	24.3	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	5.3	31.0	6.9	2.7	8.9	7.8	5.7	29.1	5.8	6.1	17.7	10.0	3.5	18.4	27.1	9.7	7.9	6.8	11.7	4.6	1.1	9.6	14.0	5.6	19.2	3.6	37.4	6.0	2.7	7.5	8.6	9.8	2.5	14.7	3.9	4.7	8.8	43.7	26.7	7.1	12.2	6.0	4.0	3.2	9.3	6.3	3.6	10.3	5.5	9.1	8.2	12.1	20.2	3.5	9.6	4.9	2.0	3.0	6.1	5.0	4.8	14.7	0.0	14.2	6.6	2.9	8.8	2.4	2.0	10.4	5.1	8.3	5.2	3.6
CRTC2	TORC2	ENSG00000160741	"CREB regulated transcription coactivator 2"	Q53ET0	1	153947669-153958615	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028454, HPA028465"	Supported		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028454: AB_10599617, HPA028465: AB_10601991"	"unprognostic (4.91e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (4.32e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (7.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (6.12e-5)"	32.9	28.6	26.1	20.5	28.1	27.9	29.6	26.6	30.2	33.7	24.3	28.5	11.1	27.2	15.7	25.7	29.2	13.7	26.0	25.2	26.6	31.1	35.1	38.8	28.8	29.2	28.0	40.5	26.3	21.0	24.9	15.8	26.9	29.0	12.6	10.0	27.0	16.7	36.6	34.8	34.7	17.2	25.5	55.9	27.9	21.4	28.2	23.6	32.3	18.5	25.3	28.5	29.2	28.7	24.2	17.9	17.1	19.6	27.2	19.8	25.2	12.8	27.2	24.9	20.3	18.5	24.0	22.8	20.4	23.2	16.8	27.0	20.5	26.8	13.9	29.5	25.7	11.2	18.8	14.4	27.4	19.0	18.7	26.1	25.5	27.6	22.3	19.7	23.3	12.8	19.2	27.1	18.0	38.4	20.6	29.9	12.8	26.1	19.5	15.5	11.7	19.6	26.3	19.4	14.2	23.2	21.5	43.3	32.7	16.5	20.9	37.3	17.7	20.0	17.9	21.7	22.9	43.6	30.7	15.7	18.4	15.9	15.1	3.2	2.2	5.0	2.3	3.5	2.0	2.5	2.5	2.6	1.9	3.2	1.6	2.0	5.7	2.9	2.7	2.6	1.9	1.0	26.1	28.1	26.6	30.2	25.2	26.6	29.2	28.0	26.9	25.5	28.2	28.7	17.8	6.4	10.0	10.4	22.3	24.6	6.9	11.1	13.6	6.3	14.6	12.8	6.0	11.5	8.7	12.9	4.2	9.7	23.0	15.9	1.9	9.0	1.4	13.4	15.0	13.7	16.1	9.7	7.4	10.2	9.4	11.1	14.3	27.7	8.2	6.1	12.5	12.8	10.9	1.7	6.9	13.8	6.1	14.6	23.6	1.2	12.2	17.4	3.6	6.5	11.8	4.8	19.6	6.0	11.1	15.0	5.0	15.1	20.6	12.6	9.8	4.0	7.3	6.9	6.6	9.3	12.1	17.0	12.0	12.7	22.6	12.2	19.6	6.1	7.9	13.0
CRTC3	FLJ21868	ENSG00000140577	"CREB regulated transcription coactivator 3"	Q6UUV7	15	90529923-90645345	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043735, HPA063691"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA043735: AB_10794286, HPA063691: AB_2685092"	"unprognostic (7.60e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.30e-1)"	27.0	15.5	16.8	14.2	25.3	10.7	21.7	20.0	19.8	26.3	10.1	28.4	7.3	26.0	10.9	12.5	23.8	14.8	19.8	17.0	16.4	14.5	13.2	23.2	15.8	21.8	23.1	36.8	10.7	13.8	9.9	17.1	21.1	18.8	9.4	13.5	17.4	17.0	19.9	19.1	16.6	20.9	16.3	13.3	15.2	16.8	23.2	15.0	22.3	17.4	15.7	28.4	18.3	31.6	9.6	15.1	9.7	16.7	21.6	15.7	46.0	11.7	16.0	17.6	15.9	12.4	9.3	0.2	8.3	23.8	14.9	15.2	15.1	9.8	13.2	16.3	18.8	23.7	83.9	6.1	24.8	6.5	38.8	17.2	16.3	14.5	19.3	13.2	12.5	10.2	12.8	5.5	13.6	11.5	2.6	9.7	3.7	2.7	7.2	8.3	16.3	0.5	6.6	20.3	18.5	16.5	34.7	11.6	19.3	10.8	11.2	12.2	16.4	19.7	14.9	19.0	14.0	7.3	10.2	7.2	8.0	12.6	9.8	21.4	2.6	1.5	3.5	0.8	3.8	2.9	4.3	3.7	1.6	5.0	6.1	3.9	0.5	3.3	0.3	2.1	4.4	3.4	16.8	25.3	20.0	19.8	17.0	16.4	21.8	23.1	21.1	16.3	23.2	31.6	17.9	6.4	9.2	44.1	35.6	23.6	27.8	8.0	13.1	24.9	15.7	12.7	17.0	14.3	7.8	12.9	27.1	14.8	30.0	8.6	1.9	14.9	29.3	6.6	18.5	20.4	15.6	17.1	70.1	10.7	43.3	23.2	14.8	12.7	23.5	34.8	24.7	16.2	15.3	57.2	72.4	9.1	6.1	18.2	18.8	24.3	26.8	21.7	17.8	39.4	20.6	17.7	58.7	75.4	160.8	11.1	10.9	43.6	21.3	26.2	6.4	11.0	2.8	59.7	46.0	30.5	45.8	10.2	17.8	11.4	24.0	17.8	36.0	13.7	11.3	38.2
CRY1	PHLL1	ENSG00000008405	"Cryptochrome circadian regulator 1"	Q16526	12	106991364-107093549	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018762	Approved		Supported	"Nucleoplasm,Nuclear membrane,Microtubules"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear membrane, Microtubules"		"CAB018762: AB_2083970"	"unprognostic (1.21e-3)"	"unprognostic (4.74e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	13.3	12.4	8.5	7.6	9.8	12.4	11.2	16.2	10.9	11.1	16.7	12.6	11.5	14.2	6.4	11.0	16.4	16.7	11.7	8.4	9.0	13.7	13.6	19.3	5.8	9.8	10.1	9.0	13.5	8.8	8.4	12.1	9.9	11.3	8.6	21.3	9.0	11.5	10.9	9.0	12.7	16.8	9.7	8.7	16.2	37.3	9.9	19.0	17.0	11.0	6.7	15.6	8.6	12.5	17.3	16.9	20.6	23.0	14.6	9.1	36.9	17.9	19.1	36.0	24.2	19.9	10.1	0.0	11.1	16.7	22.7	11.6	26.8	9.3	39.6	17.3	16.6	16.9	15.3	13.8	18.6	17.3	14.2	8.6	9.6	26.4	24.9	17.8	30.5	31.4	19.3	14.6	22.7	12.1	39.2	19.7	25.1	16.5	24.6	34.5	52.3	6.1	25.3	20.2	37.1	19.2	33.6	22.1	10.9	20.0	15.6	9.6	13.5	20.9	22.2	14.6	16.2	26.6	26.6	7.8	10.2	16.3	17.5	12.0	3.2	5.8	12.8	4.7	16.1	1.9	9.6	8.2	4.3	1.9	8.9	8.8	1.4	6.4	8.9	2.8	13.5	5.7	8.5	9.8	16.2	10.9	8.4	9.0	9.8	10.1	9.9	9.7	9.9	12.5	16.3	16.0	16.2	20.5	9.7	69.2	47.9	4.3	55.2	16.8	30.4	14.7	11.1	11.5	6.1	11.0	20.9	8.3	29.1	12.7	17.6	11.4	12.8	27.3	19.3	20.1	19.6	11.2	22.4	16.3	13.4	24.5	45.9	33.2	5.1	6.2	12.1	20.2	6.3	26.9	38.4	9.7	6.1	7.3	21.0	4.8	11.5	8.8	16.0	13.1	16.3	22.8	19.6	35.2	32.8	21.5	7.0	17.3	15.3	29.7	7.7	16.1	18.7	13.7	6.6	24.3	19.2	108.0	32.4	24.3	59.5	15.1	29.7	5.7	6.8	27.0
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Chaperone, Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"kidney: 85.6;retina: 55.5"	"Cell type enriched"	"Detected in single"	5	"Muller glia cells: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	148	"Hep G2: 38.0"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.9"					"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"							"unprognostic (3.68e-3)"											0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	85.6	6.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYAA2		ENSG00000276076	"Crystallin alpha A2"	A0A140G945	21	6560714-6564489	"Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	136	"kidney: 125.7;liver: 42.1;retina: 48.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	207	"Hep G2: 37.5"									"HPA037737, HPA038430"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"		Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"																		0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	125.7	42.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	48.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYBB2	"CCA2, CRYB2, CRYB2A"	ENSG00000244752	"Crystallin beta B2"	P43320	22	25212564-25231870	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 10.6;Breast myoepithelial cells: 12.8;Distal tubular cells: 27.4;Melanocytes: 12.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 2.1"	"Region enhanced"	"Detected in some"		"hippocampal formation: 1.7"	"Low region specificity"	"Detected in many"			HPA043749	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA043749: AB_2678652"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.57e-3)"	"unprognostic (9.51e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-3)"	0.2	0.4	2.7	0.0	2.6	0.0	0.3	2.0	4.5	0.3	2.0	0.4	0.2	0.1	0.3	0.4	0.1	0.1	0.2	2.7	2.3	0.5	0.3	0.3	0.0	2.1	2.2	0.1	0.2	0.0	1.4	0.0	2.5	0.6	0.3	0.4	0.3	0.1	0.5	0.4	0.3	0.2	2.0	0.1	0.2	1.7	2.9	0.0	1.0	0.0	0.0	0.2	0.4	2.5	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.9	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.0	2.7	2.6	2.0	4.5	2.7	2.3	2.1	2.2	2.5	2.0	2.9	2.5	0.9	0.0	0.0	2.0	1.0	5.4	0.6	6.7	0.6	0.3	10.6	12.8	1.4	1.5	1.5	1.8	0.0	0.1	0.9	1.7	27.4	0.1	3.0	1.7	1.2	2.9	0.0	8.0	2.4	0.2	0.1	3.4	0.0	2.5	0.0	3.1	4.6	3.2	0.2	0.0	0.4	0.3	0.0	1.2	3.1	9.6	2.5	0.8	12.4	1.9	0.0	0.4	0.0	0.5	0.3	0.5	0.1	8.2	0.0	0.4	0.0	9.7	0.6	0.1	0.0	6.2	2.1	2.6	3.3	0.4	3.8	0.1	1.3	7.6	0.2	0.6
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"		6	106360717-106572017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"esophagus: 61.9;placenta: 72.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 219.4;dendritic cells: 153.6;Plasma cells: 89.9;Syncytiotrophoblasts: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.7;HBEC3-KT: 124.1;hTERT-HME1: 95.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.2"	"Low region specificity"	"Detected in many"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	17.0	1.2	0.6	21.9	0.5	24.1	17.3	0.7	0.8	6.8	40.3	25.0	25.4	2.4	6.2	61.9	6.7	8.1	1.0	1.9	0.4	15.3	11.8	9.8	20.4	0.8	0.7	2.3	4.9	5.8	0.4	72.0	0.6	25.2	19.2	0.8	9.3	5.4	1.1	42.1	23.7	4.8	0.5	12.6	10.3	5.1	1.5	9.7	2.6	1.2	33.5	19.0	14.0	0.4	34.7	0.2	0.0	0.1	25.5	93.7	9.9	4.9	33.5	10.8	10.0	2.4	11.5	54.0	2.3	21.7	14.6	54.5	0.2	124.1	5.3	74.0	2.3	0.0	1.5	16.9	12.1	33.4	0.2	44.9	66.7	19.7	95.8	0.1	46.5	41.9	1.7	7.3	28.5	3.5	9.7	10.7	0.4	0.2	21.2	16.4	0.4	0.4	14.9	80.0	2.2	0.2	20.3	31.9	0.3	3.0	16.4	24.3	13.5	11.6	1.5	0.2	34.4	5.7	4.7	57.7	56.0	39.3	26.3	0.3	3.4	0.4	7.4	3.6	10.1	6.6	9.8	8.5	8.6	2.9	5.8	5.7	2.4	4.8	4.1	1.0	9.9	4.0	0.6	0.5	0.7	0.8	1.9	0.4	0.8	0.7	0.6	0.5	1.5	0.4	13.4	12.8	11.9	0.0	24.2	0.0	0.0	0.0	0.0	0.0	31.2	14.1	0.0	0.0	13.0	33.1	0.0	219.4	153.6	0.0	3.9	10.9	0.0	20.2	2.7	4.4	0.0	0.0	0.0	12.5	15.3	2.5	0.0	31.6	1.3	0.1	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	26.4	0.0	0.0	89.9	0.0	0.0	15.0	8.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	600.1	76.7	0.1	0.0	0.0
CRYBG2	"AIM1L, FLJ38020"	ENSG00000176092	"Crystallin beta-gamma domain containing 2"	Q8N1P7	1	26321698-26360080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 48.2;skin 1: 20.3;vagina: 20.6"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 48.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 11.4;BEWO: 23.2;CACO-2: 39.3;CAPAN-2: 25.7;HaCaT: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029629			Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA029629: AB_10601331"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.39e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.83e-9)"	"unprognostic (9.12e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.63e-2)"	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	10.2	0.0	2.6	6.5	0.0	0.8	48.2	0.3	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	6.0	0.0	0.4	1.9	0.0	6.1	0.0	0.0	20.3	5.9	0.0	0.0	0.0	1.4	1.5	0.0	0.1	0.0	0.0	4.2	8.4	20.6	0.0	11.4	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.1	0.1	39.3	25.7	0.3	7.7	0.0	0.1	9.7	0.1	6.9	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.6	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	1.9	6.3	0.0	0.0	0.0	0.2	0.4	2.5	0.4	0.0	0.0	4.5	0.0	1.7	6.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	1.8	0.0	6.7	0.9	0.0	1.9	2.1	0.0	2.4	0.1	0.1	0.0	0.0	0.0	1.4	4.4	0.1	0.0	2.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.6	1.2	0.0	0.0	0.0
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 329.8;liver: 254.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 485.2;Hepatocytes: 306.1;Proximal enterocytes: 509.9;Proximal tubular cells: 1033.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040403, HPA058848"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632, HPA058848: "	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	33.7	31.8	69.5	15.4	81.3	11.2	27.1	75.4	78.1	33.0	65.6	62.1	190.2	30.5	51.7	24.7	26.5	30.0	30.4	65.2	79.0	329.8	254.1	19.9	19.4	76.3	71.9	19.8	46.9	31.4	38.1	16.1	76.1	32.2	49.3	20.7	41.6	36.5	17.0	16.3	131.6	22.8	77.2	23.3	45.2	4.9	71.9	18.0	35.0	20.7	16.3	20.9	23.6	89.8	8.1	6.9	6.4	42.7	31.6	36.1	5.8	11.1	20.0	4.8	3.9	2.6	7.8	0.1	20.6	15.5	10.9	1.9	5.7	9.9	4.9	19.4	4.7	14.2	0.8	55.1	18.1	4.6	12.2	21.5	6.4	3.9	22.0	17.1	51.7	20.3	1.0	5.8	12.7	29.2	12.7	7.2	0.4	68.7	10.2	6.4	3.8	1.0	40.8	16.9	4.2	5.0	6.6	3.1	51.0	3.0	21.2	18.0	50.1	5.8	2.6	14.3	7.1	7.6	1.6	0.0	11.1	7.9	24.5	5.8	50.7	3.2	23.2	59.6	18.9	20.5	30.6	22.1	60.5	23.1	23.5	22.2	1.7	15.6	50.6	6.4	37.5	43.8	69.5	81.3	75.4	78.1	65.2	79.0	76.3	71.9	76.1	77.2	71.9	89.8	29.2	6.4	10.3	57.8	17.7	10.3	15.9	29.7	6.2	6.1	22.0	11.6	10.5	35.8	25.6	77.3	12.5	22.0	10.0	138.5	485.2	26.1	3.6	32.5	8.8	29.1	9.1	6.9	54.5	31.6	11.2	29.8	34.1	27.2	25.3	8.8	50.7	306.1	71.4	1.7	35.3	89.0	32.6	91.6	34.3	4.3	26.1	51.3	37.4	13.1	19.3	112.2	9.2	33.7	114.1	43.2	219.1	24.0	14.3	23.0	509.9	1033.9	20.9	12.6	19.7	23.4	14.7	1.0	2.7	13.0	9.2	20.8	20.1	20.7	105.2	15.0
CRYZL1	"4P11, QOH-1"	ENSG00000205758	"Crystallin zeta like 1"	O95825	21	33589341-33643926	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019120, HPA029399, CAB034129"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.28e-3)"	22.4	18.6	23.7	16.4	26.4	22.4	21.1	31.4	33.5	19.2	23.7	28.2	15.0	22.6	19.0	18.8	20.2	16.3	20.0	24.8	25.9	23.5	18.0	16.2	17.7	24.7	26.0	22.0	15.2	22.3	14.2	21.7	25.1	18.3	20.3	29.2	18.0	22.3	19.2	22.9	15.8	21.2	22.5	15.6	17.6	34.0	25.2	18.1	24.5	15.4	14.0	21.0	18.0	34.2	38.0	16.4	45.7	33.8	24.3	35.0	24.0	26.3	37.8	33.0	29.1	24.5	29.0	26.4	23.0	32.5	25.6	20.5	24.6	27.2	30.0	24.6	24.8	49.9	35.5	22.2	38.4	31.0	29.8	32.7	23.4	34.9	27.2	43.1	42.4	42.6	36.8	26.6	31.3	19.3	30.2	31.8	32.3	38.8	21.9	28.5	36.8	36.6	47.1	33.7	19.8	31.2	34.6	17.5	39.7	37.8	34.3	23.1	44.8	26.3	25.3	22.0	20.5	43.4	64.7	29.1	34.4	22.7	30.1	36.1	34.5	36.2	31.7	37.5	34.3	38.2	33.4	29.9	43.3	40.4	43.3	35.3	18.3	47.1	35.6	34.3	29.9	26.8	23.7	26.4	31.4	33.5	24.8	25.9	24.7	26.0	25.1	22.5	25.2	34.2	25.6	32.1	17.3	40.1	25.9	23.6	43.9	58.9	19.9	47.8	22.1	25.1	28.0	31.5	36.0	31.3	31.3	70.4	21.3	20.2	49.0	37.6	90.4	19.6	14.4	29.9	21.0	25.4	42.4	29.1	40.5	28.1	13.3	14.4	65.2	34.5	27.5	15.0	33.5	47.1	47.2	22.5	46.8	26.0	25.7	28.0	44.1	24.6	37.4	26.2	36.1	49.4	41.2	32.2	56.7	28.6	30.3	41.0	11.3	23.3	33.7	44.8	35.0	51.1	19.7	23.7	41.5	139.4	19.4	15.9	21.5	44.6	28.4	27.3	29.4	40.5
CSDC2	PIPPin	ENSG00000172346	"Cold shock domain containing C2"	Q9Y534	22	41561010-41577741	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 143.8;heart muscle: 288.2;ovary: 133.6"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 75.0;Distal tubular cells: 19.6;Granulosa cells: 30.7;Muller glia cells: 51.7;Proximal tubular cells: 42.5;Sertoli cells: 72.3;Smooth muscle cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 12.4;U-2 OS: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003073, HPA076549"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA003073: AB_1078578, HPA076549: AB_2686807"	"unprognostic (9.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (6.42e-4)"	"unprognostic (8.86e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.09e-3)"	6.8	143.8	29.4	1.6	21.8	0.1	3.2	64.5	32.1	69.9	4.1	16.5	0.8	83.5	1.4	3.2	24.1	2.3	288.2	30.5	35.3	40.4	2.6	11.5	0.2	44.4	41.0	133.6	51.1	0.0	20.5	0.4	36.9	26.2	0.5	5.2	1.0	10.4	2.7	2.1	3.2	10.9	26.1	1.1	4.5	31.3	44.9	0.0	2.5	2.7	0.0	27.4	29.0	22.7	0.0	0.2	1.5	0.2	0.0	0.0	0.1	3.4	0.2	0.1	0.1	0.9	0.0	0.0	0.5	4.7	0.5	0.1	0.0	0.0	0.0	0.0	2.9	0.0	12.4	1.5	3.5	0.0	0.0	1.9	0.1	0.0	0.0	3.5	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.1	1.1	0.2	0.0	0.1	0.1	1.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.1	41.8	0.3	0.1	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	29.4	21.8	64.5	32.1	30.5	35.3	44.4	41.0	36.9	26.1	44.9	22.7	0.1	0.0	0.0	4.6	0.5	0.3	0.2	0.3	0.6	9.9	0.1	0.6	75.0	0.0	0.0	7.3	2.1	0.1	0.0	0.0	19.6	0.3	1.5	0.2	6.0	0.9	0.0	0.0	6.8	10.4	0.1	5.1	0.0	0.1	0.0	30.7	0.4	0.2	0.2	6.7	11.0	0.0	0.0	0.0	0.0	5.1	5.3	0.3	1.8	0.0	0.0	51.7	0.0	1.0	0.6	2.4	0.0	2.6	0.0	0.2	0.0	42.5	0.7	3.2	72.3	0.4	19.9	2.1	0.3	0.0	0.1	0.3	0.2	0.3	0.0	0.0
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 164.0;Spermatogonia: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol		No	Yes		320000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavorable (6.91e-4)"	23.6	24.5	16.0	29.0	20.2	26.4	34.2	26.6	21.1	25.7	12.9	23.6	19.8	28.1	23.8	38.2	27.0	19.0	24.7	17.1	18.0	29.8	30.9	19.7	35.0	21.0	17.3	27.2	20.4	30.8	13.6	37.5	22.8	25.8	28.7	23.2	21.7	25.6	39.8	34.4	19.2	35.0	21.1	20.3	20.7	87.7	17.0	40.7	23.4	41.5	42.8	27.5	22.2	29.1	224.3	152.4	182.1	140.9	69.0	88.5	196.7	172.1	90.5	528.1	222.0	501.8	175.4	227.3	224.1	109.7	213.9	251.4	270.7	322.9	500.0	37.4	131.3	158.0	166.1	244.7	42.0	176.2	83.3	50.0	118.7	259.0	148.7	72.4	177.5	124.3	227.2	87.1	201.1	76.8	213.9	90.6	153.5	185.1	224.0	133.9	299.5	176.4	116.5	153.2	159.6	92.6	275.2	293.3	97.1	137.7	245.3	113.3	115.5	279.3	233.9	166.4	247.9	50.5	130.8	210.8	166.8	139.5	152.2	18.6	16.3	3.8	13.8	20.6	21.1	16.7	21.0	17.1	20.1	13.6	22.1	19.3	4.4	23.0	23.6	8.9	20.1	18.3	16.0	20.2	26.6	21.1	17.1	18.0	21.0	17.3	22.8	21.1	17.0	29.1	16.4	6.4	26.8	8.1	20.3	30.2	25.8	29.5	31.3	14.9	17.4	15.9	26.6	24.3	22.4	27.6	10.4	71.8	15.7	7.4	13.7	32.2	95.9	14.7	19.4	22.9	5.4	40.4	20.9	26.6	61.2	24.6	13.7	17.8	4.5	35.1	19.2	26.7	29.7	15.2	24.4	11.8	20.3	17.9	21.9	57.8	25.4	17.9	26.6	9.4	28.0	22.6	7.2	17.1	41.7	26.7	10.0	31.6	26.7	28.8	9.9	21.6	21.7	15.5	39.5	19.3	22.1	164.0	121.5	36.7	34.5	72.7	17.5	31.1	23.7	22.2
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 312.5;Late spermatids: 775.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	46.7	57.0	36.9	28.9	36.9	25.9	42.3	34.4	37.9	45.3	30.3	57.1	35.1	56.6	26.7	50.8	45.3	24.8	42.4	39.0	40.2	45.5	40.9	45.3	30.8	37.2	37.6	43.1	47.5	43.1	54.2	30.2	36.3	51.8	20.0	15.1	48.6	36.8	88.9	36.4	50.9	29.0	36.3	56.3	49.3	60.7	42.6	34.0	44.7	38.7	22.8	49.0	37.0	32.9	60.3	70.9	39.5	54.7	50.8	53.9	77.7	85.1	54.4	61.0	56.8	58.6	49.4	55.0	66.3	62.5	64.8	57.1	37.4	88.3	48.9	47.0	90.5	68.5	53.4	63.7	146.9	56.9	50.4	81.9	61.5	41.6	61.3	76.0	90.0	39.5	78.5	28.4	58.5	70.6	73.7	59.3	42.2	71.3	108.6	62.6	48.7	49.7	64.8	93.4	48.5	87.4	100.4	85.5	97.7	54.3	61.5	73.0	95.6	86.9	77.3	76.2	67.0	61.0	32.1	58.4	69.5	48.1	64.7	8.8	20.8	27.4	12.3	21.3	11.8	11.1	9.6	12.1	20.1	9.0	8.1	8.7	50.4	15.3	20.3	9.6	9.2	15.4	36.9	36.9	34.4	37.9	39.0	40.2	37.2	37.6	36.3	36.3	42.6	32.9	65.8	48.1	54.3	36.6	81.1	56.6	116.0	58.3	52.9	46.5	59.8	51.2	19.7	31.5	65.7	42.3	27.1	61.8	101.0	105.2	33.2	71.6	312.5	69.6	54.0	54.2	46.2	32.4	24.4	69.6	95.2	42.8	87.1	93.2	60.1	45.3	42.5	33.6	65.3	95.9	21.2	62.8	67.1	51.5	83.8	775.6	30.1	75.7	28.4	24.4	65.8	28.7	79.3	24.6	21.2	87.7	83.2	40.3	80.9	90.8	94.3	43.8	66.6	54.4	39.5	78.6	57.5	55.1	29.6	44.2	48.3	126.6	87.6	46.7	56.7	118.6
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	"Casein kinase 1 epsilon"	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 280.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009626, HPA026288"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	"unprognostic (2.32e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.95e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (2.08e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.16e-3)"	"prognostic unfavorable (4.67e-6)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.25e-3)"	87.1	52.8	81.1	41.2	82.6	51.6	88.3	80.8	95.1	93.6	66.0	73.0	41.4	82.7	52.5	69.0	83.3	48.7	80.9	82.9	73.7	70.2	37.4	92.2	40.3	78.9	78.6	109.5	64.9	74.1	85.1	71.2	79.5	80.3	35.5	47.3	71.6	44.9	60.5	94.8	50.9	45.3	70.2	63.6	58.0	29.5	83.2	33.3	64.4	47.2	37.8	65.7	88.4	93.9	101.5	57.4	121.6	114.7	61.5	88.3	92.1	126.9	168.6	116.7	114.3	63.9	76.7	74.2	53.0	120.7	70.7	77.9	96.1	177.9	79.2	123.0	215.2	23.9	181.2	47.4	123.7	48.3	61.9	90.2	143.8	171.7	220.3	141.0	121.1	60.6	50.9	155.0	110.8	68.4	71.1	60.9	87.2	67.3	69.1	130.8	90.1	123.4	99.0	92.4	181.6	69.3	102.9	109.3	124.7	68.0	59.5	73.0	134.3	94.0	111.3	58.7	102.1	61.2	105.2	104.5	151.0	56.9	176.3	4.8	1.6	3.6	3.0	0.8	3.8	2.1	3.4	3.0	1.8	3.1	1.9	2.5	3.8	5.7	0.5	15.9	1.6	1.2	81.1	82.6	80.8	95.1	82.9	73.7	78.9	78.6	79.5	70.2	83.2	93.9	73.4	38.5	21.7	0.0	32.3	78.6	158.8	89.1	68.9	132.6	53.7	42.4	49.8	34.3	73.9	23.9	60.5	35.2	42.3	28.4	7.9	30.8	46.0	94.3	72.5	76.4	62.8	12.6	0.0	41.8	49.2	60.8	39.8	126.5	3.8	46.6	45.0	21.3	23.1	72.3	0.0	46.0	46.8	17.6	54.1	69.1	85.4	21.8	60.5	0.0	13.3	117.9	28.8	0.0	0.0	57.5	33.1	66.2	83.5	160.5	9.0	6.5	62.8	60.7	72.3	85.7	98.0	8.0	20.0	50.3	104.7	125.5	26.0	34.9	37.6	280.8
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	36.1	32.6	20.9	38.6	23.2	34.0	35.9	28.2	29.6	36.5	29.3	48.3	39.1	35.8	26.6	50.0	39.9	31.3	54.0	25.7	21.0	41.0	31.8	31.6	41.2	20.6	21.1	41.5	46.9	59.1	21.2	42.4	21.1	35.8	40.7	32.9	41.1	37.7	110.5	34.2	40.5	39.1	18.8	30.2	49.5	65.2	22.3	51.6	39.6	86.4	46.6	47.4	28.5	27.3	209.5	170.4	152.9	96.0	61.1	103.8	103.5	117.9	116.1	125.8	139.5	178.5	120.0	179.1	74.2	90.1	179.1	147.8	162.1	167.4	187.2	62.6	57.7	247.3	44.7	177.7	102.5	228.1	51.3	99.5	173.3	105.8	316.0	122.2	139.5	146.4	248.9	112.6	123.8	64.2	262.0	73.7	227.4	173.4	97.6	149.8	140.5	140.9	112.9	128.5	163.9	132.3	97.2	184.0	174.8	120.7	120.4	83.9	142.7	136.0	118.4	90.0	178.5	120.6	311.8	174.1	65.8	119.5	138.6	40.5	23.8	28.7	18.2	32.3	22.4	23.0	18.0	17.6	31.5	22.5	17.9	17.4	14.9	25.1	33.5	25.7	20.4	20.8	20.9	23.2	28.2	29.6	25.7	21.0	20.6	21.1	21.1	18.8	22.3	27.3	50.7	64.1	84.6	51.9	46.1	41.0	40.0	43.8	45.5	49.4	42.1	36.1	59.4	41.5	75.8	44.1	31.3	42.2	50.5	43.5	41.1	68.5	135.5	67.6	77.0	44.5	35.2	59.3	65.6	50.6	54.4	46.3	40.2	75.7	63.8	108.6	27.1	31.1	33.2	60.6	69.3	41.8	46.8	39.2	30.3	140.0	41.0	45.3	14.2	51.5	61.7	38.6	37.0	73.9	73.6	66.6	34.4	36.9	49.6	57.2	43.2	68.8	65.5	27.8	52.6	43.6	56.8	94.2	68.7	52.3	50.2	61.4	38.9	81.2	40.6	59.4
CSNK2A3	CSNK2A1P	ENSG00000254598	"Casein kinase 2 alpha 3"	Q8NEV1	11	11351942-11353250	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 12.4;Cholangiocytes: 4.3;Smooth muscle cells: 6.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;SK-BR-3: 1.3"									"HPA059206, HPA061698"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.25e-4)"	"unprognostic (4.36e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.38e-2)"	0.5	0.5	0.7	0.2	0.1	0.0	0.5	0.4	0.6	0.4	0.0	0.5	0.3	0.6	0.0	0.7	0.4	0.0	0.8	0.9	0.0	0.4	0.3	0.6	0.0	0.0	0.0	0.5	0.5	0.0	0.3	0.2	0.0	0.3	0.0	0.1	0.6	0.0	1.8	0.7	0.4	0.2	0.0	0.2	0.5	0.9	0.1	0.0	0.5	0.0	0.0	0.4	0.5	0.0	2.1	0.4	0.1	0.6	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.3	0.2	0.3	0.2	0.2	0.5	0.3	0.6	0.1	0.9	0.4	0.1	0.3	0.2	0.3	0.1	0.5	0.6	1.3	0.3	0.0	0.4	0.1	0.3	0.3	0.4	0.1	0.2	0.2	0.3	0.3	0.9	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.4	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.2	0.5	0.0	0.5	1.8	1.0	0.7	0.0	1.2	0.6	0.9	12.4	4.3	1.0	3.7	0.0	0.7	0.5	0.4	0.0	0.7	2.5	0.1	0.3	2.0	1.2	0.0	0.0	0.8	0.5	0.9	0.0	0.4	1.3	0.6	1.8	0.3	0.3	3.3	0.0	0.3	0.0	1.6	0.8	1.9	0.6	0.2	0.0	0.0	0.6	0.9	1.0	0.0	0.0	0.5	1.2	0.0	0.1	1.2	0.6	0.7	0.9	0.5	0.0	2.3	6.9	0.9	0.9	0.0	1.0	1.0	0.6	1.1	0.6	0.6
CSPG4	"CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2"	ENSG00000173546	"Chondroitin sulfate proteoglycan 4"	Q6UVK1	15	75674322-75712848	"Predicted membrane proteins"	"Angiogenesis, Differentiation, Tissue remodeling"	"Developmental protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.4"	"Group enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 57.3;Sertoli cells: 118.3;Smooth muscle cells: 47.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.7;SK-MEL-30: 146.1;U-138 MG: 92.1;WM-115: 138.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001933, HPA002951, CAB016189, HPA042785, HPA050008"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		48000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoplasm	"CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991"	"unprognostic (5.21e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (7.60e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (4.93e-5)"	29.6	1.8	9.0	7.3	7.1	0.0	18.5	6.6	9.3	16.0	1.8	55.4	2.8	34.5	1.4	8.3	15.0	5.6	14.6	7.5	8.2	4.9	0.9	19.4	0.4	11.7	7.8	8.9	2.1	1.2	2.2	15.5	9.7	14.4	2.2	0.1	4.7	11.2	39.6	7.8	15.3	22.7	6.7	5.6	19.1	1.3	7.7	0.6	5.6	10.0	0.3	30.3	12.6	9.8	11.9	0.1	1.0	7.1	1.6	9.8	0.1	64.7	28.6	44.4	28.8	0.1	45.0	0.0	1.5	45.4	6.2	0.6	0.1	0.3	13.6	0.6	0.2	0.0	19.2	0.0	10.0	0.0	0.1	4.8	0.1	13.5	1.5	16.5	0.0	0.0	0.1	0.1	7.6	0.1	0.0	0.2	1.2	0.0	0.3	0.1	4.0	0.1	0.0	0.0	0.1	0.2	1.7	0.1	146.1	1.2	0.9	1.2	0.1	92.1	17.9	3.6	0.8	0.0	0.2	0.0	20.3	0.5	138.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.0	7.1	6.6	9.3	7.5	8.2	11.7	7.8	9.7	6.7	7.7	9.8	4.9	0.0	0.0	1.0	0.0	2.8	0.7	4.7	0.0	1.4	0.1	0.8	11.4	0.0	0.8	1.8	0.0	0.2	0.5	0.1	0.0	0.0	0.6	0.7	0.7	2.7	0.0	0.0	0.4	0.0	0.6	5.9	1.5	0.4	0.0	1.8	1.1	0.2	1.1	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.3	0.3	12.4	3.7	0.0	0.0	0.0	57.3	0.1	0.0	0.0	0.4	0.0	4.3	0.0	0.1	1.0	0.2	118.3	3.1	47.1	0.0	1.3	0.1	1.8	0.3	0.3	0.1	0.0	0.4
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562238-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 83.2;choroid plexus: 65.2;retina: 28.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 67.6;Muller glia cells: 94.7;Oligodendrocyte precursor cells: 233.7"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 32.6;HEK 293: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Mitochondria	"HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446"	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	0.9	0.8	58.3	0.2	62.4	0.1	0.6	33.6	83.2	0.3	65.2	1.1	0.0	0.3	0.1	0.3	0.3	0.1	0.5	62.5	49.7	0.2	0.2	3.2	0.2	41.2	45.6	0.2	0.3	0.3	1.7	0.8	45.8	0.4	0.2	28.3	0.3	0.0	0.5	1.1	0.3	0.4	37.0	0.0	0.4	1.9	48.0	0.1	0.4	0.0	0.1	0.1	0.2	46.1	0.3	1.7	32.6	5.7	0.6	0.0	0.9	0.6	0.1	1.2	0.3	0.3	2.0	0.1	2.5	0.1	2.4	0.5	2.7	0.3	0.3	0.0	8.8	0.5	1.4	0.0	0.0	0.4	1.4	0.0	1.1	0.1	0.0	0.9	0.1	1.1	6.6	0.3	0.1	1.5	0.2	0.4	3.1	2.4	3.3	0.5	0.2	0.7	1.4	1.1	3.4	1.5	2.1	4.1	0.1	0.9	1.6	3.1	0.3	0.1	6.5	0.1	1.9	0.8	0.8	0.0	0.5	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	62.4	33.6	83.2	62.5	49.7	41.2	45.6	45.8	37.0	48.0	46.1	0.7	3.2	2.0	67.6	0.1	0.8	0.1	0.0	0.0	28.6	2.2	1.8	1.3	0.0	0.0	0.0	6.2	0.2	0.0	0.5	0.0	0.2	2.0	0.6	0.6	0.3	1.8	0.0	18.6	0.0	0.2	0.5	0.0	2.0	0.0	6.1	0.0	0.5	0.2	6.7	25.0	0.3	0.0	0.0	0.2	0.6	0.3	0.2	0.0	7.5	0.0	94.7	0.0	233.7	9.9	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	22.7	0.0	0.8	0.8	13.5	3.3	0.0	0.6	0.1	0.2	0.2	0.4	0.1
CSRNP1	"AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1"	ENSG00000144655	"Cysteine and serine rich nuclear protein 1"	Q96S65	3	39141855-39154562	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 193.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 17.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 64.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045207, HPA058463"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"HPA045207: AB_10967202, HPA058463: AB_2683726"	"unprognostic (2.90e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.07e-4)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	88.9	55.8	13.6	34.0	13.7	193.1	51.7	17.2	22.5	34.7	15.4	35.6	12.0	30.2	6.4	61.7	79.8	67.5	49.9	12.8	18.0	29.2	67.3	80.8	14.9	21.3	16.2	41.5	39.4	23.5	43.3	25.0	15.7	32.7	15.4	5.8	21.3	18.5	36.9	57.1	26.4	64.1	18.3	20.3	48.0	14.7	17.1	34.9	33.8	19.0	8.7	51.6	27.7	15.4	4.4	9.7	2.5	4.8	4.7	4.9	7.8	15.9	22.1	13.0	10.6	13.7	4.0	14.4	3.3	12.1	9.3	4.9	3.0	21.0	6.4	21.6	4.0	16.4	8.0	10.5	5.8	4.1	15.7	2.3	11.3	20.4	3.2	11.6	17.8	3.9	12.7	24.9	10.7	13.9	0.8	6.7	11.4	7.4	8.1	6.8	10.4	23.7	10.3	15.9	7.0	1.1	8.7	64.2	5.5	14.5	7.2	7.5	9.0	6.6	28.2	5.6	11.9	6.3	5.8	6.6	14.4	5.2	8.4	0.1	3.0	3.8	1.7	5.9	2.1	3.6	1.6	2.0	3.3	3.7	2.0	1.3	17.1	2.6	11.0	4.2	2.7	2.3	13.6	13.7	17.2	22.5	12.8	18.0	21.3	16.2	15.7	18.3	17.1	15.4	200.8	48.1	66.3	6.8	75.0	103.2	88.1	40.2	153.1	1.4	121.1	95.8	15.8	37.1	31.2	11.0	0.0	19.7	86.3	77.3	9.8	37.6	54.4	119.6	65.2	92.8	59.3	13.2	3.5	38.5	43.0	98.1	75.4	199.4	96.5	4.2	73.9	40.7	38.7	0.0	1.5	54.7	22.4	36.7	165.2	46.8	1.5	94.5	69.4	4.7	14.8	7.6	7.2	1.5	1.3	49.2	60.9	4.1	74.3	49.4	54.1	6.0	21.0	1.7	13.1	154.4	103.9	0.6	4.7	85.7	79.6	90.7	132.4	8.9	38.0	38.9
CSRNP3	"FAM130A2, FLJ32093, PPP1R73, TAIP-2"	ENSG00000178662	"Cysteine and serine rich nuclear protein 3"	Q8WYN3	2	165469647-165689407	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 358.3;Inhibitory neurons: 315.3;Oligodendrocyte precursor cells: 344.8;Oligodendrocytes: 95.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.8;PC-3: 2.4;SCLC-21H: 7.1;SH-SY5Y: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017905	Approved		Uncertain	"Nucleoplasm,Nucleoli rim"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli rim"	Nucleoplasm	"HPA017905: AB_1857757"	"unprognostic (2.85e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.08e-2)"	0.9	2.3	9.4	0.4	9.3	0.0	3.2	0.0	14.4	2.3	7.0	0.8	0.7	2.7	0.8	0.7	0.9	0.9	1.4	10.6	10.5	1.5	0.6	0.4	0.2	0.0	0.7	3.4	3.7	1.1	3.4	0.2	0.0	1.5	0.9	6.4	2.2	2.1	0.1	0.7	0.6	2.5	0.0	0.8	0.7	0.6	8.6	0.5	2.3	0.7	0.2	0.6	1.0	6.5	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.4	0.0	0.3	0.1	0.5	0.0	0.2	0.0	0.7	0.4	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.0	0.6	0.5	0.0	7.1	5.8	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.6	0.2	0.0	0.3	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.3	0.0	14.4	10.6	10.5	0.0	0.7	0.0	0.0	8.6	6.5	2.5	3.2	5.1	81.6	0.2	5.2	4.0	2.3	6.8	55.7	16.2	13.5	8.7	5.7	1.6	11.0	70.9	0.3	0.0	0.7	3.9	2.7	2.9	2.3	9.6	3.6	7.7	0.0	358.3	2.3	0.1	8.2	2.0	2.3	0.0	47.9	1.4	3.6	2.6	11.8	315.3	4.7	4.1	0.3	1.6	1.7	7.5	0.4	7.2	7.5	0.0	19.6	0.0	344.8	95.4	0.9	1.9	8.2	0.0	0.6	1.7	7.2	0.5	20.4	6.6	4.4	23.0	0.6	1.6	6.3	4.5	0.3	0.2	13.2	2.6	2.0
CSRP3	"CLP, CMD1M, MLP"	ENSG00000129170	"Cysteine and glycine rich protein 3"	P50461	11	19182030-19210571	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Actin-binding, Developmental protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2613.3;skeletal muscle: 1649.3;tongue: 579.0"	"Cell type enriched"	"Detected in some"	35	"Cardiomyocytes: 3433.6"	"Cancer enriched"	"Detected in some"	6	"head and neck cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042581	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		250000		"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Nucleoplasm	"HPA042581: AB_2678061"				"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-2)"				"unprognostic (4.72e-2)"				"unprognostic (5.99e-2)"	"unprognostic (1.08e-1)"			0.3	0.2	0.3	0.0	0.1	0.1	2.8	0.5	0.3	0.0	0.0	0.2	0.0	0.1	0.0	39.6	0.0	0.5	2613.3	0.1	0.2	0.2	0.2	1.2	1.2	0.2	0.1	0.5	2.6	0.0	0.1	0.1	0.2	32.8	0.0	0.0	24.8	0.0	1649.3	0.4	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.7	579.0	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3433.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	28.8	0.0	0.0	0.3	6.0	0.0	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	95.5	32.7	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325248-122341969	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 5912.9;vagina: 1853.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2493.8;Club cells: 768.0;Kupffer cells: 579.4;monocytes: 1298.6;Squamous epithelial cells: 3020.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 227.7;head and neck cancer: 405.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 514.7;intermediate monocyte: 269.1;myeloid DC: 382.9;neutrophil: 245.6;non-classical monocyte: 161.7"	"Group enriched"	"Detected in all"	193	"dendritic cells: 382.9;granulocytes: 245.6;monocytes: 514.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 282.0;hTCEpi: 1218.6;THP-1: 789.0;U-698: 504.5;U-937: 250.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		28000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favorable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	30.7	4.7	0.8	27.1	0.9	297.8	56.3	1.0	3.7	961.0	1.4	3.8	1.1	2.2	10.3	5912.9	4.6	7.2	5.9	0.8	1.0	2.4	38.9	26.0	25.1	1.5	0.9	21.1	3.7	0.8	5.0	19.0	1.3	19.7	3.6	0.3	996.1	9.6	4.6	369.1	5.8	6.3	1.1	20.4	30.3	1.3	1.4	46.5	2.7	2.8	941.0	39.1	1853.3	1.6	14.6	1.3	0.2	3.2	31.5	58.0	2.9	0.6	0.8	0.0	0.0	0.0	0.0	3.2	7.6	5.9	0.5	86.9	0.0	282.0	0.0	0.3	0.2	0.7	0.0	6.8	6.8	117.6	1.9	30.5	1218.6	2.9	119.1	0.0	0.0	1.5	0.8	29.9	0.5	0.8	0.2	108.3	0.0	0.5	0.0	0.0	0.9	0.0	0.0	141.3	0.0	0.0	14.1	7.5	10.4	0.1	1.6	789.0	0.5	1.7	19.7	0.2	0.9	0.0	1.7	504.5	26.4	250.3	0.3	8.8	514.7	16.4	0.6	269.1	1.5	1.5	0.7	0.6	382.9	0.5	0.5	0.7	245.6	1.9	161.7	6.9	1.0	283.2	0.8	0.9	1.0	3.7	0.8	1.0	1.5	0.9	1.3	1.1	1.4	1.6	1.1	6.4	19.8	0.0	5.0	83.5	136.5	2493.8	117.8	0.0	7.1	119.8	0.2	2.8	768.0	0.0	0.0	230.6	7.4	3.9	0.0	2.1	0.4	0.3	0.4	3.0	0.0	3.8	0.1	22.1	17.8	13.6	12.8	0.3	13.9	0.1	6.1	96.0	134.5	0.0	0.1	0.5	179.0	579.4	90.6	2.4	10.2	243.7	8.8	0.0	1298.6	0.0	20.6	0.5	0.2	46.2	1.5	3.8	2.8	30.2	0.0	0.7	115.7	0.0	32.9	8.8	24.3	0.1	0.5	3020.6	205.0	334.2	4.9	26.1	2.0	134.1
CSTF1		ENSG00000101138	"Cleavage stimulation factor subunit 1"	Q05048	20	56392371-56406362	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019270, HPA047275, HPA065000"	Supported		Enhanced	Nucleoplasm		NA	NA		210000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	6.3	6.4	4.1	8.1	4.7	5.1	11.1	6.1	5.0	7.3	5.0	7.9	5.3	8.2	8.0	8.8	9.5	7.7	8.0	4.5	4.4	9.6	10.9	8.5	12.4	4.3	4.1	11.8	10.0	11.4	4.8	9.4	4.8	8.5	8.0	14.9	10.3	7.0	9.4	8.4	5.9	8.8	3.9	7.6	7.8	17.6	5.6	14.3	10.0	14.7	14.4	8.9	5.7	6.1	18.9	17.4	22.1	15.6	22.6	20.2	23.7	25.2	27.8	49.2	36.7	37.6	26.9	39.1	26.7	19.1	31.5	31.2	35.7	43.4	57.8	12.4	12.6	38.1	29.3	23.3	13.4	32.2	23.6	19.4	24.5	27.6	23.8	19.1	30.2	24.3	32.6	18.5	30.2	44.6	36.2	17.0	20.3	37.2	23.2	26.5	47.7	34.6	23.9	19.3	24.5	17.0	34.5	93.1	25.6	25.3	37.1	22.9	17.1	39.9	25.3	16.9	24.9	13.0	21.5	42.0	32.0	21.3	19.4	11.4	16.9	13.6	20.7	14.6	26.0	21.1	25.9	23.4	21.5	24.3	28.4	24.9	13.3	31.2	13.1	23.7	33.3	20.4	4.1	4.7	6.1	5.0	4.5	4.4	4.3	4.1	4.8	3.9	5.6	6.1	8.4	9.6	13.1	4.2	11.6	9.2	10.8	29.3	12.5	9.2	9.9	8.3	8.9	14.3	16.8	18.4	14.6	30.9	11.5	7.3	19.6	17.9	25.9	7.1	9.4	13.3	4.9	21.0	4.2	14.7	21.1	12.1	9.7	6.0	17.7	12.6	11.7	22.6	15.3	5.0	4.2	9.4	14.2	16.7	7.8	7.5	13.7	8.4	5.4	9.4	18.4	14.2	12.3	5.5	6.7	11.9	11.8	12.8	10.8	12.3	8.5	21.1	12.9	14.7	19.7	11.1	9.9	84.3	30.5	11.3	8.8	21.1	14.9	16.7	9.8	8.8
CSTF2	CstF-64	ENSG00000101811	"Cleavage stimulation factor subunit 2"	P33240	X	100820359-100841520	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000427, CAB004680"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nuclear bodies"	"CAB004680: AB_425385, HPA000427: AB_1078580"	"unprognostic (2.02e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.23e-6)"	"unprognostic (2.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.98e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.89e-1)"	6.3	7.2	5.7	9.9	6.0	10.5	7.7	6.7	6.3	7.0	5.0	12.0	8.6	7.5	8.2	19.2	8.1	6.4	6.1	5.9	6.4	8.0	5.3	6.3	12.5	5.4	5.4	7.1	4.7	8.9	5.3	7.2	5.3	7.5	13.1	8.5	7.9	8.4	4.5	8.4	8.2	7.6	5.3	7.0	6.6	12.7	6.6	12.0	6.7	5.1	19.9	10.0	8.4	6.3	36.0	41.7	27.5	24.9	14.7	11.4	37.2	29.6	24.0	47.6	68.0	45.4	32.1	35.6	35.2	19.1	61.2	35.1	64.2	35.3	57.2	36.5	39.9	32.8	38.8	29.8	19.4	46.9	33.8	11.3	16.5	49.8	32.6	12.7	29.0	31.3	56.2	33.7	29.2	41.9	38.4	31.8	76.8	55.7	39.9	35.8	46.3	42.3	17.5	34.4	24.1	30.4	49.1	20.5	20.4	27.6	20.5	20.3	25.8	26.2	42.3	38.1	37.8	22.8	52.3	45.9	22.5	48.6	32.4	20.0	16.1	11.1	23.4	18.9	17.9	17.4	21.1	21.8	23.3	16.9	19.0	17.8	2.6	23.9	25.8	16.7	24.2	15.3	5.7	6.0	6.7	6.3	5.9	6.4	5.4	5.4	5.3	5.3	6.6	6.3	4.1	3.2	1.1	3.9	8.2	4.2	4.6	20.7	9.6	2.2	3.1	3.0	4.9	2.8	12.9	0.0	2.1	16.7	3.6	5.9	5.9	12.5	13.3	6.3	4.9	4.6	4.2	12.8	10.4	8.3	18.4	4.3	6.1	4.3	3.8	5.5	2.5	1.5	10.8	3.3	10.8	3.7	14.2	2.5	3.7	2.4	4.7	4.3	1.8	1.0	5.9	4.5	4.1	7.1	5.7	15.4	6.7	4.1	6.2	2.0	5.4	4.0	9.9	2.9	6.6	2.7	5.7	18.8	25.5	14.4	4.1	7.7	7.1	5.0	6.4	5.0
CSTF2T	"CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64"	ENSG00000177613	"Cleavage stimulation factor subunit 2 tau variant"	Q9H0L4	10	51695486-51699595	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039216, HPA062021"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"HPA039216: AB_10795462, HPA062021: AB_2684662"	"unprognostic (2.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.96e-1)"	13.5	13.2	10.6	17.4	13.1	13.6	11.7	13.4	13.4	11.0	11.2	10.4	11.7	11.7	10.3	9.0	14.8	10.2	14.4	10.4	11.5	11.9	12.6	9.6	19.6	13.3	12.6	17.9	12.3	18.0	6.0	11.9	13.1	11.9	10.6	13.8	10.7	9.3	22.2	10.9	11.6	12.2	13.9	17.6	11.1	9.5	12.0	21.5	11.5	22.8	19.4	12.4	6.3	18.4	16.2	18.9	27.9	29.4	38.5	26.2	1.9	22.5	20.7	25.4	24.7	25.3	23.2	46.5	12.7	19.7	15.4	24.8	21.2	23.6	22.9	27.1	24.0	26.8	19.9	4.7	18.6	10.5	23.6	38.0	18.0	22.4	25.8	16.1	19.3	26.9	29.3	25.6	22.2	13.9	42.9	16.8	10.3	19.7	40.3	33.7	56.2	9.9	19.6	13.4	23.3	30.1	18.8	19.4	20.4	28.9	36.2	19.2	20.7	16.2	22.1	15.1	28.5	32.5	13.0	32.9	33.7	24.1	14.3	2.8	4.1	4.5	3.5	3.8	4.9	1.7	2.6	2.8	4.3	3.0	4.4	4.0	1.1	10.9	2.8	2.7	4.6	2.9	10.6	13.1	13.4	13.4	10.4	11.5	13.3	12.6	13.1	13.9	12.0	18.4	13.4	9.6	7.5	2.9	15.8	9.1	7.1	15.7	12.5	18.2	8.7	5.6	14.3	8.6	11.1	9.2	8.4	24.1	13.7	7.5	23.5	16.4	1.7	9.2	13.5	17.7	6.1	17.7	4.6	15.3	14.6	12.4	9.7	7.8	20.3	10.9	17.9	16.7	15.4	20.2	5.7	8.7	10.2	14.8	8.3	2.7	23.9	8.9	0.0	3.7	22.5	13.2	33.0	3.0	19.3	13.9	6.1	19.9	7.1	4.1	9.3	13.6	17.8	13.7	6.6	16.1	9.1	37.0	15.7	8.5	6.5	6.2	17.2	12.0	11.2	5.1
CSTF3	CstF-77	ENSG00000176102	"Cleavage stimulation factor subunit 3"	Q12996	11	33077188-33162371	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039743, HPA040168"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA039743: AB_10795682, HPA040168: AB_10794025"	"unprognostic (2.38e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (3.77e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (8.20e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-3)"	13.8	21.2	28.5	20.8	30.9	12.7	19.5	34.7	39.8	24.2	30.5	20.3	19.1	19.8	61.1	26.7	21.2	14.9	17.1	30.0	32.4	28.9	34.6	21.3	26.6	26.3	26.8	25.9	21.1	18.2	57.6	19.1	27.4	30.4	20.0	31.9	20.6	15.0	16.9	26.1	20.2	13.7	26.1	25.5	18.6	32.9	31.1	23.8	29.8	11.8	21.5	22.0	24.7	32.9	45.8	43.3	82.8	56.4	22.0	38.7	59.8	44.2	28.5	48.5	66.2	31.7	34.9	49.3	31.2	28.5	32.4	58.5	73.8	42.9	77.5	52.7	128.3	50.6	109.1	58.2	24.9	66.5	30.9	28.2	30.6	37.6	36.7	39.1	64.4	39.2	67.9	34.2	66.4	32.3	66.8	35.7	40.3	34.6	54.0	52.2	80.5	39.7	54.6	58.2	61.4	34.9	50.9	29.9	37.6	52.7	54.4	44.1	39.5	40.3	49.7	64.5	59.7	32.3	46.8	41.9	47.4	68.9	40.2	4.6	4.8	7.0	5.8	6.9	6.8	6.5	7.2	5.8	7.7	5.0	7.5	7.9	1.9	6.9	8.3	5.7	9.1	3.7	28.5	30.9	34.7	39.8	30.0	32.4	26.3	26.8	27.4	26.1	31.1	32.9	12.8	19.2	18.7	38.5	19.0	18.9	50.6	50.1	10.2	33.3	22.3	19.9	21.8	17.2	43.5	58.8	6.2	63.0	12.7	15.1	62.6	24.3	37.6	31.4	20.7	21.2	31.8	34.9	75.2	16.9	32.0	23.1	15.3	18.9	14.5	29.0	11.0	57.3	28.4	13.5	59.1	30.0	77.3	22.0	21.1	10.3	29.8	17.0	28.4	42.2	28.1	35.7	14.4	62.4	56.9	20.8	18.6	29.7	14.0	33.0	20.6	47.0	68.0	25.2	26.3	26.1	25.4	77.3	57.6	19.1	19.5	33.8	18.3	25.3	29.6	55.6
CT45A1	"CT45-1, CT45.1"	ENSG00000268940	"Cancer/testis antigen family 45 member A1"	Q5HYN5	X	135713453-135723539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 7.8"	"Group enriched"	"Detected in some"	50	"Spermatocytes: 3.5;Spermatogonia: 6.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 246.0;Karpas-707: 112.8"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"										"unprognostic (6.58e-3)"					"unprognostic (2.14e-1)"			0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	246.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	112.8	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	21.5	0.0	0.3	1.7	33.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.6	0.2	0.3	0.3	0.4	0.4	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A10		ENSG00000269586	"Cancer/testis antigen family 45 member A10"	P0DMU9	X	135881063-135889086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 9.2"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 47.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 85.4;K-562: 26.9;Karpas-707: 94.7;U-266/84: 88.6"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"					"unprognostic (3.55e-1)"					"unprognostic (7.08e-3)"					"unprognostic (2.08e-1)"			0.0	0.0	0.6	0.1	0.6	0.0	0.0	0.4	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	85.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	94.7	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.4	0.0	0.0	18.5	88.6	0.1	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.4	1.2	1.3	0.4	1.5	0.6	2.0	0.6	1.3	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A2	"CT45-2, CT45.2"	ENSG00000271449	"Cancer/testis antigen family 45 member A2"	Q5DJT8	X	135811668-135820012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 25: RPMI-8226 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A3	"CT45-3, CT45-4, CT45.3, CT45.4, CT45A4"	ENSG00000269096	"Cancer/testis antigen family 45 member A3"	Q8NHU0	X	135759846-135768191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 9.5"	"Cell type enhanced"	"Detected in single"		"Spermatogonia: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 94.7;T-47d: 63.5;U-266/84: 308.8"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.9	0.0	0.7	0.0	0.0	0.7	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	94.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.2	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.4	0.0	0.0	2.3	0.0	0.0	0.4	308.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.7	1.1	0.8	0.8	1.2	0.8	1.0	0.6	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A5	"CT45-5, CT45.5"	ENSG00000228836	"Cancer/testis antigen family 45 member A5"	P0DMU8	X	135777130-135785298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.8;pituitary gland: 1.9;testis: 3.5"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.3;Spermatogonia: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/84: 195.1"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.0	0.0	1.9	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	9.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	6.4	0.0	0.1	2.0	195.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.2	1.0	0.5	1.2	0.6	2.8	1.7	0.3	0.6	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A6	"CT45-6, CT45.6"	ENSG00000278289	"Cancer/testis antigen family 45 member A6"	P0DMU7	X	135794685-135802787	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 1.2;testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.1;HMC-1: 3.0;Karpas-707: 2.6;RPMI-8226: 4.5;U-266/84: 13.7"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.9	0.3	0.3	0.5	0.3	0.5	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A7		ENSG00000273696	"Cancer/testis antigen family 45 member A7"	P0DMV0	X	135829247-135837268	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"U-266/84: 70.4"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	70.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A8		ENSG00000278085	"Cancer/testis antigen family 45 member A8"	P0DMV1	X	135846497-135854538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HMC-1: 115.3"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 3: HMC-1 - Innate immune response"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A9		ENSG00000270946	"Cancer/testis antigen family 45 member A9"	P0DMV2	X	135863418-135871812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AN3-CA: 29.9;HMC-1: 111.3;U-266/84: 49.2"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"		"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	4.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.8	49.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 5.4;testis: 10.4"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 77.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 104.1;K-562: 140.6;OE19: 203.6;RPMI-8226: 311.3;SK-BR-3: 195.4;U-266/84: 356.9"									"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA071467: AB_2686402, HPA076586: "							"prognostic unfavorable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.3	0.8	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.8	1.5	0.0	5.4	0.0	0.0	3.4	0.7	0.3	0.0	0.1	0.0	0.5	2.0	0.0	0.3	2.6	0.1	0.3	0.0	0.0	0.1	0.0	3.3	0.4	0.2	0.0	0.0	0.4	0.5	10.4	0.0	3.0	0.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	104.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.6	2.9	0.0	0.0	0.2	0.0	0.0	203.6	0.0	0.0	0.0	311.3	0.0	0.0	0.4	0.0	0.0	195.4	0.3	0.0	0.2	0.6	0.3	6.3	0.2	0.7	0.2	2.6	356.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.0	0.0	1.2	0.9	0.0	3.9	0.0	0.2	0.0	1.8	0.2	0.0	0.0	0.5	0.0	11.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.7	1.2	0.5	0.0	0.0	0.6	18.5	77.3	0.0	0.0	1.1	0.1	0.0	0.0	0.0
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211445-1249953	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	76.1	88.1	92.3	86.1	91.2	71.5	72.7	96.6	104.3	94.7	73.6	94.6	91.0	98.4	47.5	85.0	89.2	61.4	100.0	92.7	98.1	88.4	109.2	82.6	108.7	99.2	94.1	93.5	141.1	58.8	140.0	45.7	94.6	94.8	41.9	38.8	90.9	50.8	170.1	74.3	97.1	48.1	77.1	118.7	79.5	47.3	90.0	98.1	86.2	91.5	62.4	87.5	79.8	89.8	108.5	156.8	118.4	146.6	81.5	58.6	101.7	83.4	76.8	101.8	102.8	135.0	255.1	131.0	93.8	97.5	156.6	84.1	72.3	109.9	30.4	101.0	86.6	119.1	185.6	177.1	135.7	108.4	163.3	101.3	82.5	86.5	49.8	97.8	76.8	147.1	138.1	219.6	56.9	178.1	351.4	338.3	140.5	87.8	148.4	244.4	71.4	173.2	65.8	135.9	222.0	138.1	79.6	85.2	114.5	70.9	187.2	164.5	99.7	168.5	94.2	97.8	182.1	157.7	164.3	155.2	133.4	166.4	135.6	12.6	15.6	17.4	31.8	23.1	24.0	20.1	22.3	27.4	20.6	19.3	17.1	25.1	12.7	23.9	23.9	34.6	20.9	16.1	92.3	91.2	96.6	104.3	92.7	98.1	99.2	94.1	94.6	77.1	90.0	89.8	33.3	41.7	39.0	17.9	36.8	34.2	21.1	22.1	13.1	32.1	52.0	39.5	54.9	37.1	19.2	36.8	4.2	25.4	72.4	57.2	11.7	29.4	4.0	34.0	46.4	35.7	46.1	42.3	19.4	40.6	32.0	37.5	37.8	41.6	24.1	31.2	45.0	85.0	43.0	40.4	21.2	49.7	20.3	72.9	31.8	5.5	45.1	37.7	46.2	21.5	45.9	46.8	82.4	19.6	17.7	45.0	35.7	35.7	42.0	36.9	42.8	37.4	25.7	17.8	6.6	31.2	32.9	10.8	13.4	30.3	37.8	19.8	41.1	32.0	57.5	27.9
CTBP2	ribeye	ENSG00000175029	"C-terminal binding protein 2"	P56545	10	124984317-125161170	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023559, HPA023564, CAB031916, HPA044971, CAB079018"	Approved	Approved	Approved	Nucleoplasm		NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: AB_2679161"	"unprognostic (8.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.99e-3)"	"prognostic favorable (1.70e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.62e-1)"	27.1	25.4	21.4	17.1	23.7	17.2	30.6	32.9	20.1	47.9	47.8	36.7	33.3	46.8	21.0	30.4	37.3	22.1	19.9	22.8	25.5	31.7	5.7	33.1	9.4	24.3	24.1	41.8	40.7	21.9	23.6	24.7	22.0	38.6	29.2	55.4	36.7	24.0	22.8	16.7	33.4	30.0	22.1	21.6	36.9	19.7	28.8	9.0	53.9	19.8	9.1	29.9	30.9	23.7	87.3	96.5	83.6	70.2	43.9	43.0	46.1	66.4	77.0	61.2	69.3	60.4	99.7	0.1	33.6	66.9	38.6	67.2	83.8	106.5	45.8	0.3	63.8	63.8	61.6	1.3	91.7	27.2	48.9	37.1	82.7	63.5	125.5	80.9	79.1	4.9	2.6	0.5	38.7	96.5	3.0	27.8	63.0	90.3	61.3	77.4	35.0	0.8	72.5	38.8	25.5	73.1	64.7	56.0	86.5	64.7	39.7	43.9	64.4	36.8	46.2	53.0	57.9	1.4	5.3	0.3	46.1	0.3	37.1	30.8	8.5	16.4	8.5	9.0	1.1	0.5	0.4	2.3	11.2	0.3	0.5	3.6	14.3	34.6	22.4	9.4	0.3	4.7	21.4	23.7	32.9	20.1	22.8	25.5	24.3	24.1	22.0	22.1	28.8	23.7	64.7	32.1	27.2	72.1	4.0	47.2	83.4	41.5	33.6	182.5	75.8	59.8	32.7	55.8	53.2	38.6	158.4	22.3	50.7	81.7	68.4	69.3	29.9	125.0	65.1	63.0	55.0	42.3	41.8	60.8	70.5	42.3	40.2	163.0	17.7	43.1	61.4	1.2	29.6	107.7	35.0	93.9	50.8	49.3	46.9	38.1	60.3	47.0	58.7	127.4	60.6	63.2	124.6	44.2	87.1	83.8	61.6	77.8	6.9	89.3	45.1	31.6	94.1	107.5	59.2	59.6	67.0	12.7	45.5	42.1	39.8	19.3	15.3	81.3	106.1	102.7
CTC1	"AAF132, C17orf68, FLJ22170"	ENSG00000178971	"CST telomere replication complex component 1"	Q2NKJ3	17	8224815-8248056	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052436			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA052436: "	"unprognostic (6.47e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"prognostic favorable (6.49e-5)"	"unprognostic (2.89e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-2)"	13.8	11.8	13.4	14.7	14.1	18.5	15.9	19.7	18.8	17.6	13.2	16.9	8.0	13.5	10.7	11.1	17.2	6.9	11.7	13.4	13.4	16.6	18.3	18.5	24.1	13.2	13.3	19.9	18.2	10.4	21.4	6.1	13.3	16.6	10.4	22.2	12.4	9.0	7.0	14.1	25.0	9.3	12.2	37.2	15.8	10.8	13.7	31.2	18.0	5.7	21.4	14.8	13.4	14.6	3.0	6.6	5.9	5.5	18.1	4.3	7.2	3.4	3.8	4.8	3.2	5.0	8.8	10.8	3.4	5.9	3.5	10.0	7.0	5.2	3.0	8.0	6.8	5.3	7.2	6.5	3.0	1.7	16.1	4.4	5.5	6.3	8.6	9.5	8.7	15.4	5.1	3.6	3.4	3.9	18.6	7.3	4.8	9.7	1.6	8.7	2.3	6.9	12.4	7.1	5.2	5.9	6.7	8.6	6.0	10.9	5.3	5.0	11.6	1.5	3.6	3.6	4.0	7.4	4.7	7.1	2.9	6.5	4.5	2.0	0.7	1.2	2.0	0.9	2.0	2.2	2.0	1.9	0.7	2.6	2.8	2.5	2.5	1.3	1.2	2.2	1.8	1.0	13.4	14.1	19.7	18.8	13.4	13.4	13.2	13.3	13.3	12.2	13.7	14.6	6.3	0.0	11.1	8.5	16.7	1.9	3.0	1.0	3.4	7.7	6.2	4.1	3.4	7.2	3.0	5.5	37.5	6.4	12.0	4.6	1.9	3.6	3.7	3.6	2.6	6.4	6.7	1.7	10.2	3.8	3.9	3.8	5.6	5.5	6.3	4.0	5.7	8.1	3.9	1.7	10.3	5.8	2.0	8.2	1.0	6.2	4.4	3.5	0.0	3.7	5.6	2.5	6.2	9.0	6.6	4.4	9.4	2.2	9.6	4.1	4.5	2.2	3.0	17.3	0.0	3.1	4.1	4.7	4.2	3.9	2.0	11.1	10.3	2.1	3.5	3.4
CTCF	"CFAP108, FAP108"	ENSG00000102974	"CCCTC-binding factor"	P49711	16	67562467-67639177	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Chromosome partition, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004122, CAB062550, CAB068181, CAB068182"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139"	"unprognostic (2.70e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (3.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-2)"	17.3	14.5	10.6	20.6	12.2	34.6	17.5	17.4	12.7	21.3	7.4	18.9	15.9	20.8	13.8	20.2	19.9	14.6	15.9	10.7	11.9	18.4	18.7	16.4	29.0	10.3	10.2	22.3	18.4	28.3	12.9	20.4	10.3	17.2	21.6	18.4	17.1	17.7	30.5	23.3	19.4	20.3	9.0	22.7	18.3	10.5	10.2	69.6	19.3	28.4	35.4	19.7	20.0	16.2	34.6	51.2	66.9	26.7	29.9	25.5	54.2	32.4	33.6	45.9	43.5	42.3	34.5	106.6	26.0	27.7	26.2	43.8	65.3	35.7	51.5	38.5	44.0	63.9	28.5	49.3	20.4	73.7	59.7	20.8	42.5	34.6	38.2	27.5	35.5	83.1	57.7	43.3	38.6	66.7	156.8	27.4	58.3	38.7	34.5	113.5	54.9	58.7	28.2	48.7	57.0	40.0	57.3	33.2	27.9	35.2	41.0	45.3	33.8	39.3	41.3	30.5	35.7	38.6	52.6	151.2	23.1	43.1	43.1	6.8	2.3	3.4	4.3	2.4	4.1	5.5	4.8	3.5	2.1	7.4	3.8	4.4	6.8	3.5	4.8	5.6	3.9	1.4	10.6	12.2	17.4	12.7	10.7	11.9	10.3	10.2	10.3	9.0	10.2	16.2	38.0	22.4	29.8	19.9	50.4	22.3	24.3	11.4	35.3	35.5	35.6	33.9	32.6	27.1	28.1	23.9	8.4	27.4	54.0	29.2	19.6	31.3	2.1	29.8	43.9	37.3	31.2	52.6	23.0	33.6	33.7	29.9	27.0	40.2	19.6	39.1	23.9	24.0	24.0	45.4	24.2	26.4	16.2	26.7	12.6	3.6	24.8	31.1	12.4	32.8	29.2	32.3	49.4	17.1	32.8	32.5	16.5	28.6	62.6	35.6	18.8	24.5	16.7	27.6	19.7	38.6	41.4	18.4	27.3	38.8	24.7	29.6	47.9	32.6	23.8	30.0
CTCFL	"BORIS, CT27, dJ579F20.2"	ENSG00000124092	"CCCTC-binding factor like"	Q8NI51	20	57495966-57525652	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.0"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 61.3;Spermatogonia: 143.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HMC-1: 79.6;K-562: 116.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001472	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001472: AB_1078583"	"unprognostic (2.50e-1)"	"unprognostic (4.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.85e-5)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.00e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.75e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.84e-2)"		0.1	0.2	0.4	0.2	0.5	1.0	0.2	1.2	0.6	0.0	0.1	0.1	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.5	0.2	0.4	0.2	0.4	0.1	0.0	0.2	0.5	0.1	0.2	0.3	0.1	0.2	0.2	0.9	0.1	0.1	0.2	0.5	0.3	0.1	0.0	0.3	0.2	11.0	0.3	0.1	0.4	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.4	0.2	0.1	0.3	0.4	0.2	0.1	0.0	0.4	0.2	0.3	0.7	0.1	0.2	0.2	79.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	116.1	0.6	0.0	0.1	0.3	0.4	0.3	0.1	0.1	0.3	0.2	0.2	0.1	0.3	0.3	0.3	0.1	0.2	0.3	0.4	0.2	0.1	0.5	0.3	0.2	0.3	0.1	0.3	0.1	2.9	0.3	0.3	0.4	0.5	0.1	0.3	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.1	0.9	0.2	0.2	0.2	0.1	0.0	0.4	0.5	1.2	0.6	0.4	0.5	0.1	0.0	0.1	0.0	0.3	2.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	3.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.2	0.0	0.0	6.6	0.1	0.2	61.3	143.8	0.0	0.0	0.0	0.1	0.0	0.1	0.2
CTDP1	FCP1	ENSG00000060069	"CTD phosphatase subunit 1"	Q9Y5B0	18	79679803-79754510	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cataract, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 113.1;Late spermatids: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032641, HPA040394, HPA070389"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Vesicles	"CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (5.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.74e-2)"	9.3	7.4	3.8	7.2	3.9	13.7	8.9	3.3	4.2	7.8	4.1	11.1	7.2	10.4	1.4	10.7	8.1	4.0	7.2	3.3	3.3	7.9	9.5	9.3	8.7	5.3	4.2	5.0	9.0	3.3	6.9	4.2	4.0	8.2	3.1	1.5	9.5	3.9	11.9	20.5	10.9	3.1	3.3	13.5	9.9	22.2	4.0	6.5	8.0	3.1	3.7	9.6	8.6	4.4	13.4	14.0	7.7	11.0	6.0	5.0	25.9	9.6	6.1	7.6	7.5	9.4	8.0	17.2	4.2	5.6	9.1	16.4	6.6	8.8	3.1	16.9	12.4	8.5	6.6	12.9	8.7	37.6	20.5	8.4	8.3	8.1	3.8	4.6	9.2	12.2	11.2	8.1	3.0	11.5	25.4	29.5	12.7	4.2	19.1	20.7	10.1	20.0	5.6	13.1	12.0	12.4	10.2	9.8	13.9	5.8	8.0	21.7	12.9	12.9	19.4	5.3	9.7	7.4	27.6	16.1	11.0	18.8	9.3	0.0	0.4	3.2	0.5	0.4	0.4	0.2	0.4	0.8	0.6	0.1	0.5	0.3	1.0	1.1	0.4	0.1	0.1	0.2	3.8	3.9	3.3	4.2	3.3	3.3	5.3	4.2	4.0	3.3	4.0	4.4	7.4	0.0	4.1	3.6	9.2	8.5	5.0	4.0	11.4	9.5	7.7	6.5	3.8	4.3	4.5	3.7	14.6	8.8	24.2	20.0	1.9	5.4	113.1	18.6	8.0	7.5	6.0	13.5	7.7	7.2	8.0	4.8	19.9	24.0	7.0	7.8	6.4	5.7	8.8	23.5	6.6	16.6	6.1	7.5	9.5	123.2	7.8	13.8	7.2	6.5	6.5	6.5	19.6	3.0	8.9	10.2	14.9	10.5	15.2	11.8	10.0	6.8	9.6	14.8	0.0	5.9	7.4	18.0	10.5	10.5	10.1	19.0	18.3	8.0	11.7	12.6
CTDSP1	"NLIIF, SCP1"	ENSG00000144579	"CTD small phosphatase 1"	Q9GZU7	2	218398256-218405941	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 184.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062654			Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA062654: AB_2684819"	"unprognostic (1.97e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.57e-1)"	84.5	55.4	42.1	43.0	47.8	53.1	76.5	41.6	42.2	82.4	40.6	72.2	56.7	80.2	31.9	71.8	74.3	46.7	79.4	36.8	38.8	83.2	118.6	74.5	49.2	55.6	47.0	82.3	79.1	56.9	28.4	77.7	44.6	104.6	44.7	8.7	65.3	57.2	60.0	71.4	75.9	48.4	45.3	92.7	88.3	16.9	45.5	48.0	78.9	53.7	45.4	82.6	70.4	43.2	29.8	37.8	21.8	71.9	58.1	53.8	80.0	38.9	56.2	37.2	32.0	49.7	72.7	18.0	33.0	69.8	25.3	59.1	32.4	47.2	19.0	63.8	25.5	68.3	48.6	67.0	69.4	42.9	89.3	61.5	56.7	28.3	31.7	58.3	55.5	27.5	56.5	62.6	39.9	84.0	37.5	122.1	15.5	47.6	37.8	51.4	30.8	39.2	47.7	36.6	14.5	36.4	34.4	72.9	38.6	27.4	40.8	101.1	48.5	58.7	35.0	45.4	17.4	40.1	28.1	42.6	52.3	39.7	33.2	54.2	30.4	74.1	24.3	24.7	15.5	7.8	14.7	15.8	15.9	7.2	9.3	12.4	56.4	17.3	26.3	5.4	13.8	21.2	42.1	47.8	41.6	42.2	36.8	38.8	55.6	47.0	44.6	45.3	45.5	43.2	65.0	44.8	40.0	15.0	43.0	27.3	29.1	24.7	37.5	14.6	34.8	34.5	35.1	58.6	23.7	31.3	2.1	42.7	70.5	95.0	33.2	36.6	1.9	15.1	35.1	43.4	21.7	52.6	0.7	42.7	43.3	44.7	45.3	27.7	18.3	23.0	67.5	57.3	39.3	6.7	1.0	53.5	12.2	83.2	28.1	4.6	59.4	59.9	33.8	14.0	56.9	55.6	184.4	13.0	12.9	38.5	43.1	44.0	35.7	39.8	85.1	51.1	10.0	28.0	26.3	36.0	44.8	1.7	8.7	37.8	20.3	54.3	55.1	29.4	41.5	30.2
CTDSP2	"OS4, PSR2, SCP2"	ENSG00000175215	"CTD small phosphatase 2"	O14595	12	57819927-57846729	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"RH-30: 1208.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052607	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA052607: AB_2681883"	"unprognostic (7.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.38e-3)"	"unprognostic (5.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.11e-1)"	90.9	82.5	66.8	65.4	80.0	45.7	81.8	79.7	69.3	84.0	61.0	108.9	54.3	96.4	51.4	67.0	89.9	64.7	72.4	64.6	63.0	66.2	58.8	113.9	66.1	90.7	80.6	107.3	119.4	68.2	40.3	94.3	76.5	70.1	83.2	30.1	109.1	82.8	122.3	88.9	77.0	94.8	71.4	75.5	89.9	32.3	74.3	104.8	68.1	102.8	77.5	85.2	71.8	83.4	83.1	35.4	165.6	105.8	145.6	248.8	55.0	87.4	165.1	85.2	75.4	45.6	131.5	101.3	98.1	187.5	33.2	64.8	70.0	85.3	88.8	34.2	29.7	140.3	54.4	37.0	135.4	64.3	78.3	239.7	88.9	77.3	65.1	181.9	135.0	60.6	74.5	172.9	43.4	38.2	69.1	38.3	84.3	52.5	44.4	91.0	1208.7	133.2	66.2	118.6	31.1	68.3	122.1	69.4	105.3	100.2	125.8	110.4	109.3	75.0	80.8	85.6	31.5	51.4	59.6	120.3	84.4	58.5	59.7	12.6	9.1	14.4	6.1	8.5	7.2	6.6	8.6	7.1	8.7	6.0	9.8	7.6	17.2	8.2	7.6	7.2	6.2	7.4	66.8	80.0	79.7	69.3	64.6	63.0	90.7	80.6	76.5	71.4	74.3	83.4	50.9	73.7	42.7	31.3	28.5	67.6	45.2	34.6	51.8	19.0	51.2	36.6	34.0	78.6	27.6	47.8	16.7	43.7	48.8	151.1	15.6	72.9	52.2	33.4	51.2	59.3	48.7	50.1	15.8	135.0	41.4	51.0	20.4	50.1	24.7	44.2	86.4	59.1	42.3	20.2	11.0	39.4	16.2	76.1	43.5	151.9	51.9	39.5	42.7	16.9	81.9	44.4	42.2	17.6	27.9	105.8	49.3	48.5	30.3	70.4	57.5	30.6	18.4	11.2	72.3	49.2	53.3	6.3	25.1	39.6	76.1	56.2	34.3	34.8	37.3	99.2
CTDSPL	"C3orf8, HYA22, PSR1, RBSP3, SCP3"	ENSG00000144677	"CTD small phosphatase like"	O15194	3	37861880-37984469	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.4;Excitatory neurons: 189.3;Inhibitory neurons: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 132.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048325	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA048325: AB_2680359"	"unprognostic (7.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.22e-14)"	"unprognostic (3.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	21.1	9.2	19.4	6.3	20.6	10.0	28.1	24.3	23.2	20.3	17.1	33.4	14.3	20.2	14.0	23.8	17.9	29.3	29.4	18.8	17.3	39.7	21.5	27.2	4.1	19.2	17.7	19.6	15.8	12.0	10.7	31.7	16.6	26.5	30.2	3.2	27.1	31.3	21.2	52.9	17.6	23.2	18.1	17.3	31.7	10.6	19.5	7.2	14.0	19.9	5.5	26.4	19.1	17.3	44.5	18.9	7.6	24.0	29.2	41.0	57.2	30.0	37.0	20.1	23.5	27.4	35.3	0.2	17.9	36.9	8.4	36.3	19.2	56.1	16.0	0.1	15.1	27.2	18.8	63.1	26.4	0.0	6.4	21.5	132.3	21.2	25.5	22.4	28.2	12.0	8.9	0.0	33.7	13.7	11.1	0.1	31.5	17.7	2.7	12.3	14.9	0.2	63.3	28.7	6.3	19.9	16.5	28.7	33.5	30.5	28.1	7.3	23.2	14.4	20.4	27.3	19.1	0.6	0.2	0.2	15.8	14.8	27.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.1	19.4	20.6	24.3	23.2	18.8	17.3	19.2	17.7	16.6	18.1	19.5	17.3	26.8	67.3	27.6	170.4	1.2	30.1	17.0	17.7	27.9	10.1	25.7	59.4	42.2	65.8	25.7	23.9	0.0	34.7	1.0	35.6	23.5	14.2	21.5	7.6	17.6	22.4	45.2	7.8	189.3	4.7	9.9	32.4	10.2	27.2	1.3	15.7	22.9	18.1	7.2	10.1	126.3	18.5	2.0	13.3	6.5	51.3	71.7	11.3	8.8	22.5	1.4	9.5	1.0	87.4	48.8	14.2	17.9	98.2	0.4	15.5	9.1	19.7	12.4	1.7	26.3	55.4	40.4	10.0	16.9	17.7	28.7	9.4	2.0	65.8	42.0	14.4
CTDSPL2	"FLJ10523, HSPC129"	ENSG00000137770	"CTD small phosphatase like 2"	Q05D32	15	44427622-44529038	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.5;Late spermatids: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040763, HPA062198"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA040763: AB_10960989, HPA062198: AB_2684708"	"unprognostic (6.64e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (8.36e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.16e-1)"	9.1	7.4	2.9	12.9	3.6	20.5	14.1	12.8	5.3	14.0	3.4	10.8	10.0	17.5	7.0	12.5	11.1	11.9	9.5	3.4	4.4	10.7	10.3	10.4	19.4	3.4	2.7	19.1	11.5	11.1	4.0	15.8	3.1	10.2	11.3	15.1	9.1	10.2	5.4	8.1	12.7	13.9	3.0	13.3	9.8	21.0	2.9	25.3	15.0	9.4	19.0	12.2	6.2	6.0	28.6	14.2	57.7	29.4	9.1	19.9	31.9	29.1	25.4	37.3	46.8	29.3	26.4	30.1	27.7	20.3	20.6	39.2	33.4	19.6	42.6	30.9	16.1	37.4	34.8	17.6	12.3	65.7	33.5	15.7	14.0	25.6	33.4	15.8	28.4	37.9	44.2	34.0	26.7	12.1	78.2	23.1	31.2	30.4	20.3	86.7	80.5	28.0	19.4	38.9	26.7	38.5	36.0	28.5	16.2	21.2	38.7	57.7	24.9	46.0	49.5	44.3	49.4	19.3	79.2	93.9	22.2	50.4	36.0	7.4	10.8	9.2	10.3	11.3	9.4	10.6	9.8	9.3	13.8	10.5	10.4	11.8	7.7	15.7	8.9	8.8	14.9	9.4	2.9	3.6	12.8	5.3	3.4	4.4	3.4	2.7	3.1	3.0	2.9	6.0	34.4	19.2	35.7	26.4	25.4	24.6	14.7	14.5	27.9	23.7	24.5	21.0	23.1	11.5	31.3	12.9	10.4	18.9	40.9	16.9	17.6	12.5	165.5	18.3	35.4	27.2	9.0	16.2	41.8	14.6	18.4	30.2	11.7	29.6	36.0	26.7	20.3	13.6	14.0	30.3	41.2	13.9	20.3	22.2	20.9	166.9	20.2	22.1	16.0	49.6	23.8	19.2	39.1	50.3	65.7	17.7	10.4	13.2	24.0	18.0	17.2	14.5	19.5	31.1	26.3	30.4	34.2	23.7	31.4	19.6	21.9	14.6	31.4	21.9	15.3	16.8
CTHRC1		ENSG00000164932	"Collagen triple helix repeat containing 1"	Q96CG8	8	103371538-103382989	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.1;gallbladder: 87.8;placenta: 90.1;urinary bladder: 84.6"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 95.2;Fibroblasts: 181.6;Langerhans cells: 45.9;Melanocytes: 49.8;Smooth muscle cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 294.6;fHDF/TERT166: 138.1;HHSteC: 197.1;HSkMC: 406.6;WM-115: 386.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059806, HPA061896"	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA		420000	"Cluster 40: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA059806: AB_2684130, HPA061896: AB_2684633"	"unprognostic (2.04e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.22e-14)"	"unprognostic (2.33e-3)"	"unprognostic (3.21e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.37e-3)"	69.1	2.8	1.6	15.4	1.8	0.5	39.0	5.7	6.3	12.8	0.4	6.6	6.3	18.7	3.3	9.7	5.3	87.8	8.9	1.5	2.3	2.3	0.8	8.9	13.8	2.0	1.6	4.2	3.7	2.2	3.7	90.1	2.5	4.7	6.2	2.4	17.0	5.6	3.6	32.5	3.5	19.7	1.8	2.6	3.6	3.6	1.5	6.2	9.1	4.1	16.0	84.6	6.6	3.3	12.1	0.9	3.3	0.8	90.6	294.6	0.2	34.8	9.3	3.7	5.0	1.1	8.3	1.5	36.6	138.1	0.2	0.4	0.1	0.2	17.7	0.5	0.0	0.5	0.6	19.2	197.1	0.9	0.7	406.6	0.5	30.7	0.4	1.4	60.2	2.3	0.5	91.6	18.7	1.7	17.2	41.1	11.0	0.4	58.0	35.8	30.9	1.1	2.9	0.2	5.7	4.3	0.1	0.2	110.8	12.6	0.1	0.2	49.0	4.6	1.8	4.8	0.4	3.0	0.8	0.6	2.2	0.2	386.9	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.2	0.0	0.1	1.6	1.8	5.7	6.3	1.5	2.3	2.0	1.6	2.5	1.8	1.5	3.3	36.9	3.2	2.3	1.0	6.7	32.0	0.2	12.1	0.0	0.3	0.9	1.4	0.8	1.5	3.6	3.7	0.0	5.6	0.9	0.0	0.0	4.1	0.5	6.4	9.8	95.2	1.2	0.8	2.3	0.6	11.3	181.6	0.0	11.5	0.0	0.5	17.5	0.1	8.0	0.0	2.0	0.0	4.1	0.3	45.9	0.8	12.5	0.9	49.8	3.7	0.6	5.5	1.0	4.5	1.8	1.8	0.0	0.4	24.2	0.8	0.0	0.5	0.8	1.2	0.0	4.7	77.4	4.3	16.5	0.3	27.3	16.6	3.5	1.2	0.2	0.5
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 177.7;skin 1: 434.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 185.7;Suprabasal keratinocytes: 291.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 13.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067089	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA		35000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"	"Nucleoli, Vesicles"	"HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	34.4	11.1	29.7	11.2	28.2	22.4	35.2	37.3	31.2	59.2	13.1	15.0	18.8	11.8	77.4	177.7	12.5	10.3	43.8	29.5	30.0	17.6	15.7	26.4	8.7	33.8	29.0	14.6	35.9	10.9	19.7	28.2	36.4	24.5	10.2	27.5	53.1	14.1	39.0	434.9	14.9	10.9	27.1	9.3	22.8	27.0	37.5	19.6	21.0	22.3	25.1	13.3	85.1	27.3	74.8	10.9	65.9	50.4	9.8	16.2	21.1	14.4	25.2	20.9	13.3	5.4	92.6	22.9	41.0	18.7	21.6	37.3	7.7	85.9	9.6	58.0	11.9	14.9	3.4	69.3	20.3	11.3	8.4	18.2	83.5	26.7	27.0	17.7	57.2	42.4	26.8	10.5	13.0	45.6	25.3	41.6	35.0	60.0	18.7	28.4	19.3	14.7	10.7	25.2	72.1	45.4	32.9	29.4	44.4	22.3	36.3	27.2	37.7	13.4	16.4	20.4	32.2	22.9	32.5	27.0	5.0	56.6	54.5	2.6	5.2	13.8	2.6	1.8	1.6	1.7	1.3	2.1	6.4	1.5	1.3	1.2	3.7	8.6	1.2	2.0	1.3	2.6	29.7	28.2	37.3	31.2	29.5	30.0	33.8	29.0	36.4	27.1	37.5	27.3	150.6	28.9	13.9	30.0	9.6	103.1	42.3	16.1	40.5	9.0	39.9	33.3	14.0	24.3	17.0	18.4	8.4	71.3	23.5	20.5	33.2	20.9	116.3	20.0	17.9	42.7	49.1	20.0	18.0	18.7	43.2	15.7	30.1	38.5	0.0	27.2	20.0	25.6	58.0	16.8	14.1	37.5	12.2	43.0	97.4	34.8	14.9	38.3	48.0	12.2	33.6	185.7	71.1	17.1	24.1	37.6	28.3	23.0	13.3	53.5	28.6	30.5	5.2	12.8	46.0	15.0	24.5	72.1	43.6	154.0	291.5	48.4	17.2	14.3	28.6	60.5
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 372.9;granulocytes: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 308.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	26.9	16.8	20.9	27.3	22.8	41.8	23.8	21.6	24.8	23.7	23.4	31.8	21.7	27.7	31.1	23.4	25.3	19.8	32.3	22.0	22.4	22.9	46.8	25.3	39.3	22.8	22.3	27.1	17.3	19.7	18.2	22.1	21.7	23.4	23.1	18.8	18.5	30.6	33.3	25.3	25.1	30.6	21.6	54.0	34.8	43.3	22.1	40.1	17.1	20.9	41.2	25.8	20.4	23.6	66.7	60.3	56.7	44.6	40.3	32.8	89.2	41.9	43.7	98.0	86.0	224.8	52.4	73.9	59.6	42.7	94.4	69.8	77.1	98.6	105.3	36.1	38.0	243.0	33.2	110.2	41.8	77.4	308.0	35.1	58.9	55.6	54.8	34.1	59.8	103.8	66.8	29.6	53.5	54.9	127.0	101.4	51.4	74.9	85.8	87.9	109.1	56.3	42.9	55.0	45.1	53.6	72.5	102.3	75.4	52.3	50.6	61.1	44.5	97.4	58.0	64.9	68.8	34.1	46.6	85.5	68.5	48.6	52.7	267.9	77.7	103.3	51.0	103.0	49.1	88.9	49.9	53.8	110.3	83.4	49.8	53.6	16.9	79.9	109.6	86.9	66.2	71.3	20.9	22.8	21.6	24.8	22.0	22.4	22.8	22.3	21.7	21.6	22.1	23.6	28.6	28.9	26.4	21.2	40.0	22.8	32.9	40.7	13.1	26.1	13.0	13.2	39.8	17.2	34.1	18.4	18.8	147.8	40.4	21.1	37.2	34.8	372.9	24.2	24.9	32.5	20.9	43.7	31.6	34.7	69.4	28.7	48.4	21.6	263.6	34.4	44.3	45.2	49.3	18.5	35.6	27.3	42.7	36.0	35.5	131.2	34.2	44.5	26.6	14.0	89.8	32.1	40.2	30.7	39.8	31.9	21.5	33.4	21.6	22.3	34.7	43.1	26.1	25.8	19.7	25.4	48.0	79.4	45.2	10.7	22.4	52.9	38.8	23.7	24.2	20.6
CTNND2	"GT24, NPRAP"	ENSG00000169862	"Catenin delta 2"	Q9UQB3	5	10971836-11904446	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 93.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2382.9;Excitatory neurons: 1253.9;Inhibitory neurons: 1124.0;Oligodendrocyte precursor cells: 1418.0;Oligodendrocytes: 433.8"	"Cancer enriched"	"Detected in many"	16	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.1;MCF7: 9.0;SK-BR-3: 5.3;U-266/84: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015077, CAB037339, HPA071124"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"CAB037339: , HPA015077: AB_2669150, HPA071124: "	"unprognostic (7.32e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.23e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.55e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.76e-2)"	0.2	0.7	79.2	0.2	79.3	0.0	0.9	49.7	75.7	0.1	15.2	1.1	0.1	0.1	0.3	0.1	0.2	2.6	3.8	84.6	56.7	0.0	0.5	0.7	0.1	93.8	72.6	0.5	15.8	0.0	9.0	0.3	71.5	0.9	0.3	7.0	0.8	0.2	0.1	0.7	0.5	0.1	77.7	3.9	0.6	2.6	83.7	0.2	0.2	0.1	0.0	0.1	0.2	76.1	0.0	0.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	9.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.0	17.5	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.2	79.3	49.7	75.7	84.6	56.7	93.8	72.6	71.5	77.7	83.7	76.1	0.1	0.0	0.0	2382.9	0.1	0.0	0.1	0.0	0.0	24.0	7.9	4.1	12.7	28.6	0.0	1.8	0.0	0.0	0.0	0.1	3.9	6.5	25.6	0.8	0.1	0.8	4.9	0.0	1253.9	6.1	0.2	0.5	0.0	0.9	0.0	0.0	0.0	0.2	0.1	8.4	1124.0	0.1	0.0	0.0	0.7	31.1	1.5	0.2	0.0	69.3	0.0	33.0	0.0	1418.0	433.8	2.2	0.0	0.0	0.0	2.8	0.0	0.4	0.0	3.6	0.0	3.3	0.3	4.6	5.9	0.0	0.0	0.0	0.1	0.5	0.3	0.1
CTR9	"KIAA0155, p150TSP, SH2BP1, TSBP"	ENSG00000198730	"CTR9 homolog, Paf1/RNA polymerase II complex component"	Q6PD62	11	10751246-10801625	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 186.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061027, HPA068122"	Supported		Enhanced	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA061027: AB_2684418, HPA068122: AB_2685959"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (3.65e-6)"	"unprognostic (6.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	15.4	20.6	10.0	21.0	10.2	23.7	18.8	9.9	11.3	19.9	13.4	16.9	16.2	22.2	48.0	17.5	16.8	15.3	17.2	10.4	10.8	22.5	25.2	17.2	26.3	10.0	12.0	22.0	13.3	30.0	12.5	20.3	10.5	17.6	18.1	29.2	18.3	16.1	17.9	19.2	16.8	16.4	9.7	22.5	17.2	27.0	10.4	30.3	23.2	15.1	26.0	21.8	11.8	11.0	40.5	30.9	43.5	41.4	93.1	37.0	21.2	43.9	29.2	34.8	36.5	51.1	83.9	36.7	23.6	36.6	42.3	40.9	54.0	36.2	56.7	56.7	64.6	186.6	31.0	29.2	29.7	74.1	98.8	34.6	28.8	22.5	30.1	32.1	40.6	34.5	77.0	43.2	42.6	18.3	47.5	28.9	36.0	48.7	38.2	43.6	52.9	25.1	29.9	54.8	19.9	47.4	39.6	38.9	31.3	41.5	34.6	32.3	40.2	29.2	30.0	51.7	24.0	23.6	59.8	39.5	31.2	49.5	30.5	54.4	15.4	31.3	20.0	17.7	26.3	16.7	21.4	19.7	18.1	17.0	20.1	19.6	11.3	26.7	18.3	9.0	19.4	15.8	10.0	10.2	9.9	11.3	10.4	10.8	10.0	12.0	10.5	9.7	10.4	11.0	51.5	57.7	48.8	14.7	49.0	87.2	46.2	29.7	64.3	34.0	30.2	31.6	49.2	31.5	41.7	25.8	56.3	37.9	42.7	30.7	19.6	26.9	28.5	34.0	38.0	37.7	26.9	25.5	16.5	24.5	24.8	36.4	15.8	52.4	85.9	33.2	28.5	38.6	29.1	63.9	21.4	45.1	32.6	32.3	23.6	13.1	33.5	36.1	12.4	15.0	31.8	31.1	29.9	20.6	18.6	26.9	17.5	31.2	37.2	26.1	22.8	18.3	33.7	45.9	26.3	47.8	33.1	100.3	71.3	51.1	81.1	45.7	48.0	56.4	25.3	31.5
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029677-97156556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 643.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 63.7;Cytotrophoblasts: 122.3;Extravillous trophoblasts: 153.0;Granulosa cells: 54.2;Syncytiotrophoblasts: 67.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.1"	"Group enriched"	"Detected in many"	8	"BEWO: 592.6;SuSa: 739.0"					"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.2	0.2	0.6	0.3	0.7	0.3	5.8	0.8	1.6	43.1	0.8	2.9	1.1	2.8	1.7	19.8	1.3	0.5	0.1	0.6	0.5	21.3	0.2	0.9	0.1	0.7	0.6	0.2	2.1	1.4	1.5	16.8	0.6	0.7	3.2	17.2	9.4	0.1	0.7	52.5	0.4	0.8	0.5	0.2	2.8	65.8	0.6	643.6	1.3	0.1	6.0	0.4	20.1	1.0	37.1	5.2	12.1	33.1	0.6	0.0	592.6	0.5	0.0	7.1	4.7	81.0	37.7	0.3	2.8	0.5	50.5	67.2	58.8	43.9	9.7	0.1	4.4	0.8	1.9	3.1	0.2	0.1	3.3	0.0	9.2	1.5	0.8	0.9	2.4	8.5	0.5	0.2	14.4	15.2	0.9	0.3	76.2	78.9	10.7	0.0	27.3	0.1	11.4	3.7	2.4	3.6	39.1	13.1	13.2	739.0	21.1	3.2	0.0	1.0	23.6	0.2	3.5	5.7	20.6	0.8	1.6	0.4	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.2	3.3	0.0	15.1	0.0	0.1	0.6	0.7	0.8	1.6	0.6	0.5	0.7	0.6	0.6	0.5	0.6	1.0	0.9	0.0	1.1	0.3	0.9	30.3	13.0	63.7	19.9	4.6	13.1	9.9	1.3	0.0	17.4	1.8	10.4	122.3	6.9	4.7	1.9	1.8	2.6	15.0	2.9	1.8	1.8	0.0	0.6	0.8	153.0	3.2	0.0	24.0	0.0	54.2	0.4	0.0	13.6	0.0	0.9	1.5	10.2	0.8	3.0	8.2	4.1	2.4	0.0	0.0	0.2	6.5	0.0	0.0	3.5	0.5	10.5	1.2	0.0	8.1	0.1	22.1	4.2	36.6	6.6	1.4	3.6	46.7	33.7	8.2	11.9	67.3	0.5	0.7	4.2	8.4
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924491-7926135	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 275.1;endometrium 1: 85.7"	"Cell type enriched"	"Detected in many"	4	"Endometrial ciliated cells: 127.7"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 69.5;glioma: 56.3;ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 96.4;HEK 293: 67.5;NTERA-2: 72.4;REH: 57.3;SCLC-21H: 56.2;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	6.5	12.5	176.3	0.9	275.1	0.1	3.2	0.0	173.0	36.9	0.0	61.3	0.9	85.7	2.9	2.6	43.0	0.2	1.0	199.1	58.0	11.7	0.4	7.0	0.0	0.0	21.3	6.2	2.2	1.1	57.0	0.3	1.0	16.3	0.4	0.2	6.4	12.4	0.5	4.1	4.7	4.9	0.0	1.4	8.8	27.8	85.5	0.3	2.8	0.1	0.0	21.2	13.2	40.7	33.5	8.1	20.5	96.4	0.0	0.3	4.8	8.5	2.3	4.1	2.4	2.4	5.0	0.2	16.2	2.0	2.2	35.9	4.7	0.9	0.2	3.0	67.5	0.7	5.3	1.5	0.9	1.8	1.9	0.0	2.7	1.4	0.9	9.8	5.4	9.1	21.3	0.3	0.5	40.5	18.5	13.6	72.4	2.4	34.1	57.3	0.0	6.4	15.0	1.4	56.2	94.5	5.2	2.8	9.9	1.7	21.2	0.6	8.3	2.1	33.1	3.9	4.8	0.7	1.0	4.8	8.0	3.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	176.3	275.1	0.0	173.0	199.1	58.0	0.0	21.3	1.0	0.0	85.5	40.7	0.6	0.0	0.0	3.3	0.7	1.1	4.1	1.5	2.2	0.3	15.3	6.7	0.4	1.5	1.0	9.2	4.2	0.2	0.2	0.5	3.9	7.8	9.5	127.7	22.4	1.6	9.1	0.0	20.6	0.4	0.4	3.0	0.0	7.9	0.0	13.3	0.7	0.1	0.3	0.0	3.5	0.5	2.0	0.3	0.5	27.1	1.2	0.5	1.8	4.7	0.0	0.6	0.0	1.5	2.9	1.7	1.2	1.9	0.0	19.9	0.0	11.9	21.0	0.4	0.0	0.2	17.7	6.0	16.0	0.3	2.0	0.3	0.6	3.2	0.2	6.4
CU639417.1		ENSG00000274559	"Histone H2B type F-S-like"		21	5972924-5973383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;Intestinal goblet cells: 1.4;Paneth cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;T-47d: 2.2;U-2 OS: 1.6;U-266/70: 1.2;U-266/84: 2.2"									"HPA042205, HPA043013, HPA048671"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"										"unprognostic (3.37e-2)"				"unprognostic (2.63e-1)"				0.5	0.3	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.6	0.0	0.4	0.1	0.5	0.5	0.6	0.3	1.3	0.4	0.0	0.1	0.7	0.9	0.5	0.7	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.1	0.4	0.4	0.0	0.0	0.6	0.4	0.5	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.4	0.2	0.4	0.0	0.0	0.4	0.4	0.0	0.2	0.6	0.0	0.5	0.3	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.0	1.1	0.3	0.0	0.4	0.1	0.0	0.4	0.1	0.0	2.2	0.0	0.0	0.0	1.6	0.1	0.2	1.2	2.2	0.2	0.3	0.4	0.4	0.6	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.1	0.3	0.3	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0
CUEDC2	"C10orf66, MGC2491"	ENSG00000107874	"CUE domain containing 2"	Q9H467	10	102423245-102432584	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036544, HPA041829"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA036544: AB_10670111, HPA041829: AB_2677694"	"unprognostic (2.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (9.78e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.58e-2)"	45.6	66.6	84.3	28.3	86.0	29.8	42.3	89.4	91.2	49.5	80.5	64.7	19.8	53.4	33.7	30.7	48.3	31.5	91.8	84.4	89.0	55.8	44.9	38.1	33.2	85.1	84.1	56.3	41.0	58.9	45.5	27.8	86.2	48.1	23.3	31.1	40.8	37.3	119.4	37.5	34.2	42.5	83.8	42.8	48.0	38.4	88.1	43.2	42.2	119.2	30.4	48.2	37.7	87.2	53.8	58.2	98.3	120.0	77.3	95.8	35.8	42.4	147.8	95.6	71.6	18.9	56.5	94.4	91.7	76.3	41.7	54.7	65.0	97.3	50.5	75.5	66.4	58.7	50.1	20.8	130.4	45.2	38.0	116.2	89.9	93.6	95.3	187.0	100.1	108.5	46.6	96.5	109.4	58.8	110.2	101.6	35.4	44.1	37.9	124.6	115.0	49.9	101.9	24.8	49.7	113.0	29.6	31.6	96.8	41.5	94.3	71.7	59.5	48.2	45.4	60.6	62.9	112.3	93.2	63.3	84.4	154.2	41.4	98.9	111.5	84.4	69.2	91.5	77.3	80.5	66.9	72.4	112.0	89.5	66.2	63.2	43.0	93.0	58.0	97.9	84.3	86.7	84.3	86.0	89.4	91.2	84.4	89.0	85.1	84.1	86.2	83.8	88.1	87.2	56.6	32.1	21.9	10.7	36.1	31.7	49.0	73.1	44.9	54.7	58.8	81.0	56.8	40.0	37.4	46.0	25.0	66.9	40.6	24.0	80.3	70.0	21.0	28.3	52.9	46.4	55.7	35.7	12.2	46.6	33.2	58.5	31.6	26.6	51.4	89.6	59.3	49.9	75.1	67.3	16.0	36.4	63.1	49.1	47.7	42.2	57.2	44.3	51.6	3.7	97.0	94.7	44.3	13.6	23.4	40.0	32.0	60.2	45.4	38.3	34.5	151.7	28.1	47.5	39.5	46.5	164.9	56.6	31.3	42.6	33.8	45.6	38.7	92.5	39.3	41.9
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 466.3;Late spermatids: 567.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: AB_2685294"	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	33.2	27.3	19.6	29.4	20.9	15.5	30.2	20.4	26.5	28.1	22.2	38.9	23.0	29.8	28.8	30.6	29.4	23.2	35.9	22.1	23.0	21.6	45.1	26.3	39.0	20.4	21.2	30.9	20.6	36.3	25.6	32.7	20.4	27.3	24.5	52.1	26.1	30.1	88.8	28.8	27.3	32.2	21.8	30.0	29.7	95.1	21.3	30.3	27.4	74.6	35.6	34.9	26.6	21.7	79.9	61.6	59.5	93.6	46.6	51.6	72.8	64.8	77.7	65.8	61.4	64.5	53.9	109.6	49.5	65.9	104.4	52.5	87.0	59.9	76.4	72.8	71.9	65.2	39.6	64.5	50.5	74.8	58.9	40.0	58.5	45.9	46.0	59.9	71.3	52.8	100.8	78.2	72.2	76.4	64.1	81.0	111.6	68.6	58.8	78.7	52.3	106.3	54.2	55.4	83.3	61.0	74.5	92.3	51.4	69.9	29.0	57.5	56.6	44.1	15.4	87.7	75.8	70.4	54.2	96.7	94.3	82.5	66.2	15.5	17.0	14.1	16.5	18.3	21.8	17.3	18.9	21.2	26.6	15.0	22.4	18.5	1.4	27.9	18.5	6.7	18.5	20.0	19.6	20.9	20.4	26.5	22.1	23.0	20.4	21.2	20.4	21.8	21.3	21.7	24.0	35.3	40.9	41.4	26.0	27.9	31.1	19.5	22.2	33.4	13.8	17.5	29.2	12.8	32.2	9.2	29.2	66.6	19.1	12.0	17.6	28.1	466.3	20.4	23.4	25.1	15.6	23.1	76.3	26.2	77.1	29.9	19.4	21.9	23.4	31.6	18.5	41.5	29.8	21.9	89.5	19.7	22.4	18.5	16.8	567.7	21.8	25.7	28.4	60.9	51.7	32.7	37.0	52.8	74.3	28.5	15.0	30.5	25.3	29.8	11.7	13.5	33.6	48.9	32.9	30.3	38.9	59.6	34.0	20.6	25.4	73.2	26.5	24.1	18.8	21.7
CUL2		ENSG00000108094	"Cullin 2"	Q13617	10	35008551-35090642	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 319.6;Late spermatids: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002677, HPA024578"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB002677: , HPA024578: AB_1847338"	"unprognostic (8.11e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (8.24e-6)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (2.26e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.29e-1)"	15.3	13.3	10.5	16.2	11.7	20.1	15.5	11.9	13.1	13.0	9.8	14.7	14.5	14.8	10.4	16.8	11.0	12.0	19.2	12.2	12.2	14.3	21.0	13.4	19.8	10.8	11.2	12.7	13.4	22.1	8.8	18.8	11.4	15.3	15.2	13.2	11.5	15.7	45.2	13.4	13.9	19.1	11.5	15.0	14.0	35.8	12.3	18.2	16.2	37.6	20.8	17.0	10.1	12.2	50.4	29.2	37.7	32.5	42.0	46.0	39.8	57.8	32.1	56.1	56.2	38.7	47.0	39.9	31.0	61.6	41.1	45.3	55.4	53.4	63.9	46.9	35.9	51.8	29.0	34.8	46.0	28.6	32.6	44.5	43.7	61.6	21.4	43.3	63.6	41.5	60.5	35.2	62.2	34.4	47.7	15.9	13.8	34.4	117.3	39.4	61.0	25.0	51.3	38.9	18.4	24.4	32.4	40.3	47.0	41.6	30.7	32.4	58.6	34.5	38.3	59.6	38.4	14.7	21.2	47.4	66.4	63.2	24.8	12.8	9.9	11.6	12.3	14.9	17.4	10.9	13.5	14.6	12.6	12.6	16.1	15.2	4.8	13.3	15.3	5.7	17.8	8.5	10.5	11.7	11.9	13.1	12.2	12.2	10.8	11.2	11.4	11.5	12.3	12.2	24.8	22.4	12.6	21.9	23.0	12.0	8.6	13.1	9.6	13.1	12.0	12.4	26.4	5.7	20.7	9.2	10.4	24.7	27.8	9.9	15.6	18.4	319.6	17.5	25.4	22.3	10.7	9.4	39.7	17.8	20.1	15.7	9.2	20.5	20.3	19.2	16.4	18.2	20.1	23.5	35.6	10.6	14.2	17.2	12.3	181.0	14.0	20.3	10.6	27.2	23.0	16.0	27.8	30.7	41.7	17.5	6.9	11.7	17.3	8.3	15.2	15.0	19.9	13.7	0.0	16.1	26.9	40.1	32.8	14.4	13.1	37.1	25.3	23.0	13.1	9.9
CUL4A		ENSG00000139842	"Cullin 4A"	Q13619	13	113208193-113267108	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 171.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058979			Approved	Nucleoplasm		NA	NA		44000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA058979: AB_2683868"	"unprognostic (3.01e-1)"	"unprognostic (5.93e-3)"	"unprognostic (6.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.41e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-3)"	"unprognostic (3.57e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.48e-1)"	39.3	34.6	17.0	26.0	19.4	63.3	34.3	19.2	17.2	30.9	29.7	33.0	26.9	30.8	24.2	36.9	29.1	24.4	63.1	16.2	20.2	30.3	40.5	30.8	33.0	23.2	21.0	28.6	36.6	33.9	25.3	30.2	21.9	33.6	29.8	21.0	37.1	25.1	171.7	47.7	31.4	25.3	19.4	31.4	34.2	47.2	19.5	26.1	31.5	125.7	31.1	32.2	32.4	23.2	106.9	50.9	50.7	43.9	60.2	67.0	65.5	104.9	79.0	88.9	68.5	93.0	85.8	129.7	44.7	92.7	87.3	67.4	76.9	58.3	82.4	57.2	77.1	85.8	109.3	74.8	72.1	134.2	56.8	48.1	70.3	52.5	82.2	59.3	60.3	47.8	88.2	24.8	89.7	51.4	67.7	123.3	47.9	149.3	53.5	70.9	52.2	59.7	61.5	47.8	73.7	43.5	54.3	118.6	53.9	43.6	84.6	141.7	83.2	42.7	90.0	47.2	59.9	65.3	49.8	113.0	93.7	108.2	69.0	12.9	20.0	18.1	27.6	29.1	25.7	17.1	27.1	31.2	17.4	16.5	23.5	27.9	5.9	16.2	30.4	13.5	19.9	25.8	17.0	19.4	19.2	17.2	16.2	20.2	23.2	21.0	21.9	19.4	19.5	23.2	27.8	28.9	36.1	46.7	28.2	46.4	30.9	24.9	52.9	14.4	35.5	27.2	140.3	31.5	24.4	35.0	10.4	32.3	25.0	29.2	25.4	28.3	61.6	28.7	28.0	30.0	23.9	73.8	46.1	37.2	40.5	33.0	36.7	41.7	11.4	26.1	23.6	56.9	30.4	28.6	41.0	34.2	24.4	40.9	30.5	118.2	35.8	31.0	39.2	37.5	28.5	13.0	28.8	43.2	66.1	39.8	25.3	31.6	38.0	54.0	22.2	26.9	26.4	18.1	32.9	30.5	30.9	65.3	38.1	53.8	60.0	39.7	32.5	25.2	32.3	45.6
CUL4B		ENSG00000158290	"Cullin 4B"	Q13620	X	120505920-120604074	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 106.9;Late spermatids: 169.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003046, HPA011880, CAB017786, HPA058979"	Enhanced		Enhanced	Nucleoplasm		NA	NA		18000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: AB_2683868"	"unprognostic (2.34e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.12e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	18.7	20.5	15.3	14.4	16.5	9.8	20.0	18.2	19.3	24.6	15.7	20.0	12.3	18.7	27.3	23.4	19.6	15.5	15.5	16.0	19.2	18.1	19.5	14.5	20.5	14.4	16.4	25.2	17.0	24.2	26.9	15.5	15.7	18.2	13.5	19.9	15.1	22.5	10.0	15.2	15.4	15.6	13.7	17.7	15.5	28.0	16.2	25.3	15.8	12.5	21.8	18.2	20.3	16.1	41.9	37.3	28.7	31.4	129.5	57.0	22.4	89.8	104.1	71.3	69.4	30.4	110.6	40.1	35.5	206.8	127.7	29.9	61.1	27.7	84.8	26.1	26.6	20.5	42.1	25.9	50.6	22.6	28.1	65.6	22.2	45.1	37.5	134.8	133.2	22.6	33.6	31.7	78.4	24.5	30.7	19.0	45.4	52.6	39.5	23.4	27.1	43.4	23.2	19.5	32.9	27.4	74.2	36.8	36.5	35.0	28.8	20.9	177.6	57.1	30.5	76.3	88.6	21.2	50.0	52.2	59.9	28.2	55.2	6.6	3.8	8.1	5.6	3.1	6.1	5.7	5.2	5.2	4.4	4.4	6.0	6.2	14.4	4.4	2.4	7.0	6.9	4.1	15.3	16.5	18.2	19.3	16.0	19.2	14.4	16.4	15.7	13.7	16.2	16.1	18.7	22.4	14.4	11.8	15.5	15.2	9.6	12.9	12.5	15.7	17.3	14.7	14.6	8.6	11.7	14.7	14.6	10.1	19.9	14.7	13.7	10.1	106.9	12.4	15.6	18.2	24.6	13.3	18.4	8.9	25.0	21.2	14.3	15.8	14.0	20.5	40.7	16.4	17.5	25.2	20.9	13.9	8.2	30.5	13.9	169.3	21.5	18.4	12.4	14.0	17.6	15.0	7.2	23.1	21.0	16.7	7.3	21.4	18.9	9.5	11.0	14.4	17.8	14.1	13.1	17.0	16.6	12.6	13.9	23.0	13.8	10.0	14.1	21.7	12.7	9.5
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 385.5;tongue: 204.2"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	38.7	15.5	19.3	14.6	21.9	23.6	27.3	20.8	25.9	17.3	17.3	19.4	11.1	14.7	11.0	16.0	17.1	12.1	41.7	18.7	20.7	13.5	30.2	15.1	22.3	21.0	20.6	12.6	14.2	8.6	7.8	11.3	21.3	16.1	15.9	28.3	16.9	11.2	385.5	18.6	20.9	14.4	20.1	28.6	18.6	43.4	20.3	23.9	13.2	204.2	19.7	43.8	16.7	25.0	27.4	57.7	19.9	60.7	71.8	32.8	10.8	22.0	28.0	21.6	24.2	26.7	20.5	98.9	19.1	37.5	10.6	22.9	40.8	36.6	23.9	29.5	39.0	32.9	26.1	42.7	33.2	61.5	15.5	34.0	22.3	34.5	71.1	26.8	37.8	56.2	29.6	21.4	16.4	19.4	55.7	63.2	20.0	27.7	21.4	37.5	23.3	38.3	22.8	11.2	6.5	14.8	10.1	15.9	28.9	27.1	25.3	34.7	21.2	9.0	12.2	9.9	29.5	34.7	48.5	69.6	29.4	130.0	8.2	70.6	42.6	111.7	56.9	35.2	60.0	73.4	53.9	54.9	47.1	66.5	74.4	57.2	68.6	63.1	46.0	54.2	57.0	45.3	19.3	21.9	20.8	25.9	18.7	20.7	21.0	20.6	21.3	20.1	20.3	25.0	26.3	9.6	12.5	15.3	32.8	12.1	14.7	23.1	5.7	18.7	12.6	15.2	40.6	14.3	14.9	5.5	8.4	18.6	23.2	4.6	21.5	16.9	12.6	11.4	12.0	19.8	12.1	28.2	8.5	17.4	13.5	32.8	10.7	8.3	30.4	14.4	27.5	23.4	20.9	11.8	9.0	7.4	12.2	17.0	11.7	10.8	13.1	16.6	30.2	7.5	28.0	25.9	21.6	8.0	26.9	10.5	7.4	16.1	27.2	16.1	19.2	34.8	21.5	33.0	19.7	27.1	15.5	163.3	36.7	14.3	10.9	13.5	25.6	36.3	9.6	11.6
CUX1	"CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6"	ENSG00000257923	"Cut like homeobox 1"	"P39880, Q13948"	7	101815904-102283958	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Transport"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 35.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003277, HPA003317"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Golgi apparatus"		"HPA003277: AB_10601804, HPA003317: AB_2666891"	"unprognostic (5.86e-2)"	"unprognostic (5.39e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.12e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-1)"	30.5	18.0	23.8	24.8	33.6	33.4	17.9	54.0	48.2	35.5	28.0	40.5	33.7	60.9	16.9	32.6	35.3	31.7	82.8	21.5	23.3	40.0	23.2	33.1	19.4	30.8	27.5	46.9	63.3	46.0	24.6	23.1	27.4	30.7	25.3	19.2	36.1	23.2	45.5	24.0	37.3	40.8	26.2	16.9	35.3	9.6	29.3	34.7	49.4	38.8	20.6	32.4	24.8	30.5	41.8	44.0	30.3	37.7	24.1	49.3	18.4	41.1	43.0	17.0	10.9	26.2	26.2	53.6	64.2	40.8	31.3	33.4	19.4	32.9	10.1	25.9	21.8	18.8	32.8	22.2	63.7	24.7	9.9	34.6	65.9	13.1	29.5	48.7	22.3	34.0	44.5	44.2	16.3	85.9	80.8	30.1	12.3	64.0	45.4	52.6	25.1	64.4	27.6	46.5	27.7	82.6	35.8	88.4	35.4	25.1	17.4	29.0	33.5	71.2	47.8	54.4	23.7	28.8	14.5	114.7	65.8	22.3	50.8	3.3	13.9	2.3	3.1	13.4	3.0	2.9	2.3	3.1	10.8	2.4	2.2	3.1	7.0	4.5	35.0	18.2	2.2	8.4	23.8	33.6	54.0	48.2	21.5	23.3	30.8	27.5	27.4	26.2	29.3	30.5	33.7	99.3	60.5	78.4	35.3	26.3	30.9	30.9	33.6	67.2	23.9	17.1	110.5	31.5	40.3	40.5	68.8	54.6	59.6	69.2	9.8	34.4	9.5	50.6	165.2	42.1	42.5	50.0	129.0	24.0	55.5	51.8	62.2	85.0	12.0	97.8	37.5	36.1	32.8	53.8	116.2	48.7	38.7	70.2	42.5	9.4	41.3	75.4	17.8	139.6	65.2	47.7	32.0	96.0	117.5	34.1	50.2	60.9	46.0	55.5	42.9	64.5	37.9	57.3	26.3	105.2	56.6	13.5	14.4	39.9	43.3	88.0	25.7	34.7	46.0	43.8
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated cyclophilin"	Q6UX04	5	64768930-65018750	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 255.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561"	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	13.4	13.0	13.6	13.0	14.6	20.5	13.4	16.7	18.4	12.6	10.7	14.3	9.8	15.5	12.3	11.8	11.8	11.2	18.9	13.1	15.5	14.1	10.2	10.7	15.4	14.5	13.7	18.2	9.0	16.9	8.8	14.6	14.4	13.9	15.0	14.0	10.5	12.3	22.2	11.5	10.1	14.3	13.5	12.8	11.1	17.2	14.1	21.7	13.9	26.4	16.0	13.2	11.5	15.4	32.7	21.4	37.5	69.9	31.4	38.2	41.8	33.5	27.7	36.7	38.2	36.0	40.3	48.0	57.0	35.0	41.2	20.2	39.8	60.5	66.2	40.4	32.4	36.2	35.6	30.3	48.0	38.3	23.5	25.6	45.7	46.3	58.3	32.3	39.4	53.9	35.8	30.8	36.8	32.6	53.5	34.7	30.4	16.9	25.6	49.0	50.4	50.3	35.0	28.0	44.4	19.6	40.8	16.4	39.7	35.5	35.9	55.5	32.9	21.4	37.8	34.6	54.2	23.9	33.1	46.5	40.1	65.9	38.8	13.2	13.1	9.6	13.6	13.2	16.8	17.5	15.3	17.4	16.9	13.2	16.2	16.9	2.7	20.4	10.2	13.8	18.0	10.4	13.6	14.6	16.7	18.4	13.1	15.5	14.5	13.7	14.4	13.5	14.1	15.4	24.2	9.6	26.2	64.3	26.0	16.4	27.7	37.5	13.6	31.4	17.4	20.3	63.6	18.6	23.2	14.7	14.6	44.0	16.8	11.6	21.5	44.1	255.6	21.0	27.2	27.2	29.9	37.8	114.1	33.1	54.5	25.1	13.7	20.2	19.6	40.7	16.4	11.4	33.0	20.2	110.3	17.0	40.7	17.1	15.2	57.9	38.5	22.3	14.2	61.8	33.6	34.2	36.0	103.0	103.2	40.4	16.0	36.1	21.0	22.1	13.3	24.4	28.6	51.3	32.9	31.3	33.6	74.2	28.3	20.6	20.0	30.8	26.2	30.7	28.6	23.8
CWF19L1	"FLJ10998, hDrn1"	ENSG00000095485	"CWF19 like cell cycle control factor 1"	Q69YN2	10	100232298-100267680	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036889, HPA036890"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Golgi apparatus"		"HPA036889: AB_10670928, HPA036890: AB_10696789"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.61e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	8.1	6.9	5.9	11.4	6.3	18.8	11.6	7.5	7.6	7.9	5.1	7.2	6.8	8.2	5.7	6.9	8.7	6.7	7.4	5.9	6.5	7.8	8.2	7.5	16.4	6.0	5.8	10.3	8.0	9.0	6.1	9.0	6.3	6.8	8.6	10.3	8.6	6.5	10.1	11.2	8.1	9.3	6.3	11.8	6.6	14.3	6.0	14.8	8.1	10.2	16.9	8.5	6.6	8.4	29.1	18.8	18.7	29.2	9.1	10.8	20.7	17.2	23.8	37.5	30.6	21.5	22.6	30.5	19.4	16.6	16.3	27.9	42.2	24.9	39.6	19.4	20.8	17.5	15.8	20.6	15.8	44.7	19.6	15.2	10.4	28.0	26.2	14.2	26.6	30.8	20.7	26.8	21.9	18.3	36.2	32.4	14.7	15.0	23.2	12.6	29.2	21.2	15.0	16.5	9.4	16.8	20.6	10.3	26.0	12.6	37.3	19.1	18.6	15.8	21.5	18.3	32.8	23.9	29.6	17.9	20.1	39.1	11.4	10.0	17.0	22.7	12.8	15.9	16.3	14.0	13.3	14.4	14.9	13.0	14.9	15.0	9.6	18.1	14.7	6.8	17.7	13.8	5.9	6.3	7.5	7.6	5.9	6.5	6.0	5.8	6.3	6.3	6.0	8.4	8.0	19.2	10.8	14.0	16.2	4.5	7.7	6.8	4.6	9.5	4.8	3.9	8.0	5.7	11.3	5.5	4.2	10.4	13.5	4.3	7.9	6.0	23.6	6.8	6.4	8.3	4.2	11.2	26.8	7.7	11.0	6.7	4.6	6.3	17.7	8.3	7.5	5.9	9.5	10.1	24.3	4.2	10.2	13.1	5.7	5.3	6.8	11.3	8.8	14.0	15.5	5.1	19.6	18.6	24.0	7.2	6.7	4.1	11.3	5.3	4.5	6.2	12.5	12.3	0.0	8.4	6.9	18.4	12.2	5.8	7.7	10.9	12.8	6.7	5.3	4.4
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137251	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.2;lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	52	"neutrophil: 3273.9"	"Lineage enriched"	"Detected in many"	111	"granulocytes: 3273.9"	"Group enriched"	"Detected in some"	11	"BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1"					"Low region specificity"	"Detected in all"			"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	13.8	1.5	0.3	40.0	0.6	7.3	0.8	0.2	2.6	4.5	0.1	0.9	0.2	0.4	1.3	27.2	2.9	7.8	1.0	0.3	0.1	0.4	2.4	6.5	0.7	0.6	0.5	0.4	2.9	0.4	0.2	4.6	1.4	0.6	0.7	0.0	3.0	3.8	0.5	4.8	1.2	2.4	0.3	27.3	0.7	0.2	0.5	2.8	0.6	11.6	3.0	7.8	7.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	16.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	1.3	0.2	0.0	0.0	0.4	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	15.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	63.5	29.5	50.3	28.8	7.4	0.4	0.2	1.3	7.3	13.5	0.2	1.1	9.9	3273.9	6.8	3.6	25.0	0.5	17.4	0.3	0.6	0.2	2.6	0.3	0.1	0.6	0.5	1.4	0.3	0.5	0.4	0.0	0.0	10.5	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.2	0.0	1.9	0.0	0.0	0.7	12.9	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	6.3	3.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.2	1.6	0.0	0.0	2.8	0.0	1.0	3.7	0.0	40.2	0.0	0.1	0.0	2.2	0.0	1.4	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.0	11.6	0.1	0.3	4.1	0.1	0.1	1.9
CXorf56	FLJ22965	ENSG00000018610	"Chromosome X open reading frame 56"	Q9H5V9	X	119538149-119565409	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038245, HPA038617, HPA064831"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Centrosome	"HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: AB_2685364"	"prognostic unfavorable (3.45e-4)"	"unprognostic (3.88e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.92e-2)"	"unprognostic (7.74e-3)"	"unprognostic (6.38e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.68e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-1)"	11.6	9.8	8.2	7.6	8.6	16.2	12.5	8.3	9.2	10.1	7.1	10.0	7.7	11.6	9.0	9.4	9.9	6.1	10.5	8.2	9.4	11.6	8.8	8.8	10.7	7.9	7.9	13.7	8.8	11.7	7.2	10.2	8.7	8.8	8.7	11.5	9.9	8.8	13.0	12.3	9.0	8.7	8.0	9.8	9.0	6.7	9.3	11.5	11.8	13.2	11.6	9.3	9.0	9.7	27.3	26.2	16.8	19.8	17.9	12.5	22.9	17.1	15.4	22.3	20.7	23.4	26.7	41.3	43.2	16.9	53.9	16.9	40.1	21.0	30.5	24.8	30.3	14.9	25.2	16.2	13.8	41.3	22.1	14.7	17.9	29.1	24.0	14.2	16.3	24.0	32.2	25.4	11.1	40.5	24.8	24.7	27.3	33.4	28.4	23.9	19.0	29.9	15.8	19.8	12.1	22.0	35.9	19.3	25.3	18.0	15.0	17.9	20.4	16.9	12.0	31.2	39.6	21.9	42.7	42.0	14.2	39.7	20.3	5.0	10.3	13.9	9.0	12.6	8.2	10.9	7.7	9.5	9.5	15.6	7.9	7.7	4.8	6.4	11.9	8.7	10.4	9.4	8.2	8.6	8.3	9.2	8.2	9.4	7.9	7.9	8.7	8.0	9.3	9.7	2.6	3.2	13.9	1.6	10.6	6.2	8.0	4.8	5.7	15.7	4.8	5.0	13.4	7.2	5.4	3.7	6.2	20.5	3.5	8.3	21.5	9.2	1.3	8.7	10.3	7.5	8.5	10.3	9.4	6.6	20.1	5.3	4.1	10.5	17.2	7.7	6.8	6.4	10.1	8.4	10.8	6.0	8.2	12.9	8.3	1.2	9.6	6.5	12.4	2.8	17.1	15.8	6.2	7.5	6.8	6.8	6.5	11.3	7.8	5.2	9.8	13.2	6.8	11.3	13.1	9.5	11.1	5.4	10.0	6.5	5.8	35.6	9.2	7.6	7.9	8.6
CXorf58	FLJ25444	ENSG00000165182	"Chromosome X open reading frame 58"	Q96LI9	X	23908006-23939509	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	8	"testis: 3.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 33.3;Late spermatids: 6.9;Respiratory ciliated cells: 5.5;Spermatocytes: 19.7;Spermatogonia: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"GAMG: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031542, HPA031543, HPA031544"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA031542: AB_2673927, HPA031543: AB_10603789, HPA031544: AB_2673929"	"unprognostic (9.74e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.06e-3)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	3.9	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	2.0	0.2	0.0	0.2	0.4	0.0	0.5	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.9	0.2	33.3	1.6	0.1	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	1.0	0.6	0.7	0.0	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.2	5.5	2.8	0.0	0.0	0.1	19.7	8.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0
CXXC1	"CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1"	ENSG00000154832	"CXXC finger protein 1"	Q9P0U4	18	50282343-50287839	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044511	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA044511: AB_10963081"	"unprognostic (4.47e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-2)"	18.1	26.7	24.4	22.8	25.4	45.9	19.3	29.8	30.5	28.0	25.9	23.6	27.3	23.3	10.3	23.6	24.9	17.5	19.9	24.6	24.6	25.5	24.5	19.2	34.3	24.6	24.5	30.0	38.7	20.3	21.0	16.0	25.2	24.4	15.9	13.6	32.4	21.4	20.2	29.5	23.5	14.9	22.8	29.6	25.7	22.8	25.0	30.7	23.2	13.1	21.1	25.6	23.7	26.3	24.6	31.9	33.4	46.9	28.9	16.2	46.9	34.3	28.4	38.5	32.1	21.6	19.6	60.2	17.6	22.0	18.5	44.6	51.6	37.0	21.7	51.9	33.0	57.9	42.3	39.5	19.6	126.4	68.7	19.5	32.9	38.0	51.0	26.0	25.0	58.8	29.9	63.8	27.3	37.7	71.6	67.7	47.8	16.9	22.4	74.5	26.9	56.5	26.8	13.9	48.4	47.2	18.0	17.8	21.6	21.2	22.9	56.9	29.2	45.1	28.4	18.4	29.6	119.1	87.7	52.5	28.4	58.6	35.5	24.7	18.8	34.0	24.0	22.0	25.0	26.9	21.6	23.6	21.9	27.5	23.1	18.9	8.1	22.6	18.8	15.5	26.4	20.6	24.4	25.4	29.8	30.5	24.6	24.6	24.6	24.5	25.2	22.8	25.0	26.3	18.1	19.2	27.4	21.9	27.8	26.8	13.1	21.7	21.1	15.3	20.2	17.4	7.3	18.6	23.8	18.4	14.6	34.5	23.7	31.4	13.7	19.4	13.8	20.9	13.8	18.3	35.3	14.9	10.2	21.8	39.2	16.6	33.1	17.6	8.2	20.5	16.8	15.3	22.0	8.4	8.7	25.0	26.4	20.2	17.2	9.8	19.9	21.0	8.8	7.5	21.3	19.3	43.3	9.5	9.4	21.8	26.1	19.5	41.5	13.3	26.5	14.9	21.4	13.5	6.6	19.5	16.9	49.4	22.1	24.5	30.1	37.1	27.7	18.3	26.5	12.0
CXXC4	IDAX	ENSG00000168772	"CXXC finger protein 4"		4	104468308-104494901	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 16.1;retina: 7.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 48.0;Cone photoreceptor cells: 31.3;Enteroendocrine cells: 102.1;Horizontal cells: 45.4;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 30.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.0;AN3-CA: 9.7;Karpas-707: 9.0;RPMI-8226: 5.5;SCLC-21H: 12.0;U-266/70: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036600, HPA036925"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Nucleoplasm	"HPA036600: AB_10673659, HPA036925: "	"unprognostic (1.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.82e-1)"	"unprognostic (4.52e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.42e-3)"	0.6	1.3	4.9	0.1	3.9	0.0	1.4	3.0	16.1	0.7	0.2	1.3	1.8	0.4	1.7	0.1	2.3	0.3	1.9	4.3	10.1	0.4	0.8	0.6	0.0	5.0	6.1	1.8	3.0	0.7	4.4	0.3	4.5	0.5	0.8	7.3	2.9	0.4	0.3	0.2	1.9	0.4	4.4	0.4	1.3	1.6	11.9	0.5	2.4	0.1	0.0	0.2	0.3	4.8	0.0	0.2	7.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	9.0	0.0	0.0	2.7	0.0	2.5	0.1	0.1	0.0	0.0	5.5	0.0	0.1	12.0	2.2	0.0	0.6	0.0	2.8	0.3	0.0	0.0	0.0	1.5	0.0	0.1	9.7	2.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.9	3.0	16.1	4.3	10.1	5.0	6.1	4.5	4.4	11.9	4.8	12.4	0.0	6.4	10.4	0.1	0.3	1.0	0.8	1.2	48.0	8.4	5.6	15.9	2.8	2.2	0.0	31.3	0.2	0.8	0.4	0.0	0.1	0.3	13.0	0.9	2.9	102.1	0.0	23.8	3.3	0.0	1.0	0.0	0.6	0.0	1.2	1.1	2.7	0.1	45.4	27.5	6.2	0.0	0.3	0.3	0.9	0.3	0.1	1.8	0.0	0.0	13.8	1.0	64.3	30.8	1.5	1.2	10.9	0.3	0.6	10.2	1.1	12.6	26.7	0.0	15.6	0.9	0.0	4.8	0.1	0.0	0.3	0.5	0.1	2.6	0.5
CXXC5	"HSPC195, RINF, WID"	ENSG00000171604	"CXXC finger protein 5"	Q7LFL8	5	139647299-139683882	"Predicted intracellular proteins"	Transcription	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 317.0;Early spermatids: 714.2;Horizontal cells: 541.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 30.0;memory B-cell: 85.1;naive B-cell: 96.7;NK-cell: 71.9;plasmacytoid DC: 59.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 210.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036508, HPA058148"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA036508: AB_10673620, HPA058148: AB_2683621"	"unprognostic (3.08e-2)"	"unprognostic (9.03e-2)"	"prognostic favorable (2.40e-4)"	"prognostic unfavorable (4.10e-7)"	"unprognostic (2.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.57e-1)"	26.5	20.6	48.9	17.6	65.6	46.9	21.5	103.6	64.5	29.2	36.4	17.5	10.8	15.1	30.0	25.6	29.8	20.1	30.4	56.2	48.2	70.7	88.1	16.1	30.2	91.5	65.1	5.0	61.2	28.0	43.6	15.9	84.0	15.3	11.6	38.7	53.9	18.3	80.1	24.8	22.5	9.1	66.5	34.5	21.0	51.8	61.4	34.3	22.5	21.5	24.7	14.8	23.9	106.4	36.5	30.1	32.6	12.3	44.5	60.6	12.7	23.3	35.3	9.9	19.5	66.8	36.0	47.4	101.0	62.5	59.7	40.5	6.7	17.9	4.7	5.2	11.5	70.5	25.8	47.0	19.2	16.0	1.8	21.8	4.0	16.7	4.8	95.6	2.7	1.5	67.8	7.6	72.6	94.7	17.2	51.1	39.4	39.2	8.5	30.8	66.5	73.5	75.3	26.0	103.0	106.3	8.3	210.6	18.0	71.2	115.5	74.2	14.6	80.2	15.6	38.8	21.4	27.3	62.4	89.9	121.2	5.3	45.6	1.1	6.6	0.6	9.7	1.4	30.0	85.1	0.9	6.8	5.5	96.7	0.5	2.6	1.8	71.9	0.6	59.0	1.4	10.7	48.9	65.6	103.6	64.5	56.2	48.2	91.5	65.1	84.0	66.5	61.4	106.4	22.9	48.1	18.8	24.5	120.4	26.3	14.8	41.9	8.6	232.0	41.0	67.8	49.3	105.8	32.5	147.1	25.0	2.9	90.2	18.6	317.0	125.1	714.2	47.1	53.9	43.6	18.6	52.2	18.7	144.9	23.9	47.8	24.5	53.7	21.5	41.9	36.0	131.8	38.4	541.8	8.7	50.7	61.1	35.6	92.1	200.3	39.1	32.2	60.5	15.0	40.9	220.5	195.7	16.6	44.3	93.9	17.5	30.5	114.1	34.1	22.6	200.0	38.6	49.1	13.1	150.9	48.5	14.2	13.9	15.7	20.9	37.6	21.1	25.1	27.0	21.4
CYB5R2		ENSG00000166394	"Cytochrome b5 reductase 2"	Q6BCY4	11	7665100-7677222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 139.2;testis: 133.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 268.0;Late spermatids: 601.1;Spermatocytes: 115.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 6.1;memory B-cell: 10.6;naive B-cell: 2.8"	"Group enriched"	"Detected in many"	9	"B-cells: 10.6;granulocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.1;BJ hTERT+ SV40 Large T+: 65.9;BJ hTERT+ SV40 Large T+ RasG12V: 59.4;HBF TERT88: 52.0;NTERA-2: 69.8;WM-115: 96.3"	"Low region specificity"	"Detected in single"							"HPA038962, HPA061707"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA038962: AB_10675954, HPA061707: AB_2732668"	"unprognostic (1.47e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.41e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.01e-2)"	8.8	3.6	17.2	5.7	23.1	4.1	15.6	18.7	25.3	15.6	13.2	4.6	2.4	22.8	25.5	19.6	10.1	6.8	4.7	18.2	19.7	5.9	5.1	11.5	2.7	19.5	22.5	29.3	4.3	29.0	1.3	13.8	19.2	19.5	5.3	139.2	35.7	22.3	1.7	51.1	4.3	13.2	16.9	3.0	5.6	133.6	21.8	0.9	5.1	1.7	10.5	13.3	17.7	28.0	7.1	3.6	1.5	0.0	0.3	1.7	22.8	43.9	125.1	65.9	59.4	0.7	9.4	0.2	10.3	22.7	20.2	0.8	0.1	0.3	52.0	0.1	0.2	0.0	3.8	0.9	35.0	0.4	6.6	17.7	1.4	0.3	3.7	0.1	5.6	0.0	6.9	0.1	0.5	0.0	0.0	0.1	69.8	7.4	3.4	34.1	0.1	0.0	0.0	4.4	0.0	0.7	0.3	28.0	1.9	11.1	4.8	9.4	0.0	6.1	0.1	0.3	3.4	0.2	0.0	10.7	0.5	0.0	96.3	0.0	0.9	6.1	0.0	0.5	0.0	10.6	0.1	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	17.2	23.1	18.7	25.3	18.2	19.7	19.5	22.5	19.2	16.9	21.8	28.0	0.6	22.4	5.1	0.0	2.3	7.0	8.4	12.3	8.6	1.3	8.8	12.8	3.0	1.5	6.3	3.7	20.9	5.3	0.1	0.6	0.0	1.4	268.0	5.5	11.2	1.7	0.0	0.0	0.0	4.7	20.0	8.1	1.5	14.3	2.5	0.5	0.4	1.8	2.5	0.0	0.1	1.8	6.1	0.0	0.5	601.1	4.7	1.5	5.4	1.9	0.5	0.8	0.0	0.5	8.5	6.0	1.4	6.0	2.9	11.2	0.3	0.4	10.2	35.2	13.1	2.3	7.5	115.6	9.8	12.8	10.1	4.5	0.2	1.8	1.8	11.4
CYB5RL	LOC606495	ENSG00000215883	"Cytochrome b5 reductase like"	Q6IPT4	1	54169651-54200036	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042671, HPA060463"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA042671: AB_2678107, HPA060463: AB_2684286"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.90e-4)"	"unprognostic (6.45e-3)"	"unprognostic (9.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.86e-1)"	2.1	4.4	1.6	1.4	1.8	2.3	2.5	1.7	2.0	2.4	2.7	2.5	2.7	2.7	2.5	2.3	2.8	2.2	3.4	1.7	1.2	2.5	2.9	1.8	2.6	1.4	1.4	4.4	4.2	2.9	3.7	1.6	1.4	2.4	2.8	2.7	3.7	1.7	4.1	3.8	2.1	2.5	1.2	3.1	3.1	1.4	1.5	1.7	3.1	4.1	2.6	2.0	1.9	1.8	3.6	4.7	6.3	6.6	5.0	4.8	2.2	2.8	4.0	5.3	5.7	4.4	3.9	6.0	3.2	1.9	12.1	3.3	10.1	2.9	6.0	6.8	4.1	6.8	8.0	4.7	3.8	5.8	3.4	2.6	3.8	6.3	2.8	3.7	4.7	5.3	7.5	2.8	3.9	4.3	5.9	3.2	6.4	4.1	3.7	9.3	7.8	5.6	2.4	4.0	9.3	4.6	1.9	6.3	5.7	5.1	4.4	4.4	2.1	4.0	3.3	6.0	5.0	4.3	7.1	8.5	4.5	12.2	6.3	0.7	0.4	0.4	0.2	0.9	0.1	0.2	0.3	0.1	0.4	0.3	0.2	0.2	0.5	0.8	0.2	0.4	0.1	0.3	1.6	1.8	1.7	2.0	1.7	1.2	1.4	1.4	1.4	1.2	1.5	1.8	1.6	0.0	7.2	1.3	1.3	0.1	1.1	0.9	0.0	4.0	2.3	2.4	5.1	2.8	3.0	3.7	4.2	1.9	0.4	1.1	7.9	3.0	0.1	3.6	2.0	6.1	2.4	6.1	2.4	4.2	2.3	2.4	1.1	2.1	2.5	4.8	3.9	2.9	5.3	0.0	2.2	1.2	4.1	1.6	0.4	1.0	1.5	1.2	0.0	2.8	1.2	1.9	4.1	2.5	3.1	1.4	0.8	1.9	2.0	0.8	1.4	2.7	5.9	4.0	0.0	2.6	1.4	1.2	5.1	0.8	0.9	0.3	1.6	2.9	2.3	0.9
CYHR1	"CHRP, KIAA0496, MGC13010"	ENSG00000187954	"Cysteine and histidine rich 1"	Q6ZMK1	8	144449582-144465667	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053653, HPA059543"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA053653: AB_2682219, HPA059543: AB_2684056"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.58e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.54e-2)"	33.6	57.9	61.2	9.2	60.3	11.1	37.1	58.2	76.1	50.5	57.1	46.8	15.8	41.0	22.8	34.7	43.1	16.0	58.9	61.7	59.5	43.1	48.8	26.6	15.3	63.7	59.9	44.7	60.9	28.9	67.5	10.2	58.6	70.5	8.8	11.2	40.5	27.6	45.9	41.5	30.0	12.0	60.5	35.0	42.1	69.8	59.6	13.7	44.1	22.6	8.5	48.9	40.3	61.2	23.0	27.6	18.3	22.6	30.8	20.7	22.9	15.5	15.9	14.6	18.4	12.8	30.6	10.4	32.5	23.3	18.1	34.0	14.4	22.6	5.6	25.3	23.9	23.6	33.7	22.1	42.9	6.0	12.4	35.6	29.9	18.2	22.7	32.2	16.9	29.0	34.8	27.7	14.0	51.5	28.9	16.6	12.0	34.5	57.5	27.3	7.7	29.6	22.5	19.5	26.7	16.4	33.5	27.9	36.6	13.9	37.5	23.8	20.1	18.4	21.5	20.5	15.6	14.0	9.9	8.4	26.5	20.2	15.2	2.9	11.7	7.0	9.5	8.4	15.5	12.9	11.9	7.8	12.7	14.0	22.2	12.5	5.8	5.3	9.5	27.0	5.0	9.6	61.2	60.3	58.2	76.1	61.7	59.5	63.7	59.9	58.6	60.5	59.6	61.2	32.6	35.3	26.5	52.5	18.5	30.5	46.2	31.8	43.9	75.6	68.7	69.6	19.0	45.8	28.7	58.8	25.0	29.2	33.3	43.2	43.0	28.1	12.5	37.2	37.3	28.9	33.7	23.4	45.9	28.7	20.1	36.4	32.6	32.7	5.1	42.9	37.9	45.6	25.6	90.9	39.4	44.0	36.7	26.7	23.2	44.1	50.7	23.0	26.6	18.7	31.0	120.5	22.6	31.7	37.2	23.2	42.9	39.9	26.2	48.5	47.6	35.0	41.7	59.0	39.5	37.4	35.5	45.8	32.3	36.8	38.8	16.7	24.3	82.2	47.3	35.6
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 94.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 136.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	14.3	22.0	23.9	38.8	23.5	94.3	13.6	17.9	18.2	13.0	22.3	16.3	16.1	15.1	12.1	23.3	11.0	20.5	20.1	17.3	23.3	14.2	21.0	21.5	53.4	21.3	27.8	15.4	15.2	23.0	15.4	15.4	23.6	16.3	19.3	22.0	18.9	16.0	34.3	15.2	16.2	16.8	21.6	39.0	19.9	38.3	32.7	35.6	24.9	20.5	48.4	24.1	12.9	24.2	26.9	8.3	9.4	10.6	14.3	21.0	8.7	39.1	56.7	39.9	23.4	6.9	12.5	30.7	13.7	38.3	43.4	10.3	11.3	23.7	58.7	136.6	16.6	15.5	15.3	5.8	29.1	15.4	69.5	23.0	18.6	48.1	50.1	37.7	16.3	21.3	6.6	26.1	56.4	4.0	14.4	22.3	10.1	8.5	13.3	13.4	18.8	29.4	12.9	9.1	12.0	9.2	33.1	11.2	9.8	14.3	11.0	18.9	18.6	67.2	15.4	23.4	15.9	68.0	68.4	33.2	49.3	16.7	14.7	64.6	15.2	38.3	18.1	17.7	21.8	17.2	27.1	24.5	18.3	11.1	24.4	19.4	32.3	25.7	18.8	11.0	37.3	19.5	23.9	23.5	17.9	18.2	17.3	23.3	21.3	27.8	23.6	21.6	32.7	24.2	28.8	44.8	31.8	31.6	87.7	120.1	59.5	32.2	40.9	89.2	35.5	26.0	34.4	21.5	32.9	18.4	93.8	6.8	84.1	28.3	5.9	20.0	48.2	22.5	24.9	36.0	31.1	26.1	51.9	19.1	4.4	37.3	22.4	47.1	80.5	21.4	27.8	25.5	21.5	67.3	54.7	10.7	30.5	40.0	127.6	31.3	25.4	66.4	74.7	57.1	63.7	23.3	70.0	51.8	119.2	18.0	22.4	21.1	79.7	66.4	15.4	13.9	23.3	48.3	6.6	54.2	30.5	59.2	15.2	64.3	155.6	4.1	119.5	21.3	14.8	66.7
CYP20A1	CYP-M	ENSG00000119004	"Cytochrome P450 family 20 subfamily A member 1"	Q6UW02	2	203238977-203306026	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA055872, HPA058461"	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions, Actin filaments"	Nucleoplasm	"HPA055872: AB_2682951, HPA058461: AB_2683725"	"unprognostic (4.72e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.64e-3)"	"unprognostic (9.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-3)"	3.1	3.2	3.1	2.1	4.3	2.2	2.4	4.1	3.4	2.7	4.2	3.6	2.1	2.3	2.4	2.4	1.9	3.2	1.7	2.7	3.0	6.1	4.6	3.5	3.9	4.5	3.8	3.8	3.1	2.9	0.9	3.4	3.8	3.5	3.2	1.7	2.3	2.1	2.6	3.8	2.6	3.2	2.9	3.7	3.7	2.9	4.2	2.2	8.0	1.3	2.9	3.2	1.0	5.7	2.8	4.7	2.9	2.9	12.1	2.9	2.5	5.0	3.3	2.4	1.7	9.1	5.2	1.9	3.8	4.8	4.4	4.0	1.9	2.7	4.6	2.9	1.0	6.1	3.0	3.5	7.2	6.4	3.3	5.5	2.2	5.7	4.9	2.1	6.4	2.8	8.0	9.9	5.1	4.2	4.3	3.7	7.7	2.3	4.2	3.5	3.7	4.5	3.2	9.2	2.0	2.2	0.4	4.0	5.5	3.3	2.7	4.8	8.5	8.4	2.5	4.0	4.1	5.2	4.4	2.3	6.4	2.8	3.6	5.7	5.2	2.1	6.5	5.6	7.1	6.1	8.0	5.9	2.3	9.6	5.9	3.5	3.0	4.9	6.5	7.4	8.0	4.3	3.1	4.3	4.1	3.4	2.7	3.0	4.5	3.8	3.8	2.9	4.2	5.7	41.2	16.0	33.2	24.2	55.5	12.4	41.6	20.2	29.6	42.0	17.1	17.8	33.6	50.1	33.8	16.5	58.4	33.4	55.8	40.3	11.7	18.3	96.6	24.2	33.6	40.5	45.4	45.5	12.1	20.3	23.0	49.0	53.0	23.7	29.1	65.4	88.2	50.4	37.9	50.5	20.5	33.0	22.4	38.1	22.5	21.9	123.0	35.8	7.2	34.7	44.5	32.4	74.2	24.1	39.1	15.2	30.6	83.8	51.7	33.6	30.8	26.2	23.5	70.5	65.7	76.6	45.7	104.5	64.1	25.4	13.4	40.8	54.4	59.7	32.8	28.7
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153446-54173986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 14.9;kidney: 35.3;lymphoid tissue: 10.5;placenta: 10.0;urinary bladder: 28.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 18.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"A549: 411.5;Hep G2: 122.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA022261, HPA063771"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.0	0.0	0.2	0.4	0.4	0.0	3.7	0.0	0.3	1.7	0.0	0.0	0.1	14.9	0.2	3.8	0.2	0.0	0.0	0.1	1.8	35.3	0.4	0.7	0.2	0.4	2.0	0.0	0.0	0.0	0.2	10.0	0.3	2.9	0.0	0.0	0.3	2.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.2	1.3	0.0	10.5	28.7	1.3	0.2	0.5	411.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.6	0.0	3.2	0.0	0.9	15.8	0.0	0.1	0.1	0.0	0.0	0.0	6.5	122.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	7.0	1.3	0.0	2.6	0.6	0.0	0.1	0.1	0.0	0.0	0.0	16.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.1	1.8	0.4	2.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	1.3	22.8	48.3	142.7	74.0	0.0	11.0	8.6	0.4	0.0	47.0	0.0	0.0	0.1	0.1	0.1	5.9	0.1	0.0	0.7	0.5	0.3	0.0	0.0	0.2	0.0	0.1	2.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	9.8	0.0	61.3	13.1	0.0	0.0	0.0	0.6	0.0	0.0	3.3	19.6	0.1	0.1	0.0	0.2	36.7
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991282-41018398	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 533.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 420.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;OE19: 1.8"					"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.0	0.0	0.2	0.2	0.2	0.5	0.1	0.6	0.3	0.0	0.3	4.7	5.1	0.1	0.0	0.0	0.0	0.7	0.1	0.3	0.1	15.1	533.7	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	1.7	0.8	0.0	0.1	0.2	0.0	6.7	0.6	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.2	1.8	0.1	0.0	0.1	0.1	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.6	0.3	0.3	0.1	0.3	0.1	0.2	0.0	0.2	0.4	0.0	0.0	1.1	0.0	0.8	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.2	7.2	1.4	1.8	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	16.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.4	420.9	0.0	0.0	0.1	1.6	0.0	11.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.1	38.3	16.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	4.3	0.7
CYP2U1	"SPG49, SPG56"	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931549-107953461	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 84.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.2;Inhibitory neurons: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	7.7	6.4	6.6	4.0	8.3	0.5	4.5	7.6	7.3	5.1	10.1	5.8	3.4	6.6	3.6	3.5	7.8	5.6	7.7	6.5	8.7	5.3	5.9	5.7	6.3	9.0	7.9	9.5	2.3	10.7	4.7	2.4	8.2	9.9	3.9	5.8	3.4	8.7	3.6	2.7	4.7	10.2	8.1	7.6	3.2	3.0	8.0	84.9	3.6	7.2	4.7	4.7	3.8	9.5	4.0	1.9	5.2	9.5	28.6	13.4	0.8	16.8	25.3	10.2	15.7	0.1	2.5	10.8	1.1	10.1	7.8	0.2	8.1	6.4	15.4	3.0	2.5	2.3	3.5	0.5	11.3	3.2	0.0	15.3	5.3	4.7	3.2	20.8	4.0	12.0	0.1	5.0	8.4	2.9	11.8	0.0	5.4	0.4	4.7	6.5	6.3	0.1	3.3	6.7	10.0	7.6	4.2	7.3	18.6	4.3	3.6	1.5	10.6	6.5	0.8	9.3	6.9	21.1	21.2	3.4	5.5	0.0	7.4	0.0	0.1	0.3	0.4	0.5	0.3	0.8	0.3	0.4	0.9	1.1	0.7	0.5	0.0	0.7	2.8	1.1	0.0	0.2	6.6	8.3	7.6	7.3	6.5	8.7	9.0	7.9	8.2	8.1	8.0	9.5	5.5	3.2	3.9	18.6	12.9	1.1	4.6	2.2	15.4	4.1	2.8	5.8	6.2	1.5	2.4	9.2	4.2	0.4	10.1	1.4	0.0	0.9	13.2	6.9	6.3	5.8	3.0	1.7	30.2	2.0	0.3	12.6	3.1	6.2	4.5	2.5	8.6	7.3	2.3	1.7	34.3	1.2	0.0	6.2	3.3	9.5	17.7	4.7	19.6	5.6	3.7	9.5	1.0	20.1	12.1	0.4	0.1	17.7	4.2	1.5	9.9	3.0	8.6	3.1	0.0	20.0	8.1	1.0	4.2	2.0	1.4	0.3	3.6	5.1	3.1	0.8
CYRIA	"CYRI-A, DKFZP566A1524, FAM49A, FLJ11080"	ENSG00000197872	"CYFIP related Rac1 interactor A"	Q9H0Q0	2	16549459-16666331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 46.4;Extravillous trophoblasts: 102.6;Hofbauer cells: 37.1;Macrophages: 24.0;Syncytiotrophoblasts: 150.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 53.1;HUVEC TERT2: 43.1;RH-30: 95.6;SK-BR-3: 28.2;TIME: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017847, HPA060398"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB017847: , HPA060398: AB_2684275"	"unprognostic (3.45e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.78e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (4.46e-4)"	13.9	11.0	29.8	21.1	34.2	23.2	8.8	4.6	37.9	15.8	2.5	7.9	3.4	10.1	2.2	5.1	9.1	10.9	4.1	37.2	18.3	1.9	7.6	13.0	19.2	9.9	20.6	11.9	2.8	1.1	6.4	20.0	13.2	8.2	6.3	6.4	4.1	8.6	8.4	3.6	6.5	10.7	14.5	27.8	4.2	1.9	24.1	5.0	40.9	7.3	18.1	10.3	9.4	19.6	0.5	0.0	6.1	0.3	6.2	1.8	18.0	0.0	0.1	0.0	0.0	0.1	0.0	2.9	1.0	0.0	4.2	3.7	1.5	2.4	0.0	6.8	0.2	3.8	0.1	0.0	3.3	0.1	53.1	3.1	2.3	0.5	0.0	4.9	43.1	0.1	0.4	4.8	3.8	0.4	0.1	12.9	2.7	0.3	0.0	2.1	95.6	0.4	5.1	24.4	1.0	3.6	0.0	28.2	0.0	7.4	1.1	1.7	34.1	0.4	5.4	0.0	0.2	2.8	0.1	3.4	13.9	2.8	2.0	0.2	100.1	140.5	21.6	129.7	2.5	37.2	1.0	11.3	66.4	32.3	0.8	8.1	195.4	58.1	159.2	33.0	0.4	43.2	29.8	34.2	4.6	37.9	37.2	18.3	9.9	20.6	13.2	14.5	24.1	19.6	12.2	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	46.4	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	102.6	4.7	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	150.0	0.7	0.0	0.0	0.0
CYRIB	"BM-009, CYRI, CYRI-B, FAM49B"	ENSG00000153310	"CYFIP related Rac1 interactor B"	Q9NUQ9	8	129839593-130017129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 198.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 117.7;dendritic cells: 66.2;Extravillous trophoblasts: 158.5;Hofbauer cells: 239.7;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009076	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1100000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA009076: AB_1848402"	"unprognostic (4.35e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.80e-2)"	"unprognostic (9.61e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.09e-10)"	"unprognostic (3.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-1)"	41.3	26.3	24.8	97.4	37.9	198.6	25.9	29.9	46.1	13.5	23.1	31.1	30.3	15.9	21.1	29.4	15.3	30.7	18.4	28.3	32.2	22.9	26.5	39.0	119.7	35.9	33.1	11.4	15.9	17.8	17.6	42.0	34.9	14.8	35.8	28.5	18.2	13.1	25.8	19.0	42.3	28.8	35.7	83.6	28.6	29.9	33.6	79.2	28.5	24.3	105.1	50.6	14.1	49.9	167.5	87.7	93.6	52.9	8.2	12.1	124.2	49.4	47.8	67.2	71.4	50.9	111.8	165.5	105.9	32.6	53.3	81.2	78.2	130.6	100.3	349.1	54.5	166.4	44.6	57.7	31.9	109.2	137.1	19.3	60.1	45.3	93.9	54.9	60.2	132.0	121.2	186.3	74.5	74.5	372.0	80.3	79.8	130.4	119.7	160.1	63.3	278.3	138.4	67.4	62.1	81.2	99.2	61.9	152.5	84.1	72.4	139.0	37.5	24.7	158.5	52.8	106.8	61.5	195.7	275.1	38.8	233.5	65.3	350.7	212.5	404.4	161.6	256.2	124.7	122.7	91.2	134.0	280.9	98.7	80.1	132.3	553.9	189.6	232.8	179.8	136.7	306.0	24.8	37.9	29.9	46.1	28.3	32.2	35.9	33.1	34.9	35.7	33.6	49.9	8.4	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	117.7	66.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	158.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	239.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	60.5	8.4	0.0	0.0	0.0
CYTH1	"B2-1, cytohesin-1, D17S811E, PSCD1"	ENSG00000108669	"Cytohesin 1"	Q15438	17	78674048-78782297	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 98.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047498			Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Nucleoli	"HPA047498: "	"unprognostic (3.82e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (6.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	30.5	26.2	41.1	52.4	53.2	69.0	23.4	45.5	45.2	16.1	38.0	30.1	22.6	12.5	8.6	50.8	16.4	25.7	31.0	40.3	45.5	22.8	33.8	44.5	78.9	52.3	50.8	10.2	29.3	10.7	14.8	27.1	51.7	24.6	32.9	82.9	32.0	8.1	35.9	31.3	41.3	16.6	44.3	57.5	43.0	15.8	50.2	58.9	26.2	22.9	89.0	25.0	25.6	68.5	24.6	16.9	16.6	14.3	11.2	14.1	15.9	11.4	10.0	13.6	15.9	10.7	26.8	18.2	11.1	15.0	23.3	21.2	8.1	29.6	10.9	38.4	22.5	7.4	22.9	19.8	8.0	15.3	70.5	6.9	23.9	15.5	15.9	9.3	44.4	59.9	12.4	68.1	16.3	12.5	98.7	13.6	4.2	39.7	14.9	25.9	18.4	64.3	14.8	16.9	9.5	34.6	20.0	38.2	16.6	16.7	18.8	17.7	21.2	10.7	15.6	17.1	11.8	78.5	39.0	66.0	7.9	15.1	11.4	150.2	41.6	85.6	96.5	51.5	69.1	63.6	79.6	78.5	35.9	55.4	86.4	74.7	85.9	59.0	48.8	49.3	66.2	93.6	41.1	53.2	45.5	45.2	40.3	45.5	52.3	50.8	51.7	44.3	50.2	68.5	65.9	60.9	52.1	48.3	83.4	41.2	31.0	28.1	45.5	65.5	18.4	14.9	18.8	18.6	34.5	5.5	110.5	3.0	123.6	50.4	7.9	12.1	29.6	62.6	17.4	58.9	27.6	11.2	29.9	18.5	8.3	16.5	58.6	110.3	36.0	13.7	27.8	28.7	48.9	43.7	58.9	49.3	34.6	80.2	135.1	46.1	4.4	76.8	37.4	61.8	121.7	21.1	122.6	52.3	170.9	42.7	32.8	5.3	88.6	39.0	16.3	6.9	50.5	78.3	6.6	8.6	10.4	16.0	15.6	54.8	34.4	7.3	113.1	10.6	20.6	58.4
CYTH3	"ARNO3, cytohesin-3, GRP1, PSCD3"	ENSG00000008256	"Cytohesin 3"	O43739	7	6161776-6272644	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 66.5;Inhibitory neurons: 96.5;Microglial cells: 57.1"	"Cancer enriched"	"Detected in all"	5	"melanoma: 47.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013979	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA013979: AB_1855799"	"unprognostic (6.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (2.63e-5)"	28.8	9.5	16.9	5.4	17.7	7.7	26.5	16.3	20.9	16.4	11.8	18.3	16.5	17.5	6.6	14.0	15.6	11.8	28.5	18.5	15.3	14.2	4.1	19.7	5.4	14.4	15.5	13.9	7.5	11.5	9.8	31.7	15.4	10.2	6.9	5.7	11.9	8.6	15.2	21.6	16.7	12.1	14.2	10.9	13.9	18.6	16.6	5.8	27.7	19.7	4.7	13.8	15.9	17.5	64.7	16.1	15.0	10.4	68.4	80.0	21.2	37.4	32.3	36.1	34.2	25.0	31.3	8.7	22.1	75.5	46.4	59.5	10.4	27.1	23.8	0.6	14.8	2.4	19.8	3.2	32.4	2.7	4.0	57.0	12.1	19.3	27.6	16.2	6.4	12.6	10.3	1.4	26.7	10.6	2.2	11.5	10.4	8.6	21.5	11.5	40.0	5.0	28.0	7.7	9.6	18.4	23.2	79.7	67.0	12.7	4.8	18.1	23.3	24.6	64.4	26.9	23.2	2.9	1.1	9.1	7.9	6.9	102.8	0.3	0.2	0.0	0.9	0.0	2.5	0.1	0.4	1.0	0.1	0.2	0.0	0.6	0.1	1.5	0.2	0.8	0.3	0.2	16.9	17.7	16.3	20.9	18.5	15.3	14.4	15.5	15.4	14.2	16.6	17.5	40.1	16.0	5.8	14.7	3.1	15.2	2.1	1.8	4.0	6.5	9.2	7.5	17.4	2.8	3.2	3.7	8.4	15.4	8.7	9.7	5.9	4.1	14.1	9.4	10.2	14.6	3.0	2.1	66.5	2.8	9.1	24.0	8.2	15.9	12.7	15.8	18.5	1.4	11.9	15.2	96.5	5.5	4.1	4.1	10.9	16.7	16.4	5.9	32.0	57.1	1.9	10.8	3.1	23.1	10.8	10.0	5.4	13.2	4.4	3.9	14.6	1.4	3.7	2.0	39.5	6.1	39.2	24.3	11.2	7.0	11.4	15.2	10.2	10.9	7.1	2.1
CYTIP	"B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP"	ENSG00000115165	"Cytohesin 1 interacting protein"	O60759	2	157414619-157488961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 105.6;lymphoid tissue: 114.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 240.4;dendritic cells: 244.3;Langerhans cells: 552.9;Macrophages: 164.0;monocytes: 490.1;NK-cells: 181.3;Plasma cells: 392.5;T-cells: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 54.6;HDLM-2: 44.3;Karpas-707: 146.4;RPMI-8226: 46.9;U-266/70: 246.5;U-266/84: 99.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA007191	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA007191: AB_1855801"	"unprognostic (3.61e-3)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.12e-4)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.78e-2)"	9.2	2.7	1.4	70.0	1.7	105.6	7.7	1.5	3.7	5.7	4.0	12.8	27.3	3.2	2.1	6.9	3.4	11.8	4.1	1.4	1.9	5.2	12.3	26.1	91.5	3.1	1.8	1.5	3.4	0.9	1.4	4.4	2.6	3.3	14.6	0.5	14.3	3.9	1.1	2.8	23.1	7.0	2.5	42.2	41.6	2.5	2.3	53.6	4.0	2.2	114.3	20.8	3.7	3.2	0.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.4	54.6	0.1	0.6	0.0	0.1	0.0	0.0	0.1	44.3	0.0	0.3	0.0	0.0	0.0	7.8	6.4	0.0	0.0	0.2	0.0	4.0	0.0	0.2	0.0	146.4	0.7	0.0	0.0	6.3	0.3	0.8	0.1	0.0	0.1	46.9	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	2.0	0.2	246.5	99.8	24.1	2.4	6.8	0.0	248.9	37.6	109.9	121.8	122.5	122.5	91.5	127.9	115.7	56.1	91.6	205.5	161.0	203.6	90.2	247.9	28.1	136.5	154.8	1.4	1.7	1.5	3.7	1.4	1.9	3.1	1.8	2.6	2.5	2.3	3.2	3.2	3.2	12.2	0.0	240.4	20.9	1.0	0.0	0.6	0.0	24.4	2.5	2.1	5.7	1.3	1.8	0.0	0.7	244.3	0.6	15.6	0.3	1.4	0.3	0.4	4.5	1.8	14.9	0.1	1.9	13.6	6.4	29.0	0.8	7.0	0.0	6.8	1.7	25.2	0.0	0.1	3.7	0.0	86.1	552.9	2.0	0.0	164.0	83.6	12.2	490.1	0.0	181.3	0.0	0.0	0.3	0.3	0.0	392.5	0.7	0.4	1.1	0.0	0.1	0.0	1.5	4.5	0.0	0.6	1.2	17.8	3.0	366.6	0.0	3.8	0.5
CYYR1	C21orf95	ENSG00000166265	"Cysteine and tyrosine rich 1"	Q96J86	21	26466209-26573286	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 200.0;Endothelial cells: 150.0;Hepatic stellate cells: 79.9;Microglial cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	38	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 31.4"	"Cell line enhanced"	"Detected in some"		"AF22: 14.1;NTERA-2: 39.2;PC-3: 11.0;RH-30: 16.6;SCLC-21H: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034921, HPA067685"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB034921: AB_2089315, HPA067685: AB_2685887"	"unprognostic (5.64e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-3)"	"unprognostic (9.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	36.4	46.4	9.7	8.1	9.0	7.8	30.2	8.7	11.4	16.4	8.4	8.4	6.1	19.2	8.1	9.0	12.9	16.1	22.3	8.1	9.4	12.7	4.8	23.7	6.0	9.9	10.5	4.5	5.5	15.5	3.8	36.3	10.6	9.5	6.6	0.9	6.8	11.4	15.1	8.2	9.6	23.6	9.6	32.5	7.7	1.9	10.8	6.0	14.1	31.8	4.6	12.6	9.5	9.4	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.1	1.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	6.5	0.0	0.4	0.0	5.6	0.0	0.0	0.0	2.6	0.0	0.0	0.1	39.2	0.0	11.0	0.0	16.6	0.0	1.7	0.0	33.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	31.4	0.0	0.1	9.7	9.0	8.7	11.4	8.1	9.4	9.9	10.5	10.6	9.6	10.8	9.4	200.0	0.0	0.6	1.6	1.5	11.7	2.0	10.2	27.3	0.1	14.9	15.0	6.7	0.0	1.7	14.7	0.0	0.1	14.9	0.0	3.9	0.0	0.7	0.4	6.9	150.0	0.0	11.1	1.6	0.0	0.2	8.3	0.0	0.4	0.0	3.7	79.9	0.4	0.3	0.0	4.6	0.0	2.0	3.2	8.0	1.5	2.1	1.4	7.2	58.1	0.7	0.5	0.0	0.0	0.7	0.1	0.0	0.0	2.5	1.1	0.0	6.8	1.1	0.3	0.0	13.3	4.4	0.2	1.3	4.9	5.4	0.3	1.5	0.4	0.0	0.7
DAAM2	KIAA0381	ENSG00000146122	"Dishevelled associated activator of morphogenesis 2"	Q86T65	6	39792298-39904877	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 245.9"	"Group enriched"	"Detected in many"	5	"Astrocytes: 275.6;Oligodendrocytes: 449.8;Sertoli cells: 151.2"	"Group enriched"	"Detected in all"	5	"glioma: 15.0;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 54.9;JURKAT: 30.4;LHCN-M2: 55.8;SK-MEL-30: 68.7;WM-115: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051300, HPA054630"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA051300: AB_2681430, HPA054630: AB_2682549"	"unprognostic (7.53e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.93e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.54e-2)"	"unprognostic (7.94e-2)"	"unprognostic (8.54e-4)"	33.7	22.5	179.4	9.0	229.4	1.8	23.3	175.8	159.3	15.7	65.1	18.9	9.8	14.0	10.4	36.6	18.5	7.4	13.5	144.0	170.5	9.3	4.8	12.4	3.6	234.8	195.8	10.0	7.5	4.1	5.1	12.2	205.0	11.0	8.7	1.6	7.6	21.7	38.3	8.5	20.9	18.3	194.3	40.2	18.9	12.3	187.7	2.5	13.1	38.1	2.3	9.9	11.3	245.9	0.1	0.0	5.8	0.1	12.2	0.3	0.2	9.8	13.1	2.2	1.2	0.9	0.0	0.1	0.5	14.7	4.5	0.1	0.0	0.0	0.8	0.0	2.4	0.0	0.0	0.1	8.8	0.0	0.1	54.9	0.0	0.3	0.0	15.6	0.0	30.4	0.0	0.1	55.8	0.2	1.5	0.1	1.6	3.1	0.1	0.0	10.0	8.1	0.0	0.0	2.0	2.3	0.0	0.7	68.7	11.7	0.0	0.1	0.6	20.8	6.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	179.4	229.4	175.8	159.3	144.0	170.5	234.8	195.8	205.0	194.3	187.7	245.9	11.2	9.6	12.2	275.6	0.1	1.8	0.9	0.0	0.0	1.3	1.5	1.5	2.5	1.5	3.8	0.0	0.0	0.5	0.1	0.0	0.0	0.5	3.8	1.2	10.4	9.0	0.0	2.7	1.4	3.3	0.5	11.8	0.5	2.3	0.0	1.9	2.5	1.2	0.2	0.0	5.8	0.0	0.0	31.5	2.4	6.4	23.6	6.2	8.8	21.5	0.0	5.8	1.0	8.5	449.8	0.3	0.0	22.2	0.0	0.8	0.0	0.1	1.5	1.6	151.2	12.7	48.8	1.0	1.9	0.4	1.1	0.3	0.7	55.9	0.0	1.2
DACH1	DACH	ENSG00000276644	"Dachshund family transcription factor 1"	Q9UI36	13	71437966-71867204	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Excitatory neurons: 77.0;Horizontal cells: 87.5;Late spermatids: 103.7;Microglial cells: 143.4;Muller glia cells: 143.8;Spermatocytes: 58.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 4.2;eosinophil: 8.4;NK-cell: 4.2;plasmacytoid DC: 6.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 6.4;granulocytes: 8.4;NK-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"AF22: 14.2;HAP1: 22.5;HEK 293: 16.8;HL-60: 37.9;NB-4: 16.7;SCLC-21H: 36.9;SH-SY5Y: 29.5;THP-1: 26.9"	"Region enriched"	"Detected in all"	5	"basal ganglia: 38.8"	"Region enriched"	"Detected in all"	5	"basal ganglia: 34.2"	"HPA012672, HPA012938, HPA073222"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear speckles"		"HPA012672: AB_1847466, HPA012938: , HPA073222: "	"unprognostic (3.16e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.17e-2)"	4.4	11.1	2.3	1.2	14.0	6.0	4.0	1.6	2.9	9.7	0.3	3.1	5.2	3.8	1.3	0.9	2.8	7.2	2.2	1.0	4.6	8.9	2.0	5.9	0.5	7.0	9.3	0.5	1.9	6.6	3.5	6.9	5.9	7.0	3.3	16.7	2.0	2.3	1.9	1.8	6.7	2.0	2.6	5.4	1.9	6.3	4.3	3.5	0.2	1.2	0.4	2.0	2.7	2.4	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	22.5	0.0	0.0	0.0	16.8	0.2	0.0	0.0	0.4	37.9	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.9	16.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	36.9	29.5	0.0	0.0	0.0	0.1	0.9	26.9	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.2	4.2	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	4.2	0.0	6.4	0.0	0.1	2.3	14.0	1.6	2.9	1.0	4.6	7.0	9.3	5.9	2.6	4.3	2.4	36.4	0.0	0.6	15.7	0.5	1.7	3.6	0.0	0.0	15.4	19.4	9.3	2.1	1.5	0.0	7.3	4.2	0.0	12.5	0.9	5.9	1.0	88.5	5.0	4.7	34.2	34.1	2.5	77.0	0.0	0.0	4.6	1.1	3.2	5.1	0.3	2.9	0.0	0.2	87.5	28.2	21.4	0.0	1.2	1.2	103.7	3.4	2.5	0.0	143.4	1.1	143.8	0.0	6.6	3.9	0.6	0.3	1.9	0.0	5.8	3.5	6.9	0.7	6.9	13.1	1.5	4.3	58.8	10.2	0.2	1.3	0.0	1.0	1.3	12.6	2.7
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148451-86832604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.1;epididymis: 3.6;fallopian tube: 3.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 27.0;Granulosa cells: 14.3;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 71.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HAP1: 6.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.2	0.1	4.4	0.0	5.0	0.0	0.1	1.3	5.8	0.3	1.4	0.1	0.2	0.3	3.6	0.0	3.7	0.0	0.0	5.7	7.0	1.0	0.0	0.1	0.0	3.7	3.6	0.5	0.2	0.0	0.5	0.0	3.9	0.4	0.0	2.0	0.5	0.1	0.0	0.0	0.3	0.0	2.0	0.0	0.4	0.0	8.1	0.0	0.1	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	1.3	5.8	5.7	7.0	3.7	3.6	3.9	2.0	8.1	3.0	0.4	0.0	0.0	4.6	0.0	0.4	0.1	0.0	0.0	2.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.1	3.3	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	4.2	0.0	71.4	4.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
DACT1	"DAPPER, DAPPER1, FRODO, HDPR1, THYEX3"	ENSG00000165617	"Dishevelled binding antagonist of beta catenin 1"	Q9NYF0	14	58633967-58648321	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.0;Late spermatids: 17.9;Peritubular cells: 27.8;Smooth muscle cells: 15.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 13.5;SuSa: 17.2;U-138 MG: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003016, HPA074619"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA003016: AB_1078623, HPA074619: "	"unprognostic (2.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	8.6	7.9	5.2	4.1	4.2	1.5	6.5	17.4	3.3	12.0	0.6	6.3	5.9	7.6	5.8	2.9	5.9	24.9	8.0	3.6	2.5	5.5	2.7	9.3	4.1	1.6	3.2	24.4	2.3	8.0	3.8	12.1	2.0	11.8	6.7	2.0	3.5	13.1	2.4	2.7	3.9	8.9	2.0	7.2	6.9	9.8	2.4	3.6	10.7	4.4	2.3	14.0	6.6	3.4	0.0	0.0	4.0	0.1	4.5	5.0	0.1	2.3	2.9	2.4	2.1	0.3	0.2	0.0	0.1	6.9	4.0	3.6	11.5	0.0	1.3	2.7	2.4	0.0	0.1	0.0	8.2	0.0	1.3	5.9	0.3	9.0	0.0	9.0	0.1	0.8	0.0	0.0	1.6	0.0	0.9	0.1	3.8	0.2	0.9	4.9	5.6	0.0	0.0	0.0	0.1	0.0	6.5	0.0	13.5	17.2	0.0	0.4	0.0	31.7	10.8	0.5	8.5	4.4	1.8	0.0	3.4	1.4	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.2	4.2	17.4	3.3	3.6	2.5	1.6	3.2	2.0	2.0	2.4	3.4	1.1	0.0	0.0	0.3	1.0	0.8	1.2	0.0	1.2	0.4	0.3	1.5	3.9	7.2	0.0	1.8	0.0	0.2	0.2	0.3	0.0	1.7	56.0	0.4	9.3	1.4	0.0	0.0	2.7	2.3	0.8	11.7	2.0	0.3	0.0	2.3	4.2	0.0	1.2	0.0	4.0	1.0	0.0	2.9	2.1	17.9	12.2	0.6	1.8	6.5	0.0	4.5	0.0	1.5	0.8	3.1	0.0	27.8	0.6	0.4	0.0	1.0	0.0	0.5	0.0	2.9	15.7	12.6	8.6	0.3	1.3	0.1	0.5	3.6	0.5	0.4
DACT3	"DAPPER3, MGC15476, RRR1"	ENSG00000197380	"Dishevelled binding antagonist of beta catenin 3"	Q96B18	19	46647551-46661182	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.9;Oligodendrocytes: 27.2;Smooth muscle cells: 22.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 10.5;SH-SY5Y: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Nucleoplasm	"HPA043053: AB_10794769"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.30e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.59e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (6.66e-4)"	9.1	3.3	42.1	5.9	42.0	1.4	5.4	41.1	54.4	34.7	3.6	53.9	3.9	48.2	14.3	7.4	37.4	7.2	27.5	48.6	33.4	5.9	2.6	14.0	1.1	45.4	40.1	17.0	1.1	1.9	4.1	1.7	39.9	19.7	6.7	5.8	1.7	24.6	2.2	4.1	13.0	31.6	34.7	6.8	18.0	18.7	46.3	0.5	4.8	2.9	0.9	39.0	15.9	58.0	0.2	0.2	5.6	5.3	1.9	1.5	0.5	3.1	5.2	1.0	1.5	0.2	0.3	0.5	2.0	10.5	1.0	0.3	3.6	0.1	1.0	0.3	1.9	1.2	0.8	0.2	2.7	0.1	2.1	4.9	0.1	1.3	0.1	0.6	0.4	0.7	1.8	1.8	0.9	0.4	0.2	1.4	2.2	0.0	0.8	4.6	1.3	0.3	0.2	0.3	2.1	24.6	0.4	0.2	0.4	5.7	0.4	0.5	0.4	2.6	3.2	2.6	0.5	1.6	0.5	0.8	0.5	0.8	1.9	2.6	0.3	0.3	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.5	0.2	0.2	1.6	0.7	0.2	0.3	0.2	0.1	42.1	42.0	41.1	54.4	48.6	33.4	45.4	40.1	39.9	34.7	46.3	58.0	1.9	6.4	5.5	13.7	0.2	2.3	1.5	0.0	0.0	16.5	1.0	2.4	17.8	1.5	0.7	0.0	2.1	5.4	0.5	0.3	0.0	0.0	23.9	0.4	9.3	3.1	1.8	0.0	9.2	0.0	2.6	7.4	0.0	0.8	6.3	0.5	1.8	0.2	1.1	1.7	16.7	0.2	2.0	1.6	9.2	8.6	7.8	1.4	3.6	7.5	1.2	9.2	2.1	15.1	27.2	0.1	1.2	14.7	0.1	1.0	0.2	0.3	0.2	6.3	6.6	2.3	22.9	2.3	2.5	0.4	3.3	9.9	1.0	4.3	0.2	1.0
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 207.9;Skeletal myocytes: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 280.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	25.2	22.0	31.5	17.9	32.6	5.4	26.6	30.7	30.7	26.2	25.5	38.8	24.0	32.1	16.2	28.3	31.8	26.4	68.9	30.1	28.9	28.1	43.0	31.8	9.4	33.3	31.4	24.6	51.4	44.3	18.6	77.0	28.6	29.5	30.6	9.8	31.8	37.9	93.8	28.5	24.0	45.9	30.2	12.6	32.0	26.9	34.1	10.5	25.5	95.7	14.3	27.8	22.0	31.2	92.3	92.4	61.9	152.3	80.3	38.8	280.9	63.9	93.7	108.0	69.0	74.2	96.0	13.0	62.2	103.2	87.6	168.4	55.6	81.2	67.2	12.7	18.6	9.6	84.3	87.2	35.5	11.2	17.4	33.3	72.5	100.3	33.3	96.7	97.1	15.3	14.5	9.8	31.2	75.5	10.1	8.1	66.4	110.0	31.2	5.5	60.5	22.3	82.5	126.4	21.8	45.2	74.8	206.0	105.5	170.3	171.6	22.8	51.8	39.1	63.9	76.0	91.4	11.0	24.2	8.1	50.4	12.6	245.9	2.3	1.2	0.7	1.1	1.3	1.2	1.2	0.9	0.9	0.7	1.0	1.0	1.0	2.2	1.1	2.5	1.3	0.7	1.4	31.5	32.6	30.7	30.7	30.1	28.9	33.3	31.4	28.6	30.2	34.1	31.2	19.0	54.5	18.4	32.0	4.0	14.3	8.0	31.7	17.1	7.4	36.1	46.4	56.6	30.0	20.6	35.0	4.2	116.4	5.8	37.3	1.9	32.4	30.0	30.2	17.3	20.9	33.0	14.3	15.6	79.6	118.4	26.1	37.8	37.9	7.0	207.9	16.8	59.9	21.2	3.3	16.5	29.7	14.2	8.6	7.0	20.0	21.5	6.3	33.8	9.4	5.6	27.1	5.2	19.6	10.7	57.2	21.4	36.9	5.1	14.4	18.9	7.6	23.2	8.7	46.0	326.1	36.2	7.1	19.9	19.0	17.0	95.9	5.9	10.0	29.2	10.2
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	7.3	15.6	9.9	6.7	9.9	15.0	6.6	7.3	11.1	7.0	5.9	6.7	7.6	5.8	3.6	8.0	5.9	6.4	5.6	11.2	8.8	4.9	7.9	9.3	7.4	9.7	7.7	7.9	6.9	7.0	4.3	8.7	8.0	5.3	5.0	3.4	7.7	4.5	13.3	12.4	7.6	5.8	8.4	8.5	7.1	5.5	8.1	8.1	7.5	7.0	6.7	5.8	7.3	10.7	21.6	23.9	10.9	14.3	16.1	12.5	8.4	29.8	21.3	26.6	28.7	13.6	24.4	12.3	12.5	15.4	64.8	32.4	17.8	16.7	15.2	5.8	11.7	6.6	26.9	9.4	17.3	18.8	10.1	11.3	27.2	17.9	17.5	10.7	11.7	15.6	18.2	6.1	15.9	16.2	6.7	26.9	39.6	11.3	18.5	57.4	12.7	25.5	16.8	8.1	13.5	8.4	17.7	26.7	5.3	17.2	19.0	34.7	14.4	22.4	41.9	28.1	13.9	6.2	11.2	10.4	11.3	28.9	28.2	10.8	22.8	22.0	6.2	21.3	5.5	8.2	4.8	4.1	28.6	4.7	11.4	6.7	10.2	3.9	19.5	5.0	4.3	12.2	9.9	9.9	7.3	11.1	11.2	8.8	9.7	7.7	8.0	8.4	8.1	10.7	6.5	9.6	12.6	5.9	7.9	16.8	3.6	6.2	12.0	4.5	5.7	5.7	3.1	4.3	5.0	5.5	2.1	5.1	4.8	12.2	0.0	7.0	0.4	10.3	6.8	9.0	2.4	13.3	13.8	6.2	8.9	5.4	19.4	19.9	3.8	5.5	8.9	8.0	17.2	0.0	9.2	5.8	6.1	16.1	17.4	1.7	6.2	16.3	5.4	26.2	15.8	1.4	7.2	2.5	6.5	12.2	8.0	2.2	5.0	5.7	10.6	1.6	3.8	4.3	0.0	4.0	5.0	8.5	7.1	9.4	13.4	12.4	6.7	7.4	7.6	4.3
DALRD3	FLJ10496	ENSG00000178149	"DALR anticodon binding domain containing 3"	Q5D0E6	3	49015488-49022293	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 158.9;Late spermatids: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036862	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA036862: AB_10673507"	"unprognostic (2.76e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.56e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.33e-2)"	"unprognostic (9.52e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	11.8	18.5	11.2	6.0	10.9	5.4	14.2	10.6	12.4	14.1	14.5	10.1	7.8	9.8	13.1	18.3	36.9	10.5	10.0	10.8	10.8	21.4	9.0	9.9	9.1	11.5	12.6	15.2	38.7	13.9	14.4	9.6	10.9	10.2	7.9	6.5	11.6	9.5	11.0	18.8	9.6	6.9	12.0	10.8	14.7	51.0	11.2	9.4	19.2	6.9	12.3	10.7	11.5	10.8	12.0	16.6	10.2	20.0	28.5	37.8	12.4	9.9	27.5	16.5	15.8	11.7	14.9	4.9	13.7	27.3	14.3	7.8	13.4	26.1	11.5	7.0	9.1	5.3	13.9	22.0	18.7	15.0	10.5	25.7	26.6	20.9	46.1	42.0	26.0	11.2	4.3	12.0	16.4	20.8	6.6	10.1	16.8	25.3	15.5	3.5	1.5	35.7	44.4	19.0	6.5	21.1	10.9	30.1	23.7	16.8	21.3	16.2	15.9	6.4	9.7	22.6	9.2	37.8	21.9	3.0	24.2	8.3	12.9	12.0	11.1	5.5	13.9	13.7	25.0	23.9	22.4	17.1	11.7	21.1	18.7	12.5	10.9	22.6	12.8	8.1	29.5	12.8	11.2	10.9	10.6	12.4	10.8	10.8	11.5	12.6	10.9	12.0	11.2	10.8	26.8	16.0	12.2	8.5	27.3	25.6	21.6	28.5	22.8	30.2	35.5	40.5	1.2	27.1	20.8	27.6	18.8	28.2	30.0	25.0	37.2	40.7	158.9	61.2	21.5	16.3	19.1	11.1	10.7	39.4	40.0	19.8	28.5	24.6	24.7	32.4	15.0	5.9	19.2	40.4	9.5	22.3	20.3	12.9	24.5	306.6	24.2	16.8	21.4	2.8	23.5	25.8	13.4	6.6	5.5	21.5	21.3	18.4	18.2	10.0	50.4	49.9	75.3	58.4	46.0	19.1	19.0	110.7	33.4	26.5	34.1	18.3	27.1	29.7	30.0	17.3
DAP		ENSG00000112977	"Death associated protein"	P51397	5	10679230-10761234	"Predicted intracellular proteins"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 193.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA029456	Uncertain		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	"Vesicles, Mitochondria"	Nucleoplasm	"HPA029456: AB_10601262"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (4.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (2.04e-2)"	54.5	103.7	34.8	47.0	33.6	44.5	69.0	30.6	38.8	75.1	91.0	65.8	93.8	59.0	68.6	39.0	63.1	83.3	60.9	35.4	32.9	99.0	161.8	64.9	45.6	39.9	37.1	75.0	241.4	82.9	80.9	64.1	33.1	76.7	69.1	13.8	129.4	92.2	9.4	46.9	87.0	63.6	34.7	46.3	106.3	27.3	36.6	41.2	92.9	14.7	50.8	87.9	49.0	32.5	107.3	76.3	92.6	86.3	169.6	203.6	102.8	255.3	394.4	189.5	217.8	54.7	88.9	46.3	163.8	318.4	119.6	20.6	58.3	151.7	205.1	245.3	42.5	62.2	137.9	136.0	159.7	117.7	44.6	105.4	51.9	124.5	223.3	109.1	358.4	51.1	73.5	152.5	188.2	85.0	63.1	74.9	33.7	143.9	172.9	86.0	40.9	76.8	250.1	195.2	62.7	84.3	261.2	105.2	69.6	70.6	83.4	170.4	177.4	116.8	125.9	78.1	137.6	85.1	118.6	68.3	115.4	225.3	179.3	40.7	78.0	45.0	32.7	70.7	38.5	39.8	33.6	29.0	76.8	25.9	24.4	24.4	63.4	33.1	72.1	62.3	39.3	62.2	34.8	33.6	30.6	38.8	35.4	32.9	39.9	37.1	33.1	34.7	36.6	32.5	29.0	16.0	44.7	8.5	36.7	19.2	62.6	14.1	19.9	8.9	90.4	39.2	12.3	72.9	27.3	53.3	6.2	66.2	42.3	75.6	133.1	97.3	13.3	45.0	31.7	38.4	44.3	23.4	5.5	193.0	98.5	45.1	61.7	58.1	35.0	68.9	41.0	109.1	52.3	5.0	7.8	115.3	10.2	49.9	34.2	33.4	29.8	56.5	28.4	35.6	44.2	29.8	32.0	22.6	6.2	124.8	69.0	34.3	74.8	78.6	133.5	100.5	15.1	8.1	0.0	18.6	41.8	30.7	7.1	15.7	18.2	101.0	24.1	43.0	70.4	108.8
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	57.0	63.6	32.5	54.7	34.9	66.7	66.2	33.6	38.8	43.3	32.5	55.7	58.7	46.0	52.3	54.5	41.9	38.6	88.1	36.1	37.5	63.1	88.2	44.6	69.3	36.1	35.8	38.1	69.3	49.4	42.4	41.2	38.9	50.7	61.4	71.9	53.3	49.4	129.9	60.1	47.6	53.2	32.1	51.3	59.1	42.3	37.1	80.8	48.9	89.4	78.6	58.4	45.3	41.6	144.9	91.9	73.5	116.7	105.9	133.0	180.0	118.8	124.8	119.4	103.8	170.7	172.4	204.1	235.0	97.3	76.5	143.1	110.3	103.7	129.8	128.6	80.4	124.7	80.5	156.5	144.5	173.3	106.4	112.1	145.8	152.2	199.4	93.3	119.2	185.2	274.5	141.2	125.6	192.0	152.6	200.9	130.1	225.2	146.9	124.2	92.1	218.9	142.5	136.0	84.9	150.4	113.9	331.9	211.6	135.1	206.4	279.8	102.8	100.5	106.1	126.0	202.6	152.9	245.9	235.3	100.2	151.6	132.7	65.4	110.5	61.6	110.1	134.2	179.0	141.5	155.8	133.9	152.0	121.1	192.5	167.5	47.8	136.0	128.0	99.1	173.1	162.1	32.5	34.9	33.6	38.8	36.1	37.5	36.1	35.8	38.9	32.1	37.1	41.6	31.8	44.8	43.6	34.0	59.2	54.9	67.2	94.2	52.9	28.2	54.6	43.8	106.2	51.5	68.3	16.5	20.9	76.2	45.0	33.2	66.5	79.8	19.0	44.9	40.5	38.1	25.7	63.8	52.7	78.6	98.5	41.3	35.7	38.7	62.1	34.9	33.2	57.4	77.8	13.5	57.4	41.9	59.0	59.4	62.9	15.3	32.3	53.0	35.6	30.9	83.7	22.2	55.6	26.7	47.1	73.8	30.8	25.2	52.4	81.7	41.7	78.0	61.2	46.4	13.1	33.7	45.1	48.3	29.3	51.1	63.1	141.6	66.4	73.3	62.5	73.5
DAPK3	"ZIP, ZIPK"	ENSG00000167657	"Death associated protein kinase 3"	O43293	19	3958453-3971123	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Translation regulation"	"Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028569	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	Nucleoplasm	"HPA028569: AB_10794319"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.01e-5)"	"unprognostic (1.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.64e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.14e-1)"	49.9	25.4	15.0	29.0	15.2	18.9	47.2	14.3	27.9	58.3	18.9	92.2	30.9	85.0	8.2	37.0	55.4	36.0	106.2	16.8	13.9	27.6	30.4	72.5	21.2	16.2	15.4	48.4	36.4	19.0	38.5	31.9	18.8	53.3	11.0	9.0	41.3	39.3	113.6	51.2	44.4	36.6	11.9	29.6	61.4	42.6	17.4	15.4	31.0	21.1	11.3	59.5	45.3	17.3	79.2	61.1	37.5	47.6	27.5	30.9	57.8	106.0	84.5	84.7	55.5	113.4	23.3	43.4	50.8	93.8	59.6	61.7	36.9	60.3	30.7	64.0	61.2	17.5	76.7	65.9	87.2	42.7	63.1	70.6	73.6	77.0	44.0	50.8	71.2	29.2	56.3	73.2	52.5	51.0	42.4	31.9	58.5	31.8	48.6	52.5	55.3	40.5	51.0	60.9	59.1	41.1	71.4	84.9	61.1	43.8	61.4	33.1	134.8	108.3	49.3	98.1	134.5	81.1	72.4	50.7	86.3	44.0	59.0	32.5	18.0	32.5	23.0	20.3	16.7	15.9	17.8	21.6	16.2	16.6	13.1	12.9	29.8	24.3	14.3	18.6	23.6	14.6	15.0	15.2	14.3	27.9	16.8	13.9	16.2	15.4	18.8	11.9	17.4	17.3	24.1	25.6	10.5	6.5	17.0	100.7	99.7	84.1	27.9	15.2	23.9	15.6	29.2	24.3	35.0	11.0	2.1	50.5	14.5	69.2	17.6	90.3	40.3	27.9	28.2	38.3	27.4	7.0	9.6	88.2	79.1	27.8	40.8	37.5	20.3	24.8	21.4	7.9	22.9	11.8	7.1	48.2	48.8	13.6	22.8	23.6	22.7	16.6	37.4	8.4	25.7	12.8	30.9	6.0	6.7	117.7	49.9	22.6	13.3	46.1	59.6	14.3	18.8	10.7	32.9	19.9	53.0	34.6	15.7	24.4	71.7	93.2	15.1	26.2	29.7	46.3
DAPL1		ENSG00000163331	"Death associated protein like 1"	A0PJW8	2	158795317-158862781	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 196.9;esophagus: 242.0;skin 1: 301.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 212.9;Muller glia cells: 913.0;Squamous epithelial cells: 736.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.0;hTCEpi: 23.2;SCLC-21H: 5.9;U-87 MG: 8.4"									"HPA046937, HPA058635"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Microtubules"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies, Microtubules"		"HPA046937: AB_2679870, HPA058635: AB_2732625"	"unprognostic (3.95e-5)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.63e-2)"		"unprognostic (8.59e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-3)"	1.9	56.0	1.6	0.1	1.8	0.8	28.7	1.6	6.6	47.6	1.2	2.9	0.5	0.6	196.9	242.0	80.5	0.6	0.5	1.3	9.3	3.6	0.2	1.6	0.6	1.5	5.3	1.0	22.8	0.0	24.4	0.1	2.4	9.2	0.7	115.6	30.2	1.1	1.0	301.0	1.0	0.5	1.3	0.3	1.5	1.5	4.3	4.8	34.3	0.0	25.0	8.6	108.1	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.0	0.1	0.2	23.2	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.4	5.9	0.0	0.0	0.0	0.6	0.0	0.7	1.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.0	1.2	0.8	0.5	0.1	0.6	0.2	0.4	0.2	0.1	0.3	0.4	0.1	0.1	0.5	0.7	0.1	1.2	0.4	0.1	1.6	1.8	1.6	6.6	1.3	9.3	1.5	5.3	2.4	1.3	4.3	1.2	0.6	0.0	0.0	0.0	4.1	106.9	51.8	74.8	212.9	7.2	15.0	19.6	0.1	2.8	29.8	9.2	6.2	6.0	4.9	2.0	3.9	7.6	13.8	5.6	2.2	2.0	3.0	0.0	0.2	6.0	12.8	2.4	0.0	5.4	4.5	148.1	0.7	14.3	14.7	3.3	0.4	2.0	14.2	9.1	9.3	56.1	4.1	5.0	12.4	0.0	5.4	913.0	2.1	1.0	0.1	5.8	7.1	2.2	3.4	11.8	5.9	13.3	4.8	23.8	0.0	1.9	10.9	10.8	4.2	736.5	126.6	4.5	3.1	1.7	2.3	67.4
DARS2	"FLJ10514, mtAspRS"	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824653-173858808	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	8.8	9.8	3.1	7.6	3.5	5.4	7.5	3.7	4.3	7.1	11.5	14.6	8.7	4.3	4.7	6.4	5.2	4.8	8.4	3.1	3.8	19.9	13.5	5.7	9.2	3.3	3.6	4.4	5.7	15.5	2.9	7.6	3.4	5.3	15.4	5.2	5.2	5.0	5.6	3.4	10.4	5.6	3.5	6.2	9.3	6.2	3.9	10.6	7.6	13.5	12.0	6.7	4.1	3.7	74.8	50.5	26.3	18.7	24.0	34.2	38.6	32.3	30.0	49.2	37.0	47.5	68.2	41.6	45.2	27.2	31.3	77.5	86.6	56.5	66.7	48.6	41.5	35.2	22.7	31.8	24.0	30.9	30.8	23.2	25.3	50.9	44.5	15.4	49.8	30.5	74.7	31.0	39.6	19.9	38.8	16.1	60.2	83.0	63.2	44.3	40.6	78.2	43.7	24.9	40.4	34.2	36.3	79.6	51.3	47.0	84.5	39.7	21.2	22.9	35.3	32.6	52.5	21.7	60.4	46.3	13.3	33.3	51.5	3.9	4.4	3.3	3.8	7.0	5.4	6.0	3.4	3.2	6.4	4.4	3.8	2.6	0.2	3.5	5.0	2.5	3.9	3.5	3.1	3.5	3.7	4.3	3.1	3.8	3.3	3.6	3.4	3.5	3.9	3.7	3.7	3.2	3.1	7.2	5.7	1.8	4.1	3.1	6.2	2.3	3.3	2.5	12.6	4.3	4.2	5.5	0.0	9.7	3.1	4.8	7.9	3.9	2.5	3.9	4.9	4.5	4.2	9.4	5.3	2.7	16.0	3.9	7.1	4.5	5.7	4.5	1.8	5.4	10.3	3.3	6.5	5.2	0.0	4.4	2.2	1.5	3.1	5.1	1.8	8.4	5.6	2.9	3.1	4.0	5.1	3.8	1.9	1.5	7.1	2.6	5.9	7.1	3.0	2.7	0.0	6.2	4.0	8.9	7.1	8.0	1.6	4.2	4.4	9.2	7.2	2.9
DAW1	"FLJ25955, ODA16, WDR69"	ENSG00000123977	"Dynein assembly factor with WD repeats 1"	Q8N136	2	227871054-227924344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 25.7;fallopian tube: 32.6;testis: 51.3"	"Group enriched"	"Detected in some"	13	"Early spermatids: 106.7;Late spermatids: 215.3;Respiratory ciliated cells: 113.9;Spermatocytes: 177.1"	"Cancer enhanced"	"Detected in some"		"lung cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.8;HUVEC TERT2: 21.8;U-2197: 40.7"	"Low region specificity"	"Detected in many"							HPA046118	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Plasma membrane"	"HPA046118: AB_10961428"		"unprognostic (1.23e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.37e-1)"		"unprognostic (1.23e-1)"	"unprognostic (5.63e-3)"	"unprognostic (2.90e-2)"	"unprognostic (9.92e-3)"		"unprognostic (1.54e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-1)"	0.6	0.0	4.3	0.1	5.3	0.3	0.4	2.9	4.7	0.7	25.7	0.2	0.0	0.1	0.3	0.5	32.6	0.3	0.5	4.5	4.5	0.2	0.4	3.0	0.2	7.3	8.8	0.1	0.0	0.2	0.2	0.8	5.5	0.0	0.0	0.7	0.1	0.0	3.6	0.2	0.0	0.1	6.8	0.2	0.1	51.3	5.4	0.4	0.1	0.0	0.2	0.1	0.0	5.4	0.8	0.0	0.1	0.0	0.3	1.2	0.6	0.8	0.4	0.9	0.6	5.4	0.5	0.2	0.0	0.2	8.8	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	1.7	0.0	1.0	0.7	5.8	21.8	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.1	0.3	0.1	0.2	0.4	0.1	0.8	0.0	0.0	0.2	0.0	0.5	2.2	0.2	2.0	40.7	0.0	0.0	0.1	0.3	3.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.3	2.9	4.7	4.5	4.5	7.3	8.8	5.5	6.8	5.4	5.4	0.0	0.0	1.1	0.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.7	0.0	11.5	0.0	4.2	0.2	0.0	0.0	0.0	0.2	106.7	11.2	0.0	0.2	0.0	0.0	6.2	0.0	2.8	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	8.2	0.0	0.0	215.3	3.4	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.1	3.0	0.2	2.6	0.0	0.1	0.0	0.1	113.9	0.3	0.0	0.7	2.1	177.1	4.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0
DAXX	DAP6	ENSG00000204209	"Death domain associated protein"	Q9UER7	6	33318558-33323016	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002224, HPA008736, HPA008797, CAB025546, HPA065779"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear bodies"		"CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558"	"prognostic favorable (6.05e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (6.32e-7)"	"unprognostic (2.43e-1)"	"unprognostic (5.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	27.5	33.6	6.4	4.0	6.2	8.1	25.3	5.0	12.0	28.4	2.9	27.9	8.1	27.8	18.9	30.8	28.6	7.2	22.3	6.8	5.8	23.2	25.0	24.0	8.7	6.9	5.9	23.8	23.1	19.3	22.1	7.9	5.5	25.1	10.8	5.2	24.2	9.3	35.4	28.8	30.4	10.6	4.8	44.3	25.0	36.7	6.7	23.5	24.2	12.5	27.3	27.2	25.9	9.0	20.8	0.1	38.0	15.6	16.0	16.0	30.1	27.4	76.7	61.5	43.6	1.6	11.8	58.5	14.8	33.3	65.5	11.8	0.3	46.1	62.5	29.9	39.6	52.0	29.9	39.9	26.5	37.0	17.0	27.0	32.5	25.8	31.0	22.7	15.5	16.2	39.1	21.2	32.1	23.2	29.7	54.1	1.2	0.2	9.1	35.2	5.6	41.8	11.7	1.6	49.7	20.2	0.0	0.9	22.7	14.8	17.5	0.5	22.9	26.3	29.1	0.5	0.3	35.4	58.3	66.4	23.3	23.0	27.7	24.1	22.5	47.3	55.6	28.9	54.9	58.8	48.3	61.3	28.2	56.8	44.5	49.6	22.9	62.9	35.1	27.0	59.0	70.5	6.4	6.2	5.0	12.0	6.8	5.8	6.9	5.9	5.5	4.8	6.7	9.0	18.4	6.4	22.8	5.2	45.3	58.5	23.5	36.2	48.3	19.2	25.8	19.4	7.9	18.6	27.6	12.9	18.8	25.2	41.3	23.3	23.5	38.5	15.7	14.5	54.8	23.9	21.0	27.1	3.7	38.3	35.9	25.2	16.8	23.6	37.9	12.9	16.4	14.5	24.3	15.2	3.8	21.2	12.2	17.2	42.5	7.6	17.7	19.7	24.9	6.5	48.8	29.9	52.5	5.0	4.6	45.4	21.8	23.3	38.7	31.8	20.3	14.4	15.6	111.1	13.1	18.7	19.9	63.8	41.5	45.9	60.9	24.8	42.8	24.1	22.0	35.7
DAZAP1	MGC19907	ENSG00000071626	"DAZ associated protein 1"	Q96EP5	19	1407569-1435687	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004201, HPA004631"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		1600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA004201: AB_1078627, HPA004631: AB_1078626"	"unprognostic (1.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-3)"	44.2	34.7	20.5	55.9	21.4	69.3	37.2	22.8	23.5	31.9	23.1	45.1	45.3	33.5	10.5	64.7	32.1	13.3	55.0	19.7	20.7	40.6	51.2	37.0	49.8	23.6	21.2	32.3	48.0	20.3	22.6	22.2	22.3	33.0	23.6	20.1	32.4	17.1	65.2	42.3	46.9	19.5	18.2	49.3	39.0	77.5	25.2	47.7	32.1	21.4	34.4	42.2	36.7	27.0	275.7	98.0	64.3	117.9	27.8	33.5	183.9	120.7	59.6	95.7	78.2	98.0	132.3	320.8	72.1	58.7	47.4	151.2	84.9	114.5	80.7	225.9	135.2	165.4	95.2	101.3	64.3	203.1	136.1	33.7	73.8	65.4	119.0	41.1	85.0	133.7	251.5	164.1	60.6	111.9	357.5	178.3	198.7	99.6	97.1	254.3	102.4	199.3	72.9	91.7	127.3	114.2	79.9	124.0	149.3	83.1	113.1	266.8	93.7	79.0	107.5	139.7	267.9	192.9	212.2	256.0	95.6	194.4	123.8	1.5	2.3	1.9	2.7	3.4	2.9	3.1	2.4	2.9	2.2	2.1	2.4	2.6	1.0	3.0	2.4	2.7	2.7	1.3	20.5	21.4	22.8	23.5	19.7	20.7	23.6	21.2	22.3	18.2	25.2	27.0	57.1	9.6	27.6	29.7	50.3	69.3	90.9	37.6	34.1	55.7	46.9	33.3	40.0	38.6	28.8	25.8	35.5	43.5	68.7	60.0	23.5	44.4	49.8	26.3	37.0	45.0	33.0	96.6	17.1	55.1	108.6	39.7	46.9	34.0	26.6	58.0	36.0	41.6	47.7	26.9	16.8	71.6	28.5	49.2	54.9	65.7	28.0	50.3	40.9	16.9	36.0	35.1	34.0	18.6	45.2	63.5	49.4	23.7	73.6	110.3	50.4	48.2	23.5	45.4	26.3	50.5	58.9	111.6	41.0	67.0	74.9	69.0	53.0	41.8	81.5	107.9
DBF4	"ASK, chif, DBF4A, ZDBF1"	ENSG00000006634	"DBF4 zinc finger"	Q9UBU7	7	87876216-87909553	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 15.1"	"Group enriched"	"Detected in all"	4	"Early spermatids: 468.6;Spermatocytes: 569.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042923			Supported	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA042923: AB_2678222"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (6.42e-7)"	"unprognostic (1.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	0.1	0.2	0.2	0.2	0.4	0.6	0.2	0.7	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.3	0.2	15.1	0.2	0.6	0.3	0.0	0.5	0.1	0.1	0.3	0.9	0.8	2.0	2.5	0.4	0.4	0.5	1.0	0.2	1.0	2.1	1.4	0.6	2.1	0.6	0.6	1.7	0.9	2.2	0.5	1.0	1.6	1.3	1.3	1.0	0.4	0.1	1.7	1.0	0.4	0.6	1.2	1.0	0.3	0.9	1.9	1.2	4.2	1.4	1.7	2.8	2.0	2.0	2.1	1.9	0.7	3.1	2.5	0.8	0.1	3.0	1.8	1.2	2.2	1.0	1.6	0.9	1.6	0.1	1.2	1.4	3.1	2.0	2.3	5.2	2.1	0.8	3.1	2.5	1.0	0.1	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.4	0.1	0.2	0.4	0.7	0.4	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.3	13.3	3.2	12.6	5.5	38.4	15.6	16.4	10.7	12.0	6.6	13.0	16.8	3.7	2.8	7.7	9.2	12.5	19.6	59.2	9.7	3.9	8.3	468.6	12.1	23.6	11.1	14.9	40.8	14.7	14.7	36.4	12.4	14.3	17.7	31.0	19.4	6.4	6.5	16.1	3.3	9.1	20.6	16.2	9.1	15.5	116.0	15.5	20.8	12.4	2.8	11.0	2.1	24.7	6.0	6.7	14.1	8.5	9.4	48.9	18.4	4.2	5.8	10.2	16.6	13.1	9.7	11.4	569.4	74.6	20.5	12.6	9.6	44.4	13.5	22.3	11.7
DBF4B	"ASKL1, chifb, DRF1, FLJ13087, ZDBF1B"	ENSG00000161692	"DBF4 zinc finger B"	Q8NFT6	17	44708608-44752264	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Horizontal cells: 30.3;Oligodendrocytes: 30.9;Spermatocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA048465, HPA077959"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA048465: AB_2680405, HPA077959: "	"unprognostic (2.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.53e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.39e-1)"	0.9	0.7	1.1	1.2	1.1	2.0	1.3	1.2	1.8	1.5	0.5	1.9	0.6	1.9	3.5	1.4	1.8	0.7	0.8	1.1	1.0	1.6	0.6	0.8	1.5	1.1	1.0	1.7	0.9	0.8	1.7	0.9	1.1	2.3	1.2	2.9	1.1	1.3	0.6	2.0	1.5	1.5	0.8	1.6	1.3	5.1	1.2	1.9	2.7	0.4	1.3	1.6	1.3	1.2	3.7	7.7	5.7	4.2	0.5	1.1	4.9	3.9	1.7	8.1	7.9	3.3	3.1	5.5	2.1	1.3	7.2	3.6	5.0	1.7	9.3	9.2	8.2	7.0	6.2	4.3	0.2	4.8	5.9	0.5	0.6	4.4	1.4	1.8	4.1	9.3	8.9	5.6	4.4	4.0	7.1	2.9	2.5	7.7	4.0	6.2	6.6	2.3	1.8	2.2	3.1	3.4	3.8	1.2	2.9	6.1	3.9	3.1	1.8	2.8	5.2	3.6	7.2	2.6	3.5	7.2	2.1	4.1	4.3	0.0	0.1	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.1	1.1	1.1	1.2	1.8	1.1	1.0	1.1	1.0	1.1	0.8	1.2	1.2	2.1	0.0	1.1	15.0	4.0	0.6	2.6	1.2	1.2	30.0	1.5	1.3	1.1	0.0	2.1	5.5	12.5	4.2	5.8	0.6	0.0	0.3	8.1	2.0	2.2	2.8	4.2	5.5	11.4	0.8	1.4	2.3	1.5	1.1	3.8	9.6	3.3	0.3	1.4	30.3	11.0	0.3	0.0	1.3	3.1	7.4	1.2	2.5	5.4	5.6	1.4	7.2	2.1	7.5	30.9	0.2	0.2	3.0	3.4	2.0	0.7	0.5	1.9	15.7	0.0	4.5	2.0	35.7	16.5	1.9	0.1	1.4	1.4	5.3	1.1	2.3
DBNDD2	"C20orf35, HSMNP1"	ENSG00000244274	"Dysbindin domain containing 2"	Q9BQY9	20	45406057-45410610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1300.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 18.8;Gastric mucus-secreting cells: 20.4;Macrophages: 10.7;Smooth muscle cells: 23.6;Squamous epithelial cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"dendritic cells: 18.7;monocytes: 12.5;T-cells: 9.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043991	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA043991: AB_10966212"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.24e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.48e-1)"	71.5	29.7	627.6	33.6	916.1	7.1	59.4	827.6	1054.5	73.6	462.6	160.9	54.5	106.6	41.7	58.7	102.7	33.1	470.5	645.7	709.8	56.3	10.4	63.1	21.3	871.6	808.2	39.1	39.9	65.3	41.3	42.9	853.0	70.2	91.1	34.9	47.7	89.4	316.2	68.6	78.4	100.9	739.9	30.3	82.2	14.4	822.1	23.2	37.2	248.2	27.3	118.7	69.7	1300.9	78.0	13.6	10.8	76.3	6.8	3.0	15.0	44.7	48.4	36.7	24.8	37.2	103.4	1.1	7.7	44.4	13.9	112.1	74.7	4.0	22.4	0.6	43.9	64.5	57.0	34.3	43.1	3.5	94.0	1.2	12.6	13.9	12.8	63.5	25.3	64.8	4.7	1.5	2.9	99.0	5.6	4.9	14.0	50.8	80.0	0.3	1.0	0.7	105.3	1.4	24.8	12.7	15.6	8.4	99.3	7.6	104.0	19.9	41.1	1.5	72.5	48.8	49.5	1.1	1.6	0.3	5.3	0.6	10.9	0.0	10.4	0.0	9.1	12.5	3.3	0.2	8.0	6.8	7.6	0.3	7.4	6.9	0.5	0.8	7.2	18.7	7.4	4.5	627.6	916.1	827.6	1054.5	645.7	709.8	871.6	808.2	853.0	739.9	822.1	1300.9	0.3	3.2	0.5	0.0	3.3	0.0	0.2	0.1	18.8	0.0	0.6	0.3	1.0	0.0	2.5	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.3	0.4	0.2	2.7	0.0	2.1	0.0	0.0	0.0	7.3	20.4	0.4	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	10.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.5	0.0	3.9	0.4	0.9	0.0	5.3	0.0	0.0	0.6	23.6	0.1	0.0	32.7	0.6	0.0	5.3	0.1	0.4	0.3
DBR1		ENSG00000138231	"Debranching RNA lariats 1"	Q9UK59	3	138160988-138174921	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035365	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA035365: AB_10611956"	"unprognostic (1.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.33e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.79e-2)"	6.6	6.7	4.4	6.7	5.1	15.3	7.6	5.4	4.8	6.2	5.8	6.4	5.3	7.4	8.2	6.6	6.5	5.6	6.0	4.2	5.1	7.2	6.1	7.7	9.0	5.1	4.8	8.2	7.3	7.4	5.6	5.6	5.4	6.7	6.2	5.1	7.0	6.1	6.7	7.6	7.2	6.9	5.4	9.6	11.3	3.0	4.8	9.7	8.2	6.5	9.0	6.2	5.5	5.9	24.5	9.9	17.7	19.7	9.6	9.0	18.4	14.2	10.4	15.1	18.2	16.9	10.6	22.3	26.4	12.9	22.8	17.8	20.6	7.0	19.7	19.2	17.1	24.2	12.3	13.9	11.8	31.5	20.5	12.4	11.6	14.0	13.1	8.9	12.6	19.1	16.0	4.7	15.4	18.9	31.2	18.5	20.4	18.9	11.4	19.3	20.1	20.4	13.2	23.6	17.1	22.0	38.0	13.1	21.1	14.4	24.6	25.5	11.9	12.6	8.8	23.6	16.7	7.1	10.5	46.6	8.2	22.4	16.8	4.2	7.1	13.3	8.4	9.7	11.1	7.0	9.6	8.1	8.6	7.4	9.6	10.7	2.9	8.4	8.4	5.2	8.4	6.2	4.4	5.1	5.4	4.8	4.2	5.1	5.1	4.8	5.4	5.4	4.8	5.9	7.5	6.4	12.9	6.5	8.2	5.2	3.4	6.2	6.2	5.9	6.9	11.9	6.1	7.2	5.9	9.2	0.0	11.3	14.7	4.7	9.8	10.8	0.1	6.1	9.8	6.7	6.0	16.2	4.2	9.0	8.6	8.6	9.2	9.5	5.7	8.7	6.1	6.9	10.4	6.7	4.8	6.6	6.1	16.7	4.8	0.5	8.7	10.2	3.6	8.4	9.0	8.0	6.2	8.5	7.8	8.2	5.6	8.2	7.0	3.7	3.9	5.3	5.5	5.1	0.0	10.0	8.7	4.3	2.1	5.6	4.1	4.5	12.9	6.5	7.3	2.9
DBX2	FLJ16139	ENSG00000185610	"Developing brain homeobox 2"	Q6ZNG2	12	45014672-45051099	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"brain: 9.3"	"Group enriched"	"Detected in some"	9	"Astrocytes: 11.4;Oligodendrocyte precursor cells: 14.1;Spermatogonia: 5.1"	"Cancer enriched"	"Detected in single"	32	"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065045, HPA066053"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065045: , HPA066053: AB_2685605"	"unprognostic (1.13e-4)"			"unprognostic (9.99e-2)"	"unprognostic (7.82e-3)"	"unprognostic (5.24e-2)"				"unprognostic (5.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.22e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.19e-1)"		0.4	0.0	3.6	0.0	4.0	0.0	0.2	3.7	3.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	3.6	0.1	0.0	0.0	0.0	8.2	4.6	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	9.3	0.0	0.0	0.6	5.2	0.0	0.2	0.2	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.0	3.7	3.7	3.4	3.6	8.2	4.6	5.6	9.3	5.2	7.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 17.9;Granulosa cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	11.4	11.3	7.6	11.7	8.8	15.9	11.2	11.2	9.4	9.4	9.8	11.0	7.9	10.3	9.4	10.6	8.9	7.4	9.5	7.8	9.3	11.0	11.5	10.0	14.8	8.4	8.8	10.3	10.4	18.9	8.6	10.3	8.6	9.7	10.9	19.7	11.3	9.6	27.9	13.5	11.4	9.2	8.0	11.3	10.3	53.4	8.5	18.6	14.6	16.1	15.9	11.2	10.0	9.0	19.9	23.9	22.8	20.7	20.1	15.9	21.6	21.8	16.2	23.1	22.5	26.4	18.8	48.1	11.7	17.2	35.3	17.1	43.3	19.5	29.6	33.7	21.5	41.2	32.4	22.8	14.7	54.4	28.7	10.6	22.2	29.8	21.6	15.0	18.2	26.1	24.5	30.3	18.3	20.3	41.8	22.0	24.0	23.5	26.0	17.5	24.4	32.0	18.0	30.5	11.8	21.0	24.1	22.0	13.2	16.7	15.0	22.8	22.9	18.8	25.1	31.4	33.9	20.5	29.7	48.2	21.9	36.6	15.7	2.5	3.0	2.4	6.5	3.3	7.4	5.1	5.6	5.6	4.8	4.9	6.0	5.1	0.7	5.8	5.0	3.8	6.7	4.9	7.6	8.8	11.2	9.4	7.8	9.3	8.4	8.8	8.6	8.0	8.5	9.0	11.1	3.2	10.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	11.3	9.4	0.0	0.0	6.8	3.7	0.0	7.6	9.7	0.0	1.9	7.0	0.0	11.2	10.3	5.6	0.0	0.0	0.0	6.7	5.7	3.0	0.0	17.9	6.3	13.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.8	0.0	0.0	6.1	5.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	10.5	5.0	7.4	0.0	0.0
DCAF11	"GL014, PRO2389, WDR23"	ENSG00000100897	"DDB1 and CUL4 associated factor 11"	Q8TEB1	14	24114195-24125242	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 201.2;Hepatocytes: 156.0;Proximal enterocytes: 147.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003583, HPA031157"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA003583: AB_2667001, HPA031157: AB_10603002"	"unprognostic (1.50e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.23e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-1)"	"prognostic favorable (3.50e-13)"	"unprognostic (2.58e-1)"	"unprognostic (3.48e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.68e-1)"	15.4	41.6	21.5	13.4	21.7	39.5	17.1	19.7	23.0	15.4	19.9	24.5	29.3	17.1	23.2	29.8	15.6	13.6	38.1	22.3	19.9	35.8	107.2	17.5	15.6	21.0	20.3	23.1	59.7	28.2	25.6	9.2	19.8	23.6	16.6	17.6	25.9	17.5	62.3	20.1	37.5	11.7	19.2	28.9	34.3	16.5	22.0	19.0	26.4	50.0	16.1	20.3	16.2	21.1	12.5	18.3	12.3	10.9	10.7	8.8	16.6	9.1	10.7	16.0	19.5	12.0	21.3	19.4	10.3	12.2	13.3	16.1	15.8	9.6	7.4	23.1	9.5	15.6	19.7	67.3	14.3	27.7	31.0	5.3	23.1	6.7	16.7	13.1	12.3	31.6	15.0	23.0	9.7	39.2	23.7	28.5	7.2	35.0	17.0	25.1	16.0	28.2	12.2	28.1	22.1	17.0	5.3	29.9	13.4	12.7	15.4	19.6	5.1	12.5	10.0	13.6	13.2	38.6	36.2	25.3	6.0	17.7	10.9	14.0	13.8	20.5	13.8	15.8	11.7	12.1	12.5	13.5	17.1	11.5	12.2	11.4	11.7	23.0	13.9	8.6	16.7	15.2	21.5	21.7	19.7	23.0	22.3	19.9	21.0	20.3	19.8	19.2	22.0	21.1	18.2	28.9	45.4	10.4	30.5	8.8	22.2	18.7	31.3	34.1	34.8	20.7	41.2	44.3	23.9	38.6	47.9	34.6	34.2	76.1	46.9	41.6	19.3	22.0	10.8	15.2	28.9	201.2	9.2	46.2	31.5	14.1	29.0	22.5	12.6	26.5	22.1	156.0	37.4	16.8	6.9	40.7	20.3	27.0	12.8	26.6	9.0	24.1	17.8	9.4	39.2	38.8	55.6	7.1	9.7	31.9	34.6	14.7	26.6	25.0	147.9	56.0	22.3	29.4	26.3	15.9	14.5	23.7	12.4	32.6	11.4	50.5	31.2	60.7	49.0	22.7
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: AB_2678963"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavorable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	16.7	19.2	10.3	22.9	11.0	15.2	23.9	11.3	15.6	17.7	12.8	20.7	16.1	16.2	19.1	21.3	18.0	12.7	16.2	10.9	11.1	32.4	20.7	12.9	24.7	10.8	13.7	13.6	18.5	20.0	15.6	18.7	11.4	14.7	21.4	13.8	14.3	12.8	18.8	15.7	14.5	18.2	11.3	14.3	15.6	32.2	10.4	24.7	18.1	16.0	30.5	33.6	14.6	11.9	96.5	84.2	76.9	79.0	54.7	62.7	57.6	70.1	53.2	64.4	65.9	83.1	90.9	132.2	116.1	73.3	64.0	69.9	105.8	89.0	124.1	127.7	74.9	183.0	48.0	95.9	62.2	76.1	75.7	51.8	59.9	95.9	157.5	40.3	91.4	89.6	125.3	56.7	99.9	78.0	144.9	79.3	118.0	268.9	129.6	92.6	93.3	136.4	95.3	78.6	97.6	92.3	43.5	67.3	83.1	67.4	103.9	51.2	60.6	65.3	105.3	85.5	94.7	61.7	116.5	188.0	88.0	162.8	85.7	19.6	37.6	22.1	35.5	46.5	48.8	60.8	37.5	38.2	54.4	50.8	37.0	38.2	4.2	52.8	35.2	28.3	58.0	44.9	10.3	11.0	11.3	15.6	10.9	11.1	10.8	13.7	11.4	11.3	10.4	11.9	40.0	16.0	17.0	9.1	39.7	79.5	76.6	92.4	38.1	19.6	21.6	24.9	20.8	12.8	53.8	33.1	25.0	57.9	34.8	11.0	39.2	55.0	54.6	26.9	35.4	39.9	14.5	22.1	9.5	48.4	75.0	37.4	17.9	24.7	40.6	49.3	17.5	16.9	42.7	16.8	9.0	17.5	69.2	14.8	23.9	16.7	24.2	22.9	26.6	11.2	28.5	28.8	27.8	16.1	20.0	43.6	12.3	17.7	30.3	51.1	24.3	79.1	36.0	23.7	13.1	50.2	48.0	102.0	86.3	37.1	77.0	33.9	33.1	41.7	28.1	56.9
DCAF17	"C2orf37, FLJ13096"	ENSG00000115827	"DDB1 and CUL4 associated factor 17"	Q5H9S7	2	171434217-171485052	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Deafness, Diabetes mellitus, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053339, HPA055040"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053339: AB_2682119, HPA055040: AB_2682680"	"unprognostic (1.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (2.79e-2)"	3.9	4.5	5.2	5.4	6.6	3.4	6.4	6.6	6.1	6.1	4.3	5.6	4.5	6.2	6.3	4.4	4.6	3.8	3.5	5.1	5.7	5.6	4.5	3.8	7.2	5.5	5.2	7.1	5.0	6.0	3.8	5.3	5.8	5.0	4.6	13.9	4.3	4.5	3.9	7.2	4.7	4.6	5.5	6.4	4.4	5.7	6.9	7.8	10.2	4.3	6.0	5.6	5.4	10.6	8.5	6.9	8.9	10.6	11.0	11.7	13.6	7.3	7.5	7.3	6.8	8.3	5.5	24.4	5.4	9.1	5.5	8.2	9.1	9.0	9.9	11.4	6.2	11.3	6.2	15.0	11.2	16.2	7.9	9.2	11.6	9.3	20.7	8.6	8.0	7.6	17.9	8.2	10.1	5.2	17.9	14.9	13.2	6.2	4.3	13.4	11.7	13.4	6.2	7.6	7.8	11.3	6.9	5.8	7.4	8.3	4.5	8.3	9.6	8.4	7.6	4.8	6.4	12.4	18.3	20.5	8.9	8.2	8.8	1.1	1.3	0.5	2.3	1.5	3.4	1.3	1.8	1.7	1.0	1.8	2.0	2.5	0.0	1.1	1.3	0.8	1.8	1.6	5.2	6.6	6.6	6.1	5.1	5.7	5.5	5.2	5.8	5.5	6.9	10.6	5.8	0.0	7.5	17.9	8.9	4.7	4.7	4.2	8.6	10.1	7.8	6.0	5.0	7.2	3.1	7.3	12.5	6.5	6.0	4.4	9.8	4.8	2.2	6.2	10.7	5.2	10.2	6.9	18.0	3.9	5.7	5.8	8.2	4.9	3.8	8.2	2.5	7.7	5.6	8.4	23.5	4.5	6.1	8.4	4.6	3.6	6.2	5.0	3.6	15.0	4.4	8.8	5.2	24.6	56.5	6.6	2.0	6.0	6.4	6.3	5.5	6.2	6.1	15.2	0.0	6.7	7.2	13.5	17.1	8.7	5.1	5.6	7.5	9.0	4.3	5.0
DCAF4	"DKFZp434K114, WDR21, WDR21A"	ENSG00000119599	"DDB1 and CUL4 associated factor 4"	Q8WV16	14	72926377-72959703	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047276	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA047276: AB_10959615"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.96e-3)"	"unprognostic (2.11e-2)"	6.8	7.9	5.9	4.8	6.0	4.9	7.1	5.2	6.6	7.8	4.6	7.9	4.1	7.0	5.3	7.6	5.6	3.7	5.5	6.5	6.6	9.1	7.4	4.5	6.5	7.4	6.2	9.1	12.5	5.5	3.7	9.3	7.6	6.9	6.5	2.6	6.8	5.2	12.8	12.8	6.9	6.0	5.2	6.7	8.0	7.0	6.1	3.9	11.4	5.1	7.4	8.1	7.5	6.6	20.7	9.4	2.3	10.8	9.9	12.5	19.0	11.6	11.6	14.9	17.4	11.3	8.9	26.0	8.5	21.9	13.6	15.6	16.0	18.2	25.5	13.2	8.9	10.8	4.4	15.1	13.9	7.4	17.8	21.9	17.4	15.5	29.1	10.0	5.2	25.1	16.2	16.1	12.1	35.3	12.7	18.4	6.3	20.2	20.3	8.9	12.2	15.2	22.5	12.3	12.5	4.9	7.0	37.4	14.1	10.4	12.5	9.9	7.8	8.0	18.5	22.6	5.7	22.8	23.5	17.7	11.0	6.1	4.9	0.4	1.6	0.3	4.1	2.5	6.1	11.6	5.0	4.6	3.3	8.7	5.7	6.0	0.9	9.1	5.4	2.5	7.2	3.0	5.9	6.0	5.2	6.6	6.5	6.6	7.4	6.2	7.6	5.2	6.1	6.6	2.9	6.4	5.3	3.3	10.8	6.1	7.3	5.8	8.0	3.4	5.8	5.1	4.0	2.8	8.3	3.7	4.2	20.9	4.4	4.3	3.9	6.7	3.8	4.3	6.6	4.4	4.2	4.2	5.7	5.6	15.3	4.9	12.8	7.5	0.0	10.9	1.1	4.7	5.8	0.0	4.7	4.3	6.1	2.2	4.2	2.6	3.7	1.9	1.8	3.7	4.1	2.1	4.1	3.5	5.8	4.4	7.0	5.7	4.7	4.0	2.9	6.6	2.6	3.5	0.0	4.4	4.0	7.5	18.6	6.4	6.7	5.6	5.3	11.8	7.1	3.3
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 641.3;tongue: 470.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 438.6;Excitatory neurons: 243.8;Late spermatids: 700.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Focal adhesion sites"		"HPA054305: AB_2682444"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	29.1	45.9	12.8	16.2	17.5	24.6	29.3	9.3	22.4	32.9	22.1	36.8	21.7	24.7	19.5	29.7	25.6	27.5	129.9	20.5	7.0	28.6	95.1	25.4	17.7	5.6	8.8	25.3	20.9	34.5	19.9	27.3	5.8	35.4	29.3	21.3	28.8	25.3	641.3	21.9	21.5	33.8	5.7	18.5	28.2	82.6	12.3	24.4	23.5	470.8	21.4	28.1	20.1	14.0	64.8	30.0	16.4	27.0	52.7	74.3	57.4	64.9	95.3	44.5	65.7	50.4	53.1	52.8	36.9	83.3	21.4	47.4	25.8	47.9	62.4	30.2	27.6	56.5	42.8	36.4	42.4	25.7	26.1	53.2	47.4	42.3	35.0	67.4	49.1	16.9	64.8	42.9	66.3	14.8	28.9	23.3	10.6	36.0	33.1	21.9	34.0	41.7	110.6	30.9	24.2	19.2	51.8	47.0	36.6	33.9	80.8	31.3	70.3	44.6	27.5	44.0	27.3	45.4	39.3	41.3	59.9	21.6	18.6	5.4	5.5	10.4	4.9	7.5	5.2	4.8	3.9	4.3	6.0	3.3	3.5	4.6	5.7	3.7	12.0	3.6	4.8	4.0	12.8	17.5	9.3	22.4	20.5	7.0	5.6	8.8	5.8	5.7	12.3	14.0	22.9	57.7	43.3	81.3	22.5	57.9	30.5	32.1	33.0	14.7	26.7	19.3	216.3	48.6	43.4	25.8	22.9	75.7	19.7	28.1	17.6	33.0	438.6	39.3	24.1	25.3	21.1	111.9	243.8	19.3	32.4	42.7	39.3	35.5	19.6	73.0	23.6	95.4	19.6	5.0	90.0	27.9	26.4	44.0	38.3	700.1	57.5	23.6	37.4	70.3	113.0	15.9	18.6	108.6	71.0	21.2	26.7	48.5	31.1	35.6	35.7	34.9	52.3	18.4	32.9	29.1	30.6	108.3	64.1	34.6	39.8	81.3	22.2	81.5	33.0	29.0
DCAF7	"HAN11, SWAN-1, WDR68"	ENSG00000136485	"DDB1 and CUL4 associated factor 7"	P61962	17	63550477-63594279	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022948, HPA022962"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA022948: AB_1858820, HPA022962: AB_1858821"	"unprognostic (7.75e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.18e-2)"	12.4	13.6	23.3	22.6	23.1	9.0	15.5	20.1	21.0	19.8	17.8	23.9	25.9	16.7	18.8	17.5	19.3	16.7	18.1	22.2	23.0	26.5	14.3	21.6	29.1	22.7	22.7	16.5	18.4	37.4	12.4	26.7	22.8	21.9	25.7	29.9	18.1	23.3	13.3	14.0	25.0	18.9	24.9	25.4	20.8	14.8	23.6	37.2	22.1	15.3	32.4	22.3	12.8	23.2	33.2	46.4	79.6	51.0	26.9	22.2	20.9	32.6	28.7	35.3	29.7	34.2	35.2	61.2	25.7	32.7	36.9	34.7	67.0	45.8	45.0	23.7	42.7	79.9	29.3	40.3	27.7	89.7	44.4	18.6	29.7	20.6	46.8	42.5	55.8	50.9	85.7	27.8	45.3	40.9	97.7	43.0	25.9	57.5	61.7	77.1	94.5	34.9	51.4	49.7	76.4	141.0	29.4	56.2	38.9	70.0	41.5	72.1	59.3	58.0	26.4	29.6	54.4	28.9	39.6	32.2	33.0	57.1	35.2	10.9	11.3	12.6	11.2	13.1	9.0	8.1	7.7	8.7	10.6	8.3	6.9	7.5	4.7	8.9	16.2	7.8	5.9	8.6	23.3	23.1	20.1	21.0	22.2	23.0	22.7	22.7	22.8	24.9	23.6	23.2	28.5	44.8	45.9	30.3	57.4	31.4	30.5	49.8	46.7	55.4	29.3	25.1	30.8	38.6	38.1	68.0	77.2	51.7	49.0	47.2	23.5	50.1	95.5	30.5	38.0	43.1	72.0	62.6	42.3	45.2	47.7	33.8	31.1	30.1	60.2	67.1	48.9	40.2	55.4	65.6	41.1	49.0	52.9	64.3	45.2	27.6	35.1	61.9	26.6	43.1	72.9	53.1	69.0	36.2	40.5	55.0	41.2	38.0	45.0	45.3	67.7	52.0	43.7	54.0	59.2	23.2	35.8	96.5	35.0	51.6	34.8	21.6	53.1	49.8	57.2	47.6
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262549	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	63.3	62.6	35.3	47.0	43.3	54.6	60.6	47.7	52.8	55.8	47.1	72.0	56.6	60.4	76.2	50.2	58.9	53.5	85.1	33.7	41.8	55.8	103.4	50.9	60.5	39.2	37.3	62.2	80.2	85.7	66.3	45.1	37.0	53.6	40.6	106.7	60.6	53.2	219.7	67.2	61.8	44.0	32.6	65.6	67.3	40.7	41.1	67.5	77.9	118.3	51.1	61.1	49.8	53.0	54.2	62.5	72.0	64.8	86.3	65.5	63.7	62.7	81.8	49.5	42.2	69.8	89.6	56.3	112.1	67.2	34.6	64.8	34.6	57.4	31.0	134.9	69.0	63.4	99.7	54.1	69.3	52.9	80.3	74.6	58.9	44.2	60.8	55.3	73.5	73.1	60.6	98.4	46.0	50.0	71.7	54.5	52.7	70.1	62.6	69.2	41.8	115.5	57.7	87.6	49.0	47.3	101.8	113.1	68.2	68.9	104.9	82.0	95.1	60.7	31.5	38.6	58.7	169.8	124.9	94.3	68.7	49.6	51.2	32.9	21.5	22.0	31.5	19.7	29.6	28.5	27.0	29.2	17.5	30.4	29.4	27.0	24.9	30.4	28.4	22.0	30.4	19.2	35.3	43.3	47.7	52.8	33.7	41.8	39.2	37.3	37.0	32.6	41.1	53.0	21.4	57.7	54.9	57.5	35.4	18.4	16.3	17.3	38.7	44.6	27.5	21.8	54.2	30.0	30.5	25.8	64.6	30.9	26.4	20.4	62.6	23.9	3.6	26.6	18.9	26.4	25.1	48.4	53.7	21.6	21.0	28.9	35.2	21.4	34.1	21.2	21.4	77.6	23.8	40.4	49.5	19.2	20.3	29.8	18.9	4.3	28.0	24.2	14.2	39.4	27.6	38.1	18.6	58.8	93.1	19.2	13.6	32.7	45.3	16.3	29.0	38.1	40.5	60.5	13.1	29.5	26.6	28.0	20.4	35.1	24.2	44.3	36.5	25.6	18.8	12.5
DCAKD	FLJ22955	ENSG00000172992	"Dephospho-CoA kinase domain containing"	Q8WVC6	17	45023340-45061109	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060997			Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA060997: AB_2797262"	"unprognostic (1.32e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.71e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.13e-1)"	"unprognostic (8.24e-3)"	"unprognostic (7.57e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.82e-2)"	18.7	36.0	50.4	9.7	54.0	6.4	21.9	54.0	47.1	24.2	47.2	20.7	8.8	21.5	20.5	24.4	24.9	12.2	27.4	45.8	63.2	20.7	23.4	13.2	11.1	64.3	61.1	26.8	15.0	24.0	37.3	10.5	55.2	27.4	9.0	15.8	35.2	18.8	13.1	25.3	14.5	12.6	62.0	13.8	15.1	17.3	62.5	17.4	25.1	9.4	10.5	26.3	24.6	65.7	17.5	32.9	31.2	47.8	26.1	27.5	17.0	15.1	10.3	19.1	19.1	7.9	18.3	30.3	31.8	14.9	16.6	21.9	21.8	15.0	16.3	99.1	41.5	32.3	15.5	40.1	31.5	13.6	18.0	34.3	34.3	21.3	6.4	17.8	16.5	47.2	30.7	21.2	22.8	39.2	43.1	15.4	16.5	31.5	26.2	25.7	24.6	25.8	17.6	22.9	38.7	48.9	10.1	8.2	18.5	26.8	24.5	19.8	24.8	24.7	16.3	35.8	16.2	26.1	13.5	14.1	43.3	13.8	29.7	1.0	4.0	2.1	6.2	5.7	7.8	4.7	6.2	5.6	6.2	4.0	5.7	6.0	0.7	4.3	4.2	11.6	6.2	4.2	50.4	54.0	54.0	47.1	45.8	63.2	64.3	61.1	55.2	62.0	62.5	65.7	7.1	6.4	9.2	31.3	8.3	7.6	14.0	9.9	21.6	11.0	17.3	10.5	16.3	11.5	6.1	20.2	4.2	18.3	5.1	6.5	23.5	4.4	2.0	13.1	11.1	6.1	12.1	11.3	15.6	4.9	12.0	11.5	6.6	12.0	0.0	11.0	7.9	11.9	7.5	16.8	20.6	9.6	8.2	4.7	4.1	3.8	9.3	5.5	16.0	6.5	17.0	28.1	5.2	20.6	12.2	3.2	8.1	10.9	10.7	10.3	4.0	14.3	8.2	11.4	13.1	11.4	9.3	4.5	5.7	17.1	8.0	11.2	7.2	18.5	14.0	10.2
DCANP1	"C5orf20, DCNP1"	ENSG00000251380	"Dendritic cell associated nuclear protein"	Q8TF63	5	135444214-135447348	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"THP-1: 1.8"									HPA048308	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"		"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Nuclear bodies"	"HPA048308: AB_2680349"																		0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 105.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 105.7;Erythroid cells: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 232.9;U-698: 191.8"	"Low region specificity"	"Detected in all"							"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA059609: AB_2684082, HPA062773: AB_2684865"	"unprognostic (9.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (6.90e-7)"	"unprognostic (3.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.27e-2)"	11.1	15.2	10.1	36.3	11.2	43.9	12.5	9.7	13.6	9.9	11.0	15.7	13.7	13.4	7.2	14.6	9.8	12.4	10.4	10.7	10.7	9.8	9.2	13.4	92.9	10.9	10.4	10.6	8.3	8.8	3.5	15.3	10.8	10.2	18.9	17.1	7.7	7.1	9.5	14.7	15.9	13.9	11.4	32.3	14.2	9.0	9.7	105.8	15.7	12.1	79.6	14.2	6.1	13.4	25.8	17.2	38.5	23.9	12.4	20.4	21.0	65.3	25.6	53.3	43.6	11.3	56.1	232.9	24.7	28.3	31.0	14.8	34.6	21.4	71.0	43.5	16.2	46.6	18.6	20.5	11.8	95.8	58.5	11.2	25.5	32.2	19.5	26.0	31.0	64.4	19.0	93.2	62.0	15.5	126.6	39.5	17.2	45.6	15.6	96.0	74.0	18.6	26.6	18.8	35.1	31.8	24.9	49.6	29.7	17.4	22.3	54.3	22.0	60.1	41.8	47.6	37.1	31.7	21.2	191.8	40.7	60.0	45.0	25.6	17.2	28.9	24.2	20.5	32.0	44.5	33.0	30.6	23.8	41.1	34.2	34.2	8.1	34.4	21.0	63.6	41.2	45.1	10.1	11.2	9.7	13.6	10.7	10.7	10.9	10.4	10.8	11.4	9.7	13.4	16.4	0.0	8.6	6.8	105.7	43.0	10.1	11.9	27.9	16.1	10.4	5.2	6.5	7.2	7.5	12.9	6.2	11.9	97.7	10.4	29.4	19.2	0.7	5.9	7.0	16.3	21.0	284.8	17.1	6.2	19.3	11.0	8.6	7.4	22.9	7.5	22.9	7.2	38.2	18.5	21.0	16.4	22.4	63.2	74.5	2.3	8.4	56.0	46.2	18.7	61.4	15.8	84.5	8.0	11.1	10.5	8.0	10.1	24.6	11.6	7.1	10.0	4.7	10.7	6.6	9.3	15.9	52.0	33.9	28.0	43.3	4.5	62.4	4.8	16.5	8.4
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131382	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.0"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 970.6;Inhibitory neurons: 664.8"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 29.0;ASC TERT1: 27.3;fHDF/TERT166: 23.5;GAMG: 34.8;HAP1: 17.9;HSkMC: 25.5;NTERA-2: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265"	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	15.5	2.5	22.0	4.0	27.5	0.0	14.2	10.2	45.3	11.8	0.0	4.2	1.1	6.0	4.1	5.4	4.6	7.2	5.5	37.1	37.8	2.8	0.1	2.4	4.2	17.9	13.2	6.1	1.2	1.1	13.7	0.1	53.0	4.1	3.8	17.3	3.4	4.0	2.1	8.4	4.1	19.1	15.7	4.5	3.6	1.3	17.5	1.6	2.8	4.6	2.2	4.3	5.9	18.7	0.0	0.4	6.8	0.0	29.0	27.3	0.0	0.2	0.4	0.2	0.2	0.0	0.1	0.0	0.0	23.5	34.8	0.0	17.9	0.3	0.0	0.0	1.0	0.0	0.8	0.0	1.1	0.0	0.0	25.5	13.0	0.6	0.4	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	37.1	0.0	0.4	0.0	2.0	0.0	1.0	0.0	7.3	4.4	0.0	0.0	2.2	10.4	0.0	0.0	0.0	0.1	6.1	7.6	1.3	0.1	0.0	0.0	2.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	27.5	10.2	45.3	37.1	37.8	17.9	13.2	53.0	15.7	17.5	18.7	8.0	9.6	0.6	132.2	0.1	15.2	1.3	1.8	0.0	9.4	7.8	7.0	5.8	0.0	7.9	3.7	4.2	0.0	0.0	0.0	0.0	0.1	1.5	0.7	1.7	3.8	0.0	0.0	970.6	0.0	0.0	82.6	0.5	0.3	0.0	75.5	0.4	0.0	0.1	10.1	664.8	0.0	4.1	0.3	14.7	1.6	20.8	0.7	14.2	44.0	0.0	73.8	0.0	31.2	19.1	0.2	0.0	4.1	0.3	0.6	0.0	0.6	3.1	4.2	6.6	10.8	22.0	1.3	1.4	1.0	9.7	0.0	0.8	30.1	0.0	1.7
DCLRE1A	"hSNM1, KIAA0086, PSO2, SNM1"	ENSG00000198924	"DNA cross-link repair 1A"	Q6PJP8	10	113834725-113854383	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036907	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036907: AB_10673626"	"unprognostic (1.22e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (6.34e-2)"	2.1	3.8	3.9	3.9	4.2	4.6	5.2	4.2	5.5	4.0	4.1	4.3	4.1	2.9	5.5	3.3	4.1	2.8	4.4	4.2	4.3	6.0	9.8	3.6	5.3	3.8	3.9	5.3	7.4	8.4	2.9	4.2	4.0	5.9	5.2	8.0	5.0	4.0	3.6	3.7	4.0	3.2	3.8	4.0	5.2	4.7	4.1	5.0	5.1	3.3	5.3	3.2	1.9	4.1	15.8	13.0	19.3	19.7	2.5	4.2	11.0	9.4	9.5	12.5	14.3	10.2	21.1	12.2	10.4	4.8	9.7	12.9	18.6	8.2	16.1	24.2	16.0	20.7	8.0	13.1	8.2	21.9	18.8	2.8	9.8	10.5	18.5	8.3	7.7	16.3	24.1	12.9	7.1	9.4	10.6	8.8	9.4	12.5	6.9	6.1	23.0	8.0	8.3	7.3	8.4	13.9	5.4	9.2	13.8	13.2	11.0	10.5	6.8	7.2	14.1	9.8	15.6	14.9	18.2	18.6	10.7	31.5	10.5	1.3	0.3	0.7	2.8	0.2	1.8	0.6	1.2	1.9	1.1	0.3	0.8	1.4	0.1	1.0	0.5	0.4	3.2	1.2	3.9	4.2	4.2	5.5	4.2	4.3	3.8	3.9	4.0	3.8	4.1	4.1	0.9	6.4	4.1	4.9	1.3	0.6	0.6	2.8	0.6	4.2	2.9	1.9	9.6	5.7	3.6	1.8	0.0	3.0	2.0	2.2	7.9	1.9	0.7	2.9	1.8	1.6	3.5	6.5	4.9	1.1	1.8	2.5	1.5	2.0	1.3	3.6	1.8	7.7	3.2	6.7	4.7	2.5	4.1	3.8	0.6	0.5	1.5	10.3	0.0	2.8	3.6	3.9	2.1	8.0	4.1	1.6	2.3	1.5	3.0	1.3	1.6	3.7	5.1	3.9	0.0	1.7	1.2	6.0	5.4	2.5	0.6	0.7	3.1	2.4	3.4	0.7
DCLRE1B	"APOLLO, FLJ12810, FLJ13998, SNM1B"	ENSG00000118655	"DNA cross-link repair 1B"	Q9H816	1	113905213-113914086	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.6;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064934			Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nuclear bodies"		"HPA064934: AB_2685387"	"unprognostic (1.21e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.92e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-3)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.03e-7)"	"unprognostic (1.24e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.08e-2)"	3.5	1.2	2.5	3.7	2.7	6.0	2.9	4.5	2.8	2.5	2.1	2.8	1.7	2.4	1.6	3.0	2.7	2.2	1.3	2.4	2.7	1.6	1.7	3.2	4.1	2.5	2.7	3.0	0.9	1.1	0.7	3.5	2.5	1.7	3.0	1.2	1.2	1.9	0.8	2.6	1.9	3.3	2.5	4.0	1.6	2.4	2.8	4.8	2.0	1.0	3.9	2.2	1.6	3.3	14.1	5.5	9.9	10.5	7.9	5.4	5.7	11.1	7.4	14.2	15.3	6.0	3.9	14.3	6.8	7.8	6.4	6.4	13.7	11.2	19.6	12.0	10.1	12.4	7.8	5.9	1.5	14.1	12.1	6.2	4.4	18.5	10.6	3.9	7.9	16.5	17.5	11.8	16.7	57.8	21.7	11.5	7.7	5.5	12.6	17.2	30.4	6.5	5.6	6.1	8.7	8.0	12.0	9.2	7.7	7.8	6.1	14.9	4.8	18.6	19.6	31.3	15.8	5.2	5.6	16.0	15.7	13.8	32.9	1.9	4.5	1.3	2.3	3.7	2.5	0.9	2.6	2.2	2.6	1.4	1.7	2.2	0.2	5.8	2.1	1.0	1.8	2.5	2.5	2.7	4.5	2.8	2.4	2.7	2.5	2.7	2.5	2.5	2.8	3.3	3.0	3.2	2.0	0.3	2.8	3.6	1.2	1.7	8.0	3.0	2.6	2.0	1.2	1.5	0.8	0.0	2.1	4.6	4.0	1.0	1.9	4.4	1.3	4.1	2.3	3.4	3.0	23.6	0.8	2.7	9.8	3.4	0.5	2.4	1.3	5.6	2.2	1.6	9.7	1.7	0.9	3.1	2.0	8.5	12.8	0.6	1.8	10.5	0.0	1.0	13.5	0.9	2.1	0.0	1.1	3.7	0.5	2.2	5.0	1.5	0.3	1.7	3.1	1.4	26.3	2.1	5.5	7.9	11.4	6.2	2.7	1.4	4.4	3.0	4.2	1.0
DCLRE1C	"A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C"	ENSG00000152457	"DNA cross-link repair 1C"	Q96SD1	10	14897359-14954432	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069295			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA069295: AB_2686112"	"unprognostic (8.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.30e-4)"	"unprognostic (8.02e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.91e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (9.03e-8)"	"unprognostic (2.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.45e-3)"	4.2	3.3	2.2	8.0	3.2	14.0	6.1	5.7	3.4	4.5	3.7	4.3	5.2	4.4	3.8	7.1	3.7	4.0	2.3	2.2	2.2	3.5	2.6	4.9	14.1	2.8	2.7	4.5	3.1	3.8	2.2	4.4	3.1	4.0	5.2	4.9	4.5	3.7	3.0	6.9	5.4	3.9	2.5	10.4	5.9	1.9	2.9	12.3	5.5	2.7	12.8	5.4	5.1	3.7	16.2	7.8	6.9	13.8	6.4	8.2	6.6	9.7	5.3	13.0	13.5	8.9	13.4	21.7	3.8	7.6	9.2	13.7	7.6	5.1	10.9	13.4	8.0	16.7	8.9	6.0	5.1	10.0	18.4	6.6	4.8	12.7	5.3	8.2	7.4	13.9	10.5	17.4	8.6	7.4	14.9	9.9	4.7	14.4	3.5	17.2	9.2	12.1	6.5	6.0	3.6	6.9	10.7	10.2	27.5	5.3	12.8	18.5	6.0	8.3	11.6	17.1	10.8	9.9	19.1	21.5	8.1	10.5	11.8	27.4	13.9	20.0	12.1	18.9	14.5	25.1	14.1	15.0	20.9	28.1	12.2	13.2	13.2	11.0	17.5	22.4	11.9	8.9	2.2	3.2	5.7	3.4	2.2	2.2	2.8	2.7	3.1	2.5	2.9	3.7	6.6	3.2	6.9	17.9	27.6	17.3	20.8	10.9	5.7	24.8	7.8	4.3	4.4	11.5	26.1	14.7	62.6	15.1	21.8	10.9	3.9	9.9	26.8	8.5	8.6	8.2	6.7	22.7	12.4	11.1	21.9	10.2	7.1	13.1	6.3	14.1	10.4	1.9	10.2	32.0	10.6	7.3	10.2	19.8	20.6	2.3	12.5	13.3	19.6	16.9	21.8	10.4	35.0	12.5	11.9	14.9	15.5	11.3	13.4	21.5	12.3	2.7	22.3	47.9	19.7	18.1	11.9	13.9	18.5	7.3	21.2	5.1	14.8	12.4	8.6	41.4
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113022195	"Enzymes, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytoplasmic bodies"	"Cell Junctions"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	4.6	4.0	5.9	8.1	6.0	14.0	6.9	9.8	5.7	6.0	6.6	3.9	3.7	4.3	3.4	4.1	4.7	3.5	3.4	5.9	7.2	4.8	4.7	6.9	12.6	5.5	4.9	6.7	3.3	3.1	3.7	12.1	5.8	4.4	4.1	7.4	5.3	3.5	4.8	5.8	5.1	3.3	4.5	10.2	4.0	3.8	8.5	17.9	3.7	3.9	12.3	4.4	5.2	5.1	6.4	5.6	24.1	19.0	4.5	5.3	37.0	6.7	4.3	7.2	9.8	25.0	13.1	32.2	8.5	3.2	5.6	7.9	27.6	7.1	8.8	9.0	11.0	29.5	4.6	9.9	5.4	20.1	15.3	4.8	5.3	8.4	9.0	6.9	12.5	24.8	22.7	12.0	6.1	8.1	29.6	19.6	20.8	4.0	2.9	27.0	22.7	12.2	10.5	15.4	5.6	11.4	8.3	8.8	11.3	24.1	25.3	24.4	7.7	7.8	13.9	4.4	8.8	8.8	19.8	23.6	4.7	26.0	6.3	14.0	4.9	3.7	3.0	6.1	4.2	3.8	3.7	3.0	5.1	2.5	3.4	3.7	9.4	3.5	7.3	2.9	4.3	2.6	5.9	6.0	9.8	5.7	5.9	7.2	5.5	4.9	5.8	4.5	8.5	5.1	30.0	19.2	16.8	16.0	50.7	27.8	19.9	22.3	31.9	24.7	43.5	26.4	12.4	8.6	24.1	20.2	79.2	66.7	65.0	11.6	19.6	11.2	24.3	21.7	38.1	28.9	16.2	41.9	25.5	11.8	49.6	25.7	17.3	25.7	19.6	66.7	28.5	7.0	31.7	28.6	34.1	8.9	20.3	78.1	41.5	53.8	19.0	57.4	26.6	56.2	90.7	36.9	35.0	26.7	28.8	17.3	10.6	10.9	27.1	33.3	13.8	14.4	22.7	34.6	6.6	16.5	32.3	36.6	29.5	20.0	26.6	64.4	50.1	52.0	13.1	48.8
DCPS	"HINT-5, HINT5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126304060-126350005	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 46.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 79.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: AB_2683770"	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	8.3	11.4	2.8	7.4	4.0	12.1	8.5	5.0	4.5	10.9	8.1	10.1	4.7	11.0	4.1	11.3	8.6	16.0	9.9	3.9	3.2	13.5	50.7	9.0	12.1	3.3	3.4	9.2	12.1	3.5	8.2	4.0	2.9	8.1	5.9	6.3	12.0	5.3	14.6	11.3	9.4	5.5	2.7	17.3	8.7	6.1	3.6	8.9	7.5	5.8	9.6	13.3	9.2	3.4	13.9	8.5	10.2	19.8	7.9	11.2	8.9	6.5	10.3	11.5	10.8	17.5	29.1	19.5	28.0	12.2	7.5	16.2	14.4	24.4	5.9	35.8	7.1	27.1	9.9	14.7	18.8	33.3	25.4	12.5	14.0	16.0	17.6	5.9	14.1	17.0	11.6	34.8	11.2	21.6	21.1	41.5	8.0	79.8	28.7	13.7	13.8	40.6	11.4	15.1	16.1	11.0	20.3	21.1	15.8	6.3	33.8	22.1	9.3	18.7	7.3	8.9	13.7	13.4	14.6	20.0	6.0	51.0	46.7	4.2	10.5	4.3	9.3	15.2	7.8	13.0	8.5	9.7	16.6	8.6	6.4	6.7	1.3	8.9	15.3	46.6	15.4	8.9	2.8	4.0	5.0	4.5	3.9	3.2	3.3	3.4	2.9	2.7	3.6	3.4	14.2	12.8	11.2	6.2	31.2	6.9	16.4	38.7	8.0	6.7	12.2	17.1	5.0	47.1	18.8	42.3	0.0	39.9	35.3	6.4	56.7	19.7	8.1	11.1	12.1	12.4	7.3	14.5	5.8	29.2	43.8	15.9	11.2	23.2	17.1	9.8	8.6	31.4	29.2	3.3	6.0	12.0	28.5	14.1	11.7	2.2	17.1	16.8	17.8	2.8	15.3	10.1	22.6	2.5	4.6	17.1	14.9	18.4	101.1	8.7	6.1	15.0	15.7	9.4	19.7	10.8	14.6	14.8	24.9	18.3	8.9	27.1	24.3	16.2	14.4	24.0
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	50.8	83.8	39.0	41.6	40.3	29.5	46.7	40.1	44.8	48.9	51.1	41.4	33.1	47.8	29.7	61.2	49.0	54.7	40.6	39.8	43.6	48.9	79.8	41.2	45.2	43.0	42.8	65.8	54.9	61.8	46.9	36.7	40.2	39.9	40.9	25.1	44.6	41.7	41.7	39.3	36.3	46.4	43.8	50.3	54.1	21.8	42.6	42.2	100.8	32.9	49.6	50.1	45.6	46.0	97.8	87.4	88.4	81.3	129.6	176.7	115.0	184.1	163.0	128.7	79.7	89.2	183.0	33.5	44.3	179.9	87.1	47.3	65.5	114.9	117.1	163.8	50.4	155.9	50.4	109.1	139.5	153.3	93.3	149.8	120.8	113.6	117.8	129.6	112.2	73.1	157.4	324.5	175.6	71.5	100.1	94.7	70.0	39.8	79.3	107.3	62.2	65.8	107.9	115.1	86.7	54.3	86.7	73.8	87.4	81.2	56.7	78.8	131.7	105.7	81.7	52.0	142.0	124.5	72.9	42.8	117.4	98.5	127.1	68.6	47.9	45.2	61.0	58.8	76.8	71.0	52.6	62.7	55.0	48.6	51.6	54.6	3.3	73.7	60.2	42.4	50.6	55.6	39.0	40.3	40.1	44.8	39.8	43.6	43.0	42.8	40.2	43.8	42.6	46.0	31.6	12.8	19.5	8.8	31.7	25.4	34.4	35.4	37.5	4.9	39.4	34.2	24.3	38.6	21.5	33.1	4.2	19.0	26.6	16.8	37.2	68.8	7.0	19.7	41.6	30.9	14.5	27.1	10.7	54.5	26.8	42.3	15.8	22.3	22.8	36.2	30.0	45.2	53.8	3.3	11.7	28.5	18.3	38.8	32.1	18.0	44.1	29.4	26.6	9.4	34.8	37.4	25.7	3.0	3.1	75.5	18.5	35.3	27.6	46.1	19.3	45.8	18.7	5.5	32.9	25.8	34.6	10.2	15.4	54.5	23.0	7.3	27.6	42.4	31.3	42.3
DCTN4		ENSG00000132912	"Dynactin subunit 4"	Q9UJW0	5	150708440-150759095	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017532, HPA038026"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Centrosome"		"CAB017532: AB_1122152, HPA038026: AB_2675792"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.87e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.83e-1)"	26.6	31.8	29.4	16.5	30.1	56.5	30.1	30.6	36.2	21.3	24.1	18.9	19.2	24.2	30.7	23.5	21.0	19.2	25.4	29.9	30.2	23.3	26.6	21.3	14.0	32.1	28.3	29.4	38.1	28.7	20.5	31.3	33.6	27.4	21.6	58.7	18.3	25.0	47.5	22.7	17.0	25.1	29.9	15.0	21.8	28.0	30.4	20.1	29.3	36.8	17.2	19.9	16.2	41.2	25.2	29.3	53.1	87.5	62.8	60.9	43.2	43.1	43.9	52.7	51.9	55.6	30.5	24.9	58.5	53.1	46.2	29.4	67.3	51.6	63.3	48.3	52.5	31.6	32.3	33.8	57.3	38.9	42.5	61.8	45.0	45.9	82.5	53.2	37.4	30.4	48.9	30.3	68.3	26.0	23.6	20.5	26.2	30.1	47.3	20.5	32.1	27.8	38.7	42.4	117.8	49.5	46.0	62.0	66.9	34.0	59.8	51.0	40.8	56.8	30.3	37.7	47.2	26.3	36.8	14.3	65.6	51.2	48.1	3.2	11.2	11.1	5.0	7.8	5.2	4.8	5.7	5.1	11.0	3.8	5.3	6.5	16.1	3.2	6.8	5.1	4.6	5.7	29.4	30.1	30.6	36.2	29.9	30.2	32.1	28.3	33.6	29.9	30.4	41.2	19.3	48.1	29.2	43.4	29.4	17.7	13.2	12.6	52.3	20.8	33.7	21.3	37.2	32.9	13.7	16.5	20.9	22.4	26.8	23.2	11.7	11.8	2.6	23.9	32.7	19.7	37.7	47.3	41.3	16.5	18.0	26.0	40.8	32.2	12.6	32.4	20.7	39.4	31.5	30.3	43.7	27.2	16.2	48.8	19.1	4.7	22.1	35.7	12.4	35.6	20.7	26.4	9.2	46.8	56.2	18.4	19.7	19.2	27.0	17.4	14.7	22.7	20.6	31.9	13.1	15.0	19.5	18.4	24.0	38.6	20.5	29.7	26.2	23.7	19.5	17.9
DCTN5	"MGC3248, p25"	ENSG00000166847	"Dynactin subunit 5"	Q9BTE1	16	23641466-23677472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042003, HPA063710"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA042003: AB_10796468, HPA063710: AB_2685101"	"unprognostic (5.90e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.36e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.28e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.55e-2)"	13.9	11.3	14.6	18.1	18.1	41.5	14.2	10.4	18.3	13.6	3.8	19.2	20.8	14.8	12.0	25.2	13.6	14.2	14.7	17.2	13.0	21.0	10.7	14.0	22.1	11.4	13.6	12.0	15.9	19.8	8.5	20.9	11.1	14.1	24.9	21.5	12.8	14.0	13.9	14.1	22.2	21.7	11.4	15.1	16.7	20.6	12.8	20.9	18.8	14.2	32.2	20.6	10.9	12.9	30.0	58.5	56.0	46.9	39.0	28.9	39.2	51.9	32.1	32.9	39.3	66.5	40.3	42.1	41.2	54.8	34.6	30.6	93.4	50.2	40.5	48.1	37.1	51.9	67.2	93.9	26.5	63.7	38.4	24.3	35.3	40.5	42.8	36.5	52.8	52.0	100.7	31.6	53.3	82.4	49.4	18.4	66.3	43.3	25.5	59.8	48.6	45.9	26.2	62.6	46.8	48.5	45.6	36.7	30.5	49.0	51.2	53.2	71.8	44.0	20.0	34.9	36.6	42.6	68.6	66.2	42.0	31.4	48.8	14.3	16.6	20.3	15.5	14.0	17.1	13.9	14.2	17.0	17.5	10.5	12.0	14.3	7.3	22.0	22.0	12.4	19.0	17.2	14.6	18.1	10.4	18.3	17.2	13.0	11.4	13.6	11.1	11.4	12.8	12.9	19.7	16.0	26.2	12.1	19.1	14.7	14.5	12.9	22.8	52.1	15.5	14.5	27.1	15.7	15.6	20.2	91.8	32.9	16.1	36.2	11.7	23.8	23.2	11.9	22.4	22.5	22.1	27.6	13.4	25.2	36.3	16.3	20.9	20.8	27.8	37.3	17.2	14.2	28.4	52.2	13.2	18.9	12.2	19.1	11.4	23.4	13.1	17.1	7.2	6.5	34.4	32.3	30.9	11.1	12.0	45.7	19.4	18.0	17.4	14.4	31.9	23.3	11.2	45.0	13.1	22.4	18.1	70.4	30.6	20.9	14.2	48.2	18.7	17.9	26.2	22.0
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423615-30430030	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002832	Uncertain		Supported	Nucleoplasm,Cytosol		NA	Yes		61000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavorable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	21.0	21.4	17.6	27.4	18.4	22.2	30.5	18.7	22.5	18.6	18.9	56.4	32.0	18.6	20.0	28.3	28.1	19.5	31.1	18.4	19.5	39.7	21.8	16.2	35.5	18.1	17.6	14.0	24.9	32.1	10.3	16.0	19.0	21.8	58.4	12.2	25.5	19.3	44.7	25.1	27.7	20.5	18.4	27.8	24.3	9.1	18.1	24.5	20.1	36.9	35.7	27.0	19.1	19.4	124.7	149.8	66.8	85.8	18.4	24.1	61.9	58.4	35.1	87.4	87.9	114.7	103.4	168.1	119.1	36.8	54.9	95.9	141.4	115.1	103.5	89.2	221.0	98.3	61.5	150.3	24.1	177.0	144.2	28.6	64.8	96.4	55.6	25.4	88.7	88.2	125.8	57.4	61.5	217.8	210.0	189.9	88.8	124.2	119.2	293.1	74.8	218.1	98.9	80.2	141.4	80.4	39.0	137.7	55.3	41.5	118.4	73.9	45.9	66.0	59.1	85.8	107.2	36.9	118.4	217.5	43.8	145.7	79.6	70.6	36.7	38.1	54.0	70.0	75.8	146.7	68.4	61.4	86.7	128.7	60.9	59.0	4.6	76.1	79.2	94.6	76.4	81.0	17.6	18.4	18.7	22.5	18.4	19.5	18.1	17.6	19.0	18.4	18.1	19.4	34.0	19.2	15.2	0.7	38.2	90.2	53.3	92.5	33.6	23.3	45.8	48.9	34.8	51.5	37.9	44.1	8.4	103.2	22.7	130.3	127.2	135.6	13.4	32.6	29.9	47.4	38.5	29.6	2.6	124.8	101.0	28.3	27.5	66.5	31.1	40.2	31.1	23.2	76.9	15.2	2.7	142.3	73.2	21.0	49.1	45.1	19.6	26.9	48.0	1.0	73.2	25.0	23.7	2.5	4.4	89.0	115.8	19.9	24.1	86.9	68.8	76.7	27.8	21.4	19.7	23.7	40.0	3.3	44.8	39.4	80.3	27.8	28.3	53.8	168.5	45.7
DCUN1D1	"DCUN1L1, RP42, SCCRO, SCRO, Tes3"	ENSG00000043093	"Defective in cullin neddylation 1 domain containing 1"	Q96GG9	3	182938074-182985953	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 246.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 13031.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA035911: AB_10673489"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.44e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.98e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.52e-1)"	14.7	12.3	10.5	12.3	13.9	22.4	13.0	13.2	16.3	11.6	4.0	14.0	13.7	12.9	9.4	18.1	10.4	12.8	15.7	10.0	10.6	19.2	31.5	10.6	15.4	11.0	12.3	12.4	10.2	12.0	8.4	12.6	13.0	13.6	13.1	11.3	11.0	13.9	34.5	14.4	14.4	15.4	11.6	12.5	11.4	246.2	12.0	13.6	17.7	38.1	17.5	14.9	10.2	18.3	54.3	23.5	31.0	13.1	32.4	30.8	26.3	33.9	37.8	37.4	36.2	34.9	39.0	63.6	72.5	32.2	56.4	29.4	27.6	28.5	49.8	52.2	14.3	61.1	17.2	14.8	20.2	36.6	44.3	23.3	32.6	22.3	20.7	28.3	26.7	38.0	20.6	32.6	27.9	28.8	36.2	19.0	25.3	40.4	21.7	27.9	32.4	41.6	27.5	37.6	22.4	22.3	59.7	41.9	33.1	32.6	86.0	29.0	25.6	22.9	22.2	31.7	40.3	26.5	53.3	64.0	29.0	33.8	33.8	10.2	8.5	16.3	6.7	9.2	6.6	6.4	5.6	6.6	10.0	4.1	6.2	6.8	13.7	10.5	6.2	7.5	7.4	5.5	10.5	13.9	13.2	16.3	10.0	10.6	11.0	12.3	13.0	11.6	12.0	18.3	23.5	22.4	29.5	54.2	22.3	43.3	26.0	28.3	23.3	13.2	26.6	15.4	32.5	21.5	30.1	47.8	10.4	18.8	36.3	29.1	37.2	28.3	2437.8	24.0	29.9	23.7	26.9	98.1	52.7	30.5	18.7	29.0	18.3	26.3	29.8	22.1	17.9	52.6	28.6	18.5	40.9	19.6	30.5	45.9	54.2	13031.2	86.6	39.5	12.4	30.0	45.9	18.1	20.6	37.7	91.9	31.9	24.1	64.3	20.2	42.0	27.3	42.3	24.0	22.6	78.9	35.9	37.4	124.6	58.7	25.7	42.5	20.0	27.1	15.3	20.7	43.6
DCUN1D3	"DKFZp686O0290, FLJ41725, MGC48972, SCCRO3"	ENSG00000188215	"Defective in cullin neddylation 1 domain containing 3"	Q8IWE4	16	20854925-20900358	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 58.6;Late spermatids: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.2;ASC TERT1: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041983, HPA043511"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA041983: , HPA043511: AB_2678521"	"unprognostic (9.34e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.42e-1)"	20.6	9.5	3.9	6.3	4.3	2.8	9.3	5.5	4.6	8.3	4.1	6.2	3.3	6.2	2.5	8.3	6.9	9.7	7.1	3.4	4.8	5.2	11.9	9.9	2.6	4.0	4.0	5.0	6.8	4.4	4.7	7.9	4.0	5.4	3.9	12.6	3.7	4.1	28.5	7.1	4.0	8.6	3.7	4.4	5.9	8.3	4.8	3.2	4.4	4.0	2.6	8.3	9.4	7.2	4.8	8.6	4.2	8.7	52.2	38.9	5.4	16.1	13.6	7.9	10.5	10.7	8.5	3.0	12.6	15.8	4.7	6.1	4.8	6.7	10.6	4.0	2.9	2.5	7.1	15.8	13.6	3.7	23.9	25.9	9.0	15.2	8.5	8.4	22.2	2.9	2.9	7.4	16.4	6.6	3.4	5.5	9.9	4.1	2.7	6.1	4.5	2.6	7.0	5.0	3.6	4.8	6.2	6.2	3.6	4.7	4.2	1.8	10.9	16.5	5.4	6.9	4.4	6.9	4.3	2.0	17.1	4.1	8.3	1.3	0.3	0.2	0.4	0.6	0.3	0.2	0.2	0.6	0.4	0.3	0.3	0.6	0.3	0.6	0.5	0.2	0.2	0.2	3.9	4.3	5.5	4.6	3.4	4.8	4.0	4.0	4.0	3.7	4.8	7.2	25.6	12.8	19.3	4.6	2.9	31.4	11.7	7.5	19.4	12.4	19.0	10.8	5.2	2.8	7.2	9.2	35.5	3.6	8.2	6.3	0.0	3.8	58.6	14.5	16.2	18.4	20.3	1.3	10.6	5.2	2.0	16.5	5.6	34.3	0.0	4.2	9.7	16.3	2.3	13.5	9.7	4.3	6.1	5.0	20.6	48.5	10.8	15.8	12.4	1.9	1.8	5.2	1.0	10.6	10.8	4.9	1.2	9.8	3.3	6.1	3.0	5.2	4.3	24.8	6.6	20.1	19.6	6.4	3.7	10.7	22.6	5.1	5.9	4.1	4.7	18.3
DCUN1D4	KIAA0276	ENSG00000109184	"Defective in cullin neddylation 1 domain containing 4"	Q92564	4	51843000-51916837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 111.9;Oligodendrocytes: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036483, HPA036484"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA036483: AB_10670719, HPA036484: AB_10671843"	"unprognostic (3.16e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.40e-1)"	14.0	17.8	14.5	7.3	14.1	2.8	9.8	14.4	20.3	13.3	8.1	15.0	5.9	13.6	11.5	10.4	12.7	11.4	12.1	13.4	17.3	14.9	28.9	9.1	7.5	16.0	16.2	16.0	9.1	9.5	15.7	6.9	17.2	12.0	8.5	15.7	13.4	16.9	11.8	7.7	9.7	17.3	14.2	9.4	13.3	17.0	18.9	6.5	13.2	11.4	6.1	16.9	10.9	16.4	10.6	18.9	25.5	36.7	25.6	27.5	9.8	31.1	23.2	18.0	15.9	11.8	12.1	8.1	20.1	35.2	23.5	11.2	31.0	19.8	27.8	4.9	9.5	13.8	14.9	28.7	54.9	20.4	17.9	25.1	23.7	19.6	17.9	27.0	19.2	7.4	15.6	5.9	35.3	15.2	24.1	13.6	14.5	21.1	15.1	11.4	12.2	4.4	23.1	12.4	14.4	15.6	13.1	17.8	28.9	13.9	18.4	12.3	28.8	24.0	19.7	19.7	25.7	11.1	18.1	7.3	16.6	18.8	14.4	6.8	3.6	8.8	5.7	3.3	8.5	3.6	6.4	6.5	2.5	2.4	6.0	6.8	1.4	3.7	2.4	1.5	3.2	4.4	14.5	14.1	14.4	20.3	13.4	17.3	16.0	16.2	17.2	14.2	18.9	16.4	13.1	6.4	14.1	86.2	9.7	37.2	19.2	16.5	16.5	23.3	18.1	11.7	40.6	14.3	13.2	16.5	16.7	5.0	9.8	14.9	13.7	10.6	76.3	10.7	16.1	17.9	6.7	11.8	90.9	12.2	8.5	23.1	21.9	10.0	13.3	18.9	17.2	35.8	8.2	30.3	88.6	7.2	12.2	7.3	18.4	111.9	14.9	7.2	32.0	51.5	5.3	14.9	15.5	69.4	131.4	13.3	10.9	25.9	6.3	17.2	8.9	24.1	18.1	17.8	0.0	13.4	20.8	24.6	25.5	17.3	33.2	3.4	11.1	12.4	8.9	15.0
DCUN1D5	"FLJ32431, MGC2714"	ENSG00000137692	"Defective in cullin neddylation 1 domain containing 5"	Q9BTE7	11	103050686-103092194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050863	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA050863: AB_2681259"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.62e-4)"	"prognostic unfavorable (2.01e-7)"	"unprognostic (1.92e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (9.52e-5)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (2.64e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.43e-3)"	15.8	14.6	11.9	4.2	12.7	4.7	13.2	16.6	17.5	11.3	7.9	11.3	1.4	11.1	3.8	21.4	10.3	1.8	23.9	13.3	12.8	14.3	13.7	11.0	5.1	11.8	13.0	9.1	14.2	3.0	13.0	3.3	12.1	11.3	2.2	7.5	12.2	3.0	31.3	11.8	9.4	2.7	13.2	12.3	13.3	18.5	13.5	4.5	9.2	7.7	4.1	11.9	12.1	13.0	18.2	14.5	18.8	16.3	11.6	13.2	10.0	17.9	6.8	9.0	12.7	51.2	24.8	8.0	32.8	13.3	29.0	21.3	24.3	24.0	16.1	9.7	22.4	21.6	16.2	22.3	18.7	33.7	12.4	7.6	23.8	17.7	22.8	18.3	18.1	32.6	26.3	0.1	10.5	21.6	24.4	46.5	24.5	33.6	32.9	9.5	15.1	22.4	15.4	33.9	12.8	11.0	10.0	21.8	21.4	25.1	20.4	22.4	4.0	12.4	14.8	16.6	17.6	7.8	12.5	33.0	7.9	31.4	13.0	12.8	6.6	6.5	8.7	8.5	10.2	11.3	10.8	9.5	9.5	9.3	9.3	10.3	2.5	15.1	7.1	11.1	11.8	9.3	11.9	12.7	16.6	17.5	13.3	12.8	11.8	13.0	12.1	13.2	13.5	13.0	24.9	16.0	11.0	26.8	30.2	79.5	63.2	101.6	38.1	11.7	34.4	36.2	30.7	15.7	42.8	9.2	8.4	57.2	29.3	8.2	49.0	59.5	5.0	26.5	38.2	27.2	14.4	52.1	50.7	55.6	88.6	35.6	21.9	25.3	15.8	37.3	16.1	25.3	44.7	6.7	39.6	17.9	67.1	29.8	32.4	8.4	14.3	22.7	30.2	15.9	26.5	18.9	15.5	25.6	27.5	63.1	12.2	19.5	52.8	92.6	8.6	39.2	28.0	14.1	26.3	31.5	74.6	121.6	119.8	59.0	83.7	43.8	30.9	59.8	23.2	73.0
DDA1	"C19orf58, MGC2594, PCIA1"	ENSG00000130311	"DET1 and DDB1 associated 1"	Q9BW61	19	17309518-17323298	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 416.9;Syncytiotrophoblasts: 253.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042134, HPA055272"	Approved		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA042134: AB_10794169, HPA055272: AB_2682767"	"unprognostic (1.30e-1)"	"unprognostic (6.35e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	7.9	11.5	15.8	5.1	14.4	7.1	7.8	12.2	19.9	7.8	10.4	11.5	5.7	8.6	3.4	10.9	8.4	4.0	12.0	14.7	15.3	9.8	10.9	9.6	6.2	14.0	15.0	7.3	6.8	6.1	8.0	8.0	14.4	10.0	4.8	3.8	8.7	5.4	9.5	13.0	11.2	4.2	13.1	9.9	10.1	10.1	15.2	7.3	7.9	5.0	4.7	9.3	8.0	13.2	15.6	13.5	10.1	8.2	10.5	7.5	15.6	10.1	13.0	15.4	14.1	12.0	13.8	6.0	13.7	10.6	7.3	13.2	7.5	15.0	7.8	9.9	19.4	7.2	11.1	11.5	12.5	8.3	14.2	11.5	17.5	9.3	8.7	9.5	9.1	13.9	8.9	10.7	8.4	7.8	17.5	12.7	11.7	16.0	22.3	11.0	7.8	10.3	12.6	11.5	10.4	15.2	7.3	17.8	9.5	6.1	9.0	11.6	13.7	10.6	8.7	26.9	14.6	12.8	18.2	8.6	23.3	14.4	10.6	3.0	3.8	6.4	4.2	4.3	3.6	3.7	3.5	4.2	3.2	3.2	3.9	3.9	4.0	3.4	3.8	6.8	4.8	3.4	15.8	14.4	12.2	19.9	14.7	15.3	14.0	15.0	14.4	13.1	15.2	13.2	24.4	28.9	14.1	13.4	26.3	54.6	38.6	84.0	30.1	18.4	41.8	30.5	17.1	11.5	54.2	27.6	12.5	140.5	38.5	70.4	39.2	77.2	416.9	48.6	32.8	26.4	20.3	29.9	10.4	46.4	152.8	26.8	34.7	53.7	38.7	25.2	20.3	26.3	65.0	13.5	9.8	43.4	54.9	22.4	36.8	130.3	22.4	34.2	30.2	7.5	57.2	34.1	58.7	4.5	10.8	139.6	79.9	27.1	31.8	41.4	47.4	55.1	43.7	19.0	19.7	19.5	36.0	107.7	40.0	36.8	61.8	253.5	34.2	31.5	28.6	89.5
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 352.3;Rod photoreceptor cells: 451.4;Syncytiotrophoblasts: 389.4;Theca cells: 303.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992"	"unprognostic (3.45e-1)"	"unprognostic (8.38e-2)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.51e-8)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	52.8	164.8	30.2	44.0	32.5	47.2	59.0	29.5	30.2	61.3	42.5	50.0	53.2	48.0	79.7	49.7	78.3	39.9	65.1	31.9	36.4	64.8	55.9	43.1	47.0	31.8	33.5	89.3	42.5	232.1	44.5	129.7	36.9	56.6	52.3	162.5	54.1	70.9	133.1	60.6	49.9	61.9	31.9	41.9	44.4	69.1	33.5	81.2	65.0	125.1	66.6	58.6	39.2	36.1	160.3	168.1	159.0	142.2	151.4	139.2	237.8	140.9	193.6	174.4	129.2	188.7	130.7	237.6	126.8	203.4	107.4	141.4	245.5	177.5	188.0	115.7	131.3	128.0	144.3	192.0	109.4	182.7	112.6	169.1	121.7	174.0	146.2	123.5	195.7	86.0	278.4	119.9	158.9	194.7	238.4	77.4	214.5	104.3	146.3	197.9	198.5	254.3	119.7	177.3	140.3	143.0	154.6	183.8	145.9	144.8	226.0	85.6	150.9	120.9	113.6	138.2	106.4	139.5	157.0	194.7	134.9	103.7	121.1	38.4	43.6	36.5	46.7	47.1	61.1	35.8	42.0	47.3	60.5	30.5	37.8	43.3	4.6	46.4	45.3	34.2	49.6	54.6	30.2	32.5	29.5	30.2	31.9	36.4	31.8	33.5	36.9	31.9	33.5	36.1	34.2	28.9	69.9	46.4	48.8	52.6	53.6	61.1	51.2	87.0	52.0	39.9	105.6	34.3	54.5	53.3	352.3	283.5	57.5	45.0	17.6	43.9	15.7	46.6	40.8	48.1	74.2	102.3	27.8	42.4	130.1	50.6	46.4	51.3	30.9	102.7	45.0	67.4	75.5	87.5	31.6	55.4	44.7	45.3	33.5	18.8	85.1	38.3	42.7	30.0	61.1	64.4	71.1	24.1	31.0	52.6	36.4	62.1	65.4	55.7	63.2	46.7	64.4	451.4	32.9	51.5	44.5	114.0	120.9	52.3	59.8	389.4	46.0	303.8	60.0	57.1
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239217	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1;monocytes: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: AB_2683708"	"prognostic favorable (7.29e-4)"	"prognostic favorable (1.58e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.07e-1)"	13.2	22.5	2.6	8.2	3.2	11.6	13.5	3.4	3.6	12.5	3.4	12.8	7.6	12.7	11.7	24.8	17.6	12.5	6.8	2.5	2.4	4.4	27.0	12.2	14.7	3.4	2.7	11.6	14.4	4.8	4.7	6.8	3.5	9.7	14.9	2.3	14.4	11.7	6.2	46.7	10.2	13.9	2.7	11.3	9.5	4.5	3.2	23.5	5.5	6.9	17.0	11.2	14.1	3.6	23.7	62.3	25.9	19.3	16.6	32.7	29.9	26.0	58.8	32.0	37.1	10.1	14.1	56.6	5.3	23.2	23.6	40.8	14.6	51.8	15.7	14.5	27.5	13.3	55.7	46.7	15.8	15.9	34.4	43.4	58.0	15.9	35.2	10.2	94.2	14.7	3.5	27.0	52.7	44.4	60.4	7.7	8.4	31.1	22.3	30.3	5.6	30.6	13.5	22.7	13.2	16.7	31.2	8.7	8.1	30.8	56.1	5.5	41.2	96.8	44.1	21.3	12.6	27.6	22.4	12.5	37.0	20.2	35.9	9.8	12.8	20.2	19.3	18.4	18.8	18.3	20.1	18.8	10.4	14.5	14.8	15.7	3.7	14.1	15.8	0.3	47.7	15.9	2.6	3.2	3.4	3.6	2.5	2.4	3.4	2.7	3.5	2.7	3.2	3.6	13.8	16.0	22.2	7.8	25.1	38.9	39.7	28.1	75.1	5.0	18.0	25.8	7.8	11.5	16.3	5.5	10.4	3.6	21.3	11.1	9.8	12.5	1.5	5.2	8.1	19.5	7.7	19.1	6.6	13.8	9.0	16.0	18.3	9.5	22.8	31.2	15.0	16.6	17.5	1.7	1.4	12.6	16.2	17.5	12.8	2.1	19.0	16.8	19.6	24.4	135.5	9.6	35.0	1.0	10.6	19.9	9.8	10.5	34.1	8.9	15.7	7.7	13.9	12.8	0.0	12.1	14.0	3.1	8.6	34.5	30.3	1.5	34.3	25.4	16.5	26.5
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617458-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA043119: AB_2678326, HPA043225: AB_2678369"	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	10.8	6.0	3.4	6.3	3.9	10.7	10.2	4.3	4.6	8.1	4.6	6.4	7.9	8.7	6.6	15.8	6.0	5.1	6.8	4.1	3.7	7.9	21.8	7.8	8.6	4.0	3.8	5.8	7.0	10.2	3.9	7.4	4.1	10.0	6.6	10.2	10.2	5.3	26.8	10.9	7.1	6.4	3.5	6.9	5.8	3.0	3.8	7.7	6.4	11.7	9.7	7.9	10.4	5.3	11.4	6.5	11.6	12.1	15.5	12.2	11.2	7.0	5.3	6.0	5.2	16.1	10.1	28.4	8.0	7.7	4.4	11.8	25.4	11.3	10.1	13.2	17.0	22.3	10.7	15.8	6.6	29.8	10.8	12.1	13.1	11.3	12.0	7.5	12.4	18.2	36.5	10.2	7.5	7.6	17.3	9.8	11.1	16.8	5.3	16.1	16.3	16.8	8.5	9.4	14.1	7.8	13.1	20.9	19.2	12.9	10.9	7.7	10.9	8.6	7.4	9.8	8.6	9.5	12.4	22.3	6.7	21.4	6.9	0.3	0.8	0.1	1.1	0.7	0.9	0.8	0.8	0.8	0.8	1.1	0.8	1.1	0.2	0.7	0.5	1.8	0.8	0.5	3.4	3.9	4.3	4.6	4.1	3.7	4.0	3.8	4.1	3.5	3.8	5.3	8.9	9.6	21.0	6.2	18.1	15.3	14.0	11.7	23.3	25.6	23.4	11.6	28.0	15.7	24.6	3.7	14.6	22.6	22.8	16.5	1.9	7.7	1.7	40.7	25.2	17.5	15.0	82.9	12.8	7.7	19.2	16.7	14.8	39.1	1.3	13.7	15.7	61.7	15.1	35.3	15.1	21.3	22.4	27.1	6.8	1.0	12.8	17.6	16.0	10.3	16.8	8.2	6.2	8.5	17.6	16.4	9.4	6.8	10.9	24.9	28.1	20.5	33.0	41.3	6.6	14.7	11.3	11.1	9.1	38.6	20.2	40.2	13.6	8.6	20.4	13.8
DDIT3	"CHOP, CHOP10, GADD153"	ENSG00000175197	"DNA damage inducible transcript 3"	P35638	12	57516588-57521737	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Growth arrest, Stress response, Transcription, Transcription regulation, Unfolded protein response, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 170.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 784.2;hTERT-HME1: 399.9;SK-MEL-30: 409.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058416, HPA068416"	Uncertain		Supported	Nucleoplasm		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA058416: AB_2683712, HPA068416: AB_2685985"	"unprognostic (1.12e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.92e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (8.55e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	65.3	66.2	90.6	16.1	97.8	196.5	64.3	97.4	145.5	51.0	92.9	52.0	20.7	39.1	109.3	31.6	41.2	32.1	85.1	89.0	99.2	106.4	81.7	55.4	18.8	95.9	98.4	57.4	37.3	80.5	81.4	37.6	97.1	45.5	26.6	123.1	43.3	25.8	44.8	48.7	28.0	29.2	95.5	34.2	44.4	40.9	106.4	17.8	182.1	55.4	17.5	56.2	49.5	129.5	17.8	16.1	10.1	34.5	90.7	61.0	53.8	48.2	106.0	70.1	65.4	57.2	45.7	25.3	46.9	14.3	186.7	21.4	38.5	7.3	72.2	21.0	15.5	19.9	19.9	42.3	784.2	31.8	29.3	175.7	152.7	118.6	399.9	81.7	16.9	26.5	86.4	94.0	31.2	10.8	21.1	41.5	19.7	37.3	37.5	11.8	220.7	22.3	25.0	22.3	20.9	15.3	14.2	16.2	409.0	37.2	34.4	82.8	9.9	47.5	20.2	45.4	42.0	164.4	60.3	26.8	57.4	29.1	85.8	121.1	17.9	48.8	25.1	16.6	22.7	48.3	17.9	23.6	12.8	44.8	34.1	31.1	170.7	35.6	19.4	15.9	23.8	18.0	90.6	97.8	97.4	145.5	89.0	99.2	95.9	98.4	97.1	95.5	106.4	129.5	237.9	19.2	55.1	17.0	96.6	56.3	176.5	93.1	177.0	114.9	86.3	265.7	177.9	37.1	56.7	22.0	91.8	42.3	101.8	265.7	115.4	43.3	9.5	111.3	39.4	62.3	230.7	12.8	9.6	16.0	17.5	115.7	74.5	82.4	204.0	26.3	27.5	20.1	45.7	55.5	14.5	218.4	101.7	30.4	81.6	6.3	28.0	81.5	88.9	6.5	8.2	156.1	17.5	14.1	23.0	33.0	300.0	38.0	43.2	115.1	61.7	61.6	38.1	160.0	13.1	56.9	122.2	77.7	15.6	91.5	45.7	107.8	89.7	37.2	127.2	65.1
DDIT4L	"REDD2, Rtp801L"	ENSG00000145358	"DNA damage inducible transcript 4 like"	Q96D03	4	100185870-100190782	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 323.5;tongue: 106.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 22.0;Distal tubular cells: 21.5;Extravillous trophoblasts: 18.5;Granulosa cells: 23.5;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 19.3;BJ: 29.6;fHDF/TERT166: 16.2;HSkMC: 14.7;hTERT-RPE1: 32.8;RPTEC TERT1: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050903			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA050903: "	"unprognostic (2.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.77e-4)"	"unprognostic (1.66e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.53e-5)"	"unprognostic (4.99e-3)"	3.1	1.0	7.0	0.6	21.1	0.4	2.2	8.5	11.0	23.0	7.7	2.0	0.3	1.5	1.7	7.7	2.1	0.6	2.3	10.2	7.6	21.8	0.4	0.8	0.5	11.8	8.8	7.7	0.4	0.6	2.0	3.7	11.1	11.2	0.9	1.2	17.4	6.9	323.5	1.1	0.7	1.6	9.1	1.2	0.5	3.0	8.7	1.2	1.1	106.9	0.4	1.2	2.6	8.9	0.0	2.2	8.5	0.0	3.7	19.3	1.2	29.6	2.5	0.5	0.1	0.1	0.9	0.0	0.7	16.2	0.7	0.0	6.2	0.5	0.5	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	14.7	0.1	0.3	1.5	32.8	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	9.7	0.0	0.0	0.6	0.0	0.0	20.5	0.1	0.1	0.1	0.6	1.2	4.0	2.0	0.0	0.1	0.1	0.0	0.0	0.0	2.3	3.9	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.0	21.1	8.5	11.0	10.2	7.6	11.8	8.8	11.1	9.1	8.7	8.9	3.8	0.0	0.0	6.2	0.0	2.7	0.2	4.2	1.8	0.1	1.0	0.9	7.3	0.0	1.3	22.0	0.0	1.9	0.4	0.2	21.5	0.1	0.8	0.5	0.3	3.6	0.0	0.0	0.0	0.0	18.5	5.1	1.5	0.9	0.0	23.5	0.0	0.0	12.0	0.0	0.5	0.3	0.0	0.0	3.0	0.4	0.9	0.3	7.2	0.0	0.0	8.6	0.0	0.5	0.0	0.5	0.0	2.2	0.2	1.1	0.0	2.2	0.1	0.2	19.7	7.3	11.9	4.7	0.8	0.9	1.4	4.0	0.6	8.3	0.4	0.3
DDN	KIAA0749	ENSG00000181418	Dendrin	O94850	12	48995149-48999375	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 165.7;skeletal muscle: 297.1"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Excitatory neurons: 5.9;Inhibitory neurons: 2.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2;head and neck cancer: 2.6"	"Group enriched"	"Detected in many"	31	"amygdala: 142.5;basal ganglia: 115.5;cerebral cortex: 165.7;hippocampal formation: 126.2;white matter: 54.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 12.0;NB-4: 7.0;RPMI-8226: 23.3;SCLC-21H: 11.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"amygdala: 165.3;basal ganglia: 212.8;cerebral cortex: 178.3;hippocampal formation: 171.2;olfactory bulb: 62.7"	HPA060952	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA060952: AB_2684396"	"unprognostic (2.80e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.56e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.20e-5)"	"unprognostic (8.61e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-6)"	"unprognostic (1.72e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.53e-2)"	0.1	0.1	142.5	0.2	115.5	1.0	0.1	0.0	165.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	126.2	0.0	19.5	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.1	1.3	0.0	0.0	1.4	0.0	0.3	1.6	0.0	297.1	0.3	0.1	0.0	0.0	0.3	0.3	0.2	3.9	0.0	0.1	9.2	0.2	0.0	0.1	54.2	0.4	0.4	0.2	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	5.2	0.5	0.0	0.2	0.1	0.0	1.8	12.0	0.0	0.1	0.6	5.4	2.7	0.6	1.2	0.0	6.5	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.0	4.0	0.2	0.2	6.3	7.0	0.1	0.9	1.6	5.7	0.3	23.3	0.0	0.1	11.8	1.1	0.2	0.6	0.3	0.1	0.3	0.9	0.1	0.3	0.5	0.3	0.0	1.4	2.8	5.5	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	142.5	115.5	0.0	165.7	126.2	0.0	0.0	0.2	0.0	0.0	3.9	54.2	0.4	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.4	0.6	0.0	0.0	3.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.8	5.9	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.4	0.1	0.1	0.0	0.1	0.0
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 90.9;HBEC3-KT: 70.1;RT4: 93.5;T-47d: 103.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		4400000	"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	26.5	50.4	24.1	5.3	49.5	0.4	54.6	47.9	20.2	55.2	4.8	57.7	12.3	23.4	4.5	150.1	46.2	11.4	42.1	17.5	40.7	96.8	6.3	33.7	1.2	68.7	47.3	41.5	99.7	19.7	67.9	4.2	57.9	70.2	10.7	4.5	131.7	13.8	40.5	121.1	47.3	1.1	38.8	11.5	71.1	16.5	46.3	7.0	85.9	4.3	3.0	45.0	88.4	58.9	58.2	18.5	26.0	5.4	1.7	2.4	16.2	1.4	0.4	0.8	0.1	25.2	29.8	0.5	30.9	5.1	26.8	90.9	5.7	70.1	0.3	32.0	9.9	0.2	18.7	6.7	5.0	0.0	1.2	3.3	35.4	0.4	0.5	16.1	2.0	1.4	17.3	0.7	4.0	36.5	2.0	0.1	4.5	31.8	3.8	3.9	19.5	2.2	13.1	93.5	4.7	2.5	5.4	41.4	19.4	8.6	103.0	0.6	4.3	12.8	11.7	1.2	13.6	0.8	0.1	2.6	8.4	0.0	11.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	24.1	49.5	47.9	20.2	17.5	40.7	68.7	47.3	57.9	38.8	46.3	58.9	1.9	35.3	24.6	54.5	3.8	53.0	68.3	125.5	67.2	7.4	77.0	57.9	18.0	37.1	79.8	90.1	0.0	63.6	1.5	109.7	5.9	125.5	15.1	58.5	6.5	4.1	46.2	2.7	1.2	76.2	26.0	7.4	63.7	58.4	1.3	29.5	2.2	0.6	6.1	6.7	7.5	69.8	109.9	0.8	5.4	30.1	8.4	2.5	16.0	9.4	13.1	139.9	1.0	60.3	73.8	71.5	78.2	5.3	0.8	68.1	77.3	5.4	104.2	8.0	6.6	10.5	11.9	1.5	6.8	81.8	51.9	46.5	1.9	4.1	67.1	88.4
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15634346	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		86000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	52.8	53.4	32.6	39.0	33.5	37.8	61.7	36.1	44.2	49.9	39.6	54.3	45.0	45.4	48.0	56.5	42.4	31.7	97.6	33.8	37.1	76.7	62.0	38.9	35.3	36.8	32.6	45.7	59.0	89.5	46.7	50.9	36.0	44.6	58.0	55.5	52.9	47.8	157.9	50.3	46.0	56.5	34.7	33.8	50.5	42.5	35.3	47.0	62.3	134.2	46.8	48.4	41.0	36.3	84.1	127.1	172.3	126.2	148.1	125.5	193.3	176.8	142.6	165.1	135.9	203.0	80.7	221.8	80.4	202.8	120.9	118.8	245.5	166.8	170.7	94.6	154.3	244.5	150.6	241.8	110.2	204.5	102.3	101.2	105.9	140.6	129.6	100.8	151.0	98.4	253.4	61.8	161.9	112.2	110.3	126.7	221.0	205.6	104.4	125.0	276.8	152.6	178.9	161.9	136.6	169.3	124.3	118.0	154.8	123.2	83.6	77.5	133.7	132.1	139.8	84.2	197.2	84.5	169.3	296.2	120.5	153.7	128.4	32.4	34.5	20.3	31.0	42.0	33.2	28.6	35.8	37.0	38.8	30.5	39.9	35.8	3.0	38.5	42.0	30.1	38.1	34.1	32.6	33.5	36.1	44.2	33.8	37.1	36.8	32.6	36.0	34.7	35.3	36.3	41.3	80.1	57.6	25.8	34.9	40.3	57.2	96.4	31.9	58.9	50.3	41.5	362.7	67.2	78.6	90.1	52.1	112.1	29.0	43.7	142.8	112.3	23.1	49.2	69.6	57.2	52.1	64.2	52.1	120.3	108.5	67.0	28.5	51.2	57.0	49.3	47.5	123.0	53.4	45.4	48.6	69.8	83.4	30.3	19.7	19.5	72.7	28.1	49.8	29.0	41.2	60.1	55.6	45.8	49.0	107.2	52.4	78.2	32.8	31.3	74.5	170.2	80.6	75.9	59.2	51.3	94.6	174.0	76.8	30.0	42.3	80.2	30.7	73.5	74.1	36.6
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073860-31104799	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	Nucleoplasm,Nucleoli		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA065197: AB_2685430"	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	5.9	6.4	6.0	10.2	6.8	29.2	7.2	6.9	7.3	10.7	7.1	9.6	8.0	7.5	4.3	9.5	8.0	5.9	5.3	6.0	6.1	9.2	9.3	6.1	13.2	6.9	6.4	11.0	17.5	5.8	9.4	5.4	6.9	10.0	10.1	6.6	8.6	5.3	10.6	16.7	13.4	3.6	6.1	13.8	9.6	8.8	6.7	24.0	8.0	6.6	11.1	6.9	9.8	6.9	36.5	35.0	42.2	34.5	5.8	11.0	58.7	21.8	10.4	25.2	28.5	44.1	58.6	49.2	23.9	10.8	23.6	35.0	31.7	28.9	21.3	43.4	66.6	47.4	71.0	25.4	2.1	37.4	35.0	11.9	13.0	32.6	24.8	16.9	12.6	55.2	26.6	103.3	17.6	30.9	64.5	60.7	84.0	39.9	19.5	55.0	53.3	66.2	13.3	38.5	30.2	21.7	23.4	33.2	10.4	65.0	27.3	25.5	8.2	22.0	42.1	42.2	40.0	39.4	29.6	95.3	24.6	32.5	20.3	0.0	1.3	0.8	2.0	1.2	1.5	2.5	1.9	1.5	1.5	2.6	2.0	2.6	0.5	2.2	4.4	2.4	2.0	1.3	6.0	6.8	6.9	7.3	6.0	6.1	6.9	6.4	6.9	6.1	6.7	6.9	10.1	3.2	9.5	1.6	9.0	6.0	4.0	6.0	2.2	9.4	8.3	7.1	2.5	4.3	6.0	0.0	14.6	7.6	8.8	7.8	0.0	2.0	1.7	5.5	8.9	5.4	0.0	15.3	2.5	3.3	7.5	5.7	9.7	7.4	5.7	15.6	6.1	7.7	5.2	8.4	3.6	6.5	10.2	4.1	5.4	1.3	7.2	4.4	7.2	3.7	3.5	2.7	4.1	1.5	1.7	3.2	2.7	4.5	17.2	6.0	2.3	1.4	6.7	25.8	0.0	4.9	4.8	5.3	18.0	5.5	6.5	2.6	8.4	4.1	9.5	5.1
DDX19A	"DDX19L, FLJ11126"	ENSG00000168872	"DEAD-box helicase 19A"	Q9NUU7	16	70346861-70373383	"Enzymes, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045252, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA045252: AB_10961128, HPA066668: "	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.38e-4)"	"prognostic unfavorable (8.05e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.68e-3)"	20.1	19.1	11.3	14.2	12.0	12.6	17.6	12.5	12.6	16.3	12.6	21.4	10.3	20.8	14.1	19.8	17.2	16.0	22.9	11.1	12.4	17.5	21.8	15.6	19.1	12.2	12.2	21.7	17.3	24.8	11.9	23.6	12.6	15.4	15.0	12.6	14.5	20.8	58.4	16.4	14.0	26.9	12.1	15.2	16.9	7.4	12.7	21.0	20.3	38.5	20.5	22.3	14.5	12.5	36.5	39.9	42.4	43.8	60.8	41.7	39.6	45.8	46.7	70.0	54.1	60.9	27.5	60.4	41.8	49.2	34.1	41.6	75.3	45.2	60.4	20.0	41.1	31.7	32.0	75.5	55.0	56.9	26.3	51.0	31.7	65.3	49.8	35.1	46.3	43.5	77.6	15.6	42.6	53.0	62.2	47.8	68.6	43.6	24.6	79.2	27.9	84.8	42.3	23.0	35.1	45.8	115.3	25.4	35.6	43.8	47.4	35.5	31.0	49.0	39.2	31.4	43.9	44.6	70.5	132.7	32.8	50.8	50.5	9.3	8.6	4.7	7.3	8.0	6.7	5.3	6.4	7.2	10.5	5.8	7.0	7.4	0.8	7.1	7.6	5.9	6.0	7.0	11.3	12.0	12.5	12.6	11.1	12.4	12.2	12.2	12.6	12.1	12.7	12.5	14.8	16.0	20.7	15.3	19.1	9.9	21.2	8.6	14.8	35.0	10.4	11.0	18.0	22.8	17.5	11.0	33.3	23.0	12.7	8.2	9.8	14.7	3.2	14.7	18.6	15.6	14.4	21.0	23.4	13.8	16.3	16.0	7.1	15.2	17.7	18.0	12.5	19.5	14.0	23.5	25.7	10.1	2.0	14.2	9.5	2.0	26.1	11.2	10.6	2.8	19.2	15.6	27.8	8.5	10.9	14.0	9.5	12.4	19.8	23.0	8.7	13.3	12.8	32.3	26.3	14.7	15.1	14.7	15.7	16.3	10.2	17.2	16.3	18.0	13.6	16.0
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335305	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 207.8;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	26.9	20.5	8.2	14.8	8.3	29.5	23.8	13.5	9.2	15.7	9.4	18.9	18.9	16.3	13.2	18.6	16.6	15.2	17.7	7.9	8.4	20.5	40.0	19.2	22.1	8.4	8.4	15.7	21.0	19.0	14.4	14.8	8.6	16.1	23.3	19.4	19.0	17.5	31.7	32.3	19.5	20.1	8.3	18.1	22.1	45.9	8.3	23.0	20.0	23.0	25.7	20.0	16.2	9.8	5.3	31.8	44.3	40.3	23.9	31.6	38.0	25.3	36.0	54.6	56.6	67.7	38.5	41.9	23.5	32.2	22.3	31.2	0.2	14.7	56.1	17.7	28.5	25.0	20.0	56.5	51.4	53.7	22.9	39.3	28.0	41.5	31.2	22.5	42.5	12.7	25.1	17.3	33.7	37.1	0.1	77.0	27.6	19.9	13.1	73.9	23.8	59.9	33.2	29.5	29.0	37.1	60.0	13.7	33.1	19.3	30.5	47.1	25.8	25.8	22.6	21.6	23.6	37.6	20.7	96.4	8.7	41.1	33.8	80.6	46.4	42.0	46.5	61.1	45.0	45.8	41.3	50.6	44.6	45.3	36.4	35.1	8.7	52.6	40.2	14.2	77.8	54.6	8.2	8.3	13.5	9.2	7.9	8.4	8.4	8.4	8.6	8.3	8.3	9.8	16.7	12.8	21.8	7.5	21.4	9.4	16.5	20.3	11.4	18.4	12.4	11.2	8.0	14.3	20.8	11.0	12.5	19.7	19.5	25.4	31.3	42.3	207.8	10.6	8.1	19.6	22.0	8.6	11.7	66.1	24.4	16.7	13.7	10.6	11.4	13.8	12.5	15.5	29.3	10.1	12.4	18.4	16.2	21.0	21.6	46.7	20.8	17.1	3.6	6.5	33.6	17.0	28.8	7.5	11.0	45.8	35.3	15.8	13.2	28.6	49.3	23.5	24.4	17.9	13.1	9.7	13.7	101.7	7.4	9.2	10.4	31.6	19.0	13.9	22.2	20.4
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111754832-111775602	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 52.8"	"Group enriched"	"Detected in all"	5	"Early spermatids: 738.2;Late spermatids: 718.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	4.6	3.6	0.8	1.3	0.7	2.3	4.3	0.4	0.9	4.2	0.3	3.9	0.5	4.8	0.9	3.3	4.5	1.6	3.6	0.8	0.7	3.0	2.6	3.2	3.0	0.7	0.8	4.3	3.6	2.5	1.9	2.4	0.5	3.0	1.9	0.8	3.3	2.5	8.8	3.6	4.3	2.8	0.5	4.8	3.8	52.8	0.6	3.7	3.2	1.8	4.2	4.0	3.3	1.3	7.0	3.8	7.1	7.3	4.7	5.0	7.0	3.3	9.1	16.3	18.6	5.8	4.5	17.7	5.2	6.4	3.9	5.8	13.5	9.4	18.2	7.3	9.2	7.4	3.2	3.0	4.6	8.4	6.1	3.0	10.4	9.2	12.2	2.4	12.8	7.2	10.8	5.9	12.0	6.5	11.8	0.9	14.1	5.2	8.5	11.3	12.7	5.3	4.8	5.2	11.7	9.5	6.7	7.0	12.7	5.7	7.0	8.5	3.5	7.9	8.2	13.2	8.6	1.2	5.3	12.3	7.5	8.1	18.5	14.9	6.2	6.0	8.2	5.6	10.7	9.3	9.1	8.4	6.8	9.1	10.6	8.6	3.4	9.1	6.6	3.5	10.0	6.9	0.8	0.7	0.4	0.9	0.8	0.7	0.7	0.8	0.5	0.5	0.6	1.3	8.5	12.8	9.4	6.8	13.0	10.8	9.7	6.0	9.6	14.3	6.5	6.6	7.7	5.7	10.0	5.5	2.1	10.2	9.4	2.9	3.9	9.5	738.2	8.1	12.0	9.3	4.2	5.9	7.4	6.9	7.5	6.9	5.1	5.4	7.6	12.3	5.7	5.9	9.3	6.7	7.7	5.8	8.2	7.2	7.0	718.9	16.4	7.3	1.8	3.7	7.5	6.9	6.2	3.0	3.6	6.3	2.3	13.2	9.0	5.2	3.0	7.6	11.8	10.4	6.6	9.7	11.7	121.7	26.3	7.0	7.2	5.1	11.1	14.0	6.6	5.5
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956170-68985068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 589.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		40000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	55.9	27.9	7.9	52.7	8.8	103.5	36.2	8.9	9.3	22.0	7.7	26.5	25.5	25.2	13.4	40.3	24.0	32.4	21.9	7.4	9.7	30.0	42.1	31.5	50.0	10.8	10.1	20.1	45.7	24.5	12.9	38.0	11.0	19.0	32.0	8.1	20.5	17.5	47.9	30.1	21.8	28.4	10.7	30.2	26.4	22.5	8.8	33.6	25.1	26.9	51.0	81.7	23.5	11.3	194.4	112.5	64.5	199.7	56.7	74.4	135.6	129.8	104.3	163.8	138.3	366.7	128.8	289.5	77.8	108.2	77.2	168.1	250.4	161.8	217.5	90.7	176.1	203.2	76.9	153.3	121.2	488.9	184.7	76.8	205.2	196.2	324.5	76.1	121.3	106.8	393.8	140.5	116.8	88.1	192.9	106.1	176.3	91.8	236.8	170.1	105.3	143.0	108.2	102.7	132.5	141.6	116.6	254.8	155.5	76.8	144.9	101.1	125.6	95.5	136.0	129.8	230.7	160.4	228.2	418.2	79.3	362.4	66.5	7.6	10.9	20.4	8.7	17.1	15.9	14.0	11.4	11.8	13.0	12.3	10.6	11.8	4.9	9.4	21.2	12.1	9.2	7.5	7.9	8.8	8.9	9.3	7.4	9.7	10.8	10.1	11.0	10.7	8.8	11.3	199.4	102.5	141.6	8.1	243.7	550.2	346.2	103.8	174.2	25.9	159.9	113.7	74.2	94.4	144.1	71.7	41.7	80.8	139.5	134.0	72.4	141.2	50.8	116.7	260.7	196.7	86.7	98.6	18.5	187.8	151.8	162.2	120.8	201.8	168.5	57.1	104.2	215.3	112.4	25.2	16.0	202.7	67.1	154.5	266.8	19.7	89.5	199.1	124.5	12.2	138.1	25.8	64.9	13.6	18.2	222.9	77.7	77.1	148.9	465.3	59.9	128.2	72.8	29.8	26.3	302.6	174.9	105.5	114.8	224.8	589.7	137.5	159.6	99.4	210.7	375.5
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829756-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		21000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: AB_2676317"	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	33.2	30.7	28.7	36.9	30.8	26.5	33.1	29.7	29.6	35.3	33.1	39.3	33.5	35.1	25.0	37.5	35.4	25.4	30.1	28.0	29.9	33.0	43.0	33.8	46.6	30.7	29.9	40.6	36.7	34.5	28.4	33.7	29.7	36.1	37.6	27.8	37.3	29.7	54.4	39.2	41.2	34.0	30.1	47.6	38.3	26.7	30.8	63.3	32.9	35.8	48.1	36.1	34.7	30.4	74.0	165.1	76.6	81.5	74.7	51.4	81.3	89.1	68.1	98.9	62.5	162.0	95.7	92.5	95.6	74.4	93.3	64.9	168.1	81.1	84.0	146.1	89.2	122.7	139.0	73.8	40.3	125.3	106.9	49.9	71.7	105.1	62.6	67.6	82.4	80.4	165.6	80.3	72.9	102.1	119.8	118.2	114.4	104.0	77.4	125.9	90.7	73.5	58.3	101.9	94.1	54.9	89.4	101.0	38.4	78.0	99.0	113.7	74.5	74.4	54.1	37.2	71.8	60.1	89.8	109.5	63.3	86.8	41.8	20.9	11.8	21.9	19.3	13.6	19.6	12.6	14.1	17.5	11.3	10.5	13.5	16.6	12.2	12.8	9.8	11.9	14.3	12.0	28.7	30.8	29.7	29.6	28.0	29.9	30.7	29.9	29.7	30.1	30.8	30.4	22.7	25.6	36.5	11.8	25.5	12.9	13.7	12.7	25.6	17.5	18.6	19.4	20.0	22.8	25.8	12.9	25.0	25.9	30.7	33.0	15.6	25.9	14.4	24.4	25.2	27.2	13.9	21.7	6.9	38.9	29.1	19.2	25.5	26.6	18.3	29.8	17.9	18.7	19.1	15.2	8.7	26.6	16.2	13.2	10.3	6.3	24.5	16.5	14.2	9.4	25.5	26.2	35.0	7.5	8.4	33.9	32.3	22.2	32.0	26.7	24.3	12.5	34.4	26.1	19.7	20.8	20.0	43.8	33.1	24.4	15.2	26.5	28.6	21.1	27.3	21.6
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 91.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 332.1;Spermatocytes: 266.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"JURKAT: 16.1;NTERA-2: 10.8;SCLC-21H: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.4	2.7	15.0	0.1	16.1	0.3	0.3	12.4	17.0	0.3	4.0	0.4	0.4	0.3	0.2	0.1	0.6	0.1	0.0	14.3	16.7	2.6	0.3	0.2	0.1	8.7	10.4	0.6	1.4	1.7	14.9	0.2	10.6	0.2	0.1	21.8	0.2	0.4	0.1	1.1	0.1	0.0	7.6	0.3	0.4	91.4	15.0	0.6	4.7	0.1	0.1	0.0	0.2	13.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.5	1.7	0.0	10.8	0.5	0.0	0.4	0.0	0.0	0.0	0.1	8.7	1.9	0.1	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	15.0	16.1	12.4	17.0	14.3	16.7	8.7	10.4	10.6	7.6	15.0	13.5	0.2	0.0	0.5	16.0	0.5	0.1	0.8	0.0	2.2	18.0	0.1	0.8	1.1	0.0	0.0	0.0	16.7	0.1	0.0	0.0	3.9	0.3	332.1	0.2	0.0	1.0	0.0	0.0	18.0	0.2	0.2	0.4	0.0	0.1	0.0	2.3	0.4	0.5	0.1	16.8	23.1	0.0	0.0	0.0	0.3	66.0	3.7	0.4	0.0	1.9	0.0	20.2	0.0	15.6	3.1	0.1	0.0	4.9	0.0	0.5	0.0	2.7	0.0	16.6	0.0	0.2	0.3	266.3	28.6	0.4	0.0	0.0	0.1	4.0	0.0	0.2
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3 X-linked"	O00571	X	41333348-41364472	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 887.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		260000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	164.7	123.2	28.7	113.3	29.9	146.1	99.8	31.9	37.3	102.4	38.8	85.6	80.7	123.4	39.1	107.6	108.8	111.0	96.4	27.0	36.0	110.5	130.6	103.5	118.7	33.6	29.8	108.1	76.9	133.0	52.5	107.3	34.2	68.7	75.8	81.9	72.9	64.8	126.9	91.2	81.6	145.1	32.4	103.2	84.4	43.0	30.9	169.6	104.3	112.5	111.5	153.3	97.7	34.7	230.5	225.6	236.3	122.3	273.6	211.1	136.4	150.6	239.3	167.1	132.3	238.8	141.4	2.5	103.9	185.8	212.4	149.4	292.2	235.0	248.3	130.2	232.9	132.6	237.6	152.1	140.5	253.8	236.4	159.1	150.9	278.4	270.3	204.1	258.3	131.5	258.4	134.5	158.9	157.8	163.0	83.2	212.2	121.3	114.2	187.8	223.3	182.6	143.7	279.1	147.1	220.0	352.3	184.3	194.3	248.9	158.9	172.4	224.5	159.6	166.3	178.7	188.2	153.6	194.0	215.7	161.5	156.1	151.5	50.8	39.0	30.7	23.3	35.3	33.5	21.0	23.3	26.3	34.7	13.0	25.4	25.3	54.0	30.7	39.4	11.7	24.8	37.8	28.7	29.9	31.9	37.3	27.0	36.0	33.6	29.8	34.2	32.4	30.9	34.7	466.5	86.6	150.0	66.9	280.1	264.3	160.5	63.7	191.8	77.1	295.1	237.6	158.0	81.5	96.5	58.8	131.3	94.6	415.2	231.1	43.0	64.3	370.6	261.1	237.7	238.5	183.7	113.0	43.8	85.6	95.1	191.8	178.9	290.1	165.5	180.6	144.2	174.5	123.1	60.6	47.1	161.4	71.2	208.7	269.1	887.5	66.5	319.0	128.1	47.8	112.2	90.0	79.3	44.7	63.1	114.1	156.7	62.8	241.8	145.0	234.9	87.3	102.5	127.1	72.3	351.4	210.1	30.6	57.7	212.6	333.4	172.9	342.4	144.8	129.1	225.8
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3 Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 275.5;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 31.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 153.7;HEL: 156.8;U-266/84: 133.1;U-698: 112.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	29.0	26.1	2.8	15.2	2.9	96.0	20.7	5.5	31.8	0.0	6.6	25.8	12.0	0.0	26.8	18.5	0.0	18.7	19.1	2.7	5.5	23.7	22.0	27.4	9.6	2.8	3.3	0.1	14.8	12.4	25.1	22.1	3.2	33.6	24.0	23.6	18.5	31.3	19.9	20.2	25.9	0.0	2.3	26.5	19.8	70.1	3.8	0.0	22.0	28.1	23.6	22.0	0.0	4.6	0.7	28.3	0.0	0.0	0.0	0.0	20.0	69.3	49.9	35.9	44.0	0.2	0.0	153.7	0.1	69.5	0.0	0.0	0.0	0.0	63.2	38.8	0.0	156.8	0.0	46.5	34.2	0.1	0.1	37.4	43.4	0.0	0.0	0.0	0.0	15.2	0.2	0.1	43.1	0.2	61.8	0.2	27.1	0.0	0.0	0.0	18.0	28.2	38.2	41.5	44.5	0.1	0.1	0.2	51.4	43.5	0.0	36.5	49.1	55.0	0.3	0.1	45.8	78.7	133.1	112.8	6.9	0.1	0.0	1.5	3.8	3.2	4.4	3.9	4.0	3.2	3.3	3.7	4.9	2.7	3.9	3.5	3.5	3.4	2.4	1.4	3.0	3.2	2.8	2.9	5.5	31.8	2.7	5.5	2.8	3.3	3.2	2.3	3.8	4.6	0.1	48.1	75.8	10.1	58.0	94.1	92.7	37.5	89.4	53.8	0.0	0.0	26.0	10.0	41.2	9.2	41.7	38.3	13.3	5.6	5.9	13.9	275.5	0.0	0.0	56.5	16.0	24.6	19.7	0.2	18.9	63.4	56.1	0.0	92.9	0.0	42.1	9.1	20.1	42.1	15.7	9.3	10.2	64.1	127.5	575.3	38.8	58.2	26.6	5.6	27.8	53.7	26.8	4.0	5.7	5.0	8.8	39.5	54.7	70.8	10.5	13.9	101.2	49.3	19.7	56.2	39.2	67.2	70.1	43.8	80.4	37.8	66.2	0.0	8.1	75.0
DDX4	VASA	ENSG00000152670	"DEAD-box helicase 4"	Q9NQI0	5	55738017-55817157	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"testis: 149.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 565.1;Late spermatids: 184.1;Spermatocytes: 320.9"	"Cancer enriched"	"Detected in single"	37	"testis cancer: 3.0"	"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;PC-3: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026170, HPA037763, HPA037764"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB026170: , HPA037763: AB_2675652, HPA037764: AB_2675653"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.54e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.43e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.55e-1)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	149.7	0.3	0.3	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.2	0.1	0.3	0.1	0.2	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	565.1	0.0	0.0	0.4	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	12.2	0.0	0.0	184.1	5.6	0.5	0.0	1.0	0.0	0.0	0.0	1.5	8.7	0.1	0.0	3.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	320.9	83.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177516961	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	26.5	29.0	15.1	28.7	16.1	22.3	25.4	13.1	21.9	26.1	13.7	26.5	24.8	25.2	16.8	33.7	30.6	18.3	18.9	17.8	14.2	26.8	27.1	24.5	24.7	15.8	13.7	28.6	23.5	31.2	18.0	22.8	16.0	22.3	19.3	14.6	28.7	19.1	43.4	35.0	28.7	20.1	12.8	26.7	26.7	17.9	16.2	24.3	29.0	20.3	25.0	24.8	27.6	16.4	62.1	71.4	42.4	44.9	43.4	45.2	125.1	58.4	35.1	47.1	36.1	107.7	61.3	67.2	83.3	57.6	67.6	47.8	57.2	128.5	33.2	175.4	68.0	90.5	70.8	66.5	52.5	89.3	82.3	48.7	47.0	45.3	59.0	43.5	53.4	68.1	72.3	50.0	55.6	135.5	80.6	45.9	62.0	59.0	61.3	72.7	48.1	86.2	50.5	78.8	45.0	41.9	64.6	83.2	56.5	27.1	54.6	110.2	51.3	74.4	42.8	43.6	87.6	49.6	75.9	120.1	81.3	100.1	47.0	14.3	31.4	22.3	18.3	28.5	23.5	17.0	18.3	16.8	27.2	14.4	14.6	18.8	9.2	25.8	31.4	11.2	18.8	25.6	15.1	16.1	13.1	21.9	17.8	14.2	15.8	13.7	16.0	12.8	16.2	16.4	17.0	25.6	17.8	7.8	20.6	21.0	22.9	37.9	18.2	16.9	17.5	16.5	9.0	25.8	24.3	9.2	2.1	46.6	22.9	22.9	41.1	42.1	11.2	16.1	16.5	22.3	11.4	25.2	6.0	39.6	63.2	17.6	17.3	19.2	29.8	21.3	16.1	18.0	48.8	8.4	6.4	27.0	18.3	23.5	15.4	22.9	14.9	22.2	12.4	4.7	34.6	23.9	20.6	5.0	3.9	33.5	23.9	21.1	23.2	19.0	29.5	40.1	20.5	10.3	13.1	14.5	29.0	24.5	26.7	26.2	20.3	37.5	19.0	25.6	31.0	22.7
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64498254-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043, HPA071154"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		310000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: "	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	202.9	124.0	75.2	75.7	80.0	219.5	163.4	93.4	91.3	190.4	122.8	176.8	36.1	181.7	61.9	136.9	181.2	186.4	109.8	83.6	83.8	113.6	157.5	185.9	124.7	85.5	79.7	134.2	83.3	177.7	118.9	119.4	79.0	122.8	157.7	211.7	112.0	144.8	165.7	130.6	116.3	274.6	65.4	127.5	137.1	88.7	83.2	272.5	172.8	107.5	157.5	228.2	128.9	100.2	204.7	85.5	353.1	144.4	316.2	316.7	134.1	221.4	349.8	306.9	300.3	98.2	105.3	299.7	102.0	364.8	238.1	87.1	361.6	291.5	428.2	107.7	76.0	211.2	84.5	81.6	216.6	383.9	186.3	301.4	306.8	270.2	264.1	241.5	362.2	303.6	174.3	247.3	284.0	108.7	520.4	44.8	159.5	294.5	32.0	310.1	286.7	239.1	201.8	145.6	151.0	305.7	181.5	167.6	284.0	326.5	138.5	132.1	158.2	123.0	146.3	170.0	207.3	112.2	283.9	622.0	166.6	140.5	184.2	232.6	160.6	170.0	117.2	143.3	149.8	111.5	105.4	125.4	148.5	106.3	107.6	109.4	86.6	112.2	197.1	85.5	135.9	319.9	75.2	80.0	93.4	91.3	83.6	83.8	85.5	79.7	79.0	65.4	83.2	100.2	990.8	535.2	690.9	200.8	909.4	879.5	1536.4	837.0	618.1	403.5	433.3	393.7	249.6	346.0	855.7	369.6	335.7	439.9	1284.6	521.5	334.6	476.2	603.0	1021.9	987.2	767.7	664.1	309.7	187.9	419.2	371.3	733.5	452.1	1288.8	874.3	647.9	528.7	254.3	445.8	420.6	165.7	475.9	801.5	577.8	629.4	136.9	415.4	833.2	432.2	280.1	800.2	587.1	777.5	291.6	325.7	464.2	598.6	437.8	661.5	537.7	552.6	287.5	737.9	550.4	493.0	1437.7	961.5	407.6	399.1	466.4	746.0	887.3	1043.4	745.0	424.7	1056.4
DDX51		ENSG00000185163	"DEAD-box helicase 51"	Q8N8A6	12	132136594-132144319	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039503	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA039503: AB_10796328"	"unprognostic (2.84e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.65e-3)"	8.5	7.1	4.6	1.9	4.7	4.3	8.6	4.5	5.8	9.7	3.3	8.6	1.6	8.5	2.4	7.2	10.5	1.0	6.8	4.8	4.0	9.3	6.9	6.8	2.5	4.5	4.3	12.9	11.2	1.9	8.7	1.3	4.7	8.7	1.4	2.6	6.9	2.3	9.7	12.0	8.0	1.7	4.2	9.6	8.1	6.7	4.2	2.3	8.5	1.4	1.9	9.3	8.0	5.1	4.1	6.5	2.7	3.4	2.5	2.4	5.0	3.1	1.8	4.5	1.9	4.0	2.0	7.2	2.6	1.9	1.0	4.2	6.7	5.0	2.2	1.7	6.5	8.5	3.8	1.3	3.0	6.0	4.7	2.1	3.6	2.5	2.3	5.0	2.4	7.8	6.4	2.3	1.3	4.1	7.4	12.2	4.7	3.4	11.0	8.6	3.6	7.9	3.1	3.2	6.5	3.4	3.4	4.8	3.5	2.2	4.2	5.5	4.2	1.7	5.1	4.1	7.2	6.4	4.0	8.2	3.5	4.5	4.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.1	4.6	4.7	4.5	5.8	4.8	4.0	4.5	4.3	4.7	4.2	4.2	5.1	9.5	3.2	17.3	5.2	8.4	12.5	10.1	2.9	7.4	28.5	9.9	10.4	4.5	10.0	9.0	3.7	25.0	6.7	12.9	7.6	1.9	4.1	1.0	6.4	9.2	8.6	8.4	5.0	22.1	5.3	6.4	9.5	9.7	8.8	6.3	18.2	6.8	7.3	5.6	33.7	17.1	11.1	0.0	6.3	8.0	1.1	8.4	6.4	10.6	11.2	4.6	11.7	11.3	8.0	9.0	6.0	8.0	8.2	8.4	11.3	3.3	3.4	4.4	28.0	0.0	17.7	9.1	7.0	11.1	6.3	14.1	4.1	11.1	17.2	12.8	6.8
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643446	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 245.1;Glandular and luminal cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA056173: AB_2683056"	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	1.8	2.5	1.6	1.0	1.6	4.2	1.7	2.3	2.0	2.0	2.1	2.2	2.0	2.2	3.9	3.1	1.6	1.8	1.8	1.6	1.7	2.6	2.8	1.8	2.1	1.7	1.6	1.5	2.9	2.2	1.4	1.7	1.9	1.7	2.2	2.1	1.9	1.7	2.5	2.8	3.3	1.8	1.4	2.0	2.4	1.8	1.7	1.5	1.3	1.8	2.1	2.4	1.9	2.2	4.7	10.2	1.0	9.4	5.2	4.6	4.0	6.3	5.4	8.1	7.7	6.6	1.7	2.8	4.2	4.3	1.5	4.4	10.5	7.2	11.0	6.5	12.8	5.9	6.6	4.6	5.1	7.8	3.1	4.5	7.6	5.5	6.3	4.1	9.4	2.7	0.9	1.7	4.7	1.6	11.9	4.3	5.4	2.6	0.8	7.3	8.4	4.9	9.9	5.8	6.6	5.5	7.5	1.8	5.2	5.0	3.3	6.1	6.7	6.6	4.2	3.6	7.3	2.2	3.8	4.9	5.3	4.6	5.2	0.9	0.5	0.7	0.8	0.7	0.6	0.6	0.8	0.6	0.4	0.6	0.7	0.9	0.4	0.8	0.4	1.2	0.5	0.2	1.6	1.6	2.3	2.0	1.6	1.7	1.7	1.6	1.9	1.4	1.7	2.2	28.5	41.7	19.7	17.3	29.4	34.5	33.9	41.2	26.2	34.0	25.4	22.7	33.3	18.6	41.4	27.6	33.3	35.4	47.4	28.7	35.2	76.6	245.1	105.8	77.7	32.3	26.3	42.7	19.4	52.3	31.1	28.1	29.6	360.4	27.3	40.8	28.5	37.2	26.1	47.1	19.3	30.1	34.6	25.8	12.6	97.8	24.5	24.1	17.8	19.7	53.8	26.0	33.0	29.7	23.0	56.8	20.5	24.0	25.4	35.8	35.7	40.2	32.0	36.0	26.3	26.7	34.1	29.6	56.0	33.4	33.2	25.0	30.3	43.7	46.8	49.5
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999960-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"brain: 2.1;testis: 5.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 62.6"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.7"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;K-562: 4.6;RPMI-8226: 2.4;U-2197: 1.4;U-266/84: 10.5"									HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.3	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.9	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX54	"APR-5, DP97, MGC2835"	ENSG00000123064	"DEAD-box helicase 54"	Q8TDD1	12	113157173-113185479	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028244, HPA070786"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA028244: AB_10603885, HPA070786: AB_2686311"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-1)"	19.6	21.7	7.4	28.9	8.6	38.8	18.7	8.0	9.7	20.0	12.0	17.9	26.8	21.4	5.6	24.0	21.1	13.3	17.8	7.4	7.3	16.2	20.8	17.0	28.5	8.9	8.1	23.2	30.3	20.7	8.4	16.8	9.3	16.2	11.4	7.3	19.7	15.8	53.9	24.7	21.0	13.5	7.7	21.5	21.8	9.2	9.2	21.3	19.0	20.4	16.5	19.9	18.2	9.0	82.7	84.0	30.8	57.1	20.2	24.1	79.3	43.8	40.3	58.3	31.9	87.1	39.0	105.8	49.7	36.8	43.4	59.8	55.0	56.8	22.0	61.3	67.7	64.0	45.1	60.3	35.3	107.5	72.1	39.8	44.1	56.7	34.7	47.7	48.4	63.2	94.2	37.1	30.4	75.8	93.0	152.4	72.1	57.6	59.2	68.2	45.6	107.8	31.7	84.3	39.8	36.0	61.8	93.4	39.9	25.2	80.4	82.6	36.3	49.2	54.8	59.1	92.7	53.3	66.4	119.5	43.4	59.0	52.9	13.0	11.3	2.9	12.6	16.7	13.1	12.4	11.5	12.6	14.5	11.3	11.6	12.9	0.6	13.1	11.7	10.9	10.1	12.7	7.4	8.6	8.0	9.7	7.4	7.3	8.9	8.1	9.3	7.7	9.2	9.0	19.1	32.1	29.8	6.5	39.4	17.3	35.9	26.4	34.7	20.5	28.2	24.3	14.5	21.5	24.1	12.9	2.1	63.9	30.6	29.2	25.4	44.5	1.2	23.3	21.8	25.7	28.2	33.4	5.9	49.9	57.2	23.2	26.0	28.5	25.3	35.6	17.9	38.2	38.6	26.9	4.3	31.5	24.4	35.9	20.9	2.4	29.5	22.3	12.4	6.5	29.5	26.8	51.5	2.0	4.8	43.0	33.4	24.0	35.0	52.9	49.3	50.5	12.8	18.1	6.6	28.7	24.9	14.8	20.1	39.5	19.6	72.4	33.3	56.8	43.8	38.0
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620943	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 74.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA039962: AB_2676774, HPA044101: AB_2678810"	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	11.0	10.3	11.1	10.4	11.1	20.3	11.1	13.2	19.5	12.1	11.2	9.7	7.6	9.6	7.7	11.1	12.2	5.6	6.9	10.7	11.4	12.3	14.7	8.4	13.8	11.5	10.8	13.1	15.4	6.5	11.3	7.7	11.6	11.4	8.8	12.6	9.5	6.3	6.4	13.6	10.8	7.1	9.9	14.9	9.7	9.6	11.3	10.3	9.1	3.4	10.7	10.7	11.1	12.9	20.5	28.4	21.4	21.7	18.0	14.2	32.2	24.8	9.1	21.6	14.8	32.5	14.6	30.2	19.3	10.9	19.5	24.4	32.8	18.4	25.1	22.8	29.7	40.8	34.0	24.3	13.7	50.7	30.7	12.0	19.2	25.7	29.5	16.7	15.8	23.9	42.3	15.5	15.5	21.1	50.0	68.2	33.3	23.6	27.9	37.1	22.7	19.7	15.2	34.8	25.3	21.0	20.2	25.9	35.0	17.7	46.2	32.4	16.3	18.6	24.5	30.6	31.2	28.4	37.4	54.2	17.7	35.8	32.4	3.4	9.1	7.8	11.4	10.6	12.4	13.9	11.1	12.3	7.7	10.7	14.9	13.9	5.2	13.3	6.4	13.2	9.9	8.6	11.1	11.1	13.2	19.5	10.7	11.4	11.5	10.8	11.6	9.9	11.3	12.9	13.3	22.4	13.9	15.7	14.2	11.0	13.4	13.9	9.6	20.2	9.6	14.9	2.5	8.6	11.7	7.3	22.9	13.8	26.3	5.9	7.9	12.2	45.1	9.0	18.4	12.0	7.2	19.6	13.4	12.0	17.4	12.0	11.2	7.2	25.3	16.4	7.1	9.4	14.3	15.2	16.5	15.9	10.2	7.1	7.4	74.8	17.1	9.0	7.2	12.2	9.9	16.1	15.5	6.6	14.3	13.3	7.6	14.7	13.8	13.3	5.9	6.3	12.3	28.1	6.6	10.5	14.1	21.9	18.6	12.5	16.9	7.7	14.2	14.0	10.2	11.0
DDX59	"DKFZP564B1023, ZNHIT5"	ENSG00000118197	"DEAD-box helicase 59"	Q5T1V6	1	200623896-200669907	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047166	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Actin filaments"		"HPA047166: AB_2679966"	"unprognostic (1.99e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.43e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.98e-2)"	15.4	16.1	13.5	14.2	15.4	33.1	26.5	17.1	18.8	16.2	15.6	14.2	10.2	17.6	20.0	13.5	15.5	12.2	13.3	14.0	14.7	16.4	17.8	14.5	17.0	16.0	15.0	17.6	18.8	15.0	11.3	18.7	17.3	15.2	15.0	17.4	14.4	13.2	32.8	26.2	14.3	14.1	16.3	22.4	12.1	11.0	15.1	22.0	16.2	20.1	16.9	15.0	14.7	17.8	17.5	20.1	22.6	19.0	10.1	17.4	49.9	19.1	17.4	20.5	16.5	6.3	20.2	17.9	9.5	15.7	16.4	16.2	13.0	19.4	14.5	56.8	13.3	13.6	26.4	18.6	20.2	19.5	24.0	18.8	29.1	15.4	41.7	16.7	15.9	24.8	17.4	25.9	20.1	20.0	12.0	29.0	23.8	10.5	16.3	10.1	15.5	34.7	21.9	19.8	13.8	35.7	30.8	31.7	35.6	28.8	27.3	27.3	14.4	17.1	9.5	16.8	20.0	19.5	27.2	23.5	16.3	12.2	30.0	33.3	12.4	24.7	15.1	11.1	12.4	14.9	12.5	13.8	10.6	14.8	12.7	11.8	22.9	16.4	22.0	11.8	19.8	10.2	13.5	15.4	17.1	18.8	14.0	14.7	16.0	15.0	17.3	16.3	15.1	17.8	22.5	19.2	20.1	8.8	19.9	16.2	13.1	16.1	24.5	4.3	10.0	13.2	18.4	7.2	10.6	7.3	2.1	22.2	14.6	9.8	15.6	8.8	2.4	14.6	13.3	16.7	1.2	10.5	4.5	8.2	28.0	14.9	6.6	12.8	20.8	7.1	14.3	7.3	13.0	6.7	6.1	11.0	14.2	12.0	13.0	1.1	8.1	16.1	5.4	8.4	18.5	8.3	25.7	19.1	10.3	8.8	7.9	13.5	13.1	12.0	8.0	11.6	10.8	6.7	0.0	22.8	15.7	14.2	20.0	12.9	15.6	43.8	18.9	9.3	8.5	11.1
DEAF1	"NUDR, SPN, ZMYND5"	ENSG00000177030	"DEAF1 transcription factor"	O75398	11	644233-706715	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030302	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA030302: AB_2673421"	"unprognostic (1.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.15e-2)"	10.9	19.7	51.5	6.5	50.6	9.2	12.5	30.6	67.1	13.2	15.3	12.1	7.8	13.3	10.0	19.8	14.6	9.4	11.0	60.8	32.5	15.4	8.0	9.1	8.7	32.4	36.0	12.4	16.2	11.3	16.9	6.9	32.9	14.6	4.1	4.5	21.4	7.2	16.6	17.5	10.1	8.0	24.5	11.1	20.0	15.0	40.2	9.7	25.3	13.9	6.3	10.7	12.8	45.9	14.1	13.6	22.9	13.1	18.4	22.8	13.5	14.1	18.2	28.3	20.6	9.7	18.6	5.4	14.8	14.0	9.0	14.4	18.1	12.9	4.3	24.2	108.1	13.5	8.5	13.0	32.8	28.0	22.3	20.4	18.1	5.1	15.4	20.1	22.4	15.5	29.0	28.8	11.3	10.9	11.7	31.9	49.9	20.3	24.0	28.1	6.8	24.2	21.9	3.0	27.3	31.8	10.4	18.2	12.9	5.8	8.4	9.7	26.6	10.5	4.7	4.5	13.7	24.5	9.3	10.2	13.4	21.2	22.9	0.0	2.0	2.3	1.6	1.3	1.7	0.6	3.4	1.7	2.8	0.4	3.9	2.0	0.8	2.0	1.2	0.1	1.4	1.1	51.5	50.6	30.6	67.1	60.8	32.5	32.4	36.0	32.9	24.5	40.2	45.9	20.1	0.0	3.9	12.7	8.7	13.3	27.1	11.8	11.4	20.0	35.8	25.7	8.2	18.6	8.0	35.0	10.4	14.9	12.3	10.0	52.8	19.5	3.6	19.6	15.0	19.3	10.9	25.0	33.8	11.1	6.4	20.1	10.7	26.2	0.0	40.1	10.8	12.4	10.0	60.6	35.2	9.3	12.2	12.9	10.2	6.5	19.9	11.2	17.8	17.8	13.7	39.9	7.2	19.1	17.4	15.4	10.6	30.1	9.0	36.0	16.9	34.2	10.0	19.9	13.1	11.4	16.8	7.5	22.1	17.3	15.5	15.5	12.4	42.2	9.1	32.4
DEDD	"CASP8IP1, DEDD1, DEFT, FLDED1, KE05"	ENSG00000158796	"Death effector domain containing"	O75618	1	161120974-161132688	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064486, HPA065101, HPA073628"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA064486: , HPA065101: , HPA073628: AB_2732230"	"unprognostic (2.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.20e-3)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.43e-2)"	34.4	21.4	20.6	19.4	22.0	29.8	29.0	21.9	20.8	26.1	18.8	30.5	20.8	24.7	14.9	25.8	26.5	21.2	24.3	20.2	20.4	21.6	24.3	28.6	21.2	21.3	20.7	28.0	21.2	18.2	17.9	22.1	20.7	23.0	13.7	23.9	20.7	15.8	56.7	29.2	23.5	21.0	20.7	27.8	22.4	28.0	21.5	22.5	24.2	34.9	18.3	26.8	25.1	22.6	24.7	24.0	27.7	24.3	21.0	22.2	19.1	20.7	29.3	23.5	26.1	16.7	41.5	26.2	20.4	31.2	17.2	22.0	21.2	32.5	15.1	26.3	23.1	24.5	30.2	22.7	37.0	17.3	35.5	26.8	34.2	25.3	40.1	31.2	38.5	35.6	21.3	38.3	27.8	38.8	42.4	18.9	46.5	49.1	24.5	34.1	19.1	35.0	23.8	29.6	29.3	44.2	21.1	55.1	37.0	29.9	33.0	34.8	27.3	25.6	27.2	30.0	30.6	52.2	35.6	46.9	30.6	18.5	18.6	64.0	36.9	52.8	27.8	34.6	23.7	24.0	27.4	27.9	33.3	22.7	30.6	25.1	41.2	27.7	38.0	29.2	38.4	31.4	20.6	22.0	21.9	20.8	20.2	20.4	21.3	20.7	20.7	20.7	21.5	22.6	27.8	25.6	9.3	8.5	16.7	25.2	13.9	11.5	14.2	6.8	10.5	8.0	10.6	18.6	10.1	9.2	6.2	19.6	16.2	12.9	23.5	13.6	42.6	9.5	8.3	22.3	11.3	13.7	4.8	19.3	19.6	13.3	15.8	11.3	16.5	7.7	21.0	10.7	14.8	13.5	5.1	8.1	2.0	19.8	27.2	43.5	11.8	16.2	14.2	4.7	20.9	6.7	8.2	5.0	10.8	15.6	13.2	9.8	24.2	10.2	12.5	13.7	7.4	13.2	6.6	12.0	16.5	23.5	18.4	22.2	24.9	27.0	15.0	5.7	9.7	17.4
DEDD2	FLAME-3	ENSG00000160570	"Death effector domain containing 2"	Q8WXF8	19	42198598-42220140	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Paneth cells: 178.2;Syncytiotrophoblasts: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043419			Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA043419: AB_10960747"	"unprognostic (1.59e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (3.26e-6)"	7.0	11.4	16.1	6.6	16.5	12.8	5.8	17.3	23.1	9.4	17.4	8.8	6.7	7.3	3.1	12.3	10.1	2.1	8.6	16.3	24.0	10.7	12.9	13.8	5.3	17.3	18.2	11.3	9.5	4.2	19.3	3.6	21.2	10.6	2.1	3.4	10.0	3.3	9.8	13.0	9.9	1.3	15.3	17.8	9.5	11.7	19.9	7.0	9.9	3.4	4.1	8.8	11.0	23.4	17.1	32.4	2.3	2.8	5.7	1.3	10.5	6.5	5.6	5.2	3.3	9.3	12.2	10.5	12.8	1.9	6.1	7.0	11.1	2.4	2.3	9.0	28.5	5.2	8.7	15.9	6.9	5.8	10.6	0.8	6.3	3.8	5.2	9.5	2.9	4.5	26.7	12.3	1.5	7.2	6.5	21.1	6.0	15.8	22.3	6.8	4.4	9.8	4.1	5.6	19.0	7.1	6.0	18.1	3.6	3.4	3.1	7.2	5.7	3.9	12.6	1.6	12.3	21.4	10.3	3.3	5.8	9.3	4.0	81.7	56.4	94.7	47.9	73.1	51.7	40.6	44.2	46.7	34.6	39.0	39.9	41.2	126.2	40.9	83.1	48.6	46.4	71.9	16.1	16.5	17.3	23.1	16.3	24.0	17.3	18.2	21.2	15.3	19.9	23.4	13.4	6.4	7.5	2.9	47.6	46.4	67.0	30.2	18.2	26.0	33.5	24.5	7.6	21.5	14.4	14.7	12.5	29.1	57.6	101.8	11.7	26.0	32.4	38.4	8.6	19.1	92.2	53.2	5.6	24.2	47.8	15.5	20.4	36.0	70.6	10.0	9.3	8.2	36.6	15.2	5.5	67.0	20.3	31.7	73.6	5.9	13.4	47.4	39.2	2.8	44.5	20.9	75.2	2.5	5.5	45.9	178.2	12.8	34.1	60.7	52.9	20.7	21.4	22.9	6.6	10.3	19.9	18.1	21.1	21.9	53.6	162.0	70.8	17.7	48.7	90.2
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6 guanine nucleotide exchange factor"	Q9H4E7	6	35297818-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2;lymphoid tissue: 62.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.0;Late spermatids: 151.4;NK-cells: 88.6;T-cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 83.3;MOLT-4: 75.5;NB-4: 99.3;REH: 68.8;THP-1: 78.9;U-937: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	5.8	3.6	5.9	33.5	5.9	63.2	6.0	6.3	7.2	8.0	7.3	9.8	10.2	2.8	8.5	28.2	4.4	7.2	2.6	5.9	6.6	4.7	5.2	14.7	48.6	8.7	7.0	3.1	21.6	1.3	8.3	7.7	8.0	21.0	7.4	2.2	15.8	4.8	1.7	28.5	30.7	3.5	7.7	62.9	16.3	26.7	8.1	50.2	8.3	1.1	38.1	10.2	16.5	8.8	24.0	0.0	0.8	0.6	0.1	0.3	29.0	2.6	3.6	0.6	0.7	1.5	10.0	28.1	8.3	1.3	0.1	15.5	0.0	19.6	0.4	1.0	1.1	31.7	0.4	12.6	0.7	57.5	40.0	4.5	24.6	0.3	22.0	0.1	0.0	83.3	14.3	65.7	0.1	12.3	75.5	99.3	1.3	3.0	2.8	68.8	0.6	38.4	2.5	17.8	0.4	0.2	2.1	5.8	5.5	1.1	15.9	78.9	3.8	0.3	0.6	0.1	0.3	37.2	37.1	23.3	0.0	117.7	0.2	49.2	39.5	119.7	78.6	29.7	62.4	34.2	63.3	76.8	55.2	31.3	65.1	65.2	69.3	72.9	27.8	36.6	73.1	64.3	5.9	5.9	6.3	7.2	5.9	6.6	8.7	7.0	8.0	7.7	8.1	8.8	1.7	6.4	8.0	1.3	49.2	11.9	16.9	15.0	20.5	2.5	5.4	7.2	0.8	2.8	8.2	5.5	0.0	25.0	52.3	4.2	0.0	0.9	56.3	2.2	0.8	3.1	4.2	6.7	2.0	10.0	17.2	2.2	26.0	3.0	17.7	1.5	2.9	0.9	94.0	3.3	1.0	9.9	2.0	28.0	26.4	151.4	2.8	31.7	7.2	17.8	30.0	0.8	88.6	0.5	0.5	8.0	8.9	1.9	57.9	6.0	3.1	0.3	5.8	1.7	0.0	0.6	1.2	40.0	0.9	20.0	11.8	12.6	78.3	1.0	9.1	13.0
DEF8	FLJ20186	ENSG00000140995	"Differentially expressed in FDCP 8 homolog"	Q6ZN54	16	89948697-89968060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041745, HPA049434"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA041745: AB_2677650, HPA049434: "	"unprognostic (4.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (9.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.09e-1)"	37.0	40.3	58.3	38.0	59.4	45.4	36.2	60.0	68.5	41.2	38.1	52.4	20.0	45.9	19.4	45.5	42.1	25.4	49.4	57.5	54.7	45.3	35.2	40.8	72.6	71.6	62.1	47.4	51.2	32.3	50.6	17.1	66.9	42.5	13.5	26.9	37.7	27.5	40.8	48.9	33.7	27.7	50.6	45.6	45.9	14.1	62.6	9.8	41.6	24.8	52.0	44.6	36.4	62.4	54.4	107.7	47.0	65.1	46.9	47.4	56.6	82.9	68.1	117.9	53.8	114.9	64.0	66.8	61.2	54.6	47.1	34.6	55.4	94.1	51.4	16.0	164.6	29.5	62.3	167.4	49.6	21.3	44.9	56.0	77.3	84.1	46.3	48.3	87.1	58.2	97.6	21.8	70.7	198.3	41.4	64.2	60.8	24.6	110.2	86.9	35.8	55.3	62.0	50.0	72.1	74.2	131.5	48.3	44.6	24.3	45.4	67.1	89.9	68.9	73.3	36.0	88.3	40.5	31.3	85.1	72.5	54.2	82.1	8.2	39.3	80.7	26.6	33.1	24.0	49.3	21.8	19.6	26.2	61.1	14.5	14.1	52.6	13.1	18.9	69.1	29.6	27.5	58.3	59.4	60.0	68.5	57.5	54.7	71.6	62.1	66.9	50.6	62.6	62.4	27.7	0.0	14.8	31.0	32.6	44.7	22.1	33.0	15.4	24.1	20.1	22.2	33.9	21.5	20.4	14.7	27.1	29.3	30.7	20.0	29.4	42.6	6.5	12.0	25.5	27.8	21.6	9.1	19.2	92.3	48.2	31.5	11.7	15.6	10.1	20.3	20.7	23.9	63.5	30.3	19.3	17.9	42.7	33.5	62.7	23.3	21.1	30.1	46.2	14.0	56.1	17.8	21.6	15.6	22.6	112.4	20.4	33.4	65.1	46.6	16.9	47.7	16.4	26.3	19.7	20.4	40.7	6.2	11.2	19.9	54.7	32.4	17.5	33.3	15.8	30.1
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100159645	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.0;intestine: 34.8;skin 1: 54.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 82.8;Paneth cells: 77.0;Proximal enterocytes: 298.9;Respiratory ciliated cells: 144.8;Squamous epithelial cells: 86.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 3.5;eosinophil: 6.6;memory B-cell: 10.9;naive B-cell: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 10.9;granulocytes: 6.6"	"Group enriched"	"Detected in some"	16	"OE19: 69.3;T-47d: 104.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046644			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"		"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.66e-4)"	0.4	0.1	6.4	1.0	7.2	0.2	6.1	18.3	7.1	4.8	3.6	8.9	24.7	3.3	0.5	37.0	2.0	6.5	0.2	5.1	4.5	10.8	0.9	1.6	0.6	5.9	5.3	1.0	6.9	0.4	3.3	0.4	6.0	2.3	4.5	0.2	8.6	2.1	0.3	54.2	34.8	0.5	4.8	0.8	20.1	1.1	5.3	0.1	2.4	0.0	1.8	6.5	10.1	4.9	0.0	0.3	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	2.4	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	1.1	1.6	0.0	0.0	4.2	0.4	0.3	0.1	69.3	0.0	0.4	0.0	3.6	0.0	1.6	5.2	0.1	0.0	3.1	0.0	0.1	104.4	1.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.5	0.4	6.6	1.6	0.0	0.0	10.9	0.1	0.7	0.7	6.8	0.0	1.0	0.2	0.2	0.0	0.1	0.0	0.7	6.4	7.2	18.3	7.1	5.1	4.5	5.9	5.3	6.0	4.8	5.3	4.9	0.7	3.2	5.0	5.2	3.7	1.8	3.3	22.9	1.2	4.6	24.2	15.2	0.6	37.1	34.8	82.8	0.0	7.7	3.3	24.2	1.9	19.0	1.2	15.3	4.3	3.8	55.3	1.3	0.5	1.5	4.9	1.3	54.6	28.9	9.5	0.9	0.4	0.3	1.6	0.0	0.4	53.5	34.6	0.9	0.6	1.6	0.3	1.5	0.0	3.7	0.5	1.2	12.3	0.0	1.5	2.4	77.0	0.0	3.7	1.7	298.9	0.4	144.8	22.0	0.0	1.1	3.1	3.2	4.0	86.9	15.3	37.4	2.5	0.2	69.6	21.0
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223860-18264548	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015226, HPA054505, HPA057799"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530"	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	50.8	43.0	17.3	82.4	20.1	158.6	63.1	29.6	25.4	48.1	19.8	74.8	76.9	74.2	29.9	65.4	45.6	49.0	61.0	17.3	18.3	46.0	68.0	53.2	125.5	19.5	20.4	61.4	40.3	43.3	19.3	67.7	20.8	56.2	74.2	46.3	37.3	56.1	116.0	49.8	86.8	63.9	18.2	63.8	58.7	22.1	19.5	116.8	102.3	73.4	112.8	59.3	43.0	26.1	450.1	118.6	330.9	276.6	68.9	118.4	184.2	347.4	210.9	338.9	457.1	190.7	165.5	504.2	390.2	181.8	269.1	251.1	260.7	196.2	591.3	346.5	221.3	305.7	179.9	260.0	70.3	499.2	238.2	58.2	98.1	238.2	198.2	164.7	170.9	188.1	392.9	0.6	236.5	156.2	380.3	222.1	208.6	177.4	131.8	471.7	459.7	299.8	184.2	239.6	196.1	183.8	328.9	290.5	224.6	218.4	277.8	212.7	168.7	382.7	220.0	223.9	474.1	32.4	77.0	540.3	95.0	251.3	380.8	116.2	78.2	41.8	69.6	74.9	83.1	66.3	72.5	78.0	72.9	56.1	55.6	55.7	93.4	70.9	92.9	49.0	75.2	67.8	17.3	20.1	29.6	25.4	17.3	18.3	19.5	20.4	20.8	18.2	19.5	26.1	149.7	121.8	130.8	16.3	126.2	271.2	189.8	128.8	146.3	70.3	143.3	161.3	218.8	161.5	112.0	79.1	81.3	284.2	174.5	156.7	82.2	172.0	17.4	118.8	157.7	156.6	88.5	448.8	10.4	173.1	235.4	159.6	85.1	170.6	111.2	195.1	105.7	125.1	190.9	26.9	18.6	188.1	67.1	185.3	300.7	26.2	189.5	219.1	101.4	31.9	263.3	136.2	212.1	26.2	37.1	136.9	117.3	191.5	44.0	252.9	140.0	129.5	89.0	138.8	210.4	189.1	197.0	87.2	220.7	169.9	233.6	108.6	189.1	138.6	232.5	209.2
DELE1	"DELE, KIAA0141"	ENSG00000081791	"DAP3 binding cell death enhancer 1"	Q14154	5	141923855-141942047	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 31.3;Cytotrophoblasts: 26.2;Exocrine glandular cells: 24.3;Granulosa cells: 24.4;Hofbauer cells: 29.1;Syncytiotrophoblasts: 25.7;Theca cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036548, HPA061490"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Golgi apparatus"	"HPA036548: AB_10673356, HPA061490: "	"unprognostic (1.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.15e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (2.28e-3)"	42.5	54.2	26.5	22.5	29.1	39.7	42.0	30.4	32.9	43.3	33.6	43.8	30.3	41.2	14.6	35.4	38.8	24.9	78.9	26.8	27.7	44.5	53.5	46.2	30.2	29.9	28.6	37.9	42.9	38.1	34.0	29.4	28.9	41.4	31.2	14.0	33.1	24.5	71.1	32.3	39.6	30.1	27.7	65.7	42.4	15.6	29.5	19.3	40.3	49.7	27.1	43.4	38.7	29.6	23.6	31.5	44.7	65.9	34.7	45.5	29.7	29.8	48.8	51.6	56.8	46.0	54.0	55.1	33.2	32.9	29.9	35.1	27.2	62.8	28.4	31.7	24.0	33.4	37.9	34.5	43.8	48.3	63.3	55.8	31.3	45.4	37.0	46.0	54.5	11.5	21.4	72.9	26.9	30.8	13.0	26.8	17.2	28.6	49.9	43.5	29.7	61.8	37.2	33.7	25.0	31.8	35.2	54.0	72.6	28.8	70.3	42.6	44.1	38.9	23.8	20.7	27.0	20.1	23.3	34.0	32.0	38.1	43.4	21.2	43.0	14.8	21.2	56.7	19.7	20.6	16.5	20.7	56.1	19.1	13.8	18.2	18.2	24.7	66.9	22.2	27.2	25.3	26.5	29.1	30.4	32.9	26.8	27.7	29.9	28.6	28.9	27.7	29.5	29.6	31.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	16.0	17.0	0.0	0.0	0.0	11.0	0.0	26.2	13.7	0.0	13.7	12.4	0.0	12.0	13.7	10.9	0.0	0.0	0.0	24.3	13.8	6.3	0.0	12.1	0.0	24.4	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	17.2	0.0	0.0	5.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	25.7	4.8	34.5	0.0	0.0
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.2;intestine: 14.4;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.5;dendritic cells: 30.1;granulocytes: 15.9;Hofbauer cells: 14.6;NK-cells: 35.0;T-cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 22.5;HEL: 15.1;HMC-1: 44.7;MOLT-4: 14.7;THP-1: 13.8;U-937: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.95e-4)"	"prognostic favorable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favorable (5.62e-4)"	2.2	1.0	1.4	21.4	1.3	21.2	1.0	1.5	1.7	0.9	1.5	3.0	4.9	0.9	0.0	1.9	1.3	2.8	1.1	1.4	1.5	1.6	2.1	5.8	32.1	2.4	1.8	0.3	1.3	0.1	0.8	1.8	2.2	1.6	1.2	0.0	3.0	0.5	0.8	1.4	14.4	1.2	1.8	35.1	5.2	0.4	2.8	20.5	1.7	0.3	14.9	3.0	1.3	2.6	0.2	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	22.5	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.0	15.1	0.0	1.6	0.0	7.5	44.7	0.0	0.0	0.1	0.0	0.0	0.0	7.4	0.3	9.4	0.1	0.0	14.7	11.5	0.0	0.5	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	13.8	0.1	0.0	0.0	0.0	0.0	0.4	2.0	10.6	0.1	31.3	0.0	18.3	19.9	32.8	40.1	32.4	35.0	23.8	28.6	35.0	19.5	18.7	35.7	32.1	27.8	23.8	35.0	11.2	35.6	37.1	1.4	1.3	1.5	1.7	1.4	1.5	2.4	1.8	2.2	1.8	2.8	2.6	0.3	3.2	3.0	0.0	27.5	0.4	0.1	0.0	1.2	0.0	0.6	0.6	1.3	2.8	0.0	1.8	0.0	0.2	30.1	0.5	1.9	0.4	0.7	1.5	0.2	0.4	0.0	5.7	0.4	0.0	0.2	0.7	1.5	0.3	15.9	0.5	1.1	0.7	14.6	0.0	0.5	0.9	0.0	11.6	9.2	0.6	0.0	13.8	3.6	2.8	10.9	0.0	35.0	0.0	0.5	0.3	0.4	0.0	13.5	0.2	2.9	6.2	1.6	0.0	0.0	0.0	0.3	0.3	1.2	1.6	0.1	0.3	34.5	0.7	1.0	0.1
DENND2B	"HTS1, p126, ST5"	ENSG00000166444	"DENN domain containing 2B"	P78524	11	8693351-8910951	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 3.2;Cardiomyocytes: 6.2;Cytotrophoblasts: 3.7;Extravillous trophoblasts: 1.8;Fibroblasts: 7.1;Hofbauer cells: 5.8;Smooth muscle cells: 5.7;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 95.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046796	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA046796: AB_2679812"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	26.3	60.0	22.0	19.2	20.4	3.4	26.6	26.6	23.2	72.7	38.2	85.4	28.8	130.3	33.2	62.7	104.6	34.6	35.0	19.1	22.3	29.4	27.4	28.8	12.1	29.7	32.6	69.2	27.5	15.4	21.5	26.4	18.3	45.4	26.7	36.5	37.5	62.9	21.9	22.2	30.3	117.2	21.3	59.7	56.9	41.0	28.0	17.5	36.6	11.1	15.1	65.0	50.4	17.1	32.6	4.9	51.8	9.0	16.8	17.6	2.5	28.9	95.8	27.5	25.4	6.8	34.0	1.0	17.2	52.7	12.1	32.2	10.0	41.7	10.8	4.4	12.7	0.0	16.7	22.8	26.9	0.2	0.2	60.8	11.6	15.6	20.1	56.0	5.5	5.0	6.7	2.8	45.4	3.5	1.8	1.5	7.9	32.2	7.7	1.1	31.5	2.0	37.5	23.4	9.8	31.7	25.7	32.1	19.8	17.7	5.4	1.1	14.9	15.8	24.7	50.6	22.8	8.0	15.5	0.2	24.1	0.2	30.4	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.0	2.9	0.0	0.1	0.4	22.0	20.4	26.6	23.2	19.1	22.3	29.7	32.6	18.3	21.3	28.0	17.1	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.8	7.1	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0
DENND2C	"dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1"	ENSG00000175984	"DENN domain containing 2C"	Q68D51	1	114582848-114670422	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.7;skeletal muscle: 41.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.1;Basal prostatic cells: 138.2;Glandular and luminal cells: 192.7;Squamous epithelial cells: 114.9;Suprabasal keratinocytes: 171.8;Urothelial cells: 340.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 11.8;U-266/70: 25.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029935, HPA054955"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA029935: AB_10601208, HPA054955: AB_2682648"	"unprognostic (2.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.89e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.57e-2)"	0.9	0.5	0.8	0.3	0.8	1.0	1.9	0.9	0.9	4.2	2.2	0.6	0.7	1.5	0.8	17.7	0.9	1.2	1.1	1.1	0.4	0.6	2.0	1.5	0.4	0.6	0.6	1.1	1.2	1.7	0.6	0.1	0.7	1.4	0.6	1.5	2.7	1.4	41.6	12.4	0.6	1.1	0.3	0.4	0.9	5.5	0.6	0.4	1.4	1.7	3.4	2.6	7.0	0.5	2.1	0.0	0.1	1.4	1.7	1.8	0.4	0.6	1.1	0.7	1.1	0.3	0.0	0.1	0.9	4.1	1.4	7.4	1.4	4.6	0.7	0.1	1.8	1.2	0.4	0.1	0.5	0.0	1.8	1.8	4.4	2.7	2.3	0.1	0.2	0.5	0.2	0.3	2.4	6.0	0.2	0.1	0.9	0.0	1.1	0.0	6.2	0.1	0.1	5.7	0.0	0.0	4.5	0.1	0.5	1.1	0.9	0.3	0.3	1.0	1.5	11.8	0.2	25.4	4.8	0.0	1.0	0.0	0.8	3.0	0.0	0.9	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.8	0.8	0.9	0.9	1.1	0.4	0.6	0.6	0.7	0.3	0.6	0.5	6.6	28.9	2.2	3.3	3.3	109.1	138.2	32.5	60.3	20.4	5.2	5.3	8.7	11.5	21.3	7.3	20.9	0.1	1.9	1.1	0.0	7.2	29.5	100.3	15.7	8.6	0.0	0.0	2.8	7.5	0.1	6.9	5.6	192.7	2.5	8.1	15.4	11.7	0.3	0.0	0.8	0.9	4.1	2.2	9.3	12.9	5.0	14.0	7.2	9.4	1.1	2.3	1.0	5.0	3.5	33.0	0.2	2.2	17.6	79.5	0.1	0.8	46.8	10.3	0.0	21.7	6.6	47.9	59.7	114.9	171.8	0.0	3.7	1.3	1.5	340.4
DENND2D	"FLJ22457, RP5-1180E21.2"	ENSG00000162777	"DENN domain containing 2D"	Q9H6A0	1	111185969-111204535	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 93.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 71.2;NK-cells: 232.8;T-cells: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"gdT-cell: 236.8;MAIT T-cell: 204.4;memory CD4 T-cell: 172.0;memory CD8 T-cell: 243.8;naive CD4 T-cell: 265.5;naive CD8 T-cell: 256.8;NK-cell: 278.3;T-reg: 79.5"	"Group enriched"	"Detected in all"	6	"NK-cells: 278.3;T-cells: 265.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;MOLT-4: 154.0;SK-BR-3: 96.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043630, HPA048642"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA043630: AB_2678589, HPA048642: AB_2680474"	"unprognostic (1.72e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (2.60e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (5.09e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (8.66e-5)"	9.1	13.0	0.8	39.3	0.7	11.8	12.0	0.7	1.3	10.9	3.7	19.2	19.2	3.5	9.6	25.2	18.6	10.8	1.8	0.5	1.0	14.3	12.1	16.5	93.8	1.8	1.1	6.5	7.8	33.4	9.8	9.0	1.3	7.6	19.7	0.3	19.0	7.6	0.6	14.2	22.5	3.3	1.6	40.1	26.8	9.7	2.7	41.6	11.4	2.2	79.5	29.2	11.6	2.7	32.6	1.4	0.1	0.0	7.3	3.0	0.3	1.9	0.1	3.4	0.8	9.9	14.8	34.4	11.0	4.9	0.2	10.2	0.1	1.7	3.3	61.2	0.0	10.1	2.4	0.0	11.3	0.1	10.1	8.9	7.0	1.0	0.0	10.2	0.3	11.1	0.2	10.3	1.0	27.8	154.0	0.9	0.0	40.8	4.4	4.0	0.0	46.0	10.9	33.6	11.2	0.0	11.4	96.5	3.6	0.2	30.3	32.0	0.0	0.0	0.1	0.0	0.2	9.5	4.1	25.8	0.0	27.1	0.2	5.3	21.0	15.0	236.8	15.5	204.4	42.6	172.0	243.8	19.7	46.3	265.5	256.8	20.7	278.3	11.9	15.1	79.5	197.5	0.8	0.7	0.7	1.3	0.5	1.0	1.8	1.1	1.3	1.6	2.7	2.7	2.1	6.4	16.8	0.3	24.7	5.0	17.9	24.1	9.6	0.1	14.9	8.6	1.2	8.6	23.8	20.2	0.0	1.7	71.2	22.8	19.6	38.0	35.4	8.9	1.4	3.7	6.0	8.2	0.2	15.9	3.1	3.7	25.5	11.3	17.7	4.6	7.5	5.3	57.1	0.0	0.2	34.6	14.2	32.4	2.5	49.2	1.2	17.2	7.2	1.9	11.9	0.0	232.8	0.0	0.1	12.7	18.2	0.4	12.3	35.4	20.4	28.7	20.7	0.4	0.0	1.2	1.8	25.4	0.7	17.7	4.0	11.5	83.2	10.2	21.0	31.3
DENND4A	"IRLB, MYCPBP"	ENSG00000174485	"DENN domain containing 4A"	Q7Z401	15	65658046-65792293	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 59.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 195.4;Oligodendrocyte precursor cells: 176.5;Oligodendrocytes: 180.2;Rod photoreceptor cells: 155.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065343	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA065343: AB_2685476"	"unprognostic (1.10e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.83e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.48e-1)"	6.2	9.8	4.0	11.4	6.5	33.8	6.8	29.9	7.5	7.4	11.2	6.6	5.8	8.8	5.1	6.6	7.2	11.2	5.1	5.6	5.1	7.9	16.8	9.5	19.7	3.5	4.7	12.8	15.5	10.1	8.4	8.5	4.7	6.0	6.8	59.3	6.1	5.6	9.2	6.5	6.3	7.4	4.2	12.4	8.9	7.9	3.3	12.7	9.3	7.8	18.2	10.2	4.5	7.6	9.9	9.6	4.9	5.1	14.3	15.9	5.9	10.1	13.9	6.8	9.9	5.5	7.8	52.0	6.8	15.1	8.4	18.1	9.7	9.2	12.0	56.7	11.2	49.4	11.7	10.4	8.3	16.8	16.7	10.6	10.3	9.5	20.0	12.0	18.5	11.4	15.2	31.5	7.9	5.2	8.1	9.1	1.5	30.5	6.9	3.9	17.2	45.1	8.0	19.0	7.7	7.0	9.8	6.9	8.9	5.8	6.7	43.1	19.6	9.3	10.3	16.7	14.2	16.8	20.1	19.3	13.1	36.2	7.8	3.2	2.6	5.2	3.6	1.0	5.5	5.4	3.1	4.6	2.3	6.1	3.2	3.1	1.4	3.5	0.9	0.9	3.3	1.5	4.0	6.5	29.9	7.5	5.6	5.1	3.5	4.7	4.7	4.2	3.3	7.6	22.7	16.0	23.1	126.7	81.5	27.9	29.8	7.9	36.5	73.8	23.9	12.2	12.3	20.0	15.2	9.2	60.5	5.6	47.8	5.8	0.0	10.1	2.4	29.3	22.2	23.7	17.4	83.1	195.4	13.0	6.8	22.4	25.0	46.1	48.8	10.5	21.0	25.9	20.4	111.0	140.3	9.7	0.0	19.0	47.5	3.0	13.1	42.2	24.9	145.2	24.5	26.9	20.6	176.5	180.2	12.0	10.1	12.4	55.1	20.2	6.4	9.8	18.1	155.9	6.6	37.9	15.7	11.3	10.9	18.7	17.0	12.6	56.5	13.2	10.0	17.3
DENND4B	KIAA0476	ENSG00000198837	"DENN domain containing 4B"	O75064	1	153929501-153946718	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040188, HPA071133"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA040188: AB_10671168, HPA071133: AB_2732173"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (9.27e-9)"	"unprognostic (4.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.56e-3)"	18.2	13.4	10.9	24.3	11.1	37.1	15.7	2.3	19.1	17.1	0.0	15.6	9.5	16.3	3.4	10.2	16.2	10.0	21.3	10.2	6.5	13.8	11.4	24.2	30.1	12.0	7.8	19.6	15.5	7.7	13.1	10.3	13.0	13.0	6.0	9.5	11.7	7.0	49.2	11.0	22.0	8.9	3.1	41.0	12.9	7.6	9.8	14.6	15.2	29.5	17.3	15.1	12.9	10.0	12.0	22.7	17.1	17.3	10.0	9.7	17.8	11.5	12.4	17.8	16.6	13.8	13.4	29.9	19.1	7.8	13.5	20.9	15.5	10.6	8.0	27.5	14.0	26.5	26.1	13.3	13.9	28.0	51.5	8.8	18.3	16.6	17.8	14.8	12.8	32.3	28.7	16.4	10.3	24.6	34.2	25.7	23.8	14.1	21.8	36.2	11.5	17.3	8.5	17.6	20.3	24.9	12.1	28.4	16.7	17.0	20.6	68.0	13.5	19.2	18.5	16.1	18.7	49.3	37.7	39.5	13.2	21.7	23.5	1.5	1.6	0.4	1.1	2.4	1.4	1.0	0.9	0.7	1.4	0.9	0.4	1.0	1.5	0.7	1.9	1.9	0.7	1.5	10.9	11.1	2.3	19.1	10.2	6.5	12.0	7.8	13.0	3.1	9.8	10.0	14.7	9.6	10.3	18.6	20.3	4.7	3.7	4.6	1.2	22.3	7.1	6.9	22.9	8.6	5.7	7.3	6.2	4.6	31.9	4.8	5.9	5.2	1.2	4.0	8.0	11.8	4.9	9.5	21.8	6.5	4.7	7.2	13.7	7.4	17.2	12.5	10.8	9.2	18.0	35.3	23.6	4.6	2.0	30.2	11.7	1.9	7.5	31.1	5.4	18.7	22.5	5.8	30.9	19.1	27.9	6.1	4.8	7.9	7.1	6.8	7.6	2.7	4.4	17.8	6.6	7.9	6.0	6.4	8.1	5.7	3.4	3.4	17.0	9.2	7.1	5.2
DEPDC1	"DEP.8, DEPDC1A, FLJ20354, SDP35"	ENSG00000024526	"DEP domain containing 1"	Q5TB30	1	68474152-68497221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"GTPase activation, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lymphoid tissue: 8.1;testis: 8.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.9;Erythroid cells: 31.8;Extravillous trophoblasts: 35.2;Late spermatids: 73.0;Spermatocytes: 86.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017845	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB017845: "	"unprognostic (2.73e-1)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.70e-5)"	"unprognostic (1.23e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.73e-3)"	"unprognostic (4.37e-6)"	"unprognostic (3.39e-3)"	"unprognostic (1.57e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.04e-6)"	"unprognostic (2.18e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-1)"	0.3	0.1	0.0	2.6	0.0	5.0	0.6	0.0	0.1	0.4	0.0	2.9	2.5	0.5	0.1	2.4	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.2	4.8	0.0	0.1	0.0	0.0	0.2	0.0	3.2	0.1	2.1	3.5	0.0	0.3	0.1	0.0	1.6	2.4	1.5	0.0	0.6	1.2	8.1	0.2	8.1	0.3	0.2	4.8	0.9	0.7	0.2	47.2	21.5	40.0	18.5	2.5	5.6	31.3	58.9	26.9	49.1	42.1	17.9	19.3	0.0	42.8	24.4	78.6	30.8	58.6	30.7	82.4	41.2	38.2	38.3	35.9	10.5	0.6	33.4	0.0	2.1	1.6	56.3	31.2	10.0	36.0	16.5	26.6	36.1	88.3	10.7	0.1	12.5	34.6	19.5	28.9	0.0	118.7	15.3	19.8	12.7	44.8	20.7	59.0	24.9	30.3	25.6	22.5	16.6	21.3	31.5	35.5	56.0	69.2	22.5	52.2	0.5	29.7	11.4	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.3	2.0	3.3	0.8	3.3	1.2	0.4	1.3	1.8	0.8	0.0	0.5	1.8	0.0	20.6	0.4	2.1	0.0	0.2	44.9	4.0	1.6	1.6	0.0	31.8	0.5	0.0	35.2	4.4	8.2	2.0	0.0	17.5	2.2	1.2	8.6	0.0	2.2	5.3	4.1	3.5	1.0	73.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	6.9	2.2	0.5	0.1	0.9	0.2	0.0	0.6	4.0	86.8	19.6	12.2	1.3	2.9	1.6	0.5	8.8	1.7
DEPDC1B	"BRCC3, XTP1"	ENSG00000035499	"DEP domain containing 1B"	Q8WUY9	5	60596912-60700190	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;gallbladder: 21.0;lymphoid tissue: 20.7;testis: 12.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Erythroid cells: 23.8;Extravillous trophoblasts: 21.6;Spermatocytes: 37.2;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038255, HPA072558"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA038255: AB_10669521, HPA072558: AB_2686534"	"unprognostic (1.38e-1)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.42e-4)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (3.08e-4)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (2.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-16)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.62e-2)"	0.3	0.2	0.4	3.9	0.7	11.1	0.9	0.5	0.5	0.6	0.1	4.1	6.0	0.6	0.0	2.5	0.2	21.0	0.1	0.3	0.6	2.9	0.4	0.4	9.1	1.2	0.5	0.2	0.1	0.0	0.0	7.5	1.4	0.2	5.5	0.1	0.5	0.1	0.0	2.1	6.4	0.9	0.6	1.6	1.4	12.6	0.6	20.7	1.2	0.0	9.7	1.0	1.1	1.5	61.0	20.3	60.5	37.2	1.3	1.9	66.2	16.1	10.9	27.7	35.8	34.0	37.5	34.6	38.5	5.0	36.0	19.8	49.2	36.1	36.9	49.5	35.5	43.3	22.7	42.6	1.0	36.7	40.3	1.2	3.7	9.0	12.9	5.4	26.1	36.3	31.4	45.8	24.7	38.0	59.8	31.9	44.7	13.0	32.6	65.4	49.2	29.4	22.8	29.9	33.6	15.4	37.7	13.4	17.7	27.0	24.9	28.8	12.1	11.7	34.2	9.5	41.6	23.0	43.3	68.0	14.7	53.2	33.3	1.5	0.1	0.9	0.2	0.0	0.2	0.4	1.0	0.7	0.3	0.0	0.1	0.1	0.0	0.6	0.0	0.0	3.2	0.4	0.4	0.7	0.5	0.5	0.3	0.6	1.2	0.5	1.4	0.6	0.6	1.5	0.2	0.0	1.8	0.0	1.9	4.7	1.0	1.5	0.0	0.1	0.5	0.8	0.1	18.6	0.3	0.0	0.0	7.4	1.1	3.1	0.0	0.3	1.9	3.3	1.4	0.9	0.0	23.8	5.5	0.2	21.6	1.1	2.6	11.7	3.8	5.2	0.0	0.3	6.4	0.0	1.7	2.3	0.0	1.6	2.9	2.4	0.3	1.9	0.0	4.7	0.1	0.2	0.0	2.0	7.0	0.9	5.8	0.0	15.9	0.7	3.7	1.0	0.1	0.1	6.6	0.3	1.4	37.2	12.7	5.8	2.0	46.9	4.5	0.6	7.9	0.9
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015876-33033582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 29.0;kidney: 19.6;liver: 74.0;testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 34.8;Early spermatids: 153.3;Extravillous trophoblasts: 47.0;Proximal enterocytes: 33.2;Spermatocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 53.7;RH-30: 40.1;SiHa: 37.3;SK-MEL-30: 34.4;U-2197: 34.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.8	2.5	1.9	3.2	1.8	0.9	2.9	3.7	2.8	2.7	4.6	24.6	1.0	2.2	4.4	0.9	4.4	1.1	2.6	2.7	19.6	74.0	0.9	0.7	3.2	2.7	1.6	3.8	2.3	0.8	1.5	3.0	1.9	5.1	0.1	2.0	1.5	4.9	6.0	29.0	1.7	2.8	0.3	3.0	28.2	2.7	2.9	0.5	0.9	1.5	1.2	3.4	4.9	9.4	5.2	7.3	3.3	3.8	3.6	4.9	16.2	5.4	9.8	13.0	13.5	0.9	0.0	3.7	16.2	4.5	9.4	10.8	3.8	11.5	0.0	14.9	2.5	16.1	19.3	3.2	9.1	10.9	4.6	5.7	5.7	4.2	5.3	0.0	0.0	6.2	0.0	53.7	1.0	0.0	14.6	4.8	7.7	0.0	0.0	40.1	0.1	3.2	1.3	1.6	4.2	37.3	6.6	34.4	5.1	1.7	4.7	0.0	6.3	10.4	34.1	10.6	0.0	0.0	0.1	2.3	0.0	31.5	4.1	0.5	6.7	0.2	0.1	0.0	0.0	0.4	0.2	3.2	0.0	1.9	2.1	0.0	2.4	0.0	1.2	0.0	0.4	2.5	3.2	2.9	3.7	2.6	2.7	3.2	2.7	3.0	2.8	2.7	4.9	0.2	0.0	0.0	1.0	0.0	34.8	12.8	4.5	12.5	0.0	0.2	0.6	0.1	1.5	0.9	0.0	0.0	0.5	0.5	6.0	3.9	0.9	153.3	0.2	0.2	0.3	3.5	3.2	0.1	0.6	47.0	1.6	0.0	0.1	2.5	0.1	1.4	22.6	3.1	0.0	0.4	2.4	0.0	0.6	9.5	16.3	1.5	1.7	1.8	3.7	1.2	0.0	0.0	3.5	10.4	0.8	0.6	1.2	0.1	2.4	33.2	18.4	0.9	0.0	0.0	4.5	1.4	42.3	6.5	6.6	7.4	1.5	0.7	0.2	2.4	1.6
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050918	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.2;tongue: 122.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Glandular and luminal cells: 66.1;Oligodendrocytes: 123.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"myeloid DC: 20.3"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 20.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 105.1;RPMI-8226: 193.2;RPTEC TERT1: 149.3;U-698: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Mitochondria	"Nucleoplasm, Nuclear bodies"	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	14.4	52.8	12.0	3.0	16.7	2.0	20.7	12.6	11.9	39.2	3.8	23.3	16.9	16.5	11.1	15.2	27.1	10.8	5.1	9.7	23.2	40.0	16.3	5.3	10.1	15.8	12.5	24.7	11.9	16.9	11.4	4.9	15.3	12.1	9.9	2.0	106.3	15.6	158.2	6.6	14.5	15.5	14.8	9.5	40.0	2.9	16.3	5.1	98.0	122.3	2.9	5.6	7.0	24.2	0.1	3.5	0.3	1.1	21.0	6.2	0.3	0.1	0.3	0.6	0.5	2.4	0.4	105.1	2.3	1.2	0.3	0.3	5.4	0.2	0.4	2.3	2.7	14.2	0.9	0.6	12.8	3.0	23.7	5.5	9.5	0.8	0.6	0.1	0.0	1.8	0.1	16.9	0.3	7.1	0.1	2.5	1.3	45.5	3.7	0.4	4.9	193.2	149.3	4.1	3.2	0.7	1.7	11.0	3.2	2.8	9.6	0.5	0.0	0.4	0.9	21.4	0.5	45.4	11.4	55.2	6.5	3.9	0.6	0.0	0.9	0.0	0.2	1.7	0.8	0.1	0.4	0.7	20.3	0.1	0.8	0.6	0.3	0.4	0.2	1.0	0.4	1.0	12.0	16.7	12.6	11.9	9.7	23.2	15.8	12.5	15.3	14.8	16.3	24.2	23.1	6.4	9.3	4.9	2.9	5.2	15.4	3.8	27.3	2.1	16.5	10.4	2.4	15.7	8.4	25.8	0.0	0.6	0.8	2.7	86.1	5.7	2.2	19.0	9.7	7.5	16.7	12.4	14.5	11.8	4.1	10.0	29.6	66.1	12.0	5.4	2.5	12.7	3.3	0.0	31.0	7.7	0.0	16.0	39.5	2.2	11.8	14.9	14.2	46.9	1.5	1.2	2.1	9.5	123.9	1.1	36.5	3.4	6.4	7.1	21.0	33.6	1.1	0.7	0.0	8.1	5.7	3.6	3.8	16.5	5.5	0.4	1.3	6.0	16.5	21.9
DERA	"CGI-26, DEOC"	ENSG00000023697	"Deoxyribose-phosphate aldolase"	Q9Y315	12	15911302-16037381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055897			Supported	Nucleoplasm		NA	NA		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA055897: AB_2682963"	"unprognostic (3.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (3.66e-2)"	21.1	16.3	13.7	17.3	16.0	17.6	21.1	15.8	17.1	16.7	21.5	39.9	41.1	16.2	27.0	30.4	15.0	20.3	18.1	13.4	16.0	74.1	104.6	25.0	20.3	16.5	14.8	6.8	27.2	15.6	12.1	20.7	16.4	13.5	42.1	28.1	17.9	14.1	27.8	25.3	54.0	20.4	15.4	17.0	21.7	9.7	15.2	19.8	27.9	29.6	22.7	18.3	18.2	17.1	63.6	51.4	40.0	36.6	27.1	60.3	80.6	36.6	35.2	48.7	63.2	63.9	118.1	44.3	31.3	47.2	44.1	43.8	43.4	47.6	84.7	71.3	25.6	37.6	24.1	60.6	38.7	40.7	25.2	40.8	54.9	40.9	81.0	42.2	71.6	36.2	5.3	13.1	92.1	24.1	30.6	34.5	86.8	37.3	25.6	45.8	85.5	26.8	125.0	23.2	29.5	49.9	69.3	23.4	75.4	158.2	124.5	50.6	66.3	53.6	33.5	24.4	39.0	13.6	21.4	76.9	66.6	41.1	39.6	15.2	58.4	36.2	16.6	68.4	18.2	29.4	17.7	17.7	74.9	29.9	19.3	15.5	15.8	46.0	76.4	40.4	38.1	41.9	13.7	16.0	15.8	17.1	13.4	16.0	16.5	14.8	16.4	15.4	15.2	17.1	37.2	44.8	28.4	20.2	19.4	29.3	31.6	55.3	21.6	4.8	22.4	18.8	13.5	27.1	43.1	12.9	14.6	65.7	22.1	51.6	109.5	64.3	55.8	27.8	32.3	28.3	26.5	28.2	8.6	59.3	69.9	23.9	14.3	52.9	8.8	30.6	36.4	52.2	61.0	3.3	5.9	44.7	54.9	46.7	26.4	6.7	24.5	44.8	72.9	30.9	47.4	29.8	14.4	28.6	18.9	74.6	49.6	30.5	30.7	19.1	140.0	152.3	27.3	29.9	6.6	17.4	27.5	8.5	16.7	35.5	25.9	71.3	13.9	49.0	42.9	34.0
DERPC		ENSG00000286140	"DERPC proline and glycine rich nuclear protein"	P0CG12	16	69118010-69132151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051872, HPA065522"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 26: Non-specific - Cell cycle regulation"		Nucleoplasm		"HPA051872: AB_2681647, HPA065522: AB_2685503"																		6.7	10.6	13.3	15.3	12.7	9.3	13.3	12.1	14.2	11.7	13.1	10.2	6.6	8.8	25.9	11.6	16.0	10.8	8.9	12.4	12.4	10.4	10.5	9.0	17.8	13.6	12.5	16.3	10.2	11.7		18.8	12.4	10.2	10.6	9.8	9.5	13.7	2.1	13.2	7.2	11.3	13.2	10.2	6.1	11.0	13.3	17.6	10.0	10.1	18.4	13.0		13.1	15.9	13.1	50.5	39.4	29.0	27.4	24.8	15.3	25.8	54.2	37.6	23.2	50.3	15.8	19.1	27.4	30.5	22.9	62.0	44.9	34.4	7.4	10.8	25.3	8.3	14.4	27.4	16.3	28.7	22.0	41.3	33.1	23.4	35.1	44.2	25.2	25.9	13.1	41.0	11.9	36.5	39.8	51.6	43.8	12.1	65.0	14.6	40.3	35.7	8.6	31.2	28.9	21.8	19.8	38.5	37.3	34.3	69.6	10.9	34.5	20.3	17.2	22.3	9.6	15.3	46.2	31.4	27.6	45.4	2.4	5.3	3.2	2.8	6.0	4.0	2.6	2.7	2.6	5.5	3.1	2.6	3.3	1.3	4.0	6.3	5.1	4.0	4.2	13.3	12.7	12.1	14.2	12.4	12.4	13.6	12.5	12.4	13.2	13.3	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DET1	FLJ10103	ENSG00000140543	"DET1 partner of COP1 E3 ubiquitin ligase"	Q7L5Y6	15	88494440-88546681	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA048873: AB_2680541"	"unprognostic (9.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.67e-2)"	3.7	5.2	2.5	2.0	2.8	1.2	3.6	2.7	2.7	6.0	3.2	4.2	3.5	6.7	5.4	2.2	5.6	3.0	5.6	2.5	2.6	3.2	2.7	2.1	2.9	2.7	2.5	10.3	3.6	3.7	3.7	3.5	2.8	4.1	3.2	5.0	4.1	3.8	9.7	2.6	3.2	5.5	2.4	2.5	3.4	1.5	2.6	5.6	4.1	11.7	3.0	4.5	3.3	3.2	1.7	6.2	8.6	6.0	3.4	6.0	1.1	5.4	6.1	4.5	5.1	1.0	4.8	3.3	4.1	7.3	4.5	2.4	8.7	1.3	3.9	0.2	5.9	6.9	3.1	1.5	6.7	2.5	1.1	5.0	5.9	1.9	6.9	4.4	3.8	2.9	8.5	3.8	6.7	2.6	3.2	2.8	3.6	2.6	1.8	4.2	6.9	3.8	2.4	5.3	3.0	4.9	6.5	2.0	14.9	5.6	2.9	5.2	3.0	5.1	3.7	4.8	5.4	2.3	1.4	2.1	5.4	4.3	4.5	0.0	2.3	1.6	2.2	3.4	1.4	1.8	1.7	1.9	3.7	2.2	2.6	1.9	0.3	1.4	2.3	1.9	2.4	1.3	2.5	2.8	2.7	2.7	2.5	2.6	2.7	2.5	2.8	2.4	2.6	3.2	3.5	3.2	2.7	6.8	3.5	0.6	2.0	3.7	4.6	11.5	4.3	3.8	2.3	1.5	2.1	3.7	10.4	7.2	1.7	2.1	1.9	3.4	1.2	3.4	6.1	2.3	3.0	5.5	5.7	3.9	6.3	4.9	2.0	2.4	0.0	10.6	2.2	2.8	4.4	6.7	6.8	2.7	2.0	1.6	2.2	0.6	4.4	2.5	3.6	3.7	4.7	7.1	2.1	6.0	9.5	3.1	1.0	3.8	1.6	1.5	3.1	2.6	3.1	7.9	0.0	5.6	4.5	8.1	9.9	1.5	1.3	4.1	2.7	8.4	3.3	1.4
DFFB	"CAD, CPAN, DFF-40, DFF40"	ENSG00000169598	"DNA fragmentation factor subunit beta"	O76075	1	3857267-3885429	"Predicted intracellular proteins"	Apoptosis	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 4.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Extravillous trophoblasts: 29.5;Oligodendrocytes: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004328, HPA052904"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli	Nucleoplasm	"CAB004328: AB_626776, HPA052904: AB_2681985"	"unprognostic (2.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.86e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.29e-5)"	1.3	1.1	0.6	1.2	0.7	1.0	1.1	0.5	0.9	1.7	0.0	1.5	4.6	1.6	0.0	0.8	1.3	1.4	0.7	0.7	0.5	0.7	0.4	1.0	1.6	1.5	0.9	1.7	2.4	0.5	0.6	1.3	0.7	0.8	0.8	0.2	1.3	0.7	0.5	0.6	2.0	0.4	0.4	1.9	1.2	0.4	0.6	1.2	0.8	0.5	0.9	1.4	1.0	1.5	3.2	3.3	2.0	4.7	0.6	1.6	1.1	2.7	1.2	4.1	2.8	2.6	2.8	2.6	2.2	0.5	0.8	1.7	0.7	3.2	0.2	9.0	9.7	10.7	1.2	3.2	3.3	8.7	7.9	0.4	0.8	2.4	1.9	0.8	4.1	7.5	7.4	1.6	0.1	1.8	6.1	4.8	2.2	3.9	7.4	4.9	1.2	4.4	1.3	0.6	3.3	5.1	2.3	6.5	10.7	0.0	1.1	3.8	4.1	1.5	1.1	6.5	2.5	2.9	4.6	5.4	1.2	9.0	2.0	3.6	3.7	5.0	3.4	3.8	2.0	2.1	2.5	3.1	5.1	1.0	2.1	3.2	1.2	2.3	7.4	0.0	4.7	2.9	0.6	0.7	0.5	0.9	0.7	0.5	1.5	0.9	0.7	0.4	0.6	1.5	3.3	3.2	4.6	4.2	3.0	0.6	1.0	1.4	1.8	5.5	1.9	2.7	1.3	2.8	1.7	1.8	45.9	3.5	7.3	1.6	1.9	1.9	1.4	3.3	4.6	3.1	2.4	2.5	17.0	1.6	29.5	3.2	1.5	2.5	0.0	4.6	2.5	1.8	2.9	15.2	18.0	4.2	0.0	5.4	1.4	1.2	1.2	3.7	0.0	8.4	2.5	3.9	15.5	5.5	22.7	1.8	1.5	4.9	3.1	0.6	5.0	2.4	1.1	17.9	0.0	1.7	3.2	1.7	2.5	1.7	0.3	1.4	6.0	3.3	4.4	0.7
DGCR8	"C22orf12, DGCRK6, Gy1, pasha"	ENSG00000128191	"DGCR8 microprocessor complex subunit"	Q8WYQ5	22	20080232-20111877	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.3;Rod photoreceptor cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076916, HPA079351"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA076916: , HPA079351: "	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.26e-2)"	5.2	4.4	5.3	6.1	5.2	7.7	4.8	9.4	5.6	6.8	5.0	7.0	5.0	8.5	3.6	7.1	6.9	4.7	5.2	5.3	4.6	4.7	4.5	5.3	6.3	5.1	5.1	8.4	6.2	6.4	5.2	11.6	5.6	5.5	5.0	6.5	7.2	5.6	14.8	7.5	6.7	6.0	4.7	5.9	6.1	15.2	5.3	9.5	6.0	9.3	5.9	6.8	5.7	6.2	22.7	15.7	20.1	11.9	7.7	12.4	25.5	21.3	12.6	14.1	9.9	17.0	11.3	20.1	11.6	20.0	9.4	21.4	18.4	17.8	12.2	19.7	27.4	21.7	17.4	14.0	20.3	40.7	17.5	10.0	21.6	14.8	10.7	12.9	12.6	12.1	78.7	14.1	16.5	14.6	24.7	12.1	19.4	16.5	11.8	29.0	21.2	6.8	8.5	20.9	22.3	14.3	19.4	11.3	13.0	12.0	10.9	17.2	18.8	20.5	17.1	13.0	21.9	7.8	11.5	19.9	15.3	18.2	20.3	0.0	1.1	0.6	2.0	0.9	1.5	0.7	0.9	2.1	1.3	0.6	0.9	1.2	0.2	1.6	3.6	1.5	1.2	1.5	5.3	5.2	9.4	5.6	5.3	4.6	5.1	5.1	5.6	4.7	5.3	6.2	8.1	6.4	7.9	11.8	6.0	9.6	5.2	6.8	10.2	37.1	9.1	8.0	4.2	11.5	7.3	5.5	39.6	13.6	6.9	9.6	0.0	6.1	61.3	5.5	8.3	10.2	7.3	10.3	12.4	10.2	11.2	7.3	12.8	7.3	3.8	19.2	9.7	14.4	5.3	43.7	12.7	10.3	4.1	8.4	6.5	39.2	18.3	5.0	5.4	6.5	7.2	10.9	11.3	9.5	14.0	10.9	5.8	10.5	9.3	8.6	6.2	3.4	8.1	60.7	6.6	9.7	8.1	25.2	17.5	10.4	9.2	13.5	9.3	15.1	9.7	5.6
DGKA	"DAGK, DAGK1, DGK-alpha"	ENSG00000065357	"Diacylglycerol kinase alpha"	P23743	12	55927319-55954027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 101.5;lymphoid tissue: 198.1"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 49.0;Squamous epithelial cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 86.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 130.4;hTERT-HME1: 133.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041645, HPA045462"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 58: T-cells - T-cell receptor"	Vesicles	"Nucleoplasm, Mitochondria"	"HPA041645: AB_2677595, HPA045462: AB_2679335"	"unprognostic (1.12e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.02e-2)"	12.7	12.8	7.6	50.0	9.8	31.9	11.0	6.6	9.2	22.9	7.0	25.6	51.2	13.1	9.9	101.5	11.4	15.8	8.5	7.2	5.2	7.9	3.7	18.6	95.5	5.2	5.0	10.9	14.6	12.0	6.9	14.9	5.3	24.8	26.9	2.8	35.5	9.6	2.3	84.7	64.8	14.1	4.8	53.8	12.4	12.3	5.0	198.1	10.5	4.2	101.8	28.4	39.0	6.8	22.2	13.2	9.3	12.4	22.4	29.0	2.8	47.2	47.8	18.2	13.5	6.9	35.2	13.5	11.1	31.5	6.2	38.7	10.3	130.4	21.4	14.4	2.5	21.1	26.8	3.6	19.1	6.7	20.9	25.1	68.4	25.2	133.9	60.6	37.9	78.8	2.4	18.7	49.4	2.3	54.3	8.6	2.0	18.1	15.5	23.8	2.9	2.0	43.7	60.9	1.6	5.6	15.5	0.9	1.7	23.8	9.3	6.4	34.0	12.0	8.4	2.8	1.7	2.9	1.2	32.4	13.8	17.5	3.4	17.0	7.4	15.3	18.5	5.2	35.5	20.4	70.6	33.0	10.5	16.2	86.9	51.5	13.3	14.1	3.5	10.5	86.7	36.2	7.6	9.8	6.6	9.2	7.2	5.2	5.2	5.0	5.3	4.8	5.0	6.8	4.5	3.2	6.5	1.6	25.7	15.0	9.7	21.1	26.7	1.2	4.0	4.6	2.9	4.3	19.1	5.5	0.0	16.3	12.2	35.4	0.0	5.1	9.4	1.9	6.5	5.3	2.4	11.2	11.2	9.4	4.3	8.2	15.3	3.0	7.0	2.4	4.2	0.2	4.2	0.0	5.2	7.7	2.0	6.9	21.6	7.0	3.7	14.0	0.0	5.6	15.7	2.6	10.3	9.0	0.8	25.3	14.4	3.0	14.8	8.2	49.0	0.3	5.2	0.5	6.6	1.5	4.2	6.6	4.2	40.4	13.9	26.4	37.4	1.6	9.7	20.1
DGKE	"DAGK6, DGK"	ENSG00000153933	"Diacylglycerol kinase epsilon"	P52429	17	56834107-56869567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 34.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 181.1;Cone photoreceptor cells: 189.7;Inhibitory neurons: 90.0;Rod photoreceptor cells: 165.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 84.8;MOLT-4: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017167	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA017167: AB_1847638"	"unprognostic (1.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (4.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-3)"	4.1	2.2	5.4	4.5	6.9	3.1	3.0	9.4	7.4	4.9	7.7	4.9	2.6	6.5	4.2	2.6	4.8	4.6	2.9	5.8	8.1	2.6	2.8	5.2	5.0	3.3	4.7	3.5	3.9	4.1	6.2	2.7	3.4	4.1	3.3	34.5	2.5	3.3	1.2	1.9	4.4	4.3	2.7	6.9	3.7	6.5	6.9	9.8	4.0	2.2	4.3	3.8	4.2	5.8	3.5	3.3	3.0	0.3	0.6	1.0	1.4	5.8	4.7	3.9	4.5	7.7	4.2	5.1	7.0	3.1	1.9	4.2	7.2	3.2	7.8	16.5	9.5	6.6	8.9	5.1	3.3	12.7	8.9	1.9	4.0	4.1	8.0	3.6	5.4	14.7	5.5	84.8	4.8	5.1	30.3	7.1	2.3	4.6	10.0	9.4	12.4	12.2	3.9	7.6	4.7	3.2	4.7	2.5	0.2	1.9	5.3	6.0	5.0	1.1	5.4	1.7	0.9	11.3	25.3	3.4	3.3	7.3	0.3	0.1	0.2	0.0	1.0	0.1	0.7	0.9	0.6	0.7	0.2	0.3	0.7	0.9	0.3	0.7	0.2	0.8	1.7	0.3	5.4	6.9	9.4	7.4	5.8	8.1	3.3	4.7	3.4	2.7	6.9	5.8	51.2	3.2	6.0	10.4	11.3	8.9	13.5	3.1	21.6	181.1	5.0	6.3	6.3	10.0	4.0	16.5	189.7	6.6	16.3	5.6	0.0	7.4	18.3	9.0	9.9	30.6	11.3	2.1	66.0	4.7	3.0	6.9	9.7	19.3	0.0	13.1	29.3	4.0	2.2	8.4	90.0	7.7	8.2	5.0	9.3	9.2	4.4	7.4	3.6	32.8	6.3	18.6	14.4	32.6	14.4	6.0	6.4	5.3	15.1	21.3	1.9	0.1	2.8	165.4	6.6	11.8	10.7	28.5	20.7	9.7	6.7	3.4	18.9	5.7	5.8	13.4
DHDH	HUM2DD	ENSG00000104808	"Dihydrodiol dehydrogenase"	Q9UQ10	19	48933699-48944969	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 17.3;kidney: 18.0"	"Group enriched"	"Detected in many"	11	"Proximal enterocytes: 213.7;Proximal tubular cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.2"	"Group enriched"	"Detected in many"	33	"granulocytes: 4.2;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2;U-266/70: 3.2;U-266/84: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044131	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Actin filaments"		"HPA044131: AB_10966968"	"unprognostic (1.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (3.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.81e-6)"	"unprognostic (1.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.54e-1)"	0.2	0.4	1.6	0.0	1.6	0.1	0.2	1.9	3.3	0.3	1.0	0.3	10.5	0.1	0.0	0.8	0.3	0.2	0.1	1.7	1.7	18.0	0.4	1.1	0.2	1.2	1.3	0.6	0.4	0.5	1.8	1.3	1.2	3.2	0.0	1.7	0.4	0.1	0.2	0.2	17.3	0.0	1.3	1.7	0.7	1.9	2.7	0.1	0.1	0.0	0.2	0.3	0.4	1.6	1.4	0.0	0.1	0.7	0.4	0.3	0.5	0.0	0.2	0.2	0.7	1.4	1.1	0.0	0.2	0.0	0.9	0.4	0.5	1.0	0.4	0.5	1.1	2.0	0.5	0.5	0.0	0.0	0.4	0.2	0.1	0.5	0.0	0.3	0.0	3.2	0.7	0.2	0.0	0.3	0.0	0.1	0.3	2.1	0.9	0.7	0.1	1.0	0.1	0.4	2.1	1.1	0.2	0.1	0.5	0.1	1.0	0.0	0.0	0.0	0.8	0.3	0.0	3.2	2.8	0.8	0.7	0.0	0.2	4.2	0.0	0.5	0.7	0.0	0.4	0.0	0.8	0.3	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	0.6	0.2	1.6	1.6	1.9	3.3	1.7	1.7	1.2	1.3	1.2	1.3	2.7	1.6	0.5	3.2	6.4	1.0	1.0	0.8	2.4	3.3	2.2	2.4	1.0	3.4	0.7	1.5	4.6	3.7	0.0	0.2	0.4	1.5	9.8	2.2	0.7	0.3	0.5	0.8	0.0	0.4	1.0	0.4	0.2	0.5	4.1	0.8	1.3	0.1	0.0	0.0	12.9	0.0	1.2	5.0	2.0	0.8	0.0	2.4	0.0	1.7	0.0	0.0	0.0	1.6	0.0	0.0	0.5	1.5	3.6	0.0	0.0	3.5	213.7	77.8	0.5	4.5	0.0	1.2	0.4	0.0	0.8	3.1	0.1	0.1	0.6	0.4	2.7	3.2
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 105.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	7.4	4.8	3.1	4.2	3.6	3.9	5.8	3.7	3.7	4.0	3.7	5.4	3.9	5.4	2.8	4.2	6.1	2.3	13.8	2.9	2.5	8.0	105.9	3.9	4.2	3.4	3.3	4.9	4.2	6.2	2.5	2.7	3.3	4.0	5.8	3.2	5.4	4.5	10.0	4.5	3.1	5.7	2.1	4.1	4.1	3.6	3.4	3.9	4.1	8.1	5.5	3.9	3.4	5.2	12.5	25.7	6.9	12.1	3.8	5.0	13.9	10.5	4.2	15.6	11.6	20.4	11.1	27.8	13.6	5.7	8.6	12.5	13.7	11.4	18.2	6.0	13.3	15.4	12.6	20.3	10.6	21.4	10.8	4.9	11.3	18.6	19.7	4.7	11.3	18.3	23.9	4.4	9.7	32.7	20.2	17.0	15.9	21.1	10.0	24.9	9.6	29.4	9.4	7.8	8.5	10.2	14.1	14.8	6.8	8.7	13.0	10.3	5.1	14.1	8.3	13.1	15.2	8.8	18.7	46.3	7.1	22.4	12.8	6.1	8.4	1.0	9.4	8.8	12.9	12.0	8.5	9.3	14.5	11.7	11.7	12.6	2.1	10.1	6.3	13.5	8.0	7.2	3.1	3.6	3.7	3.7	2.9	2.5	3.4	3.3	3.3	2.1	3.4	5.2	6.3	3.2	13.1	1.6	7.1	5.6	7.8	11.2	6.8	5.6	6.6	7.1	14.8	15.7	5.5	7.3	4.2	12.3	6.9	1.6	5.9	10.3	2.9	3.8	6.3	9.1	1.2	7.8	2.0	5.1	12.4	7.4	2.6	3.2	8.2	10.2	5.3	124.1	7.9	3.3	2.3	6.6	10.2	6.0	3.1	3.6	2.8	3.3	12.4	1.0	3.8	5.2	8.2	4.0	4.4	5.9	2.4	2.2	4.6	11.2	1.0	20.8	8.1	5.2	0.0	9.7	9.1	6.8	8.1	5.0	3.8	2.9	4.3	13.5	6.7	4.2
DHPS	MIG13	ENSG00000095059	"Deoxyhypusine synthase"	P49366	19	12675717-12681880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hypusine biosynthesis"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014461, HPA029413"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA014461: AB_1847651, HPA029413: AB_10602217"	"unprognostic (4.17e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.83e-2)"	30.6	43.2	44.6	23.9	48.1	21.7	29.6	51.0	57.5	35.7	50.0	40.9	28.0	33.2	15.6	29.5	38.6	20.1	41.0	46.5	48.6	34.2	41.0	29.6	32.7	46.4	45.1	40.6	49.7	47.0	52.8	19.7	50.0	34.8	29.5	69.1	34.1	27.9	92.6	41.3	32.8	29.1	47.7	31.6	44.2	16.0	45.9	45.2	28.7	70.5	34.7	36.7	33.1	56.2	70.8	50.8	80.8	41.5	34.2	57.7	18.6	44.0	64.9	82.8	82.9	35.4	33.8	71.7	49.4	48.2	75.6	41.0	55.7	63.0	57.4	64.2	37.8	48.8	51.4	47.1	43.8	57.2	72.1	47.2	74.8	49.7	85.2	82.9	59.1	141.5	45.1	49.5	61.5	137.0	105.1	83.3	64.2	90.3	85.1	65.8	29.1	106.6	63.5	34.6	106.7	144.4	44.0	64.2	76.0	48.1	59.0	96.5	29.8	94.4	38.2	93.5	69.2	160.0	184.9	49.9	59.7	66.2	94.5	37.0	58.8	82.7	51.0	54.1	53.0	86.2	59.0	52.8	63.4	82.1	77.7	56.8	18.2	64.2	72.8	64.9	77.6	70.0	44.6	48.1	51.0	57.5	46.5	48.6	46.4	45.1	50.0	47.7	45.9	56.2	40.3	41.7	30.7	10.1	54.8	55.6	79.2	93.0	38.7	75.8	48.3	64.5	8.6	37.1	49.1	33.1	45.9	47.1	52.2	35.2	86.1	53.7	20.9	38.2	24.5	35.0	41.3	26.7	11.9	37.6	55.1	35.0	33.6	27.9	24.1	46.0	30.4	34.6	42.8	42.1	12.5	60.8	79.3	37.6	42.5	27.5	45.1	35.3	49.8	6.5	62.7	115.2	53.5	8.0	14.7	48.7	70.1	34.6	51.1	73.3	87.9	84.1	49.6	129.2	46.0	39.6	53.8	33.3	62.3	39.7	51.0	71.8	51.1	37.4	54.3	71.0
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299780	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 68.9;liver: 61.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000599, HPA076886"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Centrosome, Cytosol"	"HPA000599: AB_1078655, HPA076886: "	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.18e-5)"	"prognostic favorable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	12.4	14.8	2.0	2.8	2.1	4.4	13.3	2.3	2.8	17.6	2.7	16.3	21.5	11.5	5.8	68.9	9.4	5.3	5.4	2.0	2.4	15.0	61.2	9.7	4.4	2.4	2.1	7.0	7.7	13.5	8.8	3.5	2.3	10.1	6.6	1.2	26.2	7.4	2.9	40.7	19.8	5.7	2.3	10.5	11.4	5.5	2.1	4.8	11.7	2.8	9.5	8.9	25.4	2.7	16.6	4.0	4.2	1.7	9.4	10.0	1.1	5.9	12.7	13.4	14.6	1.7	15.7	7.7	2.5	9.3	2.2	14.0	3.2	26.5	6.6	5.4	3.6	2.4	9.1	27.2	4.5	4.8	1.9	8.9	15.9	3.4	2.5	11.2	10.2	6.5	4.9	7.4	11.4	7.0	1.8	1.8	0.7	13.4	6.1	6.0	3.0	10.8	10.5	6.4	3.8	2.7	8.2	11.1	3.0	3.0	5.8	1.4	4.0	1.1	2.6	1.7	2.0	4.1	3.5	3.8	4.9	4.1	1.3	15.1	9.0	18.4	6.5	10.2	7.2	9.9	7.2	6.2	11.1	6.3	7.0	4.0	5.9	5.0	6.2	6.8	12.3	5.2	2.0	2.1	2.3	2.8	2.0	2.4	2.4	2.1	2.3	2.3	2.1	2.7	17.8	22.4	17.1	8.5	18.4	32.9	26.9	89.9	28.5	12.3	32.4	27.3	19.0	50.1	36.1	35.0	18.8	48.3	26.2	59.6	39.2	27.1	21.7	14.2	6.7	17.1	19.2	16.2	6.9	30.4	9.5	16.5	19.4	18.0	6.3	14.6	14.6	105.4	28.1	15.2	9.2	39.8	40.7	14.6	18.0	34.8	20.2	17.0	46.2	4.7	15.2	16.5	24.7	7.1	14.2	64.1	50.3	20.7	21.8	17.9	178.8	74.8	22.6	47.7	26.3	10.4	16.3	27.3	14.0	80.5	45.7	26.1	23.4	13.7	41.3	35.9
DHRS12	"FLJ13639, SDR40C1"	ENSG00000102796	"Dehydrogenase/reductase 12"	A0PJE2	13	51767993-51804162	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"pancreas: 66.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 69.1;Proximal tubular cells: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB034238, HPA057028, HPA058315"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB034238: AB_2091845, HPA057028: AB_2683314, HPA058315: AB_2683678"	"prognostic favorable (1.41e-4)"	"unprognostic (1.98e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.22e-16)"	"unprognostic (2.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.44e-1)"	22.7	10.6	7.8	2.9	7.3	4.5	20.5	8.9	7.8	13.9	6.5	14.0	5.5	13.1	5.0	10.3	14.5	6.1	14.3	7.3	6.7	24.6	28.9	11.7	5.3	7.2	6.6	18.4	66.8	6.6	18.7	3.6	7.0	15.4	3.7	5.9	15.0	5.9	16.0	14.1	12.5	4.0	7.6	15.7	15.0	8.2	7.0	2.3	18.8	4.1	3.5	13.2	11.2	8.3	1.1	2.5	3.8	5.6	1.2	2.6	4.4	1.6	4.1	1.8	1.3	4.5	8.6	4.2	1.2	2.5	2.5	2.0	0.0	0.3	0.3	4.2	3.4	0.6	1.1	3.2	6.6	0.4	0.7	2.7	3.9	0.6	2.4	4.5	5.2	4.0	2.0	3.0	1.3	5.5	1.0	3.5	6.1	4.2	0.6	0.5	0.8	5.8	5.6	3.2	3.4	6.9	2.9	2.5	7.1	5.0	2.8	2.8	3.7	1.3	1.5	0.1	1.7	1.4	1.8	1.9	2.3	1.4	3.7	6.6	16.6	0.5	14.0	14.2	24.1	13.7	19.7	16.9	9.0	13.4	16.4	12.9	31.4	3.8	16.5	10.6	19.8	13.5	7.8	7.3	8.9	7.8	7.3	6.7	7.2	6.6	7.0	7.6	7.0	8.3	14.1	12.8	14.8	11.1	11.4	11.3	12.1	22.2	10.8	11.9	23.5	22.9	15.7	18.6	13.3	16.5	8.4	24.9	8.0	7.8	52.8	12.5	26.1	5.6	7.7	10.1	10.3	2.1	4.9	16.7	17.5	17.1	7.1	6.4	12.0	6.8	8.6	30.7	17.1	3.3	5.4	12.4	22.4	11.2	11.6	69.1	11.1	10.1	14.2	3.7	10.5	32.4	8.2	24.6	12.9	12.6	21.9	9.8	4.8	12.2	25.5	83.5	19.5	18.5	0.0	14.2	11.4	1.4	8.2	10.5	14.9	23.8	13.7	13.4	11.0	12.2
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 336.3;urinary bladder: 392.6"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 15.1;Syncytiotrophoblasts: 24.8;Theca cells: 12.6;Urothelial cells: 30.6"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 719.8;RT4: 828.1;SK-BR-3: 4047.2;U-2 OS: 1286.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.4"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.45e-4)"	1.2	1.6	0.3	0.1	0.2	0.0	336.3	0.2	0.4	1.9	0.2	0.2	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.4	1.2	1.6	23.6	0.2	0.0	0.4	1.2	25.5	10.3	2.1	2.5	3.2	1.7	3.3	0.4	0.4	97.7	3.1	0.0	3.4	0.1	0.2	0.3	19.0	4.7	3.4	1.1	0.0	0.1	0.0	0.0	392.6	13.6	0.3	1.2	2.2	0.2	199.9	0.3	0.3	3.1	0.3	0.2	6.4	0.1	14.4	1.1	0.8	1.9	0.3	10.4	2.0	0.7	1.2	1.4	289.5	21.6	2.8	1.0	719.8	0.0	4.3	25.1	1.7	0.2	2.5	1.7	0.0	0.1	0.4	1.8	0.7	1.4	8.0	2.5	0.3	1.1	6.9	31.7	2.6	6.3	2.7	0.0	828.1	3.5	5.0	5.9	4047.2	4.9	0.7	3.9	1.0	0.0	2.4	1286.3	7.7	4.3	2.0	0.6	11.3	1.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.4	1.2	0.4	1.2	1.7	0.3	1.1	0.3	0.1	0.0	0.0	0.0	0.4	0.0	2.1	0.2	0.0	0.8	7.4	1.3	0.4	0.0	0.0	0.0	0.0	7.9	0.1	0.1	7.9	0.1	5.0	0.1	0.0	0.2	3.5	0.0	0.1	0.2	15.1	3.5	0.0	0.0	0.0	1.4	0.0	4.9	1.7	0.0	0.1	0.2	0.0	0.3	0.8	3.7	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	4.8	0.2	1.2	0.0	0.3	0.0	0.2	0.0	1.2	6.6	0.0	0.7	0.3	7.4	0.0	0.1	24.8	0.2	12.6	0.7	30.6
DHRS7	"retDSR4, SDR34C1"	ENSG00000100612	"Dehydrogenase/reductase 7"	Q9Y394	14	60144119-60169856	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 615.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 840.4"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 199.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031121, HPA078401"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Mitochondria"		"HPA031121: AB_10600803, HPA078401: "	"prognostic favorable (6.42e-4)"	"unprognostic (5.20e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.92e-10)"	"unprognostic (8.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	62.1	103.4	50.8	43.8	53.9	61.0	58.5	59.2	75.4	48.9	50.2	73.0	108.9	49.8	96.5	44.3	45.9	59.1	47.1	49.9	55.1	100.5	146.4	64.2	45.5	62.3	54.9	64.9	76.8	226.8	54.7	29.6	63.3	409.9	69.5	111.1	317.5	134.6	615.8	46.6	181.0	51.0	57.8	45.4	182.3	9.8	52.0	39.2	120.3	136.0	49.4	51.7	41.1	65.6	221.3	52.9	41.8	89.3	219.6	74.4	42.8	74.3	186.4	26.5	59.0	37.3	149.8	21.5	41.7	76.8	78.0	92.7	57.2	108.3	34.5	156.1	36.0	53.7	28.7	60.9	110.1	71.8	1.7	63.3	116.7	47.6	153.0	50.8	52.5	66.2	18.2	52.6	61.4	59.2	40.9	67.2	18.6	151.2	55.4	42.7	50.8	24.4	118.3	70.5	83.4	99.8	72.6	118.0	168.2	52.7	72.7	32.5	35.8	126.6	38.7	36.9	44.2	18.3	7.9	45.0	62.6	64.8	93.5	743.5	213.1	519.6	335.7	159.1	340.6	184.4	238.9	298.5	185.0	167.0	134.6	258.5	835.4	294.7	224.0	388.8	215.5	450.2	50.8	53.9	59.2	75.4	49.9	55.1	62.3	54.9	63.3	57.8	52.0	65.6	109.6	54.5	102.5	16.0	72.2	34.0	70.3	233.2	52.3	25.7	81.2	57.4	27.6	160.2	138.4	86.5	83.4	29.6	210.4	101.3	19.6	222.5	2.1	56.2	55.5	89.7	46.5	20.4	12.2	165.9	88.7	87.9	120.8	120.0	178.5	22.9	48.5	166.4	94.4	42.1	19.0	102.2	386.6	54.5	70.6	3.5	82.3	98.7	108.5	16.9	172.5	94.4	299.7	26.2	20.1	210.6	114.5	84.2	99.0	263.4	840.4	44.1	57.0	70.7	85.5	66.4	73.7	1.6	2.9	47.0	25.4	20.8	152.1	19.7	79.2	47.1
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673006	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.7;Spermatocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051455: AB_2681491"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	24.3	28.2	5.4	13.8	6.3	11.3	26.0	6.3	6.8	27.7	8.3	29.5	18.8	25.5	8.6	27.2	26.6	11.3	26.6	5.3	6.0	34.9	36.5	25.4	18.1	6.3	5.9	26.2	35.0	16.0	28.6	10.5	6.4	30.1	10.3	14.4	32.0	12.8	45.0	28.8	37.5	12.5	5.2	40.3	28.3	46.8	6.6	17.1	38.2	17.6	12.7	24.8	26.8	6.4	31.9	17.9	20.3	38.7	26.8	15.7	27.0	33.0	30.7	47.6	44.3	35.8	15.9	25.5	24.2	31.1	39.6	34.0	47.0	24.1	35.5	35.4	15.5	27.2	25.5	17.9	21.4	65.9	40.4	17.6	22.7	47.3	30.1	16.5	16.9	36.9	44.4	29.3	26.7	29.0	22.4	20.8	21.4	20.9	12.1	38.5	17.4	28.2	18.4	24.0	27.9	19.7	30.8	37.4	32.0	20.3	29.5	24.7	11.8	31.2	21.3	27.4	46.3	29.9	49.9	20.2	15.7	36.8	40.4	10.5	11.2	18.6	7.4	14.7	9.5	7.7	9.1	7.9	11.1	5.9	7.4	5.8	11.4	14.8	16.4	9.8	7.4	7.5	5.4	6.3	6.3	6.8	5.3	6.0	6.3	5.9	6.4	5.2	6.6	6.4	13.0	22.4	20.9	4.6	16.9	10.8	11.7	11.3	16.5	13.9	10.0	9.9	14.6	10.0	20.2	5.5	39.6	19.2	14.4	18.3	9.8	15.7	92.7	25.2	18.0	11.8	6.0	14.9	4.3	18.6	20.1	11.6	26.5	15.8	42.3	11.1	8.6	9.7	13.9	5.0	4.1	14.6	8.2	12.6	12.8	49.3	14.3	14.4	5.4	5.6	20.3	11.6	15.5	2.5	5.2	22.9	23.1	12.4	22.1	9.3	18.0	9.8	31.4	51.1	19.7	16.2	19.2	86.9	32.6	14.7	10.7	19.2	19.5	11.4	12.8	9.5
DHX34	"DDX34, KIAA0134"	ENSG00000134815	"DExH-box helicase 34"	Q14147	19	47349315-47382704	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 65.8;Spermatocytes: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 11.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042159, HPA043558"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA042159: AB_10963066, HPA043558: AB_10961262"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (8.63e-6)"	"unprognostic (9.14e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (7.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.21e-3)"	5.8	6.7	6.2	5.6	6.3	11.3	5.8	6.7	10.4	9.0	6.0	6.0	3.7	6.7	2.3	7.6	7.9	2.6	5.4	6.1	5.7	7.6	10.1	8.6	4.2	6.9	6.0	10.3	6.8	3.1	9.1	3.2	6.0	8.1	1.9	2.9	5.8	3.6	7.4	7.5	5.7	3.0	5.0	12.0	5.6	22.1	6.2	3.7	8.4	2.2	2.9	7.7	7.5	7.7	10.8	27.8	6.7	13.1	5.7	3.9	12.7	8.4	2.8	8.5	7.6	17.8	10.3	16.5	8.3	4.7	9.1	15.4	9.3	11.1	4.3	13.8	25.4	17.3	16.1	13.7	6.4	13.5	7.1	5.0	8.8	14.3	8.0	5.4	5.7	7.4	29.2	6.9	5.7	12.8	13.5	33.6	13.9	14.0	16.4	14.6	5.3	10.0	4.6	14.3	11.9	7.3	10.3	10.1	6.8	7.5	9.2	8.6	6.5	9.9	12.7	6.3	15.0	10.5	15.5	15.1	7.9	9.7	11.8	1.0	1.8	0.7	1.0	1.8	1.0	0.9	0.8	1.5	1.7	1.1	1.2	0.5	11.7	0.8	1.5	1.3	0.6	1.1	6.2	6.3	6.7	10.4	6.1	5.7	6.9	6.0	6.0	5.0	6.2	7.7	1.8	6.4	5.8	8.5	4.4	7.5	5.7	2.4	4.0	8.1	5.4	3.0	3.6	2.8	3.5	7.3	2.1	4.9	8.6	4.2	0.0	4.8	26.1	5.9	4.4	3.6	3.6	4.2	11.0	3.3	5.7	3.6	6.6	7.3	3.8	10.5	2.9	6.6	7.6	0.0	10.1	4.7	4.1	8.2	18.1	65.8	5.3	13.3	1.8	2.8	5.4	1.6	1.0	7.1	10.4	3.6	2.2	4.9	3.5	7.4	4.1	1.9	6.0	5.7	6.6	3.4	4.0	39.1	16.9	4.3	7.2	5.1	3.9	4.3	6.3	6.4
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	6.6	4.2	4.2	4.5	4.9	9.8	6.0	4.4	5.2	10.1	3.1	16.7	6.2	11.2	8.0	8.1	8.5	5.6	10.2	4.5	3.9	6.0	4.8	5.3	6.7	4.1	4.3	7.9	3.7	7.0	3.8	5.2	4.1	8.1	8.6	6.0	5.1	7.2	8.2	6.9	7.9	8.1	3.8	4.8	8.0	6.6	4.2	6.4	5.1	6.3	5.4	11.9	7.0	5.1	10.3	8.4	15.9	6.6	6.0	7.8	11.3	6.0	10.3	13.5	9.9	29.1	9.0	11.4	10.4	11.4	10.4	16.0	11.0	17.5	13.2	2.9	5.2	15.4	14.3	16.7	7.2	18.4	7.7	9.0	11.3	11.7	10.9	8.3	6.1	19.4	16.0	6.5	7.2	8.2	30.0	14.0	9.1	18.5	13.5	14.5	23.2	9.5	5.0	11.8	13.9	11.1	16.4	9.6	15.4	9.9	13.3	14.7	6.0	19.1	10.6	7.8	12.6	6.5	9.2	12.3	10.9	8.2	10.4	0.0	3.0	1.2	2.9	2.7	2.9	2.5	2.4	3.1	4.0	2.9	4.5	2.4	0.6	3.9	2.4	1.4	1.7	2.9	4.2	4.9	4.4	5.2	4.5	3.9	4.1	4.3	4.1	3.8	4.2	5.1	5.4	0.0	3.7	16.0	3.8	0.5	1.4	2.2	7.4	5.1	2.3	3.0	6.7	4.3	4.8	1.8	4.2	3.7	4.1	4.2	1.9	2.4	3.7	2.5	6.6	3.8	5.4	5.5	23.5	1.1	2.4	3.8	7.7	3.2	8.2	6.1	5.7	7.0	5.0	5.0	21.5	6.3	4.1	4.7	4.0	0.8	6.2	3.3	3.6	14.0	3.6	3.3	6.2	22.6	24.8	2.0	5.8	6.4	4.9	2.7	4.6	2.2	4.3	4.7	0.0	4.7	3.9	1.9	9.4	4.5	2.0	3.0	4.5	4.9	5.4	1.1
DHX36	"DDX36, KIAA1488, MLEL1, RHAU"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324487	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 547.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035398, HPA035399"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA035398: , HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	17.7	14.4	5.6	17.3	8.6	16.3	16.4	8.9	7.3	13.9	6.3	12.0	12.6	18.3	11.6	14.8	14.4	15.5	16.9	5.6	8.1	18.6	20.0	13.7	21.7	7.0	7.5	19.0	16.0	29.1	14.9	19.0	7.2	17.3	13.7	17.0	11.7	16.4	58.9	12.0	12.8	17.1	6.9	15.2	16.0	34.4	6.9	21.7	23.1	31.6	20.5	17.2	11.0	10.0	63.8	42.6	56.6	32.7	26.1	36.3	28.1	40.6	40.5	45.2	53.5	43.7	49.7	61.3	64.0	35.8	41.7	40.1	53.8	34.4	70.6	59.3	35.6	44.5	34.8	25.0	44.2	62.7	37.4	41.3	28.5	48.6	59.1	24.5	39.4	37.3	42.6	34.3	42.2	31.0	52.2	13.7	75.4	33.6	40.5	53.4	47.6	88.8	32.1	44.4	52.7	56.1	42.3	44.4	59.7	38.3	45.5	31.5	44.9	47.1	29.6	44.6	82.1	63.6	43.9	87.5	38.1	32.2	51.1	1.2	1.5	1.8	3.7	1.5	2.3	2.6	3.2	2.5	1.3	3.1	2.9	3.1	0.6	2.6	3.5	3.3	3.1	0.6	5.6	8.6	8.9	7.3	5.6	8.1	7.0	7.5	7.2	6.9	6.9	10.0	95.6	57.7	92.9	45.4	123.6	92.9	146.6	56.6	81.4	152.2	61.8	62.6	60.8	67.2	83.5	60.7	129.3	138.0	179.3	43.8	39.2	71.2	547.0	73.4	147.9	82.0	92.0	68.5	53.5	62.8	69.9	97.6	66.8	104.2	103.8	86.7	72.8	80.5	62.0	154.8	60.2	57.4	73.2	73.7	85.2	335.5	110.6	83.0	53.4	37.5	88.5	86.4	113.3	59.3	55.4	66.5	49.9	121.5	97.6	132.2	40.4	54.4	52.3	128.6	78.9	130.6	88.8	197.4	135.1	65.3	83.1	370.1	152.0	114.2	58.1	128.4
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093613-72112912	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041347: AB_10796571, HPA041604: AB_2677577"	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	25.8	18.7	22.4	22.8	24.4	39.7	23.8	22.2	24.7	25.1	25.9	24.8	19.6	25.5	10.7	24.2	23.8	15.0	27.0	21.5	21.6	19.6	24.0	23.9	27.8	23.2	23.2	30.6	20.2	22.9	19.3	18.6	22.5	20.9	16.1	13.2	21.1	14.4	39.9	27.6	27.3	17.6	22.2	30.4	22.5	21.3	23.5	24.2	22.8	21.4	23.1	23.7	22.9	25.0	38.5	55.0	39.4	21.9	33.4	25.8	51.1	33.6	32.6	49.1	37.8	66.4	37.5	50.5	29.2	50.9	27.0	48.6	46.3	45.8	38.0	25.3	50.0	38.7	48.9	92.5	30.8	46.9	66.7	35.6	41.2	66.1	47.4	25.9	42.9	35.7	58.9	22.9	30.6	112.8	43.9	53.1	49.7	23.9	30.9	55.8	27.1	49.9	24.0	35.6	35.6	38.9	43.8	20.3	24.5	22.5	36.8	38.4	49.4	46.6	40.8	34.8	37.3	56.2	47.6	96.7	43.9	32.1	37.5	7.1	6.2	7.1	11.3	8.3	9.8	8.1	6.8	8.2	6.2	6.0	7.4	7.9	6.4	8.8	5.1	5.5	8.6	5.5	22.4	24.4	22.2	24.7	21.5	21.6	23.2	23.2	22.5	22.2	23.5	25.0	22.5	25.6	34.3	13.7	24.4	12.2	11.0	9.5	20.5	30.7	12.0	13.6	8.6	20.0	22.0	14.7	16.7	15.0	33.3	28.5	0.0	14.5	9.0	19.3	23.0	22.3	30.5	16.8	6.7	20.6	14.3	17.1	28.1	23.6	43.0	24.0	15.0	13.6	14.9	30.3	6.1	24.8	6.1	15.2	13.9	11.0	28.9	20.3	8.8	5.6	16.9	17.9	19.6	8.0	11.1	23.7	17.1	25.2	22.4	12.7	21.1	8.6	19.0	35.3	19.7	25.6	19.1	25.5	17.8	18.5	12.8	20.4	28.2	20.6	23.4	12.6
DHX40	"ARG147, DDX40, FLJ22060, PAD"	ENSG00000108406	"DEAH-box helicase 40"	Q8IX18	17	59565558-59608345	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 103.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044350	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044350: AB_10960560"	"unprognostic (1.58e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (4.05e-5)"	"unprognostic (4.09e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-1)"	17.9	22.0	14.9	12.9	15.7	26.5	26.9	16.9	16.6	22.1	25.1	15.4	14.6	25.7	21.1	17.4	27.3	17.1	18.2	14.3	17.7	32.9	14.9	18.7	16.3	15.1	16.9	32.3	21.1	57.7	21.7	19.7	16.0	21.3	17.1	21.5	17.0	21.6	17.4	21.2	13.9	20.8	15.5	15.5	16.7	29.8	15.1	25.0	30.6	22.3	18.4	19.2	13.5	20.9	28.7	51.7	64.0	42.5	39.4	39.5	36.0	25.3	48.2	37.9	42.8	20.5	28.0	37.7	69.3	37.2	40.0	20.9	46.5	36.2	58.6	29.9	68.8	34.3	35.1	23.4	30.7	42.3	15.3	31.2	33.1	32.3	31.4	62.3	42.0	36.2	29.3	33.9	26.5	53.5	51.8	26.4	24.8	36.0	37.8	48.8	45.1	42.3	39.0	22.9	45.5	113.5	45.7	18.4	48.6	31.3	58.4	24.8	34.5	45.8	56.3	16.6	25.2	41.2	47.5	23.9	53.5	28.9	32.0	9.2	6.8	11.6	7.9	6.6	10.3	4.7	5.6	5.6	7.1	4.9	5.5	6.6	19.4	4.5	4.9	3.7	6.2	7.5	14.9	15.7	16.9	16.6	14.3	17.7	15.1	16.9	16.0	15.5	15.1	20.9	27.3	9.6	20.9	10.1	19.7	19.4	10.4	16.7	26.2	12.6	31.9	26.7	24.3	28.6	25.3	47.8	18.8	8.8	35.5	14.2	11.7	18.4	43.0	68.8	37.8	22.4	18.5	29.8	10.9	16.9	9.3	21.1	20.9	41.8	3.8	41.8	27.5	25.0	9.2	50.5	14.3	19.0	8.2	21.6	14.7	16.7	25.1	18.8	19.6	3.7	14.8	21.7	14.4	7.1	14.6	13.2	11.9	26.7	18.0	13.4	12.6	46.2	57.7	14.6	32.9	17.4	22.8	103.9	51.4	15.3	22.0	12.6	19.1	36.5	17.8	10.9
DHX58	"D11LGP2, LGP2"	ENSG00000108771	"DExH-box helicase 58"	Q96C10	17	42101404-42112714	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 52.9;SK-MEL-30: 27.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018670, HPA019570"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA018670: AB_1847665, HPA019570: AB_1847666"	"prognostic favorable (3.45e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-3)"	8.9	11.9	5.5	10.2	6.1	12.3	7.6	4.7	7.4	7.7	4.9	7.0	8.5	7.0	5.9	6.4	11.5	12.1	4.9	4.6	4.8	7.3	14.5	11.8	12.5	6.9	5.4	11.9	6.0	7.2	6.9	7.0	6.2	8.7	5.1	0.6	18.6	8.2	3.7	7.5	8.5	7.3	7.5	18.4	9.3	10.8	5.4	12.5	5.5	4.3	7.4	8.0	5.9	6.7	2.5	0.0	0.1	1.3	11.3	9.9	0.3	3.3	22.4	45.5	52.9	0.3	14.6	0.2	3.4	5.4	10.2	2.0	0.2	3.5	1.7	9.3	0.3	3.9	2.6	0.9	12.6	3.6	8.6	15.9	5.9	4.0	3.9	8.0	5.5	23.5	0.0	12.8	2.5	0.0	21.7	4.5	0.4	0.6	0.0	7.8	0.0	1.2	5.2	8.6	0.4	0.0	1.5	5.9	27.0	0.0	7.9	3.8	2.4	2.3	0.1	0.8	1.1	4.3	3.8	0.2	4.6	3.3	2.6	2.3	7.7	6.9	3.1	9.7	4.8	4.6	4.7	2.9	5.9	3.5	5.1	3.8	3.2	6.8	8.6	2.0	4.4	5.0	5.5	6.1	4.7	7.4	4.6	4.8	6.9	5.4	6.2	7.5	5.4	6.7	9.1	9.6	3.4	6.8	4.8	1.5	3.9	6.2	3.4	1.0	3.5	3.7	1.7	8.6	7.6	7.3	0.0	4.0	4.7	2.3	1.9	7.0	9.0	4.5	2.9	7.0	0.0	0.4	1.9	6.9	4.6	4.1	3.6	4.0	1.3	7.5	3.3	14.0	9.8	0.0	2.4	3.2	4.1	7.0	0.7	12.1	8.7	7.4	3.6	8.4	39.9	2.4	2.1	4.0	1.8	5.7	4.3	9.1	1.3	5.4	3.9	5.7	11.6	0.6	0.0	3.7	3.8	18.1	1.0	2.3	1.6	0.8	6.6	8.2	1.9	2.9
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43610338	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA049285: AB_2680698"	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	20.4	18.5	25.9	18.0	25.8	55.0	20.5	24.7	36.7	22.4	22.8	21.4	17.3	19.9	26.1	26.9	16.7	16.4	21.8	25.4	24.8	20.3	18.6	20.0	23.7	25.6	25.2	17.0	17.0	27.5	20.8	20.9	25.5	21.6	23.9	16.8	20.8	20.4	22.6	33.7	20.6	23.6	23.4	25.8	19.5	24.3	25.8	35.1	19.0	19.4	29.6	23.0	21.7	25.5	29.2	81.7	43.3	52.4	42.3	42.5	24.0	30.2	62.0	64.9	61.7	37.4	28.1	40.3	27.0	59.4	46.6	38.0	65.9	53.1	74.8	40.8	51.9	33.8	61.2	56.7	35.8	59.8	49.5	21.1	44.1	53.0	58.4	31.4	57.4	52.1	38.8	35.2	51.2	32.0	75.9	52.7	35.5	35.4	31.0	46.2	82.4	40.2	44.3	60.6	37.3	56.0	33.9	18.6	27.3	50.9	44.1	58.3	40.0	50.3	26.9	36.3	45.8	27.5	36.6	44.7	41.2	36.8	41.2	30.2	17.4	20.4	16.0	25.2	14.7	12.2	12.7	15.5	17.0	11.0	10.6	11.5	21.8	11.0	26.1	10.3	12.8	11.4	25.9	25.8	24.7	36.7	25.4	24.8	25.6	25.2	25.5	23.4	25.8	25.5	17.1	6.4	15.0	6.5	18.6	11.9	7.1	12.4	12.0	16.9	16.3	13.0	13.2	7.2	19.2	22.0	18.8	9.1	23.6	13.4	13.7	16.2	19.4	18.3	26.2	17.6	26.7	13.7	10.7	17.7	8.8	14.5	14.8	23.9	14.5	15.3	16.1	14.7	11.1	6.7	10.5	15.3	10.2	14.8	11.5	10.6	12.5	18.4	17.8	14.0	24.8	10.6	21.6	9.5	15.8	21.2	16.0	10.9	20.0	9.4	10.1	12.4	13.7	19.8	19.7	20.3	14.4	27.9	16.8	17.2	13.4	21.2	20.9	11.1	10.8	14.3
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839347-182887982	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	38.7	30.5	13.6	47.4	15.8	131.4	53.2	19.0	19.7	43.7	17.0	40.2	32.6	49.4	33.0	32.2	45.9	31.1	28.5	13.1	16.0	49.9	36.9	38.6	56.9	15.2	13.6	52.8	30.5	68.2	21.1	44.6	16.3	39.6	47.1	66.5	32.5	44.3	30.3	31.1	36.3	50.8	16.6	40.9	34.5	50.4	14.6	88.7	48.0	37.7	70.2	54.0	30.0	25.5	165.7	158.8	223.0	122.3	113.7	87.8	219.2	143.5	130.3	203.6	137.0	175.8	124.2	264.3	133.7	129.6	121.7	138.8	342.6	155.2	225.7	108.3	169.5	176.4	121.0	119.6	62.5	258.3	115.0	78.6	75.8	200.4	53.4	91.6	161.7	132.9	281.8	91.9	165.1	142.3	263.6	61.1	282.8	173.9	96.8	236.0	208.0	151.0	127.0	187.8	160.0	183.2	203.2	125.0	83.2	186.4	148.4	140.9	127.6	125.3	138.8	128.9	195.9	93.6	167.2	305.0	79.0	137.0	174.5	7.7	21.3	16.1	23.4	22.5	26.2	20.5	19.8	21.1	29.9	16.6	21.6	23.7	8.0	20.0	19.7	14.2	20.1	21.2	13.6	15.8	19.0	19.7	13.1	16.0	15.2	13.6	16.3	16.6	14.6	25.5	43.6	41.7	74.1	59.1	54.5	53.7	61.2	42.7	38.7	59.6	43.3	38.9	43.9	30.0	60.8	51.5	52.1	50.9	70.2	38.6	19.6	49.0	26.8	79.2	67.4	50.7	53.8	74.5	49.4	50.8	47.5	48.0	37.8	109.8	44.9	67.7	36.0	28.0	40.8	28.6	55.5	40.9	30.5	35.4	35.1	45.8	60.3	44.7	30.2	55.3	55.9	42.7	42.2	55.3	70.3	52.3	28.0	47.0	52.4	48.3	35.4	38.0	67.7	77.1	39.5	73.9	54.1	69.9	68.2	51.7	47.2	49.5	59.2	60.9	54.4	55.4
DIDO1	"BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333"	ENSG00000101191	"Death inducer-obliterator 1"	Q9BTC0	20	62877738-62937952	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004374, HPA049904"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"CAB004374: AB_2093108, HPA049904: AB_2680944"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (9.92e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.82e-2)"	30.4	20.1	15.7	21.5	17.6	29.1	31.0	22.4	17.8	33.8	23.3	36.3	19.6	38.2	26.8	27.1	36.8	17.5	27.6	15.4	17.2	25.5	24.7	30.9	31.6	16.4	16.4	39.5	24.6	28.5	28.1	24.8	16.6	34.0	19.7	19.9	33.2	24.9	32.5	39.5	36.5	20.9	14.0	35.9	28.8	27.9	17.3	30.8	33.0	22.8	26.9	32.6	31.5	22.2	29.6	22.5	36.7	21.0	18.4	22.6	19.6	21.9	18.5	79.4	22.8	96.4	29.9	29.0	29.4	26.9	46.1	45.2	33.8	42.4	51.1	16.1	22.9	41.9	40.2	69.6	23.5	37.8	41.6	23.3	57.0	27.5	15.4	18.1	22.1	54.6	41.7	25.8	20.5	28.7	76.9	33.1	29.4	35.7	32.2	53.7	47.0	18.5	13.1	26.0	45.2	26.7	43.8	41.9	28.9	21.9	41.8	42.7	27.8	64.3	44.8	21.7	31.5	17.1	11.9	38.2	29.3	18.8	23.7	32.6	7.2	20.2	15.0	9.5	15.9	11.7	13.4	14.8	5.1	9.8	17.6	16.5	10.6	13.8	7.6	10.7	11.8	9.6	15.7	17.6	22.4	17.8	15.4	17.2	16.4	16.4	16.6	14.0	17.3	22.2	24.8	25.6	30.1	37.9	28.4	24.2	35.3	17.8	25.6	25.6	23.1	19.6	27.5	22.8	23.8	25.8	33.3	28.6	49.0	32.3	23.5	18.0	42.8	32.1	26.1	26.2	19.2	21.0	44.9	13.8	15.7	24.2	30.1	34.3	22.8	33.8	20.7	19.6	14.5	38.7	46.0	23.2	14.2	16.8	13.7	13.0	35.1	20.2	21.4	32.8	26.8	16.7	42.2	40.7	47.4	22.2	20.2	33.8	30.0	26.3	25.3	9.6	45.8	23.4	6.6	35.4	23.4	26.1	32.1	26.0	25.6	19.7	32.1	25.6	21.1	34.4
DIMT1	"DIMT1L, HSA9761"	ENSG00000086189	"DIMT1 rRNA methyltransferase and ribosome maturation factor"	Q9UNQ2	5	62347284-62403943	"Enzymes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042944	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA042944: AB_2678234"	"unprognostic (1.58e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (8.90e-12)"	"unprognostic (8.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.15e-2)"	16.3	13.6	6.5	13.3	6.5	9.1	19.7	6.7	9.6	17.2	6.4	10.9	8.5	14.6	13.9	17.5	14.5	14.2	17.7	6.6	6.8	10.6	15.4	9.8	15.9	6.7	6.7	15.5	19.3	13.3	10.3	17.3	6.7	15.9	12.0	2.9	15.2	16.2	9.7	8.5	8.8	21.0	6.7	13.3	8.5	8.2	6.6	15.0	13.4	12.8	16.8	26.0	11.4	6.7	33.1	19.9	24.2	44.1	37.7	57.4	35.0	57.3	33.7	57.3	55.8	45.1	36.3	61.4	48.4	61.9	45.4	20.2	38.7	35.8	61.3	46.4	34.0	27.2	15.0	33.8	48.1	32.4	34.7	46.7	31.1	54.1	57.3	28.1	46.1	37.0	49.3	27.9	47.3	43.5	50.1	58.6	36.1	18.9	49.7	28.2	33.3	119.2	45.8	29.9	31.5	19.8	38.5	32.2	35.5	19.6	27.0	29.2	40.3	21.0	29.5	33.7	71.2	27.4	46.7	62.6	27.0	61.6	45.1	7.9	5.3	2.7	6.7	9.1	12.7	10.4	11.2	9.1	9.3	6.1	11.6	9.7	0.1	7.7	6.8	12.1	7.8	6.3	6.5	6.5	6.7	9.6	6.6	6.8	6.7	6.7	6.7	6.7	6.6	6.7	25.3	3.2	9.5	6.5	37.8	50.9	90.3	54.8	69.4	6.2	29.9	20.2	35.3	17.2	36.3	14.7	10.4	45.3	21.9	5.0	21.5	28.6	10.1	23.8	28.3	32.0	4.8	20.4	11.1	22.5	48.1	35.6	13.7	23.2	13.3	13.3	17.5	13.4	33.1	0.0	10.5	12.1	32.6	16.4	22.8	4.4	28.9	18.5	28.4	2.8	19.7	7.4	13.4	8.0	12.9	19.8	7.5	20.3	29.3	104.3	4.0	32.5	24.0	4.7	6.6	51.8	49.8	16.5	20.4	58.7	37.8	35.7	31.1	28.6	18.3	76.6
DIO2	"SelY, TXDI2"	ENSG00000211448	"Iodothyronine deiodinase 2"	Q92813	14	80197526-80387757	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 163.9;thyroid gland: 355.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 150.7;Endometrial stromal cells: 158.3;Extravillous trophoblasts: 523.3;Muller glia cells: 246.4"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 80.8;fHDF/TERT166: 41.8;HeLa: 95.4;HHSteC: 44.2;SiHa: 168.1;SK-BR-3: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048002			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA048002: AB_2680230"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.67e-4)"	"prognostic favorable (4.62e-6)"	"unprognostic (2.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.15e-2)"	1.5	3.0	18.0	0.6	15.3	0.1	15.3	15.0	24.6	163.9	5.9	1.3	1.3	40.2	0.5	58.9	0.7	5.1	11.9	17.1	13.0	5.0	0.1	1.6	0.8	13.6	19.2	0.2	1.8	6.6	31.6	14.5	17.4	9.0	1.7	7.4	33.3	30.4	6.5	7.1	1.5	4.5	5.5	0.6	5.3	4.7	13.3	1.2	355.8	70.7	33.1	6.0	25.0	16.6	0.2	9.5	0.0	0.0	0.5	1.4	0.3	80.8	16.6	6.2	0.9	0.0	0.3	0.2	0.2	41.8	0.3	1.7	2.9	0.0	6.1	0.0	0.2	0.0	95.4	0.0	44.2	0.0	0.2	5.1	0.0	1.2	0.0	3.9	1.4	0.0	0.0	0.8	0.5	1.9	0.1	0.1	1.7	0.0	0.5	0.8	3.9	0.1	0.0	0.8	0.0	0.2	168.1	35.3	0.3	7.1	0.1	0.0	0.8	0.3	7.0	17.4	20.1	2.8	0.0	0.0	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	15.3	15.0	24.6	17.1	13.0	13.6	19.2	17.4	5.5	13.3	16.6	0.1	0.0	0.5	52.9	0.3	2.9	0.1	0.0	2.2	3.3	150.7	34.4	1.9	0.0	0.0	0.0	0.0	4.8	0.5	0.2	0.0	0.0	29.5	14.2	158.3	2.3	0.0	0.0	1.0	0.0	523.3	24.6	0.0	15.6	0.0	0.1	0.7	0.2	9.2	1.7	1.0	0.5	0.0	1.3	5.7	12.5	3.4	1.3	5.4	4.7	0.0	246.4	0.0	8.5	1.4	1.0	0.0	4.1	0.3	0.3	0.0	0.0	0.0	7.8	0.0	69.1	6.5	9.7	0.7	8.9	3.0	28.2	1.7	0.9	0.1	0.1
DIP2A	"C21orf106, Dip2, KIAA0184"	ENSG00000160305	"Disco interacting protein 2 homolog A"	Q14689	21	46458891-46570015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 159.6;Oligodendrocytes: 143.0;Rod photoreceptor cells: 206.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052516	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA052516: AB_2681859"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.35e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-3)"	5.6	5.4	4.1	6.1	7.7	9.8	5.2	5.0	6.8	6.5	2.9	6.1	6.6	5.8	2.1	6.6	6.3	4.5	8.4	6.0	6.4	3.5	2.9	5.5	7.2	7.6	6.4	7.2	6.7	5.1	4.9	5.9	7.7	6.9	4.1	10.6	6.9	4.0	6.8	6.7	7.4	5.0	3.4	8.9	7.2	7.3	7.8	6.4	5.2	6.6	4.8	5.1	6.1	15.8	14.3	9.5	17.4	8.2	7.9	7.4	10.8	9.7	7.4	9.5	7.7	17.0	10.5	5.9	9.1	10.1	9.8	7.3	7.9	13.4	5.6	23.4	11.1	20.1	15.8	10.1	5.4	7.3	10.3	6.8	8.8	10.2	11.2	7.3	14.1	11.4	13.4	13.9	7.9	13.3	11.7	10.9	9.5	12.6	9.4	11.6	7.0	12.4	5.6	13.2	9.3	5.8	15.0	9.8	8.4	4.6	10.3	7.0	19.0	7.8	5.5	11.2	7.2	13.9	7.6	5.4	8.3	12.3	12.8	11.9	5.2	12.4	14.4	6.5	9.4	3.3	6.5	9.9	2.9	3.6	4.5	9.3	10.3	10.1	7.4	10.6	5.8	4.6	4.1	7.7	5.0	6.8	6.0	6.4	7.6	6.4	7.7	3.4	7.8	15.8	35.3	41.7	19.2	40.8	18.6	14.7	9.3	13.8	23.9	55.9	18.0	16.6	30.7	18.6	20.5	14.7	116.7	11.3	97.0	23.9	9.8	10.7	18.8	21.3	32.8	33.2	24.0	12.8	86.9	11.0	9.5	23.2	50.0	25.7	13.3	34.9	34.2	11.2	18.0	18.5	101.8	21.7	4.1	39.9	17.3	25.6	23.9	26.5	7.2	119.9	21.4	16.3	159.6	68.9	143.0	20.9	15.7	22.2	58.4	19.3	23.4	8.0	26.4	206.8	26.3	31.4	18.3	54.2	38.3	20.7	17.6	11.2	63.1	19.1	23.1	13.3
DIP2C	KIAA0934	ENSG00000151240	"Disco interacting protein 2 homolog C"	Q9Y2E4	10	274190-689668	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 125.4;Excitatory neurons: 219.3;Inhibitory neurons: 269.9;Oligodendrocyte precursor cells: 216.2;Oligodendrocytes: 421.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2197: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030264, HPA059325"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"	Vesicles	"HPA030264: AB_10600903, HPA059325: AB_2683979"	"unprognostic (1.72e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.10e-3)"	12.7	7.7	13.8	3.7	18.3	0.2	8.3	18.8	19.9	11.0	0.0	22.1	4.5	12.1	5.4	9.1	8.8	8.6	14.1	13.6	10.7	14.7	8.9	4.9	2.4	16.8	14.6	13.3	8.0	8.1	6.2	4.6	17.4	8.4	4.4	9.4	4.2	9.1	34.5	4.8	7.0	12.4	7.2	3.3	7.3	7.2	18.1	2.1	5.3	20.8	1.5	10.5	7.5	32.6	0.7	6.3	11.5	6.1	19.0	20.5	9.5	13.9	8.6	10.5	8.5	1.8	1.9	0.5	3.6	22.5	2.7	0.1	7.1	1.2	6.4	0.3	6.4	0.1	4.5	2.0	9.2	0.0	8.6	16.9	5.5	6.6	0.0	16.4	2.3	0.1	0.0	1.2	8.0	17.4	0.7	0.0	3.0	5.4	2.6	9.9	4.8	2.0	7.5	7.2	5.8	8.2	2.4	5.0	20.1	6.0	6.6	0.0	0.1	11.1	2.9	33.3	4.6	0.8	14.3	7.2	13.9	0.3	6.4	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.2	0.2	0.0	1.0	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	13.8	18.3	18.8	19.9	13.6	10.7	16.8	14.6	17.4	7.2	18.1	32.6	12.6	9.6	5.8	125.4	4.0	7.9	5.4	2.2	7.4	18.6	11.8	10.0	30.3	17.2	4.7	3.7	22.9	5.2	0.6	2.2	0.0	8.5	19.0	7.9	18.5	7.8	10.8	0.0	219.3	4.0	5.8	15.4	10.2	8.8	20.3	16.3	10.4	24.2	6.2	1.7	269.9	6.2	2.0	3.5	5.2	6.1	11.5	3.6	23.2	44.0	0.6	19.4	1.0	216.2	421.7	7.7	1.3	19.5	0.9	7.7	10.2	17.0	5.3	20.5	6.6	22.7	17.6	21.7	22.5	4.3	3.8	3.8	2.0	5.6	5.7	8.9
DIPK1A	"FAM69A, FLJ23493"	ENSG00000154511	"Divergent protein kinase domain 1A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 30.6;Syncytiotrophoblasts: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favorable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	18.8	4.2	20.2	14.5	23.3	10.0	9.9	22.3	29.5	7.8	14.6	15.2	11.7	15.7	4.7	12.0	9.5	14.6	6.7	20.4	21.2	7.9	32.8	6.0	14.9	21.7	20.6	7.5	4.5	15.1	3.9	16.9	22.3	11.8	15.9	8.3	7.5	13.8	11.3	7.4	11.0	25.5	23.1	10.6	11.9	8.6	20.9	16.1	8.0	7.5	12.2	14.8	6.2	31.0	11.2	12.6	4.6	11.5	17.6	33.5	5.9	33.9	69.0	18.6	37.8	6.7	2.3	38.3	6.0	62.1	38.0	13.6	0.9	25.3	30.5	15.7	12.2	1.2	9.2	17.1	6.3	3.4	2.1	19.6	19.8	40.8	9.7	31.8	0.3	22.7	13.4	37.7	24.1	4.0	12.4	3.1	8.6	18.4	4.6	11.4	36.2	11.5	2.6	11.2	11.8	9.5	9.7	9.2	12.7	10.6	4.3	1.1	1.3	22.1	17.0	43.0	12.0	57.7	60.2	44.0	10.4	2.2	2.0	0.1	1.8	0.1	19.3	0.9	15.5	43.4	22.3	15.5	8.6	26.9	25.6	22.2	0.5	24.2	0.6	14.1	21.9	12.3	20.2	23.3	22.3	29.5	20.4	21.2	21.7	20.6	22.3	23.1	20.9	31.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	30.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	25.3	0.7	0.0	0.0	0.0
DIPK1B	"C9orf136, FAM69B, MGC20262"	ENSG00000165716	"Divergent protein kinase domain 1B"	Q5VUD6	9	136712572-136724742	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"Adipocytes: 23.1;Cardiomyocytes: 7.3;Endothelial cells: 6.9;Extravillous trophoblasts: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.8"	"Group enriched"	"Detected in many"	9	"B-cells: 2.8;dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 56.4;HEK 293: 58.2;HUVEC TERT2: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054443			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA054443: AB_2682489"	"unprognostic (2.78e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.10e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (6.67e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.78e-1)"	17.4	4.8	21.7	3.7	20.3	9.1	14.0	25.7	26.8	14.9	18.7	12.3	5.4	16.8	2.1	4.9	16.7	5.5	35.9	20.1	20.0	17.8	11.4	16.4	5.8	23.5	21.1	11.5	14.3	12.8	25.1	18.7	24.2	13.6	0.8	5.9	9.8	3.1	8.9	11.5	7.7	3.0	17.3	8.6	6.8	15.0	24.2	1.7	16.8	3.8	1.3	8.0	7.7	19.4	3.2	11.3	25.3	21.0	0.0	0.0	19.5	2.9	0.0	0.8	0.9	27.7	6.6	9.2	56.4	0.0	7.9	13.5	11.7	0.3	0.2	8.1	58.2	13.5	4.7	5.9	0.2	7.0	9.0	0.2	0.0	0.3	0.1	10.1	65.2	19.7	14.8	4.2	0.0	14.8	10.8	28.3	36.9	12.6	9.7	49.9	1.9	26.2	1.4	3.7	38.5	38.3	1.8	8.2	27.4	8.7	18.3	21.9	33.3	5.6	18.7	5.3	6.8	12.9	3.3	8.9	3.2	6.7	10.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	2.8	0.2	0.1	0.0	0.0	0.0	1.0	0.1	0.3	21.7	20.3	25.7	26.8	20.1	20.0	23.5	21.1	24.2	17.3	24.2	19.4	23.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	6.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
DIRAS1	"Di-Ras1, GBTS1, RIG"	ENSG00000176490	"DIRAS family GTPase 1"	O95057	19	2714567-2721372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.8;heart muscle: 105.0;tongue: 51.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Distal tubular cells: 31.3;Excitatory neurons: 20.4;Horizontal cells: 89.2;Inhibitory neurons: 25.9"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4;melanoma: 13.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.4;REH: 49.2;SH-SY5Y: 27.8;THP-1: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050164			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA050164: "	"unprognostic (7.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.60e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-4)"	1.8	2.5	10.5	1.2	20.7	0.7	1.9	16.1	84.8	7.0	0.0	1.4	1.2	12.7	2.5	5.4	6.6	0.7	105.0	19.8	16.9	4.8	0.1	0.6	0.6	17.1	17.4	2.7	6.7	17.0	22.4	0.3	14.5	3.3	1.1	11.5	6.7	1.8	2.7	1.9	2.2	7.4	0.0	4.2	3.5	6.0	45.2	0.1	0.5	51.8	0.7	4.0	2.4	34.8	0.1	2.2	7.0	24.1	0.9	3.1	0.1	8.2	2.8	0.4	0.1	1.4	0.4	0.0	1.0	21.9	12.2	0.1	10.1	0.0	0.0	0.0	15.6	0.5	0.8	0.9	1.0	0.0	43.4	1.4	5.1	0.1	0.1	4.6	0.0	0.2	15.0	7.2	2.8	3.6	0.2	0.4	15.2	0.0	3.3	49.2	0.0	11.7	0.0	0.0	3.1	27.8	0.3	1.1	15.6	1.2	1.1	34.2	0.0	5.3	6.6	0.2	2.6	16.4	12.4	8.9	11.8	0.5	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	20.7	16.1	84.8	19.8	16.9	17.1	17.4	14.5	0.0	45.2	34.8	0.0	0.0	0.0	1.6	6.9	1.1	0.8	0.2	2.2	7.9	2.6	2.8	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	31.3	1.4	0.4	0.1	2.2	0.3	0.0	1.3	20.4	2.0	0.5	0.9	0.0	0.3	0.0	2.3	0.0	0.0	5.7	89.2	25.9	0.0	0.0	0.0	3.6	1.1	1.2	0.5	3.6	4.7	0.1	4.6	0.0	2.0	3.4	1.5	0.0	0.0	0.6	0.9	0.0	0.1	0.0	6.1	0.0	0.7	2.1	0.7	0.4	0.3	0.4	0.3	0.1	0.0	0.0	0.2
DIS3	"dis3p, EXOSC11, KIAA1008, RRP44"	ENSG00000083520	"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease"	Q9Y2L1	13	72752169-72782096	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 169.2;Late spermatids: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039281, HPA058762"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA039281: AB_10795583, HPA058762: AB_2683810"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.97e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-1)"	13.8	9.9	5.3	12.4	5.7	20.4	15.8	9.1	6.7	11.3	7.1	10.0	8.5	11.2	11.5	12.4	9.9	10.4	11.6	5.2	5.9	12.8	16.6	11.4	17.6	5.2	5.6	13.4	8.9	11.9	8.9	12.0	5.3	12.3	10.9	12.1	9.4	10.5	10.2	11.1	9.9	11.0	5.5	12.2	9.9	21.3	6.3	14.1	15.0	10.4	17.3	14.1	10.8	6.9	29.5	13.4	25.9	21.9	26.9	31.9	17.0	25.5	31.0	25.6	31.1	20.7	23.8	35.6	21.6	26.3	16.2	23.8	35.7	29.4	40.9	29.3	26.3	41.8	27.8	18.7	33.4	71.4	23.2	33.4	20.1	29.0	37.9	25.5	27.8	26.6	28.3	14.4	31.4	10.3	30.5	34.8	24.3	44.7	15.7	24.2	19.7	16.2	25.4	23.2	23.3	30.8	20.9	17.3	25.4	26.8	16.7	32.1	26.1	15.4	12.5	17.5	27.4	27.6	33.2	28.0	42.9	33.2	22.7	8.4	3.6	5.2	4.0	6.3	5.6	4.2	5.0	4.5	4.3	3.7	4.9	4.5	2.1	6.9	5.2	2.7	6.7	3.2	5.3	5.7	9.1	6.7	5.2	5.9	5.2	5.6	5.3	5.5	6.3	6.9	51.6	35.3	37.2	12.4	35.3	25.5	36.5	24.5	18.2	38.8	27.6	26.4	27.6	21.5	40.2	9.2	29.2	23.8	45.0	19.0	23.5	21.7	169.2	26.2	37.6	41.2	30.5	18.7	21.5	20.1	23.5	33.3	19.9	45.6	33.6	26.3	26.7	23.7	14.4	32.0	24.0	17.2	18.3	19.2	13.8	135.5	28.9	21.4	12.4	24.4	38.2	23.6	25.7	17.6	24.2	25.4	8.1	28.2	30.2	27.4	16.3	17.2	35.4	41.6	6.6	58.3	27.0	28.9	37.7	31.4	31.3	22.6	33.7	29.1	21.2	53.9
DISP2	"C15orf36, DISPB, HsT16908, KIAA1742, LINC00594"	ENSG00000140323	"Dispatched RND transporter family member 2"	A7MBM2	15	40358219-40378621	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 17.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.0;Distal enterocytes: 16.8;Horizontal cells: 18.5;Intestinal goblet cells: 18.2;Proximal enterocytes: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.2;HaCaT: 6.6;SCLC-21H: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059903	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Vesicles"		"HPA059903: AB_2684156"	"unprognostic (3.43e-4)"	"unprognostic (7.65e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.47e-8)"	"unprognostic (1.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	0.2	0.7	5.1	0.4	4.7	0.3	0.1	17.6	5.7	0.3	0.0	1.5	1.1	0.2	0.1	0.1	0.2	0.2	0.1	3.6	3.9	0.0	0.1	0.1	0.4	5.5	1.6	0.3	0.3	0.1	1.3	0.2	5.8	0.1	1.2	1.6	0.3	0.4	0.1	0.3	1.2	0.3	0.4	0.2	1.2	0.7	4.5	0.2	1.4	0.0	0.0	0.1	0.1	1.9	1.3	0.5	0.3	2.0	0.1	0.0	0.7	0.2	0.1	0.8	1.2	1.9	0.6	0.2	1.3	0.8	4.2	6.6	0.2	1.1	0.5	0.1	0.4	0.3	0.4	0.1	0.0	0.4	1.1	1.4	0.0	0.2	0.1	0.2	0.4	0.7	0.5	0.8	1.1	0.3	0.2	0.3	0.3	1.7	0.9	0.2	0.3	0.4	0.2	1.7	13.4	1.9	0.2	0.1	0.2	0.3	0.3	0.2	0.4	0.9	0.7	0.2	0.2	0.2	0.1	0.2	0.3	0.5	1.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.2	0.0	0.0	5.1	4.7	17.6	5.7	3.6	3.9	5.5	1.6	5.8	0.4	4.5	1.9	0.9	3.2	3.6	1.0	0.5	0.0	1.9	0.0	0.0	19.0	0.8	1.3	1.7	1.5	4.4	3.7	10.4	0.2	0.2	16.8	0.0	0.4	1.3	0.3	0.6	1.4	9.6	2.7	5.1	0.4	0.3	1.6	5.1	0.5	8.8	0.4	0.4	0.4	1.0	18.5	7.0	18.2	0.0	0.6	0.0	1.8	1.2	1.1	0.0	1.0	0.3	2.3	4.1	4.0	0.3	0.3	3.2	0.0	0.3	1.2	12.1	0.2	2.2	7.6	0.0	3.1	0.8	4.1	6.1	0.0	0.0	0.3	1.1	0.8	8.6	1.1
DISP3	"KIAA1337, PTCHD2"	ENSG00000204624	"Dispatched RND transporter family member 3"	Q9P2K9	1	11479155-11537551	"Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 9.8;pituitary gland: 3.5;retina: 4.6;testis: 6.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.9;NTERA-2: 2.1;SCLC-21H: 2.0;SH-SY5Y: 6.8;SiHa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054579	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA054579: AB_2682529"	"unprognostic (4.93e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.34e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.34e-1)"	0.0	0.3	7.1	0.1	9.4	0.0	0.0	4.1	9.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	8.6	6.9	0.1	0.0	0.1	0.1	3.3	5.7	0.1	0.5	0.0	3.5	0.0	4.6	0.5	0.0	4.6	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.3	0.1	6.3	7.8	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	2.1	0.0	0.0	0.5	0.0	1.3	0.0	0.1	2.0	6.8	1.6	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	9.4	4.1	9.8	8.6	6.9	3.3	5.7	4.6	3.7	7.8	3.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
DKC1	"Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101"	ENSG00000130826	"Dyskerin pseudouridine synthase 1"	O60832	X	154762742-154777689	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Isomerase, Ribonucleoprotein, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 707.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000166, HPA000447, HPA001022, CAB033086"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		34000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"	Nucleoplasm	"CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: AB_2666175"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (2.94e-4)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (1.46e-9)"	"unprognostic (5.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.55e-1)"	23.5	20.4	17.1	29.9	18.1	68.8	35.3	18.3	20.5	21.3	18.9	28.5	24.2	23.2	22.3	36.4	24.4	15.3	19.4	17.0	18.4	21.7	22.6	16.5	40.2	17.9	18.2	30.8	32.6	26.5	17.6	23.2	18.8	22.2	34.8	19.8	22.0	18.9	31.2	30.6	21.3	22.8	18.0	25.7	21.5	25.3	18.1	39.4	27.8	23.2	47.8	36.8	23.8	19.7	236.5	129.3	77.4	111.4	47.2	48.2	114.9	87.2	60.5	127.2	118.9	164.3	114.2	447.2	221.3	74.7	119.4	123.5	239.6	144.8	189.3	108.8	132.9	223.4	131.1	143.3	66.9	304.6	131.2	46.3	135.6	141.1	320.8	46.6	89.7	146.2	210.1	108.0	88.0	137.7	201.5	233.7	130.2	234.0	158.8	177.1	174.1	230.3	80.4	132.0	170.0	84.4	77.8	133.3	122.7	75.0	68.1	120.8	70.8	91.4	138.2	119.3	292.6	199.8	290.5	707.7	62.2	316.5	102.0	10.8	25.0	33.1	38.6	30.1	48.8	44.2	31.1	41.6	35.5	31.3	40.7	39.1	7.4	41.2	31.2	25.5	26.5	30.3	17.1	18.1	18.3	20.5	17.0	18.4	17.9	18.2	18.8	18.0	18.1	19.7	21.6	25.6	32.3	5.9	47.6	99.7	76.2	45.4	60.3	31.6	39.2	34.0	32.0	25.8	35.2	25.8	14.6	56.6	34.8	17.7	41.1	62.8	2.7	22.4	39.8	39.7	34.1	84.1	6.4	45.3	74.8	36.4	23.0	24.1	56.8	70.0	13.6	26.0	44.5	23.5	7.1	35.9	54.9	21.6	36.4	7.9	25.7	25.8	49.8	7.5	36.4	34.8	29.9	7.5	7.7	47.3	14.8	28.6	45.1	131.2	9.5	25.6	26.7	28.5	13.1	37.8	42.6	41.0	87.2	69.9	98.3	34.2	35.9	59.6	49.9	57.9
DLC1	"ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12"	ENSG00000164741	"DLC1 Rho GTPase activating protein"	Q96QB1	8	13083361-13604610	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Alveolar cells type 2: 225.9;Excitatory neurons: 208.8;Microglial cells: 317.6;Oligodendrocyte precursor cells: 244.3;Oligodendrocytes: 707.2;Sertoli cells: 223.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 4.3;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	19	"granulocytes: 4.3;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 83.2;U-2197: 98.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017753	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA017753: AB_10600805"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.79e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.67e-1)"	52.5	10.6	17.8	8.8	28.7	2.6	29.6	21.8	18.2	13.5	4.8	19.6	5.6	16.1	5.3	6.3	14.7	19.1	21.5	22.9	21.3	13.7	20.4	42.9	3.8	27.8	23.5	9.5	9.0	6.1	5.3	24.2	29.0	6.7	6.2	1.5	5.6	4.2	7.2	7.1	11.5	19.1	18.8	16.4	13.6	4.0	22.5	2.1	15.7	10.3	1.8	15.4	11.1	38.0	0.1	0.7	6.6	0.0	69.4	35.5	20.3	39.3	33.7	40.7	48.6	11.5	6.6	0.0	9.7	51.4	39.4	6.6	4.3	7.4	83.2	0.0	7.2	39.5	0.1	21.7	31.8	0.0	13.7	36.6	0.6	62.6	46.7	43.3	46.7	0.1	2.7	0.0	33.6	0.8	0.0	0.0	0.7	1.4	4.7	0.0	0.0	0.0	19.7	24.4	0.0	2.9	0.0	1.1	31.8	27.4	0.0	0.0	61.7	45.5	18.8	98.7	15.3	0.1	0.0	0.0	31.6	0.3	63.4	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	17.8	28.7	21.8	18.2	22.9	21.3	27.8	23.5	29.0	18.8	22.5	38.0	171.7	250.0	225.9	177.3	2.3	14.8	2.5	4.8	5.2	0.9	9.3	8.3	37.8	24.3	19.7	3.7	0.0	7.8	0.6	0.4	1.9	3.1	8.4	15.3	36.1	138.4	1.2	25.2	208.8	4.4	2.3	74.2	4.6	27.3	68.2	0.1	193.1	25.7	3.6	13.5	151.8	1.2	0.0	18.6	17.0	4.3	72.4	6.2	24.9	317.6	0.2	1.0	0.0	244.3	707.2	3.0	1.3	36.1	1.9	1.4	6.1	1.9	3.0	1.9	223.5	50.0	138.0	6.2	11.4	1.8	9.2	2.7	3.6	31.1	2.9	1.7
DLD	"DLDH, E3, GCSL, LAD, OGDC-E3"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107891162-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 357.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 356.2;Distal tubular cells: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	108.7	98.9	22.7	42.1	23.7	54.0	49.0	27.1	29.1	36.3	35.6	109.0	81.8	45.3	21.2	94.1	34.3	48.5	264.1	23.1	29.5	153.3	112.8	39.3	50.1	27.1	27.4	30.0	49.2	136.7	27.8	43.1	26.6	45.7	99.3	35.0	50.2	50.3	295.0	38.9	71.9	67.7	24.9	38.4	80.5	31.3	25.7	43.2	64.2	357.0	67.5	66.1	32.7	23.4	171.4	134.5	74.8	127.9	104.6	91.4	88.4	96.5	80.8	110.6	86.2	159.5	95.5	165.9	159.6	103.0	177.7	110.9	150.2	135.8	166.1	111.1	88.4	116.9	175.6	116.7	80.3	194.7	116.0	104.8	97.6	116.4	63.4	72.3	134.0	137.0	298.5	119.7	121.8	188.1	161.8	138.9	87.4	206.0	98.2	113.1	117.8	225.9	151.8	250.8	92.3	99.9	156.3	262.1	143.9	149.9	100.5	165.8	87.9	120.7	97.3	238.1	149.4	89.3	187.1	114.6	115.0	204.1	130.2	132.7	63.9	136.0	46.9	81.6	49.4	37.8	46.8	46.8	87.2	38.5	47.9	50.5	39.9	68.1	116.9	29.9	49.0	64.2	22.7	23.7	27.1	29.1	23.1	29.5	27.1	27.4	26.6	24.9	25.7	23.4	26.7	28.9	20.7	14.7	26.3	31.4	42.7	124.7	31.3	47.1	24.0	19.2	356.2	51.5	70.5	79.1	22.9	110.2	27.3	56.1	226.9	69.3	10.2	27.6	26.2	32.2	30.6	53.9	23.9	55.9	62.7	36.3	36.7	28.0	26.6	35.3	26.0	86.8	69.2	21.9	25.3	44.1	114.0	41.0	26.5	7.3	23.3	37.5	37.4	15.9	62.2	36.0	38.1	21.1	16.7	42.6	51.4	42.2	30.7	24.3	60.0	178.9	55.5	45.5	26.3	28.4	44.8	55.2	51.5	48.0	32.4	108.4	29.5	73.7	78.7	39.2
DLG3	"KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102"	ENSG00000082458	"Discs large MAGUK scaffold protein 3"	Q92796	X	70444835-70505490	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001733, HPA078130"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 12: NES - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA001733: AB_1078675, HPA078130: AB_2686879"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	"prognostic favorable (1.72e-10)"	"unprognostic (3.36e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-3)"	3.6	3.7	14.6	4.9	16.0	0.6	11.7	8.3	19.2	10.9	9.5	18.6	13.4	8.3	25.5	20.4	19.1	10.7	7.9	19.7	10.1	16.7	1.7	8.8	3.6	6.1	9.5	11.9	35.2	36.3	11.6	5.9	9.0	11.4	18.9	10.5	23.2	10.8	1.2	11.8	16.0	9.0	6.6	20.0	17.3	1.8	10.9	4.6	15.3	2.0	7.4	10.3	12.2	12.9	6.9	3.1	18.9	8.1	4.8	5.8	13.2	4.0	4.5	2.2	2.2	19.4	15.8	0.0	9.1	4.0	1.6	14.5	37.1	8.8	1.4	8.1	11.3	0.0	17.4	10.7	9.4	0.2	2.6	6.1	5.7	2.8	6.1	19.4	0.8	12.9	3.7	26.5	2.1	24.1	15.8	0.1	31.9	55.5	22.3	14.7	9.3	3.0	12.8	20.7	8.9	0.5	3.2	36.9	7.3	15.6	19.4	0.0	1.5	2.5	2.5	2.4	3.0	17.3	13.9	8.4	3.7	0.1	3.7	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.4	0.7	0.0	0.0	0.3	0.4	0.0	0.5	0.0	0.0	0.7	0.1	14.6	16.0	8.3	19.2	19.7	10.1	6.1	9.5	9.0	6.6	10.9	12.9	2.2	19.2	22.5	4.6	1.7	0.8	5.5	10.8	7.4	20.2	16.8	10.4	17.2	22.8	17.5	9.2	0.0	6.3	7.0	36.7	11.7	15.0	0.0	27.7	5.7	1.8	25.7	0.8	24.8	24.9	2.6	7.4	17.9	15.8	1.3	6.4	3.6	0.3	0.6	5.0	24.5	23.7	4.1	0.3	1.2	0.3	1.5	1.3	1.8	7.5	1.8	11.6	3.1	20.1	5.4	21.6	19.3	6.4	5.7	13.9	26.1	6.0	31.5	6.3	6.6	4.0	11.1	2.9	2.9	13.1	2.0	1.6	8.1	2.5	21.4	10.5
DLGAP4	"DAP4, KIAA0964, SAPAP4"	ENSG00000080845	"DLG associated protein 4"	Q9Y2H0	20	36306336-36528637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 213.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 212.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054105, HPA056378"	Approved		Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Focal adhesion sites"	"HPA054105: AB_2682381, HPA056378: "	"unprognostic (1.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-2)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (1.23e-1)"	"prognostic favorable (9.88e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	55.4	47.5	39.0	23.5	31.4	7.5	40.3	2.8	45.9	51.7	2.6	71.4	21.2	64.5	12.5	31.7	45.2	26.4	58.4	39.3	12.3	34.3	37.3	60.5	16.6	5.4	18.1	48.4	47.8	13.8	36.4	26.5	10.5	44.7	15.0	25.4	37.8	30.6	130.8	86.8	37.1	42.5	2.8	32.9	36.5	29.3	29.1	14.7	43.3	45.9	14.8	56.2	46.6	20.6	49.9	44.2	53.0	44.1	49.0	79.9	53.2	73.2	66.5	70.0	48.2	67.4	30.9	14.0	38.5	103.3	61.9	46.7	14.3	75.1	51.8	22.5	5.2	31.8	22.7	46.2	70.9	12.9	26.5	52.9	57.0	83.1	57.6	54.2	69.7	19.5	22.5	37.2	53.6	37.0	26.3	49.0	23.2	36.2	93.4	26.1	14.0	19.4	33.0	24.3	34.8	47.9	48.0	96.0	60.0	53.7	55.3	22.3	71.2	212.1	64.6	92.6	40.9	12.7	9.8	15.1	84.9	16.2	85.4	2.7	16.5	26.9	15.0	17.3	11.9	19.5	13.5	10.7	14.5	20.8	10.1	8.1	23.6	9.6	17.9	17.4	11.9	12.6	39.0	31.4	2.8	45.9	39.3	12.3	5.4	18.1	10.5	2.8	29.1	20.6	30.4	16.0	20.5	34.0	25.2	66.4	53.8	30.6	9.1	34.9	30.2	21.0	27.9	22.8	22.9	12.9	8.4	23.1	23.7	27.2	7.9	53.0	69.9	25.9	47.7	36.6	63.3	4.4	77.9	55.7	52.3	40.1	23.4	29.4	12.6	35.7	27.8	17.5	27.2	74.0	93.4	35.0	20.3	22.4	54.4	213.4	29.8	23.9	10.6	37.5	47.5	38.7	21.6	81.4	13.2	84.4	25.0	26.4	8.9	72.9	25.8	20.4	28.3	29.5	72.3	28.8	51.0	13.7	30.3	13.2	71.7	55.1	20.7	29.8	20.6	52.3
DLK2	"EGFL9, MGC2487"	ENSG00000171462	"Delta like non-canonical Notch ligand 2"	Q6UY11	6	43450352-43456632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.3;prostate: 12.9;skin 1: 12.7"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 96.9;Basal respiratory cells: 56.8;Basal squamous epithelial cells: 64.3;Breast myoepithelial cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 24.1;HBEC3-KT: 13.1;hTCEpi: 38.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA061223, HPA068672, HPA070955"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: "	"unprognostic (4.65e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.68e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.80e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.27e-12)"	"unprognostic (7.71e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.43e-2)"	0.8	0.5	3.8	0.7	4.5	0.9	2.9	6.9	7.0	2.9	1.8	0.4	0.4	0.6	2.0	12.3	0.6	0.3	1.7	4.4	4.2	0.5	0.7	0.5	0.9	2.7	2.6	1.1	0.8	0.1	0.8	0.6	2.7	12.9	0.0	0.6	8.1	5.2	0.2	12.7	0.6	0.1	2.6	0.7	0.4	1.0	3.5	2.3	0.7	0.0	0.9	0.8	6.7	3.2	7.9	2.8	0.8	11.3	0.0	0.6	2.5	2.8	3.0	3.1	1.4	2.7	0.4	1.5	1.7	0.5	3.8	24.1	8.0	13.1	0.7	1.5	3.0	0.6	1.5	4.2	0.8	0.5	1.6	1.3	38.5	0.9	7.1	1.0	0.0	4.5	0.7	1.1	1.2	3.0	0.6	0.6	1.0	3.0	2.9	1.6	1.4	0.7	0.4	2.6	8.3	0.8	0.9	0.3	0.4	0.6	0.7	2.4	0.8	1.1	3.6	0.8	5.6	1.8	0.4	2.5	0.1	1.1	0.8	0.3	0.1	0.1	0.1	0.0	0.8	0.1	0.5	0.5	0.0	0.2	0.2	0.1	0.2	0.8	0.1	0.5	0.0	0.1	3.8	4.5	6.9	7.0	4.4	4.2	2.7	2.6	2.7	2.6	3.5	3.2	0.3	0.0	0.5	0.3	0.4	10.1	96.9	56.8	64.3	1.3	0.6	26.7	0.6	0.0	6.0	0.0	0.0	1.3	0.5	0.0	0.0	0.1	0.3	0.1	3.0	0.7	1.2	0.0	6.1	0.0	2.7	0.4	0.0	0.2	0.0	4.7	0.0	0.0	0.1	11.8	2.8	0.0	2.0	0.0	0.4	0.5	0.3	0.6	1.8	2.8	0.0	0.6	0.0	3.0	0.9	0.1	0.0	0.0	0.1	12.9	0.0	0.0	1.1	1.2	0.0	0.5	1.1	1.7	7.0	6.7	2.6	0.3	1.3	0.4	0.0	8.3
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 5.7;choroid plexus: 2.3;pituitary gland: 3.4;testis: 1.4"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 24.6;Spermatogonia: 39.5"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.6;naive CD8 T-cell: 1.4"	"Group enriched"	"Detected in many"	13	"B-cells: 2.6;T-cells: 1.4"	"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 83.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA024559, HPA056533"			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA024559: , HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.0	0.0	5.1	0.1	5.7	0.0	0.0	3.1	5.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	4.7	0.0	0.0	0.0	0.1	4.9	4.7	0.2	0.0	0.5	3.4	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.1	0.0	1.4	4.6	0.0	0.1	0.0	0.1	0.0	0.0	5.4	0.1	3.9	0.9	2.0	0.0	0.0	0.6	1.1	0.0	0.7	0.2	0.5	0.9	0.1	3.7	0.0	1.5	0.1	2.3	1.0	0.2	1.2	6.0	0.2	0.1	0.3	0.3	1.0	4.6	0.0	0.0	0.1	0.1	0.1	0.1	4.3	1.1	0.1	0.3	0.0	0.2	0.0	0.7	0.0	6.2	0.6	0.2	0.2	0.2	0.2	13.6	14.1	2.9	0.1	83.7	0.3	0.0	0.2	0.0	0.0	2.6	0.1	1.0	1.4	0.0	0.9	0.1	0.5	2.3	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.5	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	5.1	5.7	3.1	5.6	4.7	4.7	4.9	4.7	4.2	4.4	4.6	5.4	0.3	0.0	0.0	0.3	1.1	0.3	0.3	0.4	0.0	0.5	1.3	4.7	0.5	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.7	0.6	0.1	0.7	0.2	3.0	0.0	1.7	0.6	0.6	1.0	0.5	0.3	0.0	1.7	0.0	0.0	0.3	0.0	3.4	0.3	0.0	0.0	0.0	2.2	1.2	0.1	1.8	0.0	0.0	0.9	0.0	24.6	0.5	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.7	6.6	0.0	0.6	6.5	39.5	0.2	0.1	0.3	0.5	1.7	0.0	0.1
DLST	"DLTS, KGD2, OGDC-E2"	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903743	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		70000	"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	64.5	85.5	33.5	32.3	34.7	75.0	59.6	35.8	34.7	62.1	43.8	63.3	58.7	47.5	43.2	62.9	46.1	36.2	129.0	30.8	35.1	100.4	78.4	48.5	36.9	35.8	34.5	45.8	44.8	78.8	35.4	44.8	34.3	41.3	59.3	37.1	46.5	43.5	144.7	64.3	58.3	52.1	33.6	46.1	57.7	29.3	37.3	42.5	42.9	224.2	45.7	58.0	49.7	32.5	79.1	81.1	63.7	45.4	98.1	110.6	97.5	106.3	107.8	106.8	99.0	80.9	88.1	81.0	44.3	118.1	48.1	87.8	109.0	105.6	112.0	61.5	43.3	68.4	66.3	74.8	101.4	49.5	45.4	114.0	90.5	103.8	126.7	95.5	106.1	36.6	53.4	55.6	110.3	112.0	59.0	69.7	55.0	146.6	79.0	73.8	93.8	46.7	125.8	100.8	75.5	64.1	100.6	129.4	71.3	54.2	121.7	70.5	90.8	63.8	83.2	79.5	74.0	38.7	43.7	73.4	93.9	47.9	68.8	3.0	1.3	2.3	2.1	2.0	1.8	1.6	1.9	1.6	2.1	1.0	1.5	2.2	1.3	3.5	1.8	2.8	2.0	1.5	33.5	34.7	35.8	34.7	30.8	35.1	35.8	34.5	34.3	33.6	37.3	32.5	24.2	6.4	4.8	14.0	22.7	26.4	23.5	19.7	21.6	19.1	25.1	20.4	28.5	21.5	10.1	20.2	31.3	41.0	27.7	41.9	56.7	37.8	7.3	10.9	20.4	19.8	14.8	22.5	21.9	25.7	38.8	25.6	30.5	18.9	21.0	19.4	23.2	43.6	32.1	13.5	24.6	31.8	12.2	20.9	19.0	6.2	18.0	18.8	23.2	13.1	27.1	10.0	20.6	18.6	18.5	44.3	28.0	20.7	20.0	28.2	49.8	73.3	8.7	20.8	26.3	18.3	24.0	12.1	15.3	34.2	28.4	79.5	23.1	19.3	40.5	27.7
DLX1		ENSG00000144355	"Distal-less homeobox 1"	P56177	2	172084740-172089677	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 18.8"	"Cell type enriched"	"Detected in some"	23	"Inhibitory neurons: 30.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 18.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 134.5;U-138 MG: 36.9;WM-115: 42.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 28.6;olfactory bulb: 82.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 48.8"	"HPA007175, HPA045884"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA007175: , HPA045884: AB_10960361"	"unprognostic (2.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.92e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.40e-9)"	"unprognostic (2.22e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.91e-3)"	0.1	1.3	5.9	0.2	4.8	0.0	0.1	0.0	4.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.5	18.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.0	3.5	0.0	1.0	0.1	0.3	0.1	0.2	2.7	2.4	0.6	0.6	134.5	2.0	4.5	0.3	3.2	6.5	7.7	4.1	1.0	0.2	0.0	7.8	7.2	7.5	9.4	7.4	1.2	5.2	0.3	33.3	21.1	14.4	5.7	0.1	7.9	15.9	0.0	2.2	1.9	3.2	5.4	0.0	6.7	12.4	0.0	6.3	8.1	0.1	1.9	0.1	0.0	22.9	0.4	15.8	0.0	0.9	4.5	11.3	0.0	6.1	0.8	17.5	0.4	5.2	9.5	7.1	36.9	0.2	16.4	16.4	0.2	0.0	0.1	15.2	21.4	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	4.8	0.0	4.4	3.5	18.8	0.0	0.2	0.0	0.0	3.5	2.7	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DLX3		ENSG00000064195	"Distal-less homeobox 3"	O60479	17	49990005-49995224	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 53.8"	"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 35.9;Extravillous trophoblasts: 69.1;Syncytiotrophoblasts: 96.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 135.9;SK-BR-3: 44.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031164			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA031164: AB_10603565"	"unprognostic (1.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.44e-5)"	"unprognostic (3.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	0.5	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.5	1.9	0.1	0.1	0.0	0.0	0.3	3.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.4	0.0	0.4	0.9	0.3	0.2	0.6	0.2	7.4	0.4	0.5	0.0	0.0	1.5	0.7	0.0	53.8	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.2	1.8	0.0	3.0	0.4	4.0	0.0	0.5	0.0	0.0	2.6	0.8	0.6	135.9	0.1	0.0	0.0	0.0	1.3	0.2	0.0	1.5	1.6	0.0	17.1	7.1	0.1	0.0	0.0	0.3	0.0	4.2	0.2	0.0	0.0	0.5	0.0	12.7	0.4	0.0	0.0	0.0	0.9	0.1	0.0	1.7	4.1	0.0	0.4	0.5	0.3	0.6	0.0	0.0	0.3	0.0	1.9	15.1	0.1	1.5	44.1	0.0	9.1	17.5	0.9	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.4	0.9	0.4	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	5.0	0.4	1.1	9.1	0.0	3.5	5.3	2.0	0.0	0.2	0.0	0.0	35.9	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.0	69.1	0.7	0.0	0.2	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	1.0	0.0	2.0	3.4	5.1	96.0	0.1	0.0	0.0	0.5
DLX4	"BP1, DLX7, DLX8, DLX9"	ENSG00000108813	"Distal-less homeobox 4"	Q92988	17	49968970-49974959	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 3.7;skin 1: 3.0"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 77.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.9;CACO-2: 16.8;GAMG: 15.3;HAP1: 11.2;K-562: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059933	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA059933: AB_2684169"	"unprognostic (8.12e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.88e-13)"	"unprognostic (8.79e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.86e-2)"	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.2	0.7	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.6	0.2	0.2	0.8	0.0	0.3	0.2	0.1	3.7	0.5	0.2	0.1	0.0	1.1	0.2	0.0	3.0	0.2	0.0	0.2	0.4	0.1	0.3	0.2	0.1	0.3	0.0	0.5	0.2	0.5	0.2	0.5	1.4	0.0	0.1	0.1	0.0	22.9	0.1	0.1	0.1	0.3	16.8	1.0	0.7	3.3	0.3	15.3	2.3	11.2	0.4	0.1	4.5	5.9	0.4	5.7	1.7	0.0	0.9	3.7	0.0	2.8	0.1	0.0	0.2	0.0	3.5	13.5	0.0	0.0	2.9	0.4	6.0	0.2	3.1	0.0	0.0	5.1	0.6	0.1	0.8	1.9	0.1	0.4	1.9	1.1	3.4	4.1	4.0	0.0	0.0	1.0	0.2	0.0	0.9	0.2	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.1	0.6	0.2	0.1	0.2	0.8	0.5	0.2	0.2	0.2	0.0	6.4	0.0	0.0	0.2	2.5	0.4	1.0	2.2	0.0	0.5	0.3	1.9	0.0	0.1	0.0	0.0	12.7	0.1	0.1	0.0	0.3	0.1	1.5	0.1	0.2	0.0	0.0	0.3	0.2	77.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	1.0	1.1	0.4	0.6	16.8	0.1	0.2	0.2	0.3
DLX5		ENSG00000105880	"Distal-less homeobox 5"	P56178	7	97020396-97024950	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 14.1;placenta: 11.7;skin 1: 21.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.9;Endometrial ciliated cells: 217.8;Extravillous trophoblasts: 245.2;Glandular and luminal cells: 191.2;Syncytiotrophoblasts: 314.8"	"Cancer enriched"	"Detected in many"	11	"endometrial cancer: 81.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 53.7;HAP1: 27.2;SuSa: 13.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 13.5;olfactory bulb: 29.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 7.5;olfactory bulb: 18.0"	HPA005670	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA005670: AB_1078681"	"unprognostic (3.99e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.43e-8)"	"unprognostic (1.39e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	1.5	0.3	2.1	0.2	3.9	0.0	0.9	0.2	3.4	7.6	0.4	0.6	0.3	14.1	1.0	1.9	1.3	0.4	0.5	1.5	4.5	0.5	0.0	0.2	1.7	0.2	0.3	1.6	0.0	0.2	0.8	11.7	0.3	1.7	0.0	0.0	3.3	2.8	0.3	21.2	0.1	0.9	0.3	0.1	0.1	0.9	1.5	1.8	1.5	0.0	2.1	0.7	3.0	1.3	0.0	0.0	0.0	8.2	0.0	0.0	53.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.2	27.2	0.0	0.0	0.0	4.6	0.0	0.6	0.4	0.0	0.0	0.0	0.1	8.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.0	3.6	1.5	2.1	0.2	0.0	0.0	13.4	0.0	0.0	0.0	1.7	0.3	0.4	0.0	0.0	0.0	0.0	3.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.2	3.4	1.5	4.5	0.2	0.3	0.3	0.3	1.5	1.3	1.4	0.0	0.0	0.0	0.0	9.8	1.1	1.7	0.6	0.0	0.3	0.6	0.2	0.0	0.1	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.2	217.8	13.3	2.9	0.0	0.0	0.1	0.0	245.2	1.5	0.0	191.2	0.0	1.6	0.0	0.0	16.9	0.0	12.8	0.0	0.0	0.0	1.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.1	59.2	0.2	8.0	4.2	11.6	7.9	20.6	314.8	1.6	0.1	0.0	1.6
DMAC2L	"ATP5S, ATPW, HSU79253"	ENSG00000125375	"Distal membrane arm assembly complex 2 like"	Q99766	14	50312324-50335558	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 60.5;Cytotrophoblasts: 36.6;Extravillous trophoblasts: 24.6;Hofbauer cells: 28.5;Syncytiotrophoblasts: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062690			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Mitochondria"		"HPA062690: AB_2684836"	"unprognostic (2.24e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.53e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (5.73e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.37e-8)"	"unprognostic (5.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.95e-1)"	8.0	5.6	3.9	5.5	6.2	13.5	8.6	4.1	5.7	6.9	3.0	6.8	10.3	6.3	7.1	10.0	5.2	6.9	10.0	3.4	4.3	8.0	7.5	5.4	8.6	5.4	4.9	4.7	10.8	8.8	3.8	3.7	5.1	6.2	6.3	10.1	6.7	5.0	15.7	10.8	7.3	3.8	4.7	5.9	6.3	15.4	4.2	6.3	12.9	8.9	7.6	7.2	4.2	9.7	18.8	6.7	8.5	5.6	7.2	11.8	18.8	5.9	8.5	11.4	13.3	9.5	10.4	21.1	5.9	8.8	5.4	10.9	2.3	6.3	6.8	10.9	5.0	9.1	5.4	22.5	5.6	20.6	17.6	12.0	11.3	3.5	6.5	3.0	8.9	14.3	5.4	25.9	8.0	14.2	5.2	7.7	6.2	14.0	7.7	10.2	9.6	8.7	9.1	20.4	11.2	9.1	6.9	14.5	13.4	3.1	18.6	10.4	4.2	11.3	15.4	5.3	7.4	13.2	12.4	12.2	3.4	10.2	10.4	20.5	13.1	19.8	14.3	15.6	12.4	19.3	11.7	13.5	9.9	17.1	13.8	15.4	2.5	12.3	20.4	19.0	14.5	12.5	3.9	6.2	4.1	5.7	3.4	4.3	5.4	4.9	5.1	4.7	4.2	9.7	9.4	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.0	0.0	36.6	12.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	24.6	6.3	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	41.7	1.9	0.0	0.0	0.0
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018, HPA069527"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: AB_2672597, HPA069527: "	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	19.3	53.8	31.7	13.2	32.3	14.6	20.6	32.4	37.4	22.8	30.1	21.1	13.5	20.3	9.7	18.9	20.0	11.7	26.5	32.6	31.0	26.0	28.7	17.9	16.9	30.9	31.2	26.6	33.9	25.5	25.1	14.6	31.0	24.3	11.7	19.5	21.3	13.2	36.1	21.3	22.0	10.7	30.2	27.6	24.2	25.2	32.0	20.9	23.4	25.2	14.4	21.6	19.5	32.8	21.1	22.2	30.6	16.0	15.5	14.6	35.0	18.3	24.4	43.3	37.2	35.7	25.9	31.5	24.1	29.7	16.9	17.0	27.4	23.6	22.8	25.0	44.3	29.0	41.2	36.2	28.0	28.7	21.2	23.0	25.8	35.8	20.5	27.9	28.3	29.5	20.6	28.2	25.7	24.5	40.4	35.9	43.6	10.8	27.0	40.5	30.8	34.5	23.1	26.2	28.0	23.3	34.4	24.3	35.8	29.1	20.1	32.8	27.5	12.2	36.5	28.5	37.6	33.9	21.8	25.4	23.1	28.2	20.6	45.0	23.1	23.1	30.8	20.9	31.9	27.7	31.2	32.2	24.0	28.3	27.8	27.5	9.9	43.8	17.6	19.2	37.5	24.6	31.7	32.3	32.4	37.4	32.6	31.0	30.9	31.2	31.0	30.2	32.0	32.8	23.4	32.1	23.8	11.1	23.6	19.2	25.9	36.4	19.4	43.0	18.6	22.2	22.8	18.6	24.5	11.0	25.0	72.6	30.9	32.8	29.4	31.9	41.9	15.4	14.1	23.9	54.4	25.7	10.4	41.5	34.4	20.5	28.5	14.8	27.3	38.1	23.6	19.1	32.6	23.5	12.1	32.0	44.7	22.3	12.7	69.2	18.0	15.4	17.8	4.7	26.3	46.3	25.7	9.0	9.6	22.9	38.6	17.7	26.8	9.7	46.9	36.2	26.8	56.1	6.6	23.9	25.1	24.5	47.2	15.7	17.8	52.4	25.5	29.3	29.8	16.3
DMC1	LIM15	ENSG00000100206	"DNA meiotic recombinase 1"	Q14565	22	38518948-38570204	"Predicted intracellular proteins"	"Cell cycle, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.3"	"Group enriched"	"Detected in many"	5	"Spermatocytes: 109.3;Spermatogonia: 36.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.5;hTEC/SVTERT24-B: 17.4;U-266/84: 21.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001232, CAB015397"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB015397: AB_629406, HPA001232: AB_1078683"	"unprognostic (1.29e-2)"	"unprognostic (3.11e-3)"	"unprognostic (4.48e-3)"	"unprognostic (5.71e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.16e-4)"	"unprognostic (3.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.99e-1)"	0.7	0.2	0.4	1.3	0.4	2.3	0.9	1.2	0.7	1.0	0.4	0.9	0.2	2.5	0.9	0.9	0.8	0.4	2.3	0.4	0.2	0.5	0.3	0.4	2.8	0.5	0.2	1.2	0.5	0.3	0.4	0.7	0.5	1.2	1.1	0.8	0.3	0.7	1.3	1.6	0.7	0.7	0.1	0.5	0.6	12.3	0.1	3.4	0.3	0.5	3.1	0.6	0.7	0.5	7.1	2.6	5.0	0.1	0.4	2.1	0.2	7.4	1.0	11.7	8.1	0.2	0.8	3.5	0.3	2.0	0.0	1.2	2.0	0.3	13.1	25.5	0.5	13.6	2.0	0.2	0.2	1.2	2.7	0.5	0.0	17.4	0.0	0.1	0.9	11.2	10.5	3.5	4.1	3.9	2.8	10.3	9.0	3.5	0.2	6.2	0.0	5.2	1.5	0.9	9.7	0.5	12.5	1.1	0.1	1.1	2.1	2.9	0.3	0.1	0.8	0.1	0.1	9.8	21.4	6.4	2.0	2.8	0.9	0.4	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.4	0.4	1.2	0.7	0.4	0.2	0.5	0.2	0.5	0.1	0.1	0.5	0.6	0.0	2.3	3.6	0.7	2.3	1.0	0.4	1.8	0.7	2.7	2.4	2.5	0.0	2.7	3.7	0.0	1.9	0.4	1.3	1.9	0.2	2.9	0.9	0.8	0.8	0.0	11.8	1.1	0.0	1.7	1.4	0.0	1.3	1.3	1.1	0.4	0.1	1.0	0.0	1.4	1.6	0.0	0.0	1.2	3.0	1.5	1.1	0.0	1.9	0.1	4.8	1.0	2.5	0.6	0.1	0.5	1.5	3.8	0.2	0.1	0.4	0.9	0.2	13.1	1.3	0.9	109.3	36.0	0.3	0.6	0.8	0.9	0.3	2.5	0.5
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"skin 1: 4799.0"	"Cell type enriched"	"Detected in many"	5	"Suprabasal keratinocytes: 8514.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.7;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"A-431: 150.1;CACO-2: 182.0;CAPAN-2: 153.9;HBEC3-KT: 236.4;RPTEC TERT1: 232.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 51.9"	"Low region specificity"	"Detected in all"			HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA		47000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	13.8	9.3	6.5	1.1	11.7	1.7	195.4	7.3	7.0	262.7	16.1	11.0	5.6	16.1	14.4	221.3	73.9	1.8	11.9	5.9	7.0	50.3	4.7	22.3	1.2	18.4	7.2	35.0	59.7	87.1	58.1	2.2	17.8	19.3	4.9	1.9	69.5	14.6	20.1	4799.0	8.4	4.2	6.6	2.9	19.9	4.1	6.6	12.2	60.0	0.2	50.6	14.1	378.5	6.2	150.1	24.0	0.0	0.1	5.7	8.7	40.5	0.5	19.6	1.0	1.4	182.0	153.9	0.0	57.5	1.4	7.3	81.8	44.5	236.4	1.9	0.7	43.0	0.0	0.0	41.3	6.8	0.0	0.5	77.6	62.3	4.2	133.2	13.4	0.0	0.0	0.8	0.2	0.5	130.2	0.1	0.0	129.2	107.9	9.7	0.2	0.0	6.2	232.2	97.4	0.4	0.0	35.6	0.1	14.9	36.7	58.5	0.0	0.3	22.3	67.1	0.8	0.6	0.9	0.3	1.1	18.8	0.3	1.4	0.0	0.0	0.0	6.4	0.0	5.5	1.7	0.5	3.1	0.0	0.1	0.1	2.0	0.0	11.7	0.0	0.2	0.0	1.3	6.5	11.7	7.3	7.0	5.9	7.0	18.4	7.2	17.8	6.6	6.6	6.2	13.9	105.8	115.3	1.0	5.9	1623.7	143.2	169.9	39.3	1.7	71.8	164.3	20.4	100.1	107.6	204.1	0.0	1.0	6.7	6.0	230.9	138.0	15.9	181.5	9.0	27.7	49.3	2.7	6.9	140.2	1.5	47.1	27.0	107.8	7.6	2.4	12.1	4.0	1.0	0.0	5.3	8.0	46.8	0.3	287.0	98.0	13.1	2.8	305.9	0.0	2.6	15.1	28.8	0.0	0.4	146.1	9.3	15.8	3.4	94.0	0.2	7.6	270.2	0.8	0.0	0.9	22.9	7.6	31.4	34.0	8514.1	2.3	15.0	0.2	14.2	77.4
DMRT2		ENSG00000173253	"Doublesex and mab-3 related transcription factor 2"	Q9Y5R5	9	1049858-1057552	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.2;lymphoid tissue: 20.9;parathyroid gland: 46.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 115.4;Ionocytes: 46.8;Skeletal myocytes: 22.7"	"Group enriched"	"Detected in many"	4	"lung cancer: 3.0;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;RH-30: 5.0;RPMI-8226: 19.4;SK-MEL-30: 5.2;THP-1: 3.6;WM-115: 3.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"HPA003498, HPA029297"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Vesicles,Centriolar satellite"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Vesicles, Centriolar satellite"	"HPA003498: , HPA029297: AB_10600905"	"unprognostic (5.67e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.93e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.27e-3)"	4.7	0.1	1.7	0.1	3.4	0.0	5.3	3.1	2.7	0.1	0.2	1.6	0.0	0.1	1.1	0.3	0.6	0.0	0.1	1.9	1.9	41.2	0.0	3.1	0.2	3.0	3.1	0.0	0.0	46.4	0.5	0.2	2.9	0.3	0.9	0.4	1.3	1.4	13.3	0.3	0.1	0.0	1.7	0.0	0.0	0.8	2.8	20.9	0.1	2.5	0.1	0.0	0.2	8.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.0	19.4	0.0	0.8	2.9	0.0	0.0	0.0	5.2	0.3	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.4	3.1	2.7	1.9	1.9	3.0	3.1	2.9	1.7	2.8	8.5	0.5	0.0	0.0	0.3	0.2	0.5	0.6	1.8	0.0	0.1	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.1	0.1	1.8	115.4	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	4.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	46.8	0.0	1.1	0.4	0.6	0.2	3.6	0.0	0.0	0.3	0.0	0.5	11.1	0.0	1.9	0.0	0.4	0.2	0.0	0.4	0.6	2.4	0.0	22.7	0.7	4.0	3.0	0.2	0.1	0.1	0.1	0.0	1.8	0.4
DMRTA2		ENSG00000142700	"DMRT like family A2"	Q96SC8	1	50417550-50423443	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 2.6;esophagus: 1.5;pituitary gland: 2.0;testis: 1.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.9;Basal squamous epithelial cells: 17.6;Early spermatids: 10.8;Squamous epithelial cells: 5.9"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Region enhanced"	"Detected in single"		"white matter: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;HBEC3-KT: 3.3;RH-30: 11.7;SH-SY5Y: 2.4;SiHa: 2.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA043098, HPA062958"	Uncertain		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 61: Squamous epithelial cells - Keratinization"	Mitochondria	Nucleoplasm	"HPA043098: AB_10796684, HPA062958: AB_2684911"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.75e-2)"		"unprognostic (1.15e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.08e-3)"	"unprognostic (4.16e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.68e-3)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.4	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	1.4	0.0	0.9	3.3	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	2.4	2.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.4	0.3	0.2	0.6	0.5	0.3	0.2	0.8	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	17.6	0.0	0.1	0.0	1.3	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	10.8	0.1	0.1	0.1	1.2	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.2	1.3	1.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0
DMRTC1		ENSG00000269502	"DMRT like family C1"	Q5HYR2	X	72872025-72943814	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5;pituitary gland: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"		"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (1.83e-1)"													0.0	0.5	1.5	0.1	1.3	0.0	0.0	0.0	2.5	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.7	0.2	0.0	1.0	1.8	0.1	0.0	0.1	0.3	0.4	0.2	0.5	0.2	0.2	1.8	0.0	0.5	0.1	0.2	0.8	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.6	1.3	0.2	0.7	0.0	0.3	0.1	0.1	2.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	0.0	2.5	1.0	1.8	0.4	0.2	0.5	0.0	1.3	2.4	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
DMRTC1B		ENSG00000184911	"DMRT like family C1B"	Q5HYR2	X	72777009-72848802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;pituitary gland: 25.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.3;Microglial cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (2.00e-1)"						"unprognostic (1.91e-2)"	"unprognostic (1.54e-1)"				"unprognostic (6.52e-2)"		0.2	3.2	17.5	0.8	17.9	0.0	0.6	11.6	22.5	1.1	10.7	1.0	0.4	1.6	6.7	0.2	2.3	0.4	0.2	18.7	19.7	1.4	0.0	0.8	1.0	13.7	14.3	8.2	3.8	1.5	25.3	0.0	13.7	2.7	0.5	9.7	0.8	1.2	0.0	0.3	1.0	0.4	11.9	1.0	1.0	8.9	20.5	1.2	3.3	0.0	1.5	0.3	0.8	16.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	17.5	17.9	11.6	22.5	18.7	19.7	13.7	14.3	13.7	11.9	20.5	16.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DMTF1	"DMP1, DMTF, hDMP1, MRUL"	ENSG00000135164	"Cyclin D binding myb like transcription factor 1"	Q9Y222	7	87152409-87196337	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 132.7;Oligodendrocytes: 176.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023846	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA023846: AB_1847779"	"unprognostic (3.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.26e-3)"	"unprognostic (9.77e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (6.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-3)"	20.2	15.7	17.5	16.2	23.3	28.6	20.6	21.7	22.8	24.4	17.2	23.2	16.8	26.0	37.8	13.6	22.7	15.3	16.0	16.8	20.4	21.5	11.5	21.2	20.2	21.4	19.3	29.0	17.1	16.7	23.4	18.0	20.3	19.5	19.4	36.2	15.9	17.4	12.1	19.5	21.3	19.8	16.5	20.4	15.9	50.0	20.2	21.1	27.5	12.9	18.6	20.1	19.6	30.8	27.7	13.3	58.9	50.5	17.1	28.8	25.6	33.6	13.6	19.2	30.3	12.2	25.8	34.3	23.3	20.7	23.2	15.1	40.2	22.9	37.2	17.8	20.4	24.3	40.4	18.6	16.9	23.2	26.3	26.9	19.0	37.4	37.8	32.3	26.2	35.2	44.2	39.8	32.2	25.4	40.5	29.0	45.9	18.0	23.6	34.6	31.3	21.0	18.7	23.1	40.6	50.5	41.6	17.8	29.6	74.1	25.2	15.0	32.8	35.7	18.1	47.0	30.5	29.6	45.4	59.9	20.6	18.7	32.1	14.6	3.5	7.1	7.4	4.0	6.9	8.4	5.7	5.3	2.9	6.5	6.8	6.2	5.3	5.3	4.2	4.6	7.6	3.1	17.5	23.3	21.7	22.8	16.8	20.4	21.4	19.3	20.3	16.5	20.2	30.8	20.9	22.4	31.7	91.1	38.0	13.0	16.6	8.7	12.5	28.5	11.3	9.4	11.8	17.2	16.4	3.7	37.5	15.0	43.8	20.5	3.9	10.0	24.5	15.3	26.6	20.9	19.7	12.6	82.6	8.2	8.8	21.7	23.0	23.0	37.2	42.9	20.0	9.7	11.0	18.5	88.6	14.1	12.2	19.2	11.7	14.1	23.3	18.7	0.0	81.5	20.7	10.4	30.9	132.7	176.5	9.4	20.4	22.6	33.8	21.6	17.8	5.3	21.6	25.6	32.9	18.0	17.8	51.5	19.5	11.1	12.6	7.7	34.4	16.5	11.1	18.1
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726699-786475	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavorable (8.42e-4)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	8.4	8.7	7.8	6.7	7.1	7.6	8.5	11.8	8.7	10.3	12.1	11.3	7.4	12.7	4.8	11.6	14.1	5.1	11.9	6.9	7.3	8.3	9.0	6.9	6.5	7.7	10.1	10.6	10.9	7.9	13.0	6.5	6.8	7.9	5.7	4.0	11.5	8.0	24.1	9.1	9.2	6.3	8.3	7.3	9.4	7.8	9.4	6.2	9.1	9.5	5.0	10.5	9.1	8.3	83.1	64.3	18.8	44.0	12.1	13.3	47.2	16.8	16.0	20.5	19.4	64.5	42.8	50.5	23.9	17.7	49.0	49.2	35.0	42.2	15.7	8.6	59.5	12.4	37.4	47.2	16.6	38.1	21.7	16.1	17.8	25.8	19.0	13.7	28.1	25.2	80.0	10.3	15.0	81.5	22.7	34.1	69.3	27.4	50.5	41.4	6.1	34.8	24.3	34.5	39.3	65.1	27.5	66.9	19.9	21.4	59.1	31.5	23.7	11.4	40.1	39.4	38.4	19.9	25.5	29.0	25.1	39.2	60.8	0.0	0.7	0.6	0.8	1.1	1.3	0.6	1.3	1.8	1.1	1.4	1.2	0.9	0.0	1.3	0.8	1.7	0.3	0.8	7.8	7.1	11.8	8.7	6.9	7.3	7.7	10.1	6.8	8.3	9.4	8.3	7.1	19.2	9.1	6.2	3.8	0.0	6.1	0.0	6.8	6.3	8.3	7.1	13.1	4.3	4.3	9.2	27.1	8.0	5.7	4.9	15.6	6.4	0.7	28.2	13.9	7.8	3.6	9.7	12.5	4.2	13.2	7.8	11.7	15.3	0.0	17.6	6.8	8.5	5.8	10.1	10.4	7.4	0.0	7.5	0.0	1.7	7.2	4.8	0.0	7.5	2.4	8.6	2.1	10.6	8.9	9.6	4.1	8.6	6.0	5.1	6.4	11.1	8.0	15.0	0.0	11.4	6.1	7.2	17.4	10.8	0.0	4.5	3.5	12.0	9.1	4.2
DNAH17	"DNAHL1, DNEL2, FLJ40457"	ENSG00000187775	"Dynein axonemal heavy chain 17"	Q9UFH2	17	78423697-78577396	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 2.1;retina: 2.5;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 56.4;Cone photoreceptor cells: 87.6;Early spermatids: 43.7;Late spermatids: 36.6;Oligodendrocytes: 52.5"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 2.9;lung cancer: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 5.7;MOLT-4: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA024354, HPA076261"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA024354: AB_1847911, HPA076261: AB_2732305"	"unprognostic (4.98e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.70e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.35e-3)"	"unprognostic (1.58e-10)"	"unprognostic (5.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.12e-1)"	"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.2	1.6	0.8	1.3	0.9	0.6	2.1	0.4	6.4	0.5	0.7	0.6	0.6	0.3	0.1	0.0	56.4	0.1	0.0	2.5	0.0	0.0	0.0	87.6	0.0	0.1	0.0	0.0	0.0	43.7	1.4	0.5	1.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.8	1.7	36.6	0.6	2.9	0.0	1.0	0.1	1.5	0.0	1.0	52.5	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	7.8	0.0	0.6	0.5	17.4	0.6	0.0	0.1	0.0	0.3	0.4	0.0	0.1
DNAJB1	"Hsp40, HSPF1, RSPH16B, Sis1"	ENSG00000132002	"DnaJ heat shock protein family (Hsp40) member B1"	P25685	19	14514769-14560391	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1705.1"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1392.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 1705.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017450, HPA063247"	Enhanced		Supported	Nucleoplasm		NA	Yes		23000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB017450: AB_10631418, HPA063247: AB_2684971"	"unprognostic (3.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (2.20e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.77e-2)"	206.0	216.1	228.5	40.9	241.7	133.8	62.0	320.9	1705.1	188.1	259.4	86.7	35.2	54.0	40.8	439.9	75.3	183.7	182.8	243.8	240.2	245.0	230.3	286.0	42.0	250.4	251.8	231.9	89.8	66.4	148.4	123.4	285.4	73.9	48.4	81.2	109.7	127.1	51.2	128.5	62.7	54.5	240.6	104.5	149.1	149.4	241.8	107.3	97.2	208.0	76.5	133.6	257.7	323.4	192.5	212.5	80.8	81.7	146.8	114.1	45.6	125.9	99.9	210.4	158.8	126.3	106.7	54.8	135.4	121.0	135.5	144.9	169.1	96.7	150.3	55.0	76.1	86.7	115.0	275.6	94.6	57.9	78.5	61.0	237.5	85.3	73.4	114.7	71.6	35.7	131.2	471.6	123.6	130.5	102.2	60.1	80.4	285.9	228.3	73.7	106.3	121.7	101.8	62.4	67.0	51.1	121.1	233.7	127.1	90.8	60.3	60.6	64.7	156.4	98.0	184.1	264.8	193.5	141.7	65.7	114.4	109.2	151.1	68.8	92.4	116.2	171.6	159.0	184.8	93.7	244.5	214.9	76.0	92.0	281.6	219.9	137.6	125.1	172.2	45.1	270.9	322.6	228.5	241.7	320.9	1705.1	243.8	240.2	250.4	251.8	285.4	240.6	241.8	323.4	750.2	157.0	95.4	32.3	248.7	425.8	1142.1	148.0	719.3	60.9	468.8	476.4	367.1	72.9	118.6	23.9	118.9	135.6	214.2	459.6	41.1	132.8	491.8	374.8	339.3	397.3	407.3	60.0	10.2	162.6	199.3	661.2	408.7	552.8	339.4	100.2	86.7	59.9	158.1	52.2	8.9	420.1	81.4	85.1	1392.1	475.3	63.3	559.3	503.4	23.4	31.3	160.7	25.7	3.0	16.5	123.8	380.7	36.9	697.0	461.1	117.3	59.1	138.0	164.7	26.3	398.9	673.3	290.2	53.4	1186.0	478.9	274.9	948.4	104.8	393.7	606.2
DNAJB4	HLJ1	ENSG00000162616	"DnaJ heat shock protein family (Hsp40) member B4"	Q9UDY4	1	77979175-78017964	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 119.0;HUVEC TERT2: 182.3;LHCN-M2: 312.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004995, HPA028383, HPA028385"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		9500	"Cluster 44: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.01e-2)"	31.6	49.7	21.9	11.1	24.2	6.7	15.4	24.4	74.6	24.0	19.9	14.3	6.4	21.3	10.8	26.4	13.9	32.3	50.4	23.1	27.1	20.6	20.0	17.0	9.7	23.0	24.8	16.0	22.8	14.1	11.6	26.0	23.0	23.3	11.2	15.0	7.6	14.1	44.1	9.6	9.6	29.9	23.3	42.2	12.3	7.9	25.9	10.5	44.5	71.4	6.2	23.6	12.8	35.3	6.2	11.8	14.5	8.6	61.8	115.0	6.7	119.0	28.8	50.8	56.8	3.9	8.0	8.9	19.4	55.5	20.7	9.2	18.7	10.1	86.1	10.1	5.3	4.5	32.9	28.7	84.1	2.5	2.4	47.9	27.9	66.5	18.9	28.4	182.3	2.9	19.6	6.1	312.1	0.7	3.0	6.6	9.4	1.8	5.6	5.0	25.2	5.9	12.0	3.1	10.8	3.4	13.3	10.0	11.7	15.0	3.9	3.7	88.7	72.5	17.8	51.2	15.9	5.5	1.8	7.9	9.9	5.3	12.9	3.3	0.7	1.2	1.1	0.8	1.8	1.6	1.3	1.3	0.7	1.3	3.0	2.1	0.2	1.6	0.9	2.3	1.9	0.9	21.9	24.2	24.4	74.6	23.1	27.1	23.0	24.8	23.0	23.3	25.9	35.3	81.5	60.9	6.3	35.9	23.9	41.7	112.5	16.3	48.3	29.3	90.9	57.1	98.7	18.6	20.0	18.4	68.8	51.2	15.3	40.9	37.2	11.2	144.7	55.1	37.3	84.4	21.4	42.1	41.6	14.7	23.2	87.3	45.9	51.9	56.6	16.7	42.8	22.3	19.4	30.3	39.0	37.9	12.2	18.3	70.1	62.6	24.5	33.7	65.8	21.5	5.1	40.5	8.2	28.6	53.8	11.4	27.3	35.0	70.6	33.9	16.8	31.0	34.7	56.5	26.3	82.8	120.3	23.1	12.0	55.5	39.2	181.0	52.7	32.1	30.9	43.2
DNAJB5	Hsc40	ENSG00000137094	"DnaJ heat shock protein family (Hsp40) member B5"	O75953	9	34989641-34998900	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.5;tongue: 218.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"myeloid DC: 5.5;neutrophil: 5.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.5;granulocytes: 5.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023818, HPA050794"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA023818: AB_1847793, HPA050794: AB_2681241"	"unprognostic (1.41e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.53e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-3)"	14.7	12.5	18.5	11.0	18.7	1.5	8.7	23.0	27.7	14.0	14.8	63.0	7.7	56.0	11.8	32.5	29.6	12.7	64.8	24.0	20.1	8.5	4.4	12.3	4.6	20.3	21.0	8.6	6.1	4.0	25.3	2.4	19.4	27.5	12.2	10.1	6.3	52.1	164.5	5.1	17.9	64.3	18.1	12.2	26.8	16.0	19.3	5.8	10.9	218.5	5.0	33.7	11.5	18.8	4.7	3.8	23.7	12.7	13.6	10.4	2.6	20.1	14.5	30.3	26.8	2.8	1.0	4.5	4.9	22.2	31.7	0.6	9.1	15.8	25.5	6.4	2.9	1.6	5.6	1.3	15.6	0.5	14.2	15.2	1.1	18.0	8.9	13.4	19.6	8.3	0.4	9.3	24.7	3.3	7.8	6.7	11.2	2.1	8.1	6.0	24.4	2.5	4.4	0.4	10.1	16.4	10.8	0.6	2.4	20.2	3.8	1.4	8.8	14.4	31.4	7.6	6.3	3.4	2.5	3.3	16.6	1.8	15.9	0.0	1.0	0.0	0.2	0.3	0.9	0.4	0.2	0.0	5.5	0.2	0.3	0.7	5.2	0.4	0.1	0.1	1.0	0.5	18.5	18.7	23.0	27.7	24.0	20.1	20.3	21.0	19.4	18.1	19.3	18.8	1.9	6.4	1.5	8.5	0.9	2.0	2.3	4.7	1.8	6.0	1.7	1.4	42.9	1.5	1.8	0.0	6.2	0.1	0.5	0.5	0.0	2.8	8.0	1.7	4.8	4.5	0.0	0.0	4.9	3.4	0.7	6.7	2.0	2.2	0.0	1.7	3.6	1.2	4.7	1.7	3.3	0.3	2.0	1.9	11.1	6.7	1.5	3.6	5.4	1.9	1.2	12.0	2.1	6.6	3.2	4.3	0.0	7.9	0.7	1.5	1.6	4.4	1.0	2.7	6.6	14.7	16.8	6.3	1.3	1.8	3.0	0.8	1.4	1.5	0.3	0.7
DNAJB6	"LGMD1D, MRJ"	ENSG00000105993	"DnaJ heat shock protein family (Hsp40) member B6"	O75190	7	157335381-157417439	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 960.5;Urothelial cells: 876.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004670, HPA024258, HPA058593"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767"	"unprognostic (4.37e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.52e-1)"	82.7	66.0	112.4	55.9	119.0	183.2	87.0	124.0	219.8	76.0	125.6	103.7	43.5	81.5	109.4	117.0	73.8	50.5	121.0	119.5	122.2	73.3	49.8	69.9	54.8	122.8	122.8	76.6	43.6	57.6	65.2	73.7	123.7	58.1	49.2	87.4	74.8	70.5	328.3	132.7	56.9	73.3	120.3	59.3	62.1	118.2	118.5	81.1	52.6	177.5	68.0	92.7	90.8	139.5	179.8	106.7	127.0	130.9	126.3	113.1	117.6	196.2	159.8	179.1	194.4	146.4	176.0	68.7	359.2	146.9	162.4	111.9	87.3	137.8	275.3	138.3	119.6	123.1	61.7	104.6	116.1	92.4	99.4	100.2	130.7	136.1	64.2	178.9	135.6	72.2	203.8	66.9	232.5	121.7	232.4	181.0	255.7	126.1	141.2	122.7	91.1	96.0	148.9	108.1	76.5	201.2	153.5	119.3	151.2	259.6	87.2	129.8	170.0	113.0	85.4	270.6	172.0	126.1	193.1	80.9	160.1	208.7	146.4	345.1	160.8	201.9	133.8	168.2	135.2	134.8	120.8	138.4	120.2	124.0	152.0	141.7	287.8	148.0	206.3	109.9	159.6	247.0	112.4	119.0	124.0	219.8	119.5	122.2	122.8	122.8	123.7	120.3	118.5	139.5	225.2	48.1	62.7	41.1	150.9	756.7	640.9	632.6	182.7	100.4	281.8	175.9	115.0	62.9	206.8	97.5	81.3	276.9	287.0	143.0	193.7	134.9	105.8	225.6	125.2	178.8	193.5	131.1	49.4	69.4	241.8	159.8	66.8	296.3	212.7	70.5	101.4	46.7	164.7	94.2	56.4	149.8	223.8	133.7	803.5	126.4	151.0	339.2	282.8	60.9	313.6	122.7	173.0	37.2	73.5	138.5	132.4	202.3	132.9	413.2	82.4	196.1	253.8	104.0	98.6	146.0	198.8	319.4	504.8	204.1	960.5	508.1	288.0	111.4	155.1	876.8
DNAJC17	FLJ10634	ENSG00000104129	"DnaJ heat shock protein family (Hsp40) member C17"	Q9NVM6	15	40765161-40807478	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chaperone, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040914, HPA041187"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA040914: AB_10794072, HPA041187: AB_10794192"	"unprognostic (9.79e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.58e-2)"	13.2	11.1	6.9	9.9	6.7	6.3	13.4	9.3	9.3	12.5	4.6	13.8	8.2	14.6	9.6	12.5	14.2	10.1	8.8	6.5	6.4	12.0	14.8	11.1	13.6	6.5	6.5	17.1	9.8	16.8	8.9	13.9	6.6	9.7	11.4	5.4	9.2	11.2	8.0	12.2	10.8	12.7	5.8	12.2	10.6	4.5	6.7	16.2	11.8	11.2	16.8	10.9	10.7	7.3	10.8	9.6	23.8	23.1	10.5	26.2	10.1	19.9	19.5	32.7	26.7	7.7	15.1	16.6	21.5	23.9	15.0	22.2	24.4	32.6	28.9	30.8	15.3	28.1	19.2	7.6	29.8	14.7	24.0	26.2	20.6	25.8	46.2	18.2	30.5	28.0	20.0	8.6	25.3	13.6	21.5	19.7	8.6	25.3	14.1	15.7	19.8	8.6	33.2	19.5	15.0	9.6	14.4	13.4	10.2	16.8	17.0	29.1	30.0	18.5	16.0	21.0	17.1	9.6	31.0	36.5	11.9	37.1	15.9	30.0	21.5	28.9	24.5	28.6	17.6	19.8	21.2	23.7	24.3	19.4	22.4	21.8	7.9	13.3	17.0	19.8	39.2	14.1	6.9	6.7	9.3	9.3	6.5	6.4	6.5	6.5	6.6	5.8	6.7	7.3	26.6	12.8	16.4	9.4	16.5	5.6	19.2	40.6	8.6	15.0	24.3	14.7	5.8	22.8	33.2	25.8	12.5	25.1	15.5	17.5	19.6	18.9	3.2	13.4	15.8	16.2	7.8	9.4	13.0	17.5	15.8	14.7	12.8	16.9	22.1	13.6	19.6	14.4	22.5	13.5	15.0	16.1	20.3	10.3	10.6	2.0	15.2	13.1	7.2	12.2	13.0	8.5	36.0	11.6	16.1	16.9	24.6	16.1	9.9	12.8	30.6	27.2	20.2	10.4	0.0	14.5	22.6	5.6	4.7	16.3	5.3	17.2	16.7	16.6	16.9	20.6
DNAJC25	bA16L21.2.1	ENSG00000059769	"DnaJ heat shock protein family (Hsp40) member C25"	Q9H1X3	9	111631334-111654351	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 32.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019122	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA019122: AB_1853155"	"unprognostic (3.07e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.94e-3)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (9.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.19e-2)"	3.3	5.2	1.0	2.3	1.1	1.0	2.0	1.0	1.9	1.5	2.5	3.0	2.9	1.7	4.4	1.5	1.8	2.1	2.5	1.1	1.0	5.1	32.1	1.3	0.7	1.4	1.2	1.4	2.9	4.2	1.5	2.7	1.2	3.7	1.6	0.6	4.2	2.2	2.2	1.0	2.4	1.7	0.9	0.7	2.4	1.4	1.0	0.2	2.2	1.7	0.8	3.0	1.3	1.0	2.7	2.0	1.3	2.3	14.1	6.2	5.3	10.4	4.8	3.9	3.7	3.7	1.6	2.4	4.0	7.0	6.1	8.5	1.5	2.9	3.7	1.9	2.0	2.4	0.0	8.0	4.5	4.5	3.3	5.3	8.2	3.0	5.6	3.0	3.3	1.3	4.9	1.8	5.0	2.9	1.3	0.2	2.3	5.1	4.9	2.3	7.3	2.2	8.2	2.8	2.3	1.2	5.7	7.7	3.6	2.3	4.1	0.8	6.5	4.7	2.3	12.9	6.0	3.6	6.0	1.3	8.1	2.1	4.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	1.0	1.1	1.0	1.9	1.1	1.0	1.4	1.2	1.2	0.9	1.0	1.0	9.9	6.4	11.9	0.0	8.3	10.6	16.2	13.8	6.8	7.9	14.1	12.4	13.9	8.6	16.0	11.0	20.9	14.2	16.7	16.2	13.7	17.1	10.8	18.6	18.2	7.9	17.3	3.0	0.0	16.3	24.7	15.3	10.2	19.5	1.3	8.8	6.4	85.3	12.1	13.5	0.0	21.3	6.1	6.4	10.2	2.5	10.2	10.0	12.4	0.0	6.7	4.6	5.2	0.0	0.0	11.7	7.3	10.1	22.6	29.4	21.7	13.5	18.9	19.9	13.1	13.3	15.7	29.5	16.6	7.0	9.2	13.8	8.8	10.6	15.0	22.7
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415871	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.5;retina: 52.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1038.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.1;HEL: 165.8;K-562: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	1.5	11.1	34.7	0.9	43.3	4.7	1.1	33.7	46.9	0.8	0.0	2.1	1.0	0.6	0.4	0.3	1.1	1.0	8.9	42.1	48.0	7.7	0.4	1.5	0.2	60.2	51.3	0.5	2.1	1.0	12.6	7.4	67.6	1.1	1.7	52.8	0.7	0.7	0.4	1.1	1.0	0.9	27.2	2.1	1.7	2.2	42.0	0.8	1.7	0.8	0.3	1.1	0.9	81.5	10.4	2.8	0.1	4.4	2.1	0.5	23.4	20.1	33.1	32.6	31.7	2.7	0.5	9.9	1.7	8.3	8.0	2.5	14.6	3.3	25.8	62.1	6.9	165.8	5.1	0.6	0.2	5.6	3.9	2.7	2.2	3.3	13.8	6.0	0.7	8.0	65.5	1.2	6.6	1.9	2.1	0.0	6.5	0.0	2.2	0.0	4.9	0.4	23.7	0.0	39.4	27.0	11.9	15.5	5.4	37.4	7.5	0.3	6.5	4.8	3.3	0.6	5.9	6.0	4.1	3.0	13.4	4.1	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	43.3	33.7	46.9	42.1	48.0	60.2	51.3	67.6	27.2	42.0	81.5	0.8	0.0	0.5	49.3	0.5	1.3	0.4	0.5	0.0	30.4	0.6	0.3	28.0	2.8	0.2	0.0	14.6	8.9	1.5	0.4	1.9	0.8	2.0	1.8	0.5	3.7	7.2	19.4	237.4	0.7	2.1	5.8	1.5	3.0	0.0	0.6	0.4	0.1	1.2	52.2	237.6	1.9	2.0	0.0	0.8	1.9	0.0	0.7	7.2	18.7	1.1	4.1	0.0	136.7	1038.1	0.4	0.2	0.0	0.9	1.7	0.0	7.2	1.2	21.6	0.0	0.2	8.5	1.7	2.5	0.0	0.3	7.4	0.6	6.9	0.6	0.2
DNAJC7	"TPR2, TTC2"	ENSG00000168259	"DnaJ heat shock protein family (Hsp40) member C7"	Q99615	17	41976421-42021376	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023015, HPA052395"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		22000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA023015: AB_1847804, HPA052395: AB_2681811"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.93e-3)"	41.7	50.5	122.8	43.5	126.4	40.4	39.6	125.0	204.0	39.5	124.2	46.5	37.3	28.3	50.5	66.7	33.8	26.2	85.3	126.8	128.6	65.4	67.0	38.9	53.4	127.6	127.1	43.0	54.9	54.5	55.2	35.9	127.2	37.4	45.4	49.2	39.2	25.0	99.8	48.2	38.1	27.6	124.1	45.1	49.1	46.0	125.5	56.5	38.2	73.0	67.7	40.7	41.3	128.1	99.2	129.6	130.8	100.1	68.5	106.5	120.0	103.6	98.8	139.7	110.6	143.5	93.9	142.0	118.2	113.2	118.4	140.6	192.3	127.9	169.7	123.6	220.1	102.6	116.0	189.7	100.8	185.0	102.7	92.4	82.3	131.5	104.4	101.5	114.8	122.4	160.7	98.9	122.2	66.5	210.8	155.0	139.4	92.3	87.1	124.0	175.4	123.6	116.9	104.8	117.7	104.7	84.9	243.6	126.1	128.7	139.3	177.8	110.3	80.1	105.0	100.1	163.3	72.0	159.4	122.9	103.0	124.0	97.1	49.7	55.9	35.9	30.9	57.8	35.2	39.6	36.3	36.1	57.7	41.9	33.4	32.6	19.8	49.4	59.8	98.5	43.8	38.8	122.8	126.4	125.0	204.0	126.8	128.6	127.6	127.1	127.2	124.1	125.5	128.1	62.2	35.3	38.3	39.2	87.1	65.4	94.4	107.8	37.5	80.5	46.7	43.4	57.6	61.5	54.0	66.2	135.5	108.6	139.0	81.1	115.4	107.6	108.3	83.7	77.8	71.8	111.4	52.4	33.9	132.5	103.8	50.9	38.7	70.6	57.0	105.5	71.4	56.4	102.4	63.9	37.3	63.4	67.1	102.1	99.6	52.3	67.4	94.6	48.0	34.7	166.5	100.0	121.5	36.7	142.0	125.2	62.1	61.3	79.7	77.4	79.2	155.8	61.7	143.5	46.0	78.9	78.5	104.7	111.9	49.3	68.8	126.8	81.9	127.2	79.1	94.6
DNAJC8	SPF31	ENSG00000126698	"DnaJ heat shock protein family (Hsp40) member C8"	O75937	1	28199456-28233029	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026275, HPA026283"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026275: AB_2671823, HPA026283: AB_10600907"	"unprognostic (1.42e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (6.95e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.07e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (4.84e-2)"	32.1	29.2	21.7	27.8	22.5	30.1	31.2	22.8	27.6	27.2	21.3	27.4	20.9	31.6	22.9	25.2	22.6	20.2	38.4	22.6	24.3	28.2	27.3	21.9	40.3	22.7	22.8	28.2	25.2	23.2	13.6	30.6	23.1	21.7	23.0	26.2	23.0	22.8	41.2	21.6	23.6	31.0	21.8	26.7	29.0	13.8	22.1	42.7	26.2	29.9	42.2	28.1	23.4	22.9	76.6	38.9	58.9	68.4	70.6	57.8	53.0	61.7	77.2	122.6	111.7	41.2	60.1	87.0	62.4	69.4	60.2	45.3	88.4	61.1	128.6	68.5	65.9	112.0	54.0	73.1	63.5	111.8	88.3	44.3	53.6	77.0	40.6	57.2	82.5	70.6	106.4	59.3	90.6	44.5	84.6	77.3	107.6	47.1	44.2	96.0	87.7	84.4	78.1	62.3	21.1	55.1	81.8	33.2	74.4	43.2	49.7	89.9	63.4	54.4	58.4	123.1	93.9	55.5	78.9	138.3	72.9	133.4	75.8	64.2	53.6	53.1	60.4	53.6	61.6	60.5	54.5	60.2	59.8	59.6	54.3	54.8	28.6	57.1	60.0	61.3	66.3	91.8	21.7	22.5	22.8	27.6	22.6	24.3	22.7	22.8	23.1	21.8	22.1	22.9	133.2	76.9	91.4	9.4	119.4	129.8	148.3	181.2	80.8	96.0	66.6	87.1	149.6	78.6	116.2	106.7	25.0	188.7	156.7	56.4	270.1	150.9	55.3	100.9	127.5	127.9	46.0	128.7	19.5	98.1	159.7	132.4	48.9	106.1	141.0	93.8	93.5	77.9	181.2	69.0	16.6	58.1	111.9	71.9	146.3	40.3	120.5	121.1	103.2	21.5	153.5	167.4	183.4	19.6	23.4	117.3	68.2	144.0	74.6	121.1	65.2	199.3	87.8	103.1	85.5	108.0	144.9	153.1	91.7	74.7	110.2	224.1	132.7	98.8	76.7	112.3
DNAJC9	"JDD1, SB73"	ENSG00000213551	"DnaJ heat shock protein family (Hsp40) member C9"	Q8WXX5	10	73183362-73247255	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 91.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 173.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035215, HPA035216"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		39000	"Cluster 44: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Plasma membrane"	"HPA035215: AB_10603663, HPA035216: AB_2674522"	"unprognostic (4.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.45e-1)"	"unprognostic (6.83e-3)"	"unprognostic (2.43e-3)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (5.61e-2)"	"unprognostic (3.08e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	9.2	10.6	17.1	17.6	17.5	91.9	15.4	19.2	21.5	11.2	15.4	16.0	14.6	12.8	12.4	16.9	9.7	6.9	8.6	16.9	17.0	10.0	13.4	9.6	28.2	16.4	16.5	15.3	8.7	10.2	10.6	17.6	16.9	11.4	18.0	25.1	11.3	11.2	11.5	17.7	13.9	11.8	15.7	14.8	12.2	12.4	17.0	35.8	8.4	13.1	32.3	11.5	11.9	17.6	135.0	77.3	93.8	68.4	16.1	19.3	45.7	101.5	59.4	101.1	106.1	130.8	89.4	86.9	33.5	43.6	43.7	83.1	92.9	67.5	118.1	98.5	63.8	188.3	79.4	93.4	14.8	173.1	71.0	14.8	33.2	107.1	93.4	36.4	66.2	112.1	168.3	103.0	81.4	118.4	155.0	124.7	36.3	64.4	215.1	114.2	85.1	47.6	52.9	61.5	44.3	73.4	73.5	114.5	52.9	43.7	62.1	76.8	48.0	65.2	118.3	71.3	168.0	45.0	70.6	141.8	64.8	162.9	45.9	23.9	3.7	29.1	25.5	10.7	29.2	32.8	31.3	28.2	6.5	28.3	30.3	26.9	4.5	24.8	10.9	20.3	36.8	18.0	17.1	17.5	19.2	21.5	16.9	17.0	16.4	16.5	16.9	15.7	17.0	17.6	17.3	9.6	12.3	11.1	39.5	47.7	34.1	31.9	33.0	26.1	21.5	24.8	2.7	17.2	24.8	9.2	8.4	107.8	44.6	18.3	21.5	31.5	80.4	15.9	14.0	20.6	12.0	173.8	11.8	31.4	111.4	17.6	12.2	19.0	42.3	26.0	13.9	9.8	61.9	15.2	12.8	25.6	54.9	10.9	19.6	43.3	14.0	17.4	32.0	6.5	23.0	29.5	32.0	7.5	6.5	44.1	16.7	20.3	49.7	27.6	18.2	16.3	21.9	43.2	26.3	17.7	28.3	28.7	65.4	38.2	43.5	58.0	45.2	19.7	38.0	37.5
DNAL1	"1700010H15RiK, C14orf168, CILD16, MGC12435"	ENSG00000119661	"Dynein axonemal light chain 1"	Q4LDG9	14	73644875-73703732	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 335.4;Endometrial ciliated cells: 104.0;Respiratory ciliated cells: 141.4;Spermatocytes: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053129, HPA060974"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centriolar satellite"		"HPA053129: AB_2682051, HPA060974: "	"unprognostic (1.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.17e-8)"	"unprognostic (9.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	7.5	6.2	8.3	6.2	11.0	6.1	5.1	12.2	10.0	5.9	18.5	4.7	2.7	7.9	12.2	4.6	23.7	9.3	9.2	13.0	9.6	11.2	3.7	7.7	5.2	8.8	11.0	7.5	6.1	14.7	8.4	4.7	8.9	5.7	5.5	18.1	4.4	7.0	5.2	3.0	3.0	9.5	7.6	4.7	5.6	55.2	11.2	6.1	16.4	5.9	4.5	6.1	3.3	8.8	15.4	11.2	13.5	12.3	9.3	11.8	10.7	15.2	11.6	19.3	20.0	11.7	23.9	6.1	11.1	16.2	18.4	9.2	12.8	11.7	28.0	9.0	5.3	5.1	16.7	4.3	9.7	5.9	5.8	9.0	9.0	21.3	15.2	14.8	12.7	9.7	5.8	13.7	23.8	25.2	15.4	7.0	6.3	12.7	10.9	10.7	20.2	2.6	16.1	16.1	20.7	9.8	25.0	4.8	12.2	10.3	26.7	3.9	12.0	24.1	43.8	18.2	14.3	7.8	18.2	13.4	19.9	3.1	17.2	4.3	2.3	2.5	2.7	2.5	3.8	2.7	2.6	2.7	2.1	4.1	2.3	2.6	2.1	2.1	2.1	5.9	2.6	1.3	8.3	11.0	12.2	10.0	13.0	9.6	8.8	11.0	8.9	7.6	11.2	8.8	10.8	19.2	14.9	11.4	6.3	3.2	7.4	19.8	2.2	16.0	9.4	5.7	14.4	15.7	23.1	18.4	60.5	5.4	5.4	5.7	9.8	15.5	335.4	104.0	20.4	11.2	10.2	4.8	21.7	14.0	9.3	12.9	7.7	16.4	10.1	11.8	11.0	5.3	8.4	15.2	15.5	6.1	18.3	6.7	7.9	57.8	17.4	6.9	12.4	6.5	6.5	19.9	12.3	10.1	5.8	12.3	4.1	16.6	5.8	5.9	1.7	24.9	141.4	40.2	13.1	21.6	12.4	187.7	24.7	2.1	2.0	2.5	6.2	11.9	5.6	5.0
DNAL4	"dJ327J16, PIG27"	ENSG00000100246	"Dynein axonemal light chain 4"	O96015	22	38778508-38794198	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 124.1;Late spermatids: 210.7;Spermatocytes: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 64.0"					"Low region specificity"	"Detected in all"			HPA003647	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	"Nucleoplasm, Nucleoli, Cytosol"	"HPA003647: AB_1078712"	"unprognostic (8.45e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.83e-2)"	11.3	18.0	29.1	6.7	32.3	4.4	14.5	21.0	36.5	18.3	23.2	12.9	7.9	12.2	15.0	18.9	35.4	12.9	13.7	29.2	28.3	24.4	11.1	13.9	8.1	22.1	23.3	17.5	21.3	31.1	30.9	9.9	22.1	18.3	9.6	13.8	18.1	12.1	7.0	17.5	9.8	7.5	22.0	11.4	16.4	65.5	28.0	14.3	25.4	6.2	8.3	14.2	15.5	24.5	17.9	8.9	17.5	15.5	21.8	21.7	0.0	7.5	14.0	11.4	12.2	5.7	20.1	4.5	15.7	10.7	13.1	8.3	11.0	20.5	7.7	11.4	14.8	2.6	2.5	6.6	34.9	14.5	3.7	17.1	64.0	14.9	26.8	29.7	16.6	22.1	5.3	8.5	13.8	21.9	13.6	14.0	6.8	26.3	7.4	12.8	7.5	5.9	23.7	10.8	24.3	13.5	15.4	11.5	30.7	12.1	20.7	13.7	9.8	10.1	10.1	15.5	7.5	5.3	1.8	2.1	29.9	4.9	9.8	15.0	8.5	11.9	11.2	8.9	13.8	7.1	9.3	10.2	8.7	10.6	10.5	9.0	15.0	16.2	11.3	13.2	9.3	7.5	29.1	32.3	21.0	36.5	29.2	28.3	22.1	23.3	22.1	22.0	28.0	24.5	8.2	6.4	10.5	5.5	5.1	5.6	13.4	18.9	10.2	15.0	20.6	17.8	4.3	14.3	15.2	3.7	2.1	27.6	9.7	10.9	31.3	28.4	124.1	56.4	11.8	8.5	12.6	11.2	11.0	15.5	21.2	10.1	6.1	10.5	15.2	20.3	12.8	3.8	13.7	11.8	10.6	14.7	14.2	4.4	2.8	210.7	11.8	6.5	8.8	4.7	5.7	18.9	8.2	6.6	5.1	18.4	9.1	7.5	1.3	9.8	8.5	20.0	41.0	15.4	6.6	6.6	11.6	77.7	20.0	9.1	10.5	19.8	6.0	20.1	13.2	12.0
DND1	"MGC34750, RBMS4"	ENSG00000256453	"DND microRNA-mediated repression inhibitor 1"	Q8IYX4	5	140670794-140673576	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 12.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.4;Early spermatids: 42.6;Horizontal cells: 20.2;Spermatogonia: 40.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059723			Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA059723: "																		0.4	0.2	2.5	0.0	2.6	0.2	0.4	2.7	3.3	0.5	2.3	0.4	0.1	0.3	0.2	0.4	0.6	0.0	0.4	2.5	2.6	1.1	1.0	0.6	0.1	2.7	2.7	0.4	0.8	0.4	1.3	0.1	2.6	0.9	0.4	0.0	0.3	0.2	0.7	0.6	0.6	0.2	2.6	1.0	0.3	12.2	2.8	0.6	0.6	0.1	0.6	0.3	0.4	2.7	0.1	0.2	0.3	0.2	0.3	0.1	0.7	0.0	0.3	1.1	1.0	0.3	0.2	0.3	0.1	0.2	0.1	0.3	0.7	0.3	0.4	0.2	0.7	0.1	0.7	0.1	0.4	0.2	0.4	0.2	1.1	0.9	0.5	0.1	0.4	0.3	0.2	0.0	0.4	0.1	0.0	1.1	0.2	0.0	0.7	0.9	0.1	0.1	0.5	0.1	0.5	0.4	0.0	0.0	0.3	0.2	0.1	0.2	0.0	0.3	0.6	0.2	0.0	1.6	0.4	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.6	2.7	3.3	2.5	2.6	2.7	2.7	2.6	2.6	2.8	2.7	0.4	3.2	1.1	3.9	1.3	0.5	0.9	0.8	0.0	11.4	1.1	1.0	0.0	1.5	0.7	3.7	4.2	0.3	0.7	0.5	0.0	0.2	42.6	1.2	1.4	0.9	1.2	2.7	3.6	0.4	0.6	0.7	0.5	1.6	0.0	1.7	1.1	1.9	0.6	20.2	3.5	0.9	0.0	1.3	1.5	7.2	0.6	1.0	0.0	1.0	0.2	2.5	1.0	2.5	3.6	0.4	0.1	0.4	0.6	2.0	0.4	0.1	0.5	6.6	0.0	1.7	0.8	6.2	40.0	1.0	1.0	0.3	1.9	0.4	0.9	1.6
DNHD1	"C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184"	ENSG00000179532	"Dynein heavy chain domain 1"	Q96M86	11	6497260-6593758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.5;Erythroid cells: 35.6;Excitatory neurons: 41.4;Inhibitory neurons: 32.8;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039698, HPA040267, HPA057639"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytokinetic bridge"		"HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.45e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-4)"	"unprognostic (8.15e-2)"	2.2	1.7	2.6	1.5	3.3	4.5	2.2	2.1	4.3	2.9	2.3	3.3	1.6	2.5	2.1	1.6	2.6	1.4	2.0	2.1	3.2	2.5	2.8	3.3	2.5	4.7	2.8	3.3	1.7	0.4	2.2	0.8	5.0	2.4	1.4	4.0	1.8	1.3	2.0	2.3	3.3	1.4	2.4	2.8	2.0	10.3	3.5	2.1	2.4	0.8	2.0	2.4	2.5	6.2	2.1	2.0	2.4	1.9	2.0	2.9	2.6	1.0	1.2	0.7	0.9	1.3	2.3	2.4	0.4	1.0	1.8	3.7	1.1	1.1	0.9	1.5	2.3	1.8	3.7	1.5	1.3	2.1	0.8	2.0	1.8	2.2	3.6	1.2	0.6	3.1	2.0	2.3	1.0	0.6	0.9	3.0	2.6	0.7	2.0	1.4	0.9	1.5	1.3	1.6	1.1	2.2	0.8	2.2	1.9	1.8	1.3	2.5	1.2	1.3	1.4	1.8	1.4	6.6	5.0	3.0	1.3	2.6	1.7	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.3	0.3	0.4	0.1	0.0	0.0	0.2	0.2	0.1	2.6	3.3	2.1	4.3	2.1	3.2	4.7	2.8	5.0	2.4	3.5	6.2	2.3	0.0	3.4	69.5	3.8	0.9	1.2	1.9	0.6	9.9	2.7	3.0	3.8	0.0	4.3	0.0	4.2	0.3	4.0	2.2	0.0	0.3	12.7	4.0	1.5	2.8	0.0	35.6	41.4	0.4	0.2	2.2	2.6	3.6	1.3	4.7	3.3	4.8	0.8	10.1	32.8	1.7	0.0	2.5	1.5	13.9	0.9	4.0	0.0	19.7	2.2	3.4	3.1	36.2	67.4	0.4	1.6	1.2	1.7	1.8	2.2	0.6	7.3	9.5	0.0	2.1	1.7	19.5	2.0	1.5	3.8	0.7	2.4	1.8	2.1	1.8
DNLZ	"bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17"	ENSG00000213221	"DNL-type zinc finger"	Q5SXM8	9	136359480-136363744	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 9.1;Suprabasal keratinocytes: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.4;MCF7: 13.2;REH: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062738			Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA062738: AB_2684857"	"unprognostic (2.81e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	16.4	12.2	2.1	0.9	2.5	0.9	16.4	2.7	3.4	16.0	1.4	16.9	1.1	16.6	0.4	10.0	14.1	0.5	36.5	2.1	2.0	23.0	14.4	12.6	1.0	2.2	2.3	12.1	27.9	0.9	11.4	0.4	2.4	12.5	0.1	0.3	10.1	0.5	23.1	13.8	11.3	0.3	2.0	15.5	13.5	12.0	2.3	0.8	12.5	3.8	0.4	17.3	12.2	2.6	1.7	2.8	0.9	3.3	0.5	0.9	1.8	1.8	1.3	2.3	1.0	3.5	1.9	4.1	9.7	1.8	1.7	3.4	0.6	1.7	0.2	13.4	3.1	1.1	1.3	1.0	1.9	2.2	1.4	1.4	1.7	1.8	1.1	0.6	1.2	2.0	1.7	2.9	1.5	13.2	4.5	2.7	5.2	2.7	7.6	13.4	1.6	5.1	2.9	1.6	4.1	4.7	2.8	1.9	2.9	0.5	2.6	1.4	2.8	4.0	3.5	2.8	4.6	2.7	3.3	3.5	2.6	0.9	3.7	0.7	0.0	0.0	0.4	0.2	0.7	1.3	0.6	0.7	0.1	0.5	0.6	0.6	0.1	0.1	0.1	0.3	0.8	0.0	2.1	2.5	2.7	3.4	2.1	2.0	2.2	2.3	2.4	2.0	2.3	2.6	5.4	0.0	0.0	3.3	6.0	8.4	1.1	0.0	9.1	0.6	4.7	3.9	0.8	0.0	0.7	5.5	0.0	1.0	4.3	1.2	1.9	0.5	0.1	3.0	6.9	3.4	0.0	1.7	2.0	1.1	0.9	3.7	3.6	2.6	0.0	1.0	1.4	1.1	1.0	0.0	2.1	1.2	0.0	0.3	7.5	0.2	1.2	3.0	1.8	1.9	0.6	0.3	2.1	2.5	3.5	0.6	0.3	1.2	7.1	0.6	0.8	3.0	0.1	0.4	0.0	2.5	3.7	1.5	4.8	5.7	9.1	1.1	6.9	1.1	0.9	0.9
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133342-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 388.1;Spermatocytes: 229.6;Syncytiotrophoblasts: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	7.1	3.9	0.9	16.9	2.9	23.1	7.0	11.7	3.1	9.1	0.0	6.9	6.6	7.3	3.1	7.7	6.5	6.2	4.8	2.1	6.6	3.0	3.9	7.8	26.2	3.8	4.5	5.6	3.6	4.3	4.5	26.0	5.7	4.5	6.8	7.5	5.6	4.6	5.3	7.9	7.9	8.8	0.3	8.1	6.3	12.4	3.3	20.6	6.3	5.0	24.9	7.3	6.4	10.6	77.0	40.6	49.5	45.8	24.6	24.0	138.8	52.4	43.9	77.5	74.9	50.6	40.8	138.3	33.8	30.0	38.6	46.6	68.4	44.2	68.4	57.5	100.9	181.5	39.5	27.1	9.6	91.5	73.4	11.5	9.3	68.5	24.1	18.4	39.9	37.6	75.0	82.8	63.3	37.6	109.2	50.4	87.5	38.3	76.6	117.1	67.9	77.2	21.5	49.3	64.5	41.5	58.2	26.2	16.5	33.6	28.9	42.2	31.8	111.3	42.2	73.0	84.4	49.6	69.5	166.8	35.0	68.5	87.1	20.3	21.2	5.9	29.8	22.0	25.1	14.2	22.8	20.4	19.3	20.0	25.5	20.5	4.6	42.6	13.8	31.9	21.9	12.6	0.9	2.9	11.7	3.1	2.1	6.6	3.8	4.5	5.7	0.3	3.3	10.6	36.4	6.4	26.5	12.7	38.0	29.6	20.7	26.8	21.1	86.7	32.6	29.6	14.6	7.2	28.2	22.0	56.3	388.1	54.4	29.0	13.7	26.0	46.1	48.1	42.0	38.9	15.7	109.6	17.6	14.3	73.2	33.6	33.6	60.3	37.2	43.6	25.0	14.8	76.8	65.6	22.6	25.5	38.7	31.4	47.8	50.8	28.0	57.9	14.2	15.0	52.5	32.2	123.6	14.6	20.1	21.1	11.3	28.6	73.4	16.3	4.5	9.3	42.8	50.2	13.1	22.6	32.8	229.6	145.3	41.6	22.4	323.7	70.4	38.7	43.1	16.6
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 127.2;Horizontal cells: 95.9;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 59.6;REH: 59.5;SH-SY5Y: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	5.6	9.0	8.9	9.8	12.6	8.7	6.2	9.3	10.7	9.1	2.4	11.3	6.7	9.3	8.7	6.0	7.5	6.3	5.9	8.8	7.9	11.3	5.3	7.3	11.1	9.0	7.6	13.0	8.3	4.2	11.5	15.7	8.6	7.2	6.6	15.4	6.2	5.9	21.0	4.9	8.9	7.1	5.2	13.4	8.5	5.2	9.4	20.6	6.9	10.2	9.0	7.3	6.2	11.3	1.6	8.1	34.6	8.3	3.8	2.7	45.2	1.9	2.2	4.7	3.8	21.1	13.2	0.0	4.7	4.7	3.5	2.2	3.8	5.2	2.8	5.7	4.3	14.7	12.8	25.4	8.8	2.9	7.6	8.2	2.6	6.0	2.2	9.1	19.5	34.0	18.0	2.9	3.5	20.6	33.7	36.5	59.6	14.3	4.2	59.5	32.5	3.8	2.9	3.4	18.6	71.5	2.7	19.6	6.2	29.5	2.1	16.2	6.8	5.4	4.7	1.0	2.5	5.6	5.1	19.6	2.2	8.4	5.5	2.8	1.0	2.1	2.7	1.7	4.0	1.3	1.7	2.4	1.3	1.6	4.6	3.9	2.5	5.5	2.7	2.3	1.9	1.2	8.9	12.6	9.3	10.7	8.8	7.9	9.0	7.6	8.6	5.2	9.4	11.3	18.5	6.4	13.1	28.1	11.0	5.2	10.2	6.6	5.7	73.3	12.1	9.8	15.8	5.7	9.9	20.2	127.2	40.6	15.3	6.3	5.9	16.9	1.6	13.3	19.1	20.5	13.1	15.8	49.4	9.8	10.7	16.4	9.7	10.7	37.4	37.3	11.0	6.4	23.2	95.9	43.2	11.4	2.0	14.2	3.9	1.9	19.3	13.7	7.2	38.4	7.4	20.6	13.4	36.7	63.4	9.3	9.4	15.4	9.8	12.4	6.2	6.6	7.3	143.5	19.7	15.1	14.3	2.8	14.6	8.1	2.6	32.2	19.6	26.1	12.1	10.2
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 5.3;Extravillous trophoblasts: 5.2;Horizontal cells: 5.0;Inhibitory neurons: 6.8;Sertoli cells: 6.6"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 245.7;CACO-2: 95.8;HEL: 100.7;K-562: 98.6;NTERA-2: 333.9;SuSa: 174.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm		NA	Yes				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	0.8	0.6	1.2	0.8	1.5	3.6	1.3	2.4	1.6	1.3	1.0	0.7	0.8	1.0	3.1	0.8	0.7	0.8	1.0	1.2	1.6	1.7	1.2	0.7	0.9	1.4	1.3	0.8	6.0	1.1	0.6	2.0	1.3	0.8	0.7	3.0	1.2	0.6	0.5	3.8	0.8	0.9	1.0	1.0	0.9	5.8	1.4	3.7	1.7	0.2	0.9	1.3	1.1	1.4	3.9	5.3	27.0	6.2	0.5	2.1	245.7	3.5	2.4	3.6	3.8	95.8	4.3	10.0	9.7	1.7	4.3	2.2	17.6	1.7	3.0	1.2	14.0	100.7	3.3	18.5	0.9	4.6	9.7	2.3	1.9	5.5	1.1	1.8	6.6	6.2	98.6	2.7	1.4	15.7	15.6	86.1	333.9	8.8	3.2	15.4	4.5	2.3	9.1	4.2	8.6	5.7	5.9	8.5	2.5	174.4	5.8	5.5	1.6	5.5	12.3	2.8	2.6	5.9	2.8	3.8	2.6	27.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.5	2.4	1.6	1.2	1.6	1.4	1.3	1.3	1.0	1.4	1.4	1.6	0.0	1.5	3.9	0.1	0.9	0.2	0.3	0.6	2.1	1.5	1.3	1.3	0.0	0.8	0.0	2.1	5.3	0.3	0.2	0.0	1.3	0.1	0.8	0.9	1.6	0.0	4.6	1.1	0.6	5.2	1.2	0.5	2.2	0.0	1.3	0.7	0.6	0.8	5.0	6.8	0.3	0.0	0.3	0.3	1.0	0.0	0.7	0.0	1.9	0.1	0.8	0.0	1.5	1.3	1.0	0.1	0.4	1.3	0.3	0.1	1.3	0.1	2.5	6.6	0.3	0.9	0.1	2.6	0.9	1.3	4.8	0.3	0.8	0.6	0.1
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229481	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 450.0;Proximal enterocytes: 818.0;Proximal tubular cells: 1091.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 547.1;RPMI-8226: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		540000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	46.1	103.3	42.7	29.1	45.1	23.2	37.2	40.2	66.2	45.2	66.7	68.7	104.0	50.2	8.3	62.3	57.8	13.2	46.5	41.7	45.7	172.4	136.8	31.8	33.0	39.9	42.5	40.3	100.7	75.8	37.2	9.2	41.5	42.0	17.9	6.0	45.8	18.7	89.5	42.2	88.3	11.4	43.2	61.6	57.5	10.2	46.1	17.0	35.8	44.7	18.8	39.1	39.8	42.3	189.4	135.3	20.7	86.2	14.4	44.5	64.1	44.9	16.1	29.8	38.9	55.8	67.2	134.9	69.4	15.3	1.5	95.1	16.2	35.7	8.6	72.4	318.7	63.7	127.4	161.2	34.1	54.3	40.3	28.1	44.3	9.0	26.7	12.0	39.6	96.8	147.1	232.0	24.5	311.8	52.3	135.3	41.5	547.1	81.5	87.0	27.7	347.3	52.1	63.6	79.8	96.2	41.4	108.5	95.7	6.6	149.2	177.9	49.7	22.6	39.2	51.6	90.2	160.7	79.6	109.5	14.3	71.6	36.0	1.2	109.7	4.8	42.4	237.9	78.5	219.8	138.8	74.6	178.2	194.6	122.2	83.8	4.1	42.0	176.6	135.3	269.7	92.3	42.7	45.1	40.2	66.2	41.7	45.7	39.9	42.5	41.5	43.2	46.1	42.3	16.4	28.9	38.2	5.5	73.9	61.3	91.3	147.6	68.3	11.9	138.4	181.0	91.0	163.0	80.9	115.8	2.1	53.4	12.9	164.0	450.0	201.6	0.6	159.5	66.4	30.8	64.8	78.8	4.1	107.2	66.5	60.1	88.7	39.1	33.7	108.4	28.5	231.2	308.3	6.7	4.9	216.6	93.6	75.8	62.3	3.1	67.1	63.4	110.3	1.0	36.7	78.4	10.3	5.5	5.1	157.2	155.3	59.8	81.8	112.6	818.0	1091.6	260.3	23.5	0.0	39.4	57.9	8.9	38.1	131.5	73.6	32.3	44.5	82.2	288.9	101.4
DNTT	TDT	ENSG00000107447	"DNA nucleotidylexotransferase"	P04053	10	96304409-96338564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Terminal addition"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 329.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 11.3;Late spermatids: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MOLT-4: 416.0;REH: 1415.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036532, HPA044194"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA036532: , HPA044194: AB_10960525"								"unprognostic (4.24e-1)"					"unprognostic (1.00e-1)"		"unprognostic (2.60e-2)"	"unprognostic (1.86e-2)"		0.0	0.0	0.0	0.2	0.1	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	329.1	0.4	0.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	195.3	0.0	0.0	0.0	0.0	416.0	0.0	0.1	0.0	0.0	1415.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.3	0.4	0.0	0.0	0.0	0.4	0.7	0.0	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791954-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 124.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 43.3;granulocytes: 124.8;monocytes: 50.9"	"Cell line enhanced"	"Detected in all"		"PC-3: 280.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	19.9	19.4	22.8	24.7	23.2	44.1	20.0	23.3	26.1	21.0	23.9	33.2	17.5	27.2	25.0	19.5	24.7	21.7	27.3	23.1	24.2	19.2	19.3	22.3	23.7	23.2	24.3	20.6	15.8	26.1	20.8	23.1	23.4	22.0	38.7	21.7	19.4	22.8	62.0	28.2	21.0	24.4	23.4	25.3	24.6	30.4	23.8	30.1	19.6	31.0	28.0	34.0	19.3	24.4	79.8	41.6	42.1	40.2	31.7	34.1	43.7	29.2	47.1	92.7	83.4	134.8	126.1	32.8	93.2	42.9	147.1	58.4	37.3	62.8	61.1	18.0	47.2	36.0	45.2	87.2	64.4	70.0	56.7	34.4	58.0	60.8	58.2	42.4	55.1	46.9	33.9	32.6	56.0	107.5	57.9	108.2	28.7	44.8	280.7	46.0	52.3	34.4	47.4	37.9	39.5	35.6	59.7	48.2	65.2	32.7	47.6	111.4	32.6	55.4	41.1	54.0	71.0	35.5	24.8	41.0	120.5	44.8	48.1	16.7	50.9	71.0	4.1	22.0	4.2	12.0	5.5	7.0	43.3	11.1	10.1	4.7	124.8	3.3	13.6	16.6	9.3	13.5	22.8	23.2	23.3	26.1	23.1	24.2	23.2	24.3	23.4	23.4	23.8	24.4	21.2	16.0	22.9	10.1	22.0	25.5	44.8	43.1	22.2	19.8	20.3	23.0	19.9	21.5	37.1	25.8	4.2	60.7	14.3	37.2	50.9	57.6	37.9	35.1	19.4	22.6	22.2	9.7	11.2	75.4	43.0	25.7	26.5	20.6	6.3	26.4	25.0	16.6	70.8	20.2	9.5	92.7	59.0	26.3	34.7	15.7	28.3	32.4	16.0	11.2	68.3	53.1	15.5	7.5	10.6	105.0	50.5	27.1	21.9	38.2	33.3	44.2	48.0	29.7	0.0	20.8	26.5	92.9	35.4	19.4	27.6	57.7	16.3	32.9	34.8	60.7
DOC2A		ENSG00000149927	"Double C2 domain alpha"	Q14183	16	30005514-30023270	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.2;choroid plexus: 26.5;testis: 37.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 284.7;Late spermatids: 200.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;MCF7: 10.8;REH: 11.0;SCLC-21H: 35.9;U-937: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA065676			Uncertain	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Cell Junctions"	"Nucleoplasm, Nucleoli"	"HPA065676: AB_2685528"	"unprognostic (1.46e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-1)"	2.7	4.5	47.5	0.2	57.6	1.0	1.9	34.7	72.2	2.8	26.5	6.8	0.7	1.4	0.3	1.8	8.7	0.7	1.4	60.3	28.3	5.3	0.9	5.6	0.3	34.0	38.5	15.4	1.6	0.8	9.4	0.1	35.4	8.2	1.3	1.1	1.4	0.5	0.2	0.6	2.6	0.7	27.5	6.0	0.8	37.8	38.2	0.1	1.0	0.0	0.1	1.1	2.2	42.5	0.9	1.8	1.2	0.7	0.4	0.0	13.1	0.4	0.9	0.5	0.4	5.6	3.3	0.0	1.1	0.1	1.6	0.3	7.1	2.7	0.3	0.0	0.7	1.1	0.3	0.2	0.5	1.0	3.5	1.6	0.8	0.2	0.8	6.5	0.0	3.9	0.3	0.0	0.0	10.8	2.2	4.0	1.7	4.0	5.1	11.0	0.0	0.5	0.4	0.8	35.9	2.3	0.3	3.0	0.3	2.6	3.4	2.0	0.0	0.0	1.5	0.1	0.2	0.2	0.0	0.0	0.2	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.5	57.6	34.7	72.2	60.3	28.3	34.0	38.5	35.4	27.5	38.2	42.5	1.5	0.0	4.6	8.8	0.4	0.6	3.5	2.5	6.8	3.7	4.0	3.4	0.7	1.5	7.8	1.8	22.9	0.3	0.2	3.0	1.9	0.1	284.7	12.2	0.2	1.7	1.2	0.0	28.2	0.0	1.0	2.1	1.5	0.3	0.0	3.5	2.5	0.0	0.5	0.0	10.7	3.6	10.2	1.9	1.0	200.4	0.6	2.2	1.8	4.7	0.1	2.3	0.0	3.5	2.6	0.0	1.0	1.9	0.1	2.3	0.3	0.3	57.5	2.0	0.0	0.5	0.9	3.2	6.1	0.6	0.9	0.1	0.3	2.5	4.3	1.1
DOCK1	"ced5, DOCK180"	ENSG00000150760	"Dedicator of cytokinesis 1"	Q14185	10	126905409-127452517	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 186.4;Oligodendrocyte precursor cells: 331.3;Oligodendrocytes: 429.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004378, HPA048692, HPA053277"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB004378: AB_2094604, HPA048692: AB_2680495, HPA053277: AB_2682097"	"unprognostic (4.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.49e-3)"	"unprognostic (8.98e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.83e-2)"	19.9	8.2	38.1	7.3	54.3	0.7	19.9	39.1	34.6	23.3	22.5	17.7	13.4	19.6	15.5	16.1	18.1	17.2	14.2	29.9	37.2	19.3	9.6	13.7	4.6	44.7	51.8	24.7	14.1	25.6	5.6	19.6	44.5	16.5	13.8	2.3	17.7	18.4	5.2	33.4	15.1	19.2	35.6	9.9	13.3	6.9	45.3	8.5	26.6	10.6	5.7	16.5	18.9	50.1	16.1	29.8	57.2	41.2	29.2	38.7	12.6	31.5	66.2	21.9	23.1	18.8	18.0	0.0	10.3	47.4	19.8	18.0	18.4	23.8	25.4	0.3	17.9	10.0	18.8	22.7	28.9	0.0	14.2	31.8	7.0	22.7	49.3	53.0	51.3	0.0	0.0	0.1	33.1	16.4	0.0	0.0	14.1	12.4	13.5	0.0	37.3	0.4	22.1	17.5	3.4	24.5	32.9	18.6	28.9	40.6	4.7	0.1	54.2	39.7	15.3	9.8	30.7	0.0	0.1	0.0	31.3	0.0	25.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	38.1	54.3	39.1	34.6	29.9	37.2	44.7	51.8	44.5	35.6	45.3	50.1	55.9	32.1	20.3	186.4	0.4	17.2	15.5	9.5	43.9	0.5	18.5	17.3	11.8	12.8	17.9	22.0	0.0	14.1	3.2	28.0	0.0	14.7	11.3	20.2	36.8	35.2	5.4	1.7	2.4	7.1	11.5	27.7	16.8	17.1	0.0	33.3	26.4	7.8	5.7	0.0	4.8	15.3	6.1	4.6	5.9	24.5	32.6	5.1	7.2	105.9	2.8	6.6	0.0	331.3	429.1	13.6	9.4	36.5	0.1	13.7	17.5	11.5	20.6	1.2	13.1	30.5	24.1	2.0	6.7	21.5	16.2	12.6	1.1	35.4	12.3	10.3
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042468	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;lymphoid tissue: 32.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1806.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 45.5;GAMG: 73.4;HDLM-2: 52.7;TIME: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA058106: AB_2683606"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.5	8.2	22.6	18.8	49.2	10.2	3.8	33.7	33.4	8.7	9.7	6.3	4.1	3.2	1.1	3.2	2.4	6.3	1.6	28.7	35.1	3.2	5.5	7.6	27.8	45.5	38.4	17.7	1.7	2.0	1.0	2.3	48.9	1.6	6.5	5.7	2.5	1.7	1.2	5.0	12.5	4.3	32.0	29.8	6.7	2.2	37.9	32.1	2.7	0.8	19.9	6.4	4.4	83.1	0.0	21.4	6.7	0.0	8.5	17.9	0.0	45.5	36.8	21.3	15.8	0.0	0.0	0.6	0.1	28.9	73.4	0.5	0.0	0.1	16.9	52.7	0.0	0.6	4.5	0.0	0.3	4.4	2.1	4.3	0.4	31.0	12.0	8.3	21.4	7.0	0.1	42.1	36.4	2.1	8.0	6.1	2.6	0.0	5.0	10.5	9.8	6.2	1.1	0.1	0.4	5.5	0.0	0.0	4.8	1.2	1.4	20.0	48.2	22.8	5.7	10.9	15.6	0.0	0.0	0.0	32.2	29.6	10.1	3.0	3.3	0.2	6.5	9.2	6.6	7.2	10.9	9.1	6.9	4.5	10.5	9.3	0.1	14.3	11.8	2.8	8.4	4.5	22.6	49.2	33.7	33.4	28.7	35.1	45.5	38.4	48.9	32.0	37.9	83.1	3.7	3.2	9.1	4.2	47.1	4.7	0.6	0.3	8.0	7.9	0.8	4.3	1.2	0.0	2.5	5.5	0.0	0.3	39.5	0.8	1.9	0.1	3.2	0.2	2.3	3.2	2.4	5.5	8.0	0.0	0.2	4.9	5.1	0.5	36.7	64.0	2.5	1.4	30.6	97.6	244.2	3.8	0.0	54.2	39.7	2.8	0.6	51.0	8.8	201.4	38.3	1.2	38.1	400.6	1806.0	0.2	0.3	0.0	43.5	0.5	0.2	0.3	2.6	1.8	13.1	2.5	18.9	0.3	1.1	2.1	4.1	0.8	75.1	31.4	2.5	0.7
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 45.0;lymphoid tissue: 64.8"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 506.8;monocytes: 134.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 53.0;granulocytes: 173.6;monocytes: 84.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 52.9;HL-60: 53.3;MOLT-4: 50.1;NB-4: 83.7;REH: 61.9;RT4: 54.3;THP-1: 158.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003218, HPA073349"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695, HPA073349: "	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favorable (6.89e-6)"	11.0	13.3	4.3	35.7	4.4	42.2	7.3	5.2	3.9	4.3	45.0	7.3	7.3	3.0	2.9	7.2	4.3	14.6	2.0	4.0	5.9	16.5	6.1	19.7	51.1	8.8	7.6	2.0	4.2	7.7	2.6	15.3	9.1	5.1	7.3	4.5	4.6	2.8	1.0	3.0	15.4	6.2	9.3	45.6	9.5	7.5	8.8	64.8	4.9	2.5	49.6	14.8	3.3	12.8	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	1.6	1.4	52.9	3.9	0.0	0.0	2.3	0.8	0.3	0.0	18.2	2.3	0.1	0.0	0.2	0.0	53.3	7.1	0.2	9.3	0.0	0.2	0.0	0.0	0.0	11.8	25.9	0.0	3.2	50.1	83.7	0.2	0.2	0.7	61.9	0.1	21.3	0.2	54.3	0.1	0.0	0.0	0.6	3.6	1.0	1.4	158.0	10.2	0.0	0.4	0.7	0.1	10.3	0.1	0.0	0.1	33.3	0.9	65.1	56.9	73.5	12.2	52.0	10.2	25.2	15.7	13.8	53.0	23.2	11.3	11.1	173.6	24.1	84.2	13.8	15.6	22.6	4.3	4.4	5.2	3.9	4.0	5.9	8.8	7.6	9.1	9.3	8.8	12.8	5.0	9.6	33.5	2.3	112.6	6.4	2.5	1.2	45.5	3.6	12.3	10.8	2.3	18.6	4.9	7.3	77.2	70.9	101.9	1.5	1.9	1.0	33.4	1.9	0.7	9.8	8.4	35.1	1.9	6.5	4.3	5.3	12.8	3.2	24.6	12.7	2.9	2.6	58.4	0.0	4.2	12.9	2.0	115.0	49.4	14.8	3.1	107.7	8.8	506.8	134.3	1.1	74.2	4.5	2.2	1.4	24.9	0.4	94.6	1.5	1.2	12.8	8.0	4.2	13.1	30.2	20.6	22.1	13.3	9.4	3.8	42.7	111.6	1.1	1.3	3.4
DOHH	"HLRC1, MGC4293"	ENSG00000129932	"Deoxyhypusine hydroxylase"	Q9BU89	19	3490821-3500674	"Enzymes, Predicted intracellular proteins"	"Hypusine biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041953, HPA076271"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041953: AB_10795386, HPA076271: "	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.63e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.76e-3)"	7.5	8.8	15.6	4.4	18.9	8.9	6.8	18.9	18.3	6.2	9.9	8.2	17.8	7.6	0.5	11.0	6.7	1.2	12.6	14.7	15.2	11.1	10.9	6.4	3.2	20.6	19.2	6.5	8.5	2.5	8.4	2.2	18.8	7.5	1.0	1.3	6.9	2.1	18.9	10.5	11.5	1.3	16.5	7.9	8.7	8.1	17.6	2.1	5.9	2.2	1.6	8.3	6.9	24.0	18.6	22.4	3.1	7.1	1.6	2.0	15.0	17.4	3.6	8.0	6.5	31.9	7.6	15.3	13.2	2.4	7.5	19.3	4.6	6.1	1.5	21.5	24.5	15.1	13.3	37.7	6.7	20.7	19.9	2.3	5.7	8.2	3.3	2.8	4.3	15.6	34.1	16.4	3.7	22.3	20.3	23.3	19.1	7.1	29.2	25.4	7.6	21.3	5.3	11.1	20.0	15.5	12.7	10.8	18.4	1.3	15.0	11.0	9.9	10.9	14.4	29.0	31.7	21.9	17.4	20.1	12.4	46.6	12.7	1.2	6.7	2.4	7.6	8.1	9.4	11.1	10.1	14.9	11.0	16.5	14.1	12.3	0.4	10.0	8.9	14.1	13.2	5.9	15.6	18.9	18.9	18.3	14.7	15.2	20.6	19.2	18.8	16.5	17.6	24.0	9.5	6.4	2.2	2.0	15.5	23.6	22.6	13.2	12.5	17.2	12.4	10.0	7.7	11.5	7.1	5.5	10.4	30.9	7.6	27.9	21.5	22.2	8.6	10.9	7.9	13.2	13.1	23.2	4.9	21.3	29.9	13.6	16.3	7.8	13.4	10.5	11.7	10.0	21.6	25.2	5.1	17.6	24.4	7.9	9.3	23.8	14.0	9.3	19.6	1.9	16.9	12.7	15.5	4.5	30.0	24.7	17.2	15.1	16.0	28.4	10.8	28.9	4.6	12.4	0.0	16.2	13.6	12.6	12.7	14.5	27.6	34.8	12.1	13.6	27.2	18.7
DOK2	"Dok-2, p56dok-2"	ENSG00000147443	"Docking protein 2"	O60496	8	21908873-21913690	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 25.6;lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.6;Hofbauer cells: 131.8;Kupffer cells: 171.8;Langerhans cells: 288.4;Macrophages: 181.5;NK-cells: 344.0;T-cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1565.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.3;HEL: 54.3;HMC-1: 119.8;JURKAT: 22.3;THP-1: 43.1;U-937: 42.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004379, HPA005507, HPA066571"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		220000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Nuclear bodies, Golgi apparatus"	"CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749"	"unprognostic (5.39e-2)"	"unprognostic (8.84e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.22e-2)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.22e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.80e-1)"	9.5	5.0	1.1	26.5	1.2	19.5	5.0	1.2	2.3	1.9	2.5	5.5	7.0	2.2	0.5	2.3	3.5	6.5	3.5	1.3	1.3	3.0	6.1	25.6	26.3	1.4	1.5	1.4	1.9	0.5	1.1	7.9	1.5	2.3	3.6	0.0	3.4	1.5	2.0	2.3	9.5	6.9	1.2	40.9	6.8	1.6	4.5	16.4	2.4	1.6	7.8	8.4	2.3	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	54.3	0.0	0.1	0.0	0.4	119.8	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.8	5.0	0.0	0.0	0.9	8.7	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.3	0.0	0.1	0.2	0.1	0.2	0.1	0.3	1.4	42.0	0.2	577.6	484.3	1565.6	398.3	624.0	184.5	14.5	274.3	304.8	421.9	6.6	151.0	185.9	37.2	307.6	580.7	7.6	597.2	810.3	1.1	1.2	1.2	2.3	1.3	1.3	1.4	1.5	1.5	1.2	4.5	1.5	2.0	3.2	18.1	0.0	13.2	11.5	0.6	0.0	0.0	0.0	1.2	1.8	2.1	0.0	1.3	3.7	0.0	0.7	130.6	0.3	0.0	0.1	0.2	0.2	0.5	2.8	0.0	10.5	0.1	0.0	1.0	2.6	3.1	0.4	36.3	0.1	5.7	1.1	131.8	0.0	0.0	0.2	0.0	171.8	288.4	0.6	0.3	181.5	19.6	0.0	74.8	0.0	344.0	0.0	0.0	0.0	0.0	0.0	15.4	0.2	0.0	0.7	1.5	0.0	0.0	0.6	2.5	0.2	4.3	0.7	8.5	1.0	147.4	0.0	0.2	0.8
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501904-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.6;lymphoid tissue: 118.4"	"Group enriched"	"Detected in many"	5	"B-cells: 31.6;granulocytes: 18.3;Hofbauer cells: 55.7;Kupffer cells: 51.1;Macrophages: 38.3;monocytes: 45.4;Plasma cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 133.6"	"Group enriched"	"Detected in many"	6	"B-cells: 37.2;granulocytes: 133.6;monocytes: 77.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.0;HMC-1: 87.5;REH: 148.6;U-698: 122.1;U-937: 88.0"	"Low region specificity"	"Detected in many"							HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.0	6.1	5.2	30.2	6.2	93.6	4.4	6.5	7.9	3.2	6.3	8.2	6.5	3.4	1.7	5.5	7.8	4.3	4.1	6.0	7.0	5.0	6.5	27.1	31.5	11.3	6.8	2.1	4.5	0.8	3.4	7.0	10.5	5.5	3.5	2.1	6.6	2.0	3.6	2.6	28.9	4.5	6.7	118.4	5.9	8.9	9.9	4.3	4.4	4.1	32.3	7.1	4.0	8.1	5.2	7.8	5.4	6.3	3.2	0.4	13.0	4.4	1.1	14.0	12.9	11.0	2.2	124.0	3.2	4.0	6.8	8.9	12.2	7.6	6.9	26.1	14.6	21.3	21.4	2.5	1.0	46.1	87.5	1.6	4.5	16.2	1.6	1.5	1.9	11.4	14.8	50.2	5.1	12.9	2.7	52.5	12.2	1.5	12.9	148.6	9.3	1.2	4.4	5.2	7.4	4.9	2.0	2.1	6.2	4.8	11.7	63.4	2.7	12.3	11.3	6.5	5.4	11.1	15.0	122.1	2.7	88.0	2.2	16.8	62.4	57.0	0.3	61.3	0.6	37.2	0.1	0.3	14.5	19.6	0.1	0.1	133.6	0.5	77.6	1.2	0.0	28.7	5.2	6.2	6.5	7.9	6.0	7.0	11.3	6.8	10.5	6.7	9.9	8.1	1.4	0.0	5.6	1.6	31.6	0.3	0.1	0.4	1.8	0.8	1.0	0.9	0.4	0.0	0.2	0.0	0.0	0.5	0.3	0.2	0.0	0.2	0.0	0.4	0.4	1.9	0.0	6.3	4.1	0.2	0.7	1.2	0.5	0.8	18.3	0.2	7.1	0.8	55.7	0.0	3.5	0.3	0.0	51.1	2.3	0.4	0.6	38.3	1.8	3.7	45.4	0.3	2.1	0.5	0.5	0.0	0.7	1.2	38.3	0.2	0.2	0.1	0.1	0.6	0.0	1.8	0.4	3.0	1.9	0.7	0.3	1.0	2.2	0.3	0.8	0.1
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463306-3501473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.9;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.1;Enteroendocrine cells: 6.0;Late spermatids: 9.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9"	"Group enriched"	"Detected in many"	16	"B-cells: 3.4;NK-cells: 1.9"	"Cell line enriched"	"Detected in some"	4	"MCF7: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	0.1	0.9	1.0	0.2	4.7	0.2	0.4	7.8	2.9	2.1	11.1	0.3	0.1	1.0	1.7	0.3	5.9	0.3	41.9	1.1	0.9	2.7	1.1	1.6	0.7	4.2	1.5	0.3	5.8	0.1	15.7	0.0	4.7	1.8	0.1	0.0	1.9	1.0	29.5	1.6	1.4	0.0	0.2	1.9	2.7	4.8	3.0	0.0	0.7	8.8	0.4	1.2	0.6	0.0	2.7	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.6	0.0	1.2	0.0	0.1	1.3	0.0	4.4	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	36.2	0.0	1.4	0.3	1.6	0.1	0.0	6.7	0.3	2.3	3.0	0.6	0.1	3.0	0.0	0.0	0.0	8.3	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	1.0	4.7	7.8	2.9	1.1	0.9	4.2	1.5	4.7	0.2	3.0	0.0	0.1	0.0	1.5	1.3	5.3	0.0	3.9	3.7	0.0	0.3	0.7	0.9	17.1	0.0	3.0	5.5	0.0	0.0	0.4	0.5	0.0	2.3	5.8	2.6	0.7	0.1	6.0	2.7	0.4	4.4	0.0	1.4	4.1	2.8	0.0	3.0	0.0	0.1	0.1	0.0	0.9	3.0	2.0	0.0	0.0	9.9	0.9	0.1	0.0	0.0	0.1	0.0	3.1	1.0	0.0	1.8	0.0	0.0	0.0	2.0	0.1	0.3	1.8	0.5	0.0	1.0	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.4	1.2
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	9.6	14.3	6.6	6.3	6.3	1.5	7.8	6.7	6.7	7.4	8.6	7.5	7.6	9.3	13.5	8.6	8.9	7.9	10.5	6.5	7.1	9.1	10.5	9.1	6.8	6.9	7.6	6.7	14.5	16.8	5.9	9.3	7.3	10.0	6.6	4.4	12.0	10.0	6.7	9.9	7.5	9.4	6.5	8.0	10.6	14.5	7.6	5.1	7.8	7.1	6.6	8.6	5.9	6.8	11.7	42.5	14.8	22.0	42.6	22.2	20.0	23.7	38.1	28.5	21.0	33.7	17.9	6.4	12.3	34.6	40.3	80.3	20.3	29.6	14.7	10.7	17.8	8.0	27.4	24.5	43.0	8.8	13.5	31.1	27.0	30.8	16.8	16.7	28.1	9.1	19.7	10.0	31.3	56.9	7.3	7.3	19.0	33.0	26.0	7.2	19.5	25.1	25.7	17.3	13.5	15.1	31.4	25.6	14.1	13.7	44.8	11.4	23.6	25.6	9.2	32.5	19.8	9.4	25.0	6.4	24.2	8.0	19.9	2.7	15.4	6.9	11.2	15.3	10.1	11.8	9.9	12.3	16.6	12.5	12.8	13.2	2.2	13.0	21.2	9.3	16.8	10.5	6.6	6.3	6.7	6.7	6.5	7.1	6.9	7.6	7.3	6.5	7.6	6.8	8.5	6.4	4.1	2.9	2.6	1.8	3.6	13.9	4.6	9.1	4.4	4.3	3.5	10.0	10.9	7.3	8.4	25.6	3.5	5.2	0.0	15.7	15.1	5.9	7.2	9.2	1.2	3.6	1.2	14.2	16.4	8.1	5.1	3.6	1.3	7.5	16.1	9.2	13.5	5.0	2.2	3.5	12.2	5.2	2.7	3.7	12.2	2.9	3.6	1.9	2.8	10.7	5.2	2.5	1.7	11.1	7.5	6.0	1.5	4.4	7.5	9.0	11.4	7.1	0.0	7.0	15.7	33.8	15.1	3.3	1.3	18.2	2.3	15.8	5.7	2.1
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"DNA replication fork stabilization factor DONSON"	Q9NYP3	21	33559542-33588706	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.3;Erythroid cells: 42.1;Spermatocytes: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: AB_2676570, HPA049033: AB_2680608"	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	5.5	2.9	5.8	5.5	6.5	10.9	4.1	7.9	7.5	8.5	4.2	5.2	5.4	5.7	2.4	5.0	7.0	5.5	4.4	5.4	6.5	3.9	7.9	4.6	10.5	6.7	6.2	10.8	3.4	5.6	5.5	6.6	6.7	4.8	6.3	13.3	3.5	3.4	4.4	8.5	6.1	4.5	5.7	3.6	4.9	21.2	6.5	10.6	3.5	4.8	9.2	4.7	6.2	8.6	67.9	15.5	34.8	30.4	10.7	18.5	23.9	53.7	23.2	41.2	45.1	41.9	19.7	40.5	13.9	28.3	30.6	20.0	43.6	20.2	45.1	36.5	36.5	73.8	34.9	41.5	8.1	39.0	18.2	13.9	5.7	44.4	11.1	13.1	25.1	19.8	67.0	65.2	35.4	14.7	34.0	17.2	35.9	34.8	17.3	33.2	68.4	41.3	21.3	19.0	36.0	14.8	82.1	25.3	23.1	17.1	34.9	19.4	16.4	38.0	25.3	28.6	37.7	56.8	58.1	59.3	22.1	52.1	43.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	6.5	7.9	7.5	5.4	6.5	6.7	6.2	6.7	5.7	6.5	8.6	6.3	3.2	1.9	10.4	4.8	8.2	8.1	3.1	5.2	2.8	5.6	5.7	3.9	7.2	2.3	3.7	10.4	13.2	7.8	3.0	1.9	3.3	57.3	3.0	6.6	8.0	1.2	42.1	9.7	4.7	27.9	6.9	7.1	4.4	8.2	7.5	7.5	6.2	8.9	6.7	11.2	4.2	6.1	3.4	6.3	25.3	10.2	5.5	7.2	4.7	4.0	2.1	4.1	7.5	12.7	3.9	2.5	13.9	19.3	5.7	2.9	4.4	2.8	3.6	0.0	4.4	7.6	62.3	33.5	7.6	9.8	16.6	7.6	3.0	6.8	9.2
DOP1A	"dJ202D23.2, DOPEY1, KIAA1117"	ENSG00000083097	"DOP1 leucine zipper like protein A"	Q5JWR5	6	83067666-83171350	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.7;Cardiomyocytes: 9.8;Cytotrophoblasts: 4.8;dendritic cells: 5.9;Hofbauer cells: 4.1;Plasma cells: 3.8;Syncytiotrophoblasts: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027902, HPA027904"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA027902: AB_10600003, HPA027904: AB_10600877"	"unprognostic (7.18e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.05e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	5.2	4.9	5.0	6.2	5.7	4.9	10.9	8.7	6.4	8.9	3.5	8.0	7.9	10.4	7.4	7.1	9.4	7.2	9.0	5.1	4.2	6.9	6.2	6.8	7.2	3.8	3.7	13.8	9.1	11.6	7.7	6.0	3.7	9.6	8.8	24.0	9.5	10.7	6.3	13.6	8.9	7.5	5.0	8.2	7.2	12.7	4.1	10.6	13.6	9.4	7.5	6.2	5.0	11.0	4.2	3.0	9.8	8.9	8.7	9.1	4.6	7.0	5.9	4.7	6.8	6.4	1.0	8.2	4.9	7.7	5.9	5.5	10.0	7.6	5.9	7.2	11.3	6.8	4.2	2.4	4.7	10.1	6.9	7.3	10.4	6.6	17.0	6.2	7.0	12.6	14.4	5.9	5.1	3.9	3.0	4.5	2.0	3.1	6.1	8.2	7.4	3.0	6.1	11.7	17.6	3.2	5.2	3.3	1.3	7.0	5.3	5.7	11.8	5.9	2.1	6.0	5.5	7.3	5.7	4.6	3.2	4.6	4.7	0.0	0.3	0.4	0.5	0.4	0.4	0.6	0.4	1.1	0.7	0.4	0.8	0.4	0.0	0.4	0.3	0.3	0.4	0.4	5.0	5.7	8.7	6.4	5.1	4.2	3.8	3.7	3.7	5.0	4.1	11.0	5.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	4.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.4	0.8	0.0	0.0	0.0
DOP1B	"C21orf5, DOPEY2, KIAA0933"	ENSG00000142197	"DOP1 leucine zipper like protein B"	Q9Y3R5	21	36156782-36294274	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.2;dendritic cells: 3.8;Extravillous trophoblasts: 11.4;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 19.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072065	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Mitochondria	"HPA072065: AB_2686486"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	3.5	1.7	2.9	5.6	4.8	24.2	5.8	19.8	8.0	4.6	0.0	15.4	12.6	2.3	3.0	11.8	4.2	4.1	4.5	3.6	1.0	3.2	9.1	4.9	4.7	3.6	1.1	1.6	4.6	30.4	2.3	3.1	4.5	12.1	15.1	1.6	19.3	3.4	15.9	7.1	11.7	3.8	0.1	5.5	20.5	3.5	2.1	6.5	4.0	13.5	6.3	4.0	5.9	3.4	25.9	5.4	4.0	6.8	4.4	8.4	38.2	12.0	14.2	16.7	10.4	3.8	2.0	4.8	1.8	9.0	12.7	5.2	7.8	2.8	13.5	8.8	7.0	11.0	1.2	1.4	3.9	10.8	5.5	2.9	5.5	10.9	2.9	10.0	7.1	11.2	3.5	7.6	5.0	29.0	8.7	11.1	3.3	30.4	5.6	15.4	2.3	23.7	8.8	10.2	10.7	6.1	8.0	35.9	10.1	5.5	13.1	13.2	12.2	6.4	1.7	8.4	9.8	5.7	15.0	2.2	9.2	23.0	3.7	1.0	3.0	6.1	2.6	2.7	1.4	7.3	1.7	1.5	1.9	10.5	1.1	0.9	4.8	1.0	2.4	5.9	1.4	1.4	2.9	4.8	19.8	8.0	3.6	1.0	3.6	1.1	4.5	0.1	2.1	3.4	2.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	11.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	0.0
DOT1L	"DOT1, KIAA1814, KMT4"	ENSG00000104885	"DOT1 like histone lysine methyltransferase"	Q8TEK3	19	2163933-2232578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 99.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011875, HPA071217, HPA074977"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: "	"unprognostic (1.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.25e-3)"	"unprognostic (8.18e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	11.4	12.9	3.7	10.5	7.6	22.1	8.9	9.9	9.1	8.8	4.9	12.1	12.5	10.0	1.1	14.7	8.6	5.2	9.7	5.1	3.7	19.7	15.1	18.3	8.0	7.5	4.9	10.5	15.4	2.0	13.9	5.4	6.2	9.7	3.9	8.5	9.9	1.9	12.2	14.5	17.6	3.4	1.7	17.3	12.7	99.7	7.9	7.0	15.6	2.8	5.0	7.2	9.8	11.2	27.7	14.4	48.4	26.5	3.5	5.2	63.5	15.2	3.4	8.3	6.6	18.4	10.1	31.6	7.3	10.0	7.0	24.0	16.1	8.6	3.9	16.4	20.0	29.6	26.7	18.3	5.5	42.8	52.6	5.0	6.3	15.9	8.1	6.8	6.7	17.8	36.2	32.7	6.6	15.6	34.1	46.4	37.4	17.4	25.2	34.8	13.6	21.8	4.6	12.9	31.9	24.7	10.7	31.8	20.2	12.7	14.3	32.4	9.6	22.9	20.7	34.2	30.1	29.9	42.8	22.0	22.6	28.6	13.7	0.1	0.1	0.8	0.2	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.2	3.7	7.6	9.9	9.1	5.1	3.7	7.5	4.9	6.2	1.7	7.9	11.2	9.3	32.1	16.3	12.4	9.5	17.7	14.7	4.7	10.2	27.2	12.7	8.4	7.1	11.5	7.2	9.2	66.7	6.1	15.9	29.1	3.9	11.5	37.6	14.2	10.7	10.2	20.8	8.6	7.8	12.2	13.8	11.0	27.5	28.2	6.3	15.9	5.3	14.4	9.9	13.5	6.8	12.0	4.1	12.3	30.4	18.2	3.1	19.0	12.4	10.3	8.5	5.5	8.2	10.6	15.0	13.9	28.6	3.4	8.6	12.9	35.6	3.1	7.6	28.1	0.0	14.2	10.3	32.4	23.0	12.2	19.9	16.3	6.3	15.3	15.9	15.3
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 377.4;kidney: 255.9;pancreas: 440.7"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 1217.5;Proximal enterocytes: 4683.5;Proximal tubular cells: 829.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;Hep G2: 33.1;HHSteC: 13.9;U-937: 46.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		370000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.6	2.3	0.0	1.8	0.0	0.4	0.5	0.0	0.2	4.1	0.0	1.7	85.5	0.6	0.9	0.3	0.6	3.9	0.3	0.0	0.3	255.9	0.5	0.9	2.8	0.2	1.1	0.8	440.7	0.0	0.5	0.8	0.6	0.5	0.5	0.3	1.2	1.0	0.0	2.2	377.4	0.3	0.3	4.5	1.6	46.5	0.9	0.9	0.8	0.0	0.9	2.2	0.9	0.0	0.0	0.9	0.2	0.0	1.7	0.2	4.4	0.0	0.0	0.0	0.0	8.5	0.2	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.6	0.0	0.0	33.1	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	1.1	1.1	3.4	0.0	0.0	0.0	3.0	0.0	0.1	0.9	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	1.4	0.0	0.0	0.2	0.1	0.0	46.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.1	0.6	0.3	0.9	0.0	0.1	3.2	1.8	0.0	9.2	0.5	0.0	0.0	0.0	5.8	1.7	0.0	0.3	0.0	0.6	23.9	0.0	0.2	0.0	2.0	56.7	0.5	13.2	0.2	0.2	7.0	8.9	0.0	0.3	192.1	0.8	8.9	1.1	0.1	1.3	0.7	1.1	0.0	0.5	0.0	0.3	142.3	0.0	0.3	0.3	45.2	289.8	4.8	5.4	0.0	1.0	0.1	0.0	0.0	0.1	27.4	187.4	1217.5	61.2	0.0	4683.5	829.6	0.0	0.2	6.6	0.0	0.7	17.3	2.8	0.0	0.3	0.4	2.5	0.2	151.7	0.0
DPF1	"BAF45b, NEUD4, neuro-d4"	ENSG00000011332	"Double PHD fingers 1"	Q92782	19	38211006-38229714	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 23.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.9;Early spermatids: 25.4;Excitatory neurons: 24.6;Horizontal cells: 45.4;Inhibitory neurons: 16.3;Late spermatids: 23.4"	"Group enriched"	"Detected in some"	5	"glioma: 5.6;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 19.7;SCLC-21H: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049148	Enhanced	Approved	Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA049148: AB_2680653"	"unprognostic (7.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-16)"	"unprognostic (2.56e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.96e-2)"	"unprognostic (8.20e-4)"	0.1	0.3	12.7	0.4	14.9	0.1	0.1	2.2	23.4	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.4	16.9	9.9	0.1	0.0	0.3	0.1	1.9	4.4	0.3	0.1	0.0	2.5	0.1	2.4	0.1	0.0	2.4	0.2	0.0	0.2	0.3	0.1	0.2	2.0	0.1	0.1	2.4	9.5	0.2	0.0	0.0	0.1	0.1	0.1	14.8	4.6	3.8	15.8	11.7	1.1	0.8	1.6	4.8	2.7	8.0	6.7	2.7	0.4	7.5	3.2	3.7	3.2	2.8	19.7	2.6	3.6	7.2	3.9	2.5	2.0	1.1	0.4	1.9	2.1	0.9	0.1	4.7	1.5	1.0	1.5	5.5	5.6	0.4	7.7	6.4	4.1	0.5	2.9	1.3	4.4	7.5	8.0	1.6	0.8	1.4	22.9	7.8	5.4	0.5	1.0	1.9	2.4	0.4	1.8	11.5	3.7	2.8	4.4	2.9	10.3	9.9	6.1	2.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	14.9	2.2	23.4	16.9	9.9	1.9	4.4	2.4	2.0	9.5	14.8	0.4	0.0	0.0	3.3	0.1	2.3	0.1	1.1	0.0	17.9	0.2	0.6	1.2	0.0	0.1	0.0	8.4	0.1	0.0	0.1	0.0	0.0	25.4	1.5	2.2	0.9	0.0	0.0	24.6	0.0	2.0	1.5	0.0	0.7	0.0	4.3	0.4	0.0	0.2	45.4	16.3	0.0	0.0	0.3	0.4	23.4	0.6	0.1	0.0	1.0	0.0	3.3	0.0	12.5	4.8	0.1	0.0	2.6	0.0	0.1	0.0	0.1	1.4	3.1	0.0	0.7	1.9	6.7	12.6	0.0	1.1	0.1	0.2	1.6	0.0	0.1
DPF2	"BAF45d, REQ, ubi-d4"	ENSG00000133884	"Double PHD fingers 2"	Q92785	11	65333852-65354262	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020880, HPA056786"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020880: AB_1847845, HPA056786: AB_2683235"	"unprognostic (2.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.40e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	21.2	21.0	41.3	14.2	45.1	24.7	21.6	43.6	43.3	35.0	35.2	36.1	13.1	37.6	22.8	23.1	31.3	14.7	34.2	39.5	42.2	20.8	16.8	19.5	22.3	43.1	43.7	40.9	20.5	19.7	20.1	17.6	42.8	28.6	13.8	17.6	21.1	25.8	38.6	19.3	24.3	27.8	43.7	29.7	24.2	37.7	43.0	37.6	22.5	29.2	24.5	34.2	24.1	48.7	29.9	36.4	45.9	40.5	39.7	39.8	25.5	25.0	35.1	53.5	38.6	36.0	34.8	39.5	40.8	34.0	46.6	31.2	52.2	31.9	37.7	47.6	23.1	50.4	24.6	37.7	61.1	47.0	36.5	35.0	30.4	48.4	86.6	40.1	43.3	47.0	48.7	51.0	35.2	47.3	60.0	49.3	51.6	31.9	37.4	65.1	29.9	46.8	34.0	24.1	29.9	27.3	32.1	45.7	47.0	29.7	59.0	26.2	25.8	35.2	31.3	38.9	25.9	62.7	78.8	51.1	21.6	30.6	40.4	186.4	75.4	141.1	79.7	70.8	87.0	102.0	76.9	78.4	76.2	109.1	78.6	71.9	161.5	125.8	83.0	70.6	107.3	108.4	41.3	45.1	43.6	43.3	39.5	42.2	43.1	43.7	42.8	43.7	43.0	48.7	19.2	6.4	10.1	14.0	35.7	22.7	21.8	41.7	23.9	42.2	20.1	24.9	12.7	27.1	24.2	33.1	47.9	27.2	42.0	11.5	19.6	21.2	5.2	18.3	29.5	24.2	17.4	32.8	18.5	17.4	22.9	27.2	15.3	18.5	16.5	31.8	24.3	13.3	19.5	30.3	19.9	16.8	32.6	17.5	33.8	12.3	58.7	16.9	19.6	15.0	30.0	22.8	35.0	24.1	32.3	19.3	8.6	53.4	21.6	22.6	23.7	22.0	19.3	50.5	32.9	28.8	32.2	60.2	63.5	15.4	23.2	26.5	30.6	28.7	17.9	19.7
DPF3	"BAF45c, cer-d4, Cerd4, FLJ14079"	ENSG00000205683	"Double PHD fingers 3"	Q92784	14	72619296-72894116	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;retina: 18.0;skeletal muscle: 26.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 104.5;Cone photoreceptor cells: 108.4;Early spermatids: 58.5;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 115.7;Rod photoreceptor cells: 85.5"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;BJ hTERT+ SV40 Large T+: 12.2;HEL: 31.5;Karpas-707: 12.4"	"Region enhanced"	"Detected in all"		"cerebellum: 49.5"	"Low region specificity"	"Detected in all"			"HPA066790, HPA070601"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA066790: AB_2685724, HPA070601: AB_2686284"	"unprognostic (2.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (9.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.85e-3)"	"unprognostic (4.08e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-1)"	0.3	1.4	2.8	0.5	6.7	2.6	0.4	35.5	5.1	0.4	0.0	2.0	0.2	0.2	0.0	0.6	0.3	0.3	14.2	10.2	3.8	1.4	3.0	0.2	0.8	12.0	5.9	13.7	0.3	5.1	0.6	0.3	12.6	0.1	1.5	18.0	0.4	0.2	26.5	0.5	1.3	0.5	4.4	1.0	0.5	3.5	5.7	0.3	0.4	9.1	1.0	0.2	0.2	7.7	2.1	0.0	1.6	0.1	0.2	2.9	17.7	5.4	5.1	12.2	4.7	0.1	0.2	0.2	0.3	1.7	0.2	0.1	1.7	0.8	7.4	0.3	0.6	31.5	0.2	0.0	0.5	0.2	0.5	0.7	0.3	2.8	2.0	2.0	4.0	3.4	2.8	12.4	3.9	0.1	2.7	0.3	0.0	0.0	1.8	6.9	0.8	0.4	2.1	0.0	1.2	0.7	0.0	0.1	0.0	0.5	0.0	0.0	8.7	6.0	0.0	2.2	0.6	4.3	1.2	0.4	0.5	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.7	35.5	5.1	10.2	3.8	12.0	5.9	12.6	4.4	5.7	7.7	0.8	0.0	0.0	104.5	6.0	0.6	0.1	0.0	0.0	10.5	1.1	0.9	38.4	1.5	0.0	0.0	108.4	2.6	2.6	7.5	1.9	0.1	58.5	0.1	0.8	2.9	0.0	8.6	17.7	0.4	1.3	2.8	0.0	0.1	4.5	43.2	1.1	4.4	0.4	6.7	21.7	3.4	0.0	0.8	0.7	34.3	0.3	1.7	0.0	8.4	0.1	8.6	2.1	123.1	115.7	0.7	5.1	4.9	2.6	0.1	2.7	10.7	0.0	85.5	0.0	2.6	3.5	4.5	1.2	0.3	0.3	0.1	3.8	14.5	7.4	0.0
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030137-2043898	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 19.4;Gastric mucus-secreting cells: 21.4;Plasma cells: 12.0;Squamous epithelial cells: 13.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Cell Junctions"	"HPA069750: AB_2686188, HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	24.5	32.3	13.1	6.0	12.8	5.3	22.2	16.8	17.7	29.1	10.7	26.8	8.0	28.8	5.6	19.8	31.0	9.1	19.2	13.7	11.9	28.0	36.3	16.6	7.5	10.3	10.9	26.6	32.0	14.2	59.3	8.5	10.3	36.2	6.2	12.4	23.7	11.0	42.3	29.3	20.8	8.9	10.1	24.3	27.0	20.3	11.7	6.7	28.6	13.7	6.0	24.2	22.3	11.5	15.4	24.9	6.3	16.0	22.2	14.2	18.7	19.3	26.8	29.7	18.7	24.1	11.6	29.0	23.6	52.5	11.2	11.6	20.7	21.1	15.9	9.0	52.4	6.3	10.5	13.1	19.4	8.3	10.2	20.3	20.3	22.7	19.0	20.5	13.9	16.8	23.4	11.2	11.9	18.2	14.7	4.8	6.5	17.3	25.9	16.6	5.7	22.0	13.3	8.0	13.1	15.2	17.4	17.9	17.2	6.9	25.9	6.8	10.1	19.4	10.1	26.2	16.7	10.3	8.3	6.8	20.3	10.8	8.5	0.8	4.5	0.8	8.0	6.1	8.9	8.8	6.5	7.4	7.7	7.2	9.6	6.9	0.3	6.7	4.5	5.5	10.2	5.2	13.1	12.8	16.8	17.7	13.7	11.9	10.3	10.9	10.3	10.1	11.7	11.5	0.9	3.2	9.2	1.3	9.3	0.4	0.9	0.5	19.4	2.1	0.8	0.8	1.5	0.0	2.7	0.0	2.1	1.4	0.9	0.6	0.0	0.5	1.2	1.5	1.2	1.7	0.0	9.0	4.0	0.6	0.9	4.5	21.4	0.8	2.5	1.0	0.7	0.0	0.6	1.7	3.7	0.8	0.0	0.0	0.8	1.5	0.6	3.9	0.0	1.0	0.4	0.9	2.1	1.5	1.4	0.0	0.2	0.4	12.0	0.5	0.5	0.5	3.0	2.8	0.0	1.3	3.2	1.2	0.5	13.0	0.3	1.4	5.4	1.3	0.4	0.6
DPH2	DPH2L2	ENSG00000132768	"Diphthamide biosynthesis 2"	Q9BQC3	1	43970000-43973369	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045796	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA045796: AB_2679456"	"unprognostic (2.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.17e-8)"	"unprognostic (1.38e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.37e-2)"	8.2	11.5	9.3	10.8	9.6	7.0	7.9	9.0	10.2	7.2	9.0	9.7	7.3	7.7	6.1	11.8	8.2	5.5	11.6	9.1	8.5	13.2	12.6	7.1	12.4	8.7	9.2	7.2	15.9	10.2	8.8	6.6	9.0	8.1	9.2	3.5	9.5	6.7	32.8	10.5	9.0	8.9	8.6	11.8	9.7	7.2	9.4	8.8	7.4	17.0	10.9	12.3	6.7	9.5	25.0	28.5	12.2	26.8	9.2	9.6	41.6	13.0	13.9	32.9	26.9	36.1	23.8	41.4	21.4	13.3	17.0	28.1	41.7	36.8	18.4	28.0	36.1	42.4	36.1	37.9	24.1	49.9	23.4	14.9	40.6	39.2	21.0	10.0	23.2	32.0	55.4	23.1	16.8	28.6	44.6	28.3	86.3	40.5	31.4	37.6	28.2	67.4	20.6	19.5	42.8	49.3	17.2	43.1	32.6	16.3	18.2	34.3	15.4	16.1	36.7	28.6	52.4	55.3	98.7	43.0	14.2	55.0	24.1	0.0	6.6	0.4	6.1	9.4	9.0	8.3	6.4	6.5	10.1	8.8	6.4	9.3	0.6	10.3	4.8	8.4	6.6	6.3	9.3	9.6	9.0	10.2	9.1	8.5	8.7	9.2	9.0	8.6	9.4	9.5	5.8	0.0	4.8	5.2	14.4	22.9	13.2	8.9	8.6	6.8	10.3	10.0	9.3	7.2	5.2	1.8	10.4	14.8	8.8	4.8	5.9	16.5	0.3	4.0	5.6	7.6	12.0	6.3	6.9	18.8	16.2	6.2	8.6	4.3	4.5	6.9	2.5	5.7	8.6	3.3	6.5	8.1	4.1	3.7	7.1	1.0	8.4	4.4	5.4	0.0	9.2	4.4	12.3	4.0	6.9	15.2	3.0	3.8	11.5	23.6	3.8	9.0	6.0	6.0	0.0	6.5	8.0	9.4	24.9	10.3	27.1	8.6	6.9	12.7	13.7	9.0
DPH3	"DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2"	ENSG00000154813	"Diphthamide biosynthesis 3"	Q96FX2	3	16257061-16264969	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035287	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA035287: AB_10604113"	"unprognostic (2.49e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.44e-2)"	14.2	11.9	12.7	9.6	13.5	8.4	10.3	14.3	14.3	10.2	13.6	11.5	10.7	10.0	11.0	9.4	8.9	10.2	13.9	12.2	15.6	13.1	15.3	11.1	8.9	15.4	14.4	6.1	7.8	9.0	8.5	13.2	15.0	9.3	8.7	13.4	5.7	11.1	29.4	4.9	13.3	15.2	14.7	9.1	9.4	8.5	13.6	11.5	12.4	20.1	8.1	12.4	5.8	15.5	10.5	14.6	31.9	18.9	58.9	39.7	24.8	29.9	24.4	28.0	31.3	18.1	5.8	10.0	9.3	37.5	24.0	6.2	29.4	17.7	32.6	50.5	20.4	16.6	11.5	21.0	36.7	24.5	15.6	28.6	23.6	36.0	15.2	17.6	25.5	17.4	26.9	16.4	39.9	14.1	19.0	16.5	25.6	15.9	14.7	12.9	20.7	15.4	24.9	8.0	7.2	20.2	13.8	6.7	35.4	25.6	12.5	23.9	29.9	22.9	15.0	41.7	24.0	12.6	44.5	12.8	33.6	27.2	20.7	27.1	16.7	25.7	11.3	22.8	14.0	10.1	11.9	13.8	15.9	9.9	9.9	11.9	35.5	10.7	21.6	6.2	11.9	12.7	12.7	13.5	14.3	14.3	12.2	15.6	15.4	14.4	15.0	14.7	13.6	15.5	32.3	19.2	22.4	10.1	31.0	51.6	42.9	41.0	29.0	11.6	32.9	34.7	34.9	25.8	32.4	16.5	12.5	47.9	28.1	43.0	41.1	49.5	109.1	27.5	35.3	32.5	17.9	32.0	12.0	57.2	80.6	34.4	30.1	33.3	52.0	11.2	26.7	41.6	101.6	6.7	10.3	22.6	26.4	45.5	61.7	63.3	20.5	46.4	28.4	3.7	71.5	24.8	29.9	6.6	9.2	66.6	32.4	15.8	42.2	42.6	79.1	45.4	33.9	15.1	13.1	33.4	36.7	80.4	40.1	31.3	52.4	80.9	34.5	18.7	19.0	47.1
DPH6	"ATPBD4, MGC14798"	ENSG00000134146	"Diphthamine biosynthesis 6"	Q7L8W6	15	35217345-35546193	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 91.7;Oligodendrocytes: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042976, HPA055496"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042976: AB_10964890, HPA055496: AB_2682835"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.65e-6)"	"unprognostic (9.70e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	8.6	7.5	3.7	4.9	4.7	5.4	10.8	4.6	5.0	6.8	3.6	6.7	6.1	7.9	10.7	9.6	8.1	6.0	10.2	3.6	4.7	10.4	8.1	5.3	5.3	4.6	4.4	9.7	14.3	8.7	5.9	8.1	4.8	5.8	7.0	8.9	6.7	6.1	10.8	9.7	6.6	6.4	4.3	6.3	6.8	5.9	3.9	7.0	10.8	6.9	7.4	8.0	7.1	5.7	16.9	8.9	14.7	12.5	2.6	11.7	14.3	6.2	10.8	14.7	7.6	11.9	15.5	5.2	14.8	5.7	17.9	19.0	17.2	17.9	17.5	4.1	10.7	19.6	9.9	18.9	15.3	10.6	12.1	9.9	22.2	5.9	28.5	9.0	14.4	11.0	21.8	20.6	13.6	6.6	13.0	9.8	13.0	25.4	8.1	16.0	13.7	7.2	12.9	21.0	10.7	10.4	11.6	12.8	10.7	8.5	44.6	14.4	4.4	14.2	13.8	14.4	10.0	18.2	31.3	13.4	12.3	17.7	13.9	0.0	6.7	0.3	6.0	6.7	7.7	8.9	8.1	8.4	6.7	6.3	10.3	9.3	0.3	14.7	6.2	5.8	5.8	4.5	3.7	4.7	4.6	5.0	3.6	4.7	4.6	4.4	4.8	4.3	3.9	5.7	15.9	16.0	7.5	91.7	18.7	31.0	20.0	19.8	24.5	29.2	12.0	16.6	15.8	18.6	17.2	9.2	39.6	26.7	9.3	7.5	13.7	16.3	2.2	10.7	13.7	10.0	5.4	16.8	28.0	24.1	23.5	12.0	21.4	13.3	3.8	21.1	5.7	7.4	17.5	18.5	47.0	7.4	14.2	10.3	12.9	3.3	14.0	9.8	16.0	44.0	14.3	15.0	11.3	71.9	101.5	18.7	7.1	6.8	6.9	8.9	13.4	19.9	7.6	24.2	0.0	18.9	14.0	9.8	14.0	21.2	23.2	22.6	9.9	21.9	10.5	13.4
DPPA2	"CT100, PESCRG1"	ENSG00000163530	"Developmental pluripotency associated 2"	Q7Z7J5	3	109293788-109316517	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 3.3"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 12.0;Spermatogonia: 14.5"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 35.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 6.0;EFO-21: 11.4;SuSa: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036134	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA036134: AB_10601547"				"unprognostic (2.23e-1)"						"unprognostic (2.79e-1)"				"unprognostic (1.81e-2)"	"unprognostic (3.50e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.4	0.0	0.1	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	0.0	1.6	0.0	0.1	0.0	0.0
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.2;testis: 4.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Erythroid cells: 16.4;Extravillous trophoblasts: 17.2;Spermatogonia: 11.7;Syncytiotrophoblasts: 6.2"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 7.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.3"	"Group enriched"	"Detected in some"	4	"HAP1: 89.7;NTERA-2: 327.5;SuSa: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	12.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	89.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	327.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.5	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	22.3	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	16.4	0.1	0.0	17.2	0.5	0.0	0.0	1.3	0.0	0.4	1.6	1.7	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.7	0.0	0.0	0.9	0.3	0.3	11.7	0.0	0.0	6.2	0.5	0.2	0.0	0.3
DPY19L2	"FLJ32949, SPATA34"	ENSG00000177990	"Dpy-19 like 2"	Q6NUT2	12	63558913-63668939	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 65.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 329.9;Excitatory neurons: 124.1;Inhibitory neurons: 137.2;Late spermatids: 363.0;Oligodendrocyte precursor cells: 124.1;Spermatocytes: 143.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 9.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA071264, HPA078305"	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Nucleoplasm	"HPA071264: AB_2686375, HPA078305: "	"unprognostic (1.97e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (4.22e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.79e-1)"	6.7	5.3	4.0	0.5	3.9	3.0	4.7	7.0	6.9	11.4	6.6	5.2	0.6	7.8	4.1	1.4	6.4	2.8	19.2	3.0	4.3	12.7	0.2	1.3	0.9	2.4	3.0	11.0	2.7	9.0	10.5	1.2	1.5	9.3	1.3	14.4	1.6	4.7	0.5	1.6	1.7	3.5	0.8	1.7	2.9	65.6	3.3	0.7	13.1	0.6	0.6	6.3	5.1	4.2	1.0	2.6	2.2	5.4	0.6	0.0	0.2	1.8	1.8	2.4	3.1	0.4	0.8	2.8	1.8	0.7	2.9	0.4	2.7	0.3	3.6	1.5	1.7	4.6	1.4	1.7	0.5	3.4	1.4	1.5	0.1	1.1	0.0	6.1	0.8	2.2	1.9	2.9	3.9	1.7	0.2	1.4	2.1	0.4	2.4	0.0	1.8	0.0	4.6	0.5	7.0	0.7	0.6	0.2	1.0	0.9	1.9	0.9	0.5	3.2	4.2	0.5	4.6	7.5	9.3	0.0	3.4	1.6	3.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	4.0	3.9	7.0	6.9	3.0	4.3	2.4	3.0	1.5	0.8	3.3	4.2	6.7	3.2	0.0	23.2	0.2	0.5	2.9	0.1	2.2	49.6	1.9	1.8	32.3	1.5	3.8	12.9	14.6	2.0	0.3	0.1	5.9	0.4	329.9	5.6	7.1	1.7	0.0	7.2	124.1	0.0	1.3	2.2	0.5	2.1	2.5	1.2	1.4	0.1	0.3	3.3	137.2	0.1	6.1	0.0	0.4	363.0	7.2	0.4	7.2	11.2	0.1	9.2	0.0	124.1	5.0	0.2	0.0	8.6	0.5	2.9	0.0	6.4	11.6	6.7	26.3	3.8	19.9	143.3	4.9	0.2	0.4	1.4	0.8	3.6	0.1	1.1
DPY19L4		ENSG00000156162	"Dpy-19 like 4"	Q7Z388	8	94719703-94793836	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024339, HPA024780"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA024339: , HPA024780: AB_10600869"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.28e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.17e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	11.5	12.3	7.3	6.6	10.5	5.1	12.5	9.7	9.4	13.6	8.0	8.6	6.7	12.3	10.5	7.6	11.2	10.0	15.4	6.5	10.1	14.5	15.8	9.1	6.9	9.9	9.0	16.7	9.4	26.4	6.4	12.6	10.3	11.6	9.0	13.0	10.2	9.0	7.2	9.4	7.9	9.5	9.6	11.1	13.1	9.6	8.9	7.0	16.1	9.3	5.8	8.6	8.5	14.4	24.4	15.5	26.1	16.4	25.9	33.3	14.4	21.5	20.3	19.8	19.4	7.3	35.0	5.4	25.8	20.8	13.3	25.0	16.0	16.9	32.7	12.2	12.8	25.3	15.1	12.2	30.1	10.9	5.1	22.2	14.0	16.8	16.2	23.2	24.3	16.0	18.0	9.0	23.3	15.3	20.9	20.5	10.2	27.9	17.2	14.8	17.9	10.9	19.1	18.9	12.8	28.7	17.2	3.6	16.8	15.9	22.8	13.6	24.0	20.5	12.6	23.1	18.1	9.9	13.1	14.8	15.4	18.7	29.6	0.7	0.5	0.0	1.0	0.6	1.4	1.2	1.0	1.6	1.0	0.3	1.1	1.4	0.4	1.4	0.6	1.2	0.4	0.7	7.3	10.5	9.7	9.4	6.5	10.1	9.9	9.0	10.3	9.6	8.9	14.4	21.1	16.0	16.3	20.5	6.3	9.8	14.1	11.6	15.9	19.6	16.2	12.1	26.0	11.5	13.0	40.5	4.2	16.7	3.7	8.5	1.9	8.9	2.1	13.7	20.3	19.0	7.3	9.7	13.2	10.0	11.9	20.4	12.2	13.7	3.8	23.1	65.0	27.5	9.6	13.5	18.3	11.5	10.2	14.8	11.9	5.0	17.4	8.3	10.6	25.3	5.5	11.9	9.2	23.6	39.7	13.0	6.4	18.4	7.9	15.6	10.7	10.7	18.8	17.6	6.6	13.4	14.9	11.9	9.8	16.6	12.1	9.2	7.8	32.6	12.0	14.1
DPY30	"Cps25, HDPY-30, Saf19"	ENSG00000162961	"Dpy-30 histone methyltransferase complex regulatory subunit"	Q9C005	2	31867809-32039805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 388.8;Respiratory ciliated cells: 396.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043761	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		29000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA043761: AB_10960501"	"unprognostic (2.76e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-1)"	40.2	75.2	66.9	34.3	68.6	31.4	61.3	72.1	84.4	53.2	73.6	50.9	43.4	38.3	78.3	60.2	90.5	42.4	46.7	68.4	73.6	79.1	84.8	44.1	51.8	71.6	71.5	42.7	48.1	58.3	50.9	43.9	73.6	57.3	46.4	33.3	64.6	47.0	48.8	49.7	44.4	37.4	73.2	36.1	46.8	22.6	69.1	52.3	81.6	45.4	49.3	51.8	50.0	77.5	201.8	136.8	100.8	78.1	86.7	128.8	134.9	102.1	90.8	81.2	79.5	197.2	158.3	123.2	102.2	90.8	148.3	79.9	93.1	118.6	88.1	146.4	149.5	110.8	89.7	225.5	76.5	114.3	66.8	87.4	135.6	87.4	76.9	109.1	130.4	55.1	132.5	85.3	125.6	219.4	128.8	228.9	139.2	184.3	140.5	104.0	118.9	155.7	144.2	137.1	162.5	115.9	101.2	141.1	143.6	118.2	98.3	82.1	100.5	73.9	119.1	69.2	125.4	99.9	161.3	166.2	77.6	123.2	91.7	177.6	101.0	150.8	95.5	99.9	116.5	165.9	133.5	119.4	100.5	135.6	118.1	112.0	117.3	105.8	112.8	91.5	200.3	130.6	66.9	68.6	72.1	84.4	68.4	73.6	71.6	71.5	73.6	73.2	69.1	77.5	65.7	51.3	61.5	10.1	61.7	98.0	107.7	233.5	53.5	17.9	110.5	135.1	71.3	80.1	140.8	103.0	0.0	190.2	41.0	84.2	283.7	114.3	64.5	388.8	59.7	62.9	92.1	55.5	16.0	117.2	252.4	63.1	44.4	107.3	46.9	65.1	63.1	102.7	123.5	21.9	17.7	107.6	175.0	65.4	67.2	18.5	72.4	58.7	65.8	13.1	106.8	50.8	55.6	13.6	26.7	125.7	117.8	88.0	40.6	130.5	138.4	296.7	396.4	26.8	85.5	52.4	108.4	65.7	57.4	72.0	122.6	138.7	67.3	67.7	109.0	127.5
DPYSL5	"CRAM, CRMP-5, CRMP5, CV2, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 111.5"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 85.5;Late spermatids: 134.3;Oligodendrocytes: 331.2"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 141.0;HAP1: 118.7;SCLC-21H: 167.3;SH-SY5Y: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: AB_2686516"	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	0.0	1.9	22.6	0.3	49.4	0.0	0.0	59.4	41.7	0.1	3.8	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	17.6	42.1	0.1	0.0	0.0	0.0	79.6	50.2	0.1	0.0	0.0	7.8	0.0	65.5	0.1	0.2	15.8	0.0	0.0	0.1	0.0	0.3	0.3	54.8	0.0	0.1	7.8	60.2	0.0	0.0	0.0	0.0	0.0	0.1	111.5	0.0	3.0	141.0	0.1	0.6	0.0	3.3	0.0	0.0	0.0	0.0	13.2	0.0	0.0	1.0	0.0	3.9	0.0	118.7	0.0	0.0	0.0	26.2	0.0	0.1	0.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	31.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	167.3	99.0	3.8	0.2	0.0	3.3	0.0	0.0	0.0	0.0	4.1	0.1	3.8	0.0	5.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	49.4	59.4	41.7	17.6	42.1	79.6	50.2	65.5	54.8	60.2	111.5	0.1	0.0	0.0	13.4	0.1	0.0	0.3	0.0	0.0	12.1	0.1	0.0	6.0	0.0	0.0	0.0	85.5	0.1	0.0	0.0	0.0	0.0	45.6	0.1	0.1	0.4	0.0	0.0	18.3	0.0	0.0	0.3	0.0	0.2	2.5	0.2	0.0	0.2	0.1	8.4	40.5	0.0	0.0	0.0	0.7	134.3	1.5	0.2	1.8	2.8	0.1	17.2	0.0	18.1	331.2	0.0	0.0	1.2	0.1	0.2	0.0	0.1	0.0	12.1	0.0	0.7	0.3	2.9	4.6	0.0	0.3	0.0	0.2	0.7	0.0	0.1
DR1	"NC2-BETA, NC2B, NCB2"	ENSG00000117505	"Down-regulator of transcription 1"	Q01658	1	93345907-93369493	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050785, HPA055308"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA050785: AB_2681237, HPA055308: AB_2682779"	"unprognostic (1.46e-1)"	"unprognostic (9.62e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.95e-7)"	"unprognostic (8.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.60e-1)"	21.8	18.9	9.8	28.8	9.6	59.1	16.8	12.5	9.3	17.7	23.7	18.2	27.2	21.0	11.1	30.0	14.2	23.1	27.0	8.7	10.8	21.8	20.4	19.6	43.3	9.9	9.8	15.9	18.8	16.9	12.1	32.0	9.5	17.1	16.3	14.1	19.5	14.0	50.4	29.4	22.4	19.2	10.3	27.0	30.2	55.7	10.5	47.7	18.7	42.9	30.8	27.3	22.6	10.5	97.1	29.8	46.8	60.6	42.3	47.9	57.5	76.5	46.6	50.9	54.0	34.9	34.1	101.9	86.4	56.7	69.3	50.1	56.7	53.0	74.6	86.4	53.0	85.8	58.7	38.4	67.3	102.1	60.6	33.7	62.4	71.2	102.2	53.1	45.9	60.0	90.0	95.7	61.0	29.8	97.6	32.1	78.1	33.4	72.1	83.5	103.2	104.0	36.3	58.0	45.3	57.6	65.1	59.7	80.6	42.2	42.2	79.4	72.1	91.5	73.0	90.7	116.0	54.9	65.6	105.5	26.3	80.3	38.2	95.2	46.2	82.1	35.3	52.7	39.2	36.9	38.8	40.4	55.9	31.5	38.6	37.8	62.8	35.5	47.4	45.4	57.1	41.3	9.8	9.6	12.5	9.3	8.7	10.8	9.9	9.8	9.5	10.3	10.5	10.5	36.2	28.9	22.1	10.1	43.5	171.3	38.0	38.7	47.3	32.0	29.1	24.1	33.9	22.8	27.9	36.8	25.0	74.5	84.6	42.8	45.0	31.4	183.1	18.4	33.7	37.5	20.8	59.3	8.4	27.7	73.6	34.3	38.2	24.2	48.9	19.7	29.3	27.6	53.0	50.5	8.7	42.6	10.2	50.8	82.8	106.2	28.3	55.2	44.4	15.0	68.0	16.0	69.0	7.5	10.8	52.9	25.9	26.4	31.9	51.6	29.8	40.7	17.6	25.3	32.9	27.7	42.0	163.2	41.2	69.4	160.5	109.9	59.8	26.2	26.9	79.2
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399604-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 160.2"	"Group enriched"	"Detected in all"	5	"Early spermatids: 798.4;Late spermatids: 651.5;Spermatocytes: 469.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001218	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		22000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	31.4	32.6	22.6	21.4	23.9	32.3	35.1	27.0	31.6	27.3	22.8	24.7	22.6	27.8	38.7	27.4	32.7	19.5	44.6	23.7	24.6	35.9	37.9	20.9	29.2	23.9	23.7	35.0	34.1	38.4	18.6	35.7	25.0	25.0	30.0	30.1	30.5	28.8	100.5	23.7	21.3	34.1	24.5	20.1	24.2	160.2	22.7	40.4	34.5	85.1	38.3	30.8	20.6	26.4	80.3	61.3	73.9	63.3	64.4	75.2	61.5	70.2	81.7	125.7	104.4	100.3	38.3	111.2	38.6	86.9	60.3	64.5	128.5	82.8	134.4	52.0	152.0	71.9	64.9	99.6	91.4	174.2	65.1	65.6	60.9	103.7	152.9	64.6	87.5	61.6	93.9	48.1	97.2	88.0	75.7	88.4	62.1	114.0	65.9	98.7	118.9	97.3	82.1	68.6	80.8	50.4	78.5	79.8	107.2	70.8	59.7	77.2	50.6	57.7	79.3	59.1	81.3	67.2	78.5	108.6	57.0	77.7	77.4	25.0	43.3	46.0	34.3	49.7	39.6	53.6	36.6	43.0	45.2	39.4	40.5	39.8	9.8	46.7	37.5	39.6	50.9	47.0	22.6	23.9	27.0	31.6	23.7	24.6	23.9	23.7	25.0	24.5	22.7	26.4	22.0	19.2	15.4	3.9	29.4	38.6	40.8	77.2	29.6	18.7	27.2	27.2	52.4	35.8	37.6	27.6	25.0	126.4	20.6	22.5	64.6	56.4	798.4	23.7	24.4	34.4	11.4	37.8	10.3	45.4	104.5	33.2	21.4	21.1	33.7	27.1	35.7	36.9	60.4	15.2	11.2	31.0	48.8	31.1	24.0	651.5	35.8	22.9	17.8	7.5	39.2	27.6	33.0	9.5	11.1	42.7	27.0	37.2	27.1	48.7	42.9	60.3	28.7	18.4	59.2	35.4	36.1	469.3	92.1	33.1	32.1	117.1	25.5	26.2	41.0	45.3
DRG2		ENSG00000108591	"Developmentally regulated GTP binding protein 2"	P55039	17	18087892-18107970	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007716	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	"Vesicles, Cytosol"	Nucleoplasm	"HPA007716: AB_1078705"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (1.26e-3)"	"unprognostic (7.86e-2)"	"unprognostic (8.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	19.3	19.1	14.2	12.8	14.8	15.9	19.6	14.8	15.0	21.6	13.6	19.4	14.8	22.3	12.9	21.6	19.8	12.6	19.8	14.9	15.7	18.5	16.6	15.7	18.4	15.2	15.4	22.5	19.6	15.8	17.8	12.3	16.1	20.1	10.0	5.2	17.0	15.2	36.6	20.3	17.4	13.7	15.4	19.8	17.9	8.9	14.9	16.0	18.4	16.5	14.9	20.0	18.3	16.5	37.1	51.1	17.4	17.3	31.1	31.7	33.1	24.8	24.7	40.0	37.0	55.5	21.8	35.5	31.8	29.4	21.2	38.9	28.5	35.1	27.4	32.1	74.2	16.0	26.5	31.5	33.4	14.3	24.2	36.4	30.5	39.1	33.0	22.9	38.5	46.8	27.6	13.7	23.6	42.5	38.7	25.8	12.9	51.4	36.1	41.5	41.8	66.7	24.3	21.6	9.9	28.0	25.2	15.2	31.9	102.8	30.0	21.4	29.2	19.6	18.3	23.0	42.8	15.5	19.4	20.1	27.9	26.2	36.6	17.7	21.1	23.6	24.6	23.3	20.2	14.9	17.8	20.0	24.6	17.7	16.9	18.7	2.8	28.2	30.5	13.8	24.9	19.3	14.2	14.8	14.8	15.0	14.9	15.7	15.2	15.4	16.1	15.4	14.9	16.5	23.8	0.0	12.4	8.5	19.5	16.7	19.9	21.2	11.4	14.9	18.8	23.0	3.9	24.3	13.2	7.3	2.1	37.5	26.3	20.1	29.4	29.4	7.3	12.8	19.3	20.8	21.6	10.1	11.9	27.1	40.8	19.4	17.9	12.9	12.0	32.6	16.4	19.4	32.2	6.7	10.0	19.7	16.2	21.4	12.2	14.2	21.5	18.0	12.4	8.4	23.9	19.6	23.7	4.0	8.0	24.8	16.2	24.5	22.9	17.4	31.4	31.8	9.3	13.4	6.6	22.0	21.7	12.1	13.0	18.2	11.6	39.3	21.9	33.9	24.5	14.4
DRGX	"DRG11, PRRXL1"	ENSG00000165606	"Dorsal root ganglia homeobox"	A6NNA5	10	49364066-49396089	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	19	"adrenal gland: 5.4;brain: 10.4"	"Cell type enhanced"	"Detected in some"		"Langerhans cells: 1.2;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"medulla oblongata: 10.1;pons: 10.4;spinal cord: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"RH-30: 11.6;SH-SY5Y: 46.2;U-2197: 17.7"	"Region enriched"	"Detected in single"	6	"pons and medulla: 3.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 4.0;hippocampal formation: 1.6;medulla oblongata: 2.4;spinal cord: 3.7"	HPA043978	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA043978: AB_10961154"		"unprognostic (1.42e-2)"	"unprognostic (5.68e-2)"		"unprognostic (3.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.58e-1)"		"unprognostic (4.54e-2)"	"unprognostic (3.74e-2)"			"unprognostic (8.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"		0.1	5.4	0.0	0.2	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	10.1	0.7	0.0	0.0	0.0	0.2	0.0	10.4	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	8.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	17.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.3	10.1	0.7	10.4	8.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.8	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
DRICH1	C22orf43	ENSG00000189269	"Aspartate rich 1"	Q6PGQ1	22	23608452-23632321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 17.0;testis: 46.4"	"Group enriched"	"Detected in some"	44	"Early spermatids: 405.5;Late spermatids: 589.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 11.1"									HPA020446			Approved	Nucleoplasm,Nucleoli		No	No				"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA020446: AB_1853151"	"unprognostic (7.48e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.22e-4)"	"unprognostic (6.46e-2)"	"unprognostic (8.35e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.73e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.70e-4)"	"unprognostic (1.08e-3)"	0.8	1.4	1.3	1.1	1.5	3.7	2.2	3.0	1.9	1.0	2.4	1.3	1.1	3.3	17.0	0.6	1.7	1.8	0.4	0.9	1.1	2.6	0.7	1.3	2.3	1.1	1.2	3.0	2.4	9.2	1.4	0.8	1.1	1.4	1.3	3.9	1.5	2.0	0.2	3.3	1.1	1.5	0.7	2.0	0.8	46.4	1.1	1.4	1.7	0.0	0.8	0.6	0.7	1.0	0.5	0.6	1.5	0.4	1.8	0.4	1.3	0.0	0.0	0.0	0.0	11.1	0.4	0.7	0.1	0.4	0.3	1.1	2.1	0.1	0.3	0.1	1.0	0.4	1.1	0.5	0.6	0.2	1.6	0.8	0.9	0.3	0.0	0.6	0.3	0.3	0.9	0.2	0.1	0.5	0.2	0.5	0.1	0.5	0.6	1.2	0.0	0.0	0.3	1.2	0.6	0.5	0.0	0.9	0.7	0.3	0.2	0.0	0.3	0.0	1.8	1.7	0.2	0.6	1.1	0.1	1.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	3.0	1.9	0.9	1.1	1.1	1.2	1.1	0.7	1.1	1.0	0.1	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.8	0.0	0.1	0.3	0.1	0.0	0.1	405.5	0.4	0.0	0.3	1.8	0.0	9.1	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	11.3	0.4	0.0	0.0	0.0	589.5	4.1	0.2	0.0	3.7	0.0	0.0	0.0	1.5	1.4	0.1	1.2	1.5	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	4.4	2.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0
DROSHA	"Etohi2, HSA242976, RN3, RNASE3L, RNASEN"	ENSG00000113360	"Drosha ribonuclease III"	Q9NRR4	5	31400494-31532196	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, RNA-mediated gene silencing"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031150			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA031150: AB_2673761"	"unprognostic (8.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.40e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (3.11e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.32e-2)"	12.3	11.3	2.6	15.9	3.8	11.6	11.5	9.4	8.0	13.3	4.2	13.8	13.6	15.9	20.4	11.4	14.5	11.7	13.0	2.0	8.1	12.3	9.7	10.9	16.0	1.1	2.9	20.5	14.4	15.2	4.5	13.8	2.3	13.6	15.6	27.2	12.5	13.2	22.2	13.5	12.2	13.8	0.2	12.5	13.2	11.1	5.2	24.5	15.5	19.6	17.1	12.2	3.9	4.9	38.7	47.3	51.8	70.8	27.0	32.8	74.2	50.0	24.4	45.6	33.9	50.6	49.0	43.3	55.9	36.9	52.7	33.0	63.5	37.8	50.4	40.9	44.6	52.9	157.8	37.0	24.3	59.2	151.6	25.8	26.0	50.7	24.2	34.6	39.5	45.3	68.9	19.7	40.5	38.5	58.3	44.8	49.1	31.2	37.9	52.2	98.9	31.1	25.7	43.2	26.9	35.6	127.1	51.4	30.0	46.0	47.4	34.1	33.9	43.7	50.3	39.0	48.0	35.8	63.5	47.1	30.3	65.9	42.9	0.9	1.2	1.5	2.2	1.3	2.4	1.8	2.4	2.7	2.5	2.0	2.7	2.0	0.3	2.5	2.5	3.0	2.5	1.6	2.6	3.8	9.4	8.0	2.0	8.1	1.1	2.9	2.3	0.2	5.2	4.9	6.2	12.8	14.3	45.4	7.1	3.6	5.0	7.0	10.8	19.4	7.1	6.0	23.4	5.7	12.8	5.5	0.0	8.5	11.4	12.9	3.9	7.8	3.5	12.3	11.6	9.0	11.4	8.0	43.4	8.1	7.6	12.7	8.6	13.6	9.5	20.4	10.0	7.2	7.8	6.7	45.8	8.5	14.2	6.3	3.0	8.2	10.8	6.0	1.8	34.7	8.4	10.2	9.2	74.9	43.9	9.3	10.2	13.2	8.8	6.1	7.3	5.1	16.8	18.8	6.6	10.4	11.6	7.1	10.9	8.8	3.4	4.9	8.3	13.9	11.7	5.9
DSCC1	"DCC1, hDCC1, MGC5528"	ENSG00000136982	"DNA replication and sister chromatid cohesion 1"	Q9BVC3	8	119833976-119855894	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 24.6;Extravillous trophoblasts: 17.6;Spermatogonia: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023780, HPA024401"	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA023780: AB_2671311, HPA024401: AB_2671557"	"unprognostic (7.36e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.91e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.92e-6)"	"prognostic unfavorable (3.93e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.12e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.32e-9)"	"unprognostic (2.75e-2)"	"unprognostic (5.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (8.18e-2)"	1.8	1.8	1.3	3.7	1.6	6.1	2.4	2.1	2.0	2.6	1.1	2.7	2.4	2.4	1.3	2.4	1.5	1.0	1.5	1.4	1.4	0.9	1.1	1.4	7.1	1.5	1.5	1.5	2.8	0.5	0.5	2.3	1.6	1.9	3.5	0.3	3.7	1.2	2.1	2.6	2.3	2.7	1.5	1.3	1.7	2.6	1.4	9.9	1.0	3.4	5.7	1.5	2.1	1.8	34.3	16.6	32.1	29.4	4.6	8.3	13.8	23.1	4.7	16.3	16.9	15.2	20.4	61.7	19.7	6.9	10.1	24.8	36.7	14.4	17.5	42.2	33.3	78.7	16.2	17.9	1.5	31.2	26.4	3.8	2.2	20.1	9.7	3.8	4.7	40.5	27.2	26.9	19.9	33.8	82.4	19.2	47.2	90.4	41.2	29.1	30.4	29.9	12.7	21.3	28.7	17.6	12.4	96.7	15.8	25.0	18.1	17.0	3.2	17.7	48.0	17.2	33.9	36.5	58.2	65.4	9.0	49.2	26.2	0.0	0.0	0.0	0.9	0.0	0.7	0.3	0.2	0.4	0.0	0.1	0.1	0.3	0.0	0.8	0.0	0.2	0.3	0.2	1.3	1.6	2.1	2.0	1.4	1.4	1.5	1.5	1.6	1.5	1.4	1.8	4.7	0.0	0.5	2.6	1.2	3.4	2.2	2.1	4.6	0.7	2.2	3.2	0.8	1.5	0.2	0.0	0.0	7.9	1.6	1.0	0.0	1.6	0.1	0.8	2.8	3.0	0.0	24.6	6.4	2.4	17.6	4.3	1.5	1.3	4.5	3.7	4.6	0.9	4.7	0.0	5.2	1.2	2.0	1.0	1.2	0.2	1.2	0.9	3.6	1.0	0.0	1.5	1.0	7.5	5.3	0.5	0.3	2.6	5.2	1.7	0.2	1.5	1.7	0.3	0.0	2.3	3.3	1.1	18.8	6.0	3.3	1.4	3.0	2.0	3.8	1.5
DSEL	"C18orf4, DE-epi2, FLJ11477, NCAG1"	ENSG00000171451	"Dermatan sulfate epimerase like"	Q8IZU8	18	67506587-67516720	"Predicted membrane proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 86.4;Extravillous trophoblasts: 72.5;Oligodendrocyte precursor cells: 112.6;Oligodendrocytes: 104.2;Theca cells: 83.9"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 70.7;BJ hTERT+: 43.0;fHDF/TERT166: 38.9;LHCN-M2: 92.1;U-138 MG: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060942			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane"	Nucleoplasm	"HPA060942: AB_2684392"	"unprognostic (2.49e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.11e-2)"	"unprognostic (4.91e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.16e-4)"	4.0	1.3	5.1	1.3	8.5	0.3	2.6	7.3	4.7	5.1	0.7	2.2	0.6	2.6	1.6	1.1	3.3	4.0	2.2	5.1	6.4	4.3	3.5	2.7	0.5	9.5	7.4	3.6	1.5	3.2	0.3	6.1	8.8	2.0	1.3	0.8	0.8	2.1	0.7	1.2	1.1	3.6	5.9	2.0	1.2	1.3	7.0	0.8	1.0	1.8	0.3	1.7	1.4	11.7	0.0	0.3	8.7	0.1	16.5	24.3	0.9	70.7	43.0	19.2	8.3	0.1	0.2	0.0	0.1	38.9	4.7	0.4	1.7	3.5	18.5	0.0	0.1	0.0	8.5	0.1	14.6	0.0	0.1	25.3	5.1	11.7	26.0	6.8	3.8	0.0	0.0	1.1	92.1	0.0	0.0	0.0	1.3	0.0	3.7	0.8	19.3	0.1	8.7	0.1	3.1	4.0	4.8	0.2	0.0	3.7	0.1	0.0	6.2	95.6	2.4	6.2	8.6	0.3	0.0	0.0	20.0	0.0	8.1	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	5.1	8.5	7.3	4.7	5.1	6.4	9.5	7.4	8.8	5.9	7.0	11.7	15.9	6.4	16.2	3.3	2.6	11.6	9.9	8.6	19.4	10.1	14.5	12.3	13.3	47.1	5.2	11.0	4.2	2.8	1.4	1.0	0.0	9.7	1.8	3.9	86.4	10.9	6.6	0.0	10.3	2.3	72.5	44.3	8.2	4.2	4.5	9.5	13.2	15.6	2.6	3.3	25.5	1.1	0.0	2.2	9.3	1.7	24.5	3.5	7.2	2.8	0.0	12.6	1.0	112.6	104.2	6.6	0.1	36.9	0.3	8.5	0.4	26.4	1.3	4.2	13.1	43.3	20.9	31.6	21.9	7.1	13.2	8.9	4.9	83.9	0.7	5.2
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 component of MIS12 kinetochore complex"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol"	"HPA002813: AB_1078343, HPA030627: AB_2732460"	"unprognostic (3.60e-2)"	"prognostic favorable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	5.9	9.9	4.2	7.5	4.2	14.3	8.6	3.9	4.5	5.0	5.2	9.2	6.8	4.4	9.3	7.9	4.1	4.4	5.1	4.3	4.4	4.8	9.1	6.3	12.8	4.0	3.9	4.3	4.3	5.5	3.5	8.8	4.1	6.5	10.8	10.7	5.9	6.3	4.0	8.0	7.8	6.3	3.9	9.6	7.3	23.3	4.1	16.4	5.1	4.8	14.3	4.4	4.7	4.7	36.7	29.1	35.7	29.5	14.0	18.0	24.7	42.9	35.1	63.9	70.2	52.5	44.4	39.3	27.4	23.0	69.1	45.8	33.3	32.7	60.3	18.2	22.7	78.3	26.2	36.1	3.0	46.2	34.0	7.0	9.4	43.7	13.8	10.4	31.5	42.4	30.9	33.7	41.7	25.3	59.2	34.5	16.8	63.3	55.1	46.1	109.4	28.4	16.2	20.5	37.8	16.9	52.9	53.7	25.8	26.3	55.9	30.5	16.4	60.1	35.0	56.9	46.1	27.3	39.1	46.4	49.8	40.8	42.6	53.4	6.4	14.5	7.4	11.0	8.4	14.6	8.1	10.3	7.1	18.4	10.1	9.0	11.9	11.1	10.1	46.9	12.2	6.7	4.2	4.2	3.9	4.5	4.3	4.4	4.0	3.9	4.1	3.9	4.1	4.7	6.5	6.4	4.4	1.6	10.3	5.0	11.4	7.6	3.4	8.0	8.7	7.6	5.4	2.8	8.6	5.5	29.2	49.8	9.8	9.2	7.9	6.8	10.6	5.5	5.9	8.1	2.4	22.1	6.3	6.4	30.4	8.4	20.9	9.4	3.8	21.8	7.9	6.2	14.7	6.7	4.4	13.6	4.1	6.3	4.6	8.0	8.7	6.7	1.8	5.6	7.4	6.0	7.2	3.0	3.6	5.1	5.4	7.5	22.9	7.1	7.7	3.6	8.2	17.5	0.0	5.3	8.2	115.5	75.1	12.3	7.2	47.5	7.7	6.9	13.6	11.0
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2368.6;Basal prostatic cells: 1651.4;Basal squamous epithelial cells: 3008.4;Cone photoreceptor cells: 1401.1;Oligodendrocytes: 1410.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 488.1;hTERT-HME1: 371.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	60.9	86.2	206.5	16.2	275.8	3.3	117.3	240.6	221.9	158.8	143.3	173.2	25.4	167.1	38.2	66.1	103.9	32.6	166.0	194.6	230.7	52.2	80.8	108.0	11.3	258.1	250.4	78.2	39.8	36.7	78.8	28.7	263.4	84.5	32.4	87.4	100.3	48.7	143.1	166.2	64.2	106.0	209.1	36.7	68.9	28.4	243.3	31.4	29.8	104.1	15.2	90.4	113.2	325.4	62.4	26.6	41.2	20.8	79.5	103.5	24.6	82.2	89.7	37.8	42.1	17.1	15.5	10.4	32.2	220.7	35.6	46.7	34.4	161.2	73.0	52.3	45.2	17.8	49.5	31.4	65.9	15.0	0.4	58.3	488.1	92.5	371.6	69.1	73.3	9.5	12.6	38.2	113.9	20.2	5.1	6.8	27.7	35.6	21.9	0.1	28.8	16.5	118.8	83.0	47.2	37.8	32.7	11.7	64.1	67.7	18.6	27.2	176.5	77.3	55.9	37.0	68.9	39.6	28.6	5.0	55.8	8.8	40.3	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	0.3	1.3	0.0	0.1	206.5	275.8	240.6	221.9	194.6	230.7	258.1	250.4	263.4	209.1	243.3	325.4	193.2	336.5	11.8	1048.7	5.6	2368.6	1651.4	250.1	3008.4	673.1	81.0	301.5	862.8	77.2	161.7	55.2	1401.1	61.5	7.8	357.8	7.9	204.3	53.6	133.8	218.4	122.7	44.9	12.4	550.4	66.3	11.6	212.5	71.9	166.8	17.1	478.7	60.7	80.3	21.8	307.9	591.7	100.3	118.0	74.2	124.6	15.5	133.3	56.6	215.3	215.5	46.6	200.8	2.1	630.3	1410.3	194.1	283.0	152.4	27.2	229.8	124.2	10.3	52.0	122.6	65.7	381.8	196.6	20.0	13.7	298.2	857.2	26.5	19.7	30.5	48.1	142.8
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 14.6;intestine: 4.7;lymphoid tissue: 14.2;placenta: 3.9;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.3;Erythroid cells: 36.2;Extravillous trophoblasts: 16.2;Spermatocytes: 53.2;Spermatogonia: 20.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028016, HPA032023, HPA032031"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	0.6	0.2	0.0	4.1	0.0	14.6	1.9	0.0	0.1	0.6	0.0	3.3	2.3	1.1	0.1	1.9	0.4	0.4	0.1	0.0	0.0	0.1	1.2	1.4	5.6	0.0	0.1	0.1	0.1	0.5	0.2	3.9	0.0	0.4	4.7	0.0	0.4	0.1	0.1	2.1	3.0	1.9	0.0	2.5	1.3	13.7	0.1	14.2	0.5	0.0	6.4	1.2	0.7	0.0	34.1	28.1	48.0	23.6	2.9	5.8	23.3	41.3	25.5	38.1	56.1	17.6	29.0	25.2	15.4	16.1	25.0	25.8	62.5	34.9	54.7	31.4	30.9	40.7	33.6	21.5	0.1	54.1	25.3	2.5	1.2	62.2	32.4	6.8	17.7	44.7	49.1	51.1	44.4	13.5	75.3	24.3	56.6	25.2	32.9	57.2	84.0	49.2	11.6	22.9	29.6	46.0	39.2	37.5	17.6	47.7	32.0	24.1	9.7	38.2	28.6	40.5	47.8	18.4	30.5	57.7	19.1	35.5	37.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.3	2.3	0.4	1.7	0.0	0.0	1.3	1.3	7.0	1.5	0.9	0.0	0.0	12.8	1.4	1.5	0.0	0.4	25.3	0.4	1.3	5.2	0.0	36.2	0.2	0.0	16.2	2.4	3.1	1.0	0.0	11.4	0.7	0.4	4.7	0.0	0.3	3.3	0.0	0.3	0.8	12.4	1.2	2.2	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.6	0.4	0.0	12.8	0.2	0.6	0.0	0.1	0.0	0.0	0.2	2.7	53.2	20.8	5.6	1.7	1.5	2.6	1.6	5.2	0.7
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
DTWD1	"MDS009, MGC111207"	ENSG00000104047	"DTW domain containing 1"	Q8N5C7	15	49621037-49656232	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042214	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"HPA042214: AB_2677903"	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.70e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.35e-1)"	19.6	11.8	7.7	13.0	10.1	5.4	18.2	8.2	9.1	27.4	6.5	21.1	7.4	22.6	16.8	13.3	21.1	23.0	11.0	9.0	8.9	11.0	11.5	10.9	12.9	5.7	6.9	22.7	33.3	11.5	9.2	12.8	6.0	15.7	11.9	8.8	21.5	14.7	10.3	12.2	9.1	20.5	6.4	9.0	14.9	9.5	9.9	11.7	17.6	21.1	10.0	20.4	15.9	9.8	10.0	11.9	21.2	11.5	41.3	84.1	16.6	29.3	28.6	36.8	27.5	4.2	8.3	16.7	20.3	38.7	16.8	17.8	15.6	15.8	37.7	10.8	11.2	13.8	23.5	14.5	29.1	18.0	11.1	38.8	20.4	24.3	29.7	32.9	15.5	19.3	26.3	17.3	41.7	23.3	12.3	15.1	12.4	22.6	15.7	17.4	44.7	64.9	12.3	7.1	18.6	14.4	34.7	11.5	27.3	22.1	12.1	25.4	10.7	43.6	17.3	25.6	32.3	13.2	22.2	10.0	37.5	53.9	28.3	8.7	9.7	5.2	6.8	11.7	9.8	9.7	10.3	11.6	12.8	10.1	12.0	11.5	2.6	13.9	15.3	25.3	8.9	6.0	7.7	10.1	8.2	9.1	9.0	8.9	5.7	6.9	6.0	6.4	9.9	9.8	39.9	19.2	15.0	36.6	16.6	19.2	15.4	31.9	18.2	41.8	23.0	34.0	18.8	12.8	22.1	35.0	31.3	23.4	27.1	4.7	31.3	20.1	21.0	27.8	88.1	23.6	15.5	20.8	57.2	21.0	27.7	49.9	20.4	14.1	7.0	29.3	25.4	14.9	19.5	18.5	55.2	19.2	40.7	16.4	14.9	11.2	37.9	16.7	16.0	18.7	10.4	20.3	18.6	33.7	66.1	20.8	10.3	28.2	27.0	21.5	9.5	22.0	37.9	40.0	6.6	35.5	46.7	51.2	44.3	19.6	19.0	9.7	16.2	35.4	17.1	12.7
DTX1	"hDx-1, RNF140"	ENSG00000135144	"Deltex E3 ubiquitin ligase 1"	Q86Y01	12	113056709-113098028	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.1;lymphoid tissue: 11.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 48.3;Horizontal cells: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Daudi: 109.1;REH: 45.1;U-698: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051249, HPA055275"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA051249: , HPA055275: AB_2682769"	"unprognostic (2.13e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.02e-5)"	"unprognostic (2.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.78e-3)"	9.0	1.7	6.5	5.7	6.8	2.7	6.4	3.2	5.9	2.4	0.2	0.8	1.3	1.5	0.3	0.9	1.8	0.8	1.2	5.2	11.1	3.5	8.9	0.8	11.1	5.2	8.8	0.4	1.6	0.0	3.3	0.3	5.1	0.8	0.1	2.9	2.6	0.3	0.5	1.0	3.5	0.3	3.7	11.8	0.9	1.9	10.5	0.5	2.2	0.1	6.0	0.5	0.6	2.4	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	109.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.3	4.6	0.0	2.0	0.2	0.0	45.1	0.2	2.6	0.0	0.0	2.7	7.1	0.4	0.4	2.5	0.0	0.1	0.2	1.2	0.0	4.0	0.0	0.1	0.5	0.2	110.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	6.8	3.2	5.9	5.2	11.1	5.2	8.8	5.1	3.7	10.5	2.4	0.7	0.0	0.0	48.3	8.8	1.0	0.0	0.0	0.0	4.7	0.2	0.6	0.7	0.0	0.0	1.8	8.4	0.0	0.3	0.1	7.9	2.5	0.7	0.7	17.5	1.7	0.0	0.0	10.6	0.0	0.0	4.5	0.5	0.4	7.0	0.0	0.4	12.4	0.8	171.6	13.8	0.1	0.0	0.3	0.6	1.7	7.8	0.2	3.6	2.8	0.0	11.4	2.1	13.0	1.0	0.2	0.1	7.5	2.5	0.0	0.0	0.2	0.0	2.8	0.0	0.4	1.3	0.8	2.4	0.0	0.4	0.0	2.2	0.8	0.0	0.0
DTX2	"KIAA1528, RNF58"	ENSG00000091073	"Deltex E3 ubiquitin ligase 2"	Q86UW9	7	76461676-76505995	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 54.0"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 67.7;CAPAN-2: 110.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042931	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nuclear membrane"		"HPA042931: AB_2678227"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (1.13e-8)"	"unprognostic (2.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-2)"	10.0	5.0	5.6	12.3	6.3	5.1	10.3	3.3	10.1	17.4	13.8	15.8	10.2	9.3	1.1	54.0	10.5	9.3	6.8	4.3	5.9	5.4	8.7	10.3	10.9	11.1	8.1	8.1	10.5	8.4	6.7	5.3	8.1	13.7	8.1	4.4	30.4	3.9	12.5	31.0	13.3	4.3	3.8	13.3	14.2	28.1	13.5	9.0	7.9	2.7	10.1	12.1	27.2	12.8	31.8	67.7	9.9	14.7	5.5	5.4	21.2	6.8	5.7	7.2	9.9	19.1	110.9	9.8	4.7	6.8	38.1	23.2	5.3	32.1	4.5	22.1	11.3	5.6	14.4	16.9	7.4	8.2	13.7	9.6	19.1	18.7	10.0	5.6	5.5	17.2	17.3	14.3	8.8	15.3	12.6	28.6	14.4	23.8	10.2	13.8	9.1	17.7	3.4	24.4	3.9	8.2	10.9	18.4	9.3	8.6	18.5	21.6	5.8	40.5	19.0	13.8	27.1	10.7	13.7	11.2	8.8	8.8	21.3	17.7	11.6	17.2	8.6	13.3	6.2	6.6	7.1	8.5	10.1	7.3	7.1	7.9	22.8	4.2	18.8	17.8	11.0	8.4	5.6	6.3	3.3	10.1	4.3	5.9	11.1	8.1	8.1	3.8	13.5	12.8	7.3	6.4	5.0	5.2	13.1	33.9	19.5	87.2	23.3	2.6	7.1	4.8	2.3	4.3	59.2	7.3	8.4	18.5	12.0	39.1	3.9	19.4	33.0	8.1	3.1	5.9	9.1	3.8	5.7	10.8	13.5	6.5	61.2	10.7	3.8	3.2	7.1	4.3	21.6	3.3	5.2	25.6	22.4	11.0	7.7	10.4	5.6	14.5	7.2	19.7	10.0	5.7	8.2	18.1	10.0	23.1	37.9	4.9	13.9	20.0	21.0	3.2	62.8	9.2	6.6	3.0	7.3	11.0	11.0	27.0	35.4	37.6	9.7	1.9	26.1	62.5
DTX3	"FLJ34766, RNF154"	ENSG00000178498	"Deltex E3 ubiquitin ligase 3"	Q8N9I9	12	57604622-57609804	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 70.7"	"Cancer enriched"	"Detected in all"	4	"glioma: 54.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"NK-cells: 1.0;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 84.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059654	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA059654: AB_2684097"	"unprognostic (2.31e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.84e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.62e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.99e-2)"	"unprognostic (8.81e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.48e-2)"	36.6	58.2	117.1	15.8	120.2	7.2	36.4	117.5	138.2	97.6	115.0	117.4	11.5	95.5	50.7	24.2	92.0	24.5	67.6	124.5	111.4	63.8	12.3	37.2	21.2	107.8	112.1	124.3	41.9	39.4	145.1	28.1	108.6	82.1	16.8	80.8	31.4	48.2	21.0	21.1	46.2	48.5	105.3	46.0	51.0	29.0	112.6	23.6	75.9	16.6	15.5	65.0	60.7	119.0	8.8	22.7	65.9	0.1	0.0	0.1	0.4	13.8	35.4	29.7	30.0	11.8	36.5	12.3	20.5	30.0	0.3	14.2	0.0	1.7	20.9	31.1	4.1	7.1	39.4	12.5	49.4	0.0	0.1	24.5	16.7	22.8	0.3	84.4	33.6	0.1	0.0	40.9	23.1	19.2	38.4	0.3	52.1	7.2	2.0	0.0	55.1	0.7	2.8	22.7	47.7	75.5	10.9	3.1	7.0	15.8	38.4	18.9	0.1	38.6	15.3	17.9	20.2	66.2	53.6	0.2	24.8	0.1	20.6	0.0	0.0	0.0	2.5	0.0	0.6	0.1	0.9	1.2	0.1	0.1	0.8	1.6	0.0	1.0	0.0	0.3	2.2	1.2	117.1	120.2	117.5	138.2	124.5	111.4	107.8	112.1	108.6	105.3	112.6	119.0	4.9	16.0	15.6	25.8	2.9	6.2	10.0	8.7	21.1	47.8	12.2	19.9	11.0	11.5	10.5	12.9	50.1	0.5	10.6	0.5	13.7	8.2	0.9	17.8	17.4	8.5	15.6	4.4	29.9	1.9	0.3	15.1	6.1	5.5	5.7	17.2	15.0	0.6	0.6	70.7	29.3	0.9	10.2	2.0	2.1	2.8	34.2	1.6	3.6	8.4	0.8	27.4	36.0	25.1	19.0	2.6	0.0	31.6	5.8	7.1	0.0	4.6	30.9	42.0	46.0	11.5	37.5	4.6	5.7	2.8	2.8	1.2	10.4	16.8	0.7	3.5
DTX3L	"BBAP, RNF143"	ENSG00000163840	"Deltex E3 ubiquitin ligase 3L"	Q8TDB6	3	122564338-122575203	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 91.6;BJ hTERT+ SV40 Large T+ RasG12V: 112.3;GAMG: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010570	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA010570: AB_1847877"	"unprognostic (8.15e-2)"	"unprognostic (7.36e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.51e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.61e-2)"	11.1	9.2	5.5	24.4	6.0	12.8	10.8	5.0	6.4	10.1	4.8	15.5	20.6	12.3	6.5	11.4	11.4	15.3	7.3	4.6	6.1	9.9	32.1	20.8	21.8	11.1	6.6	9.4	17.8	11.1	5.3	16.3	7.4	12.3	16.2	2.6	20.3	8.6	7.8	8.1	18.7	14.8	8.3	26.6	15.9	3.6	8.3	17.4	11.9	9.2	20.9	18.2	8.2	7.2	31.2	9.4	2.6	7.9	12.0	27.6	10.2	7.9	29.3	91.6	112.3	9.2	31.2	3.6	15.1	13.2	87.8	30.5	9.2	12.8	20.1	26.3	3.4	27.1	7.2	9.8	23.7	14.0	20.2	23.8	14.8	13.7	7.8	17.4	17.6	16.9	3.5	18.8	6.9	9.6	34.3	9.9	1.7	9.7	17.2	37.5	21.0	6.0	23.4	19.8	3.8	4.1	16.6	7.4	59.5	1.8	8.5	17.5	21.6	10.4	14.5	1.0	10.2	6.8	4.0	16.4	17.9	17.9	10.9	21.4	11.3	12.0	11.6	18.1	12.5	7.5	9.5	12.4	8.7	7.9	8.4	9.3	28.2	10.5	19.4	0.9	9.9	9.9	5.5	6.0	5.0	6.4	4.6	6.1	11.1	6.6	7.4	8.3	8.3	7.2	31.3	32.1	28.1	3.9	19.7	8.9	10.2	10.4	9.1	0.3	12.9	8.1	5.1	15.7	15.0	7.3	0.0	4.1	15.3	46.3	0.0	23.1	2.5	17.2	26.7	24.1	18.5	16.2	0.0	32.5	15.2	13.3	30.5	27.5	15.8	17.5	25.4	56.7	28.4	0.0	0.3	26.6	10.2	38.6	5.8	1.1	8.4	26.1	5.4	13.1	38.2	5.1	40.2	0.5	1.1	32.4	15.0	9.1	11.8	20.1	24.2	15.1	17.0	0.4	32.9	10.0	10.7	1.8	0.5	12.4	6.0	1.8	19.2	8.3	20.6	20.1
DUS3L	"DUS3, FLJ13896"	ENSG00000141994	"Dihydrouridine synthase 3 like"	Q96G46	19	5784832-5791225	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041854, HPA041944, HPA062846"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: AB_2684879"	"unprognostic (1.25e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.64e-3)"	"unprognostic (6.08e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (7.35e-3)"	"unprognostic (4.25e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	14.5	15.3	7.1	8.4	7.4	20.7	15.6	6.8	10.2	16.9	7.2	15.4	11.4	16.3	1.6	20.6	17.1	4.1	13.4	7.0	6.6	16.7	25.2	11.7	9.5	8.9	7.3	18.2	24.1	3.9	13.7	5.4	7.3	18.9	2.8	3.0	17.7	5.0	16.7	24.6	18.4	2.8	7.0	19.6	16.9	40.2	7.7	8.1	18.6	3.7	3.7	15.5	16.8	9.4	29.9	28.3	8.1	29.0	2.3	3.7	26.9	9.8	5.7	9.9	7.6	44.4	13.9	30.2	36.1	3.9	11.5	18.9	7.3	9.5	1.5	22.7	63.6	20.3	15.4	16.9	14.2	45.0	56.2	8.6	10.0	11.3	7.8	1.3	6.8	19.8	53.2	0.0	5.4	38.0	38.8	45.9	28.4	10.7	76.9	19.4	17.0	38.1	4.2	20.7	27.9	28.6	10.3	17.0	19.7	1.9	12.1	36.1	9.4	14.3	25.2	43.1	42.6	83.4	66.9	29.3	13.9	46.1	16.4	8.3	20.1	5.8	21.5	30.2	24.7	15.2	16.4	20.3	29.8	19.0	21.2	21.5	2.2	27.9	25.3	30.9	20.1	16.3	7.1	7.4	6.8	10.2	7.0	6.6	8.9	7.3	7.3	7.0	7.7	9.4	7.2	9.6	10.0	2.6	19.9	14.7	19.3	16.7	25.6	6.6	7.7	10.2	3.0	7.2	9.7	1.8	12.5	18.3	9.3	14.4	7.9	12.4	48.8	6.7	8.3	9.2	7.7	25.2	4.2	22.4	17.7	10.9	18.3	8.2	35.5	7.7	4.6	7.5	14.8	11.8	5.0	12.8	4.1	7.2	9.1	10.9	12.8	10.6	5.4	1.9	6.9	4.3	14.4	1.5	4.8	12.0	10.3	6.4	12.3	8.6	12.8	7.2	6.2	11.1	19.7	15.8	9.8	55.0	10.7	16.1	12.8	21.8	13.5	9.8	15.9	12.7
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742089	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 32.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 19.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 102.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	3.8	2.4	4.3	5.2	7.4	25.0	6.0	7.7	5.3	4.5	4.7	8.0	1.4	3.6	1.2	6.0	6.4	6.6	2.6	4.5	4.5	1.4	32.9	6.2	9.1	7.1	6.0	1.6	17.0	1.2	1.2	3.8	5.8	2.7	4.1	14.9	6.3	0.9	22.9	6.1	3.9	8.9	3.8	6.1	2.5	3.1	9.0	5.6	4.4	3.6	7.6	6.1	2.7	13.5	15.2	6.4	0.5	0.4	45.4	22.6	0.5	10.1	25.9	16.2	12.5	0.3	4.2	11.6	3.3	26.1	11.9	102.3	2.2	9.8	14.0	30.5	1.2	20.4	3.0	1.8	10.6	9.1	13.3	31.9	7.0	17.6	17.8	7.5	0.6	3.0	2.1	4.0	16.0	0.3	1.8	7.2	1.5	3.2	0.7	1.1	28.5	0.9	5.7	9.1	37.4	3.0	1.3	1.2	43.6	5.6	2.1	5.5	3.6	8.1	2.2	12.6	12.4	6.8	5.1	6.2	12.8	4.1	8.9	8.2	5.5	0.3	4.5	4.6	3.9	0.8	2.9	3.1	7.0	0.9	1.0	1.7	0.5	19.7	1.9	0.2	16.9	2.2	4.3	7.4	7.7	5.3	4.5	4.5	7.1	6.0	5.8	3.8	9.0	13.5	4.9	0.0	1.7	2.6	21.7	50.9	13.5	13.6	25.6	6.0	42.4	18.7	4.7	14.3	19.2	3.7	20.9	2.8	39.0	3.1	0.0	35.9	61.1	57.9	6.6	6.7	43.9	2.5	0.3	9.1	3.7	7.9	4.6	53.7	133.5	0.2	1.8	53.6	22.3	1.7	30.9	17.7	69.2	9.7	46.9	7.1	24.8	26.0	23.2	2.8	14.1	14.3	17.5	17.1	50.5	26.2	0.8	12.8	9.9	11.0	0.4	1.1	18.5	34.2	0.0	33.7	5.3	9.7	3.2	16.7	41.3	3.4	47.0	28.7	3.6	16.5
DUSP11	PIR1	ENSG00000144048	"Dual specificity phosphatase 11"	O75319	2	73762184-73780157	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021052			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge"		Yes	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli fibrillar center"	"Cytokinetic bridge"	"HPA021052: AB_2670577"	"unprognostic (2.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.28e-3)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (7.20e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.84e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.46e-1)"	16.0	13.3	7.9	17.1	7.7	35.2	20.4	13.4	11.2	22.4	7.6	16.0	17.3	21.2	19.3	30.5	39.0	15.9	14.2	8.1	6.9	20.2	17.9	14.3	25.3	6.1	5.7	23.5	11.0	14.7	14.0	20.5	6.1	16.5	17.4	8.3	16.0	14.4	14.3	27.6	15.3	19.6	4.8	19.0	16.3	16.8	6.5	24.8	16.5	17.8	26.1	25.2	22.4	8.3	39.4	16.7	17.6	18.6	31.2	38.7	31.2	28.2	36.7	35.8	36.4	24.2	29.1	50.6	17.7	30.6	32.1	26.7	22.0	56.8	34.3	35.2	22.9	31.2	12.0	37.3	32.7	35.5	28.0	31.6	67.3	32.1	44.1	31.1	40.4	24.2	33.6	28.6	40.2	21.3	34.3	37.6	28.4	36.7	22.7	13.6	47.3	46.0	29.3	32.1	25.9	14.1	26.1	30.6	35.7	21.0	16.4	18.6	23.1	25.4	31.4	29.5	33.7	30.7	26.2	68.1	23.5	35.5	25.3	72.5	42.2	99.5	56.3	39.3	73.5	68.3	65.8	67.4	47.3	65.9	69.4	65.5	65.2	69.8	40.6	35.7	88.6	71.7	7.9	7.7	13.4	11.2	8.1	6.9	6.1	5.7	6.1	4.8	6.5	8.3	26.5	9.6	12.0	7.5	39.5	83.2	55.1	93.0	39.3	11.0	12.9	15.1	8.6	27.1	45.7	12.9	4.2	32.8	34.8	15.5	50.9	29.6	9.1	18.0	15.7	34.6	12.0	21.0	14.9	27.3	42.0	26.5	16.3	13.6	40.7	20.5	52.1	15.3	30.7	5.0	12.7	18.0	36.7	20.2	27.1	7.0	28.9	17.0	23.2	10.3	34.8	9.8	41.2	13.0	13.8	28.2	17.8	25.6	31.8	30.0	22.8	50.4	38.2	16.6	6.6	18.2	23.1	23.8	34.6	42.8	83.0	38.6	39.8	20.7	18.8	60.9
DUSP12	"DUSP1, YVH1"	ENSG00000081721	"Dual specificity phosphatase 12"	Q9UNI6	1	161749758-161757238	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008840	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA008840: AB_1847884"	"unprognostic (3.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-3)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-1)"	13.3	9.6	12.1	9.1	12.5	30.9	14.1	14.3	14.6	13.8	12.1	12.9	7.6	14.3	8.9	10.3	12.5	6.7	9.4	12.0	12.4	14.4	9.4	11.4	13.8	12.2	12.2	13.6	13.6	8.2	9.5	11.2	12.3	11.0	10.5	13.2	10.9	9.5	7.4	10.9	12.4	11.0	12.3	14.1	11.5	6.7	12.0	11.7	12.1	7.3	13.0	13.1	11.5	13.3	32.6	28.2	33.1	21.7	17.2	18.5	30.4	25.9	33.7	39.2	29.9	42.1	28.2	19.9	25.7	31.9	24.4	22.7	26.0	32.0	38.0	25.5	22.0	17.8	27.7	28.4	36.4	38.6	17.1	25.4	34.6	34.1	61.0	22.2	27.6	27.2	31.7	20.9	28.3	30.0	22.7	43.2	52.1	35.2	43.1	32.2	32.0	32.9	22.2	39.3	20.6	43.6	21.9	36.2	44.1	36.2	31.3	43.6	19.3	33.3	30.8	26.3	55.6	35.3	31.0	47.0	20.3	38.1	33.3	32.0	16.9	13.7	18.4	19.5	22.9	19.2	20.8	17.8	22.0	20.0	19.6	21.8	6.8	28.4	12.2	10.0	19.5	12.9	12.1	12.5	14.3	14.6	12.0	12.4	12.2	12.2	12.3	12.3	12.0	13.3	22.9	19.2	12.8	8.1	25.5	13.6	14.4	25.9	25.6	15.9	13.4	16.1	5.0	8.6	15.6	7.3	8.4	21.7	26.4	4.8	21.5	22.2	4.2	7.4	13.7	18.4	11.3	16.2	11.9	24.3	22.7	17.3	11.7	7.2	18.3	18.7	18.5	8.2	20.5	10.1	14.8	9.8	8.2	20.6	16.2	1.2	8.7	15.4	10.6	10.3	22.1	15.8	33.0	12.1	14.4	21.2	6.5	17.7	27.5	17.1	8.6	18.5	7.0	19.6	0.0	13.2	24.5	13.9	12.6	18.2	13.1	17.6	23.5	16.4	12.1	12.0
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489891-37513501	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 179.7;Basal prostatic cells: 239.3;Cytotrophoblasts: 162.8;Endometrial ciliated cells: 146.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 36.4;SuSa: 24.9;WM-115: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes		79000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	15.3	14.2	10.9	1.3	11.2	0.3	12.4	11.2	17.0	12.8	10.9	10.3	0.0	9.5	5.5	17.4	7.5	1.2	14.1	11.0	10.9	8.7	15.2	8.6	0.4	11.9	11.1	5.6	6.6	1.0	14.5	0.9	10.6	6.4	1.0	9.9	13.1	0.3	11.0	44.1	5.5	0.8	10.4	2.8	7.6	13.7	10.8	4.4	23.1	4.4	2.7	7.2	17.1	10.7	2.6	0.2	4.9	2.1	0.1	0.6	2.1	10.4	7.8	14.3	15.6	1.2	17.9	0.2	0.9	7.6	0.2	2.8	0.2	6.1	36.4	0.2	0.7	0.0	1.6	6.2	1.5	0.5	3.0	8.5	5.5	4.8	2.5	10.2	0.3	0.2	0.6	3.1	11.4	0.4	9.7	1.7	0.3	3.8	0.0	2.5	0.6	2.5	17.5	2.4	1.9	0.3	0.5	17.6	4.1	24.9	0.8	3.9	1.4	10.8	5.8	0.1	5.8	0.1	0.3	0.1	0.1	0.0	37.5	1.1	0.0	0.7	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.7	1.6	0.0	0.2	0.0	0.0	0.2	10.9	11.2	11.2	17.0	11.0	10.9	11.9	11.1	10.6	10.4	10.8	10.7	15.0	6.4	5.4	2.9	8.3	179.7	239.3	74.8	129.1	6.8	42.6	46.0	15.0	4.3	39.6	7.3	8.4	162.8	16.6	0.3	29.4	34.8	36.4	146.9	18.5	21.7	2.4	11.4	12.0	15.1	82.1	30.2	3.1	85.3	87.0	10.6	14.6	15.7	19.7	15.2	5.3	1.2	36.7	2.8	34.8	52.5	13.7	5.9	62.2	4.7	25.3	16.1	15.5	3.0	3.3	74.8	2.9	6.0	9.9	64.9	0.1	16.9	61.3	24.5	0.0	13.2	45.2	26.0	33.4	44.0	92.6	67.9	18.2	26.3	1.1	67.0
DUSP16	"KIAA1700, MKP-7, MKP7"	ENSG00000111266	"Dual specificity phosphatase 16"	Q9BY84	12	12473282-12562863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 114.9;Oligodendrocytes: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 37.7;RT4: 34.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020326	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020326: AB_1847890"	"unprognostic (8.05e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.76e-2)"	9.3	47.8	4.9	7.8	8.3	3.6	15.0	7.7	5.3	12.2	6.3	11.3	13.6	11.3	6.2	12.7	10.5	8.0	7.2	4.8	6.0	7.6	33.3	12.0	6.4	7.3	8.1	10.7	18.8	8.0	12.9	5.5	6.2	19.7	10.9	7.5	14.6	3.4	11.3	11.1	13.1	4.9	5.4	6.8	13.2	7.1	6.7	15.2	8.8	4.7	9.0	10.7	17.0	11.8	4.5	6.5	7.6	4.2	2.8	3.3	13.6	2.6	5.8	6.4	9.1	18.1	8.6	0.4	1.4	2.9	11.3	2.9	14.1	2.4	8.6	14.4	7.0	0.7	6.8	19.2	5.4	1.3	3.0	2.8	6.7	5.1	16.3	6.8	5.0	7.3	4.0	11.8	0.4	8.6	1.7	0.9	37.7	11.1	1.9	2.0	2.6	8.6	3.6	34.3	12.3	11.5	10.6	13.6	6.7	28.2	5.5	2.2	4.5	2.9	8.3	1.8	2.9	8.3	10.6	1.5	3.8	2.9	4.0	0.0	0.0	0.0	0.5	0.0	2.3	0.0	1.6	0.7	0.1	0.0	0.5	0.3	0.8	0.0	0.0	0.0	3.9	0.3	4.9	8.3	7.7	5.3	4.8	6.0	7.3	8.1	6.2	5.4	6.7	11.8	9.6	28.9	55.5	30.3	3.3	2.8	14.9	1.5	3.4	4.8	23.8	13.1	11.5	20.0	9.7	3.7	2.1	10.5	5.6	35.7	0.0	14.3	1.3	15.1	10.2	9.2	49.6	0.0	19.5	24.6	4.1	9.9	11.7	19.9	23.5	114.9	7.5	34.2	5.3	6.7	24.8	10.0	2.0	9.4	1.9	2.3	5.9	5.7	5.4	38.4	2.9	36.8	0.0	56.3	196.3	20.9	25.3	6.8	4.3	34.3	25.4	5.2	10.4	4.8	0.0	11.1	10.3	3.0	5.8	6.2	1.8	30.1	27.9	9.9	18.7	24.5
DUSP18	DUSP20	ENSG00000167065	"Dual specificity phosphatase 18"	Q8NEJ0	22	30652051-30667887	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 123.4;Late spermatids: 344.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034070, HPA051349"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB034070: AB_2094867, HPA051349: AB_2681450"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	3.3	1.9	3.4	4.5	3.6	3.3	2.8	2.9	5.3	2.4	9.1	5.4	5.0	2.9	4.9	4.1	10.9	4.2	2.0	3.7	4.0	2.2	1.0	5.5	4.7	5.4	7.6	2.4	2.9	3.3	4.2	2.1	4.9	2.1	6.8	5.2	2.5	2.4	1.3	4.8	4.6	3.8	4.8	4.3	4.8	13.9	4.5	4.0	3.3	1.6	3.9	3.3	2.6	6.0	5.4	5.4	2.5	5.8	6.2	11.9	2.3	4.9	5.3	4.7	5.1	3.1	5.3	3.6	3.3	6.0	6.2	3.8	1.3	3.8	5.3	9.8	6.1	1.5	2.2	2.2	2.6	7.4	5.3	3.1	5.4	7.8	3.0	5.3	15.0	4.1	1.7	2.8	5.2	4.8	4.2	1.8	0.8	6.4	3.3	2.8	1.7	1.2	5.6	3.7	6.2	3.7	4.8	1.7	3.5	3.2	4.5	2.2	11.1	9.9	5.4	2.7	2.8	2.1	2.6	1.7	11.4	1.3	5.0	31.4	15.3	29.9	8.6	19.3	6.6	9.7	9.6	7.7	17.2	8.7	6.6	7.5	31.8	7.4	21.4	9.7	13.2	8.4	3.4	3.6	2.9	5.3	3.7	4.0	5.4	7.6	4.9	4.8	4.5	6.0	7.2	19.2	5.4	11.4	7.1	21.4	13.3	6.5	2.2	2.9	4.9	3.4	2.0	10.0	9.6	5.5	45.9	1.2	12.0	10.0	3.9	10.1	123.4	34.5	5.0	10.1	35.5	2.1	8.0	9.4	3.9	6.8	8.6	5.0	7.0	4.4	13.9	1.1	8.1	1.7	4.4	15.4	6.1	15.6	28.5	344.2	8.4	13.2	8.8	13.1	13.9	10.1	9.2	1.5	14.3	9.3	15.4	6.8	3.9	8.8	24.2	4.1	64.6	16.8	6.6	8.6	6.6	63.0	17.2	5.7	21.3	1.0	9.7	3.5	19.0	8.7
DUSP19	"DUSP17, SKRP1"	ENSG00000162999	"Dual specificity phosphatase 19"	Q8WTR2	2	183078559-183100008	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.2;Endometrial ciliated cells: 17.7;Respiratory ciliated cells: 15.7;Spermatocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 1.3;basal ganglia: 2.4;cerebral cortex: 2.7;hippocampal formation: 3.8"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021501	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA021501: AB_1847892"	"unprognostic (1.24e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.80e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.75e-2)"	1.1	1.4	1.3	0.8	2.4	0.3	1.1	0.0	2.7	1.2	0.1	1.4	1.4	1.4	3.5	1.4	3.2	1.3	3.1	3.8	0.1	1.8	1.1	1.3	1.0	0.1	0.0	1.6	0.9	1.6	1.2	1.0	0.0	1.5	1.0	1.2	0.9	1.9	1.6	1.3	1.1	1.9	0.0	1.6	3.9	3.7	0.0	1.2	1.7	1.7	0.7	1.1	0.6	0.4	0.1	1.6	1.8	0.9	2.5	1.4	0.0	0.7	1.1	2.9	1.0	1.5	1.9	0.6	3.8	0.8	2.1	0.2	3.8	0.5	2.3	3.9	1.8	7.1	1.1	1.0	1.0	1.8	4.2	1.1	0.3	1.3	0.7	1.8	1.5	0.0	2.2	1.0	1.8	0.6	3.4	1.6	1.5	0.6	1.2	3.3	2.9	0.2	0.6	0.7	2.3	0.9	2.6	1.1	2.0	0.1	0.5	0.6	1.3	1.6	1.3	1.1	0.6	1.3	1.6	0.0	2.0	0.3	2.4	0.7	0.1	0.6	0.6	0.2	0.6	1.1	0.5	0.8	0.1	0.5	0.7	0.7	0.3	0.7	0.1	0.4	1.0	0.3	1.3	2.4	0.0	2.7	3.8	0.1	0.1	0.0	0.0	0.0	0.0	0.4	2.5	0.0	3.2	0.7	1.6	1.0	1.3	1.1	3.4	1.8	2.1	2.7	8.3	1.5	1.8	1.8	2.1	2.0	0.8	1.5	5.9	0.9	15.2	17.7	2.3	3.3	2.4	0.0	9.9	0.7	1.5	1.7	3.6	1.5	1.3	3.0	2.9	1.9	0.6	1.7	7.8	1.9	0.0	0.8	0.3	6.0	1.8	2.2	0.0	1.0	1.1	4.8	2.1	4.0	3.1	0.6	3.4	2.6	0.3	0.7	2.2	2.9	15.7	1.5	0.0	1.9	4.4	15.5	3.8	2.3	1.6	0.7	1.2	3.6	1.8	1.1
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143169-96145440	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 919.7;Glandular and luminal cells: 321.1;Langerhans cells: 924.0;Macrophages: 353.9;T-cells: 764.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 55.0"	"Immune cell enhanced"	"Detected in all"		"gdT-cell: 199.3"	"Group enriched"	"Detected in all"	10	"NK-cells: 148.1;T-cells: 199.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.4;HeLa: 29.7;JURKAT: 27.6;Karpas-707: 33.8;NB-4: 29.1;RT4: 34.2;SCLC-21H: 29.6;U-698: 43.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	17.0	6.0	7.6	18.6	11.6	129.5	5.5	7.5	55.0	8.1	9.2	4.5	1.6	7.0	7.7	6.8	7.6	12.5	19.5	13.4	6.2	12.7	7.5	18.2	47.1	8.0	6.3	7.8	2.3	1.7	35.1	1.3	6.7	17.6	2.0	0.4	3.9	61.5	2.8	26.0	11.8	3.4	6.7	42.0	7.4	3.6	6.9	47.3	6.7	3.7	24.6	39.5	9.0	9.3	3.2	0.0	0.2	0.2	0.4	0.5	4.4	3.7	0.0	5.3	5.1	8.9	0.6	30.4	10.6	4.1	0.0	2.2	7.5	0.0	1.0	0.5	0.0	0.7	29.7	0.0	1.9	12.8	2.6	0.9	2.0	0.9	0.0	0.1	0.0	27.6	0.0	33.8	0.2	5.2	25.5	29.1	6.5	0.8	10.6	0.0	0.4	24.3	0.2	34.2	29.6	1.5	1.4	0.3	5.6	0.0	2.0	14.4	0.1	0.0	7.9	0.0	1.7	2.3	3.9	43.2	0.0	13.9	0.3	2.3	4.3	1.0	199.3	10.5	95.4	17.5	46.7	176.2	10.7	13.9	32.0	99.3	6.1	148.1	9.1	3.0	16.1	40.5	7.6	11.6	7.5	55.0	13.4	6.2	8.0	6.3	6.7	6.7	6.9	9.3	50.8	0.0	7.7	0.7	303.7	96.7	155.0	31.3	70.6	27.8	65.8	72.0	37.8	2.8	12.0	9.2	22.9	0.9	919.7	20.4	1.9	0.9	0.9	115.6	62.7	28.7	87.8	50.5	5.2	1.4	1.7	22.8	86.6	321.1	104.3	7.4	12.8	3.9	80.2	0.0	1.4	37.5	8.2	40.4	924.0	1.4	1.8	353.9	144.1	1.9	3.4	1.5	90.6	1.0	0.5	1.0	2.5	1.9	268.5	70.4	1.6	1.4	2.7	3.6	0.0	14.7	26.6	0.6	4.8	50.4	109.7	1.6	764.7	3.0	51.6	41.1
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 270.6;U-266/70: 130.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	36.9	16.4	25.6	27.7	29.1	23.7	33.0	27.4	28.8	31.6	21.2	47.8	22.5	28.9	12.2	45.7	25.9	21.3	42.1	25.1	27.1	32.4	32.7	38.5	32.4	32.3	28.5	19.6	40.8	13.2	21.2	27.3	30.3	23.2	16.1	7.8	30.4	15.1	52.3	41.4	33.7	22.0	28.0	43.9	32.7	44.9	29.3	15.0	28.1	37.7	30.5	30.3	36.8	42.7	13.7	8.3	17.3	25.9	19.5	21.5	22.8	9.9	8.0	8.6	10.3	8.8	15.1	28.4	23.3	10.3	18.3	9.4	21.9	18.3	6.1	68.6	25.1	19.3	7.1	24.7	9.9	7.0	24.4	16.2	54.1	6.2	11.3	14.1	24.8	24.0	18.3	92.2	7.2	8.2	10.3	25.1	10.4	10.0	18.7	20.2	11.7	270.6	16.2	5.8	29.7	11.6	8.5	3.4	29.6	37.4	17.6	8.9	34.2	7.7	10.1	7.8	6.0	130.0	98.6	40.0	3.0	19.0	17.7	36.4	32.5	13.6	8.6	26.5	6.2	40.4	6.7	9.1	33.5	33.3	6.1	8.8	21.8	5.9	25.1	28.8	15.9	19.6	25.6	29.1	27.4	28.8	25.1	27.1	32.3	28.5	30.3	28.0	29.3	42.7	45.5	16.0	21.3	5.5	53.7	26.5	22.0	33.3	14.2	5.7	19.4	17.5	40.8	10.0	30.7	5.5	0.0	10.8	51.1	11.7	21.5	24.2	13.4	18.6	8.2	33.4	9.5	8.2	8.5	51.4	7.7	21.9	15.3	12.9	33.0	8.8	21.8	25.0	30.1	0.0	6.1	14.7	32.6	38.6	43.0	20.5	15.5	47.1	46.2	21.5	78.4	14.9	36.0	7.1	25.9	29.2	12.4	9.4	59.7	16.5	23.2	18.2	39.7	3.2	26.3	11.6	22.8	34.5	73.8	42.5	37.1	6.6	21.3	6.8	15.4	27.9
DUSP23	"DUSP25, FLJ20442"	ENSG00000158716	"Dual specificity phosphatase 23"	Q9BVJ7	1	159780932-159782543	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 458.5;Proximal tubular cells: 800.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 142.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028211, HPA045792"	Approved		Supported	Nucleoplasm		NA	NA		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA028211: AB_2672522, HPA045792: AB_10961133"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (8.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	75.0	122.4	29.1	15.4	31.5	20.5	99.9	32.0	38.5	57.6	30.0	46.3	26.7	55.0	15.5	82.0	52.3	13.4	36.1	31.8	31.4	199.1	189.3	55.3	10.4	32.0	30.1	35.6	76.8	34.6	20.8	5.9	32.1	55.3	13.9	8.1	152.4	15.3	65.4	61.1	42.9	12.0	32.8	39.2	39.7	18.2	31.3	15.2	58.8	16.6	9.1	45.1	53.6	31.0	39.5	42.2	0.3	0.2	39.5	33.5	0.4	15.8	13.0	18.4	14.3	17.3	44.7	0.1	90.9	17.6	4.2	1.5	10.8	14.5	10.0	9.9	4.6	54.4	14.7	0.0	58.6	33.3	40.4	142.8	38.3	12.1	43.0	13.2	71.0	0.1	25.2	19.4	26.3	72.5	3.5	1.4	71.3	71.6	58.7	0.1	0.0	18.8	22.7	6.9	17.8	39.4	28.6	63.0	78.5	7.3	40.6	51.7	51.7	15.3	0.8	1.9	0.2	13.5	34.8	0.5	25.8	26.5	11.7	111.8	181.7	229.1	97.9	153.4	54.6	60.5	72.7	92.8	261.3	43.7	44.0	65.1	185.6	100.5	105.6	59.2	70.8	112.2	29.1	31.5	32.0	38.5	31.8	31.4	32.0	30.1	32.1	32.8	31.3	31.0	100.4	41.7	58.7	3.3	23.8	74.6	129.2	151.8	100.7	8.5	110.6	112.1	29.5	95.8	122.2	51.5	6.2	16.1	28.4	97.7	262.2	210.7	48.3	47.5	30.8	155.8	35.4	37.5	1.4	458.5	29.2	31.2	32.1	130.9	54.5	66.1	75.0	249.4	170.3	1.7	0.5	124.9	91.6	94.3	72.9	8.4	26.4	92.2	42.7	4.7	58.9	74.8	69.0	1.0	4.4	208.4	112.2	15.8	14.6	121.5	140.4	800.7	54.8	10.0	13.1	16.0	34.9	5.4	19.9	123.2	74.4	5.7	43.6	72.3	109.5	116.1
DUSP26	"DUSP24, MGC1136, NEAP"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591330-33600023	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 421.3;tongue: 204.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 76.8;Cardiomyocytes: 59.4;Cone photoreceptor cells: 41.7;Enteroendocrine cells: 25.7;Horizontal cells: 25.2;Rod photoreceptor cells: 75.2"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7;pancreatic cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	0.7	27.4	44.2	1.2	45.2	0.2	0.4	47.4	49.6	1.2	18.4	2.8	3.5	1.3	5.6	5.0	3.6	1.2	70.8	45.0	53.0	1.5	0.2	3.3	0.4	39.8	42.1	33.2	3.0	2.0	61.4	0.0	55.2	4.2	1.1	34.1	4.6	0.8	421.3	0.3	2.6	2.7	38.3	0.7	3.9	3.6	44.4	0.8	0.9	204.4	0.8	1.2	1.7	41.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	97.7	23.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	3.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	45.2	47.4	49.6	45.0	53.0	39.8	42.1	55.2	38.3	44.4	41.1	0.0	0.0	0.0	1.3	0.9	0.0	0.2	0.0	0.6	76.8	0.0	0.3	59.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	21.5	0.4	7.8	0.4	0.1	0.8	25.7	0.0	11.3	0.4	0.0	3.5	0.5	0.1	0.0	1.0	0.4	0.0	0.0	25.2	14.7	0.5	0.0	0.0	0.0	5.2	0.0	0.1	1.8	2.8	0.0	22.8	0.0	12.1	12.0	1.1	0.0	6.0	5.3	0.3	0.0	2.5	0.0	75.2	0.0	10.8	5.2	0.2	0.2	0.0	0.0	0.0	0.6	0.7	0.1	0.1
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766125-43778977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 274.3;Late spermatids: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"dendritic cells: 33.5;granulocytes: 11.0;monocytes: 29.3"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	39.8	43.2	63.6	21.6	67.1	9.9	32.7	57.2	91.0	32.4	59.6	96.1	27.8	49.2	31.1	48.4	33.6	33.4	194.8	69.0	65.4	72.0	108.1	50.2	14.3	64.2	64.3	18.2	48.6	47.0	33.1	31.4	64.4	57.7	26.0	30.8	31.8	72.9	261.9	24.6	38.7	62.9	58.5	40.7	57.5	24.5	65.6	6.2	30.5	213.7	13.0	63.1	33.6	64.3	32.3	57.1	21.5	23.1	61.1	32.7	18.3	23.8	56.4	54.4	65.1	55.4	21.1	4.9	36.7	44.7	112.4	27.3	33.7	29.3	56.9	11.1	25.6	16.2	25.9	45.4	74.5	2.0	16.1	30.5	51.5	42.0	36.2	59.0	38.5	15.9	14.7	5.4	64.2	23.1	8.5	8.4	9.9	45.5	41.1	10.5	64.5	12.1	75.8	33.3	12.0	21.6	27.9	18.3	71.8	58.8	82.2	44.7	40.4	61.1	41.5	87.9	40.1	28.5	40.4	1.2	72.4	22.6	20.8	11.0	29.3	6.4	1.5	15.0	2.7	2.6	2.4	1.9	33.5	2.4	1.9	1.7	7.0	1.7	20.6	13.8	1.6	11.4	63.6	67.1	57.2	91.0	69.0	65.4	64.2	64.3	64.4	58.5	65.6	64.3	23.1	25.6	21.2	6.5	9.2	22.4	47.6	17.6	10.8	17.2	20.3	21.3	274.3	54.3	17.9	42.3	25.0	16.3	9.5	36.9	41.1	47.8	88.6	18.8	16.6	33.8	36.4	11.6	18.1	58.9	21.8	25.9	42.8	25.0	38.7	6.1	25.4	108.8	86.6	20.2	15.5	19.9	24.4	49.1	52.0	160.5	14.6	47.2	10.6	15.9	53.9	16.8	4.1	8.5	13.8	56.5	32.3	26.4	8.0	46.2	57.7	87.6	21.1	17.3	32.9	24.1	28.4	3.3	5.0	16.0	28.8	45.0	6.3	15.1	18.0	42.6
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350684	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 32.2;stomach 1: 32.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 155.5;Ionocytes: 126.1;Pancreatic endocrine cells: 195.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 20.9"	"Immune cell enriched"	"Detected in single"	9	"T-reg: 6.7"	"Lineage enriched"	"Detected in single"	20	"T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"A549: 100.0;OE19: 91.7;SK-MEL-30: 157.2;WM-115: 122.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	15.2	5.2	2.3	5.4	1.4	6.2	23.7	5.0	9.0	6.0	0.4	1.2	1.2	4.5	0.1	2.5	1.9	11.3	2.3	20.9	1.2	2.8	0.7	5.7	2.6	1.6	1.1	0.4	32.2	0.6	5.3	7.5	1.1	5.2	1.4	5.9	16.1	10.1	4.2	5.6	2.0	1.2	0.3	1.0	32.4	2.8	2.9	4.2	1.2	0.9	2.7	13.8	2.8	1.1	38.0	100.0	57.9	2.8	7.2	0.0	4.9	7.7	42.0	22.8	10.1	1.1	18.8	0.0	20.5	3.6	16.0	12.0	0.7	25.7	13.5	1.0	1.9	0.3	3.7	0.7	0.2	0.5	47.3	4.6	16.7	7.1	42.1	49.7	18.9	0.4	0.3	4.5	46.0	42.9	0.1	7.1	10.1	91.7	60.5	1.2	1.9	8.1	52.3	19.7	0.4	32.0	10.8	49.5	157.2	1.1	10.7	1.1	53.3	16.7	0.3	0.0	5.7	11.6	1.4	0.1	50.2	8.9	122.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.7	0.0	2.3	1.4	5.0	9.0	20.9	1.2	1.6	1.1	1.1	0.3	2.9	1.1	11.1	0.0	2.8	0.0	33.5	12.1	98.3	27.3	4.0	43.2	80.4	62.2	2.6	51.5	51.1	0.0	12.5	3.2	24.0	1.9	0.0	74.3	7.6	64.7	13.3	16.3	97.8	0.0	3.8	78.6	40.9	9.6	121.8	155.5	6.3	0.0	21.8	0.3	25.0	43.7	8.2	8.5	126.1	4.0	102.8	25.6	0.3	47.4	65.8	0.0	75.6	0.8	0.0	1.5	0.3	195.2	0.0	0.0	31.0	30.9	0.4	0.2	43.6	3.4	13.1	18.9	17.8	1.4	8.2	2.3	11.9	17.8	115.6	0.1	4.6	102.7
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347235-89352501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 226.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 246.8;granulocytes: 456.9;Kupffer cells: 266.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 97.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1636.7"	"Group enriched"	"Detected in all"	13	"granulocytes: 1636.7;monocytes: 842.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 427.6;NB-4: 325.8;SK-MEL-30: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	113.9	24.7	12.0	63.7	12.9	178.7	50.8	10.0	28.5	39.4	29.8	47.3	24.8	26.2	14.2	34.8	36.6	75.5	30.9	19.8	11.6	58.9	143.3	88.2	42.3	12.6	12.1	14.2	17.9	34.6	17.8	74.1	12.4	18.8	56.1	6.8	226.2	22.9	8.5	17.4	52.1	43.2	12.7	71.0	28.7	6.9	16.0	47.7	77.4	40.2	27.2	76.4	13.8	13.6	6.4	6.2	127.0	427.6	108.1	89.9	0.2	47.5	58.3	9.5	6.8	38.7	6.8	0.0	11.2	20.5	17.9	51.4	0.5	118.4	13.0	0.5	0.8	20.0	1.4	61.4	75.7	86.3	210.9	18.4	40.4	81.5	75.5	94.9	214.4	2.6	0.0	20.4	29.3	3.1	2.9	325.8	78.7	149.5	102.7	216.6	15.5	8.3	129.3	129.7	2.4	88.7	1.1	0.6	253.0	43.3	6.4	46.8	59.0	30.6	0.8	5.8	22.8	3.7	18.5	0.5	126.5	60.0	200.3	1636.7	558.9	247.2	9.8	842.3	4.5	2.7	2.7	3.5	97.0	11.6	1.6	3.2	230.5	14.8	841.0	12.2	6.7	455.2	12.0	12.9	10.0	28.5	19.8	11.6	12.6	12.1	12.4	12.7	16.0	13.6	182.9	102.5	246.8	12.4	18.0	90.9	79.4	97.4	38.7	2.1	30.3	85.5	11.1	81.5	80.5	180.3	33.3	72.6	36.1	58.3	17.6	12.6	1.6	67.4	14.1	159.8	19.2	6.6	19.6	14.0	4.2	54.5	19.4	134.2	456.9	24.2	177.8	130.2	49.6	1.7	3.8	13.2	46.8	266.7	61.2	1.7	1.5	193.2	12.4	33.7	198.9	8.7	20.6	24.6	2.4	17.1	45.7	3.4	16.2	26.1	17.0	27.5	21.2	2.4	26.3	21.4	29.7	2.6	7.0	14.7	24.7	49.3	42.3	3.5	22.0	61.4
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 508.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes		31000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	73.0	65.3	54.7	61.7	58.9	162.9	76.4	57.1	77.2	90.7	60.0	69.5	29.3	76.9	49.7	72.1	77.6	33.6	68.9	53.9	59.6	67.6	53.6	58.1	97.8	58.2	55.5	86.1	53.2	48.3	80.0	45.1	58.3	77.8	47.1	49.1	66.5	48.3	57.9	71.6	66.5	40.4	57.7	82.1	61.5	57.3	57.5	111.4	89.2	53.0	87.8	69.1	78.0	63.5	196.1	60.2	143.9	137.1	98.4	104.0	85.3	202.1	128.1	182.8	224.6	69.8	131.0	539.3	106.0	112.0	149.4	262.1	152.4	138.4	177.6	383.4	157.2	442.2	151.8	96.1	54.8	469.0	202.0	64.4	92.1	123.9	65.0	117.8	123.3	316.6	244.0	297.6	136.5	79.3	422.4	548.7	90.7	197.4	114.5	338.6	313.9	570.0	120.8	130.4	207.2	210.1	150.0	119.6	184.4	145.5	169.6	368.6	103.0	190.1	183.1	228.3	269.7	238.1	534.3	532.5	143.6	789.4	213.4	32.5	50.3	46.8	52.9	53.1	68.7	94.8	94.7	84.6	74.0	90.0	97.4	64.3	30.9	60.5	68.4	85.3	94.3	71.4	54.7	58.9	57.1	77.2	53.9	59.6	58.2	55.5	58.3	57.7	57.5	63.5	153.6	54.5	38.9	39.8	126.8	179.6	212.0	222.4	131.5	48.3	158.0	205.5	120.1	95.8	118.5	104.8	14.6	221.8	103.9	62.8	203.5	94.3	36.8	67.2	123.5	123.0	96.1	418.8	36.5	46.5	286.8	147.9	76.5	86.0	84.4	118.3	101.4	77.6	174.5	82.4	32.1	98.4	105.8	87.7	112.6	31.5	184.8	92.0	154.7	23.4	89.5	106.3	95.8	23.6	45.1	45.4	58.8	177.6	192.3	133.2	27.2	256.4	59.6	40.9	157.8	167.1	154.0	508.7	270.0	206.4	168.5	97.1	124.4	82.3	195.4	181.2
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Group enriched"	"Detected in some"	26	"Early spermatids: 4.9;Late spermatids: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;U-2 OS: 2.2;U-266/70: 4.7;U-266/84: 6.9;U-698: 1.5"	"Low region specificity"	"Detected in some"							HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.4	0.0	4.7	6.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DVL2		ENSG00000004975	"Dishevelled segment polarity protein 2"	O14641	17	7225342-7234517	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009312, HPA021611, HPA022914, HPA064732"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338"	"unprognostic (7.63e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.34e-6)"	"unprognostic (5.66e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (8.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.45e-2)"	18.2	20.7	15.1	11.4	17.2	14.8	18.1	15.6	17.9	31.7	15.2	22.6	12.9	29.6	10.5	23.0	22.3	14.1	13.8	14.7	14.9	16.3	10.6	15.0	16.7	17.1	16.3	33.9	12.8	17.6	26.0	14.7	16.2	24.7	8.6	14.4	17.8	18.0	16.5	28.8	16.7	18.1	15.0	16.1	14.4	16.4	16.1	22.2	20.1	11.5	13.0	22.1	25.9	19.0	31.0	43.9	52.2	52.0	39.0	35.0	22.5	21.1	38.1	50.0	63.7	37.5	25.6	43.8	31.3	23.5	39.0	43.5	43.5	28.6	19.0	43.6	50.3	28.5	46.0	40.0	68.0	16.0	23.7	52.5	48.2	47.2	25.7	35.0	20.9	50.5	24.6	20.0	30.6	28.9	61.6	16.1	17.8	20.7	17.1	89.5	33.8	26.8	27.8	26.9	22.9	46.4	38.3	18.9	46.7	23.5	27.4	22.1	17.6	28.0	25.1	52.8	39.6	31.1	28.0	20.4	32.6	23.8	44.4	13.5	4.2	10.2	10.0	4.9	8.3	8.5	7.0	9.0	5.0	9.3	8.0	8.5	1.9	7.2	4.9	7.0	4.5	6.2	15.1	17.2	15.6	17.9	14.7	14.9	17.1	16.3	16.2	15.0	16.1	19.0	11.7	9.6	12.1	12.4	13.1	17.5	22.6	20.9	21.6	15.7	13.2	14.4	7.7	5.7	15.0	18.4	25.0	21.3	11.8	11.2	5.9	11.3	0.9	8.8	12.9	10.5	13.2	6.5	11.2	10.4	15.9	15.7	7.7	13.5	14.7	18.4	9.7	4.9	14.6	10.1	9.4	14.3	24.4	6.0	9.4	1.9	26.1	7.6	10.6	2.8	9.3	13.1	14.4	10.6	10.4	7.2	9.9	22.2	5.9	17.1	10.8	5.5	9.3	30.0	13.1	16.0	14.9	18.4	34.2	21.7	19.2	36.5	11.5	18.4	19.6	15.0
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972290	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 467.9;Late spermatids: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: AB_2679764"	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	6.6	17.8	8.2	3.9	8.1	1.4	6.9	8.2	8.5	10.7	9.6	7.1	4.5	8.1	5.8	5.7	8.5	4.2	9.6	8.1	8.4	12.3	13.0	6.4	4.6	9.3	8.6	13.4	10.8	11.8	13.0	4.4	8.7	10.3	3.9	4.8	6.7	6.0	5.3	4.9	5.8	4.8	8.6	9.7	8.6	31.3	8.3	7.0	11.5	7.1	3.0	7.9	7.4	8.5	12.9	6.3	5.8	23.1	9.5	6.4	6.7	7.5	12.0	16.2	15.5	7.6	5.9	5.2	8.5	16.6	5.2	8.7	10.1	16.8	9.4	9.6	12.9	9.3	15.8	16.4	18.7	0.0	4.6	9.7	16.3	10.5	13.5	9.9	21.3	6.6	8.3	11.9	9.8	14.7	1.5	11.1	4.4	8.4	1.3	4.0	4.1	8.2	21.2	4.5	30.1	17.0	6.6	7.3	16.9	4.1	0.0	14.8	7.0	4.7	12.6	4.6	12.3	9.1	9.4	10.2	4.6	14.4	5.2	0.0	1.9	1.0	2.2	1.6	3.9	2.4	2.3	1.4	4.3	2.1	1.6	2.3	0.3	2.1	1.4	1.3	1.6	1.8	8.2	8.1	8.2	8.5	8.1	8.4	9.3	8.6	8.7	8.6	8.3	8.5	11.2	6.4	9.6	11.8	16.8	8.5	15.3	14.3	19.9	13.3	13.6	11.4	7.1	11.5	10.5	3.7	16.7	14.5	14.1	5.0	19.6	8.4	467.9	9.3	10.6	9.8	16.2	4.4	4.4	12.6	9.5	10.9	15.8	8.7	6.3	12.1	8.6	10.9	6.6	5.0	6.2	9.0	12.2	5.9	4.9	242.8	17.7	6.9	12.4	1.9	4.3	16.0	11.3	7.5	6.6	6.9	10.5	12.4	14.7	10.8	10.6	13.3	8.9	15.6	13.1	7.1	14.3	78.4	16.1	11.8	5.5	20.1	15.4	22.6	8.3	11.5
DYNC2H1	"DHC1b, DHC2, DNCH2, DYH1B, hdhc11"	ENSG00000187240	"Dynein cytoplasmic 2 heavy chain 1"	Q8NCM8	11	103109410-103479863	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 173.7;Cone photoreceptor cells: 112.6;Endometrial ciliated cells: 124.0;Excitatory neurons: 164.7;Inhibitory neurons: 101.8;Respiratory ciliated cells: 171.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039015, HPA039016"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA039015: AB_2676309, HPA039016: AB_10673410"	"unprognostic (3.11e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (8.49e-5)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.11e-3)"	4.2	3.0	5.0	1.2	5.2	0.3	3.5	5.6	10.2	5.1	14.6	3.2	1.6	4.6	3.7	1.6	6.5	3.2	2.0	4.1	6.1	3.7	0.8	2.8	0.9	8.3	8.9	5.6	2.9	6.7	6.8	1.4	6.3	2.6	0.7	10.5	2.6	2.5	0.8	2.8	2.1	2.3	5.5	1.9	2.2	7.9	6.7	1.8	4.6	1.5	0.7	3.3	3.0	5.9	1.3	2.7	7.0	3.3	9.5	21.2	0.4	4.0	6.4	6.5	7.0	1.6	1.5	0.0	5.5	8.0	3.1	5.5	5.5	7.7	5.3	0.0	4.6	1.2	4.8	0.2	9.3	2.2	1.3	13.6	2.8	14.9	16.9	10.3	2.7	1.4	0.2	0.0	8.6	5.4	0.7	0.7	1.9	0.0	7.7	0.0	5.9	0.1	7.5	0.9	4.6	3.6	6.5	1.7	3.1	1.7	6.8	1.5	6.4	7.9	3.3	7.7	3.0	0.0	0.0	0.1	2.3	6.7	2.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	5.0	5.2	5.6	10.2	4.1	6.1	8.3	8.9	6.3	5.5	6.7	5.9	12.7	0.0	13.1	173.7	2.3	6.6	13.4	17.3	9.6	25.9	8.2	9.7	10.1	4.3	18.0	27.6	112.6	0.3	2.1	0.2	1.9	7.0	26.1	124.0	43.7	11.1	17.3	1.3	164.7	3.4	0.5	32.0	5.6	7.5	3.8	15.4	9.3	0.8	2.5	32.0	101.8	1.0	4.1	0.8	5.8	11.1	20.8	3.1	8.8	45.0	0.9	16.5	1.0	86.0	72.6	10.5	2.9	18.4	3.3	4.9	0.9	16.9	171.0	85.1	19.7	40.8	18.5	90.6	11.6	5.0	5.5	0.5	5.0	23.5	1.7	5.9
DYNLL1	"DLC1, DLC8, DNCL1, hdlc1, LC8, PIN"	ENSG00000088986	"Dynein light chain LC8-type 1"	P63167	12	120469850-120498493	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport"	"Activator, Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 4098.6;Respiratory ciliated cells: 2679.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039954			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	Yes		890000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (4.41e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (7.97e-7)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.62e-1)"	268.6	261.9	912.5	186.7	967.7	126.8	268.0	895.2	1292.9	354.2	894.7	325.8	162.8	319.4	322.3	719.9	544.2	242.7	257.5	975.4	944.7	352.6	238.4	222.6	241.6	896.1	898.5	247.0	225.1	228.2	309.7	259.2	914.2	225.9	327.4	181.3	245.4	264.6	85.6	626.7	206.3	390.1	935.1	185.2	244.5	360.3	909.7	306.5	176.1	163.9	357.8	389.8	474.4	1001.2	721.6	811.4	779.2	600.8	677.1	713.6	250.8	968.0	451.6	785.6	466.7	770.8	472.3	400.6	510.3	945.1	753.0	629.6	949.3	818.3	781.0	528.3	617.9	390.4	532.9	1062.5	676.2	412.8	620.5	436.2	863.0	584.6	477.5	855.7	831.8	421.5	502.0	446.1	1056.8	960.1	541.4	894.8	642.2	917.7	935.7	543.0	403.0	499.2	1143.1	659.8	535.2	392.0	789.3	677.7	926.6	812.6	673.6	595.3	635.2	592.3	502.1	525.6	852.2	264.0	562.8	404.6	656.8	645.1	776.6	516.6	291.9	384.2	200.6	303.3	155.3	310.4	207.2	211.7	281.8	219.0	132.0	165.7	50.1	282.9	334.8	461.6	373.5	353.0	912.5	967.7	895.2	1292.9	975.4	944.7	896.1	898.5	914.2	935.1	909.7	1001.2	810.1	195.5	101.9	79.3	341.4	922.2	359.1	1275.0	356.8	138.4	800.0	949.4	170.8	303.1	764.6	399.1	83.4	524.6	484.1	689.9	1113.2	691.2	1407.2	1842.5	528.5	541.9	480.8	332.9	111.2	538.9	897.4	538.5	240.5	488.1	316.7	611.9	521.9	499.0	732.1	85.8	62.8	801.6	1121.0	329.4	706.1	4098.6	516.6	466.3	595.9	42.2	701.6	164.0	248.2	47.3	156.4	754.9	798.6	701.8	234.9	304.7	533.4	1125.0	2679.6	193.5	368.1	440.7	1016.3	961.5	721.4	1005.4	1610.1	1006.6	396.6	586.3	498.2	389.6
DYNLL2	"Dlc2, DNCL1B, MGC17810, RSPH22"	ENSG00000264364	"Dynein light chain LC8-type 2"	Q96FJ2	17	58083419-58095542	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 455.4;Late spermatids: 892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039954			Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		1000000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (7.22e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.52e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.10e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.12e-12)"	"unprognostic (2.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.02e-2)"	24.5	41.8	76.8	17.7	84.5	17.7	16.9	78.1	77.7	18.2	45.6	26.1	25.0	19.6	22.4	20.3	19.4	13.4	62.8	63.4	80.4	42.1	35.2	17.9	15.5	83.6	90.1	20.4	17.8	47.2	28.7	30.4	83.6	30.3	20.1	41.2	30.8	26.3	113.7	19.1	24.3	18.9	83.4	18.0	21.3	26.2	87.9	22.5	33.0	58.7	18.4	20.7	17.6	72.0	54.1	36.0	72.3	33.1	44.0	24.0	114.6	53.2	21.1	25.2	19.7	80.4	25.4	48.0	58.8	33.1	30.1	28.4	33.8	42.2	43.2	47.8	24.5	52.1	21.9	47.7	34.8	56.2	31.1	24.3	28.2	29.4	23.2	26.4	17.1	39.8	52.7	28.4	24.7	81.5	64.1	23.2	49.9	35.3	36.5	58.3	42.5	19.9	22.0	57.9	49.3	39.4	47.7	19.0	42.0	37.2	56.2	26.1	31.0	49.3	62.2	33.2	39.8	52.6	68.5	57.0	25.5	44.2	35.2	1.0	0.2	0.5	0.6	0.1	0.7	0.4	0.5	0.6	0.1	0.4	0.5	0.8	0.4	0.4	0.9	0.2	0.4	0.2	76.8	84.5	78.1	77.7	63.4	80.4	83.6	90.1	83.6	83.4	87.9	72.0	33.9	12.8	43.8	1.0	28.1	49.1	40.7	13.7	45.5	63.7	55.7	39.8	186.2	44.3	23.8	60.7	39.6	102.1	59.7	56.7	31.3	37.6	455.4	51.5	57.3	32.5	67.2	40.6	1.2	31.2	73.4	30.6	20.9	55.2	22.8	19.1	23.9	104.7	43.0	70.7	2.0	55.7	26.4	28.4	37.4	892.8	29.5	32.8	65.8	1.9	31.9	74.7	19.6	0.5	2.8	38.0	38.6	26.7	19.4	35.3	50.0	78.2	18.4	41.1	26.3	40.1	86.1	46.5	44.8	45.1	46.0	60.1	46.9	29.0	49.7	36.5
DYNLT1	TCTEL1	ENSG00000146425	"Dynein light chain Tctex-type 1"	P63172	6	158636474-158644743	"Predicted intracellular proteins"	"Cell cycle, Cell division, Cytoplasmic inwards viral transport, Host-virus interaction, Microtubular inwards viral transport, Mitosis, Neurogenesis, Transport, Virus entry into host cell"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 946.1;Ionocytes: 830.0;Respiratory ciliated cells: 1335.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046559			Approved	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA046559: AB_2679698"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-2)"	80.8	114.4	65.9	71.2	66.6	40.7	114.7	69.4	87.5	109.8	83.8	126.9	109.3	100.5	144.2	155.3	165.3	84.6	131.1	64.7	71.0	171.2	100.6	96.6	62.8	73.1	72.2	79.6	52.8	115.1	72.4	81.1	72.6	101.8	129.6	34.3	99.5	115.1	125.3	52.4	123.2	164.5	70.7	80.7	90.7	129.3	67.6	54.3	119.7	94.9	84.7	127.8	98.8	75.1	188.4	130.6	211.8	208.2	214.3	216.7	87.3	190.6	152.7	229.9	270.2	155.8	165.5	45.1	77.5	398.0	172.7	169.1	134.4	205.6	277.5	64.3	187.2	71.2	115.8	182.7	225.4	33.4	48.1	187.9	217.5	190.0	188.8	198.7	295.1	62.2	139.0	52.4	342.4	166.7	14.9	86.6	116.0	336.5	106.0	29.7	113.9	41.3	323.7	126.9	421.7	211.1	268.1	216.7	83.0	178.8	147.7	73.6	258.9	113.6	143.9	123.2	174.8	31.6	42.2	75.7	161.6	136.9	125.9	158.9	383.6	39.2	106.0	374.8	119.5	76.4	112.7	122.1	192.6	51.7	93.8	96.8	681.1	92.4	290.9	93.4	146.0	254.2	65.9	66.6	69.4	87.5	64.7	71.0	73.1	72.2	72.6	70.7	67.6	75.1	91.4	96.1	96.1	7.5	56.7	54.0	253.2	946.1	62.0	16.9	186.0	206.5	150.7	160.2	610.7	211.5	12.5	227.8	84.5	227.3	416.7	422.0	137.3	710.6	152.7	107.3	172.6	43.7	16.4	274.4	197.9	124.8	86.2	271.7	60.8	137.7	116.4	93.6	155.1	23.5	19.4	238.6	830.0	108.7	67.9	68.4	107.8	126.1	113.8	13.1	201.3	114.1	143.2	16.1	19.3	451.4	317.4	127.9	51.8	291.4	379.8	661.2	1335.9	42.0	138.1	55.2	241.5	452.0	177.7	172.3	61.1	215.1	106.8	187.5	168.6	443.0
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.3;testis: 83.8"	"Group enriched"	"Detected in many"	12	"Early spermatids: 179.4;Late spermatids: 580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	9.5	19.6	4.8	2.7	4.8	4.7	10.9	4.1	6.2	12.5	4.8	12.4	5.3	11.9	7.8	11.7	13.8	3.3	20.0	4.7	3.6	16.2	7.5	8.8	4.6	3.5	3.4	11.6	10.3	6.5	31.5	2.7	3.6	13.0	2.1	4.1	14.3	3.3	131.3	14.8	10.2	2.6	1.2	14.0	12.1	83.8	3.6	5.2	16.5	49.9	2.5	11.4	10.5	3.0	0.4	9.3	8.8	6.2	4.9	4.6	0.7	2.9	1.8	2.6	2.3	0.9	3.6	1.4	11.0	3.4	0.1	3.2	1.3	2.0	2.3	5.4	7.8	0.6	5.9	0.9	4.1	0.3	1.9	6.2	1.2	0.8	2.9	8.6	0.6	3.5	1.5	2.0	0.4	4.7	2.1	0.8	2.2	2.7	2.1	1.0	0.2	0.6	5.7	2.2	12.7	14.5	4.5	4.4	0.2	4.6	4.4	0.5	4.5	1.1	2.0	1.0	0.9	3.2	1.1	1.0	7.4	0.9	0.4	0.7	1.6	1.8	3.0	1.7	3.6	2.4	2.0	3.1	1.9	1.6	1.0	1.7	2.5	3.3	1.6	4.5	2.2	1.7	4.8	4.8	4.1	6.2	4.7	3.6	3.5	3.4	3.6	1.2	3.6	3.0	6.0	0.0	0.6	6.2	10.9	3.4	3.8	8.4	10.2	15.2	9.0	6.1	6.1	7.2	3.4	16.5	20.9	2.1	21.7	10.3	9.8	13.1	179.4	15.4	6.7	7.3	20.4	19.8	4.6	4.3	1.7	5.1	7.7	10.1	1.3	11.9	12.1	3.9	5.9	10.1	6.3	9.8	10.2	8.2	3.0	580.2	7.2	4.7	5.4	7.5	5.7	8.3	10.3	5.0	3.2	9.7	9.7	5.3	5.0	4.8	11.5	17.4	10.7	13.0	0.0	11.1	4.8	30.1	13.4	6.1	2.8	1.4	10.8	20.2	7.4	3.6
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 133.1;Horizontal cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: AB_2683271"	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	9.9	4.6	2.9	14.2	3.3	14.9	6.3	2.3	6.1	7.8	3.2	25.7	20.4	13.1	6.2	10.7	10.0	14.3	24.4	8.6	2.3	4.7	4.2	9.1	21.6	3.4	2.3	8.7	8.6	4.9	3.0	14.1	2.7	6.5	21.9	14.8	5.4	8.8	39.4	7.5	28.0	13.0	3.1	14.7	20.6	5.0	2.7	24.1	6.9	10.4	14.2	11.9	7.6	3.5	24.5	13.4	19.8	14.4	9.7	13.2	15.8	24.2	15.7	11.6	6.6	17.9	13.2	45.3	29.2	35.3	7.1	27.8	16.0	9.6	12.4	19.6	20.9	7.3	9.5	6.9	3.8	16.8	15.2	11.0	13.3	31.4	24.8	19.6	6.6	18.9	9.2	22.9	15.1	13.9	14.4	8.2	17.2	15.8	21.5	37.9	19.7	20.0	13.6	30.2	26.0	30.7	10.1	13.4	13.9	13.3	9.2	13.9	10.0	18.4	17.3	12.8	19.4	10.9	1.9	24.9	17.6	11.1	19.4	2.0	0.3	4.0	3.2	0.7	2.3	1.8	2.3	4.2	1.2	2.0	1.9	3.7	0.4	4.7	0.9	0.5	2.0	1.1	2.9	3.3	2.3	6.1	8.6	2.3	3.4	2.3	2.7	3.1	2.7	3.5	13.0	9.6	10.2	3.9	14.4	11.3	11.9	6.7	8.6	18.0	7.4	8.1	44.5	20.0	11.2	1.8	22.9	3.5	28.6	133.1	0.0	19.0	0.6	28.0	35.9	12.1	24.6	4.8	11.0	18.2	7.9	18.9	25.0	15.6	5.7	13.3	6.4	6.1	17.0	80.8	11.4	62.0	4.1	15.7	22.5	2.0	11.5	15.5	8.8	13.1	12.0	16.7	42.2	6.0	9.1	17.7	61.3	13.2	9.0	16.1	62.9	11.3	30.3	23.3	13.1	53.5	33.6	2.7	10.1	15.6	16.2	4.5	31.0	17.9	32.3	34.4
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 48.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 235.3;Late spermatids: 48.1;Spermatocytes: 108.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075041			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA075041: AB_2686730"	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.6	2.4	3.7	4.2	3.8	8.8	5.7	1.7	3.7	5.6	5.6	2.3	1.0	5.3	3.1	2.8	5.7	13.5	8.3	5.1	3.8	3.3	4.1	5.5	1.6	3.8	5.1	4.9	3.9	3.0	6.5	1.2	3.4	2.9	1.4	6.4	4.3	3.0	0.8	1.5	1.7	8.1	2.6	1.3	3.1	48.0	3.8	5.9	8.3	1.9	1.8	7.5	2.8	3.5	5.0	6.7	1.6	9.8	16.7	15.9	0.4	15.4	36.7	15.0	19.6	0.4	2.7	7.6	2.2	20.1	25.8	1.5	8.6	14.1	15.8	0.1	4.8	10.5	8.9	1.7	26.9	7.5	6.8	10.9	8.9	25.6	73.6	15.1	11.8	11.6	20.1	1.4	23.2	2.0	16.9	4.4	13.2	0.5	10.8	41.1	4.9	0.1	4.8	0.4	9.3	6.9	13.6	0.6	20.3	2.0	2.0	1.9	8.1	31.1	11.2	14.8	13.2	5.6	2.2	9.1	17.7	8.3	2.9	0.7	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	2.7	0.0	0.0	3.7	3.8	1.7	3.7	5.1	3.8	3.8	5.1	3.4	2.6	3.8	3.5	13.9	3.2	8.2	4.2	1.0	6.5	10.7	9.6	3.4	0.2	4.7	3.3	10.8	1.5	4.2	1.8	10.4	0.0	1.5	0.3	0.0	5.1	235.3	12.6	8.0	8.5	2.4	23.6	3.6	2.2	0.1	12.7	1.1	5.9	0.0	3.4	3.9	1.1	1.0	0.0	1.5	0.4	2.0	1.0	4.6	48.1	4.1	2.9	8.8	1.0	1.0	3.4	0.0	2.5	0.3	1.2	1.2	1.9	2.1	3.8	0.2	1.7	10.5	8.2	6.6	10.2	10.4	108.7	6.4	1.3	3.7	0.4	2.4	3.0	0.6	5.3
DZIP1	"DZIP, KIAA0996"	ENSG00000134874	"DAZ interacting zinc finger protein 1"	Q86YF9	13	95578202-95644706	"Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 384.1;Late spermatids: 774.5;Spermatocytes: 222.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054891, HPA057272"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA054891: AB_2682631, HPA057272: AB_2683390"	"unprognostic (6.74e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.89e-3)"	5.0	3.4	8.6	2.5	8.5	0.1	4.4	6.9	9.4	12.4	5.7	10.7	1.0	12.6	7.2	3.2	12.4	5.1	4.3	7.7	8.7	11.4	1.1	4.6	2.2	7.0	8.1	16.3	9.9	0.4	10.3	2.5	6.1	6.4	1.8	4.0	2.3	6.2	1.3	1.6	4.0	6.1	5.6	1.5	4.7	14.8	11.5	0.8	2.4	2.1	1.7	7.9	7.1	7.1	1.1	4.2	17.5	15.5	14.5	16.2	3.6	11.0	13.2	12.7	15.2	0.2	0.0	0.0	2.5	9.4	5.5	0.0	11.7	3.8	14.8	1.1	9.6	15.6	4.4	11.0	9.2	0.1	0.0	11.7	0.4	4.2	5.8	23.1	9.1	1.1	0.0	0.1	11.4	0.0	0.0	0.0	8.6	0.0	0.4	0.0	10.1	0.0	15.4	1.8	4.2	9.9	8.3	0.0	0.6	22.4	0.0	7.3	1.3	12.3	5.3	1.8	8.8	0.0	0.0	0.0	3.5	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	8.5	6.9	9.4	7.7	8.7	7.0	8.1	6.1	5.6	11.5	7.1	2.4	0.0	0.0	63.6	0.0	0.6	1.1	3.1	4.6	18.7	0.6	3.4	3.5	2.8	3.9	1.8	4.2	4.5	0.0	0.0	7.9	20.8	384.1	37.2	34.1	2.5	0.0	0.0	86.8	0.2	2.6	19.0	0.5	2.7	0.0	3.1	2.9	0.4	0.7	6.7	95.7	0.0	4.1	0.3	1.5	774.5	38.8	1.2	3.6	19.7	2.0	8.3	0.0	106.6	5.1	0.6	0.0	43.6	0.0	0.8	0.0	24.4	19.4	1.5	19.7	18.2	15.8	222.8	12.6	1.2	1.0	1.8	0.5	20.8	0.0	0.3
DZIP1L	"DZIP2, FLJ32844"	ENSG00000158163	"DAZ interacting zinc finger protein 1 like"	Q8IYY4	3	138061990-138115818	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 58.8;Respiratory ciliated cells: 74.0;Rod photoreceptor cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030404	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA030404: AB_10601548"	"unprognostic (3.65e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.47e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.72e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.77e-2)"	4.9	1.4	1.7	2.2	2.2	8.8	4.7	5.9	2.1	8.6	15.3	5.0	2.2	8.1	1.9	2.5	12.8	5.7	3.3	2.2	2.3	5.6	1.0	5.7	0.9	5.7	7.4	7.0	6.3	2.7	2.1	2.0	4.2	4.1	1.5	4.6	2.1	3.3	1.0	7.8	2.1	4.6	4.3	2.6	7.2	4.1	2.6	0.4	3.6	0.9	0.7	6.1	5.3	2.2	5.4	3.1	6.1	5.1	3.8	5.1	1.4	8.6	5.1	5.0	6.3	2.0	0.4	0.0	4.3	8.0	7.0	1.7	4.5	2.0	2.4	1.2	4.4	2.4	7.5	0.3	3.1	1.8	4.0	5.4	2.0	5.5	2.6	5.1	2.8	1.4	1.8	0.0	6.9	0.3	0.0	0.8	7.4	0.0	1.1	0.0	7.1	0.0	2.3	8.5	2.1	4.8	8.9	0.0	4.3	3.4	2.3	3.7	2.2	12.3	5.6	6.0	4.5	0.0	0.0	0.1	4.9	2.6	4.8	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	2.2	5.9	2.1	2.2	2.3	5.7	7.4	4.2	4.3	2.6	2.2	1.4	3.2	2.0	4.2	0.0	3.6	0.6	1.9	7.4	8.6	0.2	2.5	2.9	7.2	7.7	1.8	8.4	0.1	0.0	0.0	5.9	3.8	17.4	58.8	8.5	2.6	0.0	1.3	4.0	1.2	0.1	6.5	7.1	1.1	0.0	7.4	0.0	0.0	1.4	3.3	2.9	0.0	2.0	3.2	2.6	1.8	6.2	3.5	0.0	3.7	0.6	2.7	0.0	2.5	0.2	5.9	0.0	4.1	0.0	0.4	0.0	0.8	74.0	19.4	0.0	7.2	9.8	0.6	2.3	1.7	4.3	0.0	0.5	1.7	0.0	0.1
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675477-33686385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.0;Granulosa cells: 11.4;Spermatogonia: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176"	"unprognostic (7.46e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.91e-1)"	1.8	5.5	7.1	5.6	7.1	34.3	1.6	5.2	9.2	1.8	3.9	3.8	3.2	1.2	0.2	5.7	1.3	0.7	1.4	6.1	5.6	0.9	1.8	3.7	8.7	7.6	6.4	3.5	1.0	1.3	0.6	2.4	6.5	1.9	3.9	0.7	1.9	0.9	1.6	4.7	4.1	2.8	7.0	5.0	3.7	10.4	6.9	10.7	0.8	0.8	6.9	2.4	2.5	8.3	48.1	45.4	52.0	40.5	5.2	3.6	39.3	45.0	21.4	55.9	46.7	81.1	48.0	87.3	44.2	20.2	67.7	35.4	25.3	23.8	24.8	26.4	36.5	71.6	71.9	47.7	0.4	34.0	43.6	2.8	1.4	30.6	5.4	5.7	14.6	54.4	19.3	60.0	34.9	42.3	72.8	71.6	15.6	47.9	64.6	71.4	140.7	36.2	9.6	28.7	76.7	54.1	54.6	37.6	22.7	14.8	47.3	42.4	7.9	65.0	37.7	45.8	64.8	58.1	42.0	72.6	54.1	20.0	39.3	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.4	1.0	0.1	0.1	0.1	7.1	7.1	5.2	9.2	6.1	5.6	7.6	6.4	6.5	7.0	6.9	8.3	1.1	0.0	1.1	0.7	3.6	2.9	1.7	0.5	0.0	2.3	3.1	4.3	0.4	0.0	1.4	0.0	0.0	5.0	2.9	2.4	0.0	0.9	1.0	0.3	1.0	1.6	0.0	25.0	1.5	0.2	9.6	3.0	7.7	1.2	0.0	11.4	0.7	0.8	4.4	0.0	0.5	4.6	2.0	0.6	2.1	3.1	2.1	3.1	1.8	1.0	0.1	1.5	1.0	1.0	3.4	0.6	0.5	1.2	9.7	0.5	1.4	0.1	0.2	2.3	0.0	1.0	3.0	7.5	32.9	3.7	1.7	1.8	3.3	1.2	7.0	3.5
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401879-20493714	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: AB_2732448, HPA065012: AB_2685403"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	6.5	4.9	4.8	9.8	5.2	19.8	4.1	2.8	5.7	3.3	3.0	5.4	5.2	3.6	3.9	4.9	2.5	6.4	5.1	6.4	4.6	5.8	4.4	4.9	11.0	3.7	4.6	1.4	2.1	3.1	1.8	5.6	4.2	3.3	6.3	6.1	2.7	3.1	10.0	2.6	5.7	6.0	3.7	8.4	3.6	3.4	5.5	8.6	8.5	9.3	9.5	8.5	2.7	3.8	14.3	11.6	32.2	35.1	10.9	11.9	22.0	18.9	16.8	18.2	19.9	14.3	8.8	32.3	35.2	18.2	16.9	14.6	37.8	17.4	30.3	12.2	25.3	58.1	20.4	16.3	11.6	38.6	33.0	9.7	12.6	17.7	21.6	18.8	12.7	29.8	65.3	19.4	20.9	15.0	43.6	43.2	24.2	11.0	11.9	46.5	27.8	36.5	21.8	25.1	22.9	42.2	17.3	24.1	26.3	20.0	12.4	23.4	17.2	28.6	17.4	14.2	30.5	12.1	40.1	38.3	7.1	23.2	41.3	5.6	2.3	1.1	1.6	1.6	2.0	0.4	1.0	2.4	2.6	0.4	0.8	1.8	7.2	3.5	1.1	1.1	1.6	1.1	4.8	5.2	2.8	5.7	6.4	4.6	3.7	4.6	4.2	3.7	5.5	3.8	4.8	0.0	2.6	53.8	10.6	9.2	12.3	7.0	7.4	34.1	11.9	7.2	10.6	4.3	10.6	7.3	22.9	8.3	15.0	12.0	9.8	7.6	12.2	3.9	14.1	8.5	12.0	17.2	67.7	6.9	13.8	9.2	12.8	10.6	20.3	32.3	14.6	4.7	17.1	32.0	31.9	11.7	4.1	47.2	17.7	5.7	2.8	28.7	5.4	27.2	23.8	2.9	15.5	37.7	2.9	14.8	10.3	3.0	19.1	22.1	4.5	25.1	2.2	9.0	0.0	9.0	11.5	3.0	4.7	16.5	8.9	3.1	15.3	5.7	13.8	18.4
E2F4	E2F-4	ENSG00000205250	"E2F transcription factor 4"	Q16254	16	67192155-67198918	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054128			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA054128: AB_2682392"	"unprognostic (1.74e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.05e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-1)"	43.5	39.6	27.9	39.7	27.2	98.2	38.3	26.5	31.0	35.3	27.1	43.8	32.1	41.2	22.2	47.4	36.7	23.5	39.6	27.4	29.2	38.2	32.0	38.0	48.5	28.7	27.7	33.1	36.1	29.1	39.2	44.0	28.2	36.5	32.0	9.9	29.8	27.6	50.5	34.0	44.3	31.8	27.9	54.7	40.6	32.9	28.2	42.5	33.6	30.0	43.4	42.0	34.1	27.9	67.3	53.2	44.4	54.3	63.5	54.6	158.6	49.1	72.7	88.5	84.8	94.6	71.5	82.7	58.1	52.3	60.7	95.8	69.2	69.2	57.4	35.2	73.4	55.9	31.9	97.5	76.7	110.9	113.0	64.8	53.9	70.4	77.9	33.2	77.8	62.9	107.1	26.8	47.2	115.0	127.9	90.8	109.1	71.7	47.4	152.7	92.8	109.7	41.8	50.9	53.6	63.9	134.2	49.6	58.2	35.2	50.6	109.7	56.0	62.4	58.9	46.1	78.2	65.6	62.0	215.0	73.3	75.5	60.7	1.2	11.8	10.9	8.4	10.7	7.0	6.1	7.7	9.9	14.6	6.6	6.1	5.5	7.5	8.7	8.1	6.3	3.9	7.7	27.9	27.2	26.5	31.0	27.4	29.2	28.7	27.7	28.2	27.9	28.2	27.9	36.2	12.8	16.5	14.7	31.2	41.6	33.9	18.0	10.8	22.3	20.9	16.3	15.1	22.8	13.4	12.9	4.2	116.1	35.1	26.7	19.6	30.2	50.5	16.0	24.4	36.2	22.8	174.7	13.9	37.2	82.8	25.5	36.7	19.4	27.3	25.4	30.0	10.2	44.7	21.9	12.3	23.6	22.4	23.8	29.0	84.9	27.1	30.1	14.2	11.2	41.5	14.3	55.6	10.6	12.2	35.8	19.3	23.7	39.7	56.8	21.4	13.4	9.5	19.2	46.0	20.0	26.9	37.9	45.3	25.8	45.9	79.8	36.7	31.4	30.2	37.9
E2F5		ENSG00000133740	"E2F transcription factor 5"	Q15329	8	85177154-85217158	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 23.7;Plasma cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 13.4;naive B-cell: 8.9"	"Lineage enriched"	"Detected in many"	9	"B-cells: 13.4"	"Cell line enhanced"	"Detected in many"		"AF22: 82.6;Daudi: 158.0;U-698: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055723, HPA065441"			Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA055723: AB_2682897, HPA065441: "	"unprognostic (8.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (2.88e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.95e-3)"	1.8	3.9	4.8	8.0	5.2	1.7	6.7	4.6	6.5	5.2	5.1	6.6	4.9	4.5	8.1	2.2	8.0	4.3	1.9	5.1	5.8	8.1	3.0	4.1	25.9	5.5	5.2	4.9	4.3	13.2	3.7	5.0	5.0	3.6	7.8	0.9	2.3	3.3	0.4	0.8	3.8	4.1	5.1	6.9	5.5	8.5	5.3	10.7	8.7	0.9	29.6	6.9	0.9	5.5	14.2	15.9	82.6	29.7	1.5	2.2	25.0	2.7	6.9	2.4	7.4	9.6	17.4	158.0	10.3	3.5	28.4	2.6	51.0	4.3	3.0	16.0	20.1	16.4	8.3	22.4	13.4	4.8	0.1	3.3	6.9	3.5	12.0	15.7	2.7	16.5	34.7	1.2	4.6	10.0	15.8	10.8	26.1	28.0	12.9	12.9	3.4	17.9	27.5	10.7	9.8	29.8	1.8	5.8	23.8	32.6	33.5	5.2	0.1	3.7	2.5	4.6	10.5	27.6	20.6	77.1	4.3	4.1	8.0	0.0	0.0	0.0	0.1	0.0	0.0	13.4	0.0	0.0	0.1	8.9	0.2	0.4	0.0	1.4	0.0	1.5	0.6	0.6	4.8	5.2	4.6	6.5	5.1	5.8	5.5	5.2	5.0	5.1	5.3	5.5	1.1	0.0	6.5	3.6	23.7	2.3	3.3	1.3	1.2	0.9	5.6	6.0	1.0	5.7	2.9	5.5	10.4	4.1	5.1	3.3	0.0	3.3	7.6	7.3	5.2	1.5	7.8	1.3	7.7	2.6	1.1	3.0	4.1	7.5	1.3	5.5	0.4	2.4	0.5	0.0	4.6	2.7	2.0	0.8	1.0	3.8	1.5	1.9	3.6	4.7	0.3	5.2	4.1	11.6	4.2	3.0	1.7	1.9	29.6	6.9	0.8	5.8	8.6	1.6	0.0	5.0	4.5	8.1	4.6	2.3	2.8	1.1	2.5	4.6	3.7	2.1
E2F6	E2F-6	ENSG00000169016	"E2F transcription factor 6"	O75461	2	11444375-11466177	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	17	"basophil: 7.8"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 7.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA075185			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA075185: AB_2732282"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-3)"	"unprognostic (7.58e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	5.5	5.2	5.0	2.5	5.3	3.8	4.3	5.1	6.2	3.3	5.1	4.5	2.8	5.4	3.9	2.7	4.9	3.1	7.6	4.8	5.8	2.6	2.8	3.0	2.4	5.3	5.4	4.7	4.6	3.4	5.0	3.1	5.1	3.3	2.2	3.5	3.6	3.4	14.6	3.7	3.6	4.4	5.1	3.2	4.9	2.8	5.2	2.5	2.7	11.5	1.9	4.0	3.0	5.2	4.2	5.2	10.7	6.0	4.8	3.9	8.0	4.0	7.1	4.6	4.2	10.3	5.6	8.2	4.5	4.6	9.3	3.1	7.6	5.9	4.8	10.6	11.3	14.9	4.0	12.8	9.4	15.4	14.7	6.7	5.5	5.0	5.9	3.9	4.2	7.1	11.3	15.3	3.7	10.1	8.9	16.9	15.3	5.1	6.7	15.6	12.1	8.4	5.0	3.7	9.2	19.1	4.6	6.7	18.8	4.6	6.2	7.7	3.5	6.6	8.5	4.2	9.0	22.0	17.4	19.9	7.2	14.5	10.3	7.8	0.2	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	5.0	5.3	5.1	6.2	4.8	5.8	5.3	5.4	5.1	5.1	5.2	5.2	15.7	6.4	4.8	7.2	8.4	24.3	23.6	10.6	13.6	12.4	14.5	9.7	9.0	10.0	8.4	3.7	16.7	17.3	8.5	3.4	7.9	11.7	1.4	11.0	14.1	12.2	6.7	3.4	13.9	11.0	13.9	14.3	13.3	14.0	0.0	13.6	8.6	8.8	12.5	13.5	14.9	4.7	8.2	5.4	11.5	2.6	8.7	11.3	17.8	6.5	7.0	10.1	5.2	3.5	20.8	9.4	3.7	11.3	6.1	21.3	5.3	8.4	4.1	11.8	0.0	22.2	12.3	15.7	48.2	8.2	21.9	22.2	8.4	11.7	6.0	16.7
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 11.8;skeletal muscle: 12.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 34.1;Gastric mucus-secreting cells: 10.2;Plasma cells: 9.7;Squamous epithelial cells: 10.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: AB_2685381, HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	0.3	0.1	0.0	2.8	0.0	14.2	0.5	0.1	0.1	1.0	0.0	4.0	3.8	0.4	0.0	4.9	0.9	0.4	2.1	0.0	0.0	0.1	0.3	0.3	7.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	5.1	0.0	0.9	0.2	12.6	3.0	3.0	0.6	0.0	1.3	5.6	1.7	0.0	11.8	0.1	0.4	7.3	1.8	1.3	0.1	23.3	7.2	7.1	9.8	0.4	1.1	31.7	13.0	3.7	15.3	16.4	25.4	7.8	23.5	5.5	4.3	9.0	20.2	17.2	1.6	13.5	15.9	14.9	8.0	4.1	7.1	0.0	12.7	19.2	0.3	0.1	3.1	1.0	0.9	21.0	17.2	17.6	22.1	6.3	11.6	25.8	16.6	6.9	26.3	10.1	26.9	12.8	16.0	6.6	16.8	6.0	7.0	5.5	11.3	1.3	4.0	7.7	13.7	4.2	7.3	9.0	18.3	11.8	7.7	16.2	30.6	9.0	24.4	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.1	1.3	0.0	0.0	0.3	0.1	3.8	0.0	0.5	0.0	0.0	0.9	0.8	2.5	0.0	0.0	0.4	3.3	0.8	0.8	1.2	34.1	0.1	0.0	1.7	1.0	10.2	3.3	0.0	3.1	0.0	0.0	2.4	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.2	0.0	9.7	0.1	0.4	0.2	5.6	0.0	0.0	1.5	0.9	4.0	3.1	10.0	0.3	0.3	2.2	0.5	6.3	0.9
E4F1	E4F	ENSG00000167967	"E4F transcription factor 1"	Q66K89	16	2223580-2235742	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052042, HPA069007, HPA071325, HPA072309"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA052042: AB_2681705, HPA069007: , HPA071325: AB_2686390, HPA072309: "	"unprognostic (3.05e-1)"	"prognostic favorable (9.13e-4)"	"unprognostic (7.31e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (9.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.12e-1)"	"unprognostic (8.93e-3)"	13.5	16.0	7.9	6.6	8.6	11.3	15.1	10.2	13.5	17.5	4.8	16.5	6.2	18.7	1.9	16.1	15.2	3.3	15.3	8.1	7.0	16.1	19.0	13.4	6.8	10.2	8.1	15.9	15.2	4.4	19.0	5.3	10.0	21.3	1.8	3.0	16.0	5.5	19.0	23.6	15.0	2.7	6.1	20.5	14.8	14.4	8.3	6.4	22.6	4.3	2.8	16.1	16.4	9.4	10.9	20.2	8.3	16.4	4.8	4.4	20.0	14.8	6.6	10.0	6.7	32.7	16.2	15.8	15.8	5.7	5.6	14.6	6.8	7.6	1.8	17.2	25.6	11.2	36.1	18.0	9.3	14.2	19.1	6.6	8.5	9.0	4.1	5.6	6.9	13.5	26.7	10.6	3.8	30.1	18.8	30.6	18.7	6.6	18.8	34.7	9.1	27.9	6.2	7.6	21.4	15.5	18.4	21.9	10.7	3.0	19.4	20.0	12.3	12.0	15.7	12.0	12.4	20.7	10.9	32.0	5.0	10.0	12.3	6.8	8.1	11.7	10.2	9.8	8.8	8.2	8.4	9.7	8.8	8.0	9.0	8.4	11.4	6.9	11.8	5.2	11.4	7.5	7.9	8.6	10.2	13.5	8.1	7.0	10.2	8.1	10.0	6.1	8.3	9.4	9.1	16.0	8.2	8.5	14.4	7.1	7.9	12.2	9.1	13.8	12.3	10.8	4.9	5.7	13.9	11.0	37.5	20.4	18.5	26.5	11.7	11.1	19.6	12.6	10.2	10.3	25.8	6.5	8.1	10.5	17.2	8.7	31.1	11.6	2.5	12.3	6.8	10.5	12.6	30.3	7.2	19.8	20.3	7.3	7.8	5.0	11.5	7.3	7.2	10.3	9.1	11.3	13.4	5.0	5.5	11.1	14.5	16.1	13.2	9.7	15.4	8.0	12.0	15.7	13.1	9.6	11.2	19.0	16.1	7.6	8.9	13.4	11.8	12.6	15.3	6.4
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427598-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.1"	"Group enriched"	"Detected in all"	6	"Early spermatids: 268.7;Late spermatids: 389.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 137.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	12.9	9.0	9.2	10.5	8.9	57.1	9.1	7.2	9.4	7.2	7.7	9.0	10.6	7.9	7.6	9.8	7.0	10.4	5.1	10.3	11.1	11.2	19.0	8.3	10.7	9.6	10.3	5.6	9.8	11.8	8.6	10.2	12.3	10.0	9.9	7.7	6.9	6.8	5.3	10.7	10.0	8.3	7.8	9.8	11.4	7.3	10.6	10.6	10.5	5.8	11.1	11.5	5.8	7.9	10.3	16.6	17.1	17.6	9.8	8.3	137.4	14.7	10.5	16.7	16.3	22.7	11.4	28.7	9.3	10.9	10.9	8.6	22.5	13.2	19.2	23.6	16.2	24.8	14.5	20.8	22.1	23.6	19.2	11.0	22.8	24.3	16.2	12.8	16.8	23.1	26.9	20.6	14.1	21.2	23.6	13.2	30.7	19.3	16.9	21.3	14.2	16.0	14.5	17.8	17.6	30.6	18.2	16.7	17.6	21.9	25.2	18.5	16.6	17.5	12.8	15.6	21.8	27.1	58.3	29.7	17.0	27.7	21.1	8.0	7.1	4.6	11.1	5.4	14.3	4.9	9.1	8.7	4.2	3.6	5.4	8.7	6.5	8.1	6.9	9.8	10.9	4.4	9.2	8.9	7.2	9.4	10.3	11.1	9.6	10.3	12.3	7.8	10.6	7.9	11.5	9.6	17.3	6.8	14.2	46.9	9.1	6.0	14.2	8.1	15.8	7.7	4.8	15.7	9.0	12.9	6.2	8.0	29.1	15.5	9.8	8.6	268.7	10.8	16.0	11.8	34.3	7.8	16.4	8.2	14.6	13.9	16.3	14.1	10.2	9.9	12.1	30.4	15.8	21.9	14.0	12.5	12.2	30.7	31.6	389.5	11.5	37.6	23.2	3.7	19.4	5.5	22.6	5.5	10.7	15.6	10.3	12.0	12.2	16.1	16.0	29.7	8.6	6.4	26.3	13.6	11.0	21.5	11.6	17.7	54.3	35.8	22.0	4.3	12.8	19.9
EAPP	"BM036, C14orf11, FLJ20578"	ENSG00000129518	"E2F associated phosphoprotein"	Q56P03	14	34515938-34539711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002916	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA002916: AB_1078715"	"unprognostic (8.76e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.81e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.64e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (3.24e-2)"	37.3	35.8	26.3	24.6	27.0	89.2	51.0	29.7	35.5	33.3	27.1	50.8	35.7	35.0	44.7	29.0	39.4	28.1	29.0	27.1	28.6	42.4	50.2	29.5	37.2	25.9	26.5	49.7	26.7	54.7	21.6	35.2	26.3	33.7	51.7	37.1	36.4	31.2	37.0	46.9	45.6	29.2	28.1	31.3	29.3	23.5	27.1	49.1	45.5	29.3	37.1	31.1	30.0	30.0	37.7	45.1	41.3	24.4	47.8	48.7	64.1	33.8	51.6	41.5	43.1	21.6	48.6	39.1	46.6	41.5	24.7	34.5	30.8	45.1	48.3	49.1	27.1	28.7	31.6	91.7	65.1	51.5	30.4	56.3	56.7	23.8	60.9	54.6	41.7	54.1	28.9	42.0	39.1	88.0	71.4	41.5	24.3	69.4	50.0	44.8	49.5	39.5	50.2	50.3	33.1	36.5	47.8	45.6	76.4	39.4	79.7	32.3	45.2	21.4	18.1	28.1	22.0	52.8	63.1	41.5	20.1	28.0	27.6	139.9	61.9	134.3	65.3	57.8	79.1	107.7	81.9	75.0	54.9	101.0	82.7	75.8	140.2	100.6	80.9	47.8	124.4	80.0	26.3	27.0	29.7	35.5	27.1	28.6	25.9	26.5	26.3	28.1	27.1	30.0	59.8	22.4	53.3	17.0	78.6	46.4	67.2	145.0	74.6	75.6	60.0	70.1	35.4	60.1	78.8	82.8	31.3	125.3	76.3	91.8	174.1	86.6	20.9	82.0	59.6	57.8	66.0	66.7	20.5	84.5	76.5	67.6	26.5	54.8	73.5	98.7	57.5	109.0	58.8	25.2	21.3	112.8	87.5	50.6	33.9	14.9	89.5	47.5	90.7	16.9	71.3	122.0	87.6	17.6	23.1	59.8	102.5	94.4	46.8	61.4	131.5	164.8	102.0	75.7	72.3	69.9	78.7	103.3	38.3	63.8	66.5	189.4	74.2	101.2	98.0	58.2
EARS2	"KIAA1970, MSE1, mtGlnRS"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23520754-23557731	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favorable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	3.7	7.6	3.3	1.2	3.5	1.5	4.0	2.7	4.0	2.9	3.6	3.7	1.1	3.7	3.0	5.2	3.0	1.0	5.3	3.3	3.6	4.9	9.9	3.1	1.8	3.3	2.5	3.3	5.6	4.8	3.5	2.5	2.6	3.0	2.3	1.9	4.6	1.4	4.2	5.6	2.9	2.0	1.5	3.3	4.1	3.8	3.5	2.5	4.3	3.8	2.4	3.3	3.3	3.2	2.6	8.3	2.4	4.8	2.9	3.8	3.9	3.2	3.1	3.6	2.4	5.0	2.9	4.8	2.6	3.3	1.8	2.9	9.6	6.4	4.7	2.9	7.7	2.4	5.3	7.1	2.4	3.4	2.1	3.2	4.4	2.4	4.7	4.5	1.4	5.2	7.0	2.5	2.6	5.5	2.1	2.3	7.5	4.4	2.8	4.1	4.5	8.0	5.5	3.8	5.0	4.1	2.1	5.0	2.7	6.3	5.9	3.0	2.3	3.1	2.1	3.1	3.4	5.1	3.7	3.4	4.1	4.0	4.3	0.1	0.8	0.0	1.0	1.5	1.6	0.8	1.4	1.1	1.7	1.0	1.3	1.1	0.4	1.8	1.1	1.6	1.7	1.3	3.3	3.5	2.7	4.0	3.3	3.6	3.3	2.5	2.6	1.5	3.5	3.2	1.8	9.6	5.9	5.2	3.8	2.2	4.0	4.0	4.0	3.8	6.2	4.7	11.6	2.8	2.9	3.7	2.1	15.1	2.3	2.5	5.9	7.0	2.9	3.3	4.9	3.2	5.4	9.4	8.3	3.5	12.3	4.3	4.1	3.4	5.7	6.5	3.6	11.4	7.1	8.4	7.9	4.3	2.0	3.2	2.5	2.5	2.5	3.4	5.4	3.7	5.3	2.6	4.1	4.0	4.7	3.7	1.7	1.9	8.8	4.9	1.6	8.6	5.3	3.9	0.0	2.7	3.4	5.8	9.8	6.5	3.0	11.4	3.3	12.6	6.2	3.2
EBF1	"COE1, EBF, OLF1"	ENSG00000164330	"EBF transcription factor 1"	Q9UH73	5	158695916-159099916	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.8;Fibroblasts: 108.4;Leydig cells: 285.5;Microglial cells: 255.8;Peritubular cells: 121.5;Sertoli cells: 98.6;Smooth muscle cells: 138.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"memory B-cell: 12.1;naive B-cell: 10.2"	"Lineage enriched"	"Detected in single"	24	"B-cells: 12.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.0;HSkMC: 26.7;REH: 82.6;U-2197: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (7.86e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (9.62e-7)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (5.75e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.37e-3)"	37.7	2.8	4.6	3.8	5.0	3.3	20.5	16.4	5.0	14.6	3.9	5.1	1.1	10.5	4.1	3.5	12.5	8.1	7.9	3.8	5.0	3.3	0.4	4.3	9.4	9.8	7.5	8.5	1.7	1.6	2.4	10.8	7.1	4.8	3.2	2.0	4.7	4.4	4.7	7.6	5.5	7.7	11.6	4.7	3.5	4.0	5.3	2.5	7.5	7.4	9.2	10.4	10.3	4.9	0.0	0.5	12.8	0.0	30.0	11.9	0.2	0.3	0.0	0.7	1.7	0.0	0.0	11.9	0.0	4.0	2.4	0.1	0.5	0.1	0.2	2.8	0.2	0.0	3.5	0.0	1.0	0.1	0.3	26.7	0.0	11.4	0.4	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.1	0.2	1.2	0.0	0.0	82.6	0.6	0.2	0.0	0.0	6.8	1.7	0.7	0.3	0.0	0.2	0.0	0.1	0.0	15.3	1.8	17.5	0.3	0.0	0.1	11.1	10.2	1.2	13.0	0.5	0.0	0.1	0.0	0.0	0.0	12.1	0.0	0.0	0.0	10.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	4.6	5.0	16.4	5.0	3.8	5.0	9.8	7.5	7.1	11.6	5.3	4.9	79.8	0.0	0.5	5.2	76.3	12.2	0.3	0.0	1.8	5.9	0.8	1.9	5.0	0.0	0.7	1.8	0.0	0.2	0.2	0.1	0.0	3.9	28.2	1.5	54.2	56.3	0.0	0.4	0.4	0.0	0.3	108.4	1.5	1.4	0.0	0.0	4.6	2.2	0.8	0.0	1.6	0.1	0.0	0.3	16.6	21.7	285.5	1.9	14.2	255.8	9.3	1.9	0.0	3.0	0.9	0.1	0.0	121.5	7.7	0.7	0.0	0.1	0.9	2.3	98.6	4.6	138.8	2.7	1.3	1.6	7.0	0.4	5.0	10.7	0.0	1.7
EBF2	"COE2, FLJ11500"	ENSG00000221818	"EBF transcription factor 2"	Q9HAK2	8	25841725-26045413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 17.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.9;Fibroblasts: 23.2;Microglial cells: 13.1;Sertoli cells: 39.5;Smooth muscle cells: 53.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 22.7;ASC TERT1: 45.7;HSkMC: 46.9;hTEC/SVTERT24-B: 26.7;U-138 MG: 17.1;U-2197: 22.7;U-87 MG: 19.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.7;cerebellum: 3.1;hypothalamus: 2.0;midbrain: 4.4;pons and medulla: 2.8"	"Region enriched"	"Detected in many"	5	"spinal cord: 8.7"	"HPA003954, HPA055101"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA003954: , HPA055101: "	"unprognostic (3.70e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (7.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.82e-2)"	17.8	0.7	0.2	0.9	0.5	0.0	8.0	0.2	0.1	0.7	0.1	1.4	0.0	0.8	1.9	0.8	4.0	2.6	9.8	0.0	0.7	0.5	0.0	0.6	0.6	1.3	3.1	1.0	0.8	2.2	0.4	0.5	2.7	0.5	0.4	0.2	1.4	0.4	4.7	1.5	0.7	1.7	3.8	0.0	0.8	1.1	0.9	1.4	6.2	9.6	0.2	1.9	1.2	0.3	0.0	0.0	0.8	0.0	22.7	45.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	26.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	17.1	0.2	22.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.7	1.3	3.1	2.7	3.8	0.9	0.3	11.9	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.6	0.1	0.2	0.3	5.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	5.6	0.0	0.0	0.5	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	3.2	5.9	0.6	0.0	13.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	39.5	2.6	53.4	1.0	0.2	0.4	0.3	0.0	0.2	0.1	0.0	0.1
EBF3	"COE3, DKFZp667B0210"	ENSG00000108001	"EBF transcription factor 3"	Q9H4W6	10	129835233-129973053	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.9;brain: 16.9"	"Group enriched"	"Detected in some"	5	"Adipocytes: 29.6;Endothelial cells: 13.1;Fibroblasts: 14.9;Skeletal myocytes: 33.5;Smooth muscle cells: 11.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 16.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;HAP1: 13.6;LHCN-M2: 25.4;NB-4: 35.7;RH-30: 13.2;SCLC-21H: 28.7;THP-1: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (2.96e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.50e-3)"	"unprognostic (8.53e-6)"	"unprognostic (2.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.58e-2)"	23.9	0.6	0.3	1.0	0.1	0.1	13.7	1.4	0.2	4.1	0.4	2.7	0.2	2.3	0.8	1.4	4.8	2.4	9.4	0.1	2.7	0.5	0.5	0.2	6.9	6.5	8.5	1.0	1.3	2.1	0.9	2.5	3.8	2.4	0.5	1.9	3.0	1.1	7.9	3.3	1.0	1.5	16.9	0.2	1.6	1.6	3.2	1.3	7.3	7.7	1.0	3.3	5.5	1.1	0.0	0.0	0.6	0.1	12.5	10.3	0.1	0.8	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.5	0.0	0.0	13.6	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	2.4	0.0	0.0	0.0	0.7	0.0	0.0	25.4	0.0	0.0	35.7	0.0	0.0	0.0	0.3	13.2	0.0	0.0	0.1	28.7	0.4	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	1.3	8.7	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.4	0.2	0.1	2.7	6.5	8.5	3.8	16.9	3.2	1.1	29.6	0.0	0.0	0.3	0.0	1.9	0.0	0.0	0.0	1.8	0.3	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	13.1	0.0	0.0	0.9	0.0	0.0	14.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.5	0.4	0.3	0.4	0.0	1.9	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.7	0.0	33.5	11.7	0.0	3.4	0.1	0.9	0.0	0.2	0.1	0.0	0.1
EBLN2		ENSG00000255423	"Endogenous Bornavirus like nucleoprotein 2"	Q6P2I7	3	73061659-73063337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA062510, HPA068795"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	Nucleoplasm	"HPA062510: AB_2684787, HPA068795: AB_2686038"	"unprognostic (1.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.38e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.12e-1)"	2.3	1.2	0.5	2.3	1.7	15.4	2.3	1.0	1.1	2.5	1.9	1.8	1.3	2.6	2.4	1.6	2.6	1.3	1.9	0.6	1.2	0.9	1.7	2.7	2.0	1.7	0.9	3.7	2.2	0.7	1.2	2.0	1.9	1.5	2.4	2.7	2.7	0.8	1.4	2.2	2.1	1.5	0.8	2.4	1.9	1.1	1.3	1.5	2.1	0.3	1.7	1.8	2.5	4.4	0.6	0.4	2.6	2.3	0.6	1.4	1.9	1.0	0.2	0.6	0.5	1.3	2.1	1.7	0.4	1.4	0.6	0.9	1.0	1.1	1.3	0.6	0.6	1.1	3.0	1.1	0.3	2.2	2.4	1.4	0.8	1.3	1.3	1.2	0.9	1.4	0.8	2.5	0.7	1.4	1.0	3.0	1.6	0.5	0.7	2.7	0.6	1.0	0.7	2.8	0.6	1.2	0.6	1.1	0.3	1.8	1.7	0.8	1.7	0.7	1.4	2.0	1.6	2.5	1.3	1.3	0.7	2.3	1.3	0.1	0.7	3.3	1.6	0.2	1.3	0.7	1.4	1.4	0.2	1.2	1.2	1.7	1.5	0.5	0.3	1.0	1.9	0.1	0.5	1.7	1.0	1.1	0.6	1.2	1.7	0.9	1.9	0.8	1.3	4.4	4.3	0.0	2.2	0.0	5.8	5.7	12.6	6.7	1.8	5.3	3.2	3.0	1.1	12.8	6.2	3.7	8.4	9.7	5.9	6.8	0.0	3.2	1.8	4.0	4.4	4.6	4.2	6.1	0.0	1.6	6.2	3.9	4.1	7.4	1.3	9.2	10.8	5.1	2.8	3.3	0.0	4.0	4.1	5.1	11.5	0.8	8.4	5.4	1.8	0.0	5.2	2.0	5.2	0.0	0.0	3.9	4.1	3.8	5.2	9.3	6.2	0.5	6.3	6.0	6.6	8.0	4.8	3.5	5.0	1.1	6.3	14.6	6.8	6.7	5.1	13.2
ECD	"GCR2, hSGT1"	ENSG00000122882	"Ecdysoneless cell cycle regulator"	O95905	10	73130155-73169055	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006465	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA006465: AB_2667595"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.55e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.84e-2)"	13.8	17.2	8.0	14.6	11.2	31.9	17.9	12.7	10.7	14.8	10.2	13.1	12.1	16.0	16.2	15.2	11.9	15.9	12.8	8.5	7.7	17.4	18.9	12.6	17.7	7.4	7.1	13.9	16.7	22.8	11.3	17.8	7.5	16.5	13.9	17.0	14.4	14.3	13.8	15.3	11.7	14.7	7.2	14.4	13.1	19.2	7.6	21.0	19.0	14.3	18.4	20.0	12.5	12.5	41.0	28.8	32.0	48.1	28.8	28.2	26.3	31.1	48.5	49.9	57.8	52.0	41.4	31.8	29.9	30.5	36.7	33.0	34.6	36.9	50.3	26.1	33.5	39.9	21.2	38.0	43.7	48.3	25.3	31.5	30.9	41.6	51.7	37.9	53.3	29.3	42.1	21.4	47.6	34.8	44.5	28.6	33.0	37.7	81.8	32.1	35.6	17.6	40.4	29.5	13.9	26.5	28.4	62.5	40.3	32.6	36.1	23.0	33.3	21.1	42.8	23.3	36.2	25.2	18.1	54.5	40.1	40.4	18.5	21.0	23.3	26.3	24.7	24.9	26.4	24.3	23.0	24.4	20.3	21.2	29.9	21.5	27.5	32.5	34.7	13.8	24.8	20.3	8.0	11.2	12.7	10.7	8.5	7.7	7.4	7.1	7.5	7.2	7.6	12.5	21.2	28.9	12.1	13.1	22.7	11.0	27.9	16.6	24.5	13.9	11.9	10.3	12.5	8.6	23.0	7.3	25.0	22.7	22.7	9.0	7.9	15.8	39.4	15.3	15.5	17.4	10.8	21.8	17.3	12.2	15.7	15.7	23.4	24.8	19.6	12.2	15.0	8.8	16.6	20.2	16.3	11.8	8.2	12.4	10.1	11.5	15.8	16.0	14.2	9.4	10.8	10.3	14.4	11.6	18.6	14.7	5.7	13.2	16.7	13.1	9.8	12.2	10.5	13.1	6.6	17.8	18.2	32.9	16.0	19.2	10.9	33.2	22.1	11.6	9.2	24.7
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487834	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 106.9;ovary: 99.7;pituitary gland: 27.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 33.5;Muller glia cells: 100.3;Peritubular cells: 21.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 106.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 44.1;HeLa: 21.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 70.7"	"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	1.8	10.0	5.2	1.0	5.5	0.0	1.7	1.2	31.6	1.0	3.4	0.8	0.1	2.2	0.0	0.4	3.5	0.5	0.2	0.5	106.9	4.1	2.5	0.4	0.3	20.9	11.3	99.7	0.7	1.2	27.6	0.3	17.1	0.4	0.0	13.4	0.6	1.5	3.0	0.6	0.4	1.4	2.4	4.5	0.9	1.9	44.2	0.2	1.4	0.0	0.4	0.4	1.1	4.5	0.0	0.1	0.1	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.4	0.0	0.2	0.0	0.6	0.0	0.0	0.0	4.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.5	1.2	31.6	0.5	106.9	20.9	11.3	17.1	2.4	44.2	4.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	33.5	0.5	0.3	1.1	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	1.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	1.5	0.1	0.0	0.0	0.0	100.3	0.0	0.0	0.0	0.1	0.0	21.1	0.0	0.0	0.0	0.1	0.0	3.7	0.0	1.0	2.3	0.5	1.6	0.0	0.0	0.0	0.1	0.6	0.0	0.1
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 484.1;esophagus: 1370.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 113.3;Fibroblasts: 118.6;Melanocytes: 74.7;Pancreatic endocrine cells: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 402.1;BJ hTERT+: 293.1;fHDF/TERT166: 279.6;hTEC/SVTERT24-B: 195.6;LHCN-M2: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		8700000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	49.3	15.4	7.6	11.8	8.5	0.8	27.1	7.3	14.7	293.8	6.1	17.7	9.4	51.2	484.1	1370.5	20.1	76.5	81.3	8.1	8.3	15.9	61.2	26.3	1.2	17.4	8.9	8.9	4.1	3.5	12.7	44.6	15.4	15.5	18.1	0.9	223.9	14.0	7.0	70.0	12.4	32.6	8.9	11.5	12.4	2.7	9.4	1.3	11.1	7.8	135.0	24.4	360.1	10.7	35.4	3.5	12.6	0.2	73.9	402.1	11.4	126.9	293.1	76.2	99.5	1.9	19.1	0.6	1.3	279.6	8.8	71.5	0.2	15.0	79.3	0.6	0.7	5.7	4.1	0.7	20.4	0.3	125.5	35.7	0.9	195.6	7.2	112.8	21.3	0.7	27.7	0.8	215.2	0.1	0.4	4.2	1.4	147.8	4.1	2.0	92.7	0.5	2.8	0.1	0.8	0.4	28.8	0.9	106.4	5.8	0.3	34.0	5.8	159.3	23.9	18.3	27.9	0.5	1.1	1.5	84.6	11.7	22.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	8.5	7.3	14.7	8.1	8.3	17.4	8.9	15.4	8.9	9.4	10.7	9.1	0.0	1.1	2.9	0.6	14.7	1.9	6.9	0.0	0.7	0.5	0.6	1.8	7.2	7.9	3.7	0.0	2.2	0.6	1.0	0.0	6.2	0.3	3.1	113.3	15.7	0.0	0.0	12.1	4.3	40.9	118.6	7.7	2.5	10.2	1.0	42.5	1.0	17.0	1.7	10.9	1.4	18.3	2.2	22.8	0.3	9.9	10.8	74.7	2.8	0.1	0.5	0.0	1.0	4.4	70.2	1.1	22.2	0.4	1.5	0.1	0.1	0.4	1.2	13.1	4.1	32.3	0.7	0.6	28.1	19.0	10.9	2.1	5.0	0.5	6.9
ECPAS	"ECM29, FLJ22036, KIAA0368"	ENSG00000136813	"Ecm29 proteasome adaptor and scaffold"	Q5VYK3	9	111360692-111484745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021646, HPA059795"	Uncertain		Approved	Nucleoplasm		Yes	No		5400	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021646: AB_2670788, HPA059795: AB_2684127"	"unprognostic (1.64e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.05e-1)"	41.6	34.1	33.8	23.5	43.7	28.6	31.8	33.9	52.9	31.6	31.6	34.0	32.1	28.4	23.6	28.7	26.5	19.9	44.4	52.7	30.6	31.0	28.2	31.0	21.6	32.0	31.9	33.0	38.4	40.6	32.7	24.0	33.7	34.3	29.6	28.3	32.0	25.6	245.0	32.4	29.6	28.5	26.1	22.4	31.2	35.6	31.4	16.2	32.4	97.1	21.2	31.6	30.9	40.1	58.9	53.1	35.0	37.7	81.6	81.1	57.5	70.8	60.4	57.0	39.1	49.7	35.6	59.3	32.5	62.6	46.5	83.7	45.1	47.4	52.7	65.4	28.3	36.6	64.5	72.0	60.4	68.9	38.2	74.2	48.8	57.3	84.4	64.6	58.8	14.7	85.4	81.1	47.1	49.5	0.3	39.9	68.6	74.7	44.1	33.4	107.2	35.7	48.9	52.2	66.7	31.7	60.5	64.1	46.2	37.6	50.5	36.4	64.7	38.1	43.6	57.5	65.5	71.2	144.9	71.3	55.7	27.8	36.0	2.7	5.8	1.9	4.6	6.0	5.3	3.9	4.7	5.3	8.1	4.2	2.8	4.9	1.7	4.8	4.5	3.6	4.1	2.9	33.8	43.7	33.9	52.9	52.7	30.6	32.0	31.9	33.7	26.1	31.4	40.1	24.6	57.7	63.9	0.0	5.3	0.0	0.0	0.0	0.0	0.0	19.0	14.7	0.0	0.0	32.8	12.9	0.0	17.3	11.6	0.0	9.8	21.0	0.0	19.3	32.0	12.1	0.0	0.0	0.0	21.7	11.4	12.5	0.0	26.2	24.0	30.6	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	25.7	0.0	0.0	4.9	0.0	0.0	14.4	24.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	20.2	6.5	29.2	0.0	0.0
ECSCR	"ARIA, ECSM2"	ENSG00000249751	"Endothelial cell surface expressed chemotaxis and apoptosis regulator"	Q19T08	5	139448560-139462743	"Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"Adipocytes: 235.8;Endothelial cells: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	122	"EFO-21: 172.1;HUVEC TERT2: 443.7;TIME: 330.9"									HPA063337			Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA063337: AB_2732701"	"unprognostic (5.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.91e-1)"	62.7	12.7	5.5	11.2	5.5	0.2	59.8	5.7	8.5	26.8	5.3	19.4	4.6	29.4	7.4	15.9	33.5	12.1	54.6	5.2	5.9	29.9	6.0	60.1	11.6	6.0	5.9	10.4	6.7	4.7	7.1	33.5	6.3	19.6	8.0	0.8	16.1	7.3	15.1	16.6	20.7	24.4	6.1	23.5	15.2	3.3	6.7	3.5	40.9	17.2	7.2	35.5	26.1	5.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.3	0.0	0.0	172.1	0.3	0.1	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	443.7	0.1	0.0	0.0	1.4	0.0	0.0	0.9	2.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	330.9	0.4	0.4	0.0	1.7	0.0	0.0	0.2	0.0	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.5	5.7	8.5	5.2	5.9	6.0	5.9	6.3	6.1	6.7	5.9	235.8	0.0	3.9	0.0	1.0	14.9	0.4	0.0	0.0	0.0	1.9	2.5	0.0	0.0	0.6	0.0	0.0	0.2	1.0	0.0	0.0	0.6	0.0	0.4	0.5	214.9	0.0	0.0	0.1	1.2	0.1	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	18.3	0.0	0.0	1.7	10.6	5.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	13.9	0.3	1.3	0.9	0.0	1.6
ECSIT	SITPEC	ENSG00000130159	"ECSIT signaling integrator"	Q9BQ95	19	11505929-11529172	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042979	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA042979: AB_10964063"	"unprognostic (9.88e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.08e-2)"	"prognostic favorable (1.48e-9)"	"unprognostic (2.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.95e-2)"	26.2	38.0	28.5	14.9	28.4	24.7	26.8	32.4	38.5	32.2	29.6	42.2	39.5	29.7	9.4	29.2	28.5	15.0	128.5	28.7	29.3	36.6	51.6	20.8	18.0	30.5	28.2	43.1	56.3	30.6	24.3	9.8	31.6	29.8	18.9	12.9	45.7	16.0	124.7	29.6	28.3	16.5	26.1	21.8	48.9	15.0	30.8	15.6	26.2	130.4	13.3	34.3	27.5	30.0	40.0	35.8	20.4	29.2	30.0	33.6	23.1	21.1	26.4	41.8	33.4	52.6	26.4	58.7	42.0	25.4	38.0	52.1	51.6	42.6	14.6	33.2	42.7	54.5	21.6	48.1	29.7	31.5	42.8	35.9	46.0	35.0	38.1	22.1	31.8	53.7	59.2	56.2	15.6	55.2	53.7	48.6	54.6	51.8	91.4	53.3	22.0	77.1	22.3	24.2	77.3	50.2	24.6	38.7	42.4	9.6	45.9	46.3	16.2	44.4	31.2	64.4	38.5	52.7	106.5	28.7	37.0	46.9	32.2	4.1	32.5	12.0	26.6	41.1	30.8	41.7	28.8	25.1	42.3	39.2	31.9	29.3	6.1	26.1	38.3	23.5	35.4	29.7	28.5	28.4	32.4	38.5	28.7	29.3	30.5	28.2	31.6	26.1	30.8	30.0	19.7	9.6	15.7	13.1	25.2	44.5	61.6	48.3	40.9	23.2	38.7	44.2	74.7	52.9	28.3	20.2	12.5	34.5	18.0	44.3	82.2	42.1	18.0	10.2	16.3	23.4	37.3	31.1	15.3	78.5	45.7	27.5	29.6	9.5	22.9	47.1	27.5	49.4	31.1	18.5	19.4	49.3	16.2	29.6	23.5	52.2	34.5	19.5	28.4	3.7	22.2	30.4	29.9	8.0	9.9	38.4	34.8	32.0	21.0	55.9	70.0	101.5	18.5	30.6	32.9	32.7	36.4	17.6	45.1	37.6	41.9	25.2	20.3	53.7	84.6	56.3
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Spermatocytes: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol		No	Yes			"Cluster 1: Neutrophils - Mixed function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA036363: AB_2732472, HPA053261: AB_2682094"	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.82e-6)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	3.6	3.3	2.1	8.2	1.9	19.8	7.5	3.4	3.4	8.1	1.4	11.5	9.3	4.4	1.8	8.9	3.3	5.3	3.2	2.4	1.4	4.3	2.6	5.2	10.5	2.1	1.7	1.3	2.9	3.6	1.2	8.8	2.7	3.2	15.8	12.5	5.6	2.6	2.1	7.1	7.6	7.5	0.7	4.3	9.4	15.9	2.3	23.3	3.9	2.7	11.4	6.9	4.2	3.5	192.0	133.6	103.2	54.0	10.6	21.8	51.6	81.5	67.5	121.4	116.9	74.7	196.9	47.2	122.1	48.8	116.0	81.8	84.2	53.1	164.3	67.8	46.6	29.6	70.0	38.5	4.6	46.2	32.8	7.1	9.0	72.2	73.2	34.0	53.0	68.6	31.3	67.2	97.2	67.6	47.5	34.6	84.4	156.7	72.0	33.7	101.1	60.7	92.2	43.7	68.6	44.1	104.5	117.4	42.2	51.5	195.4	34.1	46.5	58.5	55.7	79.6	174.9	32.8	47.2	88.2	51.6	39.7	78.0	6.0	2.0	0.7	1.0	1.7	1.1	1.4	1.4	0.9	1.6	1.3	0.6	0.9	6.3	0.7	0.7	1.6	2.5	0.7	2.1	1.9	3.4	3.4	2.4	1.4	2.1	1.7	2.7	0.7	2.3	3.5	6.7	6.4	3.2	4.2	3.8	19.5	4.9	6.2	9.1	3.4	10.1	6.5	3.6	5.7	5.7	3.7	64.6	12.0	2.9	10.7	0.0	9.5	3.3	20.1	6.6	7.7	4.8	25.2	6.5	9.2	14.9	6.0	17.9	20.5	0.0	17.9	5.3	2.9	7.3	0.0	2.5	13.5	10.2	4.7	6.3	2.8	0.9	5.1	7.2	15.0	2.8	3.1	2.1	3.0	4.9	20.7	3.8	1.5	9.6	12.8	1.5	3.7	11.0	16.3	0.0	2.9	5.2	42.6	30.4	16.9	12.8	3.8	4.1	3.3	13.5	8.8
EDARADD		ENSG00000186197	"EDAR associated death domain"	Q8WWZ3	1	236348257-236502915	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 8.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 26.7;granulocytes: 22.7;Syncytiotrophoblasts: 22.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"basophil: 49.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 49.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.9;HDLM-2: 13.2;HMC-1: 52.7;RT4: 45.3;T-47d: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA018836	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA018836: AB_1847984"	"unprognostic (3.74e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.12e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.62e-3)"	0.4	0.1	0.2	0.4	0.1	0.4	4.8	0.1	0.1	0.7	0.0	0.3	0.4	0.4	5.2	3.3	1.2	0.8	0.9	0.1	0.1	1.1	0.3	0.7	1.2	0.2	0.2	0.4	3.8	0.1	0.1	4.9	0.1	3.6	0.3	0.0	1.4	6.1	0.0	5.8	0.3	0.1	0.1	1.2	6.3	3.4	0.2	2.3	6.4	0.0	2.6	8.7	1.0	0.1	0.0	3.8	0.3	0.0	0.0	0.0	15.9	0.0	0.0	1.3	0.8	1.0	0.0	0.0	0.0	0.2	4.3	8.8	6.5	9.6	1.2	13.2	7.6	0.1	0.1	1.4	0.0	0.4	52.7	0.0	2.7	0.9	0.8	0.0	0.0	1.8	0.4	0.0	0.0	0.4	0.3	0.0	3.9	0.0	0.0	3.4	0.1	0.0	0.0	45.3	0.4	0.3	0.0	1.2	0.2	0.3	12.6	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	49.5	0.3	0.1	3.1	0.4	4.1	0.1	4.7	6.1	0.5	0.2	0.4	3.2	0.3	5.3	0.2	0.1	5.1	2.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.3	0.0	1.3	0.0	0.4	6.9	7.3	16.3	13.1	0.0	7.1	7.4	4.1	5.7	8.4	0.0	0.0	26.7	3.0	0.1	3.9	1.7	10.6	0.2	1.2	1.2	0.0	2.5	0.5	0.9	14.2	1.1	5.1	0.4	22.7	2.8	5.0	0.5	3.4	0.0	0.6	0.1	8.2	1.5	8.9	9.3	0.3	0.6	12.4	1.0	3.7	0.6	0.0	1.0	0.4	0.6	0.0	0.4	1.8	4.2	0.1	0.4	3.2	0.1	0.0	1.4	6.1	13.4	3.7	6.5	5.3	22.6	6.2	0.3	0.0	5.3
EDC4	"Ge-1, HEDLS, RCD-8"	ENSG00000038358	"Enhancer of mRNA decapping 4"	Q6P2E9	16	67873052-67884499	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 24.8;Excitatory neurons: 14.2;Gastric mucus-secreting cells: 15.3;Inhibitory neurons: 12.6;Oligodendrocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041164, HPA043038"	Supported		Enhanced	"Nucleoplasm,Cytoplasmic bodies"		NA	NA		9700	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Cytoplasmic bodies"	Nucleoplasm	"HPA041164: AB_2677339, HPA043038: AB_2678281"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.17e-1)"	10.1	11.8	36.3	11.9	36.2	24.4	10.6	36.0	42.2	11.6	34.0	15.5	13.7	12.9	9.6	12.1	13.2	12.1	17.0	34.7	34.8	12.2	10.9	10.8	16.3	34.3	34.5	15.8	18.1	13.6	14.0	10.8	34.4	11.3	11.2	8.5	11.3	10.2	21.9	16.1	14.1	9.7	33.0	13.7	15.8	18.3	34.1	20.6	10.9	11.3	16.0	13.1	10.5	37.0	23.8	33.6	22.0	19.9	19.6	14.8	43.6	21.1	17.8	42.4	33.9	55.2	22.4	38.2	22.6	29.1	17.9	32.4	43.1	17.2	21.3	14.8	54.6	27.2	21.9	29.5	23.7	33.2	29.8	20.3	23.2	42.7	19.8	24.9	32.8	28.3	48.2	7.1	25.4	36.5	44.9	83.6	21.8	15.9	18.4	66.1	26.1	42.3	17.0	17.7	38.5	20.8	56.0	15.9	15.8	17.3	29.4	45.2	21.5	17.7	24.7	16.3	28.6	34.9	22.2	94.7	13.6	39.4	16.3	0.7	5.8	4.2	8.9	6.2	7.9	5.6	7.6	8.4	6.0	4.1	7.5	5.4	2.6	8.3	10.9	4.2	11.2	6.6	36.3	36.2	36.0	42.2	34.7	34.8	34.3	34.5	34.4	33.0	34.1	37.0	0.6	22.4	24.8	8.5	4.8	0.0	0.3	0.2	7.4	1.2	0.3	0.4	1.5	0.0	3.2	0.0	4.2	0.2	1.1	1.6	0.0	0.4	0.0	1.0	1.1	2.1	1.2	8.8	14.2	0.0	0.4	2.6	15.3	1.3	3.8	0.8	1.4	0.2	0.4	0.0	12.6	0.4	0.0	0.3	0.3	0.2	0.3	4.5	0.0	11.2	0.0	0.7	1.0	8.5	13.6	0.3	1.2	0.0	8.3	0.2	2.0	0.1	4.4	1.2	6.6	1.0	0.9	0.2	0.2	8.3	0.1	0.0	5.5	0.8	0.4	0.1
EDF1	"CFAP280, EDF-1"	ENSG00000107223	"Endothelial differentiation related factor 1"	O60869	9	136862119-136866308	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 2662.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035642	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA035642: AB_10611959"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	305.1	423.1	401.9	234.1	403.4	299.6	315.7	408.4	511.3	359.2	392.1	355.4	494.2	280.8	211.9	462.9	281.6	192.2	519.3	404.5	420.1	430.0	668.7	279.5	273.3	415.5	412.3	394.2	715.5	289.9	395.9	202.8	412.2	430.3	206.9	105.1	497.8	230.7	497.6	407.3	486.4	162.7	401.3	309.8	399.1	179.5	405.5	231.3	396.3	321.6	242.2	286.6	343.4	418.0	496.0	646.9	355.3	361.3	342.6	358.5	693.9	555.9	370.3	438.7	339.8	528.1	335.9	429.6	503.5	484.3	392.3	585.0	277.0	424.5	159.7	467.6	338.4	300.4	784.0	727.5	680.2	518.7	394.9	357.4	533.8	344.9	396.9	408.1	426.7	382.7	443.0	540.6	379.7	1071.4	465.6	818.8	375.6	761.1	548.0	404.2	517.5	875.8	592.2	515.4	450.8	433.3	579.8	807.6	587.1	231.9	781.1	715.8	526.6	477.5	363.8	524.5	528.0	311.5	555.7	366.6	625.8	305.7	448.8	290.4	378.6	327.2	351.6	334.9	388.7	430.9	373.6	364.9	379.2	400.3	328.8	343.7	149.3	396.7	282.8	621.6	471.0	544.4	401.9	403.4	408.4	511.3	404.5	420.1	415.5	412.3	412.2	401.3	405.5	418.0	375.9	227.6	290.8	27.1	357.5	522.1	601.8	717.4	314.1	139.5	530.5	691.1	336.9	480.4	421.8	314.5	39.6	683.0	405.4	1157.4	1154.3	668.1	148.4	266.8	317.2	365.7	443.4	277.0	19.1	1274.9	768.6	332.7	349.7	320.2	291.1	386.5	404.8	822.2	571.2	94.2	20.8	1032.8	376.4	394.7	535.9	292.1	581.6	323.0	526.5	15.9	787.1	352.5	460.3	23.1	39.0	1103.5	1413.9	426.5	409.6	625.2	2662.5	1566.5	314.5	155.6	276.1	389.0	469.0	238.7	237.4	408.3	620.3	1127.5	377.8	364.3	764.7	682.5
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290361-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 44.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 749.7;Ductal cells: 316.3;Glandular and luminal cells: 289.7;Pancreatic endocrine cells: 268.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"non-classical monocyte: 4.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 660.4;HUVEC TERT2: 446.8;T-47d: 137.5;TIME: 334.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"	NA	Yes	9740		"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	44.6	1.8	14.7	7.3	13.8	4.7	23.6	13.6	18.2	6.2	9.7	10.6	10.4	7.0	6.3	12.1	9.4	13.5	7.8	12.6	12.2	7.7	3.1	36.6	5.6	15.1	13.6	2.6	9.6	1.4	1.1	18.5	15.2	5.5	14.5	1.0	12.1	8.9	7.6	11.8	9.8	11.3	13.1	12.3	10.4	4.7	15.7	1.7	3.4	6.4	2.4	9.9	5.9	14.2	10.3	57.6	1.1	0.1	0.3	0.2	0.2	18.2	16.0	15.0	12.4	74.6	8.6	0.0	660.4	7.2	9.2	5.4	0.0	10.6	11.0	0.8	0.0	0.0	2.1	2.3	0.8	0.0	0.0	0.4	6.2	3.0	2.1	4.7	446.8	0.0	0.0	0.0	56.8	1.6	0.2	0.3	0.6	10.4	0.7	0.2	5.1	0.1	35.3	9.4	0.6	0.0	1.8	53.1	0.1	117.2	137.5	0.8	334.3	37.1	30.1	0.7	23.5	0.3	0.4	1.3	0.3	0.0	1.6	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	4.9	0.1	0.0	0.0	14.7	13.8	13.6	18.2	12.6	12.2	15.1	13.6	15.2	13.1	15.7	14.2	190.7	173.1	23.8	2.9	0.8	189.9	749.7	99.9	151.4	0.2	68.7	26.8	2.2	8.6	110.6	38.6	0.0	1.8	0.8	189.7	3.9	316.3	13.3	187.2	16.3	236.8	15.6	2.7	3.6	218.9	0.4	9.0	22.4	289.7	1.3	0.8	169.2	1.8	1.8	1.7	3.0	43.8	12.2	5.0	6.7	19.8	5.6	5.3	8.8	6.5	10.9	0.3	0.0	3.5	0.6	268.5	145.7	0.4	0.4	185.8	119.6	8.3	27.4	0.4	6.6	1.8	21.8	1.0	0.6	53.7	64.5	0.8	9.7	0.1	196.6	141.8
EDRF1	"C10orf137, DKFZp586F1019, FLJ21617"	ENSG00000107938	"Erythroid differentiation regulatory factor 1"	Q3B7T1	10	125719515-125764143	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 145.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031820			Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Centrosome, Cytosol"	"HPA031820: AB_10600753"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.84e-4)"	"unprognostic (4.76e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.63e-3)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (3.44e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.68e-3)"	4.1	4.0	2.0	6.1	2.7	21.8	5.6	5.3	2.9	5.6	2.7	4.0	5.0	7.4	4.9	4.7	4.6	4.1	5.1	2.9	2.0	3.6	2.8	4.2	9.7	1.7	1.7	8.0	7.2	4.3	2.9	5.7	2.3	6.8	5.2	4.6	12.3	4.1	5.7	5.1	4.5	5.2	1.5	5.4	4.7	15.1	1.7	9.4	5.2	5.1	8.2	4.4	3.3	4.1	12.6	11.7	15.4	16.5	7.2	10.0	7.8	14.8	13.6	16.3	18.5	15.7	10.4	16.5	6.9	9.6	9.5	15.3	22.6	4.7	18.0	10.3	18.3	12.0	12.5	8.9	9.6	17.0	12.1	6.5	6.0	16.2	8.1	15.6	7.8	8.9	11.1	11.2	10.6	5.3	16.9	11.8	20.6	7.7	10.2	14.0	13.2	9.7	6.5	7.2	7.6	14.9	10.7	5.9	10.1	13.9	10.3	6.8	5.4	8.8	9.6	12.4	17.1	15.0	11.4	26.1	9.3	8.8	5.0	5.9	2.3	1.4	2.7	2.0	3.4	3.1	2.2	2.5	3.0	2.3	2.2	2.8	2.9	2.9	1.3	2.9	3.1	1.4	2.0	2.7	5.3	2.9	2.9	2.0	1.7	1.7	2.3	1.5	1.7	4.1	12.4	12.8	9.7	26.1	19.1	5.9	5.7	5.1	15.4	23.9	9.3	8.4	12.9	8.6	9.0	11.0	33.3	6.7	28.5	5.1	0.0	4.3	145.1	11.2	14.6	9.5	4.2	7.6	40.9	7.2	6.0	12.1	17.3	27.2	20.3	24.7	7.5	7.0	4.1	20.2	31.7	7.5	4.1	7.7	4.2	61.5	21.1	9.2	7.2	22.5	12.2	9.1	13.4	22.1	36.2	8.3	4.9	19.9	27.1	6.6	7.1	2.7	8.6	24.4	6.6	13.0	11.0	26.8	21.4	10.6	8.2	4.5	20.1	18.5	7.3	5.2
EED	"HEED, WAIT-1"	ENSG00000074266	"Embryonic ectoderm development"	O75530	11	86244753-86278813	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012211, HPA060089, HPA061140"	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.19e-3)"	"prognostic unfavorable (1.36e-7)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (2.27e-5)"	9.3	9.0	13.2	16.3	13.1	9.2	11.4	15.0	15.8	13.8	13.1	12.1	12.1	11.5	15.2	12.7	10.6	9.3	8.9	12.8	13.5	11.5	11.9	8.5	28.8	12.9	12.8	12.1	10.5	9.1	9.4	14.5	13.1	11.7	11.9	16.4	10.3	10.6	10.5	12.1	11.6	10.2	12.9	14.4	10.9	10.3	13.6	17.8	10.7	11.1	32.1	13.0	12.1	13.9	34.2	37.8	40.9	16.8	22.6	20.2	47.0	49.2	22.6	46.3	46.8	121.0	64.4	79.8	50.6	15.8	44.2	41.4	48.7	26.8	43.2	79.7	22.7	51.4	38.7	36.3	19.8	54.2	33.4	12.4	18.0	46.8	20.1	17.5	20.9	34.7	58.8	16.2	39.0	55.2	51.5	55.4	30.4	107.8	18.4	56.2	49.1	38.8	29.1	55.4	27.5	22.4	63.5	29.6	14.5	29.1	49.2	22.6	19.0	48.1	44.1	70.0	43.2	9.2	32.1	63.9	13.7	46.6	36.8	31.0	9.1	15.0	25.4	15.3	22.1	45.0	33.2	32.0	13.9	47.3	26.4	29.6	3.9	19.3	16.8	9.2	58.6	19.1	13.2	13.1	15.0	15.8	12.8	13.5	12.9	12.8	13.1	12.9	13.6	13.9	15.4	6.4	9.3	28.1	32.7	25.6	11.6	27.5	25.0	26.4	13.3	11.8	9.5	11.5	15.4	7.3	18.8	45.2	31.0	16.1	19.6	14.5	7.7	17.6	17.1	16.6	7.2	15.8	35.0	10.2	36.8	14.8	16.3	15.5	15.9	15.0	13.2	11.4	16.9	32.0	45.6	12.8	12.2	14.5	32.5	3.6	22.7	15.2	19.6	37.5	30.4	11.5	25.7	31.2	38.9	11.9	11.1	17.3	17.6	11.9	11.7	8.6	21.3	18.3	6.6	14.3	24.5	18.7	20.0	16.9	16.8	24.9	31.6	17.5	15.0	20.9
EEF1AKMT2	"C10orf138, Efm4, METTL10"	ENSG00000203791	"EEF1A lysine methyltransferase 2"	Q5JPI9	10	124748149-124791887	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.1;Distal tubular cells: 66.5;Extravillous trophoblasts: 29.8;Proximal tubular cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA050138	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Vesicles, Cytosol"	"HPA050138: AB_2681030"	"unprognostic (1.64e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.75e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.04e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.09e-2)"	4.8	3.8	3.0	2.1	3.3	3.6	5.3	4.8	4.2	4.6	3.0	3.7	1.8	4.0	4.6	4.0	3.8	2.1	4.1	3.1	3.0	4.9	5.2	3.3	2.5	2.8	3.1	5.5	4.4	4.5	4.3	2.7	2.8	4.3	3.8	2.5	5.1	2.8	4.0	5.0	3.5	2.6	2.7	3.5	3.7	5.6	2.8	3.3	5.1	3.3	3.1	3.4	4.2	3.6	12.6	3.3	4.8	8.0	3.1	8.0	3.1	5.8	7.6	7.4	6.5	4.3	7.1	8.4	3.0	4.7	2.5	3.8	6.8	4.2	11.5	7.0	2.5	6.8	4.2	3.9	6.0	10.9	4.1	3.9	3.9	4.1	9.9	6.2	4.7	7.0	7.6	9.3	9.3	3.7	5.2	8.5	5.9	4.6	4.8	2.3	5.7	2.6	4.6	2.7	1.5	3.8	3.7	6.2	8.7	3.3	5.4	8.5	5.8	2.7	2.9	4.5	8.8	4.3	3.7	6.8	4.9	5.7	3.9	0.8	1.0	1.6	1.6	1.1	2.5	1.9	1.6	2.0	1.2	1.3	2.2	1.6	0.1	4.4	0.8	1.5	1.9	1.1	3.0	3.3	4.8	4.2	3.1	3.0	2.8	3.1	2.8	2.7	2.8	3.6	23.2	3.2	11.3	0.0	8.9	0.0	0.0	0.0	0.0	0.0	20.5	22.4	0.0	0.0	2.5	11.0	0.0	29.1	13.4	0.0	66.5	20.0	0.0	11.4	11.8	7.5	0.0	0.0	0.0	20.4	29.8	10.4	0.0	10.5	2.5	17.8	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	11.4	0.0	0.0	0.0	0.0	19.8	0.0	0.0	2.8	0.0	0.0	30.5	3.6	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	17.1	7.1	14.7	0.0	0.0
EEF1AKMT3	"DKFZP586D0919, FAM119B, METTL21B"	ENSG00000123427	"EEF1A lysine methyltransferase 3"	Q96AZ1	12	57771492-57782541	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 14.9;Breast myoepithelial cells: 7.6;Exocrine glandular cells: 12.7;monocytes: 8.8;Proximal tubular cells: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	7	"RH-30: 152.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043020, HPA045492"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome,Centrosome"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	"Nucleoplasm, Mitotic chromosome"	"HPA043020: AB_2678274, HPA045492: "	"unprognostic (2.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.23e-1)"	7.5	6.2	2.5	3.6	2.3	2.6	9.2	4.1	2.7	10.5	2.6	5.6	3.9	9.3	9.6	5.6	8.4	5.4	3.7	2.4	1.8	11.6	6.5	5.3	3.6	2.6	2.4	11.4	21.7	6.4	3.7	4.6	2.7	8.2	4.6	3.7	19.4	8.7	2.9	7.3	3.8	7.6	2.1	4.0	7.2	4.2	2.4	1.9	10.1	3.1	3.1	6.3	7.3	3.1	5.4	11.0	4.6	5.9	12.8	12.0	4.0	5.8	10.9	8.9	9.0	5.6	9.5	3.1	7.4	7.6	7.2	5.2	3.7	3.3	9.3	4.0	5.6	14.9	6.6	9.2	11.3	3.7	6.6	12.6	8.7	9.3	9.8	15.2	9.7	13.2	8.9	22.6	5.4	3.8	4.7	11.0	3.4	4.3	8.0	8.5	152.1	10.0	6.0	5.3	4.4	6.0	10.0	7.5	6.2	4.1	11.9	10.0	9.5	13.7	7.7	5.8	6.4	5.7	2.3	3.8	11.3	15.4	10.0	0.4	3.0	0.1	1.8	1.1	7.8	0.5	3.5	2.2	3.1	0.4	1.7	1.4	0.7	1.5	4.6	1.5	2.2	2.3	2.5	2.3	4.1	2.7	2.4	1.8	2.6	2.4	2.7	2.1	2.4	3.1	3.9	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	7.6	0.0	0.0	1.8	1.8	0.0	3.4	1.3	0.0	5.9	5.5	0.0	2.0	6.0	1.9	0.0	0.0	0.0	12.7	4.9	3.4	0.0	2.5	2.5	5.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.0	16.4	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	4.7	0.0	0.0
EEF1AKMT4		ENSG00000284753	"EEF1A lysine methyltransferase 4"	P0DPD7	3	184249672-184258759	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 9.9;Breast myoepithelial cells: 11.7;Distal tubular cells: 15.6;Ductal cells: 14.7;Exocrine glandular cells: 15.3;Pancreatic endocrine cells: 9.2;Proximal tubular cells: 21.2"					"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062215			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA062215: AB_2684714"																		2.4	3.0	1.0	4.1	1.0	5.0	4.3	3.9	1.6	3.1	1.3	5.6	5.3	1.6	1.4	6.1	1.8	2.2	2.0	0.9	1.7	2.9	14.0	2.0	4.3	1.4	1.2	0.7	12.7	4.8		6.0	1.3	1.9	5.3	0.4	6.6	2.0	2.3	5.3	3.4	3.2	1.2	2.0	3.8	11.4	1.4	4.5	7.2	5.4	5.0	6.2		1.0	50.8	29.9	5.1	17.3	9.9	6.8	41.2	6.4	12.5	10.0	9.4	56.9	7.9	63.7	40.2	7.2	41.8	19.5	31.1	32.2	5.6	23.8	36.9	17.1	18.1	36.8	12.1	43.8	12.8	8.5	39.0	10.8	19.1	3.3	8.2	20.8	33.0	54.7	4.8	84.2	18.6	54.9	11.7	71.0	52.1	32.6	7.0	53.4	11.8	11.2	26.8	9.7	10.8	95.1	24.6	9.2	76.0	21.4	5.8	7.5	11.5	22.4	30.2	33.1	74.5	64.6	7.0	74.9	10.0	0.0	22.9	2.5	8.0	19.1	8.8	8.8	8.4	7.8	19.4	6.5	5.8	9.2	0.5	7.3	13.3	17.5	15.5	10.9	1.0	1.0	3.9	1.6	0.9	1.7	1.4	1.2	1.3	1.2	1.4	1.0	3.8	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.9	11.7	0.0	0.0	3.1	7.3	0.0	0.0	1.7	0.0	15.6	14.7	0.0	1.8	3.5	2.1	0.0	0.0	0.0	15.3	0.0	1.5	0.0	2.0	1.3	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.8	0.0	0.0	21.2	1.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.0	6.7	0.0	0.0
EEF1AKMT4-ECE2		ENSG00000284917	"EEF1AKMT4-ECE2 readthrough"	P0DPD8	3	184249695-184293031	"Enzymes, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062215			Uncertain	Nucleoplasm,Cytosol		NA	NA							"Nucleoplasm, Cytosol"		"HPA062215: AB_2684714"																		0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EEF1D	"EF-1D, FLJ20897"	ENSG00000104529	"Eukaryotic translation elongation factor 1 delta"	P29692	8	143579697-143599541	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"DNA-binding, Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045101, HPA051002"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		1300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045101: AB_10963077, HPA051002: AB_2681305"	"unprognostic (9.34e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (8.56e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (3.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.14e-1)"	556.9	600.9	278.8	254.4	299.8	474.5	552.1	276.4	339.0	638.4	302.9	716.0	205.3	497.5	228.5	524.8	523.0	179.7	795.4	267.2	277.0	491.3	582.9	435.3	380.0	303.4	283.3	979.4	1349.3	160.2	328.0	147.2	292.4	609.2	148.3	67.1	577.0	201.9	916.1	615.8	505.9	179.9	281.5	609.6	634.3	288.1	281.7	338.7	504.0	433.0	307.3	538.2	554.0	322.1	454.8	644.8	284.2	246.0	251.0	307.0	314.2	344.2	438.4	536.7	424.0	886.7	420.0	345.5	352.2	386.6	160.4	441.8	295.3	556.0	231.7	274.8	487.6	340.6	1211.8	881.5	373.6	214.1	276.9	594.8	796.6	325.1	367.8	309.6	364.5	282.0	325.2	497.6	309.3	1456.4	838.7	539.7	300.3	580.3	852.3	367.2	204.4	681.0	466.3	757.9	280.0	301.6	300.1	726.3	762.5	174.1	544.3	535.7	285.2	309.9	914.8	465.5	757.5	335.2	142.9	380.2	348.4	431.6	275.3	268.2	535.1	259.6	880.1	503.5	1128.3	1400.1	1110.3	922.6	619.1	1461.9	1365.3	1110.3	408.6	864.7	458.9	874.2	1191.8	2020.0	278.8	299.8	276.4	339.0	267.2	277.0	303.4	283.3	292.4	281.5	281.7	322.1	652.3	163.5	415.9	47.7	1397.8	1846.0	1620.8	1277.4	1438.7	75.7	1568.2	2028.8	3.9	732.0	600.3	342.1	20.9	665.5	942.8	718.8	855.0	751.4	413.0	173.0	441.3	705.7	343.3	639.1	11.3	1793.7	822.0	699.2	520.9	263.8	446.1	931.0	871.7	792.9	799.6	79.1	13.0	971.5	526.9	1361.3	1492.3	1087.1	891.3	823.6	1085.1	17.8	1400.9	502.7	1071.1	15.6	30.2	938.4	799.5	633.1	1098.8	1566.2	998.9	1552.3	241.7	88.9	479.9	1005.6	844.4	34.0	142.2	969.5	1648.6	712.5	1297.8	573.3	870.0	1619.4
EEF1E1	"AIMP3, P18"	ENSG00000124802	"Eukaryotic translation elongation factor 1 epsilon 1"	O43324	6	8073360-8102559	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 244.3;Late spermatids: 231.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027901, HPA057866"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA027901: AB_10611960, HPA057866: AB_2683547"	"unprognostic (9.39e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.79e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	15.5	29.6	26.6	21.5	26.4	57.8	26.5	33.5	33.4	14.9	24.2	18.4	12.0	19.3	26.3	22.6	15.0	13.6	19.1	27.0	31.5	50.6	20.3	13.8	31.7	30.7	34.6	14.7	28.3	31.3	23.9	17.3	31.6	17.8	20.9	25.4	20.0	18.2	22.8	12.3	12.7	19.2	26.7	16.4	23.0	57.5	30.5	25.9	20.6	24.7	31.2	26.4	13.9	30.0	129.5	67.1	104.8	71.9	35.0	56.5	63.6	105.7	67.0	94.4	97.0	111.8	52.5	140.9	229.3	69.8	169.8	51.9	122.3	123.9	156.8	79.6	160.6	113.9	92.0	196.4	63.9	228.2	79.2	47.4	113.5	117.4	116.2	66.4	136.2	113.8	283.3	35.9	91.2	54.0	98.0	183.2	95.8	123.9	107.8	117.9	61.0	221.0	156.3	98.5	156.7	48.0	45.6	100.5	131.9	141.5	79.7	75.7	70.2	77.0	76.7	70.7	156.3	58.4	290.7	199.3	43.1	95.8	126.0	16.2	22.2	14.2	25.7	31.8	36.8	42.9	34.4	34.8	61.2	46.9	38.1	39.5	2.3	30.7	25.5	26.8	45.8	29.3	26.6	26.4	33.5	33.4	27.0	31.5	30.7	34.6	31.6	26.7	30.5	30.0	31.9	16.0	30.0	0.0	39.7	65.9	61.4	99.1	60.3	34.4	43.1	54.1	23.5	21.5	63.4	60.7	10.4	78.7	23.5	11.8	140.8	67.9	244.3	59.0	31.0	34.1	40.1	43.5	0.0	89.0	76.6	30.8	32.1	71.0	15.8	45.4	24.3	30.0	49.7	30.3	0.0	36.6	75.3	31.1	33.4	231.1	26.4	31.3	42.7	0.0	32.6	44.7	29.9	0.0	0.0	69.0	12.9	23.7	48.0	81.3	7.5	186.7	45.9	21.8	13.1	32.8	38.9	131.2	92.2	59.3	76.1	32.3	34.1	69.9	42.0	44.8
EEF2K	"CaMKIII, eEF-2K"	ENSG00000103319	"Eukaryotic elongation factor 2 kinase"	O00418	16	22206278-22288738	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 49.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 69.1;Late spermatids: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;HL-60: 1.6;HMC-1: 1.8;NB-4: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007818, HPA056061"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB007818: AB_598150, HPA056061: AB_2683021"	"unprognostic (4.79e-2)"	"unprognostic (6.10e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	19.8	7.1	1.0	0.4	0.9	0.7	15.9	1.5	2.2	17.2	0.7	20.1	0.3	14.3	0.7	9.1	13.1	0.3	9.2	0.9	1.2	3.6	7.8	9.0	0.5	1.1	0.9	8.2	12.9	0.0	5.2	0.4	1.2	19.6	0.2	0.3	15.0	0.2	24.9	49.0	8.1	0.3	0.9	8.0	9.8	2.3	1.4	0.0	6.3	0.0	0.2	18.8	15.4	1.1	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.6	0.2	1.0	0.0	1.6	1.8	0.0	0.4	0.1	0.1	0.3	0.1	0.1	0.2	1.3	0.0	0.0	0.1	1.6	0.1	0.4	0.0	0.4	1.0	0.2	0.4	0.0	0.3	0.6	0.0	0.0	0.2	0.1	0.2	0.5	0.5	0.7	0.3	1.4	0.0	0.3	0.1	0.3	1.0	1.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.4	0.1	0.0	1.0	0.9	1.5	2.2	0.9	1.2	1.1	0.9	1.2	0.9	1.4	1.1	43.7	22.4	13.3	22.5	7.3	12.6	9.6	3.9	31.3	69.1	15.4	9.3	17.3	12.8	9.8	9.2	14.6	16.3	12.7	24.2	0.0	4.9	42.9	42.4	12.6	18.4	3.0	7.6	21.2	13.4	11.7	19.2	26.0	34.9	29.2	12.0	22.5	17.7	18.7	1.7	37.4	12.3	4.1	15.3	16.2	76.6	14.3	8.7	8.8	15.9	7.9	6.1	6.2	31.7	8.6	10.2	26.3	15.8	19.6	6.6	12.5	4.0	14.9	21.6	6.6	43.5	10.0	1.3	4.2	16.9	23.0	7.8	7.8	5.7	8.1	6.7
EEFSEC	"EFSEC, SELB"	ENSG00000132394	"Eukaryotic elongation factor, selenocysteine-tRNA specific"	P57772	3	128153481-128408646	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 71.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.2;GAMG: 12.3;MOLT-4: 7.9;SH-SY5Y: 10.4;SK-BR-3: 17.7;SK-MEL-30: 15.4;T-47d: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035795	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA035795: AB_10696512"	"unprognostic (1.01e-1)"	"prognostic favorable (2.98e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-3)"	"unprognostic (6.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	13.5	8.2	0.2	0.2	0.2	0.1	12.5	0.2	0.6	14.2	0.1	11.3	0.0	15.6	0.0	12.3	13.9	0.1	25.5	0.2	0.3	14.3	21.8	9.6	2.2	0.4	0.2	12.3	11.7	3.0	8.8	1.6	0.3	12.1	0.6	0.5	9.7	1.9	24.0	16.5	10.7	0.0	0.2	13.4	11.0	19.3	0.4	0.1	9.9	0.0	1.2	12.7	12.3	0.2	0.5	0.1	4.1	1.7	0.1	0.2	0.5	0.0	0.3	0.2	0.2	0.3	6.9	15.2	0.1	3.8	12.3	1.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.1	5.7	0.3	0.3	0.1	0.1	4.0	0.1	0.2	0.3	0.0	0.1	0.2	3.5	0.2	7.9	0.4	0.4	0.1	0.1	0.3	0.2	1.0	0.0	0.0	0.3	10.4	0.0	17.7	15.4	0.3	9.6	0.7	0.0	0.1	0.0	0.2	0.2	0.4	0.7	0.4	0.1	0.4	0.2	0.4	6.3	6.1	5.0	6.0	3.9	5.4	4.4	4.4	8.7	3.9	4.0	5.0	0.0	7.5	4.8	3.7	5.7	4.3	0.2	0.2	0.2	0.6	0.2	0.3	0.4	0.2	0.3	0.2	0.4	0.2	9.4	0.0	6.0	15.0	17.2	6.4	9.3	9.1	7.4	7.8	6.9	8.6	10.1	8.6	4.4	16.5	2.1	22.3	15.7	6.4	15.6	7.9	27.7	3.1	12.5	8.2	11.4	5.9	25.3	7.1	18.3	10.0	10.2	4.5	28.5	10.0	8.9	14.8	14.6	13.5	36.6	11.7	18.3	7.9	8.2	71.6	13.1	11.4	12.4	28.1	9.8	9.3	17.5	45.8	27.1	5.6	2.7	8.6	17.1	9.4	8.6	25.7	2.7	8.2	26.3	9.0	9.1	27.9	16.9	10.8	9.9	29.7	13.7	11.9	10.6	6.0
EFCAB1	FLJ11767	ENSG00000034239	"EF-hand calcium binding domain 1"	Q9HAE3	8	48710789-48735311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 91.6;testis: 37.5"	"Group enriched"	"Detected in many"	19	"Early spermatids: 538.8;Endometrial ciliated cells: 159.1;Late spermatids: 552.0;Respiratory ciliated cells: 310.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 6.5;ASC diff: 2.6;ASC TERT1: 6.2;CAPAN-2: 3.1;hTEC/SVTERT24-B: 2.6;SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023527, HPA069955"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA023527: AB_2231065, HPA069955: AB_2686220"	"unprognostic (5.29e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.94e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.47e-3)"	0.3	1.5	3.1	0.1	4.7	0.7	3.0	1.9	2.5	11.4	22.4	0.5	0.6	12.4	2.5	0.7	91.6	0.6	0.2	3.7	4.9	0.5	0.7	10.6	0.1	13.5	12.1	19.3	3.2	0.0	3.1	0.5	7.0	5.4	0.4	0.0	2.0	5.9	0.0	4.7	1.0	2.9	9.1	0.3	0.6	37.5	5.7	0.4	0.1	0.2	0.2	2.3	3.4	8.5	6.5	0.0	0.8	0.0	2.6	6.2	0.0	0.1	0.6	0.0	0.2	0.0	3.1	0.0	0.0	0.1	0.0	1.7	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.2	2.6	1.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.5	4.9	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.1	0.0	1.2	0.3	0.0	0.0	0.1	0.0	3.1	4.7	1.9	2.5	3.7	4.9	13.5	12.1	7.0	9.1	5.7	8.5	0.4	0.0	5.9	0.0	0.0	6.8	9.7	14.7	4.0	0.0	0.4	9.1	0.4	0.0	20.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	538.8	159.1	4.7	1.2	0.0	0.0	0.7	1.5	0.1	2.2	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.2	0.0	0.3	552.0	4.7	0.8	1.8	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	5.7	0.0	3.4	0.0	0.3	310.7	0.0	0.0	0.7	6.2	16.9	4.5	0.1	1.8	0.3	0.4	3.9	0.0	2.5
EFCAB12	C3orf25	ENSG00000172771	"EF-hand calcium binding domain 12"	Q6NXP0	3	129401321-129428651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.6;fallopian tube: 19.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 29.6;Endometrial ciliated cells: 31.9;Late spermatids: 20.1;Respiratory ciliated cells: 46.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;RPTEC TERT1: 1.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 8.9"	"HPA037694, HPA057532"	Uncertain	Supported	Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA037694: AB_10672605, HPA057532: "	"unprognostic (2.06e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.59e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.59e-2)"	0.3	0.4	0.8	0.1	1.0	0.8	0.3	1.7	1.1	1.1	12.6	0.1	0.0	0.3	0.8	0.0	19.7	0.2	0.3	1.4	1.5	0.8	1.2	1.7	0.1	4.9	7.0	1.0	0.6	1.7	3.6	0.1	3.2	3.0	0.0	1.6	0.2	0.2	0.0	0.1	0.3	0.0	3.6	0.4	0.7	6.9	2.4	0.2	1.2	0.0	0.2	0.0	0.1	1.0	0.1	0.7	0.2	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	1.5	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.7	1.1	1.4	1.5	4.9	7.0	3.2	3.6	2.4	1.0	0.2	3.2	1.7	0.3	0.5	0.5	0.1	0.8	0.0	0.4	0.7	0.4	1.3	1.5	1.8	0.0	2.1	0.0	0.3	0.1	0.0	0.2	29.6	31.9	0.7	0.5	0.0	0.0	2.7	0.2	0.1	0.5	3.1	1.9	0.0	0.1	0.0	1.1	0.1	5.0	0.8	0.3	2.0	0.0	0.0	20.1	0.3	0.3	0.0	0.0	0.1	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.9	46.0	5.6	0.0	0.5	0.6	6.8	2.7	0.7	0.3	0.0	0.3	0.3	0.0	0.2
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 20.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 169.8;Late spermatids: 185.7;Spermatocytes: 64.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	3.2	2.6	1.3	3.2	2.3	3.9	4.2	3.7	2.0	3.8	0.9	2.9	4.8	6.0	4.0	1.6	3.5	2.9	2.5	1.1	2.9	5.4	3.5	3.1	4.5	2.9	2.5	3.8	1.8	3.2	2.5	3.6	3.3	2.7	3.3	3.9	2.3	1.9	0.8	2.2	3.3	2.4	1.7	4.4	3.6	20.5	2.8	1.8	14.2	0.4	3.2	2.6	2.4	4.3	0.9	3.7	1.5	0.2	1.8	6.4	2.8	2.1	0.4	0.6	1.0	1.7	5.2	0.3	5.8	0.7	0.0	1.0	0.0	0.4	3.5	0.1	0.5	4.9	3.4	0.5	1.8	3.8	0.5	1.2	1.7	2.4	0.0	4.4	4.1	3.8	1.5	9.0	2.2	0.1	1.7	2.1	0.8	2.6	2.9	4.5	1.1	1.8	8.3	3.0	1.1	0.5	1.1	0.1	2.5	1.1	6.0	4.5	1.5	0.2	1.1	0.3	1.0	9.4	6.9	0.9	5.5	7.3	3.8	2.8	1.0	0.3	0.5	0.6	0.4	2.2	0.4	0.3	0.5	2.6	1.2	0.7	0.0	0.5	0.4	0.3	0.1	0.3	1.3	2.3	3.7	2.0	1.1	2.9	2.9	2.5	3.3	1.7	2.8	4.3	5.3	9.6	2.2	7.2	7.9	0.8	1.8	0.9	0.6	2.5	2.3	2.4	6.2	1.5	1.3	0.0	0.0	0.3	1.3	0.4	0.0	1.0	169.8	1.9	2.5	6.0	3.0	1.3	8.0	0.9	0.1	4.1	2.6	5.4	6.3	1.3	4.6	0.5	1.9	3.3	10.1	0.4	2.0	2.9	2.0	185.7	1.8	2.6	0.0	32.8	2.7	1.0	0.0	13.0	19.5	1.1	0.3	3.8	1.4	1.1	1.2	1.6	3.3	2.9	0.0	3.2	4.0	64.1	24.5	0.0	0.6	0.0	2.3	1.2	0.7	1.3
EFCAB6	"dJ185D5.1, DJBP, FLJ23588, HSCBCIP1, KIAA1672"	ENSG00000186976	"EF-hand calcium binding domain 6"	Q5THR3	22	43528744-43812337	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.3"	"Group enriched"	"Detected in many"	8	"Early spermatids: 286.6;Late spermatids: 473.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;RPTEC TERT1: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA003098			Uncertain	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA003098: AB_1079087"	"unprognostic (1.85e-1)"	"unprognostic (8.85e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.96e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.71e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.33e-2)"	0.4	0.8	0.9	0.1	0.9	0.0	1.1	0.0	0.7	1.1	6.8	0.5	0.3	1.2	2.1	0.4	7.7	0.5	0.4	0.9	1.4	1.4	0.4	1.2	0.2	2.2	3.2	1.4	1.2	2.4	2.0	0.2	1.5	0.9	0.2	3.1	0.8	1.1	0.2	0.4	0.2	0.5	1.4	0.1	0.9	24.3	1.4	0.2	3.1	0.2	0.1	0.4	0.4	0.4	0.1	0.3	0.4	0.7	0.6	2.1	0.0	0.5	0.4	0.1	0.2	0.0	0.1	0.0	0.3	0.2	0.8	0.6	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.7	0.8	0.5	0.1	0.5	0.1	0.2	0.0	0.0	0.3	1.4	0.0	0.1	0.6	0.4	0.2	0.0	0.0	0.0	1.5	0.3	0.9	0.3	1.4	0.0	0.7	0.3	0.2	0.0	0.1	0.3	0.1	0.5	0.1	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.7	0.9	1.4	2.2	3.2	1.5	1.4	1.4	0.4	0.2	3.2	1.8	18.9	0.5	0.3	0.9	1.0	2.2	3.0	1.2	1.0	1.7	0.0	2.3	0.0	6.2	0.0	0.0	0.4	0.0	0.9	286.6	21.8	1.5	0.4	0.0	0.0	46.0	0.7	0.1	1.3	1.1	1.9	1.3	1.5	0.4	0.4	0.3	6.7	36.8	0.4	2.0	0.3	0.3	473.7	3.1	0.3	0.0	15.9	0.6	1.7	0.0	15.1	10.2	1.0	0.1	1.5	0.2	0.5	0.1	1.1	20.4	12.5	6.6	1.3	0.8	24.1	4.7	0.8	0.1	0.1	0.1	1.4	0.4	0.3
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.3;Excitatory neurons: 58.9;Inhibitory neurons: 47.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	2.7	5.3	7.3	2.2	7.6	2.0	6.0	8.9	10.3	5.8	10.1	3.4	2.0	6.1	6.2	2.9	8.1	4.6	6.5	7.4	9.3	5.6	1.7	4.0	3.6	6.8	7.2	8.0	2.9	10.4	5.9	3.2	7.0	5.4	3.0	8.9	3.1	5.0	6.7	3.1	2.1	4.7	6.5	2.7	3.2	14.6	8.2	7.3	5.9	3.9	3.3	3.7	2.8	8.3	6.5	5.7	7.1	4.5	7.5	11.0	3.6	4.1	4.6	7.2	8.8	1.7	5.0	4.4	9.6	2.5	14.5	6.0	6.1	4.1	8.5	8.6	4.3	3.6	10.4	3.9	4.6	5.1	3.2	6.1	9.9	8.6	5.6	11.4	6.1	8.2	4.8	7.3	4.7	1.5	9.9	3.5	3.1	4.6	5.6	6.2	10.7	4.6	11.1	3.6	15.2	5.8	8.1	4.5	10.5	9.6	4.5	3.8	1.7	4.1	3.5	12.1	4.0	4.7	8.7	5.0	7.4	3.5	6.0	10.1	0.4	0.1	1.2	0.3	1.6	1.8	1.4	1.4	0.8	1.9	1.4	1.3	0.0	1.3	2.6	1.0	1.6	0.6	7.3	7.6	8.9	10.3	7.4	9.3	6.8	7.2	7.0	6.5	8.2	8.3	3.1	12.8	4.1	23.2	6.0	3.1	5.6	7.0	5.7	7.7	2.6	3.9	7.8	2.8	5.6	5.5	4.2	3.7	2.1	0.6	7.9	3.8	55.3	19.9	8.0	3.2	1.8	1.3	58.9	0.7	2.0	5.6	3.6	3.4	2.5	7.9	2.2	1.2	2.6	0.0	47.7	1.3	8.2	2.5	1.6	8.8	10.8	1.8	1.8	14.0	1.9	5.2	2.1	41.7	21.9	1.4	0.3	13.5	6.0	1.4	0.5	5.5	27.5	11.3	26.3	11.8	5.3	73.4	22.7	3.8	2.3	1.2	3.4	5.8	2.1	1.6
EFHC2	"FLJ22843, MRX74"	ENSG00000183690	"EF-hand domain containing 2"	Q5JST6	X	44147872-44343672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 17.1;fallopian tube: 14.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Early spermatids: 78.6;Endometrial ciliated cells: 55.3;Respiratory ciliated cells: 79.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 16.4;NK-cell: 5.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 16.4;NK-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.7;HEL: 3.7;HMC-1: 12.0;NB-4: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034492	Approved	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli fibrillar center"	"Plasma membrane"	"HPA034492: AB_10671227"	"unprognostic (1.93e-1)"	"unprognostic (7.80e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.07e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.13e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.97e-2)"	0.4	0.3	1.5	0.3	1.9	1.4	0.7	1.0	1.4	2.7	17.1	1.1	0.3	3.7	3.4	1.8	14.7	1.4	3.7	1.5	2.1	1.8	0.0	2.0	0.2	5.2	3.9	1.7	0.1	0.2	3.1	0.8	2.8	1.9	0.3	2.0	8.2	3.6	0.0	3.5	0.5	1.6	2.7	0.3	0.9	6.7	2.5	0.5	2.3	0.1	0.4	0.5	0.9	2.6	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.7	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.1	0.0	0.1	3.7	0.0	0.0	0.0	0.0	12.0	0.2	0.2	0.1	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.0	1.5	0.0	0.6	0.1	0.6	0.1	0.3	0.1	0.5	0.7	1.5	5.8	0.0	0.0	0.0	0.9	1.5	1.9	1.0	1.4	1.5	2.1	5.2	3.9	2.8	2.7	2.5	2.6	0.1	0.0	3.9	32.0	0.0	3.1	6.0	9.6	1.2	0.2	0.4	0.5	10.8	4.3	5.1	0.0	2.1	0.0	1.6	1.2	1.9	0.9	78.6	55.3	6.0	0.3	0.0	1.7	7.2	5.9	0.1	0.8	0.0	17.1	16.4	3.8	0.4	0.0	0.3	0.0	1.7	1.5	4.1	0.0	0.4	19.0	6.8	4.9	0.0	0.0	0.4	5.3	3.1	1.5	0.2	1.0	0.0	7.2	0.2	1.0	3.8	0.7	79.6	0.1	6.6	0.1	3.7	11.3	10.5	7.3	2.8	0.3	1.6	0.4	5.2	6.0
EFNB2	"EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228"	ENSG00000125266	"Ephrin B2"	P52799	13	106489745-106535662	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 239.7;Hepatic stellate cells: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 76.5;OE19: 45.5;SH-SY5Y: 42.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008999, CAB009368"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		940000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB009368: AB_2095700, HPA008999: AB_1078721"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.52e-3)"	"prognostic unfavorable (3.11e-6)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.70e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.27e-3)"	20.7	6.1	3.8	4.3	5.9	0.2	17.1	1.3	6.2	11.0	0.0	22.1	7.9	10.2	0.7	12.1	8.8	4.2	15.5	5.5	4.9	11.2	4.8	23.4	3.2	0.1	0.1	7.2	3.9	3.2	6.3	15.4	0.3	12.5	9.9	3.2	14.0	10.6	6.5	17.2	14.4	5.5	0.1	7.4	15.0	5.4	1.6	3.6	11.9	8.0	3.2	6.5	14.1	4.3	23.3	1.8	76.5	0.1	0.2	0.7	0.3	10.8	5.4	8.2	4.7	19.1	28.7	0.0	11.0	2.5	0.6	28.4	2.9	10.9	8.9	0.0	24.3	0.1	6.0	0.0	1.5	6.9	0.6	3.5	19.0	0.4	16.1	4.1	10.4	0.2	0.1	0.0	9.1	3.3	0.2	0.1	4.7	45.5	5.0	21.9	3.3	0.1	11.9	2.5	5.8	42.7	3.6	1.7	0.1	21.4	1.0	0.2	9.6	16.3	0.0	0.5	23.8	0.4	0.0	0.0	34.5	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.9	1.3	6.2	5.5	4.9	0.1	0.1	0.3	0.1	1.6	4.3	239.7	6.4	35.7	38.8	4.4	83.2	52.9	15.4	13.1	10.4	39.8	45.3	8.8	5.7	13.2	25.8	0.0	1.4	8.6	114.6	0.0	6.8	0.4	24.7	69.8	106.5	50.6	0.0	49.3	1.4	3.1	15.4	69.3	42.1	17.8	11.8	187.4	1.3	1.1	6.7	29.7	59.8	26.4	5.8	11.9	1.0	0.3	4.0	32.0	48.7	0.0	89.1	0.0	3.5	13.9	46.3	64.3	0.4	1.0	25.1	15.9	0.2	8.7	3.4	0.0	33.1	22.8	0.7	3.3	41.1	86.0	1.9	7.9	6.4	71.5	72.0
EFS	"CASS3, EFS1, EFS2, HEFS, SIN"	ENSG00000100842	"Embryonal Fyn-associated substrate"	O43281	14	23356403-23365752	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001581, HPA001790"	Approved		Uncertain	Nucleoplasm,Cytosol		No	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA001581: AB_2666367, HPA001790: "	"unprognostic (9.58e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.09e-5)"	"unprognostic (3.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	19.3	12.6	39.7	5.5	59.6	0.0	22.7	51.7	45.6	47.3	28.0	24.4	3.1	29.2	9.9	44.1	28.6	8.7	15.0	35.6	39.3	10.0	1.8	12.1	3.6	63.0	57.6	41.9	2.2	22.2	8.4	10.4	54.8	36.8	3.3	10.6	26.2	22.5	3.6	59.0	9.6	12.5	44.8	7.6	11.9	5.4	49.9	3.2	17.5	5.1	4.8	25.3	42.9	76.0	4.7	0.0	73.2	39.5	17.1	20.0	57.7	5.3	11.3	2.0	0.9	0.0	0.0	0.0	0.0	30.3	0.3	27.5	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	11.6	18.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	0.0	0.0	22.6	0.1	0.0	24.1	7.8	66.5	15.1	2.6	0.0	8.7	17.6	0.0	0.0	7.6	0.0	19.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	59.6	51.7	45.6	35.6	39.3	63.0	57.6	54.8	44.8	49.9	76.0	2.0	0.0	6.7	17.0	0.0	11.6	11.6	5.6	9.6	5.0	20.3	16.3	0.7	0.0	4.1	0.0	6.2	9.3	0.2	0.0	1.9	0.1	0.9	0.6	18.9	1.8	0.0	0.0	0.2	0.0	14.7	15.7	0.0	0.7	0.0	4.4	1.8	0.0	1.6	0.0	0.3	0.0	0.0	0.0	3.7	0.8	20.2	0.4	7.2	1.9	0.0	9.0	0.0	22.1	48.9	0.0	0.0	13.9	0.1	7.6	0.0	0.3	1.1	9.3	6.6	12.6	8.9	2.2	0.5	22.7	13.4	18.1	0.5	0.3	0.0	7.0
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849948-44899445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		94000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	23.6	30.7	26.7	31.3	27.2	37.4	22.4	24.6	28.0	17.6	27.9	26.5	21.6	19.4	18.8	33.1	25.0	16.3	35.3	28.0	26.3	26.1	26.2	22.6	35.5	25.6	26.1	17.6	24.0	27.9	13.2	28.6	26.4	17.8	28.8	15.5	22.5	18.6	65.8	28.5	22.8	23.5	25.1	29.8	22.5	27.5	27.3	41.0	21.2	38.3	46.5	28.8	20.3	26.6	88.7	173.6	82.8	134.9	61.9	60.9	97.1	68.7	91.4	169.6	146.0	134.6	73.9	152.1	79.0	87.1	130.3	98.6	181.5	120.2	196.2	153.9	150.8	150.9	100.9	144.5	68.2	179.9	107.5	66.5	67.4	157.2	85.0	65.2	149.1	134.8	189.6	57.8	98.0	88.2	182.3	118.6	85.7	206.8	143.1	126.1	168.1	132.0	97.0	97.8	135.7	81.1	67.7	49.5	73.9	120.6	131.6	112.2	91.4	126.5	97.4	77.7	176.3	60.2	81.4	150.0	101.6	98.4	132.0	42.7	84.3	85.9	37.2	81.6	41.7	32.3	32.9	36.1	82.8	31.3	28.8	32.2	13.0	44.2	85.0	35.5	35.2	70.7	26.7	27.2	24.6	28.0	28.0	26.3	25.6	26.1	26.4	25.1	27.3	26.6	11.3	0.0	14.0	11.1	18.1	11.7	12.2	15.1	13.6	14.7	14.1	11.8	21.1	22.8	15.3	18.4	33.3	34.5	14.0	15.6	3.9	29.4	12.5	17.8	17.9	21.4	10.8	24.8	17.5	26.7	30.9	14.0	18.3	18.8	19.7	22.6	21.8	22.4	38.5	26.9	17.2	13.4	16.2	30.1	17.5	6.5	12.8	26.2	5.4	12.2	46.7	12.0	21.6	6.0	15.5	27.7	12.0	9.1	20.3	14.5	15.9	13.2	17.4	18.0	19.7	14.8	14.8	28.2	43.3	16.0	14.6	27.2	16.3	21.4	22.2	12.5
EGLN2	"HIFPH1, PHD1"	ENSG00000269858	"Egl-9 family hypoxia inducible factor 2"	Q96KS0	19	40798996-40808434	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 269.1;Late spermatids: 740.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056649			Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA056649: AB_2683203"	"unprognostic (1.11e-2)"	"prognostic favorable (2.88e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (7.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.38e-3)"	57.6	58.5	99.3	50.0	99.8	52.1	47.6	95.1	140.9	70.0	79.6	65.4	34.3	53.9	31.5	40.2	45.5	39.1	67.8	103.4	96.2	54.2	57.7	74.3	62.4	97.3	99.3	59.0	36.6	27.7	44.5	48.3	97.7	59.9	28.5	16.6	39.2	45.1	40.0	27.4	46.7	40.9	90.5	116.8	47.6	232.1	99.9	41.9	55.8	40.8	44.1	57.9	57.9	98.1	46.5	123.4	55.9	54.4	71.1	51.5	36.5	49.4	41.1	68.9	75.4	102.8	45.7	41.1	41.1	59.3	62.5	29.3	70.8	56.3	36.4	51.7	40.5	54.8	76.4	39.4	76.1	42.7	71.6	63.9	58.5	65.8	37.4	43.3	86.0	44.3	79.3	37.3	73.4	32.9	78.9	70.2	48.7	72.4	42.6	72.7	27.7	27.8	74.0	70.2	51.4	46.9	80.9	62.9	67.2	47.2	83.4	114.0	80.5	85.9	61.7	35.7	59.5	18.7	29.6	75.6	63.0	61.4	65.5	93.2	72.5	190.5	85.8	83.4	91.1	85.2	101.7	90.3	62.6	90.0	105.2	89.6	261.6	61.4	82.3	45.5	100.2	110.5	99.3	99.8	95.1	140.9	103.4	96.2	97.3	99.3	97.7	90.5	99.9	98.1	2.8	22.4	16.8	0.0	43.9	48.8	55.2	33.8	17.6	40.5	3.3	0.8	22.2	31.5	30.7	3.7	14.6	58.1	19.0	83.0	0.0	15.8	269.1	0.9	1.5	49.9	44.9	30.7	0.0	10.1	26.5	27.6	23.9	1.2	17.2	0.8	72.8	33.7	66.7	21.9	0.0	33.9	48.8	39.8	62.4	740.8	63.0	26.3	40.9	0.0	38.5	24.4	60.8	0.0	0.0	14.0	71.0	52.3	8.7	67.6	54.9	1.4	23.0	17.8	39.5	14.6	17.2	159.4	52.5	14.2	38.4	132.6	33.2	2.1	43.7	69.8
EGR1	"AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225"	ENSG00000120738	"Early growth response 1"	P18146	5	138465479-138469303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 1113.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 133.1"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 7.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.1;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 192.0;hTCEpi: 286.6;U-266/84: 478.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019427, HPA029937, HPA029938"	Supported		Enhanced	Nucleoplasm		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259"	"unprognostic (5.47e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.74e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	565.5	354.0	7.5	135.4	15.9	176.7	173.9	133.1	70.1	302.5	10.0	246.5	54.8	197.6	13.5	370.9	911.7	345.2	258.8	20.7	30.4	173.2	149.5	173.4	145.2	9.9	13.2	974.6	137.0	93.5	243.3	54.2	12.9	309.7	161.1	56.0	140.9	84.4	66.0	363.1	107.2	474.3	4.4	77.5	254.5	26.9	10.4	301.5	584.4	354.9	19.1	191.4	115.9	19.5	21.8	0.9	45.0	67.6	119.6	192.0	5.1	36.7	22.7	48.4	39.0	26.4	18.9	1.1	5.9	80.2	165.8	10.1	2.6	74.5	22.2	1.1	3.3	3.0	11.5	7.6	15.5	8.0	57.8	15.2	286.6	43.2	9.8	37.6	4.2	53.9	112.5	26.0	14.3	108.2	3.2	34.1	4.1	80.3	0.1	0.8	6.7	4.1	36.8	13.1	56.5	6.4	44.7	120.1	106.6	43.3	1.5	6.6	1.8	17.5	22.6	8.7	14.2	60.1	478.8	8.6	20.3	103.5	5.2	0.0	2.6	0.3	0.1	3.6	0.0	0.7	0.1	0.0	0.7	0.2	0.1	0.1	7.1	0.1	1.2	0.0	0.2	0.5	7.5	15.9	133.1	70.1	20.7	30.4	9.9	13.2	12.9	4.4	10.4	19.5	920.4	275.7	485.6	6.8	116.4	181.8	719.6	207.4	816.1	43.5	550.0	459.0	652.4	420.4	124.0	29.5	64.6	159.5	46.2	645.2	7.9	255.4	1.4	356.0	836.5	383.1	960.5	27.3	20.3	101.7	110.1	989.9	736.0	645.4	354.0	274.8	347.0	183.1	131.4	3.3	2.7	747.6	93.6	218.6	109.7	3.8	164.7	300.7	106.7	20.6	8.6	191.6	0.0	1.5	2.4	135.3	380.8	53.0	67.2	405.1	224.8	5.7	127.4	101.3	223.5	1113.1	613.2	3.2	2.9	644.8	200.3	129.7	83.4	104.9	480.2	145.4
EGR2	KROX20	ENSG00000122877	"Early growth response 2"	P11161	10	62811996-62919900	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 59.9;thyroid gland: 136.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 55.5;Breast myoepithelial cells: 68.1;Enteroendocrine cells: 73.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 19.7"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 10.2;hippocampal formation: 5.2"	"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.5;non-classical monocyte: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031165			Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031165: AB_2673768"	"prognostic favorable (7.30e-5)"	"unprognostic (1.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.11e-3)"	13.7	10.6	0.4	9.8	1.2	8.2	8.6	1.3	10.2	18.5	2.0	3.3	1.9	6.0	59.9	8.8	4.5	31.9	14.9	5.2	0.2	7.9	5.4	15.2	14.4	0.3	0.3	9.4	4.2	7.0	8.7	3.0	0.7	17.5	3.7	1.4	2.9	1.9	0.9	14.2	4.6	16.8	0.1	4.5	2.3	4.1	0.6	26.4	136.4	9.1	7.1	15.7	1.7	1.5	0.0	0.2	2.5	1.0	1.8	2.4	0.4	0.5	0.2	0.6	0.8	0.0	0.3	0.6	0.0	0.6	0.7	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	3.8	0.3	0.6	1.3	0.2	0.8	0.1	0.3	0.2	0.8	0.1	1.2	0.0	1.8	0.2	0.1	1.1	0.1	0.3	0.4	0.0	0.2	0.1	0.3	0.2	0.5	4.2	0.5	0.0	0.5	0.1	0.5	0.4	0.2	0.3	1.3	0.7	0.3	22.5	0.5	0.4	0.0	0.5	0.2	0.1	2.5	0.0	0.4	0.0	0.1	0.5	0.4	0.0	0.1	0.7	0.2	2.3	0.0	0.0	0.4	0.4	1.2	1.3	10.2	5.2	0.2	0.3	0.3	0.7	0.1	0.6	1.5	15.9	0.0	12.6	0.0	14.0	21.3	30.1	36.0	33.0	1.4	55.5	68.1	7.8	0.0	9.4	0.0	0.0	1.1	9.9	9.5	0.0	1.4	8.9	13.9	14.0	16.7	73.1	0.0	1.7	0.6	1.6	30.4	13.3	26.1	20.8	2.3	5.3	2.4	25.2	0.0	0.5	29.4	14.2	28.1	39.5	4.3	1.8	40.5	8.8	0.0	0.8	4.1	0.0	0.0	0.1	1.0	4.4	7.2	6.4	5.5	7.7	0.0	7.1	0.7	6.6	20.7	12.0	0.1	2.0	14.8	12.5	1.1	13.6	5.1	25.8	3.1
EGR3	PILOT	ENSG00000179388	"Early growth response 3"	Q06889	8	22687659-22693480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2;skin 1: 45.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 284.3;Glandular and luminal cells: 116.6;granulocytes: 108.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 47.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.5;HMC-1: 9.5;MCF7: 31.9;SK-MEL-30: 22.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"amygdala: 19.3;basal ganglia: 52.5;cerebral cortex: 47.8;hippocampal formation: 41.3;olfactory bulb: 33.7"	"HPA006206, CAB009373"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB009373: AB_2097202, HPA006206: AB_10602491"	"prognostic favorable (1.83e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.44e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.48e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.07e-2)"	29.0	24.5	7.7	19.0	9.9	10.1	10.3	0.6	47.2	9.5	0.0	4.6	1.5	5.6	0.4	5.9	17.3	30.0	12.1	16.1	0.0	5.8	2.9	5.8	11.4	5.1	0.0	15.3	4.5	13.8	6.8	1.0	2.0	14.4	3.2	4.5	3.1	0.9	1.9	45.6	3.9	12.5	1.3	3.3	6.5	5.4	0.0	19.5	8.4	3.2	5.9	14.8	3.6	5.8	0.2	0.0	0.2	0.3	1.8	5.5	0.1	0.6	0.6	0.0	0.1	0.1	0.0	0.1	0.1	1.3	0.4	0.5	0.2	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.5	0.6	0.2	0.2	0.0	0.8	0.1	0.2	0.3	0.1	0.0	31.9	0.0	0.2	0.1	2.2	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.1	0.5	0.0	22.5	0.3	1.4	0.1	0.0	0.3	0.1	0.2	0.4	0.4	0.1	0.0	0.9	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	9.9	0.6	47.2	16.1	0.0	5.1	0.0	2.0	1.3	0.0	5.8	80.2	6.4	11.2	0.3	46.7	23.1	31.9	43.8	39.3	2.3	73.0	68.2	47.1	0.0	12.2	0.0	0.0	1.3	9.3	3.5	0.0	3.3	18.4	47.1	52.7	36.5	284.3	0.0	16.0	4.2	1.3	33.9	35.2	116.6	108.7	21.8	37.5	0.5	4.7	0.0	0.9	19.2	8.2	19.0	20.3	11.6	3.1	27.8	21.4	3.7	0.0	5.1	0.0	1.0	0.7	4.5	2.2	0.4	3.7	16.1	0.2	0.1	5.7	1.3	0.0	41.3	35.9	0.3	0.2	16.5	50.0	9.7	11.5	6.5	7.0	9.8
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34663288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 287.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 400.8;Basal respiratory cells: 271.6;Club cells: 323.3;Endometrial ciliated cells: 229.6;Glandular and luminal cells: 281.8;Squamous epithelial cells: 251.1;Urothelial cells: 397.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"myeloid DC: 1.7"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 138.4;HaCaT: 95.7;HBEC3-KT: 107.6;OE19: 132.9;RT4: 214.8;T-47d: 213.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.9	1.1	0.9	14.7	1.7	0.2	199.5	0.9	0.6	120.8	1.3	99.3	42.2	13.9	95.0	200.7	129.6	32.2	0.3	1.1	0.8	25.7	1.3	23.4	1.5	2.6	4.0	0.2	41.1	18.5	0.7	0.1	2.8	82.7	126.3	0.8	287.7	153.4	0.2	53.6	34.1	3.5	2.5	1.2	59.5	0.7	1.3	1.3	2.5	0.0	67.3	50.7	79.2	4.7	46.5	26.8	0.0	0.3	0.0	0.0	0.8	0.0	3.9	0.0	0.2	0.4	138.4	0.1	17.1	0.0	0.2	95.7	0.0	107.6	0.5	0.1	0.2	0.0	1.5	0.2	0.0	0.2	0.0	0.0	41.7	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.8	0.2	132.9	1.0	0.0	0.1	1.0	20.2	214.8	0.0	0.2	0.5	14.8	0.2	0.0	213.5	0.5	0.0	0.2	1.2	5.1	0.4	0.5	0.2	0.3	0.3	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.9	0.6	1.1	0.8	2.6	4.0	2.8	2.5	1.3	4.7	0.8	48.1	97.2	1.3	0.6	109.6	400.8	271.6	133.1	0.0	123.0	51.9	0.9	60.1	323.3	55.2	0.0	0.1	1.1	62.7	15.6	77.8	14.2	229.6	17.7	4.0	23.3	0.0	0.7	86.5	0.0	3.2	53.5	281.8	1.3	0.0	0.0	0.4	0.1	0.0	0.0	82.8	116.0	0.0	17.7	1.0	0.0	5.1	12.4	0.0	5.6	3.8	0.0	0.0	2.4	104.8	30.2	0.0	1.2	173.1	14.1	0.3	204.6	0.0	0.0	0.0	9.6	0.4	0.1	251.1	170.1	1.4	4.9	0.0	74.5	397.3
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618992-137870016	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 167.0;Plasma cells: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	17.7	18.3	11.0	22.3	12.0	30.5	18.2	16.0	12.3	17.0	13.8	19.3	18.8	21.5	9.7	19.1	18.1	14.0	13.5	8.6	8.3	11.0	14.4	15.8	29.6	10.7	10.2	19.9	14.9	13.8	12.9	15.0	11.1	16.2	13.1	13.7	18.4	13.9	31.4	19.3	19.6	15.1	4.4	25.9	18.2	40.5	12.7	22.9	19.6	15.0	21.2	18.3	16.2	19.9	26.7	52.3	57.4	53.2	23.9	24.6	48.1	34.5	21.4	24.7	20.2	34.7	32.5	81.6	32.7	26.0	29.9	56.2	34.8	37.8	19.2	45.3	24.7	34.4	54.2	22.4	20.9	52.9	39.5	22.6	25.9	29.9	28.9	18.1	41.3	30.1	52.6	27.5	17.9	61.9	62.5	26.3	56.0	42.1	34.8	79.3	49.5	47.2	20.7	47.7	50.6	41.1	65.4	45.4	15.3	40.6	51.1	42.0	39.0	28.9	29.5	44.8	33.2	17.2	52.0	67.0	21.3	27.6	32.0	19.5	16.2	21.2	18.0	14.3	11.3	16.4	15.6	15.6	12.9	23.0	14.9	13.5	28.8	17.3	15.6	23.3	14.2	9.7	11.0	12.0	16.0	12.3	8.6	8.3	10.7	10.2	11.1	4.4	12.7	19.9	34.3	19.2	19.2	130.6	64.9	17.5	23.4	26.9	32.5	39.7	30.5	26.7	31.5	25.8	24.7	22.0	52.1	23.8	36.9	24.4	3.9	24.1	86.8	29.3	44.8	29.9	28.1	31.7	74.4	21.0	21.8	27.6	45.3	40.6	18.9	55.8	18.9	41.7	19.7	50.5	76.4	22.2	10.2	25.8	18.1	167.0	35.8	26.9	12.4	71.2	31.2	19.7	51.5	64.3	104.0	25.4	30.3	37.6	170.6	34.9	20.7	14.3	22.6	46.8	13.1	34.7	28.5	80.4	51.9	35.3	20.2	26.5	38.9	81.3	23.8	28.8
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 13.3;NTERA-2: 19.3;U-266/84: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	8.6	9.6	0.5	0.3	0.4	1.0	8.7	0.4	0.5	15.1	0.2	12.9	2.4	19.8	1.7	10.1	12.8	0.0	5.7	0.4	0.4	7.1	4.6	7.3	1.0	0.4	0.5	16.1	7.8	0.6	12.8	0.7	0.4	10.3	0.3	0.6	9.5	1.3	5.5	9.3	10.5	1.4	0.4	11.5	9.4	12.6	0.5	1.5	10.3	0.4	1.0	13.1	11.3	0.4	0.0	4.5	7.8	0.0	3.4	1.8	5.0	3.5	2.8	3.9	3.2	0.0	0.0	0.0	7.6	5.7	4.0	0.0	0.0	8.6	1.8	5.4	11.8	0.0	0.0	0.1	0.0	13.3	0.0	4.6	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	9.4	0.0	19.3	0.0	0.0	8.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.3	6.5	3.1	0.0	0.0	3.8	4.1	3.1	6.9	0.0	11.0	16.1	3.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.4	16.9	16.0	12.0	22.9	20.3	8.4	6.3	11.9	26.2	60.6	15.9	17.8	6.6	17.2	18.9	25.8	41.7	24.6	13.4	9.2	7.9	15.7	41.5	10.1	19.1	16.1	22.6	19.3	16.6	12.2	15.0	16.0	13.3	11.8	14.5	33.8	22.1	7.5	16.3	38.7	24.4	16.4	12.2	12.9	7.3	60.0	27.4	12.1	19.6	9.4	19.9	26.8	25.7	20.1	23.9	10.8	9.1	23.0	16.5	6.2	12.5	10.1	10.8	48.2	26.3	16.3	15.0	20.8	33.7	23.5	11.1	5.6	18.3	19.9	19.0	5.2
EID1	"C15orf3, CRI1, EID-1"	ENSG00000255302	"EP300 interacting inhibitor of differentiation 1"	Q9Y6B2	15	48878134-48880173	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA051122, HPA051123"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA051122: AB_2681350, HPA051123: AB_2681351"	"unprognostic (1.38e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-1)"	128.6	206.3	96.9	95.4	103.7	61.0	112.0	98.7	153.6	149.8	107.2	143.9	81.6	161.0	132.1	96.6	134.9	120.9	280.1	103.9	111.3	147.9	125.1	99.5	112.0	102.6	101.7	186.7	102.0	144.8	130.1	93.3	100.5	156.1	71.3	158.4	98.3	147.3	278.8	57.6	79.0	141.8	102.1	115.3	84.2	67.9	104.5	117.2	138.5	227.6	83.9	113.1	81.4	123.2	131.5	109.1	260.9	231.6	239.9	316.9	16.4	337.6	304.5	220.3	294.3	95.0	58.0	174.9	305.3	207.0	155.5	115.4	130.2	130.8	247.9	484.1	127.1	300.6	235.8	4.1	186.0	183.0	132.2	278.1	115.1	146.1	91.9	221.4	262.8	151.2	182.3	162.6	258.5	188.7	134.6	174.1	0.5	98.9	97.4	185.1	302.6	290.6	287.4	142.3	233.8	234.6	210.2	80.2	401.2	212.7	145.0	240.6	262.9	322.4	177.7	305.6	299.3	208.4	616.7	125.1	264.6	410.0	230.0	345.0	311.5	275.5	221.3	285.3	209.2	168.3	249.4	231.8	358.1	183.2	179.6	165.3	40.4	230.0	297.5	354.9	332.4	440.1	96.9	103.7	98.7	153.6	103.9	111.3	102.6	101.7	100.5	102.1	104.5	123.2	327.4	387.8	207.7	31.3	127.5	175.5	139.9	459.5	138.9	345.3	188.5	286.4	480.8	183.0	329.9	261.1	120.9	351.6	168.0	46.0	606.5	386.5	17.5	116.0	324.4	356.8	233.7	219.2	38.0	268.0	151.2	443.4	88.2	116.7	188.0	173.8	339.8	166.2	211.3	238.9	43.5	114.0	301.1	208.1	262.0	49.2	702.4	189.7	487.4	30.9	302.2	844.1	213.1	28.6	80.9	191.0	102.1	651.4	134.3	81.4	91.9	446.5	240.2	329.9	322.1	350.7	379.1	98.6	75.0	125.9	145.6	109.6	180.7	463.2	101.5	96.9
EID2	"CRI2, EID-2, MGC20452"	ENSG00000176396	"EP300 interacting inhibitor of differentiation 2"	Q8N6I1	19	39538707-39540161	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045477	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA045477: AB_10959785"	"unprognostic (5.91e-2)"	"unprognostic (6.37e-3)"	"prognostic favorable (9.73e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.88e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	10.5	17.9	13.3	8.8	14.5	6.4	8.5	13.3	19.5	7.7	11.9	9.1	6.8	11.0	8.1	9.2	8.4	6.2	10.1	14.3	15.6	12.6	10.8	8.4	9.1	13.8	11.8	8.4	7.8	12.6	13.0	14.3	14.1	9.0	6.6	15.7	7.7	8.0	11.1	7.4	9.0	9.8	12.5	9.5	8.8	9.0	12.8	14.2	8.3	10.4	8.4	7.8	6.5	12.6	25.0	33.4	31.1	21.2	24.7	15.3	4.6	29.3	22.0	22.5	23.2	21.2	7.7	25.4	23.5	20.6	15.1	10.5	29.0	21.3	29.0	24.6	36.5	11.4	19.1	25.5	24.5	19.9	16.1	18.0	13.3	18.7	14.4	17.8	26.6	49.0	18.8	17.2	19.8	16.5	29.0	17.5	17.4	30.1	14.0	26.6	29.7	11.9	28.9	22.8	29.0	20.6	31.8	12.6	21.0	20.9	17.1	12.9	19.2	14.3	51.0	19.1	22.3	26.9	33.8	32.1	13.3	18.5	11.8	0.0	0.4	0.7	0.8	0.5	0.8	0.5	1.0	1.0	0.5	0.5	1.0	1.4	0.1	0.3	0.5	0.5	0.2	0.4	13.3	14.5	13.3	19.5	14.3	15.6	13.8	11.8	14.1	12.5	12.8	12.6	16.4	19.2	9.2	2.6	7.3	10.1	4.5	2.4	6.2	23.9	11.2	15.6	19.1	17.2	4.0	14.7	10.4	48.9	14.0	6.5	1.9	5.2	3.2	18.3	23.3	14.4	7.2	4.2	7.4	5.0	5.3	10.0	5.1	12.4	1.3	14.4	13.2	12.9	10.8	26.9	8.0	5.3	0.0	8.1	6.5	1.3	10.2	7.8	8.8	3.7	7.5	31.1	12.3	5.0	8.6	6.2	7.4	13.2	7.2	5.3	5.9	9.5	5.5	20.7	6.6	9.7	12.7	11.3	8.8	5.2	7.5	19.4	11.3	25.2	7.5	2.6
EID3	"FLJ25832, NSE4B, NSMCE4B"	ENSG00000255150	"EP300 interacting inhibitor of differentiation 3"	Q8N140	12	104303739-104305205	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 61.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 78.5;Early spermatids: 72.8;Spermatocytes: 306.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 9.1;BJ: 8.5;BJ hTERT+: 6.9;BJ hTERT+ SV40 Large T+ RasG12V: 6.8;HeLa: 8.9"	"Not detected"	"Not detected"							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059367: AB_2683992"	"unprognostic (1.25e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (8.02e-2)"	"unprognostic (5.88e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (8.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.87e-2)"	2.8	3.1	1.8	3.5	1.7	5.3	2.4	2.1	2.2	3.2	2.8	3.1	0.8	2.7	2.7	1.8	3.1	2.7	2.0	1.9	2.4	1.8	1.4	3.0	6.2	6.6	3.1	4.1	2.5	1.2	3.7	1.7	2.2	3.3	0.9	6.6	1.4	5.5	0.6	2.7	2.7	2.3	1.6	3.0	2.2	61.2	2.4	3.7	1.5	0.9	3.9	2.4	2.1	2.0	0.3	9.1	0.3	0.9	2.0	2.0	1.7	8.5	6.9	4.0	6.8	0.2	0.5	0.1	0.0	1.9	1.8	0.2	0.3	0.7	5.9	0.5	0.1	1.7	8.9	1.4	2.9	0.1	0.5	2.7	0.0	2.5	0.5	0.4	0.6	0.4	0.1	0.5	2.5	0.1	3.1	1.3	0.4	0.1	1.8	0.2	0.0	0.1	2.2	0.3	0.1	0.0	5.6	0.4	0.2	0.2	0.0	0.0	1.3	0.1	0.3	2.0	0.4	0.4	0.2	0.1	0.2	0.0	0.9	0.0	0.3	0.5	4.4	1.4	4.6	2.3	5.6	5.4	0.2	2.3	7.9	5.0	0.7	6.2	0.9	0.5	7.3	2.2	1.8	1.7	2.1	2.2	1.9	2.4	6.6	3.1	2.2	1.6	2.4	2.0	4.7	0.0	6.0	0.0	5.9	13.4	78.5	5.9	1.8	4.9	2.4	3.9	1.4	2.8	2.7	1.8	27.1	2.4	11.1	2.4	0.0	3.5	72.8	13.8	9.6	14.0	0.0	6.6	0.0	1.3	1.6	12.7	5.1	21.1	1.3	6.1	5.3	3.0	1.9	11.8	0.0	1.2	4.1	4.7	26.8	23.5	8.7	6.8	1.8	0.0	4.0	7.5	6.2	0.0	0.0	4.9	4.5	4.5	4.3	47.6	1.2	1.7	7.5	18.6	6.6	7.6	8.4	306.8	44.3	1.4	7.7	2.5	11.1	15.6	1.0	46.9
EIF1AD	"haponin, MGC11102"	ENSG00000175376	"Eukaryotic translation initiation factor 1A domain containing"	Q8N9N8	11	65996545-66002176	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054991, HPA058735"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"	Cytosol	"HPA054991: AB_2682664, HPA058735: AB_2683802"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (1.30e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.96e-1)"	15.7	17.7	15.3	19.9	15.8	44.6	16.0	18.7	19.8	13.1	14.4	15.8	15.1	15.9	16.2	21.0	15.3	13.0	17.1	16.4	17.7	15.2	17.3	15.0	23.4	16.1	15.7	20.4	19.2	17.1	16.6	21.1	16.3	13.4	14.7	16.6	16.8	14.9	27.2	23.1	16.9	14.8	14.8	20.0	16.1	19.4	17.3	19.9	13.8	23.3	27.6	17.1	14.5	18.4	51.0	43.9	35.0	35.9	27.6	28.8	32.8	36.4	34.6	44.2	37.7	44.8	47.5	38.2	62.6	41.2	38.0	34.9	42.2	48.8	41.5	35.1	21.7	54.4	52.0	46.4	33.7	50.3	41.8	24.1	41.9	65.3	44.1	31.2	31.0	40.9	81.1	54.4	64.7	68.7	46.6	55.1	25.9	23.3	47.5	50.3	35.9	75.0	25.6	31.8	26.5	31.2	39.3	54.7	41.5	28.1	53.1	31.0	36.5	59.7	39.9	47.8	36.1	66.7	85.5	79.8	42.9	33.8	39.5	52.6	20.5	13.5	17.7	16.6	13.6	19.4	15.0	13.0	21.3	19.0	14.1	13.5	13.1	16.4	21.3	12.7	15.3	13.3	15.3	15.8	18.7	19.8	16.4	17.7	16.1	15.7	16.3	14.8	17.3	18.4	8.2	3.2	5.4	3.3	16.2	37.7	12.2	13.4	12.5	7.2	14.2	9.1	16.2	14.3	7.3	5.5	14.6	16.3	17.7	11.6	15.6	12.7	18.3	9.0	8.3	11.6	2.4	21.0	3.0	13.1	23.0	11.4	7.1	10.5	12.7	31.7	16.4	16.5	24.5	11.8	2.8	11.2	6.1	10.4	29.5	14.3	12.2	14.4	12.4	1.0	17.6	10.5	17.5	5.5	4.5	29.0	15.2	5.7	22.6	13.2	13.8	15.7	10.6	18.5	6.6	9.8	27.0	31.3	23.2	15.7	48.9	25.3	16.2	7.4	10.9	13.2
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022247-6059175	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 219.1;Erythroid cells: 422.0;Syncytiotrophoblasts: 371.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583"	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	27.2	39.4	28.1	27.7	28.9	105.9	35.9	30.6	36.1	29.0	34.9	48.8	37.1	25.0	37.4	30.4	31.0	23.8	33.8	28.1	30.6	43.8	65.1	30.3	35.2	30.5	28.9	29.3	44.3	78.0	25.9	52.3	31.6	35.0	47.3	29.0	46.8	24.2	38.3	33.3	37.2	23.8	29.1	26.6	49.1	19.5	29.8	43.6	39.3	34.4	40.4	27.2	22.4	33.7	144.5	90.5	71.2	108.8	66.4	59.6	92.4	73.0	66.8	64.2	80.8	83.7	96.2	112.5	77.4	81.3	115.5	100.4	93.1	67.1	82.2	69.8	140.3	115.9	91.6	127.3	54.3	100.8	102.0	48.1	82.8	60.7	64.9	67.7	69.4	88.1	189.0	106.8	61.4	146.5	55.6	128.6	88.5	84.6	99.7	120.0	74.6	134.0	82.3	70.3	87.3	156.5	139.3	186.6	63.8	98.6	141.0	122.4	65.9	37.0	134.2	65.3	78.2	106.5	114.8	115.6	73.9	129.8	108.7	11.1	6.9	17.3	8.2	5.5	5.6	12.3	6.5	9.3	6.9	9.5	7.5	6.6	3.7	10.2	6.2	6.0	8.9	4.8	28.1	28.9	30.6	36.1	28.1	30.6	30.5	28.9	31.6	29.1	29.8	33.7	23.1	38.5	43.7	14.4	42.8	23.8	34.9	34.3	41.5	29.7	52.5	34.9	49.6	45.8	37.7	44.1	16.7	219.1	52.5	57.1	66.5	55.0	8.8	59.5	42.3	27.5	38.5	422.0	21.8	44.8	82.1	29.7	64.7	48.1	20.8	44.9	21.0	63.2	53.8	32.0	21.9	68.7	54.9	39.0	29.9	16.1	34.5	65.2	24.9	13.1	62.8	46.4	70.0	19.1	26.9	53.0	47.0	37.6	60.1	43.3	47.5	66.1	48.3	26.5	13.1	32.0	26.0	33.7	34.5	45.5	22.4	371.0	38.0	57.1	52.7	32.3
EIF2B2	"EIF-2Bbeta, EIF2B"	ENSG00000119718	"Eukaryotic translation initiation factor 2B subunit beta"	P49770	14	75002921-75012366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005841, CAB037105, HPA048028"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		12000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	2.7	5.3	4.0	2.9	4.5	3.2	3.6	8.7	4.8	3.9	2.2	3.0	3.0	3.6	4.9	3.8	3.1	4.0	3.9	3.6	6.1	4.9	3.3	2.7	4.0	4.5	4.2	2.9	4.0	8.5	3.5	4.8	4.5	4.1	3.8	6.8	2.8	4.5	5.5	4.0	2.8	3.4	2.9	2.7	2.6	3.9	4.8	3.9	11.5	7.1	4.2	4.0	2.6	6.9	5.9	7.0	5.6	6.4	6.3	5.2	7.4	3.7	6.1	7.1	8.2	9.0	5.9	5.2	2.3	5.8	4.5	4.4	8.8	8.7	10.6	3.2	6.5	4.6	6.3	6.2	8.2	3.4	5.3	4.8	8.2	9.1	9.3	6.1	24.8	4.5	4.2	4.9	15.5	17.4	5.5	4.3	4.0	7.3	10.3	3.4	6.6	4.3	10.1	7.0	6.0	4.8	3.9	5.5	8.4	6.9	9.0	3.2	6.4	5.4	5.2	2.4	4.8	8.4	7.5	6.2	5.9	4.3	4.2	4.2	1.8	1.4	3.0	1.9	2.5	2.1	2.6	2.5	2.4	2.0	1.9	2.0	1.0	3.3	1.8	2.0	4.0	2.5	4.0	4.5	8.7	4.8	3.6	6.1	4.5	4.2	4.5	2.9	4.8	6.9	18.9	19.2	11.5	6.2	14.1	17.7	19.5	28.9	18.2	28.2	15.4	17.0	18.2	22.8	21.5	25.8	45.9	51.5	16.1	15.3	41.1	36.2	12.1	17.0	14.5	32.1	15.6	20.8	5.3	33.1	56.5	18.3	12.8	12.8	21.5	17.5	13.2	11.9	33.7	28.6	5.4	9.0	20.3	19.1	11.9	12.7	15.8	18.8	14.2	1.9	28.0	27.3	28.8	2.5	8.5	28.1	11.7	16.1	11.3	17.5	19.0	50.8	17.2	29.4	26.3	16.9	27.9	84.2	27.4	27.3	21.9	165.5	14.9	30.5	19.7	19.2
EIF3A	"EIF3, eIF3-p170, eIF3-theta, EIF3S10, KIAA0139, TIF32"	ENSG00000107581	"Eukaryotic translation initiation factor 3 subunit A"	Q14152	10	119033670-119080823	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038315, HPA038316"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No		110000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA038315: AB_10672588, HPA038316: AB_10673168"	"unprognostic (8.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.07e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.89e-2)"	83.0	53.2	27.5	73.7	30.9	120.7	62.5	28.4	31.8	48.8	38.0	62.9	65.8	60.1	34.9	69.3	44.8	50.1	69.0	25.7	33.7	58.1	77.9	49.5	75.1	34.8	30.0	61.7	155.1	70.2	24.4	57.0	35.4	55.5	63.9	31.6	73.3	46.3	178.2	69.9	60.0	62.8	31.6	57.4	72.8	44.8	32.4	78.3	70.3	89.8	74.6	76.4	51.8	32.4	258.5	190.9	154.0	211.6	163.6	235.0	119.4	228.9	235.9	144.0	143.7	181.2	165.5	300.2	83.2	190.3	113.3	252.0	202.5	175.7	203.5	166.1	166.3	258.3	143.6	203.2	186.2	382.3	183.9	204.6	193.0	212.7	362.8	240.7	165.7	119.8	269.7	191.9	188.7	152.5	159.4	179.8	147.8	99.4	96.3	162.1	332.1	143.7	137.0	213.9	71.6	151.3	180.2	166.9	244.9	132.0	107.2	241.1	245.6	138.7	128.0	147.1	335.8	164.9	194.0	286.9	147.2	368.2	97.6	49.0	38.2	23.9	27.4	41.8	31.7	25.6	33.1	25.2	36.1	24.7	22.6	24.7	10.0	26.6	58.1	20.5	50.9	28.3	27.5	30.9	28.4	31.8	25.7	33.7	34.8	30.0	35.4	31.6	32.4	32.4	122.1	233.9	323.8	24.5	147.3	304.2	279.1	129.0	203.7	60.1	155.8	133.7	320.7	111.5	198.5	64.4	62.6	169.1	181.1	130.2	27.4	157.2	199.4	230.3	248.6	145.3	141.2	270.0	32.7	185.4	159.5	152.5	159.0	371.8	145.4	132.6	74.3	184.5	126.3	43.7	34.9	168.2	87.5	200.3	169.0	119.1	108.7	196.5	147.7	29.0	235.9	78.2	135.9	24.6	38.9	192.8	105.4	117.8	258.6	253.6	98.5	58.7	158.3	54.1	59.2	209.7	221.6	158.0	112.9	255.3	363.8	252.3	171.1	145.0	227.7	302.3
EIF3B	"EIF3S9, PRT1"	ENSG00000106263	"Eukaryotic translation initiation factor 3 subunit B"	P55884	7	2354086-2380745	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017562, HPA048983"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB017562: AB_2246341, HPA048983: AB_2680588"	"unprognostic (1.50e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (4.41e-9)"	"unprognostic (4.64e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (9.66e-6)"	"unprognostic (2.38e-1)"	"unprognostic (7.54e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.18e-3)"	59.3	54.8	29.4	49.5	31.5	88.8	55.1	31.8	31.7	49.6	31.4	74.3	39.5	55.3	28.4	78.2	53.3	34.8	55.1	31.2	32.1	44.7	60.4	42.2	58.9	33.4	32.6	51.0	83.1	39.6	37.9	51.9	33.6	50.3	44.6	17.7	63.4	42.9	155.2	82.9	48.9	52.5	32.6	56.6	59.1	60.8	32.0	53.5	37.0	65.8	64.6	69.4	53.3	35.2	510.8	253.3	102.9	280.4	113.5	102.4	254.4	174.5	130.2	193.8	180.5	334.4	193.2	293.9	139.8	186.2	273.5	269.9	287.1	229.0	212.5	88.6	334.6	224.8	240.8	227.0	159.2	277.0	159.8	127.5	147.9	210.1	219.2	101.8	157.9	133.9	580.9	133.2	179.7	358.4	134.7	306.9	322.6	176.2	224.4	163.3	208.3	304.2	123.4	228.9	233.9	174.9	184.5	403.4	102.8	178.8	270.0	301.3	169.0	149.0	326.9	231.7	319.4	145.7	210.6	295.6	169.3	303.9	372.5	2.1	7.2	4.0	7.5	7.2	9.4	6.5	7.0	8.2	8.0	6.1	8.4	8.5	0.6	16.9	6.6	8.2	9.5	4.8	29.4	31.5	31.8	31.7	31.2	32.1	33.4	32.6	33.6	32.6	32.0	35.2	43.3	25.6	64.1	19.6	35.9	64.2	55.6	25.4	34.1	37.9	74.0	62.4	37.4	30.0	38.8	27.6	64.6	64.9	52.6	49.0	3.9	35.5	11.6	37.1	57.0	50.9	47.8	56.8	20.1	62.6	63.4	47.6	48.9	48.1	17.1	77.0	63.5	67.0	47.4	52.2	19.5	63.0	14.2	39.5	32.3	23.3	43.8	34.3	16.0	8.4	32.6	45.6	38.1	15.6	19.9	70.9	28.9	37.2	42.3	68.8	33.6	31.0	27.4	44.3	26.3	69.2	48.5	34.4	39.4	63.5	78.3	82.6	34.7	119.4	77.0	50.6
EIF3L	"EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025"	ENSG00000100129	"Eukaryotic translation initiation factor 3 subunit L"	Q9Y262	22	37848868-37889407	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003028	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		72000	"Cluster 44: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoli	Nucleoplasm	"HPA003028: AB_1078726"	"unprognostic (2.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.03e-3)"	97.1	80.1	22.7	37.1	22.8	86.3	149.4	25.4	33.6	113.2	22.8	105.4	56.9	85.1	41.9	84.0	100.4	21.2	76.6	23.4	22.2	101.2	64.4	56.9	52.1	22.5	22.8	200.2	257.9	36.7	64.0	52.8	22.7	71.5	63.4	26.8	92.2	78.3	162.0	123.7	73.3	42.2	22.0	57.6	143.9	34.8	23.4	44.3	87.3	43.1	82.1	90.1	86.8	24.0	74.9	44.1	113.7	83.4	107.4	238.0	81.5	69.4	165.4	109.1	147.5	71.6	53.5	253.7	19.2	81.5	38.3	46.1	127.2	96.0	127.1	34.1	211.2	90.0	56.6	33.4	66.9	240.5	73.6	128.8	106.9	81.7	120.7	189.5	138.1	82.4	75.5	67.6	127.4	30.2	65.5	112.0	65.5	90.0	106.7	73.1	156.0	76.0	82.2	44.3	82.4	129.1	68.9	80.1	88.7	127.6	60.7	95.4	67.4	68.3	81.6	42.1	57.1	40.5	68.3	97.0	64.0	103.9	57.1	46.5	162.0	42.4	81.4	148.1	134.2	131.7	116.9	98.2	241.1	113.1	161.8	125.5	22.8	111.3	129.4	116.9	124.2	299.1	22.7	22.8	25.4	33.6	23.4	22.2	22.5	22.8	22.7	22.0	23.4	24.0	128.9	118.6	210.9	16.6	299.0	397.0	491.6	449.3	278.9	61.3	366.9	299.8	2.5	217.3	238.0	66.2	29.2	699.0	255.0	77.5	416.7	234.3	137.6	94.8	159.4	171.1	197.3	277.2	18.9	461.8	628.9	166.1	101.9	108.3	222.3	318.1	183.1	116.1	256.6	25.2	23.2	236.3	187.2	299.7	418.0	341.2	222.4	229.8	227.7	11.2	447.0	149.1	216.3	11.6	19.3	212.4	211.4	212.1	170.5	306.2	180.7	328.2	90.2	51.1	164.3	278.3	267.4	121.9	128.5	301.9	429.6	703.2	221.6	239.9	378.4	435.0
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80134369-80147151	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		280000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	65.8	81.4	19.0	49.1	21.1	185.8	44.2	21.5	27.2	51.2	22.8	44.3	38.6	46.6	38.8	81.9	54.7	40.1	38.0	22.3	21.0	45.1	42.6	44.0	67.0	19.9	19.5	66.5	37.0	58.5	41.1	52.9	20.3	38.7	47.5	32.3	42.4	32.6	37.3	64.8	38.9	42.6	22.7	47.6	41.4	42.8	20.0	78.2	37.0	34.9	74.7	83.4	55.1	24.7	237.2	208.9	140.5	103.8	105.5	63.2	114.4	119.3	91.0	177.7	141.4	223.7	110.3	221.4	67.9	112.9	126.4	152.2	194.9	136.2	195.0	71.5	192.3	142.5	159.3	244.3	103.1	253.8	133.4	98.7	68.7	149.5	119.4	71.8	147.2	128.7	189.8	140.2	105.3	178.9	224.8	132.8	145.0	223.8	190.0	168.5	282.7	172.2	85.8	196.5	186.1	100.1	170.9	334.2	151.9	130.1	219.3	166.7	100.5	108.7	138.6	159.9	200.3	104.4	86.2	403.2	88.0	158.7	113.3	126.1	167.0	137.4	101.1	174.6	131.2	142.4	128.2	119.4	200.0	119.8	116.9	115.2	98.7	132.9	143.4	326.0	158.2	232.6	19.0	21.1	21.5	27.2	22.3	21.0	19.9	19.5	20.3	22.7	20.0	24.7	117.9	41.7	48.0	6.8	135.1	283.1	273.4	212.9	107.0	23.3	77.0	109.2	61.5	38.6	107.8	29.5	16.7	140.1	165.7	75.4	64.6	85.6	33.2	132.9	109.2	70.5	60.3	24.4	4.1	115.2	225.1	144.3	149.4	248.2	92.6	42.6	32.2	27.0	108.5	6.7	4.3	83.2	89.5	63.4	255.0	12.1	67.1	199.6	103.2	10.3	67.9	48.6	23.7	5.5	7.6	86.6	83.1	49.7	118.6	96.0	47.9	65.0	61.4	32.5	85.5	109.7	207.8	99.4	123.2	77.6	299.1	261.9	138.4	98.0	77.7	252.5
EIF4E	"EIF4E1, EIF4EL1, EIF4F"	ENSG00000151247	"Eukaryotic translation initiation factor 4E"	P06730	4	98879276-98929133	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"	"Autism, Autism spectrum disorder, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 927.0;Late spermatids: 2284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004077, CAB016316, HPA068358"	Supported		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		450000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytosol, Cytoplasmic bodies"	Nucleoplasm	"CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: "	"unprognostic (3.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.03e-5)"	"unprognostic (6.55e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	38.0	37.4	27.4	37.7	28.5	57.4	35.6	32.5	34.6	28.5	20.9	45.1	35.9	30.5	38.0	51.7	31.7	31.3	37.5	27.8	34.3	47.4	43.3	27.0	44.6	29.2	31.1	29.1	27.0	45.1	17.0	35.9	29.2	31.4	52.2	54.0	31.2	30.7	39.2	24.2	34.4	39.4	36.2	31.5	35.8	62.6	31.4	53.2	52.6	48.1	58.0	54.4	29.8	34.3	101.1	85.2	139.8	96.5	73.4	74.2	87.3	184.6	105.3	137.0	100.5	111.0	122.7	194.7	59.4	104.4	94.3	49.0	181.9	124.9	158.9	133.5	56.2	135.6	52.7	105.8	62.6	199.3	104.8	54.5	78.3	104.8	82.9	81.5	108.3	97.6	226.6	95.2	120.0	82.9	189.2	110.6	115.0	189.2	72.2	119.7	94.4	90.0	122.0	85.3	123.3	80.3	85.5	188.4	65.4	93.3	89.9	85.9	86.5	110.0	121.6	96.9	153.7	71.4	185.4	179.4	99.7	102.7	127.1	39.5	34.7	59.3	38.2	42.1	44.4	50.0	43.2	40.2	39.6	43.6	47.3	47.3	26.3	54.3	54.8	33.5	46.5	50.3	27.4	28.5	32.5	34.6	27.8	34.3	29.2	31.1	29.2	36.2	31.4	34.3	45.2	32.1	42.2	29.7	93.1	362.1	227.5	202.2	149.7	87.9	81.6	41.1	27.5	55.8	106.0	60.7	35.5	105.3	56.2	140.5	256.3	88.9	927.0	76.1	84.0	77.8	64.6	192.8	45.2	67.4	150.0	87.1	80.0	119.0	51.4	28.0	40.0	77.1	121.1	85.8	45.0	77.4	227.9	61.9	327.6	2284.9	50.7	122.1	193.9	25.3	69.8	82.0	57.7	35.2	50.9	83.8	107.1	49.2	113.0	191.1	83.2	189.2	76.8	64.7	52.6	78.7	151.7	98.7	87.1	171.2	370.9	119.0	82.2	39.8	97.3	224.3
EIF4EBP1	"4E-BP1, PHAS-I"	ENSG00000187840	"Eukaryotic translation initiation factor 4E binding protein 1"	Q13541	8	38030534-38060365	"Cancer-related genes, Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 188.9;salivary gland: 164.2"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 730.0;Pancreatic endocrine cells: 277.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005032, CAB005039, HPA023501"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		44000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095"	"unprognostic (1.55e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.18e-3)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.72e-3)"	60.9	12.6	7.7	16.9	8.0	35.0	53.6	8.0	10.9	24.9	12.7	25.3	18.5	19.7	2.2	86.0	21.7	8.9	32.7	8.0	9.8	19.5	63.5	25.0	10.3	9.8	8.5	22.2	188.9	7.8	9.2	28.6	9.8	19.2	15.4	1.5	164.2	17.0	98.1	20.8	23.1	14.4	8.5	23.9	43.8	5.5	10.1	9.6	9.6	27.2	10.4	33.6	26.5	10.8	146.9	113.2	32.4	193.2	41.3	32.3	77.0	130.5	111.9	128.4	203.5	74.8	56.3	46.3	101.5	121.3	77.1	85.1	109.1	197.5	74.8	36.0	190.9	269.6	52.0	104.9	423.6	98.8	60.4	100.0	314.9	142.0	264.1	40.1	208.2	57.7	152.7	221.8	54.8	141.7	95.9	297.8	186.0	112.9	243.7	80.3	80.4	197.4	49.3	22.3	281.6	200.8	26.1	78.8	534.8	20.3	105.8	192.2	105.2	76.1	167.1	179.9	137.8	185.1	121.6	72.1	173.4	213.4	169.1	51.1	416.3	258.3	27.9	336.6	27.3	130.7	32.8	30.9	335.0	103.3	26.2	26.0	39.4	35.0	268.3	242.6	66.0	258.3	7.7	8.0	8.0	10.9	8.0	9.8	9.8	8.5	9.8	8.5	10.1	10.8	23.6	9.6	8.3	1.6	25.2	74.4	42.4	114.8	51.8	3.6	84.8	72.8	41.7	57.2	97.3	20.2	2.1	41.3	27.3	70.1	29.4	226.1	17.0	11.6	39.0	54.6	40.2	79.9	0.8	730.0	224.2	68.6	35.7	12.5	18.4	76.0	65.3	103.4	223.4	0.0	1.3	138.2	79.3	108.6	82.2	106.2	43.5	83.9	72.9	1.9	101.9	19.2	21.6	4.0	0.4	277.9	64.5	19.2	38.7	100.2	19.5	103.1	33.5	2.2	13.1	17.6	85.2	1.9	25.5	209.3	85.4	38.6	19.8	69.3	83.8	58.9
EIF4EBP2		ENSG00000148730	"Eukaryotic translation initiation factor 4E binding protein 2"	Q13542	10	70404145-70428618	"Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019415, HPA037410, HPA061665"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Mitochondria"		"CAB019415: AB_10699019, HPA037410: AB_2675461, HPA061665: AB_2684580"	"unprognostic (9.57e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.61e-2)"	67.7	27.6	27.8	23.2	25.2	30.4	44.8	21.8	23.6	29.0	28.9	41.2	40.4	25.1	16.5	31.9	25.8	23.8	40.8	21.0	23.9	57.3	50.5	30.5	26.2	28.9	26.6	34.9	30.2	27.5	11.2	43.8	21.7	24.7	39.6	34.9	28.2	33.6	64.2	35.0	47.3	27.2	23.6	26.7	30.9	18.2	34.7	34.5	23.2	67.4	29.2	36.2	28.2	20.1	56.3	17.8	93.7	92.0	176.9	66.8	51.8	33.5	40.5	24.0	25.9	77.5	48.1	57.2	20.1	48.6	14.9	35.6	46.2	30.4	26.9	63.6	24.0	41.4	21.1	30.8	41.5	74.4	28.4	74.8	30.8	29.4	26.4	48.4	36.8	46.0	69.0	50.7	37.5	31.5	64.3	76.3	80.7	54.2	31.8	66.3	37.6	37.4	30.7	56.3	51.1	77.6	45.7	103.0	44.5	63.8	47.2	65.3	40.6	15.6	20.0	25.8	30.2	35.5	73.2	66.5	18.1	108.2	16.3	20.8	19.2	28.7	16.4	16.8	13.2	9.0	13.1	13.8	17.2	8.2	10.9	11.4	21.1	11.6	23.0	5.7	15.7	19.2	27.8	25.2	21.8	23.6	21.0	23.9	28.9	26.6	21.7	23.6	34.7	20.1	72.5	25.6	37.6	21.9	31.9	52.9	53.5	25.4	27.9	46.8	42.9	32.5	147.0	68.6	29.1	36.8	20.9	47.3	45.2	196.7	43.0	43.9	25.9	33.1	52.1	41.4	26.5	70.5	13.0	59.3	119.1	49.9	34.7	57.8	11.4	39.0	61.8	157.4	46.0	23.5	17.5	73.6	34.6	95.4	45.1	59.0	65.9	50.9	21.4	24.4	92.9	73.1	76.2	22.1	9.1	59.5	94.7	61.3	33.8	63.4	195.2	137.0	23.4	17.2	78.9	46.4	37.1	43.7	47.1	39.1	70.0	57.3	43.0	47.0	73.1	109.4
EIF4H	"KIAA0038, WBSCR1, WSCR1"	ENSG00000106682	"Eukaryotic translation initiation factor 4H"	Q15056	7	74174231-74197122	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 990.0;Late spermatids: 2765.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030542	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		750000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA030542: AB_10601368"	"unprognostic (2.83e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.27e-2)"	186.9	174.9	151.0	117.8	159.3	283.3	168.3	163.8	157.3	179.8	129.6	208.4	130.2	186.4	76.6	249.3	163.6	100.0	171.0	149.9	151.9	156.6	197.0	158.4	130.3	161.9	156.9	181.2	226.4	160.7	119.9	162.8	162.2	150.3	100.2	149.8	170.1	125.1	399.8	230.9	148.9	119.2	165.2	137.4	192.9	79.9	164.6	150.2	141.2	173.4	137.2	175.3	179.7	187.1	526.3	341.4	251.3	303.1	220.8	231.8	283.4	359.8	276.3	300.3	289.5	423.3	388.6	444.3	96.6	338.8	424.2	266.6	280.5	481.5	286.3	298.0	329.2	247.5	305.2	345.9	253.1	429.0	236.9	273.2	300.8	326.2	460.7	341.5	326.8	260.1	445.8	186.4	305.2	448.2	342.0	516.8	337.6	430.3	328.9	386.9	342.7	401.5	250.9	324.7	252.7	325.4	340.9	420.3	296.0	331.3	476.8	272.4	340.2	411.6	284.6	345.1	474.4	218.8	299.8	771.4	326.3	435.1	441.4	213.7	229.7	245.6	156.9	255.6	164.5	146.4	161.4	158.3	224.2	132.9	183.9	151.7	150.1	193.5	270.2	95.1	194.7	388.0	151.0	159.3	163.8	157.3	149.9	151.9	161.9	156.9	162.2	165.2	164.6	187.1	105.8	83.3	81.2	15.7	97.1	119.2	153.8	101.5	78.0	93.1	103.0	95.5	43.3	68.6	68.7	44.1	25.0	198.8	91.9	98.7	107.6	148.1	990.0	104.8	98.3	103.0	90.4	79.5	25.3	157.7	381.4	101.6	61.2	112.5	122.4	112.1	79.6	95.7	124.2	97.6	24.6	87.2	91.6	101.2	102.7	2765.8	103.8	86.8	72.9	15.9	157.4	134.7	119.4	16.6	44.2	147.0	82.8	110.6	82.7	140.7	84.6	69.0	57.8	72.3	85.5	107.3	117.7	61.2	64.6	90.1	116.1	395.3	92.4	116.9	109.5	140.4
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005042, HPA061298, HPA074052"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB005042: AB_562281, HPA061298: AB_2684472, HPA074052: "	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	317.2	309.3	82.3	138.3	83.8	221.5	240.7	85.5	99.0	222.7	77.8	247.5	113.0	206.2	85.8	575.9	188.1	73.7	316.1	87.8	89.8	241.7	495.6	244.5	135.0	87.7	86.4	161.2	295.0	79.7	166.7	96.4	93.0	189.1	125.7	47.6	230.9	65.6	572.1	407.8	207.5	106.1	86.5	227.4	226.7	201.7	92.3	122.5	181.6	160.3	154.4	221.3	281.8	88.6	838.2	958.6	275.8	570.6	220.8	270.2	427.1	546.2	360.7	730.1	501.6	583.6	343.3	749.7	350.9	451.4	300.3	572.3	610.0	777.8	665.9	466.2	987.2	477.9	710.1	750.6	388.6	324.0	431.7	302.5	374.9	587.8	736.0	259.1	501.4	232.0	673.8	192.2	527.3	496.2	388.6	523.3	525.8	477.2	498.0	412.0	320.5	732.4	464.6	393.8	340.5	431.8	330.0	469.4	360.8	212.3	327.2	258.4	427.7	567.6	379.5	326.2	896.4	168.8	229.9	443.6	515.1	527.2	642.2	146.8	137.6	102.0	157.4	193.1	187.5	154.5	153.1	137.2	215.9	149.1	139.6	144.6	62.0	195.1	186.5	225.0	156.7	200.3	82.3	83.8	85.5	99.0	87.8	89.8	87.7	86.4	93.0	86.5	92.3	88.6	180.1	54.5	37.9	6.2	241.9	349.0	67.9	226.5	378.5	88.3	258.8	138.7	77.8	125.8	72.7	62.5	14.6	324.3	200.3	316.0	74.3	317.3	153.8	136.4	255.2	176.6	150.6	456.1	6.8	239.8	633.8	199.6	172.8	187.8	138.4	87.3	105.7	236.4	296.8	50.5	7.0	317.4	83.4	133.6	283.1	112.9	100.6	151.9	263.3	4.7	245.0	122.2	216.3	2.0	11.5	322.0	223.7	81.3	386.7	507.1	229.3	127.1	41.3	65.0	92.1	160.7	262.1	200.4	82.6	572.0	313.7	428.4	179.3	290.7	384.7	207.0
EIF6	"b(2)gcn, EIF3A, ITGB4BP, p27BBP"	ENSG00000242372	"Eukaryotic translation initiation factor 6"	P56537	20	35278907-35284985	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 700.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040873	Enhanced		Supported	Nucleoplasm		NA	NA		260000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA040873: AB_2677182"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (9.94e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.18e-2)"	"unprognostic (8.15e-2)"	66.5	99.4	55.8	61.7	56.9	75.8	87.3	58.2	64.9	91.0	64.4	120.2	142.6	80.3	80.7	242.6	99.1	64.7	51.8	57.6	64.4	129.6	172.4	64.0	75.5	59.9	58.3	67.4	73.7	93.1	56.4	68.2	61.6	76.7	122.8	21.6	88.7	84.2	52.2	169.0	119.4	92.9	58.0	68.8	83.3	71.8	57.9	78.9	64.8	56.9	120.4	146.5	125.6	60.1	338.1	447.4	115.3	137.1	136.9	161.9	148.6	205.5	250.8	431.5	322.3	864.0	306.2	232.1	251.2	258.2	326.7	261.8	234.6	671.8	299.9	60.0	154.8	397.5	188.7	752.0	262.6	225.1	177.1	162.8	430.3	331.3	680.3	185.8	298.1	131.4	253.1	116.6	459.7	325.8	128.2	285.5	151.2	367.4	375.3	173.1	203.9	207.1	590.5	243.6	194.2	178.3	163.4	675.6	266.5	93.3	314.7	177.0	248.2	478.8	211.7	244.0	326.3	135.0	149.4	221.8	243.2	216.7	274.6	420.1	267.8	230.4	166.0	278.1	182.5	261.7	165.1	183.9	318.5	263.4	132.7	158.1	89.6	247.4	316.1	291.0	196.8	353.2	55.8	56.9	58.2	64.9	57.6	64.4	59.9	58.3	61.6	58.0	57.9	60.1	80.8	64.1	54.2	4.9	75.7	281.3	270.0	333.6	95.6	32.6	81.9	102.4	27.8	114.4	201.0	165.5	10.4	237.5	82.5	363.7	197.6	375.8	68.9	92.3	60.1	90.3	105.7	50.9	5.7	378.8	217.7	78.5	73.9	90.2	99.0	62.2	60.7	216.0	176.6	25.2	5.0	150.7	193.3	78.6	169.8	94.5	81.7	89.9	106.7	1.9	226.8	68.3	81.4	2.0	6.2	700.9	468.3	67.0	53.9	213.1	373.0	527.0	116.8	32.2	65.7	70.7	170.7	130.5	77.8	197.3	346.5	256.0	70.0	120.4	215.0	468.0
EIPR1	"EIPR-1, TSSC1"	ENSG00000032389	"EARP complex and GARP complex interacting protein 1"	Q53HC9	2	3188925-3377830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.6;Distal tubular cells: 50.9;Ductal cells: 28.7;Extravillous trophoblasts: 36.9;Hofbauer cells: 34.0;Proximal tubular cells: 41.6;Syncytiotrophoblasts: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031231, HPA031232, HPA031233, HPA031234"	Approved		Supported	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"	"Intermediate filaments"	"HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (3.67e-7)"	"unprognostic (1.94e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.83e-2)"	8.5	15.2	24.8	13.8	25.6	18.2	9.8	24.3	27.3	9.3	20.5	13.6	12.2	9.9	19.4	19.7	13.2	7.7	11.9	26.0	26.2	17.9	16.5	9.3	19.2	22.2	23.2	6.9	10.5	15.8	27.8	9.1	23.9	9.5	11.8	15.9	11.2	7.8	14.0	13.9	10.6	10.6	22.9	14.6	10.8	11.6	25.1	22.2	22.4	15.2	18.0	10.8	11.1	23.6	25.4	48.2	25.9	28.2	15.7	21.1	56.2	26.8	27.8	32.0	24.2	32.5	32.6	45.3	46.8	28.3	30.1	25.9	20.9	39.3	17.3	35.5	37.5	40.7	28.4	76.2	29.9	40.2	49.9	19.5	35.1	32.2	43.6	17.6	41.9	79.0	45.2	30.9	29.7	48.5	37.6	57.9	29.4	61.5	38.1	43.6	26.6	61.6	39.6	35.7	54.5	62.6	18.5	31.7	30.1	13.8	29.0	36.9	29.9	25.3	13.1	21.2	36.9	34.9	88.0	37.8	30.0	40.8	24.1	22.2	15.2	12.8	19.7	17.9	19.6	16.8	16.1	20.6	27.4	20.6	17.6	18.8	6.5	22.2	16.7	30.3	22.2	18.6	24.8	25.6	24.3	27.3	26.0	26.2	22.2	23.2	23.9	22.9	25.1	23.6	5.6	3.2	9.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	8.5	7.0	0.0	0.0	6.2	20.2	0.0	48.6	7.0	0.0	50.9	28.7	0.0	14.9	7.5	7.0	0.0	0.0	0.0	16.0	36.9	5.0	0.0	11.5	3.8	13.7	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	16.5	0.0	0.0	0.0	0.0	20.7	0.0	0.0	2.3	0.0	0.0	41.6	4.4	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	26.7	5.7	24.5	0.0	0.0
ELAC1	D29	ENSG00000141642	"ElaC ribonuclease Z 1"	Q9H777	18	50967991-50988121	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040867, HPA066483"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA040867: AB_10697716, HPA066483: AB_2685675"	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.75e-2)"	"unprognostic (8.61e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.67e-3)"	"unprognostic (6.36e-2)"	"prognostic favorable (8.43e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.87e-2)"	5.1	7.2	4.2	5.4	4.4	2.3	6.2	3.9	6.0	5.0	4.8	6.2	5.0	4.4	12.8	4.4	6.4	4.1	3.3	4.4	5.2	8.0	9.9	5.1	6.7	3.8	3.9	5.5	8.7	11.8	5.7	5.6	4.0	6.2	7.0	5.0	6.6	6.1	3.1	4.6	6.5	4.3	3.3	6.9	6.3	7.2	5.2	7.2	10.2	2.8	6.9	4.7	3.4	5.1	9.1	6.1	16.0	13.6	17.5	7.4	6.8	9.8	12.7	9.0	6.3	2.3	7.9	7.0	6.5	9.1	7.2	8.8	5.0	10.3	6.1	15.4	1.3	8.6	2.3	1.6	10.4	22.1	5.8	9.3	8.1	4.8	11.0	7.2	9.5	10.0	8.9	16.9	16.0	4.1	7.8	6.4	8.0	7.6	3.1	8.6	5.6	13.0	10.4	3.8	9.4	10.7	8.2	1.4	15.5	6.6	7.5	16.6	8.4	11.6	6.0	3.4	6.7	15.8	14.4	9.3	10.7	7.3	14.9	5.0	9.6	10.0	15.4	11.5	17.1	18.6	14.7	14.9	15.4	16.8	14.0	18.1	0.9	20.8	11.4	13.0	12.8	10.0	4.2	4.4	3.9	6.0	4.4	5.2	3.8	3.9	4.0	3.3	5.2	5.1	5.9	6.4	6.5	7.2	7.6	2.4	5.6	14.5	4.6	7.3	8.7	10.4	8.6	12.8	8.0	3.7	2.1	23.3	4.0	8.5	19.6	14.6	21.4	8.8	6.3	7.9	10.3	5.5	4.1	13.5	13.3	8.1	3.1	4.8	8.2	11.4	10.0	15.2	15.4	5.0	5.3	8.2	14.2	8.9	2.8	22.8	5.0	6.3	5.4	2.8	10.2	15.8	23.7	7.5	8.4	10.4	9.1	7.2	5.6	8.1	15.9	25.5	11.8	8.2	0.0	8.5	6.4	29.1	12.9	5.6	3.4	18.9	6.8	11.1	10.5	4.9
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12991612-13018065	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 394.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Supported	Nucleoplasm		NA	NA		9500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	30.7	35.8	13.7	23.0	14.6	22.7	24.6	14.7	14.3	21.7	18.0	28.7	23.1	24.7	17.1	31.9	25.8	21.1	38.1	13.8	15.0	28.6	32.5	19.8	28.0	16.4	14.6	19.8	23.1	33.8	12.5	23.5	15.3	26.4	32.7	22.5	20.4	33.6	60.2	23.8	21.1	33.6	17.1	28.8	24.8	28.1	13.4	28.4	25.8	35.7	37.6	24.6	18.2	22.1	76.4	102.1	69.8	81.5	53.3	53.9	44.9	75.4	59.6	119.8	79.8	84.3	34.8	127.7	84.9	69.9	45.0	96.6	133.6	80.6	113.5	65.7	163.7	73.0	82.1	54.7	40.7	64.7	99.4	47.3	70.6	88.2	80.5	51.4	88.3	71.5	108.0	34.8	88.7	58.0	112.0	58.3	62.2	132.9	80.7	84.1	122.2	82.2	62.0	59.2	37.5	54.6	97.4	61.0	39.2	394.4	59.1	26.2	82.7	152.3	47.6	57.0	116.3	24.7	51.6	53.3	57.6	64.2	54.6	26.9	31.1	19.2	41.6	41.2	43.4	37.7	39.1	40.7	48.4	34.4	39.7	36.2	4.7	53.5	46.8	30.1	53.4	46.3	13.7	14.6	14.7	14.3	13.8	15.0	16.4	14.6	15.3	17.1	13.4	22.1	11.6	6.4	10.8	6.8	18.0	10.3	10.1	16.7	16.5	11.3	12.5	10.8	28.3	12.8	12.9	16.5	2.1	59.3	15.6	13.2	19.6	27.4	6.4	13.0	13.1	14.1	8.4	24.0	9.8	26.0	32.6	16.6	17.3	14.2	9.5	30.4	11.7	28.4	28.2	11.8	9.2	13.5	24.4	14.2	7.0	5.7	10.5	10.0	14.2	3.7	14.7	16.1	14.4	7.1	10.6	25.9	16.6	21.4	21.6	13.5	15.2	19.5	12.2	14.6	52.6	10.1	14.9	26.4	24.4	22.2	14.5	33.5	15.9	59.0	20.7	8.2
ELAVL1	"Hua, HUR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958573-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 227.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		230000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: AB_2679618"	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	27.5	27.7	14.5	33.1	15.6	27.8	25.0	16.0	15.7	29.4	19.5	27.9	25.2	31.6	25.9	30.0	34.3	22.4	34.0	15.3	15.9	24.8	29.0	24.2	40.2	13.7	15.6	31.8	28.4	37.5	21.4	32.7	13.8	26.9	27.2	19.0	29.6	29.4	37.7	24.9	25.1	35.9	16.2	30.1	24.6	46.1	15.1	52.7	27.9	32.2	44.1	37.4	25.2	16.6	127.5	84.1	137.9	104.5	52.9	52.7	76.5	89.5	78.4	136.9	106.3	122.4	73.2	153.2	125.5	104.0	76.9	86.0	155.2	107.9	114.8	134.9	131.8	135.5	58.9	115.7	77.4	129.9	103.1	65.8	63.6	95.7	57.7	64.8	106.2	115.6	140.7	112.6	95.7	95.8	215.3	103.7	122.1	96.4	101.6	239.0	89.6	100.9	87.5	93.9	98.0	70.8	88.9	89.1	71.7	82.6	101.8	101.4	79.7	127.3	87.3	119.2	161.8	109.8	114.7	161.9	71.3	154.2	112.2	29.9	19.7	37.2	16.4	17.2	17.0	20.8	24.0	26.3	25.0	27.7	21.8	16.6	5.3	33.1	22.1	12.5	20.9	16.3	14.5	15.6	16.0	15.7	15.3	15.9	13.7	15.6	13.8	16.2	15.1	16.6	45.7	25.6	23.1	18.6	56.0	72.4	79.5	29.0	51.2	47.2	54.9	37.2	31.3	30.0	20.7	47.8	56.3	86.8	48.1	32.9	66.5	37.1	227.7	41.6	46.5	52.2	42.0	95.7	20.3	33.8	102.3	53.1	40.2	47.2	21.0	59.5	47.2	89.2	64.2	60.6	21.5	52.9	18.3	57.5	79.2	164.1	50.4	47.3	51.6	23.4	43.9	43.4	57.7	33.7	26.9	35.3	45.7	56.8	88.7	98.2	38.3	65.8	27.3	55.7	52.6	45.5	71.0	164.7	61.2	72.0	71.0	74.8	50.9	44.7	60.2	84.6
ELAVL2	"HEL-N1, HuB"	ENSG00000107105	"ELAV like RNA binding protein 2"	Q12926	9	23690104-23826337	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 31.8;testis: 43.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.2;Excitatory neurons: 135.5;Inhibitory neurons: 390.6;Spermatogonia: 159.2"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 25.4;AF22: 37.2;SCLC-21H: 119.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022222, HPA063001"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB022222: , HPA063001: AB_2684918"	"unprognostic (3.51e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.74e-4)"	"unprognostic (3.98e-1)"	"unprognostic (9.08e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.65e-1)"	0.1	1.3	12.4	0.1	15.8	0.5	0.2	1.5	31.8	0.1	0.0	0.4	0.1	0.5	0.5	0.2	0.1	0.2	0.1	10.9	23.2	0.5	0.0	0.2	0.2	15.7	13.0	1.1	0.0	0.1	1.0	0.1	15.3	0.3	0.5	5.0	0.1	0.1	0.1	0.5	0.2	0.2	0.1	0.1	0.1	43.1	15.0	0.0	0.3	0.0	0.1	0.4	0.2	9.4	25.4	0.3	37.2	0.2	0.1	0.3	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	7.8	9.9	15.9	0.2	0.0	7.1	0.0	0.1	0.3	0.0	0.2	0.6	0.5	9.6	0.0	11.0	0.0	0.3	0.1	0.9	1.2	5.3	0.0	0.1	0.1	9.8	0.0	11.8	0.1	13.3	0.2	0.0	0.0	119.6	11.5	0.3	0.3	0.3	9.4	0.6	1.9	0.0	0.2	7.9	0.2	0.2	0.1	0.1	0.1	1.3	0.1	1.4	1.1	0.3	0.5	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.5	0.3	0.4	1.5	0.4	0.2	0.3	0.2	0.0	12.4	15.8	1.5	31.8	10.9	23.2	15.7	13.0	15.3	0.1	15.0	9.4	0.9	0.0	0.0	7.8	0.0	1.0	0.4	0.4	0.6	8.8	0.9	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.9	0.1	62.2	0.5	0.2	1.8	4.2	0.0	135.5	0.0	0.0	0.8	0.0	0.2	0.0	10.6	0.0	0.0	0.1	16.8	390.6	1.2	0.0	0.0	0.7	39.5	3.1	0.2	0.0	7.5	0.0	2.8	0.0	5.5	5.5	0.0	0.2	1.5	0.0	0.4	0.0	0.1	0.0	10.6	0.0	1.4	1.0	13.9	159.2	0.5	0.9	0.0	0.1	0.7	1.3	0.6
ELAVL4	"HUD, PNEM"	ENSG00000162374	"ELAV like RNA binding protein 4"	P26378	1	50024029-50203772	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 52.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 155.5;Excitatory neurons: 158.7;Inhibitory neurons: 109.7;Late spermatids: 159.4;Oligodendrocyte precursor cells: 75.4"	"Cancer enriched"	"Detected in some"	4	"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.1"	"Cell line enriched"	"Detected in some"	17	"SH-SY5Y: 157.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004442, HPA043047"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB004442: AB_627765, HPA043047: AB_2732502"	"unprognostic (1.25e-1)"	"unprognostic (6.63e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.83e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.13e-2)"	"unprognostic (7.43e-2)"	0.1	11.2	13.9	2.4	18.0	0.0	0.2	7.4	52.8	0.0	0.0	2.2	1.4	0.0	0.0	0.2	0.1	0.1	0.2	20.0	18.5	0.1	0.1	0.3	0.2	36.5	14.0	0.0	2.3	0.0	3.4	0.2	31.7	0.1	2.8	3.9	0.2	0.1	0.0	0.4	2.2	1.1	2.0	0.2	1.0	8.5	11.4	0.9	0.0	0.0	0.2	0.1	0.2	17.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.2	157.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	13.9	18.0	7.4	52.8	20.0	18.5	36.5	14.0	31.7	2.0	11.4	17.4	0.1	0.0	0.0	7.2	0.1	0.8	0.0	0.0	0.0	3.9	0.1	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	155.5	0.0	0.0	0.3	32.9	0.0	158.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	109.7	0.1	4.1	4.0	5.0	159.4	1.5	3.1	1.8	22.5	0.0	1.5	0.0	75.4	5.9	0.3	0.0	0.4	0.0	0.1	0.0	0.1	0.0	3.4	0.0	0.0	0.1	8.9	11.8	0.0	0.9	0.1	0.2	0.0	0.1	0.1
ELF1		ENSG00000120690	"E74 like ETS transcription factor 1"	P32519	13	40931924-41061440	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 200.9"	"Cell type enhanced"	"Detected in all"		"T-cells: 365.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 271.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001755, CAB005172"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB005172: AB_631428, HPA001755: AB_1078732"	"unprognostic (1.21e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.20e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.72e-2)"	64.2	22.5	8.8	64.3	14.5	200.9	45.3	13.8	9.9	45.8	11.1	45.6	53.4	35.3	28.9	52.6	41.1	59.6	29.1	8.9	12.4	31.9	50.4	47.3	95.3	19.7	14.1	34.6	56.1	39.8	9.7	48.6	19.5	35.2	48.3	4.2	35.3	33.9	21.3	38.5	57.8	43.9	13.7	68.3	49.7	15.1	14.9	134.5	54.9	25.9	96.9	61.3	36.5	21.0	35.5	20.5	15.3	15.3	68.6	72.6	57.2	35.9	84.9	48.7	55.1	51.2	90.9	199.7	22.1	60.4	36.5	78.7	2.9	45.4	30.8	44.9	23.7	179.6	16.3	36.5	50.9	103.3	271.2	75.1	78.5	32.9	62.0	32.8	69.2	93.1	45.0	51.7	32.4	32.5	136.6	63.1	12.1	117.7	15.8	179.2	25.1	58.7	49.9	54.8	6.1	21.3	31.0	31.0	62.9	21.2	22.0	132.8	63.8	21.5	12.4	17.7	13.0	23.7	14.8	131.2	29.0	65.0	45.9	265.9	60.4	134.2	70.0	66.1	73.8	63.0	79.3	77.9	58.6	65.1	84.8	75.9	97.4	73.0	98.4	38.9	86.8	80.1	8.8	14.5	13.8	9.9	8.9	12.4	19.7	14.1	19.5	13.7	14.9	21.0	156.8	76.9	68.0	51.6	326.8	108.8	188.2	86.0	90.0	2.8	71.5	37.7	41.3	52.9	86.1	57.0	10.4	35.7	292.0	62.9	19.6	70.2	47.7	121.6	69.5	122.0	58.1	78.8	8.2	69.4	55.8	79.0	64.2	126.0	323.1	8.1	91.4	25.2	97.5	3.3	8.6	57.0	95.6	115.4	206.3	21.9	42.9	244.1	120.9	125.5	123.5	8.1	133.9	52.8	138.7	65.9	54.4	43.2	211.5	150.4	58.7	28.3	84.6	3.7	39.5	52.7	52.8	7.7	11.2	95.6	114.8	53.5	365.3	26.9	56.0	221.9
ELF2	"EU32, NERF, NERF-1A, NERF-1B, NERF-2"	ENSG00000109381	"E74 like ETS transcription factor 2"	Q15723	4	139028112-139177218	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006057, HPA071166"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA006057: AB_1078733, HPA071166: AB_2686351"	"unprognostic (7.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.97e-3)"	23.7	14.2	12.1	15.2	17.3	47.3	24.5	19.2	16.1	21.8	9.6	24.6	15.0	24.7	18.5	17.3	20.7	17.8	20.1	11.1	15.6	15.5	20.4	19.0	19.9	15.6	14.9	28.2	16.7	20.0	22.6	26.8	15.9	21.5	19.2	30.7	21.4	21.7	36.0	23.2	17.6	23.0	13.2	19.6	17.4	37.4	14.5	32.8	23.0	33.6	21.4	19.2	18.4	20.2	15.9	11.3	27.9	21.4	28.2	31.7	26.9	18.4	31.8	19.6	21.8	22.2	31.2	32.3	18.5	25.7	10.4	16.8	41.2	26.3	20.5	20.2	18.6	28.5	26.4	20.0	20.7	32.1	22.1	31.1	24.8	19.3	23.3	25.7	29.5	18.0	46.8	18.4	17.7	27.8	37.8	28.6	17.0	36.4	13.1	36.0	36.8	30.1	25.1	27.2	28.4	32.6	23.1	28.5	17.6	32.4	19.7	38.5	25.0	18.3	15.9	16.7	12.4	40.8	48.6	28.3	13.5	32.4	17.2	13.3	8.3	14.1	12.0	7.2	13.2	17.5	11.8	10.8	9.9	19.3	14.6	13.5	9.1	12.9	7.9	18.0	9.4	5.3	12.1	17.3	19.2	16.1	11.1	15.6	15.6	14.9	15.9	13.2	14.5	20.2	103.0	48.1	22.5	64.0	57.6	53.2	41.1	36.1	120.1	42.0	50.3	40.4	37.0	40.0	39.1	40.5	75.0	32.6	71.9	31.0	43.0	26.4	26.0	60.0	54.3	67.1	47.3	43.5	73.6	24.2	32.3	63.7	35.7	56.3	34.8	44.0	53.2	46.9	22.2	67.3	75.3	38.1	42.7	52.2	40.1	24.6	52.5	59.5	30.2	98.4	49.2	37.3	77.2	83.9	279.4	24.1	33.5	38.0	51.0	52.6	35.9	23.1	48.2	57.7	39.5	81.4	59.2	59.7	42.0	79.0	47.6	23.7	50.7	33.6	27.7	39.6
ELF3	"EPR-1, ERT, ESE-1, ESX"	ENSG00000163435	"E74 like ETS transcription factor 3"	P78545	1	202007945-202017183	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Inflammatory response, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1599.6;Gastric mucus-secreting cells: 1390.9;Paneth cells: 1506.1;Proximal enterocytes: 1476.3;Urothelial cells: 1628.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 209.6;CAPAN-2: 296.0;OE19: 196.3;RT4: 215.3;SK-BR-3: 405.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003316, HPA003479"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA003316: AB_1078757, HPA003479: AB_1078756"	"unprognostic (9.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.05e-3)"	"unprognostic (7.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (9.92e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.37e-3)"	1.6	0.2	0.2	12.7	0.1	0.8	79.2	0.8	0.4	55.3	0.1	161.3	142.9	12.9	4.5	237.0	35.5	77.6	5.0	0.1	0.2	66.7	79.2	59.8	0.3	0.0	0.0	1.2	120.7	8.4	3.9	6.1	0.1	58.7	127.5	1.0	147.1	14.8	0.2	14.5	145.6	7.3	0.0	0.5	122.7	0.2	0.1	1.6	6.6	0.0	16.0	165.2	93.6	0.2	56.1	209.6	0.0	0.4	0.0	0.0	63.5	0.0	7.9	0.0	0.1	47.3	296.0	0.3	24.0	0.0	1.7	53.8	0.0	0.2	0.0	6.7	0.2	0.0	38.3	9.2	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.7	0.3	0.7	3.3	196.3	17.6	0.1	0.1	3.0	78.3	215.3	0.3	0.4	2.4	405.7	0.2	9.2	28.8	0.0	0.1	0.0	0.7	0.4	0.5	1.2	3.9	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.4	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	2.7	294.9	422.9	0.0	12.2	5.1	691.3	879.7	113.8	1.5	470.3	180.3	1.5	586.2	1130.0	329.2	18.8	76.6	9.5	1599.6	41.1	792.7	0.0	812.3	90.8	16.4	452.2	2.7	0.4	641.0	122.2	15.9	1390.9	1127.5	40.6	0.2	0.4	38.6	9.3	0.0	0.2	1225.3	1102.7	2.5	2.7	0.0	0.0	18.6	8.8	0.0	15.4	2.6	1.0	0.5	0.1	512.5	1506.1	0.0	6.0	1014.2	1476.3	147.1	888.2	67.3	0.0	0.8	46.3	0.0	0.3	418.5	8.4	257.2	18.7	0.3	983.0	1628.9
ELF4	"ELFR, MEF"	ENSG00000102034	"E74 like ETS transcription factor 4"	Q99607	X	130063955-130110716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 34.3;Granulosa cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058595, HPA060277"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA058595: AB_2683768, HPA060277: AB_2684239"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.43e-3)"	"unprognostic (7.86e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (1.43e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.42e-4)"	12.2	3.7	1.8	14.6	1.6	53.1	9.6	2.8	2.0	9.4	2.6	18.1	14.2	10.6	2.0	11.7	12.1	9.3	5.6	1.8	2.4	6.0	2.8	15.9	18.3	2.8	2.4	17.5	2.6	4.8	4.2	23.7	2.4	6.1	17.7	0.6	5.5	4.1	2.0	10.9	17.0	10.6	1.5	18.1	20.3	2.6	2.9	19.6	3.9	3.6	18.0	18.8	9.1	3.1	56.0	20.7	3.7	0.4	9.1	19.3	52.6	25.3	32.1	30.4	33.4	28.7	38.9	28.6	49.5	34.8	42.3	35.2	20.5	30.0	29.9	31.0	16.8	56.7	27.3	13.6	20.2	49.7	69.3	20.4	32.6	49.1	48.0	19.0	30.0	6.5	22.0	7.7	16.5	32.8	8.2	28.2	2.4	28.4	19.4	17.6	6.5	12.2	18.3	63.9	13.6	6.0	22.8	21.9	6.9	19.1	11.0	46.9	27.6	21.2	16.6	39.5	47.7	4.2	1.8	22.6	24.6	44.8	5.0	1.6	4.0	5.8	7.1	7.6	5.6	2.6	4.2	6.1	4.5	2.7	4.2	4.8	6.9	6.5	5.5	2.7	4.8	4.2	1.8	1.6	2.8	2.0	1.8	2.4	2.8	2.4	2.4	1.5	2.9	3.1	10.7	9.6	4.4	0.0	8.0	13.6	8.2	2.9	9.1	0.0	2.1	1.5	0.8	0.0	4.4	0.0	0.0	10.6	12.2	24.1	0.0	2.3	0.1	8.9	3.8	8.4	9.0	7.4	0.2	4.0	34.3	6.4	17.9	17.1	1.3	27.5	6.4	1.0	9.7	0.0	0.3	8.3	2.0	12.2	9.2	0.6	1.8	14.8	3.6	5.6	13.1	0.0	16.5	0.0	1.2	9.1	17.4	1.2	2.0	7.5	11.6	0.3	5.4	0.0	6.6	2.6	2.5	0.0	4.0	6.5	10.4	11.2	9.5	5.2	7.1	18.9
ELF5		ENSG00000135374	"E74 like ETS transcription factor 5"	Q9UKW6	11	34478791-34525193	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 151.2;salivary gland: 147.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 40.3;Breast glandular cells: 143.2;Breast myoepithelial cells: 57.1;Collecting duct cells: 101.2;Cytotrophoblasts: 26.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"RT4: 30.2;T-47d: 56.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062706			Approved	Nucleoplasm		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm		"HPA062706: AB_2684841"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.41e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.93e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-1)"	0.2	0.0	0.1	0.0	0.1	0.2	151.2	0.2	0.2	0.9	0.4	0.0	2.1	0.0	0.0	1.3	0.1	0.2	0.0	0.1	0.0	17.0	0.2	7.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	1.4	0.0	2.5	0.0	0.0	147.6	30.4	0.0	6.2	0.0	0.0	0.0	1.1	0.6	0.2	0.1	0.5	0.0	0.0	2.5	5.7	2.3	0.2	0.1	0.0	0.0	0.1	0.0	0.5	3.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	30.2	0.0	0.0	0.0	5.1	0.0	0.1	56.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	1.0	3.2	40.3	0.0	1.1	0.3	1.9	0.9	0.0	0.0	143.2	57.1	0.4	0.0	9.7	101.2	0.0	26.9	1.4	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.0	1.9	0.4	0.1	0.0	0.5	17.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.4	4.8	0.0	0.0	0.2	0.9	2.5	0.2	0.0	0.1	11.5	0.6	0.0	0.0	6.5
ELFN1	PPP1R28	ENSG00000225968	"Extracellular leucine rich repeat and fibronectin type III domain containing 1"	P0C7U0	7	1688119-1747954	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2;liver: 14.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Endothelial cells: 5.7;Hepatic stellate cells: 7.1;Hepatocytes: 13.5;Inhibitory neurons: 19.2;Rod photoreceptor cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 31.2;U-138 MG: 18.5;U-2 OS: 27.0;U-2197: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066382			Approved	"Nucleoplasm,Cell Junctions"		NA	NA		43000		"Cluster 15: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"		"HPA066382: AB_2732744"	"unprognostic (8.45e-2)"	"unprognostic (3.39e-3)"	"unprognostic (6.54e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (9.68e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.63e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-1)"	3.1	0.4	1.5	0.3	2.5	0.0	1.5	1.0	3.4	4.2	0.0	0.6	0.1	2.9	0.1	0.5	1.5	0.4	4.6	1.0	4.4	3.9	14.5	0.6	0.1	3.2	4.6	0.4	0.6	0.1	0.8	0.4	3.2	1.0	0.0	3.0	0.4	0.1	0.7	1.0	0.8	0.2	7.2	1.1	0.6	0.8	2.6	0.7	0.8	0.4	0.0	0.6	1.7	0.8	0.3	0.0	4.6	9.7	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.1	0.5	0.0	4.6	2.1	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	5.7	0.0	4.7	1.9	0.0	1.1	31.2	0.0	3.1	0.0	0.0	4.3	2.0	0.3	0.2	0.0	0.5	0.1	0.3	0.1	18.5	27.0	32.1	0.0	0.0	0.4	8.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.5	1.0	3.4	1.0	4.4	3.2	4.6	3.2	7.2	2.6	0.8	4.8	0.0	0.6	0.0	0.0	0.1	0.3	0.3	2.8	1.3	0.1	0.3	1.8	0.0	0.0	0.0	6.2	0.0	0.0	0.0	3.9	0.1	0.1	0.3	2.0	5.7	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.1	0.0	0.0	7.1	13.5	0.1	0.0	19.2	0.0	0.0	0.6	0.7	0.1	0.9	0.1	1.8	1.0	0.0	0.9	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	0.9	0.0	2.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
ELFN2	"dJ63G5.3, KIAA1904, LRRC62, PPP1R29"	ENSG00000166897	"Extracellular leucine rich repeat and fibronectin type III domain containing 2"	Q5R3F8	22	37367960-37427479	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 18.2;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 45.5;Excitatory neurons: 11.6;Inhibitory neurons: 16.2;Oligodendrocyte precursor cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 18.2;basal ganglia: 13.8;cerebral cortex: 17.5;hippocampal formation: 16.6;white matter: 4.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 12.0;CAPAN-2: 11.2;GAMG: 12.3;RPMI-8226: 11.7;RPTEC TERT1: 21.5;U-2 OS: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000781	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Vesicles"		"HPA000781: AB_1079280"	"unprognostic (2.74e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.28e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-1)"	0.0	0.6	18.2	0.0	13.8	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	16.6	0.9	0.2	0.2	0.6	0.0	2.7	2.7	0.0	0.2	0.0	0.0	0.0	1.9	0.6	0.0	6.1	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.1	1.7	2.2	2.2	0.0	0.0	0.0	0.0	0.0	4.8	12.0	4.9	0.0	0.0	0.0	0.9	0.0	5.3	2.8	1.2	0.1	1.9	11.2	0.2	6.8	3.8	12.3	8.2	0.6	1.1	0.1	0.2	0.1	0.0	5.7	0.0	0.2	0.0	0.1	0.9	0.1	0.4	1.6	4.5	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.3	7.1	10.6	0.1	0.1	11.7	21.5	0.1	1.0	0.0	4.9	6.2	0.0	0.1	0.0	0.1	0.5	0.0	24.1	0.2	3.5	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	13.8	0.0	17.5	16.6	0.9	2.7	2.7	1.9	2.8	2.2	4.8	0.1	0.0	5.1	1.3	0.5	0.1	0.0	0.9	0.0	45.5	0.0	0.0	0.0	1.5	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.2	0.0	0.0	11.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	3.3	16.2	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	1.9	0.0	0.9	0.0	36.7	0.9	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.6	2.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELK1		ENSG00000126767	"ETS transcription factor ELK1"	P19419	X	47635521-47650604	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 251.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003808, HPA036084, HPA064381"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250"	"unprognostic (2.25e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.67e-2)"	16.8	30.7	71.7	12.4	53.1	13.7	12.0	37.1	62.5	15.0	19.9	12.8	9.0	17.0	17.4	15.0	18.6	10.1	19.3	58.5	32.8	12.6	26.4	16.2	12.3	26.7	26.2	54.2	12.9	17.0	12.7	9.2	27.5	15.4	9.6	7.7	13.1	11.2	32.9	15.2	12.9	10.9	23.4	18.9	13.6	21.2	52.2	12.9	10.5	18.5	12.3	14.8	11.9	40.6	35.6	27.2	14.3	39.1	23.3	26.5	19.8	31.1	34.9	34.8	34.5	19.3	26.4	29.0	16.1	31.0	59.9	21.2	37.6	31.7	31.5	31.1	34.8	23.4	25.0	17.9	49.3	26.3	39.4	27.9	27.2	53.4	33.5	28.8	20.8	40.4	47.9	32.9	27.8	46.5	28.2	30.8	33.7	16.7	59.1	30.0	36.0	45.8	19.7	15.3	31.0	25.6	48.5	17.8	43.4	31.8	44.7	16.7	16.1	39.5	41.2	53.9	29.2	53.5	83.2	27.8	44.5	45.3	25.0	1.7	6.3	2.8	5.3	7.2	6.4	5.2	6.8	6.3	9.5	4.6	5.7	5.0	3.1	3.4	6.5	6.5	9.8	5.6	71.7	53.1	37.1	62.5	58.5	32.8	26.7	26.2	27.5	23.4	52.2	40.6	10.1	0.0	6.7	4.2	12.0	16.8	14.3	7.5	15.9	15.2	15.0	10.4	9.0	5.7	5.3	7.3	4.2	7.7	6.3	7.5	5.9	7.6	4.0	8.0	13.3	9.8	10.2	14.9	7.7	7.3	9.6	18.0	6.6	9.2	8.2	251.8	20.3	14.6	10.3	5.0	5.7	7.8	4.1	9.5	19.0	3.3	14.0	15.0	7.2	2.8	16.8	9.0	6.2	5.0	2.9	7.1	5.6	29.7	10.3	12.8	4.6	6.3	2.1	7.2	6.6	18.7	20.0	2.6	11.1	12.3	15.9	8.9	11.1	48.8	10.0	11.8
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ETS transcription factor ELK3"	P41970	12	96194375-96269824	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 170.7;Endothelial cells: 148.0;Hepatic stellate cells: 160.6;Respiratory ciliated cells: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	37.1	14.4	5.4	34.2	6.1	18.4	28.4	14.4	5.8	28.0	11.7	15.6	9.2	35.2	9.3	38.1	16.9	30.2	23.9	4.7	7.2	14.0	10.8	27.5	38.0	9.1	7.9	10.2	9.0	11.6	5.8	27.0	7.9	13.1	13.9	2.9	15.3	15.3	11.2	12.5	13.5	37.9	7.0	41.8	14.8	8.6	8.3	19.7	21.8	22.2	37.5	29.2	24.5	6.6	50.3	29.5	29.7	15.8	73.7	137.3	7.6	62.3	118.5	48.6	37.3	1.7	36.6	8.0	20.9	70.4	36.4	17.6	3.3	99.8	85.0	21.7	11.4	2.5	12.2	11.2	22.3	24.2	5.7	81.3	18.4	100.4	75.4	98.5	117.8	6.0	6.0	32.3	166.4	7.6	4.8	16.4	36.3	7.1	38.8	39.7	49.8	9.1	41.7	13.0	1.4	31.4	20.5	9.1	32.0	44.7	5.0	13.3	73.2	132.4	52.2	82.5	54.8	61.7	55.0	1.8	47.0	28.2	94.1	7.1	23.5	0.5	11.1	13.0	42.5	23.2	25.7	15.0	17.7	19.0	15.4	11.4	7.4	20.1	12.1	7.1	45.4	12.8	5.4	6.1	14.4	5.8	4.7	7.2	9.1	7.9	7.9	7.0	8.3	6.6	170.7	6.4	22.3	3.9	22.3	32.6	44.6	15.0	10.8	0.7	7.1	8.1	6.6	2.8	39.4	5.5	4.2	1.2	27.5	2.1	5.9	21.8	1.0	49.0	19.7	148.0	1.2	12.4	4.2	15.6	3.9	35.2	3.1	44.0	17.1	1.3	160.6	4.3	24.5	0.0	1.9	3.4	2.0	32.0	39.7	2.5	11.5	31.4	12.4	39.4	23.6	5.8	9.2	5.5	5.3	56.8	3.4	10.5	29.5	45.7	0.5	0.7	103.1	0.6	13.1	27.7	19.9	0.2	12.6	24.4	27.0	1.1	32.6	10.6	3.0	79.0
ELK4	SAP1	ENSG00000158711	"ETS transcription factor ELK4"	P28324	1	205597556-205632011	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 104.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 6.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028863	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028863: AB_10602492"	"unprognostic (2.08e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (2.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.58e-3)"	9.0	4.9	7.4	11.5	11.0	11.7	8.1	12.2	7.5	8.2	7.0	6.9	6.1	7.7	7.2	8.0	6.7	9.2	7.0	6.0	6.4	7.8	13.2	9.7	17.5	8.5	8.8	6.7	8.1	7.8	5.5	7.9	9.9	26.0	6.8	9.3	8.2	5.7	10.6	13.5	9.6	6.1	9.1	15.8	7.7	7.3	8.5	14.1	6.9	8.7	16.8	9.6	9.3	14.1	14.9	13.2	5.1	13.3	11.9	15.2	12.9	9.8	10.1	7.6	8.9	5.7	14.6	31.3	9.0	12.2	5.7	18.0	10.9	12.0	13.1	35.9	7.7	13.6	22.0	12.2	16.1	25.7	51.8	13.4	14.5	12.0	24.4	14.7	32.3	14.8	12.7	25.6	10.7	20.1	21.3	9.5	8.5	3.4	7.8	15.7	31.2	25.4	10.2	32.0	5.9	7.0	25.2	13.7	17.3	8.9	12.7	8.5	23.5	15.3	17.8	13.7	18.8	19.1	18.9	21.1	13.3	10.3	18.2	6.6	0.4	0.7	0.8	0.5	1.1	0.7	0.9	1.1	0.6	1.1	1.1	1.6	0.2	0.6	0.3	0.8	1.0	0.4	7.4	11.0	12.2	7.5	6.0	6.4	8.5	8.8	9.9	9.1	8.5	14.1	50.7	9.6	16.2	7.2	39.3	39.4	35.3	19.0	9.6	104.8	15.1	11.9	20.8	34.3	17.8	31.3	12.5	15.6	34.0	13.8	3.9	14.7	17.4	37.7	37.4	40.1	13.1	21.4	22.8	17.8	6.2	23.2	18.3	82.5	28.5	12.8	36.4	30.2	10.0	25.2	11.7	18.3	14.2	23.5	39.1	19.5	25.4	22.3	30.2	27.2	22.3	11.2	39.1	17.6	28.0	17.5	9.0	15.4	18.6	71.3	14.4	17.5	24.9	26.9	26.3	28.5	21.4	24.6	11.6	19.2	48.6	18.3	32.6	16.7	17.5	103.1
ELL	"C19orf17, ELL1, Men, PPP1R68"	ENSG00000105656	"Elongation factor for RNA polymerase II"	P55199	19	18442663-18522116	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 297.2;Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004202, HPA046076"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA004202: , HPA046076: AB_2679526"	"unprognostic (9.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	15.1	7.7	4.0	9.0	6.2	29.8	11.8	8.4	7.0	11.2	5.0	10.6	6.5	11.0	2.0	10.3	10.6	5.7	10.5	3.6	4.2	12.6	14.1	16.6	7.6	4.7	4.2	13.0	10.0	4.1	11.3	10.0	3.8	9.9	2.3	1.2	8.3	3.6	20.1	15.3	12.8	3.6	4.0	17.3	10.1	38.5	6.1	6.8	8.2	9.9	4.3	10.5	11.0	3.9	12.7	5.7	3.2	6.8	3.4	4.2	22.7	10.0	8.8	7.5	7.1	7.1	9.8	15.6	11.8	6.7	5.2	8.6	4.7	11.1	3.8	13.3	10.9	9.4	5.9	6.3	5.2	10.3	11.8	8.6	9.3	9.8	7.7	5.6	5.4	8.5	13.5	21.8	4.0	10.3	12.5	11.9	10.6	7.8	16.8	10.9	4.8	17.4	5.3	8.8	5.7	6.4	7.4	12.3	11.0	4.1	6.4	12.4	9.0	8.6	6.6	11.6	9.3	34.8	23.4	11.7	11.4	17.6	12.5	0.3	5.9	4.5	4.5	4.1	7.3	2.9	2.6	3.9	5.0	2.1	1.7	2.7	18.1	2.3	2.1	8.6	3.1	4.1	4.0	6.2	8.4	7.0	3.6	4.2	4.7	4.2	3.8	4.0	6.1	3.9	12.3	6.4	6.1	9.1	16.3	28.0	26.4	11.9	23.3	4.5	19.7	10.7	5.1	11.5	7.2	3.7	4.2	47.5	29.5	15.2	11.7	8.7	297.2	22.9	16.0	11.4	19.7	10.3	9.1	8.0	17.6	17.2	12.8	37.7	11.4	5.1	7.5	15.5	19.3	1.7	11.2	10.1	6.1	12.8	21.7	235.9	6.5	20.4	7.2	9.4	13.8	5.3	4.1	7.1	8.0	10.8	3.7	3.0	53.6	14.2	11.8	7.0	8.4	3.4	19.7	13.0	16.7	18.2	24.7	19.4	30.4	68.7	19.2	5.9	7.1	19.9
ELL2	MRCCAT1	ENSG00000118985	"Elongation factor for RNA polymerase II 2"	O00472	5	95885098-95961851	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 382.9;Plasma cells: 430.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 322.3;HDLM-2: 291.4;U-266/84: 216.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013569			Supported	Nucleoplasm		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA013569: AB_2668853"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.31e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-2)"	49.0	19.5	13.5	28.6	32.3	48.3	37.3	22.9	26.8	24.0	6.8	13.5	14.5	9.1	5.7	61.2	16.0	35.6	39.9	18.4	32.0	16.5	86.8	35.8	14.6	51.1	28.5	24.8	94.3	15.6	25.1	25.3	33.7	39.1	13.1	3.7	96.5	23.0	33.5	58.9	14.5	11.4	21.3	18.0	44.3	15.2	41.4	8.1	17.1	10.7	21.8	33.2	35.7	55.8	31.7	12.3	3.8	0.5	45.0	56.1	4.6	322.3	56.2	105.4	89.7	23.7	7.2	1.4	6.7	173.7	24.6	40.0	10.0	103.5	129.3	291.4	7.6	20.5	53.5	52.3	29.0	4.5	33.3	55.1	70.1	64.0	191.4	63.2	17.0	3.8	11.5	120.3	100.6	3.3	0.1	5.6	4.9	5.0	16.8	3.1	19.2	25.3	20.3	30.0	6.4	2.1	118.6	6.2	7.3	15.1	3.6	3.7	35.5	137.6	27.4	32.0	59.4	84.0	216.0	1.5	71.9	2.1	9.4	7.0	0.8	5.7	0.6	1.0	1.0	3.5	0.8	0.9	0.4	1.7	0.6	0.5	1.8	1.6	0.8	0.3	1.1	0.6	13.5	32.3	22.9	26.8	18.4	32.0	51.1	28.5	33.7	21.3	41.4	55.8	30.9	28.9	94.9	28.1	93.2	183.2	137.3	47.1	134.9	0.6	56.0	37.6	31.6	14.3	61.5	18.4	0.0	2.0	98.6	19.4	5.9	24.6	2.5	46.2	32.4	33.4	107.8	25.7	138.6	91.9	14.8	64.4	85.6	88.6	172.4	11.2	18.5	141.1	36.7	0.0	87.5	18.1	12.2	64.4	52.0	4.3	7.8	126.5	46.2	83.4	25.3	1.2	2.1	49.8	382.9	70.8	14.7	7.2	430.1	134.7	12.7	15.8	35.2	0.5	13.1	213.2	76.8	17.2	9.2	185.8	171.5	25.9	72.4	2.4	14.3	88.8
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772605-43777315	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 57.7;skin 1: 25.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.2;Gastric mucus-secreting cells: 4.6;Proximal enterocytes: 6.5;Squamous epithelial cells: 21.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 10.5;naive B-cell: 15.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 15.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 73.8;OE19: 28.5;T-47d: 39.0;U-698: 149.9"	"Region enriched"	"Detected in single"	11	"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA028938, HPA073494"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA028938: AB_10795352, HPA073494: "	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.5	0.9	1.0	9.7	1.0	0.2	5.2	1.0	1.1	1.6	4.7	8.0	14.1	0.6	1.1	4.5	3.9	0.7	0.5	1.0	1.1	1.4	0.7	1.5	49.7	1.0	1.1	1.7	0.4	1.6	0.5	3.7	1.1	2.0	12.3	0.1	2.2	1.0	0.4	25.0	12.9	1.0	1.0	1.0	1.8	16.2	1.4	1.5	0.7	1.9	57.7	0.7	0.8	1.1	2.1	0.2	0.6	1.1	4.9	1.2	0.4	0.2	1.3	2.8	3.1	0.0	1.3	73.8	0.1	1.2	0.1	13.7	1.3	0.7	1.4	1.6	7.3	0.4	2.6	4.6	1.0	0.1	0.0	1.4	12.3	0.7	0.2	0.2	1.1	0.4	0.2	0.0	0.7	4.0	1.5	1.4	0.1	28.5	2.4	0.8	0.0	0.0	1.8	0.0	9.5	0.0	1.7	21.5	0.0	0.3	39.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	149.9	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	10.5	0.6	0.1	0.0	15.9	1.1	0.2	0.0	0.1	0.0	2.2	0.6	0.6	1.0	1.0	1.0	1.1	1.0	1.1	1.0	1.1	1.1	1.0	1.4	1.1	0.1	0.0	0.0	0.0	2.2	0.4	0.1	0.2	5.2	0.0	0.7	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.3	1.2	0.0	0.1	1.8	0.4	0.1	0.2	0.0	0.4	0.1	0.7	0.0	0.5	4.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.5	0.0	0.0	0.5	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	6.5	0.1	3.1	0.0	0.0	0.2	0.4	0.2	0.2	21.0	1.0	0.3	0.1	0.1	2.3	0.2
ELMOD1	DKFZp547C176	ENSG00000110675	"ELMO domain containing 1"	Q8N336	11	107591091-107666779	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 32.8;pituitary gland: 21.7;retina: 32.6;skin 1: 28.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.5;Excitatory neurons: 126.1;Horizontal cells: 37.0;Inhibitory neurons: 103.9;Oligodendrocyte precursor cells: 80.9"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 14.9;RH-30: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038435, HPA066479"			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA038435: AB_10795575, HPA066479: "	"unprognostic (2.74e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.13e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	0.4	2.6	17.2	0.3	27.1	0.1	2.4	13.2	32.8	0.5	0.0	0.5	0.2	0.4	0.1	0.1	2.1	0.1	4.8	24.6	23.5	3.1	0.3	0.4	0.1	15.1	24.8	0.1	0.1	0.9	21.7	0.0	11.8	0.8	0.2	32.6	0.1	0.1	2.6	28.9	0.2	0.3	14.3	0.1	0.1	1.6	18.8	0.4	0.1	1.8	0.0	0.0	0.1	10.7	0.0	0.0	5.6	0.1	0.0	0.1	0.2	0.2	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.2	4.4	0.5	2.8	0.4	0.5	0.0	2.3	0.1	0.0	0.1	1.5	0.1	0.0	0.5	0.1	0.0	0.0	0.1	14.9	1.9	0.0	0.1	1.1	0.1	0.0	0.1	0.6	0.0	2.2	0.1	33.9	0.0	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	1.6	0.0	0.9	0.2	0.0	0.0	4.5	0.0	2.7	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	17.2	27.1	13.2	32.8	24.6	23.5	15.1	24.8	11.8	14.3	18.8	10.7	0.0	0.0	3.9	24.2	0.2	0.0	0.4	0.1	0.0	33.5	0.0	0.1	12.8	0.0	1.3	0.0	16.7	0.1	0.0	0.0	0.0	0.0	11.4	2.2	1.0	1.6	0.0	0.0	126.1	0.0	0.1	0.5	0.0	0.2	0.0	0.1	0.4	1.1	0.1	37.0	103.9	0.0	0.0	0.3	2.2	13.6	0.3	0.4	0.0	7.5	0.0	10.0	0.0	80.9	5.9	0.0	0.0	0.4	0.0	0.3	0.0	4.2	4.8	18.3	0.0	0.7	0.8	5.0	1.5	0.0	3.1	0.0	0.2	0.0	0.0	0.2
ELMOD2	MGC10084	ENSG00000179387	"ELMO domain containing 2"	Q8IZ81	4	140524168-140553770	"Predicted intracellular proteins"	"Antiviral defense"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047600	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA047600: AB_2680098"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (1.17e-8)"	"unprognostic (3.17e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (1.82e-2)"	10.7	13.8	6.8	8.7	7.4	8.6	14.2	9.7	6.9	9.9	12.3	12.2	12.9	10.9	13.2	8.6	10.7	9.1	11.4	6.0	7.8	14.5	15.6	8.5	8.8	8.3	7.6	8.5	8.8	15.5	7.4	9.6	8.0	13.0	13.0	18.0	9.2	9.7	4.3	9.4	15.3	10.2	8.7	7.6	10.3	8.0	7.2	12.5	16.8	5.3	10.2	9.4	6.0	10.6	11.3	12.4	24.9	19.1	25.4	29.2	16.0	26.3	24.7	14.3	17.1	12.2	23.7	18.5	11.3	16.5	17.3	10.1	23.8	16.7	17.6	18.1	14.2	15.3	10.2	16.0	23.1	23.6	13.0	20.1	27.2	12.2	12.5	22.6	15.9	22.2	19.9	29.6	24.8	8.2	25.6	8.1	13.2	16.4	10.1	29.7	19.2	12.0	20.7	17.9	11.8	43.6	17.3	17.5	19.3	27.7	17.1	9.7	16.3	32.7	11.6	15.5	27.6	30.8	47.1	23.1	23.9	18.2	25.3	2.3	6.6	8.0	6.6	7.1	7.4	3.2	5.8	7.2	5.6	6.0	5.9	5.9	15.3	7.5	5.7	9.8	7.3	4.4	6.8	7.4	9.7	6.9	6.0	7.8	8.3	7.6	8.0	8.7	7.2	10.6	14.6	28.9	17.7	22.5	13.1	9.2	11.0	30.3	11.4	20.7	14.7	10.5	14.3	7.2	26.4	18.4	18.8	23.2	19.9	17.6	1.9	22.2	3.9	29.0	24.4	14.5	9.1	7.4	20.2	26.5	8.7	15.5	9.2	15.7	19.7	17.8	11.4	27.1	19.0	15.2	15.6	10.9	22.4	16.4	11.0	1.5	13.1	13.8	17.8	19.7	14.1	16.3	9.2	20.6	35.3	25.6	12.9	10.9	21.7	10.3	27.1	15.9	44.9	24.7	6.6	10.0	18.3	26.9	19.1	12.4	11.6	20.1	13.9	10.9	12.0	8.6
ELMOD3	"DFNB88, FLJ21977, RBED1, RBM29"	ENSG00000115459	"ELMO domain containing 3"	Q96FG2	2	85354394-85391752	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012126	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA012126: AB_1848130"	"unprognostic (1.90e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.63e-2)"	"prognostic favorable (6.16e-6)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (5.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.85e-5)"	11.1	8.2	7.0	3.7	7.4	2.7	8.7	6.6	8.0	7.2	5.1	7.6	4.9	5.6	5.9	5.0	6.9	6.1	5.3	5.9	6.4	6.0	8.8	4.9	5.4	6.9	6.8	6.5	6.0	8.9	6.6	6.1	6.2	8.4	4.9	3.1	6.2	7.0	12.1	5.1	5.6	6.7	6.4	6.6	7.1	2.7	6.7	5.4	6.3	10.2	5.0	7.3	6.3	7.0	4.9	6.0	6.7	10.0	20.9	9.2	4.0	8.6	6.7	12.6	11.7	5.0	2.4	3.7	6.7	7.2	15.9	5.1	9.7	11.9	11.4	13.0	6.7	6.5	3.4	3.7	10.9	4.9	8.2	9.6	10.6	12.1	13.6	10.6	9.1	7.4	6.6	4.2	11.9	3.9	7.2	2.9	3.3	9.8	6.4	5.2	13.9	3.5	5.8	3.0	6.3	3.3	5.3	7.3	7.9	7.6	4.0	3.5	4.8	9.1	4.9	7.9	8.0	5.0	9.9	4.9	9.1	5.7	9.4	6.5	2.7	8.0	5.0	1.9	2.7	3.1	3.2	2.0	3.2	2.6	2.7	4.8	2.5	5.0	4.5	0.9	5.5	2.8	7.0	7.4	6.6	8.0	5.9	6.4	6.9	6.8	6.2	6.4	6.7	7.0	9.0	6.4	8.4	36.9	15.7	4.7	10.0	13.0	8.6	27.2	10.7	7.6	5.2	10.0	16.7	11.0	29.2	15.2	9.8	17.3	7.9	8.6	5.6	4.6	6.9	9.5	8.4	7.4	24.3	9.1	5.9	10.0	12.8	4.0	8.9	20.7	12.5	7.5	8.6	30.3	21.4	11.4	14.2	10.0	9.3	5.6	19.3	9.5	17.8	18.7	16.5	14.1	28.8	28.6	49.7	10.4	15.3	23.7	7.7	10.8	24.9	7.1	11.7	30.9	19.7	10.0	8.0	19.7	10.9	6.7	6.5	12.4	14.0	18.3	12.7	9.4
ELOA2	"HsT832, TCEB3B, TCEB3L"	ENSG00000206181	"Elongin A2"	Q8IYF1	18	47032572-47035621	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	33	"brain: 2.3;choroid plexus: 3.4;testis: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041009, HPA043501, HPA048971, HPA049178, HPA050086, HPA053158"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"			Nucleoplasm	Cytosol	"HPA041009: AB_10959881, HPA043501: AB_10960403, HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "	"unprognostic (2.38e-1)"	"unprognostic (4.47e-1)"		"unprognostic (2.54e-4)"	"unprognostic (2.39e-1)"			"unprognostic (8.75e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.64e-1)"			"unprognostic (5.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.97e-2)"		0.0	0.0	1.0	0.0	2.0	0.0	0.0	0.8	1.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	2.0	2.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	0.8	1.1	0.7	0.6	2.0	2.3	1.9	0.9	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELOA3CP	ELOA3C	ENSG00000275553	"Elongin A3 family member C, pseudogene"		18	46968695-46969912	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	28	"brain: 2.2;choroid plexus: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"			Nucleoplasm	Cytosol	"HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	1.2	0.0	1.7	0.0	0.0	0.6	1.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.7	0.6	1.1	0.8	0.7	2.0	2.2	2.0	0.9	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELP1	"DYS, IKAP, IKBKAP, IKI3, TOT1"	ENSG00000070061	"Elongator complex protein 1"	O95163	9	108866898-108934328	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.8;Collecting duct cells: 14.7;Exocrine glandular cells: 21.1;Theca cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"basophil: 36.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021340, HPA049677, HPA050686"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216"	"prognostic unfavorable (1.57e-4)"	"unprognostic (8.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.98e-2)"	13.6	39.7	5.8	6.5	6.2	6.5	13.6	6.9	8.1	21.5	8.4	17.5	5.8	17.1	9.5	13.0	19.9	6.7	18.2	5.9	7.8	14.4	18.4	15.2	9.6	6.6	6.5	29.9	17.6	29.3	38.1	6.8	7.9	18.0	8.1	24.8	14.8	8.3	15.7	15.9	15.9	8.9	5.9	18.2	15.5	12.0	6.9	9.5	20.1	11.4	8.8	15.5	18.3	6.3	15.6	26.7	19.7	12.8	21.7	21.1	21.1	23.4	15.1	20.8	16.9	31.5	9.2	31.0	12.0	20.2	27.5	35.7	40.7	29.8	25.8	28.6	26.6	15.2	38.2	63.3	18.6	28.7	13.7	18.7	19.1	34.5	26.7	18.0	20.9	33.6	43.1	17.9	22.9	25.3	21.2	13.6	32.1	41.0	34.4	20.7	31.9	18.3	17.3	16.1	26.6	23.9	27.8	23.3	15.7	22.4	33.3	14.1	15.4	10.4	16.2	26.0	25.1	15.5	47.2	13.8	20.0	20.2	19.1	36.6	1.4	2.8	2.9	2.2	4.4	2.2	3.4	4.6	2.4	1.2	3.1	4.0	0.2	4.5	3.3	1.6	2.6	2.1	5.8	6.2	6.9	8.1	5.9	7.8	6.6	6.5	7.9	5.9	6.9	6.3	7.3	12.8	18.8	0.0	2.9	0.0	0.0	0.0	0.0	0.0	7.7	7.0	0.0	0.0	3.1	14.7	0.0	6.9	5.8	0.0	0.0	5.8	0.0	9.9	10.6	4.7	0.0	0.0	0.0	21.1	6.2	3.8	0.0	9.6	2.5	11.4	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.6	0.0	0.0	2.7	0.0	0.0	6.3	6.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	5.6	2.8	24.4	0.0	0.0
ELP2	"FLJ10879, STATIP1, StIP"	ENSG00000134759	"Elongator acetyltransferase complex subunit 2"	Q6IA86	18	36129444-36180557	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002996, CAB020835"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB020835: , HPA002996: AB_1857552"	"unprognostic (5.51e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.66e-3)"	"unprognostic (4.33e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.74e-3)"	"unprognostic (7.31e-3)"	"unprognostic (7.07e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.97e-2)"	17.7	20.7	12.1	12.3	13.2	13.2	35.3	12.4	11.9	23.5	12.3	19.1	15.2	27.3	31.0	15.9	28.8	20.3	23.6	11.4	14.2	18.9	46.2	16.6	19.9	12.1	12.1	48.6	24.4	24.8	20.7	20.8	12.6	29.4	16.2	21.2	19.1	26.3	32.4	21.5	14.0	22.5	12.2	16.7	16.5	22.2	13.4	23.6	21.8	32.3	23.3	22.5	16.9	16.0	23.7	16.7	30.8	27.8	42.7	63.9	33.9	47.9	69.3	39.6	52.5	17.6	21.5	49.6	32.6	40.4	26.5	32.9	39.7	35.8	55.8	22.6	21.1	19.2	27.4	31.0	46.6	63.0	19.6	52.3	40.2	39.4	63.6	59.5	45.0	33.8	32.9	25.4	42.4	28.4	30.6	27.0	36.7	18.2	12.6	48.7	37.0	34.9	35.7	54.4	24.2	46.3	45.1	17.6	73.0	44.0	22.5	31.2	26.8	35.6	20.5	13.2	24.8	30.4	25.6	46.2	30.0	33.2	31.3	22.0	12.1	10.0	12.6	17.6	17.9	20.0	17.0	15.0	17.6	16.3	21.5	18.9	2.2	22.2	24.8	17.5	18.4	14.0	12.1	13.2	12.4	11.9	11.4	14.2	12.1	12.1	12.6	12.2	13.4	16.0	25.0	48.1	28.8	34.3	46.3	32.9	49.4	33.8	39.9	50.1	42.1	28.6	48.5	22.8	29.2	35.0	43.8	39.5	45.9	10.9	29.4	26.4	55.0	29.9	33.1	29.4	24.7	21.7	61.7	22.2	42.3	39.2	17.3	29.5	36.7	39.9	24.7	75.3	22.8	33.7	60.7	20.3	20.3	28.0	24.8	90.4	43.5	20.8	23.2	34.7	39.1	26.9	41.2	52.3	77.4	18.7	12.1	36.5	34.2	60.9	24.3	19.0	36.5	45.4	6.6	40.8	30.6	40.0	33.2	25.0	36.7	39.8	39.7	28.0	26.9	50.7
ELP4	"C11orf19, PAXNEB"	ENSG00000109911	"Elongator acetyltransferase complex subunit 4"	Q96EB1	11	31509755-31790324	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 153.5;Excitatory neurons: 93.6;Inhibitory neurons: 90.2;Microglial cells: 91.8;Oligodendrocyte precursor cells: 129.2;Oligodendrocytes: 123.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038572, HPA038573"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA038572: AB_2676090, HPA038573: AB_2676091"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.63e-2)"	7.1	7.2	14.6	7.4	16.4	8.6	6.8	37.9	19.0	7.4	13.3	9.0	4.6	6.8	8.3	9.7	7.3	7.2	10.2	14.0	13.3	10.2	9.6	7.3	9.7	13.6	14.3	7.5	9.4	8.1	5.4	7.8	14.7	6.7	7.7	12.7	6.9	7.4	8.3	9.6	6.5	7.6	13.6	6.4	6.5	8.3	15.2	15.1	6.6	8.3	8.4	7.8	7.3	18.2	13.2	11.2	12.0	14.4	10.9	14.9	4.6	11.5	12.3	16.7	18.4	10.4	11.5	18.0	9.7	10.3	20.9	23.3	16.5	14.4	18.3	15.1	18.3	5.9	13.2	16.0	11.2	12.6	11.2	14.9	8.7	7.2	19.5	13.2	20.4	22.9	27.4	15.7	10.7	20.3	21.4	14.9	6.9	38.9	13.7	12.8	25.7	12.0	25.6	13.0	13.8	6.4	22.3	13.4	10.0	11.7	25.4	18.2	8.2	15.3	13.5	25.3	15.2	6.1	12.9	22.0	10.8	17.6	13.4	5.9	8.0	8.1	6.7	9.2	8.3	9.1	7.6	7.9	9.3	5.9	8.5	7.4	2.1	7.5	9.5	8.3	10.1	6.6	14.6	16.4	37.9	19.0	14.0	13.3	13.6	14.3	14.7	13.6	15.2	18.2	13.9	12.8	10.5	153.5	11.4	8.3	11.0	20.2	6.8	4.9	7.7	8.5	7.7	5.7	14.5	7.3	4.2	20.2	11.4	4.3	29.4	9.1	18.0	11.0	14.0	7.5	6.7	4.6	93.6	11.3	15.6	10.5	4.1	8.3	10.8	12.8	3.9	5.5	11.5	15.2	90.2	6.0	12.2	5.7	2.4	3.6	5.0	8.5	3.6	91.8	7.7	16.5	8.2	129.2	123.4	6.1	3.9	6.4	14.3	2.9	4.0	33.1	8.6	6.1	6.6	8.3	12.9	23.5	10.2	9.4	8.2	18.9	11.4	11.6	6.4	6.9
ELP5	"C17orf81, DERP6"	ENSG00000170291	"Elongator acetyltransferase complex subunit 5"	Q8TE02	17	7251416-7259940	"Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 171.6"	"Group enriched"	"Detected in all"	4	"Early spermatids: 405.3;Late spermatids: 699.6;Spermatocytes: 226.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023279, HPA052411"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA023279: AB_1847613, HPA052411: "	"unprognostic (3.73e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.30e-2)"	30.6	47.9	21.1	10.0	22.0	14.1	26.7	22.0	23.8	30.0	22.0	36.4	11.5	31.8	12.8	27.9	28.7	9.3	59.7	21.0	21.8	39.6	57.1	22.7	16.7	21.7	21.6	33.7	28.0	19.9	39.7	10.4	21.6	35.4	10.8	18.9	26.1	11.8	57.3	21.2	31.2	17.8	21.2	35.0	29.0	171.6	21.9	22.9	29.3	77.9	16.9	30.9	24.8	21.6	22.4	61.7	27.3	24.9	46.8	36.8	11.9	19.5	23.1	30.7	28.2	62.0	14.3	44.0	21.1	31.3	53.7	16.4	69.6	46.1	22.0	27.4	98.2	40.7	20.5	57.3	23.2	29.2	15.4	26.2	34.0	21.0	41.1	19.4	26.5	54.9	28.6	11.5	48.4	37.5	74.4	55.4	22.5	23.4	42.5	63.0	30.6	23.9	34.5	20.7	13.3	26.4	38.0	11.5	30.9	27.0	16.3	20.9	30.4	17.6	20.6	34.1	31.7	13.3	19.4	51.8	32.0	28.1	23.3	28.6	30.7	16.1	32.3	37.8	41.0	39.3	28.9	30.1	37.4	39.5	30.2	35.9	5.3	38.7	26.1	45.9	44.7	28.6	21.1	22.0	22.0	23.8	21.0	21.8	21.7	21.6	21.6	21.2	21.9	21.6	30.4	9.6	11.7	10.7	38.3	22.0	47.7	47.8	27.9	21.5	27.8	36.6	64.3	12.8	39.9	46.0	20.9	36.1	45.1	29.7	97.8	38.3	405.3	20.5	28.1	26.5	41.6	14.1	9.4	13.6	78.1	28.6	9.7	21.5	7.0	30.1	18.2	24.2	41.4	28.6	9.7	37.0	57.0	13.5	28.8	699.6	34.2	22.8	21.4	10.3	29.0	32.7	29.9	10.6	10.5	19.3	32.9	33.1	26.7	73.5	46.9	107.0	23.1	33.6	39.5	27.1	35.9	226.4	40.8	21.0	21.7	57.9	29.9	29.0	46.5	51.6
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513712	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: AB_2685282"	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	13.5	27.0	21.3	14.3	22.8	11.5	15.8	23.6	23.6	14.5	24.3	16.2	15.2	17.2	23.1	15.5	16.9	14.7	19.6	21.0	21.6	17.5	21.3	12.1	21.9	22.8	22.2	21.7	14.8	21.1	15.1	14.4	22.7	19.4	13.9	8.7	16.4	17.7	35.6	16.6	13.4	18.0	22.2	15.7	15.7	21.1	22.9	24.6	19.3	29.0	20.5	16.0	13.3	23.7	37.6	36.4	45.3	46.8	34.9	32.0	26.5	43.4	29.7	54.2	48.6	35.1	38.4	68.7	27.1	37.6	51.3	22.1	43.6	62.5	33.0	39.9	34.4	62.6	55.5	40.4	38.5	49.1	38.5	34.9	33.2	61.4	38.3	31.5	47.3	58.8	67.1	21.7	54.1	44.0	59.8	56.7	55.1	35.4	57.9	29.2	22.3	42.2	38.4	33.9	40.3	40.9	36.9	29.8	25.8	36.0	40.8	41.1	32.8	57.3	41.9	28.9	56.9	44.8	63.5	64.9	28.4	58.8	58.4	19.7	20.4	15.1	31.8	18.9	25.2	33.4	29.4	32.9	25.9	35.2	28.3	28.9	2.8	35.3	13.7	33.9	38.5	25.6	21.3	22.8	23.6	23.6	21.0	21.6	22.8	22.2	22.7	22.2	22.9	23.7	19.3	6.4	12.3	8.8	24.9	8.4	15.2	35.7	19.4	21.7	20.3	22.4	23.0	24.3	20.0	33.1	14.6	44.0	27.8	16.0	60.7	28.1	8.3	15.3	19.4	22.6	17.4	30.3	9.4	23.6	39.6	23.4	17.9	14.0	22.2	56.3	30.0	28.5	28.6	38.7	11.9	15.0	40.7	14.5	8.3	14.5	23.0	17.4	16.0	9.4	21.7	43.7	48.4	5.5	11.7	21.3	12.7	30.5	23.1	10.9	22.9	51.1	15.7	26.0	6.6	14.2	22.6	47.2	22.4	15.6	8.4	26.8	23.9	58.4	21.7	10.4
EMC6	"MGC2963, RAB5IFL, TMEM93"	ENSG00000127774	"ER membrane protein complex subunit 6"	Q9BV81	17	3668812-3669668	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 185.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062681	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Centrosome	Nucleoplasm	"HPA062681: AB_2684831"	"unprognostic (2.21e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.32e-2)"	35.6	58.2	35.1	14.7	36.0	30.3	31.4	38.9	40.2	24.7	40.1	40.8	20.0	29.1	11.3	49.3	27.0	5.2	91.0	34.8	37.2	53.2	75.8	29.2	13.3	36.2	35.3	23.4	44.3	18.5	27.7	13.5	35.9	33.0	10.3	17.2	35.5	10.6	185.0	36.9	35.3	9.0	38.5	37.8	47.4	63.3	37.3	15.5	29.6	60.7	12.6	32.8	30.4	37.8	92.8	88.6	38.1	40.1	26.9	21.4	73.2	64.7	31.4	51.7	47.5	54.1	33.8	57.6	91.6	30.3	45.9	87.2	44.5	45.6	37.2	56.0	166.2	41.9	65.4	76.2	38.7	29.3	41.6	27.1	50.6	47.8	33.2	40.9	39.8	68.0	53.4	40.6	38.6	56.2	60.5	86.2	55.0	55.9	99.1	55.7	35.5	55.3	74.2	25.9	31.3	56.7	53.1	41.2	75.6	37.8	48.0	31.1	44.2	43.3	54.4	65.9	96.5	39.5	47.1	38.4	67.7	38.0	53.3	91.6	83.1	87.1	66.1	83.8	61.1	74.6	73.6	73.4	72.7	72.0	75.2	68.5	62.8	56.5	60.7	114.3	92.5	87.4	35.1	36.0	38.9	40.2	34.8	37.2	36.2	35.3	35.9	38.5	37.3	37.8	40.1	16.0	25.9	9.4	60.3	89.0	127.1	144.2	42.1	41.8	82.9	87.8	0.2	82.9	74.8	58.8	35.5	118.4	68.1	55.7	166.3	126.2	252.2	90.0	42.7	56.6	51.4	46.7	7.4	142.8	148.6	40.8	48.4	58.0	55.2	59.8	47.5	148.7	102.5	33.7	8.4	74.7	105.8	57.1	49.6	176.1	38.5	56.6	67.6	3.7	83.3	125.9	77.2	5.5	17.9	164.8	71.6	34.3	81.9	179.9	84.6	203.8	82.2	52.9	39.5	43.3	111.7	151.0	91.6	81.1	101.9	129.0	52.7	65.0	72.6	169.5
EMG1	"C2F, Grcc2f, NEP1"	ENSG00000126749	"EMG1 N1-specific pseudouridine methyltransferase"	Q92979	12	6970913-6997428	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039304, HPA039666"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA039304: AB_2676432, HPA039666: AB_10672891"	"unprognostic (1.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (2.83e-6)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.62e-1)"	16.8	18.0	13.0	15.2	14.2	12.6	17.3	14.4	20.2	14.9	15.9	14.0	11.1	14.5	13.6	20.2	16.1	4.6	22.6	13.2	14.1	23.2	22.8	15.9	13.4	14.4	14.2	13.9	13.6	9.4	12.8	8.6	14.5	15.7	9.7	9.3	13.6	6.1	21.2	17.4	14.0	7.4	14.3	18.1	14.6	9.9	14.0	12.3	15.6	12.8	12.8	16.1	14.1	15.3	55.5	53.7	20.5	25.2	15.8	11.5	84.7	40.1	17.9	31.2	21.2	106.4	57.6	55.4	14.7	25.1	56.8	39.8	18.9	46.1	35.2	40.1	30.6	76.8	51.7	99.6	20.3	79.0	47.8	18.5	27.2	45.5	51.8	16.2	13.9	38.6	38.6	12.1	29.8	65.3	41.4	48.3	169.6	45.4	28.0	56.3	41.2	44.0	20.0	68.8	11.9	35.7	42.2	43.9	41.4	57.5	12.0	57.8	29.2	32.4	42.6	26.8	92.9	14.6	17.9	97.7	34.8	33.7	52.8	15.5	44.1	22.3	60.7	66.4	63.3	85.3	63.6	67.6	51.2	88.0	74.4	69.1	6.2	60.9	86.4	55.8	68.1	81.3	13.0	14.2	14.4	20.2	13.2	14.1	14.4	14.2	14.5	14.3	14.0	15.3	30.1	16.0	41.3	1.3	34.0	36.6	92.2	79.1	25.0	14.7	29.0	36.8	0.0	24.3	60.9	42.3	8.4	107.3	22.8	18.1	49.0	75.3	9.6	23.1	24.8	32.3	9.6	16.0	1.3	66.8	121.0	31.8	11.7	22.7	60.9	27.7	23.2	35.9	65.4	16.8	1.4	25.7	71.2	25.0	29.3	15.5	37.9	27.7	28.4	1.9	45.1	24.5	43.3	2.0	2.7	75.7	19.8	25.9	17.3	69.0	25.1	81.1	54.0	16.0	39.5	29.2	86.5	28.9	59.7	28.4	39.9	74.3	30.6	46.4	35.7	75.8
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580632	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 230.6"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 4163.5;Suprabasal keratinocytes: 1174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 268.1;RT4: 182.0;SK-BR-3: 256.2;T-47d: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014711, HPA070816"	Approved		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA014711: AB_1848147, HPA070816: "	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	56.8	9.7	15.5	12.4	15.5	0.7	49.5	14.8	17.1	51.0	18.6	48.0	15.5	25.9	45.5	152.1	35.5	17.7	64.1	13.6	15.6	20.3	83.2	230.6	5.7	16.1	16.8	54.9	13.7	32.8	13.3	23.0	16.0	38.8	34.1	2.0	39.2	17.3	22.5	140.6	28.3	22.3	15.2	16.0	39.1	7.2	18.8	5.3	27.7	25.4	32.8	39.6	72.9	15.7	28.7	39.1	15.9	18.9	35.0	30.0	31.3	40.0	36.8	23.9	35.7	128.5	98.2	0.2	12.6	48.4	17.2	123.9	41.1	49.8	31.3	0.1	26.1	0.1	76.6	72.1	6.1	0.2	0.4	18.4	13.1	31.9	3.2	5.4	10.1	0.1	9.6	2.6	66.9	268.1	0.4	0.6	18.3	46.4	9.5	7.5	18.2	61.7	5.5	182.0	22.0	25.0	49.6	256.2	15.2	45.2	156.6	6.2	5.7	75.5	32.2	25.6	22.7	0.8	1.0	0.2	33.2	0.5	75.7	1.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	1.1	0.3	0.3	0.3	0.2	0.1	15.5	15.5	14.8	17.1	13.6	15.6	16.1	16.8	16.0	15.2	18.8	15.7	239.7	4163.5	368.4	13.1	3.1	356.9	137.9	172.2	111.0	2.3	105.0	94.0	53.1	100.1	255.8	42.3	0.0	74.2	3.1	119.5	0.0	3.8	8.0	78.8	30.9	183.9	104.9	0.0	0.7	67.0	17.8	152.7	46.4	51.9	36.7	68.7	161.0	235.1	10.1	0.0	0.6	207.8	81.4	19.6	136.5	9.3	190.7	17.0	87.2	41.2	33.6	5.7	0.0	22.6	0.6	32.9	158.4	276.1	1.6	86.0	21.0	0.2	142.8	2.2	52.6	256.3	129.3	5.7	12.9	319.5	1174.3	48.0	9.3	73.3	178.5	221.4
EMSY	C11orf30	ENSG00000158636	"EMSY transcriptional repressor, BRCA2 interacting"	Q7Z589	11	76444923-76553025	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012234, HPA050777"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012234: AB_449325, HPA050777: AB_2681232"	"unprognostic (1.69e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.74e-2)"	6.8	5.8	4.6	7.7	7.5	13.1	8.7	15.3	8.6	8.1	6.9	7.6	5.2	10.0	7.6	6.1	8.6	6.4	9.0	4.9	8.0	7.3	5.6	9.0	8.9	6.0	5.9	11.4	8.8	9.8	5.7	12.2	6.7	7.7	8.7	17.8	7.1	7.7	9.3	5.7	6.6	10.1	4.3	7.9	6.6	8.7	6.3	13.3	8.2	12.6	8.4	7.3	7.4	12.3	8.6	11.9	26.8	16.5	9.9	9.8	11.8	13.5	13.3	17.3	18.9	20.3	11.5	11.7	12.7	14.7	14.3	16.8	21.9	13.0	26.6	18.7	8.2	18.2	18.5	8.8	6.3	20.0	15.8	8.9	8.5	19.8	16.3	11.0	15.8	19.6	12.9	20.0	14.1	22.8	26.9	12.0	11.7	26.9	15.6	17.1	49.2	16.4	12.0	10.0	16.7	7.3	19.0	12.8	4.1	16.5	25.9	12.2	11.9	16.2	21.8	42.0	9.6	11.1	12.8	33.1	5.4	12.0	12.1	11.9	3.5	7.5	4.5	3.3	4.3	4.3	4.3	5.5	2.6	4.9	3.9	3.7	7.3	3.6	2.7	4.2	4.7	3.0	4.6	7.5	15.3	8.6	4.9	8.0	6.0	5.9	6.7	4.3	6.3	12.3	14.0	16.0	7.8	0.0	15.1	0.0	7.5	0.0	17.1	19.7	12.1	10.2	0.0	2.8	6.2	12.9	35.5	15.6	14.0	4.8	13.7	6.2	1.8	13.7	14.0	10.7	7.3	13.5	0.0	4.3	7.7	9.2	10.2	10.1	2.5	17.2	12.8	7.3	8.6	15.2	0.0	12.0	0.0	7.9	0.0	2.0	11.5	9.0	0.0	0.0	7.3	8.9	14.4	0.0	0.0	5.9	4.4	12.4	20.1	14.1	8.4	10.1	6.6	22.8	13.1	11.5	10.6	25.8	12.3	15.0	0.0	21.1	13.3	12.3	8.1	11.7
EMX2		ENSG00000170370	"Empty spiracles homeobox 2"	Q04743	10	117542445-117549546	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 79.0;epididymis: 104.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 239.1;Distal tubular cells: 90.1;Endometrial ciliated cells: 75.6;Endometrial stromal cells: 126.5;Glandular and luminal cells: 68.6;Granulosa cells: 88.3;Proximal tubular cells: 185.0"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 25.4;fHDF/TERT166: 31.6;RPTEC TERT1: 31.1;RT4: 9.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 14.2;cerebral cortex: 17.8;hippocampal formation: 22.8;white matter: 8.1"	"HPA003497, HPA065294"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA003497: , HPA065294: AB_2685455"	"unprognostic (1.53e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.21e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"prognostic favorable (2.28e-13)"	"unprognostic (3.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	10.4	0.1	23.2	0.2	25.6	0.2	2.8	16.9	31.3	58.2	16.7	0.4	0.1	79.0	104.3	0.4	53.0	1.5	0.8	26.9	16.5	39.1	0.1	0.1	0.6	15.8	18.0	11.9	0.0	0.1	1.8	0.4	16.4	1.1	0.1	0.3	2.4	52.6	10.8	10.5	0.1	45.0	14.7	0.2	0.1	1.2	19.6	0.1	0.3	5.2	0.4	4.7	4.4	22.9	0.0	0.0	0.0	2.6	0.0	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	25.4	31.6	0.0	0.1	0.6	0.0	0.0	0.1	2.8	0.8	0.1	0.2	0.0	0.1	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.1	0.2	31.1	9.4	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	2.6	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	23.2	25.6	16.9	31.3	26.9	16.5	15.8	18.0	16.4	14.7	19.6	22.9	4.6	0.0	0.0	43.4	1.0	10.7	2.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	239.1	0.0	0.2	0.0	0.1	90.1	0.0	1.4	75.6	126.5	3.1	0.0	0.0	0.1	0.0	0.3	18.0	0.0	68.6	0.0	88.3	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	8.0	2.6	60.3	2.5	21.4	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	41.0	0.0	2.5	0.1	185.0	0.0	0.1	52.6	8.6	32.1	0.3	0.3	0.0	7.5	0.1	2.2	2.2	0.3	1.7
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847648	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.2;skeletal muscle: 13.9;skin 1: 10.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 5.6;Fibroblasts: 4.8;Melanocytes: 12.4;Skeletal myocytes: 12.0;Smooth muscle cells: 5.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Region enriched"	"Detected in many"	6	"midbrain: 18.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;ASC TERT1: 7.2;fHDF/TERT166: 13.3;HSkMC: 13.5;PC-3: 7.8;U-138 MG: 9.9;U-2197: 11.2"	"Region enriched"	"Detected in single"	5	"midbrain: 4.9"	"Region enriched"	"Detected in some"	6	"midbrain: 23.6"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	3.5	0.2	0.1	0.0	0.1	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.7	18.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	13.9	10.4	0.0	0.0	0.5	0.0	0.0	0.1	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.5	4.0	0.2	0.6	0.2	16.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	4.7	0.5	0.6	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.3	0.0	0.0	0.0	9.9	1.0	11.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.5	0.7	18.2	3.2	0.5	1.4	0.5	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	5.6	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	12.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.4	0.1	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0
EN2		ENSG00000164778	"Engrailed homeobox 2"	P19622	7	155458129-155464831	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"brain: 19.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3.6;Glandular and luminal cells: 8.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.3"	"Group enriched"	"Detected in many"	6	"cerebellum: 19.2;midbrain: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.1;AN3-CA: 15.2;HAP1: 9.0;HEK 293: 25.1;SK-MEL-30: 12.9"	"Region enriched"	"Detected in some"	8	"cerebellum: 27.8"	"Region enriched"	"Detected in some"	5	"cerebellum: 52.3"	"HPA045646, HPA069809"			Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		No	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nucleoli, Nucleoli fibrillar center"	"HPA045646: AB_2679404, HPA069809: AB_2686205"	"unprognostic (2.44e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (2.54e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-13)"	"unprognostic (4.91e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.64e-3)"	0.1	0.1	0.1	0.0	0.2	0.0	0.1	19.2	0.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.2	8.0	0.6	0.3	0.5	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.8	0.7	41.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.1	0.0	1.4	0.0	9.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	5.5	0.0	0.0	0.0	0.0	2.0	0.0	3.2	0.0	0.1	0.3	0.0	0.0	3.0	0.0	12.9	0.0	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	19.2	0.7	0.2	0.4	0.2	8.0	2.3	0.3	0.9	2.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	3.6	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.4	1.5	0.6	0.0	0.1	0.0	0.1	0.3	0.0	0.0
ENO4	"AC023283.3, C10orf134"	ENSG00000188316	"Enolase 4"	A6NNW6	10	116849499-116911788	"Enzymes, Predicted intracellular proteins"	Glycolysis	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.5;choroid plexus: 4.7;fallopian tube: 5.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.3;Cone photoreceptor cells: 22.9;Early spermatids: 15.5;Endometrial ciliated cells: 15.8;Inhibitory neurons: 18.4;Late spermatids: 15.8;Oligodendrocytes: 62.4;Respiratory ciliated cells: 30.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037937, HPA037938"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA037937: AB_10697089, HPA037938: AB_2675746"	"unprognostic (2.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.55e-4)"	"unprognostic (8.38e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.87e-5)"	"unprognostic (1.08e-2)"	0.2	0.3	1.7	0.0	5.3	0.0	0.4	1.7	3.4	0.4	4.7	0.3	0.0	0.6	1.3	0.1	5.0	0.3	0.1	2.1	2.6	0.6	1.3	0.6	0.1	4.8	4.5	0.5	0.6	1.0	1.0	0.0	3.5	0.3	0.1	2.0	0.2	0.4	0.0	0.2	0.2	0.2	2.6	0.2	0.3	2.5	4.0	0.1	0.7	0.0	0.0	0.1	0.2	11.5	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	5.3	1.7	3.4	2.1	2.6	4.8	4.5	3.5	2.6	4.0	11.5	0.0	0.0	0.0	16.3	0.0	0.1	0.3	0.8	0.6	4.9	0.4	0.3	0.3	0.0	0.4	0.0	22.9	0.3	0.0	0.2	0.0	0.5	15.5	15.8	0.7	0.1	1.8	0.0	12.2	0.2	0.2	0.7	0.0	1.1	0.0	0.5	0.0	0.0	0.0	5.0	18.4	0.0	0.0	0.0	0.6	15.8	1.2	0.2	0.0	8.4	0.6	1.3	0.0	4.5	62.4	0.2	0.1	0.7	0.0	0.1	0.3	0.8	30.2	8.4	0.0	1.0	0.5	9.4	2.9	0.1	0.0	0.1	0.0	1.0	0.3	0.1
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430590-82461177	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		240000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	17.0	24.2	61.3	21.2	70.0	26.6	26.2	69.8	102.7	20.7	52.3	21.1	20.3	16.7	35.9	23.5	16.5	14.7	18.7	60.0	66.6	33.5	22.1	18.3	29.0	70.5	67.4	19.8	23.5	34.1	20.6	29.1	69.1	26.6	23.9	42.0	19.2	18.0	18.1	21.8	18.5	17.9	68.1	22.2	22.3	10.6	65.9	30.8	28.6	18.7	31.6	21.9	17.8	80.1	56.6	36.6	64.3	40.4	38.3	37.6	69.7	63.7	42.6	57.2	50.6	67.3	61.3	110.8	64.8	49.0	62.6	29.8	86.1	81.3	103.3	67.2	39.2	67.1	33.7	91.0	62.0	113.3	56.0	36.5	84.9	59.7	70.6	41.4	58.8	69.2	88.3	60.1	76.1	73.2	125.8	67.6	59.2	141.8	28.8	88.1	98.2	61.0	94.7	55.5	90.5	55.2	36.2	109.7	86.3	57.3	49.4	54.5	43.3	70.9	52.8	71.2	85.7	67.5	62.4	138.5	45.9	69.5	97.5	5.8	13.9	7.2	21.8	17.1	27.1	20.2	25.9	25.0	20.5	16.9	29.4	24.2	1.2	24.7	14.9	22.4	30.4	20.6	61.3	70.0	69.8	102.7	60.0	66.6	70.5	67.4	69.1	68.1	65.9	80.1	24.6	16.0	10.5	9.4	31.8	68.6	40.8	47.3	30.7	36.6	22.9	19.8	13.5	18.6	27.5	12.9	16.7	86.7	24.7	10.7	88.0	48.1	7.7	15.2	14.2	25.6	29.3	24.6	18.5	25.7	61.3	22.4	15.3	19.5	38.1	15.3	17.9	10.8	57.7	28.6	21.4	24.8	61.1	23.2	27.9	5.1	26.4	23.1	39.2	6.5	35.6	62.8	29.9	15.1	37.9	41.1	11.1	24.0	28.0	52.6	17.7	56.2	18.8	37.7	13.1	16.4	23.8	9.0	24.9	37.8	64.1	46.7	34.3	27.5	26.7	39.9
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 383.3;choroid plexus: 753.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1041.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 53.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 53.8"	"Cell line enhanced"	"Detected in many"		"AF22: 111.4;ASC diff: 147.7;ASC TERT1: 312.5;BJ: 103.2;BJ hTERT+: 188.9;fHDF/TERT166: 124.2;HSkMC: 144.7;U-2197: 108.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA		1200000000	"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: AB_2682218"	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	104.7	46.7	98.9	62.0	208.4	2.7	89.7	188.1	150.1	73.6	753.4	32.6	67.5	139.2	20.2	9.0	55.7	39.9	9.9	111.0	133.0	76.6	28.5	42.7	109.8	246.2	164.4	15.2	15.9	20.2	11.8	252.3	244.4	26.4	32.3	6.9	9.9	27.3	8.9	17.5	45.8	85.1	147.8	51.4	26.9	31.3	153.7	20.8	10.8	23.9	85.8	45.1	18.1	383.3	0.0	0.0	111.4	0.0	147.7	312.5	0.4	103.2	188.9	43.9	42.1	0.0	0.0	0.1	1.3	124.2	0.1	0.3	2.3	0.0	31.3	8.7	3.4	0.0	0.2	3.1	67.0	0.0	0.5	144.7	1.3	89.3	4.3	0.6	0.5	0.1	0.1	18.1	2.5	0.0	0.1	0.7	4.4	0.0	0.5	0.1	0.1	0.6	0.3	0.0	1.1	2.2	0.1	0.4	0.2	4.2	0.1	0.0	0.0	89.6	1.9	108.6	0.9	0.9	0.0	0.0	75.0	0.8	2.4	53.8	0.2	9.5	0.0	0.1	0.1	0.4	0.5	0.0	1.0	0.1	3.0	1.1	0.5	0.4	0.2	6.8	0.0	0.6	98.9	208.4	188.1	150.1	111.0	133.0	246.2	164.4	244.4	147.8	153.7	383.3	231.4	12.8	3.6	2.0	1.8	10.6	0.5	0.0	19.9	1.9	2.1	2.8	1.8	35.8	0.6	1.8	0.0	5.2	4.9	0.3	1.9	0.1	83.9	12.7	8.8	79.9	54.0	0.8	2.5	0.0	2.2	76.9	3.6	1.4	6.3	0.4	31.1	0.8	65.8	0.0	4.2	3.3	0.0	18.6	14.9	9.5	3.1	16.2	46.2	6.5	0.1	6.4	0.0	16.6	1041.6	0.7	2.6	3.4	1.9	0.1	4.2	47.6	3.7	1.2	0.0	3.1	9.6	1.7	0.4	7.8	5.3	6.4	1.7	1.1	2.8	1.4
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 5"	Q9UJA9	6	46159185-46170980	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 243.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 100.1;Respiratory ciliated cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.1;HSkMC: 7.1;SuSa: 6.2;T-47d: 8.7;U-266/84: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		620000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favorable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.8	8.6	6.2	1.1	7.6	0.2	13.4	6.9	12.6	12.8	4.0	2.6	1.5	1.8	243.6	1.8	15.4	7.0	4.4	7.0	9.7	24.3	0.5	8.8	1.2	5.8	13.0	9.7	9.7	46.3	19.8	1.7	6.2	29.4	3.2	30.6	14.4	31.0	10.7	1.6	1.9	0.9	4.5	5.7	6.7	35.5	14.0	8.2	51.0	10.3	1.4	5.6	1.8	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.5	0.1	0.3	11.1	1.8	3.6	0.2	3.7	0.0	0.6	1.5	0.1	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	1.9	0.0	0.5	2.3	5.4	0.0	0.0	0.2	0.2	4.5	0.6	4.7	0.2	0.0	4.6	0.0	6.2	8.7	0.0	0.0	0.0	1.2	0.0	0.1	5.3	7.9	0.0	2.8	0.0	0.1	0.0	0.0	0.0	14.9	0.1	8.0	0.5	3.0	9.7	0.0	0.8	0.9	8.7	1.1	2.8	0.0	0.0	0.0	3.2	6.2	7.6	6.9	12.6	7.0	9.7	5.8	13.0	6.2	4.5	14.0	6.3	0.4	12.8	12.2	16.3	1.6	0.9	4.8	0.5	1.2	10.6	18.1	10.8	7.5	8.6	6.1	23.9	4.2	4.9	4.2	1.9	1.9	11.6	0.7	15.3	0.8	0.4	8.3	0.0	24.6	7.5	2.9	4.2	2.0	5.4	4.5	4.0	0.4	0.1	0.4	10.1	14.5	2.8	2.0	0.0	0.4	3.8	2.8	0.5	0.0	1.9	0.6	100.1	23.7	9.0	10.5	2.2	2.3	12.0	0.1	12.0	1.7	16.3	47.3	3.4	6.6	25.7	1.8	0.5	2.4	1.1	0.6	0.3	3.2	21.2	2.9	3.3
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	11	"U-698: 8664.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol		NA	NA		700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: AB_2681425"	"unprognostic (6.27e-2)"	"prognostic favorable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	140.5	106.6	151.2	115.1	156.7	219.8	154.9	133.6	188.2	145.2	132.6	135.9	133.6	117.8	183.3	288.0	100.5	94.9	120.2	161.6	144.1	118.8	148.8	124.0	128.4	137.2	135.6	102.4	108.5	173.0	92.0	103.7	134.2	97.7	123.9	121.8	122.9	94.6	301.0	241.3	132.7	105.8	136.9	99.7	124.1	45.2	147.4	157.8	134.4	212.3	146.7	147.0	165.6	157.0	287.1	170.8	236.9	206.9	149.7	126.8	220.7	141.0	148.4	199.9	171.7	207.3	216.6	288.9	196.8	122.1	125.1	238.3	198.5	325.4	160.1	415.1	277.4	434.3	239.6	158.2	108.3	372.1	462.6	100.5	202.0	214.1	293.6	118.8	206.2	224.8	321.7	551.8	140.9	775.5	302.3	272.6	431.2	386.2	211.1	298.6	199.9	328.0	299.2	306.0	303.8	193.3	201.6	385.6	222.1	200.8	533.9	442.9	208.2	143.9	261.9	171.8	340.3	309.4	441.4	8664.2	197.1	357.6	191.8	67.3	54.4	94.3	55.6	62.9	52.2	64.3	46.3	57.5	70.7	55.3	37.7	56.0	53.0	68.8	64.3	58.3	58.2	75.1	151.2	156.7	133.6	188.2	161.6	144.1	137.2	135.6	134.2	136.9	147.4	157.0	103.1	41.7	166.1	20.9	132.9	190.3	225.1	303.9	124.7	59.7	152.7	117.1	102.6	98.7	172.9	82.8	45.9	286.5	148.9	170.7	254.3	160.3	9.7	109.1	68.5	114.2	130.8	178.2	44.7	152.4	184.2	85.9	71.9	93.7	224.3	51.1	80.3	86.9	203.3	67.3	29.3	169.1	211.6	101.1	171.4	17.7	86.0	123.3	103.2	19.7	409.7	83.6	184.4	21.6	19.3	91.5	146.8	104.2	135.6	128.0	187.2	186.0	128.8	50.0	72.3	85.5	94.4	27.6	25.0	269.7	286.8	382.8	140.4	87.9	163.9	253.7
ENTPD7	"FLJ30978, LALP1"	ENSG00000198018	"Ectonucleoside triphosphate diphosphohydrolase 7"	Q9NQZ7	10	99659509-99711241	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 14.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 17.5;Urothelial cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014351	Uncertain		Approved	Nucleoplasm		NA	NA		65000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA014351: AB_1848183"	"unprognostic (1.82e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.01e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.32e-3)"	"unprognostic (9.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.39e-1)"	1.8	3.7	0.4	4.2	0.5	7.0	2.2	1.7	0.7	3.2	3.9	3.7	14.6	2.1	2.2	4.4	1.8	4.5	1.3	0.7	0.2	2.7	6.3	1.9	2.2	0.3	0.4	1.0	6.9	2.9	1.7	6.5	0.2	2.7	3.8	2.7	2.9	2.3	0.5	2.9	14.6	2.7	0.3	2.1	3.9	1.4	0.3	1.6	2.2	0.4	2.7	10.2	2.6	0.5	5.4	5.9	8.0	14.4	4.0	3.6	8.4	10.0	19.1	11.4	9.2	11.1	5.2	4.8	5.4	14.0	3.6	13.6	6.0	4.0	9.6	2.3	5.6	4.0	4.4	11.2	5.8	13.4	7.8	3.5	6.7	14.1	15.3	14.1	11.8	5.1	6.1	4.7	4.8	4.6	2.6	3.9	4.7	6.0	2.4	0.3	6.2	2.4	15.8	16.7	3.4	6.9	6.7	2.7	9.5	5.4	7.1	5.9	8.5	11.0	6.2	7.0	8.4	4.7	7.3	4.1	11.0	4.4	2.7	0.3	0.6	0.9	0.6	0.7	0.5	0.2	0.3	0.5	1.3	0.1	0.4	0.3	0.5	0.8	0.4	2.3	0.2	0.3	0.4	0.5	1.7	0.7	0.7	0.2	0.3	0.4	0.2	0.3	0.3	0.5	1.2	0.0	0.0	2.9	1.3	8.2	17.5	4.6	10.8	0.7	2.0	1.1	0.8	1.5	2.2	5.5	2.1	6.3	3.2	3.7	0.0	2.3	1.5	6.0	2.8	1.7	5.4	1.3	9.5	5.0	5.3	2.4	9.2	5.3	0.0	0.7	0.7	4.7	1.9	0.0	7.9	4.2	0.0	0.6	2.7	2.7	0.9	2.6	0.0	6.5	4.9	0.4	0.0	10.1	3.2	4.5	3.1	0.7	7.6	2.6	11.4	1.3	3.6	1.9	0.0	1.1	1.7	1.2	0.8	6.9	7.4	5.1	1.2	3.9	2.4	23.6
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 27.6;liver: 14.5"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 194.5;Intestinal goblet cells: 181.0;Paneth cells: 174.3;Proximal enterocytes: 167.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.0;OE19: 1.7;RPMI-8226: 5.3;T-47d: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.0	0.0	0.0	1.4	0.0	0.4	0.4	0.2	0.2	0.6	0.0	21.3	27.6	0.1	0.0	0.3	0.7	3.7	0.0	0.0	0.0	3.1	14.5	0.1	0.1	0.2	0.1	0.1	3.1	0.1	5.1	0.1	0.0	0.4	11.2	0.0	6.3	0.2	0.0	0.1	27.2	0.1	0.0	0.2	8.9	0.5	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	5.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.7	0.2	0.0	0.0	5.3	0.7	0.0	0.2	0.5	0.1	0.0	0.1	0.4	2.8	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.7	1.5	0.4	11.5	0.3	20.2	0.0	0.0	0.1	194.5	0.0	1.3	0.0	3.0	0.4	0.1	3.6	0.0	0.0	7.5	0.2	0.1	31.6	4.7	0.0	0.1	0.4	10.1	0.1	0.0	0.0	181.0	8.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	174.3	0.0	0.2	0.6	167.3	5.9	1.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.3	0.1	15.6	1.7
ENY2	"DC6, FLJ20480, Sus1"	ENSG00000120533	"ENY2 transcription and export complex 2 subunit"	Q9NPA8	8	109334324-109345954	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024648	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA024648: AB_2100208"	"unprognostic (2.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (7.17e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.66e-1)"	54.4	55.5	28.1	44.7	29.1	87.6	57.0	29.3	45.3	44.2	32.9	59.5	54.5	37.9	53.8	48.2	36.1	29.9	64.2	29.1	32.2	74.4	101.3	40.4	49.6	31.5	30.5	29.5	44.9	47.2	34.4	41.3	30.1	39.0	55.1	24.5	43.7	36.0	71.7	34.7	47.9	44.1	29.8	47.7	47.9	34.8	29.7	60.3	38.0	68.5	53.8	48.4	38.9	30.9	180.3	145.9	213.6	97.1	79.5	101.0	61.4	140.0	89.9	141.2	177.2	109.0	109.1	115.3	127.9	110.9	63.6	89.7	96.8	99.5	171.7	184.1	113.9	223.5	106.7	227.4	85.4	78.3	133.5	77.5	66.7	92.5	87.3	102.2	215.1	111.5	216.5	63.7	162.7	289.9	235.9	175.5	156.1	207.1	140.3	148.4	93.2	144.5	192.5	134.7	128.9	137.5	87.7	109.3	127.2	117.0	138.6	132.3	146.9	94.1	158.9	97.8	144.7	107.9	125.6	222.2	95.2	128.3	112.7	65.6	102.5	93.5	28.9	112.8	36.7	41.4	39.0	35.6	93.8	27.3	31.9	35.8	56.8	42.4	121.8	80.3	42.3	74.5	28.1	29.1	29.3	45.3	29.1	32.2	31.5	30.5	30.1	29.8	29.7	30.9	231.3	70.5	93.8	16.3	135.0	185.6	196.3	305.7	159.9	63.8	149.2	192.7	170.6	138.7	184.6	145.3	123.0	263.3	157.0	171.5	381.5	214.3	173.3	146.4	134.7	226.3	154.2	160.1	22.7	200.0	284.5	161.0	88.7	144.8	91.8	99.3	142.5	371.1	276.8	45.4	23.9	245.1	225.9	230.3	265.7	111.0	148.2	205.0	158.3	17.8	260.9	112.4	126.7	19.6	27.6	251.2	237.1	112.5	147.2	230.3	264.5	546.1	125.0	139.9	78.9	163.9	262.9	208.7	130.4	151.0	174.6	167.3	132.4	143.9	209.1	208.0
EOGT	"AER61, C3orf64, FLJ33770"	ENSG00000163378	"EGF domain specific O-linked N-acetylglucosamine transferase"	Q5NDL2	3	68975217-69013684	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 86.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019460	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA019460: AB_1844628"	"unprognostic (2.62e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (8.97e-5)"	"unprognostic (7.41e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	19.4	9.1	7.2	12.8	7.2	5.9	19.5	6.7	10.9	14.0	22.4	25.8	7.4	29.9	9.8	17.5	18.5	17.8	28.5	7.1	7.0	10.2	5.7	28.7	8.2	7.7	7.6	11.6	12.6	5.0	9.3	22.3	8.0	27.9	8.6	8.8	16.4	33.7	20.0	9.7	11.4	25.4	7.8	10.0	15.5	8.9	7.8	11.1	7.9	15.2	8.8	24.7	13.7	7.5	19.0	7.1	12.5	14.4	16.6	32.2	8.6	25.4	31.5	16.0	21.0	9.1	10.2	1.1	3.8	28.1	13.6	6.0	8.3	32.3	19.9	62.3	5.6	20.2	15.5	13.5	18.7	11.5	8.2	26.8	29.4	20.6	25.1	19.4	86.2	0.8	5.9	11.1	53.7	5.5	2.0	3.8	13.5	6.2	3.5	0.8	12.4	8.2	13.9	43.4	1.2	6.3	29.1	1.7	23.5	12.8	6.0	15.9	44.6	40.6	13.4	5.1	24.3	6.0	20.5	9.3	16.3	17.1	23.8	5.4	1.5	0.0	2.0	1.4	2.3	1.1	3.0	4.3	2.4	0.7	2.5	2.7	0.2	2.4	0.5	0.4	6.6	1.3	7.2	7.2	6.7	10.9	7.1	7.0	7.7	7.6	8.0	7.8	7.8	7.5	29.6	12.8	10.3	14.0	3.5	7.1	11.4	13.2	16.5	2.2	7.5	11.7	20.7	4.3	14.5	1.8	16.7	0.9	3.1	5.1	0.0	4.6	16.5	15.3	7.5	23.7	6.0	3.8	11.2	8.2	5.3	9.3	9.2	15.4	0.0	9.4	20.3	3.6	6.7	0.0	21.4	4.5	2.0	6.8	9.8	15.1	3.1	8.6	8.8	30.9	6.5	1.4	1.0	9.5	12.2	12.4	3.4	40.6	5.4	8.3	2.1	1.9	13.2	5.6	0.0	26.8	15.2	5.5	2.5	14.8	4.5	0.8	7.0	6.9	3.4	8.6
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.4;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 8.4"	"Group enriched"	"Detected in many"	7	"gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0"	"Group enriched"	"Detected in many"	107	"NK-cells: 33.0;T-cells: 26.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 77.5"	"Group enriched"	"Detected in some"	27	"cerebellum: 30.2;olfactory bulb: 12.7"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.0	0.6	0.2	3.2	0.1	1.8	0.6	8.4	0.4	0.4	0.4	0.7	0.4	0.8	0.8	0.3	0.4	1.6	0.3	0.2	0.3	0.4	2.4	2.2	15.0	0.2	0.3	0.5	0.3	0.1	0.2	0.4	0.6	0.5	0.8	1.6	0.9	0.1	0.1	0.2	1.4	0.4	0.3	12.8	1.3	0.4	0.2	1.5	0.5	0.1	5.4	1.3	0.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	1.3	0.0	7.4	1.1	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.8	0.0	0.9	0.3	0.0	8.3	0.2	0.0	0.0	2.0	2.0	0.0	0.2	0.2	0.9	1.3	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	16.5	0.0	26.2	0.0	3.0	19.5	0.0	0.0	0.2	11.9	0.2	33.0	0.1	0.1	0.0	2.9	0.2	0.1	8.4	0.4	0.2	0.3	0.2	0.3	0.6	0.3	0.2	0.4	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.8	1.5	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	16.8	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	2.2	1.6	0.2	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.3	1.3	1.8	1.0	1.1	0.1	93.7	0.0	0.0	0.0	0.0	0.4	9.8	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	2.0	0.0	0.1	0.0	31.5	0.0	0.0	0.0
EP300	"KAT3B, p300"	ENSG00000100393	"E1A binding protein p300"	Q09472	22	41092592-41180077	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000146, HPA003128, HPA004112"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746"	"unprognostic (7.67e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	15.7	13.7	6.8	17.7	8.9	65.1	14.2	20.5	10.8	16.0	6.1	16.6	13.6	17.2	13.5	16.3	16.4	14.2	11.5	7.1	9.4	13.1	15.5	14.7	17.6	10.6	7.8	23.9	18.0	23.2	13.4	19.3	7.7	15.0	14.5	17.8	15.0	15.6	20.4	18.9	16.0	16.4	5.3	17.0	14.5	19.6	8.6	27.2	20.2	23.4	17.9	15.4	14.8	11.2	31.6	21.7	35.4	23.0	22.2	23.3	32.3	15.0	21.8	21.0	21.0	27.8	12.0	32.7	12.2	28.4	18.7	24.1	48.1	20.8	23.5	30.5	32.2	24.4	25.4	22.3	26.9	59.3	26.5	24.8	22.2	30.0	27.0	19.3	24.9	18.7	26.3	43.9	18.3	12.5	16.2	18.9	27.5	38.3	15.2	33.7	16.7	21.3	20.3	40.4	11.3	11.9	51.1	26.0	25.6	29.5	17.8	33.9	31.3	20.3	24.8	16.3	20.8	28.5	14.1	47.9	16.3	17.4	21.5	3.6	1.7	1.6	1.6	1.9	1.5	2.2	1.7	1.7	2.1	1.4	1.4	1.1	4.9	2.7	1.0	1.6	1.4	1.2	6.8	8.9	20.5	10.8	7.1	9.4	10.6	7.8	7.7	5.3	8.6	11.2	45.4	67.3	49.2	58.1	53.8	24.6	22.9	11.6	40.9	44.6	35.1	25.8	31.6	38.6	15.8	25.8	35.5	18.4	63.2	37.0	3.9	16.1	15.3	55.1	56.4	36.2	24.7	60.4	71.8	18.7	17.9	32.0	27.5	72.5	25.3	36.1	32.9	29.2	18.4	25.2	73.6	24.2	2.0	60.7	25.7	6.4	28.9	60.5	8.8	45.9	52.0	27.7	40.2	81.4	80.3	25.8	28.9	30.5	51.2	30.8	20.2	10.8	22.8	30.9	26.3	47.6	36.7	22.8	31.2	35.3	25.9	30.2	46.0	36.7	23.7	36.3
EP400	"CAGH32, DKFZP434I225, KIAA1498, KIAA1818, P400, TNRC12"	ENSG00000183495	"E1A binding protein p400"	Q96L91	12	131949942-132080460	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.0;dendritic cells: 4.7;T-cells: 1.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016704, HPA049013"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA016704: AB_1854888, HPA049013: AB_2680598"	"unprognostic (2.28e-1)"	"unprognostic (4.04e-1)"	"unprognostic (4.33e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.24e-1)"	11.9	14.0	18.5	7.6	15.6	12.2	11.9	15.0	18.1	16.8	9.3	15.7	6.0	14.4	13.2	11.4	15.0	5.9	11.6	18.2	14.6	15.4	11.7	11.3	11.4	14.0	12.1	19.5	12.5	9.5	17.4	6.4	13.1	14.3	6.6	18.1	10.3	8.8	19.3	15.4	13.1	7.3	8.7	18.6	11.7	14.6	15.5	11.7	14.3	8.9	8.6	13.1	12.6	16.5	23.5	30.6	28.3	14.2	16.6	16.3	22.3	13.0	9.9	9.8	8.4	18.3	7.1	19.9	11.8	16.2	11.1	17.6	13.7	13.0	13.2	8.3	20.6	28.5	10.8	20.8	13.7	30.9	21.3	14.0	12.1	18.1	16.3	16.7	16.9	12.7	28.3	5.5	14.3	29.6	23.5	42.1	22.6	12.7	26.3	24.6	19.0	8.1	13.3	28.3	22.8	19.2	15.1	10.4	15.0	20.4	17.4	24.1	25.4	15.6	24.3	17.6	18.9	14.1	11.6	19.8	16.2	17.0	16.0	0.7	0.7	0.6	1.1	0.6	1.1	4.0	1.0	0.9	0.6	4.0	1.2	1.7	0.6	0.6	0.6	4.7	0.7	0.6	18.5	15.6	15.0	18.1	18.2	14.6	14.0	12.1	13.1	8.7	15.5	16.5	19.1	3.2	17.9	44.4	27.8	9.9	10.5	11.0	17.1	34.2	14.0	10.5	13.9	7.2	14.3	16.5	39.6	12.6	22.4	13.2	1.9	11.3	12.5	21.3	25.5	18.6	14.4	14.9	59.6	10.4	11.4	17.3	14.8	21.8	6.3	34.1	15.7	12.1	15.0	25.2	56.4	13.8	12.2	14.1	7.6	6.8	16.4	17.9	7.2	24.4	16.7	15.7	29.9	55.8	48.9	15.3	14.0	17.0	24.3	17.8	8.8	4.2	35.9	37.2	19.7	31.2	20.2	62.8	54.3	20.0	13.1	17.8	26.5	26.9	13.5	13.4
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386697	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 412.0;placenta: 445.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 831.5;Endothelial cells: 425.8;Hepatic stellate cells: 538.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 20.6;eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 267.3;BJ hTERT+: 266.7;HHSteC: 326.3;RT4: 339.8;TIME: 337.8;U-138 MG: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	296.0	52.1	53.4	66.1	48.6	2.3	166.7	44.6	47.7	72.9	139.1	57.1	46.3	87.9	26.0	72.7	80.1	83.2	122.1	39.2	44.7	89.5	110.1	412.0	47.9	60.5	54.2	34.5	59.6	79.4	25.9	445.6	60.2	51.8	42.6	53.6	40.0	66.3	80.5	42.9	50.9	71.7	45.6	84.6	42.8	20.0	75.4	17.9	138.1	153.6	40.3	94.9	47.8	44.6	32.2	33.5	2.1	2.5	153.8	98.6	267.3	98.7	266.7	55.6	60.1	5.8	5.5	0.1	23.8	188.5	55.2	15.2	0.6	79.0	41.3	0.9	1.6	0.0	10.3	71.8	326.3	0.1	19.8	145.0	106.9	108.7	75.8	41.0	193.1	0.7	3.1	0.2	34.2	27.8	0.9	0.8	1.3	22.4	18.5	1.0	3.7	10.5	34.5	339.8	1.4	68.5	77.4	175.5	21.0	68.3	11.7	14.1	337.8	284.0	8.1	38.3	8.4	0.2	0.2	0.1	207.4	5.4	7.4	20.6	0.1	8.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.1	53.4	48.6	44.6	47.7	39.2	44.7	60.5	54.2	60.2	45.6	75.4	44.6	831.5	76.9	151.7	28.4	4.1	48.2	69.8	108.6	43.9	4.5	27.4	29.5	79.2	32.9	124.9	3.7	10.4	126.2	6.6	112.6	1.9	23.0	12.9	36.1	32.7	425.8	4.2	18.7	1.2	52.4	299.9	76.8	32.1	67.6	41.2	2.3	538.7	78.0	55.5	0.0	1.6	13.9	22.4	60.9	30.3	52.7	12.5	21.4	28.4	155.5	0.6	95.5	0.0	31.2	1.3	26.1	53.7	6.4	3.9	57.8	45.9	30.2	31.7	59.3	282.7	23.3	250.5	1.5	4.6	65.0	33.2	349.7	15.9	4.7	23.6	85.7
EPB41L2	"4.1-G, 4.1G"	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 368.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 433.8;Muller glia cells: 472.5;Rod photoreceptor cells: 1272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		54000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	121.0	35.0	57.8	40.9	108.2	10.0	50.1	62.4	90.2	41.4	6.0	59.1	27.5	49.2	24.1	28.6	55.2	39.6	52.5	57.5	58.2	24.3	26.7	58.6	37.7	101.3	65.5	92.6	20.2	14.8	18.0	58.8	102.1	23.6	49.7	368.5	23.3	32.9	38.7	16.0	47.8	43.1	66.8	59.7	26.6	74.5	73.4	30.7	33.7	67.8	26.4	36.0	34.8	120.8	34.0	35.6	78.0	109.5	53.4	85.7	23.9	56.4	72.2	57.9	79.9	67.5	47.7	41.7	102.9	79.6	46.6	17.1	30.6	53.2	114.2	178.4	70.9	74.0	42.5	38.5	31.5	0.1	87.4	42.3	1.1	101.7	38.8	91.8	89.3	62.5	206.1	115.8	37.2	8.5	59.4	13.1	72.6	146.3	38.5	90.9	94.4	4.0	96.5	31.9	8.4	0.3	23.7	0.7	45.4	80.1	12.2	78.3	108.9	66.9	125.0	113.6	172.1	95.6	1.7	38.5	45.8	0.5	103.8	0.1	2.9	0.5	0.9	8.0	0.8	2.5	0.9	1.1	8.2	8.4	1.4	0.6	0.0	1.1	3.2	2.2	2.6	1.2	57.8	108.2	62.4	90.2	57.5	58.2	101.3	65.5	102.1	66.8	73.4	120.8	132.5	6.4	12.0	150.5	17.0	15.4	13.3	5.3	24.5	63.1	10.2	19.9	16.5	21.5	16.0	1.8	225.2	4.4	4.8	54.7	0.0	32.7	332.6	72.3	83.3	92.9	10.2	5.9	300.9	16.6	5.7	120.5	9.7	113.2	44.3	100.3	43.9	5.4	33.5	28.6	144.0	41.9	0.0	166.7	63.3	332.1	73.0	50.8	10.6	433.8	14.0	472.5	2.1	119.1	288.8	57.9	25.0	46.3	10.2	6.2	28.0	10.4	11.2	1272.4	118.3	149.6	89.2	102.8	97.6	12.1	10.2	2.5	9.4	82.8	39.3	7.2
EPB41L4A	NBL4	ENSG00000129595	"Erythrocyte membrane protein band 4.1 like 4A"	Q9HCS5	5	112142441-112419313	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 64.3;Oligodendrocyte precursor cells: 164.4;Oligodendrocytes: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 30.1;HeLa: 36.5;RT4: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036580	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Nucleoplasm	"HPA036580: AB_10669908"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.40e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.65e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-1)"	8.7	4.5	4.8	3.2	5.7	3.6	5.3	4.1	4.8	4.1	9.0	4.0	2.6	4.3	12.7	10.1	7.4	13.8	9.2	6.0	5.1	11.7	3.3	7.7	3.3	5.7	4.6	5.7	4.9	8.0	0.5	9.3	4.8	5.8	4.8	16.0	7.2	5.4	4.2	8.8	3.4	2.7	4.9	4.7	5.6	6.1	4.8	3.6	13.5	4.2	3.6	5.1	2.3	4.8	0.8	5.5	14.3	1.5	0.0	0.0	2.9	2.1	0.0	0.0	0.0	3.0	12.3	6.2	30.1	0.0	0.8	7.4	1.1	6.9	0.0	1.0	5.0	9.8	36.5	2.0	0.1	2.6	3.1	0.0	3.0	0.0	0.0	1.6	9.2	1.7	1.9	5.6	0.0	1.8	4.6	3.5	2.7	1.2	1.1	2.3	10.7	1.3	8.4	21.6	11.8	6.1	10.7	5.2	4.5	9.8	15.9	1.4	15.7	0.7	2.4	1.9	4.4	5.6	1.3	4.6	1.4	5.2	0.8	0.5	0.2	0.1	2.0	0.3	1.1	1.4	0.6	0.6	0.2	1.6	0.9	1.8	0.2	0.1	0.5	0.1	0.6	0.5	4.8	5.7	4.1	4.8	6.0	5.1	5.7	4.6	4.8	4.9	4.8	4.8	55.9	28.9	7.7	17.3	4.7	6.0	16.8	11.2	13.6	5.0	11.2	4.7	8.3	64.3	24.2	14.7	4.2	7.4	4.5	8.5	11.7	15.0	20.8	19.7	3.1	35.2	1.2	2.1	28.6	7.5	0.7	8.4	7.1	17.1	8.8	11.9	34.6	1.7	2.7	1.7	31.8	6.3	16.2	4.6	2.1	23.0	1.8	1.8	3.6	56.2	3.2	8.2	14.4	164.4	65.4	14.1	10.9	1.9	6.5	13.7	1.9	30.4	39.5	32.1	0.0	8.7	6.0	1.8	9.1	16.0	8.1	2.5	3.7	2.2	7.5	19.1
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221018	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 98.9"	"Cell type enriched"	"Detected in many"	33	"Erythroid cells: 480.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	91	"HEL: 85.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA		1400000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	3.1	0.0	0.0	0.0	0.0	98.9	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	2.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	1.9	1.5	0.5	0.0	4.0	0.0	0.0	0.6	1.5	0.5	0.0	6.2	4.5	0.0	1.5	0.0	0.0	14.4	0.0	0.0	1.2	0.0	480.0	0.1	0.0	2.3	0.8	0.0	0.0	4.5	0.0	2.5	1.1	1.1	6.7	0.1	0.9	4.1	2.2	2.8	10.5	2.8	1.1	1.8	0.0	3.6	2.5	14.4	0.0	0.0	0.0	1.7	0.7	0.4	1.5	2.4	0.0	0.6	8.4	6.6	1.0	1.0	13.5	4.6	0.0	2.8	6.7	3.8	0.0	0.8	2.0
EPC1	Epl1	ENSG00000120616	"Enhancer of polycomb homolog 1"	Q9H2F5	10	32267751-32378798	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 149.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028931			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"HPA028931: "	"unprognostic (6.94e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.93e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.80e-2)"	"unprognostic (3.83e-3)"	"unprognostic (7.43e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-3)"	14.4	9.6	12.5	13.9	13.7	149.7	19.4	21.2	14.5	17.5	12.0	15.9	11.5	20.6	15.8	11.1	14.8	12.8	11.9	12.4	12.0	11.9	13.8	14.7	21.5	12.4	12.7	23.4	14.4	14.6	10.3	11.7	13.0	15.0	16.1	19.3	15.0	10.3	22.7	13.8	12.9	16.8	12.5	18.6	13.9	14.4	12.4	31.9	16.8	23.4	17.6	15.2	14.1	16.2	12.0	9.6	21.4	17.9	10.6	14.1	12.4	12.2	6.9	15.6	12.8	10.7	15.1	21.8	8.0	13.6	8.2	12.1	12.1	10.4	10.8	15.9	19.4	18.0	13.5	19.2	11.4	14.1	24.7	12.9	15.8	9.3	7.3	13.9	12.8	18.3	18.8	27.7	12.6	12.9	21.5	10.1	5.3	11.4	8.4	27.7	18.3	11.2	12.1	10.9	18.7	17.8	11.4	8.3	20.1	11.8	8.6	18.7	11.6	9.3	22.7	7.8	10.6	11.3	12.2	35.6	10.0	21.1	8.4	65.8	15.3	36.3	18.9	10.2	16.0	27.4	16.9	15.0	9.1	30.9	17.5	16.1	46.8	13.4	13.2	27.4	21.1	7.7	12.5	13.7	21.2	14.5	12.4	12.0	12.4	12.7	13.0	12.5	12.4	16.2	103.8	41.7	50.9	133.2	166.8	28.6	85.0	54.0	78.6	101.4	69.6	84.3	32.4	52.9	49.2	40.5	68.8	34.9	182.6	55.5	9.8	51.5	11.8	54.1	86.7	70.1	98.6	74.9	108.0	43.6	40.7	71.8	58.1	65.8	85.4	74.9	58.5	35.8	35.2	114.4	106.7	63.9	50.8	55.7	46.8	13.1	94.8	84.4	40.9	134.0	75.4	57.3	148.3	161.9	131.8	49.9	52.3	68.1	139.4	71.6	50.4	20.5	44.1	85.8	98.6	134.9	82.5	77.8	58.3	62.9	24.9	46.1	175.3	56.5	51.0	72.4
EPGN	"ALGV3072, EPG, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308470-74316789	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"esophagus: 49.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.0;Basal prostatic cells: 7.3;Basal squamous epithelial cells: 25.6;Urothelial cells: 5.1"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTCEpi: 157.9;U-2197: 74.8"	"Not detected"	"Not detected"							HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA014420: AB_10601551"	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavorable (2.40e-4)"	1.6	0.1	0.2	1.6	0.1	0.3	1.4	0.4	0.6	5.2	0.1	0.1	0.1	0.0	1.1	49.0	1.5	0.1	0.8	0.2	0.1	0.1	0.2	0.5	0.1	0.2	0.3	0.1	0.1	2.2	0.1	0.5	0.1	0.2	0.0	0.2	3.6	3.1	0.1	3.5	0.1	0.0	0.1	0.3	0.0	1.1	0.1	0.9	0.0	0.0	3.4	1.3	9.6	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.2	0.0	0.0	0.4	0.0	0.8	0.0	0.1	1.8	0.2	3.6	0.0	2.8	0.0	0.0	0.0	0.5	20.2	0.0	0.2	0.0	0.7	0.0	157.9	2.9	11.7	0.0	0.0	0.1	0.6	0.0	0.0	1.0	0.0	0.0	0.3	0.0	3.6	0.4	0.0	0.0	0.3	0.3	0.1	0.0	8.3	3.3	0.0	0.0	0.5	0.0	0.2	0.4	0.1	74.8	0.2	0.0	0.0	0.1	0.7	0.1	0.2	0.7	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.3	0.3	0.1	0.7	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.6	0.2	0.1	0.2	0.3	0.1	0.1	0.1	0.4	0.0	0.0	1.5	0.0	0.0	6.0	7.3	0.9	25.6	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	3.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.0	1.6	0.1	0.2	0.0	0.0	5.1
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107621-89482134	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 31.5"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 70.6;Inhibitory neurons: 106.6;Microglial cells: 103.0;Oligodendrocytes: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	5.4	1.0	2.1	1.8	1.3	0.0	2.3	0.2	3.8	12.3	0.1	3.8	2.3	5.5	0.2	3.2	1.3	18.8	8.2	2.2	0.7	1.3	4.9	2.4	3.6	3.3	0.9	4.1	2.1	1.0	0.9	20.1	4.0	31.5	6.2	8.0	2.2	7.1	0.8	0.7	2.4	7.9	0.8	0.9	2.5	1.0	1.7	1.0	11.0	6.3	3.2	14.3	6.4	2.2	0.0	0.0	197.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	11.2	0.2	0.7	0.0	2.4	0.0	0.0	11.8	0.0	0.0	1.7	2.0	0.0	3.9	0.0	0.0	0.6	0.0	2.5	0.1	0.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.5	0.1	0.1	36.1	0.1	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.2	3.8	2.2	0.7	3.3	0.9	4.0	0.8	1.7	2.2	2.2	0.0	0.0	5.5	0.0	0.5	0.3	0.0	0.6	6.4	0.0	0.1	2.4	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.5	1.8	0.0	0.0	70.6	0.0	0.1	18.1	0.5	0.0	0.0	0.0	1.1	0.0	0.1	20.2	106.6	0.0	0.0	0.0	0.7	1.6	2.1	0.1	0.0	103.0	0.0	4.7	0.0	2.5	48.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	18.7	6.6	0.7	19.2	0.1	0.0	0.3	0.3	0.5	0.2	1.3	0.0	0.1
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 24.2;ovary: 6.3;testis: 8.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 421.5;Early spermatids: 401.8;Excitatory neurons: 423.8;Inhibitory neurons: 879.2;Late spermatids: 208.7"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 24.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 9.3;U-266/70: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA007397: AB_2667821, HPA058047: AB_2683588"	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.2	0.0	6.5	0.0	12.7	0.0	0.2	24.2	10.9	0.8	0.0	3.2	0.1	0.9	0.3	0.8	1.9	0.9	0.3	11.4	0.0	0.4	0.0	0.1	0.0	0.0	0.2	6.3	0.5	0.1	0.1	0.0	1.1	1.0	0.7	1.1	0.1	0.6	0.0	0.0	0.3	1.4	0.1	0.0	0.6	8.4	3.5	0.2	2.0	0.1	0.1	1.4	0.6	0.0	0.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	9.3	0.0	2.2	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.9	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.4	0.0	0.9	28.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	12.7	24.2	10.9	11.4	0.0	0.0	0.2	1.1	0.1	3.5	0.0	0.0	0.0	0.0	421.5	0.1	0.3	0.3	0.0	5.2	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	401.8	0.1	1.4	0.1	0.0	0.0	423.8	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	879.2	0.0	0.0	0.0	0.0	208.7	3.1	0.2	0.0	30.0	0.0	1.0	0.0	31.2	9.0	0.1	0.0	1.5	0.0	0.1	0.0	1.7	0.0	0.3	0.0	0.2	0.1	14.7	2.7	6.0	0.0	0.1	0.0	0.4	0.0	0.1
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 45.1;Enteroendocrine cells: 48.7;Intestinal goblet cells: 61.1;Oligodendrocytes: 76.3;Pancreatic endocrine cells: 63.7;Undifferentiated cells: 97.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 86.5;HUVEC TERT2: 74.2;TIME: 79.2;U-251 MG: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		380000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.1	1.6	2.1	9.2	3.7	0.5	1.6	4.1	4.2	2.5	0.0	22.6	21.0	1.8	1.9	0.6	4.4	3.7	3.3	2.2	4.3	3.8	0.4	1.8	2.9	5.7	4.5	10.6	3.9	6.1	2.9	4.0	4.8	1.9	23.3	2.9	1.5	3.0	0.2	0.9	21.8	3.3	5.0	2.4	1.7	1.8	5.4	1.2	7.3	0.3	1.7	4.4	1.0	8.2	43.4	17.2	17.2	27.7	1.6	1.5	0.0	10.0	0.5	27.3	5.7	6.3	16.6	0.6	20.2	4.0	86.5	39.6	10.8	52.8	7.7	0.1	4.1	0.0	1.9	0.1	16.5	0.0	4.3	5.3	17.5	48.7	0.3	25.4	74.2	2.4	1.8	0.1	5.7	6.4	1.1	0.3	4.0	49.0	11.2	5.3	18.0	0.8	14.7	4.0	18.0	19.3	17.4	0.7	0.2	1.5	1.1	0.5	79.2	11.5	29.6	29.4	69.5	0.0	0.2	0.1	21.8	0.9	0.5	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	4.1	4.2	2.2	4.3	5.7	4.5	4.8	5.0	5.4	8.2	0.4	3.2	0.0	5.5	0.3	0.8	1.7	20.5	0.0	15.4	0.1	0.1	1.3	7.2	8.6	0.0	0.0	0.5	0.1	24.3	0.0	45.1	2.6	1.0	0.8	1.2	48.7	0.0	34.1	8.0	2.8	5.0	1.1	2.4	0.0	0.5	0.4	0.4	9.6	6.7	32.3	61.1	6.1	7.6	1.4	0.8	0.9	7.2	0.0	21.5	0.7	18.4	0.0	5.5	76.3	63.7	12.6	0.7	0.3	2.3	5.5	0.2	1.7	1.8	0.0	0.6	2.1	0.5	3.5	0.0	0.4	1.1	0.3	0.2	97.2	1.1
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 68.9;skin 1: 76.5;vagina: 36.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.5;Club cells: 19.3;Squamous epithelial cells: 30.7;Suprabasal keratinocytes: 43.3;Urothelial cells: 23.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	19	"dendritic cells: 1.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.5;NTERA-2: 2.3;OE19: 8.4;SuSa: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.5	0.3	0.8	0.2	0.8	0.2	1.5	0.6	0.9	14.7	0.7	0.2	0.2	0.4	0.3	68.9	1.7	1.3	0.5	0.7	0.9	3.3	0.3	1.7	0.1	0.9	0.8	0.7	0.2	3.0	1.8	0.4	0.8	1.5	0.2	0.2	7.6	0.9	0.4	76.5	0.3	0.4	0.8	2.6	0.8	2.1	0.9	1.7	0.4	0.1	26.7	8.6	36.6	0.8	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	2.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.3	2.3	8.4	0.3	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	1.3	0.0	0.2	0.8	0.8	0.6	0.9	0.7	0.9	0.9	0.8	0.8	0.8	0.9	0.8	0.2	0.0	1.1	0.0	0.2	7.0	2.6	15.5	0.0	0.4	0.9	0.6	0.5	5.7	19.3	5.5	0.0	1.6	0.0	0.1	1.9	0.5	0.2	0.7	0.4	0.6	0.0	0.0	0.1	0.0	3.4	0.6	0.0	1.7	0.0	0.4	1.1	0.0	0.6	0.0	0.1	0.1	2.0	3.2	1.4	0.0	0.0	1.5	0.0	0.0	0.6	2.5	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.6	0.2	0.0	3.3	0.0	0.0	0.8	2.5	4.6	2.1	30.7	43.3	2.6	0.2	0.2	0.1	23.3
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A glucan phosphatase, laforin"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Glycogen storage disease, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.8;tongue: 79.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Early spermatids: 33.0;Excitatory neurons: 30.4;Inhibitory neurons: 50.7;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.2"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.8	6.0	11.4	1.5	11.7	1.8	3.2	11.9	17.8	3.1	7.3	17.2	3.2	6.0	4.3	9.3	4.4	3.6	24.4	11.6	12.6	8.5	5.7	3.0	3.3	11.9	11.5	5.7	2.4	5.2	3.8	1.5	11.1	6.1	2.9	12.1	3.1	8.8	76.8	2.1	3.8	6.3	10.3	2.1	5.3	3.0	11.5	4.8	3.9	79.5	2.6	9.8	2.7	13.3	1.3	2.1	3.4	6.6	8.6	2.3	1.6	3.1	3.8	2.9	3.5	1.7	1.7	23.2	2.7	3.8	3.5	1.8	1.3	1.6	2.6	9.3	1.9	3.6	2.5	2.7	4.8	12.7	2.4	2.0	7.0	1.7	0.7	3.8	2.0	5.0	1.8	5.4	3.8	3.1	8.4	3.2	3.9	3.2	1.9	4.8	3.1	6.7	2.5	1.8	6.3	6.4	5.5	3.3	7.8	3.1	1.9	7.3	4.6	2.9	1.1	2.7	2.6	4.1	4.6	8.6	2.6	2.8	4.8	0.0	0.0	0.0	0.1	0.5	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.9	0.1	1.9	0.1	0.3	0.0	0.3	11.4	11.7	11.9	17.8	11.6	12.6	11.9	11.5	11.1	10.3	11.5	13.3	3.9	6.4	1.5	66.9	4.4	0.9	1.0	0.8	0.6	8.4	3.5	2.2	27.8	2.8	2.2	1.8	6.2	1.0	1.9	0.2	11.7	1.0	33.0	1.9	3.6	2.2	1.2	4.4	30.4	2.3	0.7	2.3	1.1	1.4	2.5	6.0	1.4	6.6	2.3	30.3	50.7	1.5	2.0	3.3	1.4	19.8	3.1	3.1	7.2	15.9	1.7	7.9	2.1	56.8	60.1	1.2	1.7	2.2	1.7	1.5	0.5	7.1	2.2	6.3	0.0	6.2	2.4	4.9	1.6	0.8	0.4	0.4	1.8	5.1	1.2	0.3
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 387.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 263.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009729, HPA061136, HPA071503"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	57.1	75.3	63.1	27.3	61.2	22.1	53.0	30.3	82.2	51.1	14.8	73.1	88.7	47.8	9.2	80.5	48.7	14.3	148.6	65.2	31.5	85.2	137.1	50.5	19.3	37.8	38.5	76.2	104.3	22.3	51.1	17.4	31.1	64.8	16.2	8.9	50.9	20.0	156.1	71.0	80.4	11.0	27.9	72.8	152.6	80.8	40.0	11.6	49.0	35.3	11.2	50.1	54.5	47.1	95.5	128.8	31.5	64.8	35.6	33.8	64.6	69.3	39.0	48.2	48.0	54.1	58.7	58.1	46.1	55.6	42.5	71.5	27.7	52.9	17.4	20.4	263.2	42.8	67.4	65.3	48.9	27.8	39.3	43.9	45.6	41.7	30.1	34.7	46.4	40.7	64.7	48.0	32.2	53.6	44.4	45.2	72.3	71.4	179.6	29.5	42.8	103.2	36.8	55.3	45.2	109.9	64.1	68.8	48.0	21.7	51.6	95.7	78.4	133.0	63.8	48.4	101.3	52.2	50.9	41.7	97.9	55.0	67.5	1.4	1.8	2.3	0.6	2.2	0.4	1.0	0.6	0.6	1.1	0.8	0.6	0.6	2.1	0.3	3.6	1.7	0.9	1.5	63.1	61.2	30.3	82.2	65.2	31.5	37.8	38.5	31.1	27.9	40.0	47.1	62.6	3.2	20.4	9.8	44.2	31.4	29.0	25.9	44.3	33.3	32.7	25.8	15.5	55.8	17.9	44.1	66.7	46.1	28.1	227.7	119.3	57.1	63.2	39.5	37.5	46.1	45.0	35.3	7.8	88.5	80.8	37.2	145.2	45.9	10.8	87.0	83.9	106.1	62.9	28.6	7.8	115.6	22.4	136.5	21.4	169.4	47.5	55.4	23.2	6.5	40.8	33.6	28.8	4.5	8.9	106.5	167.7	53.0	57.7	37.6	387.2	81.8	20.9	41.3	13.1	41.2	34.6	50.2	62.7	46.6	27.4	52.3	26.3	48.2	132.5	39.2
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532682-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;stomach 1: 37.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 77.9;Distal enterocytes: 27.6;Gastric mucus-secreting cells: 44.9;Intestinal goblet cells: 24.9;Squamous epithelial cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 28.6;HBEC3-KT: 40.3;MCF7: 66.4;OE19: 62.8;RT4: 50.2;SK-BR-3: 25.8;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA055546: AB_2682844, HPA063224: AB_2684964"	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.2	8.9	2.3	0.8	1.3	0.6	2.3	6.4	6.0	6.5	1.2	7.1	6.8	0.4	3.2	35.9	7.5	5.9	7.1	0.7	2.1	6.0	0.1	0.3	0.0	11.5	5.4	13.5	23.0	21.2	0.8	4.2	13.6	9.9	4.4	0.2	11.1	5.6	0.1	30.5	3.2	0.1	0.5	0.0	37.3	2.8	13.4	3.2	1.1	0.0	3.7	5.5	12.9	1.8	20.5	0.3	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	14.7	12.1	0.0	0.2	0.0	0.1	28.6	0.0	40.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.2	0.1	21.8	0.1	3.0	0.0	0.0	0.1	0.0	0.0	0.0	66.4	0.3	0.0	0.0	62.8	0.4	0.0	0.0	0.1	0.2	50.2	0.4	0.0	0.0	25.8	0.0	0.4	57.4	0.2	1.5	0.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.3	6.4	6.0	0.7	2.1	11.5	5.4	13.6	0.5	13.4	1.8	0.2	0.0	0.0	0.0	0.4	2.3	4.4	4.1	10.8	2.9	6.5	3.4	5.4	8.6	8.3	18.4	0.0	77.9	0.0	27.6	5.9	9.2	1.0	3.8	0.6	0.4	3.6	0.0	1.0	11.5	7.4	0.8	44.9	5.5	0.0	3.1	0.0	0.0	5.9	0.0	1.7	24.9	2.0	0.0	0.0	2.1	2.8	0.5	0.0	1.0	0.6	0.6	0.0	0.0	0.0	3.4	10.3	0.0	1.3	4.9	2.1	0.3	4.3	0.9	0.0	0.0	0.8	0.0	0.5	30.0	5.5	10.7	0.2	12.4	19.3	7.8
EPOP	"C17orf96, LOC100170841, PRR28"	ENSG00000273604	"Elongin BC and polycomb repressive complex 2 associated protein"	A6NHQ4	17	38671703-38674957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.4;testis: 10.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 19.3;Breast myoepithelial cells: 13.6;Glandular and luminal cells: 6.4;Syncytiotrophoblasts: 13.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.5;basal ganglia: 8.8;cerebral cortex: 10.4;hippocampal formation: 7.7;white matter: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 47.9;Hep G2: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055190, HPA056555"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA055190: AB_2682731, HPA056555: AB_2683172"	"unprognostic (9.08e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.78e-10)"	"unprognostic (8.97e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	1.6	2.2	4.5	1.7	8.8	0.5	1.1	0.9	10.4	0.9	0.5	0.8	0.3	1.2	0.8	1.9	1.1	0.9	1.2	7.7	0.9	1.6	3.8	1.1	2.7	1.4	1.7	0.8	3.7	4.8	0.8	1.3	1.6	1.4	0.4	2.2	0.8	0.9	0.6	3.3	0.9	0.7	1.3	1.1	1.3	10.0	1.7	1.5	0.6	0.3	3.5	2.9	0.7	5.4	9.2	10.8	6.8	47.9	1.5	0.4	11.7	1.9	0.7	2.1	3.3	10.8	3.3	17.1	11.6	1.2	6.1	7.3	22.6	4.6	3.7	18.2	17.1	3.8	1.5	57.3	3.1	2.1	9.0	1.0	8.0	2.3	4.6	4.4	1.6	18.8	12.0	25.9	1.4	14.4	15.8	5.1	1.5	6.0	9.6	37.3	3.9	37.8	1.3	2.4	10.4	15.8	6.0	7.8	2.1	11.0	11.4	7.2	2.7	2.0	2.0	2.2	1.8	13.5	16.1	21.7	3.9	25.4	7.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	8.8	0.9	10.4	7.7	0.9	1.4	1.7	1.6	1.3	1.7	5.4	4.4	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	19.3	13.6	0.0	0.0	1.3	1.8	0.0	1.7	3.5	0.0	0.0	4.2	0.0	3.4	4.8	1.8	0.0	0.0	0.0	4.0	1.5	1.0	0.0	6.4	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	13.1	0.6	0.8	0.0	0.0
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 72.8;Inhibitory neurons: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		30000000	"Cluster 34: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: AB_2677946"	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	51.5	15.8	3.7	37.0	4.3	27.9	25.5	3.1	5.6	21.8	2.3	37.9	63.4	22.0	14.4	13.2	25.5	23.7	17.1	3.4	5.2	16.4	32.9	31.2	38.2	8.4	5.7	20.7	13.7	19.1	8.2	47.0	7.0	18.6	43.7	12.4	19.3	22.0	20.9	36.5	55.1	21.7	5.0	30.8	33.7	9.1	6.6	63.7	17.5	19.6	36.8	27.3	11.7	6.8	25.9	14.1	21.3	20.0	114.7	111.5	61.4	18.3	59.6	44.0	76.2	17.6	91.1	75.3	37.6	36.0	61.8	25.7	17.8	38.1	27.3	139.8	7.5	24.7	10.0	13.9	130.9	12.0	44.1	46.8	16.2	50.6	15.5	64.3	61.1	48.8	12.9	74.7	26.7	11.6	113.2	12.4	10.6	3.1	10.4	82.4	28.8	38.4	32.8	39.0	7.8	5.5	29.6	19.8	28.6	14.6	17.1	57.0	48.8	37.4	12.6	6.2	31.1	26.9	53.9	57.8	40.2	40.2	22.5	28.8	15.2	18.0	22.6	12.3	20.2	14.8	19.2	19.1	10.5	18.3	22.3	18.1	15.8	23.1	20.6	16.7	13.9	13.7	3.7	4.3	3.1	5.6	3.4	5.2	8.4	5.7	7.0	5.0	6.6	6.8	11.1	9.6	16.3	34.0	15.3	25.0	14.2	19.2	8.6	13.6	6.6	3.9	10.6	10.0	16.9	9.2	2.1	9.6	21.1	24.4	0.0	12.4	27.0	12.7	15.0	16.3	10.3	14.1	72.8	15.5	11.9	18.4	16.3	19.8	15.2	13.9	16.8	28.0	17.6	3.3	79.3	23.9	4.1	29.9	16.1	7.3	9.9	22.9	7.2	24.4	32.5	9.0	20.6	32.6	70.1	12.3	14.1	16.1	32.3	13.5	47.3	6.9	23.1	7.6	0.0	10.3	22.6	1.4	1.8	9.8	11.1	9.2	21.8	5.7	27.3	14.9
ERCC1	RAD10	ENSG00000012061	"ERCC excision repair 1, endonuclease non-catalytic subunit"	P07992	19	45407334-45478828	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cataract"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004390, HPA029773, HPA050182, CAB072859, CAB072860"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"CAB004390: AB_2278023, CAB072859: AB_2665703, CAB072860: AB_2665704, HPA029773: AB_10602129, HPA050182: AB_2681044"	"unprognostic (1.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.57e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (9.00e-5)"	"unprognostic (6.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-1)"	47.0	49.8	34.7	28.0	33.9	31.4	50.7	37.6	42.6	50.5	44.8	45.1	26.2	47.9	40.2	43.1	43.7	30.3	109.1	35.9	37.2	57.8	38.3	40.4	30.0	38.7	35.5	54.2	57.1	48.9	56.9	22.9	37.3	55.2	20.8	23.2	70.6	29.2	84.0	63.3	40.1	33.4	35.4	43.1	42.9	27.8	36.2	24.1	46.9	83.1	30.5	41.5	44.3	36.6	61.1	104.0	84.2	125.8	57.8	108.1	27.3	90.1	119.1	106.4	141.4	12.0	58.8	34.5	24.9	94.2	57.2	45.0	26.0	277.7	65.1	79.1	28.6	57.9	39.3	36.2	120.2	55.9	96.8	81.0	60.3	111.7	99.5	89.0	117.3	40.8	33.8	69.8	167.9	40.3	50.9	44.4	20.9	54.4	42.4	77.7	40.5	46.3	78.5	36.7	36.6	76.2	58.4	47.3	79.6	27.7	55.0	103.7	70.3	97.7	91.4	59.2	93.8	49.5	43.2	39.5	105.3	45.8	296.6	30.7	131.9	26.3	61.3	142.8	41.7	75.8	37.3	48.6	134.7	84.1	29.4	47.4	17.8	60.6	107.9	315.8	49.8	90.2	34.7	33.9	37.6	42.6	35.9	37.2	38.7	35.5	37.3	35.4	36.2	36.6	43.2	22.4	36.3	13.1	53.4	70.9	109.7	82.7	41.5	0.0	73.9	76.8	39.1	37.1	43.9	20.2	0.0	36.1	67.8	26.9	90.1	54.5	27.1	50.4	43.5	37.5	39.6	20.2	32.9	65.9	33.3	62.4	22.4	24.5	50.0	103.4	38.9	29.6	96.2	0.0	21.9	41.2	34.6	61.5	71.7	107.1	79.2	69.6	67.6	17.8	49.0	0.0	38.1	16.6	13.8	85.3	33.5	57.2	49.1	94.9	69.2	73.1	67.5	0.0	46.0	60.5	60.0	37.0	37.1	51.4	52.8	35.6	36.0	98.6	43.2	89.0
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 34.1;Spermatocytes: 30.5;Theca cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104"	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	6.8	13.0	10.5	6.9	10.3	4.8	6.5	8.4	11.7	7.5	8.4	7.5	4.9	9.7	3.2	6.3	8.0	4.1	7.0	10.8	9.3	7.6	9.0	5.8	5.8	10.6	9.9	7.8	7.7	7.7	9.7	4.5	9.6	6.7	4.0	3.1	7.3	6.7	11.7	7.2	6.6	6.9	8.1	8.1	7.5	13.9	10.1	5.3	8.4	6.3	5.2	7.5	5.9	8.9	28.0	13.3	27.1	38.4	16.3	19.4	15.2	38.8	27.4	50.2	40.2	32.6	18.6	10.0	21.6	39.9	19.1	14.0	19.1	32.9	18.5	24.4	31.8	16.9	26.8	35.4	33.3	27.1	28.4	22.4	5.6	55.8	31.9	28.2	29.1	28.8	41.8	10.9	34.8	14.7	16.1	17.9	12.7	27.2	24.6	30.3	19.4	8.3	14.0	24.9	15.8	17.1	34.2	23.9	13.6	20.6	22.8	35.4	37.9	46.4	25.3	19.9	88.0	24.9	15.8	14.2	13.8	16.4	21.2	0.0	17.2	6.5	9.1	18.0	11.9	9.1	8.9	8.9	21.8	6.5	8.2	8.7	0.5	15.6	14.9	10.4	9.8	12.1	10.5	10.3	8.4	11.7	10.8	9.3	10.6	9.9	9.6	8.1	10.1	8.9	4.2	6.4	3.4	6.2	5.8	6.2	5.5	8.6	4.6	0.0	6.1	4.3	6.7	8.6	8.7	5.5	0.0	10.5	4.1	5.9	13.7	10.7	4.7	3.3	4.5	5.5	7.2	5.5	2.9	8.2	12.1	6.8	6.1	3.8	0.0	34.1	7.9	12.3	11.5	0.0	3.1	8.5	4.1	8.2	4.2	2.8	6.5	6.3	3.6	1.0	4.2	0.0	5.2	5.0	1.4	8.1	3.1	7.9	7.5	4.2	4.1	13.0	7.5	0.0	0.0	3.5	9.9	30.5	13.1	5.1	5.7	4.8	4.7	29.1	8.8	3.2
ERCC3	"BTF2, RAD25, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037153: AB_796181, HPA046077: AB_2679527"	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavorable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	24.4	25.9	15.0	14.5	16.0	19.8	24.4	15.1	16.5	32.2	19.6	28.9	9.6	27.0	11.6	22.7	28.9	14.2	23.4	16.6	14.9	22.8	22.2	22.1	21.6	15.7	14.8	29.5	23.8	26.3	33.8	13.6	16.0	27.4	13.8	4.4	23.2	16.8	35.3	27.7	24.3	21.5	15.1	32.6	23.7	29.8	15.6	26.6	25.0	25.6	22.4	27.2	26.4	15.2	45.9	30.8	37.8	40.6	40.6	27.8	46.4	41.3	52.9	65.1	62.5	48.1	32.9	34.5	33.2	37.8	41.7	40.2	57.7	43.3	56.1	54.4	51.4	43.6	35.8	51.0	30.5	38.1	45.4	28.9	39.8	75.7	32.4	41.5	42.4	44.3	43.0	22.1	41.7	45.1	54.8	42.2	55.0	29.2	47.3	44.5	42.7	28.8	36.4	42.2	45.2	49.2	35.3	52.6	55.0	42.4	28.7	43.0	34.1	39.2	45.2	35.8	49.7	39.2	81.5	54.0	34.3	18.0	42.8	8.0	11.5	8.8	18.2	12.0	18.4	13.7	13.1	15.7	16.9	12.7	17.7	12.2	3.5	25.0	9.9	13.6	20.5	15.5	15.0	16.0	15.1	16.5	16.6	14.9	15.7	14.8	16.0	15.1	15.6	15.2	12.2	22.4	14.6	24.8	17.7	7.6	9.5	20.6	21.1	0.0	13.0	11.6	13.0	5.7	25.4	7.3	0.0	18.6	18.9	6.1	1.9	13.7	9.0	22.9	13.9	12.2	6.1	3.8	22.3	14.9	12.2	16.6	18.8	13.1	10.1	17.1	15.4	8.6	14.6	0.0	23.5	10.0	14.2	12.5	7.6	5.1	16.4	10.7	8.8	10.3	12.3	0.0	14.4	18.1	22.4	15.5	7.3	12.8	16.4	7.4	6.3	8.5	45.2	0.0	13.1	17.6	13.3	41.1	31.0	11.3	9.5	14.6	15.7	12.3	10.6	8.5
ERCC4	"FANCQ, RAD1, XPF"	ENSG00000175595	"ERCC excision repair 4, endonuclease catalytic subunit"	Q92889	16	13920154-13952348	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Disease variant, Dwarfism, Fanconi anemia, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 140.7;Late spermatids: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000156, HPA045828"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB000156: , HPA045828: AB_2679463"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.41e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.88e-4)"	2.7	3.9	4.7	3.3	5.2	2.5	2.8	6.7	5.4	3.3	4.3	1.9	1.7	3.3	2.8	2.9	3.5	3.0	3.6	4.3	4.9	2.9	3.2	2.7	3.3	5.1	4.8	4.3	2.7	3.9	1.6	2.6	4.9	3.6	2.2	4.1	2.8	2.9	18.5	3.0	1.9	3.6	4.4	3.7	2.6	5.5	5.4	4.2	4.4	3.3	2.9	2.6	1.5	6.8	4.7	5.5	5.3	7.5	8.7	8.1	4.0	6.1	6.4	5.4	6.8	2.1	4.5	7.8	8.6	5.4	4.8	5.8	8.0	4.1	8.3	10.7	4.7	3.8	6.7	5.2	7.9	5.2	4.2	6.1	5.7	7.1	6.0	5.3	7.2	4.6	6.1	8.8	7.6	3.9	7.0	3.4	3.9	2.4	3.1	7.8	10.8	9.7	3.3	3.2	4.3	5.1	7.5	6.0	5.8	4.2	7.5	3.9	7.9	7.8	5.7	7.0	5.4	7.9	9.9	5.2	7.6	6.2	8.1	4.9	2.3	2.3	2.6	2.7	2.9	2.5	2.4	2.0	2.3	3.1	2.4	2.6	2.7	3.6	2.4	3.2	2.5	1.1	4.7	5.2	6.7	5.4	4.3	4.9	5.1	4.8	4.9	4.4	5.4	6.8	14.0	19.2	13.5	16.6	11.3	4.8	6.1	18.3	10.2	0.0	10.0	9.5	8.6	14.3	12.7	5.5	0.0	17.3	9.7	3.3	9.8	11.6	140.7	18.6	19.0	13.5	9.6	12.0	20.4	8.4	6.2	13.0	5.1	7.4	1.3	17.8	17.2	17.7	11.7	0.0	21.2	4.8	10.2	13.6	6.5	117.9	14.9	11.4	10.6	8.4	14.4	0.0	17.5	12.1	20.1	9.9	1.7	21.1	14.4	10.2	4.4	13.3	26.1	0.0	26.3	17.3	12.2	49.4	28.9	9.2	5.5	12.3	11.8	18.0	6.0	4.7
ERCC5	"ERCM2, XPGC"	ENSG00000134899	"ERCC excision repair 5, endonuclease"	P28715	13	102845831-102875995	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.7;Gastric mucus-secreting cells: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045845, HPA050374"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA045845: AB_2679471, HPA050374: AB_2681106"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.19e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.77e-3)"	"unprognostic (5.76e-3)"	"prognostic unfavorable (2.96e-6)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (6.82e-4)"	14.1	11.1	7.8	10.9	8.6	16.3	14.5	8.9	11.8	12.2	10.5	14.5	20.1	9.2	13.4	10.7	9.7	10.8	9.8	8.1	8.2	12.6	21.8	12.8	15.2	8.5	8.2	12.5	11.3	12.3	3.7	11.3	8.5	11.7	14.3	12.6	10.5	10.8	9.5	13.2	17.1	9.6	8.0	15.2	16.3	7.0	8.4	21.3	13.5	10.8	16.5	11.2	3.9	8.4	21.5	10.5	15.4	7.4	34.4	30.5	8.9	24.5	31.1	13.6	16.7	10.8	37.9	19.3	10.4	23.4	9.4	23.8	14.3	19.6	10.1	19.4	9.7	16.6	23.7	13.3	15.9	50.9	26.3	26.1	19.2	15.7	25.6	19.6	23.1	23.4	9.5	16.5	23.9	8.0	18.7	23.5	7.7	30.2	9.9	14.9	10.9	17.9	19.3	15.7	9.0	14.1	12.6	25.0	8.8	13.6	13.9	43.4	21.4	7.5	5.5	3.7	13.1	16.1	5.0	9.4	41.3	20.7	10.9	19.2	11.9	20.4	16.2	15.0	14.6	8.9	17.1	19.8	14.3	8.8	18.4	18.2	3.5	20.5	21.1	7.4	20.7	17.7	7.8	8.6	8.9	11.8	8.1	8.2	8.5	8.2	8.5	8.0	8.4	8.4	2.2	3.2	9.5	0.0	22.2	7.1	4.7	11.5	16.5	0.0	2.0	2.0	28.6	14.3	14.0	0.0	0.0	9.6	7.3	17.6	0.0	1.6	60.7	2.4	4.8	8.6	4.9	24.8	0.0	1.2	7.5	11.0	44.9	2.1	19.0	1.7	13.2	21.2	10.5	0.0	0.0	22.3	10.2	17.2	6.5	28.3	22.1	14.0	7.2	0.0	12.6	0.0	19.6	0.0	0.0	1.7	16.7	15.8	21.5	4.0	26.6	1.5	11.4	0.0	19.7	10.6	6.7	11.6	6.3	19.1	7.0	5.7	31.3	1.7	18.2	5.0
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"P0DP91, Q03468"	10	49454168-49539538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 53.8;hTERT-RPE1: 123.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"HPA071297: AB_2732177"	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	2.7	2.1	1.6	1.9	1.5	4.6	3.8	3.0	2.3	3.1	7.7	2.4	2.0	3.0	1.5	3.8	2.9	2.7	3.4	1.2	1.1	3.2	3.3	2.7	2.9	2.4	1.9	4.5	3.1	5.9	2.8	3.4	2.1	3.3	2.7	3.1	3.2	2.2	3.5	4.6	2.5	2.3	2.2	2.9	2.4	3.1	2.1	3.3	5.1	3.6	3.4	2.6	3.3	1.9	11.2	5.5	4.1	2.1	6.6	10.5	3.4	21.2	27.1	14.1	9.9	6.2	5.6	4.9	3.7	18.7	6.7	9.5	6.3	16.6	13.5	8.4	4.1	3.9	21.7	3.4	3.9	5.0	3.7	4.3	17.2	12.9	53.8	123.4	19.8	2.9	6.8	0.8	16.8	8.3	3.4	2.0	4.0	3.5	10.2	2.3	5.8	2.6	4.1	7.1	5.9	4.7	15.4	3.6	8.2	9.4	7.1	2.7	38.9	7.0	5.5	8.6	5.2	3.3	4.5	4.1	7.3	5.0	5.1	13.1	3.0	7.5	4.1	2.6	3.0	6.8	2.3	2.2	3.9	5.2	2.8	1.4	7.2	1.2	5.3	2.2	3.1	1.8	1.6	1.5	3.0	2.3	1.2	1.1	2.4	1.9	2.1	2.2	2.1	1.9	6.9	16.0	13.2	14.7	6.0	3.6	1.4	1.5	5.2	0.0	7.1	7.1	7.1	5.7	8.2	9.2	0.0	2.5	10.9	4.8	5.9	5.2	11.3	8.1	8.7	5.1	1.2	1.3	24.3	6.0	2.1	4.9	2.0	10.1	7.6	8.9	5.3	4.3	2.6	0.0	21.7	5.3	0.0	4.4	2.6	15.3	2.8	8.0	1.8	23.4	11.2	0.0	4.1	17.6	16.6	5.2	2.6	2.2	3.6	2.5	5.0	3.6	9.0	0.0	6.6	4.4	4.2	5.3	5.0	3.5	4.1	1.8	7.4	11.4	2.8	1.9
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239027	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2;lymphoid tissue: 3.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.4;Granulosa cells: 2.5;Spermatocytes: 2.1;Spermatogonia: 2.4;Squamous epithelial cells: 2.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: AB_2681145"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.1	0.1	0.1	1.3	0.2	3.2	0.4	0.8	0.2	0.4	0.1	0.9	0.7	0.2	0.2	1.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.1	0.0	0.3	0.1	0.0	0.1	0.5	0.1	0.1	1.1	0.5	0.3	0.0	0.1	0.6	0.6	0.3	0.0	0.5	0.7	0.8	0.2	3.6	0.1	0.0	2.7	0.2	0.4	0.6	19.0	16.3	14.6	9.3	1.0	1.7	8.0	19.8	9.1	17.0	17.7	13.3	11.6	30.5	7.3	7.2	23.0	15.2	27.8	14.8	30.1	17.5	20.2	10.5	5.5	7.9	0.0	20.7	14.2	0.2	0.9	23.7	4.4	2.8	9.6	15.1	14.1	7.3	17.6	14.8	19.8	12.1	26.6	18.3	24.8	16.4	26.2	5.4	4.4	11.5	12.0	8.6	14.7	9.8	3.6	11.8	7.5	4.6	6.0	11.4	18.3	21.8	13.1	5.7	9.4	25.9	8.1	14.1	11.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	1.7	0.1	0.1	0.4	0.1	0.1	0.2	0.8	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.3	0.6	0.5	1.5	0.2	0.0	0.0	1.1	0.9	0.6	0.0	0.0	0.3	0.9	0.8	0.3	0.0	3.4	0.9	0.0	1.7	0.5	0.0	0.5	0.0	2.5	0.0	0.0	1.0	0.0	0.7	0.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.4	2.1	2.4	2.4	0.1	0.4	0.3	0.2	0.9	0.1
ERCC6L2	"C9orf102, FLJ37706, HEBO, RAD26L"	ENSG00000182150	"ERCC excision repair 6 like 2"	Q5T890	9	95871264-96121154	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.8;Excitatory neurons: 90.1;Inhibitory neurons: 88.5;Oligodendrocyte precursor cells: 130.7;Oligodendrocytes: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021259, HPA021260, HPA021271, HPA022422"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"		"HPA021259: AB_1859542, HPA021260: AB_1859544, HPA021271: AB_1859543, HPA022422: "	"unprognostic (6.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (8.70e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.39e-2)"	3.2	3.8	3.3	2.6	4.6	5.1	4.1	5.8	4.2	4.4	3.6	4.0	2.6	4.7	3.5	3.2	3.2	3.4	2.9	4.3	3.8	3.8	3.6	3.2	4.4	3.3	3.4	5.0	2.9	5.5	2.1	3.8	4.1	4.3	3.5	5.4	2.8	4.1	3.7	3.0	2.7	4.2	3.0	4.7	4.2	4.5	3.4	6.8	5.5	3.8	3.9	3.4	2.7	6.9	5.4	8.5	8.3	9.0	5.2	4.3	3.7	5.9	7.8	8.1	5.9	8.9	4.4	6.6	2.6	9.5	10.5	8.0	12.0	5.0	8.6	3.9	3.8	8.2	7.5	5.4	4.8	9.4	6.0	5.2	2.9	8.2	6.0	3.4	6.0	7.9	8.2	3.7	4.5	6.4	8.2	4.9	6.0	6.1	5.1	6.3	14.5	2.7	5.3	5.7	7.7	6.0	5.8	4.3	4.1	4.9	5.6	4.0	7.6	8.1	6.7	9.3	6.8	3.0	4.0	3.6	6.5	5.8	7.0	1.2	1.9	2.0	3.7	1.7	4.8	2.6	4.2	3.9	2.0	4.3	5.1	5.1	1.5	2.7	3.0	5.4	3.2	1.1	3.3	4.6	5.8	4.2	4.3	3.8	3.3	3.4	4.1	3.0	3.4	6.9	20.2	16.0	16.2	105.8	13.8	5.0	12.6	7.2	12.5	0.0	6.6	6.2	18.8	8.6	13.5	0.0	0.0	6.3	18.3	7.5	0.0	8.8	7.8	9.0	32.4	12.9	4.9	12.4	90.1	8.2	3.5	19.3	11.7	11.3	15.2	24.9	8.6	6.6	6.3	0.0	88.5	8.4	6.1	11.1	3.8	3.8	26.8	10.8	3.6	62.8	13.7	0.0	12.3	130.7	117.9	8.3	4.5	27.8	13.5	9.7	7.2	4.0	15.5	0.0	19.7	26.1	19.9	17.0	11.1	12.2	4.4	4.8	15.7	45.9	6.4	9.5
ERF	"PE-2, PE2"	ENSG00000105722	"ETS2 repressor factor"	P50548	19	42247569-42255128	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 157.0;Suprabasal keratinocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058532, HPA067952"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA058532: AB_2683744, HPA067952: AB_2685932"	"prognostic favorable (8.07e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.27e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.54e-2)"	38.2	31.8	21.1	21.9	23.7	15.2	35.1	16.5	24.3	35.8	10.4	37.1	34.4	48.2	17.4	25.6	49.9	50.1	37.8	19.5	23.9	37.5	43.4	41.6	20.0	22.3	22.5	43.0	29.1	21.0	40.3	18.5	19.5	30.9	10.0	14.6	26.4	17.2	11.6	33.5	34.4	19.9	17.5	31.4	29.8	32.8	21.9	24.2	38.7	18.0	15.6	29.7	31.3	37.7	57.6	136.4	57.7	65.8	12.7	32.4	16.4	53.3	37.4	53.5	54.0	63.2	65.1	47.4	32.9	49.3	48.0	61.7	42.1	124.4	39.2	23.5	29.1	28.5	82.9	80.1	34.3	33.2	45.5	37.1	41.3	41.4	45.5	69.6	45.0	37.9	62.0	38.4	29.8	115.8	38.0	25.0	48.5	54.4	29.3	46.6	21.0	20.1	33.5	49.1	26.6	54.2	59.4	43.4	61.8	39.1	43.6	58.7	54.2	78.4	112.9	27.4	100.0	43.2	53.1	39.0	76.9	35.3	108.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	21.1	23.7	16.5	24.3	19.5	23.9	22.3	22.5	19.5	17.5	21.9	37.7	63.3	3.2	1.7	7.8	25.0	157.0	30.2	19.8	77.4	14.1	95.0	57.9	7.3	25.8	6.3	9.2	22.9	7.2	21.7	21.6	7.9	19.1	9.4	35.1	20.5	43.7	26.4	7.8	4.2	15.8	4.9	27.2	13.7	23.4	11.4	10.0	41.4	30.2	11.7	10.1	1.5	22.9	2.0	14.5	58.6	4.1	11.1	22.9	55.2	7.5	7.3	19.0	3.1	3.5	8.5	15.3	27.2	10.1	11.2	18.8	34.6	23.3	11.9	12.3	13.1	61.0	39.8	3.0	16.2	37.9	109.7	14.8	25.5	10.2	21.7	17.6
ERG	"erg-3, p55"	ENSG00000157554	"ETS transcription factor ERG"	P11308	21	38380027-38661780	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.4;Endothelial cells: 105.5;Hepatic stellate cells: 69.9;Microglial cells: 88.1"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 138.3;MOLT-4: 47.7;REH: 151.5;TIME: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018377, HPA046598"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"CAB018377: AB_675518, HPA046598: AB_2679715"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (6.44e-3)"	"unprognostic (8.64e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.03e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.63e-3)"	24.6	4.1	5.1	7.1	5.5	7.6	20.0	5.0	5.5	10.0	3.0	5.4	3.4	11.6	1.9	5.2	9.1	12.0	12.4	4.5	5.1	12.8	6.1	19.6	7.5	5.9	5.4	4.4	4.9	2.4	2.4	24.3	6.2	7.1	3.4	0.5	3.7	4.3	7.9	4.9	6.5	12.0	4.7	26.6	4.6	1.5	7.0	4.1	10.0	9.9	3.7	9.2	6.9	5.4	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.2	22.3	0.0	0.1	0.9	0.0	0.0	138.3	0.1	0.0	0.0	0.0	1.0	47.7	0.0	0.5	0.0	0.0	151.5	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	113.4	0.7	2.2	0.5	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	5.5	5.0	5.5	4.5	5.1	5.9	5.4	6.2	4.7	7.0	5.4	94.4	0.0	3.9	0.3	0.7	3.4	1.7	0.6	3.4	0.0	0.6	4.3	3.8	4.3	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.7	0.4	105.5	0.0	13.5	13.3	0.0	0.0	5.7	0.0	2.1	24.0	4.4	69.9	1.3	0.3	0.0	1.7	0.4	0.0	5.9	3.4	2.1	0.9	0.9	3.6	88.1	0.2	0.0	0.0	7.1	1.4	0.0	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.1	0.0	2.4	3.7	0.3	1.4	0.5	3.4	0.0	0.6	0.5	0.3	0.6
ERGIC1	"ERGIC-32, ERGIC32, KIAA1181, NET24"	ENSG00000113719	"Endoplasmic reticulum-golgi intermediate compartment 1"	Q969X5	5	172834251-172952683	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 247.8;Intestinal goblet cells: 202.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018666, HPA018900"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Vesicles"		"HPA018666: AB_1848241, HPA018900: AB_1848242"	"unprognostic (8.86e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.71e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.06e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.22e-2)"	67.3	147.8	33.4	49.1	31.2	44.9	60.3	47.4	35.4	127.2	26.7	97.7	79.5	67.4	75.3	55.0	72.4	50.2	60.9	35.8	31.8	66.1	193.2	77.8	40.8	41.4	36.4	56.9	80.6	50.7	48.5	47.9	38.1	146.8	102.7	21.6	97.6	69.8	92.3	46.7	79.4	64.1	33.0	69.2	107.1	25.3	41.3	83.1	75.2	91.9	55.0	58.3	54.3	34.0	120.2	112.8	95.0	211.6	353.3	262.0	51.9	239.5	179.3	105.5	97.4	159.5	120.4	114.8	166.9	406.4	181.7	43.2	68.5	316.8	123.3	92.0	67.5	70.7	156.1	86.1	258.9	33.3	21.6	223.8	128.6	155.8	143.8	173.8	171.0	117.8	42.6	156.8	177.1	150.4	96.5	57.6	56.0	283.7	101.4	327.4	62.9	358.5	245.2	68.6	52.9	96.0	82.7	234.7	120.6	91.1	98.0	37.4	132.4	171.3	69.1	165.9	99.2	246.8	294.0	47.5	236.9	78.3	76.2	3.7	7.5	19.2	3.1	10.5	5.2	9.3	1.6	2.1	6.1	6.2	1.0	2.3	30.6	14.3	14.3	3.1	1.0	5.1	33.4	31.2	47.4	35.4	35.8	31.8	41.4	36.4	38.1	33.0	41.3	34.0	41.9	57.7	29.5	22.9	62.0	22.8	32.1	22.7	14.8	37.2	51.2	35.1	32.9	68.6	29.4	49.7	16.7	20.7	44.3	83.6	21.5	101.9	11.5	36.2	48.0	33.5	26.0	25.9	35.4	60.8	90.3	47.2	49.5	77.9	23.5	64.4	37.5	247.8	41.1	21.9	41.8	202.9	36.7	77.0	105.2	33.8	65.0	54.8	7.2	30.0	91.1	39.0	36.0	47.7	30.6	86.9	59.3	58.3	96.2	74.2	95.0	38.5	28.4	12.6	39.5	56.1	41.1	1.9	10.5	27.2	26.9	9.0	25.1	103.5	73.3	47.8
ERH	DROER	ENSG00000100632	"ERH mRNA splicing and mitosis factor"	P84090	14	69380128-69398299	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002567	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes		190000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA002567: AB_1078749"	"unprognostic (2.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (8.61e-3)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.39e-1)"	107.7	113.7	143.3	119.0	146.2	144.4	119.3	145.1	186.7	97.0	146.9	110.5	110.0	111.9	150.3	75.5	112.8	70.1	100.2	145.4	159.1	118.3	142.5	76.3	147.1	142.8	146.8	107.0	66.7	128.2	58.3	98.1	147.6	87.0	122.9	116.7	110.0	84.3	107.0	58.1	99.1	114.8	153.7	96.5	88.7	91.1	149.6	212.2	97.6	85.8	168.4	117.0	51.2	154.5	972.7	574.9	704.6	409.1	271.8	201.1	356.9	450.7	261.3	401.3	372.0	598.5	403.1	879.9	224.3	305.3	340.3	296.1	563.4	376.9	484.2	437.9	428.3	441.4	366.1	731.8	419.6	389.3	334.6	227.1	203.0	355.9	317.2	239.2	337.8	584.5	454.0	301.6	335.7	1043.2	714.1	750.8	537.2	525.6	686.0	558.9	599.9	320.6	415.4	672.8	449.1	439.8	442.1	464.6	355.6	330.8	539.9	564.4	351.4	425.7	699.7	286.7	480.0	351.7	336.2	1096.1	345.1	417.5	442.4	76.6	101.4	80.9	76.6	98.9	77.5	122.2	100.0	88.0	107.4	94.3	92.7	88.2	45.3	121.5	95.1	122.8	116.5	147.0	143.3	146.2	145.1	186.7	145.4	159.1	142.8	146.8	147.6	153.7	149.6	154.5	231.2	60.9	54.3	22.2	189.1	273.1	225.0	702.7	180.4	126.4	244.2	314.2	118.9	181.6	282.2	253.8	37.5	455.3	179.4	117.5	673.1	363.8	100.4	238.1	198.9	211.9	188.5	252.6	23.9	275.3	560.3	237.0	120.3	158.7	127.6	186.7	169.6	239.9	341.5	74.0	23.1	244.0	510.6	147.5	215.2	51.3	270.9	162.5	307.7	16.9	302.3	350.3	174.0	19.6	34.6	289.8	183.9	259.2	237.9	288.9	203.9	508.5	278.4	119.8	190.7	177.7	273.8	321.5	230.9	251.0	318.8	279.9	165.3	281.4	265.9	230.6
ERI2	"EXOD1, KIAA1504, MGC16943, ZGRF5"	ENSG00000196678	"ERI1 exoribonuclease family member 2"	A8K979	16	20780193-20900349	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035384, HPA035385"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"		"HPA035384: AB_10602316, HPA035385: AB_2674600"	"unprognostic (1.25e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.28e-3)"	4.7	6.8	4.3	3.7	4.9	6.4	9.2	4.4	5.5	3.9	4.8	7.4	8.1	4.1	7.6	6.7	5.7	4.5	4.4	4.1	4.4	6.5	12.1	4.7	3.8	4.9	4.4	4.5	7.4	14.0	5.0	5.4	4.9	7.5	10.2	4.2	5.1	4.8	5.1	7.1	7.8	4.6	4.6	3.6	8.4	13.1	4.7	7.5	6.2	3.7	4.4	4.5	4.7	5.7	17.1	7.9	21.6	9.5	6.5	8.3	13.0	13.3	7.9	11.8	14.9	10.2	17.0	4.8	14.6	7.3	8.2	12.7	21.8	13.7	21.8	15.3	11.4	11.5	9.7	17.6	6.0	22.3	9.0	7.5	16.7	15.9	13.2	6.3	7.2	0.0	37.1	13.5	20.0	15.3	3.2	19.8	13.4	17.5	4.5	25.5	17.7	10.5	11.0	13.4	11.0	13.5	8.5	16.0	10.3	11.4	33.7	24.7	5.5	12.5	7.0	12.2	17.9	8.3	13.4	2.9	11.9	17.9	17.6	13.8	1.8	1.7	0.4	1.3	0.3	0.5	0.4	0.4	1.9	0.0	0.3	0.2	0.1	0.5	2.6	0.6	0.8	0.4	4.3	4.9	4.4	5.5	4.1	4.4	4.9	4.4	4.9	4.6	4.7	5.7	4.0	16.0	6.7	18.3	1.0	5.0	5.3	5.6	8.0	5.3	11.3	5.8	7.3	5.7	8.5	9.2	0.0	8.3	0.9	8.0	9.8	4.1	22.5	6.9	5.5	3.0	0.0	22.7	10.4	5.2	9.1	4.3	9.7	6.0	0.0	7.1	2.9	10.9	8.4	3.3	10.6	9.6	6.1	8.2	4.1	14.7	6.2	5.8	1.8	5.6	6.7	5.0	3.1	10.6	20.3	4.7	6.6	5.3	2.8	4.5	7.5	6.8	12.6	3.5	0.0	5.6	3.5	39.3	20.0	9.7	3.7	3.7	2.5	4.5	8.5	5.7
ERI3	"FLJ22943, PINT1, PRNPIP"	ENSG00000117419	"ERI1 exoribonuclease family member 3"	O43414	1	44221070-44355260	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 943.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027147, HPA029895"	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA027147: AB_1855725, HPA029895: AB_2673239"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (5.94e-2)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.70e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-3)"	31.1	34.8	105.3	15.5	105.9	24.6	30.5	92.0	140.3	30.1	92.2	34.4	20.6	33.3	34.2	27.9	37.2	20.5	51.7	111.9	98.7	59.8	41.8	25.6	19.3	99.4	108.1	32.4	35.0	45.2	45.1	23.3	122.2	38.8	23.2	22.4	27.8	25.2	77.2	36.1	22.7	28.6	97.2	26.4	28.9	63.3	105.7	24.1	31.2	60.2	20.4	32.2	27.2	103.4	73.6	56.5	69.3	77.7	44.9	55.5	46.0	44.0	61.4	82.1	75.1	37.8	78.3	52.3	76.4	58.7	42.2	41.2	62.6	80.6	55.9	56.9	115.8	60.0	90.2	52.0	67.9	59.3	32.8	57.9	76.9	66.2	91.3	61.0	57.3	59.5	56.4	43.9	55.2	51.2	68.7	57.0	82.2	72.2	83.7	62.6	62.4	75.3	65.2	38.9	120.5	54.9	52.5	71.3	87.7	55.1	46.6	50.1	34.1	54.3	56.5	60.7	72.0	37.7	50.1	56.4	67.7	52.4	70.4	17.6	25.8	15.8	25.5	36.4	27.2	30.8	21.1	24.5	40.3	30.9	24.8	26.0	2.4	26.1	37.3	30.3	29.4	26.2	105.3	105.9	92.0	140.3	111.9	98.7	99.4	108.1	122.2	97.2	105.7	103.4	35.4	25.6	16.5	74.4	26.2	31.6	36.5	64.7	27.3	22.6	36.2	51.3	15.1	15.7	26.2	29.5	2.1	93.2	19.3	31.2	97.8	56.9	202.7	35.3	30.7	27.4	118.3	26.5	36.7	62.5	85.9	39.8	25.0	23.1	15.2	62.8	18.9	22.3	45.0	25.2	34.0	99.1	46.8	19.2	27.2	943.6	36.4	20.1	48.0	38.4	27.9	42.6	15.5	66.4	54.5	37.7	22.2	36.5	28.3	51.0	17.0	167.3	20.4	16.4	6.6	28.5	52.0	68.0	51.4	29.4	34.5	61.6	20.2	54.0	37.1	30.7
ERICH1		ENSG00000104714	"Glutamate rich 1"	Q86X53	8	614746-738106	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003725	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA003725: AB_1853023"	"unprognostic (7.19e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.42e-1)"	15.9	8.7	7.3	17.2	6.5	23.0	13.7	6.4	8.2	10.7	8.3	11.0	8.4	10.1	6.6	10.4	10.5	9.1	10.7	6.9	7.1	22.5	11.6	14.6	21.1	9.0	7.1	11.6	9.0	7.9	11.5	10.1	8.4	9.1	7.2	5.1	9.8	5.8	10.8	13.0	12.4	7.9	6.0	15.3	10.5	8.0	8.4	11.8	13.2	5.5	10.7	12.7	11.6	7.1	15.8	22.2	11.7	14.0	12.4	15.0	24.3	14.9	7.9	13.3	14.6	14.4	9.9	36.0	6.9	12.5	25.3	26.0	21.7	22.9	9.4	15.7	28.1	25.1	15.1	20.8	13.9	15.5	22.6	17.4	14.5	10.1	13.0	13.7	14.7	31.2	26.3	20.2	13.5	13.2	30.0	27.5	18.6	17.6	9.9	27.0	7.6	25.0	14.9	28.7	5.4	15.0	10.9	13.8	20.2	19.2	5.8	18.4	23.7	9.7	4.6	0.6	16.2	13.1	36.7	38.9	19.9	24.6	10.5	24.7	33.0	12.5	8.4	32.3	7.5	17.9	9.7	8.4	17.1	20.1	8.1	7.1	30.0	12.3	29.8	12.7	7.5	10.4	7.3	6.5	6.4	8.2	6.9	7.1	9.0	7.1	8.4	6.0	8.4	7.1	71.0	44.8	36.1	17.9	75.3	36.6	47.0	47.9	32.5	23.3	32.6	32.5	23.0	27.1	31.2	33.1	12.5	62.0	55.4	49.2	109.5	38.4	16.1	35.9	52.2	65.8	19.7	43.9	24.4	36.6	60.4	40.7	66.8	57.4	41.1	48.3	62.4	31.9	41.9	48.8	21.0	50.4	32.6	70.9	68.0	9.2	60.3	69.9	35.6	23.4	126.9	18.2	78.2	11.1	22.5	55.4	54.3	40.6	34.6	51.5	33.3	58.9	26.9	22.1	39.5	33.6	35.6	48.5	58.4	23.2	40.9	54.0	68.3	27.0	39.8	37.0
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443156-41444765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 42.5;kidney: 16.6"	"Group enriched"	"Detected in some"	10	"Proximal enterocytes: 189.7;Proximal tubular cells: 90.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 2.6;Hep G2: 6.2;THP-1: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA042632: AB_2678090, HPA048484: AB_2680415"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.3	0.1	0.1	0.0	0.6	0.1	0.1	0.4	0.1	0.3	42.5	0.6	0.0	0.2	0.5	0.3	2.0	0.0	0.0	16.6	0.0	1.1	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.3	0.0	1.7	0.2	39.2	0.0	0.1	0.6	0.2	0.8	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.1	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	13.7	0.2	3.7	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	189.7	90.2	0.0	0.0	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.0	0.3	0.1	3.0	0.0
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064522-98093610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 100.1;Ductal cells: 57.6;Endometrial ciliated cells: 27.8;Proximal tubular cells: 24.5;Respiratory ciliated cells: 39.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 2.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 2.2"	"Cell line enhanced"	"Detected in some"		"A549: 7.3;HAP1: 8.0;HEK 293: 11.5;JURKAT: 14.7;RPTEC TERT1: 7.5;RT4: 18.2"	"Not detected"	"Not detected"							"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (9.38e-4)"	0.5	0.1	1.5	0.3	2.4	0.0	1.0	0.9	1.4	2.5	1.2	1.9	5.3	1.3	0.6	0.7	11.1	12.3	5.3	1.0	2.4	5.6	10.2	0.9	1.0	1.8	2.1	0.9	34.2	2.2	1.3	0.2	1.9	2.7	3.3	2.3	1.3	2.3	0.0	0.7	1.5	0.5	1.1	0.2	12.6	2.4	4.7	0.7	0.6	0.0	0.7	1.9	0.5	1.3	0.0	7.3	0.0	0.0	0.1	0.0	4.7	4.6	1.8	2.3	1.8	0.1	2.4	0.0	6.0	1.2	3.6	0.4	8.0	0.2	2.8	0.0	11.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.3	0.0	14.7	0.0	0.0	0.1	0.2	0.0	0.8	1.6	0.2	2.8	0.0	0.0	0.2	7.5	18.2	4.1	0.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	2.4	0.9	1.4	1.0	2.4	1.8	2.1	1.9	1.1	4.7	1.3	0.0	3.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	2.1	1.3	8.0	100.1	3.1	7.3	0.0	0.3	0.0	1.6	0.0	57.6	0.3	27.8	0.6	0.8	18.0	0.0	1.1	18.4	1.8	0.2	7.7	7.7	0.0	4.3	0.4	2.6	0.1	0.0	1.6	2.4	0.0	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.1	8.0	0.0	0.5	0.1	14.8	1.6	0.0	0.0	2.5	0.7	24.5	39.4	0.1	0.0	0.2	1.0	0.2	4.7	1.1	0.0	0.1	0.2	0.7	3.6	2.6
ERP29	"C12orf8, ERp28, ERp31, PDI-DB, PDIA9"	ENSG00000089248	"Endoplasmic reticulum protein 29"	P30040	12	112013348-112023449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039363, HPA039456"	Enhanced		Uncertain	Nucleoplasm,Microtubules	"Intracellular and membrane"	NA	NA		900000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Microtubules	Nucleoplasm	"HPA039363: AB_10673422, HPA039456: AB_10672963"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.43e-5)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.26e-2)"	62.7	100.9	56.9	77.9	58.0	202.3	84.0	65.1	62.0	78.4	91.1	94.5	100.7	60.5	109.8	91.5	74.8	64.1	59.0	56.0	68.7	93.0	179.9	78.8	123.8	61.1	62.6	78.9	174.6	123.6	99.1	73.0	64.2	93.4	91.3	68.3	122.7	87.4	34.3	113.3	96.1	47.1	57.8	118.3	131.4	57.6	60.8	107.6	90.4	34.3	111.2	75.9	71.0	61.6	145.4	137.2	98.8	194.2	367.4	143.7	211.3	139.2	163.7	108.5	139.3	215.2	164.4	152.7	106.4	244.5	117.8	175.4	187.8	181.2	89.3	133.7	104.2	174.3	150.1	239.2	246.8	432.1	164.0	207.5	227.6	178.4	201.6	287.4	156.1	157.9	203.2	277.3	84.7	166.6	140.9	765.7	161.5	513.1	102.5	114.2	120.9	501.2	229.8	213.5	88.6	119.8	173.6	140.1	426.1	187.4	177.1	575.7	116.5	92.6	142.7	88.8	103.3	303.4	379.8	128.0	157.8	268.5	73.2	96.2	241.4	346.2	131.6	178.8	140.4	259.1	170.7	164.1	229.7	264.1	186.5	154.9	47.5	86.5	170.9	455.8	179.6	307.4	56.9	58.0	65.1	62.0	56.0	68.7	61.1	62.6	64.2	57.8	60.8	61.6	102.6	83.3	183.4	13.7	324.8	141.4	205.5	249.3	132.6	125.3	207.8	199.9	91.6	198.8	178.0	185.8	110.5	497.7	396.6	210.1	93.9	239.5	7.7	142.1	84.9	114.9	197.9	134.4	14.4	211.8	405.3	118.3	131.5	149.9	88.8	164.4	146.3	346.6	373.1	80.8	20.6	280.6	343.8	306.9	192.6	16.6	128.9	230.4	168.9	12.2	269.0	152.8	160.6	11.6	22.8	128.7	288.0	106.8	350.1	195.4	355.5	274.6	187.0	164.9	52.6	79.2	112.2	100.3	195.3	143.1	161.0	441.6	221.7	252.4	285.2	219.8
ERVFRD-1	"envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2"	ENSG00000244476	"Endogenous retrovirus group FRD member 1, envelope"	P60508	6	11102489-11111725	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 37.0"	"Cell type enriched"	"Detected in some"	56	"Syncytiotrophoblasts: 575.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 38.8"									HPA011812			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Actin filaments"	"Nucleoplasm, Cytosol"	"HPA011812: AB_1857702"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.80e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	0.3	0.4	0.6	0.1	0.4	0.2	0.4	1.8	0.6	0.4	0.0	0.3	0.5	0.3	1.0	0.3	0.2	0.4	0.1	0.6	0.7	0.5	0.2	0.6	0.0	0.6	0.4	0.0	0.0	7.5	0.0	37.0	0.5	0.3	0.2	0.2	0.2	0.2	0.0	0.5	0.5	0.2	0.1	0.0	0.3	0.1	0.6	0.4	0.0	0.4	0.0	0.5	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	1.8	0.6	0.6	0.7	0.6	0.4	0.5	0.1	0.6	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	10.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	575.5	0.4	0.5	0.0	0.0
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751586	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 12.9;placenta: 10.8"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 74.4;Extravillous trophoblasts: 102.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 46.9;hTCEpi: 32.5;RPTEC TERT1: 24.2"									"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		6000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.1	0.5	1.0	0.2	0.7	0.0	0.9	0.7	1.2	0.8	0.7	0.2	0.2	0.6	0.6	1.2	0.5	0.2	2.6	0.8	0.8	3.5	0.1	0.6	0.2	0.9	0.7	1.3	0.5	12.9	0.0	10.8	1.0	0.4	0.4	0.0	0.4	0.8	0.0	0.3	0.1	0.2	0.9	0.5	0.4	0.7	0.8	0.0	0.4	0.0	0.4	0.5	0.6	1.0	7.6	0.3	1.5	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	46.9	9.9	0.0	1.0	0.1	0.7	0.5	0.0	3.4	0.0	0.0	0.4	0.0	0.1	0.5	0.6	0.0	0.0	2.1	32.5	0.0	4.8	0.0	0.0	0.0	2.7	0.0	0.1	0.5	0.0	0.0	3.1	3.0	1.4	0.0	0.0	0.0	24.2	0.7	2.0	0.4	3.1	1.3	0.0	4.7	4.1	0.7	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.7	1.2	0.8	0.8	0.9	0.7	1.0	0.9	0.8	1.0	0.1	0.0	0.0	0.0	0.5	0.5	1.8	2.3	2.2	0.0	2.2	1.9	2.9	0.0	0.6	7.3	0.0	74.4	0.0	0.1	0.0	2.5	4.2	0.6	0.9	1.3	0.0	0.0	0.4	0.8	102.9	1.5	0.0	1.7	0.0	2.6	0.0	0.0	7.4	0.0	0.2	0.3	2.0	0.0	0.0	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	3.7	0.0	3.0	0.1	0.0	0.0	0.2	0.5	0.2	0.4	2.8	0.1	17.4	0.0	0.2	0.4	1.4
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;intestine: 11.0;lymphoid tissue: 8.5;testis: 5.7"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 44.6;Spermatocytes: 62.0;Spermatogonia: 80.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	0.5	0.4	0.0	2.7	0.2	6.0	1.2	0.4	0.2	0.5	0.0	3.7	11.0	0.6	0.0	2.4	0.2	0.6	0.2	0.0	0.0	0.1	0.7	0.4	4.6	0.0	0.0	0.1	1.0	0.3	0.0	1.1	0.1	0.3	4.3	0.5	0.3	0.1	0.0	1.1	7.9	0.7	0.0	0.8	2.5	5.7	0.0	8.5	0.3	0.2	5.7	0.8	0.5	0.2	54.6	39.9	17.9	22.0	2.3	3.9	10.2	31.6	12.9	27.8	32.5	14.2	10.7	21.0	16.6	8.3	24.7	29.2	22.0	8.5	43.6	15.8	9.2	24.4	16.2	15.3	0.3	12.5	21.4	0.7	0.9	17.0	4.2	3.0	11.6	15.2	20.0	30.0	17.7	10.5	49.8	5.9	12.2	29.9	13.4	21.7	53.0	14.8	9.6	31.9	8.0	11.7	15.5	19.6	7.9	6.5	13.2	14.1	5.2	17.9	37.0	36.2	25.7	4.0	11.1	25.2	10.2	20.5	25.2	0.0	0.2	0.1	0.0	0.4	0.0	0.4	0.2	0.2	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	1.3	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	4.7	0.0	2.4	2.3	0.6	2.1	1.8	1.2	1.5	1.7	1.2	0.0	3.3	0.0	4.2	4.6	1.3	8.2	0.0	0.4	5.4	1.3	2.6	1.0	1.2	44.6	0.3	0.0	6.6	3.2	5.6	3.1	1.3	11.4	1.4	1.5	5.4	0.0	0.4	4.4	2.0	2.5	3.5	0.8	1.8	3.2	0.0	1.0	0.5	0.1	4.1	1.0	0.9	0.1	1.5	0.0	11.5	0.6	15.1	0.1	1.6	2.0	6.6	0.8	2.3	62.0	80.0	6.8	0.6	1.0	3.1	1.8	8.0	1.4
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 569.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	123.8	87.5	83.0	73.0	85.5	95.1	146.7	86.3	110.8	141.0	87.7	125.7	106.7	129.7	160.1	93.6	121.8	96.4	151.5	84.3	98.6	194.4	277.2	92.3	93.5	87.3	85.6	179.0	67.3	109.9	81.5	81.9	89.7	112.5	135.0	122.0	92.8	140.3	149.8	83.3	93.4	166.2	94.3	63.9	83.0	54.2	82.4	155.7	155.0	179.0	110.3	104.9	96.2	100.0	138.4	77.9	229.8	160.4	264.5	441.9	62.5	190.8	280.9	264.7	204.6	131.6	162.8	156.5	56.9	233.3	194.0	137.1	256.8	227.2	333.0	180.4	270.4	200.3	70.7	208.6	220.5	400.1	82.2	304.6	207.0	167.9	229.4	316.2	253.2	260.3	200.3	40.7	433.5	135.1	352.7	260.0	59.8	175.2	148.8	277.1	133.6	106.2	378.4	55.4	115.0	130.1	85.0	72.6	160.3	157.6	137.1	223.0	169.2	94.4	113.0	187.5	181.8	27.6	63.5	135.7	205.3	223.2	131.2	35.0	129.4	55.7	48.5	113.6	80.9	104.1	97.6	76.3	142.8	83.4	114.1	90.5	15.0	109.3	106.1	170.7	90.6	100.3	83.0	85.5	86.3	110.8	84.3	98.6	87.3	85.6	89.7	94.3	82.4	100.0	139.0	54.5	56.8	37.5	77.2	134.1	227.4	300.5	148.0	51.5	114.1	123.2	99.2	167.3	111.7	154.5	41.7	160.4	51.2	59.1	360.0	168.0	135.5	102.2	120.6	112.5	108.8	99.5	22.7	103.2	141.0	162.9	51.0	80.7	96.4	71.1	132.1	154.7	227.5	21.9	19.3	114.6	175.0	140.2	148.0	34.8	267.8	108.2	165.4	25.3	144.3	199.5	36.0	23.6	36.2	85.4	92.3	211.4	35.9	99.1	137.1	569.1	94.2	77.3	151.2	196.0	484.2	61.6	46.3	120.6	129.3	74.4	78.2	151.2	199.8	143.6
ESF1	"bA526K24.1, C20orf6"	ENSG00000089048	"ESF1 nucleolar pre-rRNA processing protein homolog"	Q9H501	20	13714322-13784919	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047083, HPA050396"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA047083: AB_2679924, HPA050396: AB_2681111"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (7.81e-9)"	"unprognostic (2.52e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.91e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.57e-1)"	12.0	9.6	11.2	9.6	12.4	7.9	10.8	11.5	13.3	8.6	8.7	8.3	7.5	10.2	10.3	9.1	6.9	8.5	9.5	9.8	12.4	9.7	13.9	6.6	10.8	12.8	12.3	12.5	6.5	10.0	5.3	11.3	14.2	9.5	9.8	9.0	6.2	7.3	12.6	10.8	6.8	8.8	12.8	9.9	7.8	14.1	12.6	9.7	10.5	12.2	9.7	12.3	7.1	13.4	30.4	24.3	24.1	13.0	18.8	23.3	14.9	28.9	18.5	21.5	19.4	26.0	29.2	38.4	15.1	14.5	40.2	45.9	36.0	30.3	41.4	11.1	18.1	49.5	10.2	64.2	25.4	59.4	13.2	18.7	23.0	33.1	28.2	16.0	17.0	18.7	70.9	17.9	27.1	22.6	46.7	39.8	25.9	27.0	17.1	30.6	61.1	30.4	16.7	22.3	25.9	16.2	23.8	41.8	42.4	22.1	20.5	27.3	23.2	36.2	24.2	25.7	59.1	17.9	43.4	45.7	14.7	27.2	33.2	2.7	8.7	2.7	10.5	11.1	12.3	18.2	12.2	11.6	8.9	17.4	14.9	13.8	0.5	15.1	14.0	19.3	10.0	4.6	11.2	12.4	11.5	13.3	9.8	12.4	12.8	12.3	14.2	12.8	12.6	13.4	71.5	22.4	45.0	36.6	60.4	61.8	63.8	50.5	44.3	92.8	31.4	53.2	61.7	50.1	47.6	33.1	45.9	47.8	55.3	53.8	33.2	55.0	80.5	35.3	61.4	50.8	48.5	34.5	56.2	42.1	39.2	48.5	32.6	34.0	26.0	55.4	45.0	51.5	45.1	95.9	59.7	49.7	28.5	35.3	22.4	30.2	65.3	35.3	26.6	34.7	57.6	58.0	33.0	53.8	63.6	56.0	48.8	73.7	26.8	62.8	47.6	38.4	34.6	81.9	32.9	117.0	78.0	210.4	175.5	31.5	53.6	41.5	40.8	71.9	61.5	42.2
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;esophagus: 15.4;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.4	0.2	0.0	2.4	0.0	8.5	0.5	0.0	0.0	3.5	0.0	1.5	3.9	0.2	0.0	15.4	0.2	0.4	0.1	0.0	0.0	0.9	0.6	0.4	4.4	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	1.4	0.0	2.0	0.1	0.0	2.6	4.3	0.7	0.0	1.0	0.9	6.2	0.1	10.7	0.1	0.0	4.9	0.6	5.9	0.0	27.8	23.6	27.6	21.1	0.6	1.9	17.5	15.9	8.6	28.8	19.2	15.8	22.7	49.9	9.5	6.8	17.4	20.2	32.6	9.9	14.3	13.7	32.8	30.6	24.1	11.1	0.1	19.5	25.2	0.6	0.6	15.5	7.6	2.8	15.4	22.2	42.6	41.0	9.1	29.2	30.6	16.4	22.5	14.5	12.9	29.3	30.2	21.4	4.2	11.6	18.9	15.8	11.9	20.4	10.1	13.0	36.9	12.7	8.2	14.5	27.2	11.9	25.5	32.5	29.7	31.9	8.2	19.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	0.6	0.9	0.3	0.5	0.6	0.0	1.0	1.3	0.9	0.0	0.4	3.7	0.0	1.9	0.6	2.7	0.0	0.2	0.8	0.2	0.8	1.0	3.5	1.3	0.7	0.0	2.3	1.1	3.6	0.7	0.0	4.4	0.7	6.8	2.6	0.0	0.4	2.7	22.4	0.6	2.1	1.2	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.5	1.5	1.3	0.4	2.1	0.4	22.6	6.6	0.2	0.0	0.0	0.4	0.9	5.5	4.1	7.4	0.6	0.3	0.4	0.1	2.8	0.4
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 83.8;endometrium 1: 110.9;fallopian tube: 64.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 86.6;Endometrial ciliated cells: 77.9;Endometrial stromal cells: 79.9;Glandular and luminal cells: 98.9;Hepatocytes: 52.1;Horizontal cells: 62.2;Skeletal myocytes: 56.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 40.2;endometrial cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"MCF7: 46.0;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoplasm	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	4.2	1.8	3.2	1.5	1.3	0.8	29.1	2.9	1.3	83.8	3.2	0.9	0.4	110.9	1.2	0.5	64.9	1.2	1.8	0.6	6.7	2.8	16.9	2.0	1.6	0.4	0.5	9.0	1.0	0.2	6.6	0.4	0.3	6.1	0.5	3.5	0.9	9.8	5.8	1.1	0.8	50.4	0.2	1.7	0.6	2.3	5.9	1.0	3.4	2.6	2.3	2.1	46.9	0.3	0.6	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.6	0.0	0.0	0.0	1.2	0.1	46.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.7	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.2	57.4	0.0	0.1	0.2	0.2	0.5	0.0	5.2	1.1	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.3	2.9	1.3	0.6	6.7	0.4	0.5	0.3	0.2	5.9	0.3	0.6	0.0	1.1	1.3	2.3	1.0	1.7	0.0	0.0	3.9	86.6	16.4	4.4	0.0	1.0	0.0	8.4	0.1	0.4	0.1	1.9	0.0	40.1	77.9	79.9	2.7	1.8	0.0	4.5	0.2	0.1	11.3	0.0	98.9	2.5	36.9	5.0	52.1	0.9	62.2	5.4	0.0	0.0	4.0	3.1	10.3	4.1	2.5	1.8	1.0	0.2	2.4	0.0	25.1	0.6	0.1	0.0	2.2	8.5	0.6	0.0	3.7	1.3	4.6	0.0	56.7	11.7	1.8	1.3	0.4	1.7	0.1	2.2	4.8	0.1	6.8
ESR2	"ER-beta, Erb, NR3A2"	ENSG00000140009	"Estrogen receptor 2"	Q92731	14	64084232-64338112	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 6.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.4;Granulosa cells: 26.6;Late spermatids: 93.7;Rod photoreceptor cells: 35.6;Spermatocytes: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.2;U-266/70: 9.8;U-698: 16.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 6.1"	"HPA068406, CAB079300"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"CAB079300: , HPA068406: "	"unprognostic (7.63e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.27e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.89e-2)"	1.5	6.1	1.2	1.2	0.6	1.0	0.9	3.0	0.8	1.4	3.5	0.9	1.0	1.2	0.4	0.7	1.0	0.5	0.6	0.5	0.9	1.5	0.7	0.6	2.1	0.7	0.6	5.4	2.1	0.1	0.8	0.2	1.0	1.5	1.0	2.0	0.8	0.2	1.4	1.0	1.3	0.3	0.3	1.8	1.0	5.7	1.7	2.5	0.6	0.2	1.6	1.1	0.6	0.9	0.8	0.4	0.7	0.6	0.0	0.1	1.5	0.2	0.0	0.1	0.1	0.3	0.9	3.1	0.1	0.1	0.4	1.0	0.8	0.0	0.1	0.7	0.4	0.3	1.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.3	1.1	0.5	4.2	0.2	0.8	0.5	0.2	0.7	0.6	0.4	0.5	0.4	0.3	0.1	1.3	2.2	0.6	0.4	0.2	1.1	0.4	0.7	0.1	0.5	0.4	1.0	0.2	0.1	9.8	3.1	16.4	0.2	0.1	0.8	0.3	0.1	0.5	0.3	0.2	0.2	0.5	0.2	0.4	0.0	0.7	0.4	0.3	0.6	0.2	0.3	1.1	0.2	0.1	1.2	0.6	3.0	0.8	0.5	0.9	0.7	0.6	1.0	0.3	1.7	0.9	0.9	6.4	0.0	6.8	5.5	0.3	2.2	0.4	2.8	1.6	0.3	0.1	0.9	4.3	0.9	0.0	6.2	0.7	5.2	0.1	0.0	0.3	61.4	3.5	0.9	3.0	0.0	0.4	12.4	0.7	0.5	2.2	0.0	4.9	1.3	26.6	1.1	0.1	0.1	0.0	17.9	0.8	0.0	0.0	0.3	93.7	0.9	0.2	1.8	7.5	0.1	0.9	6.2	10.6	7.6	0.5	0.1	1.2	16.6	3.8	0.4	0.1	1.7	35.6	0.0	1.5	1.4	28.0	1.4	0.5	0.1	1.1	3.0	16.4	0.8	1.8
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 107.2;Suprabasal keratinocytes: 79.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 138.3;BEWO: 101.1;CAPAN-2: 140.8;hTCEpi: 226.5;OE19: 142.6;RT4: 99.1;T-47d: 108.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	Nucleoplasm	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.2	0.0	0.0	5.2	0.0	0.0	24.2	0.0	0.0	15.5	0.0	57.1	25.2	3.4	29.6	64.2	21.3	8.5	0.1	0.0	0.0	8.5	0.4	15.8	0.0	0.0	0.1	0.1	42.6	28.4	7.2	12.2	0.0	19.9	62.8	0.0	25.9	10.0	0.1	60.6	22.0	2.5	0.0	0.0	38.6	0.6	0.4	5.2	36.6	0.0	15.3	22.5	28.8	0.0	138.3	0.0	0.0	0.2	0.0	0.0	101.1	0.0	0.0	0.0	0.0	44.6	140.8	0.0	3.8	0.0	0.1	81.6	3.8	70.9	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	226.5	0.0	1.4	0.0	0.0	10.7	0.0	0.0	0.0	67.3	1.9	0.4	12.4	142.6	3.4	0.0	0.0	18.3	17.4	99.1	35.1	0.3	0.0	21.0	14.0	21.4	108.0	0.9	0.0	0.1	0.2	0.1	0.3	12.0	13.8	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	38.5	36.7	0.0	0.6	44.6	18.9	30.4	35.9	0.0	29.4	18.0	1.0	21.5	32.4	27.6	0.0	55.1	0.5	76.2	13.7	19.6	12.9	47.1	3.7	0.9	33.1	0.0	2.6	27.5	69.1	0.9	58.1	46.5	1.3	0.0	0.4	0.1	6.0	0.0	0.4	107.2	16.2	0.0	3.2	10.3	0.0	0.5	24.9	0.0	0.6	0.0	0.0	0.5	0.4	21.7	48.1	0.7	1.8	25.1	25.5	0.3	35.0	0.0	0.0	0.0	1.2	0.6	0.9	71.3	79.1	62.1	0.8	0.0	73.9	40.1
ESRP2	"FLJ21918, RBM35B"	ENSG00000103067	"Epithelial splicing regulatory protein 2"	Q9H6T0	16	68229033-68238102	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 55.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.3;Gastric mucus-secreting cells: 44.9;Late spermatids: 82.4;Syncytiotrophoblasts: 58.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 55.5;MCF7: 113.2;RT4: 60.4;SK-BR-3: 59.8;T-47d: 90.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040751, HPA048597, HPA048618"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463"	"unprognostic (3.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.75e-3)"	0.6	0.1	0.2	2.2	0.1	0.0	9.6	0.5	0.3	7.6	0.7	18.1	9.9	1.1	7.4	55.2	4.9	4.1	0.1	0.2	0.0	9.9	38.8	13.3	0.0	0.1	0.1	0.2	28.9	13.4	3.3	8.0	0.1	11.6	14.7	0.0	17.8	2.6	0.2	36.5	8.2	0.5	0.0	0.0	27.0	10.8	0.3	3.4	16.7	0.0	7.1	13.0	19.2	0.2	38.6	0.2	0.1	0.0	0.0	0.0	55.5	0.2	0.0	0.1	0.2	36.7	19.1	0.0	1.7	0.0	0.0	40.4	0.1	30.1	0.0	0.1	24.1	0.1	12.5	30.9	0.6	0.0	0.2	0.0	43.4	0.0	16.4	0.1	0.0	0.1	0.1	0.0	0.0	113.2	0.0	0.3	4.1	31.4	12.0	0.1	0.0	0.2	14.5	60.4	4.2	0.0	19.6	59.8	0.1	5.4	90.1	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.2	19.2	17.2	0.0	0.3	6.4	5.3	6.8	5.7	0.8	10.7	6.9	1.0	20.0	11.1	23.9	0.0	36.3	0.3	18.8	0.0	11.0	29.1	7.3	1.4	0.4	8.4	0.0	0.0	14.0	5.5	0.5	44.9	13.8	0.0	0.6	0.4	31.1	2.7	0.0	0.0	25.3	8.2	0.8	0.8	82.4	0.9	0.2	1.8	0.0	0.6	0.3	1.0	0.0	0.0	13.7	8.5	0.0	0.3	7.9	5.1	5.6	4.2	0.2	0.0	0.2	0.7	10.4	1.2	27.2	8.5	58.4	0.5	0.0	18.3	8.9
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305497-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 159.2;Hepatocytes: 266.3;Proximal enterocytes: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053785, HPA077297"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Cytokinetic bridge"	"HPA053785: AB_2682260, HPA077297: "	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"	27.3	35.5	25.5	15.8	29.8	16.3	23.6	36.4	31.4	17.5	33.6	67.6	81.8	15.5	4.7	62.7	14.6	10.2	154.9	23.5	31.6	70.3	91.5	30.9	11.0	30.9	31.7	8.1	56.3	23.9	15.9	15.4	29.8	26.4	22.9	5.1	48.5	12.6	195.3	35.9	65.4	7.1	26.6	32.0	52.4	8.4	37.5	8.4	28.3	88.8	12.4	31.0	28.8	23.7	25.9	40.2	9.8	23.6	13.0	12.7	54.2	25.0	11.9	9.2	9.0	37.4	30.3	34.9	45.1	12.8	23.7	66.0	16.9	33.0	3.5	23.0	21.0	22.9	51.7	30.1	18.0	39.3	55.3	17.4	49.8	20.7	27.0	12.8	12.8	18.1	37.9	18.7	15.3	57.9	19.4	55.9	27.9	30.4	74.4	20.4	19.7	79.6	31.1	52.4	20.6	26.2	12.8	81.2	83.8	5.5	25.8	38.2	28.9	16.6	20.4	47.4	25.6	28.6	25.5	23.6	26.9	38.2	13.4	0.2	2.9	4.8	2.7	5.4	2.6	1.7	2.3	1.9	2.7	2.3	2.3	3.3	5.3	1.8	5.1	2.1	3.6	1.7	25.5	29.8	36.4	31.4	23.5	31.6	30.9	31.7	29.8	26.6	37.5	23.7	20.8	9.6	22.7	21.2	14.7	18.6	41.0	29.7	18.8	28.8	30.9	24.3	9.2	100.1	21.3	20.2	33.3	103.8	20.9	159.2	54.8	51.3	3.4	18.7	17.4	15.3	37.8	19.4	13.6	80.2	61.3	12.4	39.8	20.3	7.6	9.3	35.0	266.3	33.6	33.7	16.6	82.5	28.5	82.7	11.7	1.1	6.5	22.2	17.8	11.2	28.8	20.1	27.8	9.0	6.4	81.1	103.1	12.0	8.2	42.8	199.7	82.2	19.8	20.4	13.1	18.7	21.7	3.5	7.1	26.3	18.5	134.2	14.5	22.2	113.7	65.0
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 36.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 13.7;Early spermatids: 14.1;Horizontal cells: 55.5;Late spermatids: 37.6;Rod photoreceptor cells: 40.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;K-562: 5.0;U-266/70: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA074772			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA074772: "	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.4	0.4	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.9	0.3	0.6	6.6	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	36.5	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.1	2.4	1.2	0.9	0.1	0.0	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.2	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.2	2.3	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.3	0.6	1.5	1.2	0.7	0.6	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.4	5.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	13.7	0.0	14.1	0.0	0.0	0.8	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	2.0	0.0	0.0	0.0	0.0	37.6	0.0	0.1	0.0	3.7	0.0	4.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.3	0.0	0.1	0.8	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ESRRG	"ERR-gamma, ERRg, NR3B3"	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.6;parathyroid gland: 46.3;retina: 36.1;stomach 1: 35.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 330.7;Excitatory neurons: 415.2;Inhibitory neurons: 495.5;Oligodendrocyte precursor cells: 391.6;Oligodendrocytes: 218.7;Syncytiotrophoblasts: 214.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 23.0;SH-SY5Y: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm		No	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044678: AB_10963215"	"unprognostic (6.48e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.06e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.13e-11)"	"unprognostic (3.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.65e-4)"	"unprognostic (2.05e-1)"	0.4	6.4	1.1	0.2	3.1	0.0	3.6	16.9	12.3	1.5	7.4	0.5	5.3	0.4	0.9	1.6	2.5	0.7	10.6	4.4	2.3	29.0	0.7	0.5	0.2	45.4	4.9	0.7	5.7	46.3	1.5	10.6	49.6	3.1	0.3	36.1	16.0	0.7	5.8	0.8	5.0	0.2	1.6	1.1	35.1	1.1	3.5	0.6	5.9	10.2	0.3	0.7	0.2	6.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.0	0.2	0.0	0.0	23.0	3.4	2.5	8.1	42.4	0.0	0.4	0.0	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	3.1	16.9	12.3	4.4	2.3	45.4	4.9	49.6	1.6	3.5	6.1	0.2	0.0	1.8	330.7	0.2	0.3	3.8	0.6	0.6	29.5	9.5	5.2	51.2	10.0	1.8	23.9	58.4	35.4	0.0	0.0	54.8	5.0	5.1	15.9	2.0	1.3	8.3	0.0	415.2	2.4	4.7	3.0	70.3	3.5	0.0	0.5	1.1	0.6	4.8	48.8	495.5	1.7	14.2	0.3	0.4	8.1	0.3	0.5	8.8	36.5	0.0	13.3	0.0	391.6	218.7	0.4	1.3	0.7	0.1	4.9	16.3	29.0	16.0	41.3	0.0	10.3	0.4	1.6	0.3	0.8	0.3	214.9	0.3	1.1	2.6	1.7
ESS2	"bis1, DGCR13, DGCR14, DGS-H, DGSI, ES2, Es2el, ESS-2"	ENSG00000100056	"Ess-2 splicing factor homolog"	Q96DF8	22	19130279-19144684	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 4.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 15.7;Distal tubular cells: 13.7;Syncytiotrophoblasts: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 9.4;RH-30: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001221, HPA001222"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA001221: AB_1078645, HPA001222: AB_1078647"	"unprognostic (8.31e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.71e-3)"	0.6	0.4	3.2	0.6	3.2	0.2	0.5	4.9	3.3	1.2	1.9	2.2	0.4	1.4	0.5	1.0	0.9	0.5	1.3	2.9	2.9	0.9	0.4	0.5	0.8	3.2	3.2	1.3	0.7	0.7	1.1	0.5	3.3	1.0	0.4	1.3	0.6	1.2	1.6	1.4	0.9	0.9	2.8	0.9	1.1	2.0	3.0	0.8	0.8	1.6	0.8	1.7	0.9	3.4	1.6	3.0	1.7	1.9	2.7	0.5	0.7	1.5	0.9	2.6	2.1	2.4	0.6	2.3	0.5	0.7	0.6	2.8	5.1	0.8	1.3	3.4	5.8	0.6	2.7	0.4	0.7	2.8	2.0	0.4	3.0	1.8	0.5	0.7	0.5	1.6	9.4	0.3	1.2	1.7	1.7	1.6	1.5	1.8	2.3	2.6	8.3	0.0	0.7	1.2	4.3	0.9	0.7	1.3	1.9	1.1	0.9	1.3	0.4	2.2	3.2	2.2	1.2	1.1	2.5	0.8	0.7	1.7	1.4	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.0	0.2	0.0	0.1	3.2	3.2	4.9	3.3	2.9	2.9	3.2	3.2	3.3	2.8	3.0	3.4	6.3	6.4	4.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	6.1	6.7	0.0	0.0	1.8	9.2	0.0	15.7	8.3	0.0	13.7	13.2	0.0	7.5	6.9	4.0	0.0	0.0	0.0	10.4	12.4	3.7	0.0	7.5	5.1	10.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	10.3	0.0	0.0	0.0	0.0	13.4	0.0	0.0	2.3	0.0	0.0	12.7	4.4	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	16.3	4.0	10.2	0.0	0.0
ETAA1	ETAA16	ENSG00000143971	"ETAA1 activator of ATR kinase"	Q9NY74	2	67397322-67412089	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035048, HPA035049"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA035048: AB_10670300, HPA035049: AB_2674430"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.14e-2)"	4.7	11.1	2.7	4.3	3.1	3.9	7.1	4.0	3.3	6.7	3.9	5.0	3.6	6.9	6.2	5.9	6.6	4.3	3.9	2.4	2.7	6.1	5.3	5.4	6.5	2.9	2.8	7.3	8.2	6.1	3.3	4.2	2.9	5.0	4.4	5.7	6.2	3.9	3.5	6.2	5.5	5.1	2.7	5.5	5.2	4.6	2.8	6.3	6.3	3.1	5.0	5.1	6.6	3.5	7.9	5.9	10.2	9.0	7.6	10.4	8.0	8.2	10.8	8.7	8.3	4.8	9.3	14.8	4.4	6.8	12.1	9.5	8.9	10.0	12.3	8.6	6.8	8.1	14.7	7.1	7.2	8.3	7.4	8.3	13.8	6.4	9.7	13.7	13.8	11.8	6.8	6.1	12.0	3.5	12.3	9.0	10.3	12.7	6.3	8.6	16.0	6.8	10.5	5.1	8.5	16.7	8.4	7.6	8.0	9.9	6.6	4.0	9.6	11.6	8.9	5.6	9.8	6.8	6.5	11.6	10.9	8.6	9.0	1.3	1.1	0.9	2.2	1.8	2.4	3.5	2.0	1.3	1.4	3.6	2.7	2.4	0.1	2.0	2.6	2.0	3.2	1.3	2.7	3.1	4.0	3.3	2.4	2.7	2.9	2.8	2.9	2.7	2.8	3.5	7.7	22.4	21.0	10.4	7.6	2.4	7.9	8.3	6.8	5.1	8.8	8.4	10.1	15.7	9.1	12.9	0.0	6.6	9.1	3.5	11.7	17.8	0.6	15.0	15.0	7.8	10.7	13.7	6.3	18.4	6.3	10.9	6.6	11.1	6.3	15.4	10.4	8.9	4.8	5.0	6.6	7.1	2.0	5.1	1.5	1.9	12.2	4.8	1.8	2.8	9.4	6.5	15.5	15.1	13.6	20.4	4.7	13.2	7.0	8.0	5.9	15.0	16.6	4.6	0.0	8.9	7.3	12.7	8.2	7.9	2.6	2.1	7.2	14.1	7.0	6.1
ETNK1	"EKI, EKI1"	ENSG00000139163	"Ethanolamine kinase 1"	Q9HBU6	12	22625075-22690665	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 299.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010712, HPA029407"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA010712: AB_2668349, HPA029407: AB_2673026"	"unprognostic (2.06e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (3.98e-3)"	"unprognostic (8.30e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.53e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.75e-4)"	10.1	14.4	13.7	14.5	15.2	12.2	13.7	9.0	15.9	10.8	16.4	27.2	23.3	10.2	19.6	10.8	10.1	14.0	7.3	14.7	28.1	18.4	18.2	12.6	17.4	12.0	14.2	11.7	10.7	10.8	13.7	11.3	15.8	10.9	15.3	18.2	12.4	6.2	6.2	15.3	15.5	7.6	11.1	16.7	45.0	17.8	19.3	23.1	14.5	5.6	14.3	10.8	9.5	17.5	14.8	27.9	30.4	27.5	21.2	21.3	21.7	15.6	12.2	17.4	16.0	20.6	33.3	41.1	14.7	11.6	16.5	10.7	27.1	7.6	28.2	36.8	23.7	34.7	11.5	18.9	20.6	33.9	29.4	13.7	7.2	21.9	17.4	25.8	20.3	15.7	41.8	17.2	22.3	7.7	38.8	67.1	59.3	17.9	20.1	32.7	28.1	32.9	25.6	16.5	9.8	17.8	18.9	13.9	27.1	41.1	24.1	32.1	17.5	12.2	19.9	18.6	25.0	12.9	18.1	46.8	16.2	21.0	23.9	44.0	14.3	15.9	15.4	22.0	15.2	22.2	16.4	14.4	14.1	15.3	17.7	17.7	14.6	17.7	23.4	12.6	20.5	19.2	13.7	15.2	9.0	15.9	14.7	28.1	12.0	14.2	15.8	11.1	19.3	17.5	33.6	48.1	32.2	48.0	55.9	144.3	75.7	34.7	64.9	41.0	56.8	42.2	10.1	45.8	43.8	44.1	50.1	30.1	57.6	116.1	27.4	30.7	299.0	64.2	49.1	34.8	108.3	48.8	104.4	44.5	24.2	38.2	230.4	51.4	34.8	40.9	28.2	41.5	42.9	26.9	104.3	60.7	46.8	88.3	60.0	43.5	24.2	57.0	67.6	84.3	39.1	17.7	43.3	121.2	152.9	39.5	62.9	21.4	63.7	73.8	57.7	33.2	81.6	39.5	39.5	23.3	38.9	49.1	18.5	51.9	170.2	75.4	49.0	41.5	47.8	90.3
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742048-108763054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.6;liver: 191.1"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 219.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.7;Hep G2: 2.3;NTERA-2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Supported		Approved	Nucleoplasm		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	0.3	5.5	155.6	0.1	155.6	0.0	0.1	98.4	144.3	0.1	47.4	0.0	0.2	0.3	0.0	0.1	0.0	0.2	10.6	124.4	145.8	9.1	191.1	0.1	0.0	100.7	118.1	0.1	0.0	2.9	1.9	0.0	110.3	0.0	0.0	1.7	34.4	0.1	2.4	0.0	0.0	0.0	101.2	0.7	18.3	0.5	119.8	0.1	1.1	1.5	0.0	0.0	0.0	101.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.6	155.6	98.4	144.3	124.4	145.8	100.7	118.1	110.3	101.2	119.8	101.3	0.0	0.0	0.0	219.4	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.4	0.0	0.0	0.7	26.8	0.0	0.0	0.6	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	7.5	0.0	8.5	0.0	1.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 328.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 352.9;JURKAT: 362.3;U-698: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	101.2	19.2	11.7	145.7	10.4	35.3	65.4	9.8	14.1	35.9	8.9	31.2	26.9	36.5	9.3	21.8	20.2	62.5	43.0	8.9	11.3	30.4	47.6	76.2	277.1	13.1	14.7	27.0	20.1	28.4	7.8	56.3	13.4	17.1	31.4	1.8	16.5	20.7	25.6	18.1	49.3	38.1	11.6	185.8	46.1	8.0	15.2	328.8	39.8	42.3	250.2	67.9	19.2	11.3	87.7	15.7	72.8	0.3	30.7	49.3	0.2	65.7	140.2	80.9	77.3	5.1	91.7	312.1	65.7	109.5	184.7	29.8	7.0	190.0	169.0	66.6	1.1	352.9	6.4	0.3	82.2	36.7	4.0	97.2	15.0	69.6	252.2	46.1	67.9	362.3	0.6	63.3	98.1	0.0	185.7	27.4	27.0	7.9	55.0	50.4	118.7	24.5	64.2	95.6	0.9	5.0	34.5	0.7	73.6	48.5	0.3	17.7	126.1	180.5	57.1	35.5	109.1	46.7	8.9	462.5	32.2	68.0	162.1	51.2	0.1	6.6	20.4	0.3	28.9	12.3	27.0	25.0	0.2	9.2	32.5	26.1	1.1	27.8	1.0	6.2	33.3	9.5	11.7	10.4	9.8	14.1	8.9	11.3	13.1	14.7	13.4	11.6	15.2	11.3	263.1	25.6	26.5	2.9	125.6	114.8	41.0	12.4	1.8	0.0	8.2	7.2	9.0	4.3	24.3	11.0	0.0	0.2	378.9	13.1	0.0	31.9	6.2	26.3	51.0	190.4	15.5	13.7	2.0	22.6	0.5	45.5	17.3	66.2	19.6	1.3	213.8	5.4	7.3	0.0	25.6	15.0	10.2	18.3	48.2	1.5	14.0	12.5	69.4	65.6	16.8	0.2	399.6	55.3	9.5	99.3	6.6	15.4	129.6	26.8	2.2	4.6	5.9	0.2	105.2	55.5	76.6	0.7	1.8	1.5	63.2	0.4	323.2	40.4	5.8	32.6
ETS2		ENSG00000157557	"ETS proto-oncogene 2, transcription factor"	P15036	21	38805183-38824955	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 701.0;Basal squamous epithelial cells: 863.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 33.6;granulocytes: 37.0;monocytes: 32.4"	"Cell line enhanced"	"Detected in many"		"HEL: 309.0;hTCEpi: 269.6;hTERT-HME1: 210.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003176			Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003176: AB_2666824"	"unprognostic (2.06e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.10e-2)"	109.9	29.7	51.4	95.5	43.3	167.1	87.7	31.6	72.5	89.6	61.4	119.3	131.3	77.5	27.9	90.6	72.5	132.1	68.0	50.9	43.2	66.1	230.7	185.5	38.0	50.0	39.9	65.7	37.5	61.9	56.6	73.6	45.0	80.1	146.5	7.5	50.3	45.7	149.7	248.3	179.7	78.0	47.9	201.0	72.7	7.6	54.0	43.7	62.5	42.8	34.8	210.2	103.6	44.4	120.1	26.2	16.6	5.6	18.8	61.3	49.2	27.4	154.1	36.2	46.5	23.0	35.1	24.7	13.3	25.0	48.5	35.7	28.0	71.2	63.8	24.5	12.0	309.0	152.6	62.2	196.9	18.4	28.2	39.8	269.6	49.6	210.2	22.0	28.3	17.2	31.3	0.2	14.4	20.1	54.1	22.2	56.0	39.3	18.2	189.6	10.2	25.2	50.2	74.4	14.2	18.4	78.4	32.8	6.2	5.7	1.9	36.3	30.8	83.0	13.0	55.3	60.5	0.5	0.3	25.2	20.7	69.4	70.8	21.0	19.5	7.0	3.2	24.9	3.9	0.4	3.0	4.7	33.6	0.4	3.2	3.2	37.0	0.3	32.4	8.1	0.3	8.9	51.4	43.3	31.6	72.5	50.9	43.2	50.0	39.9	45.0	47.9	54.0	44.4	253.0	51.3	156.6	6.2	10.8	427.4	701.0	150.8	863.4	2.1	84.2	69.7	25.6	51.5	141.9	51.5	0.0	58.4	17.5	150.7	11.7	73.7	4.0	241.1	127.4	312.7	91.8	36.4	39.6	108.5	109.3	98.7	161.1	497.9	51.3	0.9	242.0	262.4	62.1	0.0	10.7	266.0	79.3	150.8	291.7	2.0	18.0	253.4	67.6	74.0	41.0	1.5	3.1	4.0	3.1	127.6	175.1	24.8	21.0	184.0	162.2	47.2	107.9	1.6	52.6	81.8	108.8	0.6	3.3	522.6	486.4	177.6	28.8	8.2	243.3	338.7
ETV1	ER81	ENSG00000006468	"ETS variant transcription factor 1"	P50549	7	13891229-13991425	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 119.9;salivary gland: 91.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 137.7;Astrocytes: 67.3;Cardiomyocytes: 87.7;Enteroendocrine cells: 198.1;Excitatory neurons: 66.9;Oligodendrocyte precursor cells: 135.7"	"Cancer enhanced"	"Detected in all"		"glioma: 22.5"	"Group enriched"	"Detected in all"	5	"cerebellum: 119.9;thalamus: 32.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 67.8;hTERT-RPE1: 76.2;SCLC-21H: 79.3;U-87 MG: 157.2;WM-115: 78.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 200.7"	"HPA068389, HPA077249"		Supported	Approved	Nucleoplasm		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA068389: , HPA077249: AB_2686829"	"unprognostic (2.45e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.64e-7)"	"unprognostic (7.08e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	4.9	23.0	13.6	1.9	10.9	0.2	8.2	119.9	12.1	2.3	0.1	4.1	2.2	4.4	2.3	2.7	1.5	17.3	35.6	14.6	5.6	3.2	3.9	28.7	1.4	4.6	14.0	1.4	3.1	11.5	7.4	3.5	9.0	5.5	4.3	4.5	91.6	12.6	0.8	1.9	3.5	3.5	3.1	9.1	2.6	8.9	32.8	4.7	12.2	2.5	1.9	2.7	1.5	8.1	0.1	4.9	35.5	67.8	12.1	35.4	0.1	3.2	12.1	2.0	8.0	0.0	16.6	0.0	3.6	5.6	9.8	0.4	1.5	3.8	4.3	0.9	1.6	2.1	3.1	0.0	7.1	12.3	4.5	10.7	0.0	23.3	1.9	76.2	15.3	1.1	11.0	0.6	14.6	0.0	0.1	0.0	53.2	2.1	36.5	0.0	21.5	2.9	23.7	0.4	79.3	15.6	0.0	1.2	19.6	12.2	1.2	0.5	8.6	7.0	2.2	13.8	13.4	12.2	4.1	0.0	157.2	0.8	78.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	13.6	10.9	119.9	12.1	14.6	5.6	4.6	14.0	9.0	3.1	32.8	8.1	16.0	19.2	137.7	67.3	0.0	1.0	2.8	0.9	13.6	4.9	5.8	23.6	87.7	28.6	0.7	3.7	0.0	0.6	0.1	0.8	5.9	3.6	25.4	1.3	3.9	11.1	198.1	0.8	66.9	0.9	0.4	17.7	1.1	2.0	2.5	0.2	2.9	13.1	3.4	5.0	45.3	2.4	0.0	7.2	1.6	8.7	1.5	0.7	12.4	28.1	0.0	12.6	0.0	135.7	4.3	0.9	0.1	34.6	1.2	0.6	0.0	3.0	1.4	0.6	19.7	17.4	12.6	1.2	2.1	3.1	1.3	0.3	2.2	9.7	1.2	0.3
ETV3	PE-1	ENSG00000117036	"ETS variant transcription factor 3"	P41162	1	157121191-157138474	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 361.2;monocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004794, HPA073211"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA004794: AB_1078761, HPA073211: "	"unprognostic (1.65e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.97e-2)"	"unprognostic (6.65e-2)"	13.7	7.7	6.6	11.1	6.6	24.0	12.1	7.9	20.1	8.3	5.3	8.7	15.1	9.3	7.5	15.6	7.8	12.7	7.4	8.3	8.1	6.6	6.6	12.6	10.1	7.7	6.5	11.5	6.4	23.9	5.0	12.8	7.0	10.2	9.5	5.7	9.2	8.5	9.4	31.5	14.6	10.1	7.1	10.0	10.0	9.4	7.4	10.8	7.9	8.8	12.5	17.6	11.4	7.1	11.9	11.4	11.6	10.1	17.3	11.3	9.9	10.9	11.4	10.5	9.7	12.2	11.6	14.2	13.4	13.4	5.6	18.0	12.8	16.7	13.8	31.0	8.1	11.9	12.2	6.7	10.3	19.0	18.1	12.5	19.2	15.7	13.3	8.5	11.1	8.8	13.9	10.2	12.0	15.7	5.8	10.7	38.6	16.9	8.7	8.7	13.8	16.3	8.1	43.9	9.8	19.0	11.9	28.1	29.5	20.7	14.4	20.7	18.8	13.5	11.9	13.2	13.7	24.6	13.5	16.7	15.5	10.9	45.2	6.3	4.6	3.3	4.5	4.2	6.2	2.1	3.9	4.5	4.5	2.4	3.9	3.5	5.4	4.2	4.2	1.2	3.3	2.6	6.6	6.6	7.9	20.1	8.3	8.1	7.7	6.5	7.0	7.1	7.4	7.1	22.9	35.3	16.2	3.6	20.4	70.4	18.4	20.2	71.7	2.3	18.2	14.4	9.4	5.7	24.3	12.9	10.4	7.5	37.2	22.1	0.0	6.4	9.4	18.1	18.0	19.4	10.7	5.9	8.1	6.3	9.0	16.3	15.3	29.5	22.2	6.4	15.4	8.3	8.7	1.7	6.9	12.5	10.2	13.2	361.2	7.3	4.1	69.0	16.0	5.6	97.0	3.9	10.3	6.0	4.4	10.4	13.4	4.5	25.3	16.5	16.0	3.2	29.7	6.3	13.1	16.4	15.4	10.2	9.4	64.2	78.7	14.9	40.4	6.0	14.4	51.4
ETV5	ERM	ENSG00000244405	"ETS variant transcription factor 5"	P41161	3	186046314-186110318	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.0;Oligodendrocyte precursor cells: 169.9;Syncytiotrophoblasts: 88.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 50.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 178.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009590, HPA063065, HPA073889"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB009590: AB_2101008, HPA063065: AB_2684936, HPA073889: "	"unprognostic (3.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (7.85e-9)"	"unprognostic (3.52e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.84e-3)"	6.8	39.3	17.1	6.9	22.4	1.4	15.0	17.7	24.4	4.9	9.4	3.4	6.1	8.1	7.3	4.2	5.1	5.6	11.5	17.8	16.8	8.9	7.9	29.6	5.2	20.5	17.1	2.2	17.5	42.2	25.4	17.1	17.7	7.4	3.2	15.9	6.5	5.8	11.9	6.4	3.0	7.4	14.7	10.9	14.8	9.3	17.2	4.8	21.9	7.0	4.2	4.3	4.1	19.6	42.4	28.6	36.1	79.2	21.9	22.7	2.6	35.7	39.7	27.7	29.6	31.7	25.4	1.1	46.4	34.7	41.3	7.1	0.8	27.2	40.7	9.3	1.0	12.4	1.0	36.4	36.3	31.2	22.1	19.9	4.4	44.3	53.7	32.9	41.0	4.4	11.6	14.6	47.5	19.8	4.1	47.7	54.2	12.1	32.4	86.6	36.0	28.7	23.0	9.9	1.6	45.8	8.7	0.4	178.3	14.4	0.1	17.3	40.0	15.0	24.3	38.2	70.5	11.1	49.9	0.3	45.8	24.6	91.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.1	17.1	22.4	17.7	24.4	17.8	16.8	20.5	17.1	17.7	14.7	17.2	19.6	5.7	3.2	68.5	26.1	5.6	15.7	10.6	8.2	45.5	17.8	9.4	30.4	5.7	17.2	2.4	0.0	12.5	57.6	3.1	0.6	3.9	9.4	24.6	2.0	4.3	9.2	10.7	1.7	94.0	9.4	18.8	12.5	15.8	4.7	8.2	0.8	10.4	9.0	56.4	5.0	43.7	2.8	0.0	64.4	19.4	49.0	9.0	27.1	16.0	45.9	2.1	60.4	1.0	169.9	47.5	12.5	1.1	15.4	4.9	3.6	1.5	22.9	1.3	18.8	0.0	25.4	13.6	16.9	14.4	8.7	5.3	88.8	1.9	3.1	1.5	2.7
ETV7	"TEL-2, TEL2"	ENSG00000010030	"ETS variant transcription factor 7"	Q9Y603	6	36354091-36387800	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.0;skin 1: 15.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Cytotrophoblasts: 28.8;Exocrine glandular cells: 23.8;Proximal enterocytes: 21.5;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.9;T-reg: 16.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.9;monocytes: 5.7;T-cells: 16.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.1;BJ hTERT+ SV40 Large T+: 14.7;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HDLM-2: 59.7"					"Low region specificity"	"Detected in all"			HPA029033	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA029033: AB_10601375"	"unprognostic (1.67e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (9.48e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-3)"	"unprognostic (9.08e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.32e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.27e-2)"	"prognostic favorable (2.95e-6)"	1.9	2.1	1.5	6.9	1.5	0.9	2.1	1.0	1.7	2.1	1.4	3.3	16.0	1.0	1.3	3.6	2.2	3.4	0.4	1.5	1.4	2.3	2.9	4.9	5.3	2.2	1.2	1.5	1.6	2.2	3.8	3.6	2.1	2.9	2.6	0.4	8.6	1.5	0.2	15.4	12.7	1.0	2.1	3.1	6.2	1.1	1.4	4.0	1.2	0.3	3.9	5.5	2.5	1.4	3.2	0.0	0.2	0.1	0.0	0.2	27.1	0.0	9.2	14.7	27.8	0.5	6.2	0.1	0.7	0.2	2.3	3.3	0.4	1.7	0.7	59.7	0.5	0.5	0.0	0.0	1.8	0.0	0.3	1.2	2.4	0.7	0.2	0.0	0.4	0.0	0.1	0.2	0.3	0.1	0.2	0.3	0.2	0.3	0.1	6.1	0.1	0.2	0.2	1.1	0.8	0.0	0.6	2.1	0.5	0.0	3.1	0.6	0.2	0.3	0.7	0.3	0.1	0.1	0.1	0.2	0.0	2.7	0.4	0.0	3.7	0.3	1.6	5.7	3.9	3.3	5.4	2.2	0.9	2.4	1.0	1.4	18.9	0.6	1.9	0.0	16.3	2.5	1.5	1.5	1.0	1.7	1.5	1.4	2.2	1.2	2.1	2.1	1.4	1.4	1.4	19.2	14.8	0.3	1.2	2.0	2.2	8.0	6.2	0.2	2.5	2.7	0.5	7.2	7.1	0.0	0.0	28.8	0.7	6.6	0.0	12.4	0.4	0.4	1.4	1.1	3.6	0.0	0.5	23.8	6.6	2.7	8.2	0.7	2.5	1.7	0.0	0.4	2.9	0.0	0.3	6.5	6.1	1.3	1.6	0.5	1.5	1.0	3.6	0.0	6.5	3.1	1.0	0.0	0.3	13.4	7.8	1.2	5.6	4.8	21.5	1.3	3.0	0.6	0.0	1.0	5.5	0.9	26.8	6.4	3.7	8.5	3.6	0.7	7.6	4.8
EVC2	LBN	ENSG00000173040	"EvC ciliary complex subunit 2"	Q86UK5	4	5542772-5709548	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.6;Basal squamous epithelial cells: 12.0;Fibroblasts: 8.9;Leydig cells: 11.5;Skeletal myocytes: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.7;HHSteC: 13.0;hTERT-HME1: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040910, HPA048122"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Microtubules, Cytokinetic bridge"	"Nucleoplasm, Cytosol"	"HPA040910: AB_2677195, HPA048122: AB_2680272"	"unprognostic (6.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.57e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (1.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.61e-2)"	"unprognostic (6.29e-5)"	4.8	0.7	1.3	1.5	1.4	0.1	3.6	1.2	1.1	6.0	2.3	3.7	0.6	4.7	1.7	2.2	4.7	2.7	3.1	1.3	1.4	2.6	0.7	2.1	1.9	1.6	1.5	7.8	1.7	3.1	1.1	1.3	1.2	3.2	0.6	0.3	2.8	2.0	1.1	3.8	2.0	2.3	1.4	1.0	2.1	1.6	1.5	1.0	3.8	1.9	1.7	4.1	4.4	1.3	0.0	2.7	0.0	6.6	8.4	9.3	0.0	4.1	9.7	3.6	6.0	0.0	0.0	5.2	0.0	3.3	2.0	2.8	0.0	1.7	3.4	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	5.9	4.6	4.6	10.6	0.0	3.9	0.0	0.0	0.2	5.3	0.0	0.0	0.0	3.9	0.0	0.0	8.6	8.2	0.0	0.4	0.0	0.4	0.6	0.0	0.0	0.0	1.6	0.0	0.5	6.7	0.0	0.0	2.4	0.0	4.1	4.7	1.2	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	1.4	1.2	1.1	1.3	1.4	1.6	1.5	1.2	1.4	1.5	1.3	0.6	0.0	0.5	17.6	0.8	2.2	4.9	2.3	12.0	0.0	0.9	2.2	1.0	1.5	1.3	0.0	0.0	8.3	1.7	0.0	0.0	1.9	2.2	0.7	5.6	1.2	0.0	0.4	0.3	0.5	0.3	8.9	0.5	1.7	2.5	4.7	1.4	0.1	0.5	0.0	0.3	0.0	0.0	0.3	1.2	0.9	11.5	0.8	0.0	6.5	0.0	1.9	1.0	1.0	0.3	0.6	0.0	7.9	1.7	2.8	0.0	0.9	1.0	0.1	0.0	14.7	3.2	1.8	2.1	4.4	0.9	1.4	2.8	3.4	0.0	1.4
EVI2A	"EVDA, EVI2"	ENSG00000126860	"Ecotropic viral integration site 2A"	P22794	17	31316410-31321749	"Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.7;lymphoid tissue: 105.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 81.4;Hofbauer cells: 114.2;Kupffer cells: 240.6;Langerhans cells: 112.5;Macrophages: 112.0;monocytes: 195.8;NK-cells: 87.6;Oligodendrocytes: 218.9;T-cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 57.1;Karpas-707: 99.1;RPMI-8226: 160.7"	"Low region specificity"	"Detected in all"							"HPA045033, HPA057051"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nuclear bodies"	"HPA045033: AB_2679191, HPA057051: AB_2683321"	"unprognostic (7.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (7.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.90e-2)"	10.9	7.9	72.3	47.9	106.9	31.2	8.1	98.9	126.4	8.1	53.3	11.3	11.0	3.6	1.4	6.0	2.8	17.9	4.2	73.2	82.1	2.9	9.6	20.1	53.6	105.0	89.1	2.4	2.8	2.3	1.4	21.0	109.1	3.8	13.6	0.9	4.0	3.2	0.9	1.9	12.2	7.1	88.3	38.2	12.8	1.8	83.3	105.1	2.5	3.7	40.8	20.3	2.8	155.7	0.1	0.1	0.0	0.0	4.9	30.0	0.1	4.1	6.6	5.0	17.3	0.0	1.5	26.2	0.0	5.3	29.0	0.1	0.0	0.3	14.3	0.0	0.2	0.1	0.1	0.1	57.1	31.5	33.4	37.6	0.0	7.2	20.0	7.7	1.8	24.7	1.1	99.1	39.4	0.6	22.9	35.3	0.0	0.0	0.0	23.8	3.9	160.7	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	34.5	11.6	21.5	0.6	0.9	14.8	44.2	0.0	30.1	17.1	23.0	18.1	6.0	91.0	3.6	36.0	44.6	44.0	28.5	51.0	42.6	62.4	14.7	60.4	53.8	177.1	32.4	35.8	20.4	60.9	95.1	72.3	106.9	98.9	126.4	73.2	82.1	105.0	89.1	109.1	88.3	83.3	155.7	1.2	0.0	5.6	1.3	48.3	4.0	0.4	0.4	0.0	0.3	0.7	0.9	0.7	0.0	1.3	0.0	0.0	0.7	68.7	0.1	0.0	0.2	2.8	0.3	0.5	2.7	0.0	8.8	0.8	0.0	0.8	2.2	4.1	0.9	81.4	0.0	6.1	1.6	114.2	0.0	0.8	0.1	2.0	240.6	112.5	1.6	0.3	112.0	14.2	9.4	195.8	0.5	87.6	1.0	218.9	0.0	0.0	0.0	53.6	0.3	0.0	0.6	1.6	1.0	0.0	0.7	1.2	0.2	0.3	0.4	3.1	1.4	116.0	0.1	0.6	0.4
EVPLL		ENSG00000214860	"Envoplakin like"	A8MZ36	17	18377778-18389647	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 16.9;skin 1: 6.0;vagina: 8.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.1;Basal squamous epithelial cells: 8.0;Spermatogonia: 5.8;Squamous epithelial cells: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.2;HaCaT: 1.1;HeLa: 2.4;hTCEpi: 7.1;RT4: 2.5;SiHa: 1.3;T-47d: 2.1"									HPA045728	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"		"HPA045728: AB_10960394"	"unprognostic (1.34e-1)"	"unprognostic (4.88e-2)"				"unprognostic (2.06e-5)"	"unprognostic (1.58e-1)"	"unprognostic (2.08e-2)"		"unprognostic (1.64e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.60e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.06e-2)"	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.1	0.1	0.0	0.2	16.9	0.1	0.0	0.0	0.0	0.0	1.2	2.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.0	1.9	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.4	1.1	0.0	0.1	2.2	8.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	1.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.5	1.6	1.3	8.0	0.0	0.1	0.6	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	5.8	10.9	1.3	0.0	0.0	0.0	0.2	1.0
EVX1		ENSG00000106038	"Even-skipped homeobox 1"	P49640	7	27242700-27250493	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.9;prostate: 3.8;seminal vesicle: 2.9;urinary bladder: 3.3;vagina: 3.5"	"Group enriched"	"Detected in some"	33	"Early spermatids: 62.0;Late spermatids: 73.3"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.6"	"Region enhanced"	"Detected in single"		"medulla oblongata: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"OE19: 25.2;RT4: 16.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Not detected"	"Not detected"			HPA055132			Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA055132: AB_2682707"	"unprognostic (2.73e-2)"	"unprognostic (3.59e-1)"	"unprognostic (4.31e-1)"		"unprognostic (5.16e-2)"		"unprognostic (1.76e-3)"	"unprognostic (2.08e-2)"			"unprognostic (8.48e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.26e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.83e-2)"	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.9	3.8	0.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.3	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.2	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.8	0.9	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	62.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	73.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	2.0
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim"		No	No		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli rim"	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	84.8	102.2	63.2	93.2	64.7	172.3	80.3	70.3	69.5	87.9	61.2	90.5	88.0	105.1	61.9	99.0	86.0	56.1	101.7	64.7	63.7	88.0	85.0	76.8	120.1	67.4	64.7	86.8	79.1	98.0	64.1	70.2	63.6	78.4	84.4	111.2	76.5	77.3	140.0	88.0	92.6	86.9	59.7	101.0	84.3	135.5	63.9	183.0	77.2	79.9	126.8	88.1	86.2	71.8	307.7	239.7	327.6	249.1	166.0	136.0	218.2	188.1	301.3	309.9	264.5	270.3	154.5	428.0	114.1	294.3	234.9	238.9	471.5	392.6	313.7	287.5	341.6	323.9	218.8	262.7	246.5	499.5	219.3	211.1	162.5	259.1	413.0	152.2	244.2	201.1	248.3	186.0	233.8	310.6	505.9	185.8	221.1	261.4	182.8	348.1	317.2	253.3	288.0	328.2	261.4	247.7	236.3	258.5	195.9	216.2	170.9	261.0	246.3	184.4	198.2	115.1	272.3	236.2	205.5	387.4	169.9	220.6	224.4	203.9	201.1	182.6	195.2	283.5	199.5	169.4	181.3	194.4	227.5	191.3	175.8	170.9	148.1	216.9	293.0	122.0	244.0	314.2	63.2	64.7	70.3	69.5	64.7	63.7	67.4	64.7	63.6	59.7	63.9	71.8	77.5	102.5	106.8	68.6	130.8	69.5	145.2	153.2	108.1	72.4	63.8	46.6	68.0	87.2	127.2	64.4	75.0	141.0	91.3	92.4	66.5	121.7	165.4	96.3	88.1	88.3	80.9	102.0	55.8	107.6	133.5	85.4	117.2	115.2	121.0	88.5	71.7	71.7	99.3	82.4	60.8	110.9	136.3	69.7	94.0	32.7	61.5	91.9	81.8	47.8	110.9	72.8	122.6	49.8	67.6	116.5	106.4	62.1	156.6	97.4	79.4	72.6	128.9	84.9	52.6	93.1	141.4	209.6	107.5	105.5	58.5	152.4	121.4	84.9	110.2	115.1
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.3;lymphoid tissue: 11.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 7.4;Extravillous trophoblasts: 16.7;Plasma cells: 11.8;Spermatocytes: 9.3;Spermatogonia: 9.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	0.5	0.3	0.2	3.3	0.2	17.3	1.2	0.1	0.7	0.5	0.1	3.2	2.9	0.8	0.0	2.5	0.3	0.4	0.2	0.3	0.1	0.3	0.5	0.6	5.8	0.1	0.2	0.2	0.3	0.7	0.1	3.3	0.2	0.2	3.7	0.0	0.5	0.2	0.1	1.8	2.5	1.2	0.2	1.5	1.6	5.7	0.3	11.1	0.4	0.0	6.4	1.2	0.8	0.4	41.3	26.8	43.4	28.6	2.7	6.7	36.5	53.4	17.7	46.7	50.5	33.9	22.5	44.3	25.3	12.6	25.1	40.0	55.5	22.5	54.8	69.5	48.4	41.5	28.8	17.3	1.0	59.8	29.4	1.7	1.1	46.8	12.5	5.7	14.7	43.4	84.6	57.0	37.8	19.0	65.9	33.6	60.4	49.7	26.0	46.2	40.5	47.5	9.6	25.6	48.1	60.9	34.8	27.9	19.5	20.2	25.8	36.6	5.5	44.9	39.5	42.7	72.9	41.5	59.0	71.3	15.6	48.1	54.9	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.3	0.2	0.2	0.1	0.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.4	0.2	0.0	0.0	0.3	0.7	0.8	0.1	0.7	0.0	0.0	0.3	0.5	2.3	0.0	0.1	0.0	0.0	5.3	0.2	1.2	0.0	0.1	9.3	0.3	0.4	0.7	0.0	7.4	1.0	0.0	16.7	0.9	1.1	0.5	0.0	4.6	0.4	0.0	3.3	0.0	2.9	0.5	0.0	0.3	0.8	2.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	11.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	9.3	9.8	2.7	0.1	4.0	0.8	0.8	1.9	0.3
EXO5	"C1orf176, DEM1, FLJ21144"	ENSG00000164002	"Exonuclease 5"	Q9H790	1	40508741-40516556	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 150.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028429			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA028429: AB_2092105"	"unprognostic (9.44e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (9.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.91e-3)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (9.95e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.53e-1)"	4.7	4.5	2.2	5.7	3.3	4.7	5.5	3.8	2.8	4.9	2.3	5.0	4.4	6.1	5.2	4.4	5.1	4.2	4.0	2.5	2.2	5.0	6.4	5.3	8.4	1.9	2.1	4.4	4.2	4.1	3.4	5.1	1.9	5.3	5.0	4.5	4.6	5.5	4.2	5.2	5.5	7.6	2.0	7.0	4.1	3.9	3.1	10.8	4.4	2.4	10.9	4.8	4.1	2.4	14.6	5.2	12.5	21.0	8.3	7.5	8.7	19.4	4.9	17.1	20.5	9.3	17.3	19.6	11.7	12.4	19.4	17.8	12.3	12.9	20.4	6.6	8.0	17.1	24.8	13.0	10.2	0.1	16.4	7.8	8.0	23.6	8.7	5.0	10.9	13.7	20.0	0.1	24.6	6.1	27.4	13.4	19.0	2.4	2.0	20.7	42.6	7.7	8.6	22.3	15.1	13.4	25.0	8.9	15.9	19.1	12.5	150.1	12.3	11.7	35.1	26.5	19.1	5.6	18.7	0.1	1.7	5.3	23.8	8.8	5.9	15.0	12.6	8.7	10.4	10.8	8.7	9.1	7.0	8.4	10.5	10.2	10.5	8.1	6.6	5.8	12.9	6.5	2.2	3.3	3.8	2.8	2.5	2.2	1.9	2.1	1.9	2.0	3.1	2.4	2.4	0.0	1.7	1.6	3.4	0.9	0.9	5.0	1.8	3.3	2.2	2.7	1.1	7.2	3.1	7.3	4.2	5.0	5.3	2.3	0.0	4.8	1.2	1.0	2.4	3.2	1.2	3.0	3.1	2.4	4.6	2.6	1.1	1.5	5.7	5.8	2.2	3.6	5.2	3.3	2.1	2.2	4.1	2.5	2.4	1.3	3.4	2.0	1.8	3.7	4.8	4.8	4.1	1.5	1.9	2.9	1.9	1.9	3.1	1.0	2.4	2.3	2.5	2.9	6.6	3.2	2.9	6.1	6.3	1.9	1.0	1.9	2.9	3.1	3.0	0.3
EXOC3	"SEC6L1, Sec6p"	ENSG00000180104	"Exocyst complex component 3"	O60645	5	443175-471937	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 61.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037880			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA037880: AB_2675716"	"unprognostic (2.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.82e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.70e-1)"	27.1	22.0	16.7	20.3	19.1	24.3	25.5	20.9	18.7	27.0	18.5	38.1	20.8	29.1	10.7	36.4	25.6	19.3	28.6	19.0	19.0	22.7	21.8	22.3	23.6	18.5	18.4	26.1	31.7	22.1	26.0	18.5	19.8	24.6	14.4	8.0	26.7	20.3	78.8	34.4	27.0	19.0	16.6	26.5	32.9	35.6	18.2	22.9	25.0	41.2	20.1	31.4	27.6	20.3	33.5	55.3	18.2	40.9	30.6	26.3	45.2	29.1	29.9	28.6	34.5	28.0	48.0	28.4	44.2	36.6	35.3	37.2	14.7	25.2	20.9	105.8	25.7	30.6	114.0	21.3	28.6	46.0	73.9	26.8	18.4	32.1	28.0	30.0	32.5	18.3	23.6	18.1	22.5	39.7	33.2	54.8	15.1	20.5	33.0	27.0	20.9	36.5	24.1	41.4	18.2	23.2	72.5	40.5	28.8	17.7	54.8	52.5	24.5	28.3	34.6	22.0	23.8	30.3	23.6	20.2	29.8	55.1	26.2	10.4	10.5	61.0	11.2	12.4	9.8	6.0	8.8	9.1	6.6	6.4	11.1	10.2	14.8	19.4	9.1	4.8	12.4	7.1	16.7	19.1	20.9	18.7	19.0	19.0	18.5	18.4	19.8	16.6	18.2	20.3	15.5	22.4	29.1	15.0	14.1	42.8	16.3	18.6	20.5	14.0	18.1	16.5	31.4	14.3	21.1	14.7	35.5	25.3	15.6	28.9	27.4	27.3	31.8	16.4	16.2	17.1	5.4	14.7	12.6	30.2	24.2	16.6	23.4	17.0	22.9	27.7	13.9	16.9	24.0	63.9	11.2	20.3	18.3	26.9	23.8	65.3	20.2	24.6	26.6	10.3	25.2	17.0	13.4	10.6	16.7	26.4	23.1	17.0	18.6	18.0	25.5	23.1	29.3	20.2	19.7	19.1	24.8	33.9	29.7	29.4	53.8	34.1	22.7	21.1	23.5	24.6
EXOC3L2	"FLJ36147, XTP7"	ENSG00000283632	"Exocyst complex component 3 like 2"		19	45212370-45245407	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"kidney: 19.0;thyroid gland: 17.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 15.3;Endothelial cells: 17.7;Hepatic stellate cells: 51.4;Theca cells: 21.2"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 19.1;K-562: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041595, HPA061110"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA041595: AB_10794521, HPA061110: AB_2684431"																		4.3	8.3	0.3	2.1	0.6	1.6	2.9	0.5	0.4	4.0	1.6	2.7	2.4	4.9	0.4	1.9	2.8	2.3	2.3	0.4	0.3	19.0	2.7	2.7	1.1	0.7	0.5	0.9	2.7	3.3	5.0	0.4	0.5	5.2	0.7	0.1	1.8	2.2	0.9	2.1	3.2	1.9	0.3	8.3	2.9	3.3	0.4	0.4	17.9	0.3	0.5	3.2	2.4	0.7	0.1	0.3	2.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.1	2.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.1	19.1	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	16.6	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.5	1.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.0	0.1	0.3	0.6	0.8	1.5	0.2	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.4	0.4	0.3	0.7	0.5	0.5	0.3	0.4	0.7	15.3	0.0	1.3	0.7	0.7	0.4	0.3	0.0	0.0	0.7	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	17.7	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.2	0.0	0.4	51.4	0.3	0.0	0.0	1.1	0.6	0.0	1.6	0.0	0.0	1.8	2.8	0.0	0.0	0.1	0.2	2.1	0.5	0.7	0.0	0.0	1.9	0.1	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.6	0.4	6.2	0.2	0.9	0.0	0.1	21.2	0.0	0.3
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 238.6;Excitatory neurons: 334.2;Inhibitory neurons: 306.8;Microglial cells: 341.0;Oligodendrocyte precursor cells: 395.6;Oligodendrocytes: 345.9;Rod photoreceptor cells: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		10000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	20.7	21.1	18.7	13.8	20.2	13.8	21.4	19.3	20.3	22.6	24.3	19.7	13.1	21.5	13.6	24.4	27.3	17.8	15.3	20.9	19.4	17.7	17.8	17.7	16.4	18.4	20.3	30.6	27.3	27.3	16.9	19.6	19.9	18.3	21.5	53.1	16.3	20.5	68.4	25.4	13.5	23.9	18.8	21.0	17.3	18.7	19.1	28.1	26.4	38.5	20.3	21.1	18.6	20.8	40.1	32.2	43.3	43.3	49.7	51.6	15.0	28.6	47.2	25.4	33.2	18.8	54.7	29.8	20.1	54.1	36.9	24.7	23.7	38.8	41.8	45.6	28.2	24.0	31.5	19.9	54.7	32.0	25.1	50.4	47.6	36.3	66.5	55.7	43.5	38.6	35.1	28.8	47.7	26.1	58.5	35.2	32.8	47.5	29.8	25.7	38.7	54.2	40.7	35.2	33.9	53.2	43.0	39.1	46.3	48.9	25.8	29.3	47.9	28.1	14.6	30.0	31.5	45.0	29.4	28.1	82.9	36.4	43.8	10.3	12.0	7.2	11.2	12.9	10.0	8.3	11.6	11.9	16.3	8.1	9.4	9.6	4.0	19.6	11.4	7.2	12.9	11.2	18.7	20.2	19.3	20.3	20.9	19.4	18.4	20.3	19.9	18.8	19.1	20.8	22.9	22.4	22.3	238.6	27.3	18.9	16.3	16.6	25.6	39.9	16.8	15.4	30.9	11.5	18.0	14.7	93.8	17.5	26.7	21.5	3.9	15.0	29.6	27.0	21.2	23.0	17.4	18.7	334.2	18.2	16.6	21.2	34.1	21.0	8.2	32.4	23.2	15.9	18.1	50.5	306.8	21.0	26.4	27.3	14.5	27.6	17.4	20.4	14.2	341.0	23.9	20.4	23.7	395.6	345.9	15.4	17.4	18.8	27.7	13.2	16.3	16.9	29.8	231.5	13.1	26.0	15.3	20.5	13.1	28.2	17.0	11.2	26.2	26.4	21.9	20.1
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92826831-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 164.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 181.7;Microglial cells: 146.1;Oligodendrocyte precursor cells: 157.3;Rod photoreceptor cells: 177.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 30.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: AB_2683907"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	8.7	14.4	5.9	8.2	7.5	12.9	8.0	7.7	8.6	6.5	8.0	9.6	8.1	6.1	5.7	4.2	5.8	10.1	7.1	8.2	6.0	6.4	10.1	10.7	9.5	3.4	2.4	3.9	10.0	6.3	6.1	37.4	3.7	8.6	10.2	164.2	5.6	4.3	31.8	5.0	9.5	7.7	3.3	9.1	7.0	9.9	6.1	8.5	28.4	19.7	8.2	10.1	3.5	7.1	19.8	24.3	25.7	16.8	1.3	1.6	9.1	9.0	24.9	8.1	9.7	9.1	16.5	22.5	19.0	4.3	6.6	12.3	20.8	5.7	10.1	20.1	20.9	35.1	8.3	11.7	9.6	36.4	30.6	2.2	3.0	7.2	4.8	14.6	113.8	14.6	29.2	14.5	4.0	10.7	15.3	23.2	3.5	40.2	7.0	22.5	11.2	11.6	17.4	13.2	8.5	11.9	9.2	9.2	11.8	6.4	18.2	18.8	22.4	0.6	8.2	7.5	14.7	10.8	12.4	18.1	2.8	41.6	9.3	6.2	4.9	15.2	3.0	3.9	3.0	6.7	3.4	2.8	5.1	6.6	2.7	3.2	30.6	2.8	3.9	11.1	3.3	2.4	5.9	7.5	7.7	8.6	8.2	6.0	3.4	2.4	3.7	3.3	6.1	7.1	28.3	16.0	16.7	33.6	27.6	3.3	10.7	8.6	3.4	40.2	9.8	6.5	12.0	20.0	15.0	16.5	39.6	22.9	24.1	14.3	5.9	28.3	5.4	8.8	3.0	53.1	25.6	39.2	181.7	15.4	7.8	7.8	13.7	16.5	10.8	24.3	77.1	14.2	21.4	23.5	100.3	16.6	14.2	18.2	12.5	12.6	4.4	18.9	5.4	146.1	22.8	27.1	19.6	157.3	84.7	14.1	10.3	14.7	13.8	14.1	10.8	8.4	10.0	177.8	13.1	13.6	9.0	25.0	25.5	4.9	4.8	20.5	18.4	29.8	11.9	15.8
EXOC6B	"KIAA0919, SEC15B, SEC15L2"	ENSG00000144036	"Exocyst complex component 6B"	Q9Y2D4	2	72175984-72826041	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 210.3;Excitatory neurons: 351.1;Inhibitory neurons: 393.6;Microglial cells: 286.7;Oligodendrocyte precursor cells: 288.5;Oligodendrocytes: 863.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034546, HPA063991"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034546: AB_2674218, HPA063991: AB_2685168"	"unprognostic (5.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.29e-2)"	11.3	13.4	22.3	4.2	32.7	1.2	8.6	18.8	23.9	12.6	3.2	8.6	7.3	10.1	6.0	15.1	7.8	6.5	50.7	20.7	25.7	7.2	3.8	7.2	3.1	23.9	25.7	15.0	5.0	13.2	6.1	13.0	23.3	8.0	5.7	14.1	7.7	8.9	11.1	26.5	9.1	10.0	16.4	5.2	6.9	6.9	22.2	4.4	10.2	11.5	6.4	9.7	13.0	40.9	21.7	16.3	14.7	17.8	41.2	16.9	25.3	15.6	21.9	13.2	8.6	22.3	3.3	5.6	9.5	26.2	19.6	35.4	12.4	25.7	18.9	4.2	10.1	16.7	11.0	12.8	22.2	2.4	5.5	14.6	36.6	14.9	23.1	20.6	21.8	8.7	1.8	0.0	17.6	7.5	6.4	2.9	15.3	14.9	9.0	3.4	26.4	2.3	12.7	50.1	7.3	6.3	26.7	8.2	10.9	16.1	5.7	2.3	24.3	15.2	12.8	13.1	9.6	5.5	5.9	0.0	17.7	1.2	12.4	1.3	0.5	0.0	0.7	0.4	0.5	0.7	0.5	0.4	0.4	0.7	0.6	0.9	0.0	0.5	0.6	0.1	0.8	0.4	22.3	32.7	18.8	23.9	20.7	25.7	23.9	25.7	23.3	16.4	22.2	40.9	17.8	0.0	4.1	210.3	4.1	26.1	10.2	9.8	14.8	17.4	5.2	5.2	87.1	12.8	5.1	9.2	25.0	15.1	5.0	10.2	5.9	9.3	62.9	5.6	14.5	14.1	3.0	2.1	351.1	11.5	13.2	12.4	30.5	9.2	8.2	11.6	11.4	5.6	4.6	16.8	393.6	6.0	4.1	12.0	7.1	8.2	8.4	5.0	5.4	286.7	2.0	9.9	1.0	288.5	863.3	11.0	8.6	7.5	3.7	8.1	28.2	5.5	8.4	11.1	0.0	13.5	14.7	12.0	4.9	13.1	37.4	24.6	4.7	5.5	4.5	10.7
EXOSC1	"CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p"	ENSG00000171311	"Exosome component 1"	Q9Y3B2	10	97435909-97446017	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038370	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"	Nucleoplasm	"HPA038370: AB_10672515"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.88e-9)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.41e-2)"	21.9	25.4	31.4	23.5	34.3	28.7	22.4	50.4	39.9	25.5	27.7	25.6	24.3	24.0	42.6	28.4	22.2	17.0	23.5	29.7	33.6	25.3	26.9	20.5	32.3	33.3	32.2	23.6	38.8	21.1	24.2	17.6	32.6	24.5	23.5	21.2	26.6	17.3	29.0	23.5	22.3	22.1	32.6	30.3	31.2	15.2	32.8	32.5	21.6	14.8	31.9	25.3	22.9	36.3	62.9	49.6	34.8	61.7	42.1	44.3	47.0	52.2	73.9	57.2	64.4	86.5	62.1	60.4	59.0	50.2	44.1	64.0	52.5	58.9	56.6	77.3	61.3	39.5	48.0	68.9	74.5	94.2	46.1	45.8	77.9	69.6	101.3	70.2	66.3	90.5	45.6	108.0	43.2	70.3	88.0	153.3	58.1	64.7	43.2	65.8	43.4	106.4	39.4	32.8	20.4	38.3	38.6	30.0	87.6	44.1	71.2	113.2	43.6	31.9	40.1	50.4	117.6	72.5	103.1	119.5	54.3	113.2	26.3	79.0	91.0	93.5	75.5	132.8	96.5	109.6	93.1	87.9	96.4	94.7	89.4	78.1	35.7	57.9	121.7	82.9	144.0	86.4	31.4	34.3	50.4	39.9	29.7	33.6	33.3	32.2	32.6	32.6	32.8	36.3	22.5	25.6	24.6	15.0	42.4	19.1	35.7	59.3	18.2	31.0	22.5	27.3	20.5	27.1	35.8	44.1	27.1	48.6	41.2	15.4	39.2	36.0	17.4	22.6	24.1	27.7	14.3	23.8	24.7	41.8	58.1	27.0	21.9	16.7	25.3	31.0	34.6	25.3	50.9	30.3	22.2	28.1	36.7	31.4	20.7	17.0	32.6	28.7	30.2	17.8	61.0	29.1	61.8	12.1	25.5	35.9	20.0	24.0	43.6	24.9	30.1	53.8	47.1	48.1	26.3	20.7	35.2	35.8	39.1	27.6	24.4	41.2	44.3	26.4	25.7	31.7
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099869	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.33e-1)"	31.8	21.4	18.3	25.9	18.4	39.4	30.8	23.1	22.2	32.5	14.7	27.6	20.7	28.7	23.9	27.3	26.4	19.2	20.3	17.7	15.9	21.8	20.0	24.3	31.1	17.2	15.2	35.8	24.0	25.2	26.1	26.1	16.6	25.3	27.6	35.4	25.4	21.0	33.3	37.0	26.1	27.5	13.7	27.4	26.1	23.4	17.9	32.7	23.3	22.6	34.2	24.6	28.4	19.1	66.4	41.5	84.9	33.0	44.3	48.7	48.5	63.8	46.8	109.8	99.1	61.6	94.1	66.3	40.3	61.0	48.8	64.2	95.0	71.2	100.1	74.9	95.0	96.5	80.5	63.2	43.4	79.5	73.7	38.4	60.2	108.1	63.1	40.9	69.4	58.0	103.2	59.3	61.4	37.4	78.5	73.1	56.5	50.3	49.1	79.8	72.2	58.1	64.8	33.3	54.5	53.3	68.8	58.9	77.0	59.4	51.5	72.1	63.6	58.2	60.4	53.0	76.2	35.7	60.0	130.0	59.4	116.2	71.5	57.7	32.0	26.6	36.2	41.5	43.0	36.4	37.7	36.7	37.9	36.5	31.9	35.4	6.2	49.3	51.2	19.3	39.4	43.3	18.3	18.4	23.1	22.2	17.7	15.9	17.2	15.2	16.6	13.7	17.9	19.1	18.4	28.9	18.3	17.0	26.1	13.3	14.3	19.8	26.2	14.9	11.0	23.6	6.4	12.8	29.2	5.5	47.9	26.5	18.8	16.4	9.8	25.0	16.4	14.3	21.0	20.1	9.0	28.0	20.3	31.9	34.3	17.2	31.1	19.2	20.2	26.2	13.9	11.1	24.7	21.9	24.3	16.5	22.4	15.1	14.1	7.1	29.5	18.7	12.4	9.4	24.0	6.1	28.8	30.2	15.2	30.2	9.4	23.0	26.8	8.5	12.7	8.8	27.3	34.8	13.1	18.4	17.6	21.9	20.8	28.7	13.4	22.7	21.2	19.7	20.1	10.0
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease variant, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA021756: AB_2670809, HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	9.1	8.2	8.6	13.8	8.7	9.9	12.6	8.9	11.1	8.9	8.6	10.3	7.7	12.8	6.8	10.0	12.8	5.6	8.8	8.9	8.9	9.7	13.0	6.7	13.0	8.5	8.6	14.8	9.9	11.5	3.2	9.2	8.4	9.3	11.9	10.6	7.1	9.0	15.0	8.4	8.3	12.9	8.9	8.3	8.2	4.1	8.6	14.6	8.4	12.0	15.8	10.1	8.6	9.3	39.9	79.7	46.6	41.2	16.8	18.9	34.0	58.6	28.1	57.4	44.1	64.4	33.7	79.0	31.2	31.8	62.9	71.0	75.8	58.8	62.9	46.9	36.7	63.1	75.2	45.3	31.3	96.7	39.9	24.0	21.7	80.8	94.1	21.1	41.6	52.3	70.1	33.1	41.0	70.3	68.2	27.3	57.8	109.3	51.0	52.3	85.8	85.5	27.5	36.4	28.6	31.8	68.3	51.4	31.1	32.8	53.5	34.1	25.5	56.1	43.5	50.2	83.3	16.8	71.4	117.2	40.0	55.0	44.7	1.7	7.3	6.0	10.0	8.3	10.6	11.6	10.2	8.9	10.4	10.0	11.1	9.4	1.6	16.5	5.7	7.1	10.1	7.7	8.6	8.7	8.9	11.1	8.9	8.9	8.5	8.6	8.4	8.9	8.6	9.3	7.6	6.4	20.5	3.6	13.5	10.6	12.6	7.7	8.0	12.4	6.1	8.3	8.7	4.3	5.7	3.7	6.2	19.1	10.6	6.0	5.9	13.4	1.4	3.8	11.4	8.0	1.2	23.5	5.3	11.3	22.8	9.8	5.1	4.5	12.7	14.0	7.1	10.7	12.8	5.0	5.2	7.9	4.1	2.5	5.7	1.7	8.4	7.8	7.2	1.9	5.4	14.7	13.4	4.5	4.0	8.3	2.7	7.9	13.7	14.2	5.0	10.4	6.7	15.0	6.6	11.7	10.2	5.8	10.9	10.6	8.4	8.3	10.1	11.9	10.0	8.1
EXOSC3	"CGI-102, hRrp-40, hRrp40p, p10, RRP40, Rrp40p"	ENSG00000107371	"Exosome component 3"	Q9NQT5	9	37759234-37832117	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020485	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020485: AB_10960685"	"unprognostic (7.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (1.71e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	9.9	12.3	5.4	9.7	5.7	6.5	9.1	8.7	6.3	10.4	5.6	9.1	7.2	9.7	4.3	14.4	8.8	4.1	7.8	5.4	5.4	10.5	10.1	7.5	11.1	4.9	5.4	10.3	7.9	6.9	8.5	6.6	5.0	9.4	6.2	5.2	9.3	6.5	11.4	8.2	8.9	5.1	5.7	10.8	8.9	21.6	5.5	12.9	8.4	5.3	11.8	10.2	11.5	7.1	69.2	46.8	25.1	32.5	16.5	13.4	33.7	38.5	15.0	31.7	29.6	63.0	11.1	52.3	29.0	14.3	36.2	26.2	28.3	27.3	35.7	75.1	46.9	43.4	57.5	59.3	19.4	66.7	38.5	9.1	13.5	24.0	15.2	10.2	17.0	38.1	108.7	24.7	22.8	40.9	59.3	53.1	69.6	61.7	53.9	53.9	31.2	29.2	17.9	22.0	36.8	36.4	21.9	18.0	26.3	19.8	23.7	48.0	19.7	25.4	47.1	32.0	62.2	16.5	45.4	70.7	25.7	51.2	28.9	34.1	44.4	36.8	35.6	53.9	45.7	53.1	42.9	47.8	42.4	49.1	43.0	41.3	27.8	40.2	49.3	50.4	51.2	55.6	5.4	5.7	8.7	6.3	5.4	5.4	4.9	5.4	5.0	5.7	5.5	7.1	14.7	22.4	19.9	3.3	25.8	54.2	32.7	47.2	8.6	7.4	17.1	19.3	7.8	22.8	24.0	7.3	0.0	58.0	22.6	13.5	33.2	40.6	74.3	19.2	20.1	14.6	10.7	29.5	4.3	34.9	76.7	20.9	8.6	13.2	29.2	23.7	12.8	13.1	45.4	6.7	4.1	14.9	22.4	19.9	17.9	16.4	16.8	17.6	19.6	1.9	26.3	11.2	20.6	2.5	5.9	34.9	17.7	13.2	19.9	27.6	15.7	32.7	21.9	7.5	26.3	17.6	30.6	132.4	53.1	20.0	54.1	31.5	19.6	28.9	20.2	27.2
EXOSC4	"FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p"	ENSG00000178896	"Exosome component 4"	Q9NPD3	8	144078648-144080648	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 94.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 320.6;Late spermatids: 856.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 430.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024792, HPA065103"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA024792: AB_1848325, HPA065103: "	"unprognostic (2.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (2.23e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.11e-2)"	19.3	31.2	15.1	11.4	16.5	14.9	16.9	16.0	23.4	13.1	16.1	18.8	15.4	17.0	5.0	27.5	16.1	7.2	23.7	15.6	15.0	23.6	35.0	16.0	12.1	16.8	14.9	12.3	18.8	10.3	17.6	9.2	15.5	18.8	5.7	3.5	26.6	12.5	21.2	22.1	15.2	6.1	15.4	23.8	24.0	94.9	15.8	10.1	13.9	8.2	6.6	17.4	15.2	15.9	51.8	104.8	18.1	44.2	15.6	11.7	51.8	39.9	15.2	28.9	28.9	73.4	33.4	28.9	54.6	15.5	21.0	40.4	33.8	40.5	8.3	42.5	117.8	42.7	77.9	83.3	25.9	31.4	48.6	16.9	40.9	33.2	26.2	11.4	14.8	32.0	68.8	19.8	23.8	177.8	51.4	62.0	47.6	51.2	430.6	21.7	30.2	74.8	27.7	48.3	57.6	75.4	46.6	59.7	95.4	9.3	68.1	49.0	15.2	29.9	66.3	73.6	68.1	52.4	67.8	37.5	43.1	50.8	47.7	61.5	78.3	34.1	37.4	76.6	38.7	59.7	29.3	37.4	75.0	60.2	37.7	36.2	22.9	45.6	43.0	97.4	36.1	49.5	15.1	16.5	16.0	23.4	15.6	15.0	16.8	14.9	15.5	15.4	15.8	15.9	16.3	9.6	21.3	2.9	17.8	94.4	45.2	58.6	45.5	10.0	40.7	41.4	22.3	24.3	31.9	27.6	8.4	48.2	17.2	46.6	123.3	50.6	320.6	23.8	28.3	25.5	25.9	24.6	3.2	46.3	44.2	24.7	25.0	18.8	14.0	21.0	19.2	54.9	44.7	6.7	3.3	35.6	48.8	29.8	40.7	856.7	18.6	29.9	35.6	0.0	45.7	23.5	14.4	3.0	3.6	61.7	52.4	21.1	32.5	55.5	41.0	102.5	31.7	8.2	13.1	14.7	43.5	97.0	34.7	48.1	87.9	48.2	12.8	37.8	47.1	48.7
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397359	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli	Nucleoplasm	"HPA053150: AB_2682058, HPA055677: AB_2682882"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	12.9	19.4	18.6	14.1	20.2	17.4	14.0	18.9	26.1	12.5	15.1	13.3	11.4	11.3	4.2	21.4	15.1	6.6	16.8	18.8	17.8	9.9	21.7	7.3	22.0	20.8	18.4	14.3	28.6	5.9	7.2	7.4	19.2	11.0	7.2	2.3	16.4	8.4	41.7	23.0	10.8	7.2	19.0	14.3	13.6	11.4	18.3	14.8	11.6	23.1	11.8	14.7	13.9	22.1	58.2	123.5	15.1	48.8	10.7	13.5	39.4	24.5	13.1	44.6	37.0	72.5	47.5	92.9	64.8	12.9	22.8	25.1	33.1	31.3	12.2	66.7	117.3	42.7	45.5	55.7	32.1	76.7	41.8	16.3	69.0	35.6	33.8	12.1	21.1	57.7	57.5	70.2	14.2	88.1	70.2	58.6	56.6	85.2	59.9	66.9	40.9	94.8	17.6	43.1	64.4	47.8	34.6	62.4	68.2	10.5	31.1	95.6	16.2	45.9	37.4	30.1	76.9	109.6	138.5	106.3	34.9	116.0	39.0	15.2	68.2	1.9	41.3	77.7	47.9	66.0	43.3	40.9	110.1	74.0	63.2	55.4	5.0	62.1	48.6	118.7	37.0	48.6	18.6	20.2	18.9	26.1	18.8	17.8	20.8	18.4	19.2	19.0	18.3	22.1	16.1	3.2	4.8	2.3	21.3	30.5	29.0	29.6	44.9	5.5	30.1	44.2	8.4	22.8	16.9	18.4	4.2	28.4	23.5	12.7	37.2	21.7	9.1	5.5	16.7	11.1	8.5	28.0	5.0	21.4	124.0	13.1	16.3	9.1	5.1	24.7	7.1	20.3	28.8	6.7	4.8	18.4	20.3	11.8	13.3	8.5	16.8	18.9	14.2	2.8	18.9	7.0	18.6	4.0	4.3	17.2	15.3	12.4	21.3	28.0	6.6	34.9	12.7	4.1	6.6	17.8	16.0	17.0	33.1	47.4	33.2	21.2	17.0	31.5	34.2	23.8
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801318-121817021	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.0;Spermatocytes: 170.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	14.7	14.3	9.2	16.7	9.9	37.9	14.4	10.5	15.3	11.9	8.4	11.7	9.3	12.9	14.4	12.3	12.9	8.1	15.7	9.4	9.9	11.8	16.0	13.6	25.8	9.3	9.2	12.9	11.2	14.7	11.0	14.1	9.3	10.4	12.6	9.9	11.9	9.3	21.6	13.9	12.0	10.2	9.0	15.8	11.7	43.4	9.2	32.8	10.1	18.6	21.1	14.8	11.9	10.4	66.3	29.9	76.7	44.4	10.7	20.6	39.2	83.7	45.4	114.6	84.5	32.5	53.2	113.9	20.1	50.5	35.7	23.2	83.1	38.1	95.6	51.1	39.9	56.8	43.4	43.0	26.0	98.5	51.1	16.1	20.1	77.8	20.3	23.7	56.0	72.6	102.2	42.3	110.0	38.9	154.6	78.6	42.7	25.2	34.7	80.6	134.4	52.4	41.4	21.0	51.3	53.7	28.8	45.5	52.3	38.9	38.2	64.2	35.2	50.4	76.5	44.4	80.9	63.0	49.7	132.5	52.4	67.8	34.2	15.8	14.5	23.4	17.6	21.1	18.5	20.7	20.9	25.4	17.9	22.4	22.1	22.6	3.8	14.4	21.3	15.9	24.9	14.0	9.2	9.9	10.5	15.3	9.4	9.9	9.3	9.2	9.3	9.0	9.2	10.4	20.4	44.8	19.1	4.9	20.8	12.7	15.5	31.7	18.8	10.7	6.7	10.7	13.2	17.2	25.4	3.7	10.4	31.4	21.5	5.7	1.9	23.7	154.0	10.9	15.6	17.6	6.0	27.0	10.4	30.5	31.3	15.8	7.7	11.8	31.0	25.4	10.0	5.5	24.5	16.8	8.8	9.8	28.5	11.9	10.1	21.8	13.1	16.3	8.8	11.2	22.2	15.3	16.5	6.6	10.9	20.2	9.2	10.9	22.9	8.4	6.5	8.5	16.8	17.7	6.6	23.4	21.8	170.4	62.8	14.1	14.8	10.9	26.2	16.5	11.6	12.1
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895179	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 214.1;Theca cells: 328.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		80000000	"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: AB_2686058"	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	8.8	24.6	11.4	5.0	15.0	2.2	11.5	12.0	16.4	13.9	19.1	10.8	4.8	18.1	13.7	6.5	10.9	11.4	9.2	10.3	15.4	12.9	12.6	8.4	4.2	12.9	14.9	19.6	9.0	14.6	12.9	24.9	13.7	13.4	7.6	13.9	7.1	11.9	6.9	6.5	5.4	17.0	11.2	6.5	7.3	10.7	17.8	8.2	10.1	7.1	3.7	9.2	6.9	11.3	13.0	6.9	50.2	50.7	53.2	39.3	31.4	23.2	37.5	17.5	39.4	6.1	9.9	15.2	21.8	20.9	13.5	12.7	18.3	19.6	35.4	31.8	13.4	19.0	23.6	18.3	17.5	28.9	9.3	47.3	6.8	35.9	6.6	36.5	65.0	19.2	23.9	2.0	45.1	6.9	15.5	15.5	62.2	12.2	15.5	11.2	51.5	12.1	18.4	9.7	20.6	57.5	17.4	4.6	42.0	35.8	10.9	12.7	27.7	44.0	25.8	27.8	24.4	15.5	15.0	9.8	69.2	29.3	14.4	2.0	0.5	0.0	3.4	0.7	1.5	1.2	1.1	2.3	1.7	1.7	1.2	2.7	0.1	3.9	0.5	4.6	0.0	1.2	11.4	15.0	12.0	16.4	10.3	15.4	12.9	14.9	13.7	11.2	17.8	11.3	12.3	12.8	8.4	39.8	4.9	8.5	10.2	13.8	21.1	20.7	13.2	13.5	12.7	10.0	11.0	14.7	35.5	214.1	5.0	3.3	11.7	5.8	45.3	20.3	28.7	13.1	9.5	16.2	47.1	2.1	36.9	36.0	15.3	11.0	17.7	35.3	13.6	16.4	24.3	3.3	49.9	5.6	12.2	7.3	5.7	34.9	25.1	5.8	23.2	12.2	7.4	18.8	8.2	40.7	32.9	2.4	2.6	34.6	5.9	6.2	2.9	11.9	25.3	19.7	13.1	25.4	22.4	37.1	12.3	8.5	8.1	74.3	6.1	328.5	7.1	4.9
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 18.7;parathyroid gland: 23.7"	"Cell type enriched"	"Detected in some"	11	"Astrocytes: 214.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.6;RH-30: 21.3;RPMI-8226: 9.5;SH-SY5Y: 51.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 20.7"	HPA028917			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	0.6	0.6	2.8	0.1	7.8	0.0	0.2	0.5	2.1	5.1	18.7	0.1	0.1	0.1	0.1	0.4	2.0	0.3	4.5	1.3	2.5	0.1	0.0	0.4	0.0	2.1	4.9	0.2	0.0	23.7	10.8	0.0	2.3	12.0	0.2	0.4	0.8	4.0	2.8	0.0	0.2	0.2	0.0	0.1	0.8	0.8	4.6	11.7	0.6	2.5	0.1	2.6	4.3	0.6	0.2	0.0	6.4	27.6	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	1.6	0.0	0.0	4.7	0.0	2.2	0.0	0.0	0.5	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	2.0	0.0	1.5	0.0	21.3	9.5	0.0	0.0	2.2	51.4	0.0	0.0	1.6	5.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	6.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.8	0.5	2.1	1.3	2.5	2.1	4.9	2.3	0.0	4.6	0.6	0.2	0.0	0.0	214.5	0.0	0.1	0.0	6.4	0.6	0.1	0.0	0.1	8.8	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	3.1	0.1	0.2	0.0	0.0	1.3	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	13.5	0.0	2.0	0.0	0.0	6.4	0.3	0.0	0.0	11.2	0.0	0.1	0.0	18.6	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	10.5	0.2	0.0	0.2	0.5	0.8	1.0	1.1	0.1	0.5	0.0	1.4	0.0	0.1
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088637	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 80.2;Oligodendrocytes: 80.5;Spermatocytes: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA052432: AB_2681831, HPA062889: AB_2684895"	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	4.7	4.8	7.4	8.2	7.0	5.2	7.1	8.8	7.9	7.4	9.6	5.7	5.9	6.1	6.4	9.9	6.2	4.3	6.4	6.5	7.6	11.6	6.0	5.9	9.4	7.1	7.1	6.4	6.5	8.3	7.6	7.7	7.2	6.1	6.2	10.5	5.6	5.4	7.1	9.0	6.3	5.5	6.4	7.2	5.5	11.4	7.6	9.4	9.3	8.3	14.4	7.1	6.1	7.9	16.3	6.6	13.1	9.7	14.9	11.6	7.3	11.8	11.0	13.2	12.9	6.4	9.5	25.5	12.3	7.8	4.9	15.3	24.4	9.5	15.6	13.4	13.5	28.2	14.4	11.6	8.8	27.9	25.2	7.0	8.3	14.6	9.7	11.3	17.0	9.0	26.9	9.6	11.9	7.0	18.0	18.5	27.5	12.6	8.6	13.2	24.9	16.8	15.3	8.8	14.9	8.2	12.6	7.6	11.0	10.5	6.2	7.3	16.6	15.9	8.4	15.1	9.4	13.9	15.2	22.0	11.5	26.7	7.0	5.7	6.8	7.3	7.5	6.9	6.7	5.2	5.8	5.4	8.3	4.6	4.9	5.6	6.4	7.1	6.1	5.1	5.4	1.9	7.4	7.0	8.8	7.9	6.5	7.6	7.1	7.1	7.2	6.4	7.6	7.9	12.6	9.6	10.8	46.4	17.5	17.8	11.3	10.0	9.6	18.3	12.0	7.1	9.2	12.8	7.9	25.8	16.7	13.0	10.6	8.2	15.6	13.5	80.2	13.6	13.2	12.9	20.4	9.9	66.0	8.9	14.4	11.6	16.8	15.3	12.0	15.8	14.6	8.7	9.7	18.5	58.8	9.1	12.2	13.3	46.1	39.1	10.2	14.6	12.4	39.4	12.9	8.1	10.3	45.2	80.5	14.5	10.9	6.0	13.7	12.0	13.8	18.0	5.7	20.6	13.1	11.1	8.4	98.7	50.6	10.7	22.9	10.9	15.8	9.6	10.5	11.7
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532128	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.6;tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Inhibitory neurons: 139.0;Oligodendrocytes: 79.2;Skeletal myocytes: 26.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;GAMG: 25.6;HeLa: 74.3;RH-30: 23.8;U-87 MG: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.1	2.5	2.6	0.1	1.9	0.0	0.4	2.2	1.9	2.6	13.3	0.2	0.2	0.5	1.2	0.4	7.4	0.5	5.8	2.3	1.2	5.0	0.0	1.8	0.1	5.6	7.9	1.2	0.2	0.0	0.8	0.0	4.5	5.7	0.2	0.1	0.2	11.8	27.6	0.0	0.1	0.3	4.5	0.4	0.4	3.0	3.3	6.6	2.1	21.3	0.5	2.2	2.3	4.9	0.0	25.4	2.4	0.0	0.0	0.0	0.0	0.0	20.4	0.5	2.9	0.1	0.1	0.1	19.6	0.0	25.6	0.0	15.4	6.7	0.0	0.0	20.2	2.8	74.3	0.0	0.6	0.0	6.8	5.1	0.0	14.4	4.5	3.4	0.0	0.0	0.0	10.7	8.1	0.0	0.0	0.0	0.0	0.3	1.6	0.3	23.8	0.0	0.0	3.9	3.7	4.1	0.2	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	18.4	7.2	3.4	0.0	24.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	2.2	1.9	2.3	1.2	5.6	7.9	4.5	4.5	3.3	4.9	0.3	12.8	1.8	2.6	0.0	0.1	0.1	13.3	0.0	0.0	0.0	0.0	14.4	0.0	6.7	46.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.1	0.1	0.5	1.8	0.0	4.8	0.2	0.0	2.9	0.0	0.1	0.0	1.5	0.4	0.1	0.0	0.0	139.0	0.0	8.2	1.0	0.0	2.6	0.6	0.2	0.0	2.8	7.2	0.0	0.0	1.5	79.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.8	0.0	0.0	26.2	3.3	7.9	7.1	0.0	0.0	0.0	0.1	1.5	0.0	0.2
EZH1	"KIAA0388, KMT6B"	ENSG00000108799	"Enhancer of zeste 1 polycomb repressive complex 2 subunit"	Q92800	17	42700275-42745049	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 133.4"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 258.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005478, HPA077684"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA005478: AB_1848340, HPA077684: AB_2732356"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.74e-2)"	39.6	18.1	35.0	14.4	37.4	15.2	34.1	42.4	41.5	41.5	29.4	31.6	13.0	31.1	26.5	21.6	35.6	12.8	31.8	33.9	33.9	28.6	13.4	25.7	20.5	37.7	36.5	47.8	18.3	25.5	26.3	12.5	40.2	26.0	15.4	133.4	20.2	23.8	43.8	26.1	30.6	20.4	32.3	37.8	20.7	12.0	35.8	22.9	28.4	33.2	20.4	29.2	31.4	41.5	8.9	9.3	12.4	8.5	48.4	29.1	10.4	14.0	12.7	11.4	11.6	4.4	10.8	13.4	8.6	15.0	11.2	19.8	8.1	9.2	16.3	15.0	14.5	4.7	19.7	5.4	16.6	10.2	10.8	16.7	16.6	8.6	20.8	20.0	9.4	13.4	12.5	18.5	10.2	3.7	16.6	12.9	3.4	8.2	4.7	10.7	12.4	14.5	11.7	9.3	8.4	6.8	7.8	3.8	9.5	17.5	13.2	6.5	9.8	12.2	5.0	14.4	8.9	19.3	10.4	8.0	8.8	10.4	6.4	14.2	5.2	7.8	6.0	5.4	8.2	5.8	5.3	6.1	2.0	6.3	7.7	5.8	19.7	5.8	3.6	6.3	6.4	2.6	35.0	37.4	42.4	41.5	33.9	33.9	37.7	36.5	40.2	32.3	35.8	41.5	34.2	9.6	20.8	41.1	23.6	5.2	14.2	6.6	8.6	71.7	8.7	13.1	39.3	20.0	14.1	12.9	66.7	7.9	24.6	9.3	9.8	11.2	0.7	21.8	23.2	20.7	13.1	36.4	36.8	7.5	3.2	25.3	8.6	25.5	20.3	19.4	15.4	7.8	9.0	47.1	34.0	4.9	12.2	17.1	7.2	2.8	31.1	14.7	1.8	15.0	24.1	30.8	33.0	20.6	58.9	12.1	7.7	34.3	15.9	9.1	12.9	10.7	28.0	258.1	52.6	32.7	24.1	10.7	10.6	6.6	6.1	10.8	21.8	26.2	7.4	9.6
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.9;lymphoid tissue: 43.0;testis: 27.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 109.3;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009589, HPA029131"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB009589: , HPA029131: AB_2672920"	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	1.5	1.5	1.1	10.1	1.1	47.9	2.7	2.0	1.3	2.7	1.5	7.0	6.4	2.0	1.2	10.8	1.1	1.9	1.2	1.1	1.1	2.1	3.3	2.3	22.1	1.2	1.2	1.6	3.7	1.3	0.5	4.8	1.2	1.3	8.2	3.3	2.8	0.2	2.9	10.7	6.9	2.8	1.0	5.6	4.0	27.8	1.5	43.0	1.3	1.9	21.1	3.5	3.8	1.2	65.6	30.1	99.7	66.9	3.1	5.1	54.6	49.7	19.9	39.9	40.2	45.6	73.2	114.3	23.5	18.7	36.3	39.0	52.1	17.1	50.6	164.9	51.8	48.9	38.4	35.5	8.0	110.1	38.5	4.3	9.6	29.9	15.9	12.1	24.0	108.9	105.9	73.6	36.2	74.0	215.7	91.7	79.6	57.0	39.9	131.3	56.0	70.9	18.6	31.0	95.1	60.3	62.3	46.8	16.5	25.3	34.3	46.7	14.8	42.4	19.8	85.2	90.4	65.7	76.6	115.3	38.6	74.2	84.9	0.4	1.7	1.1	1.2	1.2	0.9	1.1	2.6	2.2	3.8	0.6	1.4	0.9	0.1	7.2	3.6	0.8	8.3	1.2	1.1	1.1	2.0	1.3	1.1	1.1	1.2	1.2	1.2	1.0	1.5	1.2	14.4	0.0	6.7	1.3	14.5	26.5	6.7	6.3	10.2	6.0	15.1	12.2	6.1	2.8	7.1	7.3	35.5	28.8	35.9	14.7	3.9	9.5	109.3	16.3	17.0	9.4	9.0	57.0	6.2	8.5	32.2	9.9	15.8	24.2	21.6	45.9	3.3	2.2	11.9	15.2	9.2	20.5	6.1	9.0	33.6	27.7	3.1	19.1	14.2	14.0	14.9	2.6	12.3	16.6	7.0	12.4	10.5	0.7	37.4	4.8	6.8	1.2	9.7	21.3	6.6	13.8	24.1	142.2	58.2	35.8	29.0	30.5	25.7	4.7	22.1	5.9
EZHIP	"CATACOMB, CXorf67"	ENSG00000187690	"EZH inhibitory protein"	Q86X51	X	51406948-51408843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 5.9"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 2.3;Extravillous trophoblasts: 2.5;Syncytiotrophoblasts: 1.9"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 11.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	45	"U-2 OS: 32.8"									"HPA004003, HPA006128"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA004003: AB_2667113, HPA006128: AB_2667517"					"unprognostic (4.21e-2)"			"unprognostic (6.36e-2)"		"unprognostic (3.37e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.57e-4)"	"unprognostic (1.47e-6)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.26e-1)"		0.0	0.2	0.7	0.0	0.7	0.0	0.0	0.6	0.6	0.2	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	1.4	0.2	0.0	0.1	0.0	0.5	0.3	0.4	0.1	0.0	1.0	0.9	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	5.9	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.6	0.6	0.2	1.4	0.5	0.3	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0
FAAP100	"C17orf70, FLJ22175"	ENSG00000185504	"FA core complex associated protein 100"	Q0VG06	17	81539885-81553961	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023954, HPA024626, HPA026532"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.24e-1)"	14.7	16.8	6.7	13.8	7.0	10.1	15.9	14.7	9.5	18.6	6.8	15.8	12.0	17.3	3.1	16.2	18.8	9.5	16.3	6.7	6.4	21.2	22.7	16.0	15.9	8.1	6.5	19.5	26.6	7.8	22.4	7.2	6.3	20.7	4.9	3.7	14.6	7.8	13.2	16.1	18.8	6.9	5.1	38.1	15.5	13.3	7.3	8.8	24.1	6.0	7.3	17.9	15.5	8.8	11.7	21.3	9.4	26.8	11.0	11.5	14.6	11.2	5.9	14.3	8.9	14.5	14.0	21.0	8.6	15.5	13.8	15.0	4.9	14.5	3.3	6.1	13.9	13.5	23.3	20.0	11.6	15.4	16.0	14.0	10.7	10.4	11.7	17.6	27.0	22.0	20.7	16.5	7.0	23.0	24.4	25.8	11.3	13.6	7.7	22.1	9.4	19.3	10.4	21.1	20.5	17.1	8.5	24.4	10.4	9.7	26.2	20.7	22.8	30.6	18.8	8.3	18.9	18.3	1.5	10.7	8.0	9.9	14.3	0.0	3.0	1.2	2.4	2.8	1.9	3.0	1.6	1.6	2.9	2.0	1.5	1.2	0.4	2.4	1.4	3.2	1.6	2.2	6.7	7.0	14.7	9.5	6.7	6.4	8.1	6.5	6.3	5.1	7.3	8.8	11.4	3.2	7.5	0.0	7.5	0.0	3.5	0.0	4.6	10.3	9.8	10.9	8.9	10.0	2.5	14.7	4.2	6.1	8.5	7.1	3.9	8.2	1.9	4.5	7.3	7.5	7.3	11.8	0.0	6.9	4.8	8.3	15.8	6.8	0.0	14.9	6.8	11.7	8.4	6.7	0.0	6.2	0.0	14.1	0.0	3.0	5.0	7.0	0.0	0.0	8.9	6.2	4.1	0.0	0.0	8.9	4.4	5.3	6.6	5.3	12.7	6.8	1.5	4.9	0.0	7.4	6.4	7.3	7.5	9.5	0.0	3.1	6.2	10.7	7.3	3.6
FAAP20	"C1orf86, FLJ31031"	ENSG00000162585	"FA core complex associated protein 20"	Q6NZ36	1	2184461-2212720	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 337.5;Proximal tubular cells: 290.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038829	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Cell Junctions"	"HPA038829: AB_10673476"	"unprognostic (1.36e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.55e-2)"	39.3	57.5	18.1	3.2	18.9	5.6	41.2	20.8	28.0	52.5	20.5	48.5	4.6	50.0	1.3	38.8	37.8	1.5	50.0	14.5	19.6	64.8	52.1	37.9	3.6	24.6	18.9	45.3	38.7	5.1	75.5	3.2	19.6	61.1	1.8	3.7	30.7	7.1	26.4	42.7	31.8	1.8	20.2	45.0	47.3	54.8	26.9	2.9	52.9	4.0	3.1	43.7	40.7	18.9	27.7	4.4	5.8	7.3	3.6	4.7	34.8	30.4	11.0	9.6	12.9	6.7	18.0	31.7	43.7	4.8	9.0	13.5	4.2	4.6	4.9	68.3	61.0	26.5	6.8	14.4	13.5	18.7	24.8	8.1	9.8	5.8	6.3	5.9	11.9	24.6	37.1	7.6	6.7	11.6	27.0	57.6	20.8	5.4	55.6	36.0	18.1	30.7	4.6	4.5	47.4	63.5	19.8	8.6	58.5	5.3	8.5	7.5	25.6	15.1	35.8	18.7	17.4	68.9	39.9	48.2	28.0	11.4	6.4	9.8	16.4	63.4	18.4	16.9	18.1	28.3	16.5	19.8	17.0	25.7	22.2	18.6	20.6	10.8	15.6	42.4	16.2	10.6	18.1	18.9	20.8	28.0	14.5	19.6	24.6	18.9	19.6	20.2	26.9	18.9	71.7	6.4	11.9	0.0	82.3	0.0	97.7	0.0	79.6	29.1	120.9	138.2	22.1	62.9	6.8	97.5	4.2	119.7	83.6	14.5	170.2	128.5	102.7	44.3	77.2	62.1	43.7	36.8	0.0	110.8	144.1	65.3	64.7	49.9	7.6	74.8	84.6	94.5	134.0	15.2	0.0	56.0	0.0	110.8	0.0	337.5	86.0	82.3	0.0	0.0	178.9	84.7	91.6	0.0	0.0	141.1	40.8	82.8	60.9	152.8	56.2	290.1	8.0	29.5	65.7	63.3	68.8	101.5	38.3	88.4	0.0	89.8	62.4	102.5	42.2	113.2
FAAP24	"C19orf40, FLJ46828, MGC32020"	ENSG00000131944	"FA core complex associated protein 24"	Q9BTP7	19	32972209-32978229	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 14.6;Spermatocytes: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041168	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"HPA041168: AB_10960496"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (6.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (4.00e-7)"	"unprognostic (4.37e-3)"	"unprognostic (5.30e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.15e-1)"	1.7	1.4	0.8	2.6	0.7	3.5	1.8	1.2	1.1	1.0	1.1	1.7	1.8	1.3	2.4	1.8	1.4	2.3	0.7	0.8	0.6	1.2	1.4	1.4	3.1	1.4	0.6	2.5	0.9	0.4	0.8	1.6	1.0	4.8	2.5	0.5	1.2	1.1	0.5	2.8	2.2	1.5	0.4	2.4	1.4	6.2	0.9	2.6	1.8	0.2	3.5	1.5	1.2	2.2	6.0	15.0	5.7	9.3	3.2	6.3	4.9	7.7	8.2	14.5	18.8	10.3	9.7	7.0	11.2	3.2	11.4	4.2	11.7	5.9	11.5	19.4	5.4	15.3	5.8	7.6	1.7	5.2	7.5	3.5	3.5	9.0	5.3	2.3	5.9	11.2	8.2	7.1	11.1	6.7	11.6	7.1	2.6	8.7	6.7	10.2	5.1	3.9	2.9	3.6	5.9	4.9	8.7	9.9	6.1	6.2	6.6	13.7	3.5	14.2	6.6	6.2	7.2	5.5	12.4	9.6	10.1	11.9	9.6	15.3	5.7	8.8	3.2	6.9	3.8	6.4	4.0	4.9	3.6	6.2	3.6	5.2	13.9	7.1	7.8	6.9	5.6	3.2	0.8	0.7	1.2	1.1	0.8	0.6	1.4	0.6	1.0	0.4	0.9	2.2	1.7	3.2	1.1	0.0	3.0	0.0	3.3	0.0	1.8	1.5	3.9	3.6	0.5	2.8	1.3	3.7	2.1	11.1	6.5	1.2	1.9	1.6	7.2	4.4	3.0	2.1	1.2	7.4	0.0	8.0	14.6	3.1	0.5	6.3	1.3	7.1	3.6	0.4	8.2	5.0	0.0	2.4	0.0	5.1	0.0	12.3	3.4	3.5	0.0	0.0	7.0	0.6	2.1	0.0	0.0	4.2	2.4	3.4	2.6	3.2	3.5	1.0	0.0	1.0	0.0	2.7	2.2	22.6	8.3	2.7	0.0	5.1	2.5	5.8	2.7	2.6
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128062	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"intestine: 5501.2;liver: 13065.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 12424.2;Hepatocytes: 7459.2;Paneth cells: 3975.2;Proximal enterocytes: 15929.5"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 122.1;Hep G2: 393.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		45000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		6.7	0.8	0.6	160.2	0.6	0.0	10.7	0.5	1.8	0.7	0.4	5501.2	4751.8	13.0	0.0	2.6	3.9	0.5	0.8	0.6	0.7	727.6	13065.3	0.9	3.7	0.6	0.5	0.9	1.0	0.3	0.8	0.7	0.5	2.6	3416.4	0.1	0.5	8.4	0.9	0.5	4727.6	230.4	0.5	2.8	15.8	1.1	0.6	0.1	0.5	0.4	0.1	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	122.1	0.0	1.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	393.9	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	33.0	0.5	0.0	0.0	0.3	6.4	37.4	0.0	0.5	3.6	24.7	2.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	11.8	0.7	0.4	0.1	2.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.8	0.6	0.7	0.6	0.5	0.5	0.5	0.6	0.7	0.0	0.0	0.0	0.3	42.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	120.1	0.0	60.7	0.0	0.2	0.0	12424.2	156.5	0.0	0.0	0.0	0.0	7.5	261.9	149.7	0.1	0.0	1.2	0.1	2.6	0.0	129.2	0.0	105.3	7459.2	1.5	0.0	0.1	1061.1	0.0	166.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3975.2	0.0	0.0	0.1	15929.5	2014.4	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	1.4	29.3	0.0	1708.4	0.0
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779716-122784074	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 366.1;choroid plexus: 164.8;retina: 175.3;tongue: 199.3"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 1407.3"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 105.5;U-251 MG: 28.8;WM-115: 63.7"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 1195.2"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	1.9	0.4	184.8	0.1	210.5	0.3	38.0	228.1	366.1	1.2	164.8	0.7	0.1	0.1	0.2	0.8	0.1	0.1	0.3	198.7	176.2	0.8	0.3	0.0	0.1	188.0	175.5	0.1	0.1	0.0	8.0	0.4	171.2	0.3	0.1	175.3	8.8	3.9	8.8	41.8	0.1	0.0	170.8	0.0	0.4	0.2	174.0	1.8	0.0	199.3	0.1	0.2	0.4	182.9	0.0	0.1	105.5	0.0	0.0	0.0	3.8	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.1	0.2	0.1	0.2	0.0	0.1	28.8	0.0	0.0	0.0	1.2	0.1	63.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	184.8	210.5	228.1	366.1	198.7	176.2	188.0	175.5	171.2	170.8	174.0	182.9	0.1	0.0	0.0	14.0	0.0	12.2	0.3	0.0	0.0	11.6	44.5	38.9	1.3	0.0	0.0	0.0	12.5	4.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.9	0.0	228.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.0	1.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	30.2	0.0	0.0	1407.3	0.0	41.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	48.0	0.0	0.5	0.3	0.0	0.3	0.0	18.9	7.1	0.3	0.0	0.0	0.0
FADD	"GIG3, MORT1"	ENSG00000168040	"Fas associated via death domain"	Q13158	11	70203296-70207390	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 75.0;Ductal cells: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 331.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001464, CAB010209"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"CAB010209: AB_2100622, HPA001464: AB_1848348"	"unprognostic (2.08e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (6.91e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (8.22e-5)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (7.29e-2)"	9.8	13.8	10.6	14.0	10.5	8.8	13.6	10.9	10.1	13.1	10.6	14.8	14.1	12.6	17.6	14.3	13.2	12.1	8.4	9.9	10.8	14.2	16.0	10.6	16.9	12.6	10.8	12.5	8.2	9.1	6.4	15.3	11.6	9.2	12.8	4.0	11.3	13.4	10.9	12.5	13.9	10.3	11.2	13.2	14.8	5.7	11.4	20.3	11.3	9.0	16.9	11.4	9.2	11.3	331.2	54.7	26.6	24.3	31.6	25.4	23.8	55.3	43.6	47.5	31.6	47.1	52.3	48.7	51.9	37.1	44.8	47.7	26.3	49.3	36.8	45.7	28.8	22.3	30.6	24.3	28.5	28.0	28.4	25.4	34.5	51.4	64.7	38.1	45.3	26.7	37.0	24.4	42.1	48.5	34.4	49.5	42.1	75.1	89.1	26.3	64.3	47.0	46.8	24.1	23.5	22.3	41.0	38.0	117.1	30.3	41.3	30.7	51.0	36.6	35.7	56.7	53.9	33.8	27.8	28.6	53.2	28.0	52.6	37.1	36.2	28.2	41.7	38.4	47.5	38.7	44.1	48.9	37.1	33.9	44.6	40.7	88.6	37.7	45.3	33.7	45.7	36.1	10.6	10.5	10.9	10.1	9.9	10.8	12.6	10.8	11.6	11.2	11.4	11.3	7.8	0.0	5.3	0.7	12.1	11.9	14.8	18.1	6.2	6.8	14.0	15.7	0.1	14.3	7.7	18.4	0.0	75.0	9.3	22.9	21.5	55.9	0.7	7.3	11.7	15.6	2.4	19.8	1.4	34.7	37.3	10.0	12.8	10.6	1.3	13.8	14.6	8.5	31.2	3.3	1.6	14.3	0.0	11.0	8.8	2.4	13.4	10.8	32.0	2.8	20.9	10.0	18.6	0.5	1.4	49.0	15.3	16.6	9.6	11.8	24.5	33.7	5.4	4.1	0.0	5.2	14.5	10.4	14.2	14.4	10.5	30.8	13.3	18.9	17.4	14.4
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960267	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 202.4;Excitatory neurons: 296.7;Inhibitory neurons: 278.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 269.9;Oligodendrocytes: 424.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Supported	Nucleoplasm		NA	NA		12000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	18.2	16.8	21.0	9.2	22.0	21.0	18.5	21.8	27.5	18.9	18.7	23.7	12.4	18.2	11.7	23.1	15.7	8.7	34.9	22.3	22.1	21.5	23.6	14.9	13.1	21.5	21.5	19.9	26.2	23.2	20.6	10.6	22.0	18.5	12.7	19.6	18.1	16.3	67.9	28.1	16.4	13.4	21.8	14.0	18.2	47.8	21.2	22.2	18.3	37.6	14.1	21.4	18.7	25.9	37.4	27.1	23.1	39.3	22.4	21.1	33.9	35.5	32.1	53.9	48.8	30.4	26.0	59.9	25.7	30.5	47.5	27.2	37.3	33.1	45.9	40.1	33.5	49.9	33.5	31.6	36.4	54.3	28.5	19.8	29.4	57.0	69.4	27.8	29.5	44.5	58.9	0.2	28.1	15.0	56.6	43.0	30.6	49.3	19.2	52.1	50.7	0.0	54.9	33.1	0.3	28.6	32.3	64.9	56.4	32.0	20.4	64.1	18.2	30.4	37.3	37.8	0.2	45.1	50.6	69.3	0.0	77.6	35.7	1.1	2.1	4.9	4.0	2.7	5.5	2.5	3.6	4.0	3.6	4.2	4.3	2.8	0.7	4.3	3.5	2.9	6.1	1.6	21.0	22.0	21.8	27.5	22.3	22.1	21.5	21.5	22.0	21.8	21.2	25.9	17.9	6.4	18.2	202.4	26.9	21.4	38.5	27.8	33.6	19.9	16.9	16.9	43.9	11.5	27.2	16.5	27.1	14.2	18.0	13.1	29.4	8.8	75.1	15.1	15.6	14.2	11.4	44.6	296.7	11.6	28.2	16.0	29.0	16.9	5.7	19.2	10.4	18.2	11.4	16.8	278.9	17.8	6.1	13.6	18.0	117.2	11.1	15.4	16.0	177.1	8.9	20.0	15.5	269.9	424.4	8.5	9.7	10.9	35.4	18.3	20.0	28.3	32.7	33.0	6.6	26.2	20.3	36.9	15.6	37.9	28.1	15.3	27.9	19.6	21.6	34.1
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 301.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 266.8;Proximal tubular cells: 305.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 23.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	99.2	65.4	16.0	7.0	17.1	20.0	59.0	16.6	21.1	19.2	15.1	13.8	14.6	19.3	50.4	15.2	23.0	9.7	20.3	16.3	18.8	65.0	301.5	20.0	5.7	17.9	19.6	26.4	9.9	18.4	16.8	7.8	16.9	16.6	11.9	1.6	14.8	13.6	31.0	10.9	16.8	13.5	17.2	19.1	14.2	20.8	17.4	6.7	14.5	27.7	5.8	16.4	15.8	17.5	20.1	34.4	13.5	17.0	60.2	62.2	32.9	24.3	56.8	26.2	22.3	22.0	35.9	0.4	39.0	52.6	36.8	29.1	46.8	59.6	25.1	12.5	28.5	166.6	18.0	112.1	316.6	79.6	88.8	107.5	37.1	22.9	39.7	84.2	37.4	38.3	71.1	35.7	50.3	31.0	22.3	42.0	9.9	15.5	37.6	12.2	19.3	123.4	77.0	25.2	0.7	8.3	27.4	76.7	77.9	21.6	58.3	55.0	126.1	46.8	30.0	25.5	42.7	32.7	69.5	13.8	99.6	187.5	26.9	34.5	18.8	3.3	9.6	8.1	2.3	0.1	2.4	6.0	25.3	0.1	3.1	2.7	1.3	5.7	8.4	1.9	2.5	9.7	16.0	17.1	16.6	21.1	16.3	18.8	17.9	19.6	16.9	17.2	17.4	17.5	3.0	3.2	13.8	9.8	4.1	6.8	17.5	30.8	15.4	0.4	19.1	13.7	15.5	21.5	12.5	33.1	0.0	37.9	4.9	9.3	52.8	9.3	7.5	3.0	16.2	3.2	4.2	24.4	0.4	3.5	14.1	16.6	3.6	4.0	41.9	6.3	8.9	266.8	72.5	0.0	2.5	13.0	24.4	21.4	6.6	13.5	9.9	30.5	19.6	1.0	5.7	7.3	3.1	2.5	0.6	4.5	12.8	7.9	5.2	9.7	54.1	305.5	5.3	0.4	0.0	9.2	11.2	1.5	2.1	18.2	5.7	22.0	7.7	8.7	22.4	16.4
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.1"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 112.2;Proximal tubular cells: 210.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	12.3	21.4	9.1	8.5	9.4	10.0	9.4	9.3	11.1	8.3	9.2	22.6	36.1	9.7	8.0	19.3	6.9	12.1	19.9	10.9	11.1	64.1	58.5	7.1	7.4	10.7	10.0	8.0	15.8	12.1	9.5	7.5	10.1	9.4	14.2	6.7	11.2	10.7	30.7	17.1	27.1	8.7	8.8	8.4	21.0	10.1	9.4	7.9	7.8	24.7	6.4	11.3	11.1	9.9	20.1	44.6	20.9	36.9	27.0	19.5	12.9	32.4	16.0	21.1	22.9	28.6	20.4	12.8	26.6	20.2	32.7	40.5	16.4	25.8	19.0	19.3	39.0	11.5	38.7	67.0	26.2	20.0	21.2	25.8	33.3	19.3	12.9	17.8	27.8	15.3	12.1	12.8	26.8	92.5	10.9	30.1	12.4	18.4	33.0	24.6	28.3	36.4	76.8	24.9	40.4	33.6	42.3	33.5	52.0	13.8	49.4	13.4	41.1	34.4	24.6	20.5	17.8	18.6	42.3	15.1	22.0	14.5	15.1	15.8	40.8	16.5	25.1	51.5	22.5	37.2	24.7	27.3	42.6	32.7	27.0	24.8	3.5	38.1	38.4	33.1	28.4	24.3	9.1	9.4	9.3	11.1	10.9	11.1	10.7	10.0	10.1	8.8	9.4	9.9	14.6	25.6	16.4	2.9	11.2	14.0	13.3	29.6	13.1	19.8	12.4	15.7	42.9	27.1	17.2	42.3	27.1	22.6	10.9	50.8	50.9	57.2	89.8	16.8	19.8	16.3	29.3	36.4	8.0	39.2	14.2	15.5	17.3	18.2	5.1	13.8	9.7	35.5	30.5	18.5	8.6	25.6	24.4	9.1	14.2	45.0	14.6	13.7	16.0	4.7	18.9	17.4	20.6	3.0	6.4	34.9	36.7	15.4	4.0	11.2	112.2	210.9	14.4	24.2	13.1	12.7	16.5	9.9	9.1	27.2	24.0	15.3	9.8	30.3	52.7	9.6
FAM104A	FLJ14775	ENSG00000133193	"Family with sequence similarity 104 member A"	Q969W3	17	73207353-73236753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 44.8;testis: 153.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1305.1;Late spermatids: 1771.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021459, HPA079514"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA021459: AB_1848361, HPA079514: "	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	16.6	11.7	13.1	14.1	13.0	44.8	15.3	16.9	14.0	14.4	11.1	14.7	12.6	11.7	12.5	17.8	11.1	10.4	12.4	12.9	11.3	10.8	13.9	12.8	17.8	12.0	11.5	12.2	15.0	12.2	16.0	17.8	11.5	14.1	12.4	14.0	12.3	11.1	17.1	21.6	12.8	11.2	11.4	17.0	21.7	153.0	12.6	20.9	11.8	12.0	16.9	13.4	14.8	13.7	41.8	33.5	16.7	31.0	24.7	23.1	54.1	33.4	34.7	35.9	36.9	28.3	26.3	24.3	26.7	32.2	35.0	26.0	21.4	24.3	38.7	28.6	28.7	35.4	29.1	43.5	32.9	31.1	58.1	24.6	31.6	31.9	23.2	23.7	42.6	28.8	28.0	39.6	43.6	28.5	55.7	21.5	22.9	30.7	42.5	30.1	46.3	23.5	27.6	33.7	27.3	36.1	19.6	28.2	36.7	31.0	39.4	31.8	29.8	42.3	49.1	29.1	39.4	38.5	41.5	29.8	37.9	33.7	31.9	72.4	49.4	87.7	57.1	44.6	55.5	53.5	69.6	65.7	48.8	55.8	50.1	60.9	81.9	68.9	49.8	31.7	128.5	82.5	13.1	13.0	16.9	14.0	12.9	11.3	12.0	11.5	11.5	11.4	12.6	13.7	37.1	9.6	10.2	7.5	24.2	57.0	20.7	42.3	17.6	17.7	22.5	21.1	5.6	22.8	26.9	22.0	6.2	122.3	23.0	20.8	31.3	32.7	1305.1	21.9	16.0	23.9	19.8	103.6	14.2	25.3	70.1	19.4	28.5	24.6	29.2	20.4	18.2	18.5	35.6	26.9	14.1	22.9	26.4	21.8	34.2	1771.9	35.1	25.5	24.9	10.3	32.2	20.2	33.0	10.6	11.3	32.1	20.1	24.0	30.4	32.8	26.4	18.9	27.4	19.7	6.6	14.8	43.7	277.3	60.7	29.9	65.8	324.9	32.7	21.3	20.7	51.8
FAM107B	"C10orf45, FLJ45505, HITS, MGC11034"	ENSG00000065809	"Family with sequence similarity 107 member B"	Q9H098	10	14518557-14774897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 526.5;Proximal tubular cells: 359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 63.8;NK-cells: 53.8;T-cells: 106.2"	"Cell line enhanced"	"Detected in all"		"Daudi: 373.0;HDLM-2: 449.6;Karpas-707: 309.6;THP-1: 294.4"	"Low region specificity"	"Detected in all"							"HPA039661, HPA058814, HPA073195"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		15000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus"	"HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.82e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.53e-2)"	48.4	44.7	82.3	90.2	150.8	171.5	44.3	112.4	112.5	42.2	90.8	64.2	32.7	48.2	11.4	22.8	20.6	66.1	11.1	84.2	102.1	119.6	147.3	64.8	152.3	136.8	125.9	7.3	70.6	70.0	21.3	22.2	130.7	27.6	42.5	15.2	68.6	113.7	3.5	22.2	55.9	31.4	95.5	50.6	122.8	37.3	118.7	48.0	12.6	9.3	134.0	66.7	17.1	223.6	60.8	129.1	50.3	3.4	7.6	1.7	21.3	59.7	85.8	35.9	25.6	79.9	49.9	373.0	52.8	27.5	13.4	18.6	16.1	36.4	63.5	449.6	13.9	10.3	55.6	95.0	26.7	136.6	23.3	4.2	28.0	14.9	7.2	42.4	154.6	72.5	1.1	309.6	28.2	15.6	33.6	39.5	12.5	72.7	28.2	240.8	39.1	140.2	81.9	39.0	18.7	53.5	23.6	12.4	39.0	44.7	46.0	294.4	50.8	37.0	31.2	118.3	20.3	136.2	131.7	241.3	6.5	117.5	10.1	52.3	6.0	63.8	100.2	7.1	97.7	12.4	79.4	85.0	5.2	12.6	105.7	106.2	25.2	53.8	14.9	3.5	78.0	74.8	82.3	150.8	112.4	112.5	84.2	102.1	136.8	125.9	130.7	95.5	118.7	223.6	12.8	105.8	44.4	7.2	203.6	89.7	147.1	25.4	16.5	4.8	94.6	30.4	4.1	134.4	52.5	286.9	2.1	18.1	194.7	65.9	223.0	44.3	27.0	234.9	98.7	37.8	14.3	22.7	1.6	106.8	38.2	49.7	175.3	268.2	119.2	32.7	72.8	177.4	37.1	201.9	7.3	110.5	36.7	53.9	120.9	53.2	2.5	110.7	51.6	15.0	68.8	13.6	198.8	11.1	526.5	90.3	44.3	4.9	176.6	139.6	25.9	359.9	85.3	15.0	0.0	5.4	64.6	56.2	35.7	8.3	82.3	62.5	237.7	3.8	39.9	240.2
FAM110A	"bA371L19.3, C20orf55"	ENSG00000125898	"Family with sequence similarity 110 member A"	Q9BQ89	20	833715-857463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 71.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 71.7;Extravillous trophoblasts: 138.2;Langerhans cells: 74.2;Macrophages: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 543.5;eosinophil: 163.4;intermediate monocyte: 160.6;non-classical monocyte: 248.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 543.5;monocytes: 248.6"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 84.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034110, HPA069240"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol		Yes	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB034110: AB_1562838, HPA069240: AB_2686103"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (9.64e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.42e-3)"	"unprognostic (4.21e-3)"	4.2	5.5	4.2	5.9	5.2	8.8	9.0	3.1	3.6	10.1	3.9	5.5	10.0	2.5	4.7	39.3	2.5	2.3	4.0	2.8	3.4	8.8	3.6	12.3	6.7	5.5	5.3	2.8	5.5	11.0	7.9	6.6	5.6	19.3	3.2	1.2	18.4	3.6	4.0	71.2	9.7	1.1	3.3	23.4	6.1	3.7	6.6	6.9	7.6	0.6	7.8	9.2	18.4	3.6	27.7	7.3	4.1	7.6	4.4	1.9	27.8	8.5	4.7	5.3	4.7	16.0	16.9	8.9	3.7	5.3	7.6	43.7	3.3	22.2	4.4	7.3	2.3	18.6	4.9	4.2	2.0	5.1	6.3	1.2	27.1	7.3	7.1	1.6	3.6	8.1	10.2	21.5	4.9	16.4	14.3	13.8	5.3	17.7	12.3	14.1	7.0	11.7	4.1	19.6	7.7	9.1	7.4	84.0	3.8	1.7	34.9	7.5	4.8	12.6	9.1	11.5	9.6	7.8	7.3	3.8	2.0	13.2	9.2	543.5	28.3	163.4	13.2	160.6	11.7	7.0	23.7	27.2	36.2	11.7	28.1	27.9	15.3	6.9	248.6	3.9	43.0	24.2	4.2	5.2	3.1	3.6	2.8	3.4	5.5	5.3	5.6	3.3	6.6	3.6	3.5	0.0	7.0	0.0	18.5	32.6	17.0	31.6	71.7	0.3	26.7	20.1	2.9	7.2	15.7	11.0	0.0	41.5	24.3	5.1	1.9	10.1	9.9	3.0	1.7	8.0	10.8	16.2	0.5	6.0	138.2	3.6	5.1	5.2	51.5	1.4	17.2	0.7	20.0	5.0	0.4	8.8	16.2	36.7	74.2	24.3	3.4	70.0	7.2	1.9	29.9	0.3	25.7	0.5	0.1	13.4	7.8	1.9	3.5	20.9	16.1	2.4	7.4	2.6	6.6	1.1	4.3	3.4	4.9	57.7	36.8	31.3	26.1	14.2	10.4	24.6
FAM111A	"FLJ22794, KIAA1895"	ENSG00000166801	"Family with sequence similarity 111 member A"	Q96PZ2	11	59142748-59155039	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	"DNA-binding, Hydrolase, Protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039529, HPA040176"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA039529: AB_10795149, HPA040176: AB_10793958"	"unprognostic (4.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (4.39e-4)"	14.8	18.9	7.0	23.1	7.0	20.3	16.0	6.7	9.6	20.8	12.9	17.1	22.5	13.8	17.3	12.8	16.5	18.7	11.6	6.6	7.6	23.7	17.9	25.2	36.1	9.0	7.7	14.6	15.0	16.9	14.3	19.5	8.1	33.2	19.3	9.1	19.0	10.7	5.5	18.8	27.6	10.9	7.8	42.5	22.5	7.1	8.2	42.3	26.6	4.1	30.1	14.8	17.4	8.4	66.0	16.2	7.9	7.5	16.9	21.4	5.1	91.6	50.8	38.5	56.3	24.9	59.0	94.3	37.1	29.7	51.2	21.9	26.9	40.4	47.4	86.0	1.2	36.3	22.7	7.6	17.8	58.7	45.7	14.5	9.6	36.2	11.1	22.0	37.7	57.2	4.8	76.7	42.2	18.0	85.6	36.9	3.5	19.5	17.5	59.9	28.7	22.8	25.4	57.6	0.2	2.3	48.6	38.5	17.5	4.1	80.1	24.7	37.0	61.9	55.5	42.5	42.7	39.0	43.4	15.3	34.3	39.5	75.9	6.0	5.0	4.8	4.2	3.4	5.3	2.6	2.7	3.2	4.6	2.6	2.4	2.5	5.4	5.0	1.9	1.2	3.1	2.2	7.0	7.0	6.7	9.6	6.6	7.6	9.0	7.7	8.1	7.8	8.2	8.4	38.9	64.1	43.7	14.4	27.4	8.5	10.7	21.3	26.2	1.7	24.2	24.3	5.5	14.3	24.7	16.5	0.0	11.1	40.5	20.8	9.8	13.8	0.2	31.5	26.0	25.9	6.0	42.5	0.2	7.7	1.4	22.7	30.5	20.7	27.8	83.9	30.0	8.1	28.2	0.0	0.2	24.8	22.4	31.3	19.5	1.8	13.1	39.2	7.2	21.5	40.2	25.2	47.4	12.1	3.9	7.5	17.6	6.8	29.7	14.2	19.4	10.3	36.9	7.3	0.0	17.0	14.3	0.4	2.1	24.3	8.8	4.4	41.3	48.8	18.6	14.0
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127412	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 12.8;Erythroid cells: 9.1;Plasma cells: 8.8;Squamous epithelial cells: 7.1;Undifferentiated cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.3;naive B-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	0.9	0.5	0.5	5.9	0.6	4.8	2.7	2.8	1.8	1.0	0.1	5.6	3.4	1.0	0.5	3.4	0.5	0.8	0.3	0.6	1.1	0.4	2.5	1.1	12.3	0.5	1.0	0.2	0.6	0.9	0.0	1.7	0.7	1.0	5.8	1.3	0.8	0.4	0.4	4.4	4.0	2.0	0.1	1.8	3.2	0.8	0.6	18.0	0.9	0.1	13.3	1.7	1.0	2.1	72.6	18.5	26.6	0.4	2.7	4.9	0.3	53.5	26.7	31.2	46.1	38.7	28.0	89.8	35.4	15.7	26.3	54.7	39.5	36.2	55.2	46.8	9.5	9.8	32.3	16.9	0.1	0.3	11.1	1.2	1.2	30.3	2.4	6.0	16.9	24.1	2.8	81.9	37.2	27.3	57.7	0.6	0.3	43.2	21.0	60.1	39.7	34.7	16.8	61.2	5.2	16.9	44.4	50.8	8.7	9.7	56.2	5.0	9.4	24.1	52.4	73.5	49.6	62.6	48.4	0.6	35.0	0.4	35.4	0.2	0.1	0.1	0.1	0.0	0.1	3.3	0.2	0.3	0.1	2.6	0.1	0.1	1.6	0.0	0.1	0.1	0.7	0.1	0.5	0.6	2.8	1.8	0.6	1.1	0.5	1.0	0.7	0.1	0.6	2.1	0.7	0.0	0.0	0.0	12.8	4.2	2.2	4.2	1.8	0.0	2.5	4.2	0.3	0.0	1.4	0.0	0.0	1.1	1.4	4.0	0.0	0.8	0.0	0.9	1.6	1.2	0.0	9.1	0.0	0.0	0.4	1.5	3.6	1.9	0.0	6.3	0.0	0.2	3.9	0.0	0.0	4.4	2.0	0.3	1.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	1.3	0.0	8.8	0.7	0.5	0.1	1.6	0.0	0.0	1.3	1.8	0.1	1.0	7.1	2.7	0.1	3.2	1.1	10.4	1.6
FAM114A1	Noxp20	ENSG00000197712	"Family with sequence similarity 114 member A1"	Q8IWE2	4	38867677-38945739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.6;granulocytes: 2.4;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 204.7;BJ hTERT+: 244.1;fHDF/TERT166: 273.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067948, HPA069104, HPA069701"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		96000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175"	"unprognostic (2.13e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.40e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.63e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-3)"	28.4	48.1	7.9	23.6	11.8	2.0	20.2	7.8	9.2	48.4	23.7	34.6	22.9	29.2	17.8	35.1	19.5	36.4	23.7	9.9	11.4	11.8	54.2	21.2	8.9	13.7	12.5	41.5	25.6	22.4	18.5	35.6	11.2	35.5	33.7	3.1	61.2	27.8	16.6	15.6	24.4	61.7	9.0	8.8	34.4	12.5	12.1	4.3	17.6	22.7	19.5	35.6	26.4	13.4	43.5	30.7	18.5	21.9	197.4	204.7	6.1	167.9	244.1	69.7	105.8	8.1	33.0	0.0	23.0	273.8	118.8	11.9	0.1	53.7	80.1	0.2	4.6	3.1	30.3	40.6	70.6	0.1	5.8	122.1	17.0	101.2	23.3	157.2	101.4	0.1	3.4	0.2	102.9	11.0	0.1	2.3	3.8	18.3	15.6	0.8	90.9	3.2	23.4	8.7	0.7	9.4	33.8	0.7	33.8	42.8	20.8	3.8	156.3	75.4	34.8	95.3	39.5	0.7	0.2	0.3	123.3	3.3	63.0	0.6	3.2	0.0	0.1	3.6	0.0	0.4	0.1	0.1	2.6	0.1	0.1	0.1	2.4	0.0	1.4	0.3	0.0	0.9	7.9	11.8	7.8	9.2	9.9	11.4	13.7	12.5	11.2	9.0	12.1	13.4	28.1	16.0	13.2	5.9	2.2	12.2	47.4	43.7	15.4	0.3	29.9	21.2	17.2	14.3	56.0	7.3	0.0	2.2	0.2	46.8	9.8	45.6	1.0	17.5	88.6	35.2	15.7	3.6	1.0	61.0	47.0	94.9	35.7	39.1	1.3	30.4	31.1	68.3	16.1	0.0	1.8	78.7	83.4	7.2	15.0	6.3	110.9	8.7	21.4	17.8	6.4	12.2	0.0	14.6	31.0	47.6	41.6	116.2	8.5	92.6	39.0	11.7	47.8	1.2	19.7	49.4	44.3	1.2	5.5	23.6	10.2	3.4	3.1	94.1	32.0	82.7
FAM117A		ENSG00000121104	"Family with sequence similarity 117 member A"	Q9C073	17	49710332-49789180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.4;Erythroid cells: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 50.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 82.0;U-266/84: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022531	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA022531: AB_2101087"	"prognostic favorable (5.30e-5)"	"unprognostic (8.06e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.25e-7)"	"unprognostic (4.05e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.66e-2)"	13.5	7.3	7.6	14.8	6.8	76.5	12.5	10.0	5.9	12.6	37.4	22.8	10.6	20.4	9.6	9.4	16.7	10.4	18.9	9.6	4.8	9.0	11.7	12.1	22.9	6.3	4.6	21.6	16.0	18.6	14.6	5.4	6.1	10.0	8.5	8.0	13.5	11.3	4.0	19.1	18.7	16.7	3.3	34.2	13.3	19.0	6.7	23.5	14.5	6.3	17.4	20.2	10.5	5.0	7.2	1.7	11.4	0.2	5.0	1.0	20.2	2.4	4.0	4.3	7.1	51.2	11.8	34.4	12.4	1.4	19.1	4.1	9.0	8.5	3.3	2.4	14.5	37.9	0.1	16.6	5.6	5.8	29.1	4.9	7.1	7.1	3.9	4.4	7.8	28.9	46.9	28.1	4.1	18.6	37.5	31.1	17.0	10.0	5.7	11.6	9.6	18.4	6.7	6.4	11.1	7.5	2.4	1.1	8.5	11.1	16.7	21.5	0.7	4.2	3.4	4.6	2.0	82.0	60.2	23.0	3.6	8.4	3.5	50.4	1.7	9.1	8.5	1.1	9.2	23.6	5.5	7.2	1.3	15.3	4.5	6.2	3.6	12.8	0.3	3.6	5.9	3.4	7.6	6.8	10.0	5.9	9.6	4.8	6.3	4.6	6.1	3.3	6.7	5.0	15.5	6.4	9.3	5.2	19.5	9.1	1.3	2.1	7.4	15.1	14.6	21.7	22.2	1.5	4.1	7.3	14.6	1.1	56.4	2.2	5.9	2.0	4.1	4.2	5.9	9.9	10.7	104.4	4.5	3.5	1.9	9.3	9.2	7.9	2.5	2.9	7.1	8.6	1.2	5.0	4.0	4.9	6.1	2.9	4.5	5.6	14.3	7.6	7.2	1.9	13.0	3.5	37.0	2.0	2.3	3.8	1.0	15.4	34.9	2.6	0.5	3.6	1.5	4.0	0.0	14.2	10.2	15.5	14.5	8.8	14.1	0.8	27.9	5.5	2.7	1.1
FAM117B	"ALS2CR13, FLJ38771"	ENSG00000138439	"Family with sequence similarity 117 member B"	Q6P1L5	2	202634969-202769757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 45.8;Inhibitory neurons: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003229, HPA028746"	Uncertain		Approved	Nucleoplasm,Centrosome		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Centrosome	"HPA003229: AB_2246696, HPA028746: AB_2672760"	"unprognostic (1.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.40e-3)"	"unprognostic (5.75e-1)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-3)"	3.1	7.5	5.1	4.5	5.4	2.9	3.3	7.0	7.1	2.7	0.7	4.9	4.3	2.9	2.9	5.4	3.8	3.0	1.8	5.0	6.3	4.9	1.9	2.9	7.2	3.1	3.8	5.1	4.6	7.3	3.5	6.9	3.6	5.1	4.7	2.6	3.3	3.0	1.5	5.0	3.7	2.0	3.3	5.4	4.1	5.8	6.4	9.6	2.8	1.8	7.4	3.8	3.2	4.1	2.0	2.4	10.5	7.2	3.5	1.9	10.2	0.6	0.9	0.6	1.1	3.1	4.2	8.2	6.5	1.2	1.6	1.9	9.0	4.6	1.7	0.2	7.2	6.9	4.3	11.6	2.8	5.9	3.0	2.6	6.3	1.3	1.9	4.7	2.8	10.8	10.1	1.6	0.6	3.9	16.1	12.1	10.7	5.8	4.5	12.5	2.1	9.8	5.5	5.2	17.7	15.4	8.0	5.3	3.9	8.7	2.2	8.1	1.7	1.2	2.4	1.9	1.1	5.9	3.6	10.8	2.4	4.5	1.3	0.4	3.9	1.5	1.3	8.2	3.4	8.1	3.0	2.7	4.5	7.7	8.2	5.7	2.2	4.4	9.1	1.5	1.2	3.1	5.1	5.4	7.0	7.1	5.0	6.3	3.1	3.8	3.6	3.3	6.4	4.1	9.7	3.2	7.5	13.1	21.5	17.2	2.9	3.0	12.0	4.9	8.1	4.3	4.9	12.8	2.6	18.4	4.2	8.4	8.8	11.7	0.0	10.2	2.2	8.6	6.5	4.9	25.8	3.0	45.8	6.4	6.3	6.1	7.1	10.1	5.7	15.3	8.2	2.2	2.8	6.7	49.7	11.8	2.0	27.4	13.9	1.4	13.1	17.1	3.6	23.4	17.1	1.7	3.1	29.1	29.4	5.8	9.7	23.7	5.2	6.7	4.9	5.9	3.0	2.7	6.6	2.0	4.1	5.0	16.3	29.2	19.9	2.7	10.1	11.1	13.8	6.0
FAM120B	"CCPG, KIAA1838, PGCC1, SAN1"	ENSG00000112584	"Family with sequence similarity 120B"	Q96EK7	6	170290703-170407067	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"Early spermatids: 556.1;Late spermatids: 1847.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037518, HPA037519"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA037518: AB_10671626, HPA037519: AB_10696935"	"unprognostic (7.99e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (1.60e-4)"	"prognostic favorable (2.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	12.3	12.2	9.3	5.7	8.7	4.5	12.5	11.2	11.2	11.6	9.9	11.5	6.2	12.1	8.9	10.0	12.2	6.1	10.7	7.7	9.0	8.3	8.8	9.4	7.1	10.0	9.8	11.0	9.6	7.1	11.4	6.6	10.3	11.0	8.6	9.2	13.8	6.2	17.4	12.3	10.1	7.6	7.7	10.1	10.2	14.4	9.1	7.4	9.8	6.8	6.6	10.9	10.4	10.5	7.0	7.1	8.7	12.7	15.4	14.2	6.2	6.4	13.4	8.5	7.2	6.4	5.2	8.0	5.2	14.2	9.2	8.2	11.0	13.1	13.0	9.0	5.2	10.5	6.5	8.4	10.5	10.5	6.5	14.0	11.2	9.2	12.2	14.6	15.7	6.3	9.5	7.8	17.0	13.7	6.3	11.8	5.3	12.5	4.8	6.5	9.8	10.3	10.3	6.2	6.0	9.6	6.2	8.7	2.9	13.0	7.0	20.6	13.4	4.2	6.3	11.3	6.4	6.6	7.3	9.9	11.6	7.4	15.9	16.5	5.9	7.5	5.4	6.4	6.3	4.4	5.1	6.1	6.4	5.3	6.4	5.3	10.0	11.9	10.1	3.5	6.6	6.7	9.3	8.7	11.2	11.2	7.7	9.0	10.0	9.8	10.3	7.7	9.1	10.5	17.8	22.4	17.6	36.9	13.2	3.6	5.2	11.1	16.5	16.7	13.7	13.6	15.7	11.5	13.0	14.7	33.3	10.5	7.3	11.8	0.0	8.4	556.1	18.8	16.7	15.4	9.6	11.1	48.8	9.1	7.6	13.1	14.3	22.5	10.1	14.1	10.4	10.7	11.0	6.7	53.2	12.5	12.2	9.8	5.6	1847.0	19.3	10.2	19.6	40.3	8.8	7.7	8.2	50.3	62.6	9.2	6.5	14.3	12.0	9.3	10.1	5.4	19.9	14.2	32.9	12.9	10.1	18.4	12.7	10.8	5.8	13.4	13.9	11.2	8.8	6.4
FAM122A	"C9orf42, MGC17347"	ENSG00000187866	"Family with sequence similarity 122A"	Q96E09	9	68780065-68785566	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056646	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA056646: AB_2683202"	"unprognostic (1.88e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.18e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.58e-3)"	"prognostic favorable (1.34e-5)"	"unprognostic (9.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.89e-2)"	9.9	9.3	4.6	5.8	4.9	5.3	9.7	8.2	6.3	9.7	15.0	7.9	4.4	9.3	6.7	8.3	8.5	5.6	9.0	5.4	5.4	9.7	9.9	6.8	7.4	5.1	5.4	10.5	8.9	11.0	6.8	10.2	5.1	7.7	6.5	6.8	8.2	8.4	8.9	7.6	7.4	7.8	4.4	8.3	7.4	4.9	5.0	6.5	8.5	8.6	7.2	7.2	8.0	5.0	5.2	3.4	4.8	4.1	15.9	10.3	6.4	7.3	6.9	6.3	5.0	1.2	2.5	11.0	3.5	7.7	4.5	9.6	5.3	4.9	7.8	11.9	5.6	6.1	6.0	4.4	9.7	11.2	4.1	8.4	11.0	5.8	4.5	7.1	6.3	7.8	6.5	12.1	6.8	2.9	6.3	2.9	6.0	12.4	6.2	7.6	6.6	3.4	5.7	4.3	7.6	3.4	5.4	4.5	3.8	6.6	2.7	4.8	8.0	5.8	4.2	11.0	5.5	14.2	6.1	4.4	6.3	6.9	6.7	1.9	2.0	1.5	1.7	1.9	1.4	1.5	1.7	1.8	2.2	2.5	3.5	2.0	1.1	1.8	1.9	2.6	2.0	1.0	4.6	4.9	8.2	6.3	5.4	5.4	5.1	5.4	5.1	4.4	5.0	5.0	10.0	3.2	9.8	0.0	19.6	23.6	18.7	13.3	20.5	18.8	18.2	17.0	15.9	10.0	13.1	5.5	16.7	28.2	11.8	11.3	66.5	18.3	32.0	10.4	20.2	17.2	18.0	27.0	0.0	13.8	17.0	13.9	14.3	8.1	17.7	12.7	17.2	18.6	21.6	8.4	0.0	17.0	10.2	22.3	17.0	15.4	15.2	15.0	14.2	0.0	16.8	38.3	24.7	0.0	0.0	12.9	15.8	17.0	18.3	11.9	11.1	27.2	23.0	19.8	46.0	18.8	43.9	52.4	21.3	19.5	23.7	30.6	16.8	23.1	15.3	17.8
FAM122B	"DKFZp686L20116, RP11-308B5.5"	ENSG00000156504	"Family with sequence similarity 122B"	Q7Z309	X	134769566-134797232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000266	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA000266: AB_1078801"	"unprognostic (2.10e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.53e-3)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.26e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.19e-3)"	16.0	19.5	23.9	18.4	25.4	31.6	15.8	20.6	32.8	18.7	27.1	18.1	15.4	20.8	26.0	17.6	22.6	13.1	14.6	23.9	24.3	20.1	11.2	17.6	29.8	22.8	23.5	28.8	16.8	21.1	21.3	15.5	22.1	17.6	22.7	8.8	18.8	16.0	7.8	19.4	22.1	19.5	24.3	27.4	20.1	35.3	29.2	25.9	21.0	7.1	27.3	18.8	17.6	25.2	51.0	46.2	36.2	25.9	18.2	23.6	25.4	39.5	34.5	43.9	41.3	41.1	44.3	49.7	76.2	28.9	61.3	33.5	54.0	32.6	79.2	61.8	37.4	50.2	94.6	13.4	11.2	92.9	61.2	15.5	31.6	48.3	21.0	28.5	25.9	50.0	33.2	61.9	46.8	68.8	58.1	80.1	19.8	58.3	49.1	58.0	39.5	43.6	26.6	52.1	32.9	23.3	21.2	28.3	14.8	31.1	15.2	47.4	18.6	36.4	23.5	93.3	87.1	34.1	42.2	63.2	39.0	105.8	46.2	0.0	0.4	2.6	0.8	0.2	1.1	0.7	0.7	1.0	0.5	0.6	0.9	1.2	0.5	1.2	0.5	1.5	0.8	0.5	23.9	25.4	20.6	32.8	23.9	24.3	22.8	23.5	22.1	24.3	29.2	25.2	4.7	12.8	10.4	6.2	17.4	13.5	15.0	9.2	12.0	4.0	11.8	7.6	10.8	2.8	11.7	16.5	12.5	9.3	15.3	14.4	17.6	8.0	1.3	10.4	6.7	12.5	6.0	32.6	15.2	13.8	10.2	11.0	15.3	11.5	23.6	32.9	9.7	7.4	14.7	13.5	10.5	13.2	18.3	21.4	21.7	5.8	10.5	17.9	17.8	12.2	16.6	6.4	20.6	8.0	16.8	12.2	20.2	6.4	13.8	14.7	12.9	8.0	8.2	5.5	0.0	6.6	8.8	3.7	4.4	14.4	11.2	8.8	20.1	17.7	12.2	19.1
FAM122C	RP3-473B4.1	ENSG00000156500	"Family with sequence similarity 122C"	Q6P4D5	X	134796395-134854835	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 12.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.8;Granulosa cells: 39.0;Theca cells: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059961	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA059961: AB_2684181"	"unprognostic (1.32e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.50e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-3)"	2.3	1.8	2.1	2.6	1.9	5.8	1.2	2.7	3.5	1.7	4.0	1.8	0.9	3.8	1.8	1.8	2.5	1.8	1.5	2.0	2.0	1.5	1.8	2.1	4.3	2.1	1.7	12.5	0.7	1.5	1.5	1.6	1.8	1.8	1.6	5.7	4.0	1.6	1.6	1.7	1.4	3.1	1.7	3.9	2.8	6.1	1.7	4.3	1.6	1.4	2.2	2.0	1.1	3.3	1.1	1.3	4.1	4.2	1.0	1.6	2.4	3.6	3.1	3.2	4.3	3.0	4.2	1.4	5.3	1.5	6.8	1.6	3.4	1.3	2.3	3.7	1.4	2.5	15.3	1.3	1.2	3.8	2.1	1.6	0.6	3.1	1.9	2.0	2.7	11.0	10.8	8.1	2.3	6.5	3.9	3.1	2.2	1.1	3.1	6.7	2.8	3.2	1.0	0.9	1.6	2.8	2.2	0.6	3.4	2.9	1.0	1.0	0.8	1.9	1.2	2.9	2.3	3.0	3.0	6.1	2.6	4.2	2.1	1.8	1.2	3.5	1.1	1.4	1.2	2.3	1.3	1.7	0.9	1.6	1.6	1.4	2.1	2.2	3.0	3.3	1.2	0.9	2.1	1.9	2.7	3.5	2.0	2.0	2.1	1.7	1.8	1.7	1.7	3.3	2.9	6.4	4.5	14.7	4.8	1.3	2.1	1.8	0.0	4.1	1.9	1.9	2.1	0.0	2.9	1.8	14.6	1.7	2.9	1.7	1.9	1.3	57.8	4.4	3.9	6.5	1.2	6.9	6.7	1.8	2.7	4.3	6.6	6.9	12.7	39.0	7.5	0.9	2.2	3.3	7.0	3.0	0.0	4.1	3.0	9.6	4.1	3.4	3.6	12.2	3.8	3.8	3.1	11.1	12.1	1.9	1.7	2.2	5.9	1.5	4.5	1.7	8.8	14.1	0.0	3.2	3.9	10.4	2.6	1.5	1.1	1.9	11.7	35.5	1.8	2.8
FAM124A	FLJ30707	ENSG00000150510	"Family with sequence similarity 124 member A"	Q86V42	13	51222334-51284239	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 59.1;choroid plexus: 26.7;retina: 25.7"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 232.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HAP1: 18.0;HUVEC TERT2: 10.6;NTERA-2: 35.1;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048182	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA048182: AB_2680301"	"unprognostic (3.94e-3)"	"unprognostic (8.76e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.38e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.05e-2)"	4.6	1.8	13.2	2.7	32.1	0.2	2.9	24.0	22.0	2.2	26.7	8.1	0.6	3.1	4.6	1.2	3.1	2.4	4.9	14.8	20.8	3.7	0.7	1.9	0.8	33.8	27.4	0.8	1.4	0.6	1.3	3.6	31.3	4.6	1.3	25.7	7.3	4.4	1.0	1.0	2.0	5.2	18.4	8.3	3.3	1.2	25.9	3.1	2.4	1.3	0.5	4.5	1.6	59.1	0.0	1.7	1.2	1.1	0.3	0.1	0.1	0.2	0.6	0.2	0.2	0.1	0.6	0.6	0.0	0.0	2.2	0.1	18.0	0.2	0.1	0.1	2.7	0.1	0.5	0.0	1.4	0.9	1.1	0.4	0.2	0.5	0.0	0.0	10.6	4.8	0.1	0.1	0.0	0.3	4.6	0.3	35.1	0.3	2.8	1.0	0.1	2.6	0.0	0.1	2.5	13.3	0.6	2.2	2.0	2.6	0.3	1.1	0.2	0.1	1.2	0.9	1.3	0.3	0.0	0.0	1.6	3.2	1.5	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	13.2	32.1	24.0	22.0	14.8	20.8	33.8	27.4	31.3	18.4	25.9	59.1	8.5	0.0	0.0	17.6	0.4	0.8	2.1	0.0	0.6	10.2	1.1	1.8	10.8	0.0	0.0	1.8	50.1	0.0	0.8	0.2	3.9	2.6	4.7	0.8	3.5	9.3	0.0	0.0	12.0	0.8	0.0	2.2	0.0	1.6	1.3	0.6	8.6	0.1	0.2	6.7	4.8	0.0	0.0	0.6	0.3	5.8	0.6	1.4	3.6	9.4	0.0	3.6	0.0	10.6	232.9	0.7	0.0	0.4	0.0	2.3	0.0	11.7	1.5	43.6	0.0	1.8	2.0	1.7	1.6	0.1	0.1	0.0	0.6	0.7	0.1	0.5
FAM124B	FLJ22746	ENSG00000124019	"Family with sequence similarity 124 member B"	Q9H5Z6	2	224378698-224402107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 8.5"	"Group enriched"	"Detected in some"	4	"Adipocytes: 13.8;Endothelial cells: 10.8;Erythroid cells: 9.4;granulocytes: 4.5"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.5;eosinophil: 17.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 103.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070240	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA070240: AB_2686238"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.80e-3)"	5.2	0.5	1.4	1.1	1.2	4.7	4.3	1.4	1.7	1.5	0.9	0.9	1.0	1.6	0.3	1.4	1.2	1.2	1.8	1.3	1.6	0.6	1.9	2.3	0.7	1.8	1.7	0.4	0.4	2.4	0.2	8.5	1.5	0.5	1.0	0.2	0.8	0.5	1.2	1.8	1.0	2.3	1.6	0.5	0.6	0.3	1.7	1.1	1.0	4.6	0.7	1.5	1.4	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	15.0	0.0	0.1	0.0	0.0	0.0	103.4	0.0	4.8	0.2	0.0	0.1	0.0	0.1	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.7	7.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.5	3.0	17.2	0.2	2.3	0.0	0.0	0.7	0.0	7.9	0.0	0.0	0.0	0.1	5.4	0.8	0.0	2.5	1.1	1.4	1.2	1.4	1.7	1.3	1.6	1.8	1.7	1.5	1.6	1.7	1.1	13.8	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	1.2	0.3	0.2	10.8	0.0	9.4	0.2	0.0	0.1	0.4	0.0	0.8	4.5	0.0	2.2	0.4	0.4	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.7	0.0	1.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.0	0.0
FAM126B	"HYCC2, MGC39518"	ENSG00000155744	"Family with sequence similarity 126 member B"	Q8IXS8	2	200973718-201071671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 164.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 25.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 25.7"	"Cell line enhanced"	"Detected in all"		"U-266/84: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036166, HPA036167, HPA067307"	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	Nucleoplasm	"HPA036166: AB_10696651, HPA036167: AB_2674982, HPA067307: AB_2685821"	"unprognostic (7.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.52e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	7.8	4.5	4.7	6.3	5.2	17.4	4.8	15.9	8.1	4.0	2.3	7.2	6.8	3.9	4.0	8.2	3.2	4.3	3.4	6.5	3.1	7.8	7.4	5.4	5.9	3.3	3.2	3.8	4.9	4.9	3.8	5.0	3.3	3.7	6.4	10.4	4.3	2.7	3.0	7.1	6.6	3.9	0.6	6.8	7.5	4.5	5.2	5.9	6.9	3.6	6.1	3.8	4.4	6.1	5.4	2.8	3.9	4.2	4.0	5.3	8.2	5.0	3.0	4.0	3.7	7.2	6.2	4.9	4.8	5.1	3.7	6.5	8.1	3.1	6.0	7.1	4.9	14.3	7.6	6.7	3.3	17.6	11.9	2.3	3.9	5.5	3.3	3.1	3.9	5.2	13.4	17.6	4.1	3.3	10.5	11.4	2.8	3.5	4.7	6.1	5.9	4.6	3.7	5.9	7.7	3.8	5.3	6.0	4.7	5.1	4.2	7.7	7.9	7.5	5.3	3.7	4.6	13.1	58.8	10.5	4.3	6.7	5.4	2.6	1.8	6.3	3.8	2.4	4.0	2.6	3.2	3.0	1.6	2.7	3.1	3.7	25.7	3.1	2.7	1.1	2.4	1.9	4.7	5.2	15.9	8.1	6.5	3.1	3.3	3.2	3.3	0.6	5.2	6.1	21.5	28.9	23.9	45.1	29.3	52.6	10.7	17.0	23.3	52.9	16.3	9.4	17.2	27.1	20.4	20.2	164.7	16.6	38.3	59.1	17.6	10.6	9.1	12.7	16.4	22.7	37.1	23.1	113.4	10.5	10.1	15.9	24.5	16.2	24.7	19.9	35.3	21.0	12.0	26.9	98.3	23.4	22.4	33.9	51.6	6.6	31.7	21.1	30.2	45.0	41.5	20.3	73.2	57.8	64.6	21.3	31.1	25.6	34.0	13.2	47.3	16.4	23.1	42.7	19.7	14.8	15.9	32.8	22.9	31.6	74.2	17.4	35.6	15.3	22.0	19.6
FAM131B	KIAA0773	ENSG00000159784	"Family with sequence similarity 131 member B"	Q86XD5	7	143353400-143362770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 36.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 18.6;Inhibitory neurons: 12.0;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 33.6"	"Cancer enriched"	"Detected in many"	11	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;hTERT-RPE1: 8.5;NTERA-2: 22.3;PC-3: 21.5;SCLC-21H: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021371, HPA029992"			Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA021371: AB_1852341, HPA029992: "	"unprognostic (1.70e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-2)"	0.6	1.0	18.8	1.1	30.0	0.0	0.5	24.8	36.2	1.5	0.0	3.3	0.8	6.7	0.2	0.7	0.9	0.6	0.3	23.0	11.9	0.3	0.0	0.6	0.5	25.1	20.7	0.2	0.0	2.8	0.5	0.1	28.3	0.2	1.2	1.8	0.1	0.2	6.8	0.1	1.1	4.0	19.4	0.2	0.5	0.4	17.4	0.4	0.2	0.9	0.2	0.6	0.6	34.9	0.0	0.2	6.6	0.0	5.3	6.6	0.0	0.3	1.7	1.0	0.3	14.0	0.0	0.0	0.0	0.4	0.0	0.3	2.7	0.6	0.9	3.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	7.5	0.0	0.1	0.0	8.5	1.2	0.1	0.0	0.0	0.9	0.0	0.0	0.4	22.3	0.0	21.5	0.0	0.0	0.0	0.0	0.0	21.7	0.7	0.3	1.6	0.0	1.4	0.0	0.0	1.0	0.4	2.1	0.2	0.0	0.0	0.0	0.0	0.1	4.5	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.8	30.0	24.8	36.2	23.0	11.9	25.1	20.7	28.3	19.4	17.4	34.9	0.1	0.0	0.0	1.6	0.0	0.1	0.2	0.6	0.0	0.9	0.1	0.5	0.6	0.0	0.7	0.0	0.0	0.0	0.6	0.1	1.9	0.2	0.8	0.1	3.0	0.3	2.4	0.0	18.6	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.7	0.0	0.1	0.0	12.0	0.1	0.0	0.3	0.5	3.4	0.0	0.2	0.0	2.8	0.6	0.1	0.0	11.1	33.6	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.6
FAM133A	"CT115, FLJ37659, RP1-32F7.2"	ENSG00000179083	"Family with sequence similarity 133 member A"	Q8N9E0	X	93674013-93712274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.5;choroid plexus: 3.3;testis: 7.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 13.6;Early spermatids: 18.8;Excitatory neurons: 13.1;Horizontal cells: 20.2;Inhibitory neurons: 24.0;Late spermatids: 28.6;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 15.6;Spermatocytes: 26.4;Spermatogonia: 39.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 14.5;Karpas-707: 46.0;U-2197: 23.9;U-266/70: 35.7;U-266/84: 82.6"					"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Uncertain	Nucleoplasm,Nucleoli		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.67e-3)"	"unprognostic (4.45e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.22e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.12e-4)"	"unprognostic (1.67e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-3)"	0.0	1.2	5.2	0.0	5.2	0.0	0.2	4.3	9.5	0.5	3.3	0.1	0.0	0.3	0.2	0.0	0.3	0.1	0.9	4.7	6.3	0.0	0.0	0.0	0.0	4.6	5.6	0.4	0.0	0.0	2.2	0.0	5.8	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	4.5	0.0	0.0	7.6	5.8	0.0	0.2	0.0	0.0	0.0	0.1	4.7	0.3	2.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.8	46.0	0.0	0.0	0.0	0.0	1.1	0.0	11.6	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.3	0.0	0.0	0.0	0.9	1.1	23.9	1.0	35.7	82.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.2	4.3	9.5	4.7	6.3	4.6	5.6	5.8	4.5	5.8	4.7	0.1	0.0	0.0	3.6	0.0	0.6	0.0	0.0	0.0	13.6	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.8	0.0	0.4	0.1	0.0	0.0	13.1	0.0	0.1	0.5	0.0	0.0	0.0	3.0	0.7	0.0	0.0	20.2	24.0	0.0	0.0	0.0	0.3	28.6	1.2	0.1	0.0	1.0	0.0	2.9	0.0	22.6	15.6	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.2	26.4	39.0	0.0	0.1	0.0	0.1	3.7	0.0	0.0
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560758-92590393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	14.4	13.7	21.5	12.7	23.5	35.5	16.2	25.6	43.1	15.8	20.5	13.6	13.4	14.3	22.4	13.6	13.2	9.8	11.1	21.5	20.6	13.0	16.6	11.1	16.6	22.1	21.8	16.7	15.8	11.8	12.5	10.6	23.1	13.7	11.9	9.5	13.2	11.1	16.2	14.4	13.2	10.8	21.1	14.0	13.1	8.2	23.3	17.3	14.0	15.1	14.6	13.6	14.3	26.8	24.5	12.1	34.5	55.4	20.8	22.8	20.0	29.1	29.9	26.4	32.5	21.1	27.6	43.5	26.5	19.0	22.7	19.9	28.5	17.5	40.0	22.4	37.5	35.2	20.6	43.9	20.5	36.8	27.6	14.6	17.8	20.4	24.5	21.0	16.1	31.6	46.0	50.4	29.9	30.8	58.8	59.2	50.0	22.6	16.8	42.9	36.9	34.0	26.7	27.5	35.1	31.7	26.3	29.3	32.1	32.9	27.7	26.6	19.8	28.7	46.6	37.4	30.5	12.1	14.4	76.3	18.8	48.5	39.6	15.9	13.8	14.0	12.7	15.0	18.5	30.3	16.4	17.2	13.7	23.4	19.5	17.3	5.8	15.2	11.4	31.2	21.0	7.7	21.5	23.5	25.6	43.1	21.5	20.6	22.1	21.8	23.1	21.1	23.3	26.8	157.6	57.7	64.3	23.8	146.2	114.3	196.1	130.7	84.2	83.7	120.3	113.2	27.8	184.5	87.9	88.3	75.0	61.7	258.3	126.9	99.7	93.3	47.8	174.1	167.5	89.3	137.3	119.5	28.0	87.0	62.0	99.6	59.1	294.0	87.0	76.3	109.9	120.9	72.4	55.5	27.1	118.7	95.6	121.2	155.1	19.2	102.6	116.5	76.5	27.2	112.5	104.8	121.5	27.6	57.8	89.2	122.3	88.8	139.3	126.1	84.2	98.1	55.1	73.8	52.6	207.3	107.0	100.9	115.7	75.4	104.8	70.6	151.7	78.5	113.3	137.9
FAM135A	"FLJ20176, KIAA1411"	ENSG00000082269	"Family with sequence similarity 135 member A"	Q9P2D6	6	70412941-70561174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.1;Horizontal cells: 238.9;Inhibitory neurons: 172.8;Microglial cells: 132.1;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031743, HPA031744"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA031743: AB_10600767, HPA031744: AB_10601101"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (8.00e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.69e-4)"	"unprognostic (4.08e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (3.99e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.65e-2)"	2.6	2.8	2.5	4.8	3.6	1.3	2.5	8.1	3.3	4.9	0.6	10.7	13.6	6.3	2.5	29.8	4.1	7.0	4.1	3.2	2.1	4.9	2.4	4.2	3.8	2.4	2.3	6.3	6.0	9.7	1.9	4.0	2.4	16.1	11.1	8.2	4.5	3.5	2.6	9.6	11.5	3.7	1.2	3.5	10.7	10.1	2.2	2.9	3.8	6.5	6.4	4.9	7.1	3.7	7.9	4.8	9.5	6.1	4.5	3.2	8.9	2.5	5.0	2.6	4.3	8.9	6.2	14.3	18.1	1.9	12.6	7.3	9.6	5.6	4.6	6.8	8.2	6.2	4.6	8.0	5.5	12.3	6.4	2.9	13.8	5.0	13.4	3.1	7.2	4.4	10.6	6.8	3.1	0.8	2.2	5.5	6.4	9.2	3.9	6.8	31.3	6.8	9.8	4.0	10.1	3.1	2.9	2.6	3.0	6.3	1.8	5.2	3.6	2.2	5.7	2.2	5.8	8.5	10.3	5.5	1.6	10.4	4.2	1.8	2.3	0.1	0.8	2.0	0.9	1.6	0.7	0.3	3.5	2.0	1.1	0.7	0.6	2.7	3.3	0.5	0.9	0.9	2.5	3.6	8.1	3.3	3.2	2.1	2.4	2.3	2.4	1.2	2.2	3.7	12.0	28.9	12.5	85.8	10.8	15.9	12.9	8.3	31.3	20.8	4.5	4.1	11.5	17.2	8.9	20.2	29.2	2.9	4.7	49.9	5.9	6.7	30.4	13.9	15.6	13.0	23.4	1.7	170.1	12.4	1.5	10.2	45.9	21.4	8.8	13.5	9.7	6.5	5.6	238.9	172.8	29.2	16.2	10.6	15.5	23.8	15.5	11.9	5.4	132.1	11.9	13.8	4.1	219.2	121.3	18.4	31.7	13.2	6.4	35.4	24.0	10.0	9.9	26.4	6.6	11.6	9.3	33.2	10.5	71.4	33.5	8.2	4.6	10.9	25.5	15.8
FAM135B	C8ORFK32	ENSG00000147724	"Family with sequence similarity 135 member B"	Q49AJ0	8	138130023-138497261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.7;retina: 9.1;testis: 3.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 64.3;Early spermatids: 157.1;Excitatory neurons: 229.3;Inhibitory neurons: 267.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"RH-30: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023911, HPA023950, HPA024815"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane"	Nucleoplasm	"HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376"	"unprognostic (3.78e-1)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.36e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.85e-4)"	"unprognostic (9.92e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.47e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.30e-1)"	0.1	2.6	4.8	0.1	4.8	0.0	0.0	6.1	10.7	0.0	0.0	0.8	0.3	0.0	0.1	0.0	0.0	0.0	0.1	6.8	1.1	0.3	0.0	0.0	0.0	5.0	3.0	0.0	0.4	0.0	1.3	0.0	5.1	0.2	0.6	9.1	0.0	0.2	0.0	0.0	0.3	0.0	1.8	0.0	0.6	3.8	3.4	0.1	0.0	0.3	0.0	0.4	0.1	5.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	8.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	4.8	6.1	10.7	6.8	1.1	5.0	3.0	5.1	1.8	3.4	5.7	0.0	0.0	0.0	64.3	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	1.4	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.1	1.8	0.0	229.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	267.0	0.0	0.0	0.0	0.4	32.7	1.5	0.1	0.0	8.4	0.0	2.9	0.0	34.2	17.5	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.3	0.1	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM13B	"ARHGAP49, C5orf5, FAM13B1, KHCHP, N61"	ENSG00000031003	"Family with sequence similarity 13 member B"	Q9NYF5	5	137937960-138051961	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 140.6;Inhibitory neurons: 140.0;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036525, HPA041819, HPA071936"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA036525: AB_10696655, HPA041819: AB_2677690, HPA071936: AB_2686474"	"unprognostic (8.09e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.02e-3)"	"unprognostic (6.51e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.60e-1)"	"prognostic favorable (3.55e-5)"	"unprognostic (9.56e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.06e-2)"	13.4	22.6	14.4	15.7	18.5	24.0	15.9	18.7	15.7	15.4	7.9	14.1	9.8	22.4	14.0	14.0	14.7	14.8	20.6	13.8	22.0	13.7	8.6	13.7	21.4	14.8	14.3	24.6	9.5	15.6	8.7	16.2	15.9	24.4	12.2	12.6	11.3	35.7	4.4	11.1	10.9	32.4	8.9	17.8	11.6	34.0	21.3	17.7	15.1	7.6	23.4	17.1	11.6	18.7	18.1	9.0	26.2	21.6	34.3	10.7	20.6	39.1	31.7	29.3	33.8	24.1	16.0	40.7	12.8	34.3	37.4	13.8	16.3	12.6	38.0	30.9	17.6	18.3	21.7	7.6	11.6	30.0	24.3	13.7	6.9	22.4	13.0	15.4	10.2	14.6	10.7	20.2	27.4	13.3	30.5	16.4	10.4	14.0	10.7	21.7	26.1	8.1	17.7	31.6	29.6	26.0	30.5	9.3	38.8	37.6	25.4	30.2	13.5	31.3	13.5	23.2	29.9	16.2	42.2	38.2	17.6	24.3	27.3	10.7	2.2	8.6	4.6	3.3	3.9	5.3	3.3	4.2	1.7	5.6	3.4	4.5	7.1	6.0	5.9	2.9	3.5	1.7	14.4	18.5	18.7	15.7	13.8	22.0	14.8	14.3	15.9	8.9	21.3	18.7	21.2	22.4	19.8	63.6	56.7	15.4	15.7	10.0	64.9	19.4	23.2	20.7	43.3	14.3	15.2	5.5	20.9	12.4	44.9	8.7	3.9	6.8	40.8	28.1	25.2	17.8	10.3	18.5	140.6	3.5	4.0	21.7	16.8	36.0	30.4	29.2	18.9	5.4	13.9	11.8	140.0	9.9	6.1	24.6	28.9	30.5	16.1	31.2	12.4	73.1	17.6	5.9	28.8	130.2	227.6	6.4	7.0	25.6	37.5	12.5	7.6	5.6	12.9	15.2	26.3	29.8	24.8	29.9	21.7	39.6	13.8	5.2	46.9	49.6	8.4	12.8
FAM13C	FAM13C1	ENSG00000148541	"Family with sequence similarity 13 member C"	Q8NE31	10	59246130-59363181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.0"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 477.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.1;HSkMC: 5.1;hTERT-RPE1: 3.4;NTERA-2: 4.5;SCLC-21H: 8.6;SH-SY5Y: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037888	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA037888: AB_10962981"	"unprognostic (3.68e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.69e-5)"	"unprognostic (8.54e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-6)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.94e-3)"	"unprognostic (4.66e-3)"	13.5	16.2	20.8	3.9	45.8	0.0	9.3	33.2	32.4	8.7	3.7	7.7	4.2	8.7	8.0	13.8	14.5	11.5	8.1	21.3	34.3	3.4	2.1	9.9	4.7	49.3	36.3	21.2	2.2	4.7	4.7	2.6	40.9	17.2	6.2	9.9	5.6	7.9	17.1	7.2	5.9	12.2	35.5	5.1	3.8	5.2	37.6	5.2	6.3	22.9	2.3	4.4	7.9	68.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	1.3	0.2	0.1	0.0	1.2	0.0	4.1	1.9	0.1	0.0	0.0	5.1	0.6	0.2	0.0	3.4	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.8	0.0	0.0	1.3	8.6	5.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	2.5	2.2	0.1	2.1	0.0	0.0	0.1	3.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	45.8	33.2	32.4	21.3	34.3	49.3	36.3	40.9	35.5	37.6	68.0	47.8	0.0	0.0	33.6	0.1	4.8	9.3	0.3	8.0	10.5	0.7	2.7	2.5	0.0	0.7	0.0	6.2	0.0	0.4	0.1	7.9	0.0	49.0	18.6	1.5	35.2	0.0	0.0	66.8	0.0	0.0	19.8	0.5	5.3	0.0	26.9	3.9	0.5	0.0	3.3	73.2	0.2	20.3	0.0	2.5	22.1	23.0	0.7	3.6	7.5	0.0	8.8	0.0	56.8	477.1	0.0	0.0	21.1	0.1	5.4	0.0	0.6	20.7	13.6	39.5	23.4	36.2	1.4	0.7	2.4	6.3	0.0	1.2	17.4	0.2	1.1
FAM149B1	KIAA0974	ENSG00000138286	"Family with sequence similarity 149 member B1"	Q96BN6	10	73168119-73244504	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039189, HPA039859"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA039189: AB_10805355, HPA039859: AB_2676712"	"unprognostic (2.23e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.24e-2)"	12.3	10.6	20.7	6.4	23.1	5.2	12.4	22.8	22.9	14.1	18.9	9.2	7.7	11.5	12.6	11.7	13.6	12.6	12.6	19.2	21.3	21.8	19.1	10.4	9.4	21.6	22.1	15.0	12.2	13.9	6.2	13.3	22.8	10.9	9.9	11.8	11.3	10.6	13.6	7.8	8.9	11.5	21.1	8.0	9.9	21.9	21.3	12.4	12.3	17.2	9.7	10.6	7.6	25.3	8.7	8.4	19.8	19.0	45.9	28.5	13.9	12.5	28.6	9.8	17.1	2.5	23.6	8.1	5.8	25.8	10.8	10.1	12.6	18.4	11.7	11.1	4.7	6.3	5.6	7.4	23.8	10.2	6.1	24.6	13.4	12.6	48.6	44.5	24.9	11.7	5.8	15.2	18.0	10.4	7.7	12.9	8.7	29.8	19.7	4.3	11.2	9.9	26.4	12.1	3.3	20.1	11.1	30.1	19.6	17.8	18.6	9.9	12.7	8.2	6.6	8.2	12.6	20.0	8.8	4.4	15.9	11.3	7.0	0.7	0.2	0.6	0.3	0.6	0.2	0.3	0.1	0.2	0.4	0.4	0.5	0.4	0.5	1.0	0.2	0.6	0.1	0.1	20.7	23.1	22.8	22.9	19.2	21.3	21.6	22.1	22.8	21.1	21.3	25.3	5.4	3.2	3.1	24.8	3.9	2.0	3.5	4.6	6.8	6.7	5.3	5.2	12.2	5.7	5.4	1.8	6.2	7.4	2.4	4.6	1.9	3.9	21.8	6.1	7.0	6.2	7.7	3.0	19.7	3.6	5.8	7.2	5.1	6.1	2.5	8.2	7.1	4.0	5.4	3.3	24.9	5.0	6.1	6.3	3.1	27.6	8.4	4.0	1.8	12.2	4.1	4.6	1.0	23.6	41.3	4.2	2.2	4.5	1.8	4.6	6.6	6.9	9.8	11.4	13.1	5.9	5.0	13.4	5.1	5.3	3.7	8.2	3.4	7.2	5.4	4.3
FAM160B2	"FLJ21801, RAI16"	ENSG00000158863	"Family with sequence similarity 160 member B2"	Q86V87	8	22089150-22104911	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025040	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA025040: AB_1856049"	"unprognostic (3.45e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.67e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.75e-3)"	13.9	11.5	4.5	3.9	4.1	3.6	15.8	3.5	5.5	12.5	3.5	16.2	5.8	12.3	4.9	13.6	12.7	5.6	21.7	3.6	3.5	14.6	10.5	10.6	6.3	4.8	4.2	10.0	22.3	8.2	13.2	5.2	4.1	14.6	2.5	3.0	16.7	10.6	17.7	14.0	13.5	6.9	3.7	11.4	17.4	6.1	4.8	4.2	15.4	7.2	2.2	16.2	12.0	4.6	4.4	8.7	4.3	6.8	9.2	8.1	7.8	8.0	13.6	8.6	5.8	3.9	4.7	4.9	7.7	19.7	7.8	6.3	3.3	9.3	1.9	4.1	4.2	7.3	2.8	2.2	12.4	1.9	5.7	13.6	6.9	6.6	4.4	8.9	9.1	8.8	4.6	3.3	8.3	8.0	5.0	2.9	2.1	8.0	3.8	5.1	3.7	2.5	7.4	8.9	1.8	5.8	4.6	6.6	5.2	4.5	4.3	3.2	10.3	8.4	7.2	8.0	4.6	3.5	0.9	0.9	9.0	3.1	9.7	0.0	0.4	0.1	0.8	0.2	0.5	0.7	0.5	0.6	0.2	0.5	0.4	0.7	0.0	0.4	0.4	0.2	0.0	0.7	4.5	4.1	3.5	5.5	3.6	3.5	4.8	4.2	4.1	3.7	4.8	4.6	16.4	12.8	17.2	17.0	11.6	5.9	10.1	9.9	12.5	22.0	16.4	13.5	26.1	12.8	8.8	12.9	27.1	8.5	10.1	15.5	0.0	9.7	3.7	8.9	14.5	16.8	13.2	1.3	12.3	15.0	15.5	12.5	23.0	11.8	7.0	19.1	16.8	13.6	7.4	23.5	12.0	10.8	0.0	9.4	4.7	2.5	10.8	8.2	1.8	8.4	4.4	8.7	9.2	12.1	11.0	17.1	17.1	5.7	6.3	15.1	14.7	5.0	10.8	23.8	0.0	11.0	14.7	1.5	7.0	16.1	7.5	14.9	11.2	9.6	9.9	12.4
FAM161B	"C14orf44, FLJ31697"	ENSG00000156050	"FAM161 centrosomal protein B"	Q96MY7	14	73931501-73950414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 62.9;Late spermatids: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019125	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA019125: AB_1845570"	"unprognostic (1.50e-1)"	"unprognostic (9.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (6.78e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.60e-1)"	2.7	8.7	6.6	1.7	6.6	1.2	4.8	5.8	8.2	5.3	3.4	3.9	3.3	5.2	4.3	4.1	5.5	2.7	5.4	6.4	5.9	7.2	5.1	2.8	1.8	6.8	5.7	12.8	2.2	4.3	7.6	2.4	7.1	6.0	2.7	10.1	2.8	5.2	7.9	2.1	3.3	3.4	5.5	3.1	3.3	18.8	6.1	1.9	4.2	4.8	1.8	5.5	3.8	6.6	2.1	1.6	2.2	3.4	4.7	3.5	2.0	3.6	2.8	6.0	5.8	1.5	2.6	3.3	2.3	4.2	2.5	3.9	0.9	1.7	4.1	9.2	1.8	1.6	1.6	1.7	4.0	1.1	2.3	2.6	3.4	6.1	2.2	4.4	2.7	3.4	1.0	1.6	4.3	3.3	3.1	4.2	0.5	1.4	3.5	2.1	2.9	1.3	3.1	3.1	2.7	2.5	5.1	2.3	3.1	1.6	8.1	1.5	2.9	12.4	5.6	3.1	2.2	3.3	2.2	2.1	6.3	1.9	2.2	3.2	1.3	1.9	1.1	0.3	1.3	0.7	1.2	1.7	0.2	0.9	0.6	0.4	0.4	1.3	0.4	0.3	0.7	0.9	6.6	6.6	5.8	8.2	6.4	5.9	6.8	5.7	7.1	5.5	6.1	6.6	3.5	3.2	4.8	4.9	3.0	0.6	2.1	1.0	3.4	8.9	3.7	3.8	3.4	0.0	3.2	1.8	4.2	1.5	1.9	3.5	0.0	1.0	62.9	5.9	3.9	2.2	0.0	1.7	7.3	1.6	1.1	4.6	7.1	4.5	0.0	5.0	2.5	0.7	2.9	3.3	8.6	4.1	2.0	1.2	0.7	142.7	3.4	1.4	1.8	2.8	2.2	8.0	6.2	5.5	2.9	1.2	0.8	9.4	1.4	0.8	4.3	4.2	9.4	16.7	6.6	5.2	4.2	11.0	6.1	0.6	0.9	2.2	3.3	9.6	1.4	0.9
FAM168A	"KIAA0280, TCRP1"	ENSG00000054965	"Family with sequence similarity 168 member A"	Q92567	11	73400487-73598189	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 125.0;Excitatory neurons: 171.0;Inhibitory neurons: 161.2;Oligodendrocyte precursor cells: 166.9;Oligodendrocytes: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037580	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA037580: AB_10672906"	"unprognostic (2.65e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (4.60e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.41e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.70e-4)"	13.5	10.9	43.7	10.8	44.9	11.0	13.3	48.8	48.8	14.6	2.3	16.0	8.1	15.3	18.0	8.9	14.1	13.9	13.6	42.6	50.0	12.1	11.3	10.4	9.0	59.1	48.3	16.7	9.7	21.9	12.4	9.8	54.0	12.9	9.6	49.7	12.7	15.7	19.9	8.7	12.0	18.1	49.7	9.4	10.7	8.5	56.0	13.2	14.8	15.3	8.3	12.8	8.8	46.8	13.4	15.6	33.6	19.0	24.2	27.0	5.1	19.6	22.5	21.5	20.5	17.6	17.4	14.9	16.9	34.9	20.1	12.3	19.4	19.3	26.3	10.3	14.3	17.1	17.3	9.6	9.4	9.2	30.8	25.3	13.5	21.3	11.2	29.2	13.8	23.9	4.3	10.9	22.3	20.2	21.4	9.4	11.5	27.4	19.7	30.3	56.7	8.1	12.8	12.0	22.3	34.6	23.1	17.5	37.8	12.3	28.4	10.7	17.8	24.5	20.6	31.9	16.2	24.9	18.7	25.7	13.0	11.3	22.9	6.0	1.3	0.9	0.8	2.3	0.4	0.4	0.3	0.6	1.1	0.5	0.6	0.6	2.9	0.5	1.5	1.4	0.6	0.3	43.7	44.9	48.8	48.8	42.6	50.0	59.1	48.3	54.0	49.7	56.0	46.8	18.3	3.2	8.2	125.0	4.0	3.8	2.3	7.1	3.4	21.8	11.0	9.7	20.3	15.7	9.9	7.3	45.9	2.3	5.7	5.2	0.0	3.3	22.4	13.1	12.5	9.7	12.7	2.1	171.0	2.7	3.6	9.4	5.6	19.2	22.9	31.9	11.0	16.6	9.8	3.3	161.2	8.6	2.0	14.8	6.8	25.4	7.5	10.0	5.4	59.0	7.3	26.7	5.2	166.9	149.1	3.4	2.8	12.8	2.9	1.8	8.4	4.2	7.2	24.4	6.6	12.3	19.1	7.0	6.1	5.3	3.8	2.7	4.9	6.9	6.7	1.7
FAM171A1	"APCN, C10orf38, FLJ12884"	ENSG00000148468	"Family with sequence similarity 171 member A1"	Q5VUB5	10	15211643-15371289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 263.8;Cholangiocytes: 98.7;Excitatory neurons: 166.9;Oligodendrocytes: 214.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 1.7;MAIT T-cell: 4.4;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.7;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"TIME: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051345	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		130000	"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	Nucleoplasm	"HPA051345: AB_2681449"	"unprognostic (3.60e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.71e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (4.90e-6)"	"unprognostic (3.28e-2)"	11.0	5.0	60.1	7.5	73.2	0.5	8.8	69.8	56.4	11.8	22.7	21.6	19.1	12.8	6.4	6.4	15.6	12.9	10.6	68.5	49.5	31.9	15.4	7.4	6.0	79.6	64.8	14.2	22.4	10.9	3.7	4.1	75.6	11.2	17.6	2.6	14.1	11.9	7.6	4.2	13.0	12.3	59.3	12.4	13.3	3.5	68.7	3.9	6.9	6.1	6.6	9.0	6.3	86.7	0.0	16.2	33.3	12.6	13.2	24.9	0.4	19.5	3.9	10.2	8.8	3.0	19.2	0.1	21.5	53.4	22.7	1.4	24.0	0.2	11.5	5.9	33.4	46.7	5.2	48.1	14.3	0.0	36.0	19.7	4.9	27.8	4.0	36.8	51.4	6.8	17.5	0.2	32.8	1.4	7.7	0.1	30.4	9.3	7.8	30.4	17.0	5.1	12.7	0.0	22.4	27.6	10.9	0.2	0.1	35.0	0.2	0.6	105.6	13.9	53.6	50.4	20.8	6.3	2.1	0.1	30.3	0.0	10.8	0.0	0.0	0.0	1.7	0.0	4.4	0.0	2.5	2.2	0.0	0.0	4.7	2.4	0.0	0.2	0.0	0.0	0.5	0.9	60.1	73.2	69.8	56.4	68.5	49.5	79.6	64.8	75.6	59.3	68.7	86.7	11.1	0.0	0.0	263.8	1.0	1.3	4.0	3.1	8.0	4.0	7.6	5.7	6.8	98.7	1.7	14.7	0.0	0.1	0.2	25.4	3.9	21.1	0.7	5.9	12.5	43.7	21.0	6.5	166.9	12.2	0.2	12.3	35.7	14.6	1.3	14.4	49.2	24.7	0.4	6.7	76.6	23.7	4.1	2.8	1.7	1.1	5.3	0.3	1.8	33.7	0.7	1.5	0.0	44.2	214.4	17.5	16.1	5.7	5.2	16.5	7.3	4.5	2.4	1.1	0.0	7.5	5.9	2.3	5.7	8.0	1.8	0.1	2.0	11.4	38.8	3.6
FAM171B	"FLJ34104, KIAA1946"	ENSG00000144369	"Family with sequence similarity 171 member B"	Q6P995	2	186694060-186765959	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 258.6;Bipolar cells: 141.4;Excitatory neurons: 126.5;Inhibitory neurons: 114.2;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 78.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 15.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.7;U-138 MG: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010639, HPA013434"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"		"HPA010639: AB_1852447, HPA013434: AB_2262499"	"unprognostic (2.52e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (9.51e-7)"	"unprognostic (4.63e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.03e-4)"	2.9	14.4	36.1	1.5	52.2	0.5	3.4	8.3	54.8	6.6	0.0	1.8	1.0	7.5	2.1	1.9	2.7	4.9	1.4	52.8	33.0	1.2	0.3	1.4	1.2	15.0	16.9	10.2	1.0	7.6	10.7	3.3	17.6	2.7	2.0	24.1	23.0	2.3	0.7	3.7	1.4	4.4	17.2	1.5	2.0	0.9	28.3	2.8	2.2	3.6	1.1	2.2	2.2	30.1	4.2	4.9	7.2	22.6	20.9	15.7	0.1	4.5	8.0	5.5	7.8	13.6	21.9	0.0	1.6	12.9	9.3	0.5	9.9	4.3	7.8	0.0	5.7	5.1	2.1	0.0	1.6	1.5	1.7	20.2	1.8	4.2	3.4	7.1	12.1	3.9	0.0	43.7	10.5	2.9	3.0	0.0	9.6	0.0	4.9	0.0	13.9	1.0	8.5	15.8	22.4	12.2	2.3	1.4	6.1	4.2	1.7	1.0	7.1	29.7	3.9	0.5	2.9	11.5	12.0	0.0	9.2	0.0	4.2	0.2	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.2	0.0	0.0	36.1	52.2	8.3	54.8	52.8	33.0	15.0	16.9	17.6	17.2	28.3	30.1	9.1	0.0	0.0	258.6	0.1	8.9	2.8	1.2	4.0	141.4	10.7	5.7	0.8	5.7	5.7	0.0	14.6	11.4	0.5	0.0	0.0	1.0	1.3	1.5	13.0	14.4	4.8	1.3	126.5	0.4	0.8	14.1	2.6	4.7	0.0	0.8	6.8	0.1	2.0	23.5	114.2	0.0	4.1	0.3	2.8	4.0	7.8	1.0	3.6	18.7	0.7	16.2	0.0	102.1	78.5	0.7	0.0	13.9	0.2	1.4	0.0	0.2	2.6	17.0	0.0	8.6	4.5	0.4	1.5	0.6	5.3	8.2	0.9	2.6	0.0	1.1
FAM172A	"C5orf21, DKFZP564D172, Toupee"	ENSG00000113391	"Family with sequence similarity 172 member A"	Q8WUF8	5	93617725-94111699	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 174.3;Excitatory neurons: 259.9;Inhibitory neurons: 297.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 264.9;Oligodendrocytes: 343.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012299, HPA045505"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA012299: AB_1845724, HPA045505: AB_2679354"	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.03e-2)"	13.6	9.7	10.2	8.1	10.7	7.6	12.9	12.8	11.1	12.7	7.3	8.4	7.5	12.7	10.0	11.6	12.2	9.4	9.3	10.2	11.0	12.3	5.3	9.1	9.2	10.4	9.7	15.0	9.6	12.4	7.1	8.3	10.2	12.4	8.1	14.8	10.9	14.3	3.0	7.7	8.9	11.5	10.6	9.8	8.8	5.6	10.4	9.8	15.5	6.7	9.0	9.4	7.4	11.4	7.5	8.8	20.4	23.1	24.0	29.3	10.7	16.4	12.1	6.7	6.5	6.0	10.1	10.7	11.6	18.7	11.8	6.3	6.3	22.2	15.4	7.4	7.7	14.2	17.0	3.6	10.0	11.5	15.8	25.3	12.2	6.2	11.8	23.7	15.0	10.1	3.0	3.3	27.3	8.3	9.3	8.1	3.1	13.8	7.0	10.3	21.7	10.3	10.1	14.5	17.5	32.1	12.4	5.0	11.6	12.8	12.8	12.9	14.8	15.6	14.1	10.3	18.7	13.4	20.8	11.9	24.0	11.9	29.1	12.4	4.0	5.4	8.2	5.4	8.4	6.7	6.1	6.2	5.3	6.3	6.8	6.9	9.3	9.7	4.1	5.0	6.9	4.8	10.2	10.7	12.8	11.1	10.2	11.0	10.4	9.7	10.2	10.6	10.4	11.4	27.8	54.5	26.4	174.3	40.0	12.2	25.0	26.4	23.3	49.5	31.4	28.2	21.5	22.8	23.4	11.0	31.3	13.0	47.4	14.3	60.7	19.9	47.7	29.2	34.9	25.4	16.9	10.3	259.9	21.2	13.7	32.6	21.9	21.9	25.3	22.7	21.8	14.9	11.3	42.1	297.7	13.9	22.4	21.3	12.1	34.2	38.5	18.0	21.4	227.7	27.9	37.4	58.7	264.9	343.8	20.1	14.7	36.5	17.3	19.7	27.7	35.2	47.5	54.5	13.1	39.5	30.7	22.4	26.1	25.8	10.1	10.9	37.4	30.7	16.4	24.4
FAM177A1	C14orf24	ENSG00000151327	"Family with sequence similarity 177 member A1"	Q8N128	14	35044907-35113130	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 637.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053222, HPA055440"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA		170000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Nucleoplasm	"HPA053222: AB_2682083, HPA055440: AB_2682817"	"unprognostic (6.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (4.64e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.91e-1)"	45.3	43.2	36.8	30.0	50.1	49.6	38.2	45.3	46.5	44.2	36.9	81.5	57.2	29.4	29.6	49.7	26.8	37.7	78.1	39.0	51.3	61.3	77.0	68.6	20.2	52.4	50.6	28.2	49.4	30.6	47.4	27.3	49.1	63.1	71.5	31.3	43.4	36.1	48.3	41.3	54.6	42.3	45.0	23.6	42.5	86.2	47.0	21.6	48.0	32.8	23.2	46.7	37.7	57.0	63.4	51.2	38.0	31.3	64.6	64.6	46.7	101.3	55.8	52.4	57.1	52.2	82.6	25.1	68.1	98.9	71.1	65.8	47.1	58.5	66.7	73.5	28.8	19.5	63.8	179.5	79.4	30.7	44.9	58.5	75.3	63.5	49.5	76.7	60.6	46.7	47.7	79.8	102.5	91.5	38.0	28.1	30.9	100.9	65.2	21.9	52.7	35.9	95.2	68.7	52.1	45.9	119.3	94.2	81.3	75.2	87.2	23.9	71.3	67.5	59.2	76.6	53.2	59.3	79.8	31.2	42.3	20.5	68.0	79.9	43.9	79.2	31.0	36.7	36.5	45.0	40.3	35.7	34.8	35.8	31.7	31.4	167.5	32.6	31.9	50.8	60.0	30.4	36.8	50.1	45.3	46.5	39.0	51.3	52.4	50.6	49.1	45.0	47.0	57.0	126.7	240.4	176.3	6.5	87.4	160.7	199.4	200.4	83.6	35.8	119.0	118.4	147.8	67.2	168.1	104.8	27.1	71.0	322.2	329.3	119.3	121.9	637.1	235.5	86.6	116.4	133.8	36.0	10.7	249.6	118.0	80.5	107.0	426.4	82.3	43.1	82.5	235.6	75.5	23.5	13.4	189.5	144.5	61.1	130.9	505.9	54.0	85.4	149.4	8.4	125.1	45.3	48.4	9.0	28.4	364.6	220.1	53.0	133.3	211.4	273.7	347.2	177.8	45.5	46.0	65.2	106.2	189.3	106.8	93.1	171.5	123.3	215.7	30.4	224.2	229.5
FAM180A	"HWKM1940, UNQ1940"	ENSG00000189320	"Family with sequence similarity 180 member A"	Q6UWF9	7	135728348-135748813	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.1;heart muscle: 15.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.5;Cardiomyocytes: 6.6;Fibroblasts: 19.7;Hepatic stellate cells: 4.6;Langerhans cells: 9.5;Melanocytes: 7.2;Suprabasal keratinocytes: 4.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-2197: 259.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA021224	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA021224: AB_1851352"	"unprognostic (3.85e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.62e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.88e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.35e-4)"	"unprognostic (6.62e-4)"	3.1	2.7	0.0	0.5	0.1	0.1	3.4	0.1	0.3	2.6	4.2	1.8	0.8	4.7	0.4	4.0	2.0	16.1	15.9	0.3	0.0	4.1	10.2	2.5	0.1	0.0	0.0	7.9	1.3	0.2	0.1	0.2	0.0	0.6	2.0	0.0	1.2	0.2	0.3	3.4	1.3	4.7	0.0	0.6	1.0	0.4	0.0	0.2	2.7	1.3	0.5	4.4	1.3	0.1	0.0	0.1	0.0	0.0	27.8	28.4	0.0	14.9	56.2	0.3	0.2	0.0	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.6	0.0	35.6	4.6	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6	57.1	0.0	259.7	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.8	6.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.8	0.0	0.0	0.3	0.0	0.0	19.7	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	2.8	0.1	7.2	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	1.8	0.0	0.0	0.1	4.8	0.7	0.2	0.0	0.0	0.0
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.3;choroid plexus: 30.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.0;Astrocytes: 261.2;Oligodendrocyte precursor cells: 88.4;Syncytiotrophoblasts: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.8;HEK 293: 11.1;Hep G2: 7.9;JURKAT: 11.6;K-562: 10.4;SCLC-21H: 8.5;SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	3.1	1.6	33.3	1.3	36.3	0.2	4.7	37.3	43.3	3.6	30.5	3.5	3.0	2.5	3.0	1.4	3.2	1.8	2.5	34.3	33.0	6.7	6.3	9.9	3.5	31.9	32.4	4.5	3.2	4.8	11.0	23.0	32.4	3.9	0.9	16.3	3.3	2.8	0.9	1.7	1.6	1.6	29.1	0.6	1.7	16.9	32.6	0.6	7.0	2.2	3.5	2.4	2.1	34.5	0.1	0.3	11.8	0.9	0.3	0.3	0.0	0.6	0.4	0.5	0.9	2.0	1.1	0.9	0.0	0.2	5.3	0.0	3.4	0.0	0.2	1.3	11.1	0.1	0.9	7.9	0.2	0.0	0.6	0.4	0.1	0.1	0.0	0.3	0.0	11.6	10.4	0.7	0.3	0.3	0.4	0.1	6.0	0.6	1.3	0.0	0.1	0.0	0.1	0.1	8.5	8.0	0.7	0.6	1.8	2.2	2.1	1.4	0.3	0.8	0.5	0.2	2.9	4.9	3.3	0.3	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	33.3	36.3	37.3	43.3	34.3	33.0	31.9	32.4	32.4	29.1	32.6	34.5	21.0	48.1	103.0	261.2	0.7	2.4	5.9	0.4	11.4	35.2	3.8	8.8	6.4	2.8	17.7	3.7	29.2	61.4	0.6	0.4	17.6	1.0	22.9	2.0	2.0	5.3	6.0	0.4	66.9	1.1	18.9	11.8	1.5	0.8	6.3	8.9	1.8	4.0	5.6	13.5	55.5	0.6	0.0	0.3	1.8	9.2	3.7	1.0	0.0	34.7	0.0	11.1	0.0	88.4	20.6	0.3	1.2	7.2	2.7	1.6	0.4	3.1	37.3	28.4	6.6	45.2	4.1	61.8	16.0	4.2	3.4	266.4	5.8	1.4	0.7	2.0
FAM186A	LOC121006	ENSG00000185958	"Family with sequence similarity 186 member A"	A6NE01	12	50326230-50396622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 14.2"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 521.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047128, HPA064735"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA047128: AB_10967726, HPA064735: "	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.65e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.22e-3)"	0.1	0.3	0.2	0.2	0.4	0.5	0.1	0.6	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.2	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.2	0.3	0.0	0.9	0.0	0.1	0.3	0.1	0.7	0.2	0.0	1.1	0.3	0.2	0.0	0.0	0.3	0.1	14.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.0	0.0	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	521.1	0.1	0.2	0.1	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	64.7	0.6	0.1	0.0	2.8	0.0	0.6	0.0	1.5	3.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM189A1	"KIAA0574, TMEM228"	ENSG00000104059	"Family with sequence similarity 189 member A1"	O60320	15	29120254-29570723	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 5.3;thyroid gland: 3.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 202.9;Inhibitory neurons: 198.0;Oligodendrocyte precursor cells: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.6;HDLM-2: 12.0;REH: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009410, HPA010637"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA009410: AB_1852332, HPA010637: AB_1852333"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.12e-1)"	0.6	0.4	2.2	0.0	1.8	0.0	0.1	0.0	2.4	0.3	0.3	2.6	0.1	0.2	0.0	0.0	1.0	0.0	0.8	2.5	0.4	2.1	0.1	1.1	0.0	0.2	0.3	0.2	5.3	0.4	0.4	0.0	0.2	0.4	0.5	0.1	0.6	0.0	0.0	0.1	0.9	0.0	0.0	0.2	0.4	2.0	1.2	0.0	3.2	0.0	0.1	0.9	0.2	0.8	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	0.0	0.0	0.0	0.1	12.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	1.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	2.4	2.5	0.4	0.2	0.3	0.2	0.0	1.2	0.8	0.5	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	4.3	0.8	0.0	0.0	0.4	3.0	0.0	202.9	0.2	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.0	0.1	0.0	198.0	2.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	29.0	0.0	0.2	0.0	59.8	8.1	0.2	2.6	1.5	0.0	1.0	2.2	0.8	0.0	0.4	0.0	0.0	0.2	0.6	1.7	0.0	0.0	0.0	0.0	1.0	3.2	0.4
FAM189B	"C1orf2, cote1"	ENSG00000160767	"Family with sequence similarity 189 member B"	P81408	1	155247205-155255483	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006659, HPA050674"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA006659: AB_1078339, HPA050674: AB_2681213"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.59e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.86e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.43e-7)"	"unprognostic (4.16e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.25e-2)"	12.1	14.5	7.3	3.6	5.1	1.7	11.1	6.8	14.9	13.5	0.2	22.0	5.3	17.1	0.6	17.5	12.3	1.9	11.3	5.9	4.6	11.3	8.6	10.6	2.2	12.5	4.8	12.0	9.2	4.5	14.0	3.2	15.7	13.9	1.3	1.4	11.1	4.1	28.4	13.5	11.4	3.3	5.9	8.9	15.6	13.1	14.9	1.4	9.8	5.7	1.4	21.1	14.1	6.3	22.4	18.9	9.2	31.1	9.6	14.8	4.2	20.9	10.5	10.9	9.8	21.5	13.6	21.9	27.0	11.2	7.8	21.2	12.1	16.7	2.4	27.5	39.6	17.3	12.3	11.0	16.4	4.7	18.4	16.5	10.3	10.5	6.4	11.4	15.3	14.7	13.3	7.2	8.8	14.0	19.9	8.3	20.6	13.0	39.2	21.3	14.5	24.7	7.2	8.9	19.9	30.1	8.9	25.5	23.8	4.9	27.5	16.7	17.4	14.5	18.3	15.4	21.7	16.1	17.4	10.5	17.1	9.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.3	5.1	6.8	14.9	5.9	4.6	12.5	4.8	15.7	5.9	14.9	6.3	10.1	3.2	2.2	7.5	6.1	6.0	12.8	10.0	17.6	18.0	10.8	9.7	12.2	8.6	5.3	12.9	18.8	12.9	3.9	8.0	1.9	13.7	3.7	4.8	9.2	13.3	6.7	9.2	14.8	10.5	15.1	9.2	8.2	8.0	5.7	13.9	13.6	7.5	8.0	40.4	14.5	10.2	12.2	11.2	4.7	8.0	9.6	6.0	7.2	4.7	6.0	7.5	8.2	8.0	8.5	11.9	5.2	9.1	4.3	19.2	12.3	5.9	6.0	19.3	0.0	8.5	9.6	23.2	13.6	13.3	8.2	14.4	4.3	12.6	9.6	12.6
FAM193B	"FLJ10404, IRIZIO, KIAA1931"	ENSG00000146067	"Family with sequence similarity 193 member B"	Q96PV7	5	177519789-177554563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035847, HPA035848"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nucleoli"		"HPA035847: , HPA035848: AB_10601320"	"unprognostic (6.58e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (3.71e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.30e-5)"	37.0	25.6	23.4	24.5	19.7	58.0	40.9	22.1	25.9	52.2	14.5	38.6	22.0	38.4	14.1	34.8	41.1	17.2	27.7	24.3	19.2	41.4	51.0	45.3	31.7	16.0	16.5	51.4	52.1	11.2	37.9	21.5	15.0	50.6	15.8	20.6	37.2	17.3	22.1	55.0	49.5	14.7	12.5	70.3	36.7	31.9	27.7	30.9	41.4	7.9	22.3	34.6	43.6	18.8	10.4	13.5	29.3	25.7	14.3	13.5	63.2	9.0	9.8	14.9	14.1	36.6	19.4	19.4	13.8	9.0	18.9	17.7	13.6	19.2	11.1	43.5	13.9	13.7	22.9	17.8	8.3	13.6	27.5	13.6	21.1	12.5	13.8	26.6	15.3	30.4	13.4	18.7	10.9	34.5	24.9	39.4	20.4	9.0	10.6	40.4	6.4	16.7	14.2	29.1	27.2	17.2	10.6	30.0	9.8	22.2	29.5	18.4	19.1	16.4	13.5	10.8	11.2	20.1	9.2	16.1	13.1	21.8	13.9	0.0	0.4	0.1	0.5	0.0	0.3	0.1	0.2	0.4	0.2	0.2	0.1	0.1	0.6	0.5	0.2	0.3	0.1	0.2	23.4	19.7	22.1	25.9	24.3	19.2	16.0	16.5	15.0	12.5	27.7	18.8	16.9	19.2	26.7	45.1	8.5	8.7	5.8	7.2	11.4	11.5	12.1	18.3	14.6	20.0	11.2	11.0	18.8	5.0	11.9	14.3	0.0	6.1	6.1	8.3	10.2	12.5	8.4	6.1	41.0	8.9	8.3	11.7	22.4	10.8	5.1	14.1	12.1	13.8	5.0	11.8	39.3	15.6	6.1	10.0	8.2	8.4	9.9	10.6	8.8	21.5	8.3	7.3	9.2	39.2	38.0	6.0	8.4	5.3	6.9	7.7	9.8	2.8	10.7	12.5	6.6	12.4	11.1	15.4	13.2	11.8	12.9	4.5	10.4	8.6	11.7	6.7
FAM199X	CXorf39	ENSG00000123575	"Family with sequence similarity 199, X-linked"	Q6PEV8	X	104166453-104195902	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003093	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA003093: AB_1078597"	"unprognostic (2.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.08e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-2)"	19.9	11.7	17.0	7.1	16.9	13.8	11.6	18.2	18.7	9.2	10.2	8.4	7.9	10.6	34.8	7.8	9.1	6.8	7.3	15.2	18.8	15.1	7.7	8.1	8.6	15.5	19.1	11.9	11.1	19.9	8.5	9.0	17.5	10.2	8.4	16.1	10.2	13.9	9.4	9.5	7.2	8.7	16.8	8.8	8.3	10.1	20.5	9.0	17.5	9.7	7.8	8.0	7.6	18.8	23.9	14.9	13.2	14.5	9.6	11.5	13.3	12.4	11.6	15.8	14.7	11.6	19.4	13.1	15.0	11.4	12.5	17.6	23.9	18.3	25.7	6.4	13.4	10.4	19.0	13.2	13.7	20.0	14.1	9.0	22.9	15.5	15.6	24.7	16.2	8.3	11.5	28.6	17.8	17.1	10.8	14.2	13.2	20.9	17.3	11.4	8.6	16.5	26.9	15.8	7.1	8.8	30.0	19.7	21.4	12.9	9.8	9.8	20.1	17.6	6.4	13.8	13.5	13.6	12.1	14.4	19.8	21.1	13.1	0.6	0.5	0.3	0.7	0.4	0.7	0.4	0.6	0.8	0.6	1.3	0.9	0.5	0.6	0.3	0.5	0.3	0.8	0.3	17.0	16.9	18.2	18.7	15.2	18.8	15.5	19.1	17.5	16.8	20.5	18.8	18.6	16.0	14.5	33.0	17.8	24.0	11.5	12.6	13.6	23.3	21.3	14.7	13.7	17.2	12.2	62.5	14.6	11.8	23.1	23.9	23.5	11.9	0.6	20.6	27.3	15.7	16.8	9.4	25.9	18.7	13.0	11.7	18.3	31.5	9.5	16.8	14.6	18.8	17.6	33.7	24.5	17.0	16.2	21.4	27.0	3.9	11.8	15.7	10.6	15.9	14.6	20.0	22.6	26.2	21.6	15.4	18.9	14.7	20.2	14.6	14.2	34.8	10.3	16.9	26.3	17.1	13.7	4.1	9.7	21.0	26.3	14.6	15.9	21.6	15.9	15.5
FAM204A	"bA319I23.1, C10orf84, FLJ13188"	ENSG00000165669	"Family with sequence similarity 204 member A"	Q9H8W3	10	118297925-118342328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038182, HPA062025"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA038182: AB_10669519, HPA062025: AB_2684663"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (8.52e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (5.55e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.76e-3)"	27.9	19.3	15.7	22.5	16.9	54.4	31.4	13.4	23.6	22.2	11.5	27.5	20.9	26.6	32.2	26.1	20.0	21.8	35.3	17.1	16.1	27.7	29.0	25.0	27.4	15.8	14.8	28.4	24.8	30.3	14.1	20.9	14.8	20.7	24.1	15.9	25.3	22.1	36.7	18.7	18.5	26.5	15.0	24.8	21.7	49.2	16.0	28.4	29.3	27.6	27.9	25.8	17.1	15.8	56.4	24.9	40.2	56.2	39.1	42.4	22.8	43.6	81.4	61.6	55.4	29.4	51.2	39.7	26.3	47.2	27.7	47.3	34.0	45.5	55.6	62.8	42.0	33.0	23.4	26.2	58.4	86.7	44.9	29.4	54.8	45.3	94.3	51.7	53.3	50.2	35.3	45.5	51.6	31.5	53.6	80.1	28.6	24.7	22.0	45.2	77.7	29.3	56.0	28.2	25.8	40.5	29.9	27.7	66.8	19.6	44.0	61.7	37.4	32.2	30.1	28.8	67.4	32.4	31.0	57.0	62.8	92.2	33.3	73.5	57.5	70.4	36.9	64.2	39.0	50.6	41.8	34.4	59.6	35.2	35.6	41.8	32.0	34.4	69.3	43.0	51.5	57.1	15.7	16.9	13.4	23.6	17.1	16.1	15.8	14.8	14.8	15.0	16.0	15.8	71.9	60.9	55.7	54.5	66.0	55.6	63.0	60.9	63.7	38.8	61.0	67.4	78.6	52.9	47.3	44.1	73.0	39.5	84.8	30.2	135.0	85.5	255.8	62.5	79.4	67.8	41.9	59.5	49.9	113.7	49.8	72.4	41.8	60.3	68.4	140.6	64.6	49.8	62.4	33.7	48.3	56.0	63.1	69.4	76.2	132.0	76.4	73.0	60.5	27.2	77.2	62.5	92.7	53.3	45.4	95.3	68.9	70.0	62.9	54.6	35.4	115.7	44.2	55.4	26.3	73.7	78.3	258.5	170.3	55.6	50.6	30.6	62.8	62.6	48.4	61.6
FAM207A	"C21orf70, PRED56"	ENSG00000160256	"Family with sequence similarity 207 member A"	Q9NSI2	21	44940012-44976989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034178, HPA036354, HPA036559"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"CAB034178: AB_1564323, HPA036354: AB_10672242, HPA036559: "	"unprognostic (1.83e-1)"	"unprognostic (9.07e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (3.23e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.77e-2)"	19.8	20.9	9.8	11.3	11.0	12.6	17.6	13.9	16.1	14.3	5.7	22.3	11.1	15.1	2.1	17.9	14.5	2.2	53.6	10.6	9.8	20.3	31.1	13.0	9.3	11.1	10.8	11.6	21.5	6.0	9.4	5.3	10.7	14.2	3.7	6.1	15.7	5.7	43.3	18.5	14.3	4.8	7.7	23.8	20.2	27.3	12.3	9.4	10.5	14.4	6.5	21.4	13.4	10.0	48.4	51.9	17.2	22.2	8.3	11.4	40.9	32.4	8.7	24.4	19.6	88.1	14.8	49.0	68.7	11.5	35.5	31.8	23.9	35.5	9.7	35.9	72.8	144.6	36.4	75.2	33.1	47.7	18.1	19.9	20.4	22.0	19.2	10.5	26.7	41.6	83.9	33.5	18.6	86.7	45.2	74.3	58.2	36.0	72.1	44.0	18.4	85.7	23.5	19.0	84.0	35.7	43.0	50.7	51.4	12.2	35.4	33.8	35.2	20.4	42.3	27.5	70.8	70.0	65.5	47.6	16.3	81.1	29.1	3.1	4.0	4.1	1.8	4.1	1.8	7.7	3.2	4.3	3.8	5.0	3.5	3.5	2.4	4.4	4.7	8.9	4.0	2.3	9.8	11.0	13.9	16.1	10.6	9.8	11.1	10.8	10.7	7.7	12.3	10.0	13.8	0.0	7.5	5.5	25.6	19.2	31.7	35.3	27.9	22.7	41.4	57.7	22.6	34.3	22.7	18.4	4.2	36.9	28.8	60.0	46.9	68.1	14.8	30.6	30.1	23.3	26.4	29.2	3.2	63.5	70.7	23.3	16.8	20.9	10.2	48.6	26.4	56.3	68.4	6.7	3.8	34.3	12.2	33.3	18.4	38.5	14.6	24.9	24.9	1.0	51.7	36.9	41.2	6.0	2.9	59.3	34.8	12.8	29.4	77.9	84.1	90.2	15.2	18.3	32.9	17.7	36.2	82.0	42.0	35.1	21.0	30.8	19.5	70.7	44.3	39.9
FAM20B	"GXK1, KIAA0475"	ENSG00000116199	"FAM20B glycosaminoglycan xylosylkinase"	O75063	1	179025804-179076567	"Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007409	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		14000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"	Nucleoplasm	"HPA007409: AB_10601649"	"unprognostic (7.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	20.9	22.4	15.0	11.2	17.2	11.7	15.9	12.7	17.1	16.1	7.7	22.2	9.9	18.0	15.4	17.6	15.4	13.6	23.4	18.0	17.2	17.3	16.5	16.3	11.3	14.0	14.6	19.9	11.4	21.4	14.4	17.0	14.5	16.5	14.4	28.7	11.8	19.4	19.6	12.8	11.5	19.4	13.5	12.4	13.6	8.0	15.3	11.5	17.9	25.6	10.8	16.2	12.3	14.7	41.4	37.1	28.2	30.0	49.1	51.4	31.2	33.7	38.3	23.2	20.7	18.7	40.1	21.3	43.2	59.7	19.1	29.3	29.0	24.8	33.8	27.3	19.5	67.9	34.8	23.9	24.5	45.5	41.1	30.1	26.5	31.7	24.5	35.4	29.0	29.2	77.0	30.2	37.5	23.1	19.9	16.4	37.1	46.2	7.9	24.1	29.7	28.4	19.5	46.1	37.5	91.8	35.5	39.7	34.5	39.8	34.4	32.8	30.8	36.7	32.2	51.1	46.0	24.5	48.5	18.2	36.5	21.7	37.3	0.9	0.6	0.2	1.3	0.6	1.3	1.4	0.7	1.1	0.8	1.5	1.1	1.0	0.6	1.6	0.8	1.2	1.0	0.5	15.0	17.2	12.7	17.1	18.0	17.2	14.0	14.6	14.5	13.5	15.3	14.7	16.8	6.4	11.4	16.0	7.5	15.6	12.6	8.9	4.6	15.7	12.2	9.3	40.1	12.8	9.0	18.4	25.0	9.0	9.0	10.6	3.9	8.8	5.2	8.8	17.8	13.8	14.4	43.3	28.3	13.0	7.7	14.6	9.2	14.5	17.1	20.2	9.3	14.2	7.6	38.7	32.0	7.9	10.2	11.6	8.1	5.1	17.7	9.6	16.0	19.7	14.1	9.0	2.1	17.6	32.5	13.7	3.8	21.4	6.2	19.7	5.0	5.9	8.8	21.0	13.1	20.0	17.7	17.6	13.8	9.6	12.9	7.5	8.0	24.1	8.5	24.7
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C golgi associated secretory pathway kinase"	Q8IXL6	7	192571-260772	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 55.2;Hepatocytes: 94.0;Hofbauer cells: 54.9;Peritubular cells: 56.4;Proximal tubular cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 55.3;hTERT-RPE1: 39.9;U-87 MG: 36.0;WM-115: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		240000000		"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	32.5	14.8	7.0	7.3	5.7	1.5	32.8	5.0	7.0	19.4	0.8	44.3	4.5	19.4	2.1	14.3	20.2	5.9	30.2	4.3	5.0	34.9	56.5	27.9	1.1	12.5	9.7	20.3	13.4	1.6	18.3	2.6	6.7	29.9	1.4	1.1	20.3	3.6	30.7	14.7	23.3	6.8	6.4	8.9	38.9	7.8	12.6	0.6	19.6	6.3	0.6	36.8	15.1	6.2	19.6	6.4	0.3	10.3	11.8	20.3	0.0	17.4	23.2	7.9	5.9	0.9	10.1	0.0	9.3	21.8	10.4	14.9	1.1	0.6	1.6	4.5	0.6	0.0	3.1	3.4	8.8	0.0	1.0	55.3	1.6	0.3	0.7	39.9	5.0	0.0	0.0	0.0	1.8	1.9	0.0	0.7	8.9	0.1	0.3	2.3	0.5	0.0	4.9	0.0	4.4	0.2	17.2	0.0	2.3	1.1	9.7	6.5	14.6	10.3	5.3	7.7	5.3	0.0	0.0	0.0	36.0	1.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	5.7	5.0	7.0	4.3	5.0	12.5	9.7	6.7	6.4	12.6	6.2	5.0	6.4	5.1	11.8	1.2	10.1	2.3	4.5	1.8	26.9	27.6	18.7	9.9	21.5	1.0	55.2	0.0	0.5	4.6	3.4	5.9	1.8	0.0	4.1	19.0	4.5	11.9	0.4	7.4	4.8	0.5	22.6	13.7	9.5	3.8	3.1	9.3	94.0	54.9	1.7	17.0	5.3	2.0	24.4	9.8	2.6	16.1	34.5	1.8	5.6	10.8	17.1	0.0	8.5	15.3	6.3	3.7	56.4	0.1	6.6	33.7	48.7	3.4	9.0	13.1	8.7	17.3	0.3	1.0	3.5	8.1	0.5	0.9	0.6	9.0	1.9
FAM210A	"C18orf19, HsT2329, MGC24180"	ENSG00000177150	"Family with sequence similarity 210 member A"	Q96ND0	18	13663347-13726663	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 33.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA014324, HPA051564"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Golgi apparatus, Mitochondria"		"HPA014324: AB_2668972, HPA051564: AB_2681536"	"unprognostic (1.32e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.18e-3)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.23e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.79e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.27e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.82e-2)"	6.1	4.7	4.7	5.5	4.5	3.5	4.8	5.8	7.1	4.2	8.0	6.9	9.3	3.9	2.9	8.8	4.2	4.0	21.8	4.6	5.3	9.4	13.2	4.0	6.4	5.2	7.0	5.6	3.3	6.4	2.6	7.5	5.6	4.4	6.4	11.5	5.1	4.6	25.5	3.3	6.2	6.2	5.1	3.7	4.7	8.4	6.3	5.3	6.3	33.1	7.3	6.3	5.0	5.7	24.6	13.6	9.4	8.8	10.9	11.2	13.6	16.5	15.3	18.2	21.1	18.4	11.6	24.9	20.2	11.8	33.6	11.5	18.2	20.6	29.5	17.4	8.4	17.7	9.7	13.0	12.9	30.3	15.9	9.7	15.9	17.5	61.6	12.7	11.9	14.8	24.2	13.4	21.2	16.8	18.7	19.5	10.6	47.7	13.5	15.2	22.3	29.1	15.1	15.3	6.0	10.1	14.5	21.1	40.0	13.4	10.8	14.2	13.2	46.4	45.7	29.1	20.6	15.1	20.1	28.8	24.6	15.6	18.9	3.5	5.3	3.3	6.2	8.0	6.8	5.7	5.2	5.4	6.4	6.3	6.4	6.2	0.8	6.0	4.2	4.0	5.4	3.8	4.7	4.5	5.8	7.1	4.6	5.3	5.2	7.0	5.6	5.1	6.3	5.7	14.9	9.6	8.3	13.7	29.8	55.3	14.8	28.3	12.5	63.2	11.0	11.2	66.4	12.8	14.6	7.3	20.9	20.6	11.6	9.1	21.5	18.6	20.5	16.7	21.6	18.3	11.4	5.9	18.0	8.8	39.0	17.4	10.2	32.7	7.0	36.7	6.8	20.7	20.0	30.3	23.5	10.0	10.2	9.5	43.4	6.1	9.3	26.5	8.8	15.0	11.4	19.0	15.5	18.6	24.8	12.6	4.1	10.1	14.2	19.9	12.1	29.8	5.0	29.9	6.6	16.3	15.4	31.4	32.3	20.6	57.3	25.7	16.8	45.6	20.5	14.8
FAM214A	"FLJ10980, KIAA1370"	ENSG00000047346	"Family with sequence similarity 214 member A"	Q32MH5	15	52581317-52709817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 63.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039369, HPA040180"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA039369: AB_10795250, HPA040180: AB_10794736"	"unprognostic (1.75e-1)"	"unprognostic (6.40e-2)"	"unprognostic (4.54e-1)"	"prognostic favorable (7.27e-6)"	"unprognostic (1.08e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.32e-3)"	"prognostic favorable (8.68e-4)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.94e-3)"	37.2	20.3	6.4	15.1	12.0	21.3	28.2	24.5	9.0	12.6	41.1	15.4	14.2	17.5	10.2	27.6	16.5	12.6	15.9	6.6	6.5	12.1	38.8	14.4	24.5	7.3	8.9	12.5	21.8	43.4	11.5	8.5	10.3	15.3	16.9	17.5	16.9	15.9	50.1	11.7	14.2	13.4	5.8	16.0	18.4	21.2	9.8	18.1	25.3	27.0	30.6	12.7	12.3	13.6	5.1	6.8	6.9	12.0	20.7	12.4	8.1	12.5	21.8	6.6	8.6	3.9	5.4	35.3	14.7	11.9	3.1	10.2	5.0	11.6	5.8	28.4	7.1	8.9	15.9	3.3	7.3	4.3	4.6	29.6	18.2	6.5	7.2	12.4	22.0	10.9	5.2	36.1	9.4	20.1	6.8	10.9	1.3	8.7	8.1	16.3	7.2	27.1	10.8	23.7	7.8	13.6	12.6	23.5	9.5	21.1	36.6	9.3	16.4	6.6	2.0	7.4	2.7	55.2	35.8	63.6	11.4	5.7	2.2	0.7	0.6	5.3	3.6	0.2	3.9	6.3	2.7	2.4	0.7	5.4	3.0	2.8	3.8	4.9	0.3	8.4	4.7	1.1	6.4	12.0	24.5	9.0	6.6	6.5	7.3	8.9	10.3	5.8	9.8	13.6	43.5	44.8	27.1	60.7	53.5	16.3	13.2	23.7	28.5	19.3	50.8	30.2	27.7	24.3	35.6	3.7	62.6	2.6	49.2	25.4	3.9	11.4	2.8	78.1	34.7	28.0	29.2	20.4	80.0	14.9	3.0	25.3	30.5	123.9	3.8	19.3	24.7	39.0	7.3	26.9	90.1	27.0	28.5	18.0	9.9	3.7	28.3	15.8	26.6	57.1	7.4	24.7	16.5	73.4	123.7	15.2	13.2	32.0	100.5	20.1	12.3	7.6	46.2	28.6	13.1	36.6	20.9	36.5	9.4	28.7	14.3	20.2	34.6	26.9	11.5	42.0
FAM214B	"bA182N22.6, FLJ11560, KIAA1539"	ENSG00000005238	"Family with sequence similarity 214 member B"	Q7L5A3	9	35104112-35116341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 54.1;Late spermatids: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.8;granulocytes: 16.3;monocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"TIME: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048831, HPA055751"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048831: AB_2680535, HPA055751: AB_2682906"	"unprognostic (2.91e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.15e-2)"	13.9	14.9	26.7	12.2	27.4	38.8	10.6	27.2	29.4	11.8	20.7	15.2	10.2	10.6	7.0	29.7	8.9	11.7	19.7	26.0	26.9	14.9	11.3	21.7	6.8	30.8	29.0	8.0	6.8	11.2	15.8	9.9	29.6	13.0	10.5	4.3	11.6	9.7	14.2	15.0	11.2	11.0	27.4	27.6	11.7	8.5	30.8	5.9	11.7	11.5	7.0	12.3	14.4	28.3	6.4	5.2	14.2	10.3	11.0	16.9	3.0	31.2	27.9	17.0	10.9	3.6	4.4	1.6	9.0	50.5	44.0	2.8	2.4	10.0	11.0	8.3	0.6	7.9	12.6	3.4	11.2	2.2	33.4	12.1	17.4	19.9	12.5	39.3	33.1	7.9	4.4	6.3	36.0	1.8	3.1	9.8	2.7	4.8	7.8	3.5	2.4	1.9	22.3	1.4	1.0	9.3	4.9	3.5	16.6	14.8	4.6	5.3	56.0	23.8	11.5	11.5	11.5	4.0	4.1	0.8	37.5	4.0	26.7	5.0	5.9	5.7	2.1	7.7	0.7	0.5	1.3	1.5	4.8	0.2	0.5	0.9	16.3	2.1	10.2	1.2	0.8	3.4	26.7	27.4	27.2	29.4	26.0	26.9	30.8	29.0	29.6	27.4	30.8	28.3	10.8	0.0	3.9	17.9	3.1	8.4	4.4	11.7	11.4	3.3	8.6	5.2	8.6	2.8	6.2	16.5	14.6	2.8	7.9	43.0	3.9	11.3	12.7	5.5	7.0	11.3	5.4	54.1	5.8	12.5	9.6	6.9	9.2	7.8	8.8	3.8	18.2	6.7	14.9	0.0	5.4	12.3	12.2	28.2	21.3	77.0	3.4	32.5	16.0	4.7	26.2	8.4	16.5	2.5	14.4	40.0	19.8	7.9	3.5	6.9	14.1	11.7	4.4	3.6	6.6	7.3	9.2	3.0	6.5	23.6	14.5	4.2	7.5	5.3	14.0	9.3
FAM217B	"C20orf177, dJ551D2.5"	ENSG00000196227	"Family with sequence similarity 217 member B"	Q9NTX9	20	59933764-59948680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041021, HPA056698"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041021: AB_10959734, HPA056698: AB_2683212"	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.04e-8)"	"unprognostic (2.78e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	4.8	4.0	8.6	6.3	10.3	13.6	4.9	5.7	17.3	4.8	0.1	4.2	5.1	6.8	5.6	4.6	5.5	4.1	9.9	10.8	6.7	5.3	2.0	5.3	9.3	6.1	6.9	10.7	3.0	3.8	6.9	6.3	6.4	7.5	3.5	8.2	4.3	9.0	15.5	3.5	5.9	4.5	5.9	6.3	4.6	9.5	7.4	9.4	6.8	17.4	8.8	3.6	3.1	12.1	9.1	6.1	14.0	9.6	6.6	9.8	11.2	12.7	10.8	13.8	9.9	31.9	19.4	20.0	21.0	5.3	11.1	21.9	15.2	10.6	13.4	11.1	9.6	18.7	15.5	18.5	4.2	30.2	24.3	5.7	12.9	10.2	3.3	5.6	4.1	23.8	13.6	8.2	9.0	16.6	53.0	16.4	13.6	8.5	12.5	12.7	13.8	19.5	5.3	14.1	14.2	16.9	17.0	21.8	18.9	12.9	21.2	21.1	5.8	11.4	13.3	11.8	6.8	14.0	25.7	23.9	15.8	19.4	7.6	9.3	5.9	8.2	8.5	3.7	10.3	4.9	8.0	7.7	6.5	5.7	8.2	8.8	11.1	8.0	3.6	5.2	7.6	6.0	8.6	10.3	5.7	17.3	10.8	6.7	6.1	6.9	6.4	5.9	7.4	12.1	16.0	16.0	19.4	25.5	18.5	5.4	5.4	13.6	10.2	35.6	16.4	16.0	34.9	10.0	12.1	11.0	22.9	23.4	22.2	11.7	17.6	5.5	29.9	8.4	15.5	16.7	8.4	11.3	33.5	8.2	12.0	18.0	7.1	6.6	29.1	19.3	17.2	5.0	19.1	60.6	32.6	5.3	8.2	34.0	13.4	24.9	17.4	13.2	12.4	12.2	32.4	24.4	44.3	22.6	27.9	8.1	5.1	10.1	16.8	9.6	26.3	14.5	17.5	32.0	32.9	36.2	16.6	52.4	16.2	11.0	5.4	6.8	23.3	13.1	9.5	9.7
FAM219A	"bA573M23.5, C9orf25, FLJ39031"	ENSG00000164970	"Family with sequence similarity 219 member A"	Q8IW50	9	34398184-34458570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 94.6"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 53.8;Late spermatids: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019338, HPA052909"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA019338: AB_1845819, HPA052909: AB_2681986"	"unprognostic (9.96e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (3.46e-3)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.76e-1)"	19.8	14.0	82.5	9.0	79.4	3.8	17.5	72.4	88.0	18.5	25.9	17.0	5.4	22.5	6.2	9.8	15.7	5.6	29.9	75.9	77.5	15.7	12.7	18.8	6.5	90.0	84.8	15.3	13.2	6.4	26.3	13.4	94.6	16.3	4.6	19.3	12.1	7.0	42.7	16.2	11.9	11.9	83.8	15.1	12.7	9.7	82.9	8.3	14.9	12.6	5.0	17.7	15.7	85.4	27.9	10.6	24.5	14.0	22.3	8.5	23.8	16.5	12.4	14.0	17.7	7.4	6.3	6.1	16.6	16.1	27.7	11.4	19.6	10.6	14.0	96.0	11.2	2.5	14.6	8.0	12.5	6.1	13.6	9.0	10.5	21.0	11.7	17.4	23.4	10.6	6.1	29.6	11.0	5.6	9.5	8.5	15.8	3.8	15.6	12.1	4.1	5.3	10.1	5.9	7.8	24.8	14.3	10.3	8.5	22.2	5.2	6.1	28.0	15.4	11.9	32.3	23.2	7.8	12.0	5.1	44.2	13.9	27.8	0.6	0.1	1.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.5	0.2	0.2	0.1	0.4	0.1	82.5	79.4	72.4	88.0	75.9	77.5	90.0	84.8	94.6	83.8	82.9	85.4	14.3	6.4	3.3	17.3	3.3	6.2	3.7	5.6	4.0	21.1	5.1	2.9	11.7	1.5	2.5	3.7	4.2	9.4	4.3	2.1	0.0	6.1	13.8	2.0	6.0	17.4	10.8	0.4	28.6	5.1	16.8	7.8	6.1	2.8	2.5	3.4	9.3	2.8	5.9	53.8	31.8	2.3	8.2	5.5	2.6	35.1	3.7	4.1	8.8	15.0	4.5	9.3	3.1	22.1	15.9	6.6	1.7	5.7	3.0	5.1	1.3	3.0	2.3	11.0	6.6	5.2	9.1	9.9	3.8	3.0	6.5	20.7	3.5	2.9	0.9	2.7
FAM219B	"C15orf17, FLJ00005"	ENSG00000178761	"Family with sequence similarity 219 member B"	Q5XKK7	15	74899992-74906883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048929, HPA058064"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Golgi apparatus"	"HPA048929: AB_2680561, HPA058064: AB_2683592"	"unprognostic (1.12e-1)"	"unprognostic (6.10e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.11e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.91e-3)"	21.9	19.8	31.5	9.9	30.8	6.4	13.7	31.9	35.5	15.4	32.5	17.1	12.0	16.8	22.5	23.6	22.3	10.6	30.3	31.6	36.3	16.1	6.6	16.9	15.2	32.7	33.6	19.5	13.0	32.4	28.1	13.3	35.0	24.0	14.6	44.7	18.2	17.0	18.7	22.0	13.9	17.8	31.6	24.3	15.3	6.3	34.4	8.5	18.2	25.1	17.4	20.1	16.0	31.3	6.6	9.6	25.9	11.4	42.9	31.6	11.6	18.7	9.8	16.7	10.5	9.1	18.0	12.9	10.4	13.0	16.8	16.8	35.9	10.3	9.1	32.5	20.4	12.3	22.9	7.7	20.3	11.9	16.2	19.2	47.3	7.3	13.7	36.0	18.7	9.6	9.6	15.4	17.1	5.5	7.1	10.4	14.3	19.4	14.4	19.0	9.0	9.7	25.7	21.1	21.7	14.1	20.9	11.6	33.7	27.1	23.3	14.0	21.7	13.5	7.3	11.4	15.2	11.6	12.1	5.5	17.1	24.2	13.8	3.8	1.0	6.9	1.4	0.9	2.4	2.2	2.1	1.2	1.0	2.0	0.9	1.5	1.2	1.8	1.3	0.1	0.2	1.3	31.5	30.8	31.9	35.5	31.6	36.3	32.7	33.6	35.0	31.6	34.4	31.3	13.3	19.2	20.6	22.5	18.4	6.4	21.2	17.9	13.6	41.6	16.2	13.5	5.1	10.0	18.9	27.6	58.4	17.1	22.3	23.3	13.7	14.4	1.0	22.9	14.8	16.0	20.9	7.6	23.9	10.5	11.4	17.4	9.7	13.9	24.7	15.0	17.2	5.8	17.9	23.5	20.8	16.0	28.5	13.3	8.5	4.7	23.3	13.0	14.2	13.1	19.8	26.7	30.9	11.1	9.4	17.5	16.2	28.6	15.7	19.9	23.3	11.9	30.6	69.2	26.3	15.8	15.2	9.1	17.5	18.2	7.7	8.3	16.0	15.0	14.0	22.6
FAM222B	"C17orf63, FLJ10700"	ENSG00000173065	"Family with sequence similarity 222 member B"	Q8WU58	17	28755978-28855232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.8;Inhibitory neurons: 84.7;Oligodendrocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051840, HPA062239"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051840: AB_2681633, HPA062239: AB_2684722"	"unprognostic (4.11e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.18e-2)"	8.6	6.3	6.9	6.9	7.3	7.0	8.4	14.1	9.5	9.3	18.8	11.2	12.3	7.5	7.8	11.1	7.0	8.6	10.9	6.6	6.8	10.5	7.7	8.0	6.6	8.7	6.8	8.4	8.0	10.5	10.2	9.9	8.1	9.3	10.0	10.0	14.2	8.8	43.4	7.9	11.0	7.1	2.8	6.6	8.4	27.5	9.8	7.9	8.5	16.2	7.1	10.7	9.8	7.1	13.1	25.1	21.2	24.4	17.7	12.3	23.2	9.1	8.5	12.5	12.6	32.4	12.6	13.3	17.9	10.2	16.0	16.2	17.7	20.4	10.4	18.7	24.1	15.0	12.9	24.9	20.4	9.9	23.1	12.9	19.8	17.7	15.7	12.6	25.2	15.5	29.1	9.2	26.4	16.5	16.9	7.9	24.3	17.5	9.4	7.9	20.1	13.4	22.4	16.4	23.0	16.1	12.9	24.8	31.8	44.0	18.9	9.3	28.8	8.3	17.1	9.4	14.5	18.5	24.9	8.8	11.4	6.8	15.5	15.9	3.9	9.5	6.4	5.0	7.6	6.2	5.4	6.6	5.4	4.6	7.3	6.3	4.5	3.9	7.9	4.9	5.2	4.2	6.9	7.3	14.1	9.5	6.6	6.8	8.7	6.8	8.1	2.8	9.8	7.1	10.3	3.2	7.3	49.3	12.0	9.4	7.7	14.7	9.1	14.8	14.7	10.3	13.6	31.5	9.1	7.3	27.1	7.9	6.5	22.9	3.9	18.1	56.9	11.0	10.8	13.7	25.9	14.7	73.8	13.3	10.6	7.9	11.7	17.1	10.1	8.1	31.4	11.4	8.7	25.2	84.7	17.3	20.3	8.4	5.7	45.3	12.5	6.8	7.2	41.2	8.3	6.2	8.2	64.3	79.0	24.1	12.7	7.9	8.6	14.0	18.3	11.2	10.0	8.0	0.0	9.5	6.5	51.9	34.8	9.2	6.7	6.0	10.7	8.1	19.0	10.4
FAM227A		ENSG00000184949	"Family with sequence similarity 227 member A"	F5H4B4	22	38578120-38656629	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 7.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6;Early spermatids: 87.3;Endometrial ciliated cells: 72.4;Late spermatids: 57.0;Respiratory ciliated cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 10.4;Karpas-707: 17.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003077	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003077: AB_1079264"	"unprognostic (7.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.91e-3)"	"unprognostic (4.79e-5)"	"unprognostic (5.91e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.62e-2)"	"unprognostic (6.46e-6)"	"unprognostic (3.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.35e-2)"	0.1	0.6	1.3	0.2	1.2	0.5	0.8	0.9	1.2	1.2	7.5	0.4	0.2	0.7	1.9	0.1	3.8	0.3	0.3	1.5	1.4	1.1	0.1	1.1	0.2	2.5	3.1	0.7	0.4	0.6	4.3	0.1	1.5	0.6	0.2	3.5	0.4	0.4	0.1	0.8	0.1	0.3	1.4	0.1	0.3	4.1	1.4	0.2	1.3	0.0	0.1	0.3	0.3	0.9	0.4	0.9	1.4	1.7	0.4	1.0	0.3	0.2	0.2	0.3	0.2	0.1	0.9	0.1	0.4	0.2	0.4	0.9	0.5	0.2	0.4	10.4	0.9	0.1	2.9	0.2	0.2	0.4	0.4	0.5	0.6	1.0	0.4	1.5	0.2	1.6	0.4	17.3	0.1	0.5	0.4	0.5	0.7	0.2	0.5	1.0	0.1	0.6	0.9	0.3	2.0	0.5	1.4	0.1	0.2	0.5	1.1	0.1	0.3	0.4	0.4	0.4	0.1	1.8	0.8	0.1	0.6	0.2	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	1.3	1.2	0.9	1.2	1.5	1.4	2.5	3.1	1.5	1.4	1.4	0.9	0.3	3.2	2.6	20.9	0.0	2.4	3.2	3.7	0.0	6.8	4.1	3.8	2.1	2.8	9.0	5.5	39.6	0.3	0.2	0.3	0.0	3.8	87.3	72.4	5.9	1.6	4.8	0.8	15.5	2.5	0.3	2.6	0.0	4.1	0.0	8.5	0.4	0.3	0.2	5.0	11.1	0.7	4.1	0.6	1.2	57.0	2.1	0.6	0.0	2.8	0.3	9.5	1.0	1.5	2.3	2.3	0.2	1.2	0.1	2.1	0.0	1.4	115.2	30.4	0.0	4.6	2.8	16.4	12.9	0.0	3.4	0.1	1.4	9.5	1.2	1.7
FAM228A	"C2orf84, FLJ30851"	ENSG00000186453	"Family with sequence similarity 228 member A"	Q86W67	2	24175053-24200849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 35.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 119.7;Spermatocytes: 176.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 2.5;hTERT-RPE1: 1.1;TIME: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075817			Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA075817: "	"unprognostic (2.57e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.98e-3)"	"unprognostic (7.13e-4)"	"unprognostic (2.19e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.44e-5)"	"unprognostic (1.73e-2)"	"unprognostic (1.04e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.33e-2)"	2.0	0.9	1.9	0.6	1.7	0.0	1.6	1.4	2.8	0.9	0.0	0.9	0.3	0.7	0.9	0.9	0.6	1.1	1.7	1.3	1.0	0.8	0.3	0.8	0.6	0.8	0.7	0.7	0.3	0.1	0.4	1.0	0.8	0.8	0.3	0.9	0.2	0.9	0.4	0.4	0.4	0.5	0.2	0.4	0.7	35.1	0.7	0.3	0.6	0.4	0.2	0.9	0.5	1.9	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.2	0.2	0.0	0.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.1	1.9	1.7	1.4	2.8	1.3	1.0	0.8	0.7	0.8	0.2	0.7	1.9	0.4	3.2	0.5	3.3	0.0	0.5	0.1	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.7	119.7	0.0	0.4	0.5	0.0	0.0	5.5	0.5	0.2	1.6	0.0	0.0	0.0	0.6	1.1	0.1	0.5	1.7	5.8	0.0	0.0	0.8	0.4	24.8	2.8	0.3	0.0	2.8	0.1	0.3	1.0	3.0	3.1	0.7	0.0	4.5	0.0	0.1	0.0	0.0	0.1	0.2	6.6	1.0	0.8	176.0	10.4	0.0	0.1	0.1	0.1	0.5	0.0	0.2
FAM229B	"C6orf225, DKFZp586F0922, LOC619208"	ENSG00000203778	"Family with sequence similarity 229 member B"	Q4G0N7	6	112087591-112102790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 448.1"	"Group enriched"	"Detected in many"	8	"Early spermatids: 3403.2;Late spermatids: 7607.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA036068			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA036068: AB_10673495"	"unprognostic (1.65e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (3.74e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.06e-2)"	18.2	21.7	62.1	3.6	69.4	3.7	16.9	68.5	85.4	20.7	67.9	21.1	3.5	25.8	36.4	7.2	53.4	19.1	69.9	60.5	68.7	29.2	25.0	15.3	3.5	70.0	69.7	25.9	8.6	43.6	66.1	10.6	71.3	19.2	5.4	35.4	9.0	22.6	13.6	7.7	7.4	18.4	72.8	5.2	18.7	448.1	65.2	10.9	21.1	15.3	3.3	19.0	11.3	77.1	4.0	9.9	39.9	19.5	34.3	34.0	1.9	14.9	56.6	21.0	44.0	1.7	9.4	3.1	43.0	27.7	21.9	2.5	8.4	21.7	33.4	1.0	27.7	3.7	4.1	15.7	21.3	8.1	1.8	20.7	14.3	34.8	5.9	48.6	20.9	35.2	4.9	7.8	26.0	1.0	15.1	12.9	10.4	2.9	23.2	23.3	10.0	3.2	31.3	0.6	37.0	15.5	11.9	1.3	23.9	21.4	19.1	7.4	12.0	17.5	7.4	67.1	20.2	5.8	0.3	28.6	27.7	6.8	23.5	0.1	0.0	2.1	3.0	0.0	3.9	1.8	2.6	2.4	0.4	2.6	5.6	5.1	0.2	4.6	0.2	2.5	0.3	1.9	62.1	69.4	68.5	85.4	60.5	68.7	70.0	69.7	71.3	72.8	65.2	77.1	53.7	3.2	11.4	10.4	4.7	8.4	18.8	48.6	12.0	31.3	23.6	34.7	93.9	21.5	42.1	51.5	12.5	1.5	1.9	0.3	133.1	31.7	3403.2	207.7	18.5	24.6	3.0	9.0	17.2	10.4	6.9	32.9	7.1	11.6	1.3	36.1	33.2	54.4	3.1	16.8	14.8	0.6	52.9	3.2	7.3	7607.9	72.7	6.2	24.9	6.5	2.1	83.5	4.1	12.1	35.8	6.7	0.1	90.7	5.0	11.6	0.1	93.0	409.9	36.9	59.2	26.5	32.6	663.2	51.1	5.5	8.7	0.5	4.4	64.0	0.7	12.2
FAM234A	"C16orf9, DKFZP761D0211, FLJ32603, ITFG3"	ENSG00000167930	"Family with sequence similarity 234 member A"	Q9H0X4	16	234521-272183	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011651, HPA071871"	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA		5300000	"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA011651: , HPA071871: AB_2732188"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	59.5	57.9	22.5	25.1	38.7	19.9	46.5	41.1	30.5	38.3	41.3	71.2	101.2	52.5	21.5	59.7	40.8	37.6	116.8	21.9	25.7	57.7	51.5	36.6	19.2	59.0	37.2	39.5	68.4	48.2	58.1	38.6	54.8	52.5	30.1	9.8	41.2	39.4	175.7	49.1	64.7	40.6	35.7	30.2	59.8	45.1	37.1	16.7	50.5	77.0	15.0	60.1	38.3	71.1	29.5	67.1	72.3	152.1	110.2	66.3	39.2	71.5	92.7	41.9	54.2	67.6	76.9	30.2	104.2	90.8	37.3	55.2	27.6	48.4	35.7	40.5	48.5	35.7	38.8	53.2	81.0	21.4	22.5	74.4	58.7	67.1	48.1	119.8	74.1	39.1	42.1	6.0	44.9	140.0	22.1	25.2	89.1	44.2	31.1	66.5	48.0	120.5	73.9	29.6	83.1	73.9	107.9	58.3	61.5	63.3	81.5	31.4	63.3	76.7	25.2	43.8	21.3	15.6	7.1	37.6	54.4	30.1	104.9	11.7	17.7	13.3	10.1	17.7	5.2	7.1	8.9	10.0	18.0	9.5	10.0	11.3	6.1	15.8	17.2	6.5	9.4	13.9	22.5	38.7	41.1	30.5	21.9	25.7	59.0	37.2	54.8	35.7	37.1	71.1	20.2	9.6	12.6	0.0	7.4	0.0	11.3	0.0	9.6	8.9	23.9	19.7	0.0	21.5	5.0	31.3	25.0	58.7	8.8	25.2	7.9	49.4	27.9	22.2	26.8	18.1	35.2	14.5	0.0	26.1	48.8	21.0	23.4	33.2	8.8	59.2	22.9	23.5	25.7	10.1	0.0	26.4	0.0	14.4	0.0	78.1	16.8	10.9	0.0	0.0	39.6	11.1	10.3	0.0	0.0	18.4	41.5	21.8	5.7	14.8	102.1	18.6	6.6	12.0	19.7	16.9	20.1	29.2	30.8	18.2	0.0	66.2	6.8	73.3	40.4	10.7
FAM240C		ENSG00000216921	"Family with sequence similarity 240 member C"	A0A1B0GVR7	2	241893988-241902551	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"tongue: 225.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.5;REH: 2.4;SCLC-21H: 1.6"									HPA073342			Approved	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"		Nucleoplasm		"HPA073342: "	"unprognostic (9.31e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.75e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.29e-1)"	3.5	0.7	5.9	0.1	6.9	0.3	3.9	6.4	8.2	1.4	5.6	0.2	0.2	1.9	0.0	4.0	1.7	0.1	1.3	5.4	5.9	0.1	0.2	0.1	0.4	6.2	6.4	1.6	36.8	0.5	0.4	0.2	6.4	3.5	0.0	0.6	5.4	3.9	10.2	3.1	0.2	0.1	5.6	0.3	0.4	1.3	6.3	3.4	6.9	225.1	0.2	0.4	1.0	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.2	0.0	0.7	0.5	0.0	0.2	0.0	0.0	2.4	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.9	6.4	8.2	5.4	5.9	6.2	6.4	6.4	5.6	6.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FAM241B	C10orf35	ENSG00000171224	"Family with sequence similarity 241 member B"	Q96D05	10	69630247-69633596	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 19.4;Collecting duct cells: 16.5;Distal tubular cells: 11.7;Ductal cells: 24.3;Exocrine glandular cells: 18.4;Pancreatic endocrine cells: 20.7;Proximal tubular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"gdT-cell: 4.3;MAIT T-cell: 10.9;memory CD4 T-cell: 10.5;memory CD8 T-cell: 7.0;naive CD4 T-cell: 17.2;naive CD8 T-cell: 5.7;T-reg: 7.8"	"Lineage enriched"	"Detected in single"	25	"T-cells: 17.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 57.5"					"Low region specificity"	"Detected in all"			HPA034591	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Centrosome"	Cytosol	"HPA034591: AB_10670572"	"unprognostic (1.12e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.17e-3)"	"prognostic unfavorable (8.64e-4)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (9.72e-4)"	1.6	3.0	26.3	1.9	27.3	1.1	4.7	30.4	40.3	2.2	19.2	6.6	2.7	3.2	11.1	4.8	4.3	2.0	6.6	35.5	31.7	10.7	3.7	4.0	2.9	21.7	24.2	2.1	8.2	8.2	12.7	1.2	28.2	7.8	2.3	11.3	5.5	4.7	4.7	3.4	3.5	3.8	21.5	1.4	5.8	22.2	26.4	2.8	5.8	1.2	2.3	5.8	3.0	22.2	29.4	31.9	3.9	31.8	0.0	0.0	13.6	2.9	0.8	5.1	5.6	23.4	23.6	0.0	42.8	0.6	18.6	11.8	16.6	9.6	7.1	29.4	22.8	0.0	6.7	8.8	8.1	0.0	10.0	0.0	9.4	0.2	4.8	3.8	0.0	43.8	11.1	0.1	0.5	39.9	0.3	0.0	19.1	11.8	57.5	0.0	0.0	0.4	10.9	16.6	16.0	22.2	12.1	29.6	19.0	7.8	20.5	5.1	1.4	0.8	19.4	0.1	8.5	5.1	15.2	0.1	0.4	0.0	0.8	0.0	0.0	0.0	4.3	0.0	10.9	0.1	10.5	7.0	0.1	0.4	17.2	5.7	0.6	0.2	0.0	0.1	7.8	3.1	26.3	27.3	30.4	40.3	35.5	31.7	21.7	24.2	28.2	21.5	26.4	22.2	1.4	0.0	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.3	19.4	0.0	0.0	3.1	16.5	0.0	7.5	0.6	0.0	11.7	24.3	0.0	5.7	0.4	0.7	0.0	0.0	0.0	18.4	5.6	0.6	0.0	5.0	0.0	8.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.3	0.0	0.0	13.5	4.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.9	2.8	3.7	0.0	0.0
FAM32A	"DKFZP586O0120, OTAG-12"	ENSG00000105058	"Family with sequence similarity 32 member A"	Q9Y421	19	16185380-16192046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051712	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA051712: AB_2681582"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.49e-3)"	64.5	69.9	64.9	48.2	66.4	94.6	57.1	60.5	69.3	44.6	57.3	68.8	78.2	57.2	49.5	69.6	45.3	53.8	54.8	66.2	62.1	60.7	95.3	51.4	60.9	62.9	63.1	43.3	52.8	54.0	37.8	61.4	63.5	50.0	57.8	28.1	56.3	47.4	50.8	73.3	74.9	52.9	60.1	67.7	68.9	30.6	65.8	64.1	48.6	49.1	59.5	63.4	49.8	64.3	102.8	76.7	118.3	76.8	137.1	104.7	111.8	97.1	109.8	117.5	128.3	106.1	120.4	67.6	165.2	126.4	84.4	76.8	122.4	106.2	102.6	89.6	134.2	125.5	66.2	95.6	110.4	159.4	141.0	121.6	109.4	94.5	86.2	103.8	128.4	137.2	100.2	96.6	117.6	136.0	124.4	165.9	170.6	168.9	187.7	129.3	81.9	111.6	129.6	100.6	101.6	154.3	82.3	77.2	107.8	84.5	65.5	179.5	120.5	90.8	53.9	167.4	123.5	114.5	204.5	107.8	132.0	191.7	80.2	278.1	266.5	547.9	127.5	339.2	136.3	152.9	122.0	140.3	228.8	159.1	146.2	160.5	220.6	161.5	390.0	157.5	185.6	343.3	64.9	66.4	60.5	69.3	66.2	62.1	62.9	63.1	63.5	60.1	65.8	64.3	59.2	44.8	46.2	3.3	54.7	46.7	32.4	61.7	40.9	26.8	56.5	51.9	36.8	55.8	45.6	36.8	20.9	100.9	65.3	119.8	92.0	102.1	17.9	39.5	56.5	58.7	67.8	49.6	6.2	103.5	108.2	52.5	40.2	53.3	62.7	55.0	45.7	99.8	86.5	42.1	6.9	63.8	34.6	75.5	45.8	40.7	38.8	57.2	58.7	6.5	93.4	56.4	84.5	7.1	7.1	136.4	157.3	52.3	49.1	49.6	120.1	85.5	37.8	24.5	26.3	27.9	61.0	26.5	44.3	47.7	53.3	105.8	53.5	56.0	59.6	54.8
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"FAM3 metabolism regulating signaling molecule A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"	"Secreted to blood"	Yes	No		15000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"CAB025016: , HPA035268: , HPA056991: AB_2683303"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	28.4	37.3	43.5	11.3	49.1	11.3	27.6	50.8	51.3	44.6	38.8	35.3	28.0	36.0	7.7	41.3	38.9	8.4	58.7	40.6	45.8	38.6	63.1	26.8	9.4	52.2	47.6	51.5	52.0	14.8	40.9	10.1	47.8	39.1	6.8	6.1	28.5	12.7	36.8	31.1	33.8	7.4	46.9	28.2	36.1	10.0	46.4	12.1	39.9	13.7	5.5	35.8	35.3	58.1	44.4	41.1	10.3	34.5	30.3	15.4	28.8	22.3	15.1	14.8	17.6	19.1	26.2	28.5	109.2	36.8	29.0	31.6	16.2	19.3	3.6	23.4	21.7	11.2	36.9	13.8	47.2	7.6	17.6	19.0	17.5	30.7	21.4	17.7	10.5	18.1	21.6	20.5	17.3	46.3	14.2	32.7	4.6	47.8	52.4	17.3	10.4	79.6	16.6	18.0	20.4	15.6	10.3	24.4	37.3	7.4	18.7	11.8	12.0	19.9	12.0	54.7	30.6	77.6	46.5	36.0	36.4	19.6	20.8	23.4	10.8	15.2	13.4	12.7	13.2	6.1	8.6	9.6	11.0	8.7	10.0	12.0	5.8	10.6	11.3	14.6	9.1	10.1	43.5	49.1	50.8	51.3	40.6	45.8	52.2	47.6	47.8	46.9	46.4	58.1	23.5	12.8	16.7	13.1	16.9	16.3	23.4	29.2	22.8	25.4	21.9	24.9	21.9	22.8	16.3	22.0	14.6	47.0	19.3	60.2	27.4	27.6	1.0	13.4	18.3	18.3	17.5	29.9	7.1	42.5	50.0	28.4	50.0	15.0	5.7	34.8	23.6	30.3	29.8	21.9	9.4	58.9	18.3	16.4	15.3	2.8	33.5	18.0	33.8	6.5	17.6	28.9	24.7	11.1	14.3	28.2	57.5	29.3	32.5	28.7	116.2	33.1	12.7	20.4	6.6	26.7	24.5	5.2	10.1	32.1	21.2	71.3	19.3	23.7	39.7	22.9
FAM50A	"9F, DXS9928E, HXC-26, XAP5"	ENSG00000071859	"Family with sequence similarity 50 member A"	Q14320	X	154444141-154450654	"Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003585	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA003585: AB_1080603"	"unprognostic (1.95e-1)"	"prognostic favorable (2.05e-4)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.64e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-1)"	63.8	59.6	59.0	34.7	63.2	35.6	54.7	61.9	66.2	46.7	58.6	67.9	35.4	46.9	50.5	36.1	40.0	24.2	71.0	59.8	58.9	58.3	51.0	53.2	26.7	65.8	61.7	36.0	50.4	45.7	60.2	35.9	66.7	54.3	27.3	26.5	44.9	34.6	102.4	38.1	46.5	36.9	59.8	51.3	53.6	17.1	64.5	31.5	51.7	57.3	24.7	58.9	41.4	67.1	120.7	145.9	48.0	68.8	174.2	124.7	94.7	152.6	136.0	145.2	219.8	134.2	54.9	6.2	154.6	161.6	211.5	46.2	113.4	106.0	111.8	87.5	72.7	38.6	178.6	86.0	253.4	35.1	109.0	143.2	75.0	224.6	114.4	104.9	120.7	44.5	50.4	94.6	142.9	81.8	41.8	46.0	32.3	105.1	90.7	60.2	120.2	86.4	92.8	119.2	85.6	61.1	55.8	88.4	190.1	81.8	77.0	67.4	149.4	99.8	81.5	165.6	191.3	218.0	134.6	43.0	134.9	120.7	113.6	34.5	54.4	42.1	43.8	72.1	59.3	34.4	45.8	42.2	50.7	30.1	24.8	34.3	30.0	41.7	79.4	38.7	53.5	33.5	59.0	63.2	61.9	66.2	59.8	58.9	65.8	61.7	66.7	59.8	64.5	67.1	60.0	35.3	54.4	14.4	38.2	26.0	42.8	17.9	23.3	65.6	33.5	36.1	88.1	52.9	19.0	29.5	27.1	70.5	50.5	96.0	56.7	53.2	1.8	50.0	71.0	48.7	63.3	56.4	7.3	68.1	109.8	61.0	69.3	68.8	47.0	40.3	41.0	42.6	145.1	47.1	7.4	87.7	18.3	62.3	69.1	5.5	77.9	81.3	32.0	8.4	70.6	80.0	62.8	3.5	17.2	69.8	95.1	79.7	51.6	52.1	123.1	112.1	18.5	68.2	32.9	50.5	76.4	8.3	17.8	29.7	25.9	121.6	62.2	65.0	59.7	45.3
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849373-3851320	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.3;MCF7: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064111, HPA067817"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Midbody"		Yes	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Midbody"	"HPA064111: AB_2685191, HPA067817: AB_2685904"	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	6.9	9.1	11.7	3.7	14.3	1.8	7.0	12.3	15.1	8.3	8.5	10.2	6.6	9.7	3.9	6.6	8.8	3.7	18.0	12.5	13.6	9.8	12.9	5.3	5.1	11.7	11.1	9.3	9.2	4.2	10.4	1.7	11.5	6.4	1.4	5.5	10.2	5.8	32.1	7.1	6.5	2.8	11.2	7.1	8.1	14.0	13.0	3.9	9.8	8.8	3.5	9.7	6.3	12.6	6.6	8.7	0.1	0.0	4.9	4.7	0.4	7.6	3.7	5.1	6.5	0.0	11.7	7.0	8.0	5.5	2.0	4.9	0.0	3.0	3.8	88.3	4.6	0.0	21.1	0.0	5.2	0.0	0.1	5.2	6.0	4.0	1.1	1.6	5.1	0.0	0.0	0.0	4.6	27.5	0.0	9.8	1.9	4.0	4.1	0.0	0.0	0.0	2.5	0.0	11.8	10.3	12.4	7.7	0.4	0.0	8.4	7.8	7.2	0.0	0.9	10.1	0.0	0.0	19.7	0.0	2.7	0.6	14.1	5.7	7.9	4.4	11.3	10.8	26.7	25.0	21.8	14.6	10.5	20.8	17.7	11.2	3.3	33.8	17.7	17.3	36.0	9.0	11.7	14.3	12.3	15.1	12.5	13.6	11.7	11.1	11.5	11.2	13.0	12.6	11.4	16.0	7.0	2.6	8.3	6.4	5.7	10.2	15.4	18.1	8.7	13.5	19.8	17.2	8.3	12.9	4.2	4.2	9.3	2.3	33.2	13.5	31.5	6.8	5.0	6.7	1.2	6.7	2.5	11.1	6.9	8.0	7.1	3.3	3.8	7.5	11.0	21.6	10.1	15.2	2.6	3.5	8.2	6.8	4.7	28.8	8.4	5.6	12.4	1.0	8.7	20.9	4.1	1.0	4.6	8.5	5.1	10.9	6.9	3.3	7.4	36.9	6.8	16.0	0.0	13.0	8.4	38.3	43.9	12.5	6.7	1.0	6.1	7.8	3.8	2.1
FAM53A	DNTNP	ENSG00000174137	"Family with sequence similarity 53 member A"	Q6NSI3	4	1617915-1684261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 12.8;Oligodendrocytes: 14.8;Spermatocytes: 14.6;Spermatogonia: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"PC-3: 3.8;SCLC-21H: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036452, HPA058138"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA036452: AB_10671841, HPA058138: AB_2683619"	"unprognostic (8.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.33e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.15e-3)"	1.2	1.1	1.5	0.4	2.3	0.6	1.1	1.7	1.7	1.2	0.6	1.2	0.2	1.3	1.7	0.8	1.2	0.5	0.8	1.0	1.6	1.0	1.8	0.6	0.5	2.9	2.4	1.3	1.5	0.5	5.6	0.2	2.5	0.9	0.0	0.0	1.2	0.4	1.1	1.4	0.8	0.4	1.8	1.0	1.2	12.8	2.3	0.3	3.7	0.2	0.2	1.1	0.8	3.8	0.6	0.1	0.7	1.4	0.2	0.9	0.5	2.5	1.5	1.7	1.3	0.4	0.8	1.8	1.4	0.5	0.7	0.2	0.0	0.3	0.5	0.3	0.6	0.4	0.2	0.4	1.7	0.0	0.6	0.8	1.5	0.6	1.9	0.4	0.4	2.8	1.1	0.2	0.6	0.5	0.5	1.7	0.6	0.3	3.8	0.5	0.2	0.0	0.5	0.5	4.4	2.4	1.2	0.1	2.1	0.4	1.8	0.7	0.4	0.2	0.1	0.8	0.4	0.3	1.0	0.5	0.0	0.6	3.2	0.0	0.3	0.3	0.1	0.9	0.3	0.5	0.2	0.2	0.7	0.5	1.1	0.0	0.0	0.2	0.4	1.7	0.3	0.3	1.5	2.3	1.7	1.7	1.0	1.6	2.9	2.4	2.5	1.8	2.3	3.8	1.0	0.0	0.0	0.7	0.5	1.3	0.4	0.5	1.2	0.7	0.9	0.5	3.6	1.5	0.2	1.8	0.0	0.1	0.1	0.4	1.9	0.6	12.8	0.3	0.7	0.7	0.0	1.3	2.0	1.0	0.0	0.8	1.1	0.8	0.0	0.9	1.1	0.7	0.2	0.0	1.9	0.1	0.0	0.6	0.7	2.0	0.6	0.6	0.0	1.0	0.6	0.2	0.0	2.5	14.8	0.5	0.1	0.4	0.2	0.4	0.0	0.5	0.3	0.4	0.0	1.3	1.9	14.6	11.0	1.6	0.4	0.0	0.7	1.2	0.4	0.2
FAM71F2	FAM137B	ENSG00000205085	"Family with sequence similarity 71 member F2"	Q6NXP2	7	128672288-128687872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 26.1"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 611.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020513, HPA024248"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA020513: AB_1853077, HPA024248: AB_2671497"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.29e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.65e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.40e-4)"	"unprognostic (2.47e-2)"	1.5	2.0	2.2	0.3	2.0	1.1	1.3	1.5	2.3	1.4	1.3	1.0	0.3	0.9	0.9	0.9	0.9	0.5	2.3	1.9	1.2	2.0	1.0	0.7	0.4	1.4	0.8	1.2	1.3	0.2	2.9	0.3	1.4	1.3	0.4	2.7	1.7	0.4	1.3	1.0	0.9	0.5	0.4	1.7	1.1	26.1	1.7	0.2	1.4	0.1	0.3	1.0	0.8	2.9	0.2	0.3	0.4	0.6	0.4	0.6	0.2	0.2	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.5	0.1	0.5	0.0	0.2	0.2	0.1	0.1	0.2	0.9	0.0	0.2	0.2	0.6	0.5	0.2	0.4	0.1	0.6	0.1	0.2	0.1	0.4	0.2	0.4	0.1	0.4	0.3	0.0	0.2	0.2	0.0	0.1	0.3	1.1	0.3	0.2	0.2	0.2	0.4	0.5	0.2	0.1	1.3	0.5	0.1	0.8	0.3	0.9	0.4	0.3	0.3	0.2	0.3	1.6	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	1.1	0.4	0.1	0.4	0.1	0.0	2.2	2.0	1.5	2.3	1.9	1.2	1.4	0.8	1.4	0.4	1.7	2.9	0.5	3.2	2.2	17.0	0.4	0.0	1.8	0.3	0.6	12.2	1.3	0.8	1.4	2.8	0.2	3.7	52.1	0.6	0.1	0.5	0.0	1.5	138.7	2.1	2.0	1.5	1.2	0.0	11.9	0.7	0.7	1.4	3.1	5.6	2.5	2.0	2.2	0.8	0.9	0.0	10.2	1.1	0.0	1.3	0.4	611.8	4.1	1.4	0.0	2.8	1.1	2.7	1.0	6.6	10.6	1.6	1.8	3.0	2.0	2.5	0.5	0.3	0.2	19.0	0.0	6.5	1.4	13.1	4.0	0.4	0.1	2.5	1.1	4.0	1.4	1.1
FAM76A	MGC34648	ENSG00000009780	"Family with sequence similarity 76 member A"	Q8TAV0	1	27725961-27763116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.5;Late spermatids: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044762, HPA077897"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA044762: AB_10795886, HPA077897: AB_2686867"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.22e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.32e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-2)"	21.0	5.8	5.9	8.5	6.5	13.7	11.7	8.3	8.9	9.3	10.1	10.1	8.7	12.9	10.0	11.7	9.7	10.8	10.1	5.5	7.4	11.6	12.0	10.5	10.7	6.9	5.7	9.6	11.3	13.7	7.8	11.1	6.5	10.0	13.4	15.4	7.9	10.4	40.4	12.0	8.8	10.3	4.5	11.0	11.7	18.6	6.9	8.0	15.9	12.8	10.9	7.1	8.0	12.3	10.0	7.8	8.8	9.1	10.9	9.4	15.9	9.1	9.5	13.1	12.9	9.1	13.0	18.1	5.9	10.2	12.5	12.8	11.2	10.1	10.2	9.4	8.2	5.6	11.7	10.7	8.7	8.9	8.4	9.7	10.8	14.6	14.5	6.7	6.7	9.5	10.9	16.5	9.6	9.5	21.4	8.3	13.9	9.6	7.8	12.8	10.4	10.3	10.6	14.1	12.7	5.7	10.5	11.1	11.3	10.7	7.8	3.5	7.3	15.5	6.7	18.1	6.4	14.9	17.7	14.6	9.7	11.5	6.7	9.8	8.8	11.0	10.4	9.4	11.3	9.2	10.8	10.2	8.1	9.7	10.1	11.2	6.1	9.4	10.1	11.3	8.9	5.3	5.9	6.5	8.3	8.9	5.5	7.4	6.9	5.7	6.5	4.5	6.9	12.3	20.0	28.9	17.0	9.4	20.3	19.1	9.4	8.1	23.3	28.5	14.8	12.1	15.9	14.3	8.8	23.9	27.1	31.3	26.7	12.1	21.5	11.7	131.5	19.6	19.6	14.8	4.2	13.5	15.9	9.7	11.5	26.0	17.3	13.9	11.4	8.5	22.1	18.4	11.8	28.6	15.2	10.4	6.1	15.8	25.2	110.7	16.8	15.2	39.2	13.1	11.4	19.1	16.5	5.0	11.6	9.6	9.1	37.2	10.9	5.4	10.3	20.1	25.3	39.6	19.7	25.4	27.6	35.3	55.4	17.3	27.0	45.4	18.9	11.0	9.2	5.3
FAM76B	MGC33371	ENSG00000077458	"Family with sequence similarity 76 member B"	Q5HYJ3	11	95768953-95790409	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 261.6;Late spermatids: 372.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036608	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036608: AB_2675215"	"unprognostic (8.17e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.90e-3)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.72e-4)"	5.8	5.0	1.1	12.5	1.6	39.5	5.2	4.2	2.3	4.2	1.7	4.9	9.2	6.8	1.6	4.0	3.9	5.3	4.0	1.2	1.0	3.1	8.2	5.0	17.1	1.9	1.8	5.5	6.1	3.7	2.3	6.7	1.8	4.7	5.1	5.3	4.7	3.3	3.9	5.8	6.4	4.5	1.1	8.4	5.9	17.7	1.8	14.2	5.5	3.7	17.6	4.9	3.7	3.4	8.0	6.0	22.1	12.0	3.6	3.6	18.4	13.4	6.4	9.6	11.0	22.4	15.3	29.8	16.5	6.4	12.5	15.0	13.1	4.5	10.1	16.1	9.5	35.0	10.9	11.8	9.2	25.0	19.3	4.7	7.3	11.1	9.9	6.3	9.3	17.5	21.1	16.1	5.5	5.8	28.0	29.9	12.3	8.5	5.4	30.0	16.5	17.7	7.3	8.8	9.3	26.3	16.3	9.1	10.1	7.4	12.1	10.9	9.5	13.4	14.1	15.8	12.3	8.8	19.7	45.5	3.2	23.8	19.2	0.1	1.9	3.5	3.3	2.0	2.7	1.8	3.0	3.4	1.3	1.5	2.7	4.1	5.7	3.3	1.9	4.8	5.2	1.8	1.1	1.6	4.2	2.3	1.2	1.0	1.9	1.8	1.8	1.1	1.8	3.4	27.9	6.4	16.5	14.7	41.5	13.8	12.5	8.4	22.8	16.1	17.0	16.4	12.9	8.6	14.0	5.5	27.1	8.5	28.9	10.5	0.0	7.7	261.6	23.2	23.4	19.2	20.4	34.1	18.7	7.5	10.1	14.9	15.3	18.3	10.8	21.0	15.4	19.8	8.3	11.8	15.9	14.0	4.1	18.0	18.0	372.1	17.1	20.0	16.0	13.1	17.7	12.4	19.6	16.6	30.1	9.1	16.0	15.4	16.2	12.5	10.3	2.4	12.3	15.1	26.3	17.6	21.3	31.8	20.9	14.4	16.1	7.7	26.4	15.0	10.8	10.7
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.7;testis: 31.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.7;Early spermatids: 90.6;Granulosa cells: 167.2;Late spermatids: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.3;HEL: 38.6;HL-60: 38.7;NB-4: 60.7;THP-1: 53.5;U-937: 35.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	2.9	2.0	3.8	13.8	5.6	21.7	1.7	3.6	6.3	1.4	1.8	2.4	2.7	1.5	0.3	1.7	1.3	3.1	26.5	5.1	3.7	1.6	1.5	6.1	24.5	5.6	4.1	1.4	1.1	1.1	1.2	5.3	4.9	1.4	1.6	4.6	2.7	0.9	53.7	1.2	8.9	1.8	4.6	21.6	3.8	31.9	5.8	21.1	1.6	20.2	14.9	3.5	1.1	5.7	0.7	0.3	2.5	5.6	1.7	0.5	39.3	0.3	0.3	0.5	0.2	0.3	0.2	17.1	0.2	0.3	0.8	0.1	16.0	0.2	0.1	4.4	1.4	38.6	0.6	0.3	0.6	38.7	1.5	0.4	0.8	0.0	0.1	0.5	22.2	10.8	13.8	4.7	0.5	6.0	1.7	60.7	2.6	0.3	0.6	4.0	2.3	23.7	0.2	0.1	1.5	2.1	2.3	0.8	2.4	0.9	1.4	53.5	0.6	2.3	2.4	1.3	0.1	3.4	1.9	9.7	0.3	35.9	0.6	0.5	9.7	17.6	9.2	12.6	7.4	14.2	8.9	10.1	6.0	15.9	11.0	9.3	9.8	3.1	9.9	2.7	9.5	8.7	3.8	5.6	3.6	6.3	5.1	3.7	5.6	4.1	4.9	4.6	5.8	5.7	3.2	0.0	1.5	0.0	15.5	0.9	0.0	0.0	0.0	55.7	0.4	0.5	17.6	0.0	0.0	1.8	0.0	1.1	19.0	0.0	0.0	0.1	90.6	0.1	0.2	6.8	0.0	3.4	5.0	0.0	37.6	3.1	0.5	0.1	1.3	167.2	6.4	0.5	25.7	0.0	1.7	0.0	0.0	21.7	10.6	120.3	5.0	14.8	1.8	15.9	15.6	0.8	30.9	1.0	0.1	0.1	0.0	3.4	12.0	0.0	0.0	0.2	0.0	1.8	0.0	0.6	6.3	2.2	1.2	0.0	0.9	1.4	17.4	1.0	0.0	0.1
FAM81A	MGC26690	ENSG00000157470	"Family with sequence similarity 81 member A"	Q8TBF8	15	59372693-59523555	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 31.3;Excitatory neurons: 83.0;Inhibitory neurons: 67.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 5.1;plasmacytoid DC: 11.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.7"	"Cell line enriched"	"Detected in many"	4	"Daudi: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001847, HPA065797"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA001847: AB_2666462, HPA065797: AB_2685560"	"unprognostic (3.43e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.80e-2)"	0.4	0.1	7.0	2.4	10.5	0.2	1.4	0.0	17.0	6.7	0.5	4.3	2.4	2.4	4.4	0.4	6.1	1.6	1.5	11.0	3.2	6.8	0.4	0.7	4.9	0.0	0.1	0.6	1.9	1.1	2.6	0.8	0.1	2.3	5.2	1.3	2.6	1.5	0.5	0.9	1.4	1.2	0.0	1.4	2.4	1.8	6.0	0.4	2.1	2.8	5.5	0.4	0.4	8.3	10.5	15.0	1.1	0.2	0.4	0.2	6.0	0.6	0.0	1.0	2.8	1.8	1.7	66.5	0.3	0.2	14.1	7.8	8.3	2.5	1.9	0.7	4.3	0.0	10.6	0.8	0.0	5.7	1.3	0.0	1.5	0.4	0.8	0.8	0.1	2.7	0.1	0.0	1.0	3.5	0.1	0.1	0.9	2.7	5.4	1.5	14.8	1.7	3.3	3.8	3.0	0.8	6.0	0.3	9.9	0.6	2.5	3.4	0.3	2.4	7.4	2.9	11.4	0.1	0.0	0.8	2.5	2.2	6.7	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.1	2.3	0.0	0.0	0.3	0.1	0.0	11.7	0.0	0.3	7.0	10.5	0.0	17.0	11.0	3.2	0.0	0.1	0.1	0.0	6.0	8.3	0.2	0.0	1.3	11.4	2.5	0.5	1.4	0.2	0.6	0.0	2.4	2.4	6.9	0.0	1.0	31.3	0.0	0.1	0.0	1.7	5.9	0.5	0.5	11.2	0.9	0.7	1.2	1.3	83.0	0.2	1.6	0.6	1.1	1.5	1.3	0.2	0.4	0.2	1.3	10.1	67.0	1.9	2.0	0.6	1.5	1.4	0.3	0.7	8.8	4.7	0.7	1.1	0.0	2.5	8.1	0.4	1.9	0.0	1.2	1.4	0.8	0.3	8.4	0.2	0.0	1.1	3.1	0.2	1.6	1.5	0.4	0.0	0.4	0.2	4.0	1.0
FAM83A	"BJ-TSA-9, MGC14128"	ENSG00000147689	"Family with sequence similarity 83 member A"	Q86UY5	8	123178960-123210079	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 111.3;vagina: 55.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 71.2;Club cells: 58.2;Pancreatic endocrine cells: 28.7;Squamous epithelial cells: 19.3;Suprabasal keratinocytes: 15.2;Urothelial cells: 25.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 52.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 83.5;HBEC3-KT: 126.3;hTCEpi: 66.4;K-562: 206.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA052615			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA052615: AB_2797244"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.98e-9)"	"unprognostic (2.62e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.07e-2)"	0.2	0.6	0.0	0.1	0.0	0.2	0.3	0.2	0.1	18.9	0.1	0.1	1.0	0.0	1.3	111.3	4.3	1.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.7	0.0	0.1	7.5	6.4	0.1	10.2	2.4	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.4	0.0	7.4	3.8	55.8	0.0	83.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.6	0.7	10.6	0.0	0.0	25.9	0.0	126.3	0.0	0.0	0.1	0.8	9.2	0.0	0.0	0.1	0.1	0.0	66.4	0.0	16.8	0.0	0.0	0.1	206.3	0.1	0.0	0.3	0.0	0.1	0.0	4.2	0.1	0.0	0.0	0.1	0.0	18.4	0.1	0.0	14.4	9.7	0.1	0.2	1.5	0.2	0.6	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	4.0	71.2	1.2	0.0	4.4	0.9	1.1	0.0	58.2	1.8	0.0	0.1	0.0	1.0	0.0	0.3	1.0	0.0	0.1	0.1	0.0	0.0	0.6	0.7	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	10.2	0.0	0.4	1.6	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	28.7	0.2	0.0	0.1	0.7	1.1	0.1	9.6	0.0	0.0	0.1	1.4	2.2	0.6	19.3	15.2	0.0	0.1	0.0	0.8	25.0
FAM83F		ENSG00000133477	"Family with sequence similarity 83 member F"	Q8NEG4	22	39994954-40043534	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.3;testis: 40.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 68.1;Proximal enterocytes: 39.9;Suprabasal keratinocytes: 34.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 12.1;HaCaT: 12.8;HBEC3-KT: 15.5;hTCEpi: 37.9;hTERT-HME1: 11.8;OE19: 17.6;RT4: 18.6;SCLC-21H: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051207, HPA064657"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA051207: AB_2681388, HPA064657: AB_2685313"	"unprognostic (2.78e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.36e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.79e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.10e-7)"	"unprognostic (2.93e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.32e-2)"	1.2	0.1	0.2	0.5	0.1	1.2	4.7	0.3	0.2	2.6	0.1	5.3	3.2	0.2	2.5	20.3	1.2	0.5	2.0	0.2	0.1	4.0	2.9	0.2	0.0	0.1	0.1	0.3	13.5	5.4	1.2	0.1	0.1	9.0	3.2	0.4	8.2	6.6	0.1	18.8	7.6	0.1	0.0	0.0	6.8	40.8	0.3	0.9	5.9	0.2	1.1	2.6	7.0	0.3	8.3	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.1	2.3	0.0	0.0	0.0	0.0	12.8	0.0	15.5	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	37.9	0.0	11.8	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.1	2.1	17.6	0.0	0.0	0.0	0.1	0.3	18.6	39.8	0.0	0.3	3.4	0.0	1.3	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.3	1.1	0.0	0.0	0.0	0.5	28.7	14.5	18.0	23.9	1.2	19.1	10.4	5.2	12.8	7.4	23.9	0.0	0.2	0.0	33.1	3.9	9.6	28.4	6.2	0.5	1.0	13.1	0.4	0.2	15.1	0.2	1.0	10.7	6.5	1.3	0.2	0.0	2.2	0.2	0.0	0.2	21.0	14.2	0.6	2.9	68.1	1.8	0.5	1.8	0.0	0.0	0.9	0.0	0.5	0.1	12.5	21.6	2.2	0.2	16.3	39.9	5.9	6.4	0.6	0.0	1.1	1.3	12.4	1.8	30.6	34.5	1.4	0.8	0.4	15.6	17.8
FAM89A	"C1orf153, MGC15887"	ENSG00000182118	"Family with sequence similarity 89 member A"	Q96GI7	1	231018958-231040254	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.0;placenta: 68.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 186.3;Extravillous trophoblasts: 267.5;Rod photoreceptor cells: 102.5;Syncytiotrophoblasts: 278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 145.4;SK-MEL-30: 81.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059052, HPA059578"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA059052: AB_2683890, HPA059578: AB_2684070"	"unprognostic (7.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.05e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.26e-2)"	60.0	18.0	16.0	4.8	15.3	5.9	36.5	20.7	16.4	11.0	21.3	4.4	1.7	7.5	1.6	6.5	7.1	5.9	10.6	14.2	23.4	22.2	9.2	19.2	5.9	22.6	21.4	6.0	10.6	6.0	5.8	68.2	20.9	7.1	2.7	17.3	5.3	4.6	5.9	30.6	4.6	4.1	21.2	17.5	7.6	3.0	25.1	2.9	5.5	6.7	4.7	8.9	9.2	19.5	0.9	13.7	6.3	13.4	15.0	3.0	145.4	7.8	5.8	2.8	5.1	21.1	12.1	0.0	1.8	5.1	16.7	8.4	12.0	1.9	2.3	42.4	28.9	6.7	0.3	0.9	57.6	5.0	35.2	50.1	26.6	0.0	13.2	0.1	7.4	15.0	53.4	8.6	2.7	5.0	3.2	8.8	9.4	12.6	4.3	16.6	20.3	16.0	10.1	14.8	5.8	16.1	2.6	1.2	81.6	13.9	0.8	29.2	1.1	22.5	0.1	0.4	14.7	18.3	23.7	11.6	6.7	9.8	45.7	1.4	0.2	0.0	0.2	0.0	0.3	0.3	0.2	0.5	0.0	0.1	0.4	0.9	0.0	0.1	0.0	0.0	0.0	0.2	16.0	15.3	20.7	16.4	14.2	23.4	22.6	21.4	20.9	21.2	25.1	19.5	82.3	0.0	2.6	3.6	4.2	30.1	22.0	0.3	8.0	48.1	3.8	5.2	3.3	7.2	0.7	0.0	77.2	186.3	4.9	0.3	3.9	2.8	1.3	1.3	39.3	44.5	0.0	14.9	1.1	3.3	267.5	11.6	0.5	2.6	4.5	0.5	10.8	11.1	51.0	8.4	10.8	0.6	0.0	19.6	2.1	3.6	2.8	8.5	21.4	22.5	0.5	26.2	1.0	10.1	2.0	4.4	0.5	1.5	1.4	30.2	0.0	5.1	0.1	102.5	0.0	9.9	8.5	4.2	11.6	1.7	32.8	278.3	5.5	0.4	1.3	15.4
FAM90A1	FLJ10408	ENSG00000171847	"Family with sequence similarity 90 member A1"	Q86YD7	12	8221260-8227618	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.5;Early spermatids: 1.5;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.1;Muller glia cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;HDLM-2: 7.6;NTERA-2: 17.6"									HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (2.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.69e-3)"	"unprognostic (1.94e-4)"	"unprognostic (4.37e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.30e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.06e-2)"	0.4	2.0	3.3	1.2	3.9	0.4	0.3	1.4	3.8	0.5	0.0	0.4	0.8	1.6	1.3	1.0	1.4	2.3	1.8	4.0	0.7	0.7	0.1	1.3	1.0	0.0	0.0	4.2	1.7	0.3	1.9	0.6	0.0	1.5	0.1	4.4	2.0	0.7	0.7	2.0	0.5	0.4	0.0	0.8	0.6	1.8	0.0	0.1	2.5	0.1	0.4	0.3	0.4	1.3	0.0	0.0	0.7	1.2	0.2	0.0	4.9	0.3	0.4	0.1	0.0	0.0	2.0	0.3	0.8	0.1	0.2	0.0	3.2	0.0	0.0	7.6	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.4	1.2	0.2	0.1	2.2	0.2	0.7	2.8	0.4	0.0	1.0	0.1	2.5	17.6	0.0	0.0	0.2	0.1	0.0	1.1	0.4	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.8	0.0	0.7	0.0	0.2	0.1	0.3	2.8	0.0	1.8	2.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.3	3.9	1.4	3.8	4.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.6	0.6	0.4	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.5	0.1	0.2	0.2	0.0	0.4	1.4	0.0	0.0	0.2	0.0	0.2	0.0	1.0	0.4	0.0	0.3	0.0	1.2	0.5	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.1	1.3	0.0	0.5	0.4	0.5	0.1	0.0	0.5	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.4	0.4	0.6	0.1	0.0	0.1	0.0	0.4	0.1
FAM90A10P	FAM90A10	ENSG00000285950	"Family with sequence similarity 90 member A10, pseudogene"	A6NDY2	8	7768977-7771988	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A14P	FAM90A14	ENSG00000285814	"Family with sequence similarity 90 member A14, pseudogene"	P0C7W9	8	7715443-7718453	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A16P	FAM90A16	ENSG00000285620	"Family with sequence similarity 90 member A16, pseudogene"	A6NEW6	8	7730739-7733749	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A17P	FAM90A17	ENSG00000285720	"Family with sequence similarity 90 member A17, pseudogene"	A6NEW6	8	7746034-7749044	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A18P	FAM90A18	ENSG00000285913	"Family with sequence similarity 90 member A18, pseudogene"	A6NE21	8	7723091-7726101	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A19P	FAM90A19	ENSG00000285657	"Family with sequence similarity 90 member A19, pseudogene"	A6NE21	8	7753682-7756692	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A22P	FAM90A22	ENSG00000285687	"Family with sequence similarity 90 member A22, pseudogene"	A8MWA6	8	7571995-7575006	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A23P	FAM90A23	ENSG00000285765	"Family with sequence similarity 90 member A23, pseudogene"	A8MXZ1	8	7579644-7582653	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A26	FAM90A26P	ENSG00000229924	"Family with sequence similarity 90 member A26"	D6RGX4	4	9170409-9176730	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (1.80e-2)"				"unprognostic (3.76e-1)"			"unprognostic (1.56e-1)"		"unprognostic (1.37e-2)"			"unprognostic (2.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.41e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A7P	FAM90A7	ENSG00000285975	"Family with sequence similarity 90 member A7, pseudogene"	A6NKC0	8	7556700-7559712	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Uncertain	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A8P	FAM90A8	ENSG00000285937	"Family with sequence similarity 90 member A8, pseudogene"	A6NJQ4	8	7738387-7741396	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Uncertain	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A9P	FAM90A9	ENSG00000285607	"Family with sequence similarity 90 member A9, pseudogene"	A6NNJ1	8	7761330-7764340	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Uncertain	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM91A1	FLJ23790	ENSG00000176853	"Family with sequence similarity 91 member A1"	Q658Y4	8	123768439-123815452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027978	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Microtubules"		"HPA027978: AB_10600004"	"unprognostic (2.21e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	12.9	11.7	6.8	15.9	7.9	42.9	14.0	8.4	8.2	12.8	12.2	13.0	14.5	13.8	11.9	13.1	10.3	16.0	7.1	7.0	9.0	18.4	26.6	13.1	18.7	9.1	8.2	12.8	14.0	21.0	9.3	20.2	8.6	11.6	14.8	11.7	11.4	11.0	6.1	11.6	14.2	11.7	8.7	19.6	13.9	10.9	8.5	14.3	18.3	6.2	17.0	17.1	10.6	11.6	63.9	42.4	12.9	22.4	24.4	26.3	20.8	36.2	39.4	33.7	42.5	21.3	25.8	29.9	39.2	29.9	26.7	30.4	30.8	39.2	60.0	57.5	29.8	47.2	21.9	25.6	38.0	21.7	58.9	25.0	31.1	44.1	54.3	23.0	31.0	18.4	17.1	41.3	30.7	75.8	37.7	14.4	12.7	51.8	37.3	20.4	21.5	22.4	28.4	64.7	15.5	21.6	48.1	102.4	49.8	18.8	31.5	22.9	31.5	32.0	57.4	35.7	53.1	31.9	65.8	28.4	50.2	38.7	39.9	7.0	8.0	11.3	3.2	9.5	2.9	5.1	3.2	2.7	8.2	4.2	2.7	3.7	10.1	5.9	8.5	3.1	3.1	4.3	6.8	7.9	8.4	8.2	7.0	9.0	9.1	8.2	8.6	8.7	8.5	11.6	31.9	25.6	13.2	17.6	30.6	39.6	21.9	19.0	20.5	15.0	24.0	17.7	8.4	22.8	19.3	25.8	22.9	10.4	25.3	21.3	5.9	12.1	22.4	20.8	22.9	27.5	27.5	10.3	21.0	15.5	12.7	19.3	26.5	33.0	8.8	18.2	18.5	59.3	27.1	23.5	22.0	22.0	16.2	73.6	43.5	26.0	14.0	45.9	21.4	24.4	40.1	17.6	19.6	23.6	45.8	35.1	21.7	14.7	25.8	34.8	18.7	20.8	16.5	21.7	13.1	26.5	22.4	14.2	10.7	27.0	46.7	19.2	19.6	16.0	14.5	45.3
FAM98B	FLJ38426	ENSG00000171262	"Family with sequence similarity 98 member B"	Q52LJ0	15	38454127-38487710	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008320, HPA008502"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA		20000	"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA008320: AB_1848419, HPA008502: AB_1848420"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	12.7	11.4	9.5	12.8	10.2	9.8	12.9	16.4	12.6	9.7	7.2	15.4	9.6	13.3	9.0	9.0	8.1	7.0	12.4	10.8	10.9	13.1	7.8	8.1	13.8	9.4	9.7	11.2	6.1	19.3	6.4	12.0	10.0	12.1	11.6	19.8	6.3	10.0	13.8	8.8	10.0	9.5	10.1	11.2	9.5	8.5	9.6	28.6	11.7	16.3	13.3	11.9	7.0	12.6	30.7	16.2	77.7	40.0	14.1	25.7	37.9	38.6	28.2	37.4	37.5	35.8	14.4	21.1	41.4	32.2	37.9	31.8	47.4	39.5	52.2	21.8	25.7	62.6	33.9	27.8	20.4	59.8	34.6	23.9	24.1	33.3	38.5	27.4	38.9	45.7	45.6	25.7	36.0	13.8	50.7	31.8	42.0	34.8	22.3	53.3	42.0	17.7	32.8	39.9	47.8	48.9	42.5	27.0	19.8	34.6	33.0	36.6	32.7	42.1	51.5	28.2	44.0	47.6	46.1	78.3	23.1	38.9	44.8	2.3	0.5	1.4	2.8	0.4	2.4	1.6	2.8	2.3	0.6	1.9	3.4	2.6	0.4	2.2	0.6	1.4	1.9	0.4	9.5	10.2	16.4	12.6	10.8	10.9	9.4	9.7	10.0	10.1	9.6	12.6	17.9	16.0	21.4	16.3	16.8	14.7	12.7	14.1	14.2	36.8	15.2	11.6	48.9	12.8	18.1	16.5	16.7	30.6	16.4	11.0	7.9	16.4	3.4	19.1	21.5	16.9	12.6	16.6	22.5	19.8	22.4	16.6	16.8	17.0	13.3	18.4	16.8	13.1	12.6	20.2	20.5	22.6	12.2	15.8	12.2	2.5	12.5	10.9	5.4	18.7	21.4	18.5	21.6	12.1	23.8	14.3	9.8	17.0	18.2	12.4	11.1	12.7	18.8	27.9	6.6	21.5	16.2	27.2	17.1	19.7	14.8	21.5	15.3	14.7	19.3	14.1
FAM98C	FLJ44669	ENSG00000130244	"Family with sequence similarity 98 member C"	Q17RN3	19	38403135-38409088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040930, HPA041730"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA040930: AB_10795484, HPA041730: AB_10804114"	"unprognostic (3.01e-2)"	"unprognostic (6.44e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (8.51e-5)"	"unprognostic (2.82e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (5.53e-4)"	10.6	9.6	14.5	5.5	13.9	8.7	12.3	12.3	17.6	14.8	7.2	14.6	13.8	10.7	2.6	17.7	12.3	5.3	11.6	13.8	11.7	12.2	13.3	9.1	6.2	18.9	11.6	12.5	18.6	8.4	11.6	2.3	13.5	13.4	4.7	1.7	13.9	5.8	3.3	25.2	15.4	3.3	12.7	11.8	14.4	9.0	14.4	4.7	11.4	2.5	3.8	12.7	14.6	14.3	15.6	16.3	1.9	9.4	2.0	6.8	8.2	8.8	7.3	8.5	8.9	2.8	11.0	13.9	9.7	5.2	3.0	7.5	3.7	6.3	1.4	22.6	7.6	4.6	2.9	6.5	9.0	3.9	8.1	6.6	13.0	4.3	7.8	4.7	5.0	22.5	12.9	15.0	5.1	17.2	5.9	3.1	1.4	25.5	17.5	11.6	3.9	8.4	10.4	8.0	3.3	9.6	8.8	15.6	5.6	0.9	11.8	12.3	6.7	3.8	10.4	11.9	10.7	16.1	8.8	6.1	9.9	9.2	6.2	0.0	1.9	10.8	2.4	2.7	3.2	2.0	4.2	3.4	2.6	6.5	3.3	2.6	1.7	3.0	2.7	1.0	3.9	1.4	14.5	13.9	12.3	17.6	13.8	11.7	18.9	11.6	13.5	12.7	14.4	14.3	19.8	9.6	8.9	3.6	17.5	21.5	22.3	23.7	14.8	15.1	21.1	26.3	5.4	10.0	21.2	23.9	12.5	11.8	22.1	41.4	21.5	22.2	6.4	18.2	9.1	12.0	25.7	9.7	11.7	32.9	10.9	13.9	17.9	18.0	15.2	8.6	11.4	12.5	11.0	11.8	9.5	32.4	22.4	13.2	18.2	2.4	18.6	14.3	23.2	2.8	14.4	14.6	34.0	5.5	8.5	23.8	42.8	18.4	12.7	12.2	100.4	22.6	22.4	12.5	13.1	13.5	13.8	37.4	37.4	22.3	29.8	6.2	21.8	12.9	34.8	23.4
FAM9B	TEX39B	ENSG00000177138	"Family with sequence similarity 9 member B"	Q8IZU0	X	9024232-9295682	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 3.1;testis: 5.9"	"Group enriched"	"Detected in some"	16	"Spermatocytes: 114.8;Spermatogonia: 96.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"U-266/70: 27.8;U-266/84: 32.1"									HPA035135	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA035135: AB_10669999"		"unprognostic (3.95e-1)"			"unprognostic (4.49e-1)"		"unprognostic (3.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"		"unprognostic (1.40e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-10)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"		0.0	0.1	0.3	0.0	0.2	0.3	0.0	0.3	0.3	0.1	0.2	0.2	0.0	1.5	1.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	3.1	0.1	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.8	0.0	0.4	0.2	5.9	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	27.8	32.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.0	0.4	0.5	0.1	0.0	1.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	4.9	0.2	1.7	0.4	0.0	0.0	0.3	0.0	2.8	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.5	6.6	0.6	0.2	114.8	96.5	0.0	0.3	0.0	0.2	0.0	0.0	0.2
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30890559-30943108	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: AB_2680311"	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	6.2	8.5	9.3	0.9	9.5	0.5	6.7	9.4	9.7	10.1	9.3	10.7	0.9	9.2	6.6	6.5	9.0	1.2	8.8	8.9	9.5	9.5	9.6	5.5	0.8	9.7	9.8	11.8	12.7	5.9	11.4	3.0	10.0	11.5	2.0	2.7	9.8	1.4	18.7	10.8	7.3	2.4	9.5	6.8	8.6	8.9	9.9	4.4	10.0	7.3	0.7	9.3	9.7	10.0	5.2	9.9	3.6	1.9	12.4	9.3	0.8	4.4	2.1	4.7	5.0	4.5	1.7	0.6	7.6	3.6	7.4	9.2	4.7	9.4	5.0	4.2	1.4	1.3	5.5	1.9	4.8	1.2	1.9	2.8	7.3	3.0	7.3	7.2	3.4	5.7	4.7	6.1	4.7	0.6	8.6	3.1	2.2	11.5	2.8	7.0	12.0	2.3	6.7	2.3	4.5	4.6	9.2	5.6	3.0	8.8	4.4	3.3	3.3	9.4	3.0	5.0	3.4	7.4	8.7	1.1	4.1	1.9	1.1	0.0	0.1	0.0	1.4	0.3	2.0	1.2	1.2	0.7	0.9	1.5	1.8	1.1	0.0	1.8	4.3	1.1	1.4	0.7	9.3	9.5	9.4	9.7	8.9	9.5	9.7	9.8	10.0	9.5	9.9	10.0	9.1	16.0	8.4	21.2	5.4	4.1	5.8	4.9	9.6	17.0	11.2	9.8	17.0	0.0	10.7	9.2	20.9	6.5	3.5	7.6	9.8	4.5	11.9	10.2	12.9	8.8	7.8	6.9	23.7	2.9	2.2	8.4	8.6	9.0	8.8	15.5	6.8	13.4	3.7	26.9	25.5	11.0	8.2	5.4	2.5	7.1	10.5	3.9	5.4	15.0	3.4	14.9	7.2	13.6	44.2	3.6	6.4	6.8	7.0	6.0	4.2	8.0	13.6	23.5	6.6	9.4	7.6	20.9	16.4	7.2	2.4	4.1	5.3	9.2	10.3	3.7
FANCA	"FA-H, FAA, FACA, FAH, FANCH"	ENSG00000187741	"FA complementation group A"	O15360	16	89737549-89816657	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.2;testis: 21.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.1;Spermatogonia: 38.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063236			Supported	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA063236: AB_2684966"	"unprognostic (5.99e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.45e-4)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.48e-4)"	"unprognostic (7.82e-10)"	"unprognostic (3.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.62e-1)"	1.4	1.9	1.7	6.7	1.9	20.2	1.9	2.4	3.3	2.1	1.5	5.5	5.2	1.2	0.8	6.6	2.0	1.2	1.6	1.8	1.2	2.9	6.1	3.4	12.5	1.4	1.1	1.4	1.9	1.4	1.9	4.1	1.5	1.7	6.2	1.0	2.1	0.6	0.7	5.2	5.6	2.1	1.1	6.7	3.6	21.6	1.5	8.1	1.7	0.6	13.5	2.2	2.7	1.9	23.2	34.8	40.8	35.7	2.6	5.2	31.2	28.2	15.3	46.5	19.5	30.6	37.3	56.2	12.9	9.8	15.5	34.7	27.7	21.1	48.8	13.4	46.5	16.6	49.1	63.4	1.7	17.1	17.5	1.7	2.2	37.8	12.0	6.6	14.9	28.0	40.9	16.9	24.6	53.6	34.6	73.7	26.5	31.5	21.3	61.4	32.8	10.3	11.8	21.5	36.3	19.7	41.9	12.3	5.4	23.3	22.4	30.4	11.1	37.0	38.9	20.9	30.0	15.1	19.0	56.3	17.5	37.8	36.1	2.5	7.4	9.9	4.2	8.5	3.0	7.0	2.4	3.7	6.2	4.6	0.6	2.6	9.4	8.2	9.2	0.4	9.2	4.2	1.7	1.9	2.4	3.3	1.8	1.2	1.4	1.1	1.5	1.1	1.5	1.9	1.5	0.0	1.1	0.7	9.6	3.4	1.6	2.6	0.0	8.1	3.0	2.0	2.9	0.0	3.5	16.5	10.4	16.0	12.3	5.1	1.9	2.0	5.9	2.8	3.5	2.1	1.8	20.8	10.0	1.6	9.9	3.3	9.2	3.4	2.5	19.0	5.3	4.7	8.8	3.3	5.7	8.1	2.0	4.1	3.1	4.1	1.5	6.8	0.0	1.0	3.0	1.1	21.6	3.0	1.7	1.9	1.7	0.0	21.1	1.3	6.6	10.4	6.4	7.7	0.0	2.7	3.5	44.1	38.5	3.8	1.8	25.3	9.3	6.8	11.4	2.6
FANCC	"FA3, FAC, FACC"	ENSG00000158169	"FA complementation group C"	Q00597	9	95099054-95426796	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 24.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.6;Hepatocytes: 42.6;Late spermatids: 87.8;Microglial cells: 49.6;Oligodendrocytes: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"basophil: 8.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.8"	"Cell line enhanced"	"Detected in all"		"RH-30: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017793, HPA030771"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB017793: , HPA030771: AB_2673604"	"unprognostic (1.48e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.00e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.03e-6)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.71e-2)"	2.6	1.7	1.7	3.1	2.4	3.3	3.4	8.9	2.7	4.1	1.7	4.0	5.5	3.2	1.1	3.5	2.8	3.7	2.7	1.8	2.3	6.8	24.6	4.0	2.7	3.9	2.3	2.3	4.4	1.5	3.5	3.1	3.2	3.5	4.3	2.4	3.0	1.5	3.6	5.9	6.2	2.1	1.7	2.3	3.6	9.5	2.4	4.2	3.1	1.2	2.6	3.0	3.2	3.9	21.5	14.6	18.7	16.9	2.0	5.4	11.7	8.1	5.7	14.1	13.9	16.2	9.3	12.7	6.4	7.2	10.6	25.5	21.1	8.5	8.4	12.9	10.1	9.8	16.6	9.6	2.7	11.6	11.3	4.9	3.8	11.1	5.4	3.9	8.4	10.1	14.9	5.7	10.3	17.1	9.7	5.8	9.6	23.2	8.9	17.3	47.1	7.0	6.4	6.8	26.2	13.1	18.9	7.4	4.2	8.2	6.9	8.6	4.0	13.0	17.1	14.5	14.1	5.9	12.0	6.8	6.6	9.8	15.9	8.8	0.3	0.0	0.9	0.6	0.9	0.6	0.4	0.9	0.3	0.6	0.7	0.7	0.1	0.1	1.3	0.9	0.4	0.5	1.7	2.4	8.9	2.7	1.8	2.3	3.9	2.3	3.2	1.7	2.4	3.9	3.0	3.2	2.2	9.4	2.2	2.5	2.7	1.2	2.8	6.1	3.5	3.7	1.9	5.7	2.3	0.0	4.2	3.0	2.7	3.3	1.9	4.4	178.6	3.5	5.5	4.3	0.0	3.0	22.1	4.1	5.0	3.3	2.0	4.7	5.7	3.9	5.0	42.6	2.0	10.1	13.8	4.0	0.0	3.5	1.3	87.8	6.5	1.6	1.8	49.6	2.8	2.1	1.0	32.2	48.9	3.1	1.0	2.2	4.4	3.0	5.6	8.9	1.0	4.5	0.0	4.1	2.3	19.4	13.2	4.0	2.7	2.3	2.1	4.5	4.7	2.5
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"FA complementation group D2"	Q9BXW9	3	10026414-10101932	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Spermatocytes: 62.5;Spermatogonia: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 120.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	1.1	0.7	2.7	7.7	2.1	17.8	3.4	1.6	5.3	1.5	1.1	4.0	3.2	2.0	0.7	2.5	2.6	2.0	0.5	3.4	1.6	0.9	1.1	1.9	12.2	3.9	1.4	3.6	0.8	0.8	0.5	4.7	3.0	1.9	6.4	3.1	4.9	1.0	4.8	4.5	4.0	2.0	2.4	6.4	3.5	11.8	2.3	9.8	1.9	0.4	13.0	2.3	1.3	5.1	24.1	25.4	46.5	13.2	2.4	3.5	120.7	22.0	9.8	31.3	25.4	18.8	23.0	46.7	9.8	7.0	25.1	20.2	48.8	16.7	31.0	22.6	33.0	63.6	39.6	17.9	0.4	48.1	37.9	1.2	2.6	34.1	18.4	4.2	18.4	39.3	39.6	51.6	23.1	27.2	40.6	17.9	56.1	18.1	17.6	43.4	37.7	32.5	10.3	26.7	13.0	25.3	26.4	20.1	8.3	33.5	31.0	29.4	10.6	24.6	28.4	15.1	31.5	21.7	46.4	77.2	14.1	47.7	43.2	2.7	0.6	1.9	0.6	0.5	0.6	2.4	0.9	0.5	0.4	3.2	1.1	0.9	1.5	1.0	1.4	1.8	1.5	0.5	2.7	2.1	1.6	5.3	3.4	1.6	3.9	1.4	3.0	2.4	2.3	5.1	0.7	0.0	0.5	0.7	12.5	4.6	3.5	2.9	2.8	3.1	4.5	2.7	2.0	1.5	1.9	1.8	10.4	12.7	5.6	3.1	0.0	1.9	5.9	2.6	1.5	2.1	1.2	25.2	3.0	3.5	15.2	2.6	2.0	3.4	1.3	11.8	3.3	1.5	5.7	0.0	2.6	3.2	6.1	3.8	7.0	8.0	2.1	3.7	3.6	1.9	4.9	0.6	1.0	1.5	2.4	1.8	3.6	1.5	8.1	2.2	0.5	0.7	2.0	5.6	19.7	2.6	2.1	62.5	30.2	4.1	2.7	7.0	5.2	1.6	7.6	3.1
FANCE	"FACE, FAE"	ENSG00000112039	"FA complementation group E"	Q9HB96	6	35452338-35467102	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 22.1;Extravillous trophoblasts: 104.8;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB014893	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB014893: "	"unprognostic (2.66e-1)"	"unprognostic (8.01e-3)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (8.90e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.14e-2)"	4.6	1.5	2.6	3.2	2.5	5.8	5.0	2.8	3.1	7.1	2.0	3.1	2.1	3.7	3.4	8.6	4.8	1.5	3.3	2.3	2.9	2.1	1.3	4.1	4.5	2.7	2.6	7.8	3.5	4.0	3.1	9.3	2.6	3.8	3.0	1.8	4.3	2.7	11.0	13.8	3.5	3.1	2.4	3.8	3.4	8.7	2.7	2.6	3.0	3.1	5.7	4.0	7.7	2.7	9.9	4.2	12.8	27.6	9.2	15.9	34.6	11.4	9.6	14.8	12.1	11.1	5.3	33.0	7.5	6.7	11.2	7.2	13.7	9.8	13.9	11.0	11.9	23.8	11.7	6.8	4.8	12.6	8.2	10.1	28.6	17.7	27.7	3.9	8.7	12.6	21.3	11.6	12.2	11.4	5.8	16.6	4.7	10.6	7.0	18.8	12.3	12.1	3.1	10.0	12.1	11.4	6.4	9.1	10.0	11.9	8.8	43.7	5.6	16.7	14.5	10.9	18.1	7.4	29.3	11.6	3.9	24.3	16.8	0.0	0.2	0.2	0.4	0.1	0.7	0.1	0.6	0.9	0.1	0.5	0.3	0.3	0.0	0.5	0.1	0.4	0.3	0.2	2.6	2.5	2.8	3.1	2.3	2.9	2.7	2.6	2.6	2.4	2.7	2.7	7.0	6.4	0.0	1.0	2.4	8.8	4.1	4.7	1.8	1.1	2.0	2.8	2.7	0.0	1.6	0.0	0.0	22.1	2.0	1.6	0.0	1.7	0.3	1.9	2.4	3.7	1.2	2.5	0.4	0.8	104.8	2.8	1.1	3.4	0.0	5.2	1.4	0.7	6.0	0.0	0.9	3.6	0.0	0.8	1.3	0.6	1.5	1.4	1.8	2.8	0.5	1.9	1.0	0.5	1.0	1.1	0.4	0.7	3.1	5.8	1.1	0.3	0.1	2.0	0.0	4.0	3.4	8.2	13.2	4.6	7.1	46.7	2.2	3.4	4.4	3.5
FANCF	FAF	ENSG00000183161	"FA complementation group F"	Q9NPI8	11	22622533-22625823	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Distal tubular cells: 45.0;Early spermatids: 168.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008899			Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA008899: "	"unprognostic (1.16e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.84e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (4.29e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.14e-2)"	"unprognostic (7.64e-3)"	2.1	3.8	3.8	5.6	3.8	2.8	5.2	4.1	3.9	4.9	6.1	5.6	7.9	3.9	8.5	2.8	8.9	3.2	3.6	3.5	4.2	5.0	4.2	3.4	8.2	4.2	4.3	6.1	8.1	4.9	3.7	3.0	3.9	4.6	5.9	5.1	6.1	4.8	1.2	5.1	7.6	2.5	4.1	6.3	7.1	4.9	4.6	9.3	5.6	1.1	7.7	3.5	2.1	4.5	2.3	6.7	8.6	9.5	4.5	5.4	3.5	4.3	5.3	5.0	5.5	4.3	3.5	11.3	1.2	4.5	8.9	9.6	7.2	7.5	2.5	18.5	3.3	4.3	2.7	7.0	5.2	8.0	4.6	5.2	14.1	1.7	7.7	8.5	8.1	15.9	10.9	13.8	3.2	7.0	20.4	7.5	9.8	19.2	8.4	17.0	4.1	12.8	9.7	8.7	32.0	15.1	2.4	7.7	7.8	9.2	15.5	7.1	5.7	5.0	5.1	9.3	6.4	8.0	11.0	3.4	8.1	3.2	11.8	12.3	7.6	16.8	15.3	8.1	18.0	16.1	14.3	14.9	9.2	20.9	19.3	16.2	1.1	15.0	8.7	13.5	10.7	10.6	3.8	3.8	4.1	3.9	3.5	4.2	4.2	4.3	3.9	4.1	4.6	4.5	4.7	3.2	2.2	2.3	13.9	3.3	6.2	8.8	6.8	15.2	7.1	6.0	5.7	18.6	6.3	3.7	10.4	11.6	15.3	10.2	45.0	18.8	168.1	14.1	6.8	6.3	3.5	8.0	2.6	18.7	7.5	5.4	10.7	6.8	2.5	9.6	6.4	10.7	6.9	16.8	3.3	16.5	10.2	6.9	2.6	25.5	9.6	6.7	5.4	5.6	11.3	13.1	22.6	0.5	6.2	10.7	10.3	9.8	7.1	5.6	13.2	22.5	24.4	18.0	6.6	3.2	5.3	23.1	16.7	10.1	2.3	2.3	11.2	11.1	15.8	2.4
FANCI	"FLJ10719, KIAA1794"	ENSG00000140525	"FA complementation group I"	Q9NVI1	15	89243945-89317261	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;lymphoid tissue: 44.2;testis: 32.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 48.6;Spermatocytes: 69.5;Spermatogonia: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039972, HPA040379"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039972: AB_10673265, HPA040379: AB_2676951"	"unprognostic (6.88e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.59e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.71e-13)"	"unprognostic (2.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	3.2	2.1	1.6	13.0	1.3	31.4	6.0	3.8	2.5	3.3	0.0	10.5	6.0	4.7	1.1	8.1	3.4	3.0	1.7	1.7	0.7	1.7	2.9	3.4	23.9	1.2	0.9	3.8	3.0	3.0	0.6	11.3	1.7	3.6	12.4	5.4	2.8	2.0	0.8	8.0	7.3	6.9	0.6	6.0	6.7	32.6	1.3	44.2	2.0	0.8	26.6	5.4	3.7	1.7	108.2	122.4	127.8	86.1	10.8	16.0	78.5	101.4	58.3	123.6	150.5	96.8	95.4	198.8	53.4	33.8	79.3	143.9	196.8	69.0	116.2	127.8	123.5	197.2	176.7	45.8	1.7	146.0	96.3	8.6	6.8	87.1	44.4	17.6	51.7	120.2	139.2	142.3	83.5	61.5	150.9	49.6	101.1	70.3	44.5	130.6	187.1	84.6	28.5	196.8	93.9	80.8	105.2	73.3	46.7	85.7	81.2	64.8	35.4	103.2	103.8	94.9	155.8	93.3	209.5	151.9	38.5	125.7	104.7	23.4	2.3	3.0	4.7	3.0	2.8	3.5	4.7	6.5	2.2	3.6	3.3	5.6	3.1	5.1	4.3	4.1	11.8	3.1	1.6	1.3	3.8	2.5	1.7	0.7	1.2	0.9	1.7	0.6	1.3	1.7	2.6	3.2	1.5	3.6	3.8	4.2	2.6	4.0	0.6	2.4	2.9	2.7	3.9	0.0	3.3	1.8	0.0	17.0	3.9	4.2	0.0	2.0	7.9	5.0	3.7	3.0	1.2	48.6	7.0	2.9	18.3	3.9	5.6	4.5	2.5	14.9	6.8	0.8	8.1	1.7	5.8	5.9	0.0	3.0	3.8	7.9	3.4	4.8	1.8	1.9	3.3	11.6	1.0	9.0	6.9	2.5	1.2	1.5	13.9	2.0	1.3	1.0	6.3	1.9	6.6	3.6	4.0	69.5	60.2	9.2	2.4	12.4	8.1	2.5	9.1	2.8
FANCM	"FAAP250, KIAA1596"	ENSG00000187790	"FA complementation group M"	Q8IYD8	14	45135930-45200890	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 65.5;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055144			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA055144: AB_2682715"	"unprognostic (8.40e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.13e-2)"	1.9	1.6	0.8	2.2	1.6	5.6	2.8	1.9	2.2	2.0	0.3	1.6	1.3	2.4	2.2	1.9	1.6	1.8	1.3	1.0	0.9	1.8	1.5	1.7	3.3	1.0	0.8	2.9	1.1	1.5	0.8	1.9	1.2	1.6	1.8	2.8	1.4	1.9	1.6	2.6	1.2	1.9	0.7	2.3	1.4	7.6	1.1	4.1	1.5	2.3	2.6	1.5	1.5	1.2	8.2	7.0	8.1	7.5	6.4	3.5	6.5	10.3	4.1	8.1	10.1	11.3	6.2	10.6	5.8	2.6	4.5	10.6	9.5	4.4	11.0	7.6	5.4	5.1	7.8	6.4	1.1	13.0	6.1	2.2	1.6	8.1	5.1	1.8	7.1	6.6	9.1	8.9	6.9	8.1	9.5	9.2	3.2	6.3	11.6	9.0	12.7	4.5	3.4	5.8	7.3	1.9	9.4	7.6	4.0	5.1	8.0	6.0	5.6	11.8	11.0	10.6	8.1	4.4	8.7	10.3	2.3	7.9	7.0	6.6	0.7	2.5	2.0	2.0	1.1	4.3	1.3	0.7	0.6	2.0	2.0	1.7	1.0	1.1	0.9	1.7	1.0	0.6	0.8	1.6	1.9	2.2	1.0	0.9	1.0	0.8	1.2	0.7	1.1	1.2	6.5	0.0	3.1	9.8	8.3	2.7	1.1	1.9	4.6	6.3	3.9	2.4	8.3	1.5	3.1	1.8	2.1	7.6	5.6	1.7	0.0	2.2	65.5	3.5	5.8	5.1	0.0	12.8	21.0	2.7	3.5	4.6	5.1	3.0	1.3	9.4	5.7	1.7	3.5	3.3	15.6	1.6	4.1	3.8	2.9	206.1	9.0	4.0	3.6	18.7	5.9	4.8	3.1	20.1	22.7	2.4	0.8	5.3	8.4	0.8	1.5	1.9	1.1	6.9	6.6	4.7	6.0	26.5	14.0	4.4	1.8	2.3	5.6	9.5	3.2	0.7
FANK1		ENSG00000203780	"Fibronectin type III and ankyrin repeat domains 1"	Q8TC84	10	125896564-126009592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 34.2;fallopian tube: 35.1;testis: 56.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 603.8;Late spermatids: 603.0;Respiratory ciliated cells: 222.2;Spermatocytes: 126.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	16	"T-reg: 61.2"	"Lineage enriched"	"Detected in single"	612	"T-cells: 61.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.3;hTCEpi: 9.8;hTERT-RPE1: 13.0;RPTEC TERT1: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038413			Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038413: AB_10697249"	"unprognostic (4.25e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.02e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.44e-1)"	0.9	3.6	5.1	0.7	5.2	1.0	4.6	3.7	3.5	3.3	34.2	3.1	2.3	2.4	12.0	3.6	35.1	2.1	0.8	6.2	6.9	5.8	0.2	5.7	0.5	15.6	18.8	5.5	4.2	4.5	7.4	1.3	10.5	2.2	4.6	15.8	2.4	3.0	0.2	5.7	2.1	1.4	10.7	0.3	5.3	56.5	6.7	1.6	8.3	0.5	1.3	2.3	2.5	5.9	7.2	2.4	0.6	4.0	3.0	3.0	4.5	2.7	1.9	0.7	0.6	0.1	19.3	0.0	0.5	2.0	1.0	9.3	0.0	3.4	0.5	0.2	0.1	0.0	1.0	0.0	1.1	0.4	0.6	0.9	9.8	2.7	0.9	13.0	1.0	0.0	0.4	0.0	1.1	6.1	0.0	1.4	0.4	6.5	0.2	0.0	0.3	0.6	13.6	2.0	0.5	2.0	2.2	4.5	0.5	7.4	0.7	0.3	0.9	1.3	2.2	1.8	0.1	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.2	0.2	5.1	5.2	3.7	3.5	6.2	6.9	15.6	18.8	10.5	10.7	6.7	5.9	0.9	12.8	6.3	18.9	0.2	5.1	3.4	18.6	1.2	1.5	7.2	5.7	0.8	1.5	26.6	12.9	33.3	2.6	0.0	5.2	13.7	12.3	603.8	94.9	3.1	1.7	0.0	0.4	15.9	8.9	5.9	2.2	2.0	6.0	3.8	16.5	1.1	0.0	1.0	3.3	14.1	12.4	12.2	0.3	2.3	603.0	3.7	1.1	1.8	2.8	0.2	6.3	0.0	3.0	2.7	11.1	6.9	4.5	0.2	3.2	1.5	11.1	222.2	10.0	0.0	0.8	6.1	126.7	15.5	1.3	3.4	5.1	2.4	12.2	3.6	3.6
FARSB	"FARSLB, FRSB, PheHB"	ENSG00000116120	"Phenylalanyl-tRNA synthetase subunit beta"	Q9NSD9	2	222566899-222656092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036677, HPA036678, HPA061398"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504"	"unprognostic (9.95e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.45e-10)"	"unprognostic (8.89e-3)"	"unprognostic (4.51e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.25e-4)"	12.8	10.9	9.5	7.6	10.0	8.0	12.8	10.4	11.3	13.1	6.5	14.7	9.1	13.5	6.5	20.7	11.9	3.9	16.7	10.2	10.7	11.8	14.1	9.4	7.4	9.6	9.4	14.3	15.6	8.0	13.2	5.0	10.8	11.2	11.1	10.0	10.4	6.1	31.9	14.9	10.8	8.1	8.4	9.7	13.9	13.5	9.9	7.7	9.7	13.2	8.3	13.1	13.7	9.4	31.1	17.8	20.7	27.2	18.0	26.3	31.0	31.0	19.2	29.4	23.9	45.3	16.6	15.3	22.7	22.6	24.7	25.8	39.7	34.7	43.0	22.8	20.7	35.1	18.9	28.8	27.9	51.9	14.0	17.6	27.0	33.9	51.2	10.5	28.3	26.4	53.5	30.3	36.1	28.9	31.2	29.2	26.6	37.0	22.0	30.2	49.4	49.8	24.5	19.9	33.4	11.2	12.9	22.4	27.6	24.7	20.9	21.3	15.8	25.5	21.1	37.8	38.5	14.8	15.5	54.5	20.8	34.0	27.2	0.5	7.6	1.2	9.6	9.4	14.3	15.1	12.8	11.9	14.4	12.7	16.4	14.2	0.9	17.4	11.3	7.2	12.5	13.7	9.5	10.0	10.4	11.3	10.2	10.7	9.6	9.4	10.8	8.4	9.9	9.4	10.2	6.4	6.4	21.2	25.2	12.4	19.5	32.7	19.4	17.9	16.3	18.0	28.6	5.7	18.5	22.0	4.2	37.0	7.5	18.1	35.2	24.7	57.5	17.3	15.8	13.3	20.9	24.2	50.2	30.4	43.3	18.0	32.6	18.6	5.1	21.8	7.5	17.8	27.4	3.3	56.7	19.9	20.3	10.1	9.7	73.1	15.2	11.8	7.2	26.2	11.3	13.2	15.5	38.7	38.2	22.8	11.3	19.9	27.3	18.1	9.9	31.0	16.8	19.5	6.6	17.6	34.4	67.4	33.7	28.8	14.2	22.2	16.9	24.3	45.8	14.3
FASTKD3	"FLJ23274, MGC5297"	ENSG00000124279	"FAST kinase domains 3"	Q14CZ7	5	7859159-7869037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068525, HPA074462"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA068525: AB_2685999, HPA074462: AB_2686692"	"unprognostic (5.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (6.66e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.53e-4)"	3.5	5.4	2.5	3.8	2.6	4.4	6.2	2.4	3.4	4.0	3.2	5.6	5.3	3.3	4.0	3.1	3.1	3.2	3.2	2.4	2.5	9.1	6.7	3.6	5.5	2.4	2.4	4.5	3.0	5.8	2.8	3.3	2.6	4.2	6.6	3.5	3.3	3.4	5.7	4.7	5.9	3.9	2.5	4.6	4.8	2.7	2.2	5.2	4.1	4.3	6.5	3.4	2.6	3.0	10.5	9.0	8.5	11.1	5.2	6.6	16.8	8.5	7.2	13.0	9.9	13.6	10.8	36.0	16.6	9.3	16.5	10.8	21.5	12.0	18.7	9.9	11.1	12.6	28.7	10.7	7.2	21.0	9.8	7.7	5.0	12.3	7.3	5.8	7.2	14.1	17.5	6.1	10.0	7.6	14.2	12.2	7.8	10.9	12.7	16.0	10.4	8.3	10.8	11.1	5.9	5.6	25.9	11.1	12.6	7.7	10.0	9.5	4.8	12.8	13.2	13.6	14.3	7.0	7.2	22.9	8.7	18.9	10.8	2.9	4.2	5.9	4.6	5.7	6.1	7.7	6.6	4.8	5.2	5.7	7.2	6.8	0.2	4.2	4.7	3.0	8.1	3.6	2.5	2.6	2.4	3.4	2.4	2.5	2.4	2.4	2.6	2.5	2.2	3.0	5.3	16.0	5.9	3.9	5.7	2.5	2.3	11.6	1.8	3.3	5.4	4.7	5.0	5.7	5.1	0.0	0.0	7.8	8.8	6.5	5.9	9.1	0.4	3.1	5.4	5.3	7.2	4.6	5.6	11.8	7.1	4.8	4.1	3.3	3.8	4.2	6.4	9.7	8.4	5.0	4.9	6.5	12.2	7.0	5.1	1.1	5.3	5.2	1.8	0.0	12.1	3.5	10.3	2.0	5.9	11.6	4.4	4.5	4.9	3.0	12.4	21.3	6.5	5.3	0.0	3.5	4.0	4.0	6.0	6.6	5.5	4.2	6.8	8.0	7.7	2.1
FAXC	"C6orf168, dJ273F20, MGC2817"	ENSG00000146267	"Failed axon connections homolog, metaxin like GST domain containing"	Q5TGI0	6	99271168-99350062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Excitatory neurons: 57.1;Inhibitory neurons: 60.1;Oligodendrocyte precursor cells: 43.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.0;HAP1: 23.8;SCLC-21H: 34.2;SH-SY5Y: 23.7;SK-MEL-30: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039106	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA039106: AB_10697546"	"unprognostic (8.03e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (2.47e-3)"	"unprognostic (6.70e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.49e-3)"	0.7	2.2	11.0	1.5	12.7	0.0	3.2	9.3	19.0	2.5	2.0	22.7	1.5	6.5	11.0	6.2	3.7	2.4	0.8	14.1	7.6	2.7	0.0	1.7	0.1	7.2	5.6	2.2	2.5	6.5	15.9	0.8	6.3	8.2	2.9	10.4	7.4	10.6	0.5	0.9	3.3	7.8	4.4	0.4	7.1	2.1	8.5	2.2	1.7	0.6	0.1	14.3	2.9	11.4	4.0	3.2	10.3	14.3	0.0	0.0	3.8	5.0	3.2	8.1	7.0	1.9	1.3	0.0	0.6	1.0	26.0	0.1	23.8	4.7	7.0	0.0	11.8	0.1	1.9	0.7	0.6	0.0	0.0	0.5	7.5	0.2	3.8	5.9	0.0	2.0	0.5	0.0	2.7	7.0	0.0	0.0	12.2	0.0	4.8	0.0	1.0	0.0	4.3	0.3	34.2	23.7	4.5	3.2	22.6	4.2	10.0	0.0	1.0	2.5	4.7	0.0	15.5	0.0	0.0	0.0	0.1	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	12.7	9.3	19.0	14.1	7.6	7.2	5.6	6.3	4.4	8.5	11.4	0.2	25.6	15.2	5.5	0.5	0.4	4.2	4.2	5.7	14.4	5.3	9.0	1.1	0.0	8.1	1.8	10.4	1.2	0.4	0.2	9.8	2.3	2.6	0.6	1.0	1.7	0.0	0.0	57.1	0.7	0.2	1.4	0.0	0.4	3.8	0.4	1.4	0.1	0.2	3.3	60.1	0.2	4.1	0.6	1.1	5.0	0.0	1.2	1.8	2.8	0.1	3.6	2.1	43.7	4.4	1.0	0.1	1.9	0.1	4.8	0.0	1.0	2.1	13.6	0.0	0.2	1.3	1.3	8.9	1.2	0.3	0.3	1.2	0.2	0.4	1.2
FBLL1	LOC345630	ENSG00000188573	"Fibrillarin like 1"	A6NHQ2	5	168529305-168530634	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 35.4;pituitary gland: 15.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cone photoreceptor cells: 6.2;Enteroendocrine cells: 6.7;Horizontal cells: 6.7;Inhibitory neurons: 6.6;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 24.2;SH-SY5Y: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049546, HPA077724"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA049546: AB_2680811, HPA077724: "	"unprognostic (2.75e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.18e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.2	3.0	22.0	0.1	21.0	0.0	0.6	12.8	35.4	0.5	4.6	0.9	0.4	0.2	0.0	0.2	0.4	0.2	0.3	20.4	32.2	0.6	0.7	0.1	0.0	22.7	21.0	0.7	0.9	0.4	15.5	0.2	26.1	1.0	0.1	1.4	0.9	0.3	0.1	0.5	0.5	0.2	11.4	0.2	0.5	5.9	23.1	0.0	0.2	0.0	0.0	0.3	0.3	20.1	0.0	0.5	1.8	0.3	0.1	0.0	0.9	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.5	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	20.2	2.1	0.0	1.2	0.0	0.0	1.5	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	21.0	12.8	35.4	20.4	32.2	22.7	21.0	26.1	11.4	23.1	20.1	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.6	8.5	1.4	1.8	1.2	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.4	1.7	0.9	1.4	0.2	6.7	0.0	4.3	0.2	0.1	0.8	0.0	2.4	0.0	1.6	0.0	0.0	0.1	6.7	6.6	0.4	0.0	0.0	0.0	2.3	0.0	0.1	3.6	1.0	0.0	0.7	0.0	3.0	1.1	0.2	0.0	0.0	0.0	0.3	1.0	0.4	0.0	2.8	6.6	0.2	0.4	3.1	0.4	0.2	0.1	0.0	0.1	1.2	0.3	0.0
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"placenta: 81.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 298.1;Syncytiotrophoblasts: 163.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.2"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 134.1;HSkMC: 94.3;hTERT-HME1: 215.2;HUVEC TERT2: 122.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		11000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (7.41e-5)"	0.1	5.1	0.4	0.8	0.5	3.1	0.2	0.0	0.3	2.2	3.0	0.8	0.3	1.7	0.1	0.1	0.4	0.3	5.5	0.2	0.6	0.1	0.1	0.2	0.5	1.1	1.9	0.5	0.2	0.0	0.8	81.9	0.5	0.8	1.2	0.9	0.3	0.4	0.2	0.2	0.4	1.3	0.5	0.4	0.8	7.4	0.8	0.2	0.5	0.4	0.9	0.5	0.7	0.3	0.0	16.4	58.2	0.0	9.4	16.6	11.8	62.8	0.0	56.0	41.8	0.2	0.0	0.0	0.1	85.5	0.0	9.2	37.6	9.8	52.7	0.1	13.8	0.0	27.3	0.2	134.1	8.4	0.0	94.3	5.3	24.1	215.2	17.9	122.3	0.0	0.0	0.0	35.8	0.1	0.0	3.4	24.5	0.0	18.2	19.2	18.1	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.6	48.0	0.0	18.7	0.0	22.1	41.9	66.8	0.3	0.0	0.0	0.0	6.9	0.0	23.8	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.2	0.4	0.5	0.0	0.3	0.2	0.6	1.1	1.9	0.5	0.5	0.8	0.3	0.1	0.0	0.5	1.6	0.2	0.0	0.1	1.2	0.6	0.0	0.3	0.3	12.7	0.0	1.4	0.0	0.0	298.1	0.0	0.0	0.0	0.3	3.8	10.0	3.9	1.0	0.0	0.0	1.1	0.0	24.3	8.8	0.0	4.7	0.0	0.1	0.0	0.0	34.0	0.0	50.5	0.0	0.0	10.7	0.4	7.2	1.2	2.7	1.8	1.9	6.2	3.8	0.0	17.6	1.5	0.1	0.0	2.2	0.0	2.0	0.0	0.2	1.6	0.1	6.6	0.1	3.5	10.7	3.5	0.1	0.4	163.5	0.1	8.4	0.1	0.1
FBRS	"FBS, FBS1, FLJ11618"	ENSG00000156860	Fibrosin	Q9HAH7	16	30658431-30670810	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044117	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA044117: AB_10794394"	"unprognostic (1.87e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.01e-3)"	"unprognostic (6.32e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	25.6	34.3	23.0	24.4	22.2	55.9	25.8	21.5	24.6	34.2	14.9	39.1	21.2	35.6	5.5	57.2	36.0	9.4	28.7	22.9	19.7	33.3	29.9	29.2	21.8	24.7	20.9	33.8	29.8	16.6	57.6	12.6	19.4	37.3	6.5	6.5	30.2	15.6	38.4	53.5	40.0	9.7	16.8	53.4	33.8	117.3	22.9	21.3	36.6	11.4	15.9	34.7	33.2	23.0	28.8	30.2	15.6	12.9	15.3	15.5	39.5	20.9	16.9	17.7	13.3	17.8	25.9	26.8	34.0	17.0	16.0	23.6	16.6	19.9	8.3	72.7	41.5	36.0	29.3	33.0	37.4	26.5	52.3	23.1	26.4	34.3	16.6	19.8	22.0	24.4	32.0	50.2	13.1	59.1	33.7	51.7	4.4	12.9	19.0	48.5	11.8	29.4	18.8	21.2	21.8	24.5	16.4	31.2	22.9	6.7	70.5	34.6	34.3	40.0	24.2	25.0	27.8	58.6	30.5	25.4	38.4	25.6	24.1	0.0	1.0	0.8	0.8	0.4	0.8	0.6	0.7	0.8	0.5	0.7	0.2	0.9	2.1	0.5	0.6	1.0	0.0	0.9	23.0	22.2	21.5	24.6	22.9	19.7	24.7	20.9	19.4	16.8	22.9	23.0	21.2	16.0	21.8	9.8	30.0	18.7	15.9	13.2	38.7	22.3	26.8	19.3	9.3	11.5	11.0	7.3	33.3	10.2	38.1	36.3	5.9	11.0	82.2	33.4	25.1	18.2	16.8	4.6	9.5	14.7	9.3	15.8	29.0	32.2	19.0	21.5	19.2	9.4	14.0	43.7	8.7	21.5	10.2	15.8	22.0	109.9	17.1	25.8	10.6	7.5	20.1	14.7	15.5	7.5	14.5	21.1	26.3	16.1	13.3	22.2	33.5	8.9	24.4	25.7	0.0	19.0	17.7	69.1	23.9	37.8	24.3	33.0	28.8	22.2	19.3	27.9
FBRSL1	KIAA1545	ENSG00000112787	"Fibrosin like 1"	Q9HCM7	12	132489551-132585188	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 90.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049880	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA049880: AB_2680930"	"unprognostic (2.02e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-3)"	"prognostic unfavorable (9.82e-4)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (7.21e-4)"	12.3	19.2	16.3	8.7	13.1	10.1	13.2	20.7	21.2	17.8	7.2	20.5	11.2	18.6	7.7	15.6	18.7	4.1	31.1	16.2	6.7	19.3	26.8	16.2	8.5	10.0	7.7	22.3	39.2	7.3	28.7	5.7	8.0	22.0	3.6	5.9	14.7	7.2	31.9	19.4	23.3	4.1	4.7	28.3	21.4	29.1	9.6	6.2	15.7	9.4	4.7	17.8	15.7	10.2	11.7	18.5	8.7	14.8	3.7	4.5	64.4	10.9	3.1	7.1	4.3	32.7	6.9	19.0	18.4	3.6	6.1	22.6	9.3	6.1	2.3	14.7	47.6	23.2	11.0	25.0	8.0	24.7	23.4	4.1	10.7	6.6	4.8	6.5	7.0	15.9	49.9	3.8	3.1	29.8	33.7	90.0	22.7	8.4	33.4	50.9	9.3	13.2	6.2	11.2	33.4	28.0	10.2	15.8	14.1	3.6	18.6	23.7	11.1	7.6	18.5	13.7	13.9	24.6	13.0	12.0	8.8	23.8	9.4	1.2	0.4	1.2	0.3	0.3	0.3	0.8	0.3	0.3	0.3	0.6	0.3	0.4	0.5	0.2	0.7	1.0	0.6	0.3	16.3	13.1	20.7	21.2	16.2	6.7	10.0	7.7	8.0	4.7	9.6	10.2	14.9	3.2	5.2	24.2	12.8	9.2	7.1	3.3	11.4	28.9	20.7	18.5	13.7	4.3	4.0	11.0	41.7	6.9	19.8	24.0	7.9	6.2	1.4	16.8	17.9	8.8	31.0	12.0	17.0	7.6	5.8	11.8	15.3	22.0	1.3	22.6	7.5	22.2	6.9	11.8	17.1	21.7	0.0	11.6	11.1	2.0	16.1	16.4	5.4	15.0	7.7	9.3	6.2	12.5	16.8	9.0	15.0	15.4	11.9	16.0	13.3	6.4	6.4	22.7	6.6	12.7	11.5	5.7	8.0	10.8	10.4	11.5	10.9	12.7	18.7	10.4
FBXL14	"Fbl14, MGC40195"	ENSG00000171823	"F-box and leucine rich repeat protein 14"	Q8N1E6	12	1565993-1594581	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 47.4;Late spermatids: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053889	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA053889: AB_2682293"	"unprognostic (8.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.90e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (9.04e-6)"	"unprognostic (5.60e-3)"	"unprognostic (1.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.12e-3)"	5.2	4.3	7.9	5.9	10.6	5.8	4.6	8.7	21.4	3.6	2.4	8.4	4.9	4.5	1.6	6.0	5.7	4.8	5.2	10.6	7.8	4.6	3.9	5.7	7.5	7.8	8.1	4.7	11.3	7.1	8.7	4.2	8.3	3.7	3.5	4.2	6.2	4.0	3.3	3.4	6.2	2.1	7.4	6.4	9.7	21.1	9.0	8.3	6.4	2.5	3.3	4.7	4.3	8.6	11.8	16.3	4.8	8.4	4.0	4.1	14.3	2.6	4.7	2.4	2.7	17.1	14.8	15.8	3.1	2.9	4.0	8.1	3.9	6.0	0.4	27.2	19.0	19.6	4.7	5.5	5.3	15.0	14.4	6.5	2.7	4.4	3.7	4.3	4.3	13.4	8.3	43.2	2.9	12.4	15.9	7.4	21.2	6.4	6.7	13.5	7.8	9.9	3.8	10.3	9.2	9.1	6.3	9.5	9.8	4.9	7.5	12.1	6.4	5.3	17.5	6.8	9.5	5.3	6.1	19.7	11.3	8.7	8.2	0.7	0.1	0.0	0.1	0.1	0.1	0.2	0.4	0.4	0.2	1.7	0.4	0.2	0.3	0.6	0.2	0.2	1.6	0.1	7.9	10.6	8.7	21.4	10.6	7.8	7.8	8.1	8.3	7.4	9.0	8.6	1.9	0.0	0.0	11.4	1.1	0.0	0.3	0.5	1.8	4.2	1.1	0.9	0.9	0.0	0.3	0.0	0.0	0.2	0.5	1.6	0.0	0.2	47.4	1.7	0.8	2.3	0.0	0.4	12.3	0.5	0.1	1.3	1.5	0.9	0.0	0.5	2.9	1.1	0.6	10.1	13.4	0.7	2.0	0.8	0.8	103.7	0.3	1.2	0.0	12.2	0.8	2.7	0.0	10.6	17.1	0.1	0.7	1.5	1.8	0.8	1.4	0.8	1.0	3.0	0.0	1.7	1.1	10.4	0.5	2.9	0.0	0.1	1.8	0.9	1.2	0.3
FBXL17	"DKFZP434C1715, Fbl17, Fbx13, FBXO13"	ENSG00000145743	"F-box and leucine rich repeat protein 17"	Q9UF56	5	107859035-108382098	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Astrocytes: 270.0;Excitatory neurons: 568.2;Inhibitory neurons: 578.0;Microglial cells: 205.2;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036410, HPA036411"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA036410: AB_2675109, HPA036411: AB_10669603"	"unprognostic (8.15e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.30e-2)"	"prognostic favorable (4.60e-8)"	"unprognostic (1.86e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.35e-2)"	15.4	13.8	11.8	7.8	13.1	5.9	10.4	7.5	15.3	10.8	3.8	10.1	10.6	9.9	8.9	12.0	9.0	9.1	27.0	12.4	12.5	16.9	14.2	8.9	8.5	9.0	12.2	9.3	10.0	26.0	5.7	5.9	9.0	11.8	10.4	25.6	9.8	13.7	55.8	8.7	10.9	11.7	10.5	10.7	10.1	8.6	11.8	10.1	24.6	41.7	10.7	8.5	4.5	10.3	8.7	8.5	9.6	17.7	15.8	16.4	6.4	10.4	23.3	8.4	11.3	1.7	17.9	9.7	16.0	16.9	13.0	3.8	7.7	11.9	13.0	9.8	6.9	9.2	9.0	4.2	8.2	6.2	10.1	11.8	17.4	7.8	5.7	16.3	10.1	3.9	1.3	12.2	18.5	6.5	5.4	7.9	1.3	6.7	7.9	7.6	12.8	12.7	11.7	11.9	8.2	14.0	13.6	11.9	13.4	6.6	9.4	14.6	11.0	18.9	5.9	5.9	13.6	9.5	14.3	7.0	16.7	9.4	12.6	0.1	0.1	0.8	0.4	0.2	0.4	0.2	0.4	0.4	0.2	0.3	0.4	0.3	0.3	0.2	0.1	0.4	0.2	0.1	11.8	13.1	7.5	15.3	12.4	12.5	9.0	12.2	9.0	10.5	11.8	10.3	13.2	19.2	14.5	270.0	13.9	16.8	7.4	7.5	6.8	37.2	18.6	10.2	38.3	17.2	8.3	29.5	56.3	4.8	12.8	22.8	17.6	7.3	5.6	8.5	9.7	12.3	29.9	5.7	568.2	13.1	6.5	12.1	12.2	10.7	16.5	12.2	21.0	21.4	8.4	30.3	578.0	21.7	2.0	21.0	14.1	5.4	14.0	9.9	16.0	205.2	13.1	20.8	12.3	302.6	256.1	13.3	16.0	16.6	10.7	8.6	14.4	15.0	6.1	50.4	0.0	16.6	9.8	9.5	3.9	10.6	24.6	4.5	12.6	13.8	16.6	8.8
FBXL18	"Fbl18, FLJ11467"	ENSG00000155034	"F-box and leucine rich repeat protein 18"	Q96ME1	7	5431335-5513809	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036049			Approved	Nucleoplasm,Cytosol		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA036049: AB_2674918"	"unprognostic (2.86e-3)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.98e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.28e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.30e-4)"	"unprognostic (1.73e-3)"	2.3	1.9	6.8	2.0	7.0	2.7	1.1	3.2	14.2	1.0	1.8	1.3	1.7	1.5	1.1	2.0	1.1	0.9	1.9	10.2	4.3	1.3	1.2	1.3	1.9	5.3	2.5	1.2	2.6	2.1	1.4	1.3	2.6	1.4	0.9	1.4	2.0	1.2	3.6	3.8	1.5	1.3	0.7	1.5	1.6	1.6	5.8	1.4	1.4	2.0	1.6	1.3	1.0	5.1	11.0	15.2	3.7	9.7	5.7	4.2	6.9	6.5	2.9	4.0	3.9	12.0	7.4	5.2	7.5	4.0	7.4	17.3	4.9	14.7	2.8	3.5	6.3	2.8	10.7	4.7	4.2	4.9	4.3	4.3	7.9	6.4	3.6	3.8	5.0	3.0	8.0	3.5	3.7	16.4	3.0	5.3	13.7	5.1	12.1	6.8	7.8	3.6	4.0	6.1	7.9	12.2	10.2	18.1	3.5	4.5	17.9	4.4	11.4	12.9	16.6	10.1	9.9	5.2	7.5	3.8	7.1	7.1	16.1	6.3	2.1	0.9	1.4	2.1	1.3	1.3	0.9	1.4	1.6	1.8	1.0	1.2	5.0	2.3	2.9	1.4	1.2	1.5	6.8	7.0	3.2	14.2	10.2	4.3	5.3	2.5	2.6	0.7	5.8	5.1	4.8	6.4	4.8	6.2	2.6	2.5	3.0	0.9	1.2	9.7	3.9	9.1	5.3	2.8	5.8	0.0	4.2	3.9	5.5	4.8	0.0	2.4	1.5	7.6	3.5	2.8	4.8	0.4	10.8	2.6	2.7	2.7	4.6	7.3	2.5	3.0	2.5	1.8	1.5	1.7	8.5	1.9	4.1	3.5	2.9	0.5	1.5	2.4	0.0	7.5	3.2	4.7	5.2	4.0	7.8	2.2	2.1	0.7	1.4	2.4	2.4	1.2	3.2	6.6	0.0	4.7	3.0	2.7	4.9	2.4	3.3	2.2	2.9	1.5	4.8	1.8
FBXL19	"CXXC11, DKFZp434K0410, Fbl19, JHDM1C"	ENSG00000099364	"F-box and leucine rich repeat protein 19"	Q6PCT2	16	30923055-30948783	"Predicted intracellular proteins"	"Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074250			Approved	Nucleoplasm		NA	No			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA074250: "	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.37e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.38e-2)"	5.4	7.7	16.5	9.8	14.8	8.3	5.5	4.4	27.9	8.7	1.9	8.6	10.4	8.5	4.0	16.5	7.3	8.5	5.6	16.8	10.1	11.5	4.3	5.8	9.7	9.4	8.6	8.4	6.7	7.2	11.4	10.1	9.1	9.9	3.8	8.5	8.9	5.4	4.8	12.7	8.8	4.6	3.1	9.9	8.7	30.0	12.4	10.0	7.9	4.0	5.1	8.5	9.6	14.4	17.5	46.0	44.7	35.6	8.0	8.1	38.6	24.2	12.3	18.3	17.2	24.8	23.9	27.1	27.4	14.4	14.2	24.3	35.9	25.8	14.0	76.3	110.0	30.0	84.0	36.5	9.9	33.5	69.9	8.3	20.4	22.6	16.0	15.9	30.0	37.7	80.0	26.3	10.3	46.9	36.4	46.2	44.4	13.0	15.5	73.1	14.2	27.0	17.7	23.6	29.6	56.3	8.5	53.0	13.7	25.1	32.5	34.8	30.0	20.2	26.1	13.5	17.1	23.1	20.4	16.9	24.7	49.0	29.9	0.0	0.4	0.5	0.3	0.2	0.3	0.5	0.1	0.1	0.2	0.2	0.0	0.3	0.5	0.9	0.0	0.7	0.2	0.1	16.5	14.8	4.4	27.9	16.8	10.1	9.4	8.6	9.1	3.1	12.4	14.4	3.4	0.0	1.1	4.9	1.5	8.3	2.4	2.5	2.8	6.1	6.8	4.1	1.5	4.3	2.9	3.7	12.5	5.7	4.0	8.9	0.0	6.1	5.6	3.8	4.7	5.0	2.4	1.3	4.5	7.1	5.4	3.1	3.6	6.0	0.0	8.9	3.6	2.3	5.2	1.7	5.0	6.5	2.0	2.8	3.9	6.5	1.5	3.4	0.0	3.7	3.3	2.8	4.1	3.0	2.1	8.6	4.1	2.6	1.7	6.4	3.3	5.1	1.8	6.0	6.6	2.2	3.5	4.7	2.9	5.4	8.9	9.3	2.0	4.9	8.5	6.5
FBXL2	"FBL2, FBL3"	ENSG00000153558	"F-box and leucine rich repeat protein 2"	Q9UKC9	3	33277025-33403662	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 48.8;Excitatory neurons: 125.0;Inhibitory neurons: 92.8;Late spermatids: 50.7;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 49.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 5.7;LHCN-M2: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003240, HPA061783"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA003240: , HPA061783: AB_2684605"	"unprognostic (5.73e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.72e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.90e-2)"	0.9	1.3	3.6	0.4	3.8	0.3	1.0	2.2	4.0	1.1	4.2	1.1	0.7	1.0	2.1	0.4	1.5	0.6	0.9	3.5	3.7	1.4	0.2	1.2	0.3	2.9	2.6	1.4	1.1	2.7	2.7	1.4	3.0	1.0	0.2	4.2	0.8	1.6	0.2	0.6	0.5	0.8	1.6	0.5	0.8	1.1	3.3	0.2	2.3	0.0	0.2	0.8	0.9	2.7	2.7	0.7	1.0	1.0	1.5	2.4	0.4	2.0	1.6	1.8	2.6	0.5	3.1	0.1	0.6	1.3	0.8	0.5	0.9	2.1	1.2	0.2	1.1	0.4	2.3	0.5	1.8	0.2	0.4	0.9	1.6	1.1	0.8	5.7	3.3	1.9	0.5	0.2	6.2	0.2	0.5	0.3	0.7	0.3	0.6	0.1	0.6	0.1	4.6	0.7	1.1	1.1	0.9	0.5	0.8	1.7	1.3	0.7	2.5	0.8	0.7	0.6	1.1	0.2	0.1	0.1	0.8	0.2	0.6	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	3.6	3.8	2.2	4.0	3.5	3.7	2.9	2.6	3.0	1.6	3.3	2.7	2.7	3.2	7.3	22.2	1.0	1.1	7.6	5.6	1.8	15.3	3.0	3.7	2.4	2.8	4.8	5.5	25.0	0.5	0.4	0.1	3.9	3.9	48.8	18.8	3.6	3.8	0.0	0.0	125.0	0.4	1.5	5.0	5.6	6.2	0.0	6.2	2.2	0.1	0.5	18.5	92.8	0.3	8.2	0.8	2.4	50.7	1.5	0.5	1.8	22.5	0.1	6.6	0.0	55.8	49.6	4.2	0.1	4.1	0.3	4.2	0.2	3.2	16.5	17.7	6.6	3.6	3.9	21.3	8.6	0.7	1.1	0.7	1.5	3.5	0.1	3.8
FBXL6	FBL6	ENSG00000182325	"F-box and leucine rich repeat protein 6"	Q8N531	8	144355431-144359376	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008867			Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"HPA008867: AB_2668161"	"unprognostic (2.97e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (4.49e-10)"	"unprognostic (3.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.00e-1)"	4.6	4.8	2.3	1.4	2.3	2.0	4.9	2.5	3.2	4.3	2.5	8.0	4.6	3.5	0.6	7.2	3.1	1.0	4.1	2.3	2.2	4.6	10.8	3.9	1.8	2.5	2.4	2.1	8.1	1.6	3.8	1.8	2.4	4.2	1.8	0.5	5.1	1.6	4.2	6.6	7.8	0.7	2.4	6.8	5.5	5.2	2.6	1.5	3.3	0.3	1.2	4.6	4.3	2.3	9.0	3.0	2.1	13.3	2.7	0.7	3.8	4.4	5.1	4.5	3.1	3.2	3.9	4.1	5.3	2.2	2.2	5.8	2.4	6.1	1.0	7.6	3.0	8.2	1.6	7.9	4.0	2.1	8.4	1.2	5.5	2.5	6.6	1.2	3.7	6.7	3.8	6.6	1.7	16.7	6.0	1.9	2.6	9.8	8.3	6.7	2.4	14.0	6.0	3.0	3.1	3.0	5.1	8.0	7.7	1.2	13.2	3.7	3.3	2.2	8.1	10.8	5.4	2.5	2.1	3.0	3.4	5.1	2.9	0.0	0.1	0.6	0.4	0.4	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.3	1.6	0.7	0.0	0.0	2.3	2.3	2.5	3.2	2.3	2.2	2.5	2.4	2.4	2.4	2.6	2.3	17.9	6.4	2.0	4.6	10.1	5.7	6.0	2.1	7.4	9.9	13.2	12.8	1.1	7.2	4.6	0.0	14.6	8.3	17.3	18.2	5.9	5.2	1.9	5.2	6.8	5.9	2.4	3.0	7.4	6.2	11.6	5.2	13.7	7.8	1.3	7.7	6.8	6.7	6.9	1.7	5.6	19.4	2.0	4.7	7.6	1.6	5.3	9.0	5.4	4.7	2.6	7.9	6.2	2.0	2.7	7.5	10.8	1.9	20.1	8.2	43.7	8.1	2.0	9.0	0.0	5.1	13.6	5.0	7.8	14.8	6.7	3.8	10.7	9.9	17.3	6.3
FBXO10	FBX10	ENSG00000147912	"F-box protein 10"	Q9UK96	9	37510892-37576380	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 29.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.8;Excitatory neurons: 28.6;Inhibitory neurons: 28.2;Late spermatids: 45.7;Oligodendrocyte precursor cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.1;naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 24.0;HHSteC: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA002863, HPA072721"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002863: AB_10965996, HPA072721: "	"unprognostic (2.40e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.93e-5)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-1)"	2.9	8.0	5.9	3.2	6.2	0.8	2.4	2.6	7.4	3.3	3.9	7.4	1.8	4.5	10.7	3.2	2.5	2.7	3.9	9.0	6.4	3.8	3.6	2.3	5.5	3.6	5.1	2.5	6.6	3.8	16.4	2.0	4.4	3.3	1.8	1.6	8.5	2.9	29.8	1.9	4.7	3.2	3.6	10.0	3.2	9.4	6.8	2.0	7.6	13.9	5.3	3.0	2.7	5.6	2.3	5.6	24.0	6.2	11.1	3.9	2.0	4.2	7.6	5.3	7.7	3.2	1.5	14.4	1.4	4.6	2.1	0.2	8.8	2.1	3.8	8.2	5.8	2.9	5.3	2.8	33.8	7.9	1.0	9.0	1.7	4.7	3.1	3.4	7.5	1.4	10.4	3.9	9.4	2.0	3.0	2.6	11.2	3.3	2.1	5.5	10.4	1.8	3.0	1.5	5.1	12.8	2.8	3.4	3.2	7.1	1.4	8.0	6.1	3.7	6.3	3.4	3.1	4.5	3.9	2.3	3.1	3.0	3.5	0.0	0.0	0.0	0.2	0.0	0.2	2.1	0.4	0.2	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.2	5.9	6.2	2.6	7.4	9.0	6.4	3.6	5.1	4.4	3.6	6.8	5.6	0.7	0.0	1.1	12.4	6.7	0.3	0.1	0.4	0.6	3.9	1.2	0.8	1.7	2.8	0.5	1.8	4.2	0.3	0.3	0.1	0.0	1.1	34.8	1.1	4.3	1.4	5.4	0.4	28.6	1.5	0.8	1.8	0.5	1.3	0.0	1.9	3.9	1.2	4.1	3.3	28.2	0.5	2.0	0.3	0.0	45.7	0.9	0.6	1.8	4.7	0.7	1.6	0.0	16.6	7.0	1.2	0.2	1.5	5.7	0.9	0.2	1.3	1.1	1.0	0.0	3.1	1.0	4.2	1.9	0.7	0.6	0.3	1.3	5.0	0.3	0.3
FBXO11	"FBX11, UBR6"	ENSG00000138081	"F-box protein 11"	Q86XK2	2	47789316-47906498	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002690			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA002690: AB_1848448"	"unprognostic (1.18e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	27.9	19.6	24.5	19.1	25.9	32.2	20.9	32.7	28.7	21.1	21.0	19.7	16.8	33.1	24.8	18.7	22.2	20.9	22.8	26.5	25.6	21.7	26.8	22.5	25.7	22.8	23.1	34.4	19.6	30.2	17.5	23.0	24.0	22.7	20.1	33.3	16.5	20.4	28.3	19.1	17.3	29.7	22.9	24.2	19.1	41.0	25.9	22.5	26.1	28.7	27.7	22.1	16.9	25.2	52.8	26.9	62.9	53.9	42.6	40.2	37.2	36.0	48.6	32.6	31.9	22.9	25.9	32.8	45.4	50.2	40.5	25.6	42.5	37.1	47.9	22.3	21.5	31.6	21.3	36.6	41.0	33.5	32.1	39.3	41.7	28.8	48.2	51.9	42.1	16.6	31.3	33.9	40.4	25.5	31.7	32.8	38.2	34.7	26.2	40.9	58.3	25.5	47.1	42.5	44.1	52.3	34.2	31.5	54.6	46.4	14.7	27.9	46.4	40.2	37.2	27.5	40.0	28.9	16.5	60.9	27.4	30.8	42.1	4.3	1.1	2.1	1.5	1.2	1.6	2.1	1.4	1.7	1.4	1.5	2.6	1.7	2.6	2.2	1.1	2.0	1.6	1.1	24.5	25.9	32.7	28.7	26.5	25.6	22.8	23.1	24.0	22.9	25.9	25.2	40.6	16.0	39.0	100.9	34.1	67.0	44.4	22.0	24.5	45.1	22.3	15.1	11.0	15.7	24.9	18.4	33.3	19.6	37.8	24.7	11.7	17.2	34.4	38.6	40.3	39.4	23.9	17.1	151.4	15.2	16.0	37.0	23.4	48.6	29.1	37.3	33.2	20.0	25.5	55.5	134.8	17.1	24.4	40.1	81.4	40.4	30.1	51.8	35.6	137.7	30.9	30.2	25.7	138.7	143.8	25.8	17.1	39.9	36.3	44.3	17.3	14.6	37.4	42.5	19.7	42.3	34.6	86.6	50.7	24.2	59.0	36.0	35.6	33.4	19.5	65.1
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490278	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 18.4;pituitary gland: 17.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5;Excitatory neurons: 44.4;Inhibitory neurons: 43.6;Rod photoreceptor cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 9.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 9.6"	"Cell line enhanced"	"Detected in many"		"AF22: 20.3;Karpas-707: 22.4"	"Low region specificity"	"Detected in all"							"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: AB_2683795, HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favorable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.5	1.8	3.9	0.9	5.0	2.2	2.6	6.8	7.0	4.1	2.9	1.6	2.0	1.1	18.4	0.7	4.4	1.4	1.4	4.6	3.9	3.2	6.0	1.5	1.4	1.1	1.7	0.7	4.7	7.1	17.3	0.6	2.0	3.5	2.0	14.3	3.4	5.1	1.1	0.4	2.9	0.7	0.3	1.2	2.2	4.2	3.5	0.6	7.0	0.9	2.8	1.2	0.7	4.3	16.5	2.9	20.3	7.5	0.5	0.0	0.3	0.2	0.5	3.0	5.5	3.1	4.6	5.8	7.2	0.1	8.1	5.1	2.3	3.5	3.0	2.6	3.6	2.7	0.3	1.7	0.0	3.5	1.9	0.2	10.8	0.7	3.2	1.5	0.0	5.6	1.1	22.4	1.0	5.7	0.5	5.0	3.9	2.2	4.5	0.2	4.5	8.2	3.9	2.4	13.1	5.4	0.4	3.3	9.5	3.5	13.8	5.9	0.6	1.6	5.8	3.2	3.0	5.2	5.0	5.2	6.8	0.7	3.5	0.3	0.1	0.1	0.1	0.1	0.3	0.3	0.2	0.1	0.7	0.2	0.1	0.2	0.9	0.0	0.1	9.6	0.2	0.1	3.9	5.0	6.8	7.0	4.6	3.9	1.1	1.7	2.0	0.3	3.5	4.3	0.0	3.2	4.1	7.5	1.7	0.1	3.0	10.9	5.2	8.2	3.9	3.4	2.1	8.6	7.9	3.7	35.5	0.6	0.0	0.5	7.9	5.3	12.1	13.5	1.3	0.2	10.2	0.0	44.4	4.6	0.4	0.9	1.5	6.4	0.0	1.9	0.4	1.9	2.7	5.0	43.6	3.9	4.1	0.8	2.3	12.4	1.2	0.4	0.0	2.8	0.0	9.3	0.0	23.6	3.2	3.1	0.4	0.7	11.1	1.7	0.2	4.7	23.4	48.6	0.0	0.5	1.8	10.5	5.6	1.2	0.0	0.0	0.5	4.2	1.0	1.7
FBXO2	"Fbg1, Fbs1, FBX2, Nfb42, OCP1"	ENSG00000116661	"F-box protein 2"	Q9UK22	1	11637018-11655785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 238.9;choroid plexus: 125.3;pancreas: 86.9;pituitary gland: 118.3"	"Cell type enriched"	"Detected in many"	4	"Exocrine glandular cells: 685.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 113.4;HBEC3-KT: 96.9;Hep G2: 239.8;SiHa: 440.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA005472: AB_2667332"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (5.26e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.64e-1)"	6.8	25.2	217.0	1.8	172.1	0.0	13.5	161.1	216.1	7.2	125.3	4.9	16.4	2.3	6.7	8.9	5.9	2.5	11.6	183.3	238.9	32.8	28.1	5.7	2.0	200.2	196.2	3.6	86.9	29.7	118.3	0.1	201.7	15.1	0.4	7.5	25.1	7.5	4.8	18.1	5.3	0.7	176.0	3.7	9.6	12.0	195.1	10.6	8.4	1.0	3.6	5.1	13.1	192.3	35.7	10.8	0.4	35.1	0.7	0.0	5.3	1.5	3.0	1.1	0.2	113.4	10.0	0.0	40.6	0.3	8.3	0.1	3.6	96.9	0.1	0.8	1.0	0.0	1.7	239.8	4.6	0.1	0.0	3.0	17.0	0.0	0.9	1.1	0.4	0.1	0.3	0.1	0.0	0.5	0.0	0.0	1.3	14.3	1.3	0.1	0.1	0.2	8.2	3.0	3.6	4.7	440.5	0.1	3.9	3.5	21.1	0.0	0.0	0.3	3.1	0.0	0.0	2.4	2.1	1.7	0.7	0.0	1.0	0.0	0.0	0.0	0.9	0.0	1.3	0.7	0.5	1.2	0.0	0.5	0.8	1.1	0.0	0.0	0.0	0.0	0.4	0.2	217.0	172.1	161.1	216.1	183.3	238.9	200.2	196.2	201.7	176.0	195.1	192.3	1.2	0.0	1.5	40.8	8.4	19.6	62.3	149.9	90.5	11.3	15.0	75.4	3.7	15.7	33.5	47.8	2.1	0.8	5.9	0.2	86.1	23.2	2.1	1.2	0.7	1.8	1.2	0.0	16.5	685.9	3.9	8.7	6.6	0.7	4.5	0.2	2.5	102.0	0.4	28.6	16.7	0.7	38.7	2.2	2.6	2.4	34.8	1.1	44.4	5.6	3.2	106.6	7.2	6.6	10.4	132.1	2.2	40.6	3.3	39.2	2.0	7.2	44.4	15.8	0.0	1.1	7.7	18.4	12.1	10.0	9.9	1.0	13.0	0.5	0.4	25.0
FBXO27	"Fbg5, Fbx27"	ENSG00000161243	"F-box protein 27"	Q8NI29	19	38990714-39032785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 37.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.1;Suprabasal keratinocytes: 17.8;Syncytiotrophoblasts: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 35.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA046800, HPA062242"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA046800: AB_2679813, HPA062242: AB_2684723"	"prognostic favorable (2.15e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (1.48e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.80e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.04e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.21e-2)"	13.3	3.7	17.5	2.1	15.9	2.7	6.2	23.8	18.7	6.3	6.4	6.8	2.2	4.7	2.4	15.4	5.3	5.5	19.6	15.4	8.9	6.4	7.5	3.2	3.7	10.7	6.7	10.2	4.8	2.5	4.1	3.8	9.1	8.9	8.7	4.9	7.4	7.8	1.6	37.5	4.9	7.4	4.9	3.1	3.8	4.7	11.1	4.0	4.6	2.4	4.0	7.7	9.7	13.1	9.1	11.4	0.3	7.2	15.3	0.8	3.3	1.2	6.7	5.2	4.9	3.8	3.4	0.9	17.5	10.3	9.0	15.5	0.6	6.6	3.4	0.8	0.4	0.3	3.0	0.6	2.7	0.9	2.5	5.5	10.2	5.4	0.4	8.2	3.3	0.4	5.4	1.2	7.2	8.1	0.6	1.4	8.1	3.0	20.4	0.2	0.1	1.1	3.4	35.3	0.4	10.8	17.7	2.2	0.1	4.8	9.2	1.7	4.0	0.5	0.4	0.3	0.9	3.5	8.9	1.9	9.0	0.2	0.3	1.1	0.3	0.2	0.3	0.3	0.2	0.4	0.2	0.2	0.2	0.6	0.4	0.3	1.7	1.7	0.2	0.5	0.3	0.2	17.5	15.9	23.8	18.7	15.4	8.9	10.7	6.7	9.1	4.9	11.1	13.1	0.2	3.2	15.0	2.3	0.1	5.9	4.1	1.4	9.1	7.5	3.8	4.2	9.5	7.2	6.4	1.8	0.0	36.1	0.5	0.2	1.9	1.5	3.7	1.9	3.6	3.2	0.0	0.0	4.8	0.8	4.8	2.7	6.1	1.6	7.6	2.3	1.4	3.2	4.9	8.4	4.6	0.2	8.2	0.3	4.9	2.5	2.8	2.1	0.0	1.0	1.1	5.6	0.0	3.0	4.1	0.3	0.0	4.1	1.9	2.3	6.9	7.3	4.7	3.0	0.0	1.8	1.5	6.4	2.0	13.5	17.8	27.0	1.3	0.4	0.2	5.3
FBXO28	"CENP-30, Fbx28, FLJ10766, KIAA0483"	ENSG00000143756	"F-box protein 28"	Q9NVF7	1	224114111-224162047	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003289	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Focal adhesion sites"	"HPA003289: AB_2666879"	"unprognostic (4.91e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.61e-1)"	10.9	7.5	6.5	8.3	7.3	8.9	12.3	8.8	10.5	10.9	7.4	10.3	8.5	10.0	7.9	12.4	8.2	9.5	8.1	7.6	9.1	13.6	17.4	8.9	10.5	8.5	7.4	11.3	7.6	13.7	4.4	9.0	8.8	10.0	10.6	8.3	7.9	8.5	12.5	21.1	7.7	9.8	8.0	8.9	8.5	7.8	7.8	10.9	9.8	14.2	10.6	11.5	9.0	8.9	24.6	10.6	16.2	17.4	16.6	19.0	26.7	24.3	19.7	16.0	15.2	14.9	18.7	11.8	24.4	22.3	10.3	20.9	24.2	23.4	27.4	17.0	27.0	15.0	12.8	10.7	20.7	28.3	18.8	18.6	27.7	23.2	41.9	18.8	27.1	15.0	24.8	16.4	29.1	8.1	14.9	14.4	38.6	32.3	22.8	15.7	23.1	22.3	30.2	16.1	26.2	28.1	25.1	38.0	27.4	16.9	20.2	28.2	31.2	19.8	15.0	25.0	46.1	17.8	22.3	18.0	24.5	13.7	39.3	7.4	6.5	11.8	5.8	6.0	7.2	8.9	5.9	6.8	7.8	9.0	5.9	6.6	4.2	8.6	6.9	3.5	8.8	4.6	6.5	7.3	8.8	10.5	7.6	9.1	8.5	7.4	8.8	8.0	7.8	8.9	15.0	6.4	10.6	22.5	16.8	34.3	25.5	11.3	9.6	20.5	14.7	11.7	11.4	7.2	13.5	11.0	22.9	14.2	12.3	17.2	9.8	13.2	30.3	15.9	13.0	16.4	18.5	17.4	48.8	11.5	13.1	12.7	7.1	22.9	14.0	12.6	14.3	23.4	13.9	18.5	43.8	12.7	14.2	17.7	16.3	14.8	13.1	16.8	28.4	34.7	16.4	12.6	7.2	45.8	43.7	17.7	12.2	13.2	15.4	21.5	12.0	22.8	11.5	18.6	13.1	14.9	12.7	24.7	26.8	17.2	39.1	23.0	18.9	10.9	14.6	30.7
FBXO3	"FBA, FBX3"	ENSG00000110429	"F-box protein 3"	Q9UK99	11	33740939-33774543	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002467			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA002467: AB_2666602"	"unprognostic (1.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.36e-2)"	"prognostic favorable (2.46e-9)"	"unprognostic (6.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-2)"	21.2	24.2	18.1	14.8	21.6	26.9	27.5	20.7	24.6	21.4	19.0	21.4	18.1	24.8	24.2	33.6	23.3	21.5	46.3	20.3	19.8	47.0	42.0	19.7	18.3	16.5	16.8	28.9	27.1	56.8	17.7	16.5	17.5	25.6	23.7	33.9	23.0	25.5	124.1	28.9	20.5	24.5	17.2	19.1	23.5	25.2	19.0	20.4	34.3	98.8	21.4	20.8	22.5	19.0	22.1	19.2	25.8	27.6	30.4	23.8	15.6	25.7	25.6	20.4	25.3	22.1	21.6	14.6	17.7	28.2	25.1	37.2	34.8	33.9	34.1	14.7	48.2	7.5	28.4	18.3	19.4	17.4	16.9	24.2	33.8	14.1	22.3	29.7	27.3	10.6	25.9	28.4	23.2	14.9	13.0	10.2	13.1	49.4	29.5	9.9	57.5	20.8	29.5	27.5	36.3	20.0	36.4	24.8	19.6	24.6	35.8	13.2	25.2	25.2	22.0	35.9	22.0	15.7	22.1	24.5	22.5	13.4	25.4	25.9	11.9	18.0	21.6	11.8	24.4	16.2	25.5	24.6	12.8	20.0	32.1	22.4	12.8	25.1	15.5	6.6	34.3	15.8	18.1	21.6	20.7	24.6	20.3	19.8	16.5	16.8	17.5	17.2	19.0	19.0	33.3	35.3	17.2	31.3	28.9	48.8	64.2	32.0	35.3	56.8	24.5	14.7	42.4	21.5	31.0	25.8	27.1	22.7	28.9	22.6	56.7	49.6	130.8	17.3	19.2	31.7	23.9	32.8	45.1	25.3	28.7	30.7	17.3	21.8	16.5	25.8	32.5	41.0	12.3	57.2	37.9	18.8	54.9	15.0	20.1	51.3	29.8	11.9	28.4	22.5	15.2	46.7	40.2	30.7	40.1	34.9	25.2	27.1	28.3	33.3	23.2	63.6	34.4	52.4	59.2	26.2	37.1	64.2	27.3	43.6	67.5	36.5	32.9	19.4	16.7	50.4
FBXO31	"FBX14, Fbx31, FBXO14, MGC15419"	ENSG00000103264	"F-box protein 31"	Q5XUX0	16	87326987-87392142	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 65.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030150	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA030150: AB_10670559"	"unprognostic (4.85e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.16e-5)"	"unprognostic (3.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.26e-3)"	33.7	12.8	6.8	6.0	8.5	5.7	24.3	39.0	14.5	14.9	0.0	20.9	8.6	21.7	4.4	10.2	16.8	6.2	18.2	11.9	13.4	5.3	15.9	8.7	6.4	8.3	5.5	15.0	13.1	8.2	19.4	4.9	11.1	10.2	5.8	8.1	11.1	10.7	65.3	17.0	15.9	11.1	2.7	5.2	11.5	18.7	9.5	5.7	8.7	36.8	4.6	21.8	13.0	7.6	7.0	13.1	4.3	11.7	21.6	12.9	12.5	12.0	11.9	11.6	6.1	11.9	5.8	16.3	12.9	12.7	5.9	10.6	8.3	10.0	7.7	7.5	15.5	5.5	8.7	34.1	12.1	5.3	4.4	15.4	8.3	15.2	14.3	7.6	7.2	8.3	15.9	6.3	6.3	10.1	13.0	7.3	8.4	7.3	11.5	16.1	5.1	7.0	5.2	4.9	20.0	9.7	26.7	5.4	8.3	3.1	8.5	4.6	10.1	11.2	8.5	10.8	9.6	14.4	12.0	20.1	9.0	9.8	7.0	0.5	0.1	0.0	0.2	0.1	0.4	0.6	0.4	0.6	0.1	0.3	0.4	0.5	0.2	0.0	0.2	0.2	1.1	0.4	6.8	8.5	39.0	14.5	11.9	13.4	8.3	5.5	11.1	2.7	9.5	7.6	61.3	0.0	4.6	13.1	7.3	14.7	5.1	3.3	17.1	13.8	6.4	6.7	20.6	2.8	2.1	5.5	33.3	10.8	4.6	19.3	0.0	3.6	9.2	18.0	10.6	16.0	9.0	9.5	21.6	5.1	3.1	10.1	6.6	11.1	0.0	5.3	5.3	29.5	4.0	0.0	21.9	11.7	4.1	4.4	7.7	26.3	8.1	2.9	3.6	10.3	4.1	5.3	3.1	8.5	13.6	3.5	17.2	11.3	7.2	5.4	33.6	5.5	11.7	11.9	19.7	8.6	9.8	17.9	6.1	14.6	12.9	7.3	9.0	5.9	16.5	4.5
FBXO32	"ATROGIN1, Fbx32, MAFbx"	ENSG00000156804	"F-box protein 32"	Q969P5	8	123497889-123541206	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 649.5"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 247.5;Cardiomyocytes: 286.5;Prostatic glandular cells: 225.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 2.9;gdT-cell: 2.5;MAIT T-cell: 2.5;memory CD4 T-cell: 3.6;memory CD8 T-cell: 3.8;naive CD4 T-cell: 4.2;naive CD8 T-cell: 5.4;NK-cell: 3.2;T-reg: 3.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 2.9;NK-cells: 3.2;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 49.3;HDLM-2: 176.1;hTERT-RPE1: 58.3;U-251 MG: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058955, HPA065209"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA058955: , HPA065209: AB_2685433"	"unprognostic (2.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (8.58e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-3)"	10.9	2.7	13.2	13.9	19.6	2.2	29.2	20.0	15.5	15.0	41.4	136.6	6.7	86.9	14.9	16.2	59.5	32.5	77.9	10.6	15.1	2.7	1.1	3.8	6.0	27.4	20.3	24.9	4.6	11.7	8.9	7.7	28.8	25.8	20.7	17.9	23.0	43.8	649.5	12.9	23.5	94.9	21.5	3.9	31.8	1.7	15.9	9.2	24.3	105.6	5.1	73.3	13.8	28.6	5.3	0.9	0.2	0.0	10.6	2.5	1.9	1.0	11.4	0.6	1.1	0.0	2.9	0.0	3.1	8.5	49.3	0.3	0.2	1.0	0.9	176.1	4.0	0.0	6.3	0.0	14.5	0.1	0.7	21.1	7.4	2.6	3.2	58.3	0.8	2.5	0.3	1.5	0.8	1.3	0.7	0.1	0.1	2.1	0.9	0.0	0.2	1.1	1.9	1.7	0.3	1.1	1.2	19.2	21.5	1.1	18.9	0.4	0.7	3.1	0.8	1.1	51.9	17.4	2.6	0.4	12.7	0.2	2.5	2.9	0.2	0.0	2.5	0.1	2.5	0.4	3.6	3.8	0.2	0.4	4.2	5.4	0.1	3.2	0.2	0.1	3.8	1.1	13.2	19.6	20.0	15.5	10.6	15.1	27.4	20.3	28.8	21.5	15.9	28.6	6.8	0.0	3.7	7.5	6.1	11.5	184.8	113.3	64.9	17.7	44.9	247.5	286.5	4.3	63.6	7.3	35.5	17.8	27.9	153.0	9.8	14.4	4.7	22.2	88.2	13.0	102.4	8.0	52.2	30.7	17.5	28.9	14.8	76.0	0.0	30.3	2.2	2.9	5.3	21.9	30.9	63.6	111.9	5.9	3.4	3.5	39.7	5.6	44.4	14.0	2.4	58.6	25.7	9.5	117.2	51.7	189.5	61.3	38.3	225.2	36.9	5.2	19.9	100.1	19.7	75.2	61.3	15.9	2.9	49.9	6.3	109.2	32.5	3.7	21.1	90.8
FBXO33	Fbx33	ENSG00000165355	"F-box protein 33"	Q7Z6M2	14	39397669-39432500	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046657	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA046657: AB_10960398"	"unprognostic (8.84e-3)"	"unprognostic (6.72e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (9.61e-2)"	"unprognostic (4.54e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.58e-3)"	7.0	9.6	12.2	8.1	12.6	52.6	6.5	10.8	16.2	8.0	16.7	5.9	7.2	6.5	10.1	5.2	6.0	7.3	5.3	14.9	12.9	7.3	6.9	7.9	9.4	12.4	10.8	6.1	5.9	13.2	10.8	7.8	12.5	7.5	5.7	8.4	6.7	7.4	3.0	5.7	5.6	6.6	9.8	7.8	6.0	12.1	11.6	11.8	11.6	6.7	9.8	7.2	4.9	12.5	12.8	7.8	7.0	10.8	24.7	11.5	11.6	12.6	16.9	6.9	8.0	4.7	11.1	14.3	15.2	19.7	6.9	6.4	18.3	12.4	12.3	13.7	11.8	5.7	10.5	12.2	7.0	21.7	20.9	10.7	13.2	11.8	3.8	11.9	5.8	14.0	5.0	12.6	13.6	13.7	19.4	13.5	7.2	11.5	11.6	16.6	11.4	13.0	13.2	16.1	12.1	5.5	11.3	11.8	14.0	10.4	8.7	13.7	7.5	11.6	10.4	17.4	10.1	17.0	21.6	22.6	9.0	10.1	8.8	0.9	0.9	1.8	1.6	1.1	1.4	1.2	1.6	1.7	0.8	1.1	2.2	2.1	3.9	2.8	1.1	0.7	1.7	0.6	12.2	12.6	10.8	16.2	14.9	12.9	12.4	10.8	12.5	9.8	11.6	12.5	14.7	9.6	20.1	21.9	25.7	34.5	13.6	6.4	27.9	24.0	19.1	16.4	8.9	4.3	8.1	9.2	43.8	8.4	40.8	18.0	7.9	8.1	42.1	25.7	14.3	14.7	23.9	16.2	82.6	9.3	9.5	14.8	12.8	39.8	10.2	10.1	13.9	10.6	10.5	28.6	46.7	14.2	2.0	19.2	23.3	10.7	8.4	22.6	19.6	23.4	14.8	12.4	10.3	34.7	36.7	14.0	10.1	5.3	32.7	21.5	13.9	4.0	8.4	17.9	0.0	18.8	17.8	28.5	12.2	24.0	56.4	21.2	31.4	8.0	13.7	24.7
FBXO36	"Fbx36, FLJ37592"	ENSG00000153832	"F-box protein 36"	Q8NEA4	2	229922302-230013119	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5;Early spermatids: 61.7;Endometrial ciliated cells: 40.8;Respiratory ciliated cells: 53.0;Spermatocytes: 55.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 9.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053865			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli"		"HPA053865: AB_2682282"	"unprognostic (4.39e-3)"	"unprognostic (6.51e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.68e-1)"	1.9	3.7	4.6	0.7	4.2	0.8	3.5	4.3	4.5	3.0	3.9	1.2	1.4	2.5	2.8	1.6	11.0	1.7	1.2	3.7	4.4	5.1	1.6	2.3	0.9	5.8	5.6	2.4	1.6	4.3	2.7	1.6	5.1	2.9	1.2	9.0	2.3	2.5	0.8	3.0	1.4	1.7	5.4	0.8	1.7	6.0	4.4	1.5	7.4	0.8	1.0	1.3	1.5	5.1	1.0	1.9	2.3	0.9	1.1	6.8	4.6	1.2	3.2	1.7	2.9	0.7	3.1	0.1	0.6	2.2	2.1	0.8	1.1	0.6	2.9	0.3	0.7	0.4	0.6	1.2	4.4	0.8	0.3	7.2	5.2	3.2	2.4	2.2	1.8	3.4	1.4	0.6	2.0	4.2	1.7	1.9	6.1	2.2	2.2	2.0	0.6	0.5	3.0	0.8	2.2	2.8	2.0	1.6	0.8	2.6	3.4	1.4	1.3	2.8	1.0	4.6	0.5	2.1	1.8	0.7	3.4	0.4	2.1	0.0	0.5	0.0	0.8	0.4	0.6	1.1	0.6	0.6	1.3	0.7	1.4	0.8	0.2	1.0	0.3	0.6	1.2	0.5	4.6	4.2	4.3	4.5	3.7	4.4	5.8	5.6	5.1	5.4	4.4	5.1	3.1	9.6	1.1	11.4	1.1	3.8	2.9	8.3	1.2	8.3	4.3	4.3	3.7	0.0	9.9	11.0	35.5	1.9	0.6	2.3	15.6	6.2	61.7	40.8	4.9	2.3	0.0	2.5	19.5	6.6	2.0	3.7	3.1	4.7	0.0	4.2	1.4	2.7	1.1	10.1	22.1	1.6	14.2	1.6	3.0	10.5	3.4	1.2	3.6	5.6	2.9	7.5	4.1	12.5	12.5	6.2	0.5	4.1	0.7	3.0	2.2	12.2	53.0	28.8	6.6	2.8	4.2	55.8	8.6	3.2	4.5	2.2	1.5	9.1	1.4	1.9
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: AB_2677484"	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	12.8	11.5	7.3	12.9	8.4	9.8	13.9	8.1	9.9	14.1	8.2	12.5	9.6	12.5	11.1	10.5	10.0	11.5	17.4	7.0	7.7	12.9	18.0	14.5	14.6	8.0	7.6	12.3	9.5	18.5	10.2	13.8	8.0	14.6	13.0	11.0	11.5	12.0	18.7	12.2	11.6	12.3	7.5	14.4	12.5	12.4	7.8	20.2	12.2	16.8	15.6	13.8	11.2	9.9	12.6	13.2	20.1	14.7	22.1	24.6	10.4	16.1	30.7	22.4	30.5	19.6	15.1	18.2	15.5	26.2	23.6	17.2	21.2	20.3	26.8	20.1	13.6	10.8	19.0	13.3	21.9	29.6	17.0	24.0	17.1	21.6	21.1	24.0	30.7	16.6	12.2	19.1	22.3	5.1	18.8	13.8	9.4	13.9	19.8	16.6	29.3	18.4	21.7	14.5	17.9	17.3	21.4	14.2	21.2	17.1	15.0	21.2	20.2	20.4	7.3	10.8	18.2	23.3	25.1	15.3	20.3	16.6	15.8	15.1	6.1	9.1	5.0	8.0	5.5	4.9	4.7	5.0	7.5	3.8	4.8	6.2	11.2	7.7	15.2	3.7	7.4	4.9	7.3	8.4	8.1	9.9	7.0	7.7	8.0	7.6	8.0	7.5	7.8	9.9	10.6	16.0	45.7	25.1	13.8	3.3	5.5	7.4	7.4	10.3	8.5	6.7	18.7	11.5	10.6	11.0	10.4	7.5	13.4	11.3	5.9	8.8	11.2	8.9	9.9	10.8	9.6	7.2	40.2	6.7	6.8	11.8	14.8	10.4	15.8	9.6	11.4	16.9	12.6	13.5	37.4	10.1	6.1	24.9	6.4	2.9	9.0	17.8	3.6	38.4	12.3	5.9	12.3	33.2	44.4	9.9	8.9	18.4	11.0	8.6	9.3	9.3	16.4	9.0	0.0	6.9	7.8	20.6	8.6	9.2	3.8	12.3	12.1	11.2	9.0	8.7
FBXO4	FBX4	ENSG00000151876	"F-box protein 4"	Q9UKT5	5	41925254-41941743	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003362			Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA003362: AB_2666918"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (8.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.39e-2)"	"unprognostic (8.27e-2)"	10.0	7.5	2.3	6.8	2.8	8.4	12.4	3.0	3.6	8.8	2.2	6.8	7.9	6.2	15.8	6.3	8.3	6.6	5.3	2.4	2.9	7.4	11.2	6.6	11.6	2.5	2.5	7.3	11.8	7.0	4.4	6.0	2.8	8.3	8.0	4.9	7.3	8.1	4.1	7.0	7.0	5.9	2.8	9.3	8.0	8.3	2.5	11.1	12.7	4.9	12.5	6.3	5.5	3.3	9.0	6.5	1.2	16.4	8.5	13.9	9.6	7.4	13.9	12.3	16.8	3.2	23.9	22.6	9.7	10.5	2.8	2.3	3.9	2.5	10.3	8.0	1.5	11.5	22.8	8.2	16.6	19.4	7.4	8.4	5.4	6.3	23.6	4.6	9.4	10.2	10.8	7.1	14.4	3.6	12.6	3.9	0.5	12.9	5.4	2.3	2.5	5.9	8.5	8.7	2.5	4.8	29.0	2.3	11.2	0.6	14.6	22.2	6.8	13.9	3.8	9.3	5.9	10.7	9.8	1.6	13.9	21.7	7.2	2.9	5.4	1.3	8.9	8.7	10.2	12.5	9.7	9.4	10.6	12.0	9.8	9.2	0.4	9.4	20.1	9.4	8.4	7.3	2.3	2.8	3.0	3.6	2.4	2.9	2.5	2.5	2.8	2.8	2.5	3.3	12.3	9.6	11.9	12.1	18.5	12.6	13.3	20.1	13.6	6.1	14.8	10.7	3.7	15.7	9.6	11.0	0.0	26.4	11.4	2.9	11.7	13.7	0.7	12.9	12.0	10.2	1.8	20.4	14.7	16.0	27.9	13.1	9.7	13.7	5.1	12.9	16.1	17.6	16.3	3.3	15.6	10.8	12.2	6.5	12.3	1.5	10.5	10.0	19.6	5.6	5.8	8.7	8.2	25.1	26.7	9.8	6.8	10.5	17.4	5.1	9.7	24.8	14.7	8.7	6.6	11.4	18.9	24.9	23.8	15.8	14.2	12.4	12.7	16.5	10.5	9.4
FBXO41	"Fbx41, KIAA1940"	ENSG00000163013	"F-box protein 41"	Q8TF61	2	73254682-73284478	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.9;Enteroendocrine cells: 12.0;Excitatory neurons: 28.8;Inhibitory neurons: 22.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 21.2;basal ganglia: 31.0;cerebral cortex: 42.3;hippocampal formation: 29.6;white matter: 24.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055246, HPA058386"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA055246: AB_2682758, HPA058386: AB_2683701"	"unprognostic (1.15e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.74e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (7.97e-3)"	"unprognostic (7.55e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-2)"	1.3	3.0	21.2	4.6	31.0	3.3	1.5	7.2	42.3	1.7	0.0	1.8	1.4	1.6	2.3	1.3	1.7	1.7	1.0	29.6	4.6	1.1	0.4	1.5	7.7	4.2	3.8	2.5	3.7	5.5	13.9	0.5	4.6	2.6	1.4	3.1	2.6	2.0	0.1	2.3	5.3	1.2	1.1	9.1	1.8	2.3	5.4	5.5	1.2	0.1	6.9	1.5	1.4	24.8	6.4	3.1	1.0	0.0	0.3	0.2	1.4	1.2	1.0	2.0	2.5	7.2	3.6	46.6	0.2	0.2	4.5	5.1	6.5	4.1	2.0	19.4	0.6	14.5	8.0	3.0	1.5	22.2	10.4	2.5	1.6	0.1	1.6	5.6	0.3	12.7	2.9	7.6	2.1	1.7	7.7	20.4	4.7	2.4	2.7	25.4	11.7	23.2	1.3	2.2	15.7	5.8	8.0	3.3	5.0	0.3	4.5	9.2	0.4	7.0	5.9	6.4	1.2	8.5	3.9	22.1	1.8	23.7	3.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	21.2	31.0	7.2	42.3	29.6	4.6	4.2	3.8	4.6	1.1	5.4	24.8	0.3	0.0	0.6	2.6	5.1	0.3	0.3	1.0	1.2	13.9	1.8	1.4	2.1	1.5	0.3	1.8	0.0	0.0	3.4	0.5	0.0	0.5	0.2	0.3	2.5	0.4	12.0	0.0	28.8	2.5	0.1	2.1	0.0	1.1	2.5	2.1	0.7	0.0	1.9	6.7	22.4	0.4	2.0	4.7	1.1	1.5	0.3	3.2	1.8	7.5	2.6	0.9	2.1	5.5	0.9	1.1	0.3	0.7	3.6	0.8	0.1	0.3	1.1	2.3	0.0	0.3	0.7	1.3	2.4	0.5	0.3	0.0	3.1	5.4	0.8	0.2
FBXO42	"Fbx42, KIAA1332"	ENSG00000037637	"F-box protein 42"	Q6P3S6	1	16246840-16352480	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025071	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA025071: AB_1848461"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (3.22e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.78e-3)"	"unprognostic (3.91e-2)"	14.1	12.6	17.4	8.8	16.4	9.3	12.9	20.0	18.0	21.7	14.7	15.1	7.6	19.8	12.9	18.2	18.6	11.8	16.9	16.5	17.6	11.8	14.2	13.6	12.5	16.9	16.3	18.2	15.3	14.0	16.2	12.1	17.8	19.3	10.6	16.7	13.5	15.0	22.6	28.1	11.1	17.9	14.9	13.7	12.1	11.6	16.8	18.1	14.6	22.3	14.3	18.9	17.9	16.4	15.4	8.2	19.4	19.8	23.1	15.0	8.5	15.6	23.5	22.0	21.4	7.7	13.9	16.2	13.6	21.7	15.1	13.6	19.8	14.8	17.9	18.7	9.3	15.2	12.5	8.8	27.5	18.1	19.0	16.1	33.5	19.4	27.8	20.0	22.3	20.0	16.5	22.1	15.8	10.5	17.5	15.8	8.5	20.3	9.2	19.6	11.9	14.5	14.8	4.3	18.3	12.0	17.6	14.6	18.8	17.7	11.9	14.0	14.0	11.1	9.8	18.4	12.3	10.9	11.9	16.3	14.7	23.5	15.6	9.0	11.8	18.5	11.7	16.3	8.7	8.5	8.7	7.5	14.0	14.1	9.8	8.7	10.5	12.4	12.7	6.1	12.4	7.9	17.4	16.4	20.0	18.0	16.5	17.6	16.9	16.3	17.8	14.9	16.8	16.4	9.2	12.8	11.8	47.0	16.0	25.9	6.1	13.5	22.2	21.7	7.1	7.1	20.6	15.7	9.4	12.9	45.9	11.0	16.6	6.7	0.0	8.5	9.4	21.7	15.5	9.9	10.7	10.8	63.9	7.6	15.6	14.7	11.7	33.1	2.5	12.8	9.7	9.6	13.8	28.6	65.9	5.6	10.2	15.1	28.1	10.2	14.9	13.4	1.8	35.6	19.2	11.0	15.5	60.8	53.0	8.4	7.6	11.3	17.7	10.4	8.8	3.8	6.4	20.4	13.1	23.1	13.4	13.5	9.7	18.9	34.7	26.3	16.0	9.8	8.3	5.5
FBXO44	"FBG3, FBX30, Fbx44, Fbxo6a, MGC14140"	ENSG00000132879	"F-box protein 44"	Q9H4M3	1	11654375-11663327	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 144.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 48.2;Inhibitory neurons: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003363	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA003363: AB_1078831"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (2.63e-4)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.29e-5)"	"unprognostic (1.34e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.02e-3)"	19.1	37.1	114.2	12.5	118.5	8.2	26.9	112.6	144.5	38.8	76.3	26.8	19.9	20.9	13.4	23.7	32.4	14.5	35.1	120.6	105.3	58.7	39.9	22.3	25.2	108.1	99.8	32.0	41.4	45.5	90.5	3.1	105.1	54.5	4.2	18.0	35.2	19.4	11.4	42.7	27.6	7.9	89.2	38.6	30.1	29.0	111.1	10.1	50.2	8.8	14.0	26.1	36.8	115.6	14.9	23.3	8.2	31.6	11.8	12.4	10.9	11.0	13.9	12.1	10.7	17.0	26.6	0.3	25.7	12.4	20.6	3.3	16.5	37.4	5.0	16.1	21.1	0.4	14.0	27.9	16.2	0.2	2.0	15.9	24.7	11.4	8.7	24.9	9.6	27.4	8.5	3.5	3.1	8.8	24.2	2.4	8.7	12.9	16.5	9.8	0.1	4.8	19.7	5.2	24.8	20.7	29.7	11.3	51.1	10.1	20.4	12.9	12.1	8.8	21.4	12.2	9.1	23.1	13.9	9.3	19.7	5.9	21.0	1.8	2.3	0.7	13.0	2.7	10.0	11.0	8.6	9.8	3.8	11.5	11.6	7.9	1.8	1.8	3.0	5.7	8.6	7.4	114.2	118.5	112.6	144.5	120.6	105.3	108.1	99.8	105.1	89.2	111.1	115.6	3.4	0.0	7.4	27.1	18.3	18.4	12.5	20.1	25.0	21.5	15.7	18.0	4.3	8.6	10.1	16.5	14.6	1.3	18.3	1.2	31.3	7.8	4.5	2.3	4.4	4.3	4.2	1.3	48.2	6.5	2.5	12.3	7.7	2.1	3.8	10.7	8.6	5.4	6.1	40.4	50.1	1.9	14.2	5.3	11.4	13.7	23.0	5.8	10.6	6.5	4.7	15.6	16.5	22.1	18.2	7.0	1.7	29.0	9.7	10.8	1.7	11.9	5.4	7.2	0.0	6.4	6.6	11.1	6.7	7.6	17.0	0.8	18.2	4.5	2.9	5.9
FBXO46	"20D7-FC4, Fbx46, FBXO34L"	ENSG00000177051	"F-box protein 46"	Q6PJ61	19	45710629-45730896	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HeLa: 84.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049390	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Vesicles"	Cytosol	"HPA049390: AB_2680742"	"unprognostic (9.02e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (9.33e-2)"	"prognostic favorable (5.44e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.13e-2)"	"prognostic favorable (8.11e-4)"	"unprognostic (9.77e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (5.09e-6)"	7.5	7.2	10.6	11.1	11.0	9.2	8.9	9.5	12.6	13.5	18.4	11.7	7.6	13.6	7.5	21.4	10.3	5.1	8.5	8.8	12.2	7.9	10.5	7.4	14.7	8.7	9.6	14.1	9.6	5.8	9.4	6.6	11.5	9.8	7.5	9.9	10.1	5.3	11.4	13.4	11.1	6.3	6.0	14.4	10.8	12.3	9.9	11.1	10.4	5.4	13.9	9.3	13.0	20.9	14.0	21.5	16.2	18.9	4.1	7.3	18.3	7.1	4.0	5.6	6.5	17.8	17.9	24.1	9.5	4.0	7.9	19.9	12.1	9.1	4.2	30.0	25.5	19.6	84.1	9.8	6.2	8.7	24.2	6.1	8.1	9.5	5.9	14.0	8.4	29.4	15.6	28.4	4.6	13.2	20.3	10.2	10.2	13.0	7.3	27.3	9.0	22.6	6.7	16.3	16.1	14.1	11.4	23.7	9.4	15.3	20.1	10.7	9.6	11.8	10.6	6.5	12.0	27.2	41.0	16.1	13.1	12.3	9.8	4.6	1.1	1.2	1.8	0.9	1.2	2.1	1.3	1.3	0.8	3.8	1.2	1.4	3.3	0.6	1.2	1.3	1.4	0.7	10.6	11.0	9.5	12.6	8.8	12.2	8.7	9.6	11.5	6.0	9.9	20.9	4.8	9.6	4.8	6.2	6.5	26.0	10.0	5.7	9.1	3.3	12.7	8.5	5.4	10.0	6.1	7.3	2.1	7.9	3.4	16.3	1.9	6.5	2.9	8.0	5.1	5.2	7.3	5.9	6.5	4.9	19.0	3.6	6.1	9.2	3.8	11.4	4.2	21.1	3.7	11.8	5.5	12.7	0.0	5.7	8.8	3.1	5.6	3.3	5.4	5.6	5.6	4.0	7.2	4.0	6.1	6.9	12.2	1.9	5.5	8.0	6.3	2.2	7.2	3.4	0.0	3.6	4.7	6.5	4.6	13.3	35.8	12.4	5.1	4.9	9.3	11.1
FBXO5	"EMI1, FBX5, Fbxo31"	ENSG00000112029	"F-box protein 5"	Q9UKT4	6	152970519-152983579	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.1;lymphoid tissue: 27.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.0;Extravillous trophoblasts: 30.5;Spermatocytes: 32.3;Spermatogonia: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008106, HPA029048"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB008106: AB_828450, HPA029048: AB_10602132"	"unprognostic (1.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.43e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.25e-9)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-1)"	3.1	3.1	1.5	7.3	1.6	44.1	4.5	2.6	2.1	4.0	1.9	5.0	4.6	5.3	4.5	3.7	3.0	2.6	1.8	1.4	1.7	3.1	4.4	3.4	14.9	1.6	1.6	4.1	3.0	2.3	2.1	6.3	1.7	3.0	5.1	3.3	2.7	2.9	0.9	4.3	4.3	5.0	1.6	5.5	4.6	3.9	1.8	27.3	4.4	2.6	14.6	4.0	3.0	2.0	33.7	17.2	70.8	48.1	5.3	10.8	22.6	79.9	35.5	58.7	65.6	35.6	19.8	81.6	23.9	21.3	39.7	31.4	56.4	26.7	70.0	44.2	50.6	82.3	24.1	38.7	10.2	74.4	48.6	7.7	4.9	39.8	30.9	14.3	27.3	42.3	88.2	74.5	53.9	25.7	85.2	47.6	41.5	25.8	25.0	71.0	56.8	52.8	20.8	18.0	46.1	47.9	56.6	30.2	15.6	24.7	21.8	68.7	20.6	43.9	57.4	51.1	94.8	24.9	29.5	120.4	31.9	54.3	54.2	0.0	1.9	0.0	2.8	2.5	4.0	5.1	4.7	5.2	3.7	5.0	4.6	4.8	0.0	7.1	3.2	4.3	6.6	2.5	1.5	1.6	2.6	2.1	1.4	1.7	1.6	1.6	1.7	1.6	1.8	2.0	6.0	0.0	1.1	1.3	9.8	9.9	3.7	4.0	7.4	3.2	5.7	5.2	1.8	2.8	3.9	1.8	6.2	15.2	13.5	2.6	3.9	3.0	0.4	2.3	10.5	5.7	4.8	36.0	1.0	1.6	30.5	9.1	7.7	4.0	2.5	16.6	5.0	1.9	7.9	1.7	0.9	6.1	2.0	3.2	6.1	0.1	4.4	5.3	1.8	1.9	4.2	4.1	9.2	1.5	2.1	1.5	0.5	6.0	24.7	3.6	1.5	3.6	1.9	3.6	13.1	8.6	8.9	32.3	26.1	10.2	5.3	5.9	7.9	8.0	6.3	2.0
FBXO7	"Fbx, FBX7, PARK15"	ENSG00000100225	"F-box protein 7"	Q9Y3I1	22	32474676-32498829	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 279.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 680.9;Late spermatids: 620.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032113, HPA032114, CAB034296"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		550000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"CAB034296: AB_2102563, HPA032113: AB_2674156, HPA032114: AB_10696202"	"unprognostic (3.99e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.66e-10)"	"unprognostic (3.33e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.79e-3)"	51.6	61.7	70.3	35.9	86.8	279.9	52.9	79.9	86.5	53.5	72.3	53.5	47.7	49.2	68.7	40.1	66.6	43.9	38.5	68.3	76.2	106.5	128.4	59.6	54.6	85.0	83.8	62.7	41.0	75.9	50.6	71.5	84.1	42.6	53.8	40.1	43.1	53.5	31.0	50.6	48.4	57.1	79.0	65.6	48.4	99.5	79.8	77.9	134.2	48.3	61.8	54.8	44.0	97.8	72.1	52.1	69.3	77.1	105.8	99.5	45.9	64.3	119.6	102.7	121.9	54.4	51.1	71.2	49.6	114.6	87.8	47.6	103.3	84.7	105.1	111.8	80.9	99.1	54.4	83.7	126.8	126.2	82.8	83.8	134.1	90.6	69.2	93.4	112.2	53.1	77.5	88.0	112.7	57.7	65.3	81.2	26.7	102.3	36.1	64.1	72.2	84.0	118.2	81.0	96.6	63.1	81.3	62.4	235.2	98.3	34.0	67.2	76.0	50.6	69.4	48.4	49.5	62.1	69.3	67.6	97.4	65.6	212.3	251.5	59.9	132.1	83.3	70.6	101.5	70.2	75.9	84.9	82.2	63.6	65.6	72.6	22.4	98.3	74.9	55.8	101.3	90.4	70.3	86.8	79.9	86.5	68.3	76.2	85.0	83.8	84.1	79.0	79.8	97.8	48.8	41.7	25.3	37.9	60.4	46.3	69.4	72.7	48.9	26.0	46.5	32.3	16.1	65.8	48.1	49.7	18.8	90.2	73.6	43.4	97.8	75.3	303.3	41.3	37.8	53.1	67.6	680.9	27.6	77.4	108.9	47.9	40.2	47.2	55.8	63.6	53.9	88.6	71.9	33.7	26.7	42.7	65.1	64.8	53.2	620.8	45.1	55.0	119.2	28.1	125.2	54.1	72.1	101.0	170.6	77.2	58.0	48.9	62.7	68.3	72.2	152.9	34.2	38.1	46.0	35.3	46.2	149.4	136.9	42.3	43.3	71.6	62.3	41.8	47.2	83.7
FBXO8	"FBS, FBX8"	ENSG00000164117	"F-box protein 8"	Q9NRD0	4	174236658-174283667	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002885	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA002885: AB_1078835"	"unprognostic (8.17e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (1.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-1)"	15.7	18.6	13.8	10.5	15.3	10.2	17.8	15.7	17.5	14.3	13.8	18.4	16.3	12.5	19.9	17.0	15.5	15.5	21.2	13.5	16.6	22.9	47.5	14.0	12.9	15.8	14.7	17.0	14.2	21.2	14.2	30.9	16.1	14.7	16.1	17.8	15.2	12.6	6.7	16.1	16.4	16.3	15.1	13.0	15.0	11.2	14.8	15.8	22.2	10.1	12.6	16.0	13.7	17.8	10.0	6.3	12.3	4.3	31.5	33.2	9.8	18.8	19.2	13.3	13.6	5.2	19.9	6.9	19.5	15.7	12.2	6.7	9.2	11.7	13.8	22.5	20.9	7.2	10.4	7.4	23.5	8.5	7.5	19.1	24.5	12.9	13.4	20.5	13.4	8.0	14.9	40.5	18.3	7.9	9.8	8.6	4.4	15.4	7.6	4.9	8.2	12.5	17.8	4.1	13.9	80.8	8.7	16.1	22.4	11.8	11.0	11.0	17.0	9.1	7.3	23.5	11.3	18.5	9.7	6.2	25.2	6.4	13.0	29.4	6.5	14.0	12.1	8.4	15.2	13.2	13.7	12.1	9.0	11.9	12.7	11.6	6.6	10.5	10.0	9.1	16.6	8.4	13.8	15.3	15.7	17.5	13.5	16.6	15.8	14.7	16.1	15.1	14.8	17.8	18.9	3.2	10.0	6.5	15.8	20.6	17.0	26.0	19.4	13.2	16.9	11.4	10.8	15.7	19.5	22.0	6.2	36.6	10.1	20.3	50.9	19.0	20.5	24.9	13.2	15.8	12.1	11.2	10.1	10.9	60.6	32.7	14.8	16.3	2.5	5.3	21.0	58.1	21.2	18.5	13.0	21.5	28.5	19.6	8.2	5.5	17.4	12.2	10.6	11.2	16.3	29.1	9.2	9.0	17.8	12.4	21.4	26.4	9.1	16.8	21.5	44.6	26.2	18.1	13.1	14.9	18.4	34.7	17.6	19.8	31.4	89.6	14.3	10.3	13.7	22.7
FBXW10	"C17orf1, C17orf1A, Fbw10, HREP, SM2SH2"	ENSG00000171931	"F-box and WD repeat domain containing 10"	Q5XX13	17	18744026-18779349	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 9.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 44.4;Late spermatids: 16.1;Respiratory ciliated cells: 5.3;Spermatocytes: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.0;CAPAN-2: 1.1;HaCaT: 1.5;HeLa: 1.4"					"Low region specificity"	"Detected in all"			HPA047457			Approved	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA047457: "	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.08e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.20e-7)"	"unprognostic (3.16e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.05e-1)"	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.3	0.1	0.1	0.2	0.0	0.6	0.2	0.5	0.2	0.0	0.1	0.1	0.3	0.9	0.3	0.0	0.2	0.4	0.0	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	9.7	0.1	0.0	0.8	0.1	0.0	0.1	0.1	0.1	0.1	2.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.2	0.0	0.6	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	44.4	0.2	0.1	0.4	0.0	0.0	1.2	0.0	0.0	0.1	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	16.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	0.4	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.2	0.1	9.8	0.7	0.4	0.1	0.0	0.0	2.9	0.0	0.1
FBXW11	"BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696"	ENSG00000072803	"F-box and WD repeat domain containing 11"	Q9UKB1	5	171861549-172006873	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072204	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA072204: AB_2686493"	"unprognostic (4.04e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.76e-1)"	19.5	20.4	33.3	13.6	38.2	8.2	17.0	34.7	41.6	19.9	27.4	14.6	12.6	22.9	12.4	24.2	27.0	17.5	36.1	38.0	35.5	23.0	20.7	17.6	16.7	33.3	34.4	25.6	29.1	33.1	14.2	13.9	33.1	19.0	16.0	37.2	13.5	20.3	34.5	13.7	13.2	26.1	34.4	18.1	20.0	14.3	37.7	17.3	21.1	35.6	22.0	19.2	15.8	42.4	35.4	35.6	52.0	45.2	39.9	40.2	26.4	37.1	51.7	45.0	54.9	36.7	23.1	32.5	44.3	46.4	72.0	22.8	37.6	56.3	74.6	42.7	37.3	26.2	35.0	28.5	35.4	29.8	36.0	28.5	38.2	36.8	59.8	48.5	38.6	27.3	16.6	31.7	55.7	26.5	20.7	15.3	19.8	20.8	39.5	30.1	43.7	22.0	34.8	29.2	21.6	37.2	32.9	27.3	70.8	38.7	34.2	31.0	33.8	44.3	22.0	27.4	37.2	31.8	38.9	22.2	31.3	27.8	34.6	25.4	7.3	7.2	5.8	5.1	6.1	8.5	4.8	5.7	7.3	8.4	4.3	5.7	7.1	14.1	5.7	8.6	5.7	6.6	33.3	38.2	34.7	41.6	38.0	35.5	33.3	34.4	33.1	34.4	37.7	42.4	35.4	25.6	21.2	75.4	52.7	19.1	15.6	21.8	32.5	43.5	26.4	22.1	59.1	42.9	20.8	27.6	8.4	8.5	49.8	25.1	43.0	33.7	32.9	42.0	47.9	26.3	28.8	27.4	86.5	36.9	7.8	24.7	38.2	51.0	20.8	25.8	29.3	43.1	12.8	35.3	85.3	21.6	20.3	29.6	25.3	34.3	29.5	26.6	12.4	62.8	24.6	63.6	16.5	75.9	94.4	54.1	14.9	28.6	36.5	30.2	21.5	52.4	17.1	34.3	46.0	28.2	33.5	34.5	16.0	28.7	23.7	12.0	28.8	17.2	15.0	32.9
FBXW2	"FBW2, Fwd2, Md6"	ENSG00000119402	"F-box and WD repeat domain containing 2"	Q9UKT8	9	120751978-120793416	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 177.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067878	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA067878: AB_2685913"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (1.38e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.83e-2)"	23.7	21.7	10.0	21.0	10.3	37.4	20.1	10.5	10.6	21.7	11.7	18.0	16.7	19.9	15.4	21.3	16.5	14.7	23.5	11.8	10.9	18.0	22.2	23.1	22.1	9.5	10.5	16.9	18.5	22.7	13.0	17.4	9.4	18.4	19.8	15.2	19.0	18.8	16.1	21.4	16.0	22.7	9.5	22.5	18.7	17.7	12.2	26.3	19.9	21.7	25.3	22.4	16.7	11.4	30.1	37.3	27.5	46.5	50.7	41.4	25.4	39.5	45.1	42.7	41.3	29.8	35.4	44.9	20.4	51.8	43.1	64.4	39.9	39.4	53.0	60.6	17.2	29.1	64.8	43.5	28.6	65.6	38.6	30.3	47.9	47.2	50.0	40.1	50.8	45.7	39.4	47.5	37.4	48.2	47.3	19.6	41.0	50.8	35.3	36.1	43.8	45.1	29.5	33.5	21.9	33.0	55.3	40.6	29.5	32.2	66.5	18.7	38.1	36.3	28.9	59.3	49.6	34.1	74.2	38.5	38.4	28.7	38.1	15.3	12.0	17.2	17.3	11.4	13.1	10.0	12.3	16.3	11.0	6.2	10.0	13.8	12.4	15.5	13.7	9.6	13.0	9.8	10.0	10.3	10.5	10.6	11.8	10.9	9.5	10.5	9.4	9.5	12.2	11.4	32.3	25.6	56.9	17.3	17.6	22.7	26.4	27.3	13.1	20.0	23.5	16.6	21.9	12.8	28.7	11.0	12.5	18.5	50.9	27.1	21.5	27.1	38.8	14.5	22.7	31.9	27.6	24.0	34.0	34.0	29.2	23.2	28.1	17.8	15.8	27.2	33.5	33.9	25.2	33.7	29.0	19.0	28.5	25.0	30.0	177.2	26.4	21.7	48.0	23.4	38.0	16.5	36.0	27.6	37.0	32.5	19.4	35.7	24.5	34.9	22.7	24.7	21.0	25.1	6.6	20.4	36.1	40.5	53.7	21.9	32.0	17.8	31.2	31.0	23.2	28.1
FBXW7	"AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10"	ENSG00000109670	"F-box and WD repeat domain containing 7"	Q969H0	4	152320544-152536092	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.9"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 201.8;Excitatory neurons: 529.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013793, CAB029987"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB013793: AB_2533451, CAB029987: AB_2246842"	"unprognostic (3.32e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.32e-3)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.17e-3)"	14.2	9.5	37.9	15.0	43.1	19.8	14.2	54.3	66.9	8.7	6.7	9.5	7.8	8.6	24.3	14.3	15.6	9.2	24.7	48.2	23.0	6.7	11.2	11.4	16.1	17.1	20.9	9.1	12.8	7.8	9.2	9.4	18.1	7.8	10.3	18.0	11.8	7.5	26.0	63.1	10.4	9.1	11.8	16.2	13.0	22.8	29.4	14.7	10.3	19.7	20.3	11.9	10.7	47.4	9.8	8.0	19.1	14.2	12.2	9.4	16.2	13.4	12.9	8.5	8.1	15.7	12.0	24.7	3.9	13.7	6.5	5.2	16.9	30.9	12.1	16.2	8.0	11.9	10.7	10.9	12.7	29.2	10.6	14.8	45.7	15.2	24.4	8.4	15.2	20.5	19.2	25.7	10.8	13.7	34.9	10.6	9.7	8.0	6.1	32.2	8.0	5.3	9.8	17.0	12.7	10.2	8.5	11.3	7.5	21.6	6.4	12.6	15.6	11.3	12.6	5.4	8.2	79.0	47.5	24.4	9.4	9.2	8.3	23.5	2.7	1.6	4.0	3.0	2.7	2.8	3.1	2.7	1.6	1.8	3.4	2.5	4.8	7.1	2.2	2.1	2.9	1.3	37.9	43.1	54.3	66.9	48.2	23.0	17.1	20.9	18.1	11.8	29.4	47.4	29.5	9.6	22.9	80.0	48.1	201.8	36.5	29.9	120.1	74.9	32.1	30.9	61.8	12.8	15.1	9.2	31.3	10.9	54.7	22.2	3.9	14.3	17.4	37.7	37.3	36.1	14.5	30.1	529.6	13.5	39.9	27.2	21.4	61.6	15.8	19.1	17.9	18.3	10.5	11.8	186.5	16.4	32.6	18.8	47.0	10.2	15.2	33.7	28.4	172.4	28.0	37.0	35.0	102.5	99.8	18.7	18.2	11.3	174.5	36.3	8.9	7.5	11.9	41.4	13.1	33.2	25.5	74.1	87.2	57.0	174.9	31.2	46.2	18.7	14.9	70.5
FCF1	"Bka, C14orf111, CGI-35, UTP24"	ENSG00000119616	"FCF1 rRNA-processing protein"	Q9Y324	14	74713144-74738620	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 104.7;Smooth muscle cells: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA046681	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA046681: AB_10960541"	"unprognostic (1.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (5.54e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (7.79e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.47e-1)"	32.5	23.1	9.9	25.4	12.7	27.0	34.9	12.7	13.0	30.5	11.5	28.6	18.9	29.2	20.9	24.9	38.4	22.0	26.8	9.4	12.1	30.1	32.8	27.9	34.4	12.5	12.7	39.9	16.5	26.6	12.9	32.1	12.8	28.2	29.3	13.2	19.9	30.6	25.3	17.3	20.5	30.2	11.3	23.5	23.0	18.4	11.4	33.2	43.3	22.4	41.3	29.2	19.0	17.4	109.3	78.7	55.8	63.5	86.8	76.3	73.5	93.6	71.7	91.4	81.2	88.1	87.3	97.2	59.6	82.1	44.2	78.5	94.1	88.5	160.7	90.6	40.8	67.4	46.4	57.9	62.6	83.1	59.5	60.3	76.6	97.3	101.4	72.4	86.6	82.7	82.2	56.9	83.3	77.5	97.0	29.6	75.0	63.2	90.5	72.9	109.5	46.3	46.4	88.1	39.1	56.9	120.1	62.8	55.0	61.4	80.7	57.0	79.9	72.7	77.6	69.5	108.3	49.9	140.7	147.7	69.2	77.5	82.5	13.5	17.0	20.5	19.1	15.3	21.0	24.3	18.4	16.6	13.9	21.2	19.5	20.5	14.7	15.3	18.8	31.3	19.6	9.2	9.9	12.7	12.7	13.0	9.4	12.1	12.5	12.7	12.8	11.3	11.4	17.4	11.9	6.4	18.3	7.5	18.8	3.1	7.6	10.5	11.4	7.5	12.2	7.5	24.0	34.3	14.9	12.9	6.2	11.8	26.6	16.3	15.6	17.4	23.8	28.0	18.5	13.7	10.2	36.2	11.6	19.0	14.7	13.3	6.1	13.5	26.0	9.3	28.5	104.7	12.8	11.8	11.7	15.9	8.2	33.6	4.3	11.9	15.5	12.6	0.0	7.5	16.4	13.5	24.7	11.6	17.5	17.4	10.3	17.0	12.0	6.1	13.1	18.4	45.4	7.2	13.1	12.5	67.7	12.4	12.3	11.1	4.8	8.8	14.3	8.2	15.6	6.7
FCHO1	KIAA0290	ENSG00000130475	"FCH and mu domain containing endocytic adaptor 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.5;lymphoid tissue: 24.3;skin 1: 22.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 16.8;dendritic cells: 19.1;Oligodendrocytes: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 62.4;RPMI-8226: 43.3;U-937: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	1.8	24.9	14.7	33.7	20.2	1.5	21.7	32.6	1.0	8.6	2.5	3.2	1.3	1.4	1.1	1.5	4.2	0.8	24.1	25.6	1.4	2.2	3.7	24.3	27.5	28.6	1.7	0.7	1.1	3.9	1.1	29.7	1.0	2.2	3.4	1.3	0.8	0.6	22.2	8.1	1.7	19.9	15.5	3.4	4.4	29.2	17.6	1.0	0.8	17.4	3.0	1.0	59.5	0.9	11.9	7.5	5.2	0.2	0.2	7.5	1.1	0.3	0.3	0.5	1.5	1.4	62.4	17.1	0.5	1.4	2.3	3.7	2.3	0.2	27.6	2.1	4.9	1.4	6.4	0.6	15.7	10.2	0.1	0.3	0.0	0.4	0.4	1.6	30.2	24.9	28.9	0.0	17.4	36.2	27.8	3.6	14.7	28.7	30.2	0.2	43.3	0.2	1.2	1.3	2.5	0.3	5.9	0.9	0.9	6.0	15.4	1.3	0.1	4.1	0.9	0.4	18.2	9.0	33.4	0.9	38.5	0.5	13.2	9.6	10.1	7.0	14.3	6.0	12.4	7.9	6.3	14.5	12.3	7.4	6.1	37.8	6.4	11.5	15.3	7.6	7.4	24.9	33.7	21.7	32.6	24.1	25.6	27.5	28.6	29.7	19.9	29.2	59.5	0.4	0.0	1.5	0.7	16.8	0.0	0.4	0.2	0.6	7.8	2.0	4.3	0.9	2.8	0.4	1.8	0.0	2.9	19.1	2.0	0.0	0.5	1.5	0.8	0.2	2.4	1.2	2.5	15.0	0.0	4.6	2.5	1.5	1.0	9.5	2.9	2.5	0.0	6.8	0.0	13.0	1.7	0.0	8.7	14.3	0.7	2.5	11.0	1.8	6.5	12.3	0.1	13.4	3.0	46.9	2.1	0.5	8.6	4.5	0.3	0.1	0.1	0.7	0.8	0.0	0.2	0.6	0.9	5.5	0.2	0.6	0.8	9.8	12.2	1.8	0.3
FCHSD1	FLJ00007	ENSG00000197948	"FCH and double SH3 domains 1"	Q86WN1	5	141639302-141651418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 50.8"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043795	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	Cytosol	"HPA043795: AB_10963435"	"prognostic favorable (8.62e-4)"	"unprognostic (4.08e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.50e-3)"	"unprognostic (8.56e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (6.19e-6)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (4.12e-3)"	"prognostic favorable (1.21e-4)"	8.3	6.7	4.0	19.6	5.2	19.7	8.8	5.7	5.3	16.0	2.8	9.2	11.1	12.5	3.4	9.0	11.0	11.3	5.6	3.1	7.5	7.5	2.8	10.7	23.0	7.2	6.0	17.4	7.7	50.8	13.1	6.7	7.6	10.5	5.2	3.6	11.2	6.3	1.9	21.3	17.2	6.1	3.7	22.2	11.7	3.9	7.1	11.0	11.1	1.9	16.9	11.7	14.3	7.3	13.5	8.3	11.0	23.1	9.2	11.5	19.3	28.5	14.5	25.1	39.3	15.7	28.1	5.6	14.0	22.1	4.0	7.5	3.5	15.8	11.2	23.9	6.0	11.7	12.9	5.8	7.0	3.7	38.1	14.2	12.3	19.8	6.4	21.1	14.6	0.4	7.4	10.3	2.9	11.8	3.0	7.1	3.2	4.7	7.6	0.1	0.1	5.5	8.6	19.8	1.2	12.2	0.5	10.6	16.5	8.3	12.9	11.0	29.8	0.4	6.9	10.3	12.1	12.2	4.4	2.9	21.8	13.1	12.2	5.8	1.2	4.0	4.3	1.3	3.3	3.3	2.4	4.6	1.2	1.7	2.2	3.1	6.5	1.6	2.1	1.2	3.5	2.4	4.0	5.2	5.7	5.3	3.1	7.5	7.2	6.0	7.6	3.7	7.1	7.3	4.0	0.0	2.2	5.5	11.6	2.7	3.7	4.7	9.6	4.9	3.5	4.1	0.6	2.8	3.6	3.7	12.5	1.1	11.4	6.3	0.0	4.7	7.1	1.8	2.9	3.8	4.2	1.3	1.7	6.5	4.3	5.3	9.2	3.4	8.9	4.9	3.9	0.6	5.6	53.8	3.9	4.6	8.2	1.9	1.9	6.6	4.1	5.6	3.6	4.7	3.5	1.9	15.5	0.5	8.6	7.4	3.4	3.8	8.2	2.4	4.3	0.7	3.6	1.7	6.6	2.4	3.8	2.3	4.0	4.4	2.8	1.4	14.4	3.5	2.6	2.3
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206903317-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 65.5;lymphoid tissue: 180.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 262.3;dendritic cells: 43.5;NK-cells: 108.1;T-cells: 74.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"RPMI-8226: 171.4;U-266/70: 73.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003910	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA		5500000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA003910: AB_1078798"	"prognostic favorable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"	4.9	1.5	0.3	74.8	0.3	12.6	2.4	0.3	0.8	1.5	0.4	8.0	6.1	2.4	2.6	3.0	1.9	11.3	2.6	0.1	0.4	2.3	5.9	6.0	152.1	0.4	0.1	0.8	1.1	0.5	1.0	1.8	0.2	3.4	9.9	0.2	3.5	1.2	3.6	0.4	65.5	2.3	0.0	115.0	14.2	0.5	0.5	77.2	3.3	1.4	180.6	19.1	1.6	0.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.3	0.3	0.0	0.0	11.6	0.0	0.4	0.7	0.3	0.0	0.6	0.5	0.0	0.2	0.2	0.9	0.0	1.6	0.1	0.0	0.1	0.7	0.3	1.2	0.0	0.0	7.0	0.2	23.5	0.0	0.2	3.5	0.3	0.1	0.0	0.2	4.9	0.6	171.4	0.1	0.3	0.1	0.0	2.8	0.6	13.0	0.0	0.3	0.0	0.5	0.0	0.5	0.2	0.1	73.8	5.9	23.2	0.8	0.1	0.6	7.9	2.8	3.6	209.3	4.3	276.9	882.3	280.1	266.3	3.2	1057.5	483.2	336.0	56.0	218.8	4.3	13.7	687.7	416.6	0.3	0.3	0.3	0.8	0.1	0.4	0.4	0.1	0.2	0.0	0.5	0.6	1.3	0.0	3.9	0.0	262.3	0.0	4.9	0.0	1.2	0.0	3.5	3.0	3.6	5.7	1.3	0.0	0.0	0.1	43.5	0.9	0.0	1.7	0.2	0.8	0.7	1.7	0.0	8.4	0.0	2.9	0.1	3.4	4.1	0.9	0.0	0.6	4.6	1.4	4.4	0.0	0.0	0.6	0.0	5.7	0.0	0.4	0.3	8.1	0.0	0.0	3.6	0.0	108.1	0.0	0.0	1.2	0.3	0.0	30.5	2.9	0.1	1.0	0.7	0.0	0.0	0.2	2.9	0.1	2.3	1.7	0.0	0.0	74.9	0.0	1.9	6.8
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 355.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 927.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 1187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	73.5	188.2	48.2	66.5	50.4	69.5	68.8	60.1	58.8	63.4	51.1	88.7	167.2	57.5	73.0	142.5	57.4	39.8	72.2	49.9	64.6	78.0	355.7	86.1	76.1	71.1	62.5	45.0	75.7	67.9	40.4	72.5	77.5	56.1	102.9	45.9	82.6	42.7	60.9	107.1	81.1	66.0	53.6	59.3	81.5	42.0	55.0	72.6	46.8	66.7	102.3	47.0	76.8	55.0	293.9	156.2	561.5	204.4	128.7	467.7	199.6	136.8	268.1	213.6	344.2	255.4	677.7	222.3	323.6	120.6	506.9	319.1	338.9	1187.5	198.9	122.4	242.5	129.4	260.1	311.5	210.8	212.1	142.0	335.5	184.6	339.6	168.8	96.4	377.6	322.3	235.1	579.9	225.3	315.1	273.6	205.0	338.9	216.4	225.5	231.6	243.2	620.0	567.7	193.0	217.4	185.6	140.7	253.0	243.0	317.3	182.6	567.6	277.1	118.4	144.3	74.3	254.9	244.3	202.3	401.1	115.3	221.7	191.1	90.6	85.5	124.1	89.2	92.9	79.7	102.8	77.8	91.1	95.6	95.1	69.9	87.1	38.9	115.2	70.0	76.2	113.7	134.7	48.2	50.4	60.1	58.8	49.9	64.6	71.1	62.5	77.5	53.6	55.0	55.0	154.2	73.7	181.6	38.5	68.4	36.8	83.3	927.7	42.1	69.4	84.6	56.9	1.8	97.2	431.5	53.3	62.6	207.8	74.9	343.0	137.0	180.9	216.6	56.7	38.2	161.9	71.4	133.4	30.8	329.9	198.7	59.8	52.0	77.8	62.8	116.6	168.1	361.9	112.0	55.5	28.1	135.7	299.1	54.8	44.4	67.9	60.9	52.8	96.0	15.0	144.7	81.1	87.6	22.6	39.7	256.7	324.3	70.3	91.3	206.1	194.1	145.0	129.6	90.8	72.3	47.0	177.5	42.0	14.2	49.7	59.8	143.5	68.3	230.6	165.4	148.2
FDXACB1	"hCG_2033039, LOC91893"	ENSG00000255561	"Ferredoxin-fold anticodon binding domain containing 1"	Q9BRP7	11	111874056-111881243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.1;Late spermatids: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039012, HPA061375"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA039012: AB_10670916, HPA061375: "	"unprognostic (2.91e-2)"	"unprognostic (3.32e-3)"	"unprognostic (1.32e-2)"	"unprognostic (6.81e-7)"	"unprognostic (1.32e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.95e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.79e-2)"	1.1	1.9	0.9	1.9	1.0	2.0	2.1	0.8	1.2	1.7	0.7	1.4	1.6	1.4	2.4	1.1	1.5	1.0	0.9	1.0	1.2	1.5	1.6	1.7	3.1	1.0	1.0	1.5	1.5	1.6	0.9	1.2	0.9	1.2	1.7	0.7	0.8	0.9	0.7	2.7	1.5	1.1	1.0	2.4	1.0	3.1	1.2	1.7	1.3	0.8	3.2	1.6	0.8	1.1	1.4	1.9	2.1	5.3	2.0	1.8	1.2	1.1	1.2	1.2	1.2	2.4	3.1	5.5	2.7	1.0	1.5	4.3	2.6	2.5	2.7	6.9	1.1	6.1	1.1	1.8	1.2	6.4	5.3	1.5	1.5	1.7	2.2	1.0	2.2	6.5	4.4	6.4	2.3	1.8	6.0	6.2	1.4	6.0	2.7	3.6	1.6	6.5	2.8	2.5	1.0	1.6	1.5	3.2	1.4	1.2	4.5	3.9	1.7	2.5	2.7	3.0	2.6	3.6	5.5	14.1	1.6	9.1	3.7	0.3	2.3	1.5	5.0	3.7	6.5	4.6	4.4	4.4	3.8	3.8	6.5	7.5	0.7	4.8	3.0	3.6	2.5	3.7	0.9	1.0	0.8	1.2	1.0	1.2	1.0	1.0	0.9	1.0	1.2	1.1	2.2	6.4	0.6	0.7	3.1	0.8	1.3	4.2	1.2	3.0	1.6	1.4	1.6	0.0	3.0	0.0	0.0	3.4	1.3	1.2	5.9	2.5	37.1	1.5	1.2	1.8	2.4	0.8	1.0	3.3	1.9	1.3	1.1	0.9	1.3	2.2	2.2	1.8	4.0	1.7	1.3	1.4	4.1	1.3	1.2	14.2	3.1	2.0	0.0	1.9	2.2	3.2	4.1	1.0	1.2	2.1	0.5	0.4	1.6	1.9	0.9	2.3	1.6	2.5	6.6	1.1	1.2	7.5	9.1	1.0	1.3	2.2	2.6	3.8	1.6	0.8
FEM1A		ENSG00000141965	"Fem-1 homolog A"	Q9BSK4	19	4791734-4801273	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"skeletal muscle: 273.6;tongue: 121.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016565, HPA063622"			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA016565: AB_1848489, HPA063622: AB_2685063"	"unprognostic (4.62e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (6.18e-5)"	"unprognostic (3.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.70e-2)"	4.3	3.7	8.0	4.0	7.8	7.5	4.4	8.1	8.0	3.2	6.8	3.8	3.7	3.0	3.6	8.4	3.4	2.7	17.8	8.2	6.1	3.8	4.4	4.2	4.7	7.9	7.5	3.5	8.5	9.6	0.9	4.2	7.3	4.9	3.3	3.0	5.9	3.3	273.6	8.5	3.3	3.9	7.1	4.3	3.9	2.4	7.8	4.8	3.5	121.2	4.6	4.1	1.0	8.5	9.2	6.2	5.7	12.4	6.2	3.6	8.3	5.4	4.4	8.5	6.0	9.7	4.1	10.4	5.4	6.7	4.6	9.3	10.1	8.9	5.5	12.4	11.6	10.1	4.9	7.4	9.4	17.0	12.4	5.3	13.6	6.6	9.4	4.0	6.2	13.9	15.1	19.3	5.9	9.3	14.3	6.2	17.7	5.7	15.0	13.1	7.4	11.0	7.7	11.6	18.5	13.1	7.1	13.2	10.4	4.3	10.2	14.5	8.7	7.7	5.6	12.1	14.4	22.3	20.0	8.8	7.9	12.1	11.1	4.7	2.8	2.8	2.5	3.2	2.1	1.9	2.0	2.3	2.6	2.5	1.7	2.0	2.4	2.6	3.0	2.6	1.5	1.8	8.0	7.8	8.1	8.0	8.2	6.1	7.9	7.5	7.3	7.1	7.8	8.5	7.9	25.6	32.8	1.6	16.6	20.1	14.9	7.7	12.5	16.8	20.8	16.4	6.5	18.6	15.5	1.8	16.7	21.2	16.1	16.7	13.7	10.3	5.3	8.7	11.6	12.3	13.1	28.6	2.7	11.8	13.8	9.2	6.1	19.1	22.8	7.5	15.4	18.7	12.3	11.8	3.2	15.5	4.1	15.4	8.7	3.5	9.0	13.1	3.6	2.8	17.2	12.1	32.0	2.5	2.3	12.4	9.4	8.2	9.9	15.5	10.9	10.1	11.3	19.8	6.6	27.1	9.3	12.7	6.2	18.3	29.5	27.1	14.3	16.8	18.0	17.7
FEM1B		ENSG00000169018	"Fem-1 homolog B"	Q9UK73	15	68277745-68295862	"Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 835.0;Late spermatids: 289.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041920, HPA042192"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041920: AB_10796788, HPA042192: AB_10796574"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.67e-2)"	17.3	13.6	15.1	16.2	16.8	60.1	23.7	21.3	18.7	18.0	6.9	17.5	15.4	26.8	14.6	24.6	15.3	14.9	19.8	17.3	14.7	13.7	20.1	16.4	15.8	12.9	12.5	20.0	11.6	18.0	9.0	18.9	16.2	18.6	16.4	22.6	12.7	20.8	49.3	23.3	16.6	30.2	13.8	17.2	12.9	71.7	14.3	18.9	17.1	27.4	18.6	22.0	16.1	23.1	17.3	31.2	31.7	29.9	27.8	25.6	21.1	24.1	25.1	24.5	22.3	21.1	22.7	39.8	17.1	33.2	17.6	61.6	66.5	30.7	20.3	19.1	26.3	43.7	36.8	13.4	24.1	35.8	26.1	23.8	64.9	29.6	71.3	34.9	19.5	19.9	37.3	47.2	20.9	20.1	26.0	18.2	32.2	13.9	10.0	37.1	35.5	51.6	15.5	62.1	42.2	26.6	25.0	25.6	67.4	39.8	23.1	33.0	25.6	42.2	37.1	14.8	22.3	30.7	71.2	42.4	24.1	38.3	25.6	0.0	3.1	2.0	3.0	4.2	2.8	2.0	2.9	3.2	2.4	2.3	3.5	2.7	2.3	3.7	3.6	1.7	1.6	2.0	15.1	16.8	21.3	18.7	17.3	14.7	12.9	12.5	16.2	13.8	14.3	23.1	25.2	22.4	35.4	12.7	16.9	98.7	56.3	32.1	48.3	31.5	29.2	25.7	51.6	21.5	23.7	18.4	12.5	17.1	20.8	25.8	0.0	23.4	835.0	21.7	34.3	24.4	19.9	21.4	33.4	12.0	12.7	26.5	15.3	25.6	14.5	26.9	16.1	30.9	31.8	38.7	29.4	23.2	12.2	27.3	33.4	289.6	24.5	24.9	40.9	30.0	22.4	17.6	10.3	17.6	33.5	20.8	17.9	27.8	14.9	37.0	22.2	13.3	29.4	13.1	26.3	26.7	31.3	25.2	8.9	49.5	111.2	16.8	17.2	23.6	20.3	59.3
FEM1C	"EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785"	ENSG00000145780	"Fem-1 homolog C"	Q96JP0	5	115520908-115544775	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059919, HPA060977"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA059919: AB_2684161, HPA060977: AB_2684402"	"unprognostic (1.14e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	13.6	5.6	6.1	7.9	9.5	63.2	10.6	13.4	10.7	12.5	1.1	13.3	11.1	9.8	6.1	14.7	6.1	12.3	15.7	5.3	4.4	7.4	15.7	11.1	6.9	6.3	7.2	7.6	11.0	5.5	4.2	6.2	5.4	9.7	12.2	17.1	5.8	6.9	20.6	10.1	12.1	10.3	4.8	8.5	10.6	13.6	9.5	6.6	8.2	21.3	6.6	9.8	7.7	7.9	11.8	7.0	9.8	15.3	17.3	24.1	7.9	18.3	14.5	13.5	15.6	7.7	10.2	12.0	12.2	13.5	15.5	9.0	8.0	15.2	19.7	18.6	7.6	6.3	9.7	5.9	11.5	4.2	8.2	15.9	12.6	16.8	15.1	12.5	13.4	9.8	4.0	15.3	20.5	5.1	11.0	7.1	6.9	7.5	8.7	9.3	17.9	13.1	14.9	22.1	8.0	6.5	11.8	8.1	20.1	7.8	10.5	8.4	23.7	23.0	12.0	21.3	16.4	12.0	9.4	9.4	13.4	11.6	9.5	2.5	4.7	5.0	2.7	6.9	3.9	2.3	2.8	2.0	4.6	1.3	3.1	2.6	4.8	2.2	8.8	1.2	3.4	2.8	6.1	9.5	13.4	10.7	5.3	4.4	6.3	7.2	5.4	4.8	9.5	7.9	35.4	22.4	13.6	28.4	15.3	26.5	15.8	7.8	18.8	17.2	17.6	13.0	31.5	20.0	14.8	11.0	20.9	4.4	15.8	64.7	5.9	11.6	48.1	31.1	33.0	18.8	16.7	12.2	13.3	8.4	8.6	27.5	23.0	36.9	13.3	29.6	17.9	47.0	7.6	5.0	7.2	27.5	8.2	15.8	52.9	80.7	8.7	22.5	30.2	5.6	9.7	23.1	5.2	15.1	18.2	17.1	53.2	6.8	19.4	18.9	31.7	12.3	18.3	28.2	0.0	24.0	22.8	16.5	6.3	25.4	24.7	5.1	16.7	8.0	21.5	40.2
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792911-61797238	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 87.5;Extravillous trophoblasts: 70.9;Spermatocytes: 61.0;Spermatogonia: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		NA	Yes		160000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavorable (5.73e-6)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	5.9	10.4	7.8	21.3	7.8	39.5	10.2	10.9	9.9	6.2	9.6	15.5	11.2	6.3	7.1	14.2	5.7	4.3	6.6	8.0	7.7	5.8	9.9	5.6	34.0	10.0	8.3	3.9	6.8	5.6	8.3	12.9	10.7	6.2	16.1	17.4	6.1	5.9	13.1	9.6	11.4	8.9	6.8	12.8	8.4	19.1	9.1	46.0	4.8	9.6	37.4	8.1	4.9	8.1	154.6	139.7	149.3	81.3	14.9	18.0	94.9	133.3	76.1	160.9	181.4	123.4	112.8	222.6	100.3	57.3	150.5	158.3	214.3	117.7	163.3	117.8	117.6	117.6	187.7	127.3	11.0	184.7	115.4	12.7	15.8	148.1	39.0	23.3	63.1	122.1	181.3	155.1	136.0	195.4	259.7	165.4	165.3	120.3	134.7	173.8	173.7	228.9	64.4	144.7	170.0	140.7	89.6	115.0	79.1	70.1	167.4	127.1	43.2	141.5	178.1	182.3	134.6	120.4	204.3	228.9	98.4	121.9	124.6	24.7	6.7	14.2	16.2	12.9	16.8	14.4	12.3	15.1	8.0	14.8	14.0	13.8	2.7	20.0	12.9	24.5	25.2	10.3	7.8	7.8	10.9	9.9	8.0	7.7	10.0	8.3	10.7	6.8	9.1	8.1	2.7	0.0	2.2	0.3	14.0	10.3	5.2	18.2	7.4	23.8	7.4	7.4	5.8	5.7	7.7	0.0	12.5	53.0	15.9	6.7	7.9	17.3	21.7	4.2	5.5	5.5	4.8	87.5	2.0	12.2	70.9	8.6	7.1	6.3	0.0	18.6	1.1	7.2	25.7	15.2	2.4	8.0	18.3	5.4	6.8	14.4	5.6	6.2	5.4	0.0	12.4	31.3	13.4	1.5	3.1	12.2	9.4	7.2	45.3	6.5	3.7	5.7	6.4	23.3	0.0	6.8	12.2	61.0	62.1	11.3	6.1	30.9	11.0	9.0	22.0	5.2
FERMT2	"KIND2, mig-2, PLEKHC1, UNC112B"	ENSG00000073712	"Fermitin family member 2"	Q96AC1	14	52857268-52952435	"Predicted intracellular proteins"	"Cell adhesion, Cell shape, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040505, HPA072965"	Uncertain		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		230000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	"Nucleoplasm, Cytosol"	"HPA040505: AB_10673300, HPA072965: "	"unprognostic (4.38e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.73e-3)"	148.4	21.2	28.7	38.8	31.6	0.5	57.6	29.0	37.3	44.7	18.0	104.3	13.1	105.1	26.3	46.8	55.7	65.7	66.9	31.0	27.4	55.4	108.3	47.9	15.3	35.7	29.1	43.6	20.6	18.4	13.1	116.5	33.5	69.1	33.3	29.5	22.6	117.9	48.8	13.4	29.3	155.6	30.6	37.6	46.4	15.5	27.6	6.9	35.9	69.6	6.6	77.7	29.1	38.1	22.8	18.9	101.6	46.8	163.7	133.7	84.6	148.4	95.2	172.3	107.9	34.1	17.6	0.1	49.4	153.1	33.8	9.6	80.1	11.1	128.3	0.2	22.6	31.9	83.1	40.3	209.6	0.4	12.6	129.4	23.5	95.3	125.4	78.5	91.2	16.8	0.6	153.4	131.7	28.0	7.7	0.5	64.3	0.2	51.3	3.9	103.8	0.4	60.9	20.6	6.2	130.5	157.8	35.0	37.7	103.3	30.1	1.1	115.2	134.5	92.4	108.2	56.0	22.6	29.4	0.6	30.9	0.2	33.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	31.6	29.0	37.3	31.0	27.4	35.7	29.1	33.5	30.6	27.6	38.1	152.7	76.9	42.0	116.5	1.0	18.6	150.6	15.5	13.6	39.5	33.8	41.4	65.8	24.3	25.6	40.5	37.5	74.8	2.3	0.2	31.3	48.5	68.2	20.1	141.7	110.4	0.0	2.7	13.7	33.2	178.1	103.9	3.6	40.2	58.3	31.6	110.3	82.3	10.4	15.2	16.1	0.5	4.1	8.9	19.5	27.9	74.9	4.4	46.2	29.0	4.8	52.3	1.0	41.2	92.0	27.6	0.1	174.9	4.5	40.0	0.0	44.7	10.1	56.0	151.2	83.4	174.1	4.1	16.2	2.2	8.1	102.6	7.9	12.3	0.4	37.0
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 83.4;lymphoid tissue: 110.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 46.8;Hofbauer cells: 48.7;Kupffer cells: 92.3;Macrophages: 51.9;monocytes: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 315.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 162.6;granulocytes: 315.8;monocytes: 151.7"	"Cell line enhanced"	"Detected in many"		"HEL: 63.5;HL-60: 56.9;HMC-1: 116.6;NB-4: 76.1;THP-1: 110.8;U-937: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	30.8	8.0	9.4	20.2	8.8	83.4	21.3	9.6	10.8	18.1	9.6	12.5	5.8	15.7	2.4	5.9	19.0	14.0	19.6	8.3	8.7	18.9	25.2	30.9	13.8	11.1	9.2	13.5	7.8	2.3	5.6	16.3	10.1	17.9	4.6	1.5	58.3	8.0	6.1	8.0	12.5	10.7	10.4	110.9	9.6	4.5	10.9	4.2	16.0	7.0	5.7	15.1	13.5	9.8	0.4	0.8	0.8	10.3	3.1	8.8	17.9	2.9	0.1	5.1	2.9	2.6	0.1	6.8	0.5	6.0	0.2	1.5	1.7	0.3	1.6	3.3	1.1	63.5	0.0	11.9	6.8	56.9	116.6	8.8	0.1	7.6	0.0	0.0	31.2	9.4	1.8	0.2	0.0	21.3	1.8	76.1	3.2	2.5	0.0	8.6	0.1	0.1	0.0	0.2	0.4	0.1	0.0	2.8	2.3	2.9	0.1	110.8	24.9	0.2	10.4	0.2	0.2	0.1	8.0	2.5	0.3	48.0	2.4	64.4	151.7	315.8	0.5	88.6	0.4	5.2	0.3	0.4	162.6	4.1	0.2	0.3	100.5	51.4	39.8	65.0	0.2	81.5	9.4	8.8	9.6	10.8	8.3	8.7	11.1	9.2	10.1	10.4	10.9	9.8	46.8	3.2	5.8	3.6	5.0	3.8	5.4	0.5	0.6	0.2	4.1	3.8	3.4	8.6	0.5	1.8	0.0	5.3	25.6	0.6	3.9	7.3	1.7	2.0	4.2	29.1	3.0	8.0	2.8	4.3	4.2	9.0	2.0	4.2	29.2	10.7	20.0	15.0	48.7	0.0	0.2	2.0	2.0	92.3	27.9	8.4	9.0	51.9	7.2	5.6	57.8	2.5	26.8	2.0	0.3	2.1	2.0	10.1	4.0	3.1	0.7	1.5	0.2	1.9	13.1	4.6	12.9	4.4	15.9	1.0	2.8	4.5	6.7	3.3	3.7	5.2
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301303-122310691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 126.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 5.1;Spermatocytes: 5.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"thalamus: 126.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 152.1;SCLC-21H: 66.0"	"Region enriched"	"Detected in some"	11	"hypothalamus: 11.7"	"Region enriched"	"Detected in single"	14	"hypothalamus: 7.4"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.1	0.0	2.9	0.0	3.1	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	24.8	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	3.0	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.5	126.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	152.1	3.8	2.7	0.0	0.0	0.0	0.0	0.2	66.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	7.2	0.3	0.0	0.1	2.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.2	1.8	0.6	24.8	0.3	2.6	0.5	0.2	126.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947523-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.4;lymphoid tissue: 32.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 41.8;Early spermatids: 66.1;Late spermatids: 99.0;NK-cells: 69.0;T-cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.9;Karpas-707: 61.4;RT4: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA020963: AB_2670542, HPA021018: AB_2670564"	"unprognostic (5.66e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	4.7	1.3	1.8	21.9	1.6	39.4	3.5	1.8	4.9	1.5	2.5	3.0	3.1	1.1	0.4	2.4	2.1	4.6	2.0	1.6	2.7	4.9	2.0	10.2	30.8	3.4	2.6	1.4	7.6	0.4	0.7	3.5	3.5	1.7	2.3	0.0	4.9	1.5	1.1	3.2	11.3	2.7	2.7	29.5	4.3	6.5	3.5	32.4	3.3	2.2	17.6	8.1	3.5	4.0	13.3	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	16.0	9.1	11.3	0.6	0.0	0.1	8.4	0.6	0.0	0.0	19.7	0.1	17.4	0.1	0.6	0.0	4.8	43.9	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.7	61.4	0.0	22.8	20.7	20.4	0.4	4.3	1.1	20.1	0.0	16.3	0.1	33.5	1.2	0.4	0.0	14.4	0.4	0.4	5.8	21.4	0.0	0.0	0.6	0.1	0.1	6.2	6.6	5.4	3.1	10.3	0.0	142.9	50.6	139.6	49.5	63.4	49.9	28.6	51.4	46.6	37.5	36.9	50.1	44.7	178.2	39.1	99.2	16.8	48.4	74.0	1.8	1.6	1.8	4.9	1.6	2.7	3.4	2.6	3.5	2.7	3.5	4.0	1.7	22.4	9.2	0.0	25.3	0.8	0.6	0.4	0.6	0.1	5.8	1.8	2.5	4.3	2.3	9.2	0.0	2.9	41.8	0.4	0.0	7.2	66.1	1.2	0.2	2.1	1.8	11.8	0.6	0.2	3.2	0.9	0.0	0.6	19.6	3.7	1.8	0.8	15.5	0.0	1.6	0.6	0.0	22.3	6.2	99.0	0.3	20.7	1.8	12.2	20.1	0.4	69.0	5.0	0.5	0.4	0.1	0.4	15.8	0.1	0.0	0.7	0.3	3.9	0.0	0.3	0.8	1.6	2.4	0.5	1.0	4.5	47.3	0.1	0.4	0.5
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 295.2;choroid plexus: 125.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.1;Cardiomyocytes: 62.4;Muller glia cells: 69.4;Oligodendrocytes: 119.8"	"Cancer enriched"	"Detected in many"	12	"glioma: 33.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 44.6;BJ hTERT+: 33.0;BJ hTERT+ SV40 Large T+: 35.9;BJ hTERT+ SV40 Large T+ RasG12V: 45.0;HBF TERT88: 64.3;hTEC/SVTERT24-B: 45.4;LHCN-M2: 30.6;U-2 OS: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (1.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.55e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (3.72e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (3.01e-4)"	17.9	3.3	206.3	1.6	259.3	1.1	12.5	213.9	295.2	1.3	125.8	2.4	1.0	3.1	7.9	2.0	1.7	2.5	50.2	183.5	245.5	66.5	1.7	2.8	1.2	236.2	237.7	0.9	0.8	4.3	6.5	2.1	259.9	1.8	1.3	18.8	7.3	2.3	2.2	1.7	1.2	2.5	225.4	6.9	0.8	2.0	244.3	1.5	5.6	7.8	2.0	1.2	1.0	272.8	5.6	0.3	0.3	1.5	1.1	3.3	1.8	44.6	33.0	35.9	45.0	0.2	0.2	1.3	3.1	15.4	2.1	0.7	0.0	3.5	64.3	0.2	0.0	0.0	0.8	0.4	0.6	0.0	0.4	1.6	1.1	45.4	2.7	9.7	0.0	0.2	0.0	1.6	30.6	0.7	0.1	0.9	1.4	0.1	1.4	0.2	1.5	0.6	1.5	0.2	1.1	2.3	0.1	0.9	0.6	8.0	0.0	0.2	1.1	5.8	33.0	0.8	21.3	0.8	0.4	0.3	8.2	0.3	1.6	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.3	0.0	0.1	0.2	0.1	0.0	206.3	259.3	213.9	295.2	183.5	245.5	236.2	237.7	259.9	225.4	244.3	272.8	1.4	0.0	0.0	75.1	0.1	0.4	5.0	5.7	7.4	3.5	1.2	25.4	62.4	0.0	2.1	20.2	16.7	1.1	0.1	0.0	0.0	1.1	0.4	0.0	0.7	4.8	0.0	0.0	13.0	0.0	0.5	4.7	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	14.6	0.0	12.2	0.0	0.0	1.4	0.0	0.2	3.6	29.0	0.0	69.4	0.0	15.1	119.8	0.6	0.0	0.4	0.0	5.3	0.0	0.3	0.1	11.6	6.6	0.5	23.4	0.1	0.1	0.6	0.0	0.8	0.4	0.0	0.0	0.7
FGF12	"FGF12B, FHF1"	ENSG00000114279	"Fibroblast growth factor 12"	P61328	3	192139390-192767764	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Growth factor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.8;heart muscle: 131.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 413.7;Excitatory neurons: 1213.5;Inhibitory neurons: 1925.1;Oligodendrocyte precursor cells: 1668.3"	"Cancer enhanced"	"Detected in many"		"glioma: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;NTERA-2: 10.3;SCLC-21H: 23.9;U-251 MG: 14.7;WM-115: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071557			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA071557: AB_2686417"	"unprognostic (1.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.75e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.87e-7)"	"unprognostic (2.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.99e-2)"	1.9	35.8	8.5	0.2	14.1	0.0	1.3	0.5	21.3	0.5	0.0	1.1	0.7	1.0	0.2	1.7	1.5	0.5	131.3	17.5	14.2	2.5	0.6	1.1	0.2	11.1	1.0	0.8	7.7	1.6	5.3	0.4	9.9	1.3	0.3	15.4	5.9	6.0	1.1	0.3	0.3	0.7	0.0	11.6	0.6	2.1	3.5	0.1	1.5	0.8	0.2	0.5	0.7	2.8	0.1	1.1	15.1	0.0	0.0	0.0	0.1	0.0	0.1	1.4	1.7	0.0	0.1	0.8	7.2	0.3	0.3	0.2	0.0	0.0	1.6	0.1	0.2	3.2	6.3	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	3.7	0.2	0.0	0.1	0.1	0.0	4.4	0.0	0.0	10.3	7.1	0.3	0.0	0.1	0.0	4.7	1.8	23.9	0.0	0.0	0.6	0.0	1.7	1.1	0.2	0.4	6.2	3.2	0.0	14.7	0.2	2.5	0.0	1.3	0.0	17.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	14.1	0.5	21.3	17.5	14.2	11.1	1.0	9.9	0.0	3.5	2.8	17.8	0.0	0.0	42.7	0.1	0.6	4.2	0.0	0.6	100.2	0.9	1.7	413.7	0.0	1.9	5.5	4.2	0.2	0.0	0.0	7.9	0.7	20.9	1.6	1.6	13.2	0.0	0.0	1213.5	13.1	0.4	18.6	0.5	0.5	0.0	9.0	16.4	0.0	0.1	33.7	1925.1	0.0	0.0	0.3	0.3	38.5	6.8	0.1	1.8	46.9	0.0	3.8	0.0	1668.3	28.2	2.7	1.2	1.2	0.5	1.1	0.0	0.4	0.8	14.2	0.0	0.7	4.8	4.0	8.0	0.4	0.1	0.0	0.1	38.7	0.1	1.7
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.7;Astrocytes: 111.0;Endometrial stromal cells: 40.6;Fibroblasts: 77.1;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 243.8;BJ hTERT+: 148.4;fHDF/TERT166: 278.2;hTERT-HME1: 147.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500			"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	24.3	2.6	14.8	5.3	16.1	0.1	9.5	12.2	14.7	8.7	14.2	14.1	1.7	14.2	4.5	4.7	8.0	7.1	5.0	12.2	18.8	4.0	2.0	8.3	1.8	18.6	20.5	12.6	1.5	4.7	3.2	6.4	15.6	7.6	4.0	3.4	3.5	8.7	1.4	1.9	3.7	12.6	16.8	1.1	6.2	1.9	18.3	1.6	2.4	4.8	1.8	14.8	6.1	13.3	4.7	14.1	7.8	30.5	18.8	31.1	0.0	243.8	148.4	104.3	60.2	0.2	0.4	0.0	20.5	278.2	81.8	0.7	8.1	0.5	104.3	12.3	3.3	0.0	28.7	0.2	55.3	1.4	0.1	16.8	1.7	103.6	147.6	52.0	11.8	0.0	6.9	8.4	27.4	0.1	0.1	0.2	21.6	0.1	5.4	0.0	3.9	0.1	33.0	0.0	4.4	4.0	48.4	0.1	2.0	44.7	0.1	0.5	10.6	85.7	12.2	32.0	20.0	8.6	10.3	0.0	24.7	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	16.1	12.2	14.7	12.2	18.8	18.6	20.5	15.6	16.8	18.3	13.3	33.7	6.4	0.0	111.0	0.3	1.7	1.6	0.8	2.8	4.6	4.5	8.9	4.7	0.0	1.3	7.3	0.0	2.7	0.4	0.0	3.9	8.2	10.9	1.5	40.6	11.5	1.8	0.4	1.8	1.0	0.1	77.1	0.0	1.6	0.0	5.7	17.2	1.3	0.5	0.0	6.6	0.0	0.0	0.0	2.4	3.8	9.9	1.7	5.4	15.9	0.6	9.3	0.0	42.3	5.8	11.0	0.0	8.2	1.6	16.0	0.0	0.6	0.0	2.0	0.0	15.2	14.2	4.7	1.1	0.3	1.3	4.8	0.5	0.1	0.0	2.0
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.7;gallbladder: 3.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 9.4;Microglial cells: 1.9;Proximal tubular cells: 4.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 11.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.1;BJ hTERT+: 120.0;fHDF/TERT166: 88.0;HBF TERT88: 88.0;LHCN-M2: 81.1;U-138 MG: 109.5;U-251 MG: 55.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: AB_2678001"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.0	0.0	0.2	0.6	0.0	0.1	0.0	11.7	1.2	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	3.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	2.7	0.2	0.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	1.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.1	6.1	21.8	0.0	64.1	120.0	16.5	12.2	0.0	0.1	0.0	0.0	88.0	1.2	0.1	0.1	22.5	88.0	0.0	1.1	0.2	0.1	0.0	1.7	0.6	0.0	6.3	0.0	48.6	23.0	27.9	5.7	0.0	0.0	0.2	81.1	0.0	0.1	0.3	0.1	0.0	2.1	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.8	0.0	0.0	0.2	20.9	109.5	4.6	5.4	55.0	0.0	0.0	0.1	6.3	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.7	1.2	0.6	0.0	2.7	0.2	3.0	0.0	0.5	0.5	0.0	0.0	1.1	0.3	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.6	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	4.1	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1
FGF7	KGF	ENSG00000140285	"Fibroblast growth factor 7"	P21781	15	49423237-49488775	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 63.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Fibroblasts: 216.6;Leydig cells: 83.3;Proximal tubular cells: 53.4;Smooth muscle cells: 71.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 112.1;ASC TERT1: 66.1;BJ: 45.6;fHDF/TERT166: 50.3;HSkMC: 84.8;RH-30: 119.7;U-138 MG: 56.5"	"Region enriched"	"Detected in some"	6	"cerebellum: 8.7"					HPA043605	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA043605: AB_10960215"	"unprognostic (4.65e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.63e-3)"	43.8	4.5	3.4	31.5	3.9	0.1	8.5	4.2	5.2	29.4	2.1	11.1	3.7	29.2	4.3	9.5	15.4	46.0	10.5	3.3	4.8	4.5	1.4	12.9	8.3	4.6	4.6	13.4	2.2	3.6	2.2	23.5	5.1	16.2	9.6	8.4	5.1	12.0	2.2	2.6	3.6	26.9	4.1	1.8	5.5	2.3	4.5	3.0	7.4	23.8	4.8	63.3	10.3	4.5	0.2	0.0	0.2	0.3	112.1	66.1	0.1	45.6	25.7	0.0	0.1	0.0	0.3	0.2	0.2	50.3	0.4	0.9	0.0	0.3	0.0	0.1	0.2	0.0	0.5	0.0	10.6	0.3	0.1	84.8	0.8	9.4	0.0	0.3	0.0	0.0	0.1	0.3	5.4	0.1	0.0	0.1	0.2	0.1	0.3	0.1	119.7	0.1	0.1	0.1	1.8	0.6	0.4	0.0	0.4	0.2	0.2	0.2	0.2	56.5	0.5	1.1	0.2	0.5	0.4	0.0	13.3	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.9	4.2	5.2	3.3	4.8	4.6	4.6	5.1	4.1	4.5	4.5	16.1	12.8	19.3	2.0	2.2	14.4	16.8	1.3	1.2	7.9	11.1	9.5	46.8	7.2	0.5	9.2	2.1	6.2	3.2	0.2	119.3	2.0	3.3	8.8	46.2	5.2	0.0	2.7	1.9	0.6	3.3	216.6	2.0	29.2	1.3	0.6	1.8	2.7	2.0	3.3	3.3	0.0	2.0	1.6	15.9	4.0	83.3	1.9	7.2	1.0	0.2	9.8	2.1	1.5	2.9	0.6	0.0	4.9	0.7	9.4	0.0	53.4	0.3	6.1	6.6	43.6	71.6	0.6	0.7	1.8	12.6	2.9	2.9	2.9	0.1	8.4
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478332-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 273.8;choroid plexus: 198.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 228.2;Cholangiocytes: 213.1;Oligodendrocytes: 562.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 13.2;eosinophil: 3.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 189.0;BEWO: 60.9;CACO-2: 49.6;HaCaT: 55.6;HAP1: 63.7;NTERA-2: 57.8;T-47d: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		1200000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	5.7	21.3	103.9	8.2	186.8	0.3	22.9	178.9	198.9	19.7	198.1	44.8	10.4	54.6	15.3	25.2	29.6	31.3	5.6	109.9	124.7	26.3	41.0	30.9	2.9	250.9	185.9	18.0	31.0	61.0	6.8	15.7	220.5	27.4	21.2	1.2	59.1	54.6	0.5	109.3	12.2	43.6	165.5	0.8	22.5	7.6	148.0	10.1	54.6	0.2	9.1	16.6	27.4	273.8	7.2	0.4	30.2	189.0	0.1	0.0	60.9	0.4	0.0	0.0	0.0	49.6	1.1	0.1	12.5	2.8	0.1	55.6	63.7	13.0	0.0	0.1	12.7	0.0	0.2	1.2	1.5	0.2	11.7	0.1	26.2	0.0	0.6	0.0	0.0	0.3	0.2	0.2	0.0	11.7	0.2	0.1	57.8	8.7	0.0	0.1	0.0	7.5	18.0	15.8	0.5	0.5	0.4	33.4	0.0	36.6	49.3	0.0	0.1	0.3	8.5	0.2	0.7	0.1	0.1	0.0	0.3	0.0	0.5	13.2	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	103.9	186.8	178.9	198.9	109.9	124.7	250.9	185.9	220.5	165.5	148.0	273.8	1.4	19.2	36.0	228.2	0.6	40.1	34.3	18.4	58.6	0.2	8.7	25.4	9.1	213.1	38.4	36.8	0.0	16.5	0.3	7.3	0.0	7.4	4.1	28.1	4.4	1.0	2.4	2.7	14.8	0.2	3.0	9.0	13.3	53.1	0.0	0.1	1.8	5.0	2.3	0.0	31.2	40.8	10.2	0.6	4.4	9.6	1.2	1.1	5.4	10.3	0.6	2.0	1.0	6.0	562.5	0.7	3.0	6.0	0.1	15.0	1.8	13.6	15.3	0.2	0.0	1.6	2.6	0.7	9.9	18.7	27.7	4.0	1.5	0.4	3.8	31.4
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 77.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 191.7;Cholangiocytes: 343.1;Hepatocytes: 142.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.9;RH-30: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054971, HPA075137"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Nuclear bodies"	"HPA054971: , HPA075137: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"	4.2	14.6	10.5	2.0	12.8	2.3	6.6	21.8	10.2	6.3	4.5	7.1	7.1	4.7	36.5	5.5	9.9	5.4	11.3	7.4	12.1	19.1	77.1	4.7	3.3	12.9	13.4	4.8	12.0	10.5	9.7	3.0	12.9	7.8	6.7	9.6	7.5	10.3	41.8	5.7	8.1	4.2	9.3	2.8	6.1	4.2	16.5	4.1	7.7	17.1	3.6	7.0	5.2	12.7	4.8	1.4	9.2	3.9	4.7	16.6	0.8	4.1	6.8	2.3	3.4	0.0	3.8	5.4	13.0	11.0	4.1	2.0	1.6	11.9	4.9	42.9	1.1	3.8	2.9	8.6	12.3	2.3	2.4	23.2	10.2	5.0	7.9	10.0	4.6	6.0	2.7	3.4	15.3	5.2	3.0	3.2	5.8	13.0	5.3	6.5	28.3	2.1	12.9	8.8	7.2	3.2	5.6	3.3	12.0	8.0	2.8	2.3	4.7	4.0	2.6	4.7	2.8	7.5	2.9	4.6	12.9	9.2	3.8	1.5	1.3	1.4	3.0	1.3	2.7	5.1	1.4	3.8	2.2	3.6	2.7	4.3	2.2	2.9	3.4	1.1	2.8	1.8	10.5	12.8	21.8	10.2	7.4	12.1	12.9	13.4	12.9	9.3	16.5	12.7	3.7	54.5	191.7	83.2	7.9	20.9	23.8	45.2	14.2	10.1	33.1	66.9	29.9	343.1	40.4	12.9	12.5	9.3	3.7	4.2	17.6	62.6	14.0	33.2	7.5	6.9	2.4	12.2	20.4	42.5	4.5	7.6	7.1	20.4	10.1	5.3	5.3	142.3	11.4	8.4	33.7	11.3	22.4	8.8	7.6	11.4	1.8	6.7	35.6	17.8	11.2	12.2	3.1	39.2	36.0	17.7	7.7	3.0	3.4	19.1	14.9	47.9	91.2	16.4	0.0	31.4	8.9	4.6	11.5	13.5	31.5	4.5	5.1	5.9	17.1	35.5
FHL3	SLIM2	ENSG00000183386	"Four and a half LIM domains 3"	Q13643	1	37996770-38005606	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"skeletal muscle: 1603.0;tongue: 805.6"	"Cell type enhanced"	"Detected in many"		"granulocytes: 73.1;NK-cells: 52.5;Skeletal myocytes: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"eosinophil: 336.1"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 336.1"	"Cell line enhanced"	"Detected in many"		"HEL: 72.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045723			Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA045723: AB_10966278"	"prognostic favorable (5.62e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (4.20e-11)"	"unprognostic (8.88e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.77e-2)"	14.8	11.4	7.3	16.7	7.6	21.4	12.7	7.4	7.5	30.8	5.9	45.3	3.5	46.8	7.9	36.7	29.8	14.7	16.0	6.6	7.5	14.6	6.0	19.1	5.6	8.8	7.5	20.8	10.2	6.6	5.6	9.6	8.9	16.6	6.0	0.5	23.7	16.5	1603.0	15.5	11.4	29.6	8.8	13.0	15.5	7.2	8.1	3.7	8.1	805.6	5.3	40.8	16.0	8.0	15.4	5.6	14.3	14.4	13.3	52.9	9.3	12.0	23.1	22.1	16.3	12.2	11.8	0.1	19.7	26.8	10.3	5.8	9.5	14.2	10.8	5.8	17.2	72.0	12.5	14.2	51.7	5.6	49.8	47.4	15.8	24.9	14.2	46.3	30.9	7.2	61.7	0.3	41.6	8.1	1.9	23.5	18.5	1.1	3.7	9.5	12.2	1.0	14.1	2.8	1.8	7.4	10.9	1.0	17.1	27.0	4.3	4.9	21.6	9.2	21.6	2.7	11.1	3.9	14.5	1.7	4.4	33.0	9.9	6.0	28.7	336.1	14.1	18.2	15.1	0.3	3.5	7.2	18.0	0.6	2.6	3.4	34.5	14.3	12.0	0.8	8.1	13.8	7.3	7.6	7.4	7.5	6.6	7.5	8.8	7.5	8.9	8.8	8.1	8.0	11.6	0.0	3.0	3.3	2.0	20.9	20.9	4.5	23.3	1.5	12.1	29.3	5.1	5.7	3.5	7.3	0.0	9.2	18.0	0.2	1.9	19.8	0.8	2.4	27.4	20.8	0.0	9.4	1.3	28.1	29.1	25.6	0.5	3.2	73.1	2.7	12.1	1.0	26.1	0.0	0.4	0.2	12.2	21.7	33.1	1.4	22.4	23.5	5.4	9.4	20.3	2.9	52.5	0.5	0.1	34.5	0.0	32.0	1.3	8.9	0.0	3.6	0.2	0.5	26.3	54.4	38.1	1.1	16.6	8.6	16.2	9.7	12.6	14.9	0.2	11.6
FICD	"HIP13, HYPE"	ENSG00000198855	"FIC domain protein adenylyltransferase"	Q9BVA6	12	108515277-108525837	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	"Hydrolase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.8;Late spermatids: 52.0;Syncytiotrophoblasts: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021390, HPA071134"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA021390: AB_1851340, HPA071134: AB_2686347"	"unprognostic (1.00e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (4.61e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.22e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.65e-2)"	3.5	7.5	5.1	5.3	6.5	2.9	3.6	6.2	5.9	6.3	4.5	3.2	3.3	3.3	12.2	1.8	3.2	3.0	2.7	5.3	6.3	3.0	8.2	3.9	4.0	7.0	6.6	2.6	12.7	4.7	11.6	3.7	6.3	4.7	2.9	2.4	8.9	6.0	2.0	2.8	2.7	3.8	6.4	3.5	4.3	7.6	6.3	2.4	10.9	2.0	5.3	3.3	1.6	7.4	2.5	6.3	2.5	5.0	5.9	4.1	6.8	16.5	8.7	7.6	5.3	3.9	2.4	3.5	6.0	8.0	9.0	3.2	2.7	1.8	6.7	6.1	4.0	2.0	4.6	5.6	23.0	3.0	7.2	1.9	3.8	10.7	15.2	9.4	5.5	3.3	1.4	11.6	6.9	5.9	4.0	3.1	2.7	2.7	10.2	2.3	3.4	8.7	3.6	4.9	2.4	1.6	7.4	3.4	8.3	3.7	5.4	2.9	6.2	7.8	2.8	13.8	6.4	22.9	4.0	1.2	10.7	2.6	5.5	11.5	2.7	4.5	6.3	4.8	7.7	4.7	4.6	5.9	2.7	2.9	2.7	5.2	5.4	3.3	5.8	15.3	3.1	1.9	5.1	6.5	6.2	5.9	5.3	6.3	7.0	6.6	6.3	6.4	6.3	7.4	3.8	0.0	3.7	6.5	6.5	0.8	4.5	4.4	1.2	5.5	5.9	3.4	2.9	4.3	3.3	7.3	2.1	6.2	4.3	2.3	5.9	5.8	62.8	2.7	6.9	4.2	1.8	2.7	2.3	9.5	5.5	6.5	5.6	7.3	13.4	3.2	4.6	5.1	6.1	13.5	2.9	4.0	0.0	2.9	3.5	52.0	3.4	4.6	7.2	1.9	2.8	11.8	5.2	3.5	4.5	7.6	1.4	9.8	15.0	8.9	1.9	2.4	4.4	7.8	13.1	4.2	4.7	9.6	9.3	1.7	3.3	31.1	4.7	5.0	2.5	4.8
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 161.3;Inhibitory neurons: 82.9;Oligodendrocyte precursor cells: 309.6;Oligodendrocytes: 129.4;Sertoli cells: 72.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	34	"basophil: 3.3"	"Lineage enriched"	"Detected in single"	34	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"AF22: 18.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	3.1	2.0	3.9	0.4	5.0	0.8	2.0	2.3	4.4	2.4	0.0	2.6	0.4	1.1	1.2	0.6	1.9	1.1	3.3	2.5	5.4	1.9	3.2	1.4	0.6	3.0	4.2	4.6	2.9	0.4	2.6	1.1	3.9	1.6	0.7	1.4	2.6	2.7	1.0	1.0	1.4	0.9	1.8	3.0	1.8	1.1	4.6	0.2	1.1	1.7	0.2	1.7	2.4	5.1	6.4	2.3	18.6	0.0	0.0	0.0	6.8	2.4	1.6	1.7	3.2	0.0	2.2	0.0	6.6	2.6	3.4	0.9	6.2	2.6	1.3	0.0	4.6	0.0	4.7	4.6	1.5	0.0	0.0	0.8	2.2	3.3	9.0	2.6	4.0	0.0	0.0	0.0	5.1	1.6	0.0	0.0	7.9	0.4	2.9	0.0	6.3	0.0	4.2	2.1	2.9	2.5	0.0	1.8	1.7	10.3	2.0	0.0	0.4	7.6	6.8	0.0	5.1	1.1	0.0	0.0	2.3	0.0	4.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.0	2.3	4.4	2.5	5.4	3.0	4.2	3.9	1.8	4.6	5.1	2.9	6.4	7.3	161.3	0.7	1.9	0.1	2.8	1.8	24.4	5.7	2.7	19.4	20.0	3.0	12.9	0.0	21.2	0.2	0.1	1.9	3.7	3.8	0.7	0.7	2.1	0.0	0.0	53.4	1.5	7.4	11.6	4.1	1.6	0.0	23.6	7.9	13.5	1.4	6.7	82.9	0.0	4.1	0.0	1.6	6.4	51.9	0.6	17.8	28.1	0.0	4.3	0.0	309.6	129.4	1.1	0.0	34.3	0.0	1.8	0.0	8.1	4.0	2.1	72.3	16.6	17.8	1.1	1.2	1.0	0.4	16.8	0.2	7.0	0.0	0.0
FIP1L1	"DKFZp586K0717, FIP1"	ENSG00000145216	"Factor interacting with PAPOLA and CPSF1"	Q6UN15	4	53377641-53460862	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037475, HPA058202"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037475: AB_10696933, HPA058202: AB_2683636"	"unprognostic (3.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.87e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-1)"	19.1	15.7	5.8	14.8	5.9	31.8	17.0	11.3	8.7	18.4	1.2	14.3	11.7	17.9	12.7	15.9	16.0	11.0	13.0	4.9	9.9	13.3	13.7	14.2	20.2	4.8	5.1	22.0	9.7	16.4	9.7	21.1	4.9	12.3	15.1	17.0	14.7	11.4	25.8	17.9	14.4	15.9	4.6	14.8	14.4	31.4	7.0	29.4	14.6	11.7	23.3	17.5	16.2	8.7	43.7	29.5	51.8	32.6	36.4	31.9	63.5	52.8	64.0	45.1	35.0	43.2	37.8	79.5	42.6	47.2	44.4	26.7	55.6	37.9	55.8	27.0	31.0	60.0	25.5	40.7	51.2	95.4	53.6	31.2	35.6	51.6	49.8	42.0	32.3	47.7	71.3	34.3	34.1	33.3	88.5	44.4	35.9	53.7	28.8	79.2	22.0	36.9	33.9	34.7	40.8	41.5	37.6	40.3	65.1	47.0	25.2	33.6	33.9	44.2	39.7	39.9	67.2	43.3	27.8	100.8	38.4	59.2	84.3	45.2	23.3	51.4	32.5	25.0	38.8	34.8	33.0	32.9	31.9	32.3	36.6	32.3	28.3	50.7	37.0	46.5	45.9	33.1	5.8	5.9	11.3	8.7	4.9	9.9	4.8	5.1	4.9	4.6	7.0	8.7	36.1	25.6	25.4	47.0	50.4	38.7	46.6	41.5	30.1	41.2	24.0	25.4	14.4	21.5	34.1	27.6	18.8	58.7	54.0	26.9	37.2	45.8	10.3	37.6	51.1	33.4	36.6	29.2	78.8	34.9	52.2	41.9	29.6	41.6	49.4	40.0	28.5	21.2	33.2	77.4	78.7	27.0	32.6	19.8	24.6	15.2	66.8	32.2	32.0	60.9	41.3	48.6	29.9	137.7	91.4	36.9	33.3	53.4	40.3	36.5	25.2	23.3	44.8	30.3	39.5	38.9	46.9	118.5	87.6	31.8	34.1	86.3	49.8	56.8	29.4	38.5
FIZ1	"FLJ14768, ZNF798"	ENSG00000179943	"FLT3 interacting zinc finger 1"	Q96SL8	19	55591376-55601970	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074026			Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA074026: AB_2686653"	"unprognostic (1.97e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.43e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.51e-3)"	"unprognostic (8.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (8.42e-4)"	"unprognostic (7.02e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (2.02e-4)"	7.6	8.4	23.3	5.8	23.6	4.0	8.1	21.8	24.6	10.3	18.1	12.3	6.3	12.4	7.6	9.2	9.1	3.5	13.1	21.2	21.3	12.3	9.7	6.8	5.3	22.7	22.6	10.0	13.0	10.3	11.9	5.3	21.1	11.4	5.1	11.7	9.4	6.7	12.7	8.6	9.3	6.2	20.9	9.4	11.7	6.5	23.9	8.3	11.9	7.8	5.9	10.8	8.2	22.0	10.8	22.7	14.9	10.6	8.5	6.0	17.0	8.6	5.8	9.6	7.5	12.2	11.4	18.5	8.0	5.4	5.3	10.2	10.3	10.8	9.3	14.6	26.9	14.0	16.0	10.8	8.5	12.3	12.9	7.3	17.7	8.2	10.0	9.1	4.8	11.3	17.8	8.4	7.1	9.1	22.3	9.0	16.5	12.6	15.2	22.4	14.1	10.0	9.6	18.8	20.1	22.9	13.9	9.7	9.7	8.6	10.0	15.0	7.8	9.2	15.0	3.8	11.3	22.1	36.0	12.2	12.7	11.4	10.0	0.0	0.4	0.0	0.2	0.7	0.2	0.6	0.6	0.3	0.2	0.3	0.2	0.4	0.4	0.5	0.3	0.9	0.2	0.2	23.3	23.6	21.8	24.6	21.2	21.3	22.7	22.6	21.1	20.9	23.9	22.0	6.4	9.6	1.1	3.3	3.1	3.3	3.4	1.5	4.0	13.5	7.1	7.4	5.3	7.2	3.0	5.5	4.2	3.7	3.9	7.5	0.0	4.1	0.8	5.1	5.3	4.8	10.1	1.7	2.7	4.0	3.7	4.3	5.1	5.2	0.0	9.5	3.3	5.9	4.5	13.5	2.7	5.3	0.0	4.4	1.2	1.5	3.1	3.3	0.0	2.8	2.6	10.0	2.1	2.0	3.0	5.3	3.7	3.4	2.0	3.9	5.0	4.8	5.4	13.6	0.0	4.6	3.8	2.5	2.5	2.6	2.3	3.4	2.3	5.0	5.7	3.2
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FKBP prolyl isomerase 14"	Q9NWM8	7	30010587-30026702	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (4.25e-4)"	6.5	5.1	3.4	7.0	3.5	4.3	6.4	5.4	3.6	9.9	3.1	4.7	3.0	8.5	10.0	4.7	4.3	6.0	6.8	3.2	3.2	3.1	3.2	4.1	3.1	3.3	3.1	5.4	5.8	6.2	7.7	7.9	3.0	6.8	4.8	7.2	4.3	7.5	2.1	4.7	2.9	13.9	3.0	2.7	4.0	2.2	3.5	1.8	3.3	3.2	3.2	8.9	3.8	3.5	7.0	5.2	14.4	33.6	36.8	46.8	6.5	34.9	32.7	12.0	23.3	4.4	4.3	2.4	16.0	31.0	14.7	14.8	8.1	12.8	23.9	1.3	11.6	5.6	9.2	13.1	18.6	4.0	9.3	29.4	13.1	20.9	24.6	28.2	27.0	3.6	9.2	5.0	21.8	2.9	2.1	4.9	7.5	7.7	9.2	0.1	9.6	8.2	11.8	6.1	3.8	12.5	12.2	27.5	8.8	17.0	6.2	5.3	21.7	12.6	14.6	21.8	14.0	7.6	8.3	4.2	18.0	3.8	40.2	0.5	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.4	0.2	0.0	0.6	0.2	0.1	3.4	3.5	5.4	3.6	3.2	3.2	3.3	3.1	3.0	3.0	3.5	3.5	13.5	19.2	16.0	7.2	7.9	27.4	22.0	15.8	35.9	16.3	13.3	13.0	15.7	5.7	11.7	18.4	27.1	11.6	9.4	5.3	1.9	7.4	0.4	30.4	44.3	12.9	1.2	6.5	19.4	3.7	27.3	40.0	15.3	40.0	2.5	9.1	8.6	6.5	6.0	15.2	12.7	9.7	8.2	2.5	11.2	0.4	13.1	5.7	10.6	10.3	3.6	26.5	2.1	11.6	16.6	5.7	19.0	20.7	43.8	17.8	3.3	2.7	6.0	21.4	6.6	13.8	20.4	1.4	3.4	27.5	18.3	15.7	6.0	20.8	6.1	28.0
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FKBP prolyl isomerase 4"	Q02790	12	2794970-2805423	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 372.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		480000	"Cluster 44: Non-specific - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883"	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.12e-5)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	35.4	38.1	92.1	22.3	95.9	24.2	53.1	127.7	372.1	41.7	89.6	35.7	20.3	32.2	44.6	69.3	38.2	24.8	42.7	96.6	104.4	68.1	57.5	38.0	19.8	101.0	101.4	50.4	52.0	47.8	36.1	50.6	106.2	44.4	37.8	52.2	48.1	44.9	69.4	49.8	25.6	40.0	97.8	24.3	58.0	58.4	103.0	25.1	44.4	48.5	29.9	44.6	46.0	141.7	91.6	198.6	56.2	94.9	68.5	40.1	268.3	87.5	31.2	141.2	95.0	199.1	108.3	120.9	24.5	56.6	98.2	121.9	353.3	118.5	168.2	222.6	226.1	133.2	141.8	71.4	52.6	105.5	35.0	36.5	106.6	167.2	165.9	84.0	83.5	119.8	124.9	166.4	57.6	261.5	186.2	94.9	480.0	266.5	141.2	110.0	98.7	72.4	119.5	114.2	80.7	116.0	101.6	272.7	45.3	348.8	368.0	70.3	44.9	69.1	216.4	78.6	224.1	40.9	67.9	177.0	61.4	154.7	72.2	17.0	11.5	6.7	12.5	10.5	13.9	14.0	11.0	11.9	6.4	14.3	11.3	13.5	1.5	9.2	15.5	5.6	11.0	11.1	92.1	95.9	127.7	372.1	96.6	104.4	101.0	101.4	106.2	97.8	103.0	141.7	31.9	6.4	11.5	10.1	39.1	143.9	261.5	38.5	80.8	60.3	133.9	96.3	13.1	54.3	26.8	53.3	75.0	186.1	27.2	111.0	154.6	82.0	125.4	49.7	47.4	43.5	106.1	77.8	12.9	25.9	117.3	42.6	41.8	74.5	38.2	45.3	20.7	49.3	62.0	97.6	15.5	124.9	63.1	17.5	102.1	40.9	34.8	67.7	92.5	4.7	40.2	48.3	25.7	10.1	17.6	60.3	100.1	38.7	47.3	272.4	77.3	141.7	21.1	63.4	85.5	28.3	117.2	149.4	74.4	111.5	132.8	223.3	74.0	38.6	148.7	147.3
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FKBP prolyl isomerase 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 892.7;tongue: 925.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 759.3;ASC TERT1: 468.5;HHSteC: 593.0;HSkMC: 718.3;hTCEpi: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	400.1	92.3	18.2	70.1	26.8	26.6	160.4	19.7	32.1	86.4	20.2	110.9	11.3	97.5	63.0	130.6	104.6	78.9	93.7	16.8	20.7	108.8	144.5	92.7	166.7	22.7	23.8	122.1	200.4	227.0	52.9	28.5	23.5	85.0	37.1	25.6	61.0	49.8	892.7	114.0	135.7	81.8	17.0	105.6	129.0	41.4	22.1	229.4	97.2	925.1	80.3	108.9	109.1	26.2	40.0	17.1	73.1	109.7	759.3	468.5	1.2	21.2	1.0	13.6	31.0	29.7	6.9	195.3	19.5	4.1	11.8	0.6	44.1	93.2	32.0	77.7	41.6	84.0	14.1	41.7	593.0	53.3	8.3	718.3	368.6	23.7	220.5	14.8	80.1	38.8	91.3	77.1	144.3	25.3	222.5	99.6	18.9	8.7	12.3	97.7	19.1	95.4	60.2	23.7	27.7	16.8	17.3	19.8	4.2	15.9	108.4	62.2	178.7	19.3	17.3	2.8	29.7	34.9	42.9	243.5	6.6	102.3	7.6	57.6	105.0	70.0	64.4	92.3	78.0	9.7	90.6	68.5	107.5	12.5	133.4	96.7	85.1	45.2	46.8	32.0	37.2	158.5	18.2	26.8	19.7	32.1	16.8	20.7	22.7	23.8	23.5	17.0	22.1	26.2	180.2	12.8	11.3	23.2	42.9	17.6	59.2	20.1	37.0	1.9	32.0	20.8	131.8	74.4	14.2	5.5	0.0	1.2	102.0	14.3	23.5	0.6	9.8	55.7	76.1	57.9	20.9	102.2	25.9	7.9	0.8	97.5	18.8	79.2	38.5	54.7	117.1	225.6	35.1	0.0	2.8	35.5	34.6	384.2	44.8	22.0	160.9	192.2	7.2	66.5	110.3	4.6	44.3	16.6	26.3	2.9	19.3	218.6	66.4	49.9	157.0	27.4	18.2	22.6	144.7	188.1	106.8	14.9	19.1	37.5	21.3	0.4	128.7	2.8	39.5	22.2
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FKBP prolyl isomerase like"	Q9UIM3	6	32128707-32130288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 51.2;Squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.3	4.2	2.9	2.0	2.5	2.8	4.0	2.2	3.2	3.8	2.2	4.1	1.6	3.1	6.1	10.7	4.3	1.6	2.9	2.6	2.4	4.0	5.2	3.2	3.1	2.9	2.4	3.2	5.5	4.0	2.9	1.7	2.6	3.2	3.4	1.8	6.4	1.1	4.5	9.8	3.6	3.6	2.1	4.7	6.1	6.2	2.5	5.5	5.6	4.4	1.1	2.9	5.1	3.6	0.0	0.9	8.1	13.8	11.6	8.2	3.4	5.4	6.1	10.0	9.7	17.5	7.3	0.0	1.8	9.3	13.1	4.2	11.3	10.5	6.9	0.0	13.7	0.0	11.9	10.2	6.5	0.0	6.6	8.0	5.6	19.3	6.1	7.3	10.6	15.8	11.9	15.0	10.2	6.0	6.9	5.9	6.0	16.1	3.0	0.0	5.0	13.6	10.4	1.5	15.3	1.0	5.5	9.6	10.2	2.4	16.8	11.8	4.7	14.3	4.1	7.5	13.3	7.7	1.5	5.7	5.6	7.1	9.1	6.6	1.8	0.5	0.7	2.5	0.7	2.1	1.1	1.3	1.9	0.5	1.0	1.0	2.6	3.4	0.8	1.6	0.3	1.5	2.9	2.5	2.2	3.2	2.6	2.4	2.9	2.4	2.6	2.1	2.5	3.6	8.8	6.4	5.9	0.3	7.8	11.2	4.7	6.7	51.2	2.9	11.5	8.5	2.0	7.2	6.2	1.8	0.0	9.9	6.1	9.3	5.9	8.1	4.2	11.6	6.1	9.6	6.0	19.8	0.7	6.7	13.3	5.6	6.1	8.1	2.5	12.4	5.0	3.3	5.0	10.1	0.6	7.0	8.2	2.8	8.8	5.5	2.8	4.2	7.2	1.0	3.7	7.3	3.1	0.0	0.5	6.0	6.2	3.4	7.7	5.2	10.3	9.9	3.2	4.9	0.0	5.4	17.4	11.1	8.8	34.1	10.2	14.1	6.8	14.9	6.5	4.1
FKRP	"FKTR, LGMD2I, MDC1C"	ENSG00000181027	"Fukutin related protein"	Q9H9S5	19	46746046-46776988	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Transferase	"Cardiomyopathy, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043115, HPA060454"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA043115: AB_2678324, HPA060454: AB_2684281"	"unprognostic (4.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.59e-3)"	"prognostic favorable (8.98e-4)"	"unprognostic (3.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-2)"	10.5	9.1	8.5	8.1	8.2	8.8	9.9	3.7	11.5	11.4	4.5	13.3	4.8	15.2	5.0	8.8	12.6	6.0	15.8	8.5	10.4	12.0	11.9	10.4	7.4	10.1	7.3	12.7	11.1	7.5	16.8	10.1	8.8	13.5	4.3	5.7	11.1	7.4	19.6	7.2	10.5	5.8	6.1	14.7	10.9	9.3	9.4	5.6	13.6	9.8	4.9	13.0	10.5	8.7	12.7	26.5	17.8	12.5	15.4	16.9	15.8	31.7	21.0	12.6	19.9	17.0	21.4	11.7	17.0	18.2	20.9	13.0	6.6	14.8	11.5	21.9	22.2	11.7	14.4	10.7	13.3	9.3	19.8	19.4	12.5	15.6	15.2	14.6	16.7	6.0	12.2	11.0	12.7	5.8	6.8	22.8	17.2	7.8	6.5	18.3	11.1	4.0	8.0	26.4	12.0	23.1	15.8	7.6	10.6	11.7	8.9	7.3	16.8	18.4	19.8	6.7	25.7	11.6	15.4	11.0	15.0	7.5	25.6	1.3	1.8	0.8	1.5	1.0	0.9	1.7	1.1	1.7	1.1	2.4	1.2	1.6	2.2	2.0	1.1	1.9	0.6	1.2	8.5	8.2	3.7	11.5	8.5	10.4	10.1	7.3	8.8	6.1	9.4	8.7	4.7	9.6	7.4	6.8	3.9	0.8	4.8	3.0	1.2	9.8	5.3	5.2	15.5	4.3	5.6	5.5	6.2	9.6	9.1	4.5	5.9	4.2	12.0	7.9	7.3	6.0	7.8	7.8	6.8	2.4	5.9	6.6	3.6	5.1	1.3	6.7	11.4	16.6	7.6	3.3	8.2	4.2	2.0	10.0	1.2	13.2	5.6	4.3	5.4	3.7	6.1	7.8	2.1	8.0	6.2	4.1	4.7	4.1	3.6	4.3	4.2	8.2	9.7	11.0	6.6	7.2	7.0	12.2	4.0	2.4	1.6	18.7	4.3	4.5	4.0	4.3
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	10.2	1.9	3.7	10.9	2.3	12.2	6.0	2.1	2.8	5.7	1.2	3.7	3.2	4.6	1.1	2.8	2.7	6.1	6.2	1.8	2.9	2.1	2.8	10.8	12.3	4.7	2.7	1.2	1.7	3.5	0.7	12.5	4.3	1.9	2.9	0.5	2.2	2.2	2.8	1.7	4.0	5.9	3.5	35.8	4.3	0.9	3.9	17.2	2.9	6.6	10.4	6.7	1.9	2.8	0.2	0.0	5.6	0.0	0.8	1.0	0.1	3.3	9.2	3.8	3.1	0.0	0.0	18.5	31.7	11.1	1.1	0.1	0.8	13.5	4.1	9.0	0.2	113.9	0.5	0.0	6.0	13.7	14.6	0.8	1.1	7.7	17.3	11.1	60.5	25.6	0.0	23.3	0.8	0.0	13.3	8.1	1.8	0.0	3.1	49.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	20.4	63.0	0.7	0.0	0.2	3.5	7.3	16.4	16.6	0.1	31.8	5.2	34.5	15.5	24.5	10.1	15.3	11.9	6.8	8.9	8.2	19.1	6.0	3.7	8.2	11.8	12.3	19.1	3.3	11.1	20.1	3.7	2.3	2.1	2.8	1.8	2.9	4.7	2.7	4.3	3.5	3.9	2.8	53.4	6.4	5.3	0.3	65.7	5.1	0.3	1.7	2.2	0.0	0.7	1.3	5.5	5.7	0.1	1.8	0.0	0.4	43.1	0.0	0.0	0.0	0.5	0.4	0.6	84.2	0.0	23.4	0.3	0.0	0.4	5.9	2.0	0.3	22.8	0.0	64.6	1.3	43.2	0.0	1.5	0.1	0.0	86.4	24.7	0.5	1.8	60.3	7.2	231.4	68.4	0.1	93.7	4.0	0.7	0.0	0.0	0.7	56.9	0.3	0.0	0.4	0.8	0.4	6.6	2.1	3.1	0.2	0.1	0.6	4.1	0.3	52.8	0.9	0.2	0.4
FLII	"FLI, Fli1, FLIL, MGC39265"	ENSG00000177731	"FLII actin remodeling protein"	Q13045	17	18244815-18258738	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.4"	"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 198.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007084, HPA008903, CAB016132"	Enhanced		Enhanced	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		150000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	57.7	50.0	9.8	22.9	11.5	26.4	55.0	12.6	11.1	50.2	13.4	56.2	19.5	49.6	7.3	65.7	41.3	13.7	75.1	9.9	11.5	42.2	30.7	53.3	20.0	15.4	13.0	39.1	57.6	16.9	39.0	17.0	15.4	41.5	12.9	4.6	63.6	17.4	245.4	46.9	50.8	18.9	12.1	58.0	45.6	35.3	14.2	17.4	44.1	73.1	15.8	61.3	50.3	13.6	198.0	73.5	18.4	30.0	44.2	38.9	29.4	53.7	64.1	59.0	36.4	93.5	45.2	39.7	56.3	61.1	33.7	89.0	26.2	90.1	34.4	32.6	42.6	20.5	54.9	36.9	50.0	23.6	44.3	36.4	53.3	47.9	71.8	36.2	58.0	35.3	18.0	15.0	34.9	61.3	34.9	20.5	20.5	85.1	37.8	34.3	87.2	48.7	43.5	58.4	7.2	10.9	63.1	51.0	28.7	117.2	90.8	17.8	73.3	53.6	54.4	104.0	64.4	15.9	12.5	11.5	50.8	23.5	28.7	10.0	27.5	25.6	12.8	39.3	12.5	9.3	9.9	13.0	30.2	6.0	7.3	8.2	22.6	10.5	51.1	8.6	12.7	24.2	9.8	11.5	12.6	11.1	9.9	11.5	15.4	13.0	15.4	12.1	14.2	13.6	44.9	60.9	36.9	12.7	23.3	22.7	24.9	35.1	26.7	15.4	29.6	23.9	37.4	22.8	47.3	25.8	18.8	25.9	24.8	62.8	15.6	53.5	45.2	37.5	27.9	38.7	23.9	21.7	7.2	56.9	28.7	28.4	42.3	56.6	46.9	28.8	27.5	19.4	48.9	26.9	7.4	26.0	24.4	46.2	39.7	9.2	32.3	52.2	16.0	14.0	55.7	11.4	12.3	3.5	14.2	134.4	49.8	35.0	31.8	40.7	48.8	21.3	50.3	12.7	32.9	28.0	30.7	40.0	20.0	33.8	19.6	25.4	32.1	33.3	40.9	38.6
FLYWCH1	DKFZp761A132	ENSG00000059122	"FLYWCH-type zinc finger 1"	Q4VC44	16	2911931-2951208	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040753, HPA041001"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA040753: AB_10794880, HPA041001: AB_10794259"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-2)"	16.0	14.6	22.6	11.7	22.4	12.5	14.2	22.6	28.7	18.6	15.9	19.3	12.9	17.7	4.8	12.8	17.0	13.0	19.0	18.9	20.8	12.8	8.3	14.0	11.3	33.2	23.3	20.6	10.7	14.7	16.4	8.2	30.0	17.2	3.7	13.3	13.7	12.5	32.8	20.4	14.4	7.6	19.2	18.7	13.4	4.0	27.3	9.1	15.5	10.7	6.2	21.8	16.2	23.7	10.0	34.8	7.8	23.2	12.4	12.5	23.6	18.2	14.1	9.0	9.2	5.8	31.8	24.4	47.3	14.0	14.7	20.5	6.5	12.2	1.8	40.8	19.6	8.2	30.9	19.5	27.7	10.9	27.3	11.2	37.9	19.1	13.8	16.7	12.9	16.0	18.6	25.0	7.0	23.8	25.1	13.3	12.7	7.5	23.6	43.5	11.6	44.0	10.6	6.7	16.7	15.5	19.1	20.6	24.1	4.3	16.1	19.6	24.4	15.0	13.6	29.4	12.4	37.1	34.5	22.7	16.4	17.8	17.9	1.2	0.8	0.3	1.3	0.4	2.3	0.9	2.1	2.7	0.8	2.6	1.7	1.5	0.1	0.5	0.4	0.5	1.1	1.1	22.6	22.4	22.6	28.7	18.9	20.8	33.2	23.3	30.0	19.2	27.3	23.7	16.7	0.0	4.2	34.3	10.4	12.4	9.3	9.2	23.3	42.1	8.6	11.3	12.3	8.6	5.1	22.0	35.5	21.2	14.3	6.5	1.9	6.1	0.4	6.0	7.7	13.4	2.4	6.5	26.9	6.5	8.5	13.9	12.2	8.9	0.0	48.3	11.0	6.8	8.5	33.7	29.0	4.9	4.1	9.9	5.1	1.2	11.1	8.9	8.8	13.1	7.9	18.8	9.2	18.6	25.6	7.1	2.9	14.3	10.4	5.3	8.9	6.3	8.3	39.3	0.0	16.6	20.9	0.9	3.2	13.1	13.9	8.8	11.9	5.3	7.4	5.6
FLYWCH2		ENSG00000162076	"FLYWCH family member 2"	Q96CP2	16	2883213-2899382	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041354	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA041354: AB_10795007"	"unprognostic (3.57e-2)"	"prognostic favorable (9.38e-4)"	"unprognostic (7.33e-2)"	"unprognostic (8.53e-3)"	"unprognostic (4.40e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (5.50e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	26.1	44.8	27.0	10.2	25.8	7.6	26.5	31.3	33.2	21.9	21.9	24.9	15.7	27.2	5.7	24.1	21.8	11.0	34.9	28.8	32.9	27.6	11.7	21.5	10.7	37.8	31.4	27.3	14.1	17.6	34.8	7.7	33.2	30.3	5.3	5.8	26.1	14.0	31.5	19.5	17.4	10.1	27.8	35.2	20.2	24.2	30.6	11.6	30.6	17.7	6.9	19.3	21.9	25.8	23.0	44.7	18.9	45.0	17.4	26.2	27.8	18.0	13.7	19.0	13.2	20.9	28.7	23.1	67.0	16.0	17.7	15.0	10.8	25.5	3.4	38.7	28.5	24.9	45.3	17.1	53.3	14.7	23.9	36.5	18.8	15.1	7.4	23.5	15.1	40.5	17.7	24.1	12.9	110.1	37.4	63.8	20.9	22.1	47.3	72.4	20.8	50.7	13.7	6.7	29.2	38.1	50.5	53.2	38.4	7.1	63.2	45.5	20.7	31.7	26.0	50.0	18.6	39.9	38.1	32.6	18.9	21.8	22.9	8.5	19.2	16.2	21.7	28.2	23.1	22.9	24.7	20.7	27.7	22.0	26.7	23.4	7.9	16.2	28.7	38.0	25.3	20.2	27.0	25.8	31.3	33.2	28.8	32.9	37.8	31.4	33.2	27.8	30.6	25.8	62.3	12.8	11.2	7.5	21.9	20.4	40.4	60.0	29.6	19.9	45.5	50.5	15.0	14.3	31.8	44.1	8.4	21.5	25.9	32.8	84.1	45.5	12.6	34.1	46.0	45.0	33.6	11.1	10.5	55.6	46.2	38.3	15.8	31.6	14.5	31.3	18.2	5.5	34.5	15.2	14.0	42.2	61.1	9.2	25.3	12.2	21.1	25.1	42.7	5.6	27.2	54.1	32.0	7.5	7.2	43.8	34.4	25.2	12.8	30.5	29.3	60.2	24.5	19.3	32.9	25.9	46.3	84.8	69.3	34.1	28.4	12.0	22.0	60.5	35.2	34.7
FMC1-LUC7L2	C7orf55-LUC7L2	ENSG00000269955	"FMC1-LUC7L2 readthrough"		7	139341360-139422599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 26.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045663, HPA051631"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA045663: AB_2679410, HPA051631: AB_2681558"	"unprognostic (2.54e-1)"	"unprognostic (5.27e-2)"			"unprognostic (3.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.68e-2)"		"unprognostic (4.48e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.42e-3)"		16.8	17.7	2.4	8.8	4.4	6.4	16.1	3.8	9.8	15.8	3.7	20.2	11.0	21.8	1.1	13.4	18.2	2.7	21.9	2.3	3.9	15.0	19.3	14.8	6.2	4.9	3.0	20.4	12.3	12.3	14.1	6.9	4.1	15.3	4.0	13.9	18.1	8.6	56.9	13.3	16.0	6.7	3.5	12.7	16.5	11.7	3.2	14.1	24.7	30.5	4.9	17.7	14.9	4.6	32.6	46.2	55.1	31.7	23.3	16.2	20.8	25.2	17.0	29.9	23.8	36.5	35.8	36.5	44.3	18.6	40.1	25.5	59.7	21.3	9.4	25.2	6.3	48.6	45.9	27.8	21.7	60.2	38.2	12.7	15.3	28.8	18.4	16.9	20.9	19.1	62.1	47.4	18.7	45.6	88.9	3.2	44.5	44.2	9.7	57.5	41.6	48.5	4.8	22.3	45.7	47.5	33.9	26.4	33.8	10.4	20.2	25.1	24.0	21.5	20.2	22.5	38.8	44.4	40.3	70.5	39.9	37.8	40.1	14.6	15.7	22.3	22.2	16.1	21.3	22.2	21.3	23.0	22.8	23.0	23.9	21.7	5.6	24.6	20.4	17.9	25.8	16.4	2.4	4.4	3.8	9.8	2.3	3.9	4.9	3.0	4.1	3.5	3.2	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FMN1	"DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289"	ENSG00000248905	"Formin 1"	Q68DA7	15	32765544-33194714	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;retina: 30.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 117.0;Cone photoreceptor cells: 221.0;Excitatory neurons: 439.4;Inhibitory neurons: 340.0"	"Cancer enriched"	"Detected in many"	9	"melanoma: 14.5"	"Region enriched"	"Detected in some"	7	"cerebral cortex: 16.9"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.4;RH-30: 26.9;SK-MEL-30: 28.7;T-47d: 24.8;U-138 MG: 17.2;U-2197: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005465, HPA046786"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA005465: AB_1859515, HPA046786: AB_10963545"	"unprognostic (1.57e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (7.61e-2)"	1.8	0.8	0.0	2.4	0.0	1.2	3.0	0.0	16.9	5.3	0.0	5.7	1.3	1.0	0.7	2.0	3.1	2.4	0.9	0.0	0.0	2.8	0.5	3.4	0.9	2.3	0.0	0.2	1.2	1.4	3.7	3.7	0.0	1.8	4.4	30.0	4.2	1.2	0.7	4.2	1.8	2.2	0.0	1.0	7.9	10.2	1.7	3.8	2.5	0.5	0.6	1.3	3.6	0.0	3.8	4.0	0.8	0.4	0.1	0.4	4.9	5.4	4.1	1.5	4.0	0.6	5.0	0.6	1.8	6.1	3.4	3.7	0.1	3.7	3.9	0.0	0.2	3.1	0.8	0.4	0.2	0.0	0.2	1.5	0.2	7.9	0.1	3.1	0.0	0.1	0.0	21.4	8.8	3.9	0.1	0.0	1.1	7.0	0.3	0.6	26.9	4.9	1.8	1.5	0.3	0.9	0.0	3.3	28.7	0.9	24.8	0.0	4.9	17.2	2.7	17.9	1.6	0.0	0.0	0.9	7.3	0.2	10.1	1.3	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.4	41.7	46.9	10.1	1.6	3.7	3.2	2.0	3.4	117.0	7.7	5.1	3.1	14.3	17.3	0.0	221.0	12.0	5.4	13.3	11.7	5.7	16.5	17.4	2.4	2.7	9.0	0.4	439.4	1.8	5.9	2.6	97.9	7.0	24.0	1.8	0.0	0.4	10.9	47.1	340.0	16.8	16.2	28.0	3.9	12.8	0.9	29.6	33.8	64.6	5.8	6.9	0.0	8.0	61.9	11.4	11.4	0.7	2.2	4.5	4.0	1.6	29.4	102.4	0.0	13.0	1.0	18.4	16.0	7.3	3.4	18.3	5.0	0.1	9.9	5.7
FN3KRP	"FLJ12171, FN3KL"	ENSG00000141560	"Fructosamine 3 kinase related protein"	Q9HA64	17	82716706-82730328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056172, HPA065831"	Approved		Approved	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA056172: AB_2683055, HPA065831: AB_2685565"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-2)"	23.2	22.1	40.6	13.3	43.7	18.8	19.7	43.3	41.3	23.4	35.1	22.9	15.3	23.1	19.4	20.4	20.4	16.6	16.1	41.1	41.7	23.9	29.3	16.3	18.5	42.5	41.6	32.1	19.3	18.4	17.2	21.8	43.2	20.8	18.0	17.8	22.2	23.2	11.4	23.6	19.4	22.1	42.9	20.9	20.6	13.7	41.7	16.6	16.7	10.6	22.8	19.7	20.7	48.3	31.4	122.3	33.6	44.5	15.9	30.3	27.2	56.9	31.8	54.5	44.3	64.9	21.8	25.6	37.0	46.6	50.5	35.3	30.1	43.5	48.7	17.2	54.3	42.6	66.2	77.5	28.3	30.7	23.2	27.8	50.9	51.7	28.1	33.4	39.8	35.9	42.5	15.8	70.7	59.8	58.8	45.2	15.2	68.7	53.5	44.0	83.4	40.3	38.9	58.7	27.6	58.1	93.7	42.7	47.3	57.4	69.8	43.6	34.8	103.3	35.9	74.2	85.3	32.1	37.8	64.8	48.1	38.2	49.0	32.0	21.9	30.6	29.6	24.7	29.5	23.9	28.8	28.8	18.2	24.8	32.5	24.3	3.4	32.1	13.8	36.0	29.7	26.0	40.6	43.7	43.3	41.3	41.1	41.7	42.5	41.6	43.2	42.9	41.7	48.3	14.3	12.8	11.1	5.5	13.9	15.0	26.0	26.0	15.4	18.1	13.3	15.6	6.9	25.8	15.3	11.0	8.4	100.3	20.0	12.2	23.5	20.6	2.0	10.7	13.0	14.8	7.8	31.2	7.6	11.1	45.3	18.1	13.3	22.3	13.3	18.6	10.8	12.1	33.8	3.3	6.7	15.4	22.4	11.2	11.3	4.2	28.3	12.8	23.2	6.5	20.9	36.1	17.5	5.0	11.8	17.8	15.9	31.6	27.6	15.5	11.1	28.2	10.0	18.5	13.1	13.6	20.9	18.3	36.2	18.0	15.3	62.5	17.2	22.3	15.6	24.0
FNDC11	"C20orf195, MGC5356"	ENSG00000125531	"Fibronectin type III domain containing 11"	Q9BVV2	20	63547891-63556695	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"testis: 108.0"	"Cell type enhanced"	"Detected in some"		"Club cells: 1.3;Collecting duct cells: 1.8;Endometrial ciliated cells: 5.1;Respiratory ciliated cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.5;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;EFO-21: 2.6;HaCaT: 1.5;OE19: 1.8;SH-SY5Y: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041341			Approved	Nucleoplasm,Vesicles,Aggresome		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Vesicles"	Aggresome	"HPA041341: AB_10794991"	"unprognostic (2.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.99e-3)"	"unprognostic (7.94e-2)"	"unprognostic (8.30e-4)"	"unprognostic (3.68e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.81e-2)"	0.4	0.1	0.2	0.3	0.1	0.5	0.6	0.1	0.3	0.8	0.3	0.3	0.1	0.4	2.3	0.2	1.2	0.3	0.2	0.1	1.1	1.2	0.1	0.9	0.6	0.5	0.5	0.4	0.1	0.0	0.9	0.1	0.3	0.6	0.0	0.0	0.4	0.1	0.1	0.4	0.6	0.0	0.4	1.0	0.4	108.0	0.5	0.3	0.5	0.0	0.4	0.7	0.6	0.2	0.2	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	5.2	0.3	2.6	0.0	0.1	1.5	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.6	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.1	1.8	0.4	0.0	0.0	0.0	0.9	0.0	0.2	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	1.5	0.1	0.2	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.5	0.5	0.3	0.4	0.5	0.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	6.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0
FNDC3A	"bA203I16.5, FNDC3, KIAA0970"	ENSG00000102531	"Fibronectin type III domain containing 3A"	Q9Y2H6	13	48975912-49209779	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008927, HPA012555, HPA012825"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Golgi apparatus, Centrosome"	Cytosol	"HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.14e-2)"	17.8	39.9	15.2	18.7	18.6	17.0	26.3	12.7	16.4	35.2	13.6	23.3	27.5	32.1	38.8	13.1	26.5	26.8	14.0	15.3	39.4	29.7	66.9	21.6	16.7	16.7	19.6	35.4	43.1	27.7	30.8	44.1	17.4	22.1	24.0	21.9	36.8	33.9	10.1	11.4	23.8	26.0	15.5	22.6	28.8	30.4	31.9	21.3	51.2	13.1	18.9	25.6	14.1	17.9	11.6	13.1	47.1	12.4	58.3	73.0	9.2	53.3	70.8	50.2	36.3	17.9	27.7	8.8	9.7	40.5	21.8	12.4	28.4	18.1	72.6	22.1	21.9	14.3	36.9	33.2	35.3	13.4	2.3	37.7	24.8	44.7	51.4	47.1	52.6	11.9	18.0	21.0	55.4	4.7	13.3	26.7	23.2	25.0	11.0	12.6	18.8	16.4	42.4	21.2	17.8	29.4	20.1	17.8	38.8	29.8	9.6	26.0	41.7	26.1	17.9	24.3	38.3	25.4	14.4	8.1	19.6	16.9	27.4	1.9	3.0	1.9	2.5	2.0	3.6	3.3	2.9	2.2	1.9	2.2	3.7	3.3	4.5	2.1	4.0	4.0	2.6	1.7	15.2	18.6	12.7	16.4	15.3	39.4	16.7	19.6	17.4	15.5	31.9	17.9	46.7	54.5	49.0	88.2	36.2	18.4	37.4	17.5	44.3	52.0	33.4	25.5	27.1	27.1	28.9	36.8	37.5	13.2	36.4	21.6	13.7	30.6	45.9	42.1	74.3	42.4	43.5	17.9	159.5	36.2	38.2	58.0	57.6	56.4	31.6	38.8	32.9	74.2	25.4	35.3	170.8	37.4	18.3	31.8	24.4	13.1	33.8	45.5	37.4	112.4	27.0	52.7	24.7	177.9	178.2	25.5	29.0	39.5	165.9	44.2	37.8	48.0	35.6	42.5	6.6	48.0	50.8	89.8	33.7	20.3	11.9	32.3	30.9	46.4	24.7	26.4
FNDC4	"FLJ22362, FRCP1"	ENSG00000115226	"Fibronectin type III domain containing 4"	Q9H6D8	2	27491883-27495200	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 124.2;liver: 126.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 255.2;Hepatocytes: 130.9;Late spermatids: 557.6;Pancreatic endocrine cells: 89.2"	"Cancer enhanced"	"Detected in all"		"glioma: 39.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 35.3;ASC diff: 34.7;HUVEC TERT2: 43.3;SH-SY5Y: 33.2;TIME: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051804, HPA063581"	Uncertain		Approved	Nucleoplasm,Aggresome,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Aggresome, Cytosol"	"HPA051804: AB_2681617, HPA063581: AB_2685048"	"unprognostic (2.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (6.11e-4)"	34.5	124.2	55.4	2.9	54.6	0.0	26.2	59.8	69.0	7.5	40.3	5.9	1.1	4.2	2.7	24.9	3.8	12.2	11.7	58.9	56.0	11.4	126.9	4.6	1.1	64.6	57.5	38.3	11.9	36.5	11.2	2.5	63.6	11.8	1.8	10.4	9.0	3.2	4.1	4.9	3.4	5.4	56.2	5.4	5.6	27.3	59.2	0.4	5.9	4.0	2.8	6.0	8.0	56.1	0.0	0.3	19.9	35.3	34.7	21.2	0.3	8.1	16.3	5.8	5.0	1.6	0.6	0.0	0.9	25.9	7.5	0.0	13.3	4.9	5.0	0.0	2.2	1.7	0.1	18.7	12.9	0.0	0.2	18.2	2.3	10.0	2.0	26.0	43.3	0.0	1.9	0.0	21.3	0.0	0.0	0.1	12.4	0.0	0.7	0.0	0.0	0.0	3.4	0.0	0.3	33.2	0.2	0.0	0.3	2.6	0.1	0.0	39.7	5.4	2.4	2.1	6.3	0.0	0.0	0.0	29.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	54.6	59.8	69.0	58.9	56.0	64.6	57.5	63.6	56.2	59.2	56.1	14.8	0.0	0.5	5.2	0.8	3.4	3.2	0.4	5.7	9.1	8.3	12.8	2.4	14.3	0.2	0.0	4.2	0.2	0.4	0.0	3.9	72.9	255.2	1.6	18.8	10.9	0.0	2.7	20.1	48.3	0.2	17.3	6.1	2.0	5.7	5.9	10.0	130.9	0.5	0.0	18.7	0.5	0.0	3.2	5.3	557.6	15.5	1.0	3.6	5.6	1.0	23.7	0.0	10.6	2.1	89.2	0.0	11.7	0.7	11.9	0.0	0.4	0.2	12.9	0.0	34.4	15.6	5.0	8.4	1.4	2.4	0.0	1.5	1.0	0.1	1.7
FNDC7	FLJ35838	ENSG00000143107	"Fibronectin type III domain containing 7"	Q5VTL7	1	108712908-108742749	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 4.6;Late spermatids: 1.5;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028079, HPA054297"	Enhanced		Approved	"Nucleoplasm,Actin filaments"	"Secreted in male reproductive system"	NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Actin filaments"	Nucleoplasm	"HPA028079: AB_10602501, HPA054297: AB_2682441"	"unprognostic (2.35e-2)"	"unprognostic (2.65e-2)"			"unprognostic (3.74e-1)"			"unprognostic (8.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-4)"		"unprognostic (1.90e-10)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-1)"		"unprognostic (1.31e-1)"	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.8	0.4	1.1	1.3	0.6	0.7	0.4	0.5	0.2	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	4.6	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.8	0.0	3.5	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1
FOS	"AP-1, c-fos"	ENSG00000170345	"Fos proto-oncogene, AP-1 transcription factor subunit"	P01100	14	75278826-75282230	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 504.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 504.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 453.1;OE19: 170.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebellum: 80.9;spinal cord: 235.3"	HPA018531	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA018531: AB_1846576"	"unprognostic (1.18e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.55e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-2)"	1136.1	735.7	62.9	576.0	87.2	2270.6	477.4	184.8	113.1	700.5	111.5	479.5	235.3	410.4	58.4	1250.8	1777.3	1160.0	513.1	58.9	190.7	266.1	308.8	486.9	449.9	145.1	84.0	1188.7	298.4	264.7	452.3	417.4	92.0	791.1	627.4	233.3	555.6	462.3	99.1	1645.4	584.5	964.3	100.6	178.0	525.6	87.2	104.4	424.2	1007.6	1014.2	26.8	946.5	346.6	121.7	2.2	1.4	7.1	10.4	59.9	18.3	42.1	6.4	2.4	4.5	3.2	4.4	12.6	0.6	1.8	43.5	42.6	3.0	3.6	74.7	1.1	1.2	1.1	1.0	21.9	1.9	27.6	2.6	42.8	44.3	453.1	3.9	27.4	6.2	2.7	9.2	2.0	19.7	1.2	26.1	0.9	12.9	7.4	170.9	2.5	2.0	1.4	23.8	18.8	20.4	52.4	3.6	9.8	85.9	39.8	21.8	1.4	9.2	6.3	0.4	5.7	3.7	2.0	52.4	61.2	9.6	2.9	8.0	5.7	38.3	81.0	89.5	0.3	20.1	0.4	0.3	0.2	0.7	69.6	0.2	0.2	0.1	504.8	4.6	2.5	1.5	0.4	27.7	62.9	87.2	184.8	113.1	58.9	190.7	145.1	84.0	92.0	100.6	104.4	121.7	3911.0	1102.6	1859.4	137.1	1015.9	859.7	1644.7	1577.5	4336.7	106.1	3184.1	2874.6	1027.6	1416.9	752.7	191.3	129.3	1506.7	1323.5	1648.6	17.6	690.9	17.4	1834.4	3720.3	1624.0	1628.0	290.5	4.9	528.1	2694.6	4146.8	2049.5	3656.5	1630.6	751.3	1317.2	207.2	1693.8	35.3	3.0	1967.2	793.5	2600.2	1540.4	53.5	943.8	2910.7	855.6	58.1	269.5	1119.5	10.3	6.0	1.8	383.5	1507.8	178.3	1256.1	1115.7	1675.1	20.0	354.4	406.9	1209.6	3390.9	2705.7	10.0	10.5	2438.0	1092.4	2283.3	1497.0	417.4	1366.2	298.4
FOSB	"AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291"	ENSG00000125740	"FosB proto-oncogene, AP-1 transcription factor subunit"	P53539	19	45467995-45475179	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1627.1;Skeletal myocytes: 2234.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 45.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 11.4;HMC-1: 13.3;hTCEpi: 8.1;Karpas-707: 6.8;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010267, HPA054663"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB010267: AB_640583, HPA054663: AB_2682562"	"unprognostic (7.22e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.72e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.04e-2)"	394.7	121.6	2.1	118.4	5.5	433.8	91.7	35.7	45.6	150.3	4.8	37.6	24.8	46.6	3.9	187.7	404.1	347.1	48.9	11.1	7.8	34.7	85.5	113.5	67.7	1.5	1.6	274.4	126.3	46.2	27.3	57.8	1.5	118.5	78.4	10.7	76.8	29.6	3.3	267.8	63.1	353.7	0.8	21.8	104.4	8.8	1.2	152.2	316.0	81.3	1.6	213.9	11.0	3.8	0.4	0.6	0.1	0.3	1.2	0.3	1.8	2.3	1.0	0.7	0.7	0.5	1.0	2.0	0.4	1.5	11.4	0.8	0.5	1.6	0.5	0.3	0.7	0.6	0.8	0.4	0.8	1.1	13.3	0.5	8.1	1.7	1.9	0.4	0.9	2.3	0.8	6.8	0.2	0.2	0.2	1.2	0.4	1.0	0.4	0.5	0.1	1.4	0.6	1.3	3.1	0.4	1.4	9.6	1.2	1.9	0.5	0.8	0.1	0.5	0.6	1.1	0.7	5.1	0.8	0.5	1.1	0.8	1.3	0.9	1.2	1.0	0.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.1	2.1	5.5	35.7	45.6	11.1	7.8	1.5	1.6	1.5	0.8	1.2	3.8	1048.7	685.9	761.3	2.6	445.7	380.5	533.4	162.4	865.6	50.6	1627.1	1523.2	177.8	370.3	174.4	11.0	135.5	237.5	359.6	551.1	1.9	145.5	10.1	667.9	1204.4	442.6	877.0	68.6	1.3	74.2	301.9	788.2	911.3	1541.3	830.4	239.3	393.7	77.9	210.3	8.4	0.3	898.4	42.7	345.2	353.4	11.3	240.2	797.3	172.5	1.0	16.3	186.1	1.0	0.0	0.3	111.6	457.3	59.5	503.4	307.3	417.8	2.7	111.5	217.6	302.4	2234.0	608.8	3.3	4.5	476.3	380.9	396.9	481.8	174.2	616.5	208.5
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.4;urinary bladder: 84.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 338.0;Basal prostatic cells: 398.5;Basal squamous epithelial cells: 281.1;Prostatic glandular cells: 196.9;Squamous epithelial cells: 210.4;Suprabasal keratinocytes: 339.5;Urothelial cells: 456.4"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 51.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"myeloid DC: 3.4"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in many"		"PC-3: 829.4;U-2197: 520.1;WM-115: 1123.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB004396, HPA030728"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.80e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	56.4	11.2	1.2	7.7	1.3	26.8	10.5	2.2	4.3	6.0	1.0	7.4	1.0	3.5	0.1	48.9	8.5	29.6	11.9	1.6	1.7	12.6	5.6	16.7	0.3	1.9	1.4	1.7	12.9	0.5	4.8	2.7	2.1	6.4	1.9	0.6	11.0	0.8	4.1	25.2	5.5	4.7	1.0	1.7	21.0	0.9	1.9	2.7	5.3	0.3	2.1	84.3	13.8	1.0	324.3	43.8	5.4	20.4	45.7	44.4	45.0	288.5	257.2	239.7	131.7	14.2	252.6	0.5	65.1	199.7	379.6	60.6	19.6	227.4	210.8	9.7	0.7	20.6	4.5	34.9	57.0	13.3	6.9	18.8	23.1	191.1	297.1	117.9	80.4	0.2	48.8	1.7	320.9	12.3	0.3	26.5	21.5	27.0	829.4	1.5	25.7	1.3	116.7	20.4	0.4	0.5	18.2	0.8	229.0	13.0	1.0	12.1	200.6	282.5	62.7	520.1	423.8	0.3	1.4	0.9	389.7	4.9	1123.6	0.0	0.8	0.0	0.1	0.5	0.0	0.0	0.2	0.1	3.4	0.0	0.2	0.0	0.5	0.0	0.3	0.4	0.0	0.5	1.2	1.3	2.2	4.3	1.6	1.7	1.9	1.4	2.1	1.0	1.9	1.0	15.2	6.4	4.4	0.3	2.0	338.0	398.5	56.2	281.1	0.0	27.6	12.2	1.0	4.3	26.2	0.0	0.0	1.3	4.3	11.8	0.0	25.1	0.3	24.4	12.2	30.1	11.3	0.8	0.1	3.5	4.3	45.8	74.9	56.3	9.5	0.3	6.1	0.4	1.9	0.0	0.1	6.8	10.2	1.0	46.6	0.0	0.3	15.5	44.4	1.0	1.1	0.1	0.0	0.5	0.2	39.0	11.1	0.0	6.2	196.9	1.2	0.2	10.7	0.0	0.0	32.4	26.1	0.4	0.7	210.4	339.5	17.6	6.8	0.1	4.2	456.4
FOSL2	"FLJ23306, FRA2"	ENSG00000075426	"FOS like 2, AP-1 transcription factor subunit"	P15408	2	28392448-28417317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 287.6;Langerhans cells: 319.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 36.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004817, CAB013460, HPA061417"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.41e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.79e-2)"	149.4	169.7	18.8	67.6	18.4	232.1	78.6	18.8	31.8	83.0	17.4	64.3	30.2	77.8	7.0	129.5	85.7	79.6	75.1	34.7	32.2	65.8	30.9	83.4	9.1	36.0	19.3	133.5	37.2	7.5	46.6	46.9	18.8	53.8	40.2	10.7	47.4	26.7	101.7	103.4	52.2	81.5	18.2	32.7	76.6	7.3	23.5	17.2	35.2	33.9	16.6	82.3	112.1	15.0	45.0	30.2	2.0	23.2	23.9	41.6	62.0	37.7	38.0	58.8	51.1	35.9	34.6	0.2	53.9	48.6	59.6	42.0	2.5	49.7	52.6	10.6	3.1	4.6	59.3	6.3	37.3	7.9	18.9	66.9	123.3	69.0	60.5	49.5	31.2	1.5	0.6	12.5	39.7	7.3	0.7	24.3	3.6	45.2	14.8	1.8	57.4	4.3	94.3	152.5	15.7	2.3	61.0	35.2	10.9	16.8	3.8	35.5	93.8	122.8	81.9	72.3	55.2	19.1	7.6	0.2	81.5	43.3	21.6	17.2	9.9	8.7	7.7	7.3	7.4	0.0	1.6	3.8	3.9	0.0	0.4	2.5	36.6	4.6	6.4	1.3	1.2	5.1	18.8	18.4	18.8	31.8	34.7	32.2	36.0	19.3	18.8	18.2	23.5	15.0	183.1	32.1	50.9	4.6	20.2	143.1	86.3	85.8	90.0	0.8	76.4	41.7	27.9	70.1	59.7	167.3	0.0	27.4	287.6	140.6	19.6	58.5	1.3	115.7	88.0	111.0	28.1	4.4	11.9	59.8	148.3	79.7	115.7	193.6	108.3	68.1	56.7	16.5	37.4	0.0	8.1	65.2	40.7	58.0	319.8	4.3	22.4	181.2	85.4	15.0	62.8	2.3	53.5	0.5	0.6	54.1	91.5	24.5	67.0	82.2	124.8	35.1	38.2	1.4	26.3	93.8	122.3	1.6	2.5	157.6	150.7	50.2	142.4	23.6	57.6	152.8
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589552-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 74.7;stomach 1: 28.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 113.8;Basal squamous epithelial cells: 76.8;Breast glandular cells: 87.9;Enteroendocrine cells: 84.6;Prostatic glandular cells: 89.8;Respiratory ciliated cells: 66.7;Urothelial cells: 154.5"	"Group enriched"	"Detected in many"	5	"breast cancer: 80.0;prostate cancer: 127.0"	"Region enriched"	"Detected in single"	5	"midbrain: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 48.9;MCF7: 105.3;PC-3: 69.5;RT4: 96.7;SK-BR-3: 97.0;T-47d: 135.9"	"Region enhanced"	"Detected in some"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	6	"midbrain: 5.4"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.00e-4)"	0.2	0.1	0.0	1.6	0.0	0.0	22.3	0.0	0.0	1.5	0.0	12.4	8.4	0.1	0.6	11.9	2.4	2.3	0.0	0.0	0.3	0.1	26.9	7.5	0.0	0.1	3.5	0.0	0.5	0.0	0.7	0.0	0.2	74.7	10.4	0.0	19.3	0.3	0.0	1.3	4.8	0.2	0.2	0.0	28.0	0.4	0.7	0.0	0.0	0.0	2.3	20.5	4.4	0.0	4.9	4.4	0.0	2.8	0.0	0.0	0.5	0.0	0.4	0.0	0.0	21.3	2.7	0.0	1.4	0.0	0.1	23.4	13.2	3.3	0.1	0.0	23.4	0.0	4.1	48.9	0.0	0.0	0.2	0.0	0.7	0.0	0.4	1.9	0.0	0.4	0.9	0.0	0.0	105.3	0.1	0.3	0.0	32.0	69.5	0.0	1.1	0.4	9.9	96.7	11.8	0.0	4.8	97.0	0.0	0.0	135.9	0.4	0.0	0.9	0.1	0.4	3.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	3.5	0.2	0.2	0.7	0.0	0.3	28.9	43.5	0.0	0.1	1.0	113.8	47.8	76.8	0.0	87.9	34.8	1.3	30.0	52.3	3.7	0.0	0.0	0.5	27.5	0.0	1.5	0.4	2.7	0.2	1.2	84.6	0.0	0.0	2.4	0.0	1.0	35.7	4.4	2.5	0.0	1.1	31.7	0.0	0.0	0.0	34.9	42.7	0.9	0.3	0.9	0.0	0.7	3.6	0.0	1.0	0.0	0.0	0.0	0.0	4.3	27.2	0.0	1.2	89.8	4.9	0.0	66.7	0.0	0.0	0.0	2.3	0.9	1.2	62.9	0.1	0.0	1.4	0.1	27.9	154.5
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22580998-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 36.2;pancreas: 26.6;stomach 1: 31.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 96.1;Alveolar cells type 2: 78.0;Cholangiocytes: 47.1;Exocrine glandular cells: 37.0;Gastric mucus-secreting cells: 37.8;Hepatocytes: 63.7;Intestinal goblet cells: 87.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"midbrain: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.5;HBEC3-KT: 19.3;Hep G2: 28.8;hTERT-HME1: 12.6;OE19: 22.7;PC-3: 24.7;SCLC-21H: 42.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"midbrain: 3.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	14.2	0.0	7.3	3.7	2.1	0.0	0.1	4.3	4.0	0.0	0.0	0.0	0.2	36.2	13.7	0.0	0.0	2.5	0.0	26.6	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	31.1	0.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	19.3	0.0	0.0	1.2	0.0	0.0	28.8	0.0	0.0	0.0	0.0	10.3	0.0	12.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	22.7	24.7	0.0	0.0	0.0	0.8	0.0	42.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.0	0.0	96.1	78.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.1	0.3	0.3	47.1	12.5	0.0	0.0	0.0	0.0	21.7	0.0	25.6	0.1	30.8	2.6	0.1	28.1	0.0	0.0	37.0	0.0	0.3	37.8	27.1	4.5	0.0	0.7	63.7	0.0	0.0	0.0	87.2	6.1	1.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	24.4	6.8	0.0	0.2	1.0	1.0	0.0	10.0	0.0	0.0	0.0	0.2	4.1	0.2	0.0	0.0	0.0	1.0	0.0	28.7	0.1
FOXA3	HNF3G	ENSG00000170608	"Forkhead box A3"	P55318	19	45863989-45873797	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 17.5;liver: 64.6;pancreas: 48.2;stomach 1: 36.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 83.3;Gastric mucus-secreting cells: 152.9;Intestinal goblet cells: 230.1;Paneth cells: 74.7;Undifferentiated cells: 46.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 19.9;liver cancer: 26.4;pancreatic cancer: 20.7;stomach cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.5;Hep G2: 29.1;K-562: 23.5;OE19: 101.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB015154, HPA054034"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"CAB015154: AB_647545, HPA054034: AB_2682349"	"unprognostic (2.88e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.11e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	1.4	0.0	17.5	10.6	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	2.8	64.6	0.3	0.1	0.0	0.0	0.0	48.2	1.1	0.0	0.0	0.0	0.5	17.1	0.0	2.1	0.4	0.0	0.0	12.8	0.7	0.0	0.0	36.8	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.6	4.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	12.5	1.1	0.2	0.0	29.1	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.7	23.5	0.0	0.0	0.3	0.1	0.0	11.2	101.2	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.5	0.3	0.9	0.3	1.3	0.7	0.0	0.0	2.6	1.5	0.5	15.7	2.5	1.8	0.0	0.0	0.6	40.2	0.0	12.5	0.2	0.1	0.1	0.9	83.3	10.7	0.1	24.5	0.0	0.5	152.9	0.4	4.5	0.1	1.4	29.9	0.0	0.0	0.1	230.1	0.0	2.2	0.7	0.5	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.5	0.1	26.0	74.7	0.0	0.6	6.6	17.8	0.4	0.3	0.0	0.0	0.0	1.1	2.7	5.6	0.2	0.3	0.0	0.4	0.1	46.2	1.7
FOXB1	"FKH5, HFKH-5"	ENSG00000171956	"Forkhead box B1"	Q99853	15	60004234-60061730	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"brain: 21.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 32.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.6;HDLM-2: 14.7;HEK 293: 10.7;JURKAT: 5.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.6"	"Low region specificity"	"Detected in many"			HPA073369			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Mitochondria"		"HPA073369: AB_2686597"	"unprognostic (1.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-2)"		"unprognostic (1.47e-2)"	"unprognostic (5.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.12e-9)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"		"unprognostic (9.38e-2)"	0.0	0.0	2.0	0.0	3.0	0.0	0.0	5.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	21.6	0.0	0.0	0.0	0.2	9.7	8.5	0.0	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	0.0	0.2	0.6	9.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.5	0.0	6.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.7	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.0	3.0	5.4	0.8	0.2	21.6	9.7	8.5	5.8	8.2	9.5	4.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	32.5	7.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.6	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	6.8	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.8	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609915-1613897	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"salivary gland: 154.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 93.7;Breast myoepithelial cells: 59.4;Endothelial cells: 64.7;Hepatic stellate cells: 65.7;Urothelial cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 92.4;HEK 293: 91.8;RPTEC TERT1: 35.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 18.0"	HPA040670			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	12.3	6.0	7.7	1.2	8.3	0.6	9.0	7.1	9.3	6.3	11.0	1.7	0.9	3.7	1.7	4.8	5.0	7.5	14.0	6.0	6.5	19.9	1.2	3.3	1.7	9.0	7.4	4.7	3.6	1.6	9.5	4.1	8.7	8.6	0.9	0.3	154.4	6.4	2.4	11.1	1.6	2.3	7.1	0.4	1.7	2.0	9.2	8.3	5.6	2.9	2.2	9.4	5.6	7.1	18.0	2.0	0.6	92.4	4.2	4.6	2.9	8.9	10.3	5.4	4.3	6.7	3.7	0.0	10.0	5.2	3.9	19.9	8.8	6.5	4.5	5.7	91.8	3.7	5.3	3.3	2.8	1.4	6.0	15.6	8.7	7.3	8.3	2.8	7.9	0.6	2.7	0.1	2.3	3.8	0.0	2.0	0.3	8.9	7.6	0.0	3.7	0.5	35.9	13.3	3.4	8.0	10.9	0.1	6.4	4.5	2.6	1.5	2.0	11.5	7.1	5.9	9.6	0.4	0.8	0.0	3.2	4.5	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.7	8.3	7.1	9.3	6.0	6.5	9.0	7.4	8.7	7.1	9.2	7.1	93.7	0.0	0.6	0.0	0.4	17.7	31.9	26.3	13.6	0.0	42.2	59.4	7.1	0.0	23.6	11.0	0.0	5.3	1.9	0.9	1.9	3.9	0.6	8.6	1.1	64.7	0.0	0.0	0.0	17.1	0.6	21.2	1.5	3.8	0.0	0.7	65.7	0.4	1.3	0.0	0.0	1.5	8.2	1.3	5.5	1.4	16.1	2.7	1.8	23.4	0.0	0.3	0.0	0.5	0.1	16.2	0.1	28.2	0.1	9.5	0.0	7.4	34.9	0.0	0.0	19.2	40.4	0.7	3.1	11.2	6.5	0.8	1.1	4.4	0.6	64.9
FOXC2	"FKHL14, MFH-1"	ENSG00000176692	"Forkhead box C2"	Q99958	16	86566829-86569728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.6"	"Group enriched"	"Detected in some"	4	"Peritubular cells: 30.9;Sertoli cells: 19.7;Smooth muscle cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 25.2;HUVEC TERT2: 19.5;LHCN-M2: 31.2;TIME: 36.0;U-138 MG: 18.4;U-2197: 31.5;U-87 MG: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"spinal cord: 42.7"	HPA056302			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA056302: AB_2683093"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (1.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.84e-4)"	2.4	1.5	0.5	0.3	1.1	0.0	1.8	0.9	1.6	2.2	3.2	0.5	0.1	0.8	0.6	0.5	2.0	1.3	5.6	0.4	0.4	5.4	0.1	2.1	0.4	0.5	0.5	1.1	0.2	0.1	2.4	0.1	0.5	1.0	0.1	0.1	2.4	0.6	0.7	0.8	0.4	0.4	0.7	0.0	0.4	1.9	0.7	0.1	2.0	0.5	0.1	0.8	1.5	0.3	0.0	0.0	0.0	0.0	5.8	7.8	0.0	11.3	14.3	8.0	1.5	0.0	0.0	0.0	1.5	1.4	11.2	0.0	0.2	3.3	7.0	0.0	0.6	0.0	7.9	0.0	2.7	0.0	0.0	1.3	3.4	25.2	7.9	14.5	19.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.7	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	5.9	0.0	0.0	36.0	18.4	0.0	31.5	0.0	0.0	0.0	0.0	24.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.9	1.6	0.4	0.4	0.5	0.5	0.5	0.7	0.7	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.8	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	1.5	0.1	1.8	1.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	30.9	1.2	0.8	0.0	0.0	0.0	0.1	19.7	0.6	33.2	0.2	5.0	0.5	0.0	0.0	0.0	0.0	0.1	1.4
FOXD4	"FKHL9, FOXD4a, FREAC5"	ENSG00000170122	"Forkhead box D4"	Q12950	9	116231-118417	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;monocytes: 2.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 4.3"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (8.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.46e-2)"	"unprognostic (2.52e-4)"	"unprognostic (3.66e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-3)"	0.2	0.4	0.4	0.1	0.4	0.0	0.1	0.9	0.7	0.3	0.3	0.2	0.0	0.3	0.0	0.2	0.2	0.0	0.1	0.5	0.4	0.6	0.2	0.3	0.1	0.6	0.3	0.2	0.5	0.2	0.5	0.0	0.5	0.4	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.3	0.4	0.3	1.1	0.5	0.1	0.2	0.0	0.0	0.2	0.2	0.4	0.3	0.2	0.0	0.2	0.6	0.1	1.8	0.1	0.1	0.0	0.1	0.4	0.0	1.8	0.3	0.0	0.0	0.0	0.4	0.1	0.1	1.8	1.5	0.0	0.2	0.2	0.1	1.5	0.9	0.2	0.0	0.0	0.1	0.3	0.0	0.1	0.6	0.8	0.0	0.6	0.1	1.0	0.0	0.2	0.8	0.1	0.5	0.2	0.4	1.0	0.9	0.7	0.5	0.3	0.0	0.1	0.5	4.3	0.3	0.5	0.5	0.3	0.6	0.1	0.2	0.5	0.4	1.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.7	0.5	0.4	0.6	0.3	0.5	0.3	0.5	0.4	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.6	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.2	0.1	0.3	0.0
FOXD4L1	FOXD5	ENSG00000184492	"Forkhead box D4 like 1"	Q9NU39	2	113498665-113501155	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Cell type enriched"	"Detected in some"	11	"monocytes: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.5"									"HPA012836, HPA069839"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA012836: AB_2105429, HPA069839: "	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.02e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.41e-4)"	"unprognostic (2.54e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.18e-8)"	"unprognostic (1.57e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.91e-4)"	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.2	0.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.3	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.5	0.1	0.3	0.4	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1
FOXD4L3	FOXD6	ENSG00000187559	"Forkhead box D4 like 3"	Q6VB84	9	68302867-68305084	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Cell type enriched"	"Detected in single"	5	"monocytes: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.2;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA012836: AB_2105429"		"unprognostic (7.93e-4)"			"unprognostic (8.71e-2)"					"unprognostic (7.04e-2)"				"unprognostic (4.75e-2)"				0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.2	1.6	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXD4L4	"bA460E7.2, FOXD4L2"	ENSG00000184659	"Forkhead box D4 like 4"	Q8WXT5	9	65736555-65738784	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"brain: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"			Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (6.92e-2)"	"unprognostic (5.48e-2)"			"unprognostic (5.19e-2)"						"unprognostic (7.78e-2)"		"unprognostic (7.93e-3)"	"unprognostic (7.14e-2)"				0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	1.1	1.2	0.0	0.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXD4L5	bA15J10.2	ENSG00000204779	"Forkhead box D4 like 5"	Q5VV16	9	65282101-65285209	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (8.26e-2)"	"unprognostic (6.95e-3)"									"unprognostic (1.58e-1)"			"unprognostic (5.76e-2)"	"unprognostic (2.57e-1)"			0.1	0.2	0.4	0.0	0.5	0.0	0.1	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.7	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.2	0.9	0.1	0.1	1.0	0.2	0.0	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.9	0.5	0.5	0.3	0.2	0.0	0.5	0.8	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.9	0.3	0.0	0.2	0.1	0.3	0.2	0.1	0.2	0.2	0.6	0.2	0.2	0.4	0.4	0.8	0.2	0.1	0.0	0.5	0.2	1.1	0.1	0.1	0.6	0.3	0.3	0.2	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.9	1.2	1.0	0.0	0.6	0.2	0.6	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FOXD4L6		ENSG00000273514	"Forkhead box D4 like 6"	Q3SYB3	9	41126435-41128681	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.5;hippocampal formation: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"			Nucleoplasm		"HPA012836: AB_2105429"		"unprognostic (2.41e-1)"			"unprognostic (3.41e-1)"									"unprognostic (3.61e-1)"				0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXF1	"FKHL5, FREAC1"	ENSG00000103241	"Forkhead box F1"	Q12946	16	86510527-86515422	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 61.2;urinary bladder: 49.9"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 17.1;Fibroblasts: 46.3;Smooth muscle cells: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ: 12.8;BJ hTERT+: 27.9;HHSteC: 26.5;U-2197: 11.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028886			Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA028886: AB_10601652"	"unprognostic (7.91e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.44e-1)"	3.6	0.2	6.0	10.2	5.3	0.0	1.2	4.8	5.4	16.2	2.9	61.2	8.9	2.7	1.1	10.1	1.8	15.0	0.8	4.5	4.8	2.1	3.2	34.1	3.2	5.9	5.2	0.7	1.3	1.1	0.4	23.1	6.0	25.8	10.8	0.2	1.2	5.4	0.2	0.3	21.2	11.7	5.1	0.6	26.3	0.7	7.0	0.1	5.4	1.4	1.5	49.9	11.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	27.9	3.8	1.3	0.0	0.1	0.0	0.0	1.2	2.6	0.0	2.2	0.0	3.3	0.0	1.5	0.0	2.1	0.0	26.5	0.0	2.3	2.8	0.0	4.5	0.5	0.4	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	1.9	11.9	0.0	0.0	0.0	0.0	2.5	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	5.3	4.8	5.4	4.5	4.8	5.9	5.2	6.0	5.1	7.0	5.1	2.0	0.0	0.6	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.4	0.3	17.1	0.0	0.0	0.0	0.0	0.4	46.3	1.1	0.2	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.0	0.0	0.0	0.0	0.4	0.0	0.1	18.7	0.0	1.3	0.6	0.3	1.2	0.1	0.1	0.0	0.6
FOXJ2	FHX	ENSG00000065970	"Forkhead box J2"	Q9P0K8	12	8032716-8055517	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008723	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA008723: AB_1078903"	"unprognostic (1.68e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (9.01e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.02e-2)"	13.8	8.3	6.6	8.7	6.7	15.5	12.3	14.3	11.9	15.5	4.6	14.8	7.3	17.7	8.0	8.8	14.4	8.1	14.7	6.7	6.6	7.3	5.9	12.1	8.3	6.3	6.2	16.8	10.0	15.4	8.5	11.0	6.1	10.6	7.7	9.3	9.5	12.8	25.2	17.5	10.1	14.7	5.1	10.8	11.3	5.8	6.2	10.7	9.9	20.6	9.1	13.5	12.3	7.0	12.4	10.3	11.1	14.0	12.6	13.8	24.3	17.5	17.8	16.7	12.4	14.8	13.3	0.2	3.2	21.3	15.4	13.2	10.0	11.7	17.8	21.6	6.8	16.4	11.8	5.1	15.8	7.4	43.9	12.2	17.2	21.7	31.5	17.4	12.1	13.0	12.2	8.0	13.7	9.6	10.5	6.6	12.6	18.4	6.8	11.2	17.2	6.0	7.0	8.2	4.6	6.3	22.0	15.1	7.6	23.1	3.5	8.8	11.0	20.3	24.8	14.5	10.7	6.4	6.8	8.1	13.1	5.9	12.3	2.5	1.4	2.2	1.5	1.1	1.9	0.8	1.5	1.7	1.8	1.5	1.7	1.5	2.7	2.8	1.5	1.7	1.2	1.2	6.6	6.7	14.3	11.9	6.7	6.6	6.3	6.2	6.1	5.1	6.2	7.0	14.1	16.0	13.1	6.2	9.1	18.9	4.5	5.5	14.8	10.7	10.4	9.1	19.9	12.8	4.0	0.0	8.4	5.5	7.7	7.1	0.0	5.9	0.4	4.0	14.0	12.8	4.9	13.7	6.1	7.5	3.1	12.0	7.7	7.2	3.8	16.1	18.9	9.5	10.1	8.4	6.4	8.4	4.1	13.2	23.0	0.9	10.5	13.9	7.2	6.5	14.2	4.0	11.3	3.0	5.7	10.3	4.4	17.0	6.7	9.8	5.0	2.4	2.9	7.5	19.7	9.9	8.4	1.4	6.4	14.2	21.5	6.2	12.3	8.1	7.4	5.3
FOXJ3	KIAA1041	ENSG00000198815	"Forkhead box J3"	Q9UPW0	1	42176539-42335877	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 126.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067284			Approved	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA067284: AB_2685817"	"unprognostic (5.60e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.24e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (3.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (4.51e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (5.43e-2)"	23.2	12.9	15.6	14.9	18.6	30.2	22.2	28.6	20.1	22.6	15.2	17.8	15.7	20.2	14.8	15.5	17.9	13.1	20.1	19.7	19.6	13.4	16.2	18.5	17.8	13.4	13.2	23.1	18.9	21.4	17.1	18.4	11.9	17.1	18.1	19.4	16.9	14.6	42.1	22.9	17.6	17.7	12.5	17.2	17.5	16.4	16.2	22.2	19.2	29.2	17.3	18.3	19.1	20.6	24.8	20.5	22.1	23.0	23.3	28.5	31.7	18.4	27.1	24.2	26.8	19.0	28.9	37.8	19.1	25.8	20.7	23.1	31.1	30.2	40.8	28.5	17.5	41.7	26.3	16.3	20.1	38.7	27.4	21.3	29.3	36.2	44.6	25.7	26.7	29.6	25.7	26.6	29.2	14.1	39.3	22.0	34.4	19.8	18.3	36.4	57.9	25.9	20.5	35.4	30.6	28.8	33.1	37.8	33.1	31.4	19.0	56.9	25.0	25.1	33.5	25.7	30.8	26.2	34.8	30.2	22.7	31.6	20.7	5.1	4.9	5.5	7.2	4.3	8.9	6.4	8.9	7.9	4.0	9.2	9.3	10.7	9.3	9.9	8.9	8.3	6.2	4.2	15.6	18.6	28.6	20.1	19.7	19.6	13.4	13.2	11.9	12.5	16.2	20.6	47.5	12.8	21.3	75.4	29.5	35.4	10.9	16.7	40.5	21.4	22.9	18.3	39.9	10.0	18.5	16.5	18.8	13.9	28.8	33.2	17.6	10.7	23.7	30.6	32.0	26.7	27.0	27.3	110.8	14.7	30.8	22.6	31.6	38.1	12.7	19.3	16.4	17.0	11.7	21.9	112.6	26.5	8.2	18.6	15.3	18.4	22.4	18.7	10.6	87.1	16.0	15.0	27.8	102.5	126.6	15.9	18.9	19.9	29.2	21.4	22.6	14.8	15.1	31.3	6.6	38.3	22.0	32.1	22.5	28.2	33.4	27.9	27.7	12.6	18.9	20.8
FOXK1	IMAGE:5164497	ENSG00000164916	"Forkhead box K1"	P85037	7	4682295-4771442	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017998, HPA018864"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA017998: AB_1849077, HPA018864: AB_1849079"	"unprognostic (3.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-1)"	6.3	11.3	6.9	4.2	7.1	9.5	5.7	1.4	8.9	7.1	0.0	9.8	3.0	9.1	2.1	7.5	7.6	2.3	7.5	9.2	5.2	6.0	4.8	8.6	4.0	9.2	6.6	7.7	6.5	2.7	12.5	3.0	7.6	5.9	2.6	3.6	4.6	4.0	11.0	9.7	5.8	4.8	5.9	6.3	6.3	9.2	8.7	4.0	4.9	4.8	3.4	6.9	7.4	7.5	11.8	14.8	9.4	18.6	9.0	6.8	11.6	5.3	4.6	3.7	4.2	14.8	13.0	19.9	6.0	8.5	11.9	18.9	10.2	12.9	3.7	5.8	6.3	9.4	16.1	8.4	8.8	11.7	10.3	13.0	7.1	8.9	12.3	6.0	7.2	7.5	20.5	4.3	4.5	13.5	4.5	20.9	14.1	4.8	7.4	16.7	9.4	12.7	5.4	17.2	8.4	10.6	8.0	17.2	6.2	7.2	9.6	15.4	22.4	6.4	20.1	10.0	11.4	11.9	10.5	12.9	8.6	13.4	10.3	0.9	0.9	0.4	1.7	1.6	2.5	1.2	1.7	1.7	1.1	1.1	1.8	1.8	0.5	1.6	1.6	0.9	0.9	1.4	6.9	7.1	1.4	8.9	9.2	5.2	9.2	6.6	7.6	5.9	8.7	7.5	15.7	32.1	17.5	25.5	16.8	33.4	15.2	31.9	12.0	18.0	15.7	15.2	12.9	8.6	14.4	14.7	22.9	13.6	26.0	11.4	5.9	10.6	44.7	17.8	20.4	17.2	13.1	3.6	42.0	15.2	4.0	18.6	9.7	25.1	7.6	29.5	16.1	11.6	10.6	23.5	35.2	11.3	12.2	17.5	17.9	113.2	19.3	11.4	16.0	30.9	21.4	10.3	54.6	25.1	58.2	19.7	9.6	28.6	6.0	29.1	8.1	15.5	14.7	13.9	19.7	17.6	25.3	19.1	20.4	15.3	50.0	4.0	19.3	17.9	17.9	21.5
FOXK2	"ILF, ILF1"	ENSG00000141568	"Forkhead box K2"	Q01167	17	82519713-82644662	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027523, HPA073491"	Approved		Supported	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Mitochondria"	"HPA027523: AB_10601013, HPA073491: "	"unprognostic (2.39e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	14.0	24.0	10.7	12.6	13.2	8.0	12.1	14.7	16.3	14.2	1.2	18.1	9.3	19.7	9.8	20.2	13.2	10.0	17.1	12.4	10.5	12.7	13.1	14.2	12.5	5.8	7.1	14.7	15.4	20.0	17.7	15.7	6.3	13.3	9.4	11.6	12.1	12.5	43.0	18.8	12.1	16.4	3.0	11.6	14.7	28.1	9.4	18.4	15.4	28.4	11.9	15.5	13.4	12.7	48.4	50.4	46.3	50.9	26.2	28.5	31.0	27.6	31.6	47.4	47.9	49.1	30.1	40.7	19.6	34.4	52.3	27.6	49.7	32.0	44.4	28.3	47.9	42.3	32.7	49.4	41.0	47.3	27.2	27.2	57.2	50.4	56.8	29.2	48.9	43.7	57.7	40.7	26.3	28.8	81.8	30.4	26.5	39.7	38.2	53.0	39.4	34.2	21.7	40.1	76.2	56.1	27.4	69.0	65.1	48.8	48.7	54.3	38.3	62.2	43.2	42.2	56.6	46.7	45.1	53.5	33.4	39.0	33.4	1.5	1.0	1.2	1.4	0.7	1.1	1.5	1.1	1.4	1.2	1.0	0.8	0.9	0.1	1.6	0.9	2.0	1.3	0.6	10.7	13.2	14.7	16.3	12.4	10.5	5.8	7.1	6.3	3.0	9.4	12.7	21.5	51.3	27.1	23.5	11.5	37.2	8.0	10.6	10.2	19.2	17.7	15.7	19.5	7.2	16.2	14.7	12.5	11.9	19.3	15.6	3.9	8.7	15.6	19.4	22.4	14.9	10.9	7.8	44.6	10.7	8.8	13.2	14.3	26.7	2.5	22.1	10.8	13.4	20.0	47.1	39.6	12.6	8.2	17.3	22.0	24.1	9.3	19.2	12.4	20.6	13.9	12.3	6.2	33.2	49.1	11.4	12.4	13.2	13.3	13.6	12.2	7.1	13.9	16.7	0.0	19.8	16.6	15.0	10.3	17.0	43.0	9.7	11.6	30.6	13.0	10.7
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947137	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 12.8;ovary: 44.8;parathyroid gland: 12.5"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 208.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.9;fHDF/TERT166: 5.6;HEL: 8.1;hTCEpi: 7.1;K-562: 8.4;SiHa: 5.6;THP-1: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069613	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA069613: AB_2686160"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	2.6	1.0	0.0	0.8	0.0	0.0	0.6	0.8	12.8	0.3	0.0	0.0	7.3	0.4	0.0	11.9	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.8	0.8	44.8	0.1	12.5	10.0	0.1	0.8	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	0.8	0.0	0.0	0.7	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.7	4.9	1.8	0.2	3.4	0.0	0.0	1.4	0.1	0.0	0.4	0.0	0.0	0.3	0.0	2.2	5.6	0.2	1.1	0.0	0.0	0.1	0.0	0.0	8.1	0.9	0.0	0.0	0.1	0.0	0.0	7.1	0.0	0.0	1.1	0.0	0.0	8.4	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	5.6	0.0	0.0	0.3	0.0	5.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.6	0.8	0.6	0.6	0.8	0.8	0.8	0.8	1.2	0.7	0.2	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	41.8	1.6	0.0	0.0	0.0	0.2	0.3	20.9	0.0	1.0	0.0	208.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.2	1.8	1.4	0.0	1.0	0.0	0.3	48.4	0.0	0.0
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857680-2877174	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.0;lymphoid tissue: 32.2;testis: 21.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.4;Erythroid cells: 18.7;Extravillous trophoblasts: 18.2;Late spermatids: 25.5;Plasma cells: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB017832	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.95e-6)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.9	1.1	0.4	9.4	0.5	25.0	1.8	0.8	0.8	1.7	0.2	10.5	9.7	1.7	0.2	11.1	0.8	1.5	0.5	0.8	0.3	0.7	1.2	1.8	11.3	0.4	0.9	0.3	0.4	0.4	0.1	6.1	0.6	0.7	12.5	1.1	1.9	0.8	0.6	6.4	8.8	7.5	0.1	3.1	5.2	21.4	1.0	32.2	0.9	0.3	15.2	3.0	3.2	0.6	133.0	129.5	101.3	92.2	14.2	19.0	129.2	84.0	80.4	165.2	147.2	166.9	114.8	84.5	17.7	119.8	188.5	100.2	153.1	76.1	160.0	159.8	80.3	94.7	121.6	71.6	2.0	79.2	75.0	9.9	8.3	154.4	106.1	39.1	117.8	96.8	55.6	184.9	130.5	122.6	108.3	36.8	225.6	136.1	95.4	77.3	149.8	44.1	38.1	82.7	56.3	89.1	106.7	90.4	46.6	189.4	87.1	87.8	48.0	134.3	200.5	160.4	300.4	24.7	44.3	122.1	63.1	74.3	147.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.8	0.8	0.8	0.3	0.4	0.9	0.6	0.1	1.0	0.6	0.1	0.0	1.3	0.7	2.4	2.9	1.3	1.0	1.2	2.0	1.7	1.3	0.5	1.5	0.8	1.8	4.2	7.1	0.8	6.6	1.9	0.2	22.4	1.2	2.1	2.5	0.0	18.7	1.1	0.0	18.2	3.2	10.2	2.4	0.0	15.4	3.6	0.8	9.1	5.0	0.6	7.5	2.0	4.2	1.2	25.5	0.9	2.4	0.0	0.0	1.1	0.6	1.0	0.5	1.0	0.3	0.3	0.7	19.9	1.0	1.4	0.4	0.2	4.0	0.0	1.2	3.0	15.0	9.9	10.2	1.4	1.9	3.3	0.9	12.9	1.9
FOXN2	HTLF	ENSG00000170802	"Forkhead box N2"	P32314	2	48314637-48379295	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 54.0;brain: 53.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 152.3;Oligodendrocytes: 282.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003485	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA003485: AB_1078905"	"unprognostic (5.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.65e-3)"	"prognostic favorable (3.85e-4)"	"unprognostic (4.00e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (2.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.12e-2)"	17.9	5.5	13.3	15.4	30.3	54.0	8.0	25.3	19.0	7.7	4.2	7.7	8.3	6.7	4.2	9.3	5.5	9.7	8.6	13.9	16.3	6.6	19.8	9.5	19.4	24.1	21.0	5.9	8.9	9.5	3.0	13.4	21.9	5.0	8.0	3.4	5.5	4.2	4.8	3.6	10.3	9.8	20.0	18.1	7.9	6.3	19.2	14.9	6.9	6.4	17.1	10.6	3.9	53.3	13.1	19.5	22.2	19.6	17.2	12.7	24.3	14.4	15.8	11.9	13.2	17.3	15.9	28.4	18.7	17.0	14.5	16.2	13.7	16.5	17.2	22.3	11.7	56.1	13.3	17.4	30.0	30.9	42.1	11.4	6.9	12.9	22.3	9.6	12.8	11.6	26.6	32.7	19.5	10.1	34.4	20.3	16.8	9.8	10.2	17.0	46.5	23.2	10.2	16.5	12.4	12.6	6.9	13.2	24.9	7.5	5.7	18.0	15.0	16.0	16.1	15.2	15.2	17.8	14.2	40.5	13.9	27.5	22.2	120.9	32.4	129.6	24.0	26.2	27.4	21.2	23.1	22.4	33.6	20.6	17.2	17.7	40.8	25.7	36.4	20.8	28.8	17.2	13.3	30.3	25.3	19.0	13.9	16.3	24.1	21.0	21.9	20.0	19.2	53.3	22.1	0.0	7.4	66.6	31.3	15.6	27.5	10.0	15.4	6.7	5.4	5.6	11.1	14.3	6.1	1.8	0.0	6.7	28.3	7.0	5.9	6.0	4.8	8.9	17.2	21.8	2.4	22.5	28.1	5.4	32.1	13.3	14.3	13.3	22.8	1.2	20.7	19.7	17.9	13.5	25.2	8.0	8.2	39.5	47.3	4.7	12.2	44.4	12.4	35.6	44.1	7.8	26.8	152.3	282.0	11.0	7.1	11.3	31.0	35.2	11.3	4.8	3.3	3.6	6.6	17.8	27.4	22.7	13.1	11.9	21.2	16.6	38.3	2.8	8.9	35.9
FOXN3	"C14orf116, CHES1"	ENSG00000053254	"Forkhead box N3"	O00409	14	89124871-89619149	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 517.2;Oligodendrocyte precursor cells: 291.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.2;U-266/84: 112.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059209	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA059209: AB_2683949"	"unprognostic (1.69e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.58e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.11e-1)"	46.5	27.0	17.8	23.6	17.9	83.7	22.8	76.2	15.1	24.9	33.4	28.8	36.7	26.5	9.2	39.4	23.2	22.9	38.2	12.2	15.8	12.8	30.8	23.9	29.1	20.5	18.3	50.6	24.8	46.9	5.1	22.7	21.5	20.2	21.8	16.5	18.4	22.1	79.6	41.4	35.2	35.1	19.3	21.6	29.0	16.8	21.5	41.6	9.5	72.6	30.9	25.5	20.6	18.3	0.5	7.7	19.7	11.3	78.1	24.8	14.2	15.7	15.4	13.8	22.7	7.8	6.3	24.0	7.8	25.0	9.5	5.6	33.5	22.3	20.4	109.2	6.2	8.3	14.6	25.0	25.3	16.6	14.1	59.4	12.6	1.3	9.4	16.6	30.2	34.1	10.0	69.0	22.9	9.4	32.2	16.6	21.2	14.2	13.8	51.4	67.0	22.8	1.7	26.6	10.7	35.1	23.0	21.9	6.4	64.8	12.8	45.3	55.0	23.5	32.1	23.6	23.6	58.4	112.6	44.6	8.5	28.2	13.8	48.8	23.8	35.8	41.9	25.7	33.3	13.5	27.8	35.9	35.2	16.4	35.8	34.6	9.6	32.2	17.3	7.9	35.9	31.2	17.8	17.9	76.2	15.1	12.2	15.8	20.5	18.3	21.5	19.3	21.5	18.3	108.7	32.1	33.9	229.5	65.4	89.3	22.4	27.4	41.5	123.2	21.0	21.7	103.2	47.1	53.4	9.2	0.0	36.9	105.9	37.2	21.5	11.5	86.2	38.8	36.3	67.3	59.3	52.5	125.6	20.9	21.3	75.2	45.9	36.4	12.7	112.4	55.6	92.9	43.5	79.1	195.2	37.5	30.5	100.3	174.9	38.5	96.3	87.9	32.0	517.2	65.3	38.6	94.7	291.6	143.8	15.5	32.1	85.4	71.3	16.8	77.4	12.2	16.0	9.9	39.5	133.6	57.9	4.3	11.6	51.4	147.6	29.6	85.0	37.2	46.6	29.1
FOXN4		ENSG00000139445	"Forkhead box N4"	Q96NZ1	12	109277978-109309284	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 11.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.9;Endometrial ciliated cells: 2.6;Ionocytes: 2.0;Respiratory ciliated cells: 1.2;Spermatocytes: 2.8;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;SCLC-21H: 3.5;SH-SY5Y: 3.6;U-266/70: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050018	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA050018: AB_2680992"	"unprognostic (1.09e-3)"	"unprognostic (9.63e-2)"		"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"		"unprognostic (1.08e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"		"unprognostic (6.00e-2)"	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.2	1.8	0.5	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.3	0.8	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	11.4	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	2.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXO1	"FKH1, FKHR, FOXO1A"	ENSG00000150907	"Forkhead box O1"	Q12778	13	40555667-40666641	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 177.3;Endometrial stromal cells: 161.0;Granulosa cells: 177.9;Oligodendrocytes: 131.5;Skeletal myocytes: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;Daudi: 45.3;HSkMC: 53.6;U-698: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001252, CAB022326"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022326: , HPA001252: AB_1078906"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (1.93e-1)"	"unprognostic (5.44e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.63e-2)"	43.2	9.7	11.2	13.1	16.1	13.8	27.6	10.0	10.9	19.1	16.7	13.8	5.0	39.1	6.5	13.0	25.7	14.5	13.9	9.1	11.8	11.8	38.5	16.8	23.8	14.1	12.7	65.6	16.5	5.3	7.6	11.2	12.7	10.1	9.6	3.9	9.8	10.1	91.0	18.0	10.9	27.0	10.5	15.7	9.5	8.9	11.3	11.6	19.0	22.2	24.0	13.4	17.4	14.3	0.7	1.7	12.4	0.3	40.4	7.9	11.8	1.8	2.5	0.5	0.3	3.7	3.0	45.3	8.1	1.2	1.9	10.7	9.8	5.3	0.7	20.9	10.1	0.0	1.4	10.1	19.1	0.4	1.2	53.6	35.5	0.2	6.7	2.5	31.7	3.3	0.9	14.0	3.1	1.6	0.1	0.6	18.0	6.2	3.1	32.4	14.3	3.6	22.9	5.8	2.6	0.6	1.6	8.5	1.8	14.1	1.5	1.1	18.6	0.3	2.3	0.1	1.1	7.9	3.3	57.8	1.2	2.1	5.7	0.9	0.6	0.5	1.3	0.8	1.8	3.7	3.6	2.2	0.4	5.8	5.5	4.3	2.5	1.4	1.4	0.0	5.1	1.0	11.2	16.1	10.0	10.9	9.1	11.8	14.1	12.7	12.7	10.5	11.3	14.3	57.9	0.0	4.4	177.3	29.3	29.3	19.1	13.0	27.9	3.7	12.9	17.3	11.5	10.0	9.9	9.2	12.5	0.5	22.9	27.5	0.0	11.1	7.2	55.4	161.0	50.2	52.2	3.2	7.4	18.0	3.8	40.8	18.8	118.8	1.3	177.9	84.3	47.9	6.5	5.0	23.0	21.0	8.2	14.6	26.9	4.0	18.6	18.6	12.4	117.1	18.4	5.5	8.2	47.3	131.5	19.5	16.3	13.2	32.9	10.1	7.7	8.8	9.2	9.8	6.6	131.7	31.3	6.4	14.6	25.3	26.7	0.8	40.3	64.0	12.5	13.0
FOXO3	"AF6q21, FKHRL1, FOXO2, FOXO3A"	ENSG00000118689	"Forkhead box O3"	O43524	6	108559835-108684774	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004074, HPA063104"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004074: AB_2106672, HPA063104: AB_2684941"	"unprognostic (3.42e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.68e-2)"	46.7	11.4	14.7	13.4	15.1	68.5	43.1	34.0	19.6	28.1	19.3	21.7	12.4	23.5	15.3	35.4	25.4	28.2	18.6	14.3	9.8	16.3	23.1	30.3	12.8	17.4	15.5	43.0	86.9	30.2	8.6	21.3	13.3	20.0	17.0	28.7	25.1	11.5	84.1	30.6	16.9	21.1	11.5	18.8	22.2	11.9	17.1	18.5	18.0	51.4	15.8	23.2	27.4	17.0	21.6	6.8	9.1	20.4	41.2	48.4	16.1	17.0	17.7	13.5	19.9	11.9	19.5	11.7	14.8	20.0	22.3	15.0	12.1	20.8	20.4	12.9	18.3	32.5	6.2	9.8	47.4	8.6	24.8	56.0	43.2	29.3	40.4	19.8	10.3	10.2	21.8	94.5	26.9	12.2	9.4	12.6	6.1	10.1	11.6	12.1	32.4	48.7	30.7	16.5	23.4	59.9	12.7	11.8	16.6	18.1	12.1	27.7	18.3	24.9	12.9	13.8	20.6	0.9	16.8	13.5	13.4	16.2	16.4	7.8	2.8	6.1	3.2	1.5	3.8	0.8	1.7	2.6	1.7	1.7	1.4	2.0	15.6	3.7	5.3	2.7	1.9	1.1	14.7	15.1	34.0	19.6	14.3	9.8	17.4	15.5	13.3	11.5	17.1	17.0	88.2	44.8	46.0	112.6	41.2	67.7	73.3	34.4	91.6	63.4	64.1	46.9	31.6	71.4	44.4	25.8	70.9	25.4	41.4	86.9	17.6	50.4	19.9	91.2	41.8	55.6	66.9	246.9	102.7	30.9	36.9	105.8	46.9	105.6	15.2	46.2	84.6	77.7	46.4	52.2	99.9	55.0	20.3	85.2	83.3	17.7	106.6	96.6	56.9	160.2	55.9	78.9	22.6	108.6	133.2	73.3	44.2	100.4	83.3	122.2	28.3	21.1	57.7	68.6	32.9	236.6	81.6	9.1	17.8	61.1	46.5	41.2	37.6	30.6	34.5	184.2
FOXP1	"12CC4, hFKH1B, HSPC215, QRF1"	ENSG00000114861	"Forkhead box P1"	Q9H334	3	70954708-71583989	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 41.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTEC/SVTERT24-B: 95.0"					"Low region specificity"	"Detected in all"			"HPA003876, CAB011501"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011501: AB_732428, HPA003876: AB_1078907"	"unprognostic (2.31e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.38e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	16.5	3.8	5.0	20.3	41.1	38.5	14.5	0.3	12.5	11.2	9.9	28.7	12.2	15.3	6.5	23.0	14.3	21.0	12.7	7.8	0.0	7.0	13.0	22.9	22.2	3.1	6.7	32.4	16.8	6.5	9.1	13.7	0.9	21.2	23.4	2.6	29.7	9.6	8.2	10.9	15.3	22.7	0.1	17.8	20.6	14.4	6.6	26.3	14.5	11.1	25.4	21.6	14.2	8.1	9.6	8.0	16.8	13.2	8.4	21.3	8.2	26.3	30.9	22.0	17.4	51.9	11.2	31.1	4.3	12.9	17.6	6.9	31.0	22.8	40.3	7.8	11.7	13.0	17.0	52.7	20.5	25.7	31.6	21.7	10.3	95.0	42.1	18.3	36.6	15.4	13.6	36.7	10.8	42.6	11.9	9.3	19.7	7.2	39.9	38.0	30.7	4.7	18.8	30.1	14.5	27.6	32.6	7.7	1.9	15.9	5.6	21.9	47.7	34.9	14.3	48.9	42.2	9.0	7.1	41.8	22.5	35.7	7.5	46.9	15.3	15.2	18.3	13.1	19.4	58.1	38.7	22.6	13.0	62.2	60.8	40.0	27.0	22.2	25.3	21.7	35.9	28.8	5.0	41.1	0.3	12.5	7.8	0.0	3.1	6.7	0.9	0.1	6.6	8.1	158.8	73.7	121.3	130.9	266.5	183.0	170.6	58.2	176.4	30.3	98.5	115.1	42.1	148.7	72.0	33.1	18.8	47.2	122.9	118.1	31.3	79.0	156.0	116.3	48.2	184.9	271.6	111.5	391.0	95.1	12.6	90.4	95.8	128.0	219.8	117.7	184.9	72.3	49.5	6.7	139.9	231.2	154.6	117.6	209.0	89.6	42.0	101.3	37.4	414.1	120.3	15.5	116.4	184.5	286.4	124.8	102.8	24.8	66.0	178.8	91.7	19.4	83.7	42.8	92.1	102.9	119.4	13.7	33.6	111.5	101.4	52.4	168.1	33.1	157.2	146.3
FOXP2	"CAGH44, SPCH1, TNRC10"	ENSG00000128573	"Forkhead box P2"	O15409	7	114086327-114693772	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.8"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 186.8;Microglial cells: 288.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 21.0;RH-30: 37.3;THP-1: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000382, HPA000383, HPA001679"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415"	"unprognostic (1.21e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.69e-4)"	"unprognostic (2.04e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.04e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.84e-1)"	"unprognostic (9.81e-2)"	"unprognostic (4.19e-2)"	1.9	1.3	1.8	1.9	1.3	0.4	2.0	0.0	10.1	5.0	0.0	18.8	2.5	8.0	1.7	6.1	3.4	3.5	1.4	2.7	0.9	2.0	2.5	1.5	1.0	1.5	6.9	9.7	4.6	0.6	0.9	0.5	1.9	2.2	5.2	3.2	2.8	1.4	3.2	3.7	3.2	7.7	0.0	0.5	4.2	1.3	2.6	0.2	4.9	1.8	0.7	6.1	4.3	5.2	0.4	3.2	21.0	0.0	4.9	6.2	1.3	3.5	3.6	0.7	0.4	1.6	0.3	0.3	0.8	1.2	0.1	0.5	0.8	0.0	0.1	0.2	7.0	8.0	4.6	6.6	0.0	0.5	0.5	1.3	0.8	0.1	0.0	1.3	0.0	0.0	1.8	3.0	0.8	1.5	1.8	1.2	1.1	0.4	1.0	0.6	37.3	7.9	0.5	8.6	5.1	2.2	0.0	1.3	1.1	1.2	1.0	11.9	1.6	1.3	0.6	2.0	0.7	6.3	0.7	1.0	1.5	0.8	0.6	9.7	5.5	11.4	5.9	7.4	5.8	10.1	6.4	6.3	6.7	8.2	6.5	7.4	5.5	6.6	6.3	16.6	10.7	20.5	1.8	1.3	0.0	10.1	2.7	0.9	1.5	6.9	1.9	0.0	2.6	5.2	0.5	0.0	8.2	5.5	0.0	30.7	2.9	5.5	48.3	0.1	1.8	1.3	1.6	10.0	7.3	3.7	2.1	0.1	0.0	4.8	0.0	0.1	9.7	0.1	1.2	1.9	4.2	0.0	186.8	5.4	0.0	20.6	1.1	0.0	0.0	16.2	8.2	11.7	0.2	13.5	6.4	11.5	2.0	1.6	5.6	6.2	5.3	0.4	3.6	288.6	0.0	27.7	0.0	5.5	4.6	1.3	18.5	0.7	0.6	2.3	8.6	3.8	11.3	1.3	0.0	25.5	1.7	2.4	1.4	25.3	25.6	0.3	0.3	4.2	11.5	4.0
FOXP3	"AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID"	ENSG00000049768	"Forkhead box P3"	Q9BZS1	X	49250438-49270477	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 7.2;lymphoid tissue: 7.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Hepatocytes: 1.4;Horizontal cells: 3.3;Melanocytes: 1.8;T-cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	11	"T-reg: 53.3"	"Lineage enriched"	"Detected in single"	394	"T-cells: 53.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.9;MCF7: 5.2;SiHa: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026301, HPA045943"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB026301: , HPA045943: AB_2679508"	"unprognostic (2.46e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (4.95e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (2.55e-4)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.73e-14)"	"unprognostic (5.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-1)"	0.2	0.2	0.9	7.4	0.7	1.3	0.7	1.5	0.8	0.4	0.0	0.6	0.7	0.2	7.2	1.2	0.2	1.6	0.2	0.8	0.6	0.3	2.4	0.9	6.1	0.7	0.7	0.4	0.2	0.4	0.5	0.1	0.8	0.6	0.7	0.7	1.1	0.8	0.3	2.3	1.9	0.3	0.5	2.4	1.6	1.3	0.8	7.2	0.6	0.1	5.2	2.8	0.3	0.7	0.1	0.3	0.2	0.9	0.1	0.0	1.1	0.2	0.2	0.1	0.4	0.8	0.2	0.6	0.3	0.5	0.6	0.3	0.8	0.0	0.1	2.9	0.5	0.2	0.3	0.2	0.4	0.3	0.4	0.1	0.8	0.9	1.7	0.0	0.0	0.9	0.9	0.7	0.0	5.2	0.1	0.3	0.8	0.1	0.7	0.4	0.3	0.2	0.2	0.2	0.6	0.5	4.7	0.5	2.0	0.5	1.5	0.8	0.8	0.3	1.4	0.5	0.1	0.4	1.1	0.4	0.2	0.8	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	4.7	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	53.3	1.3	0.9	0.7	1.5	0.8	0.8	0.6	0.7	0.7	0.8	0.5	0.8	0.7	0.1	0.0	0.6	0.3	0.4	0.5	0.0	0.0	0.0	0.2	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	1.3	0.1	0.0	1.4	0.1	3.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.3	1.8	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.0	0.4	0.0	5.3	0.2	0.0	0.0
FOXP4	FLJ40908	ENSG00000137166	"Forkhead box P4"	Q8IVH2	6	41546381-41602384	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 40.2;Gastric mucus-secreting cells: 56.6;Intestinal goblet cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"CACO-2: 113.9;OE19: 118.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007176	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cytosol"		"HPA007176: AB_1078911"	"unprognostic (8.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.17e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.13e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-2)"	15.9	10.6	7.7	11.0	6.6	4.9	18.6	3.6	10.4	33.0	1.9	22.7	19.9	32.5	2.0	15.3	16.3	9.1	21.3	10.1	12.0	19.9	28.5	17.3	9.5	13.1	8.6	16.7	34.8	6.3	19.9	5.1	11.8	33.5	6.0	2.9	31.6	10.3	14.3	12.5	18.7	9.1	3.4	8.0	50.1	27.9	12.8	6.8	32.0	4.3	5.9	16.8	15.6	11.4	25.8	36.2	41.2	45.7	7.1	2.5	44.0	14.5	6.8	11.2	7.8	113.9	8.0	29.9	25.7	7.8	33.3	19.3	11.4	13.2	4.1	25.1	20.7	24.2	20.1	74.9	14.1	15.1	19.3	6.6	14.1	10.4	5.6	15.8	10.9	17.6	30.2	11.6	5.0	70.5	17.5	22.4	10.8	118.6	11.7	19.3	13.8	20.9	8.6	22.2	11.9	17.0	15.2	35.4	23.3	10.5	20.0	35.3	17.0	15.1	37.3	24.0	24.0	9.1	6.2	40.9	12.3	25.8	14.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	7.7	6.6	3.6	10.4	10.1	12.0	13.1	8.6	11.8	3.4	12.8	11.4	1.1	0.0	11.7	4.6	6.2	9.2	5.8	5.1	2.8	5.2	19.2	15.2	21.0	7.2	4.8	5.5	2.1	2.6	4.3	22.0	0.0	8.7	26.9	6.3	1.9	3.4	40.2	0.8	2.5	16.1	3.4	4.6	56.6	9.5	3.8	15.0	13.6	21.0	4.1	0.0	1.9	41.7	8.2	4.2	7.0	21.0	4.1	4.4	1.8	1.0	5.4	1.2	7.2	6.6	3.5	20.9	20.3	8.6	3.6	14.7	15.8	8.8	3.4	2.7	13.1	4.8	8.4	2.2	13.1	7.6	7.7	4.4	4.0	0.6	17.4	10.2
FOXQ1	HFH1	ENSG00000164379	"Forkhead box Q1"	Q9C009	6	1312098-1314758	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 107.2;urinary bladder: 53.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 60.4;Basal respiratory cells: 24.9;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 67.2;Suprabasal keratinocytes: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 39.0;HaCaT: 44.7;Hep G2: 93.8;OE19: 117.1;RT4: 38.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059700			Supported	Nucleoplasm		Yes	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA059700: AB_2684107"	"unprognostic (2.04e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.65e-3)"	"prognostic favorable (6.68e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	0.3	0.0	6.9	0.2	5.2	0.0	1.4	7.1	7.1	6.7	3.8	0.8	10.4	0.9	0.3	11.3	3.9	5.4	0.0	4.7	5.1	9.8	6.4	4.0	0.0	5.6	6.0	0.0	6.5	0.1	2.5	1.1	6.0	8.9	0.4	0.1	30.4	1.1	0.2	25.7	0.6	0.0	5.3	0.0	107.2	0.2	7.5	0.6	3.6	0.6	8.0	53.5	16.9	4.7	16.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.1	0.1	39.0	22.6	0.0	0.7	0.0	0.1	44.7	0.0	1.7	0.0	0.0	1.1	0.0	8.2	93.8	0.0	0.0	2.4	0.0	16.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	117.1	0.8	0.0	0.0	0.0	0.4	38.2	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	5.2	7.1	7.1	4.7	5.1	5.6	6.0	6.0	5.3	7.5	4.7	0.3	16.0	10.6	0.0	0.0	60.4	3.2	24.9	6.8	0.0	5.3	5.1	0.8	0.0	16.8	40.5	0.0	0.0	0.0	0.0	1.9	3.0	0.0	5.2	3.0	0.4	0.0	0.0	1.2	13.4	0.0	1.4	67.2	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	2.9	0.0	0.0	0.7	1.8	15.9	0.0	0.0	0.0	0.0	0.5	11.8	0.0	0.0	0.2	0.6	0.0	6.2	5.0	0.0	0.0	0.0	1.6	0.0	0.0	22.2	45.5	0.0	0.3	0.0	0.0	3.9
FOXR1	"DLNB13, FOXN5"	ENSG00000176302	"Forkhead box R1"	Q6PIV2	11	118971712-118981287	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 4.2"	"Group enriched"	"Detected in some"	19	"Spermatocytes: 13.1;Spermatogonia: 33.5"	"Cancer enriched"	"Detected in single"	34	"testis cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038124			Approved	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038124: "					"unprognostic (1.84e-2)"					"unprognostic (4.80e-2)"				"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.1	33.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
FOXR2	"FOXN6, MGC21658"	ENSG00000189299	"Forkhead box R2"	Q6PJQ5	X	55623400-55626192	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	110	"NTERA-2: 10.8;SH-SY5Y: 9.9;U-266/70: 6.2;U-266/84: 16.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA034487, HPA057358"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA034487: AB_10795354, HPA057358: AB_2683418"															"unprognostic (3.81e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXS1	"FKHL18, FREAC10"	ENSG00000179772	"Forkhead box S1"	O43638	20	31844303-31845604	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Peritubular cells: 56.8;Sertoli cells: 131.5;Smooth muscle cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;hTERT-RPE1: 13.1;RH-30: 10.9;U-2 OS: 14.1;U-251 MG: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042475	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042475: AB_10964265"	"unprognostic (2.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.09e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.00e-2)"	4.5	1.6	2.4	1.4	2.4	0.0	2.8	2.6	3.8	3.7	1.7	1.4	0.3	3.9	2.4	1.0	1.9	2.0	9.7	2.2	2.3	5.4	0.8	5.3	2.5	2.6	2.5	2.0	0.9	0.6	2.3	4.8	2.7	2.4	0.6	0.0	1.1	3.1	1.7	1.5	1.4	1.2	2.2	3.0	1.2	5.5	2.6	1.0	3.5	1.7	0.9	2.6	2.4	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.9	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	14.1	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.4	2.6	3.8	2.2	2.3	2.6	2.5	2.7	2.2	2.6	2.3	4.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.2	0.0	1.1	2.6	0.0	0.0	0.0	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.9	4.9	5.0	0.2	1.8	8.4	0.0	0.0	0.0	0.0	0.0	5.7	0.0	56.8	0.0	0.1	0.0	0.0	0.0	0.1	131.5	0.4	31.5	0.6	0.5	0.1	0.3	0.3	0.1	6.6	0.0	0.1
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 195.3;lymphoid tissue: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 119.6;Kupffer cells: 215.3;Macrophages: 178.5;monocytes: 89.7"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 4199.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 4199.5"	"Group enriched"	"Detected in some"	5	"LHCN-M2: 17.2;U-87 MG: 67.1"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	69.6	10.0	3.8	166.0	4.4	195.3	5.3	4.1	8.7	8.2	5.7	4.6	3.1	3.7	0.5	8.9	15.4	28.6	7.5	3.6	8.1	4.5	21.4	50.8	12.7	15.2	8.2	2.4	11.2	5.1	3.5	45.1	11.9	3.1	3.3	2.6	4.1	2.3	1.8	1.3	5.2	42.9	8.6	129.2	5.4	2.2	9.9	8.4	3.1	22.8	10.3	66.9	2.7	18.2	0.5	0.8	0.3	0.4	1.0	2.1	0.5	0.2	0.0	0.5	2.0	0.3	0.7	1.2	0.6	0.0	3.9	0.4	0.0	0.0	0.1	0.1	0.0	0.7	0.9	1.0	6.0	0.3	0.5	4.8	0.2	1.8	1.8	9.2	0.0	0.3	0.1	0.6	17.2	0.9	0.1	0.3	0.4	0.3	0.7	0.3	0.7	0.0	1.5	0.5	0.2	0.3	0.6	0.1	0.5	0.2	1.0	1.1	1.0	2.0	0.4	0.1	3.5	0.2	0.0	0.5	67.1	1.7	0.1	317.1	759.9	204.9	1.6	319.7	1.5	0.7	1.0	0.7	174.1	1.0	1.0	1.2	4199.5	0.4	201.8	8.1	1.3	420.3	3.8	4.4	4.1	8.7	3.6	8.1	15.2	8.2	11.9	8.6	9.9	18.2	0.1	16.0	25.7	0.0	1.8	0.6	0.3	0.0	0.0	1.0	0.1	0.3	0.2	0.0	15.5	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.8	0.0	0.1	6.3	0.0	2.5	0.2	0.0	1.6	4.7	0.5	0.1	26.5	0.0	2.5	2.1	119.6	0.0	0.1	0.0	0.0	215.3	4.7	2.0	0.3	178.5	0.0	3.7	89.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.4	8.8	0.3	6.6	0.6	0.8	0.6	0.8	0.2	0.0	3.0	2.5	0.0	0.0	0.1
FRAT2		ENSG00000181274	"FRAT regulator of WNT signaling pathway 2"	O75474	10	97332497-97334729	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 15.0;neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 58.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA049763: AB_2680868"	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.3	3.6	7.2	10.4	7.1	31.0	8.0	7.7	7.4	6.0	9.8	17.1	25.1	4.1	6.2	14.4	7.1	4.0	6.0	6.3	6.8	7.8	18.3	9.7	8.7	7.7	7.6	2.8	14.0	5.2	3.0	7.4	6.8	7.9	15.5	3.3	15.1	4.3	10.1	20.4	15.9	4.1	7.0	28.9	13.2	14.6	7.5	8.9	5.3	9.1	10.8	6.7	8.1	6.0	10.9	4.3	6.9	31.2	4.9	4.0	25.7	2.4	8.9	3.7	3.7	6.8	12.5	13.3	8.4	2.5	2.2	20.3	18.3	9.5	2.9	20.0	28.0	17.9	9.2	15.0	2.8	28.9	20.6	3.2	20.0	3.6	11.4	7.9	9.3	11.7	15.8	4.2	1.8	17.9	12.6	36.5	42.9	36.2	17.5	12.8	2.9	19.1	8.9	9.8	12.5	10.2	3.1	19.1	12.6	28.0	28.8	44.8	4.2	2.2	2.7	1.7	6.4	11.4	12.5	6.6	2.6	49.3	0.8	8.3	7.2	15.0	1.1	4.8	0.6	1.1	1.3	1.8	3.8	3.2	2.2	1.3	58.2	1.6	7.9	1.0	0.7	2.3	7.2	7.1	7.7	7.4	6.3	6.8	7.7	7.6	6.8	7.0	7.5	6.0	18.2	0.0	3.9	2.9	15.7	31.7	25.3	6.6	46.1	19.7	24.7	19.6	6.4	20.0	5.0	14.7	4.2	6.1	26.1	31.0	11.7	2.2	40.7	39.6	9.7	10.3	13.8	14.5	2.0	5.3	18.5	6.4	37.2	46.3	1.3	16.7	8.6	11.3	8.6	11.8	2.8	30.6	4.1	28.3	9.0	42.3	2.1	25.2	10.6	7.5	24.7	5.0	14.4	2.0	1.1	3.4	21.6	2.6	8.4	30.0	13.5	3.7	4.5	18.1	0.0	14.9	8.7	2.3	4.4	37.7	52.7	7.8	18.8	20.1	31.6	32.3
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060891	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.4;Oligodendrocytes: 97.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 18.3;RT4: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	0.8	1.1	1.3	1.2	2.1	1.5	2.4	5.8	5.0	1.8	13.7	4.6	6.2	1.0	2.5	2.9	2.6	2.6	1.8	1.8	0.0	9.0	6.8	1.8	0.7	0.3	0.1	0.9	2.8	1.0	0.4	0.8	1.0	2.2	4.8	2.9	4.0	2.4	2.2	1.9	6.3	0.8	0.2	0.9	4.9	1.9	1.1	1.2	1.0	0.8	1.6	2.1	1.0	5.7	2.5	4.0	0.5	0.9	0.2	0.2	0.6	0.5	0.1	0.0	0.1	3.1	3.8	0.9	3.5	0.5	0.5	5.8	0.2	1.1	0.1	3.3	0.3	1.3	3.3	2.7	0.2	0.9	0.7	0.2	1.5	0.3	0.4	0.4	0.2	0.6	0.6	2.3	1.0	1.3	0.7	0.5	1.0	18.3	0.7	1.1	3.3	1.2	4.8	7.6	0.7	0.8	0.7	5.1	0.5	0.9	1.5	0.7	0.8	1.0	1.0	0.7	0.5	3.6	2.7	1.6	1.1	0.6	0.6	0.9	0.2	0.2	0.4	0.1	0.5	0.2	0.3	0.4	0.1	0.4	0.2	0.3	0.8	0.3	0.2	0.3	0.2	0.0	1.3	2.1	5.8	5.0	1.8	0.0	0.3	0.1	1.0	0.2	1.1	5.7	0.4	0.0	10.3	10.4	0.5	2.7	20.8	23.3	6.8	0.6	7.3	2.9	9.2	11.5	22.6	23.9	0.0	4.4	0.1	34.9	11.7	20.3	89.4	28.1	1.7	0.7	19.8	0.0	12.2	16.4	4.3	3.5	29.0	30.4	3.8	0.2	1.4	21.9	0.9	6.7	7.7	14.5	34.6	0.6	0.4	38.1	0.6	0.6	0.0	1.0	1.0	0.2	0.0	2.5	97.8	21.9	23.3	1.2	0.5	23.4	49.3	28.4	36.6	0.3	13.1	9.9	16.2	4.6	1.0	16.4	3.1	0.8	1.0	2.3	19.1	46.2
FRMD4A	"bA295P9.4, FLJ10210, FRMD4, KIAA1294"	ENSG00000151474	"FERM domain containing 4A"	Q9P2Q2	10	13643706-14462142	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.8"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 1527.6;Inhibitory neurons: 1622.8;Microglial cells: 1329.4;Oligodendrocyte precursor cells: 442.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 134.0;HUVEC TERT2: 105.8;TIME: 191.6;WM-115: 163.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038449	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA038449: AB_10669539"	"unprognostic (6.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.51e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.84e-1)"	60.8	5.2	38.9	11.7	28.1	5.4	18.7	0.0	29.2	8.6	0.0	13.1	5.7	5.7	4.0	9.4	8.8	9.6	16.7	24.1	8.5	19.5	12.2	14.2	9.1	15.6	10.9	6.8	15.5	2.4	8.7	22.5	6.2	10.3	6.4	14.1	13.6	10.2	8.1	32.0	7.4	6.5	10.0	32.8	7.9	8.8	14.4	15.6	8.1	7.3	8.4	10.4	8.9	18.9	7.0	7.1	90.1	0.5	12.3	22.0	16.9	40.8	36.5	35.2	48.7	12.1	4.2	0.1	28.3	21.5	48.6	13.5	0.3	3.3	30.7	0.3	9.9	1.4	0.9	0.2	11.0	0.5	1.1	12.8	3.2	134.0	16.4	98.9	105.8	3.1	13.6	0.4	64.7	8.5	4.6	0.8	24.6	0.3	9.6	0.4	30.8	0.2	16.6	5.8	4.3	15.9	0.2	32.7	64.4	16.1	18.5	3.3	191.6	48.8	17.4	47.6	49.3	0.3	0.4	0.3	41.7	1.0	163.4	0.1	0.1	0.0	0.0	0.1	0.1	0.8	0.3	0.1	0.0	2.3	0.3	0.0	0.3	0.2	0.0	0.4	0.4	0.0	38.9	28.1	0.0	29.2	24.1	8.5	15.6	10.9	6.2	10.0	14.4	18.9	48.6	32.1	2.6	168.1	1.7	35.1	13.1	3.0	9.1	54.2	17.1	14.4	11.4	45.8	4.1	33.1	18.8	69.6	0.4	1.1	11.7	15.8	42.5	13.1	5.5	44.0	4.8	81.7	1527.6	4.0	42.1	14.9	4.6	26.9	15.2	58.1	44.3	6.2	35.9	80.8	1622.8	3.4	6.1	95.6	19.9	98.8	2.1	25.5	16.0	1329.4	2.7	46.0	0.0	442.3	61.0	1.8	1.4	1.9	0.9	8.0	0.3	2.7	2.5	12.9	13.1	41.2	45.5	1.3	2.1	20.6	32.7	28.7	3.0	5.3	5.4	4.3
FRMD4B	"GRSP1, KIAA1013"	ENSG00000114541	"FERM domain containing 4B"	Q9Y2L6	3	69168782-69542583	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 39.8;hTERT-HME1: 52.7;HUVEC TERT2: 55.1;TIME: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009705	Uncertain	Supported	Approved	"Nucleoplasm,Golgi apparatus,Centriolar satellite"		NA	NA		17000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Centriolar satellite"	"Nucleoplasm, Golgi apparatus"	"HPA009705: AB_1849147"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.59e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-3)"	11.0	4.8	17.5	12.3	46.7	15.5	16.1	26.9	30.9	24.9	7.0	12.8	9.1	11.3	9.3	26.8	13.2	19.2	17.4	20.8	29.3	16.3	34.5	24.8	10.9	39.4	37.1	10.9	8.2	3.7	4.0	25.5	36.3	16.9	12.9	21.9	37.1	10.5	2.3	23.0	12.5	10.5	22.7	32.3	15.0	4.7	42.0	14.1	27.1	4.6	11.2	13.7	15.8	84.0	6.7	1.8	10.4	0.3	0.2	1.5	11.3	0.5	1.7	0.8	0.5	39.8	11.3	0.8	3.5	0.5	1.0	25.9	4.9	35.3	1.2	2.2	3.3	20.4	2.6	2.3	0.7	5.2	10.2	1.7	35.2	1.0	52.7	1.6	55.1	4.7	1.6	5.8	3.0	7.7	0.5	0.8	5.6	8.9	8.5	32.2	2.8	1.0	14.8	4.6	12.1	15.6	1.7	12.2	35.5	9.3	4.6	6.8	47.1	0.6	4.3	0.4	1.8	0.6	0.3	1.2	0.4	13.5	13.5	18.3	27.6	2.3	1.9	13.8	7.0	1.6	6.3	2.8	16.9	2.0	1.9	1.8	7.1	3.8	2.3	16.8	15.4	7.7	17.5	46.7	26.9	30.9	20.8	29.3	39.4	37.1	36.3	22.7	42.0	84.0	20.6	41.7	83.6	2.9	3.6	60.7	33.4	57.8	69.4	13.8	34.4	21.7	33.4	41.5	58.5	14.7	218.9	49.9	20.3	74.4	33.2	32.6	18.9	207.9	49.3	64.3	24.5	8.6	4.2	17.3	19.7	32.1	75.4	282.6	34.7	97.5	89.3	53.6	92.6	0.0	92.7	42.1	36.7	138.7	112.7	4.0	6.5	105.2	28.4	93.7	26.3	13.5	1.0	129.2	1209.1	24.5	67.0	18.4	6.9	61.1	10.7	55.6	38.2	109.2	6.6	11.8	21.0	0.0	3.5	79.9	51.4	58.3	44.6	32.1	32.2	172.8
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076990-132128020	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 2.9;kidney: 2.7;smooth muscle: 2.2"	"Cell type enriched"	"Detected in single"	19	"Distal tubular cells: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.5"	"Region enriched"	"Detected in many"	28	"olfactory bulb: 65.7"	"Region enriched"	"Detected in single"	86	"olfactory bulb: 21.3"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	0.1	0.1	0.1	2.7	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRMD8	"FKSG44, FLJ90369, iTAP"	ENSG00000126391	"FERM domain containing 8"	Q9BZ67	11	65386621-65413525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002861	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA002861: AB_1078878"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (9.94e-5)"	"unprognostic (9.12e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.41e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.36e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.91e-2)"	19.8	17.5	9.6	11.8	11.0	13.0	19.7	12.2	14.5	20.8	9.1	15.0	11.7	14.6	5.3	37.3	15.8	11.6	17.1	13.1	7.9	19.7	13.4	23.5	15.6	12.9	11.3	12.2	23.0	4.0	11.6	10.4	11.4	15.8	6.7	1.7	18.0	6.5	14.8	34.0	23.8	6.6	9.5	40.8	13.4	18.0	11.5	11.1	17.8	5.1	13.6	14.6	26.4	16.2	17.8	22.1	8.7	20.4	23.0	12.0	15.6	20.1	18.1	16.7	12.7	21.2	28.5	21.9	41.9	27.6	11.6	30.3	11.3	16.9	7.0	38.8	10.6	29.9	21.5	11.7	12.4	16.9	44.8	14.9	13.2	15.7	8.2	8.9	26.6	23.2	25.5	23.5	18.3	23.9	26.6	24.6	10.2	13.0	28.7	33.7	16.6	25.2	13.5	21.8	18.9	14.0	15.0	60.1	47.7	7.7	22.0	13.7	23.6	18.4	19.7	26.1	12.3	41.0	22.5	20.4	16.0	10.7	129.8	1.1	12.4	17.7	13.1	13.2	14.1	12.5	9.6	16.7	11.3	9.6	8.8	9.8	23.0	8.2	19.6	13.4	10.8	12.3	9.6	11.0	12.2	14.5	13.1	7.9	12.9	11.3	11.4	9.5	11.5	16.2	30.3	3.2	5.8	2.0	20.5	54.3	22.5	17.7	6.2	5.4	15.4	12.6	7.4	12.8	13.8	12.9	0.0	6.4	25.8	29.3	7.9	21.0	22.3	20.1	12.1	24.8	13.1	24.0	13.4	29.1	15.5	13.0	10.7	23.1	14.0	27.3	37.5	11.0	16.0	5.0	4.9	20.5	8.2	20.2	68.7	4.6	6.2	18.7	19.6	10.3	21.6	4.3	18.6	5.0	10.3	33.8	14.0	7.2	11.9	28.1	32.8	4.6	14.3	4.5	6.6	11.4	14.4	5.3	9.6	24.9	83.5	11.4	21.9	35.2	14.6	35.7
FRS3	"FRS2B, FRS2beta, SNT-2"	ENSG00000137218	"Fibroblast growth factor receptor substrate 3"	O43559	6	41770176-41786542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 12.5;Spermatogonia: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030162, HPA030174"	Enhanced		Uncertain	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA030162: AB_10599976, HPA030174: AB_10602093"	"unprognostic (2.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.87e-4)"	"unprognostic (4.23e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.29e-3)"	5.9	6.0	13.7	2.9	15.5	2.8	5.9	11.3	21.7	7.6	3.7	8.8	3.3	8.1	2.0	3.3	8.2	3.0	8.1	15.1	12.8	6.4	5.4	5.1	4.1	14.9	12.2	7.3	6.2	3.1	7.2	3.1	14.8	7.0	1.9	4.5	5.0	5.1	9.1	2.8	5.5	2.9	8.4	6.8	6.0	17.5	12.9	3.0	9.7	5.0	2.1	7.8	5.7	17.2	2.4	2.0	3.4	4.7	2.6	2.8	7.0	2.5	3.6	3.0	3.0	2.8	1.4	4.1	2.8	2.2	3.9	1.6	2.2	2.7	2.5	4.3	2.2	2.5	4.6	4.5	3.3	2.1	3.6	2.8	3.2	2.9	2.6	3.9	3.1	9.9	2.9	3.3	2.7	3.9	6.2	4.6	1.7	5.3	2.1	5.8	3.0	3.0	2.6	4.6	4.8	7.3	1.8	2.5	5.6	2.5	3.2	4.2	2.7	5.2	5.5	3.4	2.6	5.9	5.3	7.3	1.4	3.5	1.6	0.0	0.3	0.4	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.1	0.0	13.7	15.5	11.3	21.7	15.1	12.8	14.9	12.2	14.8	8.4	12.9	17.2	4.0	0.0	3.7	4.9	1.7	1.0	1.3	1.0	2.8	5.6	2.1	1.9	3.1	7.2	1.2	0.0	0.0	1.9	1.1	0.3	0.0	1.6	0.9	1.9	2.8	3.2	1.8	0.4	7.8	1.4	1.0	3.0	0.5	2.4	0.0	2.2	1.4	1.7	1.9	5.0	8.2	1.5	0.0	2.9	3.7	1.0	2.5	1.9	3.6	4.7	0.7	2.9	0.0	7.5	5.4	1.3	1.6	4.5	0.4	0.9	1.7	1.0	1.3	4.3	0.0	2.8	2.9	12.5	12.4	0.8	0.6	0.5	1.4	1.7	1.6	1.6
FSBP		ENSG00000265817	"Fibrinogen silencer binding protein"	O95073	8	94378377-94436952	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 12.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Endometrial ciliated cells: 15.3;Glandular and luminal cells: 6.2;Rod photoreceptor cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025059, HPA026509"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA025059: AB_2671718, HPA026509: AB_10602307"																		0.7	1.0	1.2	0.5	1.5	1.4	1.4	1.6	1.7	1.7	3.7	0.6	0.6	1.5	2.6	1.1	1.6	0.9	1.3	0.9	1.2	1.0	1.2	0.7	0.9	1.2	2.3	2.7	1.0	1.1	1.6	0.9	1.0	1.9	0.7	12.0	1.1	2.1	1.3	1.5	0.7	0.8	1.3	0.8	1.4	1.8	1.8	1.2	1.1	0.6	0.8	1.5	1.1	1.3	3.7	1.7	7.6	3.8	1.1	1.3	1.3	1.4	1.4	1.5	1.3	1.9	1.9	2.6	4.1	1.1	1.2	0.9	4.7	2.4	2.6	2.6	1.8	2.9	1.4	1.6	3.3	1.9	0.8	2.4	0.5	2.1	6.4	2.5	2.4	9.0	4.5	4.4	1.4	2.4	6.6	2.3	4.9	1.4	1.1	1.4	4.4	2.5	4.0	5.1	2.5	3.0	0.9	0.3	4.6	5.9	2.5	0.7	2.1	3.0	1.3	1.6	1.5	1.3	1.9	1.3	1.8	2.8	3.4	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	1.5	1.6	1.7	0.9	1.2	1.2	2.3	1.0	1.3	1.8	1.3	0.6	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	1.1	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	15.3	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.0	6.2	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.5	0.9	0.0	0.0
FSIP1	FLJ35989	ENSG00000150667	"Fibrous sheath interacting protein 1"	Q8NA03	15	39588357-39782841	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 10.9;testis: 7.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.1;Excitatory neurons: 28.2;Inhibitory neurons: 21.5;Late spermatids: 48.3;Spermatocytes: 35.3"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041002	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA041002: AB_10796565"	"unprognostic (1.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.81e-1)"	0.2	0.2	1.6	0.2	1.8	0.6	0.9	0.0	1.6	0.2	1.7	7.3	0.1	0.3	0.3	0.1	1.2	0.2	0.2	1.2	1.8	0.8	0.1	0.2	0.1	1.1	1.3	0.1	0.1	0.8	1.4	0.3	0.9	0.2	10.9	0.9	0.1	0.2	0.2	0.9	0.1	0.3	0.3	0.2	0.5	7.2	2.0	1.4	0.4	0.1	0.1	0.3	0.1	0.4	0.4	1.3	3.4	0.5	0.6	1.1	0.0	4.1	0.8	0.6	1.2	1.0	0.3	0.2	0.3	1.2	1.7	0.8	0.5	0.7	1.0	1.4	0.3	2.5	0.9	0.0	0.3	0.5	2.7	0.7	2.8	1.5	0.6	0.8	0.7	1.4	0.1	0.3	1.0	0.1	0.3	0.2	0.4	0.2	0.6	0.3	0.7	0.1	1.3	1.5	0.8	2.5	0.8	0.1	0.1	0.3	1.1	0.3	0.6	1.6	0.9	0.9	0.4	0.7	1.6	0.2	3.3	0.9	0.8	0.4	0.3	0.4	0.7	0.2	0.5	0.1	0.3	0.4	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.4	1.6	1.8	0.0	1.6	1.2	1.8	1.1	1.3	0.9	0.3	2.0	0.4	0.7	0.0	0.5	8.1	1.1	0.6	0.6	3.4	0.0	1.1	14.5	7.9	0.8	2.8	2.9	1.8	12.5	0.9	1.4	17.5	1.9	1.0	67.1	10.0	2.1	1.0	0.0	0.0	28.2	0.4	0.1	1.5	0.5	0.6	15.8	0.4	0.4	0.0	0.1	0.0	21.5	3.5	0.0	0.0	0.3	48.3	1.2	0.6	0.0	7.5	0.1	1.0	3.1	3.0	3.2	0.1	6.6	0.7	0.4	0.7	0.0	3.2	12.6	6.1	0.0	1.2	1.5	35.3	8.3	0.2	0.0	5.6	3.3	0.7	2.9	0.3
FSTL3	"FLRG, FSRP"	ENSG00000070404	"Follistatin like 3"	O95633	19	676392-683392	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Osteogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 3647.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 164.7;hTCEpi: 181.2;SiHa: 341.5;U-2197: 173.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB024899, HPA045378"	Approved		Supported	Nucleoplasm	"Secreted in other tissues"	NA	Yes		7000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB024899: , HPA045378: AB_2679300"	"unprognostic (9.86e-3)"	"unprognostic (1.32e-3)"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.19e-3)"	"unprognostic (1.51e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (3.50e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.89e-3)"	82.9	163.3	16.6	24.1	15.3	13.3	62.4	13.3	19.8	75.6	16.0	82.7	7.7	62.0	6.1	22.0	70.2	16.5	124.1	16.4	17.3	55.9	26.2	132.7	5.5	22.6	16.0	63.8	49.3	3.2	28.9	179.4	17.9	74.9	5.9	2.4	21.1	22.1	11.7	32.3	36.5	42.4	16.7	22.6	43.2	75.2	18.1	2.3	37.9	4.9	1.6	70.5	63.1	18.9	9.5	74.0	5.1	3.7	22.3	56.4	164.7	126.1	18.5	30.7	11.3	27.1	14.4	4.1	49.4	84.7	17.6	65.2	4.1	106.4	10.1	7.8	8.7	3.5	110.2	22.4	95.6	6.7	12.0	70.7	181.2	34.0	140.2	79.3	5.5	3.9	8.2	5.3	46.7	33.1	2.4	4.0	6.2	62.0	26.2	7.2	3.4	8.7	43.1	1.7	3.3	5.7	341.5	6.9	4.3	6.4	6.2	3.5	75.5	30.6	106.6	173.4	46.9	8.5	4.4	2.3	4.7	20.0	14.2	0.0	1.9	0.0	0.4	1.8	0.0	0.1	0.6	0.4	0.9	0.3	1.0	0.6	0.0	0.2	1.4	0.3	0.0	0.9	16.6	15.3	13.3	19.8	16.4	17.3	22.6	16.0	17.9	16.7	18.1	18.9	4.6	19.2	1.9	40.5	1.5	14.5	31.0	11.7	1.8	1.3	11.3	7.9	16.7	32.9	4.4	9.2	0.0	53.9	1.0	1.1	7.9	86.1	8.8	6.4	14.8	8.7	1.2	1.7	9.8	64.3	3647.6	59.6	2.0	18.3	0.0	5.7	16.4	1.9	77.1	3.3	8.4	1.0	0.0	3.7	4.8	7.6	61.2	7.4	5.4	2.8	10.6	6.6	1.0	6.0	5.5	306.5	0.2	26.7	1.0	78.0	1.2	17.7	3.1	1.1	46.0	22.4	57.0	4.6	5.6	4.3	7.7	792.0	2.0	3.6	2.5	30.7
FUBP1	"FBP, FUBP"	ENSG00000162613	"Far upstream element binding protein 1"	Q96AE4	1	77944055-77979110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006149	Supported		Enhanced	Nucleoplasm		NA	NA		300000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA006149: AB_1849172"	"unprognostic (4.17e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.83e-9)"	"unprognostic (2.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.80e-3)"	"unprognostic (9.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.46e-2)"	29.6	37.8	13.4	35.5	15.3	79.6	30.9	24.0	17.9	28.1	18.5	24.3	24.9	36.4	36.8	24.8	28.5	16.8	29.7	13.8	15.9	39.3	17.1	31.6	42.8	15.6	13.4	46.9	33.7	23.0	41.7	23.0	15.7	24.1	27.5	57.2	30.5	13.3	33.8	27.5	27.5	19.0	15.1	35.2	26.1	17.0	15.3	35.7	36.9	15.2	38.6	25.3	27.4	24.3	49.4	36.5	106.9	40.0	11.9	19.0	77.6	53.5	23.4	35.8	29.2	34.7	49.1	91.3	22.1	31.9	49.1	51.4	54.8	45.4	48.1	91.6	38.5	58.8	87.4	56.9	25.8	104.9	22.8	25.2	35.5	39.7	36.4	39.6	29.2	59.1	65.8	45.1	31.0	39.0	74.0	60.4	75.7	38.0	26.2	94.6	78.7	30.9	35.2	49.0	54.2	61.1	41.5	42.8	44.2	44.7	52.9	38.7	50.7	50.7	66.0	14.7	62.5	44.8	39.4	106.1	21.1	45.3	44.5	6.5	10.5	12.3	20.5	17.0	23.3	19.0	19.6	20.8	9.3	14.7	19.4	23.6	5.3	29.4	19.1	15.4	24.5	15.3	13.4	15.3	24.0	17.9	13.8	15.9	15.6	13.4	15.7	15.1	15.3	24.3	38.6	73.7	57.5	48.0	70.7	84.8	107.0	49.5	39.3	44.7	48.7	31.2	76.4	24.3	71.0	33.1	41.7	46.8	68.2	27.1	43.0	59.5	33.3	54.8	50.7	52.0	55.1	43.1	48.8	72.1	66.2	49.0	28.5	60.5	77.8	59.4	30.4	23.4	33.4	18.5	53.6	35.9	36.7	32.1	37.0	19.8	48.1	41.8	39.2	61.8	61.5	32.5	52.5	56.3	88.3	69.2	33.5	30.1	68.9	54.2	23.6	28.9	73.2	40.5	32.9	70.3	65.7	33.2	41.3	40.9	63.1	35.7	72.1	38.0	37.8	72.7
FUBP3	FBP3	ENSG00000107164	"Far upstream element binding protein 3"	Q96I24	9	130578965-130638352	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047658, HPA058392"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		63000	"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA047658: AB_2680114, HPA058392: AB_2683703"	"unprognostic (1.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (3.12e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.23e-2)"	29.9	23.6	20.4	20.9	23.7	12.4	21.5	22.2	25.3	23.3	16.4	26.1	21.4	30.4	20.5	24.8	21.8	20.4	26.7	19.4	21.0	22.9	40.4	21.3	21.9	24.2	22.5	24.9	22.9	33.7	17.5	28.5	23.8	26.6	20.9	20.2	23.7	24.7	16.0	22.1	22.4	27.0	21.5	22.9	22.5	17.0	22.1	25.8	41.5	13.6	20.9	22.8	22.6	24.5	47.3	42.4	61.1	50.8	43.2	48.7	76.8	67.1	59.0	51.9	40.3	62.0	42.3	45.8	34.5	63.4	45.7	80.3	51.5	56.1	61.1	51.2	45.7	50.3	66.8	46.1	59.2	76.4	54.5	47.6	44.1	54.5	51.1	43.8	43.7	37.2	82.1	27.5	54.7	63.3	59.3	38.8	78.2	74.4	54.5	52.6	75.4	61.7	45.6	49.2	39.5	66.4	70.5	51.8	44.4	45.7	71.0	57.9	55.4	93.9	44.4	63.5	78.4	25.1	44.8	57.9	52.8	33.0	68.2	0.0	2.1	1.2	2.4	2.5	3.6	2.3	2.6	2.9	3.1	1.6	3.1	2.7	0.5	4.0	2.0	2.7	2.3	1.5	20.4	23.7	22.2	25.3	19.4	21.0	24.2	22.5	23.8	21.5	22.1	24.5	26.1	19.2	20.6	45.4	19.5	33.4	20.6	17.6	24.5	26.2	23.0	13.6	20.4	20.0	15.2	16.5	14.6	28.3	18.1	21.1	29.4	19.0	5.1	18.0	24.3	23.9	21.7	20.2	49.4	18.9	31.8	25.0	20.9	26.2	7.6	26.6	26.4	52.0	26.7	32.0	54.1	17.2	20.3	25.4	20.4	9.6	20.5	17.6	37.4	30.0	18.1	59.1	12.3	41.2	56.9	25.7	17.0	27.8	22.8	28.3	15.5	35.9	22.8	28.0	13.1	29.3	29.9	16.8	12.4	31.4	40.9	45.8	19.4	20.7	17.7	26.0
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868588-90883564	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 305.6;salivary gland: 220.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009499, HPA067869"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		130000	"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095, HPA067869: "	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	54.5	24.4	12.8	36.4	10.5	73.8	42.4	10.6	14.5	26.4	11.7	32.8	27.6	32.3	9.8	33.7	30.4	19.4	58.5	14.9	9.0	56.8	305.6	63.2	13.0	12.5	10.8	22.4	108.6	27.3	45.9	40.6	11.3	60.1	12.1	12.9	220.5	17.7	61.3	62.7	35.5	14.3	10.4	51.4	34.0	8.6	15.6	11.8	56.1	25.3	11.2	30.2	33.3	9.3	50.8	31.2	6.8	29.8	49.4	32.1	77.5	64.4	48.1	26.3	18.1	45.4	54.3	1.9	148.8	47.5	46.1	91.5	14.0	32.5	5.4	148.0	35.2	90.9	52.8	57.7	26.2	13.0	141.2	35.6	35.3	29.5	13.2	62.4	84.7	14.6	70.5	8.5	17.8	32.3	5.0	29.2	21.5	44.2	9.3	7.9	26.6	10.9	35.2	39.1	13.1	9.2	54.5	28.5	42.5	31.9	10.7	31.4	125.9	29.4	60.1	43.7	95.5	15.2	93.4	3.4	55.8	40.1	60.7	2.0	0.9	1.5	0.7	0.1	0.2	0.4	0.2	0.3	0.6	0.1	0.0	0.1	0.7	0.4	0.0	0.3	0.0	1.1	12.8	10.5	10.6	14.5	14.9	9.0	12.5	10.8	11.3	10.4	15.6	9.3	44.1	3.2	27.4	4.2	7.3	19.4	10.0	10.4	2.8	12.8	12.0	9.0	16.3	21.5	8.5	22.0	25.0	20.9	26.9	49.5	0.0	47.1	0.5	15.2	9.7	29.4	37.8	26.5	7.9	117.5	16.5	11.4	21.9	32.3	15.8	7.0	23.9	131.8	24.8	8.4	7.5	31.7	10.2	35.3	42.1	1.4	11.1	33.6	16.0	5.6	14.0	13.6	24.7	2.0	4.4	108.3	26.4	10.9	7.2	24.3	28.7	7.8	2.0	28.0	26.3	10.5	18.6	2.8	3.6	8.5	23.0	84.3	19.6	4.7	17.9	16.4
FUS	"ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS"	ENSG00000089280	"FUS RNA binding protein"	P35637	16	31180138-31191605	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008784, CAB033036, CAB058691"	Supported		Supported	Nucleoplasm		NA	NA		480000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181"	"unprognostic (3.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	88.6	47.6	43.6	102.9	48.6	98.9	65.1	50.6	59.2	85.3	27.2	72.5	59.5	102.0	40.9	58.5	99.2	38.8	70.4	46.9	48.6	83.6	54.3	64.8	97.9	44.3	43.0	134.2	57.3	85.0	47.2	58.3	46.9	59.1	62.8	59.4	60.0	70.4	98.6	53.8	62.6	98.1	45.7	69.3	59.4	69.1	44.8	174.1	58.6	86.0	113.2	87.5	63.2	52.1	386.6	337.2	492.6	292.9	128.3	101.7	429.3	504.1	253.1	319.6	238.3	440.7	254.9	579.6	359.3	310.7	349.4	173.0	563.6	421.0	284.3	341.5	304.7	486.6	224.6	445.3	222.7	529.7	348.5	222.4	99.8	437.5	258.9	120.1	295.7	419.6	537.6	204.7	357.0	483.0	446.2	475.5	649.0	307.7	402.0	677.0	535.9	350.1	344.0	265.6	279.1	478.9	344.5	255.7	267.8	314.9	291.8	597.5	276.3	371.5	365.5	242.1	520.5	181.4	350.4	779.0	204.4	364.2	460.9	12.3	38.2	52.8	53.6	67.3	49.9	29.1	36.5	45.9	41.7	35.2	40.3	43.9	35.0	37.3	59.3	50.3	31.0	27.4	43.6	48.6	50.6	59.2	46.9	48.6	44.3	43.0	46.9	45.7	44.8	52.1	414.6	102.5	121.2	58.1	470.7	144.8	345.7	201.0	507.6	272.6	209.8	223.8	102.1	112.9	156.3	104.8	131.3	299.3	488.8	266.8	68.4	183.6	130.8	201.0	366.1	278.4	212.1	188.2	75.4	154.8	398.5	309.0	222.8	309.7	229.7	445.0	174.2	59.1	208.5	201.9	85.9	229.5	132.2	148.4	270.7	51.2	307.3	282.7	165.4	94.6	185.4	230.8	341.9	117.6	122.2	175.7	219.4	215.5	266.6	245.4	205.4	69.7	115.4	266.3	164.3	584.4	344.2	221.0	237.1	443.6	154.3	295.1	518.2	327.9	232.6	281.2
FUT10		ENSG00000172728	"Fucosyltransferase 10"	Q6P4F1	8	33370824-33473146	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 140.0;Early spermatids: 248.8;Late spermatids: 334.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053970, HPA058655"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Endoplasmic reticulum, Golgi apparatus"		"HPA053970: AB_2682327, HPA058655: AB_2683789"	"unprognostic (6.02e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.76e-4)"	"unprognostic (3.06e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.01e-3)"	1.9	2.2	4.3	1.0	4.7	0.8	3.4	4.2	4.2	4.0	2.0	2.5	2.5	3.1	1.2	1.9	3.3	1.8	1.7	3.0	3.3	3.1	2.0	2.4	1.8	4.3	5.5	5.2	2.6	5.1	1.3	3.5	3.3	2.2	2.7	5.2	2.7	2.1	0.6	3.2	2.6	2.9	2.7	1.5	2.3	1.5	4.8	2.9	2.8	1.2	2.2	2.2	2.2	2.5	2.4	4.5	6.8	8.3	10.8	10.8	3.4	4.3	7.1	4.2	5.4	6.3	3.6	2.7	5.1	5.8	3.5	5.9	10.4	4.1	4.1	5.8	3.8	8.6	3.6	7.0	4.9	1.9	2.9	8.0	7.0	1.1	5.4	8.8	8.6	4.4	8.0	3.2	3.9	1.4	6.6	2.8	9.1	6.4	3.0	4.8	5.1	1.4	6.1	5.4	2.4	2.3	2.5	3.7	5.1	7.0	3.8	1.9	6.6	3.2	1.4	8.1	3.6	1.3	2.2	1.8	2.0	5.4	3.4	0.4	0.6	0.7	1.3	0.2	1.4	1.0	0.7	1.2	1.3	0.3	0.8	0.8	0.4	1.6	0.2	0.7	1.7	0.6	4.3	4.7	4.2	4.2	3.0	3.3	4.3	5.5	3.3	2.7	4.8	2.5	4.5	3.2	2.0	140.0	2.5	2.7	2.7	3.4	4.0	2.9	3.7	3.8	2.5	2.8	3.2	3.7	10.4	12.0	3.0	1.5	1.9	4.5	248.8	2.8	5.7	3.8	3.6	3.8	16.3	4.0	7.0	5.8	6.1	3.0	5.7	10.1	5.3	3.6	3.4	3.3	20.2	3.2	4.1	2.2	1.8	334.2	6.8	2.2	1.8	29.0	3.0	29.9	5.2	44.2	16.4	4.0	1.0	4.9	5.0	1.4	5.3	3.0	2.0	11.0	0.0	5.7	4.6	7.0	2.7	5.5	1.7	6.0	2.6	6.5	3.6	1.3
FUT8		ENSG00000033170	"Fucosyltransferase 8"	Q9BYC5	14	65410592-65744121	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1019.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 15.6;NK-cells: 14.8;T-cells: 10.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017129, HPA043410"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB017129: , HPA043410: AB_2678467"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.09e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	7.9	8.2	21.0	11.9	38.2	3.6	10.5	44.1	28.2	6.9	0.0	11.4	17.5	9.0	5.3	6.8	15.6	11.1	4.7	20.4	27.7	6.9	3.4	8.1	11.7	32.8	29.9	7.3	9.9	9.6	4.6	17.3	29.3	5.8	11.6	8.3	42.6	10.5	2.5	5.3	17.4	11.0	29.4	10.2	31.8	16.4	29.7	11.3	8.4	6.3	18.6	13.3	4.5	64.3	115.9	22.5	12.6	110.6	49.5	38.4	61.6	35.9	64.8	30.3	32.6	16.9	44.8	30.7	29.2	40.1	79.4	9.0	29.9	11.4	45.6	124.2	11.0	33.5	7.2	23.0	26.8	7.6	23.9	96.0	6.8	39.3	19.4	124.4	69.6	17.1	14.1	28.8	20.8	60.8	36.6	16.7	14.7	59.6	66.6	26.9	10.3	17.2	46.5	33.1	23.4	16.6	20.8	9.8	8.0	70.6	10.2	12.9	141.8	34.5	36.0	15.3	30.5	47.3	18.5	74.3	68.6	13.6	11.1	0.7	2.0	0.7	3.6	0.9	3.8	15.6	6.2	5.6	2.6	8.3	6.6	6.6	0.3	14.8	1.4	2.6	10.0	2.9	21.0	38.2	44.1	28.2	20.4	27.7	32.8	29.9	29.3	29.4	29.7	64.3	19.0	12.8	32.5	227.5	43.1	12.1	7.4	11.5	17.1	10.1	18.3	11.7	5.9	8.6	18.9	12.9	4.2	45.5	8.3	5.9	0.0	9.1	37.9	9.9	14.6	16.0	5.4	15.8	169.0	31.7	28.1	22.7	78.0	10.2	7.6	3.3	14.6	3.5	13.0	8.4	166.4	26.5	2.0	12.2	8.6	15.3	12.8	10.2	1.8	70.3	3.6	27.8	9.2	138.7	1019.1	54.7	10.3	13.5	124.3	8.8	24.5	8.4	15.3	9.1	0.0	14.3	13.2	34.6	26.8	7.4	9.8	14.1	18.9	10.6	21.7	7.2
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015974-96215612	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 18.9;stomach 1: 23.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 776.4;Excitatory neurons: 333.5;Inhibitory neurons: 238.2;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 224.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.9;OE19: 2.8;RT4: 6.5;SCLC-21H: 6.3;SK-BR-3: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	0.0	0.4	10.5	0.0	12.6	0.0	0.6	14.5	11.7	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	11.8	13.6	0.2	0.0	0.0	0.0	3.4	18.9	0.0	4.8	0.0	0.4	0.4	3.2	0.2	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	5.5	0.0	23.2	0.0	15.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.0	0.0	6.5	6.3	0.1	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	12.6	14.5	11.7	11.8	13.6	3.4	18.9	3.2	5.5	15.3	6.4	0.0	0.0	0.0	776.4	0.2	0.0	0.6	0.0	0.0	4.2	1.4	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.1	1.3	0.0	0.0	333.5	2.0	0.0	0.1	56.1	1.4	0.0	0.4	0.0	0.0	0.1	0.0	238.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.2	0.0	168.9	224.7	0.5	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1800.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1870.8;Distal enterocytes: 5605.4;Intestinal goblet cells: 2165.8;Paneth cells: 3324.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 896.3;hTCEpi: 1603.2;OE19: 3112.0;RT4: 860.2;SK-BR-3: 830.8;WM-115: 589.7"									HPA010856	Supported		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	5.1	1.1	7.3	59.5	7.4	1.3	225.2	7.1	7.9	168.0	7.5	1466.2	102.7	13.2	15.2	685.3	104.3	100.5	5.8	7.1	6.5	12.0	2.0	150.2	0.8	8.0	7.3	1.8	64.3	0.1	24.7	84.9	6.8	512.1	1800.0	45.4	569.1	33.3	2.1	568.3	308.9	35.7	6.7	0.6	572.4	0.6	7.0	18.7	1.5	0.1	163.3	295.6	395.8	7.4	166.3	0.0	0.0	0.4	0.6	0.4	150.5	0.0	0.0	0.0	0.0	6.0	235.3	0.3	0.5	0.0	1.3	896.3	0.1	339.5	0.0	0.1	0.3	1.0	7.7	0.6	0.1	0.1	0.6	0.0	1603.2	0.0	0.7	0.1	0.1	0.1	0.1	1.1	0.0	304.5	0.8	2.2	0.8	3112.0	1.4	0.8	0.4	1.2	0.0	860.2	190.2	2.1	1.0	830.8	61.8	2.3	155.9	0.2	0.0	0.3	0.6	0.9	0.7	0.1	0.4	0.7	1.0	0.3	589.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	7.3	7.4	7.1	7.9	7.1	6.5	8.0	7.3	6.8	6.7	7.0	7.4	3.1	762.8	262.6	0.3	11.1	576.9	792.9	1870.8	340.4	2.9	557.5	515.7	1.3	201.6	1026.4	134.3	0.0	883.5	8.3	5605.4	1.9	35.6	0.4	180.1	29.5	19.7	974.3	2.7	0.1	708.4	138.1	20.3	356.8	194.1	22.3	0.0	0.0	0.9	81.4	1.7	0.0	2165.8	587.9	0.0	68.3	0.0	0.0	15.6	412.6	0.0	1.6	422.1	0.0	0.0	0.6	556.5	3324.0	0.0	6.5	1041.7	1693.0	0.5	1627.1	13.3	0.0	0.5	66.5	0.2	0.2	541.1	865.5	1512.1	17.9	0.0	1499.3	1509.9
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 163.9;Leydig cells: 237.9;Muller glia cells: 128.7;Peritubular cells: 363.8;Sertoli cells: 355.0;Theca cells: 141.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"classical monocyte: 37.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 37.7"	"Cell line enhanced"	"Detected in some"		"AF22: 136.0;HAP1: 92.9;RH-30: 57.1;SCLC-21H: 204.5;SH-SY5Y: 114.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: AB_2677931"	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favorable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.60e-4)"	58.4	116.3	230.8	30.1	258.5	9.8	39.5	82.5	293.2	112.3	28.1	371.1	22.2	321.5	61.0	29.8	181.6	93.1	117.1	244.3	187.3	70.6	32.8	86.6	30.0	91.8	173.6	281.1	30.1	9.8	175.0	16.7	149.5	107.8	35.9	47.1	29.5	73.2	37.3	22.2	104.6	197.6	71.4	151.9	98.9	86.6	136.4	31.2	66.5	78.3	18.9	202.9	80.4	179.3	0.3	0.9	136.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.6	0.1	4.8	0.7	92.9	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.2	2.6	0.0	1.7	6.3	0.5	27.2	0.0	0.0	0.1	57.1	1.0	3.5	0.1	204.5	114.0	0.0	0.5	5.1	36.9	2.4	2.4	0.0	0.0	30.0	0.5	0.0	0.4	0.3	0.1	1.0	0.4	0.4	0.0	37.7	0.0	0.0	9.4	0.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.9	0.0	0.1	0.6	0.0	9.9	230.8	258.5	82.5	293.2	244.3	187.3	91.8	173.6	149.5	71.4	136.4	179.3	72.2	6.4	2.2	0.0	1.1	6.6	2.4	1.1	0.6	3.5	2.1	21.5	9.3	1.5	0.7	0.0	2.1	0.8	1.0	0.0	1.9	6.4	3.6	0.6	23.9	71.8	12.5	10.7	0.0	0.4	1.1	78.6	0.5	1.0	0.0	29.7	163.9	1.6	72.7	1.7	0.0	0.2	6.1	32.4	9.6	14.3	237.9	18.7	16.0	0.0	9.8	128.7	1.0	0.0	0.0	0.4	0.0	363.8	1.2	4.9	0.0	0.1	1.7	4.4	355.0	49.6	79.6	4.6	3.5	1.4	3.8	1.4	1.4	141.8	0.0	1.7
FYB1	"ADAP, FYB, FYB-120/130, SLAP-130"	ENSG00000082074	"FYN binding protein 1"	O15117	5	39105252-39274528	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.0;lymphoid tissue: 112.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 142.9;Extravillous trophoblasts: 88.7;Hofbauer cells: 157.0;Macrophages: 104.2;T-cells: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1670.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HEL: 61.5;JURKAT: 211.9;MOLT-4: 212.9;REH: 61.3;U-937: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025336, HPA026796, HPA067427"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		6200000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	Nucleoplasm	"CAB025336: , HPA026796: AB_10964126, HPA067427: "	"unprognostic (5.65e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-1)"	10.2	5.8	5.7	82.5	5.5	53.0	5.1	6.3	9.3	6.6	7.4	10.0	9.1	3.8	10.5	5.7	3.6	16.8	2.4	5.4	7.9	5.0	13.6	17.6	85.8	16.7	19.1	2.7	1.8	2.1	1.5	17.9	15.8	4.2	11.0	0.5	7.4	3.0	1.2	2.0	15.0	11.6	9.3	73.0	12.2	3.3	13.3	112.8	2.6	2.7	63.0	17.1	1.8	13.9	0.2	4.2	0.0	0.0	0.5	0.0	21.1	0.1	1.2	0.3	0.4	0.4	0.3	0.3	0.0	0.0	8.0	16.4	0.0	0.3	0.1	0.3	0.0	61.5	0.0	0.1	0.0	23.3	18.6	0.3	0.4	0.0	0.4	0.1	0.0	211.9	0.0	0.0	0.0	0.0	212.9	13.5	0.2	0.1	0.1	61.3	0.0	0.3	1.0	3.5	0.1	0.0	0.1	0.5	6.5	1.4	0.0	5.2	0.0	0.0	0.2	0.2	0.2	0.4	0.0	4.5	0.0	81.4	0.2	151.3	359.0	354.6	76.3	406.5	52.9	1.8	216.7	134.5	127.6	1.3	271.7	169.8	1670.8	89.9	483.9	30.8	231.5	400.1	5.7	5.5	6.3	9.3	5.4	7.9	16.7	19.1	15.8	9.3	13.3	13.9	4.4	16.0	24.7	0.0	6.2	0.0	0.0	0.0	0.0	0.0	3.2	7.6	0.0	0.0	5.6	14.7	0.0	28.8	142.9	0.0	9.8	0.4	0.0	0.7	1.1	4.3	0.0	0.0	0.0	0.0	88.7	3.8	0.0	1.0	15.2	0.1	0.0	0.0	157.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	35.9	3.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	40.2	119.3	0.1	0.0	0.0
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 16.7;skin 1: 9.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.4;Basal squamous epithelial cells: 12.5;Fibroblasts: 8.4;Skeletal myocytes: 13.1;Smooth muscle cells: 9.3;Squamous epithelial cells: 25.5;Suprabasal keratinocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 5.5;BEWO: 6.4;hTCEpi: 3.7;RPTEC TERT1: 1.9;RT4: 3.2"	"Region enhanced"	"Detected in many"		"thalamus: 6.9"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.41e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (5.05e-7)"	"unprognostic (2.81e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.62e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.66e-9)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	0.7	0.1	0.7	0.1	0.6	0.0	0.8	1.2	0.6	6.5	0.2	0.3	0.1	2.8	0.9	16.7	1.4	1.6	0.2	0.6	0.6	0.6	0.0	0.8	0.4	1.2	1.0	2.9	0.1	0.0	0.9	2.3	1.1	2.9	0.2	0.4	4.2	1.5	1.0	9.4	0.4	0.4	0.7	0.0	0.4	0.1	2.7	0.3	1.0	0.8	0.7	2.6	6.8	1.1	0.0	0.0	5.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.0	0.5	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	1.2	0.6	0.6	0.6	1.2	1.0	1.1	0.7	2.7	1.1	0.4	0.0	0.5	0.0	0.0	8.4	4.7	0.1	12.5	0.1	0.6	0.8	0.6	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.5	2.1	2.1	0.0	0.0	0.0	0.2	0.6	8.4	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	13.1	9.3	0.0	0.4	25.5	8.5	0.8	0.1	0.0	0.0	1.8
FZD2		ENSG00000180340	"Frizzled class receptor 2"	Q14332	17	44557484-44561262	"Cancer-related genes, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 10.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Kupffer cells: 9.8;Leydig cells: 23.3;Peritubular cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;myeloid DC: 1.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 53.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057667	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"	"Cell Junctions"	"HPA057667: AB_2683497"	"unprognostic (6.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.6	1.0	1.4	1.5	0.2	1.3	0.9	1.2	5.9	10.5	1.8	0.9	5.3	1.3	0.9	3.8	1.8	2.8	1.1	1.3	2.8	0.2	2.9	0.8	1.3	1.9	3.3	1.5	2.1	1.1	3.6	2.0	1.7	0.4	0.7	1.0	1.9	0.4	0.6	1.6	1.5	1.3	2.1	1.2	1.5	1.4	0.3	2.4	0.7	0.7	2.0	2.5	1.6	12.9	37.7	38.3	13.8	8.7	6.4	0.4	39.5	30.4	53.4	38.2	28.4	6.2	0.0	8.9	13.9	13.1	5.5	3.6	2.8	30.2	2.9	7.2	1.7	6.6	0.1	7.7	0.2	7.5	10.7	2.8	9.6	8.8	40.8	1.8	4.9	2.5	0.3	20.9	5.9	6.7	3.6	26.8	0.1	6.7	18.1	8.6	1.9	7.7	0.6	3.8	10.9	5.2	1.1	2.3	32.4	14.6	8.4	0.7	24.1	17.5	4.4	22.6	0.8	0.7	3.0	4.0	2.4	11.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	1.0	1.5	0.9	1.2	1.1	1.3	1.3	1.9	2.0	1.3	1.4	1.6	0.5	19.2	0.0	1.6	0.6	0.6	0.3	0.9	0.0	0.0	0.9	2.9	1.9	0.0	0.2	1.8	0.0	1.6	1.8	0.0	0.0	0.3	0.6	1.1	8.4	0.7	1.2	1.3	0.0	1.8	0.5	5.9	0.0	1.5	0.0	1.4	0.7	0.0	4.8	0.0	0.0	0.3	0.0	9.8	6.0	0.4	23.3	5.6	0.0	6.5	6.2	6.0	0.0	0.0	0.2	0.7	0.0	18.0	0.3	0.1	0.0	0.3	0.2	0.4	0.0	0.4	5.3	0.3	1.2	0.3	0.4	2.3	0.2	2.4	0.0	0.0
FZD3		ENSG00000104290	"Frizzled class receptor 3"	Q9NPG1	8	28494205-28574267	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 14.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 98.0;Excitatory neurons: 155.9;Inhibitory neurons: 82.3;Rod photoreceptor cells: 87.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 9.3;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"AF22: 53.2;Karpas-707: 27.9;SCLC-21H: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024995, HPA042320"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	Nucleoplasm	"CAB024995: , HPA042320: AB_2677948"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.69e-2)"	"unprognostic (4.26e-4)"	"unprognostic (2.11e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.09e-3)"	1.0	2.9	5.2	1.5	6.7	1.5	2.3	5.7	9.9	2.4	13.8	2.2	1.3	3.4	6.9	1.9	3.5	1.3	1.1	6.8	4.0	2.6	0.6	1.0	2.1	1.8	5.4	7.0	3.5	4.2	3.8	1.3	4.2	4.3	1.2	14.7	3.3	5.5	1.2	1.5	1.0	2.4	0.9	0.6	2.5	5.0	3.2	1.8	3.4	1.3	1.4	1.9	1.6	2.6	14.8	3.1	53.2	10.2	0.0	0.8	7.9	0.5	1.1	3.0	1.3	3.1	3.1	6.9	2.6	0.3	6.6	5.2	8.0	8.8	2.1	9.1	5.8	4.8	1.0	2.0	0.0	2.7	7.9	0.6	4.1	0.2	2.3	0.6	0.6	7.3	3.5	27.9	0.1	3.7	0.2	5.8	13.3	6.4	4.6	3.3	8.0	6.8	4.0	4.4	39.6	10.7	2.9	7.5	8.7	7.0	7.4	4.0	0.0	0.0	14.3	2.0	3.7	5.1	6.1	6.7	4.2	0.0	2.7	0.7	0.2	0.0	1.6	0.2	2.1	1.1	1.2	2.3	0.9	0.6	1.6	1.6	0.1	0.9	0.0	9.3	0.0	0.7	5.2	6.7	5.7	9.9	6.8	4.0	1.8	5.4	4.2	0.9	3.2	2.6	1.7	9.6	12.0	65.6	5.6	6.6	7.9	17.0	10.8	28.1	21.6	11.7	6.0	4.3	17.7	9.2	98.0	10.5	15.7	1.4	1.9	12.1	25.7	24.2	18.7	4.3	28.7	5.0	155.9	14.9	9.7	8.8	8.2	27.7	5.7	29.3	8.6	3.0	4.2	21.9	82.3	6.3	8.2	1.0	7.4	11.9	48.1	2.1	33.8	14.0	0.7	17.0	2.1	52.8	14.3	11.8	3.4	51.1	17.2	14.1	0.8	11.4	17.5	87.1	26.3	8.6	15.0	58.4	45.6	5.6	4.7	4.8	5.0	15.0	5.4	7.7
FZD4	"CD344, EVR1"	ENSG00000174804	"Frizzled class receptor 4"	Q9ULV1	11	86945679-86955395	"CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 120.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.0;Collecting duct cells: 36.8;Endothelial cells: 51.2;Hepatic stellate cells: 99.6;Sertoli cells: 32.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 63.6;Hep G2: 85.2;HSkMC: 46.0;HUVEC TERT2: 93.6;TIME: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042328, HPA074833"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"HPA042328: AB_10962494, HPA074833: AB_2686716"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.97e-1)"	120.1	9.5	6.7	5.8	6.2	0.3	55.6	5.1	7.3	12.5	7.8	14.9	2.8	12.2	7.6	6.5	16.3	11.5	27.4	5.6	5.9	27.1	14.6	32.9	6.2	6.5	6.3	12.9	9.5	6.4	8.7	11.7	7.0	12.5	6.3	1.1	12.2	30.2	31.5	5.9	8.8	13.4	5.6	14.1	14.1	5.1	8.5	3.9	18.1	40.6	4.6	10.5	9.5	5.9	1.3	1.1	2.7	5.2	63.6	16.5	3.7	8.4	7.6	3.2	3.3	7.1	0.9	0.0	1.8	2.6	4.4	2.8	3.1	1.3	2.5	0.2	2.1	2.8	2.3	85.2	18.9	0.0	0.1	46.0	0.5	2.8	0.5	7.5	93.6	0.1	3.9	0.4	2.2	2.2	0.0	0.0	3.9	7.5	18.8	0.1	4.8	0.2	9.0	13.7	0.6	0.8	3.5	1.0	1.4	5.6	12.0	0.0	46.3	7.8	5.1	9.2	1.7	0.4	1.3	0.0	1.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	6.2	5.1	7.3	5.6	5.9	6.5	6.3	7.0	5.6	8.5	5.9	83.0	0.0	1.3	9.8	0.5	1.5	0.5	1.3	2.2	0.7	5.5	3.2	8.3	7.2	2.0	36.8	10.4	0.2	0.5	1.0	3.9	0.5	0.7	0.4	2.7	51.2	0.0	2.7	8.1	1.6	0.2	17.7	4.1	0.5	0.0	9.1	99.6	14.1	0.2	0.0	3.4	1.3	0.0	6.7	1.8	2.2	9.3	0.6	0.0	10.3	0.0	0.2	2.1	3.0	0.7	1.0	0.1	6.8	0.3	1.4	0.7	9.4	2.1	0.2	32.9	14.4	26.6	0.3	3.2	1.3	0.6	0.3	0.4	16.6	1.1	0.2
FZR1	"CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242"	ENSG00000105325	"Fizzy and cell division cycle 20 related 1"	Q9UM11	19	3506311-3538334	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 104.2;Late spermatids: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043536	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA043536: AB_10968058"	"unprognostic (2.78e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.04e-1)"	14.8	25.2	17.0	9.3	14.0	33.5	16.4	19.1	17.2	21.3	5.2	17.2	21.9	19.3	4.0	23.5	18.2	9.4	13.0	16.7	17.1	18.1	23.5	15.6	11.4	19.2	17.3	22.9	17.3	10.9	34.1	8.9	19.3	19.1	3.7	5.6	19.7	10.5	18.5	26.2	18.4	6.3	12.0	18.8	15.6	52.7	15.8	13.9	24.0	7.5	7.0	16.2	20.9	13.5	44.0	25.7	24.3	22.4	7.5	10.4	18.9	26.7	17.8	31.0	24.2	26.2	21.1	24.3	13.5	19.7	15.0	25.2	13.7	23.4	6.2	32.9	23.5	11.6	19.5	26.2	13.4	20.9	23.8	9.8	13.5	18.8	11.2	11.7	18.4	23.0	21.0	41.1	16.1	22.8	37.5	15.2	20.5	13.6	20.1	28.0	20.6	23.6	15.6	21.6	22.3	25.0	24.1	17.5	13.1	5.5	18.2	19.1	24.9	17.6	21.3	42.9	47.4	42.9	10.8	18.5	24.4	41.5	22.3	1.1	0.7	2.0	1.0	0.7	0.6	1.0	1.0	0.7	0.6	0.8	0.6	0.8	1.3	1.2	0.5	0.5	0.9	0.6	17.0	14.0	19.1	17.2	16.7	17.1	19.2	17.3	19.3	12.0	15.8	13.5	8.1	0.0	5.0	6.5	15.4	17.8	35.8	10.6	6.2	20.7	14.5	11.2	3.4	17.2	8.6	12.9	10.4	21.9	11.0	25.8	5.9	16.5	104.2	14.1	8.2	11.0	21.6	26.5	6.3	14.9	14.2	10.1	26.5	14.3	3.8	20.4	10.0	17.9	16.4	30.3	9.1	18.1	18.3	7.9	11.4	208.2	12.8	11.9	12.4	3.7	18.1	8.5	9.2	6.6	10.4	28.1	17.0	9.4	13.7	20.6	17.4	13.5	10.8	15.6	6.6	7.3	12.9	58.4	15.8	11.9	22.6	45.4	11.9	15.6	16.1	28.3
GAB3		ENSG00000160219	"GRB2 associated binding protein 3"	Q8WWW8	X	154675249-154751583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 20.4;dendritic cells: 32.0;Erythroid cells: 20.4;granulocytes: 20.8;Kupffer cells: 24.7;Microglial cells: 30.9;NK-cells: 39.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HMC-1: 23.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA010090	Approved		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA010090: AB_1849362"	"unprognostic (2.67e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-1)"	3.7	2.1	1.8	7.0	3.5	12.5	2.3	2.6	3.4	1.8	2.2	2.6	3.4	2.0	3.8	1.7	1.9	3.7	7.4	2.0	2.6	1.0	1.9	6.0	7.6	4.7	2.2	1.3	1.0	2.7	0.4	3.7	5.0	1.3	3.4	1.2	2.1	1.9	1.3	3.6	4.2	3.5	2.1	13.9	2.6	4.9	3.6	5.2	3.6	1.6	6.6	3.1	1.1	8.6	0.8	0.0	0.7	1.0	0.9	2.3	0.5	0.3	0.6	0.2	0.3	0.0	0.5	2.5	0.7	0.0	1.5	0.4	0.6	0.4	0.0	2.9	1.0	21.3	2.9	2.4	1.6	6.5	23.3	0.9	0.2	2.0	0.8	0.8	5.2	2.0	4.8	7.3	1.0	0.3	2.4	6.6	0.2	0.0	0.1	3.5	0.0	0.3	1.3	0.0	3.0	0.4	0.3	0.3	0.4	0.5	0.9	3.7	4.8	1.2	1.9	0.8	0.6	8.0	7.0	2.5	2.0	8.4	0.6	26.4	5.9	8.7	13.3	5.7	10.2	1.0	3.5	9.7	5.8	1.3	1.2	6.8	9.0	2.5	3.6	3.3	0.8	5.0	1.8	3.5	2.6	3.4	2.0	2.6	4.7	2.2	5.0	2.1	3.6	8.6	9.9	0.0	6.7	0.7	6.0	0.6	0.0	0.3	0.0	0.1	0.2	0.6	20.4	0.0	1.3	0.0	0.0	0.1	32.0	0.0	0.0	0.8	0.3	0.5	1.2	8.3	0.0	20.4	0.3	0.5	0.6	2.3	0.0	0.1	20.8	2.2	6.1	0.3	13.8	0.0	0.3	0.0	0.0	24.7	5.8	1.7	1.8	18.8	0.0	30.9	16.1	2.6	39.1	8.5	0.3	0.4	0.0	4.5	7.5	0.1	0.0	0.2	1.7	0.4	6.6	0.7	6.6	0.1	1.0	0.2	1.0	0.1	18.6	0.5	0.0	0.1
GABARAPL2	"ATG8, ATG8C, GATE-16, GATE16, GEF2"	ENSG00000034713	"GABA type A receptor associated protein like 2"	P60520	16	75566375-75577881	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036726	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA036726: AB_10672476"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.58e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.95e-8)"	"unprognostic (3.11e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.85e-1)"	129.2	166.9	269.1	68.0	278.1	101.6	122.3	297.7	310.8	105.9	237.2	118.5	67.1	101.3	158.1	91.9	106.0	84.1	279.9	259.7	294.9	153.8	113.6	111.3	94.7	280.8	278.4	108.7	81.4	209.5	169.0	113.8	289.2	113.7	81.4	201.4	100.8	102.2	262.9	135.0	90.1	98.6	306.0	112.0	99.7	78.3	282.4	102.1	124.5	186.7	98.9	95.3	104.8	320.2	103.4	85.9	142.7	67.7	217.1	189.9	72.6	118.2	169.9	158.0	176.4	79.8	129.1	148.1	143.0	135.3	95.2	86.6	107.6	110.6	193.9	64.8	208.7	86.9	72.2	119.1	118.2	84.1	151.3	132.0	153.5	133.3	98.6	143.0	130.5	130.5	130.3	58.4	160.2	145.7	125.4	161.0	85.8	114.5	95.8	139.4	69.0	179.6	166.2	66.4	167.7	175.5	184.7	43.7	177.4	113.3	140.1	130.4	119.5	67.9	104.7	100.0	64.5	166.2	172.8	310.6	163.6	80.6	102.6	345.1	148.8	370.8	128.4	140.3	163.0	215.0	135.2	146.8	176.8	199.0	121.4	114.6	502.5	115.3	157.0	274.1	208.1	241.5	269.1	278.1	297.7	310.8	259.7	294.9	280.8	278.4	289.2	306.0	282.4	320.2	341.0	86.6	136.2	30.7	163.9	274.9	278.8	311.4	141.7	247.9	196.5	236.2	361.4	145.8	212.5	174.7	45.9	251.3	188.5	201.5	686.7	183.9	48.2	209.6	112.8	270.1	277.8	457.6	37.0	175.4	120.6	203.5	80.5	162.4	110.1	85.9	239.8	128.5	223.9	307.9	39.6	156.4	297.0	169.6	428.8	59.7	243.5	197.2	257.9	21.5	404.6	491.0	145.2	27.6	63.6	223.6	237.0	261.1	137.5	306.1	195.7	552.4	263.0	208.1	157.8	182.1	187.9	288.1	219.9	136.6	273.9	390.1	159.3	182.5	121.2	328.6
GABPA	"E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A"	ENSG00000154727	"GA binding protein transcription factor subunit alpha"	Q06546	21	25734570-25772460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003258, CAB004411, HPA028791"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598"	"unprognostic (5.50e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.73e-3)"	17.0	13.8	6.8	14.1	9.4	16.0	14.9	7.9	10.2	14.6	7.2	12.5	12.9	18.3	15.1	11.3	12.4	13.4	12.9	6.2	7.1	13.8	19.3	13.3	20.4	7.5	7.6	18.1	10.2	15.3	6.7	24.5	8.1	12.4	13.8	11.5	10.4	10.3	10.6	10.3	13.4	15.3	7.6	18.7	11.8	15.0	7.6	22.1	21.2	16.5	19.5	12.9	10.0	10.3	22.2	9.2	25.8	18.2	25.4	33.9	20.0	17.5	18.7	13.7	13.5	11.4	18.2	45.7	13.4	19.7	13.9	9.7	28.5	17.2	22.7	27.6	26.8	32.9	11.9	10.7	17.1	35.3	21.2	25.1	16.3	18.5	17.2	22.9	25.6	24.9	30.8	27.5	23.2	11.0	37.9	15.1	35.9	23.6	12.5	31.1	37.5	28.7	15.9	14.3	16.0	21.1	30.9	19.5	22.0	15.5	17.2	26.8	26.5	16.9	15.5	18.7	14.8	22.2	20.3	40.3	17.2	26.5	21.1	8.8	4.7	7.4	4.3	5.5	5.8	5.6	5.1	5.3	4.7	5.4	5.9	5.2	5.5	6.7	4.3	2.6	5.8	4.4	6.8	9.4	7.9	10.2	6.2	7.1	7.5	7.6	8.1	7.6	7.6	10.3	43.2	9.6	12.0	14.0	20.7	11.6	12.2	7.0	15.4	7.6	13.0	10.8	9.1	14.3	11.8	22.0	0.0	18.1	18.4	19.0	3.9	7.6	13.2	12.0	22.6	26.3	9.0	11.6	21.0	8.1	12.4	23.7	12.2	14.8	6.3	21.1	27.8	18.7	12.7	13.5	19.6	11.1	6.1	19.0	10.1	3.6	17.7	16.7	7.2	22.5	16.0	23.2	10.3	21.1	43.4	7.9	10.2	22.2	15.3	11.9	11.4	10.4	9.3	10.2	19.7	26.1	18.4	34.0	19.5	12.6	12.6	25.2	19.2	14.2	11.3	14.4
GABPB1	"E4TF1-47, GABPB, GABPB2"	ENSG00000104064	"GA binding protein transcription factor subunit beta 1"	Q06547	15	50275389-50355408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019653, HPA067444"	Supported		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Cytoplasmic bodies"	"HPA019653: AB_1849370, HPA067444: AB_2685842"	"unprognostic (7.79e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-3)"	14.1	7.5	5.5	13.6	6.1	34.7	11.5	11.1	7.1	8.5	5.8	9.0	7.6	10.4	9.5	8.0	8.6	9.2	7.1	5.7	5.7	7.4	13.9	9.3	18.8	6.2	5.2	8.2	7.4	9.8	4.7	14.3	6.3	9.6	10.7	8.1	8.5	6.9	7.4	8.2	7.9	10.0	5.3	11.9	8.8	16.1	5.8	24.8	9.6	8.1	20.1	16.8	6.9	9.2	25.4	28.6	41.0	32.0	10.6	14.8	54.7	32.5	25.5	37.6	32.9	48.9	20.3	33.0	19.3	26.9	29.7	40.8	37.2	27.9	47.5	46.1	22.2	39.2	29.3	33.7	25.3	37.9	29.1	19.7	26.8	35.3	45.6	21.0	66.9	35.6	36.6	40.4	25.4	58.1	56.5	34.1	28.2	27.8	19.2	68.6	29.8	31.7	22.9	31.7	38.9	32.0	29.0	27.0	33.4	38.9	23.5	37.1	32.1	34.2	28.3	60.4	58.9	28.6	42.0	57.8	21.1	34.5	35.2	44.5	16.2	32.7	19.8	20.1	26.5	31.6	19.4	21.4	22.4	26.4	17.7	20.5	16.1	27.3	15.7	17.7	27.9	20.2	5.5	6.1	11.1	7.1	5.7	5.7	6.2	5.2	6.3	5.3	5.8	9.2	18.2	9.6	11.2	10.7	80.0	47.2	126.7	15.1	23.9	43.1	10.1	9.4	17.7	24.3	7.2	7.3	35.5	43.2	47.3	11.4	3.9	12.2	79.5	8.3	11.9	38.0	50.4	38.7	13.9	7.6	50.5	33.2	23.9	10.9	47.0	8.6	41.7	30.6	37.0	37.0	12.3	24.9	12.2	73.4	22.3	33.3	57.8	42.2	19.6	15.9	54.0	32.4	120.5	22.1	19.1	14.6	21.6	38.4	58.7	89.3	21.4	8.4	8.7	45.8	26.3	64.0	32.5	28.9	34.0	32.7	35.8	55.4	77.2	6.7	27.8	116.6
GABPB2	MGC29891	ENSG00000143458	"GA binding protein transcription factor subunit beta 2"	Q8TAK5	1	151070578-151125542	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028471, HPA058483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA028471: AB_10602319, HPA058483: AB_2683730"	"unprognostic (1.21e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.76e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.65e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.98e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-3)"	5.5	4.9	4.4	4.2	6.4	7.0	4.5	6.9	5.3	5.8	3.8	5.5	3.5	5.1	3.8	4.9	5.8	3.6	6.4	4.2	4.9	4.8	3.8	4.4	5.5	5.5	5.2	9.3	4.1	5.1	5.8	3.2	5.2	5.3	4.8	5.3	4.3	3.7	5.1	7.2	4.7	3.9	3.9	5.4	4.9	11.7	5.7	9.8	5.4	3.7	5.1	5.7	5.5	7.9	9.2	3.2	2.2	2.7	7.6	11.2	2.9	8.4	5.2	4.7	3.3	0.9	6.7	9.6	3.0	8.0	2.5	7.8	4.8	4.3	6.9	3.6	1.8	2.6	5.3	0.1	5.1	10.6	5.2	6.1	4.9	6.5	9.7	3.7	1.7	10.0	6.6	6.5	5.7	13.1	14.6	1.9	1.0	5.3	3.4	4.3	3.6	4.5	4.0	2.5	3.8	1.6	10.7	3.7	3.1	2.1	9.3	11.2	5.3	1.2	4.0	8.5	6.8	3.5	1.8	33.9	3.8	7.9	5.7	1.5	0.9	0.5	1.4	1.1	0.8	1.0	1.5	1.2	0.8	1.3	1.3	1.4	1.4	0.8	1.8	1.6	0.6	1.0	4.4	6.4	6.9	5.3	4.2	4.9	5.5	5.2	5.2	3.9	5.7	7.9	9.4	9.6	16.8	21.2	10.0	11.5	9.3	9.6	10.2	26.3	8.9	10.3	22.4	17.2	14.8	12.9	25.0	5.8	18.0	12.3	9.8	5.7	36.3	13.5	15.4	11.0	9.6	14.9	18.4	5.8	4.6	16.2	9.7	9.7	7.0	11.7	15.7	7.1	8.2	33.7	25.3	15.6	4.1	13.4	9.7	17.1	22.4	11.3	8.8	15.9	14.3	10.9	33.0	11.6	39.3	5.3	8.5	21.4	8.1	6.9	10.7	4.6	20.8	36.5	6.6	38.5	15.4	75.6	55.7	9.6	10.1	4.5	16.3	15.6	16.8	7.0
GABRA1	EJM5	ENSG00000022355	"Gamma-aminobutyric acid type A receptor subunit alpha1"	P14867	5	161847063-161899981	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 55.1;retina: 17.8"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 198.0;Excitatory neurons: 220.5;Inhibitory neurons: 215.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022502, HPA029363, HPA055746"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"CAB022502: , HPA029363: , HPA055746: AB_2682904"					"unprognostic (2.58e-2)"						"unprognostic (4.78e-3)"	"unprognostic (1.84e-1)"		"unprognostic (3.31e-1)"		"unprognostic (2.43e-1)"		0.0	1.2	6.7	0.0	11.1	0.0	0.0	24.8	55.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	14.3	0.6	0.0	0.0	0.2	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	11.1	24.8	55.1	7.7	21.7	0.0	0.0	0.0	0.0	14.3	24.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	198.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	220.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	215.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	17.8	0.0	3.5	0.0	8.0	16.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRA2		ENSG00000151834	"Gamma-aminobutyric acid type A receptor subunit alpha2"	P47869	4	46243548-46475230	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.5;epididymis: 8.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 425.4;Excitatory neurons: 156.2;Inhibitory neurons: 111.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6;glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"U-2 OS: 4.2;U-87 MG: 2.1;WM-115: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029363, CAB079061"		Supported	Uncertain	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"CAB079061: , HPA029363: "	"unprognostic (2.03e-2)"		"unprognostic (2.77e-1)"	"unprognostic (2.45e-4)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	1.2	0.3	20.2	0.4	29.9	0.2	1.3	2.6	31.5	0.5	0.0	3.0	0.9	0.4	8.8	0.7	0.0	0.5	0.2	29.4	16.0	6.3	0.4	0.1	0.3	0.3	1.9	0.7	0.1	0.0	0.5	0.4	0.0	0.1	2.1	2.4	0.2	0.7	0.1	0.2	6.0	0.2	1.3	1.2	0.5	0.5	13.8	0.4	0.1	0.1	0.4	0.2	0.7	8.8	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	4.2	0.2	0.0	0.2	0.6	0.0	2.1	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	29.9	2.6	31.5	29.4	16.0	0.3	1.9	0.0	1.3	13.8	8.8	4.9	0.0	0.0	425.4	0.0	0.1	0.0	0.0	1.2	15.3	0.2	0.0	0.6	0.0	0.0	40.5	4.2	0.0	0.0	23.1	3.9	0.0	9.1	1.2	31.7	1.0	31.8	0.0	156.2	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	111.6	3.4	0.0	0.0	0.0	17.1	0.6	0.1	1.8	16.9	0.0	0.2	0.0	13.0	5.5	0.0	4.7	0.0	0.0	0.0	38.1	0.1	0.0	1.1	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.1	0.0	2.7	0.0
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor subunit alpha3"	P34903	X	152166234-152451315	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.5;choroid plexus: 16.3;retina: 9.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 70.3;Hofbauer cells: 16.2;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;HMC-1: 8.4;Karpas-707: 14.4;PC-3: 8.4;U-266/70: 7.7;U-266/84: 13.6;U-87 MG: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000839, HPA029363"	Approved	Supported	Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"HPA000839: AB_1078929, HPA029363: "	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.0	0.0	10.0	0.0	13.7	0.0	0.0	0.0	13.2	0.9	16.3	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	9.6	15.5	0.0	0.0	0.0	0.0	0.9	4.0	0.0	0.0	0.0	0.6	2.9	3.0	0.1	0.0	9.0	0.1	0.6	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.7	11.2	0.0	0.0	0.0	0.1	0.4	0.2	2.7	0.0	0.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	14.4	0.0	0.0	0.0	0.0	2.6	6.4	8.4	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	5.3	0.4	0.3	0.1	1.3	0.1	5.3	7.0	0.3	1.6	7.7	13.6	0.0	8.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.7	0.0	13.2	9.6	15.5	0.9	4.0	3.0	0.6	11.2	2.7	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.6	1.2	0.0	0.0	0.3	0.0	0.0	0.0	2.1	3.2	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.0	0.0	70.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	1.7	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	3.0	0.0	58.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	1.2	0.9	0.0	1.9	0.0	0.0	0.0	0.5
GABRA5		ENSG00000186297	"Gamma-aminobutyric acid type A receptor subunit alpha5"	P31644	15	26866911-26949208	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 111.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 27.6;Inhibitory neurons: 14.1"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Group enriched"	"Detected in many"	4	"amygdala: 52.0;basal ganglia: 73.5;cerebral cortex: 98.6;hippocampal formation: 111.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A549: 35.3;HAP1: 12.0;NTERA-2: 16.2;U-2 OS: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029363, HPA077031, CAB079022"		Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"CAB079022: , HPA029363: , HPA077031: AB_2686825"	"unprognostic (6.33e-2)"			"unprognostic (8.94e-3)"	"unprognostic (1.04e-1)"			"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.57e-1)"		"unprognostic (7.63e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	52.0	0.1	73.5	0.0	0.0	0.0	98.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.5	111.0	7.2	0.1	0.1	0.0	0.0	0.0	3.0	0.0	0.1	0.7	0.5	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.7	12.0	9.0	0.1	0.1	0.3	0.0	0.0	19.6	0.0	35.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	12.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.1	0.2	1.8	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	73.5	0.0	98.6	111.0	7.2	0.0	3.0	0.0	0.0	12.0	19.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.8	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GADD45B	"DKFZP566B133, GADD45BETA, MYD118"	ENSG00000099860	"Growth arrest and DNA damage inducible beta"	O75293	19	2476122-2478259	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1997.9;Breast myoepithelial cells: 1851.8;Smooth muscle cells: 1753.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 16.3"	HPA029816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA029816: AB_10601325"	"unprognostic (1.32e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.90e-2)"	"unprognostic (8.27e-3)"	"unprognostic (6.00e-2)"	343.5	75.9	45.3	41.4	52.8	321.4	217.4	51.4	63.8	104.8	55.0	205.1	17.2	83.4	3.3	53.9	190.0	91.4	372.7	45.1	57.8	245.6	408.9	343.2	33.1	56.3	55.5	159.2	92.6	49.2	174.1	45.1	54.9	90.8	9.9	57.1	72.6	28.5	84.1	144.8	67.9	27.3	55.0	75.9	187.3	17.1	59.7	65.9	209.2	30.8	12.7	103.9	100.0	49.5	62.1	12.2	1.4	8.1	44.1	33.6	3.8	61.7	17.7	47.6	24.4	17.1	23.3	29.1	40.7	30.7	17.1	33.8	3.2	20.5	11.5	22.5	11.0	3.2	13.9	6.6	74.3	6.7	19.7	54.8	13.1	14.3	70.2	51.3	19.0	3.1	1.6	76.9	49.5	19.9	7.7	33.0	7.3	6.2	25.7	28.5	22.0	46.6	21.7	11.0	0.6	0.6	68.7	50.6	20.9	26.2	26.9	49.5	78.8	47.2	43.2	34.0	77.9	34.3	27.9	12.5	11.5	20.0	15.7	32.1	33.5	131.2	58.1	40.8	52.3	21.0	40.7	45.2	32.9	30.2	35.5	47.9	92.5	43.3	33.5	36.9	54.6	35.3	45.3	52.8	51.4	63.8	45.1	57.8	56.3	55.5	54.9	55.0	59.7	49.5	1997.9	423.1	571.3	24.5	450.9	341.7	805.4	147.3	376.2	11.9	666.3	1851.8	952.6	173.0	226.3	51.5	6.2	93.0	988.3	213.7	191.7	374.3	1.6	614.2	539.7	800.0	85.3	8.6	3.0	209.8	54.0	1143.0	400.1	1122.9	786.6	53.9	138.8	126.1	430.9	13.5	1.5	164.4	282.8	174.8	1169.6	4.7	74.0	863.0	517.6	1.9	157.1	269.8	33.0	0.5	0.9	292.5	309.0	29.3	416.8	823.3	294.3	142.1	211.4	34.2	177.5	818.8	1753.4	1.4	7.8	399.0	308.9	144.2	514.7	128.4	98.8	301.3
GADD45GIP1	"CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6"	ENSG00000179271	"GADD45G interacting protein 1"	Q8TAE8	19	12953119-12957223	"Predicted intracellular proteins, Ribosomal proteins"	"Cell cycle, Host-virus interaction"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055205, HPA065048, HPA071910"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA055205: AB_2682736, HPA065048: AB_2685412, HPA071910: "	"unprognostic (5.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-1)"	32.0	46.3	28.9	14.0	28.8	20.6	29.9	28.7	41.3	32.0	27.2	39.0	12.4	34.4	7.7	41.8	30.7	7.5	75.7	28.4	31.0	42.0	52.2	25.2	13.5	31.1	33.1	28.7	39.0	11.6	34.6	11.0	30.6	37.1	4.8	7.4	28.9	9.5	80.1	31.4	25.4	6.8	28.5	32.5	33.1	22.7	30.4	8.8	30.9	23.1	6.5	36.3	28.4	29.9	68.7	56.9	23.5	33.2	16.1	20.8	32.7	49.4	24.5	48.2	39.5	79.1	27.1	49.1	79.8	29.8	34.7	47.0	28.9	48.2	12.4	32.1	140.5	34.9	78.6	90.2	39.2	58.2	51.3	24.7	38.4	33.6	27.5	25.7	28.3	46.1	53.6	18.8	30.3	100.6	93.2	122.8	65.0	44.0	176.7	68.1	23.7	79.2	38.1	39.9	71.9	65.7	36.8	49.3	60.4	11.6	38.4	54.7	46.4	93.0	32.9	81.7	92.3	73.4	55.1	52.0	64.5	72.7	54.8	13.4	35.6	12.6	33.3	34.6	33.1	102.5	51.3	53.1	43.6	84.1	55.1	40.0	2.1	39.9	29.9	41.4	46.9	29.5	28.9	28.8	28.7	41.3	28.4	31.0	31.1	33.1	30.6	28.5	30.4	29.9	111.9	41.7	51.6	6.5	132.4	145.4	189.2	198.9	83.6	59.9	127.0	141.1	157.0	114.4	123.4	138.0	22.9	321.9	101.5	232.1	401.1	265.8	41.8	166.8	139.9	151.8	139.1	159.3	6.1	381.7	355.8	138.3	88.2	130.6	73.6	158.1	146.7	288.8	245.5	37.0	8.1	205.7	101.7	132.9	228.9	56.0	191.3	106.0	179.7	8.4	253.1	103.9	95.8	7.1	14.7	311.5	138.3	170.4	142.4	247.0	215.9	616.7	160.6	88.8	190.7	141.0	164.4	85.4	129.4	153.3	160.8	204.3	105.6	235.8	258.9	171.0
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574665	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.6;intestine: 24.4;kidney: 18.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Muller glia cells: 35.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 53.6;Proximal enterocytes: 48.1;Proximal tubular cells: 24.6"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;CACO-2: 7.7;EFO-21: 14.6;K-562: 6.6;OE19: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001220, HPA077138"	Approved		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Nucleoplasm	"HPA001220: AB_1078933, HPA077138: "	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	1.3	0.2	14.8	0.4	33.3	0.8	1.1	27.7	25.8	2.7	0.3	5.2	23.0	2.4	1.7	0.5	3.1	5.2	1.1	14.6	18.3	18.4	4.0	1.9	0.7	32.9	29.0	2.3	6.9	0.7	1.5	0.9	31.0	3.1	2.4	2.3	0.5	1.4	3.1	1.6	24.4	0.3	23.2	0.3	8.2	5.0	29.1	0.1	0.2	0.3	0.0	1.6	1.8	51.6	0.0	27.6	0.5	0.2	0.0	0.0	2.0	0.0	0.2	0.0	0.0	7.7	3.8	0.4	14.6	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.7	0.4	0.4	5.7	0.6	0.2	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.4	6.6	0.6	0.0	0.2	0.3	1.1	3.9	10.6	0.4	0.2	0.0	0.7	1.1	0.1	0.3	1.8	0.0	0.4	0.2	0.7	0.2	0.2	0.8	0.2	0.2	0.3	0.0	2.4	1.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.6	0.0	0.0	14.8	33.3	27.7	25.8	14.6	18.3	32.9	29.0	31.0	23.2	29.1	51.6	0.5	0.0	0.0	2.3	0.3	0.4	0.1	0.0	0.0	0.8	0.6	3.3	0.6	30.0	0.0	3.7	0.0	0.1	0.0	14.0	15.6	7.0	1.1	1.1	0.3	0.3	10.9	2.7	2.0	11.1	0.1	0.3	5.1	2.4	0.0	0.9	0.0	1.6	0.1	0.0	1.9	5.7	0.0	0.3	0.3	0.8	1.5	0.2	0.0	0.0	0.0	35.3	0.0	26.7	53.6	5.0	8.8	2.2	0.1	0.4	48.1	24.6	0.1	1.3	0.0	2.1	0.3	12.4	14.3	0.0	0.3	0.3	0.2	0.0	7.6	0.1
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168617	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 27.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 37.2;Microglial cells: 23.4;Oligodendrocyte precursor cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 4.5;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.6;plasmacytoid DC: 4.7"	"Group enriched"	"Detected in many"	29	"dendritic cells: 4.7;T-cells: 15.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	4.3	4.9	9.2	3.9	9.3	0.7	3.7	8.4	12.6	11.0	7.6	6.1	3.8	9.1	3.1	7.8	6.0	5.6	5.0	9.1	9.5	1.4	0.9	5.2	2.9	13.4	9.5	6.3	1.4	3.0	4.2	5.1	10.1	4.8	6.3	0.5	25.6	3.6	1.9	27.7	5.0	9.9	10.7	2.7	2.4	4.8	15.9	22.3	1.9	1.9	3.2	6.7	10.6	13.1	0.1	0.9	5.4	2.3	4.7	9.6	10.9	3.2	3.2	1.8	2.6	0.6	0.2	1.1	0.7	10.4	3.3	12.2	0.3	1.8	0.6	0.1	0.6	0.4	0.2	0.4	3.4	0.3	2.7	11.7	4.6	5.5	0.6	4.0	3.7	4.3	1.6	0.2	3.4	0.4	4.2	0.2	1.9	11.5	1.3	2.7	2.4	0.2	0.0	0.4	0.3	2.2	1.0	0.0	6.7	1.0	0.0	0.3	3.4	0.3	1.6	0.5	0.1	0.2	0.2	2.5	1.9	0.4	43.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	4.5	0.3	0.0	0.1	15.0	4.6	0.3	0.2	0.1	4.7	1.3	2.2	9.2	9.3	8.4	12.6	9.1	9.5	13.4	9.5	10.1	10.7	15.9	13.1	0.7	0.0	0.5	2.9	0.1	4.2	2.0	3.3	7.4	0.0	2.2	2.4	1.0	1.5	0.9	0.0	0.0	0.3	0.3	1.5	0.0	0.6	0.2	0.2	2.1	1.2	0.0	2.7	0.5	0.0	0.4	7.5	0.0	0.3	0.0	1.2	1.4	0.0	37.2	0.0	0.3	1.3	4.1	1.3	0.8	0.0	4.7	9.6	5.4	23.4	0.7	0.4	0.0	24.6	0.5	0.3	2.5	5.3	0.0	0.5	0.0	0.0	0.1	0.1	0.0	3.7	3.3	0.6	0.3	4.2	8.1	0.8	0.7	0.1	4.1	1.4
GALK2	GK2	ENSG00000156958	"Galactokinase 2"	Q01415	15	49155656-49367869	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 92.2;Inhibitory neurons: 90.1;Oligodendrocytes: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043564, HPA048267"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		24000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA043564: AB_2678557, HPA048267: AB_2680335"	"unprognostic (2.27e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.88e-5)"	"unprognostic (2.33e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.93e-1)"	10.3	16.8	8.5	8.5	9.3	6.6	11.2	10.1	9.3	12.5	14.8	15.2	20.2	8.5	8.7	8.1	12.2	8.9	12.8	8.7	8.5	30.4	21.1	10.5	8.3	8.6	9.0	9.3	12.2	17.5	9.6	9.9	9.0	9.7	16.2	7.7	9.9	10.9	10.5	9.0	16.6	10.7	8.5	8.9	13.2	7.0	8.3	12.6	14.8	16.9	10.0	9.3	8.5	11.4	14.7	17.1	7.5	10.1	19.1	29.7	21.9	14.7	20.2	14.7	17.2	21.6	15.0	4.8	11.6	15.9	18.0	20.5	30.2	21.6	20.6	26.2	9.1	26.8	15.7	18.4	20.9	19.2	8.2	15.4	38.4	15.7	37.4	16.8	30.2	11.0	27.4	25.5	16.1	15.9	13.9	15.3	3.3	44.0	15.9	16.7	9.5	71.0	27.3	13.8	9.1	6.0	16.6	33.3	29.6	15.0	16.9	18.3	16.6	14.1	9.6	58.4	14.3	20.9	76.2	8.9	22.2	70.1	19.8	45.4	15.3	28.4	18.1	16.7	18.9	14.0	18.0	17.3	15.2	11.1	14.2	14.3	7.6	19.6	17.2	13.3	35.3	13.1	8.5	9.3	10.1	9.3	8.7	8.5	8.6	9.0	9.0	8.5	8.3	11.4	13.6	3.2	14.9	48.6	12.7	5.6	13.6	16.8	9.1	13.3	12.1	10.3	3.1	27.1	14.5	5.5	37.5	14.8	10.6	14.5	29.4	20.0	12.0	19.2	15.7	12.0	9.0	12.0	92.2	13.1	29.0	12.7	18.3	12.0	2.5	9.8	22.9	25.7	20.4	15.2	90.1	25.1	20.3	16.8	5.7	4.8	11.5	12.6	14.2	63.7	16.5	11.6	20.6	41.7	109.5	10.7	16.2	11.3	27.9	8.3	30.5	56.5	34.1	25.8	0.0	13.4	11.6	22.3	5.9	9.0	6.3	25.7	13.9	13.8	19.0	9.7
GALM		ENSG00000143891	"Galactose mutarotase"	Q96C23	2	38666081-38741237	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 86.5;kidney: 120.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 97.8;Proximal enterocytes: 161.1;Proximal tubular cells: 222.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 68.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 39.1;T-cells: 68.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;Karpas-707: 71.1;U-266/70: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035472, HPA035473, HPA064835"	Enhanced		Approved	Nucleoplasm		NA	NA		620000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723"	"unprognostic (5.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"prognostic favorable (1.32e-4)"	9.0	86.5	5.2	12.2	5.1	3.8	10.4	6.0	6.1	9.3	8.3	34.7	71.4	8.1	23.0	5.8	35.8	16.5	13.0	4.9	4.8	120.2	72.5	14.3	16.0	5.4	6.1	15.5	15.0	21.3	3.0	7.7	5.4	10.2	33.3	4.4	8.7	20.8	13.1	3.8	52.8	10.4	5.7	6.6	14.9	4.4	7.0	11.0	15.1	12.3	10.2	10.8	6.4	6.0	0.2	27.1	8.1	0.0	27.3	15.4	14.9	3.2	10.3	7.5	12.2	32.4	14.4	10.9	18.9	15.3	14.5	4.3	11.7	0.7	14.5	49.5	19.3	5.9	7.1	62.7	10.0	2.4	0.4	11.1	0.4	17.5	0.0	10.5	8.2	0.0	17.2	71.1	13.9	0.9	23.4	41.0	12.4	59.2	8.6	15.2	0.6	21.3	9.3	45.1	1.5	11.2	0.1	18.9	14.7	10.2	9.0	5.4	3.4	2.5	0.5	18.6	1.0	76.4	54.3	0.3	17.9	7.0	0.3	39.1	4.8	4.2	21.5	3.3	31.8	6.8	33.1	31.2	10.3	4.7	11.7	10.2	11.3	5.5	0.7	0.8	68.3	11.9	5.2	5.1	6.0	6.1	4.9	4.8	5.4	6.1	5.4	5.7	7.0	6.0	9.7	28.9	11.0	13.4	10.0	6.6	6.7	3.4	10.8	3.6	7.8	4.2	23.4	24.3	6.5	69.9	0.0	23.6	19.0	83.2	25.4	12.1	1.4	28.5	11.6	10.0	13.2	8.2	2.3	15.1	31.4	16.1	17.9	10.1	7.0	16.8	14.6	48.1	94.8	3.3	1.4	40.5	4.1	18.6	43.6	1.3	20.2	34.7	17.8	4.7	9.9	38.2	18.6	0.5	1.3	6.8	64.5	97.8	14.7	5.7	161.1	222.1	14.8	6.8	6.6	16.6	10.4	1.0	2.3	3.2	6.0	6.3	44.0	43.3	80.4	5.7
GALNT10	GalNAc-T10	ENSG00000164574	"Polypeptide N-acetylgalactosaminyltransferase 10"	Q86SR1	5	154190730-154420984	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 65.8"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 74.0;Oligodendrocyte precursor cells: 156.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 284.9;TIME: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007525	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1100000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA007525: AB_1849443"	"unprognostic (6.99e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.85e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.63e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (2.88e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.08e-1)"	12.1	15.6	10.7	14.4	14.5	19.3	13.5	12.1	10.0	24.1	33.0	16.1	14.4	6.3	6.0	4.9	14.6	16.7	9.0	9.5	12.5	9.7	4.4	15.5	9.9	16.1	13.9	65.8	9.8	13.6	11.5	4.7	12.3	9.1	14.7	7.8	13.5	3.7	5.4	6.0	12.6	11.6	9.9	15.8	22.0	4.5	13.9	7.8	16.6	8.2	9.4	11.1	5.2	12.6	25.6	85.3	20.3	17.8	42.2	37.3	15.6	71.7	39.9	27.9	26.7	12.1	56.7	16.6	49.3	121.4	49.9	4.4	9.4	56.0	25.4	43.2	6.7	45.4	16.0	16.5	32.4	9.9	42.3	46.7	12.9	22.7	33.2	284.9	54.4	12.5	10.5	50.9	48.4	26.4	1.1	6.8	8.0	71.1	17.3	5.1	10.7	16.6	38.6	17.1	2.7	6.6	31.8	117.0	9.4	29.6	45.6	7.4	161.2	67.5	15.9	16.8	77.7	14.5	15.0	8.7	44.2	19.3	21.1	2.0	1.2	2.4	3.1	1.6	2.8	1.9	1.8	2.0	1.4	2.1	0.8	2.1	2.5	1.9	1.8	1.1	1.6	1.0	10.7	14.5	12.1	10.0	9.5	12.5	16.1	13.9	12.3	9.9	13.9	12.6	17.4	9.6	46.4	32.7	17.4	4.8	3.9	5.6	1.8	4.6	12.4	8.6	5.0	5.7	8.7	14.7	4.2	0.7	27.7	23.0	9.8	9.1	10.3	12.4	7.4	14.1	3.0	21.4	14.3	30.1	1.5	13.7	30.5	22.3	10.2	10.5	23.9	5.3	8.5	0.0	15.9	20.4	6.1	19.5	7.8	22.5	38.2	12.4	0.0	74.0	11.9	17.4	44.3	156.9	66.9	36.8	13.6	50.0	15.4	8.2	15.3	2.7	0.7	10.5	6.6	5.6	7.8	2.0	4.0	1.2	3.7	0.8	21.7	27.3	12.2	4.2
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807670-98850081	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 74.7;intestine: 55.8;stomach 1: 54.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 101.2;Intestinal goblet cells: 142.4;Undifferentiated cells: 42.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 128.4;U-2197: 160.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA048292, HPA071076"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA048292: AB_2680343, HPA071076: "	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	5.0	2.0	1.2	7.7	1.3	2.2	3.4	6.5	1.8	8.7	4.3	55.3	34.2	3.7	74.7	19.6	7.5	10.5	1.2	1.1	1.4	4.8	0.4	11.7	3.2	2.6	1.4	0.4	13.6	6.3	3.4	2.6	2.7	4.6	55.8	0.6	25.5	4.3	1.3	3.4	27.1	14.0	1.1	2.2	54.8	4.6	1.5	3.3	14.7	0.6	6.1	11.9	4.6	1.6	5.4	4.1	3.4	13.5	10.0	7.8	0.0	1.4	2.1	2.0	4.6	0.8	21.6	0.0	5.0	0.9	12.2	38.0	2.9	1.3	1.6	26.2	1.7	2.4	0.2	0.0	0.5	1.6	0.5	3.8	0.9	6.4	0.0	2.7	2.3	19.3	30.2	0.0	0.6	13.9	2.6	4.7	16.7	128.4	5.6	6.5	0.3	0.1	2.3	7.7	12.4	1.1	0.5	30.6	3.0	7.7	4.5	4.5	4.3	0.0	0.3	160.9	0.0	2.1	4.8	2.3	37.1	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.6	0.0	0.4	0.2	0.0	0.1	0.6	0.3	0.0	0.6	0.0	0.1	0.0	0.1	1.2	1.3	6.5	1.8	1.1	1.4	2.6	1.4	2.7	1.1	1.5	1.6	1.3	3.2	25.7	2.0	2.3	2.4	1.3	8.3	1.2	2.4	0.4	0.1	1.0	18.6	16.9	11.0	16.7	1.0	2.6	101.2	0.0	11.2	1.8	4.8	1.6	1.6	19.9	1.3	7.4	25.4	1.7	12.5	32.1	8.7	2.5	2.4	0.0	0.0	2.3	0.0	5.7	142.4	2.0	0.3	3.9	1.4	2.1	3.9	0.0	3.7	0.2	0.8	3.1	3.5	7.0	32.0	36.5	7.5	1.7	7.4	21.9	2.7	16.9	0.2	0.0	0.7	1.5	5.9	10.5	9.9	1.3	1.1	4.5	5.1	42.5	11.1
GALNT14	"FLJ12691, GalNac-T10, GalNac-T14"	ENSG00000158089	"Polypeptide N-acetylgalactosaminyltransferase 14"	Q96FL9	2	30910467-31155202	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 21.6;Excitatory neurons: 29.1;Inhibitory neurons: 79.2;Proximal enterocytes: 21.9;Proximal tubular cells: 45.5"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	8	"neutrophil: 8.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"A549: 28.6;RPMI-8226: 32.3;RPTEC TERT1: 41.3;RT4: 35.3;SCLC-21H: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030138			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		27000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA030138: AB_2673332"	"unprognostic (5.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.51e-3)"	1.2	1.5	3.9	1.0	10.6	5.9	0.8	2.0	4.5	1.3	3.6	0.3	0.5	0.3	0.3	11.8	1.2	2.2	0.3	2.9	3.2	41.3	1.3	0.6	2.2	1.7	6.7	0.1	3.1	4.0	5.9	0.0	0.8	1.6	0.1	0.6	1.2	0.0	0.1	2.1	3.3	0.7	1.8	2.4	0.5	2.5	10.9	0.4	0.9	0.4	4.8	2.3	1.3	3.3	23.6	28.6	0.0	0.0	0.0	0.0	0.0	7.9	4.1	4.9	0.6	0.0	0.0	22.1	7.8	0.4	0.0	0.0	1.0	1.0	0.8	0.6	2.8	12.1	0.0	0.0	0.0	18.2	0.0	0.1	4.5	0.0	17.0	0.2	0.0	0.6	0.0	19.0	0.0	10.7	0.1	0.0	12.6	0.0	0.0	15.5	0.0	32.3	41.3	35.3	24.4	18.3	0.0	0.0	0.1	4.4	0.1	0.0	0.0	0.0	19.6	0.0	0.5	1.9	6.2	0.1	0.0	11.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	3.9	10.6	2.0	4.5	2.9	3.2	1.7	6.7	0.8	1.8	10.9	3.3	2.2	0.0	0.0	1.0	1.4	2.8	4.1	5.3	21.6	0.3	0.6	2.4	1.1	0.0	6.2	9.2	0.0	0.0	0.0	0.3	13.7	2.9	5.7	0.0	0.1	1.2	0.0	0.0	29.1	0.4	0.0	1.1	0.5	0.4	0.0	0.0	8.2	0.2	0.1	0.0	79.2	0.9	2.0	0.6	0.3	12.0	0.0	0.4	0.0	2.8	0.0	0.2	0.0	4.0	8.7	2.6	0.0	0.0	3.1	14.2	21.9	45.5	1.1	0.4	6.6	0.4	2.2	3.4	6.9	9.2	0.9	0.0	0.4	0.2	1.8	5.1
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132144-71713600	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.0;choroid plexus: 46.0;heart muscle: 43.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Endometrial stromal cells: 7.4;Fibroblasts: 1.5;Granulosa cells: 1.7;Theca cells: 2.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.3;NTERA-2: 10.8;RPMI-8226: 12.6;SK-BR-3: 45.7;SuSa: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	3.2	8.7	30.5	1.9	37.9	0.0	2.0	35.9	51.2	4.0	46.0	16.6	0.3	16.6	3.1	9.3	8.7	2.5	43.5	55.0	3.2	5.7	0.4	9.3	0.0	2.1	3.8	31.6	10.1	1.2	13.3	0.2	3.0	14.7	1.0	3.3	3.3	8.2	4.7	2.2	3.9	8.3	0.0	3.4	2.4	5.0	11.2	2.6	10.1	2.9	1.5	21.2	3.3	24.8	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.7	0.0	0.0	45.7	0.0	14.1	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	37.9	35.9	51.2	55.0	3.2	2.1	3.8	3.0	0.0	11.2	24.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0
GALNT6	GalNAc-T6	ENSG00000139629	"Polypeptide N-acetylgalactosaminyltransferase 6"	Q8NCL4	12	51351247-51392867	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 62.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 49.2;Gastric mucus-secreting cells: 130.5;granulocytes: 164.5;Oligodendrocytes: 57.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 31.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 29.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 29.1;monocytes: 9.7;NK-cells: 15.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 107.0;CACO-2: 104.1;OE19: 97.6;SK-BR-3: 110.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA011762, HPA017086"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		4800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"		"HPA011762: AB_1849450, HPA017086: AB_1849452"	"unprognostic (2.03e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.26e-2)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.88e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.13e-4)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.18e-2)"	1.7	3.1	3.3	8.0	11.8	9.6	18.1	7.2	9.1	32.2	0.2	6.7	21.2	1.3	24.7	2.4	6.5	2.4	0.4	4.2	7.3	2.9	1.2	5.7	7.2	8.8	11.1	0.9	8.3	1.4	1.1	9.6	10.8	0.9	6.9	0.1	31.0	3.2	0.4	5.6	21.6	1.6	5.2	8.2	62.6	0.6	9.7	6.8	2.5	0.1	5.9	3.7	1.8	18.1	39.0	4.1	0.7	0.1	0.0	0.6	59.8	63.0	107.0	25.4	17.0	104.1	19.0	0.5	5.8	34.4	0.0	35.9	1.5	27.3	17.1	8.3	4.1	24.6	0.7	0.8	1.0	13.6	82.2	2.3	25.2	23.1	23.0	0.2	65.7	14.2	5.4	1.0	0.1	73.7	43.2	10.1	5.3	97.6	66.6	0.2	0.1	10.3	21.3	2.2	0.5	23.5	0.4	110.5	0.1	12.2	59.3	5.9	75.7	0.2	12.9	0.2	0.3	2.1	0.5	3.6	7.2	29.5	0.2	7.1	5.8	29.1	3.8	5.2	1.6	1.2	2.2	3.1	4.5	3.3	3.4	2.9	1.1	15.5	9.7	4.1	1.7	3.2	3.3	11.8	7.2	9.1	4.2	7.3	8.8	11.1	10.8	5.2	9.7	18.1	0.8	3.2	2.4	0.3	11.8	2.9	3.8	5.8	5.7	0.4	38.9	18.4	1.3	1.5	15.6	1.8	0.0	14.1	11.3	12.4	3.9	2.6	2.0	3.5	0.3	4.1	0.0	15.3	1.0	10.9	49.2	1.6	130.5	5.8	164.5	3.8	1.4	0.3	14.4	0.0	0.5	17.4	2.0	16.3	10.3	1.5	0.0	15.1	1.8	1.0	7.2	0.2	9.2	0.0	57.6	24.3	33.9	0.4	5.5	7.6	39.6	2.0	12.4	0.0	0.0	1.5	1.5	0.4	1.6	2.6	9.2	4.8	14.9	1.8	11.8	5.8
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168811-173323967	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 143.4;Inhibitory neurons: 172.0;Intestinal goblet cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		6200000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	6.4	6.4	6.4	16.3	8.8	11.5	23.3	34.2	8.3	25.1	3.5	47.8	29.1	16.9	7.0	14.9	9.8	15.6	5.9	6.6	7.8	7.8	2.9	9.6	12.2	12.6	8.3	11.2	22.2	8.7	5.2	13.0	11.7	39.7	52.8	22.4	27.4	8.1	1.4	3.9	33.7	16.7	10.1	11.0	65.7	11.9	8.4	60.0	13.5	3.9	9.8	17.0	5.9	16.0	71.1	37.2	35.0	11.2	18.6	27.1	50.3	18.1	20.5	16.7	23.0	11.5	109.9	39.4	13.3	16.6	45.2	59.2	15.0	32.0	22.7	154.3	29.1	47.8	72.2	0.4	12.2	71.6	32.8	17.5	28.3	37.6	18.9	63.4	112.3	28.2	32.6	59.3	86.0	23.5	52.7	39.4	34.8	70.2	24.0	52.1	32.4	10.2	123.2	32.8	28.2	21.5	8.5	50.4	25.4	45.3	20.2	21.0	135.6	11.9	52.3	0.6	40.0	17.2	0.2	20.8	48.6	42.3	43.6	13.2	14.3	18.9	5.1	7.5	7.2	6.2	5.7	5.3	12.4	3.3	4.4	3.3	21.3	7.5	8.0	5.0	9.2	6.4	6.4	8.8	34.2	8.3	6.6	7.8	12.6	8.3	11.7	10.1	8.4	16.0	10.0	6.4	38.0	72.8	12.1	1.8	9.0	12.3	4.0	47.9	41.1	19.8	9.6	8.6	36.0	20.2	2.1	1.4	16.4	143.4	0.0	14.4	2.5	28.3	13.3	11.3	22.8	12.0	74.4	48.9	3.7	12.1	102.4	52.9	24.1	14.8	12.1	0.2	10.3	10.1	172.0	126.8	24.4	17.9	6.2	4.2	9.3	17.2	8.8	62.8	16.3	8.1	5.2	71.4	54.1	39.9	50.0	5.3	6.6	52.8	63.7	10.0	17.4	25.5	13.1	16.1	11.7	3.8	5.5	14.9	1.1	0.8	9.9	13.1	48.6	19.4
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533455-35545319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"testis: 269.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 8717.5"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		7500000	"Cluster 52: Eosinophils - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA042666: AB_2678104"	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	1.2	2.7	0.4	4.1	1.3	2.4	0.2	1.2	1.3	0.0	0.1	0.6	3.3	2.7	0.0	3.0	1.9	3.6	4.0	0.2	0.5	0.9	0.3	1.9	6.5	0.3	0.4	3.4	5.2	0.0	0.1	1.1	0.4	2.0	0.0	3.5	5.1	0.0	1.6	13.9	3.2	0.0	0.1	5.2	2.4	269.8	0.8	0.0	11.4	0.0	0.0	1.5	0.1	1.5	6.5	22.4	6.4	9.6	0.0	0.0	5.4	1.9	0.0	0.0	0.0	13.8	10.4	10.7	2.9	0.0	2.6	7.6	0.0	0.0	0.0	10.5	11.2	7.1	16.7	7.1	0.1	6.4	8.3	0.0	0.0	0.0	0.0	3.9	0.0	10.3	17.6	6.0	0.0	19.6	2.5	3.0	8.6	4.1	3.1	7.6	4.3	8.3	0.0	6.1	11.3	5.1	2.4	5.7	7.0	4.3	4.8	2.7	2.1	7.2	7.9	1.8	2.7	16.9	4.8	6.2	3.9	11.4	2.6	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.3	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.4	1.3	1.2	1.3	0.2	0.5	0.3	0.4	0.4	0.1	0.8	1.5	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1915.7	0.0	0.0	1.6	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.4	8717.5	24.8	2.4	44.4	0.0	0.2	0.0	0.0	1.0	0.5	0.0	0.0	28.6	0.0	0.0	0.0	0.1	0.0	0.0	26.3	0.0	0.1	33.4	18.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: AB_2683904"	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	14.7	16.4	10.0	13.5	10.1	31.7	15.9	9.8	13.0	12.3	10.1	16.0	11.3	13.7	11.4	23.0	13.3	6.4	12.7	10.0	10.3	20.1	16.5	9.6	13.5	10.1	10.1	15.5	14.7	9.3	11.8	11.5	10.3	12.2	15.2	7.1	13.2	8.0	12.2	23.2	13.2	11.7	9.9	15.5	12.9	15.1	10.3	13.8	10.7	6.6	16.0	16.3	13.5	10.6	45.7	65.5	34.3	49.7	19.3	26.8	34.1	47.1	24.1	35.3	30.1	100.6	60.2	103.5	27.5	38.9	39.5	22.2	68.8	47.7	66.5	31.2	68.3	57.7	57.1	113.1	46.6	150.8	35.2	27.0	49.5	48.6	37.6	27.9	44.5	48.1	146.8	34.6	50.0	121.7	78.5	115.4	59.5	78.4	68.7	58.0	57.2	41.2	55.3	79.3	51.2	55.7	26.3	80.6	46.2	29.5	25.1	48.4	39.3	38.5	51.1	27.2	61.4	42.0	70.7	132.2	26.3	69.7	43.2	7.5	4.0	2.9	6.1	6.7	6.5	8.4	5.9	6.2	6.3	7.9	6.7	6.2	0.7	7.3	6.3	6.8	6.8	2.6	10.0	10.1	9.8	13.0	10.0	10.3	10.1	10.1	10.3	9.9	10.3	10.6	25.2	3.2	17.0	4.6	29.0	57.9	40.9	42.7	27.3	11.9	36.3	37.2	13.8	14.3	33.1	16.5	14.6	69.9	23.4	18.5	25.4	49.2	1.3	54.0	39.9	30.9	18.6	62.1	6.6	53.8	65.8	24.7	30.1	36.9	19.0	38.1	18.2	19.6	35.8	5.0	6.3	40.7	10.2	13.3	17.2	4.3	22.1	16.0	17.8	5.6	16.1	39.2	17.5	5.5	7.4	49.5	22.7	18.8	24.7	68.5	14.5	40.4	35.6	9.3	6.6	35.2	27.7	45.0	38.3	40.2	60.0	87.8	24.8	44.6	46.1	40.6
GAREM1	"C18orf11, FAM59A, FLJ21610, GAREM"	ENSG00000141441	"GRB2 associated regulator of MAPK1 subtype 1"	Q9H706	18	32124877-32470882	"Predicted intracellular proteins"		Mitogen		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 29.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 54.7;Urothelial cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.5;hTERT-HME1: 20.7;RT4: 19.6;SH-SY5Y: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040709, HPA042046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA040709: AB_2677090, HPA042046: AB_2677818"	"unprognostic (9.52e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.49e-6)"	"unprognostic (2.36e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	5.0	6.0	5.1	1.8	7.0	7.2	4.5	7.5	7.2	4.2	0.3	4.8	4.4	2.3	2.1	8.2	2.7	2.9	5.1	9.5	7.1	11.2	6.7	3.2	0.6	9.8	6.5	2.7	29.9	0.6	3.3	2.8	8.5	3.0	3.7	6.2	7.9	2.9	5.9	11.0	4.2	2.2	7.6	2.0	8.5	3.4	6.7	0.4	2.0	2.8	1.7	7.2	7.4	11.7	1.2	1.8	1.8	0.4	4.9	4.0	4.5	0.5	0.0	0.0	0.0	0.4	2.7	3.4	2.6	0.1	2.0	4.0	2.7	5.0	0.0	1.0	1.9	0.0	3.8	1.3	3.0	0.3	0.3	4.4	15.5	0.2	20.7	0.2	0.2	2.0	0.2	0.9	2.2	2.8	1.0	0.2	2.0	9.9	1.0	1.2	7.4	5.6	8.0	19.6	6.3	18.0	4.1	6.5	0.1	2.3	0.9	3.4	0.2	1.3	1.3	0.0	0.6	2.3	0.4	0.9	2.3	0.0	1.5	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.6	0.3	0.5	1.0	1.1	0.0	1.9	0.0	0.0	5.1	7.0	7.5	7.2	9.5	7.1	9.8	6.5	8.5	7.6	6.7	11.7	11.9	9.6	42.6	0.0	0.2	0.0	37.6	0.0	3.4	34.2	6.9	5.1	0.0	11.5	8.6	25.8	4.2	20.4	0.0	10.7	1.9	11.8	14.8	19.8	8.7	2.0	3.6	0.0	0.0	13.3	2.6	14.3	27.0	41.7	3.8	0.9	0.4	8.8	1.7	42.1	0.0	8.4	0.0	4.0	0.0	3.4	1.8	1.9	0.0	0.0	0.6	34.9	0.0	0.0	0.0	9.3	5.7	5.3	0.5	54.7	19.8	23.4	4.4	7.4	0.0	29.8	6.5	3.9	7.5	13.7	0.0	33.5	0.9	1.7	7.6	114.2
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.1;Excitatory neurons: 178.4;Inhibitory neurons: 184.7;Microglial cells: 48.7;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 165.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 5.3;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: AB_2732270"	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	3.1	6.0	5.7	0.3	5.7	0.0	4.4	11.6	6.0	6.0	2.0	2.9	1.8	7.4	5.2	4.4	5.4	3.7	11.3	6.9	5.2	2.1	1.8	2.4	1.3	4.7	4.5	4.5	2.1	6.6	2.0	1.4	5.8	6.2	1.9	1.3	5.0	4.0	1.5	2.8	1.8	6.7	4.6	1.8	1.8	2.9	4.2	0.6	5.7	1.8	1.3	4.6	3.3	11.2	0.5	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	1.0	1.2	0.3	0.0	1.0	0.1	0.4	0.6	1.8	0.0	0.1	0.0	0.8	0.0	1.9	1.2	0.4	0.4	0.1	0.1	1.5	0.0	0.0	1.5	0.7	1.9	0.8	0.7	0.1	0.5	0.0	0.3	0.4	5.3	1.6	0.1	1.1	3.4	1.9	2.5	1.2	3.9	0.8	2.7	0.4	0.6	0.9	0.0	0.0	0.2	1.0	0.0	0.4	2.3	2.4	1.0	0.4	0.5	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	5.7	5.7	11.6	6.0	6.9	5.2	4.7	4.5	5.8	4.6	4.2	11.2	1.3	0.0	0.0	77.1	0.5	2.7	1.7	0.4	2.8	8.0	3.1	4.3	6.8	4.3	2.0	3.7	0.0	0.6	0.2	0.9	1.9	0.3	2.2	1.0	21.1	1.5	1.2	0.4	178.4	0.6	0.1	4.8	5.6	1.2	0.0	2.4	1.8	2.5	0.8	1.7	184.7	0.8	0.0	1.3	1.9	1.0	7.5	1.3	1.8	48.7	0.0	4.0	0.0	45.2	165.3	0.4	1.6	3.4	0.5	3.3	0.6	1.8	0.1	1.0	0.0	7.1	4.0	3.5	3.9	2.7	2.0	0.3	0.7	1.0	0.8	1.2
GARRE1	KIAA0355	ENSG00000166398	"Granule associated Rac and RHOG effector 1"	O15063	19	34254552-34355566	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 126.8;Cardiomyocytes: 15.7;Cytotrophoblasts: 23.8;Extravillous trophoblasts: 25.1;Syncytiotrophoblasts: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014570	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA014570: AB_1852307"	"unprognostic (1.88e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.05e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-1)"	18.8	5.6	5.0	7.2	6.7	3.4	16.8	7.3	4.5	10.8	6.7	7.8	5.4	11.0	3.0	8.0	10.1	9.5	12.0	3.6	5.6	8.2	7.3	12.4	9.1	7.0	7.0	9.4	10.4	10.8	7.7	23.3	6.6	8.3	5.6	8.1	7.4	6.4	15.4	10.3	8.2	8.6	5.2	16.1	6.6	7.1	7.1	8.5	10.9	17.0	7.5	8.0	9.9	10.3	3.4	10.2	8.9	4.6	6.0	5.7	11.6	7.6	6.2	5.7	8.4	8.1	3.9	7.7	16.4	7.1	7.1	2.4	6.6	3.6	6.2	11.0	5.8	4.7	3.9	6.2	7.6	2.1	3.7	6.7	6.2	7.5	11.0	22.6	23.7	4.3	14.4	3.8	6.2	1.8	1.4	1.9	6.8	4.6	3.7	3.4	6.2	4.1	4.8	3.8	10.3	8.5	8.7	33.9	10.9	12.9	2.7	3.8	19.7	19.5	7.2	5.0	8.1	6.4	9.5	2.4	3.7	0.8	9.7	0.0	0.7	0.0	0.8	1.4	1.3	2.3	1.8	0.8	0.8	2.8	1.6	1.0	2.2	1.5	2.1	1.1	3.0	0.8	5.0	6.7	7.3	4.5	3.6	5.6	7.0	7.0	6.6	5.2	7.1	10.3	126.8	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	23.8	10.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	25.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	34.1	2.3	0.0	0.0	0.0
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625509-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 39.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 39.8;Excitatory neurons: 114.9;Inhibitory neurons: 141.9;Oligodendrocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Hep G2: 43.2;JURKAT: 24.0;Karpas-707: 85.2;SCLC-21H: 24.8;U-266/84: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favorable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.4	0.8	2.1	0.3	1.9	0.1	0.8	4.5	5.4	0.9	0.0	0.7	1.8	0.8	0.0	0.7	1.2	1.6	3.5	0.7	2.2	5.4	39.7	1.0	1.0	6.2	7.5	2.0	9.6	0.1	2.5	0.4	6.3	1.0	0.4	2.2	1.5	0.6	4.6	0.8	1.6	0.3	3.3	1.3	2.6	0.8	6.1	8.2	0.8	1.8	0.7	1.0	0.7	6.1	0.0	0.1	1.7	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.7	0.4	0.2	0.0	43.2	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.3	0.0	24.0	1.6	85.2	0.0	0.4	0.3	0.1	0.3	2.4	0.0	0.9	0.5	4.4	0.0	1.1	24.8	1.3	0.0	0.0	0.5	0.2	0.1	0.0	1.8	0.0	0.4	1.1	0.0	1.1	30.7	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	1.9	4.5	5.4	0.7	2.2	6.2	7.5	6.3	3.3	6.1	6.1	0.1	0.0	0.0	39.8	0.4	0.1	0.4	0.1	0.6	1.9	0.4	0.1	12.7	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.3	1.3	0.1	0.4	0.0	0.0	114.9	3.3	0.0	1.0	3.1	0.7	0.0	0.2	0.7	22.9	0.0	0.0	141.9	0.6	0.0	0.0	0.0	5.4	0.6	0.0	0.0	9.4	0.2	0.2	0.0	18.6	83.9	1.6	1.4	0.0	0.5	0.1	0.1	3.2	4.0	1.2	0.0	0.3	0.8	0.4	1.1	0.6	0.0	0.0	0.4	0.1	0.9	0.3
GASK1B	"C4orf18, DKFZp434L142, ENED, FAM198B, FLJ38155"	ENSG00000164125	"Golgi associated kinase 1B"	Q6UWH4	4	158124474-158173318	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 206.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.9;Cardiomyocytes: 33.8;Endothelial cells: 12.1;Fibroblasts: 14.5;Hofbauer cells: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"classical monocyte: 50.6;intermediate monocyte: 28.8;myeloid DC: 15.1;non-classical monocyte: 14.0"	"Group enriched"	"Detected in many"	41	"dendritic cells: 15.1;monocytes: 50.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 77.0;ASC TERT1: 143.3;HSkMC: 166.4;HUVEC TERT2: 193.3;WM-115: 74.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007227	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA		13000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA007227: AB_1847689"	"unprognostic (4.87e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (9.42e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.74e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.89e-2)"	73.9	206.2	29.0	39.8	29.2	2.8	47.3	21.8	23.3	47.0	11.9	23.4	13.3	77.7	21.8	17.2	19.4	37.1	77.9	28.7	29.6	9.5	8.6	14.1	11.2	51.7	33.0	140.3	14.2	11.5	2.8	29.0	26.9	23.6	23.3	0.8	23.6	30.0	12.4	7.3	18.5	70.2	34.1	20.8	11.8	10.4	35.5	5.7	17.7	16.7	6.8	43.2	9.2	33.0	12.5	9.9	6.1	1.1	77.0	143.3	11.4	3.1	2.4	0.6	3.7	13.3	4.9	0.1	0.3	5.0	5.1	0.2	70.7	18.9	1.8	0.1	0.2	1.0	0.0	37.0	51.4	0.6	0.3	166.4	4.6	24.2	2.6	8.0	193.3	0.0	13.0	0.0	35.7	0.8	0.0	0.2	0.4	43.4	0.2	0.1	0.5	0.2	0.0	27.5	0.4	0.1	0.0	27.8	8.2	33.4	5.4	0.3	9.3	16.0	17.1	9.6	6.1	0.0	0.1	44.8	2.5	0.3	74.3	0.1	50.6	0.0	0.1	28.8	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.7	0.1	14.0	0.6	0.0	17.8	29.0	29.2	21.8	23.3	28.7	29.6	51.7	33.0	26.9	34.1	35.5	33.0	22.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	1.2	14.5	0.0	0.0	0.0	0.0	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0
GATA1	"ERYF1, GATA-1, GF1, NF-E1, NFE1"	ENSG00000102145	"GATA binding protein 1"	P15976	X	48786562-48794311	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 59.9"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 165.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 471.7"	"Lineage enriched"	"Detected in single"	1877	"granulocytes: 471.7"	"Group enriched"	"Detected in some"	9	"HEL: 221.5;HMC-1: 211.9;K-562: 238.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA000232, HPA000233, CAB009195"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951"	"unprognostic (1.93e-1)"	"unprognostic (7.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.71e-2)"	0.2	0.1	0.0	0.1	0.2	59.9	0.1	0.2	0.1	0.2	0.0	0.2	0.5	0.3	0.0	0.2	0.1	0.6	0.1	0.0	0.2	0.2	0.3	2.0	0.1	0.3	0.2	0.0	0.0	0.0	0.2	1.0	0.2	0.3	0.3	0.4	0.1	0.1	0.0	0.3	0.5	0.3	0.2	2.0	0.5	1.4	0.2	0.1	0.1	0.4	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	221.5	0.0	0.0	0.0	0.2	211.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	238.9	0.4	0.0	0.0	0.1	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	83.6	0.2	471.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.0	0.0	4.4	0.0	0.2	0.2	0.1	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.6	0.0	0.0	1.3	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	165.6	0.1	0.0	0.5	0.3	0.0	0.0	37.9	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.4	31.5	0.0	9.2	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	1.2	0.2	0.0	0.0
GATA2	NFE1B	ENSG00000179348	"GATA binding protein 2"	P23769	3	128479427-128493201	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Phagocytosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 261.6;Glandular and luminal cells: 116.5;granulocytes: 638.7;Syncytiotrophoblasts: 321.4"	"Group enriched"	"Detected in all"	5	"endometrial cancer: 12.7;prostate cancer: 36.7;urothelial cancer: 13.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	330	"basophil: 513.2"	"Lineage enriched"	"Detected in single"	4344	"granulocytes: 513.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 281.0;HEL: 360.7;HMC-1: 187.4;SH-SY5Y: 325.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005633, CAB024847"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"CAB024847: , HPA005633: AB_1078954"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.61e-2)"	"unprognostic (8.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.96e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.50e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (5.22e-5)"	16.9	9.8	7.1	2.7	5.3	5.1	12.8	3.6	4.6	32.9	2.1	6.6	4.3	42.7	7.1	4.9	49.7	10.7	19.5	3.9	3.4	20.7	1.3	34.8	2.8	8.2	12.2	4.3	13.7	6.9	9.7	22.5	7.9	54.4	2.9	0.1	4.8	52.2	6.4	9.2	8.5	10.8	4.0	11.4	6.6	2.7	8.8	0.8	7.3	5.2	1.2	33.8	23.9	4.1	24.4	5.9	1.3	15.9	2.0	0.6	281.0	53.8	45.2	18.0	6.5	10.0	10.7	0.5	14.8	31.9	1.5	25.5	14.7	0.0	7.6	0.0	8.3	360.7	42.9	16.0	4.0	36.8	187.4	0.3	0.3	0.7	0.3	2.9	28.6	0.2	96.7	0.5	0.4	9.0	0.1	74.2	1.0	0.2	1.8	0.1	7.0	0.4	0.5	21.5	21.8	325.9	13.6	70.1	2.4	14.4	13.5	15.0	52.0	1.2	0.7	12.7	7.4	0.1	0.0	0.2	0.6	2.5	3.7	513.2	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.9	7.1	5.3	3.6	4.6	3.9	3.4	8.2	12.2	7.9	4.0	8.8	4.1	69.0	6.4	27.7	0.0	0.9	4.8	25.5	0.0	1.2	0.2	1.5	1.5	5.7	0.0	1.8	75.4	0.0	63.4	2.3	0.5	1.9	0.2	10.1	74.2	43.2	75.4	3.0	62.4	0.0	14.2	261.6	8.8	0.5	116.5	638.7	0.9	57.5	0.2	10.8	0.0	0.0	0.3	0.0	0.3	4.6	6.4	0.6	7.9	8.8	15.9	0.7	0.1	0.0	0.0	0.0	0.9	0.0	0.4	5.4	29.5	0.0	0.2	0.7	0.2	0.0	2.2	11.0	0.6	4.7	0.9	2.4	321.4	14.0	0.2	0.3	10.5
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075198	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 109.9;skin 1: 172.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 267.1;Cytotrophoblasts: 323.5;Extravillous trophoblasts: 746.6;Suprabasal keratinocytes: 198.9;Syncytiotrophoblasts: 1134.9"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Group enriched"	"Detected in many"	5	"midbrain: 28.3;pons: 12.6"	"Group enriched"	"Detected in many"	41	"gdT-cell: 19.9;MAIT T-cell: 26.9;memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.8;naive CD4 T-cell: 19.9;naive CD8 T-cell: 18.3;NK-cell: 36.1;T-reg: 43.6"	"Group enriched"	"Detected in many"	57	"NK-cells: 36.1;T-cells: 43.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.2;MCF7: 473.4;RT4: 194.3;SH-SY5Y: 161.2;T-47d: 605.2"	"Region enriched"	"Detected in single"	6	"midbrain: 6.1"	"Group enriched"	"Detected in some"	11	"medulla oblongata: 5.2;midbrain: 14.0;pons: 11.8;thalamus: 13.1"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB016217: AB_2108591, HPA029730: AB_10601907"	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	6.7	6.4	0.9	3.8	0.2	4.1	34.2	0.2	0.2	3.4	0.8	0.7	1.0	0.6	8.6	0.6	0.5	1.2	2.5	0.1	0.6	24.9	1.0	3.4	7.8	3.9	28.3	0.1	0.3	109.9	5.0	32.2	12.6	11.2	0.7	0.0	19.9	24.9	2.1	172.9	2.4	0.3	0.5	7.2	1.5	0.2	4.1	25.0	3.0	1.0	3.8	38.8	10.8	0.2	33.8	8.1	0.0	0.4	0.0	0.0	190.2	0.7	0.0	0.0	0.1	12.4	29.9	0.0	0.1	0.0	0.0	28.9	3.2	0.6	0.1	95.8	10.2	0.2	0.3	0.1	2.1	0.1	0.5	0.0	6.9	0.1	1.8	1.0	15.3	45.8	0.4	0.0	0.1	473.4	54.2	0.5	3.5	6.5	4.5	2.8	2.6	0.8	0.0	194.3	9.8	161.2	0.5	26.8	0.0	34.1	605.2	0.1	0.0	2.4	5.9	1.4	4.3	0.9	0.0	0.0	1.3	0.0	1.7	0.1	0.1	0.0	19.9	0.0	26.9	0.4	36.7	28.8	0.0	0.1	19.9	18.3	0.7	36.1	0.0	0.0	43.6	7.0	0.9	0.2	0.2	0.2	0.1	0.6	3.9	28.3	12.6	0.5	4.1	0.2	14.6	0.0	6.0	0.0	3.4	94.8	69.6	1.6	0.0	0.0	267.1	167.3	1.3	0.0	1.5	178.4	0.0	323.5	49.2	0.0	0.0	0.2	0.2	0.5	0.4	12.6	0.0	2.1	0.0	0.4	746.6	5.3	2.6	0.7	2.5	0.0	6.8	0.6	30.7	0.0	0.0	0.0	0.0	3.5	9.9	0.1	0.0	3.8	8.8	1.0	1.5	0.0	51.5	0.0	0.0	4.1	1.1	0.0	12.2	45.8	0.0	0.6	0.3	0.0	0.0	1.1	2.8	0.0	1.4	1.0	198.9	1134.9	93.4	0.5	0.0	106.1
GATA5	"bB379O24.1, GATAS"	ENSG00000130700	"GATA binding protein 5"	Q9BWX5	20	62463497-62475995	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.2;testis: 11.5;urinary bladder: 15.4"	"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 22.4;Hepatic stellate cells: 7.9;Intestinal goblet cells: 8.7;Proximal enterocytes: 38.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HEL: 2.9;K-562: 4.6;SiHa: 2.0;T-47d: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067583			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"HPA067583: AB_2685867"	"unprognostic (2.21e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.34e-2)"		"unprognostic (1.69e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	2.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.2	0.2	11.2	3.5	0.3	0.1	9.5	1.4	2.8	0.0	0.0	4.0	0.7	1.9	0.0	0.0	0.0	0.7	0.1	3.4	0.4	0.4	0.0	5.4	0.0	0.0	0.3	0.3	0.0	0.2	10.0	0.7	0.0	0.0	10.9	11.5	0.0	0.0	0.6	0.2	0.0	15.4	1.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	2.0	0.0	0.0	0.8	4.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.2	1.7	22.4	0.2	0.0	0.0	7.9	0.0	0.3	0.0	0.0	8.7	0.0	0.0	0.3	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.1	0.0	0.1	0.0	0.0	0.0	3.4	0.0
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169589-22202528	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.8;ovary: 73.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.6;Gastric mucus-secreting cells: 100.9;Granulosa cells: 52.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;CACO-2: 69.7;hTERT-RPE1: 25.5;OE19: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB011581: AB_732529, HPA066629: AB_2685695"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavorable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	22.2	57.8	0.0	2.5	0.2	0.0	3.8	0.0	0.3	4.9	2.8	11.4	22.8	19.8	1.2	0.8	28.9	11.1	43.9	0.1	0.0	3.0	12.6	14.8	1.9	0.1	0.0	73.0	22.7	0.3	0.6	6.5	0.0	5.5	11.0	0.1	0.8	0.7	0.8	1.5	20.7	9.5	0.2	15.0	49.6	6.3	0.1	0.4	5.3	0.6	0.2	23.0	3.2	0.0	10.1	1.4	0.0	0.0	2.1	1.0	54.8	0.3	0.4	0.8	1.0	69.7	3.8	0.0	3.2	1.2	3.4	10.8	0.4	4.5	1.4	0.0	13.6	0.0	4.3	6.1	14.3	0.6	0.6	0.4	8.9	12.1	9.1	25.5	9.5	0.0	0.5	0.0	0.0	1.5	0.0	0.2	0.1	37.6	9.8	0.0	1.1	0.2	0.4	2.8	0.9	0.1	10.7	6.1	3.0	2.7	1.7	0.0	0.7	1.4	1.6	11.4	1.7	0.0	0.0	0.0	6.2	0.3	9.9	4.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	7.3	44.8	30.2	0.0	0.0	0.9	4.0	4.6	1.8	0.0	3.4	2.7	97.6	30.0	6.1	0.0	0.0	0.9	0.9	50.0	0.0	28.4	44.7	6.3	6.3	11.5	26.0	2.7	0.1	19.6	11.2	24.4	100.9	16.6	5.1	52.9	28.5	11.1	1.6	0.0	0.1	45.8	2.0	0.6	0.9	8.8	3.4	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	36.8	27.7	10.1	0.2	4.1	43.3	0.0	3.9	0.0	32.9	0.4	8.6	1.4	1.4	0.9	0.9	1.9	1.3	11.4	47.2	2.9
GATAD1	"FLJ22489, ODAG, RG083M05.2"	ENSG00000157259	"GATA zinc finger domain containing 1"	Q8WUU5	7	92447482-92460075	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 234.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006105, HPA072785"			Enhanced	Nucleoplasm		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006105: AB_1078956, HPA072785: AB_2686556"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-3)"	"unprognostic (6.43e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.98e-3)"	22.7	22.1	9.5	7.3	12.8	6.2	22.2	10.1	10.9	26.8	9.7	22.3	11.2	21.4	18.3	14.6	26.5	11.8	16.2	9.6	10.5	21.4	20.1	20.1	8.7	12.1	11.5	33.6	29.4	15.5	23.1	12.4	12.4	23.9	11.3	13.2	18.4	12.4	10.8	14.0	18.6	11.7	10.4	20.2	21.6	10.2	12.0	6.7	26.0	5.7	7.3	22.0	20.2	16.0	12.3	7.5	15.3	16.1	19.7	22.4	12.1	11.9	17.8	12.4	16.9	8.5	18.5	9.1	15.9	8.9	28.9	14.3	10.7	8.1	13.0	15.8	11.3	11.6	8.0	11.6	27.4	14.1	30.0	16.8	19.3	9.5	27.4	22.3	14.2	6.6	24.2	19.0	13.8	17.7	5.5	20.2	20.8	19.9	14.4	7.2	18.1	12.1	13.6	13.4	13.4	21.4	15.7	16.5	23.7	19.0	9.2	18.8	13.0	19.7	14.9	30.0	15.5	15.2	5.5	10.0	16.6	9.0	27.6	2.9	1.1	1.2	0.7	0.7	0.7	0.9	0.5	0.5	0.6	1.4	0.6	0.9	1.0	0.9	0.8	1.2	0.6	0.4	9.5	12.8	10.1	10.9	9.6	10.5	12.1	11.5	12.4	10.4	12.0	16.0	59.0	48.1	64.6	98.9	26.5	13.3	37.8	14.6	26.7	79.0	33.3	35.1	16.3	24.3	26.6	47.8	70.9	25.7	28.8	30.2	3.9	22.4	3.8	46.7	48.3	34.7	16.8	24.6	77.8	22.0	23.4	38.1	30.5	51.6	53.2	115.1	37.1	21.7	24.6	62.2	70.4	33.3	2.0	30.8	23.7	5.0	45.4	40.2	21.4	54.4	25.8	65.3	32.0	108.6	234.9	27.0	30.7	35.0	13.6	45.9	33.2	18.2	36.1	114.1	19.7	54.3	36.7	14.1	10.4	23.6	17.8	20.7	24.7	56.0	31.9	35.7
GATAD2A	p66alpha	ENSG00000167491	"GATA zinc finger domain containing 2A"	Q86YP4	19	19385826-19508931	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006759, HPA024373"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006759: AB_1079549, HPA024373: AB_1849522"	"unprognostic (1.07e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (9.84e-2)"	16.7	15.1	13.1	23.6	14.0	32.6	15.4	11.0	12.6	13.6	17.1	19.5	22.8	14.8	8.7	22.0	12.3	14.4	12.3	16.7	13.5	16.1	17.1	21.7	19.8	17.6	14.4	11.4	21.6	15.1	14.9	17.8	14.3	10.7	11.3	8.4	15.5	11.0	17.9	30.0	24.8	8.3	14.4	22.2	17.8	33.0	14.8	19.5	14.7	6.9	13.6	15.1	16.4	12.7	60.7	50.8	46.5	69.3	18.9	19.7	97.5	46.7	31.6	47.7	45.4	92.8	62.6	117.9	69.5	47.1	31.6	49.6	43.6	41.5	27.6	40.6	47.7	87.1	49.4	51.8	46.2	97.6	72.1	31.3	30.2	49.9	40.0	15.8	48.2	66.9	141.1	37.1	28.1	68.5	115.9	38.7	98.3	55.8	45.9	121.9	46.6	54.9	24.9	79.0	87.7	48.9	40.4	48.6	57.5	30.2	44.0	40.3	94.9	89.9	43.3	106.8	88.5	46.1	62.9	125.3	56.2	80.9	53.7	4.6	2.9	3.2	3.2	1.5	1.9	2.3	1.9	2.7	1.3	1.5	1.4	1.6	7.8	2.7	3.3	3.0	1.3	2.3	13.1	14.0	11.0	12.6	16.7	13.5	17.6	14.4	14.3	14.4	14.8	12.7	35.7	12.8	19.2	24.5	24.1	55.7	22.3	14.2	26.2	16.1	33.5	21.5	13.5	24.3	15.4	14.7	18.8	23.7	66.3	53.4	13.7	21.9	21.8	43.9	42.8	31.4	15.6	21.0	14.9	30.6	36.8	21.9	29.0	69.5	17.1	22.1	29.3	27.9	27.7	23.5	21.4	28.9	24.4	27.3	42.1	18.5	15.5	27.7	32.0	35.6	28.5	18.2	53.5	17.1	21.6	46.4	28.8	13.9	19.5	24.1	30.2	29.9	15.8	18.3	19.7	40.5	25.8	18.4	41.4	39.5	55.5	36.7	39.3	28.2	32.2	28.2
GATAD2B	P66beta	ENSG00000143614	"GATA zinc finger domain containing 2B"	Q8WXI9	1	153789030-153923360	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017015	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA017015: AB_1854905"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.43e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.17e-2)"	10.0	7.1	0.0	6.1	2.9	10.0	9.9	12.4	3.0	10.9	0.0	11.1	4.2	11.1	1.8	7.9	9.1	3.2	9.2	1.8	1.5	7.1	8.1	12.9	7.8	2.8	0.7	11.7	7.5	5.7	7.6	5.8	1.2	8.3	3.6	3.6	7.8	5.3	16.6	13.3	9.3	7.0	0.0	10.6	7.7	10.4	2.1	10.9	8.6	8.2	7.4	9.5	9.8	11.2	7.9	14.7	12.8	14.2	2.7	8.2	7.7	4.8	11.5	15.0	17.5	7.2	12.0	15.5	11.2	10.9	7.9	15.6	18.1	9.4	12.2	14.2	12.5	15.2	16.2	2.9	8.6	9.2	20.7	6.5	6.5	16.7	32.9	7.1	14.4	21.2	11.5	20.6	3.0	14.5	33.3	2.6	5.6	6.3	7.1	33.5	6.5	17.1	2.9	10.9	14.8	15.6	18.0	21.8	8.7	9.4	20.1	7.7	13.0	14.6	12.8	8.1	10.2	27.9	20.5	23.4	8.2	6.0	12.8	4.9	0.5	0.5	0.6	0.3	0.6	0.4	0.3	0.8	0.2	0.6	0.2	0.3	3.5	0.9	0.2	1.6	0.6	0.3	0.0	2.9	12.4	3.0	1.8	1.5	2.8	0.7	1.2	0.0	2.1	11.2	32.1	9.6	14.4	53.8	30.0	43.8	13.4	12.8	47.8	45.9	20.9	19.9	16.6	21.5	12.3	25.8	39.6	10.3	31.9	15.1	7.9	13.9	15.8	16.8	26.6	28.2	23.8	21.7	104.6	14.3	7.1	20.7	17.3	21.3	24.7	19.3	22.5	21.8	13.5	35.3	77.5	15.8	16.2	31.4	42.8	7.6	27.1	23.7	14.2	80.6	36.3	17.8	23.7	86.5	117.9	17.1	20.7	35.0	25.6	22.3	9.9	10.4	15.2	35.9	6.6	28.2	27.1	30.4	21.4	26.0	47.5	9.9	31.2	21.4	15.9	21.1
GATD1	"FLJ34283, PDDC1"	ENSG00000177225	"Glutamine amidotransferase like class 1 domain containing 1"	Q8NB37	11	767220-777488	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 22.1;Collecting duct cells: 22.0;Theca cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 120.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008812	Uncertain		Supported	Nucleoplasm	"Secreted to blood"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA008812: AB_10962724"	"unprognostic (3.39e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.23e-3)"	"unprognostic (4.89e-3)"	"prognostic favorable (3.79e-5)"	"unprognostic (2.84e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.61e-3)"	15.9	37.5	37.7	11.3	35.8	7.9	16.7	35.1	37.8	22.7	36.6	23.3	15.4	24.9	12.6	23.7	22.7	7.3	16.3	37.4	36.5	24.0	19.3	15.4	11.2	46.4	41.8	25.9	15.9	10.5	30.1	9.2	35.8	23.0	6.5	9.7	17.5	12.2	14.4	21.0	18.2	7.9	38.4	19.6	17.8	18.6	45.3	8.8	22.0	6.5	6.8	19.7	20.4	37.5	41.3	22.3	22.2	23.9	10.2	15.6	20.9	24.2	10.5	22.0	19.3	15.8	62.5	22.1	8.6	16.0	23.2	42.7	16.7	21.6	11.0	28.1	120.5	13.0	38.8	36.0	17.5	25.4	27.8	22.4	23.2	9.3	14.2	19.9	17.1	25.8	34.2	20.0	12.4	11.0	29.3	27.5	21.3	13.4	42.8	31.4	15.1	28.0	19.2	9.1	56.9	22.3	22.9	32.0	16.6	5.7	28.5	16.8	31.3	23.2	17.5	12.7	18.8	23.4	12.9	28.4	35.4	33.9	19.6	1.0	5.2	0.9	2.9	6.6	2.1	2.7	3.0	2.9	6.9	2.3	2.4	1.7	0.5	1.2	2.6	4.0	1.4	2.0	37.7	35.8	35.1	37.8	37.4	36.5	46.4	41.8	35.8	38.4	45.3	37.5	8.7	44.8	22.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	11.9	10.4	0.0	0.0	7.4	22.0	0.0	13.8	5.2	0.0	5.9	10.3	0.0	11.8	15.2	3.8	0.0	0.0	0.0	7.6	7.9	8.5	0.0	9.6	6.3	19.2	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	16.6	0.0	0.0	1.3	0.0	0.0	14.7	7.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	9.6	3.9	25.8	0.0	0.0
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	39.3	45.7	48.5	23.2	47.5	16.3	39.9	52.8	53.7	46.4	63.3	83.5	54.2	44.6	26.9	36.3	44.2	26.3	83.3	47.2	54.2	84.4	65.9	54.1	24.6	54.1	56.2	39.8	54.1	37.2	65.5	24.7	56.1	60.2	41.0	71.1	50.0	27.7	75.8	39.3	89.7	22.9	45.1	58.5	63.9	30.8	58.9	18.3	61.7	43.7	21.6	53.0	40.9	48.7	18.1	29.3	39.6	38.4	18.8	11.4	40.0	24.1	18.8	23.9	25.0	32.8	14.1	19.3	17.1	14.7	51.5	18.4	38.2	16.2	12.0	27.5	26.2	20.8	87.8	35.6	20.8	31.2	49.4	19.8	29.8	20.3	21.1	57.9	63.4	18.9	20.7	36.0	22.6	18.0	8.5	32.0	41.2	36.6	45.7	15.5	16.0	16.3	33.3	41.9	32.2	43.0	13.5	33.3	24.5	48.1	22.8	27.8	44.6	25.8	30.9	22.4	29.9	24.2	16.5	16.0	32.3	11.3	20.5	11.1	2.9	2.0	3.8	3.9	2.5	3.7	3.7	4.7	2.8	4.7	2.2	1.9	3.2	2.4	2.5	4.4	2.8	2.2	48.5	47.5	52.8	53.7	47.2	54.2	54.1	56.2	56.1	45.1	58.9	48.7	12.7	12.8	8.0	45.1	11.2	7.4	18.2	9.4	6.2	77.5	15.0	10.8	13.7	17.2	14.5	27.6	114.7	11.1	16.6	71.7	21.5	10.5	14.1	10.0	8.1	16.0	35.8	17.2	23.5	12.0	10.2	8.0	46.4	13.8	14.0	18.7	30.7	20.1	9.2	52.2	26.4	35.8	16.2	12.8	10.7	24.3	12.5	10.7	12.4	8.4	13.3	16.2	12.3	18.1	20.2	15.1	57.6	9.8	11.7	15.8	87.4	17.8	17.9	102.9	13.1	12.2	12.2	9.2	5.7	8.8	9.9	22.2	9.4	11.3	41.4	26.3
GBP2		ENSG00000162645	"Guanylate binding protein 2"	P32456	1	89106132-89150456	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.1;EFO-21: 20.3;HDLM-2: 25.9;HUVEC TERT2: 18.1;RT4: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042682, CAB045975"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB045975: AB_10584474, HPA042682: AB_2678113"	"prognostic favorable (7.57e-4)"	"unprognostic (2.92e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.14e-10)"	"unprognostic (7.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.10e-5)"	66.6	89.2	3.1	31.8	3.2	8.0	64.6	2.8	4.7	80.4	2.5	100.4	15.0	63.4	11.7	41.2	64.4	22.7	21.4	2.5	4.6	27.3	27.7	89.7	26.2	8.8	5.1	60.5	7.5	27.9	13.8	8.1	5.7	54.6	18.4	0.5	34.6	20.6	53.8	55.4	62.0	31.8	3.7	51.1	46.0	9.0	6.4	9.3	21.1	16.5	15.9	83.8	65.4	4.0	5.4	0.1	0.0	0.0	19.1	12.5	1.9	2.1	17.0	2.1	6.8	0.0	5.0	0.0	20.3	14.0	14.8	0.7	0.0	0.1	1.3	25.9	0.0	0.1	3.1	1.3	2.6	0.5	0.9	14.1	0.0	5.1	0.0	9.3	18.1	0.0	0.3	0.4	7.4	0.0	0.0	4.3	0.0	4.6	0.1	0.0	7.5	0.0	3.7	21.6	0.0	0.2	7.4	1.5	0.1	0.5	0.1	1.0	13.9	2.7	0.1	3.1	1.5	14.0	0.0	0.0	6.9	0.1	0.1	19.1	31.4	10.9	34.4	42.8	43.3	4.7	32.4	32.9	11.6	3.4	24.3	25.4	139.4	26.7	77.8	0.6	79.1	32.5	3.1	3.2	2.8	4.7	2.5	4.6	8.8	5.1	5.7	3.7	6.4	4.0	35.4	25.6	34.3	0.7	21.5	46.5	123.5	24.9	18.2	0.2	56.1	30.4	4.1	27.1	27.1	18.4	0.0	40.2	47.7	41.9	0.0	113.9	35.7	59.6	39.7	60.5	10.2	8.2	0.6	73.2	51.2	41.2	18.3	152.4	47.4	2.5	28.2	30.5	33.2	0.0	1.1	15.7	8.2	84.5	29.4	33.3	4.7	81.1	8.8	14.0	60.6	0.5	110.2	1.5	0.1	73.2	25.9	8.6	17.3	80.3	128.3	12.2	27.5	0.2	19.7	81.9	45.2	1.8	4.6	24.9	61.8	57.7	81.8	33.3	15.3	87.0
GBX2		ENSG00000168505	"Gastrulation brain homeobox 2"	P52951	2	236165236-236168386	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	58	"brain: 14.3"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 2.8"	"Group enriched"	"Detected in some"	6	"glioma: 1.7;testis cancer: 6.6"	"Region enhanced"	"Detected in many"		"thalamus: 14.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.5;BEWO: 8.3;PC-3: 14.2;TIME: 7.7"	"Region enhanced"	"Detected in single"		"thalamus: 1.3"	"Group enriched"	"Detected in some"	4	"midbrain: 2.5;pons: 2.7;thalamus: 6.4"	HPA067809			Approved	Nucleoplasm		Yes	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA067809: AB_2685900"	"unprognostic (5.30e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.55e-4)"	"unprognostic (8.69e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.39e-4)"	0.0	0.0	1.5	0.0	1.8	0.0	0.0	2.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	4.9	5.3	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	14.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.6	0.9	47.5	1.8	0.0	0.0	8.3	0.7	0.0	1.3	0.0	1.1	0.0	0.0	0.9	0.0	1.4	0.0	0.4	0.1	0.3	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	3.9	0.0	3.4	0.0	0.6	1.2	0.0	0.4	1.2	0.0	14.2	0.0	5.1	0.0	0.4	0.0	0.6	0.3	1.6	0.0	0.5	1.5	0.0	0.0	7.7	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.8	2.0	1.2	0.4	2.7	4.9	5.3	3.6	3.0	14.3	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 140.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Hepatocytes: 66.1;Proximal tubular cells: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020460, HPA063924"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548, HPA063924: "	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	6.6	15.7	25.1	3.2	24.8	14.1	6.5	26.2	33.3	6.3	22.5	7.3	4.9	7.8	3.0	17.0	6.0	5.0	43.4	26.1	25.0	13.0	53.3	5.6	2.8	25.9	27.4	9.0	140.2	6.0	9.7	2.7	27.8	22.8	4.9	2.2	13.3	6.8	19.5	8.1	5.4	4.2	24.4	1.5	13.2	10.3	27.9	4.3	16.0	19.1	3.1	7.1	7.0	24.6	18.7	4.7	11.9	68.2	24.0	19.4	8.4	25.9	26.9	19.2	16.3	10.5	2.1	5.8	11.8	11.7	11.3	10.6	11.9	18.3	4.3	2.6	21.9	12.9	15.0	42.5	39.0	23.0	16.4	22.8	10.9	12.7	27.7	6.2	16.0	23.0	33.2	6.6	9.2	16.2	24.3	42.3	5.0	28.8	19.0	25.2	2.5	34.4	24.6	14.3	24.5	16.7	20.0	32.3	13.9	4.2	25.8	11.1	11.8	19.3	10.6	12.9	9.2	21.9	11.5	12.1	13.3	21.1	20.5	0.1	0.6	0.4	0.7	0.7	0.3	0.1	1.6	0.5	1.3	0.0	3.5	1.4	0.3	1.3	0.4	1.3	1.7	1.4	25.1	24.8	26.2	33.3	26.1	25.0	25.9	27.4	27.8	24.4	27.9	24.6	3.5	6.4	15.4	9.8	2.8	7.8	18.5	11.2	12.5	8.9	18.6	17.4	54.6	11.5	9.4	11.0	4.2	15.7	0.7	13.1	80.3	7.2	4.1	9.9	8.1	5.5	2.4	22.7	5.0	10.3	19.6	9.8	15.3	16.7	8.9	17.6	5.0	66.1	4.7	8.4	4.7	32.3	8.2	2.9	1.3	7.7	3.7	2.1	21.4	1.0	1.0	25.1	1.0	6.6	4.1	5.4	8.7	9.8	2.0	19.1	8.6	163.8	6.4	2.2	6.6	4.8	30.1	12.6	33.2	19.6	6.0	27.8	3.0	27.8	24.0	14.4
GCC2	"GCC185, KIAA0336"	ENSG00000135968	"GRIP and coiled-coil domain containing 2"	Q8IWJ2	2	108449191-108509415	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035849, HPA035850"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA035849: AB_10671941, HPA035850: AB_2674821"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-2)"	9.0	12.7	3.4	17.6	5.1	25.2	17.4	0.0	5.5	12.5	26.2	19.2	21.7	15.3	41.7	7.5	15.0	21.4	8.4	3.2	3.8	16.6	10.7	14.8	21.5	2.5	4.2	15.5	12.5	15.0	4.1	13.7	2.8	19.6	20.8	17.3	15.2	17.1	2.3	7.9	22.9	9.4	0.9	18.8	26.4	16.6	1.4	18.9	20.5	9.4	16.3	14.1	3.6	6.0	12.5	10.4	12.6	5.5	14.2	22.6	27.4	17.6	26.8	9.2	12.9	18.4	17.2	14.9	22.3	16.0	16.7	10.4	10.0	14.1	15.8	16.9	13.6	18.7	16.3	15.8	12.7	26.4	14.3	29.1	13.3	23.1	16.3	20.0	13.6	13.9	25.3	12.4	17.4	7.1	13.6	18.1	21.9	11.5	12.0	11.7	17.9	16.1	12.2	20.1	13.6	12.5	21.1	16.7	18.7	18.2	8.3	12.8	21.3	13.3	20.2	12.4	6.7	18.0	26.9	18.2	17.2	7.0	9.8	47.3	8.9	25.9	25.5	8.0	25.1	27.0	28.2	27.8	7.3	24.3	38.2	33.5	35.6	14.9	17.6	31.8	23.0	8.2	3.4	5.1	0.0	5.5	3.2	3.8	2.5	4.2	2.8	0.9	1.4	6.0	92.6	150.6	103.3	44.1	125.2	23.8	68.6	54.8	29.6	155.9	60.3	57.5	85.6	75.8	95.7	104.8	139.7	44.2	157.6	152.1	50.9	114.5	73.9	253.3	85.1	68.1	85.6	39.5	104.9	81.6	56.3	74.2	65.7	118.6	82.2	113.9	65.0	36.7	37.0	70.7	73.6	152.6	52.9	49.8	39.3	39.9	71.4	66.0	33.8	62.8	88.5	59.0	134.9	50.8	66.1	116.1	125.2	82.8	108.7	91.7	134.0	63.1	259.7	127.2	52.6	61.4	66.2	163.0	120.7	21.0	17.5	65.0	139.1	138.0	88.3	114.5
GCFC2	"C2orf3, DNABF, GCF, TCF9"	ENSG00000005436	"GC-rich sequence DNA-binding factor 2"	P16383	2	75652000-75710985	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077882	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA077882: AB_2686864"	"unprognostic (1.98e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (5.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (6.07e-2)"	10.7	10.5	13.8	4.2	16.3	7.4	12.1	14.4	17.3	19.2	9.7	9.7	3.7	11.1	11.4	9.6	13.7	4.7	11.3	12.2	14.4	19.0	28.5	7.8	8.8	13.7	14.5	14.3	14.1	7.5	11.2	6.9	13.9	14.0	3.8	11.7	7.8	5.5	29.1	15.8	8.1	6.3	15.1	12.3	9.4	12.0	14.4	7.6	12.1	9.1	6.5	9.0	10.4	17.3	14.4	13.9	9.8	11.6	5.3	6.7	12.7	9.5	7.7	9.7	9.2	16.7	10.3	14.2	13.4	6.5	11.9	5.5	11.9	6.5	13.0	20.9	25.5	10.9	13.6	44.9	8.3	18.8	10.2	7.2	8.2	4.8	14.5	11.0	11.6	17.6	16.5	8.2	9.3	11.3	19.6	31.8	15.5	10.5	15.3	22.8	20.1	34.6	16.3	15.7	18.0	22.6	12.8	14.5	16.2	6.9	10.8	10.6	12.6	9.3	12.2	13.4	19.3	9.5	17.7	10.8	9.2	11.7	20.7	0.6	8.1	3.8	10.4	5.7	11.9	18.2	9.7	12.1	9.4	12.6	14.3	13.2	0.4	5.4	9.6	13.3	11.5	8.9	13.8	16.3	14.4	17.3	12.2	14.4	13.7	14.5	13.9	15.1	14.4	17.3	11.6	16.0	11.2	49.6	15.7	27.8	20.5	14.0	21.6	11.2	14.4	13.5	22.4	17.2	20.2	12.9	0.0	36.7	14.8	7.3	21.5	16.0	31.5	11.4	18.0	15.0	16.2	12.0	60.8	19.0	23.5	21.9	8.2	8.7	13.9	15.6	13.2	24.9	12.5	16.8	51.7	7.5	8.2	13.9	12.0	75.4	16.8	8.8	14.2	20.6	7.1	10.6	16.5	75.9	75.9	13.8	7.8	9.8	11.3	18.0	6.2	19.3	15.1	9.1	13.1	20.2	13.5	15.5	22.7	16.5	24.7	23.7	13.3	17.4	10.6	16.8
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902826	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease variant, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;liver: 36.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 212.5;Hepatocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 12.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	2.4	6.0	2.1	8.1	3.0	31.4	1.8	1.1	2.0	0.4	1.5	2.4	9.4	0.4	0.2	3.5	1.2	0.4	1.9	1.9	4.8	4.6	36.7	4.1	7.0	3.5	16.1	0.5	2.6	0.9	1.8	0.3	8.4	1.5	2.4	0.1	1.7	1.0	0.4	2.2	7.5	1.1	2.4	6.9	2.8	1.2	7.8	3.8	0.8	0.2	2.0	3.3	1.4	2.0	4.7	0.6	1.3	7.1	0.0	0.0	23.5	0.0	2.0	2.4	2.9	1.4	1.0	25.0	6.9	0.2	5.8	4.0	4.9	1.5	0.1	10.9	5.2	0.6	0.3	3.1	8.4	0.0	1.9	0.3	0.7	1.2	0.1	0.0	0.7	23.0	2.8	0.0	0.0	5.0	15.1	0.3	0.4	6.5	8.2	9.6	2.8	0.0	2.9	1.6	11.6	50.9	3.3	2.4	1.6	0.4	2.9	1.5	0.3	0.1	4.0	9.9	3.8	10.5	8.4	7.8	3.1	8.4	0.0	0.0	2.6	0.2	2.8	5.3	2.1	0.7	1.0	1.5	2.8	1.9	2.5	1.3	0.3	1.8	11.1	0.1	2.1	1.2	2.1	3.0	1.1	2.0	1.9	4.8	3.5	16.1	8.4	2.4	7.8	2.0	19.2	3.2	4.8	0.7	33.4	74.6	30.9	23.6	17.6	0.0	19.4	13.2	6.5	4.3	13.6	5.5	2.1	1.9	50.9	21.8	7.9	8.7	0.5	16.8	5.8	19.8	212.5	10.1	3.8	9.4	44.3	15.3	43.8	29.3	0.0	0.3	6.8	94.6	6.1	0.0	5.9	22.7	4.1	28.0	33.3	0.6	0.3	55.8	10.6	15.9	29.5	0.7	29.9	0.5	0.8	11.0	13.6	4.9	14.4	20.5	17.1	48.6	6.9	0.4	0.0	12.5	7.5	2.2	6.7	20.8	76.1	4.2	41.8	11.9	12.2	39.0
GCHFR	"GFRP, HsT16933"	ENSG00000137880	"GTP cyclohydrolase I feedback regulator"	P30047	15	40764068-40767708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 350.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 787.2;Hofbauer cells: 522.9;Proximal enterocytes: 620.8;Proximal tubular cells: 500.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 120.3;RPTEC TERT1: 146.6;SCLC-21H: 124.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 10.3;midbrain: 11.8;pons and medulla: 9.4"					HPA046258	Enhanced		Supported	Nucleoplasm		NA	NA		170000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA046258: AB_10967205"	"unprognostic (2.50e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.72e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.62e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.03e-3)"	"unprognostic (9.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.55e-1)"	37.4	20.1	13.6	8.9	13.3	19.5	34.5	17.4	20.1	16.1	18.5	18.7	38.8	6.5	2.2	57.2	15.8	10.0	10.9	13.1	14.5	73.5	350.1	46.4	24.7	18.2	67.3	19.2	15.3	9.8	12.2	6.6	33.7	19.4	6.9	4.2	22.3	3.2	4.5	31.1	60.7	1.7	13.5	13.0	16.4	3.3	15.9	23.0	12.8	7.4	19.5	12.2	17.6	12.2	0.3	7.7	6.2	33.3	9.5	3.4	16.7	2.2	7.8	3.7	7.4	90.7	49.7	46.0	31.1	1.9	2.4	6.1	16.4	3.1	0.8	36.2	26.2	45.5	65.3	120.3	7.7	29.9	15.2	7.8	3.8	1.6	0.6	2.9	14.4	3.7	23.2	13.2	1.1	17.2	7.9	60.4	16.0	8.2	56.5	64.7	0.5	28.8	146.6	24.2	124.6	1.9	20.1	87.7	10.4	8.1	25.3	30.0	0.0	0.6	1.2	2.2	0.3	0.9	6.0	28.9	4.9	66.3	4.0	18.0	73.3	102.4	76.8	23.6	129.0	48.2	67.1	71.1	48.7	31.2	68.3	44.7	11.7	132.6	22.4	90.4	144.4	109.0	13.6	13.3	17.4	20.1	13.1	14.5	18.2	67.3	33.7	13.5	15.9	12.2	24.3	3.2	54.0	0.3	24.9	14.5	21.6	72.2	8.6	2.5	81.4	48.0	0.1	84.4	87.0	64.4	12.5	161.9	25.9	75.7	76.3	52.5	0.6	46.2	4.9	13.7	60.6	24.4	1.6	32.7	37.0	10.1	16.3	35.7	44.4	12.2	31.4	787.2	522.9	0.0	1.7	74.4	111.9	56.1	18.5	0.5	17.7	71.9	67.6	0.0	29.0	26.1	102.0	0.0	0.4	18.7	161.8	8.6	12.8	25.6	620.8	500.2	58.3	22.4	0.0	4.7	12.4	2.9	12.5	79.7	14.9	36.5	49.2	1.7	125.3	40.8
GCKR		ENSG00000084734	"Glucokinase regulator"		2	27496839-27523684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	19	"liver: 136.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 96.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.4;Hep G2: 20.7;HUVEC TERT2: 6.4;TIME: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034098, HPA045855, HPA052227"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB034098: AB_2247323, HPA045855: , HPA052227: "	"unprognostic (3.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-7)"	"unprognostic (6.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.50e-2)"	0.8	7.1	0.8	0.2	1.3	0.9	0.6	4.7	1.6	0.5	1.4	0.1	0.7	0.5	0.6	1.5	0.2	2.3	0.4	1.0	1.3	0.5	136.4	0.2	0.6	1.7	1.2	5.8	1.8	0.2	0.4	0.2	1.6	0.5	0.3	0.9	0.4	0.2	0.3	0.8	0.2	0.3	0.3	1.6	6.5	2.7	1.1	0.2	0.1	0.1	0.3	0.3	0.4	1.4	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	13.4	0.7	20.7	0.8	0.0	0.4	0.3	1.0	0.5	0.1	2.2	6.4	0.1	0.0	0.2	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.5	0.2	4.2	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	0.8	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.4	0.3	0.0	0.1	0.0	0.2	0.8	1.3	4.7	1.6	1.0	1.3	1.7	1.2	1.6	0.3	1.1	1.4	0.3	0.0	0.0	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	7.9	0.1	0.6	0.6	0.0	0.0	2.0	10.4	0.0	0.2	18.3	0.1	0.0	0.1	0.7	96.5	0.1	0.0	1.6	0.0	0.0	2.1	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	13.7	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.7	0.2	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 220.7;Urothelial cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 205.4;Hep G2: 178.2;OE19: 287.5;RT4: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	26.7	18.3	18.5	16.6	24.9	37.8	27.2	18.1	23.3	9.5	14.1	22.8	41.9	19.2	10.8	37.0	62.9	32.1	16.4	16.8	18.9	34.1	152.1	10.9	26.2	18.4	19.7	8.5	15.9	18.3	4.8	9.1	20.4	26.9	26.0	14.4	13.1	15.8	11.4	18.8	32.2	16.0	18.2	39.1	32.9	11.3	22.5	13.7	30.0	14.5	24.0	63.7	14.5	36.0	31.3	205.4	16.5	39.1	19.4	8.6	22.1	15.5	24.9	11.4	13.3	30.5	70.7	59.1	28.7	14.1	86.9	43.3	50.7	112.5	15.3	46.9	31.4	39.6	38.3	178.2	22.1	52.8	23.5	13.5	46.6	12.8	56.8	15.0	17.7	50.9	22.4	18.2	5.6	32.9	45.5	20.9	30.6	287.5	19.2	14.9	10.2	52.1	37.0	189.8	47.5	23.3	25.9	40.9	27.8	23.8	28.2	24.6	24.6	10.2	35.5	26.0	23.4	24.1	39.9	34.0	25.6	37.0	17.5	1.2	0.5	0.3	0.5	0.9	0.4	0.8	0.5	1.1	2.3	0.5	0.3	0.6	0.2	4.2	1.0	1.6	0.9	0.3	18.5	24.9	18.1	23.3	16.8	18.9	18.4	19.7	20.4	18.2	22.5	36.0	17.1	0.0	2.4	36.9	12.7	34.8	61.6	56.6	47.3	14.4	23.7	13.6	20.9	38.6	47.4	0.0	25.0	6.4	22.9	22.1	11.7	14.6	2.2	34.8	14.9	14.1	220.7	113.2	22.4	12.8	8.6	13.6	43.8	69.8	2.5	50.9	10.4	118.5	22.7	8.4	30.4	19.4	40.7	87.2	10.9	1.5	6.5	32.1	8.8	24.4	10.6	12.5	17.5	30.2	84.1	15.9	13.2	9.4	10.4	88.3	18.2	27.1	66.5	5.0	13.1	14.0	13.5	3.1	9.2	72.6	24.9	7.8	14.9	26.6	14.8	144.8
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885199-93909456	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 48.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 207.9;Erythroid cells: 301.9;Prostatic glandular cells: 762.3;Urothelial cells: 374.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	12.2	13.1	5.4	6.6	4.7	15.0	6.6	5.1	5.4	4.5	5.6	6.2	19.2	3.6	4.0	6.6	14.3	14.1	4.7	4.7	7.5	11.3	48.5	5.9	4.6	6.4	6.9	2.8	7.7	6.7	3.4	10.3	7.1	5.6	5.5	3.6	4.5	5.9	16.0	3.0	12.7	3.6	5.1	6.8	5.7	3.2	5.7	5.0	16.8	11.8	10.1	6.9	3.7	6.1	37.7	58.6	6.4	12.6	20.9	13.0	24.4	43.7	27.3	32.8	24.3	9.9	21.7	14.2	84.8	28.8	106.7	37.3	9.6	18.0	26.2	38.6	12.7	98.9	37.4	42.8	39.1	36.8	15.2	16.1	6.7	67.0	10.7	13.2	36.4	16.0	40.0	20.5	24.0	7.3	26.8	8.5	21.5	36.0	27.4	12.3	19.0	20.9	23.6	43.4	14.8	6.1	41.3	32.2	15.4	71.8	7.2	22.7	38.4	34.1	20.1	64.5	66.7	18.1	25.0	14.7	28.2	20.4	12.2	2.1	0.3	0.7	2.6	0.2	1.5	1.3	2.5	3.4	0.3	2.0	1.5	1.6	1.5	2.3	0.3	1.0	0.7	0.7	5.4	4.7	5.1	5.4	4.7	7.5	6.4	6.9	7.1	5.1	5.7	6.1	28.7	41.7	19.1	16.0	14.6	11.5	207.9	33.2	24.5	24.8	24.2	34.2	16.4	61.5	29.0	29.5	6.2	63.5	39.3	21.7	25.4	25.1	3.9	66.3	27.6	55.5	52.5	301.9	32.0	12.3	19.6	44.5	15.8	50.1	19.7	17.3	31.4	102.4	19.9	33.7	30.7	19.9	22.4	20.7	51.4	4.0	21.5	32.0	8.8	15.0	9.3	21.2	34.0	11.1	11.6	24.2	8.0	12.4	21.6	762.3	47.2	65.1	64.3	13.1	0.0	48.4	37.1	32.0	36.7	33.5	9.2	45.0	34.1	26.5	17.8	374.9
GCNA	"ACRC, NAAR1"	ENSG00000147174	"Germ cell nuclear acidic peptidase"	Q96QF7	X	71578411-71613583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 6.9;Endometrial ciliated cells: 2.9;Glandular and luminal cells: 7.0;Plasma cells: 3.3;T-cells: 4.7;Theca cells: 4.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA023476, HPA030870"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA023476: AB_1844530, HPA030870: "	"unprognostic (6.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.07e-10)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.74e-1)"	"unprognostic (1.15e-5)"	1.9	4.6	4.1	1.3	4.5	1.3	1.4	5.1	8.1	2.0	3.7	1.5	0.8	1.3	0.9	1.3	1.5	0.7	1.9	4.5	4.7	2.2	2.6	2.4	1.9	4.8	3.8	1.8	2.5	0.2	2.0	0.4	4.4	1.8	0.7	2.2	1.3	0.4	4.2	1.4	2.4	0.7	3.4	4.9	1.8	11.0	4.1	1.1	2.2	1.2	1.0	1.5	1.7	4.8	0.3	0.5	1.1	1.0	2.2	2.0	0.6	1.8	1.0	0.6	1.0	1.0	0.7	2.9	1.4	1.0	0.6	1.4	2.2	0.1	0.9	0.5	1.5	0.6	2.8	0.3	0.6	0.5	2.6	0.8	3.5	0.5	0.5	2.3	0.4	2.2	0.8	1.8	1.3	0.3	0.2	2.1	1.1	1.3	1.3	0.5	0.0	2.1	1.4	0.8	0.6	0.1	0.6	0.3	1.6	1.1	0.2	1.8	0.7	0.7	1.3	0.9	0.5	0.5	1.4	1.1	1.2	1.1	1.1	0.2	0.1	0.0	0.1	0.1	0.3	0.3	0.4	0.8	0.1	0.1	0.2	0.2	0.2	0.3	0.0	0.1	0.8	0.1	4.1	4.5	5.1	8.1	4.5	4.7	4.8	3.8	4.4	3.4	4.1	4.8	1.8	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	2.8	0.0	0.0	0.0	3.7	0.0	0.0	6.9	0.0	0.0	0.8	0.0	2.9	1.5	0.5	0.0	0.0	0.0	1.0	0.1	0.9	0.0	7.0	2.5	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	4.7	4.0	0.0	0.0
GCNT4	"C2GNT3, LINC01336"	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4"	Q9P109	5	75025346-75052558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.0;lymphoid tissue: 15.4;stomach 1: 18.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Cytotrophoblasts: 39.6;Glandular and luminal cells: 16.7;Proximal enterocytes: 28.0;Syncytiotrophoblasts: 24.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"amygdala: 1.1;basal ganglia: 1.8;cerebral cortex: 3.3;hippocampal formation: 2.1;white matter: 1.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 22.4"	"Group enriched"	"Detected in many"	53	"granulocytes: 22.4;T-cells: 18.2"	"Cell line enriched"	"Detected in some"	5	"RT4: 37.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favorable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.9	0.8	1.1	2.9	1.8	0.7	1.3	0.0	3.3	1.4	0.0	1.4	24.0	1.2	1.9	2.2	2.1	5.3	0.4	2.1	0.0	4.1	1.1	1.7	4.4	0.0	0.0	1.0	4.6	9.6	0.2	6.3	0.0	1.7	1.3	0.1	0.5	4.8	1.0	2.1	20.2	2.3	0.0	1.7	18.5	1.6	0.0	15.4	0.5	1.4	3.0	4.1	1.8	1.4	0.3	0.2	1.4	2.3	2.5	0.8	0.1	2.8	7.2	1.5	1.2	3.7	0.2	0.0	0.4	2.2	0.8	1.0	1.4	2.5	0.3	0.0	0.1	1.2	0.3	0.3	1.1	0.0	0.0	0.4	3.9	0.1	0.5	0.0	0.0	2.2	0.0	0.5	0.2	0.0	2.1	0.1	0.6	8.0	0.0	0.0	0.0	3.6	0.3	37.1	0.0	0.1	0.3	0.0	0.1	7.0	0.0	0.0	0.0	0.8	0.2	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	22.4	0.0	0.0	1.2	0.0	5.0	0.0	11.4	3.7	0.0	0.0	11.1	8.1	0.2	0.3	0.2	0.1	18.2	2.3	1.1	1.8	0.0	3.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	3.2	5.0	0.7	0.3	0.6	8.7	0.5	0.0	0.0	0.9	2.3	0.5	32.9	2.7	12.9	0.0	39.6	0.8	4.9	9.8	7.1	0.1	11.9	2.4	1.8	0.0	0.0	1.3	4.4	0.9	2.5	14.8	16.7	7.6	2.0	3.3	0.7	2.3	0.0	0.0	2.7	0.0	0.3	0.0	0.3	4.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	6.9	2.6	0.5	3.0	28.0	0.7	0.6	0.0	6.6	1.6	2.5	0.2	1.7	0.6	0.1	24.4	3.7	0.0	4.4	4.2
GCOM1	"FLJ30973, GRINL1A, MYZAP-POLR2M"	ENSG00000137878	"GRINL1A complex locus 1"		15	57591908-57714745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"heart muscle: 20.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 3.9;Gastric mucus-secreting cells: 4.1;Granulosa cells: 5.7;Paneth cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.4;naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 49.0;RT4: 19.1;TIME: 20.4"									"HPA039827, HPA068141"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA039827: AB_10673364, HPA068141: AB_2685962"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.69e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.78e-2)"	5.2	9.1	0.4	2.0	0.7	3.0	2.4	3.9	0.3	1.8	0.0	3.8	5.9	3.1	0.1	14.8	0.8	2.1	20.1	0.2	1.7	1.5	0.6	7.0	2.0	3.3	0.7	2.3	9.1	0.4	0.0	10.3	3.5	2.9	3.6	0.9	3.7	2.4	6.4	5.7	7.2	2.5	0.0	3.4	7.0	2.1	1.2	0.5	0.7	1.1	4.7	9.9	0.6	0.2	6.3	1.3	0.1	5.8	0.3	0.0	1.4	0.8	5.1	1.6	1.7	4.0	5.6	0.0	0.7	0.0	5.0	3.4	0.0	4.2	1.6	0.0	0.2	49.0	1.4	0.2	0.0	0.1	0.1	0.2	2.2	0.4	11.7	0.2	6.3	0.1	2.4	0.1	0.3	1.1	0.0	0.0	0.1	12.0	0.6	0.0	10.7	0.0	0.0	19.1	0.0	1.9	1.2	2.7	0.0	0.7	5.3	0.2	20.4	0.4	3.1	0.4	0.3	0.2	0.0	0.0	3.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.2	1.4	1.4	0.0	0.1	0.0	0.7	0.0	0.1	2.1	0.4	0.7	3.9	0.3	0.2	1.7	3.3	0.7	3.5	0.0	1.2	0.2	2.7	3.2	0.5	0.3	0.4	0.0	0.3	0.0	1.8	0.0	0.5	0.3	3.9	0.0	0.6	0.0	0.0	0.1	0.0	1.7	0.0	1.8	0.2	0.4	1.0	1.8	0.0	0.0	0.2	1.1	0.1	0.2	4.1	1.4	0.0	5.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	1.1	0.4	0.0	0.3	1.8	0.0	0.7	0.0	0.0	0.5	0.0	1.6	4.8	1.5	0.0	0.4	1.4	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.1	0.6	0.1	0.1	0.0	1.1	0.5	0.9
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.7;intestine: 94.8;kidney: 42.9;liver: 60.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 112.3;Excitatory neurons: 109.3;Glandular and luminal cells: 171.1;Paneth cells: 83.7;Proximal enterocytes: 321.3;Proximal tubular cells: 98.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 34.4;EFO-21: 127.9;HeLa: 46.4;hTCEpi: 62.3;OE19: 157.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"amygdala: 36.5;basal ganglia: 30.1;cerebral cortex: 60.0;hippocampal formation: 70.7;olfactory bulb: 18.3"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1500000	"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.3	2.7	57.0	1.2	66.9	0.4	0.2	19.8	79.7	1.6	23.2	10.4	94.3	3.7	0.4	0.4	8.5	15.9	0.1	62.3	52.3	42.9	60.3	0.2	0.4	19.9	26.1	0.2	2.7	8.5	2.8	2.9	25.8	0.1	9.9	0.1	0.0	6.7	1.6	2.2	94.8	0.4	20.5	0.1	3.4	1.2	60.5	0.6	0.1	0.4	4.7	4.0	0.2	42.3	34.4	4.5	0.1	0.1	0.0	0.0	0.8	0.3	24.9	0.0	0.0	3.2	19.3	0.0	127.9	0.0	0.2	2.9	0.2	0.0	0.0	0.4	0.1	0.0	46.4	0.2	0.0	0.1	0.1	0.2	62.3	0.0	0.6	0.1	0.0	0.0	9.6	0.1	0.0	0.2	0.2	0.3	0.2	157.0	0.0	0.0	0.1	1.1	1.1	7.9	0.2	0.6	2.5	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.1	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.0	57.0	66.9	19.8	79.7	62.3	52.3	19.9	26.1	25.8	20.5	60.5	42.3	0.0	0.0	0.5	3.9	1.9	0.0	0.7	19.0	0.0	0.0	0.0	0.0	0.8	14.3	24.7	0.0	0.0	0.2	0.0	65.5	3.9	11.7	1.2	112.3	7.4	0.4	4.8	0.0	109.3	10.7	1.9	0.3	12.2	171.1	0.0	0.0	1.1	56.9	0.2	0.0	22.8	22.1	2.0	1.9	0.4	0.6	0.3	1.2	0.0	5.6	0.6	0.0	0.0	5.0	3.8	6.7	83.7	0.0	0.1	0.8	321.3	98.2	58.6	0.0	0.0	0.8	3.0	1.4	4.7	0.0	0.1	1.9	1.2	0.2	16.1	2.2
GDE1	MIR16	ENSG00000006007	"Glycerophosphodiester phosphodiesterase 1"	Q9NZC3	16	19501693-19522123	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 270.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077420			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA077420: "	"unprognostic (1.69e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (7.52e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.60e-3)"	"unprognostic (9.92e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (8.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	28.9	25.9	42.9	15.6	46.3	27.8	21.1	42.9	49.9	21.9	40.4	44.9	30.0	20.0	27.5	22.4	16.9	18.4	52.8	45.7	45.5	27.6	25.4	29.3	11.7	44.5	47.7	12.8	28.5	76.8	19.2	20.5	43.3	26.7	41.6	19.8	28.3	30.3	62.9	26.4	27.7	26.5	42.8	13.5	34.3	14.1	48.8	16.8	20.3	64.4	15.3	30.2	16.6	47.4	38.6	46.2	25.0	29.4	115.3	43.3	34.7	38.3	66.9	30.0	37.1	26.6	67.4	29.2	48.1	57.2	32.8	31.8	35.2	46.6	36.9	31.7	52.8	24.2	41.4	57.2	69.1	32.7	21.5	44.9	73.1	32.2	37.4	54.5	40.6	36.3	13.7	29.1	33.2	70.3	28.3	29.1	29.1	59.9	34.2	40.2	45.7	41.7	72.9	59.7	28.9	25.8	37.0	44.5	37.9	38.5	45.8	37.8	42.7	25.3	22.3	33.9	24.6	27.0	27.4	19.9	38.5	47.2	23.1	52.0	19.3	11.2	8.9	17.7	11.5	7.2	10.4	10.4	12.4	6.1	5.5	8.5	34.0	6.6	22.7	7.5	12.7	8.2	42.9	46.3	42.9	49.9	45.7	45.5	44.5	47.7	43.3	42.8	48.8	47.4	12.2	38.5	86.8	7.2	18.9	23.5	30.3	56.2	22.8	15.4	38.3	22.4	66.8	34.3	56.0	9.2	27.1	80.4	23.2	123.1	23.5	97.0	35.1	26.9	23.8	17.7	33.5	100.8	12.0	163.9	78.6	27.3	24.5	21.5	3.8	36.4	20.7	23.9	60.8	32.0	15.9	57.5	61.1	48.2	22.9	61.2	28.6	32.3	24.9	8.4	38.2	22.3	24.7	9.5	25.0	77.4	97.6	38.0	19.6	100.5	101.7	45.9	39.7	29.6	13.1	16.7	24.9	87.1	59.6	31.9	29.5	270.4	22.0	45.9	85.3	79.2
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142333-96160806	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease variant, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 10.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.3;Distal tubular cells: 1.9;Excitatory neurons: 1.6;Fibroblasts: 3.1;Oligodendrocyte precursor cells: 7.1;Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8;thyroid cancer: 2.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 20.4;LHCN-M2: 33.1;SuSa: 15.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 1.2"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	1.3	0.1	0.3	0.9	0.3	0.0	0.4	0.4	0.8	0.2	0.0	0.7	0.3	1.4	0.4	0.4	0.5	2.4	2.8	0.3	0.4	0.2	0.4	0.2	0.1	0.8	0.4	0.1	0.7	0.1	0.1	10.9	1.0	0.3	0.3	0.0	0.0	1.4	0.0	0.0	0.9	1.1	0.4	0.0	0.6	0.6	0.8	0.1	0.6	0.0	0.0	0.8	0.9	0.4	0.0	0.0	0.2	0.0	1.1	0.6	3.9	2.6	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	3.2	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	3.0	0.0	20.4	0.2	0.0	0.0	0.0	33.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.4	0.8	0.3	0.4	0.8	0.4	1.0	0.4	0.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.8	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.0	2.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1
GDNF	"ATF1, ATF2, HFB1-GDNF"	ENSG00000168621	"Glial cell derived neurotrophic factor"	P39905	5	37812677-37840041	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes, Disease variant, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8.2;skeletal muscle: 10.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 3.3;Skeletal myocytes: 11.5;Spermatogonia: 3.4;Theca cells: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 41.4;SuSa: 12.6;U-87 MG: 12.6;WM-115: 46.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.8"	"Low region specificity"	"Detected in some"			"CAB005210, HPA070283"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"CAB005210: AB_2247684, HPA070283: AB_2686246"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.42e-2)"	0.1	0.4	2.3	1.6	1.5	0.1	0.3	5.8	1.4	0.8	0.0	8.2	1.4	1.3	2.5	0.9	0.9	0.9	0.8	0.6	1.6	0.9	0.7	0.0	0.1	0.7	3.1	3.6	0.0	0.0	0.1	5.0	1.0	1.3	2.4	0.3	0.2	4.5	10.1	1.3	2.0	2.1	0.2	0.4	1.6	0.4	6.1	0.1	0.1	4.3	0.0	0.7	0.8	2.9	0.0	0.0	0.1	0.1	1.8	1.0	0.0	5.5	3.4	1.1	1.6	0.0	0.1	0.1	0.0	7.4	0.1	0.2	0.0	0.1	2.2	0.0	0.2	0.0	0.4	0.5	0.2	0.1	0.1	1.8	0.1	41.4	0.0	1.4	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.1	0.4	0.1	0.0	0.1	9.0	0.0	0.0	0.2	0.5	0.0	0.3	0.2	2.7	12.6	0.1	0.0	0.0	5.5	0.0	1.4	6.2	4.0	0.0	0.0	12.6	0.0	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	1.5	5.8	1.4	0.6	1.6	0.7	3.1	1.0	0.2	6.1	2.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.6	0.6	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.1	3.3	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.7	0.1	0.0	0.0	11.5	1.8	0.9	3.4	0.0	0.3	0.1	0.0	2.6	0.0	0.5
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113537	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.6"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 447.4"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 32.1;MCF7: 50.6;OE19: 53.3;SK-BR-3: 165.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	7.1	2.4	6.1	6.0	6.1	1.8	5.4	6.8	11.4	18.7	5.9	25.9	8.4	5.3	9.3	45.6	5.7	2.5	5.2	6.0	6.1	17.9	2.1	6.4	4.2	7.5	6.1	6.8	2.2	0.4	4.8	11.4	8.0	5.7	17.2	6.5	9.0	2.2	2.1	11.0	10.2	5.2	6.3	9.0	18.8	1.8	6.1	4.1	4.7	0.9	20.9	5.4	19.1	6.8	21.8	0.3	5.2	1.5	1.6	5.5	5.5	0.6	1.3	1.8	1.7	1.0	15.2	0.6	2.9	1.5	0.6	1.8	1.6	0.5	1.8	2.5	4.0	0.2	1.0	32.1	1.0	0.7	1.3	0.2	1.6	4.5	0.3	4.1	5.1	4.2	1.0	2.3	2.2	50.6	1.5	2.0	2.6	53.3	0.6	6.3	1.4	7.1	2.6	7.4	1.1	2.2	0.2	165.0	0.5	1.6	3.0	2.7	2.7	0.9	1.1	1.9	1.8	2.7	0.9	1.5	4.2	2.7	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.1	0.0	6.1	6.1	6.8	11.4	6.0	6.1	7.5	6.1	8.0	6.3	6.1	6.8	5.9	6.4	1.1	1.6	1.0	1.3	0.9	4.4	1.2	1.6	4.1	3.0	1.5	0.0	22.2	5.5	0.0	24.2	1.2	98.2	5.9	0.9	67.8	2.6	3.8	4.3	3.5	0.0	0.6	1.3	71.9	2.1	30.1	4.1	0.0	2.0	3.9	0.3	3.1	1.7	0.8	34.2	6.1	1.9	1.0	447.4	3.4	1.4	1.8	1.9	1.2	0.6	0.0	1.5	1.2	19.2	36.7	3.0	0.1	1.1	46.0	100.6	9.0	1.7	6.6	0.6	2.7	1.4	1.3	5.1	2.0	9.3	1.9	1.3	13.9	4.8
GEMIN2	SIP1	ENSG00000092208	"Gem nuclear organelle associated protein 2"	O14893	14	39114223-39136973	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 45.8;Late spermatids: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015426, HPA046570, HPA057114"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340"	"unprognostic (4.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (8.62e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.78e-2)"	6.1	4.3	6.1	4.5	6.3	10.3	7.9	10.2	7.9	5.9	4.6	6.0	6.7	5.4	7.2	5.7	5.9	4.2	7.7	5.7	3.9	6.1	5.6	4.8	8.8	3.6	2.6	5.9	4.7	3.7	4.6	5.6	3.6	4.8	6.1	4.7	4.3	4.5	12.1	6.3	4.7	7.7	1.1	5.2	5.1	8.3	3.4	9.1	5.5	7.9	7.8	6.2	5.5	6.2	23.6	34.5	33.3	23.7	11.3	12.6	17.0	11.5	9.0	30.3	30.0	30.7	27.9	36.0	23.4	9.8	11.0	17.5	45.6	18.7	31.5	17.6	26.7	21.5	18.1	76.8	23.9	32.6	12.8	7.3	17.6	18.8	27.5	8.7	26.6	31.4	25.2	25.6	17.3	48.9	36.3	31.2	23.6	29.7	38.3	32.8	36.4	22.6	17.5	15.6	32.2	6.2	24.5	17.7	12.4	18.4	41.5	14.0	11.2	12.7	20.0	13.3	18.6	26.8	44.2	54.1	6.6	34.0	19.6	10.8	12.0	9.9	13.5	13.1	9.8	15.3	12.3	13.5	16.2	15.8	13.5	14.4	3.1	11.9	11.5	16.1	11.8	9.2	6.1	6.3	10.2	7.9	5.7	3.9	3.6	2.6	3.6	1.1	3.4	6.2	11.6	6.4	3.7	4.9	10.3	8.5	8.1	20.9	8.0	5.9	7.3	12.1	6.0	5.7	11.4	5.5	10.4	12.9	7.0	2.2	11.7	10.8	45.8	11.2	11.3	10.6	3.6	17.2	7.4	6.4	18.9	12.5	2.6	7.5	5.7	11.7	9.7	6.6	11.4	5.0	6.2	7.1	14.2	10.6	7.3	41.1	9.0	6.3	7.2	4.7	9.4	8.1	9.2	4.0	7.4	6.9	2.5	9.8	9.4	8.0	3.1	14.7	15.5	6.9	6.6	8.3	8.1	25.9	15.4	11.3	8.0	3.8	9.1	11.6	9.3	4.8
GEMIN6	FLJ23459	ENSG00000152147	"Gem nuclear organelle associated protein 6"	Q8WXD5	2	38751534-38785002	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.5;Spermatocytes: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035726, HPA035727"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA035726: AB_10669528, HPA035727: AB_2674753"	"unprognostic (1.97e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-2)"	6.5	10.1	7.7	7.7	8.2	3.6	8.3	8.2	10.9	6.7	8.2	6.9	9.0	6.5	10.3	7.1	9.0	5.5	6.0	7.7	7.6	12.5	13.8	5.3	10.8	7.7	7.8	9.8	6.8	7.5	6.2	7.4	8.1	5.6	8.5	6.1	6.1	5.2	13.1	5.4	7.8	8.7	7.4	7.9	7.2	19.6	8.0	8.1	6.7	7.0	12.4	7.7	5.8	10.5	38.8	31.2	21.3	24.9	27.3	23.8	36.4	32.4	16.1	28.1	23.3	33.1	18.1	52.8	36.3	16.8	39.4	18.1	33.5	31.6	40.7	45.5	42.3	34.4	17.9	54.4	18.7	29.0	17.2	16.3	22.9	37.6	18.5	19.2	29.9	14.1	35.9	17.9	28.4	27.4	35.1	37.0	36.6	45.4	37.0	24.1	37.6	28.9	25.8	13.4	26.6	41.9	8.3	31.1	25.3	24.7	16.0	9.8	16.4	27.1	34.6	21.4	49.1	36.7	77.4	50.6	21.8	43.0	27.7	3.1	24.3	7.8	19.6	28.6	21.7	32.4	20.3	20.3	24.0	29.5	24.4	25.5	3.6	26.3	26.6	17.7	31.3	22.4	7.7	8.2	8.2	10.9	7.7	7.6	7.7	7.8	8.1	7.4	8.0	10.5	11.8	12.8	24.0	1.0	18.7	8.3	10.3	31.5	7.4	6.9	13.9	21.1	9.1	14.3	22.3	11.0	4.2	29.7	7.5	7.5	29.4	22.2	164.5	28.6	21.3	14.9	1.2	18.5	1.7	17.8	37.8	16.1	16.8	8.3	12.6	19.0	16.8	33.5	26.4	11.8	1.8	10.7	6.1	19.5	15.5	29.0	20.5	15.0	10.6	1.9	23.4	9.2	15.5	1.5	1.2	19.1	11.4	11.3	13.3	10.7	21.2	68.5	32.6	7.9	19.7	10.7	15.7	87.8	18.3	16.1	11.5	7.3	12.5	30.5	17.7	7.7
GEMIN7	FLJ13956	ENSG00000142252	"Gem nuclear organelle associated protein 7"	Q9H840	19	45079195-45091518	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052075			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"HPA052075: AB_2681718"	"unprognostic (3.32e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (5.86e-5)"	"unprognostic (7.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (9.64e-11)"	"unprognostic (7.01e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (8.00e-4)"	16.2	17.0	16.7	15.3	16.4	23.4	15.8	17.8	19.0	15.3	19.3	20.2	21.1	12.5	9.3	29.6	12.7	10.5	21.7	17.1	17.2	22.7	32.3	15.5	26.8	17.4	17.8	9.5	16.7	10.1	21.9	12.7	17.5	18.3	14.2	8.0	19.0	7.2	35.1	23.5	23.9	10.8	16.9	37.1	24.0	6.0	18.0	11.8	12.5	16.4	19.4	18.5	19.2	17.8	48.3	62.6	36.0	44.4	27.0	27.8	27.8	36.2	26.3	54.1	60.0	38.3	30.1	47.8	24.3	31.3	30.0	29.5	52.6	43.0	32.6	38.4	68.6	52.8	29.2	50.4	37.6	42.7	30.3	41.9	34.8	30.3	21.8	27.7	53.4	28.5	56.3	48.7	21.5	71.2	41.2	44.2	33.9	73.2	32.3	48.6	16.6	62.4	41.4	34.9	35.6	24.9	28.3	60.3	32.8	28.9	40.9	44.9	29.1	20.0	38.0	13.1	48.4	50.3	80.6	77.7	32.1	42.7	32.8	32.8	33.5	37.1	70.5	28.2	67.6	67.3	51.1	65.3	47.4	57.8	39.4	51.1	18.3	74.6	20.5	54.1	48.4	46.4	16.7	16.4	17.8	19.0	17.1	17.2	17.4	17.8	17.5	16.9	18.0	17.8	7.5	19.2	12.1	5.2	23.0	18.1	12.4	27.3	8.0	5.8	14.9	14.5	9.9	21.5	18.4	3.7	0.0	37.9	19.3	12.7	21.5	36.7	1.5	5.9	9.7	13.2	13.2	15.3	7.5	33.7	57.2	13.0	27.0	7.5	3.8	7.9	16.4	19.9	34.7	1.7	8.1	19.8	22.4	18.8	15.4	3.1	14.3	14.2	12.4	8.4	63.3	8.0	48.4	10.1	4.1	44.5	19.7	6.4	42.1	15.9	27.8	26.0	5.1	4.6	6.6	7.3	11.9	4.9	8.3	20.0	23.7	25.9	12.4	13.8	25.0	12.1
GEMIN8	"FAM51A1, FLJ20514"	ENSG00000046647	"Gem nuclear organelle associated protein 8"	Q9NWZ8	X	14006726-14029893	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028613	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA028613: AB_10602905"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (3.87e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (7.73e-5)"	15.7	15.0	16.3	10.9	19.1	14.3	21.4	19.4	15.9	19.8	20.9	18.3	8.7	22.3	18.8	15.6	22.1	15.2	15.2	16.0	17.8	17.8	15.7	14.3	16.2	21.2	18.8	28.1	20.4	15.0	21.5	10.5	21.2	15.8	12.4	28.5	23.4	18.2	9.5	16.6	12.3	18.9	20.3	14.7	16.3	6.9	18.2	12.9	20.8	6.0	14.1	15.5	15.7	24.0	12.7	12.7	15.2	3.2	26.9	38.6	7.9	11.8	11.7	10.1	7.5	6.0	20.7	29.3	25.7	10.5	11.1	16.0	10.7	21.3	13.1	14.8	17.1	7.5	8.9	14.2	13.8	18.9	15.3	29.5	32.1	18.0	32.1	30.3	25.2	22.0	13.2	24.6	17.0	16.2	17.2	26.6	15.2	16.5	6.6	26.3	9.7	51.4	15.6	12.9	13.0	37.1	14.6	21.5	13.8	35.7	28.4	16.3	16.6	7.1	4.2	19.7	4.6	16.7	8.7	19.1	16.2	10.5	4.3	1.0	10.1	0.4	13.1	9.9	15.2	17.2	20.5	12.2	18.9	13.3	17.4	13.5	1.2	15.4	10.9	22.1	13.0	11.5	16.3	19.1	19.4	15.9	16.0	17.8	21.2	18.8	21.2	20.3	18.2	24.0	9.5	6.4	8.9	23.2	8.1	7.6	11.7	16.8	13.6	3.4	13.3	15.4	5.2	11.5	15.0	9.2	0.0	15.2	7.2	5.1	19.6	22.7	19.9	20.7	6.7	8.4	3.5	5.5	13.2	11.8	16.0	11.3	9.7	14.8	6.3	8.0	4.6	7.5	10.9	10.1	18.0	11.1	10.2	6.0	6.1	3.4	10.2	5.0	1.8	4.7	7.6	6.7	7.2	16.1	44.0	11.2	7.4	8.6	15.8	6.5	5.5	36.6	15.9	6.4	0.0	11.2	9.4	7.4	5.5	12.9	9.5	8.3	7.2	14.0	12.2	9.4
GEN1	"FLJ40869, Gen"	ENSG00000178295	"GEN1 Holliday junction 5' flap endonuclease"	Q17RS7	2	17753858-17788946	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA020078, HPA021141"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA020078: AB_2670352, HPA021141: AB_2670599"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-3)"	"unprognostic (7.90e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.70e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.89e-12)"	"unprognostic (3.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.49e-3)"	1.6	1.8	1.1	4.8	1.0	15.1	3.2	0.7	1.2	2.3	15.4	5.2	3.2	1.8	9.3	5.6	1.4	4.4	2.3	1.5	1.7	1.7	8.6	2.0	10.8	2.1	2.4	0.9	2.2	1.1	3.0	3.9	1.8	2.7	6.9	2.5	5.6	2.7	1.7	7.5	4.5	1.4	1.7	5.1	3.0	8.5	1.6	5.4	1.9	1.5	11.8	1.5	3.7	1.8	29.4	15.0	14.0	9.9	3.2	4.1	23.9	21.3	6.7	9.9	9.6	19.6	13.0	27.4	8.2	7.3	10.4	18.4	16.4	12.8	13.7	21.4	9.1	15.7	16.3	9.5	1.9	20.2	17.0	3.1	4.7	16.8	7.7	3.0	8.0	13.7	21.0	19.6	16.4	14.1	15.2	16.4	9.5	9.4	6.8	17.7	36.3	10.9	5.6	19.6	15.3	20.8	11.5	14.3	7.5	9.5	9.8	10.6	10.7	22.4	9.8	12.2	21.8	13.1	26.0	45.1	9.6	18.3	16.0	0.1	0.4	0.3	0.3	0.3	0.2	1.7	0.3	0.6	0.6	0.7	0.4	0.4	0.1	0.4	0.4	0.6	0.5	0.3	1.1	1.0	0.7	1.2	1.5	1.7	2.1	2.4	1.8	1.7	1.6	1.8	3.6	6.4	3.6	12.1	16.9	2.8	2.7	5.2	5.7	5.7	4.5	3.0	4.4	1.5	8.1	3.7	12.5	4.4	6.9	9.3	0.0	2.1	4.6	4.9	8.5	4.0	1.8	15.3	14.1	2.3	4.8	4.2	17.3	6.6	1.3	14.5	2.2	5.4	3.8	3.3	13.0	7.3	0.0	3.1	1.0	3.7	1.8	4.0	1.8	6.5	2.9	3.8	1.0	12.5	11.0	2.9	4.0	0.7	11.2	3.2	5.3	2.5	5.0	3.6	6.6	15.0	5.3	14.2	11.4	8.1	1.8	3.3	3.7	8.0	7.2	2.9
GET3	"ARSA-I, ASNA1, TRC40"	ENSG00000198356	"Guided entry of tail-anchored proteins factor 3, ATPase"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 106.6;Extravillous trophoblasts: 80.7;Hofbauer cells: 142.4;Syncytiotrophoblasts: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		37000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli	Nucleoplasm	"HPA045951: AB_2679511, HPA048087: AB_2680258"	"unprognostic (2.87e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavorable (8.47e-4)"	47.5	61.6	56.4	39.4	58.2	66.2	46.5	59.0	72.8	48.4	62.4	43.0	39.9	49.8	41.0	58.1	47.0	39.3	62.0	59.6	58.4	61.6	38.4	40.8	48.3	55.4	57.3	41.9	48.2	73.3	48.2	28.0	57.9	34.3	28.7	36.4	47.3	31.4	67.6	59.1	38.7	33.9	55.9	43.4	50.9	60.2	58.9	46.9	56.3	58.6	38.1	46.3	43.3	57.3	143.7	116.5	60.7	132.3	118.6	72.4	74.6	72.4	99.7	137.5	107.6	90.3	69.6	64.8	111.0	95.4	157.5	75.2	84.5	97.6	65.4	100.9	132.7	54.3	82.4	105.3	125.8	83.5	104.9	83.6	84.1	111.3	66.1	89.2	99.4	75.9	71.3	86.8	109.5	320.4	112.9	68.1	154.6	92.0	215.6	82.2	93.6	128.4	130.2	120.7	111.6	95.5	97.3	131.3	119.8	51.5	108.2	80.5	85.5	193.3	65.4	217.1	172.4	153.9	279.4	61.7	136.2	137.0	109.0	33.6	44.3	26.3	24.8	34.3	21.2	20.3	22.0	22.2	44.8	17.0	15.7	19.5	15.6	16.7	42.9	29.4	34.2	35.8	56.4	58.2	59.0	72.8	59.6	58.4	55.4	57.3	57.9	55.9	58.9	57.3	14.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	106.6	13.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	80.7	12.5	0.0	0.0	0.0	0.0	0.0	0.0	142.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	110.7	1.7	0.0	0.0	0.0
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Guided entry of tail-anchored proteins factor 4"	Q7L5D6	7	876554-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 36.7;Oligodendrocytes: 15.8;Plasma cells: 37.2;Squamous epithelial cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	25.0	98.0	28.9	12.5	33.7	31.6	26.8	29.7	37.0	28.1	19.1	33.5	20.8	25.5	21.1	43.7	32.1	11.4	33.1	28.8	31.1	68.8	98.4	25.5	15.8	36.1	33.4	34.3	46.1	13.7	70.7	20.5	36.0	37.8	8.8	16.4	28.8	12.3	56.3	46.9	33.6	7.7	29.1	37.5	41.5	79.0	34.0	14.4	34.3	21.9	10.4	31.3	28.9	45.6	78.8	38.1	25.8	38.4	13.2	9.1	81.7	21.2	14.9	26.5	26.6	103.4	95.1	28.5	21.7	12.4	73.7	48.7	29.3	23.3	11.5	11.6	50.9	15.8	31.5	59.5	29.1	27.1	28.1	13.8	27.6	23.4	15.1	19.9	21.1	32.5	103.6	25.7	15.2	59.7	20.8	65.2	93.3	46.1	56.0	43.0	4.5	30.8	23.8	45.4	46.7	50.5	19.5	71.2	32.2	31.5	54.2	47.8	21.4	19.6	43.6	45.7	29.5	38.5	25.9	37.5	20.1	46.2	50.3	22.3	28.5	32.4	23.9	27.6	23.3	24.3	26.4	24.1	29.4	24.5	25.2	27.0	21.9	27.7	35.3	33.3	26.9	24.8	28.9	33.7	29.7	37.0	28.8	31.1	36.1	33.4	36.0	29.1	34.0	45.6	0.3	0.0	3.1	14.7	10.6	1.0	0.3	0.2	14.8	0.8	1.1	0.9	0.6	0.0	2.2	0.0	4.2	1.1	0.7	2.3	0.0	0.9	4.0	2.0	1.1	1.5	0.0	9.2	9.1	0.7	0.7	3.8	36.7	2.8	1.3	1.2	0.0	0.4	0.6	8.4	9.1	2.8	0.0	0.6	0.8	2.7	0.0	6.1	0.0	4.7	0.5	0.2	0.0	10.1	15.8	0.8	1.0	0.0	37.2	0.4	3.6	1.1	2.1	1.4	0.0	0.8	1.8	0.6	1.1	23.5	1.0	1.6	9.9	0.8	1.7	0.8
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"bone marrow: 39.0"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 99.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	20	"basophil: 195.6;eosinophil: 395.8"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 395.8"	"Group enriched"	"Detected in some"	5	"HEL: 168.9;HMC-1: 104.6;K-562: 53.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004420, HPA006291"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.3	0.1	39.0	0.0	0.2	0.2	0.0	0.2	0.5	0.9	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.2	1.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.0	0.1	0.1	0.4	0.5	1.0	0.1	0.1	1.8	0.3	2.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.9	0.3	23.8	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	168.9	0.2	0.1	0.0	0.1	104.6	0.0	1.4	0.0	0.2	0.0	0.0	0.0	53.0	0.2	0.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	195.6	0.3	395.8	0.1	1.9	0.1	0.1	0.1	0.0	1.9	0.2	0.5	0.1	3.9	0.5	15.1	1.0	0.0	12.5	0.0	0.1	0.2	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.0	0.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.8	0.0	0.0	0.1	0.1	0.8	0.0	0.1	3.8	0.0	0.3	0.4	1.2	99.1	0.4	0.0	0.2	0.3	0.0	0.1	14.5	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.0	12.9	0.0	15.8	0.0	0.0	0.6	0.0	0.0	0.5	0.2	0.0	24.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.3	0.2	1.0	0.6	0.1
GFM1	"EFGM, EGF1, GFM, mtEF-G1"	ENSG00000168827	"G elongation factor mitochondrial 1"	Q96RP9	3	158644527-158695581	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034764, HPA034765, HPA061405"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.62e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.78e-2)"	26.7	25.0	12.3	21.7	13.2	24.1	27.8	18.1	21.3	14.1	16.8	30.1	24.9	17.2	20.8	24.1	13.4	17.5	39.0	13.0	15.5	43.7	49.6	18.8	20.7	14.5	13.2	12.7	26.4	40.1	12.0	25.7	15.3	19.6	31.5	46.4	21.0	21.9	63.0	15.2	19.8	20.9	13.7	16.4	23.9	23.5	14.1	16.6	32.1	60.2	20.7	23.5	12.9	15.7	92.2	55.9	25.5	32.0	41.8	30.6	34.2	42.6	49.8	75.9	57.4	73.2	58.7	73.9	54.7	39.2	32.0	55.9	62.5	47.8	84.3	40.6	33.7	56.1	34.6	34.3	48.6	76.7	35.9	37.3	55.7	43.8	41.0	17.6	50.2	43.0	71.7	50.3	67.9	56.9	49.6	30.6	55.7	97.0	29.8	49.8	28.0	132.6	51.0	38.3	48.9	42.8	63.8	96.1	79.1	19.9	132.1	60.0	28.0	46.4	21.0	69.4	74.1	82.7	61.4	138.9	41.8	65.0	52.4	18.9	19.3	13.8	22.2	27.2	28.6	17.0	19.3	23.0	23.3	16.4	22.1	23.9	3.0	25.4	22.0	11.2	17.4	18.4	12.3	13.2	18.1	21.3	13.0	15.5	14.5	13.2	15.3	13.7	14.1	15.7	31.4	19.2	19.0	17.0	26.1	21.5	26.0	20.9	20.5	57.3	23.0	11.9	54.8	22.8	18.9	12.9	31.3	31.6	20.1	22.2	11.7	19.9	15.4	12.4	20.2	36.6	19.3	29.0	39.8	25.0	17.6	20.9	22.4	14.8	19.0	17.7	22.5	61.6	29.0	15.2	43.9	24.5	30.5	20.4	21.5	7.6	22.7	21.7	17.8	18.7	33.8	27.3	16.5	22.6	43.3	20.3	10.5	17.0	19.2	21.7	22.1	37.9	25.1	51.6	13.1	21.5	23.4	34.4	31.6	20.1	21.0	30.8	22.3	41.4	28.9	22.0
GFM2	"EF-G2mt, EFG2, FLJ21661"	ENSG00000164347	"GTP dependent ribosome recycling factor mitochondrial 2"	Q969S9	5	74721206-74767147	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036863, HPA069871"	Uncertain		Approved	"Nucleoplasm,Midbody ring,Mitochondria"		Yes	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Nucleoplasm, Midbody ring"	"HPA036863: AB_2675354, HPA069871: "	"unprognostic (2.58e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (9.55e-2)"	"unprognostic (4.15e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.82e-2)"	9.6	18.1	9.7	10.2	10.5	15.0	14.1	10.2	14.5	10.7	16.1	13.9	9.3	11.1	17.4	11.9	23.4	9.0	33.3	10.8	10.7	23.3	34.0	9.0	12.2	9.5	9.1	11.4	10.0	30.4	10.7	13.5	10.0	13.0	15.8	16.8	13.4	11.2	30.6	11.3	10.8	10.8	9.4	8.5	17.9	15.8	10.2	17.2	13.1	38.5	15.5	12.9	7.0	11.1	39.5	34.3	27.2	52.2	20.3	27.1	28.2	41.5	24.7	41.5	44.1	36.4	24.9	39.7	44.9	21.9	65.7	32.1	55.0	59.6	54.8	34.8	35.5	22.9	31.7	27.0	27.1	23.6	26.0	32.1	26.3	33.6	40.5	29.8	30.3	39.4	40.7	32.9	48.5	23.3	32.1	15.1	11.4	14.8	29.7	41.1	43.5	49.3	32.0	24.7	46.6	24.8	46.3	38.1	44.3	30.1	33.0	44.0	24.0	16.2	27.8	20.5	27.2	19.0	38.3	40.1	24.1	34.2	24.6	22.8	6.9	9.2	6.7	7.2	6.6	8.3	5.5	7.5	6.7	7.2	7.5	7.3	3.5	16.0	11.8	4.4	7.0	5.2	9.7	10.5	10.2	14.5	10.8	10.7	9.5	9.1	10.0	9.4	10.2	11.1	6.4	12.8	12.9	19.9	8.5	6.0	7.1	13.0	8.6	9.1	7.7	6.9	11.0	7.2	12.5	7.3	6.2	20.1	7.5	8.9	21.5	9.5	11.5	42.4	9.2	6.4	5.4	17.9	35.7	5.3	15.9	6.3	15.3	13.7	2.5	10.4	5.3	22.4	9.9	16.8	34.1	9.7	30.5	8.5	2.4	2.6	7.2	6.8	8.8	13.1	17.9	13.0	7.2	34.2	29.1	9.8	9.9	7.5	11.4	4.6	8.5	11.2	61.5	9.6	0.0	5.6	7.8	15.2	11.7	10.0	7.0	16.0	7.3	11.1	10.0	7.5
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.9;Cardiomyocytes: 108.2;Excitatory neurons: 133.2;Inhibitory neurons: 106.2;NK-cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.5;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.5;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEL: 30.5;HMC-1: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	10.5	2.0	14.3	2.8	21.6	12.7	9.6	11.2	26.1	5.0	0.0	6.2	1.8	3.6	0.8	8.6	4.4	4.3	16.7	24.5	3.7	2.3	7.2	9.7	4.3	3.0	1.5	1.5	1.5	1.7	3.5	3.9	2.3	4.0	2.8	2.1	3.6	1.4	12.0	5.5	6.5	4.9	0.6	8.8	7.9	0.6	2.5	3.0	2.7	9.7	4.2	6.2	5.8	16.9	12.5	1.3	1.0	2.1	1.7	1.8	1.3	1.0	0.5	0.7	0.4	0.4	0.9	16.8	16.6	1.2	1.0	10.9	3.4	5.4	0.7	1.2	6.0	30.5	7.2	6.6	2.4	9.0	46.3	0.9	4.1	1.6	4.5	2.6	9.5	4.5	0.9	1.5	1.3	4.1	2.0	5.2	1.8	4.3	3.3	6.9	2.1	8.8	0.6	2.4	5.5	1.0	4.0	0.7	4.0	2.1	0.9	0.9	12.2	1.6	3.2	3.5	5.6	13.4	8.3	19.8	1.4	5.3	0.4	0.2	0.4	15.5	1.5	0.9	0.2	2.7	0.2	0.7	0.2	1.9	0.1	0.5	0.3	13.1	0.9	0.1	0.1	1.0	14.3	21.6	11.2	26.1	24.5	3.7	3.0	1.5	2.3	0.6	2.5	16.9	100.9	0.0	1.8	33.0	14.3	20.3	4.9	14.5	19.9	43.8	7.4	3.7	108.2	10.0	14.4	0.0	0.0	1.5	46.1	18.2	0.0	5.3	0.1	3.8	1.0	49.0	8.4	31.2	133.2	3.1	34.7	9.1	2.0	8.0	4.5	0.2	51.4	19.5	2.5	1.7	106.2	11.2	8.2	15.7	31.3	0.3	2.5	21.4	12.4	42.2	4.7	2.1	142.2	58.8	56.6	30.5	31.7	1.2	14.5	3.1	10.6	0.3	13.6	2.7	13.1	19.9	17.5	0.0	3.3	34.6	22.4	0.7	23.4	1.0	4.4	4.7
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719339	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	12.5	12.2	13.4	6.9	13.8	16.6	12.6	27.4	14.8	17.6	13.4	11.8	11.7	10.8	5.5	33.5	13.0	7.9	7.2	13.0	13.9	12.4	40.8	9.3	8.7	11.3	12.9	6.4	8.9	12.0	13.2	14.7	13.6	10.9	9.3	8.1	12.7	7.3	9.2	16.7	9.2	9.2	8.8	18.5	8.0	11.1	12.6	8.1	10.3	7.1	12.9	10.9	26.3	11.5	15.8	25.1	15.1	31.0	14.9	11.3	18.1	12.7	16.5	23.3	23.9	21.5	13.9	26.6	11.8	14.8	12.6	19.4	15.6	14.9	19.3	16.2	20.1	6.7	14.5	30.4	11.4	11.0	12.5	9.1	16.9	31.0	9.2	11.7	34.5	26.9	14.1	4.9	13.2	33.0	18.2	13.4	20.7	9.4	13.8	28.7	8.9	20.8	14.5	21.5	30.4	18.4	31.6	10.5	9.6	8.7	15.9	7.3	26.4	17.8	18.1	16.3	13.0	13.2	19.8	29.0	11.1	15.8	13.3	0.5	4.8	5.2	4.4	2.9	7.2	6.3	7.7	7.9	4.8	7.0	6.6	5.3	9.0	5.9	3.1	5.4	9.2	3.7	13.4	13.8	27.4	14.8	13.0	13.9	11.3	12.9	13.6	8.8	12.6	11.5	36.1	0.0	8.4	8.5	7.7	22.9	15.8	8.1	15.9	13.7	21.7	12.4	5.3	15.7	10.9	11.0	14.6	10.3	10.6	23.8	5.9	21.1	89.6	22.5	10.9	33.8	43.2	56.6	18.3	11.6	24.1	10.4	3.6	8.7	4.5	12.2	31.1	46.7	6.6	21.9	16.8	17.0	16.2	7.5	10.0	29.9	8.7	4.6	8.8	6.5	5.2	12.0	11.3	8.5	7.3	15.8	14.2	11.3	9.1	12.4	20.6	13.0	24.5	11.0	6.6	11.9	11.4	19.9	14.8	10.1	27.3	22.2	10.3	9.3	18.3	21.3
GFPT1	"GFA, GFAT, GFAT1, GFPT"	ENSG00000198380	"Glutamine--fructose-6-phosphate transaminase 1"	Q06210	2	69319780-69387250	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Aminotransferase, Transferase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 184.2;Intestinal goblet cells: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047240			Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA		93000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli"	"Nucleoli fibrillar center"	"HPA047240: "	"unprognostic (4.38e-3)"	"unprognostic (8.20e-2)"	"prognostic favorable (7.13e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	31.2	17.9	6.6	21.5	6.5	15.0	22.4	5.5	7.1	37.8	31.5	74.3	38.4	15.6	41.6	16.4	24.3	32.5	24.8	7.0	11.0	21.6	23.1	17.0	10.6	4.9	10.5	12.0	33.7	26.2	18.9	36.0	10.8	36.7	76.6	10.4	42.4	25.9	10.2	6.0	41.2	23.2	5.3	9.5	64.3	46.6	8.0	10.2	91.8	13.9	15.9	21.8	9.2	6.8	46.6	42.7	34.7	20.9	107.7	75.8	73.5	97.1	94.5	44.7	59.3	109.5	50.5	31.7	31.9	92.9	61.4	22.6	47.1	28.6	73.6	38.4	18.4	38.2	25.0	94.5	123.0	27.9	17.9	47.8	132.5	88.7	158.8	55.5	43.4	29.8	34.8	58.3	85.2	30.9	31.3	22.9	37.0	116.7	27.4	28.2	79.1	18.3	70.6	42.0	25.2	11.9	35.2	52.4	93.7	73.5	22.7	17.2	61.8	37.2	62.3	64.6	47.5	39.5	32.2	25.4	65.7	18.3	46.9	9.2	3.5	4.9	7.5	4.3	7.0	6.4	6.5	8.3	4.7	3.6	6.3	6.2	1.2	5.2	5.2	4.4	5.0	4.2	6.6	6.5	5.5	7.1	7.0	11.0	4.9	10.5	10.8	5.3	8.0	6.8	14.6	51.3	49.5	15.7	29.8	28.4	21.6	31.7	26.7	13.7	50.6	16.5	43.1	42.9	54.5	44.1	12.5	28.6	30.3	184.2	17.6	34.1	123.9	54.4	54.1	17.2	75.1	3.8	49.2	89.5	70.3	37.6	110.1	60.0	24.1	19.2	17.9	53.6	17.0	6.7	56.3	244.0	16.2	10.0	31.4	23.7	23.3	16.0	53.4	27.2	28.1	10.6	13.4	42.7	43.8	66.0	83.3	28.2	82.1	72.3	62.5	30.0	89.7	14.0	19.7	21.6	41.8	134.1	45.3	20.3	21.0	34.3	33.4	15.7	135.3	56.3
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273284	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		140000		"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA043829: AB_2678689"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	10.9	3.4	7.2	4.2	14.9	0.0	23.2	2.6	9.5	9.9	0.3	18.3	1.7	4.9	20.5	6.9	17.2	5.6	4.8	9.7	18.0	6.0	16.0	2.8	4.0	7.8	28.5	4.5	6.6	2.7	3.2	0.0	7.2	4.5	3.9	3.2	6.0	5.4	4.3	7.2	8.2	4.8	6.2	3.9	8.2	3.1	7.6	4.1	2.8	13.9	6.4	7.0	9.2	6.1	0.1	3.7	12.2	0.0	0.0	0.1	0.0	7.9	0.4	44.7	77.2	0.0	0.0	0.0	46.5	89.3	0.0	0.0	0.1	0.0	63.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	11.5	0.0	3.9	0.0	9.1	0.0	0.0	5.6	59.5	7.6	0.0	5.0	0.0	0.0	0.0	1.9	0.0	5.0	0.0	1.6	0.1	0.0	0.0	0.1	2.1	0.4	0.0	0.4	0.0	0.4	0.1	53.5	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	14.9	2.6	9.5	9.7	18.0	7.8	28.5	7.2	6.2	7.6	6.1	6.1	0.0	0.0	40.5	0.5	5.7	0.0	0.0	1.8	4.1	33.1	11.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	13.2	0.0	0.2	3.2	6.0	0.0	5.1	13.5	0.0	51.2	3.1	0.0	6.3	0.1	0.4	42.2	0.0	0.0	6.6	0.0	0.0	1.0	9.6	12.8	8.1	1.0	5.4	1.9	0.0	12.6	0.0	91.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	100.1	16.7	0.1	10.4	0.7	4.5	0.0	0.7	0.1	0.0	0.2
GFRAL	"bA360D14.1, C6orf144, GRAL, UNQ9356"	ENSG00000187871	"GDNF family receptor alpha like"	Q6UXV0	6	55327469-55402493	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047372	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA						"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA047372: AB_2680017"															"unprognostic (2.31e-1)"			0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GFUS	"FX, P35B, SDR4E1, TSTA3"	ENSG00000104522	"GDP-L-fucose synthase"	Q13630	8	143612618-143618048	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 32.1;Cytotrophoblasts: 82.1;Extravillous trophoblasts: 156.4;Hofbauer cells: 69.9;Syncytiotrophoblasts: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		850000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	36.3	37.2	21.6	27.7	21.1	52.3	34.0	21.4	25.9	28.6	21.7	45.9	69.2	24.8	19.2	88.7	24.0	29.3	32.1	20.7	21.3	37.5	86.6	28.4	29.1	23.5	21.9	19.0	99.5	22.8	44.0	24.4	22.8	45.0	37.6	6.5	70.9	24.2	30.2	81.5	52.4	19.4	20.2	35.7	111.4	49.4	21.0	26.6	32.1	18.4	27.1	31.0	36.0	22.5	85.6	67.1	29.2	99.7	28.6	26.1	54.1	70.3	73.0	50.2	38.1	78.5	94.3	37.5	64.6	52.5	21.2	60.6	47.8	100.8	23.2	101.7	53.8	58.7	103.0	93.4	57.2	42.2	67.1	30.3	47.4	31.7	127.3	42.2	84.3	61.9	66.4	57.0	41.2	267.5	39.8	53.2	45.8	267.7	87.1	47.1	26.3	122.3	106.1	94.8	67.3	45.9	53.3	100.2	73.0	23.0	133.5	58.8	75.5	34.8	132.0	35.1	67.6	34.1	30.2	29.0	52.8	91.6	54.7	34.9	27.4	42.9	40.3	38.5	43.0	35.2	43.1	46.8	30.1	40.1	31.5	38.5	31.0	63.6	33.8	54.5	57.5	45.7	21.6	21.1	21.4	25.9	20.7	21.3	23.5	21.9	22.8	20.2	21.0	22.5	32.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	82.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	156.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	87.7	1.7	0.0	0.0	0.0
GGA1		ENSG00000100083	"Golgi associated, gamma adaptin ear containing, ARF binding protein 1"	Q9UJY5	22	37608725-37633564	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 179.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.2;Spermatocytes: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048280, HPA051016"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA048280: AB_2680338, HPA051016: AB_2681312"	"unprognostic (1.64e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.16e-3)"	25.0	49.3	35.9	23.3	39.7	37.2	27.3	39.0	42.3	38.0	41.0	35.0	24.3	32.1	21.5	41.1	37.4	20.4	29.5	35.3	35.0	42.4	42.1	33.7	29.1	41.1	37.6	46.3	34.5	33.2	52.7	19.1	38.4	40.0	17.8	22.8	34.9	19.6	43.1	35.7	40.7	16.9	36.1	55.6	34.9	179.3	41.2	26.9	44.7	24.6	21.1	31.6	33.5	45.0	37.4	28.3	32.9	31.1	28.0	23.0	35.4	30.8	25.0	27.0	29.6	23.3	21.8	59.9	20.6	22.9	17.0	35.0	29.4	35.6	24.8	51.0	53.6	24.0	52.3	27.3	28.1	56.1	42.6	28.4	31.3	38.9	24.2	45.1	26.5	30.3	48.0	36.8	27.8	37.7	24.8	64.2	26.2	39.2	28.7	28.5	25.8	25.2	28.8	31.0	30.4	54.0	18.7	39.0	48.9	31.3	42.4	42.0	31.0	36.8	35.2	32.1	24.4	81.1	35.3	62.5	39.9	33.6	30.8	8.1	10.7	6.1	18.0	10.2	22.1	8.3	7.2	23.3	6.7	5.0	5.1	16.5	4.5	11.6	7.9	5.8	8.0	11.5	35.9	39.7	39.0	42.3	35.3	35.0	41.1	37.6	38.4	36.1	41.2	45.0	17.9	25.6	38.5	26.8	50.9	24.2	31.1	36.5	21.1	57.6	26.5	20.8	19.2	20.0	34.5	44.1	83.4	38.8	34.7	67.3	5.9	34.9	148.2	27.6	19.8	32.6	32.4	38.3	18.4	20.1	37.4	18.8	44.4	26.5	49.4	33.3	40.7	20.4	77.1	25.2	19.3	40.4	32.6	66.9	40.3	221.2	26.4	50.5	16.0	20.6	47.9	37.0	73.2	16.6	28.7	36.6	51.6	22.6	24.4	24.7	55.4	13.2	46.7	74.1	26.3	26.9	22.1	193.4	50.4	19.7	28.6	56.8	59.6	44.4	42.8	33.6
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 212.7;Late spermatids: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029472, HPA050727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA029472: AB_10696206, HPA050727: "	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.0	23.5	20.4	17.3	21.4	7.8	34.1	23.0	27.6	24.5	18.5	24.8	21.2	23.3	30.4	22.4	21.2	20.0	23.5	21.1	22.5	27.8	21.7	20.1	21.3	21.8	20.6	23.3	16.4	21.1	17.6	19.2	22.3	29.4	23.9	38.8	31.2	19.7	29.8	20.3	20.6	25.7	22.3	20.5	20.4	48.2	20.9	27.6	27.4	28.9	21.9	23.6	17.0	25.7	41.3	22.3	54.5	41.5	41.7	59.9	20.5	36.2	50.7	23.6	33.1	17.5	64.5	28.1	51.3	40.6	38.1	33.5	29.4	37.8	31.2	28.8	54.4	24.0	19.7	29.9	46.9	30.0	19.7	39.3	66.5	32.2	43.0	41.8	42.5	46.2	58.5	24.7	31.5	24.6	37.0	35.7	46.4	109.9	11.5	22.6	17.3	32.6	66.2	22.4	43.3	59.8	27.3	61.5	54.7	20.1	76.7	46.5	35.9	27.9	20.8	47.6	34.7	42.0	55.8	34.3	35.4	33.3	51.4	43.7	31.0	48.5	31.5	37.3	32.1	38.6	39.5	33.8	30.4	32.8	36.2	33.4	27.8	31.9	54.2	25.2	42.5	36.8	20.4	21.4	23.0	27.6	21.1	22.5	21.8	20.6	22.3	22.3	20.9	25.7	18.3	32.1	34.5	16.3	27.2	39.9	60.4	64.6	27.9	32.1	29.1	22.4	24.5	17.2	39.5	20.2	43.8	30.7	24.1	21.4	72.4	37.5	212.7	16.8	15.1	29.4	17.4	12.0	26.5	28.3	43.7	31.0	14.3	12.9	24.6	16.4	28.9	13.0	26.8	48.8	25.7	26.1	69.2	26.9	49.0	290.7	35.8	24.3	67.6	20.6	36.7	55.4	36.0	15.6	23.2	31.8	23.3	35.0	8.5	65.6	29.3	61.3	30.4	51.2	26.3	26.1	32.5	111.6	50.0	18.7	40.6	47.1	33.0	30.9	22.7	55.9
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872856	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 60.9;Inhibitory neurons: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1900000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	13.2	13.8	37.0	11.8	35.8	5.5	15.4	43.4	43.8	25.6	53.2	19.1	16.0	19.3	29.1	10.1	21.1	18.2	22.3	38.6	33.3	24.9	16.8	14.4	18.2	34.3	28.9	24.1	27.1	22.9	40.5	13.7	33.6	24.8	14.9	22.7	30.8	22.6	67.5	17.9	20.1	14.9	22.5	15.4	22.1	10.1	32.0	15.8	28.8	13.8	13.6	19.7	18.0	35.4	5.2	7.7	38.5	39.5	29.7	26.4	34.2	21.7	21.9	17.5	26.0	40.6	25.5	0.0	25.1	17.1	17.8	3.6	16.8	9.5	11.5	1.8	29.9	15.9	16.0	21.3	26.5	0.8	24.9	38.5	10.6	19.7	9.1	52.2	1.5	20.3	12.0	2.8	12.2	9.1	4.2	8.1	8.9	9.1	3.8	0.1	26.3	25.9	25.3	7.7	22.4	26.1	11.2	17.6	28.2	14.4	13.5	14.2	0.6	59.8	23.6	5.7	12.6	29.6	4.2	1.9	70.4	1.5	22.4	1.4	2.8	1.5	6.9	2.0	2.0	6.1	5.8	2.6	2.5	5.4	11.5	8.2	0.3	3.0	0.7	1.4	5.1	1.8	37.0	35.8	43.4	43.8	38.6	33.3	34.3	28.9	33.6	22.5	32.0	35.4	2.0	3.2	2.7	23.2	6.4	7.4	18.1	14.8	9.1	40.2	9.6	5.8	1.9	32.9	11.1	18.4	12.5	24.2	2.2	14.2	0.0	16.1	3.2	3.3	7.6	2.1	10.8	1.7	60.9	5.6	12.3	14.0	23.4	4.5	2.5	9.0	1.4	12.1	4.5	40.4	58.0	15.2	38.7	3.2	4.4	1.8	12.5	3.2	10.6	17.8	2.8	9.7	4.1	31.2	25.5	6.3	17.8	7.9	1.9	9.3	11.9	6.1	7.2	19.3	6.6	16.0	9.4	13.9	15.5	5.7	4.3	16.8	7.2	17.0	17.9	13.9
GID8	"bA305P22.1, C20orf11, FLJ20602, TWA1"	ENSG00000101193	"GID complex subunit 8 homolog"	Q9NWU2	20	62938147-62948475	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049929, HPA055047"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cell Junctions"	"HPA049929: AB_2680957, HPA055047: AB_2682682"	"unprognostic (1.35e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.19e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.87e-2)"	12.5	13.3	18.8	13.5	18.3	39.2	17.1	18.7	18.3	19.1	16.7	16.6	13.8	16.3	16.8	41.8	20.1	11.1	14.2	19.2	18.6	17.2	24.7	12.7	20.7	17.8	18.4	26.3	20.4	19.0	15.9	13.0	17.4	16.2	14.3	13.0	17.1	14.8	14.8	30.5	15.5	12.5	18.8	16.9	18.1	13.7	19.2	25.3	18.4	13.2	23.1	15.6	22.5	18.3	39.9	25.0	36.6	33.2	29.5	23.1	35.8	21.8	18.2	61.1	27.5	121.4	37.9	49.9	36.5	28.4	25.1	45.2	33.9	45.3	36.9	13.4	16.6	46.5	32.8	58.6	23.2	54.5	37.7	25.6	49.4	26.4	30.4	22.2	30.1	32.5	36.3	21.0	21.3	56.0	65.3	48.4	37.0	66.1	37.0	51.1	68.8	29.9	22.5	55.4	38.0	31.0	51.5	49.9	32.8	27.0	69.5	51.9	30.6	36.4	45.4	28.8	29.9	21.9	27.0	51.2	24.6	26.2	23.5	5.3	9.5	15.4	9.8	8.3	11.6	7.4	10.4	11.1	8.9	8.2	11.2	12.7	13.5	12.3	7.7	6.7	9.9	8.1	18.8	18.3	18.7	18.3	19.2	18.6	17.8	18.4	17.4	18.8	19.2	18.3	33.5	19.2	27.4	11.4	42.7	51.6	46.9	76.6	50.1	23.1	56.4	53.0	30.9	52.9	46.5	40.5	6.2	101.7	48.6	57.3	41.1	44.7	19.1	46.4	27.4	37.7	45.0	71.1	17.7	40.4	105.1	35.1	27.0	40.1	26.6	24.4	46.4	77.7	51.8	16.8	15.0	50.1	50.8	47.9	46.4	19.4	32.9	42.9	24.9	11.2	62.1	28.3	51.5	11.6	14.4	40.8	39.2	42.2	44.0	68.2	55.7	42.5	38.8	16.5	13.1	34.1	30.7	49.1	57.9	82.1	79.8	156.9	45.8	21.6	52.1	71.7
GIMAP2	"DKFZp586D0824, HIMAP2, IAN12, IMAP2"	ENSG00000106560	"GTPase, IMAP family member 2"	Q9UG22	7	150685697-150693641	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 78.4"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 45.0;Kupffer cells: 132.3;monocytes: 74.4;NK-cells: 96.8;T-cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 62.7;JURKAT: 34.9;MOLT-4: 79.5;REH: 34.0;U-937: 32.4"					"Not detected"	"Not detected"			"HPA013589, HPA014746"	Approved		Supported	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Lipid droplets"	Nucleoplasm	"HPA013589: AB_1849666, HPA014746: "	"prognostic favorable (3.50e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.91e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.08e-2)"	11.7	6.9	6.7	40.3	6.6	11.6	11.9	7.1	9.7	10.6	6.5	11.8	12.4	10.7	8.9	4.9	8.3	17.0	8.0	6.3	6.9	6.0	17.0	22.0	78.4	9.2	7.4	16.9	2.1	2.7	2.6	19.6	8.5	5.0	15.7	0.5	6.5	6.2	4.2	5.8	19.4	11.4	8.3	62.1	11.9	1.8	7.4	50.2	6.1	12.3	57.4	15.7	5.2	8.7	1.6	0.0	0.0	0.0	0.6	0.6	0.8	0.0	18.1	2.2	5.1	0.0	23.7	4.2	0.4	1.4	9.8	1.0	0.0	1.0	0.2	19.8	0.0	12.8	0.0	0.5	2.8	9.9	12.6	6.8	1.8	1.7	0.1	5.3	62.7	34.9	0.4	4.9	1.0	0.0	79.5	24.9	0.0	0.0	0.0	34.0	0.6	9.7	0.1	5.9	0.0	0.0	0.1	0.1	6.3	0.0	0.9	25.2	14.2	0.9	0.3	0.2	0.1	5.6	5.5	0.0	2.3	32.4	3.4	15.1	83.8	7.3	93.9	118.3	118.3	15.8	122.0	114.8	47.6	15.8	166.7	124.8	40.7	136.2	121.4	5.7	107.6	130.2	6.7	6.6	7.1	9.7	6.3	6.9	9.2	7.4	8.5	8.3	7.4	8.7	15.5	12.8	2.2	1.0	11.8	3.3	1.9	0.6	1.2	0.1	1.7	1.3	1.1	1.5	1.1	0.0	0.0	0.4	22.8	1.5	0.0	1.6	0.0	3.8	3.8	27.8	0.0	13.5	0.1	0.7	0.7	3.4	1.1	1.1	19.7	1.4	45.0	4.2	38.1	0.0	0.2	4.2	6.1	132.3	11.1	0.1	4.1	38.5	1.8	7.5	74.4	0.9	96.8	2.0	0.3	1.0	2.9	0.7	4.0	2.2	8.4	1.2	4.6	0.1	6.6	1.7	1.1	0.1	0.3	0.5	3.1	0.4	57.7	4.8	3.7	2.5
GIN1	"FLJ20125, GIN-1, TGIN1, ZH2C2"	ENSG00000145723	"Gypsy retrotransposon integrase 1"	Q9NXP7	5	103086000-103120138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037402, HPA061362"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA037402: AB_10672790, HPA061362: AB_2684491"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.08e-2)"	2.2	4.0	1.8	2.9	2.0	0.6	4.3	3.0	3.5	3.4	1.3	2.5	2.5	3.2	3.6	2.2	3.2	1.7	6.7	1.7	2.3	4.3	4.3	2.3	3.6	2.2	2.1	5.4	2.9	5.2	1.1	2.4	2.1	3.5	3.2	7.2	3.0	3.6	7.8	2.4	2.5	2.8	2.2	3.0	3.2	4.7	2.2	4.2	4.1	6.9	3.5	2.7	1.7	3.2	4.0	4.7	5.8	4.0	2.8	7.1	4.4	5.6	3.8	4.0	3.6	2.6	5.3	2.5	5.0	2.2	3.5	4.7	5.4	7.9	5.3	3.3	4.4	3.5	4.2	3.1	5.5	3.5	2.3	2.6	8.7	3.6	7.3	4.8	3.0	4.1	3.3	3.6	6.4	2.9	4.6	2.3	4.6	3.3	7.0	4.0	6.4	6.0	5.3	3.4	5.1	3.2	4.3	2.8	5.6	4.1	8.7	5.9	2.4	4.0	2.5	4.4	4.2	4.4	3.5	3.6	5.3	5.6	3.5	0.4	1.4	2.8	1.7	1.8	2.0	2.6	2.4	2.6	1.7	2.6	2.8	3.0	2.1	2.3	4.0	1.7	4.4	1.4	1.8	2.0	3.0	3.5	1.7	2.3	2.2	2.1	2.1	2.2	2.2	3.2	5.4	9.6	5.3	11.4	6.1	0.9	4.7	12.5	4.0	9.4	3.5	4.4	18.7	2.8	6.5	5.5	0.0	7.7	3.6	2.9	23.5	8.0	1.6	4.3	6.5	3.9	4.2	1.7	9.1	4.3	4.9	4.7	4.1	3.1	16.5	6.1	3.3	4.5	5.5	0.0	12.2	4.0	10.2	3.5	2.0	0.7	5.0	4.8	0.0	4.7	4.8	9.3	5.2	23.1	23.7	4.0	4.7	6.8	2.6	3.6	4.5	8.8	7.6	13.4	6.6	4.0	6.5	23.8	12.2	2.7	2.0	8.2	6.1	5.7	3.6	3.0
GINS1	"KIAA0186, PSF1"	ENSG00000101003	"GINS complex subunit 1"	Q14691	20	25407673-25452628	"Disease related genes, Predicted intracellular proteins"	"DNA replication"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.3;testis: 9.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.2;Erythroid cells: 14.7;Extravillous trophoblasts: 17.9;Late spermatids: 21.9;Spermatocytes: 14.2;Spermatogonia: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051185	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051185: AB_2681378"	"unprognostic (6.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (5.86e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.42e-11)"	"unprognostic (5.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.55e-1)"	0.7	0.6	0.9	3.2	0.8	3.4	1.6	1.8	1.0	1.0	0.4	3.2	3.0	1.4	0.7	4.3	0.8	0.8	0.5	0.8	0.5	1.1	1.2	0.5	5.3	0.4	0.5	0.9	0.5	0.6	0.2	2.9	0.6	0.8	3.9	0.8	0.8	0.4	0.5	3.7	2.9	2.0	0.3	1.5	2.0	9.0	0.6	7.3	0.6	0.0	5.9	1.3	1.5	0.9	43.6	38.8	46.5	30.4	2.6	3.5	46.7	18.9	9.1	35.5	37.2	33.7	42.1	53.3	21.0	7.9	26.4	49.0	40.9	34.4	40.7	14.3	14.2	36.7	13.8	41.3	0.9	48.5	16.2	1.7	2.0	33.8	6.9	4.7	19.1	30.1	36.1	33.9	21.2	47.0	75.1	36.0	31.8	30.0	20.0	53.1	53.6	35.7	13.6	28.8	19.4	20.3	19.3	45.3	16.7	26.0	42.9	24.2	8.7	27.7	29.9	18.2	35.1	13.6	41.1	42.0	7.4	46.8	32.0	0.2	0.2	0.1	0.3	0.2	0.1	0.5	0.2	0.1	0.5	0.3	0.1	0.3	0.2	0.4	0.2	0.5	0.8	0.2	0.9	0.8	1.8	1.0	0.8	0.5	0.4	0.5	0.6	0.3	0.6	0.9	0.2	0.0	0.6	1.3	1.5	3.2	1.0	1.5	1.8	1.8	1.1	1.3	0.4	0.0	1.6	1.8	0.0	8.2	0.2	1.9	0.0	1.1	60.2	0.5	1.3	1.1	1.2	14.7	6.4	0.7	17.9	2.0	3.6	1.3	1.3	6.8	0.7	0.7	5.9	0.0	3.7	2.5	0.0	1.6	0.8	21.9	0.6	1.2	0.0	1.0	0.0	1.3	0.0	4.0	1.6	0.4	0.6	1.2	8.9	0.6	0.4	2.1	1.7	0.2	0.0	0.5	1.4	14.2	19.7	5.4	1.4	2.5	0.8	2.0	5.5	0.8
GINS2	"Pfs2, PSF2"	ENSG00000131153	"GINS complex subunit 2"	Q9Y248	16	85676198-85690073	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 163.5;Spermatogonia: 148.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 271.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA057285	Uncertain		Approved	Nucleoplasm		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA057285: AB_2683398"	"unprognostic (3.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.70e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.60e-1)"	1.0	0.9	3.0	5.4	2.8	14.7	3.7	3.0	3.7	1.7	2.2	6.4	4.6	1.6	1.3	4.7	1.1	0.4	0.6	4.5	2.2	0.7	3.0	0.8	9.0	2.3	2.4	1.4	0.9	2.6	0.8	3.0	2.3	1.5	7.0	11.1	1.3	0.8	2.7	3.2	5.3	1.6	2.3	3.0	2.2	9.6	2.3	10.2	1.8	1.0	11.0	1.4	2.1	2.6	50.7	36.2	69.0	28.9	2.0	6.7	18.3	33.8	13.7	49.8	30.5	48.2	32.9	60.0	18.1	12.0	26.0	38.0	73.7	28.1	47.9	20.8	63.9	29.2	25.7	54.6	0.3	20.6	15.6	1.8	3.4	30.0	11.5	6.1	21.6	47.5	82.4	13.8	28.9	107.1	72.7	77.8	38.8	45.0	27.3	100.7	41.5	33.1	16.4	20.9	94.2	30.0	49.4	10.0	10.0	27.3	100.0	28.2	12.8	32.1	42.5	30.6	39.5	25.6	48.3	271.9	18.7	43.4	37.2	0.7	0.2	1.1	1.0	1.0	0.1	1.0	3.3	2.3	1.3	0.7	1.6	1.1	0.9	3.2	2.8	0.8	8.5	1.7	3.0	2.8	3.0	3.7	4.5	2.2	2.3	2.4	2.3	2.3	2.3	2.6	0.6	3.2	0.0	0.7	8.5	9.2	7.4	9.5	4.0	20.3	13.1	18.5	1.0	0.0	3.8	3.7	2.1	35.3	3.1	11.9	3.9	8.2	9.8	1.5	3.3	2.4	3.0	43.3	0.5	1.5	31.8	7.2	5.6	2.7	1.3	21.6	0.0	2.1	23.8	8.4	0.4	14.9	4.1	1.3	6.6	29.4	1.2	3.3	0.0	0.0	1.1	5.6	0.0	1.0	0.6	2.0	4.5	1.9	43.1	2.6	2.4	0.7	1.7	7.5	19.7	4.2	7.9	163.5	148.4	13.8	3.8	12.7	4.2	2.2	33.6	7.4
GINS3	"FLJ13912, PSF3"	ENSG00000181938	"GINS complex subunit 3"	Q9BRX5	16	58295080-58406147	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 146.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041216, HPA048209"	Uncertain		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA041216: AB_10794989, HPA048209: AB_2680314"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.34e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.14e-7)"	"unprognostic (9.76e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.07e-2)"	4.3	7.4	2.0	4.2	4.2	8.4	3.7	3.7	2.6	3.7	2.2	5.8	3.2	2.8	3.7	9.1	2.4	1.5	6.2	2.4	2.5	2.5	2.6	2.1	7.8	3.0	3.5	1.3	1.7	3.7	2.0	3.7	2.7	2.2	4.2	1.8	3.4	4.6	1.8	4.5	2.8	3.8	2.8	5.4	2.6	6.8	3.2	8.8	1.9	4.9	8.0	3.0	6.7	2.7	20.2	22.4	26.5	14.3	2.9	3.7	13.3	22.4	9.8	35.4	26.8	16.9	20.2	35.0	17.5	7.6	26.3	18.7	24.5	18.8	39.6	19.5	30.4	20.4	12.0	20.5	1.6	26.1	33.7	4.2	3.5	18.4	6.3	7.9	24.4	28.9	33.5	14.4	15.0	20.9	48.1	24.2	24.5	17.2	45.3	82.6	29.4	44.4	12.8	12.6	30.3	20.1	37.3	24.3	12.8	10.6	12.9	21.4	10.4	23.5	27.8	14.2	28.4	14.3	20.2	146.3	16.2	26.1	29.3	0.1	1.8	0.1	1.9	1.6	1.5	2.5	1.6	2.9	4.1	4.4	1.5	2.5	0.4	4.1	1.0	8.2	2.4	1.5	2.0	4.2	3.7	2.6	2.4	2.5	3.0	3.5	2.7	2.8	3.2	2.7	3.9	0.0	2.6	9.1	3.2	1.8	4.9	2.7	4.0	1.5	2.0	1.7	4.1	0.0	1.4	0.0	2.1	9.1	4.5	1.6	0.0	3.7	20.7	1.8	2.1	4.3	0.0	12.4	0.6	2.0	7.6	2.5	1.5	7.9	1.3	6.9	3.6	0.8	2.8	5.0	0.2	0.9	0.0	1.6	1.1	9.2	1.5	1.9	1.8	2.8	2.6	1.8	2.1	5.0	1.2	1.9	0.3	1.2	6.2	1.7	0.2	0.5	1.1	1.8	6.6	1.6	3.0	4.6	8.7	13.0	2.4	3.1	2.4	3.2	2.8	4.9
GINS4	"MGC14799, SLD5"	ENSG00000147536	"GINS complex subunit 4"	Q9BRT9	8	41529218-41545030	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.2"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024663, HPA026580"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Centrosome	"HPA024663: AB_1857224, HPA026580: AB_1857225"	"unprognostic (7.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.25e-3)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-5)"	"unprognostic (2.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.22e-1)"	0.8	0.8	0.9	4.0	1.2	5.9	1.8	1.5	1.1	0.9	0.9	2.1	1.6	1.4	0.7	1.7	0.8	1.5	0.7	0.9	0.9	0.6	1.4	0.7	5.1	1.4	1.0	1.1	0.9	0.6	0.2	2.6	1.2	0.7	3.0	0.8	0.8	0.5	0.5	2.1	1.7	1.5	0.5	1.7	1.3	2.9	1.0	6.2	1.3	0.1	6.0	1.2	0.8	2.3	20.3	28.3	39.4	17.9	2.4	3.1	16.4	28.1	16.9	28.8	33.6	26.4	17.3	28.1	11.2	14.3	21.6	15.0	32.1	23.4	41.9	10.4	17.8	40.8	20.6	17.9	0.6	8.9	20.2	1.7	1.1	47.2	10.4	6.6	14.4	33.0	20.3	9.0	20.4	13.8	37.6	10.1	22.0	21.5	15.4	34.4	36.8	11.8	10.3	19.1	12.2	9.5	20.3	8.8	8.1	19.9	22.8	9.9	10.0	19.3	28.9	36.1	28.8	10.6	16.4	33.0	13.8	20.9	48.3	1.5	0.7	0.3	1.5	0.7	0.9	1.2	2.5	1.0	0.3	2.8	1.5	1.0	1.9	1.4	0.3	2.9	3.7	1.0	0.9	1.2	1.5	1.1	0.9	0.9	1.4	1.0	1.2	0.5	1.0	2.3	1.3	0.0	1.1	0.7	6.4	2.8	2.8	2.3	1.2	4.0	2.1	4.3	0.8	0.0	1.3	9.2	2.1	9.1	5.6	3.7	0.0	1.8	0.9	2.0	2.3	1.9	3.5	9.9	0.2	1.8	12.4	3.5	4.1	3.7	1.3	17.5	1.1	0.5	4.8	0.0	0.7	4.0	4.1	1.8	9.4	0.6	1.2	5.7	0.0	0.0	9.6	1.7	3.1	0.0	2.5	2.1	0.3	2.2	9.2	1.2	0.5	0.9	0.3	2.5	0.0	3.6	5.9	9.6	11.8	2.5	1.1	5.9	6.9	9.0	6.0	1.6
GIPC1	"C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2"	ENSG00000123159	"GIPC PDZ domain containing family member 1"	O14908	19	14477760-14496149	"Human disease related genes, Predicted intracellular proteins"			"Congenital muscular dystrophy, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 345.8"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 501.1;Pancreatic endocrine cells: 296.7;Paneth cells: 285.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043958, HPA061786"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		11000	"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA043958: AB_10963436, HPA061786: AB_2756319"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	51.0	54.8	80.0	22.4	91.5	3.3	54.3	88.7	94.4	99.8	64.7	120.2	24.7	53.7	17.6	345.8	48.9	23.4	66.1	74.5	82.1	104.1	58.4	76.3	15.9	89.4	91.4	34.4	43.5	20.8	56.0	28.7	88.1	63.6	41.1	17.9	100.9	31.0	65.1	150.2	45.5	17.5	82.0	37.7	78.7	24.9	91.1	18.6	55.8	23.3	21.0	74.1	140.1	92.3	328.1	148.6	44.7	70.6	40.6	40.7	35.2	119.7	59.8	96.7	87.3	80.3	120.6	4.7	220.3	85.2	64.6	183.8	38.7	100.6	32.6	33.8	69.0	63.9	100.7	79.7	123.7	6.9	75.3	46.7	98.5	58.8	51.3	57.4	66.0	47.2	30.1	54.4	49.9	243.8	21.3	13.3	48.6	182.1	147.8	21.7	37.4	43.7	121.6	281.6	41.8	46.2	67.1	163.2	157.0	23.1	102.5	35.1	115.4	135.7	74.6	191.7	130.1	50.5	70.5	17.3	113.9	51.9	146.2	3.0	0.7	0.1	5.1	1.1	4.7	1.9	5.1	5.1	1.1	0.8	4.2	3.3	0.3	1.5	0.5	3.6	12.0	1.7	80.0	91.5	88.7	94.4	74.5	82.1	89.4	91.4	88.1	82.0	91.1	92.3	30.6	28.9	15.2	22.9	8.3	113.9	77.4	52.1	35.9	69.8	73.6	31.6	14.8	37.1	62.8	82.8	35.5	36.3	19.3	501.1	52.8	167.9	1.1	92.2	30.5	32.4	43.1	1.7	28.8	164.3	77.1	32.6	69.3	76.8	10.2	37.3	23.2	18.0	55.9	75.7	32.2	87.8	42.7	10.8	29.8	2.4	20.5	16.1	58.7	10.3	23.4	73.3	18.6	17.1	71.6	296.7	285.4	25.2	6.8	120.4	36.0	52.7	38.0	46.0	19.7	18.1	44.5	6.4	20.4	107.0	169.8	25.7	22.9	47.7	138.1	199.7
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.0;kidney: 41.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 122.1;Proximal tubular cells: 267.7;Undifferentiated cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.1;HaCaT: 6.0;Hep G2: 23.0;HUVEC TERT2: 23.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	3.9	23.8	0.5	1.7	0.4	0.3	3.0	0.4	0.5	1.8	0.5	15.6	38.0	2.1	0.9	2.1	3.1	5.5	1.5	0.5	0.4	41.4	18.4	2.7	0.8	0.4	0.4	2.4	18.1	2.3	0.9	3.5	0.4	1.7	14.9	0.1	4.2	0.9	1.1	4.7	38.0	2.8	0.4	27.9	6.0	1.0	0.5	0.4	1.0	1.6	0.8	2.0	1.9	0.4	0.0	0.0	0.0	0.1	2.4	6.1	0.0	1.0	0.0	0.5	1.1	5.1	3.3	1.5	0.1	0.5	0.0	6.0	0.0	0.0	3.2	0.2	0.0	0.8	0.0	23.0	1.2	0.0	0.0	1.0	0.1	3.5	0.1	0.0	23.5	0.0	0.0	0.1	2.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.4	33.6	0.0	1.3	2.0	2.0	12.9	2.4	0.9	4.0	0.4	5.2	1.5	3.2	27.1	2.5	9.2	2.1	6.7	0.0	43.7	33.2	11.8	2.5	13.3	0.9	21.6	3.0	0.4	14.7	33.0	3.1	2.9	8.6	7.2	0.0	5.9	22.9	43.3	13.2	0.0	15.2	34.4	0.0	0.8	1.9	1.2	1.2	2.1	0.0	14.0	1.0	0.0	0.0	4.5	8.9	16.5	39.3	0.0	0.0	0.8	122.1	267.7	11.7	0.5	0.0	1.3	1.3	0.6	2.5	7.9	21.7	1.6	1.3	32.4	63.8	6.0
GIPC3	"C19orf64, DFNB15, DFNB72, DFNB95"	ENSG00000179855	"GIPC PDZ domain containing family member 3"	Q8TF64	19	3585478-3593541	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.7"	"Group enriched"	"Detected in some"	4	"Adipocytes: 10.4;Endothelial cells: 6.2;Hepatic stellate cells: 12.8;Rod photoreceptor cells: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 19.0;HMC-1: 11.8;THP-1: 23.1;WM-115: 44.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067765			Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA067765: "	"unprognostic (1.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.06e-2)"	4.6	2.2	1.4	1.0	1.0	0.3	2.8	1.0	1.1	3.0	0.8	1.9	1.2	2.8	2.9	5.2	2.1	2.1	3.9	1.2	1.2	3.6	1.4	3.8	2.4	1.6	1.2	0.7	0.7	2.7	1.0	1.1	1.6	3.5	1.4	16.7	0.7	2.3	1.7	1.1	4.4	8.3	1.4	3.9	2.0	0.3	1.6	3.1	3.0	1.9	1.6	1.1	1.8	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.9	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.4	0.0	1.5	0.0	0.2	6.9	19.0	0.0	0.7	0.0	11.8	0.2	0.0	1.1	0.0	0.0	2.1	0.2	3.2	0.0	0.3	0.0	0.0	1.1	0.7	0.0	1.2	0.5	0.0	0.8	0.0	0.0	0.0	0.1	0.5	0.0	4.7	1.1	0.0	23.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	44.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	1.0	1.1	1.2	1.2	1.6	1.2	1.6	1.4	1.6	1.1	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.4	0.1	0.3	2.4	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	12.8	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.8	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.2	1.1	0.0	0.4	0.1	0.3	0.1	0.3	0.1	0.0	0.1
GJA1	"CX43, GJAL, ODD, ODDD, ODOD, SDTY3"	ENSG00000152661	"Gap junction protein alpha 1"	P17302	6	121435595-121449727	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cancer-related genes, Cataract, Disease variant, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Astrocytes: 276.2;Basal keratinocytes: 234.9;Cardiomyocytes: 199.7;Endometrial stromal cells: 215.5;Granulosa cells: 494.3;Suprabasal keratinocytes: 378.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 462.7;HUVEC TERT2: 362.3;NTERA-2: 365.8;SuSa: 453.4;U-87 MG: 350.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010753, HPA035097, HPA047551, HPA069245"	Enhanced	Supported	Supported	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cell Junctions"	Nucleoplasm	"CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: "	"unprognostic (3.37e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.00e-3)"	121.2	287.6	313.5	24.7	310.2	0.9	60.6	260.1	409.0	261.7	193.1	17.5	18.2	98.7	10.6	74.9	32.7	99.9	168.9	273.6	362.6	21.2	10.6	67.9	21.1	340.3	380.9	43.5	19.4	236.2	31.3	290.2	307.4	83.3	19.7	3.3	35.6	148.0	10.3	388.2	24.7	112.5	335.9	4.2	30.7	36.9	373.3	24.3	169.1	22.1	34.9	116.0	184.9	341.0	0.1	43.5	186.8	0.4	99.7	61.5	0.4	142.5	286.9	46.9	113.7	0.7	0.4	0.0	15.8	55.8	40.2	18.3	5.1	87.4	151.3	0.1	51.6	2.3	15.7	0.0	124.1	0.0	0.4	164.6	92.1	172.5	61.7	462.7	362.3	0.0	0.1	4.3	9.4	8.4	0.1	80.6	365.8	0.1	47.2	0.1	0.0	3.7	188.6	21.0	0.4	2.9	0.0	0.3	0.1	453.4	14.9	0.3	269.5	143.8	39.4	122.8	93.5	0.1	0.1	0.1	350.4	0.1	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.5	310.2	260.1	409.0	273.6	362.6	340.3	380.9	307.4	335.9	373.3	341.0	152.2	250.0	80.0	276.2	0.1	234.9	133.6	71.1	77.4	0.3	9.5	20.1	199.7	0.0	17.5	1.8	2.1	53.4	0.4	0.0	0.0	76.9	0.5	21.5	215.5	166.6	0.0	0.0	0.3	4.2	7.9	124.4	0.5	51.7	8.8	494.3	33.9	0.1	8.6	0.0	0.6	0.0	4.1	0.9	55.3	1.7	2.5	3.6	44.4	15.0	0.6	0.3	0.0	4.0	1.0	10.8	0.0	4.1	0.1	29.7	0.0	0.1	6.2	0.3	0.0	5.9	80.2	0.9	1.8	68.3	378.2	20.0	4.9	127.1	0.4	52.7
GK5	MGC40579	ENSG00000175066	"Glycerol kinase 5"	Q6ZS86	3	142157527-142225592	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042606, HPA057998"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA042606: AB_10795509, HPA057998: AB_2683573"	"unprognostic (7.79e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.59e-3)"	4.6	7.0	2.3	3.8	2.4	7.8	6.8	4.8	2.7	5.0	7.0	6.8	9.4	5.4	9.0	4.3	6.0	3.2	2.4	2.3	2.4	3.6	2.1	3.8	2.2	4.4	3.1	8.6	4.0	3.1	5.8	1.7	4.0	8.4	7.3	4.7	11.0	4.0	2.5	5.9	8.0	3.3	2.9	2.2	5.2	3.2	3.0	2.1	4.6	1.5	2.4	4.2	4.4	4.6	11.2	2.7	3.9	2.6	8.0	15.2	6.7	3.6	2.5	3.9	2.5	4.2	6.0	7.9	3.2	3.5	4.3	4.6	4.5	3.5	5.2	2.9	4.3	5.2	7.1	3.1	4.3	6.1	6.7	6.2	3.0	2.6	3.4	2.5	2.3	9.1	4.6	4.7	7.2	7.2	5.3	5.0	2.5	7.5	3.1	4.9	4.2	2.9	4.1	6.8	3.8	2.8	10.1	10.5	3.3	2.3	14.8	4.0	2.5	3.1	2.6	6.9	4.1	4.9	5.1	8.1	5.6	3.8	5.3	2.0	0.4	0.3	1.5	0.3	0.7	0.2	0.5	0.5	0.3	0.4	0.3	0.6	1.1	1.5	2.6	0.4	0.2	0.2	2.3	2.4	4.8	2.7	2.3	2.4	4.4	3.1	4.0	2.9	3.0	4.6	13.7	38.5	30.7	31.6	6.8	4.0	12.3	3.7	15.9	30.6	26.6	13.6	10.5	17.2	17.3	27.6	29.2	13.1	80.5	37.4	7.9	14.9	2.8	32.7	22.5	9.7	27.9	8.8	37.6	20.4	7.3	15.2	25.0	39.2	8.8	23.2	5.0	11.8	5.6	15.2	44.1	42.0	0.0	10.0	3.9	5.2	33.8	20.2	3.6	15.9	9.3	10.2	127.7	27.6	75.6	19.3	31.6	46.6	34.6	21.5	69.5	6.1	14.1	33.0	26.3	16.0	9.0	4.0	5.9	19.4	4.0	6.8	21.0	21.1	34.5	17.3
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 160.6"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 182.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 21.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;NK-cell: 3.1"	"Group enriched"	"Detected in many"	24	"NK-cells: 3.1;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.9;HaCaT: 52.6;OE19: 123.6;SCLC-21H: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054808, HPA059955"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	1.5	2.1	3.0	2.6	2.1	0.3	7.0	0.1	7.7	5.9	14.7	27.6	5.7	33.9	2.1	3.5	25.6	2.8	1.2	8.5	0.3	20.7	0.6	3.6	0.6	1.0	0.8	13.7	10.6	25.0	14.1	1.5	1.0	34.5	11.7	160.6	9.1	25.2	1.0	9.4	4.0	4.4	0.1	0.6	9.0	8.3	0.7	0.5	22.7	0.2	0.6	6.7	5.0	1.3	16.0	1.6	8.2	4.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	13.3	49.9	0.0	16.3	0.0	6.8	52.6	25.2	0.4	0.0	0.0	23.9	0.0	6.7	0.6	2.2	0.0	28.4	0.3	0.7	0.0	0.0	0.0	0.1	7.6	26.3	0.0	0.0	15.3	4.4	3.0	4.7	123.6	18.2	0.0	0.0	1.5	14.1	11.0	34.9	13.1	11.4	14.2	0.0	1.2	18.4	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.1	0.0	3.1	0.0	0.0	0.0	3.2	0.0	1.2	0.0	0.6	1.2	0.0	0.1	0.9	1.4	0.0	3.1	0.0	0.0	0.0	0.5	3.0	2.1	0.1	7.7	8.5	0.3	1.0	0.8	1.0	0.1	0.7	1.3	0.2	0.0	1.8	0.3	0.4	2.2	5.2	1.0	1.8	6.2	7.2	7.9	1.6	1.5	2.5	0.0	41.7	0.2	3.4	19.5	0.0	2.5	2.1	7.9	22.1	1.2	9.0	0.0	1.6	2.4	1.0	3.6	4.1	2.2	0.0	41.9	0.0	0.2	0.2	5.0	1.2	5.9	0.0	0.0	0.3	6.8	1.2	0.3	5.4	1.0	0.0	10.8	1.0	1.0	0.3	2.2	6.3	0.7	2.2	8.1	3.0	8.4	10.1	182.0	0.0	3.7	2.3	2.6	4.6	1.9	0.9	0.1	2.5	3.4	11.5	2.7
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532467-6645729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 173.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 31.3;Cytotrophoblasts: 79.0;Extravillous trophoblasts: 41.6;Hepatocytes: 120.5;Oligodendrocyte precursor cells: 52.3;Proximal tubular cells: 31.6;Syncytiotrophoblasts: 46.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 235.7;CACO-2: 58.2;HMC-1: 45.6;RPTEC TERT1: 95.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		740000	"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.3	0.3	15.3	1.4	15.5	0.5	0.8	14.7	23.7	0.4	12.9	1.0	0.8	0.4	5.2	3.2	0.7	0.8	0.1	14.8	14.4	38.2	173.5	1.0	1.6	14.0	13.6	0.3	0.1	0.0	4.9	15.2	13.4	0.5	0.4	1.6	1.1	1.0	1.3	4.5	0.8	0.0	13.1	1.2	1.0	3.5	15.8	0.0	5.1	0.1	1.2	1.1	0.1	15.3	0.6	4.9	2.1	25.6	0.2	0.4	235.7	0.1	0.0	0.0	0.1	58.2	0.5	0.3	5.6	0.1	0.7	0.4	0.0	0.7	0.2	1.2	13.4	0.2	0.3	38.3	0.0	0.1	45.6	0.0	0.1	1.8	0.3	1.0	9.0	4.3	0.0	0.5	1.2	1.5	0.9	0.2	27.5	4.6	3.8	1.3	0.0	0.5	95.4	1.0	22.6	11.7	0.0	21.4	0.3	13.9	5.3	0.1	3.0	0.6	0.6	2.6	1.3	1.1	34.4	0.1	0.8	2.4	5.1	0.4	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.3	15.3	15.5	14.7	23.7	14.8	14.4	14.0	13.6	13.4	13.1	15.8	15.3	0.2	0.0	0.0	17.6	1.9	0.0	0.0	0.2	1.2	0.4	1.5	0.6	0.7	11.5	0.1	31.3	0.0	79.0	0.2	0.0	5.9	0.0	12.6	5.4	0.5	0.6	0.0	0.0	21.6	0.2	41.6	0.3	0.0	10.7	0.0	1.1	2.2	120.5	7.0	0.0	15.9	0.0	0.0	2.8	0.3	10.8	0.3	0.4	0.0	1.9	0.0	9.6	0.0	52.3	1.8	0.1	0.0	0.0	15.1	0.0	0.0	31.6	0.0	0.4	0.0	1.7	0.8	4.5	5.1	0.4	0.0	46.0	0.8	0.0	0.0	0.1
GLI1	GLI	ENSG00000111087	"GLI family zinc finger 1"	P08151	12	57459785-57472268	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 11.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 6.5;Leydig cells: 29.5;Peritubular cells: 42.9;Sertoli cells: 13.1;Theca cells: 7.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.2;BJ hTERT+: 16.9;NTERA-2: 14.0;RH-30: 60.6;U-266/70: 16.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009460, HPA065172, HPA068903"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122"	"unprognostic (4.97e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-8)"	"unprognostic (4.59e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-2)"	2.4	1.2	1.3	1.7	1.6	0.5	1.5	3.5	1.9	11.1	0.4	3.0	2.5	9.5	6.6	0.6	3.7	5.5	2.1	1.0	2.1	1.4	0.8	1.6	0.7	1.9	2.4	1.5	0.8	0.0	1.0	0.5	1.7	4.2	4.1	0.0	1.5	2.8	0.6	1.7	3.3	2.4	1.7	0.9	1.9	4.7	4.2	0.3	2.3	1.8	1.0	4.4	3.1	1.1	0.1	9.8	3.2	24.2	0.7	0.1	0.3	0.9	16.9	2.1	2.3	0.3	0.7	3.1	0.0	0.5	2.3	1.7	1.8	1.1	0.4	2.7	0.3	0.1	1.2	0.2	2.7	0.7	1.4	0.8	0.4	3.1	1.0	4.2	0.3	2.2	0.4	7.8	1.0	0.0	0.7	0.5	14.0	0.8	0.9	1.2	60.6	1.7	2.7	0.0	0.1	0.1	0.2	0.1	0.4	2.4	0.0	0.3	0.1	2.2	7.7	0.6	0.3	16.7	1.0	5.7	2.0	1.3	3.8	0.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.1	0.2	0.0	1.3	1.6	3.5	1.9	1.0	2.1	1.9	2.4	1.7	1.7	4.2	1.1	0.4	0.0	0.0	2.0	0.7	0.1	0.4	0.3	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.1	3.5	0.5	0.0	0.0	0.1	0.0	0.1	6.5	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	2.5	29.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	0.1	0.2	0.0	1.3	0.0	0.0	13.1	1.9	1.6	0.3	1.1	0.2	0.6	0.1	0.5	7.8	0.1	0.1
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 10.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 39.5;Fibroblasts: 10.4;Leydig cells: 25.1;Peritubular cells: 30.9;Skeletal myocytes: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.1;hTEC/SVTERT24-B: 13.1;U-2 OS: 17.9;WM-115: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: AB_2686677"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	1.6	1.0	1.9	0.9	2.2	0.0	1.4	1.4	1.3	4.3	0.6	3.4	0.4	4.7	1.2	0.8	2.8	2.1	2.3	1.1	1.9	1.4	0.4	2.0	0.3	2.1	2.1	10.9	0.3	0.1	1.8	0.8	1.8	2.9	0.6	0.0	1.4	1.1	0.9	2.7	1.6	1.9	1.6	0.8	1.6	2.4	1.8	1.3	1.0	0.4	0.3	3.1	2.4	0.9	0.0	10.3	20.1	5.5	3.2	4.0	0.0	5.8	1.8	2.4	2.4	0.0	0.5	0.0	0.9	5.2	0.9	0.3	4.3	0.2	1.9	0.0	2.1	0.4	6.1	0.2	3.8	0.0	1.2	2.3	0.0	13.1	0.0	2.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	1.6	4.3	0.1	2.2	3.5	0.0	0.0	2.0	2.1	3.8	0.0	0.2	4.3	0.1	0.0	5.1	0.0	17.9	2.5	0.0	0.0	0.1	0.0	7.4	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.2	1.4	1.3	1.1	1.9	2.1	2.1	1.8	1.6	1.8	0.9	0.3	0.0	0.0	39.5	0.0	2.0	0.1	0.5	0.6	0.0	0.1	0.9	1.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.1	0.3	6.1	0.5	0.0	0.0	0.7	0.2	0.1	10.4	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.5	2.1	25.1	0.1	0.0	2.8	0.0	0.0	1.0	3.0	0.3	1.0	0.0	30.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.0	3.4	0.1	3.6	0.1	1.7	0.0	0.0	7.9	0.0	0.1
GLI3	"ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV"	ENSG00000106571	"GLI family zinc finger 3"	P10071	7	41960949-42264100	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"Astrocytes: 301.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 47.1;WM-115: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005534	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA005534: AB_1078973"	"unprognostic (2.53e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.48e-5)"	"unprognostic (9.13e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.00e-2)"	6.1	1.9	9.2	3.6	8.8	0.1	8.9	1.0	5.4	7.2	0.0	11.6	1.2	11.8	2.7	3.7	8.2	3.8	1.6	6.3	5.5	1.7	0.3	3.4	0.9	1.7	10.4	13.2	0.7	0.5	1.1	11.9	3.0	5.5	2.9	1.8	2.8	8.2	1.1	8.3	3.4	10.7	0.5	1.1	2.6	1.7	14.4	3.0	4.6	2.3	1.7	4.8	7.3	2.3	0.0	0.0	47.1	0.4	16.9	23.6	3.5	3.1	9.0	9.3	12.8	0.0	0.0	0.0	1.7	22.1	22.7	10.1	8.7	8.9	10.8	0.0	7.0	0.0	6.0	0.0	9.0	0.0	0.1	21.0	12.9	10.6	6.8	5.7	10.6	5.4	0.0	0.2	5.6	5.6	0.4	0.0	20.9	0.0	21.2	12.4	0.1	1.4	0.2	6.4	1.5	0.0	6.3	7.0	4.1	23.8	8.0	0.1	11.3	13.6	18.8	16.0	6.0	0.1	0.0	0.0	7.3	0.2	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.8	1.0	5.4	6.3	5.5	1.7	10.4	3.0	0.5	14.4	2.3	2.9	0.0	7.7	301.3	0.2	23.5	7.2	8.5	31.9	1.6	20.5	27.1	1.8	0.0	2.3	1.8	0.0	21.1	0.5	0.0	0.0	0.0	16.6	2.4	12.6	3.4	0.0	0.0	0.8	0.0	13.6	25.9	0.0	4.6	1.3	10.5	3.9	0.0	3.3	0.0	3.6	0.1	6.1	0.3	6.3	5.4	19.3	0.4	8.8	22.5	0.0	13.6	0.0	8.5	0.7	0.1	0.0	3.4	1.2	6.6	0.0	3.8	1.5	1.1	13.1	17.0	12.1	0.3	2.2	7.9	15.5	34.2	0.7	5.2	0.1	5.0
GLI4	"HKR4, ZNF928"	ENSG00000250571	"GLI family zinc finger 4"	P10075	8	143267433-143276931	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA023131	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytokinetic bridge"		"HPA023131: AB_2671080"	"unprognostic (4.98e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.45e-3)"	"unprognostic (5.03e-1)"	"unprognostic (6.88e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.71e-3)"	11.6	6.6	8.8	4.7	8.2	5.8	10.7	8.3	15.4	12.3	3.3	10.8	6.4	10.3	2.1	12.8	10.2	2.7	13.0	9.6	7.1	13.7	12.0	6.9	5.6	7.4	6.8	13.4	12.6	4.6	9.3	2.0	7.5	13.4	3.7	2.5	9.2	3.9	9.2	12.9	10.4	1.8	5.1	11.6	11.5	10.4	7.5	5.5	10.1	2.0	4.8	11.3	11.1	7.2	6.7	13.5	6.2	9.9	9.9	4.1	7.0	3.9	2.3	2.9	3.5	3.9	19.1	8.7	7.2	6.5	4.2	8.7	3.4	4.3	1.9	15.3	10.3	13.4	7.1	4.6	7.1	4.2	4.3	12.9	2.3	4.0	8.5	6.7	6.4	13.2	7.2	14.1	8.0	18.5	19.7	3.5	5.8	12.8	19.0	11.9	2.9	8.8	7.0	15.0	6.0	7.0	11.7	5.0	8.2	5.7	22.1	1.9	3.6	4.3	12.1	6.2	4.1	18.6	9.7	7.0	7.0	8.0	7.3	0.0	0.3	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.3	0.6	0.2	0.3	1.1	0.0	1.1	0.6	0.2	8.8	8.2	8.3	15.4	9.6	7.1	7.4	6.8	7.5	5.1	7.5	7.2	9.5	0.0	0.0	13.1	11.2	7.4	12.7	1.3	13.6	14.6	10.9	12.2	2.0	12.8	1.1	12.9	20.9	5.0	20.6	15.4	25.4	2.6	6.3	8.2	10.6	6.8	11.5	5.9	7.2	4.0	4.5	9.5	11.7	7.3	4.5	15.8	8.9	7.7	7.2	6.7	8.4	7.6	2.0	10.1	5.7	4.3	16.1	9.9	8.8	12.2	6.9	11.9	13.4	4.5	15.5	3.6	17.9	16.6	8.8	9.4	16.4	20.1	2.3	11.9	6.6	11.2	10.6	13.4	14.7	15.8	10.7	2.9	11.9	14.6	13.7	9.9
GLIS1	FLJ36155	ENSG00000174332	"GLIS family zinc finger 1"	Q8NBF1	1	53506237-53738106	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.1;seminal vesicle: 7.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.6;Excitatory neurons: 28.0;Inhibitory neurons: 13.3;Proximal tubular cells: 4.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Region enhanced"	"Detected in some"		"cerebral cortex: 2.2;hippocampal formation: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.5;GAMG: 5.9;hTERT-RPE1: 4.7;PC-3: 7.3;U-138 MG: 5.1"	"Not detected"	"Not detected"							HPA001409	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA001409: AB_1078974"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.37e-4)"	"unprognostic (1.98e-4)"	1.0	0.1	0.5	0.4	0.5	0.0	1.2	0.2	2.2	5.1	0.0	0.3	0.3	0.9	0.5	0.8	0.8	0.6	1.0	2.2	0.0	4.3	0.0	0.2	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.0	0.0	8.1	0.0	0.0	0.8	7.6	0.1	2.0	0.6	0.2	0.1	0.2	0.8	2.3	0.0	0.2	0.4	0.0	0.0	2.6	4.6	0.3	0.0	0.0	0.0	0.4	2.8	3.7	0.0	2.0	4.5	1.7	1.3	0.0	0.0	0.0	0.1	2.1	5.9	0.0	0.0	0.0	0.5	0.0	1.3	0.0	1.4	0.1	1.0	0.0	0.0	2.5	0.2	2.1	2.0	4.7	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.9	0.1	1.3	0.0	0.0	3.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	2.2	2.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	1.3	0.1	6.6	0.0	0.0	4.0	1.3	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.2	0.1	0.0	0.0	28.0	0.0	0.0	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	1.0	2.9	0.3	0.0	3.6	1.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	1.2	0.1	0.1	0.0	4.8	0.0	0.0	0.0	0.4	0.8	1.8	2.8	0.3	1.7	0.1	0.1	0.1	0.0	0.1
GLIS2	NPHP7	ENSG00000126603	"GLIS family zinc finger 2"	Q9BZE0	16	4314761-4339597	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 22.1;Peritubular cells: 33.8;Proximal tubular cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062755, HPA065406"			Enhanced	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA062755: , HPA065406: "	"unprognostic (2.86e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.59e-5)"	"unprognostic (3.76e-1)"	"unprognostic (5.15e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.59e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.40e-3)"	16.3	23.4	4.4	2.5	4.1	0.1	11.4	5.2	3.9	22.3	3.3	19.2	1.5	20.9	0.7	4.9	17.3	5.6	30.9	3.1	3.8	41.5	3.2	30.6	1.6	5.6	5.6	27.5	13.2	2.3	18.9	4.4	4.3	21.7	0.4	0.7	9.8	4.0	3.0	7.1	7.4	3.3	4.4	4.5	11.9	5.3	5.5	0.2	19.4	0.4	0.5	20.2	11.4	2.5	6.1	12.3	2.0	4.8	1.5	7.2	4.3	6.1	5.3	2.3	1.6	3.2	5.1	0.0	10.8	6.0	2.2	3.7	1.2	5.6	0.1	8.9	0.3	0.0	10.9	1.9	6.9	0.0	0.9	4.1	1.2	1.9	0.9	2.6	1.9	0.1	0.5	2.0	1.3	4.0	0.0	1.2	4.6	0.7	2.2	11.7	2.6	6.7	0.4	0.0	0.9	4.6	6.1	2.9	1.7	0.6	8.2	1.0	3.2	3.2	6.0	36.8	1.9	1.4	0.9	1.5	1.4	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	4.1	5.2	3.9	3.1	3.8	5.6	5.6	4.3	4.4	5.5	2.5	4.8	16.0	9.8	8.5	0.0	5.6	5.4	8.7	1.8	10.6	3.5	2.4	5.9	15.7	5.6	12.9	4.2	0.9	0.1	0.0	19.6	11.8	0.2	1.8	9.0	6.9	0.0	0.0	2.1	8.3	0.9	18.3	0.5	2.1	0.0	2.6	6.8	0.7	0.4	6.7	3.2	0.2	2.0	0.3	6.1	0.9	22.1	0.8	3.6	5.6	1.0	10.4	0.0	4.0	1.3	10.3	0.0	33.8	0.0	5.1	0.0	21.7	3.1	7.3	0.0	8.2	14.6	0.2	3.4	0.7	2.8	1.1	0.7	0.1	0.0	2.8
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;choroid plexus: 20.5"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 649.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 21.5;HSkMC: 29.5;RPTEC TERT1: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA056426: AB_2683128"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	4.3	1.6	5.1	2.1	5.5	0.2	1.9	4.9	4.6	7.8	20.5	2.0	0.7	3.3	2.8	0.5	8.7	6.5	2.9	5.4	10.8	7.8	3.3	3.8	1.1	24.2	18.0	6.6	9.7	2.4	2.4	1.4	11.4	3.3	2.1	1.3	3.1	8.2	1.3	0.8	1.5	2.1	13.7	2.0	1.8	2.8	6.5	0.2	18.6	0.8	0.7	4.0	2.4	13.2	1.0	8.5	2.5	0.0	3.7	9.5	0.4	5.9	21.5	3.1	4.4	1.3	3.4	0.0	4.3	5.5	9.6	0.0	2.0	0.0	6.7	2.5	1.2	0.0	0.4	0.0	11.0	0.9	0.0	29.5	0.0	9.8	1.1	5.8	0.4	0.1	0.0	0.2	2.9	0.4	0.0	1.5	0.2	0.0	0.8	0.0	5.2	0.0	20.8	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	5.5	3.4	0.9	3.2	13.3	0.0	0.0	0.0	8.1	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	5.1	5.5	4.9	4.6	5.4	10.8	24.2	18.0	11.4	13.7	6.5	13.2	8.1	9.6	24.0	649.7	1.0	1.9	9.3	17.1	0.6	1.0	4.6	1.3	1.6	75.8	34.5	69.9	0.0	3.2	0.3	3.7	0.0	51.0	5.2	79.6	17.5	11.2	43.7	0.0	18.3	22.6	3.2	21.9	4.1	82.3	1.3	1.6	6.8	8.3	2.4	0.0	54.2	1.6	12.2	0.8	4.0	2.4	13.7	3.4	3.6	86.2	2.2	15.6	0.0	26.7	4.1	49.1	3.9	11.3	0.0	16.5	2.4	16.4	35.7	0.4	0.0	34.4	19.0	1.3	7.4	0.6	1.3	4.2	1.2	8.8	6.6	6.1
GLMN	"FAP48, FKBPAP, GLML, GVM, VMGLOM"	ENSG00000174842	"Glomulin, FKBP associated protein"	Q92990	1	92246402-92298987	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 39.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 102.2;Excitatory neurons: 97.8;Inhibitory neurons: 91.5;Oligodendrocyte precursor cells: 72.9;Rod photoreceptor cells: 148.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031446, HPA031448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA031446: AB_2797222, HPA031448: AB_2673888"	"unprognostic (4.20e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (7.32e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.89e-8)"	"unprognostic (7.33e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.58e-1)"	3.4	4.6	3.6	6.1	4.7	7.5	7.0	6.8	5.8	4.8	4.1	4.7	3.6	6.0	5.7	6.5	3.8	4.0	5.3	4.6	3.3	4.5	3.9	3.8	8.3	2.5	2.9	5.0	3.0	5.3	3.7	5.6	2.7	5.1	4.9	39.1	2.7	3.8	5.2	9.4	4.5	4.7	2.9	4.4	3.8	8.2	2.8	8.6	6.2	4.4	8.8	5.4	4.2	4.1	21.5	8.8	26.7	14.6	9.1	14.2	25.0	15.0	12.5	18.6	16.2	16.2	8.3	22.1	23.4	8.9	27.1	16.2	14.3	13.5	25.4	16.8	20.7	29.1	16.5	16.5	9.0	38.7	14.7	11.2	7.5	21.1	9.3	7.3	19.7	19.6	24.9	12.9	23.7	4.8	23.7	27.8	40.2	10.9	17.4	19.1	36.7	14.9	20.6	20.9	24.3	12.7	25.3	24.1	15.6	15.4	11.5	34.9	13.9	12.8	12.5	22.3	22.4	11.7	18.1	28.6	4.8	36.8	7.7	0.0	0.6	1.2	3.0	1.4	5.5	2.6	3.0	3.6	2.1	1.8	2.8	3.2	0.1	7.4	0.7	1.6	2.6	1.5	3.6	4.7	6.8	5.8	4.6	3.3	2.5	2.9	2.7	2.9	2.8	4.1	6.8	9.6	8.3	29.7	16.7	8.9	13.7	16.2	12.0	28.3	7.6	6.7	10.0	7.2	8.5	12.9	102.2	15.1	31.6	2.9	1.9	5.9	1.7	4.9	13.6	7.9	10.7	12.8	97.8	5.2	12.1	10.5	9.2	5.4	8.2	10.7	5.7	2.1	8.3	26.9	91.5	4.4	10.2	3.9	7.7	1.1	12.5	7.1	8.8	28.1	6.8	14.2	37.0	72.9	46.0	5.3	3.3	7.9	12.2	9.6	2.3	9.7	4.0	148.1	6.6	10.5	18.9	19.8	30.1	9.4	8.9	15.7	28.3	15.0	5.5	7.7
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703145	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 2571.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	55.4	62.3	69.4	38.9	74.1	31.6	74.2	74.6	83.4	55.9	77.2	51.8	116.3	57.8	110.9	60.0	72.3	41.4	88.9	72.6	76.2	87.2	157.7	66.6	48.4	73.7	72.8	82.8	42.1	106.1	23.2	64.1	75.1	171.4	52.3	100.3	43.2	62.1	154.2	66.6	67.7	61.8	77.9	48.2	48.5	27.9	72.9	50.0	54.8	128.8	60.3	52.4	51.6	77.1	201.6	92.0	257.4	256.7	119.2	213.9	227.0	171.1	161.4	235.4	243.0	224.4	75.3	222.5	132.2	137.5	280.1	129.5	222.5	221.1	295.8	203.8	343.0	329.4	105.7	211.3	178.5	126.7	2571.5	183.9	133.5	223.7	159.0	153.2	258.5	154.9	264.7	143.6	223.3	170.6	199.5	160.5	185.5	179.2	176.7	171.0	311.1	145.8	217.8	149.9	199.3	201.3	120.6	165.4	329.8	175.9	192.4	628.3	107.6	182.0	167.1	159.8	275.9	112.7	227.0	608.6	66.1	322.7	299.6	23.7	20.7	15.3	35.5	33.4	48.0	51.9	35.3	36.7	39.0	51.4	32.7	34.9	2.7	23.5	26.9	60.4	34.1	33.3	69.4	74.1	74.6	83.4	72.6	76.2	73.7	72.8	75.1	77.9	72.9	77.1	69.2	131.4	174.4	26.1	86.3	64.6	112.6	88.2	37.0	56.1	67.7	55.8	133.2	58.6	84.5	90.1	20.9	102.7	68.3	34.1	248.4	132.1	4.5	76.2	58.8	74.3	36.5	83.5	23.9	73.3	323.0	86.0	53.0	67.5	71.4	78.7	161.0	114.0	78.8	69.0	21.9	39.3	99.7	125.7	72.8	6.5	83.9	70.0	104.9	17.8	92.6	190.3	49.4	25.1	24.8	77.3	36.0	109.9	86.4	178.8	103.2	132.2	80.7	65.5	46.0	62.0	70.9	15.0	16.1	77.2	88.2	73.2	62.4	123.7	63.4	130.2
GLRX2	"bA101E13.1, GRX2"	ENSG00000023572	"Glutaredoxin 2"	Q9NS18	1	193090866-193106114	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	17	"Early spermatids: 796.4;Late spermatids: 1841.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 240.2"					"Low region specificity"	"Detected in all"			"HPA023087, HPA057224"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA023087: AB_1849778, HPA057224: AB_2683373"	"unprognostic (4.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.21e-2)"	"unprognostic (4.48e-2)"	16.1	22.3	16.0	7.9	16.5	9.5	12.4	17.0	28.7	10.2	15.4	14.4	11.7	8.2	10.7	16.7	7.2	6.9	37.0	16.5	18.2	16.2	25.9	9.8	5.2	17.3	15.8	6.2	9.6	5.5	8.4	7.5	17.9	17.9	9.0	2.5	11.1	8.4	37.6	12.9	10.6	8.7	15.9	9.8	12.9	30.2	16.8	3.8	7.2	24.8	7.3	13.9	11.7	17.2	47.2	57.8	14.6	32.8	52.2	33.9	24.0	67.2	29.8	55.6	45.9	36.3	44.2	20.0	36.1	28.6	67.1	44.4	17.5	39.4	56.7	45.6	30.4	40.4	39.0	42.6	55.9	32.8	39.0	23.1	33.8	76.5	38.4	21.6	35.7	13.7	60.8	21.9	68.4	66.3	26.9	60.6	16.8	75.6	38.2	23.7	22.9	48.3	53.7	31.4	13.8	12.4	26.9	81.2	240.2	21.6	35.2	37.5	21.6	42.8	11.2	93.7	70.5	42.6	48.7	41.4	40.8	38.1	61.2	13.6	18.8	26.6	12.7	23.1	14.2	13.2	13.4	11.7	22.5	10.8	11.7	13.4	9.6	16.1	30.0	9.2	18.6	14.5	16.0	16.5	17.0	28.7	16.5	18.2	17.3	15.8	17.9	15.9	16.8	17.2	24.2	9.6	10.1	5.5	14.8	18.2	21.1	39.1	14.2	7.2	21.7	23.6	62.8	12.8	21.5	16.5	6.2	39.2	19.5	25.8	29.4	41.1	796.4	16.1	24.2	18.7	13.8	15.6	11.3	41.4	41.6	25.2	14.8	17.7	46.9	16.4	11.0	30.3	44.2	1.7	10.1	26.5	32.6	15.0	26.9	1841.1	17.4	26.8	26.6	5.6	25.9	9.9	28.8	5.0	10.1	38.3	31.5	18.0	20.5	39.2	40.3	74.3	13.9	11.5	6.6	15.5	36.2	12.3	25.4	21.3	19.9	24.8	14.0	33.1	24.1	20.5
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847288	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favorable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	34.4	35.0	26.9	43.4	27.9	43.4	27.7	21.2	27.7	31.7	35.9	46.0	43.3	30.1	24.6	37.7	45.4	30.4	41.7	29.3	26.5	46.9	38.3	32.8	41.7	24.2	26.1	24.9	35.8	60.4	31.5	33.7	22.8	40.2	43.9	41.9	43.5	37.5	44.1	33.6	40.4	37.2	22.5	39.2	44.7	20.3	26.6	45.7	40.2	37.8	43.2	36.5	26.9	22.4	43.2	47.5	76.4	47.9	66.1	52.5	73.4	80.0	59.0	59.6	50.7	66.7	75.5	69.8	74.0	74.2	49.0	47.3	96.4	67.0	53.4	114.0	59.4	72.4	57.7	47.7	37.3	117.6	129.6	50.2	52.3	56.3	41.5	57.6	77.2	65.0	122.8	58.8	65.6	69.8	96.6	64.8	91.0	65.0	35.2	123.5	59.9	86.5	73.4	64.0	93.1	47.1	86.4	80.7	37.1	83.1	90.3	123.9	86.1	41.1	46.0	186.2	50.3	49.0	73.1	145.5	29.3	57.9	85.5	10.3	14.1	7.8	9.0	12.7	8.0	6.2	6.0	8.9	9.7	9.6	6.2	5.6	28.1	7.0	20.8	10.8	6.5	8.2	26.9	27.9	21.2	27.7	29.3	26.5	24.2	26.1	22.8	22.5	26.6	22.4	28.6	38.5	47.3	35.6	29.9	19.1	18.7	17.1	19.4	36.8	30.3	23.6	42.3	28.6	37.3	31.3	29.2	28.0	31.1	54.9	66.5	24.4	11.3	58.2	36.7	28.1	46.3	45.6	43.6	19.4	31.6	23.0	26.0	43.0	31.6	27.4	26.7	53.0	32.0	45.4	37.0	41.2	18.3	39.3	23.9	10.3	24.2	35.9	21.4	32.8	54.5	25.0	28.8	28.6	35.8	29.2	38.8	16.1	26.5	29.0	38.9	54.7	73.3	42.6	19.7	24.6	36.1	21.9	24.5	23.4	24.2	35.7	26.1	28.1	38.8	21.3
GMEB1	"P96PIF, PIF96"	ENSG00000162419	"Glucocorticoid modulatory element binding protein 1"	Q9Y692	1	28668778-28719353	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044811, HPA052975"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044811: AB_10959666, HPA052975: AB_2682003"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.91e-7)"	"unprognostic (1.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	4.7	3.0	2.3	5.7	2.2	13.6	4.3	5.9	3.1	5.1	3.1	4.4	2.9	4.9	3.0	5.2	4.4	4.2	3.1	2.5	1.9	3.6	3.4	4.3	6.7	2.5	2.2	5.6	4.1	3.3	3.7	5.7	2.5	3.5	4.4	5.6	3.4	3.1	5.3	5.0	4.4	4.8	1.9	5.5	4.1	6.0	2.6	10.6	3.5	4.4	8.0	4.3	4.4	3.1	12.1	8.5	14.1	12.9	4.6	8.5	10.0	12.5	9.0	7.9	11.7	2.7	9.4	22.1	6.5	11.7	4.7	4.6	12.7	9.7	10.2	25.4	7.9	20.4	8.9	5.2	6.9	17.1	10.2	6.8	6.8	19.2	12.3	6.9	11.1	10.8	12.6	17.1	9.6	10.5	10.7	5.7	18.9	8.0	5.7	7.2	9.7	10.3	6.0	9.6	10.4	8.6	12.1	8.0	8.1	9.4	6.1	8.7	11.2	5.4	13.1	9.3	17.0	7.6	13.8	12.1	6.6	15.8	8.7	8.1	5.4	9.9	6.7	7.0	5.1	4.0	6.5	7.9	6.3	6.0	5.3	5.5	7.6	7.5	9.0	4.6	6.0	4.6	2.3	2.2	5.9	3.1	2.5	1.9	2.5	2.2	2.5	1.9	2.6	3.1	12.9	6.4	20.0	3.9	20.5	17.0	19.9	8.6	8.6	23.6	9.0	10.2	4.0	10.0	11.0	14.7	12.5	14.1	17.7	12.7	5.9	10.9	13.3	10.1	12.5	13.2	7.8	26.7	7.0	11.1	16.6	10.0	9.2	16.3	28.5	12.8	16.8	6.1	10.7	25.2	5.9	13.1	10.2	13.4	7.9	2.8	9.6	12.2	1.8	4.7	14.8	17.5	29.9	5.0	9.2	11.5	14.1	7.9	11.5	12.4	8.5	5.7	7.1	24.7	19.7	18.3	13.0	34.8	28.6	8.3	16.8	32.3	19.5	13.2	11.0	19.6
GMEB2	"KIAA1269, P79PIF, PIF79"	ENSG00000101216	"Glucocorticoid modulatory element binding protein 2"	Q9UKD1	20	63587602-63627101	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009706, HPA067455"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA009706: AB_1078996, HPA067455: AB_2685845"	"unprognostic (4.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.29e-1)"	7.5	8.0	6.2	5.0	5.9	19.3	7.4	6.3	6.7	8.7	5.5	8.5	5.0	9.0	2.5	9.3	10.3	3.1	7.9	6.1	5.3	8.5	9.0	8.2	6.7	6.2	5.8	9.5	9.8	5.6	8.3	3.6	5.6	9.0	2.4	2.1	8.8	3.5	9.2	9.3	9.3	3.3	5.2	10.7	8.2	13.4	6.2	8.1	15.5	3.4	4.4	8.0	7.1	5.6	13.8	8.3	9.9	8.6	4.7	4.3	13.2	9.3	5.9	14.7	7.7	25.9	10.1	10.9	9.5	8.1	10.6	19.2	7.8	13.7	6.5	5.8	8.8	8.5	12.7	12.6	6.4	8.1	13.6	6.2	12.9	9.5	11.8	6.2	6.5	13.6	12.6	7.7	5.1	14.9	19.8	17.8	7.1	16.3	13.1	21.3	10.1	10.1	6.1	12.1	14.8	12.2	17.0	14.8	10.0	4.5	18.1	13.3	8.3	16.0	8.7	9.7	10.4	14.7	12.8	17.2	9.7	7.5	10.7	0.0	0.8	1.4	1.7	1.0	1.5	0.7	1.5	1.5	0.8	1.0	1.6	1.4	1.7	0.8	2.5	1.0	1.1	1.0	6.2	5.9	6.3	6.7	6.1	5.3	6.2	5.8	5.6	5.2	6.2	5.6	5.6	3.2	5.6	9.1	7.3	6.0	11.2	3.8	5.2	5.2	6.4	5.6	3.2	4.3	5.0	3.7	0.0	4.1	6.3	9.3	1.9	4.3	29.3	6.9	5.2	6.8	9.6	2.5	5.3	5.4	6.9	4.2	5.6	10.3	2.5	6.0	4.6	6.6	4.5	8.4	4.2	7.6	2.0	3.5	3.8	6.9	4.1	4.5	1.8	4.7	3.2	2.4	4.1	2.5	4.8	6.1	8.2	5.7	7.8	12.0	5.5	3.5	4.2	5.9	6.6	5.0	4.6	22.2	9.5	5.1	5.4	11.5	8.9	3.5	6.1	12.1
GMFB	GMF	ENSG00000197045	"Glia maturation factor beta"	P60983	14	54474484-54489026	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 90.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Approved	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (7.93e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.09e-2)"	25.2	21.8	62.8	23.5	68.8	28.8	26.0	61.6	90.4	18.6	39.8	35.0	33.5	19.3	14.0	15.8	14.2	16.5	17.2	61.4	75.6	33.6	25.8	24.2	25.3	73.0	64.5	16.1	12.8	20.1	12.3	26.5	71.4	14.8	35.2	18.4	10.7	12.9	7.0	13.7	29.5	18.2	84.0	18.4	19.0	11.1	71.9	16.2	21.9	10.2	24.4	22.3	11.4	85.3	92.7	36.9	71.8	53.2	75.8	94.5	53.9	93.2	67.9	66.2	82.1	42.6	79.4	85.2	42.4	92.0	39.5	33.4	73.7	64.0	104.4	30.9	25.4	42.5	37.4	39.9	64.7	59.9	35.5	72.0	58.8	57.1	56.0	67.9	60.8	38.4	31.4	28.8	106.1	45.7	36.8	22.9	46.4	52.1	38.9	36.9	84.7	24.4	84.4	86.3	42.4	65.5	64.6	54.4	71.4	59.0	59.8	46.4	48.1	94.9	71.9	48.7	58.4	10.4	19.4	52.0	80.0	36.3	61.5	6.8	10.2	9.1	5.0	13.3	7.0	6.6	5.9	5.1	12.6	7.8	6.2	6.6	16.1	8.0	14.0	4.4	8.5	6.2	62.8	68.8	61.6	90.4	61.4	75.6	73.0	64.5	71.4	84.0	71.9	85.3	23.3	25.6	16.2	8.1	39.3	59.9	50.2	33.6	48.9	18.4	28.0	18.0	17.3	20.0	22.6	25.8	4.2	39.3	33.7	61.8	21.5	38.7	27.3	21.5	29.5	22.2	29.9	14.5	16.8	23.3	84.5	35.1	23.9	36.1	21.6	25.4	16.8	24.5	45.4	21.9	13.6	33.6	26.4	34.6	36.4	7.5	20.2	43.0	46.2	8.4	37.8	25.7	25.7	14.1	16.5	37.3	32.1	15.8	16.9	56.0	26.0	60.5	16.4	15.4	13.1	77.0	54.5	16.0	11.4	33.5	43.8	58.3	26.2	18.8	36.2	56.2
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 577.4;lymphoid tissue: 460.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 304.3;Hofbauer cells: 467.5;Kupffer cells: 523.4;Langerhans cells: 343.2;Macrophages: 409.6;monocytes: 409.4;NK-cells: 423.3;T-cells: 370.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 356.7;HMC-1: 602.6;JURKAT: 464.5;Karpas-707: 494.4;NB-4: 361.6;REH: 409.8;THP-1: 641.5;U-937: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	111.6	26.3	27.1	188.6	27.4	577.4	71.3	26.9	41.6	26.0	29.3	45.6	33.8	20.7	19.6	19.7	29.0	60.8	25.1	27.9	29.1	36.8	65.9	117.7	299.5	30.7	30.1	9.2	14.4	15.6	10.8	102.4	30.5	18.5	53.2	2.0	18.9	15.0	11.4	16.2	75.0	47.8	29.1	325.3	41.5	7.4	28.6	460.7	37.6	23.6	262.7	93.5	18.3	32.6	1.4	0.0	2.0	0.4	0.0	0.0	0.7	1.1	0.3	0.3	0.2	0.3	33.1	309.6	2.4	0.3	0.1	1.5	0.0	0.7	1.2	99.7	0.5	329.7	0.4	3.5	5.1	356.7	602.6	0.7	0.6	0.5	0.8	0.8	19.2	464.5	12.3	494.4	2.4	0.0	316.6	361.6	0.6	0.1	0.2	409.8	3.2	196.8	0.5	40.9	0.8	0.5	1.3	1.9	2.1	0.6	0.8	641.5	175.7	0.2	3.2	0.8	1.1	26.9	107.3	340.0	1.7	482.4	2.7	4389.0	1574.5	3622.3	720.9	1447.6	773.8	812.5	1058.2	894.4	1139.9	742.7	1044.5	858.2	5262.9	908.0	1686.2	459.6	1840.4	2617.7	27.1	27.4	26.9	41.6	27.9	29.1	30.7	30.1	30.5	29.1	28.6	32.6	304.3	28.9	97.6	0.0	211.7	18.6	4.4	0.3	2.8	0.0	4.2	9.4	3.2	11.5	17.3	0.0	0.0	3.6	273.5	0.9	0.0	1.1	11.8	0.6	2.2	176.4	0.0	119.4	0.5	0.7	4.0	18.2	9.7	0.8	238.0	0.3	272.4	11.8	467.5	0.0	0.4	0.3	2.0	523.4	343.2	30.4	1.8	409.6	74.7	1.9	409.4	0.7	423.3	0.5	0.3	0.3	0.0	0.4	216.8	1.1	0.3	4.6	8.9	0.3	46.0	4.2	26.4	8.6	3.3	1.4	14.8	5.5	370.6	2.3	1.1	4.1
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643657	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.9;lymphoid tissue: 54.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.6;Gastric mucus-secreting cells: 24.5;Hofbauer cells: 22.7;Kupffer cells: 33.3;Macrophages: 26.7;monocytes: 27.6;T-cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 92.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042484: AB_2678018, HPA045481: AB_2679343"	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.97e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.15e-4)"	7.5	3.3	2.9	32.0	2.4	50.9	5.4	2.5	6.1	3.7	2.5	9.6	10.4	3.3	1.4	8.6	5.4	6.0	2.9	3.8	4.0	4.3	4.7	16.9	29.4	6.5	4.4	2.6	6.0	8.9	3.6	4.6	5.7	5.4	6.5	0.4	6.9	2.8	1.1	6.9	22.6	4.3	4.5	54.3	16.7	2.9	6.6	19.1	8.5	1.9	22.9	8.3	5.3	7.4	9.9	4.5	5.9	6.5	6.4	3.3	23.5	6.1	5.2	3.6	3.4	3.6	13.0	24.1	12.1	4.3	4.7	11.5	3.9	6.7	2.3	8.3	6.1	7.6	7.1	4.0	1.9	21.7	92.0	4.2	4.5	3.9	2.0	4.2	8.2	21.1	5.3	8.5	3.9	14.6	13.7	35.8	3.5	12.7	8.1	23.3	2.6	14.0	6.9	23.3	5.1	15.2	8.4	8.7	3.7	4.5	8.0	30.7	15.0	6.6	3.8	7.6	4.6	4.3	1.9	19.8	4.2	28.0	4.6	7.0	19.5	51.9	13.2	23.7	12.3	12.6	8.4	11.9	15.1	12.8	8.9	9.7	71.8	9.7	33.1	13.5	10.0	12.5	2.9	2.4	2.5	6.1	3.8	4.0	6.5	4.4	5.7	4.5	6.6	7.4	1.7	0.0	10.2	0.3	26.6	1.1	1.7	2.5	1.2	0.0	1.9	1.3	0.9	2.8	3.1	0.0	0.0	0.6	14.9	21.2	0.0	4.1	0.1	1.4	0.9	1.8	0.0	1.3	2.1	4.7	5.3	0.9	24.5	4.0	7.0	3.5	2.5	1.6	22.7	0.0	2.1	6.6	0.0	33.3	6.6	0.4	0.6	26.7	1.8	6.5	27.6	0.4	20.6	0.5	0.2	12.9	20.2	0.7	13.9	2.0	9.3	0.7	1.5	0.1	0.0	0.4	1.6	0.6	1.3	3.5	1.1	0.8	25.8	0.9	6.0	4.1
GMNN	Gem	ENSG00000112312	"Geminin DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 231.4"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 184.8;Paneth cells: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 25: Pancreas - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	10.1	7.7	16.9	17.2	18.2	68.9	24.2	19.5	23.7	11.1	13.5	41.6	17.8	10.6	5.8	16.6	16.5	7.9	8.0	14.7	20.2	24.6	18.2	8.9	30.4	17.0	20.2	14.6	231.4	8.4	11.1	16.5	17.8	41.5	44.4	16.3	8.7	24.9	7.4	40.3	16.1	12.5	16.4	19.1	22.6	37.4	19.8	37.4	10.8	14.3	23.7	28.4	13.9	15.5	110.9	64.2	159.2	66.2	22.2	23.5	106.0	106.0	55.9	124.4	135.5	125.1	38.8	110.1	131.3	34.4	91.3	63.3	139.4	78.1	133.0	41.2	145.4	151.5	109.3	207.4	20.7	119.1	53.1	19.1	25.1	75.9	29.5	25.8	62.2	84.6	193.9	56.9	88.9	86.3	224.9	128.2	87.3	89.6	50.2	128.9	124.4	141.2	53.5	94.6	127.3	78.3	47.5	77.4	95.2	89.1	81.3	72.0	30.9	75.7	76.8	88.3	182.6	62.8	207.6	210.3	23.1	220.9	111.2	5.5	5.2	17.1	4.4	6.9	5.6	9.2	8.5	6.9	7.6	4.6	6.1	6.9	3.0	5.9	5.0	9.4	15.9	5.6	16.9	18.2	19.5	23.7	14.7	20.2	17.0	20.2	17.8	16.4	19.8	15.5	24.0	6.4	15.6	8.8	17.0	33.0	28.4	57.4	18.8	9.5	51.0	52.5	12.1	18.6	68.1	44.1	2.1	83.2	19.9	72.6	9.8	113.6	94.8	84.8	30.6	18.4	25.9	66.2	3.5	112.3	136.3	17.7	12.2	184.8	13.3	36.4	13.9	17.4	54.0	11.8	5.3	66.3	10.2	10.7	13.2	28.0	9.6	15.2	23.2	5.6	12.6	30.9	6.2	5.5	3.2	31.8	300.5	10.9	41.6	25.6	20.8	20.6	25.2	13.7	19.7	8.0	21.9	158.8	58.8	26.8	63.5	48.7	19.1	30.4	156.5	30.1
GMPPA		ENSG00000144591	"GDP-mannose pyrophosphorylase A"	Q96IJ6	2	219498884-219506989	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035512, HPA035513"	Approved		Approved	Nucleoplasm		NA	NA		51000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA035512: AB_2674660, HPA035513: AB_10671934"	"unprognostic (3.43e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.75e-3)"	"unprognostic (1.40e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.57e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.90e-10)"	"prognostic favorable (5.24e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-1)"	22.6	25.8	19.3	23.9	20.1	19.0	21.6	20.1	22.6	32.1	22.4	29.7	28.8	26.4	68.7	25.5	24.6	19.7	27.1	20.1	20.5	25.7	68.5	20.9	20.7	20.5	19.8	20.1	60.3	24.7	48.5	21.2	20.0	37.3	32.3	8.0	40.1	23.4	22.8	17.8	30.0	26.2	19.6	35.2	32.5	9.6	21.3	13.2	28.6	12.6	23.8	25.2	23.1	19.8	43.4	36.0	21.2	37.8	79.5	70.6	56.4	73.8	98.6	85.2	105.2	66.8	40.5	23.4	51.1	107.7	54.3	40.1	39.7	63.9	73.3	45.3	35.0	45.5	35.7	119.3	72.0	24.1	51.7	54.3	50.7	79.9	89.9	43.9	52.8	29.7	82.3	66.3	66.8	55.5	23.8	45.3	21.7	52.8	38.5	18.6	22.9	42.4	48.6	30.1	27.4	24.0	31.0	46.3	52.1	44.4	31.5	38.8	30.9	49.2	33.6	89.4	40.9	45.4	19.4	28.9	100.4	26.7	55.8	76.0	52.6	37.3	30.1	56.0	35.0	32.1	23.4	31.9	43.5	24.1	17.3	15.7	11.8	36.4	59.3	43.9	34.8	35.2	19.3	20.1	20.1	22.6	20.1	20.5	20.5	19.8	20.0	19.6	21.3	19.8	12.5	16.0	14.4	5.5	18.8	5.6	12.8	25.2	6.2	6.1	20.9	13.5	13.2	10.0	20.1	16.5	6.2	37.6	16.6	37.7	35.2	24.3	1.3	8.5	15.8	9.5	10.8	19.1	3.1	30.0	79.8	19.2	38.7	14.4	19.0	13.3	11.0	36.3	33.7	1.7	3.6	61.6	10.2	17.6	10.0	3.4	18.3	16.5	12.4	1.9	15.9	11.1	12.3	1.0	4.9	19.0	37.6	13.5	50.3	15.1	45.9	36.8	11.6	4.7	13.1	7.9	27.1	4.4	6.5	9.9	8.5	47.2	13.5	10.7	29.1	15.1
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Approved		Approved	Nucleoplasm,Nucleoli		No	No		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032"	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	45.0	92.1	24.5	19.7	25.7	19.3	44.3	25.8	30.2	44.7	28.2	44.2	30.9	38.2	29.9	38.7	44.9	32.0	39.6	24.8	25.7	70.1	56.0	38.8	26.9	26.2	25.6	51.2	49.0	67.7	48.1	22.7	26.8	41.7	25.5	18.8	41.8	26.3	40.6	35.2	45.8	21.2	26.0	55.9	50.7	21.9	26.1	28.4	58.4	19.8	27.3	43.1	40.3	26.2	27.1	34.2	29.0	26.7	50.9	74.7	40.0	32.1	59.2	47.3	55.7	38.8	24.6	34.7	22.5	49.8	25.5	43.6	42.4	69.2	69.5	19.0	25.5	24.3	25.0	159.1	46.8	53.7	51.4	72.2	54.9	23.6	47.7	61.1	69.7	52.3	12.5	33.3	46.6	51.8	50.1	57.1	34.3	39.5	37.3	33.5	24.2	22.6	69.1	52.7	22.0	36.2	16.9	45.8	52.6	39.5	38.6	41.1	36.2	23.0	15.8	32.0	20.6	59.4	63.1	21.8	16.6	38.9	20.2	24.3	34.2	15.0	19.7	27.5	21.6	13.7	21.5	23.7	35.9	15.9	19.3	20.2	56.0	14.9	27.9	15.8	31.5	26.5	24.5	25.7	25.8	30.2	24.8	25.7	26.2	25.6	26.8	26.0	26.1	26.2	25.2	25.6	18.7	10.7	23.2	11.0	44.5	49.9	27.3	19.6	24.8	32.9	12.5	38.6	35.7	53.3	4.2	67.2	22.6	35.6	101.8	43.6	18.3	29.6	16.6	26.3	10.3	20.6	7.8	33.0	48.5	18.8	17.9	20.0	31.7	29.7	16.8	24.8	50.0	18.5	8.0	19.8	30.5	46.6	14.6	10.5	28.9	32.5	21.4	9.4	32.1	43.3	25.7	7.5	11.7	33.7	32.1	25.2	21.2	19.0	50.2	123.1	43.2	19.7	26.3	16.0	24.5	19.8	10.3	20.7	10.7	49.3	24.6	51.3	28.4	30.5
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	79768028-80226181	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 220.0;Oligodendrocytes: 410.7;Suprabasal keratinocytes: 214.2;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 12.8"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 12.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome		NA	NA		1600000	"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: AB_2677870"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	47.5	26.2	8.9	2.6	18.8	0.4	34.9	14.9	17.7	18.5	4.4	25.4	4.7	14.8	0.7	19.7	10.9	3.2	9.4	10.8	13.3	36.6	15.2	15.2	2.0	18.8	15.0	17.1	4.5	1.3	10.9	13.6	18.4	8.8	2.6	1.5	10.4	3.0	6.2	47.9	9.9	4.1	15.5	5.9	17.7	13.0	14.2	1.3	14.2	2.9	1.5	24.7	19.9	36.6	2.2	18.6	10.5	0.0	14.5	7.9	9.1	14.3	7.2	5.5	8.7	0.0	3.4	0.0	4.5	9.3	5.1	2.6	7.0	9.5	5.4	0.0	11.9	10.4	12.9	1.2	14.8	1.8	0.0	12.0	19.9	4.1	9.5	4.4	3.5	0.0	0.0	0.1	7.7	0.6	0.0	0.1	6.1	0.2	11.0	8.6	5.2	7.8	15.7	7.0	12.5	9.2	13.5	0.0	10.3	5.4	2.0	0.3	13.0	21.8	15.6	5.1	4.4	0.0	0.0	0.2	6.1	1.2	10.2	1.3	0.4	0.4	0.1	0.4	0.0	0.0	0.1	0.1	1.9	0.1	1.1	0.5	0.3	12.8	1.0	0.2	0.1	0.4	8.9	18.8	14.9	17.7	10.8	13.3	18.8	15.0	18.4	15.5	14.2	36.6	121.1	19.2	13.8	11.4	0.9	220.0	20.6	81.6	35.3	3.9	7.0	7.7	6.7	21.5	42.3	29.5	0.0	83.6	1.3	11.1	88.0	7.2	1.7	23.2	58.5	31.5	19.9	4.2	71.4	3.8	84.6	35.9	4.6	40.3	30.3	43.9	17.5	20.0	10.0	26.9	77.4	7.8	36.7	1.0	28.6	7.0	33.5	3.9	103.2	4.7	2.9	49.1	0.0	53.3	410.7	9.4	6.3	74.4	1.2	17.4	0.9	18.4	36.8	5.0	111.7	10.6	70.8	9.7	45.7	31.9	214.2	183.5	2.9	2.9	10.7	19.2
GNAI2	"GIP, GNAI2B"	ENSG00000114353	"G protein subunit alpha i2"	P04899	3	50226292-50259362	"Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 656.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007704	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		4000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA007704: AB_1849230"	"prognostic favorable (1.03e-4)"	"unprognostic (3.89e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.01e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.38e-1)"	210.2	100.3	155.2	217.9	167.3	367.1	152.8	166.3	181.6	146.0	120.2	142.1	69.9	141.7	66.9	124.4	136.9	152.5	157.1	144.3	184.6	79.4	126.5	214.5	251.3	199.8	170.2	147.7	64.1	66.9	99.2	241.8	194.8	103.6	64.3	35.6	71.9	156.9	69.3	87.0	103.0	154.0	173.6	262.1	73.6	69.6	173.3	160.3	101.3	89.4	170.4	169.7	108.4	193.2	128.2	63.0	186.3	197.6	220.7	277.5	35.5	271.1	399.6	354.9	361.1	70.4	173.2	149.1	119.2	567.0	193.4	100.1	132.8	350.3	222.8	331.2	50.9	364.8	158.0	110.2	219.8	329.2	479.8	270.3	152.9	319.1	129.8	289.6	837.8	124.1	26.1	307.1	357.5	155.7	313.6	433.0	109.7	59.0	302.4	185.0	89.8	219.7	232.6	130.9	48.4	86.1	189.5	57.1	124.4	150.4	94.3	346.1	792.3	330.9	187.5	309.2	274.7	199.4	278.3	127.0	373.6	466.9	398.1	16.6	59.3	113.7	33.7	80.9	20.2	28.8	26.8	34.3	57.3	26.1	20.2	25.8	145.2	23.5	74.5	47.2	34.0	27.3	155.2	167.3	166.3	181.6	144.3	184.6	199.8	170.2	194.8	173.6	173.3	193.2	656.8	41.7	32.1	25.1	119.5	56.7	59.7	32.3	45.5	29.0	61.6	83.8	22.9	55.8	26.6	44.1	14.6	79.5	311.4	11.7	5.9	124.3	203.3	57.8	115.7	340.3	92.2	52.1	12.4	60.5	84.4	101.9	21.9	71.8	89.9	150.0	221.3	79.7	336.0	6.7	14.8	24.6	18.3	342.7	291.7	302.0	90.7	386.1	83.6	58.1	356.6	292.6	151.4	26.7	45.4	160.3	40.9	95.5	104.8	46.1	30.3	24.5	24.4	21.9	52.6	85.3	163.1	16.6	22.6	37.6	62.9	116.4	164.9	156.3	20.5	70.1
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548615-109600195	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 350.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: AB_2677870"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	12.7	8.2	5.8	14.2	6.1	27.7	11.9	7.3	7.5	10.9	8.6	11.8	10.4	12.1	8.0	21.8	8.0	11.3	4.2	6.0	6.5	11.2	15.3	9.7	14.1	6.7	5.9	8.8	9.3	8.9	1.8	14.8	6.8	10.3	11.8	17.8	7.7	9.0	3.8	18.4	10.6	13.6	6.3	11.4	9.0	8.7	6.2	14.2	8.0	5.5	15.9	15.5	4.0	7.3	48.3	16.4	31.0	17.3	28.4	35.0	25.7	35.3	28.6	36.0	35.5	24.4	16.1	25.3	22.4	37.6	21.6	24.5	30.0	35.3	49.4	29.2	18.0	22.1	26.3	21.9	25.1	34.9	18.8	25.2	30.4	41.3	27.8	24.2	42.8	19.1	29.8	24.2	35.5	32.9	27.3	28.4	31.3	23.0	19.1	19.2	73.6	16.6	37.4	35.4	19.5	34.9	24.7	27.6	39.4	22.8	21.1	30.5	36.7	29.4	40.7	44.9	39.2	25.6	30.2	29.2	47.6	34.4	47.1	32.4	29.7	57.8	21.1	44.3	22.4	20.1	20.4	20.6	31.9	17.1	16.8	19.4	53.8	19.9	44.6	14.2	23.8	36.3	5.8	6.1	7.3	7.5	6.0	6.5	6.7	5.9	6.8	6.3	6.2	7.3	104.0	44.8	31.5	17.0	76.6	151.2	104.3	92.2	63.2	29.9	67.7	45.3	14.3	37.1	61.0	58.8	350.3	80.3	98.8	63.9	64.6	97.9	14.7	65.5	71.5	82.6	84.3	43.8	37.5	101.7	153.7	69.2	55.5	110.9	46.3	50.1	56.7	57.2	107.9	25.2	36.4	72.3	59.0	115.0	106.9	9.4	48.7	127.4	74.7	31.9	102.4	47.9	45.3	35.7	31.3	101.6	58.9	47.4	66.3	72.5	48.9	53.5	51.7	26.2	52.6	59.0	77.6	68.6	54.7	82.1	188.4	106.9	94.3	51.7	63.5	143.0
GNAL		ENSG00000141404	"G protein subunit alpha L"	P38405	18	11689264-11885685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 99.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 76.9;Inhibitory neurons: 119.5;Oligodendrocyte precursor cells: 58.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 99.0"	"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 26.4;HeLa: 27.4;U-2 OS: 13.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"basal ganglia: 164.1"	"CAB015464, HPA051160"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"CAB015464: AB_831819, HPA051160: AB_2732564"	"unprognostic (2.29e-3)"	"unprognostic (7.43e-2)"	"unprognostic (8.14e-3)"	"unprognostic (3.41e-5)"	"unprognostic (4.71e-2)"	"unprognostic (9.58e-3)"	"unprognostic (9.93e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.03e-2)"	7.7	1.5	29.2	2.9	99.0	0.8	4.1	3.5	36.7	7.3	0.0	7.1	1.5	6.6	2.2	8.0	3.9	4.6	3.5	39.6	16.7	4.0	2.0	2.7	4.9	8.3	8.9	2.9	1.8	4.8	16.3	2.8	6.8	9.3	3.6	4.1	4.7	17.0	21.7	7.2	3.2	7.5	1.9	2.9	3.1	6.5	14.4	4.3	7.8	13.1	5.5	13.2	7.0	4.8	0.7	8.7	10.3	0.7	0.8	0.2	1.2	0.1	0.4	0.7	0.0	9.2	1.6	26.4	1.6	0.1	5.7	0.4	9.7	8.1	0.0	5.6	9.0	0.2	27.4	5.2	0.1	0.3	0.6	1.2	11.9	0.0	0.2	0.4	0.0	0.3	2.4	0.3	0.3	0.3	0.3	0.8	8.4	7.2	0.2	0.2	1.4	0.2	0.6	0.3	9.4	0.2	12.3	0.6	3.0	2.3	0.2	0.3	1.5	1.1	13.2	0.5	2.6	0.5	0.3	0.1	0.5	0.3	0.3	0.6	0.0	0.1	1.3	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.5	29.2	99.0	3.5	36.7	39.6	16.7	8.3	8.9	6.8	1.9	14.4	4.8	4.3	3.2	5.9	17.0	1.1	10.6	11.6	6.6	10.2	7.2	2.4	8.9	3.6	0.0	8.0	3.7	16.7	0.5	13.8	3.2	1.9	0.4	4.2	1.7	3.6	5.7	0.0	0.0	76.9	3.0	3.5	7.2	1.5	3.8	5.7	3.2	1.8	1.9	0.9	3.3	119.5	0.6	30.5	0.8	5.2	2.7	0.9	2.3	14.2	8.4	0.0	1.1	21.6	58.8	3.7	1.2	1.9	3.0	1.7	6.8	1.5	5.0	10.4	3.9	6.6	14.5	10.9	4.3	10.5	11.5	7.5	0.5	2.9	0.3	1.4	15.0
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease variant, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 1886.1;Late spermatids: 1756.9;Skeletal myocytes: 1998.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	784.8	1215.3	1564.4	512.6	1524.7	887.4	578.9	1413.1	1768.3	828.5	1373.3	657.1	492.4	611.4	1253.8	883.1	742.9	672.7	1990.6	1557.3	2716.9	625.0	651.1	640.3	769.2	1710.5	1949.4	766.5	1917.7	1799.4	1153.6	884.6	1963.4	577.3	607.3	731.2	2943.9	594.4	2400.4	526.8	527.3	782.4	1598.4	606.6	587.1	357.9	1882.0	854.4	3432.2	2813.1	800.0	687.1	239.3	1483.9	215.6	897.3	1501.9	663.3	2691.8	1822.3	1200.1	1219.1	1635.0	1937.3	1201.8	2480.5	1446.7	911.9	1670.3	2314.3	1305.6	976.1	1499.0	2195.3	1540.9	401.4	784.6	984.9	1651.7	2232.7	1420.7	641.6	483.0	1566.4	1113.6	875.1	1399.1	1561.0	1669.7	1100.6	692.0	1294.6	1319.1	4131.0	1759.5	1452.8	487.9	214.0	894.4	1436.7	1287.3	1589.4	2165.5	1315.8	1818.3	3853.2	2157.6	2117.1	1354.2	1921.8	1570.0	1581.7	1343.3	2210.2	1477.0	688.5	1452.3	1314.0	993.3	1583.2	900.0	473.7	1107.1	217.9	96.7	114.2	68.9	127.3	80.0	103.2	73.4	74.8	129.2	93.6	65.8	82.6	103.4	95.6	150.3	174.9	92.7	100.9	1564.4	1524.7	1413.1	1768.3	1557.3	2716.9	1710.5	1949.4	1963.4	1598.4	1882.0	1483.9	982.6	221.2	258.8	192.0	310.8	130.4	182.0	130.0	205.5	397.8	465.6	684.4	1025.3	237.4	212.2	261.1	56.3	832.6	390.8	357.3	444.1	233.9	734.9	487.7	515.7	518.3	463.1	252.1	232.5	228.9	342.0	380.9	196.3	685.0	138.6	542.3	380.1	256.4	379.1	1886.1	439.7	327.2	181.0	380.4	405.7	1756.9	265.3	437.1	222.3	236.1	204.0	1367.2	137.0	194.5	166.6	339.9	300.0	197.1	309.7	268.1	273.7	153.6	218.0	222.0	210.4	1998.0	560.4	226.0	73.6	240.5	117.8	1211.7	301.8	860.9	304.4	316.5
GNL3L	"FLJ10613, GNL3B"	ENSG00000130119	"G protein nucleolar 3 like"	Q9NVN8	X	54530183-54621521	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036314, HPA036315"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036314: AB_10669986, HPA036315: AB_2675055"	"unprognostic (9.71e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.44e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	4.6	3.6	2.0	7.0	3.6	8.9	4.8	2.6	2.7	4.8	3.1	4.7	3.9	4.7	3.7	5.7	4.7	4.7	7.2	2.7	2.6	4.4	3.9	5.0	7.6	3.1	3.6	3.8	5.0	5.7	2.3	5.6	3.2	3.7	6.1	3.8	4.0	4.4	7.1	5.7	4.7	7.3	2.7	6.9	5.3	2.3	3.4	8.3	8.5	7.8	8.5	6.7	3.5	5.4	20.7	49.1	9.5	20.9	10.2	8.3	15.2	9.8	8.7	13.4	9.9	43.4	16.6	26.9	21.3	18.2	15.1	18.7	34.6	14.9	19.0	15.9	16.4	30.0	34.0	17.2	7.9	42.6	26.0	10.0	7.1	31.0	17.4	5.7	13.4	16.4	19.2	27.0	14.0	36.5	25.5	11.8	29.6	13.0	26.7	27.7	23.9	27.8	10.3	28.8	17.1	8.4	39.7	24.3	11.7	20.9	30.9	11.4	20.0	22.6	22.1	21.8	18.4	19.9	25.7	35.9	12.8	34.6	27.8	23.6	14.4	15.0	16.5	12.8	15.0	15.1	14.8	13.8	11.1	16.0	10.6	11.7	19.2	21.5	15.0	10.2	9.3	12.5	2.0	3.6	2.6	2.7	2.7	2.6	3.1	3.6	3.2	2.7	3.4	5.4	9.2	12.8	18.5	14.4	15.3	1.3	3.6	3.9	9.6	10.2	6.1	3.9	8.5	8.6	11.8	3.7	12.5	7.1	14.1	7.4	3.9	9.4	0.4	8.2	17.2	9.4	3.5	12.0	14.8	8.7	6.4	7.4	10.7	9.6	10.8	10.9	7.1	4.6	4.9	8.4	14.8	4.7	8.2	9.4	4.2	0.0	5.6	9.4	0.0	14.0	12.0	3.4	25.7	16.1	23.2	9.8	3.9	3.0	10.0	4.2	6.8	5.3	7.8	9.3	6.6	8.5	7.1	1.1	7.7	6.6	2.0	5.5	11.9	9.5	7.6	3.6
GOLGA3	"GCP170, golgin-160, MEA-2"	ENSG00000090615	"Golgin A3"	Q08378	12	132768914-132829078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039809, HPA040044"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	Nucleoplasm	"HPA039809: AB_10962348, HPA040044: AB_10981600"	"unprognostic (1.93e-1)"	"unprognostic (7.91e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.10e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (6.47e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-1)"	12.4	12.3	19.2	12.5	18.8	13.7	11.6	14.8	20.2	15.9	20.6	15.8	7.9	14.7	9.2	16.2	12.8	8.7	13.7	19.1	18.6	9.7	14.0	13.5	12.8	18.6	19.1	17.0	19.6	7.8	26.9	10.5	20.1	14.7	11.7	26.3	17.3	10.8	14.7	15.4	13.6	12.3	13.3	15.1	15.1	11.6	20.5	17.7	12.5	8.6	11.1	14.5	14.3	17.4	19.7	39.1	13.4	23.2	42.2	28.7	25.9	34.1	23.3	23.8	20.9	40.7	8.7	25.6	16.8	45.4	17.1	19.7	16.3	19.6	14.1	6.4	17.3	27.6	44.6	26.0	25.9	29.5	36.2	23.4	22.8	26.8	26.6	23.4	22.7	19.1	27.1	9.8	21.0	30.2	27.0	26.7	14.0	15.1	24.8	21.8	14.1	10.9	13.4	47.1	16.1	10.5	27.0	22.9	14.6	15.2	31.1	22.2	38.7	23.5	17.6	26.8	21.9	31.0	32.0	40.4	28.8	16.3	28.7	3.2	2.0	2.6	3.4	2.9	3.1	2.5	2.6	3.3	2.3	3.4	2.7	2.9	1.5	3.9	2.3	3.9	3.6	2.0	19.2	18.8	14.8	20.2	19.1	18.6	18.6	19.1	20.1	13.3	20.5	17.4	22.9	44.8	40.6	25.8	22.0	21.7	12.7	17.0	13.1	26.0	21.2	16.1	35.4	8.6	26.8	14.7	100.1	13.4	20.6	63.0	7.9	15.2	23.8	21.8	46.9	24.8	22.2	16.4	40.2	27.8	24.2	29.0	48.9	47.5	12.0	33.3	14.6	24.1	16.0	18.5	41.1	50.2	10.2	15.1	16.4	34.6	25.7	18.2	17.8	21.5	18.4	20.1	23.7	22.6	33.3	31.5	27.1	22.6	54.2	32.3	17.9	8.6	26.4	110.6	6.6	32.1	27.7	25.1	24.8	19.0	33.1	23.1	21.7	24.6	32.5	29.4
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 683.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	38.6	36.3	18.3	19.5	26.7	21.2	28.8	26.6	22.3	27.6	58.3	28.1	38.8	20.0	23.5	37.3	21.1	19.3	63.7	17.6	20.8	34.5	60.8	25.7	17.0	27.2	24.6	23.4	48.0	33.5	40.6	36.1	27.5	29.6	28.1	56.8	38.4	20.7	118.8	48.2	36.9	19.5	21.8	24.1	38.2	44.3	22.3	17.6	47.2	102.3	19.6	25.0	28.9	29.9	62.6	42.3	21.4	27.1	55.2	47.2	54.4	78.3	65.2	30.2	36.3	36.5	33.9	21.4	19.9	67.1	34.7	35.9	34.4	55.5	62.3	27.4	25.2	28.9	37.9	58.5	55.2	30.9	20.3	25.4	51.8	47.7	92.1	48.8	44.4	15.8	35.9	32.6	49.1	26.8	23.7	13.4	23.4	31.7	39.9	5.4	64.8	22.8	37.4	64.4	13.7	18.1	48.6	51.8	61.4	40.8	76.3	22.4	54.0	30.7	35.6	60.0	56.7	39.8	30.1	18.3	54.4	26.6	36.8	30.7	6.6	15.5	16.2	7.6	14.0	9.9	10.3	11.9	5.5	11.6	10.7	8.1	8.9	15.7	15.2	11.8	7.6	4.3	18.3	26.7	26.6	22.3	17.6	20.8	27.2	24.6	27.5	21.8	22.3	29.9	85.4	237.2	312.9	142.0	98.2	158.3	134.0	70.2	128.1	171.9	97.0	84.1	683.5	84.4	147.4	46.0	358.6	112.7	126.4	154.3	29.4	117.5	240.7	131.6	141.8	102.2	89.6	127.1	154.5	120.2	117.8	128.0	140.2	242.7	62.0	112.9	63.1	147.5	92.0	188.4	168.6	166.2	65.1	73.1	73.9	46.7	119.9	80.3	69.4	107.7	91.9	145.8	132.8	133.7	223.2	136.4	109.1	113.6	150.2	169.7	181.2	64.5	82.4	361.0	85.5	161.8	95.7	435.6	227.2	98.5	175.7	249.6	97.2	125.7	139.3	189.2
GOLGA6A	"GLP, GOLGA6"	ENSG00000159289	"Golgin A6 family member A"	Q9NYA3	15	74069857-74082550	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"liver: 4.1;testis: 15.1"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 47.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.3"									"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "					"unprognostic (1.68e-1)"		"unprognostic (2.09e-2)"			"unprognostic (9.50e-2)"				"unprognostic (9.67e-2)"	"unprognostic (6.70e-2)"			0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	15.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6B		ENSG00000215186	"Golgin A6 family member B"	A6NDN3	15	72654738-72666394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"liver: 3.5;testis: 7.2"	"Group enriched"	"Detected in some"	4	"Astrocytes: 3.9;Early spermatids: 8.6;Excitatory neurons: 2.7;Inhibitory neurons: 2.7;Oligodendrocytes: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "					"unprognostic (5.47e-3)"		"unprognostic (1.88e-2)"			"unprognostic (2.07e-1)"				"unprognostic (2.01e-1)"	"unprognostic (2.03e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6C		ENSG00000167195	"Golgin A6 family member C"	A6NDK9	15	75258599-75270199	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 9.9"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "															"unprognostic (6.53e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GOLGA6D		ENSG00000140478	"Golgin A6 family member D"	P0CG33	15	75282835-75295807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 12.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "															"unprognostic (7.95e-3)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0
GOLT1B	"CGI-141, GOT1, YMR292W"	ENSG00000111711	"Golgi transport 1B"	Q9Y3E0	12	21501781-21518408	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055909, HPA066383"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	Nucleoplasm	"HPA055909: AB_2682967, HPA066383: AB_2685667"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.37e-3)"	"prognostic unfavorable (1.99e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.83e-10)"	"unprognostic (3.13e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.04e-1)"	17.5	22.1	12.7	16.9	14.1	25.8	18.5	13.4	18.9	18.0	12.7	13.4	10.6	14.6	15.6	13.6	12.5	13.9	14.8	13.9	15.1	15.5	18.8	17.6	15.0	13.2	14.6	10.9	21.6	11.9	19.0	29.0	13.8	16.1	14.8	14.1	16.1	13.2	15.5	12.9	11.3	17.7	13.9	12.4	14.2	10.6	14.7	11.2	15.9	11.8	14.1	17.8	12.2	16.3	31.2	30.0	28.5	36.5	56.5	83.2	46.1	126.5	48.2	40.4	63.3	45.4	48.1	19.4	29.8	66.6	71.0	30.1	23.4	27.2	69.5	29.4	22.8	29.7	19.6	32.8	61.0	37.0	36.8	44.2	50.1	44.9	85.6	67.7	35.8	24.4	18.6	21.1	59.2	30.7	17.3	62.1	75.7	27.8	23.5	14.0	65.0	39.4	32.2	18.7	7.2	23.1	49.0	20.6	70.4	90.2	28.2	39.4	40.6	46.5	49.5	57.1	67.2	20.3	45.9	51.8	63.6	35.5	64.2	48.0	26.6	20.8	22.1	31.4	26.6	22.7	25.8	24.4	27.0	25.9	23.3	23.8	7.2	21.6	29.4	29.4	28.0	27.6	12.7	14.1	13.4	18.9	13.9	15.1	13.2	14.6	13.8	13.9	14.7	16.3	23.4	9.6	15.6	15.0	38.9	46.7	23.4	42.7	27.3	27.6	20.4	11.2	18.9	22.8	36.8	16.5	10.4	29.0	34.9	13.8	27.4	31.6	3.4	10.9	26.3	28.7	13.1	22.9	70.4	33.4	72.4	45.7	15.3	21.7	21.5	10.3	16.8	23.2	41.0	18.5	49.3	31.7	38.7	23.6	65.1	5.2	17.4	35.4	53.4	14.0	26.0	17.5	18.6	25.1	25.4	38.6	15.4	19.9	75.8	49.0	8.7	21.7	18.2	7.7	13.1	24.6	39.3	23.7	32.4	22.8	63.9	64.0	39.1	9.6	14.6	44.9
GON4L	"FLJ20203, GON-4, GON4, YARP"	ENSG00000116580	"Gon-4 like"	Q3T8J9	1	155749659-155859400	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 160.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006986, HPA057305, HPA074504"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear bodies"		"HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696"	"unprognostic (3.16e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (9.85e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.26e-2)"	"unprognostic (5.83e-2)"	11.3	7.6	4.7	10.7	4.9	9.5	11.4	7.6	5.9	10.1	6.3	10.9	7.4	10.7	10.4	8.3	9.7	7.4	8.4	4.4	4.5	8.9	7.9	10.5	12.3	4.4	6.1	10.1	10.1	10.8	9.5	10.0	4.3	9.9	9.2	14.0	9.5	9.1	12.4	11.4	11.2	10.5	3.5	12.6	9.4	9.0	5.2	14.3	11.3	8.1	12.1	10.0	9.4	5.9	13.7	11.1	21.2	13.0	13.0	16.2	13.2	12.0	14.7	15.4	14.9	13.2	12.2	15.7	13.0	15.8	7.7	15.3	15.9	14.1	17.6	14.7	11.1	15.3	14.0	7.3	12.2	18.6	14.0	14.4	12.2	17.0	15.9	15.7	18.5	17.0	20.3	5.8	13.2	13.5	16.2	11.1	23.4	16.7	12.6	14.8	13.2	17.7	11.2	16.1	11.8	19.8	14.3	14.4	11.6	21.0	16.2	22.2	20.5	12.4	10.1	12.7	15.4	23.9	16.9	25.6	10.8	11.0	14.0	3.5	2.6	2.4	3.6	2.0	2.4	2.1	2.4	2.5	2.7	4.0	2.4	2.2	5.7	4.5	1.8	2.9	2.5	1.8	4.7	4.9	7.6	5.9	4.4	4.5	4.4	6.1	4.3	3.5	5.2	5.9	52.3	16.0	36.1	52.5	41.8	12.1	20.6	18.6	17.6	67.2	25.0	26.2	22.1	17.2	27.7	20.2	131.3	27.1	41.6	25.5	9.8	23.5	18.8	29.5	40.0	42.2	32.4	36.4	45.0	18.1	23.8	28.8	37.8	37.5	38.1	40.8	29.3	13.8	19.7	77.4	40.3	23.5	16.2	23.8	19.1	11.7	35.1	27.0	16.0	28.1	40.2	39.2	80.3	26.2	27.6	24.0	20.6	27.4	38.5	26.9	23.2	14.0	19.8	160.7	39.5	38.8	30.6	54.7	40.5	18.3	17.5	45.0	47.9	50.1	22.6	24.0
GON7	C14orf142	ENSG00000170270	"GON7 subunit of KEOPS complex"	Q9BXV9	14	93202894-93207065	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 68.4;Endometrial ciliated cells: 187.5;Proximal tubular cells: 51.8;Respiratory ciliated cells: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051832	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		41000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli rim"		"HPA051832: AB_2681628"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.40e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.47e-3)"	"unprognostic (7.37e-2)"	"prognostic favorable (3.08e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.77e-1)"	6.9	13.2	9.0	5.8	8.8	0.4	8.3	8.6	11.5	12.1	15.8	13.9	13.2	5.4	23.3	6.8	35.4	7.2	14.7	9.0	10.1	17.8	12.9	8.8	1.9	9.8	9.4	5.6	10.4	12.6	12.8	5.6	10.2	7.9	12.0	13.4	7.9	5.7	13.4	4.9	10.2	5.2	8.6	8.8	9.1	8.7	9.6	3.7	8.7	12.9	9.9	6.9	5.7	9.1	11.6	9.2	13.3	8.9	9.2	21.4	9.3	11.0	6.2	21.6	17.5	9.1	18.1	4.7	7.2	7.0	12.6	18.2	18.3	9.2	25.1	0.1	0.0	4.6	22.5	22.6	4.7	9.7	19.6	4.1	11.9	15.1	9.7	6.0	13.3	5.5	16.7	1.5	9.3	26.8	11.3	23.4	3.4	49.6	4.3	20.0	12.9	21.4	23.4	12.9	15.8	19.8	8.2	20.4	24.8	11.8	16.8	19.9	13.6	7.6	15.1	16.5	6.2	10.0	29.6	3.1	23.2	10.8	13.2	6.2	0.9	0.4	0.8	1.7	0.1	0.0	0.5	0.6	1.5	0.7	0.2	0.4	0.9	0.3	0.8	0.2	0.8	0.5	9.0	8.8	8.6	11.5	9.0	10.1	9.8	9.4	10.2	8.6	9.6	9.1	17.2	6.4	13.6	0.0	7.2	0.0	0.0	0.0	0.0	0.0	19.7	23.9	0.0	0.0	9.9	14.7	0.0	19.6	12.7	0.0	68.4	27.7	0.0	187.5	15.8	7.3	0.0	0.0	0.0	21.7	18.1	5.8	0.0	27.4	10.1	9.4	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	17.5	0.0	0.0	1.4	0.0	0.0	51.8	94.7	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	7.7	7.0	21.3	0.0	0.0
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532131-170553834	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027250, HPA027746"	Approved		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	3.1	5.2	1.6	1.9	1.6	0.6	2.8	1.6	3.1	3.8	1.9	3.6	1.4	3.2	3.5	2.3	2.1	2.1	3.1	1.5	2.3	2.5	4.3	2.5	3.6	1.6	1.8	4.3	3.7	1.9	3.0	3.1	1.7	2.8	3.3	1.3	3.3	2.6	1.1	1.9	2.7	2.0	1.7	3.1	2.1	2.0	2.0	2.8	3.0	2.1	3.0	3.1	3.3	1.8	3.4	3.8	4.5	2.0	9.0	5.8	2.9	4.8	7.5	3.6	4.6	1.9	4.9	5.1	6.1	4.3	2.4	4.0	6.4	2.8	6.0	4.8	1.6	2.5	4.0	2.8	4.9	4.4	3.1	4.4	2.5	4.2	3.9	5.5	3.5	2.3	4.4	2.3	5.3	0.6	5.8	4.0	4.7	6.2	4.0	3.9	3.8	6.0	4.2	1.9	1.4	3.0	3.6	4.8	11.5	3.1	2.7	8.4	4.4	6.8	3.1	2.9	7.2	3.5	4.4	3.8	5.2	4.0	5.4	0.7	3.9	0.0	2.3	4.2	3.9	2.8	4.1	3.5	4.3	2.8	3.6	3.0	0.5	3.8	3.1	2.7	5.3	2.6	1.6	1.6	1.6	3.1	1.5	2.3	1.6	1.8	1.7	1.7	2.0	1.8	8.1	0.0	11.4	8.8	8.9	2.8	4.0	6.5	8.6	4.7	5.2	7.1	9.4	10.0	7.1	5.5	2.1	6.0	6.2	12.8	3.9	12.3	2.3	5.5	10.4	8.3	0.0	3.4	9.3	6.0	7.3	10.5	9.2	6.7	13.9	5.2	5.3	6.6	7.1	5.0	7.7	9.4	8.2	6.9	4.6	3.2	14.0	5.6	3.6	3.7	10.1	4.3	3.1	9.0	7.3	5.7	9.8	6.4	10.3	4.9	4.3	6.0	2.4	7.1	6.6	8.2	9.3	13.1	8.1	5.4	1.6	5.6	6.3	5.1	6.4	3.0
GOSR2	"Bos1, GS27"	ENSG00000108433	"Golgi SNAP receptor complex member 2"	O14653	17	46923075-46975524	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 303.0;Late spermatids: 796.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB017456, HPA048956, HPA054472"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"CAB017456: AB_10532285, HPA048956: AB_2680569, HPA054472: AB_2682499"	"unprognostic (3.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.29e-2)"	23.2	25.6	28.5	21.7	28.7	16.4	24.8	31.6	37.6	24.8	32.9	22.8	49.8	23.8	31.6	21.5	21.3	18.3	32.5	29.3	29.3	42.2	33.9	23.6	26.4	28.7	29.7	26.1	31.3	35.5	37.1	28.7	29.2	23.1	27.4	25.0	32.5	30.5	43.1	21.9	43.2	29.8	28.1	30.1	23.1	48.3	29.5	27.1	26.6	34.3	31.8	25.2	18.6	30.9	44.6	47.2	33.5	40.3	54.9	39.3	37.8	59.7	58.5	63.5	56.7	60.1	25.7	37.7	33.1	75.4	66.5	30.1	43.4	48.5	77.8	83.0	33.3	56.8	37.4	60.1	60.3	44.9	44.1	40.8	47.1	52.2	73.2	49.0	52.6	43.7	56.5	50.9	46.2	46.8	50.0	24.2	31.1	60.1	65.8	43.5	64.0	44.5	40.7	37.7	28.8	61.5	33.3	19.2	47.9	57.1	55.1	31.3	62.1	60.0	38.8	47.4	58.9	64.6	39.4	60.1	56.1	28.6	67.1	39.5	33.1	29.2	33.9	63.2	31.3	29.8	29.7	27.8	32.7	38.6	29.1	25.4	3.6	31.2	86.0	29.7	38.8	35.2	28.5	28.7	31.6	37.6	29.3	29.3	28.7	29.7	29.2	28.1	29.5	30.9	23.7	25.6	18.7	17.9	22.0	16.6	17.3	16.7	4.6	18.5	21.1	18.0	16.2	15.7	14.5	33.1	6.2	30.2	23.8	15.9	23.5	34.5	303.0	9.1	18.0	25.2	7.2	20.6	24.2	42.7	33.1	18.4	15.3	11.0	14.5	22.7	21.8	22.4	45.1	23.5	26.3	16.8	16.2	22.0	14.7	796.1	16.8	15.0	10.6	21.5	22.0	16.4	14.4	17.1	28.4	58.1	24.2	14.3	23.5	22.1	96.5	90.0	13.7	20.4	0.0	9.3	26.8	33.1	26.7	7.4	16.9	52.7	14.9	18.4	12.6	20.5
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 511.1;liver: 369.5;skeletal muscle: 489.9;tongue: 1011.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 449.0;Distal tubular cells: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		100000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favorable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	14.7	54.9	67.8	14.7	71.1	8.0	22.7	70.3	119.1	53.1	82.6	50.9	62.0	13.1	25.9	42.7	17.9	49.0	511.1	70.0	77.6	143.1	369.5	15.5	14.1	83.5	55.0	18.1	34.0	142.4	22.5	14.4	83.7	22.7	59.2	106.2	48.6	27.4	489.9	23.9	45.8	21.4	48.4	16.9	58.9	33.6	69.1	17.7	47.7	1011.6	30.3	22.3	21.0	70.1	73.7	40.3	46.0	114.4	35.1	30.7	127.1	58.9	108.7	101.8	109.8	89.9	56.4	71.9	20.4	50.2	89.2	88.6	107.1	78.9	105.8	25.7	46.7	28.1	46.7	114.3	184.9	77.9	44.0	47.3	82.5	86.9	228.4	69.5	49.5	48.6	71.1	106.2	65.4	64.9	42.5	56.5	29.2	118.7	56.1	45.5	44.4	72.8	173.7	37.5	19.6	28.7	44.8	59.3	222.6	66.8	115.7	27.1	23.3	25.4	56.3	28.0	68.7	76.8	99.7	74.3	65.4	40.8	34.1	4.0	8.7	6.8	19.7	25.8	18.4	17.6	21.5	20.7	21.9	21.2	15.6	22.7	0.8	20.5	31.5	36.4	27.6	15.6	67.8	71.1	70.3	119.1	70.0	77.6	83.5	55.0	83.7	48.4	69.1	70.1	10.3	16.0	16.2	26.1	38.8	11.9	41.8	82.7	24.5	95.6	18.8	21.2	449.0	72.9	34.4	73.5	62.6	35.9	10.7	62.1	240.7	51.9	166.7	17.8	9.3	16.7	19.7	39.5	47.4	30.8	18.1	23.5	76.9	21.5	31.8	20.2	17.2	191.8	31.6	75.7	63.3	45.3	54.9	12.4	6.9	24.1	11.1	13.0	49.8	13.1	10.5	36.6	6.2	21.1	37.2	27.6	34.4	14.3	22.4	13.1	97.0	163.3	27.9	76.5	13.1	15.2	20.5	116.7	10.4	40.9	10.4	55.1	14.6	47.0	66.4	42.3
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060779-129062406	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.1;lung: 3.2;lymphoid tissue: 8.9"	"Cell type enriched"	"Detected in some"	8	"Macrophages: 151.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 29.5;neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 29.5"	"Cell line enriched"	"Detected in some"	14	"HEL: 85.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		2600000	"Cluster 34: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.1	1.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	1.2	0.2	0.2	0.7	0.3	0.0	0.0	0.3	0.6	0.1	0.1	0.0	13.9	0.0	0.2	3.0	0.0	51.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	14.4	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	2.9	0.1	1.7	0.0	0.0	0.6	0.0	1.3	0.0	18.3	0.0	151.9	0.0	0.0	4.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.3	0.0
GPALPP1	"AD029, bA245H20.2, KIAA1704, LSR7"	ENSG00000133114	"GPALPP motifs containing 1"	Q8IXQ4	13	44989529-45037669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038966, HPA058739"	Approved		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim"	Nucleoplasm	"HPA038966: AB_10672656, HPA058739: AB_2683804"	"unprognostic (4.99e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.94e-2)"	6.2	6.6	2.4	3.2	2.2	6.5	5.3	4.8	3.2	6.9	0.7	6.1	3.0	6.7	3.0	5.8	6.1	2.1	5.5	2.3	2.2	6.9	5.0	5.2	4.3	1.0	1.6	8.0	4.9	1.8	6.0	3.6	1.2	5.7	2.9	5.6	5.3	2.5	4.3	4.5	5.2	2.6	0.3	5.6	5.6	5.3	1.6	3.2	6.1	1.8	3.6	6.5	6.4	3.3	4.7	3.8	6.2	4.6	2.6	5.3	6.3	6.1	3.8	6.1	5.8	7.8	9.1	10.9	4.3	4.1	5.8	9.6	6.6	5.1	5.7	9.2	9.2	8.1	6.3	5.4	3.9	10.9	4.5	3.3	2.9	4.8	3.2	3.7	4.9	8.5	7.2	2.4	4.0	5.5	11.0	9.3	5.7	11.9	4.4	11.0	5.3	4.5	3.5	4.6	3.2	5.1	5.8	4.0	3.5	4.5	4.0	11.0	7.9	4.0	3.3	4.6	5.1	4.0	4.0	11.5	4.1	6.7	5.2	2.4	3.9	6.7	4.0	3.1	3.2	4.8	4.1	2.7	4.4	6.2	4.7	4.2	2.9	4.0	3.3	5.7	3.1	2.5	2.4	2.2	4.8	3.2	2.3	2.2	1.0	1.6	1.2	0.3	1.6	3.3	18.5	32.1	34.2	26.1	19.1	7.1	15.6	11.6	15.4	24.4	13.7	13.6	16.2	15.7	22.3	23.9	18.8	27.9	19.6	6.8	23.5	13.0	7.0	15.2	26.1	17.3	18.0	14.7	65.0	13.3	13.1	19.0	9.2	17.2	21.5	27.7	16.8	17.3	15.5	23.5	57.3	11.3	12.2	14.2	7.6	5.1	26.8	12.9	12.4	24.4	15.6	18.5	29.9	53.3	42.6	11.4	11.1	26.7	10.5	10.0	10.7	21.0	22.3	26.1	26.3	20.1	23.1	48.7	26.7	16.7	9.2	18.2	16.2	22.9	12.6	11.8
GPATCH11	"CCDC75, CENP-Y, CENPY, FLJ38348"	ENSG00000152133	"G-patch domain containing 11"	Q8N954	2	37084451-37099244	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038231, HPA038232"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA038231: AB_2675904, HPA038232: AB_10675788"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.31e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.16e-2)"	23.0	6.3	7.5	7.8	8.5	10.0	6.9	8.8	9.9	7.0	6.0	4.5	4.8	4.8	3.7	5.1	3.7	4.4	5.4	7.7	8.8	5.5	5.7	6.3	12.7	8.3	8.0	5.9	3.0	5.5	3.5	5.7	8.5	4.0	4.9	21.0	3.7	4.1	2.4	5.9	5.0	4.3	8.5	8.0	4.8	11.6	8.0	10.3	6.4	5.4	11.7	5.2	3.1	10.4	12.5	7.4	12.4	9.7	25.7	11.9	13.2	22.1	8.9	13.1	10.7	9.4	5.2	14.4	12.1	8.3	11.4	8.8	14.8	5.3	19.5	24.7	16.1	26.3	9.8	9.6	8.3	31.7	27.5	7.8	9.4	18.0	10.1	8.6	11.6	9.0	25.0	65.8	15.4	6.3	20.6	17.4	5.3	20.5	10.3	16.9	26.4	40.7	5.7	5.3	14.9	13.9	11.6	7.4	11.2	9.9	7.6	14.6	12.9	23.7	13.1	17.4	24.7	25.6	28.2	21.6	16.9	26.2	21.3	5.9	2.4	2.2	4.4	2.0	4.4	8.7	3.2	3.7	3.6	6.8	3.4	3.5	0.8	6.7	0.7	12.2	2.6	1.5	7.5	8.5	8.8	9.9	7.7	8.8	8.3	8.0	8.5	8.5	8.0	10.4	14.7	12.8	8.1	3.9	23.3	4.2	2.7	5.7	7.4	24.3	6.2	7.0	14.1	8.6	5.0	11.0	25.0	8.8	48.7	12.1	11.7	9.3	32.9	12.6	20.0	12.8	3.0	22.1	14.3	14.1	30.5	12.2	8.6	13.9	12.0	8.7	17.9	15.0	13.4	13.5	12.1	9.1	6.1	18.8	15.0	10.5	16.1	21.1	3.6	5.6	12.7	28.9	22.6	10.6	12.5	14.8	4.9	22.2	23.2	1.6	9.7	13.2	11.5	52.7	13.1	13.4	21.7	75.5	43.6	7.8	5.4	3.8	16.8	13.7	6.0	2.0
GPATCH2L	"C14orf118, FLJ10033, FLJ20689"	ENSG00000089916	"G-patch domain containing 2 like"	Q9NWQ4	14	76151916-76254342	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018856	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA018856: AB_1845553"	"unprognostic (5.98e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.81e-1)"	9.9	8.9	7.5	12.1	10.1	37.5	9.7	10.7	9.7	8.9	11.4	9.9	8.5	10.5	9.5	11.3	8.0	12.2	13.3	7.8	10.2	8.9	6.8	10.7	12.1	9.9	8.9	10.4	8.7	9.2	6.9	11.3	9.4	9.8	10.8	15.5	8.2	9.8	12.1	9.0	9.2	11.9	9.9	10.8	9.3	13.8	8.8	11.6	9.7	14.0	12.1	10.5	9.3	12.8	18.7	24.0	19.2	15.3	11.0	17.0	15.7	21.7	15.0	20.7	20.1	16.0	30.8	22.2	12.6	16.8	16.8	22.0	23.4	14.2	36.6	24.7	12.9	19.5	26.1	10.1	14.2	13.7	27.6	17.6	12.6	17.8	23.0	16.2	21.9	18.1	20.6	30.6	18.6	30.6	18.3	17.7	24.2	11.1	17.5	20.3	23.2	11.5	14.7	37.0	15.5	19.2	24.5	21.6	12.0	19.7	25.2	21.2	24.0	26.7	15.3	14.9	16.5	30.7	31.3	29.2	21.4	18.4	28.0	5.3	7.3	7.9	3.5	6.6	3.0	6.3	1.9	5.2	7.2	5.3	4.2	3.0	5.6	5.6	4.8	5.6	4.5	3.7	7.5	10.1	10.7	9.7	7.8	10.2	9.9	8.9	9.4	9.9	8.8	12.8	35.3	16.0	18.2	48.0	30.2	23.3	37.4	26.0	22.2	100.0	19.9	21.2	46.3	18.6	25.2	18.4	104.3	16.2	36.8	18.8	3.9	20.0	151.4	28.9	46.2	38.2	47.8	17.1	76.0	13.3	12.7	36.6	21.9	54.5	43.7	48.2	29.3	11.6	25.2	158.2	67.0	19.3	24.4	43.0	48.9	138.9	24.8	43.5	23.2	59.0	47.7	42.3	43.3	82.0	75.0	30.4	29.4	37.6	24.6	56.9	40.2	13.5	24.4	122.7	26.3	55.0	41.7	56.6	27.2	18.7	27.3	17.4	31.2	34.9	20.6	42.6
GPATCH3	"FLJ12455, GPATC3"	ENSG00000198746	"G-patch domain containing 3"	Q96I76	1	26890488-26900467	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032078, HPA054973"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA032078: AB_10603671, HPA054973: AB_2682656"	"unprognostic (2.93e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (4.37e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.46e-2)"	"prognostic favorable (6.42e-4)"	"unprognostic (3.77e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.82e-2)"	8.3	11.5	10.9	6.3	12.1	23.2	8.2	11.2	13.0	8.0	9.5	8.6	8.5	8.6	8.9	9.4	6.8	5.7	9.9	10.2	9.9	9.1	12.5	6.7	9.0	10.7	11.0	7.1	8.9	7.9	7.6	8.0	10.2	8.2	6.2	5.4	7.9	6.1	18.1	13.0	9.3	6.4	10.4	11.8	9.9	10.8	11.2	9.3	7.5	12.4	7.5	8.5	7.6	12.9	12.5	9.9	9.4	14.5	8.9	8.5	12.7	9.4	10.9	18.6	16.2	12.1	14.6	11.4	10.3	9.6	9.7	12.6	15.8	17.8	9.9	13.0	18.1	22.5	22.3	25.2	11.9	15.2	14.6	12.5	15.7	18.3	10.1	8.2	12.1	14.9	26.7	15.0	7.8	9.2	13.5	28.2	21.5	14.4	12.2	16.6	13.5	18.0	9.2	6.5	12.2	14.6	18.8	16.0	27.9	10.1	14.3	14.5	12.9	11.8	13.9	16.2	10.7	19.0	27.4	15.2	10.6	21.6	10.6	30.3	17.9	22.3	16.2	14.6	13.1	12.5	13.3	14.2	18.7	11.9	13.6	13.0	7.8	9.8	19.0	14.2	12.6	14.4	10.9	12.1	11.2	13.0	10.2	9.9	10.7	11.0	10.2	10.4	11.2	12.9	5.4	3.2	3.9	1.6	11.7	9.7	4.8	5.6	8.0	6.4	7.0	4.7	4.0	1.5	3.7	0.0	12.5	15.5	10.3	11.6	5.9	10.9	2.2	4.5	4.1	8.1	11.3	6.9	3.5	12.5	10.0	5.3	11.2	6.1	5.7	7.8	8.2	6.2	11.2	5.0	3.0	4.7	6.1	9.4	7.5	1.4	5.3	10.0	8.8	1.9	15.3	6.6	12.3	3.5	3.5	10.6	7.5	7.2	8.3	4.3	10.4	7.4	3.1	5.5	6.6	6.6	5.9	12.5	25.3	8.3	9.8	30.1	11.2	6.6	6.2	4.9
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594301-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: AB_2682447"	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	24.5	19.5	12.1	16.7	12.4	10.6	18.9	8.7	17.3	14.9	8.0	19.8	8.9	19.9	9.1	21.7	16.6	6.8	23.0	11.5	12.4	26.5	21.4	14.9	16.8	12.5	13.0	15.0	19.6	15.6	10.1	9.6	12.8	19.2	13.0	2.9	16.3	10.6	79.0	17.3	16.2	14.3	9.9	18.6	19.3	13.1	11.7	11.8	14.4	31.9	19.0	22.8	16.1	14.7	54.6	67.6	31.2	46.3	28.1	20.4	44.0	66.0	27.8	53.3	30.7	74.9	44.8	131.6	55.0	47.8	34.3	38.7	68.9	59.4	54.5	38.2	65.2	82.1	65.2	57.3	26.2	174.9	48.3	25.0	51.1	96.9	79.3	13.1	36.6	44.0	135.5	31.8	40.7	96.2	82.0	39.8	138.9	92.5	71.4	72.9	52.1	96.3	35.0	58.4	50.4	75.8	59.6	146.7	41.6	31.9	46.2	89.3	52.8	50.7	66.0	53.4	121.1	57.8	69.5	169.9	45.7	89.7	79.7	0.1	9.4	0.1	20.9	17.9	20.4	29.1	21.2	24.0	17.5	30.7	24.1	25.1	0.4	19.0	22.0	11.1	15.7	12.6	12.1	12.4	8.7	17.3	11.5	12.4	12.5	13.0	12.8	9.9	11.7	14.7	17.0	32.1	38.3	5.2	36.0	73.7	65.9	32.5	26.2	7.7	23.8	25.4	27.2	25.8	33.4	16.5	8.4	35.6	19.5	26.5	25.4	51.9	12.9	19.1	53.7	32.5	37.0	42.9	6.4	57.1	53.0	29.0	23.0	20.1	57.7	24.3	18.5	46.9	37.4	8.4	4.6	26.1	10.2	13.6	21.3	11.4	26.8	19.0	23.2	2.8	18.8	6.9	23.7	1.5	3.3	53.0	17.5	26.7	23.8	92.5	7.8	34.3	14.9	6.4	32.9	66.0	45.4	47.4	44.3	33.5	62.7	15.5	26.3	38.6	43.6	51.5
GPBP1L1	SP192	ENSG00000159592	"GC-rich promoter binding protein 1 like 1"	Q9HC44	1	45627304-45688113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028593	Approved		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites, Cytosol"	"HPA028593: AB_10602906"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.42e-3)"	"unprognostic (9.79e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.51e-1)"	"unprognostic (7.56e-3)"	"unprognostic (6.13e-2)"	28.7	26.7	25.2	31.0	29.4	49.3	40.9	27.3	28.0	35.0	26.1	57.3	54.0	35.6	37.6	45.0	36.2	30.3	41.7	23.6	27.1	47.0	66.3	39.2	39.9	27.7	28.3	30.6	39.3	41.7	25.5	34.1	28.2	35.8	61.2	27.4	42.4	36.1	46.2	47.2	56.7	36.3	26.8	36.9	42.6	57.9	27.4	54.7	48.7	54.9	49.5	35.6	36.7	32.8	41.1	24.7	42.1	44.9	48.4	47.1	57.5	31.9	52.2	44.8	56.1	25.2	44.8	56.3	40.5	43.7	46.9	42.0	46.6	47.8	56.3	64.4	33.4	73.7	28.9	39.2	66.7	74.2	65.1	34.6	102.0	35.3	99.4	60.2	57.7	71.0	63.7	48.7	51.6	22.0	66.2	65.8	60.4	54.8	27.7	43.0	55.1	41.9	51.5	40.2	51.9	34.7	52.6	76.6	83.5	81.6	35.1	86.2	49.8	32.0	33.6	35.2	48.9	47.2	46.9	41.3	34.0	60.6	34.5	24.0	21.6	40.3	21.6	27.3	22.9	16.5	20.9	21.1	23.0	14.1	22.6	22.4	22.6	26.6	30.6	13.1	26.4	21.1	25.2	29.4	27.3	28.0	23.6	27.1	27.7	28.3	28.2	26.8	27.4	32.8	43.3	60.9	24.4	54.5	45.1	64.9	41.2	28.3	59.2	23.5	51.3	33.5	46.9	41.5	34.3	60.7	35.5	26.2	47.5	96.8	50.9	33.0	23.4	38.1	32.2	38.6	38.3	62.1	48.5	38.9	33.7	25.4	44.9	47.5	59.6	24.3	37.5	81.3	25.0	37.0	49.0	67.2	32.6	49.9	51.6	17.6	20.5	46.1	23.2	70.3	41.3	18.2	45.3	50.8	93.8	51.2	57.0	21.4	36.6	62.8	75.5	58.7	33.0	32.9	19.7	22.4	42.0	78.9	75.3	71.7	67.8	45.4	47.1	27.7	68.6	78.2
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415489	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Alveolar cells type 2: 29.2;Astrocytes: 54.5;Extravillous trophoblasts: 36.2;Granulosa cells: 30.6;Proximal tubular cells: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 209.7;HAP1: 121.8;NTERA-2: 110.3;RPTEC TERT1: 276.6;SuSa: 242.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		190000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	9.6	9.8	5.9	4.9	6.4	0.1	5.6	5.0	5.8	12.0	4.6	22.5	10.6	10.8	16.4	7.4	11.2	9.0	7.9	6.3	7.5	20.6	1.8	17.4	2.5	7.2	6.9	12.3	10.8	5.6	16.6	29.0	6.0	8.0	10.9	1.2	13.0	11.4	24.3	3.8	10.8	17.7	6.6	5.7	16.9	7.8	4.9	8.4	5.9	20.0	2.0	10.3	5.2	8.5	0.0	0.0	209.7	8.3	8.9	1.3	26.0	1.6	0.0	0.0	0.0	0.1	0.5	0.3	71.7	1.2	0.0	0.1	121.8	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.2	0.0	0.0	37.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	6.0	0.1	0.1	110.3	0.0	3.2	0.6	19.2	0.0	276.6	8.4	0.1	1.5	0.8	0.1	0.1	242.0	3.2	3.2	0.0	21.3	24.8	0.0	13.6	0.0	0.0	0.1	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.4	5.0	5.8	6.3	7.5	7.2	6.9	6.0	6.6	4.9	8.5	1.7	51.3	29.2	54.5	0.2	1.5	3.7	14.7	14.2	0.0	2.9	2.0	4.4	5.7	8.7	23.9	0.0	0.5	0.2	2.5	3.9	7.0	0.6	5.9	1.7	1.2	2.4	0.0	4.7	12.7	36.2	14.4	6.6	10.0	0.0	30.6	0.0	0.0	2.5	0.0	1.4	11.1	4.1	0.6	3.9	2.1	2.1	2.0	1.8	14.0	1.1	1.0	0.0	4.5	4.3	16.5	4.3	0.4	0.1	1.4	4.6	30.3	12.8	0.1	0.0	6.3	13.6	2.4	23.6	2.3	0.4	3.1	1.0	1.4	11.3	0.6
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398621-92873682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.1;kidney: 7.3;testis: 6.1"	"Cell type enriched"	"Detected in some"	20	"Astrocytes: 3868.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 49.9;HeLa: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA040152: AB_2676863, HPA044081: AB_2678801"	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.1	1.6	10.3	0.3	18.1	0.1	0.0	6.7	9.6	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.5	1.1	8.4	12.1	7.3	1.3	3.2	0.2	18.2	13.4	0.4	0.1	0.0	1.7	0.4	20.5	0.1	0.5	0.5	0.1	0.4	0.0	0.1	0.1	0.1	5.7	0.0	0.1	6.1	23.1	0.1	1.1	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.9	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	27.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.6	0.0	1.7	0.0	0.8	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.4	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	10.3	18.1	6.7	9.6	8.4	12.1	18.2	13.4	20.5	5.7	23.1	4.9	0.0	0.0	2.7	3868.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	64.6	0.0	1.6	0.0	0.0	0.1	0.0	0.0	116.6	0.0	0.0	0.4	0.0	0.1	0.0	7.9	0.0	0.0	0.1	0.0	190.6	0.1	0.0	0.0	0.4	1.0	0.3	0.1	0.0	118.0	0.6	0.0	0.0	127.2	20.9	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.1	0.1	0.5	0.0	0.1
GPCPD1	"GDE5, GDPD6, KIAA1434"	ENSG00000125772	"Glycerophosphocholine phosphodiesterase 1"	Q9NPB8	20	5544439-5611006	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 208.7;Microglial cells: 291.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042987			Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA042987: AB_2678254"	"unprognostic (2.25e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (2.93e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-2)"	17.5	15.5	17.4	16.3	18.6	75.5	13.5	21.6	23.4	16.3	13.0	12.9	7.9	13.3	7.1	13.3	17.2	12.1	17.1	16.1	19.1	19.5	10.2	27.4	17.9	21.2	17.8	23.3	9.7	4.0	13.2	14.9	22.1	13.1	11.1	12.2	26.5	13.1	17.5	11.1	16.6	12.8	18.6	31.9	11.2	9.1	19.2	13.3	15.5	10.2	17.0	12.9	13.0	16.8	6.5	12.1	8.0	6.5	5.2	6.1	9.1	10.0	7.9	5.7	3.8	6.3	5.0	14.4	1.8	5.6	5.0	2.2	10.1	19.8	5.5	3.1	3.2	19.6	1.5	7.4	25.0	12.2	8.6	13.0	25.3	3.4	41.3	5.7	6.0	8.8	11.5	7.3	5.2	3.5	11.1	6.7	4.4	11.3	6.7	8.0	9.5	5.2	7.7	5.3	3.0	4.0	4.4	19.2	9.5	7.9	4.6	33.7	6.8	4.8	3.6	13.2	6.4	6.9	12.7	15.1	1.5	14.8	5.4	2.9	7.4	9.2	3.7	5.5	2.9	4.2	2.8	3.2	4.5	3.6	4.2	2.9	16.0	3.9	5.8	2.0	2.5	3.9	17.4	18.6	21.6	23.4	16.1	19.1	21.2	17.8	22.1	18.6	19.2	16.8	34.8	22.4	56.4	31.6	59.6	16.6	15.8	23.0	17.1	18.0	25.7	39.6	36.8	12.8	48.5	22.0	6.2	29.9	59.1	13.2	3.9	11.9	208.7	37.8	41.2	41.1	19.7	89.0	30.9	9.1	16.8	27.1	35.7	66.9	43.1	26.0	17.9	14.4	43.9	11.8	22.8	25.7	24.4	69.2	54.9	54.6	5.6	125.0	10.6	291.4	60.9	8.5	33.0	63.3	13.4	7.3	12.7	3.4	55.2	21.1	16.6	7.7	24.6	20.3	6.6	31.9	35.1	44.1	11.3	25.8	27.4	48.7	63.1	12.7	12.8	57.7
GPER1	"CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR"	ENSG00000164850	"G protein-coupled estrogen receptor 1"	Q99527	7	1082208-1093815	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 45.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 9.6;Distal enterocytes: 15.4;Endothelial cells: 11.3;Hepatocytes: 23.5;Kupffer cells: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.9;intermediate monocyte: 2.8;myeloid DC: 5.8"	"Group enriched"	"Detected in many"	19	"dendritic cells: 5.8;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;Daudi: 12.1;fHDF/TERT166: 8.6;Hep G2: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016718, HPA027052"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoli	"Nucleoplasm, Vesicles, Cytosol"	"HPA016718: , HPA027052: AB_10612112"	"unprognostic (4.74e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.78e-2)"	10.6	12.6	12.7	1.5	11.7	0.2	8.4	9.0	15.9	5.4	8.1	10.8	0.6	5.8	0.3	2.2	4.3	1.2	7.1	10.0	9.6	9.7	27.9	12.1	1.9	9.9	10.2	2.4	2.1	0.4	6.1	6.3	10.5	7.2	1.4	0.9	2.9	5.0	4.3	2.8	3.6	1.8	8.4	8.5	45.3	1.5	11.6	0.9	9.7	1.3	1.0	6.1	4.7	9.2	1.1	0.4	0.3	11.5	2.7	2.6	1.1	6.7	4.4	2.1	3.7	0.2	0.3	12.1	1.1	8.6	0.1	0.6	0.1	0.0	0.2	2.6	2.1	0.0	1.4	22.8	0.4	0.1	0.7	1.5	0.0	1.3	0.0	1.6	0.6	0.2	0.1	0.1	0.5	0.8	0.0	0.4	2.2	2.4	7.9	1.1	0.0	0.0	0.2	0.0	0.1	4.5	0.0	0.5	2.5	0.8	0.2	0.1	1.6	0.4	2.8	6.9	2.1	0.0	0.0	4.4	3.8	0.2	0.2	0.0	2.9	0.0	0.0	2.8	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.4	12.7	11.7	9.0	15.9	10.0	9.6	9.9	10.2	10.5	8.4	11.6	9.2	9.6	0.0	0.0	1.0	1.2	0.5	0.0	0.5	1.8	0.0	0.5	0.5	2.8	0.0	0.0	5.5	0.0	0.0	0.0	15.4	0.0	0.1	0.0	4.4	0.1	11.3	1.2	0.0	0.8	3.1	0.6	1.5	0.5	1.0	0.0	0.4	1.1	23.5	0.6	0.0	0.5	2.8	0.0	16.9	2.7	0.7	2.8	2.9	0.0	1.9	0.6	4.4	0.0	0.5	0.1	0.8	7.4	1.2	0.1	0.8	0.2	5.6	0.0	0.4	0.0	0.7	7.2	0.5	2.7	0.1	0.3	0.0	0.0	0.1	2.0	0.1
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.0;Late spermatids: 1127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		86000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	196.9	283.2	83.4	74.5	101.9	222.8	129.0	67.7	130.5	95.0	84.8	162.9	113.7	92.4	27.2	197.8	88.8	87.1	407.2	108.5	73.6	196.8	222.6	91.2	66.4	73.5	58.5	97.0	84.2	166.3	147.2	47.5	69.3	94.4	84.3	156.1	105.1	61.0	416.6	120.1	126.5	78.4	34.0	102.2	122.5	95.9	83.2	50.1	100.8	374.6	76.0	147.9	121.5	95.8	572.9	596.1	58.7	433.3	167.5	121.9	134.1	183.4	132.4	206.3	253.7	314.9	169.6	303.5	311.4	177.9	149.1	343.7	337.7	437.0	259.4	461.0	105.1	382.1	252.3	310.8	108.4	517.6	259.3	173.7	136.6	289.0	132.7	273.3	209.3	230.5	210.3	261.8	140.2	319.2	245.5	133.5	158.0	421.3	174.6	242.7	149.1	649.4	254.1	275.4	304.9	185.8	331.9	634.3	131.7	100.5	144.4	161.7	171.9	80.8	185.5	256.7	312.8	535.5	383.7	318.4	287.4	372.3	170.6	188.8	93.2	331.3	80.4	141.2	99.1	59.9	73.7	93.1	101.0	50.5	61.8	72.8	7.4	58.0	180.3	31.6	83.4	123.4	83.4	101.9	67.7	130.5	108.5	73.6	73.5	58.5	69.3	34.0	83.2	95.8	34.2	28.9	40.0	98.9	43.8	25.9	30.1	104.5	42.7	98.8	34.1	27.2	232.5	42.9	51.4	57.0	75.0	44.5	41.6	76.7	115.4	101.7	331.0	35.9	41.2	38.0	63.7	46.7	121.8	66.9	69.2	47.1	109.1	58.0	23.4	36.1	42.8	89.5	89.6	237.2	127.2	75.8	50.8	52.9	40.5	1127.2	37.0	58.1	35.6	17.8	44.4	32.6	23.7	43.7	87.7	77.6	39.4	30.5	77.1	31.5	111.8	103.0	33.1	68.3	19.7	44.3	65.0	7.8	22.3	139.1	32.8	39.3	64.3	74.8	126.9	37.2
GPKOW	"GPATC5, GPATCH5, Mos2, Spp2, T54"	ENSG00000068394	"G-patch domain and KOW motifs"	Q92917	X	49113407-49123735	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000287, HPA001894"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA000287: AB_1079015, HPA001894: AB_1079014"	"unprognostic (3.34e-2)"	"unprognostic (9.54e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-2)"	17.6	15.9	21.5	11.7	22.6	16.1	16.4	22.7	21.8	14.7	14.0	17.0	14.3	16.9	11.8	14.7	15.1	10.3	18.6	19.8	21.2	15.5	14.5	13.8	14.9	24.2	23.6	13.6	12.1	19.0	17.2	13.8	23.9	12.7	12.6	11.9	13.8	16.5	34.8	20.4	14.1	13.8	22.4	15.4	15.5	7.2	25.2	17.7	13.4	25.4	14.4	16.2	14.2	24.4	36.5	38.1	24.9	20.9	21.6	18.6	27.0	23.1	25.9	36.0	38.0	27.9	35.5	15.2	17.4	28.6	36.8	25.2	27.9	27.3	23.4	32.2	29.8	15.8	31.4	19.9	25.8	18.9	32.1	20.4	34.3	28.8	29.2	21.1	27.4	30.0	19.8	23.1	23.8	59.5	26.0	31.5	17.6	19.5	30.0	32.2	27.4	41.5	18.5	45.8	20.8	24.1	26.9	25.2	25.4	26.1	48.5	24.5	30.7	20.7	31.2	30.4	22.1	35.4	26.1	20.7	26.7	31.1	32.7	26.2	22.3	28.9	37.2	31.4	30.3	20.5	28.6	27.8	22.6	34.8	24.3	22.4	17.3	25.0	35.9	20.8	31.1	20.2	21.5	22.6	22.7	21.8	19.8	21.2	24.2	23.6	23.9	22.4	25.2	24.4	10.9	19.2	11.0	7.2	10.5	8.0	14.1	21.8	4.6	14.8	6.4	5.5	13.1	21.5	19.1	7.3	4.2	28.4	16.3	16.2	15.6	26.2	1.1	15.6	10.0	13.4	7.8	22.5	2.8	25.2	20.5	11.7	14.3	10.6	11.4	10.4	11.7	14.5	16.7	5.0	2.8	12.1	18.3	10.9	9.3	1.7	15.5	8.7	5.4	2.8	13.2	20.9	28.8	2.0	3.9	25.6	23.2	15.1	9.4	9.4	19.5	20.5	12.7	13.4	39.5	12.9	13.0	9.9	18.4	6.1	9.9	43.8	16.7	10.6	11.0	12.8
GPN1	"ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1"	ENSG00000198522	"GPN-loop GTPase 1"	Q9HCN4	2	27628247-27651511	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036793, HPA036794, CAB037303"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230"	"unprognostic (9.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (2.88e-5)"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (3.50e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	22.8	22.8	19.3	20.3	19.8	34.1	26.4	19.9	26.1	18.1	19.5	22.7	19.9	19.1	19.9	25.5	21.0	18.6	21.3	19.4	21.6	26.3	24.6	18.6	28.7	22.5	22.6	18.4	22.8	25.9	16.6	26.5	21.8	17.7	25.6	24.9	21.5	16.9	32.4	24.8	19.6	22.4	19.6	22.2	20.6	25.5	21.9	30.1	22.8	27.2	30.3	24.0	19.5	21.2	94.6	53.3	48.8	35.4	44.3	44.8	48.7	52.0	50.5	70.7	52.1	58.0	47.4	58.8	49.2	56.4	65.4	39.5	67.6	63.4	71.5	55.4	47.6	66.8	38.3	70.7	57.3	100.0	33.7	46.7	54.8	72.6	67.1	49.4	75.2	51.5	84.7	53.5	84.1	54.2	60.3	75.1	83.4	70.9	50.7	60.2	144.4	61.0	57.9	53.5	42.9	67.6	57.2	61.5	58.4	44.7	37.1	56.0	62.9	61.5	91.1	30.9	122.7	60.8	71.8	156.9	88.0	85.0	51.8	92.4	61.3	55.1	79.1	71.6	86.0	74.6	72.2	92.0	89.7	68.7	63.8	78.2	9.3	106.1	72.1	46.8	79.2	82.3	19.3	19.8	19.9	26.1	19.4	21.6	22.5	22.6	21.8	19.6	21.9	21.2	17.6	12.8	10.4	2.3	18.7	21.7	21.7	28.2	10.8	9.2	14.8	11.8	11.8	14.3	19.7	14.7	4.2	43.5	28.8	9.5	23.5	46.4	86.3	20.5	14.1	17.3	17.4	18.7	6.6	36.3	46.2	14.3	9.7	21.7	24.7	17.7	17.5	10.2	33.4	11.8	6.6	13.0	20.3	20.1	26.8	76.0	14.9	17.6	23.2	2.8	28.9	15.0	27.8	5.0	5.0	46.3	13.5	10.9	11.2	20.1	16.2	20.8	14.3	10.9	13.1	13.2	19.0	36.6	23.4	13.6	18.6	33.1	31.0	20.2	20.0	18.9
GPR1		ENSG00000183671	"G protein-coupled receptor 1"	P46091	2	206175316-206218047	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.2"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 12.3;Granulosa cells: 42.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.7;HHSteC: 133.9;hTCEpi: 61.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010525	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA010525: AB_1078919"	"unprognostic (5.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.29e-4)"	"unprognostic (8.48e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.06e-3)"	1.5	2.7	0.1	0.2	0.9	0.0	0.7	0.5	0.3	2.6	12.2	0.3	0.1	0.5	0.2	4.5	0.5	1.2	1.6	0.6	0.3	0.4	0.0	0.2	0.8	0.0	0.0	1.3	0.0	0.4	0.2	3.9	0.0	0.2	0.3	0.7	0.9	0.1	0.7	4.8	0.3	1.0	0.0	0.0	0.1	0.9	0.2	0.0	0.3	2.4	0.3	1.0	5.6	0.0	2.2	0.2	1.8	0.0	0.4	7.5	0.6	14.4	24.7	8.8	7.4	0.0	0.0	0.0	0.8	7.3	0.6	0.2	0.7	0.0	2.9	0.0	0.3	0.0	4.2	0.0	133.9	0.0	0.0	5.5	61.8	12.5	20.0	10.2	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	6.9	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.3	6.1	2.9	0.0	0.0	1.6	0.1	0.0	0.3	10.5	4.8	12.5	1.1	0.0	0.0	0.0	3.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	12.3	4.5	0.0	0.0	0.0	42.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.2	0.0	0.0	0.8	1.0	0.7	0.5	0.0	0.0	0.4
GPR107	"FLJ20998, KIAA1624, LUSTR1, RP11-88G17"	ENSG00000148358	"G protein-coupled receptor 107"	Q5VW38	9	130053426-130140169	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031704	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA031704: AB_10601018"	"prognostic unfavorable (3.56e-5)"	"unprognostic (7.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (4.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.34e-3)"	18.9	17.3	21.0	15.1	22.1	12.2	20.3	21.9	21.3	20.1	24.4	21.3	11.6	18.8	15.3	18.7	22.0	16.1	18.3	19.5	23.9	20.5	13.0	20.3	11.0	23.4	25.3	17.9	18.8	28.7	16.6	23.3	25.6	23.6	22.6	26.3	18.3	19.9	17.8	22.7	12.9	23.2	21.8	13.4	16.7	17.3	23.5	14.3	34.9	17.0	14.2	15.8	14.2	23.8	29.7	42.0	39.6	31.7	42.4	44.6	39.9	45.9	52.5	37.9	37.5	40.6	39.5	16.4	33.4	52.1	44.5	73.0	30.7	28.6	32.3	24.7	20.3	17.0	49.1	23.8	40.9	36.2	24.4	37.5	44.3	38.1	38.7	44.1	35.9	19.0	25.0	15.8	33.6	36.6	19.4	14.7	26.8	60.0	31.7	18.3	58.7	25.9	32.1	40.2	13.6	30.7	59.8	42.8	33.1	34.9	75.0	19.3	42.9	48.1	25.1	40.3	35.3	9.8	35.6	15.2	43.5	17.0	46.9	1.5	2.8	1.9	0.7	3.4	1.0	1.0	0.7	0.8	1.8	1.0	0.5	1.2	3.3	0.9	3.6	1.1	0.7	1.3	21.0	22.1	21.9	21.3	19.5	23.9	23.4	25.3	25.6	21.8	23.5	23.8	14.8	25.6	19.3	47.7	8.0	6.4	5.1	14.8	5.2	16.9	17.8	12.2	23.0	14.3	16.4	16.5	39.6	15.4	11.4	20.7	0.0	13.4	6.5	23.7	19.3	14.3	9.6	4.6	32.7	17.6	19.2	16.2	16.8	26.4	6.3	17.9	24.3	11.6	15.1	18.5	39.7	19.4	6.1	17.0	17.6	5.7	19.0	13.8	14.2	22.5	15.6	11.0	9.2	38.2	48.6	21.9	15.9	19.2	11.2	13.2	9.3	6.5	24.5	15.5	0.0	16.3	15.3	16.2	11.5	12.2	10.9	26.7	10.4	13.5	18.4	10.9
GPR137	"C11orf4, GPR137A, TM7SF1L1"	ENSG00000173264	"G protein-coupled receptor 137"	Q96N19	11	64270062-64289500	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 203.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 193.1;Late spermatids: 573.0;Spermatocytes: 175.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 14.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062871	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"	"Actin filaments"	"HPA062871: AB_2684889"	"unprognostic (2.25e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.61e-3)"	"prognostic favorable (6.18e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.41e-1)"	20.6	32.6	54.4	16.4	50.9	13.7	19.6	49.4	63.8	24.5	42.5	22.6	12.2	23.6	12.6	28.9	22.3	15.0	29.1	52.8	44.3	34.0	33.9	19.4	14.9	55.3	50.5	18.7	16.2	23.2	26.5	15.6	56.2	29.1	7.5	11.8	23.7	14.8	16.8	22.5	19.5	10.4	45.9	24.5	27.4	203.8	56.2	10.6	30.8	15.9	12.8	26.7	21.4	48.2	22.0	50.2	18.6	49.5	34.9	19.9	69.6	25.5	24.3	31.0	18.4	38.0	31.6	22.7	42.4	24.1	51.9	44.3	28.8	17.1	9.7	73.0	27.9	22.7	53.7	22.5	21.6	15.0	40.9	24.8	25.0	27.5	19.0	20.8	16.3	28.4	20.6	56.2	19.1	56.9	16.8	40.5	22.5	20.4	49.9	31.0	18.0	37.5	20.0	30.3	27.2	32.6	30.0	44.6	30.6	21.4	46.0	6.3	23.1	69.1	46.8	53.3	18.7	41.9	84.9	20.5	50.0	12.3	44.9	1.9	2.8	5.1	2.3	2.5	2.9	2.7	2.0	1.7	3.0	3.8	2.1	1.8	14.0	1.9	2.1	3.0	1.6	1.4	54.4	50.9	49.4	63.8	52.8	44.3	55.3	50.5	56.2	45.9	56.2	48.2	13.0	3.2	11.2	12.7	15.0	14.4	18.5	21.8	19.4	14.1	16.2	13.3	5.3	20.0	13.7	12.9	12.5	49.6	9.5	26.2	15.6	39.0	193.1	14.4	14.8	15.8	16.2	14.7	9.3	26.6	69.7	13.4	15.3	10.0	2.5	10.3	11.4	10.8	23.2	20.2	9.0	16.8	14.2	15.4	14.5	573.0	19.3	11.5	14.2	6.5	16.4	38.9	11.3	4.5	11.2	30.8	14.6	16.1	13.4	26.7	31.5	19.6	18.6	9.1	26.3	8.7	14.1	175.0	55.9	16.9	15.2	119.6	10.8	16.6	15.1	23.3
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 41.5;smooth muscle: 27.6"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 158.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		Yes	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	3.5	1.1	3.8	5.3	2.8	0.2	2.7	3.3	4.0	6.7	1.1	8.4	1.5	41.5	3.6	9.8	10.7	5.6	3.1	3.8	2.4	1.4	0.4	4.2	0.9	3.7	9.4	7.3	11.7	5.4	1.7	2.2	3.8	9.5	3.2	2.1	1.8	11.8	1.0	2.1	3.3	27.6	2.8	2.0	2.9	1.7	4.1	2.0	1.7	1.9	1.3	4.6	5.4	2.7	11.7	7.1	28.0	18.1	6.6	11.7	0.0	11.1	11.9	9.2	9.7	44.9	1.8	0.0	6.0	16.6	17.2	33.9	6.9	10.7	5.3	4.4	8.8	4.2	5.8	0.1	2.8	1.2	2.8	4.2	6.9	7.9	12.7	21.3	18.7	3.6	3.9	0.1	14.2	1.0	1.3	0.2	11.5	19.4	11.0	3.4	12.1	0.0	4.9	3.1	5.7	24.6	12.0	0.4	32.2	10.6	6.3	1.4	25.4	18.9	9.7	25.6	12.7	0.0	0.0	0.0	5.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	2.8	3.3	4.0	3.8	2.4	3.7	9.4	3.8	2.8	4.1	2.7	5.8	3.2	1.1	13.7	0.1	2.2	5.7	2.5	5.2	2.2	2.2	4.2	3.6	0.0	1.4	0.0	0.0	0.5	0.0	2.8	0.0	4.1	0.4	1.3	19.4	9.1	0.0	0.0	10.8	8.0	0.4	12.3	1.1	1.8	0.0	15.3	8.9	0.1	0.8	158.2	10.9	1.5	0.0	2.5	6.3	0.9	7.5	2.0	1.8	3.7	1.1	3.2	0.0	9.5	0.4	2.6	2.4	17.0	0.0	10.9	0.0	0.1	1.1	2.1	19.7	8.8	15.1	0.3	3.3	2.7	1.4	0.4	1.0	0.7	2.5	2.7
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71753855-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 10.3;Breast myoepithelial cells: 7.5;Collecting duct cells: 12.9;Glandular and luminal cells: 8.1;monocytes: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"eosinophil: 2.8;neutrophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 17.9;HL-60: 17.5;MCF7: 14.6;NTERA-2: 28.9;RPTEC TERT1: 13.6;SH-SY5Y: 10.9;T-47d: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favorable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.4	4.0	21.3	1.5	22.9	15.7	3.9	13.0	19.7	3.5	7.4	1.6	0.3	5.0	2.8	3.7	6.8	1.0	3.4	19.9	20.6	3.2	0.1	1.4	0.2	18.0	18.3	4.4	3.1	17.3	9.2	1.2	16.2	5.1	0.5	1.8	1.4	4.3	0.7	2.1	0.7	2.9	19.7	3.3	2.0	4.7	22.9	0.5	6.2	1.9	0.2	2.0	2.3	18.9	0.0	1.1	1.9	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	17.9	0.0	0.8	0.1	4.3	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	17.5	0.9	0.0	2.9	0.0	1.2	0.0	0.0	3.7	0.0	0.0	0.0	14.6	1.2	0.2	28.9	0.0	0.0	0.0	0.0	0.0	13.6	7.8	3.0	10.9	3.8	0.0	0.0	3.6	9.9	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	7.2	0.0	0.1	0.0	0.0	0.1	21.3	22.9	13.0	19.7	19.9	20.6	18.0	18.3	16.2	19.7	22.9	18.9	0.2	0.0	1.1	0.0	0.1	1.9	4.2	0.0	4.0	10.3	6.5	7.5	3.5	2.8	1.3	12.9	4.2	1.4	0.4	0.2	1.9	0.7	0.2	2.1	4.9	0.4	1.2	1.7	0.0	0.0	1.3	1.2	1.1	8.1	0.0	2.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.9	3.2	0.0	0.0	8.6	0.5	1.0	0.0	0.0	0.3	0.1	1.2	0.0	5.6	0.0	0.1	1.5	0.4	0.0	2.3	1.7	0.2	4.8	4.7	1.7	0.3	0.7	0.5	0.3	2.0
GPR37L1	ETBR-LP-2	ENSG00000170075	"G protein-coupled receptor 37 like 1"	O60883	1	202122917-202133592	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 76.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 91.7;Muller glia cells: 59.6;Oligodendrocyte precursor cells: 89.0;Oligodendrocytes: 20.4"	"Cancer enriched"	"Detected in some"	57	"glioma: 36.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 1.2;MCF7: 1.5;T-47d: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061629, HPA064454"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cell Junctions"	"Vesicles, Plasma membrane"	"HPA061629: , HPA064454: AB_2685268"	"unprognostic (2.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-3)"	"unprognostic (4.52e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.26e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.49e-1)"	0.1	0.2	55.2	0.0	71.1	0.2	0.0	60.7	52.2	0.2	10.6	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	48.0	50.7	0.0	0.2	0.0	0.0	66.7	67.0	0.0	0.0	0.0	0.6	0.0	53.7	0.2	0.2	2.8	0.1	0.3	0.1	0.1	0.3	0.1	59.4	0.0	0.2	0.3	76.4	0.0	0.1	0.1	0.0	0.0	0.1	53.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	55.2	71.1	60.7	52.2	48.0	50.7	66.7	67.0	53.7	59.4	76.4	53.1	0.0	0.0	0.0	91.7	0.1	0.4	0.5	0.7	0.0	1.2	0.3	0.3	1.1	1.5	1.7	0.0	4.2	0.1	0.0	4.9	0.0	3.2	4.5	0.9	0.2	0.1	0.0	0.0	0.4	1.2	1.0	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.8	0.9	0.1	0.0	2.8	0.0	59.6	0.0	89.0	20.4	2.1	2.7	1.9	0.0	0.8	1.3	0.1	1.1	4.9	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.7	0.1	0.2	0.7	1.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176584-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 17.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 5.0;SuSa: 4.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 14.4;white matter: 5.0"	"Region enriched"	"Detected in single"	10	"hypothalamus: 4.8"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"		"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	17.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.6	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794125-96837477	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.4;Excitatory neurons: 46.2;Granulosa cells: 31.2;Inhibitory neurons: 20.3;Late spermatids: 35.2;Spermatocytes: 24.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.8;HHSteC: 13.5;Karpas-707: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	0.5	0.9	1.4	0.7	3.5	0.1	0.4	0.7	2.7	1.5	2.7	1.2	1.5	0.5	0.3	0.5	0.7	0.7	0.5	1.5	0.1	0.3	0.0	0.3	0.1	1.6	0.6	1.0	1.4	1.0	0.9	0.7	2.0	0.9	1.8	0.2	0.4	0.5	0.2	0.4	1.1	0.6	0.0	0.3	1.1	2.4	0.9	0.6	0.6	0.1	0.2	0.8	1.4	1.8	0.0	0.1	1.6	0.4	2.3	0.8	0.4	1.0	0.0	0.0	0.2	0.2	1.2	0.1	0.0	0.1	1.3	1.2	5.4	2.5	0.0	8.8	4.1	5.2	0.4	0.0	13.5	3.3	0.6	2.5	0.4	0.0	3.7	0.3	0.0	7.6	3.8	20.8	0.5	0.4	2.5	0.0	5.4	0.0	0.7	0.0	1.9	4.3	0.3	0.2	2.4	1.5	0.3	3.3	0.6	1.7	1.3	0.7	0.0	1.4	2.1	0.2	2.0	1.6	0.9	0.1	0.8	2.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	1.4	3.5	0.7	2.7	1.5	0.1	1.6	0.6	2.0	0.0	0.9	1.8	0.6	0.0	0.0	2.3	0.2	1.9	0.7	0.3	4.0	1.5	0.6	0.9	0.7	2.8	0.1	1.8	0.0	0.2	0.3	0.1	0.0	0.4	31.4	0.1	0.5	0.7	3.0	0.4	46.2	0.9	0.7	2.5	1.1	0.1	0.0	31.2	1.1	0.0	0.2	0.0	20.3	0.5	0.0	0.0	8.9	35.2	3.4	0.4	1.8	9.4	0.1	0.2	0.0	11.6	4.8	0.4	0.1	4.9	1.0	1.1	0.1	0.2	0.0	0.2	0.0	0.4	2.2	24.6	10.5	1.9	0.3	0.1	0.4	2.1	0.5	0.3
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316820	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 32.8;vagina: 23.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 139.2;Basal respiratory cells: 150.0;Suprabasal keratinocytes: 68.2;Syncytiotrophoblasts: 205.0;Urothelial cells: 211.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 110.8;CAPAN-2: 40.8;HaCaT: 90.6;HBEC3-KT: 116.7;hTCEpi: 152.8;hTERT-HME1: 62.2;RT4: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.1	0.8	10.0	2.9	0.0	0.0	0.0	3.2	35.9	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	9.6	0.0	4.3	0.0	0.0	13.7	5.5	0.1	32.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	3.5	0.0	0.0	12.4	13.2	23.8	0.4	110.8	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.9	0.2	0.0	40.8	0.0	0.0	0.0	0.6	90.6	0.0	116.7	1.1	0.0	0.1	0.0	1.1	0.0	0.8	0.0	0.0	0.0	152.8	0.1	62.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.1	6.1	0.0	0.0	0.0	3.8	46.7	0.0	0.0	19.0	0.5	0.0	3.1	0.4	0.1	0.0	0.0	10.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.1	1.0	0.0	59.3	139.2	150.0	46.7	0.0	2.8	1.8	0.1	0.0	49.9	3.7	0.0	59.0	0.4	0.0	0.0	1.2	0.7	3.3	0.0	1.5	0.0	0.0	1.1	0.7	8.7	1.1	0.0	2.4	1.3	0.0	0.0	0.0	4.2	0.0	0.4	0.0	28.5	0.0	3.6	0.1	0.0	0.6	10.6	0.0	0.0	0.0	0.0	1.0	0.0	12.9	0.0	0.0	0.0	60.6	0.0	0.1	19.6	0.0	0.0	0.0	4.1	0.0	0.0	52.7	68.2	205.0	0.9	0.0	0.0	211.4
GPRASP2	"FLJ37327, GASP2"	ENSG00000158301	"G protein-coupled receptor associated sorting protein 2"	Q96D09	X	102712176-102717733	"Disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.6;Cardiomyocytes: 16.4;Horizontal cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017438	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA017438: AB_1849504"	"unprognostic (8.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.14e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.71e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (4.60e-6)"	"unprognostic (1.19e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (6.63e-5)"	5.1	15.0	19.1	2.1	18.9	0.4	7.8	10.6	22.3	13.6	6.7	7.5	1.7	17.7	9.0	4.2	10.7	5.1	14.5	18.6	31.4	10.2	6.8	5.0	1.8	13.8	15.0	30.1	9.3	14.9	20.0	3.7	15.8	12.5	3.1	12.7	9.2	11.8	7.5	5.8	3.2	10.3	12.8	4.2	4.0	4.7	24.8	4.5	15.2	6.5	1.7	6.4	6.5	13.4	0.6	6.8	17.8	13.8	5.5	6.5	1.3	10.3	9.3	8.7	16.9	2.3	3.1	0.0	3.5	10.8	4.3	2.4	21.5	5.6	11.0	0.0	8.3	0.9	2.0	0.5	4.0	1.7	1.2	6.9	5.8	9.7	0.4	10.1	6.2	1.7	2.7	0.7	10.6	3.2	4.9	0.7	8.9	2.2	9.3	6.4	2.9	0.0	5.4	2.5	3.9	12.2	10.4	2.0	1.5	5.4	5.7	3.6	5.6	6.1	12.9	12.5	9.9	0.3	0.4	0.0	8.2	1.1	3.5	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.4	0.2	0.1	1.4	0.6	0.0	0.8	0.0	0.5	0.5	0.4	19.1	18.9	10.6	22.3	18.6	31.4	13.8	15.0	15.8	12.8	24.8	13.4	4.3	0.0	1.5	0.0	0.5	2.3	5.1	2.1	4.0	19.6	3.5	4.1	16.4	7.2	3.6	5.5	2.1	6.2	0.3	0.6	9.8	1.6	0.5	0.7	4.1	4.3	3.0	0.0	0.0	0.9	0.5	6.6	0.0	0.6	0.0	13.2	8.2	7.3	0.9	16.8	0.0	1.4	2.0	0.6	0.8	1.1	12.2	0.6	0.0	0.0	0.5	12.2	0.0	0.0	0.0	1.1	1.8	12.4	0.0	3.2	0.3	10.8	0.8	6.8	6.6	8.9	4.9	13.4	9.1	2.4	3.0	2.2	0.7	8.0	1.1	1.5
GPRC5B	RAIG-2	ENSG00000167191	"G protein-coupled receptor class C group 5 member B"	Q9NZH0	16	19856691-19886167	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 490.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 197.7;Late spermatids: 269.9;Oligodendrocytes: 171.0"	"Cancer enhanced"	"Detected in all"		"glioma: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 92.5;HHSteC: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015247	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA015247: AB_1849323"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.60e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.30e-4)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.42e-3)"	"unprognostic (6.78e-3)"	25.3	7.0	249.1	4.4	428.3	0.1	19.6	365.2	263.4	12.8	13.1	8.1	5.7	13.1	14.8	8.1	20.1	15.3	40.7	245.8	278.4	22.4	3.2	5.8	7.8	379.4	327.1	22.6	21.7	45.9	14.1	15.7	333.0	9.6	2.4	17.4	40.1	17.7	72.7	7.5	11.1	7.5	262.7	2.5	41.3	34.0	315.0	3.2	13.8	73.8	3.4	12.8	8.6	490.3	1.2	29.9	29.0	5.2	29.3	2.0	5.3	0.3	7.4	2.9	1.8	28.0	1.0	0.0	92.5	1.0	18.9	1.6	21.6	0.2	1.7	0.2	8.6	0.0	0.1	0.0	60.3	0.0	0.0	2.5	0.0	4.9	0.0	7.9	14.3	0.7	6.6	0.6	6.7	1.5	0.1	0.1	31.8	0.0	15.6	8.9	0.0	0.2	1.1	13.8	22.9	1.9	3.6	1.9	27.2	9.1	0.1	0.6	2.9	0.0	3.5	14.4	0.8	0.4	0.1	0.3	1.4	0.3	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.5	249.1	428.3	365.2	263.4	245.8	278.4	379.4	327.1	333.0	262.7	315.0	490.3	71.4	0.0	3.0	75.4	1.2	1.3	5.3	2.6	9.1	30.7	22.5	16.3	15.7	40.0	7.2	31.3	0.0	5.0	0.3	0.2	1.9	65.3	197.7	4.1	20.7	44.8	0.0	0.0	2.4	64.5	1.4	14.8	31.6	13.7	0.0	0.4	9.3	0.2	4.1	0.0	13.5	0.0	38.7	1.6	2.6	269.9	23.9	2.2	16.0	7.5	1.0	24.8	0.0	51.8	171.0	72.8	0.0	26.7	1.3	12.3	0.0	0.3	3.3	6.0	13.1	3.3	13.0	4.9	1.6	2.4	1.7	2.5	0.8	7.0	0.2	1.6
GPRC5C	RAIG-3	ENSG00000170412	"G protein-coupled receptor class C group 5 member C"	Q9NQ84	17	74424851-74451653	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 192.7;stomach 1: 230.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 211.3;Gastric mucus-secreting cells: 143.2;Hepatocytes: 183.6;Paneth cells: 153.8;Sertoli cells: 144.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 7.9"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 82.4;HMC-1: 146.7;PC-3: 80.8;RPTEC TERT1: 172.1;RT4: 89.9;T-47d: 108.0"	"Region enriched"	"Detected in all"	9	"cerebellum: 42.5"	"Low region specificity"	"Detected in all"			HPA029776	Enhanced		Uncertain	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	Yes		15000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA029776: AB_10602324"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.58e-5)"	"unprognostic (7.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.54e-3)"	16.1	19.3	17.4	3.1	18.4	0.4	20.1	48.9	18.1	42.0	28.0	38.7	25.0	17.1	10.2	12.2	30.0	21.3	33.7	14.8	16.9	135.7	192.7	23.0	2.1	18.1	18.7	38.2	136.1	28.2	14.8	11.9	18.6	45.6	14.6	1.5	37.4	24.3	110.1	43.9	30.3	4.0	16.6	22.3	230.3	4.0	17.0	4.4	74.8	33.9	3.0	30.8	20.9	15.7	17.3	61.6	3.8	5.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	66.4	73.0	0.0	45.0	0.3	18.5	52.9	7.7	1.0	0.1	0.2	10.7	0.0	4.0	82.4	15.8	0.0	146.7	1.3	26.7	0.0	0.0	69.2	0.0	0.1	4.8	1.2	0.0	18.0	0.7	17.2	9.2	79.5	80.8	0.2	0.1	2.8	172.1	89.9	27.5	2.5	3.7	5.9	0.1	33.1	108.0	4.6	0.0	0.0	5.5	0.1	0.1	0.1	0.4	0.2	6.5	2.5	0.4	0.0	1.1	0.1	0.0	2.5	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.7	7.9	0.0	0.3	17.4	18.4	48.9	18.1	14.8	16.9	18.1	18.7	18.6	16.6	17.0	15.7	11.2	3.2	57.7	13.4	1.4	13.6	39.2	79.6	26.7	0.8	27.3	19.4	211.3	67.2	76.2	136.1	0.0	0.8	11.8	74.9	29.4	65.5	0.1	62.5	6.6	20.9	45.5	5.3	0.1	68.1	20.3	11.3	143.2	74.9	10.2	0.1	48.2	183.6	12.3	5.0	0.5	50.8	69.2	16.3	4.6	1.7	18.0	6.3	3.6	2.8	4.1	15.9	0.0	5.0	0.2	41.2	153.8	22.2	1.2	44.6	61.0	73.5	45.4	1.5	144.7	4.7	64.0	0.5	5.0	14.8	11.2	25.3	2.4	1.5	48.5	63.1
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236383-89307800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 78.7;Macrophages: 53.9;Sertoli cells: 78.9;T-cells: 76.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 102.6;RPMI-8226: 27.7;SCLC-21H: 27.2;U-266/70: 15.9;U-266/84: 13.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.2"					"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli	Nucleoplasm	"HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902"	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	2.7	1.2	4.1	9.0	9.5	7.8	1.4	17.8	3.1	2.2	0.9	5.3	6.2	1.4	0.7	0.9	0.9	3.5	4.0	2.2	7.3	3.9	2.0	6.9	10.2	4.3	6.5	3.2	5.1	0.6	2.9	1.0	4.5	0.8	7.1	3.5	1.5	0.6	1.0	0.6	5.3	1.4	4.1	7.1	3.6	0.4	5.0	2.8	1.3	3.2	7.9	2.7	1.0	5.9	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.8	0.1	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	102.6	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.7	0.0	27.7	0.3	0.1	27.2	0.6	0.0	0.1	1.1	1.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	15.9	13.2	0.1	0.5	0.0	0.0	0.0	0.3	0.0	2.8	1.0	3.8	0.2	2.7	2.2	0.9	0.0	1.1	1.1	0.0	1.9	1.5	0.0	3.4	1.0	4.1	9.5	17.8	3.1	2.2	7.3	4.3	6.5	4.5	4.1	5.0	5.9	11.1	0.0	22.6	10.1	6.7	1.1	0.9	0.1	0.0	12.2	1.6	1.7	20.3	8.6	5.0	3.7	0.0	0.2	51.2	17.4	1.9	2.0	0.2	5.8	3.4	11.7	78.7	6.5	21.7	9.4	0.1	3.0	15.8	15.0	7.6	12.2	1.8	0.4	18.7	26.9	32.7	38.0	0.0	28.2	29.0	0.0	0.3	53.9	1.8	41.2	7.4	1.0	23.7	26.2	0.5	1.3	11.0	1.2	48.6	0.3	16.3	1.9	0.7	10.8	78.9	3.3	32.7	0.1	0.8	0.3	1.0	0.3	76.9	0.7	26.2	0.5
GPS1	"COPS1, CSN1"	ENSG00000169727	"G protein pathway suppressor 1"	Q13098	17	82050691-82057470	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047448, HPA052848"			Enhanced	Nucleoplasm,Cytosol		NA	NA		78000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA047448: , HPA052848: "	"unprognostic (1.96e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.07e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.15e-1)"	55.6	64.4	55.9	32.0	56.7	42.7	54.6	59.2	80.5	53.3	53.7	58.8	35.0	56.3	30.9	50.9	49.5	28.1	91.1	59.2	57.6	81.9	101.7	48.6	37.5	60.1	59.2	56.4	69.8	48.4	62.6	29.7	60.0	64.5	18.1	20.5	58.8	40.7	148.5	56.6	46.8	25.5	55.1	54.9	65.5	70.6	56.5	37.3	58.7	63.7	24.9	53.7	48.0	59.2	112.5	204.9	74.7	98.0	51.7	49.5	105.4	73.6	58.2	114.1	93.9	180.7	68.1	55.0	64.5	74.1	83.1	83.1	71.6	94.2	38.7	37.0	256.7	93.5	112.2	203.5	85.5	102.9	86.8	71.2	67.9	101.3	60.0	45.9	120.4	93.4	89.1	62.0	64.3	220.8	176.8	116.4	95.3	107.2	151.3	107.0	102.5	89.5	71.1	114.8	127.6	199.8	74.9	136.6	110.0	56.7	155.1	91.7	69.3	113.3	133.3	88.6	120.5	112.6	51.4	58.9	88.7	65.5	104.5	57.6	85.7	65.9	77.5	81.0	81.8	64.5	80.9	78.3	93.4	64.2	56.9	71.8	13.2	81.6	78.1	64.2	115.2	98.7	55.9	56.7	59.2	80.5	59.2	57.6	60.1	59.2	60.0	55.1	56.5	59.2	24.0	12.8	24.8	27.1	24.9	25.1	22.5	37.1	17.6	30.6	31.0	27.6	53.7	30.0	30.7	20.2	25.0	71.1	22.7	78.6	60.7	50.7	33.0	22.7	22.4	30.0	41.3	21.7	12.1	69.4	67.6	31.0	35.7	23.3	24.7	45.2	28.5	50.6	60.9	48.8	14.2	42.7	52.9	37.3	31.5	76.7	30.1	32.0	33.8	7.5	42.4	46.3	29.9	10.6	16.4	48.1	56.1	31.6	50.1	25.4	58.4	100.9	33.9	27.2	6.6	28.3	36.3	50.9	50.3	27.1	30.0	54.0	31.1	41.9	57.2	23.2
GPS2		ENSG00000132522	"G protein pathway suppressor 2"	Q13227	17	7311324-7315564	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 279.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067540	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA067540: AB_2685860"	"unprognostic (1.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.50e-5)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.28e-3)"	45.4	47.7	30.3	15.5	30.9	26.8	39.7	30.7	37.8	42.1	28.4	47.5	14.6	39.5	14.2	38.0	36.8	13.2	65.8	30.3	30.9	49.8	33.3	34.0	17.2	31.8	30.7	39.5	39.0	24.4	33.8	13.9	31.1	35.3	17.1	12.0	39.4	16.9	154.9	52.0	34.5	15.6	29.5	34.6	40.0	102.7	31.2	21.6	34.6	52.9	20.1	43.9	37.2	31.7	28.1	60.6	24.9	26.4	36.5	20.2	21.2	20.1	26.7	45.2	39.0	39.2	16.1	32.0	15.5	31.1	32.3	42.1	25.4	42.4	31.5	37.9	34.8	30.1	62.2	53.0	26.4	19.1	37.1	19.3	31.2	59.0	17.1	19.5	26.0	29.7	18.8	8.6	43.2	25.8	38.2	21.2	24.6	29.3	22.8	29.5	30.8	34.1	36.4	32.1	23.5	39.5	35.6	23.6	28.9	21.4	23.6	18.6	15.9	23.0	20.5	28.2	48.9	25.0	37.0	21.0	30.3	23.2	38.1	78.3	47.2	82.7	53.5	59.8	49.5	81.6	56.6	58.5	39.5	63.8	51.9	47.8	79.1	41.5	67.7	66.0	81.2	58.1	30.3	30.9	30.7	37.8	30.3	30.9	31.8	30.7	31.1	29.5	31.2	31.7	29.1	12.8	10.8	19.9	36.9	15.8	11.5	11.4	29.0	29.9	19.2	17.8	1.2	17.2	16.6	20.2	66.7	13.5	55.7	52.4	25.4	21.7	100.3	15.0	22.6	18.9	16.8	29.9	15.0	26.8	11.1	14.9	25.5	17.5	19.0	23.4	11.4	10.6	10.3	38.7	12.5	23.2	6.1	14.1	25.0	279.3	21.1	21.1	19.6	13.1	21.6	15.5	41.2	10.6	17.1	19.5	35.9	15.4	42.2	8.4	42.2	25.7	14.6	44.8	19.7	17.4	18.8	37.4	42.9	18.1	16.9	19.6	39.0	17.1	21.8	9.1
GPSM1	"AGS3, DKFZP727I051"	ENSG00000160360	"G protein signaling modulator 1"	Q86YR5	9	136327476-136359605	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.1;Bipolar cells: 37.2;Cone photoreceptor cells: 22.9;Muller glia cells: 36.0;Rod photoreceptor cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042199, HPA060736"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA042199: AB_10959329, HPA060736: "	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.07e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.48e-2)"	13.0	21.7	32.6	4.2	30.6	4.5	12.4	50.9	44.4	38.7	12.7	18.5	3.3	23.3	7.2	6.0	20.3	4.7	74.9	30.5	26.7	19.6	4.7	35.4	2.1	34.9	29.8	38.1	42.3	3.8	19.7	6.6	28.7	30.6	1.2	18.7	8.6	5.9	2.7	17.0	9.3	4.0	25.1	19.9	17.2	29.4	28.6	2.0	12.4	0.7	1.1	15.1	24.4	28.6	3.9	6.2	14.5	25.4	8.1	14.1	12.1	43.0	17.6	11.8	6.4	12.5	4.1	0.0	17.8	26.0	9.9	2.9	2.3	8.8	2.6	35.1	25.5	5.0	23.4	2.3	34.7	0.3	6.1	23.0	5.8	10.8	6.2	14.5	12.0	5.9	13.5	0.2	7.9	14.2	2.4	4.9	15.5	1.4	22.5	82.3	26.2	12.7	3.2	2.8	35.6	44.4	8.0	1.0	13.7	5.6	17.7	8.6	20.0	21.7	17.5	25.7	8.9	7.6	0.3	0.1	13.0	0.0	21.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	32.6	30.6	50.9	44.4	30.5	26.7	34.9	29.8	28.7	25.1	28.6	28.6	4.7	3.2	3.3	26.1	0.6	4.2	2.3	0.8	0.0	37.2	2.5	5.8	12.4	0.0	0.8	0.0	22.9	0.6	1.6	0.0	11.7	3.3	0.6	2.7	18.1	3.9	1.8	2.5	9.0	1.9	0.8	9.1	0.5	5.5	5.7	14.2	3.6	0.0	1.1	10.1	11.6	0.0	0.0	0.3	2.8	1.3	10.5	1.5	8.8	6.5	0.5	36.0	0.0	9.5	10.4	7.3	0.0	9.4	0.3	10.6	0.0	0.1	0.6	43.0	0.0	5.8	6.0	0.4	3.7	0.1	3.3	0.3	1.1	3.3	0.0	4.0
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 497.7;intestine: 453.8;liver: 634.0;stomach 1: 374.6;urinary bladder: 350.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 386.1;Distal enterocytes: 436.6;Gastric mucus-secreting cells: 912.3;Hepatocytes: 753.4;Intestinal goblet cells: 438.6;Paneth cells: 463.0;Undifferentiated cells: 776.8;Urothelial cells: 1062.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 493.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 4748.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.2"	"Low region specificity"	"Detected in some"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	1.9	0.2	0.1	53.8	0.3	0.3	5.3	0.5	0.3	23.5	0.1	333.5	96.7	0.7	1.7	187.7	4.9	497.7	0.3	0.2	0.5	30.6	634.0	2.6	0.1	0.4	0.2	0.2	24.5	0.0	1.2	0.2	0.4	43.3	453.8	0.0	71.8	24.9	0.3	25.4	175.7	9.7	0.1	0.6	374.6	2.5	0.3	3.3	0.5	0.0	1.2	350.5	108.2	0.7	0.0	1152.6	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	36.9	9.6	0.0	6.0	0.0	1.9	303.7	0.6	4.8	0.0	0.2	0.1	0.1	1.1	1048.6	0.0	0.1	0.4	0.0	9.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	5.6	0.6	0.3	1.3	4748.8	0.2	0.5	0.2	0.2	0.1	727.5	324.2	0.2	0.1	13.4	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.2	0.5	0.4	0.2	0.4	0.1	0.3	0.7	0.1	0.0	0.0	0.3	6.9	9.9	169.4	104.5	42.1	0.2	0.6	4.1	0.4	386.1	17.1	23.9	0.0	0.1	0.0	436.6	11.7	272.8	13.8	3.8	0.5	3.5	115.2	50.8	0.2	260.6	0.1	2.1	912.3	2.8	13.4	0.1	17.5	753.4	0.0	0.0	0.2	438.6	36.7	26.1	0.8	66.6	0.9	3.5	0.0	1.9	3.2	0.0	0.0	0.0	0.4	163.7	463.0	0.0	2.4	100.7	68.1	31.4	9.0	0.7	0.0	0.0	3.6	0.4	0.0	315.5	9.7	0.0	5.9	0.1	776.8	1062.0
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 18580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	927.8	535.3	415.1	127.4	428.7	178.0	733.3	440.7	519.1	280.8	478.7	249.0	259.0	188.4	318.9	220.4	199.2	196.6	426.0	419.2	450.3	536.5	687.8	307.9	216.4	430.9	448.3	260.3	157.9	285.5	398.4	147.2	454.1	322.1	110.9	167.5	304.9	193.8	672.3	290.4	236.2	87.9	418.2	213.2	219.0	1403.5	444.0	158.7	291.5	399.7	182.5	319.0	245.2	429.1	258.1	286.8	405.8	863.0	1202.1	706.0	449.3	199.3	713.5	371.1	375.9	590.5	339.8	92.8	211.8	405.8	313.5	283.1	239.7	289.3	180.5	522.3	436.5	175.0	246.9	849.2	697.4	207.6	269.4	707.3	432.1	188.3	314.7	665.9	527.1	317.5	249.4	225.7	311.1	660.4	353.8	354.9	386.2	569.7	458.9	482.8	55.3	271.3	408.9	629.9	348.3	220.6	390.5	366.1	422.1	246.7	358.1	498.0	450.9	392.3	257.4	680.6	254.6	786.5	582.0	224.3	369.4	412.2	230.9	578.9	539.6	564.4	219.8	405.4	256.9	352.7	319.7	230.7	404.0	309.9	339.4	245.0	265.1	196.6	462.2	278.8	310.3	841.7	415.1	428.7	440.7	519.1	419.2	450.3	430.9	448.3	454.1	418.2	444.0	429.1	415.9	179.5	189.7	21.2	281.7	510.0	525.8	1188.1	512.2	332.2	845.1	868.2	264.6	316.0	600.6	472.6	98.0	562.5	231.3	479.1	1592.6	515.8	4209.7	546.8	326.3	268.7	397.1	215.0	24.5	368.7	1327.3	536.1	99.9	442.3	346.1	242.6	322.0	826.2	1184.1	208.6	33.1	328.7	671.4	583.1	1304.8	18580.2	384.9	735.2	677.7	21.5	1786.8	502.6	192.6	13.6	35.4	484.0	507.9	312.9	189.2	694.7	1861.9	3024.7	800.9	246.0	243.3	244.6	587.1	1310.8	202.4	357.7	467.0	978.1	281.0	186.7	336.4	662.6
GRAMD2B	"FLJ21313, GRAMD3, NS3TP2"	ENSG00000155324	"GRAM domain containing 2B"	Q96HH9	5	126360132-126496494	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 73.2;Club cells: 45.8;Endometrial ciliated cells: 51.8;Endometrial stromal cells: 49.0;Extravillous trophoblasts: 46.5;Glandular and luminal cells: 153.2;Respiratory ciliated cells: 48.8;Syncytiotrophoblasts: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.9;MAIT T-cell: 2.8;memory CD4 T-cell: 1.6;memory CD8 T-cell: 2.3;myeloid DC: 1.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 1.8;NK-cell: 1.1;plasmacytoid DC: 4.3;T-reg: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.3;NK-cells: 1.1;T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 114.1;CAPAN-2: 73.6;fHDF/TERT166: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009678, HPA010095"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA009678: AB_2112580, HPA010095: AB_1849952"	"unprognostic (2.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.90e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.12e-2)"	12.8	16.0	56.5	6.9	57.1	1.6	38.7	54.1	55.1	32.2	47.7	28.6	29.6	29.4	15.5	8.9	34.3	10.9	11.7	49.4	54.6	32.9	24.4	11.3	7.4	61.3	64.7	30.3	8.9	8.7	10.0	24.7	55.2	16.9	29.8	6.6	23.1	23.7	3.8	27.3	36.0	22.1	64.9	6.1	16.4	4.1	54.0	13.2	40.4	5.6	11.2	13.8	16.3	60.5	66.1	3.7	3.0	14.6	62.4	21.5	19.4	71.2	114.1	28.7	37.2	2.6	73.6	0.0	26.4	75.4	0.7	17.5	0.9	27.6	30.9	6.1	4.8	3.1	8.2	3.9	14.2	0.0	2.3	34.6	10.4	29.2	9.4	36.4	0.2	0.0	0.0	0.0	50.7	6.7	0.0	0.9	3.1	13.7	4.6	1.3	17.6	14.3	38.8	69.1	1.1	0.1	11.9	6.0	21.2	12.8	22.9	4.2	6.6	6.6	2.1	11.6	12.7	3.9	3.5	0.1	1.4	0.0	19.2	0.2	0.4	0.0	2.9	0.4	2.8	0.5	1.6	2.3	1.7	0.2	3.0	1.8	0.3	1.1	0.3	4.3	2.4	1.2	56.5	57.1	54.1	55.1	49.4	54.6	61.3	64.7	55.2	64.9	54.0	60.5	10.2	16.0	17.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	25.5	73.2	0.0	0.0	45.8	40.5	0.0	32.3	10.0	0.0	23.5	14.1	0.0	51.8	49.0	3.2	0.0	0.0	0.0	8.7	46.5	8.7	0.0	153.2	3.8	4.9	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	2.8	0.0	0.0	18.3	48.8	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	58.6	4.7	2.8	0.0	0.0
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2 related adaptor protein 2"	O75791	22	39901084-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"lymphoid tissue: 184.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 32.6;granulocytes: 146.9;Macrophages: 82.0;NK-cells: 59.8;T-cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 51.4;MAIT T-cell: 38.2;memory CD4 T-cell: 37.5;memory CD8 T-cell: 56.2;naive CD4 T-cell: 31.3;naive CD8 T-cell: 58.2;T-reg: 35.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 58.2"	"Group enriched"	"Detected in some"	4	"HEL: 45.7;JURKAT: 175.8;K-562: 44.8;MOLT-4: 122.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.2	0.7	0.2	7.9	0.2	10.3	2.0	0.2	0.3	1.5	0.5	2.2	3.6	0.8	0.5	1.2	0.7	2.6	1.1	0.2	0.3	0.6	1.2	4.4	15.7	0.6	0.3	0.2	0.4	0.1	0.3	0.6	0.5	1.6	2.3	0.3	1.7	0.7	0.4	1.1	4.5	0.9	0.5	9.3	3.8	1.9	0.4	184.8	0.8	0.5	12.9	3.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	45.7	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.2	0.3	0.0	175.8	44.8	0.0	0.0	0.0	122.8	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	6.3	0.7	0.1	51.4	0.3	38.2	3.1	37.5	56.2	1.2	5.2	31.3	58.2	6.6	5.4	0.3	0.8	35.0	74.9	0.2	0.2	0.2	0.3	0.2	0.3	0.6	0.3	0.5	0.5	0.4	0.7	1.1	0.0	6.7	0.3	8.2	1.7	0.0	0.0	0.0	0.6	1.1	0.8	1.0	2.8	0.0	0.0	0.0	0.0	18.3	0.1	0.0	0.4	4.8	0.3	0.1	0.8	1.2	32.6	1.3	0.2	0.0	0.6	0.0	0.1	146.9	0.2	2.5	2.3	0.2	0.0	1.2	0.6	0.0	1.9	4.6	2.9	0.3	82.0	1.8	1.0	6.8	0.3	59.8	2.5	1.0	0.0	0.3	0.4	6.3	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.9	4.4	2.1	0.1	1.1	0.1	57.1	0.0	0.1	0.3
GRB14		ENSG00000115290	"Growth factor receptor bound protein 14"	Q14449	2	164492417-164621482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 12.6;tongue: 20.3"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 92.0;Granulosa cells: 272.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.5"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.5;HUVEC TERT2: 9.6;RPTEC TERT1: 9.1;TIME: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022294, HPA035052, HPA035053"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022294: , HPA035052: , HPA035053: AB_2674432"	"unprognostic (2.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.47e-2)"	"unprognostic (8.33e-5)"	"unprognostic (5.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.33e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (9.27e-2)"	0.7	3.0	0.0	0.3	0.4	0.0	0.3	0.0	0.6	0.1	0.1	0.9	0.9	0.2	5.4	1.2	0.1	0.1	2.7	1.3	0.1	6.6	12.6	0.4	0.0	0.3	0.2	2.0	4.7	0.0	0.3	1.7	0.0	0.3	0.3	0.4	0.3	0.3	2.4	0.2	0.2	0.4	0.0	0.2	0.2	2.6	0.3	0.0	0.9	20.3	0.0	0.0	0.1	0.0	0.8	5.5	0.3	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.5	0.0	2.9	0.0	0.9	0.3	0.8	1.2	0.3	0.0	4.1	0.0	0.3	1.3	0.1	0.0	0.0	0.3	0.8	1.8	0.0	1.6	9.6	0.0	0.0	0.0	1.5	2.1	0.0	0.0	1.9	0.2	1.2	0.0	0.0	0.1	9.1	0.4	3.1	0.3	0.0	0.3	0.0	1.1	0.7	0.0	11.8	0.1	1.2	0.0	0.1	0.4	0.1	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.6	1.3	0.1	0.3	0.2	0.0	0.0	0.3	0.0	4.5	0.0	5.4	0.7	0.1	0.1	0.3	0.0	0.0	1.3	1.6	1.4	17.7	22.8	0.0	16.5	0.0	0.2	1.3	0.3	92.0	13.5	1.5	0.6	0.2	3.0	0.0	0.0	24.5	3.3	0.2	2.4	0.0	1.9	0.0	272.4	1.1	40.4	0.0	0.0	6.2	2.6	0.0	1.0	0.3	4.4	9.3	3.2	19.6	1.9	1.0	0.3	0.0	3.5	2.3	4.0	0.0	17.3	0.0	0.8	0.3	14.7	0.0	0.8	13.1	0.8	10.9	0.7	6.4	0.1	0.0	0.1	0.2	30.4	1.6	0.2
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 340.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	55.7	58.0	66.1	98.3	64.8	127.1	40.3	56.6	66.1	35.9	49.9	54.7	57.3	46.4	31.5	51.0	39.5	43.2	53.3	71.0	68.7	50.5	54.0	65.5	116.9	64.1	64.8	39.3	35.0	39.8	42.6	64.5	61.5	41.8	52.6	24.1	40.6	45.8	48.8	36.3	60.6	58.9	67.5	92.2	44.6	18.5	68.5	83.1	37.6	39.1	107.3	67.5	36.1	72.3	98.6	87.7	58.9	71.1	64.1	54.5	129.5	91.2	70.5	89.3	87.3	75.8	66.7	128.9	57.9	97.0	77.5	58.5	84.0	76.1	89.8	63.4	76.5	137.2	55.7	111.8	57.3	162.8	259.0	55.2	78.0	112.9	55.8	62.3	128.3	125.3	95.5	88.8	64.9	127.4	160.3	160.5	40.5	98.9	81.3	113.7	123.8	94.9	82.7	75.0	66.6	101.1	83.7	85.4	114.7	102.8	94.4	264.9	83.4	100.0	71.0	81.8	104.9	161.1	127.3	205.5	79.1	125.8	75.3	134.5	136.1	164.9	52.3	160.9	45.0	94.5	48.0	52.2	101.2	96.5	46.8	47.8	273.8	51.5	185.1	71.9	56.5	102.9	66.1	64.8	56.6	66.1	71.0	68.7	64.1	64.8	61.5	67.5	68.5	72.3	73.5	60.9	62.2	18.3	210.5	47.0	45.7	31.0	67.7	35.7	45.6	37.5	59.7	41.5	46.9	16.5	31.3	71.9	137.6	74.4	52.8	64.8	3.0	52.9	56.4	60.9	41.9	55.5	41.5	63.4	340.9	47.2	47.9	57.6	124.4	30.0	41.7	42.3	260.3	35.3	41.1	46.4	22.4	182.0	243.8	5.6	25.1	259.9	46.2	81.5	237.0	47.1	73.2	31.7	41.5	77.2	69.6	41.8	236.3	63.3	60.1	69.9	55.1	46.4	6.6	34.6	50.5	27.4	49.9	76.3	44.8	87.2	109.0	59.7	44.9	92.7
GRHL1	"LBP-32, MGR, TFCP2L2"	ENSG00000134317	"Grainyhead like transcription factor 1"	Q9NZI5	2	9951693-10002277	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.6;skin 1: 87.7;vagina: 66.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Cytotrophoblasts: 61.9;Extravillous trophoblasts: 80.5;Suprabasal keratinocytes: 132.7;Syncytiotrophoblasts: 184.6;Urothelial cells: 104.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 212.3;RT4: 41.4;SK-BR-3: 112.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005798, HPA006420"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"HPA005798: AB_1079026, HPA006420: AB_1079025"	"unprognostic (2.26e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.33e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.14e-1)"	4.5	1.3	2.2	1.2	2.3	8.7	39.8	0.8	2.8	31.0	1.0	1.5	1.2	1.0	7.3	119.6	2.2	3.0	2.5	2.7	2.5	4.0	12.2	5.0	1.0	0.8	1.5	0.4	4.2	29.0	3.6	26.7	0.9	11.4	1.0	11.4	44.7	7.3	1.1	87.7	0.7	0.7	0.6	0.8	3.7	3.2	4.3	0.9	2.9	0.4	26.1	13.9	66.9	1.7	10.9	0.2	1.2	3.0	0.4	0.5	212.3	1.0	1.5	0.7	1.2	0.9	7.5	1.4	0.4	0.1	1.5	6.5	13.0	1.4	3.1	3.2	5.9	0.3	2.3	4.3	0.3	0.7	1.2	0.4	5.5	6.0	0.0	0.0	1.1	2.3	2.2	4.1	0.0	14.3	2.2	1.7	0.8	3.5	2.5	0.9	1.0	1.9	1.4	41.4	2.4	1.6	2.0	112.3	2.7	17.4	13.7	0.4	1.2	0.6	2.6	3.3	1.3	2.7	1.7	1.5	0.6	1.7	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	1.7	2.2	2.3	0.8	2.8	2.7	2.5	0.8	1.5	0.9	0.6	4.3	1.7	2.2	3.2	8.1	3.9	1.2	40.0	23.1	10.7	2.8	25.5	37.1	19.9	2.1	1.5	31.1	20.2	62.6	61.9	1.3	1.2	0.0	2.9	6.4	4.5	1.3	4.2	3.5	0.0	14.6	9.1	80.5	5.4	3.1	9.6	10.2	0.4	2.5	7.7	7.7	11.8	6.0	0.8	4.1	1.0	15.7	3.0	0.0	10.6	21.4	1.9	1.0	1.1	0.0	4.0	1.0	5.7	0.1	0.4	1.0	31.5	0.1	2.4	18.6	11.5	0.0	3.0	3.7	9.6	5.1	35.2	132.7	184.6	2.1	0.1	1.2	104.6
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492439-101669726	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 28.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Respiratory ciliated cells: 28.8;Squamous epithelial cells: 27.1;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 39.3;CACO-2: 28.0;HaCaT: 46.3;hTCEpi: 35.5;MCF7: 32.7;OE19: 37.9;RT4: 68.9;T-47d: 79.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.1	0.0	0.0	1.0	0.0	0.0	12.3	0.0	0.3	6.9	0.0	8.0	4.0	1.7	16.1	20.4	8.5	3.3	0.0	0.0	0.0	6.3	0.4	5.6	0.0	0.0	0.0	0.0	11.1	9.3	0.8	6.7	0.0	23.2	9.2	0.0	14.8	7.2	0.0	28.6	4.3	0.4	0.0	0.1	9.8	0.3	0.0	2.9	10.2	0.0	4.6	7.7	10.4	0.0	39.3	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	28.0	18.9	0.0	0.0	0.1	0.0	46.3	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.3	0.2	37.9	0.0	0.0	0.0	0.1	0.0	68.9	1.9	0.0	0.0	15.0	0.0	4.4	79.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.1	13.0	0.3	0.0	24.3	10.5	7.6	20.5	0.0	14.4	6.1	0.7	17.2	20.8	11.0	0.0	14.0	0.2	10.3	5.9	7.5	2.4	20.0	1.5	0.8	1.2	0.0	0.8	5.5	7.1	0.8	15.3	20.7	0.0	0.0	0.0	0.0	1.4	0.0	1.3	9.8	2.0	0.0	1.1	9.3	0.0	0.3	1.8	0.0	0.6	0.0	0.0	2.0	0.5	8.8	8.5	0.0	1.3	9.3	5.7	0.1	28.8	0.0	0.0	0.5	1.0	0.1	0.0	27.1	26.0	19.8	0.3	0.1	11.0	6.3
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319357-24364482	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 120.8;skin 1: 53.5;vagina: 47.7"	"Group enriched"	"Detected in some"	5	"Squamous epithelial cells: 113.5;Suprabasal keratinocytes: 99.3;Urothelial cells: 78.4"	"Group enriched"	"Detected in many"	4	"cervical cancer: 13.3;head and neck cancer: 16.1;urothelial cancer: 28.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 46.1;HaCaT: 36.6;MCF7: 58.5;OE19: 21.2;RT4: 64.8;SuSa: 33.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.2	0.1	0.4	0.3	0.4	0.1	1.9	1.4	0.6	23.3	0.1	0.1	0.6	0.1	1.6	120.8	0.6	0.7	0.0	0.3	1.3	0.2	0.3	0.1	0.0	3.8	4.6	0.0	0.2	0.9	0.2	1.4	3.4	1.5	0.2	0.1	16.7	1.6	0.1	53.5	0.3	0.0	2.3	0.0	0.5	2.3	0.8	1.0	0.0	0.0	25.1	34.7	47.7	1.9	1.2	2.7	1.0	0.0	0.0	0.0	46.1	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	36.6	0.1	3.3	0.0	1.2	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	14.2	0.2	2.7	0.0	0.0	0.0	0.2	0.1	0.0	58.5	0.0	0.2	2.4	21.2	0.0	0.0	0.0	0.2	4.6	64.8	0.3	0.0	0.2	6.3	0.0	33.3	4.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.4	0.6	0.3	1.3	3.8	4.6	3.4	2.3	0.8	1.9	0.0	0.0	0.6	0.0	0.0	14.4	13.2	5.2	8.6	0.0	1.1	0.3	0.5	0.0	6.4	1.8	0.0	4.1	0.0	0.9	0.0	0.4	0.5	3.8	0.1	0.3	0.0	0.0	0.1	0.0	0.8	0.3	0.0	1.3	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.1	2.0	0.3	2.1	0.3	0.0	0.3	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.1	0.2	0.0	3.3	0.0	0.0	0.0	0.3	2.6	0.0	113.5	99.3	18.5	0.0	0.0	0.1	78.4
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 652.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 864.6;Proximal tubular cells: 817.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022971, HPA078575"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		2700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA022971: AB_1849975, HPA078575: "	"prognostic favorable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	58.9	143.1	72.6	35.5	83.9	40.5	55.7	84.1	74.3	53.0	76.1	60.5	63.5	58.5	62.6	62.5	51.0	36.6	107.6	69.7	76.4	156.5	652.5	42.9	55.8	76.3	76.2	63.4	64.2	49.1	35.7	35.2	77.6	50.7	35.4	20.8	74.8	46.4	168.5	64.2	51.4	42.8	75.9	41.7	60.7	37.9	78.4	34.7	43.4	146.4	51.5	52.9	51.8	89.4	111.7	157.7	87.5	81.0	80.1	86.4	87.7	86.2	114.3	115.8	125.2	60.3	47.2	106.5	50.0	105.3	85.8	49.3	51.7	113.5	69.3	140.3	62.8	61.6	144.1	107.5	124.3	58.7	61.6	104.2	97.2	67.6	87.4	98.0	102.2	67.5	116.1	42.9	104.2	85.3	58.9	60.8	53.5	101.1	67.5	55.4	62.1	59.1	155.9	63.0	36.3	64.3	74.4	143.8	84.1	79.1	80.1	75.7	109.7	63.5	100.4	44.0	76.9	33.1	27.4	70.8	90.8	33.5	95.7	45.0	64.7	33.9	39.3	66.9	32.7	61.6	40.8	44.6	70.3	65.6	39.6	33.9	14.5	64.5	56.7	63.4	57.8	52.0	72.6	83.9	84.1	74.3	69.7	76.4	76.3	76.2	77.6	75.9	78.4	89.4	50.7	57.7	30.2	24.2	37.5	43.3	52.5	87.3	41.5	39.0	53.7	65.7	103.7	177.3	53.8	51.5	20.9	152.6	33.9	65.3	248.4	78.0	14.9	38.4	65.4	47.9	62.2	54.7	10.3	89.0	93.0	67.7	52.0	44.8	50.1	93.3	67.5	864.6	110.8	23.5	11.0	79.7	71.2	82.9	45.8	16.0	74.6	49.2	80.0	14.0	71.1	102.8	33.0	16.1	44.9	73.8	56.9	98.6	30.1	46.4	135.6	817.7	36.0	29.1	78.9	54.3	71.8	22.3	19.0	74.6	56.3	88.9	32.5	233.3	80.9	48.1
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;testis: 32.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.9;Bipolar cells: 23.0;Excitatory neurons: 32.4;Horizontal cells: 18.5;Inhibitory neurons: 31.1;Oligodendrocyte precursor cells: 31.7;Rod photoreceptor cells: 21.2"	"Group enriched"	"Detected in many"	5	"glioma: 15.4;ovarian cancer: 6.6;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.7;hTERT-RPE1: 21.2;NTERA-2: 13.1;REH: 37.5;SCLC-21H: 10.3;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.6	4.0	20.0	1.7	17.3	3.0	1.2	6.2	26.7	5.3	0.1	16.4	0.7	7.3	1.8	1.6	6.8	1.9	4.9	36.5	15.5	7.0	0.3	0.5	0.7	3.6	4.8	3.6	2.7	14.8	18.3	0.0	7.0	6.2	1.0	12.5	0.7	6.5	0.5	0.9	3.4	5.2	3.0	1.3	5.3	32.9	14.6	0.9	11.3	0.7	0.6	5.0	2.7	6.6	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.3	13.7	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	21.2	0.0	0.6	0.1	0.6	0.0	0.2	0.2	0.0	13.1	0.1	0.0	37.5	0.0	0.1	5.8	0.1	10.3	22.7	0.1	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	17.3	6.2	26.7	36.5	15.5	3.6	4.8	7.0	3.0	14.6	6.6	0.2	0.0	0.0	17.9	0.1	0.4	0.1	0.0	0.0	23.0	0.2	0.8	3.1	0.0	0.0	1.8	2.1	0.0	0.0	0.1	0.0	0.8	1.6	0.2	0.2	0.4	0.0	0.0	32.4	0.0	0.0	0.6	0.0	0.3	4.5	7.2	0.0	0.0	0.0	18.5	31.1	0.0	0.0	0.0	0.0	2.3	0.9	0.1	0.0	2.8	0.0	9.1	0.0	31.7	0.9	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	21.2	0.0	4.9	1.7	4.2	2.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564675-25729294	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 30.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.2;Club cells: 16.7;Extravillous trophoblasts: 29.2;granulocytes: 18.9;Hofbauer cells: 29.3;Macrophages: 26.4;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.1;eosinophil: 5.2;intermediate monocyte: 7.2;memory B-cell: 4.1;myeloid DC: 3.2;naive B-cell: 5.0;non-classical monocyte: 6.8;plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.6;JURKAT: 69.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.29e-4)"	30.2	5.4	6.5	12.9	8.9	7.8	9.4	2.3	14.7	4.0	0.0	3.1	2.8	5.3	1.3	2.4	8.7	4.7	4.3	18.9	2.6	2.4	3.2	9.4	15.1	5.4	6.2	2.9	7.1	4.2	3.2	4.4	2.5	7.5	3.9	4.8	3.2	1.6	0.9	3.3	4.7	5.9	2.9	18.8	3.8	15.7	7.6	10.2	4.1	1.2	15.6	6.2	1.5	6.0	0.1	3.9	11.9	3.9	8.1	1.0	17.3	1.3	3.8	3.8	6.5	6.4	6.8	22.5	0.3	0.3	10.5	0.2	11.9	9.1	11.1	43.6	7.6	10.3	1.3	14.3	0.3	33.8	16.8	2.0	6.2	2.6	4.6	0.6	0.7	69.4	1.1	0.1	4.4	5.6	24.4	2.4	8.5	12.1	0.0	10.8	18.9	3.8	0.0	6.6	27.6	37.5	2.2	0.1	9.0	10.9	3.3	13.4	0.3	0.1	23.6	0.2	4.9	2.6	9.1	17.4	15.8	11.8	3.7	0.5	4.1	5.2	0.0	7.2	0.2	4.1	0.0	0.2	3.2	5.0	0.1	0.1	0.2	0.0	6.8	2.7	0.3	1.5	6.5	8.9	2.3	14.7	18.9	2.6	5.4	6.2	2.5	2.9	7.6	6.0	3.9	16.0	32.2	0.0	10.2	0.0	0.0	0.0	0.0	0.0	11.7	9.5	0.0	0.0	16.7	0.0	0.0	2.0	1.1	0.0	1.9	9.4	0.0	12.7	5.8	2.4	0.0	0.0	0.0	1.8	29.2	4.1	0.0	2.2	18.9	3.7	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	27.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	2.1	0.0	0.0	1.8	6.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	3.3	1.1	5.0	0.0	0.0
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445841-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.0	13.7	6.3	14.0	5.8	14.0	14.4	7.0	6.9	13.7	7.2	11.5	13.1	16.1	4.2	18.2	13.0	8.6	13.6	6.2	6.7	13.0	16.3	10.9	16.0	6.9	7.4	13.7	18.6	13.0	8.6	11.4	7.4	12.2	6.5	3.7	12.7	8.9	28.4	17.5	10.9	8.6	5.6	14.1	13.8	7.4	8.7	11.5	11.8	14.5	10.6	14.6	13.5	7.3	58.3	148.9	25.0	47.3	20.2	19.8	21.6	44.9	20.8	62.2	51.8	84.0	42.4	83.4	37.8	28.7	35.0	48.8	62.7	67.9	24.9	63.8	86.5	78.2	48.6	60.4	23.0	71.9	47.8	23.8	37.0	58.9	29.4	14.3	31.5	43.8	107.3	50.1	27.0	59.1	75.1	180.1	68.1	63.8	43.2	92.9	28.3	58.5	26.4	70.4	56.2	32.1	51.3	71.0	22.4	15.4	34.6	36.5	35.2	57.9	49.1	25.9	107.1	50.6	126.8	78.3	19.7	64.8	69.0	0.3	24.8	3.3	41.5	40.7	46.4	44.4	37.1	41.0	40.9	44.8	42.6	40.3	2.0	41.6	32.4	29.7	36.3	37.4	6.3	5.8	7.0	6.9	6.2	6.7	6.9	7.4	7.4	5.6	8.7	7.3	17.3	3.2	17.5	1.0	26.8	46.3	31.7	18.6	23.3	13.4	16.0	13.7	7.1	14.3	14.3	12.9	0.0	41.4	15.1	14.4	23.5	29.0	3.8	13.1	20.5	19.1	19.2	28.8	1.6	18.2	39.7	18.1	13.3	14.3	19.7	16.8	13.6	18.5	24.4	21.9	3.9	14.5	14.2	11.1	14.3	19.4	17.1	11.4	28.4	2.8	25.3	6.1	19.6	3.0	2.6	22.4	6.5	12.4	28.5	24.2	6.8	18.8	16.8	15.7	19.7	22.7	20.4	9.4	34.3	20.5	40.6	35.0	17.9	26.3	17.1	24.0
GSC		ENSG00000133937	"Goosecoid homeobox"	P56915	14	94768223-94770113	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.8;breast: 6.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 3.5;Breast myoepithelial cells: 2.2;Ductal cells: 3.0;Exocrine glandular cells: 2.4;Fibroblasts: 9.2;Langerhans cells: 2.3;Skeletal myocytes: 2.6;Smooth muscle cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"hypothalamus: 1.4"	"Immune cell enriched"	"Detected in single"	8	"gdT-cell: 3.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HEK 293: 2.0;MCF7: 3.2;REH: 3.3;SH-SY5Y: 3.5;T-47d: 2.5;U-251 MG: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB079923, CAB079924"			Supported	"Nucleoplasm,Nuclear speckles,Actin filaments"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear speckles"	"Actin filaments"	"CAB079923: , CAB079924: "	"unprognostic (2.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.18e-10)"	"unprognostic (4.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.16e-1)"	3.8	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.4	0.1	0.1	0.2	0.0	0.1	0.4	0.0	0.5	0.0	1.4	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.6	0.1	0.4	0.0	0.0	0.7	0.0	0.0	0.9	0.5	1.2	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	1.6	2.2	0.1	0.3	0.2	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	1.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	2.4	0.0	9.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	2.6	4.6	0.0	1.2	0.0	0.9	0.0	0.4	0.0	0.0	0.1
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977768	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 58.9"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.7;Hofbauer cells: 5.0;Kupffer cells: 5.6;Macrophages: 2.6;Suprabasal keratinocytes: 2.7;Theca cells: 2.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.1;hTCEpi: 2.7;hTERT-HME1: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		44000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	3.4	0.7	0.2	0.9	0.2	0.4	3.5	0.4	0.4	0.8	0.2	0.7	0.6	0.4	6.6	3.2	0.3	0.8	0.3	0.3	0.2	0.3	0.3	0.4	0.7	0.4	0.0	0.1	0.3	1.3	0.1	1.6	0.4	0.1	1.2	0.0	0.8	0.0	0.4	58.9	0.5	0.6	0.0	0.2	0.3	0.3	0.4	0.5	0.1	0.1	3.4	1.1	1.5	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.2	0.5	0.4	0.2	0.0	0.1	0.8	0.0	2.7	0.5	5.4	0.0	0.0	0.0	0.1	1.3	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.9	0.1	0.1	2.2	0.0	2.6	0.0	1.3	0.8	0.1	0.1	0.6	0.9	0.7	0.1	0.1	0.2	0.5	0.5	0.2	0.2	0.4	0.4	0.3	0.2	0.4	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	3.7	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	5.0	0.0	0.1	0.7	0.0	5.6	0.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	0.2	2.8	0.0	0.0
GSDMB	"GSDML, PRO2521"	ENSG00000073605	"Gasdermin B"	Q8TAX9	17	39904595-39919854	"Predicted intracellular proteins, Transporters"	"Cytolysis, Necrosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2;liver: 52.8;stomach 1: 47.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 45.7;Gastric mucus-secreting cells: 62.2;Intestinal goblet cells: 30.7;Paneth cells: 54.2;Proximal enterocytes: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	8	"SK-BR-3: 458.1"					"Not detected"	"Not detected"			"CAB013681, HPA023925, HPA052407"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819"	"unprognostic (5.78e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (5.13e-11)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.91e-2)"	"prognostic favorable (5.91e-9)"	13.5	1.4	12.2	13.1	12.4	5.1	9.3	12.9	22.6	6.0	11.6	45.0	66.9	3.4	5.1	4.8	6.2	12.5	4.8	12.5	11.3	6.0	52.8	7.9	11.0	11.5	11.4	6.3	8.2	0.3	4.0	2.9	11.6	10.9	57.0	5.3	4.6	4.4	1.5	8.3	76.2	5.0	11.2	15.0	47.4	4.3	11.9	10.8	8.9	0.4	8.4	20.1	5.6	13.2	2.0	1.5	2.9	0.8	6.7	4.3	2.6	1.8	1.1	0.6	1.8	1.7	55.2	2.8	2.5	1.7	0.9	7.6	1.6	1.6	4.0	11.7	1.8	1.1	0.8	0.8	2.0	0.3	0.7	2.9	9.2	2.4	3.3	4.6	1.2	9.0	1.3	3.5	0.7	0.6	3.3	6.2	0.8	18.2	2.0	3.1	1.1	4.5	0.2	1.8	1.1	1.4	0.6	458.1	1.9	13.2	2.4	1.9	1.7	2.0	3.0	5.1	1.0	9.9	9.2	2.8	0.7	1.9	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	12.2	12.4	12.9	22.6	12.5	11.3	11.5	11.4	11.6	11.2	11.9	13.2	1.5	3.2	12.0	9.1	3.9	1.9	1.4	4.9	4.0	2.8	3.3	2.9	2.5	8.6	8.1	5.5	4.2	1.6	3.5	45.7	0.0	1.7	5.5	1.5	1.8	1.8	6.1	0.0	20.1	7.8	0.6	1.2	62.2	1.8	1.3	3.0	0.4	8.1	0.3	1.7	9.2	30.7	0.0	1.3	2.0	5.4	1.2	1.1	3.6	3.7	1.5	1.3	2.1	7.1	5.1	8.9	54.2	1.9	5.6	1.4	108.2	0.3	14.1	2.3	0.0	1.4	2.2	0.4	1.4	1.8	3.4	0.3	4.8	3.0	23.7	6.7
GSDMD	"DF5L, FLJ12150, GSDMDC1"	ENSG00000104518	"Gasdermin D"	P57764	8	143553207-143563062	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity, Necrosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 226.7;Proximal enterocytes: 297.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004656, HPA044487"	Uncertain		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		11000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB004656: AB_426076, HPA044487: AB_2678957"	"unprognostic (1.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (8.51e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.77e-3)"	43.1	36.0	6.5	34.1	6.7	39.4	41.5	6.5	9.0	42.9	11.1	48.4	51.3	36.7	9.1	22.5	41.5	15.7	24.6	6.2	6.4	50.6	88.8	54.8	42.3	7.7	7.2	39.5	35.1	19.2	18.3	16.5	7.2	39.0	13.6	1.0	32.5	15.1	11.0	16.8	60.3	12.4	7.1	120.1	37.9	7.3	7.0	24.4	46.4	6.1	16.1	35.8	31.7	7.1	40.8	18.4	0.3	0.1	13.4	14.7	23.8	13.8	36.4	44.0	47.4	3.1	54.6	14.5	21.9	21.1	19.6	12.5	0.7	31.1	11.1	43.8	2.8	23.2	5.4	22.6	17.8	4.2	1.0	35.5	2.6	16.1	9.4	14.5	34.1	34.2	1.4	49.1	2.3	0.8	87.5	7.1	0.3	27.3	67.6	30.2	1.5	48.7	22.5	39.9	0.5	0.6	44.2	39.8	43.4	5.6	69.7	24.8	13.3	0.2	44.6	3.2	22.1	16.5	22.4	0.4	26.5	19.6	21.8	65.4	44.7	45.9	55.0	73.2	44.8	39.9	48.6	53.7	40.7	31.1	33.8	40.4	46.2	41.1	69.1	29.1	71.1	46.8	6.5	6.7	6.5	9.0	6.2	6.4	7.7	7.2	7.2	7.1	7.0	7.1	91.1	12.8	29.1	6.8	39.8	10.8	47.1	55.7	23.9	0.2	31.6	30.5	12.2	47.1	37.5	31.3	0.0	62.0	54.6	226.7	60.7	68.3	2.2	33.8	20.0	57.0	39.6	14.9	0.1	92.7	98.1	34.0	68.8	27.2	27.3	171.1	75.3	72.3	63.1	0.0	0.1	114.8	30.5	50.1	18.4	7.0	23.6	52.5	17.8	7.5	74.4	28.9	81.4	0.5	0.1	50.2	181.1	22.6	41.1	34.6	297.7	121.8	43.1	1.7	59.2	24.0	34.4	1.4	12.3	13.8	8.9	41.7	61.5	24.2	131.8	45.9
GSE1	KIAA0182	ENSG00000131149	"Gse1 coiled-coil protein"	Q14687	16	85169525-85676204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 146.0;Syncytiotrophoblasts: 182.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 24.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 174.6;K-562: 205.4;T-47d: 200.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036365, HPA042090"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA036365: AB_10601762, HPA042090: "	"unprognostic (1.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.88e-1)"	27.2	15.2	1.4	14.2	0.7	31.9	22.0	24.4	7.9	16.9	0.0	17.9	15.9	15.1	5.0	12.7	15.9	10.6	23.2	3.9	3.0	12.3	14.2	17.7	11.3	4.5	5.8	23.7	23.4	38.6	28.0	31.7	2.1	12.7	11.5	14.4	30.3	13.6	37.9	18.8	14.8	14.2	0.0	18.4	20.8	14.7	2.0	40.7	19.3	9.3	8.7	13.0	14.1	0.7	19.3	33.6	22.0	55.5	13.9	12.7	174.6	25.3	17.4	13.9	5.2	29.0	25.6	11.2	29.9	28.9	12.5	17.9	35.1	9.7	7.0	21.2	29.7	82.4	33.6	36.5	17.9	38.5	44.8	23.7	22.7	14.9	7.1	14.5	3.7	65.7	205.4	2.0	4.6	129.9	138.1	33.9	38.4	20.7	9.9	89.7	7.4	29.1	12.6	7.2	142.7	99.3	49.8	91.8	4.7	19.9	200.7	94.6	6.4	28.3	35.5	7.9	6.9	30.0	19.5	65.3	16.2	23.8	25.4	2.8	0.7	2.2	1.4	1.3	1.4	1.6	0.5	0.9	1.2	1.5	0.2	1.0	0.6	0.9	3.3	0.0	0.0	0.6	1.4	0.7	24.4	7.9	3.9	3.0	4.5	5.8	2.1	0.0	2.0	0.7	52.9	67.3	68.1	30.3	16.6	14.0	7.3	11.6	21.1	65.0	39.6	16.8	37.0	25.8	24.1	38.6	146.0	52.9	25.5	33.6	1.9	14.9	4.3	48.8	34.7	27.0	59.7	65.6	53.2	12.4	75.9	21.7	39.3	61.6	43.6	80.9	17.2	34.7	12.3	35.3	45.4	67.5	20.3	15.1	24.0	5.5	47.2	17.5	10.6	19.7	12.2	7.1	35.0	14.1	13.7	17.9	20.9	61.3	18.6	14.3	12.6	6.2	30.5	62.3	6.6	15.5	10.1	2.3	18.3	33.5	30.0	182.2	21.5	55.8	25.7	12.3
GSK3B		ENSG00000082701	"Glycogen synthase kinase 3 beta"	P49841	3	119821321-120094994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 218.7;Inhibitory neurons: 246.3;Microglial cells: 197.7;Oligodendrocyte precursor cells: 241.8;Oligodendrocytes: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016263, HPA028017"	Approved		Supported	Nucleoplasm		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB016263: AB_2279451, HPA028017: AB_10600708"	"unprognostic (1.09e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (3.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.79e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.16e-1)"	11.0	13.6	9.2	11.7	9.5	15.1	11.2	16.6	16.9	10.0	0.0	11.7	12.3	10.3	11.1	13.8	10.1	11.1	18.2	8.2	13.8	12.0	14.8	13.9	10.4	15.2	15.3	9.3	10.7	17.3	7.1	16.3	16.5	10.0	12.4	23.6	13.2	9.3	17.5	16.3	15.3	13.3	4.9	12.9	12.6	23.1	9.6	20.0	15.1	18.0	11.7	12.0	9.5	12.5	59.3	22.7	46.8	25.5	31.9	29.5	50.3	36.6	57.6	28.3	29.3	25.9	23.8	24.1	19.1	43.0	33.8	46.0	22.2	59.1	45.8	15.5	6.6	42.2	18.4	16.6	35.6	31.6	49.9	34.3	39.5	27.0	56.8	27.3	31.5	29.3	13.6	34.6	40.5	25.1	44.0	10.7	25.2	23.3	28.3	16.9	41.0	22.2	25.1	45.3	37.1	22.6	38.5	29.0	44.1	41.1	30.9	27.0	40.0	45.5	55.1	12.7	20.6	31.9	35.2	44.8	29.4	22.0	33.9	1.0	1.8	6.3	0.7	1.6	1.2	0.5	1.0	1.7	1.4	0.7	0.9	0.8	6.6	0.5	2.1	1.1	1.2	0.8	9.2	9.5	16.6	16.9	8.2	13.8	15.2	15.3	16.5	4.9	9.6	12.5	39.3	32.1	26.7	113.6	28.3	50.9	37.8	22.2	46.1	63.2	21.9	17.0	39.7	20.0	21.4	18.4	60.5	27.0	29.0	37.3	11.7	26.9	138.2	25.2	31.6	31.5	26.9	15.4	218.7	32.0	49.3	25.1	46.4	32.5	17.2	18.1	25.0	22.9	21.5	143.0	246.3	22.3	20.3	27.3	29.2	48.1	13.1	33.4	35.6	197.7	35.5	31.6	22.6	241.8	202.5	49.0	23.4	19.9	29.0	28.7	35.8	17.3	16.3	42.4	13.1	24.4	38.2	38.8	29.3	50.8	41.1	43.0	36.4	32.7	25.9	41.6
GSS		ENSG00000100983	"Glutathione synthetase"	P48637	20	34928432-34956027	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 164.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054508, HPA059315"	Enhanced		Supported	Nucleoplasm		NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054508: AB_2682509, HPA059315: AB_2683976"	"unprognostic (5.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (2.90e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.64e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.31e-6)"	"unprognostic (3.35e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.52e-1)"	18.8	46.9	24.2	17.7	25.6	27.1	23.8	21.4	26.2	21.1	24.6	41.1	30.4	17.4	67.7	43.4	26.9	17.9	24.8	25.4	25.3	42.7	44.8	21.7	15.9	23.7	25.1	14.3	15.7	27.7	26.4	19.8	25.5	34.2	40.6	15.7	28.9	18.6	20.4	34.6	28.4	19.1	22.9	23.7	28.5	23.7	25.9	21.5	23.2	16.9	18.5	22.9	26.1	25.4	63.7	75.7	36.2	51.2	41.4	42.8	51.5	52.9	48.7	81.6	67.1	139.9	75.5	44.8	68.6	54.9	78.7	58.7	53.6	134.8	68.5	20.9	30.4	176.1	46.8	140.1	58.1	44.8	59.5	45.3	141.8	77.0	128.8	36.3	58.4	59.5	87.1	35.7	100.6	70.1	72.5	63.5	21.4	83.2	96.0	64.8	72.7	106.9	117.7	63.9	71.0	41.3	93.6	86.5	70.9	19.7	106.5	40.5	46.7	93.1	52.5	61.7	46.5	35.7	35.9	49.1	79.4	48.6	56.7	17.5	36.2	8.7	30.4	39.2	27.6	12.8	24.0	31.4	43.6	8.7	27.7	23.7	8.4	29.3	36.6	23.9	32.6	29.0	24.2	25.6	21.4	26.2	25.4	25.3	23.7	25.1	25.5	22.9	25.9	25.4	10.6	19.2	10.5	13.4	9.9	26.3	32.5	72.4	38.7	23.0	32.8	20.8	17.1	27.1	38.1	25.8	10.4	79.4	19.1	58.1	25.4	51.6	55.6	14.8	18.2	16.1	23.4	26.9	12.2	47.2	52.5	19.3	37.2	16.4	17.7	80.1	10.0	27.3	59.9	35.3	13.8	50.6	48.8	17.2	17.3	164.1	10.2	26.8	16.0	5.6	31.0	29.6	19.6	10.1	9.9	39.8	40.1	18.4	19.6	21.4	33.8	121.5	18.1	16.9	26.3	12.0	21.0	14.7	18.9	38.1	24.2	49.0	20.6	52.1	77.7	33.0
GSTCD	FLJ13273	ENSG00000138780	"Glutathione S-transferase C-terminal domain containing"	Q8NEC7	4	105708778-105847725	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.2;Late spermatids: 52.4;Oligodendrocyte precursor cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046160, HPA061782"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA046160: AB_10961048, HPA061782: AB_2797265"	"unprognostic (4.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.44e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.38e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-2)"	"unprognostic (7.02e-2)"	2.6	2.4	1.7	3.8	2.1	5.3	5.5	3.8	2.1	3.6	5.7	3.7	2.6	3.6	2.7	5.0	4.3	3.6	2.3	1.6	2.0	4.4	2.5	2.6	4.6	2.0	2.3	2.9	3.2	3.5	2.3	3.7	2.0	3.9	4.0	7.3	2.2	3.5	2.1	3.3	3.0	4.1	1.7	2.8	3.3	10.8	1.9	4.7	5.3	2.7	5.2	2.4	2.2	3.2	11.2	10.0	22.2	19.5	5.8	7.4	16.6	15.5	7.9	18.6	16.6	9.2	21.0	13.2	7.7	6.5	10.8	8.9	25.8	16.0	26.3	19.9	7.2	10.7	9.5	12.6	2.5	20.7	7.4	4.0	8.0	17.2	13.1	7.0	11.6	13.2	22.0	11.7	16.0	9.1	21.9	7.7	12.2	16.4	11.5	14.9	13.1	7.4	20.4	8.0	18.0	8.1	11.9	17.2	6.6	19.5	15.3	8.3	8.8	13.8	14.4	8.6	12.2	4.4	10.1	7.4	8.6	10.4	19.4	0.7	0.8	0.4	0.9	1.1	1.0	1.0	0.8	0.3	1.0	1.1	0.9	1.5	5.5	1.4	1.4	1.3	0.1	0.7	1.7	2.1	3.8	2.1	1.6	2.0	2.0	2.3	2.0	1.7	1.9	3.2	5.8	6.4	3.9	32.7	5.2	2.5	3.6	2.4	2.2	22.3	10.4	4.8	3.3	8.6	1.9	9.2	27.1	6.1	2.6	5.6	3.9	5.8	120.2	7.7	8.1	4.6	4.2	12.8	32.0	5.0	8.1	5.0	6.6	9.9	2.5	9.3	3.6	8.0	7.7	21.9	32.2	4.4	2.0	5.1	3.1	52.4	8.4	4.2	5.4	9.4	4.2	7.3	3.1	53.8	35.4	6.8	1.3	4.5	7.1	3.8	1.7	5.0	2.4	21.4	0.0	5.4	4.9	11.2	7.5	6.4	4.3	3.3	2.9	6.3	6.1	2.0
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B"	P0CG30	22	23957414-23961195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 81.8;breast: 307.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Hepatocytes: 27.6;Muller glia cells: 20.9;Peritubular cells: 28.6;Skeletal myocytes: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 57.0;HHSteC: 81.9;SK-MEL-30: 60.3;T-47d: 64.8"									HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol		No	No				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA000750: AB_1849804"	"prognostic favorable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	12.3	81.8	21.6	4.3	21.5	0.0	307.9	21.4	27.0	16.6	19.5	17.2	1.4	15.5	12.0	24.7	16.1	5.5	23.9	20.8	22.7	15.2	39.5	18.5	1.8	22.2	22.2	22.6	26.1	6.4	26.0	4.4	22.2	40.6	1.9	3.8	12.5	10.4	16.4	47.8	8.3	11.8	21.0	10.2	23.8	5.5	24.3	1.8	18.6	41.0	1.6	12.1	14.0	21.1	17.0	0.8	0.0	57.0	1.0	1.1	2.4	8.0	4.7	11.5	11.9	24.8	0.2	0.0	12.9	20.2	29.7	24.5	0.0	25.5	5.2	0.0	2.2	0.9	33.6	4.0	81.9	0.1	9.1	33.4	4.0	33.2	6.7	32.6	9.6	0.0	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.9	12.5	0.0	42.4	0.1	26.0	0.0	1.1	23.8	8.2	0.2	60.3	0.2	64.8	0.9	32.0	9.9	6.5	1.3	6.4	0.0	0.0	0.1	6.1	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	21.5	21.4	27.0	20.8	22.7	22.2	22.2	22.2	21.0	24.3	21.1	8.1	3.2	3.6	1.3	0.9	0.0	8.6	0.0	2.8	3.9	9.4	17.9	0.2	7.2	1.3	0.0	0.0	1.6	0.1	0.0	29.4	7.9	0.6	1.3	11.8	7.1	1.2	5.3	2.4	9.1	3.5	7.6	1.1	2.9	1.3	2.2	18.5	27.6	10.5	0.0	2.1	0.4	0.0	3.8	0.0	1.5	9.9	1.5	0.0	0.0	3.2	20.9	0.0	2.0	0.7	4.2	0.0	28.6	0.7	7.9	0.0	5.7	0.0	2.8	6.6	26.7	9.6	0.4	0.7	0.9	0.0	1.8	0.2	0.4	0.1	3.8
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320996-77331597	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 263.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 373.2;Late spermatids: 398.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 182.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		340000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 62: Liver - Hemostasis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	13.9	34.7	11.1	9.7	12.5	9.3	23.2	13.2	16.3	12.7	10.5	21.9	22.5	10.8	22.1	26.9	14.9	11.9	14.3	10.5	12.3	24.5	263.1	7.8	13.5	12.6	11.7	6.5	20.1	26.4	13.3	11.2	12.8	21.1	21.7	5.1	24.1	9.6	47.4	22.1	15.6	7.9	12.3	12.1	18.9	57.8	11.9	14.0	19.5	37.3	17.4	11.9	13.8	14.0	18.8	39.0	27.6	19.9	17.1	23.9	45.8	11.4	11.9	21.6	30.9	13.0	45.2	43.5	14.9	13.6	13.4	24.1	18.9	22.5	20.7	23.2	21.0	20.8	13.3	26.9	26.3	7.8	15.8	22.1	24.0	12.4	20.8	12.0	18.6	24.7	17.5	37.0	14.5	182.1	12.2	16.4	8.2	64.1	30.3	20.2	29.5	34.2	32.5	24.0	30.2	26.2	26.0	49.1	35.6	15.5	81.2	11.1	13.8	17.0	52.5	18.9	8.6	28.2	32.7	35.2	41.9	11.3	20.8	13.4	15.5	9.9	2.6	22.2	2.4	8.2	4.6	3.7	20.7	10.4	3.9	3.1	1.6	5.1	20.1	15.0	7.9	7.4	11.1	12.5	13.2	16.3	10.5	12.3	12.6	11.7	12.8	12.3	11.9	14.0	6.1	6.4	9.6	6.5	13.5	13.4	19.8	26.2	15.9	7.3	36.1	34.2	13.0	47.1	19.0	9.2	4.2	91.4	7.5	34.9	46.9	45.0	125.8	19.4	15.6	11.1	28.8	30.3	2.9	68.0	62.5	15.0	33.1	27.0	3.8	25.7	15.4	373.2	44.6	16.8	3.3	45.7	20.3	38.1	10.9	398.1	11.8	19.0	17.8	3.7	30.4	26.4	4.1	2.0	9.2	41.8	37.4	6.0	13.2	19.8	72.9	77.8	15.0	11.9	0.0	12.3	13.2	51.3	29.4	38.0	14.1	76.2	6.7	55.8	50.3	30.3
GSX1	"Gsh-1, GSH1"	ENSG00000169840	"GS homeobox 1"	Q9H4S2	13	27792483-27794768	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	41	"brain: 7.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	29	"glioma: 3.9"	"Region enriched"	"Detected in some"	4	"hypothalamus: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA047096			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA047096: AB_2679929"					"unprognostic (1.62e-1)"													0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.3	0.3	7.5	0.4	0.2	0.2	0.2	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GTF2A1	TFIIA	ENSG00000165417	"General transcription factor IIA subunit 1"	P52655	14	81175452-81221377	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000869	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000869: AB_1080253"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.87e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.88e-2)"	10.4	10.1	3.0	12.9	4.3	7.4	13.0	12.3	11.1	11.0	0.1	10.1	9.6	12.0	14.7	13.2	8.7	9.9	10.2	4.6	4.3	11.4	14.5	9.0	16.2	2.3	2.8	13.0	9.8	14.5	5.7	13.2	2.7	10.8	11.0	13.5	8.3	9.0	10.7	11.3	9.1	10.4	2.4	12.6	10.6	19.6	3.3	21.1	23.2	15.5	14.7	10.7	7.4	5.3	20.5	20.0	41.0	27.8	22.8	19.0	15.7	25.9	24.7	21.6	19.4	30.0	20.1	33.9	20.5	20.1	15.9	15.5	28.7	18.2	38.0	31.1	9.0	31.4	21.5	17.9	22.5	21.6	30.6	17.9	13.6	29.8	38.4	22.5	22.4	27.1	19.5	44.0	27.9	34.0	54.9	12.5	22.9	15.5	19.8	30.0	36.6	20.8	14.4	41.2	40.2	23.7	59.8	22.8	25.6	19.6	34.6	17.8	29.4	21.9	17.0	30.7	25.9	35.9	42.2	34.5	17.5	24.6	35.8	7.3	0.7	1.3	1.3	0.5	1.0	0.7	1.2	0.7	0.4	0.6	1.0	1.2	1.2	1.0	2.6	1.9	0.7	0.5	3.0	4.3	12.3	11.1	4.6	4.3	2.3	2.8	2.7	2.4	3.3	5.3	27.0	19.2	13.6	25.5	22.3	18.0	8.6	11.9	10.8	24.9	18.4	19.7	26.5	5.7	14.0	23.9	35.5	15.1	21.4	21.2	1.9	12.0	59.4	14.5	26.5	20.7	18.6	32.0	32.9	13.0	14.4	20.0	17.9	18.9	30.4	37.2	16.8	25.9	17.0	40.4	33.4	17.5	10.2	25.2	22.1	8.0	12.8	25.0	10.6	29.0	30.9	22.0	18.6	26.7	26.4	12.4	15.8	13.5	56.2	16.6	13.0	15.0	11.4	15.8	26.3	22.0	23.7	28.6	26.5	23.9	24.4	26.0	21.7	16.2	11.6	12.0
GTF2A2	"HsT18745, TFIIA"	ENSG00000140307	"General transcription factor IIA subunit 2"	P52657	15	59638062-59657541	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 1134.9;Late spermatids: 732.8;Spermatocytes: 1264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056239			Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA056239: AB_2683074"	"unprognostic (2.18e-2)"	"unprognostic (3.21e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	54.4	56.9	37.6	54.5	39.5	72.0	49.6	42.7	44.0	52.5	38.8	62.8	40.3	48.7	54.6	60.9	46.2	43.6	64.0	38.1	42.7	69.8	49.8	39.7	52.6	41.5	40.1	52.0	43.1	65.4	58.3	43.3	41.0	46.0	51.1	41.9	58.2	34.3	75.1	39.5	42.0	45.4	42.2	43.3	46.3	211.9	38.6	60.0	41.1	55.1	51.8	61.4	65.5	44.1	149.1	206.4	136.8	130.9	83.8	70.5	157.7	164.0	79.8	134.6	133.3	224.4	58.9	136.5	149.5	107.9	197.6	124.3	138.7	100.6	95.4	242.2	112.9	157.4	146.5	143.4	107.5	171.5	134.1	66.0	95.1	112.3	94.9	95.3	87.6	105.6	226.7	136.1	113.6	103.8	112.9	130.8	181.7	49.6	120.0	104.4	142.9	166.5	133.7	172.2	148.0	157.1	152.1	171.5	160.1	180.5	120.7	179.2	121.5	126.4	224.7	142.5	297.7	134.1	426.3	303.8	143.2	284.0	157.2	174.0	129.8	170.3	88.1	140.7	92.4	126.9	103.1	98.9	174.2	100.2	87.4	96.7	70.0	117.5	135.1	201.0	132.7	134.9	37.6	39.5	42.7	44.0	38.1	42.7	41.5	40.1	41.0	42.2	38.6	44.1	109.4	41.7	58.5	17.0	89.8	98.7	184.6	213.0	83.1	51.1	107.3	155.8	120.4	62.9	132.2	64.4	47.9	217.8	99.9	122.4	211.3	148.8	1134.9	129.9	85.8	96.6	82.1	121.4	22.4	148.8	199.7	103.7	51.5	92.4	82.2	87.9	74.6	78.4	148.3	50.5	27.5	100.8	195.3	100.1	107.7	732.8	125.9	101.9	80.0	16.9	158.9	173.8	107.1	24.1	35.4	181.6	104.6	137.3	109.6	210.7	83.5	149.2	129.7	62.2	65.7	102.9	133.7	1264.3	166.3	89.8	106.8	151.9	87.3	120.8	120.5	236.2
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852633-88891944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"HPA061626: AB_2684570"	"prognostic favorable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	25.3	26.4	14.8	18.8	15.7	62.2	28.3	16.4	24.0	22.9	17.7	22.6	17.9	21.8	30.3	26.3	22.7	23.8	15.7	15.5	16.5	22.9	32.6	22.0	28.9	15.5	15.9	26.3	23.3	22.7	20.3	25.2	15.7	18.1	23.1	17.9	22.9	16.3	23.1	28.3	23.9	20.7	16.2	28.7	23.0	16.3	15.1	40.2	21.2	18.5	31.3	31.5	23.7	17.0	40.0	13.6	34.6	18.8	49.8	34.4	42.9	32.1	39.4	44.1	46.4	17.9	24.3	45.5	37.8	28.0	53.3	22.0	36.8	32.1	38.3	42.8	34.3	48.6	21.2	32.1	31.9	56.8	28.7	30.0	32.1	38.2	21.7	33.4	25.1	41.1	43.1	33.6	47.0	12.6	54.9	46.7	28.8	35.4	29.3	34.4	46.8	34.2	47.0	47.2	26.7	22.4	28.5	35.4	57.8	30.7	15.9	51.1	22.3	19.2	24.0	35.0	38.8	35.1	29.9	62.6	12.8	48.8	16.7	91.2	49.3	82.1	45.9	57.1	53.2	57.8	52.1	50.5	62.5	48.2	62.9	53.9	99.7	54.9	60.4	40.5	70.1	50.9	14.8	15.7	16.4	24.0	15.5	16.5	15.5	15.9	15.7	16.2	15.1	17.0	106.6	6.4	29.7	13.7	114.9	46.3	75.4	63.3	58.6	14.6	39.7	104.9	12.3	21.5	45.6	11.0	2.1	74.0	122.3	39.1	39.2	49.2	22.9	53.9	28.4	30.3	20.3	51.1	22.7	38.6	60.0	53.0	41.8	29.8	48.9	30.2	16.8	17.6	40.5	18.5	21.4	30.5	52.9	32.3	42.5	7.9	36.4	93.4	28.4	22.5	40.3	30.7	33.0	18.1	25.2	49.9	70.5	29.3	74.3	27.8	26.9	47.4	55.2	18.5	13.1	86.6	65.0	24.2	29.0	40.1	50.0	150.1	122.8	34.5	22.7	79.4
GTF2E1	"FE, TFIIE-A"	ENSG00000153767	"General transcription factor IIE subunit 1"	P29083	3	120742637-120783069	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009884, HPA056359, HPA066881"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.29e-3)"	"unprognostic (4.94e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.97e-1)"	5.2	7.7	4.2	6.6	4.9	4.4	5.1	4.6	5.5	4.9	7.9	5.0	4.6	4.6	4.5	4.2	4.2	3.7	5.1	4.4	4.8	4.3	5.0	4.9	9.1	5.0	4.7	5.7	4.5	4.6	2.9	6.6	4.9	4.6	5.8	5.6	4.2	5.6	7.0	3.6	4.2	5.7	4.5	7.7	4.7	9.9	4.9	8.3	5.5	9.3	9.0	5.5	4.2	5.4	13.7	18.7	23.0	14.1	16.9	7.8	20.0	9.0	8.2	13.8	14.7	22.5	9.6	22.3	15.3	6.8	10.7	16.1	21.4	11.8	19.2	15.6	5.0	28.7	12.8	19.0	13.1	26.1	16.8	10.4	12.6	10.3	14.5	9.4	21.4	18.9	20.4	11.3	14.8	15.6	21.6	13.2	22.0	13.1	17.2	17.7	27.0	16.6	13.8	8.6	4.9	15.1	13.5	11.6	12.6	20.6	14.7	19.8	18.9	12.9	14.0	4.1	10.2	9.9	11.8	31.5	13.5	26.0	12.5	18.0	7.2	11.6	6.6	11.2	8.3	9.3	8.1	9.5	8.7	7.3	8.6	8.4	5.0	10.8	10.5	4.1	10.2	7.6	4.2	4.9	4.6	5.5	4.4	4.8	5.0	4.7	4.9	4.5	4.9	5.4	4.1	3.2	4.4	3.3	6.8	1.9	3.0	4.1	3.4	5.3	4.6	1.8	4.9	8.6	6.3	7.3	0.0	9.0	4.7	3.8	5.9	5.1	7.7	8.1	6.0	5.4	1.2	5.5	3.8	4.4	8.4	3.8	3.1	6.1	12.7	9.1	7.5	5.3	9.2	16.8	4.0	3.2	6.1	8.3	2.2	2.9	2.1	7.0	3.6	8.4	12.5	5.5	14.4	4.5	7.2	4.9	2.5	4.9	5.3	3.3	3.4	5.9	5.1	4.4	0.0	3.5	3.9	14.3	22.8	2.8	2.6	8.8	5.7	9.7	3.9	3.1
GTF2E2	"FE, TF2E2, TFIIE-B"	ENSG00000197265	"General transcription factor IIE subunit 2"	P29084	8	30578318-30658236	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004816, CAB009603, HPA025065"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658"	"unprognostic (4.84e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.38e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (8.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.24e-1)"	24.5	29.1	14.9	17.8	16.1	9.4	19.9	19.9	19.3	25.1	16.9	20.9	19.5	19.4	17.2	26.4	16.4	13.2	16.2	15.9	17.3	21.4	28.1	17.8	25.9	14.8	15.1	30.3	51.8	15.4	20.1	16.8	15.0	18.7	16.0	11.6	15.9	14.6	13.4	20.6	17.5	18.5	14.7	20.4	24.4	32.7	16.5	22.4	17.4	11.0	26.6	24.1	24.1	15.8	53.7	43.7	29.2	31.2	77.4	68.2	22.0	57.7	52.4	46.5	58.6	26.2	38.2	70.0	48.0	51.9	67.0	37.8	49.1	53.8	61.5	31.8	28.2	34.9	28.9	63.0	75.4	17.1	29.5	50.6	70.7	49.7	50.7	46.3	65.3	51.2	68.7	42.1	74.5	37.3	83.7	42.9	33.1	66.0	51.9	43.2	31.6	35.4	50.9	36.7	22.4	29.1	32.1	21.5	46.5	38.3	20.8	20.9	49.9	30.6	31.4	25.9	39.8	42.6	62.7	77.0	48.2	28.8	41.3	4.3	4.2	6.4	3.6	3.5	4.1	18.8	5.7	7.6	7.3	11.7	5.6	5.5	2.2	9.7	3.7	8.2	7.0	2.8	14.9	16.1	19.9	19.3	15.9	17.3	14.8	15.1	15.0	14.7	16.5	15.8	20.2	0.0	8.4	16.6	48.7	47.9	48.1	44.3	48.3	9.2	19.1	17.5	9.9	17.2	28.2	14.7	10.4	43.0	32.3	26.5	19.6	31.5	96.7	42.2	33.8	22.9	13.2	14.1	30.2	33.1	51.4	30.0	31.1	29.0	11.4	17.7	26.4	27.0	34.1	5.0	30.1	24.2	22.4	21.6	39.3	58.9	39.4	28.4	21.4	13.1	58.8	9.0	46.4	17.1	21.8	43.3	23.4	70.7	35.9	72.7	46.5	48.2	40.0	14.9	26.3	17.5	28.0	74.3	87.9	38.3	46.5	62.1	36.9	26.1	24.5	91.8
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379572-6393981	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 228.3;Late spermatids: 391.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Cell Junctions"	"HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163"	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	35.0	38.1	36.7	34.0	38.4	71.0	34.2	43.6	43.0	48.8	30.2	41.2	40.5	48.5	25.9	46.0	44.8	36.1	32.8	39.1	35.8	37.6	30.0	31.5	43.5	34.4	34.3	73.6	57.5	42.6	49.8	26.8	34.6	39.5	23.3	24.9	43.8	31.7	36.8	36.8	39.2	25.1	30.1	36.4	43.9	68.3	36.1	37.1	49.6	22.6	29.8	37.3	41.0	36.1	115.6	97.1	62.0	100.9	46.5	73.1	47.3	81.7	84.7	112.0	106.0	104.4	48.5	76.3	111.9	67.2	73.5	109.9	69.3	65.6	57.1	106.6	90.1	97.2	60.7	86.9	78.6	107.1	79.5	82.8	78.2	85.5	64.1	86.4	69.0	72.9	115.9	91.7	63.9	96.2	115.4	79.7	108.2	59.7	124.3	101.5	68.0	94.6	67.5	74.2	76.1	99.8	83.0	64.5	95.6	36.4	84.0	94.0	79.8	78.5	62.6	134.0	110.1	153.9	197.2	79.7	98.1	124.9	91.0	10.2	29.7	20.8	26.1	28.4	29.7	32.9	23.5	24.9	23.3	31.6	27.0	24.6	40.1	27.6	30.2	30.3	25.4	19.8	36.7	38.4	43.6	43.0	39.1	35.8	34.4	34.3	34.6	30.1	36.1	36.1	29.2	48.1	56.6	5.2	51.9	24.3	50.2	40.5	53.5	27.6	43.1	34.7	28.9	32.9	58.4	25.8	8.4	46.1	51.6	88.2	21.5	48.5	228.3	70.5	70.7	41.0	30.5	51.7	6.9	50.8	43.0	43.3	51.0	57.4	63.8	32.7	58.9	26.0	60.2	25.2	7.0	53.4	24.4	54.8	25.9	391.6	44.4	42.1	33.8	5.6	66.0	35.6	49.4	3.5	4.9	47.4	66.0	49.7	55.4	29.9	65.3	48.8	83.6	33.5	32.9	44.8	52.9	71.8	38.3	44.9	21.0	54.0	48.3	41.8	54.4	40.6
GTF2F2	"BTF4, RAP30, TFIIF"	ENSG00000188342	"General transcription factor IIF subunit 2"	P13984	13	45120510-45284893	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006912	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Microtubules	"HPA006912: AB_1080256"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (3.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (6.44e-3)"	10.9	16.6	12.4	11.0	13.2	18.3	12.9	12.4	14.9	13.5	18.1	18.3	10.4	11.6	15.4	16.5	10.0	8.4	20.0	13.1	13.2	15.0	11.3	9.6	13.4	12.3	13.0	12.1	10.7	14.1	12.9	11.0	12.4	10.7	14.2	9.9	12.2	13.0	25.0	24.9	10.0	12.9	13.5	10.2	11.3	13.3	13.0	14.8	11.4	15.8	14.4	15.5	14.8	15.6	43.2	15.9	29.3	21.8	17.6	25.8	24.3	46.2	30.2	46.1	44.9	26.8	65.7	42.9	25.4	33.9	44.8	46.9	44.3	37.1	66.7	32.6	38.4	50.8	20.7	35.2	28.1	57.0	27.9	21.8	55.9	34.4	57.8	52.0	29.9	32.9	36.6	15.8	125.6	24.2	42.0	65.2	34.8	68.6	38.3	39.0	22.2	24.8	101.4	15.0	15.6	26.0	23.5	22.9	39.8	27.5	18.6	45.9	23.7	38.6	33.1	30.8	79.9	10.0	14.6	42.7	44.9	36.1	41.2	16.2	15.9	29.9	10.3	16.7	12.4	17.3	12.1	12.4	18.8	17.8	13.5	13.5	22.5	18.9	18.9	14.7	14.7	10.1	12.4	13.2	12.4	14.9	13.1	13.2	12.3	13.0	12.4	13.5	13.0	15.6	21.6	41.7	32.1	41.1	36.0	75.1	82.8	80.2	35.9	19.2	27.3	30.2	79.4	10.0	41.6	11.0	4.2	33.0	25.7	29.0	49.0	49.7	93.0	34.9	37.5	27.6	28.2	32.6	23.7	33.6	49.4	28.9	13.7	56.8	39.3	25.6	18.2	21.4	49.1	8.4	35.1	26.4	50.8	27.1	38.2	82.3	24.2	32.0	76.5	36.5	38.2	36.8	27.8	57.8	48.9	48.5	30.3	31.6	30.4	88.3	22.6	42.7	29.4	21.5	6.6	35.6	32.3	68.6	83.9	34.5	72.7	33.8	28.8	33.5	40.7	75.1
GTF2H1	"BTF2, P62, TFIIH"	ENSG00000110768	"General transcription factor IIH subunit 1"	P32780	11	18322295-18367045	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004637, HPA046660"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB004637: AB_425470, HPA046660: AB_2679743"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (5.98e-9)"	"unprognostic (7.71e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.42e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.94e-1)"	19.0	18.2	6.0	7.6	6.4	4.7	18.2	7.6	7.2	16.5	10.0	17.9	7.5	15.6	8.2	19.4	14.6	9.4	14.9	6.7	6.0	16.2	17.2	13.9	10.9	5.5	5.8	19.2	17.9	8.2	13.8	10.0	5.6	15.8	8.2	13.1	18.7	10.0	16.6	20.0	14.7	8.4	5.8	17.2	15.2	26.5	6.1	8.8	16.0	8.3	11.1	17.7	16.9	7.6	14.7	13.3	11.0	15.5	25.1	20.1	13.7	21.8	23.6	19.0	21.9	13.9	5.6	24.9	8.4	22.4	27.2	19.8	19.1	20.1	24.1	11.0	18.5	15.9	13.4	14.1	35.8	30.7	16.5	22.4	23.8	11.7	37.3	15.7	17.3	12.8	25.2	12.6	27.7	13.6	15.6	23.3	9.8	24.7	19.8	16.1	23.4	11.3	15.3	19.6	12.5	13.5	17.8	17.1	27.0	9.4	8.8	17.5	12.6	24.9	12.2	45.3	17.8	6.3	16.0	17.7	21.5	24.0	24.4	11.0	5.0	5.4	3.8	5.0	4.2	5.4	4.8	4.3	5.4	5.7	5.8	4.7	3.5	7.5	6.0	2.9	5.2	4.2	6.0	6.4	7.6	7.2	6.7	6.0	5.5	5.8	5.6	5.8	6.1	7.6	27.8	16.0	18.2	19.2	26.1	48.3	22.7	22.2	39.9	17.3	23.4	20.6	28.3	22.8	21.9	11.0	20.9	26.1	26.8	14.7	7.9	25.2	50.2	19.0	17.7	21.6	7.7	26.1	32.1	30.5	27.5	27.1	21.4	20.2	18.3	20.0	22.1	13.9	25.2	21.9	29.9	12.9	14.2	20.8	27.2	46.1	17.1	28.8	23.2	20.6	25.9	23.4	25.7	24.1	29.4	28.8	10.5	16.1	25.7	23.4	18.6	25.1	23.6	21.2	6.6	23.4	23.2	84.8	30.1	37.6	51.7	28.2	20.4	29.2	16.8	26.8
GTF2H3	"BTF2, P34, TFIIH"	ENSG00000111358	"General transcription factor IIH subunit 3"	Q13889	12	123633739-123662604	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004844, HPA053562"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA004844: AB_2667265, HPA053562: AB_2682191"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.72e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.68e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.80e-2)"	10.4	9.0	6.1	12.9	6.0	11.2	15.6	5.8	6.9	11.7	5.0	14.0	10.5	12.9	8.9	15.4	15.0	9.7	10.7	5.8	5.2	11.2	14.1	9.7	16.6	5.9	6.3	11.2	5.6	11.7	5.9	12.9	6.4	13.0	16.2	10.1	7.3	11.3	13.8	12.8	10.6	14.2	5.8	10.4	11.7	12.2	6.2	16.0	13.4	11.1	16.1	11.4	8.2	7.1	42.0	21.7	27.6	35.5	33.3	37.1	38.9	31.2	38.2	47.1	31.6	23.2	21.1	48.4	37.4	43.0	18.8	27.8	46.2	56.4	56.2	41.4	32.5	39.7	19.3	33.3	46.8	80.9	25.3	39.7	42.2	38.2	85.9	35.3	34.2	59.4	60.4	15.7	42.9	27.4	40.5	27.2	35.6	29.6	39.9	41.3	42.1	27.4	24.1	40.1	24.8	21.8	41.1	19.8	32.1	30.1	55.4	48.1	22.9	29.3	22.3	45.9	50.7	28.8	42.3	47.6	33.7	40.5	34.3	11.4	4.6	6.0	7.6	6.9	7.6	5.9	6.1	8.1	7.0	5.7	8.7	8.0	0.6	10.7	7.0	5.9	6.7	4.1	6.1	6.0	5.8	6.9	5.8	5.2	5.9	6.3	6.4	5.8	6.2	7.1	20.8	22.4	24.3	23.5	19.2	11.7	12.3	20.9	27.9	16.2	12.6	15.2	7.4	12.8	22.3	12.9	10.4	26.3	13.8	8.4	3.9	12.9	8.6	18.3	24.7	11.1	6.7	21.6	26.6	11.0	23.4	17.1	16.8	16.7	24.1	19.9	12.1	16.9	17.2	16.8	27.8	12.3	6.1	12.3	7.9	4.3	11.8	15.3	1.8	10.3	16.1	21.9	7.2	15.6	23.1	10.8	10.8	11.3	17.1	10.5	6.1	15.8	20.7	13.7	13.1	18.8	15.2	32.6	27.1	25.7	13.2	23.7	14.5	36.2	15.7	10.4
GTF2I	"BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6"	ENSG00000263001	"General transcription factor IIi"	P78347	7	74650231-74760692	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004595, HPA026638"	Supported		Enhanced	Nucleoplasm		NA	NA		55000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004595: AB_628345, HPA026638: AB_1857959"	"unprognostic (3.47e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.35e-6)"	"unprognostic (7.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.88e-2)"	61.2	75.3	32.5	48.2	36.4	32.7	52.2	36.7	35.7	57.5	64.7	41.9	52.8	57.5	41.3	54.9	66.9	47.0	51.2	32.3	31.5	70.9	57.6	52.3	56.7	31.2	33.7	64.4	49.8	106.0	42.9	56.1	31.6	64.2	39.9	82.8	69.4	54.1	84.2	62.9	48.0	61.5	31.0	47.6	67.6	25.4	35.1	70.6	118.0	56.8	68.8	49.4	38.8	46.4	136.4	110.4	222.6	219.9	120.6	106.7	46.3	83.7	76.9	90.5	89.6	76.9	161.6	165.4	33.7	104.1	121.6	116.3	221.1	101.3	116.2	126.4	115.9	85.6	128.0	107.7	72.3	159.5	126.9	98.8	84.7	68.8	70.0	132.6	123.3	55.2	165.3	80.0	110.9	126.8	133.7	147.5	243.6	286.9	67.1	146.0	77.5	133.1	118.7	232.2	185.5	236.3	153.0	226.5	78.7	185.8	116.4	105.2	111.7	123.6	66.8	62.8	108.8	90.2	83.3	256.2	70.9	95.8	126.6	20.4	10.0	17.4	11.3	7.3	16.6	22.1	14.6	16.7	14.6	24.1	17.8	17.4	4.1	21.3	6.6	23.0	8.7	9.7	32.5	36.4	36.7	35.7	32.3	31.5	31.2	33.7	31.6	31.0	35.1	46.4	118.5	80.1	60.6	55.8	80.3	60.2	83.3	136.3	125.7	276.4	140.7	113.7	30.3	210.1	106.3	119.5	283.5	112.6	101.5	46.0	56.7	155.4	37.1	368.7	201.3	98.2	112.5	91.7	68.6	83.0	64.4	78.8	117.8	321.8	13.3	246.1	115.3	101.0	80.3	250.7	74.1	71.0	73.2	106.7	53.7	39.8	152.8	76.0	55.2	46.9	122.3	200.9	101.0	102.5	98.1	132.5	70.6	193.0	81.4	117.6	150.6	110.2	233.3	184.3	85.5	96.8	87.8	34.1	51.9	145.8	91.9	72.2	60.5	172.7	63.9	124.3
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602605	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Inhibitory neurons: 42.1;Rod photoreceptor cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol		Yes	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	6.0	12.6	7.0	3.4	7.0	0.5	6.9	7.2	8.1	16.8	14.0	15.1	7.7	11.3	8.6	26.7	8.8	5.7	11.6	6.0	8.4	18.6	4.6	11.7	1.0	9.2	8.9	10.5	10.0	18.9	27.6	5.8	9.0	13.3	5.6	36.7	17.3	8.2	68.1	22.4	6.7	8.4	6.7	2.0	13.9	5.0	10.1	3.4	17.4	29.7	5.4	15.0	19.8	10.2	21.2	12.9	28.1	30.8	22.2	10.8	0.2	8.8	23.7	17.1	17.7	21.7	30.1	5.4	6.5	18.1	41.7	11.6	22.6	10.2	12.6	0.2	13.0	1.1	43.1	26.1	71.2	0.2	0.7	14.7	42.1	12.0	48.9	39.7	8.9	10.4	15.5	0.1	19.2	26.1	2.7	18.9	22.6	25.7	12.8	28.1	16.4	20.0	32.7	14.6	23.1	30.5	21.7	39.0	19.9	14.2	23.4	21.2	4.6	17.5	16.9	11.4	20.5	1.1	3.4	8.9	6.7	0.3	14.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	7.0	7.0	7.2	8.1	6.0	8.4	9.2	8.9	9.0	6.7	10.1	10.2	0.9	9.6	8.2	48.3	0.1	7.9	9.9	10.5	9.6	30.8	5.6	4.1	10.4	12.8	6.8	9.2	33.3	1.4	1.5	4.5	11.7	7.6	1.6	11.5	8.0	4.1	4.2	0.8	24.6	9.2	1.8	5.6	6.1	17.0	2.5	8.0	2.9	3.1	2.6	21.9	42.1	3.6	8.2	1.2	5.7	0.3	4.1	2.5	7.2	14.0	0.7	5.9	1.0	25.6	24.9	11.6	3.2	5.7	0.0	17.8	3.6	17.4	12.7	41.1	0.0	19.0	5.7	0.1	3.7	18.2	6.7	2.9	1.1	2.4	7.4	15.8
GTF2IRD2	"FLJ37938, GTF2IRD2A"	ENSG00000196275	"GTF2I repeat domain containing 2"	Q86UP8	7	74796144-74851551	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 59.0"									"HPA056679, HPA056680"			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA056679: AB_2683205, HPA056680: AB_2683206"	"unprognostic (7.91e-5)"	"unprognostic (3.90e-3)"	"unprognostic (1.43e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.22e-1)"	"unprognostic (6.11e-2)"	"unprognostic (4.43e-5)"	"unprognostic (3.18e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.59e-4)"	11.6	12.7	6.5	4.6	7.5	8.5	12.6	7.3	7.1	16.8	7.6	16.3	5.9	13.0	5.0	9.6	15.5	4.6	18.7	6.5	7.7	13.2	17.4	9.1	5.7	7.3	7.5	19.6	15.3	6.7	13.0	3.8	7.6	15.4	6.5	7.7	11.9	6.8	38.7	9.3	9.7	7.4	6.9	8.9	15.1	7.4	7.4	8.2	13.5	17.8	5.5	14.0	11.3	10.0	16.6	5.4	7.3	10.6	10.2	6.6	5.6	5.6	5.7	6.4	7.3	1.5	13.9	4.3	1.3	9.1	11.0	3.3	0.1	3.4	5.5	2.1	1.3	3.5	8.3	7.9	9.6	5.8	0.7	6.3	5.3	1.8	4.9	8.0	6.6	3.3	10.3	8.8	5.8	14.6	2.3	16.5	11.5	18.2	3.8	4.3	2.6	15.8	15.7	14.6	5.1	16.7	22.8	59.0	13.3	6.3	12.5	11.3	6.0	9.8	2.5	1.7	8.9	6.6	3.0	4.7	8.0	3.9	20.9	12.3	7.1	7.8	3.2	4.1	4.7	18.9	7.2	9.5	7.3	11.6	8.7	5.5	1.0	5.5	3.6	13.0	7.1	7.6	6.5	7.5	7.3	7.1	6.5	7.7	7.3	7.5	7.6	6.9	7.4	10.0	6.7	19.2	27.4	23.5	20.7	3.2	11.7	6.9	15.4	27.4	15.8	13.1	11.7	21.5	15.5	12.9	56.3	7.2	11.2	18.1	3.9	21.4	20.3	15.5	10.6	7.2	27.0	3.8	4.5	28.1	7.4	14.3	17.9	11.1	14.0	32.0	18.5	9.6	4.7	37.0	8.5	19.9	6.1	7.9	4.6	5.2	43.8	6.8	10.6	3.7	11.7	12.4	26.8	14.6	20.5	28.8	18.0	25.9	8.5	12.3	15.0	6.7	22.5	40.7	13.1	29.2	13.2	2.8	2.6	11.2	4.3	6.4	12.0	18.2	21.1	8.0
GTF2IRD2B		ENSG00000174428	"GTF2I repeat domain containing 2B"	Q6EKJ0	7	75092573-75149817	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA056679, HPA056680"			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA056679: AB_2683205, HPA056680: AB_2683206"	"prognostic favorable (3.27e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.19e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.90e-4)"	"unprognostic (1.54e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.31e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-5)"	11.5	9.5	6.2	5.7	10.8	14.0	13.6	7.8	8.8	13.6	10.7	15.1	5.1	16.0	5.5	8.1	17.3	9.4	15.1	6.3	7.1	13.8	15.6	10.7	5.3	9.7	9.5	32.8	17.0	13.8	7.5	7.3	9.1	12.9	9.2	10.8	13.3	12.9	36.0	5.9	7.9	13.5	7.9	8.0	15.4	4.6	11.2	17.2	12.3	28.6	7.9	13.8	8.5	19.8	19.0	7.4	12.4	12.9	9.8	13.4	9.4	9.7	14.5	4.4	11.5	3.5	14.2	11.4	9.4	9.7	17.3	6.3	6.1	6.3	5.3	14.7	5.5	8.4	9.5	7.9	19.0	13.5	12.5	12.4	12.7	3.7	15.5	15.9	6.1	4.1	11.7	24.4	14.4	12.4	9.1	31.6	12.6	16.3	11.5	18.0	3.8	17.6	13.2	13.8	11.5	21.6	20.4	20.9	22.7	3.4	20.8	13.0	10.8	11.4	7.7	10.4	12.8	10.1	6.3	31.4	5.3	12.9	25.6	0.5	1.3	5.0	1.0	1.8	1.5	14.8	1.7	2.2	1.0	6.6	2.9	1.3	1.3	1.1	1.1	1.4	2.6	0.7	6.2	10.8	7.8	8.8	6.3	7.1	9.7	9.5	9.1	7.9	11.2	19.8	4.6	0.0	10.8	20.5	22.1	4.5	4.5	10.3	27.3	7.2	11.9	9.5	21.1	14.3	5.5	7.3	12.5	2.4	8.1	9.1	0.0	12.9	13.5	9.9	7.8	6.1	19.2	8.6	4.1	12.9	2.7	13.2	35.2	5.6	3.8	13.3	11.0	12.0	2.6	13.5	7.2	15.1	10.2	8.1	5.4	4.4	27.4	4.0	21.4	5.6	6.0	6.5	9.2	15.6	27.0	14.8	14.6	17.0	23.4	4.6	10.2	3.4	13.8	13.4	13.1	11.3	10.7	2.5	1.5	22.2	4.3	3.0	13.0	6.0	14.3	3.6
GTF3A	"AP2, TFIIIA"	ENSG00000122034	"General transcription factor IIIA"	Q92664	13	27424619-27435823	"Predicted intracellular proteins, Transcription factors"	"Ribosome biogenesis, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007990	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 52: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA007990: AB_1857960"	"unprognostic (9.88e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.41e-1)"	63.5	40.3	51.0	50.3	53.0	85.3	59.3	53.1	63.0	31.9	50.4	41.8	30.3	26.6	57.4	38.3	32.8	33.4	126.7	52.8	51.9	52.5	129.8	33.2	81.2	53.2	53.3	16.0	116.4	34.5	26.9	28.4	52.7	30.7	40.4	10.4	70.4	34.8	89.3	25.0	32.3	38.0	53.0	54.6	46.9	17.4	52.9	111.6	31.2	132.6	89.8	46.0	23.7	56.2	91.2	78.8	65.4	136.8	90.4	98.8	93.3	95.1	86.0	118.3	75.4	118.5	139.4	275.3	65.9	112.6	73.9	64.9	136.6	131.0	165.8	289.2	93.1	229.9	71.6	135.4	102.5	432.3	150.9	81.5	137.9	109.2	142.4	81.8	107.2	246.9	184.2	88.6	140.5	178.3	311.3	467.9	115.8	299.6	210.7	154.8	169.3	254.0	142.5	39.2	158.9	81.5	67.6	101.6	141.7	83.7	73.7	223.6	66.0	62.5	67.1	49.3	99.1	57.0	104.9	275.1	67.1	264.9	117.4	116.8	173.8	162.5	250.2	180.1	335.2	290.5	251.6	271.7	218.4	250.3	192.5	219.6	38.3	243.7	169.5	298.3	345.1	484.4	51.0	53.0	53.1	63.0	52.8	51.9	53.2	53.3	52.7	53.0	52.9	56.2	96.9	44.8	33.0	15.0	183.3	63.2	62.4	109.1	56.3	41.7	107.2	117.6	207.8	91.5	58.3	27.6	29.2	76.3	207.1	20.0	150.6	195.7	33.9	60.1	68.1	76.3	34.8	126.4	28.7	190.6	187.4	75.0	63.2	49.1	75.5	93.0	40.0	146.7	215.5	35.3	25.8	60.6	77.3	156.1	119.3	85.6	63.6	133.9	97.8	15.9	185.3	73.1	236.9	7.1	24.3	153.3	28.9	58.3	248.4	122.7	35.6	207.7	37.9	35.7	85.5	58.3	76.1	34.8	145.1	83.4	64.4	42.1	187.1	89.0	69.8	70.3
GTF3C1	TFIIIC220	ENSG00000077235	"General transcription factor IIIC subunit 1"	Q12789	16	27459555-27549913	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8;dendritic cells: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 31.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051617, HPA075900"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA051617: AB_2681553, HPA075900: "	"unprognostic (6.46e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (8.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.32e-2)"	"prognostic favorable (9.56e-4)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.06e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.23e-3)"	18.1	28.8	24.2	9.9	24.4	16.6	16.7	21.5	32.6	31.2	40.5	21.2	8.8	26.7	7.8	65.2	24.6	11.5	38.5	24.6	21.8	25.4	21.7	20.3	12.2	20.4	20.8	24.4	35.3	18.6	47.8	11.0	19.6	40.4	9.7	18.3	24.9	12.6	50.2	51.0	18.5	15.5	17.0	21.3	24.7	26.6	22.2	18.6	34.6	20.8	11.2	19.7	35.1	21.7	27.8	60.1	43.3	50.7	37.8	30.4	24.6	29.5	33.0	40.2	34.0	45.0	25.6	30.5	42.3	36.4	30.6	30.3	55.4	37.6	32.9	13.7	53.1	25.2	49.8	63.8	21.3	29.1	32.2	37.5	28.0	49.5	21.8	26.9	40.2	34.6	31.7	24.2	32.0	67.6	32.5	34.8	58.4	15.1	28.3	59.7	53.4	31.4	25.2	28.7	54.4	36.5	29.8	24.9	18.6	34.4	44.8	21.8	43.2	40.2	24.0	25.6	30.7	25.6	24.8	30.2	16.6	31.7	30.2	2.6	3.4	3.5	31.9	3.2	23.0	3.1	3.6	15.8	4.3	2.2	3.7	10.0	2.5	12.2	3.3	6.6	4.0	6.9	24.2	24.4	21.5	32.6	24.6	21.8	20.4	20.8	19.6	17.0	22.2	21.7	16.9	19.2	23.9	29.7	10.8	18.4	7.3	14.3	23.3	45.5	10.6	11.9	27.4	10.0	17.2	12.9	93.8	7.8	86.2	18.4	5.9	11.8	2.8	40.4	37.3	18.0	30.0	7.2	30.2	11.5	4.3	22.5	19.9	22.3	19.0	26.1	13.9	13.7	10.9	26.9	33.9	17.6	18.3	10.3	7.7	4.5	19.3	12.9	3.6	14.0	10.0	15.0	52.5	17.1	23.4	15.8	9.3	15.8	29.6	13.9	10.2	9.0	30.8	35.1	13.1	16.4	15.1	17.2	18.2	34.8	20.6	4.2	32.7	25.7	12.2	6.7
GTF3C2	"KIAA0011, TFIIIC110"	ENSG00000115207	"General transcription factor IIIC subunit 2"	Q8WUA4	2	27325849-27357034	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA008274, HPA035836"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA008274: , HPA035836: AB_10601813"	"unprognostic (1.76e-1)"	"unprognostic (9.64e-2)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (1.33e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.00e-1)"	18.7	25.6	19.5	23.2	20.8	23.5	21.1	26.2	27.6	19.0	23.5	25.3	22.4	19.8	23.7	34.5	24.4	15.3	23.2	19.9	20.8	23.3	21.1	19.7	26.6	21.2	18.7	20.7	30.7	33.1	20.0	19.6	20.0	20.1	27.7	25.2	25.2	18.5	28.7	32.2	24.2	23.3	17.2	26.8	24.3	26.0	22.0	30.4	29.4	18.5	33.5	23.2	21.4	28.1	86.2	75.7	62.5	60.6	36.2	35.2	91.2	30.8	41.8	39.8	33.7	56.3	53.7	75.1	54.1	43.0	40.8	50.6	93.2	59.2	38.0	59.5	81.0	63.3	48.5	76.0	33.0	69.7	60.6	44.4	52.3	45.4	58.4	38.0	51.8	50.4	90.1	54.9	38.8	70.4	64.9	50.7	118.2	69.0	47.6	79.1	69.2	83.9	56.8	63.9	58.0	101.5	33.1	78.6	57.7	52.8	42.2	39.3	39.6	48.2	52.4	36.9	58.1	60.2	71.9	169.4	48.1	55.4	53.8	29.6	18.2	14.5	14.3	15.0	15.1	13.3	12.6	15.2	15.6	11.4	12.4	12.2	8.4	13.3	19.2	9.8	8.5	19.7	19.5	20.8	26.2	27.6	19.9	20.8	21.2	18.7	20.0	17.2	22.0	28.1	7.9	19.2	22.1	11.8	17.5	9.8	9.8	11.9	18.2	11.3	13.9	11.6	11.7	14.3	14.9	5.5	22.9	19.3	12.9	22.2	9.8	16.6	54.9	13.6	10.9	10.3	3.5	24.8	17.3	22.8	23.6	10.0	17.3	14.6	18.3	16.2	10.0	11.1	16.1	10.1	16.2	17.6	12.2	18.4	7.6	61.9	9.3	12.1	5.4	16.9	18.3	8.9	12.3	14.1	18.9	21.5	9.0	7.9	18.6	13.0	16.0	11.8	14.8	18.0	6.6	9.7	11.8	9.1	16.4	19.4	12.6	20.0	13.7	11.8	15.1	14.4
GTF3C3	"TFIIIC102, TFiiiC2-102"	ENSG00000119041	"General transcription factor IIIC subunit 3"	Q9Y5Q9	2	196763035-196799725	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069179			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA069179: AB_2686099"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.92e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-2)"	11.0	10.9	18.1	9.6	20.4	36.8	19.5	25.1	23.1	10.9	23.8	10.8	10.2	12.2	15.1	11.4	11.9	19.6	10.0	19.8	19.9	9.5	12.9	10.5	18.8	21.7	19.0	13.8	13.1	13.6	9.0	12.5	25.9	10.2	13.1	18.6	9.7	10.0	13.6	20.9	10.8	14.3	17.9	13.8	12.1	13.9	19.5	13.4	15.1	7.3	10.9	11.6	9.4	31.8	14.4	19.2	28.4	22.2	13.1	19.4	28.0	26.2	16.3	24.7	25.0	41.4	23.0	29.8	15.9	15.7	24.1	19.2	24.4	23.3	28.7	35.0	26.6	37.2	59.9	38.6	21.8	32.8	28.9	25.8	21.4	17.8	25.0	21.9	22.6	25.7	45.6	54.6	14.9	34.0	28.6	29.2	16.9	16.9	29.3	24.4	20.7	19.8	17.6	43.2	22.6	20.5	16.7	14.6	17.8	35.9	15.4	21.1	15.0	21.2	15.1	16.7	19.3	26.0	34.4	22.2	21.8	24.4	16.9	8.4	4.7	4.4	3.9	3.1	3.5	4.8	3.5	4.0	2.8	6.8	4.2	4.0	4.4	4.8	5.8	4.3	4.8	2.3	18.1	20.4	25.1	23.1	19.8	19.9	21.7	19.0	25.9	17.9	19.5	31.8	17.4	22.4	16.0	19.2	11.6	4.0	12.2	16.6	10.2	18.1	8.8	8.8	35.8	7.2	21.4	14.7	18.8	15.3	18.1	7.7	13.7	12.4	4.4	18.2	17.4	17.0	12.5	19.1	24.7	12.3	12.6	12.9	11.2	13.3	14.0	24.7	12.8	8.2	13.5	0.0	29.8	10.1	16.2	12.7	5.0	4.6	13.4	11.8	7.2	27.2	22.0	12.5	9.2	23.1	38.5	14.7	6.4	10.9	16.3	8.4	12.9	10.9	37.2	15.6	6.6	10.1	13.6	44.7	24.8	11.6	5.5	15.7	12.2	18.2	11.9	9.4
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA069369: AB_2686130"	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	4.9	4.4	4.3	4.6	5.0	6.9	8.4	9.2	4.3	7.3	3.6	5.3	3.9	6.6	5.5	6.7	6.6	5.2	5.8	4.5	5.2	6.0	5.3	5.7	5.0	3.4	4.8	10.3	6.1	9.4	3.2	6.4	3.7	6.2	5.4	5.5	7.3	5.7	5.8	9.8	3.6	6.2	3.6	4.5	5.8	8.3	5.6	8.1	9.5	8.0	6.6	5.0	3.8	3.8	15.2	21.7	25.8	22.5	12.3	14.4	20.0	15.1	18.4	19.6	14.4	25.4	10.9	22.7	9.8	18.6	18.1	33.8	39.8	23.6	21.1	15.4	19.1	19.0	28.9	10.8	12.8	28.6	12.4	11.4	17.6	20.4	26.1	11.6	16.8	15.1	32.7	11.4	14.0	24.6	17.8	13.3	33.1	22.2	21.4	17.6	31.1	20.6	14.3	12.5	36.3	24.6	25.9	25.8	15.9	15.8	35.4	12.1	17.8	32.9	18.7	15.1	21.6	4.9	12.3	25.1	13.5	17.8	20.7	0.0	0.3	0.2	0.5	0.3	0.4	0.5	0.4	0.6	0.2	0.4	0.5	0.5	0.3	0.5	0.2	0.5	0.4	0.2	4.3	5.0	9.2	4.3	4.5	5.2	3.4	4.8	3.7	3.6	5.6	3.8	9.9	19.2	11.5	2.3	7.8	30.7	6.9	6.9	21.6	15.5	19.1	14.7	14.6	1.5	6.7	3.7	14.6	7.5	9.0	6.6	7.9	8.3	6.5	21.5	26.2	11.6	13.1	8.2	3.2	6.3	7.5	13.0	8.6	17.7	1.3	17.1	10.0	8.6	6.3	20.2	3.1	8.1	10.2	7.6	9.3	3.7	19.0	6.3	3.6	1.9	7.1	11.9	7.2	1.0	2.1	5.8	7.0	19.2	10.7	11.6	3.8	6.6	16.2	16.9	0.0	18.8	10.9	16.7	13.8	22.1	40.1	6.4	8.8	18.2	9.0	6.4
GTF3C5	"TFiiiC2-63, TFIIIC63, TFIIICepsilon"	ENSG00000148308	"General transcription factor IIIC subunit 5"	Q9Y5Q8	9	133030675-133058503	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067063, HPA069805"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA067063: AB_2685773, HPA069805: AB_2686201"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.73e-2)"	26.5	33.6	26.3	20.6	30.4	42.4	29.1	35.1	35.8	36.2	23.9	28.8	26.4	31.7	22.3	39.0	32.0	17.5	39.1	26.9	27.5	27.5	32.9	23.7	27.7	28.1	28.6	44.6	33.6	24.5	36.0	24.6	29.0	34.3	19.2	13.7	29.1	20.7	47.9	38.6	30.3	21.6	26.2	32.1	28.5	29.4	28.5	44.5	28.6	32.3	25.3	29.2	33.2	36.6	44.1	77.5	67.3	63.3	35.9	32.5	93.2	42.0	45.4	78.6	55.4	83.5	71.8	72.7	38.7	47.1	63.2	103.9	79.8	76.3	40.2	74.9	69.1	86.8	90.3	78.7	55.9	66.2	176.0	45.0	49.9	83.5	57.7	38.0	69.1	235.1	112.5	66.0	42.1	142.1	107.9	92.4	87.5	100.6	79.7	113.9	69.5	89.2	52.4	50.2	80.4	59.7	71.2	73.4	43.8	38.1	96.5	95.6	46.0	92.0	71.3	59.1	71.8	25.8	57.3	78.0	44.8	49.8	62.4	54.2	16.0	22.5	15.8	18.9	23.0	14.6	16.3	20.7	17.2	13.6	18.1	16.4	9.5	20.7	16.3	16.6	19.4	17.8	26.3	30.4	35.1	35.8	26.9	27.5	28.1	28.6	29.0	26.2	28.5	36.6	16.0	9.6	19.0	17.3	21.0	12.4	16.5	21.7	30.7	14.2	25.2	21.6	29.3	14.3	17.2	16.5	8.4	42.1	20.0	30.4	29.4	25.5	3.4	16.2	15.4	16.4	14.4	22.3	9.0	30.3	38.4	19.7	18.3	19.9	16.5	50.1	18.5	17.2	22.5	15.2	7.9	15.9	34.6	15.7	9.9	4.3	17.4	15.8	16.0	8.4	14.8	18.8	15.5	6.0	16.6	27.2	25.4	21.4	17.4	13.9	27.3	11.7	14.6	20.8	46.0	17.2	19.4	20.5	31.9	26.1	16.6	41.6	17.6	34.0	25.7	19.4
GTF3C6	"bA397G5.3, C6orf51, TFIIIC35"	ENSG00000155115	"General transcription factor IIIC subunit 6"	Q969F1	6	110958706-110967890	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056179, HPA061345"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"HPA056179: AB_2683058, HPA061345: AB_2684485"	"unprognostic (6.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (2.08e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.14e-2)"	53.2	55.0	71.5	53.5	73.6	53.5	47.1	73.7	114.9	42.0	73.4	66.9	52.3	30.8	45.8	44.8	45.2	57.8	86.6	70.8	76.3	76.2	51.3	33.9	55.8	72.4	72.6	28.2	30.8	65.3	37.1	32.5	72.7	94.6	65.4	39.0	38.3	41.6	231.2	31.1	46.7	48.7	72.9	33.6	49.8	61.9	72.3	49.7	40.2	168.0	58.1	61.1	27.5	74.9	85.8	154.0	166.5	155.7	59.9	121.9	145.4	143.8	105.1	131.9	109.2	229.0	74.7	121.1	137.8	132.9	30.4	38.6	141.1	120.0	145.5	175.9	205.3	234.2	145.9	347.5	113.4	360.9	190.8	121.4	103.3	115.2	112.8	89.7	155.2	154.3	281.7	79.4	246.8	166.5	198.6	371.4	169.9	109.6	121.0	183.2	95.6	109.7	221.5	214.7	105.4	148.5	107.0	16.8	133.0	98.6	58.7	244.2	163.0	38.2	112.0	260.5	232.3	51.7	127.2	235.9	39.7	208.1	191.3	112.6	116.9	71.0	104.2	170.7	117.9	164.1	130.0	131.0	158.3	133.7	100.9	118.9	18.5	116.2	141.1	173.4	292.4	167.5	71.5	73.6	73.7	114.9	70.8	76.3	72.4	72.6	72.7	72.9	72.3	74.9	58.0	70.5	47.1	12.7	67.1	30.3	70.9	169.2	34.1	37.6	85.3	90.4	279.1	203.0	99.5	104.8	16.7	94.6	75.0	138.8	305.2	190.4	169.1	119.1	82.0	66.0	109.8	86.9	4.9	293.0	251.1	66.4	47.9	167.8	54.4	71.2	55.6	94.5	284.6	26.9	6.7	98.6	144.5	79.8	50.1	223.9	65.0	104.5	55.2	6.5	172.4	133.2	81.4	7.1	13.4	210.8	125.2	68.4	78.3	126.9	118.9	404.7	74.9	37.0	65.7	63.5	88.1	153.1	105.8	72.5	29.7	90.4	72.3	120.2	121.4	117.8
GTPBP6	"FLJ20977, PGPL"	ENSG00000178605	"GTP binding protein 6 (putative)"	O43824	X	304529-318819	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA013336, CAB034924, HPA035467, HPA055418"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"CAB034924: AB_2115410, HPA013336: , HPA035467: AB_10671104, HPA055418: "	"unprognostic (5.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.38e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	31.4	24.2	22.5	17.2	24.3	26.2	29.9	22.2	33.2	25.8	17.3	29.6	19.7	28.1	3.2	26.7	29.6	9.9	46.5	20.9	19.7	33.1	38.7	25.9	19.3	26.9	23.4	30.5	42.6	12.0	17.0	9.6	23.7	26.1	5.8	4.1	30.1	12.3	69.4	30.8	26.3	6.8	21.3	26.8	35.8	13.4	22.2	13.2	27.5	27.1	6.9	29.6	22.6	30.7	40.4	65.4	14.2	29.9	16.1	17.5	52.6	24.5	18.0	30.4	27.7	100.8	32.9	50.1	34.0	13.8	41.3	24.6	15.0	23.9	4.9	42.1	44.1	41.5	32.2	70.0	43.2	28.2	38.9	21.7	31.0	20.3	14.8	11.2	24.7	32.8	31.1	23.0	12.7	79.5	50.4	37.1	34.8	8.1	46.0	22.3	25.0	80.7	17.9	46.3	39.8	33.9	26.8	30.0	46.2	7.6	26.9	24.3	33.0	44.2	30.4	66.0	38.3	30.9	30.1	78.0	23.0	36.8	20.9	5.3	4.1	4.8	4.8	4.3	4.8	4.9	4.2	5.5	4.0	3.4	5.1	4.6	0.5	3.7	4.0	7.3	6.3	2.6	22.5	24.3	22.2	33.2	20.9	19.7	26.9	23.4	23.7	21.3	22.2	30.7	35.3	19.2	19.2	17.0	33.8	28.2	48.2	7.9	34.7	28.1	38.1	34.0	20.3	32.9	9.2	27.6	27.1	22.0	45.1	32.1	52.8	13.1	1.4	20.1	27.3	26.2	17.9	16.6	10.9	15.0	46.0	32.9	37.8	23.6	11.4	44.9	21.0	38.1	29.3	13.5	9.6	24.7	16.2	25.7	28.0	1.6	19.6	32.6	26.6	6.5	16.7	22.0	33.0	12.1	18.7	10.4	17.4	18.8	32.5	98.1	23.2	89.5	6.7	27.2	6.6	33.2	31.2	4.5	13.5	36.9	26.6	29.4	38.9	54.3	38.1	51.2
GTSF1	"Cue110, FAM112B, FLJ32942"	ENSG00000170627	"Gametocyte specific factor 1"	Q8WW33	12	54455950-54473602	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 186.1"	"Group enriched"	"Detected in some"	11	"Early spermatids: 1181.4;Late spermatids: 1810.3;Spermatocytes: 531.1"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 23.2"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 294.6;HMC-1: 207.5;K-562: 290.1;NB-4: 442.3;THP-1: 405.8;U-266/84: 337.6;U-937: 216.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038876, HPA038877"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038876: AB_10670911, HPA038877: AB_2676251"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.97e-5)"	"unprognostic (4.16e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.18e-2)"	0.5	0.5	0.3	2.4	0.5	6.3	0.4	0.5	0.5	0.1	0.0	0.8	1.4	0.3	0.5	0.2	0.1	1.1	0.9	0.3	0.3	0.6	1.3	1.9	5.6	0.5	0.3	0.3	0.2	0.1	0.2	14.1	0.6	0.4	1.9	0.3	0.3	0.1	0.4	0.5	1.4	0.3	0.2	3.6	0.7	186.1	0.4	6.1	0.4	0.1	10.9	1.0	0.2	0.9	1.1	0.0	0.3	0.0	0.0	0.0	146.3	0.2	0.0	0.0	0.0	0.3	0.1	114.1	52.2	0.0	0.1	0.4	151.3	0.0	0.0	59.7	0.1	0.1	0.0	0.1	0.0	294.6	207.5	0.0	0.0	0.0	0.1	0.1	0.0	85.3	290.1	113.6	0.0	0.0	0.2	442.3	0.1	0.0	0.0	0.2	0.0	158.8	0.0	0.2	0.2	0.9	0.0	5.7	0.3	2.5	0.1	405.8	1.4	0.1	10.3	0.1	0.7	113.1	337.6	0.7	0.0	216.5	0.1	28.3	9.4	18.9	23.5	9.8	28.3	33.4	26.3	33.1	16.9	33.7	24.3	25.4	4.5	32.2	11.2	33.6	31.0	16.7	0.3	0.5	0.5	0.5	0.3	0.3	0.5	0.3	0.6	0.2	0.4	0.9	0.1	0.0	0.6	0.3	4.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	48.1	6.3	0.4	0.0	0.0	1181.4	0.0	0.0	1.7	0.0	2.1	0.2	0.0	106.6	4.1	0.0	0.0	1.3	0.0	0.0	0.0	12.0	0.0	0.2	0.2	0.0	2.2	3.0	1810.3	15.8	4.0	3.6	0.0	10.3	0.0	6.2	0.0	0.1	0.0	0.0	10.1	6.5	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.1	531.1	105.5	0.0	0.3	27.0	5.0	0.2	0.5	0.0
GUCD1	"C22orf13, LLN4, MGC1842"	ENSG00000138867	"Guanylyl cyclase domain containing 1"	Q96NT3	22	24540423-24555935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 161.3;Proximal enterocytes: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022786			Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA022786: AB_1845711"	"unprognostic (1.58e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (2.83e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.01e-2)"	36.9	27.5	19.3	25.3	22.0	89.9	29.2	20.5	18.9	19.6	17.7	37.5	67.5	19.1	16.7	25.2	21.1	25.4	62.0	17.0	19.8	43.0	93.9	34.3	34.6	23.4	23.4	19.4	37.1	24.1	12.3	21.6	21.3	31.0	36.2	10.9	25.0	20.2	96.4	27.6	59.6	23.1	22.1	30.4	37.1	18.8	23.1	27.9	16.6	117.6	36.9	26.8	19.8	22.2	40.8	37.1	30.9	38.5	62.5	58.4	25.7	38.7	59.5	63.3	61.0	56.9	30.2	72.1	26.0	50.9	39.3	51.2	35.2	43.3	33.6	74.2	45.4	31.3	36.1	51.3	50.6	83.2	63.2	59.6	33.9	64.0	29.0	38.7	67.5	35.9	32.3	75.6	48.4	47.2	49.2	34.1	31.0	95.3	30.6	57.2	52.0	73.1	49.8	44.9	33.8	33.2	47.2	60.6	33.3	23.6	49.6	56.7	48.7	143.4	59.8	44.5	34.6	70.1	53.8	50.8	57.9	45.3	49.9	20.2	14.9	52.5	7.4	14.8	8.5	37.0	7.1	7.7	13.7	42.6	6.7	7.6	15.2	7.5	14.5	9.7	7.6	13.8	19.3	22.0	20.5	18.9	17.0	19.8	23.4	23.4	21.3	22.1	23.1	22.2	20.5	16.0	33.9	6.8	41.5	12.4	11.8	13.9	21.1	5.3	25.9	18.3	51.2	78.6	13.3	5.5	6.2	18.6	21.2	99.7	52.8	27.1	15.8	13.4	13.6	16.4	19.8	86.1	2.3	66.0	20.1	17.5	35.7	17.9	15.2	19.5	18.5	161.3	27.1	3.3	3.0	52.3	16.2	23.5	12.0	8.6	19.0	21.0	17.8	2.8	28.6	18.2	18.6	5.5	7.5	48.1	72.4	16.1	17.5	32.1	149.6	84.9	9.7	13.2	26.3	12.4	16.7	24.3	32.0	18.7	11.1	16.3	14.6	28.9	36.7	18.9
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
GUF1	FLJ13220	ENSG00000151806	"GUF1 homolog, GTPase"	Q8N442	4	44678420-44700928	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003934, HPA024222"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA003934: AB_1079034, HPA024222: AB_2671488"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.65e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.38e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.98e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (5.40e-2)"	5.2	4.1	2.5	3.9	3.2	6.3	5.2	4.3	3.6	3.5	0.6	5.7	4.6	4.8	3.8	5.2	4.1	2.7	6.1	3.3	2.5	6.9	7.1	3.1	4.7	1.6	1.9	4.9	3.7	4.3	2.4	3.7	1.9	4.9	5.9	6.7	4.0	3.5	15.8	5.0	6.3	3.5	2.4	4.8	7.9	5.9	2.2	4.4	5.3	17.0	4.6	3.9	3.8	4.4	11.9	6.0	10.9	13.9	4.4	9.0	24.0	16.1	8.2	16.2	12.4	10.5	8.3	25.8	12.3	7.7	14.9	9.2	18.7	18.2	18.2	8.7	12.2	30.7	5.3	7.2	14.3	33.4	12.7	9.2	8.1	12.1	10.5	7.6	11.8	15.0	31.7	4.9	13.2	5.9	19.1	7.0	7.0	8.5	13.8	13.5	22.5	11.0	4.8	4.6	14.8	11.1	10.1	4.2	11.2	8.4	6.8	9.6	11.7	11.0	12.7	14.8	19.1	17.9	17.4	18.3	11.9	19.7	9.6	0.5	2.2	2.3	2.0	2.9	2.6	2.1	2.1	1.8	2.1	1.7	1.9	2.0	0.0	2.3	1.9	2.3	3.6	1.9	2.5	3.2	4.3	3.6	3.3	2.5	1.6	1.9	1.9	2.4	2.2	4.4	7.2	6.4	9.5	9.8	11.6	4.0	9.6	6.0	5.2	10.5	9.8	7.5	22.8	7.2	9.1	7.3	2.1	13.1	10.1	11.5	13.7	10.3	2.0	12.0	14.3	8.1	11.4	14.9	20.3	10.2	17.6	9.7	18.3	8.8	1.3	16.6	7.9	13.9	12.1	11.8	19.5	12.4	4.1	11.7	5.4	2.9	5.6	9.0	7.2	9.4	9.2	9.2	14.4	18.6	19.0	16.4	6.6	7.2	13.9	9.8	11.3	12.2	16.7	10.3	0.0	6.8	10.0	12.3	14.6	14.9	7.1	13.4	9.5	18.9	13.3	10.6
GUK1		ENSG00000143774	"Guanylate kinase 1"	Q16774	1	228139962-228148984	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028118, HPA048587, HPA068324"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA		240000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Cytosol	"HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: "	"unprognostic (9.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (2.91e-1)"	"unprognostic (5.41e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-2)"	226.7	198.9	291.7	93.9	277.9	251.9	213.3	255.3	465.2	187.1	274.1	196.5	113.8	169.2	48.6	333.8	161.8	116.3	240.0	302.8	257.9	230.6	318.1	222.8	124.5	263.1	263.0	146.9	208.9	72.0	165.7	78.9	261.8	161.3	31.5	110.8	191.0	71.6	149.0	285.7	155.0	53.6	266.3	179.4	202.0	107.3	281.3	97.1	151.3	61.8	39.2	188.6	202.4	289.4	356.1	122.4	53.0	164.5	155.6	186.6	264.3	230.8	116.5	130.8	102.8	70.6	239.1	133.4	266.5	151.4	110.0	230.3	45.7	252.0	14.0	203.7	357.1	79.3	292.9	156.3	282.8	90.5	133.0	260.0	150.6	91.9	73.3	94.2	179.2	279.9	219.5	205.1	109.5	295.2	411.4	194.3	166.8	172.6	522.9	155.3	99.9	354.9	125.2	164.1	173.7	311.3	148.7	250.2	309.7	13.5	185.2	191.7	318.5	237.7	157.4	353.4	387.5	186.8	221.9	151.6	300.3	146.2	246.0	379.0	323.8	663.9	420.6	363.0	406.5	265.0	346.8	454.1	279.7	230.8	256.5	323.4	420.1	339.5	390.9	567.3	394.6	571.4	291.7	277.9	255.3	465.2	302.8	257.9	263.1	263.0	261.8	266.3	281.3	289.4	503.7	60.9	87.2	35.3	199.9	660.0	271.5	643.5	215.7	195.5	425.9	448.7	130.8	195.9	312.2	237.3	717.2	241.6	351.2	655.8	694.6	510.9	134.0	212.5	272.0	451.4	269.6	866.9	50.2	685.5	417.9	276.9	189.1	304.2	182.6	162.5	365.5	353.4	407.5	109.4	33.5	426.5	384.5	291.7	557.0	609.3	233.6	265.6	519.4	22.5	355.5	411.0	398.6	16.1	58.6	975.0	718.8	243.8	365.6	571.5	857.7	801.1	231.6	570.9	249.8	158.2	378.6	89.8	100.3	448.6	719.7	262.4	326.7	226.3	331.5	612.2
GVQW3		ENSG00000179240	"GVQW motif containing 3"	Q3ZCU0	11	76381303-76414619	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 14.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.9;Distal tubular cells: 9.8;granulocytes: 3.8;Granulosa cells: 7.0;Proximal tubular cells: 6.7;Theca cells: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA057405	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Centrosome"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Centrosome"	"Endoplasmic reticulum"	"HPA057405: AB_2683429"	"unprognostic (8.90e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.56e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.05e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.13e-1)"	1.1	1.5	1.5	1.4	1.6	1.1	1.9	3.2	2.1	1.7	4.4	1.3	1.4	1.8	1.9	0.4	2.0	0.7	1.0	1.4	0.8	1.4	0.7	0.9	1.9	0.5	0.1	2.2	6.5	1.0	2.4	0.8	0.6	1.2	1.5	14.2	1.9	0.8	1.1	1.4	1.3	0.9	0.0	1.7	1.4	3.4	1.2	2.4	1.9	0.6	1.6	0.9	1.3	1.5	1.1	1.2	4.4	3.2	1.2	1.6	1.5	0.6	0.5	1.1	1.1	3.0	2.0	3.6	1.2	0.5	1.3	2.6	1.9	0.8	1.9	2.0	1.2	1.9	5.0	1.3	0.7	2.5	1.2	0.7	1.2	1.4	0.8	1.0	0.9	4.9	1.2	2.3	0.4	1.3	2.4	3.8	0.9	0.9	1.4	3.7	2.9	1.9	0.7	0.8	6.5	2.9	1.2	0.7	0.7	1.7	2.1	0.8	0.6	2.1	2.2	3.2	0.7	2.1	1.6	4.6	0.8	1.7	1.1	1.5	0.3	0.4	0.4	0.2	0.3	0.5	0.6	0.5	0.2	0.6	0.6	0.6	1.0	0.8	0.2	0.3	0.8	0.2	1.5	1.6	3.2	2.1	1.4	0.8	0.5	0.1	0.6	0.0	1.2	1.5	2.1	0.0	3.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.8	2.3	0.0	0.0	2.5	1.8	0.0	1.1	1.7	0.0	9.8	1.2	0.0	2.4	2.5	0.8	0.0	0.0	0.0	0.6	0.6	1.4	0.0	0.6	3.8	7.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.7	2.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.9	5.5	0.0	0.0
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888046-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Endometrial stromal cells: 45.4;Fibroblasts: 23.0;Late spermatids: 27.1;Oligodendrocytes: 61.3;Skeletal myocytes: 40.0;Theca cells: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 22.3;JURKAT: 22.1;MOLT-4: 36.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: AB_2685988"	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.42e-5)"	6.0	3.8	2.6	5.2	5.3	1.8	4.0	4.3	3.2	5.7	2.6	3.7	0.6	5.6	2.5	3.2	5.1	10.1	13.6	2.0	2.4	0.9	0.3	3.8	1.5	6.2	5.8	16.5	4.2	2.4	1.9	4.0	4.1	3.3	2.0	0.4	5.3	4.0	0.8	1.7	1.2	5.5	5.3	0.7	1.3	5.8	4.6	6.7	8.8	1.5	1.0	5.7	3.6	6.9	0.2	1.8	0.1	11.2	9.9	19.3	1.7	1.8	4.2	4.0	9.8	0.5	1.2	0.0	3.1	4.9	22.3	0.1	1.0	2.2	3.8	0.0	1.3	0.0	7.2	12.4	12.6	4.9	0.0	18.8	1.1	9.7	1.6	6.0	0.0	22.1	5.8	0.1	2.4	2.7	36.5	0.1	6.6	0.1	2.2	0.2	9.5	0.0	1.3	1.7	1.1	5.0	9.8	0.5	1.3	2.0	3.7	1.5	0.1	4.3	13.5	13.3	6.5	1.0	0.1	0.2	11.1	2.3	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.3	0.0	2.6	5.3	4.3	3.2	2.0	2.4	6.2	5.8	4.1	5.3	4.6	6.9	1.6	3.2	2.6	7.2	0.1	1.9	1.9	5.3	0.0	0.6	1.5	7.6	14.6	2.8	2.3	0.0	0.0	0.2	1.5	1.4	0.0	0.1	47.9	5.7	45.4	0.6	3.5	0.0	8.3	1.1	0.3	23.0	0.0	7.5	0.0	8.0	0.7	0.0	0.4	0.0	9.0	2.9	0.0	0.0	4.0	27.1	8.1	0.5	0.0	12.2	0.0	2.5	0.0	3.0	61.3	0.8	0.4	7.2	0.0	2.0	0.6	0.5	2.1	0.4	0.0	40.0	3.9	2.5	4.2	0.2	0.4	0.8	0.4	22.9	1.6	0.4
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828822-2882820	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"adipose tissue: 156.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7;Enteroendocrine cells: 20.4;Granulosa cells: 10.2;Hepatocytes: 20.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 39.1;CACO-2: 30.4;Hep G2: 32.6;NTERA-2: 38.4;SK-MEL-30: 87.6;SuSa: 59.0"					"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favorable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	156.3	2.2	10.3	1.9	10.8	0.2	38.9	18.4	8.8	3.0	8.5	3.9	1.5	6.6	1.0	0.9	5.1	2.2	1.4	11.2	18.9	2.0	18.5	0.5	0.6	29.4	24.5	2.5	5.4	1.0	0.8	2.1	27.3	4.0	2.8	1.4	4.7	6.6	0.3	1.9	2.1	3.7	36.0	0.3	4.5	0.9	13.7	0.4	1.7	0.5	0.3	3.7	2.0	35.4	0.1	11.5	39.1	0.2	20.5	0.0	28.5	2.0	6.3	6.1	8.2	30.4	0.6	0.0	3.1	5.2	6.6	0.0	22.5	0.5	6.8	0.2	6.3	0.1	0.7	32.6	6.7	0.0	8.9	8.1	0.4	1.0	0.0	0.2	0.0	0.0	0.3	0.1	6.6	1.9	0.0	1.0	38.4	0.4	0.2	6.1	13.0	0.0	0.0	0.1	0.0	0.7	0.1	0.3	87.6	59.0	4.1	25.4	0.0	0.0	6.7	3.8	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.3	10.8	18.4	8.8	11.2	18.9	29.4	24.5	27.3	36.0	13.7	35.4	0.3	0.0	0.0	10.7	0.2	0.4	1.1	0.5	0.0	1.2	2.1	0.8	1.2	4.3	0.2	0.0	4.2	6.0	0.0	1.2	5.9	1.0	0.4	3.8	1.0	0.3	20.4	0.0	5.9	4.0	7.9	1.6	4.6	0.7	0.0	10.2	0.0	20.2	1.1	0.0	4.9	1.7	0.0	1.0	0.0	0.5	0.6	0.1	3.6	0.0	0.0	1.6	0.0	0.5	0.1	2.1	0.6	3.0	0.0	1.0	0.4	2.4	1.1	0.1	0.0	0.3	1.2	0.3	1.5	0.0	0.3	2.3	0.0	3.2	3.5	0.7
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140751	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"bone marrow: 156.3"	"Cell type enriched"	"Detected in some"	350	"Erythroid cells: 1995.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	203	"HEL: 149.1;K-562: 37.7"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		15000000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.1	0.1	0.0	0.1	156.3	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	1995.6	2.4	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	1.7	0.0	0.0	0.9	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
GZF1	"dJ322G13.2, ZBTB23, ZNF336"	ENSG00000125812	"GDNF inducible zinc finger protein 1"	Q9H116	20	23362182-23373062	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024520	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA024520: AB_10963938"	"unprognostic (3.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.81e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-1)"	5.9	18.7	9.6	5.5	10.4	31.5	5.0	11.1	10.9	6.0	9.2	6.5	3.9	6.5	5.3	4.4	6.5	5.5	12.4	9.4	9.8	7.7	6.4	6.0	5.2	10.0	12.8	9.2	5.2	6.7	7.9	6.4	9.9	5.9	4.1	10.5	5.0	6.8	9.4	4.7	4.8	5.7	10.6	5.3	5.4	13.3	11.7	5.5	7.0	8.1	4.4	5.8	4.6	10.4	8.2	14.2	8.9	9.0	10.3	10.0	7.1	9.8	9.0	9.9	9.2	10.9	6.4	16.6	8.5	8.5	19.3	14.3	10.3	13.2	11.2	2.8	6.7	15.4	6.0	14.7	13.4	9.3	9.0	10.1	9.6	10.7	16.3	13.8	6.7	11.4	10.6	25.2	14.3	10.9	14.5	11.6	6.6	11.5	19.3	9.5	21.3	11.6	7.4	8.2	13.7	7.8	8.7	15.4	20.9	7.3	10.2	13.4	8.7	16.0	9.2	12.1	10.6	20.5	9.0	14.4	4.7	41.8	8.8	0.0	1.6	0.8	0.7	0.9	0.5	1.0	1.0	1.0	1.6	0.6	0.9	1.0	1.2	0.5	1.2	1.3	0.3	0.9	9.6	10.4	11.1	10.9	9.4	9.8	10.0	12.8	9.9	10.6	11.7	10.4	9.8	6.4	9.6	5.5	12.6	10.8	3.1	3.8	8.6	12.6	6.0	6.9	19.7	1.5	4.7	3.7	18.8	4.9	8.7	3.9	7.9	3.6	18.9	10.4	9.7	8.4	5.4	4.0	6.6	3.3	3.2	8.3	7.1	17.8	13.9	8.2	2.2	5.2	8.7	6.7	7.6	4.2	4.1	13.2	28.8	27.5	9.3	23.9	1.8	1.0	2.5	10.3	5.2	4.5	5.6	4.0	4.6	8.2	11.6	3.2	2.8	3.8	7.7	13.4	0.0	8.8	11.5	20.7	8.9	7.6	8.4	5.6	7.9	14.0	3.7	1.8
H1-0	"H1.0, H1F0, H1FV"	ENSG00000189060	"H1.0 linker histone"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 660.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 51.4;Cytotrophoblasts: 42.9;Extravillous trophoblasts: 125.7;Hofbauer cells: 73.2;Syncytiotrophoblasts: 219.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.1;granulocytes: 17.1;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"OE19: 662.8;U-2 OS: 823.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"		Yes	No		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus, Actin filaments"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favorable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	89.8	53.5	56.6	36.7	55.4	660.5	121.4	72.5	64.1	218.3	42.5	146.2	129.9	168.2	43.5	230.6	119.7	56.3	86.5	55.4	67.1	292.8	179.3	72.4	24.4	58.4	54.2	120.7	125.9	93.2	58.2	80.0	57.7	151.7	120.0	39.9	155.3	40.2	216.2	228.6	137.1	97.7	52.6	36.7	131.2	42.4	58.3	136.2	93.9	93.5	46.6	85.6	194.9	55.8	159.6	67.9	206.0	91.8	53.4	48.4	291.6	126.9	262.3	362.6	512.6	278.1	247.3	0.2	31.1	106.3	84.1	303.8	0.0	87.2	256.0	0.9	15.3	268.2	25.3	187.4	185.8	0.1	0.7	45.4	152.4	182.3	203.2	4.0	97.8	60.4	0.1	0.5	28.5	263.3	45.4	26.5	80.2	662.8	329.9	74.6	122.6	56.1	58.0	42.7	47.3	263.9	349.9	235.4	473.9	91.8	184.2	167.1	65.4	27.4	823.3	122.7	25.9	0.7	18.5	1.2	33.5	95.9	80.3	17.1	9.9	15.7	0.1	11.7	0.1	0.0	1.0	0.2	8.1	0.1	2.8	0.4	5.4	0.1	10.3	7.4	0.2	6.9	56.6	55.4	72.5	64.1	55.4	67.1	58.4	54.2	57.7	52.6	58.3	55.8	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.0	0.0	42.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	125.7	25.2	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	219.7	0.0	0.0	0.0	0.0
H1-1	"H1.1, H1a, H1F1, HIST1H1A"	ENSG00000124610	"H1.1 linker histone, cluster member"	Q02539	6	26017032-26017787	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 1.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 3.3;Cytotrophoblasts: 1.2;Extravillous trophoblasts: 4.2;Hofbauer cells: 2.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.0"	"Immune cell enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"	"Not detected"	"Not detected"							"HPA043753, HPA056830"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA043753: AB_2678654, HPA056830: "		"unprognostic (3.80e-1)"					"unprognostic (1.82e-1)"			"unprognostic (1.15e-1)"				"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.05e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.0	0.4	0.2	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0
H1-10	"H1FX, H1X, MGC15959, MGC8350"	ENSG00000184897	"H1.10 linker histone"	Q92522	3	129314771-129316286	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1004.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 188.4;Cytotrophoblasts: 66.8;dendritic cells: 73.2;Extravillous trophoblasts: 114.2;Hofbauer cells: 93.4;Plasma cells: 148.6;Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 937.8"	"Low region specificity"	"Detected in all"							"CAB012235, HPA040099, HPA068431"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB012235: , HPA040099: AB_2676846, HPA068431: "	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	121.4	54.7	39.9	42.6	43.9	1004.3	145.0	60.6	68.6	162.4	25.2	125.0	44.6	143.1	9.2	107.8	142.2	13.9	82.0	43.1	48.4	162.7	100.1	115.8	44.3	29.5	26.0	168.9	100.0	30.1	112.6	25.4	25.1	124.5	11.9	13.9	98.7	20.8	110.7	258.4	106.7	13.2	27.8	127.7	115.7	40.9	38.2	131.5	94.4	12.3	18.3	130.9	140.7	46.4	141.8	73.4	135.8	59.3	13.6	16.1	129.1	60.5	43.5	70.4	74.3	44.5	75.5	17.8	65.5	21.6	47.2	139.1	57.3	39.0	10.8	129.4	111.7	53.8	55.5	61.1	57.3	62.6	14.1	32.4	51.9	28.7	64.7	32.0	40.7	241.7	83.7	308.5	10.0	147.9	290.9	124.1	127.2	25.8	81.6	207.4	58.1	170.9	22.1	29.1	216.0	250.1	64.1	31.7	196.3	26.1	124.1	125.1	40.9	54.4	283.5	53.5	51.2	937.8	385.2	156.9	44.5	58.6	61.1	0.5	5.5	17.8	4.4	4.2	4.0	5.7	6.7	5.2	7.9	5.3	8.4	4.3	1.2	5.2	3.9	11.4	6.1	2.4	39.9	43.9	60.6	68.6	43.1	48.4	29.5	26.0	25.1	27.8	38.2	46.4	188.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	66.8	73.2	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	114.2	46.9	0.0	0.0	0.0	0.0	0.0	0.0	93.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	68.4	17.6	0.0	0.0	0.0
H1-2	"H1.2, H1c, H1F2, H1s-1, HIST1H1C"	ENSG00000187837	"H1.2 linker histone, cluster member"	P16403	6	26055740-26056470	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 49.3;Cytotrophoblasts: 42.7;Extravillous trophoblasts: 68.1;Hofbauer cells: 75.5;Syncytiotrophoblasts: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 258.6;eosinophil: 458.7;neutrophil: 229.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 458.7"	"Cell line enhanced"	"Detected in many"		"K-562: 334.2;SiHa: 311.1;U-2 OS: 601.6;U-266/70: 673.7;U-266/84: 661.8"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		5500000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli rim"		"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.06e-5)"	72.2	47.6	67.1	27.2	55.3	229.5	71.7	148.8	64.2	116.1	84.5	54.5	33.6	14.6	42.0	70.3	41.3	18.9	154.7	51.1	60.1	236.3	130.0	60.5	31.5	64.6	70.4	89.4	60.5	8.7	15.2	43.8	56.7	132.9	44.2	22.0	39.8	16.4	227.4	65.0	42.8	7.9	57.4	56.6	73.4	26.8	71.4	62.0	59.7	99.1	27.8	29.5	90.6	76.7	39.9	27.5	20.5	21.9	49.9	10.0	0.7	19.5	30.8	87.9	92.6	14.9	28.1	3.1	109.6	25.6	32.8	17.3	6.4	15.0	24.3	38.7	23.4	16.5	27.8	17.5	14.7	7.8	38.4	70.4	19.9	11.5	19.2	27.3	13.8	17.6	334.2	243.3	43.7	17.3	20.8	18.3	11.5	96.3	41.4	10.8	9.5	129.1	52.8	28.1	52.6	17.9	311.1	53.0	22.0	19.1	65.8	12.5	6.8	41.1	601.6	12.5	9.0	673.7	661.8	31.3	29.9	253.6	14.4	258.6	14.3	458.7	19.3	14.2	24.4	57.7	31.9	21.4	30.5	76.8	29.4	23.1	229.3	20.2	18.9	31.6	48.3	22.1	67.1	55.3	148.8	64.2	51.1	60.1	64.6	70.4	56.7	57.4	71.4	76.7	14.9	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	0.0	0.0	42.7	29.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	68.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	298.4	4.5	0.0	0.0	0.0
H1-5	"H1b, H1F5, H1s-3, HIST1H1B"	ENSG00000184357	"H1.5 linker histone, cluster member"	P16401	6	27866792-27867588	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 7.8;brain: 4.6;choroid plexus: 4.1;lymphoid tissue: 2.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.5;dendritic cells: 2.2;Extravillous trophoblasts: 4.7;Hofbauer cells: 3.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 10.3;dendritic cells: 12.1;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 9.2;NB-4: 4.9;U-698: 3.9"	"Not detected"	"Not detected"							"CAB012241, HPA055907, HPA060331"	Supported		Supported	Nucleoplasm		NA	NA		2300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012241: , HPA055907: AB_2682966, HPA060331: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	0.1	0.0	1.5	0.2	0.9	7.8	0.1	4.0	1.0	0.0	4.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.1	1.6	1.8	2.3	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	1.5	0.4	0.1	0.1	3.8	2.1	0.0	0.0	0.3	0.3	0.0	4.6	1.4	0.0	0.5	0.0	0.0	0.0	1.0	0.4	0.3	0.7	0.3	0.4	0.9	1.7	0.2	0.5	0.4	0.5	0.0	0.0	0.0	0.6	0.8	2.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.5	1.1	1.7	1.2	0.0	0.2	9.2	4.9	1.4	1.3	0.0	2.7	0.0	0.0	0.2	0.0	1.2	0.6	1.5	0.3	0.0	0.4	0.6	1.6	0.5	0.8	0.1	0.8	0.6	1.8	0.0	3.9	1.2	0.6	0.8	0.0	0.9	0.0	3.1	0.8	1.5	4.6	2.9	3.2	5.1	10.3	1.7	1.9	0.8	1.7	1.1	12.1	3.3	2.1	1.5	0.9	4.0	1.0	0.5	1.2	1.8	2.3	3.0	1.5	3.8	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0
H2AC1	"bA317E16.2, H2AFR, HIST1H2AA"	ENSG00000164508	"H2A clustered histone 1"	Q96QV6	6	25726063-25726562	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"			Nucleoplasm		"HPA041189: AB_2677357"													"unprognostic (4.53e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AC11	"H2A.1b, H2A/p, H2AFP, HIST1H2AG, pH2A/f"	ENSG00000196787	"H2A clustered histone 11"	P0C0S8	6	27133042-27135291	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 2.8;testis: 3.1"	"Group enriched"	"Detected in some"	10	"Cardiomyocytes: 1.2;Cytotrophoblasts: 2.0;dendritic cells: 1.5;Extravillous trophoblasts: 3.1;Hofbauer cells: 2.6;Plasma cells: 1.3;Syncytiotrophoblasts: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5"	"Group enriched"	"Detected in many"	5	"B-cells: 2.8;granulocytes: 9.5;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"K-562: 15.5;SiHa: 17.3;U-266/84: 48.8"					"Low region specificity"	"Detected in many"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.86e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.54e-2)"	0.3	0.3	0.7	0.3	0.9	2.4	2.8	0.5	0.7	0.5	0.7	0.9	1.3	0.1	0.6	0.6	0.2	0.3	0.2	0.6	1.0	0.2	0.5	0.3	1.0	1.5	1.4	0.1	0.2	0.0	0.1	0.4	1.4	0.7	0.7	0.1	0.1	0.4	0.2	0.2	1.1	0.2	1.2	0.9	0.5	3.1	1.7	1.9	0.3	0.3	0.4	0.4	0.4	1.7	2.1	2.8	2.3	2.0	7.1	1.5	1.5	0.7	1.1	2.4	0.3	1.2	2.1	0.7	3.0	0.9	2.3	4.2	2.8	1.2	1.6	3.7	1.6	1.1	5.2	0.0	1.5	1.1	2.2	2.7	0.5	0.7	0.8	1.2	0.8	2.0	15.5	6.9	0.1	2.7	2.9	1.8	1.3	3.1	1.9	1.9	2.3	8.0	0.4	0.5	9.0	2.1	17.3	2.7	1.0	1.1	0.0	0.7	0.9	2.6	5.8	2.1	1.1	12.4	48.8	4.9	0.5	1.7	1.6	9.5	0.3	0.6	0.4	0.2	0.9	2.3	1.7	1.1	0.5	2.8	1.4	1.3	2.3	0.9	0.6	1.0	2.9	5.3	0.7	0.9	0.5	0.7	0.6	1.0	1.5	1.4	1.4	1.2	1.7	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0
H2AC12	"dJ86C11.1, H2A/S, H2AFALii, HIST1H2AH"	ENSG00000274997	"H2A clustered histone 12"	Q96KK5	6	27147106-27147562	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.8;brain: 2.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.6;Extravillous trophoblasts: 2.3;Hofbauer cells: 1.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.4;MOLT-4: 6.2;NB-4: 6.9"									"CAB004030, HPA041189"	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB004030: AB_2118804, HPA041189: AB_2677357"	"unprognostic (4.07e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.35e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"		"unprognostic (9.74e-3)"	"unprognostic (1.87e-1)"		"unprognostic (1.26e-4)"	0.2	0.1	0.5	0.0	0.9	8.8	0.3	0.7	0.5	0.2	0.8	0.7	0.2	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.9	0.0	0.1	0.2	1.1	1.6	1.3	0.1	0.1	0.1	0.0	0.3	1.8	0.1	0.1	0.0	0.1	0.0	0.0	0.2	2.1	0.1	1.8	0.6	0.2	1.6	2.0	1.5	0.1	0.0	0.2	0.2	0.2	2.8	1.7	2.0	0.7	3.0	0.0	0.0	0.4	0.2	0.3	0.3	0.0	2.0	0.6	2.7	0.6	0.0	0.3	0.2	0.6	0.0	0.0	1.4	5.4	3.0	2.5	0.0	0.0	2.1	1.1	0.0	0.0	0.7	0.0	0.0	0.5	1.1	3.1	1.7	0.5	0.3	6.2	6.9	2.1	0.6	0.7	2.2	1.9	3.2	0.0	0.2	1.5	0.4	0.9	0.3	0.2	0.0	0.6	1.0	0.0	0.6	1.7	0.1	1.8	1.8	2.0	4.0	0.8	2.8	0.6	0.0	0.8	0.0	2.2	2.3	1.0	3.3	4.1	3.8	2.0	11.9	2.1	1.5	0.0	5.1	1.4	1.4	0.7	2.0	0.5	0.9	0.7	0.5	0.3	0.9	1.6	1.3	1.8	1.8	2.0	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
H2AC13	"H2A/c, H2AFC, HIST1H2AI"	ENSG00000196747	"H2A clustered histone 13"	P0C0S8	6	27808199-27808701	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.2;brain: 4.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 42.1;U-266/84: 118.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (6.82e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.54e-5)"	"unprognostic (5.50e-2)"	"unprognostic (1.50e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.24e-2)"	0.3	0.1	1.0	0.2	0.5	5.2	0.1	0.6	0.6	0.3	2.8	2.5	0.9	0.0	0.1	0.7	0.4	0.3	0.1	0.4	1.2	0.1	0.2	0.5	1.5	1.7	1.8	0.4	0.0	0.7	0.0	0.7	1.6	0.2	2.2	0.0	0.1	0.0	0.0	0.2	1.1	0.1	1.6	1.1	0.9	0.5	2.5	2.5	0.1	0.0	0.6	0.4	0.5	4.2	2.4	8.5	2.0	1.4	0.9	0.5	0.8	1.6	0.3	2.7	2.0	2.8	1.5	2.4	5.1	0.7	1.5	1.8	0.0	1.5	1.2	8.6	11.0	3.7	12.6	8.0	0.9	0.9	1.9	3.7	0.6	0.8	0.2	2.3	0.6	3.0	42.1	9.9	0.0	11.8	6.5	7.0	2.2	7.2	3.2	3.4	0.0	16.6	3.0	1.6	11.7	2.3	23.6	3.4	0.8	0.7	14.2	1.1	0.4	1.2	4.6	1.0	1.0	9.1	118.9	5.0	1.1	9.8	0.7	0.0	0.2	1.5	0.3	0.3	0.3	0.8	1.4	0.3	1.1	1.1	0.3	0.2	2.1	1.0	0.3	1.0	1.8	1.0	1.0	0.5	0.6	0.6	0.4	1.2	1.7	1.8	1.6	1.6	2.5	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H2AC14	"H2A/E, H2AFE, HIST1H2AJ"	ENSG00000276368	"H2A clustered histone 14"	Q99878	6	27814302-27814777	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 7.2"	"Cell type enhanced"	"Detected in single"		"Extravillous trophoblasts: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 6.9;Karpas-707: 9.8;MCF7: 11.5"					"Low region specificity"	"Detected in many"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (8.95e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.43e-1)"		"unprognostic (9.35e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.88e-2)"	0.1	0.0	0.2	0.3	0.4	7.2	0.0	0.5	0.7	0.5	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.1	0.1	1.0	1.7	0.0	0.0	0.1	0.2	0.1	0.8	3.5	0.0	0.9	0.0	0.0	0.0	0.7	1.0	0.8	0.7	1.8	1.4	0.1	3.1	0.3	0.5	0.1	1.0	0.0	0.8	0.4	1.4	0.3	4.6	0.7	6.9	0.2	0.0	1.7	0.0	0.2	0.5	0.2	0.0	1.0	1.6	0.0	9.8	0.2	11.5	5.0	4.6	1.4	1.5	2.4	4.6	0.0	1.4	0.1	1.9	0.3	0.8	0.8	1.0	0.3	0.2	0.3	3.4	0.0	0.0	1.6	0.3	0.1	4.8	3.1	2.9	0.8	3.2	2.2	0.0	0.0	0.0	0.2	0.2	0.4	0.3	1.3	1.3	1.1	1.3	0.4	0.1	1.1	0.1	0.1	0.1	2.8	1.7	0.2	0.4	0.5	0.7	0.2	0.4	0.7	0.5	1.3	0.4	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0
H2AC15	"H2A/d, H2AFD, HIST1H2AK"	ENSG00000275221	"H2A clustered histone 15"	P0C0S8	6	27837880-27838375	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"dendritic cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.3;SCLC-21H: 3.5;U-266/84: 3.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"																		0.4	1.0	0.9	0.4	0.9	1.0	0.4	2.7	1.3	0.9	2.5	0.4	0.1	0.5	1.7	0.3	1.2	1.0	1.7	0.9	1.8	0.9	0.6	0.8	1.2	1.9	1.5	2.0	0.6	0.4	1.3	0.3	2.0	1.2	0.4	0.2	0.4	0.3	0.8	0.2	0.6	0.0	2.2	0.8	0.4	2.6	2.2	1.2	1.3	0.4	0.2	0.4	0.7	3.9	0.0	1.3	0.1	1.7	0.3	0.0	0.0	0.1	0.0	0.3	0.0	1.1	0.0	0.6	0.1	0.2	0.1	1.4	0.5	0.0	0.3	0.4	0.1	0.4	3.3	0.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.3	0.4	0.0	0.2	0.0	1.1	0.6	0.2	0.1	0.3	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.4	0.1	0.0	1.2	3.9	0.3	0.0	0.0	0.1	0.0	0.1	0.0	1.4	0.0	1.3	4.1	1.7	1.5	0.0	3.2	2.5	1.8	0.0	0.9	0.4	0.7	1.3	2.6	0.9	0.9	2.7	1.3	0.9	1.8	1.9	1.5	2.0	2.2	2.2	3.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0
H2AC16	"dJ193B12.9, H2A/i, H2AFI, HIST1H2AL"	ENSG00000276903	"H2A clustered histone 16"	P0C0S8	6	27865317-27865798	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 7.6;brain: 2.5"	"Cell type enhanced"	"Detected in single"		"Extravillous trophoblasts: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.8;MOLT-4: 5.2"					"Low region specificity"	"Detected in single"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"		"unprognostic (2.41e-2)"	"unprognostic (2.12e-1)"		"unprognostic (6.21e-2)"	0.1	0.1	0.5	0.1	0.3	7.6	0.2	0.6	0.4	0.0	1.0	0.2	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.3	1.0	0.1	0.1	0.4	0.4	1.5	1.3	0.0	0.0	0.3	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	1.2	0.7	0.2	0.3	1.7	0.5	0.0	0.1	0.1	0.0	0.2	2.5	2.8	1.2	0.8	0.0	0.0	0.0	0.5	0.9	0.5	1.5	1.4	0.0	0.7	2.0	0.8	0.2	0.8	0.8	0.0	0.2	1.0	1.9	4.8	0.6	0.2	0.5	0.0	0.4	1.1	0.0	0.0	0.4	0.2	0.0	0.0	1.1	4.5	3.3	0.2	3.0	5.2	3.9	1.6	1.5	0.6	2.6	0.0	0.2	0.3	2.0	1.6	1.4	1.0	0.1	0.4	0.1	0.7	1.1	0.0	0.1	0.0	1.0	1.7	3.7	0.0	4.0	0.8	3.1	0.7	2.0	1.4	1.1	0.1	1.3	0.0	2.4	1.2	1.3	3.6	5.9	0.4	0.7	6.1	0.0	2.9	2.6	1.1	0.7	0.5	0.3	0.6	0.4	0.3	1.0	1.5	1.3	1.5	1.2	1.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H2AC17	"H2A.1, H2A/n, H2AFN, HIST1H2AM"	ENSG00000278677	"H2A clustered histone 17"	P0C0S8	6	27892699-27893185	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2;brain: 5.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.2;Syncytiotrophoblasts: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 63.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 28.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (6.05e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.24e-1)"	"unprognostic (8.85e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.30e-1)"	0.4	0.4	1.3	0.2	0.9	3.2	0.3	1.2	1.1	0.5	2.5	0.8	0.7	0.3	0.2	0.9	0.0	0.0	0.2	0.5	1.5	0.2	0.5	0.6	1.5	3.3	3.2	0.0	0.3	0.3	0.0	0.9	3.2	0.6	0.6	0.0	0.3	0.0	0.2	0.4	0.8	0.0	2.7	1.2	0.4	0.9	2.4	2.1	0.7	0.0	0.4	0.3	0.7	5.8	3.7	2.6	2.3	5.4	0.3	0.2	4.8	1.2	0.6	2.4	3.1	0.9	1.6	5.8	4.3	0.7	2.9	2.2	2.3	1.6	1.9	4.6	1.3	2.9	3.5	3.9	0.0	2.1	2.4	1.8	0.0	1.7	0.0	0.2	2.3	4.2	12.5	8.0	0.4	6.8	12.6	8.9	4.2	2.1	1.2	7.7	3.6	11.9	1.2	0.9	8.9	1.6	6.5	0.6	0.9	1.2	5.4	1.7	0.0	1.1	0.2	1.2	2.0	9.0	28.9	14.2	1.5	9.7	1.0	63.8	5.0	21.1	10.0	6.0	5.9	13.5	8.8	8.6	18.3	15.3	3.5	4.2	16.7	8.5	10.5	22.5	13.4	9.7	1.3	0.9	1.2	1.1	0.5	1.5	3.3	3.2	3.2	2.7	2.4	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0
H2AC18	"H2A.2, H2A/q, H2AFO, HIST2H2AA, HIST2H2AA3"	ENSG00000203812	"H2A clustered histone 18"	Q6FI13	1	149842188-149842736	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.5;Hofbauer cells: 1.0;Syncytiotrophoblasts: 2.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 116.8;U-266/70: 472.4;U-266/84: 300.7"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.41e-2)"				"unprognostic (3.79e-1)"					"unprognostic (1.53e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.20e-1)"				73.9	37.8	7.8	16.5	7.1	175.8	47.2	8.4	18.6	121.9	51.9	46.1	11.4	13.9	7.7	79.5	50.5	14.6	59.9	8.5	19.9	88.7	74.7	152.6	12.7	21.6	12.9	54.6	24.0	0.1	31.4	21.8	14.1	200.5	3.4	0.0	46.9	6.5	42.7	116.2	31.7	5.5	14.0	127.6	59.8	117.5	13.7	15.1	31.1	3.8	2.3	42.7	135.9	11.4	14.7	0.0	1.1	0.0	11.1	7.8	0.0	29.8	12.3	17.3	14.5	0.3	7.3	7.5	20.5	11.7	0.7	4.6	1.6	5.5	2.0	15.3	0.0	3.7	31.7	8.8	11.4	0.0	7.9	55.0	9.9	4.2	4.8	0.0	4.5	0.0	43.6	116.8	6.0	21.6	0.0	28.9	0.0	30.1	31.4	6.1	0.0	47.8	7.4	11.8	2.7	1.2	50.4	10.1	1.6	0.0	41.2	12.8	10.1	7.8	58.3	1.5	2.6	472.4	300.7	11.5	26.3	59.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.1	8.4	18.6	8.5	19.9	21.6	12.9	14.1	14.0	13.7	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0
H2AC19	"H2A/r, HIST2H2AA4"	ENSG00000272196	"H2A clustered histone 19"	Q6FI13	1	149851061-149851624	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 26.6"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 1820.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 1820.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 98.8;U-266/70: 270.8;U-266/84: 249.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA041189: AB_2677357"					"unprognostic (1.63e-1)"					"unprognostic (1.77e-1)"		"unprognostic (1.76e-1)"		"unprognostic (8.47e-2)"				63.3	27.8	32.4	10.1	36.7	20.9	40.2	57.3	31.8	111.3	43.3	39.5	10.8	10.0	0.0	66.7	45.2	6.9	34.4	31.6	38.9	52.0	58.3	140.4	3.8	43.5	36.7	53.3	13.7	3.0	27.2	4.7	42.4	156.3	1.0	6.1	41.1	0.0	30.3	102.5	31.9	0.0	45.7	124.6	64.4	109.9	32.3	9.6	29.1	2.6	1.4	47.4	124.3	50.6	14.9	41.0	4.2	9.4	0.0	0.0	12.9	31.6	0.0	0.0	0.0	26.4	13.9	0.0	36.4	0.0	10.0	23.0	0.0	0.0	0.0	20.4	53.9	5.4	35.5	15.5	0.0	5.2	27.4	0.0	0.0	0.0	0.0	9.7	0.0	18.7	32.9	61.2	0.0	85.0	18.5	5.6	15.7	75.7	31.8	14.3	6.4	20.1	0.0	5.9	37.8	16.1	98.8	21.2	9.1	5.3	38.5	8.9	0.0	6.9	71.4	14.1	4.5	270.8	249.5	20.8	0.0	26.9	11.6	314.7	206.9	388.5	34.8	121.2	35.8	72.9	30.4	32.6	135.6	93.1	22.8	21.6	1820.8	41.6	151.6	193.3	48.3	215.9	32.4	36.7	57.3	31.8	31.6	38.9	43.5	36.7	42.4	45.7	32.3	50.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	5.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0
H2AC20	"H2A, H2A/q, H2AFQ, HIST2H2AC"	ENSG00000184260	"H2A clustered histone 20"	Q16777	1	149886918-149887411	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.3;brain: 27.2;choroid plexus: 20.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.7;dendritic cells: 8.1;Extravillous trophoblasts: 18.2;Hofbauer cells: 9.7;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 60.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.50e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (1.20e-10)"	"unprognostic (1.42e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.86e-5)"	3.8	3.6	15.5	0.8	20.6	25.3	3.5	24.0	14.0	5.4	20.0	3.1	0.2	2.0	0.0	2.2	2.7	0.4	2.6	10.0	27.2	2.3	2.6	4.7	0.5	19.8	13.1	4.3	2.4	0.1	3.0	0.5	16.7	3.2	0.1	0.5	1.4	0.1	0.7	4.5	3.3	0.4	19.9	5.2	2.5	1.2	18.2	1.6	1.8	0.0	0.1	2.5	4.1	18.2	3.9	4.2	5.0	15.7	0.0	0.7	7.8	1.2	0.9	2.4	3.3	2.5	1.1	8.0	0.2	0.2	0.5	2.0	0.3	1.6	0.0	0.7	5.7	1.9	1.6	12.2	0.0	4.7	4.6	0.9	0.2	0.2	0.5	0.1	1.6	2.0	1.7	10.0	0.5	60.6	5.7	5.4	6.7	4.5	10.0	1.8	2.2	1.4	1.0	2.4	1.8	7.5	3.2	1.2	3.8	0.4	0.6	4.4	1.5	1.1	10.9	1.9	2.9	5.5	4.0	4.2	2.9	6.3	2.3	47.2	33.8	19.0	22.9	22.6	20.2	13.1	20.1	18.5	17.7	33.1	14.0	14.8	98.4	19.1	25.6	24.9	16.3	22.6	15.5	20.6	24.0	14.0	10.0	27.2	19.8	13.1	16.7	19.9	18.2	18.2	2.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.7	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	18.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.8	1.5	0.0	0.0	0.0
H2AC21	HIST2H2AB	ENSG00000184270	"H2A clustered histone 21"	Q8IUE6	1	149887469-149887965	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 15.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.3;NB-4: 1.9;U-266/70: 1.6;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011483, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011483: AB_732909, HPA041189: AB_2677357"	"unprognostic (6.31e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"		"unprognostic (9.97e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.36e-2)"	0.2	0.1	3.3	0.0	4.6	3.4	0.3	15.3	3.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	3.0	0.1	0.1	0.2	0.0	0.5	1.3	0.3	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.2	0.6	0.5	0.0	1.5	0.3	0.1	0.1	2.3	0.3	0.1	0.0	0.0	0.1	0.2	3.7	0.5	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.3	0.4	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.7	0.2	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.2	0.0	3.3	1.9	0.4	0.3	0.5	0.7	0.2	0.7	0.0	0.1	0.6	0.4	0.8	0.0	0.1	0.0	0.2	1.4	0.0	0.3	1.2	0.0	0.3	1.6	1.9	0.5	0.6	0.1	0.2	1.5	1.9	0.8	2.2	1.7	2.0	3.7	3.7	3.3	2.1	6.6	2.3	2.5	9.8	3.6	2.0	4.0	2.0	0.5	3.3	4.6	15.3	3.0	1.7	3.0	0.5	1.3	1.0	1.5	2.3	3.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
H2AC4	"H2A/m, H2AFM, HIST1H2AB"	ENSG00000278463	"H2A clustered histone 4"	P04908	6	26033092-26033618	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.5;brain: 2.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.7;U-2 OS: 1.4"	"Not detected"	"Not detected"							HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.53e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.04e-3)"		"unprognostic (3.28e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.47e-3)"	0.2	0.0	0.5	0.0	0.4	1.5	0.0	2.0	0.5	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.1	0.7	1.9	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.3	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.6	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.3	0.9	0.5	0.2	2.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.4	0.7	0.7	1.2	0.0	1.0	0.4	0.2	0.5	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.1	1.4	0.1	0.1	0.6	0.9	0.0	0.2	1.2	0.1	0.0	0.0	1.0	0.1	0.4	0.0	1.5	0.4	0.6	0.5	0.7	0.1	0.2	0.2	0.5	0.0	0.0	0.2	0.0	0.5	0.4	2.0	0.5	0.6	0.6	0.8	1.2	0.7	0.3	1.9	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
H2AC6	"H2AFL, HIST1H2AC"	ENSG00000180573	"H2A clustered histone 6"	Q93077	6	26124145-26139116	"Cancer-related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.9;Cardiomyocytes: 23.3;Cytotrophoblasts: 14.3;Extravillous trophoblasts: 28.5;Hofbauer cells: 16.2;Syncytiotrophoblasts: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1552.9"	"Lineage enriched"	"Detected in all"	14	"granulocytes: 1552.9"	"Cell line enhanced"	"Detected in many"		"U-266/84: 61.0"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.89e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.89e-3)"	14.0	12.7	26.8	5.0	39.2	12.9	10.7	38.1	38.5	21.6	24.1	13.1	11.5	4.7	11.3	28.1	10.8	10.3	11.2	34.5	41.7	21.5	30.2	22.9	5.5	37.9	34.4	12.7	7.2	0.9	10.5	5.2	33.9	26.0	5.3	3.9	10.8	2.1	20.2	16.7	13.2	2.1	52.1	21.2	13.8	4.7	30.6	18.1	12.7	4.7	2.0	12.0	28.6	65.4	13.2	30.7	0.1	0.0	14.4	8.8	1.5	8.4	2.4	4.0	4.1	10.3	3.7	0.0	36.8	4.2	1.8	4.0	0.0	0.8	2.7	18.4	3.5	1.8	21.5	3.8	10.8	0.7	8.8	26.5	4.5	1.4	4.5	10.9	1.4	0.7	23.1	11.9	3.9	20.0	2.9	3.4	1.3	10.4	13.9	2.3	0.2	25.6	13.2	8.7	3.2	3.2	29.5	4.0	13.4	7.1	33.3	2.4	3.2	6.9	20.5	3.6	1.7	32.7	61.0	4.7	2.0	28.4	1.1	440.2	31.9	324.6	28.0	24.6	25.7	61.7	29.7	19.4	28.3	109.5	34.9	19.6	1552.9	33.7	65.6	79.9	33.8	662.0	26.8	39.2	38.1	38.5	34.5	41.7	37.9	34.4	33.9	52.1	30.6	65.4	10.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	14.3	7.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	28.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	75.9	1.1	0.0	0.0	0.0
H2AC7	"H2A.3, H2A/g, H2AFG, HIST1H2AD"	ENSG00000196866	"H2A clustered histone 7"	P20671	6	26198784-26199293	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 17.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 17.5;U-266/84: 6.3"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.10e-9)"	"unprognostic (2.00e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	0.7	0.2	0.4	0.3	1.7	2.9	0.6	4.1	2.1	3.3	3.6	0.5	0.0	0.1	0.0	2.5	0.6	0.3	0.4	1.0	1.9	0.6	1.2	2.1	0.5	3.1	1.7	0.7	0.1	0.0	0.3	0.2	2.1	2.1	0.1	0.0	0.5	0.0	0.0	1.1	0.5	0.0	3.9	1.2	0.6	0.3	3.0	1.8	0.3	0.0	0.3	0.3	2.8	6.8	1.1	0.0	0.2	0.2	0.0	0.0	0.2	0.7	0.1	1.1	0.0	1.3	0.4	0.7	1.2	0.2	0.1	0.3	0.0	0.1	0.2	0.0	1.0	0.3	1.4	1.3	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.7	2.5	1.3	0.0	0.0	3.7	1.5	1.1	0.0	1.1	1.0	0.4	0.9	0.4	0.1	1.4	0.2	0.6	0.8	0.1	0.0	1.4	0.3	0.0	1.1	3.1	0.0	1.0	17.5	6.3	2.2	1.0	1.3	0.4	2.3	0.3	3.8	1.3	1.9	1.3	2.7	2.0	4.0	1.1	7.6	1.9	1.9	17.9	1.8	2.2	6.2	2.7	0.8	0.4	1.7	4.1	2.1	1.0	1.9	3.1	1.7	2.1	3.9	3.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AC8	"H2A.1, H2A/a, H2AFA, HIST1H2AE"	ENSG00000277075	"H2A clustered histone 8"	P04908	6	26216975-26217483	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.2;breast: 40.7"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 6.5;Extravillous trophoblasts: 5.5;Hofbauer cells: 18.0;Syncytiotrophoblasts: 13.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.9"	"Group enriched"	"Detected in all"	5	"cerebellum: 41.2;white matter: 17.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.0"									"CAB012242, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012242: AB_470265, HPA041189: AB_2677357"	"unprognostic (4.26e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.36e-2)"	4.3	2.4	2.1	1.6	5.6	19.3	40.7	41.2	6.0	14.7	4.6	7.9	3.6	1.6	16.7	8.6	7.8	1.8	4.2	5.1	3.7	11.6	5.7	7.9	2.9	2.3	1.1	6.8	1.0	0.4	3.4	1.6	3.7	32.9	2.1	1.5	4.7	1.2	0.2	16.5	4.6	0.6	1.7	9.5	5.2	4.3	3.3	9.4	5.8	0.1	0.8	2.2	17.4	17.5	4.1	0.0	3.0	0.0	4.9	0.9	0.8	1.3	2.0	4.3	2.9	2.0	3.3	0.2	10.8	0.4	3.9	3.4	1.5	2.0	1.7	4.5	3.7	2.7	5.9	2.6	0.9	0.3	4.1	8.4	0.9	1.8	0.2	1.2	2.1	0.8	11.4	2.9	0.4	7.5	9.3	7.9	3.5	14.1	3.7	7.3	2.4	14.7	1.8	2.3	11.9	5.0	10.9	3.7	2.4	2.0	14.9	4.1	0.0	0.2	0.8	1.8	1.8	37.0	0.0	0.0	1.5	5.5	2.7	18.2	2.2	8.2	2.8	2.6	4.1	4.7	3.3	4.6	5.9	6.0	1.7	2.3	10.1	4.5	1.6	17.6	4.4	10.4	2.1	5.6	41.2	6.0	5.1	3.7	2.3	1.1	3.7	1.7	3.3	17.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	6.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.2	0.0	0.0	0.0
H2AJ	"FLJ10903, H2AFJ, MGC921"	ENSG00000246705	"H2A.J histone"	Q9BTM1	12	14774383-14778002	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 565.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 58.1;Cytotrophoblasts: 130.2;dendritic cells: 56.4;Extravillous trophoblasts: 124.3;Fibroblasts: 59.5;Hofbauer cells: 241.2;Syncytiotrophoblasts: 160.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 151.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 256.2;MCF7: 338.4;RT4: 239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.38e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.66e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.87e-3)"	236.7	186.0	29.1	33.8	34.1	60.4	223.6	33.7	40.9	123.7	37.9	126.6	55.4	105.6	20.9	155.7	106.6	36.0	125.5	27.7	31.3	115.7	82.7	129.6	29.6	37.1	32.5	63.6	182.3	21.1	34.2	57.7	35.7	275.8	29.3	5.3	166.8	35.0	91.4	198.4	85.2	25.1	33.4	94.8	111.1	565.0	33.1	34.2	85.0	24.8	18.2	122.8	124.9	38.7	107.9	256.2	10.0	0.0	112.2	73.8	163.2	78.9	43.4	31.3	30.4	50.9	172.4	0.1	48.7	38.6	0.2	100.7	6.2	60.1	8.5	5.7	4.6	4.3	92.6	43.8	160.5	0.1	39.0	97.0	64.5	43.3	40.0	12.7	63.0	0.0	0.1	0.1	15.9	338.4	0.7	28.7	16.0	77.8	58.0	42.4	0.0	21.0	51.0	239.0	3.0	1.0	99.8	122.3	0.4	34.6	187.0	32.6	63.1	0.3	29.6	46.2	15.6	25.0	39.4	0.4	8.6	0.3	25.4	84.0	127.6	29.3	51.3	76.4	46.3	16.8	49.6	38.0	117.2	21.7	34.9	38.2	46.6	61.2	69.4	58.2	78.1	72.1	29.1	34.1	33.7	40.9	27.7	31.3	37.1	32.5	35.7	33.4	33.1	38.7	58.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	130.2	56.4	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	124.3	59.5	0.0	0.0	0.0	0.0	0.0	0.0	241.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	0.0	0.0	160.3	6.5	0.0	0.0	0.0
H2AW	"HIST3H2A, MGC3165"	ENSG00000181218	"H2A.W histone"	Q7L7L0	1	228456979-228457873	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.2;Cytotrophoblasts: 14.1;dendritic cells: 13.8;Extravillous trophoblasts: 10.8;Hofbauer cells: 28.4;Syncytiotrophoblasts: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 29.7;U-266/70: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (3.65e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.76e-2)"	6.0	35.9	6.3	0.8	6.1	5.9	6.8	13.4	6.9	27.9	9.9	5.9	3.2	5.4	1.6	19.2	7.2	1.2	17.8	5.8	6.7	4.4	1.1	4.4	1.2	5.0	4.9	14.1	3.9	3.7	12.9	1.0	5.3	11.1	0.9	4.9	10.3	0.4	1.0	18.0	5.5	0.3	5.0	13.0	6.3	5.8	6.9	1.8	2.1	0.7	0.9	5.4	24.2	5.5	5.9	3.1	4.0	5.6	3.3	3.3	4.8	2.9	2.8	8.2	5.7	3.1	4.8	2.7	3.4	0.6	0.0	14.3	2.9	1.4	1.9	4.2	29.7	4.2	4.0	0.0	7.6	3.0	8.1	7.3	8.4	1.5	3.5	3.3	3.5	5.4	15.0	0.0	0.0	8.4	3.9	0.0	6.2	3.5	7.5	0.0	0.0	22.9	1.4	3.5	24.7	17.4	10.2	8.9	20.7	0.6	15.7	2.2	1.3	0.0	0.1	11.0	2.6	29.4	22.4	0.0	2.9	3.0	2.1	4.4	1.4	0.0	5.8	2.8	4.3	2.7	5.5	4.3	3.0	2.1	4.2	4.1	0.6	6.5	7.0	0.5	10.4	3.4	6.3	6.1	13.4	6.9	5.8	6.7	5.0	4.9	5.3	5.0	6.9	5.5	0.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	14.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.8	2.6	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	53.8	2.4	0.0	0.0	0.0
H2AX	H2AFX	ENSG00000188486	"H2A.X variant histone"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 43.7;Cytotrophoblasts: 83.2;dendritic cells: 34.0;Extravillous trophoblasts: 106.6;Hofbauer cells: 45.8;Syncytiotrophoblasts: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		Yes	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear speckles"	"CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	13.2	20.7	35.2	12.6	37.8	24.9	8.0	39.0	42.2	13.3	20.6	18.6	13.3	14.0	2.1	43.6	13.1	3.1	13.4	33.7	32.3	17.0	13.9	14.3	16.0	43.9	38.9	18.7	11.6	3.4	24.3	11.0	37.8	15.7	4.3	6.6	11.4	4.7	12.4	18.1	18.8	3.5	38.0	24.0	16.1	15.4	37.8	30.5	10.4	3.6	12.0	11.8	15.7	51.8	132.1	77.9	120.3	72.3	10.9	7.9	126.4	146.0	44.0	80.3	70.4	124.0	55.1	89.7	85.9	34.0	60.5	134.0	57.5	41.7	21.5	133.4	161.0	182.2	20.7	129.8	11.4	90.5	108.9	6.7	9.0	34.2	21.0	13.1	40.7	115.4	149.9	143.1	38.9	335.6	207.8	269.9	87.5	60.0	162.6	200.7	141.6	42.7	37.5	56.3	127.6	152.0	116.0	66.6	20.6	20.6	99.8	68.2	50.9	77.7	204.2	63.8	110.2	38.7	40.8	92.3	17.9	145.2	155.0	3.8	1.3	4.2	1.6	0.6	0.8	0.9	1.7	1.7	1.8	0.8	1.1	1.0	0.6	2.2	0.8	0.8	1.6	1.2	35.2	37.8	39.0	42.2	33.7	32.3	43.9	38.9	37.8	38.0	37.8	51.8	43.7	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	83.2	34.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	106.6	9.4	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	64.2	7.2	0.0	0.0	0.0
H2AZ1	"H2A.Z, H2AFZ, H2AZ"	ENSG00000164032	"H2A.Z variant histone 1"	P0C0S5	4	99948086-99950355	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 621.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 211.4;Cytotrophoblasts: 625.4;Extravillous trophoblasts: 1438.5;Hofbauer cells: 711.2;Syncytiotrophoblasts: 403.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022549, HPA057236"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB022549: , HPA057236: AB_2683377"	"unprognostic (1.21e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.03e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.99e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	104.6	88.6	104.7	193.5	115.0	621.6	120.9	112.0	156.8	116.8	114.4	206.7	149.4	156.0	99.2	220.9	105.5	110.5	98.8	108.9	113.5	137.5	104.4	137.9	348.0	103.2	105.5	130.2	88.3	79.2	110.5	146.0	106.9	123.6	193.6	123.7	122.5	114.6	127.5	140.1	155.3	207.2	110.6	161.6	155.3	150.3	107.4	545.3	88.9	121.7	385.4	165.3	129.5	113.6	1249.7	864.3	1753.9	911.2	354.8	314.7	581.6	1287.6	930.7	1319.4	1229.9	897.5	1422.2	2205.2	451.5	666.0	862.3	442.9	1558.6	1268.1	1566.7	956.4	1088.7	1130.4	974.2	1029.1	212.4	2028.8	914.6	235.3	549.6	1004.5	561.1	369.3	1322.2	1313.0	1133.0	1293.1	1558.8	1751.0	1710.7	1697.0	1013.0	1402.9	822.1	1443.6	1279.6	928.0	741.0	750.1	1142.6	875.9	796.4	1507.4	1509.1	608.7	772.0	1550.7	686.7	841.6	1589.0	578.0	1674.1	736.1	1208.3	2671.0	939.8	1348.6	1342.7	780.2	689.8	1375.4	351.5	788.5	393.9	493.8	580.9	475.6	590.8	419.7	533.4	437.6	1482.5	453.8	1053.0	379.0	868.9	1555.4	104.7	115.0	112.0	156.8	108.9	113.5	103.2	105.5	106.9	110.6	107.4	113.6	211.4	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	0.0	0.0	0.0	0.0	625.4	147.1	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	1438.5	78.5	0.0	0.0	0.0	0.0	0.0	0.0	711.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	403.2	39.0	0.0	0.0	0.0
H2BC10	"H2B/k, H2BFK, HIST1H2BI"	ENSG00000278588	"H2B clustered histone 10"	P62807	6	26272931-26273412	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 2.1;brain: 3.4;choroid plexus: 1.7;lymphoid tissue: 2.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.7;THP-1: 3.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.3	0.0	0.1	0.2	0.3	2.1	0.1	3.4	0.9	0.3	1.7	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.4	0.1	0.1	0.4	0.9	1.4	1.2	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.9	0.4	0.1	0.3	1.5	2.1	0.2	0.0	0.2	0.1	0.4	1.9	1.1	0.4	0.6	0.0	0.0	0.0	0.1	0.5	0.3	0.9	2.5	0.4	0.1	0.5	0.3	0.2	0.4	0.6	0.9	0.2	0.4	1.6	0.0	0.2	0.5	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	1.3	0.0	2.2	0.0	0.3	8.7	1.5	1.6	0.3	0.0	2.3	0.0	2.7	0.0	0.2	0.2	0.5	0.6	0.5	0.0	0.0	0.0	3.7	0.5	0.4	0.0	0.3	1.8	1.9	0.3	0.0	0.5	0.3	1.2	0.0	0.2	0.0	1.2	0.5	0.7	0.7	1.2	1.6	0.2	1.4	0.4	0.3	0.3	0.1	0.0	0.1	0.5	0.1	0.1	0.3	3.4	0.9	0.3	0.4	1.4	1.2	1.4	0.9	1.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H2BC11	"H2B/r, H2BFR, HIST1H2BJ"	ENSG00000124635	"H2B clustered histone 11"	P06899	6	27125897-27132795	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.7;Cardiomyocytes: 3.0;Cytotrophoblasts: 1.5;Extravillous trophoblasts: 6.0;Hofbauer cells: 4.1;Syncytiotrophoblasts: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 16.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.2"	"Cell line enhanced"	"Detected in many"		"K-562: 150.1;Karpas-707: 86.7;SiHa: 134.1;U-2 OS: 137.1;U-266/70: 129.2;U-266/84: 151.8"	"Low region specificity"	"Detected in all"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (4.02e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.3	1.4	3.4	2.3	3.9	9.1	1.9	3.8	5.9	15.0	3.8	5.0	1.4	1.5	3.0	9.5	3.7	1.9	4.1	3.0	4.3	2.4	4.2	9.1	3.1	5.3	4.4	1.3	0.6	0.3	1.0	1.7	6.1	6.9	2.4	0.3	3.2	2.3	6.2	2.9	2.5	2.0	5.3	12.7	4.0	31.9	5.9	7.2	2.7	3.7	2.6	2.5	10.8	8.4	13.4	17.1	5.3	4.6	26.3	1.4	7.0	7.1	3.9	29.7	12.6	14.1	7.7	2.4	22.7	7.8	12.9	9.3	6.5	6.3	15.5	16.2	14.3	4.3	18.2	0.8	2.5	1.7	10.2	11.0	0.7	6.6	2.2	4.2	1.3	6.8	150.1	86.7	8.5	6.9	5.9	8.1	5.8	15.1	15.5	3.1	3.5	16.5	2.8	4.7	35.3	3.5	134.1	8.7	4.2	6.9	0.3	6.4	4.1	7.2	137.1	5.6	3.3	129.2	151.8	35.6	1.9	42.3	3.7	2.3	0.7	1.1	0.5	0.8	0.9	1.9	0.9	0.4	0.5	2.4	0.5	0.6	16.2	1.3	0.3	1.2	3.0	15.9	3.4	3.9	3.8	5.9	3.0	4.3	5.3	4.4	6.1	5.3	5.9	8.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	0.3	0.0	0.0	0.0
H2BC12	"H2BFAiii, H2BFT, HIST1H2BK"	ENSG00000197903	"H2B clustered histone 12"	O60814	6	27146361-27146855	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.4;Hofbauer cells: 1.1;Syncytiotrophoblasts: 3.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 1269.7;SiHa: 771.0;U-2 OS: 949.9;U-266/84: 1355.8"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.78e-2)"	"unprognostic (4.70e-3)"	"unprognostic (9.00e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (3.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-2)"	45.2	28.9	10.3	35.9	13.4	46.4	31.2	8.1	13.1	46.1	15.1	45.7	41.6	35.2	27.7	64.2	59.9	37.7	32.1	12.2	11.1	31.3	94.0	47.1	59.6	13.3	12.3	28.9	60.0	14.8	16.2	44.7	12.9	75.1	26.4	0.4	43.1	21.7	8.5	30.3	44.8	22.1	15.7	66.9	56.0	44.6	13.6	65.7	49.2	6.7	24.2	35.0	42.8	21.6	64.6	153.7	25.7	41.2	116.0	37.0	84.7	118.1	70.5	157.9	99.1	133.1	68.9	28.1	338.6	64.2	94.1	78.3	29.8	35.8	19.7	95.1	201.2	42.0	91.0	4.4	46.2	29.9	183.4	205.0	26.8	29.5	28.1	38.8	27.6	14.1	1269.7	194.4	66.5	166.3	49.1	52.6	20.2	204.6	98.8	27.9	24.2	265.9	55.2	23.4	124.1	74.2	771.0	178.6	56.9	18.9	473.7	29.8	41.6	57.6	949.9	54.0	18.8	293.6	1355.8	207.7	34.7	314.1	34.5	244.6	49.0	329.3	21.6	45.3	19.6	112.1	21.3	21.9	53.1	141.9	25.7	20.4	308.2	28.5	96.3	120.8	65.7	68.3	10.3	13.4	8.1	13.1	12.2	11.1	13.3	12.3	12.9	15.7	13.6	21.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0
H2BC13	"dJ97D16.4, H2B/c, H2BFC, HIST1H2BL"	ENSG00000185130	"H2B clustered histone 13"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.1;brain: 2.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.7;cerebral cortex: 1.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.3;U-266/84: 12.5"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	0.1	0.2	0.3	0.0	0.3	6.1	0.1	2.7	1.6	0.3	0.1	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.5	0.0	0.1	0.3	0.3	0.3	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.4	0.2	0.2	0.3	1.2	0.3	0.0	0.4	0.1	0.2	0.3	2.2	2.0	0.6	2.1	0.0	0.0	0.1	1.3	0.3	1.1	2.8	0.9	1.5	0.8	0.5	0.2	0.6	1.4	0.0	0.2	0.4	1.0	2.9	1.6	2.7	3.5	0.0	2.6	2.1	0.9	0.0	0.0	0.0	0.2	0.6	1.8	2.1	5.2	0.0	5.6	12.3	4.5	1.9	1.5	3.0	2.8	0.0	1.3	0.0	2.0	2.7	1.0	3.5	1.4	0.2	0.2	1.2	0.9	0.5	0.1	1.4	1.1	0.9	2.9	12.5	3.9	0.3	4.7	0.5	0.5	0.3	2.3	0.5	0.1	0.7	1.0	0.3	0.6	0.7	0.6	0.2	0.3	4.1	0.2	0.3	0.4	1.1	0.5	0.3	0.3	2.7	1.6	0.5	0.1	0.0	0.1	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC14	"dJ160A22.3, H2B/e, H2BFE, HIST1H2BM"	ENSG00000273703	"H2B clustered histone 14"	Q99879	6	27815022-27815489	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.5;lymphoid tissue: 3.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 14.8;NB-4: 9.9;REH: 6.2;U-266/70: 12.3;U-698: 5.9"	"Not detected"	"Not detected"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.5	0.0	0.1	0.3	0.5	3.5	0.0	1.2	0.6	1.1	0.2	0.3	0.0	0.1	0.0	0.4	0.0	0.3	0.1	0.4	0.4	0.3	0.2	0.5	1.5	0.4	0.7	0.2	0.0	0.0	0.0	0.1	0.7	0.5	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.6	1.0	0.2	0.4	0.8	3.1	0.2	0.0	1.1	0.0	1.0	1.1	1.5	0.0	0.2	0.0	0.0	0.0	1.0	0.3	0.2	0.3	1.5	0.3	0.2	1.9	0.0	0.0	0.4	0.9	0.0	0.0	0.0	1.1	0.0	0.7	0.2	0.6	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.1	14.8	0.0	0.4	4.0	9.9	2.8	0.9	0.6	6.2	0.0	0.3	0.0	0.0	0.2	1.7	0.6	0.9	0.0	0.1	0.8	3.0	0.0	0.0	1.6	1.0	0.1	12.3	0.5	5.9	0.9	1.0	0.7	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.4	0.3	0.1	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	1.2	0.6	0.4	0.4	0.4	0.7	0.7	0.6	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC15	"H2B/d, H2BFD, HIST1H2BN"	ENSG00000233822	"H2B clustered histone 15"	Q99877	6	27837760-27855709	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.9;Cytotrophoblasts: 11.7;dendritic cells: 4.8;Extravillous trophoblasts: 5.3;Hofbauer cells: 11.3;Plasma cells: 4.4;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 5.5;SCLC-21H: 6.4;U-266/84: 7.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-4)"	"unprognostic (9.62e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.22e-2)"	0.2	1.5	0.3	0.5	0.5	1.0	0.6	2.1	0.5	0.7	0.6	0.4	0.4	0.6	0.8	0.3	0.7	0.3	1.5	0.4	0.3	0.6	0.9	0.5	0.6	0.3	0.2	1.0	1.4	0.6	1.0	0.3	0.4	0.8	0.3	1.7	0.5	0.1	0.9	0.3	0.5	0.2	0.5	0.6	0.4	1.5	0.2	0.6	1.2	0.1	0.2	0.3	0.4	1.7	0.7	0.1	1.1	0.8	0.9	0.2	0.6	0.5	0.3	0.2	0.2	0.2	0.6	0.5	1.8	0.2	0.5	1.1	1.0	0.3	0.2	0.9	2.1	0.6	2.4	0.6	1.0	0.7	1.8	0.9	0.2	0.1	0.4	0.8	0.1	1.0	5.5	3.8	0.6	0.5	1.6	1.9	0.6	0.5	0.5	0.9	0.7	4.1	0.3	0.2	6.4	1.0	2.2	1.0	0.8	0.5	1.7	0.6	1.2	1.3	1.4	0.7	0.3	3.4	7.1	1.5	0.5	0.4	0.5	0.5	1.4	1.0	1.9	1.2	1.1	4.8	1.3	1.3	2.9	3.3	0.9	0.8	8.8	0.8	0.8	4.0	1.8	0.7	0.3	0.5	2.1	0.5	0.4	0.3	0.3	0.2	0.4	0.5	0.2	1.7	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	11.7	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	5.1	1.2	0.0	0.0	0.0
H2BC17	"H2B.2, H2B/n, H2BFN, HIST1H2BO"	ENSG00000274641	"H2B clustered histone 17"	P23527	6	27893425-27893891	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;brain: 2.3;lymphoid tissue: 2.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 36.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (7.22e-2)"	"unprognostic (1.77e-3)"	"unprognostic (9.47e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-7)"	"unprognostic (4.39e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.89e-4)"	0.3	0.1	0.7	0.2	0.3	2.4	0.1	1.1	0.8	0.6	1.3	0.3	0.2	0.1	0.0	0.5	0.0	0.1	0.2	0.2	0.7	0.2	0.4	1.0	0.7	1.2	2.3	0.0	0.0	0.0	0.0	0.6	1.9	0.5	0.3	0.0	0.2	0.0	0.1	0.4	0.2	0.0	0.8	1.3	0.2	0.2	1.8	2.6	0.2	0.0	0.6	0.3	0.8	2.0	2.8	3.0	1.6	5.1	0.7	0.0	3.0	0.9	0.1	5.3	5.1	1.1	1.5	3.2	2.3	0.2	1.3	2.6	2.9	0.5	1.4	2.4	2.0	1.9	4.7	2.1	0.0	0.3	1.4	0.3	0.0	0.4	0.5	0.1	1.4	2.3	7.6	9.1	0.2	1.3	12.9	10.9	1.8	1.8	2.2	7.4	1.7	5.5	1.1	0.4	7.3	1.4	5.8	1.3	0.8	0.6	2.3	0.2	0.0	1.7	0.3	1.8	2.4	9.1	36.0	8.8	1.0	10.2	0.8	0.6	0.1	1.7	0.3	0.2	0.4	0.5	0.3	0.6	1.0	0.9	0.1	0.2	2.6	0.5	0.3	0.7	0.6	2.0	0.7	0.3	1.1	0.8	0.2	0.7	1.2	2.3	1.9	0.8	1.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H2BC18	HIST2H2BF	ENSG00000203814	"H2B clustered histone 18"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 1.4;Fibroblasts: 1.3;Hofbauer cells: 8.5;Syncytiotrophoblasts: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"neutrophil: 30.8"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 30.8"	"Cell line enriched"	"Detected in many"	7	"U-266/70: 49.7"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	10.2	6.7	4.2	1.3	5.0	3.0	5.3	10.0	3.7	36.5	13.1	6.5	0.6	1.1	2.5	9.6	9.7	1.0	7.4	3.4	7.0	8.9	7.2	28.0	0.9	6.0	7.4	35.3	4.7	0.3	5.6	2.2	6.7	30.2	0.9	2.9	6.9	0.9	0.7	17.8	3.3	0.6	5.4	15.8	12.9	3.7	5.5	2.8	6.1	0.5	0.7	6.1	34.7	7.9	0.7	1.0	0.5	1.0	0.6	0.1	0.5	1.0	0.2	0.8	1.0	0.5	1.3	0.7	0.4	0.2	0.8	2.1	0.2	0.0	0.1	2.1	0.7	0.7	3.0	0.1	0.4	0.4	2.7	1.2	0.0	0.4	0.5	0.4	0.1	0.5	1.8	3.8	0.0	1.5	5.2	3.1	0.7	3.6	1.5	0.5	1.7	1.2	0.2	0.2	2.7	0.9	6.6	0.3	0.5	1.0	2.0	0.4	0.0	0.7	0.0	1.1	0.6	49.7	1.7	2.0	1.0	0.5	0.2	0.0	1.4	0.3	0.8	0.5	0.8	0.7	1.1	0.4	0.9	2.1	0.5	0.4	30.8	0.7	0.6	0.8	0.2	0.2	4.2	5.0	10.0	3.7	3.4	7.0	6.0	7.4	6.7	5.4	5.5	7.9	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0
H2BC21	"H2B, H2B.1, H2B/q, H2BE, H2BFQ, HIST2H2BE"	ENSG00000184678	"H2B clustered histone 21"	Q16778	1	149884459-149886652	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 86.5;Syncytiotrophoblasts: 160.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 87.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 58.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 58.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 56.8;U-266/70: 93.7;U-266/84: 53.8"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-3)"	17.8	15.3	35.1	7.2	40.2	21.2	17.7	38.7	38.7	60.8	38.7	22.0	5.2	7.4	22.8	41.7	27.5	5.5	77.3	33.5	37.2	46.3	18.0	37.2	6.2	41.6	38.0	61.7	13.4	9.5	32.5	14.8	39.0	95.2	6.1	69.1	23.5	6.6	62.8	84.0	14.8	6.2	41.0	27.3	32.0	13.7	38.9	20.1	15.2	29.2	3.4	25.1	79.5	55.8	2.8	2.8	4.5	0.9	23.5	6.3	2.2	9.7	6.5	4.0	1.3	1.1	4.4	0.5	2.6	8.6	5.7	10.9	3.6	1.7	2.2	3.4	2.8	0.8	11.5	2.1	7.4	0.8	12.6	21.4	7.9	1.7	6.6	4.8	1.3	4.0	12.0	56.8	5.0	16.8	3.1	5.1	2.8	22.6	5.8	3.6	1.7	13.7	3.8	2.3	30.3	4.9	33.4	4.5	2.7	10.7	23.4	2.4	1.7	3.0	33.6	2.2	0.9	93.7	53.8	2.6	4.0	3.6	1.9	21.3	4.8	8.2	1.3	6.2	2.3	1.5	1.8	2.1	3.3	3.8	2.2	2.2	58.6	1.3	12.3	8.9	2.2	10.1	35.1	40.2	38.7	38.7	33.5	37.2	41.6	38.0	39.0	41.0	38.9	55.8	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0	0.0	25.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	20.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	160.2	0.3	0.0	0.0	0.0
H2BC3	"H2B/f, H2BFF, HIST1H2BB"	ENSG00000276410	"H2B clustered histone 3"	P33778	6	26043227-26043713	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.1;brain: 2.6;lymphoid tissue: 1.1;testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 1.3;Karpas-707: 1.3;MOLT-4: 1.6;NB-4: 1.7;THP-1: 2.0;U-266/84: 2.2"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.92e-2)"	"unprognostic (9.15e-2)"		"unprognostic (3.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.26e-1)"		"unprognostic (6.10e-2)"		"unprognostic (1.03e-1)"		"unprognostic (2.66e-1)"	"unprognostic (2.58e-1)"			0.0	0.0	0.5	0.0	0.5	1.1	0.0	2.1	0.6	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.2	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	1.3	2.6	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.4	0.2	1.3	1.3	0.0	0.0	1.6	1.7	0.7	0.2	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.1	0.1	0.1	0.3	0.3	2.2	0.0	0.2	0.5	0.4	2.6	0.5	0.5	0.8	0.1	2.2	1.4	2.4	0.9	1.9	0.9	1.2	0.5	2.0	0.1	0.2	6.4	1.9	0.3	0.5	0.5	2.1	0.6	0.2	1.3	0.9	1.2	0.9	0.6	2.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H2BC4	"H2B.1, H2B/l, H2BFL, HIST1H2BC"	ENSG00000180596	"H2B clustered histone 4"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	18	"neutrophil: 923.6"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 923.6"	"Cell line enhanced"	"Detected in all"		"K-562: 39.8;SiHa: 75.8;U-2 OS: 51.9;U-266/70: 42.8;U-266/84: 57.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	4.3	3.4	9.5	6.0	17.4	25.0	6.7	11.4	8.8	9.1	9.9	3.1	3.2	1.2	3.6	14.7	7.1	4.6	3.6	10.5	15.0	5.3	13.1	8.0	2.9	20.3	10.9	2.6	2.6	0.9	5.8	7.2	16.3	21.8	2.3	1.5	7.5	0.9	14.5	6.7	3.0	1.2	21.5	5.1	7.0	6.4	9.4	14.9	3.6	8.0	2.3	3.5	10.2	27.6	7.0	4.0	2.1	2.0	1.9	1.1	2.6	6.8	2.5	4.5	3.7	5.6	4.1	2.7	12.5	2.3	3.3	5.2	2.8	2.8	2.2	6.3	2.3	2.2	6.1	9.6	2.6	3.4	8.4	27.3	1.7	1.9	1.1	2.2	1.8	2.1	39.8	21.1	8.6	8.0	7.5	7.2	2.2	7.4	12.4	3.3	3.0	16.3	7.8	1.7	9.4	3.0	75.8	5.8	2.6	5.5	31.8	3.1	5.6	5.5	51.9	3.4	2.8	42.8	57.1	13.2	2.3	8.6	3.8	52.5	9.3	49.9	9.2	10.5	12.4	19.1	13.3	13.0	6.6	35.1	10.3	7.7	923.6	10.5	10.4	22.0	9.3	19.2	9.5	17.4	11.4	8.8	10.5	15.0	20.3	10.9	16.3	21.5	9.4	27.6	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	42.8	0.4	0.0	0.0	0.0
H2BC5	"H2B/b, H2BFB, HIST1H2BD"	ENSG00000158373	"H2B clustered histone 5"	P58876	6	26158146-26171349	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 151.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 22.4;Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 117.9;U-266/84: 134.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	25.4	13.4	17.8	7.6	21.9	53.8	18.5	48.7	19.2	151.7	41.8	34.6	11.0	6.3	27.7	37.6	53.5	15.3	31.4	17.9	29.7	67.2	62.9	36.8	9.2	22.2	23.7	101.8	15.7	2.1	30.5	9.3	28.0	144.0	17.1	9.7	28.9	3.6	18.5	44.1	23.3	4.3	27.5	35.4	26.1	11.3	23.8	35.2	25.2	7.3	4.1	17.9	95.5	33.9	17.9	39.7	12.0	6.8	91.2	8.3	3.6	15.5	8.9	19.6	12.3	13.3	14.5	8.1	95.2	18.5	21.8	27.9	6.8	6.6	9.2	36.6	16.9	5.4	33.7	14.5	9.8	7.2	14.7	59.7	10.3	5.5	7.7	7.6	4.9	7.5	57.1	43.3	3.6	64.2	16.4	18.1	12.6	76.1	18.2	6.5	7.6	54.4	18.7	12.8	38.1	16.1	96.8	25.1	15.9	23.1	63.4	2.6	3.0	24.4	63.4	9.9	3.3	117.9	134.9	20.5	3.1	33.2	5.0	35.3	2.3	16.9	8.1	5.1	10.4	13.4	12.3	13.5	5.6	20.0	11.4	8.7	24.8	10.5	6.9	19.3	8.9	2.4	17.8	21.9	48.7	19.2	17.9	29.7	22.2	23.7	28.0	27.5	23.8	33.9	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	7.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	39.4	0.3	0.0	0.0	0.0
H2BC6	"H2B.h, H2B/h, H2BFH, HIST1H2BE"	ENSG00000274290	"H2B clustered histone 6"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.8;Cytotrophoblasts: 1.0;dendritic cells: 1.8;Extravillous trophoblasts: 1.1;Hofbauer cells: 1.0;Plasma cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 5.3;REH: 5.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.8	0.4	1.6	0.5	2.0	2.7	0.6	3.0	1.5	3.6	3.6	0.7	0.4	0.4	0.4	0.7	0.6	0.4	0.6	1.6	0.3	1.0	0.6	1.3	0.9	1.9	0.8	0.9	0.2	0.1	0.7	0.3	0.4	2.6	0.5	1.1	1.3	0.2	0.8	1.7	0.3	0.2	1.8	0.9	0.8	0.5	0.6	2.9	0.5	0.6	0.6	0.4	2.1	1.5	0.3	2.1	1.9	0.5	1.6	0.2	0.2	1.9	0.6	0.3	0.1	0.5	1.3	0.4	0.8	0.3	0.9	2.7	0.3	0.7	0.3	0.9	0.5	0.2	1.0	0.1	0.1	0.1	1.6	0.4	0.1	0.4	0.1	0.6	0.2	0.5	1.4	1.0	0.0	1.0	3.0	5.3	1.5	1.0	0.5	5.1	0.1	1.5	0.8	1.1	1.5	2.2	2.3	0.8	0.5	0.8	1.6	1.0	0.5	0.8	1.5	0.6	1.2	1.3	2.7	0.3	0.4	0.8	0.3	2.9	0.6	1.0	0.7	0.5	0.5	1.0	0.7	0.9	0.2	1.2	0.6	0.6	2.1	0.6	0.6	1.2	1.1	0.3	1.6	2.0	3.0	1.5	1.6	0.3	1.9	0.8	0.4	1.8	0.6	1.5	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0
H2BC7	"H2B/g, H2BFG, HIST1H2BF"	ENSG00000277224	"H2B clustered histone 7"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 7.4"	"Cell type enhanced"	"Detected in single"		"Hofbauer cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"U-266/70: 24.8;U-266/84: 18.8"	"Low region specificity"	"Detected in all"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.9	0.2	0.6	0.2	1.1	1.2	1.6	4.0	0.9	3.3	1.5	1.4	0.0	0.1	0.0	3.2	1.8	0.2	0.4	0.8	0.6	1.4	0.6	1.7	0.3	1.9	1.7	0.8	0.2	0.0	0.6	0.2	2.4	7.4	0.2	0.6	1.1	0.0	0.0	0.9	0.7	0.0	2.1	2.3	0.7	0.6	1.2	1.7	0.6	0.1	0.4	0.4	4.5	2.4	0.5	0.3	0.2	0.5	0.3	0.0	0.2	0.2	0.1	0.7	0.1	0.7	0.1	0.6	1.0	0.0	0.3	1.0	0.5	0.1	0.3	0.8	0.2	0.4	1.8	0.2	0.1	0.1	0.9	0.3	0.1	0.2	0.1	0.0	0.1	0.5	2.0	4.5	0.0	0.1	4.0	1.6	0.6	0.8	0.6	1.5	0.7	3.0	0.1	0.1	2.4	0.4	4.9	0.9	0.1	0.3	4.4	0.2	0.1	0.3	2.2	0.0	0.6	24.8	18.8	1.3	0.1	1.2	0.5	0.0	0.0	0.6	0.2	0.1	0.6	0.2	0.2	0.3	0.1	1.0	0.2	0.5	2.4	0.2	0.3	0.3	0.2	0.5	0.6	1.1	4.0	0.9	0.8	0.6	1.9	1.7	2.4	2.1	1.2	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0
H2BC8	"H2B.1A, H2B/a, H2BFA, HIST1H2BG"	ENSG00000273802	"H2B clustered histone 8"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 23.9"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 7.3;Extravillous trophoblasts: 7.4;Hofbauer cells: 22.5;Syncytiotrophoblasts: 24.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 9.6;SiHa: 10.5;T-47d: 21.2;U-266/70: 19.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	3.1	0.9	1.5	1.2	1.4	6.7	13.2	8.0	1.8	23.9	4.8	5.9	1.1	0.9	2.0	9.1	4.3	0.9	3.3	1.5	1.9	4.3	3.1	7.5	1.6	1.4	2.2	5.7	1.1	0.1	2.9	1.1	3.6	19.7	2.0	1.6	6.9	0.5	0.1	13.2	3.2	0.4	2.8	7.1	3.7	1.8	1.9	4.1	2.6	0.0	1.4	1.6	18.4	4.6	3.0	0.1	1.4	0.0	4.4	0.2	0.4	3.7	0.3	2.3	0.9	0.4	2.6	0.0	3.7	0.3	1.0	3.2	1.3	1.2	1.3	2.6	1.6	0.8	1.5	1.4	0.7	0.3	2.4	1.7	0.6	0.7	0.1	0.1	0.5	0.1	9.6	0.2	0.0	2.2	2.8	2.1	1.5	7.1	1.9	1.8	0.8	5.4	1.3	0.7	8.5	1.3	10.5	3.8	1.2	3.7	21.2	0.9	0.3	0.0	1.2	0.3	0.5	19.6	0.1	0.0	0.3	1.3	0.7	18.1	1.3	3.2	2.0	0.9	6.4	4.4	3.2	4.0	5.1	5.3	1.5	1.3	5.8	1.4	1.8	16.0	3.0	2.2	1.5	1.4	8.0	1.8	1.5	1.9	1.4	2.2	3.6	2.8	1.9	4.6	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.1	0.2	0.0	0.0	0.0
H2BC9	"H2B/j, H2BFJ, HIST1H2BH"	ENSG00000275713	"H2B clustered histone 9"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;vagina: 4.3"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.7;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 16.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.5	0.2	0.4	0.6	0.4	1.4	0.6	0.3	0.5	1.9	0.8	2.0	3.0	0.4	0.8	4.2	0.8	0.3	0.2	0.3	0.4	0.9	0.2	1.6	0.8	0.8	0.7	0.1	0.0	0.1	0.1	0.2	0.7	3.5	0.8	0.0	1.3	0.0	0.0	0.6	1.7	0.1	0.6	3.7	0.7	0.6	0.7	2.9	1.0	0.1	0.5	0.4	4.3	1.1	1.8	0.1	7.0	0.0	0.0	0.1	1.1	0.9	0.3	1.2	0.6	2.4	1.1	0.0	1.7	0.1	1.8	3.4	0.0	0.6	1.7	0.9	0.1	1.3	6.1	0.4	0.0	0.0	4.0	0.3	0.3	0.4	0.5	0.0	0.3	1.0	2.7	6.2	0.1	2.0	3.8	2.7	1.6	0.0	1.8	4.0	0.0	0.9	0.0	2.7	3.2	2.9	4.2	1.4	0.6	0.3	2.0	3.3	0.0	0.6	0.0	0.7	3.1	16.9	4.5	0.0	0.5	1.5	3.8	3.7	0.2	0.6	0.3	0.0	0.1	0.6	0.2	0.4	0.6	0.3	0.0	0.1	3.0	0.8	0.1	0.2	0.4	5.2	0.4	0.4	0.3	0.5	0.3	0.4	0.8	0.7	0.7	0.6	0.7	1.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	29.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0
H2BS1	H2BFS	ENSG00000234289	"H2B.S histone 1"	P57053	21	43565182-43565648	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;K-562: 1.0;U-2 OS: 1.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"					"unprognostic (1.29e-1)"					"unprognostic (4.33e-3)"				"unprognostic (2.06e-2)"				0.9	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.8	0.1	0.7	0.0	0.9	0.0	1.3	0.7	0.0	0.6	0.1	0.0	0.2	2.0	1.0	0.1	0.1	0.1	0.5	1.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.7	0.0	0.1	0.6	0.8	0.0	0.0	1.6	0.6	1.1	0.1	0.0	0.7	0.0	0.0	0.4	0.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0
H2BU1	HIST3H2BB	ENSG00000196890	"H2B.U histone 1"	Q8N257	1	228458107-228460470	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5;cervix: 4.7;vagina: 3.5"	"Cell type enhanced"	"Detected in single"		"Syncytiotrophoblasts: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"T-47d: 3.0;U-266/70: 15.1;U-266/84: 3.8"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.53e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	0.7	0.7	0.8	0.0	0.5	0.2	0.2	3.5	0.7	4.7	0.1	0.2	0.1	0.1	0.1	1.4	1.0	0.0	0.8	0.4	1.6	0.6	0.1	0.9	0.1	0.9	0.8	0.6	0.1	0.0	0.9	0.0	1.1	0.8	0.0	0.5	0.3	0.0	0.1	1.2	0.3	0.0	0.4	0.8	0.3	0.2	1.9	0.0	0.4	0.0	0.1	0.4	3.5	0.5	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.8	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.6	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.2	0.2	0.0	0.0	0.7	0.0	0.1	1.2	0.4	0.8	0.3	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	15.1	3.8	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.1	0.3	0.2	0.1	0.1	0.8	0.5	3.5	0.7	0.4	1.6	0.9	0.8	1.1	0.4	1.9	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0
H2BW1	H2BFWT	ENSG00000123569	"H2B.W histone 1"	Q7Z2G1	X	104011147-104013687	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA056289, HPA060383"	Uncertain		Supported	Nucleoplasm		NA	NA							Nucleoplasm		"HPA056289: AB_2683087, HPA060383: "						"unprognostic (5.07e-2)"				"unprognostic (1.55e-1)"					"unprognostic (1.15e-1)"		"unprognostic (1.85e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3-3A	"H3.3A, H3F3, H3F3A"	ENSG00000163041	"H3.3 histone A"	P84243	1	226061851-226072019	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 600.6;Cytotrophoblasts: 1411.0;Extravillous trophoblasts: 2181.9;Hofbauer cells: 1487.3;Syncytiotrophoblasts: 1616.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4487.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 4487.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011481, CAB037178, HPA042570"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.74e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (3.66e-2)"	"unprognostic (8.03e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.03e-2)"	409.6	440.4	240.3	662.2	255.8	2033.8	594.8	262.4	343.4	544.2	244.8	708.3	655.2	492.2	721.3	595.8	565.3	487.7	500.1	229.1	252.3	457.9	537.9	438.9	793.5	273.8	247.1	453.0	435.4	499.7	270.0	490.0	274.4	474.8	790.0	271.6	586.9	382.0	337.1	617.2	672.5	468.6	272.4	539.1	547.2	255.9	246.8	1239.6	480.5	435.5	894.6	597.6	409.0	295.7	751.2	417.0	1589.6	910.2	432.9	498.9	1186.2	337.3	416.2	547.8	429.0	446.2	1214.5	715.3	731.0	427.9	273.5	684.4	802.4	631.9	535.0	445.9	1371.0	889.5	569.9	595.2	427.8	901.4	1026.6	465.6	715.8	385.3	502.1	743.0	826.8	915.7	1271.3	1125.2	626.2	433.8	1791.8	1504.6	2163.0	1881.1	815.7	1286.9	1110.4	1871.4	1159.6	784.3	1542.1	2279.8	991.0	1227.4	842.4	882.3	1399.1	2103.7	471.4	397.1	527.2	532.6	1024.0	523.6	643.4	1178.4	380.2	853.2	874.1	869.5	1043.6	1486.1	378.9	830.2	385.9	722.1	405.2	415.8	791.8	661.7	375.0	423.1	4487.2	442.5	945.8	635.2	636.8	1364.8	240.3	255.8	262.4	343.4	229.1	252.3	273.8	247.1	274.4	272.4	246.8	295.7	600.6	0.0	0.0	0.0	202.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.0	1411.0	449.2	0.0	0.0	0.0	0.0	0.0	0.0	109.5	0.0	0.0	0.0	0.0	2181.9	188.0	0.0	0.0	0.0	0.0	0.0	0.0	1487.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.8	0.0	0.0	0.0	0.0	1616.9	75.3	0.0	0.0	0.0
H3-3B	"H3.3B, H3F3B"	ENSG00000132475	"H3.3 histone B"	P84243	17	75776434-75785893	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 4220.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1321.3;Cytotrophoblasts: 1625.3;dendritic cells: 844.9;Extravillous trophoblasts: 1626.9;Hofbauer cells: 1908.9;Syncytiotrophoblasts: 3503.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 21089.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 21089.7"	"Low cell line specificity"	"Detected in all"											"CAB037166, CAB037187, CAB037221, HPA042570"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056"	"unprognostic (1.66e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-1)"	607.2	369.9	223.8	532.5	262.6	4220.9	628.9	264.4	288.8	741.2	186.6	415.4	329.9	507.4	180.3	798.6	585.7	467.9	312.8	210.7	226.0	438.3	380.2	553.2	509.1	268.7	241.9	1166.0	578.0	341.1	357.5	427.1	242.8	348.2	223.1	299.8	519.2	237.1	332.5	1153.2	407.5	322.9	253.7	449.9	393.0	654.3	246.0	464.0	500.7	155.6	296.2	545.3	675.2	316.1	1386.5	1194.2	490.0	486.1	273.3	424.9	675.1	636.7	557.1	764.8	609.3	1290.7	952.6	683.6	593.1	373.2	539.5	530.0	390.5	881.0	432.0	375.9	883.0	612.8	668.2	1112.0	615.7	1029.2	755.0	467.3	534.2	785.6	1004.7	339.3	582.5	437.8	885.6	1193.0	399.4	2015.3	1492.3	859.5	394.8	442.8	1322.8	1091.7	894.2	746.6	607.3	803.5	988.1	1096.0	645.8	933.7	1402.2	259.3	734.2	1091.3	549.1	1359.7	1205.2	595.2	1721.1	1431.3	932.2	843.5	720.5	967.6	761.1	7991.0	3667.6	10060.5	2613.4	3365.8	2482.2	3199.5	2474.2	2478.9	3218.1	2813.7	2635.4	2173.4	21089.7	3240.7	3199.0	3294.6	2999.0	9615.0	223.8	262.6	264.4	288.8	210.7	226.0	268.7	241.9	242.8	253.7	246.0	316.1	1321.3	0.0	0.0	0.0	294.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	398.6	0.0	0.0	0.0	0.0	1625.3	844.9	0.0	0.0	0.0	0.0	0.0	0.0	172.3	0.0	0.0	0.0	0.0	1626.9	485.1	0.0	0.0	0.0	0.0	0.0	0.0	1908.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	257.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	314.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	377.9	0.0	0.0	0.0	0.0	3503.3	211.7	0.0	0.0	0.0
H3-4	"H3.4, H3/g, H3FT, H3t, HIST3H3"	ENSG00000168148	"H3.4 histone"	Q16695	1	228424845-228425360	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 1.6;choroid plexus: 1.1;testis: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001386, CAB003812, HPA042570"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"			Nucleoplasm		"CAB001386: , CAB003812: AB_365490, HPA042570: AB_2678056"	"unprognostic (4.45e-1)"				"unprognostic (4.66e-2)"			"unprognostic (1.36e-1)"		"unprognostic (3.78e-3)"	"unprognostic (1.75e-2)"		"unprognostic (4.04e-2)"	"unprognostic (1.39e-2)"			"unprognostic (2.26e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.7	0.2	1.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.7	0.1	0.1	0.8	0.2	0.8	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H4-16	"HIST4H4, MGC24116"	ENSG00000197837	"H4 histone 16"	P62805	12	14767999-14771131	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.7;Cytotrophoblasts: 1.0;dendritic cells: 2.6;Hofbauer cells: 1.6;Syncytiotrophoblasts: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 24.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 4.7;HeLa: 3.7"	"Low region specificity"	"Detected in all"							"CAB011503, CAB037279, HPA042201"	Supported		Supported	Nucleoplasm		NA	NA		25000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: AB_2677898"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-3)"	0.4	1.0	4.5	1.2	12.0	0.6	0.9	3.8	6.0	2.0	2.9	0.7	1.2	0.8	1.8	2.2	1.5	1.4	0.8	1.9	12.1	0.7	0.4	0.8	1.5	6.4	5.9	1.2	1.2	0.2	0.5	1.7	4.2	4.3	1.2	1.2	1.4	0.9	0.5	1.7	1.0	0.6	5.4	1.9	2.7	1.7	15.9	1.4	1.7	0.0	1.2	0.8	1.1	4.9	1.3	0.5	0.0	1.5	1.6	0.0	0.9	0.8	0.0	0.6	0.5	0.8	4.7	1.2	0.3	0.4	0.0	0.8	0.0	0.6	0.3	1.5	0.6	0.0	3.7	1.2	0.4	0.3	1.1	1.1	0.3	0.1	0.6	0.0	0.0	0.4	0.0	1.5	0.0	0.6	0.3	0.4	1.6	0.4	0.2	1.3	0.0	2.3	0.0	3.4	0.5	0.8	3.1	0.8	0.2	0.3	0.5	0.6	1.0	0.2	2.4	0.6	1.0	1.6	1.1	3.6	1.1	0.0	0.8	0.0	2.5	0.3	2.3	2.4	4.1	5.3	2.7	2.6	2.7	5.7	2.4	2.8	24.1	3.0	1.0	4.6	4.0	1.6	4.5	12.0	3.8	6.0	1.9	12.1	6.4	5.9	4.2	5.4	15.9	4.9	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0
HACL1	"2-HPCL, HPCL, PHYH2"	ENSG00000131373	"2-hydroxyacyl-CoA lyase 1"	Q9UJ83	3	15560699-15601852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 117.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 117.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035496, HPA035497, HPA073760"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Nucleoplasm	"HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633"	"unprognostic (6.64e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (5.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.62e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.07e-2)"	14.4	12.0	7.5	8.2	7.8	11.6	14.6	10.4	10.5	9.1	7.9	10.0	56.6	8.3	16.6	7.5	10.8	8.8	11.0	7.6	7.0	26.0	51.8	9.7	14.1	7.4	7.2	7.5	15.2	20.0	7.8	7.8	7.0	10.8	12.0	12.2	9.1	9.1	17.6	10.6	27.7	9.5	7.4	11.4	13.2	26.7	6.8	13.9	20.4	10.6	14.5	10.3	6.4	10.0	15.1	28.6	8.2	30.7	13.4	12.4	82.3	14.2	22.0	26.6	26.3	27.3	14.3	14.6	9.7	18.7	10.5	10.4	18.7	25.3	23.8	13.6	36.4	25.4	17.7	24.7	20.3	30.5	23.1	13.7	16.2	37.9	16.6	8.3	31.4	18.3	24.0	21.2	22.9	28.7	14.0	12.6	19.7	19.7	29.7	14.4	21.5	19.6	26.4	20.2	9.6	12.3	22.4	19.0	25.2	12.8	8.5	25.4	22.5	14.1	14.6	17.4	24.7	27.2	50.9	28.5	27.1	26.4	17.2	117.3	16.0	18.3	14.4	20.1	21.2	15.4	15.5	18.0	16.0	21.2	14.8	16.1	3.4	24.1	24.2	10.2	19.8	13.0	7.5	7.8	10.4	10.5	7.6	7.0	7.4	7.2	7.0	7.4	6.8	10.0	12.4	9.6	17.3	34.9	22.1	10.3	12.0	13.5	20.5	19.3	9.1	10.2	6.4	14.3	15.6	11.0	29.2	27.2	15.7	6.1	13.7	16.0	66.6	12.6	6.0	12.3	9.1	8.2	67.4	25.2	18.0	12.0	11.2	5.4	13.3	12.7	8.9	24.3	13.2	13.5	55.8	7.5	10.2	9.3	8.1	56.8	23.3	8.8	12.4	25.3	19.3	24.8	8.2	40.7	38.8	14.5	11.2	15.4	21.4	9.0	41.9	39.7	29.8	38.3	6.6	9.0	11.2	51.1	24.4	8.6	7.1	18.9	19.4	15.1	10.6	7.9
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478227	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 24.3;intestine: 66.1"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 2.8"	"Region enriched"	"Detected in single"	4	"thalamus: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"SH-SY5Y: 119.5;SuSa: 212.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040925, HPA075313"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA040925: AB_10796563, HPA075313: "			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.2	4.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.1	3.7	0.0	0.0	0.0	0.0	0.5	24.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	14.3	12.3	0.0	0.0	0.0	0.3	1.5	0.1	0.0	0.0	0.0	7.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	119.5	0.0	0.0	0.0	212.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	15.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0
HAND2	"bHLHa26, dHand, Hed, Thing2"	ENSG00000164107	"Heart and neural crest derivatives expressed 2"	P61296	4	173524969-173530229	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 60.5"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 100.3;Endometrial stromal cells: 317.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.5;stomach cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"SH-SY5Y: 410.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019591, CAB025576"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Vesicles	"CAB025576: , HPA019591: AB_2670199"	"unprognostic (4.11e-2)"	"unprognostic (7.50e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-1)"		"unprognostic (3.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.39e-3)"	4.9	28.0	0.0	5.4	0.0	0.0	2.1	0.5	0.0	22.2	0.0	60.5	2.5	33.4	0.3	1.0	16.0	16.2	36.8	0.0	0.0	0.1	5.5	0.0	0.2	0.0	0.0	15.3	4.1	0.0	0.1	20.9	0.2	1.3	4.4	0.0	0.8	1.0	0.2	1.5	11.0	27.3	0.0	1.1	22.1	0.4	0.0	0.4	1.5	1.1	0.8	12.4	5.3	0.0	0.0	0.1	0.0	0.0	16.6	7.7	0.3	2.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	17.3	0.0	0.1	1.7	0.0	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	410.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	4.1	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.2	0.0	0.1	0.1	100.3	2.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.6	0.2	9.0	317.1	2.7	0.0	0.0	0.0	0.4	1.4	30.4	0.0	5.3	0.0	0.0	6.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	2.3	0.9	39.4	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.9	0.1	0.3	0.2	0.3	2.3	1.3	0.6	0.0	0.0
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723991	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 49.6;ovary: 20.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 26.6;Bipolar cells: 20.3;Cholangiocytes: 38.6;Fibroblasts: 64.2;Suprabasal keratinocytes: 17.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"eosinophil: 2.5"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 112.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	49.6	0.5	1.4	6.3	1.1	3.6	1.3	1.1	1.1	0.1	0.0	2.8	0.1	1.0	0.0	0.8	9.0	5.5	9.2	0.9	2.0	0.5	0.6	3.7	0.0	1.8	0.8	20.8	2.1	0.3	0.9	0.3	0.7	0.2	0.5	0.2	0.2	0.0	0.2	5.4	1.3	0.7	0.3	0.3	1.7	0.3	2.2	0.1	0.7	0.0	0.0	6.3	0.6	1.3	0.0	0.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	3.2	0.0	27.0	0.0	0.1	0.0	0.0	0.0	0.2	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.3	0.8	0.0	0.0	0.0	0.0	112.6	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	1.1	1.1	1.1	0.9	2.0	1.8	0.8	0.7	0.3	2.2	1.3	1.5	0.0	1.8	0.0	0.2	26.6	0.1	0.8	0.6	20.3	0.0	0.0	1.3	38.6	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.5	0.0	0.0	1.7	0.0	0.2	64.2	2.6	0.0	2.5	0.0	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.8	9.0	0.2	0.3	8.3	8.8	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.5	0.0	3.1	10.6	0.1	0.5	0.4	17.8	0.1	0.3	0.0	0.0	0.2
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 5.3;testis: 7.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027422: AB_10601812, HPA030698: AB_2673575"	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	0.2	0.1	0.0	1.8	0.2	6.0	0.4	0.0	0.1	0.2	0.2	1.1	1.5	0.2	0.1	1.3	0.3	0.2	0.1	0.0	0.0	0.1	0.1	1.4	4.2	0.1	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	1.0	0.0	0.4	0.0	0.6	0.7	1.8	0.4	0.0	1.7	0.9	7.3	0.2	5.3	0.3	0.1	5.1	0.3	0.5	0.2	11.3	12.2	11.1	12.5	0.7	1.4	9.3	10.2	7.8	19.7	19.3	9.6	4.6	27.7	5.7	5.7	7.9	18.0	20.1	9.9	18.7	0.1	16.7	13.8	9.9	5.8	0.5	8.1	13.7	0.9	0.8	14.9	9.2	2.4	9.1	21.6	12.4	23.7	10.1	5.9	16.4	4.8	9.8	8.7	8.3	16.8	13.9	7.4	3.0	7.8	4.4	6.5	8.9	6.1	3.5	9.6	6.1	7.5	4.7	8.7	9.9	9.8	18.1	4.5	5.4	13.4	5.1	11.5	10.7	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.2	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
HAT1	KAT1	ENSG00000128708	"Histone acetyltransferase 1"	O14929	2	171922448-171983686	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036788, CAB037191"	Supported		Supported	Nucleoplasm		NA	NA		27000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037191: AB_477070, HPA036788: AB_10672267"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.39e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.69e-2)"	27.7	27.0	14.3	33.5	15.5	59.8	41.4	15.9	19.2	26.8	15.3	27.7	19.9	24.6	16.7	26.6	24.4	24.6	31.4	13.1	16.2	32.2	30.2	25.7	48.7	15.0	14.6	23.2	30.0	37.9	16.9	30.6	15.5	29.0	30.7	28.8	32.8	24.0	67.7	23.8	21.7	29.3	16.1	27.7	23.6	20.1	15.5	50.7	32.8	50.8	47.5	39.0	19.6	17.3	132.4	61.5	106.6	98.8	55.2	56.8	75.2	133.9	88.9	144.4	149.9	144.3	88.2	147.0	85.0	81.5	122.7	101.3	116.7	109.5	220.5	83.5	115.8	131.1	91.5	131.0	26.7	165.5	77.9	34.2	62.2	191.0	63.6	45.5	92.6	100.4	136.5	93.1	166.5	91.8	131.1	148.3	89.0	158.9	63.9	102.8	134.4	99.4	85.3	130.2	67.8	55.4	112.4	62.4	118.1	81.5	86.4	164.5	47.5	129.8	99.2	109.5	137.1	40.9	100.5	173.8	87.6	117.8	113.8	47.6	35.3	53.7	32.8	42.0	40.6	35.5	34.9	34.0	27.4	30.7	33.9	37.6	40.3	44.6	59.2	14.3	49.2	34.0	14.3	15.5	15.9	19.2	13.1	16.2	15.0	14.6	15.5	16.1	15.5	17.3	55.6	35.3	28.9	13.7	49.7	74.2	117.7	129.7	46.1	24.2	36.4	42.3	49.5	25.8	66.2	27.6	33.3	77.5	43.5	19.0	82.2	45.2	70.3	33.1	32.3	43.2	14.3	103.1	28.6	46.5	83.1	43.7	15.8	28.9	40.6	30.7	28.9	20.1	51.8	28.6	45.3	20.9	111.9	29.5	36.3	14.7	30.7	34.5	32.0	16.9	28.8	53.4	43.3	21.6	28.0	27.8	21.0	36.9	50.8	52.0	18.2	46.0	65.4	42.0	39.5	43.8	51.3	65.7	67.5	28.8	52.7	58.3	49.0	43.9	29.4	64.1
HAUS2	"C15orf25, CEP27, FLJ10460, HsT17025"	ENSG00000137814	"HAUS augmin like complex subunit 2"	Q9NVX0	15	42548828-42569994	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039965	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA039965: AB_10673025"	"unprognostic (5.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.81e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-3)"	7.9	5.7	5.5	5.8	5.8	36.5	7.5	5.8	9.5	4.7	4.2	5.8	4.8	6.0	5.5	6.4	4.7	4.6	5.8	6.2	5.8	5.3	5.4	7.0	8.1	6.1	5.6	5.4	6.6	4.5	4.2	6.4	6.2	4.2	5.9	5.4	5.0	3.8	7.2	6.2	5.4	6.7	5.8	5.4	4.9	5.0	5.8	8.9	5.1	5.8	7.9	7.0	4.7	7.6	23.6	12.0	21.5	13.7	10.9	12.3	20.3	22.9	13.9	21.8	17.1	24.5	11.8	13.8	11.1	13.4	18.6	34.6	23.7	15.2	21.5	19.4	13.3	20.0	19.7	19.0	15.6	34.2	14.5	10.6	11.1	16.2	17.7	9.2	22.0	19.2	36.2	17.5	21.3	14.1	21.4	28.5	16.8	31.9	15.3	27.9	26.4	15.0	12.6	16.4	17.8	14.8	23.2	20.6	13.2	15.6	18.7	22.4	17.1	28.7	21.4	39.0	43.8	18.7	61.1	40.0	18.5	38.0	21.6	4.0	4.3	3.9	4.4	5.3	4.5	6.0	4.4	3.7	3.9	5.1	3.3	4.5	1.9	2.9	7.5	4.5	5.2	2.8	5.5	5.8	5.8	9.5	6.2	5.8	6.1	5.6	6.2	5.8	5.8	7.6	17.5	12.8	14.4	5.5	19.4	13.6	20.9	10.9	18.2	7.8	8.6	8.0	4.2	14.3	11.6	3.7	16.7	14.5	17.7	7.1	3.9	14.2	35.2	10.9	12.3	14.6	17.3	31.1	11.6	16.5	27.6	12.9	12.2	10.4	24.6	9.0	7.9	9.7	21.7	16.8	9.3	10.6	8.2	18.5	23.6	7.3	11.1	19.0	1.8	9.4	19.6	9.7	10.3	11.6	10.4	18.8	11.2	11.3	20.1	20.2	8.7	13.3	15.8	16.3	19.7	16.5	12.4	34.0	9.6	23.2	15.3	13.4	21.1	14.0	10.8	17.1
HBZ	"HBZ-T1, HBZ1"	ENSG00000130656	"Hemoglobin subunit zeta"	P02008	16	142728-154503	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.9;testis: 7.3"	"Group enriched"	"Detected in some"	4	"Erythroid cells: 82.9;Hofbauer cells: 192.0;Late spermatids: 275.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	80	"K-562: 2189.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063268, HPA064073, HPA071726"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		80000000		"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA063268: , HPA064073: , HPA071726: AB_2732184"					"unprognostic (3.56e-1)"				"unprognostic (1.32e-1)"									0.6	0.0	0.5	0.0	0.4	3.9	0.6	0.2	0.8	0.5	0.8	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.5	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.6	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.1	7.3	0.2	0.0	0.1	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.1	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	27.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2189.0	0.2	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.8	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.4	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.5	0.7	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	40.0	0.0	0.1	3.7	0.0	82.9	0.5	0.0	42.4	1.8	0.0	0.0	0.0	0.1	0.4	0.0	192.0	0.0	0.3	0.0	0.0	0.3	0.3	275.5	0.6	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	6.6	1.9	4.8	1.3	1.8	0.0	0.1	10.4	0.1	0.0	0.1	0.0
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947557-153971818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA078588	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA078588: "	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	18.8	25.5	18.4	15.5	16.9	40.2	17.1	14.9	22.5	21.9	10.3	29.7	11.4	33.6	8.5	25.1	24.3	7.6	23.1	19.7	14.1	22.1	23.8	21.6	19.0	16.6	16.8	25.5	21.1	11.4	33.9	8.7	15.2	23.5	7.0	7.2	19.2	12.8	28.4	18.6	25.3	11.1	13.6	32.8	24.8	17.9	16.8	26.1	21.1	10.5	12.1	23.6	19.8	17.1	45.3	57.7	38.4	48.9	15.8	11.2	56.3	18.2	14.0	21.1	19.1	61.5	29.8	81.6	45.3	23.6	34.6	36.4	41.8	29.7	11.0	43.6	49.2	49.0	47.7	48.8	10.8	60.9	77.8	17.6	19.1	36.8	15.9	12.7	22.7	58.2	69.4	50.2	15.0	63.0	84.6	78.2	50.0	29.4	35.1	97.5	31.6	49.3	16.0	41.4	42.5	46.2	33.7	34.4	19.4	18.4	31.7	54.4	30.2	39.9	49.0	35.0	59.4	79.1	117.0	100.2	32.5	58.6	38.6	0.9	2.1	0.9	3.0	3.1	2.1	2.4	2.4	2.3	2.4	2.4	2.4	3.4	0.4	1.5	2.2	4.2	1.7	2.3	18.4	16.9	14.9	22.5	19.7	14.1	16.6	16.8	15.2	13.6	16.8	17.1	19.1	19.2	17.8	7.5	21.9	16.6	13.4	15.5	20.5	21.0	24.6	18.7	35.9	20.0	13.6	12.9	14.6	16.5	26.8	20.1	3.9	17.4	0.6	16.7	18.4	21.2	19.2	39.9	8.4	16.5	21.3	17.7	19.9	21.6	3.8	25.0	15.7	29.5	21.3	20.2	8.3	23.2	8.2	35.2	13.8	1.8	17.4	26.0	5.4	9.4	28.6	13.6	17.5	8.0	7.2	19.5	13.3	21.8	32.0	25.7	12.6	8.8	13.4	12.4	6.6	21.8	21.2	11.3	25.0	28.9	13.9	15.9	22.8	14.3	23.9	20.5
HCFC1R1	"FLJ20568, HPIP"	ENSG00000103145	"Host cell factor C1 regulator 1"	Q9NWW0	16	3022625-3024286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 511.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 396.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 376.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059647	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059647: AB_2684094"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.03e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.23e-1)"	82.6	98.5	174.5	20.9	178.9	17.9	74.8	164.1	248.1	124.9	129.3	131.5	30.4	140.6	29.2	59.0	81.7	43.1	138.7	172.0	182.0	180.5	48.2	72.0	24.2	181.5	182.7	86.7	44.0	40.9	97.7	32.1	185.2	102.8	18.8	21.6	50.6	87.4	511.6	76.3	53.1	47.5	154.0	45.9	65.6	36.6	181.0	17.0	68.0	196.2	18.3	85.2	103.0	174.1	59.6	175.6	32.5	38.1	123.0	160.9	33.4	26.0	115.0	57.8	161.2	37.9	75.8	49.2	66.1	108.3	52.8	81.0	32.7	121.5	26.3	62.7	88.4	21.3	132.2	65.5	105.2	37.3	39.5	205.7	73.9	62.1	63.4	376.5	81.5	33.0	30.4	81.6	63.3	63.0	20.1	53.0	70.5	34.7	36.5	70.1	31.3	124.6	209.4	13.7	57.3	48.4	54.7	70.7	78.5	77.5	48.6	28.1	35.5	98.4	256.8	85.8	50.7	53.0	59.1	40.7	42.9	22.1	23.8	5.3	36.3	16.3	20.1	28.2	19.3	23.2	25.5	21.7	44.9	21.7	18.5	22.9	8.0	25.8	26.5	22.1	36.7	17.9	174.5	178.9	164.1	248.1	172.0	182.0	181.5	182.7	185.2	154.0	181.0	174.1	51.3	57.7	15.0	17.9	30.7	85.4	58.0	123.7	92.2	29.3	45.2	80.0	45.8	47.1	37.4	198.6	6.2	116.2	23.7	53.7	240.7	49.7	5.2	38.0	56.0	38.3	43.7	37.0	19.3	26.5	120.7	98.4	34.1	45.3	40.0	26.1	60.3	45.9	117.9	20.2	19.8	40.9	40.7	57.5	57.0	15.8	96.3	42.2	64.0	13.1	51.0	52.6	39.1	6.6	19.0	26.7	55.4	178.3	35.0	37.8	114.2	396.2	28.4	28.1	124.9	39.7	149.2	15.2	44.3	69.5	65.8	53.9	35.0	26.7	45.9	41.3
HCFC2	HCF-2	ENSG00000111727	"Host cell factor C2"	Q9Y5Z7	12	104064531-104106524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 250.3;Spermatocytes: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006227	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA006227: AB_1079042"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.23e-2)"	6.3	6.7	3.8	3.6	5.2	2.7	5.1	4.4	5.4	7.4	2.0	9.2	5.2	7.9	5.0	6.2	5.3	5.7	5.1	3.7	4.2	5.7	7.3	4.7	4.6	4.9	5.0	7.8	6.0	6.7	4.1	6.4	4.8	7.2	4.3	8.0	4.5	9.4	9.7	4.4	5.0	7.2	4.7	5.1	5.2	9.5	4.6	5.2	6.9	11.2	3.7	5.9	6.0	6.6	2.0	2.3	2.3	2.0	12.7	12.5	1.7	9.1	4.1	6.8	3.9	1.1	0.9	2.1	3.1	7.1	2.5	2.2	2.9	1.6	7.3	3.5	2.8	2.1	2.3	1.0	8.5	1.7	3.3	7.8	4.3	4.2	3.5	9.8	5.3	3.1	2.5	4.2	12.3	1.8	3.1	4.0	0.5	1.3	4.7	2.5	7.6	1.3	3.1	1.4	3.3	2.5	4.4	3.2	3.5	1.5	5.0	1.9	8.0	10.7	1.4	5.6	3.1	5.3	1.7	1.8	5.1	2.3	4.4	0.4	0.6	0.9	0.8	1.1	0.9	0.5	0.7	0.9	0.7	0.5	0.8	0.9	0.1	0.8	1.8	0.4	0.9	0.5	3.8	5.2	4.4	5.4	3.7	4.2	4.9	5.0	4.8	4.7	4.6	6.6	19.3	12.8	14.1	18.9	10.0	8.0	6.6	5.4	8.6	19.6	6.1	5.0	12.5	1.5	9.6	5.5	20.9	5.0	8.8	7.4	9.8	6.2	250.3	7.9	18.5	14.4	8.4	7.4	31.8	3.3	5.0	16.0	6.6	6.5	17.1	9.8	15.7	11.5	7.4	23.5	33.9	4.7	8.2	11.4	5.7	59.4	21.8	8.6	7.2	16.9	9.3	13.7	7.2	30.7	45.6	3.1	6.0	27.8	12.2	2.7	7.7	8.6	10.4	22.2	13.1	18.7	17.4	130.9	16.4	8.5	7.2	10.8	11.3	17.9	3.8	3.3
HDAC1	"GON-10, HD1, KDAC1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292083-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	31.4	42.8	20.8	76.7	22.1	59.3	56.0	21.9	28.0	56.6	20.3	119.5	74.5	48.1	51.4	81.3	56.8	55.4	29.0	20.4	21.9	47.9	41.7	41.2	119.7	23.3	21.8	65.7	40.0	62.3	31.6	53.0	23.1	57.6	108.3	18.9	52.1	57.2	15.3	38.0	80.8	46.8	21.8	61.7	84.1	36.2	22.0	103.9	78.4	17.5	123.9	63.7	51.7	23.4	152.5	90.6	57.4	114.7	32.9	39.0	118.7	105.1	117.1	138.0	126.6	168.0	266.3	233.4	190.3	116.9	140.2	173.1	178.1	143.1	151.5	219.3	176.8	161.3	105.7	130.1	77.4	288.1	223.4	70.7	77.0	107.1	70.3	107.7	106.1	298.5	215.2	90.1	61.6	115.7	331.6	161.4	133.2	180.2	229.6	225.0	136.0	104.0	149.5	216.1	44.7	56.6	176.0	117.0	227.9	224.0	137.9	220.6	123.8	91.3	106.2	28.5	261.1	54.4	124.9	319.2	75.3	235.8	121.4	147.5	87.7	200.1	130.0	115.9	107.5	151.6	126.2	140.6	103.0	142.0	143.7	133.6	63.7	144.2	156.4	64.9	142.0	204.6	20.8	22.1	21.9	28.0	20.4	21.9	23.3	21.8	23.1	21.8	22.0	23.4	45.3	25.6	45.4	25.5	82.7	24.9	57.4	99.1	38.7	15.1	35.1	29.1	22.1	61.5	73.4	68.0	16.7	93.1	64.0	142.4	95.9	75.7	20.2	33.7	39.8	56.2	86.3	60.8	1.9	73.6	110.9	25.8	65.2	39.5	30.4	23.6	63.5	28.1	43.6	11.8	8.8	122.8	52.9	38.2	19.0	8.7	41.0	35.0	28.4	16.9	52.7	34.2	69.0	14.6	19.4	92.5	141.5	44.4	38.4	28.5	57.0	30.0	67.3	14.6	59.2	22.8	38.1	72.5	69.8	60.2	25.4	93.4	73.6	102.6	136.0	55.8
HDAC2	"KDAC2, RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Supported	Nucleoplasm		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"prognostic unfavorable (7.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.39e-10)"	"unprognostic (2.03e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-1)"	35.9	42.7	26.6	37.4	31.5	63.4	54.8	32.8	40.0	45.2	22.3	48.0	34.4	57.3	53.4	43.3	48.7	34.6	41.1	26.7	34.7	46.3	34.6	33.0	42.6	31.2	29.5	53.4	37.1	45.7	35.9	56.1	31.2	47.0	53.6	37.2	34.3	45.3	48.6	46.1	36.7	54.3	28.8	35.9	40.5	76.7	31.1	68.5	45.6	43.4	52.1	63.2	37.5	37.5	126.7	84.9	387.1	224.3	97.7	110.5	162.6	146.6	119.0	168.5	200.1	226.3	90.1	103.6	119.0	132.5	173.1	96.6	266.0	148.1	281.4	148.9	185.0	249.2	102.1	131.8	129.7	256.1	107.7	90.0	97.6	180.0	167.2	164.4	199.6	179.2	326.4	101.6	282.7	105.5	231.9	229.6	220.0	133.4	116.3	155.0	193.0	95.2	174.4	148.9	258.3	219.1	115.9	107.5	127.7	231.4	78.6	294.0	163.2	107.0	122.9	113.7	246.9	80.6	113.9	244.6	90.9	242.6	185.3	43.5	39.0	42.1	28.0	38.6	37.3	37.0	34.0	30.3	51.0	31.4	41.8	39.1	23.1	39.8	50.2	44.2	36.0	37.2	26.6	31.5	32.8	40.0	26.7	34.7	31.2	29.5	31.2	28.8	31.1	37.5	40.2	57.7	57.8	13.4	51.4	192.1	91.3	152.6	85.4	31.0	61.0	54.6	64.0	25.8	116.4	53.3	4.2	157.7	42.6	43.5	43.0	154.9	86.8	74.3	91.6	73.8	100.5	129.4	29.9	105.0	140.7	76.2	53.5	63.2	55.1	103.9	50.0	31.9	102.0	15.2	26.3	73.4	175.0	64.1	89.8	109.1	83.0	63.3	83.6	26.2	107.7	30.9	33.0	29.1	34.0	133.6	51.3	67.4	56.2	90.0	37.4	71.7	98.7	28.1	39.5	94.7	88.0	199.0	215.5	96.5	193.1	207.7	45.5	53.9	94.6	100.5
HDAC3	"HD3, KDAC3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636849	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	24.3	39.8	7.8	22.7	8.4	37.3	25.3	7.8	9.5	25.7	9.9	23.3	18.7	23.5	26.4	34.1	26.5	20.3	24.4	8.7	8.4	24.2	39.6	21.4	32.7	8.2	8.0	26.0	28.4	44.9	18.4	22.4	7.9	20.6	24.5	16.4	25.5	21.9	40.2	40.8	23.5	26.1	8.5	27.8	23.3	15.8	8.5	38.3	24.1	34.1	42.7	26.2	25.8	8.2	59.8	40.2	74.0	109.5	68.5	54.3	47.0	42.6	93.5	94.8	134.8	86.5	49.7	86.4	54.0	56.2	67.3	51.2	72.9	98.8	117.0	74.6	79.0	68.8	33.3	50.4	48.1	83.5	60.1	47.0	63.2	55.3	71.3	49.6	61.9	76.8	67.6	44.7	61.5	55.8	92.1	72.9	63.9	36.8	31.0	65.8	76.2	62.3	49.9	59.7	60.2	49.4	57.0	57.1	71.7	46.2	61.8	52.3	32.1	58.3	36.1	45.8	71.8	36.6	47.8	82.1	48.8	78.6	50.8	41.3	51.7	39.6	34.1	53.8	45.5	47.8	42.5	41.9	107.5	47.5	45.9	38.5	21.5	35.1	46.8	55.1	55.6	43.8	7.8	8.4	7.8	9.5	8.7	8.4	8.2	8.0	7.9	8.5	8.5	8.2	19.1	9.6	13.2	16.6	36.0	44.2	26.8	38.1	37.0	33.2	29.0	25.5	15.9	18.6	19.6	12.9	60.5	55.3	43.8	18.5	21.5	33.4	10.4	10.0	21.0	21.3	18.0	50.7	40.6	35.4	51.6	28.8	19.9	10.2	18.4	33.9	21.4	18.7	38.8	50.5	38.2	19.7	28.5	19.5	44.9	4.2	22.4	31.7	32.0	10.3	51.1	33.3	38.1	22.1	21.9	33.4	16.3	22.2	36.3	28.7	19.5	20.5	10.8	36.5	26.3	18.1	24.7	25.4	27.5	38.1	51.4	61.2	30.3	42.6	25.9	30.3
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 58.2"	"Group enriched"	"Detected in many"	4	"Astrocytes: 62.0;Early spermatids: 69.9;Excitatory neurons: 118.1;Inhibitory neurons: 84.9;Late spermatids: 59.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 85.5;Oligodendrocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 32.0;neutrophil: 47.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 47.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 49.1;MOLT-4: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.33e-4)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	4.4	6.3	9.3	5.0	12.0	17.0	3.8	0.6	13.4	7.5	0.1	29.0	2.7	9.1	2.5	8.0	6.7	7.1	5.2	9.0	6.5	3.7	2.4	3.9	3.5	9.9	6.1	7.5	3.7	2.7	6.5	1.5	11.2	5.6	3.4	2.4	3.3	5.9	58.2	5.9	7.2	6.2	2.3	5.6	7.2	9.2	6.7	9.7	4.2	35.6	2.5	10.0	4.5	10.1	3.2	5.8	4.1	6.1	4.5	3.9	5.9	3.0	2.3	2.3	1.7	2.9	7.5	2.0	1.9	3.4	3.6	3.4	4.0	2.0	1.4	12.8	1.8	3.1	5.1	5.8	3.8	5.5	4.6	4.4	2.6	4.6	3.3	2.3	2.4	49.1	3.7	4.5	2.7	4.7	48.1	10.7	4.0	6.0	2.8	7.6	7.2	4.0	5.3	4.4	4.6	6.4	5.3	2.5	16.2	2.6	1.0	17.9	1.9	5.0	0.4	6.8	4.6	3.3	3.2	3.1	6.9	6.9	7.4	32.0	10.2	2.3	1.0	3.3	1.2	0.2	1.1	1.0	1.0	0.1	0.5	0.5	47.7	3.2	1.7	0.6	1.7	1.1	9.3	12.0	0.6	13.4	9.0	6.5	9.9	6.1	11.2	2.3	6.7	10.1	8.6	3.2	7.4	62.0	5.2	7.9	2.9	3.0	8.6	12.2	6.2	4.8	13.3	7.2	2.9	11.0	2.1	1.5	12.8	4.1	0.0	2.8	69.9	7.0	15.1	7.1	6.0	6.1	118.1	2.2	1.7	14.0	7.7	7.4	2.5	6.6	11.7	6.7	3.2	16.8	84.9	5.2	2.0	17.2	10.0	59.0	11.8	10.3	5.4	38.4	14.9	8.6	15.5	85.5	124.0	1.9	1.6	12.4	7.0	6.4	5.0	1.6	2.6	7.1	0.0	18.7	6.5	2.8	3.3	11.1	9.7	1.4	12.2	4.9	6.4	2.7
HDAC6	"FLJ16239, HD6, JM21, KIAA0901, PPP1R90"	ENSG00000094631	"Histone deacetylase 6"	Q9UBN7	X	48801377-48824982	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003714, CAB004236, HPA026321"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546"	"unprognostic (9.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (3.34e-4)"	21.9	26.0	26.6	14.2	30.7	22.9	23.6	31.1	54.2	29.6	29.8	27.8	17.8	26.8	10.6	24.4	28.2	11.1	26.0	26.7	33.0	57.9	97.3	25.2	15.6	32.6	32.7	32.5	26.3	22.3	45.6	13.8	33.9	24.4	16.1	27.9	21.6	12.2	26.1	21.4	28.0	15.3	28.9	29.4	26.6	53.8	30.6	18.8	27.1	16.1	15.1	23.7	22.8	31.0	31.0	25.7	49.6	19.1	20.2	16.6	33.4	14.4	12.4	27.2	26.2	24.9	25.7	29.9	13.8	17.1	34.6	21.3	30.6	15.5	23.2	27.7	19.1	40.7	32.2	26.0	18.3	19.2	60.4	25.7	25.1	21.5	25.3	24.8	23.5	37.4	45.9	31.9	17.7	10.9	27.0	29.3	18.5	14.2	24.5	23.1	53.5	31.3	15.8	13.3	25.9	25.3	29.5	8.7	17.4	63.4	36.1	17.5	19.1	21.5	26.7	29.3	14.2	29.6	31.3	21.3	21.3	24.0	21.5	0.0	5.1	5.8	4.7	8.3	3.4	3.7	3.3	3.4	7.6	5.3	3.1	2.9	2.5	3.6	11.7	8.3	4.0	4.9	26.6	30.7	31.1	54.2	26.7	33.0	32.6	32.7	33.9	28.9	30.6	31.0	11.4	19.2	25.1	20.9	12.5	7.5	10.2	8.8	6.2	37.6	10.7	10.4	10.6	8.6	17.5	18.4	50.1	11.5	12.6	21.4	19.6	7.9	48.1	10.0	13.0	10.3	14.4	11.4	15.2	7.4	12.3	10.7	21.9	13.2	6.3	22.5	13.6	51.9	11.1	40.4	18.4	15.5	10.2	12.3	9.8	18.4	14.0	13.2	5.4	10.3	12.7	21.9	18.6	17.1	19.0	7.2	13.2	11.3	12.8	7.1	17.8	47.6	12.4	34.0	13.1	15.5	11.1	88.4	41.7	8.6	5.8	9.7	9.7	21.8	16.2	7.2
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 47.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 244.6;Excitatory neurons: 376.2;Inhibitory neurons: 442.3;Microglial cells: 334.5;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 233.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 74.1"	"Group enriched"	"Detected in all"	9	"B-cells: 52.6;dendritic cells: 74.1;monocytes: 24.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 163.6;hTERT-HME1: 79.4;SH-SY5Y: 65.7;U-698: 64.5;WM-115: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (2.06e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	8.2	12.3	5.8	8.8	6.6	5.9	5.1	4.8	7.9	10.1	47.5	5.4	3.4	13.2	6.0	2.9	9.3	6.7	14.3	5.5	3.8	2.8	2.8	5.1	18.9	6.0	6.7	2.4	1.5	1.8	6.5	6.3	6.0	11.0	5.5	25.4	7.1	14.5	16.7	2.2	4.5	13.0	3.8	17.5	8.7	5.6	12.9	6.8	2.9	5.8	18.7	5.2	4.9	7.3	40.2	0.2	6.3	0.1	0.9	8.4	0.2	2.4	23.0	9.5	16.1	0.3	12.7	16.7	41.9	26.0	51.6	5.8	163.6	3.2	24.2	0.2	1.1	0.0	0.2	0.0	0.2	3.5	0.1	3.0	3.1	29.7	79.4	8.4	0.4	2.7	0.0	25.1	13.3	0.0	1.6	3.5	20.3	0.0	3.9	4.7	2.5	10.2	5.2	10.6	11.6	65.7	0.5	0.3	12.7	9.7	0.6	15.2	1.8	34.4	11.1	1.9	22.3	28.8	13.3	64.5	9.0	1.6	69.2	0.3	24.4	0.1	4.2	16.5	4.1	52.6	1.4	2.0	74.1	43.2	0.0	2.1	1.4	5.5	10.3	15.9	5.6	12.9	5.8	6.6	4.8	7.9	5.5	3.8	6.0	6.7	6.0	3.8	12.9	7.3	31.4	6.4	2.8	28.1	46.1	2.4	0.7	6.8	6.2	33.0	1.4	0.8	15.2	0.0	12.9	0.0	16.7	0.1	16.3	15.3	3.9	6.8	244.6	24.2	2.3	16.5	7.2	5.7	376.2	0.7	0.2	5.3	13.7	26.1	1.3	0.0	8.9	1.0	12.9	20.2	442.3	0.7	4.1	51.2	64.2	80.1	1.5	34.8	16.0	334.5	21.0	5.1	11.3	322.7	233.1	10.6	6.7	0.7	46.7	1.6	0.0	0.1	17.5	26.2	6.6	2.3	9.0	34.3	8.7	0.7	2.0	0.1	7.8	0.1	0.3	12.1
HDDC2	"C6orf74, CGI-130, dJ167O5.2"	ENSG00000111906	"HD domain containing 2"	Q7Z4H3	6	125219962-125302078	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 338.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035677	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		44000	"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA035677: AB_10603768"	"unprognostic (8.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.54e-2)"	47.4	84.4	58.0	20.1	65.9	19.7	42.1	59.5	98.5	47.2	78.4	38.8	20.3	36.2	29.6	49.7	37.0	15.1	82.3	60.8	64.5	75.6	22.9	31.9	27.1	65.1	66.8	41.1	44.5	49.4	50.0	15.7	63.0	38.5	22.1	31.5	45.8	23.8	118.1	39.0	30.6	13.6	60.8	27.6	43.7	58.7	61.6	22.2	40.3	60.7	24.8	39.2	39.5	60.7	29.7	81.2	46.2	191.3	23.0	30.8	59.7	36.4	41.4	30.9	33.1	122.7	30.4	119.9	80.8	57.4	89.0	26.5	53.1	41.1	36.5	46.7	166.8	55.2	43.6	125.1	65.0	76.6	45.3	56.0	61.8	49.6	104.6	44.6	20.2	67.8	205.1	51.4	59.5	162.7	61.2	73.8	57.7	79.9	58.8	92.8	37.2	25.2	68.7	34.1	84.0	44.5	43.9	84.8	88.8	35.4	50.2	126.6	18.2	37.7	44.5	58.8	75.8	72.1	48.2	110.1	56.0	122.6	80.4	13.8	33.4	6.7	53.3	30.6	43.8	71.2	57.7	72.6	36.1	59.4	71.3	78.2	7.3	62.1	29.0	38.3	55.7	44.0	58.0	65.9	59.5	98.5	60.8	64.5	65.1	66.8	63.0	60.8	61.6	60.7	23.0	25.6	41.2	22.5	39.3	44.6	64.3	114.9	70.6	62.6	73.5	114.4	119.9	37.1	55.3	62.5	14.6	86.6	56.0	35.0	338.5	86.0	61.3	50.9	60.7	24.2	64.5	33.4	17.1	98.0	156.4	67.5	33.6	37.5	38.0	84.8	9.3	21.3	112.2	69.0	17.9	76.4	77.3	54.2	20.4	42.1	91.0	34.6	80.0	15.0	31.7	90.5	155.5	19.1	10.6	58.5	45.3	114.7	47.4	101.9	72.3	254.8	38.9	25.0	39.5	83.9	72.6	124.5	74.6	88.6	43.0	45.7	47.6	145.8	84.1	57.9
HDDC3	"MESH1, MGC45386"	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929968-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	13.0	13.1	15.5	7.9	15.1	10.4	9.2	15.0	20.0	6.5	13.9	11.2	10.3	4.3	8.2	5.9	10.4	4.6	13.3	15.1	14.8	12.1	11.4	6.4	8.2	15.1	14.8	6.5	20.0	15.7	8.0	7.0	14.7	7.0	9.1	7.1	20.7	5.8	13.3	7.7	11.9	3.9	15.3	9.3	9.7	4.5	16.1	7.4	9.8	14.6	9.2	5.5	5.5	15.7	12.7	15.7	5.3	6.4	11.8	11.8	9.0	8.5	11.4	7.7	11.5	7.7	25.5	24.2	8.5	7.0	6.1	19.3	11.1	19.3	6.3	30.4	24.4	30.5	6.0	17.7	23.9	11.6	14.1	10.5	30.1	13.9	24.8	12.2	17.0	19.5	24.6	20.7	6.9	19.1	16.1	10.0	4.3	47.2	15.6	13.2	2.1	38.2	15.8	13.2	13.3	8.5	7.1	19.2	21.4	11.0	29.2	30.5	9.8	4.7	10.5	8.1	10.9	33.5	41.4	16.7	17.5	22.4	14.3	10.1	20.1	8.5	23.3	27.4	30.1	35.1	30.0	26.3	27.4	31.4	34.6	25.5	4.7	31.5	26.7	44.0	31.9	25.6	15.5	15.1	15.0	20.0	15.1	14.8	15.1	14.8	14.7	15.3	16.1	15.7	42.8	28.9	7.4	5.9	23.5	5.6	14.1	22.5	6.8	13.8	27.8	30.1	1.1	44.3	21.6	16.5	4.2	48.2	19.1	18.1	76.3	42.3	4.6	18.8	12.4	19.0	19.9	34.3	4.8	56.5	33.0	12.7	13.7	18.6	7.0	14.3	15.7	41.4	45.9	15.2	5.2	32.9	12.2	15.1	10.9	4.3	14.3	19.6	14.2	1.9	36.3	39.9	34.0	1.0	3.9	28.4	30.2	11.7	31.7	14.7	59.7	71.5	20.6	38.8	6.6	13.2	11.5	29.6	38.4	17.2	8.4	24.2	21.4	21.7	33.0	13.5
HDGF	HMG1L2	ENSG00000143321	"Heparin binding growth factor"	P51858	1	156742109-156766925	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"DNA-binding, Growth factor, Heparin-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026035, HPA048728, HPA053422"	Enhanced		Enhanced	Nucleoplasm	"Secreted to blood"	NA	NA		790000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146"	"unprognostic (2.80e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (9.06e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.43e-8)"	"unprognostic (9.80e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (9.84e-4)"	"unprognostic (2.45e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.86e-2)"	96.3	89.7	95.9	72.8	98.8	305.3	90.6	98.4	113.4	91.4	98.0	109.2	130.2	77.6	70.0	186.3	112.8	62.5	119.0	92.8	95.1	135.4	222.3	113.5	64.6	106.3	99.7	86.8	93.2	92.8	67.8	71.8	98.8	81.7	118.1	68.9	96.6	56.8	234.9	155.3	128.4	70.5	100.8	77.2	99.1	42.6	99.6	157.2	90.7	132.5	114.9	106.7	102.7	105.7	491.5	249.1	258.2	125.6	150.0	203.0	296.8	158.4	406.3	366.8	234.4	279.4	500.9	335.5	310.6	325.0	158.6	338.8	408.9	365.0	356.0	276.1	299.9	278.1	339.4	241.2	202.0	411.9	227.4	152.4	335.7	292.8	560.4	278.6	272.4	249.6	387.0	260.4	293.7	369.3	345.5	459.2	472.1	755.4	347.7	384.8	156.9	435.1	401.0	162.6	396.9	432.0	380.4	480.3	199.3	319.8	387.6	621.9	242.4	181.1	286.5	230.3	408.9	364.0	486.0	555.6	238.9	318.4	235.2	6.2	9.9	9.2	6.6	8.8	4.9	5.6	5.6	5.9	11.6	6.6	5.0	4.7	5.6	5.2	10.0	11.9	8.2	6.8	95.9	98.8	98.4	113.4	92.8	95.1	106.3	99.7	98.8	100.8	99.6	105.7	51.9	70.5	99.2	12.1	35.3	147.3	185.1	90.5	76.2	66.7	89.9	66.0	91.0	98.7	75.3	71.7	27.1	44.1	72.4	121.4	80.3	112.2	48.4	144.0	79.2	66.1	124.6	217.8	12.0	132.0	107.3	66.7	62.7	91.8	30.4	67.4	35.0	164.5	52.7	53.8	12.4	104.3	48.8	45.6	89.1	47.0	40.7	71.0	39.2	14.0	57.3	71.4	25.7	5.5	16.1	165.7	59.5	45.9	59.0	281.3	138.2	118.1	126.8	34.9	19.7	70.9	57.8	27.7	28.3	108.6	159.4	54.9	50.5	83.2	114.9	228.6
HDGFL1	"dJ309H15.1, Hdgfrp1, HRP-1, PWWP1"	ENSG00000112273	"HDGF like 1"	Q5TGJ6	6	22569566-22571666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	215	"testis: 91.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 130.5;Late spermatids: 120.2;Spermatocytes: 165.6"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 21.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045679, HPA063707"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045679: AB_2679415, HPA063707: AB_2685099"						"unprognostic (1.55e-1)"									"unprognostic (6.18e-2)"		"unprognostic (4.03e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.2	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	165.6	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HDGFL2	"Hdgfrp2, HRP2"	ENSG00000167674	"HDGF like 2"	Q7Z4V5	19	4472297-4502208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 37.0;Endometrial stromal cells: 31.0;Extravillous trophoblasts: 30.1;Granulosa cells: 44.7;Theca cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042559, HPA044208"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA042559: AB_2678049, HPA044208: AB_2678858"	"unprognostic (1.33e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.47e-3)"	"unprognostic (6.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.73e-3)"	"unprognostic (4.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	27.2	29.0	24.8	16.5	25.5	14.4	28.1	24.2	32.3	42.9	17.8	40.4	15.7	39.3	9.6	29.4	35.6	10.0	32.0	27.4	20.5	31.2	31.3	25.4	17.7	22.9	22.2	49.5	26.9	12.5	38.3	15.0	22.0	36.4	7.6	10.8	26.0	18.6	67.8	29.3	27.0	12.6	19.7	33.4	28.1	74.6	22.2	18.6	29.3	19.1	11.8	34.2	34.8	24.6	71.6	41.2	70.1	65.5	29.9	30.3	49.0	56.2	30.1	60.4	53.3	47.5	30.4	62.6	32.1	41.6	31.8	40.2	46.9	51.1	35.2	70.4	74.7	38.6	32.4	63.5	38.5	38.3	52.8	43.5	27.4	41.6	20.2	42.8	55.9	57.8	45.1	76.3	29.6	50.6	86.9	76.4	80.2	28.5	73.3	85.4	57.6	40.6	38.0	35.8	77.0	76.1	54.7	31.0	47.2	38.1	30.6	60.2	74.8	38.0	51.7	72.3	54.1	94.1	52.9	43.6	53.2	60.8	41.1	0.0	0.9	1.7	0.6	0.6	0.1	0.5	0.7	0.5	0.7	5.6	1.1	0.4	0.2	1.3	0.3	1.0	1.0	0.5	24.8	25.5	24.2	32.3	27.4	20.5	22.9	22.2	22.0	19.7	22.2	24.6	25.5	6.4	5.4	0.0	2.3	0.0	0.0	0.0	0.0	0.0	13.3	15.2	0.0	0.0	5.0	12.9	0.0	37.0	14.3	0.0	19.6	26.4	0.0	26.9	31.0	9.8	0.0	0.0	0.0	19.8	30.1	13.9	0.0	19.8	1.3	44.7	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	15.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	2.3	0.0	0.0	23.6	9.5	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	15.2	7.1	42.7	0.0	0.0
HDGFL3	"Hdgfrp3, HRP-3"	ENSG00000166503	"HDGF like 3"	Q9Y3E1	15	83112738-83207823	"Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 96.9;Breast glandular cells: 34.3;Endometrial ciliated cells: 34.2;Endometrial stromal cells: 48.4;Granulosa cells: 41.4;Theca cells: 48.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040719	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA040719: AB_2677097"	"unprognostic (1.28e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.93e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.85e-1)"	6.3	5.9	11.1	2.9	12.0	2.4	5.6	11.6	14.9	5.0	7.2	7.0	1.2	6.0	8.3	3.6	4.7	4.0	5.7	11.8	11.5	4.8	0.8	5.1	2.9	10.5	10.5	5.0	1.7	17.7	6.8	3.0	10.5	4.9	2.6	8.5	2.4	4.6	2.5	2.0	2.9	5.3	11.1	3.4	2.9	9.7	11.8	4.3	6.5	2.5	2.2	5.6	3.8	10.7	7.2	6.2	17.9	9.3	7.4	10.1	5.9	6.7	11.9	7.0	7.3	0.5	13.2	0.1	8.0	1.8	7.5	2.9	19.9	10.3	10.1	33.5	10.2	11.6	3.0	0.1	10.3	0.4	1.8	6.0	8.4	8.0	13.9	10.8	17.0	12.4	9.0	0.3	13.2	7.4	7.1	0.7	13.3	0.0	3.5	0.1	17.4	0.1	10.5	14.6	22.5	17.1	10.1	2.4	8.9	12.9	2.8	1.3	14.7	14.5	10.8	3.0	20.9	2.1	0.8	8.6	6.7	5.5	10.0	0.7	0.3	1.0	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.8	1.8	0.1	0.2	0.0	0.1	11.1	12.0	11.6	14.9	11.8	11.5	10.5	10.5	10.5	11.1	11.8	10.7	96.9	12.8	17.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	34.3	27.3	0.0	0.0	10.5	20.2	0.0	0.3	14.1	0.0	15.6	21.1	0.0	34.2	48.4	25.8	0.0	0.0	0.0	22.9	0.6	15.4	0.0	25.6	5.1	41.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	23.6	0.0	0.0	3.1	0.0	0.0	0.3	9.5	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.3	3.5	48.1	0.0	0.0
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065970-50107272	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: AB_2683762"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	7.1	8.2	3.8	9.0	3.7	5.6	5.3	4.6	4.2	5.1	4.3	7.0	4.9	5.0	4.5	8.0	4.8	4.2	6.4	3.7	3.6	6.7	10.2	6.3	6.6	4.2	3.2	3.3	8.0	4.8	6.5	5.8	3.4	4.9	6.3	4.8	6.0	3.4	12.0	6.3	7.0	5.3	3.2	12.6	6.6	5.8	3.8	4.6	3.7	6.2	6.2	5.1	5.1	3.9	13.0	12.8	11.8	18.6	7.0	9.6	12.6	15.5	10.1	15.0	6.0	15.9	9.4	24.4	10.9	14.7	5.6	15.1	14.1	11.3	17.2	6.1	15.4	12.1	9.0	20.4	10.2	21.1	23.5	7.5	7.8	10.4	6.2	6.6	12.2	12.6	15.5	3.9	14.9	7.8	16.2	26.4	13.8	15.5	13.1	17.6	15.8	19.8	8.4	10.4	15.1	8.0	14.8	18.9	10.0	8.8	8.5	15.4	16.1	12.0	8.0	9.1	11.8	9.8	8.0	21.3	11.7	20.9	12.0	0.5	2.4	0.5	0.9	2.8	1.0	0.6	0.5	1.0	1.7	0.8	0.8	0.9	0.5	0.7	2.6	1.5	0.9	1.0	3.8	3.7	4.6	4.2	3.7	3.6	4.2	3.2	3.4	3.2	3.8	3.9	4.2	3.2	5.8	7.8	4.6	3.2	1.4	1.5	3.4	7.8	3.1	2.0	6.0	2.8	1.8	1.8	16.7	3.5	7.1	3.3	7.9	2.4	10.7	3.7	6.8	4.6	3.5	3.8	21.2	3.1	3.6	4.7	7.7	3.8	1.3	6.5	1.8	9.6	9.4	1.7	16.7	3.2	4.1	22.2	4.7	18.3	3.4	13.9	1.8	7.5	13.3	2.4	3.1	20.1	12.8	2.9	2.5	2.2	7.2	1.9	4.7	4.1	2.8	8.1	0.0	2.5	4.2	5.3	4.8	7.6	1.7	1.0	5.8	6.7	5.8	1.5
HEBP1	"HBP, HEBP"	ENSG00000013583	"Heme binding protein 1"	Q9NRV9	12	12974870-13000265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 242.9"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 837.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056417, HPA075277"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		290000	"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Nucleoplasm	"HPA056417: AB_2683122, HPA075277: AB_2686741"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.28e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.45e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.43e-2)"	72.5	108.1	43.1	21.0	49.6	57.9	66.6	48.0	46.0	54.8	47.3	44.5	242.9	43.8	17.4	42.6	49.9	41.4	58.5	40.9	46.0	69.1	145.8	54.6	28.2	52.5	46.5	80.0	75.9	50.2	27.8	34.6	49.9	42.4	21.7	15.2	43.7	36.8	39.3	59.6	165.7	38.7	49.9	58.5	45.1	29.8	46.8	19.5	122.6	37.7	21.4	51.2	50.3	53.5	74.2	46.2	29.3	54.8	229.6	167.6	20.5	65.0	91.0	60.2	79.7	29.8	26.6	21.2	25.2	128.8	51.9	64.7	37.6	54.2	69.1	3.0	30.0	12.0	51.0	74.2	159.1	22.3	11.3	134.7	47.9	80.7	101.9	187.0	124.3	25.1	13.6	19.4	103.9	48.1	18.3	34.9	42.5	71.5	30.0	40.2	85.3	22.1	50.8	74.1	16.6	14.8	85.6	41.1	86.5	84.2	21.3	33.6	140.2	45.7	53.1	72.6	36.2	16.4	14.4	7.9	73.2	38.5	18.8	15.6	65.7	17.2	9.6	49.4	13.5	11.5	16.5	10.4	51.2	11.8	20.6	12.1	21.0	18.7	69.8	25.3	9.7	25.9	43.1	49.6	48.0	46.0	40.9	46.0	52.5	46.5	49.9	49.9	46.8	53.5	120.1	54.5	21.3	2.0	14.9	37.5	56.2	38.3	39.9	43.0	73.3	95.8	26.7	115.8	19.8	57.0	4.2	36.2	14.5	56.5	99.7	89.5	33.8	8.6	27.4	80.4	20.4	174.4	1.5	100.3	27.1	68.6	28.5	14.6	1.3	31.6	162.4	121.7	82.0	6.7	1.7	45.3	18.3	85.4	43.1	13.0	89.2	53.7	62.2	0.0	78.1	44.2	10.3	4.5	3.5	71.1	90.5	94.0	8.0	79.8	837.6	93.0	7.0	6.7	52.6	35.7	40.8	13.8	7.5	44.5	36.1	26.3	14.5	84.3	93.6	54.3
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 218.4"	"Cell type enhanced"	"Detected in all"		"Urothelial cells: 302.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	43.0	48.6	27.8	23.1	33.6	54.0	37.6	58.6	33.7	43.5	34.0	38.3	25.1	37.0	30.7	74.6	33.8	26.7	47.2	27.2	30.9	37.0	74.3	32.9	28.7	30.2	30.1	38.5	34.7	56.5	34.4	35.5	32.5	30.7	31.2	66.9	42.6	31.0	218.4	50.8	33.6	30.8	28.0	30.4	43.7	42.7	31.3	26.3	51.3	133.6	37.3	39.8	51.5	36.6	95.1	54.6	49.2	30.4	144.0	77.2	44.7	54.8	54.1	47.4	39.7	41.0	47.8	72.1	57.8	97.3	34.0	62.6	63.2	47.7	69.6	44.5	24.9	75.6	44.3	163.9	66.9	81.8	52.7	66.3	64.4	52.2	80.9	63.6	87.5	42.2	54.4	32.1	72.8	72.4	31.8	31.7	36.0	76.6	47.5	53.6	58.0	30.4	71.3	93.2	36.2	40.8	79.8	54.5	49.0	56.3	58.7	49.5	93.4	56.6	42.9	41.9	49.0	34.3	52.9	79.0	28.0	37.3	49.7	9.1	5.7	8.3	4.5	4.8	5.2	4.8	5.2	4.1	6.4	6.3	4.2	4.3	3.0	6.3	3.8	5.3	5.6	2.4	27.8	33.6	58.6	33.7	27.2	30.9	30.2	30.1	32.5	28.0	31.3	36.6	63.4	48.1	80.8	84.5	60.7	86.7	93.5	61.2	48.3	98.9	40.8	28.6	108.1	25.8	94.8	71.7	98.0	70.2	72.1	40.9	11.7	44.2	3.6	101.6	83.0	60.0	48.7	41.2	89.9	36.1	42.9	59.9	96.8	118.1	32.9	81.6	46.4	84.7	29.0	65.6	101.1	33.0	63.1	43.9	34.5	8.7	69.0	54.0	33.8	90.9	65.1	40.9	78.2	100.0	127.9	52.6	33.9	74.4	71.1	106.3	37.1	22.4	148.4	194.5	46.0	77.4	78.9	50.6	100.0	83.7	114.9	140.0	61.4	97.0	44.5	302.9
HECTD2	FLJ37306	ENSG00000165338	"HECT domain E3 ubiquitin protein ligase 2"	Q5U5R9	10	91409280-91514829	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 127.5;Inhibitory neurons: 99.4;Microglial cells: 60.0;Oligodendrocyte precursor cells: 87.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 29.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	HPA037767	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA037767: AB_10671378"	"unprognostic (6.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.37e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (6.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.84e-2)"	6.6	5.8	6.9	3.7	7.7	1.6	7.3	8.1	8.7	9.0	2.2	8.3	3.0	12.0	11.3	5.3	9.4	7.9	6.0	7.2	5.2	7.1	3.2	6.9	3.4	3.5	3.6	11.8	5.3	7.5	6.9	7.3	1.9	16.8	5.0	11.7	5.7	16.4	5.8	4.6	4.6	12.6	3.3	3.8	5.5	7.0	5.3	3.8	6.7	7.2	2.3	8.2	7.4	6.8	5.8	2.9	29.0	12.0	6.2	6.8	5.2	4.7	6.2	9.2	8.5	0.3	5.4	0.0	3.9	4.8	5.4	0.4	7.9	3.3	11.3	6.3	9.8	3.4	23.1	1.8	3.1	0.7	2.1	7.0	2.9	6.7	5.7	13.0	7.0	7.1	4.5	14.6	14.5	2.7	3.6	1.8	12.1	0.5	2.9	9.0	19.1	3.5	6.5	1.6	6.8	7.2	9.1	2.0	9.4	8.8	13.2	2.0	7.3	9.2	6.3	0.6	8.9	1.0	2.0	8.2	8.1	0.1	5.4	0.0	0.0	0.0	0.4	0.4	0.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.0	2.8	0.1	0.0	0.0	0.2	6.9	7.7	8.1	8.7	7.2	5.2	3.5	3.6	1.9	3.3	5.3	6.8	9.4	0.0	5.1	45.4	3.5	6.1	8.8	3.6	8.6	20.6	6.3	8.4	7.9	4.3	6.0	5.5	27.1	0.4	1.2	1.1	21.5	2.7	2.8	6.8	14.2	8.9	9.0	1.3	127.5	3.7	0.4	12.8	7.1	7.3	3.8	7.8	8.2	1.2	6.5	28.6	99.4	2.7	4.1	7.0	6.5	2.0	12.2	7.0	7.2	60.0	2.3	13.1	0.0	87.0	21.2	2.5	1.4	14.3	4.5	4.9	0.5	1.4	7.2	9.1	13.1	15.8	10.5	9.5	9.5	8.4	4.4	0.4	3.0	4.5	1.2	4.3
HECTD4	"C12orf51, FLJ34154, KIAA0614"	ENSG00000173064	"HECT domain E3 ubiquitin protein ligase 4"		12	112160188-112382439	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 141.8;Excitatory neurons: 190.4;Inhibitory neurons: 180.0;Oligodendrocyte precursor cells: 109.1;Oligodendrocytes: 138.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041062, HPA045473"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA041062: AB_2677281, HPA045473: AB_2679338"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.51e-3)"	6.7	6.5	6.3	3.1	6.1	14.2	6.8	15.6	6.9	10.0	3.4	11.3	2.0	9.5	4.0	11.0	8.4	3.1	6.8	5.9	2.0	7.5	7.6	7.8	3.8	1.0	0.8	8.5	8.8	6.1	11.7	4.1	1.3	10.5	3.6	10.8	7.9	4.0	8.0	10.7	7.6	4.2	0.4	7.6	10.0	6.8	1.2	6.5	13.5	5.6	4.1	8.8	9.7	6.7	5.1	9.2	7.7	6.1	8.7	7.4	3.2	3.2	3.6	4.8	4.0	8.6	1.3	5.2	3.2	6.7	5.4	4.6	10.8	4.3	3.9	7.0	9.4	8.6	10.7	3.8	2.6	6.1	6.3	4.7	4.8	7.3	5.1	8.7	7.7	9.6	10.2	3.9	4.5	4.4	6.7	7.7	3.3	5.7	7.1	8.3	4.2	3.3	2.4	8.8	12.8	8.0	9.2	7.5	2.8	7.2	5.3	6.7	11.0	5.2	4.0	5.7	4.6	11.8	5.7	6.5	4.1	3.3	2.9	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.0	0.0	6.3	6.1	15.6	6.9	5.9	2.0	1.0	0.8	1.3	0.4	1.2	6.7	14.7	19.2	20.8	96.9	15.7	11.5	8.4	8.3	18.8	54.3	15.1	11.7	20.1	12.8	9.4	12.9	141.8	10.9	15.2	14.6	0.0	8.0	7.0	23.9	25.9	14.2	27.6	47.4	190.4	8.7	5.2	11.2	23.9	32.2	8.2	17.9	15.7	15.2	6.6	80.8	180.0	14.2	8.2	11.1	6.7	6.3	11.5	12.6	7.2	66.5	11.1	17.7	14.4	109.1	138.8	10.3	9.0	15.8	15.8	12.8	9.2	5.6	16.0	53.8	0.0	19.3	14.6	25.0	7.8	22.1	14.9	8.9	12.9	12.4	14.0	9.0
HELB		ENSG00000127311	"DNA helicase B"	Q8NG08	12	66302493-66343643	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 32.8;T-cells: 43.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;HDLM-2: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052461			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Plasma membrane"		"HPA052461: "	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.06e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-6)"	"unprognostic (3.97e-3)"	"unprognostic (9.19e-4)"	"unprognostic (1.93e-1)"	"unprognostic (9.50e-3)"	0.8	0.3	0.1	0.4	0.1	1.0	0.7	0.1	0.3	0.5	0.2	0.7	0.0	0.4	0.0	0.6	0.5	0.1	0.4	0.1	0.1	0.7	1.2	1.1	0.5	0.4	0.2	0.8	0.9	0.1	1.2	0.0	0.3	0.8	0.1	0.1	0.8	0.0	0.2	0.5	1.2	0.1	0.2	1.8	0.8	0.4	0.3	0.4	0.7	0.0	0.3	0.5	0.6	0.4	0.4	2.7	0.2	0.6	0.1	0.1	0.5	0.6	0.1	0.6	1.2	0.6	1.5	1.0	0.9	0.1	0.9	0.8	0.5	0.2	0.3	2.6	0.2	0.8	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.2	0.1	1.3	0.6	1.1	0.4	1.1	0.0	0.2	0.0	1.1	0.5	0.2	1.0	0.2	0.0	0.0	0.1	0.3	1.7	0.2	0.4	0.4	0.3	1.7	0.2	0.2	0.5	0.3	0.5	1.2	1.0	0.5	0.1	0.9	0.4	4.5	0.8	5.8	2.6	0.5	4.2	0.4	4.9	3.9	1.7	0.7	5.1	4.1	0.7	3.5	0.2	0.6	5.6	1.0	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.2	0.3	0.2	0.3	0.4	14.7	0.0	7.5	1.3	14.0	0.6	2.5	0.6	10.8	3.2	10.3	9.8	4.0	0.0	6.6	0.0	12.5	3.0	32.8	4.3	1.9	1.7	0.5	12.6	11.5	9.9	4.8	6.1	7.7	1.1	2.5	5.7	11.7	20.9	2.5	10.3	4.6	2.8	3.3	13.5	5.2	5.6	2.0	5.5	3.3	0.8	3.4	10.3	3.6	20.6	8.0	2.4	14.4	0.0	16.2	2.4	3.0	0.7	21.7	5.8	5.9	3.2	3.4	6.5	0.0	11.3	8.0	1.2	1.5	5.2	1.7	2.5	43.5	9.2	6.4	1.8
HELLS	"LSH, Nbla10143, PASG, SMARCA6"	ENSG00000119969	"Helicase, lymphoid specific"	Q9NRZ9	10	94501434-94613905	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Developmental protein, Helicase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 182.0;Spermatogonia: 173.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.1"	"Region enhanced"	"Detected in many"		"cerebellum: 5.5"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 36.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004491, HPA063242"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB004491: AB_627895, HPA063242: AB_2684968"	"unprognostic (1.94e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.76e-5)"	"unprognostic (7.59e-3)"	"unprognostic (7.03e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (9.45e-5)"	"unprognostic (9.93e-13)"	"unprognostic (2.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.03e-2)"	1.1	1.2	0.8	6.4	0.3	16.3	3.0	5.5	1.2	3.2	1.3	4.3	2.9	2.9	1.4	5.9	1.7	2.0	0.7	0.4	1.3	2.5	1.8	1.7	12.4	0.8	0.8	2.6	1.2	1.4	3.0	4.1	1.0	2.1	5.1	1.1	1.9	1.0	0.3	5.3	3.9	2.2	0.9	4.3	3.7	12.8	0.9	15.9	1.1	0.2	12.6	3.6	3.2	1.5	57.7	55.4	70.6	90.1	2.9	6.4	37.4	42.9	27.8	34.4	54.6	70.3	45.5	70.0	16.7	15.5	29.1	56.3	40.9	34.9	50.7	68.5	45.5	37.3	56.3	58.0	1.7	71.2	31.6	3.6	2.0	42.1	20.0	9.4	24.0	46.0	20.7	43.5	43.1	54.9	75.2	35.6	73.4	42.3	24.1	70.3	62.1	16.3	24.2	72.2	28.4	22.8	50.3	14.5	7.8	59.0	60.9	23.1	17.2	38.4	19.4	35.4	52.4	22.3	47.6	74.5	19.0	42.8	17.9	0.3	0.7	0.0	7.0	1.5	2.4	18.8	11.4	9.4	2.3	23.2	5.2	7.7	1.0	10.2	1.0	36.8	19.7	2.3	0.8	0.3	5.5	1.2	0.4	1.3	0.8	0.8	1.0	0.9	0.9	1.5	4.7	9.6	3.9	0.0	19.7	21.5	11.5	12.6	13.1	16.4	10.0	15.0	1.0	12.8	12.6	22.0	0.0	46.3	13.2	26.2	3.9	9.0	2.0	9.3	16.4	8.1	10.8	50.5	3.3	6.2	43.4	13.0	17.9	16.3	5.7	60.6	5.7	3.6	15.1	6.7	5.4	17.8	8.2	2.2	10.3	5.3	9.0	7.3	1.8	9.4	5.7	4.3	1.0	4.5	6.6	4.7	1.8	5.7	37.5	3.7	1.7	1.6	6.3	11.4	19.7	10.5	16.4	182.0	173.9	22.9	9.9	11.1	15.7	16.5	30.9	11.7
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455855	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	4.8	9.1	2.2	5.0	2.6	4.6	5.5	4.0	2.8	5.4	4.6	4.0	3.1	4.9	4.5	3.4	4.6	3.8	5.1	2.1	2.4	5.4	5.5	4.0	9.3	2.2	2.3	8.1	3.7	5.6	4.4	3.2	2.5	3.9	3.9	5.5	4.6	4.0	7.2	3.9	4.5	4.3	2.4	6.2	3.7	6.0	2.4	8.0	5.8	8.1	7.5	4.4	4.0	3.0	4.0	2.9	6.0	4.0	7.5	7.2	3.1	5.5	7.9	7.2	6.9	2.9	4.1	11.2	4.3	5.1	4.9	4.0	6.9	3.9	7.7	6.5	3.3	6.3	4.8	3.9	4.5	8.4	15.9	6.1	5.5	5.9	5.8	6.1	5.3	7.2	8.8	9.4	7.0	4.3	7.5	5.9	2.7	6.0	2.2	5.9	7.1	3.9	6.2	2.3	4.7	4.2	5.6	6.2	6.6	5.9	3.8	8.3	4.6	5.4	4.8	6.7	4.4	8.7	3.8	9.2	4.7	6.1	6.1	3.4	1.7	3.6	3.1	2.2	3.2	3.4	3.3	3.2	2.6	5.1	5.6	4.7	1.3	3.6	3.1	2.5	4.5	1.6	2.2	2.6	4.0	2.8	2.1	2.4	2.2	2.3	2.5	2.4	2.4	3.0	14.1	3.2	14.0	14.4	23.1	4.2	8.6	6.6	12.0	10.2	6.7	9.0	12.3	5.7	7.7	5.5	8.4	10.9	11.4	4.5	11.7	6.7	28.3	7.3	10.2	10.2	0.0	7.8	17.0	5.4	10.3	11.1	4.1	7.7	7.6	9.8	10.0	4.1	10.2	6.7	21.3	5.5	4.1	7.2	5.4	8.9	13.1	9.9	7.2	20.6	10.7	7.8	17.5	10.6	15.7	4.4	8.3	7.9	15.8	5.4	7.6	11.8	15.9	13.8	0.0	11.2	11.9	24.3	12.7	7.0	3.8	11.5	18.2	17.4	5.5	6.1
HEMGN	"CT155, EDAG, NDR"	ENSG00000136929	Hemogen	Q9BXL5	9	97926791-97944856	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 246.7"	"Group enriched"	"Detected in some"	27	"Early spermatids: 1329.5;Erythroid cells: 1206.7;Late spermatids: 1439.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.1"	"Group enriched"	"Detected in many"	28	"granulocytes: 2.2;NK-cells: 2.0;T-cells: 5.1"	"Cell line enriched"	"Detected in some"	5	"K-562: 290.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019572, HPA019604, HPA019606"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591"	"unprognostic (1.94e-1)"				"unprognostic (3.15e-3)"			"unprognostic (2.50e-2)"		"unprognostic (9.00e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-4)"	"unprognostic (2.77e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.25e-1)"		0.1	0.0	0.1	0.8	0.1	246.7	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.6	0.9	1.5	0.4	0.0	0.0	0.2	0.0	0.1	5.9	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.1	0.0	0.0	3.2	0.2	50.5	0.1	12.6	0.2	0.1	1.5	0.1	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.3	64.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.2	290.9	0.3	0.0	0.0	7.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.2	0.0	1.5	0.5	1.8	0.0	0.0	0.1	2.2	0.1	0.0	0.2	0.0	0.5	0.0	1.5	0.7	0.1	0.0	5.1	2.1	0.6	2.0	0.0	0.0	0.9	2.7	0.1	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.2	0.4	0.1	0.0	0.0	1329.5	0.2	0.0	0.5	0.0	1206.7	0.4	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.7	0.7	1.0	0.0	0.2	0.0	0.0	1.6	0.0	1439.7	5.9	47.4	1.8	0.0	2.1	0.0	4.1	0.0	0.1	0.0	0.0	4.1	0.5	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.1	10.0	4.4	0.0	0.0	0.5	2.3	0.0	0.0	0.0
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188534-93226469	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 96.2"	"Group enriched"	"Detected in some"	11	"Enteroendocrine cells: 218.2;Intestinal goblet cells: 387.5;Ionocytes: 349.9;Paneth cells: 318.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.4;pancreatic cancer: 10.7;renal cancer: 10.6;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SCLC-21H: 172.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	NA		210000		"Cluster 9: Intestine - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favorable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.1	0.0	2.3	0.0	2.5	8.9	0.0	0.1	0.0	0.0	64.3	30.1	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	15.2	0.0	0.1	0.0	0.1	0.1	0.0	4.3	0.4	7.3	0.2	0.0	0.8	96.2	0.0	2.6	1.4	0.0	0.0	48.0	1.5	0.1	0.1	10.1	3.2	0.0	0.1	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	172.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.4	0.3	1.1	0.7	0.0	0.0	15.1	6.6	0.2	0.0	0.9	5.5	0.0	0.0	0.0	17.2	9.8	0.1	2.5	0.0	0.0	0.1	218.2	18.7	0.5	0.0	0.0	0.1	27.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.6	387.5	349.9	0.0	0.0	2.4	0.0	0.0	7.2	1.0	0.0	0.0	0.0	0.0	2.2	0.0	318.1	0.0	0.1	0.9	11.5	0.0	0.3	0.0	0.0	0.0	0.1	5.6	1.2	0.0	0.1	0.1	0.1	0.0	19.7	0.3
HERC6	FLJ20637	ENSG00000138642	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 6"	Q8IVU3	4	88378739-88443097	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 116.1;BJ hTERT+ SV40 Large T+ RasG12V: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035846	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"HPA035846: AB_10673487"	"unprognostic (1.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.77e-2)"	4.1	5.5	6.5	5.4	7.2	7.9	6.2	5.2	8.8	14.2	4.3	6.1	5.3	8.5	4.2	20.9	9.7	10.7	9.6	7.0	7.6	6.0	4.8	8.1	5.0	8.2	6.6	8.3	5.4	7.1	4.4	5.5	7.3	8.4	6.1	4.4	30.5	5.1	3.0	4.1	5.3	8.0	11.7	8.2	7.2	3.9	6.9	12.3	4.3	4.7	5.3	6.0	11.2	6.8	6.7	4.5	0.3	0.9	0.3	3.8	1.2	0.8	22.1	116.1	85.8	0.4	8.3	0.0	1.5	2.1	18.8	2.5	10.9	5.7	7.6	13.9	2.2	6.3	3.8	0.6	3.7	11.3	4.2	5.2	1.3	9.1	0.3	7.0	3.4	5.2	0.0	1.5	2.6	4.1	5.3	3.6	1.5	6.0	2.2	3.6	0.1	0.5	7.8	8.2	0.3	2.7	8.2	2.7	13.5	5.6	4.8	2.0	1.2	1.6	2.1	0.2	2.1	0.3	0.1	0.0	5.2	2.5	5.4	4.4	3.2	4.7	6.4	3.4	12.8	3.5	8.9	6.3	2.8	3.0	6.9	4.7	1.9	6.0	7.4	0.3	12.5	4.2	6.5	7.2	5.2	8.8	7.0	7.6	8.2	6.6	7.3	11.7	6.9	6.8	11.4	12.8	10.6	14.4	5.8	2.8	5.2	3.3	4.6	18.1	4.9	4.6	13.9	7.2	9.8	5.5	16.7	5.8	5.0	8.3	0.0	7.8	1.3	6.4	3.9	11.5	1.8	4.8	21.5	17.4	1.8	6.6	5.6	5.0	5.7	25.9	5.3	2.2	5.0	1.7	25.8	2.9	4.1	2.2	0.8	1.6	4.4	4.7	5.4	28.1	5.7	3.7	4.1	24.1	2.8	13.3	2.4	5.7	3.8	8.3	6.2	4.1	14.6	1.0	6.6	2.0	3.6	0.8	2.1	18.4	1.1	2.5	8.2	13.3	2.5	8.0
HES1	"bHLHb39, FLJ20408, HES-1, HRY"	ENSG00000114315	"Hes family bHLH transcription factor 1"	Q14469	3	194136148-194138732	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 850.6;Muller glia cells: 1146.0;Paneth cells: 1137.2;Undifferentiated cells: 882.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"eosinophil: 15.6"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 94.1;OE19: 95.8;SK-BR-3: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066929			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA066929: AB_2732753"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.04e-5)"	64.2	32.2	13.6	7.9	14.9	0.9	87.0	12.5	15.0	66.0	11.8	44.1	31.2	22.5	9.0	127.8	22.4	17.7	65.6	14.7	16.8	87.3	68.7	47.1	7.0	15.3	17.4	25.3	34.8	22.6	42.7	27.5	13.5	90.1	35.7	66.5	79.9	31.5	69.9	184.5	23.9	9.8	13.5	23.4	42.1	12.8	14.5	11.9	93.2	22.4	11.8	59.8	136.6	11.6	9.3	2.6	20.8	27.1	6.1	0.0	5.2	4.3	12.2	0.9	0.5	36.4	26.1	1.3	74.6	1.6	12.6	51.4	3.9	24.2	0.3	7.7	44.0	33.1	3.5	9.4	0.1	0.2	30.1	2.2	94.1	0.8	10.9	14.3	28.6	1.7	16.1	1.2	0.0	43.9	47.5	45.7	19.4	95.8	17.8	0.1	1.5	1.0	28.0	71.2	1.2	1.6	21.0	78.9	38.9	23.6	22.2	2.6	22.3	2.3	21.8	0.3	31.3	0.2	0.1	0.2	1.6	0.1	43.7	0.0	0.0	15.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	13.6	14.9	12.5	15.0	14.7	16.8	15.3	17.4	13.5	13.5	14.5	11.6	684.0	25.6	96.0	70.2	54.2	122.9	498.5	736.7	159.4	15.9	352.0	164.1	128.8	517.6	355.1	196.8	16.7	41.1	4.7	696.8	189.8	268.9	2.2	231.9	37.6	401.8	160.1	19.2	1.2	199.1	6.0	274.1	105.0	257.4	303.4	16.1	850.6	163.1	24.4	10.1	0.4	579.7	213.6	95.3	76.2	8.7	58.7	74.6	80.0	5.6	22.8	1146.0	0.0	4.5	0.1	227.1	1137.2	18.8	5.0	231.1	297.5	126.6	190.2	54.9	164.3	76.8	291.7	1.2	13.2	367.8	296.5	209.2	24.1	31.4	882.7	358.1
HES3	bHLHb43	ENSG00000173673	"Hes family bHLH transcription factor 3"	Q5TGS1	1	6244179-6245578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	28	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 11.0"	"Region enriched"	"Detected in some"	30	"cerebellum: 34.8"	"Low region specificity"	"Detected in some"			"HPA047927, HPA072697"	Uncertain		Approved	Nucleoplasm		NA	NA					"Cluster 5: NTERA-2 - Transcription"		Nucleoplasm		"HPA047927: AB_2680213, HPA072697: "															"unprognostic (7.42e-2)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.2	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HES4	bHLHb42	ENSG00000188290	"Hes family bHLH transcription factor 4"	Q9HCC6	1	998962-1000172	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 345.1;Paneth cells: 397.4;Prostatic glandular cells: 286.6;Smooth muscle cells: 385.7;Urothelial cells: 494.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"eosinophil: 12.4"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 12.4"	"Cell line enriched"	"Detected in many"	7	"HEK 293: 198.1"					"Low region specificity"	"Detected in all"			HPA062465			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA062465: AB_2684771"	"unprognostic (6.23e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.08e-3)"	10.5	1.9	12.9	0.7	15.3	0.5	9.1	8.1	34.3	9.2	0.9	11.0	1.2	10.5	0.4	7.5	10.3	0.1	22.6	6.8	17.9	13.6	3.0	10.8	0.2	22.3	15.8	3.9	5.6	0.9	8.4	1.5	17.0	11.4	0.3	0.8	7.7	2.2	4.0	8.4	3.9	1.2	6.0	4.4	5.6	2.6	24.0	1.4	6.0	0.9	0.3	10.0	8.4	4.0	14.3	1.6	1.5	0.2	0.2	0.1	17.6	8.6	1.0	5.2	5.4	2.3	4.5	0.0	20.0	0.7	2.3	25.3	2.1	0.3	0.2	0.1	198.1	0.1	2.4	2.9	1.7	0.0	1.7	0.1	2.0	0.3	0.4	0.7	0.6	2.5	4.1	0.3	0.0	7.6	11.7	0.6	0.2	3.1	19.2	0.2	1.9	4.4	2.0	0.0	1.1	4.6	5.8	14.3	29.1	0.7	10.5	0.0	1.1	1.6	0.6	0.0	4.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	12.4	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	12.9	15.3	8.1	34.3	6.8	17.9	22.3	15.8	17.0	6.0	24.0	4.0	90.1	0.0	0.0	18.6	15.3	52.1	345.1	1.7	6.8	8.9	158.9	149.4	13.3	20.0	4.0	58.8	0.0	1.5	22.3	88.3	31.3	44.1	1.0	74.7	30.0	63.4	10.7	2.7	12.9	2.9	43.9	65.5	11.2	153.3	53.5	3.1	37.5	0.8	4.8	0.0	25.9	25.4	4.1	10.0	120.5	1.5	7.5	70.8	115.6	11.2	5.2	129.7	12.3	8.5	1.7	10.7	397.4	15.4	2.3	286.6	1.5	0.8	1.1	11.3	164.3	157.8	385.7	3.2	29.6	43.0	82.7	3.4	27.4	2.0	56.9	494.9
HES5	bHLHb38	ENSG00000197921	"Hes family bHLH transcription factor 5"	Q5TA89	1	2528745-2530263	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 18.7;skin 1: 4.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 24.8;Astrocytes: 53.5;Muller glia cells: 113.4;Oligodendrocyte precursor cells: 15.6"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.8"	"Group enriched"	"Detected in many"	4	"amygdala: 10.3;basal ganglia: 14.2;cerebral cortex: 5.1;hypothalamus: 12.4;thalamus: 18.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA065458, HPA076164"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		No	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA065458: AB_2685492, HPA076164: AB_2732303"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.60e-4)"	"unprognostic (1.76e-4)"	"unprognostic (1.60e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.67e-1)"	"unprognostic (9.95e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-1)"	0.5	0.0	10.3	0.0	14.2	0.0	0.3	0.7	5.1	0.4	0.0	0.5	0.0	0.2	0.0	0.8	0.2	0.0	2.5	2.8	12.4	0.1	0.3	0.3	0.0	1.1	0.9	0.1	0.0	0.0	2.5	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.1	4.8	0.2	0.0	0.4	0.2	0.1	0.9	18.7	0.0	0.5	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	14.2	0.7	5.1	2.8	12.4	1.1	0.9	1.0	0.4	18.7	0.0	24.8	0.0	0.0	53.5	0.2	0.1	0.3	0.2	1.8	2.9	1.1	2.8	1.4	0.0	0.3	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	5.4	0.8	5.1	0.0	0.0	0.7	0.0	0.0	0.3	0.0	8.9	0.0	0.1	0.0	0.0	0.0	3.3	0.8	4.9	0.0	0.0	0.8	0.0	0.0	0.3	0.0	1.9	0.0	113.4	0.0	15.6	0.3	0.0	2.9	0.0	0.0	0.5	0.1	0.0	0.0	7.7	0.0	1.0	6.2	0.0	0.4	6.2	1.4	0.0	0.5	0.0	3.0	0.2
HES7	bHLHb37	ENSG00000179111	"Hes family bHLH transcription factor 7"	Q9BYE0	17	8120592-8124106	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.1"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 3.6;Smooth muscle cells: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.0;Daudi: 6.0;HAP1: 8.3;HDLM-2: 6.5;HeLa: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072105	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA				"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Nucleoli	"HPA072105: AB_2686488"	"unprognostic (1.98e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.99e-2)"		"unprognostic (2.84e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.55e-1)"	0.3	0.1	0.2	0.0	0.2	0.0	0.3	1.7	1.6	0.7	0.0	0.3	0.0	0.7	0.0	0.3	0.5	0.1	0.9	0.5	0.2	2.1	0.0	0.9	0.1	0.2	0.0	0.9	0.1	0.4	0.4	0.6	0.2	0.4	0.0	0.5	0.6	0.0	0.2	0.5	0.2	0.0	0.3	0.4	0.2	1.1	0.2	0.0	0.5	0.0	0.1	0.2	0.7	0.4	6.0	0.4	0.5	1.8	0.1	0.2	0.2	0.3	0.5	0.5	2.2	0.1	0.3	6.0	0.1	0.0	1.0	0.7	8.3	0.7	0.0	6.5	3.9	0.2	13.9	0.1	0.7	0.7	0.8	0.1	1.1	1.8	4.4	1.0	0.1	1.0	0.2	2.9	0.2	0.1	0.1	0.3	0.2	0.5	1.5	0.6	0.3	1.2	0.2	0.0	0.3	2.9	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	1.3	1.4	2.1	3.9	0.9	0.4	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.7	1.6	0.5	0.2	0.2	0.0	0.2	0.3	0.2	0.4	0.9	0.0	0.0	1.0	0.2	2.2	1.0	0.3	1.2	2.3	2.3	1.7	1.3	0.0	0.1	1.8	0.0	0.0	0.8	0.2	0.0	0.1	1.7	0.2	0.1	1.7	0.0	0.0	1.1	0.0	0.0	1.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.3	1.8	0.0	0.0	0.5	3.6	0.0	0.6	0.9	0.0	1.0	0.0	0.0	0.0	0.4	0.1	1.6	0.0	0.1	0.2	0.7	0.0	1.5	5.9	0.1	0.6	1.0	1.6	0.3	0.3	0.0	0.2	0.2
HESX1	"ANF, RPX"	ENSG00000163666	"HESX homeobox 1"	Q9UBX0	3	57197838-57227606	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Spermatocytes: 36.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 6.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 73.5;U-266/84: 23.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024187	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA024187: AB_1850620"	"unprognostic (6.47e-2)"	"unprognostic (1.66e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.96e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.14e-1)"	1.3	1.8	1.7	1.0	1.7	5.9	2.6	2.2	2.2	1.2	1.4	1.0	1.1	0.9	3.4	1.0	1.1	1.6	1.1	1.7	1.7	2.1	3.8	1.4	1.8	1.9	1.7	1.4	1.8	1.6	1.8	1.1	1.9	1.5	0.8	2.0	1.1	2.0	0.8	4.2	1.0	0.6	1.8	2.2	1.9	6.3	1.8	1.3	2.5	0.6	1.3	0.9	1.0	1.9	1.3	1.2	2.6	4.3	0.4	1.6	0.8	0.1	0.5	0.8	1.4	0.6	3.9	3.4	0.6	0.1	1.0	0.2	1.2	1.4	1.0	2.0	2.9	5.0	1.8	0.4	2.9	1.6	0.5	4.1	1.2	0.4	2.8	2.1	0.7	7.2	0.8	4.3	0.3	0.3	2.2	9.1	73.5	1.1	0.8	0.8	1.6	1.7	3.6	0.7	1.1	3.5	1.0	1.4	2.7	1.2	1.0	7.0	0.5	3.3	1.3	1.0	1.4	12.2	23.7	10.1	1.2	3.1	1.6	0.5	0.8	0.4	0.2	1.6	0.0	0.6	0.2	0.1	0.5	0.5	0.2	0.1	1.4	0.7	0.2	1.8	0.0	0.2	1.7	1.7	2.2	2.2	1.7	1.7	1.9	1.7	1.9	1.8	1.8	1.9	1.0	0.0	0.5	6.5	0.9	0.4	0.6	1.4	0.0	0.3	1.3	1.8	0.8	1.5	0.4	1.8	0.0	1.5	1.7	0.9	0.0	0.4	0.5	1.7	0.7	1.2	0.0	0.0	1.7	0.2	1.1	0.6	0.5	0.4	0.0	1.0	1.4	1.0	2.1	1.7	1.5	0.1	2.0	1.6	0.6	0.4	0.9	2.0	0.0	6.5	1.1	1.6	0.0	3.0	5.1	0.5	0.2	0.4	0.2	0.7	0.7	1.2	0.9	2.6	0.0	0.8	0.5	36.3	7.6	0.3	1.1	0.5	0.7	2.7	0.7	0.4
HEXIM1	"CLP-1, EDG1, HIS1, MAQ1"	ENSG00000186834	"HEXIM P-TEFb complex subunit 1"	O94992	17	45148475-45152099	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 467.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008926, CAB011625"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB011625: AB_2233058, HPA008926: AB_1079048"	"unprognostic (2.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.26e-2)"	16.8	32.6	16.3	13.2	15.4	36.3	17.0	16.2	16.5	17.2	16.5	22.5	17.7	19.6	15.9	24.2	21.3	14.3	15.0	14.8	16.8	21.1	26.8	17.3	12.8	17.0	19.1	14.4	19.7	14.1	19.2	25.2	16.0	24.2	10.2	9.0	19.2	19.8	33.2	22.6	24.9	13.0	17.7	25.6	23.1	21.6	19.7	15.4	20.1	21.6	12.4	19.7	17.6	14.2	35.7	111.1	22.8	33.0	36.7	19.6	55.3	30.9	27.8	25.0	27.8	52.6	49.3	15.5	93.1	32.7	12.1	28.2	13.8	30.4	20.0	32.2	32.9	48.2	65.8	65.0	32.0	30.3	61.4	23.0	25.5	18.6	8.1	62.6	12.7	26.8	21.5	36.6	19.0	47.8	31.9	34.9	20.9	32.9	33.4	13.1	19.9	19.2	66.5	62.1	12.2	9.2	46.6	52.0	52.2	23.0	54.2	23.5	24.3	25.1	34.6	14.6	58.5	33.1	11.4	10.0	23.0	28.1	29.1	16.2	4.0	6.8	4.2	6.1	2.4	3.0	4.2	3.7	3.3	3.2	3.7	3.9	10.0	3.7	7.3	3.4	3.8	2.2	16.3	15.4	16.2	16.5	14.8	16.8	17.0	19.1	16.0	17.7	19.7	14.2	210.3	73.7	111.8	7.2	76.1	84.5	75.0	57.7	157.1	25.1	127.0	215.9	59.7	87.2	60.5	25.8	22.9	134.8	114.3	250.4	7.9	35.0	2.2	88.8	66.1	91.3	52.8	82.1	10.7	23.6	70.1	99.2	94.3	137.9	125.9	16.5	42.5	40.5	42.1	15.2	12.9	122.0	54.9	33.9	83.2	3.0	35.1	83.0	53.4	9.4	38.4	27.7	28.8	7.1	8.2	25.3	127.1	43.6	44.1	52.1	184.9	53.8	45.7	24.8	26.3	249.2	128.2	2.6	7.9	126.7	71.5	467.5	111.1	16.9	92.2	34.4
HEXIM2	FLJ32384	ENSG00000168517	"HEXIM P-TEFb complex subunit 2"	Q96MH2	17	45160700-45170040	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9;testis: 44.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 150.9;Late spermatids: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023323, HPA028455"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nuclear speckles"		"HPA023323: AB_1850651, HPA028455: AB_10602603"	"unprognostic (9.03e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.01e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.36e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.85e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.32e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-2)"	4.8	10.1	8.5	5.2	9.0	4.6	4.6	12.2	9.8	4.9	13.4	7.1	10.2	4.7	4.5	4.7	5.6	7.8	6.9	7.2	7.3	10.5	15.1	4.2	7.3	9.1	8.4	6.2	10.8	7.5	7.9	3.4	8.2	6.0	2.7	4.8	11.5	5.7	56.9	6.6	7.6	2.8	8.6	6.4	8.1	44.6	9.0	5.0	8.7	15.1	3.3	5.8	3.9	9.1	9.0	31.7	6.9	15.3	7.5	12.3	13.1	4.9	5.9	7.8	8.6	12.1	23.4	5.6	25.0	3.5	4.0	14.6	6.8	6.0	2.4	12.9	10.9	4.2	33.4	55.1	5.4	3.6	8.9	10.7	5.6	6.8	2.4	15.1	3.9	11.3	4.6	13.4	3.6	15.6	5.7	7.6	7.5	12.5	13.8	7.7	10.4	17.1	9.8	8.8	8.2	7.2	4.4	8.8	20.7	4.8	23.3	6.1	3.8	14.0	7.5	9.4	11.7	20.7	23.9	5.2	11.0	6.6	10.7	8.2	11.7	10.6	4.8	9.4	8.0	10.1	3.5	5.8	10.2	5.5	2.7	5.0	8.2	8.1	3.1	12.9	4.7	12.0	8.5	9.0	12.2	9.8	7.2	7.3	9.1	8.4	8.2	8.6	9.0	9.1	3.1	0.0	1.5	1.6	4.8	2.0	4.0	3.1	5.7	13.1	6.8	7.2	0.3	5.7	2.5	1.8	4.2	11.7	4.1	2.7	19.6	5.5	150.9	4.9	3.0	4.3	4.8	0.8	2.2	1.6	5.4	3.9	3.6	3.4	7.0	8.8	5.3	7.7	7.0	3.3	3.0	6.2	4.1	9.3	3.3	274.9	5.9	16.4	3.6	1.0	4.9	11.6	5.2	1.5	3.1	1.6	3.1	7.2	7.2	2.0	18.3	36.2	1.8	9.9	0.0	5.4	4.6	41.4	13.7	3.3	3.0	6.2	2.1	7.2	6.1	2.5
HEY1	"bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1"	ENSG00000164683	"Hes related family bHLH transcription factor with YRPW motif 1"	Q9Y5J3	8	79762371-79767857	"Cancer-related genes, Predicted intracellular proteins, Transcription factors, Transporters"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.2;Endothelial cells: 47.6;Extravillous trophoblasts: 112.6;Skeletal myocytes: 74.5"	"Cancer enhanced"	"Detected in all"		"glioma: 43.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 125.7;PC-3: 28.8;SK-MEL-30: 93.3;WM-115: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055599, HPA063472"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA055599: AB_2682858, HPA063472: AB_2685018"	"unprognostic (1.15e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.71e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.77e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.00e-1)"	21.1	2.2	17.4	2.1	23.0	0.6	19.0	19.4	19.1	7.2	9.6	6.7	1.7	3.5	0.9	2.8	3.9	4.2	23.9	18.4	20.3	2.8	2.8	15.2	2.2	18.1	21.0	2.0	3.4	3.3	18.4	17.8	19.3	6.0	2.6	5.3	10.1	1.7	19.5	4.2	5.8	3.2	19.1	2.4	4.8	3.1	22.8	3.4	6.5	16.2	2.5	9.3	5.2	15.4	1.7	0.1	1.1	9.1	0.8	0.7	22.0	2.1	2.1	0.3	0.3	0.1	0.1	3.3	2.3	1.0	1.0	4.6	4.9	0.1	0.2	0.5	125.7	0.0	4.1	2.1	1.4	0.0	0.7	1.3	3.7	0.1	16.2	0.4	3.4	0.0	9.0	3.6	1.3	0.1	0.0	0.5	0.1	0.3	28.8	0.0	4.6	3.3	0.4	3.9	5.2	14.6	0.1	2.4	93.3	19.6	0.1	0.1	2.0	0.7	2.4	0.0	1.8	3.3	0.7	0.2	3.4	0.0	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	0.0	1.3	0.0	0.0	0.0	17.4	23.0	19.4	19.1	18.4	20.3	18.1	21.0	19.3	19.1	22.8	15.4	105.2	0.0	1.8	15.0	0.8	3.2	3.4	27.6	2.8	6.8	8.6	12.2	4.3	0.0	19.5	0.0	0.0	6.8	1.8	5.3	15.6	2.6	4.6	12.6	4.1	47.6	36.8	0.0	7.7	1.2	112.6	5.3	1.5	33.5	10.8	1.9	41.0	0.9	1.8	21.9	8.0	2.0	26.4	0.6	5.7	3.2	0.0	2.3	33.8	20.6	0.0	10.9	0.0	18.6	1.0	0.7	7.5	0.4	0.8	1.7	0.2	0.4	7.7	12.2	0.0	74.5	12.1	0.6	15.4	3.4	3.0	23.4	1.1	1.5	2.5	2.6
HFE	"HFE1, HLA-H"	ENSG00000010704	"Homeostatic iron regulator"	Q30201	6	26087281-26098343	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 39.2;T-47d: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017276, HPA053470"	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA017276: AB_1850677, HPA053470: AB_2682163"	"unprognostic (6.96e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-1)"	9.6	7.9	1.3	5.3	2.1	0.6	7.8	1.4	1.9	6.7	9.3	5.8	5.9	4.9	12.4	4.8	4.5	8.1	3.7	1.5	1.5	6.7	15.4	7.5	3.6	2.4	1.7	7.3	6.3	15.4	1.2	6.1	2.2	6.8	6.9	1.3	6.9	9.6	2.3	2.8	5.0	6.0	1.7	8.6	8.3	1.7	1.9	1.7	9.9	3.0	3.1	7.4	3.2	2.8	17.2	39.2	0.7	18.6	27.3	21.1	0.1	12.2	28.5	15.1	23.6	3.3	34.3	1.8	32.4	20.2	22.9	10.7	0.0	14.2	19.1	4.6	0.2	0.5	8.1	2.6	5.6	0.0	0.7	21.6	4.0	16.7	1.4	13.2	10.4	0.0	0.7	0.4	13.0	7.2	0.1	0.2	0.9	8.1	0.0	2.3	0.0	0.3	12.5	11.5	0.1	0.1	7.3	0.0	10.2	0.3	54.0	1.9	8.2	10.6	1.1	10.7	10.6	0.2	0.4	0.2	15.9	0.2	23.5	1.3	10.7	0.0	1.5	10.4	1.2	3.3	1.6	2.1	4.7	1.3	0.4	1.0	1.9	0.2	9.2	0.3	0.3	3.8	1.3	2.1	1.4	1.9	1.5	1.5	2.4	1.7	2.2	1.7	1.9	2.8	3.9	3.2	5.1	1.0	1.7	1.7	2.6	3.7	6.2	1.0	3.7	2.2	3.2	2.8	6.7	5.5	2.1	1.7	0.5	3.8	0.0	4.1	0.1	1.8	2.3	3.4	1.8	2.7	0.1	3.4	0.8	4.6	8.2	1.5	2.5	3.0	6.8	12.2	11.1	0.0	0.1	4.0	4.1	25.4	7.6	0.2	3.7	7.4	0.0	2.8	3.8	2.9	2.1	0.0	3.3	2.4	0.9	6.0	0.3	2.6	2.9	2.7	5.9	1.7	0.0	5.7	2.4	0.2	1.1	3.4	3.4	1.8	1.0	2.8	3.3	1.9
HGH1	"Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236"	ENSG00000235173	"HGH1 homolog"	Q9BTY7	8	144137774-144140851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 26.4;PC-3: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042470	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA042470: AB_2678013"	"unprognostic (2.13e-2)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (4.62e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.48e-1)"	2.3	3.2	1.8	1.0	1.3	0.6	1.5	1.4	1.8	2.0	1.2	1.9	0.6	2.3	0.1	3.1	1.7	0.5	2.1	1.7	1.1	1.9	3.2	1.3	0.6	2.1	1.2	1.7	3.1	0.8	1.4	0.4	1.4	1.9	0.5	0.1	1.8	0.8	2.7	2.2	1.6	0.7	1.3	2.2	2.9	2.4	1.5	0.6	2.0	1.2	0.6	2.6	1.9	1.6	8.3	2.7	1.9	3.5	2.7	1.7	4.9	13.8	1.1	2.9	1.9	3.6	2.1	23.9	18.7	2.6	1.1	8.6	3.8	1.9	0.9	11.7	14.5	9.1	2.4	1.8	2.6	5.1	5.9	1.2	5.9	3.2	2.0	1.0	1.3	4.9	26.4	0.9	1.8	6.9	17.5	4.7	5.4	3.1	46.6	21.8	1.6	3.7	1.7	1.9	4.1	4.4	6.4	3.4	5.1	0.6	2.9	1.8	4.9	1.7	14.2	5.1	16.5	13.9	9.7	6.1	1.7	8.5	2.8	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.4	0.7	0.2	0.8	0.4	0.3	0.0	0.6	0.2	0.1	0.1	0.1	1.8	1.3	1.4	1.8	1.7	1.1	2.1	1.2	1.4	1.3	1.5	1.6	5.2	0.0	2.4	2.6	5.8	0.0	2.6	0.0	5.2	4.2	6.7	5.7	2.2	2.8	0.6	5.5	0.0	11.1	7.2	1.3	11.7	3.5	11.2	2.8	7.0	3.1	4.9	5.9	1.2	1.8	13.4	4.3	7.1	4.0	0.0	7.9	1.4	9.9	12.2	6.7	1.2	4.0	0.0	4.8	0.0	22.1	7.5	5.6	0.0	1.0	3.5	8.3	14.4	0.0	1.0	2.9	5.6	3.4	4.9	3.2	5.4	10.2	1.5	3.7	6.6	2.6	3.8	15.1	14.8	6.9	0.0	3.1	5.9	11.0	6.5	1.6
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689955-92695647	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 84.7;liver: 91.2;thyroid gland: 102.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5"	"Group enriched"	"Detected in all"	5	"liver cancer: 20.1;thyroid cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	43	"basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7"					"Low region specificity"	"Detected in many"			"HPA003257, HPA051894"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003257: , HPA051894: AB_2681653"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	16.2	18.5	5.0	22.2	5.4	84.7	11.2	5.6	8.8	7.1	5.1	7.8	6.4	6.4	3.5	4.1	6.1	27.4	6.1	4.8	5.2	7.0	91.2	16.9	39.1	6.3	5.4	3.0	38.1	1.9	2.2	14.6	6.4	4.7	6.5	0.3	3.5	4.0	2.9	4.6	19.0	5.8	6.2	39.9	5.2	2.4	6.0	4.4	102.1	6.3	30.4	12.7	5.0	6.7	11.2	20.6	10.5	0.1	0.9	0.7	0.2	5.6	46.4	7.4	6.6	4.0	2.6	10.7	87.7	0.7	0.0	2.1	9.5	0.3	9.1	0.1	11.1	99.9	8.8	67.4	21.0	58.6	105.6	0.3	0.2	6.5	0.0	3.7	106.1	0.3	154.8	0.1	0.5	3.2	0.4	101.8	0.2	30.2	11.8	34.0	3.0	0.1	0.9	4.3	4.9	1.0	6.2	0.0	0.1	0.5	3.3	30.6	37.2	0.0	0.6	0.1	0.1	2.6	1.8	21.2	0.0	79.7	51.4	28.0	41.5	61.8	0.8	45.7	0.3	59.3	0.0	0.1	30.8	65.8	0.1	0.1	31.4	1.0	50.7	36.3	0.4	15.5	5.0	5.4	5.6	8.8	4.8	5.2	6.3	5.4	6.4	6.2	6.0	6.7	31.9	0.0	3.0	0.0	77.2	6.4	2.1	0.9	2.2	0.0	3.0	3.2	3.6	125.8	1.6	0.0	0.0	0.7	57.6	0.4	0.0	107.9	0.3	0.8	0.5	80.0	5.3	28.2	0.0	12.0	0.7	2.2	0.5	1.0	7.0	0.0	88.9	58.3	72.6	0.0	0.0	1.6	0.0	63.5	29.1	1.1	0.3	51.7	7.2	5.6	50.4	0.0	9.2	0.5	0.0	10.5	0.0	1.2	1.6	3.2	0.0	0.2	0.9	0.2	0.0	1.9	2.1	0.3	6.3	1.0	3.7	1.1	8.3	3.4	0.7	1.3
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646156-144745271	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3;lung: 16.2"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 175.6;Leydig cells: 136.1;Oligodendrocytes: 413.3;Theca cells: 162.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 322.6;TIME: 376.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012616	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA012616: AB_1850687"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.66e-3)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.38e-1)"	2.3	2.3	10.4	0.4	25.4	0.8	0.3	10.7	19.6	1.3	0.0	3.2	2.6	1.6	3.8	0.0	0.1	1.1	0.2	17.1	11.0	0.8	6.8	16.2	0.0	20.0	20.2	0.6	2.6	0.0	0.3	0.0	13.6	4.7	3.2	0.9	0.3	2.6	0.4	0.2	3.7	0.1	9.4	0.0	5.9	1.5	18.1	2.7	0.6	1.3	0.0	5.0	0.3	37.3	0.0	0.1	4.9	0.1	0.3	1.9	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.0	0.2	0.3	0.0	2.2	0.0	2.0	0.1	0.0	0.1	0.1	0.0	0.0	10.4	7.8	17.2	322.6	29.1	0.1	0.0	4.8	0.0	47.7	0.0	4.4	0.0	2.8	0.4	65.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	376.7	0.4	3.9	0.3	2.5	2.2	0.0	10.1	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.4	25.4	10.7	19.6	17.1	11.0	20.0	20.2	13.6	9.4	18.1	37.3	0.3	12.8	175.6	3.9	0.4	0.0	0.0	0.5	0.0	42.7	0.0	0.0	1.2	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.5	6.0	0.6	0.0	0.0	17.6	0.4	0.0	38.9	0.0	0.4	16.5	0.1	9.3	0.1	0.1	0.0	13.9	0.0	2.0	0.0	0.4	4.5	136.1	1.3	1.8	1.0	0.0	0.3	0.0	8.5	413.3	0.1	0.0	44.0	0.0	0.0	0.0	0.0	4.4	3.3	0.0	1.7	0.9	0.3	0.5	0.0	0.6	0.0	1.0	162.7	0.0	0.0
HIC2	"HRG22, KIAA1020, ZBTB30, ZNF907"	ENSG00000169635	"HIC ZBTB transcriptional repressor 2"	Q96JB3	22	21417371-21451463	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.6;Extravillous trophoblasts: 41.4;Syncytiotrophoblasts: 39.5"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 69.2;K-562: 126.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031884, HPA059399"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA031884: AB_10602234, HPA059399: AB_2684003"	"unprognostic (2.37e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (4.83e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.33e-1)"	"unprognostic (3.86e-2)"	"unprognostic (5.64e-2)"	2.2	1.2	2.5	1.4	2.6	3.7	1.5	0.8	2.8	1.7	0.0	2.1	1.3	2.0	0.5	2.6	2.2	0.8	1.5	2.7	0.9	1.7	1.8	1.8	1.5	1.0	0.6	3.4	2.1	1.1	2.6	5.8	0.9	1.2	0.8	1.5	1.4	0.7	1.1	1.5	2.1	0.7	0.2	2.4	2.4	7.4	1.0	1.7	2.4	1.1	0.9	1.1	1.5	1.4	2.2	2.7	14.4	4.3	1.1	0.9	69.2	1.4	0.5	1.4	1.2	27.2	0.8	5.1	1.4	0.9	0.9	5.9	10.2	0.9	0.8	3.4	15.0	6.8	4.0	15.0	1.2	6.0	3.1	1.1	0.5	2.1	0.9	0.7	1.1	2.1	126.9	2.1	0.7	2.1	2.7	6.2	15.3	4.8	2.0	6.7	6.4	0.8	0.7	3.6	4.0	7.0	1.8	2.1	2.6	14.9	1.2	9.0	1.9	2.2	5.4	2.1	1.6	4.2	3.6	5.4	1.8	2.5	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.0	2.5	2.6	0.8	2.8	2.7	0.9	1.0	0.6	0.9	0.2	1.0	1.4	10.3	3.2	1.1	3.6	7.7	5.5	5.4	2.6	23.9	14.8	4.7	4.2	3.9	7.2	1.7	1.8	14.6	39.6	4.4	10.0	0.0	2.6	14.2	8.3	7.6	6.5	6.1	5.7	11.8	2.6	41.4	6.6	11.2	7.6	1.3	6.4	2.9	3.0	10.3	8.4	7.5	7.4	6.1	3.8	4.3	29.9	5.6	5.6	5.4	1.9	4.5	3.0	2.1	5.0	2.3	2.8	4.6	10.1	10.4	8.1	7.0	1.6	1.5	7.3	6.6	10.7	6.0	12.2	24.5	27.1	4.5	39.5	5.8	2.6	9.3	7.5
HIF1A	"bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8"	ENSG00000100644	"Hypoxia inducible factor 1 subunit alpha"	Q16665	14	61695513-61748259	"Cancer-related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 448.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 155.0"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 155.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 941.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000907, HPA001275, CAB017442"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.35e-2)"	"unprognostic (3.88e-2)"	64.9	133.7	22.1	146.6	24.0	448.3	36.2	28.2	26.1	132.9	24.7	42.8	33.6	52.4	74.8	62.1	41.1	145.4	36.5	21.1	28.4	104.2	51.6	75.7	71.4	29.7	29.7	35.3	36.0	91.7	30.7	77.6	33.3	46.9	41.7	35.5	45.3	67.2	12.1	34.2	37.3	59.1	27.2	72.4	37.6	32.4	38.5	55.8	49.5	17.6	88.2	169.9	43.1	26.5	313.6	123.6	112.7	344.7	185.2	297.1	161.5	253.8	270.1	288.7	258.9	54.1	100.3	75.8	186.2	293.0	73.6	71.8	71.0	416.1	352.5	33.7	41.0	46.5	105.3	93.1	414.8	20.1	49.3	523.4	129.2	216.5	225.6	408.6	198.1	44.4	32.3	0.4	941.4	65.6	59.2	24.3	108.9	49.6	159.7	4.3	269.1	22.8	400.2	204.3	100.3	111.9	472.5	67.0	170.7	148.9	70.6	36.3	119.2	700.2	157.3	235.9	215.2	39.1	61.2	84.1	369.9	38.5	194.7	43.8	22.3	155.0	11.5	18.0	14.4	19.5	15.0	13.3	19.6	19.0	22.6	15.6	56.3	19.7	19.4	9.2	11.0	18.4	22.1	24.0	28.2	26.1	21.1	28.4	29.7	29.7	33.3	27.2	38.5	26.5	93.3	70.5	116.0	69.2	157.3	106.4	101.8	102.6	97.9	54.1	38.5	30.1	43.5	87.2	69.0	261.1	50.1	24.8	65.1	44.1	103.7	278.5	3.6	95.6	131.3	152.3	66.4	35.3	45.6	251.6	67.1	81.4	49.5	272.3	223.6	339.7	176.0	30.7	136.4	156.5	39.3	39.0	57.0	145.9	111.7	6.2	24.2	240.2	103.2	53.4	87.1	134.0	26.8	78.9	35.8	236.9	21.9	48.5	60.0	59.3	20.2	192.1	37.7	54.8	52.6	75.8	136.9	80.5	44.2	128.7	87.9	25.4	91.6	92.2	51.8	116.0
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 subunit alpha inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.6;tongue: 40.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458"	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	6.5	8.1	6.9	7.8	6.5	6.2	6.5	6.1	7.3	6.2	5.7	7.5	7.2	7.3	7.2	7.5	6.8	6.3	12.3	6.6	6.0	7.5	5.4	5.7	7.8	6.7	7.5	10.3	8.1	12.1	6.5	6.0	6.5	7.5	6.6	9.8	6.5	8.3	41.6	10.1	7.2	7.4	6.0	6.8	6.5	13.9	7.0	9.3	5.5	40.8	9.6	7.1	5.4	6.5	13.8	14.4	19.0	19.1	28.8	11.9	16.3	14.4	34.4	20.9	24.5	22.3	11.5	14.8	12.8	21.7	15.4	15.9	16.9	13.0	22.6	16.5	10.2	14.2	12.8	17.2	14.9	17.1	17.9	11.7	12.9	20.4	22.2	29.4	11.9	19.5	6.3	8.1	23.9	14.4	18.3	11.2	6.2	11.6	6.9	13.2	23.4	7.2	14.6	18.2	7.2	11.9	12.4	7.6	13.7	15.8	25.7	9.2	10.1	10.6	13.8	10.6	14.7	10.9	11.8	11.1	17.6	13.8	8.1	13.7	7.6	15.3	7.7	10.7	7.7	7.9	8.0	7.3	7.2	6.4	7.6	7.8	8.0	9.1	13.0	2.6	9.8	8.4	6.9	6.5	6.1	7.3	6.6	6.0	6.7	7.5	6.5	6.0	7.0	6.5	7.9	0.0	6.5	11.8	16.7	11.0	11.5	16.4	13.1	17.9	12.3	8.9	40.7	14.3	11.7	11.0	16.7	27.8	16.5	15.5	9.8	17.3	21.5	9.0	11.3	12.1	13.2	16.0	12.2	13.9	17.6	10.9	11.2	8.7	6.3	20.0	8.2	10.9	14.3	25.2	11.2	12.0	8.2	18.5	6.8	49.3	11.1	10.1	3.6	11.2	23.4	15.0	27.8	11.1	12.8	17.7	11.3	12.0	11.2	11.4	20.1	20.5	11.6	23.1	6.6	12.0	16.1	48.2	26.6	11.4	11.6	32.7	14.0	14.8	13.3	10.3
HIF3A	"bHLHe17, IPAS, MOP7, PASD7"	ENSG00000124440	"Hypoxia inducible factor 3 subunit alpha"	Q9Y2N7	19	46297042-46343433	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.5;Astrocytes: 257.9;Endothelial cells: 60.4;Leydig cells: 136.4;Muller glia cells: 79.9;Oligodendrocyte precursor cells: 69.9;Peritubular cells: 103.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.3;HHSteC: 19.1;HSkMC: 16.8;TIME: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041141	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041141: AB_10803997"	"unprognostic (9.20e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (6.90e-9)"	"unprognostic (4.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.41e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-4)"	"unprognostic (5.98e-2)"	34.2	8.8	24.1	1.1	24.7	0.7	24.2	17.5	25.9	32.5	9.4	55.4	1.1	31.1	4.1	10.8	35.8	2.6	55.9	19.5	17.4	7.3	2.7	32.8	1.2	22.2	22.3	34.2	6.5	0.5	22.6	27.4	18.6	22.3	2.0	10.0	7.5	7.1	10.7	10.8	24.8	3.0	16.8	31.8	37.3	5.4	22.5	0.5	13.0	9.7	0.4	55.0	25.1	17.3	0.0	0.0	1.5	0.2	4.3	9.3	0.4	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	19.1	0.1	0.5	16.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	2.3	0.0	0.1	16.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	1.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.7	0.1	0.4	0.7	0.1	0.0	24.1	24.7	17.5	25.9	19.5	17.4	22.2	22.3	18.6	16.8	22.5	17.3	83.5	3.2	1.8	257.9	0.5	1.1	2.2	0.3	0.6	1.5	1.4	0.9	45.7	17.2	0.7	0.0	0.0	0.2	0.3	0.2	1.9	0.0	1.9	2.4	7.0	60.4	1.2	8.0	0.7	0.0	0.4	13.6	1.1	2.3	0.0	3.1	51.0	0.9	0.6	0.0	3.5	1.2	0.0	1.3	2.1	7.4	136.4	0.7	3.6	33.7	0.0	79.9	0.0	69.9	1.2	0.1	8.0	103.4	0.0	1.6	0.5	0.1	0.0	2.5	6.6	5.5	8.4	1.6	3.6	0.2	2.3	0.5	0.4	0.1	2.1	0.7
HIGD1A	"DKFZP564K247, HIG1, RCF1A"	ENSG00000181061	"HIG1 hypoxia inducible domain family member 1A"	Q9Y241	3	42782908-42804490	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 638.8;Distal tubular cells: 632.0;Paneth cells: 610.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 509.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043336	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA043336: AB_10795039"	"unprognostic (6.46e-2)"	"unprognostic (3.72e-3)"	"prognostic favorable (2.12e-4)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.45e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (3.99e-8)"	"unprognostic (7.37e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	121.3	130.0	134.6	75.3	140.6	53.8	81.4	151.4	198.8	90.2	135.4	295.2	162.2	65.9	95.2	162.8	62.6	79.3	323.1	139.4	155.1	198.9	343.5	66.5	50.9	148.1	148.8	39.4	60.8	111.4	90.5	64.6	153.5	101.5	300.1	152.7	75.1	96.3	174.2	68.8	134.8	96.2	156.1	48.9	145.9	63.7	145.6	52.8	115.5	316.7	80.0	99.5	120.1	174.0	159.9	67.0	182.9	165.2	420.3	244.3	195.2	205.1	151.0	168.4	165.8	132.8	166.7	95.8	120.5	161.8	114.0	92.9	143.0	203.0	225.6	135.5	145.9	301.0	127.6	257.4	191.8	180.4	131.4	274.0	233.7	129.0	181.4	94.7	159.8	135.1	299.7	110.3	247.3	51.1	96.1	61.1	162.7	133.7	176.5	80.9	138.0	72.1	454.1	361.1	82.7	108.2	187.6	142.0	207.0	182.9	145.0	130.0	166.1	127.4	105.2	341.1	219.1	89.7	184.1	207.2	165.2	185.7	100.6	115.7	66.2	130.5	72.9	115.4	65.8	56.6	71.5	73.6	77.2	43.6	60.3	70.5	70.0	65.6	143.2	509.4	99.4	171.5	134.6	140.6	151.4	198.8	139.4	155.1	148.1	148.8	153.5	156.1	145.6	174.0	50.1	54.5	82.4	32.3	39.7	131.2	153.1	244.8	59.2	35.7	86.4	62.0	351.5	80.1	133.0	138.0	10.4	114.1	99.5	638.8	632.0	113.3	8.4	87.3	41.2	50.8	82.0	126.8	32.8	145.0	202.7	98.1	100.9	63.6	93.3	49.7	59.6	197.9	77.1	28.6	27.3	193.5	343.8	46.9	113.3	13.0	30.7	63.4	176.1	21.5	82.7	232.5	43.3	14.1	32.9	279.4	610.7	52.3	65.5	193.5	122.4	296.4	106.0	41.2	78.9	28.8	119.8	186.1	78.7	94.2	204.6	299.9	50.7	101.5	168.0	254.2
HIKESHI	"C11orf73, HSPC138, HSPC179, OPI10"	ENSG00000149196	"Heat shock protein nuclear import factor hikeshi"	Q53FT3	11	86302211-86345943	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Extravillous trophoblasts: 146.2;Hofbauer cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012708, HPA035063, HPA035064"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441"	"unprognostic (1.10e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.01e-12)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.71e-1)"	34.7	27.0	46.1	17.8	46.7	19.0	31.4	47.8	71.5	33.9	44.5	40.8	10.4	32.3	24.7	33.4	31.0	15.0	57.1	46.1	47.2	17.0	24.7	23.9	26.0	46.6	46.0	37.5	22.8	22.9	31.5	28.3	47.1	24.5	19.1	32.5	19.8	28.6	59.9	29.5	20.8	31.1	49.1	28.5	23.5	19.0	47.1	32.9	17.7	57.8	30.8	32.8	31.8	50.9	28.6	30.5	72.7	40.5	59.9	74.2	38.2	43.2	52.0	44.2	52.6	90.8	77.8	29.0	96.9	57.4	83.9	59.9	54.2	95.1	47.0	62.0	47.6	47.0	47.5	68.2	80.8	58.0	36.8	52.7	94.9	52.8	62.5	56.9	85.9	54.7	51.1	64.6	91.5	78.0	69.6	136.7	59.5	186.3	20.1	53.0	35.7	65.4	77.2	53.2	44.8	38.7	53.8	39.8	31.1	72.7	64.1	38.5	44.2	52.1	36.4	105.8	32.7	27.7	68.3	57.6	26.6	54.4	52.6	47.8	53.4	44.4	48.6	52.5	54.3	61.8	59.1	53.6	68.9	52.9	51.1	52.3	11.2	57.9	53.9	53.7	84.5	43.2	46.1	46.7	47.8	71.5	46.1	47.2	46.6	46.0	47.1	49.1	47.1	50.9	59.9	38.5	32.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	53.4	81.3	0.0	0.0	14.9	27.6	0.0	129.6	28.7	0.0	41.1	76.1	0.0	41.4	60.4	28.7	0.0	0.0	0.0	66.3	146.2	30.2	0.0	36.8	22.7	52.1	0.0	0.0	94.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	50.1	0.0	0.0	0.0	0.0	49.8	0.0	0.0	4.1	0.0	0.0	43.2	27.7	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	77.6	18.1	59.3	0.0	0.0
HILPDA	"C7orf68, FLJ21076, HIG-2, HIG2"	ENSG00000135245	"Hypoxia inducible lipid droplet associated"	Q9Y5L2	7	128455849-128458418	"Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 164.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.8;Club cells: 140.2;Extravillous trophoblasts: 246.8;Ionocytes: 311.3;Syncytiotrophoblasts: 241.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 72.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 67.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 116.1"	"Low region specificity"	"Detected in all"							HPA010515	Approved		Supported	"Nucleoplasm,Lipid droplets"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Lipid droplets"	Nucleoplasm	"HPA010515: AB_1850710"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.30e-11)"	"unprognostic (9.20e-3)"	"unprognostic (4.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.15e-2)"	"prognostic unfavorable (2.05e-7)"	"unprognostic (2.23e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	101.1	8.1	14.9	6.9	19.8	20.2	59.9	22.6	18.7	59.1	12.8	23.5	5.7	11.1	7.5	164.3	10.9	8.8	56.9	15.9	18.9	40.2	38.8	50.3	5.9	26.5	26.8	45.5	12.4	4.4	13.8	36.2	22.3	14.8	7.3	43.3	23.6	7.0	6.0	50.6	8.0	8.2	21.1	8.8	19.0	17.1	25.4	7.6	14.5	5.5	7.4	38.3	86.1	21.0	30.0	61.3	34.1	37.6	45.5	16.9	62.5	11.0	13.4	22.6	24.6	15.0	26.5	21.2	8.3	16.5	22.9	19.6	19.4	23.3	28.6	11.3	17.3	12.2	13.9	14.1	10.2	19.8	16.7	28.0	19.7	17.8	11.8	23.0	18.8	32.5	18.2	8.1	22.6	37.2	60.9	36.8	41.2	22.3	26.7	45.5	15.5	31.0	12.5	44.8	32.3	29.1	17.0	116.1	21.8	30.5	95.6	18.4	13.3	28.6	13.9	21.4	13.5	8.2	6.3	25.7	51.7	30.1	25.0	23.4	6.6	67.8	4.5	7.5	6.3	17.6	5.5	5.3	6.8	17.6	5.4	5.3	2.6	13.9	5.9	11.9	4.0	4.1	14.9	19.8	22.6	18.7	15.9	18.9	26.5	26.8	22.3	21.1	25.4	21.0	22.6	9.6	5.5	0.0	9.3	64.2	14.8	170.8	9.1	6.5	11.1	13.8	4.1	2.8	140.2	1.8	18.8	114.3	5.0	10.0	0.0	27.5	0.5	23.6	49.1	30.9	13.1	12.6	0.0	8.9	246.8	44.0	6.6	38.6	18.9	85.6	11.0	3.3	27.6	26.9	0.0	11.2	311.3	4.4	89.2	2.4	30.4	14.8	37.4	0.0	13.7	15.8	3.1	0.0	0.0	35.5	4.5	24.5	6.4	27.1	2.4	9.6	98.9	23.2	6.6	7.0	43.4	7.8	17.3	10.0	52.0	241.1	9.7	16.2	14.9	122.4
HINT1	"HINT, PKCI-1, PRKCNH1"	ENSG00000169567	"Histidine triad nucleotide binding protein 1"	P49773	5	131155383-131224468	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 3537.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044577	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		2800000	"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA044577: AB_10795618"	"unprognostic (2.00e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.49e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.68e-1)"	132.6	175.0	235.7	139.8	245.1	259.3	172.7	241.6	326.2	117.6	243.8	227.6	176.1	119.6	187.5	181.3	165.6	108.0	167.2	245.9	247.8	256.7	474.2	119.0	206.5	241.6	237.2	121.5	165.5	285.6	152.5	87.5	249.1	155.1	226.5	110.8	172.8	116.4	334.1	170.0	196.3	124.2	242.6	126.9	136.5	80.1	240.8	166.5	177.2	278.4	192.3	152.9	129.7	245.3	437.1	522.7	448.2	877.2	273.1	297.1	441.3	300.3	230.9	235.4	272.1	547.1	516.8	563.3	625.7	329.6	569.1	253.4	315.4	635.3	244.1	500.0	514.6	199.1	814.0	771.9	532.6	349.4	65.4	400.1	618.6	295.8	528.2	533.7	314.1	727.8	313.4	1132.1	338.8	419.9	548.0	945.6	415.6	425.6	362.0	407.9	436.1	988.1	500.6	567.0	563.3	351.9	380.5	243.5	612.0	574.4	291.2	520.8	396.0	351.7	244.0	323.0	684.2	342.3	561.4	578.8	497.8	586.8	346.3	179.8	187.9	85.0	196.3	109.9	298.0	384.9	462.0	294.2	396.9	332.6	416.0	325.5	35.6	269.0	128.0	521.4	362.5	608.6	235.7	245.1	241.6	326.2	245.9	247.8	241.6	237.2	249.1	242.6	240.8	245.3	582.7	282.0	279.1	34.3	718.2	1301.2	1472.2	1928.1	889.5	191.2	1134.3	1831.1	517.0	1028.0	882.2	715.4	45.9	780.9	641.6	1245.1	1663.0	1024.5	783.0	718.9	443.7	501.2	698.1	669.7	53.8	774.3	1632.8	400.2	355.2	753.7	108.2	666.5	436.2	2380.1	887.1	148.0	48.0	947.2	915.5	472.4	906.9	206.3	392.4	447.0	965.8	34.7	1269.4	405.1	488.1	26.7	55.4	894.3	1094.2	418.6	679.7	1998.9	1690.3	3537.5	708.3	194.0	243.3	287.0	730.3	625.5	197.9	1109.1	1146.1	456.8	671.1	464.3	1280.4	1713.2
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929324-113977869	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	Centrosome	"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	19.8	20.0	24.7	20.2	23.5	142.0	16.8	44.5	20.9	24.4	42.4	19.0	12.7	18.1	17.2	23.1	35.0	22.2	18.0	20.6	32.5	18.2	17.8	23.4	20.9	37.2	39.4	22.8	21.8	21.3	20.5	17.7	29.8	15.4	18.9	56.5	15.2	17.7	25.7	23.4	16.8	18.2	36.9	20.7	17.8	47.1	27.5	57.4	29.8	27.1	20.6	19.7	18.8	25.6	23.4	18.8	25.4	19.5	29.2	15.2	17.1	15.8	19.0	22.2	20.9	21.8	8.8	31.4	21.2	25.3	8.2	15.5	33.1	18.6	31.7	23.0	16.7	45.8	23.7	23.0	24.3	36.7	54.2	16.5	26.5	28.3	28.7	20.8	33.2	54.2	31.8	32.8	32.1	176.4	48.8	21.0	26.2	17.1	15.8	29.1	74.4	10.9	19.8	19.9	11.2	15.0	28.9	30.6	20.5	27.9	17.7	52.3	32.6	21.5	29.0	35.3	24.3	20.1	17.2	26.7	23.7	29.3	50.3	2.1	2.5	5.0	3.0	2.1	3.0	0.9	2.7	2.8	1.7	1.1	2.6	3.3	5.8	2.7	1.6	3.7	2.0	1.5	24.7	23.5	44.5	20.9	20.6	32.5	37.2	39.4	29.8	36.9	27.5	25.6	30.1	54.5	37.2	14.4	26.0	61.4	16.2	16.7	15.4	57.7	29.8	20.2	34.6	22.8	24.5	27.6	70.9	10.7	125.8	38.9	5.9	14.6	95.2	147.9	33.4	28.9	37.2	64.4	27.4	21.0	10.3	24.3	20.9	47.0	46.9	26.3	21.8	37.4	22.2	74.0	33.9	25.4	12.2	49.5	77.7	101.4	22.1	50.2	21.4	31.9	43.1	30.6	36.0	21.1	26.5	18.8	22.4	37.2	43.5	33.7	17.8	16.4	116.4	64.8	26.3	36.5	44.3	49.7	31.5	25.6	80.6	14.2	69.7	21.9	28.3	32.7
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777998	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"brain: 397.5"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 463.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 27.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 120.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favorable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.8	9.2	253.4	6.9	359.7	15.0	10.3	124.8	187.0	4.3	39.4	6.6	7.4	6.0	4.1	9.2	8.8	4.7	30.3	146.3	235.5	25.5	14.9	10.7	4.1	253.8	268.7	5.5	11.5	11.5	8.9	10.1	192.5	9.3	4.8	27.8	12.1	5.7	23.5	3.0	6.3	3.9	187.4	6.9	14.5	1.9	318.3	6.9	9.3	17.0	4.2	6.0	5.2	397.5	11.7	51.4	23.2	14.3	55.2	39.4	2.7	6.4	6.3	7.0	7.3	3.8	6.3	0.0	14.3	12.1	43.2	0.6	10.7	16.6	17.5	120.9	4.3	53.7	8.7	18.4	31.0	14.9	14.0	60.3	10.5	32.4	47.9	16.5	17.6	10.0	31.7	14.4	54.3	8.9	18.9	10.6	5.9	6.6	34.3	22.1	12.7	1.6	31.5	2.0	14.1	12.9	14.4	0.5	7.0	4.3	7.9	6.0	59.5	24.5	11.6	28.5	31.4	68.7	44.3	10.2	49.4	7.7	13.4	27.5	1.3	3.5	0.2	1.1	0.3	0.6	0.5	0.2	0.6	0.5	1.6	0.5	1.7	0.2	4.1	0.2	0.1	0.7	253.4	359.7	124.8	187.0	146.3	235.5	253.8	268.7	192.5	187.4	318.3	397.5	107.8	16.0	31.2	82.6	45.8	9.3	30.6	24.9	16.5	116.0	65.6	32.6	213.9	55.8	35.6	64.4	152.2	8.8	72.0	38.4	35.2	32.5	3.1	39.1	12.2	80.3	67.2	18.5	17.8	67.0	1.5	28.1	70.8	41.7	44.9	24.3	151.0	145.2	15.7	222.1	36.3	32.2	63.1	119.5	10.9	4.0	13.1	53.2	44.4	49.6	47.6	78.0	95.8	145.3	463.7	63.4	24.6	18.8	97.9	118.9	22.5	75.0	48.7	62.9	46.0	96.6	60.8	2.7	4.8	42.5	9.5	9.6	30.5	20.1	29.3	43.9
HIRA	"DGCR1, TUP1, TUPLE1"	ENSG00000100084	"Histone cell cycle regulator"	P54198	22	19330698-19447450	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.7;Inhibitory neurons: 51.1;Oligodendrocytes: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 253.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB039243, CAB039244, HPA050714, HPA052902"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (8.11e-4)"	"prognostic favorable (3.97e-4)"	"unprognostic (9.05e-2)"	"prognostic favorable (5.18e-6)"	"unprognostic (4.84e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.32e-3)"	11.2	12.9	16.1	10.6	15.1	26.1	10.2	14.6	15.9	9.4	13.3	14.0	13.9	12.3	6.0	12.4	12.2	7.3	12.9	15.9	14.1	13.8	21.7	10.6	14.2	14.2	15.3	11.2	12.6	22.1	13.2	8.4	13.8	9.3	10.1	7.3	9.9	8.8	23.4	12.5	13.7	9.4	14.0	13.1	14.2	10.1	17.9	20.6	56.1	11.0	11.4	12.2	8.6	14.6	27.0	23.5	32.4	33.7	31.0	20.5	22.5	22.4	25.7	36.1	35.6	53.8	15.4	52.1	10.6	29.0	21.5	30.8	46.4	28.2	23.1	32.1	53.9	48.4	25.5	49.5	33.6	113.1	33.6	24.7	27.1	28.3	27.6	19.4	26.5	51.6	253.1	27.0	20.9	33.7	56.0	40.4	29.6	63.8	23.5	43.7	46.0	15.6	20.9	29.8	47.0	31.2	25.0	25.4	31.7	16.4	16.0	39.0	30.7	24.5	36.0	25.4	26.5	28.4	30.3	53.7	28.7	36.2	20.7	4.8	0.7	3.3	1.3	0.7	1.3	2.4	0.7	1.3	0.9	4.5	0.3	1.0	1.3	2.1	0.4	1.7	0.4	0.8	16.1	15.1	14.6	15.9	15.9	14.1	14.2	15.3	13.8	14.0	17.9	14.6	7.7	6.4	0.5	29.4	7.4	9.2	2.2	4.4	0.6	7.7	6.4	7.4	2.3	2.8	2.3	5.5	2.1	3.8	12.6	11.7	5.9	5.4	6.2	6.8	8.4	5.6	2.4	19.4	49.7	8.9	3.6	4.7	3.1	7.1	0.0	8.7	7.1	21.1	6.6	16.8	51.1	10.5	4.1	9.1	3.8	2.4	5.0	4.9	10.6	38.4	7.9	5.5	14.4	37.7	45.5	7.9	8.4	6.8	4.5	5.0	8.2	9.9	4.2	4.6	6.6	7.7	6.1	12.9	10.3	4.5	10.5	3.0	6.6	9.2	14.2	2.2
HIRIP3		ENSG00000149929	"HIRA interacting protein 3"	Q9BW71	16	29992330-29996074	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 129.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051897, HPA063205"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051897: AB_2681655, HPA063205: AB_2684963"	"unprognostic (6.99e-2)"	"prognostic favorable (2.74e-5)"	"unprognostic (4.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (8.53e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.35e-2)"	12.3	11.6	24.4	9.0	25.5	15.8	11.8	23.9	24.7	13.3	19.0	16.0	8.3	13.5	10.6	9.6	12.2	7.1	19.2	22.9	23.8	12.6	14.9	11.6	13.1	25.5	24.6	16.8	11.0	15.6	14.5	6.8	25.4	11.9	7.3	20.1	11.1	12.8	33.5	14.6	10.9	8.6	24.1	12.9	10.6	38.7	24.4	25.6	11.7	21.7	12.3	14.2	11.5	25.7	27.4	27.7	44.2	28.5	13.9	14.8	13.4	20.9	16.1	21.2	18.2	24.8	26.8	52.7	42.5	13.7	15.3	19.0	28.8	26.6	15.8	47.8	28.1	56.7	36.2	26.9	11.5	50.3	42.4	7.4	19.4	20.9	32.3	12.4	13.4	50.6	27.2	57.0	12.9	20.0	66.1	26.3	13.0	17.8	15.5	65.9	52.6	52.5	14.9	12.2	28.6	34.7	21.7	16.3	14.5	11.3	24.2	30.6	15.4	28.4	21.8	20.3	20.5	37.1	31.0	31.4	26.8	43.2	38.1	4.6	7.5	15.0	16.7	12.0	11.4	19.1	18.6	15.3	6.3	14.6	19.3	17.9	3.4	14.3	20.8	19.1	22.9	10.8	24.4	25.5	23.9	24.7	22.9	23.8	25.5	24.6	25.4	24.1	24.4	25.7	19.1	67.3	26.3	2.0	14.9	12.7	17.1	11.2	14.8	36.4	14.6	19.6	30.4	10.0	15.8	9.2	14.6	30.6	18.7	12.5	29.4	10.5	27.6	12.6	10.9	15.4	9.6	27.0	2.1	12.1	28.9	14.6	4.6	10.9	31.0	12.1	10.8	16.7	18.7	15.2	2.7	10.8	14.2	8.2	11.9	12.0	20.5	9.8	5.4	1.0	8.8	37.3	32.0	3.5	4.7	6.3	11.4	22.6	22.0	6.7	25.6	19.9	19.9	49.4	13.1	14.7	18.6	129.5	46.2	10.2	11.4	11.5	20.9	12.1	14.0	8.3
HIVEP1	"CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A"	ENSG00000095951	"HIVEP zinc finger 1"	P15822	6	12008762-12164999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050724, HPA067457"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Mitochondria, Cytosol"	"HPA050724: AB_2616457, HPA067457: "	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.65e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.38e-1)"	7.2	2.3	0.8	8.0	3.0	16.7	5.5	0.7	3.0	7.4	6.5	6.4	5.0	5.9	4.5	7.4	6.1	7.3	3.8	2.2	0.8	4.5	11.7	6.3	8.0	1.3	2.8	6.5	6.7	10.5	3.3	4.9	0.5	6.9	6.6	5.8	4.8	5.8	2.8	5.7	5.2	6.2	0.0	6.0	4.9	4.8	1.2	9.1	4.9	6.2	8.3	9.3	3.3	1.6	8.1	5.9	7.5	4.2	5.8	7.3	7.2	6.4	5.5	5.2	5.7	3.8	4.2	6.7	13.6	7.8	12.4	7.6	7.4	9.2	7.1	14.6	4.3	3.1	5.6	3.7	4.7	3.7	2.5	5.1	9.0	10.6	16.3	11.0	15.5	4.6	32.9	7.5	11.5	6.0	5.9	3.3	6.4	2.8	2.7	3.2	9.8	10.7	3.1	8.7	7.1	5.2	15.9	12.8	4.3	16.6	7.6	4.7	25.2	13.0	5.8	12.3	7.4	30.0	27.3	12.0	4.0	4.8	5.5	2.4	1.8	2.1	1.2	2.0	0.9	3.1	2.0	0.8	1.2	4.8	3.4	2.1	11.7	3.3	5.2	9.0	4.4	0.7	0.8	3.0	0.7	3.0	2.2	0.8	1.3	2.8	0.5	0.0	1.2	1.6	40.2	28.9	16.9	74.7	35.6	32.2	25.4	7.4	30.7	20.4	12.3	10.9	10.4	17.2	17.6	7.3	12.5	3.4	18.7	17.5	3.9	5.6	2.5	37.7	16.4	20.3	10.8	6.5	94.6	7.2	1.8	25.2	22.4	51.0	7.6	7.0	6.4	12.3	5.9	21.9	68.3	14.4	4.1	9.6	47.9	1.8	3.7	23.1	19.6	44.0	29.6	13.1	5.2	59.3	25.0	11.5	10.3	4.5	33.6	25.2	6.7	2.5	16.7	9.7	0.0	21.0	17.1	3.9	3.5	18.7	33.4	5.2	18.8	6.6	8.6	23.7
HIVEP2	"HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B"	ENSG00000010818	"HIVEP zinc finger 2"	P31629	6	142751469-142956698	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 326.2;Inhibitory neurons: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055954			Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055954: "	"unprognostic (1.35e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.10e-1)"	7.9	6.9	5.2	10.4	7.8	3.1	6.2	10.1	15.6	4.2	0.0	5.4	4.5	6.1	5.0	8.5	11.4	9.8	7.4	9.5	1.3	6.0	5.6	7.9	12.0	1.0	4.9	13.1	10.1	8.3	5.9	7.2	1.2	5.0	4.3	5.7	8.7	5.1	21.0	8.0	6.0	5.5	0.8	8.2	4.9	1.8	5.8	19.0	8.2	13.9	12.1	13.8	5.5	10.5	6.0	1.1	1.4	5.2	11.1	12.3	4.1	8.5	21.8	5.2	6.3	0.4	4.9	9.5	5.2	37.7	9.9	3.8	2.3	17.4	12.7	3.7	2.7	2.6	3.9	2.4	8.4	8.4	0.1	11.4	16.9	21.3	24.3	12.1	2.8	7.5	0.1	8.4	8.9	6.8	11.1	3.6	1.3	1.4	8.5	14.4	9.3	0.8	4.8	10.4	14.0	5.9	11.3	9.2	6.3	2.5	1.7	4.9	3.0	17.5	4.4	14.8	7.5	17.4	3.1	19.8	4.9	6.4	8.3	0.0	0.1	0.0	0.6	0.2	1.4	0.9	1.4	1.2	0.4	0.4	1.4	1.1	0.9	0.7	0.2	0.2	1.2	0.5	5.2	7.8	10.1	15.6	9.5	1.3	1.0	4.9	1.2	0.8	5.8	10.5	22.2	22.4	25.5	65.6	18.4	94.3	45.2	9.1	5.2	15.1	13.7	7.6	18.3	5.7	27.6	7.3	25.0	2.8	22.4	5.1	0.0	12.5	2.1	53.2	29.4	26.5	3.5	4.2	326.2	14.8	1.2	30.5	2.0	101.0	3.8	6.1	8.6	4.5	2.8	30.3	223.0	4.9	16.2	4.4	52.7	1.2	11.8	17.5	24.9	67.5	5.1	2.5	4.1	98.0	75.3	22.8	6.6	15.8	22.1	53.6	5.3	3.3	25.1	2.2	0.0	37.6	25.7	0.6	0.9	11.5	94.6	4.7	29.5	2.6	3.4	56.8
HIVEP3	"FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C"	ENSG00000127124	"HIVEP zinc finger 3"	Q5T1R4	1	41506365-42035925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.6"	"Group enriched"	"Detected in many"	5	"Astrocytes: 83.9;Excitatory neurons: 219.6;Inhibitory neurons: 271.9;Microglial cells: 163.9;Oligodendrocyte precursor cells: 83.9;Oligodendrocytes: 196.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.8;hTEC/SVTERT24-B: 9.5;Karpas-707: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005728	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA005728: AB_10612117"	"unprognostic (2.87e-3)"	"unprognostic (2.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	1.6	0.6	0.8	2.1	2.1	1.6	1.4	1.4	1.6	0.4	0.0	0.5	0.4	0.4	0.3	1.9	0.5	0.7	0.8	2.0	0.0	1.0	0.3	1.9	1.7	0.7	0.4	0.5	0.8	0.4	2.1	0.6	1.0	1.4	0.5	0.6	1.6	0.3	0.6	4.6	0.6	0.8	0.1	1.1	0.7	0.3	0.5	6.6	1.5	0.4	2.1	1.8	0.5	0.3	1.9	0.6	0.2	1.8	2.2	1.0	0.0	0.9	0.2	2.3	4.0	0.1	0.3	4.0	0.6	1.0	1.5	2.7	0.4	0.4	3.1	18.8	0.5	0.2	0.9	0.0	0.4	0.3	0.3	5.6	0.4	9.5	1.1	0.6	0.5	1.3	0.0	11.0	1.8	1.2	3.0	0.8	0.6	0.6	2.3	2.0	2.9	2.2	1.5	0.4	2.0	0.6	2.6	0.7	0.5	1.1	0.9	3.4	3.4	2.0	2.2	0.6	4.6	3.3	1.4	2.6	8.1	0.2	7.5	0.0	0.5	0.0	0.6	1.1	0.1	0.1	0.2	0.3	0.4	0.4	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.4	0.8	2.1	1.4	1.6	2.0	0.0	0.7	0.4	1.0	0.1	0.5	0.3	5.9	6.4	10.5	83.9	9.6	23.7	26.5	4.3	17.6	16.4	15.1	11.0	6.9	5.7	8.2	1.8	2.1	0.4	17.6	3.5	1.9	3.1	9.9	1.2	7.7	7.5	3.6	4.4	219.6	2.7	4.4	11.1	1.5	2.8	1.3	0.2	11.4	2.5	6.2	25.2	271.9	1.2	2.0	6.5	17.3	31.9	8.7	15.0	5.4	163.9	9.1	16.0	27.8	83.9	196.0	3.1	0.1	4.1	3.3	15.5	1.9	3.2	1.1	3.5	6.6	23.9	7.4	11.3	8.6	23.7	8.7	0.8	14.5	10.0	0.9	11.1
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.4;Erythroid cells: 38.3;Extravillous trophoblasts: 16.1;Granulosa cells: 14.8;Spermatocytes: 37.5;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	0.6	0.6	0.0	5.5	0.1	47.4	1.1	0.1	0.2	0.8	0.1	3.9	4.1	0.9	0.2	5.6	0.3	0.5	0.3	0.1	0.1	0.4	0.8	1.4	12.6	0.1	0.3	0.2	0.2	0.1	0.1	3.0	0.1	0.4	5.2	0.1	1.0	0.1	0.2	3.6	3.8	1.9	0.0	4.1	2.4	11.1	0.3	30.4	0.3	0.0	12.0	1.4	2.0	0.2	54.5	73.6	68.4	32.7	2.6	5.4	42.8	79.5	37.9	55.2	59.9	51.3	57.6	17.1	9.0	31.4	98.0	61.7	54.9	40.9	72.6	40.0	21.6	65.5	61.4	50.9	0.3	54.1	43.2	1.8	1.5	45.1	30.9	15.7	35.5	51.3	56.6	40.8	103.0	55.3	76.4	59.7	58.9	42.2	49.1	58.4	103.0	30.3	28.6	32.3	39.4	24.7	45.8	34.2	31.7	31.0	25.7	42.1	26.0	59.6	64.6	44.3	87.2	38.6	32.7	67.9	35.7	39.3	151.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.5	0.0	2.9	1.3	0.5	1.9	0.0	0.0	0.7	0.5	1.2	0.0	2.1	0.0	0.0	8.2	0.5	5.6	0.0	0.2	17.4	0.3	1.3	1.1	0.0	38.3	0.0	0.0	16.1	2.0	5.1	1.3	0.0	14.8	2.2	0.3	7.1	0.0	0.0	3.5	0.0	3.0	2.9	9.0	0.6	3.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	11.4	1.0	0.5	0.1	0.1	0.0	0.0	0.1	1.9	37.5	16.3	8.9	0.9	1.5	2.3	0.3	7.6	0.9
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075990-33089696	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 278.7;lymphoid tissue: 409.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1569.6;Kupffer cells: 2374.2;Langerhans cells: 12627.8;Macrophages: 2453.8;monocytes: 3754.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 285.5"	"Group enriched"	"Detected in all"	10	"B-cells: 227.8;dendritic cells: 285.5;monocytes: 137.5"	"Group enriched"	"Detected in some"	6	"HDLM-2: 65.9;REH: 26.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		470000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	151.6	101.3	1.0	42.0	1.0	5.8	112.8	3.3	1.3	68.2	0.9	69.4	12.4	50.2	2.9	43.9	55.7	17.2	51.1	0.8	1.8	96.1	38.6	278.7	66.7	1.8	1.3	26.2	32.4	1.0	51.5	0.8	1.8	70.3	2.5	1.5	57.2	6.4	25.1	72.3	176.5	4.7	2.1	409.4	54.1	12.8	1.0	10.9	69.5	1.3	42.2	49.2	56.5	3.0	0.0	0.0	0.1	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	6.2	0.2	0.0	0.1	0.0	0.0	0.0	65.9	1.9	1.5	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.9	0.0	0.0	26.5	0.1	0.3	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.4	0.0	0.1	1.8	0.1	0.2	0.0	0.0	7.2	0.3	4.4	1.1	0.0	0.0	0.5	59.6	4.0	14.8	137.5	1.8	226.6	5.1	22.2	285.5	227.8	2.3	11.9	1.6	8.2	60.3	77.5	22.7	107.8	1.0	1.0	3.3	1.3	0.8	1.8	1.8	1.3	1.8	2.1	1.0	3.0	354.8	67.3	330.7	1.3	1569.6	300.5	26.0	5.6	19.4	26.9	54.0	123.6	10.3	67.2	62.3	29.5	16.7	4.8	692.9	7.8	3.9	58.3	3.6	2.0	16.3	297.8	9.6	87.9	1.3	15.6	8.1	62.3	48.4	2.7	61.6	13.6	97.1	8.8	1099.4	8.4	1.6	13.0	10.2	2374.2	12627.8	10.1	27.4	2453.8	323.7	20.6	3754.7	43.3	203.9	2.5	0.2	7.4	10.0	21.1	50.9	28.2	154.7	60.2	54.4	21.9	46.0	21.4	47.5	1.3	7.8	6.4	233.3	9.0	200.7	3.9	23.0	51.7
HLF	MGC33822	ENSG00000108924	"HLF transcription factor, PAR bZIP family member"	Q16534	17	55264960-55325187	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 122.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 120.7;Excitatory neurons: 77.5;Hepatocytes: 156.8;Horizontal cells: 92.5;Microglial cells: 74.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 53.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 163.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA068156: AB_2685963, HPA071210: AB_2686361"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	15.1	21.5	9.8	1.9	23.1	0.4	15.4	0.0	53.3	14.4	0.0	18.0	1.4	14.4	11.0	26.3	12.2	7.8	24.1	17.6	0.0	12.7	122.4	13.4	2.2	0.0	0.6	50.0	2.9	4.0	9.9	1.0	0.0	13.2	3.4	43.2	24.1	12.4	7.7	16.7	4.3	12.3	0.0	8.2	6.1	4.1	3.9	3.4	34.3	9.9	7.7	12.3	7.8	17.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.9	0.5	0.0	0.0	0.0	0.4	0.2	0.0	27.3	0.7	0.0	0.1	163.0	0.1	0.9	0.2	0.1	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.6	1.1	0.0	0.1	0.0	2.4	0.0	0.4	0.4	13.0	0.1	11.1	0.6	0.0	7.2	0.2	0.0	0.2	0.0	0.1	0.8	0.2	0.6	0.5	5.1	4.9	0.0	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.8	23.1	0.0	53.3	17.6	0.0	0.0	0.6	0.0	0.0	3.9	17.2	13.8	3.2	42.8	22.2	0.4	22.3	4.4	1.4	56.9	120.7	5.9	16.4	38.6	12.8	6.3	7.3	10.4	0.1	0.5	0.0	11.7	1.9	1.3	0.1	6.2	19.7	3.0	0.8	77.5	0.9	0.0	17.6	0.0	0.6	0.0	0.5	6.1	156.8	0.1	92.5	36.6	0.6	0.0	3.5	4.0	4.7	28.3	0.7	10.6	74.0	0.1	60.7	0.0	24.6	6.9	0.4	0.0	39.1	1.5	1.3	2.8	23.3	1.0	15.0	13.1	4.5	7.4	0.4	5.0	33.7	27.6	1.2	3.8	0.5	0.4	0.4
HLTF	"HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3"	ENSG00000071794	"Helicase like transcription factor"	Q14527	3	149030127-149086554	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 143.4;Spermatogonia: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015284, HPA049001"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA015284: AB_1857263, HPA049001: AB_2680594"	"unprognostic (3.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.07e-2)"	12.2	23.6	10.3	7.4	11.9	11.5	13.8	20.7	12.0	11.1	17.6	9.9	5.3	13.6	10.2	7.5	11.5	9.3	19.0	10.3	13.4	16.9	18.5	7.8	11.9	13.1	12.6	18.8	13.6	17.2	12.4	8.2	13.9	15.7	7.5	27.6	11.1	11.6	11.6	5.6	6.8	12.1	15.1	8.7	9.9	44.7	12.2	15.8	21.0	11.4	11.2	8.3	6.0	17.5	66.7	31.8	44.3	34.6	29.0	37.3	4.3	44.1	26.2	32.0	37.0	25.8	45.1	42.7	52.3	20.6	62.3	1.9	60.1	17.5	52.9	23.7	29.1	102.6	23.6	10.5	18.1	27.2	40.7	23.7	9.3	23.9	13.9	48.4	18.7	68.1	36.5	26.9	44.2	33.5	56.4	40.9	33.5	33.3	39.3	64.2	49.8	6.6	26.2	21.1	43.5	25.6	66.9	30.4	60.8	23.3	91.5	25.9	13.2	37.1	22.4	53.1	48.5	39.3	23.5	55.4	36.2	36.3	14.6	8.2	1.0	3.5	4.3	1.7	8.0	6.9	3.8	5.8	3.4	4.9	5.6	5.7	0.0	4.7	1.9	7.8	3.9	2.8	10.3	11.9	20.7	12.0	10.3	13.4	13.1	12.6	13.9	15.1	12.2	17.5	19.5	25.6	20.4	56.8	15.6	5.6	8.5	12.9	10.8	99.3	20.1	16.5	46.4	18.6	18.5	31.3	41.7	10.2	29.9	1.9	35.2	10.1	9.9	36.7	31.1	14.3	4.9	71.5	67.5	8.4	10.1	27.6	12.8	11.7	55.7	55.8	13.2	17.2	8.7	47.1	88.7	6.9	18.3	4.6	3.1	12.3	33.8	11.9	5.4	28.1	5.2	35.4	12.3	66.4	68.7	7.4	3.6	32.4	19.3	8.2	2.0	19.2	26.2	76.2	13.1	37.5	23.8	143.4	113.2	11.5	4.3	1.6	22.1	100.6	7.5	6.6
HLX	"HB24, HLX1"	ENSG00000136630	"H2.0 like homeobox"	Q14774	1	220879431-220885059	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 86.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.7;Endothelial cells: 32.5;Hepatic stellate cells: 47.5;Hofbauer cells: 34.1;Kupffer cells: 24.8;Langerhans cells: 23.5;monocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 65.1;neutrophil: 55.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 65.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 32.4;THP-1: 100.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005968	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA005968: AB_1079066"	"unprognostic (6.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.28e-6)"	"unprognostic (8.44e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	35.2	4.7	1.4	10.3	1.3	86.5	18.6	1.4	2.0	7.5	1.5	44.4	4.8	5.5	0.5	3.9	9.3	9.6	18.9	2.0	1.6	6.8	21.8	23.1	8.5	1.9	1.7	4.2	4.3	1.3	3.0	13.8	2.0	6.3	2.0	0.0	3.5	0.4	9.2	8.7	18.9	5.6	1.9	15.7	5.2	1.8	2.6	2.1	9.5	4.2	2.3	11.0	8.8	1.9	0.0	2.1	0.0	3.2	9.2	14.7	3.0	11.4	18.9	12.8	10.6	0.2	0.3	0.0	0.1	6.8	2.5	0.0	0.5	0.0	5.3	3.0	5.9	0.0	1.1	0.3	15.1	3.9	0.8	15.4	0.2	14.7	0.8	1.1	5.7	0.0	4.0	0.0	1.6	0.0	0.0	10.3	0.3	0.0	5.2	0.3	9.0	0.1	0.8	0.1	0.0	2.4	0.7	0.0	32.4	0.1	0.0	100.4	1.8	8.7	0.0	1.3	9.3	0.0	0.0	0.0	14.1	12.3	3.6	65.1	10.4	22.3	0.0	3.4	0.0	5.7	0.0	0.0	13.0	2.7	0.0	0.0	55.9	0.7	0.7	8.7	0.4	3.3	1.4	1.3	1.4	2.0	2.0	1.6	1.9	1.7	2.0	1.9	2.6	1.9	35.7	9.6	5.3	1.0	4.3	2.8	0.1	0.0	0.6	0.1	0.5	1.3	5.7	0.0	0.0	0.0	0.0	0.6	3.0	0.4	0.0	0.5	0.5	0.2	2.6	32.5	0.0	8.4	0.3	0.4	0.7	8.4	0.5	0.3	3.8	0.1	47.5	10.8	34.1	0.0	0.2	0.3	0.0	24.8	23.5	0.4	2.5	17.8	0.0	4.7	44.2	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.2	0.0	0.1	0.0	0.0	6.6	7.5	10.6	0.1	2.2	0.3	3.1	0.4	1.1	0.4	0.3	0.4
HMBOX1	"FLJ21616, HNF1LA, HOT1, PBHNF"	ENSG00000147421	"Homeobox containing 1"	Q6NT76	8	28890395-29064764	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.0"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 125.7;Oligodendrocyte precursor cells: 118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055855, HPA058586, CAB070418"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764"	"unprognostic (2.68e-3)"	"unprognostic (2.30e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-1)"	4.6	6.7	7.6	5.1	11.9	10.8	4.2	10.6	5.7	3.7	1.7	3.8	3.1	4.4	3.0	3.2	3.7	4.2	4.5	5.3	17.9	4.3	4.2	4.6	5.3	15.0	20.0	6.1	3.3	5.0	1.8	6.8	15.6	2.9	3.9	6.2	3.1	2.5	2.8	4.4	4.3	5.2	10.4	5.7	4.3	7.6	11.6	4.9	6.2	3.7	5.9	3.8	2.4	12.9	6.2	6.8	7.1	8.2	6.5	6.7	6.0	2.6	3.5	4.0	4.3	3.1	3.9	15.1	6.3	4.5	6.0	5.3	14.4	5.3	5.6	5.5	2.4	15.6	13.8	4.2	5.3	5.4	10.2	3.3	7.5	5.3	10.1	4.9	9.1	9.0	22.7	14.4	5.7	3.8	9.9	2.7	5.0	6.6	1.6	8.1	7.1	3.4	2.8	11.5	3.0	9.2	5.1	3.9	5.4	5.9	3.9	4.8	13.0	3.6	16.8	3.9	3.8	4.4	4.8	5.9	4.6	6.5	5.4	3.2	2.4	1.1	1.9	2.6	2.7	3.4	1.9	1.8	2.5	2.6	2.4	2.4	1.4	1.2	4.7	1.9	0.8	1.4	7.6	11.9	10.6	5.7	5.3	17.9	15.0	20.0	15.6	10.4	11.6	12.9	25.5	16.0	18.1	125.7	30.3	16.7	15.8	18.1	15.9	24.4	15.3	10.5	23.6	20.0	14.0	29.5	39.6	12.9	18.7	16.2	15.6	8.3	93.0	15.0	21.2	34.2	17.4	19.6	90.1	14.4	14.1	19.2	11.2	29.4	17.1	36.7	68.6	13.7	10.3	30.3	109.8	12.9	22.4	19.8	36.4	31.5	35.8	20.1	16.0	91.8	21.4	28.3	26.8	118.1	111.8	14.1	11.3	31.6	14.4	21.0	20.4	8.8	14.3	31.6	19.7	34.6	17.3	43.6	15.2	10.1	19.7	19.2	22.8	19.5	14.7	22.6
HMCES	"C3orf37, DC12, SRAPD1"	ENSG00000183624	"5-hydroxymethylcytosine binding, ES cell specific"	Q96FZ2	3	129278828-129306186	"Predicted intracellular proteins"	"DNA damage"	"DNA-binding, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 124.9;Spermatocytes: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044968	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA044968: AB_2679160"	"unprognostic (9.18e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.16e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.08e-3)"	35.8	22.0	27.6	37.3	32.5	37.8	32.9	26.6	32.4	25.8	22.4	36.1	29.4	24.0	23.0	41.7	27.0	21.1	40.3	29.8	30.1	27.4	53.7	27.1	99.7	27.3	27.6	28.3	15.3	68.9	22.2	20.9	27.6	24.6	30.9	27.7	26.8	26.2	57.7	35.5	28.8	23.2	26.4	29.8	26.4	39.9	32.5	57.1	22.4	48.5	131.0	28.5	28.8	27.1	149.4	66.2	74.4	85.9	90.6	37.8	66.8	51.2	41.5	73.1	56.6	105.0	67.9	286.0	53.9	46.9	57.2	106.3	94.8	110.8	83.7	58.0	51.2	59.7	52.7	76.0	38.8	52.1	41.9	36.7	56.6	61.1	60.2	35.6	45.5	63.5	61.2	244.2	40.9	197.3	74.8	45.1	48.4	108.5	42.8	66.6	63.8	50.5	77.0	88.8	74.0	45.6	114.4	70.8	70.6	45.6	121.0	52.1	36.8	36.3	63.7	87.3	66.5	135.8	87.2	289.3	43.4	41.9	41.1	35.5	25.5	65.0	30.4	27.4	31.6	37.5	36.7	36.3	26.3	62.1	36.1	40.0	52.5	27.2	40.9	28.1	48.0	31.2	27.6	32.5	26.6	32.4	29.8	30.1	27.3	27.6	27.6	26.4	32.5	27.1	26.1	32.1	25.6	11.4	23.5	58.2	71.2	72.4	54.7	21.5	18.8	16.1	35.6	30.0	30.4	22.0	10.4	49.2	32.0	30.8	37.2	39.6	8.6	16.0	10.2	27.8	21.0	28.2	13.6	47.0	37.6	23.3	17.9	15.7	22.2	11.0	20.7	26.1	19.7	26.9	14.7	17.3	32.6	8.1	39.4	8.6	24.5	15.7	58.7	10.3	16.4	38.6	25.7	7.1	10.6	33.8	16.9	31.2	124.9	37.3	19.9	21.1	25.2	12.5	13.1	21.0	27.1	127.8	83.6	30.7	43.9	35.0	47.3	23.9	30.7	61.0
HMG20A	"FLJ10739, HMGX1, HMGXB1"	ENSG00000140382	"High mobility group 20A"	Q9NP66	15	77420412-77485607	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008126	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA008126: AB_1079072"	"unprognostic (2.04e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	12.2	18.2	14.5	15.9	14.2	10.2	14.2	15.1	17.6	15.2	7.8	15.4	12.4	20.3	13.6	13.4	13.2	15.5	25.1	14.4	14.8	14.0	24.9	15.7	25.2	11.5	12.9	22.2	13.0	18.1	9.7	21.8	11.3	11.6	17.0	26.0	13.5	13.9	27.2	13.4	14.2	15.7	12.0	35.8	13.6	21.3	15.0	31.6	15.0	26.4	22.1	14.4	10.8	16.6	17.8	29.8	53.8	38.4	22.4	28.4	21.6	23.2	34.6	27.2	29.5	18.6	26.7	30.2	26.4	27.0	21.0	23.8	76.6	29.3	27.6	27.1	38.4	62.3	26.6	24.5	33.4	46.1	35.7	31.9	20.9	24.2	26.8	36.3	54.9	38.9	47.8	24.6	25.1	14.1	36.8	32.1	39.0	15.8	14.2	48.0	52.1	34.2	31.1	30.7	21.1	45.3	37.5	22.6	70.6	51.2	22.3	48.3	33.8	32.3	28.4	15.2	28.4	33.2	75.7	59.9	24.1	66.3	38.4	9.2	20.8	16.9	29.1	21.2	34.4	31.3	22.9	27.3	27.8	27.3	30.8	27.3	3.4	49.2	26.1	21.1	23.7	24.9	14.5	14.2	15.1	17.6	14.4	14.8	11.5	12.9	11.3	12.0	15.0	16.6	14.6	12.8	11.5	39.2	18.1	8.8	5.3	10.0	13.6	20.6	13.0	12.3	47.2	14.3	10.7	11.0	25.0	13.7	12.9	12.2	5.9	9.9	25.9	10.4	21.1	16.8	18.0	15.4	60.1	8.0	9.5	17.2	13.7	10.0	12.7	16.5	22.9	32.4	16.6	38.7	56.9	15.6	6.1	28.6	11.9	79.5	12.8	13.0	14.2	29.0	22.1	14.3	19.6	64.3	71.1	9.0	10.8	13.9	13.3	6.0	8.4	10.6	4.9	20.6	19.7	13.4	13.2	28.2	17.0	11.3	7.4	13.8	16.4	25.5	13.8	5.5
HMG20B	"BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL"	ENSG00000064961	"High mobility group 20B"	Q9P0W2	19	3572777-3579088	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 265.7;Melanocytes: 229.5;Syncytiotrophoblasts: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 411.1;WM-115: 405.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050220, HPA053157, HPA069832"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA050220: AB_2681056, HPA053157: AB_2682061, HPA069832: AB_2686210"	"unprognostic (2.97e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (1.72e-7)"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.89e-5)"	50.4	41.4	27.3	18.2	29.3	30.1	49.9	29.1	33.7	50.9	29.4	59.0	28.1	54.5	15.6	48.1	44.7	16.8	36.8	26.0	27.5	56.0	54.4	38.3	20.1	32.6	28.4	38.0	38.1	30.3	18.1	22.7	31.8	68.9	17.2	8.8	49.9	25.6	25.9	58.3	47.6	19.9	29.6	39.2	54.2	36.0	30.3	48.2	39.3	12.0	15.9	49.0	43.8	34.1	93.1	39.0	34.6	83.0	42.2	38.1	64.1	58.7	42.4	52.6	40.0	14.1	33.5	50.5	53.7	42.6	47.5	44.4	20.3	40.0	31.3	45.1	46.6	24.8	132.2	37.7	27.2	33.9	117.5	32.5	47.0	30.2	20.0	53.4	53.4	44.8	42.0	81.9	35.0	126.3	64.7	62.0	39.7	78.5	78.4	42.3	60.4	69.5	39.0	58.4	21.7	66.0	81.7	141.3	411.1	32.4	106.8	90.5	77.4	27.7	62.1	99.3	50.8	76.4	43.0	36.2	72.0	85.6	405.1	44.9	68.1	66.2	40.1	70.1	35.8	35.2	34.1	43.6	66.1	30.2	36.3	35.3	37.9	59.5	77.0	59.5	41.4	51.8	27.3	29.3	29.1	33.7	26.0	27.5	32.6	28.4	31.8	29.6	30.3	34.1	50.1	28.9	19.3	9.8	27.9	70.5	52.1	67.4	47.8	3.4	75.0	70.9	8.7	28.6	40.0	18.4	10.4	122.9	34.1	50.0	92.0	65.0	26.7	39.7	41.4	42.5	66.8	24.4	0.7	45.5	265.7	35.4	32.6	44.4	37.5	58.1	38.6	20.9	81.9	8.4	0.7	170.8	57.0	29.6	93.4	49.6	37.3	47.1	229.5	3.7	86.2	41.2	42.2	0.5	11.7	58.6	68.5	44.8	34.9	62.8	74.7	76.2	29.5	18.7	32.9	22.4	53.4	39.9	17.4	53.0	79.8	303.7	30.8	49.6	68.7	62.9
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 275.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 947.5;Cytotrophoblasts: 894.3;Pancreatic endocrine cells: 1838.5;Prostatic glandular cells: 1483.3;Syncytiotrophoblasts: 822.8;Urothelial cells: 1681.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032200, HPA065612, HPA068442"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		72000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	28.1	9.0	22.1	79.6	20.9	184.0	27.4	17.8	27.3	93.3	2.6	59.9	118.7	22.8	16.7	275.1	41.0	39.2	35.8	24.1	23.3	89.2	20.0	46.5	139.3	24.3	19.1	4.7	31.9	15.0	15.4	82.4	21.1	27.7	57.2	32.2	69.7	12.6	119.7	141.6	103.6	9.7	15.4	68.7	73.3	80.1	22.9	156.0	31.5	35.1	154.7	100.1	109.6	25.2	1418.7	547.0	274.2	192.9	124.8	916.6	1193.8	556.0	628.8	421.5	233.4	361.3	960.0	658.9	273.1	229.1	264.0	294.7	326.2	991.8	332.3	146.0	228.2	202.6	177.1	488.2	263.7	732.1	227.3	396.1	109.4	765.1	395.8	1083.8	1290.0	369.3	832.0	32.9	596.0	143.0	650.0	898.8	1340.9	697.5	950.3	947.6	6.2	728.0	286.6	128.4	477.0	202.5	59.3	278.3	533.3	430.2	112.2	775.8	1132.1	218.5	691.2	321.3	528.0	260.5	444.5	867.4	461.2	301.7	1115.0	18.7	26.6	35.5	24.4	26.8	32.2	63.5	45.0	39.0	79.6	39.5	52.0	42.9	6.7	20.1	26.5	86.6	55.8	30.7	22.1	20.9	17.8	27.3	24.1	23.3	24.3	19.1	21.1	15.4	22.9	25.2	11.0	28.9	21.7	2.3	117.8	432.3	947.5	181.3	109.8	29.0	88.8	47.4	30.8	28.6	106.1	40.5	4.2	894.3	70.3	173.5	46.9	755.3	7.2	50.5	14.6	113.9	117.0	268.3	5.4	277.5	799.8	72.0	79.5	115.3	66.7	8.3	18.2	12.3	377.2	11.8	5.7	226.4	97.6	74.0	149.9	24.5	5.6	94.3	90.7	1.0	74.3	44.1	33.0	4.5	2.7	1838.5	249.1	2.6	198.2	1483.3	174.5	15.8	21.7	41.9	0.0	18.6	77.7	40.2	417.6	224.7	361.4	822.8	66.6	0.9	364.3	1681.0
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824460-65966291	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.9;testis: 3.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 16.0;Early spermatids: 18.4;Glandular and luminal cells: 17.3;Granulosa cells: 29.7;Pancreatic endocrine cells: 19.9;Smooth muscle cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 324.4;hTERT-RPE1: 232.6;SuSa: 216.1"									"CAB017809, HPA039076"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB017809: , HPA039076: AB_2676335"	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.86e-4)"	0.4	0.0	0.3	0.3	0.2	4.9	0.2	0.7	0.5	1.1	0.0	2.1	1.3	0.4	0.0	0.3	1.2	0.3	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.6	0.9	0.0	0.4	0.2	0.2	0.0	2.4	0.5	0.1	0.1	1.5	0.4	1.0	0.1	0.1	0.1	1.1	3.8	0.2	0.2	0.6	0.2	0.1	0.1	0.1	0.4	47.9	21.4	324.4	45.8	15.0	82.0	0.1	148.5	68.5	26.0	25.8	28.1	19.8	0.0	92.3	7.0	120.0	20.5	54.2	129.3	123.8	0.2	56.2	0.2	0.7	169.3	8.4	4.7	0.4	62.7	8.0	55.2	98.4	232.6	105.0	0.2	0.1	0.6	149.9	0.2	0.4	27.8	190.3	4.6	89.2	12.7	16.1	0.1	68.9	0.3	0.0	0.0	0.1	0.1	85.0	216.1	0.5	0.7	120.8	89.5	26.9	71.2	45.3	0.2	0.2	0.4	112.0	0.3	21.4	1.4	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.6	0.1	0.0	0.0	0.3	0.2	0.7	0.5	0.2	0.1	0.4	0.2	0.2	0.1	0.2	0.4	0.0	0.0	1.1	5.9	0.2	0.0	3.6	16.0	2.8	0.0	0.1	0.1	1.7	0.0	3.0	0.0	0.0	0.8	0.0	5.0	0.0	2.5	18.4	10.4	0.8	0.6	0.0	7.4	0.8	0.8	0.5	2.3	3.1	17.3	0.0	29.7	0.7	0.0	9.0	0.0	0.9	5.1	4.1	0.0	0.0	9.0	0.3	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.9	19.9	4.5	0.0	0.4	5.5	4.0	0.3	7.3	0.0	0.0	1.1	33.7	13.5	0.6	0.3	0.1	0.8	0.3	0.3	8.4	1.1
HMGB1	"DKFZp686A04236, HMG1, HMG3, SBP-1"	ENSG00000189403	"High mobility group box 1"	P09429	13	30456704-30617597	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003506, CAB005873, HPA073663"	Supported		Supported	Nucleoplasm	"Secreted to blood"	NA	NA		2800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB005873: AB_444360, HPA003506: AB_1079070, HPA073663: "	"unprognostic (9.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.28e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.97e-2)"	312.0	224.3	266.2	355.1	282.2	1021.3	318.2	267.6	362.4	319.0	227.0	327.8	281.9	363.6	270.1	297.0	265.5	227.0	242.2	250.1	282.9	243.7	360.8	242.2	664.8	281.5	273.3	254.9	189.3	226.1	163.3	252.1	286.2	265.9	381.2	174.8	224.5	280.1	388.5	244.2	309.2	319.5	277.7	284.9	269.0	153.9	269.9	900.3	267.4	364.7	738.9	282.7	274.1	308.2	816.7	617.4	1402.5	1054.0	384.5	380.1	551.4	1012.6	547.9	957.3	643.5	983.6	1328.6	1639.3	515.5	924.0	880.6	886.5	1484.7	817.4	1639.6	869.6	622.4	1727.4	455.4	913.5	210.3	2513.6	1009.8	253.4	426.0	713.3	656.6	497.8	1302.2	1350.8	1167.9	571.7	855.6	1508.3	3224.3	2682.1	1184.3	1424.3	683.7	2673.3	1927.8	965.8	908.1	792.8	1264.0	1139.8	928.6	682.0	541.0	672.3	668.5	1857.9	814.7	637.2	921.8	689.7	1197.1	513.9	714.8	3508.3	261.1	1634.0	1369.3	1036.6	503.7	926.1	467.3	410.9	522.1	582.6	532.3	530.7	520.1	590.7	477.4	459.7	631.7	615.4	411.0	512.5	702.6	1072.0	266.2	282.2	267.6	362.4	250.1	282.9	281.5	273.3	286.2	277.7	269.9	308.2	948.9	458.3	496.6	188.4	920.7	791.1	986.7	942.7	752.4	414.3	471.9	630.0	172.5	561.9	561.3	603.2	131.3	998.9	759.9	408.1	766.9	941.3	113.4	611.2	1040.2	766.0	423.0	1808.9	58.5	967.2	1441.4	676.5	486.3	728.3	546.8	772.2	589.0	749.5	728.8	196.9	47.2	675.6	710.1	549.9	884.4	107.2	720.1	694.2	674.1	81.5	578.7	609.9	879.5	99.5	149.3	1212.3	554.8	666.9	1252.9	811.2	506.7	827.5	418.7	252.8	650.8	588.9	1005.9	549.1	1211.0	1045.8	691.9	465.7	797.9	515.7	839.1	867.9
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331376-173334432	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"bone marrow: 2347.2;lymphoid tissue: 939.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 1915.4;Extravillous trophoblasts: 872.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 798.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 2454.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314, HPA073663"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"	NA	Yes		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109, HPA073663: "	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	90.3	31.0	36.3	146.1	38.4	2347.2	89.1	35.4	49.9	79.0	33.0	117.1	93.2	92.3	47.3	115.6	78.8	43.5	85.8	33.2	38.3	74.3	37.8	83.8	390.4	37.5	36.8	118.9	27.2	18.3	35.4	111.0	38.0	46.9	122.2	134.1	59.8	35.2	72.4	75.1	108.7	65.5	36.3	159.5	66.0	136.0	36.1	939.2	56.4	57.0	388.9	68.2	86.1	40.1	498.2	114.6	976.8	444.4	118.2	118.2	375.1	366.3	271.3	386.7	345.7	329.0	673.6	1645.5	79.2	203.0	207.4	190.3	645.0	196.1	601.0	1004.0	303.4	1823.2	308.8	487.8	115.7	1642.8	683.4	114.7	59.2	194.2	439.1	211.5	402.8	866.1	703.9	2282.4	358.9	409.9	2454.9	1513.7	355.4	289.4	199.3	1226.7	499.7	620.4	227.0	208.8	838.6	759.0	365.5	209.6	166.6	340.8	291.1	1173.2	236.0	175.5	513.6	219.0	554.9	734.8	437.1	1869.4	149.1	1178.4	464.4	798.0	135.9	407.0	94.1	57.6	86.2	72.5	137.8	131.1	112.8	57.6	88.4	85.3	316.7	83.0	49.1	43.2	266.4	107.6	36.3	38.4	35.4	49.9	33.2	38.3	37.5	36.8	38.0	36.3	36.1	40.1	167.0	28.9	64.1	5.9	153.2	158.8	141.5	131.8	75.1	48.9	75.3	107.8	229.0	38.6	78.3	55.2	35.5	472.6	222.9	116.5	142.8	25.9	30.4	71.2	71.7	128.0	74.7	1915.4	2.7	16.1	872.5	121.5	63.2	76.5	110.6	210.5	171.7	26.5	210.1	45.4	4.7	191.2	109.9	295.0	142.9	33.1	105.3	233.9	67.6	6.5	241.9	81.8	132.8	1.0	4.8	11.3	75.2	57.6	268.6	114.2	65.4	51.0	149.8	143.5	78.9	71.7	134.4	493.6	400.9	233.6	134.0	128.7	289.5	42.3	284.7	89.0
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990771	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 136.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 419.1;Extravillous trophoblasts: 820.7;Syncytiotrophoblasts: 1400.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 11.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 738.7;U-698: 675.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062583, HPA073663"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Nucleoli	"HPA062583: AB_2684800, HPA073663: "	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	8.9	13.7	10.5	19.7	10.5	85.6	15.6	10.4	20.3	34.0	6.5	43.9	27.1	16.4	44.8	26.1	16.9	9.7	11.3	14.5	13.9	19.6	101.4	15.9	25.2	13.0	11.2	5.9	17.2	85.4	4.2	136.6	11.3	13.9	32.4	3.1	23.8	15.9	53.5	19.2	28.1	13.8	10.2	21.2	16.1	40.1	13.4	65.2	14.3	8.9	35.8	18.7	10.5	9.5	263.5	115.5	351.9	184.2	14.5	42.9	437.4	112.9	73.6	127.9	66.1	91.6	106.0	183.0	354.8	87.5	72.3	123.3	324.4	738.7	143.3	125.6	94.7	159.4	110.2	145.6	21.5	243.9	78.0	33.9	171.6	52.5	131.5	32.7	168.3	110.5	84.5	105.4	154.2	201.9	269.3	186.2	209.2	171.0	138.1	325.4	286.3	103.6	95.2	125.3	252.7	164.4	167.4	177.7	56.0	199.3	157.8	158.5	128.0	53.0	123.9	169.9	253.1	94.9	128.7	675.7	63.1	121.3	109.9	0.0	4.3	11.3	0.4	3.0	0.1	2.7	2.0	2.9	6.1	0.5	0.0	0.2	0.7	0.8	5.0	3.1	5.8	2.5	10.5	10.5	10.4	20.3	14.5	13.9	13.0	11.2	11.3	10.2	13.4	9.5	10.4	38.5	31.2	0.7	15.1	23.7	18.9	158.6	12.5	0.5	24.2	16.0	16.0	8.6	123.5	31.3	2.1	419.1	4.5	32.1	37.2	82.4	232.3	61.9	18.9	19.6	65.7	136.1	1.3	86.5	820.7	17.6	22.4	55.9	8.2	44.2	13.6	84.4	101.0	0.0	3.7	37.0	219.7	20.8	43.7	75.9	3.7	22.1	21.4	2.8	23.6	4.1	1.0	1.5	0.5	91.5	35.7	3.4	47.1	27.5	31.8	66.5	113.3	1.8	0.0	39.8	29.0	22.7	50.2	41.1	20.3	1400.2	10.1	10.4	60.7	18.5
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43287470-43313512	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 390.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 511.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 797.7;GAMG: 523.5;HBEC3-KT: 467.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		470000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	19.2	55.2	25.2	27.2	32.9	15.8	40.1	23.0	38.6	56.4	16.8	50.2	93.6	19.8	36.1	137.5	12.4	23.3	16.1	36.1	44.6	32.8	390.2	51.4	21.5	46.5	34.7	21.6	26.6	31.7	15.0	22.5	47.2	40.5	45.4	34.2	53.2	15.7	17.8	85.9	47.2	19.9	24.7	14.8	43.4	33.2	35.3	19.1	23.6	16.7	31.5	18.3	69.5	30.4	103.4	48.8	797.7	93.0	45.8	178.4	54.1	16.2	63.8	22.8	45.2	86.6	146.6	108.4	35.6	23.3	523.5	80.2	199.7	467.2	24.1	23.5	240.7	40.1	45.3	119.3	71.3	88.0	28.0	98.5	56.2	119.5	47.9	14.0	23.7	98.4	73.1	291.7	19.4	48.9	81.3	111.9	143.1	41.7	25.9	57.5	111.9	121.8	357.7	158.2	68.2	33.0	83.6	41.4	25.9	114.5	63.6	116.7	28.3	17.1	85.7	18.0	15.5	38.8	64.0	148.3	15.0	106.2	15.5	3.3	1.8	1.9	2.4	3.3	2.4	3.8	2.6	3.4	3.5	2.9	2.2	3.1	3.0	3.2	3.6	2.9	2.6	1.6	25.2	32.9	23.0	38.6	36.1	44.6	46.5	34.7	47.2	24.7	35.3	30.4	27.8	67.3	172.6	70.5	44.8	108.3	42.3	93.8	68.3	43.6	46.3	30.0	8.9	47.1	79.2	47.8	52.1	22.3	43.3	211.2	13.7	43.0	9.0	47.1	20.2	31.3	92.1	22.3	44.9	59.8	41.1	32.3	100.4	98.6	58.5	56.6	22.1	511.7	25.5	48.8	42.6	101.9	75.3	21.9	38.2	3.2	12.8	27.5	26.6	15.0	49.1	26.4	14.4	53.3	41.8	50.4	132.3	14.3	38.1	149.2	56.8	21.4	51.1	50.1	0.0	40.1	32.8	20.0	8.7	197.9	236.4	44.5	36.4	129.4	62.9	74.5
HMGN1	"FLJ27265, FLJ31471, HMG14, MGC104230, MGC117425"	ENSG00000205581	"High mobility group nucleosome binding domain 1"	P05114	21	39342315-39349647	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012260, HPA048694"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB012260: AB_304786, HPA048694: AB_2680496"	"unprognostic (4.49e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.21e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (5.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (8.74e-7)"	"unprognostic (3.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.84e-2)"	"unprognostic (8.98e-3)"	56.1	73.7	54.1	120.5	52.3	202.4	121.4	52.0	63.7	115.8	54.6	126.0	121.3	78.8	187.6	124.8	100.2	72.9	39.1	53.3	58.7	114.4	100.8	72.5	219.1	57.1	57.5	72.9	92.2	132.1	73.8	111.6	55.7	93.2	136.2	245.5	97.1	75.2	16.2	82.5	133.6	65.3	57.2	100.9	113.2	64.8	56.4	238.7	117.2	26.3	294.9	114.2	73.8	58.5	517.7	135.9	450.3	316.3	74.5	131.1	299.7	266.6	191.8	261.0	233.0	262.6	420.6	1161.6	246.8	223.7	309.8	106.5	317.4	377.9	336.1	459.5	317.7	883.6	225.7	355.8	187.0	768.2	291.3	167.4	349.9	260.2	350.6	222.4	363.6	513.6	680.2	191.6	436.7	686.7	780.2	691.0	798.0	682.3	237.8	853.2	224.7	466.0	469.5	308.3	386.3	362.2	582.8	364.1	356.0	183.1	479.5	807.5	239.6	127.2	128.7	94.0	279.7	235.6	394.8	690.7	179.4	882.9	341.4	103.7	76.4	282.5	138.0	68.9	153.5	228.9	175.2	143.7	216.5	205.8	195.2	172.2	53.8	174.5	67.7	294.9	221.5	231.4	54.1	52.3	52.0	63.7	53.3	58.7	57.1	57.5	55.7	57.2	56.4	58.5	169.9	93.0	139.7	55.2	420.4	278.5	532.0	674.9	233.9	265.1	650.7	412.6	56.1	307.4	349.0	285.1	331.5	599.2	405.1	306.8	737.6	479.9	642.8	304.4	287.3	223.3	345.2	275.6	34.9	350.5	970.7	196.6	221.7	309.2	219.9	277.8	135.7	176.2	533.9	240.6	55.1	442.1	514.7	176.1	389.6	180.6	175.8	279.6	243.7	45.0	415.1	427.8	358.4	96.5	68.8	381.0	307.4	200.1	335.9	684.7	327.8	625.4	226.8	1301.8	32.9	122.0	179.5	81.9	149.1	399.7	313.7	602.1	326.1	289.2	537.1	699.9
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472440-26476642	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		640000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: AB_2686835"	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	216.3	225.6	180.2	254.5	187.3	1137.3	234.8	179.6	251.3	328.1	162.5	280.3	176.3	283.8	359.3	291.1	293.4	142.9	192.5	170.6	183.1	259.7	212.9	259.2	436.5	185.1	178.8	394.6	252.5	160.4	328.7	214.9	188.4	281.6	301.1	285.0	217.1	162.8	251.8	242.8	270.0	235.8	188.7	324.3	224.7	160.4	175.8	916.1	306.1	133.5	534.0	245.1	250.7	211.6	1074.5	304.8	1192.5	496.5	112.0	251.6	390.8	517.2	331.2	1089.4	835.7	305.8	1073.1	1107.2	443.1	482.3	338.4	627.8	1564.6	565.6	1001.7	684.2	906.7	1222.2	401.5	360.2	197.7	2793.6	738.7	254.9	303.4	602.1	369.1	245.1	541.7	866.8	964.3	643.0	623.0	690.8	1906.1	1363.3	922.7	1463.0	619.6	1384.3	1598.6	776.5	380.3	278.6	1064.5	641.1	1384.3	498.7	651.4	304.9	759.0	1508.9	322.3	536.9	920.4	977.1	943.6	641.2	899.2	1266.9	338.9	2989.0	1056.9	331.8	530.8	1430.5	279.2	622.3	267.3	532.2	379.7	343.3	531.5	505.6	412.4	337.7	462.4	355.5	690.4	704.7	746.7	1084.6	180.2	187.3	179.6	251.3	170.6	183.1	185.1	178.8	188.4	188.7	175.8	211.6	128.7	342.9	394.4	28.1	459.3	288.6	323.8	383.2	211.1	180.2	353.0	241.3	93.4	221.6	314.8	261.1	141.8	898.7	325.2	227.2	371.7	218.4	204.3	328.9	291.1	190.3	576.9	980.4	14.4	268.7	606.4	435.4	263.5	278.1	383.0	375.0	185.6	147.5	763.0	94.2	22.2	564.5	193.3	434.3	467.9	53.5	185.8	477.5	227.7	15.0	655.6	376.0	399.6	15.1	36.9	93.7	304.4	151.9	669.5	250.4	238.0	320.4	495.6	370.2	124.9	249.0	325.7	306.4	412.0	585.8	213.4	923.4	369.5	351.9	613.2	314.0
HMGN3	TRIP7	ENSG00000118418	"High mobility group nucleosomal binding domain 3"	Q15651	6	79201245-79234738	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018370, HPA027971, HPA063572"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (8.78e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-3)"	92.4	174.4	132.9	69.5	136.2	72.8	116.1	141.8	190.4	82.2	153.6	100.6	90.4	93.6	168.6	95.1	209.3	82.8	227.2	132.9	135.8	168.4	147.5	111.5	127.1	139.5	135.2	105.5	90.3	116.7	152.0	114.6	140.8	84.7	73.4	164.6	154.3	68.0	151.4	81.1	74.1	76.1	136.6	91.5	106.9	83.2	133.7	112.7	113.2	130.1	109.9	77.1	81.9	145.6	101.7	90.3	309.7	135.0	121.9	99.6	70.1	69.0	73.7	75.6	110.3	508.3	83.9	1.2	124.2	56.5	101.0	63.4	203.6	78.3	74.2	298.7	170.9	355.9	292.3	268.9	78.0	294.9	52.3	121.5	85.4	50.3	27.7	72.9	170.9	74.3	212.3	275.0	123.8	92.9	136.3	564.7	227.8	87.7	224.5	229.7	472.6	103.8	525.3	145.3	126.0	168.5	131.3	149.4	102.4	271.1	85.1	488.6	75.0	20.9	91.7	73.5	155.3	235.3	375.2	1.9	11.8	1.1	103.0	38.3	147.3	13.6	107.8	148.0	95.9	112.9	75.7	92.8	179.2	99.8	88.7	106.8	7.2	142.3	143.9	208.6	90.4	169.3	132.9	136.2	141.8	190.4	132.9	135.8	139.5	135.2	140.8	136.6	133.7	145.6	140.6	96.1	167.9	129.9	110.1	171.1	193.7	516.8	234.5	261.8	301.4	376.3	424.5	231.6	373.7	242.8	75.0	940.6	169.9	35.3	602.6	229.3	72.5	775.8	108.1	166.0	272.9	95.4	115.8	198.6	823.7	165.3	116.2	199.2	109.6	80.9	261.3	256.3	309.7	195.2	105.3	131.1	435.4	186.0	206.5	60.9	187.0	148.4	257.9	58.1	403.3	320.2	198.8	66.9	159.7	107.2	52.4	167.0	211.3	85.3	36.5	852.5	900.3	134.3	144.7	102.4	233.9	26.8	52.0	260.0	149.9	555.3	109.9	232.4	121.5	173.2
HMGN4	"HMG17L3, NHC"	ENSG00000182952	"High mobility group nucleosomal binding domain 4"	O00479	6	26538366-26546933	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 39.3;Basal squamous epithelial cells: 38.7;Plasma cells: 51.5;Squamous epithelial cells: 34.8;T-cells: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA077364			Uncertain	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA077364: AB_2686835"	"unprognostic (1.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (5.88e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.10e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (9.01e-2)"	"unprognostic (6.07e-3)"	39.6	34.5	21.3	49.2	21.5	33.0	54.3	21.5	26.5	45.4	30.4	52.7	40.7	56.6	50.2	35.2	46.0	38.4	38.1	21.4	24.3	48.6	19.9	46.0	68.7	22.4	22.9	50.1	26.3	58.4	22.3	41.2	22.5	47.0	55.8	18.6	33.2	56.7	38.6	31.4	48.9	66.9	22.8	52.4	32.8	31.3	23.0	70.6	57.0	32.6	71.6	55.3	35.8	24.2	81.3	29.7	60.2	79.3	78.6	118.0	37.4	67.0	116.1	99.2	138.0	30.6	50.5	94.4	104.0	95.1	101.0	37.4	100.2	85.0	109.3	118.9	94.1	96.7	42.3	58.9	86.9	85.2	98.9	87.6	114.0	80.0	132.7	93.0	95.5	121.2	92.8	152.8	91.5	40.7	151.0	114.9	36.2	68.0	51.9	53.8	66.6	168.8	77.9	54.6	95.0	85.4	55.4	45.0	138.6	71.0	50.1	45.6	71.2	68.5	52.1	63.5	61.7	100.4	276.9	79.3	33.1	190.1	91.1	182.8	42.1	81.9	81.8	41.5	80.5	71.7	85.2	85.8	57.2	61.2	71.0	70.2	62.5	75.7	53.9	47.9	93.6	92.5	21.3	21.5	21.5	26.5	21.4	24.3	22.4	22.9	22.5	22.8	23.0	24.2	4.2	3.2	5.8	6.8	39.3	7.5	4.0	3.1	38.7	0.5	5.6	3.0	2.1	7.2	7.5	1.8	0.0	3.5	13.9	2.9	5.9	2.2	0.4	3.9	10.0	4.8	0.0	16.8	16.1	1.4	10.1	11.8	13.3	5.7	8.8	1.8	3.3	0.7	4.0	0.0	13.9	2.3	2.0	5.1	11.1	0.4	1.5	16.3	8.8	6.5	7.5	2.6	8.2	17.1	13.5	2.6	1.9	2.6	51.5	3.7	4.3	7.8	1.1	0.8	0.0	4.4	8.3	0.6	1.2	34.8	5.1	8.1	32.5	2.5	1.9	2.1
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113699-81201913	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 107.4"	"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.6;Karpas-707: 298.5"	"Low region specificity"	"Detected in all"							"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		41000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	13.2	24.6	31.6	6.1	31.8	34.0	14.5	28.8	60.6	12.7	27.7	16.6	23.0	17.2	65.2	14.8	17.5	11.0	10.2	29.3	32.3	27.6	23.0	8.7	5.3	35.3	32.5	20.4	12.7	20.3	29.7	4.8	32.6	15.4	16.3	7.3	13.0	19.4	9.4	12.0	21.5	10.8	32.1	12.9	13.8	107.4	32.7	30.7	17.9	8.7	6.6	12.1	11.6	33.1	1.1	9.6	26.4	130.0	22.2	6.8	5.5	7.4	11.5	2.2	3.2	3.1	49.6	209.6	22.7	3.1	2.1	8.9	158.6	19.2	4.8	123.5	62.9	87.6	97.0	1.6	2.6	147.9	83.1	5.6	4.9	8.1	7.9	7.3	10.4	132.2	118.2	298.5	13.3	4.4	135.2	51.8	117.9	29.5	34.5	5.1	110.1	98.3	32.0	3.5	1.1	3.1	0.9	2.9	9.1	22.6	16.3	34.6	12.2	4.2	33.5	20.4	28.5	20.7	9.4	33.8	12.4	57.5	7.4	1.3	3.1	1.2	7.5	1.6	6.6	3.8	4.4	4.0	5.2	6.0	8.7	7.6	1.4	3.4	2.2	10.0	1.7	2.9	31.6	31.8	28.8	60.6	29.3	32.3	35.3	32.5	32.6	32.1	32.7	33.1	18.1	9.6	16.4	19.9	9.0	15.9	27.6	12.8	17.6	3.5	18.9	17.5	11.1	27.1	16.2	46.0	0.0	0.6	6.4	22.7	68.4	12.8	24.5	44.0	11.0	18.1	17.4	64.8	11.6	18.7	0.4	15.4	16.8	31.1	13.3	39.4	22.1	87.2	15.7	1.7	16.5	34.2	28.5	11.3	10.8	79.7	29.5	10.2	8.8	13.1	2.9	25.8	7.2	25.6	8.5	7.1	19.6	41.0	9.6	15.0	27.4	113.6	55.9	1.7	46.0	13.3	19.6	18.9	8.7	32.8	14.9	0.4	8.3	31.0	45.0	24.4
HMGXB4	"HMG2L1, THC211630"	ENSG00000100281	"HMG-box containing 4"	Q9UGU5	22	35257452-35295807	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000725, HPA076681"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA000725: AB_1079073, HPA076681: "	"unprognostic (2.22e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (3.24e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (2.85e-2)"	"unprognostic (8.25e-3)"	"unprognostic (6.67e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.54e-2)"	7.9	4.7	5.1	7.8	6.5	23.4	8.1	6.5	7.2	6.7	3.7	6.6	6.4	11.6	3.7	8.6	7.6	7.0	6.5	5.3	5.8	4.1	5.1	5.6	7.5	5.9	5.3	14.0	7.0	8.2	2.2	9.0	5.8	7.4	7.4	8.5	6.7	6.2	7.2	6.7	6.7	9.5	4.9	6.3	5.0	7.9	6.1	11.3	6.7	7.2	7.7	8.6	5.3	8.2	22.6	4.9	37.6	17.6	9.3	16.4	9.9	22.3	31.6	22.1	20.1	4.3	8.9	27.5	10.2	23.3	13.4	13.0	14.9	18.3	26.2	23.3	18.6	24.6	6.5	5.3	11.2	56.8	25.1	15.8	14.0	18.5	14.2	13.3	16.8	21.0	19.7	21.6	17.1	11.0	35.1	15.1	15.7	15.6	14.2	25.3	32.5	10.7	13.8	17.5	22.1	23.0	19.6	15.6	16.5	10.6	9.6	16.1	13.3	20.1	41.9	24.1	19.5	26.1	25.5	34.8	17.1	15.9	31.7	34.5	12.5	16.9	13.4	14.8	11.7	10.4	13.1	14.3	9.8	13.3	8.4	9.6	19.0	9.6	13.8	10.8	12.1	5.9	5.1	6.5	6.5	7.2	5.3	5.8	5.9	5.3	5.8	4.9	6.1	8.2	30.6	12.8	18.5	18.3	30.9	20.9	52.3	33.3	16.5	60.6	26.0	25.1	14.4	34.3	29.7	27.6	35.5	48.0	30.1	31.5	29.4	40.4	14.7	22.2	35.5	32.4	16.9	56.6	17.7	29.3	54.5	34.8	27.5	31.9	52.1	51.9	36.8	24.1	31.8	67.3	20.5	31.9	28.5	26.4	17.6	12.7	53.7	29.1	8.8	7.5	32.1	21.0	34.0	17.1	31.5	35.3	27.4	56.8	21.2	58.1	26.4	21.0	15.6	73.5	39.5	46.4	32.9	67.0	82.9	28.0	22.6	64.7	30.4	33.1	32.3	57.8
HMX3	NKX5-1	ENSG00000188620	"H6 family homeobox 3"	A6NHT5	10	123135970-123139423	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 6.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.1;HEL: 6.1;HeLa: 7.0;K-562: 17.9;NB-4: 13.4;SiHa: 7.0;THP-1: 5.7"	"Region enriched"	"Detected in single"	4	"hypothalamus: 1.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 1.4;hypothalamus: 4.8"	HPA069659			Approved	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Centriolar satellite"	"HPA069659: AB_2686165"			"unprognostic (1.79e-1)"								"unprognostic (9.65e-2)"			"unprognostic (6.07e-2)"				0.9	0.1	0.4	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.5	0.1	0.0	0.0	0.1	1.3	6.9	0.0	0.1	0.0	0.2	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	8.1	0.0	0.0	0.7	0.4	6.1	7.0	0.2	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	17.9	0.1	0.0	0.0	0.0	13.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	7.0	0.0	0.1	0.0	0.0	5.7	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.6	0.3	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.3	0.9	0.4	0.2	0.4	0.2	0.1	0.4	0.1	0.3	0.1	0.1	6.5	1.3	6.9	2.4	0.1	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"intestine: 15.4;kidney: 16.7;liver: 34.7;pancreas: 9.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.5;Hepatocytes: 15.8;Intestinal goblet cells: 9.4;Paneth cells: 14.8;Proximal enterocytes: 33.4;Proximal tubular cells: 16.0;Undifferentiated cells: 10.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 4.5;liver cancer: 3.6;pancreatic cancer: 1.4;renal cancer: 3.6;stomach cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 8.9;CACO-2: 29.4;Hep G2: 32.5;OE19: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"CAB010430: AB_2116746, HPA035231: AB_2674528"	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.2	0.0	5.5	15.4	0.2	0.0	0.1	1.1	0.8	0.0	0.1	0.1	16.7	34.7	0.0	0.0	0.1	0.1	0.0	9.5	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.2	14.3	0.1	0.0	0.0	4.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.6	0.2	0.0	1.2	4.3	0.0	1.8	0.0	0.1	0.4	14.5	0.0	2.6	0.0	1.3	0.2	0.3	4.8	0.0	0.2	5.3	0.1	0.2	4.6	0.5	0.0	0.1	0.4	15.8	0.1	0.0	0.2	9.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.5	0.0	0.5	0.0	3.9	14.8	0.0	0.1	0.5	33.4	16.0	0.0	0.3	0.0	0.8	0.3	0.1	0.3	0.0	0.3	0.0	0.5	0.0	10.8	0.4
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686431-37745105	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.1;pancreas: 33.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Collecting duct cells: 57.0;Distal tubular cells: 45.0;Ductal cells: 42.0;Early spermatids: 32.3;Glandular and luminal cells: 41.7;Pancreatic endocrine cells: 31.7;Proximal tubular cells: 38.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 139.3"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in single"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (2.51e-6)"	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.9	6.9	1.5	7.5	0.0	5.7	15.1	0.0	0.0	0.1	61.1	12.9	6.8	0.0	0.0	0.0	0.0	33.0	3.5	0.0	0.0	0.0	2.3	7.1	0.0	0.0	4.4	0.0	0.0	8.6	0.1	0.0	0.0	8.2	3.9	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	2.2	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	139.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.6	14.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.6	78.6	1.9	57.0	0.0	0.0	0.0	15.4	45.0	42.0	32.3	18.5	3.6	0.4	14.4	0.0	0.2	25.4	0.0	0.2	13.7	41.7	5.7	0.0	0.0	5.1	0.1	0.0	0.2	13.5	0.0	0.3	0.0	11.6	0.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.1	31.7	11.4	0.0	0.0	2.6	14.3	38.2	3.7	0.0	0.0	0.0	0.3	3.0	2.5	0.0	0.0	0.0	0.6	0.0	20.4	2.7
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.4;kidney: 43.3;liver: 117.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 232.6;Hepatocytes: 186.8;Intestinal goblet cells: 69.8;Paneth cells: 120.0;Proximal enterocytes: 153.9;Proximal tubular cells: 170.1;Undifferentiated cells: 136.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2;liver cancer: 38.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 154.4;Hep G2: 114.8;OE19: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.1	0.1	5.9	0.2	0.1	0.1	0.2	0.2	0.0	8.4	58.6	102.4	0.1	0.0	0.1	1.0	5.9	0.0	0.4	0.0	43.3	117.1	0.1	0.1	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	44.1	0.1	0.0	0.1	0.2	0.0	82.6	1.8	0.0	0.0	22.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	154.4	6.0	0.1	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	114.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	42.2	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	35.8	0.0	12.9	0.0	0.0	0.0	232.6	15.6	7.8	4.0	2.5	0.1	0.4	35.9	2.7	0.5	22.1	0.0	0.1	38.2	0.1	4.5	0.0	3.6	186.8	0.0	0.0	0.3	69.8	0.0	5.3	0.0	18.7	0.3	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	21.0	120.0	0.4	0.1	0.3	153.9	170.1	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.8	136.1	0.2
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566834	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 114.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.0	0.2	2.5	0.5	0.0	1.0	0.2	0.3	2.3	0.1	20.6	100.5	0.4	1.2	0.3	1.0	12.1	0.0	0.3	0.3	17.4	12.9	0.2	0.1	0.4	0.5	0.0	5.6	0.0	0.0	0.1	0.3	0.6	19.6	0.0	0.4	0.4	0.0	0.0	114.6	0.9	0.4	0.1	8.1	3.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.1	4.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.1	0.0	2.2	0.0	1.8	0.0	2.0	0.0	0.0	0.0	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	10.0	4.8	0.0	0.0	0.3	2.7	0.1	0.3	1.6	0.3	0.1	0.0	0.2	0.2	5.5	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.3	0.3	0.3	0.4	0.5	0.3	0.4	0.3	0.3	0.0	0.0	1.1	39.8	0.5	0.0	0.6	0.4	2.2	0.0	1.3	0.5	0.2	17.2	1.5	3.7	0.0	0.0	0.0	51.0	5.9	3.2	3.1	3.6	0.2	0.0	16.3	0.0	0.5	4.3	0.0	0.1	8.2	3.2	0.0	0.0	0.0	10.7	0.0	0.0	0.6	32.3	2.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.6	5.6	54.3	0.0	0.0	1.6	165.3	18.5	8.1	0.0	0.0	0.1	0.4	4.8	0.0	0.4	0.0	0.0	0.2	0.0	36.9	2.9
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 245.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 299.3;Kupffer cells: 263.7;Proximal tubular cells: 268.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"classical monocyte: 110.9;intermediate monocyte: 89.8;myeloid DC: 68.3;non-classical monocyte: 52.2"	"Group enriched"	"Detected in many"	23	"dendritic cells: 68.3;monocytes: 110.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 227.2;HSkMC: 87.9;RT4: 117.1;SuSa: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		130000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	70.4	18.2	13.0	41.7	13.3	12.6	62.3	13.1	18.8	57.3	19.2	53.9	29.3	62.8	27.1	17.5	34.5	68.7	21.7	15.6	19.1	109.7	245.9	49.0	35.1	16.0	15.3	91.0	29.0	40.2	9.5	46.8	18.1	37.0	56.4	6.1	30.5	44.3	5.9	17.4	29.1	33.1	16.1	37.5	29.1	10.3	14.5	8.2	14.6	11.9	16.4	49.7	24.5	22.2	0.7	0.9	5.6	14.6	61.9	64.6	0.4	3.9	6.2	0.4	2.3	29.7	15.7	0.9	50.2	17.0	0.8	1.1	11.9	0.0	0.1	0.7	4.9	0.2	44.5	227.2	28.0	0.3	0.6	87.9	0.1	21.5	0.0	4.7	15.9	0.1	0.5	0.7	47.4	3.7	0.0	0.5	28.1	39.3	5.6	0.5	1.5	0.2	67.9	117.1	0.1	0.8	22.1	28.4	0.1	107.9	1.0	53.2	4.8	4.8	11.8	6.2	16.3	0.4	0.3	0.7	20.9	27.8	3.3	1.3	110.9	0.7	0.5	89.8	0.3	1.8	0.2	0.2	68.3	0.5	0.3	0.4	3.9	0.5	52.2	1.5	0.7	32.6	13.0	13.3	13.1	18.8	15.6	19.1	16.0	15.3	18.1	16.1	14.5	22.2	15.5	28.9	44.1	9.4	5.0	35.6	81.5	64.6	30.7	0.7	78.1	65.4	2.2	133.0	88.9	60.7	0.0	54.9	2.6	59.4	123.3	122.1	1.5	28.3	50.6	9.4	16.4	16.8	16.8	48.0	81.6	54.2	20.9	115.3	0.0	17.4	19.2	165.7	299.3	0.0	13.8	67.8	24.4	263.7	97.2	4.2	131.4	127.4	56.9	31.9	122.0	25.5	4.1	45.8	14.3	71.0	108.6	105.3	0.2	39.8	31.9	268.3	38.4	0.8	78.9	55.2	55.7	0.5	0.9	33.2	25.9	37.6	4.0	43.9	83.5	126.1
HNRNPA0	HNRPA0	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754363	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm		No	No		150000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: AB_2684004"	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	21.9	23.8	11.1	14.5	10.9	32.1	19.2	14.8	12.1	22.3	8.3	19.0	13.7	28.5	10.7	20.1	23.2	10.2	18.1	10.8	13.4	14.8	14.8	19.1	15.7	10.9	10.4	30.3	17.5	12.3	15.5	15.6	10.9	15.2	10.7	10.9	14.5	11.9	18.1	19.8	19.1	16.1	10.2	18.0	19.4	12.9	12.6	28.7	17.6	12.8	14.6	19.1	19.1	11.8	36.9	36.2	68.6	69.7	33.1	20.9	70.3	27.6	22.7	24.2	27.8	67.8	28.3	66.3	38.9	23.7	26.6	33.1	37.4	42.8	29.4	33.6	52.1	42.9	22.5	41.6	30.4	39.8	43.9	34.0	29.6	19.2	22.0	26.6	34.0	59.0	35.7	43.2	24.7	47.8	75.0	53.2	53.7	17.3	26.1	88.6	50.0	33.8	24.2	41.7	86.6	70.5	35.6	24.5	49.1	74.8	31.1	45.6	33.4	38.6	32.8	21.6	53.3	43.4	37.6	46.8	25.0	45.4	38.9	2.7	1.4	4.6	2.9	2.1	3.4	2.1	2.8	3.0	2.3	2.5	3.0	3.2	1.3	4.4	2.5	3.2	1.7	1.1	11.1	10.9	14.8	12.1	10.8	13.4	10.9	10.4	10.9	10.2	12.6	11.8	151.5	86.6	53.6	7.2	251.2	550.9	436.4	290.2	390.9	85.1	197.5	136.1	36.1	155.8	138.6	101.2	37.5	347.9	234.6	88.8	172.1	257.5	25.5	108.6	172.1	204.4	236.4	179.6	11.3	146.5	478.1	237.2	141.7	126.8	95.8	162.4	192.1	77.0	191.7	84.1	11.5	181.2	229.9	142.3	416.4	44.9	157.8	142.4	281.1	11.2	228.6	137.1	213.1	15.6	16.8	201.6	157.2	150.8	138.9	313.1	147.3	146.9	65.3	62.9	85.5	271.8	221.9	144.0	72.8	247.6	484.3	365.7	267.5	155.8	242.0	401.0
HNRNPA1	"ALS20, hnRNP-A1, HNRPA1"	ENSG00000135486	"Heterogeneous nuclear ribonucleoprotein A1"	P09651	12	54280193-54287088	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001609, HPA001666, HPA005812, HPA007185, CAB010894"	Supported		Enhanced	Nucleoplasm		NA	NA		9300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768"	"unprognostic (1.38e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.54e-3)"	531.6	410.2	339.5	528.1	362.6	1087.9	640.6	348.2	424.9	750.3	326.5	542.3	447.5	625.3	474.8	510.3	589.2	214.7	391.4	320.7	363.0	501.4	277.0	380.6	685.7	363.3	348.2	1410.2	556.7	359.8	327.2	447.9	364.8	458.9	445.9	261.2	398.9	409.6	437.4	506.3	436.4	382.1	380.9	434.1	431.0	168.9	343.9	1010.9	396.3	174.4	824.8	513.7	580.9	372.6	1246.7	815.8	2072.5	1717.3	550.5	1057.0	1204.0	911.9	1405.6	1311.7	1153.1	1225.4	1306.6	3183.8	983.8	671.8	354.7	1045.9	1486.5	1393.4	1425.5	1216.4	1041.7	1700.0	1156.1	2250.0	320.4	2712.4	1078.2	845.2	568.3	642.9	1056.1	868.7	1408.6	1474.7	1930.7	1215.3	968.2	1244.6	2969.1	2880.9	2571.8	844.0	675.9	2911.7	1588.9	1574.1	1239.4	1395.0	1260.4	1739.0	758.0	1675.2	1392.3	1031.6	1010.9	1744.5	1063.1	781.6	1164.2	820.6	1395.1	1185.7	1349.3	2249.7	572.5	1646.7	744.0	140.4	423.5	165.9	572.8	513.1	893.3	576.5	746.2	657.5	704.5	501.8	851.2	810.1	41.0	823.3	437.7	556.5	683.4	1333.2	339.5	362.6	348.2	424.9	320.7	363.0	363.3	348.2	364.8	380.9	343.9	372.6	372.4	304.5	521.4	20.9	1018.9	1416.1	1039.8	1252.9	900.9	254.1	745.1	541.3	166.2	697.7	612.0	294.3	93.8	2076.2	900.8	407.3	739.6	1296.2	181.5	304.7	706.7	624.8	824.0	1032.4	16.5	2124.2	2894.5	600.5	458.7	400.7	528.9	790.7	562.2	183.1	1006.9	109.4	18.3	1130.9	459.8	863.9	1048.2	115.6	1050.7	609.2	588.7	21.5	1374.4	411.0	1304.9	23.1	34.1	1162.7	731.2	741.8	702.2	696.8	693.2	838.6	288.3	195.2	453.6	714.5	704.1	217.0	338.1	1030.6	1261.9	2178.8	958.6	690.9	1543.8	897.8
HNRNPA1P48		ENSG00000224578	"Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48"		16	51553436-51647132	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 88.9;Enteroendocrine cells: 67.5;Exocrine glandular cells: 138.9;granulocytes: 109.6;monocytes: 57.4;Pancreatic endocrine cells: 77.9;Undifferentiated cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001666, HPA005812"	Uncertain		Uncertain	Nucleoplasm		NA	NA						"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA001666: AB_1850836, HPA005812: AB_2667441"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (7.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-3)"	"unprognostic (2.11e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	19.2	32.8	0.0	32.7	0.0	0.0	0.0	0.0	0.0	25.1	16.4	12.2	0.0	22.3	1.8	0.0	0.0	14.9	19.1	11.7	88.9	0.0	7.0	12.6	13.1	67.5	0.0	0.0	138.9	0.0	13.7	0.0	8.1	109.6	13.0	0.0	0.0	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	57.4	0.0	0.0	0.0	0.0	77.9	14.3	0.0	1.6	0.0	0.0	21.1	14.6	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	20.9	8.7	66.2	0.0
HNRNPA2B1	HNRPA2B1	ENSG00000122566	"Heterogeneous nuclear ribonucleoprotein A2/B1"	P22626	7	26171151-26201529	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001666, HPA005812, CAB012403, HPA065537"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		11000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507"	"unprognostic (1.19e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.25e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.12e-4)"	"prognostic unfavorable (8.01e-5)"	"unprognostic (6.74e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	367.0	421.3	101.3	151.4	105.4	77.6	314.1	110.9	140.3	403.5	106.4	381.8	124.8	404.3	116.1	417.6	376.3	62.4	463.6	99.7	106.4	530.8	388.5	364.9	184.1	106.4	105.0	527.8	350.2	80.8	337.6	118.9	108.2	300.8	127.5	131.1	325.1	79.2	764.9	280.5	419.0	84.2	102.3	447.5	353.4	370.5	105.4	174.8	367.2	92.0	172.5	339.9	360.8	111.7	202.5	101.8	491.6	312.7	110.7	117.5	249.6	255.8	110.7	149.6	183.6	159.8	338.5	210.2	104.2	180.1	218.8	300.0	196.3	268.7	288.5	74.9	191.2	232.6	309.9	212.1	72.9	374.6	359.4	123.6	192.4	156.3	253.3	194.6	161.1	273.9	210.9	250.4	280.4	229.1	216.5	817.2	320.7	81.7	117.7	239.5	122.1	159.3	287.0	335.8	190.7	245.6	203.5	291.8	127.7	393.6	326.3	359.7	222.0	193.2	265.6	184.6	253.7	367.0	296.0	308.7	149.9	453.8	316.5	0.0	1.7	1.3	4.8	1.0	4.0	2.7	3.0	0.8	0.8	0.8	2.7	2.6	0.6	3.3	0.8	1.6	1.0	0.5	101.3	105.4	110.9	140.3	99.7	106.4	106.4	105.0	108.2	102.3	105.4	111.7	717.8	487.2	591.0	194.6	667.5	738.5	797.7	793.2	560.5	469.4	361.0	361.3	702.1	316.0	665.8	343.9	298.2	971.6	707.7	435.1	461.8	568.0	128.2	465.8	640.8	600.5	491.4	683.2	123.3	452.2	939.9	602.7	449.6	591.1	644.7	680.5	333.4	382.8	613.1	312.9	147.2	533.1	496.4	388.5	681.9	150.0	411.0	640.3	393.1	157.4	572.0	545.4	484.1	198.0	320.6	438.2	438.7	390.0	751.0	520.4	428.4	506.8	608.0	547.0	440.4	599.4	726.5	596.9	490.6	573.8	600.5	1082.8	701.7	652.2	541.4	632.1
HNRNPA3	HNRPA3	ENSG00000170144	"Heterogeneous nuclear ribonucleoprotein A3"	P51991	2	177212563-177223958	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001666, HPA005812, HPA066381"	Supported		Enhanced	Nucleoplasm		NA	NA		1800000	"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA001666: AB_1850836, HPA005812: AB_2667441, HPA066381: AB_2685666"	"unprognostic (2.85e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.65e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (6.95e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-2)"	162.9	119.0	101.6	210.8	104.5	235.2	144.2	107.5	114.6	183.8	98.8	185.3	129.2	180.1	178.1	244.6	164.3	75.4	118.4	93.7	124.1	193.6	144.3	175.2	232.9	111.8	103.1	208.2	141.4	130.5	137.5	158.5	106.9	141.0	194.7	181.7	138.8	118.1	136.3	179.9	152.3	164.2	103.8	174.7	143.1	175.8	108.6	308.3	176.0	93.0	304.8	153.3	189.2	108.1	657.6	432.9	934.3	469.8	248.2	221.2	717.8	489.3	235.7	382.8	358.5	885.1	337.4	1315.9	366.5	388.4	518.3	370.6	944.2	616.7	712.9	609.6	556.2	996.1	620.3	1727.6	264.8	1064.7	584.0	249.8	288.3	569.9	422.1	217.9	537.3	587.4	723.1	414.3	492.1	891.1	746.9	444.4	507.3	762.5	405.0	947.2	790.1	414.2	547.9	1227.6	545.1	484.7	729.6	228.1	316.4	700.8	325.6	652.5	582.2	476.3	540.4	338.0	719.0	387.6	759.5	1117.2	305.4	699.5	320.0	8.9	21.2	10.8	25.0	22.6	20.2	21.2	20.0	22.0	23.4	20.4	17.5	18.1	8.2	23.5	23.0	37.8	25.9	14.5	101.6	104.5	107.5	114.6	93.7	124.1	111.8	103.1	106.9	103.8	108.6	108.1	274.8	166.7	255.1	84.5	277.4	351.8	429.6	442.1	224.8	192.8	155.2	135.1	64.2	114.4	302.7	160.0	98.0	512.7	368.9	200.7	121.3	257.2	47.2	296.5	387.2	289.7	275.0	288.6	56.9	273.8	563.0	231.4	184.0	343.0	278.1	222.6	196.7	165.0	342.7	148.0	70.5	315.0	193.3	221.0	372.5	44.0	204.7	258.3	192.1	73.1	311.1	187.1	232.8	65.9	88.6	276.1	184.0	209.5	336.6	288.9	136.8	156.7	257.8	164.4	151.2	319.3	461.9	362.8	208.3	331.1	330.5	496.0	307.9	214.1	310.7	382.6
HNRNPAB	"ABBP1, FLJ40338, HNRPAB"	ENSG00000197451	"Heterogeneous nuclear ribonucleoprotein A/B"	Q99729	5	178204533-178211163	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046688	Approved		Enhanced	Nucleoplasm		NA	NA		460000	"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA046688: AB_10964924"	"unprognostic (2.23e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.17e-3)"	"prognostic favorable (9.79e-4)"	"unprognostic (9.12e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.08e-1)"	86.7	103.2	33.2	92.5	34.9	139.7	63.9	35.6	37.0	66.0	37.3	144.7	98.2	75.5	43.8	122.0	64.4	51.1	83.1	32.4	39.1	91.9	88.3	69.1	95.7	36.9	35.4	56.7	55.4	76.2	46.2	64.0	36.9	59.8	119.0	27.1	68.1	54.0	119.0	115.4	88.9	74.4	35.5	79.9	85.5	38.2	36.9	117.0	52.0	58.7	102.7	122.3	72.7	38.5	347.4	282.5	424.1	414.7	153.8	134.6	613.2	378.5	174.3	296.9	317.2	525.4	251.8	555.2	340.3	204.7	361.1	223.2	373.1	516.7	363.8	865.9	439.5	349.8	223.7	325.1	153.7	446.1	285.6	134.0	239.2	267.3	266.8	122.3	270.3	218.4	290.1	245.7	302.0	934.2	542.6	429.7	389.5	354.0	401.7	436.3	255.6	329.8	254.2	364.8	389.5	302.4	295.2	407.9	278.8	264.0	244.7	270.7	244.0	359.7	305.2	256.2	527.8	285.4	360.2	649.3	145.2	488.2	298.8	3.2	4.4	15.7	5.1	7.0	5.7	5.9	4.1	6.0	4.4	5.2	3.9	4.7	0.8	5.8	7.5	10.9	4.8	2.2	33.2	34.9	35.6	37.0	32.4	39.1	36.9	35.4	36.9	35.5	36.9	38.5	124.7	32.1	41.0	4.6	115.4	281.6	212.1	42.7	243.0	26.5	129.6	141.3	45.9	41.5	42.7	49.7	18.8	106.3	148.5	251.2	50.9	118.9	9.3	112.4	225.6	107.1	119.2	273.2	3.5	151.7	208.9	110.1	167.7	124.7	44.5	102.0	53.6	101.2	101.0	16.8	4.3	219.0	48.8	67.0	129.9	11.1	74.0	109.9	67.6	8.4	56.2	34.7	76.2	3.5	6.1	204.2	138.2	88.0	179.6	275.0	90.5	116.8	25.8	28.3	78.9	149.7	173.6	81.6	122.4	362.5	339.8	114.4	129.7	238.1	247.9	235.5
HNRNPC	HNRPC	ENSG00000092199	"Heterogeneous nuclear ribonucleoprotein C"	P07910	14	21209136-21269494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005223, HPA051075, CAB075755, CAB075756"	Supported		Enhanced	Nucleoplasm		NA	NA		1200000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335"	"unprognostic (1.92e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (8.66e-3)"	"unprognostic (5.96e-3)"	"prognostic favorable (1.19e-4)"	"unprognostic (3.31e-3)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (7.36e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.28e-3)"	"unprognostic (5.42e-2)"	286.9	309.2	274.1	319.5	290.1	540.3	328.5	283.9	332.6	307.8	248.8	266.7	232.3	318.9	311.9	318.3	328.5	246.4	269.5	275.3	289.2	372.9	334.4	251.8	497.7	287.2	275.4	427.3	237.7	257.8	237.7	342.0	299.0	249.6	290.9	407.3	225.9	247.9	288.2	260.1	255.2	265.9	295.2	306.5	232.3	193.7	276.6	557.8	259.2	244.0	496.0	374.6	278.6	327.1	1076.2	832.7	1277.7	748.5	754.8	704.7	910.2	673.2	764.3	1034.3	900.6	799.4	787.6	1935.6	414.1	772.1	656.8	775.6	1611.4	1035.4	1389.0	1236.1	918.1	992.8	614.2	1241.4	920.6	1495.2	762.6	731.8	854.2	756.5	1781.1	897.8	1078.4	957.7	1483.6	787.1	829.5	1020.0	1713.7	1435.2	1351.4	990.3	770.1	1375.0	1073.9	925.3	1159.7	956.9	699.0	665.5	838.5	760.9	786.4	1057.3	725.2	1332.6	783.1	388.9	698.2	473.8	972.8	708.8	1144.4	1873.6	370.6	1215.3	794.1	480.2	515.1	516.9	419.0	450.9	544.5	531.4	494.0	451.2	716.3	467.0	552.1	478.2	810.8	471.0	439.4	460.5	575.7	1220.5	274.1	290.1	283.9	332.6	275.3	289.2	287.2	275.4	299.0	295.2	276.6	327.1	172.7	153.8	233.9	69.5	307.2	536.2	583.9	512.2	331.8	169.8	259.9	191.5	137.9	173.0	393.2	275.8	198.1	612.6	309.4	134.0	283.7	315.0	169.0	365.1	352.2	257.5	224.0	389.9	74.3	216.6	746.8	287.1	197.2	555.6	415.9	281.3	174.2	233.9	388.5	116.1	79.2	276.0	260.4	293.8	500.1	76.5	270.0	325.7	208.1	99.3	341.9	157.9	227.6	97.5	112.2	210.7	151.1	230.9	293.6	531.5	135.0	370.8	381.9	296.1	151.2	285.1	282.6	391.5	249.0	315.5	539.9	874.9	339.1	311.8	318.0	590.3
HNRNPD	"AUF1, HNRPD"	ENSG00000138668	"Heterogeneous nuclear ribonucleoprotein D"	Q14103	4	82352498-82374503	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004911	Supported		Enhanced	Nucleoplasm		NA	NA		1100000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004911: AB_1078250"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	147.4	114.7	61.9	207.3	61.6	377.7	155.5	83.7	89.1	167.3	68.4	153.6	169.8	176.6	137.1	155.5	152.0	98.7	122.7	60.7	81.0	144.2	140.6	129.0	290.2	61.0	61.7	180.6	146.7	134.1	117.0	167.8	59.2	138.6	164.4	188.1	147.1	125.4	169.7	151.8	177.2	140.1	54.1	184.6	164.6	97.7	61.6	335.1	122.8	103.4	310.7	159.8	145.7	69.2	661.7	257.5	1073.5	344.2	138.9	179.1	508.9	506.2	384.6	566.7	484.9	461.1	565.7	1332.6	357.1	343.3	301.9	318.2	863.8	376.6	883.9	250.1	450.8	957.4	345.2	630.7	282.1	1283.9	475.2	221.0	164.7	459.6	459.5	290.2	521.2	637.3	1076.0	446.6	487.7	254.3	1569.2	887.2	897.8	487.2	236.1	1149.2	1089.0	556.7	478.0	394.8	540.9	583.3	496.5	426.0	262.2	497.0	319.7	504.9	443.7	435.3	595.3	339.7	661.7	472.5	403.1	1516.3	334.6	651.6	508.9	26.1	11.3	12.4	13.3	12.5	15.1	20.3	16.2	17.0	13.5	13.9	17.5	14.6	13.6	14.1	14.1	23.6	19.7	7.2	61.9	61.6	83.7	89.1	60.7	81.0	61.0	61.7	59.2	54.1	61.6	69.2	152.4	102.5	143.5	63.6	128.0	261.3	227.8	139.0	111.0	128.4	124.6	121.9	202.6	125.8	149.0	112.2	62.6	299.7	163.4	71.6	70.5	204.3	35.3	136.2	218.9	162.3	146.6	182.6	65.3	210.6	355.2	134.7	98.4	204.5	92.3	191.5	114.9	114.4	156.6	107.7	72.9	158.9	85.5	125.6	172.7	21.8	124.8	134.5	90.7	63.7	169.3	187.8	130.7	84.9	105.8	157.4	56.7	102.3	151.0	208.3	91.3	80.9	115.7	118.8	111.7	185.5	154.5	106.7	133.7	147.0	229.7	272.0	133.6	149.1	169.3	228.8
HNRNPDL	"HNRPDL, JKTBP, laAUF1, LGMD1G"	ENSG00000152795	"Heterogeneous nuclear ribonucleoprotein D like"	O14979	4	82422565-82430462	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056820, HPA063147"	Supported		Enhanced	Nucleoplasm		NA	NA		330000	"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA056820: AB_2683246, HPA063147: AB_2684950"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.30e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.03e-2)"	267.9	192.7	133.9	221.1	162.3	404.9	259.1	143.9	214.8	288.6	126.4	296.5	151.4	283.6	157.2	209.6	275.4	147.3	229.0	137.8	162.8	220.1	181.2	292.4	247.8	161.6	155.2	368.8	248.8	111.9	231.2	161.5	163.9	218.2	153.2	210.6	200.3	155.8	395.5	232.4	246.1	205.0	140.4	243.2	233.4	119.5	153.1	199.1	245.4	168.8	188.5	233.3	266.4	197.4	405.2	208.8	762.2	151.9	282.0	152.2	249.8	426.5	460.4	371.3	351.5	289.2	324.8	745.8	263.5	467.3	191.2	306.5	582.9	395.3	433.5	165.3	421.1	432.9	354.2	524.9	133.0	745.8	309.1	271.1	112.3	417.2	370.3	294.6	299.6	467.5	572.4	300.4	365.7	169.3	701.6	519.6	526.6	363.9	244.4	624.1	615.1	342.2	437.2	259.4	322.5	556.0	265.6	339.6	262.3	344.7	354.3	418.2	253.4	371.2	462.1	246.3	519.7	351.6	363.7	828.3	325.4	428.8	320.2	44.5	36.8	32.3	60.4	59.6	49.9	63.3	54.0	56.7	29.1	61.4	74.6	66.0	15.3	42.9	77.8	46.8	46.0	51.3	133.9	162.3	143.9	214.8	137.8	162.8	161.6	155.2	163.9	140.4	153.1	197.4	314.7	272.4	281.3	104.8	486.6	659.0	612.1	364.2	429.6	223.4	287.0	304.9	201.0	150.2	359.4	152.6	106.3	520.8	472.3	128.1	297.4	338.3	57.7	294.3	410.9	296.7	236.0	260.7	163.9	255.8	629.2	361.5	271.7	432.2	387.7	319.8	127.1	132.7	326.5	176.7	152.9	225.5	240.1	218.2	452.0	50.7	212.5	344.3	311.3	80.6	339.0	303.9	272.9	143.7	298.8	231.5	131.1	202.8	480.6	556.8	173.0	300.2	288.2	188.3	164.3	602.9	397.0	161.8	391.4	433.0	554.2	521.0	488.0	238.7	241.1	478.6
HNRNPF	HNRPF	ENSG00000169813	"Heterogeneous nuclear ribonucleoprotein F"	P52597	10	43385617-43409166	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA016884, HPA069667"	Supported		Enhanced	Nucleoplasm		NA	Yes		2500000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA016884: AB_1856444, HPA069667: AB_2686166"	"unprognostic (9.93e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.51e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.22e-1)"	114.6	77.7	43.3	133.9	48.6	161.3	102.9	49.8	47.9	86.8	65.2	124.5	134.2	78.3	58.9	114.9	119.4	88.9	63.7	40.2	45.9	94.4	173.2	97.6	181.4	52.4	51.4	87.3	87.5	73.1	50.5	113.6	51.5	90.8	118.9	80.4	85.2	74.8	93.6	104.5	130.7	89.1	49.2	123.5	118.0	84.0	49.4	193.3	72.7	79.6	182.8	160.0	81.8	58.3	292.1	302.9	184.2	280.7	220.5	239.5	269.1	222.5	371.0	305.6	358.2	285.5	394.7	581.8	139.2	242.0	179.3	401.7	496.8	363.6	249.5	245.6	297.2	371.2	178.6	370.9	271.4	550.5	360.9	293.2	282.4	237.6	434.6	177.1	266.4	281.3	382.0	256.2	234.2	453.4	542.5	300.5	139.5	439.1	252.4	449.0	172.7	276.8	314.9	442.7	226.1	226.8	226.6	410.4	344.3	199.2	457.4	265.3	200.4	140.1	264.4	231.8	356.8	228.5	415.8	352.6	227.1	520.0	139.7	205.5	234.9	227.2	247.0	269.2	301.0	238.9	256.6	273.3	251.8	200.7	213.8	204.0	152.2	287.9	253.6	140.6	315.8	460.5	43.3	48.6	49.8	47.9	40.2	45.9	52.4	51.4	51.5	49.2	49.4	58.3	223.8	134.6	102.8	13.4	206.9	336.0	336.5	204.9	189.5	51.4	156.8	126.4	66.3	157.3	147.9	112.2	47.9	292.9	201.7	164.7	176.1	218.6	360.1	203.8	153.3	176.6	126.8	199.6	10.8	142.2	414.8	157.0	154.9	147.0	116.1	106.9	127.5	222.3	226.0	48.8	12.0	230.1	164.8	193.3	181.7	92.7	146.0	178.5	99.6	24.4	213.0	116.9	219.4	16.6	32.7	161.4	152.1	117.8	163.3	280.8	189.7	233.1	242.0	163.6	98.6	179.7	278.1	184.5	167.3	210.2	330.5	210.4	229.9	126.3	238.8	314.0
HNRNPH1	"hnRNPH, HNRPH1"	ENSG00000169045	"Heterogeneous nuclear ribonucleoprotein H1"	P31943	5	179614178-179634784	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, HPA016884, CAB032820"	Supported		Enhanced	Nucleoplasm		NA	NA		2800000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (9.01e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.85e-4)"	"prognostic unfavorable (3.29e-7)"	"unprognostic (7.99e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.72e-3)"	115.8	108.5	83.6	103.2	88.9	242.9	90.4	100.4	99.6	134.4	95.6	109.5	73.3	120.3	67.9	112.7	109.5	71.4	93.0	84.6	88.2	159.3	137.1	102.5	175.0	86.2	86.0	148.4	123.5	99.2	95.5	91.3	86.1	117.5	79.2	162.9	92.5	84.1	142.1	110.5	137.4	102.9	82.8	209.3	105.0	121.2	88.1	210.8	130.8	84.3	166.6	115.6	112.0	88.6	425.0	432.1	496.0	291.0	155.8	135.0	391.5	227.3	188.7	472.0	271.1	519.4	222.0	618.0	205.4	235.2	297.1	227.0	517.8	345.3	552.9	582.8	322.2	335.5	497.3	528.4	196.1	426.0	295.5	104.7	249.1	379.8	230.0	182.6	247.1	293.8	494.4	281.7	279.8	338.5	724.8	371.1	534.9	249.0	226.8	660.7	507.2	368.3	180.4	485.0	431.5	364.3	410.7	232.7	421.8	344.6	275.7	567.1	250.5	415.3	304.2	184.8	556.0	252.0	674.2	723.6	213.0	405.1	501.6	55.7	44.8	46.5	61.4	73.2	82.6	63.4	65.8	66.4	67.9	52.1	81.5	86.8	9.1	62.9	57.6	87.3	83.1	38.9	83.6	88.9	100.4	99.6	84.6	88.2	86.2	86.0	86.1	82.8	88.1	88.6	374.3	115.4	238.0	80.6	263.0	775.3	182.3	89.2	202.1	118.0	332.7	242.1	136.4	165.8	125.5	156.3	131.3	158.3	419.8	183.0	78.2	97.1	151.3	178.7	246.3	237.8	255.2	189.8	81.8	124.1	181.8	241.7	128.0	258.9	247.3	178.6	189.5	225.3	108.2	70.7	85.8	213.7	81.4	186.2	621.4	86.6	111.6	224.0	334.4	104.9	148.3	93.4	110.2	148.8	121.8	105.2	153.0	117.4	269.3	200.4	142.7	75.4	95.9	166.0	184.1	306.3	253.2	189.1	120.6	181.0	718.0	192.5	311.9	87.4	266.4	191.5
HNRNPH2	"FTP3, hnRNPH', HNRPH', HNRPH2"	ENSG00000126945	"Heterogeneous nuclear ribonucleoprotein H2"	P55795	X	101408222-101414133	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 302.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, CAB004436, HPA016884"	Supported		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.68e-2)"	60.1	70.3	53.5	63.0	57.7	78.0	72.3	53.6	69.6	59.2	58.4	57.2	60.1	61.6	66.1	55.5	55.2	48.7	59.1	57.4	56.8	79.0	77.7	57.4	58.3	56.1	55.5	53.0	42.7	124.0	52.8	71.8	55.6	63.1	60.9	79.4	45.6	72.7	90.4	63.8	59.7	68.7	55.7	59.5	49.0	25.6	55.0	73.0	63.1	77.8	73.2	71.9	47.2	59.8	105.0	72.1	137.8	83.2	119.4	104.0	66.0	87.3	123.5	82.0	166.6	62.1	91.9	107.9	86.6	125.5	112.3	93.8	160.6	122.5	111.9	104.9	78.0	80.1	173.7	84.8	102.2	100.4	74.7	106.1	111.0	80.8	79.3	98.5	113.5	58.1	82.9	150.6	126.8	136.9	83.3	88.7	86.6	171.7	69.7	76.9	146.2	105.1	177.8	140.7	63.1	114.6	130.0	61.3	104.5	97.3	78.9	94.7	122.0	45.0	81.4	129.7	36.2	49.8	76.9	75.0	93.2	114.6	57.5	138.8	104.6	165.1	59.2	112.3	62.9	56.7	56.6	59.3	99.4	54.5	58.7	61.3	247.6	79.5	114.5	41.9	57.4	92.2	53.5	57.7	53.6	69.6	57.4	56.8	56.1	55.5	55.6	55.7	55.0	59.8	46.3	28.9	61.2	0.0	47.7	70.9	94.1	119.0	21.1	40.5	42.6	24.9	48.1	45.8	88.5	90.1	12.5	137.7	37.5	52.0	99.7	99.1	3.2	41.4	35.6	56.1	60.6	41.0	0.0	73.4	65.0	49.0	28.1	44.6	82.4	26.2	52.1	85.3	84.3	16.8	0.0	45.7	83.4	75.4	75.8	6.1	55.3	66.0	69.4	0.0	97.8	44.1	55.6	0.0	0.0	64.5	65.8	59.0	24.6	45.3	58.4	146.2	75.0	34.1	78.9	57.2	64.6	17.6	33.1	28.2	72.0	302.5	42.0	44.3	46.0	64.5
HNRNPH3	"2H9, HNRPH3"	ENSG00000096746	"Heterogeneous nuclear ribonucleoprotein H3"	P31942	10	68331174-68343193	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038264			Supported	Nucleoplasm		NA	NA		650000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA038264: AB_10697246"	"unprognostic (1.72e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (6.17e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-3)"	71.8	65.3	80.6	65.7	82.6	101.8	58.8	81.2	96.6	79.4	69.1	74.4	56.4	92.5	44.5	55.1	72.1	44.1	67.2	76.4	82.4	84.2	56.7	63.5	79.1	85.8	83.7	109.7	44.7	54.4	55.0	83.2	87.2	59.9	63.7	81.1	47.7	60.2	92.2	63.2	64.6	68.0	86.4	63.9	59.2	69.1	81.4	98.1	75.1	66.9	78.2	68.6	69.2	87.5	233.2	220.5	343.4	107.6	131.8	81.0	221.6	199.1	104.2	183.2	150.0	379.3	200.7	364.7	106.8	132.5	145.2	151.9	280.2	192.8	280.9	226.4	148.2	282.9	194.1	231.7	115.4	326.9	149.4	53.6	172.7	209.0	368.0	151.0	142.8	191.2	356.8	122.7	205.2	323.6	291.3	350.6	229.2	169.0	258.6	239.6	288.2	119.0	148.3	189.7	155.0	168.5	211.9	144.2	221.7	195.4	153.7	164.5	154.6	170.9	284.8	89.8	273.4	147.6	213.7	368.2	94.1	159.0	135.1	22.7	18.6	37.6	17.0	21.2	18.1	16.2	20.4	20.2	21.6	16.2	25.7	21.6	23.8	22.3	26.0	17.6	20.2	13.4	80.6	82.6	81.2	96.6	76.4	82.4	85.8	83.7	87.2	86.4	81.4	87.5	133.6	102.5	117.3	33.6	111.1	325.8	275.5	99.9	113.3	114.2	83.2	102.6	115.5	64.3	114.5	73.5	95.9	149.6	111.7	71.6	60.7	89.6	29.0	108.2	138.9	125.7	107.7	127.9	39.8	83.8	202.2	143.6	69.3	162.5	141.1	111.5	75.0	39.6	95.5	87.5	41.9	80.2	73.2	69.5	153.2	21.1	96.3	97.1	129.9	50.6	105.7	107.8	75.2	51.8	84.6	76.8	99.7	120.4	97.9	214.3	84.6	72.0	115.2	146.7	131.5	150.0	174.6	277.3	164.5	89.7	266.8	191.8	128.5	90.8	84.4	215.1
HNRNPK	"CSBP, HNRPK, TUNP"	ENSG00000165119	"Heterogeneous nuclear ribonucleoprotein K"	P61978	9	83968083-83980616	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004435, HPA007644, CAB016225, HPA044105"	Supported		Enhanced	Nucleoplasm		NA	NA		7100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812"	"unprognostic (4.84e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-3)"	"prognostic unfavorable (6.68e-5)"	"unprognostic (3.46e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.82e-1)"	283.6	308.1	186.1	326.2	197.1	637.3	265.3	202.4	236.6	264.5	227.4	270.2	287.0	297.0	227.3	276.8	269.7	243.8	275.8	188.8	220.3	279.2	346.8	240.4	401.9	203.1	187.8	317.5	247.4	350.8	198.2	325.8	203.0	251.3	277.5	342.2	242.2	251.4	315.3	256.1	282.9	287.6	205.7	298.3	250.1	183.4	194.4	548.5	297.2	312.9	423.7	351.2	230.7	241.0	926.1	624.2	1048.4	625.7	492.2	540.7	840.0	634.1	785.0	778.2	726.4	527.0	641.2	1087.2	425.8	671.1	673.8	689.5	1061.5	772.9	941.8	753.7	624.2	765.1	511.9	754.6	648.7	958.6	726.5	554.6	577.4	665.6	876.1	583.7	806.1	605.5	792.8	541.4	776.4	809.0	1198.4	652.1	934.7	929.3	599.3	1030.2	835.0	727.6	760.3	747.6	677.1	802.6	669.6	703.8	645.5	721.8	698.6	801.6	665.8	537.9	631.7	552.7	844.2	564.7	795.5	784.6	514.3	762.6	779.5	582.0	438.9	559.2	302.2	419.8	378.9	347.8	346.6	348.7	457.5	324.4	354.8	327.2	546.1	477.9	429.1	270.8	457.4	1012.5	186.1	197.1	202.4	236.6	188.8	220.3	203.1	187.8	203.0	205.7	194.4	241.0	354.7	205.1	270.0	58.4	398.4	506.0	540.7	421.5	313.0	180.9	281.6	203.3	195.0	230.2	322.4	263.0	89.6	585.3	379.9	288.1	395.2	448.2	43.4	326.2	329.0	331.7	387.0	447.9	45.9	368.3	738.5	323.4	233.9	384.2	336.8	300.0	260.9	356.6	388.4	156.5	51.2	379.2	307.2	352.9	412.9	45.4	334.6	333.4	327.3	58.1	448.9	362.5	338.8	71.9	116.2	397.0	282.7	321.2	281.0	353.3	260.0	416.7	308.1	182.6	276.1	340.9	479.7	345.9	241.7	309.5	448.7	728.5	368.6	334.9	406.9	453.2
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836370-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm		NA	NA		420000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905"	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	112.5	108.5	43.8	69.7	46.1	195.1	110.3	49.4	47.4	114.0	42.9	115.2	72.7	119.9	48.0	134.4	97.6	37.4	100.2	41.8	44.5	96.6	98.8	117.7	84.2	47.0	42.9	103.8	87.5	67.7	70.6	57.6	47.5	81.5	76.4	53.2	99.8	45.7	125.7	142.3	113.4	79.9	47.2	113.5	104.3	83.7	46.9	128.8	101.7	57.3	114.5	101.9	111.6	59.4	293.6	214.8	256.4	157.9	94.8	108.7	257.7	233.3	138.9	187.1	177.4	229.9	189.7	436.8	196.2	130.5	152.1	167.0	299.6	228.9	270.7	354.4	231.0	349.9	128.3	205.9	101.2	334.0	228.2	122.7	106.9	187.1	182.1	108.8	209.4	186.7	353.7	200.0	197.6	216.0	347.7	202.9	307.6	186.6	185.6	440.8	296.4	271.7	212.1	203.8	218.6	226.0	225.1	157.7	90.0	172.2	213.4	176.7	207.1	194.9	238.1	184.2	349.4	224.0	312.5	473.1	128.4	293.1	220.0	1.2	1.9	1.2	2.6	3.0	2.0	1.7	2.0	1.7	2.6	2.2	2.0	1.7	1.9	1.8	2.5	5.1	2.6	1.1	43.8	46.1	49.4	47.4	41.8	44.5	47.0	42.9	47.5	47.2	46.9	59.4	62.2	22.4	53.8	40.1	105.1	35.4	52.1	18.0	135.5	76.7	63.6	47.6	22.9	31.5	29.1	22.0	64.6	42.9	100.0	59.0	7.9	37.4	15.9	61.2	64.8	48.7	62.9	83.3	38.0	44.1	35.3	57.0	91.7	88.4	39.3	33.8	43.5	63.0	27.4	33.7	39.0	70.4	12.2	63.7	35.1	11.7	28.3	60.3	26.6	31.9	42.4	39.0	48.4	31.2	56.3	44.1	45.6	22.6	123.0	55.6	55.4	23.9	25.5	78.7	19.7	64.1	59.0	25.5	22.1	117.6	47.5	52.3	95.0	42.4	70.2	41.9
HNRNPLL	HNRPLL	ENSG00000143889	"Heterogeneous nuclear ribonucleoprotein L like"	Q8WVV9	2	38561969-38603586	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 155.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046084	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA046084: AB_10960895"	"unprognostic (2.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-2)"	16.0	16.4	16.3	12.5	20.7	51.7	14.7	19.3	21.3	16.2	12.9	16.1	15.5	18.2	13.9	10.2	16.7	14.1	12.8	28.6	8.3	11.1	10.8	16.4	12.5	5.9	8.1	16.9	15.9	16.8	9.2	13.1	7.2	13.9	11.8	26.6	12.8	15.0	13.8	11.4	12.7	12.8	7.8	12.0	15.7	22.6	9.3	31.0	17.7	11.9	9.6	15.2	12.8	15.8	36.7	16.9	48.2	28.4	22.9	21.6	30.1	33.8	27.5	28.8	24.1	19.0	20.7	0.5	29.5	30.4	30.9	23.0	30.7	25.4	29.6	54.6	26.8	26.7	32.3	48.6	21.6	49.9	26.4	16.9	19.6	24.0	26.5	28.5	30.6	23.9	45.9	79.7	34.3	17.2	54.9	27.2	48.4	35.2	30.6	10.6	33.9	18.1	25.0	47.2	32.9	36.9	29.8	25.8	26.0	26.7	21.8	21.6	32.0	21.5	32.1	23.8	28.1	43.4	46.9	0.3	18.5	12.2	26.8	10.6	6.3	9.7	10.3	3.2	17.9	0.4	24.2	18.9	12.0	1.9	7.2	4.6	4.2	6.8	1.2	0.2	38.5	5.8	16.3	20.7	19.3	21.3	28.6	8.3	5.9	8.1	7.2	7.8	9.3	15.8	17.0	19.2	23.4	26.8	5.5	28.7	35.2	16.5	33.0	13.3	18.0	15.2	18.8	8.6	18.8	27.6	8.4	26.2	6.4	13.9	19.6	22.4	155.6	18.1	18.8	20.1	14.4	22.5	68.6	24.3	28.9	26.0	32.1	11.6	9.5	26.3	22.5	7.4	24.4	6.7	40.1	15.4	6.1	15.0	90.2	48.7	27.7	23.1	39.2	37.5	24.5	22.3	2.1	48.7	28.4	21.2	14.2	52.3	23.0	23.6	16.6	18.6	14.5	11.7	39.5	22.6	28.4	91.1	28.8	19.4	21.3	22.2	48.0	22.3	18.8	21.4
HNRNPM	"CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1"	ENSG00000099783	"Heterogeneous nuclear ribonucleoprotein M"	P52272	19	8444767-8489114	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016113, HPA024344"	Supported		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB016113: AB_627739, HPA024344: AB_1850879"	"unprognostic (2.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (6.91e-3)"	"unprognostic (4.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	97.2	83.9	55.6	126.3	63.0	230.9	94.4	66.0	63.8	104.4	61.4	108.3	98.4	113.8	57.1	126.4	92.5	54.4	89.1	51.6	61.0	92.4	89.4	90.6	141.3	60.7	59.1	121.9	84.1	90.5	71.5	87.5	60.8	76.6	91.9	127.7	93.0	75.4	148.6	106.5	100.8	88.0	57.2	110.5	90.9	78.1	59.8	166.3	93.2	62.1	156.0	93.2	101.5	69.3	477.5	315.7	580.8	236.3	131.4	145.2	373.7	279.3	208.5	340.3	256.9	452.4	141.4	697.4	363.4	254.3	242.4	286.3	603.3	349.4	425.1	437.5	501.0	620.1	312.2	439.8	136.3	640.0	317.4	150.5	173.4	289.2	119.9	100.0	309.7	256.3	632.3	193.6	273.3	324.3	617.2	556.8	505.1	258.2	381.1	687.8	508.1	330.5	179.6	452.9	320.7	356.8	469.5	250.4	278.8	276.8	299.0	378.4	362.9	294.5	357.4	313.6	529.2	285.4	560.8	791.4	221.7	511.4	329.1	21.3	78.4	48.0	91.2	93.4	91.7	69.6	79.0	91.6	86.6	61.4	84.3	83.0	20.0	86.0	71.8	86.3	87.6	94.5	55.6	63.0	66.0	63.8	51.6	61.0	60.7	59.1	60.8	57.2	59.8	69.3	157.1	128.2	189.0	48.6	154.1	166.3	204.8	240.8	105.9	199.6	143.8	125.1	92.1	118.7	240.8	117.7	70.9	272.8	170.3	95.5	97.8	237.4	13.2	150.6	194.7	164.3	190.4	211.5	43.3	273.1	304.4	141.7	76.0	190.2	267.4	136.3	111.4	148.5	174.4	138.0	46.5	154.6	138.4	127.2	139.8	18.3	113.4	137.7	110.3	59.0	212.5	186.1	219.4	60.8	79.8	202.2	102.9	142.1	118.7	92.7	77.8	106.0	193.1	213.6	210.4	194.1	231.2	182.3	150.6	106.3	137.0	262.4	168.7	125.4	183.3	131.3
HNRNPR	"hnRNP-R, HNRPR"	ENSG00000125944	"Heterogeneous nuclear ribonucleoprotein R"	O43390	1	23303771-23344336	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011687, HPA026092"	Supported		Enhanced	Nucleoplasm		NA	NA		470000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011687: AB_2295532, HPA026092: AB_1850885"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.28e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.12e-1)"	51.1	47.9	18.4	48.7	21.6	56.6	49.0	26.0	22.9	55.0	22.3	44.7	33.6	66.1	25.8	54.9	52.6	29.0	40.4	18.1	22.2	43.8	27.2	47.6	58.0	20.2	19.6	61.6	34.0	42.3	33.9	50.0	21.6	35.0	43.2	40.2	46.7	31.8	55.9	51.2	46.7	44.7	20.1	41.9	38.9	31.0	19.2	71.9	43.5	27.7	60.0	48.3	50.1	26.8	161.7	103.9	200.9	123.5	70.0	73.6	103.6	102.7	118.0	178.3	123.0	73.2	113.4	202.3	52.1	141.4	88.9	89.5	211.0	143.9	208.5	142.3	161.4	192.5	131.0	121.9	68.4	224.2	125.1	74.8	86.7	141.5	113.4	73.3	112.9	153.0	185.4	139.9	119.2	98.3	268.3	71.6	111.6	105.3	103.4	196.9	186.5	144.1	96.5	88.7	137.3	132.6	141.8	116.0	88.7	109.5	98.6	102.6	121.0	102.6	133.4	123.8	129.5	81.3	149.0	276.8	71.9	200.7	117.7	21.7	35.9	44.9	49.0	47.2	51.7	41.4	45.0	47.7	45.8	41.6	48.0	45.5	12.8	53.9	48.1	30.0	58.4	46.6	18.4	21.6	26.0	22.9	18.1	22.2	20.2	19.6	21.6	20.1	19.2	26.8	112.0	118.6	109.1	29.0	132.7	127.6	207.1	139.0	95.6	127.8	89.1	78.0	72.3	84.4	138.0	88.3	43.8	253.0	125.8	60.2	92.0	126.6	22.9	110.5	183.8	129.3	116.4	150.4	28.6	126.5	274.4	135.3	92.2	146.2	172.0	171.4	61.8	73.1	106.6	126.2	32.6	107.8	138.4	77.7	92.4	17.2	120.9	98.8	83.6	36.5	147.7	159.9	112.3	63.3	60.6	125.2	64.1	116.6	144.3	208.5	59.6	76.9	114.5	111.1	85.5	159.1	170.2	170.4	148.3	136.4	129.9	206.7	136.5	157.3	116.8	182.4
HNRNPU	"C1orf199, FLJ30202, FLJ37978, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A"	ENSG00000153187	"Heterogeneous nuclear ribonucleoprotein U"	Q00839	1	244840638-244864560	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011532, HPA041057, HPA058707"	Supported		Enhanced	Nucleoplasm		NA	NA		2100000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.26e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.87e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.62e-1)"	110.3	111.9	123.7	76.1	132.5	177.5	100.9	131.8	139.8	101.6	122.3	93.3	65.5	103.0	121.3	99.9	106.6	62.7	92.7	122.5	123.5	129.9	105.6	80.7	98.3	125.7	127.9	134.5	99.4	109.6	88.2	96.0	127.3	92.2	84.2	126.3	86.8	79.5	116.5	91.9	94.5	76.7	129.8	103.0	95.0	90.2	127.6	141.2	103.6	61.6	115.5	97.0	86.8	144.6	308.9	242.9	311.8	249.4	160.5	136.4	307.9	215.2	138.2	193.3	171.1	234.0	198.6	481.9	195.6	183.0	185.4	235.3	424.4	244.0	304.5	204.8	280.2	417.4	203.4	360.7	168.8	482.7	242.9	156.2	143.9	211.6	220.1	169.8	200.4	296.9	553.0	174.0	264.3	221.2	517.8	497.8	545.5	227.4	217.2	510.6	392.7	261.9	314.3	222.9	260.6	257.5	339.2	220.4	280.9	226.8	305.2	531.7	244.5	192.6	283.7	207.0	384.3	283.4	332.9	458.6	156.8	403.1	282.2	23.0	14.4	20.6	18.0	12.9	19.2	22.6	22.0	22.1	15.8	21.8	25.5	21.5	20.6	19.8	15.0	31.3	21.3	10.1	123.7	132.5	131.8	139.8	122.5	123.5	125.7	127.9	127.3	129.8	127.6	144.6	269.6	326.9	375.8	67.9	271.9	271.2	416.4	137.1	277.2	149.5	254.3	166.5	186.8	118.7	281.4	193.1	183.5	202.2	323.4	163.7	97.8	215.5	389.9	283.4	530.1	248.6	198.1	269.4	61.8	180.9	259.5	267.1	202.9	429.8	363.6	375.3	133.2	121.9	184.5	141.3	65.2	208.0	109.9	223.7	268.6	481.9	153.7	402.7	122.7	45.9	251.4	151.4	228.6	67.8	107.7	188.9	141.8	142.6	331.6	215.8	141.4	133.2	240.1	213.7	144.7	317.0	364.3	194.9	162.7	292.7	239.2	252.7	310.6	379.9	234.6	288.1
HNRNPUL1	"E1B-AP5, E1BAP5, FLJ12944, HNRPUL1"	ENSG00000105323	"Heterogeneous nuclear ribonucleoprotein U like 1"	Q9BUJ2	19	41262496-41307787	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046290, CAB046477, HPA049475"	Enhanced		Enhanced	Nucleoplasm		NA	NA		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783"	"unprognostic (5.52e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.39e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (2.39e-1)"	85.7	65.9	53.2	89.1	62.4	176.2	75.0	64.3	63.8	78.0	58.9	85.7	81.3	85.0	49.1	81.4	82.8	58.0	75.7	52.9	58.9	48.3	52.5	75.0	102.4	63.9	56.3	116.3	71.7	64.7	58.3	48.8	60.6	59.6	73.1	91.2	84.7	66.7	92.7	93.2	78.7	79.0	53.1	86.4	73.5	79.8	56.1	140.0	69.9	75.6	109.6	75.2	72.1	66.0	284.3	371.2	216.5	200.4	104.3	124.0	82.2	163.1	194.1	207.1	187.8	218.7	213.2	250.1	112.3	206.4	116.8	91.2	208.1	191.3	234.6	248.5	172.9	272.9	168.8	170.4	121.0	259.5	244.3	132.9	116.8	185.8	171.6	186.5	195.7	187.1	203.1	233.8	185.9	217.0	341.0	151.8	165.0	270.8	126.7	219.0	171.6	142.3	149.0	298.8	171.2	154.2	363.3	212.6	95.4	147.7	163.7	290.2	188.4	231.6	218.6	105.4	318.3	264.3	184.5	238.4	147.5	210.8	311.6	13.2	6.2	11.0	11.9	6.7	18.1	8.8	14.4	12.4	7.3	9.0	9.9	7.9	13.5	12.6	7.9	13.7	10.9	5.7	53.2	62.4	64.3	63.8	52.9	58.9	63.9	56.3	60.6	53.1	56.1	66.0	57.0	80.1	69.6	14.7	105.4	56.2	42.9	35.9	71.7	63.2	69.0	58.5	64.1	52.9	36.1	31.3	73.0	50.1	151.9	51.4	45.0	65.1	51.6	52.7	76.8	57.7	76.7	129.4	13.9	62.2	58.8	67.7	55.5	54.2	58.9	78.8	60.3	43.0	63.6	48.8	16.2	66.4	30.5	102.4	76.5	73.9	86.3	92.3	35.6	16.9	81.1	70.8	93.7	21.6	22.2	68.6	39.4	71.5	152.2	48.6	49.5	29.5	49.9	97.3	78.9	74.7	70.3	113.6	108.9	99.1	60.2	53.4	134.2	60.3	73.6	43.6
HNRNPUL2	"DKFZp762N1910, HNRPUL2"	ENSG00000214753	"Heterogeneous nuclear ribonucleoprotein U like 2"	Q1KMD3	11	62712630-62727457	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA041632, HPA056696, HPA067699"	Supported		Enhanced	Nucleoplasm		NA	NA		88000	"Cluster 6: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA041632: AB_10960896, HPA056696: AB_2683211, HPA067699: AB_2685891"	"unprognostic (3.06e-3)"	"unprognostic (2.31e-1)"	"unprognostic (7.48e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.45e-2)"	30.4	20.9	44.3	28.6	45.4	27.3	26.2	47.3	52.3	28.7	37.2	40.5	29.0	32.5	36.3	37.2	29.1	17.1	33.1	45.0	43.1	26.8	21.1	25.8	35.1	42.3	43.8	26.5	32.5	24.7	20.9	25.1	43.0	26.6	28.0	37.5	30.6	30.2	48.6	39.8	35.2	28.3	42.4	34.1	31.3	16.7	45.5	47.4	24.3	35.9	37.6	34.2	28.2	44.2	110.9	49.8	83.5	50.3	45.1	55.3	14.4	70.2	41.5	52.1	40.2	34.4	37.5	129.1	36.5	57.9	45.0	62.2	51.2	66.3	69.1	59.1	27.8	123.0	64.9	39.1	41.2	127.8	78.1	43.8	50.7	50.2	61.4	41.0	64.8	33.5	46.6	47.8	61.0	63.5	128.1	114.1	39.8	41.4	42.9	88.6	77.0	62.3	65.4	65.2	48.4	56.3	71.7	57.8	75.3	39.3	43.5	55.6	72.8	61.0	28.2	77.4	74.4	60.8	54.3	124.6	55.3	62.1	57.5	1.1	0.8	1.3	1.4	0.6	1.0	1.0	1.0	1.2	0.5	1.3	0.8	0.9	1.0	0.8	1.4	1.4	1.0	0.5	44.3	45.4	47.3	52.3	45.0	43.1	42.3	43.8	43.0	42.4	45.5	44.2	21.1	28.9	12.1	0.0	19.0	29.4	15.0	20.2	13.6	31.3	25.0	18.7	43.8	30.0	17.5	53.3	10.4	27.9	32.4	68.8	5.9	27.4	9.9	20.8	26.3	30.6	38.4	23.5	0.0	36.0	26.9	23.0	19.4	29.7	15.2	28.0	37.5	40.7	37.9	42.1	0.0	48.3	22.4	54.1	29.4	6.9	42.0	27.6	14.2	0.0	38.0	18.2	24.7	0.0	0.0	35.0	42.7	45.9	12.5	24.1	59.6	25.6	16.1	19.7	32.9	22.8	27.5	15.6	20.1	19.6	32.1	25.2	19.8	20.6	58.6	17.4
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.4"	"Group enriched"	"Detected in all"	6	"Early spermatids: 309.7;Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.23e-1)"	6.1	4.9	4.6	4.7	6.2	1.5	6.7	5.9	5.8	6.5	4.0	6.7	7.3	5.3	8.0	9.8	7.0	5.2	7.8	4.8	5.5	9.4	6.2	6.1	4.6	6.8	5.5	9.9	7.8	8.8	3.6	5.7	6.3	6.5	6.2	6.0	7.0	9.6	9.0	7.7	5.0	7.2	4.9	5.6	7.8	34.4	6.7	9.4	7.3	14.9	7.9	10.9	5.7	6.4	7.0	7.2	13.0	12.3	19.8	8.7	14.8	7.2	9.4	6.8	8.7	3.3	14.6	15.2	6.1	7.1	16.0	23.3	17.3	18.0	8.5	8.4	6.6	5.2	6.0	14.1	25.8	7.6	4.4	13.5	17.7	5.4	11.8	15.1	13.1	17.0	15.6	6.0	11.8	16.1	5.9	5.2	5.3	21.3	4.1	9.2	9.7	6.7	12.5	28.5	4.2	5.2	6.9	19.3	7.8	19.7	12.0	8.9	14.6	4.7	2.1	5.9	3.3	25.1	11.3	5.0	2.5	5.5	7.2	2.9	5.0	7.3	3.5	4.5	2.8	2.6	3.0	2.9	4.8	2.3	3.2	3.9	0.8	2.4	3.4	2.9	4.1	2.9	4.6	6.2	5.9	5.8	4.8	5.5	6.8	5.5	6.3	4.9	6.7	6.4	3.7	6.4	7.0	4.6	5.6	2.8	18.4	19.9	9.1	5.8	7.0	5.7	6.9	12.8	14.4	23.9	6.2	6.9	4.6	6.8	13.7	11.0	309.7	4.4	4.2	5.7	3.6	5.0	1.9	10.9	6.6	5.2	13.7	6.9	3.8	8.2	5.3	6.9	8.7	10.1	2.0	9.2	8.2	6.1	5.1	78.9	6.8	5.8	3.6	6.5	15.1	6.9	5.2	3.0	6.8	9.1	5.5	7.5	6.1	16.3	8.6	19.8	12.9	3.7	6.6	4.7	4.7	15.2	5.3	10.1	5.1	9.3	4.2	3.8	7.9	29.1
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720895	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 117.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 727.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 5.6;HeLa: 4.9;hTCEpi: 19.4;SiHa: 6.1;SuSa: 6.5;THP-1: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA028346: AB_2672564, HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.2	0.0	0.1	0.5	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.4	0.1	0.4	0.0	0.0	6.8	0.2	0.1	0.0	0.9	0.1	117.8	0.2	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.1	0.0	0.1	4.9	0.0	0.0	0.1	0.1	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.1	6.5	0.0	11.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	5.4	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.4	0.0	0.3	0.0	0.1	88.3	0.5	0.1	0.5	0.0	0.0	2.7	0.0	2.1	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.8	0.0	2.0	0.0	0.0	1.3	0.9	35.1	5.3	0.8	0.0	1.0	1.5	0.0	0.0	1.0	0.1	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.5	0.0	32.9	0.0	0.4	727.7	163.5	0.0	9.2	2.2	0.0	0.3	0.2	0.1
HORMAD2	"CT46.2, MGC26710"	ENSG00000176635	"HORMA domain containing 2"	Q8N7B1	22	30080464-30177075	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 22.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 52.8;Spermatocytes: 133.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003074, HPA043880"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Centrosome, Cytosol"	"HPA003074: AB_1850916, HPA043880: "					"unprognostic (1.43e-1)"		"unprognostic (6.77e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.36e-2)"			"unprognostic (8.19e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"		0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.9	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.2	0.0	133.0	12.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170592-27180261	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 76.8;skeletal muscle: 76.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 174.0;Enteroendocrine cells: 68.1;Paneth cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 10.7;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.7;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 179.0;THP-1: 96.7;U-937: 100.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	190	"spinal cord: 18.9"	"CAB019384, HPA071918"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Nuclear bodies"	"CAB019384: , HPA071918: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	13.4	6.8	0.0	6.1	0.0	4.3	6.8	0.0	0.0	40.8	0.0	32.6	0.1	76.8	9.1	0.2	8.3	0.1	0.0	0.0	0.0	13.7	0.1	0.1	2.3	0.0	0.0	0.8	0.0	0.0	0.0	13.4	0.0	26.3	13.2	0.0	0.0	15.4	76.4	6.0	7.9	44.9	0.1	0.2	0.1	0.3	0.0	5.2	0.1	0.0	0.2	20.4	17.2	0.1	20.6	4.3	0.0	59.9	29.3	28.0	0.2	40.1	27.2	18.0	16.8	6.1	17.8	0.0	10.9	31.6	0.0	22.6	15.5	0.0	13.2	9.5	179.0	21.6	15.0	0.5	0.8	9.6	31.4	17.8	0.9	1.5	0.0	0.0	27.5	6.3	0.9	0.0	13.3	0.0	0.0	63.1	0.0	16.6	18.8	1.9	4.0	0.1	34.7	9.6	46.7	0.1	13.8	0.0	0.1	6.4	0.1	96.7	0.0	0.0	16.1	21.1	0.2	0.4	0.1	0.0	0.0	100.4	0.5	10.7	0.1	0.3	2.2	0.0	0.0	0.1	0.0	0.2	1.2	0.3	0.0	0.0	0.0	13.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.5	0.0	0.0	0.0	0.2	3.7	10.0	0.0	0.6	0.0	4.4	4.6	1.6	0.0	0.0	7.3	0.0	0.5	4.5	28.8	19.6	0.0	0.0	3.1	174.0	5.4	68.1	15.5	0.0	0.0	0.4	13.3	0.0	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	25.0	0.0	2.5	4.7	0.0	0.0	2.0	5.4	0.0	0.5	0.0	7.2	0.0	0.0	0.0	32.1	0.4	1.3	18.1	18.8	27.1	0.0	0.0	0.0	13.3	15.7	2.3	4.6	0.5	4.1	0.5	3.1	0.0	25.5	10.1
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181157-27185232	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 44.8;endometrium 1: 96.7;smooth muscle: 41.2"	"Cell type enriched"	"Detected in some"	19	"Endometrial stromal cells: 116.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.5;HEK 293: 44.0;THP-1: 34.7;U-937: 43.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"spinal cord: 3.5"	"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	3.5	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	44.8	0.0	23.1	0.0	96.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	10.0	0.0	14.7	3.9	0.0	0.1	9.6	7.9	1.5	0.2	41.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	17.0	10.4	0.0	4.8	0.3	0.0	13.1	15.2	11.1	0.0	26.8	32.5	18.9	13.8	0.3	1.7	0.0	6.1	23.5	0.1	3.2	16.3	0.0	14.7	1.6	44.0	5.7	11.2	0.7	0.9	12.5	1.7	6.5	0.6	0.1	0.0	0.0	14.1	1.1	0.4	0.0	2.2	0.4	0.0	9.4	0.0	4.4	13.1	0.7	0.0	0.3	9.6	8.1	5.6	0.0	6.7	0.0	2.0	3.6	1.2	34.7	0.0	0.2	12.9	3.2	1.5	0.0	0.0	0.0	0.2	43.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.3	1.1	5.9	0.0	0.8	4.0	116.8	1.3	5.3	0.0	0.0	0.0	0.1	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.8	0.2	0.2	0.0	0.0	0.0	0.9	5.8	1.2	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.3
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200091	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 23.1;placenta: 17.1;prostate: 22.3;seminal vesicle: 23.3"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 41.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 26.9;HEK 293: 37.3;PC-3: 18.4;RT4: 42.1;THP-1: 18.2;U-937: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046098, HPA069061"			Supported	"Nucleoplasm,Mitotic chromosome,Intermediate filaments"		Yes	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Mitotic chromosome, Intermediate filaments"	"HPA046098: AB_2679536, HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.1	0.0	9.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	22.3	11.9	0.0	0.0	23.3	2.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	14.1	0.0	2.2	1.6	0.0	2.5	0.2	0.0	0.1	13.2	14.4	5.1	3.3	2.8	0.2	0.0	1.6	6.2	0.7	0.0	26.9	0.0	4.3	0.0	37.3	1.9	6.9	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	8.7	0.0	11.8	18.4	2.7	0.6	0.0	0.1	42.1	0.7	0.0	3.3	0.0	0.3	2.0	0.0	18.2	0.0	0.5	4.5	0.3	0.1	0.0	0.0	0.0	0.0	20.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.6	0.1	4.0	1.1	8.4	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.1	2.8	0.5	0.0	0.0	0.1	0.1	0.1	0.0	10.3	3.1
HOXA2	HOX1K	ENSG00000105996	"Homeobox A2"	O43364	7	27100354-27102686	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 3.8;Enteroendocrine cells: 4.8;Hepatic stellate cells: 6.4;Squamous epithelial cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"medulla oblongata: 4.5;pons: 3.3;spinal cord: 4.7;white matter: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 14.5;HaCaT: 6.2;RPTEC TERT1: 4.9"	"Region enriched"	"Detected in single"	36	"pons and medulla: 5.8"	"Group enriched"	"Detected in some"	17	"medulla oblongata: 4.2;pons: 1.1;spinal cord: 3.0"	HPA078220			Approved	Nucleoplasm,Vesicles		Yes	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA078220: AB_2686880"	"unprognostic (7.30e-2)"	"unprognostic (4.90e-4)"	"unprognostic (2.81e-1)"	"unprognostic (7.43e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.98e-9)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-2)"	1.9	1.0	0.0	0.6	0.0	0.0	1.6	0.0	0.0	1.6	0.0	3.3	0.9	2.0	5.1	2.3	4.1	1.0	0.2	0.0	0.0	4.4	0.2	1.7	0.2	4.5	0.2	0.6	0.3	5.7	0.0	0.0	3.3	1.7	1.8	0.0	0.0	2.1	0.7	1.6	2.6	0.9	4.7	1.2	2.2	0.1	0.1	1.8	0.8	3.0	0.6	2.0	0.9	4.3	1.1	0.6	4.0	14.5	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.6	3.4	0.1	1.5	0.1	1.8	6.2	0.2	0.0	0.0	0.0	2.0	0.0	0.1	0.2	1.8	0.1	0.3	0.8	0.0	3.1	3.1	0.0	2.5	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.9	1.0	0.7	0.0	4.9	0.5	0.9	0.0	0.2	0.0	0.9	0.2	0.0	0.0	2.5	0.0	0.2	1.1	0.5	0.0	0.0	0.1	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	3.3	4.7	0.1	4.3	1.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	23.3	0.0	1.2	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.1	1.3	2.5	4.8	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	6.4	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	1.1	0.5	0.0	0.0	0.0	1.0	1.9	0.0	0.0	6.3	0.3	0.0	0.1	0.0	1.7	0.7
HOXA3	"HOX1, HOX1E"	ENSG00000105997	"Homeobox A3"	O43365	7	27106184-27152581	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 27.9;Endometrial stromal cells: 17.9;Intestinal goblet cells: 15.8;Proximal tubular cells: 13.2;Undifferentiated cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"medulla oblongata: 10.5;pons: 7.8;spinal cord: 9.4;white matter: 7.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.2;CACO-2: 25.2;CAPAN-2: 66.5;HEK 293: 29.7;WM-115: 35.5"	"Region enriched"	"Detected in single"	30	"pons and medulla: 3.0"	"Region enhanced"	"Detected in some"		"medulla oblongata: 3.9;spinal cord: 3.1"	HPA029157	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA029157: AB_10601020"	"unprognostic (1.32e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.61e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.82e-2)"	7.1	3.2	0.0	2.3	0.0	0.3	7.3	0.0	0.0	5.3	0.0	12.2	3.9	8.5	6.4	8.2	18.4	2.9	0.6	0.0	0.0	12.9	0.7	6.0	1.4	10.5	0.6	3.0	0.7	3.8	0.0	0.1	7.8	6.5	4.6	0.0	0.2	2.3	7.6	4.9	9.5	3.4	9.4	2.3	6.6	2.8	0.1	1.6	2.2	3.1	0.2	8.9	3.7	7.1	11.9	13.7	0.0	38.2	0.0	0.0	0.0	0.4	0.4	0.1	0.2	25.2	66.5	1.8	18.7	1.0	5.2	15.9	0.7	1.7	0.0	0.5	29.7	0.5	0.4	20.6	1.3	0.7	0.7	2.4	0.1	3.1	3.6	0.0	3.6	1.7	1.3	0.2	1.5	0.6	0.0	1.0	0.0	3.3	8.6	14.1	4.4	0.0	11.4	5.4	5.6	0.0	2.1	0.0	5.8	0.5	1.1	0.8	16.5	0.0	2.0	3.9	3.1	0.0	0.0	0.6	1.2	2.6	35.5	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.6	7.8	9.4	0.1	7.1	6.2	0.0	0.0	0.0	0.2	1.1	3.8	0.0	27.9	0.0	5.7	6.1	1.0	0.0	0.0	3.7	0.0	0.0	0.7	6.2	5.9	0.1	8.1	2.0	17.9	5.8	4.2	1.7	0.0	0.0	0.0	6.8	0.0	0.5	1.3	0.2	9.3	0.3	0.1	0.0	0.0	15.8	0.0	0.3	0.7	9.1	0.6	1.3	3.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.3	0.0	0.0	2.4	5.5	13.2	0.0	0.0	0.0	2.9	9.2	2.2	1.4	11.8	1.3	0.0	1.2	0.1	16.6	4.5
HOXA6	"HOX1, HOX1B"	ENSG00000106006	"Homeobox A6"	P31267	7	27145396-27150603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 10.0"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 5.2;Distal enterocytes: 7.5;Distal tubular cells: 5.9;Endometrial stromal cells: 14.8;Enteroendocrine cells: 9.0;Smooth muscle cells: 6.2;Undifferentiated cells: 8.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.7"	"Immune cell enhanced"	"Detected in single"		"basophil: 3.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 3.1"	"Group enriched"	"Detected in many"	9	"AN3-CA: 61.7;HEK 293: 84.4"	"Region enriched"	"Detected in single"	34	"pons and medulla: 3.3"					"HPA004203, HPA077900"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Nuclear speckles"	"HPA004203: AB_1079079, HPA077900: "	"unprognostic (1.70e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.06e-2)"		"unprognostic (9.73e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.81e-2)"		"unprognostic (3.93e-1)"	3.0	2.7	0.1	1.4	0.1	0.2	2.4	0.0	0.2	2.5	0.0	6.6	0.2	5.4	3.7	0.3	10.0	0.2	0.0	0.1	0.0	4.5	0.0	2.1	1.1	7.1	0.0	0.2	0.0	0.3	0.0	0.1	1.8	2.5	1.5	0.0	0.1	1.9	1.2	2.9	4.2	1.4	7.7	0.2	1.3	0.0	0.0	0.1	0.2	0.0	0.0	3.0	1.4	5.4	1.2	2.1	0.1	61.7	0.1	0.0	0.2	0.5	0.6	0.4	0.6	1.5	7.2	1.5	2.3	0.5	0.2	2.8	1.5	0.0	0.0	1.9	84.4	1.0	1.2	0.8	0.0	1.3	2.1	4.9	0.1	0.0	0.8	0.1	2.9	2.0	0.4	0.0	0.7	0.8	0.1	0.3	0.1	0.4	2.1	8.4	0.0	0.0	5.9	3.9	6.4	0.0	2.9	0.3	1.3	0.0	0.8	0.8	0.0	0.1	0.9	3.3	2.3	0.0	0.0	1.4	0.0	6.2	6.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	7.1	0.0	1.8	7.7	0.0	5.4	2.1	0.0	0.0	0.0	0.3	0.3	1.6	0.0	0.0	0.0	4.0	5.2	0.0	0.0	0.0	1.8	0.0	0.0	0.5	7.5	5.9	0.0	0.0	0.6	14.8	1.9	9.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.9	0.0	0.0	1.0	3.4	1.3	0.1	0.0	0.0	3.7	6.2	0.0	0.0	0.3	0.4	0.0	0.4	0.1	8.0	1.4
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 29.1;Distal tubular cells: 131.0;Early spermatids: 29.4;Proximal tubular cells: 53.4;Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"medulla oblongata: 4.6;pons: 2.1;spinal cord: 8.2;white matter: 5.1"	"Immune cell enriched"	"Detected in single"	6	"NK-cell: 4.7"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 36.9;RPTEC TERT1: 45.4;SCLC-21H: 36.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.3"	"Region enriched"	"Detected in some"	6	"spinal cord: 21.4"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear membrane"	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	8.2	17.8	0.0	5.9	0.0	0.3	9.4	0.0	0.1	4.2	0.0	13.8	0.2	5.8	17.8	2.8	15.5	0.1	0.0	0.0	0.0	20.1	0.0	2.7	2.1	4.6	0.1	0.8	0.2	0.2	0.0	0.3	2.1	4.9	8.9	0.0	0.0	6.7	16.5	12.0	8.6	3.8	8.2	1.7	3.9	2.4	0.1	2.9	0.5	0.1	0.4	7.3	5.2	5.1	13.6	4.6	0.0	14.1	0.0	0.0	0.8	4.7	8.0	9.6	11.0	7.0	5.1	9.2	12.8	3.7	0.3	9.1	36.9	0.0	5.8	0.0	23.2	0.6	4.8	0.2	0.9	0.8	0.5	7.5	0.4	1.1	12.9	0.0	18.5	15.7	0.0	0.0	3.7	2.4	0.0	2.2	0.5	9.6	1.4	4.8	8.5	0.0	45.4	9.1	36.3	0.1	25.6	0.0	0.1	2.5	0.4	3.7	1.6	0.0	8.6	26.0	4.6	0.0	0.2	0.2	0.0	17.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	4.7	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.1	2.1	8.2	0.1	5.1	11.0	0.0	0.0	0.0	0.6	9.1	7.2	0.1	12.0	0.0	18.7	29.1	0.4	0.0	0.1	12.9	0.0	1.1	1.3	10.3	131.0	0.0	29.4	0.2	2.1	5.9	16.2	5.5	0.0	0.0	3.9	5.8	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	12.5	0.0	0.0	1.9	7.2	0.6	0.6	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.8	0.0	1.7	5.2	2.3	53.4	0.1	0.0	0.0	10.8	16.1	27.4	4.1	8.6	12.4	0.3	1.0	1.2	16.1	5.3
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162438-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.4;skin 1: 25.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Endometrial stromal cells: 31.1;Enteroendocrine cells: 39.4;Proximal tubular cells: 75.1;Suprabasal keratinocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 6.7;myeloid DC: 5.6;NK-cell: 11.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.6;granulocytes: 6.7;NK-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 124.4;PC-3: 43.9;RPTEC TERT1: 42.0;SCLC-21H: 113.4;U-937: 42.3"	"Not detected"	"Not detected"							"HPA061982, HPA076200"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA061982: AB_2684651, HPA076200: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	4.7	5.9	0.0	2.8	0.0	2.5	6.9	0.0	0.2	12.7	0.0	22.0	0.0	17.0	5.6	1.0	19.6	0.0	0.0	0.0	0.0	28.4	0.0	0.4	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.1	14.1	3.9	0.0	0.0	4.5	16.1	25.7	14.8	1.9	0.2	0.9	0.2	0.0	0.0	1.9	0.1	0.0	0.0	16.8	13.8	0.2	37.7	0.0	0.0	18.4	6.0	4.4	0.0	14.6	11.7	1.2	1.2	2.4	1.4	0.3	1.4	7.9	0.0	34.7	23.5	0.0	1.2	0.0	124.4	0.3	1.1	0.0	0.6	0.0	0.5	6.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	43.9	8.1	0.0	0.0	42.0	0.7	113.4	0.0	15.6	0.0	0.3	0.6	0.0	31.3	1.4	0.0	11.4	14.0	0.2	0.0	0.0	0.0	0.0	42.3	0.0	6.7	0.8	0.0	1.3	0.2	0.2	0.1	0.0	0.1	5.6	0.9	0.2	0.0	0.8	11.5	0.3	1.8	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	6.2	0.0	0.0	0.0	2.0	25.1	14.9	0.0	3.4	0.0	12.2	14.7	0.5	0.0	0.0	18.4	0.0	0.2	2.9	10.5	54.8	0.0	0.0	1.0	31.1	4.3	39.4	16.6	0.0	0.0	0.3	4.8	0.0	0.6	0.0	0.0	0.7	0.0	0.3	0.0	0.0	21.7	0.0	3.4	4.2	0.0	0.0	1.9	5.4	0.0	0.8	0.0	2.1	0.0	0.0	0.0	20.2	0.0	0.9	19.4	13.3	75.1	0.0	0.0	0.0	3.0	4.6	0.0	1.0	2.6	27.6	0.3	2.2	0.3	21.4	14.2
HOXB1	"HOX2, HOX2I"	ENSG00000120094	"Homeobox B1"	P14653	17	48528526-48531011	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Early spermatids: 2.2"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044576	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA						"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA044576: AB_10794501"	"unprognostic (1.80e-2)"	"unprognostic (9.50e-3)"		"unprognostic (8.22e-2)"		"unprognostic (1.22e-1)"		"unprognostic (6.26e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.03e-1)"			"unprognostic (1.96e-1)"	"unprognostic (6.74e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2
HOXB13		ENSG00000159184	"Homeobox B13"	Q92826	17	48724763-48728750	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 41.1;prostate: 82.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 144.7;Enteroendocrine cells: 195.2;Intestinal goblet cells: 77.0;Paneth cells: 71.3;Prostatic glandular cells: 61.9;Undifferentiated cells: 81.6"	"Cancer enriched"	"Detected in many"	17	"prostate cancer: 187.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	13	"PC-3: 173.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004438, HPA062852, HPA065019"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.73e-11)"	"unprognostic (1.39e-2)"	"unprognostic (4.50e-2)"		"unprognostic (1.12e-1)"	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	82.3	41.1	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	4.6	0.0	1.9	6.0	0.0	13.2	0.0	0.0	0.5	0.6	0.0	0.2	0.0	2.5	3.0	0.0	3.0	0.0	1.4	0.0	8.7	0.0	0.1	1.0	4.2	2.5	1.5	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.7	0.0	0.0	0.3	0.0	2.2	173.0	0.0	1.4	0.1	0.0	0.4	0.0	0.0	2.7	0.0	4.4	0.5	0.0	0.5	0.0	0.5	4.7	4.7	1.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	144.7	0.0	0.0	0.6	0.0	0.0	0.2	195.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	77.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.3	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.0	0.0	0.1	0.2	0.1	81.6	14.6
HOXB2	"HOX2, HOX2H"	ENSG00000173917	"Homeobox B2"	P14652	17	48540894-48545109	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 156.5;Endometrial ciliated cells: 69.2;NK-cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"medulla oblongata: 14.9;pons: 10.9;spinal cord: 12.1;white matter: 10.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 54.5;EFO-21: 52.2;HEK 293: 59.1;HMC-1: 116.8;WM-115: 52.6"	"Region enriched"	"Detected in single"	34	"pons and medulla: 4.4"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 4.9;spinal cord: 7.0"	HPA047857			Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA047857: AB_2680184"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.89e-1)"	26.7	29.0	0.2	6.6	0.2	3.6	21.7	0.4	0.3	20.8	0.3	44.5	3.5	17.4	42.7	24.0	33.6	5.2	11.7	0.2	0.2	47.5	5.0	15.6	7.2	14.9	0.9	3.4	3.7	19.6	0.4	2.4	10.9	13.7	2.4	0.0	0.8	12.0	9.9	8.9	17.3	5.3	12.1	16.4	16.5	3.4	0.3	4.2	6.7	7.8	2.0	11.1	18.7	10.7	0.3	1.9	54.5	0.1	12.1	14.0	0.2	5.1	0.0	0.1	0.0	0.7	0.4	0.0	52.2	15.3	0.0	0.0	8.2	0.0	0.1	0.2	59.1	21.4	2.7	0.0	21.3	0.0	116.8	8.9	0.0	23.3	9.2	0.5	8.6	0.2	42.3	0.1	31.9	0.1	0.1	0.1	0.0	1.3	0.2	0.0	26.9	0.1	38.9	4.9	0.0	0.0	4.0	0.0	34.3	3.8	28.9	0.0	0.3	0.0	3.5	0.6	0.1	0.0	0.1	0.1	20.8	0.0	52.6	3.9	0.3	0.0	3.0	0.4	1.0	0.2	4.6	3.4	1.5	0.5	6.8	2.9	0.0	1.8	0.3	4.8	6.1	1.0	0.2	0.2	0.4	0.3	0.2	0.2	14.9	0.9	10.9	12.1	0.3	10.7	27.9	3.2	1.1	0.0	4.9	7.0	7.3	0.5	53.5	0.0	18.5	18.7	2.5	0.0	2.0	53.3	0.0	15.9	26.9	1.0	156.5	1.4	0.5	69.2	9.9	21.4	2.4	21.9	0.0	0.2	30.2	19.4	0.0	42.4	21.0	0.0	31.1	0.3	7.6	0.0	0.0	1.6	24.4	10.4	21.2	1.7	0.0	11.4	12.4	2.8	7.5	0.0	58.7	0.0	0.1	0.1	1.7	0.0	3.7	8.8	0.1	26.1	0.9	0.0	0.0	9.6	31.6	7.4	6.6	36.6	5.7	24.9	28.6	0.1	0.9	28.0
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 70.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.6;Collecting duct cells: 99.3;Early spermatids: 37.9;Endometrial ciliated cells: 25.6;Glandular and luminal cells: 35.0;Hepatic stellate cells: 25.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"medulla oblongata: 28.3;pons: 13.0;spinal cord: 24.5;white matter: 13.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.9;HEK 293: 47.4;RPTEC TERT1: 35.0;U-251 MG: 38.2"	"Region enriched"	"Detected in single"	39	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	22	"medulla oblongata: 10.1;pons: 3.9;spinal cord: 12.2"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB009860: AB_2119262, HPA064990: AB_2685398"	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.45e-6)"	22.7	11.3	0.2	7.8	0.1	1.8	19.3	0.2	0.2	23.3	0.3	43.6	6.5	13.6	70.5	13.5	38.5	7.6	5.2	0.3	0.1	38.7	4.1	12.6	4.8	28.3	1.0	1.6	4.8	20.0	0.2	4.2	13.0	9.3	11.8	0.0	0.6	25.4	10.6	7.7	27.5	9.4	24.5	15.7	17.7	10.3	0.4	1.3	4.8	8.2	1.2	11.3	10.2	13.6	6.6	13.9	10.1	4.6	8.7	12.1	2.5	0.2	0.0	0.2	0.2	6.2	43.9	3.5	34.0	30.1	4.4	0.3	2.0	0.7	0.1	10.6	47.4	10.9	7.0	0.0	13.4	0.0	27.3	12.3	0.0	13.3	0.7	6.5	13.8	13.2	14.8	0.4	8.4	0.2	0.7	0.3	0.2	14.3	1.3	0.0	7.0	1.4	35.0	6.7	0.0	0.1	1.5	0.0	7.8	7.5	13.9	3.0	15.1	4.5	13.6	2.5	38.2	3.5	4.5	0.4	9.5	0.0	8.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.6	0.2	0.1	0.2	0.1	0.2	0.2	0.3	0.1	28.3	1.0	13.0	24.5	0.4	13.6	26.6	0.0	1.9	0.0	0.5	2.5	3.0	0.0	11.4	0.0	5.9	2.7	1.8	1.5	0.7	99.3	0.0	3.2	2.0	11.4	7.9	0.2	37.9	25.6	4.3	13.6	2.4	0.8	0.0	0.0	0.8	8.1	0.0	35.0	8.8	0.0	25.0	0.4	0.7	0.0	0.0	7.5	0.0	1.6	4.2	12.9	0.3	0.8	5.4	0.0	0.3	0.0	6.2	0.0	0.0	0.4	7.7	0.4	0.4	3.2	7.6	0.9	0.0	0.0	0.0	4.8	6.2	6.1	11.7	13.9	1.4	0.4	2.0	0.0	9.5	7.0
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575507-48578350	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.6"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 28.5;Collecting duct cells: 64.4;Glandular and luminal cells: 25.1;Hepatic stellate cells: 24.3;NK-cells: 38.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	30	"medulla oblongata: 11.3;pons: 4.6;spinal cord: 9.1;white matter: 5.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 63.7;HMC-1: 37.5;K-562: 33.7"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.5"	"Group enriched"	"Detected in some"	13	"medulla oblongata: 3.7;spinal cord: 4.7"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Centrosome	"HPA057432: AB_2683437"	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	6.9	3.1	0.1	3.7	0.0	0.7	3.5	0.0	0.1	6.8	0.1	9.8	2.6	3.4	19.6	3.4	12.8	3.3	1.0	0.0	0.0	8.7	1.1	4.6	2.3	11.3	0.2	0.3	1.2	4.4	0.0	2.6	4.6	1.0	2.4	0.0	0.3	7.6	2.6	2.5	5.1	4.3	9.1	4.4	4.3	1.2	0.2	1.9	1.0	3.9	1.4	2.9	2.2	5.8	0.3	0.5	0.0	0.2	12.2	9.2	5.2	0.0	0.0	0.8	0.4	6.2	3.1	9.2	63.7	3.3	0.7	0.3	11.8	0.0	0.2	23.3	21.5	21.9	1.6	0.0	12.5	0.0	37.5	10.0	0.0	14.9	0.0	1.2	18.4	14.6	33.7	0.6	15.1	0.0	5.5	0.2	0.0	5.8	0.0	0.0	12.3	4.5	12.5	5.4	0.0	0.0	1.7	0.0	8.7	4.2	0.5	4.3	6.0	0.4	0.5	2.2	0.4	5.0	11.9	2.1	4.3	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	11.3	0.2	4.6	9.1	0.2	5.8	19.9	0.0	0.0	0.0	3.0	3.8	1.3	0.0	28.5	0.0	2.7	1.7	0.9	0.0	0.0	64.4	0.0	23.5	18.4	1.0	11.7	0.2	0.2	18.5	2.7	19.0	0.0	5.0	0.0	0.0	13.1	8.2	0.5	25.1	3.8	0.0	24.3	0.2	4.0	0.0	0.0	2.3	0.0	2.8	4.4	0.2	0.3	2.1	5.4	0.0	1.3	0.0	38.1	0.0	0.0	0.0	1.9	0.0	6.6	0.5	1.0	2.0	0.7	0.0	0.0	5.9	6.4	6.0	23.2	15.5	1.8	6.0	9.9	0.1	1.8	3.1
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593779	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.1;kidney: 32.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 53.3;Distal tubular cells: 25.4;Endometrial ciliated cells: 48.8;Glandular and luminal cells: 46.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enhanced"	"Detected in many"		"medulla oblongata: 39.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.8;HeLa: 8.7;RPTEC TERT1: 21.7"	"Region enriched"	"Detected in single"	230	"pons and medulla: 22.9"	"Group enriched"	"Detected in some"	9	"medulla oblongata: 19.3;spinal cord: 14.3"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA043851: AB_2732509, HPA074454: AB_2686690"	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (8.59e-5)"	4.8	3.9	0.1	2.5	0.0	0.1	1.8	0.0	0.1	6.2	0.0	16.6	1.7	2.3	18.4	0.2	7.4	0.2	0.1	0.1	0.0	32.5	0.6	5.9	0.1	39.1	0.3	0.2	0.7	1.0	0.0	1.2	10.9	1.1	4.9	0.0	0.0	6.9	0.4	0.8	12.2	1.9	24.8	2.6	4.9	0.8	0.0	0.0	0.5	0.2	0.0	2.8	1.5	9.0	2.6	6.5	0.0	3.2	3.2	3.5	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.0	6.5	3.7	0.7	0.0	0.3	0.0	0.0	0.0	28.8	1.3	8.7	0.0	5.5	0.0	1.4	1.8	0.0	3.9	0.0	1.1	2.0	0.2	2.1	0.0	4.4	0.0	0.0	0.0	0.0	3.6	2.3	0.0	1.2	0.0	21.7	2.2	0.0	0.0	0.2	0.0	3.3	0.1	0.6	0.0	6.5	0.9	2.6	0.7	0.4	0.0	0.0	0.0	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	39.1	0.3	10.9	24.8	0.0	9.0	4.9	0.0	1.1	0.0	0.0	0.9	0.2	0.0	1.2	0.0	0.3	0.3	0.4	0.0	0.0	53.3	0.0	0.0	0.1	13.5	25.4	0.0	0.9	48.8	4.1	6.6	4.2	2.7	0.0	0.0	0.0	3.8	1.1	46.0	0.0	0.0	8.2	0.0	0.7	0.0	0.0	11.4	0.0	4.2	0.8	0.5	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.4	0.0	0.1	7.0	0.5	0.0	0.0	0.0	0.2	4.9	8.6	11.0	0.3	0.3	0.0	0.6	0.0	11.3	0.1
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 40.3;kidney: 60.2"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 136.1;Distal tubular cells: 113.5;Endometrial ciliated cells: 80.7;Glandular and luminal cells: 56.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Group enriched"	"Detected in some"	17	"medulla oblongata: 12.9;spinal cord: 22.6;white matter: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 28.2;HEK 293: 80.3;RPTEC TERT1: 53.2;TIME: 30.1"	"Region enriched"	"Detected in single"	102	"pons and medulla: 10.1"	"Group enriched"	"Detected in some"	168	"medulla oblongata: 8.1;spinal cord: 25.4"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA042063: AB_10796470"	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	10.2	7.4	0.2	4.4	0.1	0.2	4.6	0.3	0.2	18.3	0.0	16.1	1.0	4.3	40.3	0.3	13.4	0.3	0.7	0.1	0.0	60.2	0.8	6.2	0.4	12.9	0.0	0.3	1.2	1.3	0.1	2.6	0.8	2.0	6.1	0.0	0.2	21.1	1.7	1.2	14.0	2.3	22.6	3.0	9.3	1.1	0.1	0.0	0.7	0.5	0.0	3.8	2.2	6.3	5.2	11.9	0.0	6.2	5.3	5.5	0.1	0.0	0.0	0.0	0.0	6.5	7.7	0.0	28.2	14.2	2.0	0.1	1.4	0.4	0.0	0.2	80.3	7.1	23.8	0.0	7.9	0.6	18.0	6.9	0.2	11.4	0.2	4.3	5.4	0.5	4.7	0.1	15.7	0.3	0.0	0.3	0.0	20.0	4.7	0.0	13.1	0.7	53.2	2.6	0.0	0.0	4.4	0.0	8.2	0.1	2.1	2.5	30.1	1.0	6.0	5.0	22.2	0.0	0.0	0.1	0.9	0.0	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.0	12.9	0.0	0.8	22.6	0.1	6.3	10.6	0.0	0.0	0.0	0.4	0.8	0.5	0.0	0.0	0.0	0.4	0.5	0.4	0.0	0.0	136.1	0.0	0.2	0.0	18.1	113.5	0.1	1.0	80.7	5.5	10.6	7.7	0.4	0.0	2.0	2.9	3.0	0.0	56.4	0.0	0.0	4.2	0.0	1.7	0.0	0.0	9.0	0.0	18.6	3.1	0.3	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.8	0.0	0.0	0.6	9.5	2.8	0.0	0.0	0.0	0.9	6.4	4.8	6.2	0.0	1.1	0.3	1.2	0.0	11.0	1.2
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607232-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 135.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Distal enterocytes: 131.3;Distal tubular cells: 148.7;Endometrial ciliated cells: 82.9;Glandular and luminal cells: 73.1;Intestinal goblet cells: 77.6;Paneth cells: 67.8;Proximal enterocytes: 140.3;Undifferentiated cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"medulla oblongata: 5.6;spinal cord: 13.3;white matter: 7.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 81.9;OE19: 74.7;RPTEC TERT1: 66.5;SK-MEL-30: 84.3"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.7"	"Region enriched"	"Detected in some"	7	"spinal cord: 22.2"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.39e-4)"	13.2	11.0	0.1	3.9	0.1	0.2	12.4	0.0	0.3	21.8	0.1	16.9	1.1	5.2	135.1	0.4	8.7	0.7	0.3	0.1	0.1	30.4	0.4	2.2	2.7	5.6	0.1	0.5	0.8	5.5	0.1	5.8	1.1	2.4	15.9	0.0	0.2	16.9	1.7	3.3	18.1	6.7	13.3	3.0	5.9	1.9	0.3	0.2	0.4	0.2	0.9	7.7	5.5	7.5	48.1	20.6	0.0	0.5	14.2	21.1	0.0	0.0	0.0	0.2	0.8	31.9	0.9	0.9	81.9	19.9	23.9	6.9	0.1	0.0	0.0	22.3	15.1	7.4	15.4	0.0	11.7	0.0	14.8	13.8	6.3	14.2	0.0	3.5	43.8	14.7	8.0	0.3	46.0	12.5	1.0	0.4	0.0	74.7	0.1	0.0	39.2	5.5	66.5	15.8	0.0	0.1	16.0	0.0	84.3	1.1	3.8	4.7	38.1	0.0	24.8	20.5	36.9	2.6	6.3	0.1	0.4	0.0	58.6	0.0	0.0	0.0	1.5	0.0	0.8	0.7	0.2	0.8	0.0	1.4	0.0	0.5	0.0	1.0	0.0	0.7	2.1	0.2	0.1	0.1	0.0	0.3	0.1	0.1	5.6	0.1	1.1	13.3	0.3	7.5	55.4	0.0	0.0	0.0	2.0	5.5	0.9	0.0	0.6	0.0	0.9	1.0	0.3	0.0	0.0	86.5	0.0	6.8	1.6	131.3	148.7	0.1	0.3	82.9	6.3	20.3	36.5	1.3	0.0	1.3	19.3	6.4	0.0	73.1	5.1	0.0	1.4	0.2	11.5	0.0	0.0	77.6	0.0	10.6	5.4	0.2	0.6	2.8	24.9	0.0	1.7	0.0	2.1	0.0	0.0	0.3	67.8	0.0	5.1	0.6	140.3	31.6	0.0	0.0	0.0	3.5	8.9	1.7	20.9	0.2	2.0	1.8	2.6	0.1	63.1	3.5
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48615292	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.1;epididymis: 48.1;kidney: 37.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 88.3;Distal tubular cells: 72.4;Endometrial ciliated cells: 21.3;Enteroendocrine cells: 44.1;Glandular and luminal cells: 26.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enhanced"	"Detected in many"		"spinal cord: 114.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 34.0;HDLM-2: 17.2;HEK 293: 36.9;LHCN-M2: 17.3;RPTEC TERT1: 35.3"	"Region enriched"	"Detected in single"	65	"pons and medulla: 6.5"	"Region enriched"	"Detected in all"	5	"spinal cord: 51.2"	HPA075905			Supported	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	7.2	7.2	0.1	1.5	0.0	0.0	2.7	0.0	0.0	10.7	0.0	4.7	0.0	2.8	48.1	0.0	1.4	0.0	0.0	0.0	0.0	37.6	0.0	0.4	0.0	36.4	0.0	0.1	0.1	0.8	0.1	0.3	1.8	1.0	1.2	0.0	0.0	20.8	0.4	0.5	7.1	1.5	114.1	0.1	6.6	1.0	0.0	0.0	0.1	0.0	0.0	3.7	0.7	20.8	2.1	5.3	0.0	0.8	0.7	1.0	0.8	0.0	0.0	0.0	0.0	0.3	0.8	0.0	34.0	5.3	0.6	0.0	0.1	0.0	0.0	17.2	36.9	1.0	0.1	0.0	0.3	0.0	5.5	1.1	0.0	0.1	0.0	0.7	2.1	0.2	11.6	0.0	17.3	0.0	0.0	0.4	0.0	11.3	0.0	0.0	3.6	0.1	35.3	1.0	0.0	0.1	0.6	0.0	5.4	0.1	0.4	0.0	8.8	0.0	1.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	36.4	0.0	1.8	114.1	0.0	20.8	4.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	88.3	0.0	0.0	0.1	1.8	72.4	0.0	0.3	21.3	2.1	2.6	44.1	0.0	0.0	0.0	0.8	0.3	0.0	26.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.2	2.7	8.9	0.0	0.0	0.0	0.1	0.8	2.3	9.2	0.0	0.0	0.0	0.3	0.0	5.0	0.0
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621156-48626358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 87.9;intestine: 26.3;kidney: 22.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal enterocytes: 30.4;Distal tubular cells: 39.2;Enteroendocrine cells: 176.7;Intestinal goblet cells: 40.7;Undifferentiated cells: 45.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 56.0;endometrial cancer: 26.4"	"Region enhanced"	"Detected in single"		"spinal cord: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 339.3;HEK 293: 126.4;HMC-1: 127.7;K-562: 145.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	69	"spinal cord: 6.8"	HPA004928			Supported	Nucleoplasm		NA	No				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"HPA004928: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.5	1.0	0.0	4.6	0.0	0.0	0.5	0.0	0.0	11.4	0.0	26.3	0.0	0.9	87.9	0.0	0.3	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.6	0.0	0.4	22.3	0.0	0.0	15.8	0.1	0.1	13.4	1.3	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.7	18.0	5.8	0.0	32.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.6	7.0	0.1	34.6	0.9	3.9	0.1	5.5	0.0	0.0	339.3	126.4	59.1	2.3	0.0	2.3	1.1	127.7	0.1	0.2	0.1	3.3	9.8	0.0	2.7	145.7	0.1	5.5	0.3	0.0	0.4	0.0	8.0	5.4	0.3	21.9	1.9	57.1	0.2	0.0	0.0	4.4	0.0	37.4	0.5	0.6	0.3	0.4	0.1	32.1	0.2	10.4	0.2	0.4	0.2	0.1	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.7	3.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	58.8	0.0	0.0	0.5	30.4	39.2	0.0	0.1	5.5	0.4	3.0	176.7	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	0.0	0.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.3	0.0	0.0	0.3	6.0	0.9	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.0	0.0	0.4	0.0	45.5	0.2
HOXC10	HOX3I	ENSG00000180818	"Homeobox C10"	Q9NYD6	12	53985065-53990279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 113.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 21.2;Collecting duct cells: 16.5;Distal tubular cells: 62.6;Proximal tubular cells: 100.4;Skeletal myocytes: 22.4;Suprabasal keratinocytes: 19.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 20.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 291.5;ASC diff: 82.5;ASC TERT1: 75.6;fHDF/TERT166: 67.6;T-47d: 99.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	319	"spinal cord: 31.8"	HPA053919	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"	Nucleoplasm	"HPA053919: AB_2682308"	"unprognostic (1.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.56e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.98e-1)"		"unprognostic (1.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.60e-3)"	"unprognostic (3.96e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.91e-1)"	13.1	1.1	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.7	0.0	0.2	0.0	1.5	0.0	0.1	8.8	0.0	0.0	0.0	0.0	22.5	0.0	0.0	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.5	113.5	16.4	2.1	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.1	0.7	3.3	0.0	291.5	82.5	75.6	0.5	10.1	24.4	13.6	12.6	0.6	0.9	0.5	2.7	67.6	1.9	31.4	4.1	0.0	6.5	15.2	5.6	3.0	36.2	0.0	0.4	0.0	3.7	36.0	0.5	1.0	0.0	0.0	0.1	8.5	2.3	0.0	9.4	1.8	0.1	7.5	0.1	36.4	1.1	0.0	0.4	0.0	30.6	0.0	0.0	3.9	6.9	10.0	15.7	0.4	99.4	2.2	0.0	8.0	10.2	0.2	13.3	1.3	0.2	0.1	0.1	1.7	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.0	21.2	0.0	0.0	0.0	0.0	4.8	7.9	0.3	0.0	0.0	16.5	0.0	0.0	0.1	0.0	62.6	0.0	0.2	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.4	0.6	0.9	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	100.4	0.0	0.0	0.0	22.4	5.2	3.6	4.4	0.0	19.2	0.1	0.4	0.0	0.0	0.0
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.8;skin 1: 5.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.5;Distal tubular cells: 1.9;Melanocytes: 3.6;Proximal enterocytes: 3.7;Spermatocytes: 3.5;Suprabasal keratinocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 34.7;BJ hTERT+: 17.5;HaCaT: 15.4;HeLa: 12.4;T-47d: 27.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"spinal cord: 1.3"	HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	1.8	5.0	1.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	9.3	1.1	0.0	34.7	3.2	4.9	0.0	5.1	17.5	7.4	5.3	0.3	1.3	0.0	0.3	4.8	0.0	15.4	6.6	0.0	3.3	1.0	0.1	0.2	12.4	0.0	0.0	0.1	0.1	0.9	1.4	0.0	0.4	0.0	0.0	0.3	1.5	0.0	4.8	2.2	0.0	0.1	0.0	10.1	0.1	0.0	0.6	0.0	0.7	1.2	0.0	0.2	3.2	7.8	3.1	0.3	27.4	0.0	0.0	0.0	5.8	0.4	0.3	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.0	0.0	0.0	1.0	1.0	3.5	0.9	0.0	3.8	0.0	0.1	0.0	0.2	0.0
HOXC4	"HOX3, HOX3E"	ENSG00000198353	"Homeobox C4"	P09017	12	54016931-54056030	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 9.1;Endometrial ciliated cells: 12.3;Granulosa cells: 10.5;Sertoli cells: 6.6;Squamous epithelial cells: 8.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.4"	"Region enhanced"	"Detected in many"		"medulla oblongata: 16.7;pons: 16.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.8;HDLM-2: 31.2;HEK 293: 33.0;SH-SY5Y: 27.3"	"Region enriched"	"Detected in single"	24	"pons and medulla: 9.4"	"Group enriched"	"Detected in some"	49	"medulla oblongata: 4.9;pons: 3.7;spinal cord: 6.0"	HPA053910			Supported	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA053910: AB_2682305"	"unprognostic (2.78e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.96e-6)"	"unprognostic (3.30e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.37e-2)"	"unprognostic (7.81e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-4)"	"unprognostic (9.82e-2)"	8.6	4.5	0.1	2.1	0.1	0.1	5.2	0.1	0.2	1.0	0.1	2.1	1.1	4.7	7.2	8.1	27.0	0.4	0.5	0.2	0.2	13.5	0.1	0.8	3.6	16.7	1.1	11.1	0.3	0.1	0.1	6.3	16.2	1.6	0.2	0.0	0.3	0.9	9.1	6.2	6.8	4.8	6.4	1.8	5.2	3.3	0.3	0.4	1.0	0.0	1.9	0.7	0.8	3.7	5.3	5.1	0.0	23.8	9.4	4.9	0.0	2.4	2.5	2.4	1.7	0.2	4.3	20.5	0.2	18.5	0.1	4.7	0.4	0.6	1.5	31.2	33.0	0.2	2.9	0.0	1.1	2.5	0.7	12.5	2.3	13.7	2.4	0.0	0.3	6.7	1.1	0.0	8.9	0.3	2.8	0.5	0.1	0.9	0.1	6.7	7.2	0.0	10.2	0.0	0.0	27.3	3.8	1.2	13.7	1.1	18.0	1.2	0.0	12.0	6.9	1.0	12.8	5.3	6.0	10.6	0.7	2.3	12.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.2	16.7	1.1	16.2	6.4	0.3	3.7	1.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	9.1	0.0	1.4	3.4	0.5	0.0	0.0	0.0	0.0	0.1	3.9	0.0	1.9	0.0	4.1	12.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.6	0.1	0.0	10.5	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.8	0.0	2.9	3.1	0.2	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.1	0.0	1.5	3.7	0.0	0.1	2.9	0.0	0.0	6.6	3.9	3.6	2.7	0.5	8.2	0.0	0.3	1.6	2.7	0.1	0.0
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54033050-54035361	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;fallopian tube: 4.1"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.2;Fibroblasts: 2.6;Granulosa cells: 2.5;Leydig cells: 2.5;Peritubular cells: 2.6;Skeletal myocytes: 2.6;Smooth muscle cells: 2.5;Spermatocytes: 3.2;Squamous epithelial cells: 2.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Group enriched"	"Detected in many"	15	"medulla oblongata: 3.4;pons: 3.6;spinal cord: 1.9;white matter: 1.2"	"Immune cell enhanced"	"Detected in single"		"gdT-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.1;ASC TERT1: 4.8;HSkMC: 4.5;SH-SY5Y: 7.6"	"Region enriched"	"Detected in single"	46	"pons and medulla: 4.6"	"Group enriched"	"Detected in some"	5	"medulla oblongata: 1.5;spinal cord: 2.1"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.0	0.9	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	2.7	0.9	4.1	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.2	3.4	0.1	2.6	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	0.0	0.2	1.2	1.1	0.7	1.5	1.9	0.0	2.1	1.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.8	1.9	0.0	7.1	4.0	4.8	0.0	0.4	0.3	0.8	0.6	3.0	0.4	0.0	0.5	2.1	0.0	1.1	0.1	0.0	0.3	2.4	2.4	0.0	1.0	0.1	0.1	0.0	0.1	4.5	0.4	3.3	0.4	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	7.6	0.5	0.2	3.9	0.9	1.4	0.0	0.0	1.2	0.7	2.6	0.2	0.0	0.0	0.0	0.1	0.1	2.8	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	3.6	1.9	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.2	0.0	0.3	0.9	0.1	0.0	0.0	1.8	0.0	0.1	0.8	0.0	1.9	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.6	2.5	3.2	1.0	2.2	0.9	0.3	0.1	1.0	0.1	0.0
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.1;ovary: 26.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 17.6;Fibroblasts: 14.0;Granulosa cells: 13.2;Leydig cells: 22.4;Peritubular cells: 15.1;Skeletal myocytes: 13.5;Spermatocytes: 34.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"medulla oblongata: 4.1;pons: 4.3;spinal cord: 3.1;white matter: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 94.4;fHDF/TERT166: 47.9;HDLM-2: 80.6"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	32	"spinal cord: 9.7"	HPA054981			Supported	Nucleoplasm,Cytosol		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA054981: AB_2682662"	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	18.9	14.8	0.0	1.1	0.0	0.0	13.4	0.0	0.1	1.1	0.0	1.0	0.3	5.3	19.3	2.9	27.1	0.1	0.6	0.0	0.1	17.8	0.0	0.7	4.3	4.1	0.2	26.2	0.4	0.3	0.0	5.7	4.3	1.3	0.2	0.5	0.2	0.5	17.3	13.3	11.4	8.8	3.1	0.2	0.7	3.5	0.1	0.1	1.0	0.0	0.0	1.3	1.5	1.5	6.6	4.5	0.0	94.4	34.1	32.0	1.0	4.9	4.7	7.9	7.1	4.1	7.4	3.0	6.3	47.9	2.3	10.7	3.8	0.5	6.7	80.6	27.3	5.2	14.6	0.0	3.8	0.5	12.0	30.7	5.0	15.7	5.6	0.0	0.3	0.3	3.5	0.0	27.4	1.5	0.0	3.3	0.0	0.8	4.1	0.0	3.6	0.0	24.1	0.2	0.0	11.8	7.3	7.0	21.7	8.2	16.6	1.3	0.0	9.7	21.1	10.7	7.0	0.7	0.9	0.2	3.7	0.8	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	0.2	4.3	3.1	0.1	1.5	3.9	0.0	0.0	0.0	0.3	6.2	0.0	0.0	9.1	0.0	3.2	5.8	0.6	0.0	0.0	3.7	0.0	0.4	0.2	0.0	17.6	0.0	1.6	0.0	0.6	1.1	0.0	0.0	0.0	0.0	3.0	14.0	0.0	0.0	0.0	13.2	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	1.8	1.0	22.4	0.4	12.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.8	9.6	0.0	2.1	6.6	13.5	11.8	34.0	2.7	5.1	4.0	0.3	0.4	7.4	0.2	0.0
HOXC8	"HOX3, HOX3A"	ENSG00000037965	"Homeobox C8"	P31273	12	54008985-54012769	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 15.4;skeletal muscle: 16.8"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 12.2;Granulosa cells: 11.0;Melanocytes: 10.6;Peritubular cells: 7.9;Proximal tubular cells: 7.4;Skeletal myocytes: 17.9;Smooth muscle cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.6;ASC TERT1: 27.6;fHDF/TERT166: 49.8;HSkMC: 33.2;LHCN-M2: 38.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"spinal cord: 10.5"	"HPA028911, CAB037020"	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA				"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Microtubules	"CAB037020: AB_1840935, HPA028911: AB_10602236"	"unprognostic (1.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.26e-6)"	"unprognostic (4.89e-2)"	"unprognostic (5.20e-4)"	"unprognostic (5.34e-3)"		"unprognostic (2.43e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.47e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.14e-2)"	5.2	5.2	0.0	0.7	0.0	0.0	5.6	0.0	0.0	0.4	0.0	0.4	0.0	0.4	15.4	0.2	7.9	0.0	0.0	0.0	0.0	4.9	0.0	0.1	1.8	0.1	0.0	4.5	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.3	0.0	0.1	16.8	3.1	5.7	7.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	1.0	2.7	0.0	15.0	41.6	27.6	0.2	2.8	0.1	4.9	3.1	4.4	2.4	0.0	0.3	49.8	0.8	2.0	3.9	1.2	5.4	5.3	5.3	0.9	2.1	0.0	4.9	0.0	5.8	33.2	3.9	15.7	9.0	0.5	0.4	0.8	0.6	0.0	38.7	1.2	0.0	0.4	0.0	0.3	0.7	0.0	0.0	0.0	6.1	0.0	0.0	2.0	5.4	1.0	13.8	3.6	1.6	0.0	0.0	1.0	8.0	6.8	1.7	0.1	0.0	0.0	0.9	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	4.6	0.1	0.0	1.2	0.0	1.5	2.9	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	12.2	0.0	0.0	0.0	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.2	6.2	0.2	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.3	7.4	0.0	1.3	6.6	17.9	7.6	5.6	3.1	0.2	4.3	0.3	0.3	3.2	0.1	0.1
HOXC9	"HOX3, HOX3B"	ENSG00000180806	"Homeobox C9"	P31274	12	53994895-54003337	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.0;skeletal muscle: 25.9"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 41.1;Fibroblasts: 20.1;Granulosa cells: 26.7;Melanocytes: 39.2;Proximal tubular cells: 22.0;Skeletal myocytes: 28.3;Smooth muscle cells: 19.6;Spermatogonia: 21.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.5;HDLM-2: 28.4;HEK 293: 33.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"spinal cord: 7.7"	"HPA063965, HPA072160"			Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA063965: AB_2685162, HPA072160: AB_2686491"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.19e-5)"	"unprognostic (1.23e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.53e-1)"	11.0	1.7	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.3	0.0	1.0	1.3	0.4	8.1	0.0	0.0	0.0	0.0	9.8	0.0	0.1	1.0	0.0	0.0	2.7	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	25.9	7.8	6.2	0.7	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.5	0.5	0.0	0.8	3.3	0.0	21.5	8.5	7.0	1.5	2.3	2.0	2.8	1.8	0.9	3.3	0.0	1.7	8.8	0.5	3.9	0.5	2.3	2.4	28.4	33.7	0.7	5.9	0.9	0.9	0.1	5.1	7.9	3.6	4.2	1.9	0.0	2.7	0.1	7.1	0.0	5.8	2.5	0.0	2.0	0.0	1.7	0.3	0.4	4.1	0.0	6.5	2.1	0.0	6.2	7.9	4.1	9.5	0.5	6.5	0.3	0.0	5.1	9.0	1.5	2.7	0.0	0.0	0.0	0.1	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	9.6	0.0	0.0	1.8	0.0	6.5	7.9	0.5	0.0	0.0	1.8	0.0	0.3	0.2	0.0	41.1	0.0	3.7	0.1	0.2	2.1	0.0	0.0	0.0	0.4	11.5	20.1	0.0	0.0	0.0	26.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.9	4.1	4.7	0.5	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.9	0.0	0.1	0.6	22.0	0.0	0.0	6.6	28.3	19.6	9.3	21.2	0.7	9.5	0.4	0.5	7.2	0.1	0.0
HOXD1	"HOX4, HOX4G"	ENSG00000128645	"Homeobox D1"	Q9GZZ0	2	176188668-176190907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.9;epididymis: 7.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 18.5;Distal enterocytes: 20.3;Distal tubular cells: 25.4;Endothelial cells: 18.8;Intestinal goblet cells: 20.6;Oligodendrocytes: 28.0;Proximal enterocytes: 22.0;Undifferentiated cells: 28.6"	"Cancer enriched"	"Detected in many"	5	"ovarian cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.6;Hep G2: 7.2;RPTEC TERT1: 21.3;RT4: 16.9;SCLC-21H: 5.7"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.1"	"Low region specificity"	"Detected in many"			"HPA040062, HPA056900"			Enhanced	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA040062: AB_2676826, HPA056900: AB_2683270"	"unprognostic (8.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.54e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	2.0	0.2	1.7	0.5	5.2	0.0	1.6	6.1	5.0	0.3	0.8	2.9	0.3	0.4	7.5	0.5	4.8	0.7	0.1	1.6	3.3	6.5	0.0	3.2	0.4	19.9	5.8	0.4	0.2	0.0	0.0	0.0	8.2	1.0	2.0	0.0	0.2	2.6	0.1	0.6	3.3	0.3	6.5	1.1	0.4	1.7	5.3	0.1	0.1	0.3	0.1	2.2	0.4	10.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	6.6	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	7.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	21.3	16.9	5.7	1.0	0.0	0.0	1.2	0.8	0.0	0.0	3.9	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.2	6.1	5.0	1.6	3.3	19.9	5.8	8.2	6.5	5.3	10.1	14.2	3.2	18.5	0.0	0.1	4.2	0.2	0.0	0.0	0.0	0.9	1.3	0.1	0.0	2.5	7.3	0.0	0.0	0.1	20.3	25.4	0.0	0.1	0.2	0.2	18.8	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	5.6	0.4	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	28.0	0.1	13.2	0.4	0.9	0.7	22.0	3.2	0.0	0.0	0.0	0.6	1.1	3.4	9.5	0.3	2.6	0.0	0.5	0.5	28.6	2.7
HOXD10	"HOX4, HOX4D"	ENSG00000128710	"Homeobox D10"	P28358	2	176108790-176119937	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 20.6;endometrium 1: 35.9;vagina: 25.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.0;Collecting duct cells: 14.7;Distal enterocytes: 10.6;Distal tubular cells: 15.6;Endometrial stromal cells: 25.3;Endothelial cells: 13.5;Enteroendocrine cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.0;HEK 293: 40.3;RPTEC TERT1: 32.3;SCLC-21H: 11.8;SiHa: 18.4;U-251 MG: 14.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	66	"spinal cord: 6.6"	HPA065871			Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		No	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA065871: AB_2685573"	"unprognostic (4.29e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (2.15e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.27e-1)"	2.0	0.1	0.0	0.5	0.0	0.0	2.6	0.0	0.0	20.6	0.0	18.7	0.0	35.9	0.5	0.5	4.1	0.1	0.0	0.0	0.0	19.9	0.0	0.1	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	16.8	5.8	0.0	0.1	6.7	0.1	1.5	0.1	18.1	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.2	2.2	25.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.2	6.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.1	12.0	0.0	0.0	0.5	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.9	0.0	32.3	0.0	11.8	3.1	18.4	0.0	0.1	2.2	0.0	0.0	2.7	0.0	2.1	1.0	14.4	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.0	0.0	0.0	0.0	0.0	0.9	6.2	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	14.7	0.0	0.0	0.1	10.6	15.6	0.0	0.0	1.2	25.3	13.5	24.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.8	0.2	1.8	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	1.1	0.0	0.2	0.0	4.4	2.9
HOXD11	"HOX4, HOX4F"	ENSG00000128713	"Homeobox D11"	P31277	2	176104216-176109754	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 7.1;intestine: 3.8;kidney: 4.7;prostate: 3.3;vagina: 4.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 26.7;Collecting duct cells: 22.0;Distal enterocytes: 22.8;Endometrial stromal cells: 29.0;Enteroendocrine cells: 20.6;Urothelial cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 21.9;RPTEC TERT1: 2.6;SCLC-21H: 6.1;U-251 MG: 4.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	40	"spinal cord: 3.9"	HPA055155			Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA055155: AB_2682719"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.48e-1)"		"unprognostic (1.93e-2)"	"unprognostic (2.13e-2)"	"unprognostic (6.73e-2)"		"unprognostic (5.00e-2)"	"unprognostic (2.11e-8)"	"unprognostic (2.09e-3)"	"unprognostic (2.49e-2)"		"unprognostic (2.27e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	3.8	0.0	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.9	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	1.4	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	6.1	0.3	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.4	26.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.0	0.0	0.1	0.0	22.8	9.8	0.0	0.0	1.1	29.0	1.7	20.6	0.0	0.0	0.0	0.1	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.6	0.0	0.0	1.2	0.2	0.9	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	1.2	0.0	8.8	0.0	0.3	0.0	0.0	0.0	0.1	2.3	0.1	0.4	0.0	0.9	0.0	0.1	0.0	9.2	14.0
HOXD13	"HOX4I, SPD"	ENSG00000128714	"Homeobox D13"	P35453	2	176092721-176095944	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"cervix: 14.2;intestine: 18.2;prostate: 9.7;seminal vesicle: 16.3;vagina: 17.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 12.4;Distal enterocytes: 5.5;Enteroendocrine cells: 29.0;Intestinal goblet cells: 9.1;Paneth cells: 5.5;Prostatic glandular cells: 6.3;Undifferentiated cells: 9.9;Urothelial cells: 6.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 18.4;HEK 293: 53.3;HL-60: 61.7;JURKAT: 16.7;NB-4: 36.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064064			Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA064064: AB_2685186"	"unprognostic (2.04e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.95e-5)"	"unprognostic (2.52e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.08e-2)"		"unprognostic (4.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.66e-1)"		"unprognostic (1.01e-2)"	"unprognostic (2.82e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.70e-2)"		"unprognostic (9.98e-3)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.2	0.0	18.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.7	7.6	0.0	0.0	16.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	2.2	4.7	0.0	0.0	0.0	0.0	0.0	5.1	0.0	18.4	0.0	2.8	0.0	53.3	8.3	0.0	0.0	0.0	61.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	3.9	0.0	0.0	0.0	0.0	36.3	1.9	0.0	3.0	0.0	0.2	0.0	0.0	0.4	15.2	3.7	3.8	0.0	8.9	0.2	0.0	0.0	0.0	1.8	0.0	0.8	5.1	0.0	0.0	0.0	2.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.9	0.0	0.1	0.1	29.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.4	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	9.9	6.7
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 42.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.6;Collecting duct cells: 9.2;Distal tubular cells: 15.6;Early spermatids: 14.4;Endothelial cells: 6.5;Theca cells: 4.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Group enriched"	"Detected in many"	8	"medulla oblongata: 8.9;pons: 5.7;spinal cord: 5.7;white matter: 4.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;HSkMC: 11.2;RPTEC TERT1: 12.0;SCLC-21H: 14.5;SH-SY5Y: 10.1"	"Region enriched"	"Detected in single"	35	"pons and medulla: 3.5"	"Group enriched"	"Detected in some"	6	"medulla oblongata: 4.1;pons: 1.1;spinal cord: 3.0"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"		No	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA051831: , HPA063671: AB_2685083"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	3.2	2.3	0.2	0.8	0.4	0.0	2.8	0.4	0.3	3.2	0.1	1.0	0.3	6.9	42.1	0.7	6.8	0.6	0.2	0.2	0.4	7.9	0.0	0.2	0.8	8.9	0.8	5.5	0.2	0.1	0.0	0.1	5.7	1.7	0.6	0.0	0.5	7.1	0.7	0.9	0.8	4.1	5.7	0.7	0.3	1.7	0.4	0.2	0.4	0.0	0.2	1.0	2.0	4.9	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	1.7	0.2	0.0	0.4	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.0	0.0	11.2	0.9	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	12.0	0.9	14.5	10.1	0.2	0.1	4.6	0.2	0.0	0.0	1.0	0.2	0.2	1.5	0.8	0.0	0.2	0.0	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.3	0.2	0.4	8.9	0.8	5.7	5.7	0.4	4.9	6.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.3	15.6	0.0	14.4	0.1	2.1	6.5	1.2	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.8	3.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.3	4.5	0.0	0.1	0.3	2.9	0.0	0.0	0.0	1.3	1.1	0.8	0.5	0.0	1.3	0.0	0.1	4.7	0.6	0.1
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151550-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 24.4;epididymis: 28.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Collecting duct cells: 16.5;Early spermatids: 3.7;Endothelial cells: 3.6;Leydig cells: 4.7;Proximal tubular cells: 6.5;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Group enriched"	"Detected in many"	21	"medulla oblongata: 10.6;pons: 5.6;spinal cord: 8.1;white matter: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 16.6;HEK 293: 39.7;RPTEC TERT1: 29.6;SK-MEL-30: 11.0"	"Region enriched"	"Detected in single"	46	"pons and medulla: 4.5"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 6.0;spinal cord: 7.8"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	6.9	8.3	0.0	1.6	0.0	0.0	7.4	0.0	0.1	7.1	0.0	7.3	1.0	24.4	28.0	1.1	14.3	1.5	0.6	0.0	0.0	18.5	0.0	0.4	1.7	10.6	0.3	15.1	0.6	0.1	0.0	0.4	5.6	2.9	2.0	0.0	0.7	11.1	2.8	2.4	6.2	9.7	8.1	7.2	1.0	3.0	0.0	0.2	1.2	0.5	0.4	2.7	4.0	7.3	0.5	0.3	0.0	0.0	2.0	3.0	0.0	0.2	0.9	0.1	1.1	0.9	0.0	0.0	16.6	3.4	0.7	0.2	2.6	0.0	0.4	0.0	39.7	0.5	0.0	0.0	0.5	0.0	0.1	9.3	2.6	0.0	0.5	0.2	6.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	29.6	4.1	2.5	4.2	0.6	0.0	11.0	0.6	0.0	0.0	5.0	0.5	0.2	2.9	2.1	0.0	0.1	0.0	2.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.6	0.3	5.6	8.1	0.0	7.3	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	16.5	0.0	0.0	0.0	0.9	0.0	0.0	3.7	0.1	1.1	3.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.7	2.6	4.7	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	3.0	0.0	0.1	0.3	6.5	0.0	0.0	6.6	0.6	0.9	0.3	0.4	0.0	0.6	0.0	0.1	3.0	1.3	0.0
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122719-176124937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 42.2;endometrium 1: 57.8;kidney: 52.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.4;Collecting duct cells: 23.9;Distal tubular cells: 37.2;Endothelial cells: 39.2;Leydig cells: 34.2;Peritubular cells: 26.7;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.3;HEK 293: 16.1;RPTEC TERT1: 19.0;SH-SY5Y: 21.7;SK-MEL-30: 13.2;TIME: 16.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	80	"spinal cord: 8.0"	HPA068683			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"		"HPA068683: AB_2686018"	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (9.58e-4)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	11.6	6.4	0.0	1.3	0.0	0.0	13.9	0.0	0.0	42.2	0.0	29.3	0.1	57.8	14.8	3.5	16.1	0.9	0.2	0.0	0.0	52.1	0.1	0.7	2.4	0.5	0.0	11.1	0.3	0.3	0.0	0.5	0.1	32.3	2.9	0.0	1.2	8.0	1.6	5.8	3.0	15.2	0.5	2.4	0.5	5.6	0.1	0.5	1.4	0.2	0.8	6.1	35.3	0.8	0.1	0.0	0.0	0.0	0.5	0.4	0.2	1.6	1.1	1.3	1.1	0.0	0.0	0.0	11.3	1.6	0.8	7.6	0.1	0.0	0.9	0.0	16.1	0.0	0.8	0.0	0.1	0.0	0.0	3.6	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	19.0	7.1	4.3	21.7	5.5	0.0	13.2	1.1	0.0	0.0	16.9	0.0	3.6	5.3	6.0	0.0	0.0	0.0	1.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.1	0.8	38.4	0.0	0.0	0.0	0.4	2.4	1.9	0.0	0.0	0.0	0.8	0.5	0.7	0.0	0.0	23.9	0.0	0.0	1.0	8.5	37.2	0.0	0.2	0.8	10.9	39.2	7.8	0.0	0.0	0.0	0.2	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	3.0	1.3	34.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	26.7	0.0	1.1	0.0	3.0	0.0	0.0	39.5	1.9	3.3	2.2	1.4	0.1	1.8	0.0	1.1	13.9	3.8	0.8
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326895-45328679	"Human disease related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.1;Gastric mucus-secreting cells: 8.2;Undifferentiated cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 111.7;HL-60: 34.2;NB-4: 42.8;SK-BR-3: 72.5"	"Low region specificity"	"Detected in many"							"HPA031997, HPA057346"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favorable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.4	0.2	1.0	1.3	1.3	1.8	0.4	3.1	1.0	1.2	0.0	3.7	2.4	0.6	0.0	2.2	0.6	0.0	0.3	0.9	0.9	0.6	0.1	0.3	1.0	1.3	1.2	0.6	0.3	0.0	0.3	2.1	1.3	0.6	2.8	0.4	1.0	0.2	1.6	0.8	2.5	0.3	0.8	1.8	3.4	0.3	1.3	1.2	0.6	0.6	0.9	0.5	1.1	1.3	0.1	1.1	0.5	0.1	0.1	0.4	111.7	1.5	0.0	2.0	0.4	28.7	7.7	5.8	0.3	1.5	0.0	7.0	0.0	0.4	0.7	0.2	0.3	0.6	13.4	0.0	0.7	34.2	0.9	1.1	0.2	1.2	0.0	0.1	2.2	0.2	0.0	5.2	0.2	14.6	22.1	42.8	0.5	23.0	0.0	6.6	0.1	19.4	0.4	0.4	22.2	1.5	14.6	72.5	11.4	1.6	0.2	6.3	1.0	0.0	0.3	1.3	0.0	0.9	0.6	21.3	0.1	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.2	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.1	1.0	1.3	3.1	1.0	0.9	0.9	1.3	1.2	1.3	0.8	1.3	1.3	0.1	0.0	0.0	2.9	1.0	0.1	2.3	0.5	1.2	0.2	0.7	1.0	0.4	0.0	0.1	0.0	0.0	29.1	0.3	3.0	3.9	0.4	0.2	0.1	1.5	0.7	1.2	4.2	0.0	0.0	5.8	0.8	8.2	0.2	0.0	0.9	0.4	0.1	2.5	0.0	0.2	3.3	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	1.9	0.0	5.2	2.2	0.4	0.3	0.0	0.4	0.0	0.6	0.8	0.0	1.9	2.1	1.1	5.1	0.4	1.2	7.6	1.5
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490175-174523154	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 235.0;urinary bladder: 376.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 457.8;Extravillous trophoblasts: 701.7;granulocytes: 864.5;Proximal enterocytes: 500.6;Urothelial cells: 922.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 123.7;T-reg: 45.0"	"Group enriched"	"Detected in many"	73	"granulocytes: 123.7;T-cells: 45.0"	"Cell line enhanced"	"Detected in many"		"A549: 157.8;ASC diff: 110.6;HEL: 355.0;OE19: 102.1;RT4: 565.7;SuSa: 121.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA		20000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	9.2	16.5	1.0	11.4	0.7	2.7	159.9	0.5	1.2	32.2	8.7	60.9	152.2	45.5	36.5	81.6	13.4	24.9	1.6	1.2	2.8	60.2	210.8	91.0	5.5	1.4	2.0	1.1	2.6	85.3	2.1	99.1	1.0	10.2	57.4	1.0	7.7	4.0	2.5	39.8	117.3	63.7	0.8	10.3	235.0	1.6	2.2	12.2	1.7	3.0	26.6	376.0	83.0	0.7	0.0	157.8	0.0	0.0	110.6	5.4	0.4	0.0	0.0	0.0	0.4	45.1	0.2	0.1	0.0	0.0	0.2	14.2	16.0	0.0	0.0	0.3	2.9	355.0	10.8	0.3	0.0	2.1	0.9	5.6	2.6	0.0	0.1	0.1	0.0	22.6	0.2	0.0	0.0	0.3	1.2	0.3	1.4	102.1	7.4	16.3	0.3	1.3	36.2	565.7	0.9	0.4	0.0	1.3	3.5	121.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	28.4	0.0	0.1	0.3	0.2	0.0	123.7	0.3	16.6	9.9	0.0	15.6	0.4	5.2	4.5	0.7	0.2	1.6	4.0	1.3	1.1	0.0	0.0	45.0	3.0	1.0	0.7	0.5	1.2	1.2	2.8	1.4	2.0	1.0	0.8	2.2	0.7	3.4	16.0	33.0	0.0	4.3	17.3	80.8	6.9	45.5	3.3	14.5	6.7	0.8	35.8	23.6	22.0	0.0	48.5	38.5	457.8	21.5	7.4	1.4	5.7	5.4	18.2	8.4	17.2	0.8	94.5	701.7	25.3	196.7	36.4	864.5	1.5	13.9	245.7	21.4	0.0	9.7	60.7	0.0	14.8	19.5	0.5	19.9	29.2	76.5	5.6	2.9	0.0	10.3	0.0	4.1	42.4	254.7	0.0	50.2	76.8	500.6	131.1	4.4	0.8	0.0	2.4	3.7	0.5	1.0	53.4	22.4	56.6	42.7	65.0	58.9	922.8
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Group enriched"	"Detected in many"	18	"granulocytes: 1056.2;Hofbauer cells: 631.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 18.1"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 18.1"	"Group enriched"	"Detected in some"	8	"HEL: 46.2;HMC-1: 13.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		250000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	3.4	1.9	2.2	1.1	2.1	1.1	4.0	2.3	3.1	3.5	2.1	5.1	5.8	2.4	2.3	2.9	1.4	6.9	1.8	2.3	2.3	1.5	0.8	9.4	0.6	2.7	2.6	0.5	0.5	0.8	0.4	18.7	2.9	2.6	5.3	0.1	1.5	1.3	0.5	3.3	5.6	3.3	2.6	0.3	2.8	0.7	3.1	2.0	0.3	1.7	0.9	4.8	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	3.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.2	2.1	2.3	3.1	2.3	2.3	2.7	2.6	2.9	2.6	3.1	3.5	0.3	12.8	44.7	1.0	0.2	4.1	0.8	0.0	0.6	0.0	0.2	0.8	0.3	0.0	3.7	0.0	0.0	3.6	0.7	0.5	0.0	0.5	0.1	0.2	0.0	2.0	7.1	12.2	0.8	0.0	3.0	3.0	3.6	0.0	1056.2	0.0	0.0	0.0	631.9	0.0	0.6	0.0	0.0	11.4	13.1	0.0	0.3	16.3	3.6	32.8	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.4	2.1	3.9	0.0	0.0	1.5	0.1	0.0	0.6	0.4	0.0	0.1	0.0	5.4	5.5	20.5	0.3	0.9	0.2
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 16.4;Kupffer cells: 41.5;Macrophages: 20.2;monocytes: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 27.2;neutrophil: 18.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.5;monocytes: 27.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.8;OE19: 40.1;TIME: 25.8"	"Region enhanced"	"Detected in some"		"olfactory bulb: 3.7"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		6500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	3.4	4.5	0.8	6.6	0.9	2.3	1.0	0.6	1.7	2.4	0.4	5.9	2.1	2.7	0.2	9.9	3.9	2.7	0.8	0.9	0.9	1.6	2.4	3.2	4.5	1.8	1.0	4.5	0.8	5.6	1.2	2.1	1.3	0.6	6.4	0.2	9.7	0.6	0.3	5.3	2.8	1.9	1.8	6.0	2.0	5.7	2.7	2.0	0.7	0.3	3.9	3.0	3.3	3.6	13.5	0.6	0.1	1.7	3.2	0.9	0.1	1.5	8.2	3.6	16.5	0.0	11.0	0.4	2.3	4.2	20.8	12.3	16.8	2.5	6.5	1.4	1.7	4.2	9.0	0.2	1.4	2.5	8.4	1.8	5.1	2.4	15.4	1.4	18.1	2.4	0.1	39.8	1.5	2.8	0.2	0.3	0.7	40.1	2.6	0.0	0.4	0.6	10.2	0.3	9.3	0.0	17.7	9.8	1.4	2.6	1.5	3.8	25.8	1.5	4.6	1.4	1.7	0.5	6.2	0.2	9.9	11.4	2.7	0.4	27.2	0.0	1.4	10.1	1.0	0.2	2.7	1.0	3.0	0.3	1.7	1.6	18.5	2.3	1.5	0.1	5.2	7.9	0.8	0.9	0.6	1.7	0.9	0.9	1.8	1.0	1.3	1.8	2.7	3.6	0.3	6.4	4.4	0.0	0.7	3.4	3.0	3.3	2.8	0.0	0.3	0.5	0.6	0.0	5.6	1.8	0.0	0.5	2.4	10.1	0.0	1.9	0.6	2.3	3.7	1.0	6.6	2.7	0.8	1.3	2.9	1.4	4.1	13.2	0.0	0.4	2.9	0.6	16.4	0.0	3.8	2.8	0.0	41.5	3.0	0.3	0.6	20.2	0.0	7.5	33.9	0.0	3.1	0.0	0.1	1.1	6.7	0.0	0.7	1.7	4.1	0.0	2.8	0.0	0.0	0.1	1.2	0.2	1.0	4.0	3.7	1.5	6.2	1.4	4.6	3.7
HR	"ALUNC, AU"	ENSG00000168453	"HR lysine demethylase and nuclear receptor corepressor"	O43593	8	22114419-22133384	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Oxidoreductase"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.9;skin 1: 52.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 91.4;Cone photoreceptor cells: 33.3;Distal enterocytes: 27.5;Gastric mucus-secreting cells: 26.5;Paneth cells: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 21.2;HaCaT: 81.7;OE19: 39.9;SiHa: 28.8;T-47d: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054888			Supported	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA054888: AB_2682630"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.68e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	2.4	1.0	4.3	1.8	6.7	0.0	2.7	7.8	14.5	3.8	0.0	9.0	4.8	1.6	0.1	20.9	1.1	1.3	2.3	3.1	4.8	0.6	0.4	0.8	0.3	11.3	9.0	0.6	0.5	0.0	2.7	0.1	12.0	3.8	3.2	1.8	5.1	4.2	0.7	52.7	4.7	1.5	2.4	0.5	7.7	5.3	8.8	0.6	4.3	0.9	1.2	3.0	11.7	11.5	1.9	21.2	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.0	2.6	0.0	20.7	1.5	1.0	81.7	0.0	2.0	0.0	0.0	0.0	0.0	17.8	0.1	4.7	0.0	0.1	4.1	12.9	0.0	1.4	1.3	0.0	2.1	0.0	0.2	0.0	12.7	1.5	0.3	0.0	39.9	16.3	1.9	0.0	0.5	0.3	5.7	1.0	4.7	28.8	6.4	6.5	0.3	30.0	0.0	0.0	0.4	17.2	0.0	0.9	0.0	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	6.7	7.8	14.5	3.1	4.8	11.3	9.0	12.0	2.4	8.8	11.5	1.9	0.0	0.0	1.3	0.0	12.0	4.5	4.3	10.8	91.4	4.0	3.9	2.7	0.0	1.4	1.8	33.3	0.1	0.1	27.5	0.0	0.1	0.3	1.6	1.2	0.6	7.8	0.0	8.7	0.7	0.2	2.1	26.5	2.1	0.0	0.3	1.8	0.3	0.0	10.1	3.9	8.1	0.0	0.0	2.1	1.9	3.4	0.1	21.4	0.0	0.0	3.2	0.0	2.0	9.2	0.3	31.2	7.2	0.0	3.0	11.0	0.1	1.3	8.8	0.0	5.8	3.3	0.1	0.3	15.5	17.8	0.8	0.3	0.2	19.5	6.8
HRAS	HRAS1	ENSG00000174775	"HRas proto-oncogene, GTPase"	P01112	11	532242-537287	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002015, HPA049830, HPA070222"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB002015: , HPA049830: AB_2680903, HPA070222: "	"unprognostic (3.06e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.49e-3)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.38e-1)"	28.1	24.6	64.6	3.5	67.2	2.9	27.0	62.1	86.8	30.4	58.3	34.3	2.8	23.6	12.5	80.1	18.9	3.6	56.8	64.4	64.6	33.8	21.8	27.1	4.3	65.6	65.3	20.0	20.5	13.1	38.2	9.0	66.9	38.3	6.9	10.2	27.3	12.3	59.0	69.9	19.5	8.9	64.2	20.6	24.2	16.5	64.8	9.2	20.5	25.2	10.2	34.5	44.2	65.4	59.0	105.6	44.2	25.6	22.2	17.5	39.6	49.9	25.1	64.5	29.5	62.4	29.7	20.4	10.9	63.2	60.7	43.7	46.0	114.1	19.3	19.5	108.4	6.6	43.7	56.1	38.5	13.9	12.0	28.3	118.0	42.0	51.5	19.6	31.5	34.3	29.7	32.3	40.9	110.6	34.0	50.5	26.5	39.9	94.5	31.6	40.7	18.2	47.0	33.2	87.6	43.7	25.5	55.4	17.9	31.5	43.3	14.8	35.4	47.3	44.7	16.4	39.7	20.3	17.7	15.4	39.1	17.0	38.3	0.0	0.5	0.6	0.8	0.7	0.4	0.3	0.9	0.8	0.7	2.0	0.9	0.3	0.0	0.1	4.0	0.9	1.5	0.2	64.6	67.2	62.1	86.8	64.4	64.6	65.6	65.3	66.9	64.2	64.8	65.4	51.3	12.8	10.7	9.1	18.0	131.2	101.7	25.4	82.0	46.0	38.8	75.7	25.2	22.8	11.2	35.0	18.8	78.8	21.5	72.2	74.3	35.2	1.6	36.1	28.6	32.0	29.3	11.2	9.8	37.4	63.4	25.9	33.6	34.1	2.5	26.8	22.9	17.4	39.9	48.8	10.6	26.5	4.1	11.7	38.4	7.9	17.1	21.3	64.0	10.3	12.8	50.8	11.3	4.0	12.3	48.2	30.9	23.0	26.5	61.2	30.8	54.6	20.0	37.6	32.9	20.3	40.3	5.4	21.4	118.1	145.9	78.1	22.0	18.8	26.2	106.4
HRCT1	"LGLL338, PRO537, UNQ338"	ENSG00000196196	"Histidine rich carboxyl terminus 1"	Q6UXD1	9	35906202-35907136	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.4;breast: 24.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 72.4;Distal enterocytes: 232.3;Intestinal goblet cells: 57.8;Paneth cells: 316.5;Proximal enterocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 18.0;HBEC3-KT: 10.3;HeLa: 15.9;Hep G2: 11.7;U-2197: 27.0;U-251 MG: 13.1"	"Low region specificity"	"Detected in some"							HPA067038			Approved	Nucleoplasm		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA067038: AB_2685767"	"unprognostic (2.48e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.80e-1)"	"unprognostic (9.43e-2)"	29.4	1.8	3.9	1.8	4.0	0.0	24.9	3.3	4.9	4.1	2.7	20.6	8.9	6.0	1.0	1.8	5.5	0.3	9.7	3.7	3.3	7.4	1.6	4.8	0.6	3.9	3.6	2.7	1.3	0.5	1.1	2.9	3.9	4.6	11.8	1.1	6.7	2.7	5.4	6.4	11.0	1.8	3.6	0.8	3.6	2.4	3.8	0.1	4.9	3.8	0.2	7.4	4.4	3.2	0.4	0.2	0.0	0.2	0.8	5.9	0.0	0.2	0.5	0.1	0.0	0.2	1.7	0.0	18.0	0.4	3.4	0.0	0.0	10.3	0.0	0.0	0.0	0.0	15.9	11.7	2.3	0.0	0.0	5.8	5.2	2.0	1.2	0.8	6.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	4.8	2.4	0.0	0.3	0.1	3.4	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.2	5.3	0.2	5.3	27.0	13.1	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.0	3.3	4.9	3.7	3.3	3.9	3.6	3.9	3.6	3.8	3.2	72.4	6.4	1.5	0.3	0.3	2.2	0.4	0.4	0.6	2.0	2.4	11.0	1.2	4.3	2.1	0.0	0.0	23.3	0.5	232.3	1.9	1.9	0.1	2.1	0.4	40.8	1.2	0.0	0.4	0.2	6.2	7.4	0.0	0.8	0.0	1.0	50.7	0.6	1.8	0.0	0.2	57.8	0.0	0.9	2.0	0.5	10.8	0.4	1.8	0.0	0.0	10.8	0.0	0.0	0.1	4.6	316.5	9.4	0.0	0.8	64.6	13.0	0.9	2.5	13.1	3.5	4.7	0.1	0.2	0.1	1.8	2.6	0.6	0.3	24.0	0.4
HROB	"C17orf53, MCM8IP, MGC3130"	ENSG00000125319	"Homologous recombination factor with OB-fold"	Q8N3J3	17	44141906-44162476	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA synthesis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.3;testis: 11.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.3;Cytotrophoblasts: 3.4;Extravillous trophoblasts: 8.6;Hofbauer cells: 2.9;Syncytiotrophoblasts: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023004, HPA023393, HPA024430"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879"	"unprognostic (1.72e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.59e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (9.39e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.86e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.40e-2)"	1.5	0.4	0.1	1.1	0.1	9.3	1.4	0.4	0.3	0.9	0.0	0.9	0.9	0.8	0.1	2.7	0.5	0.2	0.7	0.1	0.2	0.4	0.6	0.6	1.6	0.3	0.2	0.8	0.3	0.4	0.4	0.9	0.3	0.7	1.0	0.3	0.7	0.3	0.9	1.7	0.9	0.7	0.1	1.3	0.6	11.4	0.2	2.3	0.3	0.2	1.9	0.6	1.2	0.3	8.9	11.1	8.3	7.6	0.6	2.3	9.8	6.7	5.9	12.8	13.9	11.3	5.4	9.4	5.8	5.8	13.3	7.5	10.9	10.5	11.1	10.6	14.0	6.0	10.1	7.7	0.3	6.6	7.3	1.9	1.6	15.7	7.7	1.5	5.3	10.2	13.8	11.6	6.2	6.7	15.7	10.2	5.6	4.0	10.8	10.0	13.2	11.6	3.0	7.0	5.1	2.9	4.1	4.0	3.4	9.4	8.1	7.7	2.4	12.1	9.5	8.3	9.9	6.7	12.2	8.0	5.7	5.1	7.1	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.9	0.4	0.1	0.1	0.1	0.4	0.3	0.1	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0
HS6ST1	HS6ST	ENSG00000136720	"Heparan sulfate 6-O-sulfotransferase 1"	O60243	2	128236716-128318868	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 75.4;Granulosa cells: 285.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"EFO-21: 131.2;HMC-1: 206.6;SCLC-21H: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044586			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		72000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA044586: AB_10963057"	"unprognostic (9.94e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.94e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	16.2	63.4	36.2	8.8	33.8	5.1	16.1	24.4	45.5	15.5	10.9	15.4	8.7	12.3	6.1	34.1	17.5	21.0	19.0	35.4	26.5	71.4	46.8	17.0	8.4	32.1	34.7	26.4	30.8	8.8	15.2	12.0	33.6	28.2	6.9	26.4	26.0	22.8	36.2	26.5	15.1	6.4	31.2	32.1	12.7	25.0	39.9	14.5	14.2	18.7	7.4	19.4	23.1	28.9	12.5	17.4	46.0	26.5	17.5	32.5	24.7	15.1	19.1	14.8	8.1	9.0	8.0	11.9	131.2	19.4	6.9	32.5	17.5	29.1	5.5	19.9	18.1	10.5	6.4	87.9	21.1	18.4	206.6	43.9	33.9	11.9	3.6	4.9	8.0	31.8	6.7	12.1	5.4	25.7	49.6	81.0	55.3	4.7	10.7	16.1	12.6	61.9	13.4	36.3	112.9	28.4	12.1	30.1	6.7	30.6	12.2	6.9	9.6	13.1	28.9	49.1	12.3	7.2	7.6	2.7	7.9	13.0	9.7	3.0	0.7	0.6	1.0	0.4	0.1	0.7	0.4	0.6	0.5	0.7	0.4	0.4	0.2	0.2	1.5	2.3	0.2	0.6	36.2	33.8	24.4	45.5	35.4	26.5	32.1	34.7	33.6	31.2	39.9	28.9	9.5	25.6	8.9	20.9	4.9	16.2	11.2	16.1	14.8	9.4	15.1	12.8	7.3	10.0	10.3	75.4	31.3	9.7	7.3	22.3	5.9	15.4	0.9	22.9	11.5	12.6	3.0	6.9	24.2	5.8	36.9	12.6	4.1	39.7	57.0	285.6	30.0	23.8	10.7	21.9	20.3	6.5	8.2	14.2	9.2	3.3	11.8	9.1	7.2	5.6	6.7	8.2	1.0	6.6	10.4	6.6	12.0	17.0	3.2	9.7	6.9	3.3	8.7	32.8	6.6	7.6	9.4	1.1	3.1	18.3	17.0	23.3	3.5	27.1	3.7	8.9
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090107-96839562	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5"	"Group enriched"	"Detected in some"	27	"Excitatory neurons: 1308.8;Inhibitory neurons: 893.1;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RT4: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA		24000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: AB_2732374"	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	1.4	4.2	1.4	0.2	3.5	0.0	0.3	0.0	9.0	1.8	0.0	0.2	0.4	2.1	2.1	0.4	0.5	0.2	0.9	12.5	7.3	0.8	0.0	0.0	0.0	0.1	5.2	0.1	2.2	2.1	1.9	0.0	0.3	0.2	0.1	2.2	0.0	0.2	1.1	0.5	0.4	1.5	0.3	0.0	0.9	0.3	6.1	0.0	2.4	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	17.3	0.9	0.7	0.1	0.1	0.0	0.2	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.5	0.0	9.0	12.5	7.3	0.1	5.2	0.3	0.3	6.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	0.6	0.1	0.0	0.0	1308.8	0.6	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	3.3	893.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	38.4	0.0	0.9	0.0	968.6	16.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	1.8	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8
HSBP1L1	"FLJ10967, MGC189743"	ENSG00000226742	"Heat shock factor binding protein 1 like 1"	C9JCN9	18	79964582-79970822	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"granulocytes: 31.9;T-cells: 26.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 162.8;SK-MEL-30: 100.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048273	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA048273: AB_2680337"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.15e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.76e-2)"	9.6	17.4	18.4	2.9	17.8	2.9	9.6	19.9	26.4	10.0	23.4	16.0	6.7	7.6	11.1	17.4	8.7	5.7	6.7	17.2	18.1	18.6	29.7	10.7	4.2	19.1	18.5	6.6	20.4	19.7	6.7	9.9	19.6	10.2	13.1	14.8	12.8	7.6	12.5	16.0	6.5	5.7	18.1	5.2	10.1	0.8	20.3	4.3	8.9	10.6	4.9	6.2	10.6	17.2	32.2	8.6	0.3	0.5	4.6	15.4	12.7	14.3	32.2	14.8	13.0	16.5	21.7	0.0	3.6	18.8	0.2	18.3	28.5	18.9	7.0	30.6	6.7	0.0	8.8	9.6	162.8	0.0	0.0	18.0	49.6	1.7	10.8	31.5	0.3	4.8	0.0	0.0	0.7	26.8	0.1	0.0	0.0	17.6	30.1	0.3	0.0	0.0	53.7	7.6	0.5	1.8	15.2	20.9	100.2	1.4	11.9	7.6	0.0	0.1	0.0	0.4	0.1	0.0	16.7	0.0	0.2	8.9	0.6	31.9	6.8	8.6	5.8	4.4	6.9	2.2	10.1	6.2	2.8	2.5	26.0	14.0	0.4	5.2	1.6	3.3	4.9	6.2	18.4	17.8	19.9	26.4	17.2	18.1	19.1	18.5	19.6	18.1	20.3	17.2	36.4	54.5	34.5	12.1	5.0	39.8	66.0	135.5	67.2	12.0	89.8	93.6	12.4	48.6	109.2	49.7	22.9	126.6	9.6	119.8	68.4	63.8	1.3	47.2	13.2	23.0	11.5	11.4	5.7	62.1	67.1	16.0	31.6	59.4	19.0	37.2	30.0	122.5	44.7	20.2	11.0	81.3	71.2	20.5	18.0	1.3	19.9	16.0	39.2	6.5	4.0	33.2	6.2	1.0	3.1	137.3	99.6	24.5	2.3	80.2	70.6	80.6	80.3	33.0	0.0	6.3	15.9	1.3	1.3	46.8	57.8	117.4	12.2	34.5	99.6	104.4
HSCB	"DNAJC20, HSC20, Jac1"	ENSG00000100209	"HscB mitochondrial iron-sulfur cluster cochaperone"	Q8IWL3	22	28742039-28757515	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018447, HPA031518"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018447: AB_1853867, HPA031518: AB_2673919"	"unprognostic (8.19e-3)"	"unprognostic (6.48e-2)"	"unprognostic (9.62e-3)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.30e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.38e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (8.38e-4)"	8.6	15.3	5.1	6.0	4.9	3.2	9.8	5.3	6.9	12.3	4.7	11.1	8.6	8.0	5.1	7.9	9.3	7.1	8.4	4.8	5.1	11.0	22.0	6.2	11.0	5.6	4.8	12.0	12.5	5.3	7.3	4.5	5.7	10.7	4.5	1.0	18.8	6.2	11.6	7.9	7.3	4.6	5.0	9.0	11.5	4.1	5.4	4.3	8.0	8.1	4.9	10.7	9.0	5.8	13.8	8.5	3.4	5.5	6.3	16.0	6.5	9.9	13.8	14.2	8.8	3.8	4.8	15.1	4.6	5.6	3.4	9.5	6.9	6.3	6.9	14.6	27.2	5.3	5.8	10.7	13.4	9.7	7.7	10.9	13.8	8.0	12.6	7.5	11.0	4.2	8.2	13.1	5.7	20.1	4.3	8.9	8.4	15.0	20.9	8.6	10.8	17.2	15.9	3.9	11.8	10.8	5.4	20.5	25.9	2.9	8.6	5.9	6.0	19.3	10.2	18.6	9.2	18.2	15.9	13.5	13.5	7.1	13.2	10.1	7.8	4.1	6.1	15.2	7.3	13.0	6.2	7.2	11.5	9.6	6.6	8.3	0.4	11.1	12.0	6.0	4.9	5.9	5.1	4.9	5.3	6.9	4.8	5.1	5.6	4.8	5.7	5.0	5.4	5.8	21.4	22.4	19.6	14.4	22.8	11.6	22.2	23.3	40.5	5.5	29.4	37.7	7.8	18.6	23.9	20.2	6.2	16.0	16.7	9.0	29.4	25.0	5.5	12.7	23.3	18.4	19.8	12.6	10.0	28.0	13.5	21.4	11.7	21.6	23.4	17.2	20.3	36.3	27.9	5.0	11.2	14.6	16.2	19.0	14.9	4.3	18.6	19.2	14.2	9.4	22.6	17.4	41.2	16.1	14.2	21.2	11.3	11.7	34.1	20.5	20.2	58.1	24.1	8.1	6.6	19.1	21.9	15.1	16.7	19.8	15.6	13.3	15.9	27.1	21.2	17.2
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 249.9;kidney: 335.2;salivary gland: 260.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 191.3;Distal enterocytes: 476.1;Intestinal goblet cells: 288.8;Paneth cells: 226.2;Proximal enterocytes: 270.2;Syncytiotrophoblasts: 114.5;Undifferentiated cells: 170.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 62.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.4;OE19: 29.0;RPMI-8226: 13.9;RT4: 13.9;SCLC-21H: 14.9;SK-BR-3: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	2.1	5.4	1.6	13.4	4.6	0.1	14.0	2.8	2.8	15.5	0.7	249.9	40.0	11.8	4.0	10.9	10.4	6.8	1.9	1.6	1.3	335.2	5.5	3.2	1.0	2.7	1.3	9.3	7.4	3.6	0.5	13.0	3.3	12.9	102.2	0.0	260.2	6.2	0.9	66.1	141.8	18.3	1.5	7.0	9.8	2.5	2.0	0.4	11.1	0.2	0.9	5.3	23.6	2.4	3.6	1.1	0.4	1.4	0.1	1.7	3.6	0.0	0.0	0.1	0.1	6.1	1.3	0.0	2.7	0.1	0.1	7.8	5.1	0.5	0.0	0.0	1.8	0.0	0.7	6.6	0.6	0.7	0.0	1.7	3.0	0.3	0.1	0.0	0.0	4.6	0.4	0.0	0.0	3.8	0.2	0.2	11.4	29.0	1.0	0.0	0.2	13.9	0.5	13.9	14.9	1.0	0.8	13.4	0.6	1.3	6.5	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.6	2.8	2.8	1.6	1.3	2.7	1.3	3.3	1.5	2.0	2.4	0.7	0.0	0.5	0.0	1.1	1.5	7.2	1.3	1.2	0.0	4.8	2.2	0.5	30.0	2.3	191.3	0.0	1.2	0.3	476.1	45.0	2.1	0.2	17.4	25.2	0.5	26.9	0.0	1.1	3.0	0.7	7.1	7.1	43.5	8.9	43.4	1.1	1.2	1.4	0.0	0.8	288.8	4.1	0.3	0.5	0.5	25.4	0.7	1.8	0.0	0.0	0.0	0.0	0.5	0.3	0.6	226.2	6.8	0.2	13.5	270.2	16.3	0.4	0.0	13.1	0.3	3.9	0.2	1.6	3.5	3.4	114.5	1.2	16.7	170.9	10.5
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"liver: 1804.3"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1969.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.4;U-266/84: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	8.5	2.5	13.1	6.9	16.2	0.5	0.7	13.4	18.9	28.0	9.4	24.7	3.2	20.9	1.6	9.9	6.5	9.1	0.8	12.3	12.6	2.5	1804.3	63.2	0.8	12.0	14.6	6.0	0.6	0.5	0.6	5.4	11.5	51.2	7.6	0.8	0.4	69.2	0.4	1.2	4.8	13.1	12.4	47.5	5.7	23.3	13.7	0.9	31.4	0.5	0.9	36.7	14.6	12.8	0.3	0.8	1.9	0.4	1.9	1.4	2.3	4.1	3.5	1.9	1.9	0.4	0.4	12.0	1.7	0.5	0.5	0.3	6.1	1.1	1.1	7.7	2.2	3.7	1.2	0.6	1.2	1.9	6.0	1.0	0.4	1.2	0.6	0.6	0.0	10.3	1.1	13.4	0.9	2.4	5.6	1.3	7.5	0.7	0.7	7.4	0.8	2.9	0.2	1.4	11.0	2.3	2.0	3.6	0.9	0.7	0.6	1.5	0.3	0.9	0.8	4.0	1.0	11.7	18.0	7.8	1.3	6.9	0.6	0.0	0.0	0.0	1.0	0.2	1.2	0.7	0.8	0.8	0.2	0.3	1.1	0.7	0.0	0.0	0.5	0.7	1.0	0.3	13.1	16.2	13.4	18.9	12.3	12.6	12.0	14.6	11.5	12.4	13.7	12.8	0.4	173.1	130.6	21.2	6.1	1.3	3.1	0.6	0.6	0.4	0.7	0.6	0.2	27.1	9.3	0.0	0.0	1.4	0.4	0.0	0.0	0.1	4.6	0.7	3.5	1.3	0.0	29.5	1.4	0.0	2.6	5.0	0.0	0.1	0.0	1.6	26.0	1969.3	0.4	0.0	2.1	0.4	0.0	40.2	0.3	4.5	12.5	0.5	0.0	1.0	1.0	1.3	0.0	3.0	5.5	0.1	0.0	1.5	0.8	16.1	0.0	0.3	1.5	0.6	13.1	0.6	3.5	16.4	11.4	1.2	1.6	0.4	2.2	36.0	0.7	1.1
HSF1	HSTF1	ENSG00000185122	"Heat shock transcription factor 1"	Q00613	8	144291591-144314720	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004239, HPA008888"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB004239: AB_627753, HPA008888: AB_1079088"	"unprognostic (7.08e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.07e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	51.7	55.7	20.0	14.7	19.2	18.0	47.9	18.2	24.0	48.6	17.0	70.6	14.1	51.7	7.4	48.1	52.1	12.4	133.5	18.6	19.1	50.2	46.0	49.5	14.5	22.3	21.4	57.3	68.7	18.7	48.1	17.0	20.2	53.2	10.8	7.6	39.8	17.1	125.1	49.2	39.7	15.3	18.6	42.8	57.8	107.8	21.7	14.7	45.7	32.2	12.6	58.7	46.2	18.0	40.8	53.8	22.9	19.6	37.6	35.0	37.9	29.7	26.6	28.8	25.0	36.3	34.6	46.7	42.5	41.5	28.2	28.9	35.2	42.7	18.3	29.9	40.7	58.4	51.8	50.1	59.1	17.1	43.4	34.2	39.3	40.6	74.2	30.6	39.4	41.9	39.6	27.1	29.4	82.0	58.0	26.2	29.4	52.6	154.2	37.2	19.9	59.2	20.6	40.5	34.3	27.9	45.4	35.9	52.8	23.8	40.5	34.5	40.2	29.5	66.3	46.8	49.5	18.8	15.4	39.9	41.8	31.4	28.8	14.2	23.2	26.3	16.7	24.9	17.2	19.2	17.8	21.1	24.6	17.3	17.1	15.9	9.7	16.3	32.2	12.6	22.9	19.2	20.0	19.2	18.2	24.0	18.6	19.1	22.3	21.4	20.2	18.6	21.7	18.0	46.5	6.4	11.2	8.5	40.4	51.4	73.8	53.8	39.9	67.8	37.0	30.5	46.4	22.8	34.7	29.5	62.6	69.9	38.2	43.3	150.6	39.2	248.7	35.1	20.5	44.4	40.9	120.8	12.1	41.1	80.6	34.7	44.9	34.6	37.5	51.1	40.7	63.8	49.5	69.0	14.7	36.8	42.7	25.7	45.6	106.7	37.3	32.7	33.8	12.2	59.7	24.9	34.0	6.0	12.9	45.3	49.3	42.9	40.4	76.6	63.8	34.9	25.9	33.1	59.2	41.3	39.2	84.4	47.7	36.3	45.5	111.0	39.0	105.9	45.8	76.4
HSF2		ENSG00000025156	"Heat shock transcription factor 2"	Q03933	6	122399551-122433119	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 97.1;Spermatocytes: 73.8;Spermatogonia: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016067, HPA031455"	Approved		Supported	Nucleoplasm		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB016067: AB_627754, HPA031455: AB_10670702"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (3.40e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (9.27e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	9.5	15.2	12.2	7.9	12.3	29.6	12.7	15.0	13.5	13.1	15.9	11.6	6.9	14.5	10.3	8.2	11.9	7.5	23.3	11.5	12.6	6.8	5.5	8.8	12.7	10.5	10.9	14.6	6.4	14.0	10.6	8.2	11.3	11.1	6.9	44.5	8.5	12.7	48.6	12.7	9.1	14.0	10.7	9.2	9.4	37.9	13.0	17.9	8.8	64.3	12.5	9.6	9.0	13.1	8.5	8.7	44.5	35.8	19.6	15.6	12.2	14.6	35.5	26.9	41.6	13.0	7.0	32.2	12.4	18.9	30.2	10.5	30.1	14.4	37.4	32.7	36.4	31.8	8.6	27.1	19.9	23.5	15.4	20.0	21.6	22.3	25.2	24.9	16.4	28.8	34.0	15.5	25.6	11.5	38.8	30.9	13.6	12.2	12.3	35.6	18.0	10.3	20.5	9.7	46.5	31.5	15.1	12.5	14.5	32.5	10.8	25.5	10.4	14.3	16.2	16.1	22.6	22.1	22.7	41.4	15.5	15.3	18.9	6.9	3.9	6.1	11.7	4.7	12.6	9.2	11.0	10.3	5.5	7.0	27.9	22.0	0.6	11.0	6.8	3.8	13.2	11.4	12.2	12.3	15.0	13.5	11.5	12.6	10.5	10.9	11.3	10.7	13.0	13.1	10.6	19.2	10.3	17.0	11.9	31.7	11.4	8.1	27.3	21.8	12.1	10.9	36.6	4.3	11.1	0.0	27.1	15.5	14.4	1.9	11.7	7.7	97.1	21.3	14.6	10.3	6.6	16.2	26.6	4.2	7.4	16.2	10.2	9.6	8.8	19.4	6.1	4.9	7.9	21.9	29.4	6.1	24.4	4.8	7.8	21.3	10.2	6.0	19.6	14.0	2.9	15.2	7.2	24.1	23.5	4.8	5.2	9.8	7.9	8.7	3.2	7.5	23.3	34.2	26.3	14.9	12.1	73.8	97.0	16.1	25.7	3.1	20.5	39.6	5.4	6.4
HSF2BP	MEILB2	ENSG00000160207	"Heat shock transcription factor 2 binding protein"	O75031	21	43529186-43659488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 24.1"	"Group enriched"	"Detected in many"	7	"Early spermatids: 125.5;Late spermatids: 49.0;Spermatocytes: 132.4;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031724, HPA075775"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA031724: AB_10601022, HPA075775: "	"unprognostic (1.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.36e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.77e-4)"	"unprognostic (6.00e-2)"	0.3	0.3	0.4	0.1	0.5	0.1	0.5	0.3	0.9	0.5	0.3	0.3	0.2	0.6	0.5	0.3	0.6	0.2	0.4	1.3	0.7	0.5	0.2	0.2	0.3	0.5	0.5	0.7	0.2	0.8	0.8	0.9	0.6	0.4	0.2	0.9	0.4	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.2	24.1	0.7	0.1	0.5	0.1	0.2	0.3	0.4	0.7	4.6	0.9	1.2	0.5	0.2	1.1	1.1	1.6	0.9	1.6	1.4	6.1	4.5	3.5	2.4	0.9	5.7	1.8	0.6	12.8	0.5	0.9	1.1	0.6	1.9	0.3	1.4	1.5	0.4	0.7	8.2	0.7	3.8	7.5	0.4	2.0	1.3	1.1	3.9	0.8	2.0	1.4	3.9	1.1	1.9	2.9	1.2	0.5	2.0	0.8	1.3	1.0	3.3	1.6	1.7	0.5	1.7	1.7	2.6	0.9	3.0	0.2	2.4	1.2	0.9	2.8	0.8	3.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.3	0.0	0.3	0.7	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.9	1.3	0.7	0.5	0.5	0.6	0.3	0.7	0.7	0.2	0.0	0.0	2.6	0.1	0.9	1.5	4.7	2.8	1.0	1.3	1.7	0.7	0.0	2.0	0.0	0.0	1.8	0.2	0.2	0.0	1.1	125.5	0.5	1.4	0.5	0.0	0.0	3.0	0.2	2.8	2.1	0.0	0.4	0.0	2.4	0.4	0.3	0.7	0.0	1.7	0.1	0.0	0.0	0.7	49.0	1.8	0.5	0.0	0.0	0.0	2.1	0.0	3.0	4.4	2.7	0.3	1.5	0.0	0.8	0.0	1.1	2.8	2.5	13.1	0.5	0.9	132.4	63.1	0.6	0.4	0.8	0.2	3.8	0.3	1.0
HSF5	FLJ40311	ENSG00000176160	"Heat shock transcription factor 5"	Q4G112	17	58420167-58488408	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"testis: 48.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 53.8;Spermatocytes: 68.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.3;T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016440, HPA063613"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA016440: AB_1851142, HPA063613: AB_2685060"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (7.48e-3)"	"unprognostic (7.40e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.58e-2)"	"unprognostic (6.65e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.64e-2)"	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	48.7	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.1	0.6	0.5	0.0	1.3	1.1	0.8	0.0	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	3.9	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	53.8	0.0	0.0	0.1	0.0	0.4	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	14.6	3.1	0.1	0.0	0.0	0.0	0.2	2.1	0.5	2.4	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	68.8	3.3	0.0	0.0	0.0	1.3	0.1	0.0	0.0
HSFX1	LW-1	ENSG00000171116	"Heat shock transcription factor family, X-linked 1"	Q9UBD0	X	149774068-149776867	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"											"HPA051700, HPA063040"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"		Nucleoplasm	"Plasma membrane, Cytosol"	"HPA051700: AB_2681578, HPA063040: AB_2732695"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"			"unprognostic (2.30e-2)"	"unprognostic (6.32e-2)"		"unprognostic (3.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-1)"	0.8	0.8	1.5	0.3	1.8	0.0	1.1	1.9	2.6	1.7	2.8	1.8	0.5	1.3	3.3	1.2	1.5	0.8	1.9	2.0	1.4	1.0	1.0	0.9	0.4	1.5	1.5	3.1	1.0	0.8	1.2	1.2	2.2	2.0	0.1	0.7	1.3	0.6	1.3	1.2	1.0	0.4	1.0	2.5	1.0	3.4	1.8	0.1	1.5	0.0	0.4	1.4	1.5	1.8	0.0	1.1	0.0	0.4	1.4	0.9	0.2	0.2	0.0	0.2	0.0	0.8	0.7	0.7	1.2	0.1	0.7	0.0	0.6	0.2	0.1	0.1	0.0	0.2	0.5	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.6	1.1	0.3	0.0	0.0	0.2	0.1	1.3	0.1	0.5	0.3	0.1	0.6	0.3	0.8	0.0	1.0	0.5	0.5	0.2	0.1	0.0	0.2	0.8	0.1	0.2	0.2	0.0	0.6	0.2	0.4	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	1.8	1.9	2.6	2.0	1.4	1.5	1.5	2.2	1.0	1.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSFX2		ENSG00000268738	"Heat shock transcription factor family, X-linked 2"	Q9UBD0	X	149592512-149595314	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 12.3"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HEK 293: 1.1;hTCEpi: 1.5;MCF7: 1.4;U-138 MG: 1.5"									"HPA051700, HPA063040"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA051700: AB_2681578, HPA063040: AB_2732695"					"unprognostic (7.64e-2)"					"unprognostic (6.92e-3)"				"unprognostic (2.00e-1)"				0.3	0.4	0.8	0.2	1.0	0.0	0.6	0.9	2.2	0.5	1.0	0.6	0.5	0.6	0.2	0.4	1.0	0.0	1.2	0.7	0.1	0.5	0.5	0.6	0.1	0.5	0.3	1.0	0.4	1.3	0.4	0.4	0.4	0.9	0.5	1.0	1.0	1.4	0.7	1.2	0.3	0.7	0.0	1.1	0.4	12.3	0.1	0.6	0.5	2.1	0.2	0.3	0.5	0.8	0.5	0.0	1.1	0.6	0.0	0.2	0.0	0.2	0.5	0.2	0.6	0.0	0.0	0.1	0.2	0.3	0.0	1.0	0.0	0.3	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.1	0.3	0.5	1.5	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.9	2.2	0.7	0.1	0.5	0.3	0.4	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSFY1	"HSF2L, HSFY"	ENSG00000172468	"Heat shock transcription factor Y-linked 1"	Q96LI6	Y	18546691-18588963	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA074968			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA074968: "																		0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.6	0.9	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	10.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.6	0.9	0.4	0.6	0.5	0.5	0.6	0.4	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSFY2	FLJ25453	ENSG00000169953	"Heat shock transcription factor Y-linked 2"	Q96LI6	Y	18731440-18773735	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA074968			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA074968: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.4	0.2	0.2	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSPA12B	"C20orf60, dJ1009E24.2"	ENSG00000132622	"Heat shock protein family A (Hsp70) member 12B"	Q96MM6	20	3732685-3753111	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 65.0;Endothelial cells: 50.1;Hepatic stellate cells: 16.1;Late spermatids: 16.8;Microglial cells: 15.0;Peritubular cells: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.9;EFO-21: 4.9;HUVEC TERT2: 9.5;TIME: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013659, HPA015639"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA013659: AB_1234541, HPA015639: AB_1851192"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.66e-2)"	23.1	4.1	9.3	3.0	8.9	1.3	23.0	6.6	7.8	15.0	4.2	6.6	1.8	12.5	1.2	4.2	10.3	4.7	29.3	6.6	7.0	11.8	1.7	20.6	1.7	8.2	7.9	8.2	2.6	1.5	2.9	11.3	8.4	4.9	1.2	0.4	5.4	1.9	12.3	7.7	6.1	4.0	6.8	25.3	5.1	5.2	10.4	0.7	9.2	10.2	0.9	10.2	10.2	6.0	0.5	1.7	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.9	0.1	0.2	4.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	2.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	1.4	9.5	0.4	0.3	0.2	0.0	1.0	0.4	0.9	1.0	0.0	0.8	1.8	0.2	0.5	0.0	0.0	0.9	0.7	0.3	0.2	0.1	0.1	0.2	0.5	5.3	0.1	2.2	0.7	0.4	0.4	0.3	0.5	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.3	8.9	6.6	7.8	6.6	7.0	8.2	7.9	8.4	6.8	10.4	6.0	65.0	0.0	0.0	0.3	0.4	1.9	0.1	0.0	0.0	0.5	0.7	0.3	5.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	9.8	0.2	3.2	50.1	0.0	0.0	0.5	0.0	0.2	10.5	0.0	0.1	0.0	0.1	16.1	0.3	0.5	0.0	0.4	0.0	0.0	1.4	2.5	16.8	7.5	0.2	0.0	15.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.2	2.0	3.5	1.7	0.3	1.1	0.4	0.3	0.7	0.0	0.2
HSPA1A	"HSP70-1, HSPA1"	ENSG00000204389	"Heat shock protein family A (Hsp70) member 1A"	P0DMV8	6	31815543-31817946	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 7514.5;Langerhans cells: 2690.4;Urothelial cells: 3444.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	64	"cerebral cortex: 403.6"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;monocytes: 3.6;T-cells: 3.0"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 4450.4"									"CAB017451, CAB032815, HPA052504"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	Yes		47000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"	Cytosol	"CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.51e-1)"	640.5	350.5	3.5	12.7	3.8	0.0	167.2	6.3	403.6	414.1	3.4	497.7	0.0	209.7	15.9	452.9	194.6	5.9	927.7	4.3	3.7	745.9	1116.2	1055.0	9.1	5.4	5.1	369.7	308.2	1.1	474.3	12.0	4.0	427.7	4.2	6.5	111.5	0.5	294.4	257.3	174.4	2.2	3.8	451.9	483.2	98.0	3.7	2.5	340.2	0.3	2.3	569.2	553.7	6.1	0.2	524.1	0.0	0.1	20.1	14.4	0.0	0.3	0.0	0.0	0.0	1.6	0.7	0.0	122.9	28.7	0.0	0.4	0.0	34.1	0.0	6.9	4450.4	0.0	1.7	3.1	0.0	1.1	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.4	0.0	0.5	0.7	0.0	0.0	16.6	5.3	0.0	0.1	4.1	0.0	49.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	2.3	3.2	1.1	3.6	0.7	0.6	1.6	1.4	0.3	0.2	0.7	0.6	6.8	0.8	2.0	0.3	3.0	0.4	3.5	3.8	6.3	403.6	4.3	3.7	5.4	5.1	4.0	3.8	3.7	6.1	1537.0	147.4	97.0	427.4	312.4	362.4	7514.5	125.5	968.7	305.3	782.0	844.3	1010.7	81.5	109.3	126.9	379.5	43.2	148.1	634.6	41.1	86.8	81.0	534.7	488.1	1049.0	469.2	64.0	9.7	21.6	154.1	1208.6	592.8	753.4	445.4	18.1	123.5	95.2	270.4	205.3	11.4	560.1	114.0	319.0	2690.4	49.5	603.0	1715.2	839.6	398.2	126.6	768.2	15.5	17.1	207.0	39.5	668.8	160.6	1173.3	1404.1	68.4	72.9	177.2	690.2	151.2	443.4	1802.0	65.4	148.8	1105.8	336.3	104.3	1382.2	285.6	454.9	3444.4
HSPA1B	HSP70-2	ENSG00000204388	"Heat shock protein family A (Hsp70) member 1B"	P0DMV9	6	31827738-31830254	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 3007.4;Urothelial cells: 1619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 204.3"									"CAB008640, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes				"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"	Nucleoplasm	"CAB008640: AB_1617331, HPA052504: AB_2681854"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-3)"	"unprognostic (9.50e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.69e-2)"	"unprognostic (5.99e-2)"	526.3	340.1	0.7	0.4	1.3	0.0	126.0	1.6	5.6	475.3	0.6	361.2	0.0	154.0	9.1	375.2	231.5	2.3	718.3	1.1	1.9	555.5	685.4	845.3	0.0	0.8	1.0	682.2	336.5	3.3	438.2	0.0	1.2	303.6	0.5	2.6	94.8	0.3	159.9	299.0	139.1	0.0	0.4	274.7	372.0	93.8	1.5	0.0	289.9	0.0	0.0	415.3	503.3	1.2	0.4	24.1	0.4	0.2	1.1	0.0	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.0	8.4	0.0	0.0	3.3	0.0	0.0	0.0	0.0	15.4	0.0	0.5	2.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	204.3	0.0	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	1.6	0.0	0.0	0.3	3.2	0.0	0.4	41.5	0.4	0.4	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.3	1.6	5.6	1.1	1.9	0.8	1.0	1.2	0.4	1.5	1.2	563.2	112.2	75.0	140.7	242.7	239.2	3007.4	63.2	630.0	44.6	509.4	403.9	512.3	40.0	73.7	69.9	131.3	82.7	82.8	542.8	19.6	45.5	1.9	434.9	380.2	446.2	318.6	57.9	2.7	15.6	140.8	585.8	595.8	710.4	346.8	14.1	25.7	17.7	142.0	47.1	2.8	426.3	61.1	84.4	1140.4	9.8	220.6	627.1	642.1	126.5	17.7	192.4	1.0	5.5	61.8	21.4	524.1	54.9	967.0	584.2	159.1	38.3	75.0	144.2	105.2	226.4	846.5	15.2	46.4	904.0	221.9	259.7	604.6	116.7	400.5	1619.4
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815283	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"testis: 63.2"	"Group enriched"	"Detected in many"	22	"Early spermatids: 212.5;Late spermatids: 560.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;EFO-21: 1.5;HEK 293: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		53000000		"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: AB_2681854"	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	1.2	1.4	0.0	0.0	0.2	0.1	0.9	1.4	0.3	1.5	0.0	1.8	0.1	1.8	0.0	0.6	2.4	0.0	1.4	0.1	0.2	1.5	1.2	1.3	0.0	0.2	0.2	2.2	0.9	0.0	1.7	0.0	0.3	1.1	0.0	0.1	1.0	0.0	3.9	1.0	1.5	0.0	0.2	2.4	1.3	63.2	0.4	0.0	1.5	0.1	0.0	1.6	1.1	0.6	0.1	1.1	0.1	0.4	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.4	0.4	0.1	0.0	0.1	0.3	4.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.4	0.6	4.2	0.0	1.1	2.9	3.5	0.9	1.3	0.4	2.2	2.6	1.9	2.0	4.5	0.0	0.9	0.0	8.4	0.6	1.4	1.4	0.0	0.7	212.5	2.0	0.7	2.2	1.8	3.2	0.6	0.2	0.6	1.3	0.0	1.3	0.0	0.9	1.8	1.1	1.3	3.3	0.8	1.4	0.0	4.4	2.5	560.9	5.0	2.1	5.4	2.8	4.1	3.6	1.0	0.5	2.0	0.4	1.4	2.2	1.9	0.9	0.9	0.6	2.2	2.8	0.0	0.8	2.9	17.0	8.7	1.7	0.1	0.4	3.8	0.9	1.5	0.3
HSPA2		ENSG00000126803	"Heat shock protein family A (Hsp70) member 2"	P54652	14	64535905-64546173	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 320.2;skeletal muscle: 170.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 342.0;Distal tubular cells: 238.7;Extravillous trophoblasts: 509.9;Spermatocytes: 578.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 75.4;BEWO: 114.4;BJ hTERT+: 99.0;CAPAN-2: 52.9;SCLC-21H: 101.4"	"Low region specificity"	"Detected in all"							"HPA000798, HPA052504"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA		63000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA000798: AB_1079090, HPA052504: AB_2681854"	"prognostic favorable (1.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	9.8	6.5	83.9	7.5	161.2	0.7	6.4	148.0	116.3	12.5	84.2	94.1	5.5	51.6	18.6	42.3	17.0	5.3	39.7	88.5	96.0	73.0	4.2	14.2	3.8	170.1	122.9	5.6	8.8	7.8	15.2	61.5	174.9	10.8	9.5	1.2	16.4	4.5	170.4	31.7	29.6	28.7	128.5	20.2	18.5	121.0	125.3	3.0	2.7	60.6	5.0	42.9	16.0	320.2	30.4	75.4	11.4	0.2	8.1	0.7	114.4	42.3	99.0	16.6	27.3	2.9	52.9	7.4	16.8	46.4	3.6	33.6	0.0	2.2	10.1	4.3	5.8	0.1	4.0	0.2	7.9	0.2	10.0	3.7	1.7	2.4	0.1	4.1	1.1	0.5	0.0	6.0	8.4	13.5	0.5	0.4	8.4	11.7	9.1	6.0	0.0	0.1	26.1	4.6	101.4	5.8	1.8	3.7	0.1	3.9	2.9	3.1	1.6	0.3	0.2	3.7	0.2	7.6	0.2	0.2	9.2	0.1	11.4	0.3	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.2	0.0	0.1	0.1	0.1	0.6	0.2	0.1	0.0	1.0	0.1	83.9	161.2	148.0	116.3	88.5	96.0	170.1	122.9	174.9	128.5	125.3	320.2	74.7	0.0	5.2	18.6	21.1	54.0	31.2	35.1	342.0	1.9	37.5	57.1	39.1	5.7	8.8	132.4	0.0	42.5	30.8	29.2	238.7	8.3	35.7	56.4	63.8	59.6	28.1	0.0	0.5	5.6	509.9	40.7	83.6	54.5	13.3	1.4	32.2	0.8	15.7	0.0	1.1	63.4	24.4	3.1	25.7	27.3	8.7	24.0	30.2	6.5	0.0	14.2	0.0	2.5	157.4	5.5	15.6	7.5	7.1	7.5	8.5	1.5	4.6	2.4	26.3	48.6	66.2	578.6	77.1	175.8	42.3	75.9	29.8	4.5	12.9	11.3
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133052013-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	31.3	36.9	33.8	41.0	37.2	35.6	26.9	38.1	63.7	26.6	52.0	31.8	26.6	27.5	29.3	62.0	26.8	27.8	50.8	39.8	43.8	44.3	47.2	26.3	47.4	37.6	41.0	21.3	29.7	43.5	24.0	37.7	45.0	26.3	34.7	104.0	27.9	26.9	57.7	26.1	26.0	35.3	38.4	28.7	26.6	62.8	40.3	40.2	39.7	41.7	60.9	48.4	23.7	48.2	160.8	215.8	147.6	241.7	137.5	114.6	267.3	171.0	127.8	162.1	199.2	408.0	163.2	264.4	175.2	165.8	382.6	138.9	259.4	282.9	232.7	122.9	148.3	195.4	136.5	225.7	109.6	122.6	163.8	115.1	117.3	209.7	136.3	92.9	157.2	126.5	207.9	79.6	179.8	141.4	173.5	91.0	202.4	123.8	98.7	156.6	180.4	140.2	146.7	207.4	117.0	96.0	163.4	84.4	234.6	273.5	124.3	118.5	139.0	146.8	210.8	127.1	206.1	90.7	215.2	199.9	125.5	198.7	149.2	29.5	22.6	24.9	18.1	35.8	21.5	34.2	16.6	19.0	27.7	42.0	17.1	16.2	14.7	22.9	27.1	10.5	18.0	18.5	33.8	37.2	38.1	63.7	39.8	43.8	37.6	41.0	45.0	38.4	40.3	48.2	30.5	64.1	47.0	12.4	74.8	41.8	116.8	25.5	52.9	58.9	30.3	26.8	113.1	28.6	47.3	22.0	54.2	67.3	38.5	42.9	27.4	48.4	68.7	54.7	48.5	40.8	47.2	46.9	24.2	49.9	66.1	45.3	38.2	46.1	54.6	66.9	19.6	32.9	64.3	35.3	24.8	34.4	36.7	28.2	40.9	31.9	23.3	50.7	30.2	21.5	55.0	60.1	22.6	18.6	24.2	50.1	24.9	25.9	66.5	61.5	27.7	49.7	60.7	152.4	26.3	41.8	85.1	107.4	101.0	71.7	41.8	87.2	58.2	68.0	39.4	69.7
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526894	"Plasma proteins, Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 242.2;lung: 94.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 335.3;Langerhans cells: 478.8;Macrophages: 213.7;Prostatic glandular cells: 180.1;Smooth muscle cells: 235.6;T-cells: 391.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebral cortex: 242.2"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 317.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 317.9"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 50.7"					"Low region specificity"	"Detected in all"			"CAB017452, HPA028549, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854"	"unprognostic (3.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.36e-3)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	26.2	15.7	11.3	9.9	16.3	3.6	3.6	22.1	242.2	2.9	24.7	9.3	1.7	1.7	0.7	7.3	3.8	8.7	31.7	12.9	12.4	27.2	33.0	94.4	2.3	15.1	12.4	46.8	5.9	1.1	23.8	20.5	28.7	3.3	1.7	1.8	3.3	5.0	3.8	8.4	5.1	2.3	13.8	63.5	34.5	2.4	15.5	1.3	12.8	3.6	1.7	18.5	10.9	20.1	0.8	1.5	0.0	0.3	0.0	1.1	1.0	0.6	0.5	0.2	0.4	0.5	0.7	0.2	2.2	0.2	0.8	0.4	0.5	0.4	0.3	0.5	0.1	0.3	1.4	0.0	0.0	0.1	3.3	0.2	1.0	0.5	0.0	0.0	0.0	0.2	0.6	50.7	0.0	0.0	0.3	1.3	0.1	0.3	5.4	0.0	0.1	0.7	0.0	0.3	0.1	0.0	0.2	0.9	3.1	0.1	0.4	0.7	0.2	0.1	0.5	0.4	3.6	6.9	0.4	0.0	1.3	1.3	2.3	6.5	35.1	13.4	6.4	44.1	1.0	0.2	0.7	3.4	12.2	0.0	0.0	1.6	317.9	8.3	37.7	0.2	0.0	11.8	11.3	16.3	22.1	242.2	12.9	12.4	15.1	12.4	28.7	13.8	15.5	20.1	14.0	9.6	9.3	0.3	23.8	29.3	335.3	4.4	5.2	42.5	8.7	36.2	11.1	0.0	12.2	5.5	127.2	1.8	12.8	25.3	0.0	0.4	3.2	16.2	16.4	36.7	71.0	24.0	0.0	0.0	11.2	98.8	30.1	26.2	2.5	0.0	3.9	0.3	76.0	10.1	0.0	71.0	4.1	47.8	478.8	1.1	5.6	213.7	103.2	1.0	15.8	36.1	5.2	0.0	0.1	0.3	16.5	0.0	104.1	180.1	0.0	1.5	17.1	36.9	0.0	11.1	235.6	2.9	0.6	16.5	21.7	18.3	391.3	3.6	67.3	92.7
HSPA8	"HSC70, HSC71, HSP73, HSPA10"	ENSG00000109971	"Heat shock protein family A (Hsp70) member 8"	P11142	11	123057489-123063230	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation"	"Chaperone, Hydrolase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 2455.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002056, HPA052504"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	Yes		140000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Vesicles	"CAB002056: , HPA052504: AB_2681854"	"unprognostic (2.28e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.65e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.16e-2)"	539.8	604.9	456.3	542.1	498.1	442.4	448.9	591.6	887.9	326.6	571.4	435.8	506.9	367.3	614.7	554.2	498.5	508.6	892.4	535.1	614.9	850.5	763.2	480.1	685.0	564.8	564.2	421.4	1238.1	593.8	501.9	487.1	620.0	411.2	525.8	531.5	404.1	439.8	1519.0	224.4	453.5	508.4	554.2	520.3	676.7	395.0	559.8	628.6	422.6	1508.5	879.6	866.0	302.4	656.8	1369.6	2077.3	1370.5	1176.5	1259.4	1337.4	1775.6	2730.9	1550.4	3373.2	2004.8	3151.7	1787.3	2318.5	1614.6	1591.9	2337.3	1835.9	4091.6	1027.2	3323.5	1955.4	605.9	2570.4	881.5	1532.0	347.5	2418.0	1757.1	721.8	1594.5	1045.0	320.7	1753.4	1845.6	321.7	2727.8	1147.0	2704.5	1235.5	2507.0	1761.3	2063.2	3463.3	1874.0	2214.4	962.2	1281.3	1665.1	1008.4	1371.8	1023.9	1980.4	2110.5	763.6	1491.1	1837.1	901.9	1767.0	1621.1	1246.1	1404.5	2402.7	740.6	1985.0	1890.9	1791.1	3316.9	1970.0	517.7	592.3	587.8	1245.4	1159.8	1499.6	1009.2	1441.8	1366.1	656.1	752.2	1367.5	1326.5	201.8	1110.7	1255.0	465.5	1761.7	3439.4	456.3	498.1	591.6	887.9	535.1	614.9	564.8	564.2	620.0	554.2	559.8	656.8	795.5	192.3	228.2	72.5	576.3	282.3	2455.6	315.3	507.6	206.7	454.5	380.1	396.3	278.8	352.8	130.6	127.2	926.1	740.3	513.1	528.3	589.0	49.8	404.1	380.1	512.8	519.8	551.7	33.4	628.8	1032.6	609.7	366.0	366.5	434.8	633.8	249.9	223.9	810.9	181.7	45.6	511.1	303.2	359.8	1060.8	58.2	222.4	590.6	528.3	35.6	530.9	307.4	639.5	28.1	50.3	513.8	552.1	270.0	573.6	779.5	823.0	1002.2	465.7	278.1	243.3	416.3	893.1	248.9	419.2	590.6	284.6	1512.1	1123.5	430.3	632.0	1171.5
HSPB11	"C1orf41, FAP232, HSPCO34, IFT25, PP25"	ENSG00000081870	"Heat shock protein family B (small) member 11"	Q9Y547	1	53916574-53945699	"Human disease related genes, Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Stress response, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 412.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030140	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		38000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA030140: AB_10600713"	"unprognostic (5.73e-2)"	"unprognostic (6.37e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (9.58e-7)"	"unprognostic (5.12e-1)"	"unprognostic (6.70e-3)"	"unprognostic (8.31e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.84e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-2)"	25.9	36.4	36.2	34.1	37.1	61.2	46.5	35.5	49.9	33.9	46.4	31.9	25.0	42.6	70.5	30.1	79.6	26.8	26.6	38.4	36.9	35.3	55.1	29.7	62.5	35.5	35.5	41.8	26.4	30.8	23.1	41.6	35.6	34.9	34.5	29.8	24.0	36.6	11.4	37.3	26.0	36.8	36.3	34.8	36.8	30.7	35.3	55.8	96.8	19.6	62.3	39.5	19.2	38.6	115.4	50.3	141.8	31.2	51.1	67.7	59.4	95.8	91.4	142.5	163.8	122.2	60.5	134.7	77.1	69.6	251.8	88.9	62.2	99.5	168.7	114.6	91.6	166.6	108.1	163.7	58.2	83.7	108.0	70.0	76.7	135.5	37.0	88.4	77.4	82.5	102.3	30.6	184.4	24.9	184.8	132.4	59.5	96.1	111.5	125.5	184.3	72.5	118.3	128.7	74.2	59.8	140.7	64.8	95.4	142.7	396.4	118.5	52.7	92.4	115.1	104.9	107.8	54.6	97.3	141.7	148.5	78.1	81.5	171.2	47.4	130.6	87.0	65.9	78.8	95.6	85.6	104.7	56.8	76.9	67.1	84.9	33.5	109.4	71.8	121.8	122.0	58.3	36.2	37.1	35.5	49.9	38.4	36.9	35.5	35.5	35.6	36.3	35.3	38.6	37.8	32.1	31.4	14.7	54.3	106.4	79.6	244.6	68.9	22.4	67.5	73.2	42.7	42.9	134.6	51.5	8.4	181.9	72.0	42.4	117.4	60.4	55.7	249.2	60.0	40.7	77.3	48.6	18.2	65.7	101.3	59.0	27.5	60.3	61.5	59.3	31.8	64.9	115.0	13.5	16.9	42.2	217.7	46.5	74.8	15.7	61.5	57.2	78.2	11.2	80.5	87.8	70.0	13.0	22.9	79.6	52.0	63.6	80.8	70.5	54.7	119.2	412.1	19.8	39.5	32.6	93.0	130.0	97.9	66.4	82.8	116.8	73.7	120.3	39.7	118.0
HSPB7	cvHSP	ENSG00000173641	"Heat shock protein family B (small) member 7"	Q9UBY9	1	16014028-16019594	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 4135.3;skeletal muscle: 2417.8;tongue: 1229.5"	"Cell type enriched"	"Detected in some"	32	"Cardiomyocytes: 2389.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"fHDF/TERT166: 315.1"	"Not detected"	"Not detected"							HPA027639	Approved		Approved	Nucleoplasm		NA	NA		130000		"Cluster 38: Heart - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA027639: AB_10601756"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.35e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (1.26e-4)"	306.8	123.4	3.9	32.1	4.4	0.2	119.7	8.8	5.1	49.6	8.6	138.3	5.1	179.5	7.5	44.2	64.8	18.7	4135.3	4.1	5.6	38.5	3.2	22.1	1.7	13.1	7.9	25.4	9.2	38.8	5.3	7.1	12.0	43.0	8.0	3.1	35.1	24.4	2417.8	19.3	34.0	189.2	5.3	4.5	71.4	20.2	4.7	0.6	14.1	1229.5	0.7	99.2	30.5	6.7	0.0	0.0	0.0	1.5	70.7	3.2	1.8	18.4	1.1	0.0	0.2	0.0	0.1	0.0	0.0	315.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	3.4	0.0	0.0	2.1	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.6	0.1	0.1	0.0	0.1	5.3	3.3	0.0	0.0	0.0	1.3	0.0	11.8	0.0	1.3	0.1	1.1	0.0	14.1	0.6	1.9	0.0	10.3	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.4	8.8	5.1	4.1	5.6	13.1	7.9	12.0	5.3	4.7	6.7	0.5	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.8	0.2	0.4	2389.7	0.0	0.0	3.7	0.0	2.8	0.0	0.0	13.7	1.4	55.5	0.1	0.7	26.6	0.0	0.0	0.0	0.2	1.4	46.3	0.0	0.1	0.0	0.4	0.0	0.0	1.6	1.7	0.1	0.0	0.0	0.0	4.6	74.2	14.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	6.8	0.0	0.5	0.0	0.2	0.0	0.6	0.0	20.2	42.6	1.9	0.9	0.1	2.6	3.3	0.5	3.0	0.0	0.1
HSPB8	"CMT2L, E2IG1, H11, HSP22"	ENSG00000152137	"Heat shock protein family B (small) member 8"	Q9UJY1	12	119171555-119224855	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 897.3"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 599.1;Syncytiotrophoblasts: 1340.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 89.6;HeLa: 66.0;MCF7: 130.5;U-87 MG: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015876	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Nucleoplasm	"HPA015876: AB_1850458"	"unprognostic (1.52e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.17e-2)"	57.0	13.9	172.2	34.4	172.6	0.0	33.4	179.5	141.8	58.1	147.0	381.0	8.9	114.4	10.1	163.2	58.7	43.1	469.3	147.8	231.0	63.3	4.8	95.7	11.4	188.3	206.1	23.4	30.8	183.1	17.5	92.1	193.0	143.5	35.8	28.2	50.8	289.0	897.3	70.5	50.5	114.1	211.5	56.2	110.4	12.0	193.6	40.3	29.2	448.5	98.7	239.2	100.1	235.5	21.1	16.1	0.3	0.0	14.4	11.5	60.2	32.5	28.7	5.9	0.3	40.0	0.6	0.1	89.6	42.4	48.0	2.4	0.3	0.0	0.6	0.1	1.2	0.0	66.0	3.2	11.2	0.0	0.1	14.1	4.1	22.3	1.3	21.6	12.3	0.0	0.2	0.0	13.0	130.5	0.0	0.2	5.7	0.0	23.0	0.0	22.9	2.9	38.3	6.2	0.4	1.0	13.5	1.6	6.8	50.5	29.0	0.2	20.4	15.8	39.8	21.7	1.7	0.0	0.2	0.2	67.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	172.2	172.6	179.5	141.8	147.8	231.0	188.3	206.1	193.0	211.5	193.6	235.5	2.7	44.8	48.2	42.1	0.7	102.3	108.5	4.5	126.3	0.7	95.2	17.5	599.1	7.2	5.4	5.5	8.4	149.1	1.0	0.0	0.0	59.7	12.2	98.1	20.2	27.4	0.0	0.0	6.2	11.4	17.5	82.2	5.6	142.7	1.3	0.0	25.4	0.0	19.4	1.7	6.6	0.0	2.0	1.0	9.4	11.0	1.5	1.6	12.4	2.8	1.0	51.7	0.0	0.0	0.9	12.9	0.0	0.4	0.3	24.6	0.0	52.0	3.1	2.1	6.6	39.8	76.9	0.9	0.2	38.0	28.7	1340.0	3.5	0.1	0.2	72.7
HSPB9	CT51	ENSG00000260325	"Heat shock protein family B (small) member 9"	Q9BQS6	17	42122804-42123352	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 17.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 375.3;Late spermatids: 1017.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053091			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA053091: "	"unprognostic (2.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.42e-6)"	"unprognostic (2.31e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.68e-4)"	"unprognostic (4.78e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	0.4	0.2	1.3	0.4	1.4	0.6	0.2	1.6	1.7	0.2	0.9	0.3	0.3	0.2	0.0	0.1	0.7	0.6	0.2	1.2	1.3	0.5	3.6	0.2	0.4	1.4	1.2	1.3	4.8	0.2	0.5	0.2	1.4	0.5	0.0	0.0	2.9	0.5	1.5	0.4	0.4	0.1	1.2	0.5	0.4	17.8	1.4	0.0	0.2	1.0	0.0	0.2	0.2	1.7	0.2	0.2	0.3	0.9	0.0	0.0	3.3	0.0	0.0	0.0	0.3	1.0	0.1	0.3	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.3	3.0	0.5	1.2	0.4	0.0	0.3	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	0.2	0.0	0.4	0.3	1.1	0.1	0.3	0.0	0.1	0.2	1.0	0.0	0.7	1.4	0.3	0.0	1.5	0.2	0.1	0.2	0.1	0.4	0.7	0.0	0.6	0.2	0.6	0.3	0.6	0.1	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	1.3	1.4	1.6	1.7	1.2	1.3	1.4	1.2	1.4	1.2	1.4	1.7	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.6	0.6	0.6	0.5	0.6	2.8	0.0	0.0	2.1	3.2	0.2	0.4	19.6	0.0	375.3	0.5	0.3	0.6	0.0	0.0	0.1	1.1	0.8	0.7	0.0	0.3	0.0	0.5	1.8	15.3	0.2	3.3	0.1	0.7	0.0	0.8	0.4	1017.0	7.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.3	6.8	0.0	0.4	0.6	0.9	0.1	0.4	0.0	0.8	0.3	127.3	4.5	0.1	0.3	0.3	0.2	0.6	0.3	0.2
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822244-21937310	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.8;Endothelial cells: 322.9;Granulosa cells: 776.0;Hepatic stellate cells: 600.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 293.0;HUVEC TERT2: 620.8;TIME: 504.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1400000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	140.7	54.7	3.8	36.1	5.2	1.7	96.2	3.7	4.8	65.9	18.8	153.1	18.3	151.9	6.6	44.1	85.0	53.4	156.6	3.6	2.9	37.6	10.6	49.0	14.2	5.6	4.6	31.3	31.7	13.1	11.8	30.3	5.7	60.3	8.6	0.3	45.0	56.5	65.1	41.0	54.9	96.2	4.0	37.4	76.1	9.0	7.6	6.7	69.1	40.8	3.5	110.2	59.7	4.7	44.0	40.7	13.8	45.9	131.0	99.4	51.5	70.2	17.8	21.1	18.7	50.5	86.7	3.3	293.0	112.9	0.8	26.9	3.1	31.9	5.4	0.6	4.3	15.7	46.0	35.7	27.0	0.0	4.1	61.6	9.4	19.9	6.0	28.1	620.8	0.3	21.4	5.7	32.4	11.8	0.0	20.0	11.7	19.6	17.9	6.3	87.8	6.1	35.1	6.5	1.3	4.1	51.4	20.0	28.7	14.0	8.1	7.2	504.3	41.1	51.8	29.7	2.3	0.5	7.3	2.6	9.7	0.1	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	5.2	3.7	4.8	3.6	2.9	5.6	4.6	5.7	4.0	7.6	4.7	366.8	70.5	28.6	3.6	3.9	26.4	13.5	81.1	21.1	0.6	6.2	21.5	5.8	38.6	30.3	92.0	0.0	11.0	3.4	52.9	0.0	76.1	1.4	24.2	47.7	322.9	2.4	22.9	0.8	25.0	89.0	141.3	62.2	39.8	23.4	776.0	600.4	6.6	6.8	3.3	0.8	12.6	16.2	22.1	19.2	5.8	75.2	4.6	60.5	15.9	1.8	1.6	0.0	2.5	4.3	87.5	29.9	69.2	4.6	19.3	19.2	0.9	28.7	0.6	32.9	82.5	69.8	0.3	4.8	10.0	17.8	9.3	5.0	83.3	20.1	11.8
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134973-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 1251.1"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1316.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 1251.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol		No	Yes		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	52.2	42.1	175.9	23.5	193.6	20.7	27.9	175.2	1251.1	25.0	182.5	29.3	11.3	25.9	37.6	35.8	54.8	32.3	57.3	184.9	189.3	73.5	47.6	66.6	34.9	172.7	180.7	56.3	28.6	30.3	63.8	37.8	180.9	28.4	25.3	26.7	20.1	29.3	36.6	21.7	20.4	28.0	177.2	32.3	53.1	67.8	190.2	37.4	32.2	32.6	45.1	58.8	35.4	227.4	69.9	130.7	105.1	10.2	99.1	56.0	70.0	117.8	104.6	179.0	82.8	154.9	105.4	179.6	71.9	82.4	253.7	131.2	411.7	104.8	229.2	141.6	51.7	155.7	69.3	137.2	32.3	109.1	118.8	35.5	236.5	119.6	68.3	93.0	105.4	62.0	132.7	27.8	127.4	94.7	158.1	124.2	150.3	338.6	96.6	122.5	85.8	58.9	135.0	83.5	108.5	90.1	107.4	104.0	56.6	160.6	35.0	104.7	64.4	61.3	77.4	89.2	132.4	21.8	76.0	150.6	51.0	129.8	104.7	1.4	5.0	2.7	7.6	12.2	9.4	11.1	9.7	11.8	8.4	10.6	14.7	13.8	0.5	16.7	19.6	6.6	7.0	7.7	175.9	193.6	175.2	1251.1	184.9	189.3	172.7	180.7	180.9	177.2	190.2	227.4	171.1	131.4	87.7	36.6	130.8	214.6	1316.2	44.7	175.2	38.7	152.2	143.3	163.6	40.0	123.3	46.0	417.0	23.2	78.9	153.2	29.4	49.8	100.0	346.1	140.1	132.3	227.7	58.9	121.0	35.9	64.2	249.6	94.3	250.6	248.6	61.7	26.4	25.7	90.6	30.3	77.7	159.0	65.1	38.6	452.1	36.5	33.8	281.3	163.7	55.3	42.6	28.2	26.8	30.7	53.2	45.5	154.0	39.1	142.0	426.3	18.2	31.6	290.5	79.0	39.5	98.1	153.1	161.3	164.6	151.1	143.3	42.5	363.8	58.5	166.1	511.8
HTATSF1	TAT-SF1	ENSG00000102241	"HIV-1 Tat specific factor 1"	O43719	X	136497079-136512346	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000504	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000504: AB_10752094"	"unprognostic (3.56e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (8.13e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.05e-1)"	38.9	99.7	53.4	31.0	54.1	54.7	35.7	56.0	60.6	33.5	45.9	34.8	25.4	39.4	59.1	30.3	35.1	28.6	65.4	51.5	74.1	43.3	30.8	26.9	34.5	60.8	56.4	60.2	27.7	52.8	144.7	36.4	56.7	35.3	35.3	56.1	28.4	39.6	181.8	35.1	26.0	34.6	56.1	28.5	32.5	41.5	79.9	43.0	47.6	109.2	35.7	35.1	27.8	55.3	151.4	79.3	99.9	70.5	72.1	54.0	87.1	71.5	60.4	57.2	55.5	47.6	66.0	114.1	163.1	68.1	66.3	66.0	120.5	52.3	75.0	86.5	106.9	70.9	99.9	59.2	40.8	138.1	57.7	48.4	66.1	63.2	39.3	40.8	60.3	166.3	67.4	81.0	76.5	114.3	135.7	115.4	58.7	139.4	115.7	104.2	123.7	103.3	62.0	105.9	69.0	106.9	66.7	54.4	56.4	83.9	39.8	96.5	57.4	69.2	52.2	79.5	126.1	47.6	69.1	92.7	44.4	192.4	50.3	48.4	20.6	33.2	41.0	21.5	44.5	33.9	44.4	42.2	28.5	33.3	44.8	40.7	6.7	49.7	35.3	20.6	47.9	27.9	53.4	54.1	56.0	60.6	51.5	74.1	60.8	56.4	56.7	56.1	79.9	55.3	28.2	51.3	42.9	11.4	36.8	29.6	38.0	28.0	38.7	52.5	25.8	23.5	173.3	20.0	53.1	49.7	10.4	95.3	37.6	26.2	49.0	36.7	6.8	51.0	39.3	29.8	81.2	55.5	10.2	34.3	69.8	42.1	42.3	32.9	34.8	48.4	10.4	22.8	38.2	42.1	12.1	37.8	28.5	19.5	19.2	11.7	45.1	30.3	32.0	7.5	34.4	78.0	25.7	8.0	13.6	32.5	18.5	53.8	54.3	37.2	20.4	32.1	44.4	56.7	46.0	46.9	41.0	29.4	92.2	42.7	26.6	116.8	51.6	45.8	32.6	36.8
HTR2B	"5-HT(2B), 5-HT2B"	ENSG00000135914	"5-hydroxytryptamine receptor 2B"	P41595	2	231108230-231125042	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 17.4;cervix: 21.5;endometrium 1: 18.8;smooth muscle: 16.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Endometrial stromal cells: 17.7;Endothelial cells: 4.1;Hepatic stellate cells: 5.7;Microglial cells: 4.7;monocytes: 6.2;Peritubular cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 1.8;T-reg: 1.0"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.8;T-cells: 1.0"	"Group enriched"	"Detected in some"	4	"HHSteC: 8.7;HSkMC: 16.5;SK-MEL-30: 32.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012867, HPA063658"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA012867: AB_1856710, HPA063658: AB_2685079"	"unprognostic (1.86e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.42e-3)"	"unprognostic (7.44e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	0.9	17.4	0.4	1.5	0.4	1.2	0.8	0.9	0.6	21.5	1.2	9.0	1.5	18.8	11.8	0.7	2.4	1.2	4.7	0.4	0.6	3.4	3.6	0.9	1.0	0.5	0.4	0.8	0.2	0.6	0.3	4.1	0.5	0.3	2.1	0.2	0.5	1.4	0.1	0.1	4.8	16.8	0.2	0.4	4.5	0.4	0.4	1.2	3.2	0.3	0.8	2.2	0.8	0.6	0.2	0.3	0.0	0.1	0.5	4.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.7	0.1	0.3	16.5	0.0	0.0	0.0	0.0	3.2	1.4	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	32.7	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.4	0.9	0.6	0.4	0.6	0.5	0.4	0.5	0.2	0.4	0.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.2	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.2	1.5	17.7	4.1	0.0	0.0	0.7	0.7	0.1	0.8	0.0	3.4	0.0	0.1	5.7	1.5	3.4	1.7	0.9	0.0	0.0	0.8	0.0	0.2	0.6	2.2	0.0	4.7	6.2	0.0	1.0	0.5	0.6	0.2	0.0	5.3	0.0	0.0	0.0	0.0	2.0	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.2	0.3	0.0	0.2
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3041363-3243960	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		36000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	8.3	9.3	10.5	8.2	11.7	8.1	7.6	7.8	14.2	6.1	8.2	8.1	6.0	7.1	8.3	10.4	6.7	5.1	7.1	15.7	3.5	7.9	8.9	10.1	11.5	8.7	5.2	7.2	21.3	12.3	9.0	6.9	7.8	7.0	6.5	10.3	7.2	5.8	15.3	15.1	9.7	5.8	3.0	11.5	8.9	10.1	6.8	11.3	9.1	12.4	8.8	7.3	7.0	11.0	19.5	14.2	17.6	10.3	30.9	20.2	17.7	9.0	10.4	13.0	12.6	17.3	12.2	28.6	8.9	20.9	21.6	10.7	20.6	15.3	12.0	7.8	15.4	27.4	18.0	18.8	7.5	17.7	37.9	11.1	9.5	25.4	10.7	9.3	14.3	13.0	17.7	9.9	11.4	17.9	22.4	17.1	21.2	9.7	20.7	17.7	16.9	5.7	14.2	18.1	18.5	13.9	15.0	5.7	14.6	12.9	16.1	10.8	20.6	16.8	11.1	12.4	19.0	7.6	8.8	22.9	13.4	16.4	13.3	0.0	0.7	0.9	1.0	1.1	0.7	0.8	0.8	1.3	1.1	0.6	0.4	0.7	0.1	0.9	1.5	0.7	1.2	0.7	10.5	11.7	7.8	14.2	15.7	3.5	8.7	5.2	7.8	3.0	6.8	11.0	15.8	25.6	14.8	41.1	20.7	13.8	8.0	12.4	9.1	48.1	20.4	15.4	10.4	17.2	14.6	14.7	181.4	11.8	26.1	22.4	5.9	12.0	9.4	23.1	20.8	17.2	18.5	18.5	88.8	17.5	11.7	13.9	20.9	25.3	11.4	54.9	22.1	17.1	26.7	45.4	75.1	13.3	4.1	23.4	15.4	10.3	16.1	25.4	8.8	40.3	18.2	20.8	24.7	59.8	52.4	20.0	21.2	11.7	15.3	15.7	20.9	12.2	12.0	50.7	13.1	19.2	13.6	13.0	21.3	21.9	20.0	8.3	19.5	16.8	20.9	11.6
HUNK		ENSG00000142149	"Hormonally up-regulated Neu-associated kinase"	P57058	21	31873020-32044633	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.8"	"Cell type enriched"	"Detected in many"	5	"Inhibitory neurons: 109.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;BEWO: 16.3;RH-30: 18.1;SCLC-21H: 14.8;SiHa: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA027295, HPA027372"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA027295: AB_2672203, HPA027372: AB_2672239"	"unprognostic (9.09e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.00e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.48e-5)"	"unprognostic (8.84e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.69e-2)"	0.7	1.0	0.8	1.3	1.3	0.2	1.2	0.4	4.7	0.4	0.0	3.6	1.4	4.1	1.9	0.4	1.9	0.5	0.4	4.2	2.6	3.7	0.5	0.9	0.4	0.4	0.1	0.6	9.8	0.1	1.1	4.6	0.1	0.9	3.7	3.0	0.6	2.1	0.3	3.0	2.7	2.4	0.0	0.1	1.3	0.9	0.2	0.7	0.6	0.2	0.6	1.5	0.7	1.6	0.0	3.9	13.2	0.1	0.0	0.0	16.3	1.3	0.0	0.2	0.0	5.3	0.1	0.0	0.5	6.2	0.2	0.0	7.7	0.0	0.1	0.1	3.9	0.0	3.7	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	1.1	0.2	1.1	10.2	0.1	0.1	0.1	18.1	0.1	1.3	0.0	14.8	9.8	13.2	1.0	0.5	9.3	5.5	1.4	0.0	0.1	9.3	0.1	0.0	0.1	0.0	1.8	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.4	4.7	4.2	2.6	0.4	0.1	0.1	0.0	0.2	1.6	0.2	6.4	9.1	7.5	0.0	5.1	2.6	0.2	0.6	8.1	0.5	2.8	3.5	14.3	3.0	7.3	2.1	9.2	0.0	4.6	0.0	5.3	0.2	1.2	1.3	0.8	4.9	0.0	19.0	3.3	13.9	7.9	0.5	3.4	0.0	4.3	0.4	1.0	2.7	3.3	109.6	5.1	0.0	0.0	4.2	0.1	0.3	0.4	3.6	1.0	0.1	8.1	0.0	10.1	1.5	1.6	4.4	0.0	0.0	2.1	1.8	1.9	0.8	1.2	0.0	6.3	2.2	0.7	1.1	0.7	5.8	6.2	0.5	0.0	10.6	0.9
HUS1B		ENSG00000188996	"HUS1 checkpoint clamp component B"	Q8NHY5	6	655939-656963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.1"	"Group enriched"	"Detected in some"	4	"Sertoli cells: 6.6;Spermatocytes: 19.3;Spermatogonia: 8.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;U-266/84: 2.2;WM-115: 2.2"	"Not detected"	"Not detected"							"HPA034511, HPA063449"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA034511: AB_2674203, HPA063449: AB_2685014"	"unprognostic (3.56e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-10)"	"unprognostic (7.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	0.4	0.3	0.4	0.1	0.4	0.7	0.3	0.3	0.5	0.8	0.5	0.3	0.2	0.4	0.1	0.6	0.3	0.1	0.4	0.3	0.3	0.5	0.6	0.6	0.0	0.4	0.2	0.5	0.1	0.0	0.5	0.1	0.4	0.8	0.0	0.2	0.4	0.0	0.2	0.6	0.3	0.1	0.0	0.6	0.2	2.1	0.3	0.1	0.4	0.1	0.0	0.4	0.7	0.6	0.3	0.0	0.0	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.5	1.8	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.7	0.4	0.2	0.0	0.2	1.0	1.1	0.0	0.6	0.3	0.3	1.0	0.1	0.2	0.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.3	0.6	0.1	0.9	2.2	0.4	0.0	0.2	2.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.4	0.3	0.5	0.3	0.3	0.4	0.2	0.4	0.0	0.3	0.6	1.1	0.0	0.0	0.0	0.8	0.6	0.8	1.0	0.6	0.7	1.3	1.3	0.2	1.5	0.2	0.0	0.0	1.5	1.7	0.3	0.0	1.3	0.6	0.5	0.4	1.2	0.0	0.0	0.0	0.6	1.1	0.5	0.0	0.9	0.0	0.5	2.2	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.6	0.9	0.5	0.0	0.0	2.6	0.4	2.1	0.0	0.0	1.3	0.1	1.2	0.1	0.7	0.3	0.1	0.1	1.4	6.6	0.7	1.3	19.3	8.0	0.2	1.7	1.5	1.5	0.8	0.3	0.5
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1"	Q7Z6Z7	X	53532096-53686728	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Granulosa cells: 507.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		73000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	37.7	46.1	55.6	21.1	57.4	26.7	37.4	57.6	69.6	39.8	42.0	49.4	17.6	45.6	52.6	48.4	40.7	18.5	57.1	62.6	61.3	45.2	41.8	36.1	26.6	58.7	67.8	54.0	45.9	43.2	54.2	24.0	73.2	38.4	22.7	40.0	38.9	28.6	101.0	59.3	40.2	28.8	49.1	42.5	45.5	43.0	65.1	41.2	42.9	58.1	30.3	44.6	40.2	57.2	166.8	100.4	64.0	45.4	109.2	64.8	78.5	48.8	62.6	50.2	52.3	77.0	52.2	86.6	32.3	89.4	90.4	77.8	145.6	81.8	68.3	125.6	64.6	69.1	91.9	60.5	100.2	104.5	40.6	62.4	59.8	120.8	137.6	49.7	88.3	66.4	70.3	54.5	66.3	102.4	57.0	58.2	87.7	45.4	71.3	52.0	87.9	52.8	84.0	113.3	53.1	38.4	137.7	60.5	44.1	118.7	87.0	50.1	113.8	46.0	65.8	66.5	62.9	47.3	50.2	73.1	49.2	100.1	67.6	2.8	2.3	4.3	3.3	1.9	4.0	2.4	3.1	3.5	3.3	2.4	2.2	2.2	1.9	3.5	3.8	3.5	2.9	1.9	55.6	57.4	57.6	69.6	62.6	61.3	58.7	67.8	73.2	49.1	65.1	57.2	41.4	51.3	46.1	70.2	41.9	30.1	32.6	30.4	44.9	57.8	37.0	35.6	110.4	37.1	35.4	40.5	50.1	31.0	40.0	29.2	1.9	42.8	28.6	45.6	59.8	38.3	47.6	47.7	94.4	35.4	34.8	38.6	57.1	69.6	22.1	507.7	32.9	48.1	24.8	82.4	85.8	28.1	18.3	31.4	30.8	32.8	28.3	34.1	26.6	59.0	43.7	22.6	35.0	83.9	95.3	49.3	20.5	39.1	50.9	44.1	27.1	14.7	35.7	33.3	13.1	69.6	56.4	34.5	44.6	53.3	41.6	37.9	46.7	114.1	31.7	42.0
HYPK	"C15orf63, FLJ20431, HSPC136"	ENSG00000242028	"Huntingtin interacting protein K"	Q9NX55	15	43796142-43804427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055252	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Microtubules	"HPA055252: AB_2682759"	"unprognostic (2.89e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.39e-3)"	"unprognostic (6.52e-7)"	"unprognostic (2.05e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.78e-4)"	8.9	9.8	13.8	5.9	13.8	4.9	6.5	16.6	22.0	5.0	13.8	5.0	3.7	4.3	5.1	4.2	6.0	2.9	8.5	13.8	15.0	6.5	14.2	7.6	6.5	14.7	15.2	6.2	9.4	6.2	5.6	3.6	14.7	6.8	3.8	8.6	5.5	4.3	19.2	6.1	5.1	4.9	13.4	5.5	5.8	7.9	14.2	6.1	5.2	14.7	7.7	8.3	4.3	15.4	13.5	36.8	17.3	19.5	11.6	11.5	6.5	21.8	13.1	18.9	12.6	23.7	7.4	19.8	25.9	16.7	17.8	23.1	30.3	24.9	14.3	17.3	37.3	26.4	64.6	34.0	17.8	30.4	16.3	10.1	24.2	21.3	18.1	9.3	14.7	20.9	40.5	16.9	17.2	33.5	19.2	33.9	19.5	48.6	40.9	15.4	12.6	22.4	17.7	26.5	33.9	24.7	20.7	31.1	13.3	10.6	23.7	19.5	13.3	22.6	11.8	24.2	55.8	20.5	40.6	46.2	15.1	33.1	26.8	16.8	25.7	22.1	25.0	37.7	26.4	30.0	26.8	26.7	23.5	31.4	29.9	27.9	9.4	26.7	47.7	39.8	27.5	23.5	13.8	13.8	16.6	22.0	13.8	15.0	14.7	15.2	14.7	13.4	14.2	15.4	11.3	6.4	14.5	0.0	11.1	30.0	15.0	8.1	13.6	11.2	14.4	11.9	0.7	8.6	12.1	7.3	54.2	6.6	8.2	6.4	9.8	6.5	2.4	7.2	9.6	10.7	10.7	9.5	0.0	8.4	4.4	12.5	26.0	7.7	8.8	4.5	6.4	6.5	3.9	13.5	0.0	11.6	8.2	4.4	26.2	1.1	5.0	9.1	23.2	0.0	4.7	4.9	6.2	0.0	0.0	6.8	4.7	2.2	11.3	14.8	7.2	10.4	15.4	28.5	0.0	23.2	11.8	3.9	4.7	19.4	37.4	4.9	10.4	9.1	9.4	11.1
IAH1		ENSG00000134330	"Isoamyl acetate hydrolyzing esterase 1 (putative)"	Q2TAA2	2	9473658-9496543	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 433.4;Late spermatids: 503.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040523, HPA076040"	Approved		Approved	Nucleoplasm		NA	NA		240000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA040523: AB_2677021, HPA076040: "	"unprognostic (1.51e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.41e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.91e-2)"	40.7	47.5	27.5	16.9	28.2	27.3	34.1	32.6	37.3	33.3	32.6	41.2	20.0	30.4	31.4	26.6	28.2	23.0	56.9	27.4	29.6	39.4	46.0	31.3	27.0	27.6	27.8	35.6	23.3	45.6	31.1	24.2	28.6	26.6	29.1	22.3	22.4	29.3	43.0	22.6	26.2	27.4	27.5	25.9	29.9	65.8	29.0	28.5	28.8	72.6	31.0	30.6	29.9	31.8	41.0	40.8	4.7	0.5	73.4	140.7	0.9	33.4	76.8	48.7	46.4	0.5	44.2	21.1	17.6	106.7	35.2	27.8	15.4	32.2	48.5	81.2	26.8	26.7	16.1	27.5	139.6	0.1	21.2	85.1	92.9	36.6	42.6	93.6	49.2	37.8	0.4	13.3	100.1	39.4	106.6	4.2	6.4	53.6	20.6	26.0	0.1	6.1	79.4	21.1	29.0	56.2	26.0	37.2	52.6	2.4	37.9	46.4	38.6	38.7	17.0	17.5	52.6	10.6	0.7	8.2	53.4	16.6	44.3	33.3	38.0	31.9	30.2	35.3	33.8	38.5	35.2	34.6	49.6	32.7	27.2	30.9	23.0	37.6	42.8	52.4	46.0	25.6	27.5	28.2	32.6	37.3	27.4	29.6	27.6	27.8	28.6	27.5	29.0	31.8	44.4	32.1	26.2	25.1	53.7	89.9	100.5	92.4	21.6	33.6	41.3	51.2	45.4	52.9	40.1	49.7	12.5	74.2	65.0	36.2	92.0	68.9	433.4	49.9	56.9	30.1	25.7	41.4	43.2	76.9	109.8	73.5	16.8	50.1	36.8	74.0	36.4	53.1	87.4	42.1	35.1	28.6	42.7	78.2	95.2	503.0	93.8	66.3	92.5	19.7	116.8	44.0	80.3	23.1	44.4	90.5	37.3	73.0	38.5	75.6	68.0	138.8	42.7	57.4	98.6	82.8	75.2	243.2	48.8	41.4	95.8	44.5	64.9	87.0	47.5	89.5
IARS1	"IARS, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase 1"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 47.6;Cytotrophoblasts: 29.8;Extravillous trophoblasts: 31.7;Hofbauer cells: 17.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	22.2	24.3	6.3	28.8	5.8	13.2	27.4	8.8	11.5	26.4	10.7	29.1	17.9	32.5	15.1	31.8	27.7	16.1	32.2	6.8	10.7	28.4	19.6	18.9	28.3	5.9	7.3	20.4	40.1	52.3	11.7	27.7	8.6	27.7	33.3	25.2	25.5	31.6	43.1	21.7	16.2	42.6	3.6	19.7	31.4	20.0	5.2	27.5	64.6	47.2	37.6	28.2	11.7	6.9	150.7	154.9	83.3	132.2	110.5	142.2	126.8	156.4	146.2	118.8	138.5	52.2	99.0	216.0	54.9	231.4	130.5	194.9	254.4	197.9	149.3	126.1	97.9	135.3	128.3	62.8	235.6	181.3	90.6	134.1	194.9	208.9	348.9	78.3	123.6	230.1	229.2	189.8	145.0	79.3	173.2	31.6	139.7	294.5	143.3	116.2	129.3	103.0	72.9	72.6	110.2	91.5	118.2	117.0	128.8	87.8	95.2	94.4	101.3	89.5	104.6	149.3	119.1	134.8	156.4	99.5	218.7	133.3	173.3	2.8	5.9	0.7	11.9	7.0	16.4	13.9	11.8	11.9	12.7	9.7	12.8	12.7	0.5	19.5	6.3	4.8	10.9	9.0	6.3	5.8	8.8	11.5	6.8	10.7	5.9	7.3	8.6	3.6	5.2	6.9	7.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	29.8	7.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	31.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	17.4	1.1	0.0	0.0	0.0
IBTK	"BTBD26, BTKI, DKFZP564B116"	ENSG00000005700	"Inhibitor of Bruton tyrosine kinase"	Q9P2D0	6	82169986-82247754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 190.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023826, HPA048438"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA023826: AB_1851378, HPA048438: AB_2680392"	"unprognostic (3.13e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.27e-2)"	"unprognostic (9.78e-2)"	7.3	14.3	2.5	8.1	3.3	3.7	7.9	3.2	2.6	8.9	3.1	8.6	8.4	8.0	4.8	8.3	7.6	6.0	10.0	2.0	2.7	10.3	22.2	7.0	6.7	2.8	3.4	8.8	11.0	12.3	4.8	6.3	3.0	7.7	10.4	8.5	8.9	7.4	21.4	4.1	8.4	7.4	3.5	6.5	11.5	4.0	3.1	7.2	10.3	20.9	7.2	8.6	5.9	3.5	8.3	17.0	12.2	10.3	14.4	19.8	5.5	19.3	21.1	15.5	16.6	9.0	9.6	16.4	11.9	22.8	20.5	8.8	9.8	10.8	18.5	22.5	7.3	17.6	8.8	14.1	20.2	20.7	10.3	17.1	17.6	14.8	36.8	14.5	15.7	11.4	16.4	10.0	16.7	12.7	7.2	6.7	5.5	13.0	9.1	10.2	25.7	6.5	23.2	18.9	8.2	9.0	13.0	16.1	10.3	10.8	15.1	12.5	12.6	9.0	6.7	11.3	15.6	10.3	17.1	7.5	9.9	13.4	11.9	1.3	1.2	1.0	1.8	1.1	2.4	1.6	1.8	1.6	1.9	1.0	1.7	1.6	0.0	1.0	2.3	1.4	2.7	0.8	2.5	3.3	3.2	2.6	2.0	2.7	2.8	3.4	3.0	3.5	3.1	3.5	26.1	41.7	47.6	46.4	33.5	13.6	42.8	19.4	15.4	55.6	27.4	19.0	64.9	40.0	41.2	38.6	54.2	23.9	25.9	62.2	15.6	37.5	4.2	37.4	28.1	27.3	38.9	37.4	102.6	51.6	16.4	34.1	117.8	57.0	36.8	38.1	21.8	77.0	26.7	52.2	97.9	49.3	6.1	33.4	26.1	4.1	25.7	36.1	23.2	44.0	43.6	32.7	25.7	80.9	190.0	52.1	55.5	21.1	68.2	53.4	31.1	28.3	42.1	39.2	26.3	42.0	29.1	21.2	22.9	41.1	11.6	9.4	29.8	67.0	41.9	64.4
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339661	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 206.5;liver: 73.2;lymphoid tissue: 85.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 151.9;dendritic cells: 164.6;Hepatocytes: 168.8;NK-cells: 313.1;Plasma cells: 137.2;T-cells: 183.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1948.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 1948.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 324.6;NB-4: 222.3;RPMI-8226: 257.6;U-266/84: 188.8;U-937: 179.0"					"Not detected"	"Not detected"			"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA		390000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	18.9	7.4	4.8	50.4	4.6	206.5	10.0	4.5	6.4	4.9	4.4	16.1	15.1	3.6	2.8	7.6	6.2	9.0	18.1	4.5	4.6	11.9	73.2	16.0	72.2	4.9	5.0	2.9	15.2	2.9	1.0	4.6	5.0	6.8	11.0	0.9	15.2	2.9	18.0	4.3	28.1	4.4	5.2	85.8	19.5	2.1	5.2	48.6	6.8	11.9	50.6	14.1	4.4	4.6	12.4	5.8	4.2	13.1	6.8	5.3	7.3	7.5	5.1	5.9	5.2	5.3	8.1	0.2	24.9	6.2	0.1	5.4	0.2	5.5	2.0	106.2	3.7	23.8	5.4	22.6	3.4	96.7	102.1	4.8	4.4	7.0	2.6	6.4	2.9	57.1	13.0	324.6	6.9	24.0	13.9	222.3	3.2	31.7	38.3	11.1	2.7	257.6	6.2	11.2	1.3	5.6	6.5	20.4	17.3	1.9	17.7	23.9	4.6	28.0	3.0	31.2	7.6	20.7	188.8	37.3	20.2	179.0	22.1	193.6	395.4	872.4	362.7	287.8	436.2	280.1	343.0	331.7	327.5	271.7	301.5	283.9	1948.5	380.1	417.4	52.9	436.3	614.5	4.8	4.6	4.5	6.4	4.5	4.6	4.9	5.0	5.0	5.2	5.2	4.6	22.6	3.2	29.7	0.7	151.9	8.2	6.5	7.0	10.2	0.3	23.1	20.6	0.1	21.5	9.8	5.5	0.0	12.0	164.6	49.1	62.6	16.9	7.7	10.7	9.4	19.2	5.4	37.4	0.2	35.4	24.7	10.2	16.8	9.9	30.4	5.5	31.1	168.8	24.0	1.7	0.1	33.2	4.1	70.0	50.4	10.0	6.2	52.9	55.2	1.0	127.7	6.4	313.1	0.0	0.1	23.2	43.8	4.1	137.2	12.3	79.9	54.4	9.0	1.2	0.0	7.3	10.7	5.7	0.7	8.3	8.4	4.7	183.3	5.4	36.4	10.2
ICE1	KIAA0947	ENSG00000164151	"Interactor of little elongation complex ELL subunit 1"	Q9Y2F5	5	5420664-5490220	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054452, HPA061934"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA054452: AB_2682492, HPA061934: AB_2684641"	"unprognostic (1.45e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.39e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.33e-1)"	8.7	6.9	8.1	9.1	8.8	13.7	10.2	11.3	8.4	8.7	4.4	9.0	7.2	11.6	9.0	7.6	8.2	7.1	8.1	10.2	7.0	10.0	7.1	8.1	11.5	6.2	5.7	13.9	9.2	14.1	7.5	12.7	6.4	7.8	7.8	12.8	7.5	8.8	16.5	8.7	7.5	10.3	4.5	10.0	7.7	7.5	7.1	14.5	10.2	15.5	11.3	9.5	6.6	8.1	17.9	22.1	24.8	23.9	23.6	23.1	32.0	15.1	18.0	17.8	19.5	17.1	12.9	24.1	20.6	21.8	35.1	16.5	34.4	17.7	29.8	33.4	17.5	19.5	68.9	12.5	14.3	44.5	15.4	18.5	18.6	21.3	32.8	17.7	22.3	18.0	28.1	19.5	18.8	15.6	32.6	15.9	21.0	11.4	18.6	37.7	22.6	16.3	15.0	19.9	16.0	16.6	52.5	16.9	20.2	23.8	14.7	13.9	25.4	23.0	29.4	29.9	23.9	21.1	26.9	39.6	19.3	32.9	19.9	0.4	0.5	1.1	0.9	0.7	1.1	0.9	0.8	0.9	0.5	0.8	0.7	0.9	0.1	1.1	0.4	1.1	1.1	0.3	8.1	8.8	11.3	8.4	10.2	7.0	6.2	5.7	6.4	4.5	7.1	8.1	29.8	22.4	29.5	42.1	30.3	0.0	17.7	0.0	26.2	40.2	20.1	26.3	33.0	14.3	14.2	16.5	31.3	35.6	35.1	10.8	25.4	22.6	5.8	19.5	37.4	27.5	9.0	23.5	68.2	22.7	22.4	25.0	19.9	25.7	11.4	28.6	15.4	13.8	15.7	45.4	57.3	11.6	0.0	13.8	0.0	5.2	22.4	19.9	0.0	36.5	26.1	24.6	17.5	39.7	62.1	23.0	6.4	22.2	37.5	24.1	11.1	14.8	6.6	34.7	6.6	50.5	27.8	51.6	47.0	25.9	0.0	10.9	33.9	36.4	11.4	16.9
ICE2	"BRCC1, FLJ11896, NARG2"	ENSG00000128915	"Interactor of little elongation complex ELL subunit 2"	Q659A1	15	60419609-60479160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040058			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA040058: AB_10795686"	"unprognostic (3.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.71e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.74e-2)"	5.5	5.5	3.0	6.2	4.0	5.5	8.4	4.5	3.2	5.0	5.8	4.8	4.4	8.0	5.5	6.6	6.4	6.5	5.3	2.6	3.2	6.5	7.0	4.9	9.1	3.9	3.3	9.9	6.3	34.6	4.2	7.9	4.2	6.6	7.1	4.8	6.0	5.4	4.4	5.0	5.4	6.4	3.4	7.7	5.3	6.8	3.2	12.7	9.3	5.1	9.8	6.1	3.6	6.7	14.7	25.5	21.1	20.3	15.6	16.9	11.0	8.5	13.1	13.3	14.4	20.0	10.6	25.5	18.3	9.2	25.2	27.2	28.3	11.4	18.3	30.9	12.6	25.8	17.4	11.8	8.4	28.8	17.6	8.5	13.6	11.0	19.7	17.7	22.2	24.9	39.9	23.3	16.7	6.3	22.9	7.6	26.3	26.8	17.1	27.1	16.7	22.4	10.7	18.0	23.8	22.8	12.0	12.2	15.1	24.8	19.7	14.6	10.5	18.4	16.0	15.8	26.5	11.0	31.6	37.7	12.1	32.4	17.4	4.0	4.5	5.3	5.7	6.3	9.7	7.6	7.0	7.6	5.9	10.5	9.3	9.1	0.7	4.2	5.8	4.9	8.1	6.0	3.0	4.0	4.5	3.2	2.6	3.2	3.9	3.3	4.2	3.4	3.2	6.7	32.5	19.2	19.6	34.6	30.6	0.0	20.4	0.0	16.5	31.3	24.4	27.7	20.2	15.7	17.3	20.2	39.6	22.7	32.4	8.8	21.5	12.2	15.5	25.6	27.5	25.1	19.2	28.0	39.9	10.4	14.9	21.1	25.0	21.8	29.8	70.6	29.6	20.6	14.0	30.3	42.6	16.1	0.0	16.8	0.0	17.4	25.4	21.1	0.0	49.6	25.3	19.6	25.7	49.3	83.6	14.6	13.7	17.7	15.9	23.0	11.6	18.1	19.7	33.3	0.0	31.4	17.5	22.1	34.8	21.3	0.0	14.6	31.3	39.3	19.4	19.2
ID1	"bHLHb24, dJ857M17.1.2"	ENSG00000125968	"Inhibitor of DNA binding 1, HLH protein"	P41134	20	31605283-31606515	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1667.3;Basal respiratory cells: 1443.4;Hepatic stellate cells: 2131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 509.6;HaCaT: 500.2;Hep G2: 425.3;PC-3: 515.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025915, HPA051456, HPA058518"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740"	"unprognostic (3.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-3)"	242.2	88.5	53.0	20.2	43.1	9.0	141.3	50.1	57.1	125.7	60.9	136.7	78.4	116.0	4.7	340.4	146.3	35.0	291.9	45.3	56.8	218.1	154.1	204.7	14.0	69.3	56.0	66.8	42.4	8.1	167.8	45.7	62.3	202.5	26.4	5.1	58.5	149.6	53.8	129.6	154.3	12.2	53.3	79.7	162.5	16.4	79.1	5.9	266.8	37.8	6.2	351.1	206.9	47.1	76.1	245.3	2.7	49.3	31.2	14.1	187.6	314.1	12.6	56.9	6.2	130.5	111.4	0.6	509.6	84.3	67.2	500.2	40.1	17.9	8.6	6.2	25.6	41.5	229.2	425.3	42.3	0.9	2.2	57.4	69.7	0.3	4.3	93.5	35.0	27.6	94.0	2.3	110.4	99.8	11.4	1.8	172.7	336.5	515.3	0.9	200.8	4.2	11.1	206.1	93.5	87.4	261.3	91.9	2.4	128.8	57.0	7.6	188.5	151.3	300.0	49.0	216.1	5.6	6.3	5.2	176.2	39.5	21.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	0.1	53.0	43.1	50.1	57.1	45.3	56.8	69.3	56.0	62.3	53.3	79.1	47.1	1667.3	237.2	171.7	88.2	25.1	102.3	992.2	1443.4	406.3	2.7	98.6	114.3	35.1	112.9	685.1	228.1	4.2	129.9	46.3	594.3	37.2	584.1	5.7	794.1	450.1	907.7	572.7	49.9	0.6	535.5	493.7	195.3	675.3	707.6	22.2	8.9	2131.4	109.1	25.6	0.0	0.5	557.4	321.4	72.2	52.4	8.7	28.6	38.9	90.7	92.8	8.2	85.0	1.0	4.0	0.3	257.4	924.9	0.4	26.7	519.7	579.8	7.1	168.1	8.3	13.1	229.7	206.1	3.2	53.7	455.8	87.9	89.1	39.8	15.9	389.1	591.6
ID2	"bHLHb26, GIG8"	ENSG00000115738	"Inhibitor of DNA binding 2"	Q02363	2	8678845-8684461	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1209.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 2393.2;monocytes: 1987.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1038.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 731.4;HEK 293: 459.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027612			Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nuclear bodies"	Centrosome	"HPA027612: AB_10599729"	"unprognostic (2.53e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.39e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.92e-3)"	160.8	175.9	86.6	73.9	88.5	390.3	82.6	83.8	118.2	97.4	68.5	149.9	99.1	69.7	21.0	35.3	108.3	150.8	177.4	89.6	86.8	128.2	562.5	108.1	92.6	80.2	82.9	213.1	60.1	1209.7	65.7	70.3	85.2	125.1	124.7	69.7	114.3	142.4	18.9	69.6	99.4	85.3	81.4	107.4	66.7	13.8	90.1	73.8	223.5	41.2	47.4	110.2	76.2	95.8	2.0	132.4	56.0	68.6	86.8	13.9	208.5	156.6	18.3	68.4	29.1	266.0	7.3	4.1	175.1	262.5	16.9	115.9	36.0	1.0	20.7	731.4	459.5	101.3	81.7	333.9	24.8	76.5	266.3	23.4	3.1	30.5	1.9	19.2	1.4	6.7	6.2	113.9	109.1	45.3	7.8	9.0	102.4	338.5	102.9	9.7	38.4	75.6	71.3	60.5	103.5	146.6	8.4	117.8	12.1	142.0	19.3	44.9	27.5	83.9	14.5	126.5	9.4	8.9	7.9	88.7	106.6	230.2	46.5	110.3	76.0	1038.0	356.7	221.7	214.2	3.6	108.1	251.9	223.8	1.6	133.7	262.1	96.6	880.8	248.9	10.3	9.2	200.1	86.6	88.5	83.8	118.2	89.6	86.8	80.2	82.9	85.2	81.4	90.1	95.8	429.9	141.1	237.9	316.7	41.4	131.3	143.0	494.8	138.9	9.8	231.2	218.4	179.5	316.0	211.2	101.2	16.7	260.3	604.5	337.7	555.7	471.0	12.0	601.1	344.6	281.1	425.9	59.8	23.5	160.3	142.4	276.0	189.1	647.2	973.6	17.1	487.6	554.7	700.3	6.7	13.8	548.0	494.4	415.8	2393.2	21.7	124.2	528.4	282.8	15.9	1987.9	519.9	1070.1	26.7	3.2	69.6	301.9	32.7	86.0	130.1	231.3	264.1	66.7	27.4	19.7	166.6	185.6	2.1	39.9	97.6	104.6	666.0	690.0	16.7	323.1	51.3
ID3	"bHLHb25, HEIR-1"	ENSG00000117318	"Inhibitor of DNA binding 3, HLH protein"	Q02535	1	23557926-23559501	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Myogenesis, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1710.3;Basal respiratory cells: 1091.1;Hepatic stellate cells: 1508.2;Ionocytes: 1210.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 318.8;naive B-cell: 306.1"	"Group enriched"	"Detected in many"	39	"B-cells: 318.8;T-cells: 177.0"	"Cell line enhanced"	"Detected in many"		"U-698: 598.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021353, HPA024677"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB021353: , HPA024677: AB_2671647"	"unprognostic (6.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (5.58e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.37e-3)"	"unprognostic (8.36e-2)"	163.4	49.5	42.5	22.7	37.4	6.9	114.1	38.6	51.6	81.6	39.6	89.2	29.8	84.2	15.5	42.9	134.1	39.1	177.1	39.2	70.3	93.2	31.6	99.6	26.3	59.3	52.2	106.1	41.0	8.3	120.4	51.0	49.5	110.3	22.3	10.1	39.8	108.1	41.3	62.9	76.3	20.9	48.2	41.9	89.0	6.9	53.7	34.8	195.9	52.1	13.3	131.6	90.3	42.9	24.1	152.6	57.2	199.1	27.2	2.8	53.0	154.2	16.8	105.0	14.5	8.9	1.2	150.2	168.2	80.3	21.7	216.1	77.7	25.1	12.3	1.2	68.8	2.4	227.5	89.6	77.9	0.2	0.4	80.1	141.9	2.8	1.5	104.0	91.7	67.1	0.9	2.0	107.8	59.9	21.0	0.6	41.9	140.0	37.6	189.5	82.1	5.6	1.3	66.3	78.3	55.0	148.4	155.8	12.7	49.9	38.1	5.2	162.3	151.5	72.4	69.4	92.2	47.4	45.9	598.1	34.4	1.8	79.0	0.6	1.3	0.3	3.8	1.8	1.3	318.8	69.8	13.9	5.0	306.1	113.3	45.6	3.6	0.7	2.1	6.2	177.0	36.9	42.5	37.4	38.6	51.6	39.2	70.3	59.3	52.2	49.5	48.2	53.7	42.9	1710.3	115.4	62.6	77.7	211.6	205.2	340.3	1091.1	583.4	4.1	128.3	187.3	35.8	20.0	337.1	209.7	10.4	193.4	27.8	384.8	23.5	216.6	1.9	555.2	270.3	988.8	432.3	41.0	0.1	441.5	931.4	496.5	384.3	562.4	15.2	394.7	1508.2	7.0	70.6	5.0	0.2	560.1	1210.5	71.7	254.9	3.7	41.0	91.1	249.1	62.8	21.0	378.5	1.0	0.5	3.1	88.4	388.8	0.7	67.1	168.4	223.1	7.9	110.6	17.7	519.4	266.4	780.2	0.9	2.8	577.6	189.5	279.2	86.7	19.5	323.3	116.5
ID4	bHLHb27	ENSG00000172201	"Inhibitor of DNA binding 4, HLH protein"	P47928	6	19837370-19842197	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 274.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 246.6;Endometrial ciliated cells: 438.4;Endometrial stromal cells: 362.6;Glandular and luminal cells: 335.3;Muller glia cells: 391.8;Smooth muscle cells: 368.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 111.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 45.0;AN3-CA: 50.7;EFO-21: 105.1;HEK 293: 66.0;SCLC-21H: 117.0;SuSa: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075639			Supported	Nucleoplasm		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA075639: "	"unprognostic (3.25e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.57e-3)"	74.6	5.0	50.1	7.5	47.6	0.2	41.7	33.6	55.4	41.0	22.8	9.8	7.2	30.0	9.4	21.7	70.3	10.2	75.7	48.0	59.6	30.8	4.4	27.8	5.0	42.8	60.8	48.4	19.1	2.5	36.4	22.2	42.2	29.7	6.7	19.4	27.1	44.0	3.6	107.8	11.9	21.0	43.6	20.2	19.8	23.0	58.5	2.0	274.7	3.1	2.1	31.4	33.1	40.2	0.0	0.6	45.0	50.7	1.2	0.1	0.1	5.8	0.1	0.4	0.0	0.0	0.0	0.0	105.1	14.1	0.2	20.3	0.0	0.0	0.4	0.0	66.0	0.0	0.0	0.5	0.3	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	8.1	6.3	0.0	0.0	0.0	0.2	7.6	14.2	117.0	1.5	0.0	1.8	7.2	37.6	3.2	0.0	0.0	0.2	5.6	0.1	1.6	0.0	0.1	1.1	1.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.1	47.6	33.6	55.4	48.0	59.6	42.8	60.8	42.2	43.6	58.5	40.2	31.8	96.1	53.0	229.9	1.9	83.1	190.8	16.7	232.8	11.2	143.8	246.6	42.5	7.2	19.6	68.0	2.1	9.9	2.9	15.6	50.9	18.0	2.1	438.4	362.6	19.9	91.6	0.0	1.8	3.3	9.5	83.9	118.3	335.3	0.0	17.6	23.9	0.0	2.7	3.3	1.2	23.4	22.4	0.6	24.8	7.9	8.1	5.3	88.9	2.8	0.0	391.8	0.0	0.5	0.3	1.4	27.1	0.0	1.4	93.6	8.2	76.0	8.4	13.7	0.0	76.3	368.8	1.2	44.9	119.6	78.6	5.9	6.1	0.7	7.8	42.4
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928790	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.7;placenta: 110.9"	"Cell type enriched"	"Detected in many"	11	"monocytes: 2612.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	14	"eosinophil: 465.0"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 465.0"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 61.8"	"Region enriched"	"Detected in many"	12	"basal ganglia: 34.1"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	9.8	0.7	0.6	40.5	0.4	0.7	2.0	0.4	0.8	7.2	1.0	5.3	10.3	10.2	1.2	1.3	2.6	6.2	1.8	0.4	0.6	1.7	2.4	25.9	58.7	0.7	0.3	1.2	1.2	0.2	0.1	110.9	0.5	2.0	8.2	1.3	1.9	3.0	8.1	1.3	8.4	2.4	0.4	23.0	5.8	1.1	0.8	31.2	4.0	0.6	31.5	9.1	0.5	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	7.6	4.8	0.3	0.8	0.0	61.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	9.1	0.2	0.2	0.0	0.3	0.0	32.5	1.3	465.0	0.1	1.4	0.1	0.2	0.1	0.0	26.4	0.3	0.1	0.2	4.9	0.1	0.1	0.3	0.1	1.2	0.6	0.4	0.4	0.8	0.4	0.6	0.7	0.3	0.5	0.4	0.8	0.6	24.9	0.0	0.5	0.7	4.4	0.4	0.2	18.3	0.0	0.0	0.5	0.1	0.3	0.0	76.0	0.0	0.0	0.0	0.3	8.3	0.0	4.4	3.7	70.1	23.0	6.9	0.0	0.0	0.2	8.1	0.0	0.3	0.0	223.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	2.0	3.7	28.1	1.8	0.0	13.6	0.0	0.0	2612.3	3.0	0.0	0.0	0.1	0.4	0.0	0.4	2.4	0.5	0.0	0.0	33.3	0.2	0.0	1.2	8.4	0.0	0.1	0.1	0.6	0.0	1.3	0.0	1.3	2.0
IER2	ETR101	ENSG00000160888	"Immediate early response 2"	Q9BTL4	19	13150411-13154911	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 255.5;U-266/84: 338.3"	"Low region specificity"	"Detected in all"							"HPA055387, HPA060574"			Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055387: AB_2682802, HPA060574: AB_2684324"	"unprognostic (3.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.01e-1)"	193.3	74.8	26.8	44.2	20.3	239.8	103.8	50.0	28.5	53.8	20.7	115.7	39.6	65.1	7.3	128.6	298.3	36.8	90.7	20.0	23.3	117.8	118.5	136.4	47.3	30.0	27.1	107.5	119.3	31.0	87.8	33.9	30.3	83.8	29.9	16.7	104.8	27.9	26.4	276.3	78.3	45.4	26.4	95.4	139.7	13.7	28.9	45.2	107.7	49.5	20.8	90.7	78.4	25.7	62.4	36.3	28.2	43.0	18.3	24.5	62.2	47.4	25.6	32.0	18.8	31.4	36.9	36.7	46.7	34.5	53.8	41.4	13.1	27.4	15.9	22.2	24.6	48.2	67.9	26.5	22.4	61.2	51.9	12.7	66.3	34.5	21.4	38.9	37.9	37.4	123.6	48.1	12.5	102.4	37.1	255.5	53.5	66.9	155.8	71.8	28.4	45.0	29.5	36.2	34.7	49.7	53.0	160.0	114.5	22.1	19.1	36.6	68.8	67.0	46.2	56.1	138.6	139.9	338.3	37.9	36.3	120.4	53.0	363.9	167.4	273.7	249.7	191.3	214.5	139.9	175.1	202.5	100.5	155.3	114.7	146.8	833.3	215.0	183.7	45.1	178.2	275.5	26.8	20.3	50.0	28.5	20.0	23.3	30.0	27.1	30.3	26.4	28.9	25.7	1678.3	176.3	492.4	31.3	636.9	319.0	1201.7	587.9	659.0	82.2	977.1	1651.1	61.3	571.9	330.0	95.6	35.5	539.9	974.9	807.5	52.8	873.6	14.0	714.9	1302.8	718.1	977.5	75.6	6.7	380.3	541.6	721.1	1071.4	1261.4	489.2	279.8	427.3	83.5	593.9	15.2	7.5	973.4	553.4	316.8	366.4	11.9	137.9	714.3	236.5	48.7	144.7	453.1	185.3	7.5	6.7	494.4	691.5	38.7	484.3	779.5	680.9	44.5	221.7	141.9	644.2	591.4	730.3	6.6	10.1	720.1	441.6	915.6	671.4	313.4	652.7	418.5
IER5		ENSG00000162783	"Immediate early response 5"	Q5VY09	1	181088700-181092900	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 282.8;Macrophages: 276.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029894	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA029894: AB_10601433"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (2.42e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.81e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	12.8	6.3	9.5	11.2	10.2	49.5	8.4	10.1	19.3	10.2	11.2	10.6	5.6	14.8	2.5	26.5	15.2	6.1	27.8	10.7	9.7	5.8	6.7	23.2	9.4	10.0	9.2	3.3	5.2	1.8	5.2	11.0	9.1	5.6	5.6	1.1	6.8	3.7	33.4	22.1	13.3	8.3	9.8	32.7	9.0	5.4	10.3	8.7	5.0	16.5	10.8	10.9	13.3	12.8	25.3	21.8	11.7	10.3	15.9	21.9	31.3	43.6	45.9	24.1	21.4	6.1	13.8	8.3	18.9	16.9	16.9	45.5	3.8	29.7	15.6	47.6	18.7	7.4	11.5	4.1	24.9	8.6	23.1	15.7	29.5	28.0	18.7	18.3	16.6	6.9	31.0	36.5	43.3	11.5	8.6	13.8	12.2	9.5	10.8	9.8	20.4	31.6	8.8	13.7	16.9	18.2	22.1	21.3	51.7	14.2	17.0	7.5	25.3	17.3	30.5	19.9	26.8	23.9	9.1	6.5	13.5	9.0	4.9	3.6	1.4	2.7	1.0	5.5	1.2	4.0	0.8	1.4	1.1	3.0	0.1	0.5	1.2	1.1	5.3	0.2	1.3	0.7	9.5	10.2	10.1	19.3	10.7	9.7	10.0	9.2	9.1	9.8	10.3	12.8	156.4	22.4	66.7	3.6	124.8	69.8	163.7	24.2	53.5	24.2	198.1	197.7	110.9	21.5	25.9	9.2	37.5	10.9	131.1	94.2	0.0	10.6	5.1	66.7	83.0	87.2	56.4	32.0	8.7	6.9	56.4	74.7	50.0	67.3	36.1	35.0	41.4	5.6	50.9	8.4	2.8	110.6	6.1	149.5	282.8	11.9	12.2	276.4	46.2	11.2	56.1	17.8	17.5	0.5	1.3	21.9	54.8	9.4	61.5	94.9	35.0	1.5	27.4	21.3	0.0	177.9	102.8	3.6	5.4	115.9	59.7	34.2	151.3	15.5	62.0	146.8
IER5L	bA247A12.2	ENSG00000188483	"Immediate early response 5 like"	Q5T953	9	129175552-129178261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 177.5;Breast myoepithelial cells: 110.2;dendritic cells: 121.9;Endometrial stromal cells: 218.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 24.7;SiHa: 34.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021327			Approved	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021327: AB_2121674"	"unprognostic (2.46e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.90e-3)"	"unprognostic (8.49e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.48e-6)"	"unprognostic (6.91e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.29e-1)"	21.4	10.6	3.7	1.2	4.7	0.4	10.7	3.5	7.3	39.4	2.1	9.4	0.8	13.9	2.1	9.4	16.6	1.9	21.6	3.3	4.1	27.2	14.6	13.1	0.7	6.2	4.1	18.9	4.8	0.6	10.7	1.4	4.8	12.3	0.4	0.5	7.5	3.3	3.5	7.5	5.7	1.0	3.7	6.3	9.1	4.7	4.6	0.3	12.4	0.9	0.3	16.2	19.5	4.8	8.6	24.7	6.9	13.3	5.0	7.9	20.9	12.6	1.1	1.9	1.9	1.3	13.8	0.2	4.9	2.9	5.5	18.6	0.3	1.5	0.3	1.2	1.8	0.0	5.7	2.4	3.8	0.3	0.2	8.6	1.9	1.4	0.2	10.8	0.9	0.2	0.7	4.4	0.3	22.1	0.3	1.1	0.6	2.2	12.9	1.2	0.5	3.8	7.6	1.2	3.1	4.1	34.8	11.1	15.7	2.8	3.4	2.2	5.1	11.7	7.0	7.9	18.3	2.4	1.7	0.3	14.9	2.5	5.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	4.7	3.5	7.3	3.3	4.1	6.2	4.1	4.8	3.7	4.6	4.8	177.5	16.0	1.7	12.7	25.5	6.8	9.2	11.1	27.9	6.1	52.7	110.2	1.6	25.8	10.7	47.8	0.0	3.9	121.9	34.7	9.8	14.5	0.7	87.1	218.9	42.6	10.7	0.8	13.1	27.1	11.8	41.4	19.9	102.7	0.0	2.2	30.0	11.7	31.0	3.3	4.3	20.6	26.4	17.0	17.2	1.6	10.8	64.7	14.2	15.0	7.4	13.9	0.0	2.0	1.4	20.0	12.5	7.2	11.2	9.8	8.4	17.3	13.4	2.8	26.3	41.8	99.0	0.1	3.6	37.6	4.5	8.1	55.1	3.9	15.4	7.7
IFFO2		ENSG00000169991	"Intermediate filament family orphan 2"	Q5TF58	1	18904280-18956676	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 43.0;skin 1: 169.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 121.0;Basal prostatic cells: 83.0;Suprabasal keratinocytes: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	18	"basophil: 12.6"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 139.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015987, HPA064603"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA015987: AB_2121678, HPA064603: AB_2685296"	"unprognostic (1.43e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.27e-3)"	"unprognostic (3.24e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.36e-1)"	5.3	9.2	7.4	8.2	6.6	10.4	12.6	19.6	10.6	12.3	0.6	9.0	2.0	7.4	2.4	43.0	5.2	7.0	4.2	6.4	7.9	6.8	5.8	7.5	8.6	11.2	9.3	3.3	19.1	10.7	6.5	7.2	9.7	9.4	2.8	4.3	14.4	9.1	7.9	169.9	3.9	7.1	6.8	6.3	4.4	1.8	9.6	6.2	6.4	4.2	14.0	8.5	21.6	8.8	23.3	37.2	9.9	27.4	6.2	4.9	16.0	17.2	11.4	9.2	6.4	51.5	26.6	0.3	21.6	13.1	10.6	57.6	7.6	36.6	7.4	139.3	6.7	0.4	7.1	20.4	4.5	4.0	21.3	3.2	36.3	12.4	15.7	15.2	19.9	1.2	1.4	4.6	6.1	4.9	3.9	3.7	4.2	23.9	8.8	13.1	6.1	9.8	5.4	14.9	31.6	1.7	13.1	18.2	12.6	10.1	4.9	2.1	54.6	12.4	17.2	7.3	50.5	9.7	11.3	0.8	8.3	5.7	14.8	12.6	0.2	0.0	0.4	0.3	0.5	0.5	0.3	0.4	0.1	0.2	0.3	0.6	0.0	0.2	0.0	0.4	0.3	0.1	7.4	6.6	19.6	10.6	6.4	7.9	11.2	9.3	9.7	6.8	9.6	8.8	4.1	3.2	5.4	5.5	6.0	121.0	83.0	24.1	40.5	6.8	11.5	13.5	6.8	12.8	9.7	1.8	0.0	5.1	20.9	4.9	1.9	17.3	1.3	23.3	5.9	7.7	2.4	3.2	8.5	17.6	5.4	4.7	3.1	10.2	3.8	0.8	4.6	3.4	2.4	25.2	9.6	1.3	2.0	1.6	17.1	4.5	1.2	6.8	14.2	1.0	3.5	4.4	8.2	11.6	8.8	14.6	3.3	3.0	15.5	15.0	0.8	9.3	23.1	1.8	0.0	3.5	7.5	0.8	0.4	32.4	100.3	4.0	13.9	0.4	1.3	44.2
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA002134, CAB016293, HPA073514"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099, HPA073514: "	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	95.7	37.9	13.5	114.5	17.5	35.5	72.8	14.3	14.1	56.8	9.1	38.3	23.8	76.5	22.7	63.6	54.2	100.6	35.0	13.7	20.3	30.1	27.7	68.2	140.6	29.9	22.7	76.8	16.7	9.7	9.3	66.7	27.0	26.5	45.0	7.7	63.7	32.0	16.8	58.8	47.9	87.3	23.6	107.8	30.7	18.8	23.8	116.8	37.4	32.6	133.1	113.6	52.8	26.2	43.5	3.2	14.4	0.6	97.4	319.5	0.4	89.9	238.0	245.7	324.2	0.0	54.1	251.7	75.4	55.3	79.2	122.2	2.2	91.1	97.7	78.4	1.1	64.9	17.2	0.1	181.8	22.8	4.2	302.4	159.5	126.5	177.8	117.8	262.8	218.1	1.4	179.4	138.6	0.0	302.2	21.1	38.4	0.0	32.5	140.6	91.4	295.0	34.4	16.1	6.6	0.1	117.7	1.0	259.5	56.9	0.4	26.3	150.2	63.1	29.7	179.9	38.2	165.8	82.8	235.5	181.2	72.7	155.7	9.1	67.7	0.4	57.5	66.4	51.9	88.4	54.3	59.4	68.3	94.6	33.9	43.3	164.4	91.6	65.3	51.1	82.1	63.8	13.5	17.5	14.3	14.1	13.7	20.3	29.9	22.7	27.0	23.6	23.8	26.2	378.4	38.5	54.6	4.2	217.8	95.0	110.7	197.6	174.8	0.4	47.8	43.8	10.7	37.1	130.7	42.3	0.0	3.4	278.3	7.9	1.9	38.0	4.9	41.9	219.1	286.8	12.1	38.7	1.3	47.8	2.9	207.8	9.7	68.0	138.3	27.7	137.4	3.0	214.2	0.0	2.2	19.9	79.3	163.8	135.0	9.8	117.4	187.2	83.6	116.2	202.4	30.8	329.6	37.2	20.7	47.1	23.5	53.0	143.3	32.6	7.9	4.9	76.6	1.4	85.5	185.3	132.7	2.4	13.2	92.6	68.2	3.3	219.2	70.6	26.4	107.5
IFI35	IFP35	ENSG00000068079	"Interferon induced protein 35"	P80217	17	43006740-43014456	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 122.4;Paneth cells: 116.7;Proximal enterocytes: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 204.5;BJ hTERT+ SV40 Large T+ RasG12V: 299.2;GAMG: 108.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045946, HPA075580"	Approved		Supported	"Nucleoplasm,Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA		120000	"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA045946: AB_2679509, HPA075580: "	"prognostic favorable (1.41e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.49e-1)"	27.5	41.3	15.4	27.2	16.4	24.9	24.2	15.6	18.2	18.4	16.2	27.4	24.6	17.4	11.7	10.2	20.8	20.1	20.9	14.9	16.7	29.7	30.6	25.6	26.4	20.2	16.6	23.8	13.6	10.5	14.2	15.0	17.3	27.8	20.4	1.5	29.4	15.2	6.3	11.3	30.2	21.3	20.3	39.9	22.7	5.0	17.0	23.4	20.8	9.3	19.0	21.1	15.4	17.0	12.7	28.8	0.2	1.5	24.2	29.1	6.1	8.2	84.6	204.5	299.2	10.7	46.2	3.9	16.1	24.7	108.0	7.0	1.6	12.9	16.3	33.5	6.1	9.3	10.5	39.5	59.6	10.5	19.3	40.3	4.9	29.0	3.6	18.6	18.8	8.0	5.4	61.2	8.2	12.5	22.7	8.5	0.1	11.6	13.0	18.4	0.1	23.7	25.7	10.9	5.4	0.2	16.4	6.3	88.2	0.6	26.5	20.3	9.3	15.1	0.3	4.8	13.3	54.1	21.8	1.1	27.1	8.2	14.8	60.7	102.7	61.6	44.3	127.8	40.4	37.8	34.0	41.7	62.0	40.0	26.8	33.6	62.1	56.9	122.0	67.0	51.8	80.5	15.4	16.4	15.6	18.2	14.9	16.7	20.2	16.6	17.3	20.3	17.0	17.0	65.2	16.0	9.7	2.6	28.6	10.5	29.6	31.8	12.5	0.8	16.5	11.3	5.5	11.5	22.7	18.4	2.1	22.7	36.7	83.1	41.1	47.8	9.4	12.3	27.4	32.1	31.7	12.8	0.7	64.0	32.5	32.8	26.5	16.2	7.6	122.4	37.1	31.3	84.8	1.7	0.6	39.4	12.2	36.8	19.2	39.5	28.9	47.8	24.9	5.6	75.5	10.4	64.9	1.0	1.0	41.8	116.7	23.7	54.0	19.1	128.0	93.7	18.0	0.8	6.6	13.2	36.3	0.5	0.4	5.1	9.2	10.4	32.3	25.0	34.6	29.6
IFI44	"MTAP44, p44, TLDC5"	ENSG00000137965	"Interferon induced protein 44"	Q8TCB0	1	78649796-78664078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 100.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 54.6;Endothelial cells: 54.5;Microglial cells: 53.4;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 176.5;BJ hTERT+ SV40 Large T+ RasG12V: 216.2;GAMG: 177.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA027148, HPA043858"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA027148: AB_1851411, HPA043858: AB_2678702"	"unprognostic (1.20e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.90e-2)"	18.8	16.8	19.0	25.3	20.0	100.8	16.6	17.7	33.0	19.3	17.6	9.7	20.0	15.4	34.9	10.8	12.1	45.4	21.8	17.6	19.0	21.6	21.0	30.9	20.0	27.0	19.6	13.9	8.8	3.8	14.2	21.4	21.2	9.7	9.3	1.3	71.7	11.4	5.8	10.3	14.5	18.5	24.4	65.0	21.0	7.5	20.3	31.0	16.5	10.9	11.6	21.1	9.6	21.0	7.7	0.3	1.3	0.3	5.3	35.9	0.2	5.0	65.5	176.5	216.2	0.0	22.0	10.3	49.9	4.7	177.9	4.1	0.0	2.9	28.6	22.5	0.0	26.8	20.6	0.0	7.3	0.0	0.0	22.7	0.3	76.8	1.0	13.8	33.5	6.7	0.0	35.1	42.5	0.2	22.7	1.9	0.0	0.1	14.4	17.4	53.6	1.2	5.2	5.0	0.6	1.4	1.8	0.5	82.9	0.0	0.0	1.1	41.6	32.3	13.4	3.6	33.9	3.0	3.8	0.3	50.1	30.4	9.2	0.4	15.4	0.1	6.9	15.4	13.8	2.4	10.0	6.6	7.1	1.7	4.2	5.6	4.5	7.8	8.4	2.0	5.1	6.0	19.0	20.0	17.7	33.0	17.6	19.0	27.0	19.6	21.2	24.4	20.3	21.0	54.6	28.9	16.2	10.7	4.7	3.6	10.2	16.3	5.7	0.0	4.6	5.2	5.4	2.8	21.0	9.2	0.0	0.2	9.9	1.1	0.0	13.1	0.6	6.7	4.4	54.5	6.7	4.6	0.0	12.3	0.3	15.8	11.7	7.0	18.3	25.1	43.5	3.6	29.5	0.0	2.1	1.7	6.1	34.2	7.6	1.1	13.4	38.1	5.4	53.4	27.8	0.6	5.2	51.8	0.5	11.8	0.1	17.3	3.2	5.1	3.8	2.7	20.7	0.3	19.7	12.3	12.4	0.3	0.5	4.4	4.5	0.0	22.4	24.8	2.5	14.0
IFI44L	"C1orf29, GS3686"	ENSG00000137959	"Interferon induced protein 44 like"	Q53G44	1	78619902-78646145	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 80.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.7;Endothelial cells: 78.2;Macrophages: 55.4;Microglial cells: 97.4;Peritubular cells: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 95.0;BJ hTERT+ SV40 Large T+ RasG12V: 108.8;GAMG: 74.4;HSkMC: 58.9;SK-MEL-30: 53.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA053247, HPA060372"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA053247: AB_2682088, HPA060372: AB_2684267"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (2.95e-4)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.03e-2)"	14.3	6.4	11.3	6.3	13.7	41.8	7.0	10.5	16.2	5.7	7.9	5.3	4.6	7.5	5.3	3.2	9.1	32.4	10.7	10.0	15.3	6.7	8.3	12.7	10.5	34.5	16.4	10.6	3.7	2.5	3.4	16.3	21.8	3.0	4.1	0.9	80.5	5.3	3.7	2.1	3.9	12.0	35.3	43.9	5.9	7.1	13.9	31.9	7.3	14.2	4.6	12.5	2.0	17.5	0.2	0.0	3.5	0.0	1.9	29.0	0.0	0.4	24.1	95.0	108.8	0.0	1.5	14.4	11.8	0.5	74.4	0.0	0.0	0.1	1.8	0.5	0.0	0.1	9.0	0.1	3.5	0.3	0.3	58.9	0.2	9.1	2.2	25.8	0.9	0.2	0.0	2.3	3.2	0.0	1.0	0.3	0.0	0.0	6.9	0.3	0.2	0.0	5.4	0.6	0.0	0.0	20.5	0.0	53.7	0.1	0.0	0.4	0.4	1.1	1.5	2.5	2.5	3.3	0.8	0.1	17.5	0.2	0.2	0.1	9.3	0.2	1.4	11.1	4.5	6.6	4.8	3.5	2.5	2.7	2.5	1.8	3.7	10.3	6.6	5.0	1.4	3.6	11.3	13.7	10.5	16.2	10.0	15.3	34.5	16.4	21.8	35.3	13.9	17.5	105.7	0.0	7.4	9.1	14.6	4.0	3.1	4.0	1.2	0.0	3.4	5.2	4.4	2.8	7.9	7.3	0.0	0.1	8.0	1.1	0.0	4.0	0.7	5.4	3.1	78.2	0.0	1.3	0.0	8.3	0.2	14.9	2.0	5.8	2.5	39.5	31.1	0.3	23.9	0.0	0.1	0.0	0.0	20.1	7.0	3.7	23.6	55.4	3.6	97.4	23.0	1.2	6.2	0.5	0.4	2.1	0.0	48.2	1.9	2.0	0.4	1.1	12.4	0.3	6.6	7.4	11.1	1.1	0.5	0.6	2.0	0.3	12.6	24.6	0.1	7.2
IFITM2	"1-8D, DSPA2c"	ENSG00000185201	"Interferon induced transmembrane protein 2"	Q01629	11	303655-309397	"Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 920.0;NK-cells: 1350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 23410.9"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 23410.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 424.6;HHSteC: 547.7;HMC-1: 494.9;HSkMC: 710.9;NB-4: 603.3;U-937: 485.2"									"HPA004337, HPA044731"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		450000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Cell Junctions"	Nucleoplasm	"HPA004337: AB_1851427, HPA044731: "	"unprognostic (2.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.37e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	1086.2	307.0	90.3	258.0	90.2	177.0	681.0	89.6	116.6	785.6	101.4	358.6	40.9	702.8	52.1	237.2	903.8	97.4	619.6	92.0	97.9	703.1	1288.5	1069.9	99.9	94.4	89.4	650.1	211.1	112.0	200.6	145.3	94.9	406.1	41.8	27.0	228.9	102.5	195.9	236.7	305.6	200.4	92.8	1402.1	304.3	123.0	95.4	29.8	437.7	132.8	105.8	493.1	496.6	95.1	32.2	65.4	313.1	2.9	137.2	358.3	0.9	106.8	65.1	27.0	63.3	1.7	206.9	2.7	126.6	424.6	0.4	68.5	1.1	9.3	9.0	1.8	41.1	75.1	102.6	117.6	547.7	124.1	494.9	710.9	2.3	5.2	3.3	64.4	51.2	22.5	5.2	210.5	11.6	129.9	2.5	603.3	36.4	5.3	229.4	101.0	29.9	1.1	181.6	0.4	0.8	7.0	65.4	74.9	34.5	5.3	86.7	69.8	338.3	5.7	26.8	36.1	1.4	4.5	5.0	3.3	14.5	485.2	18.1	2706.4	537.4	3789.5	666.6	1421.9	480.8	846.9	590.1	639.5	612.5	799.2	511.7	510.3	23410.9	1225.0	2199.0	279.0	411.7	1376.6	90.3	90.2	89.6	116.6	92.0	97.9	94.4	89.4	94.9	92.8	95.4	95.1	920.0	307.7	540.0	5.9	301.1	104.4	251.1	161.4	215.1	0.3	59.7	66.5	51.8	154.4	209.2	248.3	0.0	8.3	814.7	22.5	487.2	433.0	7.8	67.1	468.6	828.4	9.6	100.7	0.0	256.7	16.9	515.8	30.5	78.5	530.5	68.8	752.1	684.1	223.4	0.0	0.0	39.4	24.4	372.8	255.9	31.5	507.6	645.9	209.9	12.2	177.3	80.5	1350.1	0.0	0.1	161.9	149.2	223.8	123.0	126.3	4.7	45.3	104.8	1.5	315.5	442.5	568.4	8.4	10.4	22.8	83.0	23.4	667.2	61.8	44.3	102.4
IFNGR2	"AF-1, IFNGT1"	ENSG00000159128	"Interferon gamma receptor 2"	P38484	21	33403413-33479348	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Prostatic glandular cells: 433.1;Urothelial cells: 602.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 661.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001535	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Golgi apparatus"		"HPA001535: AB_1078432"	"unprognostic (9.58e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (1.13e-10)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.15e-3)"	72.9	41.1	5.9	8.6	7.0	46.6	65.6	2.4	8.2	48.3	7.9	46.8	14.2	31.2	3.4	67.4	37.8	11.6	46.4	7.0	11.2	53.1	43.1	61.8	10.6	8.8	6.4	38.8	32.0	5.6	37.8	18.6	7.6	48.2	7.9	1.0	64.5	6.3	30.0	53.3	51.6	8.6	10.0	80.8	35.8	29.5	12.2	8.1	52.3	10.3	11.9	46.4	56.8	14.0	10.1	10.2	5.9	9.7	16.6	28.2	13.1	30.4	30.0	8.9	13.8	11.3	7.7	15.6	19.8	23.8	24.2	8.6	10.9	25.6	3.1	76.3	44.9	6.0	5.0	12.2	11.0	19.5	17.7	21.4	17.0	14.7	16.6	15.9	20.1	9.9	33.4	11.9	10.2	4.4	5.0	23.2	18.1	15.8	48.0	20.2	14.1	19.6	8.5	10.8	7.9	15.5	19.3	1.9	38.4	1.5	7.1	17.7	30.8	10.1	22.0	8.9	8.8	24.6	28.2	25.4	8.5	23.3	44.7	221.7	283.8	181.7	0.9	281.2	1.2	145.6	16.4	1.7	104.0	158.2	37.7	16.3	661.8	3.5	314.8	31.9	19.2	198.5	5.9	7.0	2.4	8.2	7.0	11.2	8.8	6.4	7.6	10.0	12.2	14.0	72.2	41.7	20.5	9.1	101.4	72.0	225.1	164.8	147.4	9.0	69.3	39.2	18.4	38.6	58.2	27.6	8.4	33.6	11.2	185.3	27.4	117.8	44.6	32.1	51.0	55.1	51.6	17.7	18.7	55.7	86.1	66.8	62.7	50.4	60.3	52.1	40.0	29.6	167.6	15.2	18.9	56.2	57.0	154.5	146.7	60.8	42.0	190.8	56.9	45.0	246.6	8.7	6.2	15.6	5.0	138.6	150.3	32.7	67.9	433.1	151.9	50.1	25.4	8.4	13.1	61.3	33.7	13.4	2.8	90.5	70.0	17.4	16.9	3.4	41.3	602.7
IFRD2	"IFNRP, SKMc15, SM15"	ENSG00000214706	"Interferon related developmental regulator 2"	Q12894	3	50287732-50292918	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 139.9;Prostatic glandular cells: 153.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068560	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA068560: AB_2686005"	"prognostic favorable (7.22e-4)"	"unprognostic (5.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.78e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	39.4	44.9	16.7	13.9	17.8	15.6	33.9	17.4	20.9	24.4	19.2	33.2	20.1	26.8	11.8	44.3	28.2	10.9	69.4	16.2	16.6	39.3	97.0	30.7	14.1	18.0	17.7	23.1	87.3	17.8	22.1	9.3	17.2	45.1	15.0	3.6	33.7	16.7	109.6	25.4	28.1	14.9	17.9	28.3	67.9	17.4	18.0	8.4	31.9	44.6	12.5	36.1	23.6	18.0	70.1	70.5	19.1	60.3	19.2	22.0	44.0	52.4	28.2	62.8	44.3	58.3	69.5	47.3	37.7	36.3	53.9	40.0	40.2	83.8	32.3	45.4	80.7	68.4	93.5	69.5	37.9	70.1	41.4	20.4	70.6	65.7	81.9	20.7	54.0	41.8	44.2	37.9	37.6	65.1	46.5	82.0	48.1	86.1	135.4	29.8	27.7	108.1	38.0	41.3	33.7	32.5	33.2	90.4	34.4	18.3	43.1	66.4	39.5	52.2	65.6	91.3	107.9	26.5	48.9	41.8	41.4	91.1	77.9	11.7	24.1	3.6	33.1	34.4	47.5	32.4	35.0	32.3	35.2	34.0	36.7	33.3	2.3	39.0	19.7	35.0	30.9	30.5	16.7	17.8	17.4	20.9	16.2	16.6	18.0	17.7	17.2	17.9	18.0	18.0	36.9	19.2	24.6	5.9	26.8	67.3	71.7	51.7	31.9	17.3	48.5	37.1	1.7	32.9	36.4	20.2	20.9	35.3	23.8	22.1	29.4	68.8	67.2	11.3	27.8	30.3	15.6	93.6	7.1	89.6	49.5	24.8	62.7	13.1	7.6	28.6	13.9	50.7	31.2	18.5	6.7	29.6	34.6	13.7	28.4	139.9	13.7	15.2	35.6	2.8	16.5	13.3	25.7	4.5	7.3	68.2	26.8	14.3	31.9	153.3	31.3	58.6	10.4	12.0	0.0	30.8	34.9	21.9	19.1	43.1	68.6	30.4	19.2	40.3	56.3	76.8
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;parathyroid gland: 5.1;placenta: 6.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 33.3;Cytotrophoblasts: 104.8;Early spermatids: 37.6;Late spermatids: 98.6;Syncytiotrophoblasts: 41.3"	"Group enriched"	"Detected in many"	5	"glioma: 2.2;testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 105.8;CACO-2: 27.4;Hep G2: 87.8;SuSa: 41.9"	"Low region specificity"	"Detected in many"							HPA015713			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.0	0.2	2.3	0.0	2.0	0.0	0.8	4.3	3.2	1.0	0.0	0.4	0.0	0.7	0.1	0.0	0.6	0.1	0.1	2.6	1.9	0.2	0.0	0.0	0.0	2.4	2.7	0.8	0.0	5.1	1.9	6.0	2.4	0.1	0.0	1.0	0.0	0.1	0.1	0.1	0.1	0.2	1.6	0.0	0.2	2.8	3.0	1.4	0.9	0.0	0.0	0.1	0.4	1.9	0.0	0.0	105.8	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	27.4	0.2	0.0	0.3	0.0	0.0	0.0	7.2	0.0	0.0	0.0	1.0	0.0	0.2	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	16.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	2.2	1.5	0.1	0.1	0.0	41.9	3.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.0	4.3	3.2	2.6	1.9	2.4	2.7	2.4	1.6	3.0	1.9	0.1	0.0	0.0	15.3	0.0	0.0	0.2	0.0	0.0	4.1	2.2	1.0	0.6	0.0	0.0	1.8	33.3	104.8	0.0	0.4	0.0	0.0	37.6	0.4	4.8	1.0	0.0	0.0	2.8	0.0	4.3	3.0	0.0	0.6	0.0	0.1	0.0	0.0	7.2	0.0	7.0	0.0	0.0	0.0	0.0	98.6	0.6	0.1	0.0	1.0	0.0	3.7	0.0	16.1	8.9	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.7	0.4	1.3	11.0	0.0	0.0	41.3	0.1	0.1	0.2	0.0
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381484-65422947	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;skeletal muscle: 10.6;tongue: 14.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 18.6;Cone photoreceptor cells: 31.3;Fibroblasts: 14.7;Leydig cells: 34.8;Microglial cells: 14.0;Oligodendrocyte precursor cells: 17.6;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.4;AF22: 9.4;CAPAN-2: 8.1;EFO-21: 4.5;HSkMC: 5.2;NTERA-2: 7.2;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA		64000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	0.9	2.5	5.6	2.4	6.9	0.0	0.5	5.8	2.5	3.4	0.0	0.8	0.5	1.4	4.2	1.6	1.7	4.2	0.9	2.9	7.2	0.1	0.0	0.2	0.6	11.2	9.4	8.5	0.1	0.3	0.9	5.6	6.8	0.4	0.6	0.8	0.5	0.4	10.6	0.8	0.8	1.0	6.9	0.2	1.1	0.6	11.3	0.7	1.9	14.0	0.6	2.1	2.0	4.5	0.0	4.4	9.4	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.5	8.1	0.0	4.5	0.3	0.0	0.0	2.3	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.3	0.0	0.0	5.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.8	7.2	0.0	0.0	0.0	2.3	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	6.9	5.8	2.5	2.9	7.2	11.2	9.4	6.8	6.9	11.3	4.5	0.2	0.0	0.0	18.6	0.0	2.3	0.0	0.0	0.0	7.7	0.2	0.5	2.2	0.0	0.0	3.7	31.3	0.4	0.1	0.0	0.0	0.4	0.4	0.0	2.1	0.3	0.0	0.0	0.9	0.0	0.6	14.7	1.1	0.0	0.0	8.8	0.0	0.0	0.7	0.0	6.3	0.0	0.0	0.0	2.5	1.4	34.8	0.3	5.4	14.0	0.0	1.0	1.0	17.6	1.0	0.3	0.0	4.1	0.1	0.1	0.0	0.7	0.0	12.2	6.6	29.8	1.0	0.8	2.6	0.1	1.1	0.8	0.3	7.0	0.0	0.0
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2141238	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 2749.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1104.3;Extravillous trophoblasts: 3196.3;Leydig cells: 3007.5;Peritubular cells: 643.9;Syncytiotrophoblasts: 1612.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 86.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 862.0;Hep G2: 600.5;LHCN-M2: 333.7;RH-30: 408.5;SH-SY5Y: 495.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	609000000	1200000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: AB_2667860, HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	99.7	58.4	5.5	9.2	32.6	0.9	41.8	12.6	86.0	75.5	236.8	22.3	4.7	75.2	52.7	18.8	128.4	34.8	91.7	6.5	7.1	31.8	305.9	9.8	3.4	20.2	6.6	117.8	37.5	5.2	25.4	2749.2	10.1	14.5	4.8	0.5	11.6	15.2	82.1	8.4	10.9	14.7	13.0	14.4	11.9	23.7	10.9	3.4	12.4	114.0	4.7	24.2	23.6	9.0	0.0	2.8	0.3	0.6	0.2	0.3	1.8	112.8	1.3	3.6	0.4	862.0	0.4	0.1	8.4	0.0	2.1	0.1	0.9	7.0	7.9	0.1	0.5	0.2	0.2	600.5	143.4	0.7	0.0	174.7	0.5	0.7	0.2	0.1	1.4	0.0	0.3	0.0	333.7	2.2	0.1	0.8	1.2	0.2	1.5	0.1	408.5	0.9	0.0	0.9	32.7	495.6	0.7	0.1	0.0	83.0	4.2	0.0	0.4	0.2	20.1	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	32.6	12.6	86.0	6.5	7.1	20.2	6.6	10.1	13.0	10.9	9.0	40.6	3.2	3.1	0.0	2.6	5.4	0.5	0.5	0.6	0.4	0.0	0.0	6.5	8.6	0.9	3.7	0.0	1104.3	0.0	0.0	0.0	0.0	13.1	0.0	0.0	498.4	0.0	16.0	0.0	0.0	3196.3	334.2	0.0	0.0	0.0	0.0	171.4	494.9	218.2	0.0	0.0	0.0	0.0	11.6	5.5	91.1	3007.5	3.4	3.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	643.9	0.0	1.1	0.0	0.0	0.9	0.5	65.7	33.5	37.5	3.8	6.3	1.5	4.1	1612.9	1.8	0.0	0.0	0.4
IGFBP3	"BP-53, IBP3"	ENSG00000146674	"Insulin like growth factor binding protein 3"	P17936	7	45912245-45921874	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 1864.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 457.7;Basal respiratory cells: 777.7;Extravillous trophoblasts: 2064.1;Fibroblasts: 463.4;Urothelial cells: 809.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 377.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 54.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 54.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 8578.6;U-2197: 3469.4;U-87 MG: 1774.2"	"Low region specificity"	"Detected in all"							CAB010360			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	3250000000	3600000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"CAB010360: AB_2233528"	"unprognostic (4.46e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (8.14e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (5.07e-7)"	"unprognostic (2.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.63e-1)"	350.6	16.2	15.6	28.5	20.2	1.2	278.2	12.2	24.1	291.8	18.9	96.7	67.8	547.3	43.1	28.2	130.9	44.6	284.6	16.5	22.5	65.9	721.3	37.5	68.3	20.7	13.7	233.1	14.4	28.0	98.1	1864.4	21.0	87.4	58.4	11.9	46.2	81.1	57.9	176.5	77.9	198.1	12.8	191.0	81.7	10.8	16.5	18.2	40.8	73.3	67.4	369.7	165.3	15.9	199.6	59.5	113.1	1.0	83.9	34.7	0.9	850.6	153.8	71.9	38.8	0.2	157.4	0.2	263.2	8578.6	35.6	466.5	1.5	3.4	29.2	0.6	0.1	0.3	20.8	0.2	21.9	0.4	1.6	285.7	12.8	15.1	53.8	112.3	0.7	0.0	0.1	3.2	26.8	1.2	1.3	1.4	7.8	1.8	10.9	0.8	0.4	81.4	53.2	423.6	13.6	32.7	293.9	11.4	15.3	250.6	1.5	0.7	0.5	815.4	1.7	3469.4	49.3	11.6	0.7	1.1	1774.2	0.3	282.1	0.0	0.0	0.0	10.1	0.0	8.0	0.0	10.9	10.7	0.0	0.0	4.9	8.1	0.1	0.0	0.0	54.5	0.8	4.5	15.6	20.2	12.2	24.1	16.5	22.5	20.7	13.7	21.0	12.8	16.5	15.9	260.4	3.2	3.9	0.7	1.9	457.7	148.9	777.7	8.0	2.8	12.6	30.4	12.6	8.6	409.7	228.1	0.0	94.1	10.0	0.7	11.7	145.6	1.3	32.3	220.1	168.0	273.7	5.3	2.5	2.0	2064.1	463.4	1.5	31.3	1.3	12.2	182.0	2.6	80.9	0.0	5.6	8.4	57.0	7.2	21.9	3.5	288.3	3.5	16.0	1.9	7.2	0.6	0.0	0.5	0.2	19.0	2.5	6.8	1.0	212.1	0.8	1.0	136.0	0.5	0.0	12.6	124.6	0.8	1.4	9.3	244.6	154.2	9.3	3.6	2.0	809.9
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38406528-38424454	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 16.5"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;Excitatory neurons: 2.5;Hofbauer cells: 1.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 2.5;Spermatogonia: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 360.4;NTERA-2: 104.2;RH-30: 97.5;SCLC-21H: 334.3;SH-SY5Y: 332.6;SuSa: 241.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	0.8	1.5	2.4	0.5	4.2	0.5	0.1	3.4	2.8	0.2	1.4	0.5	0.9	0.7	0.1	0.3	0.3	0.6	1.3	2.6	2.0	0.2	0.3	0.8	0.2	1.5	2.3	0.1	0.9	0.0	1.1	0.6	1.7	0.4	0.3	0.3	0.1	1.6	0.2	0.2	0.6	1.1	1.0	0.1	1.6	2.1	2.8	2.9	16.5	0.0	0.1	0.5	0.1	1.8	0.0	8.6	360.4	0.4	0.0	0.0	0.2	2.4	0.0	0.5	0.3	0.1	0.2	0.1	1.3	0.3	0.0	0.1	44.0	0.0	0.5	0.0	2.7	0.1	1.2	0.2	0.0	1.7	1.2	0.4	0.0	0.0	0.0	0.2	0.0	1.6	0.2	0.2	2.5	0.1	0.3	0.2	104.2	0.5	0.7	0.1	97.5	0.9	0.0	0.2	334.3	332.6	6.4	0.5	0.0	241.3	2.3	2.3	0.4	0.1	7.7	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.0	2.4	4.2	3.4	2.8	2.6	2.0	1.5	2.3	1.7	1.0	2.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.3	0.6	0.1	0.0	1.8	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 41.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.9;Excitatory neurons: 27.1;Inhibitory neurons: 29.3;Oligodendrocytes: 38.5;Spermatocytes: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"CACO-2: 82.4;OE19: 166.9"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Plasma membrane"	"HPA059137: AB_2683920"	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	2.4	0.0	0.2	0.0	0.2	0.0	2.0	0.0	0.8	0.1	0.0	0.5	0.0	0.2	0.5	1.5	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.3	2.0	0.7	0.3	0.0	0.0	1.5	0.3	0.9	0.8	0.0	0.8	0.4	1.0	0.0	0.0	41.6	0.1	0.2	0.2	0.0	0.0	4.1	0.3	1.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	1.7	0.5	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	82.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.0	0.0	1.6	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	166.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.4	0.7	0.3	0.8	0.2	0.3	2.1	0.0	0.0	0.0	17.9	0.0	2.2	0.0	1.1	0.0	1.7	2.0	1.5	0.6	0.0	0.7	0.0	0.0	4.3	0.0	0.7	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.0	27.1	0.2	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	29.3	0.4	0.0	0.0	0.3	5.4	0.0	0.0	1.8	0.0	0.0	0.2	0.0	6.0	38.5	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.0	1.9	0.0	0.0	0.7	9.8	8.7	0.0	4.7	2.6	0.2	0.0	1.4	0.0
IGFLR1	"FLJ22573, TMEM149, U2AF1L4"	ENSG00000126246	"IGF like family receptor 1"	Q9H665	19	35738801-35742453	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 29.9;granulocytes: 38.7;Langerhans cells: 33.7;Macrophages: 28.8;monocytes: 115.6;Plasma cells: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 899.7"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 899.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 32.9;Karpas-707: 26.0;U-266/70: 34.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA012369, HPA070778"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Plasma membrane"		"HPA012369: AB_1858095, HPA070778: "	"unprognostic (5.97e-3)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.94e-1)"	"unprognostic (5.42e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.34e-4)"	"unprognostic (6.71e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.59e-5)"	"unprognostic (1.44e-3)"	"unprognostic (3.52e-1)"	"unprognostic (8.72e-12)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-3)"	7.6	10.9	6.1	19.5	6.8	14.4	6.2	6.0	9.3	4.9	6.0	6.5	6.1	3.4	5.5	4.0	6.4	6.1	4.5	5.9	11.1	14.0	49.9	11.3	33.0	9.1	6.8	4.4	9.3	1.4	5.5	4.5	7.4	6.2	6.4	4.6	7.8	1.5	4.5	4.4	13.2	4.4	5.6	28.6	7.9	6.7	7.1	12.6	7.2	2.1	23.2	7.3	3.5	7.5	2.2	10.0	3.5	8.3	1.1	1.7	2.0	1.5	1.1	1.8	4.7	3.0	2.4	4.0	3.2	0.7	0.6	1.6	2.0	2.1	0.9	3.3	5.0	15.0	3.4	9.1	2.8	1.7	32.9	2.7	1.3	3.5	0.8	0.6	1.9	7.7	4.9	26.0	0.5	7.4	5.1	16.7	1.6	9.4	2.7	6.0	3.3	8.3	1.7	3.2	2.4	4.5	3.4	2.4	1.8	1.3	3.4	7.8	0.5	4.2	2.0	2.6	4.0	34.0	7.5	2.8	4.9	5.8	3.0	147.9	190.9	184.1	94.2	167.7	106.6	169.3	107.3	88.8	253.2	172.1	95.8	77.0	208.6	144.9	125.3	899.7	136.3	139.5	6.1	6.8	6.0	9.3	5.9	11.1	9.1	6.8	7.4	5.6	7.1	7.5	0.3	0.0	13.5	2.6	24.5	0.6	0.3	0.0	0.0	0.4	1.3	1.3	1.2	1.5	5.0	0.0	0.0	0.6	29.9	1.2	1.9	1.9	0.0	0.8	0.6	0.8	3.0	6.1	0.3	4.2	1.8	0.9	1.1	0.7	38.7	0.6	2.2	20.3	14.6	0.0	0.4	1.8	0.0	15.7	33.7	0.6	0.0	28.8	5.4	1.9	115.6	2.7	12.3	2.5	1.0	1.4	0.3	0.0	42.1	0.2	0.9	10.8	3.6	0.4	0.0	1.0	0.9	0.4	0.5	1.9	0.9	0.3	20.8	0.4	2.4	0.0
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu DNA binding protein 2"	P38935	11	68903863-68940602	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.6;Late spermatids: 46.9;Spermatocytes: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004092, HPA060994"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA004092: , HPA060994: AB_2684406"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	5.2	4.0	1.2	2.5	1.3	6.0	5.4	0.7	1.7	7.0	0.1	11.8	1.5	7.8	0.6	5.5	6.7	1.7	5.2	1.6	1.2	4.4	6.3	5.1	3.3	0.8	0.4	6.1	5.2	2.8	4.0	2.0	0.7	6.3	1.5	1.4	6.4	3.1	8.5	7.7	6.3	2.6	0.5	5.7	6.2	15.4	0.6	4.3	4.9	3.8	1.7	6.3	5.8	1.1	5.1	7.3	4.0	7.4	3.6	3.1	5.2	5.8	3.9	7.8	4.6	14.5	7.0	7.3	9.7	3.3	6.9	8.0	5.8	4.9	1.8	8.3	6.2	6.6	9.6	5.6	5.5	6.5	7.4	1.8	4.9	9.2	4.6	4.5	4.6	11.1	10.6	4.6	2.3	5.1	11.1	8.9	2.3	7.9	10.3	9.4	5.7	7.6	3.3	5.9	8.6	5.4	7.4	6.1	16.6	3.0	9.3	6.0	6.6	5.3	3.8	7.7	6.6	6.0	6.3	6.9	5.3	6.1	5.1	0.0	2.0	0.8	1.5	1.8	1.3	1.0	0.9	1.0	1.8	0.6	0.5	0.7	0.6	0.1	1.1	0.3	0.6	1.3	1.2	1.3	0.7	1.7	1.6	1.2	0.8	0.4	0.7	0.5	0.6	1.1	6.6	6.4	7.7	7.5	5.7	5.7	3.8	3.5	6.2	9.1	5.6	3.8	6.3	8.6	6.1	1.8	20.9	4.9	10.2	6.0	1.9	5.1	94.6	7.0	8.1	6.4	3.0	9.3	7.4	5.1	4.4	5.5	6.1	14.0	7.0	10.7	3.3	6.1	5.8	11.8	6.4	4.1	2.0	3.5	4.3	46.9	7.8	7.2	1.8	5.6	7.3	6.6	9.2	6.0	5.2	6.5	8.4	7.2	5.8	7.5	3.9	2.9	3.8	10.1	0.0	5.1	10.1	51.6	7.1	5.3	6.7	6.7	8.0	4.6	7.1	6.3
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 46.3;ovary: 16.2;retina: 50.6;testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.9;Early spermatids: 257.9;Inhibitory neurons: 139.1;Late spermatids: 334.0;Oligodendrocytes: 283.2"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.0;HEL: 5.9;SK-MEL-30: 35.1;U-266/70: 11.9;U-266/84: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	0.3	7.8	19.5	0.4	34.0	0.0	0.2	26.9	22.2	0.8	1.5	4.1	0.2	0.5	1.1	1.2	0.6	0.8	2.2	19.3	18.6	8.2	0.1	0.1	0.1	30.5	28.0	16.2	3.7	1.3	1.7	0.1	29.9	0.7	0.8	50.6	0.6	0.8	3.9	1.5	0.9	0.5	23.3	0.1	1.6	35.7	25.6	0.3	3.4	5.0	0.2	0.6	0.8	46.3	0.0	8.0	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	2.7	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.7	0.6	0.0	0.1	35.1	2.1	0.7	0.1	0.0	0.0	1.4	0.0	0.1	11.9	15.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	34.0	26.9	22.2	19.3	18.6	30.5	28.0	29.9	23.3	25.6	46.3	0.1	0.0	0.0	133.9	0.6	0.4	0.1	0.3	2.8	9.1	0.3	0.1	1.3	0.0	0.5	0.0	75.0	0.2	0.1	0.0	0.0	0.9	257.9	4.2	0.8	0.3	0.0	0.0	77.8	0.7	0.0	2.0	0.0	7.2	0.0	26.8	0.0	0.0	0.0	16.8	139.1	0.0	6.1	0.0	0.4	334.0	3.7	0.4	3.6	4.7	0.0	22.3	0.0	43.2	283.2	0.2	0.0	1.9	0.2	0.1	0.0	5.9	0.4	25.7	0.0	0.8	0.9	22.4	6.0	0.7	0.0	0.1	0.2	6.8	0.0	0.4
IGSF23		ENSG00000216588	"Immunoglobulin superfamily member 23"	A1L1A6	19	44613563-44636781	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"intestine: 15.9;liver: 24.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 5.7;Early spermatids: 7.9;Hepatocytes: 11.9;Late spermatids: 9.9;Proximal enterocytes: 40.8"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 12.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.5;Hep G2: 5.4;SiHa: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051811			Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA051811: AB_2681621"	"unprognostic (1.54e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.20e-6)"	"unprognostic (7.35e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-8)"	"unprognostic (1.26e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.85e-1)"	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.2	14.7	0.1	0.7	0.0	0.0	0.1	0.5	0.1	0.1	0.4	24.5	0.2	0.0	0.4	0.4	0.0	3.7	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.1	0.0	0.1	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.3	0.0	0.0	0.5	0.3	0.5	0.0	0.4	10.5	0.3	0.0	0.7	0.3	0.2	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.2	5.4	0.0	0.0	0.1	0.3	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	4.7	1.6	0.0	0.0	0.2	0.0	1.9	0.3	0.4	0.4	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.4	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	7.9	0.3	0.0	0.1	0.0	0.0	0.4	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.7	11.9	0.0	0.0	0.4	1.2	0.0	0.3	0.0	9.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	1.2	0.0	0.0	0.0	40.8	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	1.3	0.0
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 256.5;WM-115: 239.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA036305: AB_2675050, HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.5	1.8	0.9	1.3	1.8	0.3	8.5	1.8	3.9	6.1	1.4	6.5	7.7	2.9	5.7	23.2	2.0	3.2	9.1	1.1	3.0	11.4	0.5	8.4	0.5	2.0	3.5	0.4	2.6	2.1	2.4	11.1	2.3	5.6	5.8	7.5	9.1	5.7	1.6	18.2	8.8	2.9	4.7	0.4	8.7	4.1	4.9	10.9	8.3	1.5	5.3	5.0	10.9	2.9	22.3	36.9	28.2	7.2	6.4	13.4	75.5	0.1	1.0	2.9	1.0	21.5	12.4	0.0	11.4	0.3	15.8	60.7	12.6	30.4	1.3	256.5	9.3	12.1	13.7	0.6	0.0	1.2	22.2	1.7	23.1	0.2	5.2	5.3	0.2	4.1	3.7	0.2	0.6	78.0	0.9	0.8	17.8	13.4	0.9	9.1	34.6	0.1	21.6	27.5	16.4	50.0	8.9	84.7	55.1	53.9	28.7	1.5	0.1	4.9	16.4	0.2	23.0	0.3	1.3	0.1	2.2	0.7	239.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	1.8	3.9	1.1	3.0	2.0	3.5	2.3	4.7	4.9	2.9	3.5	16.0	36.0	1.0	0.0	19.6	8.6	23.2	23.9	29.3	17.1	10.8	16.1	7.2	9.1	14.7	0.0	13.7	0.1	29.3	3.9	14.0	2.1	8.3	2.1	3.3	3.0	0.0	11.8	1.9	27.3	7.8	16.8	14.4	1.3	7.3	1.8	0.6	2.1	6.7	18.8	5.0	2.0	1.3	11.1	2.2	1.2	0.5	8.8	0.0	3.1	11.3	0.0	1.5	0.4	16.4	7.3	0.0	0.0	10.2	15.4	11.4	11.3	0.8	0.0	26.4	2.8	0.5	3.8	30.6	27.7	13.3	0.4	3.5	9.3	11.4
IHO1	"CCDC36, CT74, FLJ25320, LELA1"	ENSG00000173421	"Interactor of HORMAD1 1"	Q8IYA8	3	49198428-49258106	"Predicted intracellular proteins"	"Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 7.5;testis: 26.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.7;Cardiomyocytes: 1.4;Fibroblasts: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.9;hTEC/SVTERT24-B: 9.2;LHCN-M2: 4.0;NTERA-2: 2.5;U-2197: 5.1;WM-115: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA045690, HPA069534"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA045690: AB_10964634, HPA069534: AB_2686146"	"unprognostic (1.54e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.51e-4)"	"unprognostic (3.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.33e-2)"	3.2	1.4	0.2	0.3	0.2	0.2	1.8	0.9	0.5	1.3	7.5	1.1	0.2	1.2	0.4	0.4	1.3	0.7	1.1	0.4	0.0	0.3	0.1	0.5	0.3	0.1	0.3	3.8	0.2	0.1	0.2	0.9	0.1	0.4	0.1	0.7	0.3	0.5	0.9	0.6	0.4	1.0	0.1	0.5	0.3	26.5	0.5	0.1	1.0	0.8	0.1	0.8	0.6	0.1	0.0	0.1	0.0	0.0	1.9	2.2	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.1	1.7	0.0	9.2	0.0	0.0	1.2	0.0	0.0	0.1	4.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.5	0.4	0.0	0.1	0.3	0.1	0.1	0.5	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 173.0;lymphoid tissue: 112.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 120.5;dendritic cells: 221.4;Erythroid cells: 89.8;Microglial cells: 91.8;monocytes: 106.6;NK-cells: 150.4;Plasma cells: 128.9;T-cells: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 140.4;HDLM-2: 258.6;HMC-1: 220.4;JURKAT: 128.9;MOLT-4: 184.3;REH: 192.3;U-698: 342.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	5.0	3.2	3.5	53.0	3.4	173.0	4.4	4.0	3.9	3.6	3.3	7.6	7.0	2.5	2.3	4.8	2.2	7.7	1.5	3.0	4.0	1.4	4.9	11.6	87.1	7.7	5.2	1.6	0.8	0.8	0.6	3.6	7.5	2.3	6.8	0.2	4.6	1.9	1.0	2.0	15.6	4.0	7.3	48.6	12.0	1.7	8.7	112.5	2.1	1.2	73.8	9.6	1.8	10.3	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	258.6	0.2	52.1	0.0	0.0	0.0	84.5	220.4	0.0	0.0	0.0	0.0	0.0	0.0	128.9	72.4	15.4	0.0	0.0	184.3	80.9	2.4	0.0	0.0	192.3	0.3	39.6	0.0	0.0	1.6	2.0	0.8	1.0	0.8	0.4	0.2	112.1	0.2	0.0	1.9	0.2	0.4	80.8	49.4	342.7	0.5	89.5	0.5	21.2	14.2	25.0	35.4	43.9	29.1	46.7	36.3	35.0	15.1	40.7	48.2	35.7	20.2	24.3	43.3	23.4	32.6	26.4	3.5	3.4	4.0	3.9	3.0	4.0	7.7	5.2	7.5	7.3	8.7	10.3	2.8	3.2	12.2	0.7	120.5	2.8	0.1	0.0	0.0	0.0	2.8	1.9	1.5	2.8	1.8	1.8	0.0	0.4	221.4	0.3	0.0	0.4	3.8	0.5	0.4	2.6	0.0	89.8	0.2	0.0	0.4	2.5	4.6	0.6	23.4	0.2	3.9	2.0	30.6	0.0	0.3	0.0	0.0	64.3	61.0	5.3	0.0	72.1	19.6	91.8	106.6	0.0	150.4	1.0	0.3	0.1	0.4	0.0	128.9	0.1	0.0	1.0	1.5	0.1	0.0	1.5	1.6	0.1	2.1	0.5	2.7	0.7	182.8	0.1	0.1	0.1
IKZF2	"Helios, ZNFN1A2"	ENSG00000030419	"IKAROS family zinc finger 2"	Q9UKS7	2	212999691-213152427	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.4;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 78.3;Squamous epithelial cells: 47.8;Urothelial cells: 51.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;NK-cells: 5.5;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"JURKAT: 70.5;MOLT-4: 31.1;RT4: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059142	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA059142: AB_2683923"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.93e-3)"	"unprognostic (7.09e-2)"	2.1	2.0	2.6	3.8	5.5	5.5	2.3	3.2	3.2	3.4	0.7	1.8	0.8	1.9	3.2	19.4	2.8	3.1	1.9	2.9	3.8	1.5	1.4	2.9	7.0	5.2	3.5	2.0	2.0	5.2	1.9	2.0	5.3	3.3	1.7	5.5	8.4	4.3	4.1	9.1	1.2	0.8	3.2	5.5	4.4	2.5	3.9	40.3	7.8	1.6	6.8	9.6	8.3	7.4	2.8	1.0	5.3	0.3	17.1	17.2	3.3	3.4	3.9	0.8	1.7	1.4	4.6	3.7	4.4	2.0	0.4	6.5	0.1	1.8	2.7	0.0	0.9	1.9	3.6	0.5	0.1	8.9	0.6	16.9	1.6	0.1	0.5	4.3	0.0	70.5	1.2	3.1	1.6	5.2	31.1	8.9	1.1	2.2	0.8	18.1	3.5	0.0	1.5	28.6	1.6	1.0	0.0	3.6	0.0	4.4	4.8	0.9	9.2	4.9	3.8	2.3	0.7	6.0	2.0	20.6	2.4	0.0	1.1	3.9	0.0	4.8	1.8	0.0	4.9	0.2	0.6	1.4	0.0	1.0	0.3	1.5	0.0	5.5	0.0	0.5	5.8	0.3	2.6	5.5	3.2	3.2	2.9	3.8	5.2	3.5	5.3	3.2	3.9	7.4	2.1	9.6	12.6	77.4	5.2	5.9	23.2	7.9	11.4	4.8	5.1	2.2	7.6	1.5	19.5	7.3	4.2	4.3	27.4	2.8	0.0	2.3	1.3	16.1	1.8	2.4	3.0	9.0	17.7	3.1	1.2	2.7	8.6	18.1	3.8	2.5	2.5	2.2	2.1	0.0	19.9	2.3	4.1	2.4	2.1	0.7	1.8	2.8	1.8	31.9	1.3	3.0	39.1	100.5	78.3	3.6	1.0	2.2	13.9	15.9	1.1	1.0	31.7	7.3	0.0	10.2	4.5	0.8	0.7	47.8	8.7	4.0	22.1	2.0	1.4	51.8
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757718-39864312	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 12.1;lymphoid tissue: 41.0"	"Group enriched"	"Detected in many"	4	"B-cells: 108.1;dendritic cells: 76.5;granulocytes: 47.9;NK-cells: 121.5;Plasma cells: 80.2;T-cells: 99.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.2;T-cells: 28.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.0;Karpas-707: 35.6;U-266/70: 41.7;U-266/84: 50.0;U-698: 108.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA024377, HPA073266"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favorable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"	1.0	0.8	0.3	18.8	0.2	5.9	1.8	0.7	0.6	1.5	0.6	3.3	3.5	1.0	0.7	1.5	0.7	3.0	0.5	0.7	0.1	0.6	2.0	3.1	36.5	0.5	0.1	0.7	0.4	0.1	0.2	0.3	0.4	1.0	3.1	0.3	2.2	0.3	0.5	0.9	12.1	0.8	0.1	22.3	6.2	1.6	0.4	23.0	0.9	0.3	41.0	4.5	0.7	1.0	0.2	0.2	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.3	69.0	0.1	0.0	0.1	0.3	0.1	0.2	0.0	15.6	0.3	4.2	0.4	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.1	1.8	35.6	0.0	0.2	6.2	2.4	0.2	3.9	0.1	0.3	0.2	12.7	0.0	4.2	0.4	0.2	1.2	0.5	0.1	0.1	0.2	0.8	0.3	0.3	0.5	0.2	0.1	41.7	50.0	108.1	0.1	0.2	0.1	1.0	0.2	0.8	26.3	0.1	28.8	13.2	11.0	20.3	0.1	11.9	4.5	12.2	1.1	4.5	0.3	0.6	18.9	8.7	0.3	0.2	0.7	0.6	0.7	0.1	0.5	0.1	0.4	0.1	0.4	1.0	1.1	9.6	21.8	0.3	108.1	0.1	2.2	0.0	0.0	1.7	1.2	0.9	4.0	1.5	5.6	1.8	0.0	0.1	76.5	0.2	0.0	0.1	12.8	1.9	0.9	2.4	0.0	4.0	0.6	0.0	0.4	2.3	3.1	3.9	47.9	0.4	4.2	1.2	0.1	0.0	0.4	0.1	0.0	6.3	0.0	11.8	0.0	4.4	0.0	2.8	3.3	0.2	121.5	0.0	0.1	1.2	0.1	0.0	80.2	1.8	0.0	0.3	0.7	1.7	0.0	4.0	1.2	6.3	2.3	0.6	0.1	0.3	99.9	0.1	0.0	1.6
IKZF4	"Eos, ZNFN1A4"	ENSG00000123411	"IKAROS family zinc finger 4"	Q9H2S9	12	56007659-56038435	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046270, HPA049016"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA046270: AB_2679607, HPA049016: AB_2680600"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.63e-3)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.42e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (6.52e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.98e-3)"	"unprognostic (7.74e-3)"	4.9	9.2	5.6	2.1	5.7	3.8	3.7	7.1	6.5	4.8	5.7	5.5	1.6	4.5	4.0	2.6	5.8	2.7	4.1	5.3	5.8	3.7	3.2	3.7	2.1	6.4	6.2	7.6	2.9	8.1	7.5	3.0	5.8	3.9	2.0	8.5	2.7	4.2	9.9	2.5	3.5	2.9	5.5	2.9	4.1	5.0	6.2	4.0	5.1	5.4	2.3	4.3	3.2	6.0	1.7	1.6	11.6	3.9	2.3	2.4	2.7	1.8	3.1	2.1	3.0	6.5	2.5	1.1	2.0	2.9	2.3	1.3	1.5	1.8	4.6	36.2	1.7	7.3	1.7	3.0	2.6	3.3	2.6	4.0	2.1	2.2	1.7	3.9	2.2	0.2	10.7	5.5	3.4	2.0	4.1	1.6	5.1	1.8	1.4	3.6	3.1	1.3	3.1	1.4	4.4	3.8	2.6	0.8	4.3	2.9	3.0	3.3	1.3	1.8	3.1	1.8	1.5	3.5	2.2	1.5	3.7	3.2	2.4	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.9	0.1	5.6	5.7	7.1	6.5	5.3	5.8	6.4	6.2	5.8	5.5	6.2	6.0	5.5	3.2	9.4	10.7	2.5	3.6	1.9	3.4	10.2	20.3	16.6	15.4	7.5	10.0	4.2	3.7	8.4	3.0	0.8	3.9	1.9	2.9	13.8	7.7	10.4	5.3	6.0	4.2	13.3	4.2	2.8	8.8	2.0	8.0	1.3	4.0	8.2	6.7	2.7	8.4	17.7	3.0	4.1	9.8	3.1	2.7	8.7	4.1	5.4	7.5	6.0	18.3	0.0	14.6	15.5	4.3	2.1	10.9	1.6	2.4	1.7	4.9	4.3	12.3	0.0	10.3	9.9	21.2	5.9	10.4	3.3	4.0	3.8	16.0	2.3	2.1
IKZF5	"FLJ22973, Pegasus, ZNFN1A5"	ENSG00000095574	"IKAROS family zinc finger 5"	Q9H5V7	10	122990807-123008812	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015297, HPA051574"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA015297: AB_1855183, HPA051574: AB_2681538"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.17e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.15e-2)"	8.3	8.5	8.7	7.3	11.5	34.0	12.2	10.2	15.1	8.8	5.9	7.6	6.6	9.3	9.7	7.2	8.4	6.1	7.1	8.3	10.3	8.7	12.2	8.2	11.1	10.4	10.4	13.9	11.1	9.3	10.1	8.1	11.2	8.3	7.1	13.6	8.4	6.0	9.7	11.3	8.5	7.1	10.0	9.2	7.9	10.5	9.8	10.5	10.0	9.4	9.6	7.3	8.4	17.7	7.5	3.7	7.3	12.5	11.5	10.5	7.9	6.2	13.3	8.1	9.8	6.0	8.6	18.8	4.5	7.6	4.4	10.1	13.0	9.3	11.9	10.6	11.5	12.1	6.0	9.0	7.6	14.8	10.6	8.3	12.5	9.7	20.8	11.1	9.0	12.3	16.9	12.2	8.8	5.5	13.6	16.1	6.7	5.6	5.1	10.9	9.1	10.8	6.7	5.1	7.9	7.1	5.1	6.3	12.2	5.8	5.2	9.3	9.3	5.8	4.9	8.6	10.1	11.4	6.6	17.6	7.4	25.5	3.5	6.0	4.1	5.7	5.8	5.3	6.8	4.0	5.3	5.7	4.5	4.7	7.2	8.4	4.0	6.7	5.6	3.1	7.5	4.3	8.7	11.5	10.2	15.1	8.3	10.3	10.4	10.4	11.2	10.0	9.8	17.7	11.2	12.8	13.1	8.8	16.0	32.2	11.0	7.2	20.5	12.7	23.8	15.0	15.6	8.6	11.3	5.5	14.6	5.8	20.5	7.7	9.8	5.1	8.6	12.0	13.2	11.5	18.0	12.4	10.9	5.3	5.7	15.6	7.7	20.7	17.1	11.3	9.7	15.7	6.5	11.8	13.0	9.2	4.1	10.6	11.4	3.7	13.4	11.0	16.0	17.8	8.9	9.0	17.5	13.0	30.9	4.7	4.9	10.5	14.2	16.1	7.4	11.4	10.9	14.1	13.1	14.3	11.6	22.8	22.3	20.4	32.4	14.4	19.3	7.0	6.7	11.9
IL13RA1	"CD213a1, IL-13Ra, NR4"	ENSG00000131724	"Interleukin 13 receptor subunit alpha 1"	P78552	X	118727133-118794535	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 10.9;eosinophil: 12.2;myeloid DC: 17.2;neutrophil: 29.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 17.2;granulocytes: 29.2;monocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 181.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001587			Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		17000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	Nucleoplasm	"HPA001587: AB_1079133"	"unprognostic (5.14e-3)"	"unprognostic (4.72e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.08e-2)"	51.9	34.3	15.9	40.3	16.2	7.1	41.5	18.1	17.3	27.1	20.4	52.1	48.5	31.9	26.2	53.5	35.8	39.3	20.2	14.6	22.3	33.7	120.3	48.9	25.4	26.0	20.3	37.5	22.3	22.2	15.4	32.8	24.6	22.5	61.6	25.6	34.7	27.1	31.4	20.6	60.8	40.6	22.2	29.9	35.8	16.6	19.6	16.0	29.8	55.9	34.5	31.6	27.4	24.6	31.6	37.2	17.4	48.0	39.0	113.5	33.1	63.3	86.2	29.2	37.6	21.8	55.0	0.1	111.4	86.6	84.8	29.1	19.0	26.6	32.3	181.0	16.5	5.1	30.9	55.8	23.4	0.6	13.0	104.1	23.5	40.0	48.8	87.9	61.8	0.0	16.6	3.3	41.9	44.8	0.1	8.5	16.1	57.8	38.6	0.1	43.3	0.2	43.6	32.9	6.5	6.0	102.3	35.5	24.7	22.8	22.8	28.9	79.3	56.7	26.7	99.7	50.5	0.7	16.8	0.3	125.6	16.1	24.6	0.2	10.9	12.2	0.0	2.7	0.1	2.9	0.0	0.0	17.2	2.5	0.0	0.0	29.2	0.1	1.1	2.9	0.1	2.9	15.9	16.2	18.1	17.3	14.6	22.3	26.0	20.3	24.6	22.2	19.6	24.6	36.0	70.5	48.5	1.0	20.2	17.2	37.1	17.2	18.2	2.1	32.4	26.3	11.5	37.1	46.0	29.5	16.7	8.1	2.8	61.9	9.8	36.1	38.1	25.8	34.0	58.8	93.2	4.8	0.3	98.3	31.9	38.7	38.7	27.3	0.0	13.6	78.9	149.0	41.2	0.0	2.0	138.4	16.2	124.8	140.6	7.3	24.2	120.4	21.4	73.1	199.7	43.7	2.1	0.0	6.9	87.9	27.0	18.8	1.3	42.3	70.8	25.2	49.7	11.2	32.9	14.4	26.2	7.5	28.9	37.2	12.1	9.4	2.7	7.1	29.5	30.8
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 12.0;testis: 30.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 322.4"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"PC-3: 133.0;U-2197: 425.6;U-251 MG: 297.4;U-87 MG: 167.9"	"Region enhanced"	"Detected in many"		"olfactory bulb: 7.0"	"Low region specificity"	"Detected in some"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.8	4.8	1.3	4.0	1.9	0.0	0.4	0.1	1.1	1.1	1.6	0.4	0.3	0.8	4.4	0.6	0.1	0.8	0.7	1.5	10.6	3.6	10.0	1.4	0.1	3.1	3.7	0.1	0.1	0.5	12.0	0.4	1.8	4.1	0.7	0.0	0.9	3.5	0.0	0.2	0.3	0.3	0.7	0.2	0.1	30.0	6.1	2.1	1.2	0.1	0.1	4.4	0.2	0.8	0.4	0.0	4.6	0.1	0.7	3.6	0.0	29.2	28.0	0.1	0.1	0.0	0.0	0.0	0.5	14.6	46.6	0.1	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.1	4.8	0.8	4.6	26.9	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	133.0	0.0	0.0	0.0	2.4	0.2	0.0	6.8	2.1	0.3	0.4	0.0	0.1	0.4	0.0	14.7	0.4	425.6	297.4	0.0	0.2	0.1	167.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.9	0.1	1.1	1.5	10.6	3.1	3.7	1.8	0.7	6.1	0.8	0.3	0.0	0.0	0.0	0.1	0.1	4.7	0.3	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	322.4	0.4	0.3	1.3	4.2	0.0	0.4	0.0	0.0	10.3	0.0	0.4	0.0	0.0	46.4	0.4	0.0	0.0	0.6	0.0	0.0	2.8	0.3	58.6	2.8	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	8.5	0.0	4.9	0.1	10.9	0.0	0.0	2.9	0.0	0.0	0.0	3.4	63.1	4.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3
IL15	"IL-15, MGC9721"	ENSG00000164136	"Interleukin 15"	P40933	4	141636583-141733987	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 78.0;monocytes: 72.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.6;Karpas-707: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004457, HPA037738"	Approved		Supported	"Nucleoplasm,Nuclear speckles"	"Secreted to blood"	NA	NA	182000		"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear speckles"		"CAB004457: AB_2124575, HPA037738: AB_2675640"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	7.7	3.4	1.3	7.1	1.4	4.0	6.0	2.1	1.8	5.3	1.4	7.7	6.1	4.5	2.5	4.4	4.5	4.9	5.1	1.2	1.3	7.9	3.6	7.8	9.7	2.3	1.3	1.5	2.7	0.7	3.6	3.1	1.8	4.1	5.3	4.3	3.6	2.7	8.6	3.4	10.0	4.6	1.5	15.4	4.8	2.5	1.8	6.8	15.6	3.4	6.6	4.5	6.4	1.9	2.8	6.3	0.3	0.6	0.9	5.4	1.6	6.7	6.1	6.8	5.5	3.4	8.1	2.5	8.5	6.2	6.0	4.4	0.1	3.4	3.6	17.6	1.7	0.5	16.7	0.5	4.5	1.9	1.3	2.1	1.5	4.4	0.5	13.7	4.3	2.3	4.0	18.8	4.2	0.9	4.2	0.3	3.3	2.3	1.7	1.0	16.0	0.5	9.2	0.8	0.6	1.6	3.1	4.7	3.2	0.8	0.9	0.3	6.6	6.9	4.3	2.0	4.2	13.0	1.8	1.0	7.2	0.8	2.5	10.4	16.1	0.6	2.7	15.1	5.0	4.1	3.3	2.5	5.5	4.0	1.4	1.4	1.2	3.2	16.5	0.2	2.0	6.1	1.3	1.4	2.1	1.8	1.2	1.3	2.3	1.3	1.8	1.5	1.8	1.9	14.8	0.0	2.8	0.3	9.9	6.1	2.5	2.1	2.2	0.6	2.1	1.3	2.9	2.8	5.3	5.5	0.0	1.2	5.0	4.7	0.0	9.4	6.6	6.9	78.0	14.8	0.0	1.3	2.0	14.0	1.6	5.5	4.1	5.9	0.0	0.9	11.4	2.5	4.7	0.0	4.8	5.4	0.0	17.0	22.1	2.5	2.8	16.7	8.8	4.7	72.0	21.1	8.2	3.0	0.2	19.8	8.2	1.2	9.3	6.2	9.9	12.0	3.9	0.9	6.6	7.6	4.0	1.2	0.8	5.6	3.4	0.3	6.0	0.1	2.6	3.0
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.9;Kupffer cells: 81.4;Macrophages: 61.4;monocytes: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 59.9;NB-4: 52.5;THP-1: 74.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		62000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	9.1	5.6	5.5	9.6	11.3	31.8	6.9	5.7	7.5	5.4	6.8	4.7	3.8	5.4	5.0	5.2	6.0	3.6	4.6	6.3	5.5	3.7	5.7	10.0	6.9	9.8	7.3	4.5	5.2	3.9	3.8	3.5	8.9	5.0	3.4	1.5	5.2	2.8	1.8	6.9	6.2	5.3	7.7	16.6	5.6	2.0	7.7	15.4	4.2	2.6	5.6	4.6	4.7	9.6	7.9	4.5	4.1	5.1	8.0	4.6	5.1	11.5	7.4	5.3	6.8	4.4	5.1	7.1	4.6	11.6	6.9	12.4	5.6	5.4	3.7	11.6	6.6	0.0	2.6	2.8	9.2	59.9	17.8	6.8	7.9	4.7	3.7	5.2	5.7	5.6	3.0	7.3	5.5	6.7	7.2	52.5	2.2	10.1	4.3	1.6	0.8	1.3	5.1	5.8	2.8	0.1	8.0	6.7	5.7	4.6	5.3	74.7	15.9	4.1	5.8	6.1	4.3	5.8	3.4	3.3	6.0	28.3	4.5	8.5	7.4	7.2	1.1	3.4	0.9	0.5	1.5	1.2	3.9	0.4	2.4	1.8	16.5	1.5	3.5	1.8	1.0	2.6	5.5	11.3	5.7	7.5	6.3	5.5	9.8	7.3	8.9	7.7	7.7	9.6	14.0	12.8	14.1	2.9	13.8	8.8	6.6	10.2	10.8	3.9	7.2	5.8	6.1	10.0	8.6	5.5	8.4	6.1	18.7	23.6	0.0	8.7	4.0	7.2	8.1	13.7	13.2	9.2	8.3	12.6	11.9	13.6	29.0	9.7	7.6	58.9	17.5	11.1	34.0	3.3	6.4	13.9	6.1	81.4	16.2	2.1	9.0	61.4	8.8	41.2	114.2	4.3	28.8	12.5	11.4	12.2	12.4	4.5	10.3	9.1	14.7	3.4	8.0	2.9	13.1	10.4	10.0	3.0	13.4	9.0	6.8	6.4	25.4	8.1	12.4	9.6
IL17RD	"FLJ35755, IL-17RD, IL17RLM, SEF"	ENSG00000144730	"Interleukin 17 receptor D"	Q8NFM7	3	57089982-57170306	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 28.0"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 14.0;Early spermatids: 17.9;Late spermatids: 23.7;Microglial cells: 15.0;Peritubular cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 25.0;AN3-CA: 67.9;NTERA-2: 39.2;SH-SY5Y: 102.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039577, HPA043550"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA039577: AB_2676580, HPA043550: AB_2678546"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.92e-9)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.58e-3)"	1.9	0.8	4.7	0.9	5.7	0.0	7.4	5.2	4.0	6.0	28.0	5.9	0.4	13.5	10.6	2.4	6.4	3.3	1.9	5.5	6.5	5.7	0.2	0.6	0.3	8.9	8.8	7.4	0.9	9.4	2.3	0.3	5.5	5.1	1.8	0.3	6.0	8.5	0.6	2.0	1.0	12.0	6.2	2.5	1.2	9.7	4.8	0.3	0.5	2.6	0.5	2.8	3.3	6.5	4.0	0.8	25.0	67.9	0.1	0.6	4.0	0.4	0.2	0.3	0.8	0.5	1.9	0.0	0.2	1.4	5.3	0.2	4.8	1.0	0.8	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.1	1.0	2.6	0.0	0.5	16.6	1.1	0.6	0.0	0.1	1.4	0.5	0.0	0.1	39.2	2.2	1.9	0.0	9.1	0.0	5.2	1.0	0.6	102.0	1.0	1.5	2.9	8.1	0.9	0.0	0.7	1.3	1.6	1.2	4.2	0.0	0.0	0.1	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	5.7	5.2	4.0	5.5	6.5	8.9	8.8	5.5	6.2	4.8	6.5	1.4	0.0	2.3	11.4	0.0	0.9	2.0	3.1	0.0	0.1	1.5	14.0	1.6	1.5	2.4	0.0	0.0	0.3	0.1	0.1	0.0	3.1	17.9	0.5	5.5	4.0	0.0	0.0	0.6	0.2	0.1	10.1	0.0	1.0	0.0	2.0	1.1	0.1	0.1	0.0	0.9	0.3	2.0	0.0	1.2	23.7	11.5	0.6	0.0	15.0	0.0	0.6	0.0	7.5	2.1	0.7	0.7	25.9	0.0	2.9	0.0	5.0	1.8	0.0	0.0	4.8	1.3	10.6	7.5	1.1	0.9	0.1	0.3	6.5	0.3	0.7
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143253-112164096	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 124.5;skin 1: 149.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Basal respiratory cells: 186.4;Basal squamous epithelial cells: 215.1;Kupffer cells: 241.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 117.9;CAPAN-2: 182.3;HaCaT: 167.0;HBEC3-KT: 125.8;hTCEpi: 188.5;PC-3: 110.2;U-2 OS: 208.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	Yes	196000	16000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Golgi apparatus"	Cytosol	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	19.9	6.1	5.3	18.2	5.4	31.6	12.6	5.9	8.6	38.0	7.0	34.1	22.0	2.4	3.3	124.5	8.0	23.0	3.0	5.3	6.0	23.8	9.1	23.0	67.8	7.5	6.2	1.9	17.9	1.3	2.9	6.7	7.4	6.1	29.1	6.9	15.0	3.0	6.0	149.6	22.0	3.6	6.7	29.3	13.4	1.9	5.7	8.0	3.7	2.1	25.7	25.3	77.0	11.3	117.9	40.0	0.0	0.4	0.0	0.0	0.7	2.0	0.0	0.0	0.1	22.4	182.3	0.1	25.7	0.3	3.2	167.0	0.0	125.8	0.0	0.3	1.2	17.5	35.6	9.9	3.9	9.3	32.6	0.2	188.5	0.3	43.5	0.2	0.1	0.1	0.5	0.3	1.6	0.2	0.2	0.9	0.2	31.9	110.2	0.1	0.1	0.4	79.9	24.8	0.1	0.0	78.4	52.1	0.5	1.0	31.0	25.4	0.3	0.4	208.9	1.2	35.9	0.4	0.3	0.6	0.2	67.1	0.2	6.8	8.7	16.0	0.1	10.9	0.0	0.7	0.1	0.0	25.8	0.7	0.0	0.5	9.5	19.6	6.3	5.6	0.0	2.5	5.3	5.4	5.9	8.6	5.3	6.0	7.5	6.2	7.4	6.7	5.7	11.3	1.0	173.1	38.4	0.7	6.0	122.9	33.5	186.4	215.1	2.6	4.6	7.7	1.0	41.5	66.1	9.2	0.0	2.3	10.8	109.9	80.3	24.7	2.4	94.9	1.4	4.6	14.5	26.3	3.8	143.0	3.7	18.8	20.9	32.5	101.2	2.8	8.2	1.9	68.4	0.0	4.6	30.1	57.0	241.0	37.3	1.9	0.0	123.8	3.6	61.8	38.8	2.7	6.2	2.0	1.1	161.4	104.6	4.5	4.6	23.6	67.5	22.3	69.6	39.1	6.6	0.6	3.9	1.5	1.3	152.6	111.2	1.8	9.6	0.3	47.8	90.5
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 127.1;Endometrial stromal cells: 280.2;Glandular and luminal cells: 315.4;Hepatic stellate cells: 146.7;Langerhans cells: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 624.9;ASC TERT1: 276.8;HHSteC: 196.3;HSkMC: 770.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1400000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	137.3	68.0	7.1	69.5	8.3	18.0	77.5	7.5	11.0	161.1	16.2	39.3	20.7	33.5	105.2	32.1	52.0	92.0	58.3	7.6	9.0	45.7	75.5	115.5	17.1	16.2	8.4	31.1	43.3	126.7	13.1	120.8	8.9	66.7	30.5	8.5	34.2	47.4	18.6	40.1	40.3	49.9	10.0	41.0	43.9	20.6	14.9	21.7	52.5	16.0	19.7	87.4	40.2	7.7	2.0	12.8	0.3	10.8	624.9	276.8	4.4	27.4	123.8	19.2	28.7	5.7	3.4	0.0	19.8	55.0	33.9	5.5	0.2	2.2	16.1	55.5	0.1	0.7	2.9	31.3	196.3	0.1	0.3	770.6	2.3	21.7	5.2	8.4	8.7	0.0	3.5	1.1	28.1	5.6	0.0	1.2	0.7	5.6	0.9	0.3	2.0	0.4	18.3	13.4	0.1	0.3	12.5	7.7	0.0	3.6	11.1	0.8	0.3	54.7	3.6	92.1	2.2	0.1	0.0	0.1	21.3	0.6	3.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	7.1	8.3	7.5	11.0	7.6	9.0	16.2	8.4	8.9	10.0	14.9	7.7	99.3	25.6	73.2	1.3	1.8	31.1	46.8	8.2	5.2	0.1	19.4	13.7	5.2	28.6	68.6	5.5	0.0	6.1	2.5	0.7	3.9	31.7	7.0	127.1	280.2	103.6	1.2	14.3	0.5	21.8	82.8	79.1	2.0	315.4	1.3	0.3	146.7	47.1	5.4	0.0	3.0	0.5	10.2	12.0	188.2	12.6	28.0	26.0	19.6	23.4	7.0	9.0	0.0	0.5	0.5	12.0	0.3	1.5	1.8	65.9	0.0	8.3	28.6	1.0	6.6	37.7	34.3	1.3	1.2	4.5	38.6	23.9	8.5	4.0	0.8	23.6
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"esophagus: 1969.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 184.4;Hofbauer cells: 306.0;Langerhans cells: 292.6;Squamous epithelial cells: 469.7;Suprabasal keratinocytes: 336.6;Urothelial cells: 464.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 63.8;myeloid DC: 61.7;neutrophil: 240.2"	"Group enriched"	"Detected in many"	694	"dendritic cells: 61.7;granulocytes: 240.2;monocytes: 63.8"	"Cell line enhanced"	"Detected in some"		"A-431: 59.1;HaCaT: 112.3;RT4: 106.6;THP-1: 27.3"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	NA	NA	291000	45000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	13.0	2.1	0.2	46.7	0.4	233.3	9.0	0.4	1.3	278.1	1.1	4.4	10.7	2.5	2.9	1969.7	2.1	17.0	2.5	0.3	0.3	1.6	248.5	20.1	1.4	0.4	0.5	0.9	1.8	2.0	2.3	21.1	0.8	2.4	4.0	0.0	287.1	7.5	0.8	128.6	8.8	3.9	0.8	14.7	45.5	6.4	1.3	5.2	6.4	3.0	311.7	185.7	465.0	0.6	59.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.9	0.0	0.2	0.0	0.6	0.2	0.2	0.0	1.1	112.3	0.0	3.3	0.0	0.1	0.0	0.3	0.0	17.3	0.0	0.3	20.3	0.0	14.3	0.7	0.0	2.0	0.0	0.0	0.3	0.3	0.0	0.5	0.1	14.7	0.0	13.2	0.0	0.0	0.1	0.1	0.0	106.6	0.0	0.0	0.1	0.8	0.1	0.0	0.0	27.3	0.3	1.4	0.0	0.7	0.1	0.6	0.1	0.2	10.3	10.5	0.3	0.0	63.8	1.9	0.0	27.7	0.0	0.1	0.0	0.0	61.7	0.1	0.1	0.1	240.2	0.0	13.7	0.8	0.1	19.8	0.2	0.4	0.4	1.3	0.3	0.3	0.4	0.5	0.8	0.8	1.3	0.6	1.7	6.4	7.7	0.0	4.1	184.4	81.3	151.8	56.9	0.0	4.9	3.4	0.4	11.5	60.6	3.7	0.0	1.8	0.2	6.5	0.0	27.5	34.8	7.8	1.4	4.8	0.0	3.2	0.3	28.0	2.9	11.0	44.4	23.6	10.1	0.0	3.3	53.0	306.0	0.0	0.2	1.1	6.1	39.8	292.6	93.3	0.6	111.1	24.9	0.0	22.6	0.0	2.1	0.5	0.2	149.9	0.1	0.4	2.8	58.4	9.3	0.2	20.2	0.0	0.0	0.3	3.8	0.8	0.2	469.7	336.6	4.5	3.3	0.0	3.2	464.9
IL31RA	"CRL, CRL3, GLM-R, Glmr, IL-31RA"	ENSG00000164509	"Interleukin 31 receptor A"	Q8NI17	5	55851357-55922854	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.6;lymphoid tissue: 2.1;testis: 1.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;Late spermatids: 1.2;Spermatocytes: 2.5;Syncytiotrophoblasts: 1.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 26.3;HBEC3-KT: 10.3;HHSteC: 9.5;hTERT-HME1: 11.5;U-2 OS: 16.8;U-87 MG: 20.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"HPA051532, HPA068114"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA051532: , HPA068114: AB_2732779"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.75e-5)"	"unprognostic (5.55e-2)"	"unprognostic (2.65e-6)"	"unprognostic (7.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.76e-2)"	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.1	1.8	0.0	2.1	0.0	0.6	0.1	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.4	0.5	0.2	0.5	0.3	0.1	0.0	0.2	0.0	0.0	0.4	26.3	0.0	0.0	10.3	2.2	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	7.3	2.9	4.8	11.5	0.6	4.1	0.1	0.0	0.4	1.4	0.0	0.0	1.2	0.0	0.0	6.8	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.5	2.0	0.5	16.8	0.0	0.8	0.0	0.0	0.0	20.8	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.3	0.3	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.1	2.5	0.6	0.0	0.1	1.1	0.0	0.7	0.0	0.0
IL33	"C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV"	ENSG00000137033	"Interleukin 33"	O95760	9	6215786-6257983	"Predicted intracellular proteins, Predicted secreted proteins"	Transcription	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 120.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 141.8;Fibroblasts: 87.5;Hepatic stellate cells: 499.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 53.6;U-2197: 162.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007057, HPA022899, HPA024426"	Supported		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"CAB007057: , HPA022899: , HPA024426: AB_1845820"	"prognostic favorable (4.42e-4)"	"unprognostic (8.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.85e-3)"	38.7	16.7	9.2	44.6	9.3	0.2	27.2	7.0	12.1	56.2	6.4	24.8	8.8	50.0	15.9	24.5	25.9	33.4	40.9	8.5	10.8	5.0	36.7	53.0	47.1	7.8	8.3	5.0	3.4	3.7	5.7	61.1	7.1	30.0	19.4	2.0	18.9	31.5	6.1	44.0	15.6	50.8	8.3	20.5	33.6	5.8	10.8	13.1	12.6	13.8	43.0	120.7	21.2	8.6	0.0	0.0	0.0	0.0	0.3	1.4	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.1	16.9	0.3	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.7	0.3	0.4	53.6	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	162.9	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	9.3	7.0	12.1	8.5	10.8	7.8	8.3	7.1	8.3	10.8	8.6	63.5	6.4	7.2	39.5	1.0	24.2	17.0	73.9	27.3	0.0	9.4	4.1	5.8	4.3	77.8	0.0	0.0	0.0	0.1	2.2	0.0	3.0	0.5	12.4	7.1	141.8	10.7	8.0	0.2	7.9	0.0	87.5	48.4	20.6	1.3	0.0	499.4	5.0	0.1	0.0	0.1	0.2	2.0	20.8	10.2	1.6	20.5	1.7	1.8	1.0	0.0	9.5	0.0	0.5	0.1	12.1	0.2	12.4	0.2	5.2	0.0	0.0	62.1	0.1	0.0	65.5	11.5	0.0	0.4	3.3	48.4	0.1	1.2	0.1	1.1	4.9
IL36G	"IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1"	ENSG00000136688	"Interleukin 36 gamma"	Q9NZH8	2	112973203-112985658	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"esophagus: 14.3;lymphoid tissue: 39.4;skin 1: 31.3"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 136.0;Club cells: 36.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 36.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.1;HaCaT: 1.0"	"Not detected"	"Not detected"							HPA068168			Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		11000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA068168: "	"unprognostic (1.56e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"			"unprognostic (5.79e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.06e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	3.9	0.2	0.0	31.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	39.4	0.8	3.6	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	136.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.7	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	3.9	0.0	0.0	0.0	1.3	0.2	0.0	1.7	13.2	0.0	0.0	0.0	0.0	7.8
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 136.8"	"Cell type enriched"	"Detected in some"	26	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.7;PC-3: 5.9;RT4: 3.2"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	76700		"Cluster 48: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"		"HPA054371: AB_2682465, HPA057950: AB_2683561"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.1	0.0	0.0	0.2	0.0	0.2	16.7	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.1	0.4	136.8	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.1	0.2	2.7	0.2	0.2	0.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.4	0.8	0.1	0.0	1.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.2	0.2	5.9	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	73.2	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.8	0.0	0.1	0.0	0.0	0.0
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 18.3;testis: 26.8"	"Group enriched"	"Detected in many"	5	"Langerhans cells: 295.1;monocytes: 682.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 35.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 103.4"	"Group enriched"	"Detected in many"	6	"monocytes: 36.8;T-cells: 103.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 34.3;HDLM-2: 62.4;Karpas-707: 47.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	1.6	0.6	0.4	18.3	0.6	4.2	0.9	0.8	0.6	1.1	0.7	1.7	4.1	1.6	0.2	0.6	3.9	2.0	0.5	0.6	0.5	4.8	1.2	2.4	9.3	1.7	0.9	0.4	0.7	0.2	0.6	1.9	1.8	0.8	1.4	0.1	0.9	0.5	0.3	1.3	2.7	1.5	1.0	4.1	3.1	26.8	1.2	3.4	0.5	0.2	6.7	4.5	0.5	2.3	1.0	1.2	0.8	0.7	0.0	0.8	0.3	0.5	2.0	1.4	2.1	0.7	1.9	3.5	34.3	0.4	2.9	0.5	0.4	0.0	0.2	62.4	0.2	1.6	0.1	0.5	0.1	1.2	12.3	1.0	0.4	0.6	0.1	0.4	2.6	0.4	0.4	47.3	0.1	0.4	0.7	2.1	0.4	0.9	0.1	1.0	0.9	3.6	2.5	3.2	0.7	0.8	0.5	0.9	0.5	0.2	0.4	2.8	2.9	7.1	1.0	0.1	1.0	4.1	9.7	2.0	1.0	0.5	0.7	0.3	22.0	0.3	6.4	36.8	103.4	0.4	13.2	11.5	11.6	0.2	0.3	0.1	0.5	1.3	5.3	1.3	0.7	8.8	0.4	0.6	0.8	0.6	0.6	0.5	1.7	0.9	1.8	1.0	1.2	2.3	0.8	0.0	0.0	0.0	3.6	9.7	0.6	9.8	0.0	0.1	1.2	1.3	0.5	0.0	5.5	3.7	0.0	0.4	1.0	0.2	0.0	3.5	75.4	2.9	0.6	6.7	0.0	0.0	0.4	4.0	0.7	1.3	0.5	2.1	1.3	0.1	1.1	0.2	97.4	0.0	0.4	0.3	6.1	3.0	295.1	18.4	0.3	38.8	3.6	1.9	682.5	0.1	1.0	0.0	0.4	0.5	0.1	0.4	0.7	1.4	0.3	2.7	1.6	0.2	0.0	0.2	2.5	45.2	3.6	0.4	8.2	0.8	6.3	0.0	0.2	2.1
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;granulocytes: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 78.1"	"Group enriched"	"Detected in all"	5	"B-cells: 78.1;granulocytes: 31.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.2;HBEC3-KT: 115.0;HDLM-2: 110.6;U-698: 119.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	38500	110000	"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	49.4	45.2	22.7	82.3	19.7	103.4	34.1	19.2	22.0	39.7	21.4	97.0	27.3	35.8	5.9	70.8	42.3	41.2	34.2	18.7	21.0	50.8	116.0	119.2	117.1	29.4	22.2	14.3	29.8	31.7	14.9	39.3	24.0	49.9	35.6	2.4	20.5	25.6	9.3	24.4	55.7	37.3	25.5	90.0	55.0	15.5	25.3	22.3	24.2	6.6	89.6	63.2	45.4	23.8	39.9	10.1	6.4	13.1	3.1	14.1	14.3	24.7	27.3	9.3	7.7	20.4	105.2	124.2	30.1	38.5	18.3	39.7	7.3	115.0	8.2	110.6	4.0	22.6	6.6	31.6	40.8	6.1	61.7	23.5	45.0	44.2	26.5	48.7	50.7	6.8	10.5	9.8	15.0	17.3	0.7	18.8	8.0	34.2	9.1	0.4	47.5	10.2	42.9	43.2	1.9	0.6	3.7	24.7	5.0	15.6	8.2	23.5	81.0	21.0	9.8	19.0	17.6	6.1	2.1	119.7	2.1	21.1	0.3	1.4	7.2	13.0	4.2	3.1	3.4	25.8	6.9	4.4	4.1	78.1	10.0	5.0	31.1	8.2	1.8	4.8	5.3	5.8	22.7	19.7	19.2	22.0	18.7	21.0	29.4	22.2	24.0	25.5	25.3	23.8	30.5	28.9	49.2	0.7	92.0	13.3	43.3	34.9	26.2	0.3	9.4	14.2	2.4	34.3	33.4	1.8	0.0	17.6	29.8	60.0	0.0	39.5	0.3	6.6	2.2	39.0	23.4	5.2	1.7	32.3	3.8	17.2	32.1	17.2	110.8	0.7	62.8	45.9	27.2	0.0	0.6	35.5	8.2	30.6	29.9	0.8	0.3	34.3	14.2	38.4	39.3	0.0	7.2	0.5	0.7	49.3	28.7	0.0	13.4	37.7	24.0	1.2	28.5	0.2	39.5	16.4	20.0	0.8	3.3	23.8	14.9	24.9	38.3	0.2	16.7	46.9
ILF2	NF45	ENSG00000143621	"Interleukin enhancer binding factor 2"	Q12905	1	153661788-153671028	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007484	Supported		Supported	Nucleoplasm		No	No		3400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA007484: AB_1079137"	"unprognostic (1.97e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-3)"	"unprognostic (9.70e-2)"	"prognostic unfavorable (5.71e-8)"	"unprognostic (2.64e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.61e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.09e-1)"	81.4	84.2	42.3	81.5	44.1	158.1	100.7	45.9	51.1	75.4	51.2	80.5	57.4	75.6	85.7	99.1	77.5	61.0	71.3	43.5	47.9	97.6	69.0	76.1	97.7	44.8	44.9	75.4	79.7	101.7	75.3	86.1	46.1	63.5	91.3	43.4	84.3	61.2	114.6	90.0	63.3	79.2	46.8	78.1	76.9	101.2	44.6	189.7	88.7	85.9	132.4	105.8	69.5	50.6	323.3	244.7	420.1	297.8	173.1	162.4	336.2	233.5	263.6	411.9	294.5	362.1	254.3	441.5	349.5	233.6	198.8	239.3	508.8	248.3	394.6	242.0	328.9	330.5	182.2	310.0	158.6	521.0	234.7	149.6	139.7	314.4	339.1	171.7	389.3	256.0	423.5	203.4	347.2	424.3	702.8	215.4	607.5	468.5	366.2	502.1	367.2	418.3	194.8	304.0	379.5	350.2	272.3	336.1	272.3	392.0	367.2	442.7	239.5	210.7	266.4	191.6	391.8	348.6	522.6	882.9	177.2	314.1	327.2	168.7	158.1	118.1	147.4	156.0	188.0	198.7	169.8	160.3	219.2	165.0	190.7	164.8	14.8	218.5	129.7	212.2	212.6	357.3	42.3	44.1	45.9	51.1	43.5	47.9	44.8	44.9	46.1	46.8	44.6	50.6	101.4	57.7	68.5	6.8	102.1	197.9	220.9	238.0	129.7	38.0	113.5	112.1	62.2	70.1	130.4	38.6	27.1	215.3	99.0	54.2	131.0	209.9	73.9	81.6	84.4	114.0	106.8	113.0	9.4	156.4	259.3	110.8	50.4	103.0	94.4	107.0	49.2	31.5	124.8	28.6	10.5	87.2	164.8	54.9	117.4	33.1	60.0	74.0	112.1	9.4	112.9	82.8	61.8	10.6	17.1	145.4	63.5	65.8	125.4	139.9	45.5	201.6	80.7	36.3	65.7	102.4	124.2	360.3	159.9	119.1	158.8	260.4	101.4	144.9	110.9	181.0
ILF3	"DRBP76, MPHOSPH4, MPP4, MPP4110, NF110, NF110b, NF90, NF90a, NF90c, NF90ctv, NFAR-1, NFAR-2, NFAR110, NFAR90, TCP110"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1600000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	49.2	58.5	31.6	79.4	31.5	179.5	49.8	44.2	37.5	60.8	38.5	56.0	52.0	64.5	40.9	60.4	61.1	31.9	49.0	31.4	37.9	43.1	32.1	50.5	82.9	30.6	32.8	76.5	52.6	55.5	53.8	47.8	29.7	52.4	44.8	69.5	54.0	48.8	83.6	58.7	56.1	49.8	29.4	61.7	47.8	78.9	35.4	97.3	61.6	58.2	72.3	56.1	52.1	42.8	285.9	226.7	359.5	330.9	76.5	104.0	208.9	178.1	149.6	291.8	226.5	261.8	160.8	353.2	172.1	160.8	178.0	248.9	392.5	240.7	260.9	227.2	349.5	459.3	206.9	247.5	109.2	334.8	219.5	99.0	105.0	232.1	257.4	111.1	253.1	201.7	400.0	269.4	172.3	233.8	558.1	534.0	433.3	149.2	246.2	405.2	342.2	244.2	116.3	297.1	395.1	286.7	229.0	179.4	131.6	161.6	152.2	212.0	205.2	237.6	224.2	249.3	356.5	228.9	339.7	431.4	132.8	351.6	262.2	20.2	18.1	10.2	24.4	14.1	20.6	19.3	20.2	22.3	22.8	22.9	19.5	20.2	2.7	21.3	21.2	25.1	20.6	11.8	31.6	31.5	44.2	37.5	31.4	37.9	30.6	32.8	29.7	29.4	35.4	42.8	63.6	99.3	133.9	34.3	106.2	86.2	110.0	64.2	104.7	95.4	77.5	64.3	69.7	60.1	98.8	42.3	85.5	90.0	100.0	78.4	27.4	89.0	21.2	89.8	105.7	77.4	114.0	124.3	24.4	80.4	111.1	94.8	101.9	121.4	96.8	145.9	36.8	47.9	71.4	94.2	34.0	85.6	50.8	55.0	68.3	21.0	76.4	75.8	39.2	24.4	66.0	69.2	92.7	31.7	28.9	88.2	55.6	62.4	124.9	144.6	38.8	47.2	82.9	103.6	32.9	100.3	80.1	137.2	120.6	113.8	77.0	70.9	103.5	140.8	111.7	94.9
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		30000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	108.0	77.2	49.8	85.1	52.4	43.7	91.8	51.7	50.6	151.6	55.0	398.2	66.4	359.1	81.8	115.5	164.2	88.0	175.9	47.4	50.7	78.8	65.9	107.9	72.4	51.8	50.6	101.0	89.3	73.2	47.1	98.8	50.9	182.7	116.8	28.3	69.5	412.2	90.8	61.5	117.4	364.7	51.1	95.5	149.7	26.5	53.7	45.8	72.0	92.0	70.5	226.7	118.8	51.9	127.8	94.4	148.9	51.8	224.8	159.4	67.2	182.2	360.0	211.9	256.0	102.7	145.7	47.0	47.0	304.1	206.9	99.5	84.4	155.6	213.0	83.5	74.3	69.1	84.9	82.8	150.8	55.9	74.7	153.2	72.8	143.8	108.9	217.7	206.9	40.5	63.7	55.0	282.8	97.1	49.4	97.4	94.3	107.5	110.8	51.0	77.8	50.5	160.3	100.8	25.6	57.4	86.0	118.4	103.6	144.0	82.2	62.2	238.8	263.9	118.0	111.1	90.7	38.9	25.9	67.1	195.6	82.8	125.3	314.9	260.0	417.6	127.3	258.1	124.9	96.9	114.4	122.3	242.7	92.9	70.2	88.5	165.5	257.8	254.8	98.5	142.8	402.8	49.8	52.4	51.7	50.6	47.4	50.7	51.8	50.6	50.9	51.1	53.7	51.9	79.5	44.8	17.9	24.2	33.6	50.5	73.7	100.6	24.5	21.5	43.1	68.2	0.5	70.1	49.7	57.0	8.4	119.8	46.0	71.9	58.7	136.1	64.6	33.2	78.1	69.4	37.9	53.7	14.6	125.0	177.7	83.2	50.4	52.5	30.4	41.6	76.4	31.4	127.4	8.4	17.1	50.1	69.2	51.5	97.7	143.7	71.4	115.9	85.4	30.9	143.0	54.3	77.2	15.6	15.3	117.1	60.0	147.4	35.1	42.0	74.5	98.6	31.0	32.9	157.8	53.3	165.8	31.7	17.1	32.3	43.2	110.0	49.3	65.0	50.1	43.9
ILKAP	"DKFZP434J2031, FLJ10181, PPM1O"	ENSG00000132323	"ILK associated serine/threonine phosphatase"	Q9H0C8	2	238170402-238203708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004752, HPA056099"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004752: AB_1851753, HPA056099: AB_2797255"	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (6.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-1)"	20.5	17.4	24.3	15.1	25.6	29.0	19.5	26.5	26.9	26.2	22.3	30.8	14.6	25.1	15.3	23.2	23.4	8.7	24.2	23.8	24.9	26.0	26.2	18.6	20.5	24.9	24.2	24.5	20.6	13.1	26.5	12.9	24.1	25.2	12.9	13.0	17.3	14.5	41.4	22.4	23.3	16.1	23.9	25.9	21.4	23.1	24.6	17.9	23.9	18.3	18.1	26.6	21.8	27.4	40.5	25.6	36.9	36.3	28.1	18.6	37.9	41.5	27.9	40.9	35.4	23.7	20.9	25.8	10.5	30.1	48.8	33.8	48.1	34.4	41.2	46.6	49.8	66.7	26.0	52.7	43.3	43.7	50.3	19.6	23.3	43.6	43.6	20.2	31.1	34.0	52.4	16.1	35.4	48.1	43.4	58.0	34.8	37.4	25.9	52.6	75.6	23.7	30.4	18.8	54.1	26.7	28.2	29.6	68.9	27.9	23.3	43.7	28.9	39.7	36.7	53.5	45.1	28.6	31.4	46.7	32.5	47.3	34.3	43.4	19.8	27.1	28.2	25.6	25.4	24.7	24.9	26.4	27.7	24.0	28.8	22.9	7.3	24.8	21.4	20.9	30.7	23.0	24.3	25.6	26.5	26.9	23.8	24.9	24.9	24.2	24.1	23.9	24.6	27.4	27.7	12.8	22.0	43.8	35.4	27.0	29.1	30.8	25.0	28.9	19.4	21.6	23.1	17.2	19.6	25.8	29.2	41.2	51.5	22.4	43.0	27.9	8.1	17.1	20.6	21.5	19.1	64.2	37.7	28.5	43.7	26.7	29.0	16.1	33.7	43.5	22.1	19.2	34.4	38.7	33.2	24.0	16.2	17.0	22.0	12.6	28.3	24.0	30.2	25.3	34.0	25.1	57.7	36.7	72.2	24.8	16.2	29.3	33.6	29.7	24.1	33.4	19.3	28.6	32.9	29.2	47.4	54.4	70.8	29.2	28.7	40.4	36.6	23.0	27.4	23.5
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP U3 small nucleolar ribonucleoprotein 3"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Nucleoli"		"HPA060955: AB_2684397, HPA061177: AB_2684445"	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	45.8	61.8	37.1	26.4	38.7	29.3	43.9	39.3	49.1	36.9	46.6	43.4	36.6	30.1	30.4	79.8	32.7	14.2	53.1	38.3	41.6	49.6	90.4	33.9	34.9	38.7	36.7	33.3	50.6	23.2	40.1	21.1	39.5	39.7	24.4	17.8	44.8	22.2	71.5	71.6	51.6	14.0	40.0	63.0	50.9	16.8	38.7	34.7	36.1	33.1	38.4	35.1	47.4	41.2	75.1	82.9	39.5	68.8	68.6	39.0	58.5	61.6	48.8	49.3	56.6	64.1	64.3	88.7	65.5	32.2	54.5	121.7	131.1	100.0	43.4	67.2	157.3	93.6	64.9	112.8	50.6	95.9	62.5	36.1	81.0	39.8	48.8	36.6	32.8	71.3	122.8	70.4	45.4	89.9	76.3	232.9	106.4	75.7	86.4	82.1	48.4	98.3	68.1	100.2	67.1	69.4	52.2	89.8	119.4	56.8	78.5	87.9	37.6	64.0	51.9	46.4	84.6	95.4	188.5	100.3	70.7	153.2	43.0	80.6	109.0	85.2	137.4	87.3	148.8	143.2	131.5	133.8	117.4	127.3	150.7	144.3	13.7	126.4	87.4	119.3	140.9	192.2	37.1	38.7	39.3	49.1	38.3	41.6	38.7	36.7	39.5	40.0	38.7	41.2	85.9	38.5	41.6	6.5	81.4	228.5	93.1	177.0	149.7	22.4	72.1	79.4	12.1	77.2	89.7	40.5	14.6	106.8	79.0	47.5	144.8	105.2	1.6	71.7	54.9	74.0	43.9	56.8	6.8	105.9	106.5	63.0	78.0	70.9	48.7	50.8	76.4	114.1	94.2	21.9	7.1	71.2	93.6	54.3	106.6	6.6	60.9	51.0	97.8	8.4	118.0	58.2	152.4	6.0	10.2	113.7	56.0	44.0	66.5	107.0	113.8	209.5	65.2	23.7	26.3	46.1	50.7	13.9	38.2	144.4	237.4	54.9	83.3	77.2	98.8	86.9
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030877	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 359.1;skeletal muscle: 257.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 440.3;Extravillous trophoblasts: 272.2;Proximal tubular cells: 498.6;Squamous epithelial cells: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 26.0;neutrophil: 31.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 9.0;granulocytes: 31.3;monocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 258.2;OE19: 299.8;SiHa: 155.1"	"Low region specificity"	"Detected in all"							HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	19.8	11.1	2.5	12.3	3.2	31.5	14.8	1.8	4.4	31.0	5.3	50.0	22.4	16.2	1.7	131.2	16.3	19.9	29.5	2.5	2.4	129.4	47.4	23.2	5.7	2.2	2.4	7.8	359.1	5.3	11.1	22.0	2.1	13.7	30.7	0.8	31.0	5.9	257.1	150.0	29.2	15.6	2.3	19.0	53.7	2.9	2.6	5.0	17.4	89.8	7.3	61.0	50.8	2.3	29.3	41.7	11.3	20.4	14.1	10.5	258.2	7.2	18.4	2.9	4.2	35.4	21.7	6.1	17.4	10.1	24.1	19.8	13.2	6.9	0.8	33.5	22.5	0.0	56.0	30.6	8.3	47.5	2.3	23.9	36.3	10.0	5.2	8.5	3.9	30.7	7.4	0.0	10.7	31.8	19.4	27.1	40.5	299.8	42.7	36.0	29.6	28.6	122.1	15.6	15.0	0.3	155.1	35.8	16.2	14.5	33.3	58.5	0.0	5.6	11.5	73.7	7.3	24.5	66.3	17.9	24.0	31.7	9.6	9.4	11.4	26.0	0.7	8.7	0.3	1.5	0.7	0.2	9.0	0.3	0.3	0.5	31.3	0.1	5.8	6.7	1.1	3.1	2.5	3.2	1.8	4.4	2.5	2.4	2.2	2.4	2.1	2.3	2.6	2.3	9.2	19.2	32.7	17.6	7.8	105.5	22.7	32.1	159.4	0.7	16.8	20.2	11.6	72.9	16.1	22.0	0.0	52.5	5.8	72.9	440.3	83.4	2.8	5.7	20.2	6.9	17.5	15.3	4.7	110.6	272.2	16.1	65.2	30.4	2.5	13.4	10.0	66.8	42.5	0.0	1.8	90.2	65.1	37.7	17.0	7.1	4.7	34.2	14.2	5.6	25.5	22.3	2.1	0.5	0.5	56.1	50.1	3.8	8.6	42.9	36.9	498.6	12.3	1.0	105.2	16.0	27.6	0.8	10.1	202.1	141.4	106.3	6.1	14.0	84.4	52.8
IMPACT	RWDD5	ENSG00000154059	"Impact RWD domain protein"	Q9P2X3	18	24426634-24453531	"Predicted intracellular proteins"	"Differentiation, Neurogenesis, Stress response, Translation regulation"	"Actin-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 65.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 65.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA041045, HPA041968"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA041045: AB_10793866, HPA041968: AB_10795603"	"unprognostic (1.13e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (7.90e-4)"	"unprognostic (5.60e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.60e-3)"	19.3	21.0	10.1	12.0	11.5	15.8	25.1	11.2	10.4	15.5	9.6	18.0	16.1	16.4	18.9	21.7	14.2	12.7	19.3	8.6	18.1	24.4	22.3	15.7	11.5	12.2	14.7	17.1	20.5	27.8	10.0	15.0	12.2	18.0	14.9	10.1	25.0	16.0	20.3	11.4	16.5	13.0	12.2	15.2	15.9	34.5	21.9	11.2	32.5	13.1	12.0	12.7	8.0	12.5	27.8	15.6	26.4	33.0	25.2	37.8	43.1	36.4	43.1	20.1	19.9	5.4	23.8	16.7	35.8	38.9	12.4	31.9	9.1	40.3	29.7	0.1	8.2	24.9	14.9	8.8	38.0	99.0	23.1	33.0	30.6	13.4	82.1	24.2	38.7	0.0	21.2	0.2	33.6	25.6	0.2	17.5	44.0	48.8	17.1	0.1	51.6	8.4	22.0	43.2	21.8	26.9	51.6	22.6	37.7	20.8	31.9	33.2	48.0	80.5	10.4	15.3	15.6	31.0	43.0	0.3	32.4	12.3	35.5	65.8	9.6	18.4	4.2	12.2	5.6	4.0	5.5	4.1	12.3	5.3	5.6	4.7	1.5	9.0	9.0	8.5	8.0	6.0	10.1	11.5	11.2	10.4	8.6	18.1	12.2	14.7	12.2	12.2	21.9	12.5	20.8	19.2	14.9	11.1	10.9	11.3	11.5	23.5	18.2	11.3	34.6	26.0	30.4	17.2	22.9	14.7	2.1	30.7	11.0	10.8	37.2	19.5	17.2	21.2	24.2	18.8	15.6	23.3	7.6	22.4	20.2	20.1	16.8	13.7	20.3	43.3	15.0	33.5	26.4	5.0	13.7	25.6	26.4	19.8	10.4	21.0	16.1	21.6	19.6	5.6	25.3	41.7	7.2	10.1	9.9	20.2	7.1	27.1	11.1	15.1	17.3	47.8	25.4	11.0	13.1	15.3	21.0	83.9	75.6	27.0	14.5	16.4	10.3	52.5	21.9	10.2
INAVA	"C1orf106, FLJ10901"	ENSG00000163362	"Innate immunity activator"	Q3KP66	1	200891048-200915742	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.2;intestine: 55.4;skin 1: 47.0"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 33.3;Endometrial ciliated cells: 26.8;Exocrine glandular cells: 45.5;Glandular and luminal cells: 25.1;Pancreatic endocrine cells: 118.6;Proximal tubular cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 60.3;CAPAN-2: 49.6;HaCaT: 66.0;OE19: 57.8;RPMI-8226: 54.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027499, HPA027511, HPA079622"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nuclear bodies"	"HPA027499: AB_10599708, HPA027511: AB_10600334, HPA079622: "	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.84e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.73e-2)"	0.1	0.0	1.4	4.0	1.4	4.5	1.7	0.8	1.3	8.8	1.8	33.8	47.3	1.1	0.5	44.2	4.2	16.3	0.2	1.4	1.4	15.3	0.4	3.5	0.4	1.1	1.4	0.1	13.2	0.1	0.3	1.9	1.0	7.0	30.1	0.4	12.3	2.6	0.2	47.0	55.4	1.1	1.0	0.3	27.3	1.1	1.5	0.9	0.1	0.0	5.7	17.1	20.3	1.0	27.5	40.8	23.3	0.0	0.0	0.0	60.3	0.0	0.0	0.7	0.5	43.4	49.6	0.0	13.3	0.0	1.1	66.0	0.0	17.4	0.5	0.0	5.0	3.8	1.8	17.2	0.1	8.5	0.8	0.0	26.1	0.4	1.1	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.1	1.4	45.2	57.8	9.2	0.2	9.7	54.0	24.4	34.9	0.1	2.8	2.6	41.5	0.0	27.3	17.1	7.9	0.0	0.1	10.1	0.1	2.9	46.2	20.6	0.0	0.1	8.6	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.4	1.4	0.8	1.3	1.4	1.4	1.1	1.4	1.0	1.0	1.5	1.0	0.6	12.8	7.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.5	3.3	0.0	0.0	5.0	14.7	0.0	7.6	0.1	0.0	5.9	33.3	0.0	26.8	2.2	0.7	0.0	0.0	0.0	45.5	13.2	0.4	0.0	25.1	1.3	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.6	0.0	0.0	0.0	0.0	0.0	26.0	4.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.5	0.3	0.0	0.0
INCA1		ENSG00000196388	"Inhibitor of CDK, cyclin A1 interacting protein 1"	Q0VD86	17	4988130-4997610	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 47.8"	"Group enriched"	"Detected in many"	19	"Early spermatids: 130.0;Late spermatids: 306.6;Spermatocytes: 211.3;Spermatogonia: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044359, HPA052401"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA044359: AB_10794289, HPA052401: AB_2681816"	"unprognostic (1.78e-2)"	"unprognostic (9.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.66e-2)"	"prognostic favorable (3.61e-5)"	"unprognostic (3.14e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	2.9	3.7	3.2	6.3	3.4	1.6	2.1	4.3	4.2	3.6	2.0	3.3	10.8	5.2	0.8	5.1	3.2	7.1	6.6	3.0	3.8	4.0	3.8	4.6	8.5	4.3	3.4	8.1	3.9	1.6	2.2	3.0	4.5	4.5	1.2	4.4	5.7	1.7	10.6	8.0	7.9	2.2	3.6	7.3	5.0	47.8	4.3	0.4	8.0	4.8	0.4	2.7	2.4	3.9	5.0	5.6	3.9	3.7	2.6	1.0	4.7	5.3	0.5	1.4	1.5	4.0	5.9	23.9	3.5	1.4	4.6	14.0	0.7	0.3	0.8	10.0	5.9	5.2	7.6	2.7	1.8	0.8	12.2	1.5	0.0	0.8	0.4	8.5	0.5	8.4	6.6	10.9	1.0	2.6	7.4	1.7	1.7	2.3	1.5	9.0	2.0	2.2	0.9	1.6	11.7	3.5	2.6	3.4	3.1	4.1	7.0	1.1	10.8	4.9	1.8	4.7	4.1	1.8	1.0	1.1	4.8	12.6	2.5	0.2	0.8	0.0	0.2	1.5	0.6	0.4	0.4	0.5	0.3	0.2	0.7	0.6	0.2	0.0	1.2	0.4	0.2	0.2	3.2	3.4	4.3	4.2	3.0	3.8	4.3	3.4	4.5	3.6	4.3	3.9	1.0	0.0	1.1	1.0	0.6	1.1	1.5	1.2	0.6	0.5	0.9	0.8	1.0	1.5	1.2	3.7	2.1	0.6	0.1	9.3	0.0	0.7	130.0	0.6	0.8	1.3	0.0	2.7	0.8	1.6	0.7	1.3	1.5	0.6	4.5	2.5	0.7	1.4	1.2	0.0	0.9	2.0	2.0	0.0	1.5	306.6	7.2	1.1	1.8	1.0	0.7	6.1	0.0	1.0	1.1	1.2	9.3	1.2	0.1	0.4	5.2	2.2	1.5	0.8	6.6	2.0	1.9	211.3	87.1	0.3	0.9	0.8	0.2	0.7	2.9	0.8
INCENP	FLJ31633	ENSG00000149503	"Inner centromere protein"	Q9NQS7	11	62123998-62153169	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.9"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"basophil: 1.2;NK-cell: 1.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;NK-cells: 1.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013292, HPA051339, HPA070550"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279"	"unprognostic (6.31e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (1.74e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.78e-3)"	3.1	2.5	2.7	7.5	1.1	20.9	2.8	6.2	3.0	4.6	0.0	4.8	6.8	3.0	8.1	14.0	3.5	2.2	2.8	2.9	0.5	2.4	1.9	3.0	11.6	1.6	0.8	3.8	3.1	3.1	1.5	4.1	1.3	2.5	3.6	3.4	6.1	2.9	4.2	7.9	5.7	3.4	0.1	5.5	4.5	6.4	0.5	17.8	5.1	3.4	8.2	2.8	5.5	1.2	74.3	69.4	51.6	45.5	6.8	8.4	28.1	47.6	21.2	44.4	28.3	37.0	50.7	70.0	36.2	16.0	46.2	72.6	52.2	28.4	31.8	60.5	36.6	45.7	68.0	29.6	2.7	53.5	62.1	4.3	6.5	41.3	23.6	6.8	25.8	50.2	48.8	57.6	25.3	59.7	85.0	43.3	56.2	28.0	34.4	79.3	66.4	53.4	12.0	35.8	40.1	42.2	46.8	30.8	27.9	19.8	48.2	19.4	28.5	41.8	51.9	59.8	50.0	29.7	48.3	75.8	23.5	34.7	50.6	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.7	1.1	6.2	3.0	2.9	0.5	1.6	0.8	1.3	0.1	0.5	1.2	1.2	3.2	2.3	1.3	3.4	5.6	0.8	1.0	2.8	2.4	1.1	0.6	1.3	0.0	3.7	0.0	0.0	4.2	4.2	5.4	0.0	1.9	1.0	2.0	2.1	1.5	0.0	10.9	3.3	2.5	7.1	1.9	9.2	2.7	3.8	5.7	0.0	0.7	4.2	0.0	2.5	3.4	0.0	0.9	1.6	0.5	2.8	3.3	3.6	1.0	5.0	1.5	3.1	2.0	1.5	2.2	1.6	1.5	10.9	1.2	1.3	0.3	2.6	2.3	0.0	1.9	4.3	6.5	7.8	15.1	3.3	2.2	3.7	1.9	4.8	1.1
ING1	"p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a"	ENSG00000153487	"Inhibitor of growth family member 1"	Q9UK53	13	110712736-110723339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 212.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016136, CAB017773, HPA052591"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB016136: AB_628077, CAB017773: , HPA052591: AB_2681876"	"unprognostic (1.14e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (5.81e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.40e-3)"	13.7	7.3	5.9	8.6	6.2	20.2	10.2	6.5	10.2	10.6	5.9	13.4	9.7	12.6	5.3	8.3	14.4	6.7	9.1	6.6	6.7	9.5	18.6	12.8	9.7	7.2	6.2	22.4	8.2	3.1	9.4	7.7	6.4	11.2	4.3	6.7	9.9	4.9	11.7	9.4	12.2	4.8	6.0	14.4	10.0	31.5	6.4	13.0	7.6	9.5	6.3	10.1	9.4	8.0	28.8	11.1	19.8	19.0	9.1	6.1	19.7	14.5	12.1	9.2	11.1	21.5	19.9	18.4	22.9	5.7	14.3	17.8	8.0	7.2	7.7	34.8	15.3	16.3	16.2	16.2	5.2	21.7	15.2	5.6	7.4	8.0	4.8	7.2	6.5	19.6	15.3	15.0	6.0	16.5	37.7	24.9	19.4	17.9	9.3	27.0	10.0	10.4	8.1	14.5	19.4	20.9	14.2	28.3	20.7	6.8	9.5	25.3	9.8	11.3	13.9	11.9	16.5	18.0	19.5	24.0	18.9	17.6	18.8	38.5	4.5	18.0	15.9	5.6	16.7	23.4	13.2	14.2	4.3	27.5	13.5	11.2	6.2	20.4	6.5	4.7	18.8	9.4	5.9	6.2	6.5	10.2	6.6	6.7	7.2	6.2	6.4	6.0	6.4	8.0	87.2	9.6	18.8	5.9	34.5	36.3	15.4	17.0	54.7	16.7	49.8	88.9	27.0	12.8	11.1	7.3	14.6	14.3	32.0	31.5	7.9	11.7	212.5	51.6	58.5	28.6	12.5	12.6	4.4	6.9	78.8	36.1	27.5	55.7	2.5	20.1	11.0	27.4	17.3	3.3	3.8	31.6	12.2	18.2	23.8	45.8	9.3	29.3	17.8	1.9	14.2	17.8	21.6	2.0	4.3	8.0	18.6	14.7	19.7	22.9	34.2	11.5	21.4	21.1	13.1	70.5	57.7	25.5	17.9	48.8	43.8	15.3	29.6	18.0	24.2	22.4
ING2	"ING1L, p33ING2"	ENSG00000168556	"Inhibitor of growth family member 2"	Q9H160	4	183505058-183512429	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019486, HPA021517"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA019486: AB_1851780, HPA021517: AB_10601914"	"prognostic favorable (5.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (7.47e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.30e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.82e-2)"	9.5	42.3	5.2	5.2	5.8	21.7	8.7	6.8	6.8	7.2	5.5	9.4	10.6	5.2	10.2	14.6	8.8	8.9	7.5	5.0	9.6	12.2	10.5	8.6	5.9	6.4	6.4	37.4	15.8	6.1	23.3	6.1	6.0	8.7	6.7	8.6	10.7	4.5	26.1	12.1	14.3	4.6	4.6	9.1	11.5	33.3	8.0	12.5	9.3	14.8	6.7	11.4	9.9	5.3	19.1	11.4	15.5	12.3	28.1	16.4	12.7	20.1	17.4	15.6	13.3	10.4	20.2	13.5	5.2	14.7	12.7	8.3	10.4	15.6	19.8	10.4	7.6	23.4	11.4	13.5	8.5	19.3	25.1	12.7	14.3	17.0	7.1	12.8	7.5	13.0	13.2	49.8	11.5	18.8	24.7	19.6	12.5	5.5	11.1	10.3	8.6	22.5	18.8	8.7	15.3	11.5	13.3	17.6	5.3	10.0	8.3	13.9	6.4	10.5	16.5	7.2	13.0	10.7	8.6	9.1	19.3	14.3	7.6	15.2	6.3	19.7	3.2	6.6	5.0	11.9	6.3	5.7	7.8	8.4	8.8	7.6	6.4	3.8	8.5	7.6	5.4	3.7	5.2	5.8	6.8	6.8	5.0	9.6	6.4	6.4	6.0	4.6	8.0	5.3	18.7	6.4	21.0	6.2	20.1	49.3	20.5	20.7	105.9	25.7	36.3	41.8	12.1	25.8	18.2	16.5	12.5	26.1	18.8	32.7	74.3	20.9	68.4	93.0	26.3	21.7	18.6	26.7	7.1	34.9	94.9	29.1	11.7	82.9	40.0	85.4	15.4	24.1	30.0	25.2	5.3	24.2	16.2	24.2	43.3	35.2	82.6	27.3	26.6	1.0	13.9	40.5	6.2	3.5	5.1	33.3	28.3	53.8	19.5	34.2	112.9	47.8	39.8	23.6	19.7	23.7	28.0	95.3	74.9	71.6	46.2	21.2	25.6	50.4	23.0	39.3
ING3	"Eaf4, FLJ20089, MEAF4, p47ING3"	ENSG00000071243	"Inhibitor of growth family member 3"	Q9NXR8	7	120950763-120977216	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 80.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004762, HPA067388, HPA067575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863"	"unprognostic (1.35e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.09e-3)"	"unprognostic (4.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.64e-2)"	9.3	7.7	3.8	9.9	4.5	80.5	10.1	11.3	5.5	8.3	3.3	9.1	8.2	10.8	10.5	7.4	9.7	8.5	8.5	3.5	4.5	9.7	9.2	10.9	14.9	4.2	4.7	8.9	8.5	7.7	6.0	15.1	4.7	8.0	11.8	7.6	8.6	7.7	4.7	4.6	7.6	13.0	4.8	15.5	9.7	8.1	4.2	18.6	11.5	8.4	13.5	8.5	5.0	5.7	19.3	5.6	24.8	14.0	9.2	7.3	8.3	12.9	10.1	18.1	21.1	7.3	21.6	31.3	5.7	11.3	19.0	9.2	24.1	9.9	20.7	22.1	42.2	22.5	21.2	4.3	12.6	43.8	25.5	5.4	5.0	16.0	11.3	8.7	28.7	19.1	51.0	48.4	17.5	6.7	36.0	26.0	29.9	10.9	10.4	17.6	17.7	25.7	18.4	19.4	22.4	24.1	13.3	26.9	14.0	15.3	6.1	17.0	10.4	18.5	6.8	40.0	23.7	22.2	15.1	46.0	9.3	28.9	15.6	44.0	28.0	26.4	20.1	30.8	19.9	21.7	20.3	18.7	23.4	24.3	20.4	18.6	50.7	30.6	32.3	17.7	27.1	14.8	3.8	4.5	11.3	5.5	3.5	4.5	4.2	4.7	4.7	4.8	4.2	5.7	27.1	19.2	18.4	24.5	37.7	7.6	20.4	17.6	9.1	23.3	16.3	14.4	14.2	11.5	14.0	7.3	4.2	38.8	31.7	19.6	21.5	12.6	7.2	21.5	20.1	24.7	12.0	27.0	14.5	18.0	22.0	19.5	16.8	28.3	33.7	21.8	21.4	14.3	17.9	26.9	21.5	18.7	22.4	35.8	16.6	4.3	13.7	23.4	16.0	18.7	24.3	17.6	27.8	22.6	24.3	15.5	17.7	9.8	26.8	14.0	17.7	12.8	13.5	19.8	19.7	26.9	25.9	16.6	15.3	12.0	11.2	45.7	28.6	25.7	15.4	18.7
ING4	"my036, p29ING4"	ENSG00000111653	"Inhibitor of growth family member 4"	Q9UNL4	12	6650301-6663142	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Chromatin regulator"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031817, HPA057338"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA031817: AB_2674056, HPA057338: AB_2683412"	"unprognostic (2.95e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.65e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.42e-2)"	22.9	26.4	43.8	15.5	44.5	11.6	27.9	45.8	51.7	34.9	40.7	33.7	17.9	27.4	30.7	22.8	27.4	18.1	23.9	44.0	43.9	29.7	25.7	18.6	27.6	44.9	44.0	31.3	19.7	32.0	27.7	21.6	44.8	33.0	21.8	22.3	25.9	23.1	19.3	31.0	26.7	22.5	44.8	37.7	26.9	20.4	44.7	38.5	34.9	23.8	24.5	29.5	27.2	49.3	9.2	12.3	35.8	17.0	27.3	26.9	22.9	12.0	19.4	19.6	23.4	5.6	41.1	15.9	7.8	16.8	15.6	14.3	17.8	14.1	21.7	31.1	26.4	22.9	22.5	11.5	16.0	9.1	10.4	27.3	32.3	10.4	13.3	63.4	29.8	30.6	10.9	8.9	19.0	6.6	33.2	13.9	52.8	20.3	11.7	30.9	18.8	17.0	24.7	10.4	14.7	38.3	18.6	6.2	23.2	51.5	8.2	25.0	22.7	8.1	16.1	9.1	7.9	10.7	15.6	21.6	21.6	14.0	8.3	32.2	31.1	26.8	33.5	43.5	31.2	30.9	27.8	28.7	34.3	48.2	37.9	32.9	20.1	38.0	51.0	26.5	30.9	37.9	43.8	44.5	45.8	51.7	44.0	43.9	44.9	44.0	44.8	44.8	44.7	49.3	20.5	22.4	19.0	15.0	26.8	8.2	11.1	19.1	13.6	31.2	22.2	27.6	10.9	17.2	17.9	18.4	18.8	43.3	37.0	14.4	29.4	25.0	2.0	17.1	21.6	22.4	25.2	18.1	23.1	8.1	11.7	21.8	10.2	14.8	27.9	40.7	20.0	8.9	24.6	35.3	23.0	18.6	30.5	16.6	12.4	6.7	34.5	27.0	10.6	13.1	32.6	34.6	52.5	18.6	20.7	11.9	16.9	37.6	11.7	11.8	21.3	24.4	12.5	26.4	32.9	13.6	21.2	20.7	19.1	9.9	10.1	30.6	22.3	31.8	14.6	9.7
INIP	"C9orf80, HSPC043, hSSBIP1, MISE, SOSS-C"	ENSG00000148153	"INTS3 and NABP interacting protein"	Q9NRY2	9	112683926-112718149	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020382	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA020382: AB_1845840"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.67e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.47e-3)"	"prognostic favorable (2.00e-8)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.26e-1)"	7.4	8.7	8.0	8.4	10.9	10.4	11.4	9.7	11.9	8.0	5.4	10.1	10.3	7.2	8.6	9.8	8.4	8.6	7.5	8.1	9.6	10.8	11.0	8.4	14.5	9.2	8.8	8.2	5.0	10.7	6.5	6.1	9.6	6.9	11.5	10.3	8.1	6.5	6.5	9.2	10.9	7.6	8.4	9.7	7.4	5.4	9.6	14.5	10.6	10.0	14.1	9.3	6.2	15.5	16.5	15.6	21.4	31.0	18.2	19.2	21.9	22.7	12.4	19.4	19.3	19.7	13.2	43.8	13.9	15.7	14.6	22.9	21.0	10.9	25.8	53.0	12.3	18.2	17.6	18.0	11.8	37.1	13.3	10.4	14.7	20.6	16.6	9.5	18.2	22.1	31.7	27.5	21.4	27.8	33.3	19.0	11.1	29.8	28.8	36.5	45.1	18.9	22.2	21.9	27.9	20.9	28.7	18.1	15.7	14.2	27.1	23.1	15.4	16.1	24.7	30.9	22.4	13.7	62.4	37.3	20.4	21.3	27.7	30.4	24.8	32.5	15.7	29.3	20.7	15.5	20.1	23.4	27.1	20.0	21.8	18.9	19.8	18.4	27.0	9.7	20.8	20.3	8.0	10.9	9.7	11.9	8.1	9.6	9.2	8.8	9.6	8.4	9.6	15.5	15.6	22.4	15.6	9.1	19.1	36.7	18.1	31.4	13.1	17.1	19.2	16.5	15.5	15.7	22.4	14.7	16.7	21.4	20.6	19.4	56.7	23.4	3.9	21.0	18.8	18.1	22.3	19.4	18.3	16.1	32.0	14.9	12.8	18.7	26.6	11.2	15.7	17.7	26.1	43.7	15.4	17.1	32.6	24.5	33.5	3.2	14.0	26.2	19.6	3.7	42.3	24.7	34.0	16.6	25.2	24.2	12.3	12.0	11.8	17.9	21.7	31.7	13.0	16.9	0.0	17.3	13.1	17.4	15.8	19.4	41.8	14.8	23.0	12.4	19.8	25.2
INKA1	"C3orf54, FAM212A"	ENSG00000185614	"Inka box actin regulator 1"		3	49803261-49805030	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"skin 1: 24.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.9;Breast myoepithelial cells: 9.7;Endothelial cells: 8.4;Hofbauer cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 59.6;memory B-cell: 65.9;naive B-cell: 64.4"	"Group enriched"	"Detected in many"	7	"B-cells: 65.9;granulocytes: 59.6"	"Cell line enhanced"	"Detected in many"		"HEL: 68.5;HMC-1: 45.1;NB-4: 38.5;THP-1: 42.1;U-937: 34.9"	"Low region specificity"	"Detected in all"							HPA041879	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Vesicles"		"HPA041879: AB_10797269"	"unprognostic (1.36e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.96e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.40e-2)"	5.1	2.3	4.8	2.0	5.0	3.5	4.1	5.2	7.6	6.2	2.8	3.2	0.8	4.7	1.4	19.7	2.8	1.5	5.2	5.3	5.5	5.8	1.1	5.4	4.1	6.2	5.3	2.2	1.3	0.5	2.1	3.1	5.7	6.4	0.5	0.2	4.9	2.1	11.7	24.1	4.3	1.8	5.8	6.7	2.4	2.9	6.5	1.6	2.1	2.3	3.9	5.5	10.3	7.0	1.3	1.1	1.5	1.1	1.8	4.1	0.0	3.0	1.9	1.4	1.7	0.1	0.0	14.9	0.4	2.2	1.5	8.7	0.5	10.4	0.1	2.6	0.0	68.5	0.7	0.2	2.6	10.4	45.1	5.4	14.5	2.9	2.6	0.9	6.1	1.0	4.7	1.2	1.2	0.6	0.9	38.5	1.1	0.0	5.8	13.9	0.8	3.3	0.1	16.9	0.8	5.3	2.7	0.5	1.5	0.4	0.3	42.1	3.8	7.3	0.9	3.4	1.3	1.7	1.7	1.2	3.2	34.9	1.8	59.6	2.4	11.6	1.3	5.9	0.3	65.9	1.5	1.8	0.7	64.4	2.2	3.6	1.3	0.0	8.5	9.3	1.6	6.4	4.8	5.0	5.2	7.6	5.3	5.5	6.2	5.3	5.7	5.8	6.5	7.0	19.9	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.7	0.0	0.5	1.6	8.4	0.0	0.0	0.0	1.2	0.7	3.0	0.0	0.1	0.0	0.1	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.1	0.4	0.5	0.0	0.0
INKA2	"C1orf183, FAM212B, FLJ31105"	ENSG00000197852	"Inka box actin regulator 2"	Q9NTI7	1	111680630-111755824	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"Hofbauer cells: 4.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	13	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 25.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 35.6;U-87 MG: 73.0;WM-115: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027809, HPA027810, HPA027811"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 47: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872"	"unprognostic (1.92e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.81e-2)"	"prognostic favorable (4.51e-5)"	"unprognostic (9.96e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.50e-3)"	"unprognostic (9.92e-5)"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.07e-2)"	7.4	1.0	8.8	3.0	13.0	2.9	4.0	5.0	16.7	2.3	2.0	3.5	1.2	3.9	1.7	6.6	5.1	2.9	13.8	14.6	4.0	2.7	0.9	4.8	1.0	4.3	3.8	2.1	1.2	2.3	0.7	6.1	3.9	3.0	2.4	1.4	2.3	4.0	7.8	5.5	2.4	5.8	3.5	5.3	3.8	2.6	4.0	2.1	2.5	8.9	1.7	2.8	3.4	9.8	2.5	2.3	5.1	3.2	20.5	7.3	1.7	1.8	4.0	3.3	7.8	4.1	0.1	2.0	0.9	1.8	1.6	2.2	2.2	4.9	3.2	4.6	1.9	15.0	1.8	4.0	8.1	1.1	2.3	6.0	20.9	35.6	1.6	0.9	8.9	2.6	0.1	3.3	5.3	2.8	1.1	1.2	1.2	2.4	2.0	2.2	19.4	0.7	0.9	3.5	10.2	3.4	1.1	0.1	9.8	5.6	2.8	3.3	3.5	7.1	11.4	3.9	1.5	20.7	3.8	2.1	73.0	4.5	28.0	0.2	1.8	1.4	0.0	1.4	0.0	0.2	0.1	0.1	1.0	0.4	0.0	0.0	25.2	0.6	2.0	0.5	0.0	0.6	8.8	13.0	5.0	16.7	14.6	4.0	4.3	3.8	3.9	3.5	4.0	9.8	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
INO80	"hINO80, INO80A, INOC1, KIAA1259"	ENSG00000128908	"INO80 complex ATPase subunit"	Q9ULG1	15	40978880-41116280	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"	"Actin-binding, DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041484, HPA048601"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA041484: AB_2677506, HPA048601: "	"unprognostic (5.39e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.69e-2)"	"prognostic favorable (6.30e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.47e-2)"	9.3	6.5	5.4	7.3	5.7	15.7	8.8	10.1	5.9	8.3	5.3	9.3	7.3	8.9	4.7	9.6	7.7	5.7	6.9	5.3	5.2	7.9	7.8	9.4	9.7	5.9	5.2	9.1	6.9	10.0	5.5	6.8	5.6	7.9	8.6	5.7	7.3	6.6	15.7	10.9	8.7	8.2	5.0	8.9	7.9	7.0	5.8	10.8	8.5	9.6	10.4	9.1	8.5	7.5	13.1	12.9	10.6	10.7	16.5	13.8	11.4	12.2	18.8	17.3	15.0	14.8	10.4	14.0	8.8	17.6	21.6	24.3	19.5	20.7	19.0	17.5	10.0	18.9	17.7	11.8	15.2	17.9	16.2	13.5	18.4	13.8	36.9	11.1	16.8	14.5	20.5	11.6	12.3	10.6	13.2	11.2	11.3	20.6	13.5	19.1	11.2	11.0	12.7	26.1	14.5	9.6	9.6	18.5	7.3	10.4	10.5	19.9	19.2	14.3	11.1	17.3	19.0	12.4	9.6	22.2	16.1	24.7	11.7	0.3	1.0	0.2	0.8	0.5	0.9	1.3	0.8	0.8	0.7	1.1	1.0	1.1	0.3	2.1	0.2	0.6	0.7	0.4	5.4	5.7	10.1	5.9	5.3	5.2	5.9	5.2	5.6	5.0	5.8	7.5	23.7	9.6	25.7	27.4	27.6	8.5	16.2	7.5	23.3	30.4	18.1	15.9	25.1	14.3	16.4	16.5	22.9	13.5	25.4	17.3	7.9	17.6	2.2	17.2	21.5	17.6	13.1	23.8	54.1	13.3	12.0	16.0	32.6	28.9	15.8	18.4	13.2	10.0	9.8	26.9	47.5	11.8	2.0	14.4	6.8	3.3	14.6	18.6	7.2	25.3	20.8	12.9	19.6	43.2	53.3	15.2	16.1	15.8	19.8	21.7	9.5	11.3	16.3	33.0	6.6	28.1	21.3	19.2	24.7	28.2	12.8	19.2	25.8	25.1	13.9	15.1
INO80B	"hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4"	ENSG00000115274	"INO80 complex subunit B"	Q9C086	2	74455087-74457944	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 28.0;Suprabasal keratinocytes: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA070644, HPA078274"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nucleoli, Nuclear bodies"	"HPA070644: AB_2732159, HPA078274: "	"prognostic favorable (2.89e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.56e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.18e-3)"	26.3	30.5	18.9	18.0	20.7	20.6	29.1	17.2	27.6	38.1	15.7	24.1	19.4	30.4	17.1	31.1	31.5	15.1	20.1	19.6	17.5	27.4	32.1	25.9	18.9	18.4	17.1	48.1	41.9	19.6	42.0	11.6	19.2	34.7	12.3	18.7	29.9	17.9	30.1	40.8	23.9	14.8	14.2	24.5	32.7	31.0	16.7	12.8	39.3	9.1	20.1	27.1	32.2	20.9	27.8	29.0	11.0	14.2	21.0	29.6	28.2	25.7	23.0	19.4	16.3	19.9	34.4	46.7	32.2	18.8	18.2	29.1	9.1	20.4	15.8	42.5	28.8	35.9	14.5	20.5	22.4	33.9	17.2	29.5	35.0	27.8	31.2	48.4	26.2	27.4	20.7	18.5	16.5	32.7	44.3	47.7	7.7	20.2	39.7	26.3	34.9	47.4	23.5	18.9	16.7	31.8	13.5	37.3	15.4	12.1	16.1	11.6	22.1	17.7	27.9	29.7	20.0	65.8	48.4	16.9	33.3	21.3	18.9	3.2	2.5	1.0	1.2	1.9	1.6	2.6	1.4	0.7	1.6	2.1	1.2	1.1	3.2	2.1	1.7	3.2	2.2	0.9	18.9	20.7	17.2	27.6	19.6	17.5	18.4	17.1	19.2	14.2	16.7	20.9	4.4	0.0	2.2	0.0	5.4	28.0	2.8	8.5	2.2	14.0	11.3	6.0	0.9	4.3	6.8	3.7	12.5	4.3	7.1	5.8	0.0	15.9	3.0	6.5	5.7	5.4	4.8	9.3	0.0	27.0	4.7	3.4	2.6	3.8	5.7	2.4	6.8	10.8	5.6	13.5	0.0	7.9	12.2	9.7	21.0	6.5	3.1	4.3	5.4	0.0	12.5	4.7	9.2	0.0	0.0	17.4	3.3	3.0	5.1	2.2	11.6	6.5	12.3	15.0	0.0	2.1	4.9	5.6	1.9	3.3	31.7	5.3	7.5	2.2	6.7	2.0
INO80E	"CCDC95, FLJ90652"	ENSG00000169592	"INO80 complex subunit E"	Q8NBZ0	16	29995715-30005793	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043146	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli rim"	"HPA043146: AB_10794923"	"unprognostic (5.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.38e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-3)"	25.9	22.7	36.6	22.1	39.0	33.1	26.4	38.8	43.1	31.6	29.1	35.3	19.9	30.8	29.2	29.7	40.8	24.8	25.3	35.7	36.3	21.9	26.4	28.7	32.9	40.3	38.9	38.0	25.5	39.9	23.2	24.8	38.0	24.1	36.5	13.4	32.4	34.7	30.9	27.6	24.0	40.3	37.1	26.5	24.8	27.8	38.3	42.5	33.3	29.7	46.8	30.8	25.5	42.5	79.1	95.1	59.6	88.0	54.0	45.6	55.0	66.9	75.2	95.4	93.8	54.7	85.7	101.6	100.4	75.3	63.0	52.9	73.8	109.8	80.0	106.7	88.8	50.2	57.7	79.0	63.5	66.4	59.5	53.5	89.1	112.1	87.6	54.9	115.4	137.5	64.4	55.6	89.9	114.7	142.0	87.2	120.3	55.4	55.1	176.9	72.6	104.7	73.2	39.5	90.8	111.3	36.8	65.1	83.7	48.9	80.8	53.0	62.5	68.0	48.3	58.7	84.6	58.9	120.2	92.9	77.3	96.2	97.9	1.5	6.1	5.1	4.3	4.1	3.6	4.5	3.4	5.0	4.9	3.3	3.2	3.3	3.0	3.5	6.8	5.1	5.2	21.4	36.6	39.0	38.8	43.1	35.7	36.3	40.3	38.9	38.0	37.1	38.3	42.5	32.8	38.5	19.6	15.0	27.6	14.8	19.1	34.0	37.0	15.1	23.5	22.6	0.8	22.8	24.1	20.2	20.9	36.9	27.6	32.9	33.2	29.3	1.9	17.1	13.3	25.4	35.2	14.9	6.6	39.3	40.1	20.2	45.9	19.2	15.8	16.4	23.9	18.9	27.8	8.4	6.9	28.4	32.6	22.4	15.0	5.2	26.1	24.0	19.6	14.0	25.2	20.4	29.9	9.0	14.4	38.0	39.7	27.8	35.2	12.4	48.2	29.8	19.7	20.9	26.3	17.3	23.1	44.4	23.3	33.6	17.2	18.1	30.9	13.9	31.6	12.4
INPP4A	INPP4	ENSG00000040933	"Inositol polyphosphate-4-phosphatase type I A"	Q96PE3	2	98444854-98594392	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 150.5;Inhibitory neurons: 124.4;Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001628	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA001628: AB_10961254"	"unprognostic (3.45e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-2)"	8.7	8.2	15.9	13.2	19.5	12.7	6.1	18.8	22.0	7.0	1.0	11.3	7.3	7.5	5.2	7.7	6.6	9.9	10.5	15.9	9.9	5.2	4.1	9.6	17.2	9.2	3.5	7.0	6.6	8.9	7.7	8.1	9.2	6.0	7.9	10.7	5.6	6.3	8.4	4.1	8.8	9.8	4.7	16.7	7.3	5.9	5.9	20.3	5.9	11.6	12.5	10.8	5.5	10.1	12.7	11.0	18.2	14.8	10.4	11.1	19.2	10.0	9.4	10.9	11.3	14.6	11.5	7.8	13.3	15.4	14.0	12.6	12.6	11.1	8.5	27.7	10.9	9.5	9.7	6.5	8.8	17.3	34.3	9.9	9.9	10.6	9.0	9.5	15.1	44.9	8.5	67.4	8.3	16.2	26.3	16.8	17.6	7.4	11.3	12.0	12.5	51.9	5.6	41.6	12.8	15.7	12.1	10.1	9.5	18.7	4.8	13.8	14.3	12.7	17.9	10.1	7.5	50.2	31.1	5.8	10.5	16.2	11.5	1.1	1.0	2.3	2.8	2.2	3.3	0.4	1.6	1.8	1.1	0.1	2.2	2.5	1.1	3.2	3.4	3.3	0.9	1.0	15.9	19.5	18.8	22.0	15.9	9.9	9.2	3.5	9.2	4.7	5.9	10.1	14.6	6.4	13.1	50.9	11.2	8.0	6.4	2.8	9.1	49.7	5.3	4.2	12.6	2.8	7.8	5.5	8.4	10.2	64.6	4.1	3.9	4.0	13.5	6.2	9.1	14.2	5.4	7.2	150.5	1.5	8.7	9.9	6.6	6.3	0.0	22.4	14.3	3.4	10.5	33.7	124.4	5.6	4.1	36.4	18.4	10.9	9.3	25.3	10.6	73.1	26.8	8.4	71.1	55.8	26.1	3.8	2.5	12.0	48.6	5.9	1.2	3.3	5.1	14.1	6.6	9.9	12.4	8.6	14.0	5.2	6.1	9.4	48.3	9.4	3.6	6.8
INSM2	"IA-6, Mlt1"	ENSG00000168348	"INSM transcriptional repressor 2"	Q96T92	14	35534164-35537054	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.6;retina: 2.7"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 7.2;Spermatocytes: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	134	"SH-SY5Y: 114.0"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Low region specificity"	"Detected in some"			"HPA044885, HPA051925"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA044885: AB_10794779, HPA051925: AB_2681664"	"unprognostic (9.88e-2)"	"unprognostic (8.74e-2)"			"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"		"unprognostic (3.29e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-3)"	"unprognostic (2.60e-3)"		"unprognostic (7.51e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.36e-3)"	"unprognostic (5.00e-1)"	0.0	0.3	0.9	0.0	1.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.6	0.0	0.0	0.0	0.0	1.9	0.8	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	114.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.1	2.2	0.9	3.6	1.9	0.8	2.1	0.3	1.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.4	0.0	0.0	0.0	2.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.1	4.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
INSYN1	"C15orf59, LOC388135, MGC131524"	ENSG00000205363	"Inhibitory synaptic factor 1"	Q2T9L4	15	73735458-73753351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.6;heart muscle: 48.5"	"Cell type enriched"	"Detected in single"	24	"Cardiomyocytes: 14.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;fHDF/TERT166: 5.8;HEK 293: 3.9;NTERA-2: 3.4;SK-BR-3: 4.7;U-2 OS: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041563	Approved		Approved	Nucleoplasm,Cytosol		No	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA041563: AB_10794670"	"unprognostic (2.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.67e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (5.38e-9)"	"unprognostic (4.98e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.20e-3)"	3.5	2.6	32.6	0.9	30.1	0.1	1.9	27.2	42.8	7.9	1.6	6.6	0.8	4.2	3.4	12.0	7.8	1.9	48.5	38.9	28.8	15.5	0.4	2.7	0.2	26.9	56.6	13.5	1.4	2.9	5.2	0.5	27.7	10.6	0.6	3.9	3.3	11.0	4.6	13.3	2.4	3.2	22.8	0.7	3.7	4.5	46.3	0.2	2.1	2.6	0.9	6.4	16.9	34.7	0.0	0.0	1.8	1.2	8.7	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.8	1.0	2.1	1.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.4	4.7	0.4	1.3	2.0	0.1	0.0	1.3	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.6	30.1	27.2	42.8	38.9	28.8	26.9	56.6	27.7	22.8	46.3	34.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INTS1	"DKFZp586J0619, INT1, KIAA1440, NET28"	ENSG00000164880	"Integrator complex subunit 1"	Q8N201	7	1470277-1504389	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021658, HPA053009"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA021658: AB_1852402, HPA053009: AB_2682016"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (7.72e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (4.30e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.81e-3)"	19.4	20.3	11.1	13.2	9.2	25.7	20.2	3.2	16.8	23.8	2.2	24.5	14.9	23.4	2.0	21.6	23.9	8.0	23.6	10.5	2.9	23.0	23.5	19.9	15.6	11.2	6.5	28.0	31.2	9.0	25.1	9.5	6.2	24.9	4.1	4.7	21.3	10.0	56.0	23.8	24.0	5.4	2.9	26.6	22.8	47.9	8.2	22.4	25.8	11.6	6.3	22.3	19.5	8.8	63.9	54.4	20.8	54.2	15.0	11.5	72.3	26.5	14.6	20.1	17.6	60.3	48.3	34.1	27.2	19.1	40.4	64.6	11.8	31.5	5.6	16.7	64.8	24.3	80.3	40.5	17.4	42.6	35.0	15.5	14.6	20.7	14.5	12.0	22.1	47.5	68.8	26.5	12.4	77.1	24.2	115.9	114.0	23.3	48.2	60.4	23.6	34.9	9.6	47.7	39.2	96.4	38.1	68.8	24.1	11.9	54.7	42.2	41.3	32.8	92.8	27.6	44.1	55.0	31.6	33.6	36.8	36.2	68.7	2.0	0.9	1.0	1.4	0.6	0.9	0.8	1.1	1.2	1.2	2.7	0.6	0.9	0.7	1.0	0.6	0.6	1.5	0.8	11.1	9.2	3.2	16.8	10.5	2.9	11.2	6.5	6.2	2.9	8.2	8.8	16.5	12.8	25.8	19.9	14.0	5.9	4.9	11.1	9.6	34.7	20.7	17.4	52.0	14.3	11.5	11.0	25.0	12.9	14.6	44.6	0.0	16.3	23.2	21.4	15.2	18.3	18.0	5.9	22.4	23.6	13.3	15.8	30.1	27.4	1.3	43.6	15.4	26.3	15.0	48.8	14.5	23.4	12.2	19.8	8.1	41.4	13.4	12.8	5.4	12.2	12.6	14.9	7.2	12.5	11.0	19.9	21.7	15.4	17.9	9.1	28.8	12.9	13.7	36.1	26.3	16.6	15.7	20.8	11.6	13.3	8.0	15.2	12.2	23.5	29.3	6.1
INTS10	"C8orf35, FLJ10569, INT10"	ENSG00000104613	"Integrator complex subunit 10"	Q9NVR2	8	19817391-19852083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039129, HPA050570"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA039129: AB_10794424, HPA050570: AB_2681180"	"unprognostic (9.11e-2)"	"unprognostic (8.41e-3)"	"prognostic favorable (4.00e-4)"	"prognostic favorable (1.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.33e-1)"	27.7	24.0	42.2	24.6	44.1	34.3	29.1	44.2	57.6	27.5	40.3	28.5	26.6	22.5	20.3	26.6	38.7	21.5	21.7	44.4	43.2	29.9	47.6	24.2	30.5	43.0	42.3	25.3	42.6	28.3	18.7	23.0	42.9	29.2	27.3	37.2	30.4	20.0	25.6	31.8	24.1	26.1	42.1	22.7	25.0	15.2	43.7	29.2	43.7	18.6	33.2	24.6	18.0	45.1	40.0	57.3	32.5	42.1	48.7	53.3	41.5	29.5	50.6	40.3	38.4	33.6	19.7	113.9	47.9	33.1	43.9	42.3	39.5	38.5	44.8	22.4	40.0	51.7	62.6	63.2	35.0	45.2	34.2	42.3	58.9	29.8	46.5	24.8	40.2	65.4	66.3	88.2	28.4	33.9	86.7	53.4	42.6	92.9	32.2	43.7	35.9	73.1	52.8	60.7	32.2	26.1	41.1	51.0	37.1	29.1	26.2	43.6	29.2	25.5	35.0	59.1	39.5	24.7	30.5	81.5	51.4	64.4	41.1	10.0	23.7	14.5	19.6	21.4	30.8	26.5	25.6	25.2	30.9	21.7	28.1	25.1	7.7	27.7	18.6	27.1	31.8	20.2	42.2	44.1	44.2	57.6	44.4	43.2	43.0	42.3	42.9	42.1	43.7	45.1	25.5	16.0	51.1	74.4	40.3	37.6	40.9	29.3	43.3	60.2	28.3	20.3	22.5	37.1	39.1	20.2	52.1	33.7	41.5	22.9	35.2	43.6	53.9	78.8	23.1	33.0	20.4	27.3	88.8	40.0	49.2	34.1	25.5	33.4	35.5	63.6	35.3	61.0	42.4	70.7	61.0	34.3	22.4	34.0	25.5	31.9	34.8	35.6	17.8	37.5	37.8	33.9	45.3	80.9	74.9	33.1	27.4	35.0	48.6	53.4	33.9	37.5	70.0	99.0	13.1	29.1	32.5	8.3	32.3	50.8	45.0	22.3	40.6	41.2	42.0	32.7
INTS11	"CPSF3L, CPSF73L, FLJ20542, INT11, RC-68"	ENSG00000127054	"Integrator complex subunit 11"	Q5TA45	1	1311585-1324687	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 77.3;Ductal cells: 56.4;Extravillous trophoblasts: 63.9;Syncytiotrophoblasts: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028379, HPA029025"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA028379: AB_10599598, HPA029025: AB_10600425"	"unprognostic (7.54e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-3)"	"unprognostic (5.14e-2)"	"unprognostic (5.62e-3)"	39.7	40.8	26.0	24.0	28.6	29.0	39.0	37.2	40.1	64.7	27.7	70.6	32.8	66.6	26.4	43.9	61.1	24.1	54.9	27.2	28.4	40.4	45.7	35.6	31.8	30.3	27.2	63.6	53.6	28.9	40.0	28.2	30.6	52.9	20.8	13.0	38.3	27.6	90.3	47.2	44.9	26.7	24.5	45.4	52.4	76.0	28.0	29.6	40.7	44.2	25.1	67.5	50.6	33.6	58.4	56.2	31.5	62.1	52.4	41.7	34.1	31.2	49.9	67.6	50.1	53.2	71.0	63.2	43.6	60.7	40.6	41.4	46.3	67.7	29.9	60.3	60.5	49.8	79.7	70.2	80.2	39.1	52.5	72.1	35.9	61.7	91.7	38.2	71.7	59.7	59.5	56.3	34.2	50.8	77.6	52.1	39.1	53.6	60.1	61.0	30.8	93.1	47.6	31.3	45.0	42.1	31.9	83.8	91.7	23.4	45.5	57.0	54.5	43.6	39.6	50.8	40.0	87.3	101.8	85.1	60.4	68.7	22.0	66.5	69.6	48.0	65.2	82.1	68.9	50.3	56.4	59.8	81.2	44.0	52.2	50.2	33.2	64.8	101.7	52.9	78.7	81.0	26.0	28.6	37.2	40.1	27.2	28.4	30.3	27.2	30.6	24.5	28.0	33.6	36.4	38.5	33.7	0.0	9.5	0.0	0.0	0.0	0.0	0.0	32.6	33.9	0.0	0.0	13.0	18.4	0.0	77.3	24.1	0.0	31.3	56.4	0.0	27.1	27.2	14.0	0.0	0.0	0.0	53.9	63.9	18.7	0.0	23.2	10.1	40.4	0.0	0.0	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	36.2	0.0	0.0	0.0	0.0	54.8	0.0	0.0	6.8	0.0	0.0	34.4	14.6	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	77.0	12.7	49.8	0.0	0.0
INTS12	"INT12, PHF22, SBBI22"	ENSG00000138785	"Integrator complex subunit 12"	Q96CB8	4	105682627-105895986	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035772, HPA041814"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies, Plasma membrane"	"HPA035772: AB_10671109, HPA041814: AB_2677687"	"unprognostic (5.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-1)"	15.2	11.1	12.8	10.9	13.3	30.4	20.2	14.9	18.0	14.1	12.0	14.7	18.1	14.6	17.8	13.5	13.2	12.7	18.9	12.4	14.9	18.7	22.6	16.4	14.0	12.3	14.0	11.6	12.6	17.2	10.3	11.9	12.5	18.1	15.6	17.2	14.4	13.4	26.5	14.0	15.5	17.1	12.7	12.6	15.0	13.9	14.3	19.9	19.9	26.0	17.0	15.6	11.2	13.7	24.4	12.8	28.5	29.8	27.5	32.6	20.8	28.2	29.1	34.7	35.9	18.1	26.9	34.9	15.4	31.9	26.9	13.8	31.7	40.7	42.8	36.9	19.0	26.3	19.6	25.7	44.3	46.7	23.0	31.0	51.7	34.5	51.4	22.5	32.3	29.1	39.8	26.7	37.8	25.6	55.3	28.9	12.4	35.3	19.5	28.0	31.0	26.8	32.5	16.3	30.7	24.6	19.8	32.6	31.0	22.4	26.4	27.2	21.3	22.7	23.3	24.8	30.5	40.8	40.9	52.2	25.3	31.5	46.0	64.0	23.7	38.5	25.7	26.6	28.9	33.0	29.4	29.4	27.7	32.1	30.6	28.3	17.9	42.9	28.3	42.6	34.8	21.9	12.8	13.3	14.9	18.0	12.4	14.9	12.3	14.0	12.5	12.7	14.3	13.7	19.0	12.8	11.8	14.0	15.1	11.0	11.8	25.8	15.4	10.5	12.1	11.7	18.7	11.5	12.9	3.7	10.4	16.1	13.6	8.3	43.0	25.2	35.8	8.1	11.2	16.8	6.0	15.6	13.8	20.3	18.6	10.8	8.6	8.7	24.7	9.9	11.7	9.3	17.8	10.1	15.7	5.2	30.5	9.0	9.5	28.4	12.2	9.8	7.2	9.4	15.5	14.0	21.6	27.2	19.1	20.5	6.8	8.2	18.9	14.2	16.5	17.1	6.2	9.3	0.0	12.9	20.1	13.4	16.2	14.1	10.4	18.3	13.0	14.9	10.2	11.0
INTS13	"ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30"	ENSG00000064102	"Integrator complex subunit 13"	Q9NVM9	12	26905181-26938326	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Endometrial stromal cells: 16.7;Extravillous trophoblasts: 16.1;Theca cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039543, HPA040109, HPA073020"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA039543: AB_10795150, HPA040109: , HPA073020: "	"unprognostic (2.09e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (1.17e-10)"	"unprognostic (5.22e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.78e-2)"	9.9	21.4	9.3	11.3	13.4	17.2	11.7	13.2	14.3	10.4	8.1	9.7	9.9	10.0	10.3	14.6	8.5	8.2	12.2	9.5	11.6	13.2	15.1	7.9	16.7	15.4	12.0	8.0	11.5	8.0	8.1	10.0	14.8	8.5	10.7	21.8	9.0	7.0	19.0	11.8	8.5	11.9	13.9	12.9	15.4	12.1	12.2	18.6	9.9	18.1	16.8	12.8	10.6	20.0	33.4	38.1	21.5	46.4	30.5	48.9	30.9	44.9	27.4	43.3	48.1	58.4	43.1	82.7	45.0	25.1	40.6	46.2	56.1	43.6	72.8	39.5	37.4	66.7	44.5	44.9	53.9	110.6	38.4	26.3	32.2	69.5	147.0	53.5	56.8	35.6	71.5	31.9	46.7	40.9	57.9	197.8	94.6	45.6	68.9	40.8	62.3	114.0	36.4	31.0	17.8	16.7	39.1	30.6	47.4	72.8	42.6	23.4	36.5	50.1	36.2	85.6	55.1	15.6	19.6	119.4	33.1	75.8	36.2	7.8	8.1	7.8	14.6	5.7	22.1	9.7	18.2	18.2	9.9	11.3	12.7	15.7	2.5	25.9	5.2	6.7	28.1	10.5	9.3	13.4	13.2	14.3	9.5	11.6	15.4	12.0	14.8	13.9	12.2	20.0	7.2	22.4	7.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	7.9	8.3	0.0	0.0	2.5	5.5	0.0	11.8	8.8	0.0	3.9	13.7	0.0	8.7	16.7	3.9	0.0	0.0	0.0	11.9	16.1	8.3	0.0	8.2	7.6	13.9	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	5.7	0.0	0.0	0.0	0.0	13.7	0.0	0.0	1.6	0.0	0.0	11.6	2.9	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	13.1	6.5	18.5	0.0	0.0
INTS14	"C15orf44, DKFZP564O1664, VWA9"	ENSG00000138614	"Integrator complex subunit 14"	Q96SY0	15	65578753-65611289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040255, HPA040651"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"Nuclear membrane"	"HPA040255: AB_10805710, HPA040651: AB_10796559"	"unprognostic (2.92e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.30e-1)"	12.5	15.8	13.2	14.2	15.8	18.0	22.3	14.7	16.6	20.9	18.2	21.8	14.1	18.1	27.4	16.1	24.2	19.6	13.4	13.5	14.8	21.3	21.1	15.6	22.7	14.5	14.9	18.4	17.7	22.9	16.3	19.2	14.6	19.1	23.6	13.1	16.2	19.8	9.9	18.0	17.2	18.8	14.8	18.9	18.1	18.9	15.8	25.4	23.2	13.6	24.3	23.6	13.6	17.7	26.4	46.7	46.1	36.8	25.2	31.4	29.5	28.4	36.5	46.4	42.5	42.2	61.2	42.9	38.9	35.6	38.5	52.0	99.4	47.6	40.5	37.8	60.2	37.5	32.2	46.4	50.0	38.7	46.2	30.6	46.9	35.1	53.7	34.1	50.8	64.8	52.2	24.3	33.4	41.7	44.3	41.2	33.8	66.2	25.6	37.5	38.8	49.0	36.7	48.6	33.1	26.3	34.2	34.5	49.5	39.2	32.3	44.0	25.2	31.8	33.2	28.8	45.6	23.9	48.4	58.1	32.1	70.0	38.1	25.7	11.0	6.2	19.8	12.7	22.3	19.3	20.3	22.6	19.8	14.8	21.1	19.2	1.2	23.8	9.5	17.9	30.8	16.6	13.2	15.8	14.7	16.6	13.5	14.8	14.5	14.9	14.6	14.8	15.8	17.7	12.2	22.4	10.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	13.0	11.0	0.0	0.0	5.6	12.9	0.0	40.5	7.7	0.0	21.5	18.2	0.0	12.8	11.8	6.8	0.0	0.0	0.0	15.4	30.5	6.7	0.0	12.6	7.6	22.5	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	9.3	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.5	0.0	0.0	15.1	10.9	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	49.8	4.8	24.0	0.0	0.0
INTS3	"C1orf60, FLJ21919, INT3, SOSS-A"	ENSG00000143624	"Integrator complex subunit 3"	Q68E01	1	153728050-153774808	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074391	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"HPA074391: AB_2686685"	"unprognostic (2.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (6.97e-3)"	"unprognostic (3.26e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.29e-2)"	14.3	18.7	1.7	10.8	2.0	2.9	14.7	0.5	3.2	16.8	0.9	16.1	4.2	18.3	13.4	12.1	20.7	9.7	13.0	2.2	2.1	15.9	11.8	14.9	8.6	2.7	0.9	23.3	13.0	8.2	17.8	9.6	1.3	11.9	6.5	3.6	12.1	11.3	14.9	12.2	12.9	9.4	0.0	13.2	16.7	12.8	4.4	6.7	15.3	8.3	7.7	13.6	14.4	1.5	26.2	15.8	14.0	19.2	21.3	17.4	19.1	18.2	8.7	21.7	17.4	8.5	24.5	21.3	37.8	24.2	11.8	27.0	28.0	18.7	10.2	24.6	23.0	15.4	37.7	3.8	13.8	18.8	20.5	12.3	7.5	9.5	11.7	17.5	14.4	13.8	19.2	14.6	9.0	8.5	18.6	10.0	23.6	25.5	26.8	24.5	6.4	13.1	8.1	24.7	11.8	15.5	18.9	39.7	11.4	18.4	13.3	25.3	6.1	22.7	6.7	18.1	18.1	17.1	13.7	19.5	24.9	8.9	11.3	0.0	0.8	0.9	0.9	0.5	0.8	0.3	0.3	0.5	1.2	0.3	0.2	0.5	0.8	0.7	2.9	0.3	0.5	0.2	1.7	2.0	0.5	3.2	2.2	2.1	2.7	0.9	1.3	0.0	4.4	1.5	29.1	22.4	22.8	59.7	11.9	10.5	9.5	10.4	15.9	23.7	20.2	22.4	4.6	10.0	11.7	31.3	20.9	13.9	11.6	9.2	0.0	11.9	13.1	39.3	29.4	21.5	12.1	10.9	30.8	8.4	13.4	16.3	23.9	38.8	5.7	32.9	26.7	13.9	12.2	21.9	26.1	16.5	8.2	9.1	22.0	7.6	9.6	14.6	7.2	30.0	17.6	15.4	14.4	27.2	29.7	9.9	14.9	12.0	11.6	10.6	9.8	13.3	25.9	22.4	26.3	11.2	16.5	10.2	12.2	13.9	10.2	10.3	10.0	20.2	14.0	12.2
INTS5	"INT5, KIAA1698"	ENSG00000185085	"Integrator complex subunit 5"	Q6P9B9	11	62646848-62653302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046181, HPA056915"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA046181: , HPA056915: AB_2683276"	"unprognostic (2.87e-1)"	"unprognostic (9.51e-2)"	"unprognostic (9.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (8.44e-5)"	"unprognostic (7.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.35e-2)"	8.3	9.3	5.5	8.0	5.7	5.4	8.5	5.7	6.0	10.1	5.5	9.1	7.8	11.4	5.3	12.1	12.9	5.8	8.1	5.7	5.4	8.6	12.6	7.7	10.6	6.0	5.6	10.2	10.3	8.8	6.6	6.0	5.8	9.2	5.8	2.8	11.7	6.9	13.9	12.4	8.8	8.3	5.5	10.5	9.5	6.1	5.8	8.3	7.8	8.3	9.2	9.1	8.7	5.8	17.5	21.1	12.2	11.4	23.5	17.1	11.4	14.2	14.4	18.7	13.4	15.1	19.0	33.1	25.0	18.0	15.5	26.7	24.6	32.9	9.0	20.8	17.1	17.2	15.8	10.2	21.2	19.0	15.7	19.9	25.3	20.1	17.1	14.2	18.8	14.5	26.6	18.9	16.3	35.8	22.0	22.1	18.7	20.7	26.4	22.2	16.5	39.9	14.3	11.3	16.4	13.8	15.9	22.0	22.2	8.6	31.3	12.9	15.7	17.8	13.6	27.6	12.9	26.5	21.9	23.8	20.5	14.3	17.2	4.3	5.3	3.9	6.4	3.5	10.1	4.1	5.9	5.7	5.5	5.0	6.9	6.4	1.9	7.7	4.1	5.5	4.6	6.3	5.5	5.7	5.7	6.0	5.7	5.4	6.0	5.6	5.8	5.5	5.8	5.8	5.0	3.2	7.8	2.3	8.8	2.2	7.1	8.2	4.6	7.5	6.6	6.3	3.1	7.2	9.3	3.7	0.0	14.0	10.7	4.8	11.7	12.0	6.4	5.7	5.0	6.9	6.7	2.5	2.0	10.6	9.3	5.2	4.1	4.4	8.9	6.7	9.7	11.5	8.7	10.1	2.1	7.9	8.2	7.0	3.1	8.9	6.5	4.3	0.0	1.9	12.6	10.4	8.2	2.0	1.0	9.7	2.2	7.9	7.3	8.5	8.7	10.2	13.2	3.8	13.1	5.1	8.6	10.8	11.3	5.4	4.1	19.8	6.8	9.1	7.6	5.9
INTS6	"DBI-1, DDX26, DDX26A, DICE1, HDB, INT6, Notchl2"	ENSG00000102786	"Integrator complex subunit 6"	Q9UL03	13	51354077-51454264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 374.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001552, HPA001846"	Supported		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Actin filaments"	"HPA001552: AB_1078659, HPA001846: AB_1847669"	"unprognostic (1.99e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.26e-2)"	14.0	14.8	7.7	16.6	9.1	15.0	11.8	17.8	10.0	12.8	11.1	12.1	11.2	14.8	11.6	19.7	10.5	14.0	14.0	9.5	9.0	12.9	28.2	10.0	20.9	9.1	8.2	13.7	37.9	15.9	9.4	14.8	10.1	10.7	10.9	18.9	11.5	9.7	8.4	15.2	13.1	13.4	8.2	15.2	15.4	62.1	8.3	20.7	15.7	16.7	17.3	16.0	11.7	18.2	17.6	13.8	32.8	17.2	17.2	40.6	17.8	36.3	33.5	35.9	25.1	16.2	46.9	20.3	8.5	26.3	22.7	31.0	45.2	20.0	50.6	39.3	12.6	38.7	21.9	19.1	41.6	43.4	33.6	25.3	36.5	33.7	50.7	46.1	31.3	25.5	24.1	30.2	35.9	13.3	26.9	26.8	23.5	51.6	12.4	20.2	23.4	20.3	26.8	11.6	18.2	18.0	36.5	30.2	24.3	24.2	15.4	41.5	17.7	22.1	15.2	23.6	20.8	26.5	21.7	33.0	18.2	22.7	39.2	8.0	2.0	3.2	5.9	1.3	6.7	3.9	4.0	5.0	2.1	4.0	5.6	6.5	5.5	5.0	1.5	4.6	5.0	2.4	7.7	9.1	17.8	10.0	9.5	9.0	9.1	8.2	10.1	8.2	8.3	18.2	241.6	25.6	49.5	75.4	121.4	76.3	68.7	12.0	162.8	58.3	157.5	215.6	78.4	47.1	18.3	22.0	118.9	81.4	164.8	107.2	15.6	23.4	94.3	48.4	67.4	94.5	76.0	29.5	82.2	26.3	47.5	127.4	61.7	64.5	48.2	71.4	57.8	37.3	34.8	45.4	66.7	94.8	12.2	44.2	60.1	81.3	44.1	97.5	23.2	78.7	33.3	55.9	53.5	94.0	118.9	25.9	59.7	31.6	90.9	53.7	77.1	11.9	12.9	74.9	26.3	374.7	119.4	122.4	40.5	161.3	72.5	73.7	137.8	66.5	90.3	68.0
INTS8	"C8orf52, FLJ20530, INT8, MGC131633"	ENSG00000164941	"Integrator complex subunit 8"	Q75QN2	8	94813311-94881746	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057299	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA057299: AB_2683403"	"unprognostic (1.08e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.07e-2)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.24e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-2)"	8.8	7.5	4.4	13.9	4.8	15.5	8.1	8.3	6.4	14.5	6.9	12.8	7.8	13.2	4.2	10.5	9.5	7.3	10.2	4.8	6.4	6.4	8.9	7.5	17.4	5.7	4.4	11.4	13.5	10.1	8.3	9.4	4.6	10.4	14.8	10.3	11.0	8.7	12.6	10.3	10.6	13.6	4.0	9.9	10.6	30.6	6.3	20.6	8.8	12.0	13.6	10.4	10.4	6.1	52.4	31.9	49.2	43.4	17.7	41.7	25.5	27.5	26.0	35.7	33.0	22.5	38.0	52.3	25.2	20.7	44.3	31.5	61.3	29.2	47.6	58.1	28.8	45.7	19.3	22.1	21.1	24.6	31.7	17.1	13.5	34.7	29.6	40.8	40.1	35.1	44.4	38.9	22.0	34.5	53.7	20.4	28.1	114.9	55.8	42.7	19.7	29.0	30.0	26.6	34.6	18.4	26.8	7.7	24.1	40.3	37.3	31.6	28.1	16.1	18.9	31.1	25.1	22.0	43.0	45.2	21.6	49.4	32.2	2.1	9.6	15.1	4.6	6.8	7.5	13.4	10.8	11.8	9.3	10.4	11.0	6.5	9.3	9.6	6.6	5.5	10.0	4.5	4.4	4.8	8.3	6.4	4.8	6.4	5.7	4.4	4.6	4.0	6.3	6.1	11.0	16.0	8.6	16.6	19.4	5.9	11.6	9.1	9.6	13.7	6.1	4.6	8.3	5.7	11.6	7.3	33.3	10.0	9.7	10.3	3.9	8.3	36.0	15.0	12.1	11.8	18.0	17.7	44.8	13.4	12.9	10.8	8.6	6.1	12.7	15.2	8.9	5.5	9.5	28.6	40.9	11.8	8.2	11.6	6.6	6.4	16.1	14.0	7.2	25.3	21.6	8.0	16.5	33.2	31.2	10.9	14.6	16.1	18.0	8.8	9.5	5.1	19.7	18.9	6.6	10.6	13.1	54.7	32.5	9.0	7.0	8.5	14.2	11.0	11.1	8.1
INTS9	"CPSF2L, FLJ10871, RC-74"	ENSG00000104299	"Integrator complex subunit 9"	Q9NV88	8	28767661-28890242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 29.5;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051615, HPA066822"			Enhanced	Nucleoplasm		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051615: AB_2681552, HPA066822: AB_2685729"	"unprognostic (2.19e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.91e-3)"	"prognostic favorable (7.71e-4)"	"unprognostic (3.64e-2)"	"unprognostic (5.01e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (1.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	8.6	22.0	7.9	11.1	8.9	6.8	8.3	8.7	9.4	9.1	10.5	8.8	6.9	9.2	11.3	11.1	9.7	6.7	12.2	7.9	8.6	10.7	5.9	8.8	14.6	8.5	8.8	8.2	9.7	9.5	12.5	7.9	8.6	9.1	9.3	10.5	8.9	7.2	11.6	9.9	9.6	9.0	8.6	15.7	9.4	12.8	8.9	17.5	10.6	6.9	17.9	11.0	8.7	9.4	24.7	17.0	20.1	21.4	24.3	11.3	8.8	11.1	15.1	19.0	20.9	11.9	13.4	24.4	15.2	11.4	17.0	20.1	39.2	22.7	26.1	10.3	16.1	24.4	9.5	21.0	17.6	12.3	18.2	13.0	16.0	22.9	16.3	10.2	23.8	34.5	52.2	13.7	12.8	13.5	57.5	22.3	27.4	28.8	10.9	36.5	23.3	12.8	13.4	16.8	14.4	26.4	11.5	14.8	20.5	16.0	14.4	13.8	14.1	10.9	27.6	18.7	14.2	7.0	5.3	29.8	16.8	20.3	15.8	17.0	20.6	19.0	17.3	23.0	16.1	18.0	15.1	19.3	29.1	19.5	13.4	14.5	8.3	25.1	17.4	15.4	20.3	12.0	7.9	8.9	8.7	9.4	7.9	8.6	8.5	8.8	8.6	8.6	8.9	9.4	3.6	6.4	4.2	28.7	10.9	2.3	2.4	4.7	1.8	2.1	2.7	2.3	5.8	5.7	3.7	3.7	6.2	7.7	6.1	2.8	1.9	3.7	8.3	4.8	6.2	4.6	6.0	4.2	29.5	5.1	4.8	4.7	9.2	5.9	0.0	6.7	3.9	2.5	7.5	1.7	31.3	3.6	4.1	3.8	6.1	4.1	7.8	4.1	3.6	23.4	5.4	2.4	4.1	32.2	39.9	4.9	1.7	4.5	4.3	1.9	3.3	4.3	3.4	6.1	0.0	4.2	4.0	5.1	3.5	7.7	3.0	4.8	5.4	11.2	3.5	1.7
IP6K1	"IHPK1, KIAA0263"	ENSG00000176095	"Inositol hexakisphosphate kinase 1"	Q92551	3	49724294-49786542	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040825	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040825: AB_10960426"	"unprognostic (6.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.08e-4)"	"unprognostic (9.97e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.75e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.64e-2)"	17.9	20.2	32.4	12.1	33.6	12.5	17.2	27.6	34.9	21.5	17.2	24.1	12.1	25.6	12.2	20.0	19.4	12.9	15.8	35.9	27.7	21.3	14.6	17.5	13.3	26.4	28.2	25.5	19.8	22.8	21.5	16.4	27.4	18.1	11.3	18.3	17.4	17.2	12.6	23.1	17.8	16.9	24.5	21.9	18.5	32.2	30.7	17.2	16.2	11.4	13.2	19.1	16.0	29.0	20.6	24.5	27.9	33.1	28.6	21.8	22.5	26.6	27.8	42.7	37.3	31.9	20.9	17.3	16.8	29.7	28.8	14.9	39.8	24.2	24.0	35.6	30.6	40.5	36.1	21.8	31.4	25.0	26.7	25.6	29.4	46.4	27.8	24.0	36.1	20.3	26.7	20.3	21.4	18.2	30.6	25.6	30.2	16.1	37.6	19.1	19.8	35.7	27.7	30.8	15.0	29.8	33.4	21.8	30.6	16.0	17.6	36.2	32.8	23.9	23.6	33.1	31.0	24.3	35.6	18.8	21.9	28.4	24.9	4.7	7.3	12.1	11.7	5.4	11.4	6.0	10.4	12.8	5.6	8.4	12.6	12.7	33.3	10.3	7.0	4.1	11.8	9.5	32.4	33.6	27.6	34.9	35.9	27.7	26.4	28.2	27.4	24.5	30.7	29.0	17.1	25.6	12.3	24.5	25.0	15.6	14.7	7.4	11.4	38.4	19.7	15.0	8.8	18.6	10.1	12.9	89.6	19.2	27.6	22.0	5.9	14.5	88.2	24.9	19.9	19.0	27.6	24.2	42.3	13.0	16.1	14.7	14.8	17.3	19.7	19.6	19.6	12.2	12.8	30.3	46.6	14.1	10.2	15.0	14.2	23.7	21.1	17.8	19.6	31.9	15.9	19.6	35.0	43.7	39.8	19.2	8.8	16.6	28.9	19.6	14.6	12.5	21.8	78.3	19.7	16.2	18.3	24.6	21.9	13.7	18.8	27.5	27.6	30.5	12.8	20.4
IP6K2	IHPK2	ENSG00000068745	"Inositol hexakisphosphate kinase 2"	Q9UHH9	3	48688003-48740353	"Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007532, HPA070811"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA007532: AB_1851542, HPA070811: AB_2732165"	"prognostic favorable (1.25e-4)"	"unprognostic (2.55e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (6.57e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.83e-4)"	57.6	96.3	53.1	39.5	57.2	130.1	80.1	84.6	57.8	117.2	52.8	106.0	79.8	101.8	108.4	95.4	78.3	47.9	62.3	53.7	58.4	106.9	83.5	55.4	53.7	56.2	53.3	99.1	91.2	48.0	121.8	44.8	55.1	111.6	88.0	63.7	88.7	42.2	45.8	145.4	89.1	43.1	49.7	78.9	79.5	55.5	55.2	72.2	108.8	31.5	43.5	66.7	113.4	64.2	25.9	49.5	100.6	71.2	55.5	69.3	72.6	48.0	54.0	54.0	62.2	41.1	67.0	45.5	38.7	45.5	67.8	65.3	50.6	72.1	50.0	54.1	44.9	52.2	172.7	89.5	45.0	50.3	48.9	65.7	103.0	73.3	59.7	71.8	76.2	143.8	39.5	55.4	63.9	57.3	107.4	68.3	77.4	50.0	90.4	44.4	33.3	50.0	73.7	121.7	62.4	94.6	103.9	69.5	53.0	79.6	67.7	83.3	54.8	58.3	57.4	37.0	48.7	50.6	65.4	64.2	53.3	57.7	52.4	158.1	50.5	92.7	63.4	50.8	57.6	60.8	55.1	60.4	50.1	60.2	51.1	52.7	80.3	67.5	65.3	52.0	84.2	46.8	53.1	57.2	84.6	57.8	53.7	58.4	56.2	53.3	55.1	49.7	55.2	64.2	63.3	70.5	52.9	38.5	41.3	83.1	87.2	182.5	174.2	66.5	69.9	77.5	12.9	38.6	109.1	99.3	39.6	114.3	39.4	157.4	76.3	58.7	43.8	50.8	64.8	46.1	110.2	40.1	31.1	47.4	73.9	73.7	64.2	56.9	54.5	60.3	32.5	25.1	41.4	20.2	40.6	108.6	150.5	16.6	33.5	16.4	81.1	24.5	26.6	22.5	30.3	32.4	44.3	50.8	52.6	60.5	105.7	68.4	34.0	59.0	84.7	65.5	68.4	56.0	52.6	31.5	50.6	71.6	57.9	90.3	83.0	124.0	43.3	87.9	89.8	89.3
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721662-33746905	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 308.1;tongue: 83.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cardiomyocytes: 11.2;Hepatocytes: 8.9;Horizontal cells: 10.1;Oligodendrocytes: 15.3;Proximal tubular cells: 8.2;Skeletal myocytes: 51.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 21.9;HSkMC: 7.9;LHCN-M2: 36.2;RH-30: 15.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	1.4	0.7	4.8	0.4	15.5	0.0	1.3	12.2	9.5	1.9	5.7	6.8	0.4	3.8	0.1	6.5	1.2	0.1	29.6	5.9	8.8	6.0	18.8	5.2	0.1	14.7	13.1	0.5	0.6	0.0	0.5	4.7	15.0	5.3	0.6	0.9	2.7	1.6	308.1	0.7	2.3	1.8	7.0	3.3	1.6	0.2	12.4	0.5	12.9	83.3	0.0	2.4	1.9	27.1	0.1	0.0	0.5	0.0	0.0	0.1	3.6	0.1	0.4	0.3	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	21.9	0.0	0.1	7.9	1.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.5	5.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	15.5	12.2	9.5	5.9	8.8	14.7	13.1	15.0	7.0	12.4	27.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	8.5	0.4	0.4	11.2	0.0	1.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.2	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.0	8.9	0.3	10.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.0	0.4	6.6	51.7	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2
IPMK		ENSG00000151151	"Inositol polyphosphate multikinase"	Q8NFU5	10	58191517-58267894	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 3.0;monocytes: 1.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037837, HPA057542"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA037837: AB_10670166, HPA057542: AB_2683460"	"unprognostic (4.52e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.22e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.96e-7)"	"unprognostic (1.79e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.02e-3)"	4.9	3.1	3.1	5.8	3.1	2.4	4.7	4.1	4.5	4.4	2.3	7.1	7.9	2.3	3.4	5.2	2.9	6.9	1.8	2.9	3.2	4.1	18.1	3.3	4.6	3.6	3.6	1.8	3.8	12.1	1.9	8.7	3.2	3.4	6.0	4.7	2.7	1.7	2.7	5.1	10.4	1.9	3.2	6.4	3.5	2.2	3.5	4.5	4.1	3.2	4.4	5.2	2.5	3.2	16.3	4.1	5.9	5.8	5.7	6.6	5.1	4.2	9.0	3.5	7.1	8.3	10.1	13.0	8.3	5.0	3.4	4.9	5.0	5.6	11.2	5.9	3.8	3.2	3.9	7.9	3.4	5.1	7.1	7.3	4.9	6.0	12.0	4.0	7.7	3.7	2.1	6.5	6.3	4.1	7.0	9.8	3.8	6.6	3.8	0.5	12.8	6.0	6.6	4.1	4.1	7.1	5.5	14.4	4.3	9.6	12.0	6.1	6.7	3.8	7.4	8.1	5.4	13.8	8.7	10.1	7.2	5.3	1.5	1.7	0.7	1.6	0.1	0.7	0.1	0.3	0.1	0.1	0.4	0.2	0.4	0.1	3.0	0.2	1.0	0.2	0.0	0.1	3.1	3.1	4.1	4.5	2.9	3.2	3.6	3.6	3.2	3.2	3.5	3.2	8.9	6.4	4.2	16.6	16.9	54.0	10.0	8.4	26.2	10.0	11.6	8.3	2.8	4.3	13.3	1.8	6.2	10.5	8.1	29.3	3.9	4.2	3.0	24.3	9.7	9.9	8.4	3.0	21.8	4.9	22.5	15.7	8.2	22.8	7.0	2.5	8.2	13.2	10.0	13.5	27.8	10.6	10.2	22.8	40.7	1.4	2.8	29.1	26.6	24.4	16.6	5.4	2.1	30.7	23.6	6.2	21.7	1.9	8.5	9.6	28.6	9.1	29.1	5.8	6.6	10.2	8.5	10.0	5.1	20.1	58.1	9.4	10.1	4.1	11.1	17.5
IPO11	RanBP11	ENSG00000086200	"Importin 11"	Q9UI26	5	62403972-62628582	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 68.4;Hepatic stellate cells: 65.0;Inhibitory neurons: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 22.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065346, HPA067097"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA065346: , HPA067097: AB_2685776"	"unprognostic (9.29e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (4.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.24e-2)"	16.0	9.1	13.4	9.7	13.7	6.6	14.4	13.6	14.6	10.6	16.3	9.2	6.9	9.4	8.5	12.0	10.2	10.7	14.7	14.7	13.7	11.9	11.4	7.7	10.4	14.1	13.7	9.4	8.6	13.4	6.0	16.5	13.6	9.0	8.6	6.3	8.5	8.4	12.6	8.8	7.9	11.0	14.4	13.4	8.5	21.4	13.9	10.0	14.0	14.4	10.1	13.4	9.9	15.7	27.1	25.4	22.3	34.6	17.0	23.4	30.9	28.4	20.5	29.1	31.9	27.5	20.2	45.3	22.2	28.9	35.5	21.4	47.3	32.0	45.6	17.5	24.6	21.6	24.5	24.4	12.8	23.7	11.6	16.7	17.7	34.3	35.7	13.7	113.8	22.4	41.5	14.5	27.9	26.0	26.1	32.2	28.0	15.4	14.5	31.6	33.7	41.6	17.7	26.4	24.1	13.9	24.8	19.3	21.0	21.9	24.9	17.0	51.8	17.4	19.3	19.8	26.4	11.3	20.0	31.3	21.2	33.4	21.3	16.5	2.4	2.2	3.8	3.8	4.5	3.3	3.9	3.9	4.0	4.8	5.5	4.0	2.5	22.7	7.0	2.4	2.8	3.6	13.4	13.7	13.6	14.6	14.7	13.7	14.1	13.7	13.6	14.4	13.9	15.7	39.6	9.6	3.7	35.9	11.8	8.5	4.2	3.3	13.6	4.2	6.2	4.8	13.2	5.7	4.5	7.3	2.1	7.6	7.9	2.7	3.9	4.2	42.2	8.4	7.0	40.0	3.0	21.7	68.4	5.5	6.7	7.6	6.1	5.6	13.3	9.6	65.0	6.2	5.2	5.0	55.0	4.4	2.0	6.5	6.4	25.3	5.6	7.4	3.6	20.6	2.6	3.9	10.3	28.1	48.3	3.3	1.7	4.1	10.7	5.2	2.6	3.6	25.6	4.9	6.6	9.7	8.7	14.6	16.2	10.9	8.8	5.1	8.8	4.6	5.7	4.8
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024296	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.8"	"Group enriched"	"Detected in all"	11	"Early spermatids: 1152.2;Late spermatids: 2185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		790000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169"	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	53.0	27.4	20.2	37.8	26.8	37.6	44.9	20.3	31.9	46.3	14.9	36.9	23.9	45.2	27.3	41.7	45.1	30.1	60.5	28.2	20.0	44.4	42.6	28.6	42.9	20.9	20.0	76.4	63.3	36.8	17.1	36.1	20.5	35.4	40.0	41.4	31.5	47.1	135.1	25.8	24.9	57.9	21.7	30.0	31.8	209.8	18.6	48.5	55.3	115.6	54.8	45.6	23.7	29.2	168.9	111.8	205.0	188.7	136.4	344.0	124.7	241.8	190.3	334.3	235.7	231.4	127.0	485.4	82.3	294.2	75.4	142.5	430.0	166.6	456.6	123.6	135.8	265.1	197.4	183.0	97.4	287.3	90.8	194.5	107.6	271.9	225.4	142.3	193.3	147.0	186.3	63.9	288.1	46.8	219.2	78.4	206.0	253.3	132.3	277.9	232.5	143.4	79.6	109.3	151.0	123.5	123.8	143.6	90.9	247.2	109.5	156.9	137.4	224.0	111.8	113.6	223.3	84.2	102.9	146.8	230.4	179.6	156.9	0.5	5.0	1.3	7.0	8.2	12.3	7.8	8.3	9.1	11.7	7.6	11.5	9.7	0.4	11.4	5.8	5.7	9.3	6.8	20.2	26.8	20.3	31.9	28.2	20.0	20.9	20.0	20.5	21.7	18.6	29.2	27.0	19.2	27.8	27.7	27.0	41.4	45.9	24.3	44.3	32.9	29.9	22.4	76.6	40.0	22.3	22.0	6.2	41.0	19.9	14.5	27.4	31.8	1152.2	24.9	37.5	39.5	35.3	72.8	53.4	42.3	47.5	45.1	21.4	29.3	14.5	75.6	32.9	44.2	23.9	63.9	39.5	24.8	18.3	33.3	31.6	2185.2	52.8	24.7	26.6	14.0	28.4	44.3	16.5	27.6	36.1	35.3	11.9	44.0	46.5	79.4	9.5	42.7	20.7	22.6	26.3	63.7	49.0	142.9	57.8	40.7	36.9	32.3	23.6	47.2	41.1	39.7
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384652-9448127	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: AB_2683180"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	37.9	29.1	24.1	31.3	25.7	22.7	40.4	27.3	30.7	35.7	27.5	34.6	27.2	33.9	29.2	37.9	31.3	31.8	50.4	23.2	28.0	41.4	38.5	28.9	30.1	27.6	27.4	33.1	33.8	38.9	13.0	41.1	27.3	32.1	34.1	47.8	33.3	33.2	110.3	25.3	26.0	43.4	26.8	22.9	25.6	12.7	27.4	31.8	54.0	93.4	34.8	51.8	22.8	29.9	148.7	110.8	130.6	104.4	129.4	165.7	104.4	176.0	112.4	127.1	136.4	99.1	132.6	138.1	62.5	136.3	115.5	113.5	187.5	136.7	210.7	66.3	154.5	114.3	118.8	100.1	80.7	177.0	83.3	106.7	144.8	84.0	195.6	129.5	152.8	46.7	174.7	80.5	167.9	60.3	107.5	86.3	129.0	136.3	130.2	111.4	205.5	63.0	105.3	137.5	51.7	101.5	78.6	153.5	129.1	103.2	70.7	87.6	120.9	155.6	107.4	162.0	190.9	23.2	95.3	93.6	102.0	93.6	86.4	0.1	1.5	0.3	1.4	2.6	2.7	1.9	1.5	2.0	3.2	1.4	1.9	1.7	0.7	3.5	3.8	1.4	1.5	1.0	24.1	25.7	27.3	30.7	23.2	28.0	27.6	27.4	27.3	26.8	27.4	29.9	41.3	67.3	71.5	19.6	46.4	144.0	103.3	44.8	68.9	40.1	65.5	42.4	131.9	25.8	59.7	35.0	58.4	52.8	39.7	27.2	33.2	34.2	4.6	55.9	92.5	55.7	31.1	50.9	43.9	42.2	63.8	58.0	47.4	99.5	37.9	56.5	25.0	46.8	35.3	35.3	49.7	38.8	32.6	48.0	92.2	7.1	28.0	56.6	39.2	17.8	39.2	31.8	13.4	28.1	44.9	45.5	32.9	35.7	47.6	150.6	26.5	45.7	48.4	39.8	13.1	96.2	71.0	21.6	19.8	82.2	147.9	36.7	37.7	49.0	50.9	127.4
IPO8	"IMP8, RANBP8"	ENSG00000133704	"Importin 8"	O15397	12	30628988-30695869	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018439, HPA023765"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA018439: AB_1851771, HPA023765: AB_1851773"	"unprognostic (1.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (2.66e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (8.62e-5)"	"unprognostic (9.75e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.24e-1)"	20.1	21.6	17.8	23.0	21.8	16.5	22.2	25.3	19.9	22.1	26.1	29.4	26.6	23.9	17.1	24.2	17.2	21.4	16.7	19.1	21.4	32.2	34.6	23.1	28.1	22.0	19.8	26.6	27.8	51.9	15.5	22.5	20.9	21.8	32.2	22.8	19.8	25.4	18.5	24.3	23.7	26.8	18.1	25.2	24.1	24.5	20.9	29.3	31.7	21.7	27.5	23.9	15.5	22.8	41.2	46.8	44.3	32.9	40.9	46.8	62.3	44.4	42.5	34.9	40.6	32.9	41.8	52.9	38.1	54.8	37.0	25.8	49.7	48.4	50.5	62.0	35.1	43.1	56.0	29.8	26.8	63.3	32.8	37.8	29.8	55.5	47.1	62.5	58.5	36.4	39.2	38.7	49.9	21.0	47.6	39.3	86.7	56.5	18.1	38.5	93.1	42.7	43.6	55.5	27.3	33.7	46.6	33.7	25.0	78.6	53.8	22.7	52.4	33.2	29.0	72.3	39.3	38.0	54.9	78.4	40.6	37.4	58.7	3.4	1.9	2.4	1.9	2.5	2.8	2.4	2.1	2.0	1.4	3.2	2.2	3.0	2.5	2.6	2.6	1.4	2.8	1.3	17.8	21.8	25.3	19.9	19.1	21.4	22.0	19.8	20.9	18.1	20.9	22.8	18.4	9.6	21.0	22.2	17.3	9.6	6.7	6.3	12.5	13.4	12.2	7.4	20.3	8.6	16.6	11.0	12.5	11.8	13.5	17.2	3.9	10.1	51.5	14.3	17.5	17.5	6.7	14.5	38.8	14.0	6.8	13.4	16.8	14.2	12.0	25.0	21.0	25.1	16.1	8.4	35.0	13.8	8.2	24.8	10.8	11.9	8.7	17.4	8.8	30.9	16.7	12.7	18.6	59.8	35.7	14.1	8.1	13.2	17.5	7.6	15.0	15.7	9.9	14.3	13.1	17.0	14.8	17.4	5.2	23.4	9.2	17.9	13.6	11.1	14.8	9.0
IQCA1	"DRC11, FLJ22527, IQCA"	ENSG00000132321	"IQ motif containing with AAA domain 1"	Q86XH1	2	236324147-236507535	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.0;choroid plexus: 22.7;thyroid gland: 19.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 180.9;Endometrial ciliated cells: 54.7;Respiratory ciliated cells: 115.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;HBEC3-KT: 3.3;HeLa: 3.8;hTERT-RPE1: 6.9;SuSa: 4.4;U-2 OS: 12.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 7.2"	HPA057320			Uncertain	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA057320: "	"unprognostic (1.73e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.23e-5)"	"unprognostic (1.55e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (2.54e-4)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.91e-3)"	"unprognostic (5.30e-2)"	2.2	1.2	23.3	0.4	25.3	0.0	1.8	18.1	46.0	1.3	22.7	0.2	0.1	1.7	5.4	0.7	11.0	1.7	0.5	21.2	21.1	4.6	0.1	2.7	0.4	20.8	27.0	2.4	1.3	1.4	10.3	0.2	19.7	1.5	0.1	2.2	1.2	1.3	0.0	0.2	0.3	0.5	13.9	3.1	0.5	4.5	22.2	2.8	19.2	0.0	0.6	1.7	1.0	16.7	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.3	0.1	0.0	0.0	3.2	0.0	1.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	0.2	1.7	0.0	0.0	6.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	12.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.2	0.3	1.3	0.0	0.4	0.0	0.0	0.0	0.0	23.3	25.3	18.1	46.0	21.2	21.1	20.8	27.0	19.7	13.9	22.2	16.7	2.8	16.0	12.6	180.9	0.4	0.5	7.8	26.9	1.8	26.2	1.7	14.1	1.3	11.5	26.7	3.7	16.7	0.5	0.0	0.0	0.0	10.8	24.0	54.7	5.2	10.4	0.0	0.0	26.0	1.5	5.6	3.3	0.5	9.8	1.3	6.7	2.2	0.0	0.3	0.0	11.6	0.0	16.2	0.0	0.0	14.5	2.1	0.4	0.0	9.4	0.0	0.5	1.0	4.5	2.4	1.2	0.0	6.0	0.3	1.7	0.0	11.7	115.7	2.3	0.0	0.8	2.2	31.0	28.3	0.8	0.3	0.3	0.8	1.9	0.0	3.1
IQCD	"CFAP84, DRC10"	ENSG00000166578	"IQ motif containing D"	Q96DY2	12	113195441-113221094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.0;testis: 44.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 155.2;Endometrial ciliated cells: 76.6;Late spermatids: 104.6;Respiratory ciliated cells: 125.8;Spermatocytes: 92.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.4;granulocytes: 1.9;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 28.2;RPTEC TERT1: 13.8;U-698: 15.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046810, HPA048782"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA046810: AB_2679818, HPA048782: AB_2680519"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.26e-5)"	"unprognostic (2.23e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (3.90e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.20e-2)"	0.8	0.9	2.5	1.0	2.6	0.3	1.3	2.7	2.5	2.2	8.4	0.7	0.2	1.9	2.0	1.8	22.0	1.0	1.4	2.4	2.8	2.9	0.2	2.6	1.0	4.4	5.7	1.5	1.0	5.1	3.9	0.6	3.6	0.7	0.8	3.7	1.1	1.2	0.4	0.7	0.4	1.0	3.8	0.2	0.5	44.3	2.7	0.7	1.8	0.1	2.6	1.9	0.8	4.1	3.6	4.1	1.3	1.1	1.5	1.6	0.9	0.5	28.2	1.4	1.9	0.7	10.9	3.9	3.0	0.8	11.0	0.7	0.6	1.2	2.3	0.3	1.2	1.3	1.5	0.7	0.8	0.4	0.9	0.6	0.8	4.3	1.4	7.6	0.9	1.5	0.2	0.3	0.3	4.1	0.2	7.6	0.3	1.9	1.0	0.2	0.6	1.0	13.8	4.3	3.1	1.3	1.0	1.4	4.5	1.0	5.0	2.2	0.3	0.6	2.0	1.3	0.8	1.1	0.9	15.6	2.0	0.2	2.4	1.9	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	2.5	2.6	2.7	2.5	2.4	2.8	4.4	5.7	3.6	3.8	2.7	4.1	0.7	3.2	1.7	4.2	0.6	2.4	3.2	10.1	1.2	0.5	2.4	2.8	4.3	4.3	16.2	5.5	14.6	1.4	0.3	3.7	13.7	3.7	155.2	76.6	3.4	0.5	6.6	0.0	1.2	0.8	0.3	2.7	1.1	11.6	0.0	1.0	1.1	0.4	2.1	0.0	1.0	0.7	6.1	0.3	0.6	104.6	2.1	2.3	3.6	1.9	2.5	7.2	1.0	0.0	2.9	0.7	3.4	5.3	0.3	1.8	0.2	16.6	125.8	5.2	0.0	1.2	4.1	92.9	4.8	0.7	1.7	1.9	0.9	1.5	0.3	4.8
IQCE	KIAA1023	ENSG00000106012	"IQ motif containing E"	Q6IPM2	7	2558972-2614733	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 410.0;Late spermatids: 419.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.6;granulocytes: 4.6;monocytes: 1.2"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019515	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA019515: AB_1851855"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.91e-4)"	"unprognostic (7.96e-3)"	"unprognostic (3.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.56e-3)"	"unprognostic (3.13e-2)"	4.5	6.6	19.3	6.5	16.7	5.6	6.2	9.6	19.3	7.5	22.5	9.4	12.0	8.3	10.3	5.3	14.6	7.2	6.6	17.3	16.3	6.6	3.3	7.5	4.3	16.5	18.6	7.7	7.6	11.0	14.4	3.5	11.3	7.8	8.7	9.8	9.1	9.3	4.9	7.3	10.1	6.6	13.3	4.6	9.6	31.7	18.6	4.3	10.5	5.5	3.5	5.7	4.3	15.1	35.5	18.2	7.0	23.0	9.2	13.4	13.2	7.2	11.7	8.8	9.4	9.5	19.6	2.5	8.0	16.7	19.7	17.9	5.1	7.4	8.9	6.3	10.9	4.9	21.9	2.6	6.8	12.8	6.4	5.8	13.5	8.3	9.9	10.4	10.3	8.9	15.4	4.5	11.8	35.8	5.2	8.6	6.6	15.7	12.4	4.9	8.4	8.8	10.1	15.9	15.7	18.7	8.2	33.9	7.1	4.9	41.5	17.1	10.3	7.6	15.7	30.2	12.2	4.9	8.0	0.5	15.3	8.5	22.1	0.8	0.8	2.3	0.6	1.2	0.2	0.2	0.3	0.3	0.3	0.3	0.2	0.6	4.6	0.2	0.4	2.6	0.2	0.2	19.3	16.7	9.6	19.3	17.3	16.3	16.5	18.6	11.3	13.3	18.6	15.1	4.8	12.8	14.3	14.4	2.1	5.5	5.7	5.3	6.2	8.9	12.3	7.9	9.1	14.3	11.4	12.9	60.5	4.1	13.8	27.4	17.6	20.6	410.0	44.8	15.3	5.7	8.4	1.7	16.6	19.7	10.0	7.0	24.5	9.4	1.3	7.6	6.4	2.8	10.1	20.2	17.4	12.3	12.2	8.1	5.3	419.3	14.0	9.3	0.0	3.7	12.0	14.9	12.3	4.5	4.2	24.1	18.9	15.4	8.0	5.4	12.1	9.5	58.7	36.7	19.7	7.8	6.6	40.9	43.8	3.5	4.3	1.9	4.9	11.2	12.4	4.0
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 11.2;Late spermatids: 26.6;Undifferentiated cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	0.7	0.7	0.2	2.2	0.4	15.5	0.6	0.0	0.6	1.1	0.2	4.1	6.6	0.5	1.1	5.2	0.2	0.7	0.4	0.5	0.1	0.6	0.6	1.6	1.6	0.9	0.4	0.1	0.2	0.1	0.1	2.8	0.9	0.4	5.0	0.0	1.0	0.1	0.3	3.7	5.7	2.9	0.0	0.8	4.6	3.8	0.6	3.4	0.2	0.0	2.2	0.9	2.1	0.4	59.2	28.4	25.6	18.1	1.6	4.0	12.4	43.1	28.3	41.0	36.6	32.4	52.5	5.2	15.6	25.2	21.6	54.6	17.5	22.1	36.3	0.1	15.7	7.8	62.6	16.1	0.2	9.7	0.1	1.2	2.5	34.3	50.0	10.0	24.1	12.5	16.1	8.1	30.2	31.2	5.7	13.7	18.6	57.7	28.0	18.9	28.8	6.1	10.4	20.3	16.3	25.2	38.7	44.9	14.9	29.8	35.8	25.6	16.8	36.8	43.7	30.4	51.4	4.0	2.1	2.4	12.4	15.1	42.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.4	0.0	0.6	0.5	0.1	0.9	0.4	0.9	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.4	0.6	0.0	1.4	1.3	1.0	2.8	0.1	0.0	0.0	2.2	0.1	3.9	0.0	0.3	6.5	0.5	0.7	0.6	1.2	6.5	0.7	0.0	3.6	0.9	11.2	1.4	0.0	4.4	2.5	0.4	3.9	0.0	0.2	3.7	0.0	1.3	6.1	26.6	0.3	1.9	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	0.4	0.8	0.4	0.0	0.0	0.0	0.0	1.4	6.4	2.6	3.6	1.0	0.8	0.2	0.3	7.4	0.4
IQSEC3	"KIAA1110, MGC30156"	ENSG00000120645	"IQ motif and Sec7 domain ArfGEF 3"	Q9UPP2	12	66767-178455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 39.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.8;Excitatory neurons: 81.6;Horizontal cells: 114.4;Inhibitory neurons: 76.2;Spermatocytes: 48.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 7.1;U-266/70: 9.1;U-266/84: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039025			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA039025: AB_10672768"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.82e-3)"	"unprognostic (2.83e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-2)"	4.0	0.8	6.6	0.5	8.2	0.7	1.4	17.0	39.1	2.2	0.0	0.6	0.4	2.4	0.3	0.3	3.3	1.5	1.3	9.8	5.6	2.0	0.2	2.0	0.4	5.4	2.3	1.6	0.8	0.0	8.7	0.9	1.7	1.2	0.2	7.5	0.3	2.9	1.0	0.2	0.5	1.2	4.7	0.4	0.5	1.4	8.3	3.2	0.4	0.4	0.1	0.9	1.6	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.1	2.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	6.6	8.2	17.0	39.1	9.8	5.6	5.4	2.3	1.7	4.7	8.3	15.9	9.9	3.2	0.0	1.6	0.0	0.3	0.0	0.0	0.6	50.8	0.1	0.1	2.2	0.0	0.0	0.0	8.4	0.0	2.1	0.1	0.0	0.0	0.8	0.1	0.9	3.3	0.0	0.0	81.6	0.0	0.0	1.3	0.0	0.2	2.5	0.1	2.2	0.4	1.6	114.4	76.2	0.0	0.0	0.8	0.6	4.3	0.6	1.4	0.0	7.5	0.1	6.6	1.0	4.5	1.4	0.2	0.0	0.0	0.0	0.1	0.7	5.2	0.0	16.1	0.0	0.5	1.1	48.6	21.8	0.1	0.1	0.0	0.5	0.1	0.2	0.1
IQUB	FLJ35834	ENSG00000164675	"IQ motif and ubiquitin domain containing"	Q8NA54	7	123452193-123535077	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 33.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 283.9;Endometrial ciliated cells: 82.6;Late spermatids: 157.5;Respiratory ciliated cells: 88.2;Spermatocytes: 116.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049626			Approved	"Nucleoplasm,Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	"Nucleoplasm, Intermediate filaments, Cytosol"	"HPA049626: AB_2732554"	"unprognostic (8.71e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.42e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.30e-2)"	0.1	0.6	0.2	0.0	0.4	0.0	0.5	1.7	0.9	0.8	3.9	0.1	0.0	0.7	1.1	0.0	5.0	0.8	0.1	0.2	0.5	3.0	0.0	0.8	0.0	1.8	2.0	0.2	0.3	1.7	1.0	0.1	1.3	0.5	0.0	1.1	0.2	0.6	0.1	0.1	0.0	0.2	1.0	0.0	0.1	33.4	0.6	0.0	3.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.4	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.7	0.9	0.2	0.5	1.8	2.0	1.3	1.0	0.6	0.4	1.1	6.4	0.5	19.6	0.0	0.5	0.7	3.8	0.0	2.5	1.9	1.8	1.8	0.0	11.4	18.4	4.2	0.4	0.1	0.1	1.9	1.1	283.9	82.6	3.2	0.9	1.8	0.0	12.0	0.4	0.3	1.1	0.0	1.7	1.3	0.3	0.7	0.0	0.1	3.3	8.6	0.2	8.2	0.0	0.3	157.5	2.5	0.4	0.0	4.7	0.3	1.8	0.0	5.0	2.6	0.2	0.0	3.0	0.0	0.5	0.0	5.7	88.2	9.0	6.6	0.7	2.7	116.2	6.0	0.2	0.1	0.7	0.3	2.9	0.0	0.3
IRAK1	"IRAK, pelle"	ENSG00000184216	"Interleukin 1 receptor associated kinase 1"	P51617	X	154010506-154019902	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004461, HPA054476"	Supported		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: AB_2682501"	"unprognostic (4.46e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.09e-3)"	"unprognostic (4.43e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (7.89e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (2.76e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.04e-1)"	48.6	61.2	24.4	37.6	25.3	82.4	40.7	23.6	34.9	29.0	20.0	41.4	43.3	31.8	7.7	69.1	28.8	20.2	34.4	22.3	26.5	44.2	64.7	48.9	33.7	38.1	30.0	28.9	84.9	12.4	37.5	17.8	30.8	46.1	15.0	4.5	41.6	21.0	92.5	44.3	51.1	16.4	29.6	69.9	41.9	20.8	34.3	19.4	24.5	16.8	24.0	47.7	36.5	29.4	467.2	178.9	24.5	201.2	48.4	38.5	108.3	68.8	64.5	104.0	96.0	142.3	199.4	200.8	371.4	73.6	157.6	124.3	57.6	112.4	39.8	156.7	173.4	73.3	158.6	85.7	110.8	174.2	118.7	53.2	96.1	99.0	107.8	53.2	62.8	39.6	130.9	220.3	73.3	171.4	70.8	152.1	60.9	148.4	353.5	181.6	126.4	334.7	68.5	86.3	137.4	98.7	82.2	88.6	135.2	9.5	34.3	179.2	86.4	123.8	194.6	284.6	424.2	274.8	190.6	358.2	179.6	205.1	130.8	1.3	7.2	6.2	5.3	9.2	4.7	6.5	4.3	4.4	4.8	7.9	2.5	4.7	5.2	5.4	7.5	10.9	2.3	3.3	24.4	25.3	23.6	34.9	22.3	26.5	38.1	30.0	30.8	29.6	34.3	29.4	20.2	0.0	13.3	5.9	29.7	13.4	14.5	10.9	5.2	9.1	23.9	19.0	9.3	18.6	16.0	11.0	6.2	11.4	33.0	41.4	7.9	40.5	0.9	9.8	13.5	18.1	20.4	18.1	9.7	113.6	20.9	15.2	18.3	17.3	12.7	25.5	13.2	35.9	57.2	16.8	8.9	27.2	0.0	51.4	24.7	3.8	18.0	43.0	14.2	11.2	24.2	21.8	13.4	4.5	6.6	75.0	28.6	21.4	33.5	30.0	39.4	19.6	10.0	5.3	0.0	14.5	14.9	1.6	8.1	15.1	13.1	12.3	19.6	18.4	39.4	25.3
IRF1	MAR	ENSG00000125347	"Interferon regulatory factor 1"	P10914	5	132440440-132508719	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.1"	"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 516.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 138.1;REH: 114.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011662, HPA063131"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB011662: AB_775784, HPA063131: AB_2684945"	"unprognostic (1.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.09e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.53e-3)"	53.7	19.1	8.2	88.0	7.6	142.1	29.5	8.1	9.4	21.3	7.7	46.3	84.8	21.3	11.7	24.3	24.4	32.6	25.8	7.3	7.5	32.9	54.4	119.0	86.3	17.2	8.1	18.4	15.6	7.4	17.3	22.2	15.8	36.4	38.1	2.8	28.7	16.2	16.7	19.7	68.8	33.1	8.8	117.4	47.4	13.5	10.5	66.4	25.8	13.3	45.3	63.9	24.1	8.0	26.7	22.8	2.3	8.1	22.1	18.9	42.5	14.7	58.8	41.6	52.2	11.3	79.4	26.7	15.8	18.4	64.8	35.7	7.4	33.7	14.3	54.2	7.1	33.2	8.1	6.9	138.1	14.6	34.3	36.9	9.4	31.7	32.2	26.5	22.4	19.1	6.9	97.5	13.1	15.9	87.6	32.7	3.4	9.3	14.6	114.5	23.2	31.7	22.5	27.8	6.4	3.6	14.6	30.8	13.4	10.1	4.7	24.2	13.0	20.5	8.1	12.8	19.8	74.8	27.0	19.3	24.9	27.2	15.5	175.3	167.1	257.0	157.2	244.1	106.9	68.4	104.2	129.9	95.7	62.5	63.5	91.7	621.0	136.9	272.4	52.4	122.1	160.0	8.2	7.6	8.1	9.4	7.3	7.5	17.2	8.1	15.8	8.8	10.5	8.0	369.9	102.5	114.3	1.0	216.5	88.1	129.4	66.3	306.7	14.7	216.5	186.6	17.0	47.1	58.0	22.0	33.3	24.0	396.3	183.6	19.6	112.1	92.5	242.3	170.8	223.1	87.1	36.6	1.1	114.3	42.6	224.4	212.0	288.1	105.2	32.0	58.2	14.6	49.7	1.7	1.2	137.4	57.0	73.9	228.7	9.1	27.4	134.1	72.9	7.5	257.2	16.7	399.6	2.5	1.1	88.6	140.6	7.9	248.6	270.9	155.5	22.4	110.9	46.5	13.1	516.2	225.0	1.3	6.8	118.8	82.7	11.2	301.4	20.5	94.6	95.0
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387729-184474550	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 163.6;Karpas-707: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410"	"prognostic favorable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (1.31e-3)"	25.1	30.1	18.2	47.8	23.4	18.0	21.9	22.1	19.3	25.6	21.4	27.8	31.1	21.8	22.7	26.7	25.3	24.9	19.5	17.5	21.9	18.5	37.4	27.6	62.5	25.3	22.1	28.1	14.8	20.2	12.3	28.9	25.2	20.6	28.7	9.3	29.1	21.2	28.1	19.4	33.3	23.2	21.7	54.9	31.5	6.1	23.5	49.8	21.7	23.8	52.2	35.6	22.5	29.6	20.3	14.9	17.5	12.0	37.4	37.9	10.5	14.4	44.8	34.8	36.0	4.2	37.9	12.2	7.4	21.7	28.4	18.3	12.0	27.4	22.1	163.6	6.6	34.4	7.9	26.8	37.1	21.1	27.7	41.2	24.8	19.8	50.1	29.8	26.7	14.5	6.9	165.3	14.6	14.1	40.6	25.8	4.0	18.5	10.7	52.7	6.9	55.1	26.6	30.4	7.5	11.6	20.4	16.8	31.3	7.3	13.0	18.9	22.0	9.9	10.7	11.3	12.8	47.3	40.6	11.0	20.9	20.3	17.8	106.7	95.7	175.8	76.4	126.3	77.9	104.9	74.5	82.2	79.6	107.7	78.8	78.8	407.6	94.8	145.7	20.2	111.7	100.3	18.2	23.4	22.1	19.3	17.5	21.9	25.3	22.1	25.2	21.7	23.5	29.6	58.9	38.5	24.5	53.5	68.9	49.1	50.5	60.4	45.5	13.1	25.8	27.3	21.9	27.1	36.0	25.8	6.2	31.3	48.8	40.3	37.2	30.9	0.2	53.4	40.2	42.9	30.6	62.7	23.8	30.1	16.2	35.8	34.1	63.2	26.6	23.1	38.2	37.6	48.5	20.2	27.8	29.5	44.7	90.3	53.5	3.0	37.3	65.9	19.6	41.2	144.0	23.4	70.0	43.7	77.1	28.7	38.9	53.0	63.4	72.9	42.1	46.1	58.7	8.4	39.5	25.4	44.8	0.6	2.4	49.5	44.5	26.7	56.3	37.7	22.8	70.9
IRF2BP1	"DKFZP434M154, IRF-2BP1"	ENSG00000170604	"Interferon regulatory factor 2 binding protein 1"	Q8IU81	19	45883608-45886141	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"NB-4: 82.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042164, HPA049480"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA042164: AB_2677882, HPA049480: AB_2680785"	"unprognostic (5.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.85e-5)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.07e-3)"	11.1	15.8	12.2	4.6	11.9	3.6	12.3	13.8	15.8	17.8	3.8	17.6	7.3	20.0	3.6	11.8	16.9	3.2	16.6	12.7	10.8	14.2	21.0	8.3	5.2	15.2	11.9	21.7	15.7	7.1	20.6	3.1	11.8	15.3	2.0	4.3	13.7	6.9	22.0	14.4	13.8	3.0	10.3	13.6	16.4	9.3	11.8	6.1	12.3	7.9	2.8	15.9	12.0	14.8	18.1	27.1	6.5	14.6	5.5	3.4	10.8	13.0	7.4	10.2	8.9	10.1	8.4	14.5	9.6	6.7	6.1	16.7	4.7	4.9	3.0	18.4	46.4	14.6	7.6	13.1	11.1	15.2	13.1	4.8	6.6	5.3	3.8	6.4	6.3	17.8	23.4	11.2	4.0	14.1	31.0	82.8	12.3	6.7	23.8	35.2	7.7	12.6	7.4	9.9	19.4	33.3	13.8	17.8	17.3	2.5	14.8	27.8	9.2	8.8	17.7	6.8	18.6	30.4	36.2	8.6	11.9	14.3	13.0	0.0	0.3	0.1	0.7	0.4	0.7	0.7	0.6	0.6	0.3	0.6	0.9	0.5	0.4	0.7	0.2	0.5	0.6	0.4	12.2	11.9	13.8	15.8	12.7	10.8	15.2	11.9	11.8	10.3	11.8	14.8	6.0	0.0	1.1	2.6	8.4	10.7	5.8	4.1	14.2	15.2	13.5	11.4	1.3	11.5	2.4	11.0	0.0	10.9	8.4	8.9	13.7	7.8	2.0	6.0	6.7	6.3	9.6	10.1	2.2	9.5	6.6	8.2	7.1	6.9	0.0	8.3	7.9	9.3	5.0	10.1	3.2	11.2	0.0	2.2	8.6	1.5	18.6	5.1	8.8	3.7	4.5	10.2	5.2	2.0	3.7	7.5	11.9	10.9	2.5	7.4	9.3	13.5	3.0	7.0	19.7	10.7	11.7	3.8	2.2	8.9	11.2	8.8	7.3	9.9	8.7	3.0
IRF2BP2	IRF-2BP2	ENSG00000168264	"Interferon regulatory factor 2 binding protein 2"	Q7Z5L9	1	234604269-234610178	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 440.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 277.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027815, HPA062269"	Approved		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA027815: AB_10609994, HPA062269: AB_2684732"	"unprognostic (1.15e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	35.6	39.6	43.3	25.6	50.2	157.2	45.0	48.5	49.1	50.0	43.3	42.5	39.6	55.8	26.5	47.0	45.1	40.7	45.0	40.5	45.4	34.2	53.6	43.7	36.3	55.2	49.0	54.8	49.5	45.5	24.1	29.6	51.1	39.2	49.3	26.9	55.0	33.5	47.4	64.2	42.2	31.7	48.9	28.4	44.4	18.0	44.7	29.6	57.3	40.5	30.3	38.7	43.7	61.1	28.0	41.5	29.8	45.7	61.2	48.1	35.1	21.8	18.4	12.7	14.2	24.5	33.5	0.0	49.4	21.2	43.3	37.4	16.2	28.3	20.2	45.2	36.8	26.7	32.9	72.3	49.4	101.0	91.0	57.0	65.8	28.3	53.4	74.4	33.0	24.5	23.0	55.6	33.2	8.4	25.5	107.2	27.1	65.1	15.7	49.6	13.8	66.8	25.1	22.9	58.8	41.8	35.2	46.7	72.7	29.8	45.1	277.5	36.8	45.5	19.0	34.7	41.6	122.9	33.8	9.1	23.1	89.6	63.4	10.1	4.5	8.5	3.9	3.6	4.0	4.3	4.8	4.6	4.7	4.0	4.9	4.1	2.3	3.0	1.9	17.8	4.0	2.5	43.3	50.2	48.5	49.1	40.5	45.4	55.2	49.0	51.1	48.9	44.7	61.1	96.0	134.6	191.3	28.1	75.6	325.9	440.4	142.3	139.5	34.6	126.6	109.7	63.6	133.0	143.8	51.5	10.4	44.6	168.3	84.2	13.7	65.8	24.9	180.8	126.2	101.9	145.5	76.6	14.3	50.0	58.0	97.3	47.4	285.2	107.5	39.6	117.4	185.7	88.9	58.9	22.9	117.1	71.2	131.8	271.2	27.1	69.6	159.7	110.3	30.9	83.2	87.7	38.1	20.6	64.2	68.9	92.0	81.3	39.2	138.2	81.7	40.2	95.1	19.5	78.9	117.1	102.9	29.5	24.1	182.1	396.2	79.4	91.3	15.5	162.7	370.6
IRF2BPL	"C14orf4, EAP1, KIAA1865"	ENSG00000119669	"Interferon regulatory factor 2 binding protein like"	Q9H1B7	14	77024543-77028708	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050862, HPA061333"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA050862: AB_2681258, HPA061333: AB_2684481"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.78e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	26.1	25.3	12.2	9.2	13.9	5.6	28.5	13.4	12.0	20.1	12.8	32.4	6.9	25.8	5.1	13.3	33.7	6.5	22.6	14.1	21.1	28.7	19.1	20.9	6.2	15.2	14.8	32.4	17.5	19.8	22.6	7.9	10.9	18.4	3.3	7.3	19.2	10.1	16.8	25.2	15.1	8.0	12.6	19.0	18.8	13.5	19.0	9.7	18.7	4.2	3.3	26.4	18.2	9.4	15.4	13.2	32.2	36.3	9.6	8.8	45.8	15.9	13.0	4.4	5.9	6.2	24.8	5.4	11.3	13.6	12.4	23.6	5.6	11.8	3.7	25.8	19.1	6.9	13.0	8.5	12.5	1.9	29.7	11.8	9.1	7.8	6.8	34.8	6.0	10.9	10.4	59.4	5.7	42.2	21.0	14.5	14.5	6.6	68.2	4.4	9.1	13.0	15.6	22.4	24.9	36.0	22.5	23.2	42.5	8.6	16.1	3.4	10.4	20.2	19.5	6.8	10.3	22.9	26.3	9.0	31.3	4.7	25.8	1.7	1.4	1.3	2.8	1.9	2.7	1.4	2.5	2.6	1.3	1.6	2.0	2.3	9.0	5.9	2.3	10.7	2.6	0.8	12.2	13.9	13.4	12.0	14.1	21.1	15.2	14.8	10.9	12.6	19.0	9.4	71.4	22.4	14.3	5.9	40.2	73.7	32.5	22.5	115.5	57.1	54.6	41.5	19.5	32.9	11.6	64.4	29.2	22.8	58.9	10.8	37.2	19.6	1.3	25.3	26.0	44.0	47.6	10.8	8.2	19.0	49.7	47.8	12.2	25.6	26.6	15.2	55.6	60.5	33.3	10.1	8.6	14.7	16.2	54.7	78.9	4.0	30.1	26.6	35.6	9.4	10.0	57.8	38.1	8.5	4.8	17.8	7.0	34.3	21.1	30.0	6.7	23.1	13.8	10.4	39.5	56.4	83.2	1.6	50.5	54.2	50.6	46.0	39.0	27.5	12.8	20.6
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391752-411443	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.2;cervix: 19.0;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 57.2;dendritic cells: 66.8;Langerhans cells: 109.7;Melanocytes: 44.4;monocytes: 56.1;Plasma cells: 235.6"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 10.4;myeloid DC: 10.6;naive B-cell: 10.8;plasmacytoid DC: 12.1;T-reg: 5.8"	"Group enriched"	"Detected in many"	5	"B-cells: 10.8;dendritic cells: 12.1;T-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 221.4;Karpas-707: 197.8;RPMI-8226: 200.0;U-266/70: 177.2;U-266/84: 141.3;WM-115: 109.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favorable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	3.1	0.4	0.1	15.9	0.1	29.2	3.2	0.1	0.2	19.0	0.2	6.9	7.6	1.5	0.3	0.9	0.7	2.5	1.0	0.1	0.1	0.4	2.4	2.2	23.2	0.3	0.1	0.6	0.1	0.0	0.3	0.1	0.2	0.5	6.8	0.0	4.5	0.4	0.2	6.8	10.2	0.7	0.2	17.4	7.2	1.1	0.1	7.0	1.1	0.1	26.1	6.3	2.4	0.2	0.4	0.0	0.0	0.0	22.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	221.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.8	0.0	0.0	0.1	0.1	1.2	0.0	0.0	26.1	0.0	200.0	0.0	0.0	0.4	0.0	0.0	0.2	32.0	0.6	0.1	0.3	0.0	0.0	0.1	0.0	0.3	177.2	141.3	58.4	0.2	0.0	109.0	0.1	1.8	0.0	0.6	1.5	0.0	10.4	1.0	1.0	10.6	10.8	1.7	0.7	0.0	0.3	1.5	12.1	5.8	1.5	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.8	0.0	5.3	0.0	57.2	8.3	0.1	0.0	0.0	0.0	0.6	1.5	1.2	1.5	0.0	0.0	0.0	0.0	66.8	0.2	0.0	0.1	0.0	0.3	0.9	0.6	0.0	0.0	0.1	0.7	0.0	1.8	1.5	0.4	0.0	0.0	1.1	0.5	0.3	0.0	0.1	0.1	0.0	0.6	109.7	0.2	3.4	21.7	44.4	0.0	56.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	235.6	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	1.0	0.4	4.3	0.1	29.8	0.0	0.1	0.1
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785617-209806175	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 95.4;skin 1: 114.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 387.2;Basal prostatic cells: 253.9;Basal squamous epithelial cells: 217.9;Squamous epithelial cells: 251.9;Suprabasal keratinocytes: 552.4;Urothelial cells: 290.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 10.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 61.9;HaCaT: 210.7;HBEC3-KT: 80.5;hTCEpi: 170.1;hTERT-HME1: 82.2;RT4: 78.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.6	11.4	1.6	3.2	1.5	2.8	35.9	10.9	1.8	21.6	5.2	27.1	26.9	5.9	49.3	95.4	21.7	10.8	29.7	1.7	1.4	17.0	33.3	8.8	0.9	1.9	2.9	1.9	19.7	26.4	6.5	20.4	1.9	32.4	31.5	2.4	39.0	26.4	0.5	114.0	25.0	2.0	2.1	2.1	24.8	2.9	2.3	20.3	17.1	2.7	23.0	40.5	46.8	1.2	61.9	0.0	0.0	0.0	0.4	0.0	20.9	0.1	0.5	0.1	0.3	13.6	20.7	0.0	0.1	0.1	0.0	210.7	0.0	80.5	0.0	0.0	1.3	0.1	0.2	0.0	0.2	0.0	0.2	0.1	170.1	0.1	82.2	0.0	3.7	0.0	0.1	0.2	0.0	8.3	0.0	0.3	1.2	17.0	0.2	0.0	0.0	0.3	7.7	78.8	18.7	6.1	1.4	34.1	1.9	3.8	24.1	0.3	0.0	0.0	0.1	0.0	0.3	0.8	15.8	0.1	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.2	1.6	1.5	10.9	1.8	1.7	1.4	1.9	2.9	1.9	2.1	2.3	1.2	1.9	16.0	10.4	0.3	1.0	387.2	253.9	154.0	217.9	0.1	47.2	33.3	26.0	32.9	70.4	35.0	0.0	94.2	1.3	95.5	27.4	36.7	1.1	120.2	9.5	6.0	59.9	0.4	0.0	19.2	25.4	4.5	53.0	121.7	2.5	0.0	1.1	35.9	8.3	0.0	0.1	74.9	38.7	1.0	30.1	0.7	0.6	2.3	35.6	1.9	1.0	6.5	0.0	0.0	0.0	49.2	43.8	0.0	2.5	153.9	49.5	11.9	82.1	0.6	0.0	0.4	7.4	8.2	3.7	251.9	552.4	161.6	2.5	0.7	44.5	290.3
IRF7		ENSG00000185507	"Interferon regulatory factor 7"	Q92985	11	612553-615983	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.2;lymphoid tissue: 33.2"	"Cell type enriched"	"Detected in many"	7	"dendritic cells: 576.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	12	"plasmacytoid DC: 596.9"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 596.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 9.6;Karpas-707: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017694, HPA052757"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017694: AB_2280489, HPA052757: AB_2681937"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-10)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.71e-2)"	10.4	2.6	1.3	1.6	1.6	1.6	7.5	1.5	2.1	11.2	2.2	8.8	0.0	3.4	0.0	12.7	4.7	2.2	7.9	1.2	1.6	15.6	38.2	14.4	0.9	2.7	1.6	4.7	5.9	0.2	6.2	0.7	2.4	9.2	0.3	0.3	8.8	0.8	11.3	7.8	15.3	0.9	1.3	33.2	8.6	1.9	1.6	1.4	10.7	1.3	2.2	5.1	7.3	1.6	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.4	3.9	15.5	9.6	2.2	0.1	0.0	3.7	0.6	3.7	0.5	0.2	0.1	1.0	0.2	0.0	0.1	0.0	0.2	0.8	0.0	0.0	1.6	0.6	0.0	0.6	0.7	0.1	1.9	0.0	6.5	0.1	0.0	0.7	0.0	0.0	3.1	1.3	0.1	0.2	0.0	0.2	0.1	3.1	0.0	0.6	1.8	0.4	0.3	0.0	1.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.7	20.4	30.6	8.1	46.1	7.8	16.5	6.7	7.0	24.3	20.8	7.5	8.5	12.9	18.7	49.5	596.9	13.5	19.7	1.3	1.6	1.5	2.1	1.2	1.6	2.7	1.6	2.4	1.3	1.6	1.6	65.0	16.0	19.0	2.9	59.2	34.4	32.3	19.6	18.8	0.4	27.7	20.2	4.3	18.6	18.2	20.2	0.0	6.1	576.1	70.1	9.8	29.9	5.9	20.1	6.3	33.0	26.3	4.8	0.0	16.9	39.0	19.3	40.8	21.2	31.7	20.1	17.9	31.7	37.3	0.0	0.1	42.5	22.4	23.2	65.4	28.9	12.2	67.4	37.4	3.7	65.2	2.7	40.2	1.0	1.3	29.9	73.8	4.9	65.1	24.8	37.6	6.3	25.5	4.6	13.1	8.8	19.8	0.4	5.9	8.0	28.4	24.1	42.7	4.6	18.9	34.6
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85899162-85922606	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 85.5;lymphoid tissue: 244.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 225.8;dendritic cells: 492.3;Kupffer cells: 105.1;Langerhans cells: 366.0;Macrophages: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"plasmacytoid DC: 2477.4"	"Lineage enriched"	"Detected in all"	7	"dendritic cells: 2477.4"	"Group enriched"	"Detected in some"	4	"Daudi: 240.7;THP-1: 382.3;U-698: 928.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	25.9	7.6	4.7	81.4	5.6	85.5	9.3	7.0	6.2	5.6	5.4	27.1	47.1	8.0	3.1	6.7	6.5	19.7	3.8	6.3	5.4	6.1	36.9	27.4	244.1	9.5	8.5	2.5	3.4	1.7	1.7	10.1	10.0	7.7	33.5	0.8	7.1	8.9	2.0	5.0	56.2	13.5	11.3	137.3	22.9	4.8	12.6	61.5	4.1	1.7	224.9	21.8	1.6	14.0	0.9	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	26.0	0.0	240.7	1.5	0.0	0.0	0.1	1.4	0.0	0.2	0.2	2.7	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.5	0.0	0.0	0.6	21.3	0.2	20.6	0.0	7.5	1.1	27.2	0.0	0.0	0.1	0.1	1.0	0.0	0.2	1.4	0.0	382.3	0.6	0.0	10.9	0.2	0.9	0.3	0.3	928.2	0.0	128.4	0.0	9.1	137.1	3.4	3.3	134.3	4.5	347.0	1.8	2.1	291.2	361.3	3.5	2.8	8.4	111.5	97.3	2477.4	0.7	150.1	4.7	5.6	7.0	6.2	6.3	5.4	9.5	8.5	10.0	11.3	12.6	14.0	3.7	0.0	4.2	0.0	225.8	10.5	0.8	0.0	0.6	0.0	2.4	3.4	1.5	2.8	1.3	0.0	0.0	0.8	492.3	13.0	1.9	0.5	1.5	7.3	7.6	7.6	28.7	7.4	0.6	1.4	5.7	10.8	15.3	12.5	2.5	0.4	1.8	6.5	64.1	0.0	0.2	11.8	0.0	105.1	366.0	4.6	0.3	122.2	44.4	33.7	35.3	0.4	23.7	1.0	0.4	0.1	10.7	0.0	14.1	2.3	34.2	3.5	0.0	0.2	6.6	0.7	6.7	0.7	6.7	0.4	9.2	1.1	23.1	48.8	25.6	2.5
IRS1	HIRS-1	ENSG00000169047	"Insulin receptor substrate 1"	P35568	2	226731312-226799820	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 75.4;Theca cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005261, HPA046433"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005261: AB_649615, HPA046433: AB_2732524"	"unprognostic (2.20e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.55e-3)"	7.6	9.7	1.7	2.9	1.6	0.5	11.7	5.2	3.1	14.7	1.8	10.3	3.9	17.4	1.9	3.6	15.0	5.6	5.0	1.6	1.0	3.4	10.5	5.0	1.7	1.8	1.6	20.9	3.5	3.3	1.5	9.5	1.2	7.8	2.7	1.5	3.0	7.0	28.0	5.2	5.1	10.3	2.0	2.0	5.3	0.8	1.6	8.1	20.0	2.9	1.3	11.6	6.6	1.5	5.7	26.0	18.6	0.7	25.0	14.8	0.0	15.6	12.2	20.4	13.0	15.0	14.4	2.3	2.5	10.6	14.0	10.0	1.2	15.0	11.5	5.9	1.0	0.1	1.7	7.1	12.5	0.5	0.1	20.7	8.1	16.1	14.5	12.3	0.0	2.3	3.0	22.7	14.0	22.6	4.9	6.6	7.5	3.6	14.3	1.1	24.1	0.1	9.3	18.9	3.2	0.5	5.0	3.6	8.4	14.9	13.7	0.3	1.3	26.8	24.2	20.9	15.1	10.6	4.6	3.4	26.5	0.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	5.2	3.1	1.6	1.0	1.8	1.6	1.2	2.0	1.6	1.5	1.7	19.2	4.6	5.9	2.7	35.4	31.9	29.7	19.4	19.3	36.9	28.1	13.4	14.3	12.8	0.0	0.0	6.4	0.0	13.2	17.6	15.4	1.6	22.1	28.4	2.1	2.4	0.0	17.3	11.4	0.6	28.3	2.0	24.3	0.0	75.4	1.8	57.4	1.7	20.2	31.3	6.5	24.4	1.3	4.6	1.8	22.7	3.6	16.0	15.0	0.8	8.4	0.0	26.7	1.7	11.1	8.2	14.7	9.5	14.5	23.4	3.0	8.1	1.7	13.1	9.5	22.8	1.0	1.2	4.2	23.7	18.3	1.2	110.3	7.7	22.8
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3595832-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.5;breast: 16.2;kidney: 28.9;salivary gland: 17.8"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 51.4;Breast myoepithelial cells: 87.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;REH: 37.8;U-251 MG: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	Nucleoplasm	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		7.3	0.0	3.6	0.0	4.2	0.6	16.2	6.8	1.6	0.2	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.8	5.4	28.9	0.0	3.1	0.1	16.9	10.2	0.0	0.2	0.2	1.0	0.0	17.5	0.1	0.0	0.1	17.8	0.5	0.1	8.9	0.0	0.0	7.5	0.0	0.0	0.1	6.8	0.3	0.3	0.0	0.0	0.0	0.5	6.4	0.0	0.0	8.8	0.0	0.5	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	37.8	0.0	0.0	2.8	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.2	6.8	1.6	1.8	5.4	16.9	10.2	17.5	7.5	6.8	6.4	2.5	6.4	3.7	0.0	0.4	3.6	0.0	1.6	1.2	0.8	51.4	87.6	3.5	0.0	1.5	5.5	0.0	0.3	1.0	0.0	15.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	1.0	0.0	0.5	3.7	0.0	0.2	1.1	3.0	0.3	0.6	0.0	0.0	0.0
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751677	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 24.0;salivary gland: 30.6;skin 1: 28.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 109.0;Alveolar cells type 2: 74.2;Basal keratinocytes: 202.1;Breast glandular cells: 147.4;Breast myoepithelial cells: 159.8;Suprabasal keratinocytes: 131.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 14.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 93.2;BEWO: 56.4;HaCaT: 32.0;hTCEpi: 68.9;SK-BR-3: 39.1"	"Group enriched"	"Detected in many"	5	"midbrain: 26.5;pons and medulla: 20.9;thalamus: 11.2"	"Region enhanced"	"Detected in some"		"pons: 5.1"	"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nucleoli"		"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	3.8	0.1	2.0	0.0	2.7	0.0	24.0	4.9	1.0	0.6	0.4	0.7	0.0	0.0	3.1	4.5	0.2	0.0	1.5	0.8	2.8	21.5	0.0	18.1	0.2	20.7	8.2	0.0	2.0	2.9	1.6	5.6	22.3	3.6	0.3	1.1	30.6	0.9	0.3	28.2	0.0	0.0	4.2	0.0	15.7	2.1	4.7	0.5	1.8	0.6	0.2	0.2	2.0	4.2	10.7	0.0	93.2	0.0	5.4	3.9	56.4	5.4	3.4	5.0	4.0	11.8	0.0	0.0	0.0	11.5	0.0	32.0	0.1	24.6	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	68.9	2.4	20.1	0.0	0.0	0.0	0.0	0.0	3.6	19.1	0.0	0.1	10.2	25.7	0.0	0.0	5.7	0.0	22.7	0.0	3.5	0.0	18.6	39.1	0.0	14.3	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.7	4.9	1.0	0.8	2.8	20.7	8.2	22.3	4.2	4.7	4.2	5.5	109.0	74.2	0.0	0.2	202.1	17.6	33.1	31.9	1.4	147.4	159.8	2.7	0.0	23.9	7.3	0.0	27.8	1.2	3.0	27.4	0.1	5.0	0.1	0.4	2.9	0.0	0.0	0.0	0.0	18.6	15.0	15.3	0.0	1.3	0.1	0.0	0.0	3.3	0.0	0.0	2.5	14.2	0.0	15.4	10.4	0.0	0.7	19.6	0.0	0.0	0.3	0.0	1.5	0.0	0.3	2.9	0.0	0.1	23.5	0.2	0.6	13.0	2.5	0.0	3.6	14.6	9.4	9.4	20.1	131.3	15.2	0.9	0.0	2.8	8.3
IRX3	IRX-1	ENSG00000177508	"Iroquois homeobox 3"	P78415	16	54283304-54286787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 89.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 66.7;Breast glandular cells: 133.8;Breast myoepithelial cells: 84.6;Endometrial ciliated cells: 73.0;Glandular and luminal cells: 88.2;Respiratory ciliated cells: 67.3;Squamous epithelial cells: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 119.4;NB-4: 204.4;RPTEC TERT1: 236.4;T-47d: 122.9;THP-1: 201.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA066576			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA066576: "	"unprognostic (4.21e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.25e-1)"	8.2	6.8	3.4	0.4	3.0	0.1	75.6	6.3	1.2	29.7	2.7	0.3	0.4	2.2	36.5	33.0	10.9	0.3	63.1	1.2	5.1	42.6	2.2	36.5	2.0	7.5	8.1	0.9	4.0	27.2	7.2	1.9	6.2	23.2	0.0	1.2	43.2	31.3	22.7	89.3	0.6	1.2	6.2	0.1	22.5	0.5	7.5	1.0	9.3	8.8	4.5	4.8	17.5	5.0	1.1	1.1	15.6	15.1	8.4	3.3	1.7	6.6	14.5	13.9	3.4	4.2	6.8	0.0	2.2	10.0	5.5	29.0	12.6	3.6	18.5	14.3	9.8	0.0	22.2	14.6	0.6	16.7	4.1	2.5	59.7	26.5	12.0	9.8	0.0	19.1	0.0	0.0	119.4	7.7	30.9	204.4	1.1	0.0	0.0	23.2	19.2	0.0	236.4	6.2	10.6	1.9	20.4	51.3	2.6	1.7	122.9	201.8	3.4	57.9	6.4	10.6	5.3	0.0	0.0	0.1	38.0	53.7	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.0	6.3	1.2	1.2	5.1	7.5	8.1	6.2	6.2	7.5	5.0	2.6	19.2	66.7	0.0	0.4	25.0	47.4	25.3	45.5	1.3	133.8	84.6	14.1	0.0	43.2	5.5	0.0	0.1	1.3	0.1	1.9	5.2	0.0	73.0	8.1	5.8	0.0	0.0	0.0	0.2	0.1	18.3	2.0	88.2	0.0	5.5	8.2	7.1	0.3	0.0	0.0	0.0	36.7	1.2	2.7	0.0	0.0	9.0	10.6	0.0	0.2	10.4	0.0	0.0	0.0	0.1	0.0	0.0	1.7	25.8	0.0	6.5	67.3	1.2	0.0	32.1	6.4	0.4	1.0	72.8	41.3	0.0	1.1	0.1	0.0	34.0
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.8;heart muscle: 14.3;skin 1: 22.5;vagina: 12.2"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 48.6;Basal squamous epithelial cells: 50.7;Breast myoepithelial cells: 15.6;Prostatic glandular cells: 13.3;Squamous epithelial cells: 26.5;Suprabasal keratinocytes: 20.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 5.4;head and neck cancer: 7.3;lung cancer: 1.8;prostate cancer: 6.9;testis cancer: 7.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.8;HaCaT: 16.3;HBEC3-KT: 8.1;MCF7: 8.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"medulla oblongata: 1.2;pons: 1.5"	HPA064094			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Vesicles"		"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.0	0.0	0.0	0.0	0.1	3.2	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	14.3	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.9	0.0	1.2	9.9	0.0	0.0	9.5	0.0	0.6	22.5	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	16.3	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	8.3	1.1	0.1	0.1	4.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.8	0.7	1.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	48.6	2.8	0.1	50.7	0.0	1.4	15.6	6.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.1	26.5	20.2	3.7	0.0	0.0	0.0	1.7
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55324203-55330756	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.8;heart muscle: 9.8;skin 1: 8.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.5;Collecting duct cells: 5.5;Hofbauer cells: 4.7;Late spermatids: 5.1;Melanocytes: 3.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HEK 293: 1.9;RPTEC TERT1: 7.1;SK-MEL-30: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Mitochondria"		"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	9.8	0.1	0.2	0.0	0.6	0.0	4.8	1.1	0.3	2.3	0.0	0.2	0.0	0.2	0.0	0.5	0.1	0.1	9.8	0.0	1.1	2.7	0.0	1.8	0.1	0.5	0.8	0.2	0.1	1.7	0.2	0.1	0.6	0.2	0.0	1.6	1.9	0.0	2.8	8.9	0.3	0.1	0.2	1.3	0.0	0.4	0.6	2.2	0.6	1.3	1.1	0.0	0.5	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.1	0.0	1.1	4.8	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	1.1	0.3	0.0	1.1	0.5	0.8	0.6	0.2	0.6	0.2	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.5	0.0	7.5	0.4	0.6	1.3	0.0	1.2	5.5	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.8	0.0	0.6	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.7	5.1	0.0	0.1	3.6	0.0	0.6	1.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.3	0.1	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0
ISG20L2	FLJ12671	ENSG00000143319	"Interferon stimulated exonuclease gene 20 like 2"	Q9H9L3	1	156721891-156728766	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 95.7"	"Group enriched"	"Detected in all"	30	"Early spermatids: 816.3;Late spermatids: 2897.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028005, HPA054285"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA028005: AB_2126319, HPA054285: "	"unprognostic (1.67e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (1.02e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (5.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.82e-3)"	"unprognostic (2.32e-1)"	12.0	10.5	6.2	11.4	6.1	16.7	10.7	8.3	8.1	10.7	4.9	12.5	9.2	12.9	7.5	18.5	11.5	9.0	10.2	6.9	6.2	11.8	13.5	10.0	14.9	6.1	6.0	13.8	11.7	9.3	9.1	11.9	5.8	11.3	12.3	6.6	11.3	8.0	9.8	14.6	12.0	12.4	5.6	13.3	12.2	95.7	6.0	12.2	9.7	6.6	17.0	15.3	12.4	6.3	29.8	22.6	19.1	20.5	19.4	14.2	29.5	20.4	17.9	26.3	18.2	30.2	21.3	56.7	24.3	15.3	11.9	39.2	47.0	32.2	19.9	28.4	30.6	30.9	16.4	17.8	18.9	73.7	32.3	14.3	32.4	24.6	24.7	17.1	24.2	23.9	49.5	25.4	17.0	40.4	31.8	21.3	62.9	60.3	38.0	37.5	22.3	35.9	19.6	23.8	40.4	48.5	24.8	69.8	21.3	27.8	44.5	45.8	16.2	15.2	22.4	18.8	41.9	33.9	56.3	70.3	13.8	37.1	20.2	28.2	8.7	17.2	8.5	11.0	9.8	7.2	6.5	8.7	8.2	8.6	6.6	7.7	15.1	12.1	12.4	5.5	6.7	6.1	6.2	6.1	8.3	8.1	6.9	6.2	6.1	6.0	5.8	5.6	6.0	6.3	16.4	28.9	43.4	4.9	43.6	52.9	40.4	18.9	46.7	22.4	30.5	23.6	10.1	18.6	29.1	7.3	25.0	34.9	57.7	32.0	17.6	21.2	816.3	21.7	22.8	24.9	31.8	29.8	13.5	17.3	37.5	24.2	26.0	38.5	27.8	22.7	21.4	18.6	21.3	23.5	9.8	32.3	10.2	28.4	38.0	2897.0	29.2	33.2	23.2	2.8	21.6	19.8	36.0	6.0	6.3	23.6	16.7	25.9	38.4	38.0	33.8	13.9	19.5	20.5	26.3	30.2	24.5	48.0	27.3	41.7	60.7	37.5	51.5	23.4	31.5	45.8
ISL1	"Isl-1, ISLET1"	ENSG00000016082	"ISL LIM homeobox 1"	P61371	5	51383448-51394730	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.9;seminal vesicle: 19.2;vagina: 15.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 207.5;Cytotrophoblasts: 34.4;Enteroendocrine cells: 91.6;Horizontal cells: 43.7;Syncytiotrophoblasts: 34.2"	"Group enriched"	"Detected in some"	5	"cervical cancer: 1.1;pancreatic cancer: 4.1;prostate cancer: 2.1;stomach cancer: 1.6;testis cancer: 1.4"	"Group enriched"	"Detected in many"	5	"hypothalamus: 11.5;thalamus: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 297.1"	"Group enriched"	"Detected in many"	8	"basal ganglia: 13.8;hypothalamus: 15.0;thalamus: 6.0"	"Group enriched"	"Detected in some"	9	"basal ganglia: 5.8;hypothalamus: 5.4"	"HPA048613, HPA057416"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Mitochondria"		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA048613: , HPA057416: AB_2683431"	"unprognostic (4.97e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.41e-3)"		"unprognostic (5.52e-2)"		"unprognostic (6.79e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.77e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.39e-3)"	2.9	1.3	0.4	0.0	1.4	0.0	0.1	0.0	1.8	7.8	0.0	1.1	2.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	1.0	0.5	0.0	4.8	0.0	2.2	7.8	1.2	12.0	2.4	22.9	1.1	19.2	0.0	1.1	0.7	0.1	0.0	0.0	10.0	1.6	6.0	4.3	0.3	0.0	0.4	0.7	15.9	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.2	3.0	3.8	0.0	0.0	0.3	2.7	0.0	2.5	0.0	0.0	2.2	4.6	3.4	0.0	0.0	7.1	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.9	3.2	0.0	3.0	0.0	0.0	0.0	19.1	297.1	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	1.8	0.0	11.5	1.0	0.5	1.2	0.0	6.0	0.2	0.0	0.0	0.0	0.0	0.1	1.5	5.1	11.8	0.0	207.5	0.0	0.0	0.2	0.0	2.8	0.0	4.2	34.4	0.0	0.5	0.0	0.1	17.3	0.0	0.0	1.7	91.6	0.0	0.0	0.0	10.9	6.1	11.7	0.0	0.0	0.0	0.0	0.0	2.7	43.7	0.0	1.9	8.2	0.0	0.4	3.2	0.3	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.1	0.0	0.0	0.8	11.8	0.0	0.0	4.0	2.5	7.3	0.0	1.0	34.2	0.0	0.0	0.2	5.6
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498816	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"placenta: 213.4"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 291.0;Extravillous trophoblasts: 617.2;Syncytiotrophoblasts: 177.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"BEWO: 386.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039314, HPA039742"	Supported		Supported	Nucleoplasm	"Secreted in female reproductive system"	NA	NA		1100000		"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA039314: AB_10673239, HPA039742: AB_10673427"	"unprognostic (5.69e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.34e-1)"		"unprognostic (2.16e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.95e-1)"	0.6	0.0	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.8	0.8	0.2	0.1	1.2	3.7	0.2	0.4	0.1	0.1	0.2	0.6	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.6	0.4	0.5	213.4	0.2	1.8	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.6	0.8	0.0	0.2	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	386.3	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.5	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.7	0.2	0.6	0.1	0.3	0.2	0.1	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	291.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.4	0.0	617.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	33.4	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	1.7	0.0	0.0	177.5	0.0	0.0	0.0	0.0
ISX	RAXLX	ENSG00000175329	"Intestine specific homeobox"	Q2M1V0	22	35066136-35087387	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"intestine: 37.5"	"Group enriched"	"Detected in some"	32	"Distal enterocytes: 24.2;Enteroendocrine cells: 19.4;Intestinal goblet cells: 16.0;Paneth cells: 19.4;Proximal enterocytes: 32.7;Undifferentiated cells: 23.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"CACO-2: 1.6;Hep G2: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060328			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA060328: AB_2684254"			"unprognostic (5.02e-2)"				"unprognostic (2.68e-1)"				"unprognostic (2.23e-1)"	"unprognostic (3.33e-1)"		"unprognostic (3.86e-1)"	"unprognostic (2.55e-1)"			0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	37.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	26.0	0.0	0.0	0.0	0.0	0.0	27.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.2	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.1	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.8	0.0
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438167	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 223.6;testis: 223.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1141.3;Sertoli cells: 315.5;Syncytiotrophoblasts: 1034.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;NK-cells: 14.4;T-cells: 8.9"	"Cell line enriched"	"Detected in many"	4	"BEWO: 492.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	36.0	32.6	15.2	2.8	13.8	5.8	30.5	12.5	19.5	47.3	223.6	14.2	3.6	44.2	4.4	15.2	78.9	3.7	36.1	19.4	24.5	114.4	13.1	22.2	4.4	16.8	18.8	96.0	40.1	12.8	50.7	46.3	14.2	41.4	0.7	0.9	17.7	26.7	13.2	16.2	16.1	2.8	12.7	35.1	11.3	223.8	25.4	3.0	23.7	3.1	1.8	23.5	31.9	11.3	13.9	42.4	98.6	31.0	0.8	0.2	492.7	6.6	1.0	0.6	0.3	24.5	26.1	0.2	33.5	3.2	0.2	36.6	3.0	0.1	0.0	39.8	116.4	52.0	3.1	80.3	10.2	0.6	1.1	9.4	0.4	2.8	0.4	0.4	6.3	1.1	106.0	2.1	0.0	84.1	4.0	3.4	51.7	14.2	33.7	71.2	0.2	24.6	9.5	0.3	30.4	74.3	1.7	9.9	53.1	20.2	68.2	7.1	18.7	0.5	1.1	0.7	1.6	13.9	7.3	3.2	3.0	1.9	17.7	1.0	0.1	0.0	8.1	0.2	6.2	4.5	8.1	6.9	0.8	2.4	6.2	8.9	0.8	14.4	0.1	2.2	6.2	5.0	15.2	13.8	12.5	19.5	19.4	24.5	16.8	18.8	14.2	12.7	25.4	11.3	38.8	3.2	1.1	2.6	9.0	12.0	82.1	74.9	72.8	0.8	26.1	47.0	4.7	20.0	24.0	47.8	2.1	1141.3	8.4	4.1	52.8	39.4	101.3	33.4	10.9	30.5	64.8	21.5	1.0	8.2	114.0	30.2	7.1	14.8	14.0	36.9	25.7	1.1	84.9	0.0	4.3	4.0	28.5	9.0	7.8	230.1	37.3	4.1	23.2	11.2	5.4	8.6	13.4	0.0	0.3	3.4	1.8	50.4	1.8	21.6	0.7	6.1	23.6	0.7	315.5	5.6	163.6	53.7	21.0	10.6	5.7	1034.6	14.9	14.5	6.2	36.8
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363241-34540748	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 139.7;Oligodendrocytes: 260.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607"	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	19.5	16.2	13.7	18.1	27.1	27.3	20.0	19.6	17.7	24.5	17.7	21.6	20.2	19.4	16.6	42.8	15.7	17.0	20.2	14.7	15.9	23.3	55.6	18.7	21.4	19.8	20.0	18.8	16.5	23.1	7.8	25.6	21.0	19.6	23.5	25.6	18.7	19.9	17.2	14.0	20.9	21.5	15.9	20.4	20.9	38.5	20.2	23.2	26.3	21.7	25.7	30.6	14.8	45.7	55.5	34.6	35.2	25.9	38.3	57.4	42.7	43.5	52.0	56.2	54.0	101.5	83.8	26.7	42.1	55.6	73.9	66.2	54.9	92.3	66.2	20.8	17.9	78.3	28.2	59.3	43.9	32.6	34.4	31.7	46.2	44.4	72.2	49.8	41.7	40.6	45.5	45.7	46.2	26.5	49.2	18.8	16.9	35.6	44.2	40.9	76.3	63.6	34.7	91.2	21.4	16.4	82.0	32.7	51.0	33.9	38.3	31.1	39.5	61.5	36.0	42.8	33.3	36.2	40.5	40.0	41.0	21.6	38.0	4.6	6.7	7.0	12.0	7.0	12.5	9.2	4.2	6.1	4.9	7.8	3.7	5.7	20.2	7.6	4.9	14.3	5.8	4.3	13.7	27.1	19.6	17.7	14.7	15.9	19.8	20.0	21.0	15.9	20.2	45.7	26.1	12.8	21.8	56.5	33.1	15.0	23.9	11.7	25.6	19.5	15.1	8.5	25.0	12.8	25.6	31.3	25.0	17.5	46.1	28.8	5.9	12.8	59.0	26.5	34.6	20.7	12.0	26.5	85.0	16.3	21.2	24.2	33.1	36.1	19.0	17.9	18.2	53.0	15.8	15.2	72.3	16.9	10.2	24.3	26.7	139.7	22.4	31.4	26.6	68.4	30.0	38.2	43.3	79.4	260.0	22.6	23.7	15.4	50.3	25.8	21.1	26.8	23.5	26.0	13.1	21.4	22.0	40.6	25.5	30.4	16.2	46.9	30.8	12.3	11.9	40.6
ITGA2	CD49B	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989340-53094779	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 406.2;Oligodendrocytes: 370.9;Pancreatic endocrine cells: 558.7;Prostatic glandular cells: 299.3;Urothelial cells: 363.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 91.4;HaCaT: 92.5;hTERT-RPE1: 83.2;HUVEC TERT2: 83.5;TIME: 71.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		43000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.4	12.8	2.4	4.9	6.7	0.4	7.8	4.4	3.7	5.0	0.9	6.1	7.7	4.9	7.4	11.0	2.6	9.0	1.1	2.4	4.2	9.8	0.5	12.5	0.9	4.8	4.9	1.0	1.6	9.3	1.2	4.8	5.4	6.6	5.9	2.4	10.4	11.1	0.5	17.1	7.7	2.4	3.3	6.8	7.5	0.4	4.8	4.3	2.3	0.7	4.6	15.6	8.0	12.9	60.4	15.4	1.3	0.8	3.9	7.1	4.5	60.2	91.4	2.2	3.6	29.0	41.8	0.1	9.8	25.4	33.5	92.5	4.9	67.1	8.5	0.0	4.4	4.3	3.7	17.5	13.3	0.7	1.3	2.9	11.4	59.2	10.5	83.2	83.5	3.1	0.1	0.2	1.6	11.4	0.6	0.1	3.7	15.7	29.6	0.0	0.4	0.1	18.9	32.0	0.6	3.2	3.2	4.1	6.1	2.3	9.6	0.2	71.2	10.8	6.3	1.7	12.1	0.0	0.1	0.1	64.0	0.0	48.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	6.7	4.4	3.7	2.4	4.2	4.8	4.9	5.4	3.3	4.8	12.9	7.4	57.7	13.7	9.1	0.6	151.0	406.2	141.3	56.9	2.7	24.4	39.0	1.3	15.7	133.2	53.3	4.2	1.9	0.9	23.2	9.8	144.0	0.1	20.3	5.0	39.0	13.8	0.0	0.5	169.3	2.2	11.6	13.3	90.6	1.3	45.4	5.3	0.2	0.3	0.0	0.9	37.8	20.3	0.0	6.1	0.2	1.2	2.5	12.4	14.0	1.1	14.7	0.0	0.0	370.9	558.7	20.3	0.0	2.6	299.3	20.6	3.8	103.6	4.3	0.0	4.4	12.1	0.0	1.3	57.0	37.2	0.4	5.8	23.7	30.9	363.9
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823507	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.0;Hepatic stellate cells: 54.3;Inhibitory neurons: 61.0;Leydig cells: 41.3;Microglial cells: 53.4;Oligodendrocyte precursor cells: 93.5;Peritubular cells: 74.9"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 23.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.1;HEL: 8.1;SH-SY5Y: 11.8;SuSa: 16.9;WM-115: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		500000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.8	15.5	1.9	4.5	1.8	8.5	5.9	0.0	6.2	21.8	3.6	9.6	6.3	10.6	4.0	15.5	5.4	9.4	20.1	7.8	0.7	4.0	14.8	8.9	4.1	0.9	1.3	5.0	1.8	2.6	1.7	9.8	0.4	12.5	6.8	0.7	4.2	10.8	2.8	3.0	9.1	15.8	0.7	22.6	7.5	6.9	5.0	1.8	20.7	9.8	2.4	6.5	4.5	1.2	0.2	0.0	4.3	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	10.1	0.0	3.2	1.4	0.0	0.1	0.2	3.8	0.0	0.0	0.1	0.6	8.1	0.1	0.2	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.4	0.3	0.0	0.2	0.5	11.8	0.1	0.5	0.7	16.9	0.0	3.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.8	0.0	6.2	7.8	0.7	0.9	1.3	0.4	0.7	5.0	1.2	20.8	0.0	14.7	16.0	0.1	2.5	1.1	0.1	1.2	1.2	1.1	2.9	12.9	2.8	3.1	1.8	0.0	0.2	0.0	0.0	0.0	0.1	1.5	1.4	4.9	21.6	0.0	3.0	82.0	0.0	0.5	7.5	0.0	0.9	6.3	36.2	54.3	1.3	2.8	0.0	61.0	0.1	0.0	31.9	2.2	4.2	41.3	5.7	3.6	53.4	0.1	0.6	0.0	93.5	6.2	0.0	0.0	74.9	0.4	0.2	0.0	0.1	0.0	0.0	0.0	3.2	3.3	0.6	0.9	0.0	1.7	0.3	1.8	25.9	0.4	0.3
ITGB1BP1	"ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B"	ENSG00000119185	"Integrin subunit beta 1 binding protein 1"	O14713	2	9403475-9423528	"Predicted intracellular proteins"	"Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 391.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067348, HPA071538"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA067348: AB_2732765, HPA071538: AB_2686413"	"unprognostic (2.21e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.39e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (4.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (3.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.08e-3)"	113.7	23.2	45.5	19.3	63.1	31.3	60.4	50.3	58.0	43.7	49.3	37.3	13.6	31.0	26.6	20.9	24.3	22.6	37.3	46.4	48.3	50.2	13.3	22.8	22.1	48.2	47.0	22.3	11.8	26.2	19.1	24.2	49.9	18.5	24.2	27.5	15.5	23.7	29.8	29.7	19.1	35.9	41.8	15.2	22.9	9.4	54.3	27.0	22.4	33.5	25.7	30.4	32.5	52.7	53.5	35.4	43.4	51.5	148.9	131.2	23.3	94.9	66.2	83.8	66.1	49.5	33.1	55.6	43.1	135.9	56.1	50.1	66.3	62.7	92.8	158.6	30.2	53.2	43.2	61.1	54.1	42.2	57.4	70.5	49.5	78.4	56.5	75.2	76.6	43.0	29.9	46.1	109.0	44.6	74.7	25.5	35.9	90.3	53.9	39.4	59.1	51.4	88.5	40.6	44.1	45.0	54.8	40.3	71.3	38.9	30.5	32.1	48.6	73.8	54.5	103.3	105.7	46.8	111.0	89.0	106.1	54.8	54.5	86.1	43.1	56.0	54.9	54.0	52.5	40.1	46.6	53.2	56.8	33.0	35.2	45.7	9.3	50.4	41.1	52.8	61.7	53.1	45.5	63.1	50.3	58.0	46.4	48.3	48.2	47.0	49.9	41.8	54.3	52.7	90.0	28.9	18.1	18.3	47.1	61.2	40.6	70.4	40.9	25.2	30.4	41.8	104.3	22.8	35.1	38.6	2.1	45.0	70.7	16.1	391.3	72.0	26.3	31.3	51.9	85.5	33.1	49.4	61.6	72.7	73.9	98.6	25.5	30.9	41.7	44.4	53.6	21.6	91.4	35.3	47.3	30.4	32.6	45.0	88.5	25.7	54.3	51.7	97.8	15.9	95.6	64.2	121.5	25.6	40.1	108.9	27.0	57.2	42.7	35.2	24.7	88.4	35.6	30.6	92.1	49.0	102.4	27.8	19.0	47.5	63.1	31.5	63.0	70.7	35.2	60.4
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253827-47313743	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 51.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.9;Late spermatids: 8.8;Macrophages: 15.8;Proximal tubular cells: 4.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	6	"melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"basophil: 5.4;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 167.8;HEL: 163.4;RPTEC TERT1: 109.8;U-87 MG: 78.3;WM-115: 255.9"									HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		38000000	"Cluster 34: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (1.13e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-3)"	8.0	0.6	0.3	9.5	0.7	6.2	5.3	0.7	1.0	3.8	1.0	16.9	3.5	13.2	2.6	4.2	7.6	3.5	5.5	0.5	0.8	15.0	3.4	5.6	0.9	2.3	1.0	1.5	0.7	1.2	1.2	4.5	2.0	4.8	7.0	0.9	2.6	16.1	1.5	2.7	5.8	22.9	1.2	2.9	3.8	2.5	1.2	0.3	51.4	2.4	1.2	9.6	2.6	1.1	0.1	1.5	0.7	0.1	8.6	3.8	0.1	4.7	23.1	9.6	8.6	0.3	0.1	0.6	167.8	1.2	13.4	0.0	0.1	0.0	12.6	3.4	0.0	163.4	0.5	0.0	7.8	0.0	0.2	3.4	0.0	54.6	1.4	6.7	43.6	2.5	0.5	0.3	2.1	0.0	1.0	0.1	0.1	0.0	0.8	0.0	4.2	0.0	109.8	0.2	0.0	0.5	5.6	0.0	33.2	8.8	0.1	0.2	47.1	2.1	2.4	1.3	11.7	0.2	0.1	1.1	78.3	0.0	255.9	5.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.1	0.1	0.1	0.0	6.8	0.3	0.7	0.7	1.0	0.5	0.8	2.3	1.0	2.0	1.2	1.2	1.1	1.3	0.0	0.0	0.0	0.5	0.1	0.2	0.9	0.0	0.0	0.1	0.3	0.8	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	3.9	0.8	0.9	3.1	0.0	0.0	0.4	0.4	0.0	2.1	0.0	0.9	0.0	0.6	1.8	0.7	0.8	0.0	0.6	0.0	0.0	0.3	0.7	8.8	0.3	15.8	0.0	1.0	0.4	0.0	0.0	0.0	0.4	1.5	0.0	1.2	0.0	0.3	0.0	4.6	0.2	0.0	6.6	0.3	2.1	0.0	2.0	0.1	0.4	1.2	0.3	0.4	0.0	0.2
ITGB3BP	"CENPR, HSU37139, NRIF3, TAP20"	ENSG00000142856	"Integrin subunit beta 3 binding protein"	Q13352	1	63440770-63593721	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028463	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028463: AB_10601435"	"unprognostic (4.98e-2)"	"unprognostic (5.88e-3)"	"unprognostic (6.28e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.58e-1)"	"prognostic favorable (4.32e-4)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (2.68e-2)"	"unprognostic (7.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.97e-3)"	"prognostic unfavorable (8.45e-6)"	"unprognostic (1.34e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.34e-3)"	"unprognostic (6.14e-2)"	6.8	11.5	2.3	7.9	2.3	11.9	15.0	2.5	4.6	7.8	3.7	10.7	8.0	8.8	15.9	9.0	9.3	10.8	4.4	2.2	2.5	12.6	6.4	7.2	18.0	2.5	2.4	14.1	10.1	18.2	5.3	10.1	2.5	8.7	10.1	2.8	7.8	6.2	2.5	9.1	6.0	5.6	2.4	8.9	8.0	20.6	2.3	20.2	13.5	4.4	16.4	10.1	8.3	2.6	63.6	32.9	35.9	28.6	8.6	25.2	32.3	30.3	18.7	51.6	63.4	18.2	29.0	57.4	22.6	7.3	26.2	44.3	28.2	30.8	63.7	43.4	74.2	43.9	41.3	35.1	9.2	60.4	27.6	6.5	22.4	29.9	23.5	24.3	26.6	34.5	51.5	74.6	7.3	27.8	66.4	57.0	45.5	24.1	38.2	42.5	61.4	84.7	34.8	19.4	46.1	28.8	34.7	20.0	50.4	53.0	19.9	20.0	16.1	17.9	26.1	36.6	46.2	37.1	64.1	54.4	30.0	75.4	27.7	14.2	4.0	1.4	6.5	3.2	11.3	15.9	10.2	10.6	5.1	15.4	11.3	10.2	1.1	15.6	3.9	8.8	12.2	6.7	2.3	2.3	2.5	4.6	2.2	2.5	2.5	2.4	2.5	2.4	2.3	2.6	22.0	9.6	13.9	24.2	40.9	33.9	56.3	49.8	34.7	10.7	35.9	43.7	11.5	28.6	38.2	25.8	10.4	45.9	19.3	10.1	29.4	42.2	100.8	45.2	22.1	21.6	17.4	40.0	23.6	34.3	56.3	28.6	20.4	21.1	23.5	40.7	23.9	9.7	30.0	6.7	23.6	18.1	42.7	21.0	26.1	121.4	21.5	18.9	21.4	15.0	23.7	21.2	30.9	18.6	31.0	24.8	4.1	25.9	30.7	13.7	6.0	39.1	54.3	15.8	32.9	18.2	21.9	200.5	54.4	30.8	32.7	19.2	26.6	13.6	31.9	35.8
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099667-160200313	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3;skeletal muscle: 80.0;tongue: 64.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 153.8;Alveolar cells type 2: 202.5;Basal prostatic cells: 153.5;Basal respiratory cells: 125.9;Pancreatic endocrine cells: 195.2;Spermatocytes: 286.0;Urothelial cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 139.2;RPTEC TERT1: 269.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	20.2	0.0	0.0	2.7	0.0	8.0	8.4	5.4	1.7	14.2	3.4	14.8	0.6	0.0	0.0	68.3	0.1	45.3	0.0	0.0	0.0	0.0	3.3	32.2	1.8	5.5	0.0	5.1	7.4	0.0	3.9	8.9	80.0	2.6	6.3	0.3	0.0	0.0	18.7	0.1	0.0	0.0	4.7	64.5	3.0	44.9	6.5	0.0	14.5	0.2	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	139.2	0.1	0.8	0.1	0.0	28.7	0.0	45.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	31.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	3.8	4.3	0.0	0.0	0.0	9.0	0.0	0.0	10.9	0.0	269.9	45.7	0.0	0.1	0.1	43.7	0.0	1.6	0.5	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	153.8	202.5	0.0	0.0	10.5	153.5	125.9	46.1	0.0	35.5	31.0	38.7	10.0	60.4	71.7	0.0	13.6	0.5	30.3	0.0	57.5	89.4	9.6	0.7	2.6	0.0	0.0	0.3	105.4	7.0	2.6	37.8	24.4	3.8	0.0	1.1	1.0	2.2	0.0	0.2	11.6	24.4	0.3	0.4	48.3	2.8	2.2	1.8	0.0	2.0	1.7	0.0	0.5	0.1	195.2	25.6	1.2	0.0	57.3	10.0	1.9	17.7	0.1	0.0	5.7	3.8	286.0	3.0	42.2	8.5	4.7	2.1	0.0	12.4	129.3
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	26.2	37.1	16.7	21.2	17.5	26.4	25.0	16.9	20.0	24.8	18.2	25.3	27.0	24.0	13.0	43.9	29.9	16.7	20.8	18.2	16.8	34.2	28.2	22.4	27.6	17.0	16.5	21.2	21.9	24.2	13.0	19.8	17.0	20.3	19.2	6.9	26.4	16.1	26.5	33.6	23.2	18.5	17.3	27.0	27.1	12.3	18.0	24.8	33.5	15.1	21.4	24.1	25.7	18.5	118.2	91.1	44.0	49.1	29.7	42.7	30.9	50.9	72.4	65.9	58.8	75.0	106.6	52.5	46.9	48.7	65.7	101.9	62.3	79.8	46.6	32.9	91.6	123.9	39.1	117.6	55.5	54.5	41.4	41.5	60.3	64.4	40.9	28.6	52.5	39.5	88.7	34.2	62.6	55.2	66.0	156.5	77.2	132.1	89.6	61.4	60.7	135.0	96.7	39.2	67.4	80.9	41.4	154.0	106.3	19.3	60.1	94.2	37.9	76.5	42.4	51.7	116.0	52.0	68.4	94.2	32.9	102.8	83.0	32.8	61.5	22.9	47.7	78.2	41.7	48.9	43.6	49.0	74.5	50.2	32.4	39.5	3.4	64.5	56.9	70.7	61.0	48.0	16.7	17.5	16.9	20.0	18.2	16.8	17.0	16.5	17.0	17.3	18.0	18.5	29.4	22.4	47.0	15.3	38.0	40.1	50.5	93.2	56.9	20.4	48.8	58.3	9.8	34.3	59.3	44.1	14.6	74.4	45.9	37.5	58.7	104.2	2.7	51.8	64.4	29.4	27.5	24.6	12.0	105.1	128.2	41.8	48.4	60.9	42.5	49.7	29.3	32.1	116.6	5.0	9.2	53.1	54.9	42.4	54.0	3.7	31.1	49.0	40.9	5.6	90.3	21.0	41.2	14.1	21.5	102.2	59.9	22.2	34.5	53.5	51.6	94.5	37.9	24.5	19.7	35.4	45.0	16.8	17.6	58.8	49.2	56.2	47.2	53.3	79.9	66.0
ITPKB	"IP3-3KB, IP3KB"	ENSG00000143772	"Inositol-trisphosphate 3-kinase B"	P27987	1	226631690-226739323	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 211.8;choroid plexus: 123.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.5;Astrocytes: 225.3;Microglial cells: 58.1;Oligodendrocytes: 110.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030273, HPA072923"	Enhanced		Approved	Nucleoplasm		NA	NA		39000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA030273: AB_10601127, HPA072923: AB_2686558"	"unprognostic (4.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.24e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.87e-2)"	29.6	4.5	148.6	15.6	205.6	19.0	19.6	152.0	104.8	28.0	123.3	45.3	6.6	48.8	17.0	14.0	27.0	10.0	16.2	109.0	149.5	15.1	3.2	22.5	29.0	211.8	188.0	9.5	5.8	7.1	6.8	15.9	169.1	14.5	6.7	0.6	30.2	22.7	12.4	19.4	24.9	31.7	154.6	23.5	21.2	3.7	207.6	33.2	8.3	12.3	20.3	38.6	15.6	133.7	4.7	5.0	7.9	9.1	6.1	3.9	2.1	1.2	5.5	2.5	5.7	0.7	5.8	21.6	7.4	1.2	0.5	6.8	10.1	4.1	1.2	3.0	6.9	9.6	5.5	0.0	2.3	8.8	16.4	4.4	5.9	2.8	2.5	6.9	17.2	10.8	0.1	2.9	0.3	4.5	16.7	12.1	17.3	3.5	8.0	6.4	14.2	4.8	18.2	7.5	4.6	6.0	3.8	2.8	47.2	7.7	11.7	10.1	12.0	3.2	2.4	2.9	7.6	0.2	8.0	25.8	0.8	8.0	12.1	0.9	0.9	5.4	2.6	1.3	2.3	1.2	3.2	2.7	0.6	1.8	4.7	3.5	3.4	2.1	2.5	0.5	1.9	2.0	148.6	205.6	152.0	104.8	109.0	149.5	211.8	188.0	169.1	154.6	207.6	133.7	70.5	0.0	7.4	225.3	16.0	12.2	4.8	3.1	7.4	0.3	7.0	5.3	8.5	1.5	4.5	7.3	0.0	0.6	28.9	1.2	3.9	2.2	2.8	4.7	6.8	42.2	4.2	5.2	2.4	2.4	2.3	8.9	3.6	4.5	10.1	21.8	27.8	1.0	19.8	0.0	6.9	2.8	2.0	16.0	38.0	22.9	7.2	14.4	19.6	58.1	10.2	1.2	28.8	10.6	110.6	2.7	3.7	9.4	11.8	5.1	2.0	0.6	2.6	0.1	0.0	5.9	16.3	0.9	4.7	5.3	10.1	0.4	35.2	3.7	3.1	2.7
ITPR2	"CFAP48, IP3R2"	ENSG00000123104	"Inositol 1,4,5-trisphosphate receptor type 2"	Q14571	12	26335352-26833194	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 551.4;Excitatory neurons: 287.2;Microglial cells: 802.9;Oligodendrocyte precursor cells: 441.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059144, HPA062260"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	Nucleoplasm	"HPA059144: AB_2683925, HPA062260: AB_2684728"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.76e-1)"	8.3	10.4	10.5	8.1	7.3	6.0	17.3	6.3	9.7	4.8	3.4	6.2	5.3	5.2	5.7	7.4	5.5	5.5	3.7	7.7	8.7	12.6	44.3	5.6	7.9	19.1	13.2	5.9	7.7	11.4	2.2	10.9	14.9	5.5	6.6	8.8	16.9	2.9	1.8	10.2	4.9	4.5	13.1	6.7	5.2	2.5	16.1	20.1	4.3	4.1	6.8	4.9	4.7	15.6	4.9	2.0	2.9	4.6	8.5	8.6	3.0	4.4	6.1	3.0	3.1	0.2	2.4	16.5	2.7	5.9	3.3	5.2	15.1	9.3	4.0	3.9	5.1	13.5	4.4	27.1	7.9	12.0	5.8	8.1	1.2	6.3	11.6	6.2	28.5	6.5	6.4	5.1	3.9	4.0	8.6	17.8	12.2	4.4	1.5	2.9	7.0	10.7	7.3	7.4	0.9	4.5	19.8	3.5	11.4	11.3	7.7	6.0	62.6	6.0	2.3	5.9	5.7	4.9	4.2	31.2	5.7	5.6	3.9	32.4	6.4	9.9	2.9	2.7	2.5	5.4	2.6	2.4	1.4	5.0	3.0	2.7	17.3	4.8	4.3	11.9	4.4	1.0	10.5	7.3	6.3	9.7	7.7	8.7	19.1	13.2	14.9	13.1	16.1	15.6	27.1	48.1	52.9	551.4	45.7	20.9	17.8	3.3	31.3	3.2	87.0	57.1	24.5	34.3	8.6	23.9	146.0	21.0	39.1	7.7	7.9	20.8	3.1	13.3	64.9	38.5	78.5	33.4	287.2	23.4	9.5	20.3	16.8	22.7	44.4	60.0	25.0	123.7	39.5	0.0	99.1	46.1	32.6	46.3	8.2	6.7	18.0	68.7	33.8	802.9	28.2	13.0	41.2	441.8	22.3	17.6	37.0	17.7	83.6	25.9	14.5	14.6	5.0	64.7	0.0	22.7	17.6	3.6	6.3	54.3	26.7	27.9	29.2	43.4	11.7	15.8
ITPRID1	"CCDC129, FLJ38344"	ENSG00000180347	"ITPR interacting domain containing 1"	Q6ZRS4	7	31514071-31658720	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 15.9;salivary gland: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA024103	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA024103: AB_1846132"	"unprognostic (1.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.78e-5)"	"unprognostic (9.72e-3)"	"unprognostic (1.78e-1)"		"unprognostic (3.89e-2)"	"unprognostic (6.42e-3)"		"unprognostic (1.01e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"		0.1	0.0	2.7	0.1	3.9	0.1	1.6	11.0	0.4	1.7	0.0	0.5	1.1	0.6	0.1	0.0	0.0	0.1	0.0	0.7	9.7	0.1	0.0	0.0	0.0	4.8	15.9	0.0	0.1	0.0	0.1	0.0	9.2	0.1	0.1	0.1	5.3	0.0	0.0	2.3	0.5	0.6	1.4	0.0	0.4	1.3	13.2	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	3.9	11.0	0.4	0.7	9.7	4.8	15.9	9.2	1.4	13.2	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ITPRID2	"CS-1, KIAA1927, KRAP, SPAG13, SSFA2"	ENSG00000138434	"ITPR interacting domain containing 2"	P28290	2	181891730-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 175.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 30.7;Cardiomyocytes: 30.0;Cytotrophoblasts: 25.7;Extravillous trophoblasts: 26.8;Hofbauer cells: 20.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 6.1;monocytes: 5.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: AB_2674271, HPA039989: AB_2676788"	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (5.79e-5)"	30.8	20.7	55.0	20.6	62.9	42.4	32.1	57.2	66.2	30.9	50.3	50.4	36.4	25.8	18.4	22.8	20.3	37.7	24.4	45.5	61.5	48.4	79.3	44.9	17.6	65.2	60.5	13.6	175.8	20.9	18.3	34.7	63.3	34.0	44.2	16.9	69.9	17.1	31.9	112.9	34.0	25.6	57.3	32.4	56.1	37.4	62.6	24.1	36.5	23.4	16.0	31.3	29.5	61.1	56.0	25.8	71.6	12.6	53.8	41.3	21.7	94.6	82.6	29.1	37.0	25.9	56.0	1.2	30.7	59.7	31.5	46.2	14.5	41.6	56.6	25.2	20.3	52.5	106.6	23.5	45.7	28.5	48.9	30.0	64.4	51.3	57.7	66.7	145.8	22.3	25.0	29.5	82.9	28.7	25.4	41.0	5.0	47.0	62.5	18.7	29.3	19.2	87.0	16.3	13.7	12.1	55.7	19.7	91.0	27.6	14.2	61.6	68.1	73.1	37.0	27.5	50.3	20.9	9.4	21.9	34.0	17.1	57.2	6.1	2.8	4.2	0.9	2.7	0.6	0.4	0.6	0.6	2.7	0.9	0.8	0.7	4.7	0.8	5.1	2.1	0.4	1.3	55.0	62.9	57.2	66.2	45.5	61.5	65.2	60.5	63.3	57.3	62.6	61.1	30.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	25.7	5.8	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	26.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	33.4	1.1	0.0	0.0	0.0
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405485-40435947	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.0;Theca cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA041391: AB_2677449, HPA044250: AB_2678875"	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	25.8	80.5	35.1	14.5	40.8	15.9	45.3	35.6	40.8	29.4	39.5	31.6	24.3	26.4	29.0	16.0	35.0	21.5	61.7	34.0	41.5	59.1	145.4	24.3	19.6	40.2	38.8	43.3	27.4	39.2	58.3	15.3	37.5	42.1	27.2	13.0	31.8	36.8	55.7	8.6	26.8	23.8	37.9	27.9	46.7	25.0	44.5	16.8	119.2	55.4	19.5	31.1	20.8	45.3	20.9	11.9	22.9	38.9	35.9	32.9	1.0	27.6	32.7	39.4	24.0	36.5	16.0	0.8	57.7	43.4	32.6	20.8	45.9	46.6	30.1	36.4	34.0	52.1	36.2	38.9	64.6	22.0	48.5	45.3	18.5	23.5	55.3	46.3	38.8	60.4	2.5	2.4	42.1	27.1	27.3	38.9	17.8	1.3	33.0	41.2	32.6	27.9	45.2	51.6	37.3	21.5	38.2	83.4	18.7	21.5	69.0	117.6	27.6	29.9	20.2	23.6	24.9	54.5	38.5	1.0	30.9	22.8	28.4	17.0	24.8	36.7	33.3	36.1	31.0	27.5	18.5	26.6	58.8	27.6	18.5	26.7	2.3	39.4	73.1	89.2	26.9	24.3	35.1	40.8	35.6	40.8	34.0	41.5	40.2	38.8	37.5	37.9	44.5	45.3	13.1	28.9	54.5	27.4	19.0	2.3	21.0	17.3	13.1	26.0	27.5	22.2	88.0	45.8	29.9	44.1	14.6	20.3	34.0	17.9	95.9	19.7	5.4	21.4	31.0	18.6	19.7	21.3	15.3	14.9	7.3	20.2	29.6	19.9	34.7	46.5	21.4	135.0	28.1	16.8	16.6	24.4	14.2	18.3	6.2	7.4	20.5	18.6	5.4	21.5	28.8	26.0	26.8	25.1	21.4	14.8	9.4	24.8	10.0	16.6	22.0	97.3	29.3	19.9	19.7	25.0	18.2	16.1	3.7	17.4	0.6	9.9	18.0	105.7	35.4	11.9
IWS1	"DKFZp761G0123, FLJ10006, FLJ14655, FLJ32319"	ENSG00000163166	"Interacts with SUPT6H, CTD assembly factor 1"	Q96ST2	2	127436207-127526886	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035719, HPA061866"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA035719: AB_10669527, HPA061866: AB_2684628"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.10e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.81e-2)"	24.2	18.5	26.7	23.2	32.3	31.5	22.2	30.3	37.8	23.1	30.1	24.8	23.4	22.9	23.8	22.9	21.3	18.9	48.4	26.8	32.2	30.1	40.2	22.5	28.8	30.7	32.1	18.0	21.6	23.8	24.8	26.5	32.0	23.3	23.8	26.5	22.7	19.3	76.0	21.6	24.4	21.9	27.7	27.6	23.1	23.2	31.5	31.2	20.7	62.0	28.4	25.8	23.4	40.4	52.0	34.5	68.4	45.0	51.0	42.4	71.4	73.9	50.0	67.2	55.9	81.6	38.8	48.7	38.2	59.3	51.4	41.9	66.7	58.2	79.4	50.7	45.4	68.1	50.6	92.9	60.2	78.2	54.5	42.0	43.6	71.5	64.0	35.7	58.0	60.3	72.8	37.0	64.3	48.3	77.7	63.4	92.2	43.0	46.8	68.9	53.5	44.9	67.6	62.0	53.4	34.7	52.9	65.9	60.3	73.4	29.6	53.5	66.4	66.3	50.4	40.4	43.8	28.6	33.6	64.5	36.6	54.2	45.0	3.6	13.2	18.5	9.7	14.8	11.8	11.4	11.1	11.8	13.0	15.1	10.5	11.0	13.9	15.0	17.3	11.8	11.0	9.5	26.7	32.3	30.3	37.8	26.8	32.2	30.7	32.1	32.0	27.7	31.5	40.4	23.1	112.2	74.3	35.3	36.6	15.7	55.3	22.8	23.9	27.9	16.9	15.7	77.4	21.5	53.5	16.5	27.1	40.0	33.5	35.1	19.6	38.6	13.2	38.5	39.8	28.9	28.1	30.7	21.9	25.5	56.3	41.9	32.1	36.8	42.3	42.3	20.7	25.7	27.1	21.9	27.8	25.7	30.5	16.4	25.4	8.5	39.1	29.2	10.6	25.3	40.1	26.4	46.4	25.6	105.0	41.9	28.0	31.6	37.5	53.8	25.1	19.1	44.6	44.7	32.9	29.3	35.6	69.8	52.0	24.1	17.0	92.8	37.4	34.6	26.9	77.2
JADE2	"JADE-2, KIAA0239, PHF15"	ENSG00000043143	"Jade family PHD finger 2"	Q9NQC1	5	134524312-134583230	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025959, HPA055789"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA025959: AB_1855289, HPA055789: AB_2682922"	"unprognostic (8.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.58e-2)"	"unprognostic (3.49e-2)"	"prognostic favorable (5.36e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.87e-2)"	16.1	20.1	11.8	15.2	16.5	9.8	13.7	10.3	14.0	16.3	1.1	14.5	10.2	12.9	6.4	9.7	16.1	10.7	12.1	11.2	16.0	11.9	5.5	13.8	26.8	14.4	12.8	23.9	13.3	20.4	13.1	7.1	13.9	13.0	6.2	8.9	14.5	14.1	12.7	12.0	18.4	9.8	9.8	21.8	12.7	6.8	13.9	15.8	16.2	8.5	16.2	17.9	11.6	15.7	66.6	46.2	1.3	2.0	13.8	18.5	19.6	10.7	28.9	21.0	26.4	35.2	50.4	75.2	24.7	13.4	21.3	13.0	6.4	60.8	8.2	44.2	2.3	18.0	30.0	7.7	17.5	19.2	2.5	11.8	27.3	26.3	29.5	14.5	15.1	21.4	10.5	24.4	13.1	26.4	35.6	18.5	14.7	19.5	23.9	29.9	1.2	29.8	19.9	18.1	9.0	5.6	30.2	0.8	42.2	11.4	12.1	25.3	22.5	13.9	12.7	43.2	30.1	10.6	49.7	68.3	24.1	34.1	22.6	0.9	0.6	2.0	3.2	0.6	3.4	3.8	3.1	3.1	1.1	2.3	3.0	3.1	0.7	1.9	1.6	0.5	3.1	1.3	11.8	16.5	10.3	14.0	11.2	16.0	14.4	12.8	13.9	9.8	13.9	15.7	13.6	9.6	11.2	4.2	35.1	4.2	7.0	6.5	21.6	24.4	10.3	7.1	13.3	12.8	6.0	7.3	35.5	7.3	41.0	7.7	7.9	5.5	0.6	4.6	5.4	12.5	11.5	4.6	15.3	16.9	9.7	10.2	5.6	3.6	2.5	16.0	18.2	3.5	4.2	10.1	16.0	8.8	6.1	30.5	15.7	0.8	20.5	12.1	1.8	5.6	19.4	7.4	42.2	9.0	16.5	8.8	4.9	19.2	22.4	4.6	13.8	10.4	9.5	22.9	0.0	6.7	11.6	0.3	3.3	6.0	3.7	7.3	35.0	4.2	10.7	4.3
JADE3	"JADE-3, KIAA0215, PHF16"	ENSG00000102221	"Jade family PHD finger 3"	Q92613	X	46912276-47061242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 37.2;Oligodendrocytes: 36.8;Spermatocytes: 42.7;Spermatogonia: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.8;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 65.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006007, HPA064697"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA006007: AB_1079605, HPA064697: AB_2685326"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-3)"	"unprognostic (4.55e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.18e-2)"	"unprognostic (9.70e-2)"	3.5	10.7	3.5	3.1	4.9	2.0	6.3	5.1	5.1	5.6	2.7	3.6	2.2	6.0	15.9	3.5	3.9	3.2	3.1	3.2	4.1	3.7	7.6	3.6	4.9	6.6	4.4	7.1	8.3	3.3	1.1	15.4	6.2	4.2	3.4	2.5	3.5	7.2	1.7	3.3	4.6	5.0	5.0	5.0	4.1	12.1	5.2	7.2	4.1	2.6	6.1	4.7	2.6	8.8	12.1	10.6	17.2	11.9	6.2	4.6	65.7	7.1	5.9	7.8	8.7	12.3	10.3	0.1	4.9	5.2	11.6	4.7	21.1	5.7	11.2	32.6	13.8	9.6	11.9	12.0	10.2	7.3	5.0	3.5	7.8	5.5	17.7	4.8	14.9	18.1	6.7	5.6	6.1	12.5	26.5	8.9	13.6	7.8	9.0	27.0	19.4	16.9	6.6	11.0	14.8	13.1	20.4	18.7	11.3	28.3	12.4	7.6	9.3	8.2	14.2	11.7	4.7	4.3	4.0	22.7	2.3	6.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.2	3.5	4.9	5.1	5.1	3.2	4.1	6.6	4.4	6.2	5.0	5.2	8.8	4.1	0.0	7.8	1.0	14.4	4.2	2.3	1.8	2.2	1.5	9.9	4.2	5.4	1.5	1.6	5.5	0.0	9.6	0.1	2.0	0.0	2.4	1.1	3.9	3.9	5.1	8.4	6.5	5.5	3.6	10.3	2.0	2.6	4.4	0.0	9.7	6.1	13.3	1.8	0.0	12.7	2.6	6.1	1.0	5.7	3.7	4.7	1.4	3.6	14.0	2.8	1.2	1.0	37.2	36.8	3.1	1.1	3.8	1.9	4.1	0.5	2.9	1.2	2.3	6.6	1.9	2.8	42.7	35.3	5.8	8.1	14.2	0.7	3.5	2.4	3.7
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5129948	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.4;Inhibitory neurons: 122.3;Microglial cells: 106.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 132.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 132.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 42.2;HDLM-2: 75.0;HEL: 154.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	15.6	7.6	3.2	19.2	3.7	21.7	8.9	6.3	9.1	8.5	1.1	6.7	6.5	11.3	8.6	8.8	8.0	10.5	24.5	2.7	3.1	6.8	4.5	10.9	18.2	3.3	1.8	11.5	3.8	6.5	2.9	11.0	2.0	6.8	6.5	12.8	4.0	6.2	9.8	11.2	7.7	9.5	3.5	17.6	13.4	9.8	1.7	7.5	4.8	8.9	12.7	11.7	9.1	3.9	6.8	3.7	3.7	6.3	42.2	12.4	1.1	9.1	8.6	7.2	4.6	1.2	2.0	0.3	2.1	5.4	5.4	2.3	4.4	5.1	4.9	75.0	1.4	154.7	7.6	1.7	10.0	10.5	7.1	9.5	2.1	2.8	4.5	7.6	6.6	5.1	10.9	17.4	11.6	2.2	2.9	12.8	3.3	3.3	4.3	5.1	8.2	2.2	4.7	3.5	4.2	2.4	2.6	3.5	2.8	3.6	2.0	15.4	13.1	10.2	3.6	10.7	6.4	3.1	6.4	1.5	13.6	4.7	5.3	132.5	20.5	38.2	5.6	20.1	4.5	5.6	4.1	3.1	26.5	4.9	2.2	2.8	19.2	9.6	16.4	9.7	4.5	7.7	3.2	3.7	6.3	9.1	2.7	3.1	3.3	1.8	2.0	3.5	1.7	3.9	14.3	16.0	7.9	31.6	12.9	9.7	3.3	4.9	10.8	8.0	5.2	3.4	30.0	0.0	6.7	7.3	8.4	1.9	13.9	11.7	1.9	3.3	8.6	5.1	11.2	9.4	3.0	19.8	93.4	3.9	0.9	8.9	38.7	5.6	14.0	11.4	4.6	1.9	14.2	8.4	122.3	4.5	0.0	33.6	28.8	7.1	23.6	38.9	5.4	106.8	49.5	12.6	8.2	69.9	42.3	7.0	20.9	33.4	10.7	3.0	3.9	3.3	7.1	11.2	0.0	9.7	12.5	15.0	5.5	11.6	8.4	3.4	10.4	5.1	4.1	4.5
JAM2	"C21orf43, CD322, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639258-25717562	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 63.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Astrocytes: 81.6;Endothelial cells: 148.7;Hepatic stellate cells: 112.8;Microglial cells: 82.4;Oligodendrocyte precursor cells: 76.9"	"Cancer enriched"	"Detected in all"	9	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 25.5;BJ hTERT+: 16.5;HDLM-2: 16.7;hTERT-RPE1: 22.5;U-138 MG: 18.1;U-87 MG: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"HPA028789: AB_2732443, HPA077346: AB_2732341"	"unprognostic (1.42e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.61e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.85e-3)"	20.5	15.8	16.6	3.7	21.5	0.3	16.8	24.0	21.8	16.8	12.8	17.8	6.1	18.5	11.2	7.1	16.1	12.9	19.2	19.2	22.0	9.2	2.2	15.5	3.6	25.9	23.1	16.1	2.8	4.3	8.1	63.5	21.3	9.4	7.9	7.1	6.1	15.4	7.8	5.5	10.7	19.6	26.8	1.6	10.2	17.6	25.2	2.6	10.3	13.2	5.0	11.6	13.2	23.0	0.0	0.0	25.5	0.1	1.0	0.2	0.5	0.8	16.5	2.0	7.6	0.0	0.0	0.1	0.0	0.2	9.7	0.1	2.2	0.0	4.6	16.7	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.4	0.0	1.8	0.1	22.5	0.0	0.6	0.0	0.2	8.0	0.0	0.4	0.1	8.1	0.2	0.0	3.2	5.3	0.1	0.0	0.0	0.4	3.7	0.2	0.3	0.0	0.3	0.9	0.2	0.0	18.1	1.7	0.1	2.5	1.8	0.1	0.0	13.4	0.1	0.7	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.4	0.6	0.1	0.4	0.0	0.1	16.6	21.5	24.0	21.8	19.2	22.0	25.9	23.1	21.3	26.8	25.2	23.0	173.8	0.0	2.3	81.6	0.9	7.5	1.4	0.0	2.2	1.4	1.4	9.1	33.2	0.0	0.0	3.7	14.6	0.3	0.5	0.0	0.0	0.2	16.5	1.0	4.7	148.7	0.0	0.0	15.2	0.2	5.3	28.5	0.5	2.1	0.0	4.5	112.8	0.5	1.3	0.0	45.0	0.0	0.0	1.8	10.7	15.6	9.9	2.8	16.0	82.4	0.0	1.8	0.0	76.9	4.1	0.1	0.0	24.5	1.2	1.5	0.0	0.0	0.7	5.2	0.0	5.7	7.0	6.7	4.4	0.8	6.7	0.8	1.6	2.1	0.0	1.2
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193725-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.3;lymphoid tissue: 68.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 136.9;Kupffer cells: 125.8;Macrophages: 166.6;monocytes: 204.7;T-cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 3529.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 28.0"					"Region enriched"	"Detected in many"	11	"cerebellum: 58.0"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	13.9	4.5	0.9	68.7	1.0	20.9	5.6	2.4	2.1	5.6	2.3	16.8	17.8	3.5	1.5	8.5	4.3	20.4	3.2	0.7	0.9	3.4	9.8	43.3	31.1	1.3	0.9	1.8	2.9	1.0	1.6	7.8	1.0	4.4	22.7	0.3	2.9	3.6	1.2	4.6	32.1	15.3	1.0	60.0	9.4	1.5	1.0	24.3	2.9	7.8	31.6	24.9	3.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	3.1	0.4	3.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	137.4	1023.8	3529.6	60.1	616.5	386.5	7.1	107.4	113.7	1017.6	2.9	124.7	103.1	2121.1	24.3	310.3	765.1	191.3	844.1	0.9	1.0	2.4	2.1	0.7	0.9	1.3	0.9	1.0	1.0	1.0	1.1	1.2	6.4	34.2	0.0	6.9	0.0	0.2	0.0	0.0	0.3	0.9	1.3	0.0	2.8	5.6	1.8	0.0	0.3	136.9	0.9	0.0	0.1	1.0	0.4	0.2	1.3	0.0	5.0	0.0	0.4	0.4	1.8	2.6	0.6	15.2	0.0	5.7	2.8	31.0	0.0	0.0	0.2	0.0	125.8	0.0	1.1	0.0	166.6	0.0	0.0	204.7	0.0	9.2	0.0	0.0	0.1	0.1	0.0	6.3	0.1	0.6	0.8	2.2	0.2	0.0	0.4	0.5	2.2	5.9	0.2	0.0	0.4	56.0	0.0	0.1	0.2
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246069-15522042	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 195.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 34.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 73.8;SuSa: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	7.3	4.7	6.7	9.2	7.1	57.8	6.0	23.6	8.7	5.3	3.7	5.0	5.7	5.0	6.7	13.7	3.9	4.4	6.4	7.5	6.2	4.1	3.6	7.2	9.0	7.1	6.8	5.7	3.5	3.6	4.4	7.1	7.8	4.5	4.6	20.0	6.4	3.3	11.8	13.4	6.8	4.1	5.2	10.6	7.0	16.0	8.0	20.0	3.8	4.3	9.8	5.8	6.8	8.2	12.4	8.5	34.0	19.6	4.1	4.0	33.5	3.5	8.3	4.5	5.5	8.8	9.4	6.5	12.3	7.1	6.8	6.3	8.0	20.1	4.1	13.0	12.4	23.3	10.6	11.6	4.6	23.9	26.3	5.7	12.3	6.6	26.2	13.4	4.7	73.8	30.5	10.8	2.7	12.6	47.6	44.6	36.4	6.1	3.8	20.9	10.4	18.6	4.2	13.0	26.2	15.0	7.3	24.9	32.1	78.1	8.7	25.0	8.5	20.6	11.4	11.5	12.3	6.9	17.8	11.7	7.0	21.9	26.6	10.1	3.8	3.2	3.4	2.4	2.9	2.5	1.6	2.1	3.1	3.4	2.1	2.9	13.2	4.9	2.7	4.4	1.4	2.1	6.7	7.1	23.6	8.7	7.5	6.2	7.1	6.8	7.8	5.2	8.0	8.2	30.1	6.4	12.8	175.3	40.7	80.4	10.7	23.0	31.9	74.2	28.3	23.1	10.5	15.7	17.1	5.5	87.6	27.0	62.9	10.0	1.9	8.2	89.2	30.7	18.0	27.1	26.8	50.9	125.9	4.4	25.0	17.6	19.9	77.5	25.3	14.8	15.7	13.8	24.0	154.8	124.4	16.4	16.2	61.3	195.0	40.8	8.7	89.5	26.6	97.4	49.1	134.0	54.6	136.7	136.6	15.6	9.3	8.6	34.9	6.8	16.6	3.8	8.7	89.7	6.6	18.1	23.6	9.4	71.1	43.4	151.6	25.2	43.2	17.4	14.7	15.4
JAZF1	"DKFZp761K2222, TIP27, ZNF802"	ENSG00000153814	"JAZF zinc finger 1"	Q86VZ6	7	27830573-28180795	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid metabolism, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 83.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 160.1;Excitatory neurons: 316.6;Inhibitory neurons: 306.3;Microglial cells: 168.6;Oligodendrocyte precursor cells: 241.3;Oligodendrocytes: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 25.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.7;granulocytes: 25.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 53.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019271, HPA066967"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB019271: , HPA066967: AB_2685758"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-2)"	15.4	83.8	11.1	10.9	12.4	24.4	11.7	11.5	16.5	62.4	12.4	32.8	3.4	41.8	21.3	10.1	16.4	12.4	22.4	13.2	15.3	5.1	15.7	10.1	14.6	7.3	8.3	13.9	6.6	6.3	13.4	16.1	9.1	29.5	8.3	7.8	4.6	35.2	6.9	7.1	8.3	38.6	8.1	14.6	8.3	18.8	17.4	11.5	14.9	6.9	15.9	19.2	27.3	10.0	1.4	0.8	4.8	1.0	35.6	42.9	0.0	11.1	28.6	18.4	22.8	0.1	7.6	33.7	22.6	23.5	12.5	0.7	6.3	8.5	15.0	5.1	10.2	12.2	7.7	0.0	24.2	4.8	3.1	19.4	10.2	13.8	8.9	14.1	11.8	2.2	0.3	53.2	10.3	1.4	1.3	17.5	10.0	0.2	7.7	3.6	2.2	10.1	6.7	0.3	3.0	4.7	9.2	0.3	12.0	14.0	3.5	6.1	11.7	29.0	11.0	8.0	12.9	9.2	2.9	12.5	9.2	12.5	16.2	25.6	3.9	6.9	4.8	3.3	1.3	2.8	1.3	3.2	3.7	3.7	0.5	3.0	1.5	4.1	3.5	13.7	3.2	3.1	11.1	12.4	11.5	16.5	13.2	15.3	7.3	8.3	9.1	8.1	17.4	10.0	10.2	3.2	7.0	57.8	33.4	14.7	3.0	3.8	3.4	6.7	3.5	4.8	25.3	10.0	3.0	1.8	6.2	0.5	37.9	1.3	7.9	14.8	122.1	28.3	160.1	14.5	5.4	115.6	316.6	2.3	1.4	24.6	9.2	18.6	24.1	12.6	3.6	5.5	9.4	16.8	306.3	0.6	2.0	25.7	45.6	89.8	55.0	28.0	23.2	168.6	35.5	4.4	40.2	241.3	262.5	5.3	0.4	34.6	8.7	2.7	0.0	2.4	12.7	4.7	13.1	9.9	15.3	8.7	16.5	3.4	11.2	1.4	25.3	1.6	0.3	1.5
JDP2	JUNDM2	ENSG00000140044	"Jun dimerization protein 2"	Q8WYK2	14	75427716-75474111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.7;Kupffer cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 11.8;granulocytes: 7.7;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059511	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear speckles"		"HPA059511: AB_2684046"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.30e-3)"	53.5	20.0	23.2	29.3	22.0	78.6	40.2	22.8	28.2	31.6	22.0	31.6	22.5	22.7	3.7	25.4	28.5	27.7	39.1	23.5	24.2	18.9	20.5	47.2	13.1	24.6	22.9	21.6	23.1	8.1	17.3	17.5	22.6	21.8	11.3	16.4	24.2	15.0	21.9	29.1	30.1	20.9	22.6	66.8	23.3	4.7	25.4	4.8	25.1	16.7	10.6	25.3	31.6	21.8	15.5	13.5	2.5	26.8	81.5	60.2	90.5	47.5	51.0	30.4	38.1	33.0	13.5	12.4	23.5	90.7	5.6	59.5	16.7	16.2	13.1	16.7	1.9	17.0	26.0	11.9	167.1	24.1	1.3	106.5	95.2	12.4	30.6	11.9	1.5	13.8	2.2	23.0	27.7	76.4	1.4	39.8	9.1	30.4	8.7	8.2	0.3	34.0	14.8	8.6	2.1	10.4	48.9	69.4	55.1	29.7	66.4	52.1	6.2	38.1	57.5	2.4	7.0	18.7	6.0	28.8	11.5	90.0	19.1	0.1	4.5	4.4	0.0	8.1	0.0	11.8	0.2	0.0	2.4	5.1	0.0	0.0	7.7	0.1	13.2	2.1	0.2	1.4	23.2	22.0	22.8	28.2	23.5	24.2	24.6	22.9	22.6	22.6	25.4	21.8	70.7	12.8	33.5	26.8	9.9	16.4	6.0	5.8	19.9	21.8	26.2	18.2	17.7	12.8	8.1	9.2	10.4	1.4	1.2	20.0	0.0	2.4	0.3	21.6	18.4	21.2	5.4	0.8	18.9	6.6	5.6	49.5	10.2	23.9	2.5	10.1	10.4	8.5	9.7	8.4	20.8	14.9	4.1	87.7	25.7	1.5	18.0	47.3	12.4	14.0	13.8	38.6	2.1	18.1	3.0	8.5	8.2	16.6	9.8	2.6	17.7	3.0	7.4	31.1	6.6	47.2	19.5	0.1	0.9	19.7	8.9	0.3	2.2	5.3	8.7	11.5
JHY	"C11orf63, FLJ23554"	ENSG00000109944	"Junctional cadherin complex regulator"	Q6NUN7	11	122882683-122963862	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Endometrial ciliated cells: 41.5;Glandular and luminal cells: 8.7;Proximal tubular cells: 12.0;Respiratory ciliated cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039612, HPA040344, HPA077658, HPA077748"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (9.97e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.77e-4)"	"unprognostic (6.46e-3)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (7.79e-2)"	6.0	1.8	1.7	2.2	2.7	1.1	3.6	3.4	2.4	3.1	17.3	3.5	1.5	2.1	2.7	1.8	7.4	2.6	2.2	1.8	3.8	7.8	0.4	4.5	2.2	4.1	5.4	3.2	2.8	5.6	4.8	1.3	3.8	3.5	1.7	1.6	1.4	2.5	0.2	1.9	1.9	2.0	3.8	2.5	2.0	35.7	3.2	3.2	5.1	0.8	2.0	2.6	1.8	3.6	2.8	3.9	2.2	0.1	0.6	0.4	0.7	5.9	6.8	2.5	1.1	0.3	10.3	0.1	1.5	9.1	13.6	2.4	2.7	1.4	1.1	9.5	2.8	0.1	1.8	0.1	0.9	1.7	4.7	2.8	7.4	0.4	0.6	6.3	3.8	4.1	0.0	0.1	2.0	1.8	0.1	0.6	0.3	8.2	3.5	1.0	0.0	1.3	7.0	3.2	5.8	4.2	7.1	3.9	2.6	2.8	4.7	0.6	1.2	7.9	1.0	0.2	4.8	0.1	0.0	0.1	2.1	2.1	5.3	0.5	0.3	0.1	1.3	0.1	1.8	1.1	1.3	1.7	2.4	0.6	0.9	1.0	0.4	2.4	0.1	0.6	0.3	0.5	1.7	2.7	3.4	2.4	1.8	3.8	4.1	5.4	3.8	3.8	3.2	3.6	4.4	12.8	4.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.3	3.2	0.0	0.0	7.4	5.5	0.0	0.2	2.2	0.0	3.9	5.5	0.0	41.5	3.1	1.1	0.0	0.0	0.0	1.4	0.9	2.2	0.0	8.7	0.0	2.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.7	0.0	0.0	12.0	19.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	1.8	1.3	0.0	0.0
JKAMP	"C14orf100, CDA06, HSPC213, HSPC327, JAMP"	ENSG00000050130	"JNK1/MAPK8 associated membrane protein"	Q9P055	14	59484443-59505410	"Cancer-related genes, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 174.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031172, HPA071650"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"HPA031172: AB_10670563, HPA071650: AB_2686429"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.09e-6)"	"unprognostic (2.68e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-1)"	25.9	34.9	23.6	17.7	26.5	22.9	32.5	29.5	30.3	23.0	34.2	29.6	17.3	30.5	26.4	17.8	31.2	30.8	25.9	22.9	30.2	44.5	34.0	30.7	25.2	30.1	29.8	25.8	20.7	56.6	28.6	33.8	31.3	29.9	29.5	34.7	25.4	27.0	17.1	17.9	24.0	27.7	28.7	23.0	24.4	30.4	26.1	22.1	34.6	21.1	20.7	26.4	16.2	32.0	54.8	68.0	57.3	46.8	40.9	59.0	42.8	85.9	76.6	52.6	62.9	21.8	108.1	27.7	75.6	85.5	55.3	40.0	41.2	52.8	72.1	82.8	24.0	30.3	38.5	42.3	56.0	45.6	53.6	60.9	56.6	45.9	32.6	82.1	55.7	35.8	25.4	54.9	100.7	54.1	25.6	37.8	31.2	45.9	60.4	31.4	73.6	27.9	92.1	59.3	23.7	40.9	82.8	68.4	45.1	40.0	66.4	32.3	72.4	54.9	65.6	53.0	58.0	21.7	45.5	32.7	80.7	33.2	68.0	86.3	59.3	82.3	34.4	74.8	34.3	36.1	37.0	37.0	51.9	34.1	38.9	36.5	89.4	50.2	83.0	70.5	47.0	57.8	23.6	26.5	29.5	30.3	22.9	30.2	30.1	29.8	31.3	28.7	26.1	32.0	25.5	22.4	31.2	29.7	23.6	30.0	32.8	132.9	54.1	30.3	31.6	27.1	10.2	41.5	66.3	46.0	18.8	64.2	42.0	27.4	7.9	45.4	174.5	43.3	31.7	26.9	31.2	40.8	30.3	54.8	64.8	37.4	27.5	20.9	34.9	28.0	26.4	41.9	57.8	28.6	26.8	26.7	89.5	60.3	31.4	61.2	35.4	40.4	48.0	19.7	34.2	40.1	29.9	28.1	34.5	51.4	21.3	31.6	50.2	26.3	22.4	53.0	110.6	30.3	13.1	27.5	58.8	85.1	41.1	30.7	29.1	29.8	27.6	30.3	24.6	20.9
JMJD1C	"DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8"	ENSG00000171988	"Jumonji domain containing 1C"	Q15652	10	63167221-63521850	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 590.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 49.7"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 14.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056175, HPA066195"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA056175: AB_2683057, HPA066195: AB_2685634"	"unprognostic (7.72e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.13e-1)"	16.3	12.5	3.7	18.9	5.4	40.2	22.3	49.7	6.6	19.9	6.4	11.3	16.9	24.0	11.3	12.8	12.5	24.6	12.1	4.0	4.5	15.6	22.3	16.0	22.1	5.0	5.0	24.7	13.1	21.9	6.8	14.4	6.2	14.1	12.3	41.4	13.1	11.5	11.0	11.1	18.9	15.6	3.1	20.9	14.5	15.7	4.8	20.4	20.8	13.8	21.3	16.0	9.4	7.7	23.2	11.5	26.5	20.4	13.8	25.2	9.3	15.8	32.5	13.9	19.0	19.8	24.2	31.3	9.4	14.9	12.6	18.6	7.6	15.2	24.7	8.5	9.6	11.9	11.9	14.4	16.8	25.8	4.3	25.3	15.3	24.7	71.3	31.5	25.4	22.0	21.4	23.0	33.1	6.2	19.8	13.8	28.3	5.2	40.0	34.0	57.5	15.0	14.1	16.5	14.4	23.5	23.8	14.7	22.8	19.3	14.6	46.0	30.6	12.9	18.1	11.3	20.0	20.4	17.4	29.1	15.7	15.1	11.7	0.6	2.7	3.2	1.8	1.8	2.7	4.4	1.9	1.9	2.3	4.2	2.7	2.3	14.1	1.7	1.6	4.0	1.8	1.1	3.7	5.4	49.7	6.6	4.0	4.5	5.0	5.0	6.2	3.1	4.8	7.7	256.1	112.2	93.3	214.5	184.4	151.9	369.2	46.6	93.9	88.7	106.7	92.7	69.4	55.8	96.9	55.2	152.2	34.7	117.4	80.7	13.7	63.3	38.3	155.8	179.7	176.7	86.0	75.3	590.1	47.0	27.7	141.1	119.8	210.1	93.1	79.1	118.2	37.2	57.9	117.8	416.5	66.8	38.7	89.8	185.0	42.3	103.8	206.8	76.5	355.1	96.6	61.2	58.7	419.2	378.8	76.7	88.4	89.5	124.8	161.0	90.6	32.4	104.1	170.9	72.3	214.4	112.6	158.6	146.5	56.4	134.0	33.2	145.6	76.0	52.3	286.7
JMJD6	"KIAA0585, PTDSR, PTDSR1"	ENSG00000070495	"Jumonji domain containing 6, arginine demethylase and lysine hydroxylase"	Q6NYC1	17	76712832-76726799	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 121.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004548, HPA059156"	Supported		Supported	Nucleoplasm		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004548: AB_628185, HPA059156: AB_2683934"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (5.71e-4)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (7.59e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.82e-1)"	30.3	27.0	14.2	17.0	16.3	121.7	19.6	19.2	29.5	20.2	15.3	32.3	15.4	19.4	7.4	18.8	22.4	18.7	41.2	14.3	16.5	18.3	18.5	26.8	15.7	16.2	16.2	27.6	18.0	11.0	22.4	16.2	16.2	19.9	10.3	29.5	15.2	10.7	38.2	15.6	18.4	16.0	14.6	21.1	24.4	17.8	16.9	13.4	16.6	28.1	12.8	23.9	20.4	20.8	39.0	53.3	18.0	23.5	22.6	19.4	17.6	34.7	26.8	49.6	47.6	53.6	18.7	25.3	14.9	37.6	72.6	28.8	57.3	17.3	47.2	18.6	45.9	37.3	37.5	54.4	36.8	19.7	55.0	23.9	26.8	54.2	18.2	31.6	41.6	13.8	57.1	45.2	37.0	24.4	34.7	28.4	15.9	37.3	62.4	27.1	33.6	39.2	16.6	12.1	31.1	31.1	30.2	43.7	43.7	30.4	39.5	28.6	27.7	56.7	33.3	29.9	65.8	50.6	28.8	23.4	55.7	17.4	32.5	50.8	28.6	40.2	24.7	37.8	24.0	20.5	28.4	28.2	25.9	13.0	23.3	22.2	23.3	14.6	39.4	22.4	31.0	20.1	14.2	16.3	19.2	29.5	14.3	16.5	16.2	16.2	16.2	14.6	16.9	20.8	44.1	25.6	22.9	9.1	29.3	83.2	79.9	46.1	67.2	16.5	30.8	42.8	30.5	14.3	29.2	9.2	50.1	29.0	96.5	33.1	17.6	28.1	30.3	39.1	29.6	36.0	39.4	13.0	6.6	27.4	52.9	37.9	33.1	58.6	65.2	18.6	28.2	10.2	32.7	6.7	7.4	32.0	24.4	19.5	79.2	12.5	16.1	52.4	58.7	3.7	26.9	11.8	21.6	7.1	7.9	29.6	32.1	17.7	50.0	38.5	40.8	7.9	20.5	35.4	13.1	32.7	69.2	59.6	27.2	48.8	73.6	30.5	80.4	29.9	31.3	60.2
JMY	"FLJ37870, WHAMM2"	ENSG00000152409	"Junction mediating and regulatory protein, p53 cofactor"	Q8N9B5	5	79236131-79327211	"Predicted intracellular proteins"	"DNA damage, DNA repair"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 25.2;Karpas-707: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037508, HPA043308"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA037508: , HPA043308: AB_10806502"	"unprognostic (1.87e-2)"	"unprognostic (2.12e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (7.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.15e-1)"	4.5	5.0	5.7	3.4	6.7	10.3	5.8	8.3	7.8	7.3	4.5	10.9	3.2	11.8	7.1	4.9	5.3	4.7	5.0	5.8	5.3	6.4	5.2	4.0	4.2	5.8	5.7	13.3	9.4	11.4	4.8	3.2	6.3	6.4	4.3	11.8	7.4	5.8	8.9	6.7	4.4	7.2	4.9	4.9	5.1	7.3	6.6	5.5	10.2	7.7	4.1	6.0	5.6	7.3	3.8	3.6	2.7	7.1	7.4	6.7	9.5	3.5	9.1	3.2	5.1	1.7	4.1	2.6	25.2	4.0	3.7	4.1	9.6	4.7	5.1	11.5	8.8	5.2	5.9	3.6	11.3	2.3	3.3	6.4	12.3	1.5	13.9	6.6	4.0	6.9	3.2	43.7	2.7	5.0	5.0	4.9	4.5	0.8	2.4	4.9	8.7	11.2	6.9	3.9	10.7	5.8	4.5	4.9	8.3	4.5	4.0	4.8	4.2	1.4	2.4	0.8	2.3	12.3	11.5	2.6	2.8	2.3	2.3	0.0	0.1	0.0	0.3	0.1	0.2	0.2	0.3	0.3	0.0	0.1	0.4	0.3	0.1	0.9	0.0	0.2	0.3	0.0	5.7	6.7	8.3	7.8	5.8	5.3	5.8	5.7	6.3	4.9	6.6	7.3	18.9	9.6	14.9	35.6	36.7	29.8	11.3	11.0	24.5	35.7	14.9	13.7	40.7	15.7	17.4	16.5	43.8	6.4	49.8	6.1	1.9	8.1	35.6	36.3	35.2	16.7	23.9	18.7	55.5	9.8	5.4	24.6	15.8	53.9	8.2	28.8	8.6	15.4	4.4	40.4	53.6	8.3	10.2	9.3	21.0	21.5	24.2	35.8	23.2	15.9	5.2	20.5	9.2	47.7	42.5	10.7	7.6	35.7	85.2	21.4	6.8	7.8	24.9	40.8	13.1	29.6	27.7	37.1	39.2	19.8	39.8	20.2	56.5	34.6	7.6	17.6
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321540	"Human disease related genes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"skeletal muscle: 237.4;tongue: 106.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Basal prostatic cells: 32.8;Cardiomyocytes: 35.7;Excitatory neurons: 82.2;Inhibitory neurons: 50.3;Prostatic glandular cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.1;OE19: 17.7;SK-BR-3: 34.4;T-47d: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	0.3	0.2	2.9	0.5	7.5	0.0	0.7	7.6	5.3	0.7	13.2	3.3	0.7	3.2	0.8	2.8	0.3	0.3	8.4	5.9	1.5	0.8	0.4	3.7	0.1	3.0	1.5	0.1	6.5	0.8	0.5	1.4	2.4	2.8	5.0	0.4	2.8	0.5	237.4	0.6	1.0	1.9	1.9	0.1	0.9	1.0	1.9	3.2	1.4	106.0	1.1	2.3	1.4	3.6	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	1.1	1.1	0.5	0.2	4.4	0.0	1.5	0.0	1.0	6.4	5.6	4.3	1.4	0.0	8.3	0.0	5.2	0.0	0.7	2.9	0.3	0.8	3.7	0.0	4.0	0.0	0.0	10.9	0.8	0.0	0.4	4.1	15.1	0.0	9.7	17.7	2.9	7.6	5.4	0.0	0.2	12.7	7.3	1.0	0.1	34.4	1.8	1.6	24.2	0.2	0.0	1.6	2.3	0.6	1.4	0.0	0.0	0.0	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.5	7.6	5.3	5.9	1.5	3.0	1.5	2.4	1.9	1.9	3.6	1.1	38.5	12.9	3.9	0.2	2.8	32.8	3.0	6.2	0.4	2.4	1.5	35.7	0.0	10.8	1.8	6.2	0.0	0.1	7.1	0.0	0.3	2.4	2.9	8.9	1.7	12.6	0.0	82.2	1.4	0.0	2.6	7.7	3.7	0.0	0.0	0.0	0.0	0.1	0.0	50.3	9.9	2.0	0.0	0.4	0.5	0.9	0.4	1.8	3.7	0.0	0.4	0.0	14.1	4.6	3.4	6.2	0.0	0.0	32.8	0.0	1.0	6.2	0.1	0.0	25.0	1.4	0.1	4.3	7.4	2.0	0.0	0.2	0.1	6.7	25.6
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 59.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.1;Excitatory neurons: 33.2;Horizontal cells: 50.5;Inhibitory neurons: 28.7;Late spermatids: 14.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Group enriched"	"Detected in all"	5	"amygdala: 17.1;basal ganglia: 24.6;cerebral cortex: 59.1;hippocampal formation: 42.7;white matter: 20.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;NTERA-2: 5.7;SH-SY5Y: 7.2;SiHa: 5.0;U-2 OS: 22.5"	"Low region specificity"	"Detected in all"							HPA076304			Approved	Nucleoplasm,Cytosol		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA076304: AB_2686793"	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	0.2	1.3	17.1	0.2	24.6	0.0	0.1	1.1	59.1	0.7	0.0	1.1	0.1	0.2	0.0	0.6	0.4	0.0	0.1	42.7	5.6	0.0	0.1	0.1	0.0	6.4	5.8	0.1	0.3	0.0	14.1	0.0	1.1	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.5	0.0	1.1	0.1	0.5	1.4	1.1	0.0	0.1	0.0	0.0	0.1	0.3	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.9	0.0	1.2	0.0	0.0	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.2	5.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	24.6	1.1	59.1	42.7	5.6	6.4	5.8	1.1	1.1	1.1	20.6	0.0	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	24.4	0.0	0.0	3.7	0.0	0.0	0.0	22.9	0.0	0.0	0.1	0.0	0.0	41.1	0.0	0.0	0.8	0.0	0.0	33.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.1	50.5	28.7	0.0	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.0	1.3	0.0	10.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.2	0.1	1.1	3.7	0.0	0.0	0.1	0.1	0.5	0.0	0.1
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 406.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 371.3;Exocrine glandular cells: 437.2;Extravillous trophoblasts: 1344.2;monocytes: 375.7;Pancreatic endocrine cells: 1434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 767.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA		40000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	26.1	74.9	44.0	87.5	43.7	83.5	21.3	49.4	54.7	44.1	31.0	140.1	119.2	18.0	7.3	225.1	15.5	63.7	23.3	44.3	54.4	72.2	49.1	49.3	87.6	38.6	42.8	13.4	22.6	6.7	24.3	66.3	49.3	28.3	70.4	17.0	62.1	27.8	96.1	40.7	141.6	23.4	34.3	100.5	134.2	406.9	53.1	88.0	16.1	24.3	91.5	93.9	75.7	36.3	775.3	743.0	371.8	384.7	75.5	75.2	309.5	391.8	111.5	364.6	278.0	614.8	449.1	210.1	247.4	303.0	401.7	446.5	344.3	481.9	278.5	215.7	438.3	336.1	275.2	624.8	177.5	256.3	318.3	117.1	218.4	307.3	308.7	107.1	672.2	388.7	197.3	431.3	335.4	561.4	845.0	248.7	216.9	627.8	979.0	520.8	447.5	326.8	392.7	479.1	465.4	373.8	553.8	293.3	213.4	393.8	786.0	154.9	395.1	214.3	615.7	305.0	469.0	165.9	298.1	332.5	186.9	233.4	254.4	241.7	127.0	372.6	79.6	187.8	57.2	102.3	109.3	96.8	100.7	57.2	51.6	76.1	767.6	74.5	206.7	67.4	202.6	118.4	44.0	43.7	49.4	54.7	44.3	54.4	38.6	42.8	49.3	34.3	53.1	36.3	61.6	25.6	18.1	0.0	36.2	0.0	0.0	0.0	0.0	0.0	81.8	133.2	0.0	0.0	18.0	246.5	0.0	137.6	171.2	0.0	99.7	371.3	0.0	113.2	79.7	32.9	0.0	0.0	0.0	437.2	1344.2	40.4	0.0	194.0	7.6	179.6	0.0	0.0	319.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.5	0.0	0.0	375.7	0.0	0.0	0.0	0.0	1434.1	0.0	0.0	13.9	0.0	0.0	203.3	16.8	0.0	0.0	0.0	76.2	0.0	0.0	0.0	0.0	96.9	73.9	95.0	0.0	0.0
JRK	"jerky, JH8"	ENSG00000234616	"Jrk helix-turn-helix protein"	O75564	8	142657460-142681968	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052675			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA052675: AB_2681910"	"unprognostic (3.65e-2)"	"unprognostic (5.30e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.58e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.69e-2)"	3.7	4.5	5.9	4.1	6.1	2.1	4.0	7.9	7.4	7.4	4.0	5.9	3.0	6.7	3.4	4.9	5.5	2.5	5.9	5.8	4.7	7.9	4.0	3.9	5.4	6.2	5.2	8.5	5.4	4.6	6.4	3.0	5.5	6.2	2.8	3.8	4.7	4.0	7.5	6.0	5.3	3.7	4.3	7.2	5.7	6.6	6.2	5.1	6.9	4.7	5.9	5.7	4.7	6.8	6.5	6.9	8.0	6.4	7.6	10.8	4.8	10.4	4.2	11.9	6.8	6.3	13.1	11.0	4.1	8.2	8.2	8.7	7.0	6.2	6.0	8.5	12.0	11.2	25.3	7.2	3.1	8.6	7.5	7.2	5.4	7.6	4.3	6.0	6.8	13.1	12.0	4.8	10.1	11.1	10.1	4.8	6.8	4.6	9.6	13.1	5.0	6.2	4.1	11.1	14.5	9.6	18.1	7.3	4.3	5.0	7.3	5.2	8.1	9.1	19.5	9.1	5.5	6.3	7.6	6.3	6.9	10.7	9.0	1.0	0.7	0.9	0.9	0.5	0.5	0.4	1.0	0.9	0.7	1.2	1.3	1.0	0.8	0.6	0.2	0.6	0.6	0.4	5.9	6.1	7.9	7.4	5.8	4.7	6.2	5.2	5.5	4.3	6.2	6.8	3.5	6.4	1.1	8.5	4.8	0.0	2.5	0.0	2.2	14.7	4.5	3.3	11.5	4.3	0.6	7.3	20.9	4.4	8.6	3.2	3.9	2.8	1.9	1.4	4.9	6.5	9.1	12.0	11.3	2.5	2.7	3.7	6.6	2.1	1.3	15.5	8.2	2.6	3.0	10.1	11.0	3.1	0.0	6.6	0.0	2.2	11.5	3.4	0.0	8.4	4.5	4.4	12.3	9.5	9.5	5.6	1.4	11.7	4.3	3.7	2.7	2.7	0.7	10.0	0.0	5.8	4.8	9.1	19.4	3.2	0.0	2.2	2.5	6.8	4.2	4.5
JRKL	HHMJG	ENSG00000183340	"JRK like"	Q9Y4A0	11	96389989-96507574	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 171.1;Late spermatids: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046184, HPA060341"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge"	"HPA046184: AB_10963576, HPA060341: AB_2732646"	"unprognostic (4.59e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	"unprognostic (4.94e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.57e-3)"	7.4	6.2	4.2	7.6	4.4	1.7	8.8	4.5	4.9	9.8	4.3	7.1	7.2	8.4	7.4	5.9	10.1	6.6	6.1	4.0	5.3	6.7	4.2	6.2	9.3	4.7	4.7	13.2	5.1	6.9	4.1	8.4	4.8	8.4	9.0	11.1	8.8	6.9	4.1	7.8	8.4	6.9	4.4	7.5	8.6	11.7	4.7	9.6	9.6	4.4	9.2	6.8	6.0	5.3	9.4	5.8	11.8	8.9	23.1	25.7	8.6	15.6	10.5	10.9	14.2	9.8	22.2	12.8	22.3	14.4	13.9	14.5	5.9	10.6	12.6	13.9	5.5	11.9	17.0	7.5	18.7	6.8	7.4	12.2	16.3	15.8	19.6	20.3	10.0	14.5	6.4	5.5	17.9	1.9	8.8	19.8	1.8	16.7	7.9	8.9	11.5	10.5	13.5	9.7	4.7	8.6	9.1	6.2	7.1	11.0	7.6	9.1	12.4	21.1	9.4	18.6	6.4	4.7	10.9	7.5	9.8	10.9	9.2	3.3	2.6	2.6	1.6	2.1	2.3	2.2	2.6	2.0	2.6	1.6	3.2	2.9	0.9	1.8	2.5	4.1	1.3	1.6	4.2	4.4	4.5	4.9	4.0	5.3	4.7	4.7	4.8	4.4	4.7	5.3	6.2	9.6	5.8	4.2	5.0	4.7	10.3	6.6	2.8	7.4	7.6	8.9	6.8	15.7	12.0	0.0	4.2	6.0	11.7	9.0	1.9	11.5	171.1	9.9	13.6	5.8	6.0	4.8	3.4	5.1	5.0	9.9	7.1	6.8	3.8	5.0	6.4	2.2	5.0	8.4	3.0	10.5	4.1	7.2	5.2	49.3	8.4	6.0	1.8	1.0	6.9	5.2	6.2	3.5	8.2	8.2	4.5	9.4	2.4	8.4	7.6	6.1	25.3	12.3	0.0	6.0	9.6	9.9	4.9	5.3	6.0	4.0	4.8	7.5	9.7	8.4
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58776845-58784048	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 295.6"	"Low region specificity"	"Detected in all"							"CAB003801, CAB007780, HPA031174, HPA059474"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030"	"unprognostic (2.06e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-3)"	331.1	92.7	34.4	36.3	37.0	129.1	308.2	41.6	38.1	172.0	28.0	154.7	34.7	116.4	15.8	100.2	314.1	89.6	158.4	39.1	37.2	94.0	205.2	202.8	52.1	32.7	30.7	197.0	192.2	59.8	75.0	40.1	30.5	153.4	55.0	29.7	154.5	71.7	114.3	286.6	79.1	113.3	34.3	62.0	239.5	20.2	33.8	71.5	189.5	158.8	5.4	156.4	164.5	36.9	49.8	2.8	22.4	2.6	35.3	40.0	0.2	69.4	27.0	57.1	34.3	10.1	3.5	1.7	23.8	57.4	133.6	12.9	2.0	27.7	40.6	29.8	128.9	0.5	1.9	16.9	29.4	5.3	10.2	42.0	74.0	78.1	34.0	27.7	47.2	2.4	15.6	29.6	24.9	8.0	2.5	32.5	13.5	34.6	32.2	1.1	295.6	7.0	60.7	5.8	43.7	12.8	49.9	62.3	26.4	24.5	17.2	3.0	61.6	127.5	37.3	35.3	96.8	37.9	9.8	4.4	133.9	8.4	35.2	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	34.4	37.0	41.6	38.1	39.1	37.2	32.7	30.7	30.5	34.3	33.8	36.9	2721.4	538.5	543.8	187.7	1018.8	1235.5	2850.5	772.6	2825.1	103.4	1647.1	2067.3	1487.5	1315.4	449.3	104.8	262.7	675.8	651.1	1653.6	50.9	987.0	49.3	1337.1	2845.2	1443.8	1497.4	174.3	12.2	516.4	93.9	2730.7	2663.1	1822.2	541.9	333.4	737.2	158.6	650.5	87.5	4.9	1909.1	836.2	584.9	632.0	48.2	1227.4	1034.9	757.7	65.6	140.1	1234.2	8.2	17.6	10.0	562.8	1529.6	258.8	1540.3	1489.1	1654.1	48.6	216.3	453.5	1538.3	1892.9	2392.5	17.4	20.9	2146.3	964.4	415.6	1065.5	846.5	1199.5	545.7
JUNB		ENSG00000171223	"JunB proto-oncogene, AP-1 transcription factor subunit"	P17275	19	12791486-12793315	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 679.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 679.4;monocytes: 182.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 629.0;U-266/70: 256.4;U-266/84: 411.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004464, HPA019149"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004464: AB_2130023, HPA019149: AB_1852053"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.02e-1)"	722.8	259.5	22.9	110.3	28.0	455.2	248.5	90.1	65.2	283.3	30.4	287.0	52.8	130.1	2.2	449.1	874.8	92.6	383.5	28.3	68.8	184.2	279.0	399.2	65.0	83.5	29.8	649.5	150.0	20.8	351.9	39.4	33.6	195.0	22.0	32.0	131.6	56.1	144.6	605.9	145.0	58.1	51.5	153.3	309.8	30.0	31.3	78.8	198.7	73.3	12.9	333.0	330.6	34.8	52.9	10.4	2.8	6.4	11.3	27.4	10.2	22.8	19.2	11.0	10.0	6.8	30.4	18.2	77.4	8.4	33.5	98.5	2.5	34.3	1.2	629.0	9.9	18.0	42.2	9.0	15.1	24.3	80.5	34.9	97.6	10.0	7.5	22.0	5.3	12.9	48.1	32.6	3.6	158.8	16.8	147.5	1.7	36.1	40.0	22.4	7.7	38.8	7.5	65.5	23.7	36.0	98.4	59.5	30.5	1.7	10.5	27.0	17.6	32.2	18.7	64.3	28.9	256.4	411.4	17.1	37.7	62.7	8.9	29.1	132.2	132.2	33.4	182.7	33.4	30.6	36.8	42.0	87.1	25.4	25.5	28.5	679.4	18.6	177.2	7.9	38.7	124.1	22.9	28.0	90.1	65.2	28.3	68.8	83.5	29.8	33.6	51.5	31.3	34.8	3158.0	115.4	423.2	130.2	1751.7	1463.9	1778.3	2367.7	1985.1	81.0	1296.9	1693.1	374.0	474.7	707.4	154.5	39.6	129.7	1766.9	819.7	49.0	833.3	9.5	468.5	1091.4	1469.5	1502.1	244.8	8.7	546.7	224.7	2182.3	1060.1	627.8	510.5	310.0	852.4	84.6	1178.4	21.9	4.4	1029.3	740.6	674.1	2747.6	27.9	815.2	1583.3	894.6	20.6	379.3	634.6	115.4	4.5	2.4	1026.7	875.3	263.3	842.5	1036.7	701.0	84.2	337.3	168.8	1163.6	2566.6	2624.1	9.4	10.5	1164.3	1804.1	440.3	2362.6	417.0	687.7	472.6
JUND	AP-1	ENSG00000130522	"JunD proto-oncogene, AP-1 transcription factor subunit"	P17535	19	18279694-18281622	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 2129.8;dendritic cells: 1844.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005268, HPA063029"	Supported		Supported	Nucleoplasm		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB005268: AB_2130177, HPA063029: AB_2684925"	"prognostic favorable (6.15e-5)"	"unprognostic (4.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.99e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.49e-1)"	296.3	189.3	190.3	38.9	201.6	429.1	257.3	172.1	208.5	159.7	153.1	185.2	62.9	186.6	37.5	118.3	291.4	30.0	210.6	187.5	192.5	148.8	211.8	227.3	28.8	261.3	213.2	424.2	178.4	40.4	256.4	45.1	180.9	159.1	33.0	25.7	112.7	33.8	81.0	287.7	161.3	57.5	182.5	100.5	201.4	97.4	180.4	58.2	154.8	37.1	15.9	129.5	147.7	263.8	84.2	35.3	33.3	37.9	25.9	28.8	150.5	35.0	40.8	19.2	25.4	38.3	72.9	42.1	39.4	34.8	31.1	46.1	8.2	8.3	9.5	84.6	75.9	62.7	30.3	84.9	58.6	29.5	81.4	27.8	33.7	20.0	25.9	44.5	15.3	18.8	86.5	119.8	5.2	113.6	89.9	92.5	69.7	22.7	50.6	32.7	20.9	94.0	27.8	13.1	184.2	75.1	41.7	45.4	122.0	37.5	38.6	43.9	54.7	11.8	54.8	74.4	20.9	171.3	73.8	36.3	41.5	44.7	27.9	10.5	6.5	6.8	4.9	8.2	3.8	8.4	6.4	4.5	4.9	8.7	4.5	5.0	19.7	4.8	8.3	11.3	5.7	2.4	190.3	201.6	172.1	208.5	187.5	192.5	261.3	213.2	180.9	182.5	180.4	263.8	2129.8	179.5	386.7	104.5	1176.8	317.1	400.4	76.0	188.4	129.8	1147.5	1419.1	158.8	291.7	84.4	257.5	79.2	78.5	1844.7	810.5	31.3	96.5	80.8	1026.0	1289.3	468.1	568.8	78.3	51.6	140.8	112.9	950.9	336.4	1561.4	257.7	514.1	338.4	436.1	100.1	139.7	41.0	569.6	67.1	332.7	506.0	59.2	123.3	847.7	249.1	65.6	91.7	625.2	27.8	44.7	132.0	154.4	464.2	88.8	734.5	253.6	538.1	65.4	90.4	174.3	131.5	1064.7	798.4	11.8	22.7	172.0	394.1	164.3	1158.2	448.7	297.4	232.7
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.3"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 1434.2;Inhibitory neurons: 480.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 57.4;HEL: 35.3;OE19: 20.1;SH-SY5Y: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		83000	"Cluster 35: T-regs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	9.4	6.3	15.0	2.2	23.4	0.3	6.7	0.0	31.3	9.1	4.9	2.0	2.5	7.7	1.9	9.5	4.6	2.9	12.8	21.3	3.4	3.8	5.8	4.4	0.9	0.0	6.6	3.1	8.8	3.5	4.1	4.2	0.0	2.8	1.8	4.5	2.8	4.9	27.2	2.0	2.0	6.2	0.0	8.5	12.1	2.6	10.7	0.5	5.1	19.3	1.6	2.6	6.0	20.9	0.7	1.1	6.2	1.3	0.9	0.2	8.1	2.5	1.5	2.4	1.1	57.4	4.5	0.2	0.8	6.4	3.9	0.4	1.4	0.0	2.0	0.0	0.7	35.3	0.4	8.9	0.1	0.0	0.0	0.4	0.0	0.5	0.1	2.6	2.9	0.1	8.3	0.2	0.7	4.2	0.0	0.0	3.5	20.1	5.4	1.8	2.8	0.0	0.2	0.5	2.1	15.9	0.7	0.5	0.5	6.0	1.2	0.1	14.4	7.0	2.8	1.0	1.1	0.0	0.6	0.0	0.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	1.6	0.4	15.0	23.4	0.0	31.3	21.3	3.4	0.0	6.6	0.0	0.0	10.7	20.9	56.2	3.2	3.9	191.3	0.6	1.7	1.5	0.3	0.6	61.2	6.1	7.1	32.1	18.6	0.5	16.5	6.2	8.0	2.5	40.5	1.9	5.0	57.0	15.0	18.8	23.2	9.6	5.3	1434.2	8.4	1.7	5.9	29.0	7.4	3.8	4.4	45.3	21.7	1.0	0.0	480.8	16.4	0.0	1.6	1.1	64.0	3.7	5.3	3.6	48.7	0.0	4.7	8.2	162.3	63.1	4.4	21.0	33.1	0.3	2.6	34.8	3.6	8.4	2.7	19.7	8.8	21.8	5.2	2.6	4.9	1.1	14.2	1.0	17.5	12.3	1.6
KANK2	"ANKRD25, KIAA1518, MXRA3"	ENSG00000197256	"KN motif and ankyrin repeat domains 2"	Q63ZY3	19	11164270-11197791	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 402.5;Endometrial stromal cells: 149.6;Leydig cells: 126.2;Peritubular cells: 225.7;Smooth muscle cells: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC diff: 327.8;ASC TERT1: 365.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015643	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA015643: AB_1844839"	"unprognostic (2.37e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.63e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (4.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	150.2	55.5	25.7	50.5	27.2	17.9	97.7	22.8	25.6	275.3	24.5	413.2	36.8	376.9	64.6	139.1	222.1	125.0	200.5	20.0	27.9	54.1	51.3	134.5	20.7	29.5	26.5	213.9	35.4	14.3	29.8	62.3	29.0	140.5	58.7	19.0	39.3	173.6	56.9	49.7	108.0	277.7	23.8	57.8	123.7	25.0	29.5	15.7	71.7	51.1	12.4	255.2	148.5	22.6	42.4	91.1	28.3	30.3	327.8	365.1	20.2	188.9	161.0	92.1	76.2	36.3	27.0	177.2	88.1	234.3	59.6	40.0	25.6	13.7	61.3	9.3	18.4	77.2	105.6	37.5	123.9	11.8	21.4	158.7	20.1	67.3	9.0	237.2	37.8	5.5	51.5	14.3	143.6	75.7	2.3	9.9	31.4	27.5	95.1	59.7	234.8	42.2	65.4	22.7	16.6	51.7	188.2	16.4	22.4	32.7	25.1	41.2	139.1	131.5	52.6	170.1	75.2	13.7	32.9	61.3	111.0	66.3	136.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	25.7	27.2	22.8	25.6	20.0	27.9	29.5	26.5	29.0	23.8	29.5	22.6	34.1	57.7	28.3	7.8	1.3	6.2	5.5	5.2	2.2	2.0	5.2	7.1	402.5	27.1	12.0	20.2	20.9	6.9	0.6	2.5	3.9	8.1	2.4	12.7	149.6	41.2	0.0	76.2	0.9	4.4	4.9	69.2	13.3	11.9	7.6	7.7	32.5	28.2	22.5	0.0	4.1	2.6	4.1	10.6	15.1	3.8	126.2	6.3	8.8	42.2	0.5	34.9	4.1	1.0	1.4	11.9	1.2	225.7	0.8	6.7	1.6	3.7	8.0	23.4	92.1	79.2	131.0	1.8	7.2	2.8	7.7	2.3	2.3	7.7	5.2	8.4
KANSL1	"CENP-36, DKFZP727C091, KIAA1267, MSL1v1, NSL1"	ENSG00000120071	"KAT8 regulatory NSL complex subunit 1"	Q7Z3B3	17	46029916-46225389	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 334.6;Inhibitory neurons: 326.7;Microglial cells: 327.9;Oligodendrocyte precursor cells: 313.6;Oligodendrocytes: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006874, HPA007208"	Approved		Supported	Nucleoplasm		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006874: AB_1852393, HPA007208: AB_1852395"	"unprognostic (2.46e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (1.54e-2)"	"unprognostic (9.28e-2)"	"unprognostic (7.79e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.33e-2)"	12.3	9.2	3.7	7.6	4.4	12.9	11.3	13.8	6.7	14.2	2.1	11.7	4.2	15.3	9.1	12.9	11.7	4.1	7.3	4.1	4.0	8.4	5.8	9.4	7.6	4.2	4.7	15.2	12.4	11.9	9.0	7.2	5.4	9.1	8.4	9.4	11.1	4.5	16.4	17.2	12.0	9.8	3.6	9.2	10.0	17.5	4.8	16.9	12.0	9.0	9.7	12.7	13.1	5.8	3.1	2.4	11.2	5.1	2.5	4.0	7.0	3.0	5.8	5.4	6.4	11.6	0.9	11.8	4.9	12.5	16.2	6.7	22.6	8.1	10.7	14.9	11.3	1.6	5.8	14.3	17.3	1.3	4.3	4.1	17.2	12.2	19.6	7.6	13.4	18.6	5.1	12.3	12.1	4.5	42.5	2.9	3.4	2.8	14.1	24.3	21.9	20.2	8.3	7.4	5.7	13.8	15.3	0.5	9.8	29.8	17.4	21.5	11.8	23.2	13.5	9.0	3.2	20.6	15.2	17.6	6.4	6.4	16.2	0.0	0.1	0.3	0.2	0.1	0.2	0.4	0.3	0.5	0.0	0.1	0.3	0.2	0.3	0.3	0.1	0.2	0.3	0.2	3.7	4.4	13.8	6.7	4.1	4.0	4.2	4.7	5.4	3.6	4.8	5.8	53.4	32.1	36.7	226.9	47.7	27.1	19.7	22.4	42.7	68.1	57.4	39.5	13.2	20.0	18.2	47.8	102.2	15.0	95.5	35.0	1.9	37.1	162.9	58.2	80.2	40.9	31.8	22.1	334.6	25.4	20.4	33.3	33.1	85.9	24.1	111.4	30.4	25.3	21.1	69.0	326.7	29.2	28.5	41.7	25.3	136.6	34.8	38.1	21.4	327.9	52.3	23.6	60.8	313.6	346.4	40.8	27.2	30.1	60.1	33.7	28.9	12.7	18.9	78.5	26.3	42.0	43.7	29.4	50.9	48.9	30.1	14.6	70.6	71.6	27.2	32.7
KANSL2	"C12orf41, FLJ20436, NSL2"	ENSG00000139620	"KAT8 regulatory NSL complex subunit 2"	Q9H9L4	12	48653211-48682238	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038497, HPA038498"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038497: AB_10674685, HPA038498: AB_2676046"	"unprognostic (3.87e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (5.46e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-3)"	"unprognostic (4.19e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.32e-4)"	11.9	11.4	6.0	8.2	7.0	41.8	12.2	8.6	8.0	13.9	7.3	11.8	8.1	14.1	11.5	13.3	12.6	7.7	13.4	6.5	6.9	12.2	9.8	10.9	13.9	7.0	6.5	16.3	9.7	12.2	9.3	12.2	6.7	11.1	9.3	11.8	13.0	8.3	40.7	13.4	11.9	9.8	6.7	13.2	10.8	14.6	6.8	14.2	11.5	23.1	13.8	12.4	12.8	8.8	19.5	26.5	21.8	12.8	25.6	22.0	48.1	20.8	17.6	35.9	19.5	45.2	25.1	31.9	39.0	25.5	14.0	18.3	37.1	23.5	29.5	30.4	22.5	37.1	20.2	12.9	29.2	40.0	13.9	20.8	31.2	25.5	46.2	18.0	17.2	24.8	43.7	20.9	25.0	18.7	39.2	29.2	28.6	28.1	26.0	33.4	21.3	35.9	17.2	27.1	25.1	17.6	43.2	30.0	25.7	21.8	40.2	43.4	12.8	25.5	18.9	10.9	19.7	29.8	50.7	46.2	12.4	89.5	13.6	35.3	19.7	23.5	25.1	21.2	23.7	27.3	23.9	25.9	25.8	23.8	27.9	26.9	9.0	24.3	23.0	20.2	32.2	24.0	6.0	7.0	8.6	8.0	6.5	6.9	7.0	6.5	6.7	6.7	6.8	8.8	18.0	3.2	14.3	9.8	24.7	11.9	14.7	17.9	32.5	15.6	15.7	15.5	10.9	8.6	15.0	14.7	29.2	22.5	36.5	10.2	9.8	13.3	24.4	8.2	13.9	13.7	9.0	14.1	11.5	9.8	12.5	15.1	12.2	12.4	11.4	19.8	14.6	9.6	11.9	15.2	13.8	9.1	10.2	11.9	13.2	13.8	12.5	13.7	16.0	7.5	14.8	8.2	11.3	15.1	18.8	12.2	4.7	10.1	16.9	12.1	10.8	15.6	10.2	22.8	26.3	15.7	16.6	38.5	34.8	19.9	11.2	25.3	30.6	15.9	12.4	9.8
KANSL3	"FLJ10081, KIAA1310, NSL3, Rcd1"	ENSG00000114982	"KAT8 regulatory NSL complex subunit 3"	Q9P2N6	2	96593170-96642787	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035017, HPA035018"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"HPA035017: AB_2674414, HPA035018: AB_10601763"	"unprognostic (2.19e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-3)"	"unprognostic (4.99e-3)"	11.8	9.9	1.9	8.6	2.4	14.9	12.3	1.6	3.1	13.7	8.1	11.8	7.2	15.0	7.7	8.9	12.5	6.9	10.7	2.9	2.6	8.8	6.4	9.9	8.2	2.1	2.9	15.1	9.8	15.1	8.8	9.0	2.3	11.2	6.9	6.3	12.5	14.7	33.9	10.8	12.0	10.6	3.3	10.1	9.8	12.8	3.3	13.1	12.9	21.1	8.9	13.0	10.8	2.3	13.1	7.9	26.0	19.4	10.6	6.4	11.4	9.7	15.2	20.1	21.4	15.1	7.8	18.1	14.6	16.2	14.7	8.2	18.8	9.4	17.5	12.8	14.8	26.0	8.1	16.2	15.0	17.4	9.0	15.0	5.8	12.8	11.4	12.0	11.0	21.0	18.6	12.8	12.8	6.9	32.3	13.5	12.5	6.7	12.8	26.2	16.5	10.6	12.4	12.7	26.8	16.9	12.3	11.8	11.8	14.7	11.4	5.5	15.9	13.5	11.8	9.8	8.9	10.1	6.7	15.7	7.0	19.9	12.2	2.4	1.3	0.5	2.8	1.5	2.1	1.6	1.7	2.9	0.7	1.5	1.2	2.3	0.2	3.1	1.3	0.7	1.1	1.7	1.9	2.4	1.6	3.1	2.9	2.6	2.1	2.9	2.3	3.3	3.3	2.3	11.6	44.8	30.8	29.0	10.5	4.6	9.9	8.1	9.1	15.0	14.8	12.2	23.8	10.0	18.8	11.0	43.8	8.1	10.0	15.0	3.9	10.5	13.4	13.0	13.7	12.1	13.1	6.7	35.6	9.6	4.3	12.7	17.3	13.5	18.3	33.1	15.7	12.7	8.1	15.2	36.2	18.4	10.2	12.5	5.6	28.6	9.9	11.2	7.2	16.9	13.7	10.2	9.2	29.7	37.3	13.2	7.9	12.8	10.6	10.3	10.7	5.8	13.1	29.5	13.1	16.0	13.6	23.3	9.7	11.3	6.5	11.1	14.2	18.3	15.6	10.1
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040446-20154404	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 165.2;Oligodendrocyte precursor cells: 418.2;Oligodendrocytes: 175.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	17.9	9.9	38.7	15.4	46.5	48.0	10.3	39.1	40.3	14.9	33.8	13.8	17.7	12.3	8.1	27.4	11.7	12.6	35.9	34.4	42.2	16.6	39.3	16.2	22.4	41.7	44.9	27.7	18.7	51.0	10.2	13.7	43.0	14.5	12.5	33.9	37.6	13.0	60.2	14.3	21.5	13.6	37.1	19.8	13.9	2.7	42.2	23.6	14.4	56.1	20.1	11.9	15.1	45.1	2.7	6.9	3.8	6.2	15.1	14.2	8.8	8.8	13.0	9.1	13.3	2.1	4.5	24.0	3.6	16.7	11.5	2.0	9.4	2.8	7.6	21.8	9.0	21.0	10.7	0.7	7.1	3.2	26.2	6.1	5.0	7.9	5.1	16.0	8.8	5.8	13.7	32.9	13.0	3.3	7.0	6.4	1.6	6.7	6.8	9.1	7.1	5.1	12.4	14.2	1.9	4.1	4.9	7.9	30.5	5.9	8.2	14.2	8.5	15.3	6.1	5.8	10.1	12.3	27.6	5.7	13.9	13.8	33.0	0.6	0.4	1.3	1.5	0.7	1.5	0.4	1.3	1.1	0.4	0.8	0.4	0.8	2.4	0.5	0.5	1.2	2.2	0.3	38.7	46.5	39.1	40.3	34.4	42.2	41.7	44.9	43.0	37.1	42.2	45.1	15.5	32.1	20.8	165.2	11.9	8.5	11.3	2.2	3.4	14.6	5.5	5.0	64.1	4.3	10.4	5.5	4.2	7.3	19.5	16.6	11.7	3.8	3.8	6.4	5.7	14.6	11.5	52.2	22.4	4.4	1.1	11.7	3.6	13.1	10.8	12.3	20.7	33.6	7.7	15.2	32.1	7.3	4.1	22.8	23.3	1.8	6.5	16.0	17.8	52.5	11.1	14.8	14.4	418.2	175.4	3.3	2.4	5.3	19.9	7.1	24.7	6.2	12.7	11.9	6.6	25.2	9.0	0.8	1.4	10.0	12.9	9.9	23.5	2.9	3.8	8.0
KAT5	"cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5"	ENSG00000172977	"Lysine acetyltransferase 5"	Q92993	11	65711996-65719604	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016953, HPA074328"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Vesicles, Cytosol"	"HPA016953: AB_1851277, HPA074328: "	"unprognostic (2.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.10e-13)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-2)"	31.6	30.0	38.7	23.8	41.0	52.9	32.1	41.7	48.8	39.5	38.6	43.6	21.6	45.1	33.7	34.9	44.9	20.5	32.4	37.9	38.9	32.9	26.3	29.5	28.0	40.0	39.5	39.2	32.7	45.6	33.7	29.9	41.2	33.1	27.0	31.0	29.6	36.3	42.8	47.6	32.2	35.2	40.0	34.3	35.9	45.2	39.9	39.3	38.2	34.6	30.2	39.5	34.8	43.8	37.2	44.1	40.1	29.6	31.3	32.7	41.1	26.7	43.6	44.0	38.0	32.6	42.2	34.3	36.2	47.4	47.5	30.8	50.8	45.1	26.4	44.4	32.5	50.6	36.3	38.9	44.6	55.7	56.4	35.2	49.7	28.9	59.0	33.7	28.1	39.1	52.5	51.1	42.0	68.2	45.7	62.3	33.9	26.8	28.4	38.2	26.5	63.3	40.6	56.2	37.1	38.9	25.4	46.5	51.2	20.8	45.9	34.2	36.3	33.9	30.4	27.6	28.0	38.7	43.7	50.4	29.7	27.0	29.3	42.7	33.6	58.8	33.4	32.0	29.6	28.2	28.8	34.2	34.1	30.4	36.5	29.8	34.8	35.8	34.6	20.9	31.0	36.4	38.7	41.0	41.7	48.8	37.9	38.9	40.0	39.5	41.2	40.0	39.9	43.8	17.6	12.8	17.5	10.7	26.0	21.2	44.2	60.2	17.6	44.9	17.3	15.0	1.0	25.8	33.8	29.5	31.3	51.3	25.6	27.1	35.2	42.2	11.1	20.2	14.2	18.7	30.4	12.4	7.5	51.5	42.6	21.1	20.4	19.8	33.7	27.0	18.2	10.9	36.3	38.7	8.7	25.1	42.7	17.6	15.2	11.1	28.0	20.4	42.7	3.7	38.8	40.3	33.0	7.1	13.8	39.4	30.6	38.7	10.4	24.2	23.3	32.6	30.0	44.8	46.0	27.6	27.0	61.1	27.8	14.6	21.3	102.5	21.6	29.2	26.2	31.0
KAT6B	"Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B"	ENSG00000156650	"Lysine acetyltransferase 6B"	Q8WYB5	10	74824927-75032624	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006104	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"		"HPA006104: AB_1079445"	"unprognostic (4.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.78e-2)"	"prognostic favorable (4.82e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.15e-1)"	7.6	6.3	5.0	3.1	5.6	8.8	7.3	5.6	5.3	10.5	2.0	9.6	3.2	9.2	5.2	6.9	8.3	3.8	7.5	5.7	4.0	4.3	4.6	6.5	4.4	3.1	3.5	12.2	8.6	10.5	7.4	4.4	3.0	6.5	4.1	6.4	7.3	4.3	11.8	8.0	8.1	6.0	3.0	5.4	9.3	7.8	5.6	9.8	7.3	6.0	4.1	9.1	8.9	4.9	4.7	4.4	8.0	6.9	6.2	9.2	4.1	4.1	7.5	3.4	3.6	3.4	5.3	9.8	2.1	7.1	3.5	3.8	4.2	3.3	5.6	4.2	6.8	3.6	3.9	4.5	4.5	8.6	2.4	5.9	5.3	4.5	6.9	10.5	3.8	7.7	3.9	9.0	4.2	4.7	8.2	4.3	5.0	4.9	25.7	12.7	4.3	2.4	2.3	2.3	4.2	6.9	4.1	7.4	3.7	2.8	4.5	3.2	4.7	4.6	5.5	3.1	3.8	6.4	8.1	6.4	5.0	8.9	1.3	1.7	1.3	1.6	2.3	1.0	2.6	2.2	1.9	2.1	1.1	2.8	2.9	2.6	1.8	4.4	1.1	1.7	1.7	1.0	5.0	5.6	5.6	5.3	5.7	4.0	3.1	3.5	3.0	3.0	5.6	4.9	34.5	44.8	53.7	90.1	48.1	19.9	20.8	16.3	74.6	52.8	36.7	27.3	53.9	12.8	29.3	9.2	68.8	10.4	51.8	22.5	9.8	12.7	6.2	41.1	72.7	24.9	23.8	32.0	130.2	18.0	10.6	44.4	57.6	50.8	41.7	68.0	18.9	16.0	11.0	43.7	131.2	21.7	12.2	12.3	15.0	8.3	42.3	24.1	14.2	41.2	13.6	45.5	42.2	101.0	92.1	10.5	19.4	40.3	62.5	21.0	17.8	10.2	28.6	52.5	26.3	55.3	44.1	33.1	32.2	46.6	17.5	22.7	59.7	27.1	17.5	23.5
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788648-49835026	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	17.6	14.2	16.1	8.1	16.9	40.9	16.6	24.2	21.5	20.1	15.1	20.9	7.2	22.6	12.2	20.4	20.3	6.6	22.8	16.5	14.8	17.7	11.7	14.5	10.4	13.6	12.3	20.9	12.4	23.5	17.1	10.0	15.5	17.5	10.0	19.2	17.8	14.0	37.7	25.5	16.0	12.4	10.3	15.9	16.0	38.6	14.9	17.4	21.1	20.1	13.5	22.5	19.0	18.7	17.1	22.6	22.5	17.3	10.1	14.3	27.2	11.2	16.5	24.7	18.7	35.9	11.5	17.8	21.8	13.7	24.7	16.7	23.0	12.8	32.5	18.6	20.3	20.7	14.8	17.8	15.0	21.6	17.2	13.3	16.6	21.1	25.3	14.4	22.7	16.0	23.6	18.9	27.4	28.8	26.4	23.2	79.0	38.4	20.2	20.6	34.7	18.2	12.8	17.6	25.7	15.7	7.6	9.2	14.9	40.5	38.6	22.9	8.8	24.5	13.3	16.0	19.4	21.4	32.7	23.3	17.3	13.6	23.3	17.1	6.8	9.5	8.3	5.4	10.6	5.8	7.8	8.5	7.0	6.1	9.3	8.5	10.1	11.7	7.1	4.3	8.5	7.9	16.1	16.9	24.2	21.5	16.5	14.8	13.6	12.3	15.5	10.3	14.9	18.7	16.0	25.6	21.3	9.4	23.6	16.8	11.7	10.1	25.0	32.6	18.5	16.6	28.5	20.0	15.6	27.6	31.3	22.7	27.6	11.7	9.8	11.9	23.1	22.4	21.0	18.7	25.1	25.4	14.8	7.5	14.5	15.3	15.3	29.9	24.1	18.2	15.4	10.4	13.3	45.4	16.7	13.4	12.2	22.6	13.2	16.5	16.8	15.9	14.2	10.3	19.1	16.5	25.7	13.0	18.3	10.0	8.9	18.4	18.6	15.4	12.8	10.2	18.6	25.1	39.5	21.2	24.2	73.7	31.6	17.9	20.0	33.8	28.4	15.2	12.1	10.2
KAT8	"FLJ14040, hMOF, MOF, MYST1, ZC2HC8"	ENSG00000103510	"Lysine acetyltransferase 8"	Q9H7Z6	16	31114489-31131393	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.9;Late spermatids: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 29.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066324			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA066324: AB_2685658"	"unprognostic (8.58e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.77e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.41e-1)"	28.8	30.9	40.4	17.8	41.6	32.9	31.3	50.6	50.4	40.8	38.2	36.9	16.6	39.2	46.5	21.1	41.7	14.7	42.0	41.5	41.6	28.4	29.0	31.3	24.6	42.0	41.3	60.7	31.8	37.4	31.0	20.4	41.3	32.0	17.3	27.5	34.7	23.7	49.8	33.8	30.2	25.5	40.0	39.7	28.2	32.8	41.6	39.6	35.5	49.8	23.3	30.9	31.0	43.1	18.1	27.4	33.5	10.7	38.5	28.9	34.3	16.0	29.6	24.7	26.8	13.6	38.1	42.3	24.5	19.6	22.8	22.5	53.6	26.4	24.1	35.8	35.0	18.7	21.5	43.3	34.5	30.5	31.9	27.9	51.4	18.5	52.4	33.2	23.6	44.1	49.5	33.7	13.1	51.4	47.4	57.2	38.0	43.1	15.9	75.1	28.1	49.5	20.1	10.7	35.2	35.9	9.4	25.9	14.1	20.7	28.6	49.6	14.7	11.0	22.2	12.1	11.6	32.4	34.8	24.2	16.0	40.7	16.3	8.0	7.4	29.9	3.0	4.1	3.7	3.6	3.6	4.1	6.6	2.9	4.6	3.3	28.4	3.2	8.3	2.7	2.4	3.4	40.4	41.6	50.6	50.4	41.5	41.6	42.0	41.3	41.3	40.0	41.6	43.1	26.2	19.2	18.2	16.0	30.4	20.8	41.9	18.1	34.7	19.0	21.5	26.2	16.8	21.5	21.0	9.2	14.6	30.5	20.9	17.8	21.5	21.9	113.9	17.5	18.2	21.8	24.6	29.5	16.4	26.6	21.7	29.4	17.9	18.0	27.3	33.9	23.2	12.4	29.1	32.0	18.6	21.2	18.3	30.1	25.4	147.5	53.7	28.1	24.9	12.2	32.6	41.0	15.5	11.1	13.2	15.0	25.8	54.2	16.5	35.2	25.1	17.5	11.8	26.9	26.3	32.8	30.6	27.5	26.2	20.6	15.6	45.4	24.6	24.5	22.9	23.2
KATNA1		ENSG00000186625	"Katanin catalytic subunit A1"	O75449	6	149594873-149648972	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 416.6;Late spermatids: 194.2;Spermatocytes: 109.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036207	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centriolar satellite"	Nucleoplasm	"HPA036207: AB_10672238"	"unprognostic (1.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (9.78e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.85e-2)"	12.9	8.2	7.2	10.3	8.4	19.2	12.6	9.6	9.1	13.3	12.3	13.1	8.5	13.3	9.8	12.5	11.8	9.7	11.6	7.0	7.9	13.2	9.0	11.2	14.1	8.2	7.9	19.5	9.5	7.3	7.4	12.7	8.4	9.9	9.9	16.8	9.7	10.9	23.0	12.3	10.0	12.4	7.9	11.8	10.1	45.1	7.8	17.0	11.2	14.3	15.8	12.0	12.7	9.6	22.5	8.3	18.6	42.1	22.9	32.7	28.9	28.7	24.3	29.4	37.2	17.9	11.4	33.7	16.9	28.4	20.4	17.1	34.5	18.5	37.8	30.4	33.8	42.7	17.6	27.9	31.0	60.0	16.4	22.8	22.5	33.3	27.3	27.3	27.8	44.4	46.1	20.7	26.2	32.0	41.2	40.4	19.1	26.2	15.1	30.5	33.3	15.2	21.6	11.6	13.7	20.7	48.9	15.0	22.2	24.3	14.4	61.6	23.7	14.6	23.4	39.2	33.9	20.4	20.3	43.9	19.8	42.7	26.4	39.8	20.4	29.1	25.9	28.5	22.2	27.7	25.2	25.8	26.1	18.3	21.4	20.9	8.7	18.2	25.6	22.3	34.0	20.5	7.2	8.4	9.6	9.1	7.0	7.9	8.2	7.9	8.4	7.9	7.8	9.6	27.6	16.0	11.3	11.8	20.2	29.3	35.7	23.0	12.5	9.1	17.3	26.9	15.5	10.0	15.0	14.7	29.2	23.6	31.4	12.1	17.6	19.5	416.6	23.2	21.6	19.3	6.0	27.4	8.6	12.4	19.4	25.9	11.7	19.3	20.3	23.9	10.0	7.7	17.4	13.5	9.4	9.7	24.4	12.5	19.4	194.2	21.1	17.3	10.6	7.5	22.1	12.2	27.8	13.6	16.3	15.9	12.5	16.6	9.0	19.4	9.7	20.9	23.8	36.1	6.6	40.0	28.5	109.3	58.8	17.7	28.7	25.6	25.6	17.7	12.1	15.4
KATNAL1	MGC2599	ENSG00000102781	"Katanin catalytic subunit A1 like 1"	Q9BW62	13	30202630-30307551	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 144.3;Excitatory neurons: 80.6;Oligodendrocytes: 78.5;Spermatocytes: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 63.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046205			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA046205: AB_10965325"	"unprognostic (3.34e-1)"	"unprognostic (6.44e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.83e-3)"	8.7	3.8	7.0	5.0	8.8	6.5	4.7	7.5	8.9	9.7	0.0	8.7	1.4	9.3	2.7	5.8	4.8	3.8	17.9	8.0	8.1	4.0	3.9	4.9	6.5	7.2	6.4	4.2	1.9	2.2	2.9	3.0	7.0	4.5	4.1	7.9	2.2	5.9	5.1	2.6	2.8	15.0	7.5	3.3	2.8	20.8	8.4	9.2	3.0	6.6	7.1	5.0	5.2	11.8	11.7	9.6	16.5	8.8	12.3	26.0	0.4	47.5	15.2	24.9	19.4	1.9	11.6	18.8	5.5	63.7	31.3	3.2	11.8	12.2	37.5	16.3	4.4	13.4	11.2	4.4	6.5	6.7	8.7	10.1	6.0	28.0	6.8	23.3	26.4	10.2	7.3	8.1	30.8	2.4	15.2	6.1	7.1	0.2	6.1	16.8	19.4	1.9	8.8	0.8	6.8	14.3	12.6	2.6	9.0	13.6	4.1	4.1	24.2	21.8	32.7	12.1	19.3	4.2	8.2	25.8	8.7	6.5	32.1	1.5	0.7	2.9	4.4	0.4	2.1	1.9	3.4	4.4	1.9	4.5	0.8	1.8	0.2	7.7	0.9	5.5	5.8	1.2	7.0	8.8	7.5	8.9	8.0	8.1	7.2	6.4	7.0	7.5	8.4	11.8	12.9	9.6	1.8	30.3	7.2	5.9	3.9	4.7	6.2	10.2	4.0	5.6	41.4	2.8	2.3	5.5	27.1	0.4	6.6	0.3	3.9	6.5	144.3	10.3	26.5	9.3	10.2	16.4	80.6	1.5	0.8	12.3	1.5	3.6	10.1	10.3	7.9	10.6	2.9	21.9	34.5	1.0	0.0	2.8	8.9	50.7	9.0	5.9	17.8	21.5	21.9	9.6	13.4	29.1	78.5	5.7	0.0	5.3	6.4	1.9	0.3	8.4	14.7	18.7	6.6	11.9	13.7	59.0	24.6	5.2	5.7	0.3	9.8	19.2	0.7	1.7
KATNAL2	"DKFZP667C165, MGC33211"	ENSG00000167216	"Katanin catalytic subunit A1 like 2"	Q8IYT4	18	46917492-47102243	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.2;Early spermatids: 91.8;Inhibitory neurons: 41.8;Late spermatids: 71.4;Oligodendrocytes: 38.7;Spermatocytes: 58.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.5;Daudi: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040712, HPA042029"	Approved		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Intermediate filaments"		"HPA040712: AB_2677092, HPA042029: AB_2677807"	"unprognostic (3.40e-1)"	"unprognostic (7.75e-2)"	"unprognostic (9.00e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.52e-6)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.24e-7)"	"unprognostic (1.64e-1)"	"unprognostic (7.14e-4)"	"unprognostic (1.06e-3)"	"unprognostic (1.61e-1)"	5.3	3.4	9.6	1.8	11.1	2.7	4.0	14.4	14.7	3.4	23.1	2.6	1.4	2.3	5.5	2.6	7.1	4.4	4.4	9.1	9.2	10.4	6.9	3.3	3.2	10.6	11.5	3.3	2.9	18.0	8.0	1.7	11.2	4.3	2.5	10.8	4.4	2.7	6.1	7.4	2.2	1.8	8.6	3.7	2.2	15.5	10.3	1.9	17.5	2.9	2.1	2.3	3.1	12.9	2.7	5.7	3.5	21.5	7.1	7.9	1.6	2.4	2.1	1.9	2.5	0.2	7.5	28.2	2.2	4.2	2.6	0.9	6.9	0.7	1.6	2.6	3.7	1.3	2.0	0.4	2.8	1.7	2.4	16.5	2.6	3.5	0.9	4.9	0.7	12.8	1.0	2.3	11.5	2.7	1.9	3.7	7.6	4.0	3.9	7.8	1.5	0.1	6.4	0.4	7.6	8.8	2.7	0.5	1.0	11.9	15.5	16.7	1.5	7.1	0.7	2.7	1.7	1.8	1.5	19.7	3.7	18.0	13.4	0.1	0.1	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.0	0.6	0.3	0.3	0.2	0.1	0.2	0.1	0.0	0.0	9.6	11.1	14.4	14.7	9.1	9.2	10.6	11.5	11.2	8.6	10.3	12.9	3.7	0.0	1.1	84.2	1.0	1.5	3.0	2.9	8.0	9.9	1.6	1.3	2.9	1.5	5.2	3.7	6.2	0.0	0.2	2.5	13.7	0.9	91.8	22.6	6.2	2.5	0.0	1.7	28.2	0.2	0.0	3.1	3.6	1.6	0.0	3.9	2.2	4.2	3.6	11.8	41.8	0.7	2.0	1.9	0.9	71.4	1.5	1.5	3.6	18.7	0.9	2.6	0.0	26.7	38.7	0.2	0.3	2.2	0.4	1.0	0.2	12.1	35.2	2.3	0.0	7.5	1.9	58.7	4.6	2.8	1.1	0.1	0.6	2.6	2.3	1.9
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 128.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 128.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: AB_2684796"	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	22.0	12.1	16.3	22.9	16.6	16.3	20.8	25.0	20.8	22.5	22.4	19.9	15.9	20.7	19.0	39.9	16.8	15.9	13.4	15.8	14.9	17.0	17.6	18.4	17.6	15.0	13.8	14.4	14.0	14.5	12.1	32.4	16.0	16.9	21.2	31.2	14.6	13.6	13.2	31.4	15.7	25.4	12.9	18.6	17.7	18.0	18.2	15.2	12.5	13.0	20.3	17.8	27.7	25.3	37.1	31.5	49.7	33.4	39.5	39.0	37.0	49.6	30.0	38.7	38.4	17.8	19.9	17.6	31.2	32.2	54.5	47.5	24.9	28.5	45.8	36.9	12.6	31.8	34.6	21.6	27.0	33.9	33.1	23.6	40.8	26.1	51.3	39.7	70.6	45.4	34.3	36.7	53.1	17.6	21.4	27.4	35.8	47.4	25.0	32.3	30.3	16.1	35.9	49.5	28.1	24.8	30.1	21.9	14.7	49.2	27.0	38.8	40.4	51.9	26.7	46.8	39.7	21.5	32.5	37.1	46.5	35.7	38.9	62.8	18.2	29.7	18.4	17.3	23.3	23.9	19.6	18.8	20.7	25.6	21.5	19.2	128.5	13.2	11.5	28.4	17.9	12.0	16.3	16.6	25.0	20.8	15.8	14.9	15.0	13.8	16.0	12.9	18.2	25.3	59.7	38.5	25.2	83.9	41.7	41.3	65.2	60.5	34.7	57.0	42.1	43.1	12.8	24.3	51.6	25.8	52.1	58.6	42.3	30.6	33.2	59.1	75.4	40.5	53.3	47.0	23.9	39.8	104.3	54.5	86.2	38.8	39.3	50.8	44.9	68.7	37.9	20.8	39.1	67.3	96.7	35.6	52.9	27.6	48.8	59.2	31.7	36.2	32.0	64.6	49.9	53.1	27.8	86.0	114.4	105.3	37.4	33.1	41.1	116.8	21.4	41.6	49.6	44.7	59.2	52.2	45.3	47.8	44.3	45.0	54.3	179.5	39.7	31.6	39.1	132.6
KAZN	"C1orf196, FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 91.5"	"Group enriched"	"Detected in many"	12	"Excitatory neurons: 1065.9;Inhibitory neurons: 2872.7;Oligodendrocyte precursor cells: 1360.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 85.6;SK-BR-3: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA032095: AB_2674146, HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favorable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	12.6	17.7	27.3	3.0	31.5	0.6	11.4	43.6	33.6	17.0	23.9	5.5	5.1	4.2	12.2	34.9	12.6	7.7	6.9	25.0	24.1	24.9	5.8	16.5	1.0	37.1	32.9	16.7	9.2	29.5	5.1	6.3	32.7	7.5	3.9	12.9	21.4	7.4	1.4	23.5	5.3	3.6	29.2	91.5	5.1	4.5	34.1	1.9	10.3	1.6	5.5	8.9	21.3	47.1	17.7	3.0	18.5	85.6	7.9	8.2	6.3	8.3	6.9	15.0	10.8	4.0	9.3	0.0	21.1	17.8	2.7	6.3	4.3	13.5	7.5	0.5	8.4	10.1	10.2	26.6	5.8	0.0	5.0	11.6	17.7	3.5	2.3	6.8	0.1	2.5	4.2	19.8	12.2	12.8	0.1	1.1	5.1	7.9	2.6	6.0	0.4	10.6	25.5	5.4	9.8	7.1	1.5	46.3	33.0	10.5	2.8	6.7	0.0	12.4	11.6	19.8	10.1	3.3	3.0	0.0	11.6	17.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	27.3	31.5	43.6	33.6	25.0	24.1	37.1	32.9	32.7	29.2	34.1	47.1	17.6	3.2	1.8	124.1	0.9	50.3	16.6	9.7	31.3	12.4	23.0	27.9	3.4	4.3	9.1	49.7	8.4	1.5	0.9	12.3	17.6	2.0	6.8	51.4	15.8	19.4	7.1	0.0	1065.9	1.6	8.1	27.0	3.6	16.8	3.8	9.7	31.1	0.1	0.8	0.0	2872.7	5.2	18.3	0.9	11.4	9.1	19.0	1.1	46.2	93.7	0.0	74.2	4.1	1360.7	143.5	1.5	1.6	17.3	0.3	19.4	2.0	12.9	30.3	3.2	6.6	33.5	23.6	0.3	3.2	26.2	90.4	46.4	1.4	41.6	3.5	24.8
KBTBD2	"BKLHD1, DKFZP566C134"	ENSG00000170852	"Kelch repeat and BTB domain containing 2"	Q8IY47	7	32868172-32894131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021133	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA021133: AB_1852093"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (3.96e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.96e-1)"	26.4	16.4	23.0	21.7	25.2	54.6	20.9	27.3	24.9	17.2	21.4	16.9	15.9	20.8	10.7	16.1	15.6	25.2	20.3	21.0	24.8	15.3	21.5	22.5	25.6	27.2	25.8	16.4	11.8	17.1	15.0	25.8	27.2	16.3	19.6	25.9	14.4	15.0	57.6	16.3	17.6	23.6	26.3	27.0	14.8	18.1	26.5	30.5	18.6	40.3	24.0	22.0	17.3	28.8	38.3	18.8	47.5	23.5	28.1	28.0	17.1	33.4	33.9	31.2	37.6	18.7	28.6	31.9	22.6	34.7	52.3	27.5	24.5	26.2	39.2	12.6	17.6	27.1	30.6	24.4	28.9	29.3	34.2	30.1	26.9	34.0	32.9	28.9	34.9	28.6	50.3	46.2	46.4	31.4	24.3	47.9	38.6	26.5	17.7	23.4	41.6	26.7	27.6	22.3	24.9	46.4	21.5	29.1	38.6	39.6	20.7	49.5	30.5	29.6	38.7	28.3	46.5	37.5	39.3	57.6	28.8	34.9	77.0	14.5	6.4	21.4	10.9	12.2	9.2	7.1	5.4	9.7	5.6	9.8	4.2	6.9	39.2	10.7	14.6	2.9	7.6	4.1	23.0	25.2	27.3	24.9	21.0	24.8	27.2	25.8	27.2	26.3	26.5	28.8	67.2	28.9	23.9	24.5	27.0	40.4	15.7	13.4	44.3	14.6	20.4	15.6	18.4	20.0	22.1	1.8	10.4	6.9	41.4	18.1	0.0	11.8	7.7	21.6	23.1	48.7	14.9	25.2	21.0	12.2	8.7	22.2	17.9	33.8	43.7	20.4	36.8	14.6	13.3	8.4	20.5	14.0	4.1	24.6	23.1	6.2	13.1	32.5	24.9	34.7	13.0	8.7	15.5	29.7	36.8	16.8	10.3	6.0	25.2	17.1	10.5	5.1	7.3	8.9	19.7	26.4	21.1	19.1	8.8	25.9	36.1	7.5	28.4	10.8	11.4	18.5
KBTBD4	"BKLHD4, FLJ10450, HSPC252"	ENSG00000123444	"Kelch repeat and BTB domain containing 4"	Q9NVX7	11	47572197-47578976	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037792, HPA037793"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA037792: AB_10671633, HPA037793: AB_2675671"	"unprognostic (5.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (2.70e-7)"	"unprognostic (4.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.25e-2)"	10.2	13.9	5.8	4.6	6.2	8.7	10.0	7.2	6.2	10.0	6.4	12.8	4.2	13.2	8.8	9.2	10.6	4.6	10.6	5.9	5.8	9.9	8.3	8.3	6.4	5.5	5.7	10.9	8.4	12.4	13.0	4.3	5.6	8.5	6.2	7.4	10.3	6.7	24.3	13.1	10.5	6.7	5.7	10.9	10.4	14.5	5.7	7.9	9.3	11.0	8.4	11.3	8.3	6.0	5.0	11.8	13.0	10.2	7.8	10.6	3.7	9.0	11.8	12.8	11.2	4.0	9.8	9.6	4.8	11.6	9.2	8.5	7.5	13.3	10.9	12.6	10.7	7.2	15.9	5.7	5.8	15.3	14.5	9.6	9.1	5.4	6.9	8.8	13.4	6.7	5.4	7.6	10.2	13.1	11.2	4.6	6.4	14.0	7.6	10.2	17.0	5.4	13.8	11.9	17.2	11.0	7.7	10.4	6.5	4.3	17.4	4.8	10.7	7.9	8.4	12.1	9.0	10.3	20.3	14.2	11.5	4.2	8.8	11.6	4.6	11.7	12.5	3.8	13.8	11.6	9.8	11.4	5.9	10.9	10.6	11.4	8.3	13.5	4.1	2.5	12.8	10.4	5.8	6.2	7.2	6.2	5.9	5.8	5.5	5.7	5.6	5.7	5.7	6.0	6.2	6.4	3.6	3.3	9.6	4.8	6.2	16.4	7.4	14.0	6.9	4.4	0.1	8.6	11.3	11.0	8.4	12.3	9.7	6.9	23.5	13.9	14.5	10.2	5.2	9.0	7.2	9.5	5.7	13.7	7.3	5.8	1.5	4.6	10.8	6.8	7.5	8.8	8.1	13.5	6.6	4.0	20.3	4.1	2.9	18.3	5.0	4.3	1.8	3.7	11.4	24.9	10.3	2.5	4.6	9.0	2.9	9.4	5.8	4.1	6.3	10.9	18.8	12.1	13.1	6.9	6.0	23.7	20.1	4.0	4.5	14.1	10.2	7.6	5.4	4.6
KCMF1	"DEBT91, DKFZP434L1021, PCMF, ZZZ1"	ENSG00000176407	"Potassium channel modulatory factor 1"	Q9P0J7	2	84971093-85059472	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030383, HPA030384"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA030383: AB_10599977, HPA030384: AB_10601230"	"unprognostic (8.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (5.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.01e-1)"	39.7	24.0	23.4	34.0	22.2	60.8	33.8	21.3	30.2	28.1	20.4	46.7	34.8	29.2	39.7	58.3	27.6	29.5	44.1	25.6	24.1	33.1	45.0	31.9	36.1	25.2	26.5	24.7	80.0	39.2	20.8	33.0	24.8	27.9	46.4	32.4	36.8	31.8	140.0	35.2	36.2	40.5	24.8	28.3	33.5	69.0	27.3	37.0	40.4	71.7	52.3	37.7	36.1	22.1	102.3	76.4	66.7	51.8	69.0	66.2	114.5	106.0	96.0	97.4	64.6	93.8	104.5	110.9	107.2	141.6	97.0	65.1	52.7	100.6	127.8	87.6	37.9	69.8	55.9	97.3	134.7	77.9	63.9	69.0	155.7	95.7	262.5	86.4	74.7	57.2	71.3	83.1	98.4	91.5	76.9	42.6	74.9	125.5	64.1	55.4	94.7	68.5	88.3	85.8	64.8	48.9	61.0	76.0	101.8	76.4	35.3	48.1	66.2	98.9	99.2	93.5	111.8	99.1	130.9	110.4	74.5	55.7	75.8	3.1	1.6	5.4	2.7	1.4	2.1	2.3	1.9	2.0	1.4	3.1	1.6	1.8	4.5	1.9	2.2	2.6	6.0	1.0	23.4	22.2	21.3	30.2	25.6	24.1	25.2	26.5	24.8	24.8	27.3	22.1	45.5	32.1	26.6	25.5	29.6	70.9	92.9	32.7	24.5	31.8	42.8	34.3	51.4	21.5	33.2	12.9	14.6	23.6	42.0	56.2	25.4	34.8	85.2	55.3	33.8	33.1	19.2	29.0	47.9	53.4	32.0	31.9	18.8	80.5	17.7	30.9	24.3	32.9	20.1	72.3	47.4	29.0	20.3	33.3	61.1	127.7	25.7	34.7	26.6	51.5	36.8	37.5	21.6	45.8	36.6	61.2	40.8	29.0	27.6	107.6	44.8	30.7	22.5	27.5	26.3	48.2	47.2	44.9	24.6	34.4	79.0	40.8	32.1	27.1	33.7	135.5
KCNA10	Kv1.8	ENSG00000143105	"Potassium voltage-gated channel subfamily A member 10"	Q16322	1	110517217-110519175	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015061, CAB022564"			Uncertain	Nucleoplasm,Cytosol		No	NA							"Nucleoplasm, Cytosol"		"CAB022564: , HPA015061: AB_1855573"														"unprognostic (2.96e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.8;Excitatory neurons: 108.6;Inhibitory neurons: 605.4;Oligodendrocyte precursor cells: 206.6;Oligodendrocytes: 97.5;Sertoli cells: 78.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 3.4;hTEC/SVTERT24-B: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	15.8	6.3	12.7	1.2	52.7	1.6	7.3	15.5	17.3	8.4	4.2	4.1	1.7	5.4	12.8	2.2	4.3	2.9	5.5	25.9	11.6	1.8	2.6	3.3	0.9	7.2	12.1	2.9	4.0	2.0	1.8	1.3	7.2	22.4	1.8	12.8	3.9	19.2	2.0	2.2	2.7	2.7	8.4	5.2	1.6	3.1	14.1	1.8	28.7	5.1	0.3	2.9	5.0	15.4	0.5	0.5	0.7	0.2	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.9	0.1	0.4	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.4	1.0	3.4	0.6	1.6	0.0	1.0	0.2	0.0	0.0	5.2	0.0	1.1	2.1	0.5	0.1	0.3	0.2	0.1	0.3	0.6	1.1	1.5	0.2	0.6	0.7	2.8	0.0	0.2	0.8	0.8	0.3	0.6	0.7	0.5	0.8	0.5	2.2	0.8	0.5	1.4	1.2	1.8	0.4	0.4	2.6	1.1	1.0	0.8	0.1	0.0	0.4	0.2	0.8	0.2	0.4	0.3	0.2	0.2	0.3	0.3	0.0	0.3	0.3	1.2	0.5	0.1	12.7	52.7	15.5	17.3	25.9	11.6	7.2	12.1	7.2	8.4	14.1	15.4	7.2	0.0	0.0	7.5	0.7	0.8	0.3	0.0	0.0	85.8	1.4	1.4	4.3	0.0	0.7	0.0	31.3	0.1	0.5	0.1	0.0	0.4	13.7	0.6	2.4	2.8	0.0	0.0	108.6	0.0	0.0	3.8	0.0	2.1	0.0	0.4	0.7	0.0	4.6	0.0	605.4	0.0	0.0	11.1	1.0	7.0	0.0	1.2	1.8	24.4	0.0	2.7	0.0	206.6	97.5	0.0	0.0	2.6	2.3	0.2	0.0	0.1	0.0	6.7	78.9	1.3	73.3	0.3	4.2	1.2	0.9	0.1	0.5	0.2	0.0	0.2
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 47.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 79.6;Excitatory neurons: 48.2;Inhibitory neurons: 120.2"	"Group enriched"	"Detected in some"	5	"glioma: 1.1;testis cancer: 0.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;RH-30: 3.7;SCLC-21H: 3.5;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 6: Brain - Smell perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.1	0.8	1.1	0.1	3.3	0.9	0.2	41.0	47.3	0.9	0.0	0.3	0.3	0.3	0.0	0.2	0.1	0.2	0.1	4.5	8.0	0.1	0.2	0.1	0.2	8.8	3.0	0.2	0.4	0.0	2.2	0.0	9.3	0.2	0.0	7.0	0.3	0.0	0.5	0.5	0.3	0.0	1.0	0.2	0.3	1.4	12.3	0.1	0.3	1.2	0.0	0.3	0.5	18.8	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.1	0.2	1.1	0.3	1.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.4	3.7	0.4	0.0	0.2	3.5	2.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	1.0	0.1	0.0	0.2	0.3	0.4	0.2	0.2	0.4	3.2	0.3	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.0	0.5	0.2	0.2	1.4	0.2	0.3	0.3	0.1	0.1	1.1	3.3	41.0	47.3	4.5	8.0	8.8	3.0	9.3	1.0	12.3	18.8	0.2	0.0	0.0	5.5	1.1	0.0	0.2	0.0	0.0	79.6	0.3	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	9.5	0.2	0.5	0.4	7.7	0.0	48.2	0.2	0.0	0.3	0.0	0.3	0.0	2.8	0.0	0.0	0.0	1.7	120.2	0.0	0.0	0.0	0.0	10.2	0.3	0.2	0.0	7.5	0.6	1.5	0.0	16.1	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.7	0.0	0.2	0.5	6.1	5.0	0.0	0.0	0.0	0.6	1.8	0.0	0.0
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971844	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 3.5;Peritubular cells: 3.8;Rod photoreceptor cells: 3.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 10.6;NB-4: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Supported		Uncertain	Nucleoplasm		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA000524: AB_2666013, HPA001066: AB_1079662"	"unprognostic (6.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.19e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.41e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.30e-11)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.22e-3)"	3.8	0.9	2.8	1.5	2.8	2.7	1.8	5.5	2.7	2.7	0.1	2.0	0.8	3.6	1.4	1.1	5.4	2.4	2.3	2.9	3.0	1.7	1.4	2.6	1.3	3.6	2.9	2.7	1.1	0.4	2.3	1.0	3.9	2.3	0.8	6.1	0.9	2.1	0.5	1.3	2.2	2.5	3.3	3.3	1.8	1.5	3.2	0.7	1.8	0.4	1.4	2.3	2.3	3.8	0.3	1.6	0.7	3.9	5.1	4.1	1.3	0.8	3.3	2.3	1.5	1.1	0.5	1.3	2.8	2.6	0.6	0.5	0.6	0.3	2.2	2.3	2.7	1.2	1.8	0.1	1.9	0.3	2.5	10.6	1.4	4.2	0.4	3.7	0.8	1.9	0.9	3.0	1.7	3.1	0.4	9.2	2.1	0.2	0.6	1.1	0.7	1.3	2.6	1.3	0.4	1.8	0.7	0.0	1.8	7.9	1.7	1.3	2.0	0.5	2.1	0.5	0.2	2.5	3.5	3.2	1.4	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.8	2.8	5.5	2.7	2.9	3.0	3.6	2.9	3.9	3.3	3.2	3.8	0.9	0.0	1.1	1.0	0.4	0.8	0.0	0.4	0.0	0.2	0.3	0.3	0.8	0.0	0.2	1.8	0.0	0.1	0.4	0.3	1.9	0.2	0.1	0.2	1.0	0.6	3.5	0.0	0.7	0.0	0.1	1.2	0.5	0.5	0.0	1.7	1.1	0.0	0.1	0.0	1.1	0.3	0.0	0.6	0.0	0.2	1.8	0.4	0.0	1.0	0.1	0.4	0.0	2.0	0.1	0.1	0.0	3.8	0.1	0.2	0.2	0.1	0.3	3.0	0.0	0.1	0.6	0.6	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911934-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 28.9;choroid plexus: 32.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9.3;Extravillous trophoblasts: 14.4;Inhibitory neurons: 8.8;Oligodendrocyte precursor cells: 18.1;Syncytiotrophoblasts: 7.7"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 14.3;MCF7: 5.1;T-47d: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014738, HPA062278"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA014738: AB_1852114, HPA062278: AB_2732679"	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.1	0.0	20.6	0.1	28.9	0.0	0.2	0.0	21.5	0.0	32.1	1.2	0.2	0.6	0.0	0.2	0.1	0.1	0.7	28.8	14.7	0.4	0.0	0.3	0.1	0.0	5.3	0.0	0.9	0.3	0.8	0.0	0.0	0.7	0.2	0.2	0.1	0.3	0.0	0.0	0.6	0.0	0.6	0.5	0.3	0.5	12.5	0.3	0.0	0.0	0.0	0.6	0.0	15.8	0.1	14.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	2.1	0.1	1.5	0.0	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.1	6.1	0.7	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	28.9	0.0	21.5	28.8	14.7	0.0	5.3	0.0	0.6	12.5	15.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	2.0	0.8	1.4	1.4	0.0	0.0	0.0	2.1	0.0	0.1	1.6	0.0	0.0	2.2	0.8	0.3	0.9	1.2	0.0	9.3	0.0	14.4	0.7	0.0	2.0	0.0	0.2	0.0	0.0	0.2	0.0	8.8	0.2	0.0	0.0	0.0	3.4	0.3	0.1	0.0	1.9	0.0	0.3	0.0	18.1	1.4	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	7.7	0.0	0.4	0.3	0.1
KCNG4	Kv6.4	ENSG00000168418	"Potassium voltage-gated channel modifier subfamily G member 4"	Q8TDN1	16	84218667-84239750	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 3.4;retina: 4.3"	"Cell type enriched"	"Detected in some"	14	"Bipolar cells: 56.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"cerebellum: 90.5;pons and medulla: 27.0"	"Low region specificity"	"Detected in many"			HPA063516			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"HPA063516: "					"unprognostic (3.54e-1)"									"unprognostic (6.67e-2)"				0.1	0.4	0.6	0.0	1.0	0.3	0.0	3.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	3.4	1.5	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.3	0.0	0.0	0.1	0.3	0.0	0.0	1.3	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.1	0.0	0.0	0.6	1.0	3.3	0.4	0.5	0.7	3.4	1.5	2.4	1.3	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	56.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
KCNH3	"BEC1, elk2, Kv12.2"	ENSG00000135519	"Potassium voltage-gated channel subfamily H member 3"	Q9ULD8	12	49539030-49558337	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 39.4;pituitary gland: 25.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 11.4;Excitatory neurons: 58.2;Inhibitory neurons: 19.2;Late spermatids: 10.6;Respiratory ciliated cells: 10.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.8"	"Group enriched"	"Detected in many"	21	"amygdala: 29.6;basal ganglia: 25.6;cerebral cortex: 39.4;hippocampal formation: 30.6;white matter: 24.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.8;AN3-CA: 3.5;HMC-1: 3.4;RPTEC TERT1: 9.1;U-2 OS: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051088			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Mitochondria"		"HPA051088: AB_2681340"	"unprognostic (5.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-4)"	"unprognostic (8.24e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.91e-3)"	"unprognostic (5.28e-2)"	"unprognostic (6.39e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.07e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	0.3	2.9	29.6	0.0	25.6	0.2	0.6	0.0	39.4	0.8	0.0	0.2	0.1	0.6	0.1	0.1	5.8	0.3	0.8	30.6	1.3	3.4	0.3	1.0	0.5	0.0	0.2	0.3	1.3	2.6	25.7	0.0	0.6	0.7	0.0	0.0	0.3	0.3	0.1	0.3	0.3	0.0	0.0	1.4	0.3	2.8	1.4	0.2	1.3	0.0	0.2	0.1	0.3	24.8	0.4	5.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.2	1.7	0.6	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	9.1	0.0	0.9	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	29.6	25.6	0.0	39.4	30.6	1.3	0.0	0.2	0.6	0.0	1.4	24.8	0.1	0.0	0.5	4.9	0.0	0.1	0.2	0.5	0.0	0.1	0.1	2.0	1.0	5.7	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.2	6.0	11.4	0.4	0.1	2.4	0.0	58.2	0.0	0.1	0.6	0.0	0.5	0.0	2.4	0.7	0.0	0.0	1.7	19.2	0.0	0.0	0.6	0.5	10.6	0.3	0.6	0.0	1.0	0.7	0.4	2.1	6.0	2.6	0.1	0.1	1.2	0.1	0.0	0.0	0.2	10.9	0.3	0.0	0.4	0.3	1.1	3.4	0.0	0.3	0.0	0.7	0.0	0.2	0.0
KCNH5	"eag2, H-EAG2, hEAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699464-63102037	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 8.5;retina: 4.5"	"Group enriched"	"Detected in some"	16	"Bipolar cells: 62.2;Excitatory neurons: 185.0;Inhibitory neurons: 74.4;Oligodendrocyte precursor cells: 65.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 7.2;RT4: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.2	1.0	2.4	0.0	2.1	0.0	0.0	0.0	5.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	2.9	3.3	0.0	0.0	0.0	0.3	0.2	3.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	5.9	4.5	1.8	2.9	3.3	3.0	0.8	8.5	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	62.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.8	0.1	0.2	0.2	0.0	0.0	185.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	74.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.8	0.0	0.5	0.0	65.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.6	0.0	0.0	0.1	1.6	1.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium inwardly rectifying channel subfamily J member 12"	Q14500	17	21376357-21419870	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 25.5;skeletal muscle: 69.1;tongue: 25.7"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 89.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 25.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;HeLa: 3.9;PC-3: 4.3;SCLC-21H: 4.8;SiHa: 2.5;SuSa: 5.2;U-2197: 4.2"									HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.3	1.1	2.9	0.6	2.2	0.4	0.8	25.5	3.3	1.2	0.0	0.9	0.1	0.5	0.6	1.4	2.1	0.4	6.4	1.5	2.9	1.3	0.1	1.9	0.1	4.0	6.0	0.4	0.2	5.5	0.8	0.4	3.1	0.6	0.3	1.3	0.7	0.6	69.1	3.6	0.4	0.6	1.1	1.2	1.1	0.8	10.8	0.1	1.1	25.7	1.0	0.7	0.5	1.4	0.0	0.7	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	4.3	0.0	0.6	1.1	0.0	0.0	4.8	0.2	2.5	0.0	1.1	5.2	0.0	0.0	2.0	0.0	0.3	4.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.2	25.5	3.3	1.5	2.9	4.0	6.0	3.1	1.1	10.8	1.4	1.4	0.0	0.0	0.7	0.0	1.5	0.0	2.3	0.0	2.9	0.0	0.3	14.3	0.0	1.2	1.8	0.0	0.0	0.1	1.1	1.9	0.0	0.5	0.4	0.5	3.4	1.2	0.0	2.8	0.0	0.0	3.4	0.5	1.8	0.0	0.0	6.8	0.1	0.2	89.2	5.7	1.4	4.1	0.0	1.2	0.5	7.5	0.1	0.0	2.8	0.0	10.2	0.0	0.0	0.2	0.0	0.5	4.1	0.0	0.2	0.0	0.8	0.1	1.5	0.0	3.0	0.7	0.6	2.5	0.0	2.3	0.1	0.5	0.0	1.8	0.2
KCNJ18	"KIR2.6, TTPP2"	ENSG00000260458	"Potassium inwardly rectifying channel subfamily J member 18"	B7U540	17	21692523-21704612	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 7.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8;head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027021	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"		"unprognostic (2.41e-1)"				"unprognostic (3.90e-5)"			"unprognostic (2.56e-1)"						"unprognostic (1.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314461	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 7.7;thyroid gland: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 11.0;Exocrine glandular cells: 7.9;granulocytes: 6.3;Microglial cells: 17.8;Smooth muscle cells: 5.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 63.8"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 63.8"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 83.8"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.5	0.3	0.3	0.4	0.4	1.2	0.8	0.3	0.6	0.7	0.2	0.6	1.9	1.2	0.0	0.3	0.8	2.5	5.8	0.2	0.3	0.1	4.0	7.7	0.7	0.4	0.5	0.2	3.9	0.1	1.8	4.0	0.3	0.6	0.5	0.0	0.7	0.2	0.1	0.1	1.1	1.0	0.2	0.7	2.9	0.2	0.5	1.3	6.5	0.5	1.1	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	83.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	63.8	0.0	0.3	0.3	0.4	0.3	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.5	0.3	0.0	0.0	2.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	7.9	0.0	1.8	1.1	0.1	6.3	0.0	0.7	0.2	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.9	0.0	17.8	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KCNK5	"K2p5.1, TASK-2, TASK2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188971-39229475	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.4;kidney: 37.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Distal enterocytes: 55.6;Gastric mucus-secreting cells: 31.6;Proximal enterocytes: 66.5;Proximal tubular cells: 45.4;Syncytiotrophoblasts: 45.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 34.9;HEL: 36.1;HMC-1: 31.8;K-562: 34.3;OE19: 27.4;T-47d: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	4.0	3.7	0.1	2.2	0.1	9.6	5.3	0.0	0.1	4.4	0.1	14.2	28.4	2.1	0.2	6.1	2.3	18.8	1.7	0.0	0.2	37.2	23.5	6.1	2.7	0.2	0.2	6.4	20.4	1.9	1.2	8.6	0.1	3.5	8.5	0.1	27.1	2.4	0.2	29.4	35.4	1.3	0.1	2.2	16.7	0.7	0.3	1.8	10.0	0.1	1.9	3.2	6.7	0.0	6.6	5.9	7.7	2.9	0.0	0.0	6.6	0.0	0.0	0.0	0.0	34.9	14.3	0.0	10.2	0.0	0.8	13.2	6.0	0.2	0.0	0.0	4.5	36.1	3.1	0.2	0.0	7.5	31.8	0.0	0.1	0.2	0.0	0.0	0.0	7.8	34.3	0.1	0.0	11.4	16.7	8.1	14.4	27.4	0.0	0.0	1.4	13.6	5.3	5.4	1.9	1.5	5.7	7.3	0.0	2.9	25.9	12.1	0.2	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.3	0.0	2.3	0.0	19.2	0.0	0.1	3.7	2.5	1.5	5.7	0.0	4.2	3.2	0.6	48.6	7.7	1.8	0.0	28.8	0.8	55.6	5.9	14.5	0.1	2.6	0.3	6.9	0.0	6.1	0.0	11.8	5.3	3.2	31.6	5.3	0.0	2.2	0.0	27.5	2.1	0.0	0.0	15.3	8.2	0.6	3.5	0.7	0.6	0.8	1.8	0.0	0.6	0.0	0.0	0.0	0.0	12.1	25.1	0.0	0.4	2.6	66.5	45.4	1.0	0.0	0.0	2.4	0.6	0.0	1.1	8.2	2.7	45.6	3.5	1.4	11.1	10.4
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Early spermatids: 11.2;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 4.8;HEL: 8.1;NB-4: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.76e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.95e-5)"	"unprognostic (5.93e-10)"	"unprognostic (7.22e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	4.9	3.6	1.5	2.2	1.8	1.1	4.6	1.7	1.9	3.5	1.6	4.0	1.5	3.2	1.5	2.0	2.9	1.7	3.5	1.5	1.7	4.8	5.5	3.0	2.2	1.9	1.7	3.2	5.3	1.2	3.3	4.2	1.8	4.2	1.5	2.3	3.1	1.1	1.3	2.4	3.5	1.4	1.3	7.5	3.7	3.9	1.7	0.9	3.2	0.5	1.9	3.7	2.7	1.7	2.2	0.5	0.8	0.0	0.9	0.8	1.3	0.6	0.3	0.9	0.4	4.8	1.9	0.1	2.1	0.4	1.8	0.8	0.0	0.1	1.0	2.7	0.3	8.1	2.6	1.8	0.8	0.1	2.5	1.3	0.4	0.6	0.0	0.7	0.8	0.0	0.3	0.0	1.1	1.5	0.1	5.7	0.0	0.9	1.6	2.4	0.0	0.1	0.7	1.5	1.1	0.2	0.7	0.8	0.5	0.7	2.1	4.4	0.5	0.4	0.7	0.2	0.6	0.7	0.3	2.6	0.4	3.1	0.6	0.8	0.1	0.1	0.3	0.1	0.2	1.2	0.2	0.3	0.0	0.6	0.2	0.2	0.6	1.1	0.0	0.1	0.4	0.0	1.5	1.8	1.7	1.9	1.5	1.7	1.9	1.7	1.8	1.3	1.7	1.7	4.2	0.0	3.6	3.9	2.9	0.3	1.4	0.3	0.0	2.5	2.1	1.3	1.1	2.8	1.5	0.0	14.6	1.2	0.6	3.8	0.0	5.0	11.2	1.5	2.3	5.3	4.9	0.8	3.4	3.6	1.3	1.5	0.5	2.0	2.5	3.4	2.9	1.4	1.1	0.0	4.6	1.4	0.0	2.1	1.9	13.3	2.8	1.4	0.0	5.6	1.4	1.8	1.0	4.0	6.4	3.3	0.8	3.0	0.9	1.7	1.9	0.3	1.1	7.8	6.6	1.6	1.6	2.0	2.6	0.3	0.1	1.2	1.0	2.3	1.4	1.0
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114055926-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 27.8;brain: 20.8;liver: 31.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 36.2;Excitatory neurons: 149.9;Inhibitory neurons: 97.0;Oligodendrocyte precursor cells: 63.3"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 17.5;NTERA-2: 6.4;SK-MEL-30: 12.9;THP-1: 21.8;U-937: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.4	27.8	7.8	0.2	10.8	0.0	0.5	11.3	14.0	2.0	2.2	1.4	0.3	2.9	0.3	0.2	0.4	0.4	6.8	20.8	7.5	3.9	31.3	2.3	0.4	11.1	4.7	0.7	4.5	0.4	7.6	0.0	6.7	9.6	0.7	2.5	0.5	4.3	9.5	1.3	0.3	2.0	9.0	0.5	0.7	3.0	8.2	0.2	0.3	6.7	0.2	2.3	1.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	2.1	17.5	2.7	0.3	0.0	0.0	0.2	0.0	0.5	0.0	2.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.2	0.0	0.3	0.0	1.4	6.4	0.0	0.0	0.0	0.0	0.8	0.2	0.1	2.1	0.0	0.0	0.2	12.9	0.4	0.3	21.8	0.3	0.0	0.5	1.8	0.0	0.1	0.0	0.1	2.0	7.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	10.8	11.3	14.0	20.8	7.5	11.1	4.7	6.7	9.0	8.2	11.1	1.4	0.0	1.1	36.2	0.0	0.3	0.3	0.0	0.0	7.9	0.6	1.3	15.1	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.6	0.6	0.5	0.0	8.2	0.0	0.0	149.9	0.9	0.0	0.8	0.0	1.3	0.0	0.8	5.0	18.3	0.0	0.0	97.0	1.0	0.0	1.0	0.3	0.5	0.0	0.1	21.4	6.5	0.0	0.4	0.0	63.3	9.2	1.0	0.1	0.0	1.2	4.7	0.0	0.7	0.0	7.8	0.0	0.1	0.3	0.3	6.5	0.3	0.3	0.0	0.0	0.2	0.5	0.6
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870281	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 33.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 168.8;Skeletal myocytes: 121.5"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7;memory B-cell: 2.6"	"Group enriched"	"Detected in many"	11	"B-cells: 2.6;granulocytes: 4.7;monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 39.3;HMC-1: 26.1;Karpas-707: 65.5;RPMI-8226: 18.7;U-266/70: 62.3;U-698: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057127	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA057127: AB_2683345"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.80e-2)"	0.9	1.1	24.9	3.9	24.2	0.3	0.7	15.1	12.8	2.7	0.0	7.4	3.0	4.9	0.6	1.7	5.7	1.5	2.1	16.9	18.5	2.1	0.2	1.5	3.5	14.4	33.1	0.8	0.3	1.1	1.2	0.0	16.5	1.6	2.4	0.3	1.3	1.2	6.1	0.3	2.2	6.0	12.9	3.5	2.4	0.5	25.7	1.0	1.9	5.3	5.5	3.1	1.6	11.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	39.3	3.1	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	26.1	0.5	0.0	0.3	0.0	0.1	0.8	0.1	0.0	65.5	0.6	0.1	0.2	0.0	0.8	0.0	2.5	0.0	16.2	18.7	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	62.3	8.8	21.4	0.6	0.0	6.2	4.7	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	24.9	24.2	15.1	12.8	16.9	18.5	14.4	33.1	16.5	12.9	25.7	11.0	8.7	12.8	2.7	168.8	3.9	1.3	0.6	0.7	0.6	0.5	0.1	0.0	3.4	0.0	2.1	0.0	2.1	0.1	0.0	0.0	3.9	0.2	3.4	26.6	0.6	25.9	4.2	0.0	18.2	0.2	0.0	16.3	0.0	5.8	0.0	2.0	13.9	0.3	0.4	0.0	13.6	0.0	4.1	0.0	3.0	7.7	0.3	0.9	0.0	11.2	0.0	2.2	0.0	12.1	5.0	0.0	2.2	0.0	30.9	0.5	0.0	0.3	18.3	0.4	0.0	121.5	1.3	0.7	0.2	0.8	1.7	0.0	0.5	22.5	0.0	0.7
KCTD1	C18orf5	ENSG00000134504	"Potassium channel tetramerization domain containing 1"	Q719H9	18	26454910-26657401	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 106.4;Distal tubular cells: 117.4;Excitatory neurons: 283.7;Squamous epithelial cells: 109.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 106.6;HaCaT: 113.5;hTCEpi: 100.6;RPTEC TERT1: 97.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057808, HPA062486"			Approved	"Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite"		Yes	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytokinetic bridge, Centriolar satellite"	"HPA057808: , HPA062486: "	"unprognostic (1.15e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.35e-4)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (3.65e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.60e-8)"	"unprognostic (3.87e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.02e-2)"	7.8	16.5	21.7	2.7	41.5	0.6	32.4	14.0	44.3	19.2	9.5	9.7	4.1	14.2	22.6	50.6	50.2	8.4	23.8	31.2	10.3	28.8	3.5	5.5	2.7	9.8	13.6	15.1	7.4	12.0	10.8	11.4	9.2	21.6	10.6	18.4	19.9	22.6	5.1	61.1	3.7	12.5	10.2	3.9	10.3	5.9	13.7	17.6	19.9	6.9	14.3	13.0	36.9	29.6	17.5	55.1	106.6	11.6	61.8	9.7	13.4	14.3	21.5	22.0	21.9	5.1	19.1	2.9	52.2	30.5	18.0	113.5	20.5	30.6	20.6	2.2	8.7	3.1	10.2	8.2	11.1	1.7	4.7	16.7	100.6	6.2	41.4	28.0	21.0	24.1	1.3	1.2	16.0	24.5	16.3	5.2	10.5	57.1	27.1	8.5	5.7	2.3	97.8	25.2	10.3	40.5	20.7	27.5	8.7	61.3	24.1	4.0	11.7	24.4	6.8	4.8	15.0	4.8	4.1	0.4	8.7	11.0	36.8	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	41.5	14.0	44.3	31.2	10.3	9.8	13.6	9.2	10.2	13.7	29.6	3.0	3.2	4.1	80.0	0.7	31.7	55.9	17.2	106.4	5.0	27.3	29.7	13.9	8.6	15.0	25.8	8.4	45.5	0.8	6.2	117.4	8.3	28.0	47.0	7.8	2.9	1.2	0.8	283.7	3.6	7.6	5.5	7.1	42.4	0.0	66.3	2.5	1.7	4.4	21.9	66.1	4.3	20.3	0.8	1.7	12.0	5.3	1.2	23.2	16.9	0.4	21.4	1.0	81.4	42.1	11.8	2.4	3.0	6.6	36.4	0.4	10.7	29.3	5.9	0.0	2.7	6.2	1.8	5.1	109.0	44.5	33.2	1.0	6.3	4.0	51.2
KCTD10	"BTBD28, MSTP028"	ENSG00000110906	"Potassium channel tetramerization domain containing 10"	Q9H3F6	12	109448655-109477359	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014273	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA014273: AB_1852159"	"unprognostic (7.21e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	40.3	23.4	20.5	26.2	19.7	15.4	32.9	17.2	20.3	34.2	32.1	42.5	14.7	43.8	14.0	36.6	27.4	33.0	24.1	19.7	31.0	23.0	11.4	31.9	21.9	21.1	23.1	18.1	12.4	22.2	17.0	25.4	26.6	29.2	33.2	14.3	20.7	44.3	11.5	30.3	22.3	57.0	19.2	23.2	25.8	16.3	30.1	14.9	47.1	11.7	22.8	39.0	29.4	18.9	28.4	27.9	84.6	27.5	67.8	91.2	18.5	59.0	80.2	38.8	38.2	28.1	23.1	27.5	34.0	136.4	19.2	22.0	30.7	51.6	35.9	26.0	22.0	32.3	19.2	19.3	44.5	24.9	26.7	92.2	30.7	50.0	29.3	54.7	89.5	26.4	21.5	11.5	68.0	15.1	29.8	32.9	48.1	12.7	36.0	29.2	37.7	22.6	38.5	48.9	29.5	44.3	35.6	38.8	41.8	47.5	45.2	18.8	70.0	42.3	15.5	24.0	32.8	26.0	52.8	37.1	48.8	20.2	60.5	10.9	9.5	6.4	13.5	14.4	10.1	6.6	8.0	10.0	11.9	6.2	8.8	11.1	6.5	25.1	17.2	9.0	10.0	14.9	20.5	19.7	17.2	20.3	19.7	31.0	21.1	23.1	26.6	19.2	30.1	18.9	21.1	16.0	29.9	6.2	9.0	14.7	20.1	17.4	11.4	5.4	12.1	13.5	11.5	10.0	13.7	5.5	16.7	9.1	19.4	31.5	5.9	15.3	12.2	9.9	17.8	26.8	11.5	6.5	9.8	13.1	12.8	15.5	10.7	12.8	14.0	11.3	24.7	5.3	11.5	8.4	8.1	13.4	10.2	13.6	13.3	11.3	11.5	14.6	16.0	8.4	15.7	2.8	81.4	8.0	9.4	25.9	11.8	18.8	7.5	12.2	6.4	10.5	12.2	4.4	26.3	13.4	32.6	13.5	6.3	10.2	16.6	13.5	10.6	10.4	15.0	18.1
KCTD11	"C17orf36, KCASH1, REN"	ENSG00000213859	"Potassium channel tetramerization domain containing 11"	Q693B1	17	7351889-7354944	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Ubl conjugation pathway"	"Developmental protein, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 32.2;Pancreatic endocrine cells: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.6"	"Group enriched"	"Detected in all"	4	"granulocytes: 9.6;monocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 53.6;hTCEpi: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052035	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA052035: AB_2681704"	"unprognostic (1.98e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (6.78e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	10.5	7.3	5.6	6.1	6.2	1.0	8.2	6.3	6.0	31.6	6.4	8.5	5.8	11.4	7.9	40.1	9.2	7.5	6.4	5.6	5.9	8.0	6.2	8.1	6.0	7.1	6.0	7.8	7.8	9.1	6.5	7.4	6.2	8.8	5.6	3.4	15.6	9.8	5.3	35.1	8.5	7.8	6.1	8.7	8.5	3.4	7.4	3.0	9.9	3.9	10.3	28.6	35.5	6.5	18.2	7.7	5.6	4.0	23.5	13.6	5.1	10.9	19.3	12.5	10.6	6.6	8.1	2.3	6.1	20.2	11.8	32.3	0.7	53.6	10.9	10.4	2.1	0.2	4.0	0.8	11.7	0.3	10.2	10.7	38.1	13.8	7.6	25.7	3.8	1.9	2.4	3.0	9.7	8.1	1.5	2.5	1.5	8.5	3.3	1.9	5.1	2.3	13.3	7.1	0.3	2.4	8.1	8.4	1.2	6.9	11.5	1.0	7.6	10.3	8.2	7.0	6.2	2.1	0.9	0.8	12.1	5.1	7.4	9.6	2.6	1.6	1.4	3.5	0.4	1.0	0.7	0.6	1.5	0.7	0.3	1.0	0.4	1.0	2.9	0.1	0.1	1.9	5.6	6.2	6.3	6.0	5.6	5.9	7.1	6.0	6.2	6.1	7.4	6.5	3.1	9.6	1.1	3.3	3.4	1.8	17.6	32.2	4.0	3.9	5.8	4.1	0.8	7.2	13.8	5.5	2.1	6.1	1.6	11.1	3.9	13.3	25.3	9.4	12.1	3.8	7.2	0.0	0.0	9.4	6.5	9.3	15.8	6.1	4.5	4.0	4.2	2.5	4.8	1.7	0.4	6.5	10.2	3.5	5.0	8.7	17.7	3.5	1.8	1.9	10.5	3.7	11.3	0.0	1.4	32.8	5.0	21.8	3.8	13.1	8.0	3.4	24.5	1.9	19.7	5.9	11.6	1.2	1.2	6.6	4.4	9.9	3.6	4.1	4.0	18.4
KCTD13	"FKSG86, PDIP1, POLDIP1"	ENSG00000174943	"Potassium channel tetramerization domain containing 13"	Q8WZ19	16	29905012-29926236	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Autism, Autism spectrum disorder, Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.5;testis: 36.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043524	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA043524: AB_2678528"	"unprognostic (6.97e-2)"	"unprognostic (9.06e-3)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.49e-3)"	6.0	7.5	27.3	7.8	28.7	8.5	5.4	17.6	37.5	5.0	17.4	6.3	7.3	5.1	9.9	5.9	8.3	7.8	4.4	36.9	24.5	3.9	3.5	4.5	9.8	19.5	21.3	7.5	7.5	7.9	3.6	4.5	19.6	6.7	6.5	9.4	6.5	8.0	2.7	12.2	7.0	5.2	20.5	7.6	5.8	36.3	23.0	9.6	5.7	2.4	7.1	6.0	2.7	28.8	9.7	12.4	6.2	15.5	10.0	8.1	12.5	5.8	7.2	5.7	8.9	3.5	12.6	17.4	11.3	8.5	9.6	14.4	6.8	5.5	4.4	26.5	17.0	3.7	7.1	6.0	13.7	9.2	15.9	10.2	15.3	11.6	8.7	6.1	4.7	19.9	9.1	14.8	7.9	28.1	18.7	14.2	3.6	5.0	6.0	13.9	4.5	9.0	7.8	9.1	15.5	15.4	2.4	7.0	31.7	5.8	10.1	7.2	10.0	5.0	5.1	15.3	10.6	12.4	5.3	3.9	12.0	10.4	14.4	7.2	3.3	8.0	2.9	2.6	3.0	3.0	5.4	5.0	3.5	2.4	5.0	4.7	11.1	3.1	4.4	3.8	4.4	1.9	27.3	28.7	17.6	37.5	36.9	24.5	19.5	21.3	19.6	20.5	23.0	28.8	7.1	0.0	9.7	20.9	10.6	6.0	5.7	10.4	12.5	9.9	8.5	8.0	3.4	5.7	5.8	0.0	8.4	5.3	7.9	5.2	3.9	6.9	17.9	9.1	6.8	4.7	7.7	3.0	15.4	4.2	5.1	6.5	4.6	8.7	2.5	10.9	6.4	2.4	7.6	5.0	20.5	7.2	10.2	4.4	5.6	9.0	6.2	6.3	8.8	12.2	5.7	5.0	11.3	17.6	28.9	11.0	7.4	6.4	3.6	8.7	6.5	2.9	6.3	6.5	0.0	5.0	7.8	20.6	26.5	12.4	9.1	6.7	10.6	5.8	6.1	7.0
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 13.7;Breast myoepithelial cells: 12.8;Exocrine glandular cells: 17.1;Gastric mucus-secreting cells: 14.3;Intestinal goblet cells: 20.8;Prostatic glandular cells: 14.3;Proximal tubular cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 26.1;Hep G2: 29.0;RPTEC TERT1: 45.9;U-2 OS: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Vesicles, Cytosol"	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.96e-5)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.63e-1)"	3.4	23.1	2.0	1.6	2.0	0.1	20.4	5.1	2.9	10.4	3.2	8.1	4.9	3.4	14.3	1.5	11.7	6.7	0.6	2.1	2.1	11.5	10.3	8.2	0.3	1.9	2.3	0.8	27.2	8.3	2.5	1.3	2.2	7.0	11.9	1.6	28.7	19.1	0.2	1.9	5.2	2.1	1.6	0.6	20.8	0.6	2.5	1.3	15.9	0.6	0.5	2.3	1.4	1.7	0.0	3.5	0.6	0.5	1.3	0.8	3.5	1.8	1.6	3.4	8.4	13.5	8.8	0.1	9.3	1.1	0.4	1.0	0.6	26.1	8.9	0.5	13.2	0.0	3.0	29.0	4.9	0.2	0.1	4.0	0.7	13.9	11.0	2.5	1.0	0.2	0.3	0.1	1.4	0.2	0.3	0.8	6.5	0.5	0.5	0.4	0.0	0.0	45.9	3.5	2.3	0.2	0.0	0.2	4.5	0.8	1.4	1.1	0.8	0.2	20.2	0.7	0.4	0.3	0.2	0.2	0.2	0.2	3.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.0	2.0	2.0	5.1	2.9	2.1	2.1	1.9	2.3	2.2	1.6	2.5	1.7	0.6	3.2	10.8	0.0	0.2	0.4	12.2	2.0	2.8	0.4	13.7	12.8	0.0	1.5	4.1	5.5	0.0	0.6	0.3	5.2	3.9	2.6	0.3	2.7	2.0	0.9	4.8	0.0	0.0	17.1	1.3	1.1	14.3	3.7	1.3	0.5	0.0	4.8	0.2	0.0	0.0	20.8	0.0	0.0	0.0	0.0	3.4	0.4	1.8	0.0	0.1	2.1	0.0	0.0	0.0	10.5	6.6	5.3	0.0	14.3	2.2	15.1	0.1	0.0	0.0	0.0	1.8	0.2	0.3	0.7	0.1	0.7	0.3	0.7	8.5	7.4
KCTD15	MGC25497	ENSG00000153885	"Potassium channel tetramerization domain containing 15"	Q96SI1	19	33795933-33815763	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.4;Granulosa cells: 94.8;Hepatic stellate cells: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.8;eosinophil: 5.9;intermediate monocyte: 3.3;myeloid DC: 2.5;non-classical monocyte: 4.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.5;granulocytes: 5.9;monocytes: 4.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050822			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA050822: AB_2681250"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.65e-8)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.30e-2)"	19.2	6.3	29.4	11.3	28.0	6.1	14.2	24.9	34.9	38.8	15.0	41.3	7.0	43.1	3.2	34.8	36.1	10.8	19.1	28.7	29.6	24.7	12.9	24.7	3.0	26.0	30.2	22.7	32.5	4.5	10.3	11.0	24.2	25.0	6.0	15.2	11.6	19.0	6.0	73.2	15.7	20.7	25.8	17.4	23.3	10.5	30.2	1.3	23.0	6.4	4.1	32.0	31.3	23.3	16.7	37.5	33.2	50.8	10.8	5.7	26.2	21.6	4.0	11.7	6.1	21.2	11.1	0.1	47.6	30.3	5.5	19.3	24.3	16.9	4.4	18.1	42.7	68.5	25.3	20.7	29.8	13.3	12.0	11.2	69.4	4.5	26.5	0.0	23.2	9.8	17.3	0.4	2.0	42.0	0.5	37.8	30.4	27.9	62.8	32.0	17.9	6.3	13.3	7.5	25.7	88.0	42.0	59.0	80.0	14.1	43.7	34.7	38.3	54.7	48.9	1.1	3.8	40.9	2.3	27.2	0.1	23.0	68.4	0.6	1.8	5.9	0.0	3.3	0.1	0.0	0.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.5	0.7	29.4	28.0	24.9	34.9	28.7	29.6	26.0	30.2	24.2	25.8	30.2	23.3	17.8	0.0	1.7	44.4	0.3	15.8	3.3	4.1	10.8	3.5	5.4	5.0	3.2	1.5	2.9	0.0	10.4	0.2	0.4	0.9	3.9	0.7	0.7	3.4	15.1	15.3	1.2	4.2	1.9	8.4	0.4	5.5	1.5	2.5	8.8	94.8	27.8	2.0	1.2	1.7	5.3	3.6	0.0	3.7	5.4	1.9	4.4	3.7	5.4	4.7	3.1	5.0	0.0	11.1	0.3	2.1	1.0	9.1	0.1	3.9	0.3	0.2	0.7	11.7	0.0	3.1	8.7	0.0	1.9	14.3	19.5	0.3	0.7	2.4	1.9	3.1
KCTD9	"BTBD27, FLJ20038"	ENSG00000104756	"Potassium channel tetramerization domain containing 9"	Q7L273	8	25427847-25458476	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042468, HPA047902"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA042468: , HPA047902: AB_2680205"	"unprognostic (4.18e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (7.88e-4)"	"unprognostic (7.04e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.97e-3)"	18.4	8.2	4.9	11.5	5.8	21.5	22.3	7.9	6.5	15.4	8.6	21.1	19.6	11.3	13.0	23.8	14.6	13.3	38.3	5.5	5.9	12.8	10.8	13.4	12.2	9.1	7.7	14.2	11.2	11.0	9.8	12.0	10.0	17.4	22.6	12.9	17.5	15.6	29.5	19.0	17.7	14.5	7.8	9.4	12.8	12.9	6.9	14.7	13.7	36.7	14.4	15.6	18.7	6.9	46.4	32.4	34.5	11.9	44.0	58.0	28.2	68.6	61.4	44.1	44.5	23.4	33.2	30.1	28.6	69.0	62.3	30.3	30.6	32.3	52.9	15.4	18.2	35.3	30.2	21.7	53.2	12.3	25.1	44.8	38.5	40.2	33.2	26.9	37.8	29.6	37.8	23.0	50.7	12.4	48.2	21.6	16.8	35.8	17.0	18.6	39.8	11.2	45.0	26.1	8.8	11.4	52.7	23.1	35.8	30.8	17.8	14.2	42.2	48.5	28.2	94.1	37.6	6.6	12.9	39.1	33.9	21.8	35.8	0.7	0.5	1.2	1.0	0.7	1.0	0.6	1.0	1.0	0.3	0.3	0.6	0.9	0.5	0.2	0.9	1.0	1.1	0.4	4.9	5.8	7.9	6.5	5.5	5.9	9.1	7.7	10.0	7.8	6.9	6.9	19.5	32.1	18.5	18.6	8.9	74.4	36.4	26.0	31.9	13.7	20.4	12.7	61.1	5.7	24.2	27.6	25.0	9.4	23.3	53.8	13.7	17.6	6.5	12.8	12.7	16.8	10.2	20.2	14.3	27.2	17.6	32.5	8.2	17.9	20.3	10.9	12.5	9.0	9.3	3.3	12.9	16.0	18.3	9.3	18.5	5.2	30.7	12.9	30.2	36.5	8.5	8.1	18.6	17.1	13.6	36.6	21.6	55.7	17.1	52.6	25.8	10.4	17.4	19.6	6.6	21.6	26.2	35.6	26.4	41.6	54.7	11.2	19.8	14.4	17.7	46.0
KDM1A	"AOF2, BHC110, KDM1, KIAA0601, LSD1"	ENSG00000004487	"Lysine demethylase 1A"	O60341	1	23019443-23083689	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005884, HPA053660"	Supported		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		7700	"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB005884: AB_443964, HPA053660: AB_2682220"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.47e-12)"	"unprognostic (1.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.39e-1)"	25.7	30.8	24.7	23.5	25.8	48.1	30.6	26.5	27.0	33.1	20.4	31.6	26.4	36.0	46.9	35.0	34.2	25.3	26.1	25.3	28.2	24.7	22.3	24.5	34.7	19.8	22.0	41.4	36.2	51.2	41.5	31.5	21.0	32.2	33.8	30.9	36.6	29.4	47.3	38.2	29.2	30.1	21.2	25.2	29.3	86.9	27.4	55.8	28.5	34.0	37.2	34.6	31.5	21.8	128.1	64.7	180.8	160.7	47.0	59.5	128.4	53.1	66.4	106.0	93.7	61.2	120.5	94.5	74.1	87.6	53.7	139.5	169.5	101.0	133.3	86.3	102.7	133.0	105.7	150.6	59.6	103.7	56.0	55.6	71.4	112.8	78.9	93.0	134.1	171.7	148.0	43.4	76.3	75.9	227.3	79.2	118.3	70.8	93.0	214.7	119.1	64.1	89.0	81.0	225.0	169.9	239.4	62.4	80.2	126.1	62.7	76.2	109.5	47.0	78.4	88.1	73.6	55.6	47.1	109.3	49.2	120.4	68.3	2.0	2.5	4.3	4.1	4.3	3.4	7.4	3.5	3.8	3.1	2.1	4.5	4.9	0.2	3.0	5.5	6.8	4.4	1.4	24.7	25.8	26.5	27.0	25.3	28.2	19.8	22.0	21.0	21.2	27.4	21.8	18.7	19.2	29.1	33.6	15.9	18.6	27.1	19.9	33.0	27.5	20.4	22.1	24.4	11.5	19.0	23.9	27.1	31.6	18.1	15.7	17.6	35.4	43.5	45.9	49.3	20.4	22.8	29.7	51.1	24.7	57.2	24.8	23.4	44.4	12.0	49.5	16.8	17.2	15.0	15.2	51.2	24.9	22.4	15.1	19.7	20.3	21.5	20.2	12.4	30.0	28.1	19.3	12.3	50.3	30.4	28.1	13.5	23.0	28.9	26.3	17.2	15.7	29.5	19.8	0.0	22.2	25.0	131.8	67.1	36.1	12.8	16.6	15.4	34.3	27.6	20.5
KDM1B	"AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2"	ENSG00000165097	"Lysine demethylase 1B"	Q8NB78	6	18155329-18223854	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 7.2;monocytes: 8.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031269, HPA055597"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA031269: AB_10601587, HPA055597: "	"unprognostic (1.93e-1)"	"unprognostic (7.53e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.53e-1)"	5.9	7.6	5.6	11.4	7.6	27.2	6.3	5.3	7.8	7.6	7.6	14.1	8.0	5.7	3.7	9.1	13.4	6.0	6.8	6.6	5.9	7.8	7.4	8.8	10.4	6.9	6.7	6.7	5.9	3.2	5.8	4.6	6.1	5.2	12.2	12.0	5.7	4.7	17.3	11.2	8.9	6.9	6.2	10.5	5.6	15.7	5.6	10.8	27.2	9.1	9.4	7.7	8.1	9.4	15.1	9.7	11.2	23.0	13.8	20.5	24.5	11.7	12.6	7.5	10.2	16.3	7.4	34.1	31.6	19.2	22.8	15.5	17.8	20.8	16.0	31.6	14.6	17.2	8.6	15.0	6.7	25.5	17.5	10.3	23.4	21.5	17.7	12.1	7.7	15.9	38.3	5.2	12.7	12.6	14.1	10.5	3.8	31.6	12.8	26.8	20.3	24.4	10.7	19.8	34.2	10.6	9.7	23.5	22.9	11.7	22.3	20.3	6.5	16.9	9.5	11.9	15.5	5.2	15.9	20.0	6.4	18.9	37.8	1.2	4.6	7.2	0.5	8.6	0.3	1.2	0.5	0.5	3.7	1.3	0.5	0.2	4.9	0.3	6.9	1.6	0.7	1.3	5.6	7.6	5.3	7.8	6.6	5.9	6.9	6.7	6.1	6.2	5.6	9.4	4.9	0.0	8.2	14.7	8.7	12.7	5.7	3.8	7.4	5.0	7.6	6.6	10.4	11.5	10.4	1.8	10.4	2.7	3.0	23.0	1.9	6.6	0.7	36.2	10.0	4.2	6.7	3.8	19.0	4.3	5.1	5.8	8.2	15.5	2.5	3.3	4.2	7.7	7.5	5.0	10.8	9.6	10.2	36.7	11.7	0.7	3.7	20.6	7.2	22.5	27.7	6.6	8.2	16.1	23.8	7.2	21.2	6.8	3.7	5.4	6.2	11.2	21.0	15.5	0.0	6.9	6.2	0.7	18.2	9.7	15.9	1.4	5.6	3.1	10.6	6.6
KDM2A	"CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA"	ENSG00000173120	"Lysine demethylase 2A"	Q9Y2K7	11	67119263-67258082	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012272, HPA044251"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB012272: , HPA044251: "	"unprognostic (7.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"unprognostic (9.45e-3)"	19.5	13.2	10.7	27.2	10.6	47.1	19.7	18.0	12.1	24.3	14.1	23.3	14.7	29.1	17.4	31.9	19.3	19.0	17.4	10.6	11.2	14.3	19.9	24.0	27.5	12.6	10.7	24.5	13.0	16.1	13.1	18.0	10.9	21.6	17.1	18.5	21.3	19.2	33.8	29.4	23.9	24.0	9.7	27.0	18.9	29.0	11.9	27.8	19.0	24.5	28.7	23.9	25.9	10.9	49.9	31.8	17.6	27.7	17.1	27.0	13.5	21.5	26.6	41.0	27.9	48.7	25.4	38.8	37.5	33.3	23.8	48.2	31.3	22.5	33.1	66.4	13.4	28.9	39.2	11.7	16.9	24.5	38.1	21.7	23.9	39.4	25.7	20.7	29.9	22.7	27.4	54.4	18.6	35.4	32.5	18.1	36.1	29.8	25.6	39.9	29.4	21.4	14.7	33.7	24.2	18.9	71.0	38.6	39.0	21.6	59.9	23.9	38.7	25.0	16.7	34.5	18.8	29.3	35.4	25.4	22.0	17.2	17.8	0.4	1.1	0.3	2.5	0.8	2.7	3.6	1.9	2.3	0.6	3.6	1.9	1.9	2.7	2.7	0.5	0.9	2.6	1.9	10.7	10.6	18.0	12.1	10.6	11.2	12.6	10.7	10.9	9.7	11.9	10.9	41.4	38.5	35.8	75.1	56.6	41.2	23.3	23.4	75.7	75.3	40.3	30.9	31.1	34.3	31.0	16.5	137.6	23.9	77.5	43.2	0.0	17.3	20.6	84.8	63.0	38.4	31.8	22.1	89.4	14.5	13.4	32.4	42.8	112.3	27.3	42.1	29.3	35.5	21.5	95.9	89.8	27.5	24.4	46.5	59.6	11.2	21.5	49.1	19.6	104.0	43.3	19.8	33.0	96.0	99.5	25.9	25.5	23.0	72.5	37.2	21.2	10.3	40.0	111.7	19.7	40.2	32.3	52.0	38.1	78.7	47.7	32.3	66.9	33.8	29.5	48.7
KDM2B	"CXXC2, Fbl10, FBXL10, JHDM1B, PCCX2"	ENSG00000089094	"Lysine demethylase 2B"	Q8NHM5	12	121429096-121581023	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071257			Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA071257: "	"unprognostic (7.67e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.74e-6)"	"unprognostic (1.16e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (8.64e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.82e-2)"	9.7	8.4	7.1	18.9	8.7	16.9	10.0	12.9	10.7	15.6	7.4	12.2	8.2	11.5	5.5	20.2	12.4	7.0	8.7	7.3	5.6	11.1	15.6	13.1	22.9	8.3	6.3	15.2	11.6	10.8	9.4	7.3	9.2	9.5	7.6	9.7	12.6	6.1	15.2	28.0	18.9	8.3	5.4	21.4	10.9	14.0	7.8	23.1	11.2	6.1	21.6	12.3	16.9	9.0	15.2	19.1	31.3	9.8	8.7	7.6	34.8	12.4	19.1	17.8	14.9	24.0	7.7	69.3	20.6	11.2	9.9	13.1	34.3	13.7	14.4	29.3	24.0	38.0	15.9	19.4	10.3	44.0	29.5	6.9	7.4	16.9	12.3	19.1	12.7	33.6	31.4	8.8	8.5	20.4	54.5	51.8	55.8	11.0	15.1	61.0	16.4	34.1	9.8	24.5	37.1	21.4	23.8	14.0	14.4	29.5	25.0	49.2	17.3	19.0	15.4	19.2	13.9	23.9	21.3	64.5	17.6	35.2	12.3	4.5	2.8	2.4	6.3	2.3	4.9	9.5	4.9	3.5	3.9	9.3	4.3	5.8	0.4	2.0	1.7	3.5	4.6	3.4	7.1	8.7	12.9	10.7	7.3	5.6	8.3	6.3	9.2	5.4	7.8	9.0	6.8	0.0	10.6	28.1	36.8	17.0	7.1	4.0	13.6	20.1	10.3	6.7	14.6	14.3	5.4	11.0	12.5	6.7	43.3	3.8	11.7	7.5	57.0	13.0	7.0	8.8	5.4	22.5	36.2	5.8	11.2	8.3	9.2	12.0	14.0	16.5	9.7	15.4	24.4	15.2	41.6	6.1	6.1	21.1	61.0	60.1	7.8	25.5	16.0	26.2	48.0	4.1	24.7	31.2	44.1	5.8	4.7	7.2	34.1	11.2	6.5	4.2	5.7	16.1	19.7	6.5	8.1	11.4	18.3	13.9	15.2	6.6	24.8	6.2	7.4	6.3
KDM3A	"JHMD2A, JMJD1, JMJD1A, KIAA0742, TSGA"	ENSG00000115548	"Lysine demethylase 3A"	Q9Y4C1	2	86440647-86492716	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055543, HPA065162"			Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA055543: AB_2682842, HPA065162: AB_2685424"	"unprognostic (1.97e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.32e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.15e-6)"	"unprognostic (2.01e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.50e-3)"	"unprognostic (4.44e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-2)"	21.2	12.9	17.9	13.1	19.0	70.3	19.9	17.5	18.9	18.0	18.6	25.0	18.9	20.7	18.2	20.8	18.4	15.9	21.7	15.3	18.1	15.4	12.9	16.7	17.9	18.1	17.4	21.5	16.1	14.6	12.8	22.1	17.8	16.6	15.9	54.7	19.8	19.7	21.5	38.6	20.1	15.0	16.6	18.4	14.9	50.9	18.7	27.4	20.0	21.4	19.6	20.8	20.2	20.1	34.7	13.5	31.5	8.3	15.9	16.1	29.4	16.5	16.2	15.1	18.5	17.3	14.3	20.1	30.4	13.8	31.1	21.5	23.7	16.6	29.2	27.1	19.7	32.4	12.6	24.8	11.9	26.1	19.9	17.8	24.5	13.6	24.9	51.9	19.0	18.5	21.1	31.9	16.1	8.9	36.2	36.4	28.3	20.6	20.4	24.5	42.6	44.0	13.6	19.2	24.4	25.9	21.7	15.5	30.2	27.5	9.0	16.8	21.2	30.6	12.6	31.8	19.1	33.3	33.9	29.6	38.8	26.6	38.2	16.9	3.0	5.8	6.7	3.3	7.1	4.2	7.5	6.6	4.6	3.6	7.9	7.0	13.4	5.0	2.2	4.2	8.3	3.9	17.9	19.0	17.5	18.9	15.3	18.1	18.1	17.4	17.8	16.6	18.7	20.1	26.0	35.3	17.0	56.8	19.7	30.5	23.2	19.5	43.3	24.0	18.9	14.6	30.3	7.2	24.8	5.5	52.1	5.2	29.2	24.2	0.0	12.1	82.0	36.6	15.6	23.4	15.6	21.0	28.7	9.8	8.5	19.1	23.0	35.5	38.6	11.9	15.4	7.6	10.4	55.5	27.4	13.7	26.4	10.9	18.2	29.7	17.4	17.5	21.4	28.1	8.6	36.0	21.6	26.2	23.5	11.3	8.0	17.3	21.4	16.0	23.0	5.6	44.1	34.4	6.6	21.3	20.4	38.7	14.1	35.5	40.1	11.6	27.4	15.2	10.7	13.6
KDM3B	"C5orf7, JMJD1B, KIAA1082, NET22"	ENSG00000120733	"Lysine demethylase 3B"	Q7LBC6	5	138352685-138437028	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016610, HPA057202"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA016610: AB_1852004, HPA057202: AB_2683367"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.60e-2)"	21.7	19.4	22.6	16.9	23.0	25.4	25.3	22.2	22.8	22.7	21.1	23.9	18.6	23.0	28.3	21.2	24.2	14.2	20.0	21.3	20.7	21.4	14.5	19.3	23.0	23.4	22.7	30.8	20.3	34.2	16.5	20.5	21.5	21.8	24.0	36.3	22.2	25.9	41.5	28.1	23.4	20.8	21.9	26.0	21.6	19.4	23.9	35.9	23.2	27.1	29.4	24.8	19.9	21.8	24.3	32.4	65.0	58.7	27.2	23.3	47.0	15.6	27.1	30.0	33.5	35.7	27.2	46.3	27.9	30.3	41.0	24.3	53.2	37.8	32.6	30.3	29.3	39.2	28.6	27.1	25.4	32.2	43.3	26.9	39.0	22.1	26.7	23.2	34.6	29.3	31.8	26.1	34.3	30.3	46.4	41.0	31.0	34.1	13.7	53.1	48.5	30.9	40.4	31.6	32.7	35.9	27.0	28.0	25.7	93.2	27.3	43.5	31.9	17.9	17.4	19.3	28.8	32.8	16.7	40.2	12.5	45.6	25.6	0.2	2.9	4.2	2.3	2.2	3.2	2.3	2.7	3.0	2.5	2.0	2.5	2.3	5.5	4.2	2.3	3.0	1.7	1.3	22.6	23.0	22.2	22.8	21.3	20.7	23.4	22.7	21.5	21.9	23.9	21.8	22.8	16.0	15.7	43.1	22.1	15.9	13.7	15.1	20.5	21.3	29.1	29.5	33.2	17.2	17.0	22.0	29.2	13.4	24.0	26.8	0.0	16.0	6.1	22.8	19.9	18.9	21.0	25.4	40.9	16.8	10.7	18.5	17.9	24.2	13.3	26.3	18.2	23.0	17.6	23.5	39.1	26.4	18.3	39.2	18.3	2.8	21.1	27.9	16.0	50.6	27.0	17.3	16.5	41.7	56.9	19.9	28.0	23.0	16.2	21.2	20.9	16.1	25.6	31.9	26.3	21.8	18.7	13.0	15.5	26.2	21.6	10.9	19.1	17.1	24.6	21.0
KDM4A	"JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A"	ENSG00000066135	"Lysine demethylase 4A"	O75164	1	43650149-43705518	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007610	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA007610: AB_1852006"	"unprognostic (7.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (4.88e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	10.6	20.6	10.7	12.2	11.3	12.1	12.8	12.7	12.4	15.1	11.8	18.0	28.0	14.2	13.0	14.4	18.0	11.8	10.0	10.7	9.3	12.7	14.8	14.7	15.6	10.7	10.4	19.7	12.7	19.1	10.9	11.2	10.9	13.7	18.5	19.6	13.3	11.4	11.1	21.8	22.6	14.9	10.0	13.9	14.4	5.7	10.7	21.6	17.3	15.7	18.0	13.7	11.8	11.2	25.1	22.6	36.6	63.6	34.5	32.6	25.3	23.4	26.4	34.7	34.6	26.0	21.7	32.5	23.5	23.4	26.3	25.3	45.1	27.6	35.4	23.2	37.8	46.5	33.7	21.2	32.7	33.4	35.9	35.4	43.2	33.7	42.3	26.6	37.0	27.9	23.5	45.1	25.5	19.6	26.4	28.2	59.9	21.5	23.0	35.0	42.2	23.9	24.3	48.8	32.1	29.1	50.5	34.2	63.3	52.8	20.0	111.5	28.1	20.6	32.8	18.7	31.9	20.7	26.7	29.2	21.3	27.8	39.3	10.2	4.9	9.0	4.4	3.7	4.9	4.3	4.3	3.6	4.1	3.1	2.9	2.6	3.0	4.1	5.2	3.6	4.9	3.5	10.7	11.3	12.7	12.4	10.7	9.3	10.7	10.4	10.9	10.0	10.7	11.2	5.3	9.6	22.3	12.7	14.0	9.2	5.3	8.3	25.6	20.1	8.9	7.5	7.4	8.6	8.2	1.8	37.5	8.5	10.4	19.3	5.9	8.6	9.7	11.2	9.8	9.2	12.0	16.4	21.3	6.7	6.1	9.8	23.4	6.9	13.3	12.0	7.9	13.1	8.9	32.0	17.8	16.6	10.2	9.7	5.5	6.1	12.5	7.9	1.8	5.6	11.6	10.9	13.4	17.6	23.8	10.7	13.5	14.7	14.3	5.4	17.3	6.9	25.4	23.5	6.6	11.1	7.7	0.6	2.9	21.0	4.7	8.1	9.5	13.6	15.4	6.0
KDM4B	"JMJD2B, KIAA0876, TDRD14B"	ENSG00000127663	"Lysine demethylase 4B"	O94953	19	4969113-5153598	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.1;dendritic cells: 1.7;granulocytes: 4.7"	"Cell line enhanced"	"Detected in all"		"T-47d: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071568			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA071568: "	"prognostic favorable (7.39e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.74e-4)"	"prognostic favorable (4.25e-7)"	"unprognostic (5.95e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.89e-2)"	"unprognostic (8.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.44e-2)"	12.4	19.4	7.8	8.9	9.4	13.5	16.8	15.8	10.0	23.4	5.1	14.7	6.6	18.4	6.7	17.0	20.2	4.7	16.0	9.3	5.3	10.4	21.2	12.5	11.7	9.2	7.3	17.8	13.7	6.6	18.4	9.5	7.5	25.6	2.9	14.7	14.1	7.4	32.2	21.7	13.8	4.9	4.7	22.1	12.6	16.1	8.8	8.8	29.4	8.3	7.2	13.4	18.2	11.9	16.1	5.5	12.8	15.4	7.3	7.2	25.7	7.9	5.8	6.8	8.5	9.6	4.4	22.4	8.2	9.1	5.5	8.9	7.8	9.3	4.2	10.1	19.9	7.5	9.9	8.0	13.6	7.6	16.7	11.2	9.9	5.6	4.7	12.3	9.3	12.4	18.7	13.3	6.2	8.3	8.8	11.5	11.3	5.8	13.6	14.7	9.7	19.0	6.8	10.5	23.7	18.1	10.3	11.2	12.5	12.3	61.5	19.7	13.5	10.1	5.7	12.5	8.0	36.5	16.4	17.1	20.0	15.1	6.0	1.5	0.6	1.9	0.3	0.2	0.2	4.2	0.2	0.2	0.3	5.1	0.4	0.5	4.7	0.8	0.3	1.7	0.4	0.3	7.8	9.4	15.8	10.0	9.3	5.3	9.2	7.3	7.5	4.7	8.8	11.9	15.3	6.4	10.4	18.9	73.2	7.4	14.1	10.8	7.4	72.5	36.1	22.2	15.3	10.0	9.4	7.3	98.0	25.7	25.5	15.3	7.9	10.5	17.0	25.4	18.7	16.4	8.4	9.4	33.6	7.6	26.2	14.6	26.5	30.2	8.2	34.3	15.4	30.9	9.0	74.0	30.6	16.7	16.2	14.2	7.8	12.1	18.3	15.8	10.6	27.2	17.0	23.5	19.6	29.7	28.7	18.0	14.1	23.3	23.9	19.3	7.4	6.6	11.7	69.2	6.6	23.1	13.7	25.2	9.1	14.1	15.3	24.1	13.9	29.7	9.5	12.9
KDM4C	"GASC1, JMJD2C, KIAA0780, TDRD14C"	ENSG00000107077	"Lysine demethylase 4C"	Q9H3R0	9	6720863-7175648	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 206.9;Inhibitory neurons: 235.9;Microglial cells: 148.0;Oligodendrocyte precursor cells: 189.0;Oligodendrocytes: 347.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069357			Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA069357: AB_2686128"	"unprognostic (1.56e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.64e-3)"	10.0	9.6	9.8	12.8	12.0	30.1	11.3	30.6	11.5	10.2	13.5	13.7	13.1	10.4	11.8	10.1	10.3	9.7	7.8	9.9	11.1	8.7	11.1	10.6	19.1	13.8	11.7	11.5	16.1	17.8	11.8	8.9	13.3	9.9	16.1	28.9	11.6	8.8	8.3	15.2	14.4	10.8	9.7	13.9	15.1	9.8	11.9	23.6	13.4	6.0	18.8	10.3	10.7	16.4	17.2	9.8	4.0	6.0	13.4	14.3	11.8	7.6	9.6	8.5	8.1	11.3	9.1	20.1	4.6	10.3	8.7	5.1	8.6	12.8	11.1	60.6	7.4	27.9	13.8	15.1	12.4	10.8	18.5	12.5	8.4	6.7	14.0	21.1	10.4	16.4	4.7	13.4	9.3	8.3	18.0	40.4	7.0	18.0	3.8	10.8	3.4	12.9	12.3	9.2	14.0	8.3	7.1	12.7	6.8	10.7	6.6	17.5	11.0	8.4	4.0	9.9	7.5	10.2	8.1	21.3	8.2	10.0	3.3	7.5	7.1	13.5	9.6	7.7	11.2	12.1	10.4	11.2	9.6	13.8	11.3	8.8	1.6	11.2	13.1	3.7	10.0	8.0	9.8	12.0	30.6	11.5	9.9	11.1	13.8	11.7	13.3	9.7	11.9	16.4	11.3	6.4	14.4	110.4	40.6	19.9	7.9	10.5	18.8	22.6	11.2	8.0	9.2	11.5	9.2	7.3	45.9	5.2	22.7	10.3	3.9	7.0	84.8	10.0	12.2	9.4	9.7	42.1	206.9	6.2	5.3	6.9	34.7	16.8	8.8	6.0	6.8	13.0	6.7	11.8	235.9	14.7	6.1	10.0	19.4	83.3	9.6	16.5	7.2	148.0	15.0	3.3	19.6	189.0	347.2	7.6	9.5	9.4	27.1	6.2	14.1	4.0	10.8	28.3	13.1	7.3	7.6	6.6	5.4	14.4	23.9	5.9	28.2	6.2	8.1	8.0
KDM4D	"FLJ10251, JMJD2D"	ENSG00000186280	"Lysine demethylase 4D"	Q6B0I6	11	94973709-94999519	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 33.3"	"Group enriched"	"Detected in many"	7	"Early spermatids: 115.7;Late spermatids: 43.7;Spermatocytes: 102.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA055854, HPA064037"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA055854: AB_2682944, HPA064037: AB_2685180"	"unprognostic (1.98e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	0.5	0.6	0.5	0.3	0.5	0.0	0.8	0.5	0.6	0.5	0.4	0.2	0.1	0.5	0.8	0.3	1.0	0.4	1.0	0.5	0.5	0.5	0.3	0.4	0.7	0.5	0.5	0.9	0.3	0.9	0.5	0.4	0.4	0.5	0.3	2.1	0.6	0.6	0.6	0.7	0.3	0.5	0.6	0.6	0.3	33.3	0.5	0.6	0.7	0.7	0.6	0.4	0.3	0.6	0.5	0.8	3.3	2.4	0.7	0.8	1.5	1.1	1.2	3.0	2.6	0.9	1.0	1.2	3.5	0.9	2.9	1.0	2.1	2.3	2.3	1.4	2.2	1.1	0.4	1.3	0.6	0.5	0.3	1.5	1.2	3.0	2.7	0.4	1.1	4.4	1.2	0.5	1.2	1.0	1.9	1.2	1.4	0.8	4.0	2.6	1.4	0.9	0.7	0.3	1.9	2.3	1.3	1.1	0.9	1.7	1.2	0.4	0.9	2.0	1.2	3.2	1.7	0.7	2.5	0.2	0.7	0.6	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.4	0.6	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.4	0.6	0.5	0.6	0.8	0.0	0.0	2.6	0.2	0.0	0.2	0.8	0.6	7.0	0.8	0.9	1.1	1.5	0.4	0.0	2.1	0.9	1.6	0.0	3.9	0.8	115.7	1.3	1.4	1.1	0.0	0.4	1.8	0.6	0.9	0.9	0.5	0.4	0.0	2.6	2.2	1.3	0.7	3.3	2.6	0.1	0.0	0.6	0.3	43.7	2.1	0.8	0.0	4.7	0.7	3.9	1.0	3.5	4.3	0.2	0.1	1.2	0.5	0.2	0.0	1.3	1.0	3.3	0.0	0.8	0.7	102.5	11.4	0.7	0.0	0.3	0.3	2.5	0.3	0.2
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724495-202808487	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 62.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 243.6;Spermatocytes: 390.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241"	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	9.1	7.7	1.5	2.6	2.2	14.1	9.9	5.8	4.8	14.7	7.9	10.6	2.1	12.6	3.3	21.0	9.9	2.9	6.0	4.6	1.5	6.2	4.6	10.8	2.2	0.8	0.4	12.8	8.3	2.6	6.9	4.7	0.2	10.6	2.2	17.8	12.5	2.4	4.7	24.3	8.6	3.1	1.0	7.4	8.7	62.3	1.2	4.1	8.4	0.8	2.1	10.9	15.7	2.3	9.9	2.4	14.0	9.8	7.2	6.6	23.7	6.2	9.4	6.2	6.4	2.2	8.8	0.1	5.7	7.9	2.3	11.8	9.0	8.3	5.4	0.5	12.8	7.7	2.4	1.9	5.5	17.7	8.9	9.4	12.1	7.0	7.2	10.1	11.7	7.3	20.9	0.3	4.9	6.3	5.8	16.4	21.9	4.3	28.0	18.7	0.1	0.4	6.5	10.7	10.7	23.4	14.7	7.9	8.7	15.7	16.6	10.5	12.8	8.2	5.8	1.4	5.2	2.3	1.1	8.2	6.0	5.5	4.1	44.6	6.4	19.6	7.7	4.8	4.6	10.9	8.9	4.3	4.2	17.4	9.6	6.0	34.4	12.9	10.4	6.6	7.2	3.9	1.5	2.2	5.8	4.8	4.6	1.5	0.8	0.4	0.2	1.0	1.2	2.3	24.5	89.8	38.5	46.7	22.2	64.4	34.8	53.0	84.2	35.5	57.1	50.0	9.5	11.5	53.6	16.5	62.6	41.8	12.4	23.7	5.9	47.6	191.6	65.2	71.8	31.9	43.6	50.2	75.8	22.3	34.3	42.7	47.9	69.5	27.1	28.6	17.2	10.9	7.7	15.2	53.5	38.1	44.7	15.1	21.9	243.6	36.4	15.5	26.6	40.3	11.3	69.8	10.3	39.7	42.5	45.4	21.8	32.7	25.8	43.1	15.2	8.2	61.9	138.6	32.9	22.8	40.2	390.9	71.0	95.9	116.2	82.4	21.2	61.5	30.2	55.6
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA038244: AB_2675911, HPA046147: AB_2679555"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	22.3	29.0	19.2	28.2	19.7	34.8	22.7	23.0	21.7	35.5	22.2	25.5	26.0	35.5	14.8	35.2	33.2	17.1	22.7	19.6	20.1	21.1	24.1	27.2	33.4	19.8	19.0	39.9	26.4	33.8	31.4	23.8	19.0	23.8	15.4	24.6	29.4	18.5	51.0	34.2	28.2	26.9	16.8	30.9	25.8	13.5	20.9	44.2	27.6	25.5	26.5	25.9	35.4	20.8	45.3	60.4	63.6	49.0	43.2	39.1	45.2	27.7	32.2	36.8	34.0	41.3	28.9	41.8	35.0	36.7	103.2	39.5	72.6	59.1	27.8	31.6	107.9	40.6	66.7	29.6	52.9	48.5	77.6	31.0	42.8	72.0	87.7	52.3	55.2	34.2	80.8	27.2	27.3	57.9	35.9	55.4	54.1	23.3	56.3	40.1	37.8	45.9	23.5	42.6	47.6	61.4	84.0	76.8	32.2	58.4	53.9	42.3	37.8	40.6	35.0	36.9	27.2	39.0	34.2	31.5	52.6	56.9	30.8	0.9	1.2	0.8	1.6	1.1	1.4	1.2	1.0	1.6	0.9	0.8	1.2	0.8	1.4	0.8	1.2	1.3	1.3	1.2	19.2	19.7	23.0	21.7	19.6	20.1	19.8	19.0	19.0	16.8	20.9	20.8	17.6	12.8	14.9	33.0	17.8	12.1	10.5	12.1	14.8	24.7	19.7	15.0	10.0	11.5	15.2	7.3	25.0	13.1	21.2	32.2	3.9	15.0	0.8	28.2	25.2	17.7	31.2	17.2	36.1	21.9	15.1	14.2	21.4	35.7	13.3	25.5	15.0	25.5	14.4	25.2	37.0	25.8	16.2	18.2	8.8	2.6	14.6	17.1	14.2	27.2	14.9	9.8	16.5	31.2	49.2	26.4	26.3	15.8	17.0	17.9	22.1	5.8	16.4	16.9	0.0	17.2	16.8	10.3	15.8	16.2	15.9	20.8	18.0	22.6	18.9	21.6
KDM6A	UTX	ENSG00000147050	"Lysine demethylase 6A"	O15550	X	44873188-45112779	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 116.2;Oligodendrocyte precursor cells: 118.1;Oligodendrocytes: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000568, HPA001165, HPA002111"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704"	"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.16e-2)"	9.6	8.0	6.7	4.5	7.6	19.4	10.6	7.2	10.6	15.7	6.5	9.1	6.2	14.0	5.1	11.1	14.0	3.4	6.6	6.8	6.9	6.8	10.4	10.8	8.0	7.3	6.8	17.2	10.8	6.4	8.6	3.9	7.3	7.7	4.1	3.8	10.5	3.1	10.4	18.4	13.0	4.1	7.1	14.1	12.5	12.2	7.0	12.9	9.4	6.1	5.3	9.8	15.2	9.9	7.3	5.8	7.0	9.3	5.0	6.8	15.7	4.9	4.2	4.0	4.1	10.4	5.2	4.6	3.2	3.5	10.1	13.9	6.5	5.4	3.9	7.6	10.8	2.4	4.5	5.2	3.7	2.6	13.2	2.6	6.4	8.2	6.6	5.1	4.2	5.3	6.4	10.1	2.4	6.0	6.9	13.6	6.8	4.2	7.4	6.4	7.1	1.4	3.8	9.2	6.2	4.4	18.2	6.8	10.7	14.1	8.5	0.0	3.0	5.4	5.2	5.2	3.6	5.5	8.8	5.6	4.0	3.3	3.3	7.3	1.7	1.5	1.9	3.5	2.1	1.9	2.5	2.8	3.1	1.2	2.5	2.4	2.8	2.8	3.0	1.7	2.2	2.0	6.7	7.6	7.2	10.6	6.8	6.9	7.3	6.8	7.3	7.1	7.0	9.9	23.2	6.4	10.6	92.1	26.0	26.1	14.3	9.4	38.1	7.7	16.8	12.1	12.8	12.8	10.9	7.3	14.6	4.5	26.1	24.6	0.0	8.4	1.5	26.4	25.5	13.1	13.1	16.8	88.3	7.5	7.9	14.2	23.0	39.7	2.5	27.3	6.4	17.6	7.0	25.2	74.0	14.0	6.1	9.1	13.8	2.0	6.5	19.9	10.6	116.2	12.6	6.8	6.2	118.1	264.6	9.1	17.4	7.2	31.4	14.2	22.6	3.7	8.9	9.7	6.6	20.9	17.0	14.1	12.5	29.3	26.3	10.9	27.4	10.6	13.1	17.1
KDM7A	"JHDM1D, KIAA1718"	ENSG00000006459	"Lysine demethylase 7A"	Q6ZMT4	7	140084746-140176983	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012114	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA012114: AB_1852429"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.18e-1)"	6.6	2.1	2.1	6.9	1.6	16.4	4.7	3.8	3.9	9.5	1.5	8.4	8.2	6.6	1.4	7.0	2.9	4.5	4.1	2.7	1.6	3.6	6.7	4.8	7.0	2.5	2.5	2.1	4.5	4.1	1.3	9.1	2.8	3.3	9.3	5.8	5.1	2.1	12.6	7.5	8.3	4.4	2.4	5.6	9.3	7.7	3.7	6.7	2.8	13.2	8.0	5.7	3.7	3.0	0.8	0.4	2.7	2.8	2.4	2.3	5.4	1.2	1.7	0.4	0.5	0.2	0.4	1.9	1.9	1.3	1.4	1.0	3.7	2.3	0.8	10.8	2.3	0.1	0.4	5.1	2.5	1.8	1.9	2.4	5.1	1.4	8.0	1.3	2.6	5.0	6.1	8.2	0.5	0.8	3.6	3.1	4.3	6.3	1.5	3.8	0.2	4.0	0.9	1.2	4.7	5.8	2.8	6.5	2.7	4.3	8.8	0.7	4.6	0.5	1.0	1.7	0.8	2.9	0.4	6.2	1.5	5.0	1.0	0.6	0.8	0.3	0.3	0.4	0.3	0.5	0.5	0.5	1.1	1.1	0.5	0.3	2.2	0.6	0.2	0.4	0.4	0.3	2.1	1.6	3.8	3.9	2.7	1.6	2.5	2.5	2.8	2.4	3.7	3.0	34.4	16.0	25.5	25.5	30.6	49.8	44.8	17.7	8.0	11.8	11.1	7.4	14.6	8.6	30.1	16.5	27.1	12.3	17.8	36.7	1.9	7.2	5.2	17.0	18.2	23.8	52.7	32.4	35.3	9.4	2.8	20.0	30.5	28.7	8.2	12.2	18.5	18.5	10.7	6.7	34.8	38.0	12.2	31.4	86.7	4.9	7.8	35.4	3.6	96.5	34.7	4.3	10.3	35.7	36.0	12.2	28.7	4.1	11.8	35.3	26.9	3.3	33.3	9.2	6.6	14.9	17.8	31.2	14.3	12.3	46.5	37.9	18.5	3.4	27.2	50.0
KDM8	"FLJ13798, JMJD5"	ENSG00000155666	"Lysine demethylase 8"	Q8N371	16	27203508-27221768	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 80.3"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 56.4;Proximal enterocytes: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026545	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA026545: AB_1852015"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.92e-3)"	2.1	3.5	4.0	3.1	4.0	1.3	2.2	5.3	4.2	2.6	3.2	2.7	13.3	3.0	1.8	2.0	2.5	2.2	2.4	4.1	4.0	3.0	80.3	2.2	3.4	3.7	3.5	3.0	5.1	2.4	4.0	1.5	3.9	3.6	1.7	2.3	2.3	2.1	4.6	1.7	12.5	1.6	3.6	4.6	2.6	2.7	3.8	3.5	3.1	3.0	2.6	2.7	2.3	4.1	1.4	3.0	5.0	2.7	1.1	1.5	2.7	1.7	1.9	3.8	3.3	2.6	2.4	7.6	2.9	2.5	1.9	1.6	3.0	2.7	2.2	9.2	4.4	4.9	3.3	6.2	2.7	3.6	5.5	1.9	2.1	2.4	1.7	2.2	3.1	3.5	6.1	4.8	2.4	2.3	3.4	6.4	8.5	1.1	1.8	5.2	3.1	6.9	1.4	1.6	4.8	2.9	0.7	2.5	1.9	1.7	2.7	4.8	3.4	4.5	2.2	1.7	1.8	2.9	3.1	6.3	1.9	3.3	0.4	0.2	2.1	0.8	2.5	1.9	2.1	1.9	3.6	3.5	1.9	4.3	3.4	4.9	0.1	1.3	1.9	4.0	2.3	2.3	4.0	4.0	5.3	4.2	4.1	4.0	3.7	3.5	3.9	3.6	3.8	4.1	0.7	0.0	1.7	3.3	2.4	0.3	0.2	0.7	3.4	1.9	0.7	0.6	1.5	1.5	1.6	0.0	2.1	2.0	2.4	1.0	3.9	1.3	0.6	0.5	1.2	1.6	5.4	0.8	2.4	0.7	0.7	1.0	3.1	0.4	0.0	1.5	1.1	56.4	2.0	0.0	2.5	1.6	2.0	1.9	1.2	0.9	0.3	1.3	0.0	1.9	1.4	1.4	1.0	1.5	3.2	0.7	0.5	1.2	3.0	0.5	25.4	1.4	5.9	2.5	0.0	0.9	1.4	1.1	2.5	0.6	0.0	1.4	2.0	1.6	1.2	0.2
KEAP1	"INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454"	ENSG00000079999	"Kelch like ECH associated protein 1"	Q14145	19	10486125-10503558	"Cancer-related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 178.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005558, CAB025337"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centriolar satellite"	Cytosol	"CAB025337: , HPA005558: AB_1079175"	"unprognostic (1.98e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.06e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	31.3	41.2	54.8	20.5	61.6	20.4	30.3	61.8	60.9	32.7	49.7	37.6	26.5	31.3	22.2	55.4	28.9	24.3	60.7	53.2	59.4	32.5	60.9	25.3	23.2	61.4	60.5	25.3	32.8	24.3	30.0	17.0	60.3	36.8	16.5	16.4	34.7	24.9	178.2	38.7	27.5	18.7	58.8	32.2	33.2	20.5	59.6	23.0	35.6	75.7	18.5	41.4	36.3	68.4	58.0	102.8	27.2	35.1	55.8	45.4	30.3	48.1	35.9	46.6	41.6	73.7	54.2	82.9	122.9	53.3	34.8	49.7	55.6	36.9	23.7	78.3	61.7	126.3	29.9	87.9	54.5	65.4	63.9	50.0	51.0	53.5	25.1	39.1	46.3	23.7	79.1	135.4	41.6	79.9	46.1	177.8	80.8	54.2	88.6	84.6	34.8	95.1	30.4	67.4	75.3	40.4	66.8	42.4	42.1	23.9	37.8	82.3	56.5	72.9	41.0	86.0	57.0	86.8	113.0	81.1	58.0	78.5	56.0	36.4	37.9	41.4	55.3	33.8	53.1	26.3	38.5	52.0	45.4	11.7	23.6	33.7	20.9	42.5	34.6	31.4	50.2	41.8	54.8	61.6	61.8	60.9	53.2	59.4	61.4	60.5	60.3	58.8	59.6	68.4	18.3	28.9	20.8	5.5	13.8	21.9	24.4	40.3	27.9	21.5	15.7	11.4	24.0	21.5	25.4	11.0	8.4	27.3	11.6	33.2	13.7	32.8	27.5	13.4	17.1	27.8	26.9	45.2	5.3	36.3	25.2	23.5	18.8	13.3	12.0	22.8	35.3	34.4	29.0	26.9	5.9	21.4	40.7	15.1	13.4	43.9	29.2	16.1	10.6	3.7	41.8	43.0	7.2	11.6	18.3	29.8	27.1	25.9	26.6	33.3	36.8	24.9	17.2	13.9	13.1	17.7	22.4	21.2	16.6	34.7	22.0	26.8	20.1	29.6	31.5	24.8
KEL	"CD238, ECE3"	ENSG00000197993	"Kell metallo-endopeptidase (Kell blood group)"	P23276	7	142941114-142962363	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 56.3;testis: 32.3"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 79.7;Oligodendrocytes: 30.1;Squamous epithelial cells: 16.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"HEL: 31.7;K-562: 26.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064442			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	1.8	0.8	2.7	56.3	0.3	1.7	2.2	0.9	1.4	0.1	0.0	0.2	0.0	0.8	0.5	0.0	0.3	2.0	1.5	0.6	0.3	0.5	10.6	2.5	2.2	0.2	0.2	0.0	0.2	0.4	2.4	0.3	0.0	0.1	0.6	0.1	0.2	0.1	0.9	0.0	1.9	4.9	0.2	32.3	2.4	1.3	0.3	0.0	6.7	0.1	0.4	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	31.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.5	0.1	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.2	0.0	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	1.7	2.2	2.0	1.5	2.5	2.2	2.4	1.9	2.4	2.8	0.2	0.0	0.0	0.3	0.0	0.0	1.3	0.2	4.0	0.0	0.3	0.1	0.4	0.0	1.4	3.7	0.0	0.1	0.1	0.0	1.9	0.3	2.4	0.2	0.1	0.1	0.0	79.7	3.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	3.1	0.0	1.4	0.2	16.8	0.0	0.1	0.0	0.0	0.0	0.9
KHDC4	"BLOM7, KIAA0907, SNORA80EHG"	ENSG00000132680	"KH domain containing 4, pre-mRNA splicing factor"	Q7Z7F0	1	155913045-155934413	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 57.0;Endometrial ciliated cells: 54.7;Glandular and luminal cells: 88.2;Granulosa cells: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008796	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA008796: AB_1079369"	"unprognostic (6.31e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.22e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (3.79e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (2.78e-10)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (4.36e-5)"	27.9	29.5	21.0	22.3	22.0	11.9	30.8	27.4	25.1	42.5	21.6	34.4	23.0	32.1	45.2	28.8	33.5	15.0	27.7	20.9	21.3	42.6	30.2	34.1	28.9	21.5	21.5	47.7	32.7	18.5	44.6	23.2	21.7	39.2	27.3	55.5	38.3	20.7	39.8	32.5	36.5	15.5	21.5	37.6	37.6	24.7	21.3	27.1	33.6	21.3	29.7	37.0	36.2	25.3	27.6	20.7	43.2	26.2	22.6	31.6	26.6	23.2	18.4	34.6	35.5	21.6	59.6	34.0	25.2	13.3	24.7	49.5	40.0	16.4	34.0	27.2	83.5	30.7	70.8	26.0	15.9	36.3	25.4	20.7	42.4	24.3	18.8	40.8	25.2	38.2	37.4	37.9	31.8	13.3	35.1	35.6	47.7	26.0	29.4	41.0	23.3	30.1	30.7	14.7	29.9	29.7	17.2	17.9	25.1	35.2	37.6	60.5	21.2	33.3	23.2	10.9	31.7	61.3	28.4	30.1	24.0	33.5	25.7	4.1	1.5	3.0	2.1	2.0	2.8	2.7	2.3	2.8	1.5	2.6	2.9	2.7	1.9	2.4	3.0	1.6	2.0	1.0	21.0	22.0	27.4	25.1	20.9	21.3	21.5	21.5	21.7	21.5	21.3	25.3	19.4	12.8	19.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	35.2	23.5	0.0	0.0	12.4	57.0	0.0	26.5	25.7	0.0	3.9	11.2	0.0	54.7	20.0	9.5	0.0	0.0	0.0	7.2	20.0	11.0	0.0	88.2	6.3	48.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	13.5	0.0	0.0	0.0	0.0	18.7	0.0	0.0	8.3	0.0	0.0	7.9	12.4	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	30.8	10.5	34.4	0.0	0.0
KHDRBS1	"FLJ34027, p62, Sam68"	ENSG00000121774	"KH RNA binding domain containing, signal transduction associated 1"	Q07666	1	32013868-32060850	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005355, HPA051280, HPA056813"	Supported		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240"	"unprognostic (1.31e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (5.01e-2)"	"unprognostic (2.51e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.03e-2)"	59.8	47.4	36.3	67.0	38.8	93.3	61.7	44.7	37.4	59.5	34.8	62.9	62.3	82.6	47.2	57.3	70.3	48.6	56.8	36.6	39.7	54.0	50.6	52.1	94.1	40.7	38.7	110.6	50.9	61.7	38.3	63.7	38.1	55.1	57.3	58.5	45.2	55.8	45.9	57.3	59.2	65.6	44.1	64.0	52.3	42.2	37.2	112.2	63.8	40.6	96.7	62.2	47.6	46.7	204.6	121.0	272.6	201.6	92.5	115.4	159.5	120.7	152.1	221.5	185.5	136.2	178.1	302.9	131.5	153.5	128.4	139.2	221.9	165.1	225.6	181.7	188.8	191.1	111.8	188.0	121.5	256.2	123.8	127.6	92.7	168.9	132.8	145.6	212.6	183.1	251.0	136.5	172.6	132.6	379.2	218.7	277.0	127.3	144.3	300.1	230.2	257.7	156.0	203.7	185.7	241.7	175.7	148.8	157.2	192.9	177.3	183.7	160.5	143.9	154.5	155.3	205.9	140.3	163.5	296.0	149.2	202.3	112.1	5.8	5.7	5.9	7.8	8.9	11.7	9.9	9.2	8.2	7.8	8.0	9.8	9.5	5.0	8.0	7.5	8.9	9.3	3.0	36.3	38.8	44.7	37.4	36.6	39.7	40.7	38.7	38.1	44.1	37.2	46.7	130.6	38.5	77.4	40.8	181.9	147.6	200.3	58.8	183.2	94.8	111.1	109.9	104.4	97.2	89.8	69.9	50.1	192.7	131.9	87.9	84.1	96.2	24.7	122.5	154.4	125.7	117.8	131.6	46.0	103.1	234.5	132.4	103.5	127.0	128.1	224.5	99.6	64.6	120.8	63.9	48.1	101.1	28.5	141.9	148.4	21.7	111.2	139.2	108.5	36.5	142.6	142.6	105.0	43.7	59.6	107.1	76.2	124.1	141.8	136.4	74.5	123.8	93.3	89.3	92.1	140.4	157.9	198.2	122.7	173.8	130.6	173.5	161.7	138.7	152.0	167.1
KHDRBS3	"Etle, etoile, SALP, SLM-2, SLM2, T-STAR"	ENSG00000131773	"KH RNA binding domain containing, signal transduction associated 3"	O75525	8	135457456-135656722	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 157.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 364.5;Excitatory neurons: 828.6;Inhibitory neurons: 190.8;Microglial cells: 227.7;Oligodendrocyte precursor cells: 578.6;Spermatocytes: 276.1"	"Cancer enhanced"	"Detected in all"		"glioma: 9.0"	"Group enriched"	"Detected in many"	5	"amygdala: 21.4;basal ganglia: 27.9;cerebral cortex: 50.9;hippocampal formation: 29.8;white matter: 41.1"	"Immune cell enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"REH: 87.8;RPTEC TERT1: 76.0;WM-115: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000275, HPA000500, HPA000981"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.16e-6)"	"unprognostic (6.63e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.33e-3)"	16.8	16.4	21.4	5.6	27.9	2.6	11.5	0.0	50.9	17.0	0.0	12.5	4.1	6.8	22.8	6.2	6.5	11.5	10.3	29.8	0.6	19.3	12.3	8.8	3.0	7.5	1.4	9.3	9.2	7.6	6.8	2.0	0.4	8.4	8.9	21.1	11.0	12.3	32.6	6.4	5.9	8.7	0.0	2.8	6.9	157.7	5.7	9.2	5.6	31.2	4.2	10.6	9.0	41.1	0.5	1.8	30.9	1.7	6.5	12.0	12.4	20.7	28.6	19.2	9.8	11.1	4.4	0.1	10.9	19.8	0.3	2.7	19.5	20.9	26.0	4.4	33.6	0.1	11.2	22.9	5.0	5.8	69.8	2.6	2.8	10.5	16.1	23.2	15.9	36.7	2.6	51.0	34.5	7.5	2.2	1.2	6.3	16.9	34.0	87.8	42.0	22.6	76.0	0.6	39.5	33.4	1.5	4.4	22.6	19.4	1.4	1.8	1.3	23.6	40.7	0.4	45.2	17.9	0.0	0.1	14.3	0.0	85.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	27.9	0.0	50.9	29.8	0.6	7.5	1.4	0.4	0.0	5.7	41.1	15.4	28.9	5.3	20.2	3.1	15.0	14.7	2.3	2.8	160.9	23.8	10.8	12.3	2.8	4.8	7.3	0.0	0.6	0.6	7.0	25.4	14.6	364.5	24.2	21.1	13.7	23.4	0.8	828.6	22.9	1.2	37.2	2.0	40.7	4.5	4.0	5.0	21.8	0.8	6.7	190.8	8.7	10.2	3.5	10.9	142.4	16.1	5.2	14.2	227.7	1.6	7.0	0.0	578.6	34.9	19.8	2.5	8.6	1.1	19.3	2.1	29.0	2.9	16.1	0.0	57.9	34.5	276.1	33.1	3.4	9.2	1.4	2.1	12.7	6.6	12.6
KHNYN	KIAA0323	ENSG00000100441	"KH and NYN domain containing"	O15037	14	24429286-24441843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003402	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA003402: AB_1079190"	"unprognostic (2.95e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.03e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.73e-1)"	24.5	24.1	13.9	28.8	17.1	39.1	23.6	20.7	15.0	27.2	15.0	28.9	27.7	25.1	17.3	27.8	28.1	18.2	18.0	12.3	13.9	16.6	19.0	25.2	27.9	19.7	15.5	41.4	28.3	19.9	18.1	33.0	17.5	25.0	25.6	8.4	24.4	21.2	22.5	26.6	33.4	20.0	14.5	32.4	38.8	9.5	15.4	24.2	22.5	17.7	31.2	27.1	25.2	19.6	28.2	35.1	29.2	23.4	31.2	30.5	29.7	27.3	33.2	30.9	24.2	22.1	48.6	39.3	15.6	25.9	25.3	26.9	25.8	44.4	22.9	63.4	12.0	17.8	33.1	41.1	32.0	26.3	37.1	31.3	100.2	32.0	42.4	42.3	36.4	29.1	24.0	35.7	17.6	36.6	9.6	16.5	7.6	53.7	28.6	15.0	0.3	20.2	19.9	42.1	20.9	21.8	22.4	14.6	36.9	29.0	17.5	30.4	36.2	28.1	24.4	33.9	16.0	66.5	39.9	27.4	15.3	14.4	26.0	0.9	1.3	1.9	1.7	1.6	1.0	1.3	1.4	1.4	0.9	2.3	1.0	1.0	1.7	1.6	1.3	1.5	1.4	1.2	13.9	17.1	20.7	15.0	12.3	13.9	19.7	15.5	17.5	14.5	15.4	19.6	15.3	12.8	16.3	10.7	15.6	8.9	25.3	15.1	11.4	2.9	13.8	11.9	3.4	17.2	13.0	7.3	2.1	24.7	14.3	32.2	1.9	18.1	0.4	8.6	10.3	15.0	10.8	22.1	2.9	41.8	13.6	11.6	36.7	13.4	14.0	13.5	9.7	9.5	13.6	0.0	1.5	26.1	18.3	12.6	9.3	3.1	14.0	13.3	12.4	6.5	16.6	8.3	16.5	3.5	6.7	41.1	17.3	11.3	8.6	33.7	35.0	3.9	12.9	9.2	13.1	13.6	14.3	1.1	1.6	9.4	12.8	26.8	12.7	14.6	17.6	34.3
KHSRP	"FBP2, FUBP2, KSRP"	ENSG00000088247	"KH-type splicing regulatory protein"	Q92945	19	6413102-6424811	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034739, HPA056518"	Supported		Enhanced	Nucleoplasm		NA	NA		710000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA034739: AB_10601582, HPA056518: AB_2683162"	"unprognostic (2.16e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.27e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.84e-2)"	78.3	90.9	39.2	44.8	37.0	63.9	73.6	35.0	44.6	109.8	14.0	90.2	53.8	121.7	17.0	111.3	105.3	27.5	62.5	39.3	32.0	66.8	89.9	73.5	52.1	35.8	34.4	120.7	89.5	24.7	77.5	44.0	32.6	75.7	34.2	41.0	75.1	33.1	100.5	93.7	88.4	36.3	31.1	79.6	81.8	106.5	35.5	53.8	83.4	26.0	45.7	94.5	91.5	44.1	302.1	128.6	148.0	139.2	62.0	67.0	216.8	103.7	84.0	147.2	148.3	259.2	77.2	286.8	187.3	76.7	82.8	162.6	203.5	104.5	162.2	2.6	240.3	209.2	94.9	158.2	86.0	204.9	186.2	74.9	47.6	108.3	117.0	65.8	124.0	138.6	328.7	142.5	95.7	146.9	290.7	182.3	264.3	78.9	187.9	284.3	124.5	206.5	73.0	143.9	152.5	160.7	133.8	119.7	144.3	121.7	118.5	222.4	111.4	108.0	160.9	230.4	230.9	257.1	306.8	279.8	107.3	298.1	130.9	1.6	2.7	2.1	2.2	3.1	2.5	2.4	2.6	2.9	2.9	3.2	1.5	1.6	1.9	1.3	2.8	4.8	1.9	1.7	39.2	37.0	35.0	44.6	39.3	32.0	35.8	34.4	32.6	31.1	35.5	44.1	39.8	9.6	17.5	9.1	27.9	58.8	23.6	18.7	33.6	44.6	50.9	49.7	12.8	41.5	23.5	31.3	50.1	41.8	35.7	46.5	5.9	28.0	84.2	38.5	52.4	32.7	57.6	41.8	12.3	30.9	47.5	33.8	21.9	51.9	18.4	41.8	41.4	44.0	38.9	50.5	12.9	50.5	10.2	42.9	44.2	24.4	50.7	32.0	26.6	12.2	26.7	37.9	15.5	11.1	19.1	32.9	34.9	46.3	33.8	36.9	36.0	23.0	17.4	57.4	26.3	39.7	29.9	92.1	57.3	48.8	72.5	40.0	22.9	34.6	60.4	32.1
KIAA0040		ENSG00000235750	KIAA0040	Q15053	1	175156986-175192999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 100.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 105.8;Skeletal myocytes: 107.0;Syncytiotrophoblasts: 377.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 91.3;RPMI-8226: 65.5;U-698: 115.6"									"HPA016895, HPA068812"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA016895: AB_2669476, HPA068812: AB_2686041"	"unprognostic (5.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-1)"	44.8	8.9	4.6	23.2	4.8	13.1	24.8	5.3	6.5	16.0	7.1	11.2	11.9	11.7	5.4	9.7	18.8	21.6	18.7	4.4	5.3	34.6	22.7	39.8	30.4	8.9	6.2	6.1	25.7	12.3	7.7	100.5	7.5	11.7	12.2	1.0	23.5	6.0	17.2	8.0	14.7	10.9	5.8	26.8	15.0	2.7	5.8	21.4	10.8	16.0	32.0	17.1	10.5	5.3	8.8	0.3	0.4	0.0	0.0	0.0	0.0	3.9	10.5	0.1	0.0	4.5	12.5	91.3	20.9	0.0	0.5	35.9	6.3	42.2	0.0	31.2	5.1	9.8	19.0	0.6	1.0	0.7	1.2	0.0	11.4	0.0	15.6	0.0	13.9	13.0	8.2	14.9	0.0	2.1	11.7	0.1	2.9	7.5	7.7	9.8	4.5	65.5	13.3	21.8	0.5	3.3	6.5	34.9	0.8	21.5	22.3	2.0	5.6	0.0	4.0	0.1	0.8	36.4	47.4	115.6	1.6	0.0	9.6	32.3	12.4	2.0	11.0	6.5	9.8	29.3	11.8	9.1	10.7	28.1	12.2	10.7	51.2	6.3	2.5	2.4	18.7	11.8	4.6	4.8	5.3	6.5	4.4	5.3	8.9	6.2	7.5	5.8	5.8	5.3	57.2	38.5	5.5	0.7	59.4	26.6	105.8	22.4	29.0	0.0	41.3	39.4	4.0	10.0	11.4	12.9	0.0	71.8	14.1	22.6	13.7	13.6	0.5	41.1	18.9	29.7	4.2	10.3	0.1	23.6	7.9	45.7	20.9	41.7	11.4	8.9	16.4	7.4	11.4	0.0	0.2	7.4	10.2	10.4	18.9	1.6	16.8	13.5	7.2	1.0	18.7	4.9	18.6	0.0	0.1	23.6	26.4	10.5	36.9	55.7	8.1	5.1	12.5	0.1	26.3	107.0	89.3	0.4	3.6	10.3	11.1	377.1	31.8	1.2	18.4	43.5
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127438406-127459389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.6;skeletal muscle: 28.3"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 93.0;Alveolar cells type 2: 27.1;Skeletal myocytes: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.4;SCLC-21H: 33.3;SH-SY5Y: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	16.8	2.3	16.9	0.9	18.4	0.0	3.7	20.1	32.6	4.3	8.0	9.7	0.9	2.9	1.8	6.2	2.0	1.6	2.1	18.2	17.4	1.2	0.7	13.2	0.3	16.7	16.9	2.5	0.8	0.0	13.9	0.3	17.2	4.3	3.6	8.7	1.8	1.1	28.3	1.0	4.3	1.8	18.0	2.0	5.4	4.0	17.7	0.3	0.9	10.4	0.2	6.0	3.6	19.6	0.0	2.1	10.4	0.0	0.8	1.7	0.0	0.2	1.3	1.1	2.7	0.0	0.0	0.0	0.0	0.2	7.0	0.0	1.0	0.0	1.6	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	4.3	0.0	0.9	0.0	1.2	0.0	0.0	1.2	0.0	4.7	0.0	4.8	0.0	0.0	0.0	2.6	0.0	0.2	0.0	33.3	17.8	0.0	0.0	0.2	0.0	0.0	1.1	0.0	5.3	0.8	0.0	1.9	0.0	0.0	0.0	4.7	0.3	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	18.4	20.1	32.6	18.2	17.4	16.7	16.9	17.2	18.0	17.7	19.6	0.4	93.0	27.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.7	0.0	0.3	8.4	0.0	0.0	0.0	0.3	0.3	0.6	0.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	3.6	1.1	0.0	34.3	0.5	1.0	0.1	0.0	0.0	0.1	0.1	3.4	0.0	0.0
KIAA0513		ENSG00000135709	KIAA0513	O60268	16	85027751-85094230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.2;Excitatory neurons: 53.5;Inhibitory neurons: 53.3;Late spermatids: 199.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 25.8;monocytes: 23.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012866, HPA014431"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		67000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 6: Brain - Smell perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA012866: AB_1852321, HPA014431: AB_1852322"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.88e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.34e-1)"	5.4	11.3	23.5	9.9	35.8	17.1	2.5	35.8	63.3	7.7	0.0	11.0	4.6	5.2	2.7	7.7	3.3	4.7	4.6	41.2	3.3	3.6	2.5	7.5	5.9	12.1	2.6	2.7	15.2	4.1	32.6	3.9	2.6	9.2	6.1	9.2	6.9	4.8	10.2	10.6	6.8	5.6	0.8	8.2	10.8	5.8	2.8	2.8	2.4	3.7	6.6	14.9	6.4	27.4	6.7	7.1	4.7	6.8	8.6	6.4	1.2	6.6	10.4	9.2	5.3	3.2	3.1	2.2	2.8	8.0	5.6	5.8	4.4	10.5	5.7	4.9	3.6	4.3	1.9	1.7	4.1	0.5	5.9	11.9	5.5	10.6	1.4	3.9	5.0	4.6	19.1	5.4	8.3	10.5	0.8	1.8	4.6	7.8	5.6	0.8	6.0	1.4	8.7	4.8	13.7	2.1	7.7	12.7	3.1	4.7	10.3	1.3	10.0	5.7	4.3	8.7	2.3	8.4	1.6	4.8	7.5	3.3	6.2	24.6	11.1	17.9	1.4	13.4	0.4	0.0	0.9	0.9	4.1	0.1	0.8	0.9	25.8	1.3	23.9	5.9	0.3	5.3	23.5	35.8	35.8	63.3	41.2	3.3	12.1	2.6	2.6	0.8	2.8	27.4	0.9	6.4	5.8	7.5	2.6	4.0	7.8	12.4	2.2	17.9	2.7	1.1	8.3	2.8	15.3	1.8	6.2	0.6	8.0	16.0	0.0	2.8	50.2	2.8	7.5	3.3	11.4	0.4	53.5	4.7	0.8	6.9	10.7	4.9	2.5	1.7	3.3	2.9	6.9	48.8	53.3	8.6	10.2	21.5	4.6	199.5	16.1	30.9	3.6	11.2	24.5	3.1	3.1	8.5	7.0	9.1	7.2	26.7	16.5	15.0	4.8	1.8	23.9	5.4	0.0	5.4	3.4	4.1	4.1	1.2	4.4	3.4	4.6	4.8	5.2	29.8
KIAA0586	"JBTS23, Talpid3"	ENSG00000100578	KIAA0586	Q9BVV6	14	58427385-58551297	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Early spermatids: 142.0;Late spermatids: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000846, HPA050249"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA000846: AB_2234167, HPA050249: "	"unprognostic (1.90e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (7.20e-4)"	"unprognostic (8.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-1)"	5.0	5.1	4.6	4.8	4.9	5.4	5.7	6.0	7.1	5.1	4.5	4.9	3.3	4.3	6.2	5.0	4.3	4.9	4.7	4.3	4.9	4.0	6.5	4.2	7.4	4.9	5.1	6.0	4.0	6.1	7.1	3.7	5.0	5.1	6.0	7.9	4.2	4.6	5.8	5.2	4.4	6.3	4.7	5.4	3.9	16.4	4.7	12.4	4.9	6.1	7.1	5.6	4.8	6.5	21.1	14.0	20.2	9.7	16.4	15.6	8.7	17.3	16.3	15.1	15.7	6.0	11.3	23.4	11.4	14.8	6.2	12.3	19.1	10.9	24.8	16.8	6.9	17.9	11.1	18.2	11.2	27.6	15.3	10.5	4.6	11.2	17.7	7.2	19.9	22.3	18.0	12.4	28.4	13.5	16.9	11.4	8.7	10.7	22.8	20.5	23.5	14.6	10.9	8.8	11.1	8.4	18.4	12.3	8.9	10.8	14.7	14.4	18.8	23.4	18.4	12.9	14.5	7.4	9.5	19.0	16.2	21.8	13.7	13.2	2.0	5.0	7.0	2.1	5.6	6.3	6.6	5.3	2.6	6.8	8.5	6.1	2.0	9.7	3.2	3.3	7.1	2.6	4.6	4.9	6.0	7.1	4.3	4.9	4.9	5.1	5.0	4.7	4.7	6.5	17.9	12.8	14.5	29.4	20.9	3.2	6.1	6.2	12.5	30.5	10.1	9.8	14.1	7.2	9.3	9.2	81.3	7.5	20.1	5.9	5.9	6.5	142.0	18.5	19.6	13.9	10.7	22.1	52.0	5.2	8.4	14.5	16.8	11.0	21.5	15.2	9.3	4.7	9.5	32.0	56.7	8.5	10.2	7.9	2.8	108.1	10.2	10.8	8.8	27.2	10.6	17.0	14.4	47.3	73.9	5.9	3.0	12.0	20.6	4.3	4.3	7.7	20.0	51.0	0.0	19.7	12.3	61.6	23.9	12.4	4.5	4.8	24.4	15.7	7.3	3.3
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324152-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.9;Endometrial ciliated cells: 41.8;Late spermatids: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: AB_2670571, HPA061066: AB_2684423"	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.1	8.1	5.3	0.7	5.8	2.4	3.7	14.2	5.2	2.3	10.5	2.5	1.8	3.0	6.2	2.3	5.8	3.1	1.7	5.3	8.7	9.2	5.5	3.0	0.2	4.1	5.0	8.6	9.1	11.6	6.3	1.2	3.9	2.9	1.3	15.0	2.8	2.6	1.5	5.8	1.1	2.9	3.7	0.6	11.1	22.3	6.0	3.2	3.6	1.4	0.4	1.3	1.1	5.0	10.7	6.3	13.2	12.4	0.4	0.3	2.9	2.8	3.3	6.5	7.5	2.8	5.5	0.1	3.0	0.7	11.0	6.1	18.1	5.6	5.4	0.9	10.1	0.2	9.7	2.5	2.3	1.9	0.4	1.5	9.5	6.0	7.0	7.7	0.2	5.8	4.4	0.2	0.6	3.8	6.0	4.0	0.6	2.6	1.5	2.2	0.5	0.0	13.8	1.3	38.1	13.6	4.8	12.5	4.0	9.0	11.8	1.5	0.0	0.8	3.2	1.8	4.2	6.2	14.6	0.1	2.4	0.5	2.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	5.8	14.2	5.2	5.3	8.7	4.1	5.0	3.9	3.7	6.0	5.0	1.5	6.4	2.7	7.5	1.4	9.7	5.1	3.5	17.6	17.8	13.3	8.1	3.7	5.7	3.7	3.7	27.1	2.3	0.9	0.9	5.9	5.0	87.9	41.8	2.2	1.6	8.4	0.8	22.4	2.9	1.2	2.1	11.2	13.3	1.3	8.3	0.4	5.6	0.5	11.8	25.9	1.5	0.0	0.0	0.4	65.4	2.8	0.4	3.6	1.0	0.1	5.7	0.0	12.1	13.1	3.9	1.7	0.4	3.2	3.0	0.2	10.0	25.9	16.3	6.6	5.7	2.1	28.8	11.9	4.7	8.7	0.7	1.2	7.6	1.6	2.0
KIAA0895L	LOC653319	ENSG00000196123	"KIAA0895 like"	Q68EN5	16	67175599-67184040	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 74.3;Early spermatids: 84.9;Horizontal cells: 107.7;Late spermatids: 198.4;Rod photoreceptor cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065996	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA065996: AB_2685593"	"unprognostic (8.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.90e-1)"	"prognostic favorable (3.16e-4)"	"unprognostic (3.74e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.00e-3)"	14.6	25.1	19.9	4.9	20.1	3.4	11.5	25.6	26.6	21.5	12.4	11.8	6.5	21.1	7.5	12.4	30.8	6.0	11.7	21.0	18.8	19.2	9.3	14.5	2.1	21.2	17.3	39.7	11.7	6.6	46.1	5.7	21.3	17.1	5.2	29.2	10.8	4.1	5.1	9.3	11.2	7.1	15.9	16.2	14.4	23.5	17.7	4.1	25.3	2.2	1.7	15.5	13.3	20.4	3.1	5.0	19.0	11.9	3.6	8.2	12.3	7.9	1.6	3.6	3.4	5.1	3.1	5.7	5.0	3.3	3.0	11.6	5.4	4.5	2.3	5.2	7.1	8.3	15.6	4.7	2.8	3.8	16.2	4.7	2.0	4.5	1.7	13.4	6.0	12.2	8.6	5.3	4.6	5.1	8.6	6.4	4.1	3.1	8.2	23.0	9.1	11.1	6.3	7.3	21.6	18.0	9.4	4.7	2.6	9.0	10.2	6.4	7.0	11.8	8.4	5.8	3.4	6.6	5.9	6.0	15.3	5.7	6.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	19.9	20.1	25.6	26.6	21.0	18.8	21.2	17.3	21.3	15.9	17.7	20.4	5.3	3.2	7.9	29.4	1.3	2.9	3.8	7.0	7.4	74.3	6.3	6.9	3.3	8.6	8.8	7.3	43.8	3.9	2.3	6.6	3.9	5.6	84.9	6.7	14.9	5.8	13.1	1.7	23.6	2.5	6.7	5.4	10.7	10.8	4.5	18.6	7.1	4.3	4.2	107.7	28.9	4.6	10.2	0.6	2.1	198.4	6.8	2.3	5.4	5.6	1.7	13.8	0.0	20.1	14.9	3.4	5.4	10.9	1.2	4.5	2.1	1.9	5.1	68.0	19.7	2.8	8.8	6.9	10.9	5.9	2.4	3.0	2.0	16.3	6.6	4.8
KIAA0930	"bK268H5.C22.1, C22orf9"	ENSG00000100364	KIAA0930	Q6ICG6	22	45192244-45240894	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 211.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 132.2;Excitatory neurons: 139.6;Oligodendrocytes: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 11.0;eosinophil: 8.6;intermediate monocyte: 13.9;myeloid DC: 12.1;non-classical monocyte: 17.3;plasmacytoid DC: 10.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 12.1;granulocytes: 8.6;monocytes: 17.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 327.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038091	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Mitochondria"	Nucleoplasm	"HPA038091: AB_10675627"	"unprognostic (4.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (9.22e-5)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (6.90e-8)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.44e-1)"	"prognostic unfavorable (8.95e-7)"	"unprognostic (6.89e-3)"	"unprognostic (5.32e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.15e-1)"	33.9	58.3	195.7	27.7	209.3	24.7	25.9	163.3	211.9	46.0	130.3	29.4	14.6	24.0	40.4	34.5	18.2	16.0	18.1	184.1	189.1	23.8	48.4	24.8	29.0	182.8	192.6	13.6	20.1	18.5	19.2	12.0	179.8	29.1	11.2	3.5	26.7	24.7	33.8	64.0	21.4	15.2	170.4	38.7	18.6	26.2	193.6	20.4	18.4	13.1	22.3	44.0	35.6	210.3	49.6	31.5	19.1	38.3	64.1	30.2	19.2	26.9	26.8	28.2	24.1	29.5	26.5	33.2	39.2	42.8	22.5	54.5	29.5	118.6	10.7	35.6	46.4	0.1	42.0	34.3	25.7	89.4	19.7	17.1	59.2	27.3	45.3	21.5	26.8	23.9	11.7	53.1	17.4	56.9	40.0	82.8	18.9	35.8	26.5	48.1	12.9	110.7	42.6	29.7	15.9	28.4	42.5	57.6	75.5	36.8	28.1	327.8	36.5	29.0	50.6	39.7	15.7	44.9	32.9	32.1	34.0	133.7	30.3	0.8	11.0	8.6	2.3	13.9	1.6	2.3	0.9	2.6	12.1	1.8	0.9	1.6	2.5	1.9	17.3	10.0	2.0	3.7	195.7	209.3	163.3	211.9	184.1	189.1	182.8	192.6	179.8	170.4	193.6	210.3	11.4	6.4	8.8	132.2	9.9	52.8	18.6	22.7	6.8	7.3	13.9	13.5	11.5	12.8	11.8	18.4	6.2	2.0	24.9	16.2	0.0	18.6	2.9	11.6	9.3	9.7	10.7	23.1	139.6	20.7	6.5	32.7	4.6	19.5	2.5	3.8	17.5	23.3	67.5	5.0	56.7	10.0	14.2	71.1	50.0	10.8	10.8	59.8	44.4	24.4	68.5	6.5	13.4	16.1	152.9	18.0	13.7	14.7	11.2	25.6	15.7	13.8	9.3	5.9	0.0	10.2	10.9	7.5	4.4	15.2	57.3	2.7	9.3	5.3	12.8	23.1
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152331-122362758	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 245.2;Inhibitory neurons: 246.5;Oligodendrocytes: 239.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	29.3	24.9	39.5	13.7	48.4	60.3	31.7	41.7	42.8	29.8	62.3	29.6	18.8	27.6	29.8	17.5	27.2	19.8	22.9	36.0	38.5	27.8	21.3	28.2	19.8	48.4	39.1	41.6	24.8	56.3	47.1	17.5	44.6	21.9	22.1	82.4	22.4	21.7	55.5	28.7	28.3	22.1	35.4	26.4	23.3	26.6	44.0	23.1	31.5	42.2	16.8	24.5	25.6	60.5	30.5	9.5	22.3	14.8	36.3	46.7	11.6	13.5	25.3	13.6	14.9	7.2	15.7	15.9	7.6	32.2	18.4	11.2	13.7	16.7	22.0	12.1	8.8	17.7	18.4	13.7	18.9	16.7	9.4	27.2	19.6	16.4	22.3	37.2	29.3	17.0	11.6	18.8	28.5	10.3	14.5	13.0	7.4	14.6	10.7	8.2	30.8	4.1	24.1	22.6	13.0	11.6	8.4	9.7	18.8	35.8	10.6	13.5	39.8	16.8	16.7	14.0	14.0	18.1	12.5	11.5	17.8	14.4	12.6	1.8	0.7	4.3	1.6	1.8	1.7	1.2	1.1	1.1	0.7	1.8	0.9	1.1	3.3	1.0	0.9	1.1	1.6	0.4	39.5	48.4	41.7	42.8	36.0	38.5	48.4	39.1	44.6	35.4	44.0	60.5	94.6	86.6	42.8	245.2	36.0	20.9	22.0	19.8	26.2	126.0	36.2	27.6	69.2	22.8	35.9	42.3	125.1	12.0	59.6	42.4	1.9	13.8	35.1	34.3	52.8	47.2	21.6	27.1	194.0	17.5	7.0	41.2	59.7	47.2	21.5	64.4	35.0	24.1	12.7	92.5	246.5	27.3	20.3	30.1	17.5	27.7	51.3	41.0	16.0	153.6	32.5	60.9	26.8	161.9	239.9	20.7	34.9	50.8	47.9	19.3	50.0	10.3	33.1	145.0	32.9	63.1	54.9	63.2	33.9	28.9	24.4	13.0	52.0	34.0	32.0	23.0
KIAA1143		ENSG00000163807	KIAA1143	Q96AT1	3	44737661-44761619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045018, HPA061799"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Cytokinetic bridge"	"HPA045018: AB_10964578, HPA061799: AB_2684614"	"unprognostic (1.31e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.08e-2)"	"prognostic favorable (3.26e-6)"	"unprognostic (1.82e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.46e-2)"	9.2	7.4	3.6	4.9	4.5	4.4	8.2	3.9	4.7	7.7	2.1	8.9	4.5	10.4	3.5	6.5	7.8	5.4	9.8	3.4	4.0	7.0	4.9	5.7	6.4	4.4	4.3	11.0	7.5	8.1	4.7	6.4	4.4	9.0	5.1	5.8	7.0	6.2	17.4	7.0	6.5	7.4	3.7	6.4	7.0	3.1	4.1	9.2	8.4	9.0	7.2	8.1	6.5	6.0	8.3	5.3	14.7	10.2	9.8	15.1	7.3	9.3	13.1	11.7	11.9	5.3	7.2	20.2	6.9	9.8	5.6	5.6	17.5	9.9	15.4	11.2	5.9	14.7	9.6	6.5	6.7	18.6	9.9	10.9	11.7	12.0	11.3	13.0	9.9	12.3	21.2	10.8	11.6	4.7	20.9	13.1	13.9	8.7	6.8	8.5	14.0	11.5	7.5	7.0	7.3	12.5	10.9	8.3	7.5	9.8	13.9	15.8	11.5	6.5	5.8	17.2	10.7	6.9	21.1	12.1	12.0	17.8	9.7	2.6	2.3	4.0	2.8	2.5	2.4	2.5	2.4	2.2	2.2	2.3	2.5	2.4	2.3	3.1	3.8	1.5	2.1	1.9	3.6	4.5	3.9	4.7	3.4	4.0	4.4	4.3	4.4	3.7	4.1	6.0	35.8	38.5	39.4	5.9	32.9	34.5	31.6	44.1	25.0	20.0	24.5	24.0	28.4	32.9	43.6	23.9	8.4	40.6	32.5	18.8	68.4	45.5	245.7	29.0	32.4	34.6	15.6	27.3	5.4	62.6	55.8	28.9	18.3	29.3	38.6	17.6	37.1	26.4	35.0	15.2	6.0	24.6	26.4	42.9	27.3	84.4	37.6	30.3	14.2	5.6	37.7	44.8	41.2	5.5	10.1	48.9	24.0	49.2	19.1	51.0	23.5	45.2	30.5	14.0	0.0	43.3	28.3	53.8	40.5	22.3	27.8	57.2	35.3	25.7	25.7	46.7
KIAA1191	"FLJ21022, p33MONOX, p60MONOX"	ENSG00000122203	KIAA1191	Q96A73	5	176346062-176361807	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 304.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044701, HPA048145"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA044701: AB_2679053, HPA048145: AB_2680283"	"unprognostic (7.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.39e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (5.02e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.73e-2)"	41.7	44.3	40.6	26.7	43.8	30.8	46.0	33.4	43.2	50.9	44.3	46.3	49.6	49.4	52.5	61.2	66.8	42.9	86.7	45.1	47.4	199.3	70.4	47.9	29.2	39.1	39.6	90.0	57.3	87.0	33.1	38.2	45.1	55.2	44.5	58.6	72.3	64.8	70.9	44.2	51.0	55.1	32.7	34.0	62.0	12.8	46.3	36.6	60.8	63.2	37.5	49.7	34.3	33.9	61.5	63.4	105.1	142.7	95.6	72.8	82.6	86.8	86.2	96.6	106.1	118.2	60.2	24.0	111.9	105.5	145.2	53.8	67.6	157.6	113.1	125.0	81.4	27.9	41.4	63.1	111.0	24.0	47.2	73.9	115.2	83.2	70.8	109.6	120.7	39.1	43.1	51.2	108.6	81.7	34.7	14.5	47.1	65.6	81.2	25.2	66.1	21.1	92.6	60.0	82.8	91.6	92.3	45.7	103.6	94.6	66.9	27.1	106.5	88.4	40.2	65.7	107.5	33.7	49.7	27.7	69.0	46.5	71.3	33.8	23.8	32.9	28.7	28.6	32.1	25.1	27.3	27.6	23.1	18.3	28.4	29.7	10.4	27.4	29.0	18.2	40.2	28.6	40.6	43.8	33.4	43.2	45.1	47.4	39.1	39.6	45.1	32.7	46.3	33.9	26.8	54.5	41.0	16.6	31.3	34.0	40.6	29.1	39.3	31.3	40.8	35.6	61.2	34.3	35.9	33.1	25.0	25.0	35.8	38.7	93.9	37.2	2.5	27.5	24.5	30.2	43.2	17.4	19.6	27.4	13.7	29.6	28.1	35.6	17.7	20.6	26.0	45.8	15.8	48.8	22.7	28.3	30.5	21.4	27.1	7.9	31.1	19.8	21.4	12.2	29.5	33.5	13.4	12.5	16.0	37.9	37.5	38.4	28.6	45.0	50.1	304.3	35.1	30.8	13.1	23.8	26.0	7.2	6.0	38.7	31.7	33.4	30.3	20.0	30.6	47.5
KIAA1217	"DKFZP761L0424, ETL4, SKT"	ENSG00000120549	KIAA1217	Q5T5P2	10	23694746-24547848	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 108.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 609.1;Inhibitory neurons: 1251.8;Oligodendrocyte precursor cells: 255.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 82.6;Karpas-707: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004941	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA004941: AB_2130659"	"unprognostic (3.60e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-1)"	28.4	16.5	9.8	3.5	12.1	0.2	30.5	2.2	9.6	15.7	42.2	13.1	12.9	6.0	13.3	30.9	16.9	14.7	17.8	27.5	2.0	18.0	17.5	14.4	2.6	6.0	11.2	13.1	13.6	42.8	6.5	20.9	5.7	20.5	14.7	23.7	39.2	22.5	108.4	17.6	11.3	3.3	0.5	7.5	17.4	15.7	4.2	12.6	33.6	52.7	9.3	12.1	19.1	17.2	19.5	9.7	3.8	0.1	2.4	6.8	82.6	3.7	6.0	8.6	18.2	16.6	30.3	1.0	18.6	7.6	17.6	31.5	4.7	36.2	9.5	7.2	3.4	0.4	23.1	19.4	4.2	0.0	0.3	25.3	22.8	19.0	5.2	3.9	0.0	1.7	0.0	75.7	4.4	6.8	10.8	0.6	8.5	18.9	8.7	0.8	22.0	16.2	20.1	25.3	2.4	1.3	9.4	31.4	0.0	38.3	15.2	0.0	20.3	13.1	14.1	52.9	4.9	33.4	30.4	0.1	43.4	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.8	12.1	2.2	9.6	27.5	2.0	6.0	11.2	5.7	0.5	4.2	17.2	149.7	38.5	34.4	27.4	1.0	121.3	74.1	58.0	145.1	13.6	38.8	39.0	39.1	24.3	73.7	33.1	8.4	50.2	0.4	52.5	3.9	32.3	33.7	64.5	19.6	34.4	23.9	0.0	609.1	26.2	21.2	23.3	50.0	85.9	1.3	6.6	25.0	24.8	5.3	0.0	1251.8	22.8	26.4	14.6	7.8	11.3	17.7	1.3	1.8	30.0	0.0	93.6	0.0	255.9	10.3	24.1	22.7	33.1	3.1	36.8	15.4	6.3	36.9	3.1	13.1	19.6	20.4	0.8	1.1	96.4	51.0	65.1	2.2	14.2	19.4	43.7
KIAA1522		ENSG00000162522	KIAA1522	Q9P206	1	32741830-32774970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 154.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 125.7;hTCEpi: 103.0;RT4: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032050, HPA032051, HPA064839"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.29e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (4.55e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-1)"	7.9	93.0	14.6	7.0	10.7	1.2	24.3	1.8	15.6	14.5	27.1	42.5	51.7	10.1	12.2	76.7	23.5	16.0	5.1	12.4	6.5	43.9	12.0	18.2	1.2	5.2	5.5	22.3	70.7	37.8	9.1	8.4	4.3	40.9	30.9	1.2	68.3	20.2	3.1	74.1	45.9	6.7	4.2	1.4	61.8	5.1	7.7	8.2	39.4	3.2	12.1	22.2	28.1	8.8	65.7	33.6	5.4	9.3	2.4	4.6	24.6	7.9	15.3	8.9	8.7	37.0	125.7	0.2	32.3	11.6	26.5	95.1	10.3	67.8	4.6	0.2	13.4	13.6	49.4	30.4	4.0	0.2	33.3	1.7	103.0	23.6	28.2	40.1	18.6	2.7	20.1	0.4	4.3	54.3	0.3	0.6	11.0	56.3	20.9	8.7	6.7	16.7	85.8	117.5	4.6	4.7	49.5	70.1	9.7	33.7	74.7	4.3	17.6	14.9	39.3	13.7	17.3	0.8	0.3	0.3	15.2	2.3	17.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	10.7	1.8	15.6	12.4	6.5	5.2	5.5	4.3	4.2	7.7	8.8	5.7	12.8	56.9	5.5	0.6	73.9	37.0	52.7	59.2	0.6	69.8	42.3	3.8	72.9	52.0	27.6	2.1	15.6	1.5	154.4	9.8	47.3	4.2	54.7	5.6	8.7	28.9	1.3	10.2	66.7	5.2	6.7	51.0	50.2	27.8	10.2	4.6	10.6	2.9	0.0	5.2	54.0	48.8	0.8	6.5	5.1	8.7	2.2	7.2	3.7	2.4	0.8	0.0	2.0	0.4	60.7	64.6	4.9	0.3	80.9	84.7	14.8	60.7	0.1	6.6	3.1	7.5	3.8	2.7	59.7	83.1	7.9	2.1	59.9	65.4	99.6
KIAA1549L	"C11orf41, C11orf69, G2, MGC34830"	ENSG00000110427	"KIAA1549 like"	Q6ZVL6	11	33376108-33674102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 26.4;parathyroid gland: 33.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 366.9;Inhibitory neurons: 193.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.4"	"Group enriched"	"Detected in many"	141	"amygdala: 8.6;basal ganglia: 14.9;cerebral cortex: 26.4;hippocampal formation: 12.3;white matter: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 42.4;U-138 MG: 53.8;WM-115: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010132, HPA051594"			Approved	Nucleoplasm,Vesicles		NA	NA		160000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA010132: AB_1078313, HPA051594: "	"unprognostic (3.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.34e-5)"	"unprognostic (2.63e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.59e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.09e-1)"	0.2	0.4	8.6	0.2	14.9	0.0	0.7	0.0	26.4	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.3	0.1	12.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.3	33.5	0.7	1.1	0.0	0.0	0.1	0.9	0.3	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.7	0.3	0.2	7.9	0.1	1.9	6.1	0.2	1.0	6.5	0.0	24.7	14.4	3.8	2.1	0.0	0.6	18.7	0.3	21.9	19.2	1.4	0.9	7.3	5.7	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.1	6.4	11.0	13.4	16.9	0.5	0.2	20.5	15.1	0.0	0.2	0.0	1.4	0.0	9.1	0.0	1.6	0.0	0.0	9.6	2.2	2.2	0.3	0.0	6.2	0.2	0.0	0.0	42.4	53.8	11.8	1.3	19.6	0.0	0.0	0.0	14.7	0.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	14.9	0.0	26.4	12.3	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.0	0.0	18.3	0.1	2.0	0.6	0.6	0.0	5.6	2.2	2.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.8	1.1	0.2	0.1	0.7	0.0	0.0	366.9	0.0	0.2	1.0	0.0	0.6	0.0	0.2	5.0	0.2	0.3	3.3	193.5	0.0	0.0	0.0	0.9	1.2	0.0	0.1	17.8	18.7	0.0	0.1	0.0	40.2	7.2	1.2	0.0	0.4	0.0	1.2	0.0	0.1	0.1	0.4	0.0	0.1	1.8	0.0	1.8	0.6	0.3	0.0	0.0	0.1	0.0	0.7
KIAA1586		ENSG00000168116	KIAA1586	Q9HCI6	6	57046532-57055239	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.0;Erythroid cells: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036370	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA036370: AB_10672219"	"unprognostic (7.17e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.64e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.07e-1)"	4.1	4.8	2.0	3.6	2.4	8.6	5.4	9.4	3.7	4.6	0.0	2.9	2.1	6.1	3.7	3.3	2.8	4.6	3.5	2.3	3.0	3.6	4.9	2.7	4.6	2.9	2.4	7.6	2.8	5.2	3.7	9.4	2.8	5.2	2.6	4.0	2.7	3.6	1.6	2.5	2.4	4.4	1.4	4.5	2.1	8.0	2.8	5.9	5.7	3.4	3.9	4.8	2.6	2.6	8.6	3.5	21.9	25.1	8.5	13.7	12.0	14.1	11.6	12.0	14.4	5.9	2.7	3.4	11.4	10.4	10.6	4.2	16.7	8.3	16.4	10.7	12.7	35.9	8.0	13.3	11.1	29.0	12.7	10.1	5.9	10.6	11.7	8.5	11.5	9.1	49.9	2.7	14.4	6.8	14.0	17.5	14.2	3.0	5.0	12.8	16.0	8.4	8.0	17.6	18.5	16.8	9.3	3.0	10.6	15.1	7.2	26.0	9.4	18.6	7.7	17.9	10.2	10.9	15.4	16.8	11.5	21.0	7.7	0.2	2.5	2.0	2.3	2.0	2.7	3.7	3.4	3.0	3.9	3.1	4.2	3.6	0.1	5.3	2.0	4.0	4.4	1.9	2.0	2.4	9.4	3.7	2.3	3.0	2.9	2.4	2.8	1.4	2.8	2.6	15.4	9.6	6.3	10.4	8.8	10.5	4.5	13.0	13.1	15.4	7.4	11.7	23.1	1.5	7.8	7.3	2.1	43.3	11.7	1.0	11.7	7.0	87.0	4.6	29.6	12.5	5.4	74.9	32.4	5.4	33.2	21.4	3.1	3.2	13.3	30.5	8.2	4.0	12.5	10.1	32.7	2.4	6.1	6.6	7.1	21.9	12.8	8.9	3.6	12.2	9.7	9.6	15.5	23.6	24.4	2.8	0.9	14.7	13.0	2.3	0.7	14.6	8.4	8.2	19.7	19.5	17.6	23.4	17.9	8.7	4.4	10.7	10.6	29.5	3.2	1.6
KIAA1841		ENSG00000162929	KIAA1841	Q6NSI8	2	61065871-61138034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 11.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 91.2;Inhibitory neurons: 78.5;Oligodendrocytes: 63.8;Respiratory ciliated cells: 58.0;Rod photoreceptor cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051240	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA051240: AB_2681401"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.71e-8)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.85e-6)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	2.4	1.6	3.2	1.8	3.7	1.1	1.8	4.1	6.2	4.2	1.2	3.2	2.6	1.8	2.2	1.6	3.4	1.3	2.5	3.4	3.3	1.2	1.0	3.6	1.5	5.2	3.2	1.0	1.6	1.3	3.3	1.6	5.7	4.2	3.7	11.2	1.4	1.3	1.8	3.9	2.8	2.4	2.2	1.4	2.5	3.7	5.2	2.5	1.8	2.2	1.6	1.5	1.8	6.1	5.1	10.9	12.5	5.3	6.5	7.7	4.3	10.1	2.2	4.8	4.4	3.4	3.2	2.1	2.6	7.5	9.8	6.3	8.2	3.3	6.7	10.0	3.0	2.2	6.9	8.8	3.5	2.5	2.0	3.7	4.9	8.8	3.1	5.3	7.1	3.0	2.1	1.7	13.5	0.4	2.1	1.7	3.9	5.9	2.5	6.7	10.5	0.5	5.4	10.6	7.5	4.7	11.8	2.6	3.4	9.1	1.8	2.7	9.4	7.8	3.1	6.5	6.8	1.0	3.1	3.0	5.6	1.8	5.5	0.4	0.5	1.8	0.4	0.7	0.4	0.5	0.4	0.2	0.5	0.1	0.0	0.3	1.3	0.5	1.0	0.3	1.5	0.2	3.2	3.7	4.1	6.2	3.4	3.3	5.2	3.2	5.7	2.2	5.2	6.1	12.9	6.4	5.8	26.1	1.5	2.5	3.2	4.4	1.8	14.5	3.5	2.8	7.0	2.8	11.6	3.7	56.3	1.1	4.5	7.5	0.0	3.8	4.0	22.4	8.3	8.0	7.7	5.5	91.2	6.2	2.7	8.0	14.8	4.5	1.3	18.6	7.1	0.9	5.8	8.4	78.5	5.3	4.1	5.9	5.3	2.6	3.7	5.2	3.6	22.5	9.1	5.1	7.2	19.1	63.8	9.2	8.4	1.9	2.0	4.0	4.7	0.8	58.0	45.4	0.0	4.4	7.5	10.5	20.7	4.8	3.3	0.4	4.0	0.9	4.7	2.7
KIAA2026	FLJ20375	ENSG00000183354	KIAA2026	Q5HYC2	9	5881596-6008482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002109	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Cytosol"	Nucleoplasm	"HPA002109: AB_1078071"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.41e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (8.34e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	6.8	5.1	13.5	5.6	17.2	6.4	6.2	24.1	11.7	7.8	25.1	6.4	4.8	7.9	5.8	6.1	6.4	5.7	5.7	9.9	12.1	6.1	4.9	5.9	6.7	11.6	13.3	10.2	5.2	8.6	6.2	6.9	11.9	6.2	5.0	10.4	6.1	5.4	9.5	8.2	5.6	6.3	10.3	8.1	6.5	11.5	12.6	8.3	8.4	9.5	5.9	6.2	7.1	17.0	7.1	3.5	7.2	4.6	5.4	8.5	3.2	4.6	6.8	4.4	4.0	2.3	4.0	8.8	1.7	5.8	5.5	3.5	4.2	3.9	6.5	19.2	3.0	26.5	8.4	3.7	4.2	9.4	11.6	5.3	5.0	3.9	6.4	8.3	6.9	5.7	2.8	16.2	5.5	2.2	5.1	17.2	4.0	4.1	2.8	5.3	4.6	4.5	4.8	4.9	9.3	5.3	4.3	4.0	3.7	4.9	4.1	12.6	7.8	8.4	4.7	4.2	5.3	11.1	9.5	8.8	4.3	4.3	2.3	5.0	2.3	7.0	4.2	1.9	4.8	5.9	4.1	3.8	0.9	3.8	4.5	4.8	6.0	4.8	4.5	2.9	2.6	0.8	13.5	17.2	24.1	11.7	9.9	12.1	11.6	13.3	11.9	10.3	12.6	17.0	47.8	44.8	34.0	99.9	40.3	44.6	29.9	21.4	37.5	89.0	33.5	25.5	53.7	42.9	22.1	38.6	79.2	17.1	51.9	31.0	7.9	18.2	33.0	28.3	40.9	39.7	38.5	18.7	97.8	13.4	10.6	33.2	31.1	46.7	20.2	43.5	29.3	18.7	16.9	45.4	119.1	34.7	16.2	25.5	28.8	17.2	70.5	31.9	23.2	113.4	55.1	47.7	95.8	116.1	170.1	18.4	29.1	76.3	35.4	34.4	30.1	11.9	18.2	81.5	46.0	45.8	40.1	127.7	121.2	38.3	52.4	30.0	45.1	38.7	28.5	42.0
KIDINS220	ARMS	ENSG00000134313	"Kinase D interacting substrate 220"	Q9ULH0	2	8721081-8837630	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Neurogenesis		"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014790	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA014790: AB_1852460"	"unprognostic (3.58e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (1.68e-1)"	"unprognostic (9.21e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (9.29e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-1)"	21.2	21.6	20.9	14.5	40.6	24.4	19.6	34.9	27.5	22.3	21.6	19.6	11.4	29.3	15.3	15.1	16.6	17.7	21.9	22.1	28.9	22.1	15.7	23.6	13.1	43.9	31.5	37.7	18.8	42.8	16.9	21.4	43.4	20.0	16.5	38.0	14.5	18.0	14.5	16.7	13.8	23.6	35.7	17.1	16.5	10.6	32.0	21.6	20.0	16.7	12.3	16.7	17.9	73.9	13.5	21.3	41.8	26.8	51.4	33.9	21.9	26.2	21.6	16.4	15.0	21.5	13.5	25.2	26.1	39.4	31.5	22.5	37.9	16.1	24.0	36.4	25.7	22.7	15.9	22.6	36.3	23.6	29.9	35.3	24.9	26.1	33.7	25.1	25.9	21.6	44.7	30.8	29.2	14.8	24.2	12.7	22.7	22.3	18.8	22.7	30.7	12.7	21.7	25.4	35.4	59.3	20.8	20.7	23.6	21.7	13.3	26.6	34.4	36.1	19.0	36.6	28.5	22.4	21.1	33.5	21.1	31.2	28.1	4.1	3.4	4.2	3.6	3.9	2.6	1.9	2.6	3.0	2.7	1.8	2.7	3.1	5.3	3.2	4.6	1.8	2.4	2.2	20.9	40.6	34.9	27.5	22.1	28.9	43.9	31.5	43.4	35.7	32.0	73.9	57.1	99.3	115.7	129.6	25.2	32.8	27.6	25.1	19.9	86.2	31.3	25.0	40.2	25.8	48.6	29.5	139.7	21.5	35.0	33.9	0.0	33.3	1.3	32.3	77.8	51.8	43.3	36.4	108.3	23.6	10.0	55.0	39.8	53.1	35.4	144.0	47.8	30.9	28.8	154.8	149.2	23.4	44.7	52.7	46.0	5.9	69.6	45.9	24.9	60.9	44.2	60.5	34.0	162.3	322.2	29.0	29.8	65.5	27.3	25.7	24.5	10.5	34.4	58.0	6.6	65.4	54.2	28.1	23.4	26.4	29.5	10.9	40.2	52.1	23.9	36.0
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 18.9;Early spermatids: 44.0;Hepatic stellate cells: 15.4;Late spermatids: 88.7;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;hTERT-HME1: 3.7;U-2 OS: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.0	0.2	2.3	0.0	2.2	0.0	0.0	0.0	3.3	0.3	1.8	0.2	0.1	0.4	0.0	0.0	1.8	0.0	0.0	2.3	4.9	0.4	0.1	0.2	0.0	0.6	1.4	0.2	0.0	0.0	0.6	0.0	0.4	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.5	0.3	0.0	0.0	23.2	3.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.8	0.7	0.4	0.0	0.0	0.0	0.1	1.2	1.6	0.6	0.4	0.2	0.4	0.0	0.5	0.9	0.3	0.0	0.6	0.4	0.4	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.3	0.5	3.7	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.3	0.6	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.2	2.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.2	0.0	3.3	2.3	4.9	0.6	1.4	0.4	0.3	3.1	0.0	18.9	0.0	0.0	0.7	0.2	1.7	0.0	0.1	0.6	0.0	0.2	0.3	2.8	0.0	0.2	1.8	4.2	0.1	2.8	0.1	0.0	0.0	44.0	2.8	0.3	15.2	0.0	0.0	11.0	0.0	0.1	0.9	0.0	0.2	0.0	0.0	15.4	0.5	5.1	0.0	2.8	0.0	0.0	1.6	9.8	88.7	1.2	3.2	1.8	1.9	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.8	0.1	0.1	0.1	0.3	3.5	0.3	19.7	0.5	2.7	3.2	4.3	0.1	1.3	1.6	0.2	5.2	0.1	0.2
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947773	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 9.0;Extravillous trophoblasts: 3.8;Granulosa cells: 5.9;Oligodendrocyte precursor cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.4	0.4	0.3	3.8	0.4	12.7	0.2	0.7	0.3	0.9	0.3	2.0	2.7	0.4	0.0	5.1	0.2	0.4	0.3	0.3	0.4	0.2	0.4	0.8	5.7	0.5	1.1	0.1	0.1	0.0	0.1	1.9	0.6	0.2	1.7	0.1	0.7	0.0	0.4	3.0	2.5	1.1	0.3	2.9	1.5	2.9	0.6	14.4	0.2	0.0	4.7	0.6	1.6	0.5	31.5	41.7	35.3	32.8	0.8	3.0	28.1	25.8	10.3	34.6	26.9	34.0	27.4	28.3	10.9	10.8	21.5	34.0	25.1	11.3	17.9	56.6	36.4	35.4	51.7	22.1	0.0	30.0	30.2	0.7	0.6	29.7	12.2	4.7	17.9	29.2	28.1	48.0	18.2	25.9	60.0	31.1	25.4	30.4	28.9	43.5	51.8	19.2	5.8	16.7	26.2	24.7	18.0	16.1	9.8	17.0	30.2	21.6	11.2	49.9	48.0	28.8	56.8	15.1	15.7	34.4	16.3	22.9	33.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.7	0.3	0.3	0.4	0.5	1.1	0.6	0.3	0.6	0.5	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.2	0.0	0.5	0.5	0.4	2.6	0.0	0.0	0.0	0.0	2.4	0.4	1.9	0.0	0.0	0.0	0.3	0.8	0.6	0.0	9.0	0.3	0.0	3.8	1.4	1.5	0.5	0.0	5.9	0.4	0.3	2.3	0.0	0.3	1.6	0.0	2.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	7.1	0.1	0.1	0.0	0.0	2.1	0.2	0.3	0.0	0.0	0.3	0.0	0.2	0.8	1.1	2.9	2.5	0.4	0.8	1.3	0.3	3.2	0.3
KIF20A	RAB6KIFL	ENSG00000112984	"Kinesin family member 20A"	O95235	5	138178719-138187723	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 24.6;testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.0;Erythroid cells: 24.6;Extravillous trophoblasts: 13.1;Granulosa cells: 11.1;Spermatocytes: 21.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NK-cell: 6.6;T-reg: 2.5"	"Group enriched"	"Detected in many"	46	"NK-cells: 6.6;T-cells: 2.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036909, HPA036910"	Approved		Uncertain	"Nucleoplasm,Cytokinetic bridge"		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"		"HPA036909: AB_10670245, HPA036910: AB_10671716"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (2.14e-12)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	0.7	0.8	0.0	4.5	0.1	14.1	1.3	0.1	0.1	1.0	0.1	3.3	3.5	1.4	0.0	6.6	0.4	0.8	0.5	0.0	0.1	0.4	0.9	0.9	8.6	0.1	0.2	0.2	0.2	0.1	0.0	5.4	0.1	0.2	5.1	0.0	1.0	0.1	0.1	4.4	2.8	5.8	0.0	1.9	2.1	11.7	0.5	24.6	0.5	0.1	13.1	1.6	2.0	0.1	87.8	59.5	127.8	84.4	6.7	12.3	53.9	75.0	68.9	162.3	121.4	111.9	80.5	38.8	39.2	96.5	60.6	85.9	121.7	142.5	160.9	56.4	57.4	57.2	101.1	70.7	0.3	28.2	25.1	4.8	2.3	86.2	49.5	27.1	106.7	53.9	24.4	70.4	113.9	81.5	47.6	26.7	80.6	51.8	63.7	51.2	128.5	39.5	43.9	42.3	37.8	37.5	144.1	47.9	30.9	161.6	60.8	28.5	51.1	41.6	60.5	38.0	126.4	36.0	37.5	42.0	26.7	81.1	82.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	2.5	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.5	0.1	0.3	0.0	1.7	0.0	0.8	0.4	0.4	2.9	0.0	0.0	1.1	1.3	0.3	0.0	0.7	0.0	0.0	11.0	0.1	2.8	0.0	0.1	1.0	1.0	1.9	1.7	0.0	24.6	0.0	0.0	13.1	3.1	2.6	1.3	4.5	11.1	3.3	0.4	6.1	0.0	0.0	1.6	6.1	2.2	0.4	2.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.4	3.0	0.3	1.2	0.0	0.9	0.0	0.0	0.5	4.4	21.7	7.5	5.3	0.4	1.0	0.7	0.8	3.4	0.6
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701590-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.2;lymphoid tissue: 9.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 89.2;Spermatocytes: 165.4;Spermatogonia: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050214	Supported		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA050214: AB_2681053"	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	1.3	0.7	0.3	4.5	1.0	10.2	2.5	2.4	0.4	1.5	0.1	3.2	3.6	2.3	0.4	3.3	1.2	1.3	0.9	0.3	0.3	1.3	1.3	1.5	8.0	0.5	0.3	2.7	0.7	1.1	0.2	2.4	0.6	1.3	4.0	1.1	1.0	0.9	0.4	2.5	3.4	2.2	0.4	3.3	2.5	6.9	0.6	9.8	1.8	0.7	7.5	1.6	0.7	0.6	84.8	17.0	24.3	21.7	4.7	8.0	20.2	33.8	30.9	34.8	36.3	22.6	38.1	32.5	10.4	17.3	13.0	41.8	27.3	18.9	46.4	39.5	18.6	33.1	30.5	19.5	1.4	57.1	26.3	3.4	2.8	33.7	33.9	12.2	22.8	17.0	32.2	36.5	31.3	14.6	33.6	10.8	25.0	13.8	16.1	23.1	47.8	14.3	10.7	11.2	7.7	13.9	24.4	11.0	12.2	17.3	28.5	16.3	17.9	22.2	22.1	29.1	55.3	10.1	29.5	43.2	21.1	49.4	16.8	13.1	2.4	4.2	5.5	4.1	6.8	13.0	7.4	6.1	1.3	16.0	8.6	8.0	0.2	3.0	4.5	5.2	9.5	2.2	0.3	1.0	2.4	0.4	0.3	0.3	0.5	0.3	0.6	0.4	0.6	0.6	11.5	3.2	13.5	2.3	36.4	17.7	6.2	20.8	6.8	14.3	8.3	8.5	8.7	1.5	10.7	0.0	10.4	21.4	32.3	8.8	3.9	6.9	13.1	10.6	13.2	11.0	1.2	89.2	8.1	4.7	38.1	13.2	14.8	12.9	44.4	37.2	9.3	4.4	20.7	13.5	9.5	8.6	16.2	21.0	17.9	10.5	8.1	17.1	5.4	23.4	11.3	7.5	24.7	9.0	9.1	4.1	5.7	8.6	51.4	3.7	8.9	3.2	6.6	9.8	6.6	16.9	17.1	165.4	96.7	26.1	14.1	5.2	34.2	12.9	25.5	5.2
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	13	"granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.0	1.5	0.3	5.7	0.2	21.6	1.4	0.2	0.3	1.5	1.4	4.1	3.9	2.0	0.1	5.3	0.9	1.3	0.6	0.3	0.2	4.6	0.5	1.5	7.9	0.2	0.3	0.7	0.5	0.4	0.1	6.4	0.3	0.9	5.0	0.2	1.1	1.2	0.1	3.7	3.8	4.2	0.2	2.2	2.0	10.6	0.3	15.9	0.3	0.2	9.8	1.8	2.1	0.2	100.7	81.5	64.2	59.0	3.7	7.3	36.3	105.3	57.0	154.8	120.6	50.2	72.4	56.8	31.4	53.1	78.6	110.5	121.6	39.5	158.7	52.9	60.2	55.3	78.8	30.7	2.1	55.6	48.3	3.3	4.2	71.8	60.5	19.4	52.0	46.9	36.0	70.2	95.4	44.1	31.2	28.2	71.6	35.5	33.2	37.0	133.8	31.2	39.3	49.7	32.5	25.3	120.4	51.9	44.9	74.5	50.6	25.3	34.5	90.0	120.8	62.0	157.6	26.3	74.3	48.4	31.5	72.2	78.0	0.0	1.2	4.6	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.4	0.0	0.5	0.0	2.3	1.9	3.7	4.2	0.0	0.2	1.8	2.8	0.8	5.7	4.7	7.3	2.1	24.2	1.4	3.3	3.9	1.8	13.3	13.1	3.6	2.2	1.8	42.3	1.8	0.0	32.4	5.8	3.6	8.7	2.5	22.4	3.9	0.3	8.1	0.0	1.0	3.1	0.0	2.8	3.4	4.8	0.9	3.2	0.0	1.0	8.1	0.2	0.0	0.0	0.2	0.4	0.4	1.9	6.8	1.6	0.8	0.9	3.6	0.1	6.6	0.4	8.2	70.8	20.9	11.3	1.0	2.5	4.2	3.6	8.6	3.3
KIF26A	"DKFZP434N178, KIAA1236"	ENSG00000066735	"Kinesin family member 26A"	Q9ULI4	14	104138723-104180894	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.4;Endothelial cells: 11.9;Enteroendocrine cells: 7.7;Hepatic stellate cells: 13.9;Horizontal cells: 18.5;Spermatogonia: 8.1"	"Group enriched"	"Detected in many"	5	"stomach cancer: 3.8;testis cancer: 14.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 30.6;MCF7: 24.9;NTERA-2: 20.8;REH: 18.8;SCLC-21H: 19.2;SH-SY5Y: 39.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046882, HPA060346"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046882: AB_2679856, HPA060346: AB_2684259"	"unprognostic (3.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.24e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.68e-3)"	5.0	2.3	2.1	0.7	1.3	2.0	4.6	0.5	1.5	5.0	3.0	2.6	0.4	2.4	0.2	1.4	2.6	0.4	5.7	0.8	1.4	3.8	0.6	2.2	0.3	1.3	1.3	4.1	5.7	0.3	2.9	1.8	1.4	0.8	0.4	0.1	1.0	0.8	2.9	2.8	1.9	0.4	0.9	4.2	1.8	2.8	1.8	0.2	1.5	1.0	0.1	2.0	2.1	0.5	0.0	1.7	1.0	3.9	0.0	0.0	6.7	0.3	0.0	0.0	0.0	3.1	0.0	0.0	5.3	0.0	0.7	2.5	3.1	0.0	0.0	0.0	4.9	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	6.7	0.0	0.0	0.0	24.9	0.0	0.0	20.8	0.2	2.0	18.8	7.9	2.0	0.0	0.0	19.2	39.3	4.4	0.6	0.0	2.5	0.4	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.5	1.5	0.8	1.4	1.3	1.3	1.4	0.9	1.8	0.5	22.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.3	0.1	3.2	0.0	0.0	1.8	0.0	1.0	0.0	1.3	1.9	0.7	0.4	0.2	4.4	11.9	7.7	4.8	0.5	0.2	0.8	2.1	0.0	0.2	0.0	0.4	13.9	0.2	2.6	18.5	0.7	2.6	0.0	0.3	1.1	0.1	0.0	0.1	1.8	3.7	0.0	0.2	0.0	0.0	0.1	0.2	1.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.7	0.2	8.1	1.2	1.7	0.4	0.1	0.3	2.8	0.0
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62391025	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome		Yes	No		300000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: AB_2667215, HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.9	7.7	15.6	23.2	20.7	12.8	10.8	15.5	17.7	19.5	0.0	13.8	11.5	12.0	6.3	12.5	17.6	12.9	6.2	17.4	23.0	8.0	5.3	9.8	32.8	17.9	17.5	12.9	10.2	12.3	8.5	16.9	18.4	9.9	14.7	42.7	6.9	11.4	4.8	5.9	15.9	13.1	14.6	18.4	9.6	49.1	16.1	43.6	12.6	6.8	28.9	20.2	7.2	28.0	47.3	46.9	81.4	67.3	28.8	39.6	65.2	51.2	38.5	54.6	67.5	53.1	49.6	111.9	53.3	41.9	67.2	29.1	61.3	37.7	72.5	116.8	44.2	113.8	41.2	27.8	34.7	65.3	42.9	30.5	26.6	50.1	47.5	33.1	49.1	66.5	86.6	66.7	46.9	36.1	104.4	33.1	42.6	12.0	31.9	78.3	59.6	65.3	25.4	55.4	68.0	55.9	67.0	27.9	34.7	55.3	37.6	38.5	39.8	31.9	52.2	40.5	51.3	64.8	94.9	114.1	36.4	74.5	39.8	10.4	4.6	4.7	29.2	5.0	35.3	13.5	29.8	32.7	6.2	10.5	26.3	29.0	7.8	23.2	3.3	9.6	42.3	17.7	15.6	20.7	15.5	17.7	17.4	23.0	17.9	17.5	18.4	14.6	16.1	28.0	30.8	16.0	14.1	54.5	44.1	16.8	41.4	20.1	39.3	45.5	17.9	23.9	9.4	4.3	20.5	20.2	104.3	20.3	73.4	23.1	13.7	37.5	113.8	103.3	47.2	21.4	21.0	42.3	56.7	30.9	22.6	28.2	20.4	43.4	17.7	25.6	19.6	4.4	15.4	52.2	64.5	7.9	14.2	12.9	22.1	130.7	13.1	83.6	12.4	26.2	104.9	28.0	76.2	119.6	156.0	26.6	26.1	13.2	47.8	42.7	13.5	18.7	49.2	92.9	26.3	33.1	25.4	118.9	42.8	34.3	9.5	43.9	77.9	48.9	11.0	56.1
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 33.0;lymphoid tissue: 37.4;testis: 76.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1860.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.1"	"Not detected"	"Not detected"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	0.7	0.8	0.7	7.0	0.7	33.0	1.6	2.3	0.7	1.8	1.1	6.2	5.5	1.8	0.7	7.3	0.9	1.3	1.3	0.6	1.1	0.8	0.7	1.3	16.4	1.1	0.9	0.6	0.5	1.3	0.4	5.4	1.4	0.8	7.6	0.8	1.3	0.7	0.9	6.0	5.1	3.2	0.9	3.7	3.5	76.5	0.8	37.4	1.1	0.7	19.2	2.1	2.7	0.8	119.7	45.8	99.6	79.8	5.3	11.6	66.6	86.9	62.1	175.0	151.3	77.6	84.2	136.2	41.3	43.2	121.7	55.2	102.8	59.6	158.2	89.1	44.4	162.1	83.3	65.5	0.6	121.5	71.8	2.7	5.8	125.0	60.3	16.5	57.6	95.4	130.4	113.1	112.4	46.5	127.5	72.9	97.1	58.4	56.5	101.1	149.3	86.4	29.6	42.8	68.3	48.5	116.1	81.6	71.5	71.9	47.2	90.7	34.7	62.9	124.2	69.0	155.6	59.4	65.0	195.3	40.3	115.4	123.9	0.0	0.0	0.0	0.9	0.0	0.0	0.6	1.7	1.2	0.1	0.1	0.3	0.2	0.0	2.0	0.1	0.8	2.9	0.5	0.7	0.7	2.3	0.7	0.6	1.1	1.1	0.9	1.4	0.9	0.8	0.8	0.1	0.0	0.5	1.6	1.3	1.8	0.5	2.4	0.0	1.0	0.9	0.9	1.6	0.0	1.7	1.8	2.1	12.2	1.9	2.9	1.9	0.3	461.1	1.2	1.4	1.6	0.0	34.5	0.8	0.4	23.4	3.2	3.1	2.1	0.0	13.0	2.9	0.2	9.2	0.0	1.0	3.5	0.0	1.9	1.5	1860.6	9.3	3.4	0.0	1.0	4.3	0.4	0.0	0.5	0.2	0.1	0.2	6.8	7.8	0.8	0.3	0.2	0.3	0.2	6.6	0.8	3.4	60.6	36.8	4.6	0.4	3.7	2.7	0.8	7.4	0.7
KIF3A	"FLA10, KLP-20"	ENSG00000131437	"Kinesin family member 3A"	Q9Y496	5	132692628-132737638	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.3;retina: 33.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 178.7;Horizontal cells: 185.1;Inhibitory neurons: 157.0;Spermatocytes: 147.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 68.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 68.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037085	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Intermediate filaments, Cytosol"		"CAB037085: AB_477147"	"unprognostic (8.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.80e-1)"	"unprognostic (8.21e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.08e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.23e-1)"	2.6	8.0	14.3	3.8	15.2	1.6	5.0	9.7	26.3	4.4	0.0	3.4	2.5	4.7	5.0	3.3	7.0	4.0	4.6	16.5	16.7	5.8	1.4	4.5	3.9	12.6	13.1	5.1	2.7	11.8	11.3	3.2	17.6	5.1	2.6	33.9	2.8	4.8	2.5	4.0	2.0	4.5	1.3	2.8	3.7	21.5	8.2	6.0	5.4	3.1	3.7	3.8	3.0	13.8	10.6	12.6	11.4	20.8	7.7	7.8	9.4	8.9	7.0	8.2	10.9	13.0	8.0	29.7	11.6	10.4	24.8	7.2	9.6	17.6	17.2	8.6	10.2	4.3	6.9	4.7	7.9	5.3	11.4	5.8	8.6	12.1	14.0	11.4	10.4	18.8	4.8	15.3	10.1	7.9	34.5	4.2	5.5	3.8	4.8	8.8	9.2	3.2	8.4	9.4	36.2	11.9	12.0	4.3	14.4	18.6	12.8	1.6	10.9	10.1	15.9	7.3	10.6	11.5	19.6	16.4	12.9	4.4	11.1	68.2	0.6	1.9	6.3	1.5	6.9	6.7	6.5	6.1	1.3	4.0	6.4	7.0	0.6	4.8	2.0	1.2	5.4	2.0	14.3	15.2	9.7	26.3	16.5	16.7	12.6	13.1	17.6	1.3	8.2	13.8	10.9	54.5	38.0	65.3	12.0	13.6	15.6	25.5	12.5	76.5	13.7	18.7	29.9	11.5	31.7	38.6	125.1	14.6	18.4	0.8	29.4	20.5	86.2	69.7	20.4	11.3	19.8	3.4	178.7	12.9	11.5	16.8	5.6	23.7	13.9	24.6	13.2	2.4	6.2	185.1	157.0	3.8	54.9	3.5	7.7	25.0	16.4	4.8	42.7	21.5	5.4	47.0	5.2	122.6	100.7	12.4	4.6	24.5	14.4	7.6	1.1	10.8	121.0	99.6	13.1	23.8	40.5	147.1	102.6	9.0	15.9	9.9	23.6	27.7	2.1	6.0
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290104-70420886	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.6;Erythroid cells: 29.5;Extravillous trophoblasts: 11.5;Granulosa cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.3	0.3	0.3	3.2	0.2	11.2	0.7	0.1	0.3	0.6	0.3	3.7	3.1	0.8	0.0	3.6	1.5	0.5	0.2	0.2	0.5	0.2	0.5	0.5	5.5	0.9	0.7	0.1	0.1	0.1	0.5	2.3	0.6	0.1	4.5	0.6	0.5	0.1	0.1	2.2	3.3	1.3	0.7	2.4	1.7	1.5	0.6	12.6	0.2	0.0	6.6	0.9	1.1	0.2	60.2	41.1	61.0	30.1	2.9	5.1	24.0	44.7	23.8	59.7	51.6	46.7	34.3	36.7	27.4	22.1	46.2	35.1	66.6	24.2	66.8	42.5	33.4	41.7	50.1	33.4	0.7	46.7	27.8	1.7	1.5	49.6	28.2	7.3	37.0	27.7	53.8	79.1	57.0	38.7	43.0	23.1	61.7	63.8	43.2	47.1	82.2	34.6	14.5	23.4	40.1	33.5	72.9	30.5	18.6	30.6	24.5	18.1	26.0	39.3	50.6	42.6	54.1	22.6	41.7	52.0	20.8	50.4	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.1	0.3	0.2	0.5	0.9	0.7	0.6	0.7	0.6	0.2	0.1	0.0	0.5	1.3	1.3	1.8	0.3	1.4	0.6	0.2	1.1	0.8	0.4	1.5	0.2	0.0	0.0	7.0	0.9	2.2	0.0	0.0	0.4	18.6	1.5	1.3	1.2	29.5	1.9	0.0	11.5	2.1	3.1	1.6	0.0	12.2	1.1	0.1	5.3	0.0	1.9	4.6	2.0	1.3	0.7	0.8	0.0	1.4	0.0	0.0	0.2	3.1	0.0	2.0	0.7	0.1	0.1	0.0	8.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	2.9	8.7	5.4	7.2	0.3	1.8	1.8	1.3	6.6	0.5
KIF4B		ENSG00000226650	"Kinesin family member 4B"	Q2VIQ3	5	155013755-155018141	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 3.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Early spermatids: 5.4;Late spermatids: 4.3;Spermatocytes: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034745, HPA034746, HPA061583"	Uncertain		Uncertain	Nucleoplasm,Midbody		Yes	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (9.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.71e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.37e-2)"		"unprognostic (6.48e-9)"	"unprognostic (7.24e-2)"	"unprognostic (5.10e-2)"		"unprognostic (1.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57546026-57586633	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease variant, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"brain: 1628.2;choroid plexus: 951.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.7;Early spermatids: 12.2;Endometrial stromal cells: 12.9;Excitatory neurons: 28.4;Horizontal cells: 26.9;Inhibitory neurons: 21.7;Late spermatids: 15.2;Rod photoreceptor cells: 11.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.2;K-562: 15.3;NTERA-2: 17.7;SCLC-21H: 34.4;U-87 MG: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: AB_2686601"	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	0.4	10.6	1198.6	4.6	1243.7	4.2	0.5	1056.4	1628.2	2.5	951.3	4.5	3.6	3.8	1.4	1.4	0.6	0.7	0.6	1242.7	1056.4	0.8	0.2	0.8	0.7	1103.5	1046.7	0.6	2.6	9.0	21.3	0.1	1113.3	0.9	1.9	48.0	1.1	0.6	0.3	1.1	2.5	2.0	1002.7	0.8	1.3	4.8	1052.3	0.1	2.3	0.1	0.4	0.5	1.5	1313.2	0.5	0.1	7.2	5.7	0.0	0.0	0.6	1.4	1.3	2.2	3.5	1.2	0.2	3.2	0.4	1.9	1.3	0.8	3.8	0.1	2.5	33.2	4.1	0.5	1.8	7.0	1.9	1.5	1.3	1.0	0.4	1.6	0.1	0.5	0.5	2.8	15.3	9.4	0.0	0.6	0.8	0.0	17.7	0.0	0.0	0.5	0.2	0.3	1.1	0.5	34.4	9.1	0.0	1.6	0.0	2.0	0.9	0.2	0.9	0.6	5.3	1.1	2.1	5.3	7.7	1.9	14.5	0.1	0.6	0.2	0.4	0.1	1.0	0.5	1.6	0.7	0.7	1.2	0.3	0.5	0.9	2.2	1.1	0.3	1.1	0.3	1.0	0.4	1198.6	1243.7	1056.4	1628.2	1242.7	1056.4	1103.5	1046.7	1113.3	1002.7	1052.3	1313.2	0.1	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	40.7	0.1	0.9	2.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	12.2	0.5	12.9	0.7	0.0	0.4	28.4	0.2	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	26.9	21.7	0.2	0.0	0.0	0.2	15.2	0.0	0.1	0.0	0.0	0.0	6.4	0.0	8.5	3.9	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.7	3.3	7.9	0.0	0.1	0.0	0.3	0.0	0.1	0.1
KIFC2		ENSG00000167702	"Kinesin family member C2"	Q96AC6	8	144466043-144474202	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 113.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 59.8;Gastric mucus-secreting cells: 38.7;Inhibitory neurons: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029264	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA029264: AB_10609999"	"unprognostic (2.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-3)"	"unprognostic (4.12e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.71e-2)"	12.3	17.2	68.7	6.2	78.3	7.2	14.0	58.3	113.7	24.5	33.2	26.5	11.9	11.4	6.7	45.0	15.3	6.1	10.1	74.7	42.9	32.9	20.6	17.2	7.3	54.9	41.1	13.0	24.9	9.6	45.0	3.2	54.6	31.5	6.3	3.8	19.1	8.0	4.2	75.0	24.4	2.5	35.7	27.6	19.7	25.8	46.4	5.4	24.2	1.7	4.8	22.2	31.8	63.9	13.5	12.7	6.1	13.2	8.7	5.2	13.2	5.3	6.4	4.7	4.6	4.9	18.1	11.6	3.6	5.0	7.9	24.2	6.1	8.1	2.0	10.2	3.7	8.6	34.5	6.6	11.1	2.6	23.4	6.7	28.3	4.7	6.1	21.8	3.0	14.7	7.0	15.9	3.6	25.4	10.3	7.1	0.9	16.5	15.2	24.1	0.3	8.8	19.9	23.1	18.4	16.4	6.2	19.3	6.9	4.3	50.4	5.0	7.6	9.0	22.9	9.4	7.7	6.3	2.9	3.9	17.6	12.3	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.7	78.3	58.3	113.7	74.7	42.9	54.9	41.1	54.6	35.7	46.4	63.9	3.7	9.6	11.3	35.3	4.9	6.0	3.0	2.1	6.2	16.2	7.9	5.8	0.8	7.2	5.2	14.7	6.2	2.0	12.1	29.1	1.9	3.5	13.2	6.8	4.4	2.0	23.4	3.2	59.8	1.4	2.0	2.0	38.7	13.8	8.2	3.3	2.5	8.7	2.7	15.2	39.7	12.2	0.0	5.3	9.1	8.0	7.8	6.4	3.6	12.2	3.5	7.5	3.1	8.5	6.9	2.2	18.5	3.0	7.0	3.4	11.3	5.1	4.5	4.6	0.0	1.8	2.9	7.3	7.5	10.6	11.4	3.0	8.0	6.6	18.0	3.3
KIN	"KIN17, Rts2"	ENSG00000151657	"Kin17 DNA and RNA binding protein"	O60870	10	7750962-7787993	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016339, HPA038700"			Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB016339: AB_627860, HPA038700: AB_2676159"	"unprognostic (4.33e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (3.23e-5)"	2.1	2.4	1.9	2.6	1.9	3.1	2.6	4.4	2.5	2.8	1.8	2.2	2.4	3.3	2.8	2.0	2.4	2.1	2.1	1.8	1.8	2.3	3.3	2.2	3.4	1.7	1.8	3.0	2.7	2.0	2.6	3.0	1.9	2.5	2.2	3.4	2.5	2.1	2.8	3.4	2.4	2.1	1.4	2.8	2.5	2.1	2.0	2.4	2.9	2.2	2.7	2.1	2.4	2.6	4.3	2.7	4.1	2.5	3.3	3.9	3.3	3.8	1.7	4.5	4.8	5.2	4.2	3.3	1.9	2.3	1.4	4.0	3.5	2.3	5.1	3.8	4.0	5.2	2.7	5.1	4.6	1.9	4.1	3.3	2.5	3.4	2.2	3.7	3.4	4.1	5.3	3.1	3.5	3.9	3.8	2.9	3.9	4.5	1.6	4.8	2.9	3.1	3.8	2.3	1.7	3.8	3.0	2.9	6.2	3.8	5.5	3.8	2.5	2.9	3.2	5.1	3.1	4.0	4.7	4.1	3.6	2.9	2.0	15.9	3.9	7.1	3.7	4.3	3.7	5.9	3.3	3.1	3.0	5.4	3.6	3.8	8.8	4.9	4.1	5.8	3.0	1.5	1.9	1.9	4.4	2.5	1.8	1.8	1.7	1.8	1.9	1.4	2.0	2.6	31.5	35.3	27.2	12.1	20.7	17.3	14.6	31.3	13.6	54.8	17.2	20.1	13.0	20.0	24.8	18.4	39.6	36.7	32.0	20.4	13.7	32.9	5.7	21.7	28.4	25.6	23.3	30.3	17.4	21.5	23.8	24.0	14.3	27.9	16.4	22.9	21.0	11.9	32.1	63.9	14.8	20.3	18.3	16.9	22.8	6.2	27.7	21.8	16.0	11.2	30.7	28.7	38.1	13.0	19.4	21.2	23.6	30.9	18.1	18.9	18.2	16.9	26.0	54.7	13.1	27.8	29.7	29.1	19.0	12.1	14.3	38.4	25.7	30.1	14.7	17.3
KLC1	"hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A"	ENSG00000126214	"Kinesin light chain 1"	Q07866	14	103561896-103714249	"Predicted intracellular proteins"	"Host-virus interaction"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 397.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009798, HPA044617, HPA052450"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		14000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838"	"unprognostic (6.93e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.62e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (6.84e-3)"	"prognostic unfavorable (7.17e-4)"	"unprognostic (6.58e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.49e-1)"	70.8	49.4	282.9	42.2	302.0	50.3	63.0	273.5	358.7	74.8	220.4	89.9	26.2	71.5	43.9	66.0	65.0	38.4	100.0	310.6	299.8	35.6	29.9	66.0	44.2	378.9	305.0	62.8	43.0	48.5	86.7	45.9	397.0	47.1	34.3	158.6	54.2	47.1	123.4	68.2	48.7	58.0	300.0	49.0	53.9	45.6	301.7	40.2	48.6	71.5	47.4	66.5	69.8	304.0	57.0	74.2	138.6	76.3	92.6	102.8	65.5	129.5	105.4	118.6	81.7	64.0	60.8	75.8	65.2	139.3	53.2	93.0	85.8	69.6	112.0	89.9	43.9	41.6	92.8	66.1	106.8	83.4	79.5	73.4	109.3	89.6	112.1	126.5	104.2	52.8	63.5	83.7	104.4	94.6	56.9	74.0	45.6	90.1	140.4	53.0	60.6	38.2	74.7	122.5	165.1	93.5	105.7	52.7	90.2	85.9	47.9	40.1	152.7	88.4	43.5	123.1	74.1	65.9	50.0	83.3	101.7	47.7	97.0	5.5	4.6	9.8	7.3	4.6	6.6	5.0	6.5	7.8	5.1	6.8	5.7	5.0	5.0	3.1	6.5	7.6	7.0	2.9	282.9	302.0	273.5	358.7	310.6	299.8	378.9	305.0	397.0	300.0	301.7	304.0	45.2	44.8	32.6	92.4	24.3	26.0	45.1	30.1	13.6	140.8	18.7	19.7	39.3	15.7	21.5	20.2	52.1	22.6	29.5	17.9	9.8	42.9	8.0	30.8	41.8	45.5	44.9	13.2	84.1	30.7	30.6	37.4	27.0	43.2	33.6	31.5	39.3	18.9	30.5	138.0	80.8	24.3	28.5	19.9	23.8	17.0	38.5	24.4	39.2	73.1	36.3	45.4	20.6	57.3	89.8	71.2	17.3	48.2	26.2	46.6	15.8	5.1	23.8	106.1	26.3	46.4	46.8	64.8	83.3	20.1	17.6	42.1	30.8	17.1	17.5	38.4
KLC2	FLJ12387	ENSG00000174996	"Kinesin light chain 2"	Q9H0B6	11	66257294-66267860	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040416, HPA040434"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"	"Nucleoplasm, Mitochondria"	"HPA040416: AB_10795524, HPA040434: AB_10795367"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.57e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.08e-2)"	15.2	18.0	18.8	9.5	25.4	3.6	15.9	33.0	78.1	27.3	0.0	28.5	9.8	27.1	6.3	18.2	21.6	8.9	32.1	26.6	12.7	22.4	8.2	18.9	9.1	39.8	10.8	24.6	15.5	15.2	48.3	7.2	37.0	28.7	4.7	28.4	15.9	16.0	57.8	18.3	16.3	11.2	5.7	13.7	20.2	32.2	23.1	25.1	17.7	14.2	6.4	27.2	21.7	35.8	49.4	58.2	28.3	16.9	16.9	13.5	21.9	34.1	24.2	34.2	26.1	31.9	14.3	21.3	31.9	25.6	43.9	40.7	29.3	33.2	11.4	35.7	37.2	4.4	48.0	22.4	32.1	9.9	22.7	13.5	42.7	40.1	32.8	22.0	16.1	26.2	24.1	29.0	27.8	69.2	56.8	15.0	27.8	14.2	49.2	21.4	14.6	30.1	27.2	27.4	76.3	37.5	24.6	22.1	41.3	15.7	36.3	6.7	26.8	55.5	49.8	68.2	45.5	30.7	27.4	11.9	39.3	6.7	22.9	0.0	0.2	0.5	2.4	0.1	3.1	1.9	1.1	1.6	0.3	3.2	1.1	1.4	0.3	1.3	0.2	2.1	0.3	1.1	18.8	25.4	33.0	78.1	26.6	12.7	39.8	10.8	37.0	5.7	23.1	35.8	4.0	3.2	1.5	8.8	8.9	8.9	9.2	11.1	7.4	34.4	10.1	7.2	2.4	7.2	5.5	12.9	12.5	9.9	5.1	3.1	13.7	14.8	10.1	7.7	6.2	5.2	37.1	0.8	20.7	8.2	18.2	6.5	13.7	9.7	0.0	8.6	3.9	2.3	3.1	55.5	19.0	7.2	18.3	3.2	4.0	4.6	8.7	2.8	12.4	5.6	6.3	14.6	4.1	4.0	6.2	19.1	4.9	13.9	9.1	18.2	3.9	10.3	7.3	35.2	0.0	9.5	13.3	26.2	29.8	8.9	9.7	12.7	8.2	3.4	4.9	8.5
KLC3	"KLC2L, KLCt, KNS2B"	ENSG00000104892	"Kinesin light chain 3"	Q6P597	19	45333434-45351520	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 26.1;skin 1: 104.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 142.0;Basal prostatic cells: 50.8;Ductal cells: 39.1;Prostatic glandular cells: 66.9;Suprabasal keratinocytes: 183.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 36.1;HaCaT: 16.2;HBEC3-KT: 10.5;hTCEpi: 12.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052797, HPA056508"	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Actin filaments"	"Nucleoplasm, Cytosol"	"HPA052797: AB_2681954, HPA056508: AB_2683159"	"unprognostic (4.11e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.07e-4)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (3.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.14e-1)"	"unprognostic (2.37e-1)"	0.3	0.2	0.5	0.3	1.1	3.0	3.3	1.3	0.8	10.0	0.0	0.1	0.1	0.2	2.1	26.1	0.3	0.2	0.2	0.4	0.2	5.9	0.2	0.9	0.3	0.5	0.0	0.2	4.0	4.0	2.7	0.2	0.2	2.6	0.2	1.0	11.6	1.0	0.9	104.1	0.3	0.0	0.0	0.3	0.5	3.7	0.2	1.0	0.7	0.0	1.8	0.2	20.5	0.7	36.1	0.2	0.2	0.4	0.1	0.1	2.8	0.2	0.0	0.0	0.1	3.5	6.5	0.3	2.8	0.0	3.7	16.2	2.2	10.5	0.2	0.8	5.3	0.1	1.1	0.7	0.0	0.3	2.2	0.0	12.9	0.1	2.5	0.4	0.0	0.5	0.6	0.4	0.1	4.7	0.1	0.4	0.8	0.6	1.1	5.6	0.0	0.3	0.3	1.3	4.5	0.7	0.3	7.3	1.0	0.4	6.5	0.1	0.0	0.4	3.6	0.3	0.4	0.7	0.8	0.3	0.2	0.2	0.4	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.1	0.0	0.5	1.1	1.3	0.8	0.4	0.2	0.5	0.0	0.2	0.0	0.2	0.7	0.2	0.0	2.4	0.3	0.0	142.0	50.8	17.5	14.8	0.8	10.3	25.3	0.4	2.8	7.3	1.8	0.0	0.2	0.2	0.2	9.8	39.1	3.0	0.9	0.3	1.7	0.0	2.7	0.3	3.1	0.7	1.4	0.0	2.4	0.0	6.7	0.4	0.0	0.3	1.7	0.4	0.5	6.1	0.0	10.9	12.0	1.8	0.4	14.2	0.0	0.8	0.7	0.0	0.0	0.0	11.8	0.0	0.4	0.0	66.9	0.0	1.4	3.8	2.0	0.0	1.1	2.5	0.6	11.3	25.6	183.3	0.7	1.0	0.0	0.1	22.0
KLF1	EKLF	ENSG00000105610	"Kruppel like factor 1"	Q13351	19	12884422-12887201	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"bone marrow: 41.2"	"Cell type enriched"	"Detected in some"	199	"Erythroid cells: 519.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	8	"monocytes: 1.9"	"Group enriched"	"Detected in some"	29	"HEL: 61.6;K-562: 150.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051850	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA051850: AB_2616460"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.44e-1)"	0.0	0.0	0.1	0.0	0.1	41.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	2.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	61.6	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	150.5	0.0	0.0	0.2	0.3	0.4	0.7	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.4	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	3.6	0.0	0.0	0.6	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	519.2	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.1	0.1
KLF11	"MODY7, TIEG2, Tieg3"	ENSG00000172059	"Kruppel like factor 11"	O14901	2	10042849-10054836	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.0;Suprabasal keratinocytes: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058276			Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Focal adhesion sites, Cytosol"	"HPA058276: AB_2683664"	"unprognostic (9.66e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-3)"	"unprognostic (2.63e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.24e-2)"	27.7	15.6	4.0	7.6	3.2	27.8	22.3	8.3	3.9	13.5	4.1	17.9	7.5	20.0	9.7	13.2	13.7	18.1	19.1	2.9	3.9	15.7	35.2	22.4	9.3	3.7	3.3	23.9	54.2	18.3	2.5	19.5	3.4	10.1	9.3	3.0	15.9	14.8	12.1	26.9	8.7	16.8	3.2	18.8	12.4	30.0	3.5	4.0	16.5	27.3	5.5	12.6	13.1	5.1	6.9	3.3	7.8	0.7	5.3	9.4	18.8	7.9	7.9	4.4	4.6	7.8	15.8	0.0	13.9	9.6	17.9	1.6	6.8	6.1	2.9	47.6	5.2	3.5	9.7	1.6	5.2	14.6	22.1	14.7	22.3	8.4	2.3	11.4	3.9	1.3	9.7	30.8	4.6	8.2	0.0	2.7	12.5	5.6	6.7	7.8	0.2	13.6	10.8	8.5	10.0	6.2	12.0	24.5	23.4	12.2	5.7	19.6	11.2	19.3	15.9	14.7	2.6	27.9	36.0	18.7	5.0	3.8	10.4	0.0	8.2	2.0	2.6	12.3	0.8	3.2	1.8	1.9	7.3	2.9	0.5	1.1	0.2	6.6	14.8	0.3	3.0	5.4	4.0	3.2	8.3	3.9	2.9	3.9	3.7	3.3	3.4	3.2	3.5	5.1	58.8	6.4	4.6	0.3	12.5	60.5	17.7	5.5	25.6	6.2	14.3	13.2	3.5	10.0	6.1	7.3	6.2	3.2	10.1	2.5	29.4	8.2	135.0	9.1	21.5	33.3	7.1	4.6	1.7	8.5	4.2	17.5	9.7	26.6	8.2	15.5	37.5	38.1	12.5	3.3	1.4	7.0	16.2	32.4	42.4	25.9	14.6	22.0	30.2	1.0	16.6	2.2	3.1	0.5	0.3	8.9	1.5	16.6	5.3	15.0	6.1	8.4	4.3	5.8	32.9	10.4	35.7	13.8	39.0	13.1	86.2	8.2	10.8	11.2	7.8	11.7
KLF12	"AP-2rep, AP2REP, HSPC122"	ENSG00000118922	"Kruppel like factor 12"	Q9Y4X4	13	73686089-73995056	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Astrocytes: 319.3;Excitatory neurons: 211.9;Inhibitory neurons: 562.2;Microglial cells: 208.9;Oligodendrocyte precursor cells: 760.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064146, HPA075652"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA064146: AB_2685198, HPA075652: "	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.67e-3)"	2.9	1.9	4.1	6.1	2.9	3.0	2.9	5.5	5.3	2.3	2.7	3.7	1.5	3.6	11.2	2.0	2.8	3.0	5.3	5.6	4.5	5.5	9.9	2.6	11.3	3.3	4.9	5.2	0.9	0.8	3.4	0.8	3.6	2.5	2.9	8.9	1.4	3.2	3.6	1.6	3.6	3.4	3.1	7.6	2.7	1.6	5.1	10.3	1.6	8.5	9.8	2.6	2.0	3.5	0.0	1.4	13.6	0.0	7.5	16.3	0.1	5.4	2.7	5.9	6.2	1.1	3.4	10.5	2.5	8.1	2.3	3.7	3.6	4.2	15.7	6.9	4.9	0.4	6.3	0.0	2.4	7.0	2.5	14.3	1.1	8.4	6.7	11.4	11.9	8.0	0.0	2.6	18.0	1.1	13.6	0.0	1.9	0.5	2.7	7.4	4.9	0.1	3.3	0.2	3.2	13.8	3.8	1.7	6.3	5.0	0.4	1.1	0.1	11.4	3.5	5.2	2.6	7.0	9.6	3.3	20.2	0.0	5.9	0.6	0.0	0.0	2.0	0.2	2.4	0.8	1.7	2.3	0.2	0.7	1.2	1.9	0.0	1.4	0.3	0.4	0.9	0.8	4.1	2.9	5.5	5.3	5.6	4.5	3.3	4.9	3.6	3.1	5.1	3.5	6.6	6.4	1.8	319.3	30.5	4.2	1.3	4.3	0.6	20.8	5.4	6.2	18.7	5.7	3.7	3.7	37.5	0.1	35.4	3.0	3.9	2.1	0.8	4.6	18.8	8.4	0.0	7.8	211.9	0.0	0.1	12.3	2.0	6.3	0.0	29.2	5.0	20.3	0.1	8.4	562.2	1.5	10.2	8.0	12.1	1.6	20.8	5.0	3.6	208.9	6.4	11.2	43.3	760.0	25.4	0.4	3.2	28.6	21.9	3.3	0.2	7.0	6.0	13.1	0.0	12.2	18.1	0.5	3.5	0.7	6.7	0.1	40.3	4.9	3.9	1.8
KLF15	KKLF	ENSG00000163884	"Kruppel like factor 15"	Q9UIH9	3	126342635-126357408	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 92.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.9;Cardiomyocytes: 29.7;Distal tubular cells: 29.4;Hepatocytes: 66.9;Peritubular cells: 19.9;Proximal tubular cells: 22.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.4;HHSteC: 34.8;RPMI-8226: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003286, HPA028866"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA003286: , HPA028866: AB_10600819"	"unprognostic (3.77e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (3.27e-7)"	"unprognostic (6.75e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.58e-3)"	36.5	6.2	42.2	0.8	50.7	0.1	25.4	45.1	69.5	15.8	37.5	18.6	1.2	19.1	4.1	7.1	29.7	3.5	31.4	41.7	40.6	20.3	92.5	18.6	1.8	64.9	45.9	46.3	48.5	4.5	10.4	1.7	47.2	17.6	0.9	3.9	19.7	5.2	67.3	10.3	10.2	2.5	44.9	3.6	30.2	5.6	44.7	1.2	11.1	32.4	0.8	27.0	12.0	48.4	0.8	0.0	2.2	9.2	57.4	1.0	10.0	0.6	1.4	0.7	1.3	1.1	0.0	3.4	0.9	0.0	1.7	0.1	5.3	0.1	0.2	0.2	2.0	0.1	0.8	7.9	34.8	0.0	0.2	5.4	0.5	0.0	1.2	0.0	0.6	4.5	4.3	7.4	0.2	0.7	0.0	1.3	6.6	1.3	0.3	4.7	0.2	20.2	0.1	0.8	0.7	7.7	0.1	0.3	10.2	3.3	0.5	4.6	0.3	0.3	0.4	0.3	0.3	4.7	0.6	0.7	0.2	1.5	1.3	25.1	7.6	10.3	7.0	10.2	8.2	12.3	7.3	7.4	8.2	11.4	9.4	11.3	16.7	12.8	9.3	9.0	10.5	11.7	42.2	50.7	45.1	69.5	41.7	40.6	64.9	45.9	47.2	44.9	44.7	48.4	1.5	6.4	4.6	22.9	0.8	0.0	2.9	0.2	0.6	1.3	7.8	1.8	29.7	15.7	0.7	0.0	0.0	0.1	0.1	0.0	29.4	0.1	0.1	2.5	4.4	2.1	0.0	2.7	0.6	0.0	0.2	8.1	3.1	3.4	0.0	13.7	8.2	66.9	0.1	0.0	2.8	0.1	0.0	2.6	0.0	0.8	12.2	0.4	1.8	2.8	0.0	12.0	0.0	15.1	5.7	0.4	0.0	19.9	0.9	5.2	0.0	22.1	0.8	3.3	0.0	12.0	5.5	0.1	0.1	0.3	0.0	0.3	0.5	0.6	0.1	1.8
KLF16	"BTEB4, DRRF, NSLP2"	ENSG00000129911	"Kruppel like factor 16"	Q9BXK1	19	1852399-1863579	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 58.7;Rod photoreceptor cells: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052481	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA052481: AB_2681845"	"unprognostic (3.24e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (5.85e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.76e-2)"	9.1	8.7	31.8	6.5	48.9	13.0	5.6	0.5	35.7	5.3	0.0	9.6	8.5	8.9	1.7	16.1	7.5	2.9	7.8	34.7	6.9	9.3	14.5	10.3	4.4	6.5	3.4	5.8	6.4	2.8	15.3	3.5	6.9	6.4	2.6	11.9	8.0	2.0	3.0	14.5	9.9	3.0	3.0	15.1	7.1	9.6	12.0	3.3	4.5	0.7	3.1	6.7	6.6	9.4	29.8	15.5	7.7	16.2	4.5	5.4	16.9	22.4	5.0	9.1	8.1	12.5	12.9	22.0	18.8	14.5	8.3	27.1	11.9	20.1	5.7	33.8	20.9	22.9	8.1	15.0	10.2	22.0	37.2	8.1	11.9	15.1	18.7	11.1	8.0	14.3	28.6	16.6	7.7	22.5	20.6	27.3	25.4	19.5	22.1	31.8	7.2	24.3	9.7	10.0	33.7	28.4	7.8	11.9	27.1	7.1	11.2	27.4	19.4	14.8	22.6	34.1	30.8	23.3	29.0	25.2	15.3	18.7	15.9	1.3	1.2	1.3	0.8	1.1	0.9	1.2	0.9	0.5	1.0	1.6	0.8	0.6	2.7	0.1	1.1	5.2	1.3	0.7	31.8	48.9	0.5	35.7	34.7	6.9	6.5	3.4	6.9	3.0	12.0	9.4	13.3	0.0	5.8	2.6	10.7	26.8	12.1	6.6	11.4	58.7	30.9	19.6	2.0	7.2	5.5	3.7	22.9	3.7	24.6	38.8	1.9	6.2	49.2	18.6	9.0	10.6	32.9	8.6	2.8	8.1	2.8	6.3	8.2	19.3	4.5	6.8	10.0	15.4	13.4	15.2	1.8	22.6	4.1	10.7	12.5	37.0	5.0	12.7	12.4	5.6	9.6	12.3	1.0	1.5	1.2	12.8	24.9	3.4	8.2	13.2	19.7	6.1	7.7	53.0	0.0	11.6	8.0	1.6	4.3	17.9	27.1	4.0	13.2	7.0	20.6	13.5
KLF2	LKLF	ENSG00000127528	"Kruppel like factor 2"	Q9Y5W3	19	16324826-16328685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1043.3;B-cells: 691.8;dendritic cells: 542.9;Endothelial cells: 511.8;Gastric mucus-secreting cells: 561.7;NK-cells: 466.5;Plasma cells: 806.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 26.8;TIME: 67.8;U-266/70: 45.6;U-266/84: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055964	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA055964: AB_2682989"	"unprognostic (3.22e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.55e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.56e-2)"	153.7	27.1	25.0	61.6	23.2	90.0	108.4	15.4	18.5	59.2	10.9	55.2	9.6	61.5	2.5	32.2	105.9	14.7	118.4	13.6	17.9	41.6	13.4	110.8	45.4	27.3	34.1	152.6	12.5	5.6	28.8	22.4	24.2	41.8	5.0	0.6	35.7	6.8	52.0	65.5	44.6	19.5	14.1	70.9	73.1	18.3	27.9	13.0	53.5	20.5	8.3	86.9	63.8	15.5	7.5	1.8	0.1	1.6	0.4	1.0	2.9	16.6	1.8	5.5	1.8	0.1	24.0	0.7	3.7	6.7	0.9	2.5	0.5	0.0	1.5	0.6	2.0	0.0	1.4	0.2	4.2	0.0	12.1	1.2	0.2	1.4	0.3	7.1	10.9	14.7	0.5	15.4	2.4	0.4	1.5	3.2	0.2	7.3	2.2	0.5	4.3	26.8	0.2	0.3	0.5	0.2	0.9	12.3	10.4	0.1	0.5	8.6	67.8	12.9	9.4	1.0	23.8	45.6	49.3	1.6	5.7	0.0	5.8	63.2	8.3	25.1	42.7	32.9	34.9	44.7	56.6	43.9	3.3	47.5	53.5	44.4	79.5	28.7	29.1	0.6	59.4	20.5	25.0	23.2	15.4	18.5	13.6	17.9	27.3	34.1	24.2	14.1	27.9	15.5	1043.3	35.3	60.0	1.0	691.8	23.8	25.9	7.4	30.1	5.8	69.6	51.8	47.9	31.5	9.0	3.7	8.4	4.5	542.9	151.7	0.0	10.3	2.3	53.8	31.1	511.8	46.4	35.0	0.8	6.0	7.6	350.6	561.7	20.4	33.6	8.1	393.3	10.6	91.3	0.0	1.9	110.5	2.0	242.4	58.5	6.3	89.5	272.9	64.0	48.7	74.1	7.6	466.5	0.5	0.3	64.3	61.3	73.0	806.5	10.7	4.8	1.9	18.2	8.8	65.7	460.9	235.3	0.8	2.9	22.1	26.3	6.6	417.8	57.9	33.7	12.9
KLF3	BKLF	ENSG00000109787	"Kruppel like factor 3"	P57682	4	38664197-38701517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049512, HPA065054"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA049512: AB_2680799, HPA065054: AB_2685415"	"unprognostic (4.20e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.10e-3)"	27.9	23.8	13.8	22.1	18.4	95.0	20.8	16.5	14.9	30.1	14.1	44.5	38.0	28.0	14.1	56.3	20.2	33.5	14.8	14.6	14.1	16.1	44.2	23.9	16.4	19.8	17.9	44.7	33.4	31.0	11.3	31.5	18.4	23.3	47.4	16.6	31.2	19.7	14.5	65.4	38.7	25.7	15.7	29.2	46.0	5.2	16.1	13.1	28.1	17.9	19.6	42.1	39.2	21.3	21.1	14.1	51.8	10.6	23.3	34.5	16.8	11.3	32.5	7.4	9.2	13.3	37.3	0.0	15.7	24.4	21.6	22.3	14.9	19.8	11.9	0.3	11.5	20.1	20.7	28.5	23.8	5.0	0.2	31.3	53.3	10.8	20.0	14.0	29.0	7.6	58.0	9.7	12.0	4.7	5.4	8.8	12.2	42.6	10.1	7.2	25.2	22.8	26.4	49.1	14.9	19.4	12.3	9.6	24.4	20.8	6.0	6.9	46.2	24.6	14.4	42.2	12.4	13.7	4.6	0.1	10.2	14.9	10.7	10.8	4.4	17.0	6.3	7.6	4.5	5.3	7.0	5.7	3.4	4.2	9.7	5.6	13.4	3.0	12.5	0.8	8.3	2.4	13.8	18.4	16.5	14.9	14.6	14.1	19.8	17.9	18.4	15.7	16.1	21.3	108.7	22.4	29.5	20.9	78.6	121.5	150.9	82.2	99.0	42.8	38.5	29.7	16.2	77.2	76.6	31.3	31.3	27.4	137.3	219.5	11.7	88.3	1.1	87.3	70.8	86.7	86.5	239.3	11.6	86.2	21.8	70.0	230.4	168.2	19.7	35.0	65.7	57.2	56.3	35.3	27.9	170.3	91.6	87.9	78.6	4.1	51.9	94.9	49.8	45.0	64.4	46.7	143.2	36.2	47.8	113.6	145.5	48.2	105.2	143.9	124.6	24.3	39.4	38.1	26.3	55.5	42.6	1.1	5.0	191.6	222.5	27.4	84.3	62.4	128.4	308.7
KLF4	"EZF, GKLF"	ENSG00000136826	"Kruppel like factor 4"	O43474	9	107484852-107490482	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 254.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1054.7;Basal squamous epithelial cells: 832.1;Distal enterocytes: 789.2;Intestinal goblet cells: 710.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.0;non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.2;hTCEpi: 84.4;hTERT-HME1: 54.5;OE19: 47.2;U-2197: 111.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002926	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA002926: AB_1852541"	"unprognostic (2.06e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.93e-5)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.32e-2)"	73.5	23.9	5.1	21.0	4.7	50.5	63.7	4.0	7.8	53.2	4.6	87.3	28.4	16.0	5.6	102.1	43.0	44.3	31.0	3.7	5.1	6.2	12.4	44.8	5.6	5.0	4.7	29.0	7.0	5.7	4.9	32.4	5.0	16.7	96.0	0.8	27.5	7.6	14.2	254.7	40.5	40.6	4.1	24.1	58.0	17.8	6.0	17.0	25.2	23.2	14.5	43.9	58.9	4.0	13.3	3.9	0.6	0.1	16.6	39.2	5.2	4.4	27.6	6.7	8.1	1.0	18.0	0.0	0.6	6.9	23.7	8.7	6.1	3.9	3.0	0.0	2.2	0.0	7.5	0.3	21.6	0.0	0.0	5.0	84.4	14.0	54.5	1.5	0.6	0.2	0.6	0.0	4.1	7.3	0.0	1.4	4.1	47.2	25.2	0.3	1.6	0.2	2.3	3.7	0.4	0.2	4.0	11.8	15.2	12.7	1.3	5.4	3.5	3.6	0.1	111.5	2.1	0.2	0.1	0.0	3.4	2.6	6.8	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	1.0	0.2	0.0	0.1	5.1	4.7	4.0	7.8	3.7	5.1	5.0	4.7	5.0	4.1	6.0	4.0	1054.7	12.8	41.1	0.3	32.2	436.0	284.3	143.0	832.1	0.5	206.7	205.0	70.3	35.8	71.5	1.8	8.4	49.1	15.0	789.2	1.9	24.4	263.1	154.1	216.0	336.6	123.8	4.8	0.0	38.7	75.5	463.2	537.2	297.4	54.7	4.7	216.0	4.6	89.9	0.0	0.2	710.9	83.4	232.9	282.0	163.0	143.8	401.0	206.3	16.9	36.8	2.0	0.0	0.0	0.0	49.3	540.9	60.5	38.3	187.3	198.0	2.1	46.4	2.0	39.5	463.7	130.0	21.6	15.9	639.9	674.0	107.9	26.8	63.5	332.6	236.8
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077541	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 242.0;skin 1: 234.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1105.5;Basal squamous epithelial cells: 757.5;Glandular and luminal cells: 678.2;Squamous epithelial cells: 1028.4;Suprabasal keratinocytes: 685.9;Urothelial cells: 1495.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	21	"basophil: 24.0"	"Lineage enriched"	"Detected in single"	140	"granulocytes: 24.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 111.8;HaCaT: 128.8;HBEC3-KT: 112.2;hTCEpi: 156.1;OE19: 246.3;RT4: 136.3;SiHa: 114.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 23.2"	HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	6.5	5.9	4.2	18.0	9.1	63.5	36.2	0.6	3.3	49.9	2.7	161.2	130.4	6.7	6.6	242.0	37.5	55.9	3.3	2.6	3.4	8.5	4.7	29.6	2.0	0.8	3.4	4.5	11.9	0.5	10.9	18.8	0.7	23.1	145.4	0.4	79.8	14.4	19.2	234.9	146.2	6.6	0.5	1.5	82.2	12.0	4.1	12.0	25.7	7.8	53.6	111.5	122.2	1.0	22.3	31.1	0.2	0.4	1.1	1.5	34.1	12.9	29.8	5.6	6.9	28.5	111.8	0.4	68.9	11.4	2.3	128.8	39.0	112.2	8.9	0.9	11.0	0.4	61.9	2.8	7.8	10.5	1.9	8.1	156.1	1.7	61.1	5.7	0.1	3.8	1.6	2.2	25.5	7.9	2.1	0.8	1.4	246.3	43.3	2.0	28.3	2.5	87.3	136.3	2.9	1.3	114.5	18.3	8.5	13.9	2.5	2.5	0.3	7.8	23.1	0.2	5.4	3.7	1.9	3.8	10.8	2.1	9.5	24.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	4.2	9.1	0.6	3.3	2.6	3.4	0.8	3.4	0.7	0.5	4.1	1.0	7.8	163.5	123.3	0.7	5.2	518.9	1105.5	185.6	757.5	0.4	79.9	57.0	6.0	91.5	218.5	36.8	2.1	77.8	4.6	420.7	21.5	31.8	448.3	302.1	44.1	12.5	203.2	0.4	1.6	46.1	98.5	33.4	425.1	678.2	3.8	0.9	2.2	4.7	6.1	10.1	11.6	387.4	46.8	0.9	34.6	241.4	6.5	12.4	58.7	1.9	4.3	0.0	1.0	1.0	0.6	88.6	374.9	1.5	15.7	632.1	260.0	3.5	159.3	0.2	0.0	38.4	32.4	8.8	26.3	1028.4	685.9	58.0	17.4	0.5	505.4	1495.5
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 436.6"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 2075.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Supported	Nucleoplasm,Nucleoli,Vesicles,Cytosol		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: AB_2686157"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	211.3	46.9	19.0	122.1	18.0	436.6	129.7	19.2	22.4	95.4	21.9	92.1	55.4	98.1	17.7	165.5	77.2	181.9	49.7	18.0	19.2	64.1	141.8	117.0	65.4	29.4	20.1	47.3	118.3	31.8	12.0	98.2	25.2	32.8	99.6	18.4	73.8	33.7	84.9	197.1	106.0	208.2	22.7	64.3	73.2	14.6	23.0	56.8	193.9	41.3	45.0	136.3	92.7	25.0	55.0	14.7	27.2	9.0	155.1	154.3	17.1	91.7	46.5	95.9	64.8	38.0	71.4	15.6	20.8	100.0	74.5	32.7	17.0	84.9	79.5	76.6	10.2	2.2	17.5	35.8	66.4	10.3	51.5	51.4	158.2	68.6	129.3	34.2	99.3	10.1	17.5	117.9	123.6	4.0	19.4	15.9	10.2	29.2	26.0	12.6	28.2	55.5	94.1	53.4	12.0	11.5	22.5	64.0	142.8	73.5	32.0	8.6	130.9	128.7	17.8	76.9	43.0	22.6	78.1	28.6	34.7	13.7	40.8	318.8	85.2	234.1	129.8	74.2	115.9	81.1	147.4	131.5	67.6	70.9	44.9	69.0	391.6	72.5	104.6	152.8	120.6	148.7	19.0	18.0	19.2	22.4	18.0	19.2	29.4	20.1	25.2	22.7	23.0	25.0	511.0	1246.8	489.4	14.0	716.9	585.5	1298.4	625.8	1227.0	39.6	985.9	630.0	63.6	544.7	451.9	138.0	33.3	163.1	518.3	1507.0	21.5	808.6	58.0	1065.6	618.9	469.9	397.3	77.9	18.5	553.0	473.8	545.5	1120.3	1905.9	626.7	195.9	248.4	309.9	583.6	37.0	10.0	746.7	429.3	968.7	885.1	53.2	130.5	992.1	483.8	58.1	609.8	42.9	150.4	7.5	4.3	857.9	949.9	133.9	1172.5	600.2	1009.9	97.4	342.0	90.1	138.1	194.8	441.8	9.0	19.4	2075.6	628.2	195.9	920.5	67.1	542.0	572.5
KLF7	UKLF	ENSG00000118263	"Kruppel like factor 7"	O75840	2	207074137-207167267	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 95.2;Oligodendrocytes: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003423, HPA030490"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA003423: , HPA030490: AB_10601922"	"unprognostic (5.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.85e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.47e-2)"	19.9	8.2	8.2	13.8	15.0	40.3	15.0	19.3	9.1	8.9	0.0	11.4	4.6	16.9	5.9	9.7	10.0	11.8	10.1	8.3	13.4	7.9	7.1	15.2	7.7	20.2	17.0	14.2	5.1	3.0	4.9	5.8	20.9	8.2	5.3	4.7	7.4	7.4	4.9	6.8	10.3	20.9	12.1	10.3	9.1	6.8	17.4	14.3	8.8	7.4	7.3	9.8	9.8	20.3	8.8	6.1	16.3	1.1	5.6	14.4	3.4	10.0	8.0	15.3	6.7	0.1	7.1	0.1	6.3	20.6	26.5	21.5	13.9	46.2	8.2	6.0	0.8	0.2	18.5	3.5	9.7	4.6	6.7	19.3	15.3	10.7	35.0	22.0	18.1	4.6	0.0	8.2	11.8	0.2	5.6	1.7	9.7	0.9	3.0	2.4	4.3	6.4	3.7	6.8	25.0	30.5	8.6	12.0	7.8	13.0	2.0	6.9	35.9	30.3	14.5	12.9	12.0	6.2	4.5	0.0	26.7	3.8	6.1	28.9	9.4	12.3	1.6	12.1	0.6	5.7	8.4	1.6	5.3	7.7	14.3	9.9	40.8	22.9	22.7	2.4	7.7	6.1	8.2	15.0	19.3	9.1	8.3	13.4	20.2	17.0	20.9	12.1	17.4	20.3	95.2	41.7	6.7	74.4	15.8	21.9	23.1	35.0	6.2	9.0	9.9	11.4	17.6	14.3	15.1	9.2	12.5	0.5	6.9	0.4	1.9	22.7	10.2	13.9	33.7	65.8	6.0	2.5	46.4	51.5	0.8	22.0	11.7	17.3	12.0	3.6	79.9	14.7	15.6	11.8	31.1	2.6	34.6	50.0	22.9	5.2	13.7	37.6	3.6	61.8	28.3	7.1	8.2	68.9	160.5	79.9	1.4	10.1	4.3	9.2	14.1	4.3	9.8	8.7	46.0	38.6	42.0	0.8	14.8	8.1	15.3	1.1	7.6	7.9	4.3	9.3
KLF8	"BKLF3, DXS741, ZNF741"	ENSG00000102349	"Kruppel like factor 8"	O95600	X	56232356-56291531	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 29.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 37.6;Peritubular cells: 27.4;Squamous epithelial cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;hTCEpi: 7.8;RPTEC TERT1: 3.9;RT4: 5.0;SK-BR-3: 5.4;T-47d: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071740			Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA071740: AB_2686440"	"unprognostic (2.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-8)"	"unprognostic (2.96e-1)"	"prognostic favorable (3.32e-4)"	"unprognostic (6.56e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.15e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.60e-2)"	14.7	2.1	1.1	1.3	1.7	0.6	13.9	1.5	1.4	11.7	0.6	6.4	0.5	10.0	3.7	23.5	9.5	1.7	4.9	1.3	0.8	7.4	0.7	6.1	1.6	0.5	0.6	9.8	2.0	1.1	2.0	3.9	0.6	4.8	1.8	0.6	9.9	2.0	3.8	29.4	5.8	4.9	0.6	5.2	3.7	3.1	0.8	1.2	6.1	1.8	3.0	7.5	17.8	0.9	1.3	0.0	0.0	0.1	1.1	0.4	0.7	0.2	1.5	0.0	0.0	0.0	0.0	0.4	1.9	0.1	0.0	2.9	0.0	0.0	0.0	2.0	3.7	1.0	0.0	0.0	0.1	0.1	0.3	0.0	7.8	0.0	0.6	0.0	0.0	0.3	0.9	0.6	0.2	0.1	0.3	0.1	1.0	0.0	0.0	0.2	0.0	0.2	3.9	5.0	0.0	0.0	2.4	5.4	0.0	3.3	9.5	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.2	1.2	0.3	0.4	0.6	1.2	0.1	0.0	0.2	1.5	0.0	0.2	0.1	0.1	1.1	1.7	1.5	1.4	1.3	0.8	0.5	0.6	0.6	0.6	0.8	0.9	12.1	0.0	4.1	2.3	11.2	6.9	4.5	3.6	6.2	0.4	8.0	4.1	3.5	0.0	2.2	14.7	2.1	6.3	1.3	1.0	0.0	0.8	0.6	1.9	4.1	11.1	0.0	4.8	14.0	1.0	15.0	6.2	0.0	5.6	1.3	3.5	21.4	0.0	1.2	0.0	5.4	0.7	2.0	1.3	13.9	2.0	37.6	3.2	5.4	8.4	2.1	0.5	5.2	2.5	3.6	0.4	0.3	27.4	5.6	7.5	0.4	7.5	1.5	0.1	19.7	5.2	8.1	0.9	1.1	27.0	11.6	4.5	2.2	3.1	1.2	10.9
KLF9	BTEB1	ENSG00000119138	"Kruppel like factor 9"	Q13886	9	70384597-70414624	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 264.3;Skeletal myocytes: 223.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 60.4;ASC TERT1: 83.0;HHSteC: 107.4;HSkMC: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029308			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA029308: AB_10601923"	"unprognostic (2.12e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (4.34e-1)"	"unprognostic (5.55e-1)"	"unprognostic (9.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.44e-1)"	"prognostic favorable (6.59e-6)"	"unprognostic (1.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	82.0	36.5	12.5	22.8	22.1	18.2	67.6	29.8	22.5	29.9	14.9	66.5	15.3	56.5	16.7	41.1	73.0	42.6	54.7	15.7	14.4	54.9	91.3	71.6	14.4	21.3	21.1	63.4	52.9	51.1	25.5	10.2	17.3	36.5	26.2	19.2	35.4	24.4	123.3	40.8	33.2	58.9	15.6	22.9	48.9	7.7	21.7	12.1	57.1	94.7	14.3	43.4	37.2	19.1	0.4	0.6	0.0	7.8	60.4	83.0	0.8	4.1	27.1	1.4	3.0	0.1	3.6	0.1	3.0	7.5	2.0	0.1	11.9	18.4	2.8	0.0	9.3	4.2	13.1	2.4	107.4	2.1	10.9	71.6	18.4	1.1	25.9	37.1	23.9	1.8	8.4	16.4	10.2	1.3	0.3	6.2	0.7	1.2	3.9	0.0	3.7	10.9	5.0	0.0	1.0	5.2	37.3	21.5	45.2	2.5	7.1	6.7	32.8	7.1	5.1	8.2	2.2	11.8	13.5	0.6	6.4	6.6	35.9	0.7	0.1	0.1	0.4	0.1	0.6	0.9	0.5	0.4	0.3	0.6	0.7	0.4	0.0	0.1	0.2	0.4	0.6	0.1	12.5	22.1	29.8	22.5	15.7	14.4	21.3	21.1	17.3	15.6	21.7	19.1	264.3	41.7	25.5	25.8	36.5	48.2	62.7	13.0	97.3	45.3	48.3	34.7	74.1	64.3	22.3	14.7	20.9	0.2	51.0	36.7	31.3	10.5	22.3	40.6	171.6	124.3	13.8	14.5	32.1	13.1	0.5	180.8	55.5	59.6	7.6	2.0	109.9	158.8	3.7	80.8	13.7	32.3	14.2	70.1	44.6	18.1	90.7	81.3	39.2	29.0	9.7	126.1	19.6	3.0	11.1	12.8	26.1	85.0	30.2	74.0	54.5	39.7	17.4	10.1	78.9	223.8	203.5	2.1	3.2	72.7	34.2	0.0	54.9	16.3	31.9	33.3
KLHDC10	"KIAA0265, slim"	ENSG00000128607	"Kelch domain containing 10"	Q6PID8	7	130070534-130135705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020119	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA020119: AB_2249467"	"unprognostic (2.83e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.64e-2)"	12.3	17.3	19.4	9.5	19.8	7.9	14.6	27.0	17.2	12.4	21.6	12.8	11.1	13.0	13.7	12.6	14.9	9.5	13.5	18.5	26.3	21.2	23.2	11.9	8.4	17.4	25.1	14.4	15.4	30.7	14.0	13.9	21.5	12.6	12.7	15.4	10.6	12.2	24.0	13.2	10.4	11.5	16.5	10.8	11.7	38.0	31.1	11.8	18.1	22.0	9.3	8.6	8.9	15.8	24.5	22.5	15.3	83.8	19.9	21.8	7.0	22.9	17.5	17.1	17.7	12.4	18.3	20.7	15.8	21.2	28.4	18.8	24.6	14.6	21.4	16.9	14.8	12.2	24.7	14.6	15.6	22.5	14.4	13.8	24.8	26.2	16.4	21.2	24.4	14.2	59.9	12.7	19.4	20.7	19.5	21.9	2.6	18.0	14.6	15.8	28.6	15.1	23.5	16.7	24.6	19.7	36.8	65.2	18.5	18.5	15.9	16.6	27.7	21.8	9.5	29.5	27.6	16.7	23.6	19.2	45.7	21.4	30.0	0.0	0.4	0.5	0.6	0.6	0.5	0.4	0.4	0.7	0.5	1.1	0.3	0.7	0.4	0.1	0.5	0.4	0.9	0.1	19.4	19.8	27.0	17.2	18.5	26.3	17.4	25.1	21.5	16.5	31.1	15.8	18.6	19.2	20.2	53.8	9.7	23.2	7.8	13.6	14.2	20.1	31.0	20.1	23.1	30.0	19.7	35.0	39.6	11.3	12.6	18.2	3.9	18.3	66.7	31.2	24.9	19.0	19.9	18.7	85.7	23.8	9.6	22.2	13.3	18.4	6.3	19.6	37.9	42.3	12.2	35.3	86.1	15.8	20.3	23.0	12.8	17.4	15.2	11.7	17.8	72.1	15.5	18.4	7.2	82.4	59.9	20.5	9.2	24.5	9.8	13.0	16.2	27.5	27.2	22.1	0.0	30.6	14.7	36.2	6.3	17.5	29.1	11.2	9.6	22.7	20.4	12.2
KLHDC2	"HCLP-1, LCP"	ENSG00000165516	"Kelch domain containing 2"	Q9Y2U9	14	49768130-49786385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000628	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nuclear bodies"	"HPA000628: AB_2666051"	"unprognostic (2.65e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.52e-3)"	"unprognostic (4.54e-2)"	"unprognostic (9.72e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-3)"	"unprognostic (6.77e-3)"	"prognostic favorable (2.75e-10)"	"unprognostic (2.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.34e-2)"	21.5	22.3	12.8	8.6	13.3	10.1	19.6	13.7	16.1	18.8	15.0	23.8	18.4	20.7	14.8	15.0	17.0	13.8	38.0	14.4	14.0	34.1	49.1	14.5	10.9	12.4	12.3	25.1	30.3	16.8	17.7	12.7	13.9	18.5	18.0	23.9	20.1	20.1	53.0	18.8	21.6	14.1	13.3	12.3	24.4	23.3	12.6	15.2	28.2	38.2	10.5	22.3	16.2	14.9	14.7	12.2	22.5	11.0	31.7	27.5	23.7	15.0	28.8	18.8	19.0	7.1	19.6	29.1	20.4	27.4	10.8	12.8	13.9	13.9	15.9	20.1	14.7	9.1	8.6	17.0	23.1	19.6	7.8	28.6	23.5	8.6	16.9	23.1	17.4	24.6	11.8	21.5	15.1	17.3	20.1	8.6	16.6	17.0	34.8	15.3	24.0	18.1	8.6	31.2	27.4	22.0	25.1	46.4	17.1	17.2	17.8	7.4	14.9	17.2	13.3	13.7	7.8	29.0	19.7	17.1	9.7	10.0	9.2	12.3	9.1	19.9	11.1	6.1	13.8	18.2	16.8	17.4	9.0	19.0	23.5	15.8	8.4	16.8	5.8	6.8	18.0	12.3	12.8	13.3	13.7	16.1	14.4	14.0	12.4	12.3	13.9	13.3	12.6	14.9	40.6	41.7	52.4	30.3	42.1	48.9	53.5	64.8	53.5	65.1	48.6	40.9	9.3	77.2	53.9	47.8	50.1	102.5	40.7	68.9	107.6	59.8	96.8	44.8	41.9	36.4	57.2	47.8	30.6	85.8	68.6	51.2	67.2	38.7	30.4	62.8	45.3	91.8	33.2	65.6	35.4	75.3	63.1	28.7	33.6	27.1	81.4	26.5	39.2	18.7	36.3	73.9	54.6	28.1	33.1	54.8	78.9	77.5	74.5	53.9	143.9	170.1	27.8	98.1	65.7	46.3	90.5	238.7	93.2	42.7	66.3	82.4	44.9	54.7	78.9	55.5
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 395.9"	"Group enriched"	"Detected in all"	5	"Early spermatids: 552.0;Late spermatids: 1588.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favorable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	52.5	64.9	161.4	33.9	170.8	48.6	52.7	144.2	203.3	48.5	139.0	75.0	40.1	44.5	56.3	49.5	53.0	37.4	105.7	178.2	143.8	53.2	73.0	43.2	45.4	150.6	153.9	55.6	51.1	54.6	68.8	59.2	156.5	56.8	40.7	48.2	60.6	47.8	395.9	51.4	48.6	43.3	140.5	54.0	64.8	192.2	158.6	67.1	49.7	203.9	44.8	49.8	46.2	157.1	119.1	36.0	117.1	197.3	79.0	59.4	83.8	52.6	67.7	100.7	109.4	104.5	60.6	117.0	58.7	77.3	37.8	61.6	126.1	67.8	68.5	62.8	171.3	146.0	102.1	109.7	77.4	86.5	99.7	95.8	67.1	77.6	45.2	77.9	98.7	131.1	180.7	80.9	38.4	147.3	142.3	148.9	153.4	297.3	38.0	137.2	86.0	141.4	62.3	67.9	216.1	168.8	55.8	63.2	93.1	75.7	109.8	247.6	58.8	45.7	83.9	50.8	52.9	88.0	118.8	170.9	19.9	122.7	39.4	42.3	83.5	100.3	62.0	78.9	51.9	41.6	50.8	56.0	90.7	39.6	65.6	51.8	40.4	54.7	63.3	49.8	59.5	76.5	161.4	170.8	144.2	203.3	178.2	143.8	150.6	153.9	156.5	140.5	158.6	157.1	21.3	12.8	17.0	10.4	26.7	18.7	32.9	33.5	14.8	31.9	37.8	33.7	40.3	37.1	19.1	18.4	14.6	99.6	32.7	34.8	86.1	61.7	552.0	19.2	19.0	30.4	52.3	59.3	29.1	54.7	115.1	36.2	20.9	18.8	13.4	50.7	32.5	28.4	63.8	32.0	22.0	43.7	34.6	47.0	22.7	1588.3	44.7	31.8	33.8	11.2	54.7	55.4	55.6	11.6	14.8	46.3	44.3	59.0	31.7	44.4	72.6	55.3	16.9	25.9	52.6	30.4	32.2	180.8	35.6	22.8	20.6	107.0	28.3	71.4	53.7	36.7
KLHDC9	KARCA1	ENSG00000162755	"Kelch domain containing 9"	Q8NEP7	1	161098361-161100346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 29.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 424.7;Late spermatids: 448.2;Spermatocytes: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HDLM-2: 1.5;HEK 293: 1.8;MCF7: 1.4;T-47d: 1.4;U-266/70: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043197			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA043197: AB_2678359"	"unprognostic (1.79e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.31e-2)"	"prognostic favorable (4.20e-6)"	"unprognostic (1.81e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	0.4	3.0	1.3	0.1	1.8	0.0	0.7	1.0	2.9	1.1	2.1	1.4	0.2	1.4	0.5	0.5	2.2	0.0	0.9	1.7	2.2	4.7	1.9	0.8	0.0	1.7	1.8	1.0	2.4	1.1	4.6	0.0	1.6	1.7	0.2	0.4	1.0	0.4	0.7	0.3	0.8	0.0	1.2	0.3	1.3	29.0	2.4	0.0	2.4	0.1	0.1	1.0	0.5	0.9	0.1	1.1	0.4	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	1.5	1.8	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.5	0.2	0.9	1.0	0.0	0.7	0.2	0.0	1.0	0.4	0.0	0.4	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	1.0	2.9	1.7	2.2	1.7	1.8	1.6	1.2	2.4	0.9	2.4	0.0	6.7	8.8	1.5	0.9	11.7	11.5	0.6	13.7	15.3	16.3	9.3	14.3	11.7	29.5	2.1	2.3	0.4	7.6	56.7	10.2	424.7	57.5	2.8	3.4	5.4	0.0	8.9	5.5	3.6	3.2	3.1	10.3	1.3	1.6	3.9	9.5	0.6	3.3	6.8	10.6	16.2	0.6	0.7	448.2	8.1	0.9	7.2	2.8	0.6	35.1	1.0	6.0	1.7	3.9	8.2	8.2	2.1	6.4	2.5	47.8	77.8	20.0	13.1	2.8	4.4	198.1	15.6	2.6	0.9	0.8	1.2	1.7	8.7	8.2
KLHL11	FLJ10572	ENSG00000178502	"Kelch like family member 11"	Q9NVR0	17	41848518-41865423	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 108.3;Late spermatids: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023021, HPA052403, HPA054269"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"HPA023021: AB_1852568, HPA052403: , HPA054269: AB_2682432"	"unprognostic (9.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.82e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.07e-2)"	2.0	2.5	7.5	2.0	6.9	9.1	3.6	8.7	8.2	2.2	1.6	2.0	1.7	2.8	4.0	1.8	2.5	1.6	2.0	9.7	7.6	2.6	2.5	2.3	2.8	6.8	6.3	3.9	3.0	4.6	0.8	2.0	7.4	2.9	1.8	7.1	2.2	2.7	4.3	3.2	1.7	1.8	5.1	2.8	2.2	9.7	7.5	2.7	4.5	1.9	2.8	1.6	0.8	7.0	3.3	5.6	3.9	10.3	5.3	2.8	6.8	3.1	2.9	3.3	3.1	5.2	2.5	10.7	3.4	3.8	3.0	9.3	10.1	4.4	6.0	4.1	4.5	3.8	8.2	7.1	4.9	4.7	4.1	3.4	4.0	4.4	8.3	3.4	3.4	5.3	3.4	9.1	4.3	4.2	7.1	4.9	3.4	2.9	1.8	6.1	9.5	7.7	3.7	5.7	9.8	4.8	5.4	24.9	4.2	3.8	10.9	3.8	5.3	5.1	6.9	4.9	6.2	5.6	5.1	7.9	5.4	4.9	4.8	0.2	0.5	0.3	0.5	0.7	0.8	0.6	0.6	0.6	0.5	0.8	0.7	0.6	0.2	0.4	0.4	0.3	0.4	0.4	7.5	6.9	8.7	8.2	9.7	7.6	6.8	6.3	7.4	5.1	7.5	7.0	1.2	0.0	0.5	6.8	4.5	0.5	1.4	0.2	14.8	3.8	0.9	1.8	0.2	0.0	1.5	0.0	4.2	0.4	3.6	0.3	0.0	0.4	108.3	1.6	3.4	1.5	0.0	3.0	16.6	0.2	0.4	3.0	10.7	1.9	0.0	1.1	0.0	0.0	0.3	8.4	18.0	0.7	0.0	0.0	1.0	41.8	0.3	1.5	1.8	4.7	0.9	1.8	1.0	11.1	13.9	0.5	0.1	0.0	5.8	0.9	0.9	0.2	0.0	3.6	6.6	2.2	3.2	5.5	2.1	5.5	0.3	0.4	4.6	0.9	0.6	0.9
KLHL17		ENSG00000187961	"Kelch like family member 17"	Q6TDP4	1	960584-965719	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031251	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	Nucleoplasm	"HPA031251: AB_10601539"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (3.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.73e-2)"	5.3	5.8	5.2	3.8	5.4	3.8	6.0	6.1	8.3	9.7	5.3	6.9	3.5	7.3	0.6	12.3	6.7	2.3	4.8	5.4	4.7	9.0	7.9	7.1	3.7	5.7	5.0	1.9	7.1	2.3	10.4	2.2	5.6	8.2	0.7	1.7	7.5	1.9	2.8	9.5	7.6	1.2	4.6	12.0	7.5	12.4	5.8	3.0	6.5	0.8	1.6	8.2	8.6	5.5	6.8	7.5	9.2	22.1	3.2	3.3	10.1	13.1	3.5	7.2	7.0	9.9	10.1	2.4	9.0	5.8	6.9	14.4	8.5	5.4	1.1	13.9	20.7	4.4	32.2	14.3	2.1	5.1	13.4	2.8	2.6	7.1	2.0	9.0	4.5	14.0	14.9	4.3	3.2	8.0	8.4	17.8	10.0	2.7	11.0	13.5	3.7	4.8	4.0	2.7	22.3	21.0	3.8	11.8	12.4	2.8	6.4	8.9	7.8	13.7	18.5	12.1	11.1	8.5	3.2	5.9	7.9	11.4	6.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	5.4	6.1	8.3	5.4	4.7	5.7	5.0	5.6	4.6	5.8	5.5	2.2	0.0	3.1	6.2	1.7	2.5	1.0	1.2	3.4	5.7	2.6	2.8	3.7	0.0	0.7	3.7	2.1	1.2	4.0	1.1	0.0	1.0	1.3	1.8	4.1	1.2	3.0	0.0	5.9	0.8	1.9	1.8	7.7	2.0	0.0	1.4	3.3	0.7	1.2	6.7	4.6	1.6	0.0	1.0	1.8	2.0	0.3	2.1	3.6	2.8	1.4	1.2	1.0	1.5	2.1	2.0	0.3	1.5	2.2	0.9	1.2	1.2	1.1	6.2	0.0	0.8	2.0	4.7	5.3	1.9	3.0	0.8	2.2	0.2	1.4	1.4
KLHL18	"FLJ13703, KIAA0795"	ENSG00000114648	"Kelch like family member 18"	O94889	3	47282917-47346816	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035027, HPA035028"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Nuclear bodies"	"HPA035027: AB_10602340, HPA035028: AB_10669899"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.67e-1)"	5.9	6.2	6.5	6.2	6.9	15.9	4.6	5.9	7.7	5.7	3.9	5.8	4.4	5.3	5.1	8.7	4.6	5.4	6.2	6.8	6.3	6.1	3.7	6.2	6.9	4.9	6.0	3.9	5.5	7.2	6.0	5.5	5.1	5.1	4.6	20.2	4.4	6.2	6.7	13.8	5.6	6.6	5.5	8.8	4.9	6.3	6.7	5.1	7.0	5.6	7.5	6.7	6.7	6.3	11.6	14.6	11.1	16.5	12.0	8.6	7.9	15.6	8.1	15.5	12.6	15.6	7.0	22.6	8.6	13.1	14.2	7.0	33.7	16.5	15.9	18.0	11.3	33.3	20.9	14.3	12.3	17.9	14.7	10.0	12.5	22.4	20.8	8.7	17.5	12.1	41.0	9.2	12.6	9.6	13.7	10.3	20.4	9.4	29.2	9.4	7.3	13.2	14.6	21.6	7.6	10.1	10.9	13.2	7.9	11.3	7.8	9.7	18.4	14.3	14.8	16.6	19.9	10.3	21.9	19.5	9.2	20.5	15.4	6.1	12.1	3.7	2.0	10.7	2.9	3.8	1.6	3.9	7.8	2.4	1.3	2.0	4.9	1.3	18.6	2.0	1.7	5.7	6.5	6.9	5.9	7.7	6.8	6.3	4.9	6.0	5.1	5.5	6.7	6.3	19.6	12.8	13.7	13.1	24.4	11.3	10.6	8.1	12.0	65.2	17.4	13.0	62.1	4.3	7.5	3.7	20.9	10.6	26.1	15.2	21.5	15.5	3.0	15.5	24.8	16.1	9.5	21.7	24.2	14.8	11.9	9.3	12.2	27.5	36.1	11.0	14.3	19.7	29.6	13.5	23.0	11.1	4.1	28.8	14.9	3.5	5.9	26.7	0.0	18.7	22.4	13.9	8.2	15.1	17.4	17.7	10.6	8.2	12.0	9.3	9.8	28.2	6.3	54.2	6.6	19.5	13.5	13.9	14.8	14.8	21.0	14.1	20.8	15.4	10.3	13.0
KLHL2	MAV	ENSG00000109466	"Kelch like family member 2"	O95198	4	165207561-165323156	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 125.4;Oligodendrocytes: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 7.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051637			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA051637: "	"unprognostic (1.14e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.67e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.81e-1)"	11.8	11.8	35.3	12.1	50.9	21.4	13.0	26.7	55.8	5.9	14.3	7.2	5.3	7.7	13.5	19.7	9.9	10.7	5.5	78.4	34.7	15.4	27.1	14.2	11.2	33.2	35.7	4.1	7.8	9.5	16.3	7.7	30.8	8.2	6.7	8.8	20.0	10.0	4.7	6.4	6.5	10.7	33.3	14.6	8.3	6.1	35.5	6.3	12.3	6.8	9.5	15.2	8.8	45.2	16.1	14.7	9.8	10.1	14.1	12.9	10.2	21.3	16.7	10.7	11.7	8.9	11.5	16.3	5.1	10.9	19.2	10.5	16.1	10.4	13.9	27.2	6.0	14.1	12.8	12.9	12.9	14.2	19.3	10.7	30.5	9.8	37.1	18.5	25.9	6.1	6.4	33.0	16.1	6.0	0.4	4.0	6.0	8.9	6.5	5.6	7.0	5.1	18.1	14.9	49.1	8.1	13.5	4.5	13.0	18.1	3.3	15.1	37.0	8.4	17.6	9.6	14.0	21.5	16.3	13.2	10.1	9.7	16.9	1.8	0.9	1.3	0.5	1.0	0.3	0.3	0.3	0.3	0.8	0.8	0.9	1.0	7.2	0.3	1.2	0.4	0.5	0.4	35.3	50.9	26.7	55.8	78.4	34.7	33.2	35.7	30.8	33.3	35.5	45.2	19.0	6.4	17.9	33.3	10.7	6.0	13.1	8.0	4.6	8.9	13.2	10.9	4.7	8.6	9.7	22.0	14.6	4.3	8.3	7.5	27.4	8.7	1.9	8.3	6.6	14.6	15.5	2.1	125.4	12.9	9.4	5.2	8.2	13.5	9.5	4.0	25.7	35.6	8.3	32.0	33.0	6.2	8.2	42.5	13.9	1.7	4.1	22.7	5.4	39.4	13.5	5.8	1.0	43.2	144.5	9.6	7.4	4.5	6.3	11.9	5.4	19.0	10.9	7.3	0.0	11.9	7.2	3.3	7.4	7.7	7.5	3.7	9.2	3.9	3.9	20.1
KLHL23	"FLJ37812, MGC22679, MGC2610"	ENSG00000213160	"Kelch like family member 23"	Q8NBE8	2	169694488-169776989	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 132.5;Cone photoreceptor cells: 89.6;Sertoli cells: 170.9;Smooth muscle cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047593			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Actin filaments"		"HPA047593: "	"unprognostic (4.77e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.87e-3)"	6.9	2.1	8.1	6.1	9.6	1.7	6.2	13.2	9.9	9.6	0.2	20.8	11.1	25.6	4.0	12.0	8.9	6.7	8.0	9.8	7.2	6.6	5.9	5.9	3.1	3.7	5.8	17.9	7.2	6.4	3.3	12.8	4.6	13.6	13.9	13.6	8.0	12.5	12.0	1.6	11.8	25.0	4.0	2.8	5.1	10.9	7.6	11.1	8.1	16.3	2.9	8.7	3.9	6.3	17.0	8.6	64.5	18.3	3.6	1.3	43.7	8.0	6.1	14.4	15.8	18.0	14.4	10.6	6.7	0.8	20.9	2.6	67.7	5.8	21.9	37.7	33.2	31.3	16.9	29.9	5.4	44.2	4.7	2.5	4.7	6.0	10.2	9.3	11.2	38.3	43.5	1.4	4.8	8.2	65.0	17.9	52.7	9.0	6.7	20.7	55.1	1.1	13.1	49.9	83.4	57.1	12.7	1.2	7.8	20.3	10.6	14.2	4.2	5.8	18.6	5.7	13.6	4.9	4.9	47.3	4.5	13.0	9.0	0.0	0.0	0.0	0.7	0.0	0.9	0.3	0.6	0.5	0.1	0.3	1.0	1.0	0.0	3.4	0.0	0.9	0.8	0.3	8.1	9.6	13.2	9.9	9.8	7.2	3.7	5.8	4.6	4.0	7.6	6.3	13.7	3.2	8.7	0.0	1.1	1.5	6.9	2.8	7.4	132.5	15.0	17.1	52.9	14.3	6.7	0.0	89.6	5.6	3.8	14.6	3.9	15.6	4.6	2.4	12.8	12.6	31.8	9.7	0.0	30.5	9.6	11.2	4.1	5.5	0.0	27.5	7.5	11.8	0.9	40.4	0.0	21.2	28.5	0.8	1.9	3.7	2.5	1.3	0.0	0.0	0.2	14.6	5.2	0.0	0.0	16.1	13.6	8.6	0.4	17.2	9.7	16.9	4.9	34.8	170.9	11.4	102.6	3.4	20.9	4.7	1.0	1.2	5.5	13.8	20.9	4.1
KLHL25	"ENC-2, ENC2, FLJ12587"	ENSG00000183655	"Kelch like family member 25"	Q9H0H3	15	85759326-85794925	"Predicted intracellular proteins"	"Translation regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	4	"monocytes: 3.8;NK-cells: 2.5;T-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebral cortex: 29.1;hippocampal formation: 16.3"	HPA023450	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA023450: AB_1852583"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.66e-2)"	6.5	2.4	5.6	2.6	7.6	0.5	5.4	5.8	7.5	4.3	4.3	3.8	4.7	6.6	3.1	5.7	4.0	2.2	3.9	6.0	7.6	3.7	15.1	4.3	1.9	5.4	8.2	3.3	1.6	2.2	3.6	1.1	6.9	4.6	1.1	0.8	3.6	3.1	6.5	9.3	3.4	2.8	4.7	1.6	5.0	10.5	7.6	2.0	2.4	3.0	1.3	3.7	5.0	6.7	2.7	8.1	11.6	5.7	2.3	1.2	6.0	3.4	1.6	4.6	3.5	10.9	4.4	1.7	1.7	2.8	2.9	6.6	12.5	6.4	1.0	1.7	5.8	0.5	3.5	8.4	2.7	0.5	2.0	2.4	2.1	4.5	1.5	2.0	2.5	5.8	0.7	1.5	2.0	5.0	4.3	2.6	10.5	4.6	4.2	8.7	6.9	2.8	1.7	5.6	16.1	11.1	4.9	5.6	2.2	4.7	10.2	0.6	2.1	4.9	8.9	3.2	6.2	1.6	3.7	1.7	2.2	3.0	2.8	0.0	0.1	0.2	1.0	1.2	0.5	0.0	1.0	0.7	0.2	0.2	1.7	1.1	0.0	2.5	3.8	0.6	0.9	0.5	5.6	7.6	5.8	7.5	6.0	7.6	5.4	8.2	6.9	4.7	7.6	6.7	0.8	0.0	1.9	3.6	1.2	2.7	4.0	2.1	0.0	3.3	4.0	2.8	4.3	1.5	1.5	0.0	0.0	1.0	3.6	6.3	1.9	2.3	13.0	3.0	3.6	1.8	10.7	0.0	7.7	2.7	1.5	2.4	8.6	3.2	0.0	2.0	2.2	12.4	0.8	13.5	4.1	7.6	4.1	1.3	2.7	4.6	0.9	1.4	7.2	1.0	0.6	2.7	2.1	6.0	0.9	5.3	3.1	1.5	1.3	2.7	2.7	2.1	2.1	1.1	6.6	2.9	2.9	3.3	4.1	4.4	4.7	1.8	4.0	1.4	5.2	4.3
KLHL35	FLJ33790	ENSG00000149243	"Kelch like family member 35"	Q6PF15	11	75422394-75433203	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.2;testis: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 39.6;Early spermatids: 25.9;Late spermatids: 28.4;Spermatogonia: 56.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 15.8;HMC-1: 10.3;PC-3: 8.9;SiHa: 18.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039864, HPA070736"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Nucleoli fibrillar center"	"HPA039864: AB_10794204, HPA070736: "	"unprognostic (3.53e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.28e-1)"	0.6	0.8	3.9	0.0	4.9	0.0	0.9	1.9	3.9	0.7	1.3	0.2	0.0	0.3	0.0	0.4	0.4	0.1	0.8	3.5	5.1	0.3	0.0	0.7	0.0	4.4	3.4	0.2	1.8	0.0	0.9	0.0	5.2	0.2	0.0	0.6	0.8	0.1	0.4	0.9	0.1	0.1	2.7	1.1	1.1	9.3	4.4	0.1	0.6	0.2	0.0	0.3	0.3	3.8	0.0	0.3	0.1	0.0	0.2	1.3	0.0	0.9	0.0	0.9	0.1	15.8	1.3	0.0	4.3	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.8	4.1	10.3	0.2	0.2	0.0	0.0	0.1	0.4	2.7	0.0	0.0	1.1	0.7	0.3	0.1	0.2	3.2	8.9	0.0	0.0	0.9	0.7	0.2	1.2	1.0	18.4	3.4	0.0	0.0	3.4	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.2	0.0	0.4	0.2	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	3.9	4.9	1.9	3.9	3.5	5.1	4.4	3.4	5.2	2.7	4.4	3.8	0.7	9.6	3.4	0.3	1.1	1.3	1.8	0.5	4.0	39.6	6.4	4.8	1.0	1.5	2.8	3.7	8.4	1.5	0.7	0.6	3.9	1.7	25.9	2.1	3.0	1.1	4.2	0.4	3.9	3.1	1.7	3.0	2.6	4.0	4.5	1.5	2.9	0.1	1.2	1.7	3.5	1.4	0.0	1.2	2.1	28.4	2.8	2.9	1.8	0.0	1.6	2.5	3.1	0.0	4.4	3.7	0.4	1.2	0.1	1.3	0.3	0.4	1.6	11.1	6.6	1.3	1.6	10.2	56.7	0.9	2.3	2.5	1.1	2.2	0.7	1.4
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 56.7;skeletal muscle: 268.3;tongue: 76.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.3;melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;SK-BR-3: 2.8;U-2197: 4.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.2	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.5	0.2	0.1	0.9	0.1	1.3	0.0	2.5	0.7	0.7	56.7	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.1	1.3	0.0	1.5	0.0	0.8	0.1	0.0	0.7	0.1	268.3	0.2	0.2	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	76.9	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.9	0.0	0.5	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526258	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	42	"skeletal muscle: 5038.6;tongue: 3473.7"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 108.1;Skeletal myocytes: 251.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HSkMC: 21.6;LHCN-M2: 35.4;RH-30: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	1.5	0.5	1.7	0.2	1.4	0.0	2.0	3.1	1.8	1.0	1.4	1.4	0.1	0.8	1.5	75.1	1.2	6.7	100.3	1.2	1.6	0.8	0.9	2.7	0.3	0.9	2.5	1.1	1.1	0.5	5.8	0.1	1.5	50.0	0.3	16.1	52.1	0.7	5038.6	4.6	0.8	0.6	0.9	0.8	1.3	2.6	5.1	1.7	2.2	3473.7	0.3	5.9	0.9	1.4	0.0	0.1	0.0	0.6	0.4	2.7	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.2	0.2	0.0	21.6	0.5	0.3	0.0	0.2	0.1	0.2	0.1	0.0	35.4	0.1	0.1	0.2	0.0	0.0	0.2	0.0	55.9	0.0	0.2	0.1	0.7	0.1	0.1	0.0	1.5	0.1	0.0	0.1	0.0	0.4	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	3.1	1.8	1.2	1.6	0.9	2.5	1.5	0.9	5.1	1.4	0.0	0.0	0.5	1.3	0.0	0.1	0.5	0.1	0.0	2.4	0.2	0.1	108.1	0.0	2.0	0.0	8.4	0.0	0.0	0.1	0.0	0.5	5.8	1.3	0.2	1.0	1.2	0.0	4.1	0.5	0.0	6.4	0.0	0.1	0.0	0.2	0.4	0.2	0.2	0.0	4.6	0.1	0.0	0.3	0.0	2.9	0.9	0.8	0.0	3.7	0.0	0.7	0.0	1.5	2.3	0.7	0.1	1.2	0.0	0.3	0.0	0.3	4.1	5.8	0.0	251.8	1.8	4.1	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.1
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 560.6;Late spermatids: 242.7;Oligodendrocyte precursor cells: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	9.5	18.8	12.8	7.0	13.3	12.4	13.0	16.3	15.9	10.5	12.1	9.2	7.8	11.5	12.2	9.0	9.7	9.7	50.8	12.5	13.1	11.9	10.4	7.7	8.3	12.6	12.7	11.8	7.7	10.8	7.3	8.6	12.3	10.1	7.9	14.9	8.5	8.1	9.1	10.9	6.9	10.5	12.2	8.0	6.3	42.2	13.4	12.4	9.2	9.7	9.1	8.7	9.4	14.7	24.7	20.7	55.7	66.3	26.8	23.2	20.3	21.3	31.5	30.7	35.6	25.3	17.5	24.1	16.8	26.2	50.5	26.2	21.5	15.0	25.8	6.4	15.5	15.9	16.7	32.9	20.0	32.5	12.0	20.7	19.1	35.2	28.8	24.2	39.6	29.4	28.3	25.5	50.7	28.4	27.3	51.3	77.0	16.7	24.5	23.7	31.2	22.2	29.2	21.0	33.5	32.5	46.2	22.7	23.3	33.9	18.9	16.9	17.0	25.7	26.6	56.9	25.7	39.9	35.3	58.6	17.0	33.8	31.5	44.1	15.3	67.2	13.0	17.9	13.7	9.2	13.8	12.3	11.1	11.9	10.1	10.0	14.4	9.5	15.8	8.0	16.7	12.6	12.8	13.3	16.3	15.9	12.5	13.1	12.6	12.7	12.3	12.2	13.4	14.7	12.1	22.4	5.5	45.7	13.0	23.6	18.2	13.0	18.2	23.7	12.3	13.5	101.2	8.6	11.3	9.2	29.2	20.7	14.4	5.7	11.7	17.7	560.6	18.3	16.7	15.8	10.8	25.6	74.5	17.6	27.1	19.8	10.2	13.2	21.5	16.3	13.2	7.0	19.7	37.0	75.2	7.6	14.2	16.0	17.2	242.7	16.8	12.6	12.4	35.6	13.4	30.3	8.2	168.9	45.6	19.4	1.9	20.7	12.3	11.5	7.4	13.5	18.8	16.3	6.6	14.3	17.9	83.7	19.7	24.6	33.8	23.7	17.2	12.1	7.0	24.0
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 60.4"	"Cell type enriched"	"Detected in all"	4	"Muller glia cells: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA013856: AB_1852594, HPA017762: AB_2669660"	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.7	7.3	4.6	6.1	4.7	3.1	9.4	7.0	4.8	8.7	1.9	8.0	7.8	6.8	60.4	4.8	5.4	4.9	4.6	4.1	5.6	12.0	11.2	5.2	5.8	4.1	5.4	6.0	5.2	8.5	3.6	4.2	3.6	5.5	8.9	27.2	7.1	7.4	13.7	4.0	7.6	6.6	4.7	6.3	4.2	4.3	5.9	8.5	18.9	9.7	4.8	6.0	4.2	5.0	9.9	8.5	15.1	6.8	13.5	9.8	8.1	12.4	6.6	8.1	9.5	13.8	7.3	14.3	9.8	9.2	6.6	4.1	16.2	12.2	17.4	13.7	10.1	17.4	6.0	8.1	11.5	28.9	10.5	12.4	8.6	12.4	12.4	7.9	9.7	10.6	22.8	12.7	8.5	10.9	34.8	14.4	3.8	22.1	3.4	12.9	12.9	8.7	13.7	10.1	31.6	11.0	8.1	19.6	9.2	5.6	6.8	21.0	9.2	10.2	12.6	10.9	10.4	18.7	13.1	25.1	7.7	13.5	11.4	2.0	12.2	7.6	2.9	9.2	4.6	3.2	2.2	2.4	10.4	3.5	4.0	4.0	8.6	8.4	9.8	2.6	0.9	5.0	4.6	4.7	7.0	4.8	4.1	5.6	4.1	5.4	3.6	4.7	5.9	5.0	9.5	3.2	22.9	29.4	14.3	13.8	10.8	10.1	13.6	22.8	11.1	7.7	15.4	5.7	11.6	44.1	41.7	4.1	12.1	21.4	11.7	5.2	4.0	8.3	21.4	12.8	9.0	12.4	44.6	4.5	6.9	10.4	3.1	9.8	7.6	16.8	8.6	20.0	9.7	23.5	41.5	10.8	4.1	38.8	12.0	3.5	9.6	23.3	10.6	24.4	22.1	216.0	11.3	47.3	35.7	4.9	12.2	8.2	6.4	13.8	14.5	19.2	10.1	47.0	13.1	20.1	9.2	32.5	22.5	12.9	14.8	23.8	9.9	4.4	15.2	11.4
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 253.0;esophagus: 94.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 23.9;Breast myoepithelial cells: 16.1;Collecting duct cells: 11.0;Oligodendrocytes: 87.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 575.5;CAPAN-2: 1346.5"	"Region enhanced"	"Detected in all"		"pons and medulla: 167.8"	"Region enhanced"	"Detected in many"		"spinal cord: 371.7"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		10000000		"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.2	0.0	71.8	0.0	135.8	0.0	7.2	170.8	119.8	53.1	45.6	0.1	0.2	1.5	0.4	94.2	28.9	3.5	0.0	72.9	94.3	20.4	0.0	0.0	0.0	213.8	130.8	0.8	0.0	0.0	0.7	0.0	182.1	0.1	0.0	0.0	15.8	2.2	0.0	9.9	0.0	0.0	123.6	5.8	0.1	0.9	118.1	1.5	0.0	0.0	36.4	0.0	27.4	253.0	575.5	0.0	0.0	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	67.7	1346.5	0.0	8.1	0.0	0.6	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.1	131.0	2.2	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	5.6	18.2	1.0	1.9	0.0	1.1	46.3	0.0	1.3	0.0	0.4	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.8	135.8	170.8	119.8	72.9	94.3	213.8	130.8	182.1	123.6	118.1	253.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	0.0	23.9	16.1	0.3	0.0	1.7	11.0	0.0	0.1	0.4	0.0	0.0	0.1	2.3	0.6	7.5	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	87.9	7.8	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	1.6	0.0	0.3	0.1	0.0	0.0	2.4
KLLN	killin	ENSG00000227268	"Killin, p53 regulated DNA replication inhibitor"	B2CW77	10	87859158-87863533	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 5.7;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 5.0;Karpas-707: 5.1"									HPA074502			Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA074502: AB_2686695"	"unprognostic (4.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.79e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.02e-4)"	"unprognostic (1.60e-1)"	1.0	0.7	1.0	0.6	0.7	0.5	0.6	1.5	1.6	0.7	0.6	0.9	0.4	0.5	1.0	0.4	1.4	0.4	0.5	0.7	0.9	0.9	0.9	0.4	0.8	0.5	0.6	0.4	0.2	0.5	0.5	0.6	0.6	0.4	0.8	1.0	0.3	0.5	4.5	0.4	0.4	0.5	0.3	0.8	0.6	1.0	0.6	1.0	0.7	0.5	0.8	0.3	0.3	1.5	0.8	1.0	1.1	0.7	0.5	0.3	0.8	0.7	0.9	0.5	0.7	0.6	2.6	2.0	0.3	0.2	0.5	0.9	0.7	0.8	0.4	0.5	0.3	0.7	1.5	0.6	0.6	1.4	0.5	0.6	0.8	0.7	0.8	0.9	0.3	5.0	0.4	5.1	0.5	1.8	4.1	1.6	0.4	0.6	0.5	2.6	0.1	2.6	0.4	0.8	0.4	1.0	0.9	0.6	0.1	0.7	1.6	1.2	0.3	0.5	0.3	0.9	0.3	2.9	3.3	2.9	0.9	2.9	0.6	1.6	0.3	0.6	0.2	0.5	0.4	0.4	0.3	0.3	0.3	0.5	0.4	0.3	2.5	0.6	0.8	0.5	0.2	0.2	1.0	0.7	1.5	1.6	0.7	0.9	0.5	0.6	0.6	0.3	0.6	1.5	0.6	0.0	0.0	0.3	0.5	0.1	0.3	0.2	0.6	1.7	1.0	1.3	2.7	1.5	1.3	0.0	0.0	0.7	2.0	3.0	0.0	0.2	3.9	0.8	0.9	0.6	0.0	0.8	0.4	0.2	0.4	1.1	3.6	0.4	5.7	0.3	0.7	0.4	0.3	3.3	0.5	1.8	0.0	1.3	0.0	2.0	0.0	0.6	0.0	0.0	0.3	1.6	0.0	0.0	0.1	0.3	2.5	0.0	0.2	0.3	1.8	1.9	2.3	1.0	6.6	1.1	2.9	0.3	1.2	0.6	0.4	0.5	0.7	0.3	1.3	0.2
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607916	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 36.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 642.3;NK-cells: 1855.8;T-cells: 790.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 2177.1"	"Group enriched"	"Detected in all"	140	"NK-cells: 756.7;T-cells: 2177.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favorable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favorable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favorable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (1.17e-2)"	3.1	1.7	0.7	17.8	0.8	47.4	5.1	0.3	0.8	4.2	0.2	7.7	10.7	1.6	1.4	3.2	1.5	10.7	0.7	0.6	0.7	1.4	11.3	6.7	20.1	0.6	0.6	1.0	0.4	0.2	0.3	1.4	0.6	2.1	8.1	0.1	0.8	1.0	0.7	0.8	20.1	1.6	0.6	28.9	10.1	0.6	0.6	5.7	1.3	0.9	36.4	10.6	1.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.4	0.2	9.5	2.2	1.1	519.7	2.1	2177.1	1.6	307.4	346.1	1.9	1.5	17.1	98.0	10.5	756.7	3.6	3.9	77.9	285.3	0.7	0.8	0.3	0.8	0.6	0.7	0.6	0.6	0.6	0.6	0.6	0.8	6.1	0.0	8.9	0.0	19.0	9.7	0.9	0.0	1.2	0.0	5.2	2.5	1.0	4.3	1.3	0.0	0.0	0.4	642.3	1.7	0.0	0.6	0.0	1.9	1.5	6.2	0.0	118.1	0.4	0.0	0.1	7.9	12.2	2.4	0.0	0.0	45.3	10.1	0.9	0.0	0.6	1.0	0.0	36.2	15.8	0.0	0.0	13.2	24.9	0.0	28.1	0.0	1855.8	2.5	0.1	0.0	3.3	0.0	23.0	1.1	0.9	2.0	0.0	0.0	0.0	1.6	4.1	0.0	0.1	1.2	8.8	1.0	790.5	0.0	2.0	1.3
KLRG2	"CLEC15B, FLJ44186"	ENSG00000188883	"Killer cell lectin like receptor G2"	A4D1S0	7	139452690-139483673	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.0;salivary gland: 4.3;thyroid gland: 4.1"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 5.2;Collecting duct cells: 7.3;Squamous epithelial cells: 14.2;Syncytiotrophoblasts: 7.7"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 42.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.7;HAP1: 15.7;NTERA-2: 8.2;SCLC-21H: 7.4;SK-BR-3: 31.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA018199	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA018199: AB_2133260"	"unprognostic (2.50e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.38e-8)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (2.14e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.34e-2)"	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.2	0.0	0.0	0.0	0.4	2.5	0.0	2.9	0.0	0.1	0.0	0.0	0.1	2.8	0.3	0.4	0.1	0.1	0.1	0.0	4.3	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.9	4.1	0.1	0.7	0.1	1.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.0	2.0	0.0	0.0	4.3	0.0	0.0	2.2	15.7	0.0	0.0	0.0	3.9	0.0	0.6	0.0	0.1	0.0	0.3	0.0	6.6	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	2.8	2.5	0.0	8.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	7.4	0.4	2.3	31.9	0.0	6.1	7.1	1.5	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.5	0.8	0.3	5.2	0.0	1.3	1.4	0.5	0.0	0.1	7.3	0.0	1.5	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	1.6	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	14.2	1.0	7.7	0.0	0.0	0.3	0.5
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	9.9	6.7	8.0	8.5	8.6	19.5	9.9	21.2	9.3	10.3	1.6	10.8	5.4	10.7	8.2	6.8	10.3	6.4	6.5	7.4	9.6	6.7	6.0	10.5	12.4	6.3	6.3	21.2	11.1	9.8	10.2	5.6	6.6	9.2	6.4	23.9	9.4	8.4	7.4	10.4	9.8	7.6	3.2	9.7	8.2	5.3	7.0	14.1	9.9	8.4	11.3	10.7	9.3	11.9	17.9	8.6	20.1	14.5	11.1	16.1	6.2	8.7	11.8	9.0	9.6	17.3	11.4	23.1	15.9	10.8	14.6	16.0	22.9	7.2	17.9	26.0	10.0	45.7	8.9	9.3	6.1	28.5	7.8	7.2	7.4	20.3	24.0	8.9	12.8	13.3	32.8	18.8	9.2	12.7	18.2	12.7	13.6	6.6	13.7	13.8	21.9	6.9	9.8	13.8	18.0	11.8	22.0	6.7	3.9	9.8	11.9	9.1	20.4	14.1	12.7	9.4	14.7	5.1	4.4	15.6	4.7	17.6	8.3	2.1	0.6	1.9	1.6	0.6	1.6	2.5	1.8	1.5	0.3	1.8	1.8	1.2	0.5	2.0	0.7	1.4	1.7	0.4	8.0	8.6	21.2	9.3	7.4	9.6	6.3	6.3	6.6	3.2	7.0	11.9	87.1	70.5	65.8	93.4	83.4	86.9	67.6	29.4	64.9	158.1	76.8	73.9	44.5	40.0	32.2	38.6	152.2	13.9	81.0	26.2	3.9	33.0	10.1	62.1	101.4	74.4	66.4	67.3	146.0	25.6	10.2	65.6	44.4	85.2	29.0	57.5	60.0	27.3	16.8	195.2	170.1	29.6	20.3	37.0	63.7	5.8	66.8	44.8	42.7	62.8	49.9	98.9	78.2	106.6	131.9	28.2	20.1	78.6	83.3	88.3	22.7	10.5	52.7	152.4	65.7	113.4	84.6	25.5	30.7	46.3	80.6	6.0	102.8	55.8	30.6	64.8
KMT2B	"CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7"	ENSG00000272333	"Lysine methyltransferase 2B"	Q9UMN6	19	35717973-35738878	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.5;Rod photoreceptor cells: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006487			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA006487: AB_1080587"	"unprognostic (1.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.63e-3)"	"unprognostic (9.47e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	11.6	10.1	15.4	9.8	15.7	14.3	11.8	17.2	22.9	12.9	12.2	13.6	9.8	14.1	4.4	12.8	13.1	6.8	8.4	14.7	14.8	10.3	10.0	12.1	14.5	15.4	14.4	16.1	16.0	5.1	14.5	5.8	14.7	13.4	3.9	5.8	13.3	5.8	16.1	18.8	14.5	4.5	12.4	15.6	12.7	22.5	15.9	9.3	16.6	5.0	6.8	12.6	12.0	16.0	16.7	36.7	11.1	17.3	6.0	4.3	11.0	6.7	4.7	7.3	5.0	25.3	7.4	15.5	11.8	5.1	8.5	10.8	11.3	5.2	4.2	21.2	13.6	29.7	20.2	24.4	8.6	17.4	26.1	6.9	9.4	8.9	10.7	6.9	5.7	13.5	22.5	15.8	6.4	34.1	15.9	24.4	12.0	18.8	9.2	19.8	8.9	7.6	7.8	21.3	14.0	10.0	13.5	20.6	11.3	7.9	11.8	21.3	12.5	16.3	17.0	10.5	17.4	22.2	15.7	12.4	8.5	18.8	12.2	0.3	0.4	0.4	1.0	0.1	0.5	0.4	0.6	0.7	0.3	0.7	0.6	0.9	1.8	0.5	0.2	2.1	0.8	0.4	15.4	15.7	17.2	22.9	14.7	14.8	15.4	14.4	14.7	12.4	15.9	16.0	24.6	9.6	15.4	13.7	18.6	12.7	10.0	6.2	9.6	64.5	16.1	14.6	9.2	8.6	6.3	9.2	52.1	6.5	27.4	25.2	0.0	6.4	2.8	17.9	31.6	15.6	20.3	7.4	11.7	7.7	6.1	12.4	27.5	26.0	5.1	30.5	11.0	11.2	8.4	35.3	11.8	14.1	6.1	11.8	7.1	4.7	8.1	13.4	5.4	7.5	9.5	25.7	19.6	7.5	10.0	8.4	16.7	12.4	17.9	19.6	13.9	5.0	6.7	71.2	0.0	25.0	17.3	26.5	38.5	11.9	12.9	9.4	20.6	30.7	16.3	14.8
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436641	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 363.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	12.7	11.2	16.7	7.3	25.7	16.4	12.9	16.7	15.7	15.3	5.5	13.1	5.7	14.3	13.7	14.1	11.9	7.7	10.2	13.0	18.9	8.9	10.4	12.7	8.1	25.3	19.4	16.8	18.5	12.4	12.1	10.3	20.6	9.3	7.6	21.7	14.2	9.0	25.9	17.6	12.8	7.5	12.2	12.2	15.2	13.4	19.1	16.1	14.6	16.9	9.5	11.3	12.7	28.6	13.4	6.1	11.6	11.7	19.0	13.9	10.2	4.7	6.4	5.0	5.5	10.9	4.7	22.4	8.9	11.3	9.2	5.2	14.3	7.5	9.2	12.7	6.5	14.0	7.3	4.5	8.9	22.9	12.8	6.6	9.1	7.1	8.2	7.2	8.4	9.7	22.5	15.0	11.7	12.7	14.8	11.1	6.8	8.5	7.9	9.5	12.3	8.4	5.8	10.9	19.6	12.8	13.4	15.8	6.3	10.6	4.6	15.7	12.8	8.0	4.4	9.0	8.9	15.3	7.7	22.4	10.7	14.7	8.4	6.1	3.0	4.4	1.9	2.7	1.6	6.9	2.0	1.5	1.4	3.9	1.9	1.4	15.2	2.2	2.6	3.7	1.3	0.8	16.7	25.7	16.7	15.7	13.0	18.9	25.3	19.4	20.6	12.2	19.1	28.6	62.4	76.9	71.9	292.8	75.0	89.1	38.3	31.5	62.0	89.0	59.6	35.2	65.8	44.3	72.4	46.0	173.0	38.0	61.9	61.7	5.9	37.6	32.1	94.4	92.1	58.9	67.9	55.5	180.7	33.1	51.7	58.3	89.2	200.5	65.2	52.8	56.7	46.0	33.7	80.8	172.2	53.5	42.7	54.7	79.6	17.3	67.4	90.5	42.7	202.4	77.1	57.7	59.8	299.6	363.2	37.6	49.0	60.2	90.3	53.6	36.3	14.7	46.9	73.0	26.3	83.0	55.5	42.3	33.9	80.9	96.3	127.2	76.8	54.8	39.1	61.4
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018978-49060794	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	19.9	21.9	14.0	17.0	14.4	62.1	20.3	14.7	18.1	20.2	3.8	21.3	13.2	26.9	14.4	25.5	24.1	11.7	23.7	12.1	9.1	18.2	20.5	25.1	17.5	9.3	8.2	25.3	33.2	22.9	25.4	16.2	8.6	19.2	14.7	48.0	22.1	16.2	44.9	30.4	27.9	15.5	3.1	36.6	25.5	23.6	12.7	29.0	26.5	21.9	17.2	19.4	19.4	13.4	32.3	31.9	31.0	24.7	29.3	20.4	32.6	17.3	17.1	20.3	10.9	54.8	14.1	33.4	21.2	23.9	14.0	21.5	38.1	19.9	17.7	22.4	26.7	47.2	37.7	29.9	20.5	59.1	43.2	18.4	25.8	30.7	32.0	27.3	31.8	33.2	55.1	19.2	23.7	37.4	26.8	48.0	29.9	45.4	25.0	37.4	22.4	12.0	18.1	37.2	24.6	21.2	28.1	25.5	19.5	26.1	24.0	44.1	49.8	15.5	30.7	14.5	30.5	24.8	20.9	31.7	17.1	28.0	12.5	0.5	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.5	0.5	0.0	0.2	0.0	0.1	14.0	14.4	14.7	18.1	12.1	9.1	9.3	8.2	8.6	3.1	12.7	13.4	12.9	9.6	19.1	17.6	13.3	14.0	7.8	8.1	14.2	26.8	12.1	7.1	7.8	12.8	10.9	18.4	52.1	8.2	15.3	12.3	1.9	6.3	2.8	10.7	12.7	13.2	13.1	16.0	17.4	6.0	6.0	8.8	24.5	13.1	8.2	23.3	17.9	13.0	9.8	21.9	16.5	10.0	6.1	15.7	18.4	2.4	9.6	15.4	10.6	15.0	14.9	6.4	17.5	12.5	19.8	8.8	9.5	10.9	10.1	11.0	13.3	4.5	9.0	38.4	6.6	14.4	12.5	6.5	3.8	18.9	17.6	11.4	15.3	10.8	10.3	9.6
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E (inactive)"	Q8IZD2	7	105014190-105115019	"Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	23.0	16.4	17.6	28.8	23.6	69.9	22.5	53.6	26.1	28.9	11.6	29.0	22.7	33.4	22.1	22.7	24.8	24.5	21.1	16.9	25.9	18.7	16.4	27.9	31.4	19.0	19.2	43.8	22.8	23.1	11.5	26.8	17.7	24.9	28.5	40.5	25.5	23.0	15.0	30.3	22.3	26.8	14.4	33.4	26.7	18.6	17.1	35.6	27.4	22.9	33.0	27.9	14.3	34.4	35.7	24.8	49.3	43.5	29.3	34.5	12.3	24.3	38.2	21.0	25.5	19.0	30.1	28.8	24.7	30.0	27.7	26.2	27.1	25.7	35.0	45.8	17.4	27.0	31.6	19.2	28.1	39.7	34.8	24.2	23.3	28.6	30.6	38.6	40.2	32.3	39.9	76.9	28.7	26.5	62.1	35.0	17.9	19.1	19.1	53.4	30.3	33.5	23.0	34.5	28.8	36.1	35.7	32.3	20.2	32.8	13.6	23.5	47.2	50.0	33.1	57.5	26.4	61.6	50.8	63.5	34.3	29.5	36.3	246.8	73.2	173.1	118.3	56.2	114.6	153.9	109.7	103.0	53.8	152.0	106.0	100.0	290.3	89.9	94.4	103.2	101.5	71.7	17.6	23.6	53.6	26.1	16.9	25.9	19.0	19.2	17.7	14.4	17.1	34.4	169.3	141.1	158.4	108.4	283.5	146.6	115.5	119.2	118.4	236.4	93.4	81.5	102.9	85.8	124.6	115.8	252.3	40.5	278.0	138.0	35.2	82.2	27.0	77.8	89.3	205.6	100.0	90.5	160.2	68.1	50.4	128.8	91.7	112.4	247.9	78.2	119.2	33.6	60.4	185.1	148.9	96.4	89.5	91.8	348.4	27.3	141.1	152.2	140.5	148.9	147.5	104.1	255.4	189.0	236.2	80.7	102.9	131.7	223.1	149.7	82.6	32.4	78.3	297.5	124.9	136.7	168.3	100.0	76.4	86.1	134.7	65.3	278.3	58.2	115.4	159.9
KMT5A	"PR-Set7, SET07, SET8, SETD8"	ENSG00000183955	"Lysine methyltransferase 5A"	Q9NQR1	12	123383773-123409353	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064495			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA064495: AB_2685273"	"unprognostic (5.62e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (3.88e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.75e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.06e-1)"	13.7	10.1	22.6	15.3	22.1	39.2	13.1	20.8	23.2	22.2	18.7	17.7	12.8	21.3	12.9	40.7	21.7	13.6	17.0	22.2	20.6	13.7	14.0	15.5	15.4	22.4	22.7	12.0	19.7	11.4	10.7	16.5	22.9	30.2	14.4	11.7	24.0	19.7	24.4	28.1	15.6	16.7	21.4	16.8	16.9	7.9	23.3	17.9	25.7	15.3	16.6	16.6	25.7	23.9	37.3	24.3	27.8	43.5	18.1	30.9	40.1	57.4	26.3	32.0	26.9	28.8	21.9	84.9	33.1	37.5	11.7	35.8	41.6	21.7	33.3	39.3	45.0	68.8	26.4	15.2	26.5	54.8	18.8	15.1	27.1	34.7	32.8	30.2	26.2	36.4	136.8	38.1	27.5	29.9	58.1	84.9	13.8	34.6	29.0	70.4	22.1	24.1	22.8	43.4	37.9	30.9	51.3	28.3	28.6	23.6	39.6	75.3	32.4	35.2	26.0	42.3	42.3	23.0	25.9	75.9	24.6	29.6	29.9	2.3	1.2	4.3	1.3	2.1	2.7	1.7	1.6	2.1	1.0	1.1	0.9	1.1	1.8	2.3	2.1	2.0	1.5	0.3	22.6	22.1	20.8	23.2	22.2	20.6	22.4	22.7	22.9	21.4	23.3	23.9	34.5	12.8	14.5	0.0	12.7	0.0	17.6	0.0	20.5	20.8	32.0	27.3	0.0	7.2	6.8	27.6	6.2	15.1	22.4	10.4	7.9	9.2	10.1	46.8	43.8	20.7	4.9	62.1	0.0	9.4	16.6	14.7	15.8	41.1	2.5	21.3	30.4	19.5	17.7	3.3	0.0	22.2	0.0	16.8	0.0	3.2	16.1	19.6	0.0	0.0	3.4	28.7	7.2	0.0	0.0	13.6	9.6	42.9	15.9	24.1	14.3	13.1	11.7	17.9	6.6	23.2	19.7	9.7	10.2	38.8	0.0	14.2	14.5	18.4	12.7	22.5
KMT5B	"CGI-85, SUV420H1"	ENSG00000110066	"Lysine methyltransferase 5B"	Q4FZB7	11	68154863-68213828	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 128.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063648			Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA063648: AB_2685073"	"unprognostic (5.82e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (9.30e-4)"	18.6	16.5	16.3	15.7	17.5	28.5	27.5	26.2	17.6	20.2	17.3	22.3	22.8	26.2	19.0	17.2	18.2	15.0	15.9	15.8	17.2	19.7	22.4	18.1	19.2	16.1	16.3	22.4	22.8	20.6	15.6	22.3	15.6	22.0	21.6	33.4	23.4	16.3	16.9	21.7	21.8	20.7	14.8	17.2	20.7	20.7	16.1	27.0	31.0	16.7	20.4	16.5	17.6	21.3	25.3	18.8	37.6	24.5	8.6	21.4	40.8	17.7	12.3	21.7	12.8	59.7	39.6	20.5	30.2	24.4	21.4	13.0	26.2	20.6	31.6	23.2	15.1	19.4	21.9	24.7	31.0	27.7	25.6	21.3	41.6	26.2	27.3	20.0	21.8	20.3	29.3	23.4	18.7	52.2	19.6	28.9	40.4	50.4	13.9	31.9	29.4	55.4	16.2	24.2	32.7	39.1	27.5	27.4	128.7	20.3	35.1	17.9	23.1	29.2	38.9	22.5	18.4	29.5	13.8	43.0	18.4	17.3	31.8	10.0	3.7	16.5	4.4	5.2	3.1	3.2	4.6	5.4	3.5	3.8	5.3	4.8	10.9	9.6	5.3	5.4	4.1	2.8	16.3	17.5	26.2	17.6	15.8	17.2	16.1	16.3	15.6	14.8	16.1	21.3	39.8	60.9	61.3	0.0	32.9	0.0	42.3	0.0	50.7	50.0	45.8	34.7	0.0	25.8	25.4	25.8	12.5	27.4	37.6	32.6	21.5	27.9	22.0	42.6	46.3	31.7	25.5	31.4	0.0	32.7	29.6	26.3	37.2	44.3	22.7	40.7	30.0	37.7	17.9	63.9	0.0	26.6	0.0	32.4	0.0	21.0	28.0	27.7	0.0	0.0	38.2	29.6	43.3	0.0	0.0	37.1	25.7	31.6	34.8	43.7	36.4	22.7	32.1	39.6	32.9	44.8	28.6	45.8	58.9	38.0	0.0	51.7	30.7	31.8	25.1	53.6
KMT5C	"MGC2705, SUV420H2"	ENSG00000133247	"Lysine methyltransferase 5C"	Q86Y97	19	55339853-55348121	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 47.9;Cone photoreceptor cells: 50.1;Horizontal cells: 67.3;Rod photoreceptor cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.7;SCLC-21H: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052294	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA052294: AB_2681788"	"unprognostic (4.02e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.77e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.05e-8)"	"unprognostic (7.39e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.39e-2)"	3.7	5.9	5.5	1.3	6.0	5.0	4.6	6.4	6.5	5.6	4.3	5.4	3.5	5.0	0.9	4.8	8.6	1.1	4.5	5.1	4.9	5.2	5.1	5.4	1.5	6.1	5.7	6.3	5.9	1.3	11.1	1.9	5.9	6.7	0.9	2.6	5.2	1.3	2.8	9.2	5.0	0.7	4.9	5.7	4.8	7.1	5.8	1.9	4.6	0.6	0.9	4.6	4.5	7.4	6.2	4.1	4.1	3.3	0.8	1.0	10.5	1.8	0.7	0.6	1.5	2.8	5.1	6.2	2.2	1.3	0.3	3.1	2.8	2.2	0.7	5.5	20.7	4.2	3.7	3.0	1.4	2.7	5.7	1.0	2.9	1.9	1.0	1.4	1.3	6.5	12.4	3.6	0.7	7.1	8.6	6.4	7.0	3.8	6.0	12.3	4.7	6.2	1.0	1.5	19.3	8.2	0.9	4.9	2.4	2.6	5.3	3.7	1.4	2.1	4.4	0.9	1.3	9.8	5.2	4.1	1.2	6.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	6.0	6.4	6.5	5.1	4.9	6.1	5.7	5.9	4.9	5.8	7.4	3.3	6.4	4.1	0.0	4.9	0.0	13.5	0.0	7.4	47.9	11.8	9.3	0.0	8.6	3.1	3.7	50.1	31.1	13.3	7.5	1.9	6.6	2.3	27.4	7.5	3.9	7.3	18.9	0.0	2.9	20.4	5.4	16.3	18.0	2.5	11.1	6.1	1.1	9.6	67.3	0.0	15.0	0.0	5.1	0.0	2.4	7.5	6.2	0.0	0.0	2.2	19.9	8.2	0.0	0.0	8.7	11.9	6.4	9.8	10.6	21.1	2.7	3.6	49.7	6.6	5.4	3.0	21.0	30.5	6.5	0.0	19.8	13.0	23.0	11.3	11.8
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.2	0.1	0.1	1.9	0.0	5.3	0.3	0.2	0.2	0.2	0.2	1.3	1.6	0.3	0.2	1.0	0.1	0.3	0.1	0.1	0.1	0.5	0.7	0.4	3.6	0.1	0.3	0.0	0.0	0.3	0.0	1.3	0.1	0.1	1.4	0.2	0.2	0.0	0.0	0.8	1.7	0.7	0.0	0.6	0.9	16.9	0.3	7.4	0.3	0.1	3.4	0.5	0.2	0.1	19.1	9.3	18.0	13.8	0.5	2.6	8.6	20.5	8.1	16.0	13.1	11.6	7.2	11.9	6.1	9.3	12.0	21.9	17.6	9.7	16.3	21.4	5.0	35.5	15.5	3.9	0.0	26.2	17.8	0.5	0.4	10.8	6.4	2.1	13.8	20.9	22.9	19.2	18.3	6.1	23.5	6.1	9.4	11.3	9.5	21.2	25.8	5.9	2.6	15.6	15.9	7.7	17.7	10.6	2.1	5.9	11.1	9.0	13.1	18.7	16.3	21.9	11.7	7.5	27.9	22.3	7.6	18.5	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	1.8	1.8	0.0	8.5	2.6	0.0	1.9	0.2	0.0	3.5	3.5	1.9	0.0	0.0	0.0	0.6	11.3	4.2	0.0	2.9	0.0	22.8	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	11.5	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.7	1.9	1.7	0.0	0.0
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421902-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA053627: AB_2682211, HPA063426: AB_2685013"	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	20.2	18.4	10.0	19.8	10.6	11.4	11.9	10.6	15.0	14.1	6.7	15.5	13.0	13.6	15.1	21.8	12.9	12.1	20.3	11.6	10.7	16.1	32.0	13.0	15.7	11.2	10.2	10.6	18.8	19.2	9.0	15.9	11.2	15.1	15.4	28.6	12.4	16.3	74.4	13.5	13.6	23.0	11.6	12.3	14.5	20.6	10.7	15.5	17.9	41.0	20.6	22.1	11.4	12.6	75.1	43.4	73.2	37.2	46.6	51.2	23.2	56.5	47.5	60.4	54.4	52.6	35.6	54.1	50.6	62.4	47.8	38.3	58.2	48.2	88.9	14.8	22.1	66.6	37.1	29.5	27.3	59.8	29.5	35.7	61.0	43.7	60.9	29.5	67.3	28.8	47.6	30.5	55.8	34.6	43.7	14.1	31.8	52.5	46.2	44.1	60.8	34.8	26.2	51.8	50.4	30.3	60.5	32.6	50.1	56.9	43.2	34.8	57.9	37.7	41.2	18.7	44.1	29.1	31.8	99.9	52.7	40.9	39.1	27.1	19.3	18.8	17.4	19.5	18.6	15.8	15.2	19.3	25.4	12.7	15.4	15.8	41.5	21.2	29.3	7.9	17.6	18.2	10.0	10.6	10.6	15.0	11.6	10.7	11.2	10.2	11.2	11.6	10.7	12.6	27.9	16.0	31.8	53.5	31.9	41.4	22.2	15.8	28.5	30.1	24.2	12.3	31.1	22.8	32.9	14.7	31.3	21.2	31.5	18.6	13.7	23.2	120.1	35.0	26.1	27.6	16.3	49.2	107.2	33.4	25.9	26.1	19.4	29.5	38.7	18.6	22.5	50.2	23.3	20.2	81.7	19.7	18.3	27.9	47.4	221.8	22.4	30.0	17.8	61.8	31.5	22.2	26.8	59.8	91.7	35.1	19.8	24.8	36.6	34.5	18.6	23.1	44.8	47.4	13.1	25.4	32.1	42.1	18.0	27.1	45.5	24.9	31.3	19.6	14.0	27.5
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035636-68047364	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9;Extravillous trophoblasts: 279.7;Spermatocytes: 552.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		160000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	25.9	15.9	18.9	45.2	19.3	99.2	15.2	18.7	23.3	17.4	15.7	30.7	26.1	17.6	25.7	41.4	10.8	19.4	23.9	20.8	24.7	16.2	23.1	17.9	72.1	19.1	20.5	6.5	10.0	10.6	15.6	43.8	22.2	8.2	35.8	22.2	15.4	11.6	14.8	21.0	23.3	34.6	20.5	28.3	19.0	209.1	20.0	94.7	10.9	16.7	104.9	38.6	17.7	22.7	556.0	712.3	667.1	264.4	95.7	93.9	421.1	467.9	372.9	758.1	587.9	499.5	250.4	514.4	146.7	273.4	375.1	297.4	753.8	359.4	870.7	203.8	437.5	446.5	311.7	482.7	101.9	387.6	294.3	58.1	69.3	426.0	267.2	105.8	746.8	211.0	360.8	346.0	686.1	517.3	484.4	249.8	451.4	455.2	365.8	271.5	605.1	280.6	304.0	250.0	262.2	286.3	269.5	839.1	291.9	609.6	495.6	196.9	288.6	416.7	506.2	290.6	647.3	291.5	451.9	504.7	203.0	334.9	458.0	30.1	31.0	12.7	24.1	46.5	19.2	45.8	18.8	27.3	56.2	39.6	13.3	21.5	0.9	43.9	39.6	41.4	37.7	31.3	18.9	19.3	18.7	23.3	20.8	24.7	19.1	20.5	22.2	20.5	20.0	22.7	41.0	12.8	31.0	6.2	49.4	109.7	32.2	73.7	43.3	20.1	39.8	45.5	13.8	7.2	39.7	18.4	8.4	128.3	96.4	27.7	15.6	31.4	863.9	70.8	55.1	48.6	42.9	70.9	8.5	25.5	279.7	64.9	31.1	68.0	44.4	68.2	21.8	17.2	126.0	32.0	7.3	27.6	97.6	42.9	132.1	266.6	19.3	60.0	53.4	3.7	72.1	31.2	18.6	6.6	5.9	20.7	11.9	14.7	60.3	27.6	9.3	31.2	22.7	20.0	32.9	52.4	74.1	552.9	185.2	61.3	88.5	118.9	79.8	28.0	49.3	24.2
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699320-49792682	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.4;tongue: 94.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046852, HPA077643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA046852: AB_2679840, HPA077643: "	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	20.8	10.6	13.6	16.9	15.3	29.7	11.7	14.3	19.6	13.7	9.3	17.0	12.3	13.8	11.3	25.4	12.4	14.6	31.9	16.0	15.0	13.8	23.4	17.2	18.4	14.4	13.5	8.3	10.4	12.6	7.1	14.9	14.3	15.8	16.6	33.4	10.4	19.1	145.4	16.2	12.2	25.6	16.1	13.6	13.4	28.5	15.9	19.9	19.2	94.2	20.2	20.1	11.0	17.8	41.3	28.3	53.0	44.6	53.2	58.1	26.6	73.3	60.8	63.5	46.0	86.2	37.6	89.2	14.4	86.6	42.7	47.1	64.1	59.5	105.2	53.8	44.7	65.3	25.4	101.1	51.8	98.7	40.6	42.9	42.3	53.3	69.8	41.7	79.7	36.9	36.7	23.4	88.8	19.1	53.2	53.7	61.4	57.8	19.7	68.6	52.1	27.3	39.1	33.8	22.2	34.8	27.1	33.3	29.5	43.8	19.8	39.3	73.0	46.7	37.5	43.0	49.8	18.8	27.9	76.7	28.4	44.9	47.2	10.3	3.8	3.6	6.7	4.5	9.3	4.9	6.7	6.6	4.2	2.8	6.4	5.9	2.2	6.7	6.0	2.3	8.5	3.4	13.6	15.3	14.3	19.6	16.0	15.0	14.4	13.5	14.3	16.1	15.9	17.8	44.3	67.3	33.8	64.9	35.2	43.1	30.5	21.4	43.9	29.9	23.4	15.0	76.5	21.5	25.7	12.9	33.3	15.5	31.8	26.0	17.6	49.0	316.7	57.4	35.7	44.2	30.5	39.1	90.6	53.7	17.7	30.0	27.0	40.7	33.0	25.4	30.4	36.2	33.1	52.2	83.9	18.4	20.3	37.3	38.7	168.8	22.1	41.9	19.6	55.3	47.1	49.0	35.0	73.4	85.6	51.7	15.0	50.0	36.9	41.7	14.3	28.1	45.8	65.7	26.3	29.1	32.1	66.1	31.8	52.9	49.9	10.5	38.6	61.9	24.9	33.1
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160495007-160565571	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	20.2	8.1	4.4	12.0	5.4	15.2	11.1	7.2	10.8	11.1	2.7	16.9	8.8	12.7	8.5	16.5	9.0	9.7	23.3	5.8	7.3	11.1	12.2	11.0	10.4	6.2	5.5	9.0	13.2	11.0	6.3	11.9	6.5	11.6	8.5	13.2	10.5	12.4	124.6	11.3	9.8	13.5	5.9	11.2	12.1	12.2	5.5	11.2	10.3	59.8	12.0	14.3	11.8	6.9	103.4	29.9	20.0	32.7	30.3	27.8	39.7	70.7	39.6	41.0	33.0	38.5	32.1	52.6	73.8	59.9	52.5	45.8	27.4	38.2	50.2	77.0	20.5	52.8	15.2	9.0	37.7	49.3	33.8	22.0	18.5	38.5	76.6	27.5	53.9	26.5	44.2	33.5	45.5	13.8	38.0	17.7	53.9	33.7	31.4	33.9	41.6	50.4	21.9	22.9	23.3	24.8	60.8	29.7	55.7	22.8	33.7	14.4	72.9	39.4	36.0	37.3	87.9	80.4	50.4	96.3	30.9	45.4	31.6	7.7	2.3	2.9	1.8	3.5	2.5	2.3	1.6	2.6	1.7	1.5	1.3	2.0	4.2	4.0	5.7	1.5	2.7	1.8	4.4	5.4	7.2	10.8	5.8	7.3	6.2	5.5	6.5	5.9	5.5	6.9	70.5	38.5	25.1	40.1	62.8	123.6	87.3	24.3	60.3	58.6	59.4	48.1	158.8	30.0	38.4	11.0	79.2	26.1	54.5	65.0	35.2	36.5	24.3	71.2	63.2	60.7	28.7	38.1	48.5	37.7	25.3	55.1	45.9	92.1	31.6	57.6	37.5	34.7	39.2	53.8	52.9	38.1	28.5	47.9	97.2	18.4	33.8	80.0	44.4	49.6	43.2	57.5	28.8	45.8	69.2	77.4	44.3	34.6	65.2	86.5	32.0	40.2	40.6	69.6	32.9	102.4	67.4	38.2	25.3	85.3	126.0	40.6	60.6	36.1	43.7	104.4
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108056-32176563	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	14.2	15.4	12.8	11.0	13.9	20.5	13.1	12.4	15.1	15.4	12.7	17.7	8.8	17.1	12.8	18.8	14.2	8.8	22.0	13.8	17.2	13.8	15.8	15.1	11.1	15.7	16.3	13.4	13.4	24.6	14.3	16.6	18.2	13.9	13.0	17.1	13.4	14.3	39.3	18.5	12.5	17.8	12.0	12.0	14.8	20.2	14.6	12.8	13.5	23.7	14.8	15.6	15.6	14.5	32.0	24.8	21.6	28.0	32.5	28.4	25.3	25.2	29.5	36.0	34.5	27.8	33.9	26.5	29.1	45.6	21.6	26.7	33.5	38.5	45.6	27.0	18.4	27.4	36.4	22.6	28.7	30.4	21.5	28.9	35.8	44.6	42.3	30.3	38.1	20.5	27.0	23.7	34.4	17.5	24.6	17.3	50.5	20.6	18.3	24.5	31.0	21.7	31.4	28.9	20.7	17.4	45.8	27.1	25.0	52.6	19.2	15.9	44.5	33.1	22.7	43.8	36.6	16.9	20.7	20.3	36.3	27.8	32.4	3.2	7.4	7.2	7.7	9.1	7.5	5.3	6.5	6.0	6.0	6.1	7.4	7.2	4.2	3.8	9.9	6.7	7.3	5.3	12.8	13.9	12.4	15.1	13.8	17.2	15.7	16.3	18.2	12.0	14.6	14.5	27.9	41.7	41.5	33.0	36.1	63.6	36.9	37.6	22.2	48.6	44.7	26.7	32.7	37.1	32.4	29.5	58.4	45.4	42.4	29.5	17.6	36.2	294.2	41.0	44.6	40.4	46.1	52.8	62.5	31.6	41.6	35.7	25.5	49.3	13.9	31.3	36.0	77.3	30.4	52.2	58.4	36.0	24.4	36.8	44.8	65.2	34.2	29.3	24.9	30.0	41.4	29.0	47.4	40.7	54.3	46.1	26.4	40.6	24.1	56.7	25.3	33.2	48.2	44.7	32.9	53.1	36.7	78.7	56.2	31.2	85.1	135.7	31.7	31.8	35.6	59.0
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavorable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	57.6	44.9	31.6	74.4	33.6	35.9	53.4	34.7	32.2	49.9	30.5	55.3	35.9	47.5	29.5	66.0	49.6	47.2	53.6	31.2	37.1	48.8	50.6	42.6	81.7	38.2	39.8	64.3	38.1	56.3	28.1	55.4	37.1	44.4	63.6	49.0	39.2	45.7	91.0	38.7	38.8	66.6	37.2	54.0	43.3	100.9	33.9	117.3	57.4	88.3	108.7	79.6	40.5	47.3	273.2	485.0	324.6	259.1	152.8	265.8	271.6	345.4	307.0	441.6	339.3	853.2	161.5	385.8	210.4	343.8	301.8	186.3	607.2	316.3	691.1	212.1	344.7	421.2	408.7	241.6	148.4	485.5	238.9	209.6	140.5	511.7	509.2	202.3	305.8	203.0	461.3	237.5	349.4	288.8	464.9	97.2	270.6	199.4	300.2	250.1	563.3	216.4	156.2	444.2	267.5	240.5	233.3	121.7	176.6	388.4	253.9	157.6	248.7	463.9	264.7	252.8	412.9	258.8	373.0	542.6	216.1	224.2	325.8	3.1	2.9	6.1	4.1	3.6	5.8	4.0	4.7	5.1	1.8	4.0	4.5	4.3	12.2	3.5	4.4	3.0	3.4	2.4	31.6	33.6	34.7	32.2	31.2	37.1	38.2	39.8	37.1	37.2	33.9	47.3	76.8	128.2	71.9	42.7	138.3	125.7	101.1	67.8	165.0	96.5	110.8	89.5	132.7	88.6	75.2	44.1	68.8	132.7	93.9	69.5	41.1	117.1	55.8	71.2	123.1	110.5	123.8	148.7	51.4	119.5	147.5	102.9	72.4	106.3	76.1	147.2	128.8	97.5	124.1	80.8	48.2	82.2	44.7	115.0	91.6	41.7	96.9	102.7	60.5	30.9	152.8	83.4	80.3	39.2	58.2	147.0	69.8	121.5	163.4	149.7	49.2	48.0	60.6	90.2	98.6	107.0	104.6	291.6	186.0	163.9	143.5	158.2	108.1	138.8	128.4	128.1
KPTN	2E4	ENSG00000118162	"Kaptin, actin binding protein"	Q9Y664	19	47475150-47484265	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 23.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 23.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041710, HPA041796"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA041710: AB_10961904, HPA041796: AB_10962832"	"unprognostic (4.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.54e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (9.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (1.40e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-1)"	5.2	6.6	5.1	3.0	5.5	5.6	4.7	5.9	8.4	7.2	3.6	6.2	3.4	5.3	1.4	7.7	4.4	2.4	5.8	5.6	5.1	6.3	8.6	4.5	3.4	5.6	5.1	3.2	5.5	4.0	10.0	2.8	5.0	8.0	2.2	1.6	10.1	2.0	6.9	4.8	4.5	2.6	4.6	6.1	4.7	5.4	5.1	8.2	4.8	6.7	2.1	5.1	5.8	5.4	9.7	16.8	12.9	8.6	12.9	10.0	9.3	5.4	9.9	28.4	17.5	12.6	11.3	12.3	4.1	9.5	10.1	11.1	11.0	19.1	7.9	11.4	17.2	5.2	12.2	11.4	11.5	10.1	13.8	11.5	12.3	9.5	8.7	7.2	11.0	15.2	10.1	10.9	8.3	7.8	17.7	44.8	11.6	10.5	10.3	12.6	6.3	4.8	8.8	15.0	27.8	21.1	9.1	10.3	6.8	6.4	8.5	14.5	6.6	6.9	7.6	3.7	12.2	2.8	4.8	5.3	6.1	6.4	10.4	0.0	3.9	1.7	1.4	3.4	0.4	1.5	1.0	1.2	4.6	1.6	1.3	1.1	3.2	1.2	5.3	23.9	1.7	2.2	5.1	5.5	5.9	8.4	5.6	5.1	5.6	5.1	5.0	4.6	5.1	5.4	2.6	3.2	2.7	4.6	4.8	2.8	8.5	13.8	2.8	5.8	5.8	3.9	3.7	4.3	8.9	5.5	6.2	14.5	12.1	3.4	9.8	9.6	0.8	3.1	3.3	3.0	3.0	0.8	4.7	4.2	13.3	5.0	5.1	3.4	2.5	4.9	3.3	6.2	8.5	10.1	3.5	2.5	8.2	5.6	2.8	2.5	1.2	5.8	1.8	1.9	2.5	6.9	5.2	3.0	4.3	5.0	1.8	0.7	6.5	4.4	4.3	8.3	2.9	4.0	0.0	3.5	3.5	4.9	18.9	4.5	3.1	15.3	1.7	8.2	4.0	5.8
KRBA1	KIAA1862	ENSG00000133619	"KRAB-A domain containing 1"	A5PL33	7	149714781-149734575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 40.2"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 11.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021237, HPA050448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA021237: AB_2134145, HPA050448: AB_2681129"	"unprognostic (2.19e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (7.48e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.01e-5)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (2.55e-1)"	"unprognostic (6.33e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.31e-2)"	4.1	6.0	6.0	5.0	6.7	3.9	5.4	4.3	10.1	9.2	1.8	9.0	1.5	9.6	2.3	5.7	7.0	4.3	40.2	6.5	4.2	7.6	2.6	4.7	4.6	7.6	4.7	8.9	7.6	6.0	25.2	2.3	4.8	8.9	1.3	4.9	12.9	5.6	6.3	6.9	5.3	6.4	2.6	6.8	7.4	6.8	5.6	3.9	6.1	4.1	3.7	8.1	7.5	7.1	8.0	4.9	9.5	20.0	4.2	4.1	8.3	4.2	5.1	6.6	7.5	0.5	2.1	2.4	8.6	5.3	13.3	7.8	7.2	14.0	3.3	11.1	13.7	4.4	7.5	4.7	5.2	0.0	12.0	9.2	6.5	4.6	2.5	7.8	6.1	13.0	18.4	2.5	3.4	3.2	11.7	6.8	11.4	3.7	4.7	12.2	3.8	1.3	5.1	6.3	7.5	12.7	6.4	18.3	4.5	4.3	3.2	6.8	6.2	8.0	3.4	0.0	5.8	11.7	4.1	10.7	4.7	7.6	8.5	0.0	0.7	0.1	1.4	0.7	0.9	0.6	0.7	0.8	1.0	1.3	1.2	1.0	0.5	0.1	1.6	1.4	1.6	0.7	6.0	6.7	4.3	10.1	6.5	4.2	7.6	4.7	4.8	2.6	5.6	7.1	2.0	0.0	3.2	9.4	1.9	1.8	2.6	2.7	4.6	7.9	4.4	3.9	10.3	5.7	1.6	3.7	4.2	1.2	4.8	0.0	0.0	4.9	0.6	0.8	2.0	1.6	0.0	0.4	6.9	2.7	2.3	3.0	2.6	0.9	0.0	6.3	1.4	1.2	5.2	8.4	6.5	0.1	0.0	2.8	0.9	1.2	4.1	1.8	0.0	1.9	1.6	11.7	2.1	5.5	3.3	1.3	0.0	3.4	1.1	3.0	0.0	1.8	1.6	4.2	6.6	2.8	2.2	1.8	3.5	1.2	1.8	1.2	2.8	3.0	0.1	1.9
KRBA2		ENSG00000184619	"KRAB-A domain containing 2"	Q6ZNG9	17	8356902-8376704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 34.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 16.7;Rod photoreceptor cells: 30.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA022849	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA022849: AB_1852996"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.98e-2)"	"unprognostic (8.35e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.61e-4)"	"unprognostic (6.14e-2)"	"unprognostic (5.02e-7)"	"unprognostic (1.82e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.08e-1)"	1.7	1.9	3.4	1.7	4.8	1.1	2.5	5.3	4.5	2.4	2.5	1.5	1.6	2.4	2.5	1.4	1.7	1.2	6.9	3.4	3.6	3.6	0.8	1.6	1.6	3.8	3.6	2.6	1.7	3.9	1.8	1.8	3.9	2.6	1.6	34.5	2.4	1.7	6.2	3.0	1.7	1.8	2.5	1.7	1.6	2.0	4.1	2.5	2.8	6.8	1.3	1.7	1.5	6.8	0.4	3.6	4.6	4.4	2.0	2.8	2.3	0.6	1.3	1.6	2.3	0.0	1.5	0.3	2.6	0.5	1.1	0.9	1.6	0.5	2.2	1.9	1.0	0.6	2.5	1.3	0.7	0.2	1.0	2.5	0.2	1.8	0.6	1.0	2.9	2.3	0.1	0.6	1.4	0.7	1.9	0.5	0.7	0.2	1.2	3.4	2.5	0.4	1.2	2.4	1.6	3.0	3.4	1.2	1.0	3.1	1.5	0.2	1.5	1.3	2.2	0.5	0.7	1.6	0.9	0.3	1.6	0.1	3.1	10.1	1.3	2.3	2.0	1.2	1.9	1.7	2.0	1.6	0.8	2.9	3.5	1.9	1.6	1.5	2.7	1.6	2.2	0.4	3.4	4.8	5.3	4.5	3.4	3.6	3.8	3.6	3.9	2.5	4.1	6.8	9.9	0.0	1.1	6.2	2.2	0.3	1.3	1.3	4.6	3.6	2.9	3.0	0.7	1.5	0.4	1.8	16.7	2.5	1.7	1.5	3.9	3.4	0.4	0.9	3.0	4.5	4.2	7.4	2.6	1.1	0.6	2.8	2.6	0.9	5.1	3.5	2.2	0.4	0.9	3.3	4.1	1.5	2.0	1.0	1.0	0.6	1.5	1.2	1.8	1.9	1.2	2.9	4.1	5.5	4.1	2.1	0.1	3.0	3.8	0.6	1.3	1.4	2.3	30.2	0.0	2.4	2.9	2.3	2.4	3.1	0.9	1.2	2.4	2.5	1.6	0.3
KRBOX1		ENSG00000240747	"KRAB box domain containing 1"	C9JBD0	3	42809483-42942792	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	24	"testis: 197.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 250.9;Late spermatids: 111.3;Spermatocytes: 883.9;Spermatogonia: 176.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.2;CAPAN-2: 50.0;EFO-21: 22.6;GAMG: 35.2;hTEC/SVTERT24-B: 33.7;hTERT-HME1: 23.0;U-2197: 67.7"									HPA046901			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA046901: AB_2797232"	"unprognostic (2.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.95e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	3.4	4.7	2.9	0.2	2.9	0.5	3.9	3.1	3.8	5.8	2.8	4.9	1.7	5.3	8.1	4.3	3.9	1.2	3.8	3.0	3.0	6.0	0.6	1.5	0.9	3.1	2.9	6.9	3.9	0.8	4.0	1.3	2.9	3.6	2.0	1.9	2.3	5.3	1.6	5.1	1.8	4.7	2.9	1.2	2.7	197.8	2.9	1.5	5.2	1.1	1.6	3.8	3.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	8.7	22.2	0.2	0.0	0.1	50.0	0.0	22.6	1.8	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	9.7	0.0	33.7	23.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	17.0	0.0	67.7	0.0	7.4	2.6	0.0	3.8	0.0	1.4	0.0	0.3	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	4.0	0.7	1.0	0.3	0.0	2.9	2.9	3.1	3.8	3.0	3.0	3.1	2.9	2.9	2.9	2.9	3.1	2.2	0.0	2.6	1.6	0.1	0.0	2.6	0.0	0.6	8.8	4.2	11.3	5.6	2.8	1.8	5.5	2.1	12.0	0.2	0.4	19.6	4.2	250.9	4.4	7.7	1.6	0.0	0.0	0.8	12.0	10.1	6.1	0.0	2.5	0.0	3.8	1.4	1.0	2.2	1.7	1.4	1.4	0.0	0.0	0.0	111.3	20.2	1.0	0.0	1.0	0.0	18.3	1.0	1.5	1.0	6.8	3.2	13.5	0.0	1.8	1.2	3.1	0.7	8.8	13.1	5.2	6.9	883.9	176.0	0.6	0.0	9.0	0.2	14.3	2.8	1.0
KRBOX4	"FLJ20344, ZNF673"	ENSG00000147121	"KRAB box domain containing 4"	Q5JUW0	X	46447292-46497422	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 43.2;Oligodendrocytes: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA065295			Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA065295: AB_2685456"	"unprognostic (4.12e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (2.87e-6)"	"prognostic favorable (4.67e-5)"	"unprognostic (1.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (1.98e-7)"	"unprognostic (7.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.17e-4)"	13.1	10.0	20.1	9.6	19.5	6.4	14.3	19.1	22.5	18.4	19.6	14.0	6.7	18.1	22.6	7.4	13.2	11.9	10.2	19.3	20.8	11.4	16.5	11.6	14.6	18.8	18.2	18.2	8.8	13.8	13.1	17.6	18.9	15.7	9.1	14.6	8.8	11.5	8.3	11.5	9.8	15.0	17.6	18.5	9.3	5.5	23.7	14.4	14.7	9.0	12.8	12.3	11.2	20.0	23.0	13.2	20.1	15.6	19.6	20.1	12.3	21.8	19.8	19.9	18.0	11.3	20.8	12.7	14.1	19.4	32.9	16.0	25.1	12.2	23.4	12.7	10.7	10.9	29.7	11.0	20.9	16.3	16.8	22.7	13.6	27.1	22.8	17.7	18.7	19.7	11.7	13.8	18.0	13.2	16.6	8.1	18.3	9.1	23.4	11.6	18.6	16.0	13.2	9.4	7.3	14.3	18.6	9.2	21.5	34.2	15.3	15.9	17.2	22.0	22.0	29.2	17.9	15.1	18.3	18.5	19.1	0.8	20.6	18.0	7.2	15.5	12.7	9.0	13.4	13.6	13.9	12.5	7.1	18.6	17.3	13.1	4.3	15.6	10.3	13.4	13.1	9.4	20.1	19.5	19.1	22.5	19.3	20.8	18.8	18.2	18.9	17.6	23.7	20.0	16.9	6.4	6.1	25.1	11.8	2.2	4.5	7.4	14.2	6.4	5.6	7.0	6.6	8.6	5.1	5.5	4.2	15.2	10.5	1.9	9.8	7.5	0.2	4.9	10.1	15.4	1.2	7.2	22.4	4.5	8.0	10.5	5.6	3.6	7.6	8.8	16.8	5.3	9.5	10.1	22.2	3.9	4.1	6.3	2.6	1.3	7.8	5.1	7.2	20.6	5.5	8.9	13.4	43.2	36.9	3.6	6.5	11.3	8.3	3.8	3.1	5.8	5.1	8.4	13.1	6.4	8.1	4.3	5.4	4.2	2.7	13.5	10.9	11.1	3.6	1.9
KREMEN1	"KREMEN, KRM1"	ENSG00000183762	"Kringle containing transmembrane protein 1"	Q96MU8	22	29073035-29168333	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Wnt signaling pathway"		"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 59.1;Skeletal myocytes: 82.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.3;neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 34.7;U-2197: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058513			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		1100000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA058513: AB_2683739"																		7.3	13.5	10.3	9.5	22.3	4.1	7.6	7.4	10.8	9.1	5.6	13.1	6.6	6.7	8.7	37.2	10.9	4.0	22.7	12.7	7.6	9.0	2.4	11.9	2.9	8.2	9.8	22.2	4.6	48.2	6.5	6.1	8.0	9.1	11.3	4.0	28.3	9.8	28.7	36.3	11.1	6.2	5.6	9.1	9.4	12.5	12.9	22.4	9.5	42.6	16.4	9.2	13.7	8.3	5.2	3.6	11.8	6.2	3.9	11.9	9.9	1.4	12.0	3.8	5.7	16.5	2.4	0.1	4.5	5.6	9.6	24.7	24.6	9.9	4.1	6.2	15.5	1.4	1.7	15.6	4.1	0.1	1.3	11.4	19.7	4.3	2.4	1.6	0.6	10.1	5.4	0.3	4.8	4.4	0.1	1.7	0.5	34.0	2.5	0.8	34.7	0.3	4.1	9.7	23.6	13.1	14.2	5.0	18.3	3.9	18.5	0.9	0.4	15.7	4.8	59.3	1.7	1.2	0.4	0.2	10.0	2.2	18.5	1.3	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	4.6	0.3	0.2	0.6	0.1	0.1	10.3	22.3	7.4	10.8	12.7	7.6	8.2	9.8	8.0	5.6	12.9	8.3	2.0	16.0	18.4	59.1	0.3	15.3	14.0	14.1	7.4	4.4	5.7	6.1	23.9	14.3	18.3	7.3	0.0	15.5	0.3	3.9	1.9	5.4	3.2	6.2	19.7	3.9	0.0	17.2	10.3	4.2	1.8	24.4	8.6	8.0	19.0	5.9	5.3	2.6	2.6	0.0	2.7	19.4	4.1	24.1	6.8	10.8	17.7	2.5	0.0	15.9	2.7	22.2	2.1	10.6	6.3	3.0	9.5	10.5	0.1	10.9	2.2	4.7	18.4	3.4	13.1	82.2	7.9	8.1	6.0	26.3	19.5	5.3	2.3	33.5	10.2	10.5
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1 small subunit processome component homolog"	Q13601	12	75490863-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	15.2	14.2	6.5	15.6	7.0	43.9	16.7	9.3	10.4	11.6	7.6	12.5	12.1	15.0	9.0	16.0	9.8	10.0	11.8	6.9	8.2	16.2	20.4	11.5	19.0	6.6	7.3	15.0	10.7	20.3	8.0	14.5	7.0	13.2	10.9	16.0	19.3	9.8	23.5	12.7	10.3	10.9	7.4	12.6	12.7	12.0	7.5	17.9	14.9	22.7	18.0	15.9	9.8	8.2	59.4	48.1	29.2	27.1	21.8	20.1	54.1	51.0	31.7	38.5	24.8	35.7	30.7	62.2	40.3	23.9	39.0	30.5	39.1	43.0	42.4	52.0	39.9	60.9	25.0	41.8	26.4	107.0	37.1	21.3	35.8	44.8	41.7	39.1	26.6	57.4	67.7	19.8	38.2	39.2	63.1	30.8	43.6	32.4	42.4	49.9	56.1	37.4	42.6	73.6	35.4	29.6	48.0	33.7	59.5	27.9	56.2	42.9	34.4	36.2	24.1	37.7	53.2	38.8	52.3	39.0	19.6	37.0	66.2	13.3	3.2	13.2	13.1	6.5	16.4	23.0	18.3	15.0	5.5	20.6	18.6	17.9	1.5	12.9	5.5	15.3	18.2	7.6	6.5	7.0	9.3	10.4	6.9	8.2	6.6	7.3	7.0	7.4	7.5	8.2	62.9	70.5	49.2	13.4	64.0	49.1	104.3	70.3	48.9	56.4	41.1	50.5	25.6	24.3	55.7	40.5	33.3	68.5	86.4	18.7	58.7	50.9	5.4	52.5	63.8	46.7	18.0	55.8	25.3	49.0	55.7	48.2	21.4	62.6	38.0	41.3	31.1	40.9	29.5	74.0	24.3	25.7	46.8	24.2	21.3	7.6	52.5	30.0	12.4	6.5	42.4	66.4	66.9	19.1	16.3	42.8	28.1	53.4	37.9	45.6	19.2	47.0	42.3	55.5	13.1	79.2	50.2	72.6	61.1	46.8	44.3	70.5	65.4	59.6	29.3	63.2
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513745-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 419.1;esophagus: 1156.7;skin 1: 1319.5;vagina: 423.3"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 2789.9;Basal squamous epithelial cells: 8290.4;Squamous epithelial cells: 4637.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"HaCaT: 1156.8;hTCEpi: 1001.5"	"Region enhanced"	"Detected in single"		"white matter: 1.9"	"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		No	No		480000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favorable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	4.7	0.3	0.1	0.2	0.0	0.7	419.1	0.0	0.1	148.2	0.2	1.1	1.5	0.3	2.2	1156.7	32.4	2.8	0.7	0.1	0.0	0.3	0.6	4.3	0.0	0.1	0.1	0.4	1.4	0.0	1.2	0.3	0.1	182.8	1.6	0.0	140.0	4.1	0.7	1319.5	2.3	0.1	0.0	0.3	1.6	8.0	0.1	93.7	0.5	0.0	77.6	9.5	423.3	0.1	56.4	7.4	0.0	0.0	0.0	0.0	0.7	5.3	1.3	0.3	0.2	5.9	20.2	0.0	1.8	0.6	14.0	1156.8	0.0	41.8	0.2	0.6	0.0	0.0	7.7	1.9	0.0	0.1	4.7	0.0	1001.5	2.2	6.9	2.7	3.4	0.0	0.3	0.5	0.2	3.5	0.1	0.5	0.0	3.9	6.2	0.0	0.0	104.9	3.3	5.9	2.6	0.1	1.1	15.0	1.2	0.3	20.3	0.0	18.6	0.3	2.8	0.3	2.2	0.1	0.1	0.0	8.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	6.1	12.8	10.3	0.0	2.7	1309.8	2789.9	1190.9	8290.4	0.6	577.7	670.3	0.8	5.7	287.5	1.8	0.0	0.7	16.9	18.3	1.9	8.5	117.6	4.1	0.7	22.9	4.8	0.0	0.1	7.5	7.7	21.7	4.6	8.2	2.5	0.0	0.0	0.0	0.4	0.0	0.1	10.3	189.2	0.0	61.7	44.4	1.5	17.2	320.2	0.0	0.0	0.2	0.0	0.0	0.1	14.1	10.5	0.4	88.7	872.9	8.6	0.1	57.7	0.6	0.0	0.4	32.1	0.6	0.8	4637.9	193.6	1.2	21.6	0.1	7.2	906.0
KRT34	"Ha-4, KRTHA4"	ENSG00000131737	"Keratin 34"	O76011	17	41377650-41382403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"skin 1: 66.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 5.4;Late spermatids: 15.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BJ: 201.8"	"Not detected"	"Not detected"							"HPA055194, HPA072208"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		170000000		"Cluster 61: Skin - Cornification"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA055194: AB_2682733, HPA072208: AB_2686494"		"unprognostic (2.52e-1)"		"unprognostic (2.14e-1)"		"unprognostic (9.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-3)"		"unprognostic (5.12e-7)"				"unprognostic (3.84e-2)"	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	1.1	1.8	0.0	1.6	0.0	0.0	0.0	0.1	1.9	0.0	201.8	8.8	23.5	46.4	0.0	0.1	0.0	0.0	25.1	0.1	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	8.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.1	26.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.3	0.1	0.0	0.3	0.0	0.0
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821408-52834311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"skin 1: 68.3"	"Cell type enhanced"	"Detected in some"		"granulocytes: 4.5;Late spermatids: 1.1;Melanocytes: 3.6"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HMC-1: 425.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA		1900000000		"Cluster 61: Skin - Cornification"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA059347: AB_2683986"	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	425.5	0.0	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0
KRTCAP3	KCP3	ENSG00000157992	"Keratinocyte associated protein 3"	Q53RY4	2	27442366-27446481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 182.0;Proximal enterocytes: 168.7;Undifferentiated cells: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"MAIT T-cell: 6.8;memory B-cell: 4.5;memory CD4 T-cell: 5.6;memory CD8 T-cell: 2.6;naive B-cell: 6.4;naive CD4 T-cell: 6.6;naive CD8 T-cell: 2.7;T-reg: 4.4"	"Group enriched"	"Detected in many"	13	"B-cells: 6.4;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"A-431: 84.6;CAPAN-2: 122.5;OE19: 46.6;SCLC-21H: 60.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA047136, HPA060203"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA047136: AB_2679949, HPA060203: AB_2684221"	"prognostic favorable (2.67e-5)"	"unprognostic (5.93e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.42e-3)"	2.2	2.7	3.0	6.3	3.5	3.0	16.0	5.3	5.6	11.8	3.7	39.6	44.3	5.8	1.8	18.3	24.9	9.5	0.7	2.9	3.5	7.9	9.8	11.3	3.3	3.9	3.5	2.4	44.6	18.6	14.1	2.9	3.7	20.9	27.8	7.3	38.5	12.7	3.2	14.1	45.5	1.7	3.0	3.1	42.4	2.2	3.3	3.7	11.5	0.0	5.2	10.0	11.2	4.6	84.6	1.2	6.1	2.7	0.3	0.6	17.4	0.9	0.3	1.0	0.9	32.7	122.5	1.0	1.1	0.2	0.5	28.4	0.9	25.0	0.3	1.0	0.6	2.2	1.9	2.7	0.0	0.3	3.9	1.1	2.7	0.6	1.5	1.2	1.0	2.8	1.8	1.5	0.9	27.2	0.9	7.8	27.7	46.6	1.1	0.8	1.8	2.5	1.7	2.4	60.2	2.2	2.3	25.4	3.6	2.0	2.5	1.4	2.4	3.4	5.4	1.2	1.1	7.0	5.9	1.1	2.3	1.1	0.8	0.0	0.0	0.0	0.6	0.0	6.8	4.5	5.6	2.6	0.0	6.4	6.6	2.7	0.0	0.5	0.0	0.0	4.4	1.5	3.0	3.5	5.3	5.6	2.9	3.5	3.9	3.5	3.7	3.0	3.3	4.6	1.1	22.4	27.9	2.6	2.9	23.3	125.1	135.4	71.7	4.9	100.9	105.2	0.5	88.6	92.5	42.3	8.4	17.0	1.9	74.2	5.9	105.4	6.4	50.9	3.8	2.7	62.0	3.6	1.2	182.0	27.6	3.4	68.3	47.9	4.5	0.9	1.4	15.2	2.1	1.7	1.1	123.6	105.8	1.0	2.5	4.7	0.3	2.0	7.2	1.9	2.9	1.9	2.1	1.5	1.3	108.7	112.9	0.0	0.7	123.7	168.7	7.7	85.2	5.9	0.0	0.9	6.9	3.8	29.4	48.0	15.5	7.9	3.0	0.7	190.2	144.2
KY	FLJ33207	ENSG00000174611	"Kyphoscoliosis peptidase"	Q8NBH2	3	134599923-134651636	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease"	"Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 16.3;skin 1: 9.6;tongue: 27.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.6;Late spermatids: 6.4;Oligodendrocyte precursor cells: 24.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.0;NB-4: 1.1;U-2197: 2.7;U-87 MG: 8.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"HPA036492, HPA036668"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA036492: AB_10672222, HPA036668: AB_2675239"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.47e-1)"	0.0	2.7	1.7	0.2	1.8	0.3	0.8	1.6	2.9	0.8	0.1	0.9	0.4	1.9	0.8	2.0	1.9	0.4	3.1	1.6	1.7	0.3	0.0	0.1	0.0	1.9	2.3	0.9	0.0	2.2	3.3	0.0	2.1	2.2	0.2	1.7	0.8	1.7	16.3	9.6	0.2	4.2	1.5	0.1	0.7	0.3	2.0	0.9	3.0	27.7	0.0	0.6	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	8.1	0.7	0.0	5.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	1.6	2.9	1.6	1.7	1.9	2.3	2.1	1.5	2.0	1.9	0.0	0.0	0.0	15.0	0.0	0.6	0.1	0.0	0.0	0.4	0.1	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.0	0.0	2.5	0.0	24.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877657-143055833	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.4;urinary bladder: 51.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 136.1;Club cells: 109.6;Ionocytes: 114.0;Langerhans cells: 190.5;Macrophages: 122.9;monocytes: 248.0;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"classical monocyte: 109.4;intermediate monocyte: 142.7;memory B-cell: 73.6;myeloid DC: 111.2;naive B-cell: 51.3;non-classical monocyte: 123.4;plasmacytoid DC: 77.7"	"Group enriched"	"Detected in many"	19	"B-cells: 73.6;dendritic cells: 111.2;monocytes: 142.7"	"Cell line enhanced"	"Detected in many"		"A549: 185.2;GAMG: 298.5;HeLa: 195.5;Hep G2: 128.3;hTEC/SVTERT24-B: 106.5;U-87 MG: 314.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		590000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	5.2	4.0	2.4	24.4	2.1	10.8	30.8	2.7	4.5	4.0	3.6	2.4	1.1	2.5	1.3	6.7	1.2	9.8	1.2	2.0	1.6	18.6	88.4	13.5	15.0	2.8	1.7	0.4	0.9	0.8	1.2	7.3	3.3	0.9	2.9	1.5	1.8	0.7	0.7	1.3	3.0	4.8	0.5	8.9	5.8	16.6	6.6	3.9	2.3	0.3	28.9	51.5	3.4	2.1	0.2	185.2	0.3	0.4	0.4	0.6	0.5	0.4	5.1	0.2	0.2	3.3	2.7	11.9	0.5	0.1	298.5	0.7	0.1	0.2	0.2	0.6	0.2	4.3	195.5	128.3	2.4	0.4	0.8	17.3	15.0	106.5	0.6	0.2	0.2	0.3	0.5	1.1	1.7	96.7	0.2	11.8	0.7	0.2	0.9	0.2	0.9	0.4	3.2	96.0	0.5	0.3	102.2	15.2	1.0	1.0	50.9	26.5	1.5	5.9	0.5	89.1	0.3	0.7	0.3	0.3	314.5	22.2	0.6	0.7	109.4	2.4	0.5	142.7	0.4	73.6	0.6	0.3	111.2	51.3	0.5	0.3	5.8	1.8	123.4	77.7	0.6	49.2	2.4	2.1	2.7	4.5	2.0	1.6	2.8	1.7	3.3	0.5	6.6	2.1	3.0	3.2	2.7	0.7	46.8	4.0	0.5	136.1	0.0	0.5	5.8	0.9	1.6	7.2	109.6	3.7	4.2	3.3	16.1	0.7	5.9	14.5	46.3	1.5	1.1	5.1	0.0	2.5	1.3	9.5	2.3	1.8	20.4	15.7	0.0	0.0	2.5	49.1	38.8	10.1	0.9	0.0	114.0	64.7	190.5	42.8	1.8	122.9	1.8	29.0	248.0	0.2	1.0	0.5	0.8	59.6	1.1	0.4	5.1	1.1	0.0	44.4	21.1	0.6	6.6	0.5	3.9	47.8	8.0	1.5	3.1	104.7	2.2	0.1	1.0	22.6
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886173	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;intestine: 48.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 84.6;Excitatory neurons: 23.7;Horizontal cells: 33.7;Inhibitory neurons: 23.3;Melanocytes: 44.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 372.4;BJ hTERT+ SV40 Large T+ RasG12V: 200.8;HeLa: 258.1;RH-30: 162.6;RPTEC TERT1: 218.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Cluster 24: B-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	3.5	27.2	20.4	7.6	23.0	0.5	2.1	23.0	42.8	8.4	0.0	48.5	4.2	2.4	2.1	4.4	3.4	2.4	12.1	12.6	42.4	18.5	0.9	0.6	3.2	9.0	2.5	1.3	2.2	0.1	14.4	0.6	6.1	8.3	4.7	15.7	4.8	9.0	0.9	9.2	13.0	5.4	0.0	0.9	11.3	0.8	3.2	0.7	2.5	2.1	1.8	6.1	9.6	13.2	95.2	7.2	27.6	0.2	0.0	0.0	11.8	131.6	372.4	123.6	200.8	37.8	1.0	0.0	121.8	0.9	103.2	3.9	3.5	2.3	64.1	0.3	1.0	0.0	258.1	6.1	0.4	0.3	20.4	0.9	1.6	18.7	12.9	0.2	0.1	0.1	0.3	0.3	0.6	127.9	0.4	2.6	6.5	0.4	4.7	0.2	162.6	0.9	218.4	1.9	81.4	53.0	73.4	64.2	54.1	61.0	6.7	1.7	0.3	0.1	52.6	5.8	63.7	1.1	1.6	1.0	0.9	1.1	105.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	23.0	23.0	42.8	12.6	42.4	9.0	2.5	6.1	0.0	3.2	13.2	0.4	0.0	0.0	2.6	1.3	1.1	0.1	0.6	3.4	11.6	0.0	0.4	1.2	0.0	0.0	84.6	4.2	0.3	0.1	0.0	0.0	0.5	0.0	0.3	0.1	1.9	0.0	0.0	23.7	0.0	0.2	1.3	0.0	0.6	0.0	0.0	1.4	0.0	0.1	33.7	23.3	0.0	0.0	0.0	1.1	0.0	0.9	0.3	44.4	5.6	0.0	1.5	0.0	1.5	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	10.4	0.0	2.2	0.6	0.4	0.1	0.0	1.3	0.1	1.5	0.0	0.0	0.1
L3MBTL1	"dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3"	ENSG00000185513	"L3MBTL histone methyl-lysine binding protein 1"	Q9Y468	20	43489442-43550954	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 31.2;Oligodendrocytes: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SuSa: 5.1"									HPA059648			Supported	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA059648: "	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.65e-4)"	"unprognostic (6.02e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-4)"	2.7	4.8	8.6	0.8	8.5	0.8	3.9	6.4	10.2	6.4	6.1	6.1	1.1	5.0	2.0	4.2	6.9	0.6	3.9	8.0	9.4	5.9	2.0	3.0	0.8	8.0	8.8	7.5	3.3	1.1	16.7	0.6	8.7	6.4	0.7	3.4	4.6	1.7	5.1	3.9	4.8	0.8	6.1	5.5	3.9	10.1	10.8	0.8	6.9	1.1	0.5	4.8	6.4	7.6	0.1	0.1	1.6	0.9	0.1	0.0	2.6	0.2	0.3	0.5	0.4	0.2	1.7	0.9	0.4	0.9	0.5	1.1	0.0	0.4	0.3	0.0	1.1	0.3	1.4	2.1	0.3	0.0	0.3	0.3	0.6	0.1	0.0	2.9	0.3	0.9	0.6	0.2	0.1	0.3	0.4	1.2	1.0	0.7	1.4	0.6	0.2	0.5	1.2	0.4	0.4	1.3	0.5	0.5	0.1	5.1	0.6	1.7	0.6	0.2	1.1	0.0	0.4	1.0	0.4	0.3	1.5	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.2	8.6	8.5	6.4	10.2	8.0	9.4	8.0	8.8	8.7	6.1	10.8	7.6	1.2	3.2	3.2	16.0	3.3	0.9	2.0	1.9	8.0	17.2	2.7	2.8	1.9	1.5	4.2	5.5	14.6	2.1	5.2	0.9	1.9	1.3	2.0	2.4	2.6	2.2	1.2	1.7	12.4	0.2	3.3	1.9	2.0	1.8	5.1	8.3	1.8	0.6	1.4	6.7	24.4	2.1	4.1	1.6	1.8	2.8	5.0	2.0	3.6	4.7	1.0	4.7	4.1	31.2	25.4	0.8	1.9	6.0	1.7	2.5	3.1	0.7	6.6	10.8	0.0	4.2	2.8	13.9	12.3	1.5	1.1	1.9	2.3	4.6	1.8	1.4
L3MBTL2	"dJ756G23.3, DKFZP761I141, H-l(3)mbt-l"	ENSG00000100395	"L3MBTL histone methyl-lysine binding protein 2"	Q969R5	22	41205282-41231271	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000815			Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA000815: AB_1079220"	"unprognostic (2.42e-1)"	"prognostic favorable (6.39e-5)"	"unprognostic (3.98e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (3.48e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.19e-1)"	9.8	14.6	15.8	12.3	16.6	11.0	10.5	14.7	16.8	12.8	12.6	13.5	8.6	13.2	12.1	12.1	19.4	9.5	13.2	15.4	16.3	14.2	16.6	11.8	17.7	16.3	16.4	14.0	11.0	17.0	16.4	9.5	17.0	14.2	10.2	10.0	13.0	13.8	11.9	13.7	11.6	13.9	14.7	15.5	12.7	14.9	16.6	15.0	12.2	9.0	18.0	13.9	10.4	24.3	21.3	20.8	17.6	35.6	20.9	15.6	20.6	19.8	22.7	37.7	31.1	13.7	15.0	34.6	15.7	26.7	22.6	20.3	40.9	26.3	23.9	42.3	52.8	14.4	35.7	32.9	22.1	65.8	31.4	21.4	10.2	29.6	27.8	16.4	27.2	26.1	24.9	27.5	18.1	37.4	33.4	22.4	23.9	75.6	23.8	34.1	14.3	39.9	19.0	20.9	14.3	10.0	35.5	25.3	21.4	17.0	16.9	36.0	21.6	20.2	19.1	16.2	22.2	22.6	43.1	28.6	23.3	29.7	26.3	10.0	13.4	10.7	21.4	16.6	19.6	15.7	16.7	17.1	17.0	11.0	20.0	18.9	2.1	21.2	18.6	12.9	18.4	21.6	15.8	16.6	14.7	16.8	15.4	16.3	16.3	16.4	17.0	14.7	16.6	24.3	9.4	16.0	19.6	7.5	12.2	2.7	5.1	8.0	2.8	24.7	9.0	8.9	10.2	15.7	17.1	11.0	16.7	17.7	15.8	9.6	11.7	9.9	13.9	14.8	9.1	9.3	15.0	10.5	9.9	7.9	17.4	9.3	13.7	8.0	11.4	12.0	7.9	14.2	13.0	16.8	10.8	8.7	22.4	11.1	4.6	30.0	7.2	11.6	3.6	3.7	11.2	13.7	12.3	9.5	8.1	7.6	5.8	9.4	13.3	6.9	7.3	8.7	22.6	15.0	6.6	9.4	13.4	21.5	14.4	6.7	3.8	17.1	13.9	17.5	9.4	6.2
L3MBTL3	KIAA1798	ENSG00000198945	"L3MBTL histone methyl-lysine binding protein 3"	Q96JM7	6	130013699-130141449	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 63.5;HUVEC TERT2: 62.5;TIME: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044382, HPA053035"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044382: AB_2678920, HPA053035: AB_2682021"	"unprognostic (2.33e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-2)"	4.5	11.0	3.3	9.9	3.3	7.7	4.7	1.7	3.6	9.5	9.6	4.6	2.8	11.2	11.7	2.3	5.5	5.3	2.4	4.1	3.8	4.8	5.8	4.0	11.1	2.5	3.1	10.1	2.3	5.6	5.5	5.7	2.4	7.0	5.0	2.1	4.9	6.2	2.5	2.7	5.1	8.3	2.5	12.6	3.3	7.6	4.5	7.7	6.0	2.1	8.9	5.7	5.3	2.6	1.7	6.5	15.2	2.4	10.4	13.4	3.1	7.8	15.9	3.0	5.5	8.0	8.1	2.7	11.0	9.9	9.3	6.5	8.7	13.6	4.6	6.1	8.8	18.3	3.2	2.0	5.2	10.8	63.5	8.8	9.6	3.6	10.2	15.1	62.5	8.3	13.3	7.1	7.7	0.7	23.2	1.9	7.0	1.7	3.3	8.7	4.2	0.0	9.8	2.5	0.5	2.0	2.9	0.7	6.1	18.2	16.4	9.3	43.0	5.1	6.9	0.9	5.3	1.4	0.1	4.7	2.5	4.5	5.2	8.2	4.9	4.8	3.7	5.5	3.2	10.7	3.5	4.7	1.9	13.4	3.2	4.1	4.9	2.1	22.7	14.8	5.9	1.0	3.3	3.3	1.7	3.6	4.1	3.8	2.5	3.1	2.4	2.5	4.5	2.6	9.1	3.2	6.5	6.5	20.5	5.1	5.1	2.4	10.2	4.2	5.3	2.8	3.9	1.5	3.8	9.2	2.1	13.4	20.7	2.8	1.9	5.6	24.2	6.1	12.8	9.4	3.6	5.0	20.8	5.4	7.1	7.3	4.6	16.1	40.4	24.7	8.9	6.3	4.0	0.0	10.5	9.3	6.1	8.2	4.0	3.1	9.6	9.5	1.8	11.2	12.9	5.3	13.4	15.6	8.5	10.9	5.2	6.0	5.2	4.7	0.5	5.9	4.1	0.7	6.6	11.2	8.6	5.8	7.6	4.0	4.4	6.2	15.6	9.5	5.0	5.5
L3MBTL4	"FLJ35936, HsT1031"	ENSG00000154655	"L3MBTL histone methyl-lysine binding protein 4"	Q8NA19	18	5954706-6415237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 160.4;Late spermatids: 85.8;Microglial cells: 78.7;Oligodendrocyte precursor cells: 191.5;Oligodendrocytes: 252.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.4;Karpas-707: 4.8;RPMI-8226: 11.6;SCLC-21H: 5.3;SH-SY5Y: 5.8;U-2 OS: 3.4"	"Low region specificity"	"Detected in some"							"HPA064194, HPA069042"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA064194: AB_2685208, HPA069042: AB_2686071"	"unprognostic (1.33e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	3.0	4.3	7.1	1.8	11.5	1.6	4.9	0.2	8.4	4.3	0.6	2.1	3.0	3.2	3.6	3.6	4.2	2.5	4.9	3.8	6.8	7.1	8.8	3.9	2.0	3.3	8.2	8.5	6.5	8.5	3.2	0.7	4.7	2.0	2.0	1.7	3.4	2.9	1.0	7.3	3.5	1.3	1.6	2.9	3.2	12.7	6.6	2.9	5.8	1.3	1.6	1.4	4.1	14.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	2.4	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.0	1.4	3.1	0.0	11.6	0.0	2.0	5.3	5.8	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	3.4	0.1	1.4	0.1	0.0	0.0	1.3	0.0	1.7	0.3	1.1	0.0	0.7	0.3	0.0	0.5	0.1	0.1	0.7	2.5	0.1	0.2	0.1	3.6	0.8	0.1	0.0	0.5	7.1	11.5	0.2	8.4	3.8	6.8	3.3	8.2	4.7	1.6	6.6	14.0	6.5	3.2	12.2	56.2	4.8	7.8	7.0	0.8	10.2	2.2	4.5	4.8	6.4	11.5	4.1	5.5	16.7	0.1	2.7	0.3	3.9	7.4	62.5	8.1	1.2	3.6	11.4	0.8	33.9	5.2	0.0	3.4	1.5	16.9	1.3	15.4	2.5	10.0	3.2	0.0	160.4	1.5	0.0	3.2	5.3	85.8	10.2	2.9	1.8	78.7	27.2	1.8	25.7	191.5	252.9	3.5	1.9	12.8	1.5	10.3	3.5	8.1	1.2	0.6	6.6	6.9	7.2	9.3	2.4	6.5	8.2	0.1	2.1	0.5	2.5	4.6
LACTB2	CGI-83	ENSG00000147592	"Lactamase beta 2"	Q53H82	8	70635318-70669185	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 286.3;Proximal tubular cells: 325.7;Spermatocytes: 263.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 437.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044391, HPA053040"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		37000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA044391: AB_10965168, HPA053040: AB_2682022"	"unprognostic (6.33e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (3.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.93e-2)"	20.4	39.3	6.4	12.9	8.0	3.2	18.4	8.4	9.0	10.8	8.7	21.9	38.8	9.6	11.5	10.2	9.3	28.7	29.8	5.8	8.3	77.0	96.0	20.1	15.6	8.1	7.9	10.0	14.8	21.0	8.3	10.6	8.9	15.4	21.3	12.7	15.0	9.2	28.2	12.4	33.8	15.7	8.1	11.5	16.0	63.2	7.6	14.5	20.2	32.1	13.5	13.2	7.9	10.6	65.7	66.4	20.8	8.6	35.6	53.7	12.5	36.0	20.7	37.7	28.2	32.3	72.3	0.1	14.4	17.4	75.7	45.9	25.0	38.0	30.2	38.8	26.6	30.5	8.1	18.0	74.0	30.1	25.5	64.6	44.8	18.6	28.2	18.0	10.0	23.2	53.4	60.1	50.6	19.6	17.1	5.5	22.3	88.2	60.3	15.2	12.1	14.0	146.3	33.8	29.6	10.3	79.7	437.8	41.0	27.0	72.7	40.1	16.0	3.0	20.8	67.4	29.4	47.7	38.1	0.2	21.1	50.6	28.7	15.8	13.8	13.0	8.5	16.8	10.6	12.6	8.8	8.4	17.3	11.7	8.3	9.2	5.8	11.0	16.7	11.9	13.4	5.9	6.4	8.0	8.4	9.0	5.8	8.3	8.1	7.9	8.9	8.1	7.6	10.6	15.1	57.7	45.1	3.6	16.0	16.4	22.1	58.9	12.5	15.4	12.1	15.1	38.4	18.6	43.9	18.4	8.4	25.1	12.0	27.2	76.3	51.2	286.3	29.4	11.7	15.3	12.1	19.6	3.9	117.2	15.3	15.1	20.4	31.5	9.5	8.7	19.2	76.1	48.0	8.4	4.6	25.8	34.6	34.5	11.2	40.9	20.5	24.2	16.0	3.7	19.4	35.3	8.2	2.5	10.3	70.2	25.1	15.1	18.3	16.0	59.8	325.7	44.9	14.7	6.6	9.6	14.4	263.1	25.0	12.4	16.8	19.4	13.9	34.2	34.7	11.0
LAGE3	"CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1"	ENSG00000196976	"L antigen family member 3"	Q14657	X	154477769-154479257	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036122, HPA036123"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"HPA036122: AB_2674951, HPA036123: AB_10601926"	"unprognostic (1.70e-1)"	"prognostic favorable (5.29e-6)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.88e-3)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (7.37e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	11.9	29.1	41.2	7.7	43.0	19.4	12.1	41.2	52.4	16.9	36.9	14.2	6.8	12.3	8.4	15.0	11.1	5.9	21.9	44.3	40.6	14.2	20.9	10.8	10.2	38.9	38.3	18.5	25.1	8.9	34.0	5.4	40.4	16.7	4.7	4.6	16.5	6.5	24.4	19.8	12.2	4.0	39.9	16.2	15.2	9.6	41.1	13.4	9.7	10.2	8.9	17.2	13.6	43.4	44.7	41.6	15.1	32.1	16.0	13.3	44.7	13.3	9.4	19.7	22.0	27.0	23.4	94.2	118.6	17.5	34.9	19.1	37.5	13.2	6.8	53.9	59.9	34.4	38.3	15.6	27.2	46.1	49.1	20.5	8.6	29.6	7.7	15.0	14.1	44.9	34.2	44.4	27.3	104.6	61.9	134.3	28.5	59.5	99.7	54.0	26.0	106.4	11.6	12.0	41.8	38.8	31.0	73.8	57.1	10.4	32.0	33.5	15.8	14.1	41.9	59.6	51.3	104.2	117.5	145.0	24.8	81.8	33.3	27.1	25.8	10.9	26.4	25.5	33.9	40.4	36.5	38.6	35.6	33.7	82.0	41.7	2.8	47.0	20.8	66.5	31.7	40.0	41.2	43.0	41.2	52.4	44.3	40.6	38.9	38.3	40.4	39.9	41.1	43.4	41.7	9.6	14.7	8.5	57.1	58.0	50.1	68.4	70.6	54.9	84.5	107.8	30.8	58.6	34.2	35.0	8.4	62.4	58.5	40.0	127.2	50.7	2.0	15.3	22.4	46.5	56.4	79.7	10.9	93.4	119.9	40.0	27.5	14.8	46.9	75.7	33.5	49.6	126.3	23.5	8.3	50.8	67.1	37.4	93.1	6.3	41.7	55.6	92.5	3.7	63.4	87.2	74.2	4.5	9.3	40.9	28.4	36.9	65.0	46.1	38.5	72.6	33.0	18.4	6.6	35.3	31.0	43.5	100.9	61.4	56.0	56.8	51.8	56.8	54.3	45.2
LAMTOR2	"ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3"	ENSG00000116586	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2"	Q9Y2Q5	1	156054782-156058506	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 627.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004126	Approved		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"		"HPA004126: AB_1849916"	"unprognostic (2.09e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.35e-1)"	64.3	84.4	81.9	41.6	81.4	57.1	57.7	83.9	98.9	44.8	83.0	62.0	51.5	42.3	76.7	75.2	52.1	43.8	96.1	81.6	84.7	91.0	164.3	53.8	56.3	81.6	82.5	26.7	87.8	74.4	44.6	37.5	82.0	50.9	56.5	18.0	59.3	44.0	88.6	57.8	53.7	48.9	82.2	65.7	78.1	26.6	85.8	56.1	44.7	70.2	52.0	53.6	46.7	85.8	63.9	142.3	65.4	90.9	131.9	106.7	72.3	55.7	94.4	68.8	78.1	65.9	106.1	94.0	94.4	108.7	60.0	91.5	67.7	151.1	38.7	78.4	103.0	54.9	96.2	88.6	104.4	78.0	86.5	126.1	93.4	73.1	93.3	94.4	142.6	137.3	50.8	68.1	100.9	128.7	80.6	111.4	69.4	250.9	212.1	67.5	48.7	138.7	152.5	93.2	25.3	145.3	70.4	195.1	116.3	104.1	136.5	227.9	96.6	57.5	52.4	83.4	53.0	101.6	166.5	56.2	102.2	87.3	62.9	281.8	465.8	376.2	172.2	446.9	169.8	290.6	188.2	188.7	537.2	249.4	142.6	152.8	231.8	207.0	363.2	284.1	298.3	389.7	81.9	81.4	83.9	98.9	81.6	84.7	81.6	82.5	82.0	82.2	85.8	85.8	102.5	57.7	46.5	3.6	64.5	48.4	59.5	190.3	43.3	29.4	129.9	123.2	113.5	114.4	120.2	108.5	6.2	146.3	73.9	247.5	387.4	193.0	44.5	113.2	78.7	92.6	126.1	48.0	4.5	179.3	203.1	67.5	68.3	105.0	107.3	56.7	86.7	322.1	416.1	6.7	5.4	164.7	197.4	188.9	150.1	89.0	47.2	165.0	158.3	5.6	297.4	92.8	94.7	4.5	5.8	183.2	267.4	50.8	76.8	80.2	317.8	627.2	144.1	30.5	32.9	38.9	124.6	25.5	33.9	99.4	80.0	77.2	64.2	83.3	166.9	97.7
LANCL2	"GPR69B, TASP"	ENSG00000132434	"LanC like 2"	Q9NS86	7	55365337-55433737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.5;Late spermatids: 55.3;Oligodendrocyte precursor cells: 52.8;Oligodendrocytes: 67.3"	"Group enriched"	"Detected in all"	5	"glioma: 52.5;testis cancer: 19.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"A-431: 144.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019711, HPA029535"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		13000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA019711: AB_1852699, HPA029535: AB_10602342"	"unprognostic (1.11e-1)"	"unprognostic (6.89e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.35e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.03e-6)"	"unprognostic (4.58e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.45e-1)"	3.9	6.2	17.4	2.6	18.8	3.9	5.9	11.5	18.6	5.7	8.7	4.9	5.1	10.4	5.1	4.1	5.4	3.8	4.1	21.2	14.2	6.0	5.0	3.1	3.5	12.5	12.9	9.1	4.7	9.2	6.0	4.0	12.4	5.8	4.7	8.4	4.7	6.4	7.0	5.5	5.0	6.7	13.2	3.6	4.4	6.2	14.2	4.7	6.5	5.1	2.9	3.9	4.0	17.4	144.8	4.9	9.7	6.6	2.9	5.0	5.4	6.4	7.6	9.7	8.2	5.0	4.1	10.1	5.9	9.3	9.7	6.4	5.2	3.5	5.9	4.4	10.4	3.6	3.8	5.1	5.1	11.2	6.4	9.0	3.7	7.2	2.3	5.1	4.8	4.7	6.4	6.4	9.1	4.4	2.9	5.2	18.8	3.9	6.1	4.3	4.5	5.0	6.3	11.3	16.9	16.0	9.3	13.6	3.9	3.6	5.6	11.8	8.1	6.1	8.3	11.6	12.5	6.1	7.8	10.6	4.8	2.5	11.8	0.1	1.5	0.3	1.0	1.9	1.7	1.1	1.3	1.5	1.9	1.0	1.2	1.0	0.2	1.5	1.4	1.5	2.6	1.1	17.4	18.8	11.5	18.6	21.2	14.2	12.5	12.9	12.4	13.2	14.2	17.4	3.0	3.2	8.9	28.7	5.9	4.0	6.3	5.5	5.7	8.9	6.8	6.7	9.4	10.0	5.1	11.0	6.2	12.5	5.1	8.8	5.9	7.1	52.5	6.7	11.2	5.4	12.6	12.6	41.7	12.2	12.1	16.3	5.1	7.7	11.4	10.2	7.1	10.0	7.7	15.2	39.6	9.1	4.1	7.3	4.8	55.3	9.0	5.4	0.0	8.4	9.5	10.8	6.2	52.8	67.3	7.8	7.6	7.5	5.1	5.5	9.8	27.7	7.7	7.6	0.0	19.4	5.9	22.7	17.8	7.5	3.8	19.0	4.3	12.8	9.7	6.0
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577198-17607972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 230.6;Hofbauer cells: 262.1;Proximal tubular cells: 274.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		3500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	92.8	52.6	33.0	131.4	34.8	59.2	60.3	39.0	42.9	30.7	31.4	60.3	78.3	34.4	25.4	44.6	45.4	67.3	65.0	31.8	36.3	106.3	190.4	100.6	150.4	46.3	37.7	24.0	30.9	61.0	22.1	70.9	42.2	36.7	62.0	20.0	67.7	31.0	68.1	40.3	61.3	76.2	45.6	94.1	55.3	43.8	41.9	56.8	46.4	63.8	94.3	82.8	25.3	42.9	51.7	44.4	41.6	39.4	80.5	97.9	0.4	79.6	89.1	282.3	340.3	81.4	96.1	202.0	51.7	61.6	167.9	31.3	157.7	56.3	106.7	77.7	45.2	112.1	47.3	107.6	94.1	102.3	69.2	100.0	35.3	92.7	48.6	32.3	99.7	52.2	110.6	139.9	67.6	55.6	91.9	139.5	87.1	96.3	83.9	139.8	39.8	102.7	73.5	59.6	61.4	50.2	72.9	44.4	161.1	57.3	37.9	39.1	65.2	71.3	48.5	76.1	140.6	127.7	208.8	172.7	96.3	167.2	70.8	43.1	200.6	44.7	33.7	210.0	31.0	32.7	31.2	36.3	204.6	23.5	26.7	28.3	28.1	54.0	158.1	116.6	60.2	135.8	33.0	34.8	39.0	42.9	31.8	36.3	46.3	37.7	42.2	45.6	41.9	42.9	230.6	28.9	49.6	10.7	34.4	22.0	26.1	60.1	21.6	8.1	53.5	41.7	48.9	18.6	44.1	27.6	2.1	35.9	68.3	44.2	117.4	68.6	100.5	67.3	45.7	129.7	16.3	31.7	6.4	109.2	54.7	42.0	29.6	40.7	64.1	29.4	71.0	95.5	262.1	6.7	9.6	35.6	42.7	92.1	50.5	31.7	23.0	141.9	42.7	18.7	195.0	103.8	28.8	9.5	21.2	53.3	31.8	35.0	71.2	26.9	52.4	274.0	92.5	15.4	32.9	31.3	57.8	95.7	13.7	32.5	22.9	55.7	42.4	80.7	45.6	27.1
LARP1	"KIAA0731, Lar1, LARP, Lhp1, MGC19556"	ENSG00000155506	"La ribonucleoprotein 1, translational regulator"	Q6PKG0	5	154712843-154817605	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015222, HPA051397, HPA054819"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"		"CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	42.5	50.0	30.9	36.5	28.4	37.0	36.4	12.2	44.8	38.4	15.8	38.4	33.8	43.6	37.4	51.6	39.9	29.3	48.6	34.3	25.8	40.0	36.7	34.8	41.1	26.7	40.3	45.0	103.0	70.3	39.8	37.9	47.2	31.3	34.6	32.1	57.4	32.9	78.8	45.4	37.7	38.7	5.4	35.7	44.0	38.2	27.6	42.1	53.8	46.4	44.8	38.0	40.0	37.4	93.3	140.3	107.6	124.1	93.3	73.1	103.1	99.0	101.8	114.7	110.0	218.1	116.8	252.2	128.0	127.5	168.5	92.9	196.1	185.9	135.7	83.4	94.1	187.1	143.8	106.1	117.6	250.6	81.2	91.2	108.4	144.5	185.2	66.4	103.9	114.0	149.2	180.2	111.9	102.9	156.5	100.0	107.3	89.8	60.5	158.8	97.5	120.5	74.1	120.7	180.7	93.5	132.2	215.4	112.3	112.9	126.0	119.0	130.4	140.3	83.0	106.2	170.3	136.8	126.0	219.5	92.1	134.8	99.1	2.2	2.4	0.7	2.6	3.0	3.3	2.5	3.0	3.0	2.4	3.3	2.5	2.6	1.4	5.9	5.6	3.9	2.1	1.7	30.9	28.4	12.2	44.8	34.3	25.8	26.7	40.3	47.2	5.4	27.6	37.4	37.6	44.8	33.8	67.9	37.2	78.3	39.7	38.0	34.7	64.4	45.1	33.0	104.4	50.1	33.7	40.5	37.5	43.7	35.3	45.1	29.4	42.2	14.4	70.1	70.6	48.8	43.9	73.4	72.0	82.5	35.2	46.2	46.9	65.5	17.2	63.2	47.8	66.9	57.9	87.5	92.5	49.6	18.3	53.3	42.6	12.1	69.6	43.6	37.4	46.9	49.1	26.5	33.0	47.7	69.5	62.1	37.7	80.1	47.3	75.2	53.0	50.1	46.5	38.7	13.1	63.6	39.4	56.2	40.5	54.6	84.5	23.9	34.6	71.6	68.8	53.6
LARP7	"DKFZP564K112, HDCMA18P, PIP7S"	ENSG00000174720	"La ribonucleoprotein 7, transcriptional regulator"	Q4G0J3	4	112637107-112657592	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	RNA-binding	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026842, HPA027930"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA026842: AB_10611116, HPA027930: AB_10601233"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	37.2	31.6	26.3	32.8	28.3	44.6	35.7	28.6	34.6	28.0	28.0	36.2	33.8	33.3	29.8	31.7	25.8	30.5	59.6	24.9	33.5	40.2	44.1	28.1	44.9	30.2	30.2	34.2	18.3	29.9	20.1	34.1	31.0	32.1	36.7	31.5	23.2	27.2	46.6	30.6	33.2	29.5	28.3	36.9	31.5	24.6	29.1	42.2	38.7	45.3	40.3	33.0	21.8	30.8	42.9	34.9	77.7	44.3	50.7	61.6	44.0	55.3	40.6	45.3	42.0	27.9	62.0	95.4	43.7	46.9	42.2	29.6	75.1	45.2	60.2	86.8	52.1	56.4	35.2	41.9	41.0	131.6	84.6	49.3	50.7	40.4	25.1	62.6	40.4	47.6	71.4	51.1	55.3	35.2	107.4	56.7	182.2	67.5	28.2	62.9	66.2	44.3	68.8	44.8	46.5	64.4	32.0	83.4	55.4	131.4	35.1	61.0	43.7	42.4	49.5	47.7	57.6	34.7	62.5	97.6	57.7	52.4	49.2	70.1	28.1	49.9	32.8	43.1	30.3	48.1	33.9	34.2	25.3	47.4	32.3	31.3	33.2	38.7	60.7	64.0	37.9	20.8	26.3	28.3	28.6	34.6	24.9	33.5	30.2	30.2	31.0	28.3	29.1	30.8	66.1	96.1	79.2	45.1	68.8	24.9	66.5	102.6	34.1	61.3	48.3	50.4	113.2	95.8	91.6	47.8	29.2	79.0	88.7	83.2	111.6	69.3	17.6	78.7	70.5	63.2	38.9	43.6	18.0	64.4	70.2	60.6	32.1	58.8	104.4	51.5	81.4	160.9	70.4	58.9	19.9	79.7	61.1	93.7	27.1	14.9	94.4	67.2	24.9	32.8	96.0	107.1	107.1	20.6	43.1	62.0	85.6	100.1	39.1	38.8	73.1	117.0	109.8	54.1	118.3	74.5	68.3	83.5	87.8	33.3	20.9	100.4	65.9	74.2	75.6	47.9
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388561-45554726	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 35.4;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	3.3	4.7	9.5	3.4	10.3	2.4	3.9	10.1	11.7	3.7	9.2	6.9	3.9	4.6	4.3	4.2	4.5	3.0	5.5	9.3	10.5	7.5	8.1	2.9	4.3	9.5	10.2	3.8	2.4	12.3	3.7	4.2	9.5	4.3	6.9	4.2	3.6	4.2	6.2	3.6	2.9	4.4	9.2	3.2	3.6	2.2	11.5	6.9	4.5	6.4	4.8	5.0	3.7	8.5	6.3	11.2	10.7	9.3	11.8	13.0	11.1	11.6	15.7	24.7	16.2	20.3	8.8	13.8	8.9	18.0	18.2	5.8	49.0	30.4	16.0	9.5	12.7	12.9	13.6	18.4	12.1	20.9	4.4	19.0	16.8	26.0	12.5	13.1	14.9	19.5	25.1	5.5	19.0	9.7	21.1	11.6	28.4	15.0	21.9	8.9	9.8	16.9	23.6	18.8	7.6	9.7	17.3	7.9	11.8	13.5	14.6	14.7	9.1	12.1	8.3	8.5	12.3	5.3	12.3	15.4	14.0	16.9	9.5	0.0	0.6	0.6	1.2	0.9	1.5	1.0	0.7	1.1	1.2	0.5	0.8	1.0	0.3	1.9	0.8	1.0	0.6	0.7	9.5	10.3	10.1	11.7	9.3	10.5	9.5	10.2	9.5	9.2	11.5	8.5	3.9	0.0	2.0	28.7	4.8	1.1	1.5	1.8	3.4	5.5	3.2	2.8	9.0	1.5	1.8	5.5	4.2	5.0	3.5	4.4	5.9	2.9	0.6	7.6	5.7	4.2	4.8	5.2	35.4	2.7	5.2	3.2	6.6	4.9	1.3	9.8	2.2	7.7	5.4	1.7	37.8	4.5	0.0	2.9	1.3	1.2	1.2	2.6	1.8	19.7	2.3	4.0	2.1	22.6	25.2	3.2	7.0	2.2	5.0	1.9	2.6	2.4	2.9	4.7	0.0	3.1	2.9	0.7	2.4	4.8	1.3	2.9	3.2	8.3	6.8	1.7
LAS1L	"FLJ12525, Las1"	ENSG00000001497	"LAS1 like ribosome biogenesis factor"	Q9Y4W2	X	65438549-65534810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044431, HPA061463"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA044431: AB_10965695, HPA061463: AB_2684530"	"unprognostic (9.71e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.53e-1)"	21.5	19.1	36.9	11.4	37.8	16.0	21.2	35.6	53.7	27.1	34.0	26.4	5.8	23.1	6.8	20.0	25.5	6.3	18.6	34.8	34.8	19.1	19.6	17.4	13.1	36.3	37.1	29.9	21.2	12.2	17.5	8.9	36.8	22.7	8.1	9.4	18.8	11.9	19.3	25.4	18.5	10.3	38.1	22.5	20.0	33.6	37.1	12.8	20.5	6.3	14.0	24.2	21.4	37.8	44.1	63.6	36.3	28.5	12.4	16.1	29.1	28.5	14.9	42.8	36.4	30.4	31.3	95.0	31.3	17.8	28.7	31.3	63.9	39.6	50.6	25.6	52.3	32.2	53.2	32.4	16.6	95.9	26.8	17.8	28.7	40.5	25.6	15.1	26.0	46.1	80.3	71.3	25.5	51.8	62.4	53.6	52.6	49.8	63.1	56.2	67.4	79.9	24.7	17.9	24.6	32.9	51.3	26.0	20.1	25.8	19.5	44.6	22.2	26.4	50.9	73.2	44.4	23.7	37.7	94.6	28.1	92.5	13.6	17.7	17.7	11.2	20.1	24.0	21.3	23.9	18.6	23.5	24.2	26.4	23.2	19.8	2.0	22.9	19.3	19.1	21.7	21.0	36.9	37.8	35.6	53.7	34.8	34.8	36.3	37.1	36.8	38.1	37.1	37.8	15.5	12.8	22.3	23.2	21.6	18.2	21.4	24.8	9.1	34.9	12.7	13.6	9.2	21.5	27.0	3.7	29.2	32.8	13.3	6.9	15.6	27.9	58.0	17.5	20.0	17.2	16.7	18.1	19.6	26.6	31.4	16.8	11.7	12.9	18.3	26.0	8.9	14.8	16.3	45.4	17.7	9.4	18.3	8.5	13.4	148.2	17.4	11.7	10.6	8.4	18.1	16.1	12.3	13.0	12.5	21.4	7.7	15.4	26.3	23.5	10.2	14.3	26.7	34.2	13.1	21.8	22.8	24.1	19.1	17.8	18.6	17.8	17.5	22.3	14.1	14.8
LBHD1	"C11orf48, MGC2477"	ENSG00000162194	"LBH domain containing 1"	Q9BQE6	11	62662817-62672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 65.9"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Respiratory ciliated cells: 8.7;Rod photoreceptor cells: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.8;JURKAT: 53.8"	"Low region specificity"	"Detected in all"							"HPA012127, HPA023592"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 79: Retina - Phototransduction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA012127: AB_1845527, HPA023592: AB_1845528"	"unprognostic (4.34e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.18e-8)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.78e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.72e-3)"	4.6	13.1	1.8	5.5	1.8	6.3	3.7	2.9	2.8	3.4	2.9	4.7	3.5	2.0	4.2	3.4	3.4	2.6	3.2	1.8	2.0	3.8	8.6	3.5	7.5	2.1	2.2	1.9	3.8	4.1	3.9	1.9	2.2	4.3	3.4	65.9	3.6	3.5	1.8	2.5	6.0	2.3	1.6	9.5	4.5	7.3	2.1	6.0	4.1	0.9	4.7	3.6	2.6	2.4	2.7	4.7	2.8	2.1	4.2	7.9	6.2	3.6	5.3	5.8	4.6	3.7	30.8	9.4	7.7	4.5	6.0	11.8	3.0	8.4	4.5	12.8	9.5	7.9	14.6	2.7	6.2	7.4	9.9	10.9	0.9	10.4	3.2	6.5	3.2	53.8	8.3	8.3	3.7	4.8	4.6	11.0	3.6	6.4	4.0	11.2	6.9	17.4	7.7	5.4	3.2	4.7	4.0	5.4	12.1	3.8	10.1	11.1	2.5	3.6	2.3	3.7	4.0	13.7	12.8	9.1	3.3	7.4	3.8	1.5	3.5	3.4	3.2	2.4	2.9	2.4	1.9	3.5	3.1	2.5	2.6	2.1	0.8	4.8	2.1	3.9	1.2	2.6	1.8	1.8	2.9	2.8	1.8	2.0	2.1	2.2	2.2	1.6	2.1	2.4	0.8	3.2	2.7	0.0	2.0	0.0	0.2	0.0	1.2	2.3	0.6	0.5	0.8	0.0	2.5	0.0	4.2	0.2	2.0	0.2	0.0	0.2	0.0	2.7	1.1	0.5	0.0	0.4	0.3	0.0	0.3	1.0	2.0	0.7	2.5	1.2	0.0	0.6	0.2	1.7	0.3	0.1	0.0	0.3	0.0	0.3	0.3	1.6	0.0	1.0	0.1	1.5	2.1	0.0	0.1	0.2	0.0	0.4	3.9	0.4	0.4	0.3	8.7	7.6	0.0	1.1	0.3	0.7	0.6	0.9	0.0	0.3	1.8	3.6	0.1	0.3
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 26.5"	"Cell type enriched"	"Detected in single"	5	"Skeletal myocytes: 3.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 1.9;medulla oblongata: 3.5;pons: 2.5;spinal cord: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 3.4;RH-30: 4.3;SCLC-21H: 9.1"	"Group enriched"	"Detected in some"	24	"cerebellum: 1.6;pons and medulla: 3.0"	"Group enriched"	"Detected in some"	18	"cerebellum: 1.2;medulla oblongata: 2.0;spinal cord: 2.0"	"HPA002016, HPA002086, CAB079927"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242"		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.3	0.0	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.5	0.4	2.5	4.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LBX2		ENSG00000179528	"Ladybird homeobox 2"	Q6XYB7	2	74497517-74503316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 5.3;liver: 8.7;stomach 1: 3.2"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 3.7;Proximal tubular cells: 7.5;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.5;Hep G2: 22.1;SK-MEL-30: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.9;olfactory bulb: 1.0"	HPA044257	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Midbody	"HPA044257: AB_2678880"	"unprognostic (5.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.35e-5)"	"unprognostic (8.22e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.43e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.87e-2)"	1.3	0.3	0.3	0.4	0.3	0.4	0.6	0.9	0.4	0.4	0.0	1.1	5.3	0.3	0.2	0.2	0.2	0.4	0.3	0.1	0.2	1.3	8.7	0.5	0.4	0.5	0.2	0.1	0.7	0.1	0.0	0.5	0.5	0.3	0.1	0.1	0.5	0.3	0.4	0.9	4.8	0.2	0.1	1.1	3.2	0.1	0.4	0.0	0.3	0.0	0.1	0.3	0.2	1.3	4.4	1.6	0.0	0.1	2.0	1.5	7.1	0.3	0.2	0.4	0.4	10.5	6.2	0.2	1.7	0.8	0.6	1.7	0.0	0.3	0.0	9.0	1.8	4.7	0.7	22.1	1.4	0.3	3.0	1.9	1.6	1.6	0.3	0.2	1.8	0.1	3.1	2.2	0.3	2.3	0.1	0.7	0.4	1.7	0.2	0.4	0.4	0.2	0.2	1.4	0.2	1.1	2.6	0.4	10.1	0.1	0.2	0.3	4.1	1.5	6.6	8.1	0.2	2.9	2.3	0.2	1.5	0.8	4.8	0.5	1.5	0.1	0.3	0.8	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.2	0.6	1.1	2.2	0.2	0.0	0.7	0.3	0.3	0.9	0.4	0.1	0.2	0.5	0.2	0.5	0.1	0.4	1.3	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.7	0.5	0.7	1.5	0.5	1.8	0.0	0.3	0.5	0.9	0.0	0.6	0.0	0.4	0.5	1.0	2.4	0.4	0.0	0.6	0.5	1.3	1.1	0.2	0.0	0.0	1.4	3.7	1.1	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	2.4	7.5	0.7	0.0	6.6	0.0	0.9	0.4	0.1	0.3	0.1	0.5	0.5	0.2	1.0	0.1
LCA5L	"C21orf13, MGC33295"	ENSG00000157578	"Lebercilin LCA5 like"	O95447	21	39405728-39445805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 110.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 1312.6;Late spermatids: 472.4;Spermatocytes: 465.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 3.7;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019790, HPA032010"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA019790: AB_1845690, HPA032010: AB_2674110"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.53e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.95e-1)"	0.4	1.7	0.6	0.4	0.7	0.3	1.7	1.4	1.1	1.8	3.4	0.6	0.4	1.2	7.6	0.4	7.2	0.8	0.5	0.6	0.8	2.4	0.7	1.5	0.3	2.0	2.5	0.9	1.3	2.2	2.0	0.3	1.6	0.8	0.5	10.8	0.9	0.9	2.1	0.9	0.4	0.6	2.0	0.4	0.8	110.5	0.9	0.3	4.3	1.5	0.2	0.5	0.5	1.1	0.9	1.0	0.6	1.7	0.8	0.7	0.1	0.2	0.4	0.5	0.0	0.5	1.0	0.7	0.7	0.9	0.2	0.2	0.1	0.5	0.3	0.3	0.8	0.4	0.8	0.1	0.7	1.1	0.0	0.6	2.3	1.6	1.7	1.1	0.3	1.0	1.7	0.6	0.6	3.7	0.3	0.4	3.2	0.6	1.0	0.2	0.2	0.7	1.7	0.3	1.1	0.5	2.0	0.8	1.4	0.3	3.9	0.1	0.1	0.3	0.2	0.9	0.2	1.8	1.1	0.1	1.4	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.4	1.1	0.6	0.8	2.0	2.5	1.6	2.0	0.9	1.1	1.1	3.2	0.5	5.5	0.3	0.5	0.9	2.7	1.2	2.0	4.5	5.0	2.6	1.5	16.8	7.3	6.2	1.1	0.1	0.4	19.6	3.5	1312.6	34.9	2.4	1.6	4.2	0.0	3.8	2.2	0.2	2.2	0.5	2.8	0.0	1.8	1.4	1.6	0.5	1.7	2.6	1.4	0.0	0.6	0.7	472.4	6.5	1.3	1.8	1.0	0.6	3.2	0.0	0.5	2.1	1.6	0.5	7.9	0.0	0.6	0.2	12.0	68.0	17.4	19.7	3.6	1.7	465.8	26.7	0.3	0.6	0.3	0.3	3.2	0.9	0.7
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 283.0"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 219.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 76.5;Hep G2: 62.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 29.2"	HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	6400000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	29.5	20.8	29.3	8.3	29.8	4.2	27.2	56.7	37.5	41.4	37.8	30.6	5.0	28.7	9.1	13.4	26.1	11.5	42.0	28.5	32.3	33.2	283.0	36.1	7.5	41.9	32.7	28.5	17.7	8.0	17.5	17.8	31.6	40.0	4.8	2.8	16.9	18.6	13.2	32.0	17.8	12.3	31.9	23.3	16.5	11.3	33.4	9.4	43.2	8.9	4.4	27.5	27.3	32.0	5.7	9.0	13.0	14.8	11.1	15.6	76.5	21.9	9.3	14.5	10.2	29.5	6.8	3.1	4.0	31.9	5.3	19.4	3.1	30.0	8.9	1.5	7.9	3.9	22.8	62.9	15.2	0.7	10.3	27.1	27.9	30.0	10.4	19.5	10.8	8.7	8.7	1.2	10.5	9.1	3.7	9.5	8.6	1.1	5.0	4.0	14.1	3.3	4.1	9.6	0.5	6.7	33.1	1.6	3.9	26.5	18.6	6.0	20.6	18.5	28.8	20.7	8.1	17.7	5.2	8.3	8.9	2.5	16.5	0.9	0.4	1.9	0.3	0.0	0.4	0.4	0.2	0.3	0.1	0.6	0.4	0.1	1.0	0.4	0.1	0.3	0.0	0.0	29.3	29.8	56.7	37.5	28.5	32.3	41.9	32.7	31.6	31.9	33.4	32.0	16.5	9.6	4.8	27.4	1.1	9.4	4.1	4.6	6.8	0.4	1.9	5.5	7.9	5.7	3.3	3.7	2.1	7.7	1.3	0.1	0.0	1.7	0.2	2.1	6.0	8.0	1.2	14.3	0.1	1.0	3.4	7.3	1.1	1.6	1.3	5.4	10.8	219.5	2.4	0.0	0.1	0.0	4.1	6.6	3.8	1.3	8.7	2.4	7.2	6.5	3.0	7.7	1.0	4.5	1.4	2.1	0.0	8.6	1.9	4.3	0.0	0.4	4.4	0.6	13.1	7.6	10.4	0.9	1.4	0.9	2.6	12.2	1.6	4.1	0.1	1.7
LCMT1	"CGI-68, PPMT1"	ENSG00000205629	"Leucine carboxyl methyltransferase 1"	Q9UIC8	16	25111731-25178231	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041559, HPA043530"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA041559: AB_2677548, HPA043530: AB_2678532"	"unprognostic (9.08e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.41e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-3)"	"unprognostic (6.71e-2)"	17.5	27.3	41.5	13.3	43.2	19.9	22.5	41.1	44.5	23.9	36.5	22.0	16.8	21.2	31.1	22.8	20.5	13.6	36.1	45.1	42.8	26.9	10.9	14.9	16.7	39.9	39.0	28.1	47.2	32.0	32.9	24.1	42.4	20.8	21.3	21.8	21.2	21.3	52.3	28.2	17.1	18.5	40.2	16.2	22.5	35.4	43.4	21.3	18.6	36.2	20.2	18.1	20.6	43.0	40.3	36.3	33.9	47.2	30.2	42.9	34.9	24.7	40.5	35.7	45.9	46.4	35.7	24.4	34.1	37.6	44.2	20.1	35.9	34.3	47.9	24.9	53.3	13.5	35.4	77.3	67.9	32.0	20.9	48.7	37.7	39.9	41.4	51.3	32.3	54.0	21.5	31.2	39.5	102.3	37.9	60.6	52.1	25.3	37.0	44.3	30.9	47.7	40.7	27.9	55.5	34.1	29.0	45.8	58.2	39.9	46.0	14.9	19.1	34.6	24.3	23.4	25.0	39.8	43.9	25.8	42.3	27.5	26.6	33.4	36.5	46.2	39.4	33.5	43.3	42.0	47.8	42.1	35.0	31.6	42.8	39.2	14.6	33.6	37.6	18.1	82.9	42.2	41.5	43.2	41.1	44.5	45.1	42.8	39.9	39.0	42.4	40.2	43.4	43.0	21.0	16.0	19.8	15.3	23.5	24.1	31.1	55.6	33.6	25.7	39.3	42.0	34.8	15.7	29.6	33.1	2.1	164.5	20.9	60.5	49.0	51.7	76.5	22.7	31.4	22.7	51.4	29.5	29.0	66.7	69.4	29.1	20.9	20.2	9.5	197.7	23.2	9.5	46.8	23.5	30.1	46.9	38.7	33.9	20.0	137.5	26.1	27.0	33.8	17.8	31.3	32.0	32.0	28.1	31.7	46.7	45.1	24.0	28.9	34.6	79.4	90.0	30.0	26.1	26.3	22.9	67.7	67.3	52.9	35.6	31.8	163.8	29.6	78.7	43.7	34.7
LCOR	"C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2"	ENSG00000196233	"Ligand dependent nuclear receptor corepressor"	Q96JN0	10	96832254-96995956	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031429, HPA057621, HPA077000"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824"	"unprognostic (5.61e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.16e-4)"	3.7	3.1	7.1	6.2	6.4	25.5	5.0	21.8	6.6	4.3	3.3	8.7	11.2	4.2	4.6	7.0	3.9	3.9	3.7	4.8	15.6	5.3	5.9	4.8	6.3	6.9	5.6	6.4	8.2	4.3	5.3	4.9	6.7	4.7	8.5	15.8	5.6	3.5	9.2	4.1	10.7	3.4	4.8	5.5	8.3	4.6	7.5	6.0	5.4	5.1	6.0	6.8	4.7	15.8	14.7	9.3	16.5	8.9	4.4	6.2	7.9	6.2	6.0	7.5	8.5	12.0	10.0	15.4	7.3	6.4	7.0	12.2	16.5	8.6	13.3	7.4	8.0	17.7	6.0	15.2	8.4	22.1	8.8	4.9	7.5	11.5	20.4	7.7	8.1	7.8	12.7	7.2	11.9	6.7	9.2	8.4	6.3	7.9	4.0	11.2	12.7	4.3	8.6	30.7	7.5	6.6	7.0	4.4	8.8	7.1	8.3	6.9	12.5	5.8	13.0	5.2	11.6	9.4	6.7	17.9	6.1	13.9	3.1	1.7	5.0	8.0	5.8	4.1	4.7	4.6	4.4	5.3	3.7	8.6	4.7	3.7	16.7	5.0	2.0	5.4	3.6	2.5	7.1	6.4	21.8	6.6	4.8	15.6	6.9	5.6	6.7	4.8	7.5	15.8	26.4	19.2	26.8	72.1	36.1	15.4	16.7	31.3	25.6	45.2	37.0	20.3	17.8	37.1	38.2	31.3	77.2	18.8	46.5	85.3	11.7	27.0	0.8	34.6	26.8	23.1	46.9	17.7	138.3	33.9	8.2	17.1	28.1	35.9	26.6	67.1	20.3	22.2	14.1	40.4	151.6	31.2	52.9	30.5	29.7	2.3	10.2	40.0	21.4	103.0	28.1	11.7	24.7	143.2	264.9	41.5	62.0	13.9	36.8	26.9	67.1	25.4	54.1	58.9	19.7	21.6	26.8	21.7	26.3	29.2	12.9	38.6	34.0	22.0	33.6	34.4
LCORL	"FLJ30696, MLR1"	ENSG00000178177	"Ligand dependent nuclear receptor corepressor like"	Q8N3X6	4	17841199-18021876	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 133.6;Microglial cells: 135.9;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 164.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028794, HPA028795, HPA060033"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane"	"HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192"	"unprognostic (1.06e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (3.22e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.90e-4)"	"unprognostic (3.46e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	2.6	3.7	2.8	3.0	3.6	3.7	2.8	6.4	3.4	2.6	2.1	3.2	5.8	3.0	2.8	2.5	2.0	3.4	1.6	2.3	6.9	4.0	3.4	2.8	3.6	3.4	5.0	4.1	3.3	4.6	1.6	3.9	3.6	2.7	3.6	6.5	2.3	2.1	2.8	4.9	7.0	2.7	3.4	3.4	4.5	5.8	6.3	3.9	3.7	2.9	2.7	2.7	1.9	5.5	5.3	3.4	11.5	5.1	7.1	10.5	2.8	5.9	6.3	5.0	6.7	2.1	7.0	11.4	2.7	3.5	8.8	2.2	4.9	2.2	5.4	1.6	3.7	9.7	5.6	2.4	4.6	7.5	6.7	6.0	2.9	3.3	8.1	7.9	7.1	6.9	5.6	12.1	6.3	1.7	7.3	13.0	5.3	4.1	5.3	7.8	9.1	6.1	7.1	3.0	8.7	10.2	4.8	2.7	3.3	5.2	5.0	4.3	5.8	7.9	4.6	6.7	11.5	12.0	6.2	9.6	6.5	7.9	7.1	7.6	3.3	3.3	2.2	3.5	1.7	2.8	1.3	1.3	2.8	3.5	1.5	2.2	2.5	2.3	3.0	2.3	2.2	1.3	2.8	3.6	6.4	3.4	2.3	6.9	3.4	5.0	3.6	3.4	6.3	5.5	16.9	12.8	15.6	65.6	18.2	23.8	4.4	7.9	17.1	18.4	13.0	9.0	9.4	34.3	9.5	7.3	41.7	8.8	20.9	16.1	9.8	12.3	33.2	14.0	13.1	23.4	35.4	10.1	69.2	10.9	9.0	10.2	14.8	11.8	19.6	26.5	12.8	13.6	16.4	20.2	133.6	23.5	8.2	18.9	29.2	20.1	14.6	23.5	3.6	135.9	21.0	10.4	13.4	117.1	164.2	12.4	16.1	7.5	40.7	10.1	34.1	14.6	15.9	22.5	19.7	13.6	12.8	52.2	16.3	13.6	19.0	9.9	11.6	19.8	16.5	6.3
LDB1	"CLIM2, NLI"	ENSG00000198728	"LIM domain binding 1"	Q86U70	10	102106489-102120368	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034488	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA034488: AB_10669783"	"unprognostic (8.83e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.26e-2)"	41.3	38.0	48.0	42.9	51.2	122.4	44.0	42.8	57.4	89.1	55.8	73.8	31.1	81.5	38.1	54.1	68.9	49.1	60.6	49.4	47.0	40.5	20.5	46.6	61.5	42.1	42.2	117.9	29.4	55.6	52.3	49.1	40.0	58.4	27.5	41.6	65.6	71.6	52.5	149.9	51.7	52.8	38.2	60.8	44.4	30.6	45.8	59.3	49.5	31.6	55.3	65.4	72.4	48.5	42.6	53.5	105.8	128.0	41.3	44.6	52.7	43.8	70.2	48.7	42.3	38.3	36.3	64.8	60.8	56.7	23.0	85.8	48.9	87.3	25.9	55.7	46.9	208.2	62.7	38.6	49.0	56.1	67.8	97.4	70.0	40.2	46.3	177.3	52.0	59.7	128.3	69.1	38.6	41.9	101.1	89.5	52.1	20.4	26.4	112.0	68.4	46.9	46.7	47.3	42.6	103.8	30.9	34.1	51.6	69.0	162.5	36.3	53.8	29.5	60.0	26.8	37.3	58.7	54.4	44.3	49.7	125.7	27.2	2.9	2.0	1.9	2.1	2.9	1.3	2.0	1.5	2.1	1.3	2.4	2.0	1.6	4.8	2.0	4.9	1.4	1.6	1.3	48.0	51.2	42.8	57.4	49.4	47.0	42.1	42.2	40.0	38.2	45.8	48.5	6.4	32.1	11.0	5.2	8.1	22.8	2.8	4.6	17.6	18.5	8.4	7.9	9.1	2.8	6.9	3.7	4.2	4.8	11.7	3.2	0.0	7.7	2.1	7.7	11.1	6.9	8.3	17.0	9.8	5.6	6.3	7.0	5.6	9.3	9.5	9.5	5.3	2.2	8.9	15.2	10.4	1.4	4.1	5.4	7.5	3.0	6.2	7.3	3.6	12.2	4.0	11.8	6.2	5.5	6.6	7.5	2.0	6.4	7.7	2.7	1.9	1.4	3.5	6.1	0.0	6.9	8.2	7.6	7.3	10.7	21.2	7.8	10.0	10.3	2.6	2.0
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898678	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.5;Endothelial cells: 194.4;Excitatory neurons: 1314.4;Hepatic stellate cells: 364.8;Inhibitory neurons: 196.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"AF22: 18.3;fHDF/TERT166: 19.0;HAP1: 34.4;HUVEC TERT2: 65.3;TIME: 17.1;U-138 MG: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		No	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: AB_2686012"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	58.9	15.5	13.7	8.0	19.8	0.4	52.2	3.3	45.9	43.5	7.6	12.7	6.5	65.5	23.4	15.8	28.0	31.2	33.7	23.3	7.3	28.0	26.0	58.2	11.5	4.4	10.9	18.2	7.6	17.0	9.0	58.8	4.7	18.0	8.5	5.3	10.8	13.7	14.0	9.4	12.8	53.8	7.1	50.4	11.5	5.0	7.9	8.3	31.3	24.3	4.8	22.5	22.8	19.7	0.0	0.0	18.3	0.1	10.5	16.9	0.0	10.2	8.0	1.2	2.7	0.0	0.0	0.0	0.0	19.0	0.0	0.0	34.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	9.5	0.0	12.5	0.0	2.7	65.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.7	0.0	0.1	8.8	0.0	0.0	0.8	0.0	0.0	2.3	0.0	0.0	0.0	4.9	0.0	0.0	17.1	25.7	0.1	1.2	0.0	8.3	0.1	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.2	13.7	19.8	3.3	45.9	23.3	7.3	4.4	10.9	4.7	7.1	7.9	19.7	236.5	0.0	5.5	44.7	1.5	8.7	0.3	0.0	2.8	27.1	1.7	2.2	8.7	2.8	0.0	0.0	0.0	0.2	6.8	0.0	0.0	4.4	1.3	1.4	36.5	194.4	0.0	8.0	1314.4	0.2	0.2	44.4	4.1	1.1	5.7	0.1	364.8	3.1	0.4	0.0	196.5	0.0	0.0	16.4	13.2	2.6	38.2	1.4	8.8	117.1	0.0	10.4	3.1	120.6	36.7	0.2	0.0	50.4	0.0	0.3	0.0	0.1	0.7	2.1	6.6	2.8	19.3	0.2	0.7	1.3	6.8	0.1	4.9	39.7	0.0	0.5
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668507-86736072	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"heart muscle: 1423.0;skeletal muscle: 2945.6;tongue: 1809.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 1825.0"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		750000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	11.1	1.4	12.8	2.8	39.6	0.4	6.5	29.8	29.0	10.1	0.1	36.2	2.4	15.1	4.9	54.5	17.3	3.1	1423.0	14.7	23.3	2.0	0.8	5.1	0.5	55.5	36.9	6.4	1.3	0.5	2.4	2.7	46.2	38.1	5.3	0.7	20.8	25.2	2945.6	4.8	8.8	23.7	26.4	0.6	9.0	4.7	38.4	0.7	5.2	1809.4	0.3	7.0	10.3	78.4	0.1	0.1	0.2	1.7	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.4	0.7	0.0	0.0	0.0	0.9	3.0	0.2	0.0	0.0	3.3	0.0	0.3	0.1	1.0	0.0	0.8	0.2	0.1	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.6	4.9	0.9	0.2	0.1	2.4	0.7	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	39.6	29.8	29.0	14.7	23.3	55.5	36.9	46.2	26.4	38.4	78.4	1.5	0.0	0.0	1.0	0.0	1.0	0.5	0.2	0.0	1.5	0.2	0.3	1825.0	0.0	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	23.4	0.1	0.4	15.5	0.0	0.0	4.5	1.1	0.0	31.5	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.0	2.6	0.0	4.1	0.0	1.2	19.6	11.1	0.5	1.8	1.9	0.0	0.7	0.0	1.5	245.1	0.1	0.0	6.8	0.0	0.3	0.0	0.1	0.1	4.1	39.5	48.0	54.9	1.0	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007298-54018186	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"fallopian tube: 116.2"	"Group enriched"	"Detected in some"	9	"Endometrial ciliated cells: 98.1;Respiratory ciliated cells: 329.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 2.2;Hep G2: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.5	0.2	0.1	0.1	0.1	0.6	0.6	0.2	4.4	0.2	0.1	0.0	0.7	0.1	0.6	116.2	0.8	0.0	0.1	0.1	0.1	0.1	6.9	0.1	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.2	0.1	3.4	0.1	0.2	0.3	0.1	0.0	0.0	0.2	1.4	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	2.2	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.2	0.5	0.0	6.4	7.2	0.0	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.1	0.1	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	98.1	0.8	0.7	20.9	0.0	0.1	0.2	0.0	1.1	0.0	2.1	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	12.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.0	0.0	329.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1 regulator of NFKB signaling"	O95751	X	141111605-141177129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 123.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Proximal tubular cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 24.7;MCF7: 31.9;PC-3: 34.3;U-251 MG: 21.9"	"Region enriched"	"Detected in many"	5	"cerebellum: 19.2"					"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA051768: AB_2681599, HPA061842: AB_2684624"	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	32.3	34.0	4.7	0.9	5.5	0.1	28.0	2.9	8.5	45.8	0.2	18.8	0.9	53.9	1.8	21.4	48.5	1.6	15.1	6.2	5.8	33.2	4.8	19.6	0.8	5.3	5.0	46.8	19.3	10.5	123.3	0.0	5.0	34.3	0.3	3.4	55.1	5.9	5.5	31.5	12.5	2.0	1.2	14.2	18.4	10.8	5.0	0.9	53.7	0.4	0.7	33.1	30.6	6.0	0.0	24.7	3.0	8.4	5.0	6.2	0.0	5.0	5.8	6.3	8.8	0.0	8.0	0.0	4.2	7.7	6.1	10.4	3.4	7.1	4.5	0.0	6.6	0.0	11.7	0.0	2.0	0.0	1.9	10.9	3.6	5.5	2.9	5.1	5.7	0.0	0.1	0.0	5.7	31.9	0.0	0.0	3.3	0.0	34.3	0.0	2.7	0.0	7.7	4.7	0.0	3.2	0.0	4.0	0.0	1.6	5.1	0.0	11.9	0.0	6.8	0.0	21.9	0.0	0.0	0.0	3.5	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.8	0.9	2.5	0.8	0.2	2.1	2.2	1.4	0.0	6.4	0.0	1.4	2.6	1.0	4.7	5.5	2.9	8.5	6.2	5.8	5.3	5.0	5.0	1.2	5.0	6.0	8.6	0.0	5.3	4.2	4.9	6.0	16.8	4.6	16.5	29.3	23.8	20.2	2.2	30.0	8.2	23.9	8.4	2.8	5.7	0.1	43.0	13.8	0.7	7.8	13.5	12.8	5.4	0.8	9.4	14.0	1.8	16.1	3.6	6.0	2.5	8.8	12.8	0.1	0.9	20.2	9.9	0.4	8.2	0.3	1.8	1.1	22.1	1.0	3.6	7.5	0.3	21.2	5.2	7.1	15.0	13.7	0.2	38.7	0.9	11.9	0.0	43.8	4.6	13.0	13.1	15.3	26.2	0.9	7.6	16.7	6.8	1.5	5.2	13.5	0.3	15.0
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 349.2"	"Cell type enhanced"	"Detected in many"		"Melanocytes: 33.8;Microglial cells: 145.2;T-cells: 70.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 142.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 142.6"	"Group enriched"	"Detected in many"	5	"JURKAT: 579.6;MOLT-4: 569.0;REH: 454.8"	"Region enhanced"	"Detected in all"		"thalamus: 22.6"	"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	1.0	12.7	10.7	13.8	7.6	11.6	2.0	6.1	7.9	4.2	14.3	1.5	0.7	8.0	4.8	3.2	5.1	3.9	0.2	5.7	9.9	2.5	0.3	3.3	31.3	8.9	11.2	1.1	0.1	0.3	1.0	11.0	9.4	3.7	1.4	0.5	1.0	1.0	0.1	2.8	4.1	3.9	5.9	9.8	1.5	12.3	18.2	349.2	3.0	0.1	22.8	5.5	3.0	5.5	0.1	0.0	8.0	0.0	0.0	0.0	0.0	0.2	7.2	1.8	4.7	27.1	0.0	0.0	0.1	0.0	2.5	0.2	7.9	0.0	3.7	0.3	17.6	6.9	0.0	0.0	0.0	23.6	2.9	0.4	0.4	0.0	0.7	3.5	0.0	579.6	14.2	0.0	2.6	1.0	569.0	0.0	1.7	6.3	1.4	454.8	9.1	0.2	2.4	1.3	3.0	5.2	0.0	0.5	83.8	6.7	2.4	0.2	0.0	11.9	10.3	0.0	15.3	38.3	17.0	100.9	7.8	0.0	48.4	0.3	0.2	0.0	8.2	0.0	1.6	0.6	68.3	29.9	0.1	0.9	142.6	102.2	1.9	32.9	0.3	0.5	97.7	36.8	10.7	7.6	6.1	7.9	5.7	9.9	8.9	11.2	9.4	5.9	18.2	5.5	1.4	3.2	1.9	2.0	4.4	3.3	1.4	1.0	24.5	0.1	0.4	5.0	1.6	0.0	0.7	0.0	0.0	0.1	6.2	0.0	13.7	0.0	4.2	5.8	22.3	22.0	0.0	9.2	0.2	0.0	0.2	2.1	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	4.1	0.3	1.4	7.9	0.6	2.0	33.8	145.2	3.5	0.6	10.3	0.5	0.6	0.1	0.0	0.0	5.4	1.8	0.0	0.5	2.3	0.3	0.0	0.6	9.0	16.1	6.6	11.3	1.3	0.4	70.3	0.0	0.9	0.4
LEKR1	FLJ16641	ENSG00000197980	"Leucine, glutamate and lysine rich 1"		3	156825481-157046129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 96.8;Late spermatids: 47.7;Respiratory ciliated cells: 28.0;Spermatocytes: 65.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.3;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044039, HPA047774"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA044039: AB_10794288, HPA047774: "	"unprognostic (5.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.80e-2)"	0.9	1.0	0.7	0.3	1.0	0.2	1.6	0.9	0.7	0.5	1.9	0.6	1.0	0.7	3.4	0.3	3.8	0.4	0.9	0.9	1.1	1.4	0.7	0.6	1.0	1.9	1.7	0.9	1.0	1.5	1.5	0.2	1.5	0.9	0.6	1.8	0.6	0.6	0.2	0.4	0.6	0.4	1.6	0.5	0.9	12.8	1.1	0.7	2.3	0.2	0.4	0.5	0.2	1.0	3.3	1.2	0.0	0.7	0.4	0.2	0.1	0.1	0.5	0.6	0.5	0.1	1.7	0.0	0.9	0.4	1.2	1.2	0.0	0.3	1.3	0.5	0.3	1.0	0.1	0.0	0.0	1.0	0.2	1.5	0.8	0.1	0.9	0.3	0.3	0.0	0.7	0.6	1.2	1.2	0.0	0.7	1.0	0.9	0.7	0.0	0.8	0.8	1.0	0.2	1.9	0.7	1.0	0.7	0.0	0.2	2.2	1.8	0.0	0.1	0.3	0.2	0.5	2.9	0.5	0.0	0.5	0.7	1.0	0.6	0.0	0.0	0.2	0.0	0.4	0.8	0.4	0.0	0.3	0.9	0.4	0.2	0.0	0.7	0.0	0.5	0.6	0.1	0.7	1.0	0.9	0.7	0.9	1.1	1.9	1.7	1.5	1.6	1.1	1.0	0.5	0.0	1.1	19.9	6.3	1.3	1.1	1.4	2.8	1.2	2.7	3.9	1.5	1.5	2.8	3.7	2.1	0.3	0.7	1.5	3.9	0.7	96.8	20.7	1.4	0.6	0.0	2.1	6.5	1.6	0.1	1.1	9.7	2.8	1.3	1.4	0.0	1.8	0.2	3.3	11.8	0.9	0.0	1.6	1.3	47.7	1.5	1.8	1.8	3.7	1.1	1.7	0.0	8.0	8.0	1.0	0.6	1.9	2.5	0.7	1.2	5.4	28.0	4.8	0.0	0.6	1.4	65.2	4.3	2.2	0.9	0.1	2.3	1.1	0.9	0.8
LENG1		ENSG00000105617	"Leukocyte receptor cluster member 1"	Q96BZ8	19	54155161-54159721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 98.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 4.0;HaCaT: 5.7;HDLM-2: 3.6;HSkMC: 2.1;LHCN-M2: 3.1;U-87 MG: 4.1;WM-115: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043541	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"	Nucleoplasm	"HPA043541: AB_10961190"	"unprognostic (8.75e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.73e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.22e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-2)"	8.2	8.9	0.2	0.0	0.3	0.1	8.1	0.5	0.3	9.3	0.0	9.4	0.0	8.8	0.2	6.6	9.5	0.0	12.0	0.1	0.2	9.1	8.3	7.1	0.0	0.3	0.3	10.3	10.1	0.1	8.6	0.0	0.9	8.8	0.2	0.2	7.2	0.1	15.2	7.4	8.4	0.0	0.3	11.2	10.0	14.7	0.3	0.1	8.3	0.0	0.1	9.5	7.5	0.5	0.0	0.0	4.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.1	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	3.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	2.2	0.0	0.6	1.1	0.4	0.5	0.6	0.4	0.9	0.7	0.5	0.6	0.6	0.5	0.8	0.7	0.0	0.4	0.4	0.1	0.2	0.3	0.5	0.3	0.1	0.2	0.3	0.3	0.9	0.3	0.3	0.5	28.8	19.2	8.8	2.3	31.4	20.6	22.1	28.6	11.4	10.1	15.2	14.5	7.8	17.2	17.6	18.4	0.0	27.5	30.9	33.7	23.5	21.5	98.8	23.6	18.6	24.2	27.0	17.7	1.1	28.4	14.6	18.3	10.7	17.6	54.6	15.3	29.3	17.0	30.6	6.7	1.2	27.2	34.6	21.8	23.9	15.6	22.4	22.3	21.4	0.0	26.9	19.4	51.5	1.5	4.7	26.1	28.0	15.1	18.0	15.6	35.9	38.2	26.4	15.6	39.5	14.5	24.8	37.3	31.2	10.8	21.5	42.8	38.7	21.3	18.8	16.7
LENG8	"KIAA1932, MGC40108, pp13842"	ENSG00000167615	"Leukocyte receptor cluster member 8"	Q96PV6	19	54448887-54462016	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Rod photoreceptor cells: 598.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 479.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042004, HPA061571"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042004: AB_10794642, HPA061571: AB_2684562"	"unprognostic (2.09e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.45e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.85e-3)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (3.64e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.73e-6)"	238.9	243.5	53.8	84.3	62.0	79.5	264.9	62.5	94.5	327.4	75.3	317.4	112.6	318.2	40.6	199.0	384.3	25.5	237.5	53.1	75.5	299.0	193.2	293.0	70.8	60.3	53.1	425.1	545.6	15.7	380.6	30.9	59.0	353.6	28.9	223.7	267.0	28.0	134.2	249.1	336.3	41.1	38.1	386.8	300.0	238.5	69.7	38.3	374.8	10.3	34.5	283.9	279.8	90.7	70.5	57.6	68.0	37.1	20.7	33.6	37.8	58.1	8.9	11.2	21.7	45.3	100.8	55.9	24.6	46.5	2.7	91.0	21.7	27.0	8.2	93.9	479.3	84.0	179.4	32.0	24.4	12.9	68.5	74.9	39.5	6.7	26.4	91.4	17.2	42.6	66.7	84.1	14.0	24.6	53.1	66.8	17.6	17.5	11.9	84.3	20.5	78.6	27.1	19.4	54.4	29.9	6.3	42.7	15.1	34.1	42.7	18.1	81.7	47.2	48.3	7.6	63.0	77.7	38.4	25.7	40.7	89.9	32.4	3.2	1.0	1.4	0.8	0.7	0.9	0.7	0.5	0.9	0.6	2.5	0.8	0.7	4.5	0.9	0.5	3.1	0.9	0.4	53.8	62.0	62.5	94.5	53.1	75.5	60.3	53.1	59.0	38.1	69.7	90.7	46.7	19.2	30.7	77.1	50.2	28.8	21.3	26.4	35.9	122.7	57.2	47.1	2.2	44.3	35.7	40.5	112.6	20.2	57.5	73.5	1.9	18.5	35.4	52.4	33.8	32.5	105.0	43.3	62.8	31.6	11.9	35.3	128.4	64.8	11.4	67.4	35.3	39.2	25.3	95.9	53.4	84.9	42.7	48.2	28.0	12.4	43.5	59.6	24.9	52.5	45.9	36.1	25.7	64.3	86.5	30.8	52.2	36.9	48.2	39.9	74.2	9.8	68.9	598.6	19.7	25.6	44.3	23.7	13.9	40.5	38.5	21.1	37.6	45.7	59.5	43.1
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971778	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"granulocytes: 272.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.2	11.4	8.1	13.8	8.8	9.0	15.5	14.7	12.9	11.6	6.4	17.0	13.3	10.4	10.0	19.8	8.7	13.2	8.1	8.0	10.0	13.7	22.2	9.7	18.0	8.0	8.1	8.5	8.1	18.8	9.1	12.1	7.7	12.3	19.2	12.0	18.5	8.6	13.9	20.8	14.5	11.7	6.9	10.5	13.2	9.3	8.3	22.1	11.1	11.7	17.9	19.3	14.0	10.0	28.0	63.9	40.3	32.6	40.7	35.0	28.8	44.4	36.6	37.3	33.9	44.3	17.9	56.2	25.3	45.8	41.3	53.2	54.2	39.6	35.8	37.5	24.5	88.5	50.6	78.5	32.0	80.7	118.2	37.9	30.5	29.2	37.6	35.2	37.0	46.5	54.6	30.1	44.9	118.7	43.0	61.1	17.4	82.6	27.0	47.6	69.7	58.9	32.8	77.0	28.5	43.4	33.9	51.5	36.5	43.8	42.8	72.6	44.4	36.8	25.5	34.3	53.7	23.4	78.2	50.7	32.2	113.1	40.0	11.5	14.5	15.7	27.4	23.3	25.7	18.7	27.2	22.3	23.8	16.4	27.9	25.2	3.3	30.9	26.0	17.8	31.7	16.3	8.1	8.8	14.7	12.9	8.0	10.0	8.0	8.1	7.7	6.9	8.3	10.0	16.2	35.3	24.6	10.1	15.2	26.1	16.8	33.4	18.2	38.2	11.8	10.2	21.2	17.2	37.0	7.3	10.4	24.9	24.8	24.6	15.6	26.3	2.4	19.5	38.8	18.0	7.7	12.4	16.5	24.2	26.7	19.9	15.8	29.8	272.8	16.2	10.0	18.0	19.5	26.9	16.9	17.9	26.4	14.8	6.0	2.7	8.1	13.0	3.6	5.6	12.8	23.1	22.6	13.0	13.3	18.2	14.7	13.5	11.0	9.0	20.5	23.3	31.4	23.2	6.6	18.5	29.3	21.5	11.0	19.5	24.7	17.6	25.0	23.8	17.0	21.2
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 23.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.2;hTERT-HME1: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 24.0"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	1.2	1.0	3.4	1.1	3.6	5.3	0.7	5.7	4.9	1.6	2.9	0.7	0.8	1.4	1.1	1.1	1.4	1.2	0.8	3.2	2.8	2.3	0.7	2.0	1.3	2.3	2.9	2.1	0.7	1.6	1.3	1.8	3.1	1.1	0.8	4.2	0.4	0.8	0.2	1.1	0.5	0.6	2.0	1.6	2.7	23.8	2.6	2.4	1.0	0.3	1.4	1.9	0.6	4.2	21.2	4.5	3.0	2.9	2.3	7.0	2.5	7.5	9.2	10.6	6.2	1.5	8.3	2.8	16.5	1.5	3.1	2.2	5.9	25.2	11.7	1.2	2.9	3.2	2.3	4.2	2.7	0.7	2.8	1.7	7.2	11.7	26.9	5.9	10.7	3.4	2.6	3.9	9.3	4.2	7.5	1.8	0.8	1.6	18.2	2.9	4.8	1.6	16.8	1.1	2.4	2.3	2.5	0.4	0.9	1.8	2.4	1.2	20.0	3.3	22.5	7.4	1.7	2.6	1.6	2.0	5.6	3.3	2.5	1.3	4.1	0.7	0.9	1.6	2.0	1.5	0.9	1.5	1.7	1.8	1.7	1.7	21.5	1.4	5.0	0.7	5.2	1.3	3.4	3.6	5.7	4.9	3.2	2.8	2.3	2.9	3.1	2.0	2.6	4.2	3.0	3.2	6.4	2.3	10.3	0.5	13.9	7.6	6.8	6.6	2.1	3.3	1.8	4.3	3.2	5.5	6.2	2.6	10.1	1.4	1.9	4.0	76.9	21.8	7.1	4.2	0.0	0.8	3.6	20.5	7.9	5.0	16.8	20.5	9.5	1.1	1.4	0.0	1.4	6.7	7.3	1.9	2.0	2.2	2.3	57.6	2.1	3.6	1.8	1.0	2.0	3.6	1.0	1.5	1.6	48.6	0.1	1.5	4.5	2.9	0.3	3.0	4.9	8.4	0.0	4.5	3.3	54.8	3.3	2.5	0.9	8.1	9.1	1.5	1.3	4.5
LETMD1	"HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3"	ENSG00000050426	"LETM1 domain containing 1"	Q6P1Q0	12	51047962-51060424	"Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074361			Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA074361: AB_2686682"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.86e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.58e-1)"	"prognostic favorable (3.16e-4)"	31.2	27.0	17.5	11.7	19.2	22.3	29.9	17.8	24.2	19.6	22.8	24.3	36.0	19.4	23.8	13.1	32.4	17.1	18.9	20.0	19.0	32.7	40.3	17.6	18.2	19.3	17.2	36.6	37.1	32.4	19.4	13.7	20.0	18.9	28.3	20.9	27.5	19.4	23.6	19.7	24.5	19.8	18.3	16.5	24.5	13.3	18.7	22.4	37.2	27.8	20.8	17.0	15.5	19.5	19.1	16.7	12.7	33.5	54.9	89.9	12.6	19.4	31.7	19.9	22.2	41.2	38.6	50.2	23.4	20.9	14.2	34.7	25.8	26.1	22.6	18.3	32.4	36.5	23.6	32.8	36.1	32.8	25.6	75.4	82.3	23.7	55.5	60.4	20.3	47.7	38.1	35.4	27.5	29.5	23.2	33.1	8.4	23.6	45.2	19.5	15.0	27.4	25.2	28.3	37.3	16.7	14.7	32.2	45.4	12.4	51.1	29.2	15.6	12.8	13.4	20.9	11.2	32.2	53.8	21.6	23.1	21.1	9.1	3.7	9.6	3.9	10.1	10.8	15.1	15.0	17.0	12.8	9.3	9.2	20.5	19.1	3.0	12.6	16.2	8.3	17.0	12.5	17.5	19.2	17.8	24.2	20.0	19.0	19.3	17.2	20.0	18.3	18.7	19.5	27.0	22.4	29.5	41.1	38.8	49.6	40.0	51.9	66.0	20.9	66.2	64.8	12.6	35.8	20.5	23.9	10.4	49.6	31.7	20.3	92.0	17.2	9.3	23.6	22.2	26.2	27.7	35.5	22.6	32.7	23.3	32.9	31.6	18.4	25.4	29.7	25.7	19.1	30.3	18.5	26.5	36.0	28.5	56.3	35.7	17.0	32.6	27.9	39.2	13.1	31.5	31.8	23.7	16.1	25.4	15.6	26.8	30.5	29.5	26.0	87.0	65.7	25.1	18.9	26.3	33.5	31.8	20.5	26.0	44.2	44.3	27.9	38.8	55.4	52.7	26.6
LEUTX		ENSG00000213921	"Leucine twenty homeobox"	A8MZ59	19	39776595-39786291	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041498	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA							"Nucleoplasm, Nucleoli"		"HPA041498: AB_10796346"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675636-37679802	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3949.7;Langerhans cells: 4906.5;monocytes: 7118.4;Smooth muscle cells: 4703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 1649.6"	"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	No	Yes	10000000	20000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (5.10e-4)"	1921.2	778.5	482.4	523.8	520.7	324.7	1490.9	613.5	695.3	1805.7	465.2	1634.7	197.7	2270.1	196.8	387.4	1147.0	556.0	1397.4	457.7	549.0	362.4	277.4	920.2	176.7	694.5	576.1	1440.2	155.5	188.1	254.8	426.1	661.5	903.0	207.2	39.5	397.5	756.3	1172.9	472.8	475.3	1353.4	593.8	460.7	582.7	244.9	624.9	153.9	290.9	691.9	116.9	1059.7	1156.4	782.4	2850.9	1664.3	36.5	1440.9	3314.6	6505.1	32.7	6450.7	7619.4	4761.9	4716.9	189.6	368.3	3.3	649.1	6661.4	1609.2	296.3	58.8	4309.2	1663.3	2917.2	30.9	251.3	1606.3	791.1	2155.3	145.1	3167.7	4031.7	294.2	3785.7	1609.9	4271.1	5325.7	1.7	186.6	1163.4	3771.1	1287.6	5.2	2038.4	14.3	629.6	3914.9	5.4	2388.6	799.7	2000.0	6.4	5.5	843.4	1287.4	224.3	1644.5	66.7	1187.2	1689.0	7122.0	6224.0	3070.2	2788.9	3349.3	701.8	530.6	13.6	7291.9	762.0	2535.9	1086.5	3047.4	110.2	766.5	2320.4	113.6	567.7	694.9	754.2	3653.1	287.5	114.3	478.1	122.2	415.4	2556.7	899.2	1514.7	4667.0	482.4	520.7	613.5	695.3	457.7	549.0	694.5	576.1	661.5	593.8	624.9	782.4	1505.8	166.7	90.4	12.7	294.3	730.3	144.0	2796.6	49.5	10.0	144.2	477.9	986.3	74.4	213.4	163.7	6.2	88.0	466.5	49.9	17.6	690.2	30.9	183.0	3011.6	1063.6	3.0	74.9	7.5	90.4	1573.3	2540.4	28.1	230.3	540.0	172.2	653.2	614.1	3949.7	8.4	5.4	8.4	339.7	2159.0	4906.5	106.4	975.5	1700.0	2856.6	15.9	7118.4	278.0	588.1	4.0	17.1	233.5	6.1	1300.7	590.9	118.8	0.5	28.7	109.8	45.4	1650.1	1873.6	4703.8	33.8	13.1	18.2	588.0	151.5	767.5	197.2	11.6	57.0
LGALS13	"PLAC8, PP13"	ENSG00000105198	"Galectin 13"	Q9UHV8	19	39602501-39607474	"Metabolic proteins, Predicted intracellular proteins"	Apoptosis	Hemagglutinin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"placenta: 11.8"	"Cell type enriched"	"Detected in some"	17	"Syncytiotrophoblasts: 319.9"	"Cancer enriched"	"Detected in single"	4	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	22	"SuSa: 2.1"									HPA046803			Supported	Nucleoplasm		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA046803: AB_10965990"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	11.8	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.1	0.7	0.2	0.5	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	319.9	0.0	0.0	0.0	0.0
LGALS14	"CLC2, PPL13"	ENSG00000006659	"Galectin 14"	Q8TCE9	19	39704481-39709444	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"placenta: 65.5"	"Cell type enriched"	"Detected in some"	11	"Syncytiotrophoblasts: 88.7"	"Cancer enriched"	"Detected in single"	16	"liver cancer: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"EFO-21: 4.3;U-266/70: 9.8"									HPA065180			Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA065180: "										"unprognostic (1.95e-1)"								0.1	0.0	0.7	0.3	0.8	0.6	0.4	2.2	1.2	0.2	0.4	0.1	0.3	0.2	0.3	0.0	0.0	0.1	0.0	0.7	0.7	0.0	0.0	0.2	0.4	1.1	0.6	0.2	0.5	0.0	0.0	65.5	1.0	0.1	0.1	0.5	0.1	0.0	0.1	0.9	0.1	0.2	0.2	0.4	0.3	0.2	1.2	0.1	0.1	0.2	0.6	0.1	0.0	2.2	0.1	0.0	0.2	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	4.3	0.1	0.1	0.5	0.0	0.0	0.1	1.2	0.1	0.1	0.5	0.2	0.0	0.1	0.7	0.0	0.1	0.1	0.2	0.4	0.0	0.3	0.1	0.8	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.5	0.0	0.1	0.0	0.3	0.4	0.5	0.1	9.8	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.8	2.2	1.2	0.7	0.7	1.1	0.6	1.0	0.2	1.2	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	88.7	0.2	0.0	0.0	0.0
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570248-37582616	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 335.5;intestine: 198.0;kidney: 153.0;pancreas: 211.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 779.2;Distal enterocytes: 695.4;Langerhans cells: 982.8;Proximal enterocytes: 2724.7;Proximal tubular cells: 1764.8;Undifferentiated cells: 749.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	27	"classical monocyte: 1464.7;intermediate monocyte: 553.8;myeloid DC: 1207.2"	"Group enriched"	"Detected in all"	50	"dendritic cells: 1207.2;monocytes: 1464.7"	"Group enriched"	"Detected in many"	4	"CACO-2: 109.4;Hep G2: 62.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	7.5	1.4	0.6	23.5	1.4	19.2	5.4	0.2	1.1	1.8	0.2	55.0	41.2	3.6	1.0	5.2	4.4	335.5	1.6	0.5	1.0	153.0	5.0	8.6	60.7	1.6	1.2	0.9	211.5	0.2	0.1	1.7	1.4	2.2	81.1	0.1	2.1	0.7	1.9	9.9	198.0	5.2	0.4	59.2	10.7	0.6	1.1	41.3	1.0	0.7	64.0	8.2	0.5	3.4	2.8	1.5	0.9	1.0	0.0	0.0	1.1	1.7	0.0	0.0	0.0	109.4	0.1	0.4	0.3	0.0	0.3	1.7	0.0	0.0	0.0	0.2	1.1	0.0	0.0	62.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	2.8	0.0	1.0	0.4	21.2	0.3	0.0	0.9	1.3	0.0	0.0	0.0	0.3	1.7	1.9	2.4	0.5	1.6	1.7	6.4	2.0	1.0	4.3	0.8	0.0	0.2	0.3	2.7	0.2	1.3	7.7	1464.7	8.7	1.8	553.8	3.3	9.9	1.8	2.1	1207.2	2.3	2.3	1.9	26.8	2.3	39.7	9.6	3.0	981.5	0.6	1.4	0.2	1.1	0.5	1.0	1.6	1.2	1.4	0.4	1.1	3.4	1.6	6.4	3.9	0.0	16.4	17.1	0.1	0.5	0.0	0.0	13.2	7.5	0.3	779.2	1.4	29.5	0.0	0.2	7.0	695.4	127.2	26.3	0.1	0.1	0.3	2.3	73.7	4.8	0.1	206.7	0.3	3.2	5.6	0.2	2.5	0.0	0.7	1.9	26.4	0.0	0.1	413.0	0.0	100.8	982.8	0.3	0.6	150.8	24.9	0.0	164.8	0.0	4.1	0.0	0.1	291.6	331.6	0.0	0.9	0.3	2724.7	1764.8	2.1	0.0	0.0	0.3	2.3	0.0	0.4	0.1	12.4	0.3	8.6	0.0	749.3	0.3
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 1194.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 4097.0;Paneth cells: 3445.9;Proximal enterocytes: 4397.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 651.4;intermediate monocyte: 544.6;myeloid DC: 397.8;non-classical monocyte: 441.2;T-reg: 251.9"	"Group enriched"	"Detected in all"	13	"dendritic cells: 397.8;monocytes: 651.4;T-cells: 251.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1169.3;CAPAN-2: 968.0;OE19: 1613.0;SK-MEL-30: 2329.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003162, CAB005191, HPA076528"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1900000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937, HPA076528: "	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	404.5	72.0	111.4	219.8	111.8	346.9	323.1	110.7	148.1	331.4	104.3	1194.1	691.9	162.3	53.8	437.8	223.1	273.0	246.2	110.3	109.4	120.0	27.3	356.1	84.5	118.6	111.9	251.4	79.9	19.8	60.6	141.2	108.6	143.1	875.4	68.3	358.6	177.4	78.6	473.1	853.4	158.8	110.4	61.9	340.7	63.5	125.2	53.0	72.3	105.6	114.1	300.8	273.5	114.0	298.6	96.5	3.3	2.5	581.2	1169.3	344.9	226.7	496.2	64.0	113.2	225.4	968.0	0.7	121.3	272.8	114.6	289.0	6.1	245.4	37.5	357.1	4.4	1.0	104.7	103.8	446.8	1.0	1.1	363.4	375.2	73.9	152.8	145.1	101.5	0.7	1.4	283.1	148.8	218.5	1.3	74.4	5.6	1613.0	271.1	0.7	11.3	22.4	604.8	434.2	7.8	22.6	529.0	0.9	2329.1	16.2	242.8	31.4	180.5	297.8	41.5	112.0	4.4	154.0	535.6	2.8	426.8	18.6	31.8	18.5	651.4	32.4	15.7	544.6	99.7	11.5	58.4	44.2	397.8	4.7	2.5	8.3	28.7	24.2	441.2	9.6	251.9	449.6	111.4	111.8	110.7	148.1	110.3	109.4	118.6	111.9	108.6	110.4	125.2	114.0	1157.4	721.1	359.8	33.3	42.0	631.3	624.1	1278.9	241.9	2.9	307.3	478.7	218.2	258.7	1463.3	119.5	0.0	766.1	38.8	4097.0	673.1	605.9	21.7	636.2	742.7	397.8	173.4	578.1	0.2	1057.8	1051.7	666.3	281.4	846.8	580.5	6.3	64.6	2.3	1137.4	1.7	0.5	1733.8	1778.1	287.8	844.6	44.4	555.7	651.2	848.4	14.0	639.1	300.1	9.2	2.0	0.3	1289.6	3445.9	384.0	77.4	708.4	4397.2	81.3	1506.5	14.7	144.7	220.2	521.0	11.5	6.6	524.8	797.6	483.8	119.5	2.9	1880.1	1139.7
LGALSL	"GRP, HSPC159"	ENSG00000119862	"Galectin like"	Q3ZCW2	2	64453969-64461381	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 90.6;skin 1: 93.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 95.6;Rod photoreceptor cells: 152.8;Suprabasal keratinocytes: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.5;neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 50.2;CACO-2: 35.6;HAP1: 72.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046079	Approved		Approved	Nucleoplasm		NA	NA		4100000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA046079: AB_10967075"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.77e-2)"	9.3	16.9	7.1	4.1	8.3	8.1	17.2	9.5	8.7	8.8	8.6	12.6	10.1	7.2	8.9	24.6	5.3	6.3	13.5	7.4	8.6	9.2	9.6	15.9	2.1	5.7	5.4	6.4	6.3	19.2	7.5	10.6	5.7	15.5	11.8	90.6	9.3	7.1	60.1	93.6	10.9	7.3	5.4	6.0	8.8	4.3	5.8	2.9	5.3	18.2	15.8	4.4	10.0	6.6	11.6	7.5	20.7	50.2	0.7	0.2	6.2	2.9	8.1	6.3	6.0	35.6	2.4	0.0	4.7	1.6	12.2	14.3	72.8	13.7	5.0	13.8	19.1	0.2	4.0	17.8	6.2	3.4	4.4	3.1	8.6	2.6	9.7	5.6	3.9	7.7	0.1	3.5	0.2	9.3	4.9	0.6	16.8	7.1	8.8	5.3	12.0	3.5	7.5	8.5	3.5	13.1	10.5	7.2	6.2	12.7	5.1	0.5	1.7	4.0	12.4	2.5	6.2	14.7	7.1	10.0	0.0	2.1	5.4	0.0	0.1	1.5	0.0	0.0	0.7	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.4	7.1	8.3	9.5	8.7	7.4	8.6	5.7	5.4	5.7	5.4	5.8	6.6	28.9	22.4	66.2	2.3	6.0	67.6	25.5	9.7	29.0	31.9	39.0	20.8	16.5	10.0	6.3	11.0	33.3	1.4	1.6	45.2	15.6	6.2	11.8	10.9	8.1	18.2	9.1	0.8	6.6	13.3	2.7	14.8	23.4	23.0	1.3	4.1	17.9	11.9	1.0	13.5	6.0	38.6	6.1	6.6	14.4	6.3	8.1	26.2	10.6	1.9	2.4	95.6	2.1	5.0	2.4	19.9	22.6	4.5	29.8	24.1	31.0	14.3	1.6	152.8	19.7	15.1	45.9	8.1	5.1	51.9	137.0	1.5	2.7	2.8	24.3	36.2
LGMN	"LGMN1, PRSC1"	ENSG00000100600	Legumain	Q99538	14	92703807-92748679	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 1448.9;Macrophages: 346.1;Syncytiotrophoblasts: 416.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"plasmacytoid DC: 209.2"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 209.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 898.6;U-266/70: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001426	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"HPA001426: AB_1079247"	"unprognostic (1.19e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.18e-3)"	"unprognostic (7.24e-2)"	173.7	44.4	37.6	82.2	38.6	20.6	69.7	31.7	60.8	52.6	51.2	102.5	110.4	30.8	36.8	64.5	36.6	145.8	85.3	40.0	40.3	205.9	111.1	107.3	177.0	35.6	37.3	33.0	37.9	247.0	24.9	262.1	42.4	51.9	105.9	19.7	56.4	32.2	50.4	32.7	97.6	65.0	35.9	202.2	107.0	29.8	62.8	52.8	93.2	50.4	54.9	144.7	52.1	49.4	33.2	47.5	30.8	57.4	94.3	76.0	108.4	70.3	67.0	71.7	84.2	36.9	58.6	18.2	101.5	116.5	44.3	81.5	0.0	60.8	33.7	1.6	36.2	1.2	24.4	42.8	27.7	1.0	2.7	54.2	29.1	68.4	39.4	21.3	82.1	33.7	7.4	150.9	5.2	45.2	8.9	1.2	15.1	208.2	32.1	8.4	27.1	898.6	59.2	129.1	33.6	23.2	97.9	59.4	53.0	66.8	43.9	0.6	47.2	35.3	44.8	64.5	21.8	462.5	58.0	25.0	20.0	0.2	69.1	1.9	1.6	0.1	0.8	3.1	1.6	17.0	5.1	1.3	19.3	14.5	15.2	9.0	1.6	3.7	1.0	209.2	9.7	7.0	37.6	38.6	31.7	60.8	40.0	40.3	35.6	37.3	42.4	35.9	62.8	49.4	34.9	57.7	128.0	8.8	33.9	23.1	37.5	36.0	22.2	10.6	31.2	37.6	29.8	42.9	48.1	31.3	93.8	181.8	24.5	64.2	9.8	61.3	1.3	79.4	23.5	38.3	36.5	22.7	19.2	50.6	140.2	63.8	73.4	177.7	8.8	17.6	276.3	46.4	1448.9	13.5	41.0	31.1	95.6	317.6	89.0	3.3	30.4	346.1	48.0	27.2	37.5	23.6	2.1	10.6	15.2	50.5	57.1	57.9	24.7	44.6	163.4	220.4	20.9	19.8	19.7	40.4	62.1	19.9	17.6	22.3	17.5	416.3	8.2	15.1	48.3	44.7
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439798-71586310	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;fallopian tube: 16.8;placenta: 19.0;skeletal muscle: 22.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 55.2;Endometrial ciliated cells: 35.7;Glandular and luminal cells: 84.4;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 105.0;Syncytiotrophoblasts: 26.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 26.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 37.1;SH-SY5Y: 104.5"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 34.1"	"Low region specificity"	"Detected in many"			HPA012530	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	1.4	1.6	2.7	0.4	7.6	0.0	1.5	4.6	4.7	1.5	0.1	3.3	5.1	4.0	1.1	0.1	16.8	0.4	0.2	2.9	5.7	0.8	0.9	0.9	0.1	9.5	5.2	0.7	0.0	0.2	1.0	19.0	9.0	1.2	3.6	0.2	1.9	7.3	22.3	2.9	5.5	0.2	6.0	0.0	2.3	0.1	5.6	0.1	0.3	0.8	1.7	0.1	0.4	19.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.3	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.5	0.0	11.9	0.0	1.0	37.1	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	12.2	1.6	2.4	0.0	0.0	0.0	14.6	0.2	104.5	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	7.6	4.6	4.7	2.9	5.7	9.5	5.2	9.0	6.0	5.6	19.2	0.0	0.0	0.0	1.3	0.2	0.9	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	55.2	0.0	1.2	0.0	0.0	0.6	35.7	5.3	0.5	4.9	0.0	6.8	0.0	2.3	1.4	0.0	84.4	0.0	0.0	0.0	1.0	6.4	0.0	12.3	3.0	0.0	0.0	1.6	0.2	0.0	0.4	1.8	0.0	0.0	0.0	0.0	45.2	105.0	0.1	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	3.4	0.0	0.0	0.0	1.3	26.4	0.5	0.0	20.3	0.0
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193799-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 9.0;Cardiomyocytes: 10.5;dendritic cells: 6.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 15.4;memory CD8 T-cell: 9.1;naive CD8 T-cell: 4.8"	"Lineage enriched"	"Detected in single"	37	"T-cells: 15.4"	"Cell line enhanced"	"Detected in some"		"A549: 17.4;CAPAN-2: 15.4;HaCaT: 8.3;HeLa: 3.9"	"Region enriched"	"Detected in many"	9	"olfactory bulb: 24.4"	"Low region specificity"	"Detected in many"			HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.1	0.2	2.3	0.4	5.4	1.4	5.1	8.2	1.5	3.7	0.3	1.4	0.1	1.2	2.2	5.0	8.8	6.2	14.7	1.0	7.2	0.8	2.1	3.4	0.8	14.7	7.6	1.8	0.2	0.0	17.5	0.3	8.0	5.9	0.7	0.0	5.3	1.4	0.3	4.1	1.3	0.3	6.1	6.7	0.6	7.2	9.8	0.3	5.1	0.5	0.3	2.9	3.8	2.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	1.6	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	1.0	0.0	1.7	9.1	0.0	0.0	0.7	4.8	0.0	0.4	0.0	0.0	0.5	3.4	2.3	5.4	8.2	1.5	1.0	7.2	14.7	7.6	8.0	6.1	9.8	2.0	0.1	0.0	0.0	2.6	0.2	1.3	3.6	0.5	23.3	0.0	1.5	9.0	10.5	0.0	0.6	0.0	0.0	0.9	6.0	0.8	0.0	0.0	3.1	0.0	0.0	0.2	0.0	0.4	1.0	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.8	1.6	0.0	0.6	0.3	4.1	0.0	0.2	0.0	1.9	0.0	0.0	4.1	0.0	0.2	0.0	0.7	0.0	2.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	5.6	5.5	3.3	0.3	0.1	0.8	4.3	0.0	2.7	0.9
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319983	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 2.0;liver: 3.8;placenta: 1.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.5;Inhibitory neurons: 3.7;Late spermatids: 4.4;Oligodendrocytes: 5.9;Proximal tubular cells: 5.6;Respiratory ciliated cells: 3.0"	"Cancer enriched"	"Detected in some"	4	"lung cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.2;BEWO: 3.3;CACO-2: 1.6;HeLa: 1.8;Karpas-707: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"		"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	2.0	3.8	0.2	0.0	0.3	0.1	0.0	0.3	0.0	0.0	1.1	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.2	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	2.2	0.0	1.1	1.9	0.1	1.2	2.0	0.0	0.1	0.0	0.0	3.5	0.2	0.5	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.3	0.0	3.7	0.7	0.0	0.3	0.0	4.4	0.3	0.1	0.0	1.9	0.0	0.0	0.0	1.5	5.9	0.0	0.3	0.0	0.1	0.2	0.1	5.6	3.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.4	0.1	0.1	0.8	0.2
LHFPL4	GARLH4	ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553822	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 15.5;pituitary gland: 12.2;retina: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4"	"Group enriched"	"Detected in some"	4	"glioma: 6.8;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.0	2.0	11.1	0.0	11.4	0.0	0.0	7.1	15.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.7	0.0	0.0	0.0	0.0	10.4	7.4	0.0	0.5	0.1	12.2	0.0	10.2	0.0	0.2	9.3	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.2	0.7	12.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	11.3	0.0	0.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	11.4	7.1	15.5	11.3	12.7	10.4	7.4	10.2	3.3	12.1	9.8	0.4	0.0	0.0	4.6	0.5	0.0	2.9	0.0	0.0	42.4	0.4	0.3	0.8	0.0	0.0	0.0	18.8	0.6	0.6	0.6	0.0	0.3	0.6	0.7	1.1	0.8	1.2	0.0	60.0	0.2	1.4	0.6	0.0	1.3	1.3	0.5	4.2	0.2	0.3	15.2	67.2	0.7	0.0	0.3	0.0	0.7	0.0	0.8	0.0	1.0	0.1	2.0	3.1	34.2	5.6	0.4	1.7	0.0	0.0	6.3	0.8	0.2	0.0	17.4	0.0	2.7	0.4	1.7	1.1	0.0	0.0	1.4	0.4	0.3	0.8	2.5
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"kidney: 10.7"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 361.7"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 8.1;testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 19.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 15.7"	"HPA044307, HPA073521, HPA074382"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.5	0.2	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.1	0.0	0.0	42.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	361.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.0	0.0	1.6	0.0	0.0	0.2	1.1	2.3	0.0	0.0	0.4	0.3	0.0	0.2	0.0
LHX2	"hLhx2, LH-2"	ENSG00000106689	"LIM homeobox 2"	P50458	9	124001670-124033301	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 99.8;choroid plexus: 48.5;retina: 34.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 68.6;Early spermatids: 43.1;Muller glia cells: 254.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.2;GAMG: 17.9;HAP1: 23.5;HeLa: 15.5;NTERA-2: 28.5;U-138 MG: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA000838		Supported	Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA000838: AB_2666109"	"unprognostic (3.60e-3)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.52e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.66e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.77e-1)"	0.1	0.1	77.8	0.2	78.1	0.0	0.2	48.5	99.8	0.0	48.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	88.1	51.2	0.3	6.7	0.0	0.3	49.5	52.7	0.2	0.0	0.0	9.8	3.4	50.2	0.0	0.1	34.1	0.1	0.0	0.0	6.1	0.2	0.0	48.3	0.1	0.0	3.0	54.9	0.1	0.0	0.0	0.2	0.1	0.0	73.9	0.0	7.2	0.2	23.2	0.0	0.3	2.6	0.7	0.3	1.8	0.2	7.8	0.0	0.2	3.0	1.4	17.9	0.2	23.5	0.0	0.9	0.0	5.0	0.0	15.5	0.4	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	12.1	0.0	0.2	28.5	0.0	7.0	6.5	0.1	0.0	0.0	0.1	9.2	0.1	5.7	0.0	0.0	0.2	8.0	3.1	0.0	14.6	0.6	4.2	1.1	0.4	5.0	0.0	0.8	3.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.8	78.1	48.5	99.8	88.1	51.2	49.5	52.7	50.2	48.3	54.9	73.9	0.1	0.0	0.0	68.6	0.2	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.6	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.0	43.1	0.1	0.0	0.3	0.0	0.0	20.6	0.0	8.9	0.1	0.0	0.0	0.0	0.1	3.9	0.0	4.0	8.4	2.5	0.0	0.0	0.0	0.3	21.7	0.0	0.1	0.0	1.9	0.0	254.6	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.4	0.2	4.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LHX5		ENSG00000089116	"LIM homeobox 5"	Q9H2C1	12	113462033-113472280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 5.0"	"Cell type enhanced"	"Detected in single"		"Basal respiratory cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053908			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA053908: AB_2682304"		"unprognostic (5.20e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-2)"		"unprognostic (1.06e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.56e-1)"			"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.54e-3)"	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.0	1.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.7	0.1	0.0	1.9	5.0	1.5	1.7	1.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.2;salivary gland: 2.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 1.2;Late spermatids: 1.4;Spermatocytes: 3.3;Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 6.2;hypothalamus: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 25.6;U-266/70: 8.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 9.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 9.7"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	1.3	1.7	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.3	0.0	0.0	8.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	6.2	0.0	6.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LHX9		ENSG00000143355	"LIM homeobox 9"	Q9NQ69	1	197911902-197935478	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.2;ovary: 9.2"	"Group enriched"	"Detected in some"	6	"Leydig cells: 157.5;Peritubular cells: 50.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 17.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"fHDF/TERT166: 272.7"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 6.3;midbrain: 17.3;thalamus: 12.2"	"Group enriched"	"Detected in many"	5	"midbrain: 16.8;pons: 6.7;thalamus: 14.5"	HPA009695	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA009695: AB_1079251"	"unprognostic (8.05e-2)"	"unprognostic (1.18e-1)"		"unprognostic (1.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.42e-1)"		"unprognostic (1.88e-1)"	0.1	0.0	2.5	0.0	0.4	0.0	0.0	0.6	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	4.1	0.0	0.4	1.4	0.0	1.8	17.2	9.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	15.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	27.4	4.3	7.2	0.6	0.0	0.0	0.0	0.1	272.7	0.1	0.0	6.7	0.0	2.3	0.0	0.5	0.0	7.6	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.6	0.1	8.1	7.7	3.1	0.0	0.0	0.0	0.0	6.7	0.0	2.4	1.3	11.7	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.6	0.7	0.6	4.1	1.8	17.2	2.5	0.6	15.4	1.4	0.0	3.2	15.4	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.1	1.9	0.1	1.1	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	157.5	0.2	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	50.4	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.5	2.5	0.9	0.0	0.0	0.1	0.1	0.1	0.2	0.1
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39459004-39485109	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.0;Late spermatids: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	5.4	7.5	5.9	3.0	6.5	6.6	5.7	7.6	9.8	5.1	5.9	6.4	5.5	4.6	5.3	6.7	6.1	3.6	11.1	6.2	6.7	8.7	8.6	2.9	5.1	6.3	6.4	10.0	6.8	6.5	4.0	3.3	6.8	4.1	6.4	5.4	4.3	3.1	27.2	5.7	5.2	5.2	5.5	3.6	6.3	9.8	6.2	4.3	4.2	21.0	4.2	5.8	4.7	8.3	5.7	4.5	5.4	5.2	11.5	11.4	4.8	6.6	3.7	6.1	4.1	6.8	7.8	20.8	7.3	2.5	15.2	4.9	15.9	9.1	8.0	2.4	4.0	8.8	2.3	7.0	10.4	19.1	5.5	10.8	14.6	7.1	22.4	13.4	7.0	12.7	21.1	5.2	7.5	3.6	10.9	24.9	7.3	15.3	14.2	9.1	15.2	12.9	7.1	2.9	6.0	4.8	3.8	4.9	22.5	7.6	5.6	8.8	2.6	4.7	10.6	6.3	15.5	9.9	15.8	14.3	7.2	22.2	4.0	2.5	6.4	3.9	5.7	7.6	12.7	10.0	8.1	8.0	6.2	7.6	16.2	11.6	3.4	7.7	5.6	5.5	5.7	4.7	5.9	6.5	7.6	9.8	6.2	6.7	6.3	6.4	6.8	5.5	6.2	8.3	11.0	9.6	12.6	14.0	12.9	9.7	11.6	17.4	12.0	25.8	15.7	17.3	20.1	17.2	12.7	18.4	10.4	24.0	22.6	12.9	21.5	13.2	86.0	11.2	15.8	10.3	18.1	12.4	11.9	6.4	18.2	10.4	9.2	10.3	17.7	19.0	11.4	19.0	17.5	10.1	18.8	13.5	18.3	13.5	7.8	100.1	10.2	11.4	1.8	6.5	17.6	15.4	16.5	14.6	22.9	10.3	10.1	12.4	5.8	6.6	18.3	32.6	14.1	26.7	0.0	10.8	20.5	64.9	25.1	13.7	9.2	9.6	14.2	19.0	18.4	8.8
LIG1		ENSG00000105486	"DNA ligase 1"	P18858	19	48115445-48170603	"Enzymes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 34.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037015, HPA041431, HPA048071"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248"	"unprognostic (1.83e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.45e-2)"	"unprognostic (9.76e-2)"	"unprognostic (9.47e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.10e-3)"	"prognostic unfavorable (5.75e-5)"	"unprognostic (3.59e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	2.8	3.2	3.3	9.0	3.2	34.5	3.6	3.6	3.5	5.5	2.3	6.8	8.6	4.0	2.5	7.4	5.9	2.3	1.6	2.9	3.2	2.9	4.0	3.4	15.6	4.4	2.9	6.0	7.0	4.2	4.8	5.1	4.5	4.0	4.2	2.7	4.8	3.0	3.8	10.4	9.6	2.2	2.6	6.0	5.2	8.2	3.1	20.7	5.1	1.0	9.7	3.5	5.0	3.9	43.4	64.1	57.1	37.6	2.6	4.2	41.7	27.0	19.1	44.1	47.2	35.0	42.9	83.7	15.3	11.2	11.9	30.1	24.7	26.7	16.9	45.2	48.8	56.4	38.7	47.5	1.0	63.0	43.7	5.7	2.5	23.0	3.4	5.0	24.0	51.0	46.3	29.8	23.3	44.0	107.3	123.7	33.6	46.7	15.9	84.1	48.4	43.6	12.3	64.8	36.3	36.5	32.3	33.6	10.1	12.5	22.7	44.5	22.6	31.7	54.3	23.9	40.3	29.3	49.0	83.1	12.7	38.0	33.3	0.0	1.6	2.6	7.8	6.8	7.7	10.9	8.8	8.3	1.6	10.0	11.5	8.2	1.3	12.1	3.3	1.5	10.9	5.7	3.3	3.2	3.6	3.5	2.9	3.2	4.4	2.9	4.5	2.6	3.1	3.9	3.9	3.2	13.6	5.9	16.1	8.3	9.5	8.7	24.5	21.5	7.8	12.3	3.9	7.2	10.3	3.7	10.4	31.1	9.6	10.2	7.9	5.8	19.3	12.0	5.1	8.3	0.0	36.2	4.2	5.2	35.8	6.8	5.1	8.3	6.3	23.1	5.0	5.3	16.4	8.4	5.6	10.0	6.1	3.5	6.8	8.5	2.1	6.6	3.6	3.7	7.2	10.9	11.3	3.5	8.4	3.0	4.4	1.9	23.0	2.8	7.6	4.7	19.5	11.3	13.1	4.5	6.5	13.5	26.1	15.9	9.1	10.0	13.9	6.0	15.3	8.7
LIG3	"LIG2, LIG3alpha"	ENSG00000005156	"DNA ligase 3"	P49916	17	34980512-35009743	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006723	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA006723: AB_1847781"	"unprognostic (6.05e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.71e-2)"	4.9	6.4	3.2	7.3	3.3	7.1	8.7	3.8	4.4	7.9	4.7	8.2	5.9	12.5	6.4	8.9	11.9	5.3	7.6	3.4	1.9	6.6	6.3	5.2	7.2	2.2	2.0	11.5	8.7	13.7	6.6	8.3	1.8	11.1	9.0	7.2	10.6	9.0	10.6	8.4	6.7	10.2	1.0	7.6	6.6	21.1	2.1	13.9	10.1	9.3	8.5	8.9	7.2	3.1	16.6	32.6	38.3	33.9	7.4	9.3	29.2	15.7	11.4	20.9	20.8	15.8	8.8	27.0	12.7	20.6	20.5	15.2	43.9	20.3	26.7	12.8	29.4	28.4	14.6	23.2	11.7	44.9	48.1	7.0	17.5	15.5	24.0	10.3	25.6	40.8	45.3	30.2	15.2	18.6	56.7	14.1	36.8	20.6	13.7	30.4	35.2	28.6	10.2	17.7	31.2	22.3	23.6	19.0	15.2	55.9	34.5	22.3	12.3	13.5	16.8	16.8	25.6	27.0	31.5	35.1	9.7	20.9	26.5	0.6	3.4	4.2	4.6	5.1	6.7	3.7	3.1	4.1	8.4	3.0	4.1	3.0	0.3	9.3	2.8	4.9	2.1	3.9	3.2	3.3	3.8	4.4	3.4	1.9	2.2	2.0	1.8	1.0	2.1	3.1	7.6	3.2	10.3	1.6	8.0	5.0	10.5	3.6	12.0	18.2	10.0	7.5	10.1	10.0	9.2	12.9	16.7	14.6	11.9	7.0	9.8	6.7	41.8	18.5	11.9	8.5	6.7	8.2	5.0	6.0	17.8	7.3	16.8	15.8	9.5	16.7	3.6	8.9	7.9	16.8	5.2	7.9	8.2	5.3	2.7	80.0	7.2	6.7	3.6	2.8	6.4	7.6	16.5	4.0	5.8	3.6	7.5	7.9	15.4	11.6	6.8	6.5	5.3	17.7	6.6	11.8	7.0	32.7	13.2	11.2	5.3	21.6	8.9	10.8	9.5	10.2
LIG4		ENSG00000174405	"DNA ligase 4"	P49917	13	108207439-108218368	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001334, HPA057325"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Cytoplasmic bodies"	"HPA001334: AB_1078689, HPA057325: AB_2732608"	"unprognostic (9.93e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.03e-3)"	7.2	8.3	6.3	8.6	6.5	3.9	5.6	6.1	9.0	4.0	8.7	5.7	7.2	4.4	8.5	4.2	4.5	6.8	6.7	7.1	10.2	8.2	12.0	6.9	11.0	6.8	6.6	5.8	3.8	11.3	5.2	5.8	6.8	5.6	6.6	23.1	4.6	5.2	7.1	5.3	7.0	6.6	6.1	8.3	7.8	9.8	7.1	21.8	7.7	6.5	8.3	6.9	2.3	7.9	15.5	5.8	15.3	10.2	12.4	13.3	5.4	14.9	11.2	11.2	13.3	6.9	6.7	26.0	11.9	9.8	13.7	6.3	10.2	9.9	19.2	15.4	9.8	12.3	13.8	3.6	14.8	16.6	12.5	12.3	16.3	10.8	9.6	10.7	13.5	47.0	4.4	4.7	17.4	8.3	27.7	12.1	3.9	12.6	3.6	25.1	6.0	4.2	14.6	9.7	9.6	9.9	3.3	9.0	11.7	11.7	7.7	25.4	20.1	6.6	7.2	7.5	13.5	12.4	8.7	41.7	25.4	9.4	15.2	0.6	1.6	4.8	1.1	2.5	1.6	1.6	1.2	1.2	1.4	2.2	1.2	1.7	2.2	1.9	8.3	1.0	1.8	1.0	6.3	6.5	6.1	9.0	7.1	10.2	6.8	6.6	6.8	6.1	7.1	7.9	5.6	9.6	9.5	13.4	9.2	2.7	2.8	4.9	3.4	10.7	4.9	2.8	11.6	1.5	10.0	1.8	8.4	2.3	7.3	7.9	9.8	5.3	11.6	8.3	5.7	4.3	9.6	0.4	16.6	7.5	1.0	4.2	7.7	6.0	3.8	3.6	4.6	9.8	5.8	18.5	16.1	5.3	2.0	7.5	3.9	5.1	2.8	7.4	1.8	10.3	9.3	7.3	4.1	13.6	24.9	8.9	6.3	6.0	6.2	2.5	3.5	6.3	21.9	13.6	13.1	4.6	3.8	19.1	4.4	4.0	5.7	1.8	4.1	8.7	2.9	3.7
LIMD1		ENSG00000144791	"LIM domains containing 1"	Q9UGP4	3	45555394-45686341	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064220, HPA071736"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA		8100	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Focal adhesion sites"		"HPA064220: AB_2685216, HPA071736: "	"unprognostic (2.77e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.73e-5)"	"unprognostic (8.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.61e-3)"	7.1	3.8	4.3	7.8	4.7	6.0	5.4	3.5	4.8	5.4	9.5	7.3	7.1	6.6	4.6	5.6	6.1	7.2	9.7	3.5	3.8	3.7	11.1	17.1	10.6	8.3	5.4	4.1	10.2	9.0	2.8	6.4	6.6	6.2	7.5	2.8	9.8	4.8	17.4	6.5	7.9	5.5	4.7	10.8	8.2	2.5	6.9	8.0	12.2	8.6	8.6	6.0	4.8	6.9	13.3	24.7	8.8	11.9	7.6	14.7	17.7	12.4	17.0	12.7	11.0	11.7	6.8	1.7	8.1	11.4	26.1	8.8	18.8	10.0	10.5	28.1	11.7	14.7	20.5	9.7	7.7	13.3	18.2	6.2	8.3	19.1	10.0	9.2	11.3	14.7	12.4	40.0	12.6	8.7	16.2	8.3	14.2	10.4	23.7	7.9	10.3	20.2	6.8	23.3	4.1	8.0	10.5	18.8	12.4	9.0	11.4	11.8	20.7	14.3	12.9	14.5	13.4	38.1	52.7	6.5	30.9	11.7	16.0	3.8	0.9	1.1	1.0	2.0	0.6	2.4	0.8	0.8	0.9	4.0	0.8	0.8	1.0	0.7	4.0	5.8	0.8	0.8	4.3	4.7	3.5	4.8	3.5	3.8	8.3	5.4	6.6	4.7	6.9	6.9	5.0	38.5	27.4	17.6	17.8	2.9	5.7	4.3	4.0	1.6	5.2	3.8	16.5	21.5	12.4	7.3	2.1	6.4	23.9	8.0	1.9	7.2	1.2	7.9	10.2	5.9	6.7	10.3	1.4	5.3	12.8	9.0	9.7	10.7	3.8	11.1	9.7	22.9	17.1	6.7	3.6	15.9	10.2	17.0	10.1	0.9	11.8	13.5	5.4	18.7	11.1	4.8	12.3	74.4	22.5	6.2	6.9	3.4	9.7	9.1	5.9	2.9	11.9	1.5	6.6	8.2	15.2	1.0	3.5	4.1	2.3	5.3	7.9	2.5	9.6	5.4
LIMD2	MGC10986	ENSG00000136490	"LIM domain containing 2"	Q9BT23	17	63695888-63701172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.1;lymphoid tissue: 222.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 436.9;dendritic cells: 306.6;Kupffer cells: 216.1;monocytes: 188.2;NK-cells: 510.9;T-cells: 264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 243.0;NB-4: 171.7;SH-SY5Y: 163.3;THP-1: 127.6;U-698: 260.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062432, HPA075172"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA062432: , HPA075172: "	"unprognostic (2.90e-3)"	"unprognostic (2.89e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.36e-11)"	"unprognostic (1.21e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.08e-2)"	12.5	7.9	26.2	106.9	31.3	112.1	8.2	18.8	35.4	12.1	19.1	11.2	13.6	7.8	2.0	6.4	8.9	17.5	9.8	29.9	22.6	17.3	10.4	24.8	222.2	22.9	22.1	7.1	7.1	3.3	10.7	15.5	22.3	16.3	9.4	1.0	12.9	5.5	3.1	6.7	61.0	9.1	21.8	170.8	20.5	14.0	22.8	111.3	9.3	3.4	149.8	20.3	8.2	23.7	0.8	7.7	92.9	22.9	0.8	2.4	2.3	2.6	1.4	9.4	6.4	4.2	1.9	243.0	20.5	11.6	9.4	3.9	20.4	0.9	2.6	84.3	8.7	72.4	1.8	20.6	17.6	95.2	7.6	22.8	1.0	9.6	0.3	11.0	25.5	16.5	6.7	13.8	10.7	1.3	84.7	171.7	50.3	0.0	4.4	34.6	37.4	43.6	13.1	1.0	111.2	163.3	11.8	0.2	22.2	23.9	0.6	127.6	32.2	12.8	28.1	0.7	3.4	2.9	1.0	260.4	1.4	13.3	22.7	2144.2	601.8	1434.7	368.9	716.3	364.8	688.5	512.2	432.9	609.8	855.0	679.3	496.3	1248.9	553.2	783.9	230.5	664.2	991.4	26.2	31.3	18.8	35.4	29.9	22.6	22.9	22.1	22.3	21.8	22.8	23.7	11.0	0.0	4.6	0.7	436.9	7.5	7.7	20.5	2.2	1.9	5.0	7.2	1.0	4.3	8.6	11.0	4.2	1.6	306.6	1.1	5.9	20.5	18.8	2.3	14.2	23.6	22.2	99.2	18.7	8.9	3.6	10.1	5.6	4.2	53.3	15.7	30.4	2.0	137.6	3.3	2.2	2.1	26.4	216.1	93.9	57.5	3.4	148.0	37.4	12.2	188.2	8.4	510.9	3.5	2.9	19.8	4.7	4.9	154.3	17.7	0.4	3.7	2.4	1.1	6.6	2.9	30.5	7.8	7.5	1.1	6.0	1.5	264.3	4.7	2.5	4.3
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 115.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 40.0;neutrophil: 96.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 96.9"	"Cell line enhanced"	"Detected in all"		"BEWO: 135.5;hTCEpi: 251.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	20.1	14.4	25.5	39.8	27.3	53.8	30.9	25.8	22.1	26.4	32.6	34.0	21.2	17.0	7.7	71.8	34.2	21.3	14.3	20.8	27.7	27.7	33.0	46.8	23.2	37.8	34.2	21.6	28.8	27.0	21.9	48.0	32.8	36.7	34.7	25.5	50.7	19.1	18.8	71.5	29.3	15.9	32.7	37.5	30.0	19.2	33.6	21.3	42.0	9.2	17.8	25.7	45.3	33.1	26.6	4.4	17.9	10.0	7.6	8.8	135.5	17.2	8.0	16.9	14.2	22.7	12.2	25.8	29.9	26.0	8.1	52.6	20.9	90.3	10.6	19.1	22.8	18.8	21.1	24.7	11.4	35.1	33.1	14.3	251.5	13.7	41.0	114.5	43.6	20.6	10.7	18.2	23.3	20.9	21.5	12.0	16.7	68.3	6.7	28.1	30.0	14.3	19.6	62.3	22.8	20.4	13.0	82.1	35.1	54.8	68.7	13.9	26.6	15.1	23.5	8.3	16.3	10.0	16.2	22.4	9.6	16.4	6.6	5.8	5.1	40.0	3.1	3.5	5.9	2.0	5.7	4.3	1.9	2.4	5.6	4.4	96.9	6.7	1.4	4.4	15.2	4.4	25.5	27.3	25.8	22.1	20.8	27.7	37.8	34.2	32.8	32.7	33.6	33.1	19.5	32.1	17.9	16.3	5.2	35.9	37.7	24.8	59.2	9.4	18.0	23.2	25.1	10.0	32.6	5.5	20.9	69.8	15.3	39.3	3.9	13.0	1.4	49.6	19.2	22.4	13.2	10.3	6.4	45.0	52.4	7.6	48.9	41.6	23.5	8.6	14.3	7.1	18.2	3.3	11.3	42.8	18.3	8.9	8.2	1.6	4.4	13.8	3.6	16.9	5.4	16.6	2.1	2.5	15.5	25.9	21.2	4.5	6.2	27.1	12.0	10.5	36.3	22.8	19.7	7.5	17.2	15.6	18.4	46.1	39.1	115.5	9.3	7.1	51.7	29.9
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"placenta: 65.4"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 75.4;Early spermatids: 27.5;Excitatory neurons: 40.2;Extravillous trophoblasts: 83.0;Late spermatids: 25.2;Syncytiotrophoblasts: 55.8"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 49.1;BEWO: 252.1;Hep G2: 44.0;K-562: 86.9;NTERA-2: 44.8;SuSa: 44.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	0.4	0.0	0.8	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.3	65.4	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	4.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	3.2	49.1	10.0	0.0	0.0	252.1	0.1	0.0	0.0	0.0	16.6	0.1	0.1	0.0	0.1	3.0	0.1	31.2	0.0	0.0	0.0	24.1	36.6	0.0	44.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	86.9	1.2	0.0	0.0	5.6	6.2	44.8	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.1	11.6	0.1	0.3	4.0	44.5	0.0	10.6	1.0	0.1	5.3	0.2	0.1	14.8	22.6	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.8	0.0	1.3	0.6	0.7	0.4	0.2	0.1	0.0	0.3	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	6.2	75.4	0.0	0.0	0.0	0.0	27.5	0.0	0.0	8.3	0.0	0.0	40.2	0.0	83.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	9.7	1.7	5.7	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	6.6	0.0	0.0	6.3	9.9	0.0	0.0	55.8	0.0	0.0	0.0	0.0
LIN37	"F25965, lin-37, ZK418.4"	ENSG00000267796	"Lin-37 DREAM MuvB core complex component"	Q96GY3	19	35748361-35754519	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043253, HPA047809"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA043253: AB_2678391, HPA047809: AB_2680162"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.77e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (2.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.35e-1)"	"unprognostic (5.14e-2)"	10.1	9.9	21.5	6.7	22.2	9.7	9.1	22.5	26.9	13.0	18.9	11.1	9.2	11.2	7.7	7.0	10.8	6.9	12.6	21.6	22.4	7.4	7.6	7.5	9.6	21.1	21.4	15.9	8.5	9.2	11.0	11.7	21.6	8.9	5.0	8.6	7.9	8.4	15.7	10.4	7.9	8.2	20.5	8.6	7.9	9.0	22.2	9.7	7.8	12.7	7.5	9.5	8.9	21.7	13.7	29.7	11.4	15.5	18.4	14.4	12.0	14.4	15.7	22.8	24.6	9.8	6.3	7.8	16.3	17.1	15.3	6.9	8.2	12.1	8.8	26.5	11.6	10.0	14.6	15.0	42.2	8.0	22.6	13.4	22.1	20.4	34.9	15.0	16.9	20.8	10.4	15.1	16.5	27.6	13.3	11.0	3.2	22.4	12.9	5.9	7.5	8.4	15.1	6.4	9.8	11.2	13.5	26.7	12.5	9.1	11.1	17.0	16.4	17.2	10.1	16.8	18.3	22.3	19.0	7.3	18.3	12.0	12.9	16.8	7.9	26.4	18.3	8.6	17.2	19.6	19.8	21.4	9.0	18.8	20.6	18.7	32.0	18.4	8.1	18.8	22.2	13.7	21.5	22.2	22.5	26.9	21.6	22.4	21.1	21.4	21.6	20.5	22.2	21.7	2.0	0.0	1.1	2.9	5.0	3.8	0.7	2.5	8.0	1.5	2.2	1.4	0.1	1.5	0.8	3.7	2.1	4.2	1.9	2.8	3.9	1.5	5.5	1.0	1.0	2.0	1.2	4.8	5.9	1.2	3.4	3.3	5.6	0.7	4.5	1.0	1.1	1.0	1.9	1.7	5.6	0.7	2.0	3.1	4.4	5.8	4.1	3.2	5.4	0.0	2.6	1.0	3.1	3.5	4.3	2.8	2.8	3.4	7.3	0.7	9.8	3.2	1.3	2.4	6.6	1.5	3.0	9.2	2.3	6.4	5.4	11.5	5.6	1.0	1.3	0.3
LIN9	TGS	ENSG00000183814	"Lin-9 DREAM MuvB core complex component"	Q5TKA1	1	226231149-226309869	"Predicted intracellular proteins"	"Cell cycle, DNA synthesis"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.2;Spermatocytes: 36.3;Spermatogonia: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030241	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA030241: AB_10601542"	"unprognostic (9.90e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.51e-5)"	"unprognostic (2.80e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.26e-2)"	1.8	1.6	0.9	2.8	1.0	6.6	3.5	3.5	1.6	1.8	0.6	3.2	4.1	3.2	1.6	3.2	2.4	1.5	12.8	0.9	0.7	2.1	1.4	2.5	5.0	0.6	0.8	5.0	2.0	2.2	0.6	4.0	0.7	2.1	3.9	1.8	2.0	1.9	3.6	3.4	3.9	2.8	0.7	2.6	3.0	9.7	0.7	8.1	2.2	3.5	4.8	1.9	1.7	1.1	15.9	10.0	16.2	11.6	1.5	3.8	31.2	11.4	7.3	20.2	18.1	10.8	20.0	15.0	14.1	5.3	8.9	14.4	15.9	6.1	18.0	14.4	28.1	9.4	12.2	7.7	1.4	18.6	9.7	1.5	4.3	10.5	10.6	4.9	10.0	13.7	33.5	17.8	12.3	5.8	19.5	12.0	26.0	20.1	18.2	18.7	27.5	19.4	6.6	8.2	14.2	19.9	20.3	23.6	14.7	10.0	13.4	23.8	4.8	11.4	16.3	15.7	29.4	8.2	20.2	31.0	6.6	16.7	27.2	4.1	1.0	1.1	1.2	1.3	1.9	2.2	1.9	2.7	0.5	1.6	3.4	2.6	0.2	1.7	2.8	0.6	2.8	1.0	0.9	1.0	3.5	1.6	0.9	0.7	0.6	0.8	0.7	0.7	0.7	1.1	3.1	9.6	5.1	3.3	3.3	3.3	1.4	2.8	3.4	1.2	2.1	2.2	15.7	1.5	2.2	0.0	0.0	13.0	2.8	1.6	1.9	2.3	20.2	2.0	3.4	3.1	2.4	16.4	11.1	3.3	6.9	3.3	2.0	1.6	1.3	4.3	2.2	1.4	2.8	3.3	8.7	2.5	0.0	3.5	1.1	4.0	4.4	1.9	0.0	6.5	0.4	1.9	2.1	10.1	4.7	2.8	3.8	4.5	6.4	1.2	2.0	1.7	3.7	1.0	0.0	3.0	4.5	36.3	18.7	5.1	1.8	15.5	2.8	1.9	4.9	1.5
LINS1	"LINS, MRT27, WINS1"	ENSG00000140471	"Lines homolog 1"	Q8NG48	15	100559369-100603230	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038578, HPA038579"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA038578: AB_2676095, HPA038579: AB_10697393"	"unprognostic (9.87e-2)"	"unprognostic (3.32e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.28e-2)"	4.2	4.1	2.5	8.3	2.2	5.7	7.7	3.1	3.3	7.2	2.8	5.8	4.1	6.6	9.4	7.0	5.4	4.4	3.1	2.4	1.7	6.0	5.5	6.2	11.5	1.6	1.4	6.4	5.4	6.1	3.5	6.4	1.8	6.1	7.0	6.6	5.1	4.6	4.3	6.9	4.5	6.2	1.1	8.4	6.3	7.6	2.3	9.1	8.4	5.1	10.0	5.8	4.9	2.8	4.4	6.6	8.2	8.2	5.9	8.0	7.5	6.8	7.6	7.6	8.1	6.2	8.4	11.6	3.9	6.2	5.7	18.5	7.8	8.6	7.9	4.0	11.1	10.4	10.7	4.9	4.9	8.9	6.3	7.7	7.4	5.9	9.4	7.6	9.0	6.4	17.3	9.1	4.7	5.7	5.3	7.6	9.6	16.7	8.1	7.8	13.1	10.8	6.6	11.8	4.2	5.5	6.3	6.1	10.2	10.4	10.3	6.7	6.5	9.5	8.5	6.8	8.9	9.7	13.4	10.5	6.1	11.4	7.7	12.4	7.9	11.7	16.3	7.5	23.9	12.7	25.7	18.1	8.4	11.9	35.0	25.1	10.4	15.0	6.7	6.8	17.6	10.5	2.5	2.2	3.1	3.3	2.4	1.7	1.6	1.4	1.8	1.1	2.3	2.8	7.7	19.2	5.9	0.0	16.6	0.0	9.7	0.0	11.4	16.1	11.3	8.3	0.0	5.7	2.5	12.9	18.8	8.8	20.4	4.9	5.9	5.9	10.8	6.6	11.4	5.7	4.9	11.6	0.0	5.1	5.5	7.2	15.3	6.3	1.3	10.3	7.1	7.6	15.3	16.8	0.0	5.8	0.0	6.0	0.0	1.7	12.2	6.9	0.0	0.0	7.9	9.3	26.8	0.0	0.0	5.4	3.2	7.2	12.5	9.0	10.5	4.7	7.3	16.0	13.1	8.5	5.8	20.7	12.9	9.9	0.0	12.4	29.8	18.9	4.8	7.5
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 398.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 515.0;Kupffer cells: 714.8;Macrophages: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 167.3;intermediate monocyte: 355.1;myeloid DC: 123.6;non-classical monocyte: 198.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 123.6;monocytes: 355.1"	"Cell line enhanced"	"Detected in many"		"A-431: 354.4;AN3-CA: 367.8;ASC TERT1: 450.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		280000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	76.0	46.3	43.5	66.7	65.2	39.8	47.8	64.1	74.4	54.0	39.0	67.7	167.6	38.8	21.7	28.6	37.8	83.5	24.2	43.5	53.1	44.9	218.9	169.5	159.3	74.7	55.5	32.7	21.4	68.9	12.7	79.1	82.2	30.7	72.0	12.6	22.5	33.8	11.8	18.7	227.5	47.7	65.4	398.4	34.3	13.4	57.0	44.5	31.6	22.5	45.5	58.4	19.3	115.5	354.4	49.4	30.7	367.8	343.5	450.8	10.0	171.4	194.8	65.5	121.5	18.6	176.6	63.9	34.0	264.4	73.7	338.7	13.8	92.8	53.6	86.1	34.7	25.1	19.1	81.5	87.6	48.8	48.9	190.4	69.2	72.9	40.6	88.2	14.9	45.4	0.3	108.5	58.3	28.2	45.7	34.6	22.7	62.4	60.0	26.4	39.0	60.5	69.2	50.9	10.5	21.8	41.4	49.9	133.9	20.4	64.4	65.8	26.2	58.8	15.5	132.1	44.6	60.0	65.7	25.8	71.4	112.9	82.1	4.2	167.3	16.9	40.0	355.1	40.6	31.9	35.8	38.8	123.6	33.4	36.7	40.4	7.1	29.8	198.5	25.0	38.2	159.6	43.5	65.2	64.1	74.4	43.5	53.1	74.7	55.5	82.2	65.4	57.0	115.5	75.5	41.7	33.8	11.1	35.9	17.7	30.3	58.1	25.6	5.4	16.1	14.1	9.6	45.8	31.9	33.1	0.0	34.8	31.4	2.8	21.5	35.1	6.8	11.4	20.4	56.7	21.8	27.4	34.4	36.2	32.9	34.6	21.4	15.5	28.5	10.8	54.7	66.7	515.0	16.8	15.1	8.9	40.7	714.8	69.0	2.7	11.5	303.1	48.0	30.0	71.7	33.1	29.9	15.1	143.0	19.3	12.0	21.8	15.4	11.3	161.0	14.0	28.8	2.2	6.6	19.7	21.0	5.1	13.8	31.9	12.5	20.0	33.1	17.6	9.1	24.0
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 701.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 2578.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 2578.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	139.3	43.7	53.5	165.8	81.9	207.0	95.5	79.6	70.0	121.2	70.5	121.1	46.3	100.5	77.8	62.7	108.2	114.1	63.9	52.2	63.0	182.3	107.7	192.1	112.3	94.0	79.4	67.6	64.6	56.5	39.0	71.3	92.7	105.9	116.1	63.9	116.4	83.4	36.3	71.6	57.9	93.5	77.3	119.6	70.7	10.6	77.6	68.6	116.8	37.6	123.7	214.1	83.1	109.4	79.2	157.8	89.4	43.8	13.9	11.0	90.7	100.2	309.0	93.6	139.1	62.6	206.3	39.9	126.8	86.1	108.7	95.5	40.1	186.4	88.4	304.2	45.8	2.8	117.1	310.3	212.9	12.5	12.9	35.0	320.8	79.6	210.7	84.4	0.3	2.7	25.3	149.5	1.5	75.8	1.8	183.3	146.4	104.0	0.6	12.1	19.6	228.2	79.0	110.4	22.2	68.0	172.9	219.4	183.9	136.3	122.5	66.7	0.8	38.7	65.3	23.0	24.2	59.2	140.6	100.5	45.1	95.8	225.5	508.8	149.5	284.0	459.6	130.2	277.2	174.0	284.0	412.7	178.0	173.9	318.9	381.4	2578.1	274.5	81.9	220.1	350.3	584.9	53.5	81.9	79.6	70.0	52.2	63.0	94.0	79.4	92.7	77.3	77.6	109.4	297.5	44.8	70.0	7.5	176.7	157.4	336.2	365.4	68.3	2.2	180.5	157.6	48.8	148.7	222.2	163.7	0.0	56.4	505.5	305.4	485.2	245.8	2.3	112.2	151.9	76.3	17.5	18.3	1.1	72.9	471.9	156.7	39.8	108.1	214.9	1.1	94.2	52.9	227.8	0.0	1.6	153.1	175.0	156.9	701.0	11.3	56.2	422.0	156.5	7.5	391.8	232.7	433.5	11.6	59.5	123.3	236.1	68.4	186.3	239.8	23.3	104.3	150.3	5.4	52.6	89.6	176.1	0.2	5.4	37.1	132.1	37.1	278.7	16.6	88.9	368.6
LKAAEAR1	C20orf201	ENSG00000171695	"LKAAEAR motif containing 1"	Q8TD35	20	64083380-64084359	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 32.3"	"Group enriched"	"Detected in some"	14	"Early spermatids: 496.7;Late spermatids: 694.8"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 0.8;glioma: 1.2;ovarian cancer: 1.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 8.6;non-classical monocyte: 13.5"	"Lineage enriched"	"Detected in many"	13	"monocytes: 13.5"	"Group enriched"	"Detected in some"	4	"REH: 5.6;SCLC-21H: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA056463			Approved	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA056463: AB_2683139"	"unprognostic (5.47e-3)"	"unprognostic (1.18e-1)"		"unprognostic (1.20e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.78e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.16e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.30e-2)"	0.1	0.1	1.6	0.0	0.9	0.1	0.1	0.3	1.9	0.2	0.0	0.0	0.1	0.1	0.0	0.0	2.6	0.0	0.2	1.1	1.6	0.0	0.0	0.6	0.0	1.1	1.6	0.0	0.2	0.0	0.7	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.0	32.3	1.7	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.4	0.2	0.0	0.9	5.6	0.0	0.1	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.1	8.6	0.6	0.1	0.6	0.1	1.0	0.0	0.7	0.2	0.0	0.0	13.5	0.2	0.0	0.9	1.6	0.9	0.3	1.9	1.1	1.6	1.1	1.6	1.0	0.6	1.7	0.5	0.5	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	1.1	0.6	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	496.7	40.3	1.3	0.5	0.0	0.8	1.1	0.0	0.0	0.6	0.0	0.5	0.0	0.1	1.4	0.1	1.6	0.0	0.9	0.0	0.0	1.8	0.0	694.8	3.7	2.2	0.0	0.0	1.4	0.7	0.0	1.0	0.5	0.1	0.0	3.0	0.4	0.2	0.0	0.2	0.0	1.0	13.1	0.3	0.4	24.0	6.6	0.1	0.0	0.1	0.8	0.1	0.0	0.2
LMBRD2	DKFZp434H2226	ENSG00000164187	"LMBR1 domain containing 2"	Q68DH5	5	36098407-36151887	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 71.4;Inhibitory neurons: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012165	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA012165: AB_2136131"	"unprognostic (9.43e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.45e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.35e-2)"	4.6	6.6	4.8	5.0	7.2	1.7	6.1	3.6	9.5	4.7	2.2	6.3	7.0	3.4	4.9	4.7	3.2	4.1	6.0	9.0	4.1	7.2	10.3	4.1	5.9	2.1	3.8	3.2	5.0	10.7	4.7	6.1	2.6	6.6	6.3	6.9	6.0	4.4	5.5	5.5	7.1	3.8	3.7	5.1	7.3	3.8	4.7	5.9	9.0	8.6	5.4	4.2	2.9	5.2	5.5	4.0	4.8	7.9	9.7	8.5	16.8	11.1	5.8	8.0	8.0	5.0	11.7	9.8	5.5	5.9	8.2	7.3	6.4	3.9	13.1	14.1	3.9	7.6	13.6	0.9	6.2	9.3	9.7	5.1	6.7	6.9	6.8	6.0	4.4	7.4	9.1	10.0	9.8	3.6	8.0	6.1	2.6	8.5	5.0	6.0	11.1	6.0	6.8	4.7	8.9	6.9	16.1	9.4	3.9	4.7	10.7	11.1	5.9	9.5	2.5	12.3	6.0	8.2	12.8	8.5	9.0	10.4	6.7	10.6	0.8	1.4	1.0	0.8	0.7	1.0	0.9	0.9	0.7	0.8	1.2	1.2	0.6	0.7	0.8	0.8	1.6	0.5	4.8	7.2	3.6	9.5	9.0	4.1	2.1	3.8	2.6	3.7	4.7	5.2	8.8	9.6	9.8	33.3	10.2	6.9	4.8	6.3	7.4	11.9	10.8	6.1	24.1	12.8	7.3	12.9	8.4	9.0	7.5	19.4	3.9	5.0	2.1	6.8	6.4	7.3	6.7	9.0	71.4	7.6	6.6	10.3	15.8	6.5	7.0	7.3	9.3	30.2	11.8	15.2	51.1	12.6	8.2	11.0	6.0	1.4	4.7	8.7	7.2	14.0	9.7	14.3	6.2	36.2	37.8	6.0	6.5	7.2	11.9	6.3	13.0	12.3	12.0	11.2	13.1	10.5	9.7	27.5	10.0	9.7	10.1	19.4	10.0	7.2	12.0	4.0
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501807-8574668	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 573.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 287.6;Ductal cells: 122.0;Endothelial cells: 161.9;Pancreatic endocrine cells: 114.1;Smooth muscle cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"T-reg: 20.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 20.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 88.9;HSkMC: 124.9;hTEC/SVTERT24-B: 93.8;U-2197: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No		6600	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	131.4	14.3	9.5	45.6	9.5	0.1	97.5	13.5	10.8	27.2	38.8	18.1	9.0	90.3	18.4	36.1	57.8	67.2	90.6	14.0	9.7	33.0	9.7	131.7	17.3	14.0	11.0	65.8	37.7	30.0	8.7	54.5	12.1	34.8	7.0	15.2	42.2	16.8	573.4	28.8	20.1	63.3	13.2	55.6	46.4	11.3	12.6	4.7	18.5	260.9	10.2	110.6	31.5	14.8	9.4	52.0	8.6	6.6	62.0	34.6	8.9	37.9	19.4	20.5	50.0	38.8	11.5	0.0	4.2	44.2	8.8	0.8	4.9	9.9	8.4	16.0	3.6	11.6	3.5	7.6	88.9	0.0	1.1	124.9	0.2	93.8	0.7	11.9	10.1	0.0	0.0	0.0	26.8	6.7	0.0	0.1	16.8	12.0	2.3	0.2	28.2	0.1	19.1	3.6	0.3	21.3	6.4	31.1	20.6	23.9	40.7	0.1	5.0	20.4	40.3	83.0	25.9	5.1	6.2	2.6	4.1	2.9	27.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	2.9	0.6	3.3	0.3	0.0	0.1	0.0	0.0	0.0	1.0	20.5	0.3	9.5	9.5	13.5	10.8	14.0	9.7	14.0	11.0	12.1	13.2	12.6	14.8	287.6	9.6	10.7	2.0	2.1	31.6	42.1	7.4	9.6	13.0	20.4	17.0	14.7	14.3	13.5	5.5	10.4	3.9	1.7	1.4	3.9	122.0	1.1	9.6	77.7	161.9	12.1	0.0	0.8	48.5	4.2	64.5	7.1	4.8	10.2	44.2	30.7	12.6	3.4	97.6	1.2	2.4	4.1	0.8	47.0	2.3	11.5	3.2	53.4	29.0	9.0	38.9	1.0	4.0	8.7	114.1	0.9	32.4	8.0	8.4	0.3	45.5	12.0	8.0	0.0	57.0	112.9	6.4	9.1	29.0	27.1	4.4	5.3	21.5	4.7	7.5
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 14.7;fallopian tube: 17.0;testis: 14.8"	"Group enriched"	"Detected in some"	4	"Astrocytes: 15.0;Early spermatids: 49.0;Endometrial ciliated cells: 17.6;Late spermatids: 40.6;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.2;RT4: 7.7;SH-SY5Y: 7.6;U-2197: 26.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centrosome"		"HPA038640: AB_2676127"				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.1	4.0	0.7	5.8	0.3	0.9	6.1	3.9	0.5	3.7	3.6	1.4	0.7	0.6	0.3	17.0	0.8	0.2	5.2	6.0	0.7	0.2	1.3	0.3	12.5	14.7	0.2	0.5	0.0	0.7	0.2	8.3	0.2	3.4	1.2	0.0	0.2	0.2	0.4	0.6	1.1	8.8	0.6	0.6	14.8	5.8	0.2	0.9	0.0	0.2	0.3	0.0	9.8	0.4	0.3	0.0	0.2	0.2	1.6	2.7	3.3	6.2	1.4	0.2	0.0	0.4	0.2	0.1	0.0	3.9	0.1	0.3	0.1	0.3	1.1	0.1	1.1	0.9	2.3	0.3	0.1	0.1	0.5	0.2	1.8	0.5	0.1	0.1	0.0	2.3	0.4	0.0	0.5	0.0	0.4	1.8	0.1	0.6	0.5	0.2	0.2	0.2	7.7	0.2	7.6	0.1	0.4	4.3	0.9	0.3	1.8	0.3	0.2	1.0	26.8	0.3	0.8	1.6	1.8	0.3	1.8	2.9	0.5	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.2	0.1	0.5	0.2	0.3	0.5	0.1	0.0	0.5	0.1	0.1	4.0	5.8	6.1	3.9	5.2	6.0	12.5	14.7	8.3	8.8	5.8	9.8	0.1	0.0	0.0	15.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.3	0.6	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.9	0.0	49.0	17.6	0.1	0.1	0.0	0.0	1.5	0.0	0.3	0.3	0.0	0.2	0.0	0.7	0.0	0.4	0.1	0.0	1.0	0.0	0.0	0.3	0.0	40.6	0.0	0.3	0.0	5.6	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	14.6	0.0	0.0	0.7	0.1	1.1	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.9
LMO2	"RBTN2, RBTNL1, RHOM2, TTG2"	ENSG00000135363	"LIM domain only 2"	P25791	11	33858576-33892076	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.2;Endothelial cells: 144.6;Erythroid cells: 103.7;Hepatic stellate cells: 167.4;Kupffer cells: 65.0;Microglial cells: 64.6"	"Cancer enhanced"	"Detected in all"		"glioma: 30.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.9;granulocytes: 1.5;monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HEL: 71.8;HL-60: 72.7;K-562: 60.9;NB-4: 27.3;THP-1: 81.6;U-937: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016258, HPA029285, HPA070901, HPA070910"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: "	"unprognostic (1.60e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.73e-3)"	"unprognostic (8.95e-2)"	"unprognostic (5.76e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	15.0	5.9	14.9	11.4	13.0	27.7	12.5	14.2	16.6	8.4	13.4	5.0	4.6	6.5	0.7	6.8	8.3	5.4	4.4	14.7	16.0	13.1	2.3	18.2	19.4	19.9	16.3	3.5	2.6	2.3	8.6	6.5	18.5	5.7	1.5	0.6	5.3	2.4	23.4	4.9	6.6	4.8	18.7	19.0	3.9	1.7	19.0	1.8	12.3	4.6	8.4	5.8	7.3	13.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	2.2	1.3	12.8	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.4	71.8	0.0	0.0	0.3	72.7	18.5	0.0	0.0	0.0	0.0	0.0	10.2	0.0	60.9	0.0	0.0	0.3	5.1	27.3	0.9	0.0	0.0	15.3	0.8	0.2	0.0	0.8	4.3	0.0	0.3	0.5	0.1	0.2	0.0	81.6	0.9	0.0	0.2	1.7	0.0	0.0	0.2	0.6	4.7	29.2	0.3	0.6	0.5	1.5	0.0	1.4	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.7	0.0	1.7	0.1	0.0	0.2	14.9	13.0	14.2	16.6	14.7	16.0	19.9	16.3	18.5	18.7	19.0	13.3	109.2	3.2	7.1	8.5	6.6	8.4	7.9	8.0	0.6	1.6	2.8	9.5	2.8	8.6	1.7	5.5	2.1	0.4	1.0	0.8	0.0	3.0	0.5	40.5	11.0	144.6	0.0	103.7	1.3	2.0	3.2	9.8	0.0	39.6	7.6	0.9	167.4	1.7	39.1	0.0	3.8	0.2	2.0	65.0	56.8	1.2	4.1	54.1	10.6	64.6	47.5	1.1	4.1	5.0	1.0	1.0	1.9	0.0	3.0	5.4	0.0	8.8	5.0	2.6	0.0	17.3	3.6	0.3	7.9	0.8	6.0	21.5	1.9	12.4	0.5	25.1
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328880-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial stromal cells: 508.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 586.8;T-47d: 373.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572"	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.70e-1)"	49.0	16.3	102.1	28.6	116.5	21.9	34.7	79.8	173.7	51.7	70.8	44.7	26.7	43.2	39.4	50.9	32.4	45.5	42.2	117.4	82.9	42.7	33.3	38.2	29.5	82.1	78.9	39.6	25.5	22.9	31.6	63.9	80.1	56.4	31.6	34.5	87.4	81.0	47.6	39.7	43.1	30.3	79.4	38.7	90.7	28.0	83.2	23.5	33.8	25.5	87.8	38.8	54.0	100.6	55.1	42.3	32.3	586.8	96.6	113.9	81.8	48.4	38.3	44.9	49.8	104.3	34.0	127.5	60.3	57.2	72.4	44.7	13.1	33.8	44.5	68.6	32.4	116.5	87.2	32.3	92.9	63.6	151.2	60.2	76.4	70.0	39.8	80.9	30.8	48.7	26.8	109.8	24.5	22.3	1.8	41.3	118.1	58.6	39.3	72.8	45.0	28.5	56.1	206.7	26.5	1.7	195.3	28.7	149.6	61.1	373.3	171.8	20.1	208.9	39.0	50.6	161.7	99.7	70.6	28.8	26.1	13.8	30.7	30.5	9.1	19.5	7.8	11.6	9.0	10.1	6.9	8.0	6.9	6.9	1.8	4.4	15.0	22.4	11.5	10.3	2.1	5.1	102.1	116.5	79.8	173.7	117.4	82.9	82.1	78.9	80.1	79.4	83.2	100.6	103.5	44.8	24.1	50.9	88.6	98.4	49.3	105.6	245.3	226.2	170.0	191.5	72.4	153.0	78.1	36.8	73.0	322.8	116.5	50.0	62.6	74.2	2.1	106.5	508.1	65.6	31.1	48.1	204.4	127.6	363.3	149.0	159.6	131.5	307.4	19.5	78.1	85.7	74.0	111.0	37.5	80.6	14.2	138.4	73.2	7.5	95.1	76.1	65.8	22.5	74.6	82.7	83.4	52.8	25.8	107.2	29.9	235.5	174.6	49.3	90.3	56.8	31.0	35.9	32.9	80.6	175.5	4.4	97.9	200.3	92.9	256.0	77.9	61.7	64.9	37.5
LMTK3	"KIAA1883, LMR3, PPP1R101, TYKLM3"	ENSG00000142235	"Lemur tyrosine kinase 3"	Q96Q04	19	48485271-48513935	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 44.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 41.4;Excitatory neurons: 37.0;Inhibitory neurons: 38.8;Urothelial cells: 49.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 9.4;SK-BR-3: 16.4;U-266/70: 9.8;U-266/84: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040203, HPA077070"	Enhanced	Supported	Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Cell Junctions"	"HPA040203: AB_10671690, HPA077070: AB_2732330"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.11e-2)"	0.0	1.7	23.1	0.7	27.5	0.4	0.7	6.1	44.0	0.6	0.0	0.2	3.7	0.1	1.1	0.6	0.3	0.4	0.3	31.7	6.7	1.1	0.0	1.3	1.1	9.9	1.2	0.1	0.8	3.6	5.7	0.6	1.5	1.5	0.0	2.7	2.6	1.1	0.0	0.8	1.9	0.0	0.7	0.6	1.2	0.2	8.4	0.4	0.8	0.0	0.8	0.2	0.0	21.8	6.0	4.4	0.5	0.5	0.0	0.0	5.1	0.1	0.4	0.0	0.2	3.7	5.2	1.6	1.5	0.0	1.4	3.0	0.8	1.9	0.0	0.7	2.8	0.2	2.5	0.9	0.0	0.0	9.4	0.1	1.1	0.3	0.0	2.0	0.0	5.0	1.6	3.6	0.0	7.9	1.1	4.1	1.2	3.4	1.5	4.8	0.0	2.1	1.7	1.2	1.5	2.9	0.2	16.4	0.9	1.2	5.6	0.2	0.1	0.0	1.5	0.1	0.0	9.8	9.3	1.9	0.3	4.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	23.1	27.5	6.1	44.0	31.7	6.7	9.9	1.2	1.5	0.7	8.4	21.8	0.3	3.2	1.7	11.8	2.1	0.5	13.1	17.0	2.8	15.9	20.5	6.2	2.7	2.8	41.4	7.3	0.0	4.9	0.6	0.4	25.4	21.5	0.1	8.4	0.6	0.5	0.0	0.0	37.0	0.4	2.8	0.9	6.6	8.1	0.0	0.6	1.4	0.4	1.3	18.5	38.8	1.2	8.2	0.6	0.9	0.2	0.6	0.4	3.6	1.9	0.2	6.9	0.0	26.2	9.6	17.2	0.1	0.0	14.5	18.8	3.0	0.6	25.9	2.2	0.0	0.4	3.3	4.0	3.3	7.1	1.8	6.8	1.3	2.9	1.5	49.5
LMX1A	"LMX1, LMX1.1"	ENSG00000162761	"LIM homeobox transcription factor 1 alpha"	Q8TE12	1	165201867-165356715	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"choroid plexus: 20.4"	"Group enriched"	"Detected in some"	16	"Early spermatids: 30.6;Enteroendocrine cells: 41.9;Late spermatids: 23.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA028051, HPA030088"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA028051: AB_10599731, HPA030088: AB_10601106"	"unprognostic (1.73e-1)"		"unprognostic (9.57e-2)"	"unprognostic (7.58e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.82e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.22e-2)"			"unprognostic (2.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.82e-3)"		0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.3	20.4	0.3	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	1.3	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	1.3	2.5	0.0	0.1	1.0	0.0	0.2	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.7	1.3	0.2	2.1	0.5	0.0	2.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.6	0.2	0.0	0.1	41.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	23.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126613928-126701032	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;salivary gland: 18.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.3;Breast myoepithelial cells: 7.2;Cardiomyocytes: 1.9;Early spermatids: 1.6;Spermatogonia: 2.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HEK 293: 3.6;MCF7: 11.9;OE19: 10.4;T-47d: 8.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.3"	"Region enhanced"	"Detected in many"		"midbrain: 5.0"	"HPA073716, HPA075656"			Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA073716: AB_2686630, HPA075656: "	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	0.6	0.0	0.1	0.0	0.1	0.1	4.1	0.1	5.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	1.0	3.6	0.0	0.1	0.0	3.8	9.2	0.0	0.2	1.1	0.2	0.0	3.3	0.0	0.0	0.0	18.5	0.0	0.1	2.1	0.1	0.0	6.8	0.0	0.1	1.4	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.2	0.6	0.3	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.3	0.0	2.5	0.6	3.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	10.4	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.2	0.1	8.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.6	1.0	1.0	3.8	9.2	3.3	6.8	2.6	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.6	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LNPK	"KIAA1715, LNP, LNP1, Ul"	ENSG00000144320	"Lunapark, ER junction formation factor"	Q9C0E8	2	175923882-176002839	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 19.3;Endometrial stromal cells: 24.6;Hofbauer cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 159.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014205	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		15000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"	Nucleoplasm	"HPA014205: AB_2234186"	"unprognostic (4.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.43e-2)"	13.5	8.9	6.3	7.7	10.1	30.1	9.8	10.2	8.7	12.0	4.2	12.0	7.6	8.6	6.2	13.1	6.3	7.7	12.2	7.6	13.2	8.2	14.4	6.7	7.2	11.3	9.2	10.7	5.5	15.6	6.0	6.1	14.1	10.1	10.2	24.1	6.4	8.2	34.1	12.1	7.5	9.6	11.3	5.9	7.8	24.5	9.3	14.0	8.8	26.8	7.9	7.6	9.2	19.0	24.5	12.3	28.3	40.1	58.5	36.1	14.3	70.8	33.7	32.2	45.1	17.0	28.2	24.4	39.4	31.5	42.3	26.5	26.9	18.9	44.6	37.5	27.4	27.6	14.8	15.2	13.8	47.2	32.9	29.9	17.5	31.4	15.4	26.4	6.0	19.3	28.9	31.5	44.9	16.0	31.4	18.8	9.2	24.9	23.4	31.3	28.6	18.0	13.6	22.2	32.6	32.9	31.3	17.5	24.1	26.6	26.2	15.4	9.2	159.0	23.6	53.9	33.7	18.5	36.6	20.3	49.4	15.2	30.4	3.7	4.2	7.9	4.9	4.8	5.8	4.3	4.2	5.4	3.9	3.3	4.2	6.7	3.4	6.5	4.5	4.4	7.8	3.4	6.3	10.1	10.2	8.7	7.6	13.2	11.3	9.2	14.1	11.3	9.3	19.0	10.8	19.2	13.6	0.0	4.4	0.0	0.0	0.0	0.0	0.0	19.3	15.0	0.0	0.0	6.2	16.5	0.0	5.7	14.5	0.0	5.9	14.0	0.0	10.1	24.6	3.5	0.0	0.0	0.0	9.6	17.3	12.8	0.0	12.7	11.4	10.6	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.3	0.0	0.0	9.1	8.7	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	8.3	7.2	12.0	0.0	0.0
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 196.2"	"Cell type enhanced"	"Detected in all"		"Theca cells: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No		7900	"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	30.4	196.2	31.5	22.2	32.7	23.7	27.2	34.6	42.8	24.4	39.9	27.9	22.6	25.2	14.1	27.7	22.6	15.4	76.0	30.8	35.7	43.2	79.1	25.6	24.1	37.6	35.8	26.6	38.2	35.2	41.5	18.5	37.9	26.4	13.2	13.0	30.8	16.6	69.3	28.9	25.5	14.7	30.8	29.5	33.7	24.2	37.2	17.5	34.6	40.7	14.5	28.2	22.4	33.0	108.4	111.0	35.6	114.0	41.4	29.2	110.4	67.2	52.7	71.0	86.0	96.3	37.7	134.3	91.4	70.6	68.0	45.0	92.1	81.1	34.2	80.0	78.0	74.5	97.5	127.6	190.4	169.7	74.9	55.0	114.6	67.5	132.6	34.1	57.5	183.9	200.9	259.4	33.0	71.8	85.5	101.6	127.6	43.6	143.1	89.4	50.9	146.6	39.3	63.9	94.2	94.1	59.4	85.2	242.2	24.9	50.3	211.9	41.2	36.0	39.2	100.7	99.2	272.3	182.6	121.4	161.7	185.0	66.2	4.5	2.4	0.5	3.4	3.7	2.3	4.0	3.1	3.4	2.6	3.7	3.8	2.6	0.3	2.7	1.5	3.9	2.7	1.7	31.5	32.7	34.6	42.8	30.8	35.7	37.6	35.8	37.9	30.8	37.2	33.0	12.6	6.4	13.1	18.3	14.1	8.3	11.1	14.9	11.4	26.9	14.2	12.7	19.8	15.7	14.3	27.6	6.2	28.8	8.4	40.1	46.9	33.9	6.5	24.0	16.3	15.3	11.4	17.1	13.5	28.0	31.9	13.3	29.6	25.6	5.7	51.1	11.4	47.0	30.8	21.9	17.4	26.4	22.4	14.6	8.6	6.3	12.8	16.4	14.2	9.4	17.8	24.9	8.2	10.6	15.7	26.0	16.8	17.3	17.6	16.8	27.5	50.2	17.0	26.5	19.7	17.9	24.7	12.0	14.4	11.0	10.7	35.0	10.7	85.0	35.1	11.4
LONRF2	"FLJ45273, RNF192"	ENSG00000170500	"LON peptidase N-terminal domain and ring finger 2"	Q1L5Z9	2	100271875-100322501	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 42.2;fallopian tube: 45.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.6;Excitatory neurons: 166.8;Horizontal cells: 111.0;Inhibitory neurons: 126.2;Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 15.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;GAMG: 7.3;HAP1: 5.8;HEK 293: 6.2;HMC-1: 5.1;PC-3: 5.3;SCLC-21H: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034595, HPA057366"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA034595: , HPA057366: AB_2683420"	"unprognostic (9.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.72e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.86e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.42e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.66e-3)"	"unprognostic (6.34e-2)"	3.2	31.9	20.1	0.5	20.0	0.1	3.2	7.6	25.5	11.6	5.8	5.6	0.5	26.4	42.2	2.6	45.6	2.3	6.4	26.7	40.4	2.2	1.0	1.8	0.5	2.6	3.3	24.3	6.3	9.6	18.0	0.7	9.9	4.1	0.7	11.2	2.4	4.0	7.1	1.1	1.6	28.2	0.2	0.8	4.6	2.2	27.4	0.4	4.9	4.1	0.3	4.2	3.7	9.9	0.0	6.0	1.8	2.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	1.1	0.0	1.0	0.0	7.3	0.0	5.8	0.0	0.0	0.5	6.2	0.0	0.4	0.0	0.2	0.1	5.1	0.0	0.0	0.2	0.0	0.4	0.0	1.6	3.5	0.1	0.0	4.0	0.0	0.3	0.3	1.1	5.3	0.0	0.0	0.0	1.4	0.2	12.5	3.4	0.0	0.0	0.8	1.9	3.2	0.0	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	20.1	20.0	7.6	25.5	26.7	40.4	2.6	3.3	9.9	0.2	27.4	9.9	0.5	0.0	11.7	52.5	0.5	0.8	1.4	0.0	1.2	72.6	5.1	2.3	37.4	8.6	3.1	5.5	31.3	2.3	0.1	0.3	5.9	3.7	0.6	22.5	43.6	1.8	11.4	2.7	166.8	2.2	0.2	12.7	4.1	37.1	5.7	25.8	0.0	0.6	0.4	111.0	126.2	0.5	0.0	0.0	1.2	2.3	3.4	0.6	1.8	7.5	0.0	8.4	0.0	58.3	38.7	1.5	0.1	11.7	0.1	4.9	0.0	0.3	3.4	20.6	6.6	3.3	5.3	0.8	0.6	0.8	0.1	2.9	1.6	0.9	0.4	0.4
LONRF3	"FLJ22612, RNF127"	ENSG00000175556	"LON peptidase N-terminal domain and ring finger 3"	Q496Y0	X	118974614-119018355	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 16.9;Gastric mucus-secreting cells: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 12.2;K-562: 13.8;OE19: 15.2;PC-3: 16.0;SiHa: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050422, HPA061162"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA050422: AB_2681122, HPA061162: AB_2732658"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (4.32e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.31e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-3)"	3.3	3.3	1.2	1.9	1.1	4.5	1.4	6.6	2.8	1.5	0.0	3.5	2.3	1.9	1.2	1.4	2.0	2.4	2.3	3.3	1.0	2.8	12.7	6.4	0.8	0.9	1.9	1.6	7.0	0.7	0.9	0.8	1.0	1.9	4.3	2.8	4.8	2.4	8.8	0.7	2.0	1.5	1.5	0.6	4.0	1.7	2.0	0.3	8.2	3.9	1.0	3.6	0.7	1.1	5.0	6.9	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	6.0	0.0	3.5	0.0	12.2	0.0	1.3	0.0	0.1	0.1	3.7	6.6	11.8	6.9	3.7	5.7	0.7	0.0	0.0	0.0	0.0	2.1	1.7	0.5	13.8	0.0	0.9	5.5	0.0	2.3	0.0	15.2	16.0	0.0	3.1	0.0	4.2	2.1	0.2	0.0	14.5	0.4	11.8	0.1	0.0	4.5	0.3	0.1	0.2	0.0	7.9	1.4	6.3	0.0	3.2	5.4	3.4	0.0	0.4	0.0	2.4	0.0	3.8	0.0	1.1	0.8	0.0	0.0	0.5	0.8	0.5	0.0	0.0	0.0	0.4	0.3	1.2	1.1	6.6	2.8	3.3	1.0	0.9	1.9	1.0	1.5	2.0	1.1	2.2	6.4	13.4	7.8	0.4	1.5	16.9	0.2	1.8	3.3	0.8	1.9	4.4	0.0	6.1	1.8	0.0	0.5	5.3	11.2	1.9	3.0	1.6	4.4	6.4	3.3	1.2	0.4	1.8	4.3	0.0	8.0	17.3	13.0	6.3	0.1	2.2	4.1	2.7	1.7	6.0	4.6	0.0	4.7	7.7	1.0	0.9	9.5	3.6	9.4	0.5	3.7	2.1	3.5	0.2	5.2	8.8	1.5	1.3	7.2	1.6	1.5	0.3	0.3	0.0	9.9	2.0	2.4	4.6	1.6	0.1	0.4	2.7	0.2	3.7	12.5
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23296897-23425328	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 41.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 26.9;Endometrial stromal cells: 26.9;Endothelial cells: 33.1;Extravillous trophoblasts: 22.0;Fibroblasts: 22.9;Hepatic stellate cells: 19.6;Sertoli cells: 26.3;Smooth muscle cells: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 935.5;BJ hTERT+ SV40 Large T+ RasG12V: 517.3;fHDF/TERT166: 602.7;TIME: 510.7;U-87 MG: 905.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	30.4	3.3	1.9	15.9	2.7	1.2	18.8	4.7	3.0	10.6	0.8	25.3	9.3	12.0	0.9	3.8	4.9	8.0	10.7	1.8	3.2	6.1	3.9	8.3	11.7	7.7	8.1	12.9	6.5	2.5	2.6	36.2	7.0	7.5	5.4	3.0	4.1	13.0	4.5	5.4	10.3	41.3	4.5	5.0	9.0	2.3	4.5	1.8	5.2	2.6	9.5	12.0	7.3	3.7	58.2	147.7	42.7	35.8	112.4	183.8	19.4	935.5	295.9	415.6	517.3	1.1	4.4	10.7	7.5	602.7	193.2	47.6	2.1	79.0	215.3	1.8	8.5	0.9	19.4	1.0	226.8	0.5	3.8	164.6	3.9	155.0	20.8	274.0	350.7	2.4	0.5	2.0	138.1	32.3	0.6	1.4	29.1	0.4	24.5	1.9	36.7	0.4	120.1	0.3	0.9	13.7	122.9	6.1	8.6	131.3	0.8	1.2	510.7	384.6	103.3	163.8	127.3	4.1	0.8	29.9	905.4	1.4	413.5	0.1	0.2	0.8	0.4	0.1	0.2	0.4	0.1	0.3	0.1	0.1	0.2	0.6	0.3	0.1	0.2	0.2	0.1	0.2	1.9	2.7	4.7	3.0	1.8	3.2	7.7	8.1	7.0	4.5	4.5	3.7	12.9	0.0	3.0	6.8	0.6	2.5	0.3	26.9	0.6	1.5	0.6	9.7	2.6	1.5	4.1	0.0	0.0	2.7	0.4	0.0	0.0	1.9	0.6	1.7	26.9	33.1	0.0	0.0	8.1	1.5	22.0	22.9	1.5	2.1	0.0	2.0	19.6	0.2	1.3	1.7	3.2	0.1	0.0	0.3	5.7	0.4	0.9	0.9	3.6	6.5	0.0	1.2	0.0	7.1	11.9	2.3	0.1	0.4	0.9	0.6	0.2	0.2	1.6	3.2	26.3	2.7	48.1	1.3	1.6	0.5	3.1	1.0	1.0	3.1	0.4	0.2
LRATD1	"FAM84A, FLJ35392, NSE1"	ENSG00000162981	"LRAT domain containing 1"	Q96KN4	2	14632700-14650814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.2;intestine: 41.0"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 162.2;Syncytiotrophoblasts: 207.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 35.0"	"Group enriched"	"Detected in many"	7	"amygdala: 19.7;basal ganglia: 10.8;cerebral cortex: 18.1;hippocampal formation: 13.0;white matter: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.4;hTCEpi: 18.0;RT4: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047703	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA047703: AB_2680123"	"unprognostic (1.05e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.36e-1)"	0.5	1.4	19.7	4.9	10.8	0.0	2.4	0.0	18.1	10.6	0.0	41.0	26.3	2.7	32.2	28.6	2.9	3.4	2.1	13.0	2.0	4.0	1.4	3.0	0.2	0.0	0.2	8.2	3.2	5.2	3.3	5.3	0.0	13.6	36.2	0.9	13.9	2.0	0.9	18.5	25.3	2.8	0.0	0.2	3.0	12.3	1.4	1.3	2.2	0.1	1.4	14.8	16.6	6.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	2.5	0.6	0.5	0.0	0.3	0.0	0.0	0.3	0.0	9.4	1.0	4.2	1.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	18.0	0.0	5.9	0.2	0.0	0.0	0.0	0.0	1.3	7.8	0.0	0.2	0.8	0.0	4.0	0.0	0.0	0.1	6.9	49.3	4.3	2.0	0.0	1.8	0.0	0.3	0.0	0.0	2.9	8.2	0.7	0.0	3.2	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	10.8	0.0	18.1	13.0	2.0	0.0	0.2	0.0	0.0	1.4	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	162.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	22.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	207.8	0.0	0.0	0.0	0.0
LRATD2	"BCMP101, FAM84B, NSE2"	ENSG00000168672	"LRAT domain containing 2"	Q96KN1	8	126552443-126558478	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 43.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.9;Cardiomyocytes: 6.8;Cytotrophoblasts: 5.4;Endothelial cells: 4.0;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 78.5;AN3-CA: 104.6;MCF7: 112.1;PC-3: 72.5;SuSa: 162.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050782, HPA062115"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA050782: AB_2681235, HPA062115: AB_2684686"	"unprognostic (2.46e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (2.75e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.07e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (2.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.75e-5)"	6.1	2.5	6.1	3.2	7.1	3.0	16.3	7.1	5.2	7.3	25.4	7.6	13.1	7.3	6.8	19.5	8.3	8.1	4.0	5.2	7.1	27.3	8.2	12.0	3.8	8.9	7.5	2.9	16.3	9.2	4.5	7.5	6.9	8.3	8.2	19.1	43.7	6.8	2.5	7.2	7.4	4.6	7.0	3.2	17.6	2.1	5.8	3.2	7.4	5.2	6.3	6.4	5.8	12.6	78.5	9.8	5.8	104.6	0.0	0.0	6.9	1.1	2.7	0.8	1.2	3.0	44.9	0.0	48.5	0.2	8.4	34.3	3.1	14.7	1.3	0.1	63.0	0.0	0.2	0.5	1.4	0.1	1.6	0.6	20.3	0.0	9.0	17.6	6.3	19.7	0.1	0.0	0.5	112.1	2.6	0.0	5.3	65.7	72.5	0.0	2.3	0.8	41.8	32.5	29.7	0.0	2.4	34.9	32.4	162.9	52.0	0.7	0.0	0.3	9.4	0.1	2.0	1.3	0.2	0.1	0.9	5.0	19.6	1.7	0.0	1.5	1.4	0.0	1.4	0.3	1.8	2.7	0.0	0.8	2.0	2.1	0.1	1.1	0.0	0.0	2.6	0.9	6.1	7.1	7.1	5.2	5.2	7.1	8.9	7.5	6.9	7.0	5.8	12.6	20.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	5.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	1.5	0.0	0.0	0.0
LRCH4	"LRN, LRRN1"	ENSG00000077454	"Leucine rich repeats and calponin homology domain containing 4"	O75427	7	100574011-100586129	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 205.8;Syncytiotrophoblasts: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 79.6;NB-4: 174.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037667, HPA037668"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA037667: AB_10671882, HPA037668: AB_10672910"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.32e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.98e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.63e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.26e-2)"	29.0	37.5	15.8	25.3	18.3	49.2	26.8	16.8	26.1	32.5	17.0	32.7	19.1	28.3	5.1	35.8	33.7	8.5	28.0	15.5	17.7	35.5	30.9	52.0	33.6	21.4	17.1	55.3	33.5	12.7	51.2	10.9	20.5	36.1	5.5	21.4	36.3	8.8	41.4	30.3	71.6	5.3	16.0	130.1	31.2	112.3	20.3	27.1	47.8	7.2	14.7	24.3	29.9	23.1	15.2	9.8	8.5	9.2	6.5	4.3	17.3	14.5	7.3	9.0	7.1	16.6	24.7	9.9	17.0	3.6	10.7	15.9	5.5	7.0	3.0	10.5	12.2	9.8	12.0	8.1	18.4	18.0	79.6	8.0	7.5	7.6	5.5	7.6	10.3	27.6	18.5	18.7	6.6	32.2	21.2	174.5	11.5	20.5	11.2	25.6	7.1	13.9	10.3	4.2	12.5	18.6	7.8	25.6	20.2	16.2	13.6	40.5	14.4	12.2	23.6	15.2	9.1	23.3	9.9	9.9	9.1	51.6	22.3	22.5	10.6	14.6	5.8	8.4	5.5	6.1	5.9	6.8	7.0	6.6	7.9	6.9	30.6	1.6	5.9	7.7	6.3	3.7	15.8	18.3	16.8	26.1	15.5	17.7	21.4	17.1	20.5	16.0	20.3	23.1	7.5	9.6	12.7	7.5	29.4	12.0	15.4	13.0	5.7	15.9	14.8	8.4	0.8	27.1	15.1	22.0	41.7	39.4	42.9	27.2	15.6	32.7	205.8	11.9	7.7	9.9	6.1	12.2	7.3	24.7	13.9	9.1	14.8	13.5	19.6	12.7	15.4	13.8	32.8	13.5	7.9	11.8	20.3	65.9	33.6	32.3	24.8	40.5	14.2	3.7	66.1	13.6	46.4	4.5	5.2	28.9	13.1	10.1	15.7	12.8	41.9	6.9	12.1	33.5	19.7	9.8	13.3	58.3	33.9	9.0	11.5	103.3	33.7	12.0	10.0	16.4
LRIF1	"C1orf103, FLJ11269, RIF1"	ENSG00000121931	"Ligand dependent nuclear receptor interacting factor 1"	Q5T3J3	1	110947190-110963965	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044515	Uncertain		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Centriolar satellite"	"HPA044515: AB_10796800"	"unprognostic (5.06e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.74e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.14e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.70e-1)"	6.6	9.4	8.7	10.3	9.1	5.5	11.4	10.7	18.5	6.2	8.5	6.5	6.0	6.8	19.8	5.6	8.1	5.0	14.5	9.2	10.3	7.9	13.2	6.8	16.0	8.4	8.7	15.5	6.1	6.5	7.7	10.0	8.7	8.2	6.4	21.5	7.2	5.4	18.2	9.3	6.0	4.7	8.7	13.0	7.1	25.7	9.5	13.3	10.9	17.3	17.4	7.6	4.5	10.0	33.2	14.4	26.8	18.4	12.3	19.8	30.2	19.9	22.7	33.8	27.2	36.4	40.4	25.2	27.5	15.1	36.5	21.0	12.9	12.0	40.6	45.9	15.2	27.9	14.3	37.4	35.8	52.7	32.5	12.5	32.3	23.5	41.0	14.4	18.6	26.4	88.3	111.5	23.2	11.1	5.4	41.4	40.0	20.1	32.6	35.0	43.4	30.5	8.8	17.0	22.3	24.4	0.1	33.8	59.1	16.3	28.0	83.6	13.5	30.0	1.0	35.4	16.3	51.7	19.4	46.9	17.1	59.2	53.6	24.8	8.3	18.6	21.0	9.4	26.6	29.9	16.6	22.1	16.8	22.7	18.1	24.8	31.4	28.2	13.0	15.0	16.9	12.8	8.7	9.1	10.7	18.5	9.2	10.3	8.4	8.7	8.7	8.7	9.5	10.0	22.5	12.8	8.4	11.8	39.4	14.4	48.4	21.0	19.9	22.4	27.9	35.1	27.8	8.6	17.0	9.2	18.8	19.5	21.9	15.5	15.6	18.8	15.3	15.9	15.2	21.5	11.3	24.8	17.9	19.9	32.3	16.5	23.0	18.5	8.2	11.2	17.5	31.8	13.9	15.2	16.5	13.2	18.3	10.7	53.1	11.4	15.8	23.2	32.0	3.7	20.1	28.6	49.4	4.0	16.1	23.4	12.9	13.9	28.4	56.8	10.0	11.8	22.3	35.1	13.1	20.0	19.0	49.9	54.8	25.1	17.6	37.8	31.5	21.4	11.3	50.9
LRIG2	KIAA0806	ENSG00000198799	"Leucine rich repeats and immunoglobulin like domains 2"	O94898	1	113073198-113132260	"Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015538	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		2100000	"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA015538: AB_2250170"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	2.6	2.2	3.1	2.1	4.6	1.0	2.7	4.7	3.4	3.2	3.2	2.9	2.8	3.1	3.8	2.3	2.5	1.4	2.4	2.8	3.6	2.2	2.0	2.0	2.6	4.2	3.8	3.8	2.6	2.9	2.9	2.4	3.9	2.5	2.1	6.4	2.4	2.2	3.9	4.5	3.0	1.7	3.8	3.0	2.3	1.7	3.9	2.9	3.4	2.1	2.4	2.5	2.7	6.8	2.6	1.3	3.8	2.9	3.6	3.6	2.1	1.6	2.4	1.9	3.2	2.0	1.6	2.6	2.8	2.0	1.1	2.8	2.6	1.7	3.2	1.8	1.5	2.8	2.9	1.0	3.6	3.4	1.3	3.6	3.1	3.0	4.0	2.9	2.5	3.6	3.4	2.4	2.4	1.9	3.5	3.5	3.5	1.0	2.3	3.1	4.8	1.3	1.9	1.7	2.6	2.1	2.8	1.8	3.6	3.1	1.4	3.8	3.9	3.5	1.9	4.9	2.6	2.6	1.3	2.6	3.8	2.1	3.3	1.9	0.7	0.5	0.8	0.6	1.0	0.9	1.0	0.9	0.6	1.4	1.1	1.0	0.4	1.4	0.7	0.7	0.8	0.5	3.1	4.6	4.7	3.4	2.8	3.6	4.2	3.8	3.9	3.8	3.9	6.8	9.4	0.0	15.5	14.4	12.7	8.4	3.1	5.7	8.0	21.0	7.0	7.2	11.6	7.2	7.1	14.7	37.5	7.8	14.6	13.5	0.0	3.2	1.3	6.9	14.6	9.4	5.4	5.5	22.9	2.6	5.1	10.2	13.7	8.0	5.7	22.0	6.1	5.4	4.8	18.5	23.8	8.7	0.0	8.2	5.6	0.9	18.3	6.4	7.2	19.7	11.9	20.6	17.5	25.1	40.9	3.3	7.5	16.1	7.8	5.5	8.9	4.4	10.8	23.4	0.0	12.6	8.2	11.1	16.1	5.5	6.7	5.3	10.3	20.4	9.8	3.3
LRIT3	"CSNB1F, FIGLER4, FLJ44691"	ENSG00000183423	"Leucine rich repeat, Ig-like and transmembrane domains 3"	Q3SXY7	4	109848107-109872315	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"retina: 17.6"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 33.3;Muller glia cells: 10.2;Rod photoreceptor cells: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013454	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA013454: AB_1853277"	"unprognostic (5.41e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.14e-2)"	0.2	0.2	0.4	0.0	0.5	0.1	0.3	0.3	0.6	0.4	0.2	0.2	0.0	0.2	0.3	0.2	0.3	0.0	0.1	0.4	0.2	0.7	0.3	0.2	0.1	0.3	0.3	0.2	0.3	0.0	0.2	0.0	0.4	0.3	0.0	17.6	0.2	0.1	0.3	0.6	0.2	0.0	0.2	0.3	0.2	0.5	0.3	0.1	0.3	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.6	0.4	0.2	0.3	0.3	0.4	0.2	0.3	0.5	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	33.3	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	10.2	0.0	0.5	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
LRMDA	"C10orf11, CDA017, OCA7"	ENSG00000148655	"Leucine rich melanocyte differentiation associated"	Q9H2I8	10	75431624-76560168	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		Albinism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 61.5;epididymis: 59.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 42.4;Distal tubular cells: 33.2;Endometrial ciliated cells: 27.8;Hofbauer cells: 56.9;Proximal tubular cells: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 57.6;eosinophil: 22.1;intermediate monocyte: 28.8;myeloid DC: 67.5;non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 67.5;granulocytes: 22.1;monocytes: 57.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 46.3;HMC-1: 34.0;NB-4: 65.6;SK-MEL-30: 93.0;THP-1: 48.7;U-937: 43.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047446, HPA050419"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA047446: AB_2680050, HPA050419: AB_2756316"	"unprognostic (1.04e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (6.80e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.26e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.64e-2)"	16.1	61.5	8.0	5.4	8.6	27.5	10.3	7.7	7.7	12.0	4.7	8.1	5.8	6.4	59.5	7.5	9.7	10.2	13.3	7.8	8.4	20.6	35.8	12.8	5.2	11.5	9.6	13.0	24.9	20.6	10.1	12.7	11.8	10.7	7.2	2.4	9.2	10.0	2.7	3.1	4.5	9.0	10.2	10.5	16.8	3.7	10.9	4.1	18.6	4.8	5.1	11.4	4.5	11.5	0.3	5.7	0.2	0.1	2.9	3.5	0.1	0.7	0.0	0.3	0.5	7.6	13.4	0.0	25.8	0.0	0.1	0.3	0.0	0.0	0.1	0.5	1.6	1.6	2.9	46.3	1.1	9.4	34.0	1.4	1.0	0.6	0.1	5.5	0.8	0.1	0.0	1.4	0.1	1.0	0.1	65.6	0.3	3.9	2.2	0.1	0.2	0.1	0.6	8.3	0.3	0.4	8.1	0.0	93.0	0.2	0.5	48.7	0.9	0.3	3.1	2.4	5.3	0.4	0.2	0.2	22.6	43.6	11.3	6.4	57.6	22.1	0.1	28.8	0.3	0.1	0.0	0.0	67.5	0.1	0.1	0.1	3.2	7.1	17.1	0.5	0.2	18.9	8.0	8.6	7.7	7.7	7.8	8.4	11.5	9.6	11.8	10.2	10.9	11.5	42.4	22.4	19.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	5.7	0.0	0.0	3.7	12.9	0.0	1.1	0.8	0.0	33.2	16.6	0.0	27.8	2.5	13.2	0.0	0.0	0.0	15.8	0.8	4.5	0.0	10.0	7.6	16.1	0.0	0.0	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.0	113.4	6.6	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	1.2	0.6	25.7	0.0	0.0
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128483-57213361	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Endocytosis	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 109.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 273.4;Hepatocytes: 188.4;Leydig cells: 233.3;Peritubular cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.6;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 484.8;ASC TERT1: 488.4;fHDF/TERT166: 222.2;HSkMC: 318.5;hTERT-RPE1: 248.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		180000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	109.2	14.1	21.3	29.0	36.3	8.2	40.0	30.2	19.7	32.3	8.0	24.1	23.2	36.9	6.2	19.3	30.3	31.5	35.5	16.7	21.9	5.7	35.0	34.0	4.9	46.0	31.5	71.0	10.7	7.8	10.2	39.8	27.9	13.8	11.2	9.9	20.3	20.2	13.0	20.4	18.4	28.9	27.1	13.6	15.1	7.3	48.9	5.6	17.6	23.5	2.7	25.5	29.3	27.6	7.7	14.5	30.4	24.2	484.8	488.4	91.2	85.3	109.0	27.5	26.7	26.9	12.4	0.4	10.4	222.2	6.0	33.6	5.3	8.7	9.7	0.7	1.3	0.4	17.9	56.4	66.5	0.5	14.6	318.5	3.1	61.8	7.2	248.7	1.7	1.1	0.4	1.3	87.2	1.7	0.2	0.4	34.8	11.0	8.8	3.2	171.0	1.6	1.9	2.2	1.4	16.4	19.0	0.6	13.2	42.0	2.9	1.2	1.2	96.0	35.0	53.9	5.2	1.1	0.1	0.2	167.4	0.1	18.7	0.0	4.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	1.6	21.3	36.3	30.2	19.7	16.7	21.9	46.0	31.5	27.9	27.1	48.9	27.6	24.6	12.8	8.4	113.6	3.2	24.0	11.9	28.7	19.9	29.2	4.9	19.3	14.8	15.7	14.7	1.8	0.0	87.5	1.1	81.7	0.0	7.4	1.9	9.7	111.4	13.0	4.2	0.8	39.3	1.8	53.0	273.4	49.5	4.2	6.3	36.9	11.0	188.4	73.8	8.4	41.6	14.1	6.1	145.3	28.6	8.4	233.3	102.9	28.4	89.9	48.8	154.7	1.0	173.4	6.6	14.7	27.2	184.3	4.4	5.5	86.0	2.1	15.1	7.3	39.5	129.7	77.0	1.6	2.4	35.4	16.1	125.9	4.2	11.4	25.0	12.3
LRP10	"DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087"	ENSG00000197324	"LDL receptor related protein 10"	Q7Z4F1	14	22871740-22881713	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 367.2;Pancreatic endocrine cells: 314.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 59.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 59.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000932			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA000932: AB_2281523"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (3.54e-7)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.55e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (3.06e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.14e-2)"	81.8	48.7	27.3	67.4	34.1	80.3	74.9	30.6	25.4	87.1	53.5	111.1	94.8	100.3	26.5	173.4	76.0	108.7	68.1	24.1	33.2	79.2	45.1	79.9	49.7	53.8	33.0	76.8	74.6	87.7	28.8	57.0	35.2	70.0	55.9	10.4	95.2	95.1	45.7	94.6	91.3	76.1	36.9	62.5	99.8	15.5	35.1	38.9	63.3	36.0	53.8	104.7	100.0	38.8	78.9	94.3	20.4	53.4	269.9	155.4	68.6	121.6	228.6	75.1	103.4	29.1	272.4	41.2	59.5	275.8	85.9	109.8	13.3	139.2	29.5	67.5	14.3	14.4	48.4	20.5	120.0	33.0	125.4	170.8	159.4	112.7	57.9	207.3	138.8	18.7	17.9	153.8	102.8	90.3	9.3	10.0	4.4	75.8	125.6	20.8	20.6	41.5	79.1	137.8	1.8	22.1	67.3	127.5	52.4	15.2	67.1	23.5	146.3	114.9	32.5	60.4	51.1	71.6	45.6	18.7	59.6	13.2	50.2	15.3	4.7	34.6	9.7	4.7	9.5	7.3	11.9	11.3	4.6	4.9	10.1	5.8	59.1	5.4	5.5	3.8	12.4	7.3	27.3	34.1	30.6	25.4	24.1	33.2	53.8	33.0	35.2	36.9	35.1	38.8	78.4	105.8	60.9	13.1	60.5	38.5	95.8	69.1	40.9	2.3	68.0	51.7	30.4	115.8	100.4	82.8	0.0	67.9	60.7	367.2	9.8	173.3	14.1	45.5	35.3	64.2	66.5	69.7	0.2	238.5	96.5	71.8	86.6	80.6	34.9	40.2	81.4	43.2	58.7	0.0	0.2	125.4	57.0	55.0	46.8	16.5	56.8	44.1	55.2	10.3	82.2	91.4	127.7	3.5	7.3	314.0	289.6	73.0	89.8	127.3	259.8	47.6	85.8	8.8	65.7	38.8	70.4	5.4	7.9	74.6	47.5	132.4	58.2	24.6	109.1	154.1
LRP4	"CLSS, LRP-4, MEGF7, SOST2"	ENSG00000134569	"LDL receptor related protein 4"	O75096	11	46856717-46918642	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 46.7;skin 1: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Cone photoreceptor cells: 41.7;Distal enterocytes: 31.1;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 31.3"	"Group enriched"	"Detected in all"	4	"colorectal cancer: 12.2;endometrial cancer: 8.6;glioma: 13.2;testis cancer: 15.6;thyroid cancer: 28.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 21.3;SuSa: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011934, HPA012300"	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA011934: AB_1853286, HPA012300: AB_1853288"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.73e-3)"	"unprognostic (5.29e-4)"	"unprognostic (8.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.90e-3)"	"unprognostic (6.79e-2)"	0.7	1.4	23.3	0.9	30.5	0.0	1.5	19.1	21.3	2.3	0.0	4.8	3.4	1.6	0.9	1.8	1.4	2.0	6.9	24.2	16.0	0.7	0.2	2.9	0.1	46.7	23.0	4.6	2.2	5.6	2.6	2.6	19.8	2.1	3.4	7.9	1.7	2.3	4.4	31.6	4.9	1.5	21.3	3.9	7.8	1.1	30.9	1.5	2.4	7.7	0.3	0.9	1.4	25.6	0.1	9.6	21.3	6.5	13.4	3.7	4.9	1.0	1.9	2.8	3.2	2.8	0.0	0.0	1.4	11.4	3.1	3.9	12.0	7.5	2.2	0.0	10.3	1.0	3.8	6.8	2.8	0.1	1.9	4.5	4.2	4.4	1.1	2.5	2.5	2.6	0.9	0.0	1.6	0.8	0.2	0.3	11.9	0.0	0.9	1.6	7.3	0.0	0.3	2.8	0.1	14.2	1.2	0.0	3.4	16.2	0.3	0.5	0.2	5.7	3.5	6.5	2.1	0.0	0.0	0.4	4.3	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	30.5	19.1	21.3	24.2	16.0	46.7	23.0	19.8	21.3	30.9	25.6	0.2	0.0	1.9	123.1	0.0	8.2	2.7	2.4	10.8	0.5	0.3	1.9	6.2	0.0	1.9	1.8	41.7	2.6	0.0	31.1	1.9	0.0	0.5	1.0	4.7	1.0	0.0	0.0	19.7	0.4	0.4	5.0	3.1	4.4	5.1	1.6	1.8	0.4	0.2	0.0	18.6	2.8	0.0	0.0	0.4	0.0	1.8	0.2	1.8	15.0	0.6	9.3	0.0	137.2	31.3	0.3	3.0	1.2	0.0	1.0	8.0	0.3	1.1	2.7	0.0	12.4	0.9	0.2	0.8	2.3	10.9	1.4	0.2	8.4	3.3	0.8
LRR1	"LRR-1, MGC20689, PPIL5"	ENSG00000165501	"Leucine rich repeat protein 1"	Q96L50	14	49598761-49614672	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 129.5;Spermatocytes: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA065703, HPA069364"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065703: AB_2685537, HPA069364: AB_2686129"	"unprognostic (2.73e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (7.34e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.90e-7)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.04e-2)"	5.7	5.5	1.6	9.1	1.7	22.6	5.6	1.7	2.1	3.0	1.6	12.2	9.6	3.7	2.4	6.7	3.3	3.6	3.2	1.5	1.6	3.1	6.1	4.2	14.0	1.8	1.7	2.4	4.3	2.9	1.2	4.0	1.8	3.2	10.0	3.2	4.1	3.4	4.0	4.7	10.1	6.1	1.7	7.5	4.6	29.1	1.8	23.2	3.4	4.8	13.3	5.4	3.5	1.9	66.5	39.3	34.2	38.4	15.1	10.6	38.2	35.0	30.8	72.5	68.7	38.4	49.1	60.9	25.1	22.9	23.2	41.7	42.2	29.8	64.1	56.5	31.3	27.4	29.4	24.6	8.5	64.5	34.2	6.9	11.3	33.9	19.4	9.2	35.8	49.2	29.3	45.4	49.2	55.2	87.2	60.1	22.5	31.7	53.0	54.8	56.2	41.4	25.4	27.1	36.9	21.7	33.1	35.3	25.4	12.1	49.9	49.6	13.1	50.6	83.1	24.8	44.4	23.6	35.9	69.0	23.6	47.7	42.9	22.4	14.2	25.4	10.1	22.7	13.5	16.1	13.3	14.8	15.0	12.6	10.8	12.3	8.2	11.1	16.9	17.7	15.7	10.5	1.6	1.7	1.7	2.1	1.5	1.6	1.8	1.7	1.8	1.7	1.8	1.9	6.4	3.2	6.5	2.0	12.1	15.6	5.7	12.0	4.6	3.8	6.5	5.6	3.6	5.7	9.3	3.7	2.1	12.6	9.2	11.8	1.9	16.8	129.5	3.4	5.3	8.9	4.8	48.4	0.9	22.7	34.2	7.8	6.6	2.9	14.5	9.5	6.8	6.6	21.6	1.7	1.1	11.0	12.2	10.4	19.2	41.6	7.5	11.5	10.6	2.8	16.7	8.1	13.4	1.0	2.0	14.1	3.7	3.4	31.3	11.2	8.7	7.5	4.3	5.2	6.6	5.5	8.0	151.7	14.0	8.8	14.9	7.7	10.5	7.5	14.5	7.0
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508749-61511018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 42.4;fallopian tube: 28.7;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 49.3;Muller glia cells: 9.5;Respiratory ciliated cells: 37.2;Sertoli cells: 19.7;Smooth muscle cells: 20.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 42.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 9.7;RH-30: 10.5;SCLC-21H: 5.4"	"Region enriched"	"Detected in many"	7	"basal ganglia: 222.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 30.9;hippocampal formation: 24.2"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Nucleoli	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	3.7	0.9	11.1	0.4	42.4	0.0	2.9	0.5	11.2	5.9	3.6	2.2	0.3	4.9	1.9	0.5	28.7	0.3	1.7	13.5	5.2	2.2	0.1	4.9	0.0	4.0	4.0	2.3	1.3	2.2	33.7	0.5	2.1	1.6	0.3	0.1	1.3	0.5	0.7	0.9	1.4	1.6	3.1	0.4	2.9	5.9	7.9	2.7	1.6	0.9	0.0	1.1	2.5	3.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	5.4	0.5	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	42.4	0.5	11.2	13.5	5.2	4.0	4.0	2.1	3.1	7.9	3.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.6	0.4	1.1	0.0	3.5	1.8	0.0	0.0	0.0	0.1	0.0	0.0	3.2	49.3	0.5	0.4	4.2	0.0	1.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	6.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	37.2	0.2	19.7	0.7	20.6	0.8	1.1	0.0	0.3	0.1	0.1	0.2	0.1	0.1
LRRC14	"KIAA0014, LRRC14A"	ENSG00000160959	"Leucine rich repeat containing 14"	Q15048	8	144517992-144525172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021047	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA021047: AB_1853298"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.04e-3)"	8.6	13.1	10.4	6.4	9.9	7.5	9.7	14.9	11.8	15.6	3.1	15.0	7.5	16.2	5.8	14.1	13.1	5.7	10.9	11.8	7.1	11.8	11.9	9.8	9.3	9.9	9.0	12.9	16.2	8.3	16.0	4.9	9.4	19.4	5.3	3.3	12.0	8.1	11.4	13.1	13.3	5.6	9.1	14.5	14.2	11.7	9.1	7.1	16.8	5.0	6.6	14.6	12.2	10.8	18.2	36.2	9.7	15.8	10.2	8.3	13.8	15.9	6.8	12.6	10.8	15.9	21.6	14.5	16.5	11.9	7.7	19.4	15.3	15.8	5.7	19.7	34.8	21.9	42.7	6.9	9.5	9.3	17.3	10.1	13.3	12.7	6.2	10.4	10.9	16.6	29.2	17.1	12.4	22.3	34.9	12.2	7.9	15.8	51.8	29.6	8.0	20.9	7.6	15.6	26.4	14.7	24.2	19.3	11.2	5.7	29.8	10.3	11.8	21.4	37.6	19.0	23.7	9.5	6.0	18.2	20.1	21.4	13.4	1.6	7.2	1.6	8.3	6.8	8.0	7.8	6.2	7.8	7.2	7.9	6.7	5.6	3.8	11.4	6.0	8.4	6.7	8.0	10.4	9.9	14.9	11.8	11.8	7.1	9.9	9.0	9.4	9.1	9.1	10.8	6.3	6.4	3.1	6.5	10.9	6.4	5.0	3.4	9.1	11.5	9.8	9.5	4.6	14.3	6.0	9.2	2.1	6.9	6.9	10.3	5.9	5.4	2.8	6.3	6.8	7.3	5.4	8.4	3.8	8.2	6.6	5.8	10.2	6.4	7.0	11.2	8.9	9.8	7.7	11.8	2.8	8.1	2.0	6.0	4.0	3.9	7.5	4.4	1.8	8.4	7.4	9.5	9.2	6.6	3.3	7.3	4.9	7.9	11.1	8.3	6.0	7.4	7.5	7.4	6.6	5.0	6.7	29.3	22.0	6.6	5.8	5.5	9.4	16.8	11.9	3.9
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191495-196334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 34.0;skeletal muscle: 113.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.6"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 43.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Cytosol"		"HPA038046: AB_10672504, HPA038047: AB_2675806"	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.0	0.0	0.2	0.0	0.5	0.3	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	34.0	0.0	0.8	0.1	0.0	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.9	0.4	0.0	113.8	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.4	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	4.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	10.1	43.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.5	0.9	0.3	0.0	0.8	0.6	0.5	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515385-46580099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 45.3;skeletal muscle: 165.0;tongue: 94.1"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 198.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.2;HEL: 4.2;LHCN-M2: 4.1;TIME: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039138, HPA064844"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA039138: AB_10795461, HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	2.4	0.7	1.5	0.7	3.6	0.8	1.9	1.1	2.8	3.5	0.2	1.9	0.7	4.8	2.4	1.4	2.4	3.0	45.3	2.7	0.1	4.5	5.6	1.2	0.5	0.4	0.4	5.2	1.1	0.9	1.2	0.9	0.3	2.1	1.6	0.3	2.2	0.3	165.0	1.9	0.8	4.0	0.2	2.8	1.8	0.8	0.1	3.2	22.1	94.1	0.7	2.3	2.0	1.4	0.1	0.0	0.1	0.1	0.6	1.4	0.1	0.5	1.0	0.3	0.5	0.0	0.1	0.2	0.1	7.2	0.0	0.1	2.5	0.0	0.9	0.3	0.0	4.2	0.3	0.0	0.1	0.1	0.0	0.1	0.0	2.8	0.0	2.3	0.1	0.5	0.0	0.2	4.1	0.0	0.5	0.1	1.0	0.3	0.1	0.1	0.0	0.2	0.0	0.2	0.3	0.8	0.5	0.1	1.0	0.7	0.1	0.5	3.2	0.1	0.3	1.6	1.1	0.2	0.2	1.9	0.1	0.1	0.9	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.5	0.1	1.5	3.6	1.1	2.8	2.7	0.1	0.4	0.4	0.3	0.2	0.1	1.4	1.6	9.6	1.1	2.0	0.2	1.9	1.1	0.6	0.6	0.1	0.8	1.3	198.4	7.2	0.0	1.8	0.0	0.1	0.0	0.2	9.8	0.6	2.3	0.3	1.6	4.0	3.0	0.0	12.5	1.0	0.0	11.9	3.1	0.4	10.2	2.5	5.0	10.2	2.0	0.0	11.2	1.8	0.0	0.8	5.7	2.9	0.6	0.6	10.6	3.7	0.0	0.4	0.0	3.5	0.7	1.0	0.4	0.0	3.0	0.6	0.0	0.8	0.7	0.2	0.0	32.7	2.6	0.6	0.7	0.0	2.4	0.1	2.1	7.9	1.9	0.4
LRRC20	"FLJ10751, FLJ10844"	ENSG00000172731	"Leucine rich repeat containing 20"	Q8TCA0	10	70298970-70382650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 305.6;tongue: 125.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 31.0;Early spermatids: 25.4;Hepatocytes: 17.5;Late spermatids: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039630			Approved	Nucleoplasm,Cytosol		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA039630: AB_10795467"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	2.8	5.9	17.1	2.6	17.7	3.3	2.3	13.6	21.5	15.1	10.0	14.1	2.7	6.5	3.1	14.7	4.3	3.1	40.7	18.3	14.8	3.7	32.0	4.5	3.1	17.3	15.5	4.3	3.4	3.2	13.2	1.4	18.1	4.6	4.0	4.4	6.3	4.2	305.6	3.5	4.1	6.9	14.4	3.3	5.0	12.5	18.0	7.3	4.4	125.0	5.3	6.2	19.9	17.5	26.1	18.1	16.2	29.7	9.3	6.5	0.1	4.0	14.5	9.2	8.6	17.2	27.7	5.9	13.2	2.4	31.1	9.8	14.3	18.1	8.1	14.7	3.6	3.2	4.6	53.3	8.6	8.2	2.7	2.6	7.0	11.3	5.4	11.2	18.7	34.6	4.0	7.6	8.4	3.6	31.0	8.4	5.3	26.0	46.3	23.8	8.2	14.8	15.1	2.7	32.4	16.2	2.0	2.5	10.9	4.1	3.4	9.2	10.6	6.3	64.7	10.7	8.9	13.6	22.3	9.3	12.6	32.7	1.7	0.0	0.2	0.0	0.4	0.3	0.4	0.1	0.3	0.4	0.6	0.0	1.0	0.4	0.0	0.4	0.1	0.1	0.0	0.3	17.1	17.7	13.6	21.5	18.3	14.8	17.3	15.5	18.1	14.4	18.0	17.5	1.9	0.0	4.6	9.4	1.1	1.5	0.5	0.6	0.0	8.5	1.5	0.6	31.0	2.8	1.3	0.0	4.2	0.1	0.8	0.8	0.0	3.9	25.4	1.1	1.3	2.4	5.4	1.7	10.0	4.7	0.2	2.8	1.5	0.7	0.0	2.5	2.2	17.5	0.5	1.7	10.1	2.0	0.0	0.6	0.7	50.1	3.1	0.8	1.8	1.9	1.2	7.5	1.0	6.6	3.9	5.8	3.1	1.5	1.7	0.8	0.3	1.6	0.6	2.0	0.0	5.2	1.9	8.5	4.8	0.1	0.6	0.0	1.3	1.8	2.1	0.6
LRRC27	KIAA1674	ENSG00000148814	"Leucine rich repeat containing 27"	Q9C0I9	10	132332154-132381508	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 75.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 491.0;Late spermatids: 953.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;hTERT-RPE1: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037595, HPA067395"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA037595: , HPA067395: AB_2732766"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-4)"	"unprognostic (1.48e-3)"	"unprognostic (1.94e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.27e-4)"	3.2	4.1	11.6	1.9	12.1	1.6	5.0	9.4	13.3	4.5	12.0	4.7	2.5	4.5	6.7	2.0	13.1	4.3	3.5	13.0	11.2	7.1	3.0	3.9	2.6	12.1	11.8	6.3	3.9	8.0	8.0	2.6	10.9	5.2	2.5	10.9	3.3	4.7	2.0	2.7	3.3	4.2	11.5	5.5	3.9	75.6	11.8	2.8	6.4	1.6	1.4	4.0	2.8	10.9	3.1	5.6	12.2	17.2	10.4	10.6	1.2	3.0	9.7	4.9	4.4	1.0	6.3	1.7	1.7	7.0	3.7	2.1	2.7	1.5	3.1	3.6	2.4	0.5	4.5	3.0	7.4	1.4	2.0	4.6	9.4	5.0	6.6	21.9	3.5	4.2	1.1	1.3	3.8	5.2	2.7	3.9	3.4	2.2	1.9	2.4	1.9	1.0	8.9	0.8	2.2	6.1	1.5	1.0	3.9	2.4	2.8	3.1	4.7	1.9	2.4	4.4	1.9	0.9	0.4	1.0	8.9	2.7	1.2	4.1	4.7	0.8	1.1	4.1	0.9	2.3	0.7	0.7	5.2	2.9	1.8	1.0	0.6	2.4	2.8	5.6	0.5	2.0	11.6	12.1	9.4	13.3	13.0	11.2	12.1	11.8	10.9	11.5	11.8	10.9	2.9	9.6	12.8	23.8	5.0	2.8	2.5	5.1	3.4	8.2	6.3	3.8	5.2	5.7	6.9	3.7	10.4	3.6	6.0	1.7	19.6	8.2	491.0	18.8	5.4	4.9	5.4	2.5	14.2	5.1	1.3	5.5	7.1	4.8	8.8	10.3	11.4	2.2	7.7	8.4	10.9	2.3	2.0	10.4	6.0	953.9	4.7	6.7	7.2	6.5	9.0	10.5	8.2	8.0	9.3	3.3	1.3	11.7	0.9	2.9	3.8	13.9	37.7	18.3	6.6	3.8	3.5	119.9	19.2	2.3	3.1	1.4	2.9	6.2	3.5	1.8
LRRC28	"FLJ34269, FLJ45242, MGC24976"	ENSG00000168904	"Leucine rich repeat containing 28"	Q86X40	15	99251362-99390729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 159.2;Excitatory neurons: 127.4;Late spermatids: 406.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039378, HPA040784, HPA066130"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Mitochondria"	"HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623"	"unprognostic (4.84e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.82e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.41e-1)"	8.1	7.8	4.4	4.4	5.1	8.6	6.4	4.5	5.8	6.1	4.3	8.0	16.9	5.8	7.4	9.7	4.8	9.1	9.7	5.3	3.9	19.4	47.1	5.3	6.9	3.7	3.5	4.9	19.5	9.4	4.1	6.1	3.5	5.3	9.7	6.8	6.1	6.6	18.3	10.4	16.5	7.9	3.3	4.9	8.2	28.5	3.9	22.6	6.6	18.4	9.4	6.5	6.3	4.4	4.0	9.8	9.5	12.3	13.2	18.7	4.0	4.2	11.9	7.1	8.3	7.4	8.6	8.2	7.6	10.1	8.7	8.8	7.0	13.5	10.3	5.0	10.2	5.5	4.0	7.7	11.7	5.5	8.6	11.1	18.2	6.7	13.4	16.0	22.7	13.0	4.9	8.1	14.9	8.0	15.2	8.9	4.0	31.2	3.7	9.3	8.0	7.6	15.1	12.8	4.3	5.5	10.1	5.4	16.4	14.4	8.4	10.2	8.3	7.0	4.8	5.4	8.4	15.9	24.1	5.1	8.8	5.4	13.3	23.4	9.3	32.0	7.2	7.8	5.8	6.2	6.7	7.7	8.4	5.8	6.2	5.4	5.0	5.1	8.0	6.9	10.4	6.1	4.4	5.1	4.5	5.8	5.3	3.9	3.7	3.5	3.5	3.3	3.9	4.4	13.2	16.0	4.1	29.0	13.5	13.8	14.5	14.5	12.5	19.9	8.9	12.4	13.4	12.8	11.0	11.0	22.9	17.5	11.4	18.6	27.4	12.7	159.2	7.4	8.4	11.9	9.1	12.4	127.4	29.5	22.6	8.5	15.8	6.5	2.5	15.0	12.8	37.0	19.3	21.9	86.8	16.0	20.3	19.8	20.1	406.4	12.8	15.3	14.2	37.5	19.1	14.4	14.4	63.3	63.0	14.8	24.2	8.6	14.7	8.4	72.3	74.1	10.1	19.8	0.0	10.7	11.7	77.1	39.0	15.1	15.8	13.0	11.3	18.0	19.5	15.4
LRRC31	FLJ23259	ENSG00000114248	"Leucine rich repeat containing 31"	Q6UY01	3	169839172-169869935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 21.7;salivary gland: 6.5;stomach 1: 10.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 8.9;Enteroendocrine cells: 10.3;Intestinal goblet cells: 23.5;Paneth cells: 6.0;Undifferentiated cells: 5.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;HAP1: 1.4;OE19: 8.8;RPTEC TERT1: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA058013			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA058013: "	"unprognostic (5.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"		"unprognostic (9.90e-2)"	"unprognostic (4.40e-2)"		"unprognostic (7.90e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.20e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.96e-3)"	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	1.4	0.0	17.5	8.4	0.1	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	5.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	21.7	0.1	6.5	0.0	0.0	0.0	9.6	0.4	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.8	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	1.0	0.3	0.0	10.3	0.0	0.3	0.0	0.0	0.0	3.1	3.0	0.0	0.0	0.0	2.4	0.1	0.0	0.2	23.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.1	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.4
LRRC32	"D11S833E, GARP"	ENSG00000137507	"Leucine rich repeat containing 32"	Q14392	11	76657524-76670747	"Predicted intracellular proteins, Predicted membrane proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 78.0;Endothelial cells: 88.3;Extravillous trophoblasts: 164.2;Hepatic stellate cells: 95.3;Sertoli cells: 39.5;Smooth muscle cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Group enriched"	"Detected in some"	6	"ASC diff: 115.0;ASC TERT1: 70.3;HSkMC: 44.0;HUVEC TERT2: 51.4;U-2197: 108.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055775, HPA058434"			Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		98000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA055775: AB_2732600, HPA058434: AB_2732622"	"unprognostic (3.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (3.93e-5)"	"unprognostic (7.99e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.22e-3)"	"prognostic unfavorable (2.64e-4)"	104.5	34.3	12.6	10.5	12.6	2.4	63.6	11.2	11.8	56.2	8.4	23.2	8.9	36.4	6.2	10.3	31.6	29.0	55.7	9.6	10.6	64.7	11.3	109.0	4.3	12.2	13.8	13.5	12.0	7.5	16.7	53.0	13.0	24.9	6.1	1.3	12.8	11.0	23.6	26.6	21.4	15.2	10.9	28.9	21.3	3.6	15.0	2.0	42.3	6.2	1.5	36.7	28.8	11.5	0.0	0.0	1.3	0.0	115.0	70.3	1.4	0.4	0.8	0.1	0.1	0.0	0.0	0.2	3.1	1.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	11.8	0.6	0.0	2.2	0.0	0.1	44.0	0.0	4.1	0.2	0.9	51.4	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	7.6	0.2	0.0	13.8	7.5	0.8	108.3	0.0	0.1	0.0	1.9	5.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	4.3	12.6	12.6	11.2	11.8	9.6	10.6	12.2	13.8	13.0	10.9	15.0	11.5	78.0	0.0	4.3	0.0	1.7	14.5	0.3	0.0	1.8	0.0	0.6	0.6	10.4	0.0	1.3	0.0	0.0	1.9	0.1	0.2	0.0	0.3	1.3	0.1	1.9	88.3	0.0	5.3	0.0	0.0	164.2	26.4	0.5	0.3	2.5	0.5	95.3	0.6	3.6	0.0	0.1	0.4	0.0	3.1	19.0	1.9	9.0	2.9	17.8	14.0	0.0	0.4	0.0	0.0	0.1	0.0	2.2	9.1	0.2	1.4	0.0	0.4	0.7	0.1	39.5	2.1	47.6	0.4	4.7	0.6	12.5	8.3	1.6	0.4	0.1	1.2
LRRC41	MUF1	ENSG00000132128	"Leucine rich repeat containing 41"	Q15345	1	46261196-46303616	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 133.1;Syncytiotrophoblasts: 142.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051941	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear bodies"	Nucleoplasm	"HPA051941: AB_2681669"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (7.80e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.66e-9)"	"unprognostic (6.09e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-2)"	37.7	43.5	30.4	19.1	31.1	20.0	36.7	29.1	32.7	45.0	28.0	41.4	22.7	50.7	29.0	44.3	45.9	30.9	36.7	31.7	31.4	33.4	36.0	33.7	20.7	31.9	30.2	48.5	41.6	44.1	44.3	34.0	29.8	43.3	19.8	19.4	37.6	41.4	55.3	43.3	29.4	35.4	30.4	28.5	35.1	32.7	30.9	29.9	38.7	33.2	22.7	44.8	39.5	32.6	42.2	30.2	51.1	55.8	67.7	84.0	48.1	42.7	78.6	60.8	40.6	25.7	13.7	26.7	55.5	102.0	81.4	32.0	50.5	60.5	30.7	32.5	54.7	43.5	34.3	37.7	94.6	27.1	22.1	103.8	80.1	56.9	68.2	87.0	78.6	49.3	43.7	26.7	67.5	26.8	36.2	36.0	76.9	27.4	29.3	29.6	26.4	43.4	68.4	50.9	47.4	54.0	57.8	56.6	69.5	78.3	33.5	80.9	52.4	53.0	23.9	44.8	41.5	43.5	21.8	11.8	49.7	20.6	37.6	30.6	32.7	15.5	21.1	30.8	22.6	18.7	22.9	24.0	46.4	22.0	24.9	19.3	3.3	32.7	21.7	26.4	24.4	30.2	30.4	31.1	29.1	32.7	31.7	31.4	31.9	30.2	29.8	30.4	30.9	32.6	19.0	19.2	22.7	17.0	17.9	28.4	36.6	40.4	17.1	23.7	28.6	24.8	11.3	28.6	32.0	35.0	25.0	83.1	20.2	27.4	39.2	42.0	28.2	57.5	36.2	22.0	36.6	24.0	19.8	30.0	48.7	34.8	23.9	133.1	7.0	42.4	25.7	28.0	36.5	47.1	21.1	30.4	30.5	20.6	22.8	19.3	34.8	20.7	10.6	11.2	23.5	25.4	20.6	18.6	22.3	30.1	24.2	33.1	26.5	36.7	38.0	32.7	23.4	27.4	39.5	40.4	32.1	46.6	45.8	21.2	29.0	142.6	18.8	37.7	30.0	34.7
LRRC42	MGC8974	ENSG00000116212	"Leucine rich repeat containing 42"	Q9Y546	1	53946085-53968168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047458, HPA050537, HPA064581"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA047458: , HPA050537: AB_2681161, HPA064581: AB_2685292"	"unprognostic (3.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (7.95e-3)"	"prognostic unfavorable (3.88e-5)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.67e-2)"	15.6	29.0	10.5	9.7	10.7	11.8	14.8	9.7	13.6	16.2	14.9	16.4	12.3	18.7	15.3	21.8	16.6	12.5	14.7	10.4	11.7	15.2	24.3	15.3	11.4	10.8	10.4	17.2	13.2	15.4	24.1	22.4	10.0	15.1	13.2	8.6	16.7	14.8	17.6	21.9	11.8	18.1	10.4	9.2	16.7	19.4	12.2	16.4	23.6	15.7	14.4	18.7	18.3	10.8	73.3	26.9	66.0	38.9	34.0	45.9	45.2	56.7	78.7	74.4	100.4	90.8	48.0	41.4	44.4	70.6	88.0	63.5	57.0	81.4	85.4	32.7	35.5	38.2	40.4	57.9	61.7	23.9	35.2	41.8	110.6	64.5	69.5	54.1	47.6	37.7	48.8	10.6	73.2	25.5	45.1	33.1	56.6	53.5	42.0	75.9	70.2	28.8	53.1	54.1	39.3	42.3	76.5	42.7	63.4	103.1	63.4	28.3	39.6	56.1	71.7	50.1	35.9	29.4	36.4	61.7	54.3	24.8	30.4	0.0	3.1	5.7	4.9	3.1	4.3	4.2	4.2	5.9	3.9	2.3	4.2	3.2	4.8	4.9	2.3	6.9	4.8	2.9	10.5	10.7	9.7	13.6	10.4	11.7	10.8	10.4	10.0	10.4	12.2	10.8	7.8	12.8	5.8	3.6	6.7	51.6	36.4	46.6	29.6	4.4	15.9	14.1	10.5	30.0	24.2	11.0	4.2	43.8	5.4	14.9	19.6	35.0	2.9	16.2	17.0	11.1	68.2	16.0	8.0	16.7	31.4	22.6	17.3	16.8	0.0	19.8	8.2	15.0	17.8	10.1	4.9	9.6	30.5	5.7	11.7	3.5	23.9	8.5	10.6	7.5	10.6	28.7	9.2	5.5	8.4	32.6	13.3	17.7	16.7	46.4	9.9	17.6	19.2	3.6	13.1	15.5	22.7	21.9	48.5	25.5	39.1	57.5	7.9	75.7	14.6	41.0
LRRC45	MGC20806	ENSG00000169683	"Leucine rich repeat containing 45"	Q96CN5	17	82023305-82031151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023372, HPA023382, HPA024768"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centrosome, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348"	"unprognostic (6.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.78e-3)"	"unprognostic (6.17e-3)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-1)"	5.0	6.1	2.3	3.8	2.2	7.0	5.8	7.5	5.4	6.1	2.2	8.7	5.7	5.4	0.9	10.3	9.0	1.6	5.0	2.5	1.9	7.5	18.0	6.4	3.2	3.0	2.8	4.5	10.1	2.0	5.9	2.4	3.0	8.4	1.7	0.6	9.6	2.2	2.5	8.7	8.6	1.2	2.1	9.5	10.5	4.0	2.2	3.1	8.9	0.5	1.5	6.1	6.9	2.3	18.6	20.7	6.2	12.7	2.5	3.3	24.0	12.7	5.2	7.5	6.3	18.6	12.4	13.9	11.2	2.5	7.8	21.3	6.0	7.6	1.7	8.5	38.6	8.8	43.1	25.5	2.1	10.4	21.2	3.3	3.1	4.5	1.2	3.1	11.1	13.0	6.3	6.0	2.0	31.6	23.5	34.5	6.4	15.0	27.4	19.0	12.2	7.8	4.8	16.9	19.1	18.6	5.8	29.9	11.2	3.0	24.4	12.0	6.5	13.1	16.3	20.8	21.9	11.5	3.1	2.1	7.0	8.9	13.9	2.3	1.2	1.5	1.4	0.9	1.4	0.6	1.6	1.6	0.8	0.7	0.8	1.1	0.0	1.1	0.4	1.3	1.4	1.4	2.3	2.2	7.5	5.4	2.5	1.9	3.0	2.8	3.0	2.1	2.2	2.3	3.9	6.4	2.2	4.2	4.1	4.5	5.0	2.9	1.8	5.2	8.5	8.6	2.7	14.3	7.0	3.7	0.0	12.7	7.8	18.1	5.9	7.3	1.5	19.0	3.4	3.7	4.8	10.3	2.5	4.7	27.9	4.8	13.3	5.0	4.5	13.3	7.1	12.6	8.7	5.0	2.9	12.2	4.1	6.3	3.2	4.4	7.2	4.2	8.8	0.0	4.3	5.6	7.2	1.0	1.8	5.8	9.4	6.4	8.5	2.4	10.9	10.2	24.4	4.1	0.0	2.8	5.2	2.3	11.9	6.3	2.4	3.0	7.0	4.9	18.4	3.7
LRRC58		ENSG00000163428	"Leucine rich repeat containing 58"	Q96CX6	3	120324509-120349354	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057574	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA057574: AB_2683474"	"unprognostic (7.87e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.06e-1)"	10.6	22.8	8.4	8.8	11.9	9.0	12.0	11.0	9.3	9.0	9.5	7.7	7.5	10.2	8.3	9.2	6.6	7.4	5.5	7.1	8.6	14.9	11.2	7.4	10.2	11.8	11.3	14.6	10.3	13.7	4.1	9.6	12.6	9.7	7.5	7.2	8.5	8.6	5.0	10.9	7.4	9.7	10.8	9.1	7.3	4.5	9.7	12.2	14.2	5.8	8.8	7.4	6.5	14.8	52.6	18.1	12.2	15.6	27.5	26.1	19.3	18.5	16.0	19.2	23.8	17.0	15.8	34.1	22.4	19.9	27.3	22.4	22.7	18.1	36.5	13.3	14.0	36.5	23.5	19.9	18.5	59.8	18.0	19.3	22.7	23.4	29.9	12.4	11.5	21.5	21.0	42.6	20.9	23.9	47.2	19.1	12.3	23.1	32.8	10.4	32.6	22.1	14.6	19.1	15.6	20.6	32.4	21.9	46.2	8.5	24.1	26.7	17.2	32.0	35.7	21.7	23.5	36.3	44.9	70.6	32.2	44.2	27.4	1.4	2.7	1.1	1.9	2.4	2.7	2.5	2.3	2.4	2.6	2.3	3.5	2.7	1.5	1.6	1.9	2.9	2.6	1.9	8.4	11.9	11.0	9.3	7.1	8.6	11.8	11.3	12.6	10.8	9.7	14.8	26.0	73.7	59.9	18.3	30.8	50.9	20.7	15.9	32.5	32.3	34.0	25.8	17.3	24.3	29.0	18.4	56.3	17.3	33.3	17.9	11.7	22.0	7.8	24.4	48.8	24.1	16.8	34.3	23.8	31.0	28.2	50.0	18.3	27.0	35.4	33.9	27.1	43.0	28.7	25.2	27.1	24.3	12.2	49.0	33.9	7.3	55.9	34.4	33.8	14.0	42.3	46.5	30.9	25.1	34.8	28.8	18.6	73.0	33.0	37.0	24.8	39.6	32.3	26.5	26.3	52.7	33.9	19.5	22.8	31.2	57.0	13.5	28.7	94.6	32.3	17.5
LRRC61	"FLJ31392, HSPC295, MGC3036"	ENSG00000127399	"Leucine rich repeat containing 61"	Q9BV99	7	150323263-150338156	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 80.6;Hep G2: 53.3;NTERA-2: 67.0"	"Low region specificity"	"Detected in all"							HPA019355	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA019355: AB_1853339"	"unprognostic (4.05e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.61e-3)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.85e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.69e-3)"	4.0	18.3	9.5	4.5	8.4	1.6	4.5	6.9	8.7	7.5	9.8	5.7	4.3	6.5	2.0	8.8	14.5	4.0	4.1	7.7	13.1	12.1	23.4	4.4	7.3	9.7	10.1	15.2	11.2	11.4	13.5	3.8	10.4	6.6	1.9	2.8	5.3	4.3	2.2	6.8	5.8	2.0	8.2	6.1	6.1	9.1	13.4	11.5	8.7	2.3	3.9	4.7	6.5	6.7	20.0	0.5	0.6	0.1	0.0	0.0	9.0	0.2	0.0	2.4	7.8	37.9	19.4	6.2	8.2	0.3	0.0	17.6	0.0	0.0	1.3	80.6	24.4	7.4	23.5	53.3	13.8	0.0	3.7	1.6	7.9	0.0	0.0	0.6	0.1	40.2	25.9	11.5	0.0	36.5	37.5	3.2	67.0	13.8	0.0	0.0	0.1	16.5	5.7	13.2	34.6	33.4	33.6	7.2	13.7	5.6	5.6	4.5	0.1	0.0	0.1	0.0	0.1	12.5	4.4	0.0	0.0	0.0	0.0	2.8	2.9	8.5	10.8	1.1	8.3	8.7	7.3	8.2	3.0	10.7	7.0	8.4	13.1	8.7	1.3	17.9	12.7	5.7	9.5	8.4	6.9	8.7	7.7	13.1	9.7	10.1	10.4	8.2	13.4	6.7	0.3	6.4	1.5	2.3	7.1	1.1	4.7	16.5	8.6	7.8	8.0	8.9	2.2	11.5	6.8	16.5	0.0	25.2	11.1	9.4	19.6	27.3	5.7	20.9	1.6	1.7	19.3	3.8	1.7	28.4	24.5	4.7	7.1	5.8	1.3	22.9	1.8	22.6	6.0	13.5	3.6	6.7	18.3	1.3	0.0	16.3	10.2	3.3	3.6	0.0	16.5	13.7	11.3	4.5	0.3	27.9	11.2	5.7	3.5	4.0	11.7	48.7	20.1	4.5	0.0	5.3	3.2	20.8	23.7	8.1	2.7	27.0	7.4	9.0	10.6	3.0
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"		1	69567922-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	9	"brain: 20.2"	"Group enriched"	"Detected in many"	20	"Excitatory neurons: 1132.4;Inhibitory neurons: 996.9;Oligodendrocyte precursor cells: 1038.0;Oligodendrocytes: 408.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 6.9;basal ganglia: 17.0;cerebral cortex: 20.2;hippocampal formation: 17.7;thalamus: 11.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 12.6;HEL: 44.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	0.1	0.2	6.9	0.1	17.0	0.2	0.0	0.0	20.2	0.2	0.0	0.4	0.1	0.2	0.1	0.2	0.0	1.0	1.4	17.7	1.7	0.8	0.2	0.0	0.1	0.0	2.2	0.1	0.8	0.1	0.0	0.2	0.0	0.3	0.6	1.5	0.0	0.1	1.0	0.2	0.2	0.2	0.0	0.0	0.2	1.6	11.4	0.0	2.2	0.0	0.0	0.1	0.1	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	4.4	0.0	0.0	12.6	0.3	0.0	0.0	0.0	0.6	44.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	4.7	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.1	0.0	0.0	0.0	0.0	6.9	17.0	0.0	20.2	17.7	1.7	0.0	2.2	0.0	0.0	11.4	2.9	0.8	0.0	0.0	41.4	2.5	0.8	0.6	0.4	1.8	44.4	0.3	0.3	6.2	2.8	0.2	0.0	2.1	0.4	2.4	0.0	0.0	0.0	29.4	0.5	1.4	1.2	0.0	3.2	1132.4	0.0	0.5	1.8	0.0	1.4	0.0	0.6	2.9	6.5	0.3	6.7	996.9	0.0	0.0	2.8	3.6	6.3	0.6	0.5	5.4	17.8	1.7	1.0	2.1	1038.0	408.2	0.0	0.0	3.0	1.3	0.9	0.0	1.6	0.1	8.3	0.0	1.4	1.5	9.2	3.0	0.5	1.3	0.1	2.3	0.1	0.0	0.1
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 62.1;SK-MEL-30: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	5.5	21.5	6.8	6.4	5.0	16.1	0.5	1.8	7.7	1.3	0.1	20.2	47.4	4.0	0.2	2.1	1.3	3.1	2.4	6.8	6.5	2.0	0.6	4.6	5.6	4.1	6.7	4.4	7.0	4.7	3.1	3.4	5.1	1.9	9.0	2.3	1.3	1.1	2.9	2.2	44.0	2.3	3.4	21.5	7.4	10.6	5.1	0.5	4.9	0.6	1.6	1.5	0.5	5.3	8.9	6.3	7.6	6.0	0.2	0.2	1.3	2.4	0.4	1.8	1.5	7.9	2.6	0.6	6.6	0.2	3.7	3.7	0.2	0.0	0.0	3.4	6.5	62.1	3.9	0.0	0.3	1.5	7.3	0.0	0.0	0.4	0.0	3.2	2.3	9.4	3.9	1.7	0.1	12.8	15.3	6.7	1.7	20.3	0.7	5.8	5.5	0.8	0.4	1.8	16.6	4.6	0.6	1.8	21.7	3.3	1.4	1.4	0.0	2.2	10.5	6.7	11.9	12.2	2.6	2.0	0.8	5.1	7.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.7	0.3	0.4	1.0	0.0	0.0	0.4	6.8	5.0	1.8	7.7	6.8	6.5	4.1	6.7	5.1	3.4	5.1	5.3	40.5	41.7	69.7	10.7	21.6	0.0	9.6	0.0	2.2	9.1	24.9	13.3	0.7	14.3	19.8	1.8	6.2	16.1	24.8	52.5	19.6	3.9	7.1	30.0	61.0	14.7	24.7	9.7	5.3	7.1	20.4	30.5	2.0	58.7	29.7	25.0	11.0	10.0	12.0	3.3	3.6	52.2	0.0	13.9	0.0	8.0	16.4	22.9	0.0	1.0	7.7	21.3	2.1	4.0	4.2	6.2	36.0	11.3	12.0	8.7	65.4	19.4	8.7	18.2	13.1	22.9	19.4	8.0	6.5	1.1	0.0	16.7	18.6	66.3	66.0	7.5
LRRC75B	"C22orf36, FAM211B, MGC131773"	ENSG00000178026	"Leucine rich repeat containing 75B"	Q2VPJ9	22	24585620-24593208	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 34.3;Hepatocytes: 25.6;Muller glia cells: 39.9;Proximal enterocytes: 46.7;Proximal tubular cells: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 5.3;MCF7: 5.0;SH-SY5Y: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002540	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA002540: AB_1079263"	"unprognostic (1.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.69e-2)"	1.8	0.7	5.8	0.0	5.5	0.3	1.8	5.7	7.4	1.9	3.6	3.2	0.0	1.0	0.5	2.1	1.5	0.0	2.9	5.2	6.0	5.6	3.6	0.8	0.0	6.0	6.1	3.2	3.5	0.0	1.3	0.1	5.7	2.8	0.1	0.6	2.0	0.4	2.5	1.8	1.6	0.0	5.9	0.5	2.5	7.5	5.9	0.1	1.6	0.0	0.1	3.5	1.9	5.8	0.1	2.8	0.0	1.5	0.3	1.1	0.2	0.4	0.4	0.9	1.0	2.0	0.0	0.0	0.7	0.8	0.8	3.0	0.2	1.5	0.0	0.9	1.8	0.2	0.3	5.3	2.6	0.0	0.0	0.0	1.1	1.0	0.1	0.5	0.7	0.0	0.1	0.0	0.1	5.0	0.0	1.0	1.3	3.4	1.1	0.0	0.1	0.0	1.2	0.3	1.4	4.2	1.4	0.4	0.5	0.3	0.0	0.5	1.5	1.6	0.9	0.6	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.8	5.5	5.7	7.4	5.2	6.0	6.0	6.1	5.7	5.9	5.9	5.8	1.6	12.8	5.9	9.4	0.3	0.0	2.5	0.0	2.2	2.8	16.2	18.7	4.4	34.3	0.0	7.3	0.0	2.5	0.9	10.7	11.7	9.8	1.6	2.3	3.6	1.8	1.2	1.3	3.8	8.9	0.4	7.1	14.3	6.1	0.0	7.2	2.9	25.6	1.1	1.7	4.1	8.0	0.0	1.6	0.0	7.9	12.8	1.4	0.0	1.0	0.3	39.9	0.0	7.1	2.2	4.0	6.2	9.8	0.6	8.0	46.7	44.5	0.0	1.8	0.0	4.5	4.2	0.5	1.3	2.5	0.0	1.1	0.8	2.0	6.4	1.3
LRRC9	FLJ46156	ENSG00000131951	"Leucine rich repeat containing 9"	Q6ZRR7	14	59919713-60063559	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 5.4;choroid plexus: 12.4;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 112.6;Excitatory neurons: 28.0;Inhibitory neurons: 18.0;Late spermatids: 75.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040965, HPA041381, HPA077675"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Nuclear bodies"	"HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: "	"unprognostic (1.01e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.62e-3)"	"unprognostic (8.54e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-2)"	0.3	0.1	0.9	0.0	1.6	0.1	0.0	1.0	0.6	0.0	12.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	5.2	5.4	0.0	0.0	0.7	0.5	0.0	3.7	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	4.3	0.0	0.0	8.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.0	0.6	1.0	1.7	5.2	5.4	3.7	4.3	1.9	5.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.6	1.5	0.1	0.1	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.7	18.0	0.0	0.0	0.0	0.0	75.8	0.9	0.1	0.0	1.9	0.0	0.8	0.0	5.5	2.0	0.0	0.0	0.7	0.0	0.7	0.4	0.0	2.9	0.2	0.0	0.0	0.0	10.3	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
LRRIQ3	"LRRC44, MGC22773"	ENSG00000162620	"Leucine rich repeats and IQ motif containing 3"	A6PVS8	1	74026015-74198187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 20.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 258.5;Late spermatids: 103.6;Spermatocytes: 204.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.9;JURKAT: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA030799	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA030799: AB_10601337"	"unprognostic (5.94e-3)"	"unprognostic (6.00e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.65e-2)"	1.6	0.7	0.5	0.7	0.5	0.1	0.7	0.6	0.7	0.2	1.2	0.3	0.2	0.2	0.3	0.1	2.1	0.4	0.3	0.4	0.6	2.0	0.9	0.3	0.7	0.7	0.8	0.3	0.2	1.2	0.5	0.2	0.7	0.4	0.2	0.5	0.7	0.4	0.1	0.1	0.2	0.0	0.6	0.4	0.3	20.4	0.7	1.0	1.5	0.5	0.6	0.2	0.1	0.7	0.2	1.0	0.1	0.4	1.0	0.4	0.6	0.6	0.4	0.8	0.9	0.1	1.4	1.4	1.2	0.1	7.9	0.1	2.1	2.0	1.0	3.5	0.0	1.3	0.3	0.7	0.1	2.3	0.7	0.7	1.0	1.4	0.5	0.3	0.4	4.8	1.1	1.9	1.4	0.0	0.9	0.3	1.1	2.5	0.6	1.1	0.8	1.4	1.2	0.1	1.0	0.7	0.1	0.1	3.1	0.2	0.9	1.3	0.1	0.1	0.7	0.5	1.2	2.0	0.7	1.1	1.5	0.2	1.1	0.0	0.0	0.8	0.9	0.5	1.1	1.6	1.0	1.1	0.1	0.7	0.9	1.3	0.0	0.4	0.1	0.4	1.6	0.3	0.5	0.5	0.6	0.7	0.4	0.6	0.7	0.8	0.7	0.6	0.7	0.7	1.0	0.0	1.5	2.0	2.8	1.1	1.2	4.0	0.0	1.0	2.0	2.8	1.2	2.8	2.6	0.0	4.2	1.7	0.5	0.3	13.7	1.5	258.5	21.6	0.8	0.8	3.0	0.4	4.1	1.7	1.5	0.3	0.0	1.5	0.0	3.2	0.7	1.8	1.3	0.0	3.9	0.6	0.0	0.6	0.2	103.6	1.8	0.5	0.0	1.9	0.8	1.2	2.1	2.0	4.0	0.9	0.1	1.5	0.6	0.9	0.1	6.3	36.0	0.7	0.0	0.2	1.5	204.8	31.3	0.0	0.1	0.3	1.5	3.6	0.7	1.2
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.2;thyroid gland: 19.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.0;Bipolar cells: 29.2;Cardiomyocytes: 24.8;Excitatory neurons: 81.2;Inhibitory neurons: 46.5;Leydig cells: 56.2;Oligodendrocyte precursor cells: 61.3"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.5;naive CD8 T-cell: 30.9"	"Lineage enriched"	"Detected in single"	70	"T-cells: 32.5"	"Cell line enhanced"	"Detected in some"		"AF22: 24.7;BJ: 14.7;BJ hTERT+: 31.0;GAMG: 15.6;SH-SY5Y: 43.9;SuSa: 13.6;T-47d: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA043820: AB_2678687, HPA046792: AB_2679810"	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.2	23.2	11.9	1.2	12.8	0.6	1.7	10.4	14.7	2.5	4.3	0.9	0.4	0.5	2.3	1.3	0.7	1.0	8.0	11.9	10.4	0.4	2.2	7.5	3.0	6.8	8.5	6.3	0.9	0.2	3.0	5.8	8.6	2.6	1.0	6.3	1.2	4.9	4.1	0.3	1.4	0.4	7.7	1.4	0.4	14.9	13.2	10.5	19.6	0.5	3.6	0.8	0.9	8.9	0.0	0.1	24.7	3.1	11.2	4.8	0.1	14.7	31.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	15.6	0.1	1.5	0.0	3.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.3	0.1	0.0	0.1	0.1	6.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.0	43.9	0.0	0.0	0.0	13.6	24.3	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	2.7	2.0	0.0	0.1	32.5	30.9	0.2	0.0	0.1	0.0	0.4	6.1	11.9	12.8	10.4	14.7	11.9	10.4	6.8	8.5	8.6	7.7	13.2	8.9	0.8	0.0	4.3	47.0	0.8	0.0	0.0	0.0	0.0	29.2	0.6	0.8	24.8	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	1.1	0.3	0.5	1.2	1.8	0.0	81.2	0.0	0.5	13.3	1.5	0.5	1.3	0.0	1.1	0.0	0.8	3.3	46.5	0.0	0.0	0.0	0.4	4.4	56.2	0.2	1.8	7.5	0.8	11.0	1.0	61.3	7.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	3.8	0.0	1.6	1.7	1.1	0.4	0.0	0.1	0.4	10.3	0.5	0.0	0.2
LRRN4CL		ENSG00000177363	"LRRN4 C-terminal like"	Q8ND94	11	62686406-62689530	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 62.1;Leydig cells: 27.1;Melanocytes: 33.8;Peritubular cells: 17.3;Skeletal myocytes: 33.0"	"Cancer enriched"	"Detected in many"	5	"melanoma: 26.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.7;ASC TERT1: 25.3;HHSteC: 19.8;HSkMC: 10.6;LHCN-M2: 13.4"	"Low region specificity"	"Detected in many"							HPA050317	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA050317: AB_2681084"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.95e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-7)"	"unprognostic (2.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-2)"	23.3	6.6	0.4	2.5	0.4	0.5	16.0	1.5	1.3	22.4	2.6	15.1	1.8	29.7	3.7	4.5	18.2	3.6	7.2	0.6	0.6	1.0	0.1	3.5	0.5	0.5	0.3	21.0	1.1	0.3	1.7	0.7	0.4	6.1	2.1	0.4	5.5	5.8	4.8	10.6	7.2	9.1	0.2	0.2	8.2	1.5	0.5	0.4	4.2	5.6	0.3	9.7	16.1	0.7	0.0	0.1	0.2	0.3	7.7	25.3	0.3	2.8	4.0	0.3	1.4	0.2	0.1	0.2	0.3	4.6	0.1	0.3	0.1	0.0	0.4	0.2	0.2	0.5	0.2	0.2	19.8	0.2	0.2	10.6	0.1	0.6	0.0	0.2	0.1	0.4	0.3	0.1	13.4	0.1	0.3	0.6	0.6	0.1	0.1	0.1	1.7	0.3	0.0	0.2	0.8	0.3	0.4	0.3	0.8	0.1	0.2	0.3	0.3	2.4	0.2	2.7	0.1	0.2	0.2	0.3	1.5	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.0	0.4	0.4	1.5	1.3	0.6	0.6	0.5	0.3	0.4	0.2	0.5	0.7	4.0	0.0	1.8	0.0	0.1	6.6	2.1	0.0	0.0	2.1	0.5	0.8	1.5	0.0	0.6	0.0	2.1	0.1	0.2	0.0	0.0	0.0	1.0	0.5	11.0	3.7	1.2	0.0	0.1	0.0	0.2	62.1	0.5	0.4	1.3	0.2	1.4	0.1	0.4	1.7	0.3	0.3	0.0	0.6	8.3	0.5	27.1	1.1	33.8	1.9	0.1	0.2	1.0	0.0	0.1	0.0	0.1	17.3	0.4	1.4	0.1	0.3	0.0	1.0	0.0	33.0	2.8	0.4	0.3	0.5	7.0	0.1	1.1	1.2	0.1	1.3
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926036-67101551	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.6;brain: 4.8;ovary: 2.7;pituitary gland: 3.4"	"Group enriched"	"Detected in some"	22	"Early spermatids: 164.0;Excitatory neurons: 485.6;Inhibitory neurons: 577.7;Late spermatids: 178.7;Oligodendrocyte precursor cells: 601.7;Oligodendrocytes: 253.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;HAP1: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies"	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.1	2.6	2.7	0.0	3.1	0.0	0.0	1.0	4.8	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.9	0.7	0.0	0.0	0.2	0.0	0.0	0.6	2.7	1.0	0.0	3.4	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.1	1.0	4.8	3.9	0.7	0.0	0.6	0.0	0.1	1.0	3.4	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.0	0.0	0.2	0.2	0.0	0.0	485.6	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	577.7	0.0	0.0	0.0	0.0	178.7	8.7	0.1	0.0	8.4	0.0	0.4	0.0	601.7	253.5	0.1	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.3	2.5	1.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464956-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"testis: 275.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 1002.6;Spermatocytes: 677.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	8.2	16.8	10.7	6.8	10.7	14.9	7.9	11.4	13.1	10.4	10.7	8.9	5.3	10.0	2.3	7.7	13.8	3.9	9.7	13.0	11.5	11.4	15.0	10.1	8.1	12.1	14.4	9.4	9.3	8.7	17.6	3.1	12.2	8.6	2.3	3.4	7.6	6.1	13.2	6.7	17.1	4.2	10.8	24.3	9.0	275.2	12.1	8.7	10.0	5.3	7.3	8.9	7.3	10.2	18.6	24.6	13.0	36.8	9.4	7.2	21.0	19.6	11.9	30.5	20.9	23.7	10.3	44.8	27.5	13.9	36.3	19.2	18.7	16.4	9.0	16.6	39.2	10.0	11.1	14.8	12.7	17.6	17.4	6.7	9.9	35.4	7.5	10.2	16.2	33.9	44.5	13.3	16.8	54.3	53.4	42.1	28.7	22.0	37.8	28.2	12.2	48.5	9.2	11.3	17.7	50.7	21.0	20.1	19.3	14.6	11.2	14.4	11.1	17.3	37.7	54.8	30.8	50.5	94.3	43.6	19.3	17.1	31.4	10.6	2.6	9.9	9.7	4.0	9.0	10.0	8.4	8.4	2.7	11.8	5.2	6.9	5.5	10.5	3.8	9.7	9.3	6.0	10.7	10.7	11.4	13.1	13.0	11.5	12.1	14.4	12.2	10.8	12.1	10.2	9.1	0.0	1.1	5.5	10.6	10.5	6.4	16.5	3.4	11.7	5.5	5.0	0.8	2.8	12.8	12.9	2.1	9.2	10.8	8.6	7.9	12.3	1002.6	54.4	7.3	6.5	7.8	13.7	4.7	10.5	12.4	7.0	10.7	13.7	0.0	14.8	5.7	7.2	8.8	5.0	5.0	9.8	18.3	3.4	4.0	172.3	19.0	5.0	5.4	2.8	7.2	7.9	10.3	4.5	2.8	12.4	11.2	15.8	20.2	3.9	8.6	15.9	65.3	11.4	0.0	5.4	13.6	677.0	38.3	4.5	9.8	6.2	9.3	22.2	7.5	3.4
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640791-194672463	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	14.9	12.8	13.2	15.8	13.8	28.1	15.8	13.9	15.9	12.8	14.0	15.1	17.2	15.2	19.8	15.9	14.5	12.6	14.0	13.1	14.5	16.6	21.7	12.8	18.7	14.7	16.4	14.2	15.5	16.8	11.1	17.2	15.8	14.6	18.1	14.0	13.8	13.9	23.0	19.3	14.9	14.5	14.0	15.4	13.6	14.4	14.4	17.2	15.5	18.9	21.3	18.2	14.3	15.4	55.6	36.0	21.2	35.3	32.3	17.8	43.1	31.0	30.1	42.9	37.6	47.9	25.1	43.1	93.5	29.4	75.5	39.5	68.2	35.0	52.1	56.3	32.5	46.8	38.4	27.6	22.9	51.1	42.4	17.3	31.5	44.4	41.7	16.0	47.1	29.4	39.5	46.2	36.0	76.6	46.3	30.8	57.7	73.5	65.6	56.2	35.0	49.3	23.7	46.9	40.5	27.9	39.9	38.2	40.0	39.7	90.3	32.9	36.5	32.4	37.3	46.2	66.6	50.6	71.1	97.7	26.2	64.7	52.4	3.5	10.1	13.6	15.3	13.2	17.1	16.6	12.5	13.9	17.2	14.3	14.4	12.9	1.3	21.0	8.9	9.0	15.4	10.6	13.2	13.8	13.9	15.9	13.1	14.5	14.7	16.4	15.8	14.0	14.4	15.4	25.0	19.2	29.6	10.4	22.5	16.2	13.4	8.9	25.0	18.3	12.1	11.9	17.2	18.6	27.9	9.2	12.5	25.1	21.2	14.0	5.9	23.3	12.0	22.1	24.5	23.7	7.8	16.2	10.5	22.4	19.4	17.7	21.9	24.0	53.7	21.9	11.7	14.0	13.0	15.2	8.3	14.2	12.2	4.4	10.2	8.9	15.5	15.5	12.4	8.4	14.0	18.2	12.3	12.5	12.2	19.7	8.0	14.7	23.8	11.5	10.8	9.7	34.3	18.6	19.7	22.1	14.6	26.4	35.7	30.5	16.1	28.5	24.0	23.2	17.6	9.0
LSM10	MGC15749	ENSG00000181817	"LSM10, U7 small nuclear RNA associated"	Q969L4	1	36391238-36397908	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048469			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA048469: AB_2756307"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.89e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (8.54e-2)"	39.2	32.7	53.1	32.0	54.2	23.9	32.8	54.5	67.5	31.9	55.0	62.3	20.1	36.3	30.4	26.8	31.6	22.7	72.9	53.4	58.7	42.3	51.7	30.6	52.3	54.4	55.2	31.7	30.5	36.9	41.8	18.0	55.3	40.8	17.7	9.7	29.1	30.5	165.0	30.1	36.7	27.9	55.2	55.3	38.7	28.9	57.8	27.2	31.0	110.3	47.6	42.8	28.2	54.3	54.6	81.2	29.9	80.7	68.9	67.2	31.0	47.9	69.4	75.1	57.1	36.4	50.6	127.4	64.5	65.0	55.6	29.3	51.2	62.1	49.5	87.1	61.2	64.1	47.1	87.1	83.8	49.0	90.3	56.8	54.4	67.6	47.6	40.7	77.8	71.7	60.2	60.5	53.4	96.3	54.8	55.5	77.5	67.0	83.3	40.9	28.8	86.3	73.6	32.6	38.1	28.7	38.7	49.4	120.6	47.9	25.5	41.3	52.2	34.0	47.3	90.0	76.0	79.5	115.7	102.4	68.4	73.9	78.7	240.2	264.1	340.1	125.3	266.4	139.0	386.4	125.1	132.0	189.4	388.0	112.1	120.7	346.4	111.6	256.4	243.9	172.3	301.8	53.1	54.2	54.5	67.5	53.4	58.7	54.4	55.2	55.3	55.2	57.8	54.3	27.8	12.8	14.4	3.9	82.2	32.2	37.2	53.3	13.1	17.4	40.9	44.4	55.9	21.5	30.4	46.0	6.2	56.1	58.5	23.4	140.8	40.7	9.7	18.6	32.7	31.7	28.2	40.2	8.6	47.1	58.8	36.8	19.4	23.3	41.2	25.7	32.2	66.8	105.7	18.5	9.1	23.4	63.1	77.0	89.3	32.9	38.8	67.6	51.6	7.5	72.0	41.0	66.9	3.5	6.7	47.4	35.3	47.0	67.0	40.3	47.7	106.4	12.4	14.3	13.1	28.4	38.8	7.8	23.4	27.7	40.1	40.0	51.0	43.3	28.5	27.3
LSM11	FLJ38273	ENSG00000155858	"LSM11, U7 small nuclear RNA associated"	P83369	5	157743712-157760709	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039587	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA039587: AB_10796330"	"unprognostic (3.99e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.01e-2)"	2.0	2.1	3.6	1.9	3.8	1.7	2.2	3.8	4.8	4.3	0.2	6.4	2.3	5.3	1.5	2.2	3.1	2.3	1.2	4.0	2.3	1.3	1.3	1.8	2.1	2.7	3.0	3.4	1.9	1.8	2.2	2.1	3.0	4.3	2.6	7.1	1.8	4.7	1.4	2.2	2.3	3.3	3.0	1.6	2.3	4.1	2.7	1.8	1.2	1.4	2.1	9.8	3.5	3.0	3.2	2.3	6.2	6.6	2.7	3.5	5.4	4.3	1.9	3.6	4.7	6.9	3.1	7.0	4.9	2.5	2.5	3.7	8.1	4.7	3.9	5.0	7.6	2.9	8.6	4.4	1.0	8.7	3.5	1.6	3.1	4.3	4.4	4.0	5.9	5.7	5.5	3.7	3.9	3.0	4.9	5.1	1.8	2.6	6.9	7.7	7.7	2.9	1.8	2.9	3.6	5.7	2.8	3.8	3.8	4.5	3.2	5.3	4.2	6.9	2.7	4.1	6.9	3.0	2.0	6.9	2.8	8.9	3.1	0.4	0.1	0.0	0.2	0.1	0.3	0.1	0.3	0.2	0.1	0.1	0.2	0.2	0.1	0.4	0.0	0.0	0.2	0.1	3.6	3.8	3.8	4.8	4.0	2.3	2.7	3.0	3.0	3.0	2.7	3.0	3.6	6.4	4.1	2.3	2.7	3.6	3.5	1.3	2.2	26.1	3.3	2.5	2.2	1.5	3.1	3.7	6.2	2.1	4.7	3.1	0.0	1.7	10.6	0.8	3.7	3.2	3.0	1.3	11.7	0.9	4.8	3.6	2.0	1.6	1.3	5.5	3.9	2.2	2.2	8.4	11.8	2.0	0.0	4.2	5.7	15.7	1.5	2.6	0.0	1.0	3.5	2.2	4.1	1.5	2.4	1.8	6.2	4.1	2.4	3.7	2.1	1.5	1.9	7.8	0.0	4.3	9.1	10.5	10.9	1.9	4.3	1.2	2.8	2.1	5.5	4.0
LSM2	"C6orf28, G7b, YBL026W"	ENSG00000204392	"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y333	6	31797396-31806966	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052805, HPA066718"	Supported		Enhanced	Nucleoplasm		NA	NA		97000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA052805: , HPA066718: AB_2685710"	"unprognostic (1.69e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.59e-9)"	"unprognostic (2.23e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-2)"	38.6	34.3	19.0	19.3	21.8	32.7	37.9	20.6	21.4	44.8	17.4	43.0	23.6	45.0	19.3	39.0	36.9	18.1	32.3	19.4	19.1	43.8	27.6	31.6	36.6	22.8	19.6	37.6	37.2	20.5	30.1	22.5	21.7	29.7	27.8	7.2	25.2	16.3	43.9	37.0	33.6	27.7	24.5	43.5	34.6	26.7	22.9	45.1	30.1	20.9	39.3	39.9	35.6	23.7	91.1	42.5	84.9	103.7	43.8	61.9	58.4	50.1	38.5	85.2	75.1	56.9	37.6	50.3	66.8	50.1	79.8	36.2	109.3	101.1	76.9	72.4	85.0	83.6	27.3	60.1	55.7	80.6	39.7	47.1	47.3	78.6	80.4	40.6	90.3	102.0	127.5	63.0	60.7	73.3	132.3	168.4	56.8	75.0	77.6	73.4	40.5	123.4	69.5	31.6	66.6	55.6	56.0	58.8	101.7	44.7	61.6	68.7	20.1	47.6	74.5	54.1	85.1	53.2	109.9	88.2	26.8	123.3	76.7	29.1	31.3	15.9	36.9	37.7	45.2	3.7	51.6	33.6	35.4	4.1	45.6	30.1	8.7	13.8	25.1	30.9	29.9	57.5	19.0	21.8	20.6	21.4	19.4	19.1	22.8	19.6	21.7	24.5	22.9	23.7	82.9	22.4	23.6	4.6	95.2	58.2	63.7	104.9	56.3	30.9	108.2	177.2	14.9	60.1	48.5	55.2	6.2	143.5	58.5	36.5	113.5	104.5	20.1	38.8	61.2	90.2	54.0	121.8	5.9	137.1	218.8	58.0	46.9	49.2	82.6	119.9	72.8	59.7	143.2	30.3	6.0	93.9	73.2	67.9	76.8	26.0	49.7	56.6	92.5	3.7	99.3	53.3	109.2	9.5	19.8	94.0	55.7	49.2	91.5	78.2	40.8	113.3	24.2	28.3	46.0	70.7	71.4	66.9	176.5	90.8	64.2	69.0	77.8	101.3	113.6	58.6
LSM3	"SMX4, USS2, YLR438C"	ENSG00000170860	"LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62310	3	14178817-14201122	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 752.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044966	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		30000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	Nucleoplasm	"HPA044966: AB_2679159"	"unprognostic (3.84e-3)"	"unprognostic (7.00e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.94e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.07e-3)"	"unprognostic (4.93e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-3)"	12.6	10.8	12.1	11.0	12.6	18.9	12.6	13.2	16.6	8.7	12.1	12.1	12.4	9.1	10.4	12.1	8.2	6.5	17.4	12.6	12.7	23.3	18.4	8.2	12.9	12.3	12.0	9.4	9.5	11.0	9.0	10.3	12.5	9.8	11.2	10.7	9.2	8.3	30.1	10.1	12.9	8.1	12.4	9.7	10.5	12.3	12.6	16.8	10.7	22.4	11.8	10.3	8.7	13.2	36.0	28.6	30.1	31.3	13.8	16.0	76.3	29.0	19.3	36.6	34.8	32.6	27.6	39.5	23.5	20.3	25.7	16.4	34.5	28.4	36.0	37.5	42.3	41.8	38.1	31.5	7.1	47.3	29.0	12.0	20.2	36.8	15.6	16.4	19.1	34.0	45.9	30.7	27.4	41.5	50.4	64.2	52.1	40.2	38.5	27.4	37.3	43.5	34.6	36.7	16.8	27.2	33.2	46.1	28.6	34.3	53.2	59.7	17.3	23.3	37.2	28.3	50.6	21.4	67.3	73.6	29.5	45.9	33.8	44.1	18.9	30.0	14.8	23.7	17.7	27.3	17.1	17.5	18.3	21.7	18.4	19.7	17.8	21.9	20.3	28.7	22.9	25.7	12.1	12.6	13.2	16.6	12.6	12.7	12.3	12.0	12.5	12.4	12.6	13.2	114.2	67.3	94.3	11.4	118.2	97.8	135.4	328.8	115.5	52.5	124.2	171.4	263.4	155.8	164.6	126.9	18.8	391.8	114.2	158.2	485.2	220.4	337.8	111.2	97.8	104.5	104.7	111.9	8.3	265.5	409.6	120.0	67.8	115.2	138.2	142.4	128.8	234.8	235.5	55.5	8.3	195.4	175.0	132.9	115.0	153.1	140.1	119.6	97.8	5.6	202.4	180.7	170.0	7.1	13.3	219.2	196.7	139.9	154.2	110.2	203.9	752.2	122.3	68.2	105.2	111.5	117.9	288.5	295.5	150.8	101.2	318.4	93.6	144.6	205.7	177.2
LSM8	YJR022W	ENSG00000128534	"LSM8 homolog, U6 small nuclear RNA associated"	O95777	7	118184144-118204035	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020116	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Vesicles"		"HPA020116: AB_1853385"	"unprognostic (1.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.46e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.00e-3)"	26.8	19.1	6.2	22.3	8.3	44.8	25.6	16.5	7.7	20.5	6.2	22.0	15.5	19.9	16.5	24.4	18.7	9.2	19.2	6.3	7.5	23.7	18.5	21.2	28.9	7.5	7.4	19.8	24.9	8.4	16.3	10.1	7.7	20.8	14.2	16.7	22.7	7.8	21.7	21.6	26.0	8.3	6.8	30.9	21.3	17.3	7.2	18.2	22.1	7.8	27.5	20.0	20.6	10.5	37.2	21.2	53.7	43.6	11.3	19.4	25.3	36.1	26.4	19.2	21.5	16.8	35.6	70.0	78.9	13.4	51.5	28.2	23.1	16.3	18.6	35.9	27.7	49.5	63.3	48.6	29.2	63.9	59.1	20.8	19.6	24.6	25.8	17.7	19.6	55.8	45.8	71.2	26.1	13.2	142.9	155.6	43.6	28.9	26.0	40.8	32.0	53.3	20.3	27.8	28.2	41.6	29.2	83.0	89.1	36.9	17.3	72.7	17.4	36.9	27.7	56.3	51.2	69.9	52.0	101.1	29.1	66.9	61.5	65.3	46.5	45.5	61.8	66.7	59.8	68.0	67.8	75.6	51.5	58.0	64.6	67.5	15.4	43.9	65.7	93.2	74.2	39.5	6.2	8.3	16.5	7.7	6.3	7.5	7.5	7.4	7.7	6.8	7.2	10.5	108.5	25.6	58.6	15.0	130.3	0.0	93.6	0.0	82.6	41.5	71.8	92.1	43.5	74.4	35.3	62.5	47.9	133.2	141.2	76.8	90.1	101.2	54.6	76.1	92.8	79.6	86.4	83.1	19.5	172.0	193.6	69.0	66.3	76.4	101.4	87.1	88.5	75.3	139.8	42.1	22.4	99.1	0.0	148.9	0.0	19.1	97.3	102.2	0.0	36.5	184.9	52.6	158.6	23.6	39.1	144.8	109.0	76.0	95.6	108.6	83.6	106.8	36.5	42.0	85.5	65.3	66.2	135.3	117.8	106.7	0.0	120.8	121.1	76.1	100.7	121.2
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279087-50288114	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.9;skeletal muscle: 16.5"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 283.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA079523			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA079523: "	"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.4	0.4	2.9	0.1	4.8	0.4	0.3	3.1	3.7	1.3	1.8	0.5	0.3	0.7	0.2	0.5	0.7	0.2	23.9	3.2	3.2	0.8	0.2	0.4	0.0	3.7	3.7	1.2	0.2	0.0	0.1	0.1	3.4	0.4	0.1	0.3	0.2	0.4	16.5	0.2	0.3	0.4	2.7	0.2	0.3	3.9	3.8	0.0	0.2	5.5	0.0	0.4	0.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	4.8	3.1	3.7	3.2	3.2	3.7	3.7	3.4	2.7	3.8	6.0	1.0	0.0	0.6	0.7	0.3	1.0	0.2	0.2	0.0	0.2	1.5	0.9	4.4	0.0	0.8	1.8	0.0	0.1	0.3	0.9	0.0	0.1	40.5	3.3	0.6	0.8	0.0	0.0	0.2	0.2	0.1	0.4	0.0	10.1	5.1	0.2	0.0	0.3	0.1	0.0	0.2	0.3	0.0	0.3	0.4	283.1	1.2	0.3	1.8	0.0	0.0	0.5	0.0	0.0	2.8	0.2	0.0	0.7	0.0	0.4	1.5	0.1	0.2	0.2	0.0	1.4	4.7	1.8	1.1	0.4	1.3	0.1	0.2	0.1	0.7	0.1
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000753-96043520	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 207.2;Kupffer cells: 255.8;monocytes: 245.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		86000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	40.2	66.9	24.6	64.5	25.5	180.4	53.6	29.4	30.6	55.6	33.8	48.2	78.1	51.1	38.4	110.1	61.7	40.3	35.5	25.0	27.8	58.1	43.9	190.8	64.1	26.3	25.4	110.5	54.9	53.3	37.4	27.4	26.0	41.1	49.6	36.9	41.2	40.9	45.0	67.8	60.5	58.3	25.7	57.8	46.6	19.9	28.1	49.2	49.4	45.0	96.4	51.9	52.7	33.0	85.2	90.4	123.5	73.4	104.2	115.1	53.8	33.7	101.8	67.5	78.1	66.6	72.0	190.0	42.0	51.9	52.8	108.3	103.4	140.1	92.3	63.3	97.0	68.5	54.3	81.8	61.8	35.7	39.4	110.1	118.4	91.9	114.5	305.3	134.9	101.1	42.9	32.5	98.7	59.2	96.7	115.0	145.8	100.7	115.5	88.9	90.5	109.7	125.7	107.7	63.9	75.5	64.2	80.4	78.3	95.1	98.7	44.7	49.0	28.3	47.6	40.2	38.2	42.8	79.4	85.4	19.1	66.2	22.3	4.4	662.9	17.7	33.4	699.2	63.4	126.1	46.6	43.4	282.3	157.5	65.0	50.5	46.0	120.4	638.8	70.4	51.2	591.5	24.6	25.5	29.4	30.6	25.0	27.8	26.3	25.4	26.0	25.7	28.1	33.0	32.8	38.5	135.0	15.3	82.8	51.9	64.8	96.6	52.3	21.4	41.8	41.1	25.3	25.8	110.2	38.6	33.3	29.3	47.9	17.6	74.3	42.9	74.3	18.4	20.8	38.2	21.6	50.5	21.3	28.0	28.2	29.7	38.2	27.3	7.6	31.5	57.8	21.7	207.2	11.8	18.5	40.4	40.7	255.8	76.6	16.4	36.7	183.3	21.4	10.3	245.5	35.5	26.8	19.6	17.5	20.8	27.1	41.0	40.1	35.4	73.2	69.3	45.0	55.6	6.6	26.7	35.4	46.9	11.6	108.0	74.9	20.8	39.1	32.9	70.4	49.7
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7;skin 1: 46.4"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 18.2;Squamous epithelial cells: 15.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	5.1	5.8	0.4	2.1	0.5	5.4	4.7	0.5	0.4	15.8	0.4	2.7	2.6	3.0	0.8	37.7	4.0	0.9	2.2	0.3	0.3	2.8	4.0	4.7	2.0	1.2	0.4	4.9	4.7	0.2	3.9	1.0	0.5	5.0	0.5	2.1	11.7	1.2	3.0	46.4	5.1	0.5	0.5	13.5	2.7	4.2	0.6	1.7	3.9	0.1	3.2	2.7	21.6	0.8	2.4	3.9	1.6	1.7	0.3	0.5	7.1	0.8	0.4	1.2	0.7	3.1	1.3	2.9	1.4	0.5	1.6	15.0	1.1	2.5	0.8	3.7	4.4	2.0	3.7	1.5	0.4	3.4	3.7	0.5	3.1	1.7	2.0	1.0	0.5	5.3	2.6	3.3	0.5	4.4	1.8	3.5	0.9	0.1	4.7	7.4	1.5	1.7	0.3	2.8	3.1	1.5	1.5	1.8	1.3	1.7	3.4	2.5	1.5	2.3	2.8	3.6	1.3	7.1	2.1	4.7	0.5	5.5	1.8	0.0	0.5	0.3	0.6	0.3	0.3	0.0	0.5	0.5	0.5	0.0	0.3	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.4	0.5	0.5	0.4	0.3	0.3	1.2	0.4	0.5	0.5	0.6	0.8	2.3	0.0	0.0	0.0	0.7	0.3	3.4	0.1	18.2	0.4	0.6	1.3	0.0	0.0	0.0	1.8	0.0	0.2	1.2	0.5	0.0	0.2	0.0	1.9	0.2	1.6	1.8	2.1	0.0	1.4	0.1	0.5	1.5	0.4	0.0	0.2	1.1	1.0	0.7	3.3	0.0	0.4	0.0	1.9	0.0	0.0	0.3	1.8	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.4	1.2	0.0	3.0	0.4	1.1	0.3	0.7	0.5	0.0	0.3	0.2	0.9	0.2	15.7	0.1	0.3	2.3	0.3	0.8	0.8
LTBP2	"C14orf141, LTBP3"	ENSG00000119681	"Latent transforming growth factor beta binding protein 2"	Q14767	14	74498183-74612378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Heparin-binding"	"Disease variant, Dwarfism, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 60.6;Fibroblasts: 59.5;Peritubular cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 240.8;HUVEC TERT2: 129.1;LHCN-M2: 129.4;TIME: 564.5"	"Group enriched"	"Detected in some"	10	"cerebellum: 5.3;olfactory bulb: 2.4"	"Region enhanced"	"Detected in many"		"olfactory bulb: 15.4"	HPA003415	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		14000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA003415: AB_1079284"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.94e-4)"	34.2	4.0	1.1	15.2	2.9	0.6	24.4	4.1	5.6	66.2	9.5	6.6	3.1	22.5	23.9	10.7	11.7	33.1	45.4	1.2	1.1	4.1	2.1	64.9	8.3	2.2	1.1	39.4	8.7	9.6	7.3	28.0	1.4	15.7	2.6	2.3	26.7	19.6	13.6	12.6	6.9	16.0	2.2	3.9	8.5	5.4	1.9	3.1	53.0	21.4	6.1	14.2	21.6	1.0	2.5	4.9	1.2	0.2	36.9	67.7	0.2	47.4	16.2	9.2	5.7	0.0	17.4	0.4	13.8	240.8	4.1	4.8	0.2	17.7	3.8	0.2	0.8	0.8	2.2	2.1	8.8	0.1	0.6	70.2	7.7	50.7	29.1	68.9	129.1	0.1	0.2	0.1	129.4	1.1	0.1	0.3	0.3	0.2	4.5	0.5	1.1	0.1	11.3	6.7	1.0	3.3	33.1	0.1	1.1	3.4	1.1	0.2	564.5	3.3	54.0	17.0	18.0	0.7	0.7	0.1	13.1	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	2.9	4.1	5.6	1.2	1.1	2.2	1.1	1.4	2.2	1.9	1.0	3.8	0.0	2.2	2.3	0.1	5.6	15.1	13.0	13.1	2.1	1.9	60.6	6.4	0.0	6.1	0.0	0.0	0.5	1.2	0.1	5.9	1.4	1.2	0.5	7.9	6.5	0.0	5.7	1.1	0.4	0.3	59.5	1.5	0.9	1.3	1.9	9.3	0.4	4.2	3.3	0.7	0.0	20.3	0.3	5.8	5.8	16.4	3.7	0.0	22.5	0.1	0.4	0.0	1.0	0.3	4.4	0.0	82.4	0.3	10.7	0.0	0.0	0.3	1.0	6.6	3.2	10.8	2.8	3.8	5.2	1.0	1.2	0.9	2.2	0.1	2.1
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"granulocytes: 327.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 20.2;eosinophil: 63.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 63.1"	"Cell line enriched"	"Detected in some"	11	"HMC-1: 102.0"					"Low region specificity"	"Detected in many"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	8.9	6.9	1.1	0.5	0.8	2.3	5.5	1.5	1.3	4.2	0.7	3.3	0.7	5.7	0.0	3.1	11.8	0.3	12.4	1.0	1.4	7.1	1.9	7.7	0.2	2.1	1.5	5.7	2.0	0.2	3.5	0.4	1.4	4.8	0.2	0.0	4.3	0.8	1.0	3.1	3.2	0.4	2.9	6.1	3.0	1.5	2.6	0.0	5.9	0.0	0.1	4.8	4.0	4.7	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.9	8.9	0.2	0.4	0.3	0.6	102.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	3.2	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.0	0.1	20.2	0.5	63.1	0.8	0.6	3.0	0.3	2.1	1.5	8.6	0.2	0.4	1.0	0.3	4.7	0.0	0.4	0.2	0.6	1.1	0.8	1.5	1.3	1.0	1.4	2.1	1.5	1.4	2.9	2.6	4.7	32.3	0.0	3.2	2.9	2.3	9.9	9.6	11.2	14.8	0.4	26.4	38.6	0.0	14.3	6.2	14.7	0.0	10.4	5.0	0.6	1.9	5.9	0.3	4.0	1.5	49.5	3.0	2.1	0.8	2.4	1.9	8.3	3.1	5.6	327.4	0.5	72.1	0.9	41.5	0.0	0.7	1.7	0.0	20.8	46.3	0.9	16.4	53.9	1.8	28.1	2.0	0.1	2.1	1.0	1.5	1.9	0.5	47.4	10.0	3.7	2.2	54.8	5.8	0.5	0.0	0.8	1.6	0.1	0.7	5.2	7.0	3.0	10.0	1.5	3.1	10.0
LTO1	"CIAB1, ORAOV1, TAOS1"	ENSG00000149716	"LTO1 maturation factor of ABCE1"	Q8WV07	11	69653076-69675416	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.2;Cardiomyocytes: 2.7;Cytotrophoblasts: 7.9;dendritic cells: 3.6;Extravillous trophoblasts: 3.5;Hofbauer cells: 6.7;Syncytiotrophoblasts: 5.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 75.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062696			Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA062696: AB_2684837"	"unprognostic (2.15e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.65e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.19e-3)"	10.9	15.7	20.3	8.1	21.6	8.4	11.6	20.7	22.4	13.7	18.1	14.0	8.8	13.0	17.8	16.0	12.9	4.7	16.8	20.2	20.2	15.4	14.7	9.9	9.9	21.2	20.6	14.8	19.5	5.7	16.2	5.4	21.8	17.5	6.6	5.8	12.3	6.0	10.3	17.9	13.7	5.8	19.5	18.0	15.1	13.2	20.9	8.6	13.9	5.3	8.9	14.4	13.9	25.4	75.8	16.1	11.1	12.9	11.0	9.5	13.4	24.6	13.4	18.5	10.6	26.6	24.1	17.3	12.8	15.0	14.0	30.6	15.5	13.1	22.7	9.9	20.3	18.0	32.1	17.2	16.9	13.5	10.8	11.1	16.6	20.4	20.5	10.7	13.7	15.8	18.7	11.5	18.2	24.9	12.6	25.6	11.8	33.1	30.7	11.5	18.8	14.8	12.1	11.9	13.2	12.0	16.9	13.0	58.9	9.4	19.4	14.3	14.9	19.7	16.3	31.5	20.1	15.4	11.0	13.5	30.9	15.0	18.9	1.5	3.3	2.8	5.5	2.9	4.3	5.7	5.0	3.8	3.8	4.5	6.1	5.3	3.4	2.9	7.4	5.4	6.4	2.9	20.3	21.6	20.7	22.4	20.2	20.2	21.2	20.6	21.8	19.5	20.9	25.4	4.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	7.9	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.7	0.5	0.0	0.0	0.0
LTV1	"C6orf93, dJ468K18.4, FLJ14909"	ENSG00000135521	"LTV1 ribosome biogenesis factor"	Q96GA3	6	143843338-143863812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030159, HPA030160, HPA030161"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001"	"unprognostic (2.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (7.09e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (6.01e-13)"	"unprognostic (2.94e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.41e-1)"	26.3	22.6	12.2	22.4	13.2	52.5	24.1	13.4	16.3	18.8	12.9	20.3	15.7	22.2	15.6	23.3	19.4	12.4	18.7	12.6	13.7	18.5	24.6	19.0	26.2	13.0	12.9	21.2	23.5	14.1	14.0	19.6	13.0	17.5	20.5	10.3	18.0	17.4	36.9	29.3	20.0	21.0	12.6	22.2	20.6	20.7	13.5	16.8	17.0	18.5	25.6	23.1	19.4	14.7	42.5	39.0	45.3	101.4	32.9	39.7	52.5	64.5	47.2	69.7	55.2	63.6	21.6	88.7	50.6	58.7	76.5	46.8	76.3	63.2	96.8	51.2	74.4	175.8	45.1	98.4	57.9	219.0	97.8	45.1	45.5	77.7	84.4	28.7	49.0	51.1	170.3	57.2	54.4	71.7	75.2	92.8	53.6	48.5	42.5	64.1	85.6	40.1	51.9	58.1	40.0	48.2	65.8	53.8	62.3	41.1	30.2	138.1	44.7	44.4	51.6	100.0	120.0	70.9	93.6	118.9	44.5	112.3	63.8	2.0	16.7	7.3	18.9	21.8	20.6	28.6	19.6	20.5	25.3	24.5	21.5	24.9	0.5	36.0	19.5	30.7	18.7	14.2	12.2	13.2	13.4	16.3	12.6	13.7	13.0	12.9	13.0	12.6	13.5	14.7	19.8	6.4	34.1	9.1	22.1	25.6	22.3	28.8	13.1	9.9	10.8	15.7	25.6	10.0	28.3	7.3	2.1	25.5	22.1	9.0	13.7	29.4	25.0	11.5	29.0	20.6	19.7	18.3	13.7	28.7	30.5	27.6	12.8	14.0	24.7	17.6	11.4	18.0	27.9	11.8	14.2	13.3	38.7	13.1	14.8	10.7	25.7	17.0	5.4	10.3	33.6	9.9	23.7	13.6	13.7	29.9	10.4	27.4	17.6	21.9	6.9	17.3	24.1	10.2	6.6	29.0	24.5	57.5	62.5	18.9	32.1	16.3	16.2	57.8	19.7	16.3
LUC7L	"hLuc7B1, Luc7, LUC7B1"	ENSG00000007392	"LUC7 like"	Q9NQ29	16	188969-229463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056424, HPA069321"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Mitochondria	"HPA056424: AB_2683126, HPA069321: AB_2686119"	"unprognostic (9.55e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-3)"	32.9	47.3	46.0	16.5	46.5	24.0	32.2	47.8	62.9	58.9	46.4	42.8	17.1	40.8	28.2	31.8	40.8	19.4	33.5	46.8	47.1	54.6	43.0	31.9	27.6	45.6	44.9	48.3	48.9	14.9	58.8	18.4	45.4	68.6	13.8	19.6	27.4	18.5	23.3	26.0	40.7	16.2	43.8	63.7	39.2	41.8	45.6	20.3	72.9	12.9	16.9	34.7	36.7	48.3	14.6	62.5	65.1	25.0	24.0	18.8	29.2	26.2	19.7	40.6	29.7	65.8	16.7	27.1	33.5	14.8	22.2	18.5	77.5	23.5	41.2	46.7	53.9	31.7	48.2	77.7	27.4	37.8	34.2	17.0	26.8	33.9	13.3	35.3	31.8	22.1	38.7	16.9	33.8	68.6	60.4	63.8	98.1	32.2	30.0	52.3	28.6	27.8	59.1	15.4	38.8	43.1	28.3	19.6	25.9	38.4	25.2	20.3	27.2	30.5	45.6	13.1	32.2	18.2	25.6	28.2	9.3	26.4	28.1	0.3	9.3	3.9	6.3	11.0	5.1	6.4	6.1	6.4	10.2	2.8	3.5	2.7	1.1	4.5	13.3	11.4	7.5	5.9	46.0	46.5	47.8	62.9	46.8	47.1	45.6	44.9	45.4	43.8	45.6	48.3	64.2	51.3	67.9	59.4	46.9	53.2	39.9	36.4	47.8	48.9	33.1	32.8	22.3	12.8	46.7	23.9	37.5	30.1	63.1	27.2	11.7	35.8	56.7	48.9	81.6	48.2	42.3	26.9	56.7	21.1	42.9	44.4	52.5	55.5	41.1	66.9	26.0	12.7	24.3	45.4	54.0	26.0	28.5	16.6	54.9	21.5	32.6	34.0	39.2	30.0	32.2	24.4	17.5	54.8	40.6	25.8	28.0	32.4	47.4	43.5	27.9	15.5	34.6	59.7	26.3	50.0	50.4	82.1	56.7	29.3	54.3	49.9	45.4	42.5	26.2	37.6
LUC7L2	"CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2"	ENSG00000146963	"LUC7 like 2, pre-mRNA splicing factor"	Q9Y383	7	139340359-139423457	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051631	Approved		Approved	Nucleoplasm		NA	NA		28000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051631: AB_2681558"	"unprognostic (1.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.28e-3)"	38.6	32.2	43.0	29.9	43.4	79.4	46.5	45.0	63.4	51.9	37.0	40.4	26.0	40.4	39.7	44.4	46.7	33.0	40.8	41.2	49.4	42.5	49.0	34.2	49.5	42.2	41.8	50.8	46.0	40.3	26.1	36.6	42.4	46.4	35.2	43.6	38.1	37.1	62.3	49.3	37.3	35.5	38.6	40.0	40.6	35.8	43.4	62.7	60.8	41.4	53.6	41.9	45.2	52.9	65.7	37.4	79.3	73.6	53.0	43.6	58.0	74.4	71.6	71.5	74.6	41.4	61.2	108.5	43.4	60.7	44.6	46.3	96.5	75.7	100.7	51.1	94.7	92.5	56.1	41.9	44.8	150.2	75.4	38.6	93.6	67.3	81.9	49.5	58.5	56.1	119.5	57.1	78.6	62.5	180.4	140.9	65.2	87.6	53.1	107.7	77.7	98.7	81.9	72.7	68.2	65.2	82.0	82.5	75.5	59.3	55.8	59.1	56.0	54.7	31.8	61.1	68.3	86.5	88.0	230.1	60.5	143.8	74.3	10.7	9.4	17.9	17.7	14.3	19.8	16.0	17.3	18.6	12.8	14.9	21.3	18.3	8.7	16.3	17.1	13.2	19.0	12.3	43.0	43.4	45.0	63.4	41.2	49.4	42.2	41.8	42.4	38.6	43.4	52.9	53.5	54.5	56.8	0.0	63.0	0.0	74.8	0.0	72.8	54.0	54.4	45.1	0.0	35.8	39.6	38.6	52.1	77.0	48.5	16.5	54.8	45.1	18.7	31.4	43.1	46.8	21.9	102.9	0.0	38.5	74.3	48.2	57.1	32.8	60.5	37.7	42.1	58.5	43.9	43.7	0.0	29.0	0.0	42.5	0.0	8.5	53.1	41.9	0.0	0.0	46.4	46.7	43.3	0.0	0.1	34.9	18.7	67.7	68.6	62.0	34.6	40.8	37.2	49.2	59.2	54.9	45.6	74.1	68.7	51.5	0.1	82.4	63.7	43.0	28.0	56.2
LURAP1L	"bA3L8.2, C9orf150, FLJ38505, LRAP35b, MGC46502"	ENSG00000153714	"Leucine rich adaptor protein 1 like"	Q8IV03	9	12775020-12823060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 90.2;Paneth cells: 88.8;Prostatic glandular cells: 104.3;Urothelial cells: 140.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 100.6;hTERT-HME1: 81.9;T-47d: 118.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024407	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoli	Nucleoplasm	"HPA024407: AB_10603780"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.38e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-2)"	14.6	9.3	3.4	5.5	4.6	0.1	10.6	11.8	6.1	10.9	2.5	19.9	4.1	6.2	3.3	4.6	6.6	11.8	4.4	3.5	4.2	5.4	32.2	25.0	3.9	5.2	4.6	4.2	19.6	0.8	5.5	21.0	5.0	6.9	9.4	4.7	27.7	6.7	2.5	12.2	9.2	8.3	5.7	10.4	12.5	0.5	4.7	1.2	8.7	3.4	2.0	12.1	12.4	5.8	2.2	7.1	0.0	2.3	11.0	15.1	0.0	3.9	20.2	5.1	5.4	0.0	2.6	0.0	1.5	20.6	24.3	3.0	0.0	0.4	3.9	0.0	0.8	1.1	6.7	4.0	100.6	0.0	0.0	6.0	9.7	17.4	81.9	8.6	3.3	0.0	0.0	25.8	3.1	1.8	0.0	0.0	0.1	9.6	7.8	0.0	1.3	0.1	20.7	1.2	15.5	1.5	4.7	2.9	3.8	1.7	118.5	0.4	1.3	4.5	0.7	11.7	2.8	0.1	0.0	0.0	7.2	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	4.6	11.8	6.1	3.5	4.2	5.2	4.6	5.0	5.7	4.7	5.8	9.6	9.6	18.4	1.3	0.7	90.2	34.4	19.3	5.2	10.2	60.1	26.2	7.1	20.0	40.2	1.8	2.1	1.0	0.5	58.7	7.9	66.6	5.0	11.5	3.2	7.8	26.7	0.0	18.4	11.8	2.7	19.7	10.2	29.2	10.8	12.9	1.8	30.2	0.6	18.5	41.6	12.8	24.4	0.0	8.4	0.8	9.3	2.3	26.6	6.5	0.0	4.3	0.0	8.0	44.1	27.5	88.8	3.0	0.0	104.3	20.7	5.5	16.1	10.2	39.5	8.0	47.4	0.1	0.6	2.9	64.4	1.1	1.9	1.3	49.5	140.4
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082638	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 30.6"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 1890.0"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.9;HAP1: 4.4;HeLa: 1.9;hTERT-RPE1: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: AB_2676307, HPA046161: AB_2679564"	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	0.3	6.5	8.6	0.1	8.5	0.1	0.5	11.8	8.0	0.1	1.1	0.8	0.1	0.2	0.0	0.1	0.0	0.1	0.1	6.3	15.1	0.2	0.9	0.2	0.0	10.8	30.6	0.0	0.0	0.0	0.6	0.0	17.2	2.4	0.6	1.1	0.1	0.1	0.0	0.1	0.2	0.3	17.6	0.1	0.1	0.5	15.3	0.0	0.0	0.6	0.0	0.3	0.1	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.9	4.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	8.5	11.8	8.0	6.3	15.1	10.8	30.6	17.2	17.6	15.3	16.5	0.3	0.0	0.0	11.4	0.0	0.6	0.1	0.0	1.8	6.9	0.3	1.7	0.6	0.0	0.0	3.7	0.0	0.0	0.1	1.2	0.0	0.0	33.7	0.6	0.7	0.1	0.0	0.0	149.4	0.0	0.1	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	371.4	1.7	0.0	0.0	0.0	6.4	0.9	0.1	0.0	4.7	0.0	0.3	0.0	1890.0	9.1	0.2	23.9	0.0	0.0	4.5	0.0	0.7	0.0	0.8	0.0	0.4	0.3	0.3	0.6	0.9	0.3	0.1	0.0	2.4	1.5	1.6
LXN		ENSG00000079257	Latexin	Q9BS40	3	158645822-158672648	"Predicted intracellular proteins"	"Inflammatory response"	"Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 97.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 123.0;Respiratory ciliated cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"hTERT-RPE1: 1196.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014179, CAB025128"	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		4700000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB025128: , HPA014179: AB_1853404"	"unprognostic (4.46e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (8.45e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.84e-2)"	59.0	47.0	3.7	21.5	6.4	27.1	22.4	7.3	4.4	20.3	14.1	42.0	30.3	13.7	23.7	9.9	34.3	40.5	23.1	4.5	5.4	21.6	5.6	26.3	18.6	3.9	4.3	49.7	14.1	14.0	16.0	22.0	4.1	36.9	44.0	3.6	42.4	17.9	5.4	12.4	26.1	22.9	3.6	10.2	15.0	4.5	6.2	13.8	18.3	7.8	14.3	97.7	14.4	4.2	0.1	40.7	3.1	0.5	17.0	58.2	3.4	31.3	80.4	7.6	15.2	0.1	91.3	0.3	28.2	8.7	0.2	14.1	8.1	12.7	11.2	0.1	40.2	19.6	33.0	0.4	19.5	5.0	0.5	131.5	2.3	14.5	2.4	1196.4	296.5	0.1	0.3	0.9	0.0	167.0	2.1	0.0	3.6	7.3	10.5	5.5	0.0	40.0	27.6	113.4	5.1	0.1	0.0	42.5	10.4	9.4	0.3	0.1	42.8	0.3	0.3	42.3	0.1	0.6	0.0	0.2	14.8	1.6	0.5	28.8	5.8	8.6	5.6	5.8	5.8	10.3	11.7	9.3	7.3	6.9	12.9	7.2	36.7	9.8	3.6	7.6	29.8	6.5	3.7	6.4	7.3	4.4	4.5	5.4	3.9	4.3	4.1	3.6	6.2	4.2	71.0	16.0	9.2	0.3	4.4	5.6	84.1	27.0	4.6	0.3	17.3	21.2	3.8	11.5	38.7	16.5	4.2	13.4	5.5	34.1	15.6	18.5	3.9	20.7	16.5	88.5	35.2	86.3	0.5	26.4	16.2	28.8	6.1	7.6	123.0	3.6	77.8	0.8	22.9	0.0	0.3	73.1	22.4	6.3	18.1	7.9	8.4	8.0	19.6	4.7	17.7	8.9	6.2	0.0	0.3	15.1	58.4	2.6	2.8	49.8	48.6	15.5	120.3	1.2	13.1	1.3	29.4	0.9	10.8	8.6	8.2	4.0	6.5	5.9	30.8	77.0
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 1.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.4;Respiratory ciliated cells: 16.1;Spermatocytes: 15.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 71: Testis - DNA repair"		"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.3	0.2	0.0	0.6	0.4	0.3	0.2	0.2	1.0	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.5	0.5	0.3	0.0	0.0	0.5	0.3	0.5	0.3	0.0	0.0	0.2	0.6	0.0	0.9	0.1	0.3	0.4	0.0	0.6	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.6	0.3	1.7	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.8	0.4	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	7.8	3.2	1.5	0.3	1.4	1.7	1.8	2.0	0.0	2.8	7.7	8.0	1.2	1.5	2.1	1.8	2.1	0.5	4.2	3.8	3.9	2.1	21.4	6.9	1.4	5.6	3.5	3.0	0.8	4.9	0.2	1.6	3.1	1.8	5.1	1.4	10.4	2.2	6.2	0.0	1.2	2.0	8.2	5.5	3.1	7.5	1.2	11.6	1.8	0.0	3.7	6.0	2.1	1.0	0.6	3.4	3.1	1.5	3.2	2.1	3.0	4.6	16.1	1.1	0.0	2.6	1.7	15.9	13.9	2.0	0.9	0.3	5.2	1.3	3.1	1.9
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;skin 1: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	114	"HEL: 23.7"									HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"		Nucleoplasm		"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.1	0.0	0.2	0.0	0.2	1.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.4	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6K	"CT97, FLJ35226, HSJ001348"	ENSG00000160886	"Lymphocyte antigen 6 family member K"	Q17RY6	8	142700111-142705127	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.5;testis: 36.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 186.7;Prostatic glandular cells: 105.2;Spermatocytes: 404.4;Spermatogonia: 105.8;Urothelial cells: 131.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 11.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 125.2;BJ: 131.9;HeLa: 142.4;SiHa: 206.3;U-2197: 273.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017770, CAB075742, CAB075743, CAB079929"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB075742: AB_2665748, CAB075743: AB_2665749, CAB079929: , HPA017770: AB_1853414"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.17e-5)"	"unprognostic (4.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.61e-2)"	5.4	0.2	0.6	0.2	0.6	0.3	4.4	0.9	1.7	3.3	0.0	0.5	0.3	0.5	0.2	12.5	1.2	0.4	1.5	0.8	1.0	3.0	0.2	0.8	0.2	1.7	0.8	0.7	0.3	0.0	0.4	2.4	2.0	1.1	0.0	2.4	1.7	0.8	5.4	6.8	0.3	0.1	1.1	0.2	1.1	36.0	0.7	0.6	1.0	1.3	0.6	1.0	5.1	1.1	125.2	2.0	0.0	6.3	2.4	7.9	1.5	131.9	15.3	39.9	24.0	0.2	0.5	0.0	10.9	15.0	14.3	10.8	0.0	7.5	33.5	1.2	0.2	0.1	142.4	0.3	1.9	0.0	0.0	11.7	21.1	29.7	38.0	0.1	3.7	0.0	0.0	0.6	76.2	1.0	0.2	0.3	4.2	4.1	2.0	0.3	0.5	0.2	6.7	1.7	3.7	0.5	206.3	2.7	41.3	6.6	0.5	0.2	5.4	1.9	11.8	273.2	0.2	0.2	0.1	0.3	0.6	0.1	13.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.6	0.6	0.9	1.7	0.8	1.0	1.7	0.8	2.0	1.1	0.7	1.1	25.6	3.2	0.5	0.0	0.4	38.9	54.2	4.3	21.6	0.6	15.1	49.8	0.2	5.7	9.8	25.8	0.0	13.5	0.3	0.0	0.0	0.8	7.7	3.1	8.5	9.2	0.0	0.0	0.0	0.0	186.7	8.0	0.0	9.0	0.0	0.0	3.3	0.1	6.0	0.0	0.0	0.0	6.1	0.3	28.7	14.8	4.1	4.6	12.4	0.0	0.0	0.5	0.0	0.0	0.1	6.7	1.1	3.0	0.0	105.2	0.0	0.2	3.6	0.6	0.0	17.8	13.1	404.4	105.8	32.2	44.9	25.3	0.7	0.1	0.0	131.4
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290154	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 102.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 223.1;NK-cells: 197.8;Spermatocytes: 718.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	14.8	8.4	7.8	19.8	8.4	20.4	11.2	8.2	13.0	10.0	7.1	10.8	8.8	9.1	5.7	15.9	10.4	8.2	15.6	8.0	9.0	8.8	10.4	11.8	24.3	9.0	8.6	12.4	9.6	5.3	8.4	11.1	8.9	7.8	10.1	11.1	7.3	6.7	21.2	9.2	9.3	9.0	7.9	18.7	7.9	102.1	8.5	12.8	6.7	11.7	17.8	18.8	10.8	9.3	59.9	30.8	26.7	39.3	22.9	26.0	46.1	53.2	18.1	53.7	37.1	97.1	75.6	158.9	37.5	23.0	86.2	37.0	100.6	55.4	69.8	28.6	74.8	159.2	29.5	109.0	38.7	184.4	41.4	20.5	34.4	61.8	103.9	13.9	47.2	89.1	217.9	51.2	37.8	60.5	63.4	236.6	134.0	62.1	99.2	96.2	48.6	76.4	24.4	40.7	63.4	27.4	29.0	31.0	55.8	34.0	32.3	54.4	44.7	53.3	42.7	70.2	169.1	36.2	59.1	250.4	36.5	154.7	44.2	37.3	26.4	24.4	73.5	26.8	85.5	21.7	48.2	80.3	19.5	15.0	22.1	47.9	7.6	30.3	39.2	14.3	25.4	30.2	7.8	8.4	8.2	13.0	8.0	9.0	9.0	8.6	8.9	7.9	8.5	9.3	29.1	16.0	23.5	6.8	26.9	120.1	59.2	19.9	27.9	10.1	15.7	32.9	20.9	14.3	25.6	1.8	8.4	47.7	128.9	11.5	9.8	24.9	223.1	17.7	29.4	32.3	10.7	46.3	3.6	19.8	55.6	31.9	9.7	12.7	21.5	31.5	14.3	11.2	35.8	15.2	4.2	16.1	4.1	30.4	34.0	113.4	34.2	44.7	21.4	2.8	35.2	14.1	197.8	6.0	9.3	30.0	11.4	26.7	36.1	117.5	3.0	7.4	19.2	30.2	39.5	34.4	27.9	718.6	36.6	36.0	115.8	20.2	135.3	46.8	28.9	64.1
LYL1	bHLHa18	ENSG00000104903	"LYL1 basic helix-loop-helix family member"	P12980	19	13099033-13103161	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.9;lymphoid tissue: 36.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 335.4;Erythroid cells: 298.9;Late spermatids: 763.9;Spermatocytes: 120.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.4"	"Group enriched"	"Detected in many"	4	"B-cells: 3.7;granulocytes: 6.4;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"HEL: 127.7;HL-60: 90.5;HMC-1: 206.6;K-562: 102.1;NB-4: 131.9;REH: 96.5;THP-1: 86.1;U-937: 86.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA072177			Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA072177: "	"unprognostic (8.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.76e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.18e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.28e-1)"	9.7	4.1	6.3	10.9	6.0	35.9	7.3	7.1	7.5	6.7	4.9	6.4	2.0	7.7	0.3	3.2	5.8	1.4	10.1	6.4	6.4	5.7	2.6	12.3	12.3	8.9	6.8	2.8	2.0	0.5	2.5	5.6	8.1	5.7	0.6	0.0	3.7	1.3	2.8	3.2	14.1	1.8	9.1	36.7	4.1	20.8	9.0	2.3	5.3	1.9	6.2	7.8	5.6	9.6	0.1	0.3	0.2	0.0	0.0	0.3	0.0	1.4	0.2	0.4	0.1	0.5	0.0	24.8	8.4	0.2	0.0	0.1	0.4	0.0	0.0	14.7	0.0	127.7	0.1	1.2	1.4	90.5	206.6	0.4	0.0	0.1	0.0	0.0	31.9	0.0	102.1	4.4	0.0	0.0	0.5	131.9	0.0	0.4	3.2	96.5	0.3	11.2	0.0	0.0	0.1	9.1	2.8	0.0	6.0	0.0	0.0	86.1	51.8	0.0	0.1	3.6	0.1	0.0	0.0	20.3	0.1	86.1	0.1	2.4	1.4	6.4	0.0	1.9	0.1	2.1	0.2	0.1	1.0	3.7	0.1	0.1	2.4	0.0	2.8	0.3	0.4	0.4	6.3	6.0	7.1	7.5	6.4	6.4	8.9	6.8	8.1	9.1	9.0	9.6	33.7	0.0	0.5	0.0	80.1	2.5	0.5	0.1	0.6	0.0	1.0	1.4	2.3	2.8	0.2	1.8	0.0	0.7	6.6	1.6	0.0	0.4	335.4	0.4	1.9	40.1	1.8	298.9	0.4	0.0	1.3	3.2	1.1	0.2	45.1	0.8	32.9	1.1	113.2	0.0	0.3	1.2	0.0	60.3	35.1	763.9	8.1	68.3	7.2	13.1	36.4	1.5	4.1	0.5	1.3	2.0	1.6	12.0	6.3	0.4	1.7	0.5	1.7	0.2	13.1	1.8	2.2	120.6	5.8	1.4	1.8	1.5	9.0	0.5	1.0	0.6
LYPD1	"LYPDC1, MGC29643"	ENSG00000150551	"LY6/PLAUR domain containing 1"	Q8N2G4	2	132643286-132671579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.2;choroid plexus: 15.4;fallopian tube: 53.5;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 73.8;Exocrine glandular cells: 74.5;monocytes: 62.0;Oligodendrocyte precursor cells: 28.1;Pancreatic endocrine cells: 43.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 57.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 41.6;HUVEC TERT2: 32.7;SK-MEL-30: 36.5;U-251 MG: 65.9;WM-115: 140.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068333			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA068333: "	"unprognostic (9.25e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.40e-3)"	"unprognostic (5.60e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	0.6	0.8	24.8	0.3	27.1	0.4	0.8	19.5	25.5	0.3	15.4	8.1	0.1	0.9	0.1	1.5	53.5	1.2	0.8	24.2	29.2	5.9	1.0	1.0	0.6	29.9	30.0	1.3	5.1	0.3	33.7	0.0	27.7	0.7	0.2	1.6	5.5	0.1	0.3	0.3	1.6	0.6	27.3	0.3	0.9	0.7	31.2	2.2	0.9	0.1	1.0	0.8	0.6	21.5	0.4	8.6	11.6	0.2	0.0	0.0	0.0	1.9	1.5	6.3	1.4	0.6	1.1	0.0	18.3	5.1	3.0	7.2	0.0	0.0	2.9	0.1	1.8	0.0	4.0	0.0	0.0	0.0	0.2	0.0	0.1	41.6	0.0	1.7	32.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	11.1	0.2	3.3	0.0	0.0	0.0	15.1	0.2	1.1	2.3	1.8	0.2	36.5	26.8	0.1	0.3	1.5	0.7	17.4	5.9	65.9	0.1	0.0	0.1	10.0	0.0	140.5	0.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	27.1	19.5	25.5	24.2	29.2	29.9	30.0	27.7	27.3	31.2	21.5	0.7	0.0	0.0	8.1	0.2	0.1	0.1	0.4	0.0	1.6	2.0	0.9	0.2	2.8	0.2	5.5	0.0	0.0	0.0	0.5	1.9	73.8	5.6	1.4	0.1	0.2	1.8	0.0	0.8	74.5	0.0	2.2	0.0	0.9	0.0	0.1	0.4	0.0	0.1	15.2	4.7	0.0	0.0	0.8	0.7	9.3	4.1	0.1	0.0	0.0	62.0	1.4	0.0	28.1	4.4	43.4	0.0	0.0	0.0	0.1	0.1	4.8	0.3	0.8	0.0	0.2	3.9	2.6	2.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43785874-43827206	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.0;Late spermatids: 81.8;Melanocytes: 17.8;Syncytiotrophoblasts: 21.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.0;HaCaT: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA042511: AB_10794279, HPA054670: AB_2682567"	"unprognostic (4.27e-3)"	"prognostic favorable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.1	0.6	2.6	1.4	2.5	0.1	2.9	1.8	6.0	9.3	0.0	2.3	0.1	0.9	1.4	11.4	0.8	1.1	1.5	3.0	2.9	3.0	0.4	4.0	0.7	6.8	3.2	0.4	0.3	0.6	1.6	1.0	6.6	1.3	0.8	2.0	3.1	0.8	0.2	50.6	1.2	1.1	1.7	4.8	1.0	3.8	4.1	0.9	1.4	0.4	1.7	1.9	9.0	4.1	3.5	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.5	0.6	0.4	1.2	0.2	0.7	0.4	1.4	5.2	0.0	0.7	0.3	0.6	0.0	0.1	0.4	0.0	1.5	0.1	0.0	1.7	1.5	0.2	0.7	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.3	1.9	1.2	0.0	0.0	0.0	0.3	0.6	0.2	0.1	0.7	0.7	0.0	1.1	0.4	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.1	2.6	2.5	1.8	6.0	3.0	2.9	6.8	3.2	6.6	1.7	4.1	4.1	0.5	0.0	0.0	4.6	0.0	3.6	2.6	1.6	4.0	1.4	1.8	1.5	0.7	0.0	0.4	0.0	0.0	1.6	0.1	3.7	3.9	0.6	33.0	0.2	0.1	3.1	0.0	0.0	7.7	0.9	8.4	1.2	0.0	0.2	0.0	0.5	0.7	0.0	2.4	0.0	8.8	1.9	0.0	0.6	0.8	81.8	0.3	0.5	17.8	1.0	0.0	0.9	0.0	9.5	7.8	0.3	2.3	1.2	0.0	1.4	0.2	0.0	1.4	0.9	0.0	1.0	0.2	9.9	2.6	3.7	2.8	21.6	0.1	0.1	0.8	6.2
LYPLA1	"APT-1, LPL1"	ENSG00000120992	"Lysophospholipase 1"	O75608	8	54046367-54102017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 787.7;Late spermatids: 796.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050941, HPA063151"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		330000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA050941: AB_2681284, HPA063151: "	"unprognostic (2.62e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-3)"	25.8	30.3	8.8	31.8	7.6	43.6	45.0	10.5	12.7	23.3	14.7	42.6	44.4	19.7	16.1	55.0	22.9	25.9	40.9	7.9	10.8	63.4	83.5	25.9	49.0	9.9	9.5	11.7	23.8	40.8	8.8	50.4	9.1	35.0	42.1	45.9	35.5	15.0	54.5	41.4	42.8	24.3	9.7	30.2	35.4	65.1	10.3	28.8	28.4	70.7	52.0	63.1	27.5	10.0	124.0	69.3	85.9	78.7	31.0	49.4	109.8	71.7	41.6	65.0	61.1	53.2	116.7	214.8	83.6	47.2	70.5	80.7	122.8	119.9	89.8	78.9	70.0	148.8	37.9	80.0	50.8	91.4	196.1	44.6	103.8	50.8	114.0	55.6	171.6	91.6	154.5	63.4	91.3	32.7	141.1	69.9	129.3	206.3	31.5	85.3	45.2	99.3	100.2	163.6	45.2	77.6	50.1	93.6	113.4	81.0	137.0	81.7	83.4	39.0	56.9	68.7	67.8	89.3	143.8	194.0	52.9	97.1	78.7	93.7	80.7	111.1	44.8	79.6	44.6	73.0	42.2	43.5	92.3	64.4	42.1	41.1	49.3	69.6	108.2	59.7	75.5	98.3	8.8	7.6	10.5	12.7	7.9	10.8	9.9	9.5	9.1	9.7	10.3	10.0	60.4	28.9	53.3	19.9	83.8	61.7	94.8	96.6	82.6	34.9	103.8	64.0	70.8	57.2	71.8	62.5	52.1	199.7	74.5	70.4	303.3	82.8	787.7	86.6	34.7	69.3	57.5	50.0	30.0	89.0	318.3	36.4	74.9	96.3	49.5	31.5	81.4	120.1	121.0	18.5	43.7	77.3	99.7	108.4	83.3	796.2	28.3	82.6	74.7	25.3	102.1	36.9	69.0	20.6	9.8	127.4	63.7	23.0	104.5	171.0	91.6	194.3	62.9	70.3	46.0	24.5	43.1	92.1	239.1	118.2	81.1	334.2	57.0	94.0	90.2	229.7
LYPLA2	APT-2	ENSG00000011009	"Lysophospholipase 2"	O95372	1	23791145-23795539	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063151			Uncertain	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA063151: "	"unprognostic (8.84e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (3.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.24e-1)"	32.6	41.1	31.3	33.3	33.2	55.2	33.4	31.1	43.9	33.1	82.4	48.9	49.6	28.2	13.7	76.2	43.2	32.3	40.9	40.4	31.3	79.5	82.2	40.8	43.5	31.1	32.3	28.4	43.7	77.2	35.0	37.1	30.2	45.2	29.4	15.7	51.2	24.7	43.4	51.3	51.3	20.1	30.6	61.1	47.7	23.4	33.0	42.8	39.0	25.2	33.2	46.3	40.3	28.2	80.3	54.2	61.0	70.6	30.4	37.0	83.7	50.8	49.4	50.0	42.6	75.2	130.1	45.8	67.7	49.4	34.9	78.2	45.7	141.2	19.8	88.4	67.9	58.1	87.1	127.5	49.8	54.0	72.5	48.1	85.3	74.9	27.5	61.9	118.8	52.6	84.2	45.4	55.0	89.4	67.3	90.0	120.3	72.6	76.6	78.9	35.0	79.1	122.6	64.6	87.2	149.4	57.7	87.0	88.5	43.5	71.7	58.6	98.6	46.5	61.2	56.7	43.2	116.4	104.1	62.6	74.3	125.1	58.5	82.7	95.3	125.0	105.8	96.0	87.1	62.9	89.1	93.9	77.9	67.9	75.6	80.0	113.2	83.5	80.2	58.8	88.7	113.6	31.3	33.2	31.1	43.9	40.4	31.3	31.1	32.3	30.2	30.6	33.0	28.2	21.3	9.6	27.3	6.2	27.7	38.9	31.0	80.0	23.3	34.1	36.9	35.4	16.1	35.8	36.5	36.8	18.8	118.7	29.9	105.0	68.4	105.8	15.5	44.9	13.7	33.8	44.3	26.9	5.1	112.8	108.8	19.1	40.8	27.5	36.8	23.1	21.0	35.0	69.3	23.5	5.7	53.5	52.9	17.2	23.3	13.4	10.5	27.6	19.6	4.7	62.1	30.2	46.4	7.5	5.2	130.2	71.9	6.4	20.8	33.3	77.1	92.2	57.6	26.0	26.3	8.6	23.3	8.0	19.1	33.1	41.5	115.9	36.2	64.0	56.6	42.4
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 188.1;Late spermatids: 464.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 154.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 154.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Midbody	"HPA059840: AB_2684137"	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favorable (9.50e-4)"	37.8	31.1	26.7	16.4	27.2	24.2	30.0	28.7	31.4	30.4	31.6	32.0	13.8	27.6	35.2	18.7	34.4	16.2	50.8	27.1	28.3	51.8	95.8	18.8	24.2	28.1	27.7	34.0	27.3	33.5	21.2	13.6	28.7	29.1	20.4	26.5	16.2	26.8	42.3	19.2	18.0	22.6	27.3	16.9	27.9	37.6	27.7	25.1	22.8	34.1	21.9	34.8	23.0	28.5	33.2	29.7	30.3	25.9	74.1	64.0	9.6	27.9	39.3	14.8	21.7	42.8	39.2	22.6	92.2	31.5	21.6	21.6	14.1	25.5	25.6	41.6	19.8	10.1	8.3	112.1	56.6	35.9	20.4	45.0	24.5	40.0	98.6	41.4	58.5	37.3	23.2	39.6	59.0	43.5	39.1	26.3	34.3	46.5	17.2	47.8	18.4	30.8	56.3	15.1	29.8	27.7	16.6	26.3	45.1	18.5	27.5	19.5	16.0	21.4	15.8	35.1	19.6	35.1	51.2	38.5	59.7	35.6	20.1	154.9	16.7	59.3	19.7	21.8	28.2	29.5	29.8	24.2	14.3	24.8	24.3	24.1	63.8	22.1	25.9	17.9	33.0	24.5	26.7	27.2	28.7	31.4	27.1	28.3	28.1	27.7	28.7	27.3	27.7	28.5	32.5	19.2	18.9	9.1	29.9	21.0	57.6	26.8	25.6	28.9	41.2	39.4	55.1	27.1	17.2	23.9	14.6	29.1	24.6	9.6	76.3	41.3	188.1	24.2	12.9	35.8	30.0	8.4	10.6	44.2	10.6	30.8	21.9	15.9	15.8	20.5	15.0	53.9	16.5	15.2	14.1	15.0	28.5	16.4	14.5	464.6	28.9	16.2	17.8	4.7	45.7	48.0	22.6	9.5	11.2	30.2	14.6	38.0	15.8	41.6	19.2	125.4	25.4	34.0	13.1	25.8	26.3	112.5	27.5	18.2	20.9	14.9	22.9	16.3	24.5	56.7
LYSMD1	"MGC35223, RP11-68I18.5, SB145"	ENSG00000163155	"LysM domain containing 1"	Q96S90	1	151159748-151165948	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028055, HPA064537"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA028055: AB_10601912, HPA064537: AB_2685281"	"unprognostic (1.71e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.26e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.31e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.47e-3)"	"unprognostic (6.33e-2)"	4.9	7.0	7.4	2.7	7.6	1.1	5.6	9.5	10.1	7.2	6.9	6.8	6.1	6.2	4.2	5.0	7.1	3.4	8.6	7.4	7.4	5.4	6.5	3.3	3.2	7.5	7.0	10.9	4.9	9.8	5.5	7.4	7.7	5.6	5.4	9.6	4.9	6.3	13.8	6.5	4.2	5.9	6.6	4.2	5.8	4.2	7.3	6.2	6.2	13.5	3.3	7.2	6.1	7.8	5.0	5.3	11.4	8.9	6.5	7.2	8.9	7.2	6.2	8.4	7.5	3.4	5.9	6.6	8.6	4.6	4.3	8.6	8.9	5.1	6.2	12.8	9.8	3.8	8.7	3.6	10.2	4.0	6.0	10.1	10.9	7.9	11.2	11.3	3.5	14.9	7.7	6.2	5.8	7.9	10.3	5.0	7.2	5.0	6.8	7.2	8.3	3.9	6.1	2.3	13.6	16.6	5.4	16.4	9.5	14.3	10.0	13.4	3.6	6.4	3.5	4.1	9.6	19.6	16.0	3.1	5.5	1.6	6.2	1.6	0.8	1.4	0.8	0.5	0.9	0.7	1.0	0.5	0.7	1.7	1.3	1.4	3.1	1.3	0.8	1.4	1.5	0.3	7.4	7.6	9.5	10.1	7.4	7.4	7.5	7.0	7.7	6.6	7.3	7.8	2.2	0.0	0.5	3.3	0.3	0.9	0.9	0.8	1.8	4.0	4.1	2.0	8.8	0.0	2.8	5.5	6.2	4.6	0.1	3.4	3.9	1.8	0.3	2.9	5.1	2.0	4.2	3.2	3.1	0.6	3.1	3.0	0.0	2.1	0.0	5.0	3.9	4.2	0.6	1.7	3.4	1.7	2.0	0.0	0.8	0.4	4.4	0.2	1.8	1.0	0.1	3.7	0.0	2.5	4.3	2.2	1.1	6.0	0.3	1.1	3.8	8.2	2.4	8.0	0.0	2.5	3.9	2.0	2.7	1.3	1.1	2.9	0.5	3.0	2.7	1.0
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Phagocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.3;retina: 27.9"	"Cell type enhanced"	"Detected in all"		"monocytes: 277.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.2;monocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.8;SK-MEL-30: 27.1;THP-1: 99.5;U-937: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA053366: AB_2682129, HPA055725: AB_2682898"	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	5.2	2.7	2.0	8.5	2.7	31.3	6.4	10.1	3.3	7.1	9.1	4.5	3.0	4.3	2.7	4.2	3.9	5.1	2.2	2.0	2.5	3.6	5.5	5.5	7.5	2.2	2.6	4.5	2.2	6.2	1.8	4.6	2.5	3.4	4.3	27.9	4.3	3.3	1.7	9.7	3.3	4.4	1.1	10.8	7.7	6.1	3.3	25.7	6.4	3.8	6.5	5.7	5.2	3.4	8.6	1.9	0.9	2.0	12.7	14.4	1.3	3.1	12.5	3.3	3.1	0.0	2.3	1.1	1.2	6.8	7.7	4.1	1.2	1.6	2.9	30.8	2.7	2.8	1.9	0.6	2.3	4.2	3.7	4.8	7.8	4.0	10.0	4.8	2.8	1.3	0.2	1.7	2.6	0.4	5.3	8.7	0.2	1.6	0.9	0.4	1.2	0.0	9.2	9.2	5.4	1.1	3.4	0.2	27.1	1.0	1.2	99.5	5.8	2.4	1.1	2.8	2.8	2.1	0.1	0.2	4.1	38.0	7.0	0.4	2.9	5.7	0.6	3.4	0.8	1.0	0.2	0.7	1.7	1.4	0.2	0.4	12.2	1.7	6.1	0.2	0.2	0.7	2.0	2.7	10.1	3.3	2.0	2.5	2.2	2.6	2.5	1.1	3.3	3.4	66.3	19.2	41.1	71.2	70.9	71.0	89.8	14.6	18.8	67.4	17.6	15.6	11.6	15.7	28.4	11.0	93.8	6.7	77.3	25.0	11.7	6.6	24.6	22.6	23.8	51.2	9.6	21.0	151.5	12.3	5.0	27.0	41.3	22.4	112.5	9.4	26.0	15.4	31.9	52.2	155.9	14.3	28.5	65.6	81.3	17.7	28.0	111.4	120.9	159.3	277.4	25.6	88.6	112.1	81.6	39.6	24.2	21.8	37.3	56.0	12.7	10.9	26.7	162.5	13.1	31.2	22.7	93.3	28.0	18.7	65.1	8.8	71.3	13.6	7.6	98.5
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	95.8	27.8	3.5	802.1	4.0	10588.1	128.2	3.7	18.5	156.2	11.4	309.0	3605.0	65.7	4.2	106.3	33.9	1054.6	34.8	2.6	4.3	32.4	138.0	1355.2	739.7	8.0	7.3	20.4	63.1	13.8	7.2	91.3	12.2	40.2	273.8	4.4	21115.5	21.8	34.0	58.7	1322.2	123.9	5.4	621.0	8941.1	21.8	10.9	321.8	27.8	36.4	652.8	428.5	16.2	11.7	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.5	4.0	3.7	18.5	2.6	4.3	8.0	7.3	12.2	5.4	10.9	11.7	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
LZIC	MGC15436	ENSG00000162441	"Leucine zipper and CTNNBIP1 domain containing"	Q8WZA0	1	9922113-9943407	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 304.7;Spermatocytes: 191.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028184, HPA058614"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA028184: AB_10602706, HPA058614: AB_2683779"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.79e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	20.6	18.1	20.2	18.8	24.4	19.4	25.5	24.8	23.4	24.3	16.2	28.5	29.0	25.9	16.2	22.9	23.7	18.1	29.6	19.8	21.2	28.9	30.4	17.0	21.9	24.0	24.1	35.0	13.4	29.2	12.3	22.3	24.2	21.9	27.6	25.9	20.9	19.8	27.3	20.1	27.1	24.8	24.2	15.8	16.7	66.9	21.6	30.0	24.6	27.5	23.8	18.1	15.3	28.4	43.0	27.8	52.5	37.2	32.0	51.9	23.3	38.1	32.1	52.8	50.9	34.6	73.4	51.6	42.3	48.1	33.3	31.9	49.7	55.1	78.7	48.5	33.5	75.7	34.9	57.9	30.7	69.7	37.5	34.3	77.0	74.1	69.2	37.6	41.8	67.4	95.6	28.7	49.1	30.5	57.3	33.8	26.6	53.7	44.5	60.7	69.4	41.9	28.5	19.2	26.1	41.2	46.6	20.2	91.2	49.9	33.5	35.1	38.6	36.5	49.6	52.4	40.8	23.2	57.5	87.4	37.3	101.7	49.6	34.9	25.1	40.3	20.5	29.5	17.8	18.4	20.6	20.1	24.8	20.4	20.1	21.2	25.6	23.2	33.2	38.0	29.3	17.5	20.2	24.4	24.8	23.4	19.8	21.2	24.0	24.1	24.2	24.2	21.6	28.4	34.3	6.4	17.3	6.8	20.7	12.7	21.9	24.1	17.6	12.0	22.6	27.3	57.4	10.0	15.9	7.3	6.2	26.9	26.9	25.9	49.0	27.0	304.7	34.7	36.4	19.9	9.1	24.0	11.1	21.2	45.7	27.8	13.3	27.0	30.4	27.2	14.3	23.9	42.7	42.1	14.8	18.1	10.2	22.6	15.7	91.6	26.4	34.9	14.2	14.0	36.8	45.6	20.6	13.6	23.8	22.6	27.8	27.4	22.4	27.6	41.7	53.0	27.4	18.0	19.7	26.6	31.1	191.3	86.2	29.2	16.8	34.5	26.8	21.4	22.5	21.6
LZTR1	"BTBD29, LZTR-1"	ENSG00000099949	"Leucine zipper like transcription regulator 1"	Q8N653	22	20982269-20999032	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067852, HPA068772, HPA071248"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.25e-2)"	18.4	15.2	9.0	8.9	9.7	6.0	17.3	8.9	10.1	20.1	7.2	20.1	9.9	23.3	4.4	12.6	18.5	9.4	13.4	9.1	9.1	15.8	12.0	16.0	7.3	10.3	9.5	19.5	12.4	11.5	24.7	9.8	10.8	16.2	6.4	3.4	13.0	8.6	14.7	13.6	15.9	11.3	8.1	18.3	13.9	8.2	8.9	6.5	18.8	8.0	5.7	18.1	15.8	9.3	10.3	8.4	12.2	15.0	27.6	18.9	9.6	20.8	14.6	11.6	15.8	4.9	4.2	11.0	7.6	23.4	10.7	13.7	9.3	17.1	4.7	20.5	21.0	11.8	11.8	7.4	14.6	6.4	14.9	17.5	8.5	14.7	10.6	18.4	22.9	10.0	49.8	18.5	13.4	6.3	11.5	6.0	3.8	12.6	9.1	13.4	17.8	4.4	9.2	13.9	11.9	17.9	11.3	19.5	12.4	7.4	9.1	11.7	20.6	27.0	13.3	12.3	11.5	8.0	7.4	3.2	12.2	6.2	13.5	0.0	0.5	0.0	0.7	0.7	0.4	0.4	0.3	0.8	0.4	0.1	0.4	0.3	0.0	0.3	1.0	0.3	0.1	0.5	9.0	9.7	8.9	10.1	9.1	9.1	10.3	9.5	10.8	8.1	8.9	9.3	12.4	12.8	8.6	20.5	7.9	2.2	1.8	3.7	4.0	9.5	7.5	7.6	11.7	5.7	5.2	9.2	6.2	4.1	11.9	10.7	1.9	7.0	0.9	5.5	12.7	10.1	9.1	2.5	14.2	4.9	4.0	10.9	11.2	8.4	5.7	14.7	12.1	8.5	7.7	3.3	13.2	10.0	6.1	8.8	3.5	1.6	8.7	7.1	7.2	14.0	5.0	5.6	5.2	8.0	17.6	6.1	8.9	9.8	9.2	2.3	7.0	7.6	7.3	9.8	0.0	7.0	11.6	4.5	1.5	5.9	3.7	3.6	7.7	10.1	6.7	1.4
MAB21L1	CAGR1	ENSG00000180660	"Mab-21 like 1"	Q13394	13	35473789-35476689	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein, Nucleotidyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 21.9;retina: 68.7"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 57.7;Cone photoreceptor cells: 50.1;Horizontal cells: 87.5;Muller glia cells: 151.1;Rod photoreceptor cells: 125.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Region enhanced"	"Detected in many"		"cerebellum: 21.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 36.6;BJ hTERT+: 29.9;BJ hTERT+ SV40 Large T+: 41.7;HBF TERT88: 44.9;hTERT-RPE1: 86.2;SH-SY5Y: 133.5"	"Group enriched"	"Detected in many"	10	"cerebellum: 40.9;midbrain: 18.6;pons and medulla: 12.4"	"Region enhanced"	"Detected in all"		"cerebellum: 33.0"	"HPA049324, HPA059864"			Approved	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (4.44e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.79e-3)"	"unprognostic (3.87e-4)"	"unprognostic (5.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.86e-1)"	2.3	4.3	1.3	0.5	1.2	0.0	7.5	21.9	2.0	0.4	0.3	2.2	0.5	0.1	0.1	0.2	0.1	0.2	0.7	1.6	0.3	0.1	0.0	0.1	0.8	2.8	6.1	0.9	0.1	0.0	0.3	0.0	3.7	1.4	0.5	68.7	2.9	0.3	5.7	2.0	1.1	0.2	3.2	0.4	0.7	0.1	2.1	0.4	1.2	0.6	0.3	0.8	0.9	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	36.6	29.9	41.7	23.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.6	0.1	44.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.0	0.1	86.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	3.6	133.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	1.5	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	21.9	2.0	1.6	0.3	2.8	6.1	3.7	3.2	2.1	0.6	2.6	0.0	0.0	0.0	0.0	0.8	0.5	0.6	0.0	57.7	0.2	0.9	0.5	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	2.5	1.2	0.7	0.0	0.1	87.5	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.4	1.8	0.0	0.0	151.1	0.0	1.5	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	125.8	0.0	5.6	3.1	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.0	0.3
MAB21L2		ENSG00000181541	"Mab-21 like 2"	Q9Y586	4	150582151-150584693	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 174.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.0;Cholangiocytes: 28.6;Horizontal cells: 25.2;Muller glia cells: 7.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3;pancreatic cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTERT-RPE1: 101.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA049324, HPA059864"			Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (1.12e-1)"		"unprognostic (3.67e-2)"		"unprognostic (4.03e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-2)"		"unprognostic (8.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.68e-1)"	0.9	4.1	0.7	8.7	0.7	0.0	0.1	1.0	1.0	0.0	7.5	174.2	9.0	0.1	1.3	1.4	0.1	1.0	1.1	0.5	1.8	0.0	0.9	0.0	0.0	16.8	10.4	0.0	0.1	0.0	0.2	0.0	17.0	0.1	10.2	7.4	5.8	0.3	0.2	0.2	38.7	20.3	5.7	0.0	0.5	0.0	2.0	0.7	3.3	0.0	0.0	0.1	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.5	0.0	0.0	0.0	101.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	1.0	1.0	0.5	1.8	16.8	10.4	17.0	5.7	2.0	3.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.0	0.0	0.0	1.4	28.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	25.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MAB21L3	"C1orf161, FLJ38716"	ENSG00000173212	"Mab-21 like 3"	Q8N8X9	1	116111755-116135240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;esophagus: 7.0;skin 1: 6.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 48.3;Club cells: 18.5;granulocytes: 17.7;Oligodendrocytes: 31.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;EFO-21: 13.4;RT4: 14.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 6.2"	HPA039551			Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA039551: AB_2676565"	"unprognostic (9.25e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-3)"	"unprognostic (5.23e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.61e-2)"	0.1	0.0	0.8	0.1	1.4	0.6	0.3	2.0	5.2	1.7	0.0	1.5	0.2	0.2	0.1	7.0	0.0	0.0	0.0	1.0	0.8	1.3	1.7	0.2	0.1	1.5	2.1	0.1	0.0	0.0	0.0	0.7	3.5	0.8	1.3	1.3	0.8	0.6	0.3	6.2	0.3	0.0	0.5	0.2	0.2	0.4	3.3	0.2	0.1	0.1	0.6	0.6	2.9	5.3	2.6	0.0	0.4	0.2	0.0	0.0	4.6	0.2	0.1	0.0	0.0	0.3	0.7	1.8	13.4	0.0	0.1	2.5	0.1	0.1	0.0	0.4	0.0	0.4	0.2	2.7	0.0	0.5	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.5	1.3	0.0	0.2	0.2	0.2	1.1	0.4	0.9	0.4	0.5	0.2	0.5	14.4	0.3	0.3	2.0	1.4	0.3	1.4	1.6	0.3	0.2	0.6	1.1	0.3	0.2	1.2	2.2	0.7	0.3	0.2	0.7	0.9	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.6	0.1	0.1	1.5	1.2	0.1	0.3	0.0	0.0	0.8	1.4	2.0	5.2	1.0	0.8	1.5	2.1	3.5	0.5	3.3	5.3	0.1	44.8	48.3	2.0	0.0	0.6	2.5	0.4	0.6	0.1	0.1	0.0	0.4	0.0	18.5	3.7	0.0	6.3	0.0	5.3	1.9	0.1	0.6	3.1	0.3	2.9	0.0	0.0	13.2	0.2	0.6	4.4	0.0	4.8	17.7	0.0	0.0	0.5	0.3	0.0	10.1	1.2	6.1	0.3	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.2	0.0	6.0	31.6	0.0	1.1	0.0	0.0	0.8	1.2	0.9	13.2	0.3	0.0	0.1	0.2	0.0	0.2	3.7	1.7	13.7	2.6	0.1	1.4	0.5
MAB21L4	"C2orf54, FLJ22671"	ENSG00000172478	"Mab-21 like 4"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 262.6;vagina: 80.4"	"Cell type enriched"	"Detected in single"	7	"Cytotrophoblasts: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 45.9;HaCaT: 34.3;SK-BR-3: 117.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052722			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.2	0.1	0.3	1.0	0.5	0.0	1.8	0.5	1.3	36.0	0.0	2.9	11.5	0.2	0.1	262.6	0.9	0.5	0.1	0.8	0.0	13.3	13.0	10.0	0.3	0.3	0.0	0.1	1.2	0.0	0.2	0.8	0.5	1.5	2.5	0.3	29.2	0.2	0.3	60.8	4.9	0.1	0.0	0.2	5.8	0.2	0.2	1.1	0.1	0.0	23.5	2.0	80.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	45.9	2.7	0.3	0.3	0.0	0.0	34.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	5.7	0.1	0.1	0.2	7.3	0.0	0.1	0.0	11.4	0.3	5.9	2.3	0.0	0.0	117.0	0.0	0.2	0.9	0.7	0.0	0.0	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.3	0.8	0.0	0.3	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MACROD1	LRP16	ENSG00000133315	"Mono-ADP ribosylhydrolase 1"	Q9BQ69	11	63998558-64166113	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 290.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 137.0;Proximal tubular cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.8;RPMI-8226: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041031: AB_10794435, HPA071075: AB_2686341"	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	14.9	14.1	6.4	1.3	5.9	2.8	17.3	6.8	12.7	15.6	5.9	21.3	5.7	13.8	0.9	18.6	15.3	2.2	111.6	6.4	8.2	55.1	50.2	10.4	1.1	8.6	7.9	21.6	49.5	4.1	11.8	1.6	8.8	19.6	1.4	1.2	30.1	5.5	290.1	26.0	10.7	1.1	6.6	6.5	27.2	4.7	9.1	1.0	32.0	58.9	0.5	17.4	16.8	7.4	12.7	5.7	1.9	10.2	1.7	1.0	10.9	7.5	3.2	5.3	5.1	5.3	33.2	44.9	25.4	0.6	2.6	29.8	1.9	0.1	0.6	3.6	21.9	16.8	23.3	29.7	6.1	13.8	1.8	2.5	3.4	0.6	1.7	4.5	1.8	14.7	15.2	8.5	1.1	73.8	20.1	45.1	5.5	4.3	24.4	18.7	11.5	145.4	1.8	0.7	15.7	31.2	5.7	40.3	41.4	0.2	29.8	1.0	2.9	4.9	7.4	7.0	0.8	17.8	3.1	7.4	3.4	13.4	4.6	0.0	0.0	0.0	0.4	0.2	0.4	0.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	6.4	5.9	6.8	12.7	6.4	8.2	8.6	7.9	8.8	6.6	9.1	7.4	19.4	0.0	4.6	6.8	7.1	28.0	39.8	7.5	57.5	15.1	46.2	45.0	32.5	30.0	8.6	42.3	0.0	35.6	1.3	34.6	137.0	20.8	7.1	19.0	13.3	11.9	22.9	8.0	7.1	40.4	16.1	15.9	20.9	22.7	0.0	41.6	9.7	45.3	11.7	11.8	12.4	55.2	8.2	6.9	5.1	26.8	24.8	7.2	39.2	4.7	2.4	16.9	1.0	13.6	6.9	19.2	35.2	14.3	12.9	37.6	23.0	333.4	3.1	20.6	19.7	55.7	19.1	8.2	32.5	46.3	37.1	23.9	6.1	18.8	67.9	49.8
MACROD2	"C20orf133, dJ631M13.5"	ENSG00000172264	"Mono-ADP ribosylhydrolase 2"	A1Z1Q3	20	13995369-16053197	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 349.7;Excitatory neurons: 752.7;Inhibitory neurons: 1058.5;Oligodendrocyte precursor cells: 672.0;Oligodendrocytes: 301.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 8.9;naive B-cell: 13.2;neutrophil: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 13.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 15.5;Karpas-707: 19.1;RT4: 8.4;SCLC-21H: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049076	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA049076: "	"unprognostic (1.70e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.15e-5)"	"unprognostic (9.80e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-2)"	1.9	3.1	3.9	2.2	8.4	1.2	2.8	2.3	4.7	3.1	0.1	1.3	0.7	5.0	2.3	1.4	7.3	2.8	1.1	4.8	2.8	3.9	1.8	10.9	4.0	3.3	3.6	2.9	2.9	2.5	2.2	1.1	3.7	4.7	1.3	4.9	1.3	9.9	1.5	2.7	0.9	4.0	2.1	5.0	2.3	5.1	7.3	1.8	2.6	0.6	5.3	4.5	1.2	4.3	1.0	0.4	3.0	1.2	0.8	0.7	0.5	0.3	2.1	1.2	0.7	0.4	0.7	2.0	15.5	1.4	2.6	1.5	0.3	0.7	1.9	1.0	0.9	1.2	1.2	2.4	3.4	0.3	0.3	1.9	1.3	0.0	0.5	1.1	1.1	0.2	1.4	19.1	3.1	0.5	0.5	0.8	0.9	7.1	0.6	1.2	0.5	4.0	2.2	8.4	10.6	1.9	1.6	0.2	0.6	1.1	1.0	1.8	0.7	1.4	3.2	0.3	0.0	0.7	0.3	2.1	0.9	1.0	1.7	0.1	0.5	0.5	0.2	1.2	0.2	8.9	0.2	0.2	0.4	13.2	0.2	0.3	3.4	0.1	1.6	0.2	0.0	0.5	3.9	8.4	2.3	4.7	4.8	2.8	3.3	3.6	3.7	2.1	7.3	4.3	1.6	51.3	203.8	349.7	18.3	4.5	49.8	1.4	5.2	94.0	7.6	6.9	5.9	11.5	37.5	12.9	39.6	7.1	0.1	1.8	9.8	11.9	35.4	8.6	2.5	3.0	1.2	0.4	752.7	1.6	0.4	4.6	9.2	6.7	1.3	7.6	7.1	4.8	0.9	8.4	1058.5	4.5	0.0	0.3	2.1	62.2	3.4	0.9	3.6	87.1	0.0	10.2	0.0	672.0	301.4	6.6	1.7	17.7	2.8	6.2	2.4	8.6	9.8	20.3	6.6	2.1	6.0	23.7	18.8	5.8	6.7	2.1	0.9	13.2	2.8	5.4
MACROH2A1	"H2AFY, macroH2A1.2"	ENSG00000113648	"MacroH2A.1 histone"	O75367	5	135333900-135399914	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 67.2;Cytotrophoblasts: 151.6;Extravillous trophoblasts: 148.8;Hofbauer cells: 419.5;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041189, HPA050962"	Supported		Supported	Nucleoplasm		NA	NA		2700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357, HPA050962: AB_2681292"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (3.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.53e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.89e-3)"	"unprognostic (8.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	64.4	58.7	44.3	97.0	45.2	247.8	55.6	46.8	49.0	59.4	52.2	111.5	115.0	48.0	49.1	146.1	61.5	70.6	56.4	45.6	51.7	52.7	50.4	72.7	126.0	45.0	48.5	39.3	31.2	85.6	57.2	78.7	49.2	54.1	118.7	114.1	64.6	36.3	90.8	95.7	117.4	61.4	47.7	75.1	81.3	26.0	48.3	219.4	53.2	73.4	130.9	99.6	76.2	51.6	303.5	208.8	314.9	217.5	144.5	85.6	282.8	124.2	133.1	215.8	151.8	331.3	295.6	356.5	206.5	101.2	182.8	200.7	239.2	526.1	160.8	194.4	237.7	426.3	227.7	226.0	105.7	205.0	179.7	91.3	140.0	180.5	192.3	132.0	140.6	239.0	150.9	142.4	124.4	264.5	594.1	388.7	123.7	359.4	110.5	528.3	179.2	252.5	270.7	339.4	441.1	277.6	241.8	232.2	204.4	164.2	275.8	558.0	114.7	188.1	158.2	140.1	259.1	67.9	296.2	334.5	157.0	455.0	135.5	16.1	178.7	84.3	40.3	122.6	34.0	47.2	51.1	49.8	203.0	67.8	49.2	40.4	93.2	87.8	80.1	147.2	65.3	138.4	44.3	45.2	46.8	49.0	45.6	51.7	45.0	48.5	49.2	47.7	48.3	51.6	57.6	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	151.6	38.3	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	148.8	30.4	0.0	0.0	0.0	0.0	0.0	0.0	419.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	183.5	5.8	0.0	0.0	0.0
MACROH2A2	H2AFY2	ENSG00000099284	"MacroH2A.2 histone"	Q9P0M6	10	70052544-70112282	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.1;Fibroblasts: 1.7;Hofbauer cells: 4.9;Syncytiotrophoblasts: 1.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 12.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 173.9;AN3-CA: 111.5;SCLC-21H: 137.0;SH-SY5Y: 132.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035865, HPA041189"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA035865: AB_10672099, HPA041189: AB_2677357"	"unprognostic (1.62e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.17e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.66e-2)"	3.8	3.2	5.3	5.6	4.5	1.9	10.2	7.3	6.3	14.7	3.3	10.8	9.5	18.3	11.6	17.4	16.5	8.7	13.5	4.1	4.9	15.2	5.2	5.6	4.9	3.8	3.9	13.3	7.8	14.9	14.0	2.1	3.7	13.1	10.5	3.2	10.9	14.4	6.5	10.7	10.1	15.3	3.6	2.7	8.6	11.8	4.2	7.4	10.2	8.6	7.2	13.2	11.8	4.4	4.7	31.1	173.9	111.5	2.5	5.1	0.1	8.6	0.3	16.2	11.0	0.5	55.8	0.0	23.5	2.8	9.1	27.4	15.3	44.8	5.1	81.1	63.4	0.0	0.2	59.1	11.2	1.9	0.8	8.1	30.4	6.4	8.5	23.4	0.0	6.3	0.1	0.6	15.7	37.5	0.2	0.9	74.8	0.2	44.9	0.4	0.5	0.6	30.7	34.0	137.0	132.4	28.6	0.2	0.0	35.2	41.5	20.3	0.0	0.3	32.3	12.4	6.2	0.4	0.1	0.3	0.0	0.2	0.3	1.6	2.4	0.8	0.6	5.4	1.1	0.3	0.9	0.8	12.6	0.3	0.8	0.9	1.4	1.1	3.0	0.2	0.5	1.6	5.3	4.5	7.3	6.3	4.1	4.9	3.8	3.9	3.7	3.6	4.2	4.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0
MAD1L1	"HsMAD1, MAD1, PIG9, TP53I9, TXBP181"	ENSG00000002822	"Mitotic arrest deficient 1 like 1"	Q9Y6D9	7	1815793-2233243	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 316.9;Late spermatids: 685.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003635, CAB015338"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"CAB015338: AB_627901, HPA003635: AB_1853472"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.26e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-1)"	9.4	6.0	6.2	11.1	8.3	14.9	9.0	4.6	8.4	11.4	5.1	7.7	6.0	9.3	2.5	9.2	7.4	4.8	8.8	5.6	6.7	6.5	6.4	10.2	17.8	7.8	6.6	7.4	5.6	4.1	7.1	5.0	7.6	8.2	3.4	4.0	7.3	5.6	13.6	14.5	9.7	5.3	5.5	18.2	6.6	10.7	7.0	15.3	8.6	5.0	10.7	8.3	10.1	9.4	37.2	15.5	16.5	30.1	11.1	11.2	26.5	25.6	13.0	26.0	20.7	28.5	21.5	23.4	10.4	14.7	39.9	28.5	12.4	18.3	15.7	11.1	17.8	30.1	19.4	45.0	15.7	21.1	55.1	13.9	13.3	28.8	14.0	6.3	14.9	13.7	30.3	17.4	10.3	45.4	8.7	61.0	30.7	5.8	20.5	38.5	16.7	17.5	12.7	18.7	10.7	33.4	20.0	24.9	65.2	11.2	17.1	48.9	17.6	21.8	60.0	62.3	26.0	30.3	31.4	27.3	18.1	60.6	80.3	60.4	36.2	25.4	71.3	62.4	66.6	54.6	69.2	72.3	63.4	63.0	92.0	66.0	8.6	22.7	60.1	26.0	131.5	53.6	6.2	8.3	4.6	8.4	5.6	6.7	7.8	6.6	7.6	5.5	7.0	9.4	9.3	3.2	10.4	12.1	33.8	17.6	13.9	14.0	15.4	8.3	6.2	6.5	7.4	14.3	11.9	7.3	10.4	16.2	35.7	12.4	15.6	12.3	316.9	5.5	6.7	10.7	32.4	19.1	20.9	11.4	16.3	11.4	11.7	6.9	41.8	15.5	6.4	36.4	39.6	23.5	24.4	9.4	16.2	31.4	84.1	685.9	12.5	28.2	37.4	21.5	25.7	24.3	47.4	16.1	32.4	16.5	7.9	10.5	14.9	9.4	5.4	15.2	6.6	13.9	19.7	11.2	10.2	60.3	33.8	9.3	21.5	24.5	43.1	17.5	8.8	9.7
MAD2L1	"HSMAD2, MAD2"	ENSG00000164109	"Mitotic arrest deficient 2 like 1"	Q13257	4	120055623-120066858	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.9;lymphoid tissue: 5.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.8;Extravillous trophoblasts: 119.2;Spermatocytes: 127.8;Spermatogonia: 76.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003348	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA003348: AB_10603014"	"unprognostic (4.08e-3)"	"unprognostic (7.31e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (5.15e-5)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (6.74e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (3.07e-11)"	"unprognostic (3.06e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	0.3	0.4	0.5	2.1	0.6	5.9	1.2	0.8	0.7	0.5	0.2	2.2	1.8	0.7	0.3	1.6	1.4	0.4	0.5	0.5	0.5	0.4	0.5	0.4	4.0	0.4	0.4	0.5	0.2	0.4	0.1	1.4	0.5	0.6	2.6	1.0	0.3	0.5	0.2	1.0	1.9	0.8	0.4	0.8	0.9	2.3	0.4	5.7	0.4	0.2	3.6	0.7	0.5	0.6	27.2	11.6	26.9	17.5	2.8	3.4	11.5	21.0	11.8	21.5	16.5	15.7	16.3	39.6	6.8	7.6	9.5	7.1	27.1	16.1	30.0	18.8	18.8	22.0	10.5	14.9	0.8	36.3	12.0	1.9	2.3	14.6	9.1	5.4	12.6	16.4	26.7	22.0	11.4	12.0	35.0	15.6	18.3	14.1	13.0	17.8	35.9	16.2	8.7	10.3	28.4	20.1	10.5	12.8	6.5	12.9	8.4	13.0	7.8	14.2	16.1	14.6	27.0	20.1	23.2	25.7	13.3	18.4	19.1	0.9	0.1	0.1	0.4	0.1	0.6	0.5	1.2	1.0	0.1	0.4	1.1	1.1	0.3	0.9	0.2	0.7	1.3	0.5	0.5	0.6	0.8	0.7	0.5	0.5	0.4	0.4	0.5	0.4	0.4	0.6	2.4	0.0	1.3	1.0	11.5	17.3	7.3	23.5	4.0	9.7	7.2	8.3	3.4	1.5	6.0	7.3	2.1	52.0	7.6	7.5	0.0	3.4	2.4	31.3	6.0	5.4	1.8	81.8	1.3	1.5	119.2	13.7	8.6	7.8	15.2	34.6	3.9	2.9	27.9	20.2	1.2	13.7	36.7	7.3	13.4	4.8	4.7	6.1	8.8	0.0	3.1	12.3	5.2	0.5	1.0	1.6	3.7	1.5	33.1	5.0	3.7	7.2	12.9	3.8	13.1	7.3	14.9	127.8	76.2	26.0	8.9	10.8	20.1	11.9	29.2	8.7
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640941	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: AB_2672752"	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	13.3	16.2	13.6	14.1	13.8	53.5	17.3	14.1	15.8	14.6	15.4	25.9	23.6	12.4	17.3	17.6	16.7	14.4	25.4	14.3	14.9	17.5	21.9	14.9	21.7	13.8	13.2	13.0	16.7	21.1	12.6	14.0	14.2	14.4	27.7	15.2	22.8	13.5	28.5	13.2	18.8	14.5	13.6	17.4	19.3	20.4	14.3	29.3	15.6	44.6	26.6	21.4	10.6	13.8	53.9	24.4	37.7	42.2	32.1	34.7	22.7	31.7	50.9	68.5	63.8	50.3	21.4	41.6	17.6	37.3	62.2	34.4	59.2	43.9	52.6	38.5	46.0	51.5	26.1	43.8	34.6	30.6	29.9	35.3	53.0	51.1	31.0	34.5	52.2	32.8	67.2	21.8	48.4	50.6	27.4	56.5	23.3	221.1	31.3	31.3	29.3	39.4	48.9	42.5	44.7	45.3	22.8	34.5	152.2	28.6	40.6	80.3	28.7	36.5	30.7	24.4	51.3	27.7	25.8	99.0	33.2	51.3	41.0	105.4	41.4	49.4	46.3	42.8	46.5	52.6	54.7	51.4	52.7	47.9	56.5	51.2	35.2	55.6	41.3	34.9	78.9	43.6	13.6	13.8	14.1	15.8	14.3	14.9	13.8	13.2	14.2	13.6	14.3	13.8	11.6	25.6	12.7	3.3	18.2	14.4	20.5	44.9	17.6	12.8	11.6	9.3	10.8	15.7	32.5	3.7	12.5	21.1	11.1	30.7	27.4	28.0	47.0	13.2	8.6	12.5	17.4	20.6	3.0	21.2	21.5	12.0	14.3	10.8	31.6	7.8	11.4	12.7	17.6	10.1	3.2	17.1	32.6	10.4	8.6	36.5	12.2	19.6	28.4	1.9	17.3	13.9	11.3	3.0	5.0	24.7	29.5	12.0	11.1	11.5	28.2	21.2	21.1	15.1	26.3	8.3	13.4	26.4	18.3	12.6	9.7	6.2	14.8	11.9	23.4	27.2
MAEA	"EMP, GID9, HLC-10, p44EMLP"	ENSG00000090316	"Macrophage erythroblast attacher, E3 ubiquitin ligase"	Q7L5Y9	4	1289887-1340147	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036886, HPA058185"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA036886: , HPA058185: AB_2683633"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.94e-3)"	"unprognostic (4.65e-3)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.51e-2)"	28.5	44.2	21.9	23.5	21.3	18.3	28.8	19.8	24.0	32.6	25.9	39.7	33.5	34.4	10.9	46.7	29.2	17.5	38.6	21.1	27.2	40.9	32.3	24.0	24.3	25.7	23.0	34.9	35.4	30.7	38.9	17.2	26.3	29.2	14.2	8.8	35.7	21.5	37.1	41.2	35.7	14.9	18.1	40.0	37.1	26.8	23.2	20.7	33.9	19.2	15.7	30.7	33.5	20.0	58.1	66.9	47.6	47.7	31.5	31.1	61.4	57.4	30.6	47.1	42.2	70.5	73.5	52.5	43.6	42.4	85.5	42.0	46.1	72.2	19.1	42.4	52.2	49.2	74.1	68.1	37.1	55.8	50.9	38.8	38.6	37.8	23.6	31.8	38.0	50.4	70.4	41.6	41.3	61.5	84.2	86.5	62.2	63.4	72.9	81.0	38.1	47.8	50.3	68.2	84.7	57.8	51.1	39.3	41.5	26.3	71.5	48.4	52.8	85.9	36.0	39.0	96.1	50.5	83.4	58.1	59.0	51.3	48.2	74.9	49.9	70.9	59.2	52.6	83.5	47.6	47.1	56.4	47.1	38.1	41.4	42.5	117.9	45.5	77.3	33.0	59.8	59.1	21.9	21.3	19.8	24.0	21.1	27.2	25.7	23.0	26.3	18.1	23.2	20.0	22.0	19.2	25.0	28.4	21.6	18.7	15.7	33.9	8.0	28.1	22.5	25.3	35.5	14.3	24.3	16.5	20.9	48.2	29.7	41.2	46.9	43.4	8.0	21.9	25.2	24.4	20.4	26.3	19.6	30.3	46.4	25.0	25.5	25.0	10.8	30.4	19.6	15.0	39.6	21.9	23.2	33.1	30.5	29.2	15.9	9.8	35.4	23.2	28.4	14.0	46.3	22.3	28.8	22.6	20.0	40.3	31.3	37.2	23.5	22.7	30.4	36.4	17.9	19.1	13.1	24.9	27.9	36.6	44.0	19.3	19.9	95.2	29.7	59.6	38.1	21.8
MAF1	DKFZp586G1123	ENSG00000179632	"MAF1 homolog, negative regulator of RNA polymerase III"	Q9H063	8	144104461-144107611	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024821, HPA058548"	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA024821: AB_2671696, HPA058548: AB_2683751"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.12e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.02e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.99e-2)"	96.2	84.4	86.6	61.7	89.7	164.4	92.4	87.3	98.3	97.1	82.5	186.9	62.1	101.9	63.6	81.8	93.3	63.0	193.4	83.5	82.7	89.8	61.1	78.0	78.6	91.2	87.6	110.3	84.6	87.4	71.0	65.1	86.4	103.6	58.3	35.4	77.5	94.6	413.1	69.6	92.2	80.5	85.3	96.5	102.1	76.4	88.7	90.8	78.6	294.7	69.5	130.7	84.1	90.5	119.8	187.1	85.4	86.3	229.0	113.3	68.9	91.8	151.0	140.5	142.1	69.2	129.1	131.0	150.4	154.9	78.1	71.4	117.4	129.9	103.0	115.4	139.5	144.5	127.8	109.6	154.1	62.0	94.4	100.7	150.0	112.8	211.4	156.7	153.6	94.1	112.5	86.9	85.0	281.2	230.9	112.3	64.0	216.3	490.2	90.3	119.7	141.8	89.0	88.8	123.8	102.2	122.0	156.7	152.6	79.5	106.7	93.9	93.0	65.0	146.0	116.1	117.5	102.7	86.0	62.2	107.8	113.7	44.0	50.4	98.0	126.5	72.8	76.1	81.0	110.2	105.0	117.5	107.6	129.9	110.9	105.0	52.9	93.1	78.4	81.0	84.1	111.9	86.6	89.7	87.3	98.3	83.5	82.7	91.2	87.6	86.4	85.3	88.7	90.5	76.8	16.0	15.6	6.8	95.2	92.9	92.4	51.6	53.5	41.4	76.5	77.8	54.2	42.9	24.8	44.1	14.6	106.4	113.9	82.6	105.7	101.1	86.1	30.0	39.3	69.7	93.3	129.0	5.0	107.9	103.6	66.3	28.5	43.6	32.5	77.3	67.5	29.3	97.6	37.0	5.5	89.7	32.6	72.3	85.6	41.0	88.3	84.9	78.2	6.5	138.0	82.0	138.0	7.1	10.7	106.0	97.4	93.3	60.3	170.3	155.0	110.2	12.9	37.6	98.6	65.5	84.8	96.1	43.3	54.0	89.8	144.3	87.6	72.4	88.5	122.4
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689236	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 273.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 264.0;Hofbauer cells: 377.6;Kupffer cells: 672.8;Macrophages: 456.7;Squamous epithelial cells: 361.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 88.3;non-classical monocyte: 121.4"	"Lineage enriched"	"Detected in many"	15	"monocytes: 121.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 28.6;hTCEpi: 61.2;SCLC-21H: 16.7;SiHa: 15.6;U-138 MG: 16.4;U-2197: 24.4;U-87 MG: 16.0"	"Low region specificity"	"Detected in many"							HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	35.3	13.8	4.8	37.3	4.9	59.2	27.3	4.4	10.5	16.5	6.9	9.5	7.8	9.3	5.4	33.0	11.3	24.4	10.7	3.7	5.7	17.5	29.3	20.9	27.8	14.3	6.3	6.8	15.8	273.1	3.1	13.2	7.2	8.3	7.2	0.6	18.3	4.7	15.8	85.3	13.2	14.2	9.0	96.3	11.0	3.9	13.1	6.7	50.1	16.7	12.7	13.9	21.9	15.8	0.0	0.0	0.0	2.6	1.5	0.2	0.4	0.3	0.1	0.3	0.1	0.4	0.2	0.0	1.9	0.4	0.0	3.8	0.0	0.0	0.0	0.0	1.4	0.0	1.2	0.2	0.9	0.0	0.1	28.6	61.2	0.2	2.1	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.3	7.4	2.6	6.2	0.0	0.0	0.0	0.0	0.5	0.4	16.7	1.4	15.6	1.5	3.9	5.4	1.5	0.3	0.5	16.4	0.3	24.4	0.0	0.0	0.0	0.0	16.0	0.6	0.0	0.4	24.3	0.0	0.0	88.3	0.0	0.0	0.0	0.1	7.9	0.1	0.0	0.0	2.1	0.0	121.4	0.1	0.0	10.6	4.8	4.9	4.4	10.5	3.7	5.7	14.3	6.3	7.2	9.0	13.1	15.8	70.0	22.4	37.9	1.6	7.8	68.6	50.5	17.1	264.0	12.0	112.2	217.8	208.9	7.2	16.8	51.5	25.0	9.8	7.6	117.1	1.9	2.3	0.8	15.7	64.4	39.1	57.7	4.0	0.8	3.4	2.8	172.7	49.5	27.6	10.8	0.9	34.6	36.1	377.6	3.3	25.4	50.7	6.1	672.8	91.7	2.8	29.5	456.7	21.4	6.5	65.3	21.9	3.1	2.0	1.3	4.9	30.9	24.5	5.6	29.7	89.5	1.3	2.4	8.3	13.1	160.6	102.4	0.8	1.7	361.5	88.2	12.4	9.5	114.6	39.0	19.2
MAFF	hMafF	ENSG00000185022	"MAF bZIP transcription factor F"	Q9ULX9	22	38200767-38216507	"Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 682.0;Syncytiotrophoblasts: 479.1;Urothelial cells: 409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 23.9;neutrophil: 8.7;NK-cell: 21.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 23.9;NK-cells: 21.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 79.2;SK-MEL-30: 104.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 5.6"	"CAB025341, HPA055371"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Mitochondria	"CAB025341: , HPA055371: AB_2682797"	"prognostic favorable (4.32e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.42e-3)"	"unprognostic (7.83e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-2)"	102.9	22.8	9.4	12.9	9.0	36.2	69.9	9.3	10.7	37.4	9.4	26.6	8.1	28.8	2.1	53.4	64.2	41.4	53.8	8.2	11.9	32.0	30.8	59.2	4.7	14.5	10.0	53.9	19.7	5.3	19.5	34.5	13.4	39.5	10.3	19.6	28.6	5.5	73.3	45.7	19.6	23.2	10.5	9.3	45.4	3.0	14.1	7.4	25.0	6.9	11.3	53.8	41.4	16.6	20.8	3.3	4.4	6.6	6.9	21.3	20.6	41.4	54.2	19.8	21.0	6.1	16.0	0.7	3.9	16.9	29.5	13.5	1.1	15.7	33.2	3.9	0.6	2.1	2.1	5.2	18.0	1.3	7.1	9.3	25.7	79.2	43.6	17.6	42.1	1.9	4.2	18.6	15.6	4.9	0.8	5.2	3.3	22.0	16.8	1.4	3.8	4.3	19.9	30.6	2.2	3.7	6.1	15.4	104.9	10.7	3.3	1.5	57.9	24.7	19.2	18.8	13.7	7.2	8.0	0.7	37.4	1.4	15.9	23.9	0.4	0.3	2.9	0.7	2.8	0.8	1.7	2.1	1.4	0.5	2.1	1.6	8.7	21.1	3.5	0.2	0.7	1.8	9.4	9.0	9.3	10.7	8.2	11.9	14.5	10.0	13.4	10.5	14.1	16.6	215.4	54.5	43.4	1.0	19.3	125.9	344.1	56.8	169.0	2.9	302.9	214.1	18.6	67.2	49.5	11.0	0.0	37.8	112.5	134.2	7.9	49.9	0.5	284.7	149.3	97.3	104.8	5.7	0.8	24.2	77.5	134.7	132.5	682.0	22.2	11.5	22.1	8.2	26.0	0.0	1.6	112.5	34.6	14.0	131.1	0.4	9.9	113.5	58.7	1.0	10.2	36.0	17.5	1.5	1.3	76.0	181.0	3.8	25.8	258.4	67.6	3.7	37.9	3.6	19.7	265.2	153.1	2.4	1.0	139.5	103.1	479.1	59.0	8.4	75.5	409.2
MAFK	"NFE2U, P18"	ENSG00000198517	"MAF bZIP transcription factor K"	O60675	7	1530702-1543043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026820, HPA060841"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026820: , HPA060841: AB_2684377"	"unprognostic (6.82e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	40.9	31.0	37.0	13.0	34.8	19.5	34.4	26.8	34.8	30.9	38.2	61.1	18.2	34.7	1.8	30.1	33.6	11.6	80.5	26.8	28.0	50.3	32.8	60.0	9.4	35.5	33.3	21.7	39.7	4.2	25.6	25.4	32.2	49.2	4.7	2.4	25.6	10.7	78.6	38.6	31.1	6.7	30.2	21.0	37.2	9.7	35.6	22.9	27.3	13.1	4.9	39.4	35.7	43.2	50.0	35.0	1.2	5.2	3.9	4.8	26.2	32.3	18.3	7.7	5.4	25.2	13.4	11.6	11.7	8.2	51.8	38.1	2.9	9.2	3.3	17.9	25.2	6.8	50.8	18.7	8.7	16.2	20.7	4.8	11.8	12.9	9.6	9.5	7.1	35.7	17.8	6.2	3.6	32.7	18.2	57.6	11.2	12.2	35.2	27.1	1.2	19.5	7.3	20.2	14.8	5.4	19.5	56.4	14.6	7.5	22.0	21.3	16.8	11.8	82.3	59.5	17.9	11.8	3.9	19.8	15.5	22.0	17.1	0.5	0.4	1.2	0.6	0.2	0.6	0.3	0.3	0.7	0.2	0.5	0.7	0.5	0.6	0.5	0.5	1.5	0.7	0.4	37.0	34.8	26.8	34.8	26.8	28.0	35.5	33.3	32.2	30.2	35.6	43.2	33.0	41.7	17.6	2.0	8.8	63.9	52.2	21.3	37.0	2.2	33.7	20.2	2.8	11.5	25.7	31.3	2.1	11.0	13.2	45.8	1.9	15.2	2.9	57.3	13.3	24.6	23.2	8.2	8.8	14.9	9.0	16.6	20.4	94.3	9.5	6.6	9.7	14.8	10.9	11.8	3.7	24.4	16.2	13.2	27.9	6.0	4.7	18.0	19.6	9.4	8.7	7.1	8.2	0.5	3.1	46.2	38.9	3.0	6.0	60.8	27.4	2.5	29.6	1.6	13.1	33.2	27.1	0.9	4.0	25.8	57.7	78.0	11.0	2.0	19.8	73.5
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"placenta: 9.5;testis: 2.6"	"Cell type enhanced"	"Detected in some"		"Sertoli cells: 6.6;Spermatocytes: 57.3;Spermatogonia: 26.2;Syncytiotrophoblasts: 11.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"GAMG: 78.6"					"Not detected"	"Not detected"			"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: AB_2686310"		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	9.5	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	0.2	4.9	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.0	6.0	0.0	0.4	0.0	12.7	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	57.3	26.2	0.0	0.0	11.2	0.0	0.0	0.0	0.1
MAGEA11	"CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511"	ENSG00000185247	"MAGE family member A11"	P43364	X	149688228-149717268	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 21.0"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 29.4;Spermatogonia: 30.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-2 OS: 23.8"									HPA052687			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA052687: AB_2681915"	"unprognostic (4.06e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-2)"		"unprognostic (9.64e-2)"		"unprognostic (1.32e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.16e-1)"				"unprognostic (6.67e-4)"	"unprognostic (1.14e-1)"		"unprognostic (1.33e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	23.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	30.9	0.0	0.0	5.9	0.0	0.0	0.0	0.0
MAGEA9	"CT1.9, MAGE9, MGC8421"	ENSG00000123584	"MAGE family member A9"	P43362	X	149781930-149787737	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	38	"testis: 3.7"	"Group enriched"	"Detected in some"	16	"Spermatocytes: 2.3;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"U-266/70: 45.2;U-266/84: 32.9"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEA9B		ENSG00000267978	"MAGE family member A9B"	P43362	X	149581653-149587453	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"testis: 10.0"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 39.6;Spermatogonia: 16.0"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"OE19: 82.4;RT4: 131.1;U-266/70: 55.1;U-266/84: 73.7"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "															"unprognostic (6.12e-3)"		"unprognostic (3.26e-1)"	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.0	0.1	82.4	0.0	0.2	0.0	6.3	0.0	131.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	55.1	73.7	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	39.6	16.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MAGEB16		ENSG00000189023	"MAGE family member B16"	A2A368	X	35798342-35803735	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	33	"testis: 3.3"	"Group enriched"	"Detected in some"	35	"Spermatocytes: 7.4;Spermatogonia: 13.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 59.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055743, HPA076456"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA055743: AB_2682902, HPA076456: "															"unprognostic (2.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.4	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB17		ENSG00000182798	"MAGE family member B17"	A8MXT2	X	16167481-16171464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"pancreas: 2.0;testis: 1.7"	"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-138 MG: 2.7;U-2 OS: 6.0;U-266/70: 14.8"									HPA003756	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA003756: AB_2250114"	"unprognostic (1.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.04e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.44e-2)"	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	1.5	0.0	0.0	2.7	6.0	0.0	0.1	14.8	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEC1	"CT7, CT7.1, MAGE-C1, MGC39366"	ENSG00000155495	"MAGE family member C1"	O60732	X	141903894-141909374	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 7.3"	"Group enriched"	"Detected in some"	9	"Sertoli cells: 6.6;Spermatocytes: 17.1;Spermatogonia: 13.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 54.3;Karpas-707: 51.6;U-2 OS: 33.8;U-2197: 65.4;U-266/70: 46.5;U-266/84: 44.4"									"HPA004622, CAB015452"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB015452: AB_784404, HPA004622: AB_1853495"	"unprognostic (5.63e-2)"				"unprognostic (1.59e-1)"		"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.47e-1)"					"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.6	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.3	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.1	33.8	65.4	0.1	46.5	44.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	17.1	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEC2	"CT10, HCA587, MAGE-C2, MAGEE1"	ENSG00000046774	"MAGE family member C2"	Q9UBF1	X	142202342-142205290	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	197	"testis: 19.6"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 84.6;Spermatogonia: 91.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 19.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 87.3;U-266/84: 99.8"									HPA062230	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA062230: AB_2684718"					"unprognostic (1.25e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.82e-1)"						"unprognostic (1.04e-1)"		"unprognostic (4.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.9	3.7	0.0	0.0	0.0	0.2	5.7	0.9	11.3	0.0	0.1	99.8	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	84.6	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816015	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Granulosa cells: 1684.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No		120000	"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.88e-4)"	"prognostic favorable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	81.6	125.1	102.3	52.8	97.8	31.8	162.6	104.9	112.2	174.5	111.7	106.8	54.3	134.3	101.9	67.4	149.0	94.3	142.2	95.5	121.9	141.0	57.5	85.9	48.0	125.4	118.4	255.9	75.5	148.0	195.3	177.1	128.8	208.8	53.5	74.4	103.3	169.9	88.9	60.5	62.5	140.6	108.5	60.8	77.6	63.1	110.1	68.8	149.2	91.4	46.2	111.7	95.7	108.9	34.0	61.4	373.7	111.0	171.6	229.5	66.8	137.9	243.7	106.4	187.5	62.3	84.4	47.1	361.2	279.0	88.5	45.2	106.5	104.2	76.1	84.5	87.0	100.0	68.6	122.1	145.5	25.4	71.8	310.4	43.0	109.3	55.5	223.6	209.9	55.2	24.5	55.7	207.6	94.0	57.0	41.9	134.7	59.1	72.4	37.4	132.9	68.2	148.5	25.3	56.6	149.5	54.7	62.4	330.6	437.5	263.1	42.9	185.0	90.4	141.3	135.9	39.5	35.7	32.7	34.5	132.0	66.7	477.6	178.5	31.9	132.1	119.1	80.0	91.7	59.2	98.1	112.1	41.1	63.9	97.3	112.0	11.8	108.6	140.8	25.8	108.9	127.4	102.3	97.8	104.9	112.2	95.5	121.9	125.4	118.4	128.8	108.5	110.1	108.9	77.9	44.8	42.8	17.6	37.4	42.4	96.4	198.6	43.3	69.8	123.3	97.8	60.5	44.3	175.4	77.3	29.2	231.5	36.9	11.9	246.5	107.4	3.4	42.4	96.8	116.4	58.3	10.3	12.9	53.7	133.7	151.7	20.9	57.1	102.1	1684.0	79.9	16.2	69.1	138.0	20.3	48.8	173.0	19.5	47.4	17.4	233.3	41.1	158.3	21.5	42.1	175.9	44.3	17.6	20.4	47.9	33.7	320.4	46.7	75.2	25.5	149.3	119.9	66.0	157.8	77.7	236.3	12.8	13.7	15.3	34.9	169.2	51.4	58.6	25.3	76.6
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 497.7;Inhibitory neurons: 809.8;Oligodendrocyte precursor cells: 368.4;Oligodendrocytes: 532.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	11.3	5.0	3.7	1.3	4.8	0.0	12.5	6.3	5.9	5.5	3.9	9.7	5.0	6.2	2.0	8.0	5.8	5.3	9.0	4.7	5.3	10.2	13.4	8.8	1.1	3.7	3.8	2.7	12.6	5.9	7.7	5.3	2.6	7.1	4.2	7.0	11.6	4.9	3.8	12.5	6.4	3.1	2.7	11.9	14.7	10.3	4.1	2.0	13.4	4.1	1.8	5.4	7.2	4.9	4.1	2.2	12.3	1.3	2.4	1.7	5.5	7.0	5.9	2.6	4.0	15.1	3.5	0.0	1.0	8.3	2.1	1.2	3.4	2.4	4.1	0.0	1.9	36.1	4.3	10.2	1.5	0.0	1.1	2.7	2.0	8.9	1.8	6.8	6.0	4.7	15.6	0.0	2.8	3.1	0.0	0.0	16.6	12.2	2.1	0.0	3.5	0.9	3.1	13.5	3.9	10.8	2.7	3.3	0.1	8.0	6.4	0.0	1.6	8.2	6.0	2.1	2.9	0.0	0.0	0.0	4.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.8	6.3	5.9	4.7	5.3	3.7	3.8	2.6	2.7	4.1	4.9	102.8	76.9	29.8	204.7	1.3	22.3	17.7	7.9	26.2	98.3	46.5	37.5	35.6	102.9	22.5	23.9	75.0	20.2	0.5	51.0	3.9	44.3	179.1	35.8	35.5	55.5	36.5	2.7	497.7	31.8	2.4	9.6	47.4	50.8	1.3	78.4	82.5	60.9	4.8	232.2	809.8	40.3	12.2	5.0	3.6	27.0	6.5	1.8	5.4	170.5	0.6	15.2	0.0	368.4	532.1	40.3	25.4	8.6	0.2	14.7	33.2	12.2	40.3	26.4	32.9	7.0	17.5	44.7	12.3	12.7	18.8	5.1	2.7	27.1	26.3	11.9
MAGIX	"FLJ21687, JM10, PDZX"	ENSG00000269313	"MAGI family member, X-linked"	Q9H6Y5	X	49162564-49168483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Hepatocytes: 35.0;Proximal tubular cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 5.5;RT4: 12.8;SK-BR-3: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007390, HPA035302"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Mitotic chromosome"	"HPA007390: , HPA035302: AB_10603015"	"unprognostic (1.11e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.64e-6)"	"unprognostic (6.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"prognostic favorable (6.91e-9)"	"unprognostic (4.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (2.10e-4)"	1.3	2.1	3.9	0.7	3.6	1.4	1.8	9.5	4.3	2.4	7.9	3.4	1.7	1.8	1.2	4.3	4.0	1.3	9.9	3.9	3.9	9.7	19.1	2.8	0.4	4.2	4.2	1.0	13.9	3.7	5.9	0.5	4.2	5.1	1.0	1.1	10.0	2.8	2.1	2.7	1.5	0.3	3.5	1.2	12.4	0.7	4.0	0.6	7.0	0.5	0.3	2.8	2.1	3.7	0.3	1.9	0.4	0.5	0.5	0.1	1.4	0.3	0.3	0.3	0.3	1.1	5.5	0.5	0.5	0.6	0.7	1.2	0.3	1.3	0.0	1.6	1.8	2.4	3.4	0.6	0.2	0.6	4.7	0.5	0.2	0.4	0.1	0.6	0.4	0.8	0.3	2.0	0.4	0.7	0.5	1.7	0.5	1.5	1.0	0.3	0.1	1.0	1.0	12.8	2.4	0.5	1.1	5.7	0.6	0.3	4.5	0.5	0.2	0.6	1.4	0.5	0.4	1.3	0.7	0.4	2.3	0.8	1.8	3.1	1.1	2.0	0.1	1.0	0.4	0.6	0.5	0.0	0.7	0.5	0.3	0.5	4.2	0.7	1.1	1.4	0.1	0.6	3.9	3.6	9.5	4.3	3.9	3.9	4.2	4.2	4.2	3.5	4.0	3.7	1.6	3.2	5.4	1.0	2.8	3.2	10.3	5.6	4.6	8.0	18.7	10.4	8.5	11.5	7.0	12.9	2.1	2.1	3.9	33.7	46.9	13.1	0.2	24.7	2.5	2.0	17.5	0.4	1.2	20.8	4.1	2.4	28.5	16.0	0.0	0.8	4.2	35.0	5.1	8.4	1.1	23.4	2.0	3.2	5.7	0.0	0.6	5.7	1.8	0.0	4.8	8.3	0.0	1.0	1.3	8.9	30.7	0.4	5.2	5.8	15.2	44.3	20.4	9.7	0.0	6.9	3.8	3.0	2.7	8.0	4.4	3.8	3.9	1.7	15.3	9.9
MAGOH	"MAGOH1, MAGOHA"	ENSG00000162385	"Mago homolog, exon junction complex subunit"	P61326	1	53226900-53238518	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015425, HPA043036, HPA047754"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB015425: AB_629914, HPA043036: AB_2678279, HPA047754: AB_2680148"	"prognostic favorable (1.85e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (2.01e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.75e-3)"	51.4	48.5	36.5	59.0	36.5	141.1	51.8	37.8	47.1	41.0	38.4	61.2	53.1	57.2	59.0	48.1	55.9	37.9	43.3	36.6	38.1	53.6	76.4	44.8	85.0	37.5	37.1	49.2	43.8	50.4	34.9	67.9	37.9	39.9	55.5	34.4	44.5	37.4	43.8	42.9	55.2	50.7	37.5	55.2	46.8	32.3	36.8	101.7	51.7	42.5	86.3	62.1	38.9	38.1	207.8	101.0	169.4	150.2	88.1	56.9	197.6	152.3	92.0	202.4	204.5	233.2	97.1	293.5	168.8	93.1	248.4	125.9	228.3	136.7	242.3	197.1	249.6	266.1	127.4	253.3	141.4	459.3	143.3	62.7	95.3	184.4	150.6	77.7	136.8	260.8	279.6	63.8	109.9	169.3	377.2	316.0	310.0	171.1	218.4	256.1	323.2	154.5	109.1	208.3	142.7	115.7	202.0	161.2	250.1	206.8	85.1	330.2	122.0	122.6	167.7	170.7	354.9	93.6	184.8	453.4	109.4	289.5	127.0	31.5	34.8	53.9	49.3	51.9	48.1	47.4	46.9	51.5	50.0	42.9	42.6	44.9	41.9	52.9	50.2	58.6	54.2	32.7	36.5	36.5	37.8	47.1	36.6	38.1	37.5	37.1	37.9	37.5	36.8	38.1	134.5	51.3	47.6	10.1	93.5	144.4	121.3	231.6	99.0	31.0	62.1	85.9	50.6	60.1	106.9	57.0	14.6	206.9	123.5	47.0	178.1	96.2	44.9	123.9	83.7	89.6	54.4	90.9	13.0	84.9	195.4	83.5	46.9	102.2	83.6	78.4	57.8	44.2	116.0	23.5	12.4	89.2	130.2	47.8	103.2	16.1	75.5	80.0	81.8	7.5	102.5	67.2	84.5	10.6	15.1	87.4	70.9	68.1	62.6	92.3	69.0	152.0	100.4	36.4	59.2	93.9	148.1	90.0	67.9	82.7	120.8	241.9	107.6	89.5	87.1	92.1
MAMDC4	"AEGP, DKFZp434M1411, EDTB"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 30.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 22.9;Hepatocytes: 26.6;Horizontal cells: 16.8;Intestinal goblet cells: 21.8;Proximal enterocytes: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.9"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol		NA	Yes				"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB026377: , HPA059977: AB_2684186"	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favorable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.7	3.2	1.6	1.6	2.0	1.4	2.4	7.2	3.1	3.9	1.5	7.3	3.9	2.5	0.3	2.8	4.5	0.7	6.1	1.4	1.3	8.3	30.7	3.6	0.9	2.1	1.9	3.1	7.4	0.6	15.0	1.0	2.2	7.7	0.8	0.7	3.3	1.0	2.5	2.0	5.8	0.5	1.1	9.7	3.9	4.3	1.7	0.6	11.4	0.9	0.2	2.6	3.1	3.3	1.5	2.5	1.3	2.6	0.5	0.1	16.9	2.5	0.3	0.3	0.5	1.9	1.4	1.3	0.6	0.6	0.7	2.1	0.3	1.2	0.0	1.9	0.9	0.8	6.1	2.2	1.0	0.1	4.6	0.8	1.5	1.2	0.5	1.3	0.7	2.3	2.6	1.1	0.2	4.0	0.9	3.5	1.3	1.0	0.7	1.5	0.4	2.3	0.8	1.3	1.5	1.9	0.5	1.2	1.1	0.8	4.0	0.8	0.7	6.8	4.2	1.4	0.4	2.8	1.6	0.4	1.5	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.0	7.2	3.1	1.4	1.3	2.1	1.9	2.2	1.1	1.7	3.3	1.0	0.0	3.4	6.8	2.0	0.8	1.0	3.9	1.2	5.9	2.4	3.6	7.9	11.5	1.8	1.8	0.0	2.5	2.6	22.9	1.9	0.8	2.2	0.6	1.1	1.5	0.0	3.2	1.1	4.8	3.9	2.4	4.1	1.4	0.0	6.7	2.5	26.6	2.6	16.8	2.1	21.8	6.1	1.9	1.2	2.7	1.8	1.6	0.0	0.0	1.7	2.9	1.0	2.5	1.9	0.9	11.3	1.5	3.0	1.4	23.4	2.5	2.9	7.6	0.0	1.0	2.4	1.6	2.1	0.9	0.4	2.3	1.8	1.8	12.4	0.6
MAML1	"KIAA0200, Mam-1"	ENSG00000161021	"Mastermind like transcriptional coactivator 1"	Q92585	5	179732822-179777283	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 11.2;hTCEpi: 11.3;SK-MEL-30: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037687, HPA057531"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA037687: AB_10672604, HPA057531: AB_2683458"	"unprognostic (2.64e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (3.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.69e-2)"	14.6	15.8	0.4	2.5	0.6	4.9	14.0	0.6	0.8	17.2	0.4	17.7	3.3	17.8	5.1	15.3	16.9	0.0	12.2	0.3	0.3	11.1	11.0	13.9	1.6	0.5	0.4	20.2	15.2	0.0	12.7	3.0	0.4	15.7	2.6	1.5	13.4	0.0	12.5	16.5	14.7	3.7	0.3	16.2	13.9	9.7	0.4	0.0	14.4	3.7	0.0	15.8	15.4	0.5	0.0	0.0	0.0	0.0	9.3	9.1	0.0	5.9	10.8	11.2	8.1	0.0	0.0	7.1	8.2	0.0	0.0	0.3	0.0	0.0	7.1	0.0	0.0	0.0	8.7	0.0	8.2	0.0	0.1	0.0	11.3	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.2	0.1	0.0	0.0	0.2	19.8	10.1	8.9	0.0	9.0	0.1	1.4	0.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.4	0.2	0.1	0.7	0.2	0.3	0.1	0.5	0.2	0.2	0.7	0.2	0.5	0.2	0.1	0.3	0.4	0.6	0.6	0.8	0.3	0.3	0.5	0.4	0.4	0.3	0.4	0.5	15.0	16.0	9.3	11.8	14.0	25.0	12.1	12.1	20.5	12.5	13.9	15.2	7.2	15.7	7.5	9.2	18.8	10.1	20.8	12.0	1.9	6.4	2.4	10.1	15.6	26.4	9.0	16.2	18.1	6.5	12.0	11.6	13.7	13.9	56.0	14.4	33.5	9.9	13.0	21.9	18.2	11.6	12.2	24.2	26.7	2.3	17.4	16.6	5.4	9.4	19.6	7.9	13.4	18.6	14.8	6.7	6.4	25.2	14.0	12.6	7.7	3.9	6.1	9.4	13.1	11.6	14.1	6.1	10.0	19.7	29.8	9.3	17.1	9.7	12.3	16.0
MAML2	"KIAA1819, MAM3"	ENSG00000184384	"Mastermind like transcriptional coactivator 2"	Q8IZL2	11	95976598-96343195	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 690.5;Microglial cells: 579.9;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 311.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035223	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA035223: AB_10671101"	"unprognostic (8.11e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (9.11e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	10.9	2.7	5.8	6.3	5.5	3.1	14.2	17.2	3.9	10.6	6.9	6.1	3.0	5.4	1.8	5.5	8.0	7.7	4.4	7.1	10.6	9.9	2.4	9.8	8.7	9.0	9.0	7.9	5.9	5.9	4.0	12.2	7.4	7.4	6.2	6.8	11.0	5.7	2.0	7.9	4.8	6.5	7.0	10.3	4.8	2.3	7.5	13.7	6.5	4.8	7.0	8.8	6.5	6.6	10.7	2.0	17.8	4.7	18.1	20.7	3.8	12.1	17.9	7.8	8.1	1.3	22.1	2.3	27.7	28.1	4.1	9.6	3.6	11.7	10.7	52.8	1.3	1.4	3.7	4.1	10.5	0.1	0.0	30.4	1.1	13.9	8.2	14.3	4.5	0.3	6.1	3.2	14.0	0.9	0.2	2.9	1.9	5.5	3.3	3.7	3.4	12.3	11.6	14.8	0.1	1.6	4.5	1.9	5.0	5.7	1.7	0.5	19.7	13.6	3.2	4.7	7.7	2.2	0.4	3.3	6.5	2.0	25.6	0.1	0.6	0.0	0.8	0.3	1.3	0.9	1.6	2.1	0.6	1.2	3.2	2.2	2.6	2.4	0.4	0.5	0.6	1.2	5.8	5.5	17.2	3.9	7.1	10.6	9.0	9.0	7.4	7.0	7.5	6.6	43.5	16.0	8.6	690.5	35.4	19.5	21.5	12.6	19.9	44.1	28.6	43.1	5.3	18.6	16.6	12.9	91.8	15.4	21.8	31.0	11.7	19.3	1.4	61.6	49.4	24.0	6.7	2.7	81.6	0.4	26.0	41.6	20.9	52.3	1.3	44.0	9.3	0.4	18.6	0.0	36.8	7.6	4.1	19.2	21.2	3.0	8.7	29.3	12.4	579.9	26.0	21.9	16.5	1300.8	311.4	15.0	16.8	8.6	18.1	19.1	9.4	17.1	24.2	25.9	32.9	3.6	51.5	0.6	0.8	19.4	13.5	13.0	38.1	9.0	14.3	19.2
MAMLD1	"CG1, CXorf6, F18"	ENSG00000013619	"Mastermind like domain containing 1"	Q13495	X	150361422-150514178	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 33.0;Excitatory neurons: 27.5;Leydig cells: 33.8;Oligodendrocyte precursor cells: 81.4;Peritubular cells: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 23.3;U-2197: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003923	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA003923: AB_10602034"	"unprognostic (4.18e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (9.76e-3)"	4.7	2.6	4.9	1.4	5.6	1.6	3.4	0.1	4.6	4.2	0.0	3.1	0.9	5.3	2.2	1.7	5.0	2.4	2.0	4.3	9.3	1.9	1.7	4.8	1.6	1.8	1.3	12.9	3.1	2.0	4.3	1.7	4.4	3.1	1.1	2.9	1.8	6.6	4.5	1.8	1.3	3.1	1.0	1.4	1.9	10.3	11.1	0.8	1.1	1.9	1.0	3.7	2.3	0.1	7.3	2.9	3.8	7.6	10.9	4.1	0.0	6.8	14.3	10.3	23.3	0.0	0.4	0.0	3.4	16.3	8.1	0.2	4.2	3.2	14.0	10.4	0.3	0.1	8.8	0.2	8.1	0.4	0.0	5.6	0.6	11.7	1.4	5.2	2.2	0.6	0.2	0.0	9.9	1.4	0.0	0.1	0.7	0.0	5.4	0.5	14.7	0.4	1.7	0.1	0.9	0.8	2.4	0.2	3.8	0.9	0.2	0.1	2.8	5.5	6.9	36.8	12.2	0.4	0.5	0.2	15.2	2.9	7.6	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.4	0.3	0.0	0.2	0.3	0.7	0.1	0.1	0.0	0.0	0.5	0.2	4.9	5.6	0.1	4.6	4.3	9.3	1.8	1.3	4.4	1.0	11.1	0.1	3.3	0.0	0.5	33.0	0.4	3.4	0.9	1.2	0.0	1.5	1.9	0.9	1.9	5.7	0.2	0.0	10.4	0.0	0.1	0.0	1.9	3.2	1.1	1.4	5.2	5.5	3.6	3.2	27.5	2.5	0.0	4.8	0.0	3.3	0.0	5.4	4.6	4.8	0.5	13.5	18.3	0.6	0.0	0.8	20.5	4.6	33.8	2.3	3.6	11.2	0.6	2.2	0.0	81.4	5.0	2.2	0.1	24.0	0.3	3.1	0.0	0.4	0.1	0.6	6.6	2.8	3.4	0.3	0.4	0.2	4.1	0.0	1.9	8.3	0.0	0.4
MAN1C1	HMIC	ENSG00000117643	"Mannosidase alpha class 1C member 1"	Q9NR34	1	25616791-25786206	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Excitatory neurons: 72.8;Hepatic stellate cells: 63.9;Hepatocytes: 57.8;Inhibitory neurons: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 30.5;HSkMC: 108.9;U-266/70: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048352	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA		1800000	"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA048352: AB_2680368"	"unprognostic (2.75e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.18e-2)"	12.5	11.6	13.3	9.4	15.2	2.2	6.2	16.6	16.1	19.6	27.3	10.0	4.5	14.5	7.5	7.0	9.7	18.6	10.1	15.9	16.9	25.4	29.6	9.2	12.4	45.1	23.2	17.3	3.6	24.0	17.1	21.1	26.1	17.6	4.6	11.0	5.7	17.9	4.6	8.1	6.1	19.9	29.4	19.3	7.3	4.2	16.4	10.5	26.0	5.5	9.4	12.3	9.1	37.8	0.1	0.4	30.5	6.4	22.4	17.2	8.6	0.4	5.8	1.4	0.4	0.6	0.2	0.1	0.3	2.3	3.9	0.4	3.0	0.3	0.6	9.8	1.3	0.6	0.5	0.1	2.6	5.2	12.0	108.9	0.5	0.7	0.0	0.4	0.1	1.2	0.1	1.3	0.0	1.6	0.0	5.8	7.8	0.1	0.2	0.6	18.9	0.6	0.2	0.7	17.7	0.6	0.7	4.7	1.5	5.5	2.4	3.6	0.1	0.0	1.6	20.1	0.7	31.7	0.1	0.1	4.6	10.7	1.5	0.3	0.9	0.4	0.3	0.6	0.5	0.2	2.1	0.9	0.3	0.5	4.7	2.7	0.6	0.4	0.8	0.2	0.5	0.7	13.3	15.2	16.6	16.1	15.9	16.9	45.1	23.2	26.1	29.4	16.4	37.8	5.8	3.2	3.2	18.3	2.0	6.6	2.9	3.6	5.2	23.5	1.1	1.5	7.0	4.3	7.3	22.0	54.2	10.6	1.6	0.5	9.8	1.0	0.3	0.4	8.1	8.4	3.0	2.7	72.8	3.8	0.9	23.3	1.1	0.6	2.5	0.3	63.9	57.8	24.8	21.9	65.8	0.1	16.2	19.0	4.3	2.1	27.1	6.8	1.8	39.4	3.3	17.8	3.1	25.1	21.7	1.4	0.3	22.2	2.2	2.0	0.0	23.3	2.2	4.4	6.6	17.0	7.1	0.2	2.9	1.0	5.3	42.7	6.9	0.7	0.2	1.9
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 32.8;Plasma cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 201.8;intermediate monocyte: 178.8;myeloid DC: 158.8;non-classical monocyte: 138.4;plasmacytoid DC: 187.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 187.5;monocytes: 201.8"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	35.8	21.4	5.3	54.6	6.4	83.6	24.8	6.6	5.9	19.6	18.5	30.3	31.0	21.8	9.0	19.8	19.9	28.4	16.0	4.9	7.4	17.3	23.7	46.8	52.1	10.3	6.7	16.7	39.7	16.6	9.9	24.6	9.5	20.5	22.6	1.6	35.2	14.9	12.1	28.9	33.6	20.2	8.9	70.1	32.7	6.4	9.7	23.1	16.3	9.4	39.3	35.6	16.7	12.4	52.4	26.3	26.4	31.3	85.8	57.3	74.0	37.9	79.2	33.1	32.4	21.3	21.4	56.9	44.9	30.4	9.4	40.1	13.6	25.6	15.7	28.5	41.6	19.8	13.6	34.9	43.5	131.6	130.2	68.5	49.2	18.5	23.3	35.6	31.7	21.1	25.6	41.9	17.8	40.9	17.9	74.2	21.9	26.2	32.8	40.8	36.1	28.8	38.9	59.8	8.2	25.5	37.7	32.0	63.0	15.8	49.4	80.0	42.0	44.8	18.4	44.0	36.2	55.4	65.5	28.0	30.4	127.5	51.2	12.2	201.8	29.7	31.9	178.8	35.4	32.9	28.9	29.0	158.8	26.4	15.4	15.9	29.4	13.2	138.4	187.5	30.7	150.3	5.3	6.4	6.6	5.9	4.9	7.4	10.3	6.7	9.5	8.9	9.7	12.4	1.6	6.4	7.5	8.5	25.1	3.6	2.0	2.7	14.2	2.6	1.9	1.0	0.9	2.8	2.0	1.8	0.0	2.5	20.5	2.0	1.9	1.7	3.7	1.4	2.5	3.1	1.8	9.4	7.8	2.3	2.8	7.2	20.9	1.3	1.3	3.4	1.8	0.8	8.4	0.0	6.4	0.9	0.0	15.4	24.7	11.1	3.7	32.8	1.8	17.8	11.0	1.5	9.2	3.5	13.4	1.5	2.5	4.5	78.1	2.5	3.8	1.5	3.9	4.0	13.1	2.3	2.0	0.6	1.6	11.5	3.3	2.7	9.4	2.7	2.0	2.0
MAN2C1	"MANA, MANA1"	ENSG00000140400	"Mannosidase alpha class 2C member 1"	Q9NTJ4	15	75355207-75368612	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040627, HPA067407"	Uncertain		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040627: AB_10795490, HPA067407: AB_2685834"	"unprognostic (4.68e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-3)"	49.3	66.1	20.2	23.9	21.1	37.6	49.3	17.7	28.8	52.1	18.6	41.8	25.5	49.3	12.1	29.9	50.5	16.4	55.6	20.0	17.8	52.8	50.0	50.3	20.3	22.8	18.1	58.5	49.1	26.3	56.6	21.1	20.9	49.4	14.9	14.8	37.3	19.5	58.5	36.8	41.6	18.6	17.5	54.7	46.0	34.8	19.8	17.1	64.8	24.5	12.7	45.7	41.5	22.0	11.0	25.5	21.3	15.7	23.8	20.4	27.1	25.3	23.5	12.9	10.9	20.3	38.3	5.7	14.6	18.6	11.8	33.0	11.7	17.1	8.4	30.8	26.1	34.0	58.5	18.1	35.3	23.1	5.7	25.3	17.0	12.3	15.3	27.3	30.9	16.9	20.5	27.4	10.7	22.1	11.9	25.2	9.0	13.2	11.8	16.0	11.0	34.6	16.8	49.8	13.2	22.7	16.4	23.9	11.5	15.6	26.1	26.1	61.5	27.1	18.7	19.0	25.5	27.9	7.1	9.3	17.6	25.9	27.6	4.0	19.8	3.5	9.2	23.0	9.1	3.2	6.9	6.8	22.6	2.6	9.5	6.9	2.2	6.0	18.9	9.2	10.2	14.3	20.2	21.1	17.7	28.8	20.0	17.8	22.8	18.1	20.9	17.5	19.8	22.0	34.1	22.4	51.7	29.0	12.5	13.5	15.2	13.0	11.4	30.7	18.2	16.3	2.8	5.7	19.2	9.2	54.2	17.2	17.2	22.4	3.9	11.4	10.4	10.1	18.3	23.2	34.2	7.6	28.9	8.7	10.9	20.4	39.3	12.7	31.7	46.8	32.5	22.4	20.4	28.6	23.8	19.5	12.2	29.8	20.2	14.0	23.3	26.3	16.0	15.0	31.4	17.3	19.6	18.1	19.5	11.2	20.0	12.4	12.9	16.0	27.9	15.9	19.3	52.4	26.3	25.6	16.3	21.1	10.4	14.9	8.5	21.2	16.2	17.0	24.0	15.3
MANBAL	dJ1141E15.2	ENSG00000101363	"Mannosidase beta like"	Q9NQG1	20	37289638-37317260	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052348	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria	Nucleoplasm	"HPA052348: AB_2681795"	"unprognostic (1.86e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.21e-3)"	"prognostic unfavorable (7.07e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.70e-2)"	51.5	70.5	68.6	23.4	68.2	7.3	51.6	67.3	76.3	67.5	68.8	92.7	35.0	86.1	57.1	64.4	71.6	30.6	43.5	70.0	71.3	57.8	42.0	40.5	16.7	69.4	68.8	66.9	45.5	49.8	57.5	33.2	70.2	77.4	40.1	28.0	45.9	61.8	24.4	58.3	48.7	65.4	68.4	34.2	60.3	42.7	71.9	22.6	55.1	17.9	25.4	81.2	58.5	68.3	66.0	126.5	63.0	63.9	101.0	73.1	54.5	89.9	93.1	85.1	66.6	150.3	87.4	16.9	104.8	109.8	86.7	88.5	60.3	140.2	57.9	12.7	62.5	17.8	51.3	135.3	109.0	19.1	10.8	80.1	97.8	79.3	130.1	85.4	60.2	22.1	29.1	18.1	86.2	77.3	24.0	25.1	50.4	109.6	117.0	14.4	82.7	19.9	81.6	90.3	60.4	68.9	91.1	135.1	76.3	53.7	91.1	30.2	66.6	155.5	58.1	88.6	70.3	24.0	34.9	14.0	111.8	10.4	82.3	12.3	22.8	33.2	14.9	27.0	17.0	24.3	17.9	18.0	21.0	25.6	21.4	20.9	33.8	21.1	21.4	29.2	12.8	16.7	68.6	68.2	67.3	76.3	70.0	71.3	69.4	68.8	70.2	68.4	71.9	68.3	19.9	25.6	27.1	10.1	9.5	30.1	87.3	84.2	33.0	22.7	41.3	47.9	19.6	35.8	42.1	44.1	4.2	97.0	9.1	24.7	39.2	74.5	6.6	23.8	26.6	28.5	30.5	2.1	8.6	109.3	133.4	42.6	23.9	20.4	7.6	31.5	28.9	22.5	30.3	20.2	10.7	36.7	50.8	15.1	20.6	8.0	46.9	12.3	46.2	6.5	18.0	71.4	18.6	13.0	8.4	103.2	48.4	68.4	16.8	96.0	40.9	61.1	29.9	15.4	19.7	27.4	38.7	26.4	43.8	36.5	30.4	76.9	8.4	40.7	34.8	124.7
MAP1LC3B	ATG8F	ENSG00000140941	"Microtubule associated protein 1 light chain 3 beta"	Q9GZQ8	16	87383953-87404779	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB037216, HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"CAB037216: AB_796155, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253"	"unprognostic (4.70e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.21e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.98e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (2.77e-7)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	92.0	82.9	108.4	37.5	112.9	245.6	72.9	123.7	135.3	46.1	110.7	46.2	25.5	52.6	44.7	45.0	48.2	57.0	102.7	105.2	130.1	71.3	50.3	50.9	52.5	131.5	132.0	43.3	37.1	74.2	51.1	75.6	140.8	43.6	47.1	125.9	49.2	49.3	195.2	62.5	36.9	66.6	120.5	44.4	42.3	51.8	126.5	54.9	63.5	176.7	51.4	57.3	42.0	123.8	56.9	33.7	63.8	59.2	188.5	145.3	41.9	111.4	130.1	88.0	59.9	56.0	42.4	37.7	82.0	155.7	97.5	50.8	95.2	72.3	125.3	49.9	81.0	39.4	40.2	94.4	313.4	28.3	40.0	194.9	234.8	137.0	326.0	131.1	101.1	57.2	107.4	79.0	150.4	61.5	48.4	64.0	66.1	27.7	81.2	76.2	42.2	37.6	119.0	28.4	53.0	60.3	174.8	29.4	230.8	85.2	48.0	34.0	134.1	94.7	59.7	86.4	65.3	99.4	131.5	137.7	133.9	68.3	69.6	312.5	86.8	198.1	78.6	81.6	80.5	72.5	75.8	81.1	69.2	58.2	58.4	62.0	214.3	104.7	85.3	75.1	108.2	109.2	108.4	112.9	123.7	135.3	105.2	130.1	131.5	132.0	140.8	120.5	126.5	123.8	523.1	89.8	90.5	15.7	185.3	221.0	203.1	176.2	301.7	70.4	183.9	227.3	180.7	72.9	117.2	77.3	52.1	130.6	242.7	309.1	262.2	310.9	222.1	283.6	235.9	191.7	132.2	364.2	29.2	134.8	140.2	177.7	96.4	530.5	131.1	49.3	80.7	70.1	206.4	87.5	41.4	137.3	238.0	150.9	268.5	269.7	90.7	262.2	188.5	19.7	207.0	194.3	143.2	14.6	26.9	322.8	407.6	89.1	202.0	209.3	217.4	236.9	133.5	124.0	59.2	129.5	168.2	361.2	206.7	221.8	213.5	631.5	221.6	85.7	122.4	294.5
MAP1LC3B2	ATG8G	ENSG00000258102	"Microtubule associated protein 1 light chain 3 beta 2"	A6NCE7	12	116548105-116576606	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 40.5;Langerhans cells: 33.4;Paneth cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.2"									"HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Nucleoplasm	"HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253"	"unprognostic (1.50e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-3)"	"unprognostic (6.66e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.42e-1)"	1.8	2.2	0.3	0.7	0.4	3.9	1.5	2.0	0.6	0.7	0.8	0.9	1.2	1.3	1.2	1.8	1.0	1.6	2.4	0.3	0.8	1.3	1.1	1.2	1.1	0.5	0.6	1.4	0.8	0.1	0.9	0.7	0.7	0.8	1.5	0.9	1.2	0.0	4.2	1.6	1.4	1.5	0.5	0.8	0.8	1.1	0.4	0.7	0.9	0.5	1.5	0.8	0.9	0.7	1.4	0.7	1.5	1.8	0.4	0.5	1.6	2.8	0.2	0.0	0.1	2.7	2.0	1.1	1.8	0.2	3.4	1.0	0.4	0.3	0.5	1.0	1.9	0.6	2.7	4.9	0.9	0.9	1.0	0.1	0.4	0.9	0.7	3.9	1.9	1.2	3.3	3.0	0.3	2.7	1.0	1.9	0.8	1.2	2.6	1.4	0.2	3.6	0.2	1.5	1.5	2.3	1.9	0.6	7.2	2.8	1.0	0.4	0.7	2.6	0.9	2.2	1.4	2.2	3.3	3.6	3.9	1.4	1.3	38.6	11.6	34.2	7.8	11.8	7.2	9.0	8.8	7.9	9.4	7.7	6.1	7.0	43.5	9.8	14.2	9.6	15.9	13.6	0.3	0.4	2.0	0.6	0.3	0.8	0.5	0.6	0.7	0.5	0.4	0.7	1.9	0.0	1.7	10.7	4.0	24.2	17.3	6.1	0.0	1.5	1.1	2.5	40.5	1.5	4.6	0.0	0.0	2.5	2.8	22.7	7.9	0.2	12.3	2.8	2.2	8.0	1.8	24.0	4.4	0.0	2.4	8.3	0.0	5.9	7.0	0.9	2.5	2.0	4.5	13.5	8.6	7.5	12.2	7.2	33.4	14.2	4.7	5.5	10.6	1.0	2.4	0.5	7.2	4.0	1.7	0.4	63.1	3.8	0.1	12.5	2.5	8.1	3.1	1.1	0.0	9.0	8.0	20.8	11.5	0.0	21.5	11.4	8.2	0.8	5.9	21.8
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734513	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 82.9"	"Group enriched"	"Detected in all"	4	"Early spermatids: 98.1;Late spermatids: 293.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Nucleoli, Cell Junctions"	"HPA050934: AB_2681281, HPA054637: AB_2682552"	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	20.5	13.9	48.2	8.7	51.9	11.2	19.1	36.8	82.9	18.9	30.1	21.5	7.7	24.8	5.4	11.9	19.2	7.9	18.8	51.4	40.5	15.4	12.4	23.5	9.0	44.7	41.1	21.6	15.6	5.4	22.0	9.7	43.3	17.4	2.4	2.8	19.7	6.5	32.4	12.2	17.7	3.6	39.2	18.3	20.1	74.7	40.6	6.1	16.1	5.4	3.9	21.6	14.6	47.7	30.1	43.2	12.4	16.9	10.4	15.4	34.0	18.3	8.8	10.9	12.3	61.3	16.0	17.3	33.8	11.4	12.8	15.3	10.5	14.5	4.6	21.8	61.1	15.1	36.3	39.2	22.1	16.8	20.9	16.7	8.3	16.7	10.5	7.9	22.6	12.5	24.2	9.5	6.0	39.0	20.8	42.0	28.7	17.1	50.8	33.3	10.2	17.5	14.8	43.4	23.0	26.5	10.7	14.8	18.9	9.0	9.9	17.8	37.3	19.7	18.2	40.7	27.2	18.1	23.3	17.4	23.7	26.7	25.1	18.5	22.6	25.9	15.7	22.2	15.1	15.7	12.3	15.6	25.9	15.5	10.1	13.9	31.4	13.0	17.9	21.2	12.2	19.0	48.2	51.9	36.8	82.9	51.4	40.5	44.7	41.1	43.3	39.2	40.6	47.7	11.1	3.2	7.5	4.2	14.7	10.3	14.0	13.1	13.1	11.1	12.3	8.6	5.5	15.7	12.1	3.7	8.4	21.7	14.0	30.9	3.9	22.2	98.1	12.9	11.5	18.5	20.4	3.8	8.4	17.2	16.9	12.3	19.4	26.9	10.2	12.0	20.7	4.8	26.1	40.4	5.5	16.6	12.2	18.7	25.1	293.2	22.4	20.7	1.8	2.8	17.4	8.1	8.2	4.5	7.1	24.2	15.8	31.6	8.8	14.9	19.0	5.9	6.2	6.3	13.1	7.7	13.0	25.9	21.4	5.4	3.3	33.8	11.3	8.1	18.3	13.7
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315232	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 212.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 325.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	47.3	32.5	12.9	35.3	12.1	212.4	30.7	17.6	23.2	22.7	22.6	33.1	49.0	17.1	14.5	62.7	29.9	40.0	66.7	11.5	14.4	45.7	95.7	67.5	34.0	13.6	14.3	12.6	33.6	17.9	37.1	28.9	14.2	28.9	24.1	6.0	45.3	16.5	132.7	53.1	41.0	22.5	14.3	60.4	42.8	6.2	15.8	20.9	24.0	74.6	41.1	54.1	33.4	17.0	75.5	73.9	9.7	44.5	57.7	36.6	36.3	113.0	121.8	88.3	80.5	82.9	46.6	68.1	44.7	178.3	74.2	72.4	31.0	100.5	62.1	69.5	56.9	39.2	42.0	76.1	18.2	51.9	76.7	28.5	28.2	120.6	35.9	27.7	40.0	38.6	7.7	33.2	74.7	74.1	25.5	49.3	28.1	134.1	42.3	53.0	62.2	50.0	50.5	77.4	26.3	9.4	41.7	45.9	82.0	95.7	22.5	17.7	36.8	83.0	68.4	90.1	73.9	39.8	21.8	88.1	80.2	44.3	44.1	54.1	49.3	77.8	35.9	72.1	31.1	33.3	29.1	33.6	49.6	25.5	17.9	24.1	145.6	15.3	104.7	35.4	44.5	35.6	12.9	12.1	17.6	23.2	11.5	14.4	13.6	14.3	14.2	14.3	15.8	17.0	44.2	38.5	53.6	2.6	51.5	258.0	188.4	57.0	97.9	7.1	69.3	51.3	21.9	44.3	50.5	22.0	4.2	73.3	117.4	109.1	74.3	99.1	1.5	130.5	44.8	49.4	120.4	325.0	7.2	79.8	82.0	43.7	68.3	237.8	94.0	11.5	22.1	73.1	49.0	18.5	8.0	77.0	28.5	59.4	278.7	1.8	12.2	118.1	87.2	4.7	48.3	17.3	35.0	5.5	2.0	129.1	135.3	16.6	85.2	158.7	60.8	44.2	40.4	7.4	0.0	61.9	42.4	1.1	5.3	97.3	218.1	67.0	62.6	10.5	58.5	255.7
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020829-12143830	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 226.9;Inhibitory neurons: 189.3;Oligodendrocyte precursor cells: 148.3;Oligodendrocytes: 203.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.4"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SuSa: 177.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: AB_2684197"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	11.4	13.1	27.3	10.1	30.2	3.6	14.5	18.7	44.8	12.0	8.7	12.0	10.1	12.1	17.5	18.8	11.4	10.9	15.8	32.7	28.5	16.2	21.8	11.7	11.7	30.0	21.8	12.6	11.5	19.4	13.8	15.8	30.9	14.3	13.1	15.4	10.5	12.7	24.1	15.1	10.5	13.8	19.0	11.6	11.2	11.0	25.9	15.2	16.7	28.2	14.4	14.7	13.0	30.1	31.1	26.2	33.8	17.5	18.3	23.5	21.3	20.6	27.1	23.1	21.9	15.6	10.4	12.8	16.4	32.4	15.2	20.2	29.7	28.8	34.3	22.7	33.7	14.2	14.1	29.8	21.4	13.7	20.5	19.6	27.9	27.0	28.0	23.9	21.3	17.8	15.4	7.3	29.4	11.5	16.8	12.9	19.6	33.2	12.4	20.3	37.8	8.9	31.6	19.7	6.8	19.9	23.8	12.7	20.3	177.7	16.1	10.0	19.6	11.3	17.4	15.8	24.9	14.2	16.9	9.9	21.3	10.7	16.8	0.4	2.1	1.7	2.2	1.2	1.9	2.1	1.8	1.8	1.5	2.7	1.5	2.4	10.4	2.7	3.9	1.5	2.2	1.8	27.3	30.2	18.7	44.8	32.7	28.5	30.0	21.8	30.9	19.0	25.9	30.1	13.9	9.6	19.4	71.8	27.1	41.4	36.1	12.7	66.0	15.3	20.4	16.3	22.6	7.2	18.3	14.7	8.4	12.6	17.7	19.1	25.4	12.3	7.2	16.9	16.4	12.0	12.0	14.5	226.9	14.3	10.3	19.4	42.3	27.3	1.3	20.1	11.0	20.8	11.7	18.5	189.3	13.1	20.3	19.9	14.7	8.9	11.8	15.4	12.4	68.4	24.1	11.3	14.4	148.3	203.0	16.9	9.3	12.8	26.9	37.7	11.0	25.2	8.6	10.0	13.1	19.2	20.2	7.3	9.3	56.7	39.2	25.3	20.7	15.0	13.3	41.5
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414697-69553865	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 53.9;Glandular and luminal cells: 82.7;Oligodendrocytes: 52.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 8.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 22.0;neutrophil: 45.9;plasmacytoid DC: 78.3"	"Group enriched"	"Detected in all"	9	"dendritic cells: 78.3;granulocytes: 45.9;monocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"A549: 40.0;AN3-CA: 21.4;HUVEC TERT2: 28.4;MOLT-4: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	5.2	1.3	4.2	8.4	4.0	15.9	20.4	11.6	4.0	27.0	7.6	30.7	10.3	6.1	3.2	3.1	4.5	7.2	1.4	2.7	6.2	5.5	12.2	1.8	8.0	5.4	3.8	3.1	8.3	0.3	1.6	1.6	3.9	3.3	31.7	5.8	2.5	3.1	40.5	2.0	10.8	3.3	4.4	4.0	7.4	1.3	5.7	11.5	3.3	21.1	5.9	3.3	1.2	7.7	0.1	40.0	17.6	21.4	7.4	4.0	2.5	0.3	5.8	1.6	2.4	1.2	1.7	1.1	14.2	0.8	1.3	1.9	6.1	0.8	0.5	1.3	3.2	0.1	10.3	11.4	7.4	1.7	1.3	19.0	0.5	0.3	0.0	1.4	28.4	5.3	0.1	2.5	0.0	0.3	21.6	0.7	12.5	0.9	7.3	7.7	1.8	0.5	7.8	5.4	7.8	11.8	1.7	1.3	3.9	9.3	5.4	2.3	5.1	1.9	2.3	1.6	0.5	1.7	2.2	0.5	1.6	2.5	1.5	2.5	22.0	4.0	2.8	2.6	5.0	4.1	3.1	3.5	7.1	5.2	3.6	3.4	45.9	4.7	1.1	78.3	5.0	6.2	4.2	4.0	11.6	4.0	2.7	6.2	5.4	3.8	3.9	4.4	5.7	7.7	11.2	3.2	6.7	27.7	7.7	2.7	4.1	0.8	8.6	5.2	14.3	29.1	1.3	5.7	3.6	0.0	2.1	9.7	29.2	42.3	23.5	1.9	10.2	53.9	11.5	7.9	45.6	5.0	26.0	4.1	6.6	5.0	9.2	82.7	1.3	13.4	4.2	2.5	6.2	3.3	22.4	22.9	0.0	6.8	7.4	2.9	4.4	6.9	3.6	24.4	9.6	31.8	10.3	32.6	52.5	1.1	16.7	3.8	10.7	1.3	14.5	1.5	4.2	4.2	0.0	3.9	5.7	0.1	1.8	4.8	4.3	0.8	13.3	1.4	30.6	2.8
MAP3K10	"MEKK10, MLK2, MST"	ENSG00000130758	"Mitogen-activated protein kinase kinase kinase 10"	Q02779	19	40191426-40215575	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.9;Horizontal cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 22.8;basal ganglia: 17.5;cerebral cortex: 46.2;hippocampal formation: 37.7;white matter: 11.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007039	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Actin filaments, Cytosol"		"HPA007039: AB_1079357"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.69e-4)"	"unprognostic (4.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.62e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.77e-3)"	"prognostic favorable (2.13e-4)"	6.9	8.3	22.8	2.3	17.5	1.9	6.5	0.0	46.2	7.7	0.0	8.6	2.0	7.9	0.3	5.3	6.6	1.8	10.7	37.7	0.1	7.4	5.2	6.7	2.3	3.2	0.6	7.3	6.9	3.3	14.3	1.6	0.0	8.1	0.6	1.4	5.9	2.0	16.8	7.1	6.3	1.8	0.0	8.1	7.1	11.1	2.4	1.8	6.9	4.3	0.9	7.2	6.6	11.6	6.3	7.2	2.2	5.2	2.0	1.2	6.2	4.3	2.0	1.9	1.9	1.7	1.7	5.7	4.4	1.4	4.6	1.9	0.8	2.2	0.2	10.9	6.8	1.4	3.3	1.7	3.8	1.2	3.4	1.1	5.0	2.0	1.4	2.0	1.7	7.6	5.5	9.1	0.5	3.7	4.5	2.2	2.6	2.0	4.7	5.8	2.3	3.4	1.7	3.8	7.4	10.7	4.9	1.7	10.0	1.3	2.4	2.2	2.9	4.9	4.8	7.3	8.3	12.7	7.7	2.6	5.7	2.3	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	17.5	0.0	46.2	37.7	0.1	3.2	0.6	0.0	0.0	2.4	11.6	5.6	0.0	0.0	6.5	4.2	1.5	1.8	1.1	1.2	14.9	2.9	2.4	2.8	5.7	0.5	7.3	8.4	0.9	3.3	2.4	0.0	2.5	2.8	2.4	3.6	3.6	4.2	5.3	18.9	4.3	0.8	2.6	5.6	3.8	0.0	10.3	3.9	3.2	2.5	23.5	15.9	1.7	0.0	1.6	2.9	7.6	3.1	2.7	1.8	9.4	2.5	5.7	4.1	9.0	12.4	3.7	2.9	4.9	1.5	2.5	1.7	3.1	0.6	7.7	6.6	4.5	4.0	4.1	1.8	1.8	2.7	1.4	4.4	3.2	2.4	2.0
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 85.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.9;HHSteC: 53.7;HSkMC: 51.8;hTERT-RPE1: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Plasma membrane"		"HPA039936: AB_10795239, HPA071996: AB_2686481"	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavorable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	12.6	7.6	12.9	5.4	15.2	3.2	10.3	25.9	19.6	23.5	4.3	13.3	3.2	22.9	4.8	4.0	18.5	14.0	8.6	15.6	11.3	8.5	1.7	11.2	4.4	11.9	11.1	21.6	3.6	7.3	22.7	6.4	13.2	9.6	3.8	13.6	4.9	10.9	2.7	5.7	8.9	14.4	8.0	9.0	7.3	9.0	13.0	6.0	8.6	6.3	2.7	14.0	12.2	13.7	0.5	15.1	8.6	14.2	55.9	28.9	1.2	10.1	18.9	10.8	11.0	0.3	1.8	3.5	5.4	10.8	8.7	0.1	4.3	6.8	4.3	4.9	5.4	3.5	8.3	0.0	53.7	0.1	3.6	51.8	5.2	14.6	7.8	69.1	16.9	7.8	0.1	15.7	10.0	6.7	3.8	0.9	3.2	0.0	5.5	5.4	6.3	1.0	5.4	0.1	9.3	12.4	5.6	6.8	14.9	1.8	4.6	10.3	12.9	10.2	10.8	4.5	2.5	6.1	8.0	0.0	16.8	6.9	10.4	0.0	0.5	0.0	0.4	0.4	0.8	0.1	0.5	0.6	0.2	0.0	0.2	0.3	1.0	0.2	0.1	0.0	0.1	0.1	12.9	15.2	25.9	19.6	15.6	11.3	11.9	11.1	13.2	8.0	13.0	13.7	11.4	6.4	14.6	21.5	8.1	0.8	2.4	0.5	4.6	28.9	5.6	5.2	0.8	7.2	6.4	1.8	37.5	1.9	12.2	4.8	9.8	6.7	1.5	11.5	27.6	10.4	3.5	1.3	21.1	1.8	2.2	11.0	2.0	15.8	12.7	7.0	15.0	7.8	4.1	30.3	19.1	2.8	2.0	10.3	2.2	1.8	8.1	8.6	0.0	8.4	8.5	19.9	5.2	10.6	11.0	4.4	2.1	8.2	6.7	5.3	7.1	14.8	5.5	85.0	6.6	23.5	10.2	2.5	2.1	2.5	1.0	2.2	11.6	12.5	4.1	3.9
MAP3K13	"LZK, MEKK13"	ENSG00000073803	"Mitogen-activated protein kinase kinase kinase 13"	O43283	3	185282941-185489094	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 22: Epithelial cell types - Mixed function"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	"unprognostic (8.95e-2)"	"unprognostic (6.72e-3)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (1.11e-4)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.70e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.31e-3)"	14.7	34.0	18.5	13.0	19.8	15.8	21.0	23.2	25.8	17.0	18.5	24.6	24.3	17.9	56.8	19.7	20.2	18.1	10.4	19.7	20.4	30.9	29.6	17.5	11.7	20.7	21.7	22.2	25.9	34.6	20.7	13.1	21.1	19.7	26.2	36.2	26.2	14.9	4.7	14.0	25.0	17.0	21.2	13.1	23.9	18.8	21.5	11.1	25.7	6.8	15.0	23.2	15.8	23.5	73.9	14.5	27.4	0.7	24.4	29.9	16.1	16.5	11.2	26.2	31.5	27.9	27.0	0.6	55.1	30.4	43.7	41.1	0.8	38.4	46.5	82.1	36.8	0.3	18.9	23.3	26.5	39.2	20.1	27.2	32.8	22.6	28.1	27.1	29.6	0.7	0.9	57.5	23.8	23.0	4.6	18.2	31.5	56.5	33.4	0.6	32.8	40.5	46.9	18.8	44.7	29.8	28.0	41.5	59.9	29.8	62.8	21.5	19.7	21.5	27.8	39.4	36.5	29.3	40.8	24.4	31.4	19.5	36.1	14.0	21.6	9.4	16.6	22.1	25.7	42.8	19.6	21.0	37.4	34.9	27.2	26.6	35.9	20.8	15.9	16.4	8.6	12.4	18.5	19.8	23.2	25.8	19.7	20.4	20.7	21.7	21.1	21.2	21.5	23.5	69.5	54.5	82.7	80.0	41.8	141.6	219.1	196.7	100.7	117.9	144.0	115.1	25.2	144.4	131.6	79.1	91.8	139.5	22.9	96.1	287.6	106.6	134.8	76.5	50.7	65.9	106.4	43.8	170.7	127.5	38.9	49.0	72.4	73.1	29.8	96.6	93.5	99.4	64.9	45.4	184.5	130.9	138.4	53.2	193.0	213.0	43.2	52.7	85.4	28.1	283.9	137.5	22.6	102.1	89.8	137.5	95.1	54.2	40.6	322.2	111.6	283.9	125.7	88.8	46.0	38.5	62.7	119.5	39.1	94.6	145.6	203.4	32.2	50.0	109.3	279.4
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	"Mitogen-activated protein kinase kinase kinase 14"	Q99558	17	45263119-45317029	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 40.6;U-251 MG: 43.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_2732436, HPA027270: AB_2732437"	"unprognostic (1.05e-2)"	"prognostic favorable (5.27e-5)"	"unprognostic (2.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.82e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.28e-1)"	5.9	4.7	2.6	12.5	5.0	5.2	6.4	2.9	2.3	7.1	2.8	15.6	8.1	5.7	1.9	7.8	6.6	5.9	9.9	3.2	2.7	5.1	7.3	8.1	17.7	3.6	4.6	6.0	8.3	4.6	5.9	2.7	3.1	7.0	5.2	2.2	8.1	4.7	28.0	8.5	10.3	5.9	2.5	12.4	7.6	6.9	4.8	13.4	5.8	9.9	16.0	7.2	7.1	2.1	17.1	40.6	3.6	6.5	2.4	7.1	9.4	4.5	3.4	14.9	9.1	5.5	21.0	7.4	24.1	5.3	14.6	11.6	1.5	6.5	7.6	24.3	3.1	1.4	10.1	2.1	7.1	1.1	6.9	10.0	3.6	7.3	3.6	15.6	3.0	3.2	2.7	30.1	8.1	6.1	6.8	1.7	1.8	11.1	5.1	9.5	12.1	17.9	10.5	2.6	3.5	3.0	7.6	3.4	5.0	5.5	2.8	0.4	5.6	6.5	10.2	5.7	43.1	29.1	12.1	4.1	3.9	4.0	9.2	0.0	2.0	0.8	1.6	1.8	1.0	4.2	1.1	1.0	1.4	4.4	1.2	0.9	1.6	2.0	0.6	1.7	2.9	1.6	2.6	5.0	2.9	2.3	3.2	2.7	3.6	4.6	3.1	2.5	4.8	2.1	5.8	3.2	12.8	23.5	15.3	0.0	14.7	0.0	14.8	4.5	5.6	4.8	2.3	18.6	2.5	0.0	4.2	0.9	14.5	13.9	0.0	4.8	4.7	7.0	4.0	6.1	13.1	1.3	8.9	2.7	1.5	6.3	10.2	5.6	1.3	2.1	6.4	9.2	4.9	1.7	15.6	7.8	0.0	9.4	0.0	6.2	4.7	11.3	0.0	26.2	33.4	1.9	5.2	6.6	5.5	3.3	9.6	1.2	8.5	6.2	13.4	3.8	5.1	2.9	0.0	12.9	2.8	4.2	3.0	7.9	0.0	0.0	10.6	2.4	8.5	6.8
MAP3K2	"MEKK2, MEKK2B"	ENSG00000169967	"Mitogen-activated protein kinase kinase kinase 2"	Q9Y2U5	2	127298730-127388465	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 11.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021540	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA021540: AB_2670742"	"unprognostic (5.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.97e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.11e-1)"	12.6	8.9	12.1	13.4	16.3	37.6	10.5	13.5	15.9	12.0	9.9	12.5	15.3	11.2	8.3	9.5	9.0	12.9	6.6	10.3	14.3	11.9	22.3	10.8	12.9	18.0	14.9	10.6	10.6	14.0	7.8	9.9	17.4	8.9	10.1	15.6	10.2	9.0	13.4	12.6	14.1	12.7	15.2	13.5	14.7	11.3	18.3	14.4	17.9	9.1	13.8	10.4	8.3	24.8	29.4	12.3	9.6	9.7	13.2	17.4	16.0	17.9	19.4	17.2	13.9	14.8	12.7	19.2	30.0	25.7	16.0	24.3	15.6	12.0	19.3	48.6	12.1	17.9	22.3	13.0	15.2	18.2	37.2	15.7	12.9	21.0	25.5	15.1	8.1	14.2	8.6	37.3	17.2	10.7	21.4	12.9	9.9	8.2	15.8	14.0	18.0	14.5	7.0	27.1	19.0	10.2	26.1	15.8	16.4	7.8	10.3	13.7	18.7	33.6	31.3	15.7	24.5	38.4	30.0	19.5	16.1	11.7	14.8	3.4	2.5	1.7	1.3	1.5	1.6	2.7	1.2	1.3	2.1	2.2	1.5	1.6	11.3	2.0	2.0	4.2	1.1	1.0	12.1	16.3	13.5	15.9	10.3	14.3	18.0	14.9	17.4	15.2	18.3	24.8	45.7	83.3	46.0	53.8	88.9	72.0	36.9	34.3	55.2	53.6	42.2	32.1	30.1	45.8	44.2	29.5	106.3	20.5	107.9	72.6	13.7	21.2	4.6	77.0	71.0	36.9	45.4	27.8	60.6	34.0	19.8	54.9	42.3	90.2	60.9	42.2	25.4	69.1	47.7	72.3	57.7	40.1	30.5	80.1	113.7	7.6	42.3	107.7	56.9	50.6	79.1	25.9	30.9	49.8	87.7	49.0	28.8	51.9	57.3	48.3	54.5	33.1	58.5	59.2	19.7	69.2	47.4	42.3	52.6	43.5	78.6	26.3	65.5	51.7	31.8	46.1
MAP3K3	"MAPKKK3, MEKK3"	ENSG00000198909	"Mitogen-activated protein kinase kinase kinase 3"	Q99759	17	63622415-63696305	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007764, HPA035410, HPA035411"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"CAB007764: AB_562314, HPA035410: AB_2674614, HPA035411: AB_2674615"	"unprognostic (9.65e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	30.1	12.3	11.3	23.7	12.4	31.5	23.6	13.9	12.3	21.6	13.6	28.8	8.7	23.8	6.5	17.7	24.2	21.8	40.9	10.5	12.1	22.9	13.9	28.7	22.3	14.9	12.7	24.0	12.9	15.2	13.8	22.9	13.2	22.2	8.5	6.9	15.1	18.4	23.7	19.3	18.7	22.0	13.1	34.5	18.7	17.2	12.9	15.1	18.0	30.3	14.5	23.4	19.1	13.6	22.6	16.3	20.4	20.1	37.7	30.2	9.4	22.0	24.4	27.0	21.2	7.8	4.5	24.2	15.0	43.2	18.7	8.3	13.4	15.5	16.9	21.7	29.3	19.6	22.6	11.0	19.5	15.6	20.1	22.3	10.4	33.6	17.1	16.3	65.7	17.4	12.2	31.1	21.4	15.9	27.3	15.9	12.5	4.5	16.8	14.3	53.0	15.6	9.4	10.3	10.6	25.3	14.6	17.1	17.9	24.9	17.3	14.8	60.5	67.8	17.8	37.3	26.9	30.3	33.6	8.9	14.4	12.0	18.0	15.0	11.4	15.3	2.8	11.8	3.0	2.0	3.4	2.8	4.9	2.4	3.3	3.2	25.1	1.9	12.5	1.9	2.9	3.5	11.3	12.4	13.9	12.3	10.5	12.1	14.9	12.7	13.2	13.1	12.9	13.6	31.6	19.2	14.5	23.5	11.0	7.8	5.4	3.9	5.7	15.8	9.5	8.9	10.3	12.8	5.1	16.5	14.6	3.2	25.8	3.3	9.8	4.5	8.3	10.0	12.3	33.0	4.2	2.1	39.8	8.1	3.3	13.6	3.1	9.3	3.8	7.1	48.2	10.1	16.3	18.5	34.2	3.9	2.0	47.1	13.0	6.4	14.9	35.1	23.2	54.4	42.7	8.8	24.7	31.2	36.1	5.2	1.9	13.2	8.3	8.2	3.7	2.4	5.4	14.0	19.7	21.9	12.9	23.9	17.8	6.1	11.2	1.4	15.6	6.2	4.5	3.8
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27354067-27366961	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.13e-4)"	"prognostic favorable (7.26e-4)"	"prognostic unfavorable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	42.9	17.8	17.2	5.5	17.0	0.6	42.6	17.4	20.7	50.2	16.8	25.4	1.8	30.9	4.1	70.0	38.8	4.7	61.8	16.6	17.4	37.3	10.4	54.2	4.7	18.4	17.5	15.6	15.2	5.2	18.0	5.1	17.6	41.3	4.5	1.4	30.3	7.3	15.2	65.7	17.7	12.1	17.3	22.3	23.6	8.3	18.4	2.8	30.3	11.3	7.9	39.8	53.4	16.6	7.2	7.2	6.9	4.4	9.9	12.5	1.4	9.0	5.3	7.2	4.4	2.0	9.4	0.1	8.4	16.4	3.2	10.1	2.0	6.4	3.6	6.5	7.1	0.3	16.0	4.7	2.7	0.5	0.4	10.2	17.6	7.8	2.3	8.8	4.0	0.7	2.0	2.7	10.2	25.1	0.2	9.0	2.2	8.7	8.1	2.3	3.2	1.7	12.9	9.1	2.0	3.0	8.5	7.1	6.3	3.1	4.4	5.0	11.6	13.2	7.2	16.6	5.2	3.5	4.1	0.0	12.1	5.8	4.3	0.9	0.6	3.3	2.8	2.0	3.7	1.5	2.5	3.1	1.3	2.0	1.8	1.6	1.2	0.7	4.5	0.0	3.0	1.2	17.2	17.0	17.4	20.7	16.6	17.4	18.4	17.5	17.6	17.3	18.4	16.6	45.8	19.2	17.8	6.2	3.9	12.5	11.9	8.8	17.1	1.1	8.1	8.9	12.2	5.7	10.3	3.7	0.0	1.2	4.3	8.4	3.9	2.8	0.4	2.3	6.0	27.7	0.0	0.8	1.5	4.4	2.5	10.3	8.6	5.2	2.5	1.2	28.9	0.9	2.8	5.0	1.7	6.1	4.1	8.5	7.1	1.2	16.1	6.4	5.4	5.6	9.3	5.4	8.2	0.0	0.2	12.8	1.9	15.1	3.1	9.5	1.1	1.7	6.2	0.8	6.6	10.8	11.1	13.5	7.7	14.7	14.8	0.1	8.2	0.3	8.8	14.9
MAP3K7CL	"C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4"	ENSG00000156265	"MAP3K7 C-terminal like"	P57077	21	29077471-29175889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.2;tongue: 45.6"	"Cell type enhanced"	"Detected in many"		"Macrophages: 77.2;monocytes: 24.7;Smooth muscle cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 53.1"	"Group enriched"	"Detected in all"	8	"B-cells: 22.8;granulocytes: 53.1;monocytes: 14.1"	"Cell line enriched"	"Detected in many"	4	"RH-30: 231.7"					"Not detected"	"Not detected"			"HPA030079, HPA042439"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA030079: AB_2673299, HPA042439: AB_10794422"	"unprognostic (2.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.00e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (8.31e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.10e-2)"	5.4	7.1	6.5	8.3	4.2	4.3	3.8	2.7	6.0	4.4	1.8	3.5	2.3	6.0	4.9	3.6	4.8	5.5	29.2	4.5	5.1	6.4	5.4	10.5	9.5	6.8	5.2	5.1	7.9	3.0	3.8	2.8	5.0	7.1	3.7	2.5	2.5	3.3	41.2	4.9	4.9	5.7	4.0	6.2	3.5	5.3	4.0	3.8	3.2	45.6	9.1	5.1	3.1	6.0	3.3	1.0	0.4	1.3	0.6	18.9	0.7	5.1	11.6	10.6	29.4	5.5	1.4	22.5	1.6	19.7	0.4	0.0	0.4	15.5	51.8	6.1	0.2	3.0	3.1	0.4	2.8	0.0	0.2	6.5	26.8	37.6	38.5	5.4	2.2	0.9	3.1	12.0	55.9	0.7	0.8	0.2	1.6	2.5	1.3	0.1	231.7	0.4	1.4	0.9	1.7	0.9	0.0	0.0	1.6	4.3	0.3	1.6	2.3	23.5	18.8	5.5	0.8	5.6	1.8	1.2	4.1	2.2	5.3	53.1	14.1	3.4	1.7	11.3	3.9	18.0	1.2	1.7	2.0	22.8	1.8	3.1	21.1	2.1	5.3	2.2	3.1	95.7	6.5	4.2	2.7	6.0	4.5	5.1	6.8	5.2	5.0	4.0	4.0	6.0	4.0	0.0	3.0	5.9	9.4	8.5	7.5	5.8	2.8	2.5	1.7	1.1	1.5	2.8	1.2	0.0	2.1	0.4	3.3	0.7	0.0	1.4	1.2	2.0	2.3	4.9	4.8	0.8	4.0	1.5	0.5	3.7	0.5	1.8	1.3	1.7	1.4	4.5	3.3	0.0	6.2	2.9	0.0	16.5	5.8	1.3	0.6	77.2	5.4	16.9	24.7	1.4	19.6	14.1	3.6	4.0	3.1	4.5	1.0	3.1	4.8	3.9	2.0	1.7	19.7	19.2	47.7	1.2	1.7	3.1	9.5	0.4	4.9	3.4	1.8	2.9
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	"Mitogen-activated protein kinase kinase kinase 9"	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;retina: 9.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.6;Inhibitory neurons: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000942	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA000942: AB_1079360"	"unprognostic (1.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.75e-5)"	"unprognostic (2.58e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.23e-6)"	"unprognostic (5.71e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-1)"	0.2	1.0	3.3	1.0	4.6	0.7	1.3	10.7	22.7	0.9	0.4	1.5	1.5	0.4	1.5	5.1	1.0	0.4	0.5	4.0	3.2	1.4	0.7	1.9	1.4	8.6	3.0	0.6	2.2	2.7	1.1	0.6	7.7	0.9	1.5	9.6	1.7	0.5	0.8	4.0	1.4	0.2	0.3	0.9	1.6	5.5	10.0	0.9	2.7	0.4	3.6	0.7	1.8	6.8	22.3	10.5	2.0	2.5	0.0	0.0	6.7	0.5	0.3	2.1	1.9	7.8	8.6	4.5	2.8	0.1	4.7	10.3	6.5	12.8	2.2	3.0	1.7	0.2	4.1	5.2	0.3	0.5	0.9	0.1	6.5	1.5	12.7	3.7	0.0	4.1	1.7	1.0	0.5	9.4	3.7	0.5	4.2	9.0	4.5	1.3	3.9	0.9	4.6	10.9	13.8	3.0	6.3	7.7	1.2	3.7	6.9	0.8	0.0	0.0	8.5	0.0	3.5	2.2	5.6	2.4	3.4	0.4	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	3.3	4.6	10.7	22.7	4.0	3.2	8.6	3.0	7.7	0.3	10.0	6.8	0.3	6.4	13.4	6.8	3.9	8.7	13.7	9.4	6.8	17.7	11.2	4.8	2.3	14.3	12.4	7.3	12.5	2.8	1.7	5.7	1.9	6.1	19.8	7.4	0.7	0.8	8.4	0.0	49.6	4.8	1.6	1.0	4.1	8.5	1.3	1.8	1.1	4.8	1.2	30.3	58.1	4.0	4.1	0.8	1.9	20.0	0.6	0.8	3.6	5.6	0.4	3.2	0.0	8.5	1.3	11.1	3.9	0.0	2.8	15.8	2.6	2.8	7.1	12.7	0.0	0.8	1.3	8.0	8.4	12.6	9.1	4.0	3.7	6.0	5.8	27.9
MAP4K3	"GLK, MAPKKKK3, RAB8IPL1"	ENSG00000011566	"Mitogen-activated protein kinase kinase kinase kinase 3"	Q8IVH8	2	39249266-39437301	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 118.8;Excitatory neurons: 201.0;Inhibitory neurons: 198.3;Microglial cells: 144.3;Oligodendrocyte precursor cells: 160.4;Oligodendrocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"AF22: 102.3;RT4: 97.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030380	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite"	Nucleoplasm	"HPA030380: AB_10601132"	"unprognostic (4.82e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.87e-3)"	"unprognostic (7.34e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.73e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.08e-2)"	15.8	17.1	11.6	6.7	12.5	10.5	16.6	21.6	16.7	15.0	15.3	15.5	13.2	17.2	13.4	10.2	13.6	14.7	19.3	14.2	11.2	24.5	15.1	13.3	6.1	9.9	10.0	20.2	12.2	25.3	12.2	27.4	10.0	16.9	13.0	28.0	10.8	14.0	30.9	16.4	14.3	14.5	11.3	11.6	26.6	21.3	10.2	8.1	24.4	22.2	6.1	18.3	11.4	14.4	25.6	15.6	102.3	16.3	16.3	32.4	28.0	22.1	28.3	21.6	18.3	13.3	12.6	5.5	24.3	15.3	22.1	13.6	39.0	19.7	32.6	6.3	16.0	9.2	10.8	30.9	42.3	4.0	14.5	29.3	19.0	28.1	30.1	22.6	18.8	5.0	12.1	9.9	29.2	13.9	9.0	6.0	30.7	24.0	23.4	9.9	33.3	4.2	28.3	97.3	18.2	20.7	12.9	20.7	58.8	32.0	13.9	5.6	15.4	16.7	19.7	15.0	12.1	15.1	9.3	1.9	20.5	6.6	19.0	0.7	0.1	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.4	0.1	0.1	0.0	11.6	12.5	21.6	16.7	14.2	11.2	9.9	10.0	10.0	11.3	10.2	14.4	36.2	3.2	8.4	118.8	8.1	17.6	17.9	11.0	16.5	24.7	14.1	12.3	38.2	21.5	16.5	22.0	25.0	13.1	4.1	12.5	19.6	10.3	45.1	22.3	19.9	20.6	9.6	4.6	201.0	12.4	6.7	18.2	25.5	59.4	2.5	15.6	14.3	18.6	9.7	6.7	198.3	13.9	2.0	10.9	20.6	103.0	20.8	14.4	5.4	144.3	4.4	13.2	3.1	160.4	129.2	17.5	5.7	17.7	14.3	18.6	14.0	11.9	19.5	37.9	19.7	18.7	17.6	22.6	19.8	11.8	19.2	10.4	5.9	17.4	10.6	30.2
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.6;epididymis: 36.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 93.0;Excitatory neurons: 45.5;Inhibitory neurons: 55.2;Spermatocytes: 57.8;Spermatogonia: 134.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 13.3;CACO-2: 19.3;HEK 293: 25.0;HeLa: 21.4;Hep G2: 11.4;SCLC-21H: 29.1;SiHa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA051508: AB_2681513, HPA059537: AB_2684054"	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.2	2.8	11.6	0.3	15.3	0.7	0.4	12.5	66.6	0.3	0.0	0.7	0.7	0.6	36.4	0.2	2.3	0.5	0.4	13.9	16.3	3.5	0.1	0.2	0.2	35.8	7.0	0.3	1.1	0.0	3.9	7.6	28.9	0.8	0.8	14.6	0.2	2.0	0.5	0.9	1.2	0.4	3.0	0.1	8.7	9.6	17.1	2.3	0.1	0.1	0.3	0.1	0.3	20.0	0.0	13.3	1.1	0.1	0.1	0.3	0.0	1.4	0.0	0.2	0.1	19.3	0.5	2.3	2.0	0.0	0.2	0.0	0.0	0.0	0.1	1.0	25.0	0.0	21.4	11.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	5.0	1.0	0.0	0.3	0.0	0.0	1.5	0.0	29.1	5.0	12.8	4.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.5	1.4	0.1	1.4	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	11.6	15.3	12.5	66.6	13.9	16.3	35.8	7.0	28.9	3.0	17.1	20.0	0.2	3.2	0.0	4.6	0.6	1.8	0.3	7.2	0.6	29.1	0.9	1.1	1.2	0.0	2.5	0.0	2.1	93.0	0.8	2.2	3.9	1.3	16.4	0.6	0.2	0.7	9.6	0.0	45.5	0.9	9.2	1.1	28.1	0.7	0.0	12.3	0.0	0.2	6.1	18.5	55.2	0.6	2.0	0.0	0.7	17.8	0.6	0.7	0.0	6.5	0.0	2.8	0.0	11.1	3.6	0.8	4.8	1.9	0.9	1.0	3.5	18.8	6.9	8.1	0.0	0.6	0.8	57.8	134.9	0.9	1.6	30.6	0.4	0.9	1.3	0.5
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 102.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 146.2;Late spermatids: 282.5;Proximal enterocytes: 178.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 63.8;RPMI-8226: 40.2;RT4: 47.0"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in all"	14	"cerebellum: 37.5"	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol"		"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	8.7	55.9	3.1	8.8	3.0	9.4	14.2	0.5	4.4	18.6	0.0	44.6	30.9	3.4	11.5	102.4	7.6	7.5	2.5	2.9	2.2	17.3	6.7	23.8	7.9	0.6	0.0	5.4	47.7	38.9	33.3	5.6	0.2	16.7	24.4	2.7	49.5	15.5	1.2	74.1	40.1	1.9	0.1	16.1	24.1	40.0	4.2	6.9	18.9	1.0	12.4	12.2	39.3	2.7	31.4	0.3	0.7	0.5	2.4	11.2	4.3	3.3	0.4	0.3	0.8	22.3	28.4	7.0	2.0	2.5	4.6	24.4	0.3	63.8	0.7	20.0	7.9	0.2	1.2	22.8	4.0	0.4	2.2	9.2	25.9	4.3	1.0	4.5	4.1	1.2	0.6	9.4	0.9	12.7	0.4	2.6	0.4	30.9	0.4	21.0	0.5	40.2	11.6	47.0	30.5	0.7	2.5	0.5	0.2	1.3	33.0	4.1	6.3	2.4	0.4	1.0	0.7	0.8	12.7	2.3	0.1	1.3	0.2	7.6	0.4	6.5	18.3	0.1	12.3	13.9	14.5	15.4	0.1	22.0	12.8	14.4	4.6	3.8	0.1	0.2	38.0	8.6	3.1	3.0	0.5	4.4	2.9	2.2	0.6	0.0	0.2	0.1	4.2	2.7	1.5	28.9	33.0	1.0	16.4	27.3	43.5	24.9	15.4	0.7	58.8	17.7	1.7	25.8	27.3	29.5	6.2	55.3	14.9	146.2	15.6	56.9	110.3	9.1	2.8	2.1	65.5	0.0	10.0	115.9	11.8	5.0	32.1	26.2	2.5	21.1	1.1	1.7	40.3	0.0	6.7	83.2	34.6	6.8	3.3	282.5	7.2	8.8	17.8	3.7	14.2	2.1	21.6	1.5	1.2	103.6	102.2	9.8	11.4	37.1	178.4	11.5	3.7	2.4	0.0	2.2	3.4	56.6	2.9	62.6	53.3	32.3	18.5	2.5	93.0	59.9
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716340-143722458	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 54.9;fallopian tube: 46.7"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 62.5;Respiratory ciliated cells: 107.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.6;HeLa: 20.7;MCF7: 14.3;T-47d: 14.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA002704: AB_1079307"	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	1.6	0.1	3.3	0.2	4.0	0.0	1.9	1.7	8.1	6.9	54.9	1.0	0.3	2.5	2.4	1.1	46.7	0.2	0.6	5.0	3.6	10.5	0.3	12.1	0.4	10.2	14.5	0.9	4.4	9.4	6.9	0.3	7.0	2.2	0.2	0.0	2.2	1.7	0.1	4.0	0.8	0.4	6.6	0.7	0.8	11.4	6.4	1.1	16.1	0.0	0.2	0.5	2.1	3.0	0.4	0.6	1.9	0.0	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.5	9.6	0.0	1.6	0.0	0.0	5.5	0.1	0.2	0.0	1.0	2.0	0.0	20.7	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.2	3.4	0.0	0.0	14.3	0.0	0.0	2.5	1.2	1.2	0.0	3.7	0.5	1.0	1.6	3.6	5.1	0.0	3.3	0.0	0.2	14.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.0	1.7	8.1	5.0	3.6	10.2	14.5	7.0	6.6	6.4	3.0	0.1	0.0	6.4	0.0	0.1	0.4	0.3	5.7	0.0	0.0	1.0	1.3	0.7	0.0	11.8	0.0	0.0	0.0	0.0	0.1	0.0	1.1	13.8	62.5	0.5	0.3	0.0	0.0	0.2	0.0	0.7	0.8	0.0	1.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.6	16.2	0.0	0.0	11.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	1.4	107.9	0.0	0.0	0.4	2.2	2.3	0.9	0.0	0.3	0.1	0.2	0.1	0.3	0.1
MAPK1IP1L	C14orf32	ENSG00000168175	"Mitogen-activated protein kinase 1 interacting protein 1 like"	Q8NDC0	14	55051647-55070194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034506	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA034506: AB_10669784"	"unprognostic (3.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.17e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (4.82e-5)"	"unprognostic (7.96e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.40e-2)"	31.2	26.3	15.6	27.5	16.5	83.2	26.5	16.7	22.3	26.0	15.4	24.4	18.9	30.2	29.4	27.6	28.9	26.4	33.3	16.0	19.6	42.0	27.3	25.7	29.5	18.0	17.8	34.6	21.9	23.4	22.3	30.2	17.5	24.6	24.8	19.1	30.2	24.6	25.7	27.0	21.2	35.6	17.0	24.2	23.1	21.6	18.0	23.9	25.8	19.9	36.5	34.2	21.8	18.1	49.0	42.3	73.1	46.8	57.8	56.6	56.5	53.7	56.8	65.2	75.2	34.1	42.2	56.3	44.4	72.0	39.2	52.5	79.3	81.3	90.7	51.4	50.6	54.3	39.4	51.7	63.0	67.3	57.4	73.6	60.0	54.5	85.9	47.5	87.9	35.4	51.2	48.7	95.6	59.0	56.9	51.7	53.1	46.2	70.4	48.1	80.4	34.0	89.9	54.1	47.5	55.0	51.9	36.7	51.6	65.1	65.5	38.4	66.8	66.6	87.0	41.7	48.6	29.9	46.3	73.3	53.3	34.7	49.0	44.1	26.7	32.1	24.2	37.4	32.0	31.8	28.3	26.3	29.0	27.4	26.0	26.1	19.7	26.0	36.4	37.2	37.9	25.1	15.6	16.5	16.7	22.3	16.0	19.6	18.0	17.8	17.5	17.0	18.0	18.1	73.5	70.5	66.9	25.5	106.3	71.9	164.0	77.3	53.5	22.9	44.1	36.2	71.2	40.0	66.3	47.8	37.5	121.2	78.0	60.3	70.5	65.0	28.5	73.7	57.1	69.5	57.9	57.7	34.3	69.4	112.3	60.7	70.3	86.2	83.1	41.5	43.2	51.5	75.1	38.7	32.2	54.8	50.8	64.4	88.4	14.1	51.3	72.9	49.8	28.1	65.0	60.0	49.4	27.2	38.1	94.4	44.2	54.2	109.5	104.8	44.1	103.4	39.6	24.9	32.9	59.1	66.5	81.1	60.6	53.6	71.6	151.3	86.4	40.5	46.9	145.3
MAPK3	"ERK1, p44erk1, p44mapk, PRKM3"	ENSG00000102882	"Mitogen-activated protein kinase 3"	P27361	16	30114105-30123506	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 336.9;Early spermatids: 267.2;Proximal enterocytes: 235.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 49.1;neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 49.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002683, HPA003995, HPA005700, HPA030069"	Approved		Supported	Nucleoplasm		NA	NA		46000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (5.03e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.70e-3)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (2.09e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-2)"	99.5	64.3	178.7	42.4	162.3	45.2	86.3	113.0	200.9	93.3	86.0	117.2	103.1	74.9	27.4	129.6	71.6	65.3	65.4	168.6	132.7	49.4	21.2	71.3	37.8	135.6	148.7	78.7	33.7	61.2	55.8	70.2	142.3	49.2	91.9	71.5	61.0	43.3	51.7	77.6	113.2	58.7	127.4	57.4	86.4	31.6	129.5	31.4	58.0	57.0	49.3	64.8	89.0	130.9	56.3	30.0	62.2	35.7	153.7	202.4	35.1	40.7	101.1	63.4	75.3	36.4	110.0	56.3	39.7	115.5	73.2	20.6	53.3	47.8	61.0	106.9	61.8	17.3	31.6	61.8	154.2	13.0	46.2	125.8	27.3	72.5	32.2	96.1	163.7	60.3	24.3	70.0	85.2	147.1	59.2	21.5	16.9	113.6	26.1	68.9	37.3	127.4	58.0	35.0	55.2	39.3	23.2	81.8	24.1	50.5	53.5	30.7	117.2	41.7	35.4	48.4	14.5	79.1	39.3	29.6	83.3	27.1	30.0	6.2	5.1	49.1	1.6	3.7	2.6	2.3	3.7	3.0	2.8	2.5	2.6	2.9	21.5	2.2	2.0	2.8	6.6	2.8	178.7	162.3	113.0	200.9	168.6	132.7	135.6	148.7	142.3	127.4	129.5	130.9	95.5	22.4	17.5	7.5	10.7	9.8	22.2	11.4	5.7	30.4	23.3	19.9	15.4	20.0	13.0	9.2	22.9	77.6	15.2	336.9	23.5	39.8	267.2	24.8	25.1	68.1	54.7	6.1	7.7	61.2	134.2	34.7	79.0	15.7	2.5	19.1	71.7	7.0	45.2	8.4	10.3	159.3	22.4	26.4	12.3	176.0	32.3	20.6	23.2	7.5	24.5	67.0	13.4	7.1	9.8	118.8	167.2	27.4	6.2	13.5	235.6	23.9	24.7	41.5	19.7	18.8	29.3	10.9	19.8	15.8	13.2	33.8	14.5	40.0	94.9	22.4
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	"Mitogen-activated protein kinase 4"	P31152	18	50560087-50731826	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;parathyroid gland: 51.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 202.7;Excitatory neurons: 105.2;Inhibitory neurons: 58.5;Late spermatids: 66.4;Muller glia cells: 62.6"	"Cancer enriched"	"Detected in many"	4	"glioma: 15.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;HeLa: 3.3;NTERA-2: 2.2;SCLC-21H: 11.6;SH-SY5Y: 2.8;SK-MEL-30: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		Yes	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Golgi apparatus"	Midbody	"HPA007461: AB_1079308"	"unprognostic (4.12e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.96e-4)"	"unprognostic (5.99e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	0.9	26.8	56.5	0.2	79.9	0.0	0.8	56.4	46.0	1.5	28.0	6.8	0.6	0.8	3.1	2.3	1.5	1.8	22.1	41.6	57.5	3.3	4.5	2.3	0.0	65.4	70.0	2.9	1.4	51.0	17.8	2.6	56.7	5.0	0.8	22.6	0.9	9.8	1.5	1.3	1.6	1.8	48.8	0.1	2.1	2.4	81.9	7.3	6.2	1.5	0.0	4.6	1.3	38.7	0.0	0.0	1.0	0.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.1	1.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.6	2.8	0.0	0.8	1.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.5	79.9	56.4	46.0	41.6	57.5	65.4	70.0	56.7	48.8	81.9	38.7	0.4	9.6	0.0	202.7	0.0	0.0	0.4	0.0	0.0	11.4	0.9	1.1	22.9	1.5	0.0	0.0	0.0	4.6	0.0	0.0	5.9	0.9	30.1	0.0	0.0	0.3	0.0	0.0	105.2	0.0	0.3	1.0	0.0	0.0	0.0	0.7	0.0	1.0	0.4	5.0	58.5	0.0	0.0	0.0	0.0	66.4	0.9	0.1	0.0	7.5	0.0	62.6	0.0	18.6	1.9	0.4	0.0	1.5	0.0	0.7	0.0	0.2	0.0	1.0	0.0	1.0	0.7	0.8	0.6	0.0	0.0	1.8	0.0	0.4	0.0	0.1
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 43.1;SuSa: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: AB_2673706"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	8.3	13.7	4.0	4.0	4.4	5.2	7.7	4.0	5.9	14.3	4.4	10.6	5.5	11.1	3.3	16.3	8.7	4.5	6.2	3.9	4.5	7.7	3.9	8.7	3.7	5.3	6.1	12.5	3.4	2.9	6.1	6.7	4.4	8.9	3.5	2.2	6.7	6.1	5.0	12.5	7.3	6.7	3.3	9.4	6.7	11.8	5.0	3.5	7.4	3.4	3.6	10.1	15.2	4.1	6.9	11.0	9.9	7.7	43.1	17.2	10.4	9.0	8.3	13.0	12.4	12.2	1.4	4.1	7.3	16.5	10.4	8.2	10.4	9.4	7.8	7.2	8.3	1.9	8.4	5.4	21.2	1.9	7.8	21.6	6.2	18.2	7.2	12.0	9.5	7.5	3.7	1.4	13.2	4.8	13.0	7.4	10.7	8.4	6.7	8.6	12.9	3.0	5.4	3.7	4.4	12.3	9.7	1.0	5.0	53.7	6.1	3.1	6.0	14.6	10.8	15.5	6.7	2.6	4.0	1.2	16.5	1.6	9.2	0.8	3.4	10.7	3.7	6.5	2.0	1.8	1.8	3.2	2.3	1.0	1.6	2.0	1.1	4.9	6.0	1.4	1.0	3.1	4.0	4.4	4.0	5.9	3.9	4.5	5.3	6.1	4.4	3.3	5.0	4.1	10.7	6.4	3.3	2.6	7.8	5.5	6.1	9.5	13.6	2.4	5.8	4.6	5.3	2.8	5.6	5.5	2.1	5.7	6.7	16.2	5.9	8.1	8.7	3.0	7.9	8.5	10.7	1.7	2.0	6.2	8.0	9.6	12.2	5.2	2.5	7.7	7.5	1.1	7.7	0.0	2.1	6.9	10.2	6.9	6.1	5.7	11.5	14.4	3.6	6.5	3.4	13.1	17.5	1.0	2.0	8.0	20.8	11.7	9.3	6.3	9.0	3.5	3.2	2.1	26.3	8.4	11.1	33.2	16.4	9.8	4.3	5.1	6.2	7.7	6.7	5.3
MAPKAP1	"MGC2745, MIP1, SIN1"	ENSG00000119487	"MAPK associated protein 1"	Q9BPZ7	9	125437393-125707234	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029091, HPA029092"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA029091: AB_10599732, HPA029092: AB_10601568"	"unprognostic (6.65e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.27e-2)"	42.9	47.1	43.4	36.7	48.6	34.7	32.8	39.2	45.6	36.4	44.9	47.3	30.4	29.1	35.9	44.0	29.2	28.0	69.7	44.3	41.6	48.0	46.0	30.1	34.8	47.8	46.2	26.1	36.9	53.3	19.2	30.2	41.9	30.3	38.5	42.9	42.1	36.1	103.7	26.2	32.6	46.2	43.2	28.8	36.2	42.0	51.6	36.6	47.4	76.4	37.9	39.4	31.6	40.9	87.4	97.1	64.3	68.3	86.7	82.2	107.9	108.6	110.0	82.0	57.2	97.9	94.9	89.1	65.9	151.6	89.7	119.1	99.5	126.9	110.8	101.8	41.1	64.3	111.9	95.1	97.3	116.0	72.1	80.9	114.6	117.0	121.7	91.2	123.0	85.8	103.6	67.7	176.4	180.3	87.5	46.8	102.4	204.3	122.0	72.4	152.0	119.3	90.2	62.3	77.9	76.7	109.7	100.9	70.0	86.6	115.8	67.1	79.7	115.3	76.1	140.5	182.5	86.1	225.2	89.9	165.5	52.5	127.6	4.4	6.1	5.7	4.3	6.0	5.9	8.2	4.7	4.8	4.9	7.4	4.1	7.1	19.1	5.8	5.6	7.2	5.8	2.5	43.4	48.6	39.2	45.6	44.3	41.6	47.8	46.2	41.9	43.2	51.6	40.9	22.3	12.8	17.0	64.6	33.5	15.8	30.2	15.3	25.6	25.6	30.6	24.1	68.3	22.8	27.5	14.7	41.7	35.4	31.7	28.9	54.8	48.3	80.2	26.2	42.6	27.1	9.6	22.3	82.6	65.6	50.9	27.0	32.1	29.3	17.7	31.2	19.6	34.5	50.7	32.0	80.1	20.8	22.4	29.5	23.4	116.9	19.0	37.3	23.2	59.0	55.1	30.1	35.0	97.0	96.4	59.2	20.1	17.7	32.3	45.2	27.2	84.6	14.6	26.2	6.6	29.1	33.0	75.4	71.4	29.1	19.5	50.9	29.5	38.4	27.6	37.8
MAPKAPK2	MK2	ENSG00000162889	"MAPK activated protein kinase 2"	P49137	1	206684905-206734281	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 21.9"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 21.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263"	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	61.9	80.4	34.8	56.2	39.1	174.6	50.5	36.9	33.9	47.3	38.7	50.3	65.5	53.3	24.1	55.8	50.8	52.5	190.1	30.8	36.6	79.5	66.8	79.3	57.8	53.1	42.1	44.8	53.8	38.0	63.3	25.7	43.9	42.8	35.3	17.6	54.9	33.1	196.7	54.4	61.7	45.4	40.1	78.3	68.2	46.9	45.2	45.6	47.7	94.3	54.4	63.5	46.6	38.6	85.4	33.1	44.8	50.6	128.4	75.0	55.1	57.3	130.0	86.0	80.7	63.8	40.4	40.6	38.8	116.9	54.1	63.0	33.8	61.7	61.4	46.5	25.4	69.1	41.7	41.3	99.0	102.3	219.5	104.1	77.3	82.8	91.3	71.8	71.7	54.1	79.7	180.2	70.5	105.2	41.2	73.3	51.5	29.9	45.1	103.7	94.0	13.5	64.9	51.5	35.7	45.7	68.0	114.2	83.1	83.0	55.4	97.2	68.7	77.6	64.7	91.0	79.7	232.0	220.6	33.2	87.8	60.9	26.0	1.6	0.8	1.8	1.8	1.4	1.6	1.1	1.3	1.7	0.7	1.2	0.6	1.2	3.7	2.6	1.3	21.9	1.8	0.7	34.8	39.1	36.9	33.9	30.8	36.6	53.1	42.1	43.9	40.1	45.2	38.6	49.2	54.5	49.9	15.7	27.9	85.4	52.3	18.3	20.5	12.4	61.4	37.8	102.5	37.1	26.8	31.3	20.9	6.4	185.9	51.9	15.6	30.6	76.2	32.2	40.9	43.7	61.7	15.4	4.7	58.5	9.2	33.4	32.1	46.6	34.9	24.8	19.2	40.0	24.8	0.0	10.6	38.1	16.2	34.6	82.7	36.1	22.7	60.9	33.8	13.1	23.7	21.7	74.2	8.5	17.4	61.6	34.4	17.3	69.6	67.3	22.2	25.0	14.4	16.0	26.3	36.9	48.5	13.7	10.3	31.5	72.0	16.6	46.0	19.2	30.5	75.0
MAPKAPK3	"3pK, MAPKAP3, MK-3, MK3"	ENSG00000114738	"MAPK activated protein kinase 3"	Q16644	3	50611520-50649291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 106.5;heart muscle: 256.3;skeletal muscle: 224.2;tongue: 284.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 226.6;Hofbauer cells: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 142.8;granulocytes: 126.3;monocytes: 341.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA058275: AB_2683663"	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	15.3	43.3	18.0	29.8	19.6	106.5	15.8	19.2	19.2	15.0	21.3	19.7	30.2	11.3	10.3	49.6	15.1	12.1	256.3	18.0	19.7	40.0	18.7	28.2	21.7	23.6	20.5	14.2	36.2	47.2	23.5	13.9	22.5	18.4	20.0	4.7	27.7	12.6	224.2	53.4	24.2	15.9	21.6	25.3	27.6	9.2	21.1	42.0	41.2	284.3	24.2	20.3	22.2	21.6	99.6	30.3	12.4	35.9	18.4	45.7	27.9	23.8	33.7	35.7	30.3	47.1	90.2	39.8	23.5	79.5	88.5	34.6	85.9	92.7	31.9	88.3	22.3	209.5	40.6	43.5	36.8	152.1	106.4	36.9	57.0	83.1	112.2	35.6	31.9	70.2	59.7	25.4	76.1	40.5	65.3	153.3	46.4	34.6	127.0	28.5	29.9	60.1	165.5	56.2	23.0	16.5	21.3	58.9	27.7	20.6	37.8	93.4	23.8	28.1	64.5	146.4	59.5	17.2	33.7	33.1	148.3	234.7	11.8	45.3	169.5	126.3	27.6	271.6	27.3	15.1	30.9	32.1	142.8	8.8	23.9	27.8	104.4	42.1	341.5	91.2	28.0	132.6	18.0	19.6	19.2	19.2	18.0	19.7	23.6	20.5	22.5	21.6	21.1	21.6	3.5	9.6	14.0	8.5	8.6	11.3	26.9	14.0	19.4	1.1	15.3	12.3	226.6	15.7	10.4	11.0	0.0	6.0	38.1	16.2	64.6	45.6	34.5	3.4	2.7	7.1	6.0	19.1	0.3	30.4	7.4	14.9	11.7	5.4	36.2	8.3	5.3	14.2	102.1	0.0	0.7	15.4	10.2	68.0	23.9	86.2	7.2	59.4	7.2	0.0	76.6	17.1	41.2	0.5	2.0	76.2	15.6	3.4	12.7	30.9	30.7	35.4	5.7	2.3	26.3	9.7	12.0	4.1	4.6	34.2	20.2	5.1	24.3	22.0	28.2	33.5
MAPKAPK5	"MK5, PRAK"	ENSG00000089022	"MAPK activated protein kinase 5"	Q8IW41	12	111842228-111902222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004546, HPA015515"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	"unprognostic (6.45e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.98e-8)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.25e-2)"	18.1	20.8	12.6	17.9	14.4	27.1	20.4	14.9	15.0	15.2	15.7	28.2	25.5	15.7	20.7	17.2	16.1	12.2	16.7	15.3	14.3	20.3	19.4	17.5	20.7	12.3	12.4	18.1	20.4	21.4	11.6	20.3	11.8	17.0	30.7	27.2	17.4	15.6	30.4	20.1	28.2	18.9	11.3	15.6	18.0	15.9	12.9	23.2	19.3	25.3	19.3	18.5	14.4	13.8	32.4	42.1	40.0	33.7	28.2	28.4	60.6	31.7	38.1	47.7	32.7	54.8	25.9	48.6	22.9	37.7	28.4	31.6	53.1	33.2	44.4	32.6	29.0	43.4	29.5	44.2	34.1	55.1	29.4	30.2	46.7	45.6	53.7	36.0	35.6	43.4	61.0	18.7	35.3	36.4	55.2	86.6	56.9	79.1	29.4	53.7	29.1	46.9	37.9	46.2	49.0	41.4	36.1	60.5	46.3	36.2	49.1	62.0	31.2	26.8	27.2	27.9	40.4	37.8	50.1	57.4	32.7	39.4	38.9	1.1	3.3	2.3	4.2	2.4	2.2	3.5	2.7	3.0	2.2	3.1	4.2	3.1	1.6	2.9	8.8	2.6	4.8	1.8	12.6	14.4	14.9	15.0	15.3	14.3	12.3	12.4	11.8	11.3	12.9	13.8	16.9	3.2	23.1	12.1	22.3	20.5	22.3	12.5	21.1	47.0	18.3	14.0	20.1	22.8	15.4	3.7	41.7	29.9	32.4	34.1	13.7	28.2	17.2	14.2	17.3	16.0	36.6	15.8	24.6	29.6	33.3	19.4	20.9	15.2	2.5	22.3	14.6	13.4	19.9	23.5	22.3	47.3	14.2	21.2	17.7	7.3	15.5	15.0	8.8	14.0	27.8	19.6	25.7	15.6	21.8	36.3	27.4	17.7	21.6	37.5	63.6	21.8	12.0	36.4	19.7	22.6	19.8	30.7	40.3	23.6	21.3	30.1	22.2	22.5	32.3	32.3
MAPKBP1	"KIAA0596, NPHP20"	ENSG00000137802	"Mitogen-activated protein kinase binding protein 1"	O60336	15	41774434-41827855	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 204.3;Excitatory neurons: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030832, HPA030833"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA030832: AB_10601869, HPA030833: AB_2673628"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	6.2	10.5	10.9	4.6	12.4	4.4	7.7	31.1	13.7	11.1	10.1	10.2	9.6	9.9	4.5	18.6	10.4	4.6	6.4	9.9	8.5	7.1	4.1	6.0	3.9	9.0	8.0	15.1	5.5	4.2	12.7	5.4	9.0	8.9	3.6	9.0	7.5	5.9	5.1	24.2	9.9	9.0	5.3	8.0	9.3	34.4	9.1	6.3	13.4	3.7	6.8	12.2	12.0	10.2	7.4	3.8	10.0	9.5	10.9	10.8	6.9	10.1	25.5	9.1	6.6	7.6	2.7	1.8	8.1	8.3	12.5	17.2	9.8	28.5	6.5	6.7	2.7	7.3	12.8	2.6	4.7	4.7	14.5	5.6	22.3	14.3	25.9	14.8	13.4	11.9	4.6	3.4	12.9	1.5	4.0	4.2	1.1	4.3	7.6	4.3	7.2	0.7	5.3	8.1	11.3	6.3	5.7	5.9	4.5	10.2	7.1	3.7	10.6	13.0	6.2	12.4	10.0	7.3	12.7	4.3	8.7	6.3	11.0	1.1	0.4	0.3	0.8	0.1	0.6	0.4	0.4	0.3	0.5	0.4	0.6	0.5	0.1	0.6	0.5	0.1	0.2	0.5	10.9	12.4	31.1	13.7	9.9	8.5	9.0	8.0	9.0	5.3	9.1	10.2	7.1	6.4	10.3	33.0	3.5	54.7	10.0	8.6	36.5	14.5	5.4	8.9	3.4	2.8	7.3	3.7	204.3	6.8	5.6	4.0	0.0	3.0	15.7	10.9	7.1	9.5	4.8	0.8	62.2	3.7	4.4	5.8	9.2	8.9	1.3	12.2	5.3	2.6	3.9	15.2	55.1	1.7	4.1	2.5	6.1	27.1	7.2	5.0	8.8	33.7	4.2	4.4	3.1	34.7	51.9	4.6	1.8	7.9	5.1	12.5	8.1	0.5	13.0	8.9	13.1	7.8	5.7	12.7	4.2	27.7	53.6	5.3	5.8	8.0	2.5	15.2
MAPRE2	"EB1, EB2, RP1"	ENSG00000166974	"Microtubule associated protein RP/EB family member 2"	Q15555	18	34976928-35143470	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 163.3;Oligodendrocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016738, HPA016739"	Enhanced		Uncertain	Nucleoplasm		NA	NA		13000000	"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016738: AB_1853571, HPA016739: AB_1853570"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-3)"	22.4	58.7	54.2	29.1	65.2	22.1	16.6	58.5	89.4	19.3	1.9	24.5	15.0	14.0	18.9	17.4	12.7	41.1	89.1	68.8	56.9	18.4	33.4	27.2	35.8	74.0	61.0	24.9	12.8	19.2	16.3	28.3	70.6	16.1	24.6	49.1	20.2	17.2	50.4	26.1	19.6	23.8	70.0	27.8	30.6	6.4	68.2	74.4	21.7	91.9	32.6	27.2	14.4	109.0	0.8	26.3	28.9	15.4	17.1	15.9	2.0	18.7	44.7	22.3	37.2	2.0	9.9	87.8	21.3	41.1	23.5	35.0	22.8	15.2	39.8	51.5	21.3	88.9	26.9	52.8	12.6	49.5	72.3	19.6	4.0	30.4	10.5	21.2	124.0	61.4	28.3	37.7	28.8	1.7	104.6	16.4	22.5	28.8	5.2	41.6	35.2	20.0	11.9	0.4	35.9	23.9	14.0	0.7	15.5	27.2	3.2	29.0	21.0	24.1	13.4	14.2	12.7	19.9	50.8	50.8	41.4	65.1	38.2	69.0	30.0	46.7	63.8	37.7	49.5	60.8	44.4	58.3	33.4	55.5	50.6	61.5	21.5	74.4	51.6	47.3	52.9	76.9	54.2	65.2	58.5	89.4	68.8	56.9	74.0	61.0	70.6	70.0	68.2	109.0	27.0	22.4	18.3	104.8	73.0	23.7	5.1	2.0	38.1	109.6	18.9	19.7	105.6	12.8	4.8	5.5	25.0	0.6	107.9	13.3	5.9	9.8	12.4	11.9	12.6	29.4	29.3	25.0	163.3	12.8	9.7	28.5	42.3	14.6	27.3	4.6	33.5	26.1	26.1	52.2	141.7	25.8	4.1	44.7	38.3	6.8	19.3	44.6	30.2	70.3	17.1	40.3	52.5	97.5	435.9	10.1	15.6	21.1	31.6	2.9	12.0	5.1	6.5	12.5	78.9	25.4	74.9	1.9	10.6	9.1	27.6	0.8	76.1	15.0	11.1	3.5
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857345-113863475	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 12.7;neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 405.8;TIME: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	42.8	16.8	65.1	58.2	64.1	104.6	50.2	73.2	78.5	31.9	21.6	75.7	38.9	31.2	13.5	45.1	27.3	35.8	18.2	56.8	89.2	24.6	26.1	35.0	45.4	81.0	87.6	39.0	42.4	7.0	20.6	63.0	73.1	37.8	68.2	22.0	28.0	18.0	15.7	32.1	43.3	30.1	106.8	57.0	62.8	10.3	85.5	44.8	16.2	12.9	45.3	86.2	34.5	102.8	39.2	22.6	405.8	22.3	134.0	86.6	2.2	123.0	171.4	84.9	140.6	40.7	54.1	0.1	25.3	228.0	67.3	118.0	67.9	35.7	109.7	0.3	40.2	0.0	22.2	53.3	89.2	10.3	0.7	90.2	68.8	81.8	77.4	231.9	243.1	0.4	4.6	107.6	122.1	0.4	1.3	0.3	52.7	43.5	29.4	0.2	40.7	4.1	26.9	73.6	56.4	163.4	78.7	39.6	89.6	95.0	2.1	11.3	326.0	78.3	0.5	129.9	212.7	288.3	22.4	11.4	60.2	55.8	153.4	0.0	3.9	0.0	0.0	12.7	0.0	4.6	0.0	0.0	1.1	1.9	0.0	0.0	18.7	0.0	7.5	0.0	0.0	0.5	65.1	64.1	73.2	78.5	56.8	89.2	81.0	87.6	73.1	106.8	85.5	102.8	211.2	9.6	15.5	44.7	139.0	504.1	540.7	232.3	275.4	157.0	213.2	176.7	16.6	57.2	115.0	38.6	29.2	7.2	5.5	629.5	37.2	144.3	55.7	111.2	444.0	271.6	336.3	2.5	33.0	229.9	11.2	372.6	135.1	130.4	2.5	526.1	236.0	8.8	371.6	84.1	21.0	369.4	126.1	286.3	605.5	35.7	120.5	381.3	273.9	60.0	447.2	315.5	2.1	194.5	9.7	208.1	223.1	67.0	105.2	380.1	89.9	6.9	145.0	37.7	39.5	89.8	222.8	22.7	16.2	326.3	638.5	29.4	22.3	62.3	352.3	620.2
MARCKSL1	"F52, MacMARCKS, MLP, MLP1"	ENSG00000175130	"MARCKS like 1"	P49006	1	32333839-32336233	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 712.7"	"Cell type enhanced"	"Detected in many"		"monocytes: 941.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"eosinophil: 252.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 252.7"	"Cell line enhanced"	"Detected in many"		"AF22: 1016.3;NTERA-2: 984.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020787, HPA030528"	Enhanced		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	Yes		170000	"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Nucleoplasm, Actin filaments"	"CAB020787: , HPA030528: AB_2673514"	"unprognostic (8.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.16e-3)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (3.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-2)"	63.4	59.9	363.5	82.1	510.3	50.1	102.9	540.1	438.2	81.2	206.4	108.1	61.8	93.4	155.8	15.1	72.2	97.2	55.0	343.0	408.0	51.1	38.7	40.0	176.0	631.5	504.7	358.0	23.7	6.5	22.9	42.9	534.9	84.7	116.5	37.9	75.9	49.9	8.7	28.3	56.1	42.7	467.9	63.1	132.8	139.2	466.4	166.0	110.3	11.0	199.5	77.8	27.1	712.7	82.9	73.3	1016.3	418.6	22.5	8.3	181.0	34.0	21.2	99.9	66.0	176.0	59.9	185.7	124.4	23.2	0.3	43.0	333.1	3.8	73.3	4.5	246.5	10.0	27.0	392.4	68.7	48.8	0.9	114.8	13.7	75.0	2.1	154.2	295.0	312.6	291.5	2.2	135.7	197.5	613.5	205.9	984.3	267.4	168.1	754.8	109.4	87.7	152.1	163.1	629.0	597.8	178.8	194.2	587.8	411.9	135.4	85.8	87.8	41.8	241.3	3.9	66.1	27.8	2.3	489.8	4.7	73.6	225.7	3.1	4.0	252.7	3.8	23.1	1.4	20.0	7.4	4.9	6.6	27.7	15.3	6.4	18.2	1.1	30.3	9.0	4.8	4.9	363.5	510.3	540.1	438.2	343.0	408.0	631.5	504.7	534.9	467.9	466.4	712.7	242.5	0.0	1.3	27.1	191.1	93.7	114.7	43.5	40.5	27.7	465.7	385.8	8.5	178.7	68.8	60.7	6.2	16.1	110.1	194.1	82.2	389.7	37.4	68.7	190.3	326.9	746.2	74.4	4.2	307.2	116.4	124.3	246.2	115.2	22.3	378.6	462.3	5.3	21.2	10.1	21.9	514.2	236.0	61.0	365.3	66.7	613.3	82.0	300.6	9.4	941.4	464.3	46.4	93.0	428.3	751.6	292.8	641.3	39.5	418.8	30.2	9.8	15.6	14.8	131.5	40.3	210.0	14.8	102.7	22.5	83.1	13.4	89.8	172.0	447.1	586.9
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	"Microtubule affinity regulating kinase 2"	Q7KZI7	11	63838928-63911020	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: AB_2686722"	"unprognostic (1.33e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.13e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (2.73e-3)"	"unprognostic (4.41e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.77e-1)"	"unprognostic (5.20e-3)"	"unprognostic (5.15e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-1)"	11.3	13.8	12.6	21.1	16.1	24.0	16.8	8.1	16.3	18.5	10.8	25.9	26.1	14.6	7.7	51.8	16.6	14.1	20.9	14.9	9.3	13.9	13.1	17.0	21.5	11.8	9.3	12.0	22.4	19.4	19.8	14.9	11.5	20.5	22.4	8.8	27.0	13.1	20.8	40.9	25.1	16.3	7.3	24.1	20.9	10.6	9.5	23.2	19.5	13.7	24.0	19.3	25.0	17.9	52.0	34.1	26.6	28.6	14.6	18.6	35.2	20.8	20.0	29.5	22.3	34.1	49.5	37.8	35.6	20.8	32.0	57.5	26.9	28.7	24.6	26.7	20.9	40.7	23.9	20.3	17.0	45.9	51.4	10.9	36.8	27.0	21.4	13.5	24.7	33.6	35.7	36.5	19.5	64.4	49.3	29.9	31.7	36.0	24.2	39.9	20.4	39.7	19.1	39.8	37.9	25.4	34.7	90.2	24.3	28.9	65.1	26.4	22.7	30.3	19.1	39.6	23.4	24.5	28.8	36.7	20.1	23.2	25.3	1.4	0.7	2.1	1.3	0.7	2.1	0.9	1.0	1.3	1.0	1.6	0.8	0.9	3.6	1.6	1.1	0.9	0.6	0.7	12.6	16.1	8.1	16.3	14.9	9.3	11.8	9.3	11.5	7.3	9.5	17.9	17.3	6.4	6.8	29.7	18.5	25.2	21.1	9.1	19.4	26.8	30.0	18.2	12.8	27.1	11.9	20.2	8.4	26.0	33.4	90.3	1.9	20.2	0.6	29.5	15.8	14.7	29.9	14.7	43.6	21.4	20.6	11.7	27.0	41.0	17.2	21.1	13.6	13.0	17.9	20.2	30.3	39.9	10.2	26.7	18.5	0.9	12.8	25.0	3.6	29.0	17.0	18.8	36.0	31.7	51.8	27.3	39.4	10.9	15.6	30.4	33.4	8.1	14.5	18.1	19.7	19.6	13.1	9.1	18.4	39.9	34.4	65.0	23.6	16.0	33.6	44.3
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.1;epididymis: 1.9"	"Cell type enriched"	"Detected in single"	62	"granulocytes: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				0.4	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.7	0.3	0.7	1.9	1.1	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.2	0.0	0.3	0.7	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217282-187291980	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 120.0;heart muscle: 116.1;liver: 183.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cardiomyocytes: 38.1;Cholangiocytes: 20.0;Endometrial stromal cells: 30.6;Fibroblasts: 16.4;Hepatic stellate cells: 23.2;Hepatocytes: 65.8"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 133.3;BJ hTERT+: 498.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1900000000		"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	6.3	3.6	9.4	1.3	9.4	0.0	2.8	12.9	7.0	120.0	4.9	57.5	1.9	88.4	3.3	11.1	17.7	5.1	116.1	10.4	27.0	4.8	183.4	6.0	1.0	19.2	16.5	2.7	0.2	0.3	1.0	9.0	15.3	46.0	5.6	0.0	2.3	52.2	37.5	6.3	7.5	44.4	22.2	0.8	1.6	0.5	14.6	0.2	3.2	18.9	4.3	9.9	61.5	32.0	0.0	0.0	0.3	0.4	15.7	17.3	0.1	133.3	498.3	1.8	0.9	0.0	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.4	12.9	7.0	10.4	27.0	19.2	16.5	15.3	22.2	14.6	32.0	1.1	0.0	1.8	28.1	0.2	2.9	0.1	0.2	0.0	0.0	0.0	0.0	38.1	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.7	30.6	2.0	0.0	0.0	0.2	0.0	0.3	16.4	0.0	0.7	0.0	0.2	23.2	65.8	0.4	0.0	0.9	0.0	0.0	1.9	3.7	7.5	2.5	0.3	1.8	1.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.7	0.1	0.1	0.0	2.4	0.0	0.0	0.0	5.4	4.5	0.0	0.0	0.2	1.7	0.1	0.5	5.1	0.0	0.1
MAST4	KIAA0303	ENSG00000069020	"Microtubule associated serine/threonine kinase family member 4"	O15021	5	66596361-67169595	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 519.7;Basal prostatic cells: 507.3;Excitatory neurons: 636.6;Inhibitory neurons: 489.6;Suprabasal keratinocytes: 399.2;Urothelial cells: 676.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 27.7"	"Immune cell enhanced"	"Detected in many"		"basophil: 15.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 33.2;HDLM-2: 43.2;HEL: 35.5;RT4: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000544	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA000544: AB_1079315"	"unprognostic (1.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (9.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.08e-2)"	14.9	11.0	4.6	4.5	5.2	1.9	11.1	0.9	27.7	12.1	0.0	6.0	5.1	10.0	5.0	27.0	9.4	8.0	29.5	4.2	5.4	12.0	8.4	11.0	4.4	5.0	5.5	16.4	4.6	15.3	4.6	8.8	1.2	7.6	4.1	4.7	11.5	6.6	11.2	14.8	4.5	9.3	1.1	5.0	7.0	10.0	3.3	16.8	6.5	7.2	10.1	16.0	21.2	11.4	14.6	7.8	3.8	0.2	12.4	10.9	9.0	3.2	4.9	1.1	1.0	7.3	3.9	1.0	6.5	2.7	2.9	12.8	11.8	33.2	1.3	43.2	3.8	35.5	4.7	3.1	0.9	0.1	11.9	18.4	17.8	7.1	14.2	13.3	26.2	3.2	3.5	3.9	8.9	12.6	5.1	0.2	2.5	1.2	6.3	1.1	3.3	0.7	3.1	42.9	5.5	4.4	4.3	1.7	0.2	2.7	2.8	0.2	25.2	3.0	4.1	4.6	5.4	9.9	4.8	0.2	7.7	0.1	2.4	15.2	0.3	0.8	0.9	0.4	2.5	2.9	4.0	1.0	0.4	2.5	4.2	1.8	3.5	2.3	0.9	1.0	6.9	1.3	4.6	5.2	0.9	27.7	4.2	5.4	5.0	5.5	1.2	1.1	3.3	11.4	130.2	32.1	53.3	519.7	11.4	368.6	507.3	127.9	114.9	15.9	79.3	38.1	139.1	27.1	78.7	18.4	2.1	40.7	4.9	24.4	37.2	59.0	129.2	35.8	5.3	111.8	32.2	5.5	636.6	115.8	50.0	33.2	28.5	55.3	93.8	19.4	70.6	42.2	5.1	8.4	489.6	18.1	40.7	6.9	33.7	127.4	41.3	9.8	48.0	78.7	2.1	55.2	4.1	165.9	108.4	70.8	27.2	32.7	13.5	355.5	14.8	93.9	57.2	4.5	39.5	15.9	31.1	14.8	9.2	211.7	399.2	137.2	21.0	14.7	16.1	676.4
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27187953	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027175: AB_1853591, HPA054273: AB_2682433"	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	5.0	3.9	1.7	6.2	1.9	18.7	5.3	2.3	2.3	3.8	2.1	4.1	4.4	3.9	4.5	5.9	3.0	3.9	2.5	1.9	2.0	3.9	4.9	4.0	8.9	2.0	2.0	3.4	3.3	6.0	3.1	6.5	2.1	3.1	5.2	2.7	4.1	3.0	2.3	6.0	4.3	4.5	1.6	4.6	4.7	6.5	2.0	10.4	4.7	2.2	7.1	4.5	4.3	2.3	29.4	22.0	43.8	15.5	6.2	9.1	25.4	43.3	18.0	68.4	83.8	26.7	27.2	22.4	16.1	18.4	33.5	26.8	27.9	16.0	48.2	20.2	26.5	26.9	14.5	15.5	3.8	10.4	19.8	5.6	7.5	41.6	7.9	9.0	14.7	18.2	21.1	49.9	41.5	17.9	34.8	11.2	32.0	15.9	8.9	22.2	71.9	18.9	17.4	10.6	19.2	26.8	26.0	17.6	19.1	28.1	17.2	21.4	12.6	17.0	36.3	44.0	37.4	5.9	10.3	34.7	18.3	31.1	14.8	0.2	1.8	1.7	0.7	1.7	1.1	1.1	0.9	0.7	1.0	1.6	0.9	0.8	2.3	1.0	1.8	1.1	1.6	0.8	1.7	1.9	2.3	2.3	1.9	2.0	2.0	2.0	2.1	1.6	2.0	2.3	4.3	6.4	7.8	2.6	7.4	11.0	4.9	4.4	4.0	1.7	4.2	4.8	3.0	2.8	7.0	1.8	0.0	8.6	10.1	7.0	0.0	4.0	3.0	9.7	5.3	4.6	4.2	7.8	4.3	2.5	24.9	7.3	6.1	17.9	12.7	6.9	2.5	2.5	5.8	3.3	4.3	3.7	4.1	7.8	19.3	1.7	3.1	11.3	0.0	3.7	5.1	1.8	3.1	3.5	4.9	4.4	2.9	2.6	7.1	5.0	2.8	1.9	4.0	1.0	0.0	3.8	5.3	14.9	14.1	10.9	9.9	6.2	11.6	5.4	4.5	6.6
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539168-85545281	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 874.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	270.4	277.5	184.1	153.2	226.7	98.3	136.1	199.3	235.9	173.0	152.6	193.2	141.4	165.5	236.0	166.2	200.1	209.5	189.6	191.5	207.3	203.6	115.7	168.5	121.8	226.8	219.3	211.0	874.7	165.8	284.1	122.3	208.0	196.2	146.5	248.7	137.7	120.0	278.9	141.1	155.6	127.2	194.4	116.7	225.5	132.3	219.2	102.1	388.8	112.0	127.7	262.9	168.2	289.7	175.3	253.0	290.4	181.6	195.3	236.7	171.1	213.5	195.6	219.3	232.4	208.4	569.9	404.5	137.0	261.0	178.9	264.3	369.6	318.6	279.8	207.0	271.0	242.5	408.7	181.9	355.6	364.3	259.7	215.9	315.8	237.4	164.1	278.1	211.5	230.7	277.9	309.0	505.1	149.5	334.4	398.2	193.5	148.7	320.8	350.3	275.0	264.2	328.9	271.2	227.9	209.6	193.2	183.4	354.6	145.9	156.0	192.3	207.7	267.4	160.9	149.3	260.5	189.0	161.4	290.6	175.0	447.3	143.8	9.1	24.7	8.2	22.3	26.9	32.7	19.8	25.2	23.7	23.6	18.9	23.1	20.5	2.5	27.3	22.3	16.6	24.2	24.9	184.1	226.7	199.3	235.9	191.5	207.3	226.8	219.3	208.0	194.4	219.2	289.7	150.5	48.1	83.6	122.4	104.2	143.5	217.1	47.1	206.1	73.5	116.3	134.6	6.5	82.9	57.6	71.7	68.8	36.2	126.3	60.6	19.6	59.2	75.2	28.8	49.2	83.6	83.3	87.1	56.1	58.5	40.6	121.9	106.0	47.4	84.4	83.3	45.0	44.6	67.4	26.9	60.4	65.1	26.4	118.8	141.9	25.8	72.1	165.7	67.6	26.2	64.6	58.8	27.8	28.6	95.5	53.6	48.0	83.8	78.4	66.7	73.8	138.7	35.2	89.0	111.7	298.5	231.0	54.1	56.2	168.2	118.3	38.2	102.0	51.1	70.6	88.4
MATR3	"KIAA0723, MGC9105, MPD2, VCPDM"	ENSG00000015479	"Matrin 3"	P43243	5	139293674-139331677	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	RNA-binding	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 155.9;Inhibitory neurons: 160.2;Langerhans cells: 122.3;Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 162.4;Respiratory ciliated cells: 127.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB033552, HPA036564, HPA036565"	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		260000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623"	"unprognostic (9.33e-2)"	"unprognostic (6.57e-2)"	"unprognostic (8.37e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.86e-2)"	"unprognostic (7.90e-2)"	112.9	127.9	145.2	93.6	156.1	323.5	161.0	172.2	224.5	144.1	109.6	106.3	76.9	166.6	124.0	103.3	131.1	115.3	111.4	158.4	146.1	150.1	112.9	115.2	157.9	126.2	132.1	199.3	102.8	168.6	95.1	122.9	131.4	130.2	106.5	223.4	93.5	133.2	119.6	82.0	90.0	142.4	144.8	124.5	89.1	114.9	139.3	221.7	190.5	114.0	170.2	133.5	91.2	156.3	209.0	191.1	559.5	260.7	192.4	212.5	283.2	172.2	300.9	300.4	347.5	273.1	208.8	351.2	236.8	244.1	284.8	135.8	376.8	269.6	403.0	278.4	189.1	236.5	205.0	285.0	183.2	262.5	174.4	222.5	203.7	247.4	226.3	247.1	296.1	219.4	216.9	170.3	313.8	186.7	496.0	285.8	303.6	205.2	182.6	304.7	416.4	217.8	278.0	316.5	279.5	348.7	248.3	176.7	264.6	426.3	194.4	254.5	192.2	272.0	177.7	180.6	246.3	171.0	300.4	423.0	189.8	226.5	268.0	187.0	71.2	116.3	109.6	82.2	134.8	116.3	114.3	124.6	92.6	97.7	124.4	116.5	34.7	150.9	106.7	50.7	136.1	159.8	145.2	156.1	172.2	224.5	158.4	146.1	126.2	132.1	131.4	144.8	139.3	156.3	0.1	44.8	50.2	83.6	17.6	114.6	0.8	99.2	15.9	1.8	0.3	0.3	0.7	0.0	92.0	0.0	2.1	1.2	0.0	27.6	0.0	0.0	0.3	0.2	0.2	13.6	83.5	15.5	155.9	0.0	1.0	17.5	5.1	0.4	100.3	0.1	0.0	0.0	1.3	1.7	160.2	35.3	87.5	0.0	122.3	0.6	0.6	4.7	103.2	60.9	0.1	0.7	0.0	117.6	162.4	0.1	12.4	0.7	7.3	0.7	0.8	0.2	127.9	1.3	0.0	1.0	33.3	1.1	0.5	15.1	111.2	0.8	21.8	0.5	41.9	1.0
MATR3		ENSG00000280987	"Matrin 3"		5	139273752-139331671	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA036564, HPA036565"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA036564: AB_10669907, HPA036565: AB_10673623"	"unprognostic (3.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.69e-9)"	"unprognostic (1.10e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.91e-10)"	"unprognostic (2.91e-2)"	"unprognostic (9.21e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.89e-2)"	10.5	13.5	14.6	24.4	14.6	25.1	31.1	9.9	24.5	9.7	5.5	22.4	16.2	15.3	34.0	17.8	19.2	9.6	30.6	15.4	12.9	10.2	9.7	8.4	36.1	18.4	10.9	14.3	7.5	8.3	2.2	10.3	18.8	15.5	29.3	11.8	26.4	8.6	41.2	20.4	12.1	14.8	13.9	19.9	17.7	18.6	13.5	17.4	9.7	38.4	33.7	14.7	2.8	21.2	81.0	58.9	30.2	162.9	65.9	79.7	58.6	42.8	36.4	69.4	87.0	101.7	71.7	284.8	60.7	61.2	45.0	91.2	257.9	136.3	120.5	48.7	125.6	190.2	100.3	89.8	57.6	176.9	67.9	93.7	95.4	79.6	90.7	38.6	78.9	103.7	143.2	50.3	74.0	31.7	98.5	53.4	122.7	35.4	38.8	199.0	92.8	125.1	40.3	55.7	92.6	56.5	49.4	60.7	113.6	77.3	57.0	71.1	56.3	52.8	78.5	43.7	63.7	23.3	33.6	153.2	45.8	148.1	61.6	0.1	0.8	0.1	0.5	1.2	1.3	3.4	1.7	2.4	3.2	2.0	2.6	1.7	0.2	0.9	0.4	0.1	1.4	1.2	14.6	14.6	9.9	24.5	15.4	12.9	18.4	10.9	18.8	13.9	13.5	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MAU2	"KIAA0892, mau-2, MAU2L, MGC75361, SCC4"	ENSG00000129933	"MAU2 sister chromatid cohesion factor"	Q9Y6X3	19	19320829-19358754	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059897			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA059897: AB_2684154"	"unprognostic (3.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.57e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-3)"	"unprognostic (5.56e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	16.2	15.9	15.9	12.6	19.1	21.2	15.8	16.4	19.4	18.8	15.1	17.9	13.1	18.4	11.8	20.2	18.4	10.6	19.6	15.1	15.2	15.1	14.3	14.2	14.6	20.1	17.4	23.4	16.5	13.4	21.1	12.2	18.7	17.6	7.6	10.9	15.5	12.1	36.0	21.7	16.5	11.2	15.7	22.2	15.0	19.7	17.6	17.4	17.0	17.6	12.0	16.5	17.2	26.1	13.6	10.4	18.0	16.1	14.5	15.1	24.9	12.7	12.9	16.8	15.1	14.8	18.9	16.9	26.7	13.7	8.5	15.9	15.5	12.8	7.8	9.0	39.3	13.0	16.5	13.2	16.8	23.7	19.5	16.7	14.4	12.1	13.8	17.4	16.3	15.0	18.0	20.3	11.3	15.5	24.3	32.5	15.8	18.7	29.1	27.1	11.6	18.2	11.8	17.6	26.0	23.8	15.7	16.2	16.1	9.1	14.0	32.9	14.8	25.9	6.0	25.7	19.3	26.1	23.5	16.9	12.8	24.8	19.9	3.1	5.8	4.3	6.0	5.0	6.8	4.6	5.3	5.7	5.1	4.5	5.6	5.4	10.4	6.5	11.1	4.9	5.4	6.1	15.9	19.1	16.4	19.4	15.1	15.2	20.1	17.4	18.7	15.7	17.6	26.1	16.4	19.2	18.3	33.6	17.3	6.2	5.5	8.5	18.8	30.4	13.1	15.2	19.1	11.5	10.5	11.0	54.2	10.4	16.4	15.8	3.9	8.2	9.7	16.5	17.0	13.4	14.4	17.4	26.1	9.4	7.1	13.0	15.8	14.5	10.1	26.0	14.6	8.6	8.8	50.5	31.8	11.9	4.1	13.8	6.4	12.3	15.2	13.9	10.6	14.0	15.4	12.0	20.6	26.7	55.3	11.8	10.7	13.9	12.8	10.5	13.7	6.2	21.0	29.3	6.6	17.2	14.8	31.9	12.6	11.8	9.7	15.2	13.6	21.1	13.1	8.6
MAX	"bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8"	ENSG00000125952	"MYC associated factor X"	P61244	14	65006174-65102695	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 390.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000328, HPA003474"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB000328: AB_2281783, HPA003474: AB_1079317"	"unprognostic (4.50e-3)"	"unprognostic (1.51e-3)"	"unprognostic (4.08e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (6.03e-2)"	48.1	36.3	57.4	43.5	63.2	105.1	41.2	74.6	62.9	61.0	44.8	51.1	41.3	51.1	29.2	75.8	67.2	36.2	52.8	55.0	59.4	39.5	36.8	51.6	63.7	65.5	61.8	56.2	29.3	31.3	32.5	39.8	65.0	52.2	31.8	23.6	43.5	38.7	43.8	55.3	51.7	39.5	59.4	66.3	39.4	21.5	62.1	63.7	42.7	54.0	55.1	51.3	68.7	65.3	117.1	40.4	27.8	44.6	73.4	58.0	35.4	39.9	62.3	47.5	58.4	29.1	86.7	88.1	33.1	48.8	45.0	60.4	63.4	52.7	37.3	84.5	40.5	143.4	29.9	32.0	90.9	56.2	390.3	67.6	43.5	42.7	54.9	71.9	54.9	71.8	66.8	42.4	53.1	63.9	140.1	217.6	36.3	71.3	70.6	75.2	42.7	47.3	49.2	38.8	61.8	38.2	49.6	60.6	60.4	25.1	58.0	71.6	69.7	47.8	55.8	42.0	33.6	50.7	43.6	61.7	56.9	56.1	46.0	667.6	141.9	540.8	125.7	126.4	140.1	115.7	147.5	130.5	119.9	114.9	151.1	127.9	305.1	126.9	120.3	114.6	194.0	314.2	57.4	63.2	74.6	62.9	55.0	59.4	65.5	61.8	65.0	59.4	62.1	65.3	45.8	28.9	27.4	31.0	74.5	170.2	66.0	63.3	126.3	28.2	59.8	43.1	27.4	32.9	42.0	18.4	20.9	38.4	79.1	116.3	52.8	38.8	45.5	38.1	43.6	59.9	44.3	40.4	50.7	31.4	43.4	46.7	32.6	36.0	62.8	38.2	71.0	23.8	59.9	47.1	43.3	49.7	38.7	81.8	66.7	115.6	77.9	147.2	56.9	32.8	67.1	47.3	69.0	28.1	60.4	61.6	96.7	60.2	58.0	80.3	100.6	66.4	32.9	16.9	138.1	47.4	76.3	43.2	28.4	84.8	180.6	54.0	83.9	25.4	29.7	76.2
MAZ	"Pur-1, ZF87, Zif87, ZNF801"	ENSG00000103495	"MYC associated zinc finger protein"	P56270	16	29806106-29811164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048315, HPA059495, HPA065930"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA048315: AB_2680353, HPA059495: AB_2684039, HPA065930: AB_2685579"	"unprognostic (1.05e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (7.08e-2)"	71.0	91.7	156.7	92.1	153.0	270.3	65.5	147.4	179.9	87.4	125.2	139.4	92.7	90.1	51.4	92.6	88.6	73.6	74.4	158.9	134.8	63.6	101.2	73.2	123.9	140.4	144.6	96.7	105.4	113.3	83.0	61.8	136.6	122.9	101.0	50.8	86.2	75.4	126.2	96.3	87.7	75.8	134.8	97.8	85.5	89.9	143.9	256.0	79.5	93.1	111.2	94.4	68.4	145.2	227.2	294.8	298.8	326.9	158.4	149.6	268.4	161.0	130.6	246.0	177.4	378.5	316.5	402.4	205.2	316.9	121.6	201.3	494.2	210.9	87.5	329.9	792.4	267.7	641.3	526.2	222.1	668.7	318.8	160.7	292.1	207.2	232.5	228.7	249.4	556.7	398.5	343.3	118.3	927.1	644.8	566.3	303.7	246.1	227.6	627.9	281.3	468.5	202.3	242.2	456.1	355.1	153.8	330.1	204.6	190.5	284.3	633.7	172.8	269.8	215.4	103.6	256.1	249.3	344.4	448.5	131.9	435.4	227.9	18.1	14.7	23.9	58.8	24.0	63.6	13.5	39.1	56.5	19.4	10.2	31.6	47.3	11.9	40.1	16.4	19.9	45.8	21.3	156.7	153.0	147.4	179.9	158.9	134.8	140.4	144.6	136.6	134.8	143.9	145.2	52.1	6.4	5.4	9.4	35.3	32.9	14.7	26.7	35.3	61.6	77.8	66.9	0.3	31.5	14.5	11.0	12.5	26.8	106.7	111.5	29.4	31.6	2.5	58.5	59.0	41.0	133.3	90.3	12.8	41.9	55.6	46.3	34.7	39.6	33.0	103.1	30.7	37.7	57.5	47.1	13.0	103.6	32.6	47.8	47.8	6.6	28.0	47.6	46.2	8.4	26.4	35.6	50.4	9.5	14.2	36.3	68.5	36.9	41.6	32.8	37.8	21.9	25.6	35.1	32.9	30.1	49.1	22.2	24.5	38.6	35.5	16.7	67.5	70.9	126.8	14.9
MBD1	"CXXC3, PCM1"	ENSG00000141644	"Methyl-CpG binding domain protein 1"	Q9UIS9	18	50266882-50281774	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 97.4;Spermatocytes: 136.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009017, CAB036003, HPA068850"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121"	"unprognostic (2.12e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (5.08e-6)"	"unprognostic (5.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (7.06e-3)"	"unprognostic (7.70e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	28.5	39.8	23.9	26.2	25.9	44.2	29.1	24.8	28.2	32.3	19.3	35.7	24.8	32.1	20.5	39.2	31.6	19.6	35.7	26.7	22.2	32.5	35.7	29.9	30.2	23.1	22.0	34.8	34.5	32.4	42.8	24.6	21.1	33.0	17.7	24.0	30.5	23.5	51.0	43.4	33.7	20.4	19.5	41.0	33.6	88.1	23.1	29.6	35.4	28.6	24.2	35.3	32.2	25.6	30.9	28.6	31.5	35.9	33.2	26.9	33.9	36.2	41.4	49.2	37.7	21.6	23.9	48.5	25.8	35.3	28.8	54.4	36.3	63.4	28.4	54.7	23.2	30.6	43.8	23.1	63.9	74.8	62.1	31.5	100.4	56.2	127.2	31.1	40.9	47.4	39.3	73.8	38.3	28.5	63.3	38.9	29.8	16.1	22.7	57.8	23.3	53.2	24.4	13.8	41.5	39.5	27.0	25.5	33.2	25.4	32.4	67.4	44.7	53.0	24.1	17.3	37.2	135.8	62.2	51.6	34.3	56.8	49.0	16.0	11.2	22.7	15.3	9.7	14.6	11.6	13.5	12.9	11.2	11.4	13.8	11.4	14.5	14.3	7.8	10.2	13.8	12.6	23.9	25.9	24.8	28.2	26.7	22.2	23.1	22.0	21.1	19.5	23.1	25.6	17.7	9.6	24.6	19.6	20.1	22.7	13.9	18.2	23.3	15.1	16.5	14.5	28.1	14.3	20.5	16.5	18.8	31.1	25.0	24.5	13.7	15.7	85.1	17.1	16.1	17.6	13.1	9.7	20.4	13.8	24.2	16.5	28.1	17.3	8.8	17.7	13.9	18.1	18.7	15.2	17.3	19.5	24.4	15.8	11.1	97.4	15.5	17.5	16.0	9.4	15.7	17.4	14.4	12.1	16.4	21.1	24.5	19.2	34.6	14.4	21.3	9.7	16.9	20.3	13.1	14.8	18.9	136.0	32.5	21.6	29.3	51.4	20.0	28.1	18.6	17.0
MBD2		ENSG00000134046	"Methyl-CpG binding domain protein 2"	Q9UBB5	18	54151606-54224669	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037282, HPA067582, HPA067615"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872"	"unprognostic (4.86e-2)"	"unprognostic (7.21e-2)"	"prognostic favorable (6.49e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.19e-2)"	26.9	10.5	6.5	19.2	8.9	20.3	19.9	9.5	9.4	16.0	6.5	17.3	12.0	11.3	15.8	29.5	11.3	11.5	14.9	6.8	8.9	16.7	16.9	16.4	32.1	7.6	8.3	11.4	17.4	16.5	9.2	18.8	7.7	13.4	16.4	14.3	19.4	15.1	15.4	25.4	15.5	11.9	7.0	21.2	13.9	31.5	7.9	20.1	31.0	16.8	35.2	21.0	20.1	8.2	29.1	13.2	23.2	11.7	27.3	23.0	22.5	26.5	33.9	30.6	26.6	8.5	15.8	68.7	13.1	42.1	13.5	45.1	20.1	36.6	33.4	50.2	11.1	10.2	20.4	18.3	28.2	32.7	17.7	20.2	40.3	23.5	34.1	20.3	35.9	20.7	8.0	62.0	28.0	14.0	33.1	18.1	24.2	11.3	17.2	21.8	13.9	27.9	44.5	29.9	25.6	10.8	21.0	21.1	14.7	30.3	10.9	16.3	31.2	31.1	14.1	10.9	24.4	65.1	38.3	52.5	27.4	27.4	19.0	0.0	1.4	0.7	0.6	2.6	0.9	0.7	0.7	1.0	0.8	1.3	0.3	0.6	1.2	0.2	5.0	0.7	1.5	0.4	6.5	8.9	9.5	9.4	6.8	8.9	7.6	8.3	7.7	7.0	7.9	8.2	71.1	28.9	21.0	30.3	44.9	49.3	37.3	21.2	13.1	19.3	46.0	35.3	35.8	24.3	23.0	33.1	16.7	14.3	57.6	51.2	7.9	26.3	1.9	62.1	48.9	38.0	16.3	22.7	42.5	58.4	49.4	32.7	21.9	103.3	8.2	32.0	32.2	25.2	30.3	21.9	38.3	35.9	10.2	142.6	38.7	4.8	25.1	82.2	26.6	43.1	69.3	45.9	8.2	32.2	49.5	54.3	28.0	26.4	53.7	51.5	35.7	23.5	30.0	27.0	26.3	39.0	35.2	6.5	6.1	54.6	62.5	18.3	47.7	43.0	38.7	79.5
MBD3		ENSG00000071655	"Methyl-CpG binding domain protein 3"	O95983	19	1573596-1592865	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013265	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB013265: "	"unprognostic (1.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.44e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	40.1	46.1	12.7	7.0	11.3	12.8	36.2	18.2	16.5	41.5	7.2	45.8	7.6	46.2	7.6	42.4	40.6	6.6	60.3	13.7	9.0	45.3	59.3	38.3	9.6	12.9	11.7	48.9	32.8	7.4	50.0	9.0	10.7	54.8	6.4	4.1	30.4	7.0	74.0	40.2	34.6	7.4	10.1	49.8	39.0	43.4	12.2	9.0	45.3	4.7	9.1	41.1	33.8	13.0	26.4	56.3	22.5	34.9	21.6	15.0	20.8	20.9	13.5	21.5	19.5	44.9	15.6	49.9	12.1	26.7	7.5	35.8	37.8	23.7	13.0	41.2	36.8	24.6	77.4	27.9	17.6	28.2	24.5	20.3	23.1	35.6	17.4	14.2	25.2	25.7	55.8	34.2	17.6	56.6	32.7	30.5	29.4	12.6	25.5	31.1	23.3	21.2	14.1	50.0	64.5	36.8	25.2	18.3	12.6	12.2	23.5	21.1	20.0	28.9	15.5	65.5	42.1	31.8	39.8	38.6	21.2	37.0	27.7	0.7	0.4	0.1	0.3	0.4	0.3	0.2	0.2	0.2	0.3	0.4	0.3	0.3	0.5	0.3	0.2	0.5	0.1	0.2	12.7	11.3	18.2	16.5	13.7	9.0	12.9	11.7	10.7	10.1	12.2	13.0	21.6	12.8	24.3	14.4	10.6	10.8	8.9	9.4	5.2	22.6	23.8	20.6	20.8	12.8	11.0	11.0	14.6	46.4	17.4	48.1	5.9	15.0	3.1	9.8	20.5	19.8	14.9	14.9	8.4	26.2	42.7	20.0	18.3	16.1	3.8	48.4	24.7	42.6	27.2	18.5	9.2	26.4	14.2	32.0	10.3	8.1	22.4	16.9	5.4	15.9	17.5	40.5	14.4	10.6	12.3	19.3	16.8	25.6	9.7	14.9	20.8	19.1	4.8	11.3	39.5	21.6	18.7	9.2	10.3	11.0	12.8	121.5	10.8	36.0	40.6	8.8
MBD3L2		ENSG00000230522	"Methyl-CpG binding domain protein 3 like 2"	Q8NHZ7	19	7049321-7051735	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051259			Uncertain	Nucleoplasm,Nucleoli,Cytosol		NA	NA						"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA051259: AB_2681411"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD3L2B		ENSG00000196589	"Methyl-CpG binding domain protein 3 like 2B"	A0A1B0GVZ6	19	7018969-7021432	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051259			Uncertain	Nucleoplasm,Nucleoli,Cytosol		NA	NA							"Nucleoplasm, Nucleoli"	Cytosol	"HPA051259: AB_2681411"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD3L3		ENSG00000182315	"Methyl-CpG binding domain protein 3 like 3"	A6NE82	19	7056209-7058640	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051259			Uncertain	Nucleoplasm,Nucleoli		NA	NA						"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nucleoli"		"HPA051259: AB_2681411"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD3L4		ENSG00000205718	"Methyl-CpG binding domain protein 3 like 4"	A6NDZ8	19	7037748-7040179	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051259			Uncertain	Nucleoplasm,Nucleoli,Cytosol		NA	NA							"Nucleoplasm, Nucleoli"	Cytosol	"HPA051259: AB_2681411"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD3L5		ENSG00000237247	"Methyl-CpG binding domain protein 3 like 5"	A6NJ08	19	7030578-7033011	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051259			Uncertain	Nucleoplasm,Nucleoli,Cytosol		NA	NA						"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA051259: AB_2681411"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD5	"FLJ11113, KIAA1461"	ENSG00000204406	"Methyl-CpG binding domain protein 5"	Q9P267	2	148021011-148516971	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 317.4;Excitatory neurons: 510.1;Inhibitory neurons: 456.0;Microglial cells: 288.6;Oligodendrocyte precursor cells: 604.2;Oligodendrocytes: 438.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035964			Supported	Nucleoplasm,Midbody		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Midbody"		"HPA035964: AB_2674891"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.82e-1)"	2.5	3.2	3.7	2.2	4.3	2.0	2.3	7.2	5.1	3.1	0.5	5.2	1.8	3.2	1.6	2.6	2.2	3.2	2.8	3.9	3.1	3.4	2.0	2.3	2.4	2.2	2.2	3.7	1.7	4.1	3.8	3.0	2.1	3.0	1.9	5.7	1.8	2.5	2.8	1.9	2.3	2.7	2.0	2.6	2.7	3.1	3.3	4.2	3.4	3.0	2.2	3.7	2.2	4.1	1.1	1.1	4.4	4.1	3.5	3.6	2.9	4.0	3.9	3.1	2.3	2.8	2.9	1.9	0.9	3.4	1.7	0.8	3.1	5.1	4.1	1.6	1.6	3.5	2.8	1.5	2.0	0.6	0.6	2.9	4.1	4.5	3.3	5.0	4.1	2.7	1.9	3.6	4.8	2.7	1.5	2.7	2.2	2.5	1.7	1.6	1.2	0.8	3.2	3.8	2.9	3.5	3.2	1.6	3.0	3.2	2.3	3.4	2.8	3.7	1.8	0.6	1.9	2.4	1.1	1.5	4.8	1.6	3.6	0.8	0.1	0.5	0.3	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.4	0.2	0.2	0.3	0.3	0.1	0.1	3.7	4.3	7.2	5.1	3.9	3.1	2.2	2.2	2.1	2.0	3.3	4.1	27.3	16.0	13.7	317.4	23.4	3.8	11.9	4.1	10.8	24.7	16.5	15.0	10.5	11.5	14.8	12.9	37.5	7.3	23.8	5.0	3.9	18.6	94.5	14.8	25.8	15.2	11.5	36.6	510.1	15.7	9.8	15.5	12.2	18.0	3.8	35.9	15.0	8.4	7.0	13.5	456.0	4.9	6.1	16.9	3.3	37.6	18.0	15.1	0.0	288.6	13.6	8.1	24.7	604.2	438.3	20.4	4.6	10.5	22.8	7.8	9.4	14.0	8.5	17.4	6.6	16.5	16.8	15.7	9.4	10.4	3.3	8.5	27.7	23.7	5.8	12.6
MBD6	KIAA1887	ENSG00000166987	"Methyl-CpG binding domain protein 6"	Q96DN6	12	57520710-57530148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in all"		"RH-30: 116.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038948, HPA038949"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA038948: AB_2676285, HPA038949: AB_10671868"	"unprognostic (2.56e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.01e-2)"	32.8	40.0	18.7	34.5	22.1	57.1	36.5	19.5	21.3	43.3	21.9	38.8	41.6	46.9	17.9	35.8	40.7	19.1	25.8	17.7	22.8	38.8	44.2	34.4	26.1	24.1	20.8	43.8	44.5	23.0	105.0	25.6	20.0	38.6	20.7	38.5	46.9	27.1	34.1	37.8	44.9	19.8	17.2	64.9	42.6	57.5	25.0	27.9	110.2	18.8	18.8	34.3	35.0	26.8	22.7	31.7	24.2	26.0	16.6	11.9	33.9	25.7	15.8	16.6	12.3	33.0	35.3	22.8	19.3	14.0	16.2	31.3	22.3	19.4	11.6	45.2	22.5	40.2	33.4	22.8	20.3	24.2	99.7	20.8	33.7	17.8	24.8	25.1	22.3	19.3	26.1	58.7	13.5	23.3	25.3	23.9	23.3	16.7	23.2	24.6	116.7	17.7	14.3	44.4	33.3	20.2	20.5	40.6	25.0	14.2	45.7	38.7	21.9	17.8	29.0	18.2	17.4	60.5	22.4	15.7	23.2	15.1	30.6	0.0	1.0	0.4	1.3	0.9	0.5	1.3	0.2	0.4	0.5	0.8	0.5	0.5	13.6	0.7	0.4	0.3	0.2	0.6	18.7	22.1	19.5	21.3	17.7	22.8	24.1	20.8	20.0	17.2	25.0	26.8	24.7	6.4	17.8	12.4	14.1	11.0	13.4	11.9	22.2	55.5	27.5	22.4	6.2	25.8	13.0	9.2	27.1	12.4	12.6	20.6	5.9	9.4	13.3	18.9	19.7	16.7	15.6	18.7	5.4	12.0	8.8	12.2	29.0	32.8	19.0	21.7	14.6	24.3	14.0	25.2	6.6	20.5	8.2	23.8	11.0	9.4	14.6	23.1	12.4	15.0	9.1	30.4	11.3	6.6	8.1	9.2	20.7	12.8	14.8	12.3	20.8	4.4	16.3	69.4	19.7	14.9	17.3	51.7	30.8	23.7	12.4	22.6	16.8	16.9	16.8	15.8
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298564-36320637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 316.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 30.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	16.2	19.4	17.4	12.1	18.5	35.1	24.9	20.7	22.0	27.9	17.9	17.0	16.9	26.6	21.3	16.5	16.5	16.5	14.2	16.7	19.7	26.2	29.0	76.7	17.4	15.9	17.5	32.2	17.6	19.7	22.4	19.1	16.4	18.5	22.2	22.3	15.9	16.3	7.2	28.5	17.3	20.2	17.2	15.6	31.2	18.2	20.0	17.9	81.7	9.3	16.0	15.2	13.5	21.4	29.6	15.4	31.7	32.1	31.3	30.0	24.1	24.8	30.7	32.2	33.6	31.2	28.9	28.0	36.8	32.1	16.8	22.1	33.7	22.9	39.3	40.5	25.5	16.4	14.7	55.0	33.9	33.8	17.5	30.8	35.1	21.1	27.2	33.2	20.4	38.3	28.4	33.8	24.2	28.8	32.5	27.7	26.9	25.2	44.6	15.4	27.7	19.5	37.2	22.7	47.3	18.8	20.4	19.5	33.4	27.3	31.9	21.6	16.0	35.6	23.2	26.3	26.0	27.8	34.5	44.0	13.6	17.3	25.3	2.0	12.6	3.0	14.6	9.9	18.5	16.4	17.6	18.0	12.8	12.3	22.6	18.5	7.0	12.9	8.1	14.5	23.6	13.3	17.4	18.5	20.7	22.0	16.7	19.7	15.9	17.5	16.4	17.2	20.0	21.4	16.0	218.0	316.0	18.3	14.9	90.2	30.7	41.5	22.2	24.9	15.3	23.0	10.7	10.0	106.7	25.8	2.1	24.7	12.2	16.1	58.7	21.2	4.2	20.9	28.2	18.3	31.5	9.7	21.2	19.0	21.1	29.7	13.3	35.6	13.3	30.2	16.1	25.2	18.7	92.5	24.8	15.5	20.3	9.5	15.4	4.2	32.0	14.5	21.4	9.4	11.5	29.0	12.3	31.7	27.0	17.8	18.6	27.1	18.9	29.0	18.9	49.6	34.9	24.1	13.1	18.0	27.8	50.1	35.5	17.9	65.5	19.8	20.6	25.5	21.1	21.4
MBLAC2	"DKFZp686P15118, MGC46734"	ENSG00000176055	"Metallo-beta-lactamase domain containing 2"	Q68D91	5	90458209-90474771	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037757, HPA037758"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA037757: AB_10670528, HPA037758: "	"unprognostic (6.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.96e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-2)"	2.6	3.8	4.3	3.3	4.4	1.5	5.2	4.7	5.9	4.4	1.2	3.1	3.3	5.1	3.3	3.8	3.8	2.4	2.8	4.6	4.8	5.0	6.3	2.3	4.2	3.0	5.1	8.6	3.1	8.1	2.4	2.9	3.5	4.5	3.2	3.4	4.6	3.9	2.3	5.2	3.0	3.7	3.3	3.8	2.6	3.1	6.4	4.3	5.2	2.2	3.9	2.5	2.9	4.7	6.4	2.7	4.6	5.9	6.0	8.0	5.6	5.0	4.5	4.2	4.4	2.1	4.7	14.9	2.9	4.4	5.8	6.4	6.0	7.5	6.6	8.5	4.1	6.7	4.6	4.8	6.3	6.7	2.8	7.0	9.9	3.0	11.6	4.9	5.4	7.9	10.2	8.0	7.2	3.9	6.5	9.1	3.0	1.3	13.1	6.9	7.7	20.5	6.3	2.3	7.9	9.3	4.5	6.5	12.1	2.7	5.4	4.9	6.7	5.2	3.6	6.4	6.5	5.6	6.8	6.5	4.5	13.8	7.2	0.0	0.7	0.5	1.4	1.8	1.6	1.3	1.5	1.5	1.3	2.4	2.0	1.6	0.0	1.6	0.9	0.4	0.6	1.1	4.3	4.4	4.7	5.9	4.6	4.8	3.0	5.1	3.5	3.3	6.4	4.7	3.8	3.2	3.6	2.9	4.7	2.7	1.2	2.8	8.6	8.1	4.6	5.0	4.9	2.8	1.7	1.8	8.4	3.9	3.9	1.9	1.9	1.6	0.3	2.0	5.0	4.2	4.2	6.3	14.4	1.3	3.1	3.5	3.1	2.0	0.0	5.3	3.6	5.8	2.6	3.3	16.4	2.9	4.1	5.1	1.0	0.6	4.1	2.1	1.8	6.5	2.1	5.5	3.1	8.5	15.6	1.8	1.8	5.3	2.1	1.2	3.0	5.5	2.4	6.7	0.0	4.3	4.9	2.5	6.1	7.3	3.3	0.8	3.7	12.6	3.9	0.7
MBNL1	"EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL"	ENSG00000152601	"Muscleblind like splicing regulator 1"	Q9NR56	3	152243828-152465780	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 537.7;Oligodendrocytes: 471.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016398, HPA035098"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB016398: AB_784435, HPA035098: AB_2674461"	"unprognostic (5.46e-3)"	"unprognostic (6.01e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (9.49e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (7.53e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.98e-1)"	116.4	35.8	18.2	105.0	24.9	90.4	48.1	22.9	22.3	76.9	18.9	69.0	43.6	68.0	30.1	65.3	38.4	75.2	63.2	18.7	23.0	31.5	47.6	78.1	138.4	25.5	20.1	45.1	24.3	26.5	11.8	29.9	26.0	55.1	71.1	17.7	32.3	66.0	188.8	61.5	58.3	116.5	25.0	92.3	40.5	14.9	25.2	108.4	31.8	131.0	135.1	78.4	32.7	32.5	133.8	107.8	17.3	38.9	132.5	135.8	12.7	163.3	131.5	105.6	87.8	48.0	76.3	136.3	81.3	230.8	32.8	59.7	32.1	94.5	155.0	106.9	43.7	149.3	52.2	22.7	73.8	180.5	104.5	63.8	50.2	121.9	94.0	80.8	219.5	54.1	77.3	180.5	103.6	45.9	169.0	66.0	7.2	38.9	85.4	170.5	53.0	171.6	53.7	66.3	13.8	15.7	71.1	38.2	69.8	6.2	53.1	270.5	186.6	143.6	55.1	96.4	142.7	186.9	115.9	154.6	83.8	220.6	79.1	95.3	53.7	90.1	79.4	61.7	84.4	56.2	64.5	66.5	70.1	49.7	80.6	70.7	78.4	79.6	54.7	24.9	62.6	104.3	18.2	24.9	22.9	22.3	18.7	23.0	25.5	20.1	26.0	25.0	25.2	32.5	175.5	150.6	193.7	179.2	252.1	213.6	49.0	25.9	156.0	28.5	51.8	48.0	179.8	52.9	89.5	38.6	64.6	26.1	266.0	164.7	21.5	36.0	2.6	64.0	92.2	142.9	47.3	160.2	258.6	63.6	9.2	122.9	78.0	68.5	162.6	31.5	90.0	91.5	60.9	32.0	185.5	68.8	14.2	216.4	195.5	9.7	89.5	235.0	103.2	537.7	249.4	18.2	230.7	224.7	471.9	57.3	90.3	71.5	181.3	61.2	121.4	42.2	63.1	84.1	98.6	102.7	145.6	4.3	12.7	149.4	243.6	14.8	340.1	46.8	80.7	50.1
MBNL2	"MBLL, MBLL39"	ENSG00000139793	"Muscleblind like splicing regulator 2"	Q5VZF2	13	97221434-97394120	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 325.5;Oligodendrocytes: 702.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062685			Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA062685: AB_2684834"	"unprognostic (8.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.17e-2)"	64.4	64.6	34.6	20.7	52.0	8.5	35.1	51.4	58.5	38.7	18.3	31.8	21.1	35.0	16.0	38.2	21.7	44.8	36.8	32.9	38.6	36.9	94.9	29.6	20.8	47.5	46.6	59.3	46.4	25.8	23.8	52.6	49.0	31.9	24.5	50.1	41.4	38.4	41.6	18.9	19.1	41.5	45.2	19.8	30.5	14.4	42.2	24.2	36.6	87.9	24.2	34.9	24.5	80.6	34.7	12.1	13.5	13.7	68.9	36.1	1.3	77.8	38.4	34.8	35.3	14.8	49.8	11.7	31.4	106.3	39.5	48.6	6.1	34.1	44.6	31.2	5.9	14.2	26.4	34.7	101.7	1.6	12.4	37.9	56.7	28.6	54.7	39.5	67.4	15.5	18.1	6.0	17.6	9.2	8.2	4.9	0.4	4.2	20.2	3.8	27.9	9.8	46.2	41.1	17.3	28.7	45.0	44.6	76.2	30.3	18.9	2.0	21.1	5.2	16.1	9.7	16.2	16.0	4.3	3.1	33.1	4.0	93.2	15.0	5.4	8.0	8.1	7.1	10.3	7.6	7.3	7.4	5.7	6.2	6.3	8.6	0.8	4.9	5.4	4.7	8.3	6.2	34.6	52.0	51.4	58.5	32.9	38.6	47.5	46.6	49.0	45.2	42.2	80.6	153.8	83.3	45.1	148.9	52.3	70.2	27.4	15.7	129.1	23.7	50.7	49.9	69.8	50.1	40.1	29.5	47.9	25.3	31.6	22.6	19.6	26.6	3.1	59.1	113.8	66.6	48.6	24.8	325.5	42.7	78.0	75.7	83.6	50.0	17.7	40.5	45.3	78.8	14.4	47.1	108.3	29.0	8.2	32.1	30.6	9.1	70.5	31.2	56.9	144.3	19.5	84.8	18.6	144.3	702.4	54.0	14.5	44.8	169.1	22.3	16.3	40.1	54.5	112.6	46.0	29.9	80.8	1.1	1.0	54.2	48.6	25.0	40.8	28.2	17.9	30.3
MBTD1	"FLJ20055, SA49P01"	ENSG00000011258	"Mbt domain containing 1"	Q05BQ5	17	51177425-51260163	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021876	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA021876: AB_2140367"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-3)"	7.2	5.3	4.9	5.4	6.0	10.8	11.4	8.2	6.9	8.6	4.6	7.1	7.9	8.5	7.7	7.2	7.0	5.0	4.5	4.9	5.3	6.1	9.8	6.1	8.7	5.3	5.2	11.8	8.6	5.7	5.5	8.6	5.4	6.8	7.8	10.0	6.9	4.8	6.3	14.4	8.1	5.6	5.1	8.7	8.3	25.4	5.1	14.4	8.3	6.8	7.9	6.9	8.3	7.1	6.6	6.1	32.0	12.9	7.5	8.8	16.7	5.0	6.2	5.3	6.4	7.2	8.3	25.7	11.5	3.8	3.9	6.3	14.8	3.7	9.8	7.4	13.4	26.7	7.5	11.1	5.0	18.0	7.7	7.5	7.0	4.0	7.2	10.5	9.4	22.3	21.0	6.3	4.3	6.7	24.8	18.8	18.1	14.0	5.5	28.4	19.3	12.9	8.0	12.4	20.1	30.7	4.5	8.6	10.7	26.6	12.2	35.0	5.7	5.7	5.8	4.2	5.4	15.4	10.5	22.8	3.4	11.8	3.3	2.6	0.1	0.7	0.2	0.1	0.0	0.4	0.2	0.1	0.2	0.2	0.1	0.2	0.3	0.1	0.1	0.3	0.3	0.0	4.9	6.0	8.2	6.9	4.9	5.3	5.3	5.2	5.4	5.1	5.1	7.1	11.2	16.0	15.0	47.7	10.3	17.2	6.5	5.4	17.1	9.0	14.7	11.7	7.3	17.2	7.1	7.3	16.7	7.9	9.6	7.8	1.9	5.4	51.6	11.8	15.0	11.3	13.8	17.7	61.5	5.1	5.1	10.8	17.9	16.0	5.1	18.8	10.4	12.8	5.8	10.1	59.9	13.5	6.1	12.3	8.5	12.4	14.6	11.5	10.6	56.2	16.4	4.1	11.3	78.4	94.9	6.4	9.0	10.5	5.1	10.8	10.1	4.6	6.2	12.0	0.0	10.2	13.0	47.8	19.2	10.5	22.0	8.6	8.6	15.6	12.1	9.7
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839617-21885423	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease variant, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	8.6	10.6	3.5	5.2	4.0	1.7	8.8	7.8	4.9	7.5	4.5	5.1	5.2	9.7	6.0	5.8	7.3	6.7	7.7	3.7	4.1	9.4	18.7	5.5	5.0	4.4	4.1	12.5	7.3	11.0	3.8	11.6	4.9	10.5	6.0	8.8	6.6	8.5	7.1	3.7	4.2	10.1	4.1	4.8	5.8	4.1	4.2	4.9	9.0	9.1	4.7	6.8	4.0	6.1	16.9	34.5	16.1	16.5	19.8	24.4	7.7	24.4	24.7	22.7	19.7	13.8	22.5	14.6	12.4	26.2	44.4	15.4	22.4	14.0	27.9	10.9	17.8	7.2	19.7	11.4	27.1	15.6	6.8	23.2	14.8	34.3	25.1	23.0	17.8	8.4	20.3	15.8	26.1	10.5	6.4	8.1	15.0	8.8	25.1	7.9	29.8	16.4	15.7	8.4	3.9	32.8	34.3	21.5	30.5	21.3	28.9	13.2	21.2	28.4	6.6	41.9	18.5	19.1	26.0	6.9	31.6	6.4	28.0	0.0	2.2	0.8	2.2	2.5	2.0	1.9	1.6	2.0	3.6	1.7	2.2	2.6	0.2	2.6	2.6	2.4	3.2	1.7	3.5	4.0	7.8	4.9	3.7	4.1	4.4	4.1	4.9	4.1	4.2	6.1	5.5	9.6	11.5	16.6	5.8	5.5	4.8	7.0	8.0	11.8	7.5	5.1	13.3	8.6	7.1	7.3	18.8	7.0	2.2	3.8	0.0	5.9	0.3	4.0	11.5	5.6	2.4	2.1	16.8	8.9	7.1	10.8	6.1	3.7	10.8	14.5	7.5	18.7	9.4	30.3	25.0	3.4	12.2	9.2	4.0	1.9	10.5	4.8	10.6	11.2	5.0	7.3	3.1	21.6	22.2	6.1	2.4	13.2	9.1	7.4	4.9	7.2	10.7	14.5	0.0	8.6	8.3	2.7	1.5	6.5	2.7	4.8	5.1	12.3	4.3	4.9
MCC		ENSG00000171444	"MCC regulator of WNT signaling pathway"	P23508	5	113022099-113488823	"Predicted intracellular proteins"	"Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 70.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.7;Bipolar cells: 115.5;Inhibitory neurons: 128.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 52.9;hTCEpi: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037390, HPA037391"	Approved	Approved	Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"	"Cytoplasmic bodies"	"HPA037390: AB_2675451, HPA037391: AB_10671248"	"unprognostic (6.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.70e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.90e-1)"	10.0	2.9	8.2	4.8	11.6	0.4	8.4	12.4	8.8	18.1	1.7	3.7	2.3	12.1	5.1	12.8	12.1	5.0	12.7	6.4	15.0	5.2	18.9	6.2	4.6	15.7	24.5	70.6	3.1	32.9	3.1	10.7	11.0	10.3	3.1	14.6	7.9	12.8	8.3	20.8	2.9	9.1	11.6	5.0	4.9	3.5	18.9	4.7	4.3	6.3	6.4	12.4	11.9	8.2	0.8	0.2	13.5	1.0	10.9	9.8	12.8	2.2	5.7	2.4	2.8	0.5	12.5	0.1	14.3	1.0	6.6	15.7	8.2	52.9	1.2	4.6	5.0	0.1	4.9	3.6	3.3	0.7	0.3	12.9	34.5	6.7	24.2	12.4	16.0	1.6	0.1	20.3	5.2	1.0	0.2	0.3	7.3	0.0	1.0	0.2	11.8	3.5	0.2	30.7	5.7	12.8	11.2	0.1	29.8	4.6	3.7	0.1	19.3	8.7	7.9	14.5	4.3	5.9	0.1	0.0	24.6	0.1	9.7	0.0	0.1	0.0	0.2	0.1	0.6	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.5	0.0	0.0	2.7	0.7	0.0	8.2	11.6	12.4	8.8	6.4	15.0	15.7	24.5	11.0	11.6	18.9	8.2	50.2	0.0	1.1	170.7	1.8	37.6	27.3	27.3	23.9	115.5	11.7	8.8	16.8	11.5	10.4	3.7	56.3	0.8	8.5	0.2	0.0	3.5	12.5	11.5	50.1	32.1	4.8	0.0	29.5	1.4	2.4	30.2	4.1	25.4	0.0	22.9	24.7	56.9	2.3	37.0	128.7	0.2	12.2	2.9	12.3	34.3	21.1	2.2	16.0	72.1	3.2	7.1	3.1	34.7	13.2	4.6	1.3	27.1	5.4	8.5	0.0	2.2	7.1	9.2	0.0	22.0	13.1	7.9	9.3	33.4	47.2	1.2	8.0	24.9	0.5	16.0
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161558-13211110	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.2;lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	1.2	0.1	0.0	3.3	0.1	9.2	0.8	0.1	0.2	0.4	0.1	1.7	1.5	0.4	0.1	1.9	0.2	0.2	0.1	0.0	0.0	0.1	0.7	0.3	4.8	0.0	0.1	0.2	0.1	0.2	0.1	2.1	0.1	0.1	2.2	0.1	0.3	0.0	0.5	1.1	1.2	0.8	0.0	1.0	0.8	1.5	0.2	8.1	0.3	0.1	4.5	0.6	0.6	0.1	38.0	42.0	48.6	36.9	1.6	2.9	21.2	38.7	5.9	42.7	44.0	41.3	26.4	56.7	17.1	9.9	15.7	43.3	69.0	22.8	39.2	29.7	32.9	70.9	17.6	27.7	0.0	36.6	30.8	0.6	0.8	43.3	4.0	3.5	14.0	45.0	85.2	37.6	23.4	34.0	87.7	15.7	28.9	36.3	10.3	68.3	43.0	34.6	9.8	13.7	9.7	36.6	31.3	22.0	5.9	25.2	27.7	24.9	8.6	27.0	50.3	41.0	42.4	11.7	49.0	74.3	17.2	39.6	21.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.9	0.3	0.1	0.1	0.7	0.4	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	1.7	0.0	0.0	0.0	1.8	1.7	0.4	0.8	0.0	0.0	0.8	0.5	2.4	0.0	0.8	0.0	0.0	11.8	0.8	2.4	0.0	0.4	1.0	0.3	1.2	1.4	0.0	23.5	0.4	0.2	20.9	1.8	1.1	1.0	0.0	7.2	0.0	0.2	5.3	0.0	0.4	1.2	2.0	0.6	0.4	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.4	15.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	6.4	15.8	12.9	3.6	0.4	3.4	1.2	0.8	3.1	0.4
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264014-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 122.7;Erythroid cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		150000	"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	24.3	15.9	12.8	41.5	13.6	55.5	29.1	13.7	13.7	27.5	13.4	32.9	19.6	30.8	23.8	33.4	29.2	16.4	25.4	11.9	12.7	27.5	18.8	21.4	68.8	14.1	13.6	31.9	17.0	28.9	10.8	40.0	14.1	19.7	39.3	19.3	19.2	30.7	16.0	32.2	29.3	37.0	14.5	31.3	24.1	21.1	14.0	81.1	18.3	17.7	78.5	28.1	24.5	13.9	187.9	121.7	208.0	196.9	43.9	39.4	136.1	135.8	103.7	226.6	230.3	251.6	99.2	202.8	132.5	79.7	147.8	145.4	277.4	165.9	226.9	230.0	261.4	383.6	233.2	358.2	11.8	381.7	150.8	23.7	38.1	166.6	46.2	55.6	117.3	240.4	318.1	452.9	118.3	123.8	386.9	293.5	173.1	369.8	84.8	338.3	317.0	271.2	101.1	195.8	210.3	160.5	142.2	81.1	125.3	289.4	159.7	266.9	60.5	153.5	163.6	160.8	206.4	132.9	163.5	356.4	132.2	323.8	184.0	30.5	18.3	27.3	50.0	31.3	42.8	47.7	49.9	50.3	30.0	41.2	47.6	51.2	2.6	55.0	18.3	19.0	71.6	46.9	12.8	13.6	13.7	13.7	11.9	12.7	14.1	13.6	14.1	14.5	14.0	13.9	24.3	22.4	12.3	3.3	26.4	19.2	20.0	24.9	12.5	16.1	14.1	17.1	19.9	7.2	19.2	22.0	4.2	122.7	18.6	10.9	13.7	30.9	1.1	9.6	16.7	30.9	7.3	92.6	2.5	20.2	63.6	22.3	15.8	15.1	37.4	48.3	15.0	10.5	36.0	0.0	2.1	20.4	8.2	10.1	7.5	3.6	27.1	12.1	7.2	8.4	12.5	17.8	34.0	2.5	6.1	17.3	10.5	21.1	37.6	10.9	7.3	7.5	17.0	16.0	6.6	16.8	27.9	22.5	64.0	24.5	10.1	27.4	26.0	19.0	37.1	13.9
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235133-46286297	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	16.8	12.0	10.0	20.3	11.5	19.7	13.6	8.9	10.7	14.7	17.0	15.1	14.0	16.5	8.3	14.3	15.2	14.2	15.1	8.5	7.8	13.0	9.7	16.0	21.0	10.8	10.4	17.6	15.4	16.9	9.2	16.3	9.5	14.2	15.0	12.8	13.7	13.4	41.3	13.8	16.1	17.1	9.4	19.6	15.4	14.1	11.0	21.7	16.0	28.7	21.5	13.6	11.2	14.6	38.0	36.3	41.8	45.5	33.1	41.4	38.0	40.8	48.1	37.1	30.2	33.1	21.9	53.6	32.9	43.2	40.3	21.9	55.9	34.0	32.7	55.7	50.8	87.9	35.0	25.9	29.6	40.6	47.7	31.7	28.7	51.2	35.2	25.4	40.7	31.7	107.3	39.6	43.3	21.1	43.5	26.8	72.3	40.0	30.2	56.3	26.6	48.9	17.8	34.1	35.2	37.6	52.4	33.7	39.0	31.5	46.0	41.2	51.6	39.1	29.7	33.1	31.0	71.8	86.2	33.0	35.3	38.0	51.8	0.6	2.0	1.6	2.3	1.9	2.4	1.1	1.3	2.6	1.9	1.6	1.2	1.3	1.2	1.1	1.1	1.6	1.8	2.1	10.0	11.5	8.9	10.7	8.5	7.8	10.8	10.4	9.5	9.4	11.0	14.6	17.3	9.6	18.9	28.1	21.3	7.0	7.1	9.0	22.2	21.8	13.8	13.0	4.7	14.3	12.7	11.0	20.9	11.4	20.6	17.5	1.9	11.3	3.5	16.8	23.7	14.8	12.0	18.5	28.0	14.2	11.7	12.8	27.0	17.7	8.8	20.1	11.7	18.6	15.4	16.8	34.2	19.2	10.2	19.7	8.4	4.3	18.3	18.6	10.6	34.7	24.3	9.3	16.5	37.2	35.3	15.9	8.6	14.3	21.6	14.0	13.8	6.6	15.5	21.7	19.7	17.9	12.9	19.7	15.0	21.2	10.4	9.3	19.1	16.0	17.9	7.9
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 153.2;Erythroid cells: 60.8;Late spermatids: 77.9;Spermatocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	6.5	8.8	4.8	21.7	4.8	63.2	16.0	5.7	5.2	7.7	1.8	17.7	13.3	6.9	4.6	22.4	9.7	5.6	14.5	5.2	3.5	8.2	9.2	6.3	38.7	3.6	4.2	7.1	5.5	7.7	4.1	18.3	3.9	5.6	21.3	12.3	8.8	4.9	13.4	24.2	16.7	9.2	4.2	8.1	10.6	41.6	4.8	47.0	6.5	15.8	41.8	11.8	10.9	5.2	184.0	139.6	188.1	83.2	20.7	36.6	102.8	122.6	99.8	178.5	190.3	156.6	181.1	229.8	70.3	72.1	119.2	143.2	278.7	128.2	199.8	64.2	190.4	371.8	133.3	169.2	5.4	189.7	82.0	20.3	24.1	147.8	54.3	28.6	72.0	136.8	216.2	167.0	129.9	155.6	435.5	141.5	241.2	246.5	54.2	266.6	159.6	139.2	64.9	168.1	209.0	97.8	325.6	133.6	46.3	117.7	154.9	110.5	45.1	138.1	125.4	144.5	131.9	54.7	104.6	347.2	114.8	185.7	131.5	2.3	1.8	1.1	4.0	3.1	2.0	3.9	3.8	5.4	3.9	1.6	3.3	2.7	0.1	4.1	3.5	1.5	10.2	3.6	4.8	4.8	5.7	5.2	5.2	3.5	3.6	4.2	3.9	4.2	4.8	5.2	3.3	0.0	6.3	3.3	6.5	21.7	11.1	9.0	13.6	12.2	9.0	7.7	25.1	1.5	8.4	5.5	10.4	36.7	5.8	12.1	3.9	8.0	153.2	11.0	7.9	6.7	6.7	60.8	5.0	6.0	40.2	10.6	11.2	13.4	1.3	24.9	2.2	3.2	12.3	16.8	5.7	13.9	4.1	2.9	6.5	77.9	5.3	7.9	3.6	1.9	2.4	7.0	3.1	4.0	2.9	4.5	4.8	3.0	22.3	7.7	5.6	3.0	13.1	16.7	0.0	9.5	11.4	65.8	39.9	19.1	19.0	29.8	9.0	11.7	26.2	9.7
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400134-35425431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.8;Erythroid cells: 96.6;monocytes: 137.7;Syncytiotrophoblasts: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		44000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	15.2	7.1	5.8	49.1	10.4	138.7	14.4	8.3	7.4	14.5	5.8	20.2	19.6	16.3	3.3	25.1	13.7	9.6	8.9	5.8	7.0	9.1	14.9	14.8	70.1	10.3	7.7	25.6	12.6	10.3	5.3	25.2	9.6	10.2	16.7	2.3	13.9	9.6	13.3	17.6	28.3	12.2	8.1	47.3	17.9	20.6	9.0	58.9	12.1	8.0	53.6	12.7	15.6	12.3	213.0	147.5	115.7	118.8	11.0	22.2	100.6	138.1	71.2	199.4	188.3	98.9	102.4	137.9	78.8	70.5	83.6	103.8	116.0	108.3	64.4	112.7	212.6	198.3	141.5	203.7	3.9	414.0	172.4	12.3	9.7	120.0	32.4	18.4	88.7	124.5	124.0	201.2	76.9	172.7	341.8	137.9	154.9	143.4	86.7	379.6	164.8	173.0	39.4	120.1	88.2	94.8	188.3	75.4	41.8	60.9	78.8	155.6	54.1	201.3	153.1	127.2	145.4	111.9	150.2	265.2	130.9	153.5	157.6	66.5	59.8	43.4	49.5	69.6	35.8	127.5	43.1	53.1	77.8	106.1	34.0	39.0	28.4	65.5	81.2	88.8	96.6	77.1	5.8	10.4	8.3	7.4	5.8	7.0	10.3	7.7	9.6	8.1	9.0	12.3	8.1	6.4	7.3	1.3	49.5	10.6	13.6	12.1	8.6	1.5	9.2	10.8	3.5	8.6	6.0	7.3	0.0	147.8	30.4	12.0	5.9	19.8	2.8	6.2	4.1	11.8	3.5	96.6	0.3	12.7	77.1	11.2	18.8	9.0	15.2	65.7	13.2	5.3	53.1	1.7	0.4	16.6	4.1	24.0	29.4	5.1	10.8	28.4	7.2	7.5	137.7	5.7	13.4	3.0	6.0	11.0	8.6	6.0	49.3	4.0	6.5	5.7	4.8	3.7	19.7	8.8	14.5	16.1	58.8	14.9	6.3	82.2	19.4	8.5	34.6	9.8
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876443	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Erythroid cells: 50.5;Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		33000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	10.0	5.3	4.7	20.7	5.1	35.6	11.6	6.3	6.4	10.2	3.5	12.8	11.7	10.0	5.1	11.1	7.9	6.8	5.3	5.0	5.1	6.4	9.5	7.8	34.4	4.4	4.6	11.3	3.9	4.6	3.0	12.6	4.7	6.9	15.6	3.2	6.0	8.3	8.1	10.5	13.2	11.8	4.8	9.9	8.2	14.6	5.4	48.5	4.5	7.6	38.0	9.6	8.9	5.5	104.4	62.8	133.8	85.7	28.2	36.5	52.3	73.9	55.8	84.3	93.0	129.3	77.7	181.0	52.9	54.0	36.9	60.4	136.7	67.6	89.5	93.6	94.4	179.9	85.0	40.9	13.1	218.4	76.9	21.7	8.6	61.7	18.9	16.8	58.1	139.8	130.8	147.9	62.6	106.3	268.6	159.6	120.9	91.3	62.1	131.1	159.9	165.7	42.3	90.3	83.7	71.3	97.6	45.9	47.0	95.2	53.1	135.4	29.0	58.3	48.0	63.4	56.8	87.8	153.7	234.2	81.4	163.5	70.9	9.2	1.6	1.1	8.1	4.7	7.6	6.1	11.1	9.9	5.2	4.7	9.9	12.4	0.9	9.1	4.5	10.6	16.1	6.3	4.7	5.1	6.3	6.4	5.0	5.1	4.4	4.6	4.7	4.8	5.4	5.5	6.4	0.0	2.7	3.9	10.3	6.6	4.1	5.4	7.4	3.3	4.2	5.8	4.6	2.8	5.4	3.7	0.0	40.1	28.2	3.0	0.0	7.2	3.2	2.5	8.9	8.3	2.4	50.5	3.5	6.6	28.0	13.3	9.7	7.1	9.5	27.2	8.9	3.0	24.4	3.3	3.4	11.7	0.0	4.7	3.5	2.1	9.3	9.6	5.4	3.7	3.2	2.4	4.1	2.0	2.8	3.9	4.9	17.0	27.6	1.6	2.4	0.9	3.0	0.5	0.0	7.2	10.0	26.6	40.4	10.2	4.1	10.7	22.0	9.6	15.4	2.7
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 180.8;lymphoid tissue: 156.4"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 132.9;Erythroid cells: 173.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	22.9	14.2	56.4	50.2	61.7	180.8	32.0	51.4	70.4	17.4	45.8	45.3	38.7	29.7	13.1	31.2	25.6	18.2	17.0	48.8	50.5	13.7	26.3	23.0	82.4	58.5	59.8	37.0	24.1	15.1	8.9	35.0	55.1	20.4	50.8	10.6	21.3	22.2	25.7	44.9	41.3	32.3	55.1	29.4	27.4	49.4	55.6	156.4	20.4	28.5	88.5	21.6	11.9	60.8	310.1	359.5	399.9	306.7	28.7	35.5	214.4	195.7	165.5	374.9	407.7	281.9	335.2	469.2	184.6	112.0	321.6	252.5	439.3	241.6	303.9	238.6	498.1	274.7	251.9	248.9	18.9	553.6	226.2	30.1	43.4	306.9	179.6	61.8	154.0	295.1	542.2	444.6	200.8	786.2	940.1	442.9	361.9	295.2	236.4	572.5	517.7	651.6	92.3	221.5	253.4	397.0	264.9	294.3	104.9	217.9	126.2	314.4	81.0	198.1	346.7	379.8	411.1	200.3	311.8	875.0	135.9	463.1	354.3	3.7	4.0	4.3	14.1	7.5	10.9	9.1	10.3	13.2	9.3	15.0	11.2	10.5	1.4	15.9	13.3	11.3	17.2	11.6	56.4	61.7	51.4	70.4	48.8	50.5	58.5	59.8	55.1	55.1	55.6	60.8	23.2	9.6	17.9	6.2	34.5	46.7	28.5	25.7	37.0	9.4	30.8	36.3	9.6	11.5	13.3	3.7	14.6	132.9	32.5	42.3	9.8	28.2	54.7	11.8	16.3	23.8	17.4	173.6	4.0	26.2	102.7	22.8	40.8	19.8	24.1	67.3	10.4	10.3	40.4	6.7	4.0	48.8	18.3	10.4	22.2	32.0	21.1	17.6	19.6	3.7	14.1	11.1	18.6	12.1	11.7	16.7	22.8	15.4	59.8	20.8	19.0	11.5	18.0	12.5	13.1	30.7	46.0	90.0	79.8	41.3	35.4	72.0	29.4	14.9	79.0	22.9
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.8;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA045141, HPA066433"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	2.9	2.9	3.0	4.6	4.1	10.2	2.8	6.8	4.4	4.0	4.2	3.9	3.6	3.1	2.1	3.7	3.2	1.7	3.3	3.1	3.4	2.4	1.8	2.4	7.5	2.9	3.1	2.6	3.1	2.0	1.6	3.3	3.1	3.6	3.2	5.3	2.9	1.8	6.9	4.7	3.7	2.1	2.6	3.6	3.3	13.4	3.1	9.0	2.4	4.6	6.5	3.4	3.6	5.8	48.6	33.0	27.7	30.3	4.6	6.6	27.4	38.1	12.3	26.6	32.0	35.4	27.6	48.3	11.3	10.2	51.5	50.9	46.1	25.7	47.9	13.4	21.5	49.3	16.8	27.9	0.9	56.6	7.4	2.5	3.8	47.2	17.6	5.3	12.3	28.7	56.7	45.8	27.1	12.3	27.6	30.0	40.3	25.3	21.6	34.8	50.9	18.6	5.0	15.3	21.6	23.2	40.0	36.3	22.5	28.6	27.1	16.4	9.6	51.5	43.2	28.2	56.8	20.1	53.8	82.2	9.6	33.5	43.4	1.0	0.1	0.4	0.4	0.1	0.7	0.3	0.2	0.4	0.0	0.3	0.2	0.4	0.4	0.4	0.2	0.4	0.5	0.1	3.0	4.1	6.8	4.4	3.1	3.4	2.9	3.1	3.1	2.6	3.1	5.8	3.3	0.0	4.4	1.6	6.0	2.3	3.0	1.9	4.6	7.3	2.1	2.8	10.3	7.2	2.4	12.9	16.7	7.2	4.2	5.8	0.0	1.9	8.5	4.9	3.5	4.2	4.2	14.9	3.7	2.8	6.3	5.0	3.1	5.4	1.3	24.4	2.9	1.9	4.5	6.7	2.9	4.0	6.1	2.8	4.6	3.2	3.7	3.7	1.8	2.8	0.3	3.7	8.2	3.5	6.6	3.6	3.9	3.0	9.2	3.3	4.7	2.4	4.0	11.5	6.6	5.7	4.8	71.8	37.1	5.0	2.6	4.0	6.0	3.0	6.3	2.2
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Microglial cells: 40.3;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031137	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	5.7	4.4	2.5	5.7	3.3	12.7	7.0	2.4	2.9	6.8	3.5	5.1	4.9	5.3	10.2	6.5	5.8	3.7	3.4	2.2	2.5	6.6	5.0	5.2	7.5	3.2	3.2	5.1	6.9	5.3	4.6	7.0	3.1	6.8	5.7	4.1	7.5	4.7	2.6	6.5	5.8	4.2	2.8	6.3	4.9	5.7	3.0	8.0	8.0	2.1	7.1	5.8	6.9	3.7	4.2	6.5	10.3	11.8	4.2	4.8	7.3	3.9	7.1	5.4	6.8	5.2	6.7	12.1	4.5	6.2	3.9	12.5	7.1	4.7	7.2	7.5	10.1	11.4	9.5	5.5	3.0	11.7	7.3	5.2	5.7	6.0	7.3	3.7	5.5	8.0	12.9	6.3	4.2	9.4	10.0	9.4	4.7	7.3	3.1	8.3	7.0	4.2	5.4	7.9	8.5	6.0	6.9	5.7	3.7	2.9	7.3	15.8	6.0	4.3	3.7	2.9	5.7	7.8	7.2	13.9	5.5	8.7	5.6	4.3	2.6	4.4	2.2	2.7	1.8	1.5	1.4	2.3	2.9	1.4	1.7	1.6	2.9	4.8	1.7	2.1	3.5	2.1	2.5	3.3	2.4	2.9	2.2	2.5	3.2	3.2	3.1	2.8	3.0	3.7	6.6	6.4	6.7	32.0	10.8	2.9	3.8	2.9	7.4	3.5	6.4	4.1	6.0	2.8	4.4	7.3	10.4	11.8	7.6	7.2	3.9	3.0	2.9	7.4	6.0	6.3	7.2	4.6	16.8	2.8	3.4	5.0	9.2	6.9	7.0	8.1	2.9	3.9	3.5	1.7	15.2	6.0	6.1	5.5	2.8	2.6	3.7	7.4	0.0	40.3	6.3	1.6	11.3	35.7	39.7	2.7	5.6	4.1	10.9	3.9	6.8	3.3	10.6	5.6	0.0	5.7	5.8	6.3	4.6	8.6	2.0	7.3	9.8	4.7	4.1	4.3
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	30.5	14.2	9.1	16.7	10.5	10.0	26.1	12.9	11.9	23.8	9.7	25.9	13.3	26.7	10.8	25.0	23.7	12.1	18.2	9.4	10.4	16.1	18.6	24.9	18.9	11.3	10.2	22.2	17.0	16.1	11.0	25.3	11.5	15.2	16.6	12.3	20.5	13.7	30.1	25.6	19.6	18.3	11.5	19.5	20.3	11.8	9.9	20.7	17.5	15.9	19.7	25.1	24.1	12.4	54.4	28.6	49.6	40.3	24.0	27.1	27.0	49.2	55.9	62.2	63.3	42.5	32.9	69.7	20.3	34.8	20.7	46.8	65.1	46.8	74.1	46.0	50.3	34.7	20.8	38.3	35.7	71.3	80.6	24.1	25.8	47.4	60.7	27.6	38.9	37.5	35.3	43.9	41.7	28.5	77.4	52.6	33.3	34.7	26.5	49.8	104.0	30.8	29.0	30.0	25.0	28.7	32.9	33.1	39.3	33.0	20.4	50.2	34.3	26.5	24.1	29.8	56.3	36.1	37.7	71.1	35.5	46.1	16.2	9.8	2.3	1.4	2.0	4.2	2.0	2.0	2.0	1.9	3.2	0.9	2.0	2.2	3.0	1.8	2.5	1.5	1.9	1.1	9.1	10.5	12.9	11.9	9.4	10.4	11.3	10.2	11.5	11.5	9.9	12.4	39.0	16.0	16.5	11.8	26.2	42.8	35.0	12.3	24.5	11.4	18.1	14.2	18.6	25.8	15.6	20.2	4.2	40.5	35.4	23.7	13.7	11.7	4.6	18.8	31.7	38.3	10.8	25.0	14.0	13.7	52.6	27.4	12.2	26.2	18.3	18.2	26.7	25.6	38.5	32.0	17.3	20.8	12.2	35.5	35.0	6.2	30.1	35.9	23.2	15.0	34.2	18.3	26.8	17.6	25.3	15.8	11.9	22.6	28.0	32.8	15.6	18.7	12.5	18.3	19.7	32.8	27.4	42.5	68.7	29.9	42.8	39.7	31.6	12.7	29.1	29.1
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522624-7534009	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 109.4;Kupffer cells: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 117.5;classical monocyte: 45.2;eosinophil: 105.7;intermediate monocyte: 95.5;neutrophil: 41.1;non-classical monocyte: 105.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 117.5;monocytes: 105.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	21.2	37.4	6.4	9.2	6.5	10.4	15.3	7.0	8.4	11.7	8.3	13.6	8.3	11.6	2.7	11.0	12.2	10.1	15.7	7.0	7.4	11.7	14.7	20.3	13.2	8.2	7.4	10.0	9.9	10.2	21.7	15.9	9.0	8.7	5.6	5.0	12.3	6.1	22.2	20.8	12.1	8.1	7.1	48.2	12.8	5.6	8.2	6.2	8.5	11.7	4.1	15.8	10.9	9.9	11.6	11.7	5.6	19.1	32.0	10.3	16.1	21.2	16.9	25.2	21.6	9.0	10.0	6.5	25.5	14.5	22.2	5.3	9.5	7.3	7.4	12.7	21.1	5.8	11.0	7.3	28.0	6.6	24.5	14.5	16.8	24.1	4.2	7.9	10.7	14.2	10.9	27.9	14.7	3.9	9.1	6.6	12.6	6.1	24.8	12.6	9.4	13.8	9.6	9.9	14.4	17.8	9.1	15.8	26.8	6.1	9.6	11.4	13.5	12.0	6.9	48.8	16.0	21.5	35.5	4.7	19.2	9.2	18.4	117.5	45.2	105.7	7.7	95.5	6.3	4.2	6.5	6.3	19.2	4.1	6.0	6.5	41.1	10.3	105.1	21.1	10.0	17.1	6.4	6.5	7.0	8.4	7.0	7.4	8.2	7.4	9.0	7.1	8.2	9.9	15.1	3.2	2.6	5.9	8.0	13.4	6.5	16.9	10.2	27.3	15.9	15.0	2.3	15.7	8.1	31.3	22.9	11.6	12.1	32.0	1.9	23.7	4.8	5.0	19.8	14.1	16.8	21.7	10.6	23.1	20.0	16.0	9.7	6.5	1.3	22.2	13.6	13.6	109.4	58.9	8.0	10.0	22.4	117.1	32.2	17.0	16.4	70.6	21.4	7.5	18.0	23.0	16.5	7.5	11.4	23.4	19.3	15.8	8.0	5.6	21.8	12.3	6.5	44.1	6.6	11.2	14.8	10.3	14.7	8.9	17.3	29.6	8.7	17.3	9.4	4.8
MCPH1	"BRIT1, FLJ12847"	ENSG00000147316	"Microcephalin 1"	Q8NEM0	8	6406596-6648508	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 107.5;Inhibitory neurons: 94.3;Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008238, HPA012064, CAB012177"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear bodies"		"CAB012177: AB_303207, HPA008238: AB_1853655, HPA012064: "	"unprognostic (1.00e-1)"	"unprognostic (2.17e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.79e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.94e-1)"	5.7	3.7	1.9	2.9	2.1	12.3	5.7	2.9	2.4	5.7	2.2	5.0	2.4	5.7	2.5	4.7	5.2	2.5	4.3	1.9	1.9	4.3	3.8	4.4	4.7	1.9	1.9	5.4	5.1	3.3	3.8	4.0	1.9	4.6	2.8	3.3	5.9	2.7	9.8	5.2	4.6	3.4	1.7	4.7	4.7	6.1	2.1	5.5	4.6	3.9	4.2	5.4	5.1	2.7	4.5	3.9	7.0	4.9	3.4	6.1	5.9	6.7	5.8	8.3	6.2	5.0	3.3	8.7	1.8	5.5	7.6	5.1	8.9	6.3	9.8	3.6	4.9	11.1	3.9	6.7	5.6	5.6	8.4	5.8	6.4	5.7	8.1	5.8	6.2	9.2	13.7	8.5	6.4	2.9	15.1	6.1	12.0	8.2	3.9	8.9	6.6	5.3	4.8	8.2	4.8	6.4	4.9	5.2	7.4	7.7	4.5	7.8	5.2	6.4	3.5	2.1	6.4	3.9	5.7	12.7	5.9	6.4	9.0	1.6	2.1	8.7	3.1	2.5	4.1	4.0	2.7	3.7	2.1	4.4	3.4	3.7	0.3	4.3	3.2	2.8	3.0	2.1	1.9	2.1	2.9	2.4	1.9	1.9	1.9	1.9	1.9	1.7	2.1	2.7	21.3	3.2	16.1	50.6	28.3	4.6	14.5	7.1	10.8	13.4	9.7	9.0	13.7	10.0	17.7	14.7	16.7	10.9	28.2	4.6	3.9	10.9	46.6	20.0	21.2	15.6	0.0	17.9	107.5	10.5	10.6	14.2	14.8	25.9	19.7	15.5	11.4	6.9	7.0	30.3	94.3	6.1	2.0	12.2	2.7	30.6	12.2	12.1	0.0	69.3	14.2	13.1	19.6	78.4	79.5	10.4	7.8	13.2	27.0	9.7	6.3	8.7	25.6	10.6	6.6	20.2	13.8	29.5	12.6	10.9	6.0	12.3	23.5	12.8	7.2	10.1
MCRS1	"ICP22BP, INO80Q, MCRS2, MSP58, P78"	ENSG00000187778	"Microspherule protein 1"	Q96EZ8	12	49556544-49568145	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039057	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA039057: AB_10794085"	"unprognostic (2.60e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.83e-3)"	"unprognostic (6.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.26e-2)"	22.3	29.7	29.2	27.3	29.9	32.1	23.4	28.3	33.4	26.4	27.8	30.3	27.3	31.3	23.7	34.9	30.1	22.9	68.2	29.6	27.2	34.5	24.6	24.3	33.2	29.9	28.1	23.6	32.7	35.7	24.0	24.5	28.5	31.3	25.9	17.2	27.0	26.9	53.2	26.9	29.2	26.1	28.2	32.8	31.8	35.2	29.4	39.4	35.5	61.4	31.1	29.3	26.2	31.4	43.8	81.5	62.9	54.5	33.2	40.9	69.3	37.5	40.4	95.7	53.2	127.3	69.7	72.6	76.4	66.0	43.7	48.5	97.8	89.0	38.3	57.6	120.3	72.4	53.4	46.9	59.6	85.0	76.0	47.7	68.3	63.8	51.3	56.0	71.0	66.0	90.9	48.0	55.4	77.8	59.1	51.1	87.4	40.7	60.1	69.1	50.7	84.0	59.4	40.3	60.6	63.5	40.8	51.7	36.5	42.8	84.4	101.7	51.6	45.8	58.4	44.7	56.7	47.3	50.9	69.2	60.1	49.8	27.8	96.2	63.7	76.4	63.2	82.7	49.1	44.5	53.6	68.1	79.1	46.1	46.8	51.0	31.8	90.7	64.7	53.5	60.4	76.3	29.2	29.9	28.3	33.4	29.6	27.2	29.9	28.1	28.5	28.2	29.4	31.4	17.0	35.3	13.8	6.2	23.3	10.7	25.1	38.5	10.8	15.6	19.8	19.7	24.2	28.6	22.4	23.9	8.4	52.1	22.1	34.3	52.8	37.7	32.1	16.3	15.3	17.4	27.5	35.1	12.8	36.1	51.8	20.2	39.8	15.7	27.3	24.3	15.0	10.5	40.6	23.5	12.6	27.2	28.5	22.0	12.5	37.8	27.4	20.9	28.4	9.4	38.0	28.1	40.2	7.1	12.3	39.7	37.1	27.1	24.3	26.7	34.1	45.4	22.8	20.5	6.6	14.7	26.9	41.6	64.0	27.4	12.6	59.2	25.6	23.7	33.8	27.0
MCTP1	FLJ22344	ENSG00000175471	"Multiple C2 and transmembrane domain containing 1"	Q6DN14	5	94703741-95284575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 45.3;brain: 37.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 113.3;Excitatory neurons: 510.6;Inhibitory neurons: 412.2;Oligodendrocyte precursor cells: 263.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 37.0;classical monocyte: 28.6;eosinophil: 13.2;intermediate monocyte: 41.4;myeloid DC: 22.3;neutrophil: 40.5;non-classical monocyte: 40.6;plasmacytoid DC: 11.4"	"Group enriched"	"Detected in many"	54	"dendritic cells: 22.3;granulocytes: 40.5;monocytes: 41.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 71.4;RPMI-8226: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019018			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA019018: AB_1853665"	"unprognostic (1.20e-2)"	"unprognostic (6.70e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.43e-2)"	21.3	2.3	12.8	12.5	37.1	45.3	15.9	27.7	19.4	6.0	0.0	7.7	5.1	5.9	2.0	6.4	4.9	17.4	3.8	20.9	10.0	4.4	3.7	12.9	6.1	3.8	0.5	1.7	3.2	1.9	4.0	7.3	5.7	3.5	7.2	1.7	3.7	2.2	3.2	4.3	4.9	11.2	0.5	8.8	5.5	2.1	1.4	7.9	4.6	7.9	4.4	21.3	6.1	13.4	0.3	5.2	3.3	0.1	49.0	19.6	0.2	0.3	25.1	2.3	8.1	0.1	13.3	18.7	19.2	0.0	51.1	0.2	0.4	0.2	2.8	0.0	3.6	11.4	13.3	0.2	6.4	23.6	14.6	7.3	0.0	9.0	32.5	21.2	52.7	7.6	0.3	71.4	18.7	0.6	1.4	17.9	4.1	0.3	20.7	0.9	0.2	73.7	52.7	29.0	10.0	0.5	1.7	0.1	37.1	1.4	0.0	21.8	0.3	9.0	13.9	0.4	4.2	5.0	0.1	0.2	41.8	38.5	9.1	37.0	28.6	13.2	0.1	41.4	0.0	0.6	0.1	0.2	22.3	0.3	0.4	0.0	40.5	0.3	40.6	11.4	0.0	8.5	12.8	37.1	27.7	19.4	20.9	10.0	3.8	0.5	5.7	0.5	1.4	13.4	113.3	3.2	10.8	15.3	3.2	18.1	0.2	6.9	3.4	2.2	1.7	1.1	3.1	0.0	6.6	3.7	0.0	0.3	9.8	0.1	0.0	0.0	27.8	5.5	1.2	97.9	0.0	5.0	510.6	0.2	0.2	18.5	5.6	11.6	63.3	0.1	2.2	0.3	12.2	3.3	412.2	0.0	4.1	42.4	76.5	16.2	0.6	63.5	12.4	67.5	32.9	3.2	2.1	263.4	9.0	1.3	0.0	0.0	2.4	0.8	0.0	0.5	3.5	3.5	0.0	1.8	2.0	1.8	1.4	0.7	13.4	0.3	3.7	0.3	0.0	0.6
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 72.8;NK-cells: 97.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 20.8;HMC-1: 16.4;U-698: 22.4;U-87 MG: 24.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	4.1	3.8	1.0	6.6	1.8	18.0	2.9	0.0	6.8	5.4	0.8	10.6	6.9	1.8	8.6	3.9	4.1	4.5	0.6	1.1	2.8	2.3	1.5	8.7	6.1	0.0	0.3	1.6	5.7	3.5	7.3	19.3	1.0	5.4	12.2	2.6	5.9	4.1	0.1	3.6	6.4	1.6	0.0	21.1	4.7	1.0	1.3	3.0	5.5	0.4	6.2	6.6	3.7	0.6	3.6	0.0	0.1	0.0	0.0	0.0	2.5	1.9	1.1	0.3	0.1	2.4	4.4	10.3	0.5	0.1	0.1	8.0	0.1	6.6	0.0	2.1	0.8	20.8	2.9	1.2	1.4	4.4	16.4	1.1	7.8	0.1	8.2	0.0	0.0	3.6	0.8	5.9	0.0	0.0	2.0	11.4	0.8	3.6	3.7	4.7	0.1	4.0	0.5	10.7	1.9	0.4	0.2	3.4	1.3	0.8	0.0	0.3	0.2	0.1	1.7	0.0	0.0	12.0	0.3	22.4	24.1	11.1	1.2	6.6	0.8	12.1	6.1	0.2	3.0	3.5	1.7	2.8	0.0	3.6	0.7	2.7	32.1	10.9	0.9	0.3	0.1	1.9	1.0	1.8	0.0	6.8	1.1	2.8	0.0	0.3	1.0	0.0	1.3	0.6	1.1	3.2	18.6	1.0	38.9	4.2	12.9	8.6	22.8	15.6	3.8	4.3	1.1	7.2	13.2	3.7	0.0	17.0	72.8	39.4	0.0	3.4	4.0	6.5	3.4	1.8	15.6	35.7	15.6	4.7	7.3	7.8	5.6	6.6	36.2	0.3	1.4	1.4	9.6	0.0	10.3	43.8	8.2	8.7	2.1	4.8	0.3	11.1	1.8	25.3	4.7	0.1	97.9	0.0	0.7	4.2	24.6	0.0	45.8	14.2	18.1	1.9	8.7	0.6	0.0	2.5	1.6	3.4	2.5	15.0	2.3	24.5	26.6	0.5	21.5	19.6
MCUB	"CCDC109B, FLJ20647"	ENSG00000005059	"Mitochondrial calcium uniporter dominant negative subunit beta"	Q9NWR8	4	109560209-109688719	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 32.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 127.7;Exocrine glandular cells: 111.4;Extravillous trophoblasts: 91.9;Hofbauer cells: 106.8;Pancreatic endocrine cells: 67.9;Syncytiotrophoblasts: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 93.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048776	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Vesicles, Mitochondria"		"HPA048776: AB_2680518"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.35e-6)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	10.2	2.0	2.6	18.4	3.0	10.6	7.6	2.1	3.4	7.0	3.5	5.3	3.8	8.8	1.5	6.8	5.8	7.8	10.5	2.7	4.6	3.5	2.2	7.2	32.2	4.3	3.0	5.6	1.5	1.2	3.7	6.1	3.2	3.0	6.3	3.7	4.9	2.1	1.4	6.2	7.8	8.2	3.7	13.5	4.6	3.0	5.2	31.4	3.3	3.5	25.7	9.2	7.5	4.6	26.9	11.7	6.4	32.6	6.9	18.1	23.9	23.3	14.2	24.9	22.1	0.6	21.6	93.0	4.6	20.2	13.8	7.6	24.1	14.0	21.9	59.2	18.4	11.3	11.6	1.6	12.1	23.6	0.4	11.7	3.8	15.1	13.0	17.7	33.9	35.0	3.3	59.4	19.2	34.0	54.1	0.4	28.2	4.8	15.6	20.4	47.7	10.8	29.6	12.1	25.6	11.1	24.2	73.4	7.7	5.3	9.2	1.2	23.9	9.8	12.6	51.8	40.2	22.3	16.4	22.7	29.9	4.9	6.9	0.4	51.4	0.8	18.9	32.2	26.6	43.6	79.1	56.5	49.8	50.7	114.7	66.2	3.6	65.0	24.4	35.1	74.9	92.2	2.6	3.0	2.1	3.4	2.7	4.6	4.3	3.0	3.2	3.7	5.2	4.6	21.5	9.6	5.2	0.0	19.5	0.0	0.0	0.0	0.0	0.0	12.7	9.9	0.0	0.0	2.5	5.5	0.0	127.7	36.0	0.0	0.0	25.2	0.0	7.0	5.9	11.7	0.0	0.0	0.0	111.4	91.9	15.1	0.0	8.9	1.3	9.1	0.0	0.0	106.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	14.5	0.0	0.0	0.0	0.0	67.9	0.0	0.0	5.8	0.0	0.0	0.9	2.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	73.5	28.2	7.4	0.0	0.0
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717447	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Focal adhesion sites"	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	11.3	7.0	2.7	8.6	3.2	13.0	10.9	4.1	5.2	12.4	3.3	11.0	4.9	13.7	8.5	6.2	12.3	4.6	9.5	2.4	4.1	8.2	9.7	9.5	10.2	4.5	3.3	16.8	10.8	8.6	12.8	7.4	3.5	10.1	6.9	14.1	9.1	8.2	11.0	9.4	10.9	8.9	2.0	11.3	8.4	28.2	3.4	14.5	16.4	5.8	11.3	10.7	9.3	3.6	36.7	11.1	47.4	34.8	6.3	10.0	23.0	14.8	10.0	25.2	21.3	22.7	8.5	37.7	17.5	17.0	23.5	20.2	63.0	28.6	34.9	29.9	65.6	43.4	28.7	12.5	4.1	27.1	16.9	7.9	9.2	48.6	27.3	9.0	11.5	25.7	61.0	36.7	19.1	14.7	14.6	20.0	20.6	8.4	7.8	33.2	24.7	37.4	11.0	10.7	39.9	23.2	11.5	26.2	13.5	29.1	21.8	16.8	13.8	24.8	26.4	19.2	26.3	19.3	21.6	34.5	7.8	63.9	34.3	0.1	0.1	0.1	0.6	0.1	0.3	0.4	0.4	0.5	0.1	0.7	0.5	0.5	0.0	3.2	0.1	0.7	0.0	0.3	2.7	3.2	4.1	5.2	2.4	4.1	4.5	3.3	3.5	2.0	3.4	3.6	9.7	16.0	13.0	10.1	13.4	4.5	5.5	5.6	15.9	11.5	6.8	8.6	7.6	7.2	5.7	5.5	8.4	7.9	11.0	2.5	3.9	5.3	4.7	8.0	8.7	9.7	6.7	14.5	8.3	6.2	11.4	11.2	4.1	13.7	17.1	12.8	6.1	12.0	6.7	5.0	8.1	3.3	12.2	6.0	5.7	3.9	7.8	7.3	1.8	11.2	5.9	10.6	14.4	12.5	9.9	5.2	1.1	6.0	16.9	2.9	1.2	3.0	8.0	17.1	13.1	16.2	8.3	74.5	18.0	8.7	3.7	1.9	12.1	7.7	6.0	1.9
MDFI	I-mfa	ENSG00000112559	"MyoD family inhibitor"	Q99750	6	41636882-41654244	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 221.7;Extravillous trophoblasts: 113.7;Pancreatic endocrine cells: 134.9;Syncytiotrophoblasts: 138.7;Urothelial cells: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 80.5;HBEC3-KT: 117.2;OE19: 100.0;REH: 315.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 17.0"	"Low region specificity"	"Detected in all"			HPA049973	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA049973: AB_2680975"	"unprognostic (9.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.82e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.32e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.66e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.22e-2)"	33.0	4.3	3.9	5.7	4.2	0.2	23.1	4.1	5.8	23.2	4.3	2.5	1.7	5.8	1.2	44.7	10.0	12.8	8.8	3.5	4.3	5.5	1.5	18.6	1.7	8.2	5.8	15.6	3.2	1.6	9.1	11.0	6.3	14.3	0.4	0.1	22.4	2.2	0.9	15.4	3.2	2.5	3.6	0.3	4.6	5.0	4.6	1.5	4.6	1.1	2.5	13.6	27.1	4.2	60.1	0.2	50.4	0.1	0.1	0.0	80.5	0.0	0.0	0.0	0.0	0.0	28.2	0.1	18.2	0.0	0.3	48.4	13.8	117.2	0.0	0.0	0.0	0.4	0.0	2.5	2.2	0.0	0.3	3.6	53.3	0.6	24.6	0.0	38.4	16.1	0.2	0.3	0.0	0.0	41.8	0.4	34.4	100.0	1.6	315.3	29.6	0.5	3.3	9.2	9.4	23.2	0.6	43.1	0.0	34.5	0.2	4.0	40.3	0.1	44.1	0.5	1.7	0.1	0.3	0.1	0.3	2.8	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.2	4.1	5.8	3.5	4.3	8.2	5.8	6.3	3.6	4.6	4.2	1.8	0.0	0.0	0.0	0.0	24.5	48.6	36.8	12.0	0.5	18.9	16.9	0.9	0.0	8.2	5.5	0.0	221.7	0.2	0.4	0.0	33.8	0.5	0.5	1.7	12.7	0.0	0.0	0.1	51.2	113.7	12.8	0.0	0.7	0.0	10.0	7.9	0.1	19.6	0.0	0.3	1.2	6.1	0.0	4.5	0.5	39.1	0.4	0.0	2.8	0.6	0.0	0.0	4.5	0.2	134.9	0.0	6.0	0.0	55.6	0.0	0.0	3.5	0.0	0.0	19.7	9.1	0.1	7.9	10.7	9.1	138.7	0.6	2.7	0.3	73.5
MDFIC	"HIC, MDFIC1"	ENSG00000135272	"MyoD family inhibitor domain containing"	Q9P1T7	7	114922359-115019202	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Muller glia cells: 139.7;Skeletal myocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 109.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030716	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA030716: AB_10671364"	"unprognostic (1.24e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (6.13e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.55e-1)"	44.9	17.3	4.9	22.5	4.3	11.1	14.5	4.7	5.2	21.1	25.5	10.6	7.2	20.6	5.1	17.2	12.2	13.2	24.6	4.1	7.2	12.6	13.3	23.3	32.1	12.1	9.0	16.1	5.0	16.7	4.6	20.2	8.8	10.2	10.3	21.1	15.7	11.1	27.6	10.3	9.4	17.7	12.8	33.7	10.5	1.8	6.0	17.2	19.3	14.2	30.0	16.4	8.2	9.2	0.1	13.2	18.3	0.1	37.8	52.0	7.1	69.9	83.9	15.9	19.8	0.4	41.7	9.8	0.8	46.4	25.4	7.7	5.7	12.2	27.1	34.0	12.3	0.0	16.8	0.0	19.5	22.2	14.2	43.7	11.5	35.7	11.1	40.2	10.7	9.7	0.0	66.8	54.2	0.2	0.1	1.8	14.8	0.6	15.6	0.2	53.5	21.5	16.2	16.9	0.7	0.0	30.5	28.3	32.5	24.7	9.0	19.7	30.2	58.2	16.4	109.1	34.1	27.5	0.1	0.2	40.8	0.1	50.9	0.2	0.9	0.6	1.8	1.2	2.8	2.3	4.1	3.6	1.5	2.4	2.3	2.1	0.0	1.6	1.8	5.5	3.5	0.7	4.9	4.3	4.7	5.2	4.1	7.2	12.1	9.0	8.8	12.8	6.0	9.2	61.3	16.0	26.1	32.7	41.5	9.4	7.0	2.2	17.6	0.5	13.1	10.2	24.8	24.3	12.2	14.7	0.0	7.5	58.1	1.5	9.8	2.3	2.5	9.4	12.7	42.8	0.0	1.7	27.2	2.9	5.3	25.8	5.6	1.3	2.5	29.9	59.6	18.6	21.9	0.0	5.4	2.7	0.0	55.6	34.0	1.3	4.4	41.1	37.4	55.3	22.0	139.7	21.6	6.6	0.8	9.2	2.0	2.6	63.2	6.6	0.1	5.1	15.1	5.0	6.6	131.8	13.8	0.2	1.0	20.0	13.8	3.7	70.6	38.2	4.6	10.2
MDM2	"HDM2, MGC5370"	ENSG00000135679	"MDM2 proto-oncogene"	Q00987	12	68808177-68850686	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 257.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 504.6;U-698: 517.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000086, CAB016303, CAB079977"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB000086: AB_563872, CAB016303: AB_627920, CAB079977: "	"unprognostic (1.16e-1)"	"prognostic favorable (3.23e-4)"	"unprognostic (6.16e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.95e-2)"	14.0	11.6	5.4	10.4	10.0	28.6	11.9	7.4	7.6	13.9	28.0	20.7	6.4	9.5	7.1	13.0	14.1	12.0	6.8	3.8	7.4	9.5	26.9	14.3	13.8	9.9	8.5	10.8	14.3	10.9	5.0	16.4	9.2	11.3	21.9	14.2	9.6	11.5	18.6	10.9	7.5	12.4	6.0	11.4	10.0	6.6	9.2	15.6	15.4	12.9	17.0	15.1	10.8	12.8	18.7	42.1	43.5	22.6	55.9	51.5	223.4	49.7	50.3	26.2	41.5	26.8	8.4	188.6	13.5	34.7	7.3	11.0	31.4	504.6	42.1	51.0	22.0	35.3	36.0	115.0	55.7	32.6	31.0	77.8	46.5	101.5	69.4	26.9	73.7	32.1	37.1	45.4	50.8	28.0	43.1	10.7	36.9	10.1	8.2	149.4	31.7	16.2	16.0	146.0	34.3	20.2	32.0	25.0	11.3	88.8	58.3	21.4	82.3	20.2	38.0	16.8	18.5	68.2	47.7	517.6	31.3	12.8	81.2	6.1	5.4	5.2	4.1	4.1	3.7	4.7	3.5	4.1	3.0	5.4	3.6	3.5	19.2	3.7	7.2	3.9	4.1	3.6	5.4	10.0	7.4	7.6	3.8	7.4	9.9	8.5	9.2	6.0	9.2	12.8	23.1	32.1	56.3	26.1	36.4	15.6	30.5	42.6	22.8	26.8	21.4	17.1	20.9	24.3	75.8	25.8	33.3	47.5	32.1	19.3	13.7	19.5	2.5	257.4	34.5	22.0	25.1	29.9	28.8	24.2	28.0	31.9	28.5	74.8	32.9	33.2	15.7	45.0	18.3	30.3	32.9	23.4	32.6	49.0	25.0	2.9	19.3	44.9	12.4	37.5	35.4	27.8	10.3	25.6	71.8	22.4	20.1	15.1	117.7	39.8	15.8	21.3	141.7	35.3	19.7	30.0	32.4	17.3	20.0	59.5	22.0	94.3	31.8	49.4	20.9	82.0
MDM4	"HDMX, MDMX"	ENSG00000198625	"MDM4 regulator of p53"	O15151	1	204516379-204558120	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018919, HPA048821"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA018919: AB_1853694, HPA048821: AB_2680531"	"unprognostic (4.63e-2)"	"unprognostic (3.73e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.87e-4)"	"prognostic unfavorable (7.06e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (2.49e-4)"	13.7	10.5	9.2	13.4	18.7	56.1	14.3	16.3	12.1	17.6	35.0	12.4	5.8	12.0	18.6	11.5	13.6	6.7	11.4	10.6	17.8	14.4	14.8	16.3	18.8	17.5	14.6	18.9	18.8	5.3	16.3	10.1	17.5	14.6	9.6	25.2	11.9	7.3	10.5	20.7	16.7	7.1	10.5	22.6	13.2	19.9	15.9	30.4	15.8	4.2	17.4	12.1	13.7	36.0	6.5	12.7	12.5	17.3	8.6	9.4	58.7	4.8	4.9	6.1	8.9	6.6	8.7	22.4	4.5	6.7	5.1	6.8	8.5	7.2	8.2	6.8	6.0	17.8	32.0	7.6	6.5	14.0	16.9	9.4	4.5	9.9	17.4	6.3	6.0	14.2	10.4	31.5	5.4	21.9	8.6	12.3	17.3	2.4	5.3	10.1	10.2	7.5	6.0	31.1	5.6	12.6	4.9	9.1	9.1	12.4	18.0	8.1	6.1	6.8	12.1	4.5	7.9	15.8	6.2	18.2	4.7	5.9	10.1	7.5	4.3	5.8	5.7	4.2	4.9	7.9	4.4	4.1	3.6	11.9	6.1	5.4	6.4	4.1	3.8	7.8	2.6	2.5	9.2	18.7	16.3	12.1	10.6	17.8	17.5	14.6	17.5	10.5	15.9	36.0	73.6	28.9	56.9	76.0	118.1	61.6	48.2	31.0	22.8	96.0	55.2	33.7	38.5	47.1	51.2	69.9	168.9	52.0	135.7	35.5	13.7	29.9	82.3	39.6	74.2	54.5	65.0	64.4	61.8	26.7	26.1	53.0	36.7	63.2	65.9	82.6	87.1	61.0	35.5	42.1	65.7	48.3	54.9	96.4	128.3	160.2	80.2	62.0	42.7	83.4	81.8	40.1	90.6	106.6	170.3	26.5	42.3	54.2	81.0	66.3	49.0	18.6	32.0	192.7	52.6	99.6	50.5	75.7	64.8	23.0	68.3	60.9	73.7	58.2	51.1	48.3
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642498-89819794	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.5;Inhibitory neurons: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 24.7;NTERA-2: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	4.2	4.6	3.4	1.9	3.6	4.2	4.3	4.4	3.3	4.5	1.7	4.4	1.2	5.6	2.1	4.9	5.0	1.2	4.9	3.1	3.3	4.4	9.1	3.9	2.6	3.3	3.1	7.6	5.9	3.0	4.6	1.2	3.7	3.6	1.8	3.0	3.9	1.5	8.3	7.1	5.0	1.7	2.2	4.5	4.6	6.5	3.3	2.8	6.0	3.4	2.5	4.2	4.3	5.7	4.2	4.1	4.1	3.8	6.6	6.3	4.1	2.8	2.1	3.1	3.8	9.4	1.5	12.5	3.1	2.9	3.3	3.6	10.7	3.8	5.5	4.9	7.1	13.5	5.6	6.1	2.5	17.7	3.2	3.9	3.1	8.3	7.6	1.9	5.6	5.6	24.7	2.9	3.1	5.0	2.8	6.6	22.7	3.4	3.5	5.5	7.8	3.1	2.7	5.8	7.5	3.3	3.9	2.3	2.5	5.4	1.6	7.7	7.2	2.1	3.8	2.8	6.5	3.3	3.9	5.9	2.8	9.8	3.7	3.2	0.3	0.6	0.7	0.2	0.6	1.0	1.0	0.8	0.2	1.3	1.3	1.0	0.0	1.1	0.3	3.0	0.4	0.1	3.4	3.6	4.4	3.3	3.1	3.3	3.3	3.1	3.7	2.2	3.3	5.7	13.2	28.9	19.1	55.2	19.2	29.3	8.2	6.0	30.7	24.4	14.0	11.0	39.2	11.5	16.9	14.7	25.0	5.5	25.2	6.6	0.0	6.3	7.5	20.1	21.9	15.0	7.7	58.5	82.5	8.1	7.2	13.3	19.4	25.2	6.3	26.4	6.4	48.5	6.6	18.5	79.5	7.7	6.1	6.3	9.5	4.3	7.2	8.6	12.4	33.7	6.6	8.0	9.2	35.7	74.8	6.9	3.7	8.6	26.0	18.1	4.7	2.5	12.9	18.7	0.0	33.1	12.7	37.5	50.1	26.1	30.1	3.4	19.4	17.4	10.3	8.5
MDP1	"FN6Pase, MGC5987"	ENSG00000213920	"Magnesium dependent phosphatase 1"	Q86V88	14	24213943-24216070	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003064, HPA070338"	Uncertain		Approved	Nucleoplasm		NA	NA		29000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA003064: AB_10602350, HPA070338: AB_2686256"	"unprognostic (2.70e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-2)"	14.0	18.6	6.8	3.2	6.8	3.9	14.6	7.0	7.5	14.7	6.4	12.6	3.1	11.5	7.9	7.3	12.1	4.0	18.2	7.0	6.9	16.8	10.3	9.2	5.8	6.7	6.8	12.3	15.3	5.8	20.1	4.0	6.9	13.7	3.5	4.1	10.6	4.8	15.0	12.6	9.5	4.5	7.2	11.6	11.9	7.8	6.6	5.3	13.6	4.8	4.7	12.5	11.1	7.8	4.1	9.5	7.2	4.7	6.9	6.3	0.3	4.2	8.9	8.2	8.4	5.0	10.9	15.7	10.4	4.3	2.4	3.7	3.4	8.2	5.0	5.4	3.9	6.0	3.3	12.1	6.7	7.9	4.2	4.5	7.7	4.9	9.4	8.3	5.9	11.1	1.9	11.4	7.4	21.1	11.7	12.6	2.2	7.8	16.9	8.0	5.0	12.6	8.0	5.7	8.7	8.6	6.6	14.3	9.4	3.9	8.3	4.5	3.5	8.8	8.7	3.9	4.4	18.6	8.4	11.7	8.3	3.8	6.9	5.1	13.9	16.5	7.7	15.2	7.3	13.4	9.9	9.0	16.1	12.9	11.7	9.9	4.6	12.4	13.0	29.9	16.3	10.3	6.8	6.8	7.0	7.5	7.0	6.9	6.7	6.8	6.9	7.2	6.6	7.8	6.6	6.4	12.9	0.0	11.0	4.6	3.5	5.6	16.5	3.9	8.2	11.7	0.0	4.3	2.1	5.5	0.0	3.7	7.3	5.9	13.7	13.8	5.7	4.6	5.5	8.2	11.5	7.8	0.0	19.6	5.3	8.1	9.2	4.3	5.1	4.3	8.6	5.8	7.9	3.3	0.0	10.8	12.2	3.3	8.7	3.0	6.2	10.6	17.8	0.0	21.9	5.2	4.1	0.0	0.0	11.7	6.2	7.5	25.8	2.9	23.7	21.7	13.2	2.9	13.1	7.7	8.7	4.4	3.5	11.5	4.5	2.5	9.7	3.4	8.8	2.6
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210402-83431051	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Excitatory neurons: 117.1;Inhibitory neurons: 70.6;Kupffer cells: 74.4;Muller glia cells: 100.6;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"MAIT T-cell: 16.0"	"Lineage enriched"	"Detected in many"	10	"T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 139.4;OE19: 158.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	41.4	44.4	13.4	5.2	15.4	0.4	29.9	14.5	18.1	8.0	8.5	7.7	21.7	4.2	6.5	28.6	4.2	15.5	18.6	13.1	17.4	3.6	9.8	8.8	4.2	15.0	19.1	10.8	3.4	19.9	12.5	2.9	18.3	8.4	11.0	30.0	10.3	17.2	34.7	14.4	10.4	7.8	13.4	7.3	23.8	16.1	16.8	5.6	6.7	30.5	4.5	15.3	12.0	13.5	29.0	59.1	1.4	0.0	48.0	44.4	0.1	18.4	47.0	19.2	37.1	139.4	24.9	0.0	46.8	43.4	38.2	29.8	43.4	16.4	20.9	0.0	24.4	0.0	33.8	0.0	61.4	14.3	50.3	49.0	32.3	38.7	26.3	32.1	30.4	0.0	20.4	0.1	26.4	32.7	0.0	16.2	0.0	158.3	23.0	0.0	48.5	27.9	56.8	13.7	5.8	14.9	31.2	45.7	1.0	25.0	0.0	34.5	32.4	11.9	14.1	3.9	0.1	10.9	13.3	0.1	0.0	0.0	35.9	0.0	1.6	0.0	0.8	0.3	16.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	13.4	15.4	14.5	18.1	13.1	17.4	15.0	19.1	18.3	13.4	16.8	13.5	0.9	19.2	12.1	71.8	0.6	1.9	5.1	12.5	6.8	17.1	2.5	0.9	41.0	7.2	12.7	5.5	2.1	0.6	0.5	12.7	1.9	12.3	5.5	0.7	6.8	2.3	0.0	0.0	117.1	9.5	0.9	8.5	62.7	0.2	0.0	11.2	4.2	12.1	7.1	13.5	70.6	4.1	8.2	74.4	25.6	6.5	25.7	16.7	0.0	23.4	5.5	100.6	0.0	123.6	38.6	15.0	4.5	37.2	0.5	5.2	15.2	3.1	7.2	7.5	0.0	4.5	8.3	7.5	2.3	22.3	3.4	0.8	1.8	33.6	8.9	3.3
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 804.1;Late spermatids: 2062.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017921, HPA073087"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708, HPA073087: "	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	48.6	56.1	96.7	41.3	99.3	39.6	48.4	96.0	114.3	58.3	91.5	54.4	36.5	49.9	65.9	51.0	55.1	33.1	42.6	100.3	110.1	62.4	52.7	38.4	45.1	98.9	98.6	59.4	46.1	69.3	59.0	43.6	101.2	53.0	46.3	55.6	45.8	52.4	30.4	55.4	39.7	53.4	95.5	43.8	46.0	222.9	102.1	70.9	45.6	33.8	61.5	58.9	49.4	96.8	200.9	113.7	166.9	133.0	147.6	97.7	66.3	130.6	137.9	156.8	172.3	169.9	51.6	103.6	133.9	159.9	232.8	99.7	128.8	177.7	147.0	119.8	176.3	192.7	121.8	188.1	76.4	142.7	97.8	79.0	87.5	211.3	137.3	162.0	96.8	166.7	132.9	113.4	176.0	384.7	193.0	165.5	78.3	569.8	99.1	93.3	98.6	104.2	112.4	186.9	160.3	112.0	100.5	86.2	155.3	134.2	130.8	154.9	73.1	175.8	141.2	115.3	229.4	128.0	113.4	174.1	88.3	105.4	146.3	229.1	112.3	214.8	128.9	136.0	118.7	190.3	116.3	126.8	119.8	180.7	115.6	122.7	104.7	145.5	161.6	117.3	158.3	201.2	96.7	99.3	96.0	114.3	100.3	110.1	98.9	98.6	101.2	95.5	102.1	96.8	45.1	25.6	16.7	10.1	46.9	66.3	73.6	129.3	85.4	19.6	56.9	69.8	28.2	42.9	78.1	55.2	4.2	111.8	32.8	56.7	168.3	89.4	804.1	36.2	27.1	51.1	29.9	42.7	11.5	92.4	101.5	52.0	36.7	29.3	46.9	38.9	45.3	54.0	108.1	16.8	11.6	48.7	89.5	39.2	55.3	2062.6	63.3	51.6	67.6	5.6	70.1	98.5	68.0	7.5	11.9	80.5	61.4	59.8	55.0	84.7	82.8	142.2	73.0	23.4	118.3	26.8	102.8	285.9	98.1	73.6	69.6	85.0	51.1	35.0	49.9	86.3
MEAF6	"C1orf149, CENP-28, Eaf6, FLJ11730, NY-SAR-91"	ENSG00000163875	"MYST/Esa1 associated factor 6"	Q9HAF1	1	37489993-37514766	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029599			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA029599: AB_10599996"	"unprognostic (4.95e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.41e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.87e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.68e-3)"	"unprognostic (3.57e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.19e-1)"	37.9	31.4	28.8	18.7	30.5	28.4	39.0	23.9	38.5	42.3	23.5	45.2	19.7	36.7	32.0	37.3	35.6	26.9	25.8	30.5	38.4	32.9	29.5	32.9	29.0	25.9	29.6	41.7	38.9	52.4	67.6	20.9	29.8	66.5	20.3	18.8	43.1	45.1	43.3	46.5	31.8	26.4	23.8	26.7	35.5	38.8	34.2	50.5	31.0	25.1	28.0	41.6	38.7	28.1	56.3	11.2	36.0	37.5	42.3	57.9	32.8	49.0	51.8	57.4	47.4	24.0	48.2	45.9	52.4	41.8	39.0	30.4	47.6	43.0	44.5	75.8	55.6	67.4	17.6	44.5	46.1	59.4	46.2	37.6	72.0	53.7	78.5	31.2	49.5	58.7	89.1	36.4	46.2	23.4	61.9	39.5	69.7	36.4	49.3	60.4	53.4	65.0	42.7	26.6	68.2	38.9	61.8	35.2	73.3	23.0	41.1	41.3	39.4	47.3	36.1	58.5	39.4	58.1	88.0	83.7	43.4	77.8	33.4	108.4	71.1	123.0	97.7	61.3	100.3	102.2	87.6	95.8	73.4	101.8	86.0	79.7	33.3	80.3	70.3	62.3	109.9	114.4	28.8	30.5	23.9	38.5	30.5	38.4	25.9	29.6	29.8	23.8	34.2	28.1	71.4	64.1	47.2	30.0	102.9	211.8	179.3	158.5	84.2	44.0	115.7	81.8	28.1	107.2	98.1	108.5	22.9	88.6	94.0	23.0	223.0	96.0	47.0	127.2	53.3	59.4	70.2	83.5	34.1	63.0	58.3	74.2	47.9	89.7	54.3	67.5	75.3	59.9	88.9	20.2	28.9	60.3	146.5	66.3	125.5	103.2	75.8	61.5	131.6	9.4	81.4	71.2	115.4	28.6	36.9	64.2	35.8	81.6	59.4	251.4	52.8	184.2	174.7	42.5	46.0	52.4	79.2	143.7	197.5	91.8	246.6	53.8	111.6	56.5	52.3	120.4
MEAK7	"KIAA1609, mEAK-7, TLDC1"	ENSG00000140950	"MTOR associated protein, eak-7 homolog"	Q6P9B6	16	84476355-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 40.4;Syncytiotrophoblasts: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	3.0	2.2	3.5	3.6	3.0	1.3	4.7	2.1	2.8	4.6	3.4	4.8	4.1	4.7	5.6	12.8	3.7	4.3	2.4	4.0	2.0	4.5	3.4	4.1	4.5	4.1	1.7	5.1	2.6	6.4	2.0	10.8	4.2	4.7	4.9	6.4	3.8	3.8	3.0	7.2	5.4	4.2	0.3	3.4	4.0	2.2	2.3	4.5	4.9	2.1	6.4	7.2	6.6	4.2	29.1	20.0	17.1	9.2	7.8	13.3	8.1	21.1	18.8	21.2	6.1	11.5	34.2	4.0	11.1	40.8	15.5	31.5	4.9	56.1	27.7	2.2	4.2	3.2	9.7	10.0	9.6	2.5	9.6	9.5	23.9	19.8	25.8	17.1	9.0	11.1	5.3	4.7	14.3	6.8	2.2	2.5	5.2	15.1	7.0	9.0	4.3	1.3	18.7	15.9	5.6	4.0	19.1	13.5	9.4	17.9	19.1	3.9	22.0	14.6	6.7	7.8	8.8	3.7	6.7	10.6	8.8	1.3	5.1	16.9	2.9	4.0	3.3	2.4	3.1	2.8	5.6	4.6	2.5	2.3	6.1	3.8	2.3	2.8	3.2	0.6	8.0	2.5	3.5	3.0	2.1	2.8	4.0	2.0	4.1	1.7	4.2	0.3	2.3	4.2	5.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	40.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	47.1	0.2	0.0	0.0	0.0
MECP2	"MRX16, MRX79, RTT"	ENSG00000169057	"Methyl-CpG binding protein 2"	P51608	X	154021573-154137103	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 47.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 47.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000593, HPA001341, CAB037264"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347"	"unprognostic (1.27e-3)"	"unprognostic (2.60e-3)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.22e-1)"	"prognostic favorable (7.32e-9)"	"unprognostic (7.63e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.05e-2)"	21.0	17.7	11.2	13.4	12.8	24.9	18.0	19.4	17.1	24.0	6.6	21.8	9.9	19.0	10.8	14.4	21.7	10.8	23.3	12.0	13.4	17.8	16.5	24.6	13.4	13.7	13.7	24.8	14.8	14.7	22.8	8.6	12.7	23.9	5.3	23.0	14.4	15.6	33.5	14.8	16.1	11.5	9.1	23.6	15.4	8.6	13.6	15.6	18.9	14.4	9.1	20.0	19.3	16.9	34.4	19.2	15.9	18.6	13.1	8.8	12.7	17.0	14.6	14.9	25.2	14.1	13.3	37.4	39.5	13.3	28.9	16.0	19.3	15.9	8.8	32.5	27.8	13.6	17.6	9.4	14.9	18.2	28.2	8.7	10.0	15.6	13.2	15.4	12.9	17.5	17.3	28.9	11.1	17.9	23.1	21.8	11.2	21.9	19.9	20.0	16.2	13.2	9.2	13.3	21.9	13.6	13.0	14.1	31.6	7.7	8.8	24.8	18.0	14.5	28.8	29.2	35.6	41.0	32.6	41.7	19.6	33.2	25.1	47.8	4.7	19.5	9.1	4.7	6.2	7.8	6.1	7.2	3.5	6.8	5.8	5.4	22.7	4.4	8.2	6.0	7.2	2.7	11.2	12.8	19.4	17.1	12.0	13.4	13.7	13.7	12.7	9.1	13.6	16.9	53.9	6.4	34.4	26.4	74.7	30.8	43.4	28.3	21.6	88.0	40.7	24.6	41.2	34.3	34.9	46.0	206.4	17.0	130.8	23.9	66.5	39.4	1.4	28.2	34.4	41.0	36.5	48.4	31.7	30.7	17.7	38.5	16.3	22.7	52.6	32.2	66.4	38.1	25.6	99.3	35.3	21.0	52.9	45.5	68.7	3.5	53.4	54.1	30.2	45.0	58.9	39.8	85.5	30.2	45.0	36.2	30.3	73.7	56.1	34.8	36.7	44.5	28.1	92.7	32.9	53.6	57.1	16.0	39.0	18.1	29.0	18.5	93.6	25.6	17.3	36.4
MED1	"CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2"	ENSG00000125686	"Mediator complex subunit 1"	Q15648	17	39404285-39451272	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 206.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017696, HPA052818"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB017696: AB_1128703, HPA052818: AB_2681962"	"unprognostic (1.77e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.50e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.79e-2)"	10.3	8.7	7.2	11.3	7.7	12.9	10.6	8.5	8.2	9.7	7.4	10.6	7.7	11.0	5.9	9.8	9.3	7.6	9.6	6.9	7.4	8.8	9.0	8.7	13.3	7.2	7.3	11.3	7.9	16.8	6.0	10.4	7.5	8.3	9.5	8.0	8.6	7.7	13.7	11.1	9.7	11.2	7.4	11.2	8.6	10.7	7.7	16.9	9.1	12.2	14.7	10.9	9.1	8.8	20.1	24.5	32.5	22.7	23.1	23.7	25.8	24.0	25.6	30.6	30.1	24.9	20.1	51.4	26.2	28.9	37.2	38.3	38.0	22.9	50.0	49.2	31.8	32.3	24.1	24.0	24.4	59.8	33.9	22.1	23.6	39.3	55.0	20.1	28.1	30.6	42.1	28.4	25.7	10.7	56.5	23.2	20.9	19.4	15.1	41.3	43.1	22.9	18.5	22.4	20.3	23.2	30.9	206.2	27.6	28.0	38.5	33.4	23.7	24.8	31.1	28.1	42.3	25.3	36.4	53.6	24.3	28.4	32.0	1.3	1.4	1.8	1.6	1.4	1.9	2.2	1.8	1.8	1.5	2.0	1.8	2.1	1.2	1.9	0.8	1.5	1.5	1.0	7.2	7.7	8.5	8.2	6.9	7.4	7.2	7.3	7.5	7.4	7.7	8.8	18.8	25.6	13.9	10.1	24.7	27.1	14.2	13.1	19.4	13.7	18.0	13.8	18.9	12.8	21.0	9.2	14.6	17.2	20.6	12.7	3.9	12.3	7.9	19.0	27.1	21.2	13.8	26.9	13.4	12.0	12.8	19.7	10.7	27.0	9.5	19.9	17.2	20.2	14.9	11.8	13.9	14.8	16.2	20.0	16.5	7.7	14.6	16.4	21.4	11.2	21.0	13.5	17.5	11.1	16.0	13.7	12.1	18.0	20.2	19.9	9.4	8.5	17.4	12.0	19.7	26.1	21.2	22.3	17.0	21.7	32.7	22.2	22.8	18.7	15.0	18.7
MED10	"L6, MGC5309, NUT2, TRG20"	ENSG00000133398	"Mediator complex subunit 10"	Q9BTT4	5	6371874-6378571	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042795, HPA054188"			Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA042795: AB_10796679, HPA054188: AB_2682410"	"unprognostic (2.33e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.14e-1)"	26.3	20.6	33.3	22.3	34.8	55.5	23.8	32.5	39.2	19.0	28.6	35.5	19.6	20.3	24.1	27.0	19.9	20.5	31.3	36.5	38.7	21.9	22.7	20.4	35.5	33.8	35.2	20.5	27.1	22.2	18.2	20.9	37.4	21.0	12.6	8.5	21.6	22.3	34.0	27.0	23.9	20.2	33.8	23.4	24.4	17.6	36.1	26.7	20.0	20.2	22.8	26.4	22.3	36.1	55.0	59.8	23.5	43.9	36.3	40.2	66.7	67.9	61.1	70.6	51.7	91.4	43.5	70.8	53.3	57.5	101.7	40.3	40.7	50.3	63.6	116.6	46.6	47.0	94.0	46.5	111.9	56.7	39.8	46.1	65.1	66.7	95.4	43.6	57.5	39.9	69.8	41.3	55.3	68.7	84.2	86.2	40.2	38.0	154.4	47.6	41.6	29.6	48.6	57.3	44.7	66.3	128.8	53.1	106.2	29.2	36.9	50.6	63.5	70.6	77.7	65.5	73.5	65.5	70.1	102.4	63.4	89.5	53.8	127.4	42.3	94.6	75.0	47.1	92.6	98.2	93.9	81.8	36.5	88.6	101.7	85.7	31.6	76.1	52.0	67.5	93.1	109.2	33.3	34.8	32.5	39.2	36.5	38.7	33.8	35.2	37.4	33.8	36.1	36.1	108.3	22.4	21.7	11.1	96.7	92.0	87.8	142.0	58.1	68.0	49.8	68.8	46.9	34.3	56.3	46.0	29.2	81.9	116.2	38.6	58.7	103.2	5.5	43.5	50.5	74.7	44.2	46.3	28.3	92.0	78.5	67.9	35.2	50.8	51.4	58.0	75.7	23.0	64.5	74.0	18.8	56.2	95.6	30.7	61.9	11.8	70.2	44.4	62.2	13.1	96.9	55.1	133.9	12.5	21.0	148.4	52.2	45.1	72.5	108.0	68.7	51.9	53.1	49.1	32.9	51.1	71.5	63.7	83.8	53.4	70.5	79.4	105.8	68.0	45.8	88.6
MED11	"HSPC296, MGC88387"	ENSG00000161920	"Mediator complex subunit 11"	Q9P086	17	4731428-4733608	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056669	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear bodies"		"HPA056669: AB_2683204"	"unprognostic (4.01e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (8.24e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.61e-2)"	20.5	41.3	28.6	22.5	32.0	11.2	20.3	32.3	33.8	21.1	28.2	25.4	27.2	18.9	25.3	29.2	24.4	19.0	29.5	28.2	30.5	32.7	38.6	22.9	28.5	31.9	31.2	16.8	29.0	35.6	19.1	16.4	31.6	23.3	23.4	17.2	26.6	19.5	39.0	27.2	26.5	16.9	30.4	34.5	30.6	16.2	31.3	25.3	22.4	32.9	26.5	22.3	21.3	35.3	26.2	73.5	26.9	27.8	28.6	34.6	20.7	18.4	30.8	26.4	33.0	25.6	19.7	35.7	18.9	22.3	17.2	38.8	27.1	51.9	20.5	42.5	63.1	17.8	42.6	40.6	17.7	12.9	20.7	30.1	35.6	28.3	17.3	28.2	30.3	36.4	18.1	26.5	23.4	37.6	24.8	16.8	16.0	39.3	23.6	24.5	19.7	23.3	54.3	27.5	10.9	18.1	23.7	31.5	18.5	22.0	28.4	15.1	18.1	14.1	14.1	27.4	29.3	12.5	11.8	14.2	24.4	22.0	18.8	49.1	31.0	79.3	41.6	45.6	45.4	62.8	40.8	41.8	31.0	61.9	48.3	53.1	136.3	40.9	68.0	49.8	33.7	38.5	28.6	32.0	32.3	33.8	28.2	30.5	31.9	31.2	31.6	30.4	31.3	35.3	12.5	6.4	23.5	7.8	31.5	12.2	28.8	42.6	19.4	22.1	20.0	17.8	15.1	32.9	32.3	14.7	10.4	45.4	34.3	32.8	64.6	37.0	1.2	35.1	24.8	15.8	10.8	13.5	5.5	35.3	34.2	17.3	28.5	25.0	29.1	9.3	22.5	29.4	33.8	30.3	7.2	30.9	48.8	31.5	21.1	3.8	17.4	25.5	10.6	5.6	44.6	20.9	50.4	5.0	14.6	22.4	51.1	13.9	18.8	22.9	66.4	99.5	36.9	26.6	19.7	16.5	18.2	56.6	49.9	31.3	18.8	25.0	27.3	33.8	29.7	28.6
MED12	"ARC240, CAGH45, FGS1, HOPA, KIAA0192, Kto, OKS, OPA1, TNRC11, TRAP230"	ENSG00000184634	"Mediator complex subunit 12"	Q93074	X	71118556-71142454	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003184, HPA003185"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA003184: AB_1079349, HPA003185: AB_1079350"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.89e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.16e-2)"	18.9	32.3	10.1	13.4	11.6	15.1	19.3	10.8	12.2	20.3	9.3	15.2	8.1	18.1	10.7	13.4	17.8	8.5	13.4	9.7	10.5	13.1	10.3	15.2	13.6	12.3	10.9	28.9	14.9	14.1	16.3	16.8	11.3	17.4	9.2	8.2	14.3	12.6	15.4	14.7	15.9	12.6	10.2	28.4	15.5	13.4	11.2	19.1	18.1	10.6	12.2	15.2	17.1	12.0	14.2	16.4	25.5	15.3	18.3	16.1	37.1	9.9	14.0	15.2	10.8	19.8	13.1	18.5	12.7	17.2	10.5	13.8	29.7	12.3	12.1	19.6	23.0	30.7	37.9	27.5	14.3	28.8	26.2	18.9	13.2	20.0	23.3	19.6	23.8	23.1	29.0	31.6	15.2	24.3	30.5	16.3	14.7	18.2	21.3	28.0	28.5	14.0	11.8	27.5	14.0	16.9	22.7	11.8	12.2	26.2	13.9	14.2	21.1	16.5	19.7	15.4	7.0	15.4	9.5	13.7	9.8	15.8	11.2	6.9	2.1	4.3	3.0	1.9	2.5	2.0	2.1	2.8	2.1	1.9	2.3	2.0	4.1	2.7	1.3	2.8	4.4	2.4	10.1	11.6	10.8	12.2	9.7	10.5	12.3	10.9	11.3	10.2	11.2	12.0	15.4	9.6	4.2	7.2	8.4	6.0	6.3	6.5	4.6	7.2	8.6	11.0	9.3	11.5	7.6	9.2	6.2	20.7	10.9	10.8	1.9	6.9	0.4	7.9	8.9	12.8	7.8	13.7	3.8	6.3	8.0	8.2	8.6	7.1	9.5	21.1	14.6	4.4	9.1	13.5	4.2	5.8	2.0	6.5	9.8	2.3	14.0	8.9	5.4	6.5	7.4	6.3	13.4	4.0	4.2	9.4	10.0	13.5	7.3	7.5	7.5	2.7	7.5	4.9	0.0	10.0	7.6	6.6	7.3	6.1	5.7	27.2	8.8	27.9	6.8	8.6
MED13	"KIAA0593, THRAP1, TRAP240"	ENSG00000108510	"Mediator complex subunit 13"	Q9UHV7	17	61942605-62065278	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067939			Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA067939: AB_2685928"	"unprognostic (7.26e-2)"	"unprognostic (4.50e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.30e-1)"	12.4	9.6	7.9	10.7	12.4	34.1	11.2	16.4	9.6	12.3	11.3	12.5	11.5	11.8	8.8	11.2	9.3	12.7	8.8	9.2	6.9	13.6	22.1	10.9	12.7	9.5	9.8	13.5	12.5	17.6	5.5	15.3	10.6	10.2	12.7	17.8	10.0	8.9	19.4	11.4	10.6	11.9	8.0	11.5	12.2	19.5	10.2	20.7	15.9	28.1	12.7	13.3	8.4	15.3	24.9	29.0	22.0	18.0	19.8	21.4	16.7	13.4	19.4	26.5	25.5	22.2	13.2	26.4	12.3	21.2	19.9	15.0	28.2	17.5	36.9	17.2	16.6	43.1	20.9	14.3	20.7	38.1	19.3	16.6	19.8	29.0	32.8	19.1	20.3	20.4	35.8	43.9	18.3	41.8	34.6	11.4	11.7	28.9	14.8	28.1	56.2	16.2	18.6	28.8	17.3	32.6	28.0	8.0	17.5	21.7	28.8	26.7	25.6	30.2	44.3	15.9	25.6	21.2	25.8	35.4	16.0	16.7	17.6	1.1	1.1	1.3	1.3	0.5	1.6	1.0	1.3	1.4	1.1	1.5	0.9	1.6	4.0	1.4	2.9	2.8	1.6	0.4	7.9	12.4	16.4	9.6	9.2	6.9	9.5	9.8	10.6	8.0	10.2	15.3	54.7	64.1	54.0	107.7	37.7	78.0	45.9	23.6	45.5	52.3	45.8	28.1	27.8	52.9	36.6	23.9	45.9	19.1	57.2	57.9	9.8	16.7	47.4	48.1	63.7	42.0	44.3	42.3	96.9	20.0	11.7	45.2	35.7	83.3	26.0	42.0	35.3	45.5	19.1	62.2	107.3	41.7	32.6	30.5	78.6	60.1	30.7	52.0	32.0	89.0	36.7	36.5	24.7	135.2	136.7	28.6	38.4	32.7	41.1	62.6	33.4	19.1	29.9	40.3	32.9	81.6	45.9	48.1	22.6	48.0	81.7	43.4	40.7	32.3	32.9	81.0
MED13L	"KIAA1025, THRAP2, TRAP240L"	ENSG00000123066	"Mediator complex subunit 13L"	Q71F56	12	115957905-116277693	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 303.9;Excitatory neurons: 311.5;Inhibitory neurons: 321.0;Microglial cells: 427.2;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 305.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"T-47d: 124.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA039445: AB_10673532"	"unprognostic (1.81e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (4.64e-1)"	18.4	7.9	5.5	15.8	7.3	52.7	20.8	27.0	6.3	15.8	5.3	12.9	10.3	20.5	6.5	13.8	12.5	13.2	11.5	6.4	5.9	12.4	7.9	14.4	14.6	9.2	7.3	24.3	17.5	15.3	5.5	16.3	6.9	12.7	13.5	12.6	14.8	12.8	18.6	19.0	13.4	15.9	6.3	16.6	12.2	13.8	7.7	39.1	18.0	25.8	16.2	13.1	12.7	10.7	16.9	33.2	19.6	16.9	23.6	42.0	16.5	15.8	21.3	23.7	16.3	25.2	5.9	13.3	13.6	29.0	14.5	9.9	20.4	14.2	29.6	24.3	14.0	26.9	10.0	7.2	26.2	24.8	28.6	30.6	21.8	26.8	40.7	17.4	15.9	28.2	28.9	11.4	18.7	21.8	42.1	22.2	10.5	7.1	8.2	28.7	25.0	24.8	11.1	18.4	17.7	12.4	14.2	7.8	15.0	34.9	124.8	39.9	20.7	26.0	16.8	17.2	19.5	17.9	9.7	21.6	12.0	22.3	12.8	1.5	0.6	1.5	0.2	0.3	0.2	0.3	0.5	0.2	0.7	0.7	0.3	0.4	3.5	0.3	0.4	1.1	0.0	0.1	5.5	7.3	27.0	6.3	6.4	5.9	9.2	7.3	6.9	6.3	7.7	10.7	84.4	64.1	54.9	303.9	47.5	99.2	38.4	21.7	70.6	52.4	51.4	42.4	35.6	21.5	35.5	25.8	54.2	9.4	38.5	30.5	3.9	13.5	84.0	42.5	115.2	56.9	31.3	49.6	311.5	26.0	19.6	56.0	29.0	96.7	14.0	93.4	53.6	30.6	21.1	57.2	321.0	31.8	14.2	48.7	60.6	47.2	92.2	60.5	32.0	427.2	56.4	22.8	17.5	352.8	305.4	26.8	21.0	67.0	65.6	49.4	22.7	12.3	27.2	44.6	46.0	61.9	57.0	20.3	23.3	48.0	101.6	14.2	30.5	23.7	25.9	51.0
MED14	"CRSP150, CRSP2, CSRP, CXorf4, EXLM1, RGR1, TRAP170"	ENSG00000180182	"Mediator complex subunit 14"	O60244	X	40648305-40735858	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064182			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA064182: AB_2685204"	"unprognostic (5.21e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.95e-3)"	"unprognostic (4.38e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.64e-1)"	10.8	10.2	11.7	12.5	13.4	22.4	9.8	13.3	15.9	11.8	15.2	14.3	17.9	11.2	20.4	13.9	9.7	9.6	14.5	11.7	13.2	11.3	15.1	11.0	17.3	13.0	12.1	13.1	12.0	18.7	10.7	13.2	13.5	11.0	14.7	19.2	9.6	9.4	60.7	16.5	13.9	10.1	10.8	11.1	12.4	5.1	14.3	24.9	14.6	33.4	18.6	14.2	12.6	16.0	44.3	21.4	33.8	30.0	14.7	19.0	6.9	17.1	21.3	24.1	30.6	19.8	21.4	25.4	11.4	21.8	51.7	32.7	57.8	27.1	35.9	23.3	43.5	25.7	25.8	18.1	15.8	27.2	25.4	13.7	16.3	35.3	30.5	28.5	29.5	16.6	17.7	24.1	25.5	22.8	25.1	24.2	37.5	27.9	24.7	12.6	36.1	25.6	23.3	20.2	21.6	19.2	40.6	18.3	19.2	62.7	26.8	16.1	26.9	24.5	25.6	31.1	21.2	22.4	24.6	25.2	23.7	18.4	18.1	1.9	1.5	2.8	1.9	3.2	2.2	1.6	1.8	1.8	2.5	1.5	2.0	1.6	0.8	3.5	1.8	1.3	1.8	1.2	11.7	13.4	13.3	15.9	11.7	13.2	13.0	12.1	13.5	10.8	14.3	16.0	12.6	16.0	12.0	36.9	17.5	23.7	11.7	8.4	11.4	16.5	13.9	9.8	14.1	11.5	12.1	12.9	18.8	6.3	22.2	24.0	5.9	8.4	0.8	16.9	14.8	12.9	20.4	8.4	30.9	10.0	5.4	11.3	29.6	21.6	10.8	21.5	8.2	20.9	9.3	18.5	35.6	19.0	8.2	15.6	17.4	1.0	8.7	17.3	12.4	27.2	16.0	6.3	12.3	41.7	63.5	13.9	15.0	8.6	23.8	17.6	19.1	9.2	6.8	16.3	26.3	12.7	14.2	20.5	7.7	18.7	30.3	6.6	16.7	12.5	17.2	27.3
MED15	"Arc105, CAG7A, PCQAP, TIG-1, TNRC7"	ENSG00000099917	"Mediator complex subunit 15"	Q96RN5	22	20495913-20587632	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 240.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003179	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA003179: AB_1079581"	"unprognostic (7.98e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (7.30e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (9.09e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.57e-2)"	33.0	32.6	16.4	28.5	20.5	42.1	28.7	24.8	33.5	31.0	12.9	34.1	31.7	40.5	6.2	33.4	26.2	23.1	26.4	17.9	18.4	24.1	14.9	35.8	31.6	14.9	15.7	26.5	22.4	15.2	20.6	25.0	18.5	26.2	11.9	8.8	26.7	14.9	55.1	36.1	30.9	17.3	9.1	31.8	23.9	20.1	13.5	23.2	23.3	15.8	16.1	33.9	30.7	26.2	73.6	38.5	24.2	29.3	25.0	24.2	44.3	72.9	52.9	56.4	51.9	58.8	32.5	29.6	32.9	51.8	25.4	74.1	22.1	54.2	22.7	42.5	39.5	56.4	42.2	43.2	41.4	51.7	49.6	29.7	41.7	44.7	45.0	31.8	44.3	22.2	240.2	26.8	36.4	49.0	21.7	29.4	26.2	32.2	26.0	37.7	54.7	12.1	34.3	52.7	22.7	39.0	55.0	54.9	77.4	15.7	31.0	28.7	80.4	90.3	67.6	48.7	59.4	35.3	34.3	22.6	65.3	31.5	82.5	6.3	11.8	10.5	24.3	12.4	11.5	5.7	16.9	27.8	10.1	6.3	9.7	16.4	13.0	21.9	23.1	9.0	28.9	15.0	16.4	20.5	24.8	33.5	17.9	18.4	14.9	15.7	18.5	9.1	13.5	26.2	24.4	51.3	30.9	26.4	19.4	29.8	26.3	25.1	22.8	20.2	18.7	17.5	4.6	12.8	26.5	25.8	18.8	48.9	33.4	46.9	15.6	32.3	34.3	36.3	24.9	25.6	18.0	10.3	31.4	28.6	42.0	21.4	39.8	49.1	20.8	21.3	23.6	9.7	31.4	15.2	32.7	26.0	14.2	24.1	35.1	19.8	14.3	31.1	24.9	34.7	30.7	13.8	47.4	21.6	28.2	67.8	43.4	14.7	24.8	40.2	36.5	11.9	33.1	16.3	46.0	23.2	23.3	22.6	15.4	26.2	27.6	61.8	43.7	24.7	25.4	36.5
MED18	"FLJ20045, p28b, SRB5"	ENSG00000130772	"Mediator complex subunit 18"	Q9BUE0	1	28329002-28335965	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027429	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA027429: AB_10610137"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.78e-3)"	"prognostic favorable (3.93e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.38e-5)"	"prognostic favorable (6.72e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.69e-2)"	4.9	7.7	1.8	3.9	1.8	2.8	4.9	2.0	2.3	4.0	2.5	9.4	4.2	5.7	3.6	10.0	4.8	2.2	7.0	1.8	2.0	7.6	15.3	3.9	5.6	2.0	1.9	3.3	6.7	2.4	4.6	3.1	2.0	4.8	4.3	1.8	5.8	2.8	9.2	7.2	9.4	2.9	1.8	10.2	7.8	5.8	2.1	3.8	4.1	3.1	6.0	5.6	5.2	2.2	12.6	6.1	6.0	5.2	7.9	7.6	6.7	7.4	8.7	9.4	8.1	3.5	11.6	15.6	7.5	7.6	5.7	7.7	9.7	9.1	7.3	10.6	6.9	12.0	5.4	7.7	10.9	7.3	12.3	8.1	11.0	7.4	11.2	5.6	8.2	7.6	11.6	4.0	8.9	6.1	9.3	9.2	7.1	6.9	3.4	6.7	8.7	8.3	8.3	6.2	5.8	6.1	7.4	7.5	10.9	6.3	6.3	6.9	10.0	5.7	6.4	9.4	7.8	6.9	9.8	8.5	8.4	15.2	4.1	3.6	3.4	5.1	3.2	3.3	2.4	3.7	2.5	2.7	2.9	2.7	3.1	3.2	5.0	2.5	4.2	3.9	3.7	3.4	1.8	1.8	2.0	2.3	1.8	2.0	2.0	1.9	2.0	1.8	2.1	2.2	3.3	9.6	4.8	0.7	5.1	0.8	4.0	7.9	1.8	3.1	1.8	2.4	5.9	4.3	7.6	1.8	12.5	11.9	12.0	7.9	7.9	7.9	0.4	7.1	4.8	2.7	3.5	3.2	0.8	6.0	13.5	3.0	4.6	4.6	1.3	3.4	4.2	4.3	7.9	10.1	0.8	5.9	6.1	4.1	0.9	0.7	4.7	3.5	1.8	0.0	7.0	4.5	10.3	0.0	0.7	5.7	7.2	5.3	2.6	3.1	8.0	8.6	5.9	4.6	19.7	2.5	5.4	7.5	7.7	1.9	1.3	14.8	4.6	4.8	4.6	6.0
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	8.1	11.8	6.3	7.7	7.3	6.1	10.9	9.1	8.0	10.6	7.9	10.6	10.5	9.7	13.5	9.8	9.9	7.7	11.6	6.5	7.1	12.8	10.4	7.4	10.0	6.6	6.6	8.2	9.3	10.6	6.4	13.6	7.0	11.2	11.8	5.9	8.7	10.2	14.5	9.7	8.7	12.0	5.8	9.2	9.7	7.4	7.2	12.7	11.9	16.6	13.3	10.2	7.6	9.0	28.5	23.0	25.7	32.1	23.1	24.8	31.7	18.2	17.1	25.9	20.5	29.5	20.3	41.4	34.3	23.0	15.5	22.0	39.7	26.4	31.2	22.2	14.7	37.5	19.6	28.6	23.9	30.5	22.2	18.6	36.8	22.5	33.3	19.6	33.9	36.4	49.0	19.3	32.7	25.7	36.3	22.3	35.1	93.5	19.3	48.0	29.4	15.1	34.9	19.9	23.7	18.6	25.3	12.6	26.5	28.7	24.7	32.4	33.2	18.2	38.9	11.4	22.5	19.3	27.1	85.7	9.9	33.3	26.3	18.7	24.9	18.4	10.7	29.4	14.0	19.0	7.3	12.2	26.1	23.6	9.4	11.3	9.3	17.4	20.7	23.5	14.4	16.7	6.3	7.3	9.1	8.0	6.5	7.1	6.6	6.6	7.0	5.8	7.2	9.0	4.4	9.6	3.9	2.3	6.6	3.7	4.2	7.2	6.8	2.4	7.0	5.1	5.2	2.8	6.8	7.3	0.0	22.7	7.3	6.6	7.9	6.9	0.6	5.1	7.1	4.2	9.6	8.0	2.8	3.3	18.6	5.0	6.1	6.7	7.0	8.3	8.6	8.3	8.7	1.7	2.8	5.6	14.2	6.3	2.6	0.7	3.4	3.7	1.8	4.7	6.3	3.7	7.2	5.5	3.0	4.9	3.1	6.8	5.7	4.7	5.8	10.1	4.6	4.2	0.0	3.6	4.9	8.3	13.6	5.8	5.7	24.9	3.0	7.1	7.2	5.4
MED21	"SRB7, SURB7"	ENSG00000152944	"Mediator complex subunit 21"	Q13503	12	27022546-27066343	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 228.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017177	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA017177: AB_1857665"	"unprognostic (3.02e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.74e-8)"	"unprognostic (3.18e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-2)"	16.7	24.9	10.5	9.9	11.4	29.0	18.2	14.6	15.2	25.2	11.2	20.4	12.2	20.3	15.0	23.9	19.2	15.0	25.4	11.2	11.6	26.2	16.1	16.6	13.0	9.4	9.5	24.9	13.3	25.7	17.8	16.4	9.6	18.3	16.9	12.4	20.9	17.0	27.9	15.8	12.0	21.8	10.1	12.0	16.3	29.7	10.5	21.1	18.9	35.5	17.1	22.6	23.8	11.3	36.6	40.5	18.6	27.5	41.3	36.1	29.7	46.2	24.5	30.2	32.5	42.5	37.3	21.4	25.9	26.5	54.2	30.7	41.1	36.3	53.8	21.6	36.8	36.5	37.9	22.4	22.0	41.3	21.2	31.1	46.4	45.3	50.0	54.0	46.6	30.8	25.8	28.2	34.7	27.1	38.1	63.8	54.3	50.1	49.8	29.3	133.5	23.7	28.1	37.4	13.4	17.7	57.3	18.2	26.1	79.9	34.6	26.4	39.0	34.8	28.7	43.3	40.3	9.6	21.4	37.8	34.7	39.4	23.3	54.9	23.8	33.6	26.2	26.0	25.4	28.8	30.0	30.8	22.5	26.9	35.2	30.4	18.7	19.0	24.6	18.3	34.5	26.9	10.5	11.4	14.6	15.2	11.2	11.6	9.4	9.5	9.6	10.1	10.5	11.3	30.9	16.0	23.0	7.8	35.4	98.9	121.4	95.1	72.8	9.9	39.4	33.5	32.1	22.8	45.0	53.3	0.0	62.0	33.1	18.5	93.9	41.7	228.6	32.7	26.3	33.0	17.9	68.8	23.8	38.0	56.8	50.8	18.8	35.1	18.4	31.3	25.7	21.8	31.7	13.5	17.6	20.8	65.1	21.7	50.2	87.8	48.4	22.4	71.2	7.5	29.1	27.1	11.3	10.6	14.4	33.4	19.9	47.4	24.5	85.3	22.4	109.3	20.8	13.6	19.7	37.4	54.8	157.7	61.8	70.5	101.3	61.0	46.7	30.6	20.4	145.8
MED22	"Med24, SRB6, SURF5"	ENSG00000148297	"Mediator complex subunit 22"	Q15528	9	133338312-133348131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020391, HPA063694"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA020391: AB_1857668, HPA063694: AB_2685093"	"unprognostic (2.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.56e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (4.99e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.46e-4)"	"unprognostic (3.99e-1)"	"prognostic favorable (3.76e-11)"	"unprognostic (9.25e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.62e-1)"	14.1	20.4	7.1	6.2	7.1	4.9	14.0	7.3	7.2	22.1	6.3	24.6	5.2	23.2	2.8	15.6	20.4	3.4	22.2	6.8	6.8	19.5	12.1	15.1	6.3	8.4	7.2	21.4	14.8	6.7	16.7	4.4	7.3	21.7	2.9	2.8	14.3	7.4	13.3	14.3	17.6	5.6	7.5	21.9	15.7	10.2	6.9	4.6	19.2	3.3	5.0	23.2	16.2	7.1	10.0	11.5	17.7	12.7	3.8	6.5	20.5	11.9	8.3	14.5	9.6	25.4	9.1	20.0	6.9	8.5	12.6	19.4	13.3	11.5	6.0	15.7	7.7	10.6	28.8	6.9	6.4	13.7	10.5	5.0	9.0	13.0	8.6	6.8	7.0	11.5	15.7	9.3	6.9	13.8	19.5	11.4	24.8	12.4	13.8	26.4	14.1	18.4	6.0	7.2	14.3	11.6	13.8	17.4	10.4	7.1	19.7	4.7	9.5	18.7	13.0	13.0	15.8	6.4	9.4	19.4	10.8	10.6	15.8	1.1	1.5	2.6	0.7	1.2	0.9	1.1	0.8	0.9	1.1	1.5	0.9	0.7	2.3	0.6	2.2	1.5	0.7	1.1	7.1	7.1	7.3	7.2	6.8	6.8	8.4	7.2	7.3	7.5	6.9	7.1	6.4	22.4	11.7	4.6	8.3	8.3	10.6	4.0	4.0	13.6	6.9	5.2	9.9	7.2	3.1	16.5	0.0	6.1	12.8	8.8	3.9	5.8	1.9	3.7	6.7	8.4	6.7	3.8	3.0	5.3	5.1	11.2	6.1	6.2	7.6	8.4	6.4	4.3	7.8	13.5	3.3	6.5	4.1	7.2	8.3	2.8	11.8	8.3	1.8	3.7	5.6	9.6	5.2	3.0	5.3	8.1	2.1	16.6	6.8	8.4	8.3	5.2	1.7	12.1	26.3	14.8	15.2	13.2	13.7	5.2	6.5	5.5	5.8	5.9	5.9	4.7
MED23	"CRSP130, CRSP3, DRIP130, MRT18, Sur2"	ENSG00000112282	"Mediator complex subunit 23"	Q9ULK4	6	131573966-131628242	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 72.0;Inhibitory neurons: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070341			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA070341: AB_2686257"	"unprognostic (1.11e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.53e-2)"	7.7	10.5	3.4	11.5	3.7	22.0	14.3	9.8	5.0	12.0	3.7	10.6	11.4	13.3	10.6	8.5	11.0	8.9	6.5	3.5	3.6	10.3	7.9	9.9	14.8	2.4	2.8	14.2	10.7	18.3	6.0	11.0	3.1	11.7	12.4	11.5	12.7	11.6	7.4	11.5	10.6	10.4	2.7	12.8	11.6	10.5	3.5	18.0	14.4	10.1	15.3	10.1	7.8	6.4	7.2	7.8	18.2	23.0	22.1	16.8	16.7	17.6	19.8	16.0	23.0	8.2	9.8	15.9	12.5	18.2	15.4	12.6	9.9	11.4	24.7	18.1	13.8	16.6	14.9	14.0	16.0	27.8	27.1	14.9	13.3	17.7	17.8	18.6	20.1	16.9	21.7	16.2	17.0	11.0	21.3	17.4	8.7	12.3	7.8	18.9	11.4	9.6	12.2	10.4	13.6	12.3	12.6	17.4	11.6	20.9	4.8	19.3	20.4	11.8	13.3	19.0	16.2	17.0	12.3	22.6	14.5	12.6	16.1	4.9	4.5	7.6	5.5	4.6	8.3	4.7	5.5	6.2	5.6	4.2	5.5	5.1	3.6	12.9	3.3	2.9	6.6	3.9	3.4	3.7	9.8	5.0	3.5	3.6	2.4	2.8	3.1	2.7	3.5	6.4	16.3	19.2	9.6	24.8	21.5	9.2	6.3	11.9	13.6	23.7	15.5	10.9	6.5	8.6	15.7	23.9	16.7	8.7	23.7	15.5	3.9	7.6	2.1	14.8	14.7	13.9	14.4	12.0	72.0	7.7	6.8	12.5	14.3	16.6	14.0	18.3	14.3	12.4	8.1	11.8	67.1	17.4	6.1	17.6	9.5	3.2	14.3	12.8	5.4	36.5	16.9	7.7	21.6	42.3	60.8	9.1	14.9	10.1	19.4	10.7	14.7	8.5	13.4	24.4	13.1	13.8	10.2	13.5	5.3	12.0	8.7	7.8	20.7	14.6	14.3	12.8
MED25	"ACID1, ARC92, DKFZp434K0512, TCBAP0758"	ENSG00000104973	"Mediator complex subunit 25"	Q71SY5	19	49818282-49840383	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068802	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA068802: AB_2686039"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (6.67e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.02e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.04e-3)"	21.6	76.1	16.2	18.5	14.4	34.5	23.7	14.7	23.4	28.6	28.4	30.5	18.6	36.2	8.7	32.3	33.3	14.8	42.5	16.3	15.5	27.7	15.8	26.4	18.3	16.3	17.5	44.9	30.6	15.8	43.7	18.9	15.8	23.8	13.2	16.0	26.9	11.9	97.8	28.7	27.9	16.0	13.2	30.5	39.3	82.1	16.6	16.9	39.8	18.4	17.8	27.3	26.4	12.9	44.6	65.3	30.5	33.3	20.8	18.4	30.7	23.6	27.4	37.3	36.6	58.7	50.1	51.2	16.3	30.9	25.6	38.4	32.8	34.0	23.1	30.9	58.3	33.7	45.6	41.2	24.6	36.0	46.1	22.7	28.3	32.8	22.9	31.4	32.3	29.0	61.6	36.3	20.8	25.5	36.0	69.8	22.5	36.9	40.6	43.5	30.3	53.3	33.6	64.1	54.4	50.1	32.4	48.9	15.2	23.3	29.1	27.1	39.3	40.1	29.2	19.4	26.6	41.3	63.1	55.3	35.6	30.8	24.4	0.8	2.2	3.8	1.3	1.7	1.5	2.3	1.1	1.4	1.8	3.3	1.2	0.8	13.8	0.9	1.6	2.2	1.4	2.0	16.2	14.4	14.7	23.4	16.3	15.5	16.3	17.5	15.8	13.2	16.6	12.9	10.6	35.3	22.9	17.0	18.5	5.6	15.8	16.0	10.2	10.8	17.7	13.3	5.7	8.6	16.8	20.2	43.8	27.5	16.1	28.8	1.9	23.6	54.3	58.3	18.3	10.8	44.3	54.7	10.5	24.3	22.8	15.8	23.0	24.1	7.6	62.5	7.1	5.8	21.5	8.4	12.6	18.8	18.3	13.8	11.6	111.7	15.8	16.5	3.6	7.5	22.8	9.1	11.3	10.6	10.9	28.7	28.6	11.3	20.4	8.8	27.8	17.6	77.4	28.3	13.1	11.9	19.8	49.1	39.0	11.3	5.3	33.8	14.5	62.0	18.0	16.5
MED26	"CRSP7, CRSP70"	ENSG00000105085	"Mediator complex subunit 26"	O95402	19	16574907-16629062	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.4;Late spermatids: 67.4;Spermatocytes: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057997, HPA071835"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA057997: AB_2732618, HPA071835: AB_2686455"	"unprognostic (2.02e-2)"	"prognostic favorable (2.46e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (5.50e-5)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.98e-3)"	4.5	3.8	4.4	3.8	4.0	11.0	4.1	5.1	4.7	4.0	4.0	4.1	2.4	4.3	1.8	5.2	3.2	2.3	3.2	5.0	5.1	2.8	3.7	4.0	4.9	5.2	4.7	4.7	3.9	3.5	3.6	3.2	4.7	4.2	1.9	2.0	4.5	2.4	6.9	6.4	3.6	2.5	3.6	4.7	3.6	35.9	4.5	4.4	3.1	3.2	4.6	3.9	4.6	4.2	11.1	4.2	3.8	8.3	4.8	3.8	11.1	6.3	4.4	6.7	6.0	6.3	6.5	17.6	6.5	4.0	2.1	8.2	5.9	6.3	4.6	13.0	12.2	6.9	4.2	5.1	4.7	7.9	6.3	4.6	6.1	5.7	5.9	4.0	3.6	9.1	11.5	20.7	4.2	11.1	8.4	7.4	9.0	5.2	13.4	8.7	5.8	19.3	4.0	4.3	10.0	5.4	5.5	5.3	6.4	2.7	3.9	10.3	4.5	8.5	6.8	10.4	8.5	14.3	12.6	14.4	6.0	10.4	5.0	0.7	0.1	0.1	0.5	0.3	0.1	0.4	0.0	0.2	0.2	0.7	0.3	0.0	0.3	0.4	0.1	1.4	0.7	0.1	4.4	4.0	5.1	4.7	5.0	5.1	5.2	4.7	4.7	3.6	4.5	4.2	13.7	3.2	12.7	11.4	11.8	14.1	5.0	3.8	11.4	4.2	14.3	12.2	1.1	2.8	3.0	5.5	10.4	6.2	15.8	5.9	3.9	4.4	65.4	12.9	7.7	6.1	2.4	5.0	8.6	4.0	11.1	7.0	5.6	16.6	1.3	5.8	4.2	5.6	5.0	5.0	7.6	4.7	2.0	8.5	10.7	67.4	6.5	9.9	1.8	1.9	4.9	6.0	4.1	7.1	8.5	6.0	3.0	3.8	15.9	6.7	3.6	2.0	3.5	6.4	0.0	17.7	8.0	54.1	19.4	11.5	10.7	16.8	11.0	6.1	5.1	8.7
MED27	"CRSP34, CRSP8, MED3, TRAP37"	ENSG00000160563	"Mediator complex subunit 27"	Q6P2C8	9	131852928-132079867	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 87.7;Oligodendrocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007002	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA007002: AB_1078574"	"unprognostic (8.81e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.60e-2)"	14.6	14.7	20.4	10.1	22.7	18.4	14.8	19.6	22.1	14.0	17.6	16.6	8.3	19.0	23.5	17.0	15.2	9.6	18.5	22.8	19.7	14.6	9.9	14.0	15.4	20.3	19.2	12.8	9.0	15.8	17.1	13.1	19.6	15.5	11.1	13.7	11.3	13.7	20.9	20.5	11.7	16.7	19.3	14.2	12.9	18.2	19.3	28.2	13.3	14.4	14.1	17.3	13.7	21.7	33.1	29.8	40.9	32.0	28.4	24.7	33.3	34.7	48.8	73.9	58.8	53.0	29.4	31.7	21.5	39.3	48.1	60.9	54.5	51.8	46.8	34.6	36.1	24.5	31.1	31.3	42.7	43.2	33.4	28.9	37.9	57.9	61.4	22.9	41.4	52.1	36.7	29.0	57.2	57.8	52.4	30.8	40.6	36.5	62.6	44.7	51.0	43.6	31.0	17.8	72.5	28.9	44.4	22.7	26.5	25.7	37.6	22.1	29.5	71.8	31.4	52.6	51.5	10.8	32.0	57.2	40.3	33.9	50.6	5.7	18.1	21.2	26.5	28.6	21.5	16.7	20.2	26.3	28.3	19.3	16.5	21.8	7.0	27.8	24.9	29.2	30.0	18.7	20.4	22.7	19.6	22.1	22.8	19.7	20.3	19.2	19.6	19.3	19.3	21.7	10.4	16.0	7.8	55.8	12.0	6.0	14.4	28.2	18.8	24.6	3.8	6.7	6.2	2.8	17.2	12.9	18.8	33.1	14.5	4.7	13.7	15.0	14.3	8.6	10.3	12.4	5.3	6.3	87.7	16.7	20.4	12.0	10.2	8.3	10.8	12.6	6.8	5.2	17.5	21.9	63.3	5.5	18.3	3.1	5.0	8.4	14.3	9.1	7.2	33.7	10.1	25.0	3.1	69.4	130.0	16.1	2.0	17.0	13.9	7.0	2.3	7.8	9.2	20.0	6.6	16.7	17.0	24.2	28.7	10.9	5.1	54.7	15.5	18.8	4.8	10.1
MED28	"DKFZP434N185, EG1, magicin"	ENSG00000118579	"Mediator complex subunit 28"	Q9H204	4	17614641-17634105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035900, HPA035901"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA035900: AB_10673223, HPA035901: AB_2674853"	"unprognostic (1.14e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.07e-3)"	6.9	5.6	8.8	7.5	9.3	12.2	9.2	9.4	8.8	12.2	8.8	9.8	5.9	11.5	9.7	7.9	10.6	5.2	6.4	8.4	9.4	7.7	6.2	9.7	10.8	9.4	8.8	14.8	7.3	6.6	10.3	8.5	8.4	9.1	6.9	11.7	9.2	7.3	12.6	10.2	9.6	7.2	8.6	10.2	8.7	6.0	9.6	11.2	9.8	5.9	11.1	9.1	9.9	11.9	4.6	2.9	23.2	11.7	10.0	7.8	9.4	6.5	7.7	8.6	7.8	8.1	10.9	12.6	4.5	6.0	7.6	4.5	14.1	7.0	8.6	5.0	7.0	22.2	10.1	12.3	7.0	15.7	10.7	7.6	9.6	5.4	4.5	9.0	7.5	18.0	20.0	11.3	7.7	4.5	23.3	27.0	16.1	9.1	4.8	17.8	8.5	5.9	8.2	6.8	16.6	8.3	5.7	4.9	5.7	13.6	9.3	16.0	9.4	5.6	3.9	4.0	6.2	8.4	4.0	16.1	5.1	14.9	6.1	5.2	6.6	6.5	4.5	5.2	4.4	5.5	4.9	4.2	6.4	5.6	6.4	5.0	9.0	5.5	4.4	4.4	4.2	7.5	8.8	9.3	9.4	8.8	8.4	9.4	9.4	8.8	8.4	8.6	9.6	11.9	45.7	19.2	27.6	4.9	67.6	92.2	114.0	86.2	46.1	42.6	54.9	65.8	19.5	38.6	55.2	22.0	16.7	114.5	69.9	25.9	84.1	61.6	11.6	31.2	47.3	63.9	44.3	93.2	5.1	53.8	167.8	57.9	19.4	35.5	59.1	78.4	52.5	31.5	93.9	33.7	5.8	41.2	65.1	74.1	103.0	20.4	56.5	61.7	60.5	5.6	115.4	58.9	94.7	9.5	8.9	57.2	47.4	47.0	33.0	110.2	33.6	58.8	40.6	35.1	32.9	50.5	74.7	76.0	100.5	46.0	93.5	134.6	61.3	62.7	47.5	104.6
MED29	"DKFZp434H247, IXL, MED2"	ENSG00000063322	"Mediator complex subunit 29"	Q9NX70	19	39391303-39400641	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055956			Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055956: AB_2682986"	"unprognostic (3.30e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (9.51e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.87e-2)"	18.8	28.6	38.3	16.0	39.5	18.1	19.0	37.5	39.5	22.6	27.9	23.1	17.2	23.2	21.4	16.3	28.7	17.1	24.1	37.8	37.0	21.8	27.9	17.4	19.1	39.6	39.2	31.9	24.0	42.0	27.9	15.6	37.7	23.1	13.1	18.3	23.1	22.8	38.0	17.7	17.4	18.5	37.2	19.7	20.2	16.5	42.1	18.6	29.9	14.1	16.7	20.7	17.5	38.9	28.3	73.2	21.7	22.3	31.0	23.5	17.3	29.9	31.9	27.1	21.8	36.2	26.6	20.9	38.9	27.7	23.7	14.5	20.3	25.4	16.1	40.8	37.3	26.9	28.8	24.6	25.2	25.8	22.7	25.0	20.3	28.5	31.5	29.3	21.8	39.4	18.1	25.3	27.9	36.7	25.3	7.7	16.6	34.5	25.4	41.3	29.8	29.6	26.3	47.0	33.3	30.1	60.8	39.4	26.6	13.1	30.8	27.9	25.2	22.9	23.8	29.0	30.4	32.5	40.3	35.2	32.3	19.2	37.7	48.2	48.3	41.2	38.3	59.7	38.2	46.5	35.7	35.2	36.9	43.0	42.4	40.6	54.2	40.0	77.5	30.0	46.8	47.0	38.3	39.5	37.5	39.5	37.8	37.0	39.6	39.2	37.7	37.2	42.1	38.9	33.6	28.9	41.1	8.8	36.5	22.2	30.2	31.9	25.6	24.9	45.0	57.9	36.5	25.8	30.1	31.3	12.5	36.6	34.9	53.3	52.8	28.0	49.8	46.6	40.6	30.4	32.8	27.8	8.1	28.4	31.4	36.3	126.9	46.7	43.7	28.0	37.5	43.4	40.7	23.5	10.1	40.2	40.7	40.3	72.5	71.6	38.5	46.9	28.4	8.4	38.1	37.5	26.8	5.5	13.5	25.5	60.2	32.4	47.8	17.6	86.8	62.3	37.1	15.9	52.6	33.3	52.5	34.8	16.4	29.3	20.3	28.9	40.1	27.9	32.7	17.9
MED30	"THRAP6, TRAP25"	ENSG00000164758	"Mediator complex subunit 30"	Q96HR3	8	117520713-117540262	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 169.9;Suprabasal keratinocytes: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045767			Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA045767: AB_2679446"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (5.38e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-2)"	18.4	9.4	10.7	11.6	11.4	44.6	17.6	11.4	14.4	15.5	10.1	14.6	9.3	15.7	8.3	12.6	18.4	6.6	11.0	10.4	10.6	8.2	15.2	13.0	17.3	11.1	10.8	20.1	9.1	7.3	10.0	11.4	11.1	11.4	11.6	5.0	9.7	10.3	10.4	17.0	12.4	9.3	11.5	14.0	11.2	11.4	10.9	25.1	12.1	10.4	15.3	13.3	14.9	12.7	54.0	5.6	20.8	13.9	14.2	13.3	22.9	15.9	16.9	23.8	29.4	10.2	26.2	42.7	24.7	8.7	18.3	23.7	18.6	12.4	30.4	57.4	23.0	34.7	3.2	13.2	15.6	27.7	28.9	12.3	13.8	12.3	27.5	8.8	14.9	60.7	19.7	25.2	11.4	12.7	85.9	70.9	11.6	50.6	38.7	31.5	26.1	19.1	12.2	9.3	29.2	24.7	18.8	42.6	25.6	18.8	10.3	35.1	7.1	11.5	30.2	21.2	28.0	22.0	16.1	50.1	10.7	31.2	19.7	64.0	37.9	111.3	46.7	46.2	49.7	56.3	46.8	46.7	42.8	63.6	51.8	49.4	90.7	44.5	69.9	82.5	55.6	43.4	10.7	11.4	11.4	14.4	10.4	10.6	11.1	10.8	11.1	11.5	10.9	12.7	47.6	9.6	21.7	9.1	71.4	169.9	81.2	65.2	52.9	6.0	33.7	46.6	5.5	25.8	32.2	9.2	6.2	45.3	62.8	27.9	11.7	22.6	32.7	49.5	38.0	33.2	37.7	35.7	10.0	22.7	69.4	46.9	15.8	42.0	21.5	15.7	30.0	21.9	30.4	0.0	12.7	43.4	42.7	28.8	65.4	11.9	59.7	37.7	40.9	6.5	23.5	10.4	43.3	9.0	18.4	20.5	34.4	37.2	37.5	76.5	24.2	16.9	64.8	5.3	32.9	68.4	44.6	47.8	37.1	46.4	152.3	61.6	60.4	13.5	35.5	72.1
MED31	"CGI-125, Soh1"	ENSG00000108590	"Mediator complex subunit 31"	Q9Y3C7	17	6643311-6651634	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035947	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA035947: AB_10696646"	"unprognostic (1.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (6.87e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	12.1	22.4	17.2	9.3	19.3	9.9	14.4	17.2	26.4	13.2	17.6	9.6	8.7	11.2	26.5	25.0	12.8	12.5	15.6	18.3	19.7	16.6	18.2	11.0	14.8	17.1	17.8	12.8	9.7	13.1	25.3	9.7	18.6	12.5	8.5	10.8	12.8	8.9	14.4	21.1	10.3	12.4	17.5	16.5	10.9	17.5	19.4	13.7	14.7	10.6	14.7	14.2	14.4	17.1	37.7	41.2	36.4	23.2	32.5	27.4	13.1	28.8	29.5	43.6	56.6	20.6	19.2	5.0	35.6	14.3	32.3	40.5	29.2	35.7	37.7	27.1	48.9	9.3	34.5	32.3	24.4	10.5	18.8	15.2	37.8	39.6	13.4	23.2	32.8	20.0	16.5	9.4	32.2	13.7	20.2	27.4	13.0	16.9	23.5	15.0	16.2	13.6	36.7	18.4	14.5	16.0	14.8	11.8	33.1	17.2	12.3	11.5	14.8	21.3	18.6	27.1	29.2	8.5	11.9	12.8	29.4	12.4	15.4	77.7	22.6	38.6	26.0	16.4	24.7	22.7	24.2	25.7	19.9	23.7	21.5	23.1	63.3	23.7	20.0	25.6	31.2	20.2	17.2	19.3	17.2	26.4	18.3	19.7	17.1	17.8	18.6	17.5	19.4	17.1	34.1	16.0	22.9	13.4	37.0	106.9	48.3	92.3	68.3	8.4	38.0	35.3	4.8	37.1	47.6	33.1	10.4	40.8	29.1	23.1	54.8	36.4	34.2	78.8	31.9	35.7	12.6	30.5	32.7	31.5	40.3	31.5	15.3	38.6	26.6	21.4	39.3	57.1	33.7	13.5	24.6	23.1	59.0	23.9	37.9	62.5	44.4	25.1	40.9	12.2	29.3	22.9	21.6	18.1	21.9	46.4	15.3	26.4	34.4	51.0	22.4	81.8	97.2	12.8	39.5	29.7	33.7	101.9	81.3	46.6	120.2	47.9	37.5	35.6	19.3	66.6
MED4	"DRIP36, HSPC126, TRAP36, VDRIP"	ENSG00000136146	"Mediator complex subunit 4"	Q9NPJ6	13	48053323-48095131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006232	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA006232: AB_1079351"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.79e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.34e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.54e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.84e-1)"	44.2	34.1	26.5	34.0	26.0	78.6	46.7	33.6	35.1	37.2	25.2	41.3	40.6	40.3	43.5	41.1	31.2	32.9	49.4	26.5	26.7	38.4	51.4	36.9	46.7	25.7	25.5	31.9	27.4	43.2	31.4	45.6	27.0	36.7	46.4	41.4	33.6	38.5	57.7	39.9	41.1	43.2	25.7	35.9	33.9	55.9	26.2	63.7	41.1	58.4	55.5	43.4	35.8	28.4	40.2	25.8	86.1	47.8	55.8	71.4	59.5	57.1	70.9	66.8	47.1	49.3	66.9	65.2	16.0	60.5	41.3	59.6	63.1	54.2	86.7	85.0	51.9	85.6	49.5	77.6	51.7	128.1	76.4	49.6	75.2	39.7	58.2	65.2	63.1	64.8	61.9	40.7	75.5	40.6	121.3	121.4	85.4	128.2	33.5	87.4	58.3	52.9	87.0	61.7	38.0	61.2	46.5	57.8	63.4	55.5	49.3	94.6	51.1	37.5	43.4	47.0	52.7	39.2	61.7	100.2	32.2	65.9	72.6	105.0	65.5	106.3	74.6	70.0	82.6	65.4	84.2	76.6	64.5	58.0	80.4	77.0	69.8	86.6	74.3	58.5	101.6	91.2	26.5	26.0	33.6	35.1	26.5	26.7	25.7	25.5	27.0	25.7	26.2	28.4	71.3	96.1	53.4	12.7	71.1	91.3	72.8	164.9	34.7	51.5	48.1	42.9	100.8	60.1	116.5	57.0	16.7	116.4	96.0	51.7	152.6	79.4	87.9	46.4	69.8	73.8	26.9	106.9	24.7	63.4	104.4	74.1	31.6	60.5	98.1	43.9	59.3	66.8	70.3	37.0	20.1	51.2	124.1	51.9	65.4	185.6	76.7	51.2	78.2	14.0	136.6	65.2	102.0	20.1	20.4	66.8	67.4	77.5	46.5	69.7	66.1	100.1	62.8	50.2	52.6	58.7	78.7	141.4	162.8	48.6	97.3	134.9	79.4	61.1	56.9	71.5
MED6	NY-REN-28	ENSG00000133997	"Mediator complex subunit 6"	O75586	14	70581257-70600690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030764, HPA069039"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA030764: AB_2673601, HPA069039: AB_2686070"	"unprognostic (1.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-2)"	13.0	14.9	13.3	14.0	13.3	21.6	17.2	22.5	17.3	14.8	10.6	13.2	11.8	14.8	17.7	17.2	15.0	12.2	14.6	12.6	13.8	11.5	16.8	13.0	24.3	10.3	11.6	19.0	11.2	12.2	12.1	15.3	10.8	11.2	13.0	22.0	12.3	12.4	23.2	18.6	12.2	14.4	10.1	15.0	12.4	13.7	12.9	24.3	14.8	22.6	26.5	16.4	13.9	13.3	81.0	43.5	56.1	24.2	29.6	32.0	44.9	39.6	42.7	60.8	60.3	43.8	48.9	60.9	22.7	34.6	36.0	37.9	67.5	41.0	64.4	44.0	35.7	44.8	31.6	59.5	36.0	39.5	34.4	36.1	47.2	43.1	39.7	26.7	48.1	45.8	42.3	37.4	45.2	60.3	56.7	53.2	41.9	56.7	53.7	46.5	51.9	32.0	37.8	42.4	37.9	40.3	41.8	44.3	47.0	32.6	69.2	49.1	37.7	49.7	71.2	24.8	37.3	39.2	63.7	85.8	43.1	34.1	34.7	19.1	16.2	24.6	17.6	18.9	20.9	17.9	23.1	20.3	18.5	20.2	21.3	21.7	15.8	22.6	22.9	13.9	23.4	14.1	13.3	13.3	22.5	17.3	12.6	13.8	10.3	11.6	10.8	10.1	12.9	13.3	36.7	19.2	25.7	16.0	48.7	19.4	34.2	50.3	28.5	73.5	23.0	21.1	7.4	12.8	34.5	18.4	79.2	39.1	49.4	13.9	5.9	30.3	7.6	22.7	24.9	27.6	22.1	22.5	27.1	23.1	44.3	30.1	24.5	30.5	46.3	29.5	25.4	15.0	26.2	26.9	24.2	14.0	20.3	19.2	15.4	6.3	27.1	21.4	17.8	16.9	30.4	38.5	47.4	18.6	18.6	27.2	19.5	29.3	41.6	38.3	22.5	14.1	37.2	97.7	26.3	28.0	26.4	25.3	37.7	23.5	20.0	49.0	44.7	25.2	14.8	39.2
MED8	"ARC32, MGC17544, MGC19641"	ENSG00000159479	"Mediator complex subunit 8"	Q96G25	1	43383917-43389808	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028377, HPA028438"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA028377: AB_10600112, HPA028438: AB_10600057"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.11e-7)"	"unprognostic (7.08e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-1)"	30.4	27.8	24.0	20.9	25.1	27.0	26.5	24.6	29.1	24.0	27.3	25.1	23.1	21.8	24.0	43.5	20.6	16.8	20.7	24.6	25.1	27.3	43.6	24.4	21.7	26.8	25.0	21.9	29.5	20.9	36.3	25.5	26.1	23.7	24.7	40.3	26.9	20.5	22.4	36.4	22.9	24.3	24.8	25.9	28.2	22.3	25.3	17.5	25.6	14.5	28.1	24.1	27.3	27.2	56.8	35.3	31.8	38.0	48.7	48.2	42.7	56.5	51.4	65.8	69.3	65.7	40.7	33.2	39.7	71.8	43.2	34.7	50.2	47.7	62.9	47.9	48.5	56.5	60.5	82.8	82.3	50.7	57.5	47.5	60.6	71.2	84.6	39.4	53.3	31.1	50.8	57.1	42.9	36.4	26.1	40.8	30.5	52.3	39.9	30.9	37.3	53.6	43.5	35.8	33.2	25.1	33.2	53.7	111.9	43.6	36.3	97.8	39.9	29.2	52.0	55.9	80.5	67.5	83.4	40.2	60.8	61.2	39.0	44.7	57.0	54.9	33.6	53.1	32.1	44.5	30.5	38.0	57.0	36.8	30.7	32.0	45.3	32.6	48.4	26.2	43.3	38.8	24.0	25.1	24.6	29.1	24.6	25.1	26.8	25.0	26.1	24.8	25.3	27.2	25.6	16.0	12.9	5.9	25.8	18.7	23.2	35.6	11.4	27.7	23.9	23.4	12.6	27.1	28.2	14.7	14.6	52.9	26.2	26.4	33.2	51.1	13.6	16.3	23.9	25.1	19.3	42.5	11.5	75.6	72.3	30.3	23.0	19.7	31.7	21.8	16.4	27.8	60.4	16.8	8.0	29.2	28.5	18.2	32.0	22.8	24.5	26.2	19.6	4.7	35.9	32.3	28.8	6.6	13.8	57.9	30.0	21.8	41.2	24.6	40.8	48.5	16.0	58.7	26.3	12.3	42.9	64.6	45.0	24.3	25.4	88.4	23.3	31.9	22.6	39.9
MED9	"FLJ10193, MED25"	ENSG00000141026	"Mediator complex subunit 9"	Q9NWA0	17	17476994-17493221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056415	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Midbody	"HPA056415: AB_2683120"	"unprognostic (1.81e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (3.96e-2)"	"prognostic favorable (2.83e-9)"	"unprognostic (2.26e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-1)"	9.3	14.9	21.6	4.9	23.0	10.6	10.3	20.6	28.0	12.4	19.2	11.3	8.2	12.1	11.9	10.2	8.6	4.6	32.7	22.5	21.0	20.4	23.6	7.3	6.8	21.8	22.1	9.4	10.0	18.3	12.8	5.7	20.6	11.8	7.4	9.9	12.9	8.5	27.3	14.2	9.4	5.8	20.9	10.4	12.4	10.9	22.3	11.6	13.8	41.5	6.7	8.8	9.4	21.8	12.0	15.0	12.7	13.7	10.0	9.0	11.0	9.6	11.9	14.5	13.0	22.0	5.9	14.7	10.8	9.9	8.8	15.3	16.3	13.2	13.5	9.6	26.3	9.0	10.0	15.9	10.8	7.2	7.5	14.6	12.3	12.2	12.5	10.8	10.0	21.3	10.7	6.7	9.7	10.1	32.7	14.9	11.7	24.8	15.4	24.8	28.7	9.8	13.0	8.4	8.2	13.0	12.6	9.8	21.7	47.6	11.6	9.3	6.8	10.6	12.3	18.6	15.3	12.4	9.9	8.2	13.3	12.5	11.5	2.6	7.0	11.8	9.3	9.5	12.3	9.9	9.7	9.7	7.7	9.1	10.2	11.4	2.3	10.7	12.4	12.5	10.2	7.8	21.6	23.0	20.6	28.0	22.5	21.0	21.8	22.1	20.6	20.9	22.3	21.8	6.0	3.2	4.4	10.1	5.8	4.6	8.9	5.5	5.2	25.9	8.2	6.7	19.6	10.0	5.0	9.2	14.6	8.6	8.1	9.1	11.7	6.6	8.7	6.0	6.3	6.0	15.7	4.2	14.4	4.5	5.8	5.6	11.7	8.8	0.0	14.5	7.5	5.5	6.1	16.8	12.9	9.6	8.2	4.4	2.8	8.9	5.6	4.0	1.8	1.9	4.7	24.1	10.3	14.1	6.5	3.3	5.7	9.4	7.2	8.4	9.5	6.1	4.0	25.0	0.0	6.0	6.9	10.9	29.9	5.6	4.8	9.6	6.6	13.4	8.1	9.0
MEF2A	"RSRFC4, RSRFC9"	ENSG00000068305	"Myocyte enhancer factor 2A"	Q02078	15	99565417-99716466	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 262.8;Microglial cells: 708.3;Oligodendrocytes: 264.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004499, HPA046597"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004499: AB_627921, HPA046597: AB_2679714"	"unprognostic (1.89e-1)"	"unprognostic (8.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (6.93e-4)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-3)"	32.8	22.9	18.7	20.3	25.4	18.3	22.1	16.4	27.6	27.7	12.9	23.5	12.8	34.5	23.8	21.7	21.8	22.6	89.7	21.9	12.1	24.8	24.5	30.4	25.0	17.4	20.7	30.1	12.8	37.6	9.8	26.4	15.4	23.0	15.0	24.2	19.5	23.7	61.5	54.8	17.6	35.7	18.4	27.2	17.8	15.0	28.4	23.3	19.7	81.9	22.9	22.5	16.6	25.7	17.9	10.1	16.7	8.5	20.7	26.3	8.2	17.8	40.8	14.4	19.5	10.4	24.4	22.3	24.5	38.6	22.1	19.3	17.1	14.1	18.6	15.3	24.8	45.2	22.3	9.4	35.4	18.1	21.3	17.6	23.2	19.3	39.7	59.6	26.5	18.3	16.3	41.6	27.0	7.4	29.7	26.3	8.9	11.9	14.6	43.3	36.1	18.5	29.5	24.9	10.7	14.8	27.2	11.6	51.0	17.6	11.0	16.4	43.7	39.8	21.9	19.9	21.7	22.6	27.8	48.5	27.8	19.6	38.7	7.7	12.1	14.3	3.9	15.6	3.3	15.8	3.6	3.6	13.3	12.1	5.0	3.9	10.8	6.5	19.3	7.8	2.6	5.6	18.7	25.4	16.4	27.6	21.9	12.1	17.4	20.7	15.4	18.4	28.4	25.7	152.7	80.1	43.9	113.9	87.2	88.6	31.7	26.9	62.0	52.0	31.6	37.0	175.8	20.0	40.7	29.5	50.1	7.7	32.9	26.5	25.4	18.0	10.4	80.3	60.6	100.6	12.7	24.8	262.8	18.8	3.4	61.5	34.7	130.7	31.0	30.5	50.3	41.0	39.5	30.3	174.9	17.2	12.2	107.5	63.1	7.8	55.9	104.1	35.6	708.3	65.8	25.2	23.7	157.3	264.4	26.8	22.6	64.7	55.6	27.0	18.9	19.7	51.7	44.9	72.3	62.4	69.4	29.9	29.6	29.4	50.4	9.2	27.8	28.8	17.9	26.8
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145567-19192131	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 39.3"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 29.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"Daudi: 223.4;U-266/70: 217.6;U-698: 299.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	3.0	1.8	4.4	13.9	5.4	2.3	2.6	4.4	6.1	4.0	4.4	3.1	1.8	2.3	0.7	2.2	3.5	1.4	2.2	4.5	4.7	2.7	3.8	2.6	39.3	5.2	4.9	3.9	1.5	0.4	2.6	1.0	4.8	4.5	1.1	0.9	2.6	1.3	1.0	2.8	4.9	1.3	4.3	8.8	2.6	3.2	5.2	1.8	3.4	0.7	31.5	2.3	3.3	6.1	2.3	0.5	1.5	2.1	1.3	2.5	2.2	1.3	0.9	1.8	2.2	0.0	3.2	223.4	1.0	0.9	0.5	2.0	0.3	0.8	0.3	1.0	5.1	1.4	0.6	1.1	2.8	1.2	2.0	1.0	1.8	1.1	1.6	1.0	0.1	4.2	0.9	3.9	0.8	3.9	1.6	1.8	0.2	0.2	12.8	4.6	0.9	5.2	0.5	0.3	0.3	1.8	2.5	0.3	1.7	0.0	0.0	2.5	0.7	1.1	4.0	6.9	1.8	217.6	24.0	299.5	2.6	3.9	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	4.4	5.4	4.4	6.1	4.5	4.7	5.2	4.9	4.8	4.3	5.2	6.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	29.3	0.0	0.0	0.0	0.0	0.0	6.6	0.0	1.4	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 555.4;tongue: 246.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 471.5;Excitatory neurons: 735.7;Inhibitory neurons: 759.5;Microglial cells: 730.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 29.7;basal ganglia: 58.6;cerebral cortex: 75.3;hippocampal formation: 55.7"	"Group enriched"	"Detected in many"	4	"classical monocyte: 72.0;intermediate monocyte: 82.6;memory B-cell: 141.6;myeloid DC: 95.2;naive B-cell: 187.9;non-classical monocyte: 71.5;plasmacytoid DC: 100.3"	"Group enriched"	"Detected in many"	5	"B-cells: 187.9;dendritic cells: 100.3;monocytes: 82.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 103.6;HEL: 229.3;Karpas-707: 121.6;REH: 261.8;WM-115: 145.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 70.0;cerebral cortex: 253.1;hippocampal formation: 220.0;olfactory bulb: 66.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	28.9	26.8	29.7	39.2	58.6	11.1	17.5	0.0	75.3	18.8	0.0	15.9	6.9	25.9	7.3	13.6	17.3	28.5	35.2	55.7	0.0	10.4	10.5	21.3	62.9	0.0	0.0	34.9	5.6	9.3	6.3	45.5	0.0	20.0	15.4	34.2	9.0	17.7	555.4	4.9	11.2	31.5	0.0	43.8	12.7	9.4	0.0	12.8	21.7	246.8	77.7	21.3	7.6	11.0	1.6	0.0	7.1	0.0	7.7	4.6	0.2	2.2	4.5	0.3	1.0	0.2	1.0	103.6	0.6	12.0	2.5	3.1	9.6	9.1	0.2	31.7	12.5	229.3	12.3	0.0	2.8	10.4	0.6	21.6	0.0	0.3	0.0	1.4	35.1	0.0	12.3	121.6	9.0	0.0	0.3	0.1	2.2	0.1	8.4	261.8	63.1	50.5	0.0	1.2	0.0	8.3	0.0	0.7	29.5	3.9	0.3	58.0	40.4	5.6	1.0	0.6	5.4	92.0	11.5	62.0	1.5	70.1	145.2	0.6	72.0	0.2	0.2	82.6	0.1	141.6	0.2	0.1	95.2	187.9	0.2	0.2	24.3	16.7	71.5	100.3	0.5	34.4	29.7	58.6	0.0	75.3	55.7	0.0	0.0	0.0	0.0	0.0	0.0	11.0	367.4	32.1	52.0	117.5	471.5	10.7	4.2	0.0	7.4	22.6	5.2	26.5	86.4	10.0	21.7	1.8	214.8	0.8	138.6	9.2	27.4	0.8	11.0	0.8	13.4	197.5	1.2	59.1	735.7	12.7	1.2	26.8	2.0	1.0	5.1	107.5	283.4	3.4	171.1	5.0	759.5	1.5	0.0	205.8	127.5	8.6	29.8	205.1	67.6	730.7	202.7	61.8	8.2	119.6	18.7	0.4	3.0	71.8	314.7	2.1	0.2	0.8	3.7	202.9	335.2	72.7	257.6	4.0	29.5	2.5	8.4	1.6	12.2	58.6	6.3	2.3
MEF2D		ENSG00000116604	"Myocyte enhancer factor 2D"	Q14814	1	156463727-156500779	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 170.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 211.3;U-266/70: 193.0;U-266/84: 214.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004807, HPA007114"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA004807: AB_1079354, HPA007114: AB_1079353"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.45e-1)"	33.3	32.6	15.7	24.4	22.6	79.8	27.5	21.8	24.9	43.5	0.0	43.6	16.0	48.9	14.3	19.2	39.1	20.2	54.9	24.1	4.8	17.8	19.6	37.0	21.1	1.3	3.2	44.5	31.6	27.9	26.1	22.9	1.0	31.1	13.9	50.0	21.6	24.1	170.9	32.8	27.0	25.6	1.5	29.4	28.2	14.7	2.7	27.5	25.2	69.2	14.8	33.8	32.8	14.0	19.7	32.2	7.2	10.7	15.6	22.2	12.4	26.1	29.6	12.0	12.5	10.4	24.1	42.5	30.3	31.4	12.7	18.8	8.2	13.2	7.1	65.7	11.6	10.8	42.1	6.2	19.2	25.6	32.8	24.5	21.6	21.0	27.9	24.8	22.5	13.5	8.6	72.7	19.1	16.6	18.6	56.4	10.6	10.2	20.5	80.6	16.5	48.3	10.4	8.7	12.0	19.2	24.1	48.2	39.6	13.4	13.7	211.3	40.2	29.1	29.3	22.1	19.7	193.0	214.3	81.3	24.5	19.2	15.9	1.1	1.4	1.7	1.3	0.7	1.5	1.1	0.9	1.2	1.0	1.0	0.5	0.8	5.3	1.1	1.4	5.8	1.3	0.7	15.7	22.6	21.8	24.9	24.1	4.8	1.3	3.2	1.0	1.5	2.7	14.0	21.8	6.4	18.6	21.9	29.8	37.2	10.9	10.6	25.6	82.3	25.2	19.7	42.0	17.2	16.2	1.8	173.0	5.0	72.5	60.6	0.0	7.7	2.5	26.4	26.0	24.0	21.5	11.0	28.7	11.1	4.9	25.1	25.0	43.1	3.8	9.0	22.9	13.2	18.0	70.7	18.8	32.2	8.2	25.4	64.1	4.4	31.4	35.5	14.2	20.6	17.7	19.0	33.0	13.0	20.2	25.8	46.3	32.4	44.6	19.7	17.2	3.4	9.1	85.3	98.6	48.8	46.1	5.1	10.7	16.6	38.1	15.3	33.1	11.0	14.0	19.3
MEFV	"FMF, MEF, TRIM20"	ENSG00000103313	"MEFV innate immuity regulator, pyrin"	O15553	16	3242027-3256633	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	Actin-binding	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.1;lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 7.6;Kupffer cells: 15.1;Macrophages: 15.5;monocytes: 26.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.3;monocytes: 5.7"	"Cell line enriched"	"Detected in some"	6	"THP-1: 6.6"	"Not detected"	"Not detected"							HPA077497			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA077497: "	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.58e-7)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	2.4	0.6	0.1	6.5	0.2	6.1	0.3	0.4	1.0	0.2	0.3	0.4	0.5	0.2	0.2	0.3	0.6	1.0	0.5	0.3	0.1	0.4	0.7	4.0	0.4	0.3	0.2	0.1	0.2	0.0	0.2	0.8	0.5	0.2	0.3	0.2	0.3	0.0	0.7	0.2	0.6	1.0	0.0	8.9	0.4	1.3	0.3	0.4	0.3	0.3	0.3	1.8	0.3	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.2	1.1	0.0	2.4	3.2	0.1	0.0	3.4	0.0	0.1	0.1	0.0	1.7	0.2	0.0	0.1	8.3	0.3	5.7	0.1	0.0	1.2	0.1	0.2	0.4	1.0	0.3	0.1	0.3	0.2	0.5	0.0	0.3	0.4	0.2	0.0	1.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.3	7.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.4	0.2	1.0	0.0	0.1	0.0	0.0	15.1	2.4	0.3	0.0	15.5	0.0	0.0	26.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.2	0.3	0.7	0.0	0.1	0.0	0.6	0.0	0.0	0.1
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600811-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 68.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.0;Cone photoreceptor cells: 212.7;Oligodendrocytes: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 25.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 25.2;monocytes: 7.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		96000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: AB_2681060"	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favorable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	18.1	10.1	24.1	11.5	28.7	18.8	13.6	28.7	26.1	12.0	4.8	7.2	7.0	6.3	5.6	14.0	14.0	8.5	6.4	26.0	34.4	13.5	38.7	20.3	6.5	37.2	33.6	9.7	5.6	11.5	5.3	5.1	27.3	8.7	6.0	68.2	7.7	6.6	7.3	21.5	7.2	8.9	28.2	15.2	8.0	3.3	34.0	5.6	28.4	8.5	6.2	9.7	7.4	37.3	5.0	19.4	16.7	5.2	22.6	13.9	5.3	5.0	4.4	1.3	1.8	1.1	2.9	18.6	7.4	4.8	6.0	21.2	24.1	8.7	3.6	15.2	6.9	2.5	34.1	8.1	9.6	7.5	15.3	6.5	26.1	8.2	6.6	46.0	11.8	9.9	6.0	8.6	13.9	14.4	14.8	2.7	0.7	11.1	5.2	11.2	18.6	7.9	34.0	16.1	16.4	13.9	6.0	4.8	14.7	2.7	14.5	7.5	13.9	5.0	2.8	18.4	7.7	15.5	19.5	6.0	7.0	8.7	28.8	0.6	7.4	5.1	0.8	2.5	0.3	0.4	0.7	0.6	3.0	0.4	0.6	0.5	25.2	0.5	4.5	0.2	0.7	1.9	24.1	28.7	28.7	26.1	26.0	34.4	37.2	33.6	27.3	28.2	34.0	37.3	6.5	86.6	65.0	143.0	8.4	27.4	5.6	8.4	25.0	31.5	30.3	12.8	28.2	14.3	15.6	23.9	212.7	0.5	10.8	7.5	0.0	4.0	0.9	11.8	5.8	7.6	6.6	18.9	85.9	5.4	1.9	10.3	14.3	19.3	7.0	8.4	10.0	48.0	5.8	13.5	63.8	4.7	16.2	45.2	13.9	2.7	11.5	41.3	26.6	22.5	107.2	30.9	13.4	93.0	240.7	13.8	8.6	11.7	11.5	8.3	7.4	6.6	6.1	75.4	13.1	26.5	9.3	14.8	7.3	41.3	43.9	1.2	11.4	4.8	5.5	6.2
MEIOSIN	"BHMG1, HMGDC"	ENSG00000237452	"Meiosis initiator"	C9JSJ3	19	45733439-45764541	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	15	"testis: 7.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Daudi: 1.5;K-562: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049521	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"		Nucleoplasm		"HPA049521: AB_2680803"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.08e-1)"	"unprognostic (6.53e-12)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.87e-1)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEIS1		ENSG00000143995	"Meis homeobox 1"	O00470	2	66433452-66573869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	Transcription	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Endometrial stromal cells: 117.2;Horizontal cells: 82.4;Oligodendrocytes: 227.5;Rod photoreceptor cells: 121.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.6;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.5;HeLa: 29.3;HHSteC: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011521, HPA056000, HPA058641"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 51: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB011521: AB_776272, HPA056000: AB_2683004, HPA058641: AB_2683784"	"unprognostic (6.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-2)"	21.8	52.0	7.0	12.0	10.4	2.5	13.1	33.1	8.7	89.8	4.0	72.2	5.7	84.0	23.0	23.0	82.7	15.7	13.8	4.1	8.0	9.5	3.8	34.1	2.3	14.0	10.5	43.6	45.0	6.9	1.6	15.3	18.1	33.8	12.2	43.0	39.0	35.4	5.6	11.7	19.7	50.0	11.3	18.4	31.7	2.9	8.8	4.7	5.8	3.4	6.9	39.2	55.9	19.4	0.3	1.6	12.4	2.7	16.3	10.9	1.6	17.0	43.5	14.4	15.2	1.5	12.3	0.0	4.2	13.5	0.8	2.0	7.7	7.5	14.1	0.0	6.9	20.3	29.3	3.1	31.3	0.0	5.8	9.6	8.8	6.0	2.4	11.5	6.7	3.3	1.8	0.0	0.6	0.7	1.8	0.4	0.3	1.6	1.8	0.0	3.3	3.6	1.2	4.0	3.8	26.2	3.0	1.0	1.3	9.4	1.3	2.5	2.1	3.1	4.8	2.3	4.8	3.4	1.1	0.1	2.3	18.2	0.8	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.5	1.6	0.0	1.3	0.1	2.1	7.0	10.4	33.1	8.7	4.1	8.0	14.0	10.5	18.1	11.3	8.8	19.4	0.6	0.0	0.5	55.5	0.2	3.2	11.9	10.1	15.4	19.8	2.5	1.4	18.7	1.5	8.3	0.0	110.5	5.7	0.4	2.1	0.0	21.6	10.3	36.8	117.2	4.4	1.2	5.9	6.5	17.5	1.6	19.4	7.1	27.9	0.0	0.2	16.1	1.8	2.2	82.4	5.8	0.7	10.2	1.4	1.9	14.1	34.5	10.3	3.6	15.9	0.5	21.4	1.0	54.3	227.5	20.1	67.3	28.2	0.0	2.4	0.6	3.2	6.8	121.0	19.7	6.7	12.5	2.7	2.0	17.9	2.3	1.9	2.0	6.3	1.2	18.8
MEIS2	"HsT18361, MRG1"	ENSG00000134138	"Meis homeobox 2"	O14770	15	36889204-37101299	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 522.3;Cone photoreceptor cells: 254.4;Excitatory neurons: 164.7;Hepatic stellate cells: 207.4;Oligodendrocyte precursor cells: 262.4;Oligodendrocytes: 219.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"basophil: 2.9;eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 114.0;SH-SY5Y: 104.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 68.4;olfactory bulb: 177.4"	"HPA003256, CAB004999"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB004999: AB_425545, HPA003256: AB_1079356"	"unprognostic (4.33e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.71e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (6.47e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.15e-1)"	11.1	21.9	14.4	5.3	50.4	0.0	7.4	11.7	24.9	20.9	0.6	33.2	20.6	37.0	4.1	14.2	23.3	17.8	15.7	16.0	14.7	11.1	6.9	8.4	3.4	19.2	25.7	21.1	13.4	3.5	16.4	8.6	20.0	37.7	6.4	18.8	56.8	21.6	0.7	4.4	8.3	36.3	18.0	7.6	14.1	1.6	11.8	11.1	5.4	9.5	3.4	25.6	13.5	20.3	13.3	12.0	15.3	43.6	16.7	20.6	3.6	28.3	15.6	32.9	18.4	17.2	10.8	7.6	0.7	114.0	20.8	22.4	26.9	7.2	18.1	10.9	17.3	58.8	15.8	13.9	28.6	17.5	57.2	27.3	6.3	22.3	6.6	43.2	19.1	2.8	20.1	0.1	6.4	14.3	0.1	6.7	0.2	15.8	3.9	0.0	11.1	4.1	0.0	25.7	11.9	104.0	10.8	7.1	8.0	16.5	3.4	13.3	27.3	37.6	4.6	10.1	12.1	7.5	8.1	14.6	44.3	9.7	9.6	2.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	50.4	11.7	24.9	16.0	14.7	19.2	25.7	20.0	18.0	11.8	20.3	6.5	0.0	7.3	522.3	3.4	17.5	97.3	14.1	79.1	43.8	21.0	16.3	23.9	77.2	11.4	1.8	254.4	23.3	1.0	1.0	0.0	58.4	15.2	10.5	17.1	67.2	1.8	5.3	164.7	27.1	10.0	61.7	25.5	0.8	63.3	14.9	207.4	9.6	3.4	3.3	5.0	0.4	30.5	6.5	6.1	7.4	47.8	1.1	8.8	21.5	0.6	10.7	0.0	262.4	219.7	25.7	0.3	41.3	1.8	38.3	1.4	0.1	26.5	135.9	32.9	14.7	46.4	3.6	3.1	23.8	6.1	4.5	2.3	31.2	1.0	54.1
MEIS3	"DKFZp547H236, MRG2"	ENSG00000105419	"Meis homeobox 3"	Q99687	19	47403124-47419527	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 102.3;endometrium 1: 77.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.4;Endometrial stromal cells: 23.5;Excitatory neurons: 39.1;Horizontal cells: 45.4;Late spermatids: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046699	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA046699: AB_2616456"	"unprognostic (3.27e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.49e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.76e-2)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (9.29e-3)"	"unprognostic (9.21e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.80e-3)"	13.1	6.9	68.8	9.0	64.3	0.0	16.3	20.5	102.3	41.7	15.7	18.7	6.6	77.3	2.3	10.8	51.8	11.2	10.2	69.2	50.4	7.5	2.0	8.1	2.9	19.8	22.4	21.8	4.2	6.6	17.2	13.7	21.6	18.9	3.9	8.0	6.9	10.9	2.5	6.0	14.1	38.9	16.3	6.7	6.3	12.2	36.4	1.2	6.2	2.7	1.6	17.1	15.7	46.8	1.0	33.4	76.3	0.3	42.0	36.4	1.3	33.1	53.8	27.5	47.5	3.0	5.3	0.3	3.8	58.2	22.6	3.8	8.1	9.6	8.8	50.4	11.3	0.0	12.7	0.3	26.4	0.6	65.0	26.5	1.9	10.5	5.6	9.5	0.0	0.0	0.8	7.7	3.0	32.2	0.0	0.4	22.1	1.0	1.9	0.1	5.8	0.8	1.8	2.4	3.1	59.9	29.3	2.6	14.4	30.5	1.8	9.8	0.0	20.2	49.3	15.1	4.7	0.1	0.0	0.1	56.3	3.2	41.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.8	64.3	20.5	102.3	69.2	50.4	19.8	22.4	21.6	16.3	36.4	46.8	1.7	0.0	3.2	2.3	0.0	0.8	1.2	0.6	0.0	10.0	8.7	4.6	1.4	0.0	1.9	3.7	6.2	0.2	0.1	0.0	0.0	0.1	22.4	0.7	23.5	0.9	0.0	0.0	39.1	0.0	0.4	11.1	0.5	1.6	0.0	0.3	1.4	0.1	0.7	45.4	11.2	0.0	0.0	0.0	1.9	57.4	11.5	0.4	7.2	4.7	0.0	17.0	0.0	13.0	2.0	0.1	0.0	4.1	0.3	4.0	0.0	0.0	1.5	2.9	13.1	0.9	11.8	3.1	4.8	0.1	1.0	0.8	1.2	0.9	0.0	0.9
MEN1		ENSG00000133895	"Menin 1"	O00255	11	64803510-64811294	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030342	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA030342: AB_10610138"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (1.40e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	15.1	24.2	13.1	8.4	13.7	6.5	15.7	12.7	15.0	19.3	13.0	16.8	7.8	17.4	8.1	23.9	16.3	5.5	12.4	14.3	12.7	19.4	30.3	16.1	10.9	12.5	12.5	20.8	26.2	6.3	21.7	7.8	12.6	20.2	4.7	4.7	21.3	7.7	11.0	24.0	20.9	5.3	11.9	25.5	20.6	16.3	13.5	17.1	24.5	5.8	10.2	16.4	18.7	12.9	30.8	33.7	22.4	37.7	30.4	17.4	24.8	19.2	23.3	35.6	21.2	19.0	25.5	43.6	33.8	16.7	29.8	39.0	36.4	28.3	19.3	30.5	48.1	35.6	17.3	30.9	27.2	23.6	22.8	19.2	18.2	26.8	21.9	16.5	33.7	49.3	51.5	15.7	18.9	54.2	60.3	29.3	36.7	30.3	54.7	45.1	29.8	44.1	23.2	22.8	33.6	28.9	26.0	36.9	27.9	16.5	56.6	27.1	17.4	23.5	28.8	36.5	16.7	21.8	30.4	22.1	25.5	16.2	21.0	0.5	0.5	1.4	1.5	0.6	1.8	1.8	1.1	1.9	0.6	1.8	1.9	0.9	0.1	0.9	0.2	1.3	0.9	0.5	13.1	13.7	12.7	15.0	14.3	12.7	12.5	12.5	12.6	11.9	13.5	12.9	6.9	3.2	5.4	5.9	10.6	5.7	4.6	5.3	7.4	8.5	10.2	11.0	4.5	4.3	2.8	3.7	6.2	19.4	8.0	9.2	3.9	8.9	0.9	7.9	11.0	7.0	4.2	10.8	7.4	7.1	21.7	6.9	13.7	12.1	1.3	14.1	7.9	10.9	9.0	3.3	6.2	9.0	6.1	3.1	2.3	0.9	12.2	4.8	8.8	8.4	6.3	7.7	6.2	4.5	5.0	7.5	10.7	3.8	8.4	6.1	9.3	8.0	4.0	6.5	13.1	5.4	5.6	14.2	13.0	9.4	7.0	16.3	8.9	14.3	10.2	3.3
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640389-43661922	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.0;breast: 26.1;heart muscle: 24.9"	"Group enriched"	"Detected in some"	9	"Adipocytes: 63.5;Endothelial cells: 41.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 17.5"	"Lineage enriched"	"Detected in single"	48	"T-cells: 17.5"	"Cell line enriched"	"Detected in some"	14	"HeLa: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	36.0	0.5	0.0	4.7	0.0	0.0	26.1	0.0	0.1	8.0	0.0	4.7	1.6	5.5	1.1	3.7	9.0	5.7	24.9	0.0	0.0	0.2	0.1	1.4	6.6	0.0	0.0	1.0	1.5	1.2	0.5	0.1	0.0	2.6	2.4	0.0	4.9	1.9	8.3	6.6	5.1	10.6	0.0	10.8	3.0	1.1	0.0	3.0	1.9	17.1	5.3	7.7	7.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	1.8	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.3	2.7	0.0	0.0	1.7	0.5	0.0	0.3	0.0	0.0	17.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	1.0	0.3	4.1	0.0	0.0	1.2	0.0	0.4	0.6	2.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	41.3	0.0	0.0	0.7	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.1	0.3	1.8	0.1	1.5	0.3	0.0	0.0
MEPCE	"BCDIN3, FLJ20257"	ENSG00000146834	"Methylphosphate capping enzyme"	Q7L2J0	7	100428790-100434118	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026384, HPA051587"	Supported		Approved	"Nucleoplasm,Cell Junctions"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Cell Junctions"	"CAB026384: , HPA051587: AB_2681544"	"unprognostic (8.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (6.01e-6)"	"unprognostic (1.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.01e-10)"	"unprognostic (9.66e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.57e-1)"	"unprognostic (9.50e-3)"	26.4	41.0	27.5	19.4	28.3	28.3	24.2	30.4	31.5	26.1	23.6	25.8	18.5	28.8	27.8	27.5	27.0	19.4	26.8	26.7	27.0	37.0	36.9	21.9	29.0	27.6	27.3	36.0	22.5	35.0	23.6	20.9	27.4	26.5	12.9	9.9	24.9	20.7	38.5	34.5	27.2	18.0	26.8	56.6	24.6	79.8	28.0	28.1	36.5	31.5	24.2	28.3	21.9	28.2	42.6	53.6	38.9	41.9	36.8	36.7	29.1	46.4	66.5	48.7	37.4	43.8	60.1	87.1	75.5	29.1	38.5	38.4	43.0	34.9	32.0	39.4	49.4	45.1	41.5	33.3	30.9	58.0	53.0	38.2	40.9	55.7	70.0	26.5	41.1	27.4	90.6	62.2	47.2	155.6	66.3	129.8	72.1	35.0	58.9	53.0	31.5	79.1	32.7	25.6	58.5	50.6	72.5	139.1	49.1	19.3	35.6	52.1	36.2	81.5	63.5	55.9	62.0	41.0	42.4	96.3	45.8	71.1	72.9	2.6	2.6	3.7	3.8	2.3	4.6	6.2	4.4	4.2	3.3	6.6	6.2	5.5	6.4	5.9	1.9	6.3	4.5	7.5	27.5	28.3	30.4	31.5	26.7	27.0	27.6	27.3	27.4	26.8	28.0	28.2	34.2	9.6	18.9	5.5	33.8	30.2	17.3	7.1	19.9	9.9	30.2	21.6	25.6	20.0	7.8	22.0	8.4	15.8	34.3	32.2	15.6	10.3	29.6	18.3	13.1	21.7	10.7	9.9	2.8	12.0	8.5	17.3	54.6	18.8	18.3	14.5	28.9	22.1	12.7	11.8	2.6	26.1	8.2	26.7	16.9	66.5	17.4	32.9	8.8	7.5	18.1	19.4	15.5	2.5	2.7	10.4	23.6	15.4	14.9	15.6	39.9	14.4	10.4	9.5	6.6	35.0	17.9	44.8	15.1	22.3	25.1	21.2	25.0	19.5	20.3	9.9
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 4.5;prostate: 7.3;skeletal muscle: 4.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 52.2;Breast myoepithelial cells: 58.9;Distal enterocytes: 40.1;Exocrine glandular cells: 43.0;Spermatocytes: 41.5"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.5;HDLM-2: 3.1;HEK 293: 3.0;PC-3: 5.7;SCLC-21H: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Nucleoli	"HPA069981: AB_2686225"	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	4.5	1.4	2.4	0.0	2.7	0.1	3.0	1.7	3.5	0.5	0.5	1.4	0.1	0.1	0.0	0.3	0.2	0.0	1.3	2.7	2.1	0.7	0.8	0.2	0.0	1.7	1.5	0.2	1.2	0.2	1.0	0.0	1.9	7.3	0.0	0.2	2.1	0.1	4.5	0.2	0.5	0.0	1.2	0.1	0.5	1.3	2.6	0.0	0.5	0.3	0.0	0.3	0.4	2.0	3.5	1.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	1.3	0.0	0.4	0.0	0.2	0.0	0.0	3.1	3.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.0	0.1	0.5	0.8	0.0	0.0	5.7	0.1	0.0	0.8	0.0	0.0	2.6	0.1	0.7	1.1	0.8	0.0	0.0	0.4	0.0	0.0	0.2	2.0	0.6	1.3	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.7	1.7	3.5	2.7	2.1	1.7	1.5	1.9	1.2	2.6	2.0	1.7	0.0	1.1	2.6	2.9	0.3	2.8	5.1	0.6	11.6	52.2	58.9	6.3	17.2	33.9	1.8	10.4	3.0	3.2	40.1	11.7	18.6	5.3	0.3	0.3	2.1	6.1	3.0	2.8	43.0	0.2	3.5	0.5	0.9	4.5	22.1	4.2	12.8	2.0	8.4	3.0	7.4	12.2	1.6	2.1	2.1	1.2	2.5	7.2	1.0	2.1	19.2	2.1	1.5	1.7	4.8	17.9	0.0	4.6	35.7	7.2	16.2	8.7	20.6	0.0	4.0	3.7	41.5	21.7	2.0	0.3	0.3	2.2	18.0	15.5	6.2
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995659-99062809	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8900	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	14.8	9.5	10.2	20.5	11.6	25.1	28.7	10.5	13.8	24.0	8.8	31.8	24.1	25.7	43.7	52.3	24.3	15.1	41.1	11.2	10.0	24.7	24.0	15.6	24.9	9.5	10.1	14.0	19.5	14.0	11.6	16.9	9.4	29.2	33.5	11.3	23.1	29.7	33.8	28.7	23.4	25.7	9.2	17.6	19.6	51.6	10.6	41.9	18.8	28.7	31.2	34.5	30.8	10.4	57.6	55.9	47.7	51.7	37.2	59.1	52.9	80.3	51.5	67.1	63.7	62.9	83.3	84.1	31.3	65.5	40.3	56.1	84.8	80.5	92.9	59.2	39.9	75.6	37.8	68.2	40.2	103.6	60.8	42.8	57.5	57.0	60.4	52.4	56.3	46.9	60.0	49.7	73.2	44.0	90.9	49.3	58.7	97.7	44.3	58.9	74.5	45.4	109.2	73.6	64.7	38.5	27.0	82.5	32.8	53.1	31.6	39.3	46.1	53.9	68.0	49.9	70.9	35.5	53.5	66.2	46.5	51.9	54.8	19.1	11.6	5.7	17.7	14.6	23.1	16.0	18.0	17.6	14.9	11.4	17.4	15.8	2.9	17.7	14.7	7.2	17.7	14.1	10.2	11.6	10.5	13.8	11.2	10.0	9.5	10.1	9.4	9.2	10.6	10.4	16.1	41.7	14.6	20.2	19.8	42.4	47.5	26.2	51.2	5.2	21.0	24.9	57.0	17.2	19.5	14.7	2.1	24.4	17.4	36.7	13.7	28.4	330.3	45.4	30.0	17.3	7.8	24.2	22.6	29.4	70.5	15.3	22.4	60.9	3.8	16.9	12.8	21.4	17.2	3.3	15.0	23.3	24.4	20.2	16.2	1627.3	19.3	17.4	16.0	14.0	13.9	10.6	25.7	17.6	22.3	28.0	30.8	22.6	17.8	34.4	25.3	31.6	17.2	3.7	26.3	11.5	21.7	15.7	41.6	54.3	38.8	7.7	23.6	18.1	36.2	46.9
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715118-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 299.3;choroid plexus: 238.6"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 1153.9"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MCF7: 178.2;PC-3: 133.1;SK-MEL-30: 93.5"	"Region enhanced"	"Detected in all"		"cerebellum: 612.9"					HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: AB_2681369"	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	16.1	36.3	238.0	4.0	233.8	1.5	14.1	203.7	299.3	15.5	238.6	30.7	4.1	17.3	3.0	10.4	37.0	2.5	56.8	209.7	210.3	29.2	49.9	16.8	2.1	258.1	239.0	5.2	46.1	5.5	88.0	3.7	208.5	25.4	1.2	3.0	25.2	13.1	23.3	11.9	12.0	2.9	244.4	12.3	22.2	15.3	258.3	2.4	30.6	5.1	1.8	20.5	11.3	237.4	8.9	73.4	14.2	72.4	24.6	13.8	22.9	17.5	8.7	6.9	4.4	11.0	21.5	1.5	39.6	12.4	26.3	32.6	2.1	17.0	1.1	4.7	32.0	2.9	13.3	57.1	15.1	6.5	9.2	33.3	18.3	2.1	4.2	21.3	2.3	20.3	5.3	1.7	5.2	178.2	2.4	22.0	5.2	9.8	133.1	24.3	16.4	24.4	18.4	2.6	22.5	28.5	6.9	18.9	93.5	1.6	28.6	12.6	8.0	19.4	36.8	22.7	15.4	11.0	3.3	1.7	30.3	4.8	46.6	0.0	0.1	0.2	0.8	0.3	0.5	1.2	0.4	0.8	0.0	0.1	0.2	0.5	0.0	0.5	0.3	0.2	1.0	0.1	238.0	233.8	203.7	299.3	209.7	210.3	258.1	239.0	208.5	244.4	258.3	237.4	46.7	0.0	2.2	91.4	8.5	3.8	17.1	3.3	0.0	45.5	79.5	75.8	16.3	48.6	1.8	16.5	14.6	0.6	26.7	29.0	50.9	8.4	8.0	230.7	54.8	21.5	27.4	2.7	6.6	5.1	2.1	15.1	5.6	14.4	0.0	2.7	20.0	39.5	6.4	70.7	5.7	10.7	2.0	7.8	6.5	25.8	11.1	6.6	10.6	8.4	1.1	1153.9	23.7	44.2	57.6	5.3	26.7	9.4	7.9	27.7	6.2	55.6	9.5	37.9	26.3	11.8	26.7	4.6	11.7	1.4	3.0	0.4	12.7	5.2	9.2	16.2
METTL1	"C12orf1, TRM8, TRMT8"	ENSG00000037897	"Methyltransferase like 1"	Q9UBP6	12	57768471-57772119	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"RH-30: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020914, HPA050450"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA020914: AB_1853830, HPA050450: AB_2681130"	"unprognostic (5.24e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (4.25e-6)"	"unprognostic (5.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	13.6	23.2	8.9	9.8	9.2	11.0	12.8	8.7	11.9	9.8	9.9	8.4	4.0	10.8	20.8	13.1	10.2	5.5	10.3	9.2	9.4	22.0	17.5	9.3	8.1	9.2	9.3	11.3	28.0	9.1	12.7	8.7	9.0	13.4	10.8	3.7	10.6	7.1	15.5	11.7	6.9	12.3	8.9	9.0	9.8	9.9	9.6	4.8	14.3	6.9	9.3	16.5	9.4	9.0	24.7	44.1	17.7	14.9	22.6	15.7	23.4	24.8	23.1	41.9	24.7	32.0	32.6	28.8	45.7	33.0	23.1	27.9	27.4	39.8	38.0	17.2	32.6	34.9	17.4	35.0	17.9	39.0	17.4	14.7	32.7	47.8	33.5	18.9	22.2	17.8	34.1	28.2	23.1	47.0	26.1	39.6	40.6	29.1	41.5	23.0	293.1	43.1	33.6	29.8	18.7	16.2	26.9	29.6	22.9	16.0	38.5	32.0	17.1	17.4	18.0	29.6	34.0	13.2	9.3	32.6	24.4	25.3	34.5	0.0	7.1	0.0	8.0	10.8	27.4	6.9	10.0	9.6	16.3	10.5	13.4	13.2	1.1	12.9	1.8	19.3	5.1	7.5	8.9	9.2	8.7	11.9	9.2	9.4	9.2	9.3	9.0	8.9	9.6	9.0	6.3	9.6	3.3	0.7	8.3	10.5	17.1	14.8	13.6	3.7	12.2	12.4	4.3	10.0	14.1	5.5	0.0	18.7	3.1	6.3	25.4	16.8	12.1	5.3	13.2	8.2	6.6	6.3	0.8	24.1	25.3	11.3	10.2	8.9	12.7	8.7	3.3	7.9	22.7	3.3	0.6	8.4	12.2	2.2	9.8	10.9	11.1	6.4	7.2	0.0	16.7	2.6	3.1	3.5	1.1	12.3	2.3	4.9	14.9	15.4	1.1	60.4	2.6	5.4	0.0	9.7	13.0	8.0	17.7	12.1	10.4	9.7	4.1	14.0	10.7	11.3
METTL14	KIAA1627	ENSG00000145388	"Methyltransferase like 14"	Q9HCE5	4	118685392-118715433	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038002	Supported		Supported	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA038002: AB_10672401"	"unprognostic (4.48e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.76e-3)"	8.9	8.8	5.2	8.6	6.0	19.5	11.5	6.8	6.3	8.8	5.5	8.8	8.8	11.7	10.7	8.9	8.8	7.7	8.3	4.8	6.3	10.2	14.9	9.1	11.6	5.5	5.2	12.7	7.8	10.9	8.2	9.0	6.3	9.7	8.2	11.7	7.6	8.0	8.4	10.9	9.2	9.2	5.4	10.8	7.9	15.1	5.7	12.5	10.6	7.7	11.0	8.5	7.9	7.4	19.6	8.9	19.0	17.8	11.7	14.7	13.8	17.1	13.0	12.6	14.4	12.9	22.8	22.0	9.8	12.0	12.6	9.4	16.2	14.1	16.1	17.5	9.8	18.5	11.4	14.4	13.3	30.2	21.2	13.1	15.8	14.6	9.6	16.5	11.5	17.4	20.1	18.2	17.5	13.2	29.7	24.7	16.2	16.7	7.7	16.8	23.7	11.2	13.8	12.7	15.4	17.3	12.0	22.0	17.2	17.2	10.0	28.5	15.8	18.1	16.6	16.3	13.7	15.2	17.0	24.9	12.9	16.5	15.1	37.7	12.8	29.0	17.0	19.6	19.3	24.3	17.8	17.7	15.3	25.3	21.0	19.0	10.3	21.8	23.7	12.1	20.8	13.7	5.2	6.0	6.8	6.3	4.8	6.3	5.5	5.2	6.3	5.4	5.7	7.4	18.6	25.6	25.9	14.7	20.6	10.8	18.3	10.6	16.5	16.8	13.4	12.6	15.7	17.2	20.8	23.9	22.9	18.7	28.3	13.7	11.7	11.9	96.9	14.5	21.7	17.3	12.1	8.4	18.7	15.6	10.2	16.8	9.2	18.0	22.1	18.3	16.4	32.1	12.1	8.4	17.0	15.2	6.1	17.9	7.6	16.7	18.6	13.3	7.2	14.0	14.0	13.4	25.7	14.1	26.9	14.8	13.0	13.9	8.2	17.1	15.4	20.6	15.2	25.4	13.1	15.3	15.5	42.2	28.1	12.4	11.9	15.3	20.6	17.0	12.8	16.0
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	6.8	6.2	4.4	6.6	6.2	8.8	7.8	5.1	5.2	7.2	4.3	6.0	5.3	9.5	5.7	5.9	9.1	4.9	7.2	4.0	4.4	6.3	3.8	7.0	8.3	4.7	5.2	12.3	7.5	10.1	4.5	4.2	4.9	7.4	5.8	7.7	6.6	7.0	6.6	6.4	5.2	8.5	5.0	6.9	4.7	5.4	4.8	10.4	9.3	7.4	8.3	6.4	5.3	7.9	9.0	25.3	12.7	12.9	9.7	12.1	12.3	11.8	9.6	12.4	10.3	34.5	6.1	28.1	11.9	10.1	13.3	12.5	30.2	15.3	16.8	11.0	20.7	14.2	21.2	16.0	10.8	13.3	11.0	10.2	14.0	17.3	24.9	8.5	13.0	16.1	19.1	14.8	8.4	11.0	19.1	7.8	14.9	10.9	10.1	31.8	13.8	12.7	9.2	8.3	6.8	11.4	16.7	9.3	9.0	13.5	11.9	8.6	10.2	11.6	7.3	16.3	16.3	8.3	11.3	19.4	15.5	11.1	15.8	1.6	2.1	0.8	3.5	1.4	4.4	3.5	3.3	3.4	1.5	2.9	4.9	3.7	0.0	1.3	1.0	2.0	2.3	1.4	4.4	6.2	5.1	5.2	4.0	4.4	4.7	5.2	4.9	5.0	4.8	7.9	17.5	12.8	33.5	19.2	25.7	11.5	21.4	12.6	9.6	28.7	14.9	14.1	15.8	15.7	25.8	7.3	45.9	8.9	19.3	11.8	13.7	9.9	20.8	18.8	21.7	13.9	20.4	6.3	20.9	10.8	9.1	18.9	15.3	15.0	24.7	25.5	17.5	9.2	10.4	26.9	21.6	13.7	10.2	10.0	5.9	7.6	14.9	11.6	8.8	17.8	13.7	20.2	30.9	23.6	42.2	9.7	6.3	12.8	14.5	20.1	23.2	9.0	26.3	37.4	6.6	28.0	21.3	11.8	16.7	14.7	12.8	6.0	25.5	28.7	16.8	17.0
METTL17	"FLJ20859, METT11D1"	ENSG00000165792	"Methyltransferase like 17"	Q9H7H0	14	20989973-20997035	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002955, HPA059802"	Uncertain		Enhanced	Nucleoplasm	"Intracellular and membrane"	No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA002955: AB_2144183, HPA059802: AB_2684129"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.29e-2)"	11.9	32.2	11.0	11.1	11.5	26.6	12.2	12.3	16.1	14.1	13.2	20.6	17.6	12.8	11.2	22.4	13.0	10.3	23.7	10.7	11.1	20.0	19.7	11.7	18.0	12.0	10.9	13.8	18.8	19.4	9.6	12.2	11.6	12.3	21.7	8.0	15.6	13.8	21.3	16.1	21.5	14.2	12.0	23.3	17.6	18.6	12.0	21.7	13.6	29.2	19.3	12.2	14.6	12.3	37.5	48.0	41.8	16.1	25.3	12.2	32.0	22.3	32.8	69.1	58.2	34.3	44.9	85.8	24.4	29.1	43.7	54.0	57.5	48.5	49.6	32.5	44.7	41.8	27.5	56.6	31.5	71.5	42.8	23.4	41.7	35.1	27.8	23.0	27.9	70.5	40.4	38.6	33.8	24.9	48.9	72.2	49.6	62.7	56.2	56.8	42.9	48.2	37.5	34.4	30.2	36.5	30.0	43.9	24.8	31.1	29.4	60.0	15.5	22.4	72.0	25.1	30.2	28.7	49.8	62.1	15.5	46.0	29.3	28.8	8.1	8.6	11.7	9.8	7.0	13.9	12.7	13.2	16.8	10.8	12.4	11.7	0.1	10.7	5.5	11.1	11.5	6.9	11.0	11.5	12.3	16.1	10.7	11.1	12.0	10.9	11.6	12.0	12.0	12.3	11.2	9.6	17.7	21.9	33.6	18.9	17.9	21.2	46.1	37.5	16.5	16.4	5.4	21.5	17.9	11.0	43.8	30.8	23.0	19.3	5.9	20.4	49.2	11.8	16.2	13.5	12.2	26.9	9.7	15.4	17.4	17.7	36.2	11.1	29.7	22.0	11.7	24.2	18.1	21.9	9.3	24.0	16.2	11.3	12.4	10.2	33.5	16.3	3.6	6.5	19.8	23.4	26.8	8.5	11.0	13.8	32.5	21.4	33.6	11.0	27.9	18.0	21.4	53.1	13.1	14.6	17.0	23.4	17.3	40.6	17.8	12.7	27.6	29.0	35.6	24.8
METTL18	"AsTP2, C1orf156, HPM1, MGC9084"	ENSG00000171806	"Methyltransferase like 18"	O95568	1	169792529-169794963	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035314	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA035314: AB_10601146"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.28e-4)"	5.6	5.3	5.4	6.2	5.7	4.0	10.5	6.5	6.8	5.8	5.7	6.5	5.2	6.0	8.7	5.2	7.5	4.8	6.1	5.0	5.5	7.4	6.2	5.5	14.1	5.4	5.5	9.2	4.9	22.4	3.4	6.0	5.7	6.8	6.2	7.3	6.3	5.9	4.3	6.2	6.0	5.0	5.8	8.8	7.3	6.5	5.5	10.3	9.0	6.9	11.6	5.6	3.8	6.7	13.0	7.5	11.6	8.3	6.6	12.2	8.6	5.9	6.9	7.8	6.6	9.6	20.7	22.2	16.2	7.7	10.8	14.5	11.5	13.6	9.9	14.0	9.9	15.9	6.6	8.0	13.7	16.9	7.2	5.6	14.2	7.5	8.1	7.6	14.2	16.8	17.1	10.8	10.1	6.3	18.0	11.1	14.9	27.7	18.7	13.0	12.0	16.8	11.7	12.9	8.6	13.4	13.2	14.4	18.2	17.1	19.3	18.1	6.7	9.3	9.0	9.9	13.8	19.8	27.6	29.9	7.1	13.4	9.9	18.2	9.5	23.1	24.8	10.6	31.7	21.6	27.1	28.8	10.0	24.2	31.8	30.9	5.5	24.0	6.6	7.7	34.5	18.3	5.4	5.7	6.5	6.8	5.0	5.5	5.4	5.5	5.7	5.8	5.5	6.7	5.8	3.2	4.6	1.0	9.5	1.5	6.1	10.8	1.8	7.4	4.6	5.2	5.0	2.8	8.5	5.5	0.0	13.7	4.5	3.7	25.4	12.1	16.9	3.7	5.1	8.3	3.0	8.6	1.4	8.0	5.5	5.5	2.0	2.8	7.0	13.4	7.5	2.9	7.7	6.7	1.9	3.6	10.2	5.9	3.2	5.4	6.2	3.7	5.4	2.8	2.6	12.0	14.4	1.5	4.0	5.3	5.7	5.3	2.5	3.1	5.7	11.6	10.9	8.5	0.0	6.1	6.5	16.7	10.2	2.4	0.9	11.5	10.1	10.0	5.5	4.2
METTL21A	"FAM119A, HCA557b, HSPA-KMT, LOC151194"	ENSG00000144401	"Methyltransferase like 21A"	Q8WXB1	2	207580631-207625928	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Paneth cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034712	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA034712: AB_10670160"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (4.80e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	11.1	9.0	18.9	10.8	20.3	22.7	7.9	24.8	24.6	8.9	14.7	9.4	8.2	9.7	7.9	6.7	7.9	7.0	13.7	17.7	19.9	11.2	23.7	9.0	16.5	20.1	19.2	11.1	8.8	9.9	9.9	12.5	20.1	8.4	8.9	16.0	8.6	6.5	21.9	9.2	8.8	7.6	15.1	16.2	12.1	7.6	21.6	17.6	12.4	8.8	15.0	8.5	6.8	27.6	18.4	16.8	27.4	20.8	11.9	12.4	53.0	10.1	12.3	15.9	16.0	32.3	28.6	26.2	21.5	7.7	27.8	10.4	39.6	13.2	13.1	15.3	27.1	30.9	26.7	53.6	21.0	40.7	30.0	11.1	17.2	7.9	13.2	19.5	18.1	43.3	45.0	15.1	10.6	29.7	41.2	69.4	45.5	24.9	11.8	30.1	11.4	38.2	23.0	15.3	32.3	26.5	21.8	7.4	21.6	37.8	10.3	59.4	9.3	13.8	30.6	12.9	17.8	22.3	29.8	54.1	22.6	31.5	20.9	32.8	28.6	54.8	9.5	29.0	16.0	54.2	14.4	13.7	24.1	44.8	26.8	17.4	10.4	16.9	45.6	30.0	12.7	16.6	18.9	20.3	24.8	24.6	17.7	19.9	20.1	19.2	20.1	15.1	21.6	27.6	30.8	16.0	25.3	16.0	55.0	15.9	38.1	25.7	5.7	22.0	16.6	16.4	23.8	21.5	23.1	11.0	8.4	35.5	24.3	17.1	29.4	27.9	31.4	12.5	10.1	24.6	5.4	42.5	20.6	25.1	31.3	16.9	18.3	8.5	46.3	17.7	20.7	12.3	29.9	18.5	17.6	16.3	69.2	22.2	93.7	45.6	9.9	32.8	44.4	44.0	29.7	17.4	16.5	20.6	25.9	23.8	114.4	7.5	16.6	48.1	8.9	23.4	23.3	20.3	13.1	9.6	16.0	24.8	19.1	9.3	12.6	10.5	23.0	15.6	18.6	19.6
METTL22	"C16orf68, FLJ12433,MGC2654"	ENSG00000067365	"Methyltransferase like 22"	Q9BUU2	16	8621683-8649654	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 119.9;Late spermatids: 357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040803, HPA059882, HPA074173"	Uncertain		Supported	"Nucleoplasm,Nucleoli rim"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"	Nucleoplasm	"HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672"	"unprognostic (1.74e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.90e-2)"	4.4	5.8	9.0	5.7	10.2	7.7	4.5	16.4	13.2	6.7	9.5	5.9	4.9	5.9	6.1	5.3	5.4	4.4	9.3	8.8	9.1	5.1	6.6	4.7	6.1	12.7	10.7	6.4	6.1	3.1	5.1	5.0	13.3	7.2	4.0	10.4	4.7	5.2	20.2	8.4	4.1	4.7	9.1	4.7	5.1	13.7	12.6	4.0	5.2	5.9	5.0	5.5	5.8	12.9	4.3	8.7	9.7	9.3	3.6	9.1	8.4	7.2	3.8	8.4	9.5	8.5	9.8	6.7	6.3	6.4	3.1	7.9	6.1	11.5	5.5	9.8	8.4	6.9	17.3	24.6	10.8	7.2	5.1	9.2	8.2	9.2	10.1	5.1	6.8	9.2	9.4	6.6	6.5	15.2	7.4	17.0	5.2	1.9	8.5	11.1	7.3	13.9	4.1	4.5	11.9	7.9	6.3	7.3	4.7	5.2	8.0	5.9	5.4	10.0	8.7	8.2	3.3	8.9	5.3	10.4	3.6	9.3	4.7	1.6	2.5	2.0	0.9	1.9	0.9	0.9	0.9	1.0	2.3	0.8	1.1	0.5	9.7	1.6	2.2	1.3	1.2	1.0	9.0	10.2	16.4	13.2	8.8	9.1	12.7	10.7	13.3	9.1	12.6	12.9	5.1	9.6	5.6	8.5	7.6	3.3	6.9	7.5	8.6	13.8	5.8	6.1	18.3	4.3	6.0	0.0	4.2	12.8	2.7	4.9	11.7	9.3	119.9	3.5	6.5	7.2	7.2	18.5	13.4	9.8	9.8	7.4	9.2	3.5	8.2	11.3	5.7	7.4	29.5	1.7	14.3	7.0	2.0	31.8	9.6	357.8	10.8	27.5	1.8	12.2	17.6	4.9	11.3	12.5	13.3	8.4	6.8	13.9	7.7	11.0	8.3	8.9	3.4	11.8	0.0	9.0	8.5	39.6	15.7	7.5	2.7	13.3	6.6	7.8	6.5	8.1
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 414.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: AB_2682203, HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	63.6	100.6	41.9	31.1	52.7	118.7	54.5	39.5	53.2	62.9	53.1	45.2	28.3	46.3	70.5	67.8	42.4	32.9	42.0	44.9	41.7	140.8	16.5	49.2	36.1	44.7	43.4	48.6	39.7	68.1	44.7	36.8	40.3	45.6	31.1	38.6	49.8	28.0	77.4	51.5	39.2	33.1	47.1	54.7	44.3	11.0	46.5	56.9	52.7	52.9	44.1	49.5	57.5	48.2	50.8	41.8	95.3	77.0	99.5	156.2	36.1	85.7	103.8	58.8	68.5	30.4	79.9	92.4	64.8	132.6	53.3	33.0	61.1	71.4	71.2	70.5	72.0	41.1	34.1	120.6	75.1	35.8	81.0	111.6	76.6	54.3	81.1	119.4	111.4	97.8	61.8	57.6	112.3	60.2	93.7	71.2	87.6	60.8	64.0	124.8	80.8	82.7	116.3	44.5	61.8	116.0	66.1	53.1	195.0	65.6	44.5	16.7	75.0	96.9	43.9	62.2	49.5	72.8	102.8	71.4	107.6	80.8	66.3	111.0	75.7	33.4	11.4	14.3	13.5	18.3	19.0	21.1	42.5	20.6	20.4	16.2	36.1	17.0	12.0	14.3	20.4	28.8	41.9	52.7	39.5	53.2	44.9	41.7	44.7	43.4	40.3	47.1	46.5	48.2	82.4	19.2	26.1	32.3	66.9	71.8	89.5	143.8	51.2	52.6	77.7	61.7	53.6	34.3	81.3	86.5	45.9	79.4	94.3	49.6	281.8	119.5	7.8	56.4	68.9	89.2	84.9	146.9	48.2	122.9	124.2	67.6	42.8	64.7	47.7	70.0	98.6	11.2	95.8	45.4	37.8	80.4	101.7	181.7	103.3	6.3	63.3	124.2	104.9	40.3	270.1	92.9	109.2	34.2	28.3	114.9	51.5	65.1	58.0	149.4	81.1	414.2	50.4	43.7	65.7	48.9	108.8	17.1	25.1	74.7	77.0	139.1	111.4	57.4	80.5	142.9
MEX3B	"DKFZp434J0617, RKHD3, RNF195"	ENSG00000183496	"Mex-3 RNA binding family member B"	Q6ZN04	15	82041778-82046119	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 14.0;testis: 46.8"	"Group enriched"	"Detected in many"	8	"Early spermatids: 204.7;Granulosa cells: 99.5;Late spermatids: 201.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 65.9;HEL: 49.2;SH-SY5Y: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041093	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA041093: AB_10793868"	"unprognostic (2.42e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.93e-8)"	"unprognostic (1.24e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.51e-2)"	2.2	0.4	1.7	1.5	1.6	2.0	1.5	2.8	2.8	14.0	0.0	3.4	0.6	6.2	0.5	0.9	1.3	2.5	2.7	1.8	0.7	0.7	0.9	1.5	2.7	0.7	0.9	5.6	0.6	0.2	0.8	2.3	0.7	2.5	0.7	0.8	2.6	3.2	1.6	1.1	1.1	1.4	0.3	1.1	1.0	46.8	1.9	6.4	0.8	2.0	1.0	1.4	4.1	1.0	0.2	2.5	17.2	65.9	1.4	2.0	4.9	2.1	1.0	3.6	3.2	0.5	0.4	3.2	1.2	3.9	1.1	0.5	8.2	0.3	2.5	0.7	5.3	49.2	2.8	2.2	2.8	0.6	15.1	1.0	1.3	2.0	4.0	8.4	7.6	6.1	2.4	0.0	6.2	1.6	8.3	4.2	22.4	0.1	0.6	11.4	10.4	1.7	0.1	0.0	13.7	26.2	3.5	0.6	2.4	4.8	0.2	0.8	6.9	9.0	10.3	5.0	3.1	6.1	3.4	3.7	2.9	5.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	2.8	2.8	1.8	0.7	0.7	0.9	0.7	0.3	1.9	1.0	3.6	0.0	0.6	0.0	1.3	2.8	0.4	1.4	5.2	3.1	6.0	8.0	4.5	1.5	0.4	0.0	2.1	11.3	1.6	0.7	0.0	0.8	204.7	1.8	13.5	5.3	1.2	7.2	2.1	0.2	8.7	8.3	0.5	1.3	1.3	99.5	2.5	0.2	1.5	0.0	3.4	1.0	0.0	1.0	9.8	201.1	6.5	5.0	7.2	1.0	0.5	5.2	0.0	4.0	1.3	0.5	0.2	4.5	0.8	0.8	0.0	0.0	0.3	2.9	6.6	1.9	16.8	2.7	18.8	5.8	2.0	2.5	2.0	1.0	1.4	0.2
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824690	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	15.9	24.0	17.5	17.6	18.0	12.9	21.4	21.3	23.2	16.6	19.7	17.1	14.5	18.8	23.4	22.2	18.4	14.9	22.1	17.7	19.3	23.7	18.1	15.2	26.6	18.3	19.3	24.8	15.3	33.2	14.5	23.2	18.7	22.8	18.1	25.0	17.0	17.7	26.3	20.5	15.0	19.1	17.7	17.1	16.8	19.3	18.5	24.4	24.7	23.2	32.4	20.6	17.5	19.1	40.1	41.0	69.4	46.0	57.9	36.3	42.7	63.1	43.8	50.3	58.2	64.1	25.6	42.8	58.7	39.4	50.9	70.8	62.5	51.7	58.9	72.9	37.6	103.7	71.6	48.5	45.4	62.3	53.2	34.1	55.3	48.0	43.3	48.0	49.8	48.3	95.8	35.7	60.9	30.0	51.1	47.0	49.2	74.2	35.4	73.9	69.6	27.6	52.0	59.0	43.8	43.0	55.6	47.0	27.0	55.2	70.7	39.5	47.4	50.6	35.8	56.3	51.7	43.5	112.2	91.8	42.5	58.4	37.9	42.5	25.5	56.9	35.3	34.8	34.7	35.0	35.1	33.6	32.6	28.3	35.7	35.0	22.6	50.5	29.1	26.8	44.1	26.3	17.5	18.0	21.3	23.2	17.7	19.3	18.3	19.3	18.7	17.7	18.5	19.1	30.4	35.3	30.2	5.2	32.8	30.3	59.6	50.1	35.9	41.8	22.4	28.8	31.0	25.8	43.2	51.5	6.2	94.6	33.2	27.4	56.7	44.2	6.2	43.1	39.9	35.6	11.3	32.0	9.0	29.4	55.0	29.8	21.4	39.4	46.3	37.6	20.7	18.8	35.4	32.0	8.6	24.4	38.7	20.7	20.5	6.3	28.0	25.5	26.6	5.6	30.6	51.5	33.0	2.0	8.2	26.8	27.1	35.7	20.6	39.3	22.1	42.9	60.0	35.2	19.7	35.9	41.7	49.7	84.8	28.1	27.7	147.4	33.6	39.4	21.3	50.6
MFAP3		ENSG00000037749	"Microfibril associated protein 3"	P55082	5	154038959-154220478	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.3;Inhibitory neurons: 24.5;Microglial cells: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015883, HPA049198"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA015883: AB_1853840, HPA049198: AB_2680672"	"unprognostic (6.02e-2)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (9.35e-3)"	16.0	8.5	5.4	13.2	5.4	12.1	12.5	8.1	7.0	13.2	10.1	10.8	9.5	12.0	9.8	14.7	9.7	11.8	14.1	5.3	6.3	13.5	13.7	11.3	10.6	5.8	6.2	9.4	7.1	24.4	3.1	19.6	6.3	9.4	10.8	12.2	7.2	9.0	10.4	7.6	9.6	16.6	6.5	11.4	9.6	5.7	5.7	11.8	13.4	17.1	13.0	16.1	6.5	6.0	14.9	19.7	36.5	37.7	29.8	24.7	31.5	26.4	28.0	27.0	37.1	27.4	34.1	25.0	30.6	26.3	25.8	33.5	32.5	35.6	41.9	9.5	21.0	15.7	26.5	12.9	29.5	27.7	16.0	29.2	32.4	35.0	29.1	22.6	38.4	19.9	17.5	20.5	21.4	11.0	15.2	9.9	20.0	16.0	9.9	14.6	40.7	20.8	20.8	21.0	32.1	40.3	27.4	35.0	31.1	30.1	34.6	14.8	32.9	34.3	26.4	19.4	26.9	25.7	33.5	21.4	18.7	19.2	27.4	6.7	7.5	11.9	5.0	7.9	6.9	2.4	4.0	3.5	8.1	2.5	5.2	4.1	6.8	6.5	5.6	3.7	3.9	4.3	5.4	5.4	8.1	7.0	5.3	6.3	5.8	6.2	6.3	6.5	5.7	6.0	9.7	0.0	0.5	14.0	3.5	6.0	1.0	6.1	6.2	3.2	1.6	1.5	2.7	0.0	3.9	5.5	6.2	4.3	2.7	1.9	1.9	1.4	7.1	1.4	4.3	7.6	0.0	9.1	24.3	1.1	3.0	3.9	4.1	2.2	4.5	2.1	1.4	1.9	1.9	3.3	24.5	1.2	8.2	0.6	4.4	4.9	1.8	2.7	8.8	17.8	0.7	6.9	1.0	12.1	15.1	1.1	0.3	0.0	9.5	1.3	2.1	1.1	4.6	4.6	0.0	1.5	3.3	3.9	2.0	4.3	5.5	6.0	4.0	1.2	1.0	1.5
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.5;choroid plexus: 88.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1840.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 5.7;eosinophil: 1.8;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.5;RT4: 38.0;SK-BR-3: 34.3;SuSa: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.0	3.4	32.9	0.9	61.0	3.2	12.0	49.1	34.4	13.0	88.8	2.7	0.6	5.1	38.9	0.8	4.2	2.6	1.7	35.2	40.1	30.0	37.4	2.7	0.9	46.3	58.3	0.6	1.5	6.5	4.1	3.0	48.5	2.8	2.0	25.0	2.1	12.8	5.1	24.5	1.0	4.1	38.8	1.5	1.3	46.3	54.9	0.6	2.8	2.3	0.5	10.1	1.8	65.5	0.4	5.7	3.0	3.1	2.6	1.3	1.1	6.2	0.9	2.8	2.5	1.9	0.4	0.0	0.2	9.6	5.4	2.9	10.9	1.4	1.2	0.0	4.7	0.0	6.7	2.4	1.4	0.0	22.5	1.8	3.4	0.3	1.0	1.5	0.3	3.5	0.9	1.1	5.8	3.4	1.0	0.8	3.1	0.7	4.7	0.0	1.8	0.0	8.1	38.0	2.5	5.5	5.1	34.3	11.6	19.1	1.9	0.0	0.2	2.9	11.2	5.5	11.9	0.6	0.0	0.0	7.5	1.2	11.4	5.7	0.1	1.8	0.6	0.7	0.3	0.0	0.5	0.1	0.2	0.0	0.2	0.1	3.5	0.0	0.0	0.5	0.1	4.6	32.9	61.0	49.1	34.4	35.2	40.1	46.3	58.3	48.5	38.8	54.9	65.5	1.0	0.0	5.6	112.6	0.6	2.5	0.4	0.1	2.8	12.2	8.5	9.7	3.4	0.0	0.2	36.8	20.9	3.1	0.2	0.6	5.9	0.5	417.5	8.5	1.1	2.0	2.4	11.2	36.3	1.1	1.0	0.6	0.0	12.4	4.5	11.0	3.3	49.1	1.2	3.3	25.0	0.3	0.0	1.0	0.7	1840.0	5.3	13.5	7.2	3.7	1.5	2.9	2.1	53.8	127.6	1.4	0.3	9.1	0.5	0.9	0.3	24.0	0.3	15.8	19.7	1.7	4.2	17.6	13.2	0.3	8.4	9.4	0.6	1.4	0.8	2.2
MFHAS1	"LRRC65, MASL1, ROCO4"	ENSG00000147324	"Malignant fibrous histiocytoma amplified sequence 1"	Q9Y4C4	8	8783354-8893630	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Signal transduction inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.4;Glandular and luminal cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 128.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051213, HPA054471"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA051213: AB_2681391, HPA054471: AB_2682498"	"unprognostic (1.33e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.23e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.01e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-1)"	5.8	2.0	7.3	7.9	6.9	11.9	3.6	7.5	8.7	6.3	4.1	12.8	6.1	5.1	3.3	5.3	6.6	5.5	6.6	8.3	6.4	13.5	6.0	9.9	10.4	6.1	7.4	3.4	4.6	5.7	2.0	8.8	6.5	5.3	11.4	5.4	3.4	4.4	2.4	6.1	7.0	8.2	6.5	11.1	6.3	6.0	9.0	9.0	5.4	2.7	8.6	9.2	3.5	6.2	19.5	14.4	8.6	6.6	8.0	10.1	28.3	7.9	17.0	5.6	7.6	23.3	3.7	28.5	9.5	7.6	16.2	6.5	9.1	7.3	4.9	37.0	8.1	2.1	5.3	15.1	9.5	8.2	2.9	5.5	15.0	7.6	7.5	6.0	12.5	34.8	13.4	0.0	4.7	7.0	128.0	7.2	16.8	25.8	6.1	17.4	13.1	4.4	39.3	20.0	13.6	11.0	4.6	7.2	12.7	14.6	4.9	11.1	5.3	6.8	10.1	27.3	15.4	1.5	6.9	21.7	12.6	10.8	4.2	0.0	0.1	0.0	0.9	0.0	0.7	0.4	1.3	0.8	0.2	0.3	0.6	0.5	0.0	0.1	0.0	0.0	1.2	0.3	7.3	6.9	7.5	8.7	8.3	6.4	6.1	7.4	6.5	6.5	9.0	6.2	10.7	54.5	43.9	105.4	6.5	37.5	24.5	6.0	2.8	19.0	6.2	3.2	17.2	20.0	16.5	31.3	4.2	3.7	6.5	30.9	13.7	12.0	2.5	50.8	20.3	19.2	18.8	71.4	46.9	15.4	3.2	17.8	8.2	119.2	22.2	5.4	25.4	17.8	31.8	3.3	56.8	29.3	10.2	27.5	21.0	3.4	11.5	13.0	10.6	61.8	8.0	24.3	14.4	38.2	6.2	28.5	20.7	8.2	2.1	47.5	6.7	16.5	5.4	8.1	0.0	4.5	24.1	1.9	21.7	2.4	50.0	2.3	24.0	1.7	36.3	16.9
MFSD10	"IT10C3, TETRAN"	ENSG00000109736	"Major facilitator superfamily domain containing 10"	Q14728	4	2930561-2934834	"Predicted membrane proteins"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 251.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 275.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043209	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"	Nucleoplasm	"HPA043209: AB_2678364"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.76e-2)"	"unprognostic (9.43e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (8.32e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.00e-2)"	35.2	20.2	15.8	9.9	16.4	66.1	30.5	13.6	24.1	43.1	19.3	30.3	12.3	34.7	3.3	27.6	36.9	12.5	26.5	16.1	14.4	33.6	10.8	36.9	13.2	16.9	14.7	41.6	29.0	3.6	28.7	11.5	14.7	34.3	3.8	1.1	30.4	11.3	14.0	22.0	31.0	7.6	13.2	36.1	31.6	15.6	17.6	6.3	37.6	3.4	6.3	34.6	32.8	14.3	50.4	46.2	13.3	33.7	21.7	15.5	36.0	45.1	21.9	21.5	24.6	24.7	117.3	8.8	23.7	28.4	40.0	45.9	12.1	65.6	5.8	56.9	40.7	19.1	39.2	25.9	36.5	59.9	27.1	23.5	37.5	24.5	15.4	33.4	24.7	20.0	26.4	18.0	16.5	53.8	16.9	275.6	43.0	38.9	54.5	20.7	6.4	41.8	32.9	30.6	34.2	40.7	10.8	31.5	49.1	13.5	82.9	112.9	37.1	17.7	30.4	22.2	36.6	12.2	5.8	13.8	50.0	153.3	27.8	64.7	55.0	117.4	73.0	71.2	62.6	45.1	46.8	82.1	57.4	35.2	23.3	41.1	44.2	45.9	95.8	45.7	34.4	42.6	15.8	16.4	13.6	24.1	16.1	14.4	16.9	14.7	14.7	13.2	17.6	14.3	64.6	38.5	29.1	17.6	41.3	31.4	78.8	251.5	28.5	9.2	56.3	68.1	5.0	28.6	123.2	46.0	8.4	67.4	71.0	37.8	3.9	96.0	11.7	41.5	33.4	41.1	28.2	13.3	21.5	45.9	93.0	42.9	33.6	44.3	32.4	50.7	45.7	3.1	69.6	15.2	14.8	37.2	93.6	49.3	36.7	18.8	36.4	45.6	42.7	9.4	62.1	11.0	64.9	9.5	8.8	86.0	51.5	22.6	28.1	92.1	60.0	17.9	104.9	10.0	92.1	27.0	56.6	15.5	16.1	26.9	26.9	83.7	62.4	44.7	49.4	100.5
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374569-94461042	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA017978: AB_2116836"	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	24.4	32.3	25.5	26.1	28.0	18.4	24.6	26.6	33.1	24.0	34.6	24.4	18.8	24.1	29.0	40.2	26.7	20.7	20.8	24.0	26.3	21.9	15.2	32.0	29.4	29.1	28.5	19.0	18.1	95.1	12.7	33.3	28.5	21.3	28.5	17.9	20.8	21.3	12.4	42.4	21.3	23.8	28.5	25.2	24.9	14.1	27.3	30.7	25.7	14.1	34.6	34.7	27.6	29.8	76.4	48.3	36.9	28.8	79.3	56.4	58.4	72.5	62.7	63.3	61.6	24.4	88.9	91.2	42.2	63.1	73.0	163.9	44.6	46.3	61.0	65.7	23.9	31.6	43.0	36.8	56.2	100.0	55.8	52.2	68.5	67.1	51.2	35.4	54.9	49.3	60.6	52.5	85.2	57.8	73.7	56.6	54.2	111.0	38.4	36.6	84.6	29.6	68.2	57.8	35.4	46.4	61.6	71.6	79.6	44.0	32.9	58.3	59.4	65.6	46.1	102.1	68.2	57.6	77.2	24.8	58.6	48.1	60.1	0.5	6.1	4.9	4.1	9.2	3.7	3.3	3.6	4.2	6.2	2.1	3.6	5.1	8.0	3.1	6.3	6.0	4.0	3.0	25.5	28.0	26.6	33.1	24.0	26.3	29.1	28.5	28.5	28.5	27.3	29.8	21.6	6.4	20.0	0.0	17.3	0.0	23.2	0.0	22.2	12.2	29.4	15.6	0.0	14.3	6.8	44.1	4.2	14.2	20.6	16.2	7.9	16.8	3.6	32.2	20.7	18.9	7.3	30.7	0.0	19.0	26.4	17.3	16.3	32.7	3.8	14.1	26.4	13.5	28.9	5.0	0.0	22.9	0.0	66.1	0.0	3.1	16.8	31.0	0.0	0.0	39.1	19.5	15.5	0.0	0.0	26.7	12.1	16.1	12.7	38.5	11.7	7.6	7.3	9.9	13.1	18.1	14.9	14.1	18.2	37.6	0.0	19.2	15.7	17.7	14.4	42.6
MFSD6	FLJ20160	ENSG00000151690	"Major facilitator superfamily domain containing 6"	Q6ZSS7	2	190408355-190509205	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 110.6;Respiratory ciliated cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 79.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022274	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA022274: AB_2142776"	"unprognostic (9.47e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (3.46e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.14e-2)"	"unprognostic (9.18e-2)"	20.8	40.3	29.1	12.7	31.7	7.6	21.3	37.0	40.3	21.8	0.0	31.8	19.8	10.5	32.8	40.6	19.5	15.8	17.9	35.5	27.6	10.8	2.3	26.4	14.8	45.8	48.3	4.1	16.8	64.5	35.4	8.6	52.4	23.0	28.9	14.9	30.8	32.3	6.4	29.8	24.6	14.4	28.6	20.9	32.1	7.9	38.3	19.9	38.9	14.2	20.6	22.9	21.5	51.2	25.1	15.2	0.5	5.2	10.6	13.6	20.4	12.7	25.3	8.4	10.5	5.6	31.1	39.1	5.8	26.4	15.6	41.5	7.4	22.1	9.5	79.7	11.6	20.9	14.2	2.9	4.2	8.3	6.4	2.1	39.3	12.5	8.1	27.1	3.0	30.5	5.4	42.2	2.2	9.7	38.8	1.8	3.4	27.1	16.1	8.6	1.2	34.1	15.9	45.1	47.5	12.2	17.9	41.7	24.9	1.7	13.6	9.5	12.6	1.4	2.9	16.6	19.7	19.3	8.6	13.8	13.5	16.9	6.9	4.6	1.1	0.4	1.4	0.3	1.5	1.6	1.8	2.0	1.5	0.7	0.9	1.9	0.1	2.1	0.5	0.7	3.5	0.8	29.1	31.7	37.0	40.3	35.5	27.6	45.8	48.3	52.4	28.6	38.3	51.2	48.6	32.1	20.0	7.2	7.6	6.4	11.5	11.7	10.8	9.7	16.8	9.8	21.4	5.7	30.3	23.9	8.4	0.2	14.9	25.1	0.0	13.2	46.8	27.9	5.9	26.7	35.4	7.8	55.7	20.5	0.2	8.9	31.1	22.5	24.0	8.7	16.1	0.8	4.0	28.6	47.9	42.7	12.2	4.0	8.0	13.7	5.6	12.3	8.8	11.2	9.7	6.8	3.1	41.7	110.6	24.9	20.8	5.3	14.9	13.5	13.6	1.0	88.5	7.9	0.0	16.7	7.2	1.0	1.4	28.8	18.3	0.0	17.0	18.6	21.1	22.7
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917799-127966034	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	4.6	5.7	1.3	6.8	1.3	2.6	6.9	1.9	1.6	6.2	1.1	6.8	10.0	5.6	3.9	5.4	5.5	4.8	3.8	1.1	1.7	6.4	10.0	4.8	5.4	1.4	1.3	6.8	8.1	9.1	7.1	5.9	1.5	5.5	8.2	4.6	5.8	4.4	3.7	5.9	7.6	5.8	1.1	7.3	6.4	3.9	0.8	5.2	7.0	4.4	7.9	5.3	5.9	2.2	10.9	7.3	9.5	4.6	7.2	6.9	7.0	8.3	10.3	10.2	10.5	5.2	14.3	5.2	14.5	14.3	14.8	7.8	10.2	7.4	14.4	10.8	7.9	5.7	9.1	8.0	9.4	6.0	6.6	8.3	2.7	8.6	7.7	5.0	10.6	6.6	9.5	5.9	14.6	8.9	5.0	1.9	1.7	11.8	5.2	5.3	0.6	4.7	7.5	13.9	8.5	2.9	9.0	12.0	3.5	6.4	5.6	5.1	6.7	2.9	3.1	10.7	7.8	12.5	22.1	9.6	10.3	5.3	8.8	1.9	1.6	2.8	2.5	2.4	2.4	2.5	2.7	2.2	1.6	1.1	2.4	2.6	2.5	2.4	3.7	2.2	3.4	1.2	1.3	1.3	1.9	1.6	1.1	1.7	1.4	1.3	1.5	1.1	0.8	2.2	9.5	12.8	14.1	17.0	18.8	3.2	4.9	8.5	10.2	17.2	8.1	5.3	3.0	5.7	14.0	16.5	20.9	12.5	17.9	7.2	1.9	8.5	10.4	7.7	7.2	7.2	4.2	3.8	32.1	7.0	7.3	8.6	11.7	8.2	12.7	18.4	8.9	10.1	7.6	11.8	34.9	6.8	10.2	8.5	3.3	14.7	9.3	6.5	3.6	27.2	10.5	8.6	20.6	20.6	24.6	7.8	9.5	9.4	19.9	5.4	11.1	6.3	12.1	24.9	6.6	5.8	6.6	12.6	8.4	8.9	5.7	22.0	13.7	11.4	7.3	4.8
MGA	"FLJ12634, KIAA0518, MAD5, MXD5"	ENSG00000174197	"MAX dimerization protein MGA"	Q8IWI9	15	41621224-41773081	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.6"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042278, HPA058183"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA042278: AB_10794647, HPA058183: AB_2683632"	"unprognostic (5.78e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.97e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.82e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.89e-1)"	3.9	5.2	7.0	5.4	12.1	8.7	7.2	33.6	8.5	7.3	0.0	4.5	3.7	7.4	6.0	4.5	5.8	4.2	4.5	4.9	11.6	5.2	4.6	4.3	7.6	6.4	6.9	12.0	5.0	6.0	3.9	6.9	8.8	5.7	5.1	7.0	5.1	5.5	5.1	6.2	3.9	5.7	3.8	6.8	4.6	8.7	8.6	11.6	7.5	7.8	7.6	5.4	3.9	17.3	2.4	13.5	16.6	10.9	12.8	10.1	13.3	6.7	6.8	7.8	7.7	14.5	7.8	16.2	11.8	7.8	14.2	9.3	25.9	5.9	10.7	7.7	8.5	34.3	22.1	12.8	11.3	31.9	16.4	7.7	7.2	10.9	10.7	3.2	10.3	15.5	40.7	7.2	7.1	6.7	19.4	12.3	10.3	7.0	6.9	21.7	16.9	8.5	4.1	9.8	15.7	15.3	24.0	8.2	4.3	12.1	6.6	20.1	11.0	9.5	13.3	9.8	8.0	9.8	15.7	15.3	6.0	11.9	4.8	3.6	1.4	1.6	2.5	1.0	2.5	2.8	2.1	2.9	1.4	3.0	2.1	2.4	0.6	5.8	3.3	2.4	1.1	1.0	7.0	12.1	33.6	8.5	4.9	11.6	6.4	6.9	8.8	3.8	8.6	17.3	18.5	22.4	19.8	56.5	28.1	7.9	10.9	7.2	13.6	25.5	11.1	8.9	29.5	5.7	16.2	12.9	33.3	18.1	23.6	9.7	7.9	11.8	16.7	16.8	35.4	18.6	7.8	28.6	62.4	5.3	12.0	20.5	18.8	24.9	14.5	32.9	15.0	9.3	11.8	13.5	60.1	10.0	8.2	11.9	8.8	7.0	20.8	17.1	8.8	44.0	13.2	16.0	25.7	64.8	122.6	8.1	13.5	20.7	16.4	16.2	7.6	5.2	14.9	23.6	39.5	35.6	19.2	45.4	40.4	11.7	11.2	26.0	27.5	23.5	11.3	10.7
MGAT4B	GnT-Ivb	ENSG00000161013	"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B"	Q9UQ53	5	179797597-179806952	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 277.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 224.7;Proximal enterocytes: 224.5;Undifferentiated cells: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012804, HPA052134"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		19000	"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus, Vesicles, Cytosol"	"HPA012804: , HPA052134: AB_2681741"	"unprognostic (2.01e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (3.61e-3)"	"unprognostic (7.57e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.42e-1)"	48.4	105.0	17.2	19.0	16.9	24.6	39.9	16.8	19.3	37.0	18.1	147.0	134.1	36.9	13.4	75.1	37.2	23.5	103.3	18.9	14.2	124.8	277.1	61.2	15.5	16.3	15.0	41.1	63.3	22.9	37.7	17.9	15.1	42.3	65.0	4.4	57.9	11.9	43.8	53.4	168.3	14.9	14.6	52.8	96.3	30.6	18.0	10.5	60.1	14.9	16.0	38.7	42.1	16.2	84.2	85.3	40.8	93.7	117.4	65.1	71.1	48.3	98.3	44.4	34.8	91.7	226.4	14.4	122.3	108.2	193.1	61.6	57.9	110.1	32.2	121.0	33.0	43.5	75.1	78.4	85.9	53.7	13.4	70.5	76.6	44.1	53.0	165.2	89.1	16.9	28.7	38.5	73.6	92.6	8.4	47.4	24.7	123.7	35.1	21.6	31.4	40.4	132.3	158.5	67.5	39.7	73.7	75.2	139.1	33.8	51.3	56.3	109.2	106.6	48.6	61.2	80.2	32.5	39.5	35.4	125.0	68.2	78.7	0.0	0.4	5.5	0.1	0.1	0.0	0.0	0.3	0.1	0.3	0.9	0.2	0.3	0.1	0.0	0.3	0.3	0.0	0.2	17.2	16.9	16.8	19.3	18.9	14.2	16.3	15.0	15.1	14.6	18.0	16.2	35.7	12.8	9.2	9.4	7.7	12.5	17.8	12.5	5.2	15.5	29.6	30.7	24.1	37.1	11.1	27.6	4.2	8.1	22.1	224.7	3.9	66.7	0.7	27.2	17.8	24.3	22.9	5.5	11.4	54.0	11.1	15.3	78.5	50.5	5.1	39.5	26.7	89.9	17.7	30.3	10.0	72.2	14.2	20.7	11.7	2.6	15.2	24.5	10.6	9.4	16.8	25.7	6.2	4.5	6.3	89.9	114.6	17.0	7.0	49.0	224.5	22.4	7.7	11.1	13.1	16.2	24.7	1.5	6.5	21.1	11.9	14.0	12.5	24.9	131.8	64.8
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B"	Q3V5L5	17	76868404-76950393	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 12.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.0;Early spermatids: 7.3;Excitatory neurons: 26.2;Inhibitory neurons: 21.9;Late spermatids: 8.1"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 12.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 32.1;SCLC-21H: 15.9;U-138 MG: 19.2;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: AB_2668423"	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	0.2	0.2	2.4	0.2	2.1	0.1	0.1	0.0	12.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.0	5.2	0.0	0.2	0.0	0.3	0.1	0.3	0.0	0.2	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	1.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	3.7	32.1	6.4	3.4	0.0	0.0	3.7	0.4	1.3	11.7	6.9	0.1	0.7	0.0	2.5	1.5	13.7	0.2	1.6	0.2	3.0	0.1	0.5	0.0	1.7	0.1	0.0	0.0	0.2	0.1	0.2	0.0	1.8	5.2	2.0	0.7	0.2	0.0	0.0	1.5	0.1	0.0	1.8	0.8	3.5	4.8	5.6	7.1	8.9	0.1	15.9	6.1	5.5	2.4	5.0	0.4	0.2	0.2	5.8	19.2	20.9	0.3	6.3	0.0	0.0	0.7	0.6	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	12.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.0	0.1	0.1	0.1	0.0	0.0	5.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.1	0.1	0.8	0.0	0.0	26.2	0.0	3.2	0.2	0.0	0.2	0.0	0.6	0.7	0.0	0.1	0.0	21.9	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	2.8	0.0	0.2	0.0	5.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	1.1	2.4	0.0	0.0	0.1	0.1	0.2	0.0	0.0
MGLL	"HU-K5, MAGL, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-128052190	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 565.4;Distal enterocytes: 398.7;Pancreatic endocrine cells: 535.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 84.7;plasmacytoid DC: 89.8"	"Group enriched"	"Detected in all"	14	"dendritic cells: 89.8;granulocytes: 36.0;monocytes: 84.7"	"Cell line enhanced"	"Detected in many"		"BJ: 209.1;BJ hTERT+: 238.6;LHCN-M2: 191.3;RPTEC TERT1: 170.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	174.8	16.1	100.8	22.9	91.0	18.9	92.0	87.2	123.4	26.8	48.0	81.9	36.9	17.7	9.9	139.9	34.3	44.8	101.9	96.9	75.9	71.0	106.9	72.0	13.5	72.5	86.6	6.1	7.8	3.6	12.5	41.6	70.9	25.8	60.4	6.2	102.1	27.5	66.0	38.1	50.3	27.8	63.0	44.9	38.2	6.2	107.2	10.0	18.9	64.9	21.3	42.5	39.4	88.6	52.4	46.2	0.1	0.5	76.8	90.0	6.2	209.1	238.6	45.3	72.2	1.2	21.0	14.0	56.9	71.3	13.7	2.1	0.4	27.9	25.2	23.5	0.9	1.6	31.4	0.4	27.7	0.3	1.7	34.2	16.1	85.0	92.4	25.6	97.5	1.0	0.3	3.0	191.3	5.6	0.5	0.9	0.5	33.6	71.5	0.2	24.6	109.4	170.4	5.9	26.5	2.1	36.3	70.4	12.6	2.0	3.5	2.1	125.9	49.5	14.8	121.0	29.1	0.5	0.4	43.4	102.4	3.4	156.6	20.6	8.3	36.0	0.5	84.7	2.8	4.9	0.5	1.1	9.2	0.5	0.2	0.2	1.5	2.0	57.2	89.8	0.0	17.1	100.8	91.0	87.2	123.4	96.9	75.9	72.5	86.6	70.9	63.0	107.2	88.6	565.4	195.5	108.6	83.2	8.5	22.8	11.9	14.1	5.7	22.8	25.2	19.9	53.7	118.7	32.2	42.3	0.0	84.6	16.1	398.7	168.3	99.4	4.1	100.0	36.4	207.7	88.6	30.7	39.0	160.7	154.6	71.5	47.9	132.1	8.8	0.1	17.2	148.7	123.9	0.0	48.9	239.1	63.1	32.8	86.3	5.8	32.6	77.8	21.4	52.5	235.2	54.5	2.1	43.2	5.8	535.2	201.0	69.6	36.2	18.5	134.2	102.0	48.0	7.8	85.5	22.3	141.4	0.7	1.7	64.7	22.3	72.7	9.3	1.1	74.0	6.0
MGMT		ENSG00000170430	"O-6-methylguanine-DNA methyltransferase"	P16455	10	129467190-129770983	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 465.7;Proximal tubular cells: 340.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 60.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002786, HPA032135, HPA032136, HPA069497, CAB069881"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134"	"unprognostic (1.10e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.81e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.32e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	21.5	17.0	14.7	10.3	15.1	12.7	20.4	14.8	18.6	13.9	16.6	14.7	16.9	13.3	8.1	15.9	23.7	19.6	18.5	14.1	14.5	23.5	89.3	11.7	19.4	15.9	15.4	16.9	26.5	12.3	9.5	6.8	16.0	15.0	5.0	3.9	22.7	7.8	25.5	17.1	15.3	8.0	14.7	14.3	18.2	15.2	15.0	23.2	16.3	16.0	11.1	18.4	13.8	15.2	0.0	7.0	7.1	35.2	14.9	30.9	27.1	15.6	17.0	10.9	10.7	44.0	45.6	33.0	24.6	20.2	0.0	20.8	4.5	16.4	4.6	0.0	2.7	6.6	16.2	28.6	22.7	0.7	17.8	19.7	0.0	6.6	0.0	0.0	0.1	53.5	0.1	22.0	14.0	60.0	26.1	34.0	1.6	29.9	27.8	29.3	0.1	12.7	20.7	16.0	7.2	18.0	18.3	7.7	0.0	5.5	29.8	25.3	0.0	14.6	7.1	0.1	0.0	0.0	0.0	17.1	0.0	10.8	0.0	9.6	37.2	17.1	43.9	39.2	43.6	49.7	40.4	42.0	39.0	48.2	39.6	42.8	4.6	49.5	37.2	43.7	54.0	42.1	14.7	15.1	14.8	18.6	14.1	14.5	15.9	15.4	16.0	14.7	15.0	15.2	106.0	12.8	19.0	32.0	59.2	51.2	80.6	91.5	49.5	17.4	69.0	112.9	49.3	94.4	48.7	103.0	8.4	51.3	51.1	55.6	127.2	50.0	107.6	138.0	29.6	70.4	54.5	48.2	28.5	58.7	67.0	59.2	31.1	34.1	64.7	93.9	108.1	465.7	89.7	15.2	16.9	73.1	50.8	75.0	48.7	140.6	67.4	44.6	65.8	62.8	56.4	37.2	78.2	23.1	30.7	82.4	57.9	55.3	37.0	47.1	108.4	340.3	102.5	45.6	46.0	48.6	70.6	45.3	81.4	46.9	42.6	26.8	52.5	87.4	63.8	75.2
MGST3	GST-III	ENSG00000143198	"Microsomal glutathione S-transferase 3"	O14880	1	165631213-165661796	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 2092.0;Syncytiotrophoblasts: 2371.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 793.9;OE19: 781.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053311, HPA077929"	Enhanced		Approved	Nucleoplasm		NA	NA		27000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA053311: AB_2682108, HPA077929: "	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	260.2	163.3	218.0	57.7	224.9	126.2	196.5	245.4	273.1	96.6	214.1	219.6	358.6	91.9	520.6	97.6	112.3	114.4	770.2	232.6	258.0	254.3	166.8	117.5	48.9	239.5	228.8	118.0	90.1	139.1	86.1	173.2	248.3	113.4	217.8	89.9	164.0	114.8	568.0	87.8	301.6	118.8	227.4	54.4	163.0	64.2	230.3	51.9	142.9	578.7	47.7	107.2	90.0	240.5	178.2	128.0	150.0	106.1	533.4	312.1	653.1	158.1	244.2	119.1	205.2	126.8	219.1	10.9	117.1	198.6	117.8	204.7	36.2	155.2	118.5	793.9	94.5	27.1	84.7	60.4	144.9	45.0	58.9	284.2	107.5	178.0	62.3	239.4	202.0	54.2	72.3	65.6	233.6	37.0	48.9	97.4	292.3	781.6	165.8	44.8	63.0	22.2	599.8	159.4	104.1	134.2	148.7	181.1	313.2	308.4	139.1	215.9	174.7	135.8	82.6	92.9	110.8	49.7	37.0	5.8	239.8	109.7	92.3	44.8	172.9	81.2	107.2	150.2	107.9	79.3	130.5	117.3	138.0	78.2	81.4	89.1	32.3	62.3	195.0	58.2	125.5	185.0	218.0	224.9	245.4	273.1	232.6	258.0	239.5	228.8	248.3	227.4	230.3	240.5	915.1	102.5	164.8	48.3	87.6	228.3	251.8	603.8	111.0	144.6	177.0	267.6	670.1	301.7	292.6	557.3	266.9	2092.0	96.5	500.3	1001.8	380.2	18.2	325.6	132.6	268.0	152.8	785.4	75.8	425.9	1327.2	300.3	193.7	257.7	91.8	519.5	257.7	295.0	837.4	131.2	86.4	302.9	374.3	130.0	243.1	46.1	388.0	234.9	519.4	43.1	296.6	257.9	87.6	45.8	90.6	401.8	613.9	399.8	92.9	173.9	1004.1	1227.6	459.9	162.5	506.2	197.5	652.1	23.1	40.4	157.1	232.6	2371.4	123.1	288.6	440.7	237.6
MICAL2	KIAA0750	ENSG00000133816	"Microtubule associated monooxygenase, calponin and LIM domain containing 2"	O94851	11	12094008-12359144	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 193.5;Inhibitory neurons: 108.8;Late spermatids: 192.7;Peritubular cells: 112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 109.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030437, HPA039895, HPA040438"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896"	"unprognostic (2.68e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	4.7	3.8	13.9	12.2	13.6	11.6	2.5	61.6	38.1	6.9	42.6	18.8	9.8	12.3	7.2	18.6	7.4	10.0	42.2	37.8	0.0	2.3	2.9	17.5	3.3	0.0	0.0	3.9	4.1	1.0	0.2	7.3	0.0	2.9	16.3	4.0	0.8	9.6	16.8	14.0	10.8	30.8	0.0	3.3	6.7	32.5	0.0	1.9	6.1	4.1	2.5	12.4	0.3	19.9	29.1	9.7	0.4	2.7	2.3	6.8	14.2	32.1	53.7	16.2	28.3	24.3	23.3	0.2	8.4	25.3	47.7	25.0	4.0	65.1	41.6	35.9	4.8	27.5	4.1	0.9	12.8	5.3	2.7	12.7	11.1	76.0	54.6	25.3	46.9	1.6	43.5	0.8	22.9	1.2	0.3	1.6	1.2	13.6	9.8	0.3	15.2	14.2	2.1	35.5	14.3	0.8	8.6	38.6	2.9	9.9	4.5	2.3	42.6	109.6	35.0	17.4	39.6	0.9	2.6	1.5	64.3	5.2	1.4	0.1	4.2	0.5	1.3	0.7	1.5	0.1	0.8	0.4	3.4	0.2	0.0	0.4	8.9	2.2	0.4	0.9	0.7	1.5	13.9	13.6	61.6	38.1	37.8	0.0	0.0	0.0	0.0	0.0	0.0	19.9	3.2	41.7	37.1	7.2	1.2	10.1	11.8	4.5	4.0	5.7	4.2	5.3	32.2	7.2	8.5	3.7	0.0	2.6	11.2	66.5	0.0	10.2	74.4	7.8	8.9	9.2	22.6	35.6	193.5	14.3	12.6	9.0	12.2	11.4	1.3	1.4	12.8	19.6	3.4	0.0	108.8	10.6	6.1	10.1	5.6	192.7	21.1	11.1	5.4	4.7	21.6	0.5	8.2	6.6	17.5	42.5	24.0	112.8	2.1	8.9	18.3	0.9	5.5	1.6	13.1	1.9	29.4	1.2	1.3	1.7	9.5	2.3	10.8	0.7	14.5	11.9
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024561	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.5;Inhibitory neurons: 164.6;Oligodendrocytes: 216.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 104.9"	"Immune cell enriched"	"Detected in some"	4	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in all"		"WM-115: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	15.9	12.0	18.3	14.9	20.3	17.3	11.2	104.9	34.5	16.5	3.6	28.1	11.0	31.0	17.0	19.6	38.6	13.4	35.6	14.3	13.7	10.9	18.8	8.3	23.0	13.2	6.4	26.5	14.0	38.5	7.2	16.7	15.6	16.4	20.6	14.1	10.9	19.8	48.2	18.9	14.5	37.3	1.9	17.8	10.7	24.4	12.7	6.0	14.7	20.8	20.3	15.9	12.0	45.9	34.0	39.6	20.2	33.7	15.6	19.2	25.6	32.6	33.1	43.6	34.5	36.1	4.8	35.1	15.5	39.3	51.2	38.7	30.1	31.9	43.0	35.6	25.2	35.9	44.6	11.9	9.6	17.1	20.2	14.4	25.9	46.9	43.7	25.2	24.9	9.7	47.6	22.8	16.9	26.6	16.9	10.7	13.0	27.3	26.4	23.2	30.3	1.9	32.1	24.8	53.5	21.1	40.6	26.0	65.2	31.5	10.8	7.0	43.9	46.0	28.4	29.7	63.6	16.4	30.2	50.8	40.0	7.7	131.6	11.1	0.0	0.1	0.3	0.0	0.6	2.5	0.3	0.3	0.0	2.6	0.2	0.1	0.1	0.9	0.0	0.2	0.7	0.2	18.3	20.3	104.9	34.5	14.3	13.7	13.2	6.4	15.6	1.9	12.7	45.9	19.6	3.2	10.2	57.1	32.1	11.2	15.2	17.9	13.1	20.9	13.7	15.5	16.5	12.8	13.2	12.9	52.1	14.1	6.2	43.5	0.0	23.9	10.5	36.4	10.2	16.4	10.2	19.3	176.5	9.8	40.3	10.5	13.3	38.8	19.0	9.7	8.9	37.3	3.1	1.7	164.6	20.8	8.2	3.2	9.6	13.9	4.1	4.2	8.8	23.4	6.0	38.2	5.2	71.9	216.0	24.6	23.6	6.4	12.5	14.4	19.8	5.5	27.8	12.2	0.0	11.0	12.1	19.8	13.8	11.2	11.8	11.2	9.1	24.2	21.5	10.1
MICB	PERB11.2	ENSG00000204516	"MHC class I polypeptide-related sequence B"	Q29980	6	31494881-31511124	"Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Cytolysis, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 10.3;Erythroid cells: 10.5;Hofbauer cells: 11.1;Kupffer cells: 17.8;monocytes: 13.2;T-cells: 11.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 15.2;U-266/84: 36.5"									HPA064618			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA064618: AB_2685301"	"unprognostic (3.63e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (7.04e-5)"	"unprognostic (2.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.94e-9)"	"unprognostic (1.91e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.21e-2)"	2.6	1.2	0.1	1.4	0.2	2.2	2.2	0.2	0.4	1.4	0.2	1.9	0.2	1.7	0.3	1.4	1.2	0.4	2.5	0.2	0.1	1.8	1.2	6.2	2.8	0.2	0.1	0.7	0.8	0.1	0.6	0.2	0.2	1.1	0.5	0.0	1.3	0.0	0.5	1.0	4.5	0.4	0.1	9.9	1.4	1.3	0.3	0.7	1.6	0.7	1.6	1.4	1.5	0.2	3.4	1.3	0.0	0.0	1.9	3.2	0.1	2.3	2.2	2.9	3.7	0.0	0.4	3.9	5.9	4.3	8.1	0.8	1.0	4.1	1.0	3.4	2.3	4.6	0.6	1.3	0.7	1.4	3.5	4.1	0.8	5.0	3.5	3.1	1.9	6.0	4.2	7.8	3.5	0.0	1.3	5.9	0.4	0.0	0.5	4.7	0.0	8.2	3.8	0.2	0.0	0.0	1.5	0.0	0.7	1.2	2.0	1.6	1.9	2.2	0.0	1.9	0.1	15.2	36.5	8.3	0.5	12.0	4.9	1.8	0.9	1.2	0.8	1.1	1.0	0.6	0.8	1.1	0.6	0.5	0.4	0.9	0.9	0.6	1.6	0.4	1.4	0.7	0.1	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.2	3.0	3.2	1.5	0.0	8.2	2.9	0.5	0.3	0.0	0.0	3.1	1.9	0.5	1.5	0.8	0.0	0.0	0.1	10.3	0.8	1.9	1.6	0.0	3.1	1.6	3.0	0.0	10.5	0.6	0.7	0.3	1.5	2.0	5.2	0.0	0.1	3.9	0.1	11.1	0.0	0.1	0.6	0.0	17.8	8.2	0.4	0.3	8.0	1.8	3.7	13.2	0.0	7.2	0.0	0.1	1.9	1.9	0.4	8.7	2.1	0.5	0.3	0.9	0.0	0.0	0.6	2.2	4.6	5.2	0.1	1.1	0.1	11.3	0.5	2.1	1.1
MICOS13	"C19orf70, MIC13, P117, QIL1"	ENSG00000174917	"Mitochondrial contact site and cristae organizing system subunit 13"	Q5XKP0	19	5678421-5680516	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 344.8;Cytotrophoblasts: 154.4;Extravillous trophoblasts: 196.7;Hofbauer cells: 242.2;Syncytiotrophoblasts: 125.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042672	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	Nucleoplasm	"HPA042672: AB_10794531"	"unprognostic (9.54e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.04e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.47e-2)"	71.0	68.8	139.7	48.4	143.6	54.1	59.3	153.6	180.2	44.4	137.0	76.5	78.6	46.9	44.0	86.9	67.3	53.8	271.2	141.2	154.5	93.5	78.3	44.2	60.4	148.7	143.8	44.7	86.7	97.4	59.8	37.9	147.1	50.1	40.7	18.6	95.3	60.7	279.3	59.7	66.7	43.8	142.0	45.0	61.8	149.2	151.4	38.8	57.9	186.5	35.2	61.3	49.3	146.7	175.7	167.9	43.4	87.6	98.3	117.1	58.7	100.7	121.0	142.6	120.3	132.6	85.2	82.0	157.6	105.2	65.3	124.7	25.8	175.5	34.6	128.9	311.9	76.1	101.2	153.4	162.5	105.8	79.2	133.0	157.9	71.5	92.6	68.0	104.9	112.5	120.5	220.6	101.2	186.3	145.7	129.2	45.1	118.5	474.3	79.5	57.8	286.7	145.3	126.1	111.5	134.8	37.8	198.1	152.2	25.2	128.3	123.8	87.4	121.9	50.5	217.4	169.2	315.8	280.6	66.9	174.5	183.6	126.0	76.8	214.3	77.8	198.9	274.7	237.5	291.6	228.5	225.8	261.4	235.7	222.8	211.3	29.6	192.1	238.8	302.5	211.1	278.1	139.7	143.6	153.6	180.2	141.2	154.5	148.7	143.8	147.1	142.0	151.4	146.7	44.6	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	344.8	0.0	0.0	0.0	0.0	154.4	24.5	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	196.7	46.9	0.0	0.0	0.0	0.0	0.0	0.0	242.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	125.9	5.8	0.0	0.0	0.0
MICU2	EFHA1	ENSG00000165487	"Mitochondrial calcium uptake 2"	Q8IYU8	13	21492691-21604181	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045511, HPA058790"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA045511: AB_10959894, HPA058790: AB_2683821"	"unprognostic (4.32e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.50e-1)"	22.6	44.4	19.3	24.5	21.0	36.3	32.4	23.9	29.7	26.2	24.2	37.6	26.5	22.1	27.8	23.2	25.1	20.2	57.5	20.4	20.4	76.3	32.2	23.0	26.9	21.8	20.6	22.7	21.3	45.9	27.0	24.5	20.2	28.5	34.1	45.7	23.4	22.1	56.4	22.9	27.4	21.1	20.8	22.6	30.6	27.0	19.7	28.8	37.6	61.5	29.7	23.5	18.7	24.2	35.2	20.0	46.2	29.6	40.4	53.8	39.7	58.3	47.5	60.8	42.0	29.0	55.6	54.4	36.8	56.0	31.3	45.9	45.9	49.1	83.4	55.5	46.5	94.2	20.5	34.3	48.7	71.4	52.7	46.8	47.7	34.5	24.4	54.4	41.2	50.5	33.9	23.9	100.3	30.8	47.9	68.1	31.5	123.2	30.3	51.9	117.2	36.6	121.3	28.6	36.9	28.6	39.8	46.4	39.6	40.2	45.3	66.7	51.1	26.4	23.6	54.1	48.9	17.7	24.8	39.6	26.1	59.0	66.8	34.0	24.8	35.1	30.6	30.5	28.0	42.1	26.9	30.9	27.3	24.4	23.7	30.2	23.3	30.2	25.6	25.1	40.3	23.9	19.3	21.0	23.9	29.7	20.4	20.4	21.8	20.6	20.2	20.8	19.7	24.2	22.0	38.5	26.8	70.2	51.3	30.0	39.8	51.9	26.2	27.1	24.0	17.8	74.5	30.0	46.8	51.5	22.9	60.7	31.8	52.2	144.8	43.3	40.7	39.7	28.4	24.3	30.5	65.2	126.1	27.2	42.6	32.0	27.0	28.7	24.7	26.5	17.9	24.0	36.5	42.1	142.5	25.7	57.0	28.8	22.1	16.2	33.8	28.5	48.0	55.3	43.1	63.9	43.3	77.9	121.7	36.9	51.7	36.1	29.3	27.8	31.3	108.4	56.0	49.0	59.2	37.6	30.7	86.9	48.5	23.0	25.6	70.3	45.5	47.4	34.2	30.0
MIDEAS	"C14orf117, C14orf43, ELMSAN1, LSR68"	ENSG00000156030	"Mitotic deacetylase associated SANT domain protein"	Q6PJG2	14	73715122-73790285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 59.4;Cardiomyocytes: 21.0;Cytotrophoblasts: 41.3;dendritic cells: 15.8;Extravillous trophoblasts: 32.5;Hofbauer cells: 25.8;Syncytiotrophoblasts: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003111	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA003111: AB_1078329"	"unprognostic (1.54e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.36e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-1)"	9.0	5.0	4.1	9.3	4.2	14.5	6.6	5.1	5.2	6.4	0.4	7.1	7.7	7.3	1.3	9.3	6.7	9.2	6.7	2.6	4.0	3.0	4.7	6.9	9.3	5.3	2.3	11.3	5.9	9.7	2.6	8.8	1.6	5.7	3.9	2.9	7.8	5.8	10.1	11.8	8.8	6.5	0.4	13.7	7.5	5.4	5.5	5.8	6.2	5.9	5.6	5.7	6.2	7.9	12.8	14.1	5.0	9.4	4.6	7.8	9.6	5.1	8.7	7.0	6.3	12.5	14.8	18.5	5.6	7.0	7.3	19.3	8.3	14.5	2.8	24.6	5.1	29.7	12.8	4.5	7.4	5.2	61.9	10.4	8.8	6.1	7.6	6.1	11.2	6.4	15.5	16.7	3.4	29.7	12.0	8.3	1.6	6.4	11.7	13.8	27.0	4.9	10.4	13.5	6.4	5.3	19.3	26.4	10.3	2.8	20.3	10.8	22.6	14.3	16.3	10.8	5.6	13.0	6.7	20.4	11.7	6.3	17.0	0.6	0.5	0.2	0.3	0.2	0.4	0.4	0.1	0.3	0.6	0.7	0.2	0.2	0.8	0.5	0.3	1.2	0.4	0.4	4.1	4.2	5.1	5.2	2.6	4.0	5.3	2.3	1.6	0.4	5.5	7.9	59.4	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	41.3	15.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	32.5	9.4	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	29.4	3.6	0.0	0.0	0.0
MIDN		ENSG00000167470	Midnolin	Q504T8	19	1248553-1259140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 455.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 11.8"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 11.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042018, HPA049432"	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA042018: AB_2677800, HPA049432: AB_2680765"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.19e-2)"	71.4	61.9	25.6	25.2	25.0	82.6	42.7	24.9	32.3	48.0	16.1	53.9	22.3	34.2	6.3	99.2	64.6	31.4	72.9	21.1	32.1	46.9	50.5	67.0	19.1	44.8	30.1	61.4	37.4	8.2	81.9	15.5	29.8	39.2	12.0	12.4	46.6	11.5	141.6	79.1	52.6	12.4	29.8	50.3	56.1	19.6	32.4	19.0	35.0	17.4	15.1	42.2	55.7	23.1	14.7	31.8	53.5	25.0	11.2	19.0	39.2	25.0	14.9	12.6	8.9	41.8	16.1	23.3	26.6	18.9	6.8	29.6	16.3	26.5	4.9	32.9	30.0	32.8	21.8	33.3	22.7	33.3	46.9	29.4	24.4	15.1	14.3	19.5	20.8	27.3	42.7	24.0	13.5	58.9	44.6	13.6	117.6	28.6	21.1	68.8	15.2	10.7	23.8	17.2	42.7	55.9	52.9	50.1	33.7	27.7	20.2	37.7	26.2	22.9	25.4	106.2	27.3	22.4	13.2	32.2	43.9	14.6	79.5	1.6	1.0	1.1	1.0	1.0	0.7	0.2	0.3	0.7	0.4	0.3	0.2	0.5	11.8	1.3	1.1	0.4	0.1	0.7	25.6	25.0	24.9	32.3	21.1	32.1	44.8	30.1	29.8	29.8	32.4	23.1	330.7	38.5	60.5	17.3	101.1	98.9	128.3	114.4	175.8	53.9	290.6	224.2	84.3	117.2	86.2	134.3	31.3	15.8	184.8	455.8	19.6	125.5	34.7	220.6	84.5	186.1	164.5	19.4	8.0	155.5	47.3	84.0	132.0	294.7	61.5	60.6	197.4	80.9	77.9	21.9	5.6	219.5	59.0	100.0	134.9	33.3	49.7	150.9	42.7	24.4	49.7	77.8	96.8	32.2	10.3	259.0	306.8	33.1	69.9	190.9	242.1	35.8	109.6	35.7	39.5	219.8	142.4	3.3	12.0	227.3	148.0	81.3	122.9	33.2	167.8	190.7
MIEN1	"C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4"	ENSG00000141741	"Migration and invasion enhancer 1"	Q9BRT3	17	39728496-39730532	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"OE19: 1667.9;SK-BR-3: 502.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056650, HPA061344"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA056650: , HPA061344: AB_2684484"	"unprognostic (2.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.37e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.22e-3)"	29.1	35.9	33.4	17.5	35.4	27.0	31.5	36.2	44.8	31.1	34.2	42.4	26.3	29.0	14.6	47.3	27.2	12.1	49.5	32.5	35.3	57.2	53.7	29.6	20.2	34.5	34.8	18.5	40.7	21.6	39.6	13.5	34.5	46.3	12.8	4.8	46.2	13.8	47.2	35.0	37.5	9.5	32.9	36.2	48.5	41.3	35.4	13.9	37.0	5.3	13.7	31.0	32.0	37.2	38.8	59.7	13.4	34.5	16.3	12.0	16.2	40.7	21.4	24.2	23.6	12.9	27.2	28.1	55.5	15.1	39.0	47.1	15.6	13.8	8.2	58.2	65.8	26.5	29.8	36.5	28.2	33.9	39.2	10.8	23.3	11.7	12.0	18.8	15.6	52.9	38.2	48.9	14.7	22.5	70.1	38.2	12.5	1667.9	26.4	32.2	23.6	56.8	12.2	21.8	43.6	41.7	40.8	502.3	70.7	12.0	66.1	48.1	41.5	16.4	41.8	78.9	47.1	62.3	62.8	55.1	64.5	41.1	32.4	138.5	76.2	107.3	80.1	100.9	43.4	109.2	56.2	72.3	54.5	88.3	43.9	63.1	132.9	58.7	104.2	79.4	94.6	119.9	33.4	35.4	36.2	44.8	32.5	35.3	34.5	34.8	34.5	32.9	35.4	37.2	59.8	44.8	64.2	7.8	60.9	60.2	138.1	185.1	95.6	25.7	127.0	114.2	59.6	82.9	129.3	99.3	4.2	150.2	69.1	226.6	303.3	137.0	136.2	81.6	48.7	58.9	188.8	72.0	11.0	176.1	74.4	50.9	76.5	77.3	81.8	43.8	54.7	118.9	148.0	35.3	9.6	178.3	254.3	101.3	42.8	76.7	42.3	81.3	138.7	12.2	80.1	90.7	130.7	4.5	20.8	216.8	283.7	49.7	54.0	194.8	188.5	224.9	122.1	17.3	46.0	31.5	61.1	108.5	68.0	131.7	70.3	266.1	65.4	51.7	128.1	204.0
MIER1	"hMI-ER1, KIAA1610, MI-ER1"	ENSG00000198160	"MIER1 transcriptional regulator"	Q8N108	1	66924895-66988619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 97.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019589, HPA050306"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA019589: AB_1853953, HPA050306: AB_2681080"	"unprognostic (3.38e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (3.44e-8)"	"unprognostic (1.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.45e-2)"	18.6	20.8	10.7	18.4	12.4	97.9	16.5	12.8	13.8	19.7	10.4	27.5	15.5	18.7	13.5	16.6	13.1	18.8	11.4	8.9	11.6	16.2	24.6	16.3	20.7	11.4	10.8	20.7	9.1	12.3	7.8	20.2	12.1	14.4	23.5	18.9	11.3	17.1	8.2	12.6	16.1	17.9	11.0	20.0	18.8	18.2	10.9	24.4	14.1	13.1	19.6	18.5	11.8	14.8	29.7	16.8	20.4	36.8	41.9	27.2	22.7	30.3	33.5	29.7	32.1	13.7	17.7	29.8	11.1	34.3	26.7	19.2	24.9	33.1	42.5	34.6	19.3	65.2	44.0	21.8	33.2	52.5	36.9	28.2	24.5	33.3	34.3	34.5	32.9	35.6	34.6	25.6	35.6	9.4	76.0	18.8	29.2	13.4	10.8	32.7	49.1	20.4	25.5	32.6	12.0	23.7	45.5	27.9	29.8	19.3	14.4	34.2	39.7	34.5	24.2	33.7	28.4	31.8	31.6	42.5	28.1	22.5	21.2	43.7	10.9	26.8	18.5	12.4	21.5	11.2	16.4	16.5	8.6	13.1	16.6	16.3	37.1	15.8	20.8	11.7	15.1	8.7	10.7	12.4	12.8	13.8	8.9	11.6	11.4	10.8	12.1	11.0	10.9	14.8	77.4	16.0	45.7	40.8	65.7	48.3	40.5	37.3	51.2	37.7	45.9	44.7	32.9	35.8	35.0	27.6	25.0	41.6	92.1	125.7	45.0	36.8	55.3	54.3	56.8	54.7	42.1	50.1	50.6	40.6	26.8	62.8	34.1	70.6	92.4	48.9	40.4	50.3	22.2	40.4	48.6	54.6	34.6	45.6	38.3	49.3	81.4	56.1	14.2	46.9	69.8	68.7	86.5	40.7	83.8	54.1	77.7	93.3	48.1	52.4	41.3	34.1	35.2	48.5	78.9	64.7	77.5	53.0	62.9	42.0	34.7	34.3	97.1	35.7	53.5	60.4
MIER2	KIAA1193	ENSG00000105556	"MIER family member 2"	Q8N344	19	301444-344815	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041439	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA041439: AB_2677481"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (2.89e-4)"	"prognostic favorable (1.72e-5)"	"unprognostic (6.71e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (7.22e-6)"	"unprognostic (8.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.68e-2)"	25.0	13.1	14.0	4.5	12.7	2.1	21.2	10.9	18.8	21.6	7.9	17.3	4.5	22.9	2.9	19.7	16.6	3.2	34.3	12.1	11.6	17.7	8.4	28.1	3.8	13.7	13.0	15.3	11.5	2.3	15.7	6.3	12.6	23.1	1.2	2.0	12.9	4.6	18.1	25.5	14.2	2.8	11.1	33.4	13.4	29.4	12.6	3.4	17.1	7.8	1.8	19.7	19.8	11.6	12.8	7.9	7.0	8.1	2.5	3.7	15.1	10.3	4.8	7.6	7.9	12.3	4.0	6.6	5.4	5.4	3.0	10.7	4.5	6.0	2.3	16.0	21.8	3.9	6.9	9.5	7.5	0.0	30.1	4.8	4.6	6.2	2.2	5.1	8.6	8.8	11.3	0.1	4.3	13.5	10.5	14.3	18.1	3.8	0.0	9.1	2.3	1.8	3.7	7.2	11.2	10.1	6.0	4.5	10.7	4.2	5.1	7.1	9.3	10.3	7.2	15.8	11.6	18.5	9.9	5.5	9.7	5.7	10.4	3.7	3.6	2.5	1.1	3.1	0.9	0.5	1.4	1.6	3.9	1.0	1.8	1.2	0.2	0.9	3.5	2.1	0.7	2.3	14.0	12.7	10.9	18.8	12.1	11.6	13.7	13.0	12.6	11.1	12.6	11.6	28.7	0.0	5.4	4.2	5.0	11.2	11.2	8.8	7.4	7.6	7.7	6.9	1.3	7.2	6.0	3.7	16.7	22.3	3.7	4.4	1.9	9.2	6.4	3.4	6.3	24.1	10.7	6.1	4.9	5.4	19.2	6.9	10.2	4.8	0.0	6.9	7.9	2.3	10.2	3.3	4.4	4.6	4.1	8.5	6.3	19.0	6.2	8.7	5.4	13.1	6.7	7.4	5.2	3.0	6.7	8.5	5.9	5.7	4.5	11.9	3.8	0.9	5.7	12.8	6.6	4.1	5.7	18.4	25.1	6.3	10.7	29.4	5.5	6.5	4.9	12.7
MIER3	"DKFZp686L09111, DKFZp781I1119, FLJ35954"	ENSG00000155545	"MIER family member 3"	Q7Z3K6	5	56919602-56971675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Distal enterocytes: 128.8;Paneth cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058349, HPA065946"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA058349: AB_2683688, HPA065946: AB_2685583"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.31e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-3)"	6.8	6.8	4.5	7.4	5.7	11.0	8.8	12.7	6.4	8.0	4.4	30.6	22.8	10.1	8.8	6.3	7.4	6.3	5.1	3.7	5.2	7.5	11.1	5.2	8.5	4.9	4.9	11.7	8.2	12.5	4.7	6.9	5.2	8.1	22.0	16.9	5.9	6.6	6.3	6.5	15.5	9.1	4.7	6.8	7.2	15.8	4.6	10.0	9.1	10.7	7.9	7.5	6.0	8.1	10.0	14.2	19.5	36.9	12.8	10.0	26.9	9.2	11.9	17.1	19.0	22.9	8.3	10.7	10.8	10.8	15.6	12.3	24.9	9.8	18.3	5.7	11.4	9.2	17.6	11.0	9.6	12.6	18.3	11.7	12.2	12.7	10.6	10.5	11.3	13.0	12.2	17.9	10.0	11.0	19.3	14.5	15.5	4.5	8.3	31.9	18.4	11.1	8.2	19.7	16.2	25.8	28.0	10.2	14.2	15.5	14.8	12.0	10.9	4.9	15.2	8.8	16.8	11.1	16.0	26.7	9.3	9.6	10.9	0.2	0.9	1.6	1.1	1.6	1.6	1.3	0.9	2.0	1.3	1.3	1.5	1.1	0.8	1.5	1.2	1.6	0.9	1.3	4.5	5.7	12.7	6.4	3.7	5.2	4.9	4.9	5.2	4.7	4.6	8.1	7.7	16.0	5.4	14.0	7.8	13.5	4.7	4.6	13.1	8.0	11.1	5.8	8.2	11.5	6.7	3.7	14.6	3.9	8.5	128.8	5.9	4.0	15.4	12.0	13.6	7.5	12.0	1.7	11.5	5.9	3.6	8.8	5.1	15.5	4.5	8.3	7.5	9.1	4.1	10.1	12.1	17.4	10.2	5.5	10.7	8.5	5.9	6.2	1.8	14.0	8.6	7.1	5.2	17.6	18.1	7.1	78.7	8.6	9.0	9.4	18.1	6.1	5.9	13.9	13.1	10.8	10.7	11.3	6.0	6.6	9.8	6.8	8.4	4.8	14.0	8.0
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894383-23895227	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 2032.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 4974.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	No	13800000	5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	233.3	467.9	195.8	119.5	200.0	146.0	223.3	209.3	450.0	235.0	204.3	194.3	98.9	205.3	49.8	514.2	219.4	20.9	290.8	245.2	289.7	530.3	484.6	208.2	61.5	225.2	224.7	223.7	255.7	127.8	368.0	100.4	217.2	318.7	35.2	23.8	233.6	132.8	99.3	302.5	171.7	43.4	250.8	204.5	230.7	113.5	204.2	65.0	274.0	19.5	46.2	255.8	316.7	369.4	1698.3	605.3	122.2	499.0	58.9	111.3	590.7	581.2	154.7	298.9	382.1	526.4	364.4	761.3	499.8	83.1	115.2	788.1	155.0	546.8	51.5	642.2	4974.4	286.2	534.6	1126.5	225.3	1077.2	758.6	230.9	354.9	173.8	103.5	248.8	241.3	589.4	466.9	540.1	122.2	1476.0	827.0	2345.5	532.8	488.6	2365.8	1040.4	127.9	2398.8	294.7	179.6	1080.9	1290.4	380.3	531.9	1374.7	37.6	671.2	442.6	424.7	232.5	1227.9	127.3	9.9	1647.2	732.5	1020.9	967.5	484.6	477.9	484.2	543.5	443.5	872.4	579.5	1250.8	1527.9	1221.7	983.3	796.9	1378.9	1040.4	928.4	166.8	1158.9	383.3	977.1	1258.3	1803.3	195.8	200.0	209.3	450.0	245.2	289.7	225.2	224.7	217.2	250.8	204.2	369.4	161.2	157.0	199.4	21.5	433.4	672.2	295.5	1134.8	1027.2	28.3	856.0	778.2	0.3	479.0	489.1	693.4	2.1	462.7	171.3	317.9	1649.4	859.0	190.5	733.7	485.3	248.5	348.9	455.7	17.1	377.7	885.0	336.2	606.5	844.3	180.3	192.2	261.6	885.2	278.8	21.9	24.1	432.5	697.8	207.7	505.2	153.9	336.1	232.6	773.7	19.7	217.0	59.5	155.5	17.6	52.8	649.9	360.4	302.8	1337.1	269.8	476.8	2032.7	404.6	33.2	138.1	338.1	349.7	21.3	124.2	1511.3	758.8	686.0	386.3	227.6	473.0	256.1
MIIP	"FLJ12438, IIp45"	ENSG00000116691	"Migration and invasion inhibitory protein"	Q5JXC2	1	12019466-12032045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"HDLM-2: 362.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044948	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA044948: AB_10795887"	"unprognostic (1.36e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.02e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (8.02e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	15.6	9.6	12.3	12.3	12.8	43.5	15.0	12.0	16.3	15.8	8.7	16.8	7.2	20.8	2.3	10.5	18.0	5.6	16.0	11.7	11.1	12.3	16.3	17.5	14.2	13.1	12.2	23.8	17.4	5.5	9.1	7.2	12.3	14.5	2.3	2.8	12.5	8.5	28.0	14.8	15.8	6.6	12.1	26.1	13.3	26.8	13.4	7.5	15.7	7.8	5.4	17.2	12.4	13.2	20.4	13.4	10.4	20.8	5.7	6.3	36.3	10.9	5.6	20.9	15.1	26.8	32.2	25.8	25.3	5.8	14.7	21.0	7.9	12.3	2.7	362.4	29.4	16.3	22.8	28.5	11.7	24.6	47.4	8.3	15.7	18.6	7.9	3.6	11.7	33.7	49.1	23.4	6.5	20.8	24.6	37.5	19.0	15.2	19.7	34.6	13.3	39.8	9.1	6.2	19.2	20.2	15.9	20.3	39.1	5.8	13.5	42.2	12.3	19.2	20.2	38.8	17.0	19.3	26.4	35.7	12.5	43.0	20.1	18.0	68.7	22.8	25.1	82.2	23.3	44.1	25.9	22.1	43.5	41.5	16.1	12.6	55.7	33.8	90.8	139.5	60.1	41.3	12.3	12.8	12.0	16.3	11.7	11.1	13.1	12.2	12.3	12.1	13.4	13.2	16.4	12.8	7.7	12.4	28.7	13.0	7.4	11.6	9.1	14.0	29.5	17.4	5.4	5.7	7.2	9.2	8.4	37.8	35.5	17.0	25.4	13.8	40.6	7.9	17.2	12.7	16.7	26.7	4.1	18.5	95.9	14.4	14.3	7.3	17.7	17.9	8.9	13.5	39.7	8.4	4.6	10.7	10.2	23.2	20.7	55.6	8.4	30.8	16.0	4.7	56.6	15.4	26.8	5.0	5.0	16.7	16.8	6.8	16.6	11.4	26.0	15.1	8.1	15.3	13.1	12.4	16.2	24.7	48.2	9.9	17.2	33.1	23.6	16.6	16.9	6.2
MINDY1	"FAM63A, FLJ11280, MINDY-1"	ENSG00000143409	"MINDY lysine 48 deubiquitinase 1"	Q8N5J2	1	150996086-151008375	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Distal tubular cells: 39.2;Ductal cells: 11.6;Proximal tubular cells: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 98.4;eosinophil: 56.2;neutrophil: 85.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 98.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028351, HPA028358, HPA061086"	Approved		Enhanced	Nucleoplasm		NA	NA		220000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.43e-8)"	"unprognostic (2.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.06e-2)"	13.8	13.0	24.9	8.2	49.9	7.2	15.0	42.7	33.7	19.0	30.9	18.4	16.8	18.1	7.0	37.1	17.4	14.0	33.5	22.2	30.7	30.4	19.0	12.9	6.4	58.7	43.9	21.7	47.6	30.1	15.1	6.8	53.4	14.3	17.2	13.3	29.6	13.7	16.7	20.6	14.8	15.6	33.3	15.1	25.9	23.6	43.1	3.6	47.3	18.0	8.7	15.0	20.1	75.6	11.3	7.3	7.7	10.8	13.4	11.1	6.4	3.6	9.1	5.0	7.9	15.6	26.3	0.7	8.4	4.7	1.5	5.5	6.1	6.8	2.2	8.6	9.2	11.0	13.8	13.5	3.0	3.3	4.3	9.1	5.9	9.0	2.5	16.8	12.9	3.8	7.0	27.5	5.3	17.4	0.6	7.4	3.5	3.5	2.5	8.3	1.4	34.8	23.4	22.1	13.1	9.7	6.9	12.4	7.4	3.6	49.5	11.1	12.0	4.3	5.5	2.2	3.1	10.1	9.9	37.5	10.2	7.2	20.4	98.4	9.3	56.2	0.4	4.1	0.3	0.8	3.5	1.0	11.5	1.5	5.8	2.0	85.4	4.7	2.8	1.7	4.8	9.9	24.9	49.9	42.7	33.7	22.2	30.7	58.7	43.9	53.4	33.3	43.1	75.6	4.5	9.6	5.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.8	5.8	0.0	0.0	3.7	3.7	0.0	3.8	1.4	0.0	39.2	11.6	0.0	3.4	3.7	3.7	0.0	0.0	0.0	7.0	0.8	2.9	0.0	4.5	3.8	6.4	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	12.0	2.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.6	0.8	5.0	0.0	0.0
MINDY2	"FAM63B, KIAA1164"	ENSG00000128923	"MINDY lysine 48 deubiquitinase 2"	Q8NBR6	15	58771192-58861900	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Collecting duct cells: 82.8;Endometrial ciliated cells: 66.4;Extravillous trophoblasts: 108.7;Glandular and luminal cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 72.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051103, HPA063669"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA051103: AB_2681345, HPA063669: AB_2685082"	"unprognostic (4.71e-2)"	"unprognostic (8.92e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (3.00e-8)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.77e-2)"	9.4	5.4	9.3	5.7	9.6	3.8	6.6	15.0	10.4	7.0	8.9	5.4	3.5	7.1	4.6	7.1	6.8	6.3	10.8	8.0	11.6	10.1	3.5	7.7	4.1	10.5	11.0	6.8	3.3	7.3	4.9	9.0	10.0	8.9	3.9	16.3	4.9	6.1	3.4	7.1	3.6	8.5	9.2	6.1	4.8	3.9	11.2	5.9	9.6	8.9	3.7	8.0	5.2	10.3	10.9	5.3	7.3	4.4	10.7	19.7	11.5	9.8	20.8	3.0	4.3	8.4	5.4	5.6	10.5	11.8	5.3	10.3	13.4	7.9	4.6	5.6	4.9	7.8	5.7	7.6	6.6	5.9	6.9	8.7	12.9	3.5	8.0	11.3	7.4	5.9	13.7	6.1	7.1	1.4	7.4	4.4	15.7	1.4	2.7	3.3	21.0	6.0	8.9	12.1	6.7	4.9	7.1	10.0	17.9	15.3	3.0	12.5	8.7	4.2	3.7	72.5	4.3	5.4	8.3	5.4	9.4	9.5	10.2	3.0	0.7	1.3	1.1	0.6	2.1	0.9	1.0	1.3	0.2	1.6	0.8	1.2	1.4	0.8	1.4	1.1	0.9	0.5	9.3	9.6	15.0	10.4	8.0	11.6	10.5	11.0	10.0	9.2	11.2	10.3	65.2	147.4	39.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	43.8	44.8	0.0	0.0	18.0	82.8	0.0	65.2	27.5	0.0	46.9	44.4	0.0	66.4	46.8	19.8	0.0	0.0	0.0	21.2	108.7	21.7	0.0	73.2	11.4	11.6	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	32.4	0.0	0.0	7.5	0.0	0.0	14.2	28.4	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	53.2	11.3	17.6	0.0	0.0
MINDY3	"C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042"	ENSG00000148481	"MINDY lysine 48 deubiquitinase 3"	Q9H8M7	10	15778170-15860507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038400, HPA038406"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear membrane"		"HPA038400: AB_10669724, HPA038406: AB_2676001"	"unprognostic (9.20e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.85e-2)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.19e-1)"	15.0	22.4	12.8	8.6	16.3	19.1	19.2	21.9	19.0	18.6	2.9	15.0	9.3	19.5	20.6	14.1	15.6	14.2	9.9	14.7	10.5	16.8	17.5	12.1	12.4	10.6	11.4	18.5	13.7	20.5	5.3	21.1	10.9	19.3	18.7	20.0	11.5	16.4	4.3	16.4	11.6	16.4	11.3	10.5	15.7	21.3	15.5	7.5	18.3	2.4	11.6	15.3	10.3	17.7	12.4	11.1	21.5	22.9	30.9	28.9	17.9	38.1	19.4	28.4	33.1	9.6	19.0	9.2	7.2	41.8	19.9	11.2	18.5	22.8	25.5	28.2	25.5	30.0	16.0	10.8	39.3	6.2	24.3	22.5	19.6	25.3	18.1	27.4	23.1	21.7	18.6	7.6	28.5	13.4	13.2	7.5	7.8	19.9	21.6	6.5	12.5	6.4	32.1	9.2	17.6	19.2	18.5	17.5	16.1	19.2	20.4	13.4	23.9	18.5	14.4	31.4	11.2	45.6	18.8	15.7	21.2	13.6	15.1	2.6	1.7	1.5	2.2	3.5	1.8	1.3	1.5	2.4	1.9	1.9	1.0	2.0	1.5	1.7	4.0	2.0	3.1	1.5	12.8	16.3	21.9	19.0	14.7	10.5	10.6	11.4	10.9	11.3	15.5	17.7	17.3	22.4	14.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	9.7	7.4	0.0	0.0	3.7	14.7	0.0	18.7	10.7	0.0	19.6	11.6	0.0	8.2	18.1	5.2	0.0	0.0	0.0	8.3	17.0	7.5	0.0	9.7	1.3	11.5	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	9.0	0.0	0.0	4.0	0.0	0.0	17.7	11.7	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	32.7	3.0	13.7	0.0	0.0
MIOS	"FLJ20323, MIO, Sea4, Yulink"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566875-7608932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: AB_2681768"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	10.0	9.5	7.0	15.2	6.6	18.8	14.5	12.1	8.7	12.3	26.8	11.3	8.8	9.9	10.4	22.9	10.8	9.9	11.9	5.7	9.3	12.6	17.3	11.7	22.4	6.7	7.4	13.3	17.3	28.1	8.9	11.6	6.1	21.7	13.0	18.8	13.5	11.2	85.5	18.1	9.3	12.2	6.7	15.3	13.4	19.2	7.2	16.2	9.3	51.1	29.9	13.9	14.3	8.2	42.4	18.8	21.8	26.4	17.1	35.9	18.3	32.9	26.8	20.6	20.6	23.2	16.5	37.1	9.9	19.7	55.3	37.6	23.1	24.2	27.0	14.8	19.5	9.5	22.5	16.1	24.3	40.1	10.2	30.9	29.0	18.3	46.2	20.1	18.2	12.4	47.2	29.4	88.0	29.1	9.2	17.0	45.3	21.3	19.8	27.4	33.4	36.3	19.0	21.3	23.0	37.2	17.7	49.1	19.3	40.5	26.7	35.1	15.7	31.3	33.2	17.4	27.7	25.9	30.9	33.2	27.6	23.0	37.2	0.0	5.4	8.8	4.3	9.9	3.6	10.1	4.6	4.2	7.6	8.8	6.0	4.9	0.6	5.4	5.0	4.5	5.1	4.0	7.0	6.6	12.1	8.7	5.7	9.3	6.7	7.4	6.1	6.7	7.2	8.2	8.2	9.6	11.9	18.6	30.3	12.1	14.8	6.6	15.4	8.2	13.2	10.8	18.2	12.8	9.2	7.3	12.5	16.8	12.2	9.0	17.6	11.7	38.5	22.7	11.4	7.5	4.2	15.6	22.9	17.5	8.7	9.3	16.3	18.6	9.5	15.4	6.8	17.0	15.5	11.8	21.0	7.2	4.1	22.7	12.2	57.9	5.9	18.4	7.2	27.2	10.1	9.4	13.4	23.1	18.2	14.1	11.3	7.5	19.4	24.9	6.7	11.3	11.0	17.0	13.1	13.1	9.3	36.0	30.4	24.8	18.9	21.2	15.3	15.3	11.1	19.7
MIS18A	"B28, C21orf45, C21orf46, FASP1, hMis18alpha"	ENSG00000159055	"MIS18 kinetochore protein A"	Q9NYP9	21	32268228-32279049	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 109.9;Spermatogonia: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA018286, HPA020585"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"HPA018286: AB_1845693, HPA020585: AB_1845694"	"unprognostic (1.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.28e-1)"	4.3	5.4	4.3	7.5	4.3	16.9	7.6	5.0	5.6	4.1	3.9	9.5	8.3	6.6	6.3	8.5	5.7	3.2	3.6	4.6	4.2	6.3	6.1	3.7	11.1	4.1	4.0	9.6	4.2	4.0	3.0	7.5	4.0	5.4	10.6	4.2	5.2	3.9	3.2	8.3	9.1	4.9	4.0	6.0	6.7	21.4	4.0	16.4	3.7	2.4	12.1	4.9	5.1	4.7	63.6	15.5	43.8	42.2	6.5	11.2	67.0	32.6	16.8	31.5	27.1	31.0	34.2	69.0	23.6	12.5	37.8	21.1	43.3	24.8	37.6	39.7	48.3	79.3	16.8	40.4	4.3	68.7	25.8	4.9	10.6	26.5	18.9	10.3	22.4	68.9	93.9	56.3	31.1	43.5	79.0	61.9	90.7	43.7	45.0	68.1	65.4	64.4	22.1	21.4	52.4	25.8	49.9	41.7	30.9	31.3	50.8	41.4	13.2	39.2	72.6	30.9	34.1	30.3	51.8	86.8	25.0	108.9	36.4	4.6	7.7	13.0	14.3	10.6	14.4	30.0	15.7	16.6	7.4	29.6	21.4	15.7	2.5	16.9	19.8	20.0	23.5	9.3	4.3	4.3	5.0	5.6	4.6	4.2	4.1	4.0	4.0	4.0	4.0	4.7	8.4	19.2	8.9	1.6	9.5	15.6	7.7	16.9	9.1	9.2	15.0	17.5	5.3	11.5	10.9	11.0	4.2	36.8	11.2	5.6	13.7	13.2	7.5	16.6	12.8	8.4	6.1	22.9	6.8	12.3	53.1	12.4	5.1	15.0	3.8	29.7	12.5	7.4	16.6	8.4	5.2	21.1	14.2	6.3	6.2	7.4	10.5	6.5	5.4	2.8	7.8	10.1	18.6	5.5	6.5	10.8	6.2	10.1	13.9	5.6	3.0	17.2	10.6	7.3	19.7	16.1	12.0	109.9	86.0	20.1	14.8	14.6	7.8	16.5	20.0	5.9
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227060	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 18.5"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.7;Hep G2: 9.0;SuSa: 1.9;U-698: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005662			Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.1	0.1	0.3	1.0	0.2	0.2	0.2	1.2	0.3	0.1	0.2	0.7	1.3	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	2.4	0.3	0.2	0.2	0.1	0.6	0.0	0.2	0.3	0.1	0.6	0.1	0.2	0.2	0.0	0.2	0.7	0.1	0.1	1.0	0.8	0.4	0.2	0.2	0.1	0.0	3.4	0.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.1	0.2	9.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	49.7	6.5	13.0	6.4	10.0	12.6	11.3	7.3	7.3	7.2	10.4	9.6	9.7	18.2	19.6	19.5	11.0	10.3	6.2	0.3	0.2	1.2	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.4	0.6	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.5	0.1	0.1	0.1	0.0	0.5	0.0	0.3	0.1	0.1	1.5	0.0	0.0	0.3	0.1	0.1	0.0	0.1
MKI67	"MIB-1, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 46.3;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	0.9	0.7	0.0	8.5	0.1	46.3	1.7	0.0	0.1	1.2	0.2	8.1	6.2	1.0	0.0	10.0	0.3	0.9	0.3	0.1	0.1	0.4	0.8	1.4	14.9	0.1	1.0	0.2	0.2	0.1	0.1	4.1	0.6	0.4	9.2	0.0	1.4	0.1	0.0	6.6	5.8	2.6	0.0	4.8	4.2	2.3	0.9	52.7	0.4	0.1	16.4	1.8	2.8	0.3	204.6	101.5	103.2	73.6	4.3	8.7	32.1	75.7	55.3	70.3	62.3	83.9	82.3	152.6	21.3	51.9	46.4	120.7	109.3	56.8	104.7	161.8	53.1	131.0	79.4	52.7	0.1	186.0	68.0	2.0	2.5	72.2	73.2	17.2	69.8	69.5	61.2	142.1	70.5	80.9	111.7	56.6	41.3	52.7	45.7	82.2	135.1	20.3	25.6	56.2	35.9	38.9	107.1	38.0	17.3	33.9	31.4	39.3	65.0	37.0	73.6	53.0	206.8	64.2	54.9	177.2	30.7	83.3	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.0	0.9	0.3	0.6	0.0	5.4	0.0	16.0	6.4	1.6	5.3	0.6	0.0	3.9	3.2	1.6	1.5	5.3	0.0	0.0	30.6	7.4	25.0	0.0	0.8	4.2	2.3	10.2	6.7	6.7	232.9	0.0	0.0	86.1	13.5	34.7	13.2	1.3	87.0	5.7	1.7	42.1	0.0	0.0	22.4	2.0	12.9	13.7	0.9	0.3	16.6	3.6	0.0	0.2	0.0	8.2	0.0	0.0	0.1	3.0	0.4	107.4	4.6	2.6	0.1	1.6	0.0	0.0	0.5	13.6	8.1	24.1	50.4	3.0	7.8	23.0	2.7	47.1	4.8
MKNK1	MNK1	ENSG00000079277	"MAPK interacting serine/threonine kinase 1"	Q9BUB5	1	46557407-46616843	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 128.6"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 142.8;Microglial cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB027355, CAB037310, HPA071293"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382"	"unprognostic (4.05e-3)"	"prognostic favorable (7.05e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (3.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (7.02e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.67e-3)"	30.6	21.8	15.5	23.5	14.4	30.3	23.1	19.0	18.0	22.8	17.0	27.4	15.6	18.5	12.0	23.5	21.4	16.1	22.3	15.1	14.6	17.5	21.8	31.5	17.0	14.2	13.3	19.0	128.6	12.0	18.4	22.1	14.4	19.4	17.7	3.9	16.7	8.5	23.9	18.0	24.9	18.4	13.7	48.1	23.1	12.4	16.6	22.6	16.2	23.9	13.8	20.1	20.7	16.5	34.1	21.7	13.5	15.7	12.0	17.9	18.0	16.7	16.4	20.7	27.1	26.4	13.5	23.1	20.2	17.8	23.0	38.5	23.8	27.5	23.1	37.7	21.4	47.8	28.3	21.7	17.3	25.4	34.8	22.0	17.7	25.2	13.4	10.8	24.1	26.2	24.7	16.6	12.2	21.5	18.3	21.8	9.9	19.6	24.8	16.7	30.5	22.1	20.2	35.2	10.4	9.0	32.3	27.9	25.6	26.5	21.5	28.6	18.5	7.6	1.4	22.2	19.9	12.6	23.7	21.2	14.6	31.9	13.4	9.7	26.3	36.1	15.3	25.7	44.7	9.9	12.9	14.2	13.1	11.6	9.2	13.9	69.7	11.2	20.6	9.7	10.6	14.5	15.5	14.4	19.0	18.0	15.1	14.6	14.2	13.3	14.4	13.7	16.6	16.5	20.3	12.8	21.5	41.4	15.3	13.9	17.8	15.2	9.1	19.4	17.8	12.3	19.2	15.7	17.8	22.0	2.1	21.6	23.7	27.9	7.9	18.9	15.5	12.5	12.8	18.3	16.8	21.9	42.2	37.1	34.2	20.5	11.7	13.3	12.0	22.8	18.2	22.7	142.8	18.5	52.7	12.0	4.1	84.5	61.0	23.8	21.5	49.9	10.6	100.2	26.7	5.2	21.6	21.6	8.5	32.3	17.7	36.5	13.3	19.5	27.8	15.7	11.1	5.0	6.6	31.2	15.0	15.3	17.2	22.6	11.1	18.5	25.2	35.1	15.0	29.6
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453033-140479536	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 328.0;Erythroid cells: 424.2;Late spermatids: 340.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 129.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	39.5	36.8	50.9	47.9	50.7	202.6	47.8	52.6	57.1	43.0	46.6	97.9	69.2	46.7	43.3	49.0	51.3	37.5	64.6	51.0	53.7	47.9	42.7	46.9	49.7	57.6	50.7	56.5	58.1	66.8	42.3	43.0	58.9	48.6	80.1	58.6	56.5	44.4	84.0	51.7	65.8	43.5	50.2	52.7	53.9	123.2	55.6	47.1	46.9	58.5	56.4	45.7	38.9	50.9	96.5	72.3	55.6	83.1	86.5	75.5	78.2	64.6	83.3	49.8	57.2	30.0	98.8	69.4	98.4	63.4	99.2	45.7	63.2	71.2	62.8	138.0	55.6	72.1	43.5	55.9	69.4	62.5	107.1	75.4	105.1	56.2	52.8	81.9	50.8	46.9	58.0	84.8	49.1	82.6	73.4	114.2	143.3	80.7	53.6	52.4	47.4	107.6	80.8	109.2	76.6	79.1	80.8	108.5	120.6	81.6	53.3	53.5	71.9	34.9	27.4	85.8	59.8	200.2	159.2	60.9	99.3	96.1	73.3	58.6	22.5	100.4	15.4	21.3	18.0	33.6	29.5	23.0	18.0	32.9	39.9	25.5	42.5	31.1	26.5	6.0	35.3	15.3	50.9	50.7	52.6	57.1	51.0	53.7	57.6	50.7	58.9	50.2	55.6	50.9	28.4	51.3	37.2	13.4	76.8	82.1	66.6	57.1	57.5	61.5	60.9	36.2	57.7	67.2	71.1	42.3	35.5	75.8	54.0	172.1	103.7	69.8	328.0	58.4	30.6	34.2	97.3	424.2	28.9	67.8	96.6	43.3	38.7	65.7	37.4	79.5	45.7	45.0	59.5	119.5	28.0	107.7	89.5	95.9	93.3	340.6	66.5	86.3	69.4	22.5	119.0	61.4	92.7	15.1	22.1	57.6	140.3	62.4	41.8	101.2	112.4	54.4	70.0	46.4	46.0	34.7	53.3	303.0	60.1	62.4	95.5	138.0	62.9	39.6	103.5	145.9
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557057-12586208	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"Early spermatids: 572.9;Late spermatids: 774.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favorable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	16.3	11.5	15.1	10.9	15.1	3.5	13.8	16.9	17.6	15.7	13.5	16.3	13.0	16.6	12.0	17.9	14.7	11.6	32.5	15.1	17.0	16.0	15.1	13.4	14.5	15.5	15.9	21.7	24.1	23.9	12.8	16.7	16.1	12.5	13.5	11.4	14.0	14.0	32.0	14.5	12.2	18.9	16.7	10.7	13.7	56.3	16.7	21.4	21.1	24.5	17.3	15.3	14.3	17.6	20.6	18.8	24.5	17.4	45.2	44.3	40.6	30.0	35.5	41.7	34.1	19.2	18.8	26.7	16.9	37.7	18.8	10.9	38.4	33.1	37.1	30.9	29.2	40.3	19.1	31.1	51.9	38.8	14.4	46.8	30.6	47.6	30.2	34.8	34.9	39.1	39.7	30.8	37.7	25.9	51.4	17.8	16.5	21.7	40.4	45.9	26.0	32.2	30.4	24.8	14.8	26.4	28.4	12.8	30.4	17.3	29.7	38.0	31.1	23.0	23.0	28.5	43.0	26.6	62.8	60.8	28.8	49.5	41.1	20.9	17.9	32.9	20.7	16.4	26.4	21.3	21.4	22.0	19.8	16.5	22.8	20.8	13.2	27.8	23.3	15.9	24.5	20.2	15.1	15.1	16.9	17.6	15.1	17.0	15.5	15.9	16.1	16.7	16.7	17.6	15.4	19.2	9.6	9.8	13.8	9.6	9.9	13.5	10.2	13.8	8.5	8.9	14.7	1.5	14.2	5.5	4.2	19.7	20.8	7.6	19.6	16.1	572.9	9.7	13.8	14.1	2.4	5.0	15.9	16.8	19.6	11.4	5.1	10.1	19.0	17.3	7.9	5.8	15.5	11.8	15.5	10.0	6.1	7.2	9.1	774.2	20.5	9.6	16.0	6.5	20.1	19.1	20.6	14.1	11.1	16.0	10.8	20.7	14.7	9.5	12.0	11.6	14.2	13.2	13.1	11.3	17.4	66.5	38.4	8.1	9.2	16.1	15.7	23.6	10.1	9.8
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565674-23630075	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1;retina: 8.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.8;Cone photoreceptor cells: 25.0;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 9.0;Rod photoreceptor cells: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"JURKAT: 26.3;K-562: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	0.3	0.1	4.5	0.4	7.7	1.8	0.5	4.8	6.7	0.1	2.4	0.5	0.2	0.4	1.6	3.4	3.1	0.1	0.1	5.2	5.1	0.3	0.1	0.2	0.7	7.0	6.1	0.2	0.4	0.0	1.1	3.3	7.0	0.3	0.1	8.9	3.1	0.2	0.8	0.4	0.3	0.1	4.0	0.6	0.2	2.4	6.6	2.4	0.2	0.8	0.8	0.2	0.2	14.1	8.5	2.9	6.1	5.6	0.0	0.0	13.0	0.9	0.0	4.3	4.5	14.7	0.0	0.1	0.1	0.0	11.8	12.5	2.4	0.0	2.7	0.1	0.5	15.3	17.0	0.9	0.4	18.6	10.2	0.6	0.0	5.8	0.0	2.8	0.0	26.3	30.6	12.9	3.5	0.0	20.3	7.3	0.0	9.6	12.1	10.7	2.5	7.5	0.0	0.1	1.6	4.4	0.0	7.7	0.1	0.2	4.2	5.2	0.1	13.5	9.9	0.9	9.6	16.8	24.5	8.6	7.9	0.1	0.1	0.6	0.2	0.1	0.6	0.0	0.3	0.2	0.2	0.4	0.0	0.2	0.6	2.3	0.4	0.1	0.1	0.3	0.1	0.3	4.5	7.7	4.8	6.7	5.2	5.1	7.0	6.1	7.0	4.0	6.6	14.1	0.0	0.0	0.0	0.7	0.1	0.5	1.2	0.0	0.0	13.8	0.3	0.0	0.7	0.0	0.1	0.0	25.0	0.8	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.6	0.5	0.0	0.1	1.8	1.0	0.1	3.4	0.0	6.0	9.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	7.4	0.0	0.7	1.6	2.6	0.9	1.8	0.0	0.5	0.2	0.1	0.0	0.4
MKX	"C10orf48, IRXL1, MGC39616"	ENSG00000150051	"Mohawk homeobox"	Q8IYA7	10	27672874-27746060	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 11.1;prostate: 15.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 39.1;Granulosa cells: 11.1;Inhibitory neurons: 15.7;Peritubular cells: 7.2;Respiratory ciliated cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 51.3;BJ hTERT+: 29.4;BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 22.6;fHDF/TERT166: 148.4;SiHa: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006927	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear speckles"		"HPA006927: AB_1853981"	"unprognostic (2.04e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.38e-3)"	2.7	2.2	1.1	0.7	1.5	0.0	1.1	5.1	8.5	2.8	0.0	3.3	0.2	1.2	2.3	1.0	5.2	1.3	0.4	1.0	3.9	0.2	1.2	0.7	0.2	5.0	3.8	11.1	0.5	1.3	4.9	0.0	4.9	15.7	0.9	0.3	0.3	5.3	0.3	0.6	0.3	0.6	4.4	0.4	2.0	0.8	0.9	0.0	3.3	0.0	0.0	4.2	0.9	3.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	51.3	29.4	33.1	22.6	0.2	0.1	0.0	0.1	148.4	1.3	0.0	0.4	0.0	8.8	0.0	3.3	0.0	9.1	0.1	1.3	0.0	0.0	1.4	2.2	0.0	0.1	0.0	0.0	3.3	0.0	6.3	0.8	0.0	0.2	0.0	0.7	0.0	4.3	0.0	0.7	0.0	0.0	0.0	0.5	0.0	21.4	0.0	0.0	0.2	3.6	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	5.1	8.5	1.0	3.9	5.0	3.8	4.9	4.4	0.9	3.6	0.0	0.0	1.9	4.6	0.1	0.0	0.0	0.2	0.6	0.3	0.0	0.1	1.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.5	0.1	0.1	0.0	0.0	39.1	0.2	0.0	2.2	0.0	0.1	0.0	11.1	0.0	0.8	0.0	0.0	15.7	0.0	0.0	0.0	0.8	2.1	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.5	1.2	0.1	0.0	7.2	0.1	0.1	0.0	0.1	7.3	0.1	0.0	0.0	1.0	0.1	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0
MLF1		ENSG00000178053	"Myeloid leukemia factor 1"	P58340	3	158571163-158607252	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 182.3;testis: 393.7"	"Group enriched"	"Detected in many"	10	"Early spermatids: 4964.0;Late spermatids: 12837.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.7"	"Lineage enriched"	"Detected in single"	9	"T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"A-431: 84.0"	"Low region specificity"	"Detected in all"							"HPA069479, HPA079339"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA069479: AB_2686140, HPA079339: "	"unprognostic (6.49e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.72e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (9.34e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.36e-2)"	10.9	6.8	16.8	3.0	19.8	3.2	17.4	17.3	22.0	9.8	34.5	10.0	1.8	15.9	14.8	10.2	67.9	15.1	138.9	19.1	19.3	21.2	3.6	17.9	2.9	25.1	25.2	12.8	9.6	20.2	18.1	2.7	24.0	6.2	4.7	46.9	5.1	4.6	182.3	6.2	4.0	14.2	22.0	3.5	6.2	393.7	19.4	2.3	16.5	107.2	4.8	14.1	4.2	24.2	84.0	7.7	28.4	0.1	13.8	18.1	7.8	6.8	8.4	31.9	30.5	0.0	44.8	0.0	29.3	13.1	42.8	16.3	0.3	14.2	44.5	0.0	15.3	3.9	6.3	0.9	10.2	0.0	6.4	10.5	22.3	13.8	8.8	28.2	7.3	0.0	6.3	0.1	22.2	12.5	0.0	0.2	7.6	46.4	21.3	0.0	15.4	0.7	25.0	6.4	34.8	21.7	38.1	13.7	43.9	27.7	41.1	8.9	3.8	27.2	27.2	35.4	31.0	15.6	8.2	0.1	20.0	0.1	20.6	0.0	0.0	0.0	2.8	0.0	1.4	0.5	6.9	6.9	0.2	0.3	1.5	3.2	0.3	0.9	0.3	0.1	8.7	2.0	16.8	19.8	17.3	22.0	19.1	19.3	25.1	25.2	24.0	22.0	19.4	24.2	42.0	25.6	28.2	11.8	6.0	44.7	143.4	35.3	27.3	14.9	52.8	68.7	231.2	17.2	55.2	20.2	33.3	0.7	12.0	12.8	72.4	26.9	4964.0	203.9	29.3	28.4	33.9	3.6	20.2	7.6	5.0	56.3	18.8	24.0	43.8	10.0	18.5	0.2	8.0	10.1	14.1	29.3	28.5	4.1	19.7	12837.2	69.9	11.5	23.2	3.7	1.0	28.5	3.1	9.0	12.7	10.2	14.3	50.4	3.4	37.4	1.3	36.6	329.7	71.1	19.7	131.0	40.5	854.2	192.2	10.4	34.2	1.6	25.3	55.9	14.7	83.1
MLF2	NTN4	ENSG00000089693	"Myeloid leukemia factor 2"	Q15773	12	6747996-6767475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010811, HPA010859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA010811: AB_1079389, HPA010859: AB_1079388"	"unprognostic (1.65e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.42e-1)"	"unprognostic (9.88e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.63e-1)"	121.0	199.0	214.6	67.9	225.7	123.8	109.8	206.5	243.7	119.8	215.4	161.8	106.3	148.5	85.2	168.6	120.6	68.1	181.8	234.6	219.0	163.3	298.7	107.0	66.2	208.0	205.8	116.3	111.0	158.2	145.1	79.4	205.8	142.7	74.1	78.2	131.6	96.3	192.8	144.6	117.8	93.0	205.4	101.5	135.9	97.6	211.1	78.3	114.1	129.2	71.2	135.2	117.5	223.6	222.0	354.3	179.1	294.4	159.3	157.9	283.1	216.6	230.6	318.8	286.9	353.8	195.5	163.1	55.0	265.5	228.1	173.5	220.1	295.3	220.0	274.9	239.3	115.3	174.0	200.7	176.0	128.9	143.0	151.7	240.8	255.2	209.8	257.4	140.7	152.0	152.5	61.8	247.8	320.7	165.7	197.9	554.2	236.1	141.2	102.5	160.2	134.0	310.8	247.7	111.2	224.8	188.8	303.6	203.4	385.8	89.8	186.4	133.7	191.4	279.3	213.5	299.9	80.9	98.2	208.9	259.0	102.2	231.2	259.6	120.3	461.0	82.0	109.9	80.9	85.6	63.7	78.3	134.0	97.6	66.2	75.3	528.0	76.6	129.2	231.6	69.7	115.3	214.6	225.7	206.5	243.7	234.6	219.0	208.0	205.8	205.8	205.4	211.1	223.6	106.3	38.5	30.9	19.2	77.9	136.5	149.3	230.2	261.2	110.2	157.7	156.3	71.9	92.9	108.7	110.3	41.7	264.3	92.4	120.6	279.7	169.9	12.1	64.6	70.7	86.4	100.7	74.9	36.2	125.9	213.7	100.6	91.7	74.9	84.9	84.1	71.0	168.6	147.7	80.8	32.7	138.6	197.4	57.8	70.6	13.3	114.0	78.9	103.2	13.1	138.9	142.7	39.1	19.1	23.5	153.8	124.7	107.2	108.2	202.6	219.6	324.7	58.6	63.5	52.6	77.1	131.8	96.6	80.8	193.1	125.6	427.6	70.2	138.3	145.0	174.6
MLH1	"COCA2, FCC2, HNPCC, HNPCC2"	ENSG00000076242	"MutL homolog 1"	P40692	3	36993350-37050846	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013294, HPA052707, HPA060714, CAB070868"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348"	"unprognostic (1.26e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.86e-2)"	15.6	17.9	7.3	17.4	8.0	22.1	15.4	7.1	9.1	17.4	7.6	17.4	12.0	16.3	14.0	14.3	14.9	11.1	35.4	6.9	8.3	16.0	19.1	15.8	21.9	8.6	7.4	15.1	16.6	22.4	22.7	14.8	7.6	16.2	14.5	9.6	12.1	14.0	49.1	13.4	13.4	19.2	7.1	18.8	15.5	25.4	7.7	28.4	19.2	42.2	24.3	17.2	14.0	9.0	37.1	56.7	66.7	0.2	25.9	34.5	30.7	54.7	44.4	64.1	62.3	43.4	40.1	92.2	25.0	44.1	33.6	24.7	65.2	45.8	68.5	42.2	32.1	68.1	42.3	54.9	23.2	81.9	40.5	28.4	29.0	54.8	57.8	21.9	37.6	55.0	86.0	32.0	66.2	27.6	81.0	22.2	49.4	38.4	31.6	4.6	90.6	40.2	35.1	39.3	14.2	36.1	52.1	56.9	32.7	33.3	79.9	55.6	28.8	46.0	50.5	44.0	65.9	29.1	93.7	88.1	37.8	71.9	45.7	12.6	12.5	15.1	12.7	22.6	9.8	11.3	7.7	11.4	14.3	9.7	8.4	9.6	2.6	7.8	29.2	5.9	15.0	11.0	7.3	8.0	7.1	9.1	6.9	8.3	8.6	7.4	7.6	7.1	7.7	9.0	10.8	25.6	15.8	22.9	18.5	7.1	12.4	18.7	7.4	18.5	9.6	9.7	41.8	12.8	15.8	11.0	10.4	33.4	16.0	6.1	19.6	14.6	31.3	12.5	11.3	10.7	5.4	19.0	18.5	14.7	26.9	14.4	12.2	9.5	7.6	13.0	13.6	14.9	20.1	3.3	21.6	8.6	16.2	16.3	8.9	13.2	11.1	13.8	8.8	10.3	18.2	15.9	11.3	27.2	31.3	9.3	7.4	13.9	22.1	6.4	5.3	12.9	16.5	18.1	13.1	10.0	14.0	58.6	29.3	9.3	5.5	20.0	15.9	14.8	8.4	6.5
MLH3		ENSG00000119684	"MutL homolog 3"	Q9UHC1	14	75013769-75051532	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease variant, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060570			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA060570: AB_2684323"	"unprognostic (2.94e-1)"	"unprognostic (6.70e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.35e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.11e-2)"	4.3	9.4	7.2	5.6	11.7	2.3	7.9	12.7	8.6	7.2	5.8	5.8	5.3	7.4	7.5	5.3	6.5	6.1	6.0	6.3	9.3	7.5	7.3	5.2	6.6	8.1	8.8	8.1	5.3	12.6	5.1	5.8	9.3	7.6	6.6	8.5	5.4	8.6	6.6	4.7	4.8	5.5	7.9	6.4	4.5	6.7	9.0	6.4	11.1	7.8	7.7	5.3	3.2	19.8	13.1	13.5	10.3	1.7	10.6	17.0	10.4	4.5	4.2	7.0	6.3	11.7	16.5	14.2	3.7	5.5	9.2	9.2	0.2	4.3	10.4	14.1	0.2	9.3	8.7	7.1	8.6	4.0	6.3	6.3	10.4	7.2	0.5	8.7	12.0	0.1	8.8	11.4	15.8	11.3	6.3	4.5	8.7	10.6	7.6	11.3	6.3	3.1	17.4	13.4	14.9	10.5	14.4	9.9	0.9	10.3	13.1	9.0	6.1	2.9	5.9	4.3	4.5	14.4	15.0	15.4	10.7	0.4	13.2	5.1	2.6	1.7	4.6	2.1	3.5	3.0	2.5	4.2	2.9	5.9	4.1	3.3	1.1	6.3	1.5	2.4	3.1	5.9	7.2	11.7	12.7	8.6	6.3	9.3	8.1	8.8	9.3	7.9	9.0	19.8	19.4	25.6	17.3	47.3	16.6	7.9	23.3	14.3	8.6	49.8	11.6	11.0	19.5	27.1	15.6	36.8	43.8	16.2	15.0	8.5	7.9	16.4	6.0	13.6	35.3	18.5	13.1	6.7	43.4	11.1	6.8	25.8	6.6	10.8	23.5	40.8	13.6	15.6	10.3	35.3	52.9	12.4	12.2	9.1	6.1	7.9	39.7	47.7	16.0	31.9	14.6	28.5	29.9	51.8	106.7	12.3	12.0	51.1	8.7	16.9	29.2	17.1	17.6	59.3	46.0	29.7	23.3	54.4	10.8	7.9	8.7	10.1	13.6	31.0	18.9	12.2
MLIP	"C6orf142, CIP, MGC18257"	ENSG00000146147	"Muscular LMNA interacting protein"	Q5VWP3	6	53929982-54266280	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 209.2;liver: 131.3;skeletal muscle: 246.6;tongue: 149.5"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 224.9;Excitatory neurons: 244.1"	"Group enriched"	"Detected in some"	4	"glioma: 0.8;head and neck cancer: 0.5;liver cancer: 1.9;melanoma: 1.4"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 15.4;hippocampal formation: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 19.6;SK-MEL-30: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029252, HPA046654"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA029252: AB_2732446, HPA046654: "	"unprognostic (7.95e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.29e-3)"	3.7	4.3	0.1	0.1	2.2	0.0	3.5	0.0	15.4	1.7	0.0	0.9	0.3	0.2	0.9	12.6	0.7	1.6	209.2	6.0	0.0	0.9	131.3	0.4	0.2	0.0	0.0	0.2	0.8	0.3	0.5	0.1	0.0	1.6	0.7	0.9	6.9	0.3	246.6	17.4	2.6	0.5	0.0	0.1	0.3	1.0	0.0	0.3	6.9	149.5	5.2	1.3	2.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	2.4	0.0	0.0	0.0	19.6	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	1.2	0.0	0.1	0.6	1.4	0.0	0.0	0.5	19.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	15.4	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.9	0.0	0.4	0.1	0.5	0.6	0.1	0.2	0.0	224.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	15.7	0.5	0.5	2.6	0.0	2.7	244.1	0.0	0.0	4.9	0.0	0.4	0.0	0.1	0.7	20.0	0.0	13.5	4.6	3.7	0.0	0.8	0.6	12.9	0.3	0.2	7.2	16.9	0.0	0.0	0.0	5.0	4.2	0.0	0.0	0.0	0.0	0.1	1.0	1.9	0.6	0.1	0.0	17.8	1.9	1.5	0.4	4.1	2.0	0.0	0.1	0.1	0.1	0.1
MLLT1	"ENL, LTG19, YEATS1"	ENSG00000130382	"MLLT1 super elongation complex subunit"	Q03111	19	6210381-6279975	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Cytotrophoblasts: 570.1;Syncytiotrophoblasts: 1138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031166	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA031166: AB_10601874"	"unprognostic (3.21e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (6.03e-5)"	"unprognostic (1.30e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.93e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-3)"	28.9	22.4	33.3	16.5	31.5	8.7	26.4	32.2	38.0	42.9	26.7	41.4	12.2	40.5	13.2	25.6	42.6	9.9	35.5	36.4	26.2	30.0	37.5	33.5	10.9	25.8	28.3	47.7	26.8	20.9	28.9	42.6	21.8	40.8	5.6	13.5	24.0	15.6	34.8	30.8	24.3	13.3	19.8	27.0	30.0	16.8	29.9	11.9	36.8	12.7	7.5	37.3	28.8	27.0	49.5	23.8	28.7	34.1	22.0	19.0	33.3	29.9	19.3	24.7	25.1	39.5	16.2	35.6	38.1	39.4	27.6	30.2	22.9	29.4	14.6	30.2	35.9	44.3	66.0	30.1	42.2	29.0	39.0	30.7	25.2	23.6	19.1	27.1	28.2	31.5	43.6	40.4	16.4	27.1	49.8	27.8	35.0	24.6	49.5	42.3	21.4	28.7	13.4	30.1	49.7	45.2	30.9	33.8	37.8	14.1	30.6	34.1	29.8	34.3	26.5	53.7	41.8	49.1	41.0	28.0	39.6	49.3	49.9	0.1	0.8	0.2	0.7	1.2	0.9	0.5	0.4	0.7	0.6	0.5	0.4	0.5	2.0	0.8	1.5	2.0	0.2	0.7	33.3	31.5	32.2	38.0	36.4	26.2	25.8	28.3	21.8	19.8	29.9	27.0	20.5	22.4	32.7	12.1	5.2	0.1	13.2	0.0	2.8	29.8	13.6	13.5	23.4	5.7	8.6	12.9	18.8	570.1	11.1	5.8	7.9	12.6	27.5	34.8	21.7	21.7	4.9	1.3	10.8	16.6	38.6	14.8	13.3	14.5	10.1	16.2	23.6	18.9	60.9	58.9	13.3	9.9	0.0	15.6	0.0	57.8	19.0	12.1	0.0	11.2	13.2	35.6	10.3	8.0	16.7	13.0	3.6	18.4	8.6	17.8	8.4	6.9	4.4	15.8	26.3	20.7	11.0	10.6	5.7	7.2	0.1	1138.2	5.8	19.5	9.6	14.7
MLLT10	AF10	ENSG00000078403	"MLLT10 histone lysine methyltransferase DOT1L cofactor"	P55197	10	21524646-21743630	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 93.0"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 201.3;Spermatocytes: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005736, HPA005747, HPA072790"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA005736: , HPA005747: AB_1079393, HPA072790: "	"unprognostic (6.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (1.03e-3)"	"unprognostic (9.56e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.85e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	15.6	13.0	11.9	12.0	13.6	30.5	14.4	21.5	16.0	18.2	16.6	20.8	9.1	18.7	16.0	16.1	17.4	11.4	17.1	11.5	15.2	15.1	15.6	14.6	15.3	14.6	11.9	24.7	13.5	18.6	12.6	16.4	14.1	13.0	12.7	20.6	13.7	11.8	15.6	25.4	13.2	16.8	11.9	12.8	12.3	93.0	13.7	23.2	21.8	14.2	14.5	19.1	16.5	18.6	32.1	29.6	38.3	22.2	23.3	25.0	44.1	19.6	10.6	21.7	21.6	29.5	31.3	34.9	10.8	20.7	21.1	24.1	43.3	25.1	22.2	25.0	21.9	59.2	24.5	44.5	29.6	1.6	33.4	21.3	28.6	17.7	19.2	21.8	30.1	34.3	65.4	26.5	19.3	28.1	44.1	28.5	17.3	17.5	9.2	36.6	23.5	31.7	23.2	12.6	13.8	39.6	24.7	29.0	45.8	30.7	13.3	37.1	29.8	14.7	24.6	26.7	18.9	23.5	32.2	43.4	15.4	21.5	9.9	10.3	6.5	13.5	5.0	4.1	4.6	5.3	6.1	6.1	5.1	4.3	6.6	6.0	4.8	4.6	4.7	7.5	5.5	2.5	11.9	13.6	21.5	16.0	11.5	15.2	14.6	11.9	14.1	11.9	13.7	18.6	33.3	28.9	40.4	155.7	25.1	37.7	17.4	22.4	44.3	38.4	19.9	20.7	31.5	18.6	19.6	18.4	43.8	34.0	24.9	13.3	13.7	14.6	66.1	16.1	26.6	28.7	3.5	30.9	201.3	12.8	58.6	26.6	21.9	21.3	25.2	28.6	26.0	22.7	28.9	30.3	169.6	16.3	26.4	36.1	23.0	109.0	39.4	28.6	48.0	107.7	29.7	17.8	21.6	148.3	160.0	13.2	14.6	48.2	23.5	22.7	18.8	23.1	18.7	53.7	39.5	31.4	35.7	233.8	57.4	48.5	43.9	50.2	29.5	24.2	18.0	13.5
MLLT11	AF1Q	ENSG00000213190	"MLLT11 transcription factor 7 cofactor"	Q13015	1	151060397-151069544	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 109.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 54.1;Early spermatids: 76.9;Excitatory neurons: 57.9;Late spermatids: 215.6"	"Cancer enriched"	"Detected in all"	4	"glioma: 29.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 216.7;EFO-21: 164.9;SH-SY5Y: 238.6;U-698: 207.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000540	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA000540: AB_2666024"	"unprognostic (2.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.25e-12)"	"unprognostic (5.66e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-3)"	5.3	19.0	59.4	4.7	61.8	2.0	2.5	41.1	109.3	4.5	8.8	7.2	1.6	10.7	1.3	4.0	6.2	6.0	38.1	66.2	80.6	3.8	2.0	3.8	2.1	63.1	50.5	8.2	3.1	16.2	10.4	1.0	66.1	4.3	3.6	35.6	3.8	1.5	11.3	2.6	4.9	13.8	29.9	4.6	5.1	2.8	49.7	20.6	3.8	10.8	2.1	4.0	3.9	57.1	6.3	31.0	216.7	34.4	3.5	5.8	1.4	11.6	15.2	13.2	24.0	3.0	12.6	10.0	164.9	10.6	35.9	4.5	54.3	13.0	7.6	65.8	14.5	28.9	17.7	0.9	6.9	0.8	1.0	9.9	1.6	73.5	2.9	42.2	100.1	43.3	30.8	2.3	43.6	1.4	106.4	19.0	95.7	0.6	4.4	99.8	28.1	0.6	25.5	1.7	132.8	238.6	0.8	1.3	6.9	142.5	5.3	2.7	65.9	27.0	29.0	9.2	24.7	2.4	3.2	207.1	70.0	0.6	51.7	1.1	0.3	1.4	5.9	0.6	2.7	2.5	3.9	6.2	0.7	1.9	5.3	9.1	1.6	4.0	0.9	1.4	4.1	3.2	59.4	61.8	41.1	109.3	66.2	80.6	63.1	50.5	66.1	29.9	49.7	57.1	1.4	0.0	1.1	11.8	4.2	3.6	5.0	14.6	4.6	54.1	2.5	4.8	10.2	1.5	2.2	3.7	8.4	2.9	15.3	0.1	17.6	3.9	76.9	0.8	11.3	5.2	10.7	6.3	57.9	1.2	2.5	17.5	2.0	0.9	4.5	4.3	4.2	0.4	6.0	37.0	40.6	0.1	16.2	6.6	14.5	215.6	2.1	12.3	5.4	10.3	33.3	20.6	19.6	16.1	14.4	3.0	0.2	3.8	4.8	1.3	0.2	2.4	0.6	26.3	0.0	3.4	30.0	8.6	12.3	2.8	3.4	7.4	9.9	3.0	0.2	4.3
MLLT3	"AF-9, AF9, YEATS3"	ENSG00000171843	"MLLT3 super elongation complex subunit"	P42568	9	20341669-20622499	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Astrocytes: 144.6;Excitatory neurons: 284.0;Inhibitory neurons: 288.4;Intestinal goblet cells: 112.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 254.3;Oligodendrocytes: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 5.1;T-cells: 16.3"	"Cell line enriched"	"Detected in many"	5	"HEL: 316.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001824	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA001824: AB_1079394"	"unprognostic (3.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-1)"	6.7	15.4	11.6	10.0	16.0	37.3	12.7	9.7	16.4	11.7	2.6	28.8	8.1	12.6	10.6	8.8	12.8	13.9	8.9	17.4	10.9	12.3	2.4	12.6	11.3	6.4	7.8	11.9	4.8	10.1	9.8	11.9	6.6	12.7	37.8	8.2	25.3	12.8	11.1	7.0	15.7	12.3	6.4	6.9	20.1	4.2	9.1	24.3	27.2	11.1	8.3	10.6	6.3	12.0	8.7	24.4	8.4	9.6	19.8	11.7	5.4	22.3	37.8	9.6	11.5	22.8	8.2	36.1	11.9	10.6	3.2	4.4	8.5	38.0	9.2	68.0	23.6	316.4	68.3	12.3	13.8	4.9	20.1	9.4	15.4	3.8	25.3	34.7	9.8	13.8	0.4	42.5	21.7	6.8	24.9	18.6	5.1	50.8	6.8	0.0	15.4	8.8	50.0	13.4	27.2	11.0	18.1	10.2	10.1	8.4	9.3	11.9	6.5	0.0	5.6	6.0	8.3	18.4	18.7	13.1	0.4	10.6	4.8	2.3	0.4	0.6	4.5	0.3	4.3	0.6	8.6	6.5	0.9	1.4	16.3	10.3	0.1	5.1	0.4	0.6	10.8	3.6	11.6	16.0	9.7	16.4	17.4	10.9	6.4	7.8	6.6	6.4	9.1	12.0	20.0	28.9	30.0	144.6	8.0	8.3	15.9	18.7	21.1	7.8	21.2	12.3	13.5	18.6	32.5	22.0	33.3	0.9	17.3	23.5	13.7	29.2	3.0	10.3	17.5	13.7	33.0	28.4	284.0	8.2	6.1	18.0	23.0	19.5	12.0	8.7	11.4	2.2	2.4	5.0	288.4	112.3	16.2	1.9	6.5	7.4	13.7	7.1	23.2	114.3	2.7	31.9	17.5	254.3	216.6	27.3	23.6	9.4	18.2	14.5	13.8	9.0	11.7	2.2	0.0	25.2	21.6	1.0	10.5	14.2	8.4	1.6	33.3	9.8	27.0	15.7
MLLT6	"AF17, FLJ23480"	ENSG00000275023	"MLLT6, PHD finger containing"	P55198	17	38705273-38729795	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 291.2;Cone photoreceptor cells: 204.3;NK-cells: 218.3;Rod photoreceptor cells: 200.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.9;U-266/70: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004021	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA004021: AB_1853995"	"prognostic favorable (4.18e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.12e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.46e-3)"	38.0	45.5	1.7	2.8	1.1	2.0	42.5	2.4	2.0	55.0	0.2	49.8	3.0	46.0	1.3	35.2	63.7	0.9	48.8	0.9	0.0	56.5	20.7	45.3	2.2	0.7	0.0	81.1	52.8	0.9	79.2	1.2	0.1	52.1	0.8	3.7	44.4	1.5	81.8	36.6	54.4	1.1	0.0	67.0	48.5	33.4	0.6	0.8	70.5	1.0	0.8	44.7	40.7	0.0	2.1	3.8	0.8	1.2	0.8	0.8	0.9	3.3	0.3	0.3	0.6	2.3	1.5	5.4	3.7	0.5	1.1	4.2	0.1	1.2	0.6	14.9	6.5	3.2	7.4	3.5	0.0	2.5	2.6	0.7	0.1	1.1	0.5	2.4	0.9	1.5	2.4	4.4	0.5	1.0	3.7	0.8	0.9	0.3	1.3	2.5	2.8	1.5	0.2	4.6	3.8	4.0	2.1	1.2	1.5	0.8	2.2	0.1	3.9	1.3	2.3	3.2	3.4	10.0	5.8	4.6	1.4	1.8	1.0	0.4	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	1.7	1.1	2.4	2.0	0.9	0.0	0.7	0.0	0.1	0.0	0.6	0.0	60.8	48.1	46.8	46.4	35.3	30.5	25.2	20.2	18.2	291.2	41.2	35.6	32.2	24.3	31.5	33.1	204.3	20.1	69.5	24.4	11.7	25.5	3.2	25.0	35.0	46.0	49.7	9.9	24.5	42.4	4.5	27.9	22.4	35.5	37.3	49.1	31.8	12.6	13.6	119.5	18.8	31.5	10.2	18.0	39.9	6.0	46.9	22.7	19.6	45.0	28.4	36.2	218.3	32.6	26.5	32.2	25.6	42.2	28.0	40.0	37.1	15.7	25.8	200.9	32.9	51.3	37.0	17.1	23.4	27.1	29.1	38.3	65.0	27.9	39.3	29.4
MLST8	"GbetaL, GBL, Lst8, Pop3"	ENSG00000167965	"MTOR associated protein, LST8 homolog"	Q9BVC4	16	2204248-2209453	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 105.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019935, HPA041841"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Golgi apparatus, Cell Junctions"	"CAB019935: AB_561447, HPA041841: AB_2677701"	"unprognostic (2.19e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.70e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.60e-4)"	"unprognostic (8.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.48e-2)"	16.7	29.4	31.5	9.8	31.8	13.3	17.1	31.4	51.1	16.0	25.5	17.3	12.5	15.5	5.6	24.8	14.6	9.1	25.0	32.4	29.9	26.0	31.3	13.3	10.5	32.0	31.0	19.4	35.8	13.3	19.8	11.1	32.4	20.5	4.6	5.7	19.7	8.0	39.4	22.2	15.6	4.5	29.4	16.5	22.3	33.6	32.5	9.7	22.4	21.8	5.2	16.7	15.5	34.1	20.5	61.9	23.1	60.5	29.6	20.8	38.2	17.9	20.4	26.7	22.9	83.4	29.5	51.3	40.6	20.1	12.7	25.8	23.1	51.4	3.1	39.4	113.4	36.0	61.0	51.7	44.7	57.3	49.7	29.7	34.8	31.7	41.8	22.6	28.6	74.1	54.9	35.9	14.8	89.4	55.5	74.9	47.3	18.1	57.4	55.6	23.4	93.8	20.7	13.4	73.5	40.1	26.6	62.1	46.3	8.7	38.6	54.2	22.4	33.5	38.9	27.3	23.7	43.0	26.4	57.8	17.6	47.5	29.9	0.0	25.0	4.2	14.1	29.9	11.8	14.4	13.1	15.2	24.6	12.5	15.0	15.1	2.8	14.6	30.1	13.3	13.1	20.7	31.5	31.8	31.4	51.1	32.4	29.9	32.0	31.0	32.4	29.4	32.5	34.1	11.5	6.4	16.0	10.4	24.6	14.7	16.2	29.6	21.6	31.5	24.7	29.8	3.3	15.7	16.2	16.5	20.9	63.2	13.0	44.6	35.2	34.4	48.7	9.6	13.1	16.8	28.8	26.9	8.9	42.6	50.4	19.2	42.8	11.2	8.2	26.8	20.3	16.7	46.9	30.3	8.4	37.9	22.4	19.1	14.6	105.4	14.9	18.4	17.8	1.0	28.0	29.4	19.6	5.5	5.9	28.6	37.9	15.1	34.1	17.9	43.2	36.3	11.1	30.6	19.7	11.6	16.5	34.7	28.2	29.4	15.5	52.7	15.4	26.8	49.3	17.4
MLX	"bHLHd13, MAD7, MXD7, TCFL4"	ENSG00000108788	"MAX dimerization protein MLX"	Q9UH92	17	42567072-42573239	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025329, HPA052766, HPA064438"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB025329: , HPA052766: AB_2681940, HPA064438: AB_2685265"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.55e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.25e-1)"	31.3	28.0	15.8	21.7	16.4	16.4	26.2	16.6	18.0	19.3	19.1	38.5	47.5	15.7	16.6	29.1	17.2	20.3	55.5	16.2	16.9	28.7	51.5	27.9	27.5	16.9	15.9	14.8	32.7	19.6	18.8	21.5	16.8	18.2	38.8	9.3	24.7	18.1	74.4	25.6	42.2	20.3	16.7	24.1	35.4	8.1	16.8	30.1	24.8	86.4	29.4	27.9	20.8	17.2	36.8	41.5	32.1	33.1	48.0	55.3	22.0	53.5	47.5	57.1	51.4	38.0	37.5	43.6	36.8	46.4	51.6	54.4	59.4	34.8	50.0	35.2	55.5	45.4	27.2	43.1	56.3	61.6	63.4	47.9	38.4	45.6	41.8	38.9	42.9	52.2	50.7	38.3	66.2	49.3	87.0	31.3	22.9	90.9	37.3	39.2	66.1	47.5	46.8	44.7	49.9	24.6	23.9	31.2	61.8	42.5	63.3	72.1	30.2	50.7	32.5	55.7	80.8	38.7	47.2	41.2	56.5	39.2	60.8	43.3	64.0	91.4	34.2	80.1	37.6	35.2	35.0	34.6	66.5	30.2	30.5	31.1	82.7	33.7	90.9	35.7	48.0	68.3	15.8	16.4	16.6	18.0	16.2	16.9	16.9	15.9	16.8	16.7	16.8	17.2	31.6	67.3	69.8	9.4	35.6	41.9	28.1	41.5	33.0	29.4	39.8	30.4	24.1	40.0	47.2	27.6	25.0	37.8	35.8	97.7	60.7	48.9	19.1	30.5	29.1	28.2	25.8	42.7	8.0	68.9	49.5	26.0	55.5	26.3	46.7	18.7	27.8	49.7	68.6	25.2	8.1	46.9	30.5	63.4	62.3	24.5	35.1	59.5	32.0	7.5	58.3	13.1	51.5	5.5	7.1	77.5	86.4	31.2	61.8	24.4	132.3	62.1	30.4	31.7	52.6	22.9	31.4	9.3	41.2	45.2	49.9	44.1	38.3	48.0	54.2	36.4
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 609.7"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 84.4;Enteroendocrine cells: 90.1;Hepatocytes: 286.6;Proximal enterocytes: 108.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 46.5;K-562: 15.2;SCLC-21H: 25.5;T-47d: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	72.3	85.1	5.5	0.7	4.1	0.2	51.2	16.3	9.4	3.0	0.2	7.8	58.8	0.6	16.3	3.4	12.9	5.5	3.5	4.5	1.4	36.2	609.7	2.7	0.0	5.6	1.4	4.9	23.1	6.3	13.4	0.0	6.1	3.7	1.5	0.7	8.7	0.8	58.1	4.5	46.8	0.5	1.3	0.3	4.7	30.9	2.2	0.9	7.3	13.8	0.0	2.0	2.7	2.1	0.2	2.5	0.0	5.9	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.3	0.0	0.6	1.2	0.0	0.0	0.0	0.2	6.1	0.0	4.8	46.5	1.3	0.2	1.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.1	6.3	0.1	0.0	0.7	8.2	1.0	0.0	0.0	1.2	0.0	0.1	25.5	0.7	1.0	4.4	0.0	0.1	11.4	6.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	4.1	16.3	9.4	4.5	1.4	5.6	1.4	6.1	1.3	2.2	2.1	0.6	0.0	16.2	2.3	1.6	1.1	4.8	0.6	0.6	9.9	1.4	1.3	3.4	84.4	4.7	3.7	20.9	0.1	0.3	3.2	1.9	2.9	3.2	0.7	0.2	2.5	90.1	16.0	33.4	1.0	0.1	6.5	4.6	0.8	0.0	0.1	12.8	286.6	0.4	1.7	29.1	19.6	0.0	11.2	1.5	1.2	2.8	2.8	7.2	30.9	0.2	2.0	1.0	2.0	0.9	1.4	13.9	1.2	0.1	2.2	108.9	14.1	3.2	6.5	0.0	23.9	1.0	5.1	1.1	0.5	0.9	0.5	1.7	0.0	31.9	4.0
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Metabolism of cobalamin associated C"	Q9Y4U1	1	45500300-45513382	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 17.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	2.0	3.1	3.3	1.7	5.3	1.2	3.5	5.1	4.2	2.9	2.3	3.7	3.3	1.7	3.0	2.8	3.5	1.3	6.9	3.4	5.1	3.5	17.4	1.2	1.8	4.1	5.6	3.5	2.9	5.5	1.3	1.5	3.9	2.0	4.4	2.1	5.0	2.4	10.8	2.0	2.4	2.3	3.5	1.6	2.3	4.3	5.6	2.2	2.3	6.6	2.0	1.7	1.5	6.0	7.7	3.9	6.6	10.0	6.1	3.7	8.1	5.9	3.9	10.5	9.4	8.3	4.7	12.0	7.4	4.9	2.0	6.2	12.3	14.0	9.6	3.3	11.4	9.4	6.5	9.2	5.8	13.5	3.3	5.3	7.8	11.6	12.6	3.7	5.1	12.5	10.8	6.7	8.1	8.2	9.1	4.3	10.9	8.8	8.9	11.1	2.7	13.2	6.2	6.0	10.5	5.4	8.8	14.5	19.3	4.9	8.3	4.6	2.3	7.3	9.9	8.3	3.3	9.9	8.5	6.9	5.3	6.4	6.9	2.3	0.5	0.5	0.5	0.8	0.8	0.7	0.7	0.4	0.6	0.6	1.3	0.6	0.9	0.8	2.7	1.3	0.4	0.4	3.3	5.3	5.1	4.2	3.4	5.1	4.1	5.6	3.9	3.5	5.6	6.0	1.1	3.2	5.5	1.6	2.1	0.1	1.8	0.8	5.7	1.3	2.7	1.5	9.8	4.3	2.2	1.8	0.0	3.7	0.6	2.8	5.9	1.3	1.0	3.6	4.8	1.5	4.2	4.8	2.6	1.4	4.3	3.6	7.1	3.2	2.5	2.9	2.5	22.9	3.3	3.3	2.7	3.2	2.0	3.2	0.9	1.2	1.8	2.7	0.0	0.0	0.6	1.4	3.1	1.5	5.3	1.8	2.3	1.5	10.4	1.7	2.0	4.6	1.2	5.2	0.0	5.0	2.4	7.4	2.1	11.5	0.1	2.7	2.4	3.9	5.8	1.8
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025754-58046901	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 55.8;Distal enterocytes: 109.3;Proximal enterocytes: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 93.6;Hep G2: 51.1;OE19: 44.6;SK-BR-3: 47.3;WM-115: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: AB_2676956"	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.08e-4)"	11.9	3.8	8.9	4.4	6.0	0.4	7.6	7.3	11.2	5.7	5.8	28.0	40.2	3.5	1.1	4.6	6.1	14.3	41.2	6.9	8.7	14.9	50.1	9.9	2.1	15.8	10.6	1.1	18.5	12.7	8.8	28.4	16.8	4.4	14.3	1.5	8.4	9.5	7.0	4.3	33.0	3.7	5.8	9.3	29.6	34.9	18.7	1.0	46.7	5.6	1.3	5.1	2.8	8.6	15.3	11.4	5.8	30.4	6.0	0.3	93.6	1.4	0.8	5.4	1.2	9.1	38.3	0.2	17.7	1.6	4.2	21.0	5.1	4.4	1.6	0.1	10.0	0.1	4.9	51.1	7.7	0.3	19.5	3.1	7.8	0.9	2.3	8.4	3.7	8.5	12.9	0.1	1.8	7.6	0.7	2.6	17.2	44.6	3.2	7.6	0.7	8.3	16.6	5.4	1.6	10.4	20.0	47.3	9.5	13.2	5.2	8.2	3.4	0.4	9.1	3.5	1.3	0.2	0.1	0.3	1.9	2.3	78.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.9	6.0	7.3	11.2	6.9	8.7	15.8	10.6	16.8	5.8	18.7	8.6	14.3	19.2	14.4	9.1	0.7	2.5	1.0	4.9	2.8	3.4	5.0	3.0	24.7	55.8	12.6	18.4	16.7	48.2	1.6	109.3	1.9	35.7	5.0	3.6	1.1	17.2	11.4	2.7	1.4	12.0	49.2	4.5	35.2	6.4	0.0	18.6	13.6	39.2	12.9	1.7	1.2	33.3	10.2	3.0	0.3	6.9	0.9	0.9	1.8	1.0	0.0	2.1	0.0	4.5	1.4	13.3	38.5	3.4	0.3	1.3	67.3	7.3	6.0	1.9	0.0	0.7	2.4	0.9	4.6	3.3	2.3	48.4	0.7	23.2	45.0	1.7
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.7;Basal respiratory cells: 56.8;Distal enterocytes: 82.0;Paneth cells: 46.2;Proximal enterocytes: 47.2;Urothelial cells: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 6.3;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.8;HaCaT: 86.9;hTCEpi: 38.3;OE19: 41.7;RT4: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	14.7	2.0	18.7	0.5	18.1	0.2	8.3	12.1	18.8	4.1	11.9	17.5	1.8	5.2	2.1	13.5	6.1	1.4	3.8	16.2	15.6	1.9	0.3	14.1	0.2	15.2	17.8	1.1	0.8	0.1	1.3	2.0	12.9	5.0	10.5	3.0	2.5	3.5	1.8	23.7	10.2	4.1	14.4	1.1	8.8	22.3	19.3	0.3	5.9	2.4	3.2	16.3	7.6	13.9	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.1	1.5	0.0	0.1	86.9	0.0	0.2	0.0	0.0	0.7	0.0	0.2	0.0	4.3	0.0	0.0	1.2	38.3	0.0	3.1	0.7	0.3	0.3	0.0	0.2	0.0	0.3	0.1	0.3	0.0	41.7	0.1	0.8	0.0	0.0	0.0	15.7	0.2	0.7	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.6	0.2	1.0	0.0	0.4	6.3	3.7	0.0	0.9	0.2	0.9	0.0	0.4	18.7	18.1	12.1	18.8	16.2	15.6	15.2	17.8	12.9	14.4	19.3	13.9	31.5	28.9	26.5	47.7	0.4	38.5	5.3	56.8	21.1	2.7	1.0	1.5	1.3	7.2	15.2	7.3	0.0	0.0	0.2	82.0	0.0	1.2	6.7	0.1	0.0	16.8	3.6	0.4	2.8	0.4	0.0	4.4	12.2	0.1	0.0	0.0	17.9	0.0	0.1	1.7	4.8	32.9	2.0	0.0	1.8	13.4	1.2	0.5	3.6	10.3	0.4	9.4	1.0	1.0	0.6	16.7	46.2	3.0	0.1	8.6	47.2	0.8	4.5	0.5	6.6	0.7	5.5	1.1	3.7	34.9	33.1	0.0	1.0	0.1	21.5	43.9
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530750	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 509.9;salivary gland: 267.9;urinary bladder: 211.2"	"Cell type enriched"	"Detected in many"	8	"Ductal cells: 8176.2"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 145.9;CAPAN-2: 815.9;EFO-21: 189.8;RPTEC TERT1: 350.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000	35000		"Cluster 5: Breast - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	3.8	0.1	0.0	2.0	0.0	0.3	168.7	0.0	0.3	13.3	0.0	1.6	0.6	97.4	27.9	21.3	91.2	509.9	0.2	0.0	0.0	140.2	3.4	31.6	1.9	0.0	0.0	0.7	85.2	0.0	0.3	0.8	0.0	54.0	1.0	0.0	267.9	34.9	0.1	32.4	0.6	4.8	0.0	0.2	7.3	0.6	0.4	3.3	0.4	0.0	29.3	211.2	1.7	0.0	0.2	145.9	0.0	0.4	0.0	0.0	0.2	0.0	2.1	0.1	0.1	1.9	815.9	0.0	189.8	0.0	0.0	1.1	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.6	1.0	0.1	0.2	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.5	11.8	0.0	0.0	0.0	0.0	350.1	1.0	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.1	0.0	0.7	3.0	0.0	1.6	0.1	0.6	0.4	1.0	5.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	86.6	43.3	0.0	1.5	1.0	382.2	135.4	1.2	0.0	124.2	93.7	0.7	100.1	401.2	1017.0	0.0	0.7	2.9	1.2	0.0	8176.2	6.1	62.1	3.3	8.8	0.0	0.0	0.0	209.4	0.3	3.4	0.0	124.6	2.5	0.0	0.0	0.0	98.0	0.0	0.0	0.0	38.7	0.6	0.3	10.3	11.8	12.6	0.0	0.0	65.2	0.0	0.0	0.0	0.0	850.9	0.0	0.0	0.1	603.3	0.0	33.9	72.6	0.0	0.0	0.0	31.4	0.1	0.2	17.0	2.4	0.8	3.6	0.0	2.3	840.8
MMS19	"CIAO4, hMMS19, MET18, MMS19L"	ENSG00000155229	"MMS19 homolog, cytosolic iron-sulfur assembly component"	Q96T76	10	97458324-97498794	"Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051936, HPA056299"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051936: AB_2681668, HPA056299: AB_2683091"	"unprognostic (8.57e-2)"	"unprognostic (2.38e-3)"	"unprognostic (9.34e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (4.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.39e-4)"	25.9	23.3	45.1	14.9	47.1	16.4	27.0	45.7	66.4	27.7	45.3	26.1	14.2	24.6	18.3	32.8	24.8	13.1	39.3	47.6	44.0	37.3	24.0	25.1	22.3	44.7	44.2	30.3	30.6	17.1	35.7	20.6	45.2	23.5	17.5	28.8	26.7	15.8	38.0	44.4	28.4	17.8	43.4	33.4	27.9	47.2	45.8	25.8	23.5	29.2	22.7	25.6	30.3	44.9	39.1	36.5	43.3	61.1	41.4	49.9	26.3	30.7	61.6	45.8	53.5	48.9	49.7	59.9	32.5	42.1	30.4	43.5	71.5	82.7	43.1	26.3	54.5	32.0	30.5	51.8	31.3	42.7	29.9	41.5	35.7	40.7	86.3	88.8	78.2	44.7	45.5	32.8	45.1	35.1	40.5	77.3	24.6	39.0	29.8	32.1	33.0	27.1	55.0	27.9	17.8	29.5	17.8	23.4	48.3	53.7	47.9	37.8	45.0	21.1	26.0	14.2	35.6	29.5	35.0	34.6	31.5	62.3	17.3	10.5	6.1	4.6	5.4	6.6	9.3	6.0	7.2	6.8	8.5	5.0	8.7	7.1	1.2	5.7	5.2	6.3	7.2	6.3	45.1	47.1	45.7	66.4	47.6	44.0	44.7	44.2	45.2	43.4	45.8	44.9	9.4	22.4	16.0	21.2	10.0	10.5	6.2	11.3	12.5	10.6	9.2	11.2	18.0	12.8	8.2	5.5	18.8	13.7	13.4	8.7	11.7	11.1	9.6	5.6	12.1	13.0	10.2	11.6	32.8	8.1	18.8	9.9	16.8	9.0	3.8	12.8	15.4	14.4	12.4	10.1	29.7	14.6	4.1	12.6	9.6	7.4	15.5	9.0	14.2	7.5	15.6	6.4	6.2	27.6	38.6	9.7	4.1	11.3	10.7	6.1	9.1	6.7	7.6	22.2	13.1	9.1	8.8	22.2	28.5	12.7	11.5	8.8	9.7	9.7	13.1	4.9
MMS22L	"C6orf167, dJ39B17.2"	ENSG00000146263	"MMS22 like, DNA repair protein"	Q6ZRQ5	6	97142161-97283217	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Oligodendrocytes: 52.3;Spermatocytes: 56.9;Spermatogonia: 45.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA067042			Supported	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA067042: AB_2685768"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.00e-5)"	"unprognostic (9.63e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.21e-3)"	"unprognostic (9.39e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-6)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	1.1	1.1	0.7	2.0	1.8	7.0	2.3	1.3	1.2	1.6	0.7	1.6	1.2	1.5	0.5	1.7	1.4	1.0	0.7	0.7	1.0	0.8	0.9	1.1	3.4	2.1	1.4	1.4	1.3	1.4	0.5	2.0	1.8	1.3	2.3	2.4	1.0	0.8	0.6	2.9	1.6	1.5	1.2	1.4	1.1	6.8	1.5	5.2	1.1	0.5	3.4	1.3	1.1	2.4	7.5	8.2	13.5	14.8	2.2	4.0	10.6	15.0	6.9	13.8	20.1	11.4	8.6	16.4	9.0	5.7	16.0	13.4	17.1	8.3	27.4	14.1	12.7	16.7	11.3	7.2	1.3	25.8	11.3	2.2	4.3	19.5	9.0	2.8	6.0	15.2	23.1	25.6	13.1	8.9	9.5	10.4	5.2	12.1	6.1	15.8	12.8	5.8	5.9	9.7	7.7	6.6	9.8	4.9	4.0	7.6	7.6	15.7	4.5	14.0	13.3	11.8	20.8	3.2	10.3	18.3	8.0	16.0	15.7	0.5	0.4	0.9	0.6	0.7	1.0	0.5	0.9	1.0	1.1	0.7	0.8	1.1	0.4	0.6	1.6	1.2	0.9	0.4	0.7	1.8	1.3	1.2	0.7	1.0	2.1	1.4	1.8	1.2	1.5	2.4	5.9	3.2	8.6	16.6	9.7	9.2	5.8	4.0	4.0	11.6	6.1	6.2	4.2	5.7	6.9	3.7	41.7	12.5	14.6	3.3	1.9	2.9	67.8	4.4	6.1	6.5	1.2	26.3	11.3	4.1	11.2	6.1	7.7	2.8	7.6	24.0	10.8	3.1	6.4	3.3	7.7	8.4	8.2	7.5	6.0	17.2	9.9	6.8	7.2	36.5	6.4	6.1	6.2	22.6	52.3	3.0	2.0	5.7	13.1	2.9	5.4	0.8	6.1	31.9	6.6	7.9	5.1	56.9	45.8	7.1	8.2	3.6	9.6	5.2	10.3	3.0
MN1	"MGCR, MGCR1, MGCR1-PEN"	ENSG00000169184	"MN1 proto-oncogene, transcriptional regulator"	Q10571	22	27748277-27801756	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.7;skeletal muscle: 61.6;tongue: 42.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 12.1;Early spermatids: 22.3;Fibroblasts: 13.9;Langerhans cells: 11.2;Late spermatids: 15.2;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 30.7;HeLa: 12.7;hTERT-RPE1: 13.7;RH-30: 12.4;TIME: 20.1;U-2 OS: 16.3;U-2197: 17.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003072	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA003072: AB_1079399"	"unprognostic (5.64e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.13e-7)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.21e-4)"	4.1	0.8	6.0	1.6	20.7	1.3	2.3	6.4	9.5	2.2	0.5	6.1	0.8	2.7	1.0	3.6	4.3	3.0	6.7	1.9	5.3	0.9	0.4	3.3	0.1	4.3	13.0	9.6	0.7	0.1	2.7	1.3	6.8	2.3	0.9	1.8	2.7	1.2	61.6	1.8	2.1	2.5	2.1	0.4	4.0	0.8	8.5	0.3	2.1	42.6	0.7	3.3	3.5	3.1	0.0	1.5	30.7	0.9	0.6	1.3	0.0	0.7	1.1	0.0	0.0	0.0	0.1	0.0	3.1	5.7	1.3	2.7	1.5	1.8	0.0	0.0	0.8	0.0	12.7	0.0	0.7	0.0	0.3	0.1	3.5	0.7	3.0	13.7	0.3	0.0	0.0	0.2	1.0	0.0	0.0	0.4	4.0	0.0	2.8	5.3	12.4	0.0	0.4	0.0	0.1	0.4	2.7	0.0	0.0	7.5	0.3	0.1	20.1	1.0	16.3	17.9	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.0	20.7	6.4	9.5	1.9	5.3	4.3	13.0	6.8	2.1	8.5	3.1	2.1	3.2	2.3	12.1	0.3	4.2	0.1	2.6	3.4	8.4	1.8	0.6	7.4	1.5	0.7	0.0	0.0	0.1	0.2	0.0	0.0	1.4	22.3	1.4	1.0	6.6	0.0	0.0	6.4	1.0	0.1	13.9	0.5	3.1	0.0	0.6	2.5	0.6	0.3	0.0	9.6	0.0	2.0	1.4	11.2	15.2	5.0	2.7	0.0	2.8	0.3	3.9	0.0	13.0	4.3	2.8	0.0	10.1	1.3	0.2	0.0	0.1	0.1	0.7	0.0	2.4	2.3	0.4	1.1	1.9	2.7	0.0	0.3	0.4	0.0	0.2
MNAT1	"MAT1, RNF66"	ENSG00000020426	"MNAT1 component of CDK activating kinase"	P51948	14	60734742-60969965	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 365.2;Inhibitory neurons: 223.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000701, HPA001154, CAB004495"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212"	"unprognostic (4.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.34e-2)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.14e-3)"	21.5	20.4	25.0	9.5	26.9	14.0	25.8	27.8	31.6	21.0	16.7	18.5	8.8	18.1	18.9	16.8	24.7	14.1	21.0	25.3	26.0	27.0	23.5	14.3	13.5	22.9	22.9	22.4	14.7	55.3	22.2	16.0	22.2	20.8	12.7	29.2	25.7	15.7	79.9	13.0	10.7	19.3	21.3	11.6	16.8	12.2	27.2	26.1	18.3	65.3	17.3	19.8	16.4	28.7	203.9	38.5	47.0	33.3	53.5	58.6	51.3	73.1	78.4	87.5	70.2	30.9	69.4	48.6	53.9	53.9	47.3	63.2	53.0	84.1	124.7	61.0	55.0	32.9	36.2	45.9	66.4	77.0	16.8	36.0	60.5	56.5	62.1	84.1	84.6	69.6	49.6	45.3	98.5	69.5	48.2	48.2	25.8	38.3	85.1	49.4	127.9	30.9	102.9	94.3	41.9	28.5	56.0	46.6	71.7	54.0	72.2	37.0	64.9	66.8	70.7	31.8	55.6	19.7	17.8	70.4	53.9	12.9	49.4	12.2	6.1	22.3	14.3	8.6	14.7	26.9	15.3	15.3	11.9	19.8	17.6	17.8	0.5	34.6	10.1	46.6	13.6	6.6	25.0	26.9	27.8	31.6	25.3	26.0	22.9	22.9	22.2	21.3	27.2	28.7	30.1	32.1	25.5	91.1	31.1	24.9	59.4	88.3	23.3	43.0	28.0	35.6	58.4	22.8	50.8	29.5	31.3	50.6	51.1	6.1	80.3	35.2	6.1	85.6	34.6	28.9	17.4	14.5	365.2	44.5	36.3	33.9	25.5	60.4	32.9	23.3	18.5	23.3	20.2	23.5	223.4	13.8	52.9	6.9	10.7	6.9	30.1	13.3	14.2	119.9	12.6	50.3	44.3	196.6	148.1	59.3	9.3	30.5	30.1	48.1	4.3	74.3	81.4	59.2	52.6	77.5	52.2	50.9	41.2	26.6	18.2	36.0	35.3	26.9	16.0	44.2
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831351-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 292.9;lymphoid tissue: 107.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 219.1;Kupffer cells: 408.5;Langerhans cells: 241.7;Macrophages: 412.0;monocytes: 1118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 6012.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 6012.8"	"Group enriched"	"Detected in some"	14	"NB-4: 151.8;THP-1: 282.7;U-937: 185.5"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol"		NA	NA		400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nucleoli, Nucleoli rim, Vesicles, Cytosol"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	24.2	14.9	2.7	82.4	2.8	292.9	6.0	2.9	4.4	6.3	3.2	6.7	3.7	4.0	1.4	7.4	5.7	26.6	4.3	2.6	3.1	3.6	11.5	47.3	15.6	5.2	4.3	2.2	4.8	3.7	1.6	20.4	4.3	3.8	7.7	12.1	5.7	3.5	3.8	5.1	7.7	20.7	5.1	107.8	4.5	5.1	4.2	14.4	3.8	19.0	14.5	23.4	1.8	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	282.7	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	185.5	0.0	155.4	1354.4	243.8	2.6	534.3	3.7	33.5	1.6	1.9	616.5	15.3	1.6	1.4	6012.8	2.8	270.6	9.6	1.5	1099.5	2.7	2.8	2.9	4.4	2.6	3.1	5.2	4.3	4.3	5.1	4.2	5.4	2.6	35.3	56.0	0.0	34.7	2.4	0.0	0.0	0.0	1.2	1.1	3.4	0.9	5.7	9.3	0.0	0.0	0.9	5.9	0.0	0.0	0.0	0.4	0.1	0.1	5.0	0.0	22.3	0.0	0.4	1.3	6.5	0.5	0.1	44.1	0.0	3.9	2.2	219.1	0.0	0.1	0.0	0.0	408.5	241.7	3.3	1.2	412.0	1.8	33.7	1118.9	136.1	26.8	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	1.7	8.0	4.8	13.1	1.5	8.2	0.9	0.3	0.4	2.3	1.0	11.7	0.0	0.0	0.1
MNS1	"FLJ11222, SPATA40"	ENSG00000138587	"Meiosis specific nuclear structural 1"	Q8NEH6	15	56421544-56465137	"Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.2;testis: 48.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 504.6;Endometrial ciliated cells: 256.5;Respiratory ciliated cells: 232.5;Spermatocytes: 249.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039975, HPA040382"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear speckles"		"HPA039975: AB_10793858, HPA040382: AB_10794740"	"unprognostic (7.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.20e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.71e-2)"	1.9	1.4	2.6	1.6	2.4	4.6	3.1	10.1	2.9	3.5	12.3	1.9	2.3	3.6	1.3	2.7	21.2	3.3	2.5	2.2	2.4	10.5	1.9	3.4	1.3	7.2	6.8	4.0	2.4	0.6	3.5	1.6	5.1	2.3	2.0	4.7	2.0	1.7	1.0	1.4	2.1	1.3	6.1	1.4	2.2	48.2	2.7	5.6	2.9	1.1	1.2	1.3	2.5	3.9	32.1	7.4	3.8	11.3	3.1	6.7	0.7	7.6	4.4	8.8	18.6	10.5	15.0	17.8	9.4	3.2	12.8	12.3	4.7	4.4	17.9	0.0	1.9	22.9	8.8	1.8	1.1	7.9	2.4	2.7	0.2	17.9	2.6	3.7	1.6	6.8	5.2	0.0	7.6	4.2	0.3	9.8	1.2	16.4	4.3	15.0	22.6	0.2	8.7	6.1	29.5	8.9	12.7	3.8	13.6	0.9	9.1	12.1	0.7	12.0	13.6	11.6	18.8	3.6	11.9	0.3	13.4	18.3	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	10.1	2.9	2.2	2.4	7.2	6.8	5.1	6.1	2.7	3.9	0.7	0.0	4.7	1.0	0.8	3.3	8.8	9.3	1.8	10.5	4.7	8.3	6.0	4.3	28.3	35.0	25.0	1.8	0.2	3.7	11.7	10.9	504.6	256.5	7.8	2.0	1.2	3.0	4.9	1.9	3.9	14.0	5.1	7.2	0.0	11.0	6.8	0.4	7.0	15.2	3.7	4.5	10.2	1.0	5.5	60.8	12.8	2.0	0.0	0.0	0.8	12.4	0.0	1.5	2.8	1.2	0.1	8.6	0.5	3.0	0.3	12.3	232.5	32.6	0.0	21.6	6.5	249.6	25.0	7.1	1.4	0.5	1.0	6.4	6.0	3.5
MNT	"bHLHd3, lncRNA-HAL, MAD6, MXD6, ROX"	ENSG00000070444	"MAX network transcriptional repressor"	Q99583	17	2384073-2401104	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059532, HPA067578"			Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA059532: AB_2684053, HPA067578: AB_2685864"	"unprognostic (3.72e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.30e-3)"	"unprognostic (1.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.09e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.98e-2)"	11.8	11.1	10.1	7.0	7.2	15.4	9.8	1.2	10.1	11.8	0.3	15.7	6.5	13.4	4.0	16.7	13.4	5.1	7.4	10.1	4.8	9.2	7.1	10.0	5.1	4.8	6.2	13.8	7.9	6.8	15.3	4.7	4.1	11.1	3.3	3.9	8.7	6.8	5.8	14.8	10.1	5.2	2.0	11.3	10.6	13.6	6.9	4.6	10.7	2.8	3.3	12.8	11.7	7.3	8.9	10.4	8.8	11.2	10.8	12.1	8.3	6.2	7.5	3.1	3.4	7.5	8.1	12.4	6.0	8.5	6.8	13.4	6.4	12.2	2.3	6.8	10.4	8.6	19.3	6.1	7.4	3.5	15.4	19.6	11.4	6.6	9.0	9.8	5.4	9.2	7.7	10.4	3.5	6.1	8.7	6.3	4.1	6.3	7.9	9.6	4.4	7.8	5.7	12.7	9.5	13.7	6.8	6.4	15.2	4.5	5.2	6.8	10.3	7.6	5.4	12.3	4.7	9.4	5.0	4.7	15.2	7.8	5.2	0.4	0.4	0.9	0.1	0.5	0.3	0.3	0.2	0.3	0.1	0.1	0.2	0.2	1.3	0.2	0.4	0.3	0.0	0.2	10.1	7.2	1.2	10.1	10.1	4.8	4.8	6.2	4.1	2.0	6.9	7.3	9.6	6.4	19.1	11.4	10.3	18.6	20.2	15.8	13.1	16.1	11.6	9.7	6.6	14.3	20.3	14.7	22.9	6.8	16.4	25.7	1.9	10.2	8.3	33.5	24.7	13.5	19.8	5.0	9.4	10.2	9.8	12.8	19.9	51.8	13.9	12.4	14.6	9.9	14.3	26.9	6.7	25.1	14.2	26.0	9.5	20.7	11.1	17.2	10.6	7.5	13.9	13.0	13.4	1.0	4.7	12.3	18.7	13.2	8.2	25.4	18.2	2.7	14.7	12.1	6.6	15.5	14.2	34.6	26.4	19.4	25.7	9.3	10.9	10.3	28.4	65.5
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010663	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 7.2;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 6.6;Enteroendocrine cells: 25.1;Intestinal goblet cells: 19.7;Paneth cells: 7.0;Proximal enterocytes: 7.3;Undifferentiated cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;BEWO: 12.7;EFO-21: 16.2;HEK 293: 13.2;RPMI-8226: 37.6;SCLC-21H: 19.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	39	"spinal cord: 3.9"	HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: AB_2686437"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.3	0.6	0.0	0.0	3.7	7.2	0.0	0.0	0.2	0.0	0.8	0.0	0.5	0.2	0.1	0.0	0.0	0.0	1.3	0.3	0.0	16.3	0.0	2.6	0.0	0.9	0.3	3.0	0.0	1.1	0.0	0.0	0.1	6.1	0.0	0.8	0.0	2.2	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.4	5.8	0.0	17.2	0.0	0.0	12.7	0.0	0.0	0.1	0.0	7.6	2.5	1.4	16.2	0.0	0.5	0.3	3.0	2.3	1.3	2.2	13.2	0.0	1.5	3.6	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	6.1	5.7	2.9	0.0	10.1	0.9	0.2	0.0	1.7	1.1	0.0	2.5	37.6	6.5	0.6	19.3	0.0	2.5	2.2	0.4	0.1	5.4	4.4	0.0	0.0	0.0	0.0	0.0	5.3	2.9	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.6	0.5	0.2	1.3	0.3	0.9	0.8	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	4.4	1.3	0.1	0.0	0.1	25.1	0.0	0.0	3.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	19.7	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	3.1	7.0	0.0	0.4	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.8	0.0	0.0	0.0	0.2	0.0	13.6	0.0
MOAP1	"MAP-1, PNMA4"	ENSG00000165943	"Modulator of apoptosis 1"	Q96BY2	14	93182199-93184923	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000939, HPA076948"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Cell Junctions"	"HPA000939: AB_1079402, HPA076948: "	"unprognostic (9.40e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.37e-9)"	"unprognostic (1.98e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (6.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	17.7	32.2	39.9	11.3	39.8	40.5	19.0	17.8	54.6	25.8	9.4	36.2	13.9	20.9	26.8	17.4	24.0	17.1	55.8	46.4	59.2	30.8	20.3	21.5	19.4	30.1	25.1	19.1	19.3	45.7	37.0	16.2	39.9	32.4	15.9	92.4	20.9	30.6	44.2	17.5	22.2	22.3	22.1	19.2	26.6	10.3	33.7	23.2	24.1	34.6	17.6	24.1	12.3	38.8	9.8	8.2	19.1	25.0	16.3	6.4	11.1	10.2	14.4	12.4	11.5	8.4	8.9	30.4	19.7	14.6	8.5	16.5	13.9	12.7	13.9	10.7	15.8	16.2	17.4	11.5	19.7	15.8	25.0	9.3	18.4	7.6	13.4	30.3	15.9	35.6	6.2	15.6	11.5	40.4	24.1	10.8	7.5	20.8	8.6	12.7	23.3	14.7	29.4	28.7	36.7	31.0	9.1	16.4	48.4	14.8	25.3	12.1	14.6	4.1	5.6	9.9	5.1	30.9	31.3	15.1	12.8	10.2	7.5	53.5	5.9	19.6	15.5	6.9	19.8	6.8	19.1	19.4	6.2	11.9	23.1	21.1	6.1	16.1	8.8	5.4	16.6	12.1	39.9	39.8	17.8	54.6	46.4	59.2	30.1	25.1	39.9	22.1	33.7	38.8	20.4	32.1	32.1	11.8	21.8	16.2	18.2	11.4	13.1	91.8	18.7	12.4	71.9	24.3	13.9	20.2	50.1	28.9	33.7	10.2	41.1	36.2	4.7	26.5	15.3	18.2	48.5	9.9	37.4	15.1	5.7	16.3	12.2	60.6	27.8	36.0	16.8	8.2	16.5	84.1	35.0	21.0	34.6	13.7	9.8	1.7	17.7	15.9	12.4	12.2	16.1	85.4	50.4	18.1	16.3	22.3	7.5	27.4	15.8	21.2	15.7	19.4	7.5	96.0	19.7	15.5	21.8	27.9	22.2	10.5	15.5	47.7	28.2	23.7	16.2	23.9
MOB1A	"C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B"	ENSG00000114978	"MOB kinase activator 1A"	Q9H8S9	2	74152528-74178898	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (5.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (9.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.11e-3)"	36.6	24.7	12.6	64.2	11.8	90.5	31.4	12.9	13.5	36.4	18.6	41.0	42.3	35.0	25.5	40.2	33.2	35.5	25.3	11.4	15.6	48.1	30.7	38.9	91.9	15.8	13.6	31.9	16.0	28.6	9.1	35.8	16.7	30.3	42.7	10.2	19.5	29.4	13.2	38.9	41.7	40.5	15.8	61.1	34.2	19.8	12.8	56.1	33.6	19.4	93.1	46.6	26.0	17.9	78.2	43.9	53.9	58.5	86.9	94.0	63.5	61.3	82.0	78.1	76.6	60.2	55.4	159.0	51.3	77.4	58.2	63.7	69.6	70.2	117.7	113.0	41.5	143.7	28.0	64.3	69.1	126.1	222.1	80.2	67.1	62.6	52.5	58.6	83.3	60.4	62.5	57.2	76.8	42.1	159.4	106.9	50.3	66.4	35.6	108.2	185.2	85.2	67.3	96.1	27.3	35.6	87.1	63.6	56.4	40.4	51.0	59.1	79.6	100.9	53.0	71.4	98.7	42.2	40.5	119.5	68.0	105.3	55.3	103.7	65.3	91.5	37.3	106.1	40.3	57.8	33.3	40.3	60.5	46.1	30.2	36.4	65.6	56.4	126.0	42.1	37.2	79.7	12.6	11.8	12.9	13.5	11.4	15.6	15.8	13.6	16.7	15.8	12.8	17.9	82.6	51.3	58.0	3.9	173.0	136.9	96.5	107.4	60.9	13.3	66.8	45.1	40.0	35.8	79.5	82.8	6.2	63.8	170.1	114.1	92.0	60.9	11.1	88.3	91.3	73.1	37.7	48.8	7.4	52.6	101.9	67.2	55.0	102.2	110.4	58.5	61.1	43.0	169.5	26.9	7.9	67.4	65.1	196.6	246.9	11.8	62.4	226.1	67.6	14.0	350.8	25.2	117.4	6.0	10.1	83.4	85.7	68.4	106.4	127.8	80.4	170.2	116.6	14.5	72.3	60.6	75.3	99.5	44.6	86.6	132.0	66.4	124.4	79.3	74.0	155.3
MOB1B	"MOB4A, MOBKL1A"	ENSG00000173542	"MOB kinase activator 1B"	Q7L9L4	4	70902326-71022449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-3)"	7.3	7.5	9.4	9.6	12.0	30.0	8.4	5.4	13.0	7.5	19.4	5.8	4.8	7.8	5.0	7.5	8.9	6.9	8.5	19.1	13.5	22.5	6.5	9.6	11.3	9.7	11.3	7.8	8.6	12.5	4.0	8.8	10.0	9.6	6.3	4.9	8.5	5.4	6.1	8.8	5.4	7.7	12.9	8.8	8.1	6.0	8.1	20.0	11.0	6.3	10.3	6.9	5.3	15.8	8.2	6.6	24.2	19.9	12.9	16.2	20.2	24.2	13.2	13.3	11.5	8.8	15.3	45.6	11.5	21.6	9.1	5.7	15.2	20.3	31.9	25.1	5.5	71.5	7.4	6.8	12.9	15.6	13.8	13.5	10.9	14.9	12.0	14.8	15.9	23.4	45.0	14.5	21.3	8.9	49.2	9.7	8.0	5.3	8.5	15.6	23.5	6.1	22.1	14.1	8.4	16.5	10.6	4.7	32.9	12.9	10.9	10.0	19.3	36.6	18.9	16.8	10.0	9.2	3.4	19.1	12.8	11.5	17.2	0.3	1.2	1.1	0.5	0.6	0.4	0.1	0.2	0.2	1.7	0.2	0.3	0.2	0.1	0.2	0.4	2.1	0.6	0.5	9.4	12.0	5.4	13.0	19.1	13.5	9.7	11.3	10.0	12.9	8.1	15.8	11.1	25.6	19.1	42.4	8.9	17.8	6.0	6.1	18.8	3.3	13.7	8.8	17.4	5.7	10.2	44.1	18.8	5.6	31.5	2.6	9.8	5.4	0.8	27.2	16.0	12.8	37.8	99.1	38.4	4.6	5.6	12.1	7.1	25.6	10.8	24.5	9.7	7.1	11.2	6.7	36.5	8.9	4.1	29.2	39.7	1.6	4.4	33.5	10.6	65.6	45.6	6.0	8.2	41.7	12.1	9.4	2.1	8.6	6.9	11.5	1.4	17.1	16.9	4.5	26.3	8.7	23.0	6.4	9.0	15.1	17.0	5.7	10.3	23.4	6.6	9.4
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	32.3	19.6	34.7	19.2	36.3	24.2	28.3	37.8	39.7	27.4	36.2	61.1	18.0	30.7	36.5	51.9	34.4	27.8	43.5	35.3	36.5	18.6	20.0	24.7	26.8	36.1	36.8	28.1	32.8	34.9	11.2	25.7	36.5	32.5	34.8	14.6	35.2	42.3	50.9	50.0	28.6	49.0	36.1	25.1	27.9	14.2	37.1	34.1	24.2	70.4	27.0	39.9	31.6	37.8	29.3	31.2	18.3	15.7	44.2	30.8	17.1	22.5	30.9	40.4	31.8	20.1	39.0	20.9	16.7	50.6	26.0	34.8	28.1	48.6	24.3	28.8	44.3	16.0	11.7	26.2	30.2	21.2	24.2	25.1	57.9	21.9	25.3	32.7	43.6	27.0	26.3	21.2	20.7	20.6	27.4	37.7	23.0	54.3	29.4	19.9	19.0	22.2	34.4	26.9	34.6	37.3	27.3	34.0	27.9	23.0	15.9	21.3	37.7	25.6	13.1	8.3	14.5	21.6	22.3	21.8	17.9	20.3	19.8	9.7	8.7	11.9	16.2	9.2	13.6	8.1	14.1	13.7	10.6	11.0	11.6	10.2	7.1	12.1	13.4	7.5	15.3	10.6	34.7	36.3	37.8	39.7	35.3	36.5	36.1	36.8	36.5	36.1	37.1	37.8	84.8	6.4	10.0	6.5	20.2	82.2	30.1	39.4	12.0	18.4	27.8	33.3	14.8	12.8	18.4	7.3	12.5	31.1	64.5	58.6	27.4	33.5	24.3	18.9	17.7	58.2	20.9	36.2	15.2	38.5	31.0	23.3	16.8	29.2	24.8	20.3	33.9	9.0	26.4	43.7	10.9	32.8	32.6	18.2	39.3	12.1	23.9	28.1	56.9	11.2	29.4	21.5	81.4	6.6	14.8	39.6	63.2	51.1	17.0	48.6	54.3	23.9	12.9	21.4	85.5	20.8	68.3	29.8	41.1	13.7	82.0	59.4	36.4	20.2	27.7	37.6
MOCS2	"MOCO1, MOCS2A, MOCS2B"	ENSG00000164172	"Molybdenum cofactor synthesis 2"	"O96007, O96033"	5	53095679-53110063	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 573.2;Proximal tubular cells: 281.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037679, HPA037680"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear speckles"	"HPA037679: AB_2675604, HPA037680: AB_10673635"	"unprognostic (3.27e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.86e-2)"	48.7	79.4	79.1	24.9	84.9	9.1	42.1	80.3	107.6	34.7	74.4	41.9	40.8	30.0	45.9	35.2	26.5	31.3	87.0	84.3	86.3	114.8	126.2	28.2	26.1	79.2	80.5	43.5	42.4	89.6	30.5	35.9	82.4	36.8	32.3	59.3	48.9	44.9	109.3	16.6	40.2	34.4	85.6	23.6	37.2	26.0	88.0	28.3	55.4	111.8	25.2	30.8	24.6	87.4	79.4	62.7	42.9	109.9	85.0	83.2	51.6	99.5	91.9	74.4	89.8	79.7	56.5	76.7	143.5	69.9	127.1	45.0	91.7	96.7	117.2	19.6	84.8	61.7	58.2	75.9	94.4	65.0	43.0	65.1	41.7	91.7	83.5	81.0	85.1	101.4	58.7	44.2	129.5	115.5	72.7	31.8	37.0	34.2	130.1	36.0	93.0	67.0	144.1	56.6	29.4	33.7	69.4	57.3	72.9	56.9	107.2	15.4	55.6	76.9	81.0	69.1	120.5	49.4	84.8	91.5	106.7	16.8	125.1	14.5	21.8	15.6	36.9	26.9	46.2	37.5	42.7	42.8	29.8	40.5	55.3	49.2	3.8	43.5	25.4	27.8	44.9	28.9	79.1	84.9	80.3	107.6	84.3	86.3	79.2	80.5	82.4	85.6	88.0	87.4	51.7	54.5	29.7	14.4	23.5	13.4	40.1	48.5	19.9	30.2	55.7	50.5	122.9	62.9	37.9	69.9	27.1	95.4	19.4	18.2	573.2	43.7	7.3	22.6	29.0	37.6	26.4	18.7	19.1	43.7	37.3	55.7	19.9	26.8	10.1	38.8	26.0	132.6	41.3	6.7	18.4	22.7	44.7	31.2	20.1	14.6	50.7	28.7	23.2	6.5	12.2	67.5	29.9	4.5	11.9	22.1	18.2	68.8	26.7	34.5	65.7	281.7	32.9	21.7	32.9	73.8	49.4	46.7	62.9	37.5	15.6	32.3	25.8	64.2	30.9	34.5
MON2	KIAA1040	ENSG00000061987	"MON2 homolog, regulator of endosome-to-Golgi trafficking"	Q7Z3U7	12	62466817-62600476	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 197.9;Inhibitory neurons: 172.7;Oligodendrocyte precursor cells: 177.9;Oligodendrocytes: 271.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038697, HPA057607"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA038697: AB_10697396, HPA057607: AB_2683482"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.69e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.80e-3)"	"unprognostic (4.36e-2)"	9.9	8.7	4.8	9.1	11.2	9.1	9.5	9.4	7.3	11.7	10.4	9.0	8.3	10.7	8.6	9.0	8.3	8.7	6.3	5.6	6.0	10.3	14.2	8.7	9.5	9.5	7.5	12.8	13.7	15.5	7.1	10.4	10.5	9.9	10.5	17.5	12.4	8.0	6.4	9.1	7.8	9.2	7.0	9.4	10.7	7.0	7.4	12.6	13.0	7.5	9.8	8.9	6.8	20.9	13.5	20.3	15.0	7.9	19.0	17.8	13.6	14.2	12.0	12.9	12.7	9.2	5.3	9.6	10.8	13.8	10.0	12.6	15.0	10.4	17.4	12.2	11.7	15.0	15.2	9.6	8.1	13.1	10.2	12.0	7.8	14.0	17.1	17.1	12.6	8.6	14.3	22.2	11.4	15.4	11.6	6.2	8.9	8.3	11.1	10.6	13.4	13.3	7.1	17.9	6.4	7.0	24.0	12.9	9.8	15.3	28.0	9.5	17.7	12.4	9.0	15.9	9.3	12.3	12.1	10.7	13.2	8.1	14.2	1.1	3.0	3.2	2.4	3.1	3.2	2.5	2.0	3.4	2.7	2.8	2.8	3.2	4.4	1.9	2.3	1.5	2.6	1.8	4.8	11.2	9.4	7.3	5.6	6.0	9.5	7.5	10.5	7.0	7.4	20.9	29.4	35.3	22.9	113.9	31.5	16.8	13.9	11.7	29.0	36.2	21.5	14.4	16.9	15.7	22.5	27.6	58.4	14.1	29.9	21.9	0.0	7.2	2.7	20.7	38.1	22.6	14.4	18.5	197.9	11.0	7.0	26.9	47.4	28.7	17.1	49.8	23.2	34.8	10.7	21.9	172.7	23.0	12.2	21.4	13.4	2.6	21.8	27.3	8.8	99.3	21.0	11.9	15.5	177.9	271.5	10.9	18.4	18.0	48.7	17.6	17.0	6.7	22.4	55.8	26.3	38.7	24.3	8.0	9.5	26.7	19.6	20.4	28.0	21.1	16.7	18.1
MORC2	"AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1"	ENSG00000133422	"MORC family CW-type zinc finger 2"	Q9Y6X9	22	30925130-30968774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	5	"T-cells: 16.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000436, HPA077137"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000436: AB_1079404, HPA077137: "	"unprognostic (3.43e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.89e-3)"	"unprognostic (4.63e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.54e-8)"	"unprognostic (5.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.66e-3)"	15.6	14.4	6.6	7.0	6.7	6.6	16.6	8.5	8.3	20.6	6.6	20.7	5.3	18.1	6.8	17.0	18.7	5.3	19.2	6.6	6.5	16.7	26.9	14.6	9.0	6.6	6.9	20.0	20.1	7.4	16.6	7.5	6.7	21.8	5.9	5.8	14.8	7.7	26.8	19.5	15.6	7.7	6.4	19.5	16.2	45.2	7.0	8.0	15.6	10.2	7.3	21.2	18.5	7.3	19.2	12.2	20.2	23.3	21.4	18.3	15.5	15.6	12.9	16.1	16.7	17.5	10.2	26.9	11.7	14.3	9.4	17.2	17.7	6.9	18.2	15.5	23.8	20.5	12.4	15.3	15.6	18.1	19.8	15.3	12.1	15.1	18.9	12.0	14.0	9.5	26.3	19.0	17.2	23.7	16.2	17.9	23.0	23.9	12.6	31.5	12.8	22.9	12.5	19.1	20.5	17.2	18.8	21.9	8.8	19.6	16.2	21.2	16.3	17.8	18.7	14.3	12.3	15.0	19.0	22.2	10.3	9.1	13.3	0.8	1.6	1.0	12.0	2.9	10.0	2.3	15.1	9.6	1.6	2.1	15.2	11.0	0.3	1.8	3.3	3.2	16.5	5.2	6.6	6.7	8.5	8.3	6.6	6.5	6.6	6.9	6.7	6.4	7.0	7.3	8.7	0.0	4.6	14.0	4.5	7.4	7.3	3.9	6.2	7.9	8.8	9.1	4.6	2.8	6.2	11.0	10.4	8.4	5.9	6.0	3.9	7.3	30.8	6.1	7.8	7.3	9.0	8.6	9.5	8.0	11.4	6.2	4.1	6.0	1.3	8.9	5.7	8.8	5.4	13.5	11.7	4.8	6.1	3.8	4.1	10.3	7.8	4.5	7.2	10.3	2.8	4.1	6.2	11.1	8.8	11.7	4.1	10.1	3.2	11.6	4.6	3.7	3.8	10.4	19.7	7.7	7.7	26.6	24.1	6.0	9.2	6.3	7.8	7.0	7.3	5.6
MORC3	"KIAA0136, NXP2, ZCW5, ZCWCC3"	ENSG00000159256	"MORC family CW-type zinc finger 3"	Q14149	21	36320189-36386148	"Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018406, HPA034848"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018406: AB_1858988, HPA034848: AB_2674359"	"unprognostic (4.01e-3)"	"unprognostic (4.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	11.2	7.5	6.3	17.3	7.9	34.5	13.9	13.6	7.7	14.6	4.7	10.9	10.9	17.3	9.4	17.7	12.0	12.6	11.6	6.4	6.6	9.4	14.1	12.9	20.3	7.2	6.2	23.8	11.1	10.4	6.5	17.2	8.0	13.6	11.6	7.7	11.5	11.8	17.7	14.9	11.0	13.9	8.6	18.6	13.0	10.8	7.2	19.4	11.7	15.8	20.0	15.4	13.8	11.8	19.7	7.8	19.1	12.8	16.5	16.3	25.1	17.9	30.0	20.3	17.5	12.8	12.9	9.4	7.0	19.9	21.0	9.8	12.9	16.9	18.8	18.7	10.3	37.2	8.2	7.2	11.4	23.4	34.7	12.0	21.3	18.3	26.5	22.2	14.5	14.6	31.0	24.3	14.9	5.8	14.1	9.8	14.2	24.9	7.9	16.4	7.5	17.8	6.6	20.1	7.1	17.4	22.2	12.3	22.8	14.3	14.9	16.3	23.3	17.7	4.9	14.3	15.2	10.9	9.8	8.9	12.7	32.3	13.2	32.5	8.9	19.5	9.1	10.9	9.0	11.3	9.9	8.6	8.8	12.6	12.6	9.1	13.5	9.9	13.6	5.7	13.4	7.9	6.3	7.9	13.6	7.7	6.4	6.6	7.2	6.2	8.0	8.6	7.2	11.8	29.0	28.9	24.1	44.4	49.6	68.3	65.7	33.1	36.5	19.4	19.6	17.4	20.4	14.3	28.9	22.0	8.4	16.1	44.3	14.7	3.9	17.8	51.7	20.9	30.1	24.1	11.4	63.3	36.4	12.5	19.7	31.0	19.4	28.0	47.5	22.4	16.8	16.5	17.5	16.8	37.1	17.1	18.3	26.8	56.8	18.3	18.6	35.8	24.9	52.5	41.4	12.2	40.2	41.7	55.3	23.3	14.5	26.7	17.1	42.0	9.5	7.1	33.5	12.2	13.1	44.8	41.5	33.5	31.4	45.8	81.7	25.2	44.6	16.7	11.1	68.1
MORC4	"FLJ11565, ZCW4, ZCWCC2"	ENSG00000133131	"MORC family CW-type zinc finger 4"	Q8TE76	X	106813871-107000212	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 79.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Alveolar cells type 2: 130.4;Cytotrophoblasts: 329.8;Syncytiotrophoblasts: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000395, HPA015547, HPA050250"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.69e-2)"	13.4	30.9	24.8	7.8	35.5	11.8	12.2	47.8	51.0	12.1	17.8	8.5	10.4	11.5	16.3	9.6	10.4	10.1	7.0	32.4	22.4	10.8	21.1	8.8	5.6	11.1	11.4	17.4	15.1	11.7	6.2	79.9	16.6	12.4	10.8	22.3	10.9	11.5	20.2	18.7	10.0	11.4	3.9	6.0	8.4	20.2	16.6	5.6	10.2	10.3	7.0	7.5	11.1	55.7	29.8	121.0	11.4	26.4	35.0	40.3	60.5	28.7	30.8	14.6	18.3	64.6	13.1	3.7	14.2	30.5	23.9	22.5	39.8	25.5	17.1	4.6	23.0	6.4	40.7	27.1	25.6	4.7	13.9	20.8	24.3	19.6	28.6	85.7	13.1	4.1	3.9	41.4	32.7	26.7	10.7	6.4	8.9	82.0	45.2	4.2	22.9	4.3	47.0	23.3	9.2	11.5	35.4	33.9	23.0	15.9	19.7	5.0	12.6	22.5	21.4	44.7	15.7	11.1	16.2	11.5	24.0	3.8	16.2	8.3	1.5	1.8	1.9	1.3	1.7	1.7	1.9	1.5	0.7	2.7	2.1	1.7	3.7	1.5	1.7	2.5	1.5	0.4	24.8	35.5	47.8	51.0	32.4	22.4	11.1	11.4	16.6	3.9	16.6	55.7	8.6	131.4	130.4	6.2	5.1	17.5	19.1	4.9	21.1	5.4	11.5	9.5	3.0	10.0	61.8	5.5	4.2	329.8	10.4	3.6	21.5	9.9	0.9	6.2	11.5	13.6	1.8	0.4	4.2	7.4	28.2	33.4	10.2	15.5	66.3	10.3	7.5	24.0	23.4	1.7	6.5	10.5	6.1	2.1	5.0	1.8	11.1	8.2	12.4	3.7	0.3	6.7	3.1	15.1	8.7	7.5	6.7	11.7	5.8	16.4	4.4	12.7	62.2	7.2	26.3	16.9	12.0	9.9	26.6	19.7	16.1	257.8	11.9	10.1	10.1	11.8
MORF4L2	"KIAA0026, MRGX"	ENSG00000123562	"Mortality factor 4 like 2"	Q15014	X	103675496-103688158	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1214.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031872, HPA054102"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA031872: AB_2674081, HPA054102: AB_2682379"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.14e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (5.27e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (7.86e-7)"	"unprognostic (8.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-1)"	142.9	184.7	173.9	97.3	180.9	99.0	179.3	156.9	261.5	249.3	183.1	113.4	89.5	262.5	217.7	121.1	209.8	129.2	138.4	180.9	210.1	130.2	204.9	132.6	72.5	170.8	180.3	358.2	137.2	137.2	198.8	242.6	191.2	161.9	140.1	94.1	121.2	191.6	175.6	103.9	99.6	328.5	166.9	90.6	118.0	90.1	183.6	79.3	159.2	130.7	109.6	172.1	143.1	179.1	404.7	257.2	372.6	167.3	541.7	388.2	486.6	533.0	479.4	437.1	462.2	259.6	369.5	289.1	401.4	533.5	522.0	272.0	477.1	406.9	535.6	120.9	219.0	157.5	413.9	308.9	602.7	212.2	141.6	449.6	351.2	380.8	489.6	389.2	478.9	142.2	249.5	383.0	551.5	403.7	188.0	207.6	355.5	512.0	322.3	186.9	340.9	292.1	456.5	221.4	347.3	275.5	425.7	310.1	418.5	385.2	203.3	198.1	433.8	263.2	171.2	459.1	289.3	179.3	221.3	241.2	472.1	420.1	403.8	54.1	40.9	32.9	41.2	44.0	46.9	37.0	38.9	38.2	41.8	32.3	41.7	37.0	16.1	46.0	47.3	70.2	36.1	40.3	173.9	180.9	156.9	261.5	180.9	210.1	170.8	180.3	191.2	166.9	183.6	179.1	102.5	125.0	160.1	39.8	75.8	363.5	572.5	292.0	75.1	46.9	198.6	103.6	130.1	123.0	242.0	110.3	10.4	443.3	106.2	103.2	246.5	269.1	46.9	231.7	235.5	146.6	178.6	68.5	109.6	129.9	1214.1	266.0	90.7	187.2	155.8	153.5	118.5	196.8	163.6	58.9	104.4	202.0	219.7	61.7	254.9	34.2	330.9	90.8	188.5	32.8	68.7	117.0	40.2	59.3	78.2	176.8	118.9	574.8	120.9	332.7	105.1	282.9	429.7	38.8	144.7	164.9	287.9	37.2	48.0	112.7	317.8	583.5	118.2	171.5	134.4	396.8
MORN1	FLJ13941	ENSG00000116151	"MORN repeat containing 1"	Q5T089	1	2321253-2391707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.4;Endometrial ciliated cells: 38.1;Late spermatids: 25.1;Respiratory ciliated cells: 36.7;Spermatocytes: 25.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005858, HPA070703"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Mitochondria"		"HPA005858: AB_1848709, HPA070703: AB_2686299"	"unprognostic (1.39e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.21e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.88e-3)"	"unprognostic (2.53e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	2.5	2.7	2.5	1.5	3.2	1.0	4.2	14.3	4.7	7.1	8.2	3.7	1.9	5.3	4.4	3.1	15.7	2.3	1.9	2.6	2.4	6.4	3.2	3.8	1.5	4.6	5.7	9.8	4.0	2.7	10.0	0.9	2.5	6.0	1.1	3.9	4.4	3.2	2.3	2.9	2.6	1.1	3.2	2.2	2.8	14.8	3.1	2.0	13.5	1.0	1.4	3.0	4.0	2.1	6.4	7.6	5.2	4.8	1.7	0.8	5.4	1.9	1.3	3.0	2.5	3.6	7.0	1.7	4.0	1.2	2.2	7.7	1.1	3.0	2.9	3.9	8.0	1.6	16.4	4.0	1.5	2.1	0.9	1.0	0.6	2.8	2.5	2.3	2.1	3.2	2.7	1.9	1.1	8.9	2.1	0.7	3.1	3.3	6.5	2.2	4.7	2.7	2.3	2.8	8.6	4.2	5.0	8.9	4.1	2.3	4.8	0.6	0.7	3.4	5.0	2.5	2.2	4.5	1.8	1.1	6.9	1.2	2.4	0.0	0.3	0.1	0.5	0.1	0.3	0.4	0.6	0.4	0.4	0.8	0.9	0.4	1.7	0.3	2.0	1.5	0.0	0.4	2.5	3.2	14.3	4.7	2.6	2.4	4.6	5.7	2.5	3.2	3.1	2.1	1.7	3.2	3.2	9.8	3.7	1.7	4.1	4.6	1.8	8.9	5.3	5.2	3.3	4.3	3.9	14.7	20.9	3.6	1.0	2.1	3.9	2.2	25.4	38.1	4.4	1.4	5.4	4.8	17.7	1.4	1.8	2.5	5.6	4.3	5.7	3.4	1.1	1.8	2.9	10.1	10.7	0.9	6.1	0.6	0.7	25.1	2.5	1.0	1.8	4.7	1.2	7.1	4.1	3.5	2.9	1.3	0.6	3.0	2.1	2.0	2.3	9.7	36.7	21.5	0.0	5.7	3.6	25.3	6.4	2.5	2.3	1.9	2.0	2.8	2.2	3.2
MORN2	MOPT	ENSG00000188010	"MORN repeat containing 2"	Q502X0	2	38875962-38929072	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 174.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1976.5;Endometrial ciliated cells: 783.4;Late spermatids: 3753.7;Respiratory ciliated cells: 848.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057815			Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA057815: AB_2683537"	"unprognostic (7.28e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.80e-2)"	13.5	30.5	41.9	6.2	44.6	9.7	20.6	42.8	55.9	30.5	62.8	14.5	6.6	16.6	73.3	13.7	96.3	16.0	26.2	42.4	44.9	69.3	17.6	18.0	5.5	45.0	46.4	19.4	20.2	79.5	56.8	8.0	45.7	18.0	13.5	37.6	21.3	18.8	20.0	10.2	8.1	11.3	43.7	6.6	15.2	174.2	43.6	8.2	46.0	17.3	5.7	14.5	13.2	44.3	60.9	30.5	37.2	46.0	40.4	60.5	21.0	27.7	42.9	42.5	40.2	18.3	33.5	3.8	21.8	40.9	42.4	15.9	16.5	34.9	63.4	25.3	32.8	12.9	32.6	46.1	34.8	21.2	9.2	35.6	42.8	51.5	18.9	54.0	39.9	11.7	22.7	8.9	35.8	58.6	9.3	40.5	27.6	40.0	31.7	5.2	38.8	13.3	83.0	33.4	37.1	49.4	41.3	27.0	59.6	21.7	36.5	28.5	26.5	30.2	29.8	48.0	44.1	16.6	26.4	2.3	68.8	6.0	54.4	1.5	8.3	1.2	1.6	6.7	3.1	2.5	1.9	2.4	5.9	2.7	3.2	3.3	0.7	2.7	5.5	3.0	4.0	3.8	41.9	44.6	42.8	55.9	42.4	44.9	45.0	46.4	45.7	43.7	43.6	44.3	14.1	16.0	25.3	2.6	7.9	9.7	25.5	103.9	10.2	16.7	29.5	45.7	40.5	35.8	90.9	60.7	10.4	15.9	4.2	19.5	270.1	61.4	1976.5	783.4	34.1	16.0	22.9	7.4	2.5	44.4	22.9	28.8	18.8	43.6	9.5	35.2	12.8	24.5	23.6	16.8	2.3	18.1	73.2	9.0	6.7	3753.7	53.4	15.1	23.2	0.0	10.2	106.7	3.1	1.5	1.8	41.0	34.3	51.6	5.5	22.4	7.4	396.6	848.6	35.1	26.3	21.3	40.5	530.7	92.0	15.7	10.5	7.7	6.1	51.8	22.0	30.0
MORN3		ENSG00000139714	"MORN repeat containing 3"	Q6PF18	12	121648742-121672631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 4.1;fallopian tube: 3.9;testis: 4.5"	"Cell type enriched"	"Detected in many"	6	"Late spermatids: 2271.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"BEWO: 13.6;CACO-2: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038709, HPA038710"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038709: AB_2676164, HPA038710: AB_2676165"	"prognostic favorable (1.16e-4)"	"unprognostic (2.70e-3)"	"unprognostic (5.56e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	0.2	0.3	1.4	0.5	1.6	0.9	0.4	1.3	1.6	0.4	4.1	0.2	0.2	0.3	0.5	0.1	3.9	0.4	0.2	1.5	1.5	0.7	0.1	1.0	1.2	1.7	2.2	0.3	0.3	2.3	1.3	0.8	1.1	0.2	0.2	0.6	0.4	0.3	0.2	2.0	0.4	0.2	1.3	0.7	0.6	4.5	1.6	0.9	0.6	0.0	0.6	0.2	0.2	1.4	0.2	0.1	0.4	0.2	0.0	0.3	13.6	0.2	0.1	0.0	0.1	8.3	0.4	0.2	0.2	0.1	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.6	0.5	0.5	0.2	0.5	0.9	0.1	0.3	0.4	0.0	0.1	0.3	1.0	0.2	0.3	0.1	0.3	0.9	0.7	0.3	0.0	0.1	0.4	0.0	0.1	0.5	0.2	1.2	1.1	0.1	0.2	0.0	0.6	1.1	0.1	0.2	0.2	0.2	0.4	0.2	0.2	0.1	0.4	1.0	0.4	0.2	1.3	0.3	0.1	0.7	0.1	0.8	0.3	0.8	0.4	0.1	0.5	0.7	0.5	1.2	0.9	0.3	0.5	0.8	0.2	1.4	1.6	1.3	1.6	1.5	1.5	1.7	2.2	1.1	1.3	1.6	1.4	1.1	3.2	1.3	0.0	1.6	3.2	1.2	3.3	0.0	1.3	2.5	1.8	1.4	4.3	8.2	1.8	0.0	0.5	6.6	0.0	7.9	4.4	352.0	34.1	1.2	2.1	0.0	0.0	2.7	1.4	0.7	1.4	0.0	3.0	2.5	2.5	0.7	0.0	0.9	0.0	2.3	0.0	4.1	0.0	0.3	2271.5	9.3	1.7	0.0	0.0	1.8	5.4	5.2	0.0	0.1	2.2	0.0	9.4	3.5	0.7	0.1	1.1	51.7	2.2	0.0	1.5	1.4	8.7	6.7	0.0	4.0	7.3	6.7	3.4	0.2	1.1
MOSPD1	dJ473B4	ENSG00000101928	"Motile sperm domain containing 1"	Q9UJG1	X	134887632-134915257	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 106.9;Endometrial ciliated cells: 80.3;Erythroid cells: 150.1;Late spermatids: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031158	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Vesicles"		"HPA031158: AB_10603874"	"unprognostic (2.23e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.45e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.15e-1)"	5.1	14.0	4.1	4.9	4.1	15.4	8.3	4.5	5.5	8.7	12.4	6.7	5.9	16.2	12.8	15.2	26.9	7.1	20.0	4.0	4.4	10.9	7.6	7.5	6.2	4.8	4.4	10.9	7.7	15.1	3.4	11.8	4.5	8.4	7.4	6.7	9.4	7.7	21.5	10.4	5.6	11.3	4.4	6.4	5.4	10.4	4.4	9.7	9.6	14.1	8.5	10.6	8.8	4.5	19.6	15.1	12.5	8.7	19.5	11.4	27.3	32.2	58.2	30.4	29.4	37.2	7.6	6.5	43.7	20.6	54.9	6.9	19.6	16.7	39.9	21.9	11.5	5.6	36.7	15.1	82.2	15.6	9.1	20.6	20.0	34.2	14.7	34.5	22.6	13.3	7.0	25.9	37.3	27.2	11.2	7.1	12.8	10.2	34.1	8.3	22.2	12.4	13.0	55.3	7.4	9.2	16.3	16.2	56.7	60.6	6.5	9.7	11.3	14.9	9.2	56.0	29.0	20.1	29.0	10.4	20.2	26.4	19.9	4.9	5.4	10.5	5.8	4.3	7.9	4.7	6.9	6.4	6.3	4.1	7.7	7.6	3.5	5.1	5.1	6.7	12.4	4.1	4.1	4.1	4.5	5.5	4.0	4.4	4.8	4.4	4.5	4.4	4.4	4.5	13.2	6.4	5.8	3.9	11.0	21.3	10.6	13.8	29.6	8.5	10.8	9.4	43.7	4.3	11.8	11.0	2.1	9.0	6.9	7.6	21.5	26.3	106.9	80.3	10.5	12.2	4.2	150.1	7.6	12.4	16.0	10.5	8.6	12.0	5.7	21.5	13.9	6.7	14.9	5.0	8.8	6.9	16.2	11.9	7.7	82.9	6.8	7.5	30.2	4.7	7.4	9.3	11.3	9.0	4.4	20.9	12.7	10.9	14.7	11.8	5.7	27.9	20.0	8.5	6.6	6.8	16.9	3.8	6.6	12.2	20.5	26.1	13.2	15.8	7.1	9.9
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1472.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: AB_2680325"	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	16.7	36.6	14.9	5.6	14.1	13.8	16.8	12.6	19.0	22.1	11.2	17.2	6.8	18.7	3.1	33.5	16.2	8.3	15.1	13.4	14.0	21.0	38.9	13.6	8.0	15.5	13.6	19.2	18.4	7.8	15.6	4.1	13.7	18.1	3.0	2.1	19.6	7.0	10.7	41.8	12.8	5.1	13.3	16.3	19.6	57.9	14.4	7.1	14.9	5.4	5.3	17.4	23.4	13.3	12.6	16.2	13.0	22.9	6.6	4.9	9.3	9.3	10.7	9.3	9.3	15.4	16.1	7.7	20.2	8.3	13.3	9.5	7.5	12.9	1.7	20.4	9.9	8.0	12.1	23.2	8.5	6.1	30.0	13.8	10.8	7.9	4.6	8.2	15.8	12.7	19.2	15.4	9.4	35.9	17.4	47.4	11.9	16.0	24.9	16.4	13.6	18.9	14.8	17.9	7.1	42.8	17.5	26.3	9.8	5.3	16.2	18.3	19.0	18.5	28.3	38.2	9.2	12.2	12.4	5.5	18.3	69.5	22.7	38.7	29.1	40.3	31.3	22.7	36.9	21.7	36.0	36.7	31.7	22.4	21.3	22.2	21.3	37.5	15.9	21.1	57.2	14.8	14.9	14.1	12.6	19.0	13.4	14.0	15.5	13.6	13.7	13.3	14.4	13.3	18.5	9.6	7.0	4.6	10.9	12.1	20.0	31.0	21.1	5.7	28.0	25.8	3.6	21.5	16.9	20.2	6.2	6.6	19.8	9.3	43.0	43.2	324.0	15.7	12.8	16.4	21.6	21.7	4.7	42.8	26.3	16.4	12.8	11.2	3.8	11.5	23.6	31.3	29.8	6.7	7.6	14.2	22.4	25.1	14.8	1472.9	27.7	15.6	26.6	1.9	17.4	19.0	25.7	8.5	4.9	43.9	17.3	21.8	7.8	16.2	15.1	48.7	15.9	4.0	13.1	10.7	17.5	20.3	31.1	26.7	19.6	6.2	24.4	16.7	17.0	25.3
MPG	MDG	ENSG00000103152	"N-methylpurine DNA glycosylase"	P29372	16	77007-85851	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006531	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA006531: AB_1854075"	"unprognostic (1.78e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.82e-5)"	"unprognostic (8.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.86e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	45.6	63.1	28.6	24.5	28.4	32.8	45.8	28.3	43.8	45.5	25.8	43.0	23.7	46.6	9.4	39.8	40.4	27.5	59.7	28.1	28.7	33.6	66.9	44.6	40.4	27.4	27.5	43.1	59.2	11.9	44.4	21.2	27.4	50.3	7.6	2.0	55.6	21.2	69.2	37.9	37.1	14.7	28.3	53.0	46.8	16.2	29.5	14.2	46.6	21.1	15.1	46.7	38.4	28.5	50.2	70.4	18.1	54.9	34.1	77.2	51.9	78.0	95.1	44.1	49.3	44.2	61.5	40.2	65.0	39.8	20.5	64.7	13.1	30.4	6.7	67.6	59.3	25.3	34.3	67.1	99.3	25.4	141.9	75.4	41.9	50.0	20.4	57.4	80.0	39.9	56.1	58.6	57.8	167.5	43.6	118.1	36.4	27.3	86.1	84.2	25.7	140.5	37.5	17.1	15.5	42.5	41.0	36.2	91.9	8.3	54.1	119.4	80.6	34.1	47.9	49.4	34.4	67.7	23.6	49.6	67.8	71.2	129.9	47.3	75.3	80.9	60.6	56.6	55.0	92.5	57.1	60.3	80.3	85.9	42.5	43.7	38.9	130.2	47.6	110.3	90.8	67.0	28.6	28.4	28.3	43.8	28.1	28.7	27.4	27.5	27.4	28.3	29.5	28.5	72.6	3.2	25.6	14.0	73.9	35.8	82.9	102.9	47.8	13.8	76.8	80.4	1.3	37.1	63.0	40.5	4.2	78.7	74.2	59.1	33.2	76.4	9.9	33.5	63.1	59.3	49.8	39.9	14.2	114.2	89.4	78.7	43.8	36.1	56.3	57.1	62.8	55.6	89.8	10.1	13.9	92.5	83.4	69.4	43.7	5.0	65.9	55.6	56.9	10.3	77.9	39.8	66.9	14.1	12.9	134.8	78.6	57.9	80.1	110.6	83.1	67.7	43.5	11.4	85.5	51.5	73.3	15.1	36.7	53.9	41.1	61.8	59.8	197.2	68.3	114.0
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170224	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favorable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	19.8	21.3	26.7	25.5	26.8	20.0	72.5	29.6	32.8	23.6	19.1	22.7	13.8	25.8	22.4	36.2	15.9	16.5	13.9	26.7	28.3	17.8	15.9	18.7	24.7	22.1	24.7	13.4	9.0	16.2	21.3	24.4	23.1	15.3	24.9	31.6	26.0	13.0	18.0	40.1	15.9	22.8	21.7	16.7	15.7	14.1	27.5	20.7	11.6	17.5	26.2	34.7	21.0	28.4	67.8	36.2	79.0	38.9	37.7	52.7	43.5	71.1	84.7	60.6	29.3	58.5	38.4	55.2	42.0	39.2	44.7	69.2	76.2	73.6	80.8	41.3	49.9	44.5	31.2	106.5	37.5	111.9	65.9	33.6	64.7	36.2	102.8	30.5	70.6	75.7	106.2	15.3	93.4	54.8	86.5	131.2	72.4	83.4	49.5	105.5	36.6	36.5	55.3	69.8	54.1	23.3	119.6	52.5	53.6	32.4	92.2	68.6	56.0	56.5	56.3	50.2	51.3	22.4	58.0	217.9	51.0	89.9	73.2	26.1	38.3	36.9	38.2	46.5	48.5	35.6	38.7	39.9	44.9	29.2	41.1	38.8	4.9	33.1	33.8	27.2	44.3	28.3	26.7	26.8	29.6	32.8	26.7	28.3	22.1	24.7	23.1	21.7	27.5	28.4	13.2	19.2	38.3	20.5	22.9	38.7	40.3	123.9	19.4	14.5	74.3	50.0	31.5	14.3	66.2	20.2	10.4	56.9	23.0	21.7	50.9	45.2	6.5	13.9	18.5	19.3	9.0	23.1	38.5	28.1	46.1	31.4	15.8	22.0	18.3	21.9	20.0	19.0	49.6	20.2	35.6	20.7	40.7	29.1	42.7	7.5	11.1	55.9	32.0	12.2	56.0	61.1	34.0	29.7	17.1	56.4	28.4	10.1	22.3	38.6	12.2	46.5	32.7	24.5	19.7	15.4	30.1	36.9	57.5	30.6	54.0	32.8	27.4	26.3	34.0	48.1
MPHOSPH8	"HSMPP8, mpp8"	ENSG00000196199	"M-phase phosphoprotein 8"	Q99549	13	19633659-19673441	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039701, HPA040035"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039701: AB_10805484, HPA040035: AB_10794207"	"unprognostic (4.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.90e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.02e-1)"	29.0	32.5	32.4	30.0	31.9	27.9	28.7	36.5	48.7	38.6	31.1	39.7	22.5	36.1	31.6	23.3	34.0	23.4	36.1	31.6	40.2	22.9	21.1	28.7	39.2	31.8	35.7	51.4	28.2	26.3	31.6	25.4	31.5	31.2	24.4	36.9	32.3	31.2	23.4	33.6	33.3	26.6	26.8	39.9	28.3	21.5	33.6	23.2	32.9	18.5	26.4	32.3	31.7	36.5	26.0	16.4	23.9	39.0	30.3	38.2	42.2	38.2	27.5	23.6	20.1	25.1	44.5	40.8	29.7	23.1	36.6	42.2	44.4	26.7	30.2	51.1	22.7	65.7	27.8	30.8	27.0	47.8	51.4	22.8	33.8	18.6	26.1	35.8	31.6	32.5	32.5	25.5	22.2	25.1	36.8	39.9	23.4	48.0	18.1	29.3	55.2	32.6	40.7	19.8	32.7	20.0	35.7	32.3	35.3	39.8	19.7	39.1	37.3	18.1	16.4	34.8	19.6	17.2	19.2	40.1	13.8	43.4	28.7	133.6	23.4	42.5	31.5	18.2	28.1	64.3	35.6	31.1	11.4	54.1	42.5	34.8	69.2	30.4	27.8	35.8	30.9	9.9	32.4	31.9	36.5	48.7	31.6	40.2	31.8	35.7	31.5	26.8	33.6	36.5	117.3	93.0	110.6	42.1	129.7	69.0	102.1	99.0	97.3	201.0	74.8	95.0	94.4	110.1	92.2	103.0	83.4	151.1	132.0	95.1	49.0	57.6	84.3	82.3	129.2	109.0	58.8	78.9	94.7	54.6	83.7	118.8	62.7	118.8	144.2	101.0	133.2	81.3	72.9	210.3	89.4	113.2	67.1	74.5	55.5	37.9	179.3	71.4	67.6	51.5	99.8	114.9	166.9	56.3	78.7	48.2	99.7	157.2	118.5	80.8	100.5	61.6	66.6	219.0	177.5	111.5	118.5	211.0	203.7	57.9	74.0	58.7	142.7	105.3	86.8	65.3
MPHOSPH9	MPP9	ENSG00000051825	"M-phase phosphoprotein 9"	Q99550	12	123152320-123244014	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 114.7;Excitatory neurons: 87.7;Inhibitory neurons: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037485	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus, Centrosome"	"HPA037485: AB_10672792"	"unprognostic (2.98e-2)"	"unprognostic (5.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.17e-1)"	4.6	5.4	13.7	8.0	15.2	26.2	5.0	21.6	19.8	4.7	18.9	6.1	6.8	5.3	11.1	3.1	5.3	3.6	5.6	14.3	13.2	6.2	9.6	3.9	12.1	13.8	13.7	4.5	4.0	8.9	4.4	5.2	13.9	4.6	6.8	21.3	5.5	4.4	6.8	5.0	5.2	5.2	13.4	8.1	5.1	12.4	14.4	32.8	5.2	7.8	10.3	4.2	1.9	16.0	15.0	15.9	23.9	28.0	10.7	10.1	9.1	15.7	7.8	18.7	15.2	15.1	7.2	29.6	10.6	10.1	15.7	10.2	30.3	11.1	26.0	17.6	20.7	30.5	17.9	15.0	6.6	27.0	24.6	10.5	4.7	18.2	16.1	15.6	19.5	40.1	21.4	12.7	17.3	12.9	32.6	44.6	17.1	9.4	17.2	27.6	24.9	19.1	14.7	14.8	31.4	15.0	23.7	9.3	15.4	22.4	17.5	21.2	11.1	15.3	21.5	17.5	22.1	19.0	33.8	24.4	12.2	26.4	32.4	11.5	3.7	5.4	10.1	3.7	7.2	6.5	8.4	9.5	3.7	6.0	11.6	12.0	0.8	10.1	3.3	5.3	7.8	2.8	13.7	15.2	21.6	19.8	14.3	13.2	13.8	13.7	13.9	13.4	14.4	16.0	7.3	9.6	9.5	50.3	15.6	4.5	4.5	5.7	8.6	43.5	5.8	5.2	16.3	10.0	7.2	7.3	114.7	12.2	25.3	2.8	5.9	4.8	57.9	21.2	12.4	8.5	14.3	33.6	87.7	1.8	7.1	10.6	5.1	6.5	2.5	23.6	7.9	31.1	8.6	53.8	84.7	5.6	6.1	15.3	7.4	73.3	7.2	10.4	3.6	24.4	17.0	14.7	32.0	46.3	48.1	1.8	1.6	11.3	21.4	3.0	4.3	11.0	14.9	65.9	0.0	11.6	7.2	31.7	20.4	8.4	2.3	1.6	26.8	17.2	9.8	2.7
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.8;skin 1: 8.3"	"Cell type enriched"	"Detected in single"	14	"granulocytes: 10.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	14	"HEL: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		330000	"Cluster 15: NK-cells - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	"Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol"	"HPA054404: , HPA073017: AB_2686566"	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.1	0.2	1.0	0.1	0.3	0.1	0.4	0.0	1.6	0.5	0.2	0.8	0.1	0.1	0.1	0.3	3.5	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.6	0.0	0.2	8.3	0.4	0.0	0.0	4.8	0.3	2.3	0.1	0.0	0.5	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.8	0.0	2.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
MPLKIP	"C7orf11, ORF20, TTDN1"	ENSG00000168303	"M-phase specific PLK1 interacting protein"	Q8TAP9	7	40126027-40134622	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058457, HPA065463"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA058457: AB_2683724, HPA065463: AB_2685493"	"unprognostic (5.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.08e-2)"	2.9	3.8	2.6	2.0	2.6	2.4	2.8	4.7	3.0	2.8	3.0	2.8	2.2	2.6	2.0	3.1	2.5	1.2	2.1	2.6	2.3	4.2	8.0	2.1	2.6	2.4	2.3	2.8	2.9	2.5	3.0	1.8	2.6	2.5	1.8	3.1	2.7	1.5	2.4	3.0	2.6	1.1	2.0	3.1	2.4	2.3	2.5	3.3	3.0	1.4	2.0	2.5	2.7	4.0	8.2	2.5	4.8	6.6	4.3	4.9	4.9	3.1	3.3	4.4	4.3	3.1	4.0	6.8	4.2	3.0	8.7	10.3	3.0	5.3	5.6	5.2	9.2	5.4	3.7	6.9	4.9	6.7	5.2	4.8	6.7	3.4	4.1	4.5	5.1	7.5	13.1	5.5	4.4	4.1	6.8	20.4	6.7	6.7	7.4	9.6	3.3	8.9	5.0	2.1	7.1	8.4	5.0	4.8	7.7	6.2	6.1	9.3	5.5	2.8	7.5	3.6	4.7	8.6	9.6	10.9	4.4	10.5	7.6	20.6	11.2	16.8	8.0	10.8	9.0	16.9	10.1	9.4	11.8	15.3	11.3	9.9	9.2	10.6	10.4	13.1	14.2	13.1	2.6	2.6	4.7	3.0	2.6	2.3	2.4	2.3	2.6	2.0	2.5	4.0	49.8	51.3	34.5	6.5	53.3	110.1	96.2	151.8	58.6	43.5	53.8	66.2	18.0	67.2	79.6	58.8	25.0	110.8	41.3	60.3	117.4	66.6	118.4	73.6	62.3	58.0	48.6	52.2	7.4	54.6	79.7	51.1	35.7	56.6	51.3	63.6	47.2	133.4	69.0	53.8	8.1	63.4	85.5	59.3	62.6	38.6	75.8	50.4	58.7	7.5	74.6	52.9	66.9	12.1	12.5	59.9	97.2	55.3	36.3	76.2	61.6	190.5	91.1	50.1	52.6	57.1	58.4	66.6	53.9	67.1	134.1	95.6	46.8	125.7	82.3	105.7
MPND	FLJ14981	ENSG00000008382	"MPN domain containing"	Q8N594	19	4343527-4360086	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 84.7;Paneth cells: 42.7;Proximal enterocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043274, HPA045475"	Approved		Approved	"Nucleoplasm,Nucleoli rim"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli rim"	Nucleoplasm	"HPA043274: AB_2678403, HPA045475: AB_2679339"	"unprognostic (3.16e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (4.85e-2)"	"prognostic favorable (6.12e-4)"	"unprognostic (8.60e-2)"	"unprognostic (5.37e-3)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.22e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.04e-2)"	10.5	21.9	22.6	9.3	22.4	15.8	10.7	27.1	35.0	13.2	20.8	25.4	30.6	11.9	8.6	18.1	11.5	9.5	22.4	23.1	20.5	22.7	46.5	12.6	11.7	22.7	20.7	13.0	24.4	15.4	11.0	6.9	23.3	19.0	16.2	4.0	17.2	9.6	23.2	15.6	19.8	6.5	19.4	15.2	20.1	6.6	20.6	10.2	13.3	14.4	7.1	15.2	12.7	25.0	16.0	13.2	21.3	24.6	13.1	6.1	21.7	7.6	7.2	6.2	7.6	25.6	8.1	14.4	23.3	9.9	18.2	16.1	9.8	13.2	3.4	16.4	21.5	11.0	18.4	37.4	10.0	14.9	19.1	9.4	9.4	6.8	7.1	9.3	18.9	37.4	6.0	36.4	7.8	41.8	35.4	12.6	9.8	26.5	18.2	28.8	6.5	21.0	15.5	25.4	23.7	24.3	13.5	19.4	9.9	12.1	13.0	18.1	7.3	9.8	10.4	60.4	15.4	30.1	20.1	9.7	10.9	8.3	11.5	9.3	3.1	1.5	1.3	3.7	2.1	1.0	1.6	1.9	2.9	1.6	1.0	1.1	0.8	1.7	1.8	2.9	3.7	1.3	22.6	22.4	27.1	35.0	23.1	20.5	22.7	20.7	23.3	19.4	20.6	25.0	6.1	0.0	3.7	1.6	5.1	5.4	8.4	1.4	3.4	8.2	9.5	8.5	13.9	11.5	2.7	11.0	2.1	13.6	9.8	84.7	0.0	4.1	0.8	8.0	6.1	6.0	16.7	2.5	2.6	5.1	11.9	5.2	9.2	8.9	4.5	7.8	5.7	23.5	14.8	6.7	2.4	31.2	2.0	26.0	9.6	3.9	6.2	14.4	3.6	1.9	8.8	8.6	21.6	3.5	2.1	4.3	42.7	3.8	7.7	6.9	50.7	15.0	2.3	5.6	6.6	6.1	11.7	0.2	7.6	7.8	8.4	10.4	6.3	9.1	34.6	9.6
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269855-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"bone marrow: 4023.1"	"Cell type enriched"	"Detected in some"	30	"Erythroid cells: 87.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"HL-60: 3517.4;NB-4: 4589.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.5	0.4	0.8	0.6	0.6	4023.1	0.3	0.6	1.1	0.0	0.3	0.2	0.0	0.2	1.1	0.1	0.1	0.3	1.1	0.8	0.7	0.2	1.8	8.4	1.7	0.9	1.0	0.1	0.1	0.0	1.5	1.4	0.9	0.2	0.2	0.4	66.3	0.1	1.1	4.3	0.2	0.3	0.8	21.7	0.1	0.4	0.8	10.9	0.3	0.3	0.2	0.5	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3517.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4589.9	0.0	0.0	0.0	5.3	3.2	0.6	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	4.0	0.0	0.0	6.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.1	7.5	0.8	0.6	0.6	1.1	0.8	0.7	0.9	1.0	0.9	0.8	0.8	0.7	0.0	0.0	0.5	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.9	0.0	0.5	0.1	0.0	0.1	0.0	87.4	0.3	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.7	0.3	0.9	0.0	0.2	0.0	0.0	1.2	0.0	1.3	0.0	2.9	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.3	0.1	0.0	0.1	0.6	0.0	0.0	0.0
MPP3	DLG3	ENSG00000161647	"Membrane palmitoylated protein 3"	Q13368	17	43800799-43833170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;heart muscle: 11.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 29.2;Early spermatids: 38.4;Late spermatids: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021818, HPA024742"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA021818: AB_1854086, HPA024742: AB_1854087"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.23e-5)"	"unprognostic (4.59e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.02e-11)"	"unprognostic (9.98e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.75e-2)"	1.4	0.6	2.4	0.3	1.5	0.0	1.4	10.2	2.0	1.5	2.8	0.9	0.4	0.7	1.8	1.0	1.1	0.7	11.8	1.9	2.4	1.1	0.3	2.2	0.2	4.9	2.2	0.6	2.2	0.3	1.8	0.4	4.4	1.6	0.3	0.9	0.5	0.9	0.2	1.0	0.5	0.6	1.5	1.2	1.0	0.8	3.4	0.0	0.7	0.1	0.2	0.8	1.1	2.0	0.5	1.4	0.5	0.6	0.9	1.2	0.0	1.1	0.4	1.1	0.4	0.9	0.8	0.0	0.3	0.8	0.7	0.5	1.1	1.1	1.6	0.0	1.3	0.2	3.3	0.7	0.1	0.0	0.0	0.7	2.3	1.5	2.1	1.4	0.3	0.0	0.5	0.0	0.6	1.1	0.0	0.0	0.6	0.5	1.1	0.0	0.9	0.0	1.8	0.0	4.8	1.1	0.7	1.5	0.3	0.8	2.6	1.1	1.0	1.2	1.9	0.5	1.4	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.5	10.2	2.0	1.9	2.4	4.9	2.2	4.4	1.5	3.4	2.0	12.1	12.8	4.1	3.9	0.0	4.0	8.3	2.7	5.7	2.7	3.2	4.8	29.2	7.2	5.4	1.8	0.0	0.1	0.0	1.2	0.0	3.9	38.4	0.8	1.9	5.3	1.2	0.8	3.6	1.4	0.6	3.3	12.8	1.9	1.3	1.1	3.6	0.7	1.1	10.1	5.4	1.2	0.0	0.0	3.9	76.0	3.7	1.1	1.8	1.0	1.9	0.8	0.0	3.5	10.0	2.9	3.4	2.6	0.0	8.1	0.4	0.3	0.8	1.7	6.6	0.8	2.9	0.8	2.6	4.7	2.7	0.1	0.5	0.3	2.3	3.2
MPP5	"FLJ12615, PALS1"	ENSG00000072415	"Membrane palmitoylated protein 5"	Q8N3R9	14	67240713-67336061	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000993, HPA063890"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000993: AB_1079407, HPA063890: AB_2732707"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.56e-2)"	"unprognostic (9.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (1.71e-12)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.87e-2)"	7.4	8.7	13.9	6.3	20.9	5.6	10.6	17.6	16.5	8.8	26.6	12.7	20.4	6.3	21.1	13.6	7.3	7.9	7.4	11.9	17.4	31.4	19.6	12.3	4.8	18.2	18.2	6.1	8.7	19.6	7.2	9.8	18.3	16.2	12.0	17.2	18.4	12.7	18.0	8.4	20.7	7.2	18.1	6.6	9.4	8.8	17.5	10.3	25.1	13.6	6.1	9.0	8.4	27.5	156.4	24.4	24.1	18.5	13.3	12.3	20.6	46.4	23.6	33.2	21.6	23.8	45.9	12.7	21.5	37.8	11.0	31.0	13.9	26.1	50.2	5.5	9.5	11.8	23.6	16.8	15.5	4.5	8.5	13.1	10.0	17.9	23.7	24.2	19.0	13.5	12.6	4.7	53.9	20.4	14.4	5.0	7.7	22.2	16.2	12.2	37.1	15.2	30.1	36.8	13.2	9.4	28.2	27.0	15.5	21.1	28.6	9.2	29.2	41.4	87.2	13.8	19.9	7.8	7.6	19.3	27.2	10.1	14.7	0.1	0.5	0.8	0.4	1.0	0.3	1.1	0.5	0.6	0.8	0.4	1.1	0.6	0.0	2.2	0.7	0.6	0.3	0.4	13.9	20.9	17.6	16.5	11.9	17.4	18.2	18.2	18.3	18.1	17.5	27.5	13.2	64.1	28.9	37.2	8.8	21.0	26.0	14.6	22.2	8.5	22.4	12.8	24.7	11.5	21.1	22.0	43.8	23.1	5.2	47.2	13.7	21.7	5.9	29.5	15.0	17.7	5.4	6.7	24.8	26.9	11.3	17.3	18.3	46.2	5.1	15.8	17.2	20.7	17.6	3.3	34.7	21.2	12.2	11.9	13.4	4.5	8.1	9.2	3.6	22.5	6.6	23.4	3.1	41.2	129.8	26.7	32.5	11.3	13.1	30.1	54.3	33.5	14.9	34.3	6.6	17.7	22.2	22.4	36.1	29.2	17.3	17.5	7.7	7.5	22.4	38.7
MPP7	FLJ32798	ENSG00000150054	"Membrane palmitoylated protein 7"	Q5T2T1	10	28050993-28334486	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.3;Excitatory neurons: 76.7;Suprabasal keratinocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 4.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.3;CACO-2: 45.2;CAPAN-2: 27.9;T-47d: 89.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037597, HPA037598"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	Nucleoplasm	"HPA037597: AB_2675569, HPA037598: AB_10696941"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.64e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.79e-14)"	"unprognostic (2.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	3.8	2.7	0.1	5.7	1.0	8.8	9.7	4.7	2.2	6.4	0.1	10.7	6.0	5.1	1.9	37.1	11.8	6.4	6.6	0.4	0.0	12.2	1.9	10.1	2.6	0.0	0.0	3.4	12.1	11.8	2.2	11.7	0.1	8.0	9.3	9.7	7.6	4.8	13.8	24.8	7.2	8.7	0.0	2.4	8.8	9.0	0.0	3.2	14.4	14.3	6.9	9.7	9.6	1.1	5.9	0.1	0.6	0.0	0.1	0.1	23.3	1.2	0.9	4.7	7.4	45.2	27.9	0.0	0.3	3.4	3.4	10.4	3.9	7.5	10.9	0.0	7.5	0.0	1.3	2.8	0.0	0.0	0.0	0.3	11.6	0.7	0.4	0.0	0.0	2.2	1.1	0.0	6.2	10.9	2.3	0.0	1.4	8.9	2.1	1.2	13.3	0.0	0.4	19.0	1.1	0.0	2.3	11.3	0.0	3.6	89.3	1.1	0.0	1.8	12.5	0.0	1.0	0.2	0.0	0.1	0.1	10.7	0.0	0.0	7.7	9.0	3.8	2.5	5.6	0.6	4.2	2.6	7.8	0.5	7.9	5.7	3.1	5.0	1.5	0.1	1.1	5.1	0.1	1.0	4.7	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.1	1.6	44.8	48.3	10.4	5.5	23.1	10.9	9.5	7.4	1.1	14.7	8.6	12.1	10.0	24.3	14.7	16.7	50.0	9.8	15.3	9.8	5.5	82.3	9.3	0.6	11.7	6.7	4.2	76.7	12.9	3.5	2.6	11.2	6.6	1.3	0.7	2.9	3.2	5.4	3.3	30.3	10.4	8.2	4.7	5.3	20.3	0.9	8.1	7.2	12.2	16.2	24.0	4.1	4.5	2.5	6.6	7.8	0.4	5.1	7.5	12.1	9.5	19.3	8.5	0.0	1.5	7.6	5.4	9.5	48.0	61.1	46.5	16.3	0.1	11.3	17.4
MPPE1	"Cdc1, PGAP5"	ENSG00000154889	"Metallophosphoesterase 1"	Q53F39	18	11882622-11908366	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, GPI-anchor biosynthesis, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 100.8;neutrophil: 293.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 293.9"	"Cell line enhanced"	"Detected in all"		"OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012639	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA012639: AB_1854088"	"unprognostic (9.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (6.45e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-2)"	"unprognostic (6.15e-2)"	14.9	13.1	11.3	20.0	11.7	28.3	15.4	11.0	11.9	16.1	11.7	21.5	17.7	17.0	20.6	17.2	16.4	21.8	18.6	10.9	11.9	28.8	23.8	25.6	16.0	12.6	11.8	12.7	31.8	20.1	15.0	14.1	12.5	16.3	21.4	15.9	15.0	19.0	23.5	29.0	20.3	15.8	10.6	15.9	22.8	8.5	12.1	16.0	47.1	11.7	14.7	14.9	13.7	13.1	7.8	11.1	8.4	19.9	22.9	26.7	7.9	18.6	26.0	10.6	16.5	20.8	21.6	15.8	39.2	17.6	10.7	8.6	5.8	10.1	9.9	17.7	10.4	4.6	22.9	4.9	31.9	20.3	30.9	40.1	13.3	9.4	6.6	15.7	6.5	13.9	5.8	14.5	17.8	18.1	15.1	13.6	5.6	65.9	3.1	6.0	5.4	18.8	17.2	11.9	11.8	6.7	17.1	13.5	16.0	9.3	9.8	25.9	13.5	21.4	8.3	20.5	10.3	22.6	21.5	19.7	15.8	10.4	21.5	20.6	42.9	100.8	24.8	34.5	18.1	17.9	15.2	23.9	37.3	21.7	18.5	23.8	293.9	29.2	24.6	29.6	27.0	31.8	11.3	11.7	11.0	11.9	10.9	11.9	12.6	11.8	12.5	10.6	12.1	13.1	19.3	57.7	33.0	13.4	24.5	18.0	16.2	20.7	12.5	17.4	14.6	11.6	2.4	24.3	23.1	22.0	12.5	27.9	35.7	43.9	21.5	30.5	20.5	17.9	14.8	15.5	9.6	13.3	20.9	41.9	32.5	16.6	29.6	22.6	27.8	23.5	15.7	27.6	25.4	8.4	21.4	23.4	14.2	33.2	25.7	36.0	12.8	24.8	19.6	20.6	24.2	23.3	52.5	12.5	24.4	36.3	18.4	15.1	16.0	10.1	36.3	27.0	26.7	20.5	13.1	17.2	13.9	7.0	8.7	21.8	20.0	16.7	33.7	16.4	16.1	22.0
MRE11	"ATLD, MRE11A"	ENSG00000020922	"MRE11 homolog, double strand break repair nuclease"	P49959	11	94415570-94493885	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Meiosis"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Cytotrophoblasts: 39.2;Granulosa cells: 34.1;Syncytiotrophoblasts: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002691, CAB004081"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004081: AB_2145100, HPA002691: AB_1079409"	"unprognostic (5.59e-3)"	"unprognostic (4.35e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.66e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.06e-3)"	9.1	6.1	3.4	11.7	3.7	22.6	13.9	6.8	3.4	8.8	6.0	7.6	6.8	11.7	8.9	7.1	7.9	7.3	5.0	3.3	3.5	6.0	6.4	7.7	12.6	5.1	4.4	11.1	7.5	5.6	3.1	12.1	3.8	9.3	11.5	6.3	7.8	7.3	5.0	15.6	7.7	9.9	4.0	12.7	7.3	8.3	4.4	14.3	7.4	5.4	16.1	8.5	7.4	6.7	21.5	21.5	39.9	5.0	13.1	18.2	22.8	29.4	19.0	25.9	30.6	39.4	43.3	55.8	47.0	15.3	32.5	40.1	33.7	22.1	34.1	37.5	20.0	48.7	31.5	22.7	6.0	32.7	33.6	12.8	13.4	33.7	21.0	11.7	23.0	26.8	34.9	35.6	20.9	15.5	33.2	30.5	13.0	49.3	23.3	29.0	35.3	28.1	16.8	29.6	14.1	19.8	40.6	26.0	8.6	33.2	43.4	19.3	16.9	38.7	28.6	33.9	21.5	8.8	33.2	54.4	10.4	50.3	31.5	5.7	8.0	6.5	8.2	10.0	8.3	6.4	6.0	8.9	11.6	6.9	5.1	8.4	3.8	8.6	8.4	8.7	8.8	6.7	3.4	3.7	6.8	3.4	3.3	3.5	5.1	4.4	3.8	4.0	4.4	6.7	23.6	28.9	14.3	0.0	6.3	0.0	0.0	0.0	0.0	0.0	12.5	13.7	0.0	0.0	9.3	9.2	0.0	39.2	20.8	0.0	3.9	11.4	0.0	19.5	22.2	8.4	0.0	0.0	0.0	8.1	15.8	8.9	0.0	16.3	17.7	34.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	8.8	0.0	0.0	6.1	0.0	0.0	6.5	11.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	28.0	7.2	16.8	0.0	0.0
MRFAP1	"PAM14, PGR1"	ENSG00000179010	"Morf4 family associated protein 1"	Q9Y605	4	6640091-6642745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB042447, HPA056367"	Approved		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB042447: AB_2145271, HPA056367: AB_2683107"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.03e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.90e-7)"	"unprognostic (1.24e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	227.9	291.8	348.2	126.4	355.0	108.2	209.1	360.6	382.1	222.2	330.6	254.2	147.1	254.8	207.9	189.0	221.4	134.3	260.4	335.9	359.7	266.1	245.3	203.4	114.8	409.8	362.8	243.2	156.1	260.7	262.1	194.2	367.5	193.0	132.7	165.7	164.8	207.0	372.3	179.8	163.4	215.1	358.3	181.3	196.1	154.7	359.7	131.0	177.7	308.2	132.8	220.3	194.6	389.3	344.4	371.8	311.7	360.9	373.9	336.6	245.7	444.2	407.3	401.1	398.9	368.7	362.7	214.4	333.0	411.9	455.0	192.2	425.4	462.3	482.5	85.4	306.6	319.6	430.5	405.8	349.7	241.6	151.2	351.0	416.2	369.2	371.6	380.2	452.2	185.9	427.9	136.4	401.2	432.5	182.2	565.1	387.7	297.6	472.6	233.6	564.5	182.3	490.3	255.6	488.0	381.6	287.7	204.2	429.7	270.4	569.8	291.2	408.6	350.3	235.2	262.6	592.2	196.8	266.4	351.5	362.5	507.6	347.7	202.0	186.2	163.2	126.9	154.0	127.9	89.4	125.3	127.0	177.8	94.8	127.8	126.3	198.6	137.1	153.1	143.8	147.1	196.4	348.2	355.0	360.6	382.1	335.9	359.7	409.8	362.8	367.5	358.3	359.7	389.3	141.8	160.3	158.9	14.4	84.7	188.5	262.6	155.6	130.9	113.9	148.6	155.2	227.0	163.0	124.4	88.3	16.7	547.5	103.7	83.8	219.2	241.8	43.1	161.8	184.2	196.4	178.1	123.1	18.7	204.2	312.7	197.2	69.8	166.8	150.4	141.4	171.4	179.7	200.4	111.0	20.9	129.7	130.2	144.4	114.1	65.1	314.0	106.8	126.3	12.2	158.5	270.7	113.3	12.5	33.7	189.0	121.3	304.6	61.1	257.3	168.0	252.6	126.0	111.5	216.9	230.7	197.7	349.3	211.8	126.3	173.8	322.2	121.4	337.1	138.3	236.7
MRGBP	"C20orf20, Eaf7, FLJ10914, MRG15BP"	ENSG00000101189	"MRG domain binding protein"	Q9NV56	20	62796473-62801729	"Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.0"	"Group enriched"	"Detected in many"	7	"Early spermatids: 124.0;Late spermatids: 408.9;Spermatocytes: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017012	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA017012: AB_1845679"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (8.56e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavorable (3.80e-6)"	"unprognostic (2.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.01e-3)"	7.0	7.5	8.8	5.5	8.9	6.7	6.8	9.4	9.8	7.9	7.9	8.8	8.1	6.7	3.2	7.5	6.8	4.6	9.8	8.7	8.7	8.4	13.6	7.1	7.8	8.7	8.8	10.8	6.7	8.7	7.8	7.3	8.7	7.1	4.0	6.6	7.4	4.4	9.2	7.2	8.8	3.2	8.0	9.7	7.6	48.0	9.0	7.0	7.5	6.7	5.3	7.3	7.5	10.2	32.2	20.0	16.1	24.8	8.7	13.1	15.6	18.2	23.5	69.2	30.0	71.5	25.1	29.3	35.4	14.1	34.3	26.7	18.5	30.7	38.9	9.2	15.8	21.4	22.9	41.8	13.5	25.2	38.7	11.3	22.2	18.9	20.0	14.7	16.6	27.8	29.6	15.7	17.5	48.8	48.0	47.7	13.6	33.5	35.7	42.5	30.5	21.8	10.5	13.1	22.6	18.2	25.9	22.9	33.9	8.9	28.3	36.5	17.4	42.9	44.6	29.4	39.2	20.9	13.7	34.9	42.3	24.8	24.6	0.0	0.6	0.9	0.5	1.0	0.7	0.4	0.6	0.7	0.4	0.4	0.5	1.0	0.7	0.1	0.4	0.5	0.8	0.3	8.8	8.9	9.4	9.8	8.7	8.7	8.7	8.8	8.7	8.0	9.0	10.2	15.2	0.0	2.2	6.2	17.1	14.7	14.8	9.0	13.1	12.3	14.4	11.9	9.4	18.6	5.3	12.9	8.4	12.6	18.0	9.2	19.6	23.3	124.0	9.3	11.5	12.0	2.4	12.8	7.9	22.2	24.7	13.1	12.8	9.7	1.3	14.5	11.0	14.5	14.3	13.5	7.3	9.6	8.2	11.3	16.5	408.9	12.2	16.1	7.2	2.8	12.4	16.5	8.2	5.0	5.2	24.3	8.0	7.9	18.8	23.5	12.4	18.6	3.2	14.5	0.0	10.2	13.8	113.0	27.8	16.4	13.1	14.6	15.6	19.5	12.0	17.6
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764522-13774282	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No		880000	"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: AB_2678141"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	15.8	19.2	7.9	9.0	8.2	9.5	18.5	9.3	8.5	24.8	7.0	17.3	9.6	21.6	4.1	20.5	21.8	5.3	12.9	7.6	7.5	22.3	23.8	15.8	10.5	8.9	7.7	24.4	19.6	7.8	18.0	11.9	8.7	19.3	6.4	5.3	20.5	8.8	11.6	26.0	21.1	5.2	7.1	23.1	18.3	3.6	8.4	7.8	23.0	4.4	8.7	17.6	22.4	10.9	14.7	9.3	5.5	13.1	6.1	9.5	13.0	17.9	9.3	13.8	12.4	9.9	11.5	7.9	6.5	6.6	7.3	25.4	24.5	15.5	10.8	12.6	39.3	6.6	18.5	12.0	4.7	20.3	14.8	9.9	9.4	7.1	6.0	14.3	13.7	7.9	11.6	0.6	7.4	18.7	21.9	14.3	9.1	6.0	27.2	20.5	7.6	17.4	8.1	11.4	10.4	9.9	6.6	13.9	14.5	7.7	11.1	8.2	8.2	8.2	7.6	29.3	8.8	11.0	11.3	2.4	6.8	22.5	9.7	3.4	1.8	0.7	1.7	1.7	1.8	1.5	1.7	2.2	1.4	1.6	1.3	1.1	1.6	1.8	1.1	2.7	1.5	1.3	7.9	8.2	9.3	8.5	7.6	7.5	8.9	7.7	8.7	7.1	8.4	10.9	9.2	9.6	19.8	15.0	10.8	11.1	8.9	10.8	6.8	4.3	9.0	8.4	0.9	8.6	13.4	16.5	8.4	13.2	17.2	8.1	5.9	9.2	0.7	11.5	14.4	13.8	9.1	13.3	22.3	12.7	8.7	12.3	14.3	14.2	13.3	9.9	12.8	10.0	7.2	1.7	19.6	9.3	6.1	7.2	8.4	1.7	17.4	7.4	1.8	9.4	10.5	5.0	17.5	18.1	15.2	6.8	11.0	15.1	13.3	4.7	16.5	10.5	19.2	9.3	26.3	10.8	13.3	0.3	4.5	13.3	11.4	5.3	16.0	22.2	9.8	6.8
MROH1	"HEATR7A, KIAA1833"	ENSG00000179832	"Maestro heat like repeat family member 1"	Q8NDA8	8	144148016-144261940	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.8"	"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024287, HPA044465"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA024287: , HPA044465: AB_10960985"	"unprognostic (1.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (6.74e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-2)"	9.2	17.0	7.3	6.3	6.9	18.0	11.0	5.4	15.5	10.5	6.4	16.2	13.3	9.1	5.3	17.0	11.0	3.6	14.0	7.5	2.7	17.2	11.7	17.0	7.0	11.8	4.2	7.7	26.7	5.6	22.3	5.5	10.9	17.2	3.4	0.9	17.3	5.7	5.2	17.8	17.6	2.1	1.1	21.7	18.9	13.0	4.9	4.2	58.8	2.1	3.7	12.9	12.6	3.8	17.0	6.9	0.9	6.5	3.1	3.3	29.3	7.3	5.1	4.0	5.5	11.6	29.7	8.9	10.5	4.2	9.8	15.9	1.0	11.2	1.8	5.1	9.5	10.8	22.1	10.7	7.8	4.8	11.0	6.1	11.4	6.4	9.2	4.7	5.8	7.2	4.5	3.9	4.5	36.3	8.4	10.2	2.5	11.6	32.0	10.8	2.2	9.3	5.9	33.0	7.4	6.4	18.3	17.5	5.4	2.5	12.8	6.7	14.6	8.1	15.2	16.6	6.1	6.8	3.6	9.5	16.0	14.3	4.9	4.8	5.7	1.5	1.8	7.5	1.3	0.9	1.5	1.8	4.3	1.5	1.4	1.0	1.1	0.8	6.8	1.3	4.6	2.2	7.3	6.9	5.4	15.5	7.5	2.7	11.8	4.2	10.9	1.1	4.9	3.8	5.2	9.6	26.3	33.0	6.5	6.2	8.5	9.2	6.8	36.4	12.6	9.5	12.4	5.7	16.6	5.5	12.5	31.3	7.0	39.8	3.9	12.2	5.1	17.8	6.7	7.8	23.4	1.7	56.7	16.6	19.2	6.4	63.7	25.2	14.5	14.3	3.9	7.0	19.7	37.0	61.2	24.8	18.3	11.9	11.4	12.2	3.1	14.5	1.8	13.1	11.4	5.7	7.2	14.6	7.9	18.6	17.5	2.6	9.7	17.6	30.7	5.8	18.8	3.5	6.6	7.2	6.7	19.1	26.2	9.7	5.8	50.1	9.1	7.8	22.3	14.8
MROH6	C8orf73	ENSG00000204839	"Maestro heat like repeat family member 6"	A6NGR9	8	143566192-143572772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 23.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 13.8;Hepatocytes: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 11.6;HaCaT: 13.6;OE19: 14.8;SK-BR-3: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068049	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA068049: AB_2685945"	"unprognostic (2.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.04e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.18e-1)"	2.5	3.1	1.1	0.5	1.2	1.7	2.1	1.2	1.4	6.5	1.0	4.5	2.0	2.4	0.1	23.4	2.4	0.7	1.4	1.2	0.9	3.7	7.4	4.0	0.3	1.2	1.2	3.2	1.1	0.2	1.9	0.2	1.1	2.8	0.0	0.1	4.2	0.4	0.9	13.9	5.0	0.1	1.0	4.6	2.9	5.8	1.2	0.3	1.7	0.1	0.7	3.3	8.5	1.0	11.6	2.0	0.2	0.4	0.7	0.7	0.5	0.5	0.4	0.5	0.2	0.4	6.0	1.1	0.6	0.2	0.0	13.6	0.0	2.7	0.0	1.2	1.2	1.3	4.3	0.3	0.6	0.5	1.1	0.7	0.7	0.0	0.0	0.0	0.2	0.4	0.6	0.7	0.0	2.8	0.6	0.3	0.0	14.8	1.1	0.7	0.4	1.1	0.7	1.1	0.2	0.3	0.6	30.0	0.7	0.0	1.3	0.9	0.0	0.4	3.9	0.7	1.2	0.5	0.4	0.3	0.5	6.8	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	1.2	1.2	1.4	1.2	0.9	1.2	1.2	1.1	1.0	1.2	1.0	4.0	0.0	4.7	3.9	1.6	2.8	2.2	1.4	4.0	1.4	7.2	4.3	1.5	7.2	2.7	9.2	0.0	1.0	3.7	13.8	1.9	1.3	0.0	1.5	2.9	2.4	1.8	6.1	1.4	0.7	3.4	3.0	6.6	3.0	1.3	3.6	1.1	13.4	5.2	1.7	1.3	4.5	0.0	8.1	3.7	1.3	4.7	6.0	3.6	0.0	3.3	3.5	4.1	0.5	0.3	7.2	6.0	2.6	3.1	2.1	7.3	2.3	0.9	0.3	0.0	2.8	2.3	0.7	7.6	3.2	2.6	1.0	2.6	2.3	8.2	2.8
MRPL2	"CGI-22, MRP-L14, RPML14"	ENSG00000112651	"Mitochondrial ribosomal protein L2"	Q5T653	6	43054029-43059438	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007455, HPA064814"	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA007455: AB_1079410, HPA064814: AB_2685358"	"unprognostic (2.31e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (6.01e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.78e-1)"	26.5	32.4	27.9	12.6	28.8	20.0	26.0	31.0	37.6	23.2	27.9	27.5	25.6	23.5	13.7	24.6	22.2	10.1	48.2	28.3	31.7	33.7	51.2	18.6	13.4	29.8	28.9	24.5	27.1	29.6	29.5	13.3	30.1	22.0	16.8	10.9	22.6	17.6	75.1	25.1	20.3	12.0	27.4	19.9	23.6	19.7	29.0	17.7	26.7	56.7	14.4	22.6	21.4	28.9	47.9	43.1	20.3	39.3	28.4	20.7	38.9	20.4	24.8	47.3	41.3	109.0	15.4	61.8	42.3	24.6	36.2	49.9	50.5	48.7	27.8	30.4	90.9	46.8	34.9	109.5	57.2	43.5	21.0	27.6	51.4	52.5	82.8	22.6	32.6	68.7	84.6	36.6	23.6	84.0	48.1	127.1	22.7	175.7	49.5	59.0	25.1	77.3	38.2	26.3	51.3	27.4	18.2	39.4	73.4	18.6	41.4	73.9	27.3	27.6	40.0	35.7	58.7	47.7	44.9	115.2	21.5	65.2	27.8	17.5	37.8	30.2	28.4	40.9	36.5	46.5	31.8	33.6	54.3	48.6	32.7	32.3	9.8	38.5	33.7	56.1	39.2	31.3	27.9	28.8	31.0	37.6	28.3	31.7	29.8	28.9	30.1	27.4	29.0	28.9	36.8	22.4	18.6	5.5	27.5	24.3	32.0	86.5	19.4	22.7	25.9	30.0	37.5	38.6	48.9	60.7	27.1	74.0	21.3	43.1	185.9	59.1	94.0	30.6	34.1	32.1	30.6	35.3	5.3	53.7	53.1	31.1	30.1	32.5	28.5	43.1	33.2	75.9	49.3	5.0	5.8	44.2	69.2	23.7	26.6	37.0	55.0	22.9	53.4	2.8	41.3	44.7	43.3	2.0	5.5	44.2	51.3	51.6	35.6	31.6	77.6	159.4	40.4	23.4	26.3	32.5	82.7	53.1	41.7	35.7	27.1	63.5	27.2	59.0	65.7	28.7
MRPL21		ENSG00000197345	"Mitochondrial ribosomal protein L21"	Q7Z2W9	11	68891276-68903835	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051657	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA051657: AB_2681565"	"unprognostic (1.80e-1)"	"unprognostic (6.09e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.12e-1)"	43.5	44.4	56.0	34.0	57.3	60.5	52.5	62.8	71.9	45.3	57.7	67.1	38.7	50.4	48.4	58.4	45.2	27.1	120.2	57.6	59.5	68.0	66.1	31.5	43.8	59.5	57.4	48.6	53.6	56.3	44.7	33.1	59.6	44.1	42.5	29.7	99.5	39.1	131.0	50.4	46.0	35.1	56.9	37.0	53.0	47.0	57.9	37.2	44.7	109.1	42.9	49.8	44.9	56.9	105.2	145.6	86.0	82.3	59.1	63.5	101.4	71.8	77.2	132.8	90.4	297.3	132.7	163.5	157.2	78.0	122.0	129.9	143.8	138.6	102.8	109.7	112.6	114.4	102.4	181.0	116.6	201.4	83.4	95.0	69.4	134.1	156.0	64.7	93.7	115.1	229.2	119.4	80.7	196.7	95.5	210.5	78.0	307.6	210.3	135.2	102.9	253.0	134.0	120.8	139.3	111.3	91.1	181.6	302.7	68.7	188.7	115.4	79.3	90.6	90.6	201.3	135.5	88.9	149.5	232.3	120.6	120.4	125.7	79.6	113.0	61.6	72.4	122.8	77.1	162.2	94.5	78.8	124.2	105.8	89.3	74.1	32.1	93.3	114.2	92.0	113.2	114.0	56.0	57.3	62.8	71.9	57.6	59.5	59.5	57.4	59.6	56.9	57.9	56.9	38.9	35.3	38.7	5.5	47.4	50.2	76.8	145.1	68.9	36.3	56.5	65.4	179.8	67.2	82.0	80.9	8.4	122.8	34.6	127.7	299.3	106.7	176.9	72.2	59.8	50.4	61.7	56.0	5.6	105.3	114.8	53.9	42.8	63.0	65.2	31.8	40.7	115.9	110.4	11.8	6.4	115.6	85.5	56.3	41.3	227.3	74.9	47.0	78.2	1.0	69.8	69.0	34.0	2.0	5.1	86.3	93.0	72.2	63.8	79.6	150.6	272.9	72.8	51.4	26.3	59.3	85.8	86.6	60.5	83.2	51.9	81.3	44.2	55.0	141.6	75.0
MRPL43	bMRP36a	ENSG00000055950	"Mitochondrial ribosomal protein L43"	Q8N983	10	100969458-100987515	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073022			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA073022: "	"unprognostic (2.65e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.11e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.53e-2)"	58.5	84.9	26.4	21.0	30.2	25.4	61.6	34.0	37.7	63.3	27.6	69.2	28.6	56.3	7.4	63.7	57.7	18.9	65.2	25.0	27.9	79.4	82.8	45.0	23.6	30.1	29.0	71.4	76.3	27.5	51.7	21.7	30.4	62.5	6.9	9.2	65.7	30.8	117.9	71.8	50.7	7.5	30.5	50.7	68.1	41.1	27.7	12.5	65.3	18.2	7.4	66.5	57.5	34.3	102.5	113.6	23.3	41.5	24.0	30.6	72.4	69.7	62.2	52.9	53.4	65.1	78.0	87.1	92.8	29.3	28.9	62.8	8.5	58.1	7.0	66.4	146.1	68.9	76.6	102.6	51.1	55.1	53.2	47.8	44.6	45.1	19.8	25.2	50.0	54.7	34.9	43.3	16.3	107.7	51.4	124.5	37.9	27.7	105.8	54.7	77.8	59.4	29.4	51.9	26.1	67.6	51.0	24.5	80.7	7.5	130.9	26.1	62.4	49.4	65.9	53.4	74.4	89.9	73.5	44.5	63.1	101.5	36.4	100.4	62.2	70.8	58.0	58.8	59.4	67.1	63.5	57.7	69.7	62.8	59.9	54.9	20.9	72.3	58.7	54.3	77.0	68.0	26.4	30.2	34.0	37.7	25.0	27.9	30.1	29.0	30.4	30.5	27.7	34.3	84.3	44.8	49.6	9.8	64.5	55.7	70.6	97.2	60.3	44.0	93.6	130.8	34.3	88.6	74.7	75.4	41.7	135.3	63.7	47.2	180.0	101.1	114.1	74.3	53.2	58.8	61.1	52.6	8.9	127.2	140.6	68.9	53.5	44.5	46.9	64.8	69.3	75.7	98.4	18.5	13.4	77.7	67.1	51.5	43.6	51.5	85.4	47.6	64.0	7.5	67.6	91.5	71.1	12.1	31.0	91.0	77.4	73.7	70.8	72.0	94.3	221.0	79.7	62.4	52.6	66.1	82.2	277.1	76.6	82.6	68.5	103.7	61.6	98.1	80.6	79.2
MRPL44	"FLJ12701, FLJ13990"	ENSG00000135900	"Mitochondrial ribosomal protein L44"	Q9H9J2	2	223957463-223967714	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038147, HPA038148"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Mitochondria"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"HPA038147: AB_10671521, HPA038148: AB_2675863"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.33e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-1)"	16.2	26.9	16.2	14.9	17.4	45.4	17.6	17.1	20.3	12.9	19.0	21.8	19.3	12.7	13.2	18.0	16.3	17.5	33.8	17.1	18.8	37.4	39.3	12.5	32.5	16.2	16.1	15.2	17.4	19.7	11.6	20.0	16.8	15.3	22.9	10.0	16.1	13.2	42.6	15.7	17.9	14.4	17.5	17.8	16.2	18.2	17.8	21.4	16.2	40.6	26.5	17.1	11.5	17.9	27.3	22.6	33.1	38.3	30.6	36.1	52.4	30.0	33.6	48.0	50.4	81.0	33.4	41.1	31.9	26.0	43.9	35.3	54.5	41.5	44.1	39.0	38.7	45.0	24.0	64.4	44.9	50.0	33.1	42.5	50.9	29.1	38.7	40.4	47.8	41.4	43.7	31.6	38.9	31.9	37.8	62.9	49.4	54.8	23.6	43.8	40.6	25.5	64.3	22.8	45.0	25.7	22.0	49.0	74.8	48.6	41.4	71.2	31.5	31.8	24.7	27.3	24.5	34.5	25.9	58.7	32.2	47.4	35.6	55.7	44.5	35.3	28.5	44.8	36.5	45.9	30.4	34.4	42.2	42.3	36.5	32.3	58.1	33.8	41.2	33.9	33.7	36.3	16.2	17.4	17.1	20.3	17.1	18.8	16.2	16.1	16.8	17.5	17.8	17.9	11.7	6.4	13.1	3.9	31.3	17.8	27.4	52.6	23.9	17.3	15.6	17.4	10.4	27.1	30.0	27.6	0.0	95.3	29.5	25.0	82.2	45.3	8.1	17.1	22.3	20.7	13.1	26.5	6.5	35.1	64.8	24.9	14.3	26.6	18.4	22.0	20.7	51.5	46.6	11.8	6.9	22.0	48.8	33.3	14.5	7.9	18.0	25.4	33.8	4.7	35.3	16.5	20.6	7.5	9.7	37.2	18.1	18.0	24.8	21.7	23.6	106.1	25.6	12.7	19.7	14.2	18.8	41.1	56.3	22.8	16.6	48.7	20.9	40.9	28.3	37.6
MRPL46	"C15orf4, LIECG2, P2ECSL"	ENSG00000259494	"Mitochondrial ribosomal protein L46"	Q9H2W6	15	88459477-88467390	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Proximal tubular cells: 133.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050166, HPA076046"	Approved		Supported	"Nucleoplasm,Cell Junctions,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cell Junctions"	"HPA050166: AB_2681039, HPA076046: "	"unprognostic (1.42e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (2.09e-6)"	"unprognostic (7.73e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.63e-1)"	25.1	51.5	20.3	12.9	21.7	11.3	22.7	23.7	25.4	14.6	22.0	24.2	20.0	17.1	18.2	26.4	17.1	13.0	76.1	20.8	23.6	34.7	70.9	12.7	20.9	23.1	22.1	17.2	16.2	24.6	16.2	19.6	23.6	14.9	23.6	16.8	17.1	15.2	73.3	17.9	19.7	18.4	21.7	19.1	24.8	28.1	22.7	18.9	17.2	84.6	20.3	20.7	16.2	22.6	27.8	87.2	27.2	29.8	38.0	28.6	51.5	38.6	35.5	56.9	50.4	108.6	59.3	64.9	38.6	34.9	51.0	65.9	107.4	47.4	44.8	26.3	86.4	53.6	61.5	114.3	24.6	54.2	40.4	32.7	56.6	42.8	28.7	29.0	50.2	63.2	60.7	26.6	42.7	59.6	44.2	68.4	43.5	50.5	52.9	51.9	37.9	49.2	44.5	88.2	42.1	26.5	36.6	57.7	81.8	44.6	64.8	65.7	31.3	44.0	41.9	23.3	56.4	24.2	55.7	53.0	48.5	58.1	34.2	27.1	45.5	33.7	60.0	60.5	69.6	78.8	63.3	58.7	58.7	69.5	69.5	61.6	7.9	62.9	45.0	50.5	68.0	61.5	20.3	21.7	23.7	25.4	20.8	23.6	23.1	22.1	23.6	21.7	22.7	22.6	18.9	0.0	10.3	5.2	21.0	13.8	22.4	59.8	9.6	21.2	17.3	21.3	70.4	37.1	32.3	36.8	27.1	94.3	10.7	20.4	119.3	35.0	67.1	20.0	16.6	18.4	28.3	17.7	4.2	38.0	42.1	19.2	19.9	19.5	22.2	25.8	17.2	105.0	35.6	15.2	5.9	20.6	44.7	13.4	5.5	16.3	14.3	10.8	7.2	3.7	42.1	25.1	20.6	4.5	6.1	31.7	18.4	18.8	17.3	21.9	32.1	133.6	26.2	28.4	26.3	19.5	25.5	55.3	27.4	27.1	23.3	80.7	18.5	66.9	36.1	29.4
MRPL52		ENSG00000172590	"Mitochondrial ribosomal protein L52"	Q86TS9	14	22829879-22835037	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 549.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012319	Approved		Supported	Nucleoplasm,Mitochondria		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA012319: AB_1854118"	"unprognostic (8.98e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.41e-1)"	76.5	105.6	106.9	53.7	109.6	51.9	72.4	113.6	130.8	66.5	109.4	88.3	70.0	72.8	30.8	141.6	61.0	20.6	193.7	107.7	110.4	130.8	154.2	73.5	41.7	113.4	109.8	59.9	108.7	70.6	70.1	32.9	113.6	83.5	33.9	15.2	79.6	35.6	155.2	96.6	77.7	25.6	111.5	96.3	113.4	67.7	112.0	62.0	83.2	55.4	41.3	85.0	78.2	112.9	237.5	181.4	97.4	121.4	59.3	69.1	236.8	161.2	115.0	140.8	133.4	224.1	321.9	178.8	172.5	111.3	143.4	210.8	79.8	223.4	105.6	190.8	132.6	133.6	65.6	518.5	180.3	211.9	183.6	104.8	150.4	182.7	154.5	111.2	226.6	222.7	139.4	172.8	104.6	329.2	172.5	320.0	180.1	292.5	397.5	210.2	121.5	210.4	149.9	138.7	96.8	125.1	124.5	120.6	178.3	68.9	116.0	198.9	176.5	146.4	172.0	185.1	249.2	169.4	219.1	228.0	133.3	143.3	239.6	101.5	111.2	60.2	74.5	128.9	69.5	140.9	82.2	68.2	159.1	111.6	75.9	74.2	19.1	74.5	96.4	131.3	100.7	98.5	106.9	109.6	113.6	130.8	107.7	110.4	113.4	109.8	113.6	111.5	112.0	112.9	105.5	73.7	85.4	5.2	132.5	121.2	88.0	169.2	98.4	23.2	131.2	145.2	103.4	167.3	118.0	136.1	18.8	177.3	82.5	220.9	277.8	245.2	72.4	106.5	89.8	104.4	138.0	112.5	5.7	314.5	287.7	65.8	165.1	116.3	123.0	70.5	106.4	291.0	236.2	20.2	6.2	268.0	107.8	140.2	125.1	58.3	55.9	120.1	124.5	6.5	221.5	80.4	107.1	5.5	9.1	396.9	215.6	49.2	156.4	111.8	313.7	549.8	99.9	33.7	65.7	70.7	147.7	135.4	105.3	190.8	149.2	126.0	85.0	80.3	233.8	98.8
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 60.1;Distal tubular cells: 56.7;Ductal cells: 50.9;Exocrine glandular cells: 60.3;Hofbauer cells: 48.1;Pancreatic endocrine cells: 53.7;Proximal tubular cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003634, HPA076987"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nucleoplasm, Plasma membrane"	"HPA003634: AB_1851388, HPA076987: "	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	22.7	36.3	22.1	18.0	22.8	22.8	24.6	24.4	23.0	17.1	31.9	25.9	19.1	19.4	18.2	32.1	17.5	13.1	49.1	21.9	23.6	34.7	47.2	16.3	24.4	23.4	22.6	14.2	27.4	25.0	14.0	19.3	23.4	18.6	22.8	11.2	21.8	18.6	79.0	28.4	21.7	18.8	23.3	21.6	26.0	10.5	22.9	18.3	18.7	50.3	23.8	24.5	19.9	24.5	81.1	111.4	36.5	42.1	38.3	37.9	50.5	46.7	50.7	95.7	80.7	86.3	49.5	56.0	37.3	46.8	58.9	56.3	75.6	80.7	100.2	28.1	87.7	43.8	50.5	72.2	72.5	92.5	28.8	40.9	37.8	63.3	101.0	32.3	73.8	57.0	71.7	39.9	54.8	100.9	80.7	63.4	27.5	125.3	147.1	41.2	64.8	81.2	71.1	58.5	33.5	64.1	40.3	72.5	92.9	46.7	97.5	75.6	31.6	50.8	56.0	54.3	89.7	41.0	34.8	63.2	58.5	102.5	43.5	26.6	41.2	21.4	30.8	40.9	27.1	33.8	38.0	31.4	55.3	29.3	27.8	31.1	4.0	42.2	36.1	37.2	67.2	42.5	22.1	22.8	24.4	23.0	21.9	23.6	23.4	22.6	23.4	23.3	22.9	24.5	18.8	32.1	8.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	22.5	32.8	0.0	0.0	8.1	25.8	0.0	60.1	11.4	0.0	56.7	50.9	0.0	29.3	18.3	8.4	0.0	0.0	0.0	60.3	40.5	8.9	0.0	19.0	1.3	22.3	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.8	0.0	0.0	121.1	21.1	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	29.1	7.4	43.5	0.0	0.0
MRTFA	"BSAC, KIAA1438, MAL, MKL, MKL1, MRTF-A"	ENSG00000196588	"Myocardin related transcription factor A"	Q969V6	22	40410281-40636719	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Actin-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.5;Cardiomyocytes: 8.7;Cytotrophoblasts: 8.9;Extravillous trophoblasts: 8.7;Fibroblasts: 4.3;Hofbauer cells: 12.7;Syncytiotrophoblasts: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 189.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 93.1;granulocytes: 189.4;monocytes: 58.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030782	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA030782: AB_10600930"	"unprognostic (7.90e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (9.05e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.98e-1)"	21.1	15.4	15.8	27.3	18.0	80.7	19.9	10.9	22.8	25.5	12.3	20.8	11.7	33.1	7.3	16.6	22.6	11.7	21.3	20.2	10.0	14.6	12.3	24.5	27.5	9.3	8.7	20.9	16.1	8.9	13.8	18.3	7.9	19.4	8.8	11.1	18.2	15.2	19.1	24.4	18.6	16.3	6.7	29.7	19.1	35.9	9.5	21.7	22.1	8.0	22.8	22.0	19.6	15.3	26.5	33.9	14.5	17.5	21.6	15.9	27.8	25.6	16.6	23.1	22.8	19.1	7.9	27.2	10.2	27.0	20.3	35.5	12.7	31.9	13.8	32.0	29.2	46.3	39.9	24.7	17.8	53.5	79.8	15.5	36.7	22.4	15.1	17.5	18.3	15.0	12.9	12.3	11.5	25.3	20.7	57.4	11.7	14.2	12.1	35.4	17.5	16.4	16.9	22.1	8.7	8.7	43.7	19.4	13.8	18.3	16.0	59.0	27.8	14.7	38.7	21.4	20.9	16.1	16.5	39.1	12.1	25.6	26.5	49.0	53.5	189.4	18.5	43.7	16.9	13.0	15.8	13.6	64.3	18.6	21.1	18.1	57.2	16.8	58.8	93.1	22.0	34.2	15.8	18.0	10.9	22.8	20.2	10.0	9.3	8.7	7.9	6.7	9.5	15.3	4.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	8.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	8.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	7.8	0.6	0.0	0.0	0.0
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251805-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	18.9	18.5	17.0	16.8	17.1	13.4	20.2	14.8	17.9	13.0	13.7	13.5	16.8	15.8	12.9	23.7	17.6	8.9	14.4	17.4	16.1	17.9	20.3	11.1	20.0	15.8	16.0	17.0	23.4	12.5	8.9	12.1	16.1	12.9	16.5	7.2	12.3	10.5	22.7	17.4	19.5	16.7	15.4	13.8	15.5	14.0	16.1	14.8	11.1	11.4	22.8	21.4	14.1	16.4	90.9	65.9	51.1	67.0	24.2	38.6	44.7	69.0	38.9	116.7	76.1	92.9	92.0	133.6	56.7	60.5	50.4	70.1	142.7	104.6	114.0	47.4	109.6	98.4	55.4	80.8	30.3	133.4	38.7	34.0	69.8	131.6	69.6	31.7	66.1	59.0	151.1	42.3	68.9	68.0	106.3	96.5	65.0	95.6	95.4	99.3	62.7	100.5	64.8	31.3	82.9	59.2	54.0	73.0	75.4	37.6	50.8	76.5	44.2	61.9	77.5	97.6	118.0	33.8	64.3	178.2	61.2	172.4	102.5	1.4	11.6	1.3	11.4	12.7	22.9	23.1	13.7	15.9	17.6	19.7	18.4	16.7	1.4	16.6	10.2	19.7	10.6	11.4	17.0	17.1	14.8	17.9	17.4	16.1	15.8	16.0	16.1	15.4	16.1	16.4	30.0	6.4	14.5	6.2	31.2	37.3	59.1	45.8	42.7	20.4	23.6	37.7	10.3	38.6	26.4	7.3	10.4	50.4	14.9	15.7	41.1	61.8	23.3	19.1	46.8	32.1	21.6	31.3	8.4	55.0	69.9	29.5	19.4	21.1	26.0	36.8	15.4	16.3	47.1	15.2	7.3	25.4	36.7	13.3	18.2	36.5	23.0	21.0	19.6	1.9	32.0	25.7	16.5	4.5	4.3	57.5	17.0	20.3	29.0	57.4	6.0	37.9	15.8	16.4	19.7	44.8	35.9	55.6	49.7	48.2	33.5	26.0	18.6	58.1	34.8	36.7
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.0"	"Group enriched"	"Detected in some"	44	"Early spermatids: 262.3;Late spermatids: 672.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.5;non-classical monocyte: 8.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 8.0"	"Cell line enriched"	"Detected in single"	23	"THP-1: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058973	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	5.1	3.7	6.2	3.5	5.6	0.6	3.6	5.8	8.8	1.2	7.5	2.7	0.7	0.9	0.6	0.9	1.3	0.9	2.6	5.8	6.3	1.8	2.0	11.9	1.3	7.7	6.8	0.7	1.3	0.3	1.5	2.4	7.2	1.8	1.1	0.4	1.9	0.5	0.9	0.9	2.7	1.2	6.0	10.4	1.2	73.0	8.5	0.3	1.5	0.3	1.9	2.0	1.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.4	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.9	6.2	5.6	5.8	8.8	5.8	6.3	7.7	6.8	7.2	6.0	8.5	8.0	0.2	0.0	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	262.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	7.3	5.5	672.0	4.1	10.4	0.0	3.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.7	0.0	6.6	0.1	0.0	6.5	3.4	0.0	0.3	0.1	0.1	0.0	0.0	0.0
MSANTD2	"C11orf61, FLJ23342"	ENSG00000120458	"Myb/SANT DNA binding domain containing 2"	Q6P1R3	11	124766498-124800706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 33.5;Microglial cells: 31.9;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038694, HPA038695"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Nucleoplasm	"HPA038694: AB_2676155, HPA038695: AB_10674693"	"unprognostic (2.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.77e-4)"	"unprognostic (4.77e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.65e-4)"	9.8	6.3	8.0	3.8	9.0	0.7	9.9	8.2	10.8	16.2	8.5	10.2	4.0	11.5	7.5	7.5	12.8	2.8	7.2	7.4	8.6	19.1	8.3	9.3	4.5	8.4	8.6	14.1	14.2	3.2	15.3	5.1	8.6	13.5	3.8	5.9	9.3	4.0	4.7	8.4	10.1	2.8	7.8	13.7	10.5	4.7	8.4	3.4	25.3	1.9	3.9	9.4	11.4	10.9	3.0	0.9	10.5	9.9	5.2	6.7	6.1	6.4	3.6	2.3	3.0	4.3	6.2	3.5	5.9	3.3	3.4	5.5	4.5	2.1	3.6	5.8	4.0	3.3	3.9	4.5	2.6	1.9	2.7	3.4	3.8	4.0	3.3	9.1	5.3	3.0	3.9	4.7	5.8	2.6	1.4	9.4	8.0	5.5	14.4	4.2	2.6	3.3	4.4	2.6	3.3	13.0	2.9	3.7	1.9	7.7	8.6	2.1	6.8	15.4	4.3	4.5	6.4	3.0	2.2	2.1	3.2	3.4	8.0	0.0	0.2	0.6	0.6	0.4	0.3	0.3	0.5	0.9	0.3	0.8	0.5	0.4	0.0	0.2	0.5	0.2	1.1	0.2	8.0	9.0	8.2	10.8	7.4	8.6	8.4	8.6	8.6	7.8	8.4	10.9	10.9	3.2	10.3	28.7	7.7	8.8	4.4	2.5	9.6	8.7	6.7	6.7	3.3	5.7	1.8	7.3	2.1	2.9	7.7	3.4	3.9	4.6	5.2	3.2	11.1	9.4	1.2	1.3	33.5	1.0	4.4	10.1	6.6	5.6	1.3	9.0	10.4	3.0	3.0	13.5	30.6	3.1	4.1	3.8	7.3	1.5	9.6	4.1	1.8	31.9	4.4	5.6	8.2	33.7	48.4	4.6	4.0	7.2	4.3	5.0	2.2	3.6	2.9	6.2	13.1	11.3	14.0	2.4	1.6	4.4	4.1	1.9	5.8	7.3	5.0	3.2
MSANTD3	"C9orf30, MGC17337"	ENSG00000066697	"Myb/SANT DNA binding domain containing 3"	Q96H12	9	100427143-100451734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062662			Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA062662: AB_2684826"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.66e-5)"	"prognostic unfavorable (3.23e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.61e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (3.22e-7)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.16e-2)"	12.3	11.3	8.6	13.7	8.6	13.2	10.0	11.4	15.0	12.1	5.1	14.3	6.8	14.3	8.3	10.0	8.2	14.0	18.9	9.6	9.7	15.5	13.8	15.2	7.4	9.3	10.7	8.8	11.3	11.4	10.1	10.5	9.4	10.8	6.6	8.4	9.8	9.2	22.4	8.1	8.2	14.3	6.5	6.4	11.0	5.9	8.6	9.0	12.9	27.5	8.3	16.3	10.5	13.8	54.0	47.3	30.2	34.2	44.3	50.8	38.7	74.8	72.6	66.6	47.1	28.6	48.5	31.4	37.4	65.6	154.1	60.0	19.8	68.6	73.6	47.6	15.3	14.6	34.8	22.3	46.7	21.8	18.4	22.8	28.6	58.5	108.5	60.9	75.9	25.4	26.0	11.6	92.3	35.2	29.5	14.3	49.4	53.7	74.7	34.4	85.4	9.7	63.3	14.0	39.6	46.2	25.4	22.4	63.9	36.6	10.0	24.6	91.3	93.7	115.7	71.6	116.1	17.0	34.2	14.7	130.7	13.6	72.9	8.0	0.4	2.3	2.6	0.2	3.8	2.6	2.3	3.2	1.0	2.7	2.8	2.4	0.3	3.6	0.1	0.6	2.0	1.7	8.6	8.6	11.4	15.0	9.6	9.7	9.3	10.7	9.4	6.5	8.6	13.8	17.3	16.0	4.2	0.7	4.6	5.9	9.6	9.3	22.2	16.5	7.5	9.1	17.6	8.6	6.7	7.3	2.1	33.3	7.7	1.7	31.3	27.7	1.7	12.5	22.0	16.1	9.6	10.3	4.3	24.5	13.9	16.8	5.6	16.0	3.8	12.9	12.5	10.1	10.6	20.2	4.2	3.7	6.1	2.6	7.7	4.3	7.5	17.8	7.2	1.0	24.5	14.5	7.2	2.5	2.8	49.6	4.6	8.6	5.5	7.6	1.5	9.3	6.3	7.9	6.6	19.1	17.7	2.9	12.8	12.6	4.3	10.8	8.1	7.9	5.7	5.9
MSANTD4	KIAA1826	ENSG00000170903	"Myb/SANT DNA binding domain containing 4 with coiled-coils"	Q8NCY6	11	105995623-106022403	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 48.3;Muller glia cells: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014411	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA014411: AB_2668995"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.04e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.90e-1)"	8.4	10.1	11.7	8.4	13.4	3.2	8.3	15.5	16.0	11.7	6.6	7.1	5.2	11.6	6.9	8.8	7.4	7.1	15.8	12.4	11.3	9.5	7.0	8.5	9.9	11.9	12.0	10.8	9.6	8.2	9.7	7.3	10.4	9.6	6.2	33.3	7.3	12.0	11.9	4.4	5.8	10.6	9.5	8.5	7.2	10.3	12.7	8.3	13.4	16.6	10.0	8.8	5.6	15.2	8.3	12.0	26.6	0.2	28.4	31.2	0.2	23.1	31.7	17.7	22.5	21.2	15.9	18.1	38.3	19.6	19.5	21.0	30.1	14.8	22.0	33.3	14.5	35.5	14.3	13.2	42.6	28.0	26.9	21.3	17.8	24.0	47.2	22.1	16.0	19.2	16.8	11.4	26.3	3.4	26.4	14.0	10.3	12.3	24.3	17.7	34.4	26.1	24.3	10.2	17.5	33.5	6.1	20.8	16.8	16.4	16.5	14.2	23.0	26.1	20.3	13.8	23.5	11.3	13.9	9.5	12.1	11.0	19.4	2.4	5.7	3.2	8.7	8.7	8.6	6.5	7.8	6.2	7.2	7.5	9.2	8.0	1.4	8.5	5.2	6.1	6.4	5.4	11.7	13.4	15.5	16.0	12.4	11.3	11.9	12.0	10.4	9.5	12.7	15.2	5.8	16.0	15.4	16.6	6.9	5.4	3.3	6.4	6.2	48.3	6.2	6.3	25.1	10.0	14.4	3.7	20.9	1.6	6.2	2.4	1.9	6.7	39.0	6.6	16.8	8.3	8.4	2.5	8.6	5.8	1.3	13.0	5.6	7.2	6.3	11.9	6.1	6.2	5.3	37.0	10.3	3.3	8.2	9.5	5.3	16.0	14.0	6.2	12.4	5.6	8.8	140.7	8.2	31.7	17.3	6.5	1.0	9.8	6.4	2.0	1.8	10.2	9.0	20.1	0.0	15.0	8.2	12.3	6.9	6.1	5.8	0.3	7.4	10.8	3.2	1.5
MSC	"ABF-1, bHLHa22"	ENSG00000178860	Musculin	O60682	8	71841560-71844412	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 40.9;Fibroblasts: 31.4;Leydig cells: 42.6;Melanocytes: 26.6;monocytes: 50.7;Pancreatic endocrine cells: 27.5;Peritubular cells: 41.3;Sertoli cells: 26.3;Skeletal myocytes: 70.0;Smooth muscle cells: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 25.8"	"Group enriched"	"Detected in many"	37	"B-cells: 6.9;dendritic cells: 6.4;T-cells: 25.8"	"Cell line enriched"	"Detected in many"	15	"HDLM-2: 819.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"cerebral cortex: 16.3;hippocampal formation: 13.2"	HPA062878			Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA062878: AB_2684891"	"unprognostic (2.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.07e-13)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.40e-2)"	13.3	8.9	2.5	11.4	1.2	3.9	7.0	0.4	4.5	6.7	0.9	3.0	2.2	4.8	0.9	3.1	4.2	11.1	19.9	5.9	0.6	6.3	3.6	9.5	12.1	3.1	0.7	5.1	5.2	0.3	3.3	16.3	1.0	5.5	1.1	0.0	4.3	3.1	3.0	3.5	5.3	2.3	0.6	6.4	5.4	3.0	0.7	1.6	4.4	2.4	3.5	20.5	6.5	2.8	0.1	6.2	0.0	0.0	28.1	4.9	0.0	1.2	23.8	0.5	1.3	0.0	0.0	0.0	0.3	4.8	28.5	1.3	0.0	1.5	0.0	819.3	0.3	0.0	0.0	0.0	49.8	0.0	2.8	11.1	0.0	49.2	30.1	11.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	55.3	0.0	0.0	0.0	2.4	0.0	0.1	0.0	44.9	0.5	0.0	5.5	0.0	0.2	0.1	7.8	0.3	5.0	0.2	0.1	20.4	0.1	34.5	0.0	0.1	0.0	5.2	0.1	7.2	6.9	9.2	25.8	0.1	6.2	0.2	8.7	0.2	0.0	0.3	6.4	13.0	3.2	2.5	1.2	0.4	4.5	5.9	0.6	3.1	0.7	1.0	0.6	0.7	2.8	1.2	0.0	0.0	0.0	2.7	5.1	0.2	0.4	0.0	0.0	0.2	0.3	1.9	0.0	0.0	1.8	0.0	0.1	4.3	0.0	0.0	16.1	0.6	0.3	1.0	4.5	0.0	0.0	1.1	40.9	0.1	31.4	1.5	0.1	0.0	0.0	3.9	0.0	1.8	0.0	0.1	0.0	0.0	0.3	8.9	1.5	42.6	5.8	26.6	0.0	50.7	0.0	0.0	0.0	0.2	27.5	0.0	41.3	7.0	0.7	0.0	1.2	0.0	0.0	26.3	70.0	27.8	0.4	0.3	0.3	3.3	0.0	10.0	8.1	0.0	0.3
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47403067-47663146	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 46.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes		28000	"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	8.1	7.5	8.3	12.8	10.5	15.7	15.7	14.6	10.6	9.7	12.2	11.9	7.8	11.7	14.0	9.5	12.4	5.8	10.1	9.6	9.0	8.2	6.7	8.1	23.7	8.6	8.0	8.7	6.5	14.8	6.2	11.6	9.5	8.6	15.0	34.9	8.5	7.7	7.1	11.1	9.3	8.8	8.5	10.8	8.1	16.2	7.9	32.6	15.8	7.2	25.0	7.9	6.4	8.9	114.3	35.3	103.3	57.9	7.3	21.2	64.3	62.9	33.3	80.9	76.9	72.3	50.1	141.2	84.6	23.8	56.6	49.8	78.6	37.4	122.3	68.1	55.8	99.3	42.3	65.6	7.7	97.7	34.9	12.3	11.2	68.1	19.0	19.1	45.2	3.9	165.1	34.0	63.1	44.2	119.6	75.4	195.7	69.3	45.1	151.1	182.2	84.4	35.8	57.3	85.9	91.6	58.4	49.2	48.0	83.6	46.9	38.8	18.7	55.5	70.9	57.1	74.6	20.8	63.4	180.1	33.1	72.5	35.4	3.0	1.3	4.9	8.0	4.4	9.3	6.7	7.7	10.3	2.5	7.9	12.6	13.1	1.0	14.2	3.9	3.4	11.8	6.5	8.3	10.5	14.6	10.6	9.6	9.0	8.6	8.0	9.5	8.5	7.9	8.9	14.7	9.6	11.5	18.6	13.0	8.3	7.9	14.4	8.6	17.4	7.5	7.1	15.6	5.7	12.6	9.2	45.9	19.9	14.2	6.6	3.9	11.5	17.8	21.0	11.3	13.4	3.5	54.1	59.9	8.4	20.7	12.2	7.1	18.8	12.0	28.2	5.0	1.6	11.4	11.8	58.0	12.1	14.2	4.1	4.6	22.8	5.3	5.1	8.8	16.9	5.5	22.6	17.5	35.7	54.7	7.3	5.0	6.4	12.4	2.8	5.4	4.5	23.3	41.1	0.0	9.8	9.0	56.5	50.8	9.3	6.5	5.1	12.8	24.3	13.5	3.8
MSH6	GTBP	ENSG00000116062	"MutS homolog 6"	P52701	2	47695530-47810063	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 119.6;Theca cells: 114.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009091, HPA028376, HPA028446, CAB070870"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes		15000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182"	"unprognostic (5.10e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.48e-2)"	11.7	22.7	9.3	17.7	13.7	24.0	16.2	15.0	12.7	15.5	12.7	13.0	9.0	27.7	10.2	11.7	17.8	10.9	9.3	8.9	11.5	12.1	19.8	11.6	28.4	12.7	11.7	53.0	31.3	17.0	9.8	20.3	13.0	15.0	12.4	21.6	10.8	15.6	10.5	13.1	9.8	27.2	10.7	12.7	10.9	35.3	11.3	36.3	17.2	11.2	31.0	12.8	12.2	19.9	116.5	77.6	128.4	37.5	42.3	46.3	67.9	63.6	51.1	60.2	59.8	67.2	41.4	158.1	84.5	59.5	82.0	46.0	130.3	74.3	82.1	80.7	69.0	117.0	60.8	71.1	28.8	131.5	37.8	38.6	28.3	60.7	41.6	53.8	40.8	5.3	115.9	69.8	61.8	85.5	144.2	80.1	130.7	81.3	37.7	219.6	204.3	84.7	44.5	76.2	92.8	100.3	79.1	40.4	42.7	124.3	54.6	42.6	33.4	72.2	92.3	54.6	80.6	63.8	79.3	276.2	61.9	77.9	42.4	7.7	3.7	3.8	4.8	6.2	5.5	4.3	5.5	5.0	5.5	4.2	8.4	4.5	2.5	5.9	6.4	2.7	5.3	3.6	9.3	13.7	15.0	12.7	8.9	11.5	12.7	11.7	13.0	10.7	11.3	19.9	19.8	28.9	21.4	5.9	19.2	25.2	22.0	12.3	31.9	25.4	14.4	15.1	8.6	2.8	21.8	7.3	35.5	35.6	20.7	7.4	3.9	15.7	46.4	27.1	31.1	18.4	4.8	47.1	8.5	9.6	21.8	24.0	8.6	31.7	17.7	119.6	13.6	10.2	13.0	15.2	12.1	9.7	20.3	5.6	13.2	17.5	25.4	16.8	3.6	7.5	10.0	22.7	8.2	9.5	27.4	9.1	3.7	22.6	31.1	16.1	2.6	6.7	22.1	31.4	6.6	27.4	33.0	54.3	48.8	22.0	17.5	9.6	19.8	114.9	12.1	11.7
MSI1		ENSG00000135097	"Musashi RNA binding protein 1"	O43347	12	120341330-120369164	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 104.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Early spermatids: 55.4;Late spermatids: 58.2;Muller glia cells: 82.4;Rod photoreceptor cells: 109.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 119.7;HAP1: 55.3;NTERA-2: 62.6;SCLC-21H: 88.4;SH-SY5Y: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074923, HPA075573"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA074923: , HPA075573: "	"unprognostic (1.21e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	0.5	5.1	11.3	0.3	10.6	0.1	0.8	8.8	11.6	3.2	18.2	1.5	6.1	3.5	1.1	0.9	2.6	0.9	3.3	11.6	10.7	1.0	0.6	0.5	0.3	13.0	13.3	1.8	5.0	1.5	13.7	0.9	9.9	4.0	1.0	104.3	0.7	1.7	22.5	0.7	4.1	1.4	11.0	0.3	4.3	16.2	11.9	0.0	0.8	0.1	0.0	0.5	1.1	8.4	0.1	1.4	119.7	30.5	0.0	0.0	15.2	0.1	0.0	0.8	1.3	21.7	0.6	0.1	1.7	0.0	0.7	0.4	55.3	0.0	0.4	0.6	12.6	0.1	0.5	2.6	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	16.2	0.2	0.3	62.6	0.6	0.7	0.3	0.0	0.5	0.0	0.1	88.4	42.9	0.1	1.0	1.0	11.4	18.5	0.1	0.1	0.5	15.9	0.2	0.1	1.6	0.5	0.2	0.3	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	10.6	8.8	11.6	11.6	10.7	13.0	13.3	9.9	11.0	11.9	8.4	0.1	0.0	0.0	23.8	0.0	1.0	1.4	0.0	1.8	18.4	4.8	2.8	3.3	0.0	0.0	0.0	54.2	0.2	0.0	1.1	1.9	1.2	55.4	3.8	2.1	1.3	10.1	0.0	1.1	5.2	0.6	2.0	0.0	3.5	0.0	1.2	0.0	0.0	0.1	3.3	2.5	3.5	0.0	0.0	0.4	58.2	0.3	0.1	0.0	1.9	0.6	82.4	0.0	9.5	0.5	1.2	12.0	0.4	0.0	8.3	1.2	0.0	0.0	109.9	13.1	4.6	3.2	7.6	3.1	0.1	0.0	0.4	0.1	0.1	8.6	0.6
MSL1	"DKFZp686P24239, hMSL1, MSL-1"	ENSG00000188895	"MSL complex subunit 1"	Q68DK7	17	40121971-40136917	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 8.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 358.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022800, HPA023567"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA022800: AB_1853057, HPA023567: AB_1853059"	"unprognostic (1.94e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (2.92e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.61e-2)"	60.2	52.0	34.3	48.0	33.6	56.7	56.7	26.1	39.6	76.6	16.1	62.7	51.7	75.1	55.9	48.1	77.5	38.6	46.8	32.1	26.5	57.1	43.9	61.5	50.8	24.1	25.7	58.3	59.3	47.8	78.8	48.5	22.2	59.8	46.8	41.1	56.5	51.9	63.6	60.8	61.6	53.7	21.8	88.2	57.1	66.2	27.9	62.3	79.8	51.6	51.6	53.3	62.0	27.7	35.9	42.2	88.3	57.9	78.5	67.6	45.0	61.6	65.3	76.1	68.4	42.4	37.8	78.8	45.6	65.0	48.4	65.2	74.7	40.5	78.2	68.0	59.6	43.6	60.5	50.6	40.9	59.7	81.6	56.9	63.6	56.1	46.5	77.4	71.0	47.2	69.3	62.8	61.4	22.8	95.0	64.8	37.6	39.4	27.2	77.1	48.7	72.1	55.4	38.9	80.9	48.0	57.5	358.8	46.5	80.1	83.5	81.0	58.7	51.0	56.4	37.8	52.3	98.5	58.5	77.7	52.0	43.7	60.7	0.0	1.0	0.8	1.7	0.6	0.8	1.1	0.9	1.3	0.7	0.9	0.9	0.8	8.7	0.7	0.8	1.4	0.6	0.5	34.3	33.6	26.1	39.6	32.1	26.5	24.1	25.7	22.2	21.8	27.9	27.7	44.1	28.9	40.7	42.7	22.7	50.0	37.8	21.7	69.4	55.2	41.6	32.3	29.5	25.8	25.8	11.0	12.5	15.4	43.8	36.4	3.9	17.2	16.1	35.8	53.9	43.3	31.2	22.3	39.8	20.7	15.4	37.4	20.4	48.1	3.8	24.8	36.4	35.9	25.2	52.2	33.4	29.1	8.2	36.4	42.8	28.5	58.4	34.2	32.0	33.7	30.6	31.3	30.9	25.1	32.4	24.7	32.1	39.9	26.8	72.7	35.4	9.0	32.7	28.4	39.5	29.2	40.7	71.8	49.2	57.5	65.8	17.0	29.9	27.5	31.4	58.7
MSL2	"FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184"	ENSG00000174579	"MSL complex subunit 2"	Q9HCI7	3	136148917-136197241	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003413	Uncertain		Approved	Nucleoplasm,Cytosol		NA	No			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA003413: AB_1848659"	"unprognostic (9.86e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.79e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-3)"	11.9	9.4	6.0	21.3	8.7	57.9	13.8	18.8	8.6	14.7	5.0	12.9	13.3	15.2	9.2	12.7	15.5	12.8	9.5	6.3	7.3	11.3	14.1	14.5	33.1	6.5	7.2	20.9	11.5	15.3	8.0	13.1	9.2	12.0	12.7	14.8	13.0	11.5	12.6	11.4	14.8	12.1	6.0	25.8	14.7	17.4	7.2	60.3	17.0	17.2	31.7	13.3	10.1	12.1	26.5	7.5	20.8	23.2	14.4	15.6	33.1	16.1	16.0	14.9	14.9	19.4	15.0	52.1	21.2	14.3	17.0	20.4	24.6	16.2	23.5	25.3	11.9	59.6	19.8	11.0	14.8	51.7	26.1	12.6	17.7	11.7	34.0	14.2	15.1	48.1	22.0	47.7	12.5	15.8	93.8	26.7	25.3	14.7	13.1	40.5	33.5	35.3	7.1	21.2	25.2	16.8	37.7	16.1	26.5	16.2	14.7	28.5	20.6	19.0	15.0	17.4	15.1	47.5	28.0	78.7	15.9	20.2	13.2	5.1	2.5	4.1	5.1	2.9	6.2	3.1	4.7	6.0	2.7	5.4	9.6	6.4	5.9	5.1	2.2	1.5	3.9	4.2	6.0	8.7	18.8	8.6	6.3	7.3	6.5	7.2	9.2	6.0	7.2	12.1	15.0	19.2	11.2	18.9	30.4	28.0	15.6	5.6	23.3	12.9	15.8	9.5	15.2	8.6	7.0	12.9	4.2	8.9	47.1	9.3	3.9	5.1	4.1	9.6	15.3	13.9	18.0	23.1	28.0	5.6	6.3	14.7	9.2	12.9	7.0	12.6	16.8	23.4	8.5	16.8	31.6	14.1	2.0	24.2	25.4	3.7	9.3	18.9	21.4	37.5	21.4	8.0	30.9	39.2	55.1	6.4	5.6	8.6	27.8	14.5	7.7	7.4	5.7	9.7	6.6	18.6	12.3	16.0	12.5	22.8	26.7	4.8	36.2	8.5	12.2	14.0
MSL3	MSL3L1	ENSG00000005302	"MSL complex subunit 3"	Q8N5Y2	X	11758159-11775772	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034535, HPA034536"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA034535: AB_10603878, HPA034536: AB_10670973"	"unprognostic (2.58e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.36e-2)"	"prognostic favorable (3.28e-4)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (8.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.14e-9)"	"unprognostic (1.20e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.35e-1)"	"prognostic favorable (2.17e-4)"	17.6	11.8	13.4	23.1	14.3	17.0	15.9	12.7	15.4	12.9	13.1	15.4	8.6	13.4	5.4	17.8	14.0	10.0	12.9	14.5	15.0	12.5	13.9	21.9	31.3	13.3	14.1	12.1	11.0	6.8	11.1	10.4	13.4	14.5	8.5	5.7	14.4	8.5	35.8	16.0	25.4	9.9	13.8	49.3	13.6	15.7	16.2	38.8	14.5	22.6	27.0	14.8	14.5	13.2	18.6	20.3	28.0	15.0	21.6	30.1	10.2	24.0	21.9	25.2	30.9	13.7	16.8	22.5	25.2	21.6	16.2	14.0	29.7	17.0	34.1	12.6	20.2	14.0	23.0	7.0	18.5	19.6	20.8	18.7	21.6	29.1	10.9	20.6	38.4	26.6	22.2	14.2	24.5	18.3	19.0	19.3	22.3	21.2	32.7	10.8	25.8	34.1	16.1	21.2	17.8	20.8	22.0	10.4	16.9	23.5	18.0	13.0	34.4	23.7	18.2	40.0	22.6	10.6	20.1	32.9	18.1	12.4	21.0	46.6	53.6	37.2	36.6	47.0	31.9	41.7	42.6	41.3	42.3	45.9	57.9	52.2	66.2	39.4	60.4	41.5	60.4	62.1	13.4	14.3	12.7	15.4	14.5	15.0	13.3	14.1	13.4	13.8	16.2	13.2	30.1	9.6	19.2	7.8	52.7	13.3	15.1	10.7	22.2	10.4	19.1	17.9	16.1	17.2	12.7	7.3	8.4	22.9	73.5	12.7	9.8	18.0	57.0	32.0	30.1	29.1	6.7	24.4	10.7	17.1	33.7	18.2	15.8	25.2	26.6	24.3	27.8	16.8	21.9	8.4	7.3	16.4	8.2	58.2	36.1	24.5	12.5	46.9	14.2	14.0	68.4	10.9	41.2	8.5	8.3	22.5	8.7	16.6	41.3	12.6	12.2	15.2	23.2	7.7	6.6	20.5	21.8	41.8	24.8	24.9	18.5	11.8	54.5	21.6	13.6	13.2
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760734-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 93.4;fallopian tube: 278.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 189.1;Alveolar cells type 2: 85.6;Club cells: 121.9;Glandular and luminal cells: 57.1;Paneth cells: 214.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	39	"dendritic cells: 5.9;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 513.4;EFO-21: 77.4;HeLa: 173.4;hTCEpi: 111.5;OE19: 96.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"spinal cord: 1.7"	"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		17000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	93.4	0.2	0.7	1.1	1.0	3.2	0.5	0.6	1.5	15.9	0.3	8.9	7.1	6.2	24.1	7.1	278.2	16.4	8.4	0.7	0.8	6.5	0.2	71.8	0.2	1.9	1.2	3.7	0.9	0.1	0.7	2.7	1.3	3.8	4.0	0.7	39.3	9.9	0.0	1.4	2.9	3.4	1.0	0.4	13.0	1.1	1.2	0.8	0.2	0.0	27.2	2.9	2.9	1.0	0.4	2.1	0.0	1.0	0.0	0.0	2.3	0.3	7.7	8.7	2.0	7.4	513.4	0.0	77.4	0.7	0.1	1.3	0.0	0.7	0.7	0.2	0.3	0.0	173.4	5.9	4.4	0.2	0.1	0.0	111.5	0.0	2.0	7.8	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.6	96.4	0.8	0.2	0.2	0.6	2.4	0.1	0.1	0.0	29.7	0.1	0.0	0.1	0.7	0.0	0.0	0.4	12.1	0.1	0.0	0.3	0.3	0.4	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.3	0.7	1.0	0.6	1.5	0.7	0.8	1.9	1.2	1.3	1.0	1.2	1.0	0.0	189.1	85.6	0.0	0.0	0.3	3.0	49.0	0.0	1.4	0.3	0.3	1.6	52.9	121.9	25.8	0.0	0.2	0.0	4.1	0.0	9.3	1.6	35.8	3.3	0.7	3.0	0.0	0.0	0.9	0.0	4.6	0.0	57.1	0.0	0.0	0.4	0.1	2.9	0.0	0.0	1.6	22.4	1.0	1.9	7.4	4.7	3.7	1.8	1.0	4.4	0.0	0.0	0.0	0.0	33.0	214.4	0.0	1.4	3.3	1.7	0.1	54.2	0.6	0.0	0.0	2.8	0.6	0.7	0.5	0.1	0.1	1.3	0.0	3.1	50.8
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054292-10428891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 86.0;liver: 64.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 625.8;Inhibitory neurons: 318.6;Oligodendrocyte precursor cells: 268.9;Proximal tubular cells: 666.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 28.4"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.3"	"Low region specificity"	"Detected in all"							"HPA023804, HPA075766"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	No	No		55000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"	"Plasma membrane, Actin filaments"	"HPA023804: AB_1853826, HPA075766: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	17.0	20.4	2.2	1.1	3.0	13.5	16.1	28.4	5.4	9.1	0.0	13.9	1.1	10.7	0.1	11.6	7.4	0.4	29.0	3.8	0.0	86.0	64.0	12.2	0.6	0.0	0.4	6.4	14.5	0.7	9.2	0.8	1.8	9.2	0.6	0.6	10.5	1.0	14.5	9.5	20.1	0.8	0.0	18.6	14.2	15.2	0.3	1.5	9.6	1.3	0.6	11.6	8.2	2.8	0.1	0.9	1.3	4.3	1.2	1.4	0.5	2.5	0.2	0.3	1.7	0.6	2.1	0.0	0.6	2.5	5.8	2.3	0.4	0.1	1.3	0.2	0.0	0.3	1.5	2.2	4.3	0.8	12.3	0.4	3.2	0.3	0.0	1.4	0.6	0.3	0.4	0.2	4.9	0.1	0.0	0.3	0.6	3.3	0.8	1.6	1.3	2.0	1.1	1.1	2.5	1.5	4.6	0.2	0.5	0.4	2.3	2.8	2.6	1.7	2.0	0.4	1.2	0.2	0.1	0.7	4.8	0.8	3.1	0.5	1.9	5.6	0.4	1.2	0.3	0.6	0.4	0.3	1.2	0.1	0.3	0.2	2.2	0.7	0.9	0.2	0.3	0.2	2.2	3.0	28.4	5.4	3.8	0.0	0.0	0.4	1.8	0.0	0.3	2.8	44.1	0.0	7.4	152.8	21.4	16.4	29.3	10.8	14.2	10.1	21.2	21.8	21.6	25.8	7.2	25.8	31.3	7.7	12.4	26.4	92.0	32.3	80.6	13.6	8.7	30.3	9.6	3.4	625.8	47.1	4.6	13.1	14.8	11.8	80.7	13.7	19.6	97.2	47.0	16.8	318.6	20.8	4.1	33.6	48.3	167.9	9.3	38.0	30.2	85.3	22.3	14.6	11.3	268.9	60.7	51.1	37.8	9.8	16.2	33.8	195.5	666.1	5.6	6.2	13.1	11.3	16.9	39.3	26.5	20.1	14.1	8.3	18.0	14.1	24.5	31.1
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938229-1943293	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 234.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 275.6;monocytes: 178.7;Proximal tubular cells: 496.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1414.9;neutrophil: 3051.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 3051.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153"	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	28.1	15.1	26.2	31.8	27.3	96.3	21.3	27.8	28.4	17.5	25.8	36.7	29.4	29.5	11.2	45.3	33.5	23.2	47.3	25.6	26.8	80.3	234.2	30.4	17.7	29.3	28.0	16.4	149.6	14.8	14.5	13.2	27.1	32.0	17.4	2.7	16.5	29.2	76.0	31.1	27.5	36.8	27.5	67.0	33.3	17.7	28.5	13.7	12.5	93.6	12.2	40.8	20.1	27.1	23.6	59.1	21.3	50.4	39.9	17.0	36.4	27.8	36.0	41.2	35.6	96.2	25.5	22.7	90.6	33.5	36.0	37.9	36.3	25.2	12.8	127.7	41.1	17.5	20.5	154.9	36.1	49.3	40.3	32.0	21.9	29.6	6.0	12.9	41.9	28.8	28.2	12.3	22.3	131.2	28.2	82.7	29.2	42.7	33.5	40.3	29.3	106.0	66.0	37.2	20.5	26.9	32.3	35.6	17.3	13.9	38.7	87.9	24.8	12.3	33.7	24.3	16.7	32.0	53.4	42.4	12.5	47.4	22.0	493.5	412.0	1414.9	31.9	194.8	32.2	28.0	26.5	26.7	171.2	28.3	20.5	22.7	3051.8	42.2	182.9	73.2	45.9	226.7	26.2	27.3	27.8	28.4	25.6	26.8	29.3	28.0	27.1	27.5	28.5	27.1	24.9	9.6	13.4	3.9	10.0	6.5	9.1	21.5	8.0	6.5	27.9	21.3	36.1	32.9	14.9	33.1	4.2	33.3	12.3	69.1	93.9	65.9	5.9	23.9	13.4	15.4	60.3	21.5	0.8	111.2	121.4	13.7	11.7	17.0	4.5	12.2	20.7	275.6	63.5	8.4	1.2	38.6	34.6	59.2	21.2	13.9	9.3	37.9	16.0	2.8	178.7	22.5	25.7	1.5	2.9	66.0	62.8	23.0	13.0	16.3	97.3	496.8	37.9	4.2	0.0	8.1	22.8	28.9	8.7	11.1	9.5	38.6	10.6	14.8	33.5	21.9
MSX1	"HOX7, HYD1, OFC5"	ENSG00000163132	"Msh homeobox 1"	P28360	4	4859665-4863936	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 57.0;choroid plexus: 98.0"	"Group enriched"	"Detected in many"	6	"Adipocytes: 118.4;Endometrial ciliated cells: 364.0;Glandular and luminal cells: 462.0"	"Cancer enriched"	"Detected in all"	17	"endometrial cancer: 246.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 47.9;EFO-21: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB026198, HPA063895, HPA073604"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (1.64e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.16e-3)"	"unprognostic (4.07e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (4.35e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.33e-2)"	18.4	6.0	12.2	0.7	11.8	0.2	12.8	12.2	16.9	57.0	98.0	1.8	0.5	17.5	0.3	0.9	9.6	1.3	10.3	18.8	12.2	2.9	0.5	4.3	0.6	17.2	11.8	3.5	2.3	0.4	21.1	4.1	11.8	5.5	0.1	0.6	8.8	3.6	20.1	5.2	1.1	3.2	15.1	4.5	2.0	0.7	13.0	0.2	9.2	2.0	0.4	11.2	14.5	12.3	2.5	1.5	0.5	2.8	8.0	5.1	8.9	6.1	2.8	3.5	1.7	47.9	15.3	0.3	21.4	4.4	17.0	0.1	10.6	0.0	1.2	2.0	12.2	0.1	8.0	17.4	0.6	0.1	1.4	1.0	0.8	2.6	0.9	1.1	0.8	4.1	7.9	0.3	1.9	1.2	1.3	2.4	0.2	0.7	11.1	6.4	6.4	0.6	0.2	1.5	0.4	0.3	5.4	0.3	4.0	0.8	0.9	2.1	2.0	4.1	9.1	13.0	9.9	1.0	0.9	5.7	2.6	3.1	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	12.2	11.8	12.2	16.9	18.8	12.2	17.2	11.8	11.8	15.1	13.0	12.3	118.4	0.0	0.0	17.3	0.5	7.1	2.4	0.3	4.6	0.8	8.6	24.3	5.5	0.0	0.0	0.0	4.2	0.3	1.6	3.9	0.0	0.2	0.4	364.0	35.7	48.1	0.0	0.0	1.1	0.9	0.1	34.8	1.1	462.0	0.0	1.1	5.7	0.2	0.5	0.0	1.2	2.5	0.0	0.6	8.8	0.0	1.2	4.4	16.0	3.7	0.0	0.7	0.0	1.0	0.3	0.3	0.1	0.4	1.6	3.3	0.6	0.5	0.0	0.7	0.0	13.6	18.2	0.8	1.5	2.6	4.7	0.3	4.8	14.6	2.6	2.0
MT1E	"MT1, MTD"	ENSG00000169715	"Metallothionein 1E"	P04732	16	56625475-56627112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1787.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 4001.6;Paneth cells: 4625.0;Proximal enterocytes: 5720.1;Proximal tubular cells: 8933.3;Undifferentiated cells: 2966.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.8;T-cells: 20.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 1095.1;LHCN-M2: 827.5;RPTEC TERT1: 946.2;U-2 OS: 527.7"									HPA041152	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 15: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041152: AB_2732490"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.63e-1)"	"unprognostic (9.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.86e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.78e-2)"	927.5	339.2	364.4	52.2	378.0	2.8	264.0	393.5	510.1	109.2	317.9	261.4	105.1	60.3	12.6	135.4	299.6	40.9	128.8	354.1	378.2	497.9	1787.5	230.3	11.7	376.7	390.6	72.4	537.3	16.3	53.3	19.1	394.6	240.3	189.3	36.8	94.7	20.6	323.0	192.4	357.7	85.5	366.2	30.3	584.7	11.5	400.8	4.0	382.6	92.5	8.0	89.1	140.9	355.9	102.2	0.0	0.0	0.0	154.5	177.0	1.6	263.8	278.6	70.7	82.1	0.9	133.0	0.0	20.3	91.6	10.7	216.7	241.2	1095.1	96.8	102.7	0.0	4.1	139.4	17.5	69.2	0.6	0.6	122.7	362.4	185.5	211.6	426.7	43.5	0.1	0.2	0.7	827.5	0.2	0.4	67.3	94.3	0.0	1.1	0.3	0.0	2.9	946.2	0.0	14.2	0.7	0.7	0.2	1.0	17.4	0.5	124.1	108.6	0.4	527.7	82.5	51.5	0.5	1.9	2.8	296.9	170.2	0.9	0.0	2.9	0.0	14.7	2.1	5.0	0.5	8.2	20.3	5.8	0.0	3.7	14.7	0.1	0.2	1.8	0.3	20.6	3.8	364.4	378.0	393.5	510.1	354.1	378.2	376.7	390.6	394.6	366.2	400.8	355.9	1237.9	394.2	158.2	83.9	59.6	178.6	240.1	86.9	306.2	0.0	214.2	311.0	106.8	589.0	168.4	496.6	0.0	18.4	32.7	2403.7	1402.9	392.8	1.8	710.8	161.7	210.0	241.9	186.9	0.2	193.7	908.6	522.8	880.2	1646.2	28.5	184.3	222.8	4001.6	34.9	0.0	0.2	2467.0	22.4	110.6	29.0	4.6	149.5	121.0	110.3	8.4	61.9	0.0	1.0	7.5	2.0	314.3	4625.0	51.1	20.6	998.6	5720.1	8933.3	137.6	0.0	216.9	818.8	513.7	3.2	3.7	286.4	148.0	79.8	96.0	14.7	2966.9	84.3
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favorable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.1	23.8	24.1	10.8	23.4	15.4	24.6	23.7	31.0	31.7	19.4	31.2	13.1	29.9	11.6	22.6	31.8	6.2	39.2	24.1	20.1	24.7	24.1	19.6	12.1	22.2	21.5	38.6	30.1	9.4	36.9	9.2	20.1	31.8	5.6	8.3	23.6	12.7	25.6	21.1	22.1	9.0	20.0	26.7	22.5	37.6	22.5	16.5	30.4	7.7	9.1	29.2	24.4	22.3	33.6	26.3	47.9	48.2	18.0	30.5	42.3	26.2	19.9	25.4	24.3	34.4	44.1	65.4	26.7	19.3	17.9	45.3	35.1	25.0	17.1	43.2	59.0	34.1	25.2	35.5	39.6	43.2	25.3	34.4	30.9	18.0	41.1	35.5	36.4	48.0	39.3	27.7	13.4	60.4	78.3	85.2	69.1	47.7	55.1	73.1	29.1	21.5	20.6	26.0	76.9	80.1	35.5	40.5	40.8	24.3	36.7	40.7	26.6	20.4	21.6	34.1	27.8	55.9	28.9	41.3	25.6	28.7	36.6	0.1	0.2	0.8	0.3	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.3	0.4	0.0	0.4	0.1	0.9	0.2	0.2	24.1	23.4	23.7	31.0	24.1	20.1	22.2	21.5	20.1	20.0	22.5	22.3	32.1	3.2	16.0	37.9	20.9	15.6	28.8	14.6	13.1	0.0	64.8	38.6	9.2	27.1	15.2	35.0	0.0	11.6	17.7	17.2	17.6	13.2	32.8	25.0	28.4	20.4	18.6	25.4	17.2	19.6	8.0	21.8	28.1	23.9	5.7	47.6	18.2	15.5	11.0	0.0	16.1	21.6	10.2	18.5	13.5	11.3	36.1	15.7	12.4	21.5	13.8	0.0	20.6	32.6	27.0	16.3	11.5	32.0	17.8	45.4	18.5	8.8	27.0	0.0	19.7	30.5	25.4	21.5	13.3	16.8	19.0	9.3	18.7	27.1	24.9	46.2
MTA2	"MTA1-L1, MTA1L1"	ENSG00000149480	"Metastasis associated 1 family member 2"	O94776	11	62593214-62601865	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005315, HPA006214, CAB017522, HPA072727"	Supported		Enhanced	Nucleoplasm		NA	NA		10000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: "	"unprognostic (5.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (4.82e-5)"	"unprognostic (3.32e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.50e-2)"	41.6	34.4	44.4	46.2	46.7	60.7	35.7	45.7	45.3	40.2	38.2	40.0	31.0	37.2	28.7	79.3	33.4	32.6	29.7	44.3	44.1	31.9	30.3	37.8	70.1	49.0	46.1	37.8	23.0	30.2	31.8	39.1	49.4	37.0	47.4	119.8	37.3	36.7	21.2	74.7	40.1	43.8	46.1	60.7	33.9	30.4	45.8	90.2	26.8	24.1	91.8	51.7	47.2	52.7	97.1	83.4	129.8	171.1	57.0	53.2	88.8	80.0	112.3	157.5	114.7	79.7	82.7	137.0	84.0	106.3	84.3	127.2	177.2	222.1	132.8	136.4	87.9	146.4	91.2	81.0	88.3	167.2	180.0	59.6	122.6	111.3	164.1	74.8	148.3	140.4	164.2	106.1	114.6	189.0	213.9	212.1	112.3	91.7	95.1	201.5	92.4	160.6	112.1	143.4	102.9	94.2	83.5	118.2	67.6	102.4	138.9	113.2	104.5	87.9	80.4	100.4	94.0	78.3	109.4	191.8	64.4	120.4	86.9	7.3	7.2	9.9	18.6	12.6	15.6	13.9	15.2	13.5	11.8	10.0	14.0	14.3	3.1	12.1	16.4	13.8	13.5	6.7	44.4	46.7	45.7	45.3	44.3	44.1	49.0	46.1	49.4	46.1	45.8	52.7	22.9	3.2	3.9	2.3	16.9	13.4	4.2	4.2	34.1	0.0	11.3	7.9	3.7	1.5	4.9	1.8	0.0	15.3	16.5	12.1	5.9	5.1	0.8	5.2	10.0	12.0	12.0	20.8	1.5	9.5	8.3	8.6	15.3	9.5	10.8	7.5	13.2	8.2	8.9	0.0	1.6	11.9	4.1	12.8	7.6	0.7	5.0	8.9	1.8	2.8	8.9	0.0	9.2	2.0	2.7	9.7	8.2	4.1	24.1	4.2	6.6	2.7	0.9	0.0	0.0	8.2	11.7	5.9	5.2	32.5	11.2	18.9	18.1	13.6	12.2	4.5
MTA3	KIAA1266	ENSG00000057935	"Metastasis associated 1 family member 3"	Q9BTC8	2	42494569-42756947	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 137.0;Oligodendrocyte precursor cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039433	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA039433: AB_10794747"	"unprognostic (5.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.28e-2)"	11.8	41.8	16.4	5.6	18.9	1.6	14.9	9.1	19.4	18.5	7.1	16.6	7.8	16.8	27.5	21.8	16.1	10.0	12.4	21.9	14.9	13.6	7.9	8.8	10.7	12.3	13.9	29.2	18.8	17.3	15.1	15.3	18.8	14.4	13.2	9.3	13.6	16.8	9.1	19.1	11.4	12.0	11.7	7.8	16.8	21.0	16.1	70.4	12.6	9.9	14.5	15.3	17.8	14.8	13.0	16.6	20.1	14.3	17.4	28.0	46.6	7.4	18.6	21.7	19.2	22.2	26.2	45.4	12.6	22.1	15.9	8.2	51.6	25.2	34.2	14.1	21.0	6.7	8.8	36.4	21.9	5.0	29.0	29.5	29.1	13.4	16.6	28.1	30.4	23.9	16.5	6.1	25.7	27.8	30.3	22.0	84.4	20.8	9.7	18.4	18.9	0.0	25.7	12.1	12.3	37.1	13.5	45.5	17.8	61.6	23.2	7.0	14.2	8.9	12.1	7.2	8.1	11.5	4.7	63.5	12.6	5.7	11.1	2.5	0.9	0.0	1.7	0.6	2.6	1.2	2.0	2.9	1.5	1.3	4.4	3.0	0.2	1.8	0.9	0.4	1.1	1.5	16.4	18.9	9.1	19.4	21.9	14.9	12.3	13.9	18.8	11.7	16.1	14.8	12.7	12.8	12.5	60.4	10.8	15.3	21.1	33.0	15.4	0.0	24.6	19.6	12.5	15.7	25.7	22.0	0.0	58.5	5.1	19.1	17.6	22.9	10.7	44.5	23.1	13.1	9.6	2.5	137.0	28.0	42.0	21.7	31.1	32.3	12.0	72.3	20.7	13.3	12.4	0.0	81.8	20.0	50.8	6.6	7.1	26.0	33.8	5.2	17.8	53.4	6.9	0.0	9.2	106.1	65.9	20.2	21.8	39.9	10.9	17.7	25.2	33.1	18.4	0.0	13.1	15.8	35.9	25.5	41.1	24.5	18.3	59.9	12.6	44.5	21.5	17.3
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802636-21937651	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046915, CAB080036, CAB080037"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3000000	"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB080036: AB_11128130, CAB080037: AB_11129069, HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	5.9	6.5	4.1	5.4	4.8	5.8	8.5	4.2	5.7	7.8	7.6	6.7	4.8	8.8	7.1	8.8	7.1	4.9	7.0	3.8	4.0	6.9	10.9	5.8	6.3	5.0	4.5	12.1	6.6	8.4	2.8	8.9	5.1	7.2	8.0	3.9	6.5	7.0	4.5	7.0	5.9	9.0	4.0	7.3	7.2	2.9	5.4	6.8	7.2	5.4	7.3	10.1	7.4	6.0	30.4	1.0	23.0	19.0	19.4	19.0	28.3	42.3	21.0	21.9	24.3	21.7	14.6	15.3	13.4	21.1	16.3	15.2	24.4	59.5	36.8	0.3	19.8	0.3	56.8	28.8	18.6	24.5	26.3	23.5	0.1	38.6	42.6	24.4	22.6	0.5	0.3	20.1	21.9	3.1	26.8	0.7	27.5	14.7	35.2	0.4	18.0	26.0	18.3	0.4	14.4	15.3	14.4	17.1	21.1	17.9	10.9	0.6	23.8	0.3	15.7	0.2	34.4	13.7	25.5	30.0	0.2	24.3	12.0	1.2	5.6	0.2	3.6	4.5	6.1	5.9	5.3	4.2	6.9	8.4	4.6	4.2	0.7	6.7	2.9	6.3	3.2	2.7	4.1	4.8	4.2	5.7	3.8	4.0	5.0	4.5	5.1	4.0	5.4	6.0	18.8	22.4	19.8	26.1	16.3	14.1	58.4	22.4	16.5	0.0	20.2	23.9	22.4	24.3	27.9	14.7	0.0	52.3	11.4	6.8	15.6	38.6	77.9	28.8	28.5	14.9	9.6	19.1	14.8	28.0	80.0	18.7	15.3	40.6	10.8	30.0	17.5	22.2	27.1	0.0	9.1	14.3	30.5	25.5	11.1	14.8	14.9	15.1	10.6	48.7	15.0	0.0	10.3	40.7	32.9	41.5	6.8	14.7	13.7	45.0	9.2	19.5	19.1	0.0	13.1	20.6	23.1	1.3	13.9	35.1	13.1	22.6	15.1	33.0	20.7	62.9
MTBP		ENSG00000172167	"MDM2 binding protein"	Q96DY7	8	120445400-120542133	"Predicted intracellular proteins"	"Cell cycle, Growth arrest, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Excitatory neurons: 14.7;Oligodendrocytes: 16.1;Spermatocytes: 16.2;Spermatogonia: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA025694, HPA050594"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA025694: AB_1854169, HPA050594: AB_2681185"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.53e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.40e-3)"	"unprognostic (2.77e-6)"	"unprognostic (3.99e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.20e-10)"	"unprognostic (3.41e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.86e-2)"	1.3	1.1	1.0	2.5	1.2	4.0	2.6	3.6	1.7	1.6	0.7	1.7	1.5	2.1	2.4	1.4	1.7	1.2	0.6	1.0	0.9	1.0	0.8	1.3	4.3	1.0	1.0	2.4	0.9	1.0	0.8	2.1	1.2	1.5	2.6	4.3	1.1	1.0	0.7	3.0	1.3	2.0	0.9	1.8	1.1	5.0	1.1	4.6	0.8	0.8	4.0	1.0	1.3	1.4	15.3	4.5	14.6	6.0	2.1	3.5	7.1	11.4	6.5	16.4	21.0	4.9	8.3	13.8	11.2	3.8	4.9	13.0	13.9	6.8	20.3	11.5	10.6	11.6	6.7	5.6	1.1	12.4	8.6	1.3	2.9	12.7	8.1	2.5	7.3	12.6	7.6	10.2	9.7	6.9	19.8	7.6	6.5	12.0	9.0	11.3	15.0	9.8	3.9	5.3	7.4	8.6	7.7	44.8	7.0	7.9	8.5	8.9	4.5	7.0	12.7	9.0	18.6	3.9	8.9	8.0	6.6	15.1	8.3	0.0	0.1	0.1	0.3	0.6	0.5	0.7	0.5	0.7	0.2	0.5	0.8	0.7	0.0	0.5	0.3	0.0	0.7	0.3	1.0	1.2	3.6	1.7	1.0	0.9	1.0	1.0	1.2	0.9	1.1	1.4	1.6	0.0	1.5	7.5	2.9	0.8	1.7	1.5	1.8	0.0	1.4	1.3	1.1	0.0	1.1	1.8	0.0	2.3	2.5	0.5	0.0	0.9	0.8	1.3	2.6	1.1	0.0	12.8	14.7	1.8	3.0	2.5	2.6	1.5	2.5	5.0	1.8	0.9	1.6	0.0	9.1	0.9	0.0	0.3	1.8	0.4	1.5	1.7	1.8	3.7	1.0	0.0	2.1	9.0	16.1	0.6	0.1	1.2	2.3	1.2	0.3	0.3	2.4	0.0	0.0	5.6	2.6	16.2	10.2	1.4	0.6	0.7	3.3	1.5	0.8	0.8
MTCP1	"P13MTCP1, p8MTCP1, TCL1C"	ENSG00000214827	"Mature T cell proliferation 1"	P56278	X	155064034-155147937	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.2;Respiratory ciliated cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA032040			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA032040: AB_2674122"	"unprognostic (2.42e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.29e-3)"	"unprognostic (8.30e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.40e-5)"	"unprognostic (9.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (4.52e-8)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-2)"	1.0	2.1	0.8	1.9	1.1	2.8	1.8	1.7	1.4	1.3	1.1	1.6	2.0	1.7	2.7	1.2	1.4	1.3	1.4	0.8	1.0	1.8	2.5	1.2	2.5	1.1	0.9	2.3	2.6	1.0	1.7	1.0	1.0	1.7	2.0	2.5	1.6	1.4	1.2	4.2	1.8	1.4	0.9	1.9	2.0	5.3	1.0	1.9	1.9	0.7	2.5	1.4	0.9	1.2	1.2	3.9	1.9	3.1	1.2	1.0	2.1	2.4	1.2	1.5	3.7	3.5	6.0	2.2	2.4	0.5	2.4	3.9	2.6	2.8	1.9	1.5	2.5	1.0	13.6	1.9	1.1	2.4	2.5	1.9	1.3	2.5	2.4	1.8	1.4	3.8	0.9	3.9	1.1	1.7	3.2	5.1	0.9	1.5	0.6	3.4	2.0	5.1	2.0	1.7	0.9	1.4	1.7	1.0	1.7	1.3	1.8	1.1	1.5	1.8	3.0	1.7	1.9	8.6	4.1	4.4	3.4	2.9	2.6	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.8	1.1	1.7	1.4	0.8	1.0	1.1	0.9	1.0	0.9	1.0	1.2	0.5	0.0	1.5	0.0	0.5	0.3	0.3	0.7	0.6	0.0	0.6	0.5	1.4	1.5	1.4	0.0	0.0	0.2	0.8	0.6	0.0	0.8	0.0	0.7	0.3	0.5	1.8	3.2	0.0	1.2	0.4	0.6	0.0	0.6	0.0	2.2	0.4	2.0	0.4	0.0	0.0	0.0	0.0	1.0	0.3	0.6	1.2	0.8	1.8	0.0	1.0	0.0	1.0	0.0	0.0	1.0	0.2	0.4	0.9	0.3	0.3	0.3	2.4	0.0	0.0	0.6	0.4	0.6	0.2	0.4	0.9	0.3	0.7	0.8	0.5	0.1
MTF1		ENSG00000188786	"Metal regulatory transcription factor 1"	Q14872	1	37809574-37859592	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 20.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028604, HPA028689"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028604: AB_10600304, HPA028689: AB_10611384"	"unprognostic (5.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.33e-2)"	"unprognostic (8.15e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.19e-1)"	4.7	3.5	4.6	5.2	6.0	20.5	4.1	4.7	5.4	4.7	5.5	4.4	2.8	4.2	2.6	8.4	5.6	3.5	2.7	4.2	4.3	3.8	2.5	4.3	4.0	5.6	5.6	5.5	4.0	6.1	3.4	3.3	5.2	3.3	4.6	4.8	3.2	3.1	5.3	4.5	3.0	4.6	4.6	4.5	3.3	6.6	5.1	4.3	3.8	6.4	5.8	5.3	4.0	6.2	7.5	4.5	4.4	3.9	11.0	7.6	8.4	7.2	7.4	8.4	8.0	4.9	4.2	7.9	5.4	8.2	5.5	6.8	7.6	6.0	9.7	27.5	4.7	7.5	6.4	3.8	6.2	8.9	8.0	7.1	10.4	11.9	12.0	6.0	5.4	5.6	4.9	6.2	6.3	4.2	4.5	4.6	6.2	3.9	4.4	4.7	10.4	4.8	5.6	7.3	6.7	4.9	8.6	6.9	6.2	6.1	4.2	7.3	7.7	5.2	5.9	6.0	9.6	11.4	13.8	4.4	7.1	9.1	4.6	2.8	3.7	2.4	1.8	3.6	1.5	1.3	1.5	1.3	2.3	1.6	1.6	1.3	3.7	1.1	6.0	0.8	1.1	1.8	4.6	6.0	4.7	5.4	4.2	4.3	5.6	5.6	5.2	4.6	5.1	6.2	9.7	9.6	10.3	10.7	15.4	20.6	11.4	11.0	15.9	0.0	13.2	10.8	12.7	8.6	8.8	7.3	0.0	10.0	11.2	20.4	1.9	11.8	50.0	30.0	14.2	13.0	23.8	9.9	16.3	15.6	23.2	10.7	9.2	30.4	16.5	9.2	13.2	7.2	10.2	0.0	14.3	8.8	16.2	20.1	9.1	18.2	9.6	22.6	7.2	8.4	26.8	0.0	11.3	9.5	20.7	12.9	8.6	11.7	15.7	14.8	11.5	6.2	28.8	0.0	6.6	18.2	12.1	33.7	22.5	23.2	29.7	17.1	12.9	7.1	9.2	16.0
MTF2	"M96, PCL2, TDRD19A"	ENSG00000143033	"Metal response element binding transcription factor 2"	Q9Y483	1	93079235-93139079	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 117.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069047, HPA069066"			Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA069047: AB_2686073, HPA069066: AB_2686078"	"unprognostic (1.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.88e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (1.26e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.05e-4)"	"prognostic unfavorable (2.47e-7)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	5.5	6.5	5.6	10.4	6.2	23.5	9.3	10.0	7.9	7.5	5.0	7.5	7.6	8.1	7.3	5.7	6.7	6.2	4.4	5.7	5.7	7.4	6.7	7.2	20.1	4.9	5.0	10.1	5.4	5.5	5.8	12.3	5.2	5.5	7.6	8.8	5.2	4.1	7.2	7.5	7.9	5.9	5.3	11.5	6.8	16.9	5.8	29.2	7.1	5.9	18.8	6.7	6.6	6.5	20.8	9.8	33.7	22.8	5.7	5.5	38.8	12.8	10.3	21.9	27.3	17.3	11.0	66.9	23.3	8.2	19.2	10.4	31.1	13.4	32.5	25.8	22.7	45.7	15.7	22.4	8.5	61.4	19.4	7.0	7.2	21.2	12.4	10.1	21.3	50.9	53.2	20.0	13.9	9.2	88.1	49.5	57.4	8.9	13.0	70.4	40.8	17.9	20.5	22.1	20.8	24.8	21.1	25.1	26.5	34.8	15.2	42.1	12.1	14.7	21.4	14.1	19.8	15.3	19.2	117.7	2.8	35.4	9.8	9.1	7.3	11.8	7.9	8.1	9.3	7.2	8.3	10.3	9.4	8.6	9.8	8.9	5.4	10.6	5.1	8.7	10.1	4.9	5.6	6.2	10.0	7.9	5.7	5.7	4.9	5.0	5.2	5.3	5.8	6.5	36.4	28.9	29.7	52.2	53.8	46.5	28.5	37.0	26.2	0.0	33.2	25.0	13.6	18.6	32.6	38.6	0.0	68.3	64.5	26.2	7.9	33.8	5.0	24.7	29.2	40.2	32.2	51.6	70.3	19.3	67.4	23.9	23.4	36.0	60.1	56.4	43.5	15.0	34.1	0.0	58.0	31.1	40.7	27.4	54.0	7.4	32.6	34.5	17.8	54.4	50.4	0.0	90.6	68.9	68.1	30.9	28.5	23.7	39.6	41.2	39.2	15.5	21.0	0.0	39.5	24.2	39.4	125.5	89.3	24.1	43.2	60.7	54.0	45.8	33.7	48.1
MTFMT	FMT1	ENSG00000103707	"Mitochondrial methionyl-tRNA formyltransferase"	Q96DP5	15	65001512-65029639	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040710	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA040710: AB_10794879"	"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (3.31e-8)"	"unprognostic (2.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.85e-2)"	1.6	2.2	2.6	0.7	2.9	1.9	1.6	3.8	3.1	2.4	4.0	2.5	1.5	2.5	1.5	2.2	2.6	0.9	4.3	2.5	3.4	2.4	3.5	1.5	1.3	2.5	2.2	2.7	1.4	1.7	2.2	0.8	2.5	2.8	1.5	1.6	1.8	1.3	3.0	1.7	2.2	1.7	1.9	2.3	2.0	1.5	2.9	1.0	1.7	1.5	1.2	2.5	2.1	2.6	1.4	1.9	1.8	3.2	2.5	1.7	1.7	1.3	2.2	1.6	1.5	1.2	1.5	4.7	1.7	2.3	2.7	4.0	3.3	2.2	1.5	1.9	2.8	1.9	1.9	1.3	2.9	2.7	0.6	2.3	2.8	0.9	1.9	2.2	1.5	4.2	2.3	2.2	2.4	1.9	2.3	3.1	2.4	4.0	3.6	2.0	2.5	2.2	2.7	1.6	1.8	1.8	3.1	2.7	2.5	2.2	1.6	2.0	2.8	1.9	1.9	2.4	2.6	1.9	3.1	1.8	1.7	4.6	1.9	3.7	3.3	2.6	4.8	3.1	4.8	4.8	4.7	5.0	6.0	4.7	5.1	5.4	16.5	4.5	2.2	10.1	5.4	2.3	2.6	2.9	3.8	3.1	2.5	3.4	2.5	2.2	2.5	1.9	2.9	2.6	8.5	3.2	9.7	17.0	11.8	3.3	15.2	19.1	14.8	0.0	7.0	7.7	15.8	10.0	10.5	3.7	0.0	11.4	18.1	10.5	25.4	11.8	1.7	7.8	11.6	8.2	7.8	9.4	49.8	10.0	11.7	11.8	8.6	7.0	8.8	8.0	12.8	12.2	16.5	0.0	44.2	8.9	2.0	12.2	12.2	1.7	15.5	9.7	8.8	27.2	7.1	0.0	11.3	19.1	12.9	10.3	15.9	15.4	10.3	16.7	17.5	25.1	5.1	0.0	0.0	12.5	14.5	13.3	20.7	10.7	4.5	8.9	10.1	11.4	15.7	14.5
MTHFSD	FLJ12998	ENSG00000103248	"Methenyltetrahydrofolate synthetase domain containing"	Q2M296	16	86530178-86555235	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041333	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Vesicles"		"HPA041333: AB_10795006"	"unprognostic (4.09e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (9.88e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.77e-1)"	"unprognostic (5.85e-3)"	7.2	8.2	5.3	8.7	6.5	6.3	10.4	6.3	6.2	9.2	7.6	8.7	7.4	9.6	10.6	10.1	13.0	8.4	7.9	5.2	5.1	7.6	7.9	8.3	11.7	6.4	6.2	11.5	9.9	11.8	9.3	8.1	6.4	10.2	10.5	6.6	11.0	8.1	11.3	12.7	8.6	8.3	6.1	10.6	9.7	17.7	6.4	10.6	11.0	8.3	11.7	8.9	8.8	9.6	15.7	14.6	14.2	12.3	11.8	18.0	17.0	15.3	11.1	19.0	9.4	13.0	25.8	14.2	16.3	13.4	10.2	21.4	15.8	15.0	17.7	9.4	12.8	12.9	20.0	12.0	16.0	10.1	6.9	11.4	23.4	24.4	20.9	16.4	11.5	20.5	26.9	0.0	13.9	19.8	12.6	15.0	9.3	12.9	18.3	38.6	8.0	11.2	11.1	9.4	13.8	9.5	34.7	6.8	12.6	14.1	34.5	10.3	11.9	18.3	15.7	12.2	15.1	11.1	14.7	41.6	16.7	15.8	18.2	5.9	4.8	2.4	4.7	3.5	5.0	4.6	5.2	4.9	6.0	3.4	4.2	5.0	1.9	6.3	4.3	2.7	4.5	4.8	5.3	6.5	6.3	6.2	5.2	5.1	6.4	6.2	6.4	6.1	6.4	9.6	6.4	6.4	5.9	10.4	6.4	1.1	2.7	4.2	1.2	0.0	6.8	7.1	4.4	2.8	4.7	5.5	0.0	7.9	5.6	7.2	11.7	5.2	35.6	7.4	5.9	4.6	4.2	7.4	6.6	4.2	4.5	4.5	2.6	4.9	4.5	9.4	5.7	3.4	6.1	0.0	7.1	5.3	2.0	5.5	2.0	18.8	6.5	4.3	3.6	3.7	4.7	0.0	6.2	5.5	13.5	3.6	3.6	8.2	4.1	2.6	5.3	4.4	8.2	0.0	6.6	2.2	5.5	11.4	4.0	4.5	1.4	7.7	3.8	5.7	5.5	2.0
MTIF3	"IF-3mt, IF3(mt)"	ENSG00000122033	"Mitochondrial translational initiation factor 3"	Q9H2K0	13	27435643-27450591	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 610.0;Proximal tubular cells: 475.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039791	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA039791: AB_10795296"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (8.41e-4)"	61.8	55.0	59.5	29.2	59.8	17.1	51.0	61.0	93.4	36.7	60.4	46.7	42.8	28.4	67.1	39.9	30.4	37.0	133.4	59.0	61.7	63.1	65.5	29.2	44.5	60.9	60.2	37.1	54.4	43.4	50.8	30.9	60.9	45.3	44.6	74.7	82.9	43.9	90.8	39.9	41.8	30.5	58.8	49.6	48.1	61.8	60.6	47.3	36.9	109.8	46.1	36.7	34.0	62.0	29.9	21.9	48.5	23.5	53.2	78.8	22.6	44.0	51.1	33.8	33.8	28.3	37.5	33.3	28.4	50.8	22.8	25.1	27.2	37.1	46.3	34.3	31.2	42.6	19.1	36.7	52.2	43.8	38.8	44.6	65.5	27.7	35.1	75.6	60.0	33.8	24.0	13.6	51.2	54.0	39.7	54.2	24.4	100.1	24.0	22.8	24.3	37.5	69.8	31.3	32.9	20.6	28.4	39.1	50.7	51.8	31.3	62.5	38.1	21.4	12.5	56.1	29.5	10.0	14.9	19.1	21.5	44.3	31.1	85.8	53.0	75.4	30.8	51.2	32.9	49.1	38.9	31.1	55.2	42.8	34.0	35.2	36.5	37.2	48.3	88.2	47.4	41.3	59.5	59.8	61.0	93.4	59.0	61.7	60.9	60.2	60.9	58.8	60.6	62.0	88.5	28.9	47.4	29.0	74.0	34.0	34.0	103.9	43.9	0.0	91.6	95.4	179.1	87.2	76.3	115.8	0.0	102.6	60.4	102.2	326.8	89.6	610.0	93.7	63.4	70.3	64.1	59.7	22.8	104.1	67.0	62.7	47.4	74.5	71.7	50.6	79.9	223.0	102.3	0.0	26.4	112.8	103.7	114.8	50.2	283.4	139.8	67.7	106.7	24.4	106.4	0.0	80.3	30.7	43.7	98.3	108.8	124.8	71.1	43.7	142.8	475.5	83.2	0.0	124.9	48.8	69.2	243.6	87.6	62.8	42.5	56.8	58.5	69.6	96.8	44.8
MTMR10	FLJ20313	ENSG00000166912	"Myotubularin related protein 10"	Q9NXD2	15	30938941-30991628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.2;Oligodendrocytes: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006081	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA006081: AB_2667508"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (7.77e-12)"	"unprognostic (9.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-1)"	18.6	9.5	29.3	10.7	46.9	18.7	10.3	49.4	33.3	11.2	24.8	9.9	12.8	9.4	9.4	20.9	7.5	9.6	12.7	28.0	36.3	30.6	24.2	13.6	12.0	57.6	48.5	11.5	12.4	21.3	1.9	25.9	56.5	11.0	10.3	12.1	14.9	11.4	29.4	11.2	11.6	10.0	45.3	15.1	13.0	8.5	40.8	16.7	14.2	24.0	10.6	10.1	5.4	63.3	8.1	9.0	8.2	5.2	17.7	9.6	7.2	11.9	23.9	9.4	9.4	5.9	3.5	3.9	15.5	15.5	9.1	11.5	6.5	7.0	8.9	12.5	2.1	5.5	6.2	10.4	10.3	8.9	12.2	13.2	5.4	6.1	6.7	10.8	23.7	10.9	4.9	9.2	8.9	2.3	9.3	5.6	4.7	9.7	4.3	6.7	6.7	19.5	35.6	12.7	3.0	7.8	5.4	6.3	2.4	10.4	4.2	16.4	10.9	10.6	8.0	5.6	6.8	9.4	7.8	9.0	6.7	4.7	13.4	3.7	3.2	3.1	0.7	4.0	0.8	1.9	0.8	0.6	3.1	2.8	1.2	1.2	13.5	1.4	7.4	3.7	1.2	1.7	29.3	46.9	49.4	33.3	28.0	36.3	57.6	48.5	56.5	45.3	40.8	63.3	15.8	25.6	15.2	86.2	11.3	8.9	4.3	3.3	8.0	0.0	6.7	4.6	24.1	10.0	7.0	33.1	0.0	19.3	12.9	12.7	1.9	3.4	13.6	10.1	9.6	16.8	6.0	5.2	15.4	3.8	3.1	8.6	13.3	19.7	17.1	9.4	11.4	33.9	11.8	0.0	13.6	7.7	2.0	24.9	16.2	24.9	10.5	19.0	8.8	55.3	13.8	0.0	3.1	25.6	149.3	5.6	9.2	7.5	8.0	6.7	14.4	18.6	4.7	0.0	0.0	10.6	8.9	11.1	8.9	33.6	11.1	38.4	6.8	6.7	8.2	8.7
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883169-30030868	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Inhibitory neurons: 78.3;Microglial cells: 90.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	17.8	18.4	18.5	13.0	19.4	81.6	17.0	21.2	18.6	18.9	17.0	15.5	11.1	16.0	12.8	22.4	16.4	12.5	13.9	20.8	19.3	11.7	10.8	20.7	11.5	19.2	19.8	20.4	16.5	18.3	17.0	15.0	17.3	16.0	12.7	21.2	17.2	11.3	36.7	25.5	14.5	14.8	18.6	21.7	15.7	26.2	21.6	16.2	17.2	30.0	13.9	15.1	19.4	16.6	13.4	11.7	17.0	18.3	16.7	12.1	12.8	12.2	17.4	15.7	18.2	10.0	7.9	10.2	7.6	22.1	12.4	16.0	18.5	14.3	16.6	21.0	15.4	18.6	10.6	10.1	15.3	15.9	45.0	12.8	22.9	14.9	26.9	14.7	15.3	10.7	11.6	17.5	10.3	16.2	10.7	11.1	6.5	13.7	7.5	12.5	23.3	10.4	14.1	24.3	19.2	13.1	22.1	19.7	11.7	14.1	11.2	15.3	16.8	25.3	16.7	5.5	8.3	14.7	11.1	9.3	11.0	7.5	11.8	8.3	7.4	11.2	3.2	4.9	4.0	2.3	2.5	3.4	4.1	2.4	3.1	2.7	17.8	4.1	5.4	1.5	2.9	4.3	18.5	19.4	21.2	18.6	20.8	19.3	19.2	19.8	17.3	18.6	21.6	16.6	15.9	3.2	14.8	111.3	13.3	16.7	9.8	11.5	14.8	0.0	13.7	11.0	4.2	10.0	17.7	12.9	0.0	13.6	10.4	21.5	1.9	9.5	14.0	16.8	14.9	10.6	12.5	21.0	61.2	8.8	7.0	12.6	31.6	24.5	7.6	14.7	13.9	10.1	10.9	0.0	78.3	9.2	46.8	20.6	11.7	16.7	13.7	20.8	14.2	90.9	22.3	0.0	12.3	96.5	73.2	12.3	11.1	11.3	13.0	14.6	12.2	7.3	16.4	0.0	6.6	15.3	11.0	26.8	28.0	18.1	13.8	13.7	13.0	8.9	11.5	21.2
MTMR7		ENSG00000003987	"Myotubularin related protein 7"	Q9Y216	8	17296794-17413528	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.9;retina: 28.4"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 79.2;Inhibitory neurons: 116.4;Oligodendrocyte precursor cells: 83.9;Oligodendrocytes: 171.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.7;SCLC-21H: 9.5;SH-SY5Y: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075682			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA075682: "	"unprognostic (1.01e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.66e-3)"	1.4	2.1	6.3	0.7	6.9	1.7	0.8	9.0	8.2	1.1	0.0	0.9	0.7	0.9	0.1	0.6	1.1	0.5	0.7	8.2	5.2	0.9	1.3	1.0	0.6	5.9	6.0	2.2	1.2	3.8	6.9	0.6	7.5	0.7	0.3	28.4	0.6	0.2	1.0	1.3	1.0	0.2	5.8	0.7	0.9	1.4	9.2	0.1	3.0	0.2	0.0	0.8	0.8	11.9	0.5	0.4	0.8	0.6	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.7	0.2	0.6	0.3	0.0	0.5	0.2	2.6	0.0	0.0	0.1	2.1	0.9	1.2	0.4	0.7	0.5	0.6	0.1	0.0	0.0	0.0	0.6	0.1	0.3	0.4	0.5	0.0	0.4	0.9	1.2	3.7	0.5	0.4	0.3	1.1	0.4	0.0	2.3	9.5	5.5	0.4	0.5	0.7	1.3	0.2	0.6	1.1	0.6	0.3	1.4	0.8	0.2	0.3	0.4	1.8	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	6.9	9.0	8.2	8.2	5.2	5.9	6.0	7.5	5.8	9.2	11.9	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.0	2.3	0.2	0.1	0.0	0.0	14.0	0.5	0.4	0.2	3.6	0.4	79.2	0.5	0.5	0.5	1.5	1.1	0.0	0.0	0.0	0.0	0.4	0.0	116.4	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.6	0.0	0.0	0.0	83.9	171.9	0.2	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	6.6	0.2	1.5	0.9	1.8	0.4	0.1	1.4	0.1	0.1	0.0	0.0
MTO1		ENSG00000135297	"Mitochondrial tRNA translation optimization 1"	Q9Y2Z2	6	73461578-73509236	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030230, HPA030232"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030230: AB_10598910, HPA030232: AB_10600891"	"unprognostic (2.17e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.64e-1)"	5.8	5.6	3.3	5.5	3.4	4.1	6.0	5.6	4.9	6.6	3.1	6.7	6.1	5.6	4.4	6.3	6.4	3.5	8.3	3.3	3.2	11.6	17.6	5.0	7.8	3.3	2.9	7.3	6.2	9.3	5.7	4.1	3.4	6.2	6.6	6.7	5.6	4.6	9.3	5.3	7.5	5.2	2.7	9.8	6.5	9.9	3.4	7.2	6.3	9.8	9.3	6.8	6.7	4.6	6.5	6.0	8.0	5.9	12.4	13.7	4.3	13.5	14.7	15.7	15.7	13.2	4.1	13.7	9.4	13.9	9.5	10.1	18.6	12.5	24.9	7.6	9.6	15.7	12.0	13.5	16.3	27.0	7.1	9.2	17.4	16.0	16.7	7.8	11.3	14.6	22.5	16.8	14.4	10.9	6.4	9.0	6.5	9.4	5.8	11.3	27.8	25.8	9.2	12.0	5.5	3.9	5.5	14.2	12.2	7.1	7.6	24.1	6.9	7.9	6.6	5.1	13.0	8.5	15.1	6.6	4.7	17.8	11.6	1.3	4.5	3.8	5.9	6.1	9.2	6.2	7.1	5.7	4.7	5.4	7.9	5.9	1.6	8.2	6.0	4.5	12.0	7.0	3.3	3.4	5.6	4.9	3.3	3.2	3.3	2.9	3.4	2.7	3.4	4.6	9.4	16.0	17.9	11.1	22.7	7.8	14.5	13.2	4.6	0.0	5.7	5.0	15.7	11.5	12.1	11.0	0.0	12.1	19.9	6.7	21.5	7.3	127.7	12.0	13.7	11.7	8.4	5.0	14.3	7.5	8.6	10.9	10.2	22.7	6.3	8.4	10.0	22.6	8.7	0.0	15.8	9.0	6.1	8.2	7.2	20.1	11.1	10.6	0.0	11.2	15.1	0.0	18.6	11.1	21.9	7.0	6.9	9.8	20.1	14.4	16.0	17.4	7.5	0.0	6.6	19.7	10.4	42.9	11.6	7.2	10.1	10.3	21.2	11.5	11.7	10.8
MTREX	"Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2"	ENSG00000039123	"Mtr4 exosome RNA helicase"	P42285	5	55307989-55425579	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 42.3;Endometrial stromal cells: 44.0;Exocrine glandular cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037379	Supported		Supported	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA037379: AB_10601713"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.11e-1)"	20.4	22.7	10.2	21.9	11.5	18.5	22.0	17.4	12.7	22.5	14.4	17.7	24.6	22.1	14.1	19.1	17.8	19.8	24.3	9.7	11.2	20.8	19.6	16.7	25.9	11.1	10.8	20.1	21.2	26.6	17.2	18.9	11.5	21.6	19.9	17.8	18.9	14.7	29.9	20.8	24.1	13.8	11.4	19.2	20.9	23.4	10.3	21.9	25.8	22.5	21.8	21.0	19.8	14.9	40.9	49.2	38.4	39.9	32.8	35.0	49.5	33.4	28.3	39.7	50.1	57.1	51.2	79.3	37.4	33.1	52.9	28.5	76.8	50.3	59.9	14.2	53.2	51.6	45.4	45.9	31.3	33.4	44.8	27.5	31.3	42.9	51.6	33.6	35.1	29.7	60.9	45.0	37.9	35.8	32.3	36.5	38.4	16.8	46.6	39.5	44.1	33.9	41.3	56.9	42.0	28.8	40.4	24.5	35.4	42.4	52.5	44.8	33.2	10.0	27.5	28.4	62.0	31.5	33.6	59.0	27.0	69.5	40.8	3.6	5.0	5.4	7.2	4.7	6.9	6.1	5.7	6.8	6.4	6.4	6.1	6.2	1.3	4.5	7.9	6.7	5.6	4.1	10.2	11.5	17.4	12.7	9.7	11.2	11.1	10.8	11.5	11.4	10.3	14.9	27.6	32.1	42.3	0.0	10.1	0.0	0.0	0.0	0.0	0.0	22.3	13.8	0.0	0.0	21.7	20.2	0.0	25.0	24.6	0.0	11.7	32.0	0.0	28.2	44.0	10.0	0.0	0.0	0.0	40.7	21.5	16.2	0.0	26.2	25.2	30.8	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	13.9	0.0	0.0	0.0	0.0	35.7	0.0	0.0	8.3	0.0	0.0	22.3	26.2	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	34.9	11.6	31.7	0.0	0.0
MTRR	cblE	ENSG00000124275	"5-methyltetrahydrofolate-homocysteine methyltransferase reductase"	Q9UBK8	5	7851186-7906025	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 70.1;Late spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038113	Supported		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA038113: AB_10671520"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.56e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	11.2	10.6	5.1	9.5	11.2	5.7	6.3	10.1	10.9	7.2	3.4	8.3	8.9	11.7	12.3	9.3	9.6	11.8	14.4	6.5	9.0	18.7	19.4	13.1	11.1	10.9	10.4	11.4	11.9	12.8	6.7	10.8	10.6	9.0	10.1	19.2	10.5	7.1	28.9	9.1	10.2	12.0	8.2	6.7	6.7	7.1	9.3	7.5	9.0	32.9	10.6	14.4	5.5	20.0	19.3	18.1	10.2	20.0	34.0	13.6	25.1	31.1	18.5	16.5	15.4	27.8	15.1	32.6	27.9	24.6	27.4	11.8	17.0	14.2	27.9	22.9	15.8	14.6	62.0	15.3	21.9	23.4	6.8	18.3	11.4	24.6	18.4	20.4	10.4	8.0	21.9	24.2	9.8	4.2	14.2	11.7	7.3	29.4	19.0	12.4	9.5	14.1	16.2	16.0	14.0	2.5	51.6	33.7	28.6	18.1	10.7	17.5	14.6	31.9	19.7	24.1	22.7	34.7	13.5	27.3	23.1	50.5	19.1	5.3	4.0	3.0	4.1	5.5	7.0	3.3	6.5	5.7	3.6	3.3	4.1	3.6	0.1	3.1	4.4	2.3	9.1	3.3	5.1	11.2	10.1	10.9	6.5	9.0	10.9	10.4	10.6	8.2	9.3	20.0	7.7	16.0	70.1	10.1	11.1	16.3	9.4	4.6	12.0	0.0	9.7	5.1	12.9	5.7	9.0	9.2	0.0	9.9	11.4	11.0	21.5	10.2	50.1	10.0	10.7	8.0	9.6	12.4	25.4	5.5	8.9	11.8	9.2	6.7	10.2	6.5	8.6	19.3	7.7	0.0	20.8	9.1	0.0	11.1	9.4	99.2	10.5	9.7	1.8	15.0	8.1	0.0	7.2	20.1	50.9	7.2	6.0	11.7	26.5	14.3	8.7	28.9	10.1	0.0	6.6	10.7	10.1	17.4	13.1	10.5	20.6	11.2	13.8	11.8	9.4	8.7
MUC20	"FLJ14408, KIAA1359"	ENSG00000176945	"Mucin 20, cell surface associated"	Q8N307	3	195720884-195741123	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 58.5;kidney: 69.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.2;Ductal cells: 55.5;Ionocytes: 152.5;Respiratory ciliated cells: 66.5;Urothelial cells: 84.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		170000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042249: "	"unprognostic (1.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.99e-4)"	"unprognostic (7.66e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.17e-1)"	6.7	5.1	4.3	1.3	5.0	0.9	7.9	7.0	6.7	23.0	3.0	30.0	3.0	5.0	4.5	58.5	20.0	6.4	6.3	3.6	3.4	69.7	21.1	7.9	0.8	4.1	2.7	11.8	16.1	2.0	16.5	0.5	4.0	20.9	7.2	8.1	40.3	1.1	7.0	8.0	14.7	0.8	1.4	6.1	9.8	8.5	4.2	0.8	16.2	1.0	1.4	21.0	26.0	5.0	0.9	0.0	0.2	0.7	0.4	0.0	0.7	0.0	0.2	0.0	0.1	0.0	3.7	0.1	0.7	0.0	0.2	1.5	0.1	0.0	0.1	1.3	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.4	0.1	0.7	3.9	0.1	1.0	0.1	1.1	0.1	3.6	1.3	0.4	0.0	28.1	0.2	0.5	0.2	0.0	0.0	0.2	0.8	1.0	0.1	1.3	1.7	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.0	7.0	6.7	3.6	3.4	4.1	2.7	4.0	1.4	4.2	5.0	0.9	35.3	16.7	16.6	0.5	1.8	10.0	6.4	0.6	19.9	3.2	1.5	0.7	14.3	43.7	22.0	35.5	0.1	0.2	53.2	1.9	55.5	0.1	3.5	1.3	1.7	13.8	5.3	7.5	9.9	0.1	1.8	13.3	6.2	1.3	5.3	3.3	7.3	0.5	11.8	7.7	7.3	152.5	1.0	0.8	0.4	5.3	1.1	3.6	1.0	0.0	4.7	0.0	5.0	3.0	12.2	16.9	6.4	1.7	14.2	16.9	3.3	66.5	20.5	0.0	8.8	3.3	1.3	1.3	4.3	1.8	0.0	1.7	1.0	15.2	84.4
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508151	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	16.7	18.1	18.1	12.0	18.7	28.8	16.2	19.9	19.4	15.9	23.3	21.2	14.2	20.4	11.1	21.2	19.6	14.9	33.7	17.8	19.4	19.5	24.6	15.8	13.6	20.3	19.1	19.1	19.8	36.3	14.6	16.3	20.1	16.0	15.7	7.4	19.3	20.0	35.5	21.8	15.8	20.0	18.7	15.2	18.7	12.2	19.5	12.0	16.2	50.4	15.0	19.2	15.5	19.9	34.1	32.1	18.1	37.9	38.5	21.6	19.6	32.9	39.1	40.1	38.2	19.9	54.8	25.4	35.9	46.8	30.4	50.3	32.9	47.5	28.9	25.4	26.1	19.4	20.4	29.2	45.2	27.0	32.0	35.3	61.6	41.1	42.3	23.4	26.5	22.5	25.8	30.1	44.1	17.3	16.4	18.1	18.7	28.1	30.3	15.8	22.8	32.9	47.1	18.7	18.4	27.3	29.6	31.2	40.5	14.6	22.0	25.6	30.2	38.8	22.3	34.1	29.9	34.9	32.9	27.3	30.4	36.1	36.7	36.2	30.0	38.2	33.1	34.7	34.4	25.3	24.8	33.8	29.6	22.8	28.1	27.6	26.7	32.3	30.7	22.8	37.9	34.0	18.1	18.7	19.9	19.4	17.8	19.4	20.3	19.1	20.1	18.7	19.5	19.9	14.5	22.4	10.3	10.4	9.8	5.2	9.2	13.9	5.2	13.5	12.3	11.9	16.6	10.0	9.5	18.4	6.2	37.1	13.2	21.6	11.7	26.3	2.2	7.7	9.5	13.1	8.5	8.6	4.9	23.4	22.5	13.9	7.7	9.4	3.8	14.7	13.6	17.6	23.0	13.5	6.8	12.9	16.2	10.0	6.5	4.0	13.1	9.3	19.6	2.8	15.5	16.0	16.5	5.5	6.0	25.6	14.6	15.4	13.1	9.2	13.2	10.6	9.6	11.9	19.7	11.9	14.7	14.6	15.4	7.4	7.1	37.6	9.2	18.0	12.2	10.7
MUS81	"FLJ44872, SLX3"	ENSG00000172732	"MUS81 structure-specific endonuclease subunit"	Q96NY9	11	65857126-65867653	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059530	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA059530: AB_2684052"	"unprognostic (2.34e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.86e-2)"	20.6	18.0	15.2	13.3	15.6	11.3	20.3	15.7	20.0	32.0	14.4	31.4	16.9	35.4	7.7	16.9	30.8	10.9	25.3	14.6	13.4	28.8	19.4	21.6	18.6	16.6	15.6	29.8	19.9	10.2	22.4	11.0	15.9	26.2	7.1	8.1	16.6	15.9	24.3	14.1	23.7	12.4	14.8	29.0	22.5	16.6	16.7	16.1	23.5	16.9	13.6	29.7	22.5	18.8	21.6	13.3	22.1	22.0	9.5	11.5	28.2	22.7	17.9	28.2	18.8	17.7	34.4	20.4	30.0	17.8	35.2	20.6	19.9	19.9	6.3	44.5	14.7	37.3	39.8	10.8	29.0	26.9	38.2	18.3	36.2	35.8	28.0	20.7	24.0	36.5	22.9	55.4	18.7	14.2	38.1	41.0	16.1	14.1	29.2	37.2	10.6	39.7	21.5	13.3	22.1	25.3	15.5	27.7	48.7	13.5	32.6	27.3	21.5	21.2	18.0	27.3	24.9	37.6	26.9	29.7	24.1	17.5	36.3	22.6	13.7	27.4	21.0	16.3	21.0	13.1	15.9	18.4	14.7	10.4	12.3	15.4	9.4	13.3	18.5	14.7	15.1	13.0	15.2	15.6	15.7	20.0	14.6	13.4	16.6	15.6	15.9	14.8	16.7	18.8	19.3	12.8	18.4	15.0	17.2	8.0	21.5	13.5	10.2	19.2	11.8	15.6	10.0	11.5	16.0	7.3	20.9	20.8	22.0	27.0	5.9	24.7	62.8	12.2	22.0	16.1	16.8	25.7	9.0	22.2	23.6	13.5	27.0	13.0	14.0	15.0	16.8	9.2	19.6	23.5	8.8	23.9	10.2	13.3	8.8	130.0	21.8	14.3	10.6	9.4	27.1	15.0	32.0	8.5	12.9	26.6	24.5	27.1	12.6	11.0	36.1	12.4	16.0	24.7	39.5	11.5	21.9	27.9	16.7	8.4	7.4	19.7	19.9	15.0	21.4	10.2
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340893	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008732	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	5.0	5.0	11.9	5.5	12.7	6.7	5.3	16.7	15.6	7.6	10.6	6.0	6.4	6.3	4.6	5.1	5.7	4.2	4.0	11.6	11.9	7.0	5.9	4.4	7.7	12.8	12.4	7.3	5.1	5.1	5.9	6.4	12.7	5.8	5.6	4.9	4.5	5.0	5.6	5.9	6.1	3.6	11.7	7.8	5.8	3.3	12.2	9.8	6.6	4.7	7.0	5.9	5.8	14.4	7.9	6.9	15.5	10.5	11.3	8.4	26.6	5.7	7.4	11.8	9.2	14.3	11.2	22.5	9.0	3.6	9.5	11.3	8.7	11.0	5.4	18.1	7.0	10.2	11.4	10.5	10.0	9.4	7.1	4.6	10.3	16.0	25.7	3.1	8.6	28.6	17.5	7.4	5.0	13.3	27.3	8.7	39.6	19.5	7.9	36.2	12.6	12.3	6.1	14.6	14.5	11.8	11.3	8.7	18.2	20.1	6.7	11.1	4.9	8.3	6.2	7.2	8.2	11.6	14.6	13.3	8.0	14.6	7.5	1.6	7.0	2.9	11.5	11.8	17.2	8.1	11.8	11.5	8.1	8.0	12.7	12.2	1.4	8.8	9.1	6.5	13.4	8.6	11.9	12.7	16.7	15.6	11.6	11.9	12.8	12.4	12.7	11.7	12.2	14.4	10.0	0.0	5.6	17.0	12.1	6.9	10.7	8.1	6.2	15.6	6.7	8.8	3.2	1.5	6.9	7.3	2.1	40.2	8.8	16.5	3.9	6.5	0.9	3.2	5.1	7.6	7.8	6.7	4.0	5.3	14.3	7.5	16.8	3.2	10.8	8.4	5.7	4.3	10.0	5.0	7.0	15.1	12.2	4.0	10.2	1.6	10.8	5.6	7.2	8.4	8.2	12.0	10.3	11.6	12.7	3.8	16.4	12.0	7.5	9.5	12.9	12.2	8.6	20.1	13.1	8.7	7.6	10.5	11.2	5.2	5.4	22.2	13.9	9.5	13.5	8.0
MXD1	"bHLHc58, MAD, MAD1"	ENSG00000059728	"MAX dimerization protein 1"	Q05195	2	69897688-69942945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 173.4;esophagus: 130.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 507.0;Langerhans cells: 224.8;Paneth cells: 369.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 496.3"	"Lineage enriched"	"Detected in all"	49	"granulocytes: 496.3"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001599	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA001599: AB_1079434"	"unprognostic (1.59e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (8.14e-6)"	"unprognostic (1.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (8.72e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.77e-2)"	13.5	3.6	6.2	40.4	6.9	173.4	7.0	10.0	15.8	35.2	6.4	30.3	28.8	5.4	1.9	130.0	8.1	9.4	8.3	6.5	7.8	6.8	11.3	36.5	3.9	7.1	6.3	6.1	4.6	6.8	6.7	10.9	8.1	5.5	28.9	15.6	17.4	2.0	6.0	12.8	43.7	9.1	5.4	32.8	16.9	6.3	10.7	13.9	7.5	6.5	15.1	17.4	50.6	10.5	5.0	2.1	3.0	2.2	6.5	3.2	11.2	5.5	3.1	2.6	1.9	6.8	3.8	2.8	2.8	2.1	2.5	17.3	5.8	10.7	2.7	1.6	6.9	5.9	6.6	7.0	21.9	7.3	5.7	3.7	17.8	5.9	27.0	3.2	3.4	2.8	10.4	10.9	1.6	4.0	3.4	14.1	0.8	7.3	3.5	1.6	3.1	7.1	3.4	5.8	9.8	4.1	7.3	9.3	3.9	3.4	1.4	4.1	13.2	3.7	1.0	4.1	5.2	7.5	13.7	1.1	3.8	12.5	1.4	124.0	10.2	105.7	2.3	6.4	2.5	1.1	1.6	1.7	5.2	1.3	1.8	1.9	496.3	2.8	5.5	1.6	1.5	4.5	6.2	6.9	10.0	15.8	6.5	7.8	7.1	6.3	8.1	5.4	10.7	10.5	18.0	38.5	23.7	16.0	25.4	25.7	31.6	61.8	21.6	29.8	51.6	29.3	6.9	10.0	44.7	1.8	54.2	10.1	46.2	507.0	7.9	12.9	17.0	34.3	17.5	12.0	97.5	17.7	23.6	16.5	8.0	17.9	110.1	81.6	27.3	3.0	5.7	6.8	28.6	10.1	20.2	155.5	71.2	56.5	224.8	17.8	4.7	190.8	16.0	11.2	40.7	62.1	18.6	20.1	21.7	70.1	369.6	2.6	33.1	43.3	178.8	6.9	24.2	21.7	0.0	14.7	18.3	19.9	2.7	88.2	56.4	105.9	30.3	5.2	65.9	126.7
MXD3	"bHLHc13, MAD3"	ENSG00000213347	"MAX dimerization protein 3"	Q9BW11	5	177301461-177312757	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.7;Granulosa cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.7"	"Group enriched"	"Detected in many"	5	"B-cells: 4.1;granulocytes: 16.7;monocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 176.0"	"Group enriched"	"Detected in many"	5	"amygdala: 1.8;basal ganglia: 2.0;cerebral cortex: 1.1;hippocampal formation: 1.0;white matter: 2.4"	"Low region specificity"	"Detected in all"			HPA070111			Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA070111: AB_2686228"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.33e-16)"	"unprognostic (8.55e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-3)"	5.8	5.1	1.9	6.5	2.1	39.3	6.1	1.6	4.6	7.1	2.0	9.4	7.1	5.6	1.4	13.2	7.9	1.0	4.8	1.7	2.0	6.3	14.2	8.3	7.8	2.7	2.0	5.5	12.1	0.4	8.5	1.9	2.6	9.9	0.8	0.4	6.7	1.8	4.0	10.8	10.8	1.2	1.6	19.0	8.1	6.8	2.7	10.5	7.1	0.4	2.4	6.8	7.8	4.0	24.2	16.8	9.9	27.3	0.6	1.3	16.8	31.2	10.0	13.6	13.0	11.9	24.6	12.9	12.6	4.2	7.8	12.1	1.1	3.6	0.7	176.0	22.1	7.7	25.5	16.3	1.4	7.5	21.3	1.1	1.8	0.9	0.6	1.2	12.7	55.1	4.6	39.0	2.8	31.2	64.9	19.7	3.7	7.8	28.2	31.5	30.9	18.7	3.1	3.7	24.3	20.3	19.9	19.9	11.1	1.6	31.3	18.4	9.5	16.5	41.6	13.1	17.0	51.1	18.6	14.8	12.9	24.3	9.7	4.1	3.1	9.9	0.7	9.1	0.0	1.8	0.2	0.1	2.1	4.1	0.1	0.4	16.7	1.0	10.9	1.3	0.9	1.7	1.9	2.1	1.6	4.6	1.7	2.0	2.7	2.0	2.6	1.6	2.7	4.0	1.9	3.2	3.6	5.2	4.9	5.6	2.5	4.9	0.6	2.6	7.0	5.1	2.2	2.8	4.6	5.5	0.0	16.7	4.8	8.9	0.0	1.3	15.5	3.8	3.7	4.1	1.8	45.7	3.4	3.9	6.6	6.0	8.6	3.4	9.5	24.5	4.6	4.3	10.3	3.3	3.0	10.9	4.1	6.0	5.0	2.2	1.8	6.5	3.6	1.9	5.2	1.7	2.1	2.0	3.6	2.3	3.4	1.5	18.5	3.9	4.4	0.8	6.6	2.3	0.0	2.1	4.4	1.0	6.2	10.2	5.7	13.1	5.6	1.9	12.5	3.4
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 264.7;Oligodendrocytes: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 108.2;SK-MEL-30: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Nucleoli rim, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229"	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavorable (9.17e-4)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	34.0	32.7	86.8	13.2	98.0	68.0	45.1	92.9	106.1	38.8	67.0	55.9	24.4	45.6	36.2	52.3	42.4	32.8	63.2	84.9	91.1	39.2	51.1	26.4	13.8	93.9	91.8	81.4	44.7	50.6	22.1	28.5	94.7	41.0	35.0	80.2	80.1	52.1	47.3	47.6	29.6	29.8	89.3	14.8	28.0	23.3	94.9	31.2	54.5	53.2	12.3	34.6	41.2	110.8	18.2	8.3	18.0	39.6	30.7	21.4	7.4	11.1	39.2	7.1	23.1	3.2	33.5	24.6	17.6	20.0	11.3	24.3	23.5	27.8	20.0	13.5	30.9	7.3	15.7	14.5	19.5	14.3	14.4	21.7	96.0	12.4	55.2	108.2	7.1	17.5	26.9	54.9	11.3	12.3	10.1	26.1	7.7	31.0	21.2	6.1	26.0	39.9	22.8	1.6	34.3	52.4	11.1	7.3	167.1	23.3	9.9	42.2	7.7	13.5	21.0	13.6	5.6	44.6	26.1	10.0	34.3	46.1	12.7	1.8	2.7	9.7	2.7	2.3	5.1	3.9	5.1	2.8	1.6	3.6	7.7	1.9	5.6	1.4	5.0	1.7	4.8	2.0	86.8	98.0	92.9	106.1	84.9	91.1	93.9	91.8	94.7	89.3	94.9	110.8	28.9	16.0	16.8	139.1	27.9	58.0	57.9	22.8	51.2	49.9	67.2	66.8	80.2	41.5	27.6	33.1	47.9	5.4	23.0	160.7	46.9	19.3	5.1	29.1	36.4	34.1	16.9	264.7	60.8	14.8	20.1	36.0	15.8	37.3	3.8	19.1	27.8	56.6	11.1	52.2	102.5	20.1	18.3	24.1	20.5	8.8	45.1	22.6	104.9	30.9	29.9	144.2	9.2	131.7	214.9	10.4	52.5	55.7	22.5	73.4	57.0	67.1	25.3	46.0	46.0	69.6	63.0	23.8	28.2	37.4	67.3	9.7	36.9	27.4	16.6	36.9
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181308-135219173	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 35.2;breast: 20.1;intestine: 26.5;lymphoid tissue: 66.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.3	0.5	1.6	5.3	1.7	35.2	20.1	0.0	0.7	1.6	0.4	25.3	10.9	1.0	0.1	3.0	8.4	0.9	0.1	0.3	0.2	0.1	0.4	2.0	6.3	0.9	1.0	0.0	0.3	3.6	0.0	0.4	0.6	1.4	26.5	0.3	0.6	0.9	0.1	3.0	9.4	1.4	0.2	1.2	2.0	0.7	0.3	66.1	0.1	0.0	7.0	1.1	1.3	0.1	1.8	0.3	1.9	3.0	0.0	0.1	0.3	1.0	0.6	1.1	1.1	0.3	1.4	10.9	0.4	0.3	0.4	0.9	5.6	0.0	0.7	18.0	2.5	138.8	1.0	0.5	0.1	219.8	105.1	0.0	0.1	0.6	0.0	0.5	0.3	133.4	114.6	20.1	1.1	11.6	403.1	208.5	1.5	19.2	1.7	244.9	5.9	33.2	0.3	1.5	10.5	6.9	0.5	10.4	0.6	0.5	7.9	343.8	0.4	0.3	1.6	7.9	2.4	27.7	7.7	66.0	0.1	186.1	2.3	4.6	0.7	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.4	0.2	1.6	1.7	0.0	0.7	0.3	0.2	0.9	1.0	0.6	0.2	0.3	0.1	0.2	0.0	1.3	0.0	2.3	2.7	1.3	1.3	0.6	0.9	47.8	12.6	0.4	2.8	7.1	0.0	0.0	1.4	9.1	18.1	0.0	0.0	0.1	24.3	0.3	0.3	17.6	83.2	0.6	0.8	0.4	0.5	4.6	2.2	26.0	0.4	0.0	0.0	1.1	0.0	2.7	32.7	26.4	1.2	1.7	0.2	0.0	2.1	8.8	0.0	2.8	0.9	0.0	0.0	0.2	0.1	10.2	0.0	4.6	2.1	2.3	0.0	37.2	0.0	0.0	0.6	0.9	0.0	1.8	10.2	7.0	0.3	3.6	0.1	52.0	2.2
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 11.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 127.3;NK-cells: 107.1;Plasma cells: 40.2;Spermatocytes: 35.8;T-cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.9;MAIT T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 82.5;BJ hTERT+ SV40 Large T+ RasG12V: 69.4;Daudi: 87.7;HBF TERT88: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008791	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"	1.0	0.7	1.1	6.1	2.2	2.5	1.7	2.0	1.7	0.7	0.3	1.0	1.3	1.1	0.5	0.7	0.8	2.3	3.4	1.0	1.3	0.4	2.0	2.3	20.1	2.9	1.7	0.6	0.2	0.4	0.4	0.9	3.2	1.2	1.4	5.9	0.5	1.6	0.9	1.2	1.9	2.3	1.9	7.6	1.3	11.8	1.6	2.5	0.6	0.8	16.1	1.1	0.8	3.7	35.4	11.9	3.7	10.1	1.0	2.1	2.6	47.7	21.8	82.5	69.4	1.6	34.9	87.7	4.2	40.4	31.0	10.0	3.5	4.0	113.0	10.6	5.5	1.8	13.4	1.6	0.2	0.8	3.4	0.7	0.4	22.7	19.0	14.8	2.7	6.4	0.4	28.3	51.0	3.1	5.8	1.3	2.8	3.3	15.8	1.9	14.1	2.2	19.4	1.2	8.2	3.3	8.4	3.0	8.6	5.6	50.6	2.3	14.5	49.4	11.3	11.1	44.2	8.2	12.1	25.7	13.0	5.3	20.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	1.1	2.2	2.0	1.7	1.0	1.3	2.9	1.7	3.2	1.9	1.6	3.7	3.0	0.0	2.3	3.3	4.0	1.8	0.4	0.3	1.8	10.4	4.7	6.6	9.1	2.8	0.1	0.0	2.1	2.0	127.3	0.5	0.0	0.5	3.9	0.8	2.4	1.7	0.0	6.6	3.9	0.0	0.7	2.7	3.1	1.4	0.0	5.6	4.2	0.9	0.7	5.0	2.7	0.4	0.0	1.6	3.2	4.2	0.9	5.1	1.8	8.4	1.6	10.3	107.1	5.5	12.4	0.2	1.1	0.0	40.2	0.3	0.0	0.5	1.5	9.1	0.0	2.5	4.5	35.8	6.8	3.2	0.4	1.5	89.1	1.4	0.8	0.3
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716495	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;lymphoid tissue: 55.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 91.5"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 91.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 763.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.6	0.6	0.1	24.2	0.1	91.8	1.6	0.1	0.2	1.1	0.2	8.6	7.0	1.4	0.1	10.1	0.4	1.0	0.4	0.1	0.1	0.6	1.1	1.8	55.5	0.1	0.1	0.3	11.2	0.1	0.2	5.7	0.1	0.5	6.9	0.0	1.6	0.2	0.1	4.2	7.8	2.1	0.1	27.8	6.1	15.6	0.4	33.3	0.5	0.0	53.5	3.5	2.5	0.1	195.8	121.8	105.4	109.6	1.0	3.5	136.2	87.0	29.0	265.6	194.6	600.2	118.8	393.6	49.2	37.8	55.8	116.1	192.1	59.6	98.8	74.2	124.1	183.2	118.7	164.2	0.2	168.6	121.7	2.4	5.1	101.6	22.9	5.9	72.2	189.6	188.1	470.3	23.8	763.7	346.0	236.3	121.8	155.4	105.4	237.3	216.3	222.1	49.6	39.7	96.7	140.6	255.6	253.3	26.1	110.4	167.2	183.1	34.0	16.3	264.3	118.3	151.5	162.1	363.8	606.5	34.2	142.3	103.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	91.5	1.3	0.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	33.0	4.2	0.8	0.8	0.0	0.0	2.5	3.4	2.0	1.5	0.1	0.0	0.0	14.4	32.6	3.4	0.0	0.4	5.9	0.9	1.3	1.8	0.0	82.3	0.4	0.9	32.3	4.8	10.2	2.9	0.0	18.9	0.7	1.4	13.5	0.0	0.3	5.1	0.0	2.4	2.6	14.1	0.0	3.2	1.8	0.0	0.0	0.0	1.0	0.0	0.5	0.7	1.1	0.0	139.6	0.3	0.5	0.0	0.0	0.0	0.0	0.1	3.9	7.0	33.6	8.2	2.4	3.7	3.0	1.2	8.6	2.4
MYBPH		ENSG00000133055	"Myosin binding protein H"	Q13203	1	203167811-203175826	"Predicted intracellular proteins"	"Cell adhesion"	"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 16.2;skeletal muscle: 74.2;tongue: 19.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.3;Hofbauer cells: 1.0;Microglial cells: 1.0;Skeletal myocytes: 2.5"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 20.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.5"	"Group enriched"	"Detected in some"	5	"CACO-2: 30.6;HSkMC: 56.7;THP-1: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061383	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		9700	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA061383: AB_2684497"	"unprognostic (2.26e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.62e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.74e-1)"	0.2	0.0	0.7	0.5	1.3	0.2	0.5	0.7	2.0	0.1	0.9	0.0	0.0	0.2	0.0	1.1	0.2	0.0	0.1	0.9	0.7	1.9	3.4	0.3	0.1	1.7	1.3	0.0	0.0	0.0	1.3	0.1	3.3	3.3	0.0	0.1	16.2	0.0	74.2	0.5	0.0	0.0	0.0	1.0	0.0	0.0	2.8	1.8	0.1	19.6	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.4	7.3	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	56.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.9	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.7	1.3	0.7	2.0	0.9	0.7	1.7	1.3	3.3	0.0	2.8	1.0	0.0	0.0	1.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
MYC	"bHLHe39, c-Myc, MYCC"	ENSG00000136997	"MYC proto-oncogene, bHLH transcription factor"	P01106	8	127735434-127742951	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 254.6;skin 1: 289.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1013.3;Basal prostatic cells: 1080.5;Basal squamous epithelial cells: 1270.8;Squamous epithelial cells: 768.8;Suprabasal keratinocytes: 1070.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 1069.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000084, CAB010307, HPA055893, HPA066556"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691"	"unprognostic (1.45e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.41e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.80e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.19e-3)"	"unprognostic (9.86e-3)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (7.85e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (4.96e-5)"	254.6	59.8	2.6	62.3	2.2	53.7	115.8	3.7	3.3	54.4	3.0	57.9	30.6	53.8	3.8	99.5	167.5	83.3	45.5	2.3	6.3	20.0	64.9	47.0	49.4	9.2	5.0	100.0	103.1	7.0	12.3	33.4	6.0	32.7	36.8	0.7	42.2	14.1	50.6	289.1	48.6	54.8	4.5	60.1	70.6	12.5	5.5	47.2	27.0	15.7	39.2	63.2	96.3	4.4	56.8	89.3	9.3	100.9	166.6	209.8	28.4	72.2	31.6	87.5	72.7	137.0	150.2	587.3	86.4	43.0	82.4	122.2	383.8	226.5	67.8	128.9	167.0	370.7	189.5	203.6	150.0	282.0	52.0	138.8	560.4	55.5	490.8	74.8	104.3	217.3	549.8	315.5	49.7	151.9	394.4	616.9	27.4	273.2	204.0	203.7	46.1	1069.6	79.2	61.9	660.7	64.9	32.6	270.7	195.9	17.5	106.4	172.2	120.5	63.4	71.6	49.7	87.2	5.5	8.7	275.9	55.3	286.2	30.8	3.0	39.5	0.7	31.5	36.0	161.5	92.0	114.3	67.4	33.5	71.4	195.2	128.0	4.1	85.5	26.9	1.4	95.6	88.9	2.6	2.2	3.7	3.3	2.3	6.3	9.2	5.0	6.0	4.5	5.5	4.4	218.0	57.7	70.4	0.7	108.0	1013.3	1080.5	278.9	1270.8	0.6	251.3	207.3	10.9	44.3	98.4	12.9	0.0	20.6	20.9	23.0	1.9	78.3	1.0	43.9	224.5	158.0	12.5	189.1	1.6	43.6	61.2	337.9	46.4	72.0	57.0	47.6	141.0	25.8	26.9	0.0	1.1	67.8	97.6	43.7	133.1	3.9	98.8	23.3	168.9	1.0	17.0	1.4	5.2	0.0	0.2	66.5	40.4	67.4	45.7	364.8	4.8	13.3	21.5	0.3	46.0	458.5	349.1	0.6	0.6	768.8	1070.1	5.9	75.0	56.0	117.7	409.4
MYCBP	AMY-1	ENSG00000214114	"MYC binding protein"	Q99417	1	38862493-38873368	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 106.0;Respiratory ciliated cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041188, HPA078331"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (2.42e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (7.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.34e-3)"	"unprognostic (5.81e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.41e-2)"	11.5	11.0	2.6	16.9	3.4	16.1	18.7	3.4	4.3	12.5	3.7	22.6	16.3	9.6	17.4	23.1	27.1	11.3	8.4	2.4	2.9	18.0	11.5	12.4	16.3	5.6	7.4	6.7	16.1	18.6	8.7	19.3	4.5	14.9	22.5	8.6	16.8	16.1	12.1	13.2	21.6	11.7	2.7	11.2	16.1	15.5	3.2	12.6	18.5	5.6	17.9	16.8	11.7	5.6	51.3	22.5	18.0	13.0	10.7	18.4	74.4	38.9	12.9	38.6	29.7	27.8	56.5	42.1	43.3	18.3	6.5	35.8	29.1	51.9	46.0	52.3	49.7	44.1	29.5	26.7	2.8	107.7	38.9	16.4	38.9	32.3	20.3	14.7	28.3	45.6	64.1	35.8	41.4	31.3	35.1	54.9	47.3	75.3	53.4	33.4	54.4	58.0	50.3	40.6	34.9	23.5	37.0	47.5	25.7	42.4	33.5	52.6	23.2	20.4	33.5	31.2	45.6	25.3	48.7	45.1	20.5	63.9	26.0	51.6	32.8	85.2	18.8	39.7	21.6	22.0	22.1	22.5	40.9	17.7	18.8	21.4	64.4	27.2	38.0	54.3	33.8	22.6	2.6	3.4	3.4	4.3	2.4	2.9	5.6	7.4	4.5	2.7	3.2	5.6	9.2	9.6	13.1	0.0	18.7	10.6	15.7	31.8	22.2	0.7	25.9	14.1	7.9	20.0	37.5	27.6	0.0	106.0	26.7	35.1	64.6	27.0	68.3	84.1	11.4	11.8	9.6	38.7	0.0	27.2	86.2	9.5	21.9	17.9	26.1	9.3	8.9	15.3	21.0	10.1	0.0	25.2	26.4	15.0	14.8	25.2	7.2	20.5	19.6	0.0	31.0	5.5	18.6	0.0	0.0	29.7	40.2	9.1	69.6	18.2	31.2	50.3	142.2	5.0	6.6	6.7	14.8	29.9	64.5	53.4	17.8	88.1	19.3	14.0	31.5	22.4
MYCBP2	"FLJ10106, KIAA0916, PAM, PHR1"	ENSG00000005810	"MYC binding protein 2"	O75592	13	77044657-77327094	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 425.4;Inhibitory neurons: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 110.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058807			Supported	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA058807: AB_2732627"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	69.9	22.2	42.3	19.0	46.2	32.8	49.3	37.3	52.4	43.4	18.8	29.4	9.0	27.2	29.8	45.9	29.2	12.5	32.9	48.6	35.9	22.6	24.5	28.3	40.0	34.6	29.6	43.1	30.9	14.9	32.3	10.9	36.9	28.0	12.5	28.9	29.1	13.3	26.5	79.7	34.8	11.9	30.1	56.4	24.9	26.3	33.9	34.6	27.2	18.1	37.8	30.4	41.5	38.7	21.6	10.8	12.9	14.1	62.9	27.9	7.5	13.4	19.8	11.5	14.7	9.7	11.0	61.4	8.3	26.6	11.2	19.5	22.4	24.7	15.5	24.5	22.2	52.2	22.2	20.1	21.4	110.8	17.7	31.5	20.2	10.6	20.8	11.4	26.5	22.3	11.3	18.8	20.7	13.1	30.5	74.3	6.8	28.7	13.6	34.2	13.1	15.0	19.6	21.1	20.2	9.4	16.2	23.1	12.8	13.0	8.6	83.8	35.0	10.9	9.1	7.3	13.0	20.3	15.0	42.7	22.1	89.2	11.3	1.4	2.0	2.0	3.2	2.1	2.8	4.9	3.6	2.8	1.9	4.3	4.1	3.2	1.8	2.8	1.6	2.7	4.5	1.4	42.3	46.2	37.3	52.4	48.6	35.9	34.6	29.6	36.9	30.1	33.9	38.7	92.2	38.5	52.2	158.7	170.3	82.3	39.9	32.6	63.7	229.3	36.8	38.4	69.7	25.8	30.9	35.0	104.3	46.1	109.2	14.2	1.9	26.1	56.0	50.9	61.1	83.8	32.6	46.9	425.4	33.1	31.5	80.6	38.2	66.6	48.2	34.0	44.6	52.4	41.8	218.7	471.3	19.7	26.4	106.9	48.2	23.4	65.9	100.4	32.0	282.9	116.7	121.5	120.5	338.8	212.5	30.2	15.8	96.3	121.9	53.7	15.2	13.2	19.5	94.8	105.2	76.7	76.0	81.5	71.6	129.1	150.7	43.9	121.5	67.4	28.1	42.4
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 67.8;skin 1: 41.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 34.9;Hepatocytes: 24.3;Intestinal goblet cells: 25.0;monocytes: 27.4;Squamous epithelial cells: 34.2;Urothelial cells: 27.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 17.3;intermediate monocyte: 8.2;myeloid DC: 18.7;plasmacytoid DC: 22.8"	"Group enriched"	"Detected in many"	72	"dendritic cells: 22.8;monocytes: 17.3"	"Group enriched"	"Detected in many"	7	"U-266/70: 444.0;U-266/84: 364.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Mitotic chromosome"	"HPA063132: AB_2684946, HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"	0.8	0.3	1.8	4.7	2.0	0.6	3.3	1.2	2.0	5.2	1.8	6.1	4.8	0.9	7.2	22.1	3.1	1.5	0.5	2.2	1.7	1.5	11.4	3.3	6.4	1.5	1.5	0.3	67.8	0.3	2.9	6.7	1.6	4.2	6.7	0.2	6.4	7.5	0.5	41.5	5.7	1.1	1.9	7.6	6.2	1.3	2.0	6.5	5.3	0.5	9.5	15.9	12.8	1.6	1.2	0.4	14.4	3.5	0.2	0.1	31.8	0.5	0.2	1.0	0.7	0.4	0.8	2.2	1.4	0.1	0.4	3.3	10.4	2.7	0.8	2.0	4.9	0.5	0.3	0.5	0.4	0.3	7.5	1.0	12.1	0.4	1.3	0.2	1.2	5.4	3.2	0.4	0.6	1.2	0.2	0.3	13.4	2.2	0.4	1.3	15.5	2.9	1.1	58.0	2.5	3.1	1.4	2.1	0.8	5.5	3.7	18.7	0.0	0.0	4.6	6.2	0.5	444.0	364.6	1.0	0.1	2.3	0.3	0.0	17.3	0.0	0.0	8.2	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.2	0.0	3.4	22.8	0.0	6.7	1.8	2.0	1.2	2.0	2.2	1.7	1.5	1.5	1.6	1.9	2.0	1.6	0.4	0.0	1.1	0.0	0.8	6.6	10.0	2.1	13.1	0.4	3.8	6.0	3.7	0.0	5.5	9.2	0.0	34.9	20.1	13.4	0.0	1.5	0.1	5.1	0.6	0.5	17.3	0.0	0.2	5.8	15.4	0.9	5.1	6.3	0.0	0.0	1.4	24.3	5.1	0.0	0.3	25.0	8.2	8.3	13.1	0.4	0.0	10.6	1.8	0.0	27.4	0.8	0.0	1.0	0.0	2.9	6.5	0.0	3.6	5.3	6.4	0.1	4.9	0.1	0.0	1.4	0.7	0.0	1.2	34.2	11.8	17.5	0.3	0.0	10.8	27.1
MYCN	"bHLHe37, MYCNOT, N-myc, NMYC"	ENSG00000134323	"MYCN proto-oncogene, bHLH transcription factor"	P04198	2	15940550-15947007	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 9.5"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 84.2;Granulosa cells: 26.4"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 45.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 44.1;BEWO: 239.1;HMC-1: 57.3;NTERA-2: 91.3;RH-30: 63.3;SuSa: 40.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057420			Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli	Nucleoplasm	"HPA057420: AB_2683434"	"unprognostic (8.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.23e-1)"	0.4	0.8	3.5	0.6	3.5	0.9	0.4	3.1	3.9	1.5	0.8	0.6	1.6	0.9	0.1	0.7	0.5	0.3	1.2	3.4	3.0	3.3	0.8	0.7	1.6	4.4	3.9	5.1	0.2	0.1	0.3	9.5	3.7	0.1	0.5	1.0	4.7	0.2	0.4	1.4	0.9	0.3	3.3	0.3	4.6	3.6	3.5	2.9	2.9	0.7	1.2	0.5	0.4	5.9	0.0	0.0	44.1	0.0	0.0	0.0	239.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	4.2	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	16.8	0.0	0.0	0.0	0.0	57.3	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.8	0.4	0.2	91.3	2.1	0.0	0.0	63.3	12.8	0.0	3.1	1.0	16.0	0.0	0.1	0.0	40.9	0.1	0.0	0.0	0.0	1.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.5	3.1	3.9	3.4	3.0	4.4	3.9	3.7	3.3	3.5	5.9	0.8	0.0	0.0	0.7	0.0	0.5	0.1	0.0	0.0	2.6	0.1	0.9	0.7	0.0	0.0	0.0	0.0	5.6	0.0	0.2	0.0	0.0	1.2	0.5	0.1	2.7	0.0	4.2	2.0	0.0	84.2	1.0	2.6	0.8	0.0	26.4	0.0	0.6	2.4	0.0	4.2	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.0	0.1	1.0	0.0	10.1	7.5	0.3	1.1	0.4	0.0	0.0	0.4	3.2	0.0	0.2	0.0	4.2	0.7	1.3	3.7	0.3	0.0	11.5	0.0	9.4	0.3	0.0
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.6"	"Group enriched"	"Detected in some"	5	"Adipocytes: 123.0;Endothelial cells: 141.3;Hepatic stellate cells: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"eosinophil: 30.7"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 30.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 124.6;TIME: 104.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047992			Approved	Nucleoplasm,Vesicles		NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	26.6	3.2	6.8	5.2	6.9	1.2	21.4	6.9	10.2	9.0	5.2	6.1	3.5	10.1	4.5	4.6	9.2	10.5	17.1	6.3	7.1	6.6	13.1	15.6	6.2	7.7	6.9	3.6	2.7	4.3	2.2	20.7	8.6	4.4	5.8	1.0	3.7	3.8	12.8	4.7	5.6	12.4	6.8	49.6	4.5	1.8	10.0	2.5	12.2	20.5	3.0	8.1	7.3	7.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	17.7	0.1	0.0	0.2	0.0	0.1	0.0	23.0	0.3	0.0	0.7	0.1	0.1	0.0	0.2	0.2	0.3	0.0	124.6	0.0	0.3	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	104.4	0.5	0.8	1.5	0.0	1.1	0.0	15.6	0.0	0.0	0.0	0.9	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.6	6.8	6.9	6.9	10.2	6.3	7.1	7.7	6.9	8.6	6.8	10.0	7.5	123.0	0.0	5.2	0.7	0.8	7.1	0.2	0.1	2.8	0.2	0.4	0.9	3.1	2.8	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	10.2	1.3	0.2	141.3	0.0	13.7	0.1	0.2	0.0	4.0	0.0	0.1	1.3	0.0	230.6	2.1	0.1	0.0	0.1	0.0	0.0	7.3	7.3	3.7	0.3	13.3	14.2	30.9	0.1	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.5	0.0	0.0	17.7	0.0	0.0	1.5	2.2	0.1	0.1	0.5	5.5	0.0	0.9	0.5	0.0	0.7
MYEF2	"FLJ11213, HsT18564, KIAA1341, MEF-2"	ENSG00000104177	"Myelin expression factor 2"		15	48134632-48178353	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 87.8;Oligodendrocyte precursor cells: 88.4;Spermatocytes: 106.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 101.9;SCLC-21H: 90.8;SK-MEL-30: 91.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004883	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA004883: AB_1079436"	"unprognostic (4.30e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.76e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.55e-5)"	"unprognostic (1.32e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.05e-1)"	4.7	15.0	17.2	4.9	18.1	1.6	7.7	26.0	23.5	2.3	13.5	11.4	3.6	5.7	10.0	2.5	12.1	6.9	8.8	17.4	21.1	17.8	0.5	5.8	7.0	17.6	17.1	1.7	14.2	13.9	22.8	1.4	16.9	8.9	4.9	33.1	6.4	10.5	1.4	4.4	4.9	7.5	17.2	6.2	9.2	28.2	17.4	10.4	5.5	2.2	7.6	3.7	1.3	20.8	0.3	30.1	101.9	63.9	1.0	0.1	0.0	31.4	8.3	15.7	6.9	12.1	12.8	22.1	40.2	7.1	10.9	0.2	43.1	1.9	20.9	60.3	16.5	13.5	0.0	5.1	5.1	15.6	10.5	0.5	1.2	0.2	2.1	47.5	28.5	30.5	2.2	30.5	12.8	17.6	24.0	0.2	44.1	7.5	5.3	0.0	8.0	0.7	51.2	5.8	90.8	69.7	0.0	9.2	91.9	47.6	49.3	19.7	18.6	5.0	24.3	18.9	73.6	13.5	54.4	0.1	9.3	0.1	20.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.4	0.0	0.2	0.2	0.0	17.2	18.1	26.0	23.5	17.4	21.1	17.6	17.1	16.9	17.2	17.4	20.8	15.9	12.8	16.8	56.8	13.9	0.8	2.3	1.2	1.2	80.4	26.2	17.0	9.4	7.2	11.6	49.7	79.2	0.6	7.9	3.3	31.3	20.5	70.7	40.1	3.0	10.9	52.1	8.8	80.8	11.3	0.2	5.5	4.1	18.3	4.5	47.6	6.8	0.1	0.4	82.4	87.8	8.2	2.0	1.0	6.8	41.0	2.1	3.9	10.6	22.5	3.8	33.5	3.1	88.4	43.9	11.0	6.8	1.2	5.8	7.3	0.5	26.7	47.7	61.0	0.0	7.1	13.2	106.1	25.3	0.5	1.0	0.0	7.8	2.8	6.9	1.6
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294151-69367726	"Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.4;breast: 5.3;esophagus: 9.6;stomach 1: 6.0"	"Cell type enriched"	"Detected in many"	5	"Pancreatic endocrine cells: 199.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 172.8;A549: 83.5;CAPAN-2: 24.3;U-2 OS: 36.1"									HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Vesicles	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	5.4	0.1	0.0	0.6	0.0	0.1	5.3	0.0	0.0	1.8	0.0	0.5	0.3	0.0	0.7	9.6	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.6	0.0	0.0	4.1	0.2	0.0	0.0	0.2	6.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	3.9	0.0	172.8	83.5	0.0	0.0	0.0	0.0	2.5	0.2	0.1	0.0	0.0	0.5	24.3	0.5	6.3	0.0	0.1	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.4	0.0	0.0	6.4	0.0	0.0	0.1	0.0	0.1	8.5	0.0	2.4	0.2	0.1	3.8	0.1	0.1	0.2	3.4	6.8	0.0	0.1	3.5	0.6	0.2	0.0	0.0	0.0	2.4	0.6	0.0	2.9	0.7	1.6	0.1	36.1	0.0	1.4	0.3	1.7	0.2	0.2	0.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.0	0.8	0.8	3.8	0.0	0.0	30.7	37.7	0.4	0.0	17.6	3.7	0.0	0.0	0.9	7.8	0.0	12.6	12.7	1.2	0.1	0.5	0.0	0.0	0.0	9.4	0.4	3.4	23.9	1.5	0.0	0.1	0.0	0.2	2.4	0.0	0.0	1.3	2.0	0.0	0.0	6.9	0.3	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	199.3	22.3	0.0	3.9	1.4	0.0	0.0	1.5	0.0	0.0	0.1	2.9	0.0	0.4	3.4	1.3	0.1	0.4	0.0	2.7	8.5
MYF5	bHLHc2	ENSG00000111049	"Myogenic factor 5"	P13349	12	80716912-80719671	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 5.6;tongue: 8.9"	"Cell type enriched"	"Detected in single"	1159	"Skeletal myocytes: 347.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"LHCN-M2: 478.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041691			Supported	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA041691: AB_10796780"						"unprognostic (2.65e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	478.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	347.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MYG1	"C12orf10, Gamm1, MYG"	ENSG00000139637	"MYG1 exonuclease"	Q9HB07	12	53299695-53307177	"Disease related genes, Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 16.4;Cytotrophoblasts: 38.4;Extravillous trophoblasts: 60.7;Hofbauer cells: 70.1;Syncytiotrophoblasts: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038626, HPA038627"	Approved	Supported	Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		20000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA038626: AB_10674692, HPA038627: AB_2676123"	"unprognostic (5.33e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.61e-1)"	33.8	35.8	40.0	18.0	41.4	20.8	31.8	45.5	66.7	35.0	40.4	33.2	18.6	32.8	21.2	24.9	35.7	20.7	32.0	39.7	44.0	36.9	28.0	20.8	22.5	45.4	45.6	40.6	45.4	31.4	29.0	15.4	46.8	25.3	14.9	17.3	26.1	20.8	48.0	31.3	21.1	19.8	41.9	20.5	33.2	104.8	43.5	22.7	30.6	26.3	19.9	34.4	27.5	42.2	42.3	78.0	33.8	53.5	35.1	52.4	3.9	27.3	43.6	62.0	44.1	74.5	44.9	40.6	63.2	38.3	35.1	46.6	46.8	60.8	32.8	34.0	78.9	41.7	60.4	91.5	81.0	43.8	27.1	49.7	40.1	57.4	58.1	61.7	53.8	46.8	2.4	81.0	41.5	164.8	58.9	71.0	55.0	42.7	73.9	54.9	31.9	93.6	53.7	41.0	66.7	63.9	30.9	60.3	68.3	19.3	94.8	42.0	37.3	60.3	55.8	43.7	43.9	73.3	81.8	43.8	75.7	37.2	47.6	24.2	55.0	26.1	35.8	44.4	52.6	49.9	46.3	35.5	63.5	41.5	47.8	44.3	14.6	42.4	32.9	39.8	69.5	50.1	40.0	41.4	45.5	66.7	39.7	44.0	45.4	45.6	46.8	41.9	43.5	42.2	13.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	38.4	6.8	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	60.7	9.7	0.0	0.0	0.0	0.0	0.0	0.0	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	25.9	1.5	0.0	0.0	0.0
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 191.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 487.2;Paneth cells: 306.4;Proximal enterocytes: 376.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 48.6;CAPAN-2: 59.4;HaCaT: 119.0;MCF7: 59.0;OE19: 61.7;RT4: 147.8;SK-BR-3: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		NA	NA		9600000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.97e-8)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	12.6	1.0	24.1	7.0	35.0	0.0	8.8	38.2	23.3	13.3	22.0	64.5	83.8	1.5	0.2	63.7	15.4	3.6	41.3	20.0	30.9	10.2	25.4	24.4	0.1	38.7	35.6	0.4	17.3	16.7	18.5	0.4	35.7	8.8	19.5	5.1	44.0	5.7	191.3	87.7	76.7	1.3	29.5	0.1	45.5	2.6	34.4	1.5	33.2	35.1	6.1	11.0	31.8	37.4	48.6	5.0	0.0	25.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.1	59.4	0.2	30.1	0.0	3.7	119.0	0.1	0.0	0.0	0.1	8.7	0.0	0.0	25.7	0.0	0.0	17.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	59.0	0.0	0.3	0.8	61.7	0.7	0.1	29.4	0.7	0.0	147.8	0.1	0.2	2.9	51.8	0.0	0.2	9.7	1.9	0.0	0.1	11.7	0.2	0.1	0.9	11.2	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	35.0	38.2	23.3	20.0	30.9	38.7	35.6	35.7	29.5	34.4	37.4	0.1	80.1	36.5	23.5	2.8	3.3	18.7	29.3	0.0	3.7	17.9	9.3	21.8	44.3	50.9	57.0	2.1	0.1	0.3	487.2	0.0	53.2	0.9	58.1	6.0	1.2	51.6	0.0	10.9	27.2	0.1	1.1	85.1	70.7	14.7	0.0	2.9	45.8	0.1	16.8	21.7	109.4	22.4	0.8	1.6	0.8	0.3	1.3	5.4	2.8	0.0	19.7	0.0	23.6	27.5	67.5	306.4	0.0	0.3	30.8	376.1	7.6	80.6	11.5	0.0	17.7	3.5	0.5	4.6	30.8	21.0	0.0	2.0	0.0	122.8	86.2
MYL5		ENSG00000215375	"Myosin light chain 5"	Q02045	4	673580-682033	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 66.1"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 87.3;Proximal enterocytes: 55.5;Rod photoreceptor cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 60.4"					"Not detected"	"Not detected"			"HPA037381, HPA039262"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA037381: AB_10672484, HPA039262: AB_2676418"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-2)"	17.9	21.4	21.8	7.0	21.8	11.4	16.6	21.9	36.0	10.6	19.4	20.7	20.7	7.4	17.8	20.0	7.9	8.3	10.4	21.0	20.4	19.4	22.2	11.0	11.0	22.8	21.1	7.7	9.9	15.3	13.7	5.1	22.3	18.2	13.0	66.1	13.3	8.9	24.6	18.6	25.2	5.6	20.9	16.1	12.3	22.2	21.9	10.0	13.6	8.3	10.3	11.2	13.3	23.5	4.3	6.9	24.8	13.2	60.4	41.2	11.9	10.2	13.6	10.2	9.3	8.4	17.7	4.9	4.8	16.6	7.3	6.2	4.0	7.0	3.0	9.2	5.0	7.4	11.7	7.9	21.0	11.3	6.5	31.3	6.5	8.1	8.4	14.8	6.3	10.4	7.7	6.5	12.7	8.0	6.1	7.8	5.2	8.8	10.4	5.4	5.3	3.0	16.9	19.9	11.3	6.4	3.4	8.5	7.2	8.0	13.7	10.2	10.4	8.7	1.6	7.5	6.0	24.7	5.3	2.9	9.5	10.1	4.6	15.5	8.2	1.5	3.3	5.5	4.2	8.7	5.6	2.0	7.7	12.7	6.7	6.8	5.8	18.4	12.3	14.5	2.6	5.8	21.8	21.8	21.9	36.0	21.0	20.4	22.8	21.1	22.3	20.9	21.9	23.5	4.5	0.0	11.9	2.3	11.7	12.0	6.8	12.8	18.2	6.3	12.9	14.5	1.4	7.2	5.7	7.3	20.9	7.3	9.2	22.7	11.7	9.6	22.2	9.1	6.9	5.9	5.4	4.2	1.4	4.7	5.4	7.5	13.7	5.3	13.9	4.9	10.4	18.3	22.7	11.8	1.3	11.4	6.1	21.2	8.6	87.3	7.2	12.4	7.2	1.0	22.8	22.2	13.4	0.5	1.6	6.1	13.2	3.8	5.1	8.3	55.5	42.6	8.2	74.3	6.6	21.7	5.6	14.1	4.4	21.2	13.4	5.5	5.9	14.7	15.4	9.7
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46702282-46790407	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 103.4;skeletal muscle: 46.5;tongue: 72.6"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 169.0;Endometrial ciliated cells: 44.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.9;HEL: 40.2;K-562: 6.5;SK-BR-3: 7.9"	"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.6;hippocampal formation: 5.1"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 3.5"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	1.9	0.1	1.7	0.3	0.1	1.1	2.3	0.4	1.7	0.0	0.1	0.3	0.8	4.3	1.7	0.2	103.4	2.5	2.8	1.1	0.1	0.4	0.2	9.8	12.2	0.3	0.1	0.0	0.4	0.5	8.2	2.2	0.1	0.2	2.1	0.1	46.5	0.1	0.1	0.2	5.9	0.1	0.1	6.0	1.9	0.1	0.1	72.6	0.1	0.0	0.0	3.0	0.0	0.1	0.1	0.1	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	2.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	6.5	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	7.9	0.2	3.5	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	1.9	1.7	1.1	2.3	2.5	2.8	9.8	12.2	8.2	5.9	1.9	3.0	0.2	0.0	3.3	0.7	0.5	0.0	0.7	0.0	0.0	0.9	1.3	0.0	169.0	0.0	3.7	0.0	2.1	2.0	0.2	0.0	0.0	0.0	8.1	44.8	7.1	1.7	0.0	0.0	0.9	0.2	0.5	6.7	0.0	2.2	1.3	1.6	0.7	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	7.2	0.6	0.8	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.8	0.0	0.2	8.7	1.3	0.0	4.9	2.7	1.0	0.7	0.0	0.0	0.3	0.8	0.7	0.0	0.8
MYNN	"SBBIZ1, ZBTB31, ZNF902"	ENSG00000085274	Myoneurin	Q9NPC7	3	169773396-169789716	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045149	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA045149: AB_10960839"	"unprognostic (7.13e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.36e-3)"	6.0	5.3	3.4	6.5	4.1	14.8	9.7	7.2	4.5	7.9	4.4	5.7	5.1	10.3	6.3	7.1	6.8	6.2	5.8	3.1	3.4	6.8	7.9	6.4	8.7	3.0	3.5	10.0	7.3	8.4	3.6	7.1	3.3	7.2	7.0	15.3	6.3	6.3	7.9	7.8	6.8	8.4	3.5	7.9	7.0	9.9	3.4	7.6	8.5	10.8	9.8	7.4	5.5	5.2	13.1	6.0	6.9	13.6	14.2	12.2	8.7	8.6	12.4	13.0	14.3	7.3	13.1	19.7	15.3	9.4	10.3	10.2	12.5	10.9	17.2	17.7	9.8	18.4	9.1	7.2	12.0	17.1	12.9	10.8	13.9	7.9	22.8	10.5	11.7	8.6	7.9	18.9	13.0	11.0	10.1	8.8	10.4	16.1	6.6	11.1	9.7	21.4	8.6	22.1	9.6	11.3	10.4	23.5	14.8	9.0	29.0	12.5	8.7	11.9	5.4	11.1	16.6	21.6	16.4	26.8	9.5	10.6	11.7	22.2	4.8	11.2	7.3	5.2	10.0	8.1	8.4	7.1	5.5	7.9	10.0	7.7	6.7	10.8	4.5	5.5	9.1	7.7	3.4	4.1	7.2	4.5	3.1	3.4	3.0	3.5	3.3	3.5	3.4	5.2	25.8	28.9	21.6	10.7	25.2	41.3	31.1	21.4	46.7	9.0	14.9	12.1	14.7	14.3	20.3	11.0	22.9	14.6	20.1	9.8	13.7	10.4	46.3	15.8	14.8	20.3	14.3	14.5	15.6	9.4	17.0	16.6	19.4	20.3	7.6	12.7	11.4	7.3	8.2	10.1	15.0	8.4	20.3	7.5	14.0	12.6	17.1	12.3	16.0	13.1	12.7	13.3	19.6	12.5	14.0	9.9	9.4	18.8	31.6	18.1	12.2	12.3	18.3	31.7	6.6	15.7	14.7	34.9	18.8	27.3	38.4	20.8	25.5	12.0	9.6	25.7
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"	Q8IUG5	22	25742144-26031045	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 120.8;skeletal muscle: 262.7;tongue: 55.6"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 95.5;Early spermatids: 61.4;Late spermatids: 37.3;Skeletal myocytes: 32.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.8"	"Region enhanced"	"Detected in single"		"thalamus: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.6;REH: 15.0;RH-30: 30.5;U-2 OS: 13.2;U-266/70: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Centrosome"		"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	0.2	0.1	0.3	0.1	0.1	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	120.8	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.8	0.0	0.1	0.0	0.2	0.0	0.3	1.0	0.0	0.0	2.7	0.0	262.7	0.5	0.0	0.0	0.2	0.0	1.5	10.2	2.3	1.9	0.1	55.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	5.3	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.0	4.0	0.0	0.4	1.6	0.0	0.0	0.0	15.0	30.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.2	0.0	0.0	9.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.1	0.3	0.3	0.8	0.3	0.2	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.2	1.2	0.0	0.0	1.8	0.0	0.0	1.7	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	37.3	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.7	0.9	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 330.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 174.5;Proximal enterocytes: 690.2"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in many"		"white matter: 8.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 43.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA053490: AB_2682168"	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.2	0.2	0.1	5.1	0.4	0.1	0.1	0.8	0.2	0.0	0.7	68.3	330.0	0.4	0.0	0.2	0.1	4.1	0.0	0.1	0.2	0.1	0.1	0.2	0.3	2.1	2.0	0.0	0.2	0.0	0.1	0.2	1.8	0.1	65.7	0.1	0.0	0.2	0.1	0.1	309.8	3.0	3.7	0.1	16.3	1.0	0.6	0.4	0.0	0.0	0.1	0.0	0.1	8.3	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	8.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	1.5	0.1	43.3	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.2	0.1	0.2	2.1	2.0	1.8	3.7	0.6	8.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.9	4.3	0.1	0.0	0.0	0.0	0.0	174.5	0.0	0.1	0.7	0.3	0.0	0.1	24.7	0.0	0.1	0.0	0.0	0.1	26.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	85.4	0.0	0.3	1.0	1.2	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.3	66.8	0.0	0.1	0.0	690.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.4	0.1	0.0	0.4	0.0	102.3	0.1
MYO1E	"HuncM-IC, MGC104638, MYO1C"	ENSG00000157483	"Myosin IE"	Q12965	15	59132434-59372871	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 319.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 23.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 224.1;HaCaT: 208.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003003, HPA023886"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		13000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA003003: , HPA023886: AB_1854253"	"unprognostic (7.90e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (4.19e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (5.38e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	30.6	7.1	19.4	32.9	34.9	1.8	19.5	32.2	30.7	27.7	43.6	54.3	25.3	31.0	29.6	37.6	17.4	38.7	13.3	19.6	24.9	47.7	52.2	19.9	36.9	38.6	35.0	10.3	12.0	22.4	9.3	34.7	39.4	22.9	34.4	9.9	18.7	21.6	11.9	45.6	44.2	22.2	28.4	17.1	32.5	8.3	33.1	7.6	15.2	10.9	41.2	38.1	28.1	57.1	133.3	224.1	12.1	8.2	92.4	74.8	62.2	52.9	25.7	28.8	33.6	55.7	50.5	52.7	37.0	41.3	117.5	208.6	18.9	81.5	38.2	24.1	10.5	0.5	178.4	50.3	85.5	0.3	7.2	103.4	48.8	37.0	107.4	90.7	47.8	0.9	0.3	0.8	49.2	12.4	0.6	1.2	29.3	21.5	49.8	0.2	53.8	32.4	156.9	61.8	6.5	21.9	117.1	24.2	45.8	36.5	16.3	5.8	58.4	57.5	16.6	177.1	52.0	0.3	3.3	1.3	105.4	0.6	53.2	0.0	4.5	0.0	0.2	4.6	0.0	9.2	0.0	0.0	15.4	8.6	0.0	0.0	0.6	3.6	1.6	23.7	0.5	2.5	19.4	34.9	32.2	30.7	19.6	24.9	38.6	35.0	39.4	28.4	33.1	57.1	31.0	6.4	7.7	27.1	19.6	24.9	40.0	24.7	24.5	0.2	9.3	10.2	3.9	17.2	15.4	25.8	0.0	4.3	19.9	73.6	3.9	39.8	4.2	49.4	30.2	30.4	19.7	2.5	9.3	18.1	23.8	14.9	86.6	47.3	4.5	6.7	5.0	13.0	33.5	0.0	8.7	31.2	8.2	5.0	50.1	8.5	9.3	17.6	19.6	56.2	9.0	11.3	3.1	6.6	319.1	64.0	60.0	12.0	9.2	28.3	37.4	3.1	40.9	0.9	13.1	33.7	25.0	1.3	5.1	30.1	24.0	12.9	4.7	6.7	29.3	56.9
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979088	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.6;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 81.3;Langerhans cells: 65.1;Macrophages: 74.2;monocytes: 392.2;NK-cells: 252.4;T-cells: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.6;HEL: 64.1;HL-60: 39.9;JURKAT: 85.9;MOLT-4: 97.3;NB-4: 52.1;THP-1: 68.6;U-937: 57.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.2	0.8	0.4	16.6	0.3	43.6	1.0	0.3	0.6	0.8	0.3	2.0	3.3	0.7	0.3	1.5	1.2	3.5	0.9	0.3	1.0	0.9	1.3	12.0	25.1	1.4	0.7	0.3	0.7	0.1	0.5	1.2	0.6	1.1	1.8	0.0	2.3	0.7	0.3	0.9	7.8	2.8	0.6	19.0	3.3	0.4	1.6	27.2	1.6	0.4	14.8	6.1	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	52.6	0.0	64.1	2.7	0.0	0.0	39.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	97.3	52.1	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	57.3	0.0	41.5	58.3	18.5	61.5	95.5	38.4	27.7	40.5	55.6	42.7	18.9	14.1	29.6	6.0	23.9	129.8	4.5	79.9	79.9	0.4	0.3	0.3	0.6	0.3	1.0	1.4	0.7	0.6	0.6	1.6	0.8	0.9	3.2	7.7	0.0	55.7	2.8	0.4	0.0	0.0	0.2	1.2	1.3	1.1	1.5	1.3	0.0	0.0	0.2	81.3	0.2	0.0	0.3	0.6	0.3	0.5	1.0	0.0	6.3	0.1	1.1	0.3	2.3	2.0	0.6	30.4	0.4	2.2	1.4	10.5	3.3	0.0	0.2	0.0	58.7	65.1	1.6	0.0	74.2	3.6	0.0	392.2	0.3	252.4	0.5	0.0	0.2	0.1	0.4	33.4	0.4	0.0	0.6	0.7	0.2	6.6	2.0	1.4	3.8	1.2	0.2	1.7	0.1	87.1	1.2	0.1	0.2
MYO5C	MGC74969	ENSG00000128833	"Myosin VC"	Q9NQX4	15	52192322-52295804	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 68.5;Alveolar cells type 1: 131.4;Alveolar cells type 2: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;MCF7: 46.3;OE19: 41.2;RT4: 26.4;SK-BR-3: 34.0;T-47d: 40.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020790, HPA032115, HPA032116"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"CAB020790: , HPA032115: AB_2674158, HPA032116: AB_2674159"	"unprognostic (1.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (2.94e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.82e-2)"	"prognostic favorable (2.47e-5)"	"prognostic favorable (5.82e-4)"	"unprognostic (9.15e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.32e-1)"	11.1	1.5	3.0	2.8	3.3	0.8	13.2	7.9	3.1	14.1	17.0	14.0	5.3	4.2	12.8	7.0	11.5	6.9	1.6	2.6	2.9	5.6	3.4	13.8	1.9	5.1	2.8	1.6	27.3	13.7	7.3	2.5	6.3	10.3	17.7	1.6	21.1	4.4	2.1	4.8	5.1	4.0	7.3	3.5	19.4	4.7	3.3	1.9	17.9	2.6	2.4	4.4	4.4	5.9	21.4	25.4	3.5	0.0	0.0	0.1	3.0	0.0	0.3	0.1	0.0	3.9	8.8	1.2	5.3	0.1	0.2	3.4	5.3	7.4	0.0	1.1	8.4	0.1	17.3	15.7	0.0	0.0	0.2	0.0	7.2	0.0	6.8	3.6	5.6	0.9	0.0	0.3	0.1	46.3	1.3	0.2	1.4	41.2	12.0	17.6	2.1	10.6	19.5	26.4	3.5	3.9	1.6	34.0	0.0	5.4	40.9	0.0	0.0	0.0	0.2	0.0	3.3	0.7	0.7	2.1	0.1	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.0	3.0	3.3	7.9	3.1	2.6	2.9	5.1	2.8	6.3	7.3	3.3	5.9	68.5	131.4	84.5	3.9	1.5	0.6	20.5	10.2	2.2	0.4	22.4	10.9	4.9	18.6	47.1	22.0	0.0	2.3	0.3	26.5	3.9	21.1	2.8	34.1	4.8	26.1	5.4	2.1	29.3	29.6	1.5	3.7	41.3	50.4	3.8	5.1	2.5	5.1	0.9	0.0	3.9	47.1	22.4	0.8	3.1	3.2	1.8	1.4	7.2	14.0	0.1	5.6	1.0	8.0	2.8	39.0	21.5	0.4	2.7	28.1	2.1	1.3	49.8	0.5	0.0	1.3	1.5	9.0	5.9	14.1	1.4	0.7	1.6	2.0	25.8	38.7
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.5;MAIT T-cell: 3.0;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.1;naive CD8 T-cell: 3.0;NK-cell: 2.9"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.9;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"RT4: 103.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	9.9	9.5	18.6	7.1	29.3	0.3	28.3	22.6	32.0	18.5	32.6	22.1	33.0	7.6	22.9	32.0	11.5	27.0	5.3	19.6	19.5	51.4	15.2	23.2	4.7	23.7	24.4	4.7	21.6	40.4	14.5	7.6	24.3	17.2	19.2	49.0	25.9	19.9	3.4	16.8	33.9	5.7	16.0	7.6	27.6	14.6	23.9	5.1	15.9	3.1	12.8	24.0	15.8	34.6	52.2	13.0	12.3	8.9	29.7	23.7	42.6	20.7	23.6	12.3	18.3	22.2	44.2	0.1	16.1	25.7	14.0	40.0	15.3	29.2	18.6	17.0	30.3	17.4	5.6	14.1	25.0	0.0	22.2	17.5	21.6	19.3	14.5	24.0	43.3	7.9	22.4	7.2	15.4	48.3	0.2	0.8	7.7	44.1	3.8	0.7	29.1	1.6	51.1	103.6	26.8	14.8	5.6	46.6	6.8	28.3	16.5	35.8	59.4	13.7	9.3	0.6	20.0	13.2	16.1	0.3	10.9	0.2	5.3	0.2	0.1	0.1	5.5	0.0	3.0	0.2	1.8	3.1	0.0	0.1	0.4	3.0	0.6	2.9	0.1	0.1	0.2	0.8	18.6	29.3	22.6	32.0	19.6	19.5	23.7	24.4	24.3	16.0	23.9	34.6	74.8	141.1	207.0	286.3	4.7	30.1	87.5	49.2	18.2	83.6	99.6	35.9	8.1	38.6	91.3	150.8	120.9	32.0	14.7	112.2	54.8	128.9	7.0	86.9	26.9	57.2	85.0	0.0	147.8	120.3	23.8	30.5	91.7	169.2	26.0	81.0	37.9	33.8	6.3	95.9	167.2	76.4	116.0	2.9	6.1	9.6	30.1	6.7	30.2	105.9	2.7	307.3	12.3	179.4	409.1	197.0	99.7	43.2	11.4	165.9	105.7	97.6	109.5	188.4	13.1	26.5	32.7	14.4	32.1	28.3	34.1	78.4	13.4	191.8	77.5	199.7
MYOCD	MYCD	ENSG00000141052	Myocardin	Q8IZQ8	17	12665890-12768949	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.2"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 47.3;Endometrial stromal cells: 48.5;Peritubular cells: 100.8;Sertoli cells: 26.3;Smooth muscle cells: 32.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 6.5;BJ hTERT+: 6.4;HBF TERT88: 10.4;hTEC/SVTERT24-B: 11.7;REH: 8.4;SuSa: 12.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.1"	"CAB046485, HPA071528, HPA072582"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB046485: AB_10600720, HPA071528: , HPA072582: "	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.79e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.15e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.91e-2)"	3.2	1.0	0.4	4.3	0.7	0.0	1.2	0.3	0.8	9.4	1.6	24.2	2.6	13.0	2.4	13.1	8.5	4.6	14.2	0.4	0.4	0.7	0.2	2.7	0.1	0.5	0.5	4.4	0.3	0.1	0.2	3.4	0.8	8.8	4.9	0.0	0.2	20.7	0.5	1.3	5.1	15.8	0.5	0.6	6.1	2.1	0.8	0.1	0.7	0.8	0.1	17.2	4.4	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	6.4	2.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.4	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	12.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.8	0.4	0.4	0.5	0.5	0.8	0.5	0.8	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	47.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.0	48.5	1.2	7.8	0.0	1.2	0.2	0.1	3.6	0.0	1.0	0.0	8.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.5	0.6	0.2	0.0	9.4	0.0	0.0	0.0	1.0	0.3	0.0	0.0	100.8	0.0	0.1	0.0	0.1	0.0	0.0	26.3	0.2	32.9	0.3	0.8	0.1	0.9	0.5	0.4	6.0	0.0	0.1
MYOD1	"bHLHc1, MYF3, MYOD, PUM"	ENSG00000129152	"Myogenic differentiation 1"	P15172	11	17719571-17722136	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 36.1"	"Group enriched"	"Detected in some"	9	"Skeletal myocytes: 10.0;Spermatogonia: 3.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 461.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA055436, HPA078647"			Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA055436: , HPA078647: "						"unprognostic (1.07e-3)"				"unprognostic (2.10e-1)"					"unprognostic (1.01e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	461.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083129-203086012	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"skeletal muscle: 101.0;tongue: 46.7"	"Cell type enriched"	"Detected in single"	36	"Skeletal myocytes: 11.0"	"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	222	"HSkMC: 29.6;RH-30: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA028336			Supported	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA028336: AB_2672562"	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.2	0.0	0.2	4.1	0.0	101.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.6	0.0	46.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.0	0.4	0.2	2.5	0.4	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MYOZ2	"C4orf5, CS-1, FATZ-2"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135832-119187789	"Disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 771.4;skeletal muscle: 225.5;tongue: 173.4"	"Cell type enriched"	"Detected in some"	51	"Cardiomyocytes: 2275.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;HSkMC: 2.3;SK-MEL-30: 6.2;U-87 MG: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	0.6	0.3	0.2	0.0	0.3	0.0	2.1	0.1	0.5	0.7	0.0	1.0	0.0	2.0	0.3	1.0	1.0	0.3	771.4	0.2	0.3	0.7	0.1	0.9	0.3	0.2	0.2	0.6	0.1	0.0	0.2	0.2	0.1	4.8	0.1	0.0	1.8	0.3	225.5	0.5	0.4	0.8	0.2	0.6	0.6	1.0	0.3	0.3	0.3	173.4	0.1	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.2	1.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2275.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	20.8	0.0	0.0	3.4	2.2	0.0	44.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.7	0.0	0.2	0.0	2.9	0.0	0.0	6.6	6.9	22.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 64.1;skeletal muscle: 283.6;tongue: 172.8"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 114.2"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 39.8;fHDF/TERT166: 112.3;HBF TERT88: 25.6;LHCN-M2: 47.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	0.1	0.3	0.2	0.2	0.1	0.6	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.1	0.1	2.2	0.0	0.1	64.1	0.8	0.8	0.0	0.0	0.0	0.2	0.6	0.2	0.1	0.6	0.0	0.0	0.1	0.1	1.7	0.1	1.7	2.7	0.0	283.6	0.1	0.1	0.2	0.0	0.1	0.8	0.9	0.0	0.1	0.0	172.8	0.0	0.1	0.0	0.3	2.9	1.3	0.0	0.0	0.7	4.1	0.1	39.8	19.7	14.4	5.4	0.0	0.1	0.1	0.0	112.3	20.5	0.7	0.0	0.2	25.6	0.4	0.0	0.0	14.6	0.0	0.3	0.0	0.1	1.6	0.0	7.9	0.9	3.6	0.4	0.0	0.0	0.2	47.6	8.6	0.0	0.1	0.0	0.0	1.3	0.0	2.2	0.0	0.1	0.1	0.1	0.0	5.7	0.9	0.2	0.1	0.0	0.0	1.1	0.7	0.2	4.1	0.1	0.1	0.0	0.0	4.6	0.1	4.2	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.8	0.8	0.6	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.2	0.0	114.2	0.0	0.0	0.0	25.0	0.0	0.0	1.8	0.0	0.0	1.0	1.5	0.1	0.7	0.0	0.0	0.5	0.2	0.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.1
MYPOP	P42pop	ENSG00000176182	"Myb related transcription factor, partner of profilin"	Q86VE0	19	45890023-45902613	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 27.7;NB-4: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065307			Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA065307: AB_2685460"	"unprognostic (5.13e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.67e-5)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-3)"	5.8	7.8	15.5	3.0	14.6	1.4	5.7	10.0	23.2	8.6	3.6	8.5	4.4	7.5	2.3	8.5	8.8	1.5	12.0	17.0	9.8	10.0	8.4	5.4	3.4	13.5	10.2	6.5	7.9	2.9	12.9	2.1	13.0	9.0	1.9	5.3	7.3	2.7	17.3	7.5	7.2	2.1	8.2	10.7	7.3	7.6	12.4	4.1	6.2	7.8	2.5	7.7	8.2	15.9	6.2	9.7	3.6	7.4	4.5	2.9	7.2	4.4	4.5	4.8	6.2	3.9	3.8	5.9	4.2	2.2	4.7	5.1	2.7	2.0	3.4	27.7	15.5	2.8	5.8	6.3	5.0	2.8	8.5	2.8	5.6	2.7	2.5	5.1	4.0	9.7	3.8	5.1	3.1	2.6	14.7	37.8	4.0	7.9	9.6	11.6	1.5	3.4	2.8	3.4	7.4	5.6	4.3	4.7	5.0	2.6	3.2	10.2	5.1	4.4	7.4	4.2	7.1	15.0	11.6	3.8	6.5	7.4	5.4	0.0	0.2	0.5	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	15.5	14.6	10.0	23.2	17.0	9.8	13.5	10.2	13.0	8.2	12.4	15.9	4.6	3.2	2.0	3.3	5.8	11.5	5.2	7.5	9.6	10.9	4.4	5.5	16.0	4.3	3.3	5.5	8.4	5.4	3.5	8.1	23.5	8.2	7.3	2.6	5.4	4.9	9.0	5.2	9.4	8.9	19.4	6.6	3.1	3.6	0.0	4.8	4.2	3.4	5.6	6.7	10.2	5.1	4.1	5.7	9.8	2.3	7.2	5.5	3.6	7.5	7.6	4.9	8.2	6.0	7.7	6.1	5.5	7.5	10.5	4.2	15.8	8.5	2.1	11.7	19.7	4.2	5.5	7.0	5.1	6.6	9.8	5.3	4.8	4.8	5.2	3.1
MYRF	"C11orf9, MRF, Ndt80, pqn-47"	ENSG00000124920	"Myelin regulatory factor"	Q9Y2G1	11	61752636-61788518	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 168.0;stomach 1: 88.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1;Cholangiocytes: 60.1;Gastric mucus-secreting cells: 130.0;Oligodendrocytes: 255.8;Pancreatic endocrine cells: 70.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 38.8;CACO-2: 63.6;CAPAN-2: 34.0;EFO-21: 48.6;Hep G2: 21.8;OE19: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018310			Approved	Nucleoplasm,Cytosol		NA	NA		1400000		"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA018310: AB_1845534"	"unprognostic (3.51e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	15.4	0.6	31.3	1.1	99.0	0.3	0.4	67.9	67.5	2.2	0.0	3.8	11.4	13.1	0.1	2.4	15.4	17.3	2.4	36.9	48.8	12.0	16.9	22.3	0.1	101.7	89.4	17.6	31.6	0.0	0.4	1.1	84.9	0.7	1.1	0.4	0.6	0.3	0.1	0.5	10.8	1.9	43.5	0.5	88.3	3.1	85.7	0.0	0.3	0.0	0.1	0.5	0.6	168.0	3.1	38.8	4.7	1.5	0.0	0.0	0.2	0.2	0.1	0.9	0.8	63.6	34.0	0.9	48.6	0.0	1.2	0.3	1.3	0.0	0.9	0.1	0.6	0.2	0.7	21.8	18.9	0.0	0.4	0.3	0.0	0.6	0.0	10.9	0.1	1.6	11.7	0.3	0.2	0.5	0.0	0.9	1.6	37.2	4.8	0.0	0.1	1.9	6.5	0.0	0.1	0.9	0.0	0.4	0.3	10.6	0.6	0.4	1.4	0.4	19.5	0.0	0.6	0.2	0.1	0.3	0.1	2.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	99.0	67.9	67.5	36.9	48.8	101.7	89.4	84.9	43.5	85.7	168.0	0.1	48.1	5.1	2.3	0.6	0.1	0.1	0.2	0.0	0.5	0.8	0.8	1.3	60.1	3.4	3.7	0.0	0.4	1.6	6.4	0.0	31.7	0.2	1.4	3.2	0.6	1.2	0.0	0.9	36.7	0.3	5.6	130.0	4.1	0.0	4.4	0.7	6.0	0.9	0.0	1.1	4.5	6.1	0.0	0.6	1.2	5.9	0.8	3.6	0.0	1.0	3.5	0.0	5.5	255.8	70.5	13.0	3.8	0.4	0.2	12.8	2.2	1.3	0.3	0.0	0.2	1.2	1.4	3.7	0.8	0.0	0.8	0.7	0.3	7.7	3.1
MYRIP	"DKFZp586F1018, exophilin-8, SLAC2-C, SLAC2C"	ENSG00000170011	"Myosin VIIA and Rab interacting protein"	Q8NFW9	3	39808914-40260321	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 295.6;Inhibitory neurons: 507.3;Microglial cells: 210.8;Oligodendrocyte precursor cells: 98.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.1;HUVEC TERT2: 15.6;REH: 3.7;SCLC-21H: 3.2;SH-SY5Y: 9.4;T-47d: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006433			Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus"		"HPA006433: AB_10603023"	"unprognostic (1.87e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.96e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.16e-2)"	4.1	1.0	16.8	1.3	13.3	0.0	3.7	11.1	18.4	5.7	15.4	2.7	1.7	3.2	2.2	1.3	2.8	2.7	2.4	17.3	7.7	1.5	11.5	0.8	1.6	9.2	17.8	3.1	8.9	2.1	2.9	0.1	13.0	2.0	2.6	4.3	12.5	0.8	1.7	1.2	2.4	2.3	4.2	7.2	5.6	0.9	12.0	0.5	1.5	0.5	1.7	1.4	2.6	15.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.0	0.1	3.7	0.0	0.0	0.4	2.0	3.2	9.4	0.0	0.0	0.0	0.0	3.8	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	13.3	11.1	18.4	17.3	7.7	9.2	17.8	13.0	4.2	12.0	15.0	15.8	0.0	3.2	36.2	0.4	0.8	0.1	0.0	1.2	2.7	0.5	0.3	2.4	5.7	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.1	19.9	1.1	0.7	21.3	0.0	1.7	295.6	2.8	0.0	1.6	3.1	6.2	2.5	14.0	42.8	17.4	0.0	5.0	507.3	11.9	0.0	2.8	0.7	6.1	0.9	0.1	0.0	210.8	0.0	6.6	0.0	98.0	24.5	0.6	0.1	0.0	0.0	1.4	0.1	1.8	0.1	4.2	0.0	0.3	0.7	3.1	0.6	0.1	0.6	0.0	0.3	0.1	0.7	0.1
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58643440-58700077	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	11.2	7.5	4.0	4.4	3.9	12.5	12.0	4.3	5.9	11.9	4.2	11.8	5.4	10.6	6.2	10.0	10.2	3.1	10.5	4.1	3.9	7.2	8.0	10.1	6.3	3.9	3.7	13.2	12.1	5.9	8.7	4.4	3.9	9.6	4.4	8.4	11.8	4.1	10.0	10.5	12.6	3.6	3.7	11.4	9.9	4.4	3.9	5.3	11.5	3.1	4.9	9.3	11.1	4.4	10.1	2.6	5.0	6.7	6.0	7.2	10.5	5.9	5.6	5.1	3.9	5.3	4.2	10.3	1.8	3.8	4.8	7.4	7.7	2.1	11.0	6.2	4.3	11.3	2.1	5.1	7.4	19.6	9.7	5.4	5.9	7.5	3.8	6.1	1.2	4.2	12.6	6.3	6.8	2.6	7.8	16.3	11.4	3.5	3.5	7.3	16.4	6.1	4.6	3.8	5.8	6.6	4.4	9.4	13.9	9.0	3.1	10.6	4.9	9.3	4.6	6.4	11.3	10.8	5.8	13.9	5.8	13.7	11.6	0.9	0.3	0.1	0.3	0.4	0.2	0.4	0.3	0.3	0.1	0.3	0.5	0.4	1.0	0.1	0.5	0.4	0.4	0.1	4.0	3.9	4.3	5.9	4.1	3.9	3.9	3.7	3.9	3.7	3.9	4.4	36.5	22.4	33.7	47.7	26.0	19.1	22.8	13.5	30.7	19.5	25.6	21.0	28.2	10.0	35.1	11.0	25.0	8.4	36.6	22.1	15.6	8.8	3.9	22.1	34.8	25.4	16.2	14.1	87.4	9.4	5.7	20.8	19.9	36.9	56.3	30.1	23.9	16.3	11.3	18.5	58.2	17.0	24.4	13.9	14.2	6.3	12.8	22.2	8.8	35.6	21.3	12.7	22.6	58.3	106.9	12.7	13.1	17.3	29.5	19.3	19.2	8.8	21.2	27.8	26.3	28.8	21.5	15.5	20.6	25.0	18.5	11.4	30.8	22.0	18.5	26.4
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.6;retina: 8.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 31.9;Cone photoreceptor cells: 60.5;Horizontal cells: 26.9;Oligodendrocyte precursor cells: 112.1;Rod photoreceptor cells: 29.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 7.6;SCLC-21H: 23.1;SH-SY5Y: 6.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.5"	HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.2	3.5	5.8	0.2	3.8	1.1	0.1	24.6	4.3	0.0	0.0	0.2	0.8	0.1	0.2	0.0	0.2	0.1	0.1	3.8	6.6	0.1	0.1	0.1	0.1	5.0	5.6	0.1	0.6	0.3	5.5	0.1	5.2	0.1	0.2	8.3	0.0	0.1	0.0	0.1	0.2	0.1	2.7	0.2	0.6	0.7	5.9	0.1	0.6	0.0	0.1	0.1	0.0	3.6	0.0	0.1	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.7	0.3	0.1	0.3	0.0	2.4	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.2	1.7	0.0	0.1	1.8	0.1	0.9	0.0	0.5	7.6	0.2	0.2	0.0	0.1	23.1	6.0	0.0	0.2	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	2.2	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.8	24.6	4.3	3.8	6.6	5.0	5.6	5.2	2.7	5.9	3.6	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	31.9	0.1	0.0	1.2	4.3	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	0.4	2.4	2.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.5	26.9	5.8	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	5.0	0.0	112.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	29.0	0.0	0.4	0.1	1.6	8.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0
MZF1	"MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6"	ENSG00000099326	"Myeloid zinc finger 1"	P28698	19	58561931-58573575	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 46.0;HeLa: 41.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001757	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA001757: AB_1080718"	"unprognostic (8.25e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.16e-3)"	"unprognostic (7.15e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.62e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.83e-8)"	"unprognostic (1.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (4.09e-5)"	7.5	13.5	5.4	6.5	5.5	5.8	8.5	6.5	8.5	14.7	12.7	11.3	11.6	12.0	7.0	9.6	17.5	4.4	7.5	5.5	5.1	13.5	11.4	10.0	5.9	8.1	6.6	15.8	11.4	6.7	16.9	3.6	6.3	15.4	4.0	9.2	10.1	6.0	10.8	10.3	10.4	4.3	5.4	8.2	12.8	6.6	6.2	4.5	19.0	2.4	2.9	10.7	10.6	7.2	8.0	19.9	8.1	5.0	4.5	4.0	10.1	7.2	3.5	1.2	2.4	4.3	9.4	5.7	3.5	1.9	5.9	9.0	2.0	4.7	0.6	10.3	46.0	6.0	41.5	2.6	2.7	4.5	10.0	2.7	12.3	1.8	5.3	7.7	4.1	6.4	5.0	7.0	1.8	8.8	2.7	2.6	3.1	4.6	8.1	7.4	2.0	10.5	4.1	16.9	7.9	11.0	3.7	6.7	4.6	1.6	7.1	6.1	5.1	13.0	4.1	2.3	3.7	12.6	15.3	4.9	10.5	5.0	3.4	0.0	0.9	0.4	2.1	0.6	3.2	2.1	3.6	2.6	1.6	2.7	5.9	3.8	1.7	5.3	0.7	0.4	2.4	2.4	5.4	5.5	6.5	8.5	5.5	5.1	8.1	6.6	6.3	5.4	6.2	7.2	7.9	12.8	17.0	28.4	15.0	8.0	11.4	11.9	22.2	39.4	22.0	22.4	5.9	10.0	8.0	11.0	33.3	6.0	11.1	20.3	3.9	8.3	22.1	39.1	9.8	7.2	16.8	10.7	23.4	5.4	3.6	8.8	43.3	16.7	4.5	15.8	9.7	10.7	4.9	30.3	20.1	14.5	16.2	5.3	3.3	28.7	10.5	7.6	10.6	7.5	4.2	19.4	15.5	10.6	21.3	6.5	13.4	13.2	9.0	9.6	14.7	10.6	29.8	47.8	19.7	16.6	7.7	10.2	3.8	11.2	8.2	6.4	12.5	16.3	11.9	7.8
N4BP1		ENSG00000102921	"NEDD4 binding protein 1"	O75113	16	48538726-48620148	"Predicted intracellular proteins"	"Immunity, Innate immunity"	"Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 134.6;Glandular and luminal cells: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 8.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040849, HPA041080"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040849: AB_10794866, HPA041080: AB_10794186"	"unprognostic (1.07e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (9.03e-8)"	"unprognostic (9.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.36e-2)"	9.3	6.7	8.0	7.3	7.8	10.3	9.0	9.7	8.0	10.2	7.9	8.8	5.9	8.6	8.3	18.9	8.4	6.3	7.9	7.6	11.0	7.4	7.0	14.7	7.5	8.5	7.8	9.7	7.6	11.4	9.1	7.5	8.2	8.8	6.3	6.9	10.7	6.4	10.5	19.9	9.3	6.3	7.1	10.9	9.2	4.7	10.7	10.3	8.3	7.9	9.0	8.1	11.3	8.4	7.1	11.8	8.3	8.5	11.4	9.0	6.9	6.5	9.9	12.4	6.3	9.3	5.8	7.9	5.9	10.0	5.5	14.4	7.5	10.3	6.8	4.9	6.2	4.1	4.7	8.3	11.1	6.2	10.8	13.0	15.5	4.4	6.4	9.1	6.3	8.1	6.4	8.2	7.5	4.0	7.4	11.2	6.6	7.3	6.7	11.1	13.5	12.4	6.2	11.9	9.3	6.6	5.5	10.0	9.2	8.6	4.2	8.5	9.3	6.3	5.6	3.5	3.9	12.2	7.8	12.0	7.3	4.9	5.6	0.9	1.3	1.8	1.0	1.2	1.3	0.9	1.3	1.6	0.8	0.6	1.1	1.1	8.4	0.4	0.9	1.0	1.0	0.6	8.0	7.8	9.7	8.0	7.6	11.0	8.5	7.8	8.2	7.1	10.7	8.4	41.2	134.6	32.7	28.4	15.3	20.0	21.6	32.4	19.4	24.1	21.3	21.2	15.1	22.8	25.8	7.3	16.7	13.4	53.8	35.4	5.9	8.4	6.4	36.8	35.8	25.7	9.6	6.5	47.5	13.2	10.5	20.1	30.5	113.8	12.6	23.1	24.3	13.4	19.5	26.9	50.1	21.2	6.1	25.9	40.3	3.7	16.1	36.5	5.4	58.1	31.9	15.3	21.6	38.7	54.8	26.7	21.6	20.7	30.2	30.6	16.1	9.4	18.4	23.0	0.0	26.3	17.6	12.6	24.4	26.8	22.7	28.5	36.5	23.8	13.4	47.5
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056850-40158252	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	1.0	0.7	1.4	2.5	1.2	4.1	2.9	1.8	1.6	2.5	1.7	2.2	2.4	3.4	1.9	1.8	1.8	1.6	1.1	0.7	4.2	1.5	5.8	1.6	3.6	2.1	1.7	3.0	4.2	1.4	1.2	3.6	0.7	2.4	2.2	2.2	3.5	0.9	0.7	1.9	2.2	0.8	1.4	1.9	1.9	1.8	4.0	11.3	3.5	1.0	4.1	2.1	1.4	0.5	2.0	2.0	12.0	1.9	0.8	3.8	9.5	2.2	2.5	1.3	2.7	3.9	4.0	10.7	4.3	2.1	2.2	1.5	7.7	2.4	3.0	3.4	2.3	4.8	1.5	1.8	1.9	13.0	11.2	4.3	3.3	2.1	4.6	0.4	3.3	10.0	10.8	4.5	2.5	1.9	26.8	6.4	6.0	1.6	1.7	15.4	14.1	2.5	1.0	4.7	4.7	8.3	2.2	1.6	2.1	7.8	1.5	3.8	4.5	1.5	7.3	0.9	1.7	7.4	8.0	7.3	1.4	4.8	3.0	5.1	0.8	0.4	1.7	0.9	1.8	1.2	2.3	1.3	1.4	1.7	3.4	1.9	0.2	8.2	0.9	6.5	1.1	0.9	1.4	1.2	1.8	1.6	0.7	4.2	2.1	1.7	0.7	1.4	4.0	0.5	9.6	22.4	24.4	19.2	18.2	12.0	14.3	5.1	18.8	33.0	12.3	11.2	12.3	11.5	13.2	22.0	27.1	44.2	36.7	9.0	0.0	6.0	4.7	17.6	15.1	11.4	19.3	22.5	16.5	12.6	12.9	15.5	12.2	20.7	5.1	36.1	6.8	20.7	12.4	72.3	47.2	17.1	10.2	16.3	24.6	4.3	9.9	24.0	7.2	36.5	17.9	12.4	27.8	44.2	3.1	11.4	10.8	3.8	36.0	12.4	7.3	3.6	8.7	22.6	13.1	17.9	6.3	22.0	24.3	13.0	13.1	27.0	28.4	30.4	8.5	9.2
N4BP2L2	"CG005, PFAAP5"	ENSG00000244754	"NEDD4 binding protein 2 like 2"	Q92802	13	32432417-32538885	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039338, HPA039434, HPA059327"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA039338: AB_2676453, HPA039434: AB_10673143, HPA059327: AB_2683981"	"unprognostic (1.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.81e-2)"	"unprognostic (6.83e-2)"	"unprognostic (6.51e-2)"	"unprognostic (8.95e-2)"	"unprognostic (6.29e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.03e-3)"	29.0	28.4	29.7	19.9	33.1	26.4	40.9	39.3	36.3	28.7	25.8	26.0	17.9	39.1	37.8	23.3	27.3	29.0	42.7	26.6	29.2	30.8	36.8	34.9	28.4	28.3	28.4	47.5	18.1	33.7	23.0	23.4	29.4	36.1	28.2	38.0	24.0	30.3	65.3	29.2	24.9	31.6	30.0	31.7	26.1	20.0	27.9	33.0	36.6	60.8	25.0	31.5	19.8	37.0	18.1	13.7	35.0	25.4	31.6	39.1	29.7	34.0	31.8	28.3	25.7	24.1	44.7	19.4	18.2	37.4	44.7	30.2	36.1	32.6	37.7	46.7	17.9	35.6	30.9	29.4	50.1	46.0	20.3	42.4	42.4	26.1	31.2	47.7	43.9	34.4	28.6	18.2	39.8	24.1	36.1	44.5	31.4	79.2	15.6	29.7	32.0	21.5	36.2	24.9	12.8	32.1	22.2	25.0	48.4	39.9	27.6	64.7	33.5	15.4	17.1	17.1	16.4	17.3	19.6	16.4	21.2	30.5	25.7	35.4	13.7	29.3	17.1	16.4	23.7	18.1	20.3	18.0	13.0	16.1	23.4	20.1	20.3	21.2	23.0	16.6	20.1	12.2	29.7	33.1	39.3	36.3	26.6	29.2	28.3	28.4	29.4	30.0	27.9	37.0	269.4	173.1	174.2	321.3	275.3	137.9	319.5	236.5	166.8	222.0	167.1	144.8	186.6	138.7	180.1	217.0	248.1	182.4	311.3	208.5	92.0	132.9	132.3	164.3	180.6	199.5	175.8	118.9	354.5	74.7	81.8	189.0	175.8	139.2	212.8	256.3	198.5	134.6	119.1	249.0	386.1	173.0	217.7	161.6	129.6	140.2	370.0	175.9	124.5	244.5	308.4	108.4	382.1	367.4	586.4	116.7	282.3	301.7	187.9	253.3	338.7	92.3	175.1	335.8	315.5	234.5	197.3	187.6	89.8	89.3	137.7	191.5	292.6	180.5	122.4	275.1
N4BP3	LZTS4	ENSG00000145911	"NEDD4 binding protein 3"	O15049	5	178113532-178126081	"Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 35.7;Extravillous trophoblasts: 130.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.7;naive B-cell: 1.6;naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	16	"B-cells: 1.7;dendritic cells: 2.1;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.9;MCF7: 21.2;RH-30: 20.3;SK-BR-3: 72.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030972, HPA030973, HPA061387"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Centrosome	"HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: "	"unprognostic (1.84e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.88e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.55e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	1.9	0.8	1.6	1.0	1.0	2.9	2.5	3.0	3.7	2.6	0.6	1.4	0.5	0.8	0.3	15.7	1.0	0.7	2.3	1.0	2.1	3.1	0.1	3.9	1.8	2.6	1.8	0.5	0.7	4.1	2.2	8.3	2.7	1.0	0.4	4.7	6.8	0.8	4.4	7.8	1.8	0.5	0.2	1.8	2.2	0.9	4.1	0.9	1.4	3.0	2.9	1.4	4.0	2.1	0.1	0.1	2.3	1.7	0.2	0.0	14.9	0.0	0.0	0.0	0.0	3.3	1.1	1.4	2.0	0.0	0.1	4.7	0.4	0.1	0.0	2.5	0.8	4.1	1.8	0.1	0.1	0.2	0.0	0.3	0.5	0.0	0.1	0.0	12.0	1.3	2.6	0.9	0.0	21.2	0.2	0.3	11.2	3.6	0.1	11.6	20.3	5.4	1.2	2.4	1.7	0.8	0.6	72.2	4.9	2.8	2.8	0.1	2.4	0.0	1.7	0.0	0.0	3.2	2.3	13.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	1.7	0.1	0.1	0.0	1.6	0.4	1.2	0.0	0.1	0.0	2.1	0.0	0.2	1.6	1.0	3.0	3.7	1.0	2.1	2.6	1.8	2.7	0.2	4.1	2.1	7.8	3.2	0.6	0.0	12.7	9.4	13.1	6.7	4.0	35.7	7.3	3.6	1.7	2.8	3.4	1.8	12.5	3.0	10.4	9.4	13.7	3.4	0.4	1.9	1.1	15.7	4.2	0.0	2.9	0.8	130.4	1.6	6.6	5.8	4.5	0.5	0.4	0.2	2.3	1.7	4.9	3.7	6.1	0.0	1.7	0.8	0.6	1.0	12.4	3.7	1.1	2.0	0.0	0.5	0.2	7.3	8.7	1.9	6.1	10.3	0.1	0.8	0.3	9.2	0.0	2.5	0.7	0.2	8.1	14.1	6.8	23.1	3.0	0.7	3.5	12.1
N6AMT1	"C21orf127, HEMK2, KMT9, MTQ2, N6AMT, PRED28, PrmC"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957"	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	2.4	5.0	4.9	2.5	5.6	0.9	5.0	4.8	5.3	6.2	4.8	3.4	3.2	6.4	6.1	2.5	4.7	2.8	5.3	4.5	5.3	4.9	2.8	2.5	3.4	5.7	5.0	7.9	2.9	5.7	4.4	6.4	5.6	4.6	3.4	8.4	3.1	4.0	6.1	3.8	2.8	3.5	4.7	3.6	3.1	3.7	5.0	2.2	5.3	5.6	3.3	3.9	4.1	8.8	2.8	2.5	6.2	8.6	5.1	5.6	4.8	6.1	2.5	3.5	2.0	3.2	5.0	3.1	3.0	3.3	6.2	3.3	5.4	3.0	4.3	4.0	4.1	6.7	4.2	4.0	4.5	4.0	2.5	2.9	6.4	3.5	2.4	6.3	2.6	3.8	8.4	5.5	7.3	2.9	1.9	3.2	7.9	6.0	3.5	2.8	5.9	2.4	6.0	4.1	4.7	6.6	5.5	1.9	2.3	5.6	2.7	3.5	5.4	2.9	5.2	5.4	3.7	3.3	4.0	1.7	4.6	10.4	5.5	0.3	0.4	0.6	0.5	0.7	0.6	0.7	1.0	0.7	0.6	0.6	1.4	1.0	0.1	1.4	0.5	0.5	0.4	0.5	4.9	5.6	4.8	5.3	4.5	5.3	5.7	5.0	5.6	4.7	5.0	8.8	7.8	3.2	5.4	5.2	7.1	1.9	5.8	10.3	1.8	10.8	6.3	6.5	17.0	7.2	8.7	12.9	8.4	18.3	4.0	1.5	7.9	11.0	2.9	10.7	9.6	6.9	0.0	13.0	4.6	6.4	12.2	7.9	8.6	4.2	1.3	15.1	5.3	3.5	7.2	10.1	5.1	3.0	10.2	1.3	0.9	4.5	9.6	2.6	1.8	1.0	2.7	11.1	4.1	6.6	15.1	7.7	4.3	10.1	1.2	4.5	2.5	9.3	15.8	10.5	0.0	7.7	8.9	4.5	10.5	4.2	3.7	14.9	5.1	20.1	3.1	4.8
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N-alpha-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326061	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 2.6;placenta: 4.2;testis: 6.2"	"Group enriched"	"Detected in some"	12	"Cytotrophoblasts: 19.4;Early spermatids: 30.6;Extravillous trophoblasts: 16.4;Late spermatids: 23.9;Spermatocytes: 25.1;Spermatogonia: 15.9;Syncytiotrophoblasts: 13.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 19.3;K-562: 12.3;U-266/70: 32.9;U-266/84: 11.3"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.6	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.0	4.2	0.3	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.0	32.9	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.6	0.1	0.1	0.2	0.5	0.4	0.3	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	15.9	0.0	0.0	13.3	0.0	0.0	0.0	0.0
NAA35	"bA379P1.1, FLJ21613, FLJ22643, MAK10"	ENSG00000135040	"N-alpha-acetyltransferase 35, NatC auxiliary subunit"	Q5VZE5	9	85941146-86025462	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021547	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA021547: AB_1853505"	"unprognostic (5.87e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-2)"	7.7	12.2	6.9	6.3	7.3	6.6	9.3	9.8	7.0	8.9	8.2	11.1	8.6	9.4	7.8	10.9	8.4	5.7	8.8	6.9	7.2	8.4	8.7	7.1	6.2	6.3	6.0	9.9	10.8	9.4	12.0	7.4	6.2	9.7	10.5	14.3	10.1	6.8	17.4	9.1	8.1	7.0	6.4	6.5	8.8	15.4	8.4	7.3	10.4	13.2	7.2	9.0	9.1	8.9	25.4	15.8	17.7	13.5	9.8	13.1	24.8	15.5	15.1	16.1	13.1	12.4	15.7	8.4	8.5	15.4	13.1	34.9	15.0	18.4	16.8	22.3	13.1	21.6	19.9	14.6	16.6	30.4	17.6	13.1	15.2	17.0	24.6	12.4	14.0	15.6	25.3	15.6	14.9	14.6	15.7	16.0	17.8	28.0	18.2	14.4	26.9	12.6	17.3	20.4	16.7	15.5	17.6	15.8	13.6	17.0	11.9	11.7	14.0	11.2	12.4	16.9	15.0	22.3	29.1	5.7	16.3	12.5	10.2	1.7	2.5	5.1	3.4	2.6	4.3	9.5	3.5	3.1	3.0	9.3	4.6	3.4	1.3	3.5	1.9	2.2	3.1	2.6	6.9	7.3	9.8	7.0	6.9	7.2	6.3	6.0	6.2	6.4	8.4	8.9	14.6	3.2	14.1	58.4	16.8	16.3	20.2	19.0	19.9	25.5	18.0	13.1	23.3	18.6	22.8	11.0	22.9	22.6	14.9	20.2	1.9	19.7	8.7	29.4	18.6	14.3	20.9	14.5	51.8	25.8	18.9	13.6	16.3	22.5	12.0	32.9	9.3	9.8	12.2	21.9	58.7	14.5	30.5	11.0	8.4	5.3	9.3	10.7	14.2	52.5	12.3	18.7	14.4	44.7	68.8	18.3	16.6	11.7	17.1	22.0	12.0	8.9	33.7	36.6	13.1	21.4	24.7	56.7	36.3	17.7	16.6	31.1	15.8	24.4	16.6	19.2
NAA38	"LSMD1, MGC14151, PFAAP2"	ENSG00000183011	"N-alpha-acetyltransferase 38, NatC auxiliary subunit"	Q9BRA0	17	7856685-7885238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059189			Supported	Nucleoplasm	"Intracellular and membrane"	No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA059189: "	"unprognostic (6.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.31e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.75e-2)"	72.1	102.2	137.4	33.3	142.4	76.0	67.3	143.6	188.0	58.3	135.3	77.4	30.8	54.9	30.9	65.8	57.4	29.1	99.7	139.4	139.3	87.6	67.8	50.7	45.7	137.7	137.3	45.3	60.1	76.6	73.0	22.6	137.9	71.5	27.0	29.4	56.2	31.8	130.4	59.5	49.2	24.5	138.1	72.6	65.9	97.8	142.5	45.2	60.1	93.4	31.4	60.0	55.5	142.0	131.4	234.9	129.4	132.9	70.8	78.3	44.8	59.7	68.4	108.3	89.9	89.0	54.6	89.6	98.5	63.6	69.2	105.4	69.8	110.3	26.8	134.1	318.2	137.3	279.7	131.0	68.4	38.6	101.9	114.3	60.4	71.0	46.3	74.5	105.9	201.9	29.1	95.3	63.6	157.3	140.0	91.6	29.2	98.9	271.5	142.0	59.6	59.4	101.0	72.6	57.6	110.5	46.6	111.1	87.3	18.7	68.8	100.0	57.6	72.2	52.0	59.0	170.8	39.1	43.8	34.8	121.5	159.1	72.2	313.1	275.2	196.9	176.1	244.0	163.4	273.8	186.3	181.9	332.4	234.2	167.1	173.6	201.1	152.9	239.8	304.0	215.3	299.0	137.4	142.4	143.6	188.0	139.4	139.3	137.7	137.3	137.9	138.1	142.5	142.0	263.1	76.9	140.5	16.3	117.8	94.1	85.8	171.8	144.5	98.5	218.1	305.4	344.3	128.7	107.7	253.8	50.1	160.2	107.4	227.2	518.5	100.6	646.3	189.4	104.9	183.6	226.6	201.2	18.3	158.4	128.0	102.6	80.5	133.1	100.1	131.1	213.5	381.3	210.5	40.4	21.7	211.2	146.5	222.8	96.8	1601.4	116.8	149.9	76.5	14.0	195.2	221.6	182.3	34.7	13.3	134.0	161.6	113.2	161.7	86.8	184.1	468.0	107.1	126.5	111.7	70.2	109.8	120.5	132.4	182.1	99.4	91.9	103.5	175.3	289.5	129.3
NAA40	"FLJ13848, NAT11"	ENSG00000110583	"N-alpha-acetyltransferase 40, NatD catalytic subunit"	Q86UY6	11	63938959-63957319	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 102.6;Late spermatids: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037816, HPA056142"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA037816: AB_10672289, HPA056142: "	"unprognostic (3.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.29e-3)"	"unprognostic (3.42e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.25e-2)"	3.3	8.9	5.1	3.9	5.1	2.5	4.4	4.5	5.7	4.0	5.7	5.2	5.7	3.0	3.3	6.7	6.8	3.6	9.5	5.3	4.9	9.1	3.8	3.6	7.5	5.6	5.3	2.7	6.5	15.1	10.4	6.7	5.2	4.2	4.7	7.2	6.6	4.0	4.7	2.7	5.7	3.1	5.0	8.8	4.8	15.3	5.2	10.0	6.1	8.5	7.3	4.2	3.6	5.0	15.5	17.3	21.7	11.8	6.0	5.9	13.8	11.3	12.0	27.3	19.1	14.8	19.3	9.5	13.6	10.2	18.9	13.7	18.3	8.2	20.1	12.5	11.2	13.0	11.1	16.9	7.9	20.9	10.8	6.0	7.4	17.0	4.6	10.6	18.0	16.1	22.4	6.9	12.9	11.8	22.3	16.3	20.2	14.3	11.8	21.9	19.5	12.1	18.5	11.8	28.7	15.1	17.7	15.2	9.2	15.8	25.1	9.2	11.6	15.1	18.3	8.9	9.3	8.3	5.6	16.5	9.2	8.9	11.9	2.3	0.5	2.7	6.9	0.4	2.4	2.7	1.8	3.3	2.7	2.4	1.1	2.6	0.1	5.2	0.2	3.5	0.5	2.3	5.1	5.1	4.5	5.7	5.3	4.9	5.6	5.3	5.2	5.0	5.2	5.0	4.3	3.2	4.8	12.1	8.1	2.8	2.0	4.5	10.8	30.9	11.5	7.0	14.8	5.7	9.4	18.4	33.3	9.6	12.1	13.6	0.0	5.7	46.3	20.0	7.4	7.6	17.5	7.4	14.3	5.4	12.8	4.8	6.1	8.5	1.3	14.3	9.7	5.2	9.5	102.6	15.6	6.1	10.2	10.3	5.3	130.5	4.7	7.3	1.8	15.0	4.4	8.6	17.5	11.6	10.1	5.9	3.5	7.2	12.2	2.1	10.6	4.1	22.5	23.9	0.0	4.3	4.4	27.4	16.5	6.5	2.8	4.1	8.9	10.4	7.3	1.8
NAALAD2	"GCPIII, NAALADASE2"	ENSG00000077616	"N-acetylated alpha-linked acidic dipeptidase 2"	Q9Y3Q0	11	90131515-90192894	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 19.9;testis: 13.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 39.7;Excitatory neurons: 109.3;Horizontal cells: 70.7;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 153.8;Oligodendrocytes: 83.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 19.2;SH-SY5Y: 6.1;SuSa: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060820, HPA065419"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA060820: AB_2684373, HPA065419: AB_2685487"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.97e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.93e-1)"	3.8	10.0	2.3	0.4	3.3	0.1	3.3	1.5	5.3	10.3	0.0	1.9	0.2	4.1	1.9	0.8	3.4	1.2	2.1	2.4	2.8	1.5	0.9	2.1	0.4	3.6	3.5	7.4	0.7	0.1	19.9	3.5	3.4	3.2	0.6	3.5	1.1	1.2	1.1	0.7	1.3	1.1	2.0	2.6	1.2	13.9	3.0	0.1	1.4	0.7	0.1	2.2	4.0	4.2	0.1	0.2	1.8	0.1	0.5	0.1	2.2	0.1	0.1	0.1	0.0	19.2	0.7	0.3	0.2	0.0	0.3	0.3	1.3	0.0	0.0	0.0	0.3	1.9	0.4	1.7	0.2	0.1	0.1	1.9	0.0	0.0	0.0	0.5	0.4	0.2	0.1	0.0	0.0	0.0	0.3	0.3	1.8	0.5	0.2	0.3	0.0	0.2	0.0	0.0	0.2	6.1	0.0	0.2	0.0	4.3	0.2	0.4	2.4	0.1	1.4	0.3	0.3	1.0	0.3	0.3	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	3.3	1.5	5.3	2.4	2.8	3.6	3.5	3.4	2.0	3.0	4.2	2.6	0.0	0.0	3.3	0.1	0.3	0.1	0.0	0.0	17.3	0.0	0.0	2.4	1.5	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.1	39.7	0.8	13.7	1.2	0.0	0.0	109.3	0.0	0.6	7.5	1.1	0.6	0.0	1.7	0.7	0.2	0.3	70.7	110.2	0.0	0.0	7.2	0.4	17.7	11.1	0.5	0.0	12.2	0.0	8.4	0.0	153.8	83.7	0.0	0.0	14.7	0.4	0.4	0.0	0.1	0.0	2.4	0.0	6.4	4.6	0.6	11.3	0.4	0.0	0.8	0.2	19.4	0.2	0.1
NAALADL2		ENSG00000177694	"N-acetylated alpha-linked acidic dipeptidase like 2"	Q58DX5	3	174438573-175810548	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 311.5;Inhibitory neurons: 135.1;Microglial cells: 155.5;Oligodendrocyte precursor cells: 468.0;Oligodendrocytes: 532.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.5;BJ hTERT+: 5.4;fHDF/TERT166: 6.4;WM-115: 5.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA012413, HPA017425, CAB025586"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275"	"unprognostic (7.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.29e-4)"	"unprognostic (3.44e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.49e-2)"	"unprognostic (3.66e-6)"	"unprognostic (7.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	2.4	1.1	1.1	1.0	2.3	0.2	5.8	1.2	1.4	6.3	1.1	3.0	1.7	3.7	5.5	1.5	3.8	4.2	2.6	1.4	0.6	3.3	2.9	2.0	0.5	2.2	1.3	3.9	2.2	10.2	0.5	1.2	1.8	4.9	2.4	1.6	5.8	3.7	1.0	0.8	1.6	3.5	1.4	1.9	2.7	0.9	1.5	1.2	2.3	1.7	0.5	3.8	1.2	3.3	0.0	0.0	0.3	0.0	4.4	14.5	0.1	3.1	5.4	0.7	0.9	0.2	1.7	0.0	0.6	6.4	0.2	0.1	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	4.1	0.8	0.1	0.0	3.8	0.5	0.0	0.0	0.1	3.1	0.6	0.2	0.0	0.0	2.2	0.0	0.0	0.2	0.1	2.2	0.3	0.1	0.1	0.3	0.3	1.2	0.3	4.0	0.2	0.7	2.9	0.1	0.1	0.6	0.0	0.0	0.0	1.9	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	2.3	1.2	1.4	1.4	0.6	2.2	1.3	1.8	1.4	1.5	3.3	5.1	0.0	11.5	311.5	0.1	2.3	8.9	2.7	1.2	7.7	35.1	13.7	3.0	12.8	9.1	12.9	12.5	19.6	0.3	11.1	7.9	10.1	74.9	23.7	8.7	2.8	9.0	2.7	113.4	2.5	1.4	15.0	23.9	30.2	4.5	3.4	2.9	4.5	1.8	0.0	135.1	2.6	10.2	0.3	3.0	39.6	15.2	1.1	3.6	155.5	0.0	6.7	0.0	468.0	532.9	3.6	4.4	12.0	0.0	13.6	13.2	2.4	21.9	6.2	0.0	23.4	4.9	3.2	2.8	5.3	1.8	12.3	0.8	5.7	16.4	16.0
NAB1		ENSG00000138386	"NGFI-A binding protein 1"	Q13506	2	190646746-190692766	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 102.0;Suprabasal keratinocytes: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002738	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"HPA002738: AB_1079447"	"unprognostic (1.44e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.04e-3)"	"unprognostic (9.05e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.52e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.85e-2)"	29.3	20.3	19.4	23.5	16.7	18.6	34.8	50.4	23.5	28.1	7.4	22.8	15.8	32.3	50.1	36.3	27.5	28.0	28.5	18.7	9.7	19.9	37.8	22.8	26.8	13.4	13.2	26.0	17.9	23.5	21.1	26.4	14.9	18.5	25.6	41.4	20.7	20.9	8.0	66.7	17.1	25.2	14.9	19.8	37.9	26.0	13.8	21.2	37.9	17.2	26.3	31.2	24.2	25.9	35.5	25.8	65.0	22.6	24.5	42.7	111.0	35.5	55.7	26.4	29.8	62.8	38.4	39.6	40.6	28.3	48.9	88.4	37.4	45.9	51.8	126.1	31.0	46.7	96.3	30.2	15.8	19.8	22.4	24.6	70.4	55.9	17.1	37.4	41.5	23.9	46.3	33.2	40.6	17.4	28.7	20.0	22.8	38.4	35.2	35.0	46.7	15.9	19.3	34.5	57.9	46.9	41.8	13.9	37.3	82.8	11.4	30.6	29.0	54.5	43.0	31.0	21.6	25.7	30.3	29.5	57.3	17.6	43.7	0.0	1.3	0.6	1.3	1.1	1.9	0.7	1.3	1.7	0.9	0.4	1.4	1.5	2.9	2.6	3.7	0.8	3.3	0.8	19.4	16.7	50.4	23.5	18.7	9.7	13.4	13.2	14.9	14.9	13.8	25.9	24.1	6.4	21.2	14.0	5.9	102.0	23.1	24.6	31.3	26.1	19.7	19.7	18.2	11.5	29.8	12.9	12.5	4.3	9.2	11.4	3.9	10.3	1.4	17.5	10.8	30.1	14.4	12.0	37.2	8.0	11.1	25.2	21.4	23.4	20.3	14.2	44.6	25.7	6.7	6.7	21.2	17.5	14.2	17.3	77.4	3.2	13.4	20.7	39.2	24.4	10.6	12.4	11.3	29.1	28.3	10.2	26.3	14.7	14.9	30.5	4.8	5.1	22.3	15.5	46.0	24.6	39.2	1.7	27.3	55.7	138.9	1.2	16.7	7.3	16.0	29.9
NAB2	MADER	ENSG00000166886	"NGFI-A binding protein 2"	Q15742	12	57089043-57095476	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 98.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004510, HPA027464"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"CAB004510: AB_627982, HPA027464: AB_10601138"	"prognostic favorable (7.41e-4)"	"unprognostic (4.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (5.67e-3)"	"unprognostic (6.19e-3)"	21.8	16.1	25.2	9.9	26.8	6.8	14.2	30.3	31.0	33.7	24.0	29.8	10.1	32.3	21.0	24.5	31.0	17.4	20.5	28.3	25.0	20.1	22.3	24.0	12.0	23.2	23.1	51.1	10.2	19.5	35.4	11.1	22.1	25.4	5.0	10.7	11.6	16.6	7.6	33.4	15.7	13.4	21.6	16.9	15.9	16.8	25.4	17.4	20.7	9.9	10.4	27.7	33.8	24.8	15.2	9.8	49.2	45.2	43.3	56.7	5.5	44.1	40.8	28.0	23.1	15.6	8.7	9.6	17.6	44.4	8.1	27.0	16.9	34.0	14.3	4.0	4.5	11.4	8.1	16.6	33.2	9.1	26.5	64.4	36.1	32.6	10.9	43.7	7.5	7.2	26.5	9.6	32.4	73.4	14.0	44.5	9.9	12.9	16.6	10.4	64.1	5.1	11.8	6.0	5.5	13.1	21.9	12.5	98.3	12.3	28.0	20.0	8.4	40.7	34.1	28.8	13.2	22.7	6.0	5.1	39.5	5.9	25.1	0.0	1.1	0.2	0.5	2.7	0.6	0.9	0.9	0.7	0.6	2.3	1.1	1.1	0.4	0.4	2.9	0.0	1.0	0.6	25.2	26.8	30.3	31.0	28.3	25.0	23.2	23.1	22.1	21.6	25.4	24.8	7.6	12.8	13.0	5.9	11.6	29.6	19.5	23.4	39.3	20.3	17.3	13.8	2.9	2.8	13.6	9.2	2.1	3.7	4.9	1.1	7.9	7.4	0.6	22.9	21.2	13.7	6.6	4.8	11.4	1.4	10.5	19.7	8.6	25.4	17.1	7.8	18.2	17.1	11.2	10.1	5.4	1.1	10.2	16.3	43.7	2.9	19.6	14.3	21.4	8.4	1.6	7.9	1.0	1.0	1.9	4.1	0.0	18.8	8.7	12.9	8.7	5.6	5.9	4.4	19.7	9.8	16.3	2.6	18.7	23.4	32.5	56.2	10.7	2.5	1.5	8.6
NABP1	"DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2"	ENSG00000173559	"Nucleic acid binding protein 1"	Q96AH0	2	191678068-191741097	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.7"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 452.0;Langerhans cells: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054978, HPA067802"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA054978: AB_2682660, HPA067802: AB_2685899"	"unprognostic (5.43e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.07e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (8.20e-7)"	"unprognostic (5.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.02e-2)"	22.0	5.3	2.3	23.2	1.8	5.5	9.8	1.5	2.4	4.7	4.9	5.2	10.0	4.6	0.6	13.2	5.4	7.4	3.9	2.5	2.5	10.5	9.8	21.1	12.4	2.7	2.7	4.5	3.8	0.8	4.3	7.6	2.5	4.4	3.8	1.0	5.2	3.2	2.8	4.4	18.8	3.7	2.2	36.7	4.7	9.2	5.1	6.3	3.2	3.3	11.6	18.4	7.6	3.6	36.2	5.5	1.5	1.6	15.7	16.4	10.2	53.4	31.3	28.6	15.1	30.9	18.7	2.6	43.1	26.3	23.9	11.5	5.7	22.1	29.0	21.2	5.5	18.4	10.8	5.6	14.3	9.8	16.5	22.5	20.3	47.9	23.4	13.8	8.3	4.8	28.7	76.3	31.8	3.3	3.5	10.8	3.6	6.8	31.4	7.1	6.1	16.8	30.2	22.2	2.0	1.3	21.3	7.7	14.1	18.7	2.7	4.7	31.4	28.2	24.6	15.4	33.6	25.2	12.7	9.1	25.1	9.7	6.4	20.0	10.4	8.8	13.2	17.1	19.1	10.8	17.3	13.7	7.3	3.5	8.0	10.7	38.8	6.6	21.5	6.9	28.5	8.5	2.3	1.8	1.5	2.4	2.5	2.5	2.7	2.7	2.5	2.2	5.1	3.6	42.2	214.7	452.0	2.0	66.5	53.0	141.0	15.7	32.5	3.3	33.1	34.3	9.3	8.6	106.2	11.0	2.1	23.6	46.9	79.0	3.9	16.7	212.8	64.9	28.1	34.0	4.2	9.1	3.5	5.7	43.5	62.2	32.1	179.6	139.6	2.2	10.8	8.6	54.9	3.3	3.6	20.2	8.2	113.8	301.8	69.9	10.2	151.3	40.9	18.7	108.8	1.9	18.6	1.5	1.7	30.7	85.7	3.8	43.9	44.8	109.2	22.4	57.6	3.6	6.6	101.5	46.3	25.7	18.4	35.6	45.3	146.3	111.6	12.2	31.7	112.8
NABP2	"hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1"	ENSG00000139579	"Nucleic acid binding protein 2"	Q9BQ15	12	56222015-56229854	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 243.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044615, HPA057213"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA044615: AB_10795884, HPA057213: AB_2683371"	"unprognostic (1.45e-1)"	"prognostic favorable (8.35e-6)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (7.44e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-2)"	21.7	39.4	31.6	17.9	34.3	18.8	20.7	33.5	39.5	21.2	28.9	27.1	23.0	23.6	19.0	21.7	21.2	14.9	23.3	31.8	33.4	25.8	23.1	15.4	20.1	33.2	33.2	24.5	34.6	21.8	24.9	8.4	33.0	20.5	19.4	24.8	17.3	18.0	59.2	21.1	23.0	16.2	32.2	18.0	23.5	24.4	35.4	17.5	19.6	32.2	19.6	25.5	18.5	34.5	74.8	75.9	70.3	78.4	30.8	33.1	13.8	43.5	36.6	63.0	37.9	45.8	65.7	56.3	85.8	41.1	44.6	57.8	66.5	56.1	48.0	107.1	64.1	94.7	49.2	36.0	32.4	67.9	89.0	28.6	44.5	75.4	60.3	53.5	41.9	69.0	50.1	94.9	46.2	67.4	94.1	78.6	51.8	45.0	74.3	83.2	65.2	84.9	31.3	30.4	89.1	65.6	69.0	86.3	62.5	11.2	98.9	60.8	29.8	43.8	41.3	92.0	81.2	64.2	104.5	36.1	81.0	63.9	82.9	33.0	15.6	14.9	26.5	22.7	29.6	26.4	21.9	23.9	21.4	21.2	13.4	22.4	3.0	42.7	25.9	21.6	34.3	16.6	31.6	34.3	33.5	39.5	31.8	33.4	33.2	33.2	33.0	32.2	35.4	34.5	17.2	16.0	18.9	5.2	17.5	18.6	18.5	25.0	21.1	15.3	22.5	27.1	9.6	31.5	12.0	23.9	2.1	28.4	13.6	27.3	49.0	36.7	88.4	11.3	17.1	20.7	18.0	30.3	6.7	70.8	40.0	20.6	13.7	13.4	17.7	17.6	22.9	22.5	31.2	15.2	6.6	27.5	16.2	17.7	20.3	243.5	23.6	16.0	32.0	1.9	27.6	35.8	33.0	2.5	6.4	38.4	22.7	34.3	30.9	13.3	41.6	43.1	11.6	14.8	19.7	23.2	22.9	20.2	25.0	22.1	17.0	15.2	20.1	23.0	37.9	15.1
NACAD	KIAA0363	ENSG00000136274	"NAC alpha domain containing"	O15069	7	45080437-45088969	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 84.2;pituitary gland: 24.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 32.0;Oligodendrocytes: 23.1;Peritubular cells: 12.0"	"Group enriched"	"Detected in many"	7	"glioma: 12.1;testis cancer: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 33.4;SCLC-21H: 25.6;SH-SY5Y: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020981, HPA079208"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	Nucleoplasm	"HPA020981: AB_2670549, HPA079208: "	"unprognostic (5.54e-6)"	"unprognostic (1.89e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.72e-3)"	"unprognostic (2.72e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	3.3	5.2	23.4	1.2	50.2	0.1	3.2	54.2	42.1	6.2	0.0	8.3	0.7	7.9	0.8	2.0	5.5	1.8	4.5	26.3	34.6	2.1	0.2	2.5	0.7	58.9	48.3	8.9	1.0	0.8	24.3	1.9	58.6	4.3	0.8	3.7	1.7	3.0	1.2	1.7	3.0	4.3	32.7	1.6	3.9	3.7	57.4	0.3	1.3	1.0	0.3	5.0	4.6	84.2	0.0	0.0	2.5	0.1	1.6	0.7	0.1	2.9	3.5	7.7	4.8	0.2	0.1	0.0	2.2	5.1	33.4	0.2	2.2	1.9	2.7	0.0	0.8	0.0	1.7	0.0	1.8	0.0	0.0	1.6	0.0	3.3	0.3	4.1	2.4	0.0	0.0	3.5	2.0	0.0	0.0	0.0	2.3	0.0	2.2	0.0	0.9	0.0	0.3	0.0	25.6	17.7	0.0	0.1	0.1	6.7	0.0	0.1	0.9	0.0	0.0	0.2	0.5	1.8	1.0	0.0	1.5	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.4	50.2	54.2	42.1	26.3	34.6	58.9	48.3	58.6	32.7	57.4	84.2	0.3	0.0	0.0	6.8	0.0	0.6	3.5	0.9	1.2	5.5	0.4	1.8	6.0	0.0	0.2	1.8	0.0	0.1	0.4	0.1	0.0	0.6	2.9	0.5	3.1	0.9	1.2	0.0	4.4	0.2	0.1	3.9	1.1	1.2	1.3	3.9	0.7	0.0	0.1	32.0	5.2	0.0	0.0	0.0	0.0	4.9	6.8	0.7	1.8	1.9	1.0	2.7	0.0	3.0	23.1	0.1	0.0	12.0	0.1	2.3	0.0	0.4	0.8	2.8	6.6	5.3	4.2	1.5	1.4	0.2	0.1	0.1	0.3	9.6	0.1	0.9
NACC1	"BEND8, BTBD14B, BTBD30, NAC-1, NAC1"	ENSG00000160877	"Nucleus accumbens associated 1"	Q96RE7	19	13116862-13141147	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021238, HPA062245, CAB069927"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724"	"unprognostic (2.19e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.74e-2)"	12.6	19.5	31.0	14.6	19.2	8.8	10.3	7.1	26.6	9.7	0.0	17.3	13.3	18.4	7.9	27.6	11.9	6.4	20.9	25.7	7.4	14.8	20.5	16.7	12.1	13.4	15.9	7.7	12.2	10.7	14.8	12.4	15.1	14.6	6.6	3.7	15.8	11.2	24.2	17.4	16.0	7.7	8.9	15.9	16.0	17.0	20.6	11.3	14.0	7.9	8.8	15.0	12.6	16.4	98.8	110.0	28.0	59.6	15.0	17.7	74.9	47.4	34.2	42.4	32.4	114.8	40.4	50.9	104.1	39.8	37.3	49.0	34.8	80.7	16.2	89.1	52.5	32.4	87.9	84.7	35.5	52.0	82.3	28.8	28.0	46.1	24.7	36.5	50.2	46.4	72.5	19.8	22.9	206.1	82.9	39.6	123.6	28.9	101.7	47.8	32.9	49.5	28.2	101.1	58.2	37.7	49.6	64.9	39.1	29.8	59.3	46.4	76.7	94.6	58.8	67.2	87.0	53.4	88.1	42.4	99.7	52.8	58.9	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	31.0	19.2	7.1	26.6	25.7	7.4	13.4	15.9	15.1	8.9	20.6	16.4	4.9	0.0	1.7	6.2	5.6	12.1	7.5	11.8	2.8	16.6	11.5	7.5	2.1	12.8	8.5	16.5	2.1	19.0	12.9	22.7	7.9	12.3	2.3	10.9	8.9	8.1	4.9	12.2	7.2	8.8	20.0	5.2	10.7	17.6	10.2	13.3	8.6	18.0	21.1	26.9	5.9	16.2	14.2	9.6	9.6	2.0	4.4	8.8	5.4	3.7	10.5	12.0	10.3	5.5	5.4	21.7	11.1	9.4	5.6	16.5	14.0	15.0	5.9	7.7	6.6	7.5	7.0	11.1	15.6	8.4	13.9	27.1	7.9	15.2	15.4	17.2
NADK	FLJ13052	ENSG00000008130	"NAD kinase"	O95544	1	1751232-1780457	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 506.2"	"Group enriched"	"Detected in all"	7	"granulocytes: 506.2;monocytes: 162.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048909, HPA053368"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Vesicles	"HPA048909: AB_2680553, HPA053368: AB_2682130"	"unprognostic (1.29e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.03e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	53.6	81.8	24.8	37.5	26.6	100.7	44.7	22.1	29.0	28.6	27.8	45.1	38.0	30.9	13.3	29.9	36.1	23.3	28.7	24.1	24.3	30.2	134.0	40.3	41.2	25.4	24.6	37.2	38.9	17.2	26.4	26.0	25.0	32.9	25.4	10.9	40.2	17.4	19.6	28.3	43.3	19.8	24.5	93.1	43.2	27.5	26.5	16.4	31.7	19.2	26.6	32.3	27.1	23.8	41.6	39.3	34.4	50.7	47.8	34.5	44.2	40.9	35.5	45.6	40.3	42.1	74.2	54.5	30.4	30.5	14.7	34.6	37.3	32.5	20.3	53.5	59.1	44.7	65.0	73.6	46.2	63.4	72.1	40.6	28.9	28.4	40.3	24.8	44.9	42.6	55.9	75.8	34.4	47.4	48.1	54.8	23.5	69.4	43.8	60.4	29.4	113.1	39.7	33.9	46.2	35.2	45.8	99.2	43.7	20.3	34.2	43.6	43.8	33.1	23.7	34.6	37.5	67.1	32.7	121.8	32.7	69.3	17.6	84.2	141.3	329.7	7.4	158.6	8.8	10.8	4.3	5.9	45.9	12.1	2.8	4.1	506.2	3.8	162.6	37.9	7.0	82.9	24.8	26.6	22.1	29.0	24.1	24.3	25.4	24.6	25.0	24.5	26.5	23.8	29.0	12.8	30.7	14.4	27.2	9.8	15.7	11.2	13.6	7.9	21.4	17.9	6.8	25.8	21.6	14.7	16.7	24.5	46.8	57.8	15.6	19.1	14.9	18.7	22.2	20.8	22.8	15.8	10.2	29.4	26.3	18.7	52.0	22.8	2.5	21.2	22.5	94.3	36.6	6.7	10.4	38.7	16.2	58.4	13.7	26.7	37.6	45.0	8.8	9.4	67.3	5.7	27.8	10.6	11.1	28.7	34.6	34.6	26.0	34.7	28.6	24.3	13.5	17.7	13.1	12.6	18.2	12.4	22.4	19.5	12.8	42.8	15.4	44.2	31.0	27.5
NAE1	"APP-BP1, APPBP1, ula-1"	ENSG00000159593	"NEDD8 activating enzyme E1 subunit 1"	Q13564	16	66802875-66873256	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatogonia: 219.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041178, HPA042041"	Enhanced		Approved	Nucleoplasm,Microtubules,Centrosome		NA	NA		100000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Microtubules, Centrosome"	"HPA041178: AB_10964773, HPA042041: AB_10964772"	"unprognostic (3.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (3.92e-8)"	"unprognostic (2.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (9.44e-5)"	"unprognostic (1.97e-1)"	23.9	28.3	26.0	26.0	26.0	38.8	32.5	28.8	29.6	23.0	27.1	31.9	32.4	32.9	35.2	30.3	26.8	24.2	29.7	25.5	27.1	26.5	28.6	22.5	36.1	25.8	26.1	35.6	27.3	41.5	22.6	28.4	27.1	28.8	35.3	33.9	25.9	26.7	35.0	33.1	33.2	30.3	27.0	22.2	21.6	47.1	27.1	35.0	32.3	33.0	31.6	28.6	22.1	30.3	107.6	81.1	140.4	139.4	55.1	78.9	116.9	79.9	80.3	115.6	139.8	99.5	80.9	118.1	89.1	60.4	74.8	105.6	107.7	96.5	162.0	43.8	122.1	83.9	53.6	153.9	63.2	157.3	100.7	64.0	69.6	92.8	80.7	61.0	82.5	141.2	201.9	40.3	89.9	37.5	165.7	177.7	196.2	83.4	144.6	175.7	167.8	157.7	89.1	92.6	151.3	110.6	239.5	50.7	94.7	86.0	54.2	105.2	64.7	80.2	80.1	84.7	93.9	75.3	125.3	423.8	72.3	103.0	99.7	2.8	6.0	13.4	27.3	5.8	34.9	18.2	29.0	30.1	8.2	14.4	31.0	31.4	2.7	17.1	6.5	12.2	27.4	18.3	26.0	26.0	28.8	29.6	25.5	27.1	25.8	26.1	27.1	27.0	27.1	30.3	29.2	32.1	32.2	23.5	30.1	33.0	66.6	87.2	17.1	52.0	28.4	31.4	30.7	18.6	53.4	31.3	12.5	101.3	33.9	28.0	39.2	70.0	4.6	27.7	23.2	30.7	22.9	38.9	41.3	60.2	70.9	38.4	20.9	22.9	35.4	55.9	19.2	21.3	28.6	50.5	40.7	33.3	67.1	10.4	13.5	14.3	48.7	16.2	49.8	17.8	25.7	68.4	51.5	33.2	39.8	65.0	114.3	54.2	32.0	68.8	34.7	48.2	44.8	35.9	19.7	41.0	63.7	145.4	219.3	33.6	32.1	52.4	36.9	49.4	42.5	49.5
NAF1		ENSG00000145414	"Nuclear assembly factor 1 ribonucleoprotein"	Q96HR8	4	163110073-163166890	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036241, HPA036242, HPA066090"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614"	"unprognostic (6.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.05e-1)"	9.5	8.1	4.7	7.6	5.9	7.6	8.3	3.9	7.1	8.7	9.2	7.2	4.7	10.4	6.1	7.0	12.3	7.0	6.5	6.2	3.5	6.8	7.1	7.0	8.7	2.4	3.7	10.9	7.7	10.7	4.8	6.6	1.8	8.5	8.1	13.5	7.6	8.6	19.4	8.3	4.9	8.7	3.1	7.3	6.0	13.3	2.5	7.1	10.2	10.3	7.9	9.5	4.8	4.0	15.2	12.7	16.0	16.4	9.2	14.5	18.8	17.6	11.7	15.1	15.0	14.4	17.8	39.4	5.0	10.9	12.2	12.5	32.7	18.9	19.7	17.5	20.2	41.7	11.4	12.3	16.1	27.2	14.3	13.7	16.5	18.5	14.9	15.6	13.6	12.5	47.7	20.3	20.4	15.0	31.8	15.5	20.9	11.5	12.5	26.1	11.8	20.7	15.0	6.9	17.3	13.1	11.6	20.9	13.0	13.9	11.3	11.8	14.4	18.0	15.6	14.1	20.2	12.7	19.1	30.2	17.1	15.6	18.2	0.0	0.5	0.0	0.7	0.5	0.2	0.6	0.7	1.0	0.8	0.7	1.0	0.7	0.0	0.4	0.5	0.8	0.2	0.5	4.7	5.9	3.9	7.1	6.2	3.5	2.4	3.7	1.8	3.1	2.5	4.0	15.2	6.4	16.7	24.8	25.9	32.4	23.6	10.5	19.4	10.9	10.7	12.8	4.0	11.5	8.0	9.2	18.8	14.3	19.0	4.2	3.9	9.8	48.0	35.7	13.3	9.2	19.2	11.1	44.8	6.8	15.6	25.1	9.2	22.1	10.8	10.2	12.1	5.0	11.7	8.4	30.9	8.2	4.1	17.9	13.3	19.1	6.8	32.8	8.8	19.7	6.0	10.3	4.1	31.7	29.8	7.8	4.0	5.3	16.4	14.4	2.8	8.9	30.3	14.7	32.9	29.8	24.7	23.6	16.2	14.8	41.1	21.3	24.9	13.0	8.0	13.1
NAGK	GNK	ENSG00000124357	"N-acetylglucosamine kinase"	Q9UJ70	2	71064344-71079808	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 216.9;Syncytiotrophoblasts: 318.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 391.8;granulocytes: 288.7;monocytes: 594.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035206, HPA035207"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	Nucleoplasm	"HPA035206: AB_2674517, HPA035207: AB_10602031"	"unprognostic (6.15e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.44e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (8.60e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.13e-2)"	41.2	36.0	47.0	61.2	48.0	21.9	35.1	49.5	52.1	57.5	47.0	37.7	21.0	33.6	40.6	156.2	29.0	44.1	31.4	46.9	52.9	35.1	42.8	39.6	79.6	50.9	50.4	31.0	42.2	80.7	42.3	44.3	53.7	30.0	34.2	16.5	75.0	37.9	26.6	63.0	33.6	50.1	48.3	88.9	33.9	50.2	49.0	60.8	27.4	32.3	98.4	71.7	59.7	52.1	55.9	39.2	22.6	25.8	114.2	67.5	98.3	119.0	65.5	95.6	86.8	54.3	29.5	30.3	29.3	107.4	113.5	25.7	22.4	43.9	62.7	44.9	16.4	17.0	12.6	37.5	91.6	10.5	37.7	60.7	49.6	101.8	16.4	68.3	107.7	31.7	8.1	34.8	143.4	52.2	28.6	40.2	28.7	53.5	38.4	22.1	64.2	15.8	65.5	91.4	25.1	13.0	35.2	62.1	45.1	50.7	30.4	13.9	66.0	99.0	37.8	36.9	44.8	23.0	24.8	18.0	69.6	31.5	54.5	86.6	594.1	245.1	36.9	526.5	39.2	102.5	44.2	37.0	391.8	103.7	36.7	30.0	288.7	65.3	378.2	318.5	54.7	466.2	47.0	48.0	49.5	52.1	46.9	52.9	50.9	50.4	53.7	48.3	49.0	52.1	22.9	38.5	34.2	15.0	48.6	26.9	28.4	60.8	19.4	46.1	27.4	27.6	18.0	17.2	56.9	38.6	22.9	146.0	67.4	13.9	41.1	66.1	151.3	22.5	26.1	31.7	23.4	12.8	11.5	45.7	144.0	35.6	15.8	24.9	51.9	31.1	30.0	12.9	216.9	47.1	15.2	20.4	28.5	121.8	67.5	33.0	30.1	106.0	39.2	26.2	118.6	45.4	17.5	17.1	24.0	59.1	32.3	37.6	51.2	15.5	23.3	64.7	35.2	55.6	19.7	31.8	37.4	68.0	25.6	39.9	41.6	318.8	29.1	32.2	16.2	34.7
NAIF1	"bA379C10.2, C9orf90, DKFZp762G199"	ENSG00000171169	"Nuclear apoptosis inducing factor 1"	Q69YI7	9	128061233-128068206	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054898, HPA064931"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054898: AB_2682633, HPA064931: AB_2732725"	"unprognostic (7.09e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.60e-1)"	"unprognostic (6.15e-2)"	"unprognostic (9.41e-2)"	"prognostic favorable (1.02e-5)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.30e-5)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.92e-2)"	2.0	2.4	1.2	1.8	1.4	4.3	1.8	1.2	1.6	2.1	1.3	2.0	2.0	2.2	0.7	2.6	1.8	1.0	2.0	1.2	1.2	1.7	2.6	1.6	2.6	1.4	1.2	1.7	2.4	1.8	1.5	1.6	1.3	1.5	1.2	0.7	2.2	1.4	2.7	2.3	2.3	1.4	1.1	3.2	2.1	3.4	1.6	2.4	1.7	1.9	2.2	1.6	1.8	1.2	5.1	4.4	2.7	7.0	2.5	2.2	6.1	3.8	2.3	3.2	2.6	3.5	4.0	6.2	3.3	2.4	4.5	3.8	2.8	2.9	2.6	19.1	3.8	4.6	5.4	2.0	4.1	6.4	12.5	2.0	3.4	2.5	4.0	2.6	2.9	6.9	11.0	3.9	3.0	5.9	6.2	7.7	3.0	6.9	7.4	5.9	4.3	5.7	2.5	3.1	3.9	4.5	3.8	5.2	4.0	2.0	4.0	6.3	2.0	3.8	11.8	3.2	4.5	6.3	14.0	4.1	3.6	4.1	5.1	0.0	0.7	1.2	0.5	0.6	0.4	0.3	1.1	0.7	0.7	0.9	0.7	0.6	1.5	0.5	1.0	0.5	0.3	0.5	1.2	1.4	1.2	1.6	1.2	1.2	1.4	1.2	1.3	1.1	1.6	1.2	5.6	0.0	3.0	2.0	5.4	4.8	4.6	3.9	4.6	4.0	3.9	2.8	4.2	4.3	3.4	5.5	0.0	5.8	6.6	6.3	3.9	3.5	8.7	2.6	3.5	6.4	5.4	0.8	1.0	6.6	5.7	3.1	1.5	3.2	8.2	3.7	7.1	2.4	5.7	10.1	0.9	4.0	0.0	7.0	3.6	10.9	6.2	3.1	0.0	0.0	5.1	4.6	7.2	2.0	0.7	3.7	5.1	3.0	3.4	3.3	7.3	4.2	1.8	5.0	0.0	4.2	3.5	15.1	7.8	5.0	3.8	4.7	4.0	4.4	3.6	2.9
NANOG	"FLJ12581, FLJ40451"	ENSG00000111704	"Nanog homeobox"	Q9H9S0	12	7787794-7799146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 8.4;Spermatocytes: 5.5"	"Cancer enriched"	"Detected in single"	1164	"testis cancer: 58.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 125.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB019380, HPA072117"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"CAB019380: , HPA072117: "	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"		"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.46e-2)"		"unprognostic (6.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.51e-7)"	"unprognostic (3.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.85e-2)"	0.0	0.1	0.3	0.1	0.7	0.4	0.1	1.9	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.4	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	125.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.5	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.7	0.3	0.2	1.7	0.1	0.0	0.3	0.7	1.9	0.4	0.3	0.1	0.3	0.1	0.3	0.1	0.4	0.7	0.4	0.0	0.0	0.0	0.2	1.7	1.8	0.8	0.0	2.2	0.3	0.1	0.8	0.0	0.3	0.0	8.4	1.6	1.4	0.1	0.0	0.4	1.0	0.3	0.5	0.6	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.3	0.0	2.1	0.7	0.6	0.5	0.0	0.0	0.3	2.0	0.3	0.0	0.3	1.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.4	1.5	0.0	0.9	0.0	0.3	0.9	1.0	0.0	1.7	0.4	5.5	0.6	0.0	0.6	0.7	0.7	0.7	0.4	1.8
NANOGP8		ENSG00000255192	"Nanog homeobox retrogene P8"	Q6NSW7	15	35083410-35085295	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	415	"testis cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	69	"NTERA-2: 33.2;SuSa: 11.6"									HPA072117			Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 5: NTERA-2 - Transcription"		Nucleoplasm	Vesicles	"HPA072117: "										"unprognostic (1.58e-1)"			"unprognostic (9.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"			0.1	0.1	0.7	0.0	3.7	0.2	0.1	2.1	1.8	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.7	1.2	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	3.7	2.1	1.8	0.2	0.5	0.3	0.2	0.4	0.2	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NANOS1	"NOS1, ZC2HC12A"	ENSG00000188613	"Nanos C2HC-type zinc finger 1"	Q8WY41	10	119029714-119033730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 10.2;Cardiomyocytes: 11.3;Cone photoreceptor cells: 10.4;Muller glia cells: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 80.4;SK-BR-3: 46.7;SK-MEL-30: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB012219	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB012219: "	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.22e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.64e-4)"	"unprognostic (7.89e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.52e-3)"	9.5	11.3	7.4	0.3	7.3	0.2	8.3	7.4	7.7	1.9	5.0	2.9	0.3	2.1	1.7	1.0	1.0	0.2	10.3	5.9	11.8	4.6	0.3	1.1	0.4	8.8	8.9	0.3	2.2	0.3	2.8	6.3	8.5	1.0	0.4	4.1	1.3	0.9	38.6	1.6	0.9	1.8	7.1	0.3	3.4	1.9	9.2	0.3	7.1	1.7	0.3	3.3	1.0	10.9	16.4	1.3	2.2	0.4	7.4	1.1	9.7	0.4	0.5	0.4	0.2	2.0	5.6	8.7	2.2	0.1	0.0	5.8	2.7	2.9	0.7	2.6	6.6	0.2	3.8	1.8	3.5	1.0	0.0	1.5	11.7	0.1	1.6	2.4	0.4	3.0	1.7	1.0	0.5	2.3	2.2	2.8	7.1	3.4	1.3	0.0	2.7	5.9	3.1	1.3	6.3	80.4	4.7	46.7	37.4	12.2	7.4	4.7	0.5	0.0	3.4	0.1	0.8	2.4	8.6	3.2	0.7	2.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	7.4	7.3	7.4	7.7	5.9	11.8	8.8	8.9	8.5	7.1	9.2	10.9	5.7	6.4	1.1	2.0	1.3	0.8	5.0	1.3	0.6	4.1	10.2	6.1	11.3	1.5	1.2	1.8	10.4	6.5	6.3	4.4	0.0	0.6	0.2	3.9	2.8	1.7	3.0	0.0	0.5	0.2	0.4	4.0	1.1	3.7	0.0	2.6	0.7	0.1	0.7	1.7	2.3	3.8	0.0	0.0	2.1	0.1	1.8	0.9	0.0	0.0	0.0	14.7	1.0	2.0	0.2	0.3	0.1	0.7	1.6	2.9	0.2	0.5	1.2	2.1	0.0	7.7	3.9	0.4	1.0	0.8	1.3	1.0	2.9	0.7	2.1	1.3
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056732-98083077	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Enhanced	Nucleoplasm		No	No		410000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	39.4	28.9	16.2	49.3	15.0	67.8	36.5	13.8	18.2	49.9	29.8	133.5	52.2	28.5	33.5	51.4	29.4	34.2	46.3	15.1	17.0	32.8	67.0	45.9	59.5	16.2	17.2	26.2	67.6	20.4	42.5	31.7	18.4	106.4	129.2	8.3	120.0	19.7	34.2	29.2	47.8	29.0	15.1	53.3	76.1	27.2	17.2	18.8	27.3	17.4	60.5	47.5	41.5	17.2	387.9	111.8	32.5	94.5	64.0	68.8	70.5	120.9	93.7	96.3	78.3	134.8	53.6	118.1	57.2	133.3	101.9	134.1	61.0	103.6	80.0	95.7	91.0	70.3	128.4	271.9	176.3	80.3	55.3	58.4	69.1	102.9	116.4	111.8	104.3	57.9	129.9	119.8	71.2	265.0	54.1	114.9	56.2	277.5	143.3	103.4	89.0	121.5	78.2	116.6	65.7	34.4	77.8	414.4	107.2	35.8	137.6	85.3	274.2	74.8	72.5	193.4	125.8	110.7	99.3	45.7	88.4	95.9	59.6	30.9	190.9	29.5	34.9	237.6	53.4	55.6	45.5	36.8	194.7	54.9	48.8	33.7	77.4	38.9	217.0	178.8	58.3	91.4	16.2	15.0	13.8	18.2	15.1	17.0	16.2	17.2	18.4	15.1	17.2	17.2	46.7	28.9	54.9	3.6	57.0	70.1	134.0	183.0	30.7	11.4	61.6	45.5	25.3	42.9	206.3	22.0	18.8	86.7	50.2	234.3	70.5	49.4	42.8	63.4	37.9	63.4	64.9	18.7	6.7	100.7	159.2	50.6	99.4	55.8	43.8	29.5	34.2	33.6	160.0	10.1	7.2	362.7	95.6	67.7	107.6	71.5	32.3	89.8	129.9	6.5	53.1	14.1	14.4	2.0	3.1	70.9	181.0	26.4	141.1	213.6	66.5	68.3	204.5	8.0	13.1	32.9	91.3	10.5	21.9	42.0	61.7	150.8	50.6	44.6	260.1	223.3
NAP1L4	NAP2	ENSG00000205531	"Nucleosome assembly protein 1 like 4"	Q99733	11	2944431-2992377	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011567	Approved		Supported	Nucleoplasm		NA	NA		3100000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011567: AB_776638"	"unprognostic (1.61e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (8.99e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.54e-1)"	39.6	43.5	44.3	36.1	59.2	50.3	41.3	53.0	178.1	46.7	70.3	60.3	20.1	45.4	17.3	79.6	41.2	32.5	111.4	41.3	52.1	63.7	56.2	40.5	65.7	57.2	53.8	42.9	38.0	63.5	61.4	36.8	60.2	51.9	34.2	38.6	66.4	32.1	146.1	49.0	53.8	39.1	52.2	59.0	56.6	87.4	56.4	78.8	44.6	110.7	75.8	61.9	52.1	72.2	82.8	59.9	81.7	65.7	83.9	92.4	37.7	159.8	104.1	145.4	132.5	129.7	208.4	149.5	95.3	98.0	15.1	140.0	21.9	136.3	166.8	159.2	57.5	106.7	151.4	168.2	57.7	93.0	110.5	77.8	65.1	78.6	59.1	12.0	88.9	77.6	139.3	150.7	128.0	74.5	206.4	4.2	199.8	98.9	75.2	101.4	98.1	117.0	12.2	131.7	121.4	104.3	80.5	118.1	78.3	82.5	7.3	7.4	67.8	112.5	104.4	152.4	13.8	79.3	136.5	201.5	8.4	66.0	75.3	67.5	22.9	32.6	42.3	24.0	39.9	24.7	51.9	53.0	27.2	28.4	45.7	52.1	14.5	57.6	30.4	25.0	70.5	48.0	44.3	59.2	53.0	178.1	41.3	52.1	57.2	53.8	60.2	52.2	56.4	72.2	53.6	44.8	49.8	56.2	64.3	70.1	67.4	76.9	83.1	80.4	54.6	48.3	200.4	42.9	69.0	75.4	45.9	103.8	99.4	37.2	97.8	78.7	97.0	107.7	65.9	55.4	45.4	168.7	36.9	50.4	109.2	56.6	54.0	91.1	74.6	100.6	43.5	50.0	47.3	65.6	56.6	41.4	67.1	30.8	44.7	142.6	48.1	49.7	35.6	38.4	65.3	67.5	95.8	60.8	125.3	74.1	26.8	50.0	100.7	76.1	39.8	76.9	92.6	68.1	46.0	58.8	64.7	166.1	129.0	102.3	66.9	91.3	123.8	79.7	55.1	83.7
NAP1L5	DRLM	ENSG00000177432	"Nucleosome assembly protein 1 like 5"	Q96NT1	4	88695913-88697829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 49.6"	"Low region specificity"	"Detected in all"							HPA058227	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA058227: AB_2683644"	"unprognostic (1.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.39e-1)"	9.3	27.7	41.3	4.5	35.7	7.2	5.9	24.1	53.9	7.0	11.6	5.7	2.1	7.9	12.9	4.8	5.8	6.7	7.3	34.1	72.9	7.5	6.2	3.6	3.8	38.0	49.1	9.9	3.3	9.0	23.0	6.0	55.3	8.1	3.5	21.0	2.8	10.4	2.8	2.1	2.8	8.0	25.5	4.4	3.9	6.2	37.6	3.8	11.6	4.0	2.7	7.6	3.5	26.7	0.0	1.9	12.4	7.6	17.7	11.3	0.0	13.5	8.2	6.8	10.5	0.0	1.6	0.0	5.4	7.9	3.0	2.6	22.2	5.4	12.2	4.3	0.0	23.8	7.9	1.9	15.4	12.4	15.0	18.0	1.7	8.0	1.2	8.7	12.2	13.1	6.8	0.1	20.1	0.2	15.3	0.9	5.1	6.6	0.0	8.2	3.6	1.4	4.5	5.7	16.4	49.6	0.0	2.4	10.4	13.2	0.0	3.5	8.8	7.7	1.9	4.9	6.8	3.4	0.0	0.0	16.4	0.0	6.1	0.0	0.1	0.1	1.4	0.1	0.9	0.0	0.6	1.0	0.3	0.2	1.2	1.1	0.2	0.5	0.3	0.3	0.7	0.3	41.3	35.7	24.1	53.9	34.1	72.9	38.0	49.1	55.3	25.5	37.6	26.7	6.4	3.2	6.7	8.5	4.2	1.8	3.8	2.2	5.2	32.4	3.0	5.2	5.3	1.5	4.7	5.5	14.6	16.0	12.2	0.6	15.6	1.8	1.0	2.8	13.0	7.2	17.3	10.5	21.2	2.6	2.2	12.8	4.6	3.3	31.1	5.6	16.8	3.0	5.6	15.2	30.8	2.2	2.0	0.9	3.1	0.7	10.8	2.9	5.4	3.7	1.8	36.8	8.2	5.5	7.6	1.0	1.3	18.0	4.3	2.0	0.1	5.9	1.4	16.1	19.7	9.2	14.5	8.6	3.0	2.2	1.4	22.2	9.0	16.3	0.9	2.2
NAPRT	"NAPRT1, PP3856"	ENSG00000147813	"Nicotinate phosphoribosyltransferase"	Q6XQN6	8	143574785-143578649	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Ligase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 63.1"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 597.2;Proximal tubular cells: 203.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 49.8;RPMI-8226: 73.4;SK-BR-3: 84.1"	"Low region specificity"	"Detected in all"							"HPA023739, HPA024017, CAB068206, CAB068207"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		2300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309"	"unprognostic (7.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-2)"	15.7	13.6	4.1	6.3	4.7	21.9	14.6	3.9	8.7	15.8	4.6	22.2	61.4	9.7	1.7	37.1	10.6	5.8	10.8	4.3	4.8	15.7	63.1	13.8	6.6	5.4	4.1	9.6	12.4	5.0	6.0	5.4	4.0	11.3	3.9	0.2	29.2	10.5	10.1	27.9	47.3	2.9	4.4	19.4	22.5	10.5	4.7	4.1	9.8	4.6	5.2	13.2	18.1	5.6	14.8	7.2	0.6	1.4	3.2	2.0	4.0	0.7	7.5	4.5	1.7	5.6	34.3	1.8	7.8	0.5	0.0	25.6	1.8	34.6	0.4	4.3	12.1	16.7	25.5	1.9	42.5	2.1	14.8	3.2	16.6	0.3	0.0	0.1	18.1	32.9	21.5	8.8	0.1	11.1	6.7	8.0	5.6	49.8	4.2	13.8	0.3	73.4	16.0	2.0	7.4	0.9	9.1	84.1	30.7	0.6	2.1	20.3	3.8	0.9	10.1	8.0	2.9	0.8	0.8	3.1	1.8	41.8	16.1	6.9	11.4	14.1	2.9	12.7	1.9	2.0	4.4	1.9	6.7	1.3	1.3	2.4	10.6	0.8	23.0	6.9	1.9	5.8	4.1	4.7	3.9	8.7	4.3	4.8	5.4	4.1	4.0	4.4	4.7	5.6	50.6	35.3	23.1	7.5	16.2	0.0	64.9	0.0	24.5	12.1	18.3	14.7	10.0	54.3	9.3	75.4	18.8	48.8	21.8	88.0	68.4	62.7	44.2	18.5	26.0	32.7	10.9	63.8	3.8	54.3	74.8	20.6	100.9	26.8	7.6	21.7	49.6	117.4	80.6	16.8	3.2	70.4	0.0	89.7	0.0	59.8	32.0	55.0	0.0	7.5	108.9	23.7	28.8	1.5	2.8	111.7	124.6	21.8	12.7	44.2	597.2	203.7	1.5	13.4	13.1	15.8	16.5	41.7	16.0	35.9	0.0	56.2	17.2	29.7	100.9	73.9
NARF	"DKFZp434G0420, FLJ10067, IOP2"	ENSG00000141562	"Nuclear prelamin A recognition factor"	Q9UHQ1	17	82458180-82490537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 292.6;Late spermatids: 474.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053006			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Nucleoli	"HPA053006: AB_2682013"	"unprognostic (1.84e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (1.48e-10)"	"unprognostic (3.57e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.83e-2)"	19.2	18.0	17.2	12.4	18.5	32.9	17.4	19.5	21.7	15.8	16.1	23.4	10.3	14.5	5.8	21.5	16.1	7.7	38.7	17.7	16.8	19.6	23.1	15.1	10.7	17.8	17.0	16.9	20.6	6.6	18.7	7.4	17.8	17.0	6.5	11.5	18.4	8.2	49.2	25.1	19.1	7.1	15.8	28.7	23.3	59.1	16.9	14.6	16.5	25.9	8.9	19.9	16.3	19.1	21.2	23.3	32.8	50.6	15.2	14.3	18.2	13.1	12.7	21.2	21.2	23.6	8.4	14.0	13.6	9.8	23.8	18.6	23.8	15.5	14.2	15.3	55.7	29.0	30.4	27.7	13.1	30.9	50.6	21.9	26.4	16.5	5.7	20.7	39.2	44.9	67.5	9.6	9.2	18.1	51.2	49.8	13.7	16.3	44.1	42.6	34.3	21.6	9.7	23.3	40.1	55.9	32.1	21.3	38.8	20.7	18.4	23.2	21.7	26.4	22.4	22.4	21.7	94.1	38.4	30.1	24.3	20.6	15.9	94.5	33.0	96.2	34.2	30.0	38.1	38.2	33.1	33.7	32.0	40.9	37.7	31.2	156.0	53.7	23.9	26.2	44.1	38.6	17.2	18.5	19.5	21.7	17.7	16.8	17.8	17.0	17.8	15.8	16.9	19.1	45.2	12.8	23.2	25.1	50.7	37.3	32.9	55.4	28.5	38.1	30.4	30.1	43.2	21.5	40.0	5.5	54.2	32.4	87.9	38.5	39.2	53.3	194.2	46.2	23.3	53.1	56.9	292.6	30.6	66.7	57.7	30.1	80.5	25.3	52.7	24.4	45.7	18.5	34.3	50.5	31.6	32.4	95.6	23.8	35.3	474.5	25.1	39.3	62.2	15.0	56.7	24.2	72.1	12.5	20.8	65.7	29.6	18.0	89.9	23.7	41.9	22.1	61.6	37.3	13.1	36.9	36.0	152.5	87.6	20.7	35.4	30.6	57.4	28.4	36.3	30.2
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435968-78574874	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	7.3	11.9	10.7	6.8	12.3	6.2	11.1	12.4	13.3	9.6	19.8	11.3	10.3	9.1	11.2	8.1	9.9	7.0	11.7	10.4	11.7	19.0	23.5	7.6	9.6	11.7	13.9	11.4	10.6	11.4	7.6	8.0	13.1	10.8	10.9	13.4	10.7	7.3	23.5	7.2	9.7	7.4	11.3	7.4	9.9	7.5	11.4	11.7	11.5	19.6	9.7	8.7	8.1	12.3	16.7	22.8	23.5	15.4	16.1	13.5	19.5	13.5	13.1	20.6	16.9	39.4	17.4	40.9	34.1	8.7	19.8	21.5	39.9	26.3	28.3	27.0	21.3	28.9	17.3	33.7	13.3	31.3	10.1	9.4	16.8	18.1	32.0	18.3	17.9	33.7	44.5	11.0	23.1	19.4	32.7	50.3	25.6	67.3	27.3	33.6	38.2	55.5	27.2	23.0	27.8	17.5	20.1	25.4	35.5	25.1	24.1	12.3	10.9	27.7	32.8	32.0	23.1	18.1	33.1	91.1	5.4	27.7	19.2	9.5	9.3	4.4	11.1	10.4	13.8	17.6	12.8	12.5	16.6	15.0	18.5	16.7	2.0	20.3	12.8	12.7	10.5	10.3	10.7	12.3	12.4	13.3	10.4	11.7	11.7	13.9	13.1	11.3	11.4	12.3	5.8	19.2	26.4	27.7	14.5	13.5	14.2	12.0	12.5	5.2	9.4	6.5	8.8	5.7	10.3	5.5	2.1	20.0	4.4	4.0	29.4	9.5	13.1	10.1	7.4	6.6	12.0	9.2	34.7	7.3	23.6	9.0	10.2	9.0	8.2	14.0	2.5	19.8	12.4	0.0	45.1	8.3	22.4	6.3	11.6	5.4	7.8	6.3	17.8	45.0	2.9	6.3	4.1	42.7	47.7	7.5	9.9	4.9	14.6	17.5	7.0	28.9	10.2	9.0	6.6	7.5	8.8	8.6	19.5	12.0	13.8	15.3	7.8	9.0	14.6	10.7
NASP	"DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999"	ENSG00000132780	"Nuclear autoantigenic sperm protein"	P49321	1	45583846-45618904	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 476.2;Spermatogonia: 514.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028136, HPA030518, HPA030520"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		170000	"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (5.02e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.36e-3)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (1.62e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (5.32e-2)"	66.2	39.6	57.4	55.9	62.6	165.0	58.8	60.6	95.7	67.4	57.1	52.7	34.6	54.6	29.9	55.2	65.6	26.7	51.0	57.2	68.0	48.6	52.0	50.4	91.5	65.0	61.6	72.4	34.9	41.1	40.9	61.9	63.0	54.1	51.5	38.2	43.5	43.4	41.7	46.7	58.3	45.1	56.0	83.3	47.3	108.9	62.4	100.7	48.1	22.2	97.7	51.1	56.0	65.3	191.3	110.8	520.2	184.6	85.8	44.9	243.8	150.9	112.4	230.5	286.5	205.7	134.4	357.9	103.5	65.8	251.9	180.2	351.9	161.0	291.5	164.0	222.9	462.7	201.6	326.9	30.2	489.3	186.4	52.5	38.3	254.0	87.6	60.1	159.5	294.8	396.3	204.1	157.6	131.4	559.6	445.0	755.5	189.5	93.1	697.4	454.0	343.8	115.3	189.4	198.3	239.8	248.7	140.4	159.7	389.2	100.8	377.0	86.7	105.5	322.8	204.4	250.0	124.5	251.2	616.2	107.6	306.7	107.3	6.4	9.4	10.9	14.1	12.1	16.4	16.1	16.1	16.3	14.3	22.3	13.9	13.7	4.0	9.7	7.3	14.7	22.0	9.1	57.4	62.6	60.6	95.7	57.2	68.0	65.0	61.6	63.0	56.0	62.4	65.3	196.5	57.7	106.7	70.8	136.1	78.1	135.2	72.4	133.7	45.3	77.4	87.4	58.4	37.1	99.1	36.8	37.5	319.3	150.8	64.8	31.3	55.0	16.6	119.6	138.1	138.4	51.3	142.8	32.7	37.4	223.2	100.6	81.1	137.9	115.2	134.2	90.3	38.6	108.1	43.7	34.8	68.1	44.7	43.7	62.6	26.6	94.8	82.7	40.9	31.9	52.3	60.9	62.8	63.8	160.3	29.8	44.9	78.2	107.4	88.6	28.9	36.6	109.1	77.3	85.5	148.1	106.6	476.2	514.5	92.1	57.0	268.2	142.2	90.7	101.7	85.3
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170496-101180293	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 2.7;pancreas: 2.3;pituitary gland: 3.6;retina: 6.9;thyroid gland: 1.8"	"Cell type enriched"	"Detected in some"	36	"Horizontal cells: 292.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3;melanoma: 2.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.4;SH-SY5Y: 3.4;SK-MEL-30: 2.7;U-2 OS: 2.9;U-87 MG: 1.7"									HPA021918	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.0	0.1	1.5	0.0	1.4	0.2	0.0	0.7	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	2.7	0.0	0.1	0.0	0.0	0.8	1.2	0.0	2.3	0.3	3.6	0.0	0.5	0.0	0.0	6.9	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.4	0.1	2.5	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.1	0.0	2.4	0.0	0.2	0.0	3.4	0.0	0.1	2.7	0.2	0.1	0.0	0.0	0.1	2.9	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	1.5	1.4	0.7	2.7	1.0	2.7	0.8	1.2	0.5	0.2	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.1	0.7	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	292.7	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	5.5	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1
NAT9	DKFZP564C103	ENSG00000109065	"N-acetyltransferase 9 (putative)"	Q9BTE0	17	74770529-74776367	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021820, HPA057149"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021820: AB_1847958, HPA057149: AB_2683350"	"unprognostic (7.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.26e-6)"	"prognostic favorable (7.80e-4)"	"unprognostic (8.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.03e-3)"	18.2	57.5	24.0	11.4	24.6	13.5	18.1	25.8	27.6	23.3	25.0	17.3	8.0	18.7	23.2	16.3	21.5	8.9	19.4	23.6	24.2	25.1	29.9	17.6	13.6	25.2	24.9	31.0	25.2	18.0	29.4	14.2	25.2	27.7	9.8	11.5	17.1	12.5	16.4	16.0	15.8	11.1	24.4	20.8	19.3	20.9	24.5	13.7	24.4	11.0	11.3	21.7	18.2	25.6	20.9	30.0	18.7	17.2	29.9	37.4	22.3	39.5	34.2	40.7	35.1	51.3	22.8	57.4	14.7	31.2	26.2	22.8	25.6	42.9	25.9	12.0	37.0	37.0	24.6	46.2	34.9	19.1	22.9	34.2	31.9	40.5	61.2	33.7	44.7	36.2	46.8	17.6	30.2	19.9	38.9	15.6	14.5	40.5	42.8	25.6	55.7	33.4	29.2	33.5	27.0	35.7	16.5	48.1	78.0	25.5	44.4	24.7	26.2	47.0	37.7	20.4	37.5	24.1	9.4	32.0	19.4	12.9	30.5	20.4	16.2	7.4	9.2	24.0	18.9	20.7	16.7	13.8	19.9	30.5	28.5	21.1	4.2	16.7	13.9	15.2	9.8	12.0	24.0	24.6	25.8	27.6	23.6	24.2	25.2	24.9	25.2	24.4	24.5	25.6	15.3	6.4	14.5	15.7	22.6	35.1	41.7	25.9	12.5	39.5	24.7	18.9	5.6	5.7	16.4	18.4	47.9	23.3	20.3	14.5	7.9	14.9	5.5	7.6	13.3	14.3	26.4	10.3	24.4	19.5	19.2	17.3	17.3	13.1	1.3	33.0	9.3	9.9	18.0	45.4	20.2	17.7	20.3	14.1	21.0	4.0	29.5	16.8	10.6	5.6	20.7	11.3	18.6	15.6	16.4	18.3	17.0	17.0	15.8	43.7	11.8	14.5	13.5	46.4	6.6	15.1	16.1	20.5	26.4	9.0	29.7	22.2	14.3	23.7	20.8	39.0
NAV2	"FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1"	ENSG00000166833	"Neuron navigator 2"	Q8IVL1	11	19350724-20121601	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.7;heart muscle: 61.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 466.8;Excitatory neurons: 333.8;Inhibitory neurons: 525.7;Oligodendrocyte precursor cells: 863.6;Oligodendrocytes: 354.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 89.9;SH-SY5Y: 81.9;TIME: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011755, HPA011891"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA011755: AB_1854319, HPA011891: AB_1854318"	"unprognostic (7.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.28e-2)"	7.4	1.6	11.6	3.3	18.8	1.8	12.0	16.1	10.8	6.3	3.5	16.2	4.4	7.6	11.1	6.5	4.4	1.8	61.2	9.6	13.8	9.5	14.9	9.5	1.8	55.7	43.7	3.1	8.8	6.0	5.1	14.8	36.5	6.2	4.9	8.7	15.0	9.3	2.6	6.7	4.1	8.5	39.3	1.4	7.2	0.9	27.7	2.5	16.9	9.4	3.9	5.7	7.4	35.6	16.2	4.7	10.2	1.4	33.7	21.6	11.0	13.3	22.6	17.2	13.0	18.2	2.1	0.1	0.6	20.1	28.0	1.9	0.6	10.4	20.1	3.8	1.2	0.4	25.1	20.9	6.1	0.0	0.5	14.1	26.5	8.3	89.9	12.7	23.2	0.1	1.9	8.0	50.2	17.2	0.0	0.1	26.4	5.3	13.1	0.1	47.1	2.6	14.8	4.6	18.2	81.9	10.3	7.9	14.8	54.2	0.3	0.0	65.2	39.6	6.3	47.7	12.7	2.7	2.0	0.1	13.5	0.8	12.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.6	18.8	16.1	10.8	9.6	13.8	55.7	43.7	36.5	39.3	27.7	35.6	5.5	64.1	22.6	466.8	1.4	4.2	23.6	13.8	14.2	4.6	33.6	31.0	14.3	8.6	18.3	20.2	0.0	31.8	0.8	2.8	13.7	20.3	2.6	34.4	4.6	14.5	10.8	0.0	333.8	21.3	23.3	16.5	11.2	62.1	1.3	152.4	11.7	47.0	10.7	26.9	525.7	10.1	18.3	1.4	5.0	7.9	0.9	3.2	16.0	194.9	1.0	28.9	0.0	863.6	354.4	37.5	0.8	4.1	0.4	33.7	1.8	0.4	24.0	2.4	0.0	30.7	17.8	1.5	0.6	23.1	3.7	14.6	1.7	54.7	9.2	17.8
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591756-156609507	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"	"Lipid transport, Transport"	Isomerase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 136.7;Distal tubular cells: 201.5;Ductal cells: 112.8;Exocrine glandular cells: 100.1;Proximal tubular cells: 219.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		3300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	47.1	74.8	61.0	20.9	63.7	22.2	47.9	66.1	69.6	56.8	71.1	62.9	45.5	68.8	88.7	58.0	59.5	26.5	111.1	60.9	64.3	83.8	86.5	43.6	27.0	62.7	64.8	46.5	69.7	104.7	70.0	23.7	61.8	62.5	41.6	17.4	53.9	48.3	71.8	55.8	48.3	39.7	64.7	43.2	67.5	40.8	63.5	30.6	59.8	68.2	34.3	55.0	47.8	70.5	114.2	155.4	43.9	84.4	64.0	43.8	55.5	29.5	62.3	69.5	72.6	130.6	76.8	62.4	113.4	52.5	55.9	111.1	49.4	99.0	47.5	81.2	98.5	58.1	76.2	86.1	75.1	60.0	60.9	44.2	123.7	87.9	81.9	53.4	95.4	104.7	54.7	70.1	71.6	209.6	83.3	98.0	43.1	158.1	118.2	87.7	40.2	212.6	93.0	93.6	114.7	102.9	90.4	172.4	141.6	66.4	178.3	117.5	51.1	45.1	64.8	64.6	70.6	180.1	110.3	53.0	63.1	37.0	70.4	25.4	96.3	52.9	121.2	111.3	121.3	236.2	109.4	124.3	89.1	186.5	122.8	114.9	11.4	141.3	89.1	225.7	110.1	186.6	61.0	63.7	66.1	69.6	60.9	64.3	62.7	64.8	61.8	64.7	63.5	70.5	29.5	41.7	32.9	0.0	14.8	0.0	0.0	0.0	0.0	0.0	87.5	96.0	0.0	0.0	23.5	68.0	0.0	136.7	28.7	0.0	201.5	112.8	0.0	27.3	29.9	18.4	0.0	0.0	0.0	100.1	43.1	27.2	0.0	32.0	5.1	53.5	0.0	0.0	92.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	40.8	0.0	0.0	0.0	0.0	91.0	0.0	0.0	6.2	0.0	0.0	219.6	11.7	0.0	0.0	0.0	24.5	0.0	0.0	0.0	0.0	81.3	13.4	48.1	0.0	0.0
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942270-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 23.5;retina: 65.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 1016.1;Inhibitory neurons: 953.0;Oligodendrocyte precursor cells: 466.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.1;SH-SY5Y: 80.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	2.4	7.2	7.7	1.5	10.7	0.3	4.9	19.0	23.5	3.5	2.8	5.8	1.4	6.1	2.2	3.3	5.5	3.4	6.9	17.4	2.8	4.1	0.6	2.0	1.6	4.1	0.1	6.2	3.1	7.1	8.3	0.6	4.8	6.6	2.5	65.7	4.7	8.4	5.6	1.5	2.5	6.5	0.4	3.2	2.7	3.5	0.0	5.6	6.3	5.7	1.2	3.6	2.8	4.5	0.0	4.5	10.9	6.1	0.7	0.1	0.3	7.0	10.8	7.9	6.6	0.1	1.0	3.0	0.0	12.9	4.7	0.3	3.7	1.5	16.3	1.4	3.6	0.0	3.4	1.2	0.5	1.9	4.7	2.1	1.2	0.1	0.7	33.1	1.8	1.2	0.1	17.6	1.1	1.9	1.1	0.0	4.6	6.2	2.0	1.1	4.7	0.9	9.3	2.1	6.2	80.1	5.4	0.1	3.6	8.1	2.0	0.4	0.1	2.0	1.2	0.0	1.6	1.9	0.5	1.3	5.4	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	7.7	10.7	19.0	23.5	17.4	2.8	4.1	0.1	4.8	0.4	0.0	4.5	19.7	28.9	9.2	132.9	5.2	1.0	5.3	2.7	1.2	124.8	5.0	6.5	51.8	11.5	14.1	9.2	146.0	0.1	4.4	0.3	1.9	9.2	19.3	5.6	18.4	10.1	22.9	0.8	1016.1	1.8	0.1	12.3	2.0	0.6	25.2	20.7	11.0	0.3	0.9	47.1	953.0	2.1	6.1	3.5	3.9	13.6	17.7	3.5	7.2	150.9	1.2	69.1	0.0	466.9	163.7	2.3	0.1	19.2	5.8	8.5	0.2	7.6	56.5	87.0	6.6	22.2	13.1	8.5	8.0	0.3	0.9	0.0	1.2	11.9	1.1	13.5
NBEAL1	"ALS2CR16, ALS2CR17, MGC164581"	ENSG00000144426	"Neurobeachin like 1"	Q6ZS30	2	203014879-203226378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 1030.4;Langerhans cells: 1016.1;Suprabasal keratinocytes: 1304.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049189, HPA049447"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA049189: AB_2680669, HPA049447: AB_2680771"	"unprognostic (3.66e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.59e-2)"	3.0	2.1	1.5	1.7	3.3	1.1	3.3	4.1	1.9	2.7	8.5	6.9	4.6	2.6	2.1	2.1	3.4	3.1	2.6	1.2	2.2	6.5	5.7	4.4	1.1	2.7	2.2	3.7	2.9	2.9	0.9	2.8	2.7	2.2	6.7	3.9	1.7	1.8	1.5	2.2	5.5	2.7	1.6	1.7	7.1	3.6	2.6	1.3	4.6	3.9	1.3	2.9	1.7	3.6	4.2	3.9	1.6	1.4	9.7	7.5	2.3	4.0	2.9	2.1	3.2	4.4	2.1	0.9	3.2	6.8	4.1	3.4	3.2	4.7	4.8	1.9	1.4	1.6	6.0	2.5	2.3	1.5	1.8	2.9	3.0	3.4	4.2	5.0	3.3	1.7	2.9	1.4	4.8	2.9	0.6	0.8	0.8	1.8	3.6	0.7	2.6	1.0	5.8	7.8	1.0	0.8	3.4	2.5	2.5	3.9	2.9	1.5	5.7	5.5	4.6	2.6	1.8	2.4	1.9	1.2	3.3	0.6	1.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	1.5	3.3	4.1	1.9	1.2	2.2	2.7	2.2	2.7	1.6	2.6	3.6	53.0	38.5	72.2	103.5	145.5	1030.4	399.8	231.1	117.8	18.4	81.2	89.2	21.4	223.1	94.4	38.6	27.1	205.9	58.8	173.8	84.1	57.4	30.9	57.8	73.5	155.1	293.5	49.0	88.0	99.2	276.5	154.4	103.9	69.3	107.2	43.3	287.0	203.7	154.5	82.4	79.7	515.3	91.6	531.4	1016.1	49.5	274.3	78.0	629.7	81.5	186.0	19.5	171.9	105.1	130.9	78.5	335.8	129.4	52.4	304.8	343.9	103.1	59.2	26.9	118.3	388.6	265.6	45.1	41.2	118.4	1304.2	229.3	182.3	31.4	528.3	305.2
NBN	"AT-V1, AT-V2, ATV, NBS, NBS1"	ENSG00000104320	Nibrin	O60934	8	89933331-90003228	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 265.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001429, CAB003836"	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoplasm	"CAB003836: AB_562172, HPA001429: AB_1854460"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (5.05e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.03e-1)"	22.5	12.4	9.2	27.8	12.8	54.0	25.4	9.3	10.0	16.9	7.4	18.3	15.1	22.3	11.4	20.0	14.5	22.5	12.1	10.2	12.5	20.7	22.3	18.1	24.3	10.7	8.6	16.9	15.5	15.4	9.0	14.1	9.9	17.5	22.5	9.8	16.6	14.9	10.0	10.3	16.0	24.2	11.0	23.4	12.7	16.4	11.0	19.0	22.7	16.2	26.4	21.8	9.6	15.0	54.8	30.1	29.3	15.6	16.5	38.7	18.9	37.9	49.5	46.6	50.8	17.2	41.8	83.8	42.2	35.5	19.1	17.7	35.7	35.7	59.8	38.0	19.7	67.7	16.8	23.6	30.8	40.0	35.2	30.5	18.3	27.2	57.9	22.8	39.5	33.9	50.6	46.6	55.3	46.9	65.6	26.0	8.5	39.5	31.4	42.3	25.3	47.0	62.8	73.8	8.1	26.6	23.5	265.1	23.1	16.3	49.8	31.4	29.2	40.9	28.0	25.5	38.0	21.2	25.0	45.5	41.3	39.4	39.1	32.4	17.7	32.9	11.9	19.7	12.7	15.2	8.5	8.8	18.9	8.9	8.1	9.0	34.4	16.1	31.5	10.4	5.9	13.1	9.2	12.8	9.3	10.0	10.2	12.5	10.7	8.6	9.9	11.0	11.0	15.0	36.9	48.1	14.2	24.5	39.8	11.9	13.5	20.4	23.9	25.4	29.7	22.9	30.3	14.3	33.7	27.6	2.1	23.0	29.3	11.2	43.0	35.1	17.6	45.4	46.9	22.9	12.1	31.7	45.0	32.0	19.7	36.3	19.9	31.2	79.7	38.3	18.9	30.6	25.9	13.5	39.9	16.9	16.2	29.2	27.1	7.2	19.0	51.1	12.4	32.8	54.7	29.4	36.0	40.7	40.3	24.7	9.9	26.4	38.8	11.6	9.9	40.5	36.4	11.2	6.6	50.3	31.7	20.2	46.0	31.5	13.5	10.8	35.3	68.7	19.4	11.0
NBPF4	FLJ32833	ENSG00000196427	"NBPF member 4"	Q96M43	1	108223341-108244081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.1;intestine: 1.2;testis: 3.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.1;K-562: 10.2;Karpas-707: 3.1;MCF7: 12.6;THP-1: 3.8"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (6.33e-2)"		"unprognostic (2.08e-1)"						"unprognostic (2.18e-2)"					"unprognostic (8.29e-2)"	"unprognostic (2.90e-1)"		"unprognostic (8.73e-2)"	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.2	3.1	0.0	12.6	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.2	0.0	0.0	0.1	1.4	0.0	0.1	3.8	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF6		ENSG00000186086	"NBPF member 6"	Q5VWK0	1	108450282-108471002	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 2.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.2;Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.5;HeLa: 1.9;K-562: 11.6;SK-BR-3: 2.4;SK-MEL-30: 1.9"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (4.36e-2)"		"unprognostic (5.87e-2)"						"unprognostic (4.62e-2)"					"unprognostic (2.39e-1)"	"unprognostic (2.61e-1)"		"unprognostic (8.02e-2)"	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.9	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBR1	"1A1-3B, CA125, KIAA0049, M17S2"	ENSG00000188554	"NBR1 autophagy cargo receptor"	Q14596	17	43170481-43211689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 276.9;Late spermatids: 909.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022944, HPA022999, HPA023999"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Nuclear bodies"	"HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (1.65e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	45.7	52.3	48.4	39.4	54.5	20.1	55.9	52.1	48.2	52.0	51.2	66.2	70.1	48.9	39.9	40.3	53.4	44.5	67.3	43.7	49.9	84.7	91.3	47.3	41.0	52.2	50.4	69.7	43.9	97.1	28.8	60.1	52.9	64.7	70.4	80.1	49.4	52.0	112.2	42.9	73.8	49.3	52.1	53.0	52.6	141.0	51.6	59.0	68.2	116.0	45.4	47.3	34.5	65.2	42.3	49.8	42.6	44.6	93.5	95.2	41.0	77.1	147.2	60.5	50.4	26.6	65.1	22.7	77.8	105.1	62.6	46.1	48.5	97.4	90.3	70.0	51.2	27.1	62.0	60.0	89.4	23.2	40.1	108.4	111.6	67.2	133.7	127.3	96.0	50.8	58.1	58.7	83.7	23.9	48.9	17.7	13.6	50.0	32.8	16.5	65.6	73.3	81.6	48.0	25.9	45.8	53.1	26.1	79.8	70.7	70.7	38.0	82.2	89.9	34.1	42.7	31.5	69.9	61.8	29.1	61.8	31.5	63.6	41.6	25.7	40.1	20.3	23.3	20.7	13.7	18.1	19.6	19.3	9.4	17.0	16.6	34.4	24.3	36.4	12.0	26.4	25.0	48.4	54.5	52.1	48.2	43.7	49.9	52.2	50.4	52.9	52.1	51.6	65.2	36.9	41.7	44.1	24.5	21.9	23.8	29.2	28.1	54.1	37.3	33.8	27.4	86.4	35.8	40.4	36.8	39.6	28.0	34.6	94.2	19.6	25.4	276.9	40.5	30.4	39.0	40.2	53.2	24.7	21.9	19.4	37.6	31.1	33.0	25.9	53.1	45.3	67.8	22.0	20.2	28.2	56.4	20.3	62.9	19.9	909.9	58.7	35.7	26.6	29.0	35.6	49.3	44.3	33.2	41.4	25.8	64.5	44.4	26.1	41.1	100.3	57.4	63.4	56.9	39.5	33.9	36.2	49.6	30.9	26.7	27.3	15.7	31.9	68.6	52.4	38.7
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 48.0;Late spermatids: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes		34000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	8.3	7.4	7.3	21.5	11.4	35.5	10.9	9.9	8.3	10.2	7.4	17.9	17.0	10.7	10.6	15.9	11.2	9.8	7.6	7.2	8.0	7.4	4.8	10.6	38.1	11.0	10.0	8.0	7.7	11.3	5.5	17.5	11.7	9.4	20.4	11.1	11.8	10.2	7.9	21.9	16.0	13.4	8.4	16.1	12.1	18.2	10.2	76.8	11.3	10.2	44.8	10.1	9.3	13.9	125.3	99.3	134.6	97.9	29.9	28.4	159.2	76.1	69.8	138.3	109.1	123.5	150.8	135.8	24.2	63.2	126.7	128.6	188.0	105.4	194.1	214.1	92.8	112.2	113.8	79.4	12.5	145.0	96.5	20.5	31.6	112.4	107.8	61.9	89.9	94.0	71.0	63.4	104.7	79.6	162.2	73.8	207.5	129.9	78.2	153.7	260.6	77.7	39.5	64.1	54.0	61.9	121.5	64.9	44.3	189.1	27.0	101.7	51.0	94.1	149.6	60.8	168.4	45.3	51.7	181.0	55.7	92.2	126.1	11.0	1.7	3.7	7.1	2.8	5.3	5.1	6.4	7.3	3.4	3.5	7.3	7.3	1.4	8.1	2.2	4.1	8.3	3.9	7.3	11.4	9.9	8.3	7.2	8.0	11.0	10.0	11.7	8.4	10.2	13.9	4.3	6.4	7.4	4.9	11.0	3.6	3.8	4.4	17.1	3.7	4.7	6.9	4.1	5.7	3.4	1.8	8.4	13.5	8.9	7.3	0.0	4.5	18.3	5.3	6.3	5.4	1.2	48.0	5.6	3.7	17.8	6.4	7.1	5.8	3.8	20.0	8.9	3.3	10.1	5.0	5.0	9.9	6.1	16.4	4.4	34.3	5.9	10.8	0.0	2.8	9.5	11.8	15.5	2.5	17.8	5.3	4.6	6.0	22.6	4.1	6.0	2.4	4.2	8.4	0.0	4.2	5.2	21.3	13.7	19.3	3.4	6.3	12.0	6.1	14.7	4.1
NCAPD3	"CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056"	ENSG00000151503	"Non-SMC condensin II complex subunit D3"	P42695	11	134150113-134225454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"prostate: 58.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 50.8"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040286			Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA040286: AB_2676918"	"unprognostic (4.27e-2)"	"unprognostic (6.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.48e-1)"	4.7	5.5	1.9	3.1	2.0	10.0	4.9	4.0	3.8	4.2	2.3	4.4	3.5	4.0	3.3	7.1	3.8	2.6	5.0	3.1	1.6	3.6	8.8	4.9	4.2	2.0	1.1	3.4	4.5	1.9	7.0	3.1	1.1	58.5	1.5	4.5	5.7	0.9	3.7	9.0	5.4	1.3	0.9	6.2	5.1	9.5	1.6	3.1	6.0	0.9	1.7	3.7	5.2	3.0	5.5	1.9	12.3	25.3	1.8	1.3	10.6	11.5	1.9	3.5	4.0	5.6	3.4	6.1	11.1	3.5	9.8	6.1	3.5	5.2	4.4	9.2	21.7	26.6	5.1	8.5	2.3	13.1	15.4	1.7	1.1	5.1	2.0	3.6	2.6	11.6	7.1	4.7	4.2	6.0	10.9	15.1	8.6	5.5	13.8	2.9	13.7	8.5	4.1	3.2	22.1	13.4	9.1	5.9	1.7	10.0	9.7	6.9	1.7	11.8	5.7	11.8	9.9	4.5	4.5	5.5	8.3	16.4	15.2	1.6	3.3	1.6	5.7	2.7	2.2	2.3	3.7	3.8	2.5	5.2	5.5	5.8	1.6	1.7	2.2	8.0	6.5	1.9	1.9	2.0	4.0	3.8	3.1	1.6	2.0	1.1	1.1	0.9	1.6	3.0	7.7	3.2	8.1	8.5	12.1	9.2	4.4	6.0	8.0	20.2	9.9	8.6	6.7	2.8	7.0	12.9	10.4	13.0	13.2	5.4	0.0	2.7	7.2	7.8	12.8	5.6	7.8	32.8	19.7	2.6	9.9	7.5	7.7	9.0	2.5	19.6	5.7	9.7	8.8	11.8	16.7	7.2	10.2	6.4	8.7	10.4	4.7	10.9	1.8	15.0	17.1	9.0	17.5	11.1	16.0	2.8	1.6	4.1	22.9	8.8	3.2	3.6	4.9	20.9	0.0	9.5	9.2	21.5	14.4	10.7	9.1	4.5	14.2	11.3	11.6	3.4
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631169-158704804	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.91e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	3.7	2.5	2.0	8.8	2.2	24.4	5.4	2.5	2.1	4.0	1.3	6.9	4.4	4.3	2.1	6.9	3.0	2.9	2.9	2.2	2.1	2.6	4.1	3.1	12.4	2.0	1.7	3.1	2.2	4.6	3.5	5.9	2.1	2.8	7.6	2.8	3.5	2.8	3.4	6.8	5.8	4.8	1.6	4.6	5.6	14.8	1.8	27.9	3.2	4.1	13.8	4.0	3.9	2.4	103.9	53.7	64.1	41.8	9.5	15.4	25.3	74.3	47.4	89.0	99.0	48.5	52.0	64.0	45.0	30.3	95.1	51.7	53.7	33.8	117.2	68.4	40.4	57.2	64.8	38.8	4.2	72.2	62.3	6.8	3.7	73.1	21.0	16.2	50.4	72.9	71.9	91.6	82.8	111.4	119.2	48.8	63.7	58.8	43.3	69.7	67.8	60.6	22.6	45.9	69.6	54.5	91.6	35.0	20.2	40.4	31.4	46.5	25.9	60.6	45.9	166.2	120.6	61.3	48.2	77.2	64.6	89.6	118.5	5.9	0.9	1.1	5.2	1.2	7.5	1.6	5.2	3.6	2.3	1.0	1.6	1.8	0.7	5.2	5.1	1.1	7.2	2.2	2.0	2.2	2.5	2.1	2.2	2.1	2.0	1.7	2.1	1.6	1.8	2.4	3.6	6.4	1.5	3.9	4.1	4.0	2.1	2.8	1.8	3.9	3.7	3.3	4.8	2.8	4.6	1.8	0.0	6.7	5.1	3.4	0.0	2.3	15.1	4.0	4.6	4.3	0.0	19.6	10.7	3.3	10.4	4.5	4.1	5.9	1.3	12.6	2.9	2.6	7.3	8.4	7.2	2.9	2.0	3.8	5.2	7.2	2.8	4.4	1.8	3.7	2.7	2.1	2.1	10.1	10.7	2.3	0.4	4.1	11.0	1.1	0.3	1.3	6.0	2.8	6.6	4.3	5.7	48.2	18.5	6.1	2.0	2.6	4.9	5.0	5.7	3.0
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335766-96377091	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.2;lymphoid tissue: 37.4;testis: 35.4"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 26.3;Spermatocytes: 89.3;Spermatogonia: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.8;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (9.53e-6)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.2	0.7	0.3	9.9	0.4	35.2	1.8	0.9	0.9	1.3	0.1	7.7	5.6	0.9	0.2	6.3	0.5	1.6	0.4	0.3	0.2	0.4	1.0	1.1	20.3	0.1	0.0	0.3	0.3	0.5	0.2	5.2	0.3	0.4	9.3	1.8	1.5	0.2	0.3	4.7	6.2	2.8	0.0	3.7	3.6	35.4	0.1	37.4	0.4	0.1	22.0	2.6	2.0	0.3	134.1	52.0	115.1	60.6	3.9	6.1	80.8	58.7	40.3	115.1	118.4	93.5	71.5	121.0	41.8	26.6	106.2	57.2	100.2	39.6	117.2	110.0	63.4	123.7	49.3	74.5	0.7	112.2	101.3	1.8	4.2	89.1	35.9	10.2	46.6	89.7	89.5	88.8	53.0	59.5	183.8	104.2	85.9	57.6	56.6	133.4	106.7	95.5	23.6	49.6	71.2	52.3	34.8	46.5	19.9	42.4	36.6	80.0	24.1	83.5	126.3	76.9	101.9	44.4	70.1	134.0	33.7	111.5	95.3	3.8	0.0	0.2	0.8	0.9	0.1	0.9	1.2	1.0	0.4	0.9	0.0	0.4	0.3	0.1	0.0	0.0	6.2	0.5	0.3	0.4	0.9	0.9	0.3	0.2	0.1	0.0	0.3	0.0	0.1	0.3	4.9	0.0	0.0	0.0	3.5	0.6	0.7	1.9	1.2	0.4	1.0	0.8	0.5	0.0	1.6	0.0	8.4	9.4	2.0	2.1	0.0	0.5	5.9	1.7	0.9	1.8	0.0	16.4	0.4	0.0	16.3	1.8	4.1	1.2	1.3	5.5	1.4	0.4	8.5	0.0	0.3	2.8	0.0	3.8	3.7	4.9	0.9	2.2	1.8	0.0	0.2	8.5	0.0	0.5	1.0	0.2	0.1	0.4	26.3	0.7	0.4	0.0	1.6	2.3	0.0	0.2	3.5	89.3	29.4	8.8	0.9	1.9	5.1	0.6	5.7	1.1
NCAPH2	"384D8-2, CAP-H2, hCAP-H2"	ENSG00000025770	"Non-SMC condensin II complex subunit H2"	Q6IBW4	22	50508224-50524780	"Predicted intracellular proteins"	"DNA condensation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067932, HPA069056"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge"	"HPA067932: AB_2685926, HPA069056: AB_2686076"	"unprognostic (2.01e-1)"	"prognostic favorable (2.24e-8)"	"unprognostic (3.65e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	25.7	21.9	32.9	24.5	33.6	78.8	26.9	32.7	39.2	31.8	25.4	29.3	17.7	29.8	12.4	30.3	30.0	13.0	36.7	32.0	30.9	26.6	27.6	28.2	27.6	32.6	29.0	37.6	40.7	16.7	38.6	17.1	28.7	28.4	11.7	15.5	25.7	16.6	30.7	32.6	28.4	14.7	27.5	33.2	30.2	52.3	28.5	29.6	28.9	19.3	20.2	25.9	26.9	33.5	60.7	32.1	53.8	57.1	15.8	18.4	71.6	45.8	31.6	81.8	89.5	67.2	41.4	68.8	25.5	32.9	45.5	47.1	49.0	44.2	23.5	40.3	82.8	39.8	86.7	63.6	19.1	90.3	69.5	16.1	27.6	64.4	22.2	12.2	26.2	59.4	51.5	132.5	33.4	83.9	61.7	109.9	39.3	34.9	37.9	103.3	71.0	77.2	23.8	40.6	35.6	47.5	36.7	55.4	44.3	16.5	37.5	86.7	17.6	64.2	80.5	54.4	72.3	67.7	45.8	110.1	48.8	45.7	62.3	11.9	9.8	18.2	18.7	11.6	22.9	16.0	19.4	19.1	8.0	14.2	19.9	17.3	11.4	13.9	14.4	11.8	19.3	15.5	32.9	33.6	32.7	39.2	32.0	30.9	32.6	29.0	28.7	27.5	28.5	33.5	10.1	22.4	24.5	12.1	15.9	18.9	23.8	17.5	6.2	18.3	11.5	12.6	19.6	15.7	10.4	9.2	4.2	36.3	15.5	24.6	15.6	16.6	36.8	8.5	7.5	12.9	13.1	31.5	8.6	23.5	55.1	13.8	14.8	14.5	17.1	16.3	8.9	10.6	19.3	8.4	8.8	18.8	6.1	7.9	16.3	111.5	17.4	9.2	12.4	3.7	16.2	14.7	18.6	3.0	8.2	17.3	13.5	17.3	26.6	15.2	18.4	9.5	5.9	16.1	19.7	17.8	16.9	36.2	39.7	10.9	18.5	31.5	15.9	7.6	22.6	18.2
NCBP1	"CBP80, NCBP, Sto1"	ENSG00000136937	"Nuclear cap binding protein subunit 1"	Q09161	9	97633668-97673748	"Predicted intracellular proteins, Transporters"	"mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042411, HPA049031"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA042411: AB_2677985, HPA049031: AB_2680606"	"unprognostic (4.76e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-2)"	10.9	11.0	11.9	16.0	13.7	29.5	11.7	28.3	13.6	10.5	13.7	15.4	12.7	11.7	10.0	12.3	8.8	11.4	12.2	11.8	11.8	11.0	16.6	9.7	19.8	11.6	11.1	12.7	13.2	10.1	10.5	14.6	11.7	12.2	17.9	30.6	10.8	10.2	18.7	15.8	12.6	11.4	11.2	13.3	13.0	16.9	10.9	21.3	15.7	14.9	18.7	14.0	10.6	17.4	57.7	40.6	44.2	41.0	30.8	30.9	41.6	41.2	25.9	40.1	37.4	54.7	30.2	49.0	17.9	41.1	38.5	62.1	72.3	51.6	57.3	33.8	22.2	45.8	58.5	34.4	30.0	60.8	43.2	23.5	25.0	47.3	35.8	28.5	42.4	35.4	68.6	27.0	68.5	43.5	44.3	33.5	46.4	85.4	39.8	41.9	100.4	20.4	33.0	42.9	55.2	35.4	44.2	38.5	23.5	37.9	23.7	38.7	35.2	31.1	28.0	61.9	44.5	21.7	34.3	25.7	27.3	48.6	40.9	14.0	10.0	9.4	7.2	13.4	8.0	5.3	7.7	7.2	12.7	6.5	6.6	8.0	2.9	12.7	13.9	4.5	7.9	7.4	11.9	13.7	28.3	13.6	11.8	11.8	11.6	11.1	11.7	11.2	10.9	17.4	9.8	6.4	11.1	34.9	13.9	13.6	6.8	9.3	13.1	21.9	7.9	5.6	23.4	10.0	13.7	9.2	20.9	13.7	9.7	16.0	3.9	8.9	20.3	12.2	16.7	10.4	9.1	21.4	26.1	6.9	15.0	11.7	17.3	13.2	8.2	12.8	7.1	16.5	11.3	21.9	25.5	12.1	14.2	12.0	9.6	9.8	6.5	12.0	5.4	12.2	15.8	8.9	11.3	20.1	24.4	9.7	7.8	7.5	15.9	7.9	9.0	5.3	15.1	23.4	6.6	10.4	11.2	29.4	14.1	14.3	7.4	14.4	15.0	9.5	10.9	8.4
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942594	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044850: AB_10961012, HPA062483: AB_2684779"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	38.3	44.0	40.3	38.7	41.4	17.2	36.0	39.7	46.6	34.5	38.6	35.4	29.4	32.6	41.1	29.0	30.1	28.8	31.3	41.5	45.8	41.7	30.1	27.1	43.5	42.7	42.1	35.7	25.7	38.2	26.0	33.9	42.3	36.4	35.2	46.2	24.4	35.5	38.6	27.2	27.8	33.8	43.6	34.2	29.6	25.8	43.8	49.9	37.7	38.6	42.2	45.6	26.1	43.1	144.3	44.6	105.5	131.8	118.6	102.8	74.1	106.1	80.9	66.4	69.7	99.5	51.2	97.0	229.7	76.3	85.4	84.6	136.1	113.0	104.7	50.8	85.0	125.2	55.3	87.5	103.9	146.4	85.3	84.1	101.2	48.7	134.1	99.5	104.3	103.2	71.6	99.7	113.7	165.5	111.3	88.4	134.5	137.2	139.5	86.9	78.6	92.9	99.3	101.9	57.3	153.1	63.8	126.4	189.4	85.4	279.1	112.4	97.5	67.1	71.4	85.0	193.0	155.6	149.4	162.1	93.8	162.5	103.2	9.9	37.7	20.9	37.5	44.5	56.6	53.2	46.2	44.8	40.1	43.5	52.8	48.1	4.0	43.1	47.0	32.2	45.0	40.4	40.3	41.4	39.7	46.6	41.5	45.8	42.7	42.1	42.3	43.6	43.8	43.1	38.5	25.6	43.5	9.1	71.1	52.5	83.6	55.9	36.5	55.7	48.9	36.8	40.5	25.8	51.6	42.3	58.4	59.1	58.9	44.0	97.8	64.3	116.2	39.5	66.6	50.2	45.0	35.1	12.8	49.8	81.8	47.1	30.5	35.9	52.6	54.7	30.0	31.1	65.4	45.4	14.0	44.9	54.9	54.1	60.7	66.2	37.6	38.6	32.0	2.8	68.2	91.0	51.5	10.6	10.4	69.1	45.9	51.6	42.0	81.9	37.0	82.5	44.6	60.3	26.3	40.9	51.3	52.9	59.5	33.5	44.8	53.2	49.8	58.8	52.1	84.2
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	212.0	192.8	128.8	226.0	146.3	301.4	228.7	129.1	139.6	180.0	114.1	183.6	160.7	205.2	150.2	228.8	173.2	132.2	164.3	115.9	152.3	166.2	218.5	147.4	289.7	148.8	141.5	258.2	209.0	258.9	115.9	203.4	140.4	155.4	219.2	147.1	157.0	160.9	350.9	197.1	157.4	201.0	137.9	176.3	164.7	126.2	142.1	347.0	198.4	228.2	329.0	271.1	169.1	143.9	718.3	691.8	715.7	640.1	485.7	592.0	823.0	790.4	497.2	690.8	628.2	1227.4	521.4	1083.7	608.6	651.0	892.6	719.5	1614.4	1059.9	1284.7	554.6	644.0	1587.3	605.9	1749.5	544.0	1930.4	632.7	513.5	613.2	872.3	1019.6	394.9	834.2	770.5	1745.4	378.6	760.5	1176.4	1443.2	1086.7	1202.0	728.7	435.9	1290.8	1452.0	918.4	583.8	959.9	749.0	502.0	555.8	704.5	706.9	625.7	476.8	985.3	686.3	611.4	626.7	714.5	1063.7	624.3	554.5	1885.9	467.2	1173.1	685.2	27.3	95.6	62.5	136.5	100.3	152.8	113.5	118.4	121.9	130.6	111.9	130.3	114.2	16.8	177.8	121.7	102.0	102.3	151.0	128.8	146.3	129.1	139.6	115.9	152.3	148.8	141.5	140.4	137.9	142.1	143.9	286.2	291.7	411.7	8.1	468.9	459.9	633.8	241.0	644.9	145.0	315.2	303.8	320.9	147.3	401.6	195.0	47.9	386.9	596.2	215.0	230.9	294.4	20.6	348.7	669.8	291.1	200.0	419.2	9.3	254.4	444.6	370.9	292.0	421.8	451.7	262.7	130.6	242.0	239.5	80.8	10.4	319.6	156.6	133.7	231.1	32.2	217.2	281.8	165.4	10.3	268.9	199.6	346.1	14.1	14.9	268.0	153.9	159.9	543.5	651.1	120.1	277.6	250.3	141.0	151.2	548.9	442.0	433.3	532.4	707.9	441.4	379.0	454.0	442.6	380.6	449.1
NCLN	"NET59, NICALIN"	ENSG00000125912	Nicalin	Q969V3	19	3185563-3209575	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006625	Approved		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA006625: AB_1079453"	"unprognostic (4.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-4)"	"unprognostic (8.55e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (8.37e-5)"	"prognostic favorable (8.82e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	25.8	62.4	19.7	16.2	18.5	33.3	22.3	18.6	25.2	23.1	13.9	36.5	31.1	25.9	4.3	31.0	23.4	6.9	28.0	22.2	15.7	29.5	59.8	33.1	12.7	20.4	18.8	22.0	53.6	11.0	23.5	7.5	18.6	28.9	8.7	3.5	22.9	8.0	29.2	25.8	35.8	8.6	17.4	42.8	29.7	21.8	21.1	8.6	24.4	10.5	6.6	26.3	21.7	17.5	70.8	74.2	21.6	60.3	20.3	15.4	55.4	84.5	33.2	57.5	45.5	103.6	36.8	43.3	67.0	49.4	37.8	87.2	24.7	57.1	12.7	57.4	61.3	31.7	46.2	73.2	41.1	56.8	51.3	29.0	36.2	46.4	24.7	15.2	31.7	41.7	84.1	41.4	25.6	59.3	48.9	64.1	59.3	43.2	63.6	77.8	23.2	71.9	36.5	42.6	45.3	47.1	31.1	56.2	50.3	10.3	38.3	61.9	47.6	45.4	45.8	77.3	100.4	59.0	58.1	36.0	51.1	71.5	72.7	1.4	13.4	9.8	7.1	13.1	5.8	5.4	4.3	7.9	9.2	4.5	4.6	6.2	7.6	4.8	5.6	18.8	4.2	9.6	19.7	18.5	18.6	25.2	22.2	15.7	20.4	18.8	18.6	17.4	21.1	17.5	15.3	16.0	14.7	12.1	19.8	8.3	9.4	18.2	5.7	15.1	15.6	11.9	10.2	15.7	14.8	11.0	10.4	20.4	26.0	71.0	3.9	31.0	15.0	11.3	15.6	14.3	12.6	12.4	13.6	37.4	49.3	14.9	30.5	17.4	15.9	31.1	12.8	43.8	39.3	23.5	14.6	41.2	14.2	18.8	9.2	49.1	9.3	18.1	14.2	8.4	19.2	5.8	14.4	9.0	10.3	35.8	45.3	9.1	51.7	22.0	75.7	11.7	10.5	13.2	13.1	11.8	16.9	13.6	20.1	12.4	12.5	17.0	12.0	115.1	72.7	14.2
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 467.5;Excitatory neurons: 313.0;Inhibitory neurons: 421.8;Microglial cells: 341.9;Oligodendrocyte precursor cells: 459.4;Oligodendrocytes: 305.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276"	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	16.6	15.1	24.0	13.3	25.4	17.3	17.3	24.6	28.2	18.6	13.6	15.9	20.9	19.0	12.8	17.6	15.7	14.0	15.3	29.6	19.5	18.9	15.0	16.0	15.3	17.7	19.2	26.6	17.4	30.0	16.6	17.1	16.0	15.2	16.6	47.3	16.0	20.2	33.4	15.7	18.9	19.0	19.5	16.3	12.5	19.9	21.8	26.1	11.8	36.1	16.3	14.9	15.5	22.3	14.1	10.3	17.7	9.2	19.2	17.3	26.9	7.4	14.7	9.1	8.1	9.6	5.9	10.2	3.1	13.5	17.4	3.4	10.7	6.3	9.8	48.6	15.5	36.5	4.1	4.1	12.0	16.9	29.1	27.9	9.4	8.8	7.1	11.3	9.4	12.9	22.6	16.5	14.0	9.4	15.1	6.0	8.5	8.2	6.8	11.8	81.5	5.1	9.9	18.9	16.2	12.8	17.1	10.2	7.4	9.3	12.3	8.6	10.2	15.2	11.9	10.5	7.5	18.8	17.5	17.2	8.6	10.5	7.7	10.6	3.3	7.0	3.4	2.6	3.8	1.6	3.0	3.8	2.5	2.4	2.9	3.5	13.8	3.5	2.9	5.2	3.7	2.0	24.0	25.4	24.6	28.2	29.6	19.5	17.7	19.2	16.0	19.5	21.8	22.3	41.0	38.5	31.5	467.5	16.7	30.5	11.6	7.8	14.2	96.5	32.3	26.7	41.9	17.2	22.8	14.7	52.1	13.1	47.0	39.0	7.9	16.5	29.7	14.6	37.6	34.9	25.2	29.9	313.0	26.6	18.1	39.8	19.9	28.4	20.2	52.9	36.8	22.8	17.9	62.2	421.8	20.7	20.3	29.8	30.3	7.4	47.2	37.7	19.6	341.9	34.7	66.7	78.2	459.4	305.8	20.1	33.5	43.2	14.3	15.7	30.4	12.5	16.9	71.6	39.5	116.9	34.4	37.7	37.6	16.6	31.0	5.3	33.4	27.2	24.1	21.7
NCOA2	"bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2"	ENSG00000140396	"Nuclear receptor coactivator 2"	Q15596	8	70109782-70403808	"Cancer-related genes, Disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 161.6;Excitatory neurons: 158.9;Inhibitory neurons: 314.8;Microglial cells: 233.3;Oligodendrocyte precursor cells: 249.8;Oligodendrocytes: 186.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060243			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear bodies"		"HPA060243: AB_2684229"	"unprognostic (9.79e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-1)"	8.4	8.9	8.9	9.9	10.5	23.3	13.4	8.9	10.0	10.0	1.5	10.6	11.6	10.1	29.6	15.3	10.9	8.9	15.0	13.6	13.2	14.4	23.8	10.0	11.6	8.0	6.8	16.2	7.3	15.2	7.3	12.1	7.7	12.9	10.6	26.1	11.3	12.1	8.3	10.5	12.1	9.0	4.6	12.4	10.9	14.7	9.9	15.3	12.1	15.9	12.5	10.0	9.9	6.1	13.7	16.9	18.2	10.3	16.2	16.5	18.6	7.8	7.8	5.9	5.5	8.6	15.6	16.3	3.1	14.3	9.7	8.0	22.5	10.7	6.5	38.7	17.9	28.5	8.5	13.8	8.5	5.8	7.2	14.5	11.7	7.9	11.3	9.2	4.0	11.7	9.2	24.0	6.9	13.7	14.5	5.8	9.6	15.7	7.9	14.1	7.6	10.3	9.3	22.5	13.8	10.2	13.4	7.1	11.0	12.7	16.7	10.5	5.3	8.4	10.6	10.8	4.2	31.5	17.3	15.4	8.6	7.6	12.5	3.1	1.6	2.2	2.2	2.3	1.5	1.3	1.3	1.9	1.5	2.1	1.5	1.6	5.7	1.4	5.2	0.6	2.0	1.2	8.9	10.5	8.9	10.0	13.6	13.2	8.0	6.8	7.7	4.6	9.9	6.1	20.9	12.8	25.1	161.6	27.3	16.2	8.6	10.8	17.6	25.8	29.5	17.5	34.1	28.6	25.8	25.8	52.1	22.1	26.9	30.8	11.7	9.3	6.4	23.6	26.4	17.7	25.2	28.8	158.9	12.4	12.5	21.6	21.4	38.0	22.2	23.2	22.1	65.9	17.4	74.0	314.8	17.4	10.2	46.8	17.8	7.6	19.9	28.1	21.4	233.3	23.1	14.3	19.6	249.8	186.0	12.8	14.8	22.2	49.9	15.5	22.7	17.6	19.0	33.4	26.3	22.5	20.2	13.3	16.5	18.8	21.5	31.7	36.6	10.9	17.0	15.8
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501887-47656877	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 155.8;Plasma cells: 168.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 187.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"	14.7	8.2	4.7	22.9	4.7	13.4	11.5	5.7	9.0	11.1	3.8	9.9	8.8	11.8	7.1	14.3	10.7	10.3	13.3	4.0	5.5	9.4	10.5	14.8	35.0	6.5	5.3	14.1	11.1	11.2	6.0	28.1	6.9	9.6	11.2	11.6	11.3	8.8	25.2	14.0	14.8	11.5	5.3	27.5	14.8	7.5	5.9	17.9	12.9	16.5	39.2	15.3	12.5	6.4	17.6	50.1	16.1	21.5	37.5	41.9	105.2	16.4	24.2	27.3	14.1	25.2	19.0	61.8	11.0	28.5	36.1	43.2	12.2	20.7	20.9	31.3	6.4	8.1	15.3	39.3	22.6	6.8	43.3	19.9	61.2	24.4	30.3	23.5	20.0	10.0	18.7	14.0	16.2	187.0	9.9	12.8	5.8	14.2	20.6	17.8	11.0	27.4	16.8	38.2	3.1	5.7	41.0	53.7	18.8	18.0	24.3	17.8	35.8	16.4	12.9	20.5	7.4	38.5	35.9	60.6	19.4	7.0	10.8	2.8	3.9	3.0	2.5	5.2	2.2	9.3	2.3	2.2	5.0	6.8	2.6	2.9	4.5	2.1	5.0	4.2	3.1	2.6	4.7	4.7	5.7	9.0	4.0	5.5	6.5	5.3	6.9	5.3	5.9	6.4	86.7	12.8	23.7	27.7	155.8	34.5	15.7	25.0	52.9	18.1	23.8	13.8	26.1	20.0	29.0	14.7	8.4	69.5	39.9	12.5	5.9	12.9	12.1	36.4	29.1	49.8	14.9	14.9	48.5	19.6	26.2	26.4	26.5	78.8	8.8	15.3	68.2	20.0	22.8	13.5	64.3	10.7	36.7	46.8	62.2	6.0	24.8	58.2	33.8	109.6	46.1	9.3	28.8	49.3	54.1	21.0	16.9	27.4	168.8	28.1	9.0	6.5	39.8	23.8	19.7	19.7	30.3	43.2	30.0	63.3	51.7	89.2	47.6	14.2	11.7	59.2
NCOA5	"bA465L10.6, CIA"	ENSG00000124160	"Nuclear receptor coactivator 5"	Q9HCD5	20	46060991-46089962	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050231	Uncertain		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Actin filaments"		"HPA050231: AB_2681058"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.41e-5)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.32e-1)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.91e-2)"	19.1	17.0	15.8	18.5	16.7	9.5	19.6	21.7	17.4	25.1	17.2	22.2	14.2	24.8	19.4	18.6	21.8	12.2	15.6	16.1	17.6	18.8	15.3	15.2	25.1	16.5	15.7	28.5	20.5	20.3	21.8	18.7	15.2	21.4	16.3	23.1	20.4	14.6	19.6	21.9	21.6	17.7	15.7	25.7	19.2	25.8	16.9	26.2	20.7	14.6	25.0	20.8	19.6	17.4	39.5	34.2	47.4	49.0	22.2	23.3	37.8	26.7	24.0	42.5	34.7	47.8	30.6	64.3	44.0	26.0	36.1	51.2	39.6	33.5	36.5	39.1	19.9	38.7	33.4	40.7	23.5	53.4	36.1	16.8	43.8	22.5	20.4	22.2	30.6	33.1	36.3	50.9	33.9	50.9	74.2	41.3	43.2	33.3	41.8	55.6	31.4	28.0	25.1	44.3	42.5	38.5	42.8	51.7	37.3	26.9	41.1	62.3	28.7	44.6	33.8	27.1	42.2	32.9	50.5	43.2	31.1	31.1	29.1	3.9	9.5	13.4	13.4	10.3	15.4	13.1	14.3	13.6	9.8	17.7	13.3	12.4	7.0	8.8	10.7	21.6	10.0	7.1	15.8	16.7	21.7	17.4	16.1	17.6	16.5	15.7	15.2	15.7	16.9	17.4	7.3	9.6	12.6	24.2	12.5	6.4	3.1	6.7	10.8	13.2	9.7	8.0	5.2	10.0	7.3	9.2	22.9	11.2	11.8	8.2	0.0	8.9	7.5	6.9	11.7	9.1	9.5	9.7	29.4	12.4	8.8	7.9	12.2	7.7	1.3	11.6	9.3	9.3	7.8	3.3	31.6	10.4	4.1	10.1	3.2	5.0	13.7	6.7	3.6	42.2	9.2	7.4	13.4	19.6	35.8	11.7	3.2	15.4	12.1	4.4	4.5	5.2	8.6	9.0	6.6	10.7	7.0	28.1	15.7	8.7	5.4	6.7	8.7	8.4	9.2	3.6
NCOA6	"AIB3, ASC2, KIAA0181, NRC, PRIP, RAP250, TRBP"	ENSG00000198646	"Nuclear receptor coactivator 6"	Q14686	20	34689097-34825651	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 130.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004198, HPA050211"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004198: AB_1078228, HPA050211: AB_2681052"	"unprognostic (2.48e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.78e-5)"	"unprognostic (9.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.42e-2)"	10.2	9.0	5.2	9.1	6.7	14.0	9.2	12.7	12.4	10.8	4.8	12.9	13.2	10.7	12.2	11.7	11.3	8.8	9.2	6.1	8.2	9.9	8.4	10.4	8.9	6.3	4.6	11.6	12.6	22.0	10.0	13.5	4.6	9.8	14.5	26.7	12.9	11.3	12.7	13.5	12.0	13.2	2.3	9.4	11.4	18.8	7.4	18.1	13.8	13.1	10.3	10.4	10.5	9.6	25.2	14.7	32.6	19.7	17.5	19.4	21.3	12.0	15.3	21.1	16.9	37.9	17.2	17.7	12.9	21.5	25.8	30.0	29.3	20.2	23.9	9.0	13.2	41.6	16.7	22.4	19.3	23.5	29.4	14.8	36.5	19.8	24.5	14.6	20.2	20.1	21.5	23.7	17.7	16.3	37.5	14.8	6.7	21.0	21.1	24.9	39.3	15.9	15.6	16.6	27.2	18.5	22.0	52.5	20.5	15.0	22.2	18.5	20.0	34.1	20.7	25.6	20.2	26.9	24.3	20.0	22.5	13.5	15.5	1.1	0.6	2.5	0.9	0.5	0.8	1.0	0.8	0.8	1.1	0.8	0.7	0.5	1.5	0.7	0.7	1.0	0.5	0.5	5.2	6.7	12.7	12.4	6.1	8.2	6.3	4.6	4.6	2.3	7.4	9.6	17.3	25.6	16.0	54.9	11.0	17.0	9.1	10.6	13.6	28.8	14.3	10.9	20.1	18.6	11.6	16.5	29.2	13.0	12.2	31.9	5.9	12.5	23.5	16.4	21.3	14.0	10.8	13.3	50.9	12.4	12.1	14.5	15.8	23.3	6.3	18.5	13.9	12.1	10.8	33.7	58.8	17.4	20.3	12.2	10.3	17.3	18.0	13.0	10.6	45.9	17.6	11.5	13.4	54.3	130.4	15.4	12.4	13.5	14.2	16.9	20.3	9.3	17.5	29.8	26.3	16.6	16.9	25.6	27.1	19.2	20.9	15.9	13.1	13.6	17.6	14.6
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932034	"Predicted intracellular proteins, Transporters"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	53.9	60.4	19.5	45.8	30.6	42.7	27.4	21.4	50.2	29.0	0.0	30.1	33.0	22.3	5.2	30.4	15.9	46.6	16.0	28.2	23.9	56.6	32.9	52.1	30.1	47.5	12.3	14.8	19.9	8.8	29.7	12.9	45.0	18.6	29.2	18.2	38.2	12.9	6.9	11.1	39.2	28.3	10.6	24.4	30.8	7.8	19.0	21.7	25.1	9.2	28.5	101.8	19.7	48.3	13.7	36.6	2.2	16.0	78.2	46.3	23.7	18.2	71.9	22.1	30.1	34.3	12.7	55.2	96.5	10.0	108.0	78.7	12.6	12.4	13.3	120.2	16.5	28.0	43.7	12.3	44.5	16.4	25.4	33.3	29.4	21.1	16.3	39.1	46.7	18.0	38.7	30.6	13.9	13.7	16.1	16.2	2.7	33.8	7.6	12.3	5.7	10.3	39.1	90.4	36.9	33.5	93.7	22.6	42.1	6.5	3.8	19.3	27.7	5.1	10.9	26.3	14.1	39.9	34.1	28.8	11.5	21.2	18.7	17.0	11.4	4.0	19.2	9.1	24.1	17.7	18.1	15.6	10.0	11.1	9.6	9.4	6.4	13.6	14.2	34.1	8.1	5.1	19.5	30.6	21.4	50.2	28.2	23.9	47.5	12.3	45.0	10.6	19.0	48.3	144.6	314.1	371.9	27.7	33.7	98.1	270.8	311.2	709.7	50.2	94.2	47.9	11.4	98.7	324.1	62.5	43.8	9.3	84.6	113.2	80.3	241.7	0.9	160.1	90.2	130.2	35.8	29.8	144.9	139.2	8.9	94.8	142.8	298.2	37.3	18.5	106.7	23.2	13.6	37.0	89.5	119.3	288.9	33.8	57.4	6.8	42.3	41.9	51.6	75.9	33.4	76.8	59.8	34.2	303.9	108.7	160.1	29.3	44.1	129.5	24.3	103.2	335.8	53.3	13.1	33.8	49.3	11.2	33.9	515.9	59.2	3.8	63.5	36.5	130.6	294.4
NCOR1	"hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1"	ENSG00000141027	"Nuclear receptor corepressor 1"	O75376	17	16029157-16218185	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043246, HPA050288, HPA051168, CAB072830"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (7.92e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	22.1	18.3	37.8	28.1	39.7	42.8	29.0	60.8	84.7	27.3	41.0	44.0	47.1	30.7	20.3	30.6	25.1	26.4	23.4	39.3	34.7	33.6	46.2	26.9	29.9	32.7	35.7	33.5	34.2	42.3	17.1	28.3	31.0	27.6	40.6	41.4	22.4	31.4	42.0	31.6	38.2	29.7	28.2	29.3	42.7	32.4	35.4	51.9	34.8	39.9	34.7	28.8	18.3	43.4	68.0	110.6	77.7	65.1	62.4	47.1	38.6	48.9	54.8	52.4	47.1	59.8	30.3	70.9	33.6	85.9	39.3	50.4	96.4	59.2	77.3	95.6	71.1	70.7	96.3	71.1	60.8	45.3	80.7	48.5	60.6	81.2	94.4	45.2	73.9	98.0	63.0	28.8	52.3	44.3	79.3	29.1	38.6	118.6	29.9	78.1	78.5	33.5	54.9	76.0	26.5	43.8	80.7	34.7	37.7	197.5	33.5	50.3	65.5	53.7	32.6	39.9	68.3	19.7	25.0	40.4	51.0	52.4	47.0	408.4	104.8	240.4	126.9	86.0	106.7	188.4	144.0	141.0	76.3	191.4	139.8	139.0	205.2	139.9	112.3	130.3	144.7	98.8	37.8	39.7	60.8	84.7	39.3	34.7	32.7	35.7	31.0	28.2	35.4	43.4	90.9	80.1	113.2	116.2	130.0	67.8	106.2	91.3	86.0	150.3	76.8	60.8	91.5	82.9	86.9	53.3	158.4	102.1	121.7	198.1	35.2	95.5	69.7	75.7	109.5	88.4	87.9	132.1	127.0	96.5	101.7	77.1	149.4	103.7	87.3	88.9	67.5	126.4	76.1	129.5	122.2	118.8	81.4	81.9	76.7	43.6	101.5	96.7	37.4	107.7	172.8	83.1	197.8	123.1	151.4	111.7	148.3	121.5	88.5	95.6	194.4	46.7	63.8	167.1	92.1	106.0	106.2	98.7	90.2	78.0	68.2	87.6	142.1	89.5	153.0	122.9
NCOR2	"CTG26, SMRT, SMRTE, TNRC14, TRAC-1"	ENSG00000196498	"Nuclear receptor corepressor 2"	Q9Y618	12	124324415-124567589	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.0;non-classical monocyte: 2.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 6.0;monocytes: 2.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001928	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA001928: AB_1079454"	"unprognostic (9.51e-3)"	"unprognostic (7.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.90e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.90e-2)"	48.1	51.1	41.2	34.3	15.8	29.9	49.7	27.2	45.6	62.9	13.6	56.2	25.2	58.6	9.0	33.3	49.0	21.4	56.7	61.3	12.6	37.6	27.5	62.8	19.5	56.4	29.2	70.8	49.3	18.1	84.1	20.2	53.0	57.7	10.9	20.7	55.1	22.0	109.2	56.2	36.8	22.5	5.4	35.7	45.8	26.1	26.4	19.9	40.5	19.9	11.2	47.4	43.9	27.0	78.6	143.6	40.4	38.7	23.0	31.1	120.4	79.3	39.0	45.2	20.1	76.9	56.3	78.7	57.0	65.1	40.7	72.6	16.2	84.7	18.5	83.6	31.5	63.6	142.1	48.0	46.0	48.3	77.5	50.1	30.9	56.6	33.4	69.2	43.7	35.5	83.3	22.9	41.2	67.4	174.3	55.5	56.4	29.8	139.0	55.8	67.1	40.2	21.6	89.9	106.0	77.1	97.3	81.1	47.7	30.2	66.3	59.8	212.0	104.5	178.9	104.3	170.5	43.5	48.0	48.1	59.4	35.4	100.1	6.0	0.4	1.0	1.0	0.2	0.3	0.3	0.3	0.8	0.2	0.1	0.3	0.2	0.9	0.1	2.5	0.9	0.0	0.3	41.2	15.8	27.2	45.6	61.3	12.6	56.4	29.2	53.0	5.4	26.4	27.0	30.6	115.4	58.9	46.4	14.7	33.3	24.6	22.2	33.0	95.3	33.3	28.3	30.4	18.6	38.8	18.4	39.6	8.8	27.4	39.1	3.9	22.1	2.2	28.0	53.4	28.2	18.7	11.6	61.9	27.2	39.7	50.6	37.8	32.4	42.3	43.5	18.5	19.0	28.4	121.1	37.0	20.3	4.1	50.0	48.7	7.1	62.1	44.8	16.0	51.5	27.0	28.0	20.6	70.9	65.9	38.0	22.2	65.1	22.6	23.7	25.4	8.0	16.8	65.9	6.6	63.0	35.5	1.8	11.6	17.7	24.4	12.6	25.1	69.4	21.9	23.1
NDC80	"HEC, HEC1, hsNDC80, KNTC2, TID3"	ENSG00000080986	"NDC80 kinetochore complex component"	O14777	18	2571557-2616635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.2;lymphoid tissue: 29.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 63.4;Spermatocytes: 82.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 7.2;granulocytes: 8.3;T-cells: 11.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA066330			Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Centrosome	"HPA066330: AB_2685661"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (1.16e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-3)"	"unprognostic (7.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.69e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.71e-1)"	1.8	0.9	1.4	9.6	1.3	31.2	2.5	2.2	1.7	2.7	0.1	7.0	5.9	4.3	2.1	5.6	1.2	2.5	1.2	1.0	0.6	1.2	1.6	1.5	20.5	1.9	0.6	0.8	0.9	0.5	0.1	10.4	2.9	5.3	9.8	0.7	1.1	14.0	0.9	7.9	6.2	5.0	0.4	5.5	3.8	15.1	1.2	29.2	1.6	0.6	19.3	3.2	4.6	2.5	80.3	17.7	86.5	38.6	4.5	9.8	44.5	91.7	49.1	117.7	99.7	49.2	44.0	86.6	40.4	35.9	49.7	47.9	98.2	39.9	123.6	32.2	24.6	68.8	49.5	38.1	1.5	133.2	55.1	5.1	3.7	67.8	47.8	12.0	54.3	52.8	56.8	107.1	104.0	36.2	65.1	57.2	44.9	51.6	25.3	71.0	88.6	69.7	31.0	38.0	69.3	31.4	84.4	21.7	32.7	34.0	36.7	52.4	33.2	75.7	168.1	60.7	123.2	46.5	78.6	116.0	33.5	60.8	65.8	3.5	0.6	2.5	1.8	0.4	1.7	7.2	3.2	3.8	0.2	5.3	2.0	2.0	8.3	1.7	0.5	1.3	11.3	1.3	1.4	1.3	2.2	1.7	1.0	0.6	1.9	0.6	2.9	0.4	1.2	2.5	2.8	0.0	0.6	0.3	5.8	2.3	0.7	3.8	0.6	0.0	0.6	0.9	15.8	0.0	2.4	0.0	0.0	15.5	4.8	2.1	0.0	0.9	22.0	1.3	3.7	1.9	0.0	63.4	0.6	0.4	21.7	6.8	2.6	2.1	0.0	20.8	5.7	0.5	11.5	0.0	0.5	2.8	8.2	3.2	2.4	7.6	7.5	1.7	0.0	1.0	0.4	0.0	7.2	0.5	0.5	0.3	0.1	23.3	14.1	0.4	0.4	0.2	1.4	0.0	19.7	0.6	6.8	82.8	21.1	4.2	0.6	2.1	8.7	9.8	6.2	1.5
NDN	"HsT16328, PWCR"	ENSG00000182636	"Necdin, MAGE family member"	Q99608	15	23685400-23687305	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 236.4;Peritubular cells: 207.6;Theca cells: 121.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 55.0;ASC diff: 52.9;HSkMC: 71.3;NTERA-2: 44.0;SuSa: 57.4;U-2 OS: 80.4;U-266/70: 51.7;U-266/84: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074457			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA074457: AB_2686691"	"unprognostic (3.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.81e-2)"	46.8	49.4	43.3	11.1	40.5	1.2	35.1	26.0	39.7	70.5	30.4	35.9	11.1	63.7	24.0	16.8	47.2	23.8	34.6	36.7	89.6	13.0	4.5	19.6	10.9	36.0	41.3	69.8	11.8	8.7	56.3	32.6	46.2	27.3	10.7	20.8	12.7	39.3	14.7	11.9	20.8	33.5	36.7	19.1	20.3	18.5	69.6	6.8	17.4	22.4	6.6	31.4	40.4	32.3	0.1	0.0	55.0	0.0	52.9	20.1	0.1	35.4	0.0	0.8	9.6	0.0	0.0	0.0	0.1	10.6	8.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.3	0.0	31.8	71.3	0.0	10.2	0.0	0.0	0.0	21.7	1.2	0.0	18.0	0.0	27.6	0.1	44.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.1	0.4	0.0	0.4	0.0	57.4	9.4	0.0	0.0	2.6	80.4	0.0	0.1	51.7	51.7	0.0	5.5	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.2	1.5	0.0	0.0	43.3	40.5	26.0	39.7	36.7	89.6	36.0	41.3	46.2	36.7	69.6	32.3	24.1	25.6	11.0	6.8	0.3	13.0	13.8	0.3	27.9	66.0	2.3	19.8	36.8	15.7	1.4	12.9	20.9	1.9	2.9	18.5	23.5	17.9	2.5	1.4	60.8	18.7	6.7	4.2	7.8	10.7	1.4	103.1	4.1	1.1	0.0	83.9	38.9	0.2	7.3	50.5	21.8	4.3	0.0	7.6	13.3	8.6	236.4	2.8	39.2	9.4	0.7	88.7	0.0	9.5	16.4	4.5	2.6	207.6	0.0	6.9	8.1	1.1	4.1	51.0	98.6	91.4	94.0	28.5	21.8	13.4	8.2	2.5	1.4	121.8	7.1	4.1
NDOR1	"bA350O14.9, CIAE1, NR1"	ENSG00000188566	"NADPH dependent diflavin oxidoreductase 1"	Q9UHB4	9	137205685-137217009	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.4;Oligodendrocytes: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024504	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA024504: AB_1854338"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.74e-3)"	6.5	8.2	8.7	9.8	9.6	17.2	6.9	7.9	12.5	8.1	5.4	8.4	9.6	7.8	2.0	8.3	7.9	4.6	6.6	8.3	7.1	9.0	7.1	8.6	11.5	10.7	9.0	7.0	8.9	4.0	8.2	4.0	10.2	9.6	2.9	3.9	8.6	5.2	4.0	9.5	10.6	3.7	7.9	14.2	8.7	10.5	9.9	8.9	10.1	1.5	5.4	7.8	7.2	12.9	14.2	21.2	13.8	21.8	5.7	5.6	42.7	20.4	9.1	19.1	13.0	21.6	16.3	19.9	15.6	7.7	15.3	52.1	10.0	14.3	3.8	25.9	16.3	17.6	59.7	11.6	9.6	19.9	36.2	7.8	9.7	21.6	7.9	5.3	8.9	25.9	29.2	20.6	7.0	25.8	21.0	35.8	22.5	12.9	26.0	38.0	16.5	28.2	6.0	12.4	17.6	17.5	16.8	17.0	10.6	6.1	27.2	22.8	12.0	35.3	22.9	41.7	23.2	12.5	26.8	20.7	15.4	18.1	20.7	1.1	2.1	3.1	1.3	2.2	1.1	0.5	1.2	1.2	1.7	1.0	0.6	0.6	2.9	0.7	1.7	1.1	1.8	1.5	8.7	9.6	7.9	12.5	8.3	7.1	10.7	9.0	10.2	7.9	9.9	12.9	1.4	0.0	2.6	13.4	3.9	0.5	0.7	1.0	5.2	0.4	1.5	1.3	1.6	1.5	1.6	3.7	0.0	4.5	1.4	3.3	1.9	1.1	0.8	1.3	1.9	1.8	2.4	1.3	8.6	1.1	3.5	1.6	5.1	2.1	1.3	2.0	1.1	0.8	2.5	0.0	7.5	1.9	2.0	3.2	1.3	1.1	0.6	2.7	1.8	6.5	5.4	0.1	5.2	3.5	10.5	1.6	1.5	0.4	6.9	0.7	2.6	1.2	0.3	0.9	0.0	0.9	1.4	1.9	1.2	3.2	0.3	3.7	3.8	1.6	2.2	0.8
NDP	"EVR2, norrin"	ENSG00000124479	"Norrin cystine knot growth factor NDP"	Q00604	X	43948776-43973395	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision, Wnt signaling pathway"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8;ovary: 46.2"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 181.3;Muller glia cells: 105.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"U-87 MG: 72.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.5	0.0	31.5	0.0	33.4	0.0	3.3	30.9	35.8	20.9	22.4	0.2	0.1	15.4	22.0	0.0	20.8	0.4	0.3	31.5	29.6	0.1	0.0	0.0	0.2	30.1	33.2	46.2	0.0	0.2	0.1	4.0	31.6	7.1	0.2	19.2	0.1	13.1	0.0	0.6	0.2	11.4	32.4	0.1	0.3	1.0	34.2	0.0	0.2	0.0	0.2	0.5	2.3	32.4	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.1	1.9	0.0	0.0	0.0	1.8	0.0	4.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	2.2	0.0	0.0	0.0	72.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	33.4	30.9	35.8	31.5	29.6	30.1	33.2	31.6	32.4	34.2	32.4	0.0	0.0	0.0	29.0	0.0	0.1	0.0	1.2	0.0	0.6	1.3	0.1	0.3	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	9.1	17.7	0.2	0.0	0.0	4.2	0.0	0.3	0.9	0.0	17.0	0.0	181.3	0.0	0.0	0.1	0.0	0.8	0.0	2.0	0.0	0.0	0.7	13.4	0.6	0.0	0.0	0.0	105.5	0.0	1.5	9.5	1.2	0.0	9.8	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	5.4	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2
NDRG2	"KIAA1248, SYLD"	ENSG00000165795	"NDRG family member 2"	Q9UN36	14	21016763-21070872	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1885.3;salivary gland: 2081.6;skeletal muscle: 1828.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 379.0;Distal tubular cells: 485.2;Muller glia cells: 548.0;Sertoli cells: 598.2"	"Cancer enhanced"	"Detected in all"		"glioma: 78.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"myeloid DC: 204.4"	"Lineage enriched"	"Detected in all"	11	"dendritic cells: 204.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 57.0;HMC-1: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002896, HPA003590, CAB017491"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458"	"unprognostic (9.27e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.43e-12)"	"unprognostic (1.46e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.19e-2)"	192.0	400.6	1613.1	27.4	1885.3	2.8	321.6	1623.2	1666.4	395.4	1189.8	198.3	72.1	229.7	260.3	229.5	305.0	130.7	327.2	1551.7	1590.0	150.1	544.4	115.5	48.6	1690.6	1686.1	476.1	93.7	278.5	88.5	45.3	1581.9	171.3	111.0	134.1	2081.6	208.0	1828.7	220.3	125.4	127.7	1584.5	152.0	130.9	33.3	1752.7	40.1	99.9	1591.4	100.4	158.0	265.8	1597.9	10.9	2.3	6.8	12.6	1.1	0.0	1.0	0.2	4.5	3.9	2.2	15.1	20.0	0.6	4.0	0.3	6.2	17.6	30.3	6.3	5.4	0.1	10.9	14.3	2.2	57.0	1.3	1.3	39.0	11.8	13.1	0.9	1.9	6.3	0.0	12.6	29.0	1.2	0.6	9.4	5.0	4.0	17.9	35.2	0.8	14.6	0.7	3.7	7.6	27.4	0.1	19.4	3.0	3.3	14.4	17.3	26.6	8.2	0.0	1.2	20.8	0.4	0.4	6.1	4.8	0.3	1.8	0.3	4.7	0.0	6.5	0.7	8.3	1.5	11.4	6.4	12.6	11.9	204.4	4.4	18.7	14.0	1.4	3.0	0.1	7.0	9.4	15.3	1613.1	1885.3	1623.2	1666.4	1551.7	1590.0	1690.6	1686.1	1581.9	1584.5	1752.7	1597.9	98.0	0.0	11.9	379.0	6.7	28.7	83.7	86.4	12.0	6.3	240.7	201.2	180.2	151.5	110.9	40.5	10.4	11.5	9.1	81.4	485.2	104.9	6.3	33.3	11.0	53.9	33.5	8.4	1.1	21.7	0.7	62.3	18.8	40.2	48.8	79.0	164.2	214.9	20.7	3.3	3.9	77.4	57.0	30.8	137.6	14.4	348.6	30.4	321.9	47.8	8.7	548.0	1.0	42.7	71.0	16.3	37.9	166.3	1.2	68.5	18.5	41.3	70.8	15.5	598.2	167.7	162.8	1.7	5.5	21.6	30.4	21.6	11.9	66.8	118.9	155.9
NDRG4	"KIAA1180, SMAP-8"	ENSG00000103034	"NDRG family member 4"	Q9ULP0	16	58462846-58513628	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 380.7;heart muscle: 352.7"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 433.0;Horizontal cells: 516.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 23.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 32.5;GAMG: 28.6;hTERT-RPE1: 26.8;HUVEC TERT2: 21.0;SCLC-21H: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015313, HPA017587"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA015313: AB_1854343, HPA017587: AB_1854344"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.17e-2)"	16.4	128.8	122.7	2.9	136.0	0.1	11.4	239.4	248.6	25.3	0.0	6.5	3.7	25.5	6.8	20.8	8.0	3.6	352.7	195.0	170.4	1.6	1.0	17.7	4.1	379.4	113.0	1.8	2.7	12.0	71.6	2.0	380.7	3.1	3.2	115.5	5.3	30.2	8.7	21.5	3.9	13.3	41.6	21.9	4.1	48.1	190.9	4.5	2.7	3.6	4.0	3.7	57.5	91.7	0.2	16.9	15.8	3.1	0.4	2.9	1.3	5.2	8.2	2.5	1.7	6.5	4.3	0.4	32.5	4.0	28.6	1.5	1.2	0.9	2.2	0.0	3.3	0.7	3.3	4.7	4.4	0.3	0.3	3.6	0.3	1.6	0.0	26.8	21.0	0.1	0.3	0.2	2.4	4.3	1.7	0.2	1.4	0.6	12.4	0.4	4.4	0.4	0.7	10.6	49.2	18.4	0.5	1.4	0.1	2.0	0.6	0.2	7.7	2.1	6.0	0.6	0.8	0.9	0.5	5.7	11.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.7	136.0	239.4	248.6	195.0	170.4	379.4	113.0	380.7	41.6	190.9	91.7	8.9	0.0	1.9	53.5	0.2	2.0	6.8	0.6	1.2	52.3	0.7	1.5	433.0	0.0	0.3	0.0	4.2	0.0	0.1	0.6	0.0	4.0	5.9	4.0	5.6	17.0	1.8	0.0	95.7	0.2	0.1	10.1	1.5	11.5	0.0	13.6	29.3	0.3	0.0	516.5	94.3	0.1	2.0	1.0	1.2	10.8	4.4	0.3	7.2	22.5	0.0	82.6	0.0	29.7	14.1	3.7	0.0	2.6	0.0	4.9	0.0	0.2	0.2	33.4	6.6	3.5	6.7	4.8	6.5	14.5	5.8	0.0	0.3	0.3	0.0	8.8
NDUFA9	"CI-39k, COQ11, NDUFS2L, SDR22E1"	ENSG00000139180	"NADH:ubiquinone oxidoreductase subunit A9"	Q16795	12	4649095-4694317	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 617.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042268, HPA073212"	Supported		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (2.26e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.57e-7)"	"unprognostic (7.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (5.75e-4)"	19.6	29.2	25.6	14.8	26.5	35.3	19.1	29.1	38.5	18.4	29.5	41.1	30.6	20.4	14.7	30.9	17.5	6.1	116.7	26.1	25.7	43.4	49.4	18.0	11.8	26.0	25.5	14.7	24.2	34.2	21.9	10.2	26.7	21.4	31.2	20.1	24.3	11.1	110.3	24.1	31.0	12.7	25.7	23.7	31.6	14.3	26.4	18.1	19.3	110.6	14.5	21.2	19.8	27.0	29.8	52.5	25.3	33.9	18.3	18.1	73.1	22.1	22.4	41.9	31.6	114.4	58.0	33.2	11.6	24.2	47.5	48.9	37.1	32.9	27.0	64.8	65.3	32.5	51.0	88.1	40.0	48.0	33.8	23.3	31.2	28.7	38.6	26.0	32.0	46.8	23.1	60.8	31.5	57.6	48.5	55.1	65.5	55.6	43.2	67.4	37.5	34.5	59.2	66.6	18.2	20.6	27.9	74.4	41.9	54.4	15.4	45.4	22.2	31.8	64.7	29.3	52.3	11.9	15.1	57.1	33.2	29.4	35.7	75.9	134.3	53.3	99.2	165.1	102.1	148.3	102.4	109.3	161.9	110.0	88.9	91.1	11.8	107.5	133.5	168.0	143.6	265.0	25.6	26.5	29.1	38.5	26.1	25.7	26.0	25.5	26.7	25.7	26.4	27.0	37.5	28.9	32.1	26.1	45.2	48.6	63.7	199.3	21.6	48.6	40.1	37.0	185.1	45.8	99.4	64.4	58.4	111.1	45.7	89.4	166.3	130.0	112.2	29.3	29.6	46.4	47.4	36.0	21.0	131.3	118.7	38.5	35.2	26.0	57.7	36.6	34.6	78.5	114.7	33.7	26.3	125.4	140.4	35.6	31.8	617.2	28.3	41.8	55.2	15.9	60.0	48.2	49.4	27.2	20.1	108.0	83.5	36.9	50.8	40.5	108.5	163.2	74.9	67.8	19.7	32.0	54.8	30.6	31.3	38.5	47.2	99.9	43.4	66.3	147.7	69.4
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581014-23596316	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 588.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054364, HPA076020"	Approved		Supported	Nucleoplasm,Mitochondria		No	No		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA054364: AB_2682463, HPA076020: "	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	89.7	127.1	104.3	49.6	106.8	60.4	81.0	114.8	157.6	64.0	117.4	123.0	102.9	68.8	50.1	98.8	66.5	32.0	588.8	107.1	113.5	132.9	165.8	61.9	52.2	110.4	105.6	54.3	84.5	110.4	94.2	47.5	112.0	63.5	89.0	91.9	75.7	58.6	425.0	71.9	90.1	51.1	107.5	72.1	109.6	61.7	108.2	60.2	66.0	432.0	59.2	79.8	70.7	106.9	172.8	125.6	151.8	136.8	107.5	116.0	212.9	129.4	96.8	129.2	105.7	110.1	135.8	284.0	206.6	94.7	158.2	138.6	271.2	155.4	102.6	161.8	312.6	151.8	203.0	507.0	112.2	284.8	121.0	108.0	212.6	95.2	102.2	120.0	167.0	249.5	326.6	139.6	142.7	262.1	221.6	431.9	394.7	254.5	288.5	299.5	171.0	389.3	120.2	140.6	209.8	163.1	144.6	260.8	258.2	167.2	211.2	235.0	131.1	116.5	122.4	113.4	180.5	175.2	283.2	321.9	130.2	228.7	134.9	77.1	179.9	80.0	127.0	222.8	142.3	171.7	150.7	143.4	239.4	151.6	139.0	145.8	37.9	117.8	175.8	268.1	177.6	204.7	104.3	106.8	114.8	157.6	107.1	113.5	110.4	105.6	112.0	107.5	108.2	106.9	136.2	99.3	99.7	9.8	96.1	122.1	142.9	416.9	79.6	91.1	131.7	191.5	1366.5	105.8	200.3	112.2	45.9	290.9	101.3	210.9	708.3	187.3	129.5	185.5	113.2	129.4	202.4	125.1	13.1	210.2	312.2	153.3	119.3	110.8	84.9	124.4	93.9	300.6	263.2	52.2	14.3	253.5	321.4	109.0	89.1	39.6	96.9	114.3	156.5	5.6	179.6	165.0	109.2	7.5	13.2	227.1	174.8	121.5	166.9	180.3	316.8	611.4	261.6	127.6	92.1	134.0	261.9	142.9	118.8	181.5	142.2	224.5	94.5	256.6	360.0	190.7
NDUFB2	"AGGG, CI-AGGG"	ENSG00000090266	"NADH:ubiquinone oxidoreductase subunit B2"	O95178	7	140690777-140722790	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3191.4;Distal tubular cells: 1997.6;Proximal tubular cells: 2437.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051377	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA051377: AB_2681460"	"unprognostic (1.17e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (7.60e-7)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	187.2	225.3	347.4	123.4	363.9	143.1	159.9	377.3	441.6	142.0	374.0	239.9	166.0	153.4	171.5	196.9	129.6	141.8	847.4	343.6	369.1	420.0	281.2	140.1	164.8	359.0	355.8	108.0	159.4	362.6	182.3	105.9	361.1	152.0	183.0	175.9	197.6	152.3	834.7	152.0	161.1	154.8	369.8	155.1	216.4	125.5	378.3	162.3	350.5	913.1	134.0	186.6	145.5	377.6	322.5	497.0	182.1	400.9	291.9	297.5	259.9	227.0	207.6	241.4	229.1	389.7	317.3	243.1	331.7	289.9	441.7	155.4	167.0	333.4	194.1	399.5	556.9	179.1	442.3	461.3	230.0	279.2	231.0	331.6	287.5	227.0	138.2	201.3	368.1	338.8	311.2	289.9	343.2	945.8	448.2	719.4	424.0	670.0	585.0	251.1	174.6	569.4	492.0	634.2	369.0	359.3	310.4	513.8	281.0	205.7	222.9	315.7	295.2	307.0	179.2	365.6	401.5	267.6	567.2	457.2	469.0	447.7	395.8	713.9	1045.5	503.4	779.4	1117.0	673.3	1009.8	755.0	768.2	1161.9	787.8	800.5	793.7	85.6	823.9	1037.9	926.9	772.0	1795.1	347.4	363.9	377.3	441.6	343.6	369.1	359.0	355.8	361.1	369.8	378.3	377.6	262.7	189.1	238.4	25.5	191.1	226.5	289.3	693.4	128.1	181.9	458.3	514.8	3191.4	351.8	398.1	673.1	98.0	555.4	275.3	776.2	1997.6	373.9	901.2	294.2	298.4	283.6	428.7	143.7	19.9	314.4	466.6	327.2	307.3	366.3	280.6	212.8	205.6	1079.3	710.8	139.7	22.7	576.3	687.7	280.3	337.3	246.9	222.7	336.5	434.0	13.1	356.7	367.2	465.5	19.6	42.3	279.4	647.9	243.8	210.7	440.1	867.3	2437.9	370.2	284.1	197.2	199.2	372.0	77.0	208.6	321.9	280.6	515.0	241.7	288.6	669.6	435.8
NDUFB4	B15	ENSG00000065518	"NADH:ubiquinone oxidoreductase subunit B4"	O95168	3	120596328-120602507	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 945.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1493.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051739, HPA064441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Nuclear membrane"	"HPA051739: AB_2681585, HPA064441: "	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.95e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.79e-4)"	148.6	338.4	159.7	90.3	169.1	112.4	145.1	175.9	203.2	126.2	173.2	170.0	147.8	117.9	133.8	159.5	113.0	85.7	619.5	163.5	178.4	232.4	187.4	102.9	93.8	168.3	163.0	119.8	137.4	260.3	170.2	76.8	168.6	118.1	148.7	100.2	148.4	117.4	945.3	144.5	135.6	103.4	170.7	112.1	162.3	106.5	161.7	125.6	113.1	562.2	114.2	133.5	142.1	172.8	294.8	204.3	246.7	248.5	151.0	181.4	199.2	157.0	212.1	205.4	224.5	200.9	219.8	147.8	311.6	177.8	255.6	272.5	191.3	202.7	155.7	227.5	212.6	226.1	205.7	208.1	90.4	202.7	256.8	161.3	268.5	98.9	125.8	246.0	258.5	271.7	138.5	219.2	220.9	224.1	398.6	294.8	193.9	478.9	554.7	228.8	141.0	325.8	337.3	177.9	273.8	283.4	186.5	205.7	360.0	162.0	348.0	319.9	199.8	179.0	233.2	76.9	226.5	263.2	260.1	454.3	283.6	279.8	250.8	205.0	164.8	197.2	156.0	229.5	162.2	231.6	215.2	176.8	213.9	176.3	182.2	181.8	101.6	152.7	238.2	267.9	300.6	205.7	159.7	169.1	175.9	203.2	163.5	178.4	168.3	163.0	168.6	170.7	161.7	172.8	274.1	163.5	162.6	36.9	167.0	222.3	289.0	612.6	190.6	137.8	290.1	351.3	1493.1	311.7	348.3	320.0	58.4	366.0	158.1	472.4	1226.7	556.7	999.2	259.9	188.9	235.7	298.7	196.9	22.6	620.9	421.0	213.7	175.3	293.5	174.8	139.4	183.5	513.9	330.3	84.1	22.0	526.3	451.6	240.2	247.9	164.6	275.2	196.2	434.0	15.9	339.2	340.7	186.4	13.0	31.2	567.9	581.8	277.2	283.2	243.2	613.4	1225.1	266.2	168.4	256.4	208.1	259.0	418.9	87.5	288.4	251.5	352.4	168.1	271.3	462.8	344.0
NDUFB5	"CI-SGDH, MGC12314, SGDH"	ENSG00000136521	"NADH:ubiquinone oxidoreductase subunit B5"	O43674	3	179604690-179627647	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 241.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005640	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA005640: AB_1079461"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.46e-2)"	"unprognostic (5.96e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	61.0	88.4	35.6	29.0	38.5	19.5	47.8	39.4	57.3	37.7	52.8	64.0	75.1	30.2	15.6	56.7	33.4	28.8	217.0	38.4	40.0	93.5	74.0	34.4	36.1	37.1	36.6	41.9	52.3	66.6	40.2	27.0	37.4	32.6	36.1	22.7	43.7	20.2	241.4	43.6	57.0	22.3	35.4	46.3	63.8	42.2	39.8	31.4	41.6	166.9	24.8	46.2	41.5	38.9	96.5	23.2	51.2	66.8	52.3	66.0	75.6	58.5	42.0	48.1	50.7	79.8	53.4	72.7	193.4	32.7	119.5	89.9	48.9	47.4	38.9	182.5	43.1	90.4	31.2	44.8	52.3	97.9	64.0	64.9	60.7	31.2	51.0	61.0	62.8	62.1	71.2	98.7	51.8	68.8	55.8	60.5	80.2	138.7	80.8	64.2	63.3	205.1	82.5	46.8	41.1	62.4	34.9	169.9	126.7	36.2	265.9	151.2	64.5	46.6	47.8	61.7	139.9	158.0	193.6	122.5	75.8	91.7	67.9	94.6	104.5	49.9	43.8	127.8	64.5	90.2	60.0	51.6	145.5	67.2	59.8	62.9	18.9	48.1	154.8	81.0	84.0	105.6	35.6	38.5	39.4	57.3	38.4	40.0	37.1	36.6	37.4	35.4	39.8	38.9	113.6	48.1	48.5	17.3	90.2	85.1	115.2	374.4	73.4	45.9	121.0	138.6	362.3	88.6	164.3	88.3	33.3	234.0	54.5	115.9	508.7	132.5	162.6	118.4	79.0	89.2	117.5	75.3	16.1	105.7	150.0	87.1	77.5	62.9	93.8	120.1	105.7	118.3	253.5	40.4	22.6	196.0	266.5	261.3	133.0	28.9	81.1	133.6	135.2	15.9	180.0	107.2	70.0	19.6	25.8	81.5	163.4	70.0	75.0	89.8	293.5	462.8	157.9	73.4	72.3	87.1	98.5	265.7	128.3	105.9	88.7	230.0	72.9	257.4	268.8	163.4
NDUFV2	CI-24k	ENSG00000178127	"NADH:ubiquinone oxidoreductase core subunit V2"	P19404	18	9102630-9134345	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 606.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003404, HPA077896"	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No		7600	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA003404: AB_1079466, HPA077896: AB_2686866"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.95e-3)"	97.4	171.6	94.3	69.2	97.4	149.8	101.7	106.8	139.7	63.9	106.0	124.2	102.3	69.7	91.1	142.6	64.0	68.7	419.3	96.7	106.0	180.7	404.2	88.6	105.0	105.9	104.4	52.4	111.6	136.7	72.1	73.7	105.9	88.5	119.8	129.9	97.4	72.4	606.9	94.7	100.5	80.6	103.7	86.4	133.8	79.6	102.7	90.2	72.7	538.3	105.1	122.1	76.5	104.6	136.5	139.8	159.1	148.4	116.6	164.0	133.4	165.4	266.5	217.7	205.5	265.1	109.4	209.4	149.5	158.6	200.3	66.9	157.5	175.5	208.8	104.6	136.6	133.0	135.3	364.8	133.6	373.8	159.2	139.2	144.3	134.9	146.2	156.8	239.3	184.3	216.5	644.0	204.6	171.6	263.5	328.9	131.4	750.5	172.3	124.5	118.2	794.2	354.3	218.7	167.0	122.3	164.6	188.0	220.3	113.6	174.2	282.8	145.8	273.4	194.3	198.8	223.0	180.4	292.3	237.1	195.4	166.0	181.0	250.8	161.8	194.2	118.1	196.1	148.3	237.6	176.9	140.5	237.9	201.1	153.5	142.7	76.0	124.2	187.9	315.1	231.9	231.8	94.3	97.4	106.8	139.7	96.7	106.0	105.9	104.4	105.9	103.7	102.7	104.6	107.3	80.1	145.8	17.6	143.1	148.0	319.0	629.4	159.4	101.2	165.0	167.3	69.9	178.7	339.5	150.8	87.6	344.1	146.6	211.0	876.5	415.2	271.5	160.3	108.2	117.3	106.5	165.4	32.9	531.4	323.3	122.0	144.3	183.9	120.3	109.7	96.4	351.5	313.5	94.2	37.3	201.7	480.1	115.7	267.1	186.2	122.1	170.2	231.3	17.8	293.2	167.1	96.8	32.2	46.5	530.3	201.2	102.0	244.9	554.3	349.9	810.6	293.4	184.2	105.2	124.0	196.3	217.4	175.0	226.5	147.6	289.4	165.7	266.7	227.3	469.0
NECAB1	EFCBP1	ENSG00000123119	"N-terminal EF-hand calcium binding protein 1"	Q8N987	8	90791741-90959393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 59.4;choroid plexus: 24.3"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 374.6;Oligodendrocytes: 307.8"	"Cancer enhanced"	"Detected in many"		"glioma: 2.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 4.0;MOLT-4: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210"	Enhanced	Supported	Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815"	"unprognostic (8.09e-3)"	"unprognostic (3.78e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.96e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.39e-3)"	2.2	3.5	20.5	0.9	28.2	2.4	1.6	6.7	59.4	3.3	24.3	8.3	0.6	5.5	3.1	2.2	3.4	1.8	9.0	33.2	20.0	2.3	0.2	5.4	0.4	8.4	12.7	3.2	0.3	0.5	3.8	1.7	7.2	3.3	0.1	0.9	1.3	0.8	0.3	1.7	1.6	0.2	12.4	1.4	2.9	4.8	27.1	0.0	2.0	0.1	0.0	4.5	2.4	41.2	0.1	0.1	1.4	0.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.3	0.0	0.7	0.0	0.0	0.0	2.7	4.0	1.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	3.9	0.0	1.0	2.8	2.8	0.0	3.7	4.2	2.2	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.8	2.8	0.1	0.0	1.4	1.7	0.0	0.1	1.0	2.5	2.4	0.0	1.0	3.8	2.4	2.0	2.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	20.5	28.2	6.7	59.4	33.2	20.0	8.4	12.7	7.2	12.4	27.1	41.2	0.8	19.2	69.7	20.9	0.0	0.5	0.2	0.1	0.0	4.8	0.2	0.8	64.0	0.0	2.5	12.9	0.0	0.0	0.4	0.1	0.0	0.0	4.4	0.4	2.2	3.4	0.0	12.2	374.6	0.2	0.0	6.4	0.0	0.2	1.3	0.2	0.7	0.0	0.1	0.0	63.5	0.0	0.0	0.0	0.6	1.4	2.5	0.3	3.6	38.4	0.0	0.4	0.0	17.6	307.8	0.1	0.0	2.2	0.1	0.1	0.0	9.0	0.0	0.5	6.6	1.0	6.1	4.6	2.2	0.1	0.9	0.0	0.2	0.5	0.0	0.0
NEDD1	"GCP-WD, TUBGCP7"	ENSG00000139350	"NEDD1 gamma-tubulin ring complex targeting factor"	Q8NHV4	12	96907224-96953780	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 255.8;Late spermatids: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 133.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038591	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Centrosome"		"HPA038591: AB_10674688"	"unprognostic (7.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.94e-4)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.59e-2)"	9.1	5.8	3.4	9.7	4.3	15.2	12.8	4.0	3.9	9.9	7.7	8.3	7.1	12.7	6.4	10.0	9.1	7.5	9.2	3.1	4.7	8.9	6.3	8.8	15.4	5.0	4.5	9.8	7.1	14.9	3.8	11.0	4.7	10.6	9.7	7.2	6.8	8.2	38.0	8.2	6.9	13.1	4.8	13.4	7.2	23.6	3.7	22.5	10.5	25.6	15.2	9.6	6.1	6.3	39.4	25.8	43.3	26.8	21.1	19.0	30.7	133.1	47.0	60.5	51.7	17.0	14.2	24.1	12.6	107.7	28.8	34.5	29.5	31.0	80.7	46.7	26.2	30.2	16.1	15.1	17.5	41.8	26.2	14.1	24.9	37.2	28.3	39.8	30.0	41.0	17.8	17.3	43.9	16.3	76.1	19.0	23.8	20.6	80.8	40.0	43.7	24.0	25.0	25.7	13.4	23.6	37.4	20.9	23.7	33.5	28.2	14.6	21.5	38.0	28.8	27.2	31.9	17.0	22.0	32.3	11.7	20.9	46.7	14.1	8.5	25.6	13.8	13.8	15.8	11.1	15.4	15.0	7.4	10.4	15.7	12.5	6.3	19.9	10.2	5.7	17.8	9.4	3.4	4.3	4.0	3.9	3.1	4.7	5.0	4.5	4.7	4.8	3.7	6.3	18.8	9.6	11.5	11.4	19.1	19.4	28.1	7.3	13.1	8.0	10.4	6.9	10.5	21.5	11.9	16.5	0.0	8.2	20.5	6.3	9.8	9.8	255.8	15.3	10.0	14.6	6.1	34.1	3.7	8.2	13.9	13.3	8.6	9.7	16.5	9.3	15.0	4.8	8.6	18.5	3.0	7.5	4.1	8.1	9.2	92.0	12.5	9.4	7.2	15.9	7.5	11.5	17.5	9.0	15.1	8.3	8.3	10.1	13.3	49.6	4.7	11.2	21.8	8.4	19.7	13.9	13.6	34.3	26.0	12.0	14.1	4.0	24.6	9.8	8.0	18.3
NEDD8	Nedd-8	ENSG00000129559	"NEDD8 ubiquitin like modifier"	Q15843	14	24216857-24232367	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		990000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644"	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	169.0	224.3	156.9	71.5	162.3	91.0	156.7	158.6	219.1	152.4	152.5	172.9	55.9	147.6	132.6	202.1	131.3	51.0	299.8	163.1	168.6	195.8	175.7	147.7	81.2	163.7	158.7	138.1	110.9	289.1	143.9	84.3	162.4	133.7	88.7	74.6	139.3	85.5	294.3	182.2	128.8	97.7	157.5	164.6	146.8	77.9	162.1	125.7	132.8	197.1	113.1	152.0	157.5	162.0	166.9	292.7	223.8	159.9	255.2	223.2	165.6	218.7	237.4	259.5	237.5	204.6	196.1	142.1	126.9	317.1	212.3	169.2	230.8	349.5	365.6	201.9	139.7	150.2	272.9	710.7	220.8	251.8	151.6	237.0	231.8	217.2	172.0	239.1	317.3	162.3	139.3	161.5	409.4	380.3	203.4	241.1	166.1	303.7	335.8	141.3	176.9	146.1	302.7	322.1	96.7	221.7	188.3	192.6	168.4	229.5	117.6	199.2	230.3	145.4	144.9	184.9	198.5	187.9	322.7	210.6	102.6	146.2	139.6	461.6	277.3	459.9	214.7	302.8	235.5	311.9	246.0	241.0	276.3	273.4	229.8	233.1	299.8	233.7	310.5	369.7	327.3	526.6	156.9	162.3	158.6	219.1	163.1	168.6	163.7	158.7	162.4	157.5	162.1	162.0	276.4	144.2	156.8	0.0	182.1	277.9	227.5	644.7	166.8	101.0	263.4	301.5	464.7	215.9	301.5	310.8	47.9	525.7	237.0	267.8	594.8	344.9	72.6	201.8	189.4	259.5	212.4	220.7	0.0	406.9	625.0	246.0	108.1	195.4	218.6	228.7	222.0	431.5	576.3	106.0	0.0	286.4	362.2	288.7	345.5	77.3	272.1	255.4	268.6	0.0	394.0	275.0	346.1	0.0	0.0	449.8	311.5	275.7	161.3	254.4	340.2	845.8	279.7	95.9	210.4	178.7	318.4	150.0	196.9	252.1	386.6	419.5	216.0	289.8	291.8	275.5
NEDD8-MDP1		ENSG00000255526	"NEDD8-MDP1 readthrough"		14	24213955-24232352	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.3;testis: 1.3"	"Group enriched"	"Detected in some"	11	"Alveolar cells type 2: 3.1;granulocytes: 1.3;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;MCF7: 1.5;MOLT-4: 2.3"									"HPA003064, HPA060254"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA003064: AB_10602350, HPA060254: AB_2732644"	"unprognostic (2.72e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.83e-2)"	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	1.3	0.3	0.4	0.1	0.0	0.1	0.2	1.3	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	1.1	0.0	0.3	0.2	0.4	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.3	0.1	0.3	0.5	0.1	0.5	0.3	0.4	0.2	0.6	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.2	0.7	0.0	0.2	0.2	0.0	0.6	0.1	0.0	0.1	1.5	2.3	0.2	0.1	0.8	0.0	0.1	0.0	0.8	0.1	0.0	0.3	0.1	0.0	0.3	0.5	0.1	0.2	0.4	0.0	0.0	0.7	0.0	0.4	1.3	0.9	0.9	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 323.2;Alveolar cells type 1: 471.1;Glandular and luminal cells: 337.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 137.3;HSkMC: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009689, CAB009720, HPA038768, HPA039270, HPA072955"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	94.7	8.6	8.3	23.3	8.1	8.6	64.2	6.4	12.3	26.6	14.4	30.7	15.5	19.2	17.5	14.5	22.7	31.4	32.7	7.7	6.4	33.8	20.7	91.9	25.8	8.3	7.3	8.3	17.1	9.5	8.1	69.2	8.5	22.4	30.2	9.8	26.7	29.8	27.2	20.6	38.1	25.8	7.4	25.2	23.5	6.9	9.7	22.2	25.6	12.0	22.2	34.5	15.3	7.9	4.4	29.0	26.4	0.4	17.7	2.3	27.7	6.6	8.2	12.2	22.4	9.3	1.9	9.2	137.3	14.7	1.5	12.6	36.0	13.5	15.8	4.1	1.0	0.8	4.4	62.3	8.3	10.1	0.4	67.7	4.0	7.9	1.3	4.4	21.0	0.8	0.1	7.6	27.7	1.3	5.8	4.0	4.1	34.6	2.9	1.6	0.7	5.4	6.1	39.8	0.6	4.8	1.1	31.2	55.5	29.3	2.3	7.7	53.8	8.2	14.3	0.8	16.5	7.8	34.8	11.4	0.2	7.9	36.6	24.2	13.3	37.3	18.3	28.5	14.7	10.9	12.2	17.5	14.1	12.3	6.4	9.9	80.9	12.3	50.6	8.7	12.1	17.1	8.3	8.1	6.4	12.3	7.7	6.4	8.3	7.3	8.5	7.4	9.7	7.9	323.2	471.1	135.1	11.1	34.9	60.5	235.6	83.5	98.4	4.7	43.1	38.0	14.2	50.1	89.0	44.1	25.0	56.3	45.9	103.4	9.8	62.0	8.2	244.8	24.8	148.1	108.3	2.5	18.2	19.8	42.6	37.2	107.6	337.0	64.5	15.7	86.7	21.6	14.7	10.1	11.3	108.4	12.2	29.8	28.9	4.3	7.5	51.4	24.9	34.7	15.4	84.1	64.9	8.0	4.9	69.1	43.6	29.0	34.8	66.1	100.5	26.7	64.4	12.4	26.3	8.8	30.0	2.1	1.1	11.4	20.6	42.8	59.4	37.2	46.6	90.3
NEFL	"CMT1F, CMT2E, NF68, NFL, PPP1R110"	ENSG00000277586	"Neurofilament light"	P07196	8	24950955-24956721	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 675.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 32.7;Distal tubular cells: 103.7;Enteroendocrine cells: 33.3;Excitatory neurons: 64.6;Horizontal cells: 30.3;Rod photoreceptor cells: 110.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"memory CD4 T-cell: 11.2"	"Lineage enriched"	"Detected in single"	113	"T-cells: 11.2"	"Group enriched"	"Detected in some"	4	"HEK 293: 456.2;PC-3: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014850, HPA015021"	Enhanced	Supported	Approved	"Nucleoplasm,Intermediate filaments,Midbody"		Yes	NA		200000	"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Intermediate filaments"	Midbody	"HPA014850: AB_1854397, HPA015021: AB_2669135"	"unprognostic (7.63e-2)"	"unprognostic (1.36e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (5.76e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.17e-3)"	0.1	18.0	35.4	1.3	36.7	0.0	0.0	103.6	675.9	2.0	0.0	2.5	0.6	0.1	0.3	5.4	1.3	0.1	0.1	50.9	75.6	5.0	0.0	0.0	0.1	425.7	41.1	0.2	0.2	0.1	4.0	0.0	231.3	1.8	1.5	89.5	0.0	15.6	0.0	0.9	1.9	1.1	33.9	0.2	0.8	1.7	216.1	12.7	0.7	0.1	0.3	0.0	1.4	184.0	0.0	0.6	68.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.6	0.0	0.0	456.2	0.0	0.0	0.0	21.6	0.0	1.0	8.3	2.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	18.8	0.0	145.4	0.0	0.0	0.0	31.7	4.2	30.9	31.6	11.2	0.0	1.9	2.2	0.0	0.0	0.0	2.2	31.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	1.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.2	1.5	35.4	36.7	103.6	675.9	50.9	75.6	425.7	41.1	231.3	33.9	216.1	184.0	0.1	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.6	32.7	0.0	0.0	3.2	0.0	0.0	0.0	8.4	0.0	0.1	0.1	103.7	0.1	0.4	0.1	0.3	3.7	33.3	0.0	64.6	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	30.3	29.1	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	27.2	0.1	27.8	0.0	14.6	18.4	0.0	0.1	9.4	0.0	0.0	0.0	0.2	0.0	110.0	0.0	0.1	0.2	0.0	13.2	1.5	0.0	0.0	1.6	1.4	0.0	0.0
NEIL1	"FLJ22402, FPG1, hFPG1, NEI1"	ENSG00000140398	"Nei like DNA glycosylase 1"	Q96FI4	15	75346955-75357115	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.2;memory B-cell: 4.8;naive B-cell: 6.4;NK-cell: 15.8"	"Group enriched"	"Detected in many"	11	"B-cells: 6.4;NK-cells: 15.8;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.5;HeLa: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054084	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA054084: AB_2682372"	"unprognostic (9.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.50e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.27e-3)"	8.0	14.6	2.0	3.1	3.1	4.3	11.6	6.2	5.0	14.7	2.0	9.3	5.8	10.0	1.7	7.3	12.9	3.9	5.8	2.2	1.7	8.8	12.8	8.3	6.1	1.4	0.4	13.3	10.9	3.3	11.0	2.5	0.7	12.4	1.1	2.6	16.6	4.1	9.0	8.9	8.3	1.9	0.0	8.8	10.5	3.7	1.1	2.7	10.7	0.6	3.0	8.2	10.9	2.2	2.2	3.6	2.3	1.4	0.7	0.8	4.5	1.3	0.0	0.5	0.1	0.6	4.0	11.5	2.1	0.2	1.1	6.1	1.4	0.4	0.0	5.7	9.1	2.0	11.8	1.7	0.9	2.1	2.6	0.3	1.7	0.6	0.0	5.6	1.4	1.1	1.4	3.3	0.3	2.9	0.4	6.3	2.1	0.4	0.8	2.1	1.5	0.5	2.1	2.4	1.4	2.8	2.2	1.0	3.2	1.2	4.2	3.5	6.3	1.3	2.3	1.8	1.2	5.2	5.5	9.7	1.1	9.4	1.2	0.0	0.6	0.0	5.2	0.3	1.3	4.8	0.9	1.2	0.2	6.4	1.4	1.4	0.8	15.8	0.2	0.3	0.3	1.4	2.0	3.1	6.2	5.0	2.2	1.7	1.4	0.4	0.7	0.0	1.1	2.2	15.9	22.4	19.2	19.9	33.7	6.4	15.4	10.1	23.3	20.0	22.1	15.9	2.9	10.0	21.9	14.7	10.4	10.8	19.1	13.6	1.9	9.0	20.4	31.8	7.3	16.9	21.6	8.0	33.5	8.3	3.6	7.7	22.4	15.4	11.4	105.6	24.3	11.5	3.4	10.1	29.9	20.0	10.2	5.7	7.0	2.6	19.0	3.3	8.8	8.4	1.7	14.6	55.6	5.5	4.5	7.3	16.0	13.5	9.1	9.2	21.4	8.9	41.9	6.5	6.6	6.6	6.4	1.6	1.5	11.0	5.8	4.8	10.0	2.0	14.5	8.7
NEIL2	"FLJ31644, MGC2832, MGC4505, NEH2"	ENSG00000154328	"Nei like DNA glycosylase 2"	Q969S2	8	11769639-11787345	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 68.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA073029, HPA073916"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA073029: AB_2732216, HPA073916: AB_2732245"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.05e-1)"	9.5	27.8	29.2	5.9	28.8	2.3	9.5	27.7	27.9	13.1	23.8	8.6	2.8	9.5	12.5	6.9	15.0	5.7	14.6	29.6	35.6	12.8	16.3	7.4	7.1	32.0	34.3	11.1	11.2	9.0	17.9	6.4	36.8	11.3	4.8	13.4	10.0	8.1	24.5	15.8	6.8	8.5	31.9	12.4	6.9	26.1	36.1	4.7	11.8	13.7	6.9	9.8	8.8	28.3	8.2	22.9	14.1	27.7	6.6	12.2	6.3	13.0	10.6	12.2	8.4	7.1	8.8	3.2	4.9	15.7	26.3	7.1	13.5	14.1	16.7	9.7	6.7	11.3	5.7	13.9	5.3	5.0	8.2	10.8	20.7	10.7	9.9	11.8	11.6	3.7	16.1	10.8	15.0	8.6	0.9	5.2	12.6	33.9	12.1	14.4	18.1	8.8	14.4	12.3	21.5	17.0	10.2	5.3	19.1	11.2	8.4	0.7	14.3	13.9	19.8	3.8	18.4	10.0	22.3	5.7	36.6	16.7	28.8	0.7	2.2	0.2	12.7	3.9	17.5	21.9	12.9	15.3	4.6	16.9	18.7	16.8	1.3	15.1	2.0	8.3	9.3	7.0	29.2	28.8	27.7	27.9	29.6	35.6	32.0	34.3	36.8	31.9	36.1	28.3	7.2	0.0	5.8	6.2	14.0	8.5	17.1	8.0	13.6	32.3	13.1	7.7	19.6	14.3	7.0	7.3	16.7	18.6	5.6	1.5	33.2	21.1	1.1	6.9	8.4	8.9	10.1	10.3	6.3	23.3	15.8	10.3	3.1	3.8	2.5	14.9	7.9	23.6	15.1	8.4	6.9	6.1	14.2	6.9	6.6	2.1	14.0	6.8	14.2	0.0	6.6	38.9	11.3	6.0	3.7	15.1	1.0	24.5	3.8	15.3	0.8	32.2	6.8	17.1	6.6	11.8	10.2	19.0	68.1	8.3	12.8	5.3	9.7	8.9	6.2	12.0
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309874-177362936	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.6;lymphoid tissue: 23.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 14.7;Granulosa cells: 4.8;Plasma cells: 6.1;Squamous epithelial cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 72.1;HL-60: 79.1;Karpas-707: 99.1;MOLT-4: 80.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.3"	HPA065761			Enhanced	Nucleoplasm		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.1	0.0	0.0	1.7	0.0	6.6	0.3	0.0	0.1	0.2	0.0	1.1	1.1	0.1	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	2.3	1.3	0.5	0.0	0.4	0.6	1.5	0.1	23.6	0.0	0.0	3.5	0.4	0.4	0.0	19.3	15.8	16.4	8.2	1.8	3.3	8.0	23.4	8.6	25.3	14.9	5.8	16.5	21.2	3.4	6.2	25.1	8.8	17.4	9.3	36.6	72.1	11.4	14.7	11.9	15.2	0.5	79.1	9.7	0.3	0.5	26.2	5.6	5.2	9.9	53.9	15.3	99.1	16.7	8.4	80.7	30.2	7.5	5.7	11.5	16.2	11.2	6.8	6.8	2.6	12.8	8.9	11.7	13.4	6.3	7.2	10.9	20.4	4.7	15.2	11.8	7.8	24.0	6.8	4.8	33.5	10.1	27.8	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.1	0.4	1.2	0.0	0.2	0.1	0.4	0.0	1.3	0.0	0.0	2.6	1.6	0.5	0.0	0.0	0.1	0.1	0.6	0.3	0.0	14.7	0.1	0.2	3.3	0.9	0.0	0.5	0.0	4.8	0.4	0.0	1.5	0.0	0.1	1.0	0.0	1.3	0.4	0.2	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	6.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.5	2.7	2.4	4.5	1.3	0.3	1.0	0.5	1.2	0.2
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392809-169612627	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 126.3;Inhibitory neurons: 170.5;Oligodendrocytes: 196.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	6.0	6.1	5.1	4.9	6.8	4.2	5.2	7.1	5.3	7.6	2.7	4.0	3.2	7.3	2.8	4.6	9.3	6.1	6.9	3.5	8.8	5.9	4.2	4.6	5.3	7.5	7.7	9.4	4.0	6.5	2.9	4.3	7.6	6.7	4.4	8.7	4.2	6.0	3.3	2.3	3.5	6.6	7.6	5.1	4.9	11.8	5.3	6.8	7.9	4.6	4.6	5.6	2.8	7.7	5.8	2.5	10.0	11.0	15.5	17.1	3.3	11.9	10.6	9.3	8.8	3.3	6.7	15.4	2.2	10.4	9.0	1.9	9.7	10.1	10.5	16.9	6.5	10.3	10.4	3.9	9.0	10.6	7.9	13.7	5.9	9.5	16.7	19.1	9.3	14.5	18.6	28.2	12.1	3.7	13.6	4.6	3.3	3.6	6.0	8.4	6.5	4.9	9.7	6.8	11.0	12.5	8.6	4.2	8.1	7.7	5.3	4.6	11.2	6.0	5.4	6.2	8.1	11.3	18.6	11.6	9.7	5.1	10.7	5.1	0.9	0.9	1.9	1.5	2.2	2.0	1.5	1.2	0.7	2.0	2.2	2.3	0.6	1.1	0.7	1.6	1.6	0.7	5.1	6.8	7.1	5.3	3.5	8.8	7.5	7.7	7.6	7.6	5.3	7.7	12.2	12.8	16.4	162.6	34.2	9.6	15.8	12.1	21.1	21.8	11.3	12.7	37.2	4.3	17.8	18.4	29.2	20.8	17.0	6.4	17.6	10.4	109.7	67.2	21.6	13.2	7.2	26.7	126.3	6.2	8.6	25.0	17.3	23.7	18.3	20.1	9.7	7.8	10.7	18.5	170.5	5.6	20.3	7.0	7.4	48.2	23.6	14.5	5.4	53.4	6.6	26.1	15.5	115.1	196.1	8.9	4.0	31.6	23.2	6.9	5.3	9.6	68.4	24.9	13.1	32.8	25.5	67.9	37.3	21.3	6.3	29.6	22.0	26.0	6.3	9.2
NEK10	FLJ32685	ENSG00000163491	"NIMA related kinase 10"	Q6ZWH5	3	27110085-27369460	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 36.6;tongue: 20.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 123.5;Endometrial ciliated cells: 59.3;Excitatory neurons: 131.4;Inhibitory neurons: 130.2;Late spermatids: 61.7;Respiratory ciliated cells: 104.2"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 6.0;LHCN-M2: 8.2;U-2 OS: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038941	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles	Nucleoplasm	"HPA038941: AB_10673600"	"prognostic favorable (4.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.14e-1)"	0.2	0.3	3.0	0.3	5.3	0.3	14.0	0.0	9.4	1.4	3.3	2.0	2.5	0.8	8.3	1.8	11.0	1.4	3.3	9.6	5.0	1.7	2.5	2.4	0.5	3.3	5.7	0.7	0.7	0.4	3.4	0.1	2.7	1.7	0.5	6.2	0.3	1.2	12.4	0.3	0.8	0.3	2.3	0.4	1.0	36.6	6.1	0.5	0.7	20.0	0.6	1.2	0.2	0.9	0.8	1.6	0.8	0.9	0.6	1.5	0.3	6.0	0.9	1.6	1.4	0.0	0.4	0.5	1.4	2.5	1.1	0.1	0.4	0.4	1.7	1.1	0.6	0.1	3.4	2.9	0.1	0.3	0.8	1.8	0.4	2.5	0.1	2.0	1.1	3.4	0.1	0.6	8.2	0.1	0.6	0.4	0.5	0.2	0.2	0.8	0.3	0.2	3.0	0.5	0.1	0.2	0.9	0.3	0.4	0.5	4.8	0.3	0.7	4.3	6.8	0.2	0.6	0.2	0.2	0.4	3.6	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	5.3	0.0	9.4	9.6	5.0	3.3	5.7	2.7	2.3	6.1	0.9	1.5	6.4	0.0	11.4	0.3	0.3	0.3	3.2	0.0	14.5	25.8	7.4	12.9	4.3	9.3	1.8	87.6	0.0	0.8	0.2	0.0	0.4	123.5	59.3	1.3	2.4	0.0	0.0	131.4	0.0	0.3	3.1	0.0	7.7	0.0	1.1	0.7	1.3	0.2	0.0	130.2	0.4	12.2	1.0	0.8	61.7	1.8	1.1	0.0	32.8	0.1	1.0	1.0	20.6	12.9	0.2	2.7	1.2	0.1	1.9	2.1	0.3	104.2	19.1	0.0	14.9	2.4	32.2	2.2	0.1	0.4	0.0	1.1	3.7	0.6	0.4
NEK11	FLJ23495	ENSG00000114670	"NIMA related kinase 11"	Q8NG66	3	131026850-131350465	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 26.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.7;Early spermatids: 156.4;Endometrial ciliated cells: 69.2;Excitatory neurons: 91.0;Late spermatids: 109.2;Respiratory ciliated cells: 102.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016908	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA016908: AB_1854364"	"unprognostic (9.15e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.92e-6)"	"unprognostic (2.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	3.1	4.3	8.3	0.5	8.3	0.1	6.6	6.9	7.7	5.4	26.2	2.1	1.3	4.9	7.1	2.3	21.4	4.6	2.1	7.3	9.0	6.3	0.6	4.3	1.0	14.2	15.5	6.4	2.2	4.8	5.6	2.2	12.4	2.9	2.4	5.6	2.9	3.7	1.1	2.2	1.8	2.7	12.8	1.2	1.6	15.5	9.3	0.9	9.6	0.8	1.2	2.8	2.5	12.8	5.7	2.2	1.6	4.8	6.2	9.3	0.9	2.7	5.0	4.1	3.1	2.1	7.7	0.2	1.9	4.8	3.9	3.0	0.4	4.6	5.6	0.5	0.6	0.8	0.3	1.0	2.1	0.6	1.3	3.9	7.7	4.2	1.9	4.3	0.8	2.4	0.2	0.8	6.9	3.9	0.1	0.4	0.5	0.9	2.1	0.0	0.1	0.1	9.3	2.2	2.0	2.2	1.3	0.1	1.9	0.7	4.4	0.1	0.9	4.1	2.0	3.3	1.3	1.2	2.2	0.1	2.9	0.2	0.7	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.6	0.5	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.2	0.3	0.0	8.3	8.3	6.9	7.7	7.3	9.0	14.2	15.5	12.4	12.8	9.3	12.8	2.5	16.0	3.2	60.7	1.5	4.2	3.4	4.5	4.6	2.6	7.3	7.5	1.6	4.3	18.8	1.8	6.2	1.0	1.4	3.3	5.9	6.4	156.4	69.2	6.1	3.5	2.4	0.4	91.0	2.5	1.1	7.7	2.6	6.6	0.0	8.1	5.7	0.6	2.0	0.0	42.0	3.5	6.1	0.3	1.7	109.2	6.8	2.0	0.0	21.5	0.8	6.4	1.0	38.7	38.9	3.7	3.9	6.0	0.8	1.6	1.7	10.6	102.7	7.3	6.6	7.2	3.7	33.4	5.2	2.6	2.0	1.6	1.4	11.5	2.4	2.7
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.9;lymphoid tissue: 19.2;testis: 67.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 76.1;Spermatocytes: 244.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.7"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	0.7	0.4	0.5	5.3	0.4	17.9	1.5	0.9	0.6	1.1	0.6	5.9	7.4	1.3	0.5	4.4	2.2	0.8	0.4	0.5	0.3	0.3	0.7	0.7	9.0	0.4	0.2	0.4	0.1	0.1	0.0	3.2	0.3	2.5	7.6	1.5	0.8	0.2	0.4	4.3	6.9	2.0	0.2	1.7	2.7	67.1	0.6	19.2	0.4	0.2	10.6	1.3	1.6	0.9	86.0	60.5	45.3	32.6	2.6	4.5	49.7	32.4	30.1	55.4	47.5	32.3	81.7	45.1	15.2	25.2	35.1	44.5	39.9	24.2	69.6	69.5	33.2	21.6	51.4	44.2	0.4	43.2	28.3	1.4	2.9	42.9	45.9	13.4	36.3	45.2	59.9	76.9	56.0	23.6	47.3	28.8	43.0	55.0	30.5	46.2	69.2	68.7	19.7	24.2	41.0	45.0	46.6	51.5	39.3	38.4	79.4	25.1	19.0	27.6	54.1	54.8	88.3	31.6	62.6	59.6	24.1	32.6	46.8	1.2	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	0.4	0.3	0.2	0.7	1.5	0.1	0.2	1.6	0.3	0.5	0.4	0.9	0.6	0.5	0.3	0.4	0.2	0.3	0.2	0.6	0.9	0.1	0.0	0.5	0.3	1.7	2.9	0.7	3.8	0.6	11.3	1.9	2.2	0.5	0.0	2.9	0.0	0.0	9.4	0.8	1.9	0.0	0.2	76.1	15.2	0.7	0.8	0.0	39.6	0.8	0.2	14.1	1.4	5.6	1.5	0.0	3.6	3.6	0.7	5.8	3.3	0.0	3.2	10.2	2.5	1.1	39.0	2.5	2.1	0.0	0.0	0.0	1.6	2.1	0.0	0.1	0.0	2.5	0.7	5.4	0.7	2.1	0.1	5.2	1.8	6.6	0.0	1.5	244.2	26.1	8.6	1.7	1.4	2.0	0.9	9.5	1.4
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 121.0;Hofbauer cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"	"Centriolar satellite"	"CAB045993: AB_2150651, HPA056828: AB_2683250"	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	18.0	6.1	33.5	32.6	34.3	19.6	14.7	28.1	32.4	26.1	26.5	22.3	17.5	12.2	3.4	8.5	11.2	25.4	7.4	31.8	37.0	17.2	68.2	24.3	27.4	49.8	41.2	9.0	16.7	1.9	6.1	30.2	33.9	19.6	22.5	11.3	20.6	16.7	8.2	5.4	25.8	18.7	34.4	16.6	27.1	7.8	44.2	10.2	7.3	3.1	31.7	24.3	6.4	30.4	31.8	50.0	47.8	18.8	88.3	113.9	59.3	38.8	61.1	58.4	48.4	47.7	57.0	38.2	61.0	74.6	133.2	5.9	24.7	111.7	39.4	43.7	21.8	104.4	42.1	85.4	105.2	19.4	250.0	152.8	17.8	55.4	56.9	152.3	64.3	17.6	19.5	1.7	105.6	32.6	0.9	20.8	12.2	163.7	45.5	40.6	35.6	19.6	62.6	11.4	21.4	7.5	12.6	23.6	54.5	48.3	51.4	76.4	127.5	42.2	42.8	29.5	26.7	8.4	11.4	21.6	53.5	42.3	57.5	28.1	47.6	76.4	9.2	32.1	5.9	52.5	5.5	7.8	29.0	30.2	0.9	3.8	58.8	23.3	41.4	26.9	7.6	21.6	33.5	34.3	28.1	32.4	31.8	37.0	49.8	41.2	33.9	34.4	44.2	30.4	8.4	9.6	4.7	37.9	24.5	2.4	13.8	18.9	4.6	1.0	9.4	6.5	3.3	18.6	8.8	3.7	0.0	47.1	11.3	8.5	1.9	41.3	18.2	9.4	17.7	8.4	6.0	4.0	8.3	23.3	121.0	11.1	19.4	22.2	22.2	1.1	5.0	43.5	112.0	0.0	5.3	18.2	18.3	10.4	22.5	20.0	5.0	31.2	7.2	12.2	57.7	34.6	8.2	15.1	2.4	30.6	11.9	3.8	5.5	17.1	17.2	38.0	3.3	2.1	0.0	4.9	6.4	1.3	17.1	2.4	1.1	36.1	4.5	2.1	18.7	10.2
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156994-198322420	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 172.6;Oligodendrocyte precursor cells: 131.2;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 554.5;fHDF/TERT166: 753.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	63.8	49.9	48.3	29.3	58.7	11.1	27.7	45.9	53.3	26.1	35.7	30.0	21.1	26.6	19.7	31.2	22.3	27.2	140.4	39.5	56.1	29.3	30.0	41.6	30.8	61.1	51.3	29.6	20.3	25.1	12.3	42.1	60.0	27.1	23.3	19.6	22.3	36.5	56.6	14.9	25.3	32.2	59.7	32.1	20.1	13.7	49.1	27.7	26.8	63.7	23.6	30.9	20.1	64.2	47.8	12.3	14.8	6.0	37.5	42.6	17.4	554.5	227.6	218.7	102.9	23.0	46.2	17.1	39.4	753.3	12.6	29.0	22.7	30.3	220.8	56.0	32.7	23.6	48.7	9.6	45.3	40.2	46.3	26.7	25.3	144.8	43.5	82.2	42.4	140.0	18.8	41.2	102.3	15.1	34.7	23.4	8.4	37.5	9.9	18.5	36.5	30.7	37.3	24.5	9.5	17.0	92.1	53.0	63.5	20.6	38.8	36.0	95.7	61.8	52.0	178.6	58.9	29.3	28.5	11.8	26.9	36.3	48.7	1.8	2.2	3.3	2.9	1.8	12.8	1.4	3.2	4.1	2.0	1.9	2.7	3.1	6.0	3.6	1.6	1.3	6.0	1.4	48.3	58.7	45.9	53.3	39.5	56.1	61.1	51.3	60.0	59.7	49.1	64.2	34.3	28.9	30.7	78.0	32.4	51.4	15.0	10.2	33.6	8.2	22.8	18.2	172.6	10.0	18.7	18.4	14.6	15.0	32.9	25.8	11.7	10.6	2.8	21.6	20.9	29.3	19.8	32.6	17.0	19.6	15.9	30.0	18.8	19.6	8.8	11.8	40.4	23.5	17.5	3.3	34.6	19.5	8.2	49.5	51.6	3.3	29.2	35.5	30.2	124.6	29.0	11.4	15.5	131.2	153.5	50.1	19.3	38.4	28.5	30.6	25.1	16.6	27.9	24.2	19.7	28.1	35.9	7.7	6.0	29.2	49.2	64.3	41.6	28.7	15.6	33.1
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982717-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737"	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	9.3	7.8	7.5	10.8	8.6	14.2	6.0	8.0	11.5	7.1	6.1	9.4	13.4	11.3	6.3	9.5	12.4	5.7	6.3	8.0	6.9	6.8	5.8	6.6	10.8	8.7	8.9	15.5	16.7	10.1	3.0	10.3	6.8	8.9	4.7	7.0	18.2	8.4	12.0	12.8	13.4	5.7	8.1	12.1	12.7	16.5	7.4	9.4	7.4	4.6	7.4	6.8	1.8	9.5	27.2	24.6	21.0	38.8	8.5	8.9	41.6	14.3	10.1	16.9	13.4	41.1	45.7	47.8	20.1	9.3	21.0	25.2	21.3	17.9	8.2	24.5	33.2	31.5	18.0	39.4	12.4	33.1	30.9	7.6	15.6	11.3	12.0	12.5	13.0	26.6	60.5	22.3	7.4	31.7	63.8	94.4	60.8	23.2	36.5	57.6	18.3	30.2	12.1	22.5	57.1	35.7	16.4	19.3	24.4	13.0	37.1	24.5	14.7	17.0	19.2	19.8	31.9	47.2	52.7	53.6	19.4	34.5	21.4	7.0	14.4	14.9	15.4	16.9	18.5	16.3	17.9	13.9	13.9	24.0	15.0	12.0	5.3	15.4	14.0	17.3	22.1	13.1	7.5	8.6	8.0	11.5	8.0	6.9	8.7	8.9	6.8	8.1	7.4	9.5	11.1	12.8	17.9	30.7	18.5	32.6	18.6	20.3	17.6	19.2	17.6	19.3	4.6	14.3	19.1	12.9	39.6	27.9	16.2	14.6	9.8	18.7	24.0	25.2	17.7	13.2	16.2	17.2	55.9	13.6	28.1	14.7	13.3	28.5	9.5	23.3	11.4	8.3	16.4	37.0	40.9	17.8	14.2	10.1	12.1	7.4	15.5	11.3	14.2	13.1	19.6	18.1	19.6	31.7	30.2	16.2	18.7	13.2	14.0	23.6	17.5	8.9	17.3	21.9	0.0	15.4	15.2	32.9	39.4	29.8	38.2	28.5	18.8	15.8	20.1	27.0
NELFB	"COBRA1, KIAA1182, NELF-B"	ENSG00000188986	"Negative elongation factor complex member B"		9	137255327-137273542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020259	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA020259: AB_1847072"	"unprognostic (2.56e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (7.74e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (6.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-2)"	25.7	24.5	40.1	21.8	36.4	23.9	25.1	33.6	52.1	28.8	28.0	29.5	23.9	24.9	6.9	34.6	23.2	15.7	37.1	38.5	35.0	32.8	30.2	25.0	27.4	41.4	40.1	28.2	37.4	18.2	20.6	18.5	36.4	30.5	11.5	7.6	29.6	16.1	36.3	36.2	26.6	13.0	36.4	31.5	30.3	28.4	40.0	21.6	24.0	21.2	16.7	29.0	27.9	35.3	50.4	79.5	41.1	53.1	34.8	24.8	62.1	42.0	28.4	48.0	33.9	84.7	56.9	70.2	60.8	40.0	56.3	96.0	41.0	47.8	14.0	68.2	64.9	45.4	97.9	69.7	35.3	66.5	54.2	29.7	47.2	44.3	25.8	28.9	45.0	46.9	77.8	57.7	28.6	116.8	51.0	106.2	67.2	88.8	92.9	83.6	76.1	114.7	27.1	43.9	60.8	57.2	56.7	59.7	40.6	21.4	79.3	79.7	59.9	71.1	56.1	113.4	65.9	32.1	55.2	59.1	56.9	47.4	64.6	1.1	3.3	5.5	4.3	2.8	2.9	3.5	3.6	3.3	2.9	3.5	3.3	3.5	1.9	4.0	2.7	4.7	4.3	2.2	40.1	36.4	33.6	52.1	38.5	35.0	41.4	40.1	36.4	36.4	40.0	35.3	31.6	6.4	17.9	16.6	11.7	14.9	11.8	12.7	5.7	19.7	21.8	20.6	12.4	17.2	14.1	23.9	18.8	24.3	24.7	40.0	13.7	27.9	3.7	14.7	18.1	19.8	28.2	13.0	8.9	38.5	27.8	17.4	13.3	21.8	18.4	39.1	20.3	19.5	26.5	43.7	8.4	37.2	12.2	14.0	15.6	5.6	23.3	17.6	7.2	11.2	37.7	33.8	22.6	9.5	11.7	33.5	18.7	20.7	13.8	18.9	29.2	13.9	9.9	17.1	39.5	15.5	20.6	10.7	23.6	12.6	13.9	15.6	15.4	35.0	31.5	13.5
NELFCD	"HSPC130, NELF-C, NELF-D, TH1, TH1L"	ENSG00000101158	"Negative elongation factor complex member C/D"	Q8IXH7	20	58981208-58995133	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050641, HPA066262, HPA074936"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear bodies"	"Vesicles, Cytosol"	"HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: "	"unprognostic (1.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.98e-5)"	"unprognostic (6.20e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.07e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	18.9	29.5	20.5	17.7	22.8	23.8	24.5	21.7	23.4	20.7	21.2	18.2	19.3	18.2	16.3	32.9	24.4	16.2	16.9	19.6	21.0	31.7	31.2	14.7	26.4	21.2	20.9	25.2	21.2	30.7	31.8	25.6	21.8	20.4	17.9	31.9	30.0	17.1	29.4	25.9	19.6	14.1	20.8	20.7	19.3	27.9	21.5	31.5	28.5	20.5	27.9	22.6	22.7	24.3	54.7	57.6	68.5	71.9	22.5	38.9	49.6	42.4	38.8	117.1	66.8	189.6	70.7	68.3	64.0	39.8	60.8	89.1	90.1	98.0	94.8	22.4	64.1	90.5	72.4	150.5	26.7	64.2	60.1	40.9	34.3	44.2	32.8	32.8	68.3	54.0	118.1	51.8	53.3	198.2	135.6	95.4	40.3	151.5	122.9	78.4	56.6	121.1	49.0	76.5	75.9	112.6	126.0	148.3	85.9	38.2	157.5	75.0	30.2	91.6	88.8	36.3	67.7	44.4	80.0	71.1	53.7	57.3	80.6	20.0	44.6	22.9	42.0	51.5	50.0	48.6	39.7	51.2	64.9	44.5	37.7	40.1	5.6	47.1	68.8	33.0	39.7	49.0	20.5	22.8	21.7	23.4	19.6	21.0	21.2	20.9	21.8	20.8	21.5	24.3	23.0	9.6	27.6	18.3	50.5	30.2	62.6	43.8	40.9	67.3	32.7	34.2	10.9	47.1	24.3	22.0	41.7	133.1	35.5	14.5	50.9	57.0	18.8	26.2	33.3	26.7	23.4	60.0	23.0	31.4	69.2	26.2	26.5	27.4	16.5	50.9	23.2	24.1	36.9	55.5	22.8	21.9	26.4	15.3	24.0	32.1	37.0	24.0	26.6	10.3	48.1	52.9	49.4	21.1	23.6	34.9	14.4	26.4	37.4	37.8	27.8	49.9	15.0	61.5	39.5	31.6	34.2	63.1	94.9	40.5	31.4	103.0	48.5	43.9	36.2	52.8
NELFE	"D6S45, NELF-E, RD, RDBP, RDP"	ENSG00000204356	"Negative elongation factor complex member E"	P18615	6	31952087-31959038	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 635.4;Late spermatids: 1699.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007187, HPA007594, HPA046502"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.68e-2)"	51.9	48.5	37.4	15.2	38.2	23.5	49.4	38.6	40.3	47.9	36.6	45.9	12.7	50.1	26.9	51.7	46.9	11.9	57.1	35.8	39.2	50.0	24.5	43.6	16.9	39.1	38.3	47.4	52.4	41.1	42.5	20.5	37.4	35.4	24.2	6.3	40.5	26.7	58.2	51.3	37.2	27.7	38.7	38.7	46.6	166.2	39.2	36.8	39.6	30.8	25.4	44.1	43.5	39.6	51.8	59.9	55.5	48.4	54.7	59.9	50.9	40.3	73.8	90.1	74.6	69.5	35.7	49.0	41.3	79.0	117.1	44.0	47.4	85.7	64.5	39.4	63.2	35.9	41.9	80.5	110.6	43.4	29.0	63.2	119.2	96.2	113.5	75.6	84.2	87.6	51.6	56.6	90.2	89.6	77.1	44.6	22.9	79.6	68.1	63.0	49.1	95.2	61.0	49.8	42.3	52.8	30.4	44.4	80.1	48.4	66.0	89.6	37.1	39.7	63.5	34.5	67.8	65.9	77.8	47.6	26.0	36.4	69.8	44.9	60.4	58.7	49.4	68.8	46.2	50.9	45.4	47.2	56.9	49.9	41.9	41.0	31.4	48.8	67.8	45.4	49.0	55.4	37.4	38.2	38.6	40.3	35.8	39.2	39.1	38.3	37.4	38.7	39.2	39.6	49.0	16.0	27.9	4.6	42.8	47.2	69.0	61.5	40.5	15.5	55.1	62.5	47.2	72.9	43.1	33.1	12.5	98.4	37.7	84.6	133.1	93.3	635.4	68.4	40.8	49.8	34.2	52.2	6.2	136.5	112.1	47.7	31.1	45.6	45.6	46.7	45.3	34.8	82.8	11.8	6.2	71.1	46.8	55.3	42.6	1699.6	71.1	45.0	49.8	3.7	73.2	65.5	51.5	6.6	9.9	113.1	99.1	45.1	68.6	79.6	124.8	107.7	112.5	25.6	32.9	48.7	84.9	224.7	91.0	54.2	41.8	114.4	41.7	41.0	72.4	64.6
NEMF	"FLJ10051, NY-CO-1, SDCCAG1"	ENSG00000165525	"Nuclear export mediator factor"	O60524	14	49782083-49852821	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004160	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		830000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA004160: AB_1079884"	"unprognostic (9.92e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.15e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.81e-2)"	16.5	13.8	9.5	18.0	13.0	42.1	14.7	18.1	14.7	16.2	5.9	13.6	10.0	16.2	13.5	22.5	12.2	13.2	17.7	7.9	10.6	14.9	11.9	13.8	17.9	11.8	11.6	15.2	15.2	24.8	10.3	18.2	11.9	16.0	14.5	14.7	14.6	15.8	23.0	14.3	13.6	15.7	10.9	15.5	14.1	10.7	10.7	16.3	18.5	21.5	17.9	18.0	11.6	18.4	34.3	39.2	35.9	24.1	37.3	31.0	32.1	42.0	28.3	27.6	27.3	23.2	35.3	13.3	32.0	35.7	21.2	47.5	34.1	26.7	42.2	38.9	22.7	38.7	40.3	29.1	23.8	50.7	33.4	26.8	19.6	29.9	27.2	36.3	39.8	23.8	47.3	36.2	37.7	30.6	31.2	17.9	21.9	28.6	36.8	32.6	35.5	20.8	33.7	44.8	23.6	22.2	41.6	40.4	39.2	37.2	37.6	31.1	47.2	39.2	34.4	26.6	28.9	24.5	47.6	40.9	14.7	23.9	35.5	76.4	38.9	45.8	45.7	36.9	44.8	83.7	47.1	44.4	33.9	86.7	55.6	59.1	61.3	47.8	54.4	79.7	46.1	20.3	9.5	13.0	18.1	14.7	7.9	10.6	11.8	11.6	11.9	10.9	10.7	18.4	66.2	41.7	76.7	65.3	81.1	34.4	67.4	81.6	29.6	92.1	31.7	43.1	97.2	34.3	74.4	44.1	100.1	85.8	78.4	51.8	37.2	57.0	13.9	52.2	60.1	65.2	54.0	57.0	75.7	39.1	58.1	53.0	41.8	60.7	89.3	68.0	49.6	28.1	58.9	131.2	80.7	48.9	71.2	48.7	57.0	13.1	65.9	57.9	24.9	62.8	79.4	54.8	82.4	56.8	99.5	46.4	68.5	67.4	50.0	66.1	59.4	29.9	82.4	90.0	72.3	65.7	70.7	83.0	58.3	32.5	34.1	108.4	66.9	64.1	54.6	88.6
NEMP1	"KIAA0286, TMEM194, TMEM194A"	ENSG00000166881	"Nuclear envelope integral membrane protein 1"	O14524	12	57055643-57088063	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014394	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA014394: AB_2204899"	"unprognostic (9.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (8.36e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.05e-2)"	6.2	5.1	3.3	8.0	3.5	6.8	6.3	3.6	3.9	6.6	3.7	8.7	3.8	8.2	5.3	5.6	6.3	4.3	3.0	3.2	3.3	4.3	6.1	6.3	12.2	3.3	3.2	7.2	4.0	3.7	3.5	7.8	3.7	6.8	6.8	9.3	4.5	5.2	2.3	10.8	7.5	7.4	3.3	7.3	5.4	7.7	3.2	16.1	5.4	3.0	11.6	6.5	5.7	4.2	20.0	16.8	37.5	40.5	12.3	12.0	21.5	30.2	17.1	41.1	33.3	20.0	37.2	47.2	38.1	10.4	35.0	28.8	50.4	13.0	47.0	25.3	22.9	27.9	19.5	10.6	5.2	35.0	30.7	4.1	12.3	33.8	21.0	17.1	11.6	42.2	57.5	91.2	35.0	10.9	38.5	29.7	21.0	18.8	18.4	38.5	53.2	21.5	9.0	12.2	22.3	15.1	25.7	21.3	24.1	26.4	38.5	34.7	8.3	39.0	22.5	36.4	28.6	40.8	83.2	40.5	23.1	32.9	41.1	2.4	0.5	0.8	1.1	1.5	1.5	1.9	1.2	1.5	0.5	1.6	1.8	1.6	0.2	2.4	0.9	0.9	1.2	0.8	3.3	3.5	3.6	3.9	3.2	3.3	3.3	3.2	3.7	3.3	3.2	4.2	4.7	22.4	2.6	0.0	7.1	0.0	3.1	0.0	8.0	2.6	5.0	2.9	1.6	2.8	1.8	5.5	4.2	5.0	4.1	1.4	0.0	1.8	1.2	3.3	4.4	4.0	0.0	12.2	0.0	0.8	3.6	4.4	3.1	3.7	0.0	11.1	5.7	3.6	5.8	1.7	0.0	1.8	0.0	7.1	0.0	1.0	6.2	7.2	0.0	0.0	4.4	3.5	3.1	0.0	0.0	2.0	0.7	5.3	4.9	4.1	1.0	1.3	2.9	4.0	13.1	3.6	3.4	12.2	7.4	7.6	0.0	3.0	4.1	3.1	2.2	2.4
NEMP2	TMEM194B	ENSG00000189362	"Nuclear envelope integral membrane protein 2"	A6NFY4	2	190504338-190534722	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 10.8;NK-cells: 14.4;Spermatocytes: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA057719			Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA057719: AB_2683510"	"unprognostic (3.51e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.65e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.82e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.32e-1)"	1.5	1.7	0.7	2.5	1.0	1.9	1.5	2.7	1.0	1.4	0.1	1.3	0.9	1.3	1.0	1.5	1.1	1.1	1.0	0.6	0.4	1.3	1.8	1.7	3.7	0.7	0.7	0.9	1.2	1.0	1.3	1.0	0.9	1.3	0.9	1.2	2.1	0.6	0.5	2.1	1.6	1.2	0.4	2.3	1.9	3.0	0.8	4.7	1.9	0.7	3.0	1.3	1.6	1.4	5.0	2.7	1.8	2.3	1.0	2.7	4.7	3.5	3.0	3.4	4.3	4.0	6.8	7.3	2.3	1.8	2.4	8.7	2.8	7.6	6.9	5.4	2.4	5.2	2.6	2.8	2.6	5.7	1.7	2.8	3.1	15.9	4.1	3.2	1.6	8.0	4.6	8.3	6.8	2.3	6.3	2.7	1.9	2.7	2.9	2.6	3.9	3.4	3.1	3.7	3.2	2.7	5.6	0.6	5.6	3.0	1.4	6.1	2.9	7.7	6.0	1.5	3.9	4.5	5.4	3.8	6.0	5.8	5.7	0.0	0.4	0.0	1.5	0.4	2.0	1.3	1.7	1.3	0.5	1.9	2.7	2.3	0.1	1.3	0.3	1.9	3.1	1.2	0.7	1.0	2.7	1.0	0.6	0.4	0.7	0.7	0.9	0.4	0.8	1.4	4.5	0.0	0.6	0.0	5.9	0.0	2.1	0.0	4.0	5.5	2.0	1.3	1.6	0.0	0.0	1.8	0.0	3.0	10.8	0.2	0.0	2.0	4.5	0.9	3.3	4.0	0.0	4.6	0.0	2.0	3.1	4.1	2.0	1.2	1.3	5.4	3.9	3.4	2.9	3.3	0.0	1.0	0.0	3.3	0.0	6.2	2.8	3.1	0.0	0.0	2.4	2.5	14.4	0.0	0.0	0.7	1.8	1.2	9.5	2.1	0.6	2.3	0.0	2.0	0.0	4.9	5.1	17.0	6.1	3.9	0.0	1.2	6.4	5.3	1.7	2.2
NEO1	"HsT17534, IGDCC2, NGN, NTN1R2"	ENSG00000067141	"Neogenin 1"	Q92859	15	73051710-73305205	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 231.8;Excitatory neurons: 124.5;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 439.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009320, HPA027804, HPA027805, HPA027806"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		390000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006"	"unprognostic (1.90e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.76e-2)"	"unprognostic (5.44e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.75e-1)"	9.6	7.4	28.9	8.9	43.8	1.5	16.7	38.1	31.4	18.2	10.7	46.0	27.3	19.6	9.9	11.5	21.9	19.6	7.8	29.4	29.2	23.4	8.7	15.9	3.9	34.6	38.0	24.8	17.2	41.8	6.7	1.7	35.6	33.0	55.1	19.5	18.3	36.0	30.9	37.5	26.5	23.3	28.7	5.3	22.9	13.5	36.6	7.2	18.2	24.8	6.2	10.5	9.6	60.0	8.9	42.9	50.1	33.2	29.6	8.6	12.5	3.3	4.1	8.2	1.7	6.4	42.8	2.5	4.9	9.4	30.8	1.9	35.3	19.5	3.5	15.8	26.0	29.0	0.5	6.0	8.6	0.8	0.9	21.3	35.4	1.6	16.2	9.5	0.0	22.3	0.2	53.9	2.0	26.8	10.5	0.7	47.9	6.7	3.6	23.9	26.8	5.8	15.8	23.7	22.7	32.1	40.2	17.6	20.7	39.9	18.6	5.3	0.1	38.0	19.9	12.5	9.3	22.8	45.2	6.2	8.2	8.3	10.9	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	28.9	43.8	38.1	31.4	29.4	29.2	34.6	38.0	35.6	28.7	36.6	60.0	3.1	9.6	10.4	231.8	2.3	14.1	8.2	20.7	13.6	15.7	14.2	18.2	6.9	21.5	11.4	22.0	14.6	0.5	4.8	55.6	1.9	11.6	3.3	14.4	13.4	3.4	60.1	3.0	124.5	6.4	0.8	14.6	20.9	24.6	0.0	11.8	5.7	8.9	0.9	10.1	72.8	51.2	10.2	1.2	2.7	7.1	31.7	1.2	10.6	62.8	0.1	12.5	2.1	120.1	439.4	9.9	40.0	62.8	2.6	11.5	39.6	15.5	12.7	21.9	6.6	22.2	10.2	11.8	20.3	14.7	25.4	0.3	6.0	3.1	60.5	7.2
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002444-113019861	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA069654: AB_2686164"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	6.7	6.7	4.7	7.0	5.4	10.6	8.8	6.9	6.5	6.5	6.3	7.0	7.1	8.4	10.3	6.0	6.5	7.4	8.4	5.2	4.9	6.3	5.9	6.4	12.3	5.8	5.3	8.1	8.2	6.9	6.6	6.7	5.6	6.6	5.4	11.7	6.9	6.1	18.7	10.8	7.0	5.8	5.1	8.8	8.3	11.3	5.3	9.4	11.5	7.7	7.8	6.7	5.3	7.9	13.6	10.9	17.3	13.0	5.5	10.1	9.2	12.6	8.1	6.9	4.7	10.1	8.5	17.6	6.6	4.3	9.6	13.7	12.7	5.8	9.4	3.5	8.0	27.3	10.0	7.5	10.0	17.4	9.4	15.7	10.0	5.5	14.2	18.8	6.1	17.2	9.5	13.5	5.2	8.6	15.1	10.3	18.1	12.0	14.0	12.1	13.7	9.3	7.8	11.2	11.9	17.3	7.3	9.1	21.4	12.7	10.4	14.7	12.4	9.4	9.3	3.6	9.1	13.3	11.2	20.6	15.2	13.6	7.0	1.9	1.3	1.6	2.2	1.6	2.3	1.8	2.6	1.9	1.8	1.4	3.2	3.2	0.8	4.3	0.7	1.3	1.2	1.4	4.7	5.4	6.9	6.5	5.2	4.9	5.8	5.3	5.6	5.1	5.3	7.9	16.3	9.6	12.8	0.0	7.6	0.0	0.0	0.0	0.0	0.0	17.4	16.9	0.0	0.0	10.5	18.4	0.0	18.4	23.4	0.0	17.6	14.1	0.0	11.9	20.7	6.3	0.0	0.0	0.0	12.6	15.5	9.3	0.0	16.1	17.7	24.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	4.5	0.0	0.0	14.8	8.7	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	20.4	9.1	33.9	0.0	0.0
NET1	"ARHGEF8, NET1A"	ENSG00000173848	"Neuroepithelial cell transforming 1"	Q7Z628	10	5412557-5459056	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 252.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020068	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA020068: AB_2670348"	"unprognostic (1.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (8.27e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.46e-1)"	48.8	10.8	35.5	23.4	34.2	40.5	52.8	38.5	57.6	43.7	52.8	92.2	56.2	41.8	56.2	68.4	46.2	35.9	13.2	30.2	32.4	49.3	45.1	22.2	26.7	41.8	37.2	28.5	37.9	5.4	10.6	65.7	43.8	41.3	88.2	6.5	93.1	24.3	25.0	39.8	74.7	36.9	37.5	8.1	77.8	14.4	41.1	30.4	26.2	28.0	33.0	60.8	59.3	40.1	115.9	67.7	45.2	51.0	26.8	11.9	252.9	69.1	37.6	53.4	50.4	36.4	215.2	40.6	27.7	42.4	11.4	185.5	54.9	104.3	63.9	38.1	38.5	77.5	22.9	84.0	7.2	21.5	31.1	18.2	61.0	54.0	12.3	47.6	31.1	42.6	138.5	64.4	30.0	54.3	74.3	30.6	61.5	158.6	51.0	45.0	85.0	32.4	33.4	57.6	38.5	20.6	60.7	110.9	20.3	76.2	36.7	65.3	29.5	20.3	30.9	30.7	56.0	39.3	23.1	53.4	18.1	33.1	43.4	2.0	0.6	1.4	0.6	1.0	0.0	1.4	1.2	0.4	4.9	0.6	8.7	1.7	0.1	0.8	0.4	2.0	4.0	2.2	35.5	34.2	38.5	57.6	30.2	32.4	41.8	37.2	43.8	37.5	41.1	40.1	18.4	32.1	55.8	2.6	12.7	40.3	127.2	49.0	103.0	11.0	52.6	28.3	12.1	41.5	84.3	12.9	4.2	110.2	8.4	242.2	5.9	13.1	2.4	97.7	30.6	42.7	80.8	54.1	5.1	24.4	109.1	33.2	107.0	131.4	15.2	16.9	12.5	55.7	14.5	3.3	7.7	145.3	34.6	10.5	59.8	2.4	21.8	31.2	35.6	44.0	48.7	3.8	0.0	8.5	5.7	62.1	148.3	87.6	39.2	67.8	123.6	29.2	85.7	3.5	111.7	183.0	185.0	26.3	16.0	158.1	32.4	117.5	9.3	2.9	145.0	186.5
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988279-75018893	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Spermatocytes: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	3.2	12.7	8.1	6.4	9.7	23.7	6.5	5.1	10.8	3.8	2.9	4.2	4.3	4.9	5.2	2.6	4.2	4.5	6.2	5.3	5.0	5.1	8.2	5.1	8.3	4.1	4.0	8.0	6.1	10.4	5.7	3.9	5.4	11.5	6.4	10.4	4.2	3.2	26.4	8.0	4.3	4.8	1.1	6.2	4.8	13.9	5.1	12.3	8.1	22.6	7.8	3.5	2.5	7.5	9.1	8.2	6.7	11.7	5.2	4.4	7.1	8.7	5.7	9.4	7.7	24.3	7.2	25.7	8.5	7.2	12.9	8.1	16.1	11.4	14.7	13.2	7.9	21.8	14.4	10.8	5.6	34.7	19.3	5.5	9.4	9.9	15.0	6.5	7.2	37.3	35.1	17.5	11.2	9.7	33.1	16.8	8.0	18.5	10.3	27.0	17.5	22.2	12.8	9.3	12.0	7.2	13.7	8.4	37.0	8.0	18.9	8.2	10.4	11.6	11.7	8.0	9.1	15.5	15.8	51.8	3.6	17.2	9.8	1.2	2.6	2.4	1.5	1.4	1.1	1.0	1.2	1.5	1.5	1.2	1.2	1.5	1.5	0.5	1.8	1.1	0.9	0.9	8.1	9.7	5.1	10.8	5.3	5.0	4.1	4.0	5.4	1.1	5.1	7.5	1.4	3.2	4.6	4.6	5.3	0.5	2.0	0.4	0.6	8.6	3.5	3.9	7.7	2.8	2.7	1.8	62.6	2.1	4.1	1.0	0.0	1.2	9.2	2.2	2.3	2.3	7.2	5.0	12.5	3.1	1.4	2.1	3.1	2.7	1.3	3.7	3.6	6.9	5.4	11.8	10.3	2.9	2.0	10.1	1.1	7.6	1.5	6.2	0.0	8.4	6.8	3.4	3.1	9.5	9.9	2.6	1.0	1.9	5.8	3.0	1.6	3.7	1.6	6.4	0.0	5.8	1.8	32.0	2.2	1.6	0.6	1.4	3.9	3.8	2.8	0.6
NEUROG1	"AKA, bHLHa6, Math4C, NEUROD3, ngn1"	ENSG00000181965	"Neurogenin 1"	Q92886	5	135534282-135535964	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"Bipolar cells: 9.1"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072232			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA						"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Nuclear bodies"	"HPA072232: "															"unprognostic (3.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEUROG3	"Atoh5, bHLHa7, Math4B, ngn3"	ENSG00000122859	"Neurogenin 3"	Q9Y4Z2	10	69571698-69573422	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 5.4;intestine: 2.6"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 9.5;Enteroendocrine cells: 5.3"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.4"	"Group enriched"	"Detected in some"	20	"cerebral cortex: 4.5;hippocampal formation: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"THP-1: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039785	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"	Nucleoplasm	"HPA039785: AB_10795114"	"unprognostic (1.22e-2)"		"unprognostic (7.33e-2)"		"unprognostic (3.04e-2)"			"unprognostic (2.42e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"		"unprognostic (5.85e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.19e-1)"			0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.5	0.0	0.0	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	4.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925472	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast glandular cells: 1.4;Club cells: 2.5;Hofbauer cells: 1.3;Respiratory ciliated cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HAP1: 3.7;Karpas-707: 5.9;SiHa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: AB_2665984"	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.1	0.9	3.0	0.1	3.1	0.0	0.3	1.0	2.5	0.4	0.0	0.8	0.1	0.5	0.2	0.3	0.3	0.1	0.0	2.6	6.7	0.7	0.0	0.1	0.1	0.3	0.7	0.4	1.5	1.8	1.7	0.1	0.5	0.9	0.3	1.0	0.4	0.6	0.0	0.3	0.4	0.7	0.2	0.1	0.6	0.2	4.8	0.0	0.4	0.1	0.1	0.2	0.2	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.9	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.1	1.0	2.5	2.6	6.7	0.3	0.7	0.5	0.2	4.8	0.7	0.3	0.0	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NF2	"ACN, BANF, merlin, SCH"	ENSG00000186575	"Neurofibromin 2"	P35240	22	29603556-29698598	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.1;Late spermatids: 121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003097, CAB005385"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB005385: AB_2298548, HPA003097: AB_1079473"	"unprognostic (3.27e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.66e-1)"	"prognostic favorable (2.89e-5)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.62e-2)"	8.8	13.6	19.7	8.4	17.2	8.0	7.6	13.6	28.7	8.9	10.7	10.8	6.2	11.1	6.2	13.4	8.6	5.3	21.4	27.3	13.9	17.2	10.5	9.3	6.4	14.4	18.1	8.5	12.7	27.4	9.5	4.6	14.3	9.9	5.4	7.3	8.5	6.7	22.8	10.2	8.8	8.0	14.3	9.9	10.0	20.9	17.6	9.3	11.1	19.1	7.1	9.3	7.7	16.6	75.8	36.7	12.2	74.3	21.5	22.0	7.7	57.3	37.9	74.1	53.7	32.7	18.4	21.1	50.4	69.9	48.9	27.1	25.1	37.8	52.0	31.9	12.5	26.8	24.4	26.4	22.4	35.1	28.6	20.1	16.4	53.3	51.0	21.8	47.7	13.7	12.0	18.7	64.5	35.1	21.4	16.6	8.3	16.9	20.4	24.2	56.8	18.8	68.5	37.3	17.0	11.6	36.0	24.5	14.0	9.4	14.9	15.4	92.7	101.1	109.6	44.8	112.5	30.0	26.7	25.5	27.0	14.5	68.5	10.0	10.0	4.2	15.5	14.7	13.1	8.3	11.5	10.4	15.1	8.6	9.7	9.2	2.3	13.2	21.0	10.2	10.7	12.2	19.7	17.2	13.6	28.7	27.3	13.9	14.4	18.1	14.3	14.3	17.6	16.6	8.1	6.4	20.1	14.7	9.4	14.1	11.6	9.8	8.6	16.3	14.5	9.0	23.1	18.6	10.0	14.7	10.4	11.7	12.7	9.0	21.5	40.0	77.1	14.5	17.7	13.2	13.1	13.9	27.5	24.9	6.7	12.5	7.7	15.2	22.9	12.2	11.7	14.4	13.5	30.3	27.1	7.9	6.1	14.7	7.5	121.4	7.2	10.2	8.8	18.7	8.6	19.1	14.4	17.6	16.7	40.1	14.5	12.4	14.7	13.6	10.5	30.1	8.6	9.6	6.6	13.7	15.6	29.5	8.1	15.5	14.3	3.8	12.9	17.4	11.2	9.5
NFAT5	"KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP"	ENSG00000102908	"Nuclear factor of activated T cells 5"	O94916	16	69565094-69704666	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 281.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057304, HPA069711"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA057304: AB_2683407, HPA069711: AB_2686180"	"unprognostic (2.71e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.42e-2)"	2.3	3.1	0.6	2.8	1.2	5.6	2.1	0.5	3.7	3.7	0.0	2.0	0.7	3.3	0.7	2.9	1.9	1.5	2.0	1.4	2.2	2.6	2.3	3.1	1.1	0.0	0.6	2.5	1.6	4.0	2.0	4.2	0.0	2.3	1.5	4.2	3.7	2.4	2.7	3.5	1.9	1.8	0.0	2.5	2.3	1.4	3.0	2.2	3.6	4.8	1.4	2.7	3.1	0.0	8.4	10.1	4.8	5.0	5.8	6.0	6.4	7.2	8.6	6.6	4.2	4.5	4.2	4.5	5.8	5.8	3.4	7.3	3.9	3.1	4.2	2.9	3.2	2.6	2.8	6.2	3.4	3.5	5.5	3.5	1.1	6.4	5.9	5.4	5.5	2.3	7.2	1.1	3.3	3.2	2.8	1.7	2.5	1.1	2.5	4.5	2.2	1.7	2.5	8.0	3.1	0.9	22.2	1.3	2.6	4.1	3.3	1.3	13.1	5.7	5.6	4.8	2.2	4.6	4.9	7.3	5.1	3.4	3.6	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.2	0.1	0.0	0.9	0.0	0.2	0.5	0.1	0.0	0.6	1.2	0.5	3.7	1.4	2.2	0.0	0.6	0.0	0.0	3.0	0.0	65.0	48.1	49.7	236.7	55.7	148.1	94.8	42.5	155.4	51.8	61.6	42.9	9.2	30.0	43.3	145.3	85.5	60.6	69.4	27.8	5.9	17.8	7.2	93.7	87.8	93.6	24.5	27.3	281.8	12.7	15.9	60.9	38.2	158.3	19.7	31.0	52.8	28.3	17.6	60.6	189.3	29.1	28.5	21.7	169.5	6.9	59.4	58.2	58.7	172.4	37.4	45.7	36.0	177.4	167.2	23.7	29.3	54.9	50.2	83.1	24.7	14.6	31.8	62.4	26.3	72.0	51.4	84.5	48.8	77.9	140.1	50.9	57.4	43.1	20.8	105.7
NFATC1	"NF-ATC, NFAT2, NFATc"	ENSG00000131196	"Nuclear factor of activated T cells 1"	O95644	18	79395856-79529325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 50.4;Skeletal myocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004513, HPA071732"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	Nucleoplasm	"CAB004513: AB_628011, HPA071732: AB_2686439"	"unprognostic (3.53e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.08e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.85e-3)"	"unprognostic (7.02e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.11e-3)"	12.8	4.6	4.8	11.7	6.0	3.9	10.6	5.6	4.1	6.0	27.9	10.1	3.0	7.7	0.9	3.0	8.0	10.0	15.5	4.3	5.4	4.8	2.7	13.6	21.2	8.3	7.2	7.2	7.0	4.1	3.4	4.1	6.4	6.4	1.5	0.5	6.4	2.9	32.7	10.6	13.2	3.2	7.5	18.7	5.4	8.5	7.2	8.3	7.7	9.3	13.5	7.1	6.1	6.4	0.0	4.0	1.9	3.6	3.3	3.6	6.9	2.4	0.3	0.6	0.3	0.3	3.6	22.0	1.5	3.2	5.6	0.4	9.9	0.0	0.8	15.3	8.0	15.4	0.9	0.1	7.3	4.9	8.2	4.3	0.0	1.2	0.1	0.0	12.2	9.0	12.5	4.5	2.4	8.4	12.8	1.7	3.5	2.9	2.6	4.0	2.5	5.0	1.8	1.6	0.0	0.0	3.2	2.6	5.6	4.2	3.2	19.7	11.4	5.0	20.9	0.0	0.3	0.1	0.1	60.2	0.0	6.6	9.3	1.8	3.4	7.5	4.0	9.1	4.2	7.6	6.2	5.5	3.1	10.0	5.2	3.7	2.9	2.1	13.6	3.0	5.0	4.7	4.8	6.0	5.6	4.1	4.3	5.4	8.3	7.2	6.4	7.5	7.2	6.4	19.4	0.0	6.0	13.4	50.4	37.2	30.0	7.0	6.2	0.1	19.2	13.5	8.4	5.7	8.1	0.0	0.0	0.3	11.8	0.1	0.0	5.7	12.1	10.6	5.4	25.2	0.0	5.9	0.2	4.0	7.2	24.3	8.6	16.1	31.8	1.2	39.3	0.6	12.3	0.0	0.2	0.0	2.0	12.6	35.4	20.3	8.4	21.9	10.6	9.4	6.9	2.5	13.4	4.0	1.3	4.9	0.0	9.8	8.9	12.0	0.0	0.5	4.4	0.1	0.0	52.1	14.2	11.4	13.2	1.5	29.7	0.5	29.4	2.1	0.1	7.7
NFATC2	"NF-ATP, NFAT1, NFATp"	ENSG00000101096	"Nuclear factor of activated T cells 2"	Q13469	20	51386957-51562831	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 26.0"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 96.5;NK-cells: 105.0;Skeletal myocytes: 152.0;T-cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 24.5;HMC-1: 26.8;SK-MEL-30: 20.4;WM-115: 41.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008789, CAB018567, HPA024369"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"		"CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413"	"unprognostic (2.69e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.59e-2)"	7.6	2.1	2.8	7.4	5.4	4.8	4.6	2.8	3.2	3.8	26.0	4.2	7.9	3.9	3.4	3.6	4.2	16.5	3.1	2.1	3.6	1.7	6.1	4.8	16.1	6.5	7.4	2.1	8.0	3.1	1.4	7.5	4.6	2.4	3.7	0.1	4.8	2.5	3.3	3.8	6.1	2.8	3.5	12.6	10.7	1.6	6.7	5.0	3.5	0.9	13.6	6.5	2.0	3.7	2.7	2.9	0.0	3.6	0.0	0.0	7.5	0.4	1.9	1.2	0.6	14.0	2.5	18.7	2.1	0.9	2.5	0.0	0.9	0.0	1.1	24.5	0.4	8.0	2.1	3.6	0.0	2.2	26.8	0.0	0.0	1.0	0.1	0.2	8.4	6.5	8.0	12.1	0.0	3.1	3.3	13.3	0.3	1.7	6.6	1.4	0.0	8.3	0.4	0.0	0.3	0.0	8.6	2.1	20.4	1.7	3.3	5.3	0.9	1.7	3.0	4.1	0.2	10.2	7.2	18.6	1.7	8.7	41.1	0.4	0.0	3.1	5.3	0.5	2.2	1.3	2.9	4.3	1.2	1.1	1.6	3.0	0.1	5.7	0.2	0.5	1.7	1.3	2.8	5.4	2.8	3.2	2.1	3.6	6.5	7.4	4.6	3.5	6.7	3.7	16.0	6.4	5.4	14.0	38.1	14.4	16.1	0.9	0.6	0.0	8.7	4.3	3.6	4.3	5.6	0.0	0.0	3.3	42.7	1.9	1.9	3.7	1.6	13.1	12.1	28.0	7.8	18.1	1.7	5.6	0.8	37.2	23.4	12.2	15.2	0.2	30.7	7.5	37.1	0.0	1.0	6.2	0.0	32.5	56.6	0.8	2.1	19.0	62.2	96.5	5.0	0.0	105.0	2.5	5.0	11.4	1.8	0.4	55.8	5.3	1.4	0.3	9.3	0.0	0.0	152.0	15.2	0.4	0.7	3.8	12.9	1.0	65.5	0.0	7.0	6.6
NFATC2IP	"ESC2, FLJ14639, NIP45, RAD60"	ENSG00000176953	"Nuclear factor of activated T cells 2 interacting protein"	Q8NCF5	16	28950807-28967097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053587			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053587: AB_2682202"	"unprognostic (6.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.90e-1)"	"unprognostic (7.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (5.23e-4)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (8.00e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.25e-1)"	"unprognostic (5.94e-2)"	20.9	16.6	10.4	27.6	10.5	48.6	21.7	15.6	11.0	25.2	9.9	30.6	21.1	23.3	14.4	29.0	24.5	14.3	20.9	11.0	9.1	26.0	27.9	25.8	36.6	11.1	10.6	24.1	22.7	20.0	15.0	15.5	11.1	23.9	32.2	26.6	24.3	15.5	25.7	32.5	36.9	22.8	9.8	45.4	25.9	30.3	12.1	34.3	22.0	15.8	38.5	26.0	23.5	11.7	38.6	27.2	36.5	36.7	21.7	22.8	46.0	36.7	27.6	42.1	53.7	32.0	47.0	41.1	27.0	26.4	25.6	44.8	44.3	40.3	56.9	35.0	32.4	37.5	81.2	39.8	13.9	34.1	55.0	16.1	32.1	45.9	27.6	20.8	34.3	40.9	34.4	49.5	37.8	47.9	44.9	60.2	35.9	30.9	32.0	77.0	32.4	37.5	30.2	34.2	28.0	20.0	24.7	37.7	14.4	29.6	39.1	25.2	38.1	46.3	26.1	36.5	28.1	36.5	51.5	49.7	25.6	55.5	27.8	5.0	1.5	1.8	1.9	2.0	1.8	1.5	1.4	2.3	0.9	1.5	2.3	2.0	1.1	2.8	1.2	3.2	2.4	0.7	10.4	10.5	15.6	11.0	11.0	9.1	11.1	10.6	11.1	9.8	12.1	11.7	40.9	35.3	52.2	15.7	43.1	31.7	23.0	19.1	33.0	63.1	29.4	25.7	17.4	21.5	29.8	29.5	100.1	30.1	69.8	51.3	19.6	21.9	6.3	28.3	43.6	35.1	40.9	77.2	21.3	22.9	30.5	23.3	50.0	37.6	36.7	69.5	38.9	26.0	23.2	43.7	27.0	63.1	18.3	38.8	32.2	7.6	29.5	37.8	23.2	26.2	56.7	15.3	57.7	19.6	18.2	44.6	31.6	20.3	55.4	40.4	40.7	17.8	21.7	84.5	39.5	26.7	26.6	95.0	92.2	35.7	30.3	26.1	51.4	38.3	53.0	42.1
NFATC3	"NFAT4, NFATX"	ENSG00000072736	"Nuclear factor of activated T cells 3"	Q12968	16	68084751-68229259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 102.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 105.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050665			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA050665: AB_2681210"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-1)"	10.5	6.5	11.3	12.0	13.2	23.0	11.3	15.0	12.3	11.4	13.0	9.2	11.8	10.0	9.1	10.7	10.6	8.4	7.2	10.2	11.2	11.0	19.8	17.6	23.4	13.1	12.4	11.7	11.6	23.1	5.1	11.2	12.5	10.3	10.2	10.4	10.6	9.8	28.6	22.6	11.7	11.4	11.6	17.6	9.1	27.2	12.2	102.0	14.0	22.2	22.8	9.4	6.9	14.6	12.8	15.5	24.6	26.3	20.9	13.6	21.4	8.3	10.7	23.6	19.9	21.4	11.0	43.0	12.4	14.1	7.7	18.7	29.0	14.4	22.1	8.6	18.9	44.0	15.2	48.3	13.6	37.1	105.0	10.2	17.4	23.5	12.6	12.1	20.0	35.4	54.5	12.7	17.3	25.5	60.5	51.0	15.0	19.4	7.7	34.3	23.0	44.7	9.9	14.4	17.7	18.5	62.6	15.0	8.1	14.3	20.7	28.4	11.9	12.0	12.5	14.2	12.5	16.2	30.7	77.7	9.3	34.9	16.6	17.7	3.5	7.7	20.4	5.3	19.3	7.3	11.6	20.5	4.1	8.2	11.6	18.3	4.7	20.4	11.2	4.4	8.5	15.0	11.3	13.2	15.0	12.3	10.2	11.2	13.1	12.4	12.5	11.6	12.2	14.6	26.4	35.3	49.5	50.3	41.8	78.4	41.7	39.4	33.0	28.8	64.0	36.4	1.5	78.6	32.5	58.8	33.3	53.1	64.9	20.8	23.5	27.2	155.3	33.8	17.0	27.2	26.0	34.0	46.2	21.9	16.0	19.7	7.1	37.4	49.4	24.3	37.1	117.0	23.7	37.0	53.8	37.3	34.6	51.0	28.9	99.9	21.8	29.5	23.2	91.8	40.6	9.1	129.8	45.8	73.5	33.1	33.1	26.7	28.6	75.3	57.6	53.5	31.3	27.3	19.7	27.9	18.0	68.6	61.7	25.9	143.2	85.0	59.4	19.7	39.1	58.1
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301015	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 112.5;lymphoid tissue: 45.3"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 1489.2;neutrophil: 810.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1489.2"	"Group enriched"	"Detected in some"	5	"HEL: 376.9;K-562: 168.1;NB-4: 118.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Actin filaments"		"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	3.8	0.3	0.5	6.2	0.7	112.5	0.6	0.5	1.0	1.4	1.4	0.4	0.5	0.3	0.1	0.8	2.4	1.2	1.9	0.5	0.5	1.4	2.6	13.0	0.3	0.7	0.6	0.2	0.7	1.1	0.9	4.0	0.7	0.5	0.2	0.0	0.5	0.1	1.3	4.8	0.6	1.9	0.5	45.3	0.8	1.2	0.6	1.4	1.4	3.7	0.1	2.3	0.5	0.6	0.3	0.3	0.0	0.0	0.0	0.5	1.4	1.1	6.9	0.7	0.9	5.5	10.0	0.1	0.9	0.9	0.4	0.3	0.0	0.0	0.3	0.0	0.1	376.9	0.9	9.1	0.0	5.8	48.5	0.5	0.1	0.3	0.2	4.4	0.0	0.1	168.1	0.1	0.0	0.1	15.3	118.8	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.2	0.6	1.8	1.0	18.9	0.3	0.2	0.4	1.1	0.1	0.0	0.0	0.1	0.4	23.4	0.0	1489.2	241.7	232.3	0.6	66.7	1.0	0.3	0.8	0.5	156.7	0.5	1.0	0.7	810.6	1.1	42.0	2.7	0.2	160.2	0.5	0.7	0.5	1.0	0.5	0.5	0.7	0.6	0.7	0.5	0.6	0.6	0.0	0.0	3.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.1	5.9	0.1	0.0	0.0	0.0	265.6	0.0	0.0	0.5	0.4	0.0	0.1	3.8	0.1	0.4	0.2	1.0	0.0	0.0	0.0	0.0	22.8	0.2	19.0	0.0	44.3	1.8	0.0	33.9	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.3	1.2	1.1	0.0	0.1	0.1
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061545	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1357.5;tongue: 858.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063384: AB_2684998, HPA065424: AB_2685488"	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	154.3	130.5	109.3	75.0	99.3	31.1	91.1	101.6	98.3	103.5	225.0	107.6	106.0	149.4	88.2	126.0	130.6	97.3	430.8	112.4	146.3	159.6	104.0	83.3	63.8	135.0	131.1	148.8	65.2	115.2	82.5	100.6	131.0	95.7	80.1	67.1	92.1	123.5	1357.5	121.1	113.3	141.0	116.3	113.0	79.0	69.3	126.8	62.3	132.6	858.4	59.2	89.7	86.3	138.2	122.2	265.4	172.0	147.4	349.8	168.2	128.6	193.7	269.2	135.1	149.8	327.6	137.6	139.8	379.2	244.6	175.2	245.5	122.5	154.5	144.7	239.9	104.1	78.8	181.0	111.1	418.6	178.0	122.1	232.6	380.7	246.7	267.2	228.7	214.6	93.5	142.5	377.4	169.4	103.3	115.5	56.0	113.0	110.0	101.4	80.1	241.8	136.4	150.0	181.0	105.8	160.2	132.4	89.0	272.4	222.5	175.7	120.5	291.2	324.2	141.4	112.3	197.4	626.6	460.1	134.1	310.4	73.6	191.3	14.2	11.8	4.0	3.4	6.5	2.0	5.2	3.1	3.5	2.6	4.9	2.4	2.7	26.1	3.0	8.7	12.9	1.2	1.3	109.3	99.3	101.6	98.3	112.4	146.3	135.0	131.1	131.0	116.3	126.8	138.2	60.1	57.7	49.4	25.1	15.8	55.7	19.3	45.0	34.1	68.8	39.2	33.8	303.1	50.1	34.4	77.3	35.5	22.7	14.7	150.7	25.4	41.3	8.1	57.9	92.0	66.3	30.1	11.6	24.5	36.2	21.5	47.9	27.5	58.8	28.4	89.3	80.3	126.7	36.0	72.3	28.0	51.5	38.7	32.8	18.9	10.6	102.2	23.8	21.4	20.6	31.5	25.4	15.5	9.0	14.4	51.8	64.8	83.8	17.4	33.8	100.3	39.1	49.5	34.8	59.2	39.3	53.8	30.0	35.5	25.9	48.4	22.3	14.2	44.6	49.4	24.4
NFE2L2	NRF2	ENSG00000116044	"Nuclear factor, erythroid 2 like 2"	Q16236	2	177227595-177392697	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002990, CAB020317, HPA043438"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB020317: , HPA002990: AB_1079476, HPA043438: AB_2678482"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.77e-3)"	87.0	73.6	64.8	65.4	83.9	58.9	78.3	74.9	86.7	83.2	78.7	83.4	100.1	92.6	97.2	257.0	88.5	97.7	77.6	66.5	71.6	143.5	176.6	88.5	50.4	82.0	77.5	137.3	47.3	60.4	58.4	80.4	84.5	72.7	85.8	68.2	79.7	90.5	64.4	162.3	82.9	91.8	70.4	69.0	176.9	65.2	75.7	68.2	130.4	65.9	93.8	160.7	108.7	91.8	53.1	57.3	52.2	56.4	181.4	190.2	61.7	91.8	124.9	81.4	90.5	75.9	97.9	52.8	93.8	102.8	148.4	96.9	65.1	136.7	111.5	40.8	41.1	65.9	95.9	156.3	231.2	39.3	60.6	134.0	314.5	115.5	169.3	184.4	80.9	39.7	72.7	91.4	111.8	49.8	42.3	101.9	58.8	277.2	58.9	34.0	46.5	54.6	120.9	182.1	69.0	45.0	202.9	64.8	216.6	147.8	49.1	105.0	119.9	80.4	54.5	89.5	54.7	70.1	44.7	43.1	81.6	43.3	159.4	130.6	89.3	55.4	55.2	84.3	62.9	61.8	64.0	57.0	100.4	51.9	101.2	66.8	103.2	68.1	83.0	38.8	66.6	66.0	64.8	83.9	74.9	86.7	66.5	71.6	82.0	77.5	84.5	70.4	75.7	91.8	193.3	157.0	93.5	66.3	143.3	295.8	241.8	448.4	306.7	61.3	90.0	113.7	67.9	117.2	247.0	154.5	16.7	113.2	249.1	120.7	393.2	154.5	81.4	238.1	126.9	139.6	75.6	58.0	25.3	170.8	34.5	206.6	170.7	279.9	212.7	141.5	120.0	93.2	88.1	57.2	26.6	73.5	321.4	111.6	569.9	39.0	287.7	266.0	96.0	88.1	170.6	191.4	55.6	63.8	113.0	128.3	91.8	214.0	118.8	150.5	94.9	85.0	205.9	48.4	39.5	211.8	152.4	66.1	32.1	617.9	315.4	186.2	150.6	153.5	119.6	225.2
NFE2L3	Nrf3	ENSG00000050344	"Nuclear factor, erythroid 2 like 3"	Q9Y4A8	7	26152198-26187137	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7;placenta: 34.4"	"Group enriched"	"Detected in many"	14	"Cytotrophoblasts: 305.9;Syncytiotrophoblasts: 698.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 133.5;NTERA-2: 113.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055889	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Vesicles"		"HPA055889: AB_2682958"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.88e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (7.58e-12)"	"prognostic favorable (2.14e-4)"	"unprognostic (2.40e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.13e-3)"	3.6	3.1	4.2	10.6	7.3	2.5	2.2	19.5	19.7	1.5	2.3	6.3	8.0	2.2	0.2	2.4	1.6	4.3	1.4	6.3	4.8	2.5	1.6	4.8	8.0	7.0	4.6	1.1	4.8	0.4	1.3	34.4	7.2	1.4	4.8	5.1	3.2	0.6	2.7	7.3	5.7	1.0	5.1	7.6	7.3	1.4	6.3	5.9	1.0	0.2	7.0	4.8	1.5	10.8	40.9	3.5	1.6	4.0	0.0	0.0	133.5	7.9	15.2	15.0	27.3	26.2	68.8	3.0	51.2	0.8	57.5	8.6	6.0	13.4	33.7	27.9	8.5	5.7	7.0	19.8	10.5	5.0	52.3	1.3	1.6	6.2	2.3	22.4	35.0	11.3	8.6	69.9	3.0	5.5	3.5	8.8	113.9	11.1	13.9	5.0	0.4	20.5	20.5	40.5	12.3	14.7	0.2	3.2	1.2	37.5	1.9	3.0	76.0	1.4	2.3	0.6	32.6	42.0	72.2	3.4	0.2	17.5	53.1	0.0	0.2	0.0	0.1	0.2	0.3	0.2	0.4	0.2	0.6	0.2	0.2	0.1	0.1	0.2	0.0	0.2	0.6	0.1	4.2	7.3	19.5	19.7	6.3	4.8	7.0	4.6	7.2	5.1	6.3	10.8	14.6	6.4	2.8	3.9	4.6	1.8	4.2	12.7	5.2	1.4	3.1	2.3	1.9	14.3	6.9	11.0	0.0	305.9	1.6	6.1	0.0	13.0	1.0	6.1	1.8	7.6	1.2	12.0	3.8	5.3	33.9	2.8	14.3	6.4	27.9	35.2	2.2	0.3	24.3	0.0	4.4	6.6	12.2	15.6	17.2	0.3	0.0	16.7	1.8	2.8	11.1	1.1	4.1	1.5	11.6	15.6	4.1	0.0	18.2	10.4	2.7	0.5	8.9	1.9	0.0	2.9	2.7	0.6	7.1	5.5	1.6	698.6	9.0	4.8	9.8	6.7
NFIA	"KIAA1439, NFI-L"	ENSG00000162599	"Nuclear factor I A"	Q12857	1	60865259-61462788	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 75.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 777.3;Oligodendrocyte precursor cells: 606.7;Peritubular cells: 438.5;Skeletal myocytes: 513.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006111, HPA008884"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA006111: AB_1854422, HPA008884: AB_1854421"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.20e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (2.03e-4)"	23.0	12.4	28.4	5.2	37.7	10.0	15.1	75.9	24.6	18.3	31.8	14.2	7.2	8.9	11.7	18.8	15.6	14.3	16.9	28.4	31.3	10.8	40.5	8.4	5.1	51.5	33.4	15.7	13.5	10.9	5.4	4.3	34.9	15.0	9.1	4.2	17.5	11.6	13.8	8.7	6.4	13.2	37.3	9.4	9.7	5.8	33.6	8.6	27.4	15.8	6.8	13.8	10.3	27.1	5.0	6.8	1.0	74.2	31.8	20.2	0.2	1.6	5.1	1.6	2.4	0.4	4.8	10.9	4.8	2.7	0.7	7.2	3.1	15.4	0.9	23.4	6.6	0.4	15.2	4.8	7.3	1.2	1.8	25.7	14.9	6.8	27.6	5.5	19.1	3.0	5.1	16.9	1.5	3.6	0.3	0.3	2.9	6.9	6.6	1.1	6.9	18.2	4.3	13.1	4.8	5.7	4.1	28.2	10.3	0.8	30.2	0.5	15.5	1.3	8.5	15.2	3.1	1.2	3.1	0.1	1.7	0.2	1.7	3.2	2.7	1.5	1.9	1.9	2.9	0.6	2.3	3.0	1.3	0.3	2.2	2.7	0.1	0.5	2.5	1.0	0.1	1.8	28.4	37.7	75.9	24.6	28.4	31.3	51.5	33.4	34.9	37.3	33.6	27.1	232.1	35.3	44.7	777.3	4.4	85.0	68.8	72.1	220.9	42.6	140.7	107.4	192.9	148.7	68.1	47.8	2.1	5.7	8.1	28.4	27.4	38.0	28.9	85.8	69.8	132.7	25.2	163.7	142.3	47.8	1.1	265.6	30.5	68.2	27.3	11.6	197.0	304.5	14.8	42.1	125.7	46.8	36.7	60.8	42.6	26.4	408.8	19.2	46.2	259.5	14.9	150.2	5.2	606.7	431.3	20.8	37.6	438.5	8.0	53.0	19.1	109.9	82.6	6.9	144.7	513.1	133.7	5.0	13.5	148.4	76.3	1.6	15.0	34.9	69.7	57.1
NFIB	"NFI-RED, NFIB2, NFIB3"	ENSG00000147862	"Nuclear factor I B"	O00712	9	14081843-14398983	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 542.6;Oligodendrocyte precursor cells: 565.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 160.3;HBEC3-KT: 65.9;HEL: 61.3;HUVEC TERT2: 64.8;TIME: 64.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003956	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA003956: AB_1854424"	"unprognostic (1.93e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-3)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (3.53e-4)"	"unprognostic (4.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.62e-1)"	28.3	8.8	22.6	7.2	19.3	0.2	36.8	35.7	25.9	12.5	5.8	16.8	10.1	13.0	15.1	9.8	17.5	15.9	25.7	23.7	9.1	16.7	20.3	15.9	7.8	13.2	14.7	14.1	15.6	5.0	4.9	13.0	13.1	20.3	8.7	10.0	39.7	16.9	21.5	22.0	13.0	15.7	17.6	9.7	14.2	2.4	10.9	7.1	17.4	18.9	5.6	17.7	13.3	15.2	19.7	14.7	8.6	160.3	39.8	22.9	0.5	0.5	0.0	3.7	13.7	0.2	7.9	0.5	12.1	1.2	12.0	4.3	7.8	65.9	7.3	2.8	7.4	61.3	31.6	1.8	13.2	1.8	0.3	20.3	9.0	14.2	49.5	15.4	64.8	0.0	1.8	0.5	5.3	9.0	0.1	0.4	3.0	8.8	15.9	0.2	7.5	0.2	11.9	7.4	13.5	49.9	13.5	16.9	5.7	0.5	34.0	0.1	64.6	12.1	18.1	9.7	12.2	1.6	1.4	4.8	11.2	0.3	15.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	22.6	19.3	35.7	25.9	23.7	9.1	13.2	14.7	13.1	17.6	10.9	15.2	328.7	51.3	31.4	542.6	4.6	268.9	165.7	63.0	115.5	60.8	238.6	317.4	195.6	214.4	59.1	46.0	0.0	5.1	2.1	42.1	39.2	70.7	3.6	147.8	39.0	230.9	22.8	2.7	278.5	125.2	1.2	190.9	62.2	135.9	3.8	5.7	228.5	104.0	2.2	0.0	352.9	35.4	28.5	8.4	48.9	5.0	133.9	7.3	94.3	157.4	1.7	238.0	0.0	565.5	206.0	68.1	48.7	48.5	4.1	166.2	101.9	190.7	55.6	11.5	85.5	270.5	160.8	0.9	9.7	78.6	169.2	1.6	7.1	6.5	74.2	64.3
NFIC	"CTF, CTF5, NF-I, NFI"	ENSG00000141905	"Nuclear factor I C"	P08651	19	3314403-3469217	"Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 293.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 168.4;U-2197: 164.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004300, CAB004674, HPA052625"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004300: , CAB004674: AB_425564, HPA052625: AB_2681889"	"unprognostic (2.59e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (1.52e-6)"	"unprognostic (8.38e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.80e-3)"	42.9	51.0	18.8	18.0	28.4	9.3	38.5	27.2	46.4	50.5	14.1	58.9	9.2	53.6	10.1	32.5	44.7	16.3	62.6	15.5	17.1	21.2	56.8	34.7	6.3	40.0	33.6	52.3	68.7	29.5	29.2	7.5	39.4	39.2	7.7	10.5	45.3	33.1	293.6	42.0	22.9	28.8	31.4	20.1	43.1	13.1	35.7	7.8	33.7	63.1	5.7	46.3	36.3	30.0	63.5	92.8	1.1	53.7	47.9	41.2	5.6	55.6	30.3	36.9	25.7	2.3	20.8	0.5	19.2	51.1	26.4	30.1	15.4	37.8	15.6	44.6	13.7	11.6	75.1	19.2	37.2	19.0	22.8	34.8	25.9	50.2	19.8	24.3	34.9	3.6	32.8	55.3	28.1	45.7	11.1	4.0	3.0	2.8	37.8	28.1	34.0	23.1	14.7	13.3	12.6	32.1	168.4	16.4	17.0	0.8	48.7	14.1	49.5	61.7	56.2	164.1	76.3	1.9	2.5	0.5	83.9	38.6	91.8	1.5	4.1	1.8	2.3	4.0	1.9	1.5	2.2	2.2	3.1	1.6	1.5	1.5	8.7	5.9	0.9	1.2	0.8	3.0	18.8	28.4	27.2	46.4	15.5	17.1	40.0	33.6	39.4	31.4	35.7	30.0	96.4	80.1	82.6	40.8	18.9	100.1	136.5	85.5	174.8	189.5	117.1	101.2	124.8	270.2	50.0	92.0	58.4	9.7	12.4	25.6	52.8	146.5	32.0	77.7	156.3	101.9	47.9	31.1	42.2	190.8	5.9	174.6	80.5	140.1	26.0	85.5	112.5	394.2	55.9	80.8	34.4	41.9	63.1	146.1	50.2	22.0	252.5	58.2	46.2	46.9	56.8	151.1	11.3	21.1	44.5	113.8	32.0	253.2	20.8	175.1	27.0	59.4	67.7	65.4	72.3	285.7	110.8	14.6	39.2	124.7	97.7	8.5	26.1	62.3	59.3	101.2
NFIX	NF1A	ENSG00000008441	"Nuclear factor I X"	Q14938	19	12995475-13098796	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 410.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 145.2;Oligodendrocytes: 140.9;Skeletal myocytes: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 149.5;fHDF/TERT166: 211.3;U-138 MG: 191.5;U-2197: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007533	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA007533: AB_2667855"	"unprognostic (3.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.66e-4)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-2)"	76.4	14.9	30.4	19.7	80.2	14.9	48.0	99.8	97.7	67.2	4.0	60.4	20.9	88.5	10.9	72.4	69.5	53.9	60.9	54.0	15.0	8.9	20.3	50.0	6.2	50.9	45.1	73.8	23.8	13.2	18.9	11.8	39.4	85.0	19.7	11.7	150.4	60.0	410.3	99.2	24.3	67.8	45.6	11.3	37.3	16.0	46.9	11.6	31.0	138.2	6.2	45.0	52.7	105.2	39.2	16.2	1.0	119.9	111.7	149.5	1.3	48.1	68.6	45.7	31.8	1.3	3.3	0.6	13.4	211.3	31.4	17.5	12.8	37.4	20.1	25.8	19.7	20.2	7.6	17.2	53.8	8.5	10.3	99.0	10.9	44.1	24.6	80.3	12.4	8.6	6.7	6.2	29.3	12.1	14.9	5.7	0.5	8.6	132.3	43.5	22.2	23.1	0.4	8.5	17.9	47.6	34.5	0.3	43.0	0.0	22.7	17.3	12.2	191.5	23.5	185.1	68.5	4.5	1.7	0.3	49.9	12.1	62.0	0.1	0.1	0.0	0.5	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	30.4	80.2	99.8	97.7	54.0	15.0	50.9	45.1	39.4	45.6	46.9	105.2	19.5	12.8	59.3	62.7	6.8	58.8	45.5	22.4	134.9	13.3	57.9	74.2	33.2	27.1	15.9	14.7	4.2	0.2	3.7	16.5	1.9	24.3	64.0	12.1	40.1	20.0	12.1	145.2	69.0	12.7	0.3	89.7	32.6	3.0	3.8	4.3	17.9	33.9	1.0	0.0	38.1	25.8	2.0	4.1	15.2	43.1	112.2	5.8	26.6	17.8	1.9	93.7	0.0	52.3	140.9	15.2	12.0	126.0	2.5	60.3	8.4	10.0	19.0	3.0	6.6	174.7	38.3	15.6	13.2	99.4	51.4	0.3	3.8	56.0	29.5	31.8
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501331-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 610.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	26.7	16.2	3.9	30.3	7.0	34.6	19.8	6.5	5.7	22.0	5.5	20.4	15.2	18.9	2.7	23.0	19.1	20.8	15.8	4.2	5.8	17.4	16.4	25.0	33.1	7.6	6.1	18.8	16.0	11.7	7.7	21.2	7.8	17.3	19.6	4.9	18.9	17.8	20.9	23.7	20.3	17.0	5.6	23.0	17.5	7.6	6.4	37.0	16.3	10.7	35.1	48.5	19.9	10.1	36.8	19.2	11.2	13.6	27.0	28.5	10.9	20.0	64.2	27.7	27.1	21.5	40.8	58.0	17.6	32.6	39.4	29.5	22.0	34.5	35.2	53.6	10.8	22.7	14.5	15.0	20.0	44.3	44.3	19.7	20.2	22.0	34.4	15.0	34.5	18.1	25.8	34.1	17.6	17.7	4.1	9.1	5.0	24.3	15.4	33.4	25.9	24.0	15.3	38.8	7.1	11.8	38.3	37.2	16.3	8.3	8.6	24.2	40.5	32.5	16.6	14.5	26.4	17.0	13.3	52.0	20.8	19.4	44.1	0.0	2.1	2.6	0.9	3.0	1.9	1.9	3.0	1.6	4.8	1.7	4.5	3.2	1.9	3.7	3.1	1.5	0.8	1.6	3.9	7.0	6.5	5.7	4.2	5.8	7.6	6.1	7.8	5.6	6.4	10.1	32.5	41.7	49.4	42.1	90.0	165.4	91.5	57.1	31.3	6.6	41.5	32.6	19.1	24.3	40.8	20.2	6.2	14.4	119.6	41.1	3.9	28.5	7.6	82.5	62.0	47.6	33.6	13.0	78.4	37.3	16.9	63.1	29.6	207.0	111.1	19.8	23.9	23.9	24.8	20.2	77.2	43.2	18.3	56.2	610.3	2.4	23.9	178.3	55.2	59.0	207.9	9.5	23.7	66.9	127.4	46.3	27.1	34.6	56.3	78.5	21.1	24.4	31.5	6.7	0.0	73.7	41.2	2.5	8.1	35.3	150.3	14.2	88.2	16.7	35.4	90.2
NFKB2	"LYT-10, NF-kB2, p105, p49/p100, p52"	ENSG00000077150	"Nuclear factor kappa B subunit 2"	Q00653	10	102394110-102402524	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 168.0;Karpas-707: 157.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008422, CAB022098, HPA023900"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435"	"unprognostic (1.10e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.98e-2)"	"prognostic favorable (8.45e-5)"	"unprognostic (4.04e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.69e-12)"	"unprognostic (2.37e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.56e-1)"	26.5	21.0	7.6	44.4	7.4	69.3	19.6	7.1	9.2	22.9	8.5	39.1	15.5	21.6	2.3	17.7	20.4	18.5	20.6	7.2	7.2	34.6	28.2	41.0	40.7	8.5	7.5	21.4	24.1	6.1	10.8	14.7	8.0	29.0	6.8	1.1	21.3	9.1	18.4	20.0	26.5	12.2	7.5	50.6	22.7	10.0	8.4	16.9	20.1	7.6	25.7	37.0	19.1	8.0	67.9	48.6	7.7	31.7	11.1	16.6	19.3	18.5	61.0	19.6	25.9	28.6	55.2	32.9	43.5	11.9	48.8	40.9	20.5	28.2	6.8	168.0	11.2	7.0	11.7	15.9	30.1	5.1	45.5	22.0	14.6	34.1	32.3	26.5	7.8	16.1	7.6	157.8	7.4	26.4	7.1	22.7	10.3	15.7	16.6	16.8	24.5	27.0	34.3	22.1	1.7	8.2	16.2	36.7	26.3	7.2	29.3	16.4	21.2	19.0	28.9	25.4	47.0	113.1	105.0	32.6	31.1	14.8	10.9	0.0	1.3	0.0	0.7	0.9	0.7	2.6	0.8	0.7	0.7	2.1	0.8	0.8	5.6	0.8	2.1	0.6	1.1	0.5	7.6	7.4	7.1	9.2	7.2	7.2	8.5	7.5	8.0	7.5	8.4	8.0	20.8	9.6	8.8	3.3	88.3	43.5	59.3	41.2	34.7	2.2	17.1	14.5	3.1	25.8	29.9	18.4	16.7	6.3	39.0	33.3	5.9	33.2	1.1	33.7	14.4	26.1	16.3	0.4	0.1	21.0	15.8	26.0	80.0	52.0	71.8	5.5	11.7	3.7	20.9	0.0	0.1	30.4	22.4	19.4	122.9	1.7	7.5	52.5	30.2	1.9	75.1	3.9	12.3	1.5	0.7	44.9	37.4	4.9	49.1	49.3	33.2	8.6	19.9	5.3	0.0	36.4	43.6	4.7	11.1	17.5	44.6	23.1	54.6	8.8	17.9	45.6
NFKBIB	"IKBB, TRIP9"	ENSG00000104825	"NFKB inhibitor beta"	Q15653	19	38899700-38908893	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 76.4"	"Group enriched"	"Detected in all"	15	"Early spermatids: 892.6;Late spermatids: 1179.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063734			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA063734: AB_2685107"	"unprognostic (2.73e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.50e-3)"	12.6	12.7	3.8	5.2	5.1	10.8	11.7	4.3	3.9	9.3	2.4	12.5	4.2	10.6	0.5	16.0	9.9	1.1	16.7	2.9	3.7	10.6	22.5	13.1	3.6	4.6	4.5	8.0	11.1	1.8	7.7	1.8	4.2	9.8	1.1	1.0	11.8	1.9	30.5	15.6	12.8	0.9	4.0	13.5	13.9	76.4	4.7	2.0	9.7	1.5	1.7	13.5	10.5	5.3	13.7	16.9	2.4	6.2	2.4	1.4	7.8	9.0	3.5	4.7	5.4	11.7	7.2	15.0	9.8	2.0	4.5	7.6	6.2	4.4	1.6	46.2	7.8	10.1	3.0	6.7	8.2	11.7	20.6	1.9	4.9	5.2	6.6	1.3	2.7	10.9	12.0	13.4	1.8	8.7	14.3	11.1	8.2	11.6	7.0	20.0	10.1	14.1	2.3	5.4	14.1	8.6	5.7	8.1	6.7	1.4	5.0	9.8	6.5	8.1	10.5	14.0	14.0	27.5	26.4	32.8	5.2	12.1	10.1	1.2	3.3	10.4	4.0	4.9	3.1	2.9	2.3	3.4	3.0	2.6	1.7	2.5	7.4	7.1	4.2	4.3	5.9	2.5	3.8	5.1	4.3	3.9	2.9	3.7	4.6	4.5	4.2	4.0	4.7	5.3	17.5	9.6	24.3	3.3	34.6	31.6	40.2	25.8	37.0	11.9	17.8	12.6	6.7	11.5	16.6	12.9	4.2	27.0	48.1	56.9	7.9	33.2	892.6	23.7	19.9	23.4	22.1	14.5	4.4	31.0	25.7	19.8	59.1	43.8	66.7	7.6	10.4	21.3	24.6	25.2	5.0	31.1	16.2	17.9	29.9	1179.8	13.7	30.0	17.8	3.7	29.1	16.6	33.0	4.0	8.9	52.4	36.6	15.1	50.2	43.3	49.1	26.3	10.5	12.1	19.7	27.8	28.8	21.3	16.5	33.4	24.2	59.1	38.4	9.5	28.4	38.7
NFKBIE	IKBE	ENSG00000146232	"NFKB inhibitor epsilon"	O00221	6	44258166-44265788	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002692, HPA005941, CAB010272"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478"	"prognostic favorable (1.72e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (8.07e-4)"	6.8	5.8	10.9	19.1	10.8	31.5	5.9	12.1	17.6	4.1	10.7	7.2	7.4	3.7	4.7	5.9	3.3	8.3	5.3	11.3	10.6	16.1	10.5	13.6	19.9	11.5	11.4	2.7	8.3	5.3	4.5	5.5	11.2	8.3	5.9	3.7	7.4	3.3	3.5	9.9	12.1	3.6	11.7	35.0	7.0	10.7	11.8	9.9	5.3	3.9	25.1	16.3	5.0	12.3	28.4	7.9	9.5	15.1	3.7	2.8	5.3	4.9	23.8	14.9	15.4	15.0	12.9	15.7	17.0	5.1	39.7	6.2	10.3	15.4	16.6	26.1	6.0	7.9	3.0	17.0	11.4	26.1	23.0	7.1	6.7	13.8	8.8	12.5	10.7	7.2	7.7	39.2	3.9	14.4	5.2	52.7	5.0	44.1	4.0	9.9	8.5	14.0	34.7	30.3	6.1	7.8	3.4	12.5	20.9	8.0	8.6	29.9	18.1	8.4	9.8	5.3	15.4	25.0	11.4	28.7	7.4	28.4	16.1	8.8	7.5	4.0	1.6	9.4	3.2	8.6	2.2	1.5	6.6	6.5	1.0	1.6	3.0	0.8	11.1	8.1	3.1	1.7	10.9	10.8	12.1	17.6	11.3	10.6	11.5	11.4	11.2	11.7	11.8	12.3	7.5	0.0	9.7	1.0	26.0	38.2	28.7	11.6	14.8	3.4	15.3	9.9	5.4	22.8	9.2	3.7	2.1	5.2	12.5	12.2	17.6	49.5	17.3	10.0	6.2	15.9	14.9	1.7	1.1	21.0	8.0	17.3	10.7	12.8	32.5	2.5	6.1	2.0	57.2	3.3	2.0	11.9	6.1	22.6	151.2	34.1	1.8	48.6	48.0	3.7	55.2	3.3	1.0	0.5	0.9	58.9	33.3	2.6	18.7	32.6	14.3	14.4	6.1	4.1	6.6	11.8	11.0	25.9	12.3	11.6	39.2	5.3	13.8	7.0	8.5	34.7
NFKBIL1	"IKBL, NFKBIL"	ENSG00000204498	"NFKB inhibitor like 1"	Q9UBC1	6	31546870-31558829	"Disease related genes, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.8;HBEC3-KT: 5.0;HEK 293: 20.2;JURKAT: 9.8;U-266/70: 10.8;U-266/84: 9.6;U-698: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006298			Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA006298: AB_1079480"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.97e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.50e-2)"	20.4	18.3	0.0	0.5	0.0	0.0	21.5	0.0	0.3	22.8	0.0	26.9	0.0	21.1	2.2	17.5	22.3	0.0	19.4	0.0	0.0	20.8	23.4	16.7	0.0	0.0	0.0	33.0	42.8	0.0	23.9	0.0	0.0	24.3	0.0	0.4	19.8	0.0	27.6	24.2	16.5	0.0	0.0	19.4	30.4	17.4	0.0	0.0	23.4	0.0	0.0	23.1	19.4	0.1	0.0	4.0	0.0	0.1	4.4	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	2.8	0.0	0.0	5.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	9.6	5.9	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.9	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.7	6.4	3.6	7.8	14.9	20.8	26.7	31.4	30.1	18.8	25.6	25.5	5.7	25.8	12.8	25.8	2.1	21.8	13.2	23.1	39.2	27.0	8.7	15.9	14.6	18.4	7.8	9.2	5.6	31.8	28.1	19.6	25.5	12.9	7.0	25.2	24.3	15.8	24.4	6.7	6.1	27.1	14.2	29.3	16.1	8.9	25.4	17.4	8.8	1.9	26.2	26.8	24.7	3.5	5.2	32.7	22.4	25.9	8.3	24.3	61.4	24.8	13.0	17.9	26.3	20.2	30.9	12.7	10.0	17.4	18.8	29.6	11.6	30.7	26.2	22.3
NFRKB	"DKFZp547B2013, INO80G"	ENSG00000170322	"Nuclear factor related to kappaB binding protein"	Q6P4R8	11	129863636-129895590	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007082, HPA007128"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA007082: AB_1079481, HPA007128: AB_1079482"	"unprognostic (1.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (6.36e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.15e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.93e-2)"	9.8	9.0	7.2	10.8	9.9	22.7	11.0	9.7	7.3	15.0	9.1	11.8	13.1	15.6	17.5	13.2	17.9	9.9	7.5	8.3	6.5	10.6	11.8	10.8	14.5	4.9	5.5	20.6	13.9	10.5	11.7	13.1	5.5	12.4	10.1	9.8	14.3	13.3	15.4	21.9	12.4	13.5	4.5	11.2	11.2	20.3	7.2	15.0	20.0	9.7	13.4	12.6	13.8	6.7	17.9	16.8	37.4	20.3	15.6	15.4	23.5	12.2	11.0	14.2	13.9	52.6	30.1	42.6	32.5	9.4	20.8	44.8	36.5	23.8	13.2	16.9	31.9	84.2	32.8	22.2	11.4	21.7	27.3	9.9	25.9	23.3	24.3	16.3	24.9	28.1	49.9	31.5	14.4	16.2	18.6	37.1	19.1	26.2	39.1	27.2	16.3	19.6	17.7	55.6	19.0	20.0	27.4	26.7	7.3	27.5	62.3	19.9	19.7	21.1	20.6	15.6	15.4	10.0	13.3	39.0	8.8	41.9	18.5	6.6	5.1	6.3	6.0	5.8	6.3	3.3	6.1	5.1	5.1	3.9	5.0	4.2	6.0	2.4	5.2	4.5	4.4	4.5	7.2	9.9	9.7	7.3	8.3	6.5	4.9	5.5	5.5	4.5	7.2	6.7	6.2	9.6	15.0	17.0	10.0	29.3	16.8	17.5	18.8	10.2	12.1	10.0	7.6	20.0	17.0	7.3	10.4	19.2	7.8	9.5	7.9	11.9	14.8	12.9	14.4	9.5	8.5	9.4	13.1	10.0	15.6	9.7	6.1	17.8	10.8	14.1	8.9	10.9	10.4	8.4	10.7	9.7	8.2	7.7	6.2	7.1	14.6	8.4	14.2	9.4	12.4	9.7	12.3	12.1	7.7	10.9	8.0	10.5	10.5	15.4	15.6	8.1	12.9	11.1	32.9	10.8	14.2	43.0	49.0	10.7	35.2	23.3	13.1	9.4	12.2	17.9
NFS1	"IscS, NifS"	ENSG00000244005	"NFS1 cysteine desulfurase"	Q9Y697	20	35668052-35699355	"Enzymes, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034314, HPA051801, HPA054755"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594"	"unprognostic (1.72e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.93e-2)"	"prognostic favorable (4.72e-6)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.54e-2)"	12.0	28.7	17.8	7.7	19.0	4.5	10.6	19.5	20.4	11.6	19.0	13.1	12.4	9.1	10.3	11.0	12.5	8.5	22.6	18.2	20.0	42.2	37.7	6.8	8.6	17.4	17.7	13.1	11.9	25.9	12.3	8.6	19.8	9.9	14.1	17.1	13.5	12.6	25.3	10.6	11.1	11.0	17.3	7.7	12.1	19.0	19.6	9.3	10.7	36.5	12.1	9.7	9.1	19.4	29.6	36.0	12.3	13.0	32.7	29.9	24.9	21.9	23.1	32.2	20.9	65.4	16.3	25.1	42.1	20.6	33.3	36.3	42.6	44.5	29.3	11.3	20.0	53.7	37.6	51.4	27.1	22.9	9.9	24.2	41.6	25.5	27.9	24.1	24.6	29.0	38.9	16.3	23.1	45.3	25.8	24.0	14.3	67.1	53.3	10.1	39.9	42.2	33.0	19.6	15.4	14.1	54.9	52.3	36.9	28.6	46.9	20.1	18.2	36.4	17.4	21.6	21.9	23.5	34.3	22.6	30.9	24.2	18.5	3.0	6.8	6.5	5.8	6.7	7.7	8.4	6.7	8.9	9.4	5.6	7.8	7.2	2.7	10.6	5.2	4.5	9.6	5.5	17.8	19.0	19.5	20.4	18.2	20.0	17.4	17.7	19.8	17.3	19.6	19.4	9.7	6.4	15.0	9.4	8.0	6.1	8.1	16.7	6.2	14.9	11.7	10.3	20.6	21.5	10.4	18.4	10.4	35.2	5.4	12.3	33.2	15.9	6.0	7.2	8.5	6.9	6.7	13.9	9.0	11.2	22.5	10.7	11.2	8.8	7.0	8.7	6.8	26.8	16.1	15.2	9.9	7.0	16.2	8.9	4.8	4.4	5.6	7.0	10.6	6.5	12.3	15.2	5.2	4.5	12.6	10.9	11.0	10.5	5.8	5.6	17.3	56.6	7.6	13.5	13.1	8.6	9.1	50.7	19.7	9.1	5.7	21.1	7.4	25.4	14.8	7.9
NFU1	"CGI-33, HIRIP5, NifU, NIFUC"	ENSG00000169599	"NFU1 iron-sulfur cluster scaffold"	Q9UMS0	2	69396113-69437628	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 189.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035826	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA035826: AB_2674803"	"unprognostic (4.49e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.87e-1)"	66.8	46.3	36.8	22.5	39.3	33.4	56.8	40.0	56.0	35.6	37.4	51.4	31.3	35.9	51.9	27.9	35.3	29.0	110.4	37.5	40.9	64.2	39.5	31.8	30.0	40.2	39.7	38.0	39.9	43.3	45.1	38.1	41.4	34.3	38.1	56.9	41.2	36.5	140.8	22.3	33.4	33.1	39.9	31.0	43.8	34.6	39.0	22.8	41.9	120.2	29.5	44.8	31.1	42.0	59.3	59.2	56.1	55.5	70.4	75.4	61.6	61.0	62.0	59.0	47.8	114.7	56.9	42.4	30.0	57.0	85.6	25.4	63.7	64.2	79.5	77.8	62.3	43.5	38.2	102.0	70.1	73.7	59.2	58.4	37.2	67.5	41.2	56.0	65.6	41.8	80.1	41.8	99.1	11.9	39.1	119.0	53.9	62.9	64.3	42.6	85.5	15.6	83.5	57.6	45.9	34.3	35.2	32.2	92.5	57.6	40.8	49.4	67.8	71.3	47.1	52.2	80.8	53.8	48.4	23.1	54.2	74.7	55.8	20.2	13.6	25.5	15.9	18.6	15.6	21.7	16.3	18.9	12.4	25.1	16.9	18.6	4.3	18.0	28.5	25.0	24.8	12.3	36.8	39.3	40.0	56.0	37.5	40.9	40.2	39.7	41.4	39.9	39.0	42.0	30.6	32.1	22.5	9.8	37.0	16.2	35.9	96.7	21.1	23.9	33.2	29.6	92.3	37.1	42.6	38.6	12.5	113.9	34.1	34.6	189.8	56.9	111.0	40.0	27.1	34.9	53.3	25.7	15.4	60.9	70.5	30.9	20.4	25.3	58.3	21.6	33.5	32.0	82.6	18.5	18.8	47.7	57.0	35.8	24.0	34.2	34.8	30.2	39.2	10.3	66.8	55.6	46.4	21.1	27.1	50.3	39.7	36.9	25.4	28.8	56.3	163.0	58.9	33.4	46.0	36.9	44.1	82.9	60.4	18.8	14.9	61.3	33.3	42.7	46.3	35.4
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290512-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	16.8	16.8	13.7	15.6	14.5	21.9	20.6	20.4	17.6	15.5	15.9	17.1	16.9	17.4	15.7	18.3	15.4	12.4	23.4	13.8	15.0	14.6	27.7	16.0	22.3	13.7	12.8	21.9	15.8	23.4	13.5	13.5	13.5	16.5	19.1	19.4	17.9	16.0	37.7	25.5	17.5	15.7	10.9	18.2	15.8	12.2	14.0	26.3	22.9	26.5	25.2	16.8	15.7	18.2	29.8	24.0	21.4	20.3	31.3	35.1	21.5	27.6	27.4	30.6	30.5	21.7	11.9	46.0	17.0	32.0	20.5	16.3	38.8	29.8	28.4	33.9	18.9	24.1	58.2	24.5	38.1	43.3	25.6	32.7	48.9	26.1	65.4	27.3	18.9	25.6	37.6	38.3	32.2	20.9	28.3	40.7	34.7	21.9	26.8	30.0	23.3	25.2	20.7	28.1	29.3	20.6	27.5	29.3	15.9	25.1	17.0	42.7	23.8	24.8	20.6	18.1	30.4	20.4	19.9	44.6	27.3	21.5	14.4	35.9	5.5	10.4	9.8	8.9	10.5	13.0	10.7	10.8	9.0	10.3	11.8	11.9	3.5	9.3	7.4	15.4	7.6	6.7	13.7	14.5	20.4	17.6	13.8	15.0	13.7	12.8	13.5	10.9	14.0	18.2	16.0	60.9	42.5	35.3	41.9	8.4	24.6	12.5	21.6	29.3	13.2	13.5	36.9	22.8	35.4	27.6	54.2	12.5	17.2	20.6	7.9	16.1	65.9	16.7	19.0	14.9	9.1	25.2	59.7	13.2	11.8	18.5	26.5	19.8	18.9	15.7	17.5	32.4	15.0	21.9	59.0	23.9	12.2	19.4	10.2	17.0	18.3	19.0	3.6	47.8	16.4	13.7	16.5	37.7	55.0	12.4	21.6	23.0	47.1	25.3	23.3	8.2	43.7	32.2	13.1	27.3	17.5	16.1	14.8	20.9	11.2	18.1	20.9	19.2	16.7	21.0
NFXL1	HOZFP	ENSG00000170448	"Nuclear transcription factor, X-box binding like 1"	Q6ZNB6	4	47847233-47914667	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 213.2;Spermatocytes: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059132	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA059132: AB_2683917"	"unprognostic (5.37e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (1.13e-2)"	"unprognostic (6.26e-3)"	"unprognostic (8.48e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (4.72e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.01e-2)"	3.0	2.2	1.6	4.4	1.8	4.2	6.4	3.2	1.9	5.4	1.1	3.7	4.6	5.3	10.9	3.8	5.4	3.3	1.8	1.3	1.6	4.1	3.9	3.0	4.1	1.9	1.9	6.1	4.6	6.6	3.2	3.8	1.9	5.0	4.8	3.7	5.2	4.4	2.7	3.9	3.9	5.0	2.0	3.7	4.8	13.7	2.3	4.3	10.1	2.8	4.6	4.3	3.6	1.8	7.0	4.4	4.8	9.9	8.9	14.6	16.2	4.7	6.7	7.6	9.3	7.4	15.6	5.5	8.8	3.1	14.6	7.1	12.4	9.4	8.9	4.3	4.8	6.0	8.7	13.6	11.5	14.8	11.5	9.6	12.3	5.2	30.7	8.9	6.6	11.5	10.8	6.7	7.8	7.0	11.7	6.9	11.6	9.7	6.7	10.3	9.2	9.3	9.6	13.2	15.1	7.3	3.5	9.8	6.8	9.1	6.8	4.2	5.5	9.8	6.2	4.6	10.6	10.8	7.0	11.2	5.7	8.2	8.8	0.0	0.5	0.6	0.7	0.7	0.9	0.8	1.0	0.8	0.5	0.8	1.1	1.0	1.9	0.4	0.4	0.6	0.7	0.6	1.6	1.8	3.2	1.9	1.3	1.6	1.9	1.9	1.9	2.0	2.3	1.8	6.9	6.4	8.7	15.0	6.3	5.4	4.0	5.2	7.4	19.6	10.0	7.0	213.2	11.5	9.9	7.3	10.4	5.6	10.5	6.2	11.7	9.2	36.9	15.7	16.7	7.8	11.4	6.9	35.6	7.1	11.5	27.3	7.1	18.4	2.5	10.9	7.9	7.5	4.8	8.4	35.0	11.2	12.2	6.5	4.3	20.2	12.8	9.9	1.8	17.8	7.3	11.0	8.2	33.7	30.7	7.4	4.7	10.1	13.8	7.0	6.5	4.2	9.9	16.5	0.0	8.1	9.1	81.1	27.2	9.9	4.3	6.7	6.8	5.5	8.1	5.2
NFYA	"CBF-B, HAP2, NF-YA"	ENSG00000001167	"Nuclear transcription factor Y subunit alpha"	P23511	6	41072945-41099976	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009250, HPA050779"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB009250: AB_2152107, HPA050779: AB_2681234"	"unprognostic (2.56e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.62e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	10.8	8.9	13.3	14.0	18.1	40.7	15.6	14.3	13.2	11.3	9.6	11.9	9.9	14.9	14.7	10.8	11.6	12.5	8.8	12.5	13.4	10.1	14.3	11.8	19.5	15.8	16.6	18.7	11.5	15.3	9.0	13.8	15.5	13.6	14.6	21.5	9.4	8.0	9.3	10.6	11.2	10.8	13.6	14.5	12.6	38.5	14.8	41.5	18.4	12.4	20.5	14.6	9.4	24.3	32.8	26.3	49.2	82.7	19.9	19.3	20.9	24.2	22.4	37.2	31.4	34.6	23.3	39.4	19.7	16.0	19.6	21.0	30.1	29.1	40.9	28.4	38.0	51.7	23.2	49.4	14.1	55.0	43.3	12.3	24.4	29.8	40.0	18.1	32.6	64.5	51.4	46.4	36.9	32.4	62.5	22.1	22.1	95.8	25.9	50.3	27.1	29.6	27.2	43.8	49.8	34.3	21.1	18.9	37.5	31.2	17.7	55.1	32.2	65.7	35.6	13.2	46.9	18.2	19.8	64.2	13.0	46.2	26.5	2.7	2.9	4.8	5.8	3.9	7.6	3.7	5.4	6.4	3.3	4.1	5.7	6.3	8.0	6.5	3.5	4.3	6.7	3.2	13.3	18.1	14.3	13.2	12.5	13.4	15.8	16.6	15.5	13.6	14.8	24.3	7.6	9.6	3.9	6.2	11.1	14.5	9.9	4.2	2.8	4.1	13.2	7.1	4.7	11.5	5.3	11.0	4.2	7.7	11.7	9.3	1.9	11.3	41.4	7.4	7.7	7.5	4.8	12.2	4.4	7.4	12.5	6.8	5.1	8.1	2.5	11.9	7.5	7.0	10.0	0.0	5.1	4.2	4.1	9.3	14.0	44.4	3.7	6.4	7.2	10.3	7.2	3.3	7.2	5.0	13.8	9.6	9.6	3.0	5.6	12.8	5.1	2.6	6.9	5.0	0.0	4.3	8.3	20.0	8.2	6.3	15.9	10.8	10.1	5.6	7.6	18.7
NFYB	"CBF-A, HAP3, NF-YB"	ENSG00000120837	"Nuclear transcription factor Y subunit beta"	P25208	12	104117086-104138241	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Syncytiotrophoblasts: 433.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004211, HPA065646"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004211: AB_628018, HPA065646: "	"unprognostic (5.82e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.62e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.81e-3)"	32.9	40.8	34.0	15.2	34.3	14.7	27.2	30.5	50.8	28.6	26.8	60.4	15.0	30.5	33.1	16.1	30.1	18.5	37.4	31.0	31.2	24.0	30.6	29.0	24.7	32.9	34.0	23.2	21.3	21.7	17.4	23.6	32.0	39.0	18.4	21.2	20.6	67.9	36.2	18.4	21.7	21.1	34.7	19.4	26.3	22.6	32.1	26.3	22.7	36.3	22.8	38.1	23.9	36.2	30.1	25.3	55.3	35.7	34.2	35.6	48.6	31.5	27.2	37.2	25.6	21.2	14.0	44.4	15.1	30.3	22.9	22.0	46.5	20.9	37.4	28.9	14.7	27.4	31.0	19.7	31.0	35.0	17.6	49.3	25.6	14.5	25.5	62.0	24.0	40.1	27.1	16.2	31.6	29.6	53.2	40.5	52.8	22.1	26.0	43.5	30.9	18.8	27.3	25.3	31.3	26.2	58.0	132.5	19.3	36.8	53.1	42.9	15.2	21.3	13.1	17.5	24.0	28.5	29.5	42.0	12.5	23.7	22.8	18.0	5.7	18.5	12.1	7.8	16.6	12.3	12.1	12.5	5.7	8.5	13.0	13.7	7.2	13.5	9.0	5.0	16.9	9.1	34.0	34.3	30.5	50.8	31.0	31.2	32.9	34.0	32.0	34.7	32.1	36.2	42.5	54.5	26.7	8.8	21.1	37.3	106.8	42.9	15.9	22.7	24.3	31.8	39.5	12.8	30.3	18.4	4.2	58.8	24.5	13.3	37.2	24.2	6.2	20.4	36.4	36.5	12.0	39.4	13.1	18.3	86.3	43.0	11.2	17.5	21.5	30.8	77.1	31.2	23.1	15.2	13.7	15.4	30.5	14.4	29.8	5.4	34.2	19.2	28.4	8.4	20.2	43.3	22.6	11.1	25.3	27.3	16.9	30.5	17.1	54.5	12.6	42.5	26.7	27.2	19.7	35.4	40.0	90.0	32.4	18.0	37.1	433.2	25.6	18.8	18.3	55.7
NFYC	"CBF-C, NF-YC"	ENSG00000066136	"Nuclear transcription factor Y subunit gamma"	Q13952	1	40691648-40771603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 347.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055011			Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA055011: AB_2682671"	"unprognostic (1.20e-3)"	"unprognostic (1.51e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (1.47e-2)"	"unprognostic (5.66e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.25e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.12e-1)"	"unprognostic (7.75e-3)"	27.2	26.9	29.4	29.8	30.6	40.6	29.6	37.7	35.3	31.9	37.2	31.3	28.9	32.4	24.0	33.6	31.1	23.7	60.8	31.0	28.9	31.8	33.8	24.3	37.1	28.6	29.6	40.6	32.7	50.2	20.9	30.2	28.5	25.8	23.5	27.7	46.7	24.5	72.9	42.9	29.6	28.9	28.0	39.7	31.2	22.7	31.4	41.1	34.8	63.5	33.8	29.4	30.3	33.8	34.7	46.6	67.3	51.0	26.6	24.1	67.2	28.3	31.5	49.4	46.2	65.4	85.7	83.0	43.2	27.1	43.7	40.8	54.6	42.5	51.5	50.6	57.7	90.1	33.8	59.9	31.6	48.0	73.8	26.8	45.2	48.9	51.4	38.0	32.6	62.4	40.3	51.5	23.7	47.6	86.6	47.3	58.2	41.4	36.0	64.2	71.7	74.9	46.6	41.9	45.8	42.4	33.9	73.4	77.4	77.2	33.3	347.6	29.8	22.9	77.9	40.5	42.4	47.6	84.0	68.9	53.2	61.1	62.8	54.8	61.8	64.7	28.4	69.3	29.2	47.0	37.6	32.2	59.8	43.1	40.3	30.5	103.2	41.3	81.1	46.2	44.2	41.0	29.4	30.6	37.7	35.3	31.0	28.9	28.6	29.6	28.5	28.0	31.4	33.8	27.3	19.2	21.3	51.6	40.0	29.2	28.1	25.5	31.3	18.6	22.6	24.5	32.6	15.7	20.6	11.0	10.4	74.4	22.6	23.7	37.2	27.6	9.2	14.8	22.0	29.0	16.3	39.5	37.6	37.5	51.9	21.7	25.5	21.7	38.0	25.2	26.0	23.1	51.9	25.2	46.8	21.9	30.5	30.5	31.6	6.2	27.7	33.0	17.8	49.6	44.2	29.3	25.7	39.2	41.9	26.8	18.7	21.4	33.6	19.6	25.2	22.3	10.7	12.6	19.7	24.0	27.5	43.8	39.1	27.3	32.4	76.1	30.2	27.7	27.4	25.1
NGDN	"C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD"	ENSG00000129460	Neuroguidin	Q8NEJ9	14	23469689-23509862	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000944	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA000944: AB_1079483"	"unprognostic (2.63e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.70e-1)"	32.2	26.4	25.6	23.3	28.4	64.4	40.3	30.5	37.7	30.5	25.0	30.1	23.4	34.7	32.5	26.2	32.0	17.6	23.7	25.9	26.6	31.3	32.9	24.2	35.3	27.1	27.0	39.6	25.7	33.3	20.8	29.2	27.7	24.8	29.0	25.2	24.6	26.6	53.4	35.2	26.8	31.4	27.7	28.6	27.0	28.6	26.9	37.5	28.4	39.2	36.8	32.3	27.7	31.7	37.6	73.1	54.5	51.5	52.0	37.3	72.1	48.6	50.7	101.3	81.4	72.1	66.8	92.6	35.0	44.7	71.1	63.7	109.0	60.1	118.7	61.8	57.3	83.2	44.1	229.3	70.5	110.4	56.9	46.5	75.0	79.9	94.4	39.6	52.2	69.5	93.6	64.1	50.4	88.8	82.3	86.0	69.5	84.8	97.1	67.1	65.6	47.9	65.7	70.4	55.6	62.8	57.6	68.3	83.8	55.0	42.2	70.4	39.8	47.8	57.3	45.1	71.3	79.4	148.7	133.3	20.6	56.1	52.2	67.0	62.3	58.5	88.0	71.8	93.5	129.0	94.6	89.9	74.8	107.7	121.3	95.5	19.1	109.5	71.7	79.1	116.1	93.3	25.6	28.4	30.5	37.7	25.9	26.6	27.1	27.0	27.7	27.7	26.9	31.7	33.8	35.3	29.2	2.9	52.1	70.6	63.8	78.2	72.8	23.2	25.5	31.2	20.2	21.5	46.8	27.6	16.7	59.3	45.3	19.9	33.2	38.6	7.2	24.3	25.9	36.5	24.6	35.1	7.5	36.0	43.3	34.4	16.3	27.5	45.0	23.2	25.4	21.4	29.8	25.2	6.8	22.7	28.5	19.2	39.0	6.9	35.1	21.1	32.0	9.4	34.3	26.8	46.4	4.0	11.0	31.1	22.8	28.2	30.4	42.9	25.8	35.5	36.6	28.6	19.7	51.5	36.0	68.7	64.2	39.6	67.6	57.2	47.6	20.5	27.2	49.5
NGFR	"CD271, p75NTR, TNFRSF16"	ENSG00000064300	"Nerve growth factor receptor"	P08138	17	49495293-49515008	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Apoptosis, Biological rhythms, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 52.4;Basal squamous epithelial cells: 36.5;Ionocytes: 89.5;Leydig cells: 96.0;Muller glia cells: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.2"	"Group enriched"	"Detected in some"	7	"RH-30: 200.1;WM-115: 225.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 10.1"	"CAB000143, CAB001995, HPA004765"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		490000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"CAB000143: , CAB001995: , HPA004765: AB_1079233"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.77e-3)"	"prognostic unfavorable (3.40e-4)"	36.8	20.7	4.1	8.2	12.1	0.4	20.3	17.3	63.6	13.1	1.4	16.8	2.4	12.0	4.0	6.5	20.2	9.4	40.9	3.2	25.1	8.0	22.8	2.9	5.0	16.9	15.2	4.1	10.9	1.3	10.5	14.7	15.1	19.1	2.4	45.1	21.2	7.6	4.8	15.9	8.0	8.2	10.9	23.0	7.9	7.7	17.2	2.0	28.9	1.3	3.9	15.3	13.2	27.8	0.0	0.1	6.3	10.2	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.1	0.0	2.1	0.1	3.4	4.8	1.5	4.6	0.0	0.4	0.7	0.4	0.0	3.8	0.4	0.3	0.3	20.9	0.3	0.6	1.5	0.1	0.0	0.0	0.0	0.1	29.5	0.6	0.0	0.1	3.8	0.0	0.2	3.9	200.1	0.2	0.0	0.0	1.9	1.3	0.1	0.0	14.0	7.4	0.4	0.2	0.0	0.1	3.4	0.6	10.2	0.2	0.3	0.1	0.2	1.9	225.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	4.1	12.1	17.3	63.6	3.2	25.1	16.9	15.2	15.1	10.9	17.2	27.8	1.2	0.0	0.0	0.0	1.1	3.6	33.1	52.4	36.5	4.8	2.4	10.9	0.7	0.0	3.8	0.0	4.2	0.5	4.0	0.0	0.0	0.1	0.7	0.2	0.6	1.3	0.0	0.0	0.1	0.0	0.5	7.3	0.5	0.2	0.0	0.0	1.8	0.2	0.1	0.0	0.0	0.0	89.5	0.0	3.1	2.9	96.0	0.7	16.0	0.0	0.0	151.7	0.0	0.0	6.5	0.0	0.0	27.8	1.0	3.7	0.0	0.1	1.7	7.0	32.9	1.7	12.9	0.4	0.9	1.8	1.7	0.1	2.3	0.4	0.0	2.9
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90275778	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 385.3;skeletal muscle: 376.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	61.0	91.8	322.8	32.9	334.0	31.7	61.4	312.4	385.3	68.8	312.1	47.0	39.7	63.4	98.3	51.7	65.3	47.1	133.0	332.8	329.8	71.7	59.1	50.3	31.8	316.3	322.1	67.8	46.4	87.6	3.0	46.4	318.1	80.1	51.1	157.0	46.3	88.9	376.8	32.6	35.6	74.6	324.8	37.0	41.5	54.2	334.5	39.6	74.0	291.8	37.4	69.2	2.7	320.9	62.1	127.8	151.7	99.7	138.4	63.9	70.4	100.7	88.4	110.5	94.0	133.2	90.5	38.4	113.8	108.9	110.2	118.2	120.3	64.7	121.5	42.6	104.6	61.0	88.4	110.6	117.7	44.5	36.1	83.4	183.3	60.8	132.9	83.7	79.5	45.7	105.0	64.7	112.8	106.5	35.9	53.5	152.7	198.8	55.0	65.6	72.8	63.1	109.8	168.3	145.8	117.0	107.1	90.1	239.1	149.1	141.9	82.6	64.6	138.3	92.3	85.7	161.7	96.9	268.2	66.4	76.8	90.1	106.4	66.4	62.1	99.0	87.2	65.2	109.9	107.7	106.1	101.9	59.2	105.7	122.6	106.8	23.4	86.7	76.0	62.8	133.5	108.0	322.8	334.0	312.4	385.3	332.8	329.8	316.3	322.1	318.1	324.8	334.5	320.9	10.8	19.2	27.4	21.5	26.2	7.1	10.6	3.7	75.1	10.4	9.1	5.8	10.1	1.5	21.6	5.5	10.4	5.9	5.0	12.1	5.9	33.6	1.9	16.2	14.6	15.8	26.5	12.0	58.3	23.4	4.5	23.0	30.1	9.4	20.3	5.5	7.5	3.8	4.2	16.8	54.0	14.4	4.1	3.8	3.6	4.0	9.0	8.4	8.8	16.9	11.6	15.1	0.0	12.5	22.2	29.9	20.0	8.6	25.0	9.2	12.6	7.8	59.8	11.2	13.1	10.5	19.6	5.2	4.3	55.2	5.1	6.7	19.9	5.7	15.4	8.7
NHEJ1	"Cernunnos, FLJ12610, XLF"	ENSG00000187736	"Non-homologous end joining factor 1"	Q9H9Q4	2	219069357-219160865	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7.8;Microglial cells: 11.2;Oligodendrocytes: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012334, HPA043869"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB012334: , HPA043869: AB_2678707"	"unprognostic (5.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.29e-2)"	10.2	8.4	2.4	4.4	2.5	4.5	8.5	3.8	3.8	9.4	2.2	14.0	6.9	8.7	4.3	7.2	7.4	4.8	6.2	2.4	2.9	12.8	8.1	6.9	6.1	3.3	2.5	9.1	8.4	3.4	2.8	4.6	3.2	6.7	8.4	3.4	5.7	4.3	17.1	8.4	12.2	8.1	2.7	6.9	9.0	18.7	2.7	6.1	4.6	7.6	5.8	10.4	8.7	3.5	5.5	8.2	13.9	12.6	15.6	17.9	8.0	10.9	9.6	13.2	15.4	25.4	5.9	12.2	8.4	11.4	13.4	7.2	20.5	10.9	11.8	13.8	9.0	18.1	10.0	17.5	12.5	8.5	13.9	15.5	21.2	10.5	12.5	8.9	11.1	7.8	22.3	11.8	10.7	4.6	11.5	10.3	15.9	5.1	8.0	14.6	10.2	9.8	10.5	8.2	10.2	11.4	5.0	7.1	15.8	15.6	6.4	8.0	9.9	10.0	9.3	4.4	9.1	6.3	8.0	13.2	6.1	16.2	10.3	6.3	11.9	6.6	7.0	17.7	12.2	12.0	11.4	9.3	8.7	9.0	14.1	10.4	3.3	11.6	15.6	4.8	12.8	9.1	2.4	2.5	3.8	3.8	2.4	2.9	3.3	2.5	3.2	2.7	2.7	3.5	0.3	0.0	0.0	5.9	3.5	0.4	0.0	0.2	5.7	0.0	0.2	0.1	0.1	0.0	0.7	0.0	0.0	0.2	1.7	7.8	0.0	1.6	0.7	0.1	0.3	1.0	2.4	3.8	4.7	1.9	0.3	0.6	5.6	0.2	0.0	0.0	0.0	0.3	0.3	0.0	5.1	3.4	0.0	0.0	0.0	0.2	0.3	2.1	0.0	11.2	3.1	0.0	0.0	5.0	8.1	1.0	2.9	0.0	6.1	0.2	3.4	0.4	0.0	0.0	0.0	0.1	1.3	0.2	0.5	5.9	0.0	0.3	2.6	0.2	3.1	0.0
NHLH2	"bHLHa34, HEN2, NSCL2"	ENSG00000177551	"Nescient helix-loop-helix 2"	Q02577	1	115836377-115843917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 7.4;esophagus: 2.3;retina: 2.1;skin 1: 3.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 14.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 7.9;Spermatocytes: 5.1;Squamous epithelial cells: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 58.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055238	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear bodies"	Nucleoplasm	"HPA055238: AB_2682752"	"unprognostic (2.20e-2)"	"unprognostic (2.28e-1)"		"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.11e-2)"	"unprognostic (5.26e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.25e-1)"	0.0	0.0	2.0	0.0	1.4	0.0	0.1	5.9	2.1	0.3	0.2	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	3.2	4.0	0.0	0.0	0.2	0.0	3.8	5.1	0.0	0.0	0.0	0.2	0.0	7.4	0.2	0.0	2.1	0.4	0.1	0.2	3.3	0.0	0.0	2.5	0.0	0.2	0.4	6.7	0.0	0.0	0.0	0.0	0.0	0.7	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.4	5.9	2.1	3.2	4.0	3.8	5.1	7.4	2.5	6.7	3.0	0.0	0.0	0.0	0.3	0.0	2.8	2.8	3.3	14.8	3.9	0.0	0.6	3.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	1.8	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	4.5	7.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.4	0.0	3.5	0.3	5.1	3.4	7.0	2.3	0.0	0.0	0.0	0.0	0.4
NHLRC2	"DKFZp779F115, FLJ20147, FLJ25621, FLJ33312, MGC45492"	ENSG00000196865	"NHL repeat containing 2"	Q8NBF2	10	113854661-113917194	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038493, HPA057564"	Approved		Approved	Nucleoplasm		NA	NA		120000	"Cluster 14: Monocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA038493: AB_10672519, HPA057564: AB_2683469"	"unprognostic (7.09e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.88e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-2)"	5.9	5.6	4.4	4.9	5.1	4.2	6.2	5.8	5.2	7.0	7.6	6.5	5.4	6.2	6.9	4.7	5.7	4.1	16.5	3.5	4.3	5.4	8.7	6.6	5.9	5.1	4.8	7.2	7.9	10.5	5.3	6.4	5.1	8.8	5.8	10.1	6.7	4.8	10.6	7.0	6.2	5.2	4.2	7.2	6.4	3.8	4.6	4.6	7.6	7.5	5.5	6.2	6.2	6.0	10.8	6.8	13.1	10.8	4.7	8.4	8.3	7.4	8.8	6.3	6.9	4.7	10.3	5.8	5.2	7.5	5.5	9.4	10.8	6.1	10.7	7.0	5.4	6.2	5.7	6.7	7.1	8.9	6.8	5.8	7.4	7.0	14.4	12.2	7.7	4.1	7.4	6.5	8.6	5.0	5.1	6.9	3.9	6.6	3.4	4.7	18.8	3.4	7.8	5.9	3.4	6.9	5.8	7.3	9.1	6.1	5.3	6.6	9.9	7.5	7.6	4.8	11.3	4.4	2.3	5.7	6.2	14.0	5.1	0.9	0.5	0.7	0.6	0.4	0.6	0.6	0.4	0.7	0.6	0.6	0.4	0.5	0.3	0.6	0.9	0.8	0.5	0.3	4.4	5.1	5.8	5.2	3.5	4.3	5.1	4.8	5.1	4.2	4.6	6.0	22.4	19.2	21.3	40.5	13.7	7.9	13.1	8.9	11.4	20.8	15.2	9.7	74.4	18.6	18.8	36.8	14.6	16.8	8.3	8.5	7.9	10.9	5.4	15.6	24.1	19.4	10.3	27.6	45.5	12.3	12.9	19.3	16.3	14.4	10.8	23.3	19.2	28.2	10.1	28.6	34.7	15.8	10.2	17.6	6.7	8.6	18.0	13.7	7.2	44.0	13.2	20.6	13.4	58.3	55.2	11.1	15.4	26.4	9.1	17.3	12.4	11.8	8.9	25.7	65.7	29.1	19.1	16.0	11.4	9.9	8.4	18.2	10.9	18.7	12.3	14.1
NHSL1	"bA43P8.1, C6orf63, KIAA1357"	ENSG00000135540	"NHS like 1"	Q5SYE7	6	138422043-138692571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.6;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 46.2;TIME: 64.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029966, HPA029967"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"HPA029966: AB_10601972, HPA029967: AB_2673271"	"unprognostic (1.85e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.06e-2)"	4.1	1.2	15.7	2.4	14.1	0.3	2.5	9.7	8.5	2.4	16.6	13.2	15.8	1.2	4.6	10.4	1.0	3.0	15.7	14.6	11.2	5.8	14.8	12.8	1.0	16.2	15.9	0.5	3.3	2.1	1.1	4.3	10.7	0.8	11.4	2.6	3.5	0.5	0.5	11.4	23.2	3.2	9.2	2.6	7.8	0.4	14.4	0.6	1.4	0.8	2.1	2.7	4.5	5.6	5.5	4.7	32.8	13.8	9.4	11.4	12.2	4.8	2.3	1.7	1.6	6.2	3.1	0.0	6.0	4.1	3.1	12.3	20.0	12.5	0.9	0.4	13.4	3.4	2.2	46.2	13.8	12.4	2.3	16.7	7.0	0.9	14.1	1.8	23.3	1.9	0.0	1.8	7.2	10.7	1.3	1.0	13.1	3.1	8.8	14.1	3.4	1.0	11.2	13.7	12.4	0.0	5.1	10.3	33.4	21.5	3.3	3.9	64.3	4.6	4.5	4.6	13.3	1.2	2.7	0.0	0.4	5.0	25.5	0.4	1.2	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.2	15.7	14.1	9.7	8.5	14.6	11.2	16.2	15.9	10.7	9.2	14.4	5.6	6.2	60.9	66.9	502.1	0.5	42.8	3.1	6.6	4.0	0.6	4.1	6.0	22.7	15.7	9.9	29.5	29.2	14.2	0.1	84.1	9.8	3.7	1.1	19.0	1.8	9.3	20.3	2.7	3.3	3.6	3.5	15.6	16.8	16.9	8.8	1.5	26.4	38.1	4.5	37.0	2.9	32.3	6.1	9.4	7.1	0.4	0.6	7.5	21.4	104.0	0.6	15.4	0.0	79.9	2.3	3.9	43.0	0.0	0.1	5.4	87.3	15.8	22.0	1.4	6.6	2.3	4.7	0.0	1.1	7.7	49.2	43.4	1.8	0.8	45.4	10.5
NHSL2		ENSG00000204131	"NHS like 2"	Q5HYW2	X	71910818-72161750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 101.2;monocytes: 57.7;Prostatic glandular cells: 90.5;Urothelial cells: 80.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 14.3;neutrophil: 15.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.1;granulocytes: 15.6;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"AF22: 25.2;EFO-21: 29.5;HUVEC TERT2: 27.8;TIME: 16.3;U-937: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049771, HPA075115"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA049771: AB_2680872, HPA075115: "	"unprognostic (9.71e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.72e-4)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.37e-4)"	4.7	1.3	8.1	3.0	9.6	2.2	3.2	11.8	6.6	3.2	12.3	4.9	0.8	3.2	1.4	3.1	2.3	4.3	2.2	6.6	5.9	1.1	0.9	3.4	0.8	1.5	9.1	1.6	0.6	1.6	2.6	2.2	4.6	3.5	1.9	0.3	1.5	4.8	0.8	1.4	1.7	6.9	0.8	2.8	1.9	2.4	6.9	1.0	2.7	2.4	0.9	3.7	2.3	0.0	0.4	0.6	25.2	0.1	0.3	1.0	0.2	0.9	4.7	0.1	0.4	0.1	0.0	0.2	29.5	2.6	0.1	0.0	1.6	0.0	0.6	0.1	0.6	0.1	0.1	0.0	0.1	0.1	1.4	0.5	0.0	0.9	0.0	0.1	27.8	0.1	0.0	4.1	0.2	0.2	0.1	2.1	4.8	0.0	0.0	0.1	1.4	0.0	0.1	2.9	0.6	5.7	0.0	0.0	0.0	7.1	0.1	1.7	16.3	0.0	1.6	2.0	0.0	0.1	0.0	0.1	1.1	20.5	0.0	5.0	7.1	14.3	2.0	4.7	1.9	0.0	1.0	1.7	4.1	0.0	0.1	0.2	15.6	1.0	3.7	0.0	0.1	2.3	8.1	9.6	11.8	6.6	6.6	5.9	1.5	9.1	4.6	0.8	6.9	0.0	29.2	0.0	1.9	1.0	7.3	0.5	101.2	0.0	0.6	0.9	5.0	3.7	19.6	21.5	0.0	1.8	0.0	17.9	10.1	2.0	0.0	0.2	4.7	3.3	2.8	32.9	1.2	17.3	7.8	0.7	24.3	15.2	0.5	9.0	7.6	0.9	51.0	19.0	19.1	0.0	5.8	3.7	0.0	49.0	0.5	7.4	31.7	19.7	1.8	19.7	57.7	1.5	32.0	5.5	1.1	0.6	3.1	21.4	2.8	90.5	7.8	2.9	0.0	0.5	26.3	39.7	12.6	2.7	3.7	0.3	0.3	24.9	17.0	2.9	3.8	80.7
NIBAN2	"bA356B19.6, C9orf88, DKFZP434H0820, FAM129B, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Niban apoptosis regulator 2"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 606.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 73.6;Extravillous trophoblasts: 40.5;Hofbauer cells: 23.0;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	48.7	107.5	26.7	36.6	24.7	27.3	42.0	25.2	24.5	96.0	45.3	74.6	50.8	38.9	12.6	606.7	39.4	39.6	39.4	22.7	35.0	72.3	16.7	121.9	6.6	48.9	34.3	31.6	142.6	26.2	34.0	84.8	36.3	66.5	30.3	2.7	142.1	32.2	13.6	111.3	53.9	22.0	39.7	32.2	83.3	11.0	34.7	5.6	110.6	11.3	53.6	68.4	189.6	31.9	134.0	149.8	29.9	39.3	87.9	170.1	138.2	259.1	238.5	140.1	86.4	48.2	143.7	0.4	100.4	295.5	172.9	217.5	25.9	192.2	45.9	25.2	27.5	22.8	218.9	50.4	173.1	1.0	62.0	187.3	118.3	231.4	80.8	256.8	213.6	8.4	43.5	1.2	269.8	157.3	1.6	37.6	30.9	228.0	194.4	16.0	99.9	70.1	120.5	105.6	47.4	22.1	212.3	149.0	93.4	42.1	98.2	7.5	279.9	143.1	62.4	182.2	218.0	2.5	5.1	0.6	403.3	21.6	271.1	0.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	26.7	24.7	25.2	24.5	22.7	35.0	48.9	34.3	36.3	39.7	34.7	31.9	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	73.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	40.5	4.2	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	120.9	0.1	0.0	0.0	0.0
NIBAN3	"BCNP1, FAM129C, FLJ39802"	ENSG00000167483	"Niban apoptosis regulator 3"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"bone marrow: 15.4;intestine: 16.6;lymphoid tissue: 34.7"	"Cell type enriched"	"Detected in some"	8	"B-cells: 11.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7"	"Group enriched"	"Detected in many"	476	"B-cells: 52.1;dendritic cells: 110.7"	"Group enriched"	"Detected in some"	19	"Daudi: 50.1;REH: 23.8;U-698: 33.2"	"Not detected"	"Not detected"							HPA043277	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.4	0.0	0.0	10.7	0.1	15.4	0.1	0.0	0.2	0.1	0.0	0.8	0.0	0.1	0.0	0.4	0.1	1.0	0.1	0.0	0.0	0.5	0.3	0.4	26.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	16.6	0.0	0.0	34.7	0.7	0.5	0.0	1.8	0.6	0.0	12.2	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	52.1	0.0	0.1	0.0	0.0	0.0	110.7	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NICN1	MGC12936	ENSG00000145029	"Nicolin 1"	Q9BSH3	3	49422333-49429326	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.3;Late spermatids: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058014			Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA058014: AB_2683579"	"unprognostic (4.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.46e-1)"	"prognostic favorable (8.81e-7)"	"unprognostic (3.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.96e-2)"	7.8	11.2	20.1	4.6	22.5	2.6	7.8	16.9	24.0	9.7	15.6	11.7	4.3	10.5	8.1	5.8	10.2	5.5	11.5	21.8	18.0	16.9	10.5	8.3	6.9	18.8	18.2	11.1	7.6	9.9	11.6	4.5	20.4	11.5	4.0	9.0	9.1	6.8	12.5	6.7	7.9	6.6	17.8	9.9	9.7	11.8	20.0	10.6	13.6	9.9	6.5	9.1	8.1	21.6	3.7	10.9	11.8	9.6	5.1	6.1	3.8	4.6	4.0	3.8	5.2	2.6	10.9	10.8	4.0	9.1	8.0	3.1	6.4	5.6	4.3	18.2	4.2	10.6	12.2	13.0	9.5	4.2	6.6	13.0	7.2	8.7	3.1	19.8	5.8	22.6	6.5	0.2	4.2	3.5	6.7	6.3	3.5	4.1	3.4	5.9	3.8	13.5	7.0	2.1	1.9	4.6	3.8	3.1	8.0	22.1	5.9	2.1	12.2	3.1	3.2	3.0	1.7	13.7	4.1	3.7	9.3	11.6	5.1	5.3	3.7	3.1	4.1	3.1	2.7	5.0	2.4	5.0	3.3	2.1	3.1	3.7	0.8	4.1	5.2	4.2	6.2	3.8	20.1	22.5	16.9	24.0	21.8	18.0	18.8	18.2	20.4	17.8	20.0	21.6	0.0	0.0	1.1	4.9	3.7	4.1	5.6	7.6	1.8	6.8	0.0	0.0	14.3	5.7	3.3	0.0	10.4	6.2	4.0	2.3	0.0	0.0	24.3	0.0	0.0	2.9	12.1	6.5	4.4	0.0	2.2	3.3	8.6	0.0	1.3	0.0	3.9	5.5	5.8	3.3	4.9	4.2	0.0	5.2	3.0	52.7	9.6	1.7	3.6	1.9	1.0	6.2	9.2	3.0	2.9	0.0	1.6	6.0	3.5	2.2	5.4	0.0	3.0	6.8	6.6	4.7	2.8	11.0	2.3	3.3	3.3	3.3	3.8	0.1	3.4	4.6
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831162	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 240.5;Muller glia cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim, Centrosome"	Nucleoplasm	"HPA005939: AB_2667474, HPA070691: AB_2686296"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	11.2	4.4	10.1	19.9	10.8	43.2	8.9	9.5	15.0	7.2	0.0	8.3	4.8	7.7	2.8	12.9	10.5	8.9	18.2	10.4	0.9	6.7	5.7	9.5	25.9	0.0	1.3	9.7	7.2	9.0	8.9	16.8	0.0	6.9	8.6	19.1	5.4	5.4	6.0	12.9	7.1	10.3	0.0	16.2	9.3	5.2	3.0	19.9	7.7	7.4	23.7	13.6	5.7	7.5	29.1	21.6	42.4	36.8	16.7	26.8	20.4	26.5	22.1	21.4	18.0	14.7	14.6	48.5	17.7	35.5	19.9	32.5	34.2	16.3	45.3	34.7	10.4	25.1	13.2	12.3	9.8	41.6	57.5	18.4	11.4	37.2	14.9	13.3	34.6	25.9	6.6	26.3	31.8	36.8	22.6	14.0	6.4	10.1	23.6	37.1	81.6	5.7	20.1	42.9	18.6	22.2	34.0	9.6	25.1	10.2	21.2	39.3	50.9	55.2	74.3	20.5	29.0	18.6	12.1	34.3	14.4	32.8	30.4	31.9	2.9	24.0	3.9	2.5	3.3	8.9	2.4	6.2	2.0	6.2	5.1	4.7	9.6	2.9	2.1	7.7	2.5	1.4	10.1	10.8	9.5	15.0	10.4	0.9	0.0	1.3	0.0	0.0	3.0	7.5	34.0	6.4	7.7	100.2	85.6	18.4	9.1	10.2	18.8	13.3	13.3	10.9	68.0	14.3	27.1	11.0	62.6	12.4	102.7	8.7	3.9	7.3	22.2	17.3	28.5	26.7	12.6	29.0	240.5	4.2	11.3	32.9	7.7	14.9	31.6	3.9	21.8	4.4	22.7	6.7	110.4	5.7	20.3	46.8	42.2	10.4	8.4	61.3	23.2	63.7	63.2	150.2	57.7	105.6	75.1	5.2	6.2	9.4	48.1	16.5	3.2	7.3	29.4	21.0	32.9	44.9	24.1	0.2	4.3	20.1	21.0	9.7	56.2	21.8	6.9	15.5
NINJ2		ENSG00000171840	"Ninjurin 2"	Q9NZG7	12	564296-663779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.8;Alveolar cells type 2: 39.9;Erythroid cells: 35.4;Hofbauer cells: 30.7;Kupffer cells: 38.3;Oligodendrocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 153.5;MOLT-4: 263.8;THP-1: 54.4;U-698: 49.3"	"Low region specificity"	"Detected in all"							"HPA058980, HPA067226"			Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol"	"HPA058980: AB_2683869, HPA067226: "	"unprognostic (1.16e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.60e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.23e-1)"	20.6	1.8	21.0	11.3	30.8	38.3	16.5	25.9	29.6	7.8	14.5	5.7	5.2	4.3	2.5	9.6	4.1	5.3	12.2	21.8	23.7	2.1	18.7	36.8	14.8	30.5	26.7	1.0	1.9	0.8	1.5	4.4	28.5	4.3	4.9	0.5	7.4	2.9	38.2	11.3	6.4	5.5	23.9	13.3	4.2	5.5	26.0	8.8	4.0	12.8	11.2	8.5	6.5	45.1	1.7	0.4	0.1	1.8	0.3	0.6	2.9	0.2	0.0	0.0	0.1	3.1	11.8	0.0	0.6	6.1	1.7	0.2	0.2	0.0	0.0	8.6	0.1	153.5	34.2	1.9	0.0	4.3	6.1	2.2	0.2	0.0	0.0	0.0	3.1	3.2	9.0	25.5	0.1	0.1	263.8	8.5	2.6	0.1	0.0	6.8	0.2	0.8	2.7	0.0	0.1	0.0	28.3	0.2	0.0	0.3	0.3	54.4	0.7	0.0	1.5	9.8	0.2	0.1	4.2	49.3	0.4	28.5	0.1	6.7	58.1	48.3	32.8	47.2	9.8	18.8	36.2	34.9	49.9	17.7	7.7	16.7	112.9	21.4	39.4	26.2	157.3	33.4	21.0	30.8	25.9	29.6	21.8	23.7	30.5	26.7	28.5	23.9	26.0	45.1	29.8	22.4	39.9	0.3	5.3	5.7	0.3	2.5	6.2	0.0	1.3	1.3	1.5	1.5	8.7	0.0	0.0	2.6	8.9	2.1	1.9	0.2	3.1	5.5	1.6	9.4	4.2	35.4	1.7	0.0	3.9	13.5	1.1	1.2	2.5	0.4	4.2	11.2	30.7	0.0	1.0	3.5	0.0	38.3	7.8	3.1	8.1	18.0	7.2	11.2	12.4	0.2	7.2	3.5	109.7	0.8	2.6	4.1	8.1	0.1	2.1	0.2	5.0	0.1	0.0	1.3	1.6	3.3	3.1	7.6	5.5	0.8	12.5	0.1	3.1	0.2
NIP7	"CGI-37, FLJ10296, HSPC031, KD93"	ENSG00000132603	"Nucleolar pre-rRNA processing protein NIP7"	Q9Y221	16	69337996-69343106	"Predicted intracellular proteins"	"Ribosome biogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040856, HPA059850"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA040856: AB_2677171, HPA059850: AB_2684142"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.37e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (6.99e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	17.9	14.1	7.1	17.9	7.5	26.2	16.0	7.8	8.1	11.4	9.6	16.6	14.4	11.3	14.2	17.2	12.1	12.9	7.7	7.8	7.3	13.2	17.2	10.6	23.6	7.7	7.3	7.4	10.3	11.4	5.2	14.5	8.1	9.8	16.1	3.5	8.5	8.9	8.7	12.7	12.0	14.1	7.6	13.1	11.5	12.3	8.1	21.4	11.2	9.8	26.9	24.9	8.6	8.5	57.9	39.7	31.2	43.0	44.0	38.5	48.8	52.7	40.6	87.8	62.7	66.7	61.6	105.5	57.1	48.3	36.5	60.1	63.7	80.0	112.5	28.9	51.2	53.8	27.0	83.6	42.6	118.1	34.0	42.2	63.1	83.1	88.7	25.7	50.5	60.7	115.1	17.5	62.3	69.8	78.6	81.9	94.4	50.9	47.7	108.6	34.3	95.7	54.6	38.8	41.3	57.8	107.8	31.0	59.8	35.0	44.3	72.4	43.5	63.5	54.7	49.5	97.0	54.4	45.0	250.2	37.9	69.4	63.4	16.7	12.7	9.8	28.4	14.9	29.9	28.9	25.2	33.3	22.8	21.1	23.3	30.1	4.3	24.8	21.4	20.7	28.9	16.9	7.1	7.5	7.8	8.1	7.8	7.3	7.7	7.3	8.1	7.6	8.1	8.5	28.2	3.2	12.7	3.9	33.7	53.7	58.1	34.6	45.5	8.8	21.7	18.3	5.5	14.3	21.1	20.2	16.7	33.2	33.2	14.7	21.5	35.9	43.8	24.5	32.0	28.3	3.0	37.9	5.1	26.1	36.5	24.0	11.2	23.2	17.7	20.5	18.2	12.1	24.8	11.8	4.5	12.7	30.5	12.2	19.2	41.4	17.1	14.7	19.6	1.9	18.3	9.2	35.0	3.0	6.4	37.5	16.6	17.3	15.6	46.2	14.6	28.9	25.6	8.1	13.1	35.2	25.9	40.7	43.8	43.0	52.6	25.6	33.2	36.2	20.8	42.2
NIPAL3	"DJ462O23.2, NPAL3"	ENSG00000001461	"NIPA like domain containing 3"	Q6P499	1	24415802-24472976	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 88.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Oligodendrocytes: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 101.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039978	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA039978: AB_10697712"	"unprognostic (9.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (3.03e-7)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.85e-1)"	8.4	7.4	49.6	8.4	67.3	8.4	12.9	67.7	58.5	9.6	25.8	13.8	11.3	6.2	11.7	15.9	14.6	8.9	12.8	43.6	58.1	13.8	3.5	13.9	11.6	61.8	58.6	7.2	17.1	21.9	7.3	3.5	65.0	55.9	14.4	27.7	15.2	7.6	5.9	14.0	12.7	12.3	56.1	7.8	14.8	4.9	65.0	13.2	29.2	11.9	13.1	8.0	10.4	88.5	32.4	12.1	1.1	4.2	18.9	20.7	4.5	101.8	71.7	35.0	26.2	4.5	36.4	15.4	30.2	55.2	7.3	31.5	12.5	37.1	37.3	29.5	38.1	16.0	18.5	5.4	17.7	14.2	14.4	20.7	36.1	22.3	75.7	34.8	12.2	27.5	9.5	9.7	22.4	7.2	11.5	6.6	8.3	15.4	34.0	5.5	0.1	17.1	41.6	10.1	44.6	4.3	13.1	19.5	26.9	8.6	26.0	10.6	17.9	31.5	6.7	10.9	22.9	29.4	24.1	5.4	21.4	26.8	28.8	16.9	5.8	7.9	16.7	5.7	16.9	22.1	28.8	22.5	11.2	20.1	38.9	24.8	2.5	15.6	4.2	14.6	31.8	16.0	49.6	67.3	67.7	58.5	43.6	58.1	61.8	58.6	65.0	56.1	65.0	88.5	17.1	48.1	27.5	8.8	15.4	9.2	13.5	25.7	14.8	50.3	15.9	12.2	25.9	15.7	24.7	40.5	110.5	3.8	32.1	25.0	3.9	13.1	3.6	11.0	3.5	10.2	18.7	26.1	29.3	15.5	4.7	7.4	16.8	18.3	13.3	10.5	9.3	3.8	4.5	13.5	32.2	16.7	16.2	7.0	7.8	8.0	4.1	5.5	14.2	10.3	8.6	18.7	23.7	24.6	91.8	22.6	22.6	5.3	16.0	34.5	33.2	4.5	16.5	53.6	0.0	4.4	5.9	2.6	6.0	20.0	16.3	4.2	25.3	8.2	17.2	20.9
NIPBL	"DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2"	ENSG00000164190	"NIPBL cohesin loading factor"	Q6KC79	5	36876769-37066413	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040834, HPA058239"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040834: AB_10796562, HPA058239: AB_2683650"	"unprognostic (4.92e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.40e-2)"	11.5	9.4	5.6	14.7	8.6	25.1	13.5	12.0	7.3	12.9	7.8	12.2	10.0	13.4	6.6	11.4	10.5	11.1	7.7	5.3	5.9	11.6	12.7	11.9	16.5	7.3	6.6	17.6	13.1	19.6	5.0	13.9	8.2	11.1	12.2	22.4	11.2	10.7	9.5	14.2	13.2	12.4	6.3	15.3	13.4	14.2	6.9	29.8	17.2	14.3	16.7	12.6	7.5	11.1	22.5	13.1	33.3	15.6	20.7	22.3	24.4	17.6	19.3	18.9	15.7	18.2	22.6	33.5	11.3	21.6	22.2	19.2	28.9	15.9	27.0	27.9	14.7	40.9	57.4	13.3	14.0	48.4	26.4	16.5	19.3	21.3	28.1	18.1	24.0	20.8	39.3	24.5	17.9	10.8	33.8	18.1	16.0	12.9	11.3	28.2	51.9	13.0	13.1	31.4	24.5	17.2	84.6	22.5	18.0	26.2	23.0	27.3	26.3	24.9	27.1	21.0	13.3	17.7	25.5	39.1	13.6	32.4	19.1	10.9	2.9	4.3	3.2	2.2	3.0	2.8	2.7	2.9	2.3	3.1	2.9	3.3	7.7	2.8	3.3	3.4	2.1	1.6	5.6	8.6	12.0	7.3	5.3	5.9	7.3	6.6	8.2	6.3	6.9	11.1	80.6	131.4	108.6	169.8	84.8	48.4	66.2	34.2	58.1	62.6	43.6	49.4	87.0	38.6	63.3	33.1	77.2	44.1	107.1	45.9	5.9	55.5	13.4	72.9	75.7	74.1	41.5	85.4	179.2	46.7	34.1	64.3	61.2	91.7	84.0	77.7	44.6	28.2	37.1	40.4	165.5	46.3	38.7	51.8	46.6	15.1	66.5	86.7	24.9	236.1	103.3	49.2	97.9	229.2	303.7	55.0	48.6	56.4	84.5	66.4	45.2	12.2	65.2	72.8	52.6	102.9	80.1	185.8	133.6	58.2	47.0	75.9	92.0	73.8	42.9	88.0
NISCH	"I-1, IRAS, KIAA0975"	ENSG00000010322	Nischarin	Q9Y2I1	3	52455118-52493068	"FDA approved drug targets, Predicted intracellular proteins"	Apoptosis	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Enteroendocrine cells: 169.3;Peritubular cells: 246.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023189	Approved		Approved	"Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nucleoplasm, Cytosol"	"Vesicles, Microtubules, Cytokinetic bridge"	"HPA023189: AB_1854495"	"unprognostic (6.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.96e-2)"	"unprognostic (8.33e-3)"	"prognostic favorable (1.91e-4)"	"unprognostic (1.40e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.05e-3)"	55.2	69.8	46.5	28.7	55.5	38.7	60.5	78.2	56.6	105.8	22.2	68.5	24.3	76.2	34.0	51.3	72.0	29.9	48.5	56.3	38.7	54.6	45.6	56.2	32.5	20.9	32.6	93.0	54.1	32.5	181.8	39.1	32.9	107.5	20.6	19.0	53.6	51.6	36.3	80.7	55.3	33.0	9.1	54.1	52.7	84.5	35.2	30.1	60.8	16.3	23.3	78.1	71.6	35.2	15.6	16.0	48.8	40.1	35.7	39.2	40.0	32.8	21.5	25.7	26.0	24.2	22.8	21.7	9.0	45.6	21.0	20.4	26.1	35.7	15.1	22.3	28.2	39.2	65.2	23.9	32.4	23.2	33.6	61.9	28.2	27.7	23.5	54.0	42.0	42.4	21.1	23.4	24.3	22.2	41.8	51.2	30.1	19.8	27.1	24.5	13.4	25.4	29.2	30.6	20.6	35.9	35.6	9.3	23.1	42.3	28.9	38.5	46.3	36.0	34.1	36.9	24.1	38.7	23.8	27.3	24.7	37.3	22.4	5.2	4.5	3.5	3.0	4.0	3.1	2.5	2.6	4.0	2.3	2.8	3.1	3.3	1.5	3.2	0.6	3.4	3.0	3.6	46.5	55.5	78.2	56.6	56.3	38.7	20.9	32.6	32.9	9.1	35.2	35.2	26.1	25.6	32.3	34.0	14.9	27.5	14.6	23.3	40.5	40.9	29.2	37.1	20.4	8.6	19.1	14.7	8.4	32.4	24.2	20.5	9.8	12.1	10.3	14.5	26.7	22.1	169.3	4.6	64.9	9.4	14.0	23.4	23.4	18.9	25.3	40.2	46.1	15.3	30.5	28.6	44.0	19.1	22.4	50.5	14.5	25.9	88.3	24.3	19.6	15.0	13.0	12.1	17.5	21.1	26.1	10.0	14.2	246.0	12.4	12.6	16.5	15.6	15.2	22.4	26.3	17.2	24.8	31.2	18.0	16.7	22.3	24.2	18.4	47.6	15.7	11.7
NKAP	FLJ22626	ENSG00000101882	"NFKB activating protein"	Q8N5F7	X	119920672-119943751	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Repressor	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000916	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA000916: AB_1079486"	"prognostic unfavorable (4.20e-4)"	"unprognostic (4.28e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	9.5	13.1	10.6	9.8	11.5	13.6	10.6	11.8	16.2	9.2	11.1	9.8	10.3	10.6	10.7	7.3	11.0	8.9	11.0	10.5	11.6	11.3	14.5	10.5	14.4	11.9	11.5	14.1	10.1	14.2	2.7	13.5	11.4	10.4	10.1	9.6	9.9	13.5	18.2	7.4	12.7	10.3	11.2	12.5	9.3	8.5	11.0	12.7	10.1	14.4	13.0	9.7	2.4	13.0	25.0	24.3	17.6	22.3	15.3	24.7	28.9	17.7	20.4	23.4	17.2	15.9	20.9	17.6	29.9	14.6	45.8	18.3	33.7	20.6	27.9	29.6	31.2	11.1	20.6	23.3	25.1	25.2	20.4	17.9	26.4	25.1	24.7	25.3	23.2	23.8	30.6	25.5	18.4	33.8	21.4	47.0	23.6	32.4	32.8	22.8	24.3	32.7	17.5	9.6	19.2	27.2	36.8	19.7	52.3	20.9	16.8	21.1	17.4	14.8	9.0	38.4	27.4	25.4	26.7	30.2	20.4	18.9	26.1	39.7	23.5	55.6	20.8	20.0	21.6	32.2	25.4	21.2	20.6	36.6	25.6	24.3	44.5	22.2	23.1	32.5	26.6	14.3	10.6	11.5	11.8	16.2	10.5	11.6	11.9	11.5	11.4	11.2	11.0	13.0	39.9	22.4	40.4	5.2	36.1	25.9	36.1	45.5	26.7	34.0	26.2	33.3	30.3	15.7	42.3	20.2	25.0	62.5	36.0	17.5	37.2	36.7	8.8	33.6	37.4	40.3	22.8	20.6	7.2	44.3	132.0	39.1	17.9	26.7	47.4	41.6	41.4	46.3	53.0	55.5	9.0	27.9	22.4	28.0	23.2	8.9	45.1	33.9	35.6	4.7	35.3	56.3	36.0	7.5	11.0	37.5	23.3	55.3	30.6	40.3	25.8	51.3	49.4	38.5	13.1	33.4	45.0	82.7	69.6	19.6	28.7	72.9	41.5	48.3	23.1	33.7
NKIRAS2	"DKFZP434N1526, kappaB-Ras2, KBRAS2"	ENSG00000168256	"NFKB inhibitor interacting Ras like 2"	Q9NYR9	17	42011382-42025644	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062861			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA062861: AB_2684884"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (9.37e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.42e-3)"	21.7	15.7	14.1	20.8	17.1	25.6	18.4	15.3	15.4	18.8	15.6	20.8	15.2	19.0	11.0	32.7	14.4	17.8	45.8	14.3	12.0	16.9	19.3	16.7	17.8	14.8	13.3	16.0	13.3	19.4	10.8	33.9	13.1	16.1	16.3	13.7	16.2	18.0	50.0	26.6	16.2	26.4	12.1	15.1	16.9	20.8	15.5	22.1	13.5	36.8	19.0	20.8	20.1	15.0	22.4	42.5	57.4	31.1	39.8	26.8	33.7	36.4	28.1	56.6	41.6	43.6	31.3	37.4	57.3	38.6	38.4	47.1	47.3	28.6	29.6	30.6	54.2	32.9	37.1	33.0	62.8	45.8	25.9	41.0	50.8	38.1	29.8	38.6	71.3	47.8	47.1	36.9	33.8	23.7	87.3	30.4	34.4	30.0	30.0	67.9	63.7	35.8	40.3	23.2	68.5	90.0	26.6	84.0	38.6	55.6	51.5	55.5	50.3	36.2	38.8	40.5	41.5	47.4	82.7	30.0	24.6	27.5	52.2	54.5	54.2	46.1	14.2	45.1	14.1	15.4	14.2	14.4	43.5	17.1	14.4	14.0	30.7	27.0	50.0	48.4	13.4	25.2	14.1	17.1	15.3	15.4	14.3	12.0	14.8	13.3	13.1	12.1	15.5	15.0	26.6	16.0	10.3	3.9	19.0	17.0	18.7	27.2	12.5	21.0	19.9	17.1	26.3	10.0	23.8	16.5	20.9	52.3	13.8	19.1	21.5	30.0	27.8	11.9	18.5	27.1	19.2	21.2	5.4	28.1	39.7	20.1	11.2	16.3	14.0	28.1	19.2	15.6	37.9	23.5	4.8	17.5	42.7	31.1	29.1	6.6	19.6	27.8	10.6	5.6	37.2	24.7	14.4	1.5	4.5	30.4	14.7	18.4	13.3	20.8	20.9	19.0	10.9	26.6	6.6	15.3	24.5	34.7	41.3	21.0	25.7	62.3	12.8	23.3	15.2	21.6
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119606443	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	4.4	6.5	11.3	5.7	11.8	6.9	5.4	9.6	16.9	4.2	7.3	3.7	4.1	3.9	4.0	5.6	4.4	3.5	4.1	11.5	13.1	6.1	6.0	4.1	8.7	11.2	10.1	6.1	3.8	5.2	5.5	6.5	11.5	4.1	3.5	5.3	4.0	3.5	5.5	6.2	4.3	4.0	9.4	5.9	4.1	1.9	11.4	9.5	4.6	4.6	8.4	6.3	4.3	10.6	17.9	18.3	10.4	11.3	8.7	8.5	15.5	10.7	8.5	14.1	15.0	19.8	15.3	31.8	18.4	9.2	12.1	20.4	43.8	16.4	17.2	16.4	28.9	16.8	20.3	12.9	8.3	33.5	11.8	9.5	13.2	16.3	19.2	9.6	14.1	15.3	18.5	12.6	12.5	27.6	20.8	25.2	23.1	26.2	19.9	16.5	15.2	32.7	18.8	12.7	16.7	14.2	15.2	23.1	16.5	10.6	9.7	20.0	12.2	8.7	9.5	19.3	27.1	10.5	14.1	32.9	9.3	36.3	10.1	1.1	0.5	0.7	1.0	0.8	1.1	1.3	1.2	1.3	0.6	1.2	1.9	1.6	0.1	0.5	0.3	0.9	1.8	0.8	11.3	11.8	9.6	16.9	11.5	13.1	11.2	10.1	11.5	9.4	11.4	10.6	5.4	6.4	8.9	5.9	11.1	19.4	10.4	4.1	6.8	13.3	6.1	6.9	4.5	8.6	3.1	5.5	27.1	14.4	8.5	3.0	1.9	4.2	0.1	6.1	7.4	7.0	10.7	2.5	20.6	3.6	14.3	6.1	3.1	8.1	14.7	6.6	3.3	3.9	6.4	8.4	20.6	4.4	10.2	7.5	33.1	0.6	7.8	11.6	5.4	7.5	5.6	4.4	1.0	9.0	9.2	4.1	1.9	6.8	5.2	10.7	3.6	4.4	3.9	7.9	0.0	10.1	7.2	1.7	1.9	6.9	25.7	14.9	15.7	6.9	7.4	9.5
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600655-42648735	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: AB_2681540"	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.01e-4)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.05e-5)"	17.4	19.2	16.4	17.6	18.7	46.5	19.3	22.3	17.1	28.4	17.9	17.7	13.2	18.4	22.4	17.0	23.0	11.4	17.8	15.0	20.3	18.2	21.1	23.9	22.1	20.5	16.4	29.0	22.1	10.6	36.5	11.1	17.6	23.2	13.4	41.3	17.5	10.5	19.5	32.6	25.4	10.7	14.0	36.7	16.3	18.0	18.2	15.4	25.4	10.4	20.0	18.3	22.6	27.8	15.1	7.7	32.3	15.6	16.6	19.3	14.9	22.8	6.8	9.9	12.9	14.7	13.3	25.9	10.7	9.1	9.0	12.6	16.1	8.4	19.2	11.0	13.1	31.4	30.5	24.6	7.3	25.4	19.9	9.6	12.2	18.4	10.5	19.1	17.4	7.1	30.3	20.2	18.6	6.9	17.8	35.5	23.1	7.6	12.3	17.3	12.0	10.5	15.7	12.7	9.4	8.5	24.1	11.1	4.8	16.3	17.5	17.8	28.0	18.0	13.1	21.4	23.2	17.2	21.7	17.7	10.1	30.0	11.3	7.8	3.6	7.5	5.7	4.6	5.3	5.5	5.6	4.9	2.9	5.3	5.6	4.9	5.3	7.0	6.8	5.1	5.3	2.3	16.4	18.7	22.3	17.1	15.0	20.3	20.5	16.4	17.6	14.0	18.2	27.8	221.8	109.0	141.4	169.4	129.5	59.0	60.3	57.8	66.0	200.0	76.3	69.8	68.7	65.8	73.2	88.3	246.0	72.5	156.0	60.3	17.6	47.3	23.9	114.4	125.5	166.2	71.8	76.6	143.5	38.8	51.1	83.3	86.6	132.4	96.8	210.0	110.7	58.6	45.9	132.9	170.0	70.2	61.1	53.8	70.2	21.8	167.7	78.9	51.6	194.9	97.4	101.9	163.7	180.0	267.2	47.6	59.2	134.3	131.3	77.5	106.8	17.0	53.3	279.9	92.1	103.5	88.9	246.2	186.1	42.4	57.3	31.3	164.4	104.5	75.0	54.2
NKX2-5	"CSX, CSX1, NKX2.5, NKX2E, NKX4-1"	ENSG00000183072	"NK2 homeobox 5"	P52952	5	173232109-173235311	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Atrial septal defect, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 229.0"	"Cell type enriched"	"Detected in some"	26	"Cardiomyocytes: 68.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 32.9;NTERA-2: 11.4;SK-MEL-30: 15.2;U-2 OS: 25.4;U-251 MG: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065034			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA065034: AB_2685409"	"unprognostic (3.81e-1)"	"unprognostic (8.53e-2)"		"unprognostic (2.62e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.22e-3)"		"unprognostic (6.63e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.31e-1)"			"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"		"unprognostic (1.77e-2)"	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	229.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	34.9	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	5.0	1.7	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	7.6	32.9	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	0.5	6.3	0.0	15.2	4.2	0.0	0.1	0.0	5.9	25.4	7.8	20.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.1	0.1	0.0	0.7	0.0	0.0
NKX2-6	"CSX2, NKX4-2"	ENSG00000180053	"NK2 homeobox 6"	A6NCS4	8	23701740-23706756	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"salivary gland: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTEC/SVTERT24-B: 5.6;JURKAT: 2.1;LHCN-M2: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA025288			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA025288: "												"unprognostic (1.86e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	2.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580004-36582614	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;esophagus: 2.6;testis: 7.9"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.3;Basal squamous epithelial cells: 6.8;Late spermatids: 2.1;Oligodendrocytes: 2.6;Prostatic glandular cells: 2.1;Squamous epithelial cells: 3.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;PC-3: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Plasma membrane"	"HPA062879: AB_2684892"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.0	0.0	0.4	0.0	1.1	0.0	0.0	1.2	0.5	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.3	0.0	2.3	1.3	0.0	0.0	0.1	1.1	0.0	2.4	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	7.9	2.1	0.0	1.4	0.0	0.0	0.0	0.0	4.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	3.6	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	1.2	0.5	0.2	2.1	2.3	1.3	2.4	2.0	2.1	4.4	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.9	6.8	0.0	1.0	1.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	3.4	0.4	0.0	0.0	0.0	0.0	0.4
NKX3-1	"BAPX2, NKX3.1, NKX3A"	ENSG00000167034	"NK3 homeobox 1"	Q99801	8	23678697-23682938	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"prostate: 303.3"	"Group enriched"	"Detected in many"	6	"Basal prostatic cells: 51.0;Prostatic glandular cells: 124.8"	"Cancer enriched"	"Detected in many"	65	"prostate cancer: 392.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 54.0;neutrophil: 51.6"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 54.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 25.7;SiHa: 26.1;U-138 MG: 25.8;U-251 MG: 23.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA025693, HPA078571"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA025693: AB_1854522, HPA078571: AB_2732384"	"unprognostic (1.47e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.56e-6)"	"unprognostic (6.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.69e-1)"	1.7	3.9	1.0	1.5	1.2	2.2	2.1	1.4	1.4	1.1	0.9	1.4	1.4	1.5	1.3	3.7	1.8	1.1	2.6	1.2	1.6	1.4	4.1	1.4	1.2	1.8	1.5	2.8	1.8	1.0	0.9	0.8	1.6	303.3	0.5	1.7	62.0	1.8	3.2	0.4	1.0	1.9	1.7	0.8	1.4	24.0	1.5	0.5	0.7	3.9	1.6	2.9	1.9	1.4	4.9	3.7	0.0	8.7	3.1	0.7	7.1	6.7	4.2	13.8	16.2	2.1	5.5	0.0	1.0	5.0	25.7	1.2	3.5	7.6	10.9	0.0	1.8	3.4	2.6	5.5	6.0	0.0	1.2	1.2	2.0	14.0	0.8	8.5	0.7	20.1	0.2	0.0	5.5	1.6	11.8	1.0	2.0	0.0	2.6	0.0	5.5	0.5	0.8	5.7	1.6	0.4	26.1	4.8	0.4	9.9	3.5	0.5	0.9	25.8	9.1	2.0	23.0	0.0	0.0	0.0	12.5	2.6	3.2	10.2	0.0	54.0	1.0	0.1	0.2	2.2	0.4	1.0	0.1	1.8	1.4	2.5	51.6	0.6	0.1	0.0	0.0	0.3	1.0	1.2	1.4	1.4	1.2	1.6	1.8	1.5	1.6	1.7	1.5	1.4	6.0	3.2	5.3	0.0	4.1	5.6	51.0	4.1	4.6	3.7	13.5	6.5	9.8	1.5	4.7	0.0	8.4	0.3	0.3	1.0	0.0	2.7	2.7	1.3	2.0	6.8	6.6	0.0	0.4	7.0	1.4	9.1	5.1	2.2	0.0	0.8	4.6	4.9	0.3	3.3	0.4	1.2	2.0	0.3	9.4	6.1	2.1	2.5	1.8	0.0	0.6	4.9	0.0	0.5	0.1	5.2	0.1	6.4	1.0	124.8	0.4	0.7	1.4	4.5	0.0	11.4	5.1	1.8	2.1	2.5	2.0	0.3	2.5	0.8	1.1	12.2
NKX3-2	"BAPX1, NKX3.2, NKX3B"	ENSG00000109705	"NK3 homeobox 2"	P78367	4	13540830-13544508	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 18.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.2;Cardiomyocytes: 4.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.3;NB-4: 11.3;NTERA-2: 6.2;THP-1: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027564	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm		"HPA027564: AB_10601973"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.24e-5)"	"unprognostic (3.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.93e-8)"	"unprognostic (5.81e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	1.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.9	0.0	18.7	0.6	0.4	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.1	0.6	0.0	0.0	0.4	1.0	0.0	0.1	0.2	0.0	0.1	1.8	1.4	0.0	2.3	1.8	0.7	0.0	0.0	0.2	0.4	0.0	0.0	1.4	0.0	0.0	0.4	2.0	1.8	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.9	0.0	4.3	0.0	0.0	0.0	2.2	0.6	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.5	1.4	0.0	0.6	0.0	0.3	11.3	6.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.9	6.6	0.0	0.5	2.5	0.1	0.4	1.7	0.0	0.0	0.4	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
NKX6-1	"Nkx6.1, NKX6A"	ENSG00000163623	"NK6 homeobox 1"	P78426	4	84491985-84499292	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.2;esophagus: 9.2;pancreas: 6.4"	"Group enriched"	"Detected in some"	5	"Ductal cells: 9.3;Early spermatids: 25.8;Spermatocytes: 16.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 14.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.4;HAP1: 6.2;HEK 293: 5.0;HMC-1: 4.1;PC-3: 3.0;U-2197: 6.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.6"	"Group enriched"	"Detected in many"	5	"hypothalamus: 2.5;medulla oblongata: 3.4;midbrain: 3.8;pons: 3.8;spinal cord: 7.9"	"HPA036774, CAB070169"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB070169: AB_10011794, HPA036774: AB_10673664"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"		"unprognostic (9.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.68e-1)"	0.0	0.0	0.7	0.0	1.0	0.0	0.2	0.6	0.6	0.0	0.6	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.6	2.8	0.0	0.0	0.1	0.0	4.2	14.2	0.1	6.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.7	2.2	1.6	0.0	3.2	0.0	0.0	0.0	0.0	1.3	0.2	0.1	4.4	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	2.0	0.0	6.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	3.0	0.0	2.0	0.0	0.0	0.3	1.1	0.0	0.7	0.0	0.0	1.3	0.0	0.5	0.0	0.0	1.8	6.8	2.0	0.0	0.0	0.0	1.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.6	0.6	0.6	2.8	4.2	14.2	4.0	4.2	1.6	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	25.8	0.2	1.0	0.1	0.0	0.0	0.0	0.4	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	16.7	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128730-35142304	"Predicted intracellular proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (6.39e-4)"	7.3	7.4	5.0	5.8	5.0	6.2	8.8	5.1	5.3	7.4	3.4	5.6	4.0	6.8	2.9	8.4	7.4	3.1	4.2	5.0	4.5	6.5	7.3	4.6	6.8	4.7	4.0	12.0	23.7	3.9	4.2	4.9	4.0	6.0	4.0	2.5	7.6	4.6	8.0	6.8	5.1	4.1	3.5	6.2	7.6	4.4	5.0	6.6	5.1	3.5	5.4	7.4	5.8	4.6	15.9	36.8	12.5	22.7	6.9	11.4	19.6	14.0	12.7	24.4	19.3	26.1	14.8	34.9	18.6	12.0	18.0	21.0	26.8	35.6	15.1	5.6	44.2	14.9	18.2	33.2	10.3	29.9	12.0	12.9	19.0	25.6	38.3	10.7	15.5	33.9	42.4	12.7	14.6	22.1	47.1	25.5	23.6	13.5	16.6	37.6	20.9	38.5	14.3	14.8	25.6	14.8	13.1	13.4	17.1	11.1	32.4	22.4	14.5	13.3	18.3	13.0	47.4	9.8	7.8	29.1	9.3	24.9	25.8	0.1	2.2	0.0	4.0	2.4	6.2	3.4	3.8	4.2	3.4	4.6	5.2	3.5	0.3	1.8	1.2	0.8	2.1	2.2	5.0	5.0	5.1	5.3	5.0	4.5	4.7	4.0	4.0	3.5	5.0	4.6	4.7	3.2	1.1	0.3	8.6	8.7	8.6	7.4	9.6	4.7	12.3	14.0	2.6	10.0	3.7	3.7	2.1	12.1	2.4	3.9	0.0	8.9	1.0	2.1	5.4	5.0	4.9	8.8	1.3	15.4	20.9	7.4	6.6	2.8	3.8	9.4	5.3	6.6	7.6	1.7	1.5	8.1	2.0	4.6	2.6	5.4	4.1	2.8	1.8	1.0	3.8	1.9	2.1	1.0	0.7	8.5	3.6	4.9	5.1	8.6	3.4	7.1	2.8	3.1	0.0	6.5	7.2	4.2	6.5	12.5	10.1	4.9	4.1	9.2	13.4	5.5
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 78.6"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 154.3;Early spermatids: 261.1;Excitatory neurons: 315.5;Late spermatids: 355.3;Oligodendrocytes: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	45	"basophil: 29.9"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: AB_2683160"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	8.2	36.6	16.7	8.6	27.6	9.9	9.4	5.7	41.9	7.9	1.0	9.0	10.3	7.0	11.2	5.5	6.4	8.7	11.5	28.5	9.2	16.6	11.1	9.1	16.4	11.9	10.4	5.0	14.3	28.2	11.1	12.2	8.4	8.2	9.2	78.6	7.4	10.8	6.6	5.9	10.2	5.9	6.5	12.2	8.9	22.0	12.2	13.2	16.8	6.7	15.4	10.1	4.5	30.1	9.5	11.6	28.4	9.7	6.1	7.6	12.1	9.6	10.9	16.9	13.1	59.4	9.1	13.6	13.8	8.4	20.2	8.6	19.6	18.7	19.3	29.7	12.2	52.2	11.2	9.9	10.3	11.6	51.0	9.6	11.9	10.4	12.5	16.0	20.4	36.3	20.1	15.9	16.4	11.6	28.8	13.4	10.4	20.1	5.5	23.8	17.2	10.0	32.0	12.2	19.6	7.2	14.4	14.4	62.4	32.2	22.0	18.2	19.2	11.7	14.1	9.0	19.5	17.6	17.9	13.1	11.6	12.6	13.0	29.9	0.3	0.3	0.5	0.4	0.2	0.6	0.5	0.6	0.3	0.3	0.3	0.6	0.2	0.2	0.5	0.5	0.5	0.3	16.7	27.6	5.7	41.9	28.5	9.2	11.9	10.4	8.4	6.5	12.2	30.1	17.8	22.4	6.0	57.8	7.8	5.4	3.8	3.0	5.7	94.4	8.7	5.0	27.4	5.7	5.3	33.1	154.3	3.7	4.3	11.4	1.9	3.9	261.1	8.9	5.8	15.0	28.2	11.8	315.5	6.4	3.5	4.8	5.1	11.9	24.1	17.6	9.3	9.4	8.8	37.0	98.2	10.0	2.0	16.9	6.0	355.3	5.6	11.3	16.0	103.0	7.9	11.2	6.2	104.5	366.6	5.7	8.1	2.6	6.4	5.4	5.1	8.4	9.5	89.9	13.1	5.0	6.9	37.1	11.8	4.1	4.8	6.4	5.5	6.7	10.3	6.6
NLRP1	"CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1"	ENSG00000091592	"NLR family pyrin domain containing 1"	Q9C000	17	5499427-5619424	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 561.7;Muller glia cells: 151.8"	"Cancer enhanced"	"Detected in all"		"glioma: 20.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 55.4;Karpas-707: 90.9;U-266/70: 45.0"									"CAB009189, HPA064431"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Cytosol"		"CAB009189: , HPA064431: AB_2685262"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-2)"	27.9	4.0	3.6	27.8	3.7	25.0	22.1	3.2	5.3	22.9	3.5	10.8	5.8	13.8	1.8	16.2	14.4	13.4	15.7	2.9	3.7	9.4	5.3	26.9	38.1	5.5	3.8	5.8	3.2	1.8	4.1	12.1	5.5	13.2	7.8	0.3	10.8	9.0	7.7	50.8	31.1	9.7	3.7	56.3	6.9	6.1	4.0	15.1	21.8	7.7	32.4	15.8	27.7	4.1	14.2	0.0	0.0	0.0	8.6	10.2	1.8	6.9	6.3	2.6	5.7	0.2	5.5	5.3	20.8	7.6	1.1	6.5	0.0	23.4	4.0	55.4	0.0	1.4	4.8	0.5	7.1	0.0	1.6	6.6	14.5	20.7	13.7	10.4	25.6	1.1	13.0	90.9	11.8	0.0	0.1	4.6	0.0	0.0	0.3	6.0	4.0	23.0	0.0	4.8	0.7	0.0	0.0	0.2	0.4	0.6	0.0	0.5	25.2	5.3	3.0	3.2	1.1	45.0	15.9	4.1	8.7	0.6	0.3	18.3	7.1	5.0	5.9	4.9	6.6	4.4	5.1	6.3	5.0	4.9	5.5	5.2	18.9	4.2	8.6	0.5	7.7	4.6	3.6	3.7	3.2	5.3	2.9	3.7	5.5	3.8	5.5	3.7	4.0	4.1	46.4	0.0	7.8	1.3	29.0	17.7	7.1	8.0	15.4	60.6	2.7	6.2	4.9	2.8	10.4	7.3	4.2	0.8	30.3	0.3	3.9	0.4	561.7	4.9	18.0	26.9	77.9	3.6	2.9	0.0	1.1	31.6	3.6	1.0	3.8	7.8	44.6	0.6	7.0	85.8	1.5	1.2	0.0	23.0	24.3	93.4	25.4	26.2	7.2	56.2	27.0	151.8	26.8	1.5	0.8	7.0	0.0	28.2	25.9	2.0	0.0	0.4	12.7	11.6	6.6	33.1	17.3	25.0	11.0	10.7	24.9	1.5	37.6	3.6	0.2	8.0
NLRP10	"CLR11.1, NALP10, NOD8, PAN5, Pynod"	ENSG00000182261	"NLR family pyrin domain containing 10"	Q86W26	11	7957537-7965426	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 6.3"	"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.3;BJ: 5.9;HBF TERT88: 7.7;LHCN-M2: 3.7"	"Region enhanced"	"Detected in some"		"olfactory bulb: 2.1"					"HPA039498, HPA040101"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 10: BJ & FHDF - ECM organization"		Nucleoplasm	"Nuclear membrane"	"HPA039498: AB_10795679, HPA040101: AB_10795519"						"unprognostic (4.06e-1)"			"unprognostic (4.34e-1)"						"unprognostic (9.78e-3)"		"unprognostic (2.87e-2)"	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.3	0.0	0.0	0.1	0.0	0.3	0.1	5.9	2.8	1.3	2.8	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	1.0	7.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
NMB	"MGC17211, MGC2277, MGC3936"	ENSG00000197696	"Neuromedin B"	P08949	15	84655129-84658563	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 68.3;brain: 58.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 319.5;Club cells: 164.2;Ductal cells: 123.9"	"Cancer enhanced"	"Detected in all"		"glioma: 93.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 90.1"	"Region enriched"	"Detected in all"	16	"olfactory bulb: 168.0"	"Group enriched"	"Detected in all"	5	"olfactory bulb: 43.3;pons: 14.1"	CAB019302	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"CAB019302: "	"unprognostic (2.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.79e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.81e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.36e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (7.92e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	68.3	24.0	19.9	4.1	17.9	6.0	30.7	18.2	23.5	8.3	16.3	5.3	3.1	7.5	4.9	6.9	8.6	4.8	5.4	21.4	58.9	10.7	3.1	6.2	5.7	29.3	22.7	7.1	8.4	4.5	9.8	1.9	26.2	5.0	2.9	3.0	7.4	2.5	2.5	4.9	4.1	4.7	22.4	4.8	5.5	11.9	21.4	4.5	17.7	3.1	3.0	8.5	6.5	44.7	90.1	35.3	6.1	1.3	17.1	7.7	0.8	4.7	10.5	12.5	16.6	12.9	23.5	3.4	12.9	14.7	0.1	15.0	34.0	7.0	7.4	30.3	36.7	12.4	13.2	59.7	4.4	8.2	13.6	7.6	2.8	18.2	7.2	7.6	17.9	23.3	0.2	1.4	6.9	55.2	8.8	30.0	22.9	18.0	8.9	25.7	0.1	38.7	11.5	7.3	3.1	34.6	8.2	5.1	40.5	6.0	5.9	33.8	4.0	2.4	10.3	10.3	7.9	0.7	9.9	8.2	26.3	52.9	14.1	0.0	1.0	7.8	7.9	0.7	2.9	5.9	5.9	7.7	4.5	11.3	5.8	4.1	1.6	1.8	0.5	13.4	7.6	3.4	19.9	17.9	18.2	23.5	21.4	58.9	29.3	22.7	26.2	22.4	21.4	44.7	39.0	3.2	2.7	5.5	13.6	15.6	29.5	319.5	21.6	1.9	30.7	37.6	3.5	20.0	164.2	31.3	0.0	2.4	25.3	5.3	13.7	123.9	33.7	21.3	7.3	19.6	18.6	7.4	0.6	58.2	14.1	19.7	11.2	15.6	5.7	12.0	7.5	3.7	32.3	5.0	1.2	6.5	18.3	8.8	86.4	29.0	4.4	26.0	33.8	1.9	18.5	6.5	25.7	2.0	1.0	45.2	5.1	3.8	32.5	39.3	0.8	32.0	57.8	4.1	13.1	22.5	28.6	24.0	21.6	29.5	12.8	3.1	19.7	8.2	9.1	60.6
NMD3	CGI-07	ENSG00000169251	"NMD3 ribosome export adaptor"	Q96D46	3	161104696-161253532	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035019			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA035019: AB_10600922"	"unprognostic (1.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.97e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-3)"	26.9	21.5	13.1	18.1	13.8	64.7	32.3	19.3	14.1	27.0	12.8	18.6	17.6	26.3	15.3	24.4	20.2	22.6	40.0	11.2	14.2	29.2	77.7	19.7	22.3	10.8	13.4	26.4	34.9	21.9	12.7	25.6	11.8	27.7	21.2	17.0	32.8	20.0	60.3	17.2	15.4	28.3	12.1	21.1	42.5	16.0	13.0	18.7	25.2	34.5	24.7	39.3	16.5	13.9	68.7	39.2	37.8	38.6	46.3	63.1	51.9	76.3	57.9	55.9	64.8	66.5	54.9	86.4	94.8	53.8	39.3	43.8	60.9	56.1	86.4	90.2	37.4	89.0	31.4	41.7	50.7	108.0	51.7	53.2	40.9	39.7	129.1	59.4	61.4	29.9	66.3	46.3	66.8	155.7	49.6	41.3	47.4	82.1	61.7	59.8	54.5	87.9	53.1	153.2	59.8	37.3	43.5	105.2	63.9	40.9	78.3	49.0	54.2	44.1	31.5	51.3	93.4	75.6	54.5	87.1	55.5	69.5	61.5	30.5	16.6	8.9	16.5	17.6	25.9	17.3	19.2	20.4	19.8	15.6	25.3	20.1	3.6	35.4	11.4	11.0	26.8	20.7	13.1	13.8	19.3	14.1	11.2	14.2	10.8	13.4	11.8	12.1	13.0	13.9	30.6	19.2	14.6	22.9	25.3	64.9	52.9	23.8	34.7	24.7	26.8	16.5	43.9	21.5	25.1	11.0	14.6	33.3	25.2	14.0	35.2	25.6	19.3	13.8	29.6	30.1	13.8	32.2	16.6	38.9	48.8	34.0	31.1	19.3	25.4	20.3	22.1	41.6	23.4	30.3	15.3	19.4	26.4	33.1	47.0	7.0	25.4	21.6	24.9	12.2	26.1	12.8	21.6	19.6	18.2	33.0	13.9	27.4	20.9	46.7	19.7	39.9	18.5	20.8	26.3	29.1	87.5	39.2	27.4	33.4	74.3	56.6	25.8	24.4	21.2	72.7
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153559-51162428	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	63.6	84.4	79.3	74.7	81.6	77.0	63.1	78.7	102.2	38.2	79.0	60.1	38.8	49.7	46.8	91.0	48.6	20.8	37.7	88.0	92.0	65.4	83.2	41.3	73.9	83.9	78.4	33.6	67.8	52.8	47.4	39.2	82.4	38.7	77.6	218.4	50.7	30.4	35.6	57.5	33.1	66.3	76.5	48.5	41.8	25.3	81.0	61.1	41.3	20.9	95.8	72.2	48.9	80.1	483.6	833.1	285.9	444.8	118.6	183.7	479.7	355.3	227.3	652.2	489.7	656.9	288.1	754.2	372.4	304.1	272.4	252.1	542.5	553.3	553.4	398.4	729.3	504.9	605.8	975.9	237.1	575.8	243.8	177.8	341.7	493.1	458.6	120.6	404.6	247.8	739.0	270.0	392.8	720.4	715.2	647.1	390.7	957.5	739.3	446.9	587.6	751.3	511.5	320.2	418.6	461.1	188.1	521.0	385.3	246.2	554.0	419.6	279.5	476.9	452.2	307.0	774.4	374.0	840.9	956.3	286.2	480.4	385.8	1.1	55.0	2.1	47.2	77.1	69.3	96.4	50.3	53.8	134.0	67.6	54.3	60.4	1.7	69.6	48.6	84.8	49.1	68.4	79.3	81.6	78.7	102.2	88.0	92.0	83.9	78.4	82.4	76.5	81.0	80.1	53.1	32.1	30.5	0.0	71.3	132.4	97.5	198.8	88.8	283.3	98.8	118.1	34.2	65.8	92.3	71.7	285.7	180.0	25.4	54.2	150.6	211.3	34.2	40.2	107.2	85.1	89.7	81.8	0.0	201.5	269.7	85.0	64.2	37.2	45.7	113.5	27.8	123.3	207.1	40.4	0.0	107.4	101.7	25.7	88.9	93.7	61.2	48.9	129.9	0.0	47.2	105.6	27.8	0.0	0.0	194.0	50.5	58.6	113.8	170.6	12.2	195.2	42.0	323.7	13.1	83.0	182.9	22.7	98.8	139.4	133.1	88.5	38.0	215.5	157.7	98.2
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		12000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA041113: AB_2677305, HPA052733: AB_2681930"	"prognostic favorable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	34.0	84.4	21.3	8.0	22.7	3.9	34.2	21.0	36.3	41.9	16.8	47.7	15.9	36.7	3.4	27.2	44.3	2.1	36.0	20.2	23.1	44.6	36.3	29.1	5.4	23.7	22.2	43.7	37.2	4.5	71.9	5.2	19.6	59.4	3.1	1.8	35.9	13.0	17.1	31.1	33.8	3.2	22.5	39.4	38.6	16.0	22.0	1.0	40.3	3.1	1.9	38.5	33.5	24.9	1.6	26.9	0.6	21.8	6.1	3.2	2.5	15.7	4.5	2.7	2.1	0.0	31.8	0.4	42.6	2.2	2.8	23.0	1.3	8.8	0.3	32.1	70.9	0.0	12.0	13.0	11.3	5.5	9.8	14.0	7.9	2.7	1.5	5.1	5.6	0.2	11.2	4.4	2.7	40.4	0.4	10.8	28.0	5.4	21.5	15.3	0.3	43.5	4.5	1.2	30.6	23.6	47.1	35.2	4.2	1.2	33.7	13.1	19.9	5.8	21.4	18.5	10.8	11.1	3.7	2.5	8.1	0.9	13.3	10.0	50.7	34.6	33.3	49.6	32.9	36.8	46.3	31.4	45.1	31.9	39.6	31.3	10.8	44.8	55.4	70.3	45.4	41.3	21.3	22.7	21.0	36.3	20.2	23.1	23.7	22.2	19.6	22.5	22.0	24.9	128.8	35.3	62.7	69.9	64.6	72.5	141.3	97.7	179.8	116.3	147.3	165.6	28.0	90.1	76.6	126.9	60.5	86.6	77.9	76.2	60.7	62.9	22.1	66.5	102.9	84.1	135.5	25.7	34.6	37.6	46.3	100.9	76.0	77.6	50.8	71.6	99.9	63.0	74.8	65.6	30.2	109.4	50.8	60.3	91.0	20.3	149.5	71.1	81.8	29.0	136.5	126.9	77.2	40.7	63.7	37.0	104.7	127.5	93.1	98.4	157.2	150.2	70.9	126.7	118.3	75.9	100.8	2.0	40.4	100.9	65.6	46.1	87.3	183.8	107.6	100.6
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115175-138139443	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 37.2;testis: 53.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 704.9;Endometrial ciliated cells: 205.8;Late spermatids: 256.5;Respiratory ciliated cells: 431.9;Spermatocytes: 326.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555, HPA058103"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear bodies"		"HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: "	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.4	6.5	9.7	0.5	10.5	0.0	4.5	9.2	11.7	8.6	18.6	2.1	0.2	4.9	23.1	1.0	37.2	8.7	3.6	10.5	9.2	20.5	0.5	4.5	0.4	10.5	12.3	5.3	4.4	24.3	8.9	0.1	12.1	5.0	1.1	12.9	3.7	4.5	0.4	0.3	0.6	3.1	9.6	0.2	2.8	53.3	11.0	0.7	12.4	0.6	0.2	2.1	0.6	8.9	0.0	0.0	3.9	4.3	0.0	0.0	0.0	0.7	0.4	0.7	0.3	0.1	1.8	0.0	1.1	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	2.1	0.0	0.9	0.0	3.8	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	29.9	0.0	6.7	2.5	0.0	0.8	4.9	1.7	0.5	1.6	0.0	0.7	0.0	0.0	0.9	0.4	0.8	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.5	9.2	11.7	10.5	9.2	10.5	12.3	12.1	9.6	11.0	8.9	1.0	6.4	7.5	26.8	0.3	0.6	8.5	41.1	0.0	11.7	9.0	7.9	4.3	8.6	38.1	33.1	14.6	0.5	0.1	0.3	86.1	23.8	704.9	205.8	9.2	3.5	5.4	0.0	57.9	4.0	0.0	4.2	2.6	12.7	0.0	7.7	3.6	0.6	0.1	6.7	42.2	3.3	44.7	0.0	0.3	256.5	9.0	1.4	10.6	3.7	0.6	19.1	0.0	11.1	8.1	4.2	0.3	13.9	0.0	4.8	0.2	92.3	431.9	25.8	0.0	0.5	12.6	326.8	24.7	0.0	0.3	0.0	0.8	10.9	1.7	5.9
NME7	"CFAP67, FLJ37194, NM23-H7"	ENSG00000143156	"NME/NM23 family member 7"	Q9Y5B8	1	169132531-169367948	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 274.9;Inhibitory neurons: 307.2;Oligodendrocytes: 277.7;Respiratory ciliated cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028334, HPA038014, HPA054289"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA028334: , HPA038014: AB_10673037, HPA054289: AB_2682437"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.44e-3)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	6.7	10.6	9.4	5.5	9.9	3.5	11.1	8.4	12.2	13.0	11.8	9.8	3.9	12.9	13.3	7.5	27.7	10.0	6.2	10.8	10.8	12.5	7.9	7.6	5.6	10.2	10.0	13.6	7.2	18.3	14.2	4.8	9.9	8.0	5.6	20.7	4.3	11.5	4.1	4.0	4.6	14.9	9.3	4.4	5.8	16.0	9.9	11.1	13.6	4.9	6.4	8.8	6.2	9.6	24.3	23.6	26.4	20.9	25.1	26.1	9.4	16.6	24.2	28.5	35.8	13.8	33.7	7.1	29.4	14.5	38.8	16.2	15.6	35.3	46.1	25.5	12.3	12.5	21.3	14.1	18.5	23.8	8.3	18.8	20.1	29.5	38.3	39.2	40.8	21.1	12.6	9.5	28.8	7.1	22.7	16.8	26.5	27.4	25.2	16.1	29.4	15.3	46.0	7.3	27.5	40.6	23.0	7.6	18.4	28.3	24.4	16.4	25.4	17.4	59.5	16.5	40.2	11.7	21.3	14.8	19.8	8.2	17.8	1.6	3.9	2.1	9.6	6.3	11.6	9.9	12.0	9.9	6.3	9.3	10.1	11.7	1.1	11.4	9.8	5.1	14.9	5.3	9.4	9.9	8.4	12.2	10.8	10.8	10.2	10.0	9.9	9.3	9.9	9.6	12.3	6.4	10.9	97.6	9.0	14.4	34.5	61.9	15.4	18.9	13.7	14.7	5.1	20.0	29.3	27.6	25.0	7.6	9.2	2.1	23.5	26.6	43.2	75.7	20.4	12.8	17.5	13.7	274.9	8.9	7.4	21.1	12.8	22.2	21.5	21.8	13.9	11.2	14.6	28.6	307.2	4.1	36.7	4.1	11.9	13.8	18.0	6.5	8.8	64.6	3.3	23.8	10.3	106.1	277.7	16.9	6.0	20.7	7.2	8.6	4.9	40.9	142.9	64.9	19.7	21.2	24.7	67.7	21.9	9.2	10.2	2.7	18.7	26.4	6.0	16.5
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270470-151289894	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 207.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	20.6	15.7	7.3	44.5	7.1	74.5	23.3	7.0	10.4	15.2	7.4	25.9	33.7	13.9	16.6	19.0	19.8	24.0	7.5	7.1	7.7	14.0	35.5	28.6	43.4	8.6	7.7	16.8	7.8	6.3	4.2	34.2	8.2	13.2	26.7	1.4	20.2	17.2	4.8	19.4	33.8	20.9	8.2	47.5	24.9	6.6	7.9	44.4	16.9	8.3	33.5	27.9	10.5	8.2	53.2	25.7	1.3	0.0	14.4	39.4	49.3	14.6	36.8	74.1	112.0	5.9	119.9	51.0	55.4	23.5	24.5	29.6	5.6	13.8	18.6	110.0	3.0	144.9	27.3	3.1	63.1	139.9	40.2	25.7	18.3	44.1	10.0	32.1	91.8	56.4	74.0	12.6	14.4	41.6	116.4	207.7	29.5	10.9	37.6	125.5	2.9	45.8	60.9	46.1	7.4	0.3	32.0	35.1	20.5	5.1	5.6	157.9	47.5	10.5	23.3	33.8	22.3	1.8	2.0	3.2	24.5	166.4	11.3	251.3	121.3	140.5	62.7	172.8	74.3	64.8	66.1	63.4	108.8	58.5	52.1	54.3	466.8	98.1	170.0	43.3	62.3	104.3	7.3	7.1	7.0	10.4	7.1	7.7	8.6	7.7	8.2	8.2	7.9	8.2	37.3	25.6	24.9	2.9	22.9	16.7	21.1	47.0	15.4	0.3	13.8	15.1	7.0	18.6	35.6	12.9	0.0	76.4	33.4	21.4	15.6	66.6	3.4	36.2	9.0	41.1	18.0	55.5	0.4	41.1	69.4	19.1	15.3	23.8	36.1	17.7	27.5	17.8	80.2	0.0	0.2	25.1	8.2	49.7	25.6	1.7	19.6	51.5	1.8	12.2	86.5	7.4	57.7	5.0	0.7	40.2	34.5	13.9	12.9	19.1	35.3	35.3	47.4	0.1	6.6	11.7	15.2	3.6	2.2	19.4	17.8	54.5	36.2	23.1	24.9	23.3
NMNAT1	"LCA9, NMNAT, PNAT1"	ENSG00000173614	"Nicotinamide nucleotide adenylyltransferase 1"	Q9HAN9	1	9943428-9985501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059447	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA059447: AB_2684022"	"unprognostic (1.94e-1)"	"unprognostic (3.81e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (3.85e-14)"	"unprognostic (3.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.16e-2)"	5.2	7.4	5.4	4.4	6.0	2.5	5.7	4.8	7.7	5.4	9.2	9.0	6.0	3.8	5.8	5.2	4.8	3.4	10.7	5.1	5.2	8.2	7.8	3.2	4.3	5.6	5.4	2.9	4.9	8.2	3.8	3.7	5.5	4.5	9.0	5.3	5.2	5.4	23.3	5.7	6.1	5.0	4.7	5.0	4.4	4.3	5.9	4.2	7.3	16.9	4.6	4.0	3.6	7.2	4.6	5.4	7.5	7.1	13.4	12.2	1.8	9.1	7.2	10.3	6.7	2.4	7.7	4.8	5.7	12.9	4.5	4.6	9.4	12.4	11.0	10.4	4.8	7.6	3.0	7.6	11.4	6.7	7.7	13.3	14.2	12.1	17.4	9.5	10.2	10.4	9.7	3.1	10.9	8.0	3.8	4.4	0.9	10.2	10.2	4.2	4.7	2.7	11.9	2.5	5.4	2.8	11.8	9.7	10.4	3.8	3.5	7.2	10.2	4.1	3.3	8.7	4.2	4.5	4.3	4.5	7.1	13.8	8.6	7.5	3.7	3.2	1.6	2.6	0.8	4.9	1.6	1.9	3.3	2.3	1.4	1.8	9.1	2.5	3.9	3.2	1.5	1.8	5.4	6.0	4.8	7.7	5.1	5.2	5.6	5.4	5.5	4.7	5.9	7.2	5.6	3.2	4.4	10.1	3.7	2.3	5.6	14.3	2.2	7.7	6.1	5.1	14.4	4.3	7.3	7.3	6.2	10.1	3.7	18.8	23.5	9.1	7.8	5.5	8.1	7.9	3.0	2.1	13.0	6.9	4.7	5.7	4.1	6.1	4.5	9.2	7.5	9.0	12.9	10.1	14.3	7.6	12.2	10.3	2.7	3.7	6.5	7.2	5.4	4.7	13.5	9.6	12.3	6.0	13.2	6.0	6.2	6.4	0.9	5.9	19.0	14.3	8.6	7.1	6.6	5.9	5.1	17.3	8.3	3.6	1.8	9.0	3.6	13.1	14.5	4.8
NMRAL1	"FLJ25918, HSCARG, SDR48A1"	ENSG00000153406	"NmrA like redox sensor 1"	Q9HBL8	16	4461691-4495763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041353, HPA062287"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA041353: AB_10796343, HPA062287: AB_2684738"	"unprognostic (2.56e-1)"	"prognostic favorable (3.33e-7)"	"unprognostic (4.16e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	20.8	39.6	40.2	8.8	42.5	13.4	25.5	41.2	49.4	25.5	36.7	23.3	16.1	24.0	24.7	27.4	23.8	16.1	25.3	41.0	40.4	36.7	57.3	19.9	18.1	42.5	40.4	30.3	44.1	16.2	27.3	13.9	42.4	36.7	11.5	5.0	32.8	19.3	5.2	34.3	23.6	13.6	39.6	26.2	41.4	11.5	41.2	18.6	27.3	4.3	14.8	22.2	24.0	43.5	36.7	47.6	10.3	28.5	26.1	23.7	34.9	26.5	12.0	32.9	25.3	44.3	69.2	0.8	46.2	41.8	9.9	35.3	26.3	43.7	15.7	28.5	10.5	31.1	38.0	24.5	50.5	36.5	22.2	32.4	54.4	41.5	16.7	28.6	39.8	116.3	32.7	0.9	19.2	116.0	81.7	39.2	31.4	55.8	39.7	73.7	0.7	42.4	42.1	21.2	12.9	26.6	50.4	78.1	27.4	6.5	66.5	39.4	17.9	17.5	0.8	14.9	0.3	0.9	0.6	57.1	8.9	35.6	31.5	13.1	59.3	6.1	61.1	35.9	45.6	38.9	42.6	57.2	53.9	35.0	43.2	44.3	32.5	27.9	26.6	52.7	42.3	53.7	40.2	42.5	41.2	49.4	41.0	40.4	42.5	40.4	42.4	39.6	41.2	43.5	16.2	25.6	26.0	11.1	19.3	27.3	38.1	48.8	43.3	11.7	48.7	46.4	22.6	40.0	38.7	42.3	0.0	105.8	30.6	29.1	52.8	34.6	12.5	24.9	21.8	19.0	20.4	20.8	9.1	49.8	102.5	23.8	46.4	34.4	20.8	41.3	26.4	78.7	67.1	5.0	11.1	38.2	30.5	29.5	18.7	35.7	29.2	23.1	35.6	8.4	30.9	45.5	54.6	7.5	19.0	37.4	36.5	30.5	27.8	29.0	46.3	114.5	35.7	10.0	26.3	10.6	24.0	5.4	37.3	29.6	30.5	64.2	32.9	37.9	38.5	32.8
NMRK1	"bA235O14.2, C9orf95, FLJ20559, NRK1"	ENSG00000106733	"Nicotinamide riboside kinase 1"	Q9NWW6	9	75060573-75088217	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 68.6;Karpas-707: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049795	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	Centrosome	"HPA049795: AB_2680886"	"unprognostic (1.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (3.70e-6)"	"unprognostic (3.56e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.64e-2)"	22.1	11.5	14.6	14.3	15.0	12.6	20.2	17.0	18.9	21.8	15.4	15.3	17.8	11.2	18.5	39.5	16.4	14.1	15.5	15.2	15.4	32.5	53.7	21.7	17.5	14.9	14.8	22.7	45.1	64.1	19.8	14.8	15.2	23.7	13.0	8.8	31.2	13.6	27.2	23.2	22.4	8.8	14.8	31.1	26.0	9.7	14.4	17.3	25.6	13.4	20.0	18.8	25.6	15.2	11.7	2.7	3.2	7.9	21.4	28.0	18.1	17.0	22.4	3.5	5.8	0.1	29.8	6.8	10.0	13.8	7.2	18.5	3.8	9.4	10.0	68.6	3.5	5.1	5.6	5.7	20.3	4.8	0.8	22.5	23.5	6.3	11.8	20.8	25.1	10.8	0.5	79.0	24.6	8.4	4.3	4.3	3.9	40.2	10.0	1.6	29.7	42.1	28.9	19.5	2.2	0.5	7.3	6.4	9.0	19.2	18.4	4.5	20.6	13.5	2.9	12.9	4.6	37.5	31.4	4.1	23.1	4.9	13.8	16.4	5.4	9.3	25.1	5.1	30.5	13.4	43.7	29.2	6.1	9.1	39.4	30.2	9.8	17.2	14.5	17.2	31.6	18.1	14.6	15.0	17.0	18.9	15.2	15.4	14.9	14.8	15.2	14.8	14.4	15.2	42.2	38.5	21.7	11.8	22.6	21.0	36.4	38.2	38.7	8.4	33.4	37.5	15.5	21.5	27.9	23.9	8.4	53.3	43.7	32.8	52.8	30.5	17.8	42.4	16.8	33.4	4.2	10.3	26.2	35.5	75.7	22.7	49.5	37.4	1.3	8.3	55.3	45.2	62.4	11.8	20.6	34.8	22.4	32.5	9.6	30.8	23.6	22.9	26.6	14.0	67.6	15.2	43.3	13.6	23.9	21.5	26.1	12.4	68.8	23.4	83.8	92.1	30.5	8.3	13.1	24.5	15.0	10.7	8.3	50.9	27.0	45.6	48.8	22.2	25.0	32.6
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	116	"heart muscle: 1438.4;skeletal muscle: 634.8;tongue: 722.1"	"Cell type enriched"	"Detected in some"	36	"Cardiomyocytes: 995.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8;testis cancer: 13.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 29.2;NTERA-2: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522"				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.7	1.7	0.2	0.0	0.2	0.0	0.8	0.2	0.8	0.2	0.2	0.5	0.0	0.4	0.1	5.7	0.6	0.0	1438.4	0.2	0.4	1.9	0.3	2.1	0.0	0.3	0.4	0.5	0.6	0.0	1.7	0.1	0.1	2.6	0.1	0.0	8.0	0.8	634.8	0.7	0.5	0.0	0.2	0.1	0.6	0.5	0.2	0.0	0.6	722.1	0.0	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.8	0.2	0.4	0.3	0.4	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	995.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.4	0.0	0.0	0.2	0.0	0.6	26.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	24.6	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0
NOC3L	"AD24, C10orf117, FAD24, FLJ12820"	ENSG00000173145	"NOC3 like DNA replication regulator"	Q8WTT2	10	94333226-94362959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063958, HPA067638, HPA070981"			Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331"	"unprognostic (1.29e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.93e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.30e-1)"	8.6	9.0	5.1	9.5	6.5	3.6	11.2	5.9	5.9	6.7	5.9	5.2	5.4	8.5	6.4	9.0	6.2	5.7	5.3	4.6	5.8	7.2	9.9	5.2	13.1	6.5	6.4	8.2	5.3	9.1	4.3	8.9	6.5	7.4	6.3	6.2	5.3	6.5	9.4	9.3	5.4	7.1	6.4	11.4	5.5	10.4	5.8	7.5	11.1	10.4	13.2	10.3	6.4	7.1	38.4	20.6	13.6	44.1	13.9	22.4	16.1	29.9	23.6	40.2	46.3	35.1	26.4	41.3	21.4	15.0	20.6	26.9	39.2	18.0	64.6	28.3	29.3	28.1	16.6	22.6	27.8	45.0	12.2	13.0	17.3	42.5	42.2	26.2	18.1	15.1	44.2	20.3	40.0	12.9	28.5	33.2	28.9	22.3	22.4	12.5	31.3	22.8	23.7	11.7	9.7	24.1	21.4	10.7	33.9	15.2	27.6	17.1	17.7	25.6	25.9	23.4	50.9	19.1	40.8	56.8	23.4	42.6	19.5	0.1	2.6	0.6	4.3	4.3	5.4	14.4	4.4	5.5	4.6	12.8	5.7	5.2	0.1	8.2	5.0	4.1	4.3	3.3	5.1	6.5	5.9	5.9	4.6	5.8	6.5	6.4	6.5	6.4	5.8	7.1	33.5	19.2	13.7	11.4	38.0	23.7	32.7	17.0	33.0	20.7	16.4	20.7	22.5	14.3	31.8	22.0	8.4	21.1	17.7	5.1	25.4	20.6	3.9	20.3	50.1	26.1	5.4	26.7	11.7	13.8	15.1	27.0	10.2	17.0	29.2	26.9	11.7	12.9	13.2	13.5	15.5	8.1	12.2	17.0	11.9	5.0	18.3	15.0	12.4	11.2	23.3	20.5	20.6	19.6	23.6	15.3	3.4	24.8	26.3	34.1	1.7	22.7	21.1	20.9	13.1	37.8	23.7	64.0	64.5	25.5	21.7	15.2	17.3	44.5	10.7	19.1
NOC4L	"MGC3162, NET49, Noc4, UTP19"	ENSG00000184967	"Nucleolar complex associated 4 homolog"	Q9BVI4	12	132144457-132152473	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.6;Late spermatids: 80.3;Spermatogonia: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053424			Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA053424: AB_2682147"	"unprognostic (9.44e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.79e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	12.6	11.5	2.0	3.3	2.0	6.1	12.8	1.9	3.1	13.1	1.5	11.1	4.2	12.6	1.6	13.8	11.9	1.9	10.8	2.6	2.2	13.2	13.4	10.5	3.6	2.4	1.9	14.4	13.6	2.4	11.3	2.7	2.1	11.1	1.8	0.8	11.5	2.2	24.3	15.6	11.3	1.8	1.5	13.5	12.3	33.2	2.0	3.5	11.7	3.2	2.3	11.4	11.2	2.7	14.4	26.0	5.7	9.0	2.8	3.0	29.0	9.7	5.0	12.0	6.5	21.4	6.7	21.8	10.4	5.0	7.1	12.7	10.2	10.7	2.5	8.7	28.3	14.7	8.8	14.4	7.6	17.3	16.5	4.3	7.2	9.2	7.3	4.5	8.3	16.8	25.4	4.9	4.8	17.1	16.6	40.6	16.7	8.6	20.7	21.2	6.3	19.5	6.3	10.6	13.9	11.0	8.2	11.1	7.5	3.3	15.6	10.7	11.1	7.0	17.7	11.3	16.5	12.4	8.2	19.1	10.6	14.8	15.0	1.6	8.4	4.3	7.5	11.7	7.2	9.1	6.9	7.5	11.1	10.7	5.9	5.7	1.2	5.8	9.1	13.1	6.2	5.9	2.0	2.0	1.9	3.1	2.6	2.2	2.4	1.9	2.1	1.5	2.0	2.7	10.9	9.6	9.1	2.3	15.5	22.3	15.6	20.6	12.0	8.2	11.5	12.1	8.0	20.0	12.4	3.7	0.0	32.3	15.5	15.6	7.9	35.5	72.6	12.1	8.4	13.6	7.3	7.8	2.2	32.9	33.9	14.6	15.3	11.1	15.9	15.8	10.4	11.6	24.9	8.4	2.0	14.5	24.4	11.0	15.8	80.3	14.6	13.2	14.2	1.9	14.5	8.3	6.2	1.5	3.1	28.0	11.2	7.9	12.0	15.4	19.2	21.7	6.2	6.2	19.7	14.2	15.0	37.1	77.1	11.2	21.6	30.5	13.6	24.4	22.7	15.0
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015781-139045939	"Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	8.2	2.0	2.8	3.2	2.6	36.3	4.5	1.7	7.1	1.4	0.0	1.8	1.2	1.6	0.5	1.9	1.0	5.5	2.9	5.0	2.9	3.6	13.9	2.9	2.1	1.5	3.4	0.6	3.0	1.7	2.2	5.6	2.6	1.0	1.6	3.4	1.6	0.5	6.5	2.2	2.2	3.0	1.4	1.7	1.7	2.2	4.4	1.9	1.5	6.1	2.6	4.9	1.3	2.9	6.5	7.1	2.9	5.7	6.6	2.7	17.2	9.4	6.9	13.7	10.0	10.3	2.8	22.7	7.4	7.3	18.4	4.5	15.8	8.9	13.7	9.5	6.1	10.3	4.4	8.7	6.2	15.3	6.0	3.2	4.4	15.4	10.4	2.7	6.3	4.3	18.6	7.0	6.6	8.0	10.0	7.8	10.1	3.0	8.1	8.5	8.6	7.7	9.4	4.3	11.3	7.3	6.0	6.8	5.6	11.2	5.0	11.2	8.7	7.7	9.4	7.2	11.8	5.9	5.5	14.0	7.0	29.8	9.9	0.8	0.5	0.3	1.0	0.6	0.5	0.4	0.4	0.5	0.2	0.7	0.3	0.6	2.7	0.6	1.6	0.6	0.3	0.1	2.8	2.6	1.7	7.1	5.0	2.9	1.5	3.4	2.6	1.4	4.4	2.9	10.9	9.6	1.1	0.0	2.8	0.0	2.7	0.0	5.7	5.6	2.7	2.5	0.0	1.5	0.6	0.0	14.6	6.1	4.7	0.6	1.9	2.3	0.7	10.4	6.3	2.6	0.0	1.7	0.0	0.2	11.8	2.9	6.1	20.6	2.5	0.8	1.1	2.6	1.5	1.7	0.0	0.4	0.0	1.6	0.0	0.1	0.9	6.9	0.0	0.0	0.1	0.6	4.1	0.0	0.0	2.5	0.0	0.0	5.5	2.5	2.6	4.0	0.7	5.2	0.0	5.4	4.3	1.0	3.9	6.5	0.0	12.0	4.3	0.8	0.2	2.3
NOL12	"MGC3731, Nop25, RRP17"	ENSG00000273899	"Nucleolar protein 12"	Q9UGY1	22	37681673-37693476	"Predicted intracellular proteins"		"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003547	Uncertain		Approved	"Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Mitotic chromosome"	"Nucleoplasm, Vesicles"	"HPA003547: AB_10602012"	"unprognostic (3.37e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (2.65e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.23e-3)"	"prognostic favorable (9.41e-4)"	"unprognostic (9.96e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (2.56e-6)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (3.24e-4)"	17.1	29.2	11.3	15.1	12.7	28.7	17.5	12.1	18.0	20.5	9.6	21.3	14.9	15.5	7.9	35.1	16.2	9.0	18.6	11.8	12.3	22.0	16.2	14.3	20.9	12.3	11.8	18.5	17.5	11.5	16.5	8.1	12.1	19.8	9.5	4.9	20.5	4.4	12.6	22.7	19.5	6.6	11.2	26.5	18.8	10.4	11.8	16.1	23.1	8.2	12.6	17.1	23.3	12.9	38.3	33.5	24.4	29.5	8.1	7.8	32.2	17.1	7.7	7.4	8.4	20.0	15.7	30.2	9.8	6.2	8.1	41.4	11.6	50.0	2.2	34.4	51.9	26.3	28.9	43.6	21.3	59.3	38.2	9.6	12.4	31.2	11.7	10.0	15.3	16.7	19.8	26.9	6.8	32.3	36.4	48.0	29.5	16.6	46.7	48.5	16.7	24.7	18.2	10.1	19.2	40.3	22.1	19.5	30.8	2.7	26.9	31.0	22.9	34.2	32.5	24.8	34.5	24.0	29.9	41.0	33.3	46.2	40.0	57.3	24.4	26.9	15.1	28.4	11.7	14.1	14.8	13.6	17.6	15.8	14.8	12.6	53.1	16.7	33.8	13.6	22.3	11.9	11.3	12.7	12.1	18.0	11.8	12.3	12.3	11.8	12.1	11.2	11.8	12.9	10.9	3.2	15.3	4.9	15.3	39.0	13.7	33.0	25.0	11.0	10.2	7.7	3.5	7.2	20.3	14.7	6.2	19.4	11.0	35.6	3.9	25.7	105.7	5.4	5.0	12.9	12.6	8.8	11.4	29.1	16.2	10.2	15.8	4.7	15.2	9.7	10.8	6.2	13.9	28.6	10.9	24.8	20.3	10.7	21.8	48.3	9.9	12.7	21.4	2.8	17.7	13.8	18.6	5.5	8.2	22.4	39.9	11.3	14.0	8.6	27.4	7.8	15.9	8.3	13.1	10.0	10.6	14.5	25.9	45.4	39.8	19.8	14.3	9.7	24.1	14.5
NOL3	"ARC, CARD2, MYP, NOP30"	ENSG00000140939	"Nucleolar protein 3"	O60936	16	67170154-67175735	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009208	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"CAB009208: AB_634091"	"unprognostic (2.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (5.74e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.39e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.48e-2)"	34.4	77.5	36.1	3.8	37.1	0.7	35.4	36.7	36.2	37.1	30.7	32.5	6.7	27.8	11.4	48.6	35.4	10.2	99.3	32.9	35.0	33.0	52.0	28.9	3.1	43.9	36.2	29.3	50.6	37.7	60.2	11.6	39.6	70.1	7.6	28.6	51.1	13.8	142.2	79.2	18.1	8.0	35.4	15.9	28.2	7.6	36.9	2.8	35.6	97.5	4.1	38.7	39.8	38.1	14.9	23.9	3.9	22.1	19.2	14.5	22.0	11.8	12.5	12.6	7.4	5.2	38.2	0.3	38.0	13.8	3.3	24.3	5.4	18.3	3.0	13.4	8.3	0.6	19.8	7.8	12.0	1.3	2.9	8.9	33.1	9.9	7.0	35.9	5.3	5.2	5.5	15.3	24.0	38.7	0.3	1.9	3.7	13.5	58.1	13.3	8.3	29.8	21.5	4.5	31.1	16.6	49.5	35.3	5.7	5.1	75.5	4.0	12.4	16.5	14.1	16.3	10.3	22.1	7.5	4.2	46.4	3.7	5.7	0.0	3.5	0.0	0.1	0.3	0.0	0.0	1.7	0.1	1.1	0.0	0.0	0.2	0.8	0.4	0.1	1.1	0.0	1.3	36.1	37.1	36.7	36.2	32.9	35.0	43.9	36.2	39.6	35.4	36.9	38.1	5.1	28.9	33.6	19.2	2.7	13.8	27.6	70.6	21.6	18.5	29.3	32.6	51.2	35.8	28.8	3.7	16.7	8.1	0.8	18.2	15.6	61.3	1.2	8.6	14.0	10.1	22.3	0.0	5.0	34.7	11.3	13.8	11.2	16.4	2.5	7.6	13.2	30.9	11.4	55.5	7.6	23.7	38.7	4.1	4.5	0.7	25.1	3.4	21.4	4.7	14.6	36.3	1.0	4.0	11.3	44.2	11.4	30.1	10.4	28.5	15.5	26.2	21.3	47.9	13.1	38.7	32.3	0.3	1.2	16.4	19.7	11.1	3.2	3.6	16.4	31.6
NOL4	"CT125, HRIHFB2255, NOLP"	ENSG00000101746	"Nucleolar protein 4"	O94818	18	33851100-34224952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 11.8;pituitary gland: 8.0;retina: 6.3;testis: 12.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 133.9;Early spermatids: 268.1;Excitatory neurons: 195.6;Inhibitory neurons: 207.7;Late spermatids: 95.7;Oligodendrocyte precursor cells: 326.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 36.0;SH-SY5Y: 9.5;U-698: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046740			Supported	Nucleoplasm		No	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA046740: AB_10960527"	"unprognostic (7.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.43e-7)"	"unprognostic (5.76e-2)"		"unprognostic (1.56e-2)"	"unprognostic (7.19e-2)"		"unprognostic (3.45e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.77e-2)"	"unprognostic (7.71e-2)"	0.0	1.8	6.1	0.1	7.2	0.0	0.1	7.6	7.8	0.5	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.1	8.2	11.6	0.7	2.2	0.2	0.2	0.8	4.1	0.0	1.7	0.0	8.0	0.0	1.0	0.3	0.7	6.3	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.7	12.6	11.8	0.0	1.6	0.0	0.2	0.5	0.0	3.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.2	0.1	0.0	0.0	0.0	36.0	9.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	7.2	7.6	7.8	8.2	11.6	0.8	4.1	1.0	2.5	11.8	3.4	0.0	0.0	0.0	133.9	0.0	0.0	0.0	0.0	0.0	17.0	0.5	1.0	0.6	0.0	0.0	0.0	2.1	0.2	0.0	0.4	1.9	0.0	268.1	0.0	0.0	0.5	73.8	0.0	195.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.1	32.0	207.7	0.2	0.0	0.0	0.0	95.7	2.5	0.1	0.0	22.5	0.0	11.6	0.0	326.8	4.5	0.1	0.1	2.2	0.0	0.0	0.0	5.3	0.0	2.1	0.0	0.0	0.0	10.9	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1
NOL4L	"C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424"	ENSG00000197183	"Nucleolar protein 4 like"	Q96MY1	20	32443059-32585074	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 49.3;testis: 50.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 107.4;Late spermatids: 171.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 73.4;HEL: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041768, HPA043600"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA041768: AB_10964172, HPA043600: AB_10961001"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.10e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.88e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.08e-3)"	"prognostic favorable (2.63e-4)"	10.4	9.1	12.8	8.7	17.5	20.8	10.2	20.8	19.9	8.7	3.1	17.2	18.7	6.6	12.0	2.5	8.6	8.6	5.6	13.2	14.7	14.5	7.0	13.4	8.0	14.5	13.5	4.0	11.1	4.3	22.3	11.1	14.8	8.7	13.6	49.3	9.7	8.2	1.6	3.5	19.8	6.5	10.3	12.9	13.2	50.0	13.1	15.1	9.7	1.7	5.8	9.7	5.2	19.5	9.1	27.4	16.9	11.6	3.6	5.4	2.3	5.7	4.6	7.1	4.9	73.4	20.8	0.6	16.6	7.5	11.0	2.5	5.4	15.9	3.2	2.1	4.3	58.2	14.5	53.2	9.3	0.9	3.3	13.6	2.2	5.2	3.4	16.1	43.1	12.5	17.7	7.6	3.4	5.1	19.3	17.8	9.9	27.7	25.3	8.2	2.1	3.0	12.0	1.6	22.3	18.1	17.9	0.4	9.8	17.4	3.7	17.8	45.5	6.6	22.6	6.1	5.9	5.6	2.1	4.0	7.2	31.4	20.3	2.9	2.0	1.2	5.8	4.5	5.1	1.6	3.8	3.4	2.1	1.1	7.6	6.4	6.5	8.3	12.1	0.2	6.9	4.9	12.8	17.5	20.8	19.9	13.2	14.7	14.5	13.5	14.8	10.3	13.1	19.5	23.1	6.4	3.3	7.2	4.1	0.0	10.8	0.0	2.2	49.9	20.8	18.3	8.8	11.5	1.3	12.9	66.7	0.3	29.5	57.9	9.8	8.0	107.4	9.4	2.9	25.3	17.5	4.6	29.7	7.8	2.1	5.8	20.4	8.7	12.0	11.1	21.8	4.7	9.8	8.4	22.0	36.6	0.0	3.3	0.0	171.5	5.6	8.6	0.0	33.7	6.1	17.2	24.7	14.1	51.2	14.0	36.6	4.9	9.0	15.2	59.4	24.0	2.2	57.3	19.7	1.7	5.0	75.3	3.8	0.8	0.0	0.4	16.5	16.9	29.5	28.7
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461353-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli	Nucleoplasm	"HPA055891: AB_2682959, HPA061002: AB_2684410"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (4.09e-1)"	19.0	22.0	15.6	13.5	15.5	19.9	17.8	14.3	17.6	19.8	14.5	15.3	8.7	19.5	9.3	29.7	17.1	8.0	20.5	16.5	14.4	21.4	27.0	18.1	14.3	15.2	14.6	19.3	28.4	13.6	24.3	12.1	15.1	23.5	11.8	6.8	17.3	10.1	31.0	27.9	16.2	13.7	13.9	23.5	18.0	28.8	15.8	13.8	17.3	12.0	16.0	22.9	20.6	15.6	37.5	52.3	20.0	45.6	30.5	20.6	33.6	41.2	30.8	46.7	39.3	57.8	13.5	65.3	18.3	46.4	20.7	25.7	58.8	59.1	49.5	41.5	23.9	33.8	62.9	33.1	29.8	78.2	47.0	23.7	48.0	62.9	60.9	19.7	31.6	23.5	54.8	24.5	38.1	33.1	43.3	77.1	71.4	42.0	47.6	36.9	19.9	33.5	36.7	44.1	23.3	31.8	34.0	43.9	14.9	21.3	17.7	44.1	34.7	28.2	38.5	36.6	72.7	22.9	34.4	54.5	25.3	40.6	33.4	0.0	3.0	0.2	3.6	5.9	4.1	2.8	2.7	3.6	5.0	2.2	3.3	3.2	0.1	2.8	6.3	2.7	3.0	2.7	15.6	15.5	14.3	17.6	16.5	14.4	15.2	14.6	15.1	13.9	15.8	15.6	4.8	3.2	12.9	5.2	5.7	20.0	6.6	3.7	4.0	6.5	6.7	6.5	6.6	4.3	8.6	3.7	6.2	4.2	5.4	3.8	3.9	6.3	30.4	7.1	7.7	6.5	10.2	5.7	11.6	4.0	6.1	4.8	9.2	13.6	3.8	7.3	4.2	8.8	5.0	3.3	7.3	5.6	2.0	1.6	4.0	22.0	5.9	3.4	5.4	4.7	3.8	4.2	4.1	6.0	5.9	5.7	2.1	6.0	4.8	10.6	2.4	3.0	6.0	3.8	0.0	6.9	4.5	2.7	5.6	9.5	25.9	3.0	4.9	7.0	7.2	9.5
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71254814-71301522	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"		NA	NA		450000	"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	106.4	147.2	58.6	96.4	57.7	115.3	109.2	71.5	64.9	116.8	64.4	101.3	86.2	130.2	107.9	111.9	115.4	100.7	81.2	55.3	69.9	103.3	121.5	103.2	136.5	60.3	61.5	197.9	164.8	114.8	97.1	99.1	60.5	97.0	101.2	70.2	106.8	89.6	99.1	112.2	102.0	113.5	59.2	109.5	114.3	55.2	68.5	255.5	116.0	86.1	165.2	116.8	102.6	61.0	421.2	539.7	595.3	344.4	251.2	238.5	345.3	330.9	319.2	459.3	388.5	413.4	312.9	481.4	379.9	320.5	309.7	310.5	949.5	299.4	488.1	383.9	605.7	394.8	498.4	398.0	212.3	547.7	338.7	272.0	206.0	473.1	305.7	370.5	382.0	342.1	535.3	509.0	406.2	413.9	756.0	466.8	771.3	433.9	365.2	660.0	657.3	414.0	345.9	426.1	431.7	519.4	467.8	299.1	392.5	354.9	271.4	354.0	343.9	268.0	438.6	402.9	400.1	297.3	503.2	516.0	216.8	627.1	433.8	107.5	117.3	91.1	107.9	120.0	119.9	107.4	107.9	106.4	118.7	107.2	115.1	115.6	50.8	119.6	140.7	101.1	128.0	178.1	58.6	57.7	71.5	64.9	55.3	69.9	60.3	61.5	60.5	59.2	68.5	61.0	72.9	76.9	81.1	16.3	97.2	126.3	99.9	105.8	116.7	62.3	111.4	83.6	63.5	90.1	99.8	44.1	41.7	132.3	103.6	52.0	56.7	147.8	11.8	81.6	137.8	95.4	139.8	144.6	16.2	111.4	179.9	93.9	71.4	104.8	88.0	135.9	83.9	128.3	112.6	53.8	20.7	105.6	95.6	153.2	107.7	15.9	106.6	95.0	56.9	13.1	132.0	84.8	96.8	19.6	22.8	110.7	75.4	127.9	115.2	94.9	89.0	121.0	71.1	50.3	65.7	78.7	127.8	45.7	66.5	137.3	122.3	130.1	108.5	163.7	117.2	103.0
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963406	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.5	15.7	4.6	18.4	5.9	22.9	16.5	11.2	5.1	13.2	6.9	13.7	12.4	13.2	6.0	18.3	12.2	9.3	13.0	4.3	5.8	11.5	19.0	12.4	23.4	5.5	5.4	19.2	24.6	11.1	11.0	12.1	5.6	11.6	12.7	7.1	13.9	9.0	41.7	22.3	13.6	11.5	4.6	15.2	15.4	7.7	6.1	15.7	15.5	14.6	19.7	19.8	14.6	6.8	52.7	43.8	25.6	52.9	33.6	37.9	44.6	47.4	33.5	48.2	39.6	57.5	54.1	148.0	32.8	38.7	35.1	35.5	71.1	61.5	51.6	28.4	67.8	117.8	40.5	52.6	44.3	129.3	49.2	38.6	54.2	54.7	49.5	23.9	41.3	44.6	108.7	50.9	37.0	37.7	137.4	94.4	66.6	48.0	70.7	87.8	38.7	49.3	24.1	83.2	52.6	30.9	39.4	28.8	37.9	23.0	55.0	50.3	51.7	40.3	23.3	49.6	88.3	37.9	65.8	124.8	41.9	93.6	42.6	1.0	2.1	0.4	2.8	2.4	4.9	2.1	3.4	4.3	2.5	3.5	4.1	3.1	0.2	3.2	1.6	3.1	2.5	2.1	4.6	5.9	11.2	5.1	4.3	5.8	5.5	5.4	5.6	4.6	6.1	6.8	13.3	19.2	30.5	3.6	22.2	25.9	23.4	11.6	27.9	9.6	12.2	12.2	20.2	12.8	23.9	1.8	14.6	16.8	21.0	11.8	11.7	19.5	2.6	13.6	27.8	16.5	9.0	22.3	4.7	24.0	18.4	16.3	20.9	16.4	20.8	25.9	8.6	24.3	11.0	20.2	5.7	11.6	4.1	7.0	12.1	2.6	12.5	14.6	0.0	3.7	15.3	6.3	10.3	3.0	4.7	21.3	6.5	9.8	28.1	27.1	5.1	14.1	12.0	7.7	13.1	23.3	19.7	11.8	19.1	32.5	32.5	11.5	24.1	38.5	17.0	21.4
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265736-202303661	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	36.0	35.1	33.5	43.9	33.6	76.3	43.7	38.8	58.4	29.5	33.4	30.4	28.2	32.2	33.4	37.8	31.6	23.6	25.1	33.4	36.3	32.8	40.7	26.4	60.3	32.3	33.3	37.4	37.8	24.8	30.2	32.6	32.6	29.5	35.8	28.1	26.5	23.1	41.8	30.7	29.7	27.3	32.6	33.9	29.6	24.9	34.8	41.9	27.1	21.5	59.8	43.3	30.2	35.3	126.4	86.0	85.1	106.8	62.0	55.6	199.2	118.5	62.9	89.1	82.9	191.5	110.9	193.1	95.4	72.5	111.6	114.0	170.1	144.7	158.4	75.0	152.5	233.6	133.3	193.7	91.5	234.7	108.6	72.1	85.3	124.6	284.6	48.6	81.2	112.3	260.4	144.1	113.4	131.4	215.1	258.7	212.9	139.4	146.5	179.5	128.3	257.1	107.1	148.5	130.5	95.8	109.0	156.6	140.8	136.2	106.4	181.8	70.3	113.5	133.8	102.5	206.0	115.7	226.1	274.8	84.2	163.7	138.5	13.4	24.0	7.4	37.2	35.6	55.0	56.1	53.1	51.2	37.4	45.0	57.5	58.9	2.3	52.1	28.3	53.1	58.0	32.5	33.5	33.6	38.8	58.4	33.4	36.3	32.3	33.3	32.6	32.6	34.8	35.3	56.3	109.0	116.2	22.2	111.6	85.8	150.5	98.0	78.0	28.1	53.8	70.2	82.7	37.1	116.8	40.5	41.7	78.1	87.1	35.7	29.4	59.9	39.2	59.6	75.9	62.3	35.2	65.2	39.0	67.8	96.9	82.6	51.0	97.0	137.3	47.7	32.2	46.1	47.7	25.2	47.5	61.5	61.1	23.2	43.5	11.1	43.2	51.5	24.9	20.6	59.6	18.8	35.0	20.6	27.0	50.3	17.3	29.7	118.6	89.9	18.3	37.8	70.6	44.2	26.3	112.2	116.8	70.4	58.4	77.5	74.7	68.0	124.1	45.4	79.6	94.6
NOP9	C14orf21	ENSG00000196943	"NOP9 nucleolar protein"	Q86U38	14	24299850-24309124	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000850			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA000850: AB_1078287"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (9.39e-6)"	"unprognostic (7.03e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	9.9	13.0	6.3	5.5	6.7	7.0	9.3	6.2	6.1	8.6	4.6	11.1	7.8	9.9	3.5	16.1	9.5	3.3	13.2	5.8	6.3	8.6	13.8	8.7	6.2	6.7	6.5	11.7	12.6	6.7	7.9	4.1	6.4	9.0	5.5	7.4	10.6	4.4	27.2	12.6	11.4	4.9	6.9	17.3	10.6	7.7	6.8	5.9	8.6	11.2	6.7	9.8	9.3	6.3	6.5	12.8	10.2	12.8	8.7	7.3	9.8	11.4	8.5	13.2	10.2	9.7	11.3	16.7	6.3	10.5	10.7	16.6	20.4	14.2	13.7	10.6	7.8	12.3	18.3	22.4	7.0	28.4	13.5	7.4	10.9	9.7	8.9	7.0	12.4	9.3	10.6	8.0	9.3	11.3	13.2	10.7	4.6	22.9	16.2	16.0	6.1	10.6	8.1	14.8	10.2	7.8	16.1	18.4	3.5	7.3	6.9	7.4	12.8	8.7	7.2	6.9	10.9	11.1	10.6	12.2	4.8	12.7	7.1	0.3	0.6	0.5	0.4	0.7	0.4	0.3	0.3	0.2	0.5	0.4	0.2	0.2	0.1	0.1	1.2	0.3	0.3	0.4	6.3	6.7	6.2	6.1	5.8	6.3	6.7	6.5	6.4	6.9	6.8	6.3	4.0	3.2	3.3	2.6	6.2	12.5	3.2	4.9	6.2	8.1	5.3	3.9	1.2	7.2	8.5	9.2	8.4	6.3	6.7	15.2	0.0	7.3	3.1	5.2	4.8	5.6	10.7	9.9	3.6	10.3	5.8	4.5	6.1	5.0	1.3	9.6	6.1	18.1	7.3	6.7	4.3	7.6	0.0	10.7	6.3	1.3	6.5	5.8	0.0	1.0	7.6	5.5	2.1	3.0	5.0	11.6	8.5	4.5	5.5	5.2	12.5	6.6	7.7	8.0	6.6	5.4	5.4	4.6	5.7	8.1	13.5	6.4	4.9	5.5	14.3	4.6
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 23.0;skeletal muscle: 36.9;tongue: 57.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 10.0;Hepatic stellate cells: 18.2;Inhibitory neurons: 32.1;Oligodendrocyte precursor cells: 48.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.6;RH-30: 9.4;RPTEC TERT1: 5.8;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.1	0.1	12.7	0.4	12.4	0.2	0.1	5.7	7.0	0.3	0.0	2.2	0.1	0.1	0.2	0.8	0.3	0.0	0.0	4.0	16.2	1.3	0.0	0.8	0.1	12.1	11.0	0.0	1.4	0.0	0.9	0.0	12.2	0.9	0.4	0.3	3.4	0.1	36.9	1.9	0.4	0.3	2.3	0.0	0.2	0.5	23.0	0.0	0.1	57.2	0.1	0.0	0.7	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	9.4	0.0	5.8	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	12.7	12.4	5.7	7.0	4.0	16.2	12.1	11.0	12.2	2.3	23.0	3.3	0.0	0.0	0.0	1.3	0.0	3.8	10.0	2.4	4.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.0	3.0	5.1	0.4	3.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	8.4	0.0	0.0	18.2	0.0	0.0	0.0	32.1	0.2	0.0	0.3	0.7	0.6	0.3	0.2	1.8	1.9	0.0	0.0	0.0	48.2	5.7	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.1	1.8	0.1	0.6	0.0	0.2	0.0	0.0	1.0
NOS1AP	"CAPON, KIAA0464"	ENSG00000198929	"Nitric oxide synthase 1 adaptor protein"	O75052	1	162069691-162370475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 22.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 204.3;Excitatory neurons: 142.3;Horizontal cells: 67.3;Inhibitory neurons: 107.6;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 82.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;HaCaT: 3.1;HEL: 4.6"	"Low region specificity"	"Detected in all"							"CAB018582, HPA030066, HPA055561"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB018582: AB_2251417, HPA030066: AB_2673294, HPA055561: AB_2682851"	"unprognostic (7.04e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.08e-3)"	0.4	2.8	16.3	0.1	20.1	1.8	1.2	8.0	16.2	0.6	0.0	1.3	0.6	0.5	0.2	0.7	0.6	0.6	0.8	22.2	2.4	0.9	3.1	0.4	0.0	3.0	2.1	0.2	0.9	0.5	0.8	0.4	0.4	0.7	1.1	3.6	1.5	1.4	0.2	1.1	0.7	0.4	0.0	0.0	1.4	1.8	5.5	0.1	0.1	0.2	0.2	0.6	0.4	21.5	3.9	0.0	1.8	1.1	0.0	0.0	0.2	0.3	0.4	0.5	0.4	0.9	1.0	0.0	2.2	0.1	0.6	3.1	0.6	0.1	0.1	0.1	1.7	4.6	0.6	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	1.0	0.6	0.4	0.0	0.1	2.1	0.3	0.0	1.3	0.6	1.5	0.0	0.7	0.1	0.9	1.4	1.4	0.9	0.8	0.1	0.6	0.5	1.1	0.2	0.4	0.0	0.4	0.0	0.6	2.2	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	20.1	8.0	16.2	22.2	2.4	3.0	2.1	0.4	0.0	5.5	21.5	4.4	0.0	0.5	5.9	0.4	2.9	6.1	0.7	0.6	11.6	14.1	21.5	2.3	2.8	1.5	22.0	204.3	0.2	0.4	7.9	9.8	1.0	36.8	4.5	3.5	3.6	6.7	2.7	142.3	1.2	0.3	1.3	9.7	7.9	0.0	8.0	3.3	21.2	0.1	67.3	107.6	10.2	0.0	0.8	0.4	12.4	4.4	0.2	0.0	43.1	0.0	13.4	1.0	79.9	82.9	0.7	5.3	7.2	0.1	6.8	3.9	0.6	1.7	3.8	6.6	0.9	1.1	2.0	2.2	2.3	2.0	0.5	0.5	1.9	5.3	7.8
NOSIP	CGI-25	ENSG00000142546	"Nitric oxide synthase interacting protein"	Q9Y314	19	49555468-49590262	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 364.8;Late spermatids: 844.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043464, HPA062132"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA043464: AB_10794284, HPA062132: AB_2684693"	"unprognostic (2.27e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-3)"	42.4	48.0	33.2	27.1	37.0	31.7	42.8	37.2	45.1	50.0	29.4	49.0	29.1	49.3	10.0	47.8	45.1	15.4	60.9	31.9	35.0	48.1	48.6	39.5	51.8	36.2	34.9	44.5	125.1	24.0	40.8	21.6	36.9	44.0	14.6	10.1	38.3	20.6	134.7	46.7	50.8	16.2	34.7	63.2	44.8	143.5	36.0	40.0	40.9	65.2	26.5	41.3	41.7	38.0	239.7	114.5	49.6	113.1	43.5	32.7	44.5	54.8	50.0	90.9	85.3	84.9	43.1	63.4	93.5	48.2	37.0	51.0	47.8	98.4	40.3	74.1	126.0	81.3	67.9	96.6	66.6	67.8	64.6	43.4	66.5	71.4	37.7	38.0	54.4	101.8	90.7	46.0	50.3	59.7	66.2	127.0	65.9	89.3	100.4	89.3	74.0	58.3	43.5	70.6	57.4	71.2	74.9	59.1	50.2	21.8	53.9	72.6	83.5	83.6	64.4	27.0	99.3	87.8	186.7	86.6	31.2	90.7	65.2	261.9	129.1	192.3	257.3	126.1	328.8	161.8	519.8	294.6	127.8	157.2	841.3	466.7	244.1	244.5	117.6	168.8	303.6	579.4	33.2	37.0	37.2	45.1	31.9	35.0	36.2	34.9	36.9	34.7	36.0	38.0	78.3	19.2	34.9	13.1	67.3	72.8	54.8	109.8	40.9	25.4	45.5	49.5	38.4	62.9	59.3	51.5	22.9	94.2	74.7	171.6	86.1	84.5	364.8	56.3	44.9	73.0	58.7	58.5	9.2	283.6	85.0	51.7	57.6	68.6	68.4	57.0	93.9	49.5	72.2	11.8	9.1	108.9	91.6	63.8	67.0	844.8	71.7	55.5	62.2	13.1	100.5	45.5	120.5	9.0	12.3	219.2	138.2	72.2	55.4	43.2	129.6	133.8	58.4	37.2	59.2	85.1	66.1	268.7	50.9	39.6	76.3	136.3	154.2	73.1	108.5	54.4
NOTCH1	TAN1	ENSG00000148400	"Notch receptor 1"	P46531	9	136494433-136546048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.2;Astrocytes: 67.3;Hepatic stellate cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 47.0;HDLM-2: 32.3;HMC-1: 39.7;MOLT-4: 72.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm		NA	NA		29000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795"	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	18.2	4.2	10.4	4.9	16.1	4.3	15.0	12.1	9.3	14.3	0.0	19.8	4.3	12.7	0.2	16.3	11.9	0.9	14.9	8.6	5.5	11.8	9.2	22.2	3.0	13.5	12.3	5.1	14.0	0.7	6.3	2.6	9.8	15.4	0.6	0.6	10.7	3.1	5.0	24.2	14.2	1.3	9.7	24.8	10.0	2.5	13.9	4.0	11.2	1.2	0.9	14.2	16.5	14.0	8.8	10.6	4.0	2.6	0.0	0.4	17.7	3.3	0.4	1.4	0.4	1.8	0.9	13.3	10.3	1.3	1.6	47.0	1.0	8.6	0.1	32.3	2.0	5.5	6.1	0.6	2.1	6.9	39.7	0.3	16.7	1.4	1.9	0.7	9.0	3.7	3.6	1.1	0.0	9.0	72.3	13.1	8.4	2.9	7.7	15.7	9.2	19.3	0.6	4.2	0.0	0.7	6.1	4.3	3.4	1.0	3.2	10.4	22.7	5.0	9.3	5.9	4.3	2.4	2.6	4.1	3.7	5.0	26.1	0.2	0.4	0.6	0.3	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.3	2.3	0.7	0.1	0.1	0.1	0.5	10.4	16.1	12.1	9.3	8.6	5.5	13.5	12.3	9.8	9.7	13.9	14.0	56.2	9.6	21.9	67.3	8.4	24.9	12.3	35.1	23.9	0.8	10.7	12.4	11.0	5.7	16.3	1.8	2.1	1.1	14.2	11.8	0.0	5.1	0.3	12.3	9.9	53.2	2.4	5.2	0.3	4.0	2.2	6.4	1.1	17.3	34.9	1.0	68.2	7.7	9.3	1.7	0.4	14.8	18.3	10.1	17.5	0.3	1.2	15.2	7.2	18.7	14.3	46.6	24.7	33.7	19.6	2.1	11.5	0.7	5.7	8.4	4.1	3.4	3.8	2.0	6.6	14.7	18.4	0.2	3.3	20.6	29.8	1.1	15.0	1.4	28.8	15.6
NOTCH2		ENSG00000134250	"Notch receptor 2"	Q04721	1	119911553-120100779	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		160000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane"		"HPA048743: AB_2680508"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.24e-4)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	27.1	12.9	16.4	20.4	13.6	13.7	24.8	11.9	16.4	31.0	20.3	16.0	5.4	21.2	20.8	24.9	25.7	18.5	14.2	15.9	13.7	10.9	19.6	20.2	16.7	20.6	18.6	33.9	20.1	12.1	5.5	24.9	13.9	20.4	13.6	19.3	17.1	22.2	6.4	32.3	11.9	26.6	15.7	25.3	10.5	25.4	19.3	15.3	21.2	8.9	17.9	19.0	24.1	14.8	54.2	17.7	27.0	20.7	108.5	92.7	26.6	39.7	54.8	51.8	55.8	16.3	14.2	1.4	32.6	75.3	46.2	20.1	42.8	35.3	82.5	64.0	27.2	32.1	45.7	1.6	40.5	32.7	8.0	75.5	22.5	155.2	103.7	78.4	26.9	14.5	0.8	65.3	63.7	59.2	13.9	9.2	34.6	5.0	19.6	9.1	94.2	36.1	27.3	33.4	1.1	13.4	54.5	50.0	27.9	53.4	28.0	11.7	97.0	67.0	45.8	102.7	63.1	27.9	16.8	16.5	98.7	29.5	65.2	15.0	14.9	22.9	1.4	7.3	1.4	39.0	1.6	0.9	23.7	33.3	3.1	2.0	8.9	2.4	10.5	12.3	3.8	4.4	16.4	13.6	11.9	16.4	15.9	13.7	20.6	18.6	13.9	15.7	19.3	14.8	4.6	35.3	19.5	125.4	36.6	46.3	56.6	14.8	31.3	3.3	38.1	25.3	16.0	24.3	28.5	18.4	6.2	1.6	26.0	6.2	0.0	46.8	17.7	33.8	21.9	5.4	6.1	18.3	4.2	12.9	8.9	67.8	5.1	61.1	15.8	78.3	3.9	41.5	32.7	3.3	22.6	7.9	20.3	74.7	78.2	12.6	55.0	76.6	39.2	43.1	79.3	46.2	15.5	75.4	0.6	26.8	105.5	85.4	14.2	37.2	3.2	4.9	16.4	10.5	19.7	83.6	34.0	10.0	4.3	75.1	88.9	1.6	18.5	22.0	15.8	66.9
NOTCH3	"CADASIL, CASIL"	ENSG00000074181	"Notch receptor 3"	Q9UM47	19	15159038-15200995	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 414.2;Skeletal myocytes: 131.6;Smooth muscle cells: 317.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;MCF7: 66.9;RT4: 41.2;U-87 MG: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005393, HPA044392"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		46000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB005393: AB_2151246, HPA044392: AB_2678926"	"unprognostic (4.97e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (9.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (3.35e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-3)"	85.7	5.3	14.8	10.4	12.4	0.2	50.5	11.0	21.3	49.4	7.1	14.8	5.5	39.9	16.9	74.3	35.8	23.5	43.6	9.5	11.3	26.0	3.2	38.3	9.2	12.0	15.2	18.9	10.7	12.6	10.3	59.8	14.3	22.0	4.2	0.5	24.4	16.5	29.7	82.1	14.3	16.9	8.2	15.0	11.6	3.8	15.8	34.1	32.3	25.1	10.4	26.3	55.1	10.0	13.0	8.1	66.3	30.3	9.2	7.3	29.8	10.2	0.4	0.4	0.3	15.6	13.4	0.4	7.7	18.9	0.1	15.1	12.1	0.2	0.6	0.1	3.1	0.4	12.4	3.5	4.5	0.0	1.2	8.4	7.3	15.5	1.6	0.6	0.8	4.6	0.5	0.6	1.2	66.9	15.9	0.1	38.8	11.2	0.0	0.1	3.7	0.3	0.0	41.2	1.9	21.4	0.1	37.8	0.0	19.6	40.3	0.1	0.0	1.9	21.0	0.3	0.1	0.1	0.7	0.0	45.7	0.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	14.8	12.4	11.0	21.3	9.5	11.3	12.0	15.2	14.3	8.2	15.8	10.0	39.6	9.6	1.5	5.9	0.4	24.1	7.8	17.8	4.6	0.4	41.5	30.7	60.7	0.0	28.5	16.5	0.0	20.2	1.0	0.0	5.9	14.8	0.5	4.8	13.5	32.0	0.0	0.0	0.6	0.0	3.9	24.2	2.0	11.8	0.0	5.9	4.2	0.0	2.8	0.0	0.3	0.3	6.1	10.4	12.3	0.1	9.0	4.1	17.8	13.1	0.7	0.8	0.0	0.0	0.2	0.9	0.1	11.7	0.0	13.0	0.1	0.0	4.2	0.8	414.2	131.6	317.0	0.9	1.2	72.1	72.2	31.5	2.0	1.2	0.2	36.0
NOTO		ENSG00000214513	"Notochord homeobox"	A8MTQ0	2	73202574-73212513	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA034660, HPA063906"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"			"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA034660: AB_10601974, HPA063906: "						"unprognostic (6.09e-2)"		"unprognostic (9.77e-2)"		"unprognostic (4.84e-2)"				"unprognostic (1.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-2)"		0.0	0.1	0.3	0.1	0.2	0.5	0.0	0.6	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.6	0.3	0.2	0.2	0.5	0.3	0.4	0.2	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOVA1	NOVA-1	ENSG00000139910	"NOVA alternative splicing regulator 1"	P51513	14	26443090-26598033	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 222.9;Excitatory neurons: 414.9;Oligodendrocyte precursor cells: 1269.7;Oligodendrocytes: 319.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 53.3;ASC diff: 25.6;HAP1: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004155	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Nucleoplasm	"HPA004155: AB_1079497"	"unprognostic (1.46e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.21e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.04e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.27e-4)"	"unprognostic (9.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-4)"	23.4	5.4	44.0	2.4	39.7	0.1	28.9	85.4	56.3	12.1	18.9	11.6	1.4	8.5	4.9	2.9	6.7	4.8	3.3	38.8	65.3	6.1	0.9	1.4	3.4	50.3	51.2	5.0	1.2	2.4	19.3	0.1	48.5	5.6	5.1	13.4	2.7	15.9	4.3	4.7	3.6	9.5	49.2	0.9	3.3	8.8	71.1	1.2	3.4	8.7	4.5	5.9	8.4	45.5	0.0	11.6	53.3	0.0	25.6	14.6	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.7	0.7	7.1	0.1	23.7	0.2	0.0	0.0	1.8	0.0	0.1	0.3	8.5	0.0	2.1	16.8	0.0	3.6	2.9	17.8	10.3	8.7	0.0	0.1	8.4	0.0	9.8	0.1	13.5	0.0	10.9	1.3	14.8	0.2	6.8	9.1	15.5	9.4	0.0	0.0	0.0	4.2	1.1	0.0	0.0	6.5	7.7	5.2	1.4	0.0	0.0	0.0	8.8	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	44.0	39.7	85.4	56.3	38.8	65.3	50.3	51.2	48.5	49.2	71.1	45.5	24.8	0.0	1.5	141.0	0.2	5.2	5.9	0.0	4.6	222.9	51.5	29.6	1.1	5.7	0.0	14.7	4.2	0.1	1.4	6.6	9.8	0.4	20.1	0.6	15.0	9.4	65.9	0.0	414.9	0.4	0.0	188.8	0.5	0.2	0.0	18.2	38.6	0.5	0.2	136.3	203.5	7.1	0.0	0.6	10.5	16.5	150.4	2.1	3.6	93.7	0.0	32.3	0.0	1269.7	319.5	2.0	11.7	65.8	1.9	6.7	0.3	30.3	4.4	12.0	6.6	28.6	17.7	163.1	64.3	0.7	3.1	0.0	1.5	30.0	8.4	0.6
NOVA2	"ANOVA, NOVA-2, NOVA3"	ENSG00000104967	"NOVA alternative splicing regulator 2"	Q9UNW9	19	45933734-45974044	"Human disease related genes, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 39.4;Bipolar cells: 56.7;Endothelial cells: 32.0;Excitatory neurons: 21.8;Hepatic stellate cells: 42.5;Horizontal cells: 21.9;Inhibitory neurons: 20.9"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HDLM-2: 11.0;HUVEC TERT2: 16.9;SH-SY5Y: 5.6;TIME: 25.8;U-2 OS: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045607	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"HPA045607: AB_10962628"	"unprognostic (9.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.42e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.31e-2)"	6.7	1.9	12.4	0.7	15.1	0.0	5.7	0.5	16.7	3.2	0.0	1.8	0.6	3.4	0.6	1.4	2.9	1.4	6.7	16.0	5.8	4.7	1.0	9.3	0.5	4.6	3.0	1.2	1.1	1.0	6.2	3.9	3.6	2.3	0.5	5.6	1.1	0.8	2.3	1.1	1.7	2.0	0.6	1.5	1.5	2.0	4.6	0.4	4.5	2.5	0.2	2.5	2.0	9.8	0.0	0.1	9.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	1.3	0.0	0.0	11.0	0.4	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	5.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	15.1	0.5	16.7	16.0	5.8	4.6	3.0	3.6	0.6	4.6	9.8	39.4	0.0	0.0	5.9	0.1	0.6	0.2	0.0	0.6	56.7	0.1	0.5	3.4	1.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.1	32.0	0.0	0.0	21.8	0.2	0.0	1.2	0.0	0.1	0.0	0.1	42.5	0.5	0.1	21.9	20.9	0.0	0.0	1.6	1.5	3.5	0.0	0.1	0.0	9.4	0.0	1.3	0.0	11.6	9.5	0.2	0.0	0.4	1.2	0.3	0.0	0.0	0.0	3.3	0.0	0.6	0.6	2.4	2.3	0.3	0.1	0.0	0.5	0.4	0.0	0.3
NPAP1	C15orf2	ENSG00000185823	"Nuclear pore associated protein 1"	Q9NZP6	15	24675775-24683393	"Predicted intracellular proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;testis: 2.9"	"Cell type enriched"	"Detected in some"	5	"Granulosa cells: 125.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA018828, HPA019562"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA018828: AB_2669941, HPA019562: AB_2670190"										"unprognostic (4.40e-2)"	"unprognostic (1.85e-2)"		"unprognostic (6.98e-3)"	"unprognostic (7.45e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.11e-3)"	0.0	0.0	0.9	0.0	1.8	0.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.5	1.7	0.9	0.0	0.0	0.1	0.9	0.7	0.5	0.4	0.0	0.5	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.1	2.9	1.5	0.0	0.5	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	1.8	0.1	1.1	0.5	1.7	0.9	0.7	0.5	0.5	1.5	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.2	0.7	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	125.9	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.3	24.1	12.7	0.0	0.0	0.0	0.0	0.5	0.0	0.2
NPAS1	"bHLHe11, MOP5, PASD5"	ENSG00000130751	"Neuronal PAS domain protein 1"	Q99742	19	47019837-47045775	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;skin 1: 7.7"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 16.7;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 28.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 9.9;Daudi: 10.2;HEK 293: 11.1;HMC-1: 9.0;NB-4: 18.1;U-266/84: 11.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA043364, HPA072259"		Approved	Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA043364: , HPA072259: AB_2686500"	"unprognostic (2.34e-3)"	"unprognostic (6.25e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.14e-8)"	"unprognostic (8.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.20e-2)"	0.9	0.4	3.1	0.3	1.8	0.2	0.7	0.3	6.3	0.4	1.9	0.4	0.0	0.1	0.0	1.0	0.6	0.0	1.1	5.4	2.8	1.7	0.6	0.4	0.5	2.9	2.5	0.2	0.6	0.0	1.3	0.1	4.3	0.4	0.0	0.5	0.4	0.0	0.1	7.7	0.4	0.1	0.7	2.8	2.7	0.6	1.5	0.1	0.5	0.0	0.3	0.4	0.7	2.0	0.2	2.4	0.3	0.5	0.2	0.2	0.0	9.9	0.3	0.1	0.4	0.7	0.5	10.2	2.2	8.1	0.4	0.2	2.1	0.2	0.1	0.7	11.1	0.8	1.2	2.5	0.0	5.5	9.0	0.9	0.4	0.0	0.1	0.6	0.2	1.3	3.5	0.8	1.3	0.9	0.4	18.1	2.4	0.4	1.7	0.9	0.4	0.8	0.6	0.6	0.7	0.6	0.8	0.3	2.4	0.8	2.1	1.7	0.1	0.2	0.9	0.1	0.2	5.4	11.5	2.2	1.2	1.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	0.3	6.3	5.4	2.8	2.9	2.5	4.3	0.7	1.5	2.0	0.1	0.0	0.6	1.6	1.1	0.8	1.4	1.1	1.8	0.7	2.2	2.5	1.1	0.0	1.1	0.0	16.7	0.0	0.1	0.3	0.0	0.6	0.1	0.4	0.2	0.2	1.2	2.7	5.7	0.4	0.1	0.5	27.0	0.4	0.0	0.7	0.0	0.1	0.3	0.0	28.3	1.4	2.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	5.4	0.0	2.0	1.2	1.0	0.2	0.0	2.6	1.5	0.0	0.9	2.0	5.4	0.0	0.1	1.1	0.4	2.1	2.2	2.3	0.0	1.2	0.1	0.6	1.2
NPAS2	"bHLHe9, MOP4, PASD4"	ENSG00000170485	"Neuronal PAS domain protein 2"	Q99743	2	100820139-100996829	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 112.6;Early spermatids: 65.1;Excitatory neurons: 150.5;Inhibitory neurons: 58.5;Microglial cells: 69.3;Oligodendrocyte precursor cells: 58.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 142.8;PC-3: 110.3;RT4: 90.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019674	Uncertain	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 50: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA019674: AB_10601275"	"unprognostic (2.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (5.47e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (3.55e-7)"	"unprognostic (7.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-3)"	9.6	12.5	17.9	6.0	19.5	0.1	9.5	1.9	17.6	14.5	3.2	15.6	20.9	13.5	2.9	50.3	10.9	9.9	29.2	16.5	8.4	23.0	23.6	7.9	2.3	6.7	10.6	3.9	39.5	1.2	14.9	5.3	5.2	17.3	11.1	6.2	18.2	4.4	22.0	28.1	17.3	9.1	6.0	5.9	24.0	11.1	18.0	1.2	9.6	7.7	5.0	28.3	22.2	11.3	13.4	74.1	0.1	0.9	69.9	30.1	10.6	24.4	72.2	9.8	21.1	1.3	6.0	0.0	28.5	4.0	142.8	0.6	10.8	18.1	10.2	0.9	4.2	0.0	13.7	34.6	33.1	0.0	3.0	25.6	28.7	23.9	38.3	39.8	41.0	7.8	0.3	0.2	8.0	27.1	5.1	0.6	1.3	21.8	110.3	0.3	1.6	0.8	51.0	90.4	0.2	1.4	0.1	4.4	54.8	0.8	0.7	0.8	15.8	7.3	9.6	14.6	10.7	0.0	0.0	0.1	77.3	0.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	17.9	19.5	1.9	17.6	16.5	8.4	6.7	10.6	5.2	6.0	18.0	11.3	1.2	0.0	11.4	112.6	0.4	3.8	8.6	12.0	3.4	6.4	9.0	10.2	16.0	21.5	8.8	12.9	0.0	0.8	0.2	32.6	0.0	12.9	65.1	10.1	5.7	7.1	9.1	0.0	150.5	15.6	1.0	5.7	24.5	22.0	0.0	3.7	21.4	14.4	0.1	28.6	58.5	8.9	6.1	0.3	1.0	14.0	7.2	0.7	3.6	69.3	0.8	3.2	0.0	58.3	4.2	14.3	15.5	5.3	0.1	27.3	30.5	11.3	6.0	0.6	0.0	4.8	3.9	0.6	3.5	9.6	6.5	0.3	1.3	5.5	12.4	39.1
NPAS3	"bHLHe12, MOP6, PASD6"	ENSG00000151322	"Neuronal PAS domain protein 3"	Q8IXF0	14	32934396-33820863	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 3405.1;Inhibitory neurons: 1408.3;Oligodendrocyte precursor cells: 1893.0;Oligodendrocytes: 1772.0"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 6.4;glioma: 7.7;ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 9.3;U-266/70: 23.6;U-266/84: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075337	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA075337: "	"unprognostic (6.02e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.29e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (3.27e-1)"	0.8	0.8	17.3	0.1	19.9	0.0	0.9	14.6	12.9	6.0	0.0	1.4	0.3	3.9	0.8	0.3	3.9	0.7	0.4	14.0	15.0	0.9	0.1	0.2	0.1	22.8	18.0	2.7	0.4	0.5	1.0	0.5	15.8	0.8	0.3	1.4	0.8	1.3	0.2	0.2	0.4	0.6	18.0	1.1	1.0	1.3	15.9	0.4	1.8	0.2	0.2	0.5	0.5	18.3	0.0	0.0	9.3	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	23.6	7.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	19.9	14.6	12.9	14.0	15.0	22.8	18.0	15.8	18.0	15.9	18.3	5.1	0.0	0.0	3405.1	0.1	1.0	1.0	0.0	0.6	8.9	3.8	5.1	2.1	0.0	0.1	1.8	0.0	1.5	0.1	0.1	1.9	0.1	22.2	24.6	5.7	3.2	1.2	0.0	341.9	0.0	0.1	3.5	0.0	72.3	0.0	0.7	4.2	0.1	0.5	10.1	1408.3	0.0	0.0	0.0	1.4	17.0	7.2	0.7	0.0	116.2	0.0	7.4	0.0	1893.0	1772.0	0.2	0.0	5.3	0.1	0.5	0.0	0.5	1.8	0.7	0.0	11.5	3.1	0.2	0.8	0.1	0.4	0.3	1.0	1.1	0.0	0.5
NPAT	"E14, p220"	ENSG00000149308	"Nuclear protein, coactivator of histone transcription"	Q14207	11	108157215-108222638	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045908, HPA066370"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA045908: AB_2679493, HPA066370: AB_2685665"	"unprognostic (6.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.93e-1)"	4.6	4.2	1.6	8.1	2.1	4.5	6.9	7.4	2.8	6.4	3.9	5.4	4.1	6.7	5.9	4.6	4.6	4.7	4.3	1.4	2.4	5.6	5.6	5.4	14.9	2.6	3.0	7.6	3.1	6.8	3.2	6.6	2.4	5.6	6.2	6.6	4.4	4.4	3.1	5.2	4.9	5.1	2.2	9.9	5.9	7.0	2.3	12.0	8.3	5.3	13.3	7.0	3.8	3.0	7.9	6.3	9.7	12.1	11.7	8.5	7.9	11.6	14.6	10.0	14.9	13.0	16.8	13.5	15.2	7.3	11.2	14.6	13.4	11.7	17.8	12.2	5.3	22.5	6.8	6.7	5.0	17.0	14.3	8.1	6.7	17.6	11.2	7.8	14.3	15.5	21.2	6.5	14.1	3.9	21.0	9.1	8.0	12.6	8.7	14.3	13.6	18.5	6.4	11.3	10.3	9.5	14.9	8.8	11.3	10.1	10.0	8.3	11.8	17.3	9.3	10.3	10.5	4.5	6.1	51.9	4.3	12.4	13.7	6.8	1.6	2.9	4.9	2.6	5.5	4.1	5.7	6.3	1.8	4.3	8.9	7.5	1.9	5.3	2.9	1.5	4.6	3.2	1.6	2.1	7.4	2.8	1.4	2.4	2.6	3.0	2.4	2.2	2.3	3.0	23.1	19.2	13.2	24.2	40.8	16.3	16.4	10.5	27.3	16.5	12.0	7.6	15.2	4.3	13.2	12.9	29.2	10.3	32.8	5.6	1.9	8.4	4.9	11.1	15.0	21.1	10.3	29.5	25.5	6.8	8.2	15.9	12.2	14.2	19.6	16.7	22.9	9.1	7.4	10.1	32.2	7.9	8.2	13.0	12.8	3.2	15.8	13.8	8.8	19.7	14.5	11.8	27.8	19.6	24.3	6.8	6.5	17.0	37.8	14.1	7.1	5.6	10.9	16.9	6.6	19.8	13.1	26.2	32.5	14.0	13.2	14.1	35.3	14.9	8.7	15.9
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586506	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 110.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 70.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	17.5	76.7	35.1	16.9	69.6	42.6	20.0	55.3	47.8	16.7	28.6	13.7	14.5	16.7	15.0	20.5	13.4	15.3	11.5	41.1	44.3	16.8	15.2	29.0	20.4	73.3	55.8	16.0	11.9	72.6	15.0	27.8	66.6	13.1	12.0	28.0	36.8	13.2	22.9	24.3	17.8	15.1	49.8	17.1	20.4	13.7	55.8	12.2	11.8	14.1	15.6	15.8	18.0	110.6	21.5	41.4	17.8	29.3	55.8	44.6	40.7	37.3	81.1	38.8	84.3	28.1	30.7	18.4	28.0	55.0	132.8	59.3	22.6	63.2	35.2	15.0	17.9	6.8	35.7	63.2	79.2	25.0	28.5	42.2	61.3	81.7	273.2	76.8	40.3	20.7	20.1	47.5	44.2	32.4	10.6	14.9	12.5	24.4	37.3	15.3	28.1	45.0	88.8	51.9	7.5	14.5	44.6	62.0	54.3	27.7	15.9	19.5	50.0	81.1	15.3	32.4	32.3	29.7	97.1	12.2	177.7	21.8	37.1	4.4	9.0	8.8	29.7	8.7	20.5	5.0	12.4	20.7	4.0	6.7	5.5	15.0	7.9	10.5	13.8	70.9	17.4	10.6	35.1	69.6	55.3	47.8	41.1	44.3	73.3	55.8	66.6	49.8	55.8	110.6	18.4	25.6	56.1	32.7	9.6	9.3	34.1	16.5	8.0	6.7	10.5	9.4	4.4	11.5	21.8	9.2	18.8	15.1	61.0	24.8	0.0	11.2	1.2	23.3	12.2	16.4	3.6	2.5	23.8	15.1	7.8	13.0	15.3	53.9	10.8	31.6	6.8	9.8	28.9	3.3	20.2	7.3	2.0	11.9	6.5	1.5	9.0	21.0	12.4	59.0	7.2	15.1	25.7	39.2	182.0	34.4	22.6	10.5	15.6	41.5	8.3	5.4	10.0	12.7	0.0	10.3	14.4	13.9	25.1	17.6	14.5	23.8	19.1	52.4	7.6	64.0
NPDC1	"CAB-, CAB1, DKFZp586J0523"	ENSG00000107281	"Neural proliferation, differentiation and control 1"	Q9NQX5	9	137039463-137046179	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 397.0;Endothelial cells: 307.2;Enteroendocrine cells: 281.6;Hepatic stellate cells: 406.2;Intestinal goblet cells: 589.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 146.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 12.3;MAIT T-cell: 14.7;memory CD4 T-cell: 19.0;memory CD8 T-cell: 18.9;T-reg: 15.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 19.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 138.4;RPMI-8226: 132.8;T-47d: 140.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		240000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA008189: AB_1854584"	"unprognostic (6.94e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.84e-2)"	129.5	45.7	140.8	12.2	128.1	3.4	133.0	110.6	181.3	130.5	55.0	93.1	23.4	121.6	4.3	53.7	148.6	24.9	149.1	143.3	143.1	75.9	23.7	115.4	13.0	138.9	142.3	68.2	81.2	23.0	266.0	21.1	131.3	260.5	13.4	9.2	137.4	35.1	34.0	56.4	72.1	16.9	120.7	145.2	126.2	35.3	142.9	2.9	68.4	12.4	3.9	97.9	90.5	114.7	33.6	41.9	10.1	67.1	23.7	23.8	2.8	68.7	23.0	16.9	6.7	17.1	18.5	30.3	50.7	28.6	4.6	122.4	8.6	20.5	1.6	25.0	40.4	13.6	123.7	12.9	33.3	11.9	0.3	16.5	31.9	8.7	17.9	43.1	43.6	13.2	0.7	0.8	3.5	138.4	1.0	1.1	21.1	111.0	68.1	19.9	0.0	132.8	28.6	22.7	77.2	50.0	18.4	65.3	46.5	3.6	140.1	17.9	73.9	12.4	21.6	84.1	21.0	0.1	0.4	1.4	17.7	1.2	10.5	0.0	0.6	0.9	12.3	0.1	14.7	0.1	19.0	18.9	1.1	0.0	0.5	3.1	0.0	0.2	0.1	3.4	15.9	3.3	140.8	128.1	110.6	181.3	143.3	143.1	138.9	142.3	131.3	120.7	142.9	114.7	397.0	0.0	7.7	64.3	3.4	23.6	77.6	15.0	31.3	97.5	174.0	139.7	18.3	71.4	19.8	29.5	16.7	1.1	5.5	122.2	0.0	52.5	1.8	39.0	27.7	307.2	281.6	19.3	71.7	66.0	1.3	61.2	153.9	101.3	0.0	9.2	406.2	1.9	22.2	62.2	64.7	589.1	18.3	21.0	20.0	6.9	161.2	6.6	30.2	37.5	3.0	38.5	1.0	38.2	39.0	33.0	106.0	145.6	1.4	234.9	37.5	0.7	7.5	62.0	39.5	23.9	38.9	2.8	19.0	15.9	23.7	1.8	12.3	9.1	98.1	103.1
NPEPL1	"bA261P9.2, FLJ11583"	ENSG00000215440	"Aminopeptidase like 1"	Q8NDH3	20	58689131-58719238	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 23.9;classical monocyte: 18.5;eosinophil: 7.2;intermediate monocyte: 13.0;myeloid DC: 11.4;neutrophil: 13.7;non-classical monocyte: 18.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.4;granulocytes: 23.9;monocytes: 18.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004986, CAB017025, HPA036356"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		14000	"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.87e-9)"	"unprognostic (7.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.73e-4)"	31.9	24.8	20.6	9.4	21.5	19.9	28.1	20.2	28.9	20.4	22.5	40.8	15.9	24.8	3.9	26.9	23.2	15.8	30.7	20.7	19.0	40.6	20.6	26.6	13.6	22.6	20.3	23.6	24.1	16.7	27.0	10.0	20.9	29.3	4.4	2.5	29.7	15.2	66.3	23.7	25.4	8.6	19.7	40.1	27.1	23.1	22.1	7.7	39.2	28.8	6.1	39.2	22.1	21.0	22.5	31.2	5.5	4.5	11.8	21.7	1.7	8.5	0.7	26.6	14.9	18.0	16.6	1.0	44.6	15.7	0.3	24.0	7.5	10.4	2.6	20.0	7.5	8.0	26.0	8.3	29.6	8.1	13.0	21.3	31.7	9.3	0.0	9.8	22.6	6.1	1.1	3.5	10.6	106.6	3.3	21.2	8.3	13.1	33.8	6.6	2.6	12.6	11.1	14.8	10.1	3.2	22.4	6.1	41.8	3.0	23.4	15.3	25.3	6.7	5.4	14.0	4.4	11.7	4.3	0.7	9.8	15.2	2.7	23.9	18.5	7.2	2.5	13.0	3.1	1.4	1.5	1.7	11.4	0.9	0.9	1.8	13.7	3.2	18.8	0.5	3.7	6.3	20.6	21.5	20.2	28.9	20.7	19.0	22.6	20.3	20.9	19.7	22.1	21.0	23.6	9.6	15.6	0.0	3.5	9.2	8.2	17.1	10.8	19.0	17.2	16.0	16.7	10.0	16.4	27.6	25.0	15.0	11.8	7.6	13.7	14.8	2.3	11.9	8.1	13.6	12.0	3.0	0.0	9.2	7.8	16.1	18.8	6.4	2.5	32.3	15.0	9.1	11.2	8.4	0.0	10.2	20.3	16.7	12.0	8.5	22.1	15.1	7.2	0.0	16.3	20.1	6.2	0.0	0.0	10.8	14.3	14.7	8.4	4.4	17.6	19.9	19.0	8.5	19.7	14.9	15.2	6.7	3.0	16.9	11.2	8.9	9.0	9.7	13.1	7.7
NPHP4	"KIAA0673, POC10, SLSN4"	ENSG00000131697	"Nephrocystin 4"	O75161	1	5862811-5992473	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Ciliopathy, Disease variant, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.2;Cone photoreceptor cells: 33.3;Excitatory neurons: 47.1;Inhibitory neurons: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.7;hippocampal formation: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063852, HPA065526"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Nuclear bodies, Vesicles"	"HPA063852: , HPA065526: AB_2685505"	"unprognostic (1.82e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	2.7	2.2	1.0	2.3	0.8	3.7	2.7	0.0	2.7	2.9	2.5	2.2	2.1	2.8	2.3	2.0	7.9	2.1	1.9	3.1	0.0	2.2	1.3	3.0	2.3	0.0	0.0	2.9	2.4	2.7	7.8	1.6	0.0	2.2	1.2	2.4	2.2	2.3	2.2	4.9	2.1	2.2	0.0	2.2	2.0	5.3	0.0	2.5	6.7	1.9	1.1	2.1	2.5	0.0	7.8	4.8	5.4	4.3	4.7	6.8	4.1	3.9	3.9	5.3	4.2	4.1	6.5	4.0	9.6	4.6	3.6	7.4	2.7	6.6	2.7	5.1	7.3	3.4	8.1	4.1	3.7	6.5	5.1	5.6	3.2	6.3	3.9	3.4	3.8	9.4	6.2	4.1	2.4	5.9	8.3	7.1	1.0	4.0	5.5	7.1	3.4	6.5	2.6	1.0	17.0	5.5	6.1	4.5	6.5	2.3	6.0	7.2	3.7	7.6	3.2	13.0	4.8	5.0	7.0	4.2	3.4	8.3	2.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	1.0	0.8	0.0	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	24.2	1.3	4.0	1.2	1.8	3.4	7.3	3.0	3.6	3.1	4.3	3.9	3.7	33.3	0.6	2.2	2.1	1.9	1.6	2.0	10.2	3.3	2.9	3.6	3.2	47.1	1.8	0.5	3.5	4.1	3.0	0.0	4.0	1.8	1.5	2.0	5.0	30.8	2.2	2.0	3.5	3.7	1.4	4.1	2.4	10.6	14.0	1.8	6.3	2.1	10.6	17.3	2.1	2.2	2.2	2.6	1.8	1.1	1.9	10.9	18.2	6.6	1.6	2.7	11.6	6.5	1.9	5.3	1.1	1.7	4.0	1.7	1.1
NPIPA1	"morpheus, NPIP"	ENSG00000183426	"Nuclear pore complex interacting protein family member A1"	Q9UND3	16	14922802-14952060	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 938.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.4;Excitatory neurons: 37.7;Respiratory ciliated cells: 37.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	15	"cerebral cortex: 938.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 76.6"									HPA053611	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.82e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.74e-7)"	"unprognostic (2.28e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-5)"	55.4	49.4	43.3	10.7	42.1	12.7	54.6	60.6	938.3	69.6	30.2	88.8	5.7	57.1	0.0	47.1	74.6	7.7	60.4	43.7	39.7	43.0	44.6	51.5	14.6	43.1	36.3	102.2	49.3	13.9	157.0	8.3	44.1	70.5	9.1	38.4	41.1	26.6	69.7	63.6	49.2	30.0	34.9	55.8	50.0	96.8	37.8	17.0	57.3	23.6	12.0	67.6	56.9	39.3	0.4	12.5	56.7	22.0	0.1	0.9	9.9	22.0	15.3	19.9	17.5	8.6	13.6	3.6	30.4	30.5	23.5	9.9	26.4	3.0	20.1	11.3	10.0	0.0	20.9	47.0	76.6	28.3	6.4	42.8	42.6	16.6	29.6	11.6	9.7	19.0	3.2	15.2	22.7	26.9	0.0	14.5	0.6	0.0	0.6	10.8	0.3	5.2	32.1	26.7	2.4	21.0	11.6	1.4	29.1	6.7	4.4	24.2	2.0	26.4	1.2	0.4	7.2	8.3	6.7	7.5	0.9	1.8	14.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	43.3	42.1	60.6	938.3	43.7	39.7	43.1	36.3	44.1	34.9	37.8	39.3	6.8	6.4	20.0	22.2	4.4	9.3	1.0	3.7	12.5	9.0	8.1	7.4	2.0	7.2	17.6	9.2	6.2	2.6	6.5	5.1	0.0	5.3	64.4	5.2	7.3	6.2	4.9	9.1	37.7	2.0	1.8	9.9	3.6	4.0	22.1	5.3	6.8	3.3	2.3	6.7	27.2	5.3	4.1	4.7	4.1	22.3	21.5	3.9	0.0	5.6	6.1	3.2	4.1	24.1	17.5	4.4	4.3	19.2	14.7	1.5	4.1	1.0	37.4	6.3	19.7	6.8	5.5	14.9	10.8	9.6	4.0	1.2	5.1	2.3	6.1	1.0
NPIPA2		ENSG00000254852	"Nuclear pore complex interacting protein family member A2"	E9PIF3	16	14748066-14765413	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.8;Astrocytes: 2.9;granulocytes: 10.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.8;NB-4: 2.4"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA053611: AB_2682206"																		5.2	2.8	1.0	0.3	0.9	0.3	4.7	1.2	2.9	5.7	0.9	8.9	0.2	4.4	0.8	3.9	3.6	0.2	4.1	1.1	0.9	6.6	2.8	4.0	0.3	1.2	1.0	6.8	4.4	0.3	9.6	0.3	1.1	5.0	0.8	1.5	3.1	0.3	7.0	5.6	4.0	0.2	0.9	3.6	4.2	14.6	1.0	0.5	4.1	0.3	0.2	5.4	4.7	1.3	0.2	0.2	0.1	0.0	0.2	0.1	6.8	0.5	0.3	0.0	0.1	0.2	0.9	0.0	0.6	0.5	0.1	0.8	0.2	0.0	0.0	0.5	0.4	0.4	0.6	0.1	0.2	0.1	1.6	0.0	0.9	0.9	0.6	0.0	0.1	0.8	0.5	0.4	0.1	1.4	0.8	2.4	0.4	0.0	0.2	0.7	0.4	0.1	0.3	0.3	0.6	0.3	0.2	0.4	1.1	0.9	0.0	0.6	0.5	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.8	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	1.2	2.9	1.1	0.9	1.2	1.0	1.1	0.9	1.0	1.3	0.8	3.2	4.8	2.9	0.1	2.3	0.0	0.2	0.0	0.0	0.8	0.5	1.1	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.4	0.9	0.0	0.0	2.2	0.8	0.0	1.1	0.0	0.1	10.1	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.0
NPIPA3		ENSG00000224712	"Nuclear pore complex interacting protein family member A3"	F8WFD2	16	14708944-14726338	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 4.2;Respiratory ciliated cells: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 4.4;hTERT-RPE1: 6.4;NB-4: 10.6;SK-MEL-30: 15.9"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (1.44e-1)"	"unprognostic (7.83e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.58e-3)"	"unprognostic (4.87e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.71e-2)"	5.1	3.6	2.0	0.8	2.0	0.7	4.7	2.8	9.4	6.6	1.5	9.3	0.2	6.8	0.8	4.4	5.8	2.5	4.4	2.2	1.7	5.5	3.8	4.7	0.4	2.0	2.0	7.7	4.0	2.5	10.7	0.5	2.1	5.8	0.9	2.0	3.1	1.0	7.4	5.8	4.1	0.4	1.7	4.0	4.7	6.5	2.0	0.1	4.7	0.3	0.4	7.2	5.4	2.1	0.0	0.6	0.1	0.3	0.0	0.1	1.4	0.5	0.0	0.4	0.4	0.0	1.9	3.3	0.2	1.2	0.7	0.1	0.1	2.1	0.2	0.1	0.0	0.3	0.7	0.4	0.2	0.1	0.5	4.4	0.7	1.2	0.1	6.4	0.1	0.6	0.1	0.2	0.2	1.2	0.0	10.6	0.8	0.0	0.0	0.1	0.0	0.0	2.9	1.0	0.4	0.4	0.0	0.2	15.9	0.6	0.2	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.2	0.1	1.7	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.0	2.8	9.4	2.2	1.7	2.0	2.0	2.1	1.7	2.0	2.1	0.2	3.2	0.5	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.1	4.2	0.0	0.7	0.0	0.0	0.1	0.0	1.2	0.0	0.1	1.1	0.1	0.1	0.8	1.2	0.0	0.1	0.2	0.1	1.2	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.6	0.0	0.7	0.6	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.3	1.0	0.5	0.3	0.0	0.0	0.3	0.3	0.0	0.7	0.1
NPIPA5		ENSG00000183793	"Nuclear pore complex interacting protein family member A5"	E9PKD4	16	15363628-15381047	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.4;granulocytes: 11.4;Respiratory ciliated cells: 11.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"THP-1: 17.7"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.19e-4)"	"unprognostic (5.85e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (6.58e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.18e-2)"	"unprognostic (4.02e-2)"	26.3	24.4	21.7	1.2	22.1	4.1	22.9	27.7	26.3	29.9	16.7	43.1	2.8	32.8	8.3	21.3	18.1	5.1	23.5	22.3	22.7	36.8	22.0	21.9	3.1	23.1	21.7	43.0	28.1	4.8	78.3	1.4	22.9	32.4	2.7	10.8	18.7	2.9	33.9	26.8	24.6	2.7	18.7	28.8	26.0	42.8	21.0	5.4	28.8	4.1	1.5	25.8	23.7	21.5	1.1	1.5	5.4	0.8	9.9	10.3	0.8	2.1	5.0	6.9	7.0	2.3	1.0	2.3	0.6	5.5	2.1	2.3	1.8	5.5	3.5	4.5	2.1	3.0	7.8	11.3	1.5	0.8	4.1	2.1	9.1	2.7	3.6	3.1	3.7	8.5	3.2	1.7	6.7	1.2	2.4	3.6	7.7	4.5	0.9	0.8	0.8	0.7	5.9	2.1	0.0	0.8	6.0	2.7	6.7	0.7	2.6	17.7	8.9	0.0	2.8	8.5	0.4	4.8	7.1	8.2	1.0	4.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	21.7	22.1	27.7	26.3	22.3	22.7	23.1	21.7	22.9	18.7	21.0	21.5	2.0	0.0	3.7	8.8	1.6	4.8	0.4	2.3	8.6	2.0	1.5	2.9	4.1	4.3	2.5	1.8	0.0	0.6	0.7	0.6	0.0	0.1	20.4	2.4	2.1	1.8	0.0	6.9	10.2	0.2	0.3	4.8	1.5	0.9	11.4	2.9	2.2	1.8	0.3	1.7	8.1	0.5	2.0	1.0	2.3	4.1	1.5	1.2	0.0	1.9	0.1	0.8	0.0	7.1	6.9	0.0	0.0	0.7	0.8	0.4	0.4	0.2	11.1	2.5	0.0	2.2	2.9	5.8	1.0	6.2	4.5	0.3	1.8	0.1	0.6	0.2
NPIPA7		ENSG00000214967	"Nuclear pore complex interacting protein family member A7"	E9PJI5	16	16379055-16393954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 16.2;Endothelial cells: 3.8;Fibroblasts: 4.8;granulocytes: 5.7;Respiratory ciliated cells: 2.9;Smooth muscle cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HMC-1: 91.3;THP-1: 81.3"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA053611: AB_2682206"					"unprognostic (1.17e-2)"													16.5	24.2	32.7	9.7	32.2	12.9	10.9	38.4	44.1	16.7	30.8	20.1	9.7	11.1	24.7	23.2	14.6	16.7	9.9	32.4	32.8	28.5	28.9	14.8	16.0	31.8	31.2	17.6	36.5	26.8	84.7	9.9	32.0	23.4	22.6	28.8	16.9	9.1	9.5	35.5	18.6	11.0	30.5	28.1	18.7	26.3	32.1	14.3	28.2	4.1	12.9	13.7	13.6	32.5	7.6	16.6	19.6	7.6	11.5	9.2	12.8	15.7	6.1	17.6	9.2	17.3	11.9	19.0	12.2	16.5	10.6	22.8	13.9	16.1	13.0	5.6	4.2	19.2	59.5	26.0	10.9	6.8	91.3	16.5	61.1	9.7	20.6	21.7	9.2	31.3	11.6	23.8	19.4	32.5	15.4	39.5	13.6	27.8	5.5	22.5	13.2	11.1	29.1	32.3	25.3	13.5	12.4	28.3	12.8	23.9	20.4	81.3	7.9	16.8	7.9	7.7	13.5	4.9	19.7	15.4	9.6	21.2	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	32.2	38.4	44.1	32.4	32.8	31.8	31.2	32.0	30.5	32.1	32.5	0.0	3.2	2.6	0.3	0.2	1.7	0.0	0.5	0.0	0.0	0.0	0.0	16.2	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.6	0.0	0.0	4.8	0.0	0.0	5.7	0.1	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.5	0.0
NPIPA8	LCR16a9	ENSG00000214940	"Nuclear pore complex interacting protein family member A8"	P0DM63	16	18317942-18336736	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;granulocytes: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 28.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 61.3;EFO-21: 58.1;HMC-1: 217.0;SCLC-21H: 53.1;THP-1: 60.6"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA053611: AB_2682206"					"unprognostic (1.68e-1)"					"unprognostic (3.60e-2)"				"unprognostic (2.81e-1)"				14.3	9.6	3.7	2.5	3.9	6.9	13.3	6.5	28.6	13.1	2.4	28.7	0.2	12.6	0.5	10.1	28.7	0.1	11.3	4.0	3.4	18.4	9.6	12.4	2.5	4.0	3.2	20.7	11.0	6.3	36.4	6.3	4.6	16.9	2.1	5.0	9.8	7.5	18.9	14.6	12.9	0.4	2.7	13.1	13.9	20.8	4.3	3.1	13.7	0.1	0.1	15.8	10.8	3.6	0.0	2.3	0.3	0.5	1.5	0.7	0.7	0.0	0.0	0.1	0.2	0.4	10.5	61.3	58.1	0.5	0.0	0.1	23.6	7.1	0.1	0.1	0.1	0.1	1.9	2.0	9.7	0.1	217.0	0.3	0.0	0.0	0.0	0.1	4.3	14.4	24.4	0.2	0.0	0.1	0.0	0.2	16.4	24.8	0.0	2.5	36.2	1.7	0.3	0.2	53.1	16.8	0.0	0.4	0.6	11.2	0.0	60.6	0.0	1.1	0.1	0.2	13.8	0.0	0.1	0.2	18.6	16.5	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	3.9	6.5	28.6	4.0	3.4	4.0	3.2	4.6	2.7	4.3	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0
NPIPA9		ENSG00000233024	"Nuclear pore complex interacting protein family, member A9"		16	18358086-18379331	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											HPA053611	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (9.10e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (5.87e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.25e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.90e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.45e-3)"	67.7	62.8	166.9	26.7	164.4	29.4	66.5	232.7	283.1	82.8	136.2	119.7	25.7	74.7	58.4	63.5	78.1	30.6	77.6	168.1	177.5	79.6	64.1	67.1	32.4	165.7	150.8	135.0	75.1	44.7	224.4	22.8	169.8	89.4	40.2	72.4	55.9	43.0	115.1	73.9	69.2	47.7	132.7	74.7	64.7	84.8	152.5	30.7	81.4	29.1	27.3	70.2	66.3	162.9	23.6	15.1	82.7	67.9	69.4	64.4	19.3	88.5	32.1	42.6	63.0	15.2	13.6	32.6	33.2	78.4	25.2	41.7	26.0	24.0	51.9	27.8	24.8	87.0	85.7	75.4	70.3	41.7	190.6	66.6	105.3	53.5	71.4	89.2	21.1	39.3	20.4	62.7	43.1	35.8	68.2	89.3	34.8	23.2	19.0	97.1	20.6	32.5	42.4	43.9	23.4	36.2	55.5	34.5	49.3	31.6	31.9	48.4	40.4	56.9	24.9	48.4	27.5	46.9	40.3	49.2	25.5	56.2	30.1	0.0	0.1	0.1	0.5	0.0	0.2	1.4	0.4	0.3	0.0	0.3	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	166.9	164.4	232.7	283.1	168.1	177.5	165.7	150.8	169.8	132.7	152.5	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPIPB11		ENSG00000254206	"Nuclear pore complex interacting protein family member B11"	E5RHQ5	16	29381354-29404029	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Early spermatids: 17.5;Intestinal goblet cells: 9.4;Undifferentiated cells: 9.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (6.82e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-4)"	"unprognostic (7.41e-2)"	"unprognostic (2.94e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.79e-5)"	2.8	1.6	6.0	2.8	5.4	4.7	2.5	7.2	8.4	2.9	6.3	2.7	2.0	2.1	3.2	2.1	3.1	1.8	2.3	5.6	6.7	3.3	4.2	2.5	6.0	5.5	4.6	3.3	2.0	0.9	2.6	1.2	5.4	2.8	1.7	5.8	2.2	0.6	4.4	6.7	3.7	0.9	3.4	4.4	2.7	4.9	5.8	2.0	3.2	0.9	1.1	2.3	2.5	6.6	1.5	1.2	2.2	3.2	1.6	1.2	2.9	1.4	0.6	1.2	0.5	1.7	2.9	9.0	2.1	0.7	0.5	2.6	1.8	2.1	1.2	2.2	2.4	2.1	4.4	2.8	0.8	2.6	4.9	0.7	1.6	1.3	1.8	2.5	0.6	2.4	2.7	2.6	1.1	3.5	2.2	8.3	3.8	0.9	2.7	3.3	0.9	3.0	1.3	1.1	2.9	1.4	0.4	2.0	1.1	6.8	1.1	3.3	3.0	3.0	1.3	2.1	1.9	2.5	1.7	7.3	1.7	3.3	2.3	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.5	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	6.0	5.4	7.2	8.4	5.6	6.7	5.5	4.6	5.4	3.4	5.8	6.6	1.4	9.6	5.6	3.6	4.2	0.0	0.1	0.3	0.6	0.2	1.5	0.9	2.5	1.5	2.6	0.0	0.0	0.3	3.7	8.8	0.0	1.2	17.5	0.6	0.5	2.6	7.2	1.3	4.6	0.8	0.2	1.8	3.6	0.6	5.1	0.4	0.4	0.2	0.3	5.0	5.4	9.4	0.0	0.0	0.0	5.9	0.3	1.6	0.0	1.0	1.5	0.1	5.2	2.5	4.2	1.9	5.9	0.7	2.7	0.1	3.7	0.3	2.3	0.3	0.0	0.5	1.0	0.8	0.1	0.5	0.0	0.4	4.4	0.3	9.8	0.0
NPIPB12		ENSG00000169203	"Nuclear pore complex interacting protein family member B12"	F8W0I5	16	29483642-29505999	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"brain: 198.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.5;granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.3"	"Group enriched"	"Detected in all"	4	"B-cells: 8.4;granulocytes: 29.3;NK-cells: 14.2"	"Cell line enhanced"	"Detected in all"		"NB-4: 166.4"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (3.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.28e-7)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.14e-4)"	25.4	21.7	135.6	40.5	135.5	63.7	21.9	136.7	198.1	30.8	109.8	27.5	24.0	24.0	38.5	24.8	27.5	24.8	29.2	127.2	143.6	31.8	58.2	27.5	57.0	128.7	140.4	26.9	24.2	15.1	26.3	20.4	128.8	33.3	25.6	32.2	34.5	20.0	44.3	108.9	33.6	19.7	105.7	51.2	23.5	29.1	137.3	28.1	28.8	15.5	29.8	26.7	24.2	131.2	26.2	26.7	20.6	52.8	24.7	14.7	40.0	15.7	4.4	7.8	6.7	23.1	52.5	43.8	27.4	13.1	15.4	34.5	35.2	25.3	10.7	28.1	25.6	33.3	36.0	46.5	22.2	36.1	61.5	23.0	19.5	17.6	18.5	19.9	9.0	24.3	34.5	37.2	12.7	42.6	26.6	166.4	31.5	17.6	19.3	61.6	9.1	42.7	19.1	18.6	21.9	15.4	8.9	36.5	22.5	9.2	18.7	43.4	22.4	49.9	19.2	34.9	30.2	19.5	21.3	42.7	20.3	63.9	23.9	29.3	3.5	1.4	3.9	1.2	1.0	3.7	2.3	2.7	2.4	8.4	3.1	2.1	9.5	14.2	3.0	2.6	1.8	1.3	135.6	135.5	136.7	198.1	127.2	143.6	128.7	140.4	128.8	105.7	137.3	131.2	0.0	3.2	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
NPIPB13		ENSG00000198064	"Nuclear pore complex interacting protein family, member B13"	A6NJU9	16	30222937-30254510	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 16.0;Alveolar cells type 2: 10.6;Club cells: 7.4;granulocytes: 12.6;Respiratory ciliated cells: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (7.11e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.58e-2)"	3.2	2.2	4.0	2.1	2.2	6.1	3.0	4.3	4.7	4.4	0.0	3.8	1.6	2.2	4.5	2.5	3.8	1.6	3.2	3.6	3.3	3.0	4.1	4.1	3.6	2.0	1.1	3.9	2.5	1.8	4.1	1.5	1.4	4.0	2.0	3.9	2.8	1.5	3.8	7.2	4.8	0.5	0.1	5.1	2.9	2.8	3.1	1.1	4.1	0.6	2.1	3.2	3.4	2.8	2.2	5.4	1.3	4.4	0.6	1.4	2.6	0.4	0.0	0.2	0.2	0.6	2.9	3.3	2.1	0.8	0.5	2.5	2.4	1.2	0.7	1.9	1.1	3.5	6.3	2.8	0.2	4.4	2.7	2.0	1.7	1.9	1.1	0.6	0.9	1.4	1.5	4.5	1.0	4.5	2.0	4.3	1.8	0.5	1.3	4.1	0.7	1.8	1.2	3.6	1.5	1.6	0.6	1.6	0.8	1.7	1.3	1.1	2.1	2.5	2.6	2.4	1.3	1.8	2.3	4.1	2.4	2.0	1.3	0.0	0.3	0.0	0.6	0.1	0.3	0.0	0.2	0.2	0.1	0.2	0.3	0.1	0.1	0.4	0.4	0.1	0.0	0.1	4.0	2.2	4.3	4.7	3.6	3.3	2.0	1.1	1.4	0.1	3.1	2.8	0.8	16.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	7.4	1.8	0.0	0.5	0.8	0.0	0.0	0.6	0.0	0.3	0.4	1.7	0.0	0.0	0.0	1.5	0.1	1.3	0.0	0.7	12.6	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.3	10.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.5	0.2	0.0	0.0
NPIPB15	"LOC440348, NPIPL2"	ENSG00000196436	"Nuclear pore complex interacting protein family member B15"	A6NHN6	16	74377878-74392080	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 55.9"	"Group enriched"	"Detected in many"	9	"Early spermatids: 394.8;Late spermatids: 241.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.6"	"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"T-47d: 11.7"									"HPA011188, HPA053611"	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (2.23e-2)"	"unprognostic (3.48e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.14e-3)"	9.6	7.9	0.6	0.8	1.0	4.1	10.5	1.3	5.6	10.0	0.4	19.6	4.6	4.6	0.1	13.5	9.2	2.5	7.0	0.6	1.5	16.2	35.3	11.1	3.4	0.6	0.6	8.5	19.9	1.6	19.6	3.2	0.7	26.5	11.9	3.1	26.3	1.5	4.4	11.5	20.2	1.8	0.4	13.3	19.1	55.9	0.9	2.0	17.1	0.0	2.7	11.3	9.5	0.7	2.5	0.0	2.3	1.3	2.7	1.9	0.4	1.5	2.3	1.9	5.1	1.3	0.1	4.2	0.0	3.3	0.0	4.5	0.0	2.0	1.4	0.0	2.6	0.1	6.6	2.5	1.3	1.7	8.1	2.7	3.9	3.7	2.7	2.7	0.0	0.1	0.3	1.6	1.6	3.9	0.9	0.0	0.5	1.2	0.0	0.8	2.1	2.8	0.0	1.6	3.2	0.0	6.2	0.0	4.4	0.0	11.7	2.0	0.1	1.7	4.6	0.0	0.9	5.4	1.7	1.0	2.3	1.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.6	1.0	1.3	5.6	0.6	1.5	0.6	0.6	0.7	0.4	0.9	0.7	5.7	3.2	5.9	6.2	3.8	2.0	1.8	2.5	4.0	3.5	8.0	5.0	1.3	7.2	6.1	7.3	8.4	1.9	5.3	17.4	0.0	1.7	394.8	6.0	3.1	4.1	17.5	0.4	3.6	3.8	1.0	4.5	29.6	11.3	0.0	11.7	2.9	3.3	1.3	0.0	4.2	32.8	6.1	1.5	1.3	241.9	11.5	3.1	3.6	2.8	2.8	0.8	1.0	4.5	7.9	2.6	20.4	7.5	5.8	9.6	27.4	1.4	4.6	2.6	0.0	4.3	2.7	28.4	5.3	3.1	2.7	2.5	3.5	4.7	16.2	9.7
NPIPB2		ENSG00000234719	"Nuclear pore complex interacting protein family member B2"	A6NJ64	16	11927259-11976643	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"testis: 15.1"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;granulocytes: 2.5;Granulosa cells: 3.1;Proximal tubular cells: 4.4;Respiratory ciliated cells: 2.2;Theca cells: 2.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 15.5;U-266/70: 26.9"									HPA053611	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (8.80e-2)"	"unprognostic (4.83e-1)"	"unprognostic (5.20e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.89e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.58e-2)"	2.6	2.0	5.4	0.4	5.4	0.9	2.1	6.0	6.3	2.9	5.2	2.1	1.6	2.3	4.0	1.1	2.5	1.3	1.5	5.2	5.7	3.5	1.6	1.5	1.3	5.5	5.1	3.0	2.1	2.8	2.7	1.1	5.4	2.1	1.4	4.1	1.6	1.8	1.5	3.4	2.0	2.2	4.7	1.9	1.7	15.1	5.6	7.8	2.9	0.4	0.7	1.8	2.0	5.9	0.1	1.6	2.0	1.1	4.6	7.4	3.0	2.2	3.9	1.0	0.6	1.2	1.8	1.0	0.7	2.1	0.3	0.4	1.3	1.7	2.0	1.2	1.7	0.5	2.1	1.8	7.4	1.1	0.4	0.3	3.5	2.3	4.9	0.3	0.3	0.2	0.2	5.5	0.7	2.3	0.3	0.8	0.6	1.4	1.6	2.2	0.1	15.5	0.7	1.0	2.9	0.0	5.0	0.3	0.0	2.0	0.3	3.6	0.5	0.3	0.3	0.4	0.2	26.9	8.8	1.2	3.1	0.4	1.2	0.0	1.0	0.2	0.3	0.0	0.0	0.8	0.5	0.4	0.8	0.4	0.9	0.2	0.2	1.5	0.1	0.7	0.0	0.4	5.4	5.4	6.0	6.3	5.2	5.7	5.5	5.1	5.4	4.7	5.6	5.9	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.0	0.0	0.0	1.8	0.0	0.7	0.5	0.0	5.9	0.5	0.0	1.1	0.7	0.1	0.0	0.0	0.0	0.7	0.2	0.6	0.0	0.5	2.5	3.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	4.4	2.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.4	2.6	0.0	0.0
NPIPB3	"KIAA0220, NPIPL3"	ENSG00000169246	"Nuclear pore complex interacting protein family member B3"	Q92617	16	21402237-21448567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 2.8;Gastric mucus-secreting cells: 2.0;Skeletal myocytes: 3.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 161.9"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-5)"	"unprognostic (1.50e-7)"	"unprognostic (1.30e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.00e-4)"	53.3	47.1	141.3	37.2	137.3	149.4	47.7	127.7	184.3	71.8	111.9	72.4	28.5	38.3	51.8	44.4	58.6	28.5	60.8	118.8	134.1	71.1	65.1	66.3	77.0	133.3	147.3	49.6	47.2	13.1	70.5	21.9	127.9	74.9	34.9	51.7	43.5	22.6	87.9	140.9	76.7	28.1	90.1	99.7	51.3	46.6	134.8	53.6	75.6	24.1	34.8	48.0	52.5	122.8	37.9	37.2	24.5	40.1	30.0	18.1	73.5	25.7	9.6	13.3	14.1	57.5	44.0	56.4	24.1	38.9	17.7	47.0	13.6	41.4	12.5	30.8	20.6	26.6	58.7	161.9	25.6	48.8	46.0	8.8	16.8	35.3	44.3	20.4	19.4	52.5	49.7	77.3	20.4	69.7	51.8	114.0	41.0	22.5	42.5	75.7	25.4	35.0	28.8	23.2	27.8	21.1	15.7	32.5	25.9	47.2	35.7	20.7	29.5	62.9	36.4	6.4	40.4	37.8	30.8	49.2	25.0	38.3	34.9	3.5	2.3	1.5	2.6	1.4	1.2	2.2	1.5	1.6	1.2	2.4	2.0	1.3	2.1	2.0	1.1	4.8	0.9	0.1	141.3	137.3	127.7	184.3	118.8	134.1	133.3	147.3	127.9	90.1	134.8	122.8	0.1	0.0	0.0	1.6	0.5	2.8	0.4	0.2	0.6	0.0	0.1	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	1.7	0.0	0.0	1.0	2.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.2	1.8	1.9	0.0	0.0	1.0	1.5	1.3	0.0	0.0	0.0	0.7	0.8	0.0	0.0	1.7	0.0	0.0	3.1	0.8	0.0	0.0	1.3	1.7	0.0	0.8	0.2	0.0	0.2
NPIPB4		ENSG00000185864	"Nuclear pore complex interacting protein family member B4"	C9JG80	16	21834569-21880827	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Astrocytes: 149.5;Early spermatids: 150.6;Excitatory neurons: 255.3;Inhibitory neurons: 182.5;Microglial cells: 391.6;Oligodendrocyte precursor cells: 207.6;Oligodendrocytes: 217.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (3.09e-3)"	"unprognostic (3.51e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.04e-8)"	"unprognostic (3.37e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.46e-3)"	25.3	18.6	29.4	26.3	11.2	88.8	24.9	45.3	24.1	28.1	0.0	27.0	17.3	20.5	71.0	19.4	27.8	17.6	21.3	12.1	5.1	25.0	30.4	27.6	38.8	8.3	4.6	24.4	22.4	6.6	23.6	14.8	8.9	28.8	27.8	31.2	23.3	11.8	28.5	104.5	36.7	13.0	0.0	41.1	26.5	20.8	14.8	17.3	31.9	7.5	27.1	20.6	24.8	9.0	14.0	18.6	17.3	13.7	12.2	17.3	29.3	16.7	5.1	5.5	8.9	38.6	19.2	27.2	12.4	14.5	5.1	15.5	9.4	14.0	10.9	10.9	8.7	10.5	56.2	53.0	8.0	44.2	26.9	13.0	16.8	14.6	24.3	11.3	12.1	21.2	23.3	22.8	8.4	40.0	16.9	27.7	20.8	4.5	9.9	25.4	10.3	15.3	6.2	13.6	17.2	10.5	11.1	12.8	8.2	16.3	16.9	12.9	26.9	29.1	14.7	14.0	14.7	11.6	11.9	27.8	9.2	20.4	14.0	3.1	0.9	0.3	0.7	0.5	0.6	1.0	1.0	0.5	0.2	2.7	0.8	0.9	1.4	2.2	0.6	2.0	0.2	0.2	29.4	11.2	45.3	24.1	12.1	5.1	8.3	4.6	8.9	0.0	14.8	9.0	7.1	3.2	16.8	149.5	4.3	7.6	1.2	0.9	3.4	5.1	1.3	0.9	2.1	0.0	6.1	0.0	4.2	0.5	7.6	1.7	0.0	1.0	150.6	5.1	5.4	3.6	1.2	4.4	255.3	0.6	0.3	3.6	6.1	8.8	10.8	3.0	1.4	0.8	0.7	1.7	182.5	2.1	2.0	1.2	5.2	25.3	0.3	4.3	0.0	391.6	2.8	1.2	3.1	207.6	217.1	1.4	3.0	0.4	5.9	0.7	1.0	0.1	3.9	6.4	0.0	3.1	3.1	1.5	0.5	2.3	8.4	0.8	7.0	1.8	2.2	0.7
NPIPB5		ENSG00000243716	"Nuclear pore complex interacting protein family member B5"	A8MRT5	16	22479121-22536521	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 57.1;Club cells: 50.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (7.52e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.43e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.90e-10)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.76e-5)"	58.6	36.5	63.2	66.8	37.2	136.4	58.0	69.0	90.4	67.1	6.8	61.8	36.5	41.8	124.9	41.2	54.9	27.7	50.9	24.8	27.4	49.0	38.4	77.0	82.6	22.1	37.3	57.1	49.4	14.7	50.4	29.3	22.9	58.9	47.3	115.7	56.7	22.8	78.4	212.1	90.9	25.3	2.6	84.6	50.9	41.0	57.1	43.1	75.5	17.7	61.0	45.9	58.8	33.2	31.3	25.7	16.3	23.3	27.8	24.9	35.4	18.9	6.3	11.5	13.9	35.4	53.3	43.9	34.7	17.4	11.3	24.5	41.2	21.3	19.0	53.8	17.2	16.1	85.6	66.1	27.5	83.5	29.1	30.1	20.9	23.0	41.1	20.6	18.3	45.0	43.5	52.8	10.3	57.6	26.6	101.3	46.4	4.9	11.7	44.7	12.1	51.1	18.2	18.9	21.0	14.9	23.3	36.6	19.7	32.9	19.9	30.8	71.4	39.4	17.4	31.2	30.6	35.7	18.9	54.4	15.7	63.6	14.3	6.2	2.7	2.1	3.9	1.2	1.6	6.8	3.8	2.6	1.4	7.7	4.0	3.5	6.0	2.8	2.5	5.2	2.0	1.3	63.2	37.2	69.0	90.4	24.8	27.4	22.1	37.3	22.9	2.6	57.1	33.2	30.0	28.9	57.1	1.0	20.3	14.4	11.2	3.0	17.1	16.5	10.5	7.1	34.8	4.3	50.6	5.5	10.4	5.1	22.8	3.3	0.0	3.8	7.1	19.3	20.5	23.6	1.2	17.2	0.3	1.4	2.8	20.4	22.4	32.7	10.1	21.0	8.2	2.0	4.4	6.7	0.2	3.8	0.0	8.1	16.7	2.8	10.2	25.5	5.4	1.0	14.2	5.5	12.3	0.5	0.3	5.0	4.0	6.4	21.7	13.0	4.3	1.6	31.6	23.8	0.0	32.7	22.7	3.6	2.3	14.0	11.5	5.9	29.7	9.3	3.3	10.3
NPIPB6		ENSG00000198156	"Nuclear pore complex interacting protein family member B6"	E9PJ23	16	28342555-28363508	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 39.7"	"Group enriched"	"Detected in some"	19	"Early spermatids: 300.0;Late spermatids: 151.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.1;hTCEpi: 3.0;NB-4: 3.1;RPMI-8226: 3.4"									"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (1.99e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-3)"	1.2	0.6	4.9	0.3	5.0	0.7	1.3	5.2	8.7	2.5	4.2	2.1	0.3	1.3	1.0	0.9	2.9	0.2	0.9	4.8	5.2	1.1	1.2	1.4	0.5	4.7	4.5	3.2	1.5	0.2	2.5	0.2	5.2	2.3	0.6	1.3	1.1	0.6	1.4	2.1	2.1	0.4	4.3	1.9	1.2	39.7	4.8	0.4	2.4	0.1	0.3	1.5	1.7	6.2	0.1	3.1	1.4	0.3	0.7	0.0	2.7	0.2	0.3	0.0	0.2	0.1	1.3	1.1	0.2	0.1	0.3	0.4	0.3	0.3	0.1	0.7	0.2	0.8	0.7	0.0	0.0	1.0	0.2	0.4	3.0	0.2	0.6	0.5	0.0	1.7	0.1	2.4	0.0	0.7	0.3	3.1	0.7	0.3	0.1	1.6	1.1	3.4	0.0	0.0	0.4	0.6	0.1	0.1	0.3	1.5	0.6	0.3	0.2	0.4	1.0	0.2	0.2	1.0	1.1	0.3	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	5.0	5.2	8.7	4.8	5.2	4.7	4.5	5.2	4.3	4.8	6.2	0.2	0.0	1.1	0.0	0.1	0.5	0.4	0.0	0.0	0.5	1.6	1.7	0.5	0.0	0.8	0.0	0.0	0.5	0.1	0.4	0.0	0.0	300.0	0.7	0.4	0.3	0.0	0.0	0.0	0.2	0.2	0.4	0.0	1.5	0.0	1.4	1.1	0.2	0.2	0.0	0.0	0.1	0.0	0.3	0.3	151.0	1.2	0.6	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	1.4	1.9	0.0	0.6	0.3	0.2	6.0	0.2	0.0	1.7	0.4	11.7	3.1	0.0	1.3	1.4	0.4	0.3	0.5	0.7
NPIPB7	"LOC440350, NPIPL1"	ENSG00000233232	"Nuclear pore complex interacting protein family member B7"	O75200	16	28456372-28471175	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 22.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 152.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-1)"		"unprognostic (7.43e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.03e-2)"	1.4	0.9	4.0	1.4	4.0	2.6	1.0	6.1	8.2	0.5	0.1	1.4	1.0	1.3	2.1	0.2	0.7	0.3	0.4	4.0	3.0	0.6	1.2	0.8	1.5	3.1	0.7	1.6	1.7	0.4	0.3	0.7	1.9	1.0	1.4	4.5	0.8	1.1	5.0	3.2	1.3	0.7	0.0	1.3	2.4	22.2	2.7	1.0	0.6	1.0	0.6	0.5	0.1	1.7	0.6	4.1	3.0	2.0	1.3	1.3	6.3	1.5	0.1	0.3	0.5	1.5	1.8	3.2	0.9	1.0	0.3	2.0	0.9	0.6	0.2	1.1	1.5	1.2	4.5	3.1	0.6	2.8	6.3	1.4	3.1	1.0	0.9	1.6	0.1	1.9	1.0	2.2	0.7	5.4	0.7	2.9	1.9	0.2	0.2	2.6	1.8	1.6	0.2	1.5	1.6	0.8	1.3	0.5	0.6	2.8	2.2	1.2	2.2	1.1	2.8	1.5	1.0	4.4	2.2	3.1	0.4	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.0	6.1	8.2	4.0	3.0	3.1	0.7	1.9	0.0	2.7	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.0	152.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
NPIPB8		ENSG00000255524	"Nuclear pore complex interacting protein family member B8"	E9PQR5	16	28637654-28658682	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	7	"testis: 13.9"	"Group enriched"	"Detected in some"	14	"Early spermatids: 19.9;Late spermatids: 35.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"hTCEpi: 20.6"									"HPA011188, HPA053611"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (8.28e-2)"				"unprognostic (1.88e-1)"			"unprognostic (1.10e-1)"		"unprognostic (5.78e-2)"			"unprognostic (1.05e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.19e-1)"			0.9	0.6	0.4	0.2	0.6	0.2	1.1	0.5	0.8	1.7	0.2	1.8	0.9	0.9	0.2	1.0	0.9	0.0	0.8	0.5	0.5	0.9	1.8	1.2	0.1	0.5	0.4	1.6	1.6	0.0	1.8	0.0	0.6	1.6	0.1	0.6	2.0	0.0	0.7	1.4	1.8	0.0	0.4	1.1	1.4	13.9	0.4	0.0	1.5	0.0	0.1	1.0	1.2	0.9	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.5	0.2	20.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.5	0.8	0.5	0.5	0.5	0.4	0.6	0.4	0.4	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	35.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPIPB9		ENSG00000196993	"Nuclear pore complex interacting protein family member B9"	F8W1W9	16	28751787-28772807	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"testis: 14.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.4;Oligodendrocytes: 1.0;Plasma cells: 1.5;Respiratory ciliated cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.4;U-266/70: 2.8"									"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (7.38e-2)"	"unprognostic (6.63e-4)"		"unprognostic (6.63e-2)"	"unprognostic (5.05e-2)"			"unprognostic (5.53e-2)"		"unprognostic (4.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.36e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.71e-2)"	1.1	0.6	1.8	0.4	1.5	1.0	1.2	1.7	3.1	1.7	0.8	1.5	0.0	1.2	1.1	0.7	2.1	0.3	0.9	1.7	1.6	1.0	1.2	1.4	0.8	1.4	1.6	2.9	1.1	0.1	1.5	0.2	1.8	1.8	0.4	1.7	0.9	0.4	1.0	3.1	1.7	0.3	1.1	1.7	1.0	14.9	2.1	0.1	1.9	0.0	0.6	1.3	1.4	2.4	0.2	1.8	0.5	0.3	0.2	0.7	1.5	0.0	0.1	0.0	0.0	0.2	1.0	0.7	0.5	0.0	0.2	0.1	0.2	0.0	0.1	0.2	0.9	0.3	0.0	0.4	0.0	1.3	1.2	0.1	4.4	0.3	0.8	0.2	0.0	1.4	0.2	1.2	0.1	1.2	0.4	1.7	0.7	0.1	0.4	1.7	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.2	0.1	1.0	1.1	0.5	0.0	0.0	1.3	0.9	0.3	2.8	1.4	1.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.8	1.5	1.7	3.1	1.7	1.6	1.4	1.6	1.8	1.1	2.1	2.4	0.0	0.0	0.5	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.1	0.1	0.1	0.0	0.0	0.1
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 20.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		30000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	37.3	46.6	27.2	32.4	27.6	41.7	32.0	22.2	28.3	30.4	27.1	35.2	24.5	35.3	23.5	51.5	28.8	23.3	58.4	26.6	31.2	42.2	54.8	37.9	33.2	31.8	27.2	25.9	36.7	29.7	33.2	27.1	28.5	33.3	21.3	20.1	32.4	22.7	164.3	42.1	34.4	29.3	24.1	42.8	36.8	42.8	28.7	33.4	28.4	55.5	28.8	33.2	31.7	32.8	91.9	118.6	46.2	72.1	56.0	46.0	57.2	74.2	82.3	120.4	110.6	90.7	80.2	67.2	57.9	87.7	87.8	72.5	46.0	62.6	104.5	43.0	60.8	77.5	95.5	81.5	53.4	83.4	95.4	45.8	59.1	113.2	40.1	57.7	124.8	62.0	84.1	99.1	73.6	59.5	113.0	45.2	54.3	45.5	74.0	73.6	73.8	54.4	43.6	86.8	61.6	70.6	92.6	127.4	85.7	87.1	100.1	60.9	89.6	156.1	108.1	86.1	121.4	74.8	57.9	84.0	124.6	55.2	102.9	4.1	20.0	4.4	4.6	4.9	2.8	4.7	3.1	3.7	6.3	3.3	2.8	3.7	5.6	2.8	3.1	4.8	3.2	10.0	27.2	27.6	22.2	28.3	26.6	31.2	31.8	27.2	28.5	24.1	28.7	32.8	19.2	12.8	18.1	24.8	15.3	17.6	16.2	12.7	7.4	24.3	19.5	16.1	44.5	11.5	18.5	20.2	29.2	19.5	22.2	38.9	1.9	19.0	96.2	32.8	19.6	22.2	30.5	20.6	38.0	37.4	21.3	15.9	26.0	38.8	3.8	29.2	27.1	54.3	19.1	20.2	36.4	17.2	8.2	27.3	18.7	79.6	17.7	22.8	12.4	19.7	28.7	19.6	14.4	23.1	38.6	47.2	22.8	12.8	16.5	28.4	22.2	27.9	21.5	33.5	19.7	22.3	18.5	29.7	23.9	15.7	24.2	37.1	16.9	19.3	18.9	28.7
NPM1	"B23, NPM"	ENSG00000181163	"Nucleophosmin 1"	P06748	5	171387116-171411810	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011384, CAB012983"	Supported		Enhanced	"Nucleoplasm,Nucleoli rim"		NA	Yes		2000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoli rim"	Nucleoplasm	"CAB012983: AB_2533084, HPA011384: AB_1854692"	"unprognostic (1.84e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (7.48e-4)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (1.86e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.24e-2)"	515.1	370.6	180.7	468.4	190.3	789.2	597.1	188.6	233.5	759.2	195.9	486.6	347.1	656.6	421.5	623.0	596.1	355.4	336.7	169.0	210.7	375.3	370.3	364.5	777.0	196.2	188.6	1384.6	810.6	278.0	314.4	423.7	207.5	386.2	421.2	161.3	385.2	318.5	450.9	386.6	374.1	436.0	213.9	358.1	467.8	284.7	202.6	683.3	510.1	282.4	761.7	524.9	565.4	204.5	2476.2	1522.7	1864.0	2663.1	1073.3	1915.6	2736.9	2111.3	1826.0	2678.1	2387.2	3640.2	1622.2	6243.9	1683.2	1194.5	1927.6	1386.6	2552.2	4639.2	3423.4	2027.9	2027.3	2149.1	1361.9	2740.2	1593.2	4556.3	1790.7	1732.2	1559.7	1845.8	3572.3	2184.3	2019.4	1460.9	2712.8	1406.5	1945.5	2826.5	3071.1	3087.4	2400.7	1280.7	1857.2	2695.2	2051.7	3241.9	2306.9	1583.1	1433.8	1167.4	1210.6	2084.4	4091.0	1288.7	2513.8	2000.7	1289.5	916.7	2114.4	1082.5	3705.3	1161.5	2139.6	3702.2	1403.3	3561.5	1897.0	153.6	287.1	92.3	443.1	311.4	834.2	847.9	832.8	654.3	564.2	634.9	1189.9	973.4	38.0	656.2	264.4	516.8	782.6	1076.1	180.7	190.3	188.6	233.5	169.0	210.7	196.2	188.6	207.5	213.9	202.6	204.5	462.2	346.1	461.1	12.4	911.0	1400.1	1224.1	1692.5	993.1	177.2	779.0	1045.4	243.5	514.8	764.5	323.7	43.8	1647.8	615.9	175.3	743.4	1073.6	135.8	466.3	707.3	568.2	362.1	865.5	15.6	919.2	2021.0	685.9	489.8	544.6	443.8	688.8	383.8	254.1	1071.0	127.9	20.3	656.0	679.5	629.2	817.6	98.6	974.9	557.2	610.1	19.7	862.8	339.2	476.8	14.6	21.2	922.5	370.1	649.9	671.6	1051.5	404.2	911.0	357.4	144.1	433.9	617.8	1074.1	855.7	578.6	907.2	1019.1	1538.8	865.1	1019.5	866.2	967.3
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.0;parathyroid gland: 39.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.6	18.4	11.0	0.1	16.9	1.2	2.1	7.4	40.0	4.9	2.2	1.1	2.2	5.0	0.9	1.0	3.2	1.9	2.3	12.4	9.2	6.6	1.6	1.8	0.6	7.5	7.6	1.5	11.0	39.2	18.5	0.5	10.0	6.6	1.0	5.7	2.7	1.4	0.3	2.2	1.2	3.6	2.3	12.5	1.9	5.1	7.1	2.9	25.3	0.3	0.4	2.0	2.3	13.5	3.9	0.5	0.2	0.2	0.9	0.0	1.5	0.5	0.5	2.4	4.9	1.6	3.6	0.0	1.1	0.0	0.2	17.7	0.5	0.0	1.4	0.1	0.5	14.5	1.0	32.4	3.1	1.9	1.3	0.5	2.3	0.0	0.3	3.7	0.0	9.5	0.5	0.0	0.1	0.0	0.2	3.9	0.7	6.4	0.4	0.3	1.4	0.8	5.6	0.1	3.8	0.2	0.0	0.1	4.6	0.0	0.7	11.2	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	0.0	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	11.0	16.9	7.4	40.0	12.4	9.2	7.5	7.6	10.0	2.3	7.1	13.5	0.1	0.0	1.1	1.0	0.7	0.1	9.7	3.7	0.6	29.4	3.1	5.2	2.1	5.7	8.8	0.0	20.9	0.1	0.5	0.6	3.9	9.4	15.1	1.1	0.3	0.6	11.4	0.4	21.3	8.0	0.2	1.7	1.5	1.1	0.0	1.4	2.5	0.5	4.6	6.7	21.9	2.1	2.0	0.0	0.3	14.4	0.6	0.9	10.6	1.9	1.0	0.9	0.0	2.5	1.6	4.3	0.8	0.4	0.6	3.4	0.5	14.6	7.7	4.2	0.0	0.4	1.6	0.5	0.9	1.1	1.1	0.3	2.7	7.6	1.2	5.8
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 137.0;thyroid gland: 234.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 185.9;Alveolar cells type 2: 103.7;Club cells: 56.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.9;CAPAN-2: 19.1;HeLa: 32.3;Hep G2: 27.1;MCF7: 24.3;RPTEC TERT1: 37.7;T-47d: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA		120000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	22.8	6.3	9.7	5.6	7.9	0.2	27.0	4.7	8.0	32.4	5.7	24.5	56.1	20.9	22.2	10.9	22.4	30.5	5.2	7.5	14.6	105.0	4.0	137.0	4.5	6.1	31.8	10.9	40.1	1.0	47.4	3.4	9.2	82.9	25.2	2.4	8.9	18.7	4.9	8.2	74.1	14.1	4.4	14.8	14.9	3.1	10.5	14.2	234.5	11.5	5.4	9.7	22.1	6.6	0.0	0.2	0.3	0.6	0.0	0.0	30.9	0.2	0.1	0.0	0.0	14.9	19.1	0.2	0.8	0.2	0.0	1.7	7.4	0.0	0.0	0.0	8.4	0.8	32.3	27.1	0.1	0.0	0.2	3.2	2.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.0	24.3	0.4	1.5	0.3	0.1	12.0	0.0	0.1	0.3	37.7	1.6	1.7	0.6	1.8	14.1	0.0	4.1	51.2	1.3	0.0	0.6	0.4	0.5	1.1	0.3	1.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	7.9	4.7	8.0	7.5	14.6	6.1	31.8	9.2	4.4	10.5	6.6	5.2	185.9	103.7	15.3	0.0	1.9	5.2	13.1	1.8	1.1	22.2	7.0	2.5	27.1	56.4	33.1	0.0	2.4	0.7	5.9	1.9	24.7	11.0	1.0	1.5	18.4	15.6	0.0	1.0	2.5	0.2	8.3	1.1	1.9	0.0	3.3	2.9	0.3	0.3	0.0	10.0	10.6	4.1	0.0	1.5	15.4	2.5	0.6	5.4	14.0	0.0	0.0	0.0	2.0	0.3	7.5	3.4	0.0	0.0	28.4	19.6	4.3	6.4	0.2	0.0	1.9	26.4	2.4	2.0	3.6	1.1	1.5	0.3	1.5	11.0	5.7
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678688-153693992	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 67.1"	"Group enriched"	"Detected in many"	6	"Adipocytes: 99.6;Endothelial cells: 52.5;Hepatic stellate cells: 132.8"	"Group enriched"	"Detected in all"	4	"ovarian cancer: 39.2;renal cancer: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"ASC diff: 158.5"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 18.7"	"Low region specificity"	"Detected in many"			HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	67.1	8.7	1.7	3.4	1.5	0.0	44.3	1.4	1.4	8.8	1.5	10.1	1.5	31.0	5.5	4.3	36.4	5.9	15.8	1.3	1.4	28.8	4.3	24.2	2.3	1.5	1.5	27.7	3.9	8.4	3.8	17.7	1.5	4.4	2.0	0.1	3.7	12.1	7.2	6.6	9.3	9.7	1.8	2.2	8.8	1.3	2.4	1.9	14.0	11.1	1.3	12.8	9.7	1.4	0.0	1.3	0.1	0.0	158.5	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	28.0	0.0	19.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	15.9	0.0	0.0	2.1	0.0	0.1	0.0	1.9	0.0	5.7	1.0	0.1	0.0	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	1.4	1.4	1.3	1.4	1.5	1.5	1.5	1.8	2.4	1.4	99.6	0.0	6.9	0.0	0.2	1.5	0.5	0.0	0.6	0.0	0.5	0.5	4.5	2.8	0.0	14.7	0.0	0.2	0.1	0.0	0.0	0.7	9.1	6.2	8.8	52.5	0.0	0.0	0.0	0.0	1.3	15.2	0.0	15.4	0.0	0.0	132.8	2.4	0.3	0.0	0.0	0.0	0.0	4.7	4.0	11.5	10.2	0.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.0	0.0	4.1	0.0	0.5	0.0	4.0	0.0	0.0	0.0	1.4	2.2	0.5	0.1	0.2	1.0	0.7	0.3	1.4	0.2	0.0
NPTXR		ENSG00000221890	"Neuronal pentraxin receptor"	O95502	22	38818452-38844028	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 280.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Excitatory neurons: 41.7;Inhibitory neurons: 50.4;Oligodendrocyte precursor cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 280.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 23.3;SCLC-21H: 30.8;SiHa: 23.6;U-87 MG: 87.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001079	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		420000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA001079: AB_1078414"	"unprognostic (6.29e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (6.82e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.55e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.77e-2)"	2.7	5.0	91.6	1.9	75.4	0.3	2.8	0.3	145.7	8.7	0.0	9.5	1.3	10.9	3.8	3.0	7.9	2.0	15.7	280.2	17.0	1.6	1.9	1.9	1.6	4.1	15.2	8.1	5.2	7.0	6.8	0.4	0.7	8.1	1.5	5.3	4.8	7.0	0.6	1.1	3.3	7.6	3.1	2.5	5.0	1.8	58.0	0.7	2.7	2.5	1.5	7.3	4.8	46.0	1.0	6.2	0.2	1.8	12.2	1.2	0.0	4.1	0.9	7.9	2.7	6.2	1.3	0.0	7.2	1.1	23.3	0.8	1.7	0.2	2.6	0.6	2.0	0.0	0.2	9.6	1.2	0.1	0.3	3.9	0.4	7.2	0.1	11.4	0.3	0.1	7.7	0.3	0.3	9.7	0.0	0.5	7.3	3.0	2.2	1.6	0.0	15.3	2.0	17.1	30.8	2.0	23.6	0.1	0.7	1.7	9.9	2.5	0.4	14.1	8.4	0.0	0.7	2.1	0.0	0.0	87.9	18.5	7.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	91.6	75.4	0.3	145.7	280.2	17.0	4.1	15.2	0.7	3.1	58.0	46.0	4.7	0.0	0.0	9.4	0.3	1.1	2.7	0.9	0.0	6.6	3.3	1.5	18.0	4.3	3.0	3.7	2.1	0.0	2.3	0.0	0.0	7.3	1.7	1.7	3.2	4.2	1.8	0.0	41.7	3.8	0.0	1.5	0.5	3.0	0.0	1.5	5.0	0.4	0.2	0.0	50.4	0.2	6.1	0.3	0.9	0.8	1.8	0.3	1.8	1.9	0.0	4.8	6.2	19.1	10.5	2.0	0.0	2.2	0.9	3.8	0.1	0.5	2.2	3.3	0.0	2.4	2.8	0.2	1.3	0.1	1.0	0.0	1.7	0.3	0.0	3.4
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3019755	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 202.5;Proximal tubular cells: 730.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 240.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	60.0	121.5	48.1	27.0	48.8	72.1	45.0	61.1	65.4	32.6	64.3	28.2	35.3	25.8	32.9	32.8	30.0	31.5	76.5	48.5	49.6	190.3	124.2	30.4	19.5	61.8	47.9	29.8	42.6	33.5	21.2	28.6	61.4	28.1	19.6	31.1	61.9	28.9	123.6	50.7	35.6	19.8	42.9	39.3	36.1	18.2	51.5	18.3	26.8	144.9	18.2	31.8	29.0	53.2	45.7	75.7	42.1	95.3	73.0	42.9	45.4	40.5	51.2	37.1	40.9	80.0	16.1	36.9	144.7	71.1	86.4	33.7	45.4	28.5	28.9	95.9	37.1	23.6	83.0	77.3	59.7	24.4	73.9	27.8	34.2	44.9	40.9	53.4	36.8	47.9	142.3	24.1	30.8	95.5	27.0	44.4	54.9	87.6	59.8	49.3	50.1	108.2	56.6	24.0	11.4	15.9	59.5	25.9	128.9	75.0	35.4	16.9	60.7	34.8	14.4	45.9	18.1	45.4	116.7	12.3	43.3	69.5	72.7	25.2	91.8	52.8	33.1	64.2	24.4	12.1	29.6	29.8	61.7	9.1	17.8	19.6	240.2	30.0	60.8	6.5	37.2	43.2	48.1	48.8	61.1	65.4	48.5	49.6	61.8	47.9	61.4	42.9	51.5	53.2	30.3	9.6	16.1	9.8	16.3	35.2	41.5	32.7	12.5	34.8	34.2	32.1	72.8	47.1	21.3	25.8	10.4	42.6	18.2	21.2	162.4	29.1	51.6	15.1	21.4	28.0	4.8	43.8	47.0	63.4	53.9	51.5	33.1	9.0	13.9	11.0	25.7	202.5	76.6	42.1	46.7	23.3	30.5	44.7	105.7	62.8	35.8	75.4	67.6	19.7	148.6	54.0	20.6	10.6	9.1	55.8	18.3	41.0	15.0	38.6	103.7	730.3	28.7	22.5	26.3	35.0	42.9	24.8	11.4	35.4	41.2	31.2	20.8	21.9	25.4	41.8
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913975	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Receptor, Repressor"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.9;liver: 142.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 97.2;Distal tubular cells: 52.8;Exocrine glandular cells: 42.4;Gastric mucus-secreting cells: 90.2;Hepatocytes: 173.4;Proximal enterocytes: 49.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 52.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"Hep G2: 78.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.7"	"Not detected"	"Not detected"			HPA003983			Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Vesicles	"HPA003983: "	"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"	0.0	21.4	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	76.9	0.0	0.0	0.0	0.0	10.1	12.9	0.0	0.0	33.8	142.4	2.4	0.0	0.0	0.0	0.0	30.6	1.6	0.3	0.0	0.1	0.0	0.4	0.2	0.0	0.0	2.7	0.0	26.5	0.0	0.0	11.5	26.4	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	78.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.3	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	15.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	8.4	97.2	0.7	12.9	0.0	0.0	0.0	0.9	52.8	31.3	0.4	0.1	0.0	0.2	24.4	8.0	0.0	42.4	0.0	0.3	90.2	0.0	0.0	3.0	2.5	173.4	0.1	28.6	0.0	7.6	16.2	3.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.2	0.3	0.0	0.2	0.0	49.8	0.1	0.0	0.4	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.3	0.1	11.0	0.2
NR1D2	"BD73, EAR-1r, Hs.37288, HZF2, REVERBB, REVERBbeta, RVR"	ENSG00000174738	"Nuclear receptor subfamily 1 group D member 2"	Q14995	3	23945286-23980617	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053868, HPA054798"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA053868: AB_2682284, HPA054798: AB_2616453"	"unprognostic (8.64e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.47e-7)"	"unprognostic (2.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	15.4	16.0	14.1	10.9	13.7	15.3	20.9	26.8	21.5	13.7	8.7	13.7	13.6	24.9	13.8	15.8	16.8	14.5	31.7	14.2	14.8	21.8	29.5	14.1	14.7	13.1	15.2	31.2	17.0	52.8	11.9	8.7	13.7	17.5	11.3	34.4	32.4	24.7	54.5	14.0	13.9	13.3	13.7	18.7	14.8	7.4	17.3	12.2	54.2	50.4	14.2	10.6	12.4	18.8	22.5	5.0	11.5	10.9	11.8	12.6	7.1	32.7	42.7	17.8	19.7	3.7	21.6	16.0	10.7	46.0	27.8	14.7	14.6	21.4	36.9	5.8	16.9	2.6	11.3	4.5	24.6	8.6	2.3	16.9	22.1	21.7	55.4	32.9	12.3	9.3	5.8	56.3	14.2	12.9	4.7	2.7	12.5	18.2	24.8	4.1	18.6	11.1	9.9	30.6	11.8	26.2	23.9	13.6	29.2	18.5	11.9	7.4	24.5	46.2	47.0	30.2	37.6	27.4	39.4	7.4	26.3	12.6	27.5	0.0	0.3	0.0	1.4	1.1	2.6	1.0	1.6	1.3	0.4	0.7	1.1	1.1	0.1	0.5	0.6	0.4	1.0	0.4	14.1	13.7	26.8	21.5	14.2	14.8	13.1	15.2	13.7	13.7	17.3	18.8	51.8	12.8	7.5	51.6	39.6	33.3	34.7	14.5	59.2	82.5	29.7	23.9	39.5	17.2	17.5	20.2	39.6	11.1	43.0	17.1	7.9	11.3	10.0	77.5	49.8	38.9	28.5	3.8	58.6	15.1	2.5	47.7	35.7	135.2	8.2	33.2	15.4	33.1	9.6	95.9	62.0	18.2	26.4	12.8	32.0	11.3	34.2	26.8	28.4	32.8	12.6	62.8	11.3	44.2	57.5	19.8	10.3	42.5	28.5	41.4	17.9	11.9	16.0	53.6	32.9	46.8	45.5	7.6	10.9	42.0	33.5	6.8	44.4	37.0	12.1	31.1
NR1H2	"LXR-b, LXRb, NER, NER-I, RIP15, UNR"	ENSG00000131408	"Nuclear receptor subfamily 1 group H member 2"	P55055	19	50329653-50383388	"Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005446, HPA056838, HPA070212"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Vesicles	"HPA005446: , HPA056838: AB_2683254, HPA070212: AB_2686234"	"unprognostic (1.31e-1)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.69e-3)"	59.6	61.4	43.2	37.1	45.6	143.4	57.9	43.1	53.3	61.1	41.3	78.7	43.1	67.3	10.8	56.0	63.6	28.4	89.6	40.7	45.0	63.9	61.0	66.4	33.9	55.8	47.3	56.9	49.8	32.1	40.6	26.3	48.5	63.7	11.9	9.4	46.9	37.9	132.1	60.7	55.1	20.3	44.4	56.7	60.2	31.8	48.4	21.4	56.5	36.7	16.7	77.1	58.3	47.8	56.2	124.1	12.1	32.4	34.5	36.4	42.0	75.8	53.4	38.4	41.7	25.8	48.9	34.8	67.1	39.4	31.7	46.8	7.8	34.1	9.5	89.9	57.6	32.5	41.8	26.4	63.7	58.2	84.0	34.8	45.2	39.3	27.3	37.7	33.4	24.7	51.7	65.4	20.8	53.2	39.3	40.5	25.5	32.2	94.4	22.8	35.8	57.2	30.4	54.3	14.9	50.6	50.9	54.0	46.7	6.6	37.9	42.5	53.9	54.3	45.3	58.4	66.8	82.5	79.3	26.4	108.6	36.5	53.8	159.1	123.9	232.4	90.4	125.4	89.3	112.3	89.9	86.2	121.3	117.7	90.8	81.4	194.8	85.9	146.4	103.9	89.0	129.3	43.2	45.6	43.1	53.3	40.7	45.0	55.8	47.3	48.5	44.4	48.4	47.8	50.7	28.9	30.7	3.6	70.7	43.0	89.3	53.2	32.5	37.9	33.4	27.3	29.6	37.1	31.1	31.3	14.6	64.5	57.0	82.1	64.6	63.6	15.5	31.9	19.5	50.0	20.8	58.9	5.9	72.6	53.3	40.2	37.2	33.8	50.2	25.1	36.8	20.7	51.3	37.0	5.5	45.5	46.8	37.0	48.3	9.5	45.4	54.5	60.5	4.7	65.2	46.8	65.9	0.5	6.9	74.3	89.6	53.4	47.5	91.0	93.5	61.8	21.7	25.4	39.5	45.5	50.2	34.6	25.9	27.9	45.7	140.0	54.8	27.7	35.7	109.0
NR1H3	"LXR-a, LXRa, RLD-1"	ENSG00000025434	"Nuclear receptor subfamily 1 group H member 3"	Q13133	11	47248300-47269033	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 66.6;Hofbauer cells: 54.4;Kupffer cells: 100.9;Proximal enterocytes: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 13.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 45.3;HSkMC: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036443, CAB037109"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB037109: AB_1840991, HPA036443: AB_10966142"	"unprognostic (2.95e-3)"	"unprognostic (5.31e-3)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (3.56e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.40e-4)"	60.7	19.9	11.3	19.4	11.8	3.3	51.1	11.2	14.3	25.3	10.2	24.6	48.4	13.6	17.6	7.6	20.3	19.6	18.5	10.3	11.1	23.4	83.8	24.1	46.7	11.0	12.1	15.2	16.7	6.8	7.2	25.4	11.7	19.4	12.0	2.2	14.8	11.5	9.1	11.7	41.0	7.9	10.5	53.2	16.3	21.8	13.8	11.0	20.3	6.3	13.6	22.4	17.5	11.5	3.5	13.8	6.4	6.1	41.0	45.3	31.1	3.5	17.9	5.7	8.8	17.0	43.2	6.1	6.5	2.8	2.1	9.2	7.6	6.1	3.8	5.8	6.1	8.3	18.7	26.1	17.5	2.9	1.0	61.2	3.7	8.7	5.5	9.7	5.0	9.4	10.2	2.5	4.5	14.8	5.8	17.0	7.1	18.7	4.5	8.4	8.3	4.1	5.0	31.9	6.1	2.3	12.2	7.9	10.4	6.1	19.5	8.8	1.3	4.5	6.1	9.1	2.0	11.9	18.3	7.6	8.2	3.9	2.2	7.8	2.7	2.5	1.4	13.3	1.9	1.0	1.5	1.3	4.3	0.7	1.7	1.4	1.6	5.8	4.2	0.7	3.8	1.9	11.3	11.8	11.2	14.3	10.3	11.1	11.0	12.1	11.7	10.5	13.8	11.5	27.2	0.0	11.3	8.1	3.0	3.3	8.6	4.6	2.2	2.4	12.7	12.1	6.6	15.7	4.9	5.5	2.1	11.0	1.5	24.4	11.7	5.8	31.0	2.4	15.3	12.5	1.8	7.0	9.2	8.7	13.3	14.1	17.9	2.8	13.3	7.1	24.7	66.6	54.4	1.7	10.9	14.6	2.0	100.9	3.3	49.0	9.0	24.7	3.6	1.0	5.4	4.4	2.1	3.0	5.6	4.2	10.7	6.0	2.4	4.1	69.5	26.1	2.5	0.8	19.7	7.4	16.3	32.4	16.8	3.0	2.4	6.6	2.1	5.4	19.0	6.3
NR1H4	"FXR, HRR-1, HRR1, RIP14"	ENSG00000012504	"Nuclear receptor subfamily 1 group H member 4"	Q96RI1	12	100473708-100564414	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.1;liver: 120.6"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 92.9;Hepatocytes: 105.1;Proximal enterocytes: 331.0;Proximal tubular cells: 153.8"	"Group enriched"	"Detected in some"	11	"liver cancer: 18.7;renal cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"Hep G2: 28.3;HHSteC: 14.1;RPTEC TERT1: 44.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047699			Approved	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA047699: AB_10965320"			"unprognostic (1.78e-1)"		"unprognostic (1.81e-1)"		"unprognostic (6.68e-2)"	"unprognostic (2.49e-1)"		"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"		"unprognostic (3.77e-3)"	0.2	22.6	0.1	1.4	0.1	0.4	1.0	0.5	0.4	0.2	1.8	8.3	29.6	0.1	0.1	0.2	0.2	12.6	0.4	0.2	0.1	28.2	120.6	0.4	0.3	0.1	0.1	14.0	3.1	0.0	1.4	0.0	0.1	0.3	1.6	0.3	0.3	0.0	0.3	0.5	39.1	0.8	0.0	0.4	0.5	0.7	0.2	0.1	0.3	0.1	0.2	6.5	0.1	0.5	0.0	0.9	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	28.3	14.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	44.9	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	92.9	0.0	22.0	0.0	0.0	0.0	8.0	43.0	11.5	0.7	0.0	0.0	0.3	0.0	2.7	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.6	8.9	105.1	0.0	0.0	1.6	17.0	0.0	3.5	0.0	2.0	0.9	0.8	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	19.9	0.0	0.0	0.0	331.0	153.8	0.0	0.0	0.0	0.0	0.1	0.4	1.3	0.0	0.0	0.0	0.9	1.1	30.4	3.7
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818487	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 31.2;liver: 47.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 26.1;Hepatocytes: 32.2;Paneth cells: 13.8;Proximal enterocytes: 51.7;Undifferentiated cells: 9.0"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 2.8"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.1	0.1	0.2	1.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	12.3	28.2	0.0	0.1	0.0	0.1	5.2	0.0	0.1	0.3	0.0	47.4	0.0	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	13.3	0.2	0.0	0.1	0.0	0.0	31.2	0.6	0.1	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	1.5	0.0	1.8	0.0	0.0	0.1	26.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.1	3.1	0.0	0.0	1.7	0.0	32.2	0.2	0.0	0.4	6.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	13.8	0.0	0.1	0.2	51.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.5	9.0	0.0
NR1I3	"CAR, CAR1, MB67"	ENSG00000143257	"Nuclear receptor subfamily 1 group I member 3"	Q14994	1	161229666-161238244	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 169.9"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 134.8;Proximal tubular cells: 47.1"	"Cancer enriched"	"Detected in single"	67	"liver cancer: 17.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA051365			Approved	Nucleoplasm		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA051365: AB_2616454"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.92e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.62e-2)"	0.1	0.1	0.2	0.0	2.2	0.6	0.0	0.4	1.0	0.1	0.0	0.1	2.4	0.1	0.0	0.2	0.1	0.0	0.4	0.1	0.0	10.0	169.9	0.2	0.2	0.2	0.1	0.1	0.2	0.0	1.7	0.0	0.3	0.1	0.0	1.0	0.0	0.0	1.5	1.2	3.6	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.1	0.4	0.4	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	3.8	0.1	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.9	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.2	0.0	0.3	0.1	0.2	0.7	0.7	0.5	0.4	0.3	0.2	0.0	0.7	0.8	0.6	0.1	1.2	0.1	0.5	0.8	0.5	0.8	0.2	0.3	0.6	0.1	0.6	1.0	0.5	0.2	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.4	1.0	0.1	0.0	0.2	0.1	0.3	0.0	0.2	0.6	0.8	22.4	11.7	0.0	1.3	0.6	1.2	0.1	0.0	0.7	0.2	0.1	0.5	5.7	5.0	3.7	0.0	0.1	0.2	0.2	3.9	0.1	1.7	0.1	0.2	2.3	0.0	8.0	0.4	0.0	0.2	1.9	0.0	0.1	13.3	0.1	3.9	134.8	0.3	0.0	0.6	0.0	0.0	4.1	1.1	3.1	0.3	1.8	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.1	0.0	0.4	0.8	0.5	5.0	47.1	4.4	1.6	0.0	2.4	0.5	0.2	0.2	0.0	0.0	0.0	1.6	0.1	0.3	0.9
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073628	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898"	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.62e-5)"	8.3	10.4	4.9	5.0	5.6	9.3	7.7	14.0	9.3	9.3	8.2	8.6	5.6	10.3	9.9	5.4	10.2	4.4	10.0	5.1	5.1	6.6	10.0	8.6	5.5	4.7	4.9	9.9	8.2	6.1	7.2	5.8	5.6	6.7	6.2	15.6	5.2	7.5	14.3	6.1	7.6	7.8	4.6	9.2	6.1	11.9	5.6	5.7	11.9	5.5	5.3	8.1	7.4	6.9	11.4	13.9	23.0	10.2	5.8	10.0	30.5	10.9	7.9	10.6	9.9	12.2	6.2	13.8	3.8	7.3	6.8	11.8	10.7	8.6	8.1	6.0	23.1	16.7	11.5	15.4	11.1	11.3	7.0	10.2	7.0	7.9	9.5	13.3	11.6	16.8	12.9	5.2	12.9	8.3	12.4	26.0	14.5	9.1	24.0	11.7	15.0	8.1	12.3	13.9	11.1	8.8	17.6	7.4	8.4	11.8	12.9	7.5	10.9	8.6	8.4	10.7	6.2	7.7	13.1	13.0	2.1	13.0	4.2	0.3	2.4	2.1	3.9	2.6	5.0	2.0	3.1	3.3	3.7	2.3	4.0	2.8	1.5	2.1	2.3	3.6	2.3	2.3	4.9	5.6	14.0	9.3	5.1	5.1	4.7	4.9	5.6	4.6	5.6	6.9	18.7	35.3	15.4	28.4	14.4	8.3	14.4	7.8	15.4	44.8	7.6	7.5	18.5	8.6	5.6	11.0	18.8	15.3	19.9	10.3	3.9	11.6	25.2	14.8	23.3	15.5	7.2	15.6	55.4	9.4	12.7	17.4	16.3	18.8	10.1	28.0	13.2	12.7	9.5	25.2	73.4	11.4	12.2	11.1	9.5	6.4	43.8	10.9	14.2	34.7	10.7	14.9	12.3	26.2	51.1	18.7	9.9	30.1	13.7	9.4	5.8	8.1	19.6	49.6	6.6	17.3	14.6	67.0	25.9	12.1	7.4	7.8	15.0	18.0	13.3	20.2
NR2C2	"hTAK1, TAK1, TR2R1, TR4"	ENSG00000177463	"Nuclear receptor subfamily 2 group C member 2"	P49116	3	14947584-15053600	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006313	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA006313: AB_1079503"	"unprognostic (1.32e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.51e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.82e-3)"	14.1	12.4	11.4	18.0	12.0	19.1	13.6	21.6	13.3	15.7	2.5	16.9	18.4	17.1	9.8	12.4	15.3	11.3	15.7	12.4	9.0	13.9	13.0	16.8	18.0	7.6	6.1	18.6	14.2	14.2	19.2	9.7	4.6	13.7	11.7	36.2	13.5	11.5	20.1	19.5	18.8	12.8	4.7	19.9	14.8	20.7	8.7	22.4	24.3	17.9	15.7	14.4	13.7	13.5	18.3	20.2	22.8	17.7	15.8	18.8	52.0	25.8	20.7	20.5	21.0	13.0	17.4	28.0	13.2	23.3	17.9	17.9	21.2	13.3	21.2	37.1	30.0	36.8	45.8	12.0	13.4	27.3	27.3	15.0	17.2	25.9	13.4	17.1	23.5	27.2	26.6	18.7	18.3	16.2	41.9	21.3	15.1	8.6	20.7	33.4	27.1	18.8	9.9	27.1	14.5	36.1	23.5	19.4	23.2	17.9	19.5	26.7	30.5	31.6	37.2	29.1	35.6	28.4	40.0	30.4	22.7	25.6	28.2	2.7	0.9	0.7	1.6	1.2	1.5	0.8	0.9	1.0	0.9	1.8	1.2	1.1	1.2	1.0	1.1	1.5	0.9	0.6	11.4	12.0	21.6	13.3	12.4	9.0	7.6	6.1	4.6	4.7	8.7	13.5	14.0	22.4	12.2	35.9	15.7	3.7	11.1	1.0	17.1	17.4	15.1	9.7	6.2	11.5	4.7	7.3	14.6	7.8	15.2	16.5	5.9	6.6	58.8	8.0	10.3	13.4	25.1	20.4	35.5	7.2	7.3	11.5	14.3	9.1	9.5	17.2	18.9	8.2	7.8	13.5	39.9	10.2	0.0	20.1	2.3	65.4	19.3	14.2	5.4	52.5	13.6	13.9	9.2	50.8	92.2	12.3	12.4	20.7	14.2	19.6	13.0	6.8	13.7	17.2	0.0	18.8	10.3	33.9	22.2	13.3	3.1	14.9	15.3	17.0	10.4	18.4
NR2C2AP	TRA16	ENSG00000184162	"Nuclear receptor 2C2 associated protein"	Q86WQ0	19	19201409-19203414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042054, HPA055653"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA042054: AB_10965022, HPA055653: AB_2682877"	"unprognostic (9.54e-2)"	"unprognostic (2.93e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.81e-2)"	"unprognostic (6.26e-3)"	"prognostic unfavorable (5.63e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.65e-3)"	"unprognostic (5.89e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (2.10e-2)"	14.5	10.0	13.8	12.5	14.2	7.6	15.6	14.3	14.2	14.6	12.6	15.0	8.2	14.8	13.7	17.0	14.9	6.7	10.7	14.2	13.8	16.2	10.6	9.5	13.6	14.4	14.1	16.4	15.3	7.8	8.2	7.6	14.4	14.8	11.0	3.5	13.3	10.6	12.6	21.0	12.4	11.4	14.5	13.4	13.4	5.5	14.1	10.2	11.1	7.8	13.6	17.8	14.6	15.6	50.7	29.2	13.6	28.9	11.1	11.1	52.7	28.3	16.0	37.9	35.8	19.7	60.4	27.3	77.2	15.0	26.5	44.2	36.0	37.3	23.1	24.3	39.0	15.6	18.0	21.9	12.9	30.5	23.2	11.3	45.1	26.3	35.4	10.7	15.2	31.0	28.4	35.0	22.8	130.0	51.2	27.6	24.4	72.9	58.8	36.3	22.0	53.3	23.5	26.4	45.2	20.7	24.3	47.1	37.0	16.5	25.6	18.9	12.2	24.5	23.3	61.7	54.7	20.7	32.4	36.3	28.5	51.3	33.2	2.6	14.9	1.5	31.4	21.5	41.2	43.6	40.7	30.4	12.6	42.8	42.3	39.7	2.7	27.4	17.4	24.7	37.7	26.3	13.8	14.2	14.3	14.2	14.2	13.8	14.4	14.1	14.4	14.5	14.1	15.6	14.7	0.0	9.4	2.3	19.2	31.7	41.3	19.8	38.1	3.8	26.8	31.8	2.5	5.7	12.3	7.3	0.0	24.8	17.2	10.3	7.9	20.8	0.7	8.9	7.8	13.5	4.8	8.8	2.9	16.2	34.3	12.1	6.6	11.4	14.0	14.0	5.3	4.5	18.5	8.4	1.7	12.8	10.2	5.0	11.0	1.2	16.4	9.3	10.6	1.0	15.2	5.5	11.3	2.0	2.4	19.0	5.4	13.5	8.0	67.8	7.6	10.9	9.2	3.9	0.0	11.7	10.9	4.6	16.7	26.3	25.1	12.6	16.3	8.7	17.9	36.0
NR2F1	"COUP-TFI, COUPTF1, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1"	ENSG00000175745	"Nuclear receptor subfamily 2 group F member 1"	P10589	5	93583222-93594611	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 294.1;Hepatic stellate cells: 171.4;Leydig cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 232.4;AN3-CA: 92.9;HHSteC: 174.1;hTERT-RPE1: 155.1;PC-3: 194.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019281, HPA058974"			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Cytosol	"CAB019281: , HPA058974: AB_2732629"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.75e-1)"	"unprognostic (7.68e-3)"	"unprognostic (3.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.24e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (1.47e-4)"	42.2	40.3	41.8	5.0	39.0	0.2	20.4	32.9	50.7	65.1	12.8	11.3	2.6	29.4	25.2	10.4	77.9	34.3	16.1	44.7	25.6	32.8	13.0	44.4	8.3	31.6	41.1	62.7	7.6	1.6	21.6	52.6	23.8	44.9	3.0	8.7	6.9	40.3	0.3	2.0	7.4	11.8	31.5	7.2	28.8	3.8	42.4	2.1	16.9	3.6	3.8	49.1	40.6	30.8	20.1	9.5	232.4	92.9	48.3	14.8	11.0	11.6	4.7	6.9	7.1	1.3	3.6	0.1	0.7	4.7	2.8	5.0	5.7	0.4	3.0	24.7	45.2	9.2	61.9	15.1	174.1	1.9	0.9	69.7	0.1	3.3	1.3	155.1	26.3	0.1	0.1	0.1	21.4	0.1	0.0	2.7	0.1	1.4	194.2	2.8	1.9	0.1	1.4	0.8	23.9	48.4	5.2	0.0	0.6	4.0	1.9	3.7	26.7	39.3	1.8	20.6	29.4	0.0	0.0	0.1	64.2	0.8	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.8	39.0	32.9	50.7	44.7	25.6	31.6	41.1	23.8	31.5	42.4	30.8	16.1	0.0	1.7	68.2	1.5	1.3	0.2	0.4	1.8	32.8	3.8	2.4	37.3	1.5	3.5	14.7	54.2	0.6	0.0	0.2	7.9	4.0	3.8	10.1	294.1	70.1	0.0	0.0	23.3	1.6	0.6	69.1	0.5	5.7	0.0	29.7	171.4	5.0	1.3	0.0	47.1	0.0	0.0	15.8	0.4	5.9	93.5	1.9	0.0	59.0	0.0	69.0	0.0	13.0	1.7	3.6	0.0	10.5	0.0	0.5	0.1	37.3	10.8	3.7	13.1	2.9	51.6	4.8	4.4	2.8	0.6	1.1	2.2	11.8	0.0	0.6
NR2F2	"ARP1, COUP-TFII, COUPTF2, COUPTFB, NF-E3, SVP40, TFCOUP2"	ENSG00000185551	"Nuclear receptor subfamily 2 group F member 2"	P24468	15	96325938-96340263	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 292.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 542.2;Hepatic stellate cells: 395.5;Leydig cells: 510.4;Peritubular cells: 610.5;Sertoli cells: 486.4;Smooth muscle cells: 385.7;Theca cells: 572.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058974			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA058974: AB_2732629"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.28e-2)"	95.5	43.1	32.7	18.8	19.2	0.1	59.7	15.0	19.6	128.6	23.5	52.6	21.5	120.9	61.8	22.1	101.5	65.7	44.4	20.0	24.8	79.8	32.1	56.8	42.4	16.2	21.9	292.4	20.0	30.7	20.3	74.7	18.2	60.6	26.7	2.5	22.9	126.4	33.1	24.1	32.1	81.8	12.5	106.2	82.3	26.7	49.3	7.8	46.2	31.5	15.1	46.3	74.5	10.7	154.7	39.1	125.6	78.5	249.1	85.5	41.9	109.1	83.2	111.1	94.3	134.8	153.4	0.1	86.8	55.2	44.1	90.4	22.3	78.3	138.8	0.5	86.5	49.9	48.7	24.6	69.5	38.7	18.0	61.3	26.5	92.5	19.8	130.5	207.3	0.1	135.3	0.4	71.2	105.5	0.1	27.6	1.2	59.6	52.7	0.1	30.9	0.2	244.7	165.7	15.8	0.2	12.3	3.7	17.5	55.0	61.1	2.8	215.3	119.9	39.7	28.3	38.8	0.1	0.4	0.4	67.0	18.9	85.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	19.2	15.0	19.6	20.0	24.8	16.2	21.9	18.2	12.5	49.3	10.7	133.4	28.9	18.1	0.7	1.1	14.4	24.9	71.7	39.3	7.5	51.9	50.8	46.4	203.0	34.6	62.5	25.0	126.2	2.0	35.7	46.9	22.0	3.2	70.9	542.2	166.1	26.4	5.3	0.1	10.9	50.3	125.8	80.0	68.9	0.0	41.5	395.5	51.6	10.3	3.3	24.8	35.5	32.6	12.2	20.1	22.9	510.4	5.0	26.6	36.5	0.6	30.2	0.0	0.0	0.5	15.6	23.9	610.5	2.8	22.3	14.3	65.5	37.3	13.8	486.4	27.8	385.7	6.4	7.9	20.5	10.4	35.3	5.8	572.5	27.1	21.3
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 411.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	35.3	11.8	15.2	22.6	18.1	49.4	25.5	34.0	24.7	19.7	18.2	13.7	19.2	18.8	13.6	25.7	18.8	21.1	24.2	14.9	25.0	19.2	39.8	31.9	25.6	18.1	14.9	21.1	14.7	33.8	16.2	46.9	16.1	19.7	14.5	9.5	16.1	20.0	45.0	20.4	18.0	23.8	15.0	24.5	16.0	11.1	21.6	40.0	25.6	40.1	27.3	18.2	16.0	28.5	30.4	60.6	4.4	0.1	38.2	42.3	5.2	46.5	55.3	39.3	45.1	4.5	39.7	26.8	20.8	68.6	46.0	28.1	0.3	36.6	48.3	15.2	21.0	6.9	77.0	13.5	35.7	28.1	20.6	30.8	46.3	64.7	62.5	49.0	15.0	12.1	10.3	98.8	35.1	10.9	16.7	20.0	11.9	5.1	13.0	6.0	41.4	58.0	11.5	2.1	8.0	6.1	81.3	11.7	19.4	4.9	5.3	39.8	35.8	94.7	18.7	45.7	35.9	20.1	19.7	41.5	49.7	28.5	33.6	67.4	21.3	38.9	18.3	24.2	15.1	15.9	18.6	17.9	28.5	22.3	17.8	17.2	68.4	23.1	23.6	25.9	12.8	17.3	15.2	18.1	34.0	24.7	14.9	25.0	18.1	14.9	16.1	15.0	21.6	28.5	152.3	67.3	69.1	71.2	134.1	58.8	35.9	37.9	79.6	13.1	39.0	55.8	43.4	57.2	41.2	25.8	16.7	48.9	158.3	22.9	17.6	30.8	165.6	8.1	30.1	82.3	28.1	55.9	411.4	33.3	39.5	112.2	23.9	10.4	89.3	7.5	63.5	193.9	53.2	37.0	169.5	4.1	10.2	66.3	99.2	144.1	63.0	97.4	53.4	241.7	87.6	34.6	83.4	240.3	237.5	35.9	17.9	71.5	115.1	46.2	25.3	67.9	37.9	65.0	151.2	181.9	105.0	24.5	40.1	57.4	56.3	36.5	204.5	12.6	12.9	14.3
NR3C2	"MLR, MR"	ENSG00000151623	"Nuclear receptor subfamily 3 group C member 2"	P08235	4	148078762-148444698	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 265.8;Excitatory neurons: 275.7;Inhibitory neurons: 269.9;Microglial cells: 176.1;Oligodendrocyte precursor cells: 230.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.8"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.7;HUVEC TERT2: 6.0;Karpas-707: 6.9;PC-3: 6.1;RPTEC TERT1: 7.8;TIME: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009155, HPA074979"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB009155: AB_2155949, HPA074979: AB_2686724"	"unprognostic (2.75e-3)"	"unprognostic (2.63e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.10e-11)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	4.6	4.5	4.5	3.7	5.6	1.0	4.8	9.2	11.7	5.6	4.0	21.8	8.7	6.2	3.8	3.1	5.9	5.8	9.4	13.7	3.5	12.1	8.5	7.3	3.1	3.0	5.9	14.7	7.6	12.5	5.5	1.8	3.0	3.7	26.2	8.5	10.7	4.3	12.1	3.0	15.3	4.9	3.2	5.2	8.3	4.3	6.1	2.9	19.7	14.1	2.1	5.9	3.3	4.8	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.4	2.6	1.0	0.2	0.0	1.3	0.7	0.1	0.2	2.3	0.2	0.6	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	9.7	6.0	0.9	0.0	6.9	2.0	0.0	0.0	0.0	0.1	1.2	6.1	0.5	0.0	0.1	7.8	0.1	0.1	0.0	0.0	1.4	0.6	0.1	0.7	0.0	8.7	4.3	2.5	0.1	0.8	0.0	0.0	0.1	1.4	0.6	1.0	0.0	0.0	0.0	0.5	0.0	1.8	0.1	0.7	0.4	0.0	0.2	1.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	4.5	5.6	9.2	11.7	13.7	3.5	3.0	5.9	3.0	3.2	6.1	4.8	11.9	28.9	13.9	265.8	5.1	2.0	2.2	0.4	6.2	10.3	6.2	5.8	20.3	7.2	6.7	11.0	18.8	0.9	1.0	76.1	9.8	3.0	68.2	2.1	1.1	8.2	18.0	0.0	275.7	5.8	0.5	5.9	13.7	2.6	5.7	6.4	8.6	7.0	0.6	13.5	269.9	44.6	6.1	2.9	2.4	41.8	4.4	1.7	7.2	176.1	1.2	8.1	1.0	230.2	95.7	3.2	26.8	3.8	0.8	1.8	26.4	2.3	4.7	9.6	0.0	14.7	5.1	1.8	5.6	2.6	1.7	0.1	4.9	1.8	21.5	2.1
NR4A1	"GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3"	ENSG00000123358	"Nuclear receptor subfamily 4 group A member 1"	P22736	12	52022832-52059507	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 879.9;Basal squamous epithelial cells: 729.1;Glandular and luminal cells: 739.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 36.7;non-classical monocyte: 54.2"	"Lineage enriched"	"Detected in many"	15	"monocytes: 54.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 78.4;MCF7: 86.9;SK-BR-3: 80.5;SK-MEL-30: 150.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059742, HPA070142"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA059742: AB_2684119, HPA070142: AB_2732149"	"unprognostic (2.40e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.99e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-2)"	"unprognostic (8.89e-3)"	709.0	562.0	21.7	96.9	19.6	34.5	227.6	141.0	79.9	151.6	44.4	227.1	29.7	124.6	7.2	133.6	495.8	377.4	671.5	21.5	28.5	203.5	95.5	290.9	45.9	21.8	17.4	876.0	88.4	86.9	442.4	41.9	21.0	303.2	71.4	28.3	146.5	85.9	294.1	225.7	111.9	144.2	13.0	36.0	264.6	32.4	21.5	59.1	301.7	71.9	3.8	296.5	186.0	22.6	5.7	28.2	5.6	10.2	4.0	1.3	21.3	5.4	10.8	4.3	6.0	28.2	5.4	5.9	2.3	9.7	4.2	3.2	16.9	2.6	2.5	0.3	6.0	8.1	78.4	8.3	4.1	3.1	26.5	0.8	3.3	4.2	0.3	2.9	1.3	6.6	7.9	1.4	0.3	86.9	2.2	8.5	15.3	9.2	3.1	2.7	0.9	14.6	0.2	2.2	4.6	14.0	17.4	80.5	150.9	3.8	5.1	9.1	0.0	4.2	13.3	2.8	4.7	46.8	25.2	13.0	2.8	2.3	23.7	0.3	1.3	0.0	0.2	36.7	0.3	0.9	0.1	0.1	3.7	0.8	0.5	0.1	0.4	0.2	54.2	0.3	0.2	2.0	21.7	19.6	141.0	79.9	21.5	28.5	21.8	17.4	21.0	13.0	21.5	22.6	328.9	240.4	879.9	4.2	259.5	445.7	289.5	211.3	729.1	34.8	353.8	384.9	9.8	65.8	178.4	86.5	125.1	64.5	102.1	195.7	5.9	19.9	19.7	346.9	183.5	209.6	345.3	16.0	17.4	12.3	34.7	378.8	380.7	739.1	674.8	45.3	227.0	10.1	54.1	16.8	5.9	492.5	105.8	64.4	527.4	7.3	30.4	283.0	371.8	8.4	6.3	85.4	0.0	6.6	1.3	5.1	277.2	23.7	244.1	160.6	74.6	0.9	92.6	94.6	124.9	268.0	379.3	2.5	13.4	200.2	472.8	110.5	135.1	85.1	259.0	86.8
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507420	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 188.3;lymphoid tissue: 142.8"	"Group enriched"	"Detected in some"	8	"Granulosa cells: 47.9;Theca cells: 180.1"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Region enriched"	"Detected in some"	9	"thalamus: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 82.9;Hep G2: 59.2;K-562: 20.6"	"Region enriched"	"Detected in single"	52	"hypothalamus: 5.2"	"Region enriched"	"Detected in single"	8	"hypothalamus: 1.2"	HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.1	188.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.1	0.0	0.0	35.8	0.0	0.0	21.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	142.8	0.1	14.1	18.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	59.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.3	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	180.1	0.0	0.0
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771311	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 22.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 105.5;Extravillous trophoblasts: 160.0;Inhibitory neurons: 114.7;Oligodendrocyte precursor cells: 112.6;Spermatogonia: 111.1"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 110.7;CACO-2: 26.5;Hep G2: 25.8;K-562: 34.1;NTERA-2: 39.2;U-266/84: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: AB_2673894, HPA045145: AB_2679233"	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.3	0.8	1.8	0.9	1.9	4.4	0.9	2.2	1.9	0.8	4.5	2.2	1.7	0.5	0.5	1.9	0.5	0.4	1.0	1.8	1.5	1.7	2.7	1.5	0.3	2.0	1.5	0.3	2.9	0.8	1.4	2.3	1.5	1.4	1.5	3.1	1.2	0.5	1.4	2.2	2.5	0.4	1.4	0.8	0.4	22.9	3.4	0.1	5.4	0.8	0.7	0.7	1.3	1.6	1.2	3.0	14.7	2.0	0.3	0.2	110.7	0.2	1.1	0.8	1.3	26.5	2.9	5.0	1.0	0.1	3.8	2.8	1.6	1.3	1.7	1.1	4.6	4.1	4.8	25.8	0.1	2.3	7.2	0.1	1.3	1.2	1.6	0.3	0.2	1.2	34.1	0.7	0.6	0.6	0.1	3.2	39.2	1.3	1.1	1.2	1.5	2.2	0.5	2.0	2.2	0.8	0.2	0.7	0.9	21.7	2.6	1.3	0.0	1.4	3.1	0.9	0.7	3.3	25.0	4.3	0.9	2.3	0.8	0.0	0.6	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	4.9	0.0	0.3	0.1	0.0	0.1	1.8	1.9	2.2	1.9	1.8	1.5	2.0	1.5	1.5	1.4	3.4	1.6	0.8	0.0	7.7	47.0	0.6	37.3	17.4	4.2	13.6	3.8	6.8	3.7	2.0	7.2	5.9	5.5	29.2	36.7	1.6	8.9	1.9	10.1	53.5	4.1	0.9	3.2	4.8	6.1	105.5	3.5	160.0	2.0	2.0	3.7	1.3	16.1	1.4	6.0	8.2	1.7	114.7	6.9	8.2	2.2	30.6	30.3	1.2	3.2	8.8	54.4	5.2	7.0	0.0	112.6	73.0	1.9	6.0	1.9	0.5	19.4	24.5	3.3	8.6	10.7	0.0	1.5	3.5	72.7	111.1	8.6	39.8	30.6	0.3	8.1	11.9	15.5
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137299631-137302271	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 47.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.3;Basal keratinocytes: 97.0;Langerhans cells: 97.9;Squamous epithelial cells: 101.8;Suprabasal keratinocytes: 381.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 45.1;MCF7: 23.3;NTERA-2: 31.9;OE19: 30.8;T-47d: 23.1;TIME: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol	Nucleoplasm	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	8.9	1.7	7.8	7.6	7.9	1.5	6.9	8.8	7.8	6.5	4.2	47.9	22.0	4.4	1.2	22.6	3.6	12.0	12.5	7.3	10.8	6.1	2.7	7.1	1.6	11.5	12.6	2.0	16.8	2.7	7.6	10.3	10.5	9.5	30.5	1.5	3.0	2.1	2.9	26.3	17.8	3.4	9.8	4.2	8.7	10.2	14.8	2.7	4.9	6.5	4.1	10.4	13.5	6.6	4.8	1.0	8.0	8.8	0.0	0.0	2.6	0.1	0.2	0.0	0.1	6.8	3.0	0.0	10.2	0.0	0.4	45.1	13.9	0.4	0.1	0.3	20.6	1.4	2.1	7.6	0.8	2.8	4.3	0.0	2.3	0.0	0.6	0.2	11.8	0.1	11.8	0.3	0.0	23.3	0.2	6.4	31.9	30.8	6.7	8.4	1.5	17.7	1.2	0.6	4.9	8.1	1.4	2.4	0.1	1.7	23.1	5.8	31.9	0.0	0.1	0.1	1.9	0.3	0.2	3.0	0.1	5.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.9	8.8	7.8	7.3	10.8	11.5	12.6	10.5	9.8	14.8	6.6	75.3	0.0	0.0	33.3	17.6	97.0	5.9	20.1	15.9	0.6	24.4	39.2	4.4	5.7	14.3	0.0	0.0	0.1	9.7	22.4	0.0	0.5	17.3	35.2	4.4	21.9	10.2	0.0	2.5	1.1	0.0	2.1	19.4	43.0	0.0	0.3	8.9	0.1	0.4	0.0	0.4	20.5	8.2	0.6	97.9	5.2	0.0	18.6	17.8	9.4	0.0	6.8	0.0	2.0	0.6	0.6	28.3	0.4	3.9	6.2	5.0	0.1	3.2	2.8	6.6	4.0	32.1	0.1	0.6	101.8	381.0	0.0	6.7	3.7	23.4	6.0
NRBF2	"COPR1, COPR2, DKFZp564C1664, FLJ30395"	ENSG00000148572	"Nuclear receptor binding factor 2"	Q96F24	10	63133247-63155031	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 687.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 687.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021670, HPA059477"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"HPA021670: AB_2670803, HPA059477: AB_2684032"	"unprognostic (7.71e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.59e-2)"	18.8	12.6	8.7	20.9	9.2	33.8	17.8	10.5	12.1	15.0	8.6	16.6	16.8	13.1	11.1	14.9	9.5	17.2	12.6	9.5	10.2	14.1	45.1	16.4	21.2	11.0	13.0	11.4	10.4	10.8	9.7	22.0	13.1	10.3	16.7	7.2	14.5	8.6	24.7	15.3	15.7	14.2	10.3	22.6	13.4	11.9	10.5	22.5	18.5	26.3	20.2	19.8	10.7	10.7	23.9	20.8	20.7	19.3	48.5	74.5	20.7	33.2	56.4	26.0	36.7	44.5	24.9	30.8	15.8	37.6	26.1	18.3	20.3	28.0	35.7	27.7	19.6	22.9	10.3	36.0	61.4	30.6	25.5	69.1	59.0	42.5	103.4	48.8	27.1	19.7	23.4	34.8	33.6	17.4	25.9	54.1	24.3	19.4	84.8	25.0	18.8	18.2	30.2	13.4	11.9	20.3	19.9	38.4	61.7	33.8	23.8	30.0	28.2	18.1	26.7	28.3	36.2	43.5	35.6	37.2	50.6	48.2	14.8	124.6	79.5	162.1	28.8	92.3	30.4	47.9	29.4	32.2	68.7	42.5	35.9	33.1	687.6	32.6	93.4	34.1	36.6	55.2	8.7	9.2	10.5	12.1	9.5	10.2	11.0	13.0	13.1	10.3	10.5	10.7	29.7	3.2	30.6	3.9	45.7	28.8	41.8	42.8	20.5	12.2	30.1	40.0	8.9	14.3	30.6	12.9	4.2	53.1	44.0	31.5	23.5	31.6	10.3	30.6	49.9	26.0	15.6	13.2	9.4	35.0	76.8	34.8	16.8	37.7	14.0	15.2	17.9	53.2	48.9	20.2	8.4	41.1	32.6	49.7	34.9	6.3	23.3	56.0	46.2	10.3	56.6	15.4	35.0	5.5	9.3	40.0	32.0	21.4	43.1	40.0	31.9	31.4	24.7	9.0	19.7	26.0	30.6	55.4	71.1	29.4	31.8	285.3	43.3	25.2	29.6	68.6
NRCAM	"Bravo, KIAA0343"	ENSG00000091129	"Neuronal cell adhesion molecule"	Q92823	7	108147623-108456717	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 37.3;brain: 38.3;epididymis: 34.4;retina: 38.0"	"Group enriched"	"Detected in many"	7	"Astrocytes: 612.5;Excitatory neurons: 764.5;Inhibitory neurons: 392.4;Oligodendrocyte precursor cells: 1259.2"	"Cancer enriched"	"Detected in all"	7	"glioma: 57.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"A549: 99.6;AF22: 94.8;EFO-21: 175.4;HMC-1: 187.9;SH-SY5Y: 115.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012606	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in brain"	NA	NA		110000000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA012606: AB_1854636"	"unprognostic (2.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.42e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.28e-2)"	3.1	37.3	19.8	1.8	31.9	0.3	1.5	2.4	34.6	5.0	0.0	0.8	0.7	2.1	34.4	0.7	3.6	7.3	0.4	33.1	9.4	6.2	0.4	2.3	0.8	2.3	22.7	1.5	29.4	7.3	11.4	7.8	2.0	0.8	0.7	38.0	1.9	14.2	0.2	0.8	0.6	0.7	1.5	4.8	1.8	1.7	38.3	2.8	4.1	0.4	2.7	0.5	0.4	2.6	0.1	99.6	94.8	0.0	11.4	2.2	1.8	0.7	0.4	1.0	1.7	40.7	0.0	0.0	175.4	0.7	1.5	0.4	2.2	1.6	1.0	0.1	12.7	0.0	0.7	1.0	0.2	0.9	187.9	15.5	0.0	0.2	0.6	0.2	61.7	0.2	0.2	0.8	1.5	38.2	0.4	0.3	13.1	60.1	0.0	0.0	27.8	33.3	21.4	0.1	18.6	115.9	1.3	0.0	1.9	3.3	0.2	0.1	66.2	4.2	1.0	0.1	16.4	0.2	0.5	0.9	0.7	0.1	55.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.2	19.8	31.9	2.4	34.6	33.1	9.4	2.3	22.7	2.0	1.5	38.3	2.6	0.2	0.0	0.0	612.5	0.8	0.4	0.1	0.8	1.2	66.2	1.5	0.9	0.7	7.2	0.1	5.5	102.2	3.6	0.0	0.2	3.9	1.6	37.3	10.4	2.4	1.3	0.0	0.0	764.5	12.1	0.2	2.0	3.6	25.0	23.4	4.4	1.4	0.4	0.8	13.5	392.4	0.3	0.0	0.8	0.4	8.3	0.9	0.2	3.6	51.5	0.6	45.1	0.0	1259.2	21.9	3.7	0.0	0.4	2.6	1.2	0.0	3.3	0.1	8.8	0.0	1.0	2.6	1.1	2.7	0.2	0.1	4.4	1.1	34.2	0.0	0.0
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 267.3"	"Group enriched"	"Detected in many"	9	"Early spermatids: 597.7;Late spermatids: 1672.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm		NA	NA		58000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	48.2	36.8	33.3	48.2	33.9	48.5	34.2	33.6	42.3	31.1	37.2	32.5	32.3	31.1	20.2	40.4	29.7	31.0	58.5	34.4	35.5	26.5	55.7	34.3	43.8	35.2	34.6	32.6	40.1	60.9	32.8	40.2	37.8	38.6	35.3	48.1	28.7	30.5	267.3	51.4	31.4	38.4	33.6	40.9	35.2	95.6	36.5	54.9	33.1	182.0	46.7	36.5	28.4	38.1	166.8	91.0	94.2	133.4	98.9	145.5	106.8	165.6	143.9	116.6	123.5	65.6	65.3	108.3	84.7	128.4	157.6	95.1	136.5	127.9	156.2	127.7	66.1	129.5	125.4	62.9	97.9	114.4	95.4	117.2	102.1	169.7	160.0	105.0	125.7	113.1	174.7	71.7	153.4	62.9	105.0	45.2	161.5	71.8	97.4	101.6	106.4	122.6	92.8	94.7	86.5	65.2	148.0	124.8	94.5	185.7	79.3	152.5	102.4	103.8	94.2	114.2	146.0	103.9	168.4	100.1	120.8	146.6	120.1	44.5	33.8	50.0	23.2	35.1	23.3	23.2	21.5	26.0	33.7	15.6	20.9	22.7	67.8	29.8	28.3	27.5	26.9	33.1	33.3	33.9	33.6	42.3	34.4	35.5	35.2	34.6	37.8	33.6	36.5	38.1	43.5	35.3	69.0	0.0	58.9	0.0	46.3	0.0	38.7	73.3	38.2	31.0	0.0	28.6	34.7	27.6	81.3	56.8	94.3	11.1	31.3	48.1	597.7	63.1	78.8	39.4	18.2	85.8	0.0	64.0	45.5	40.1	56.6	55.4	35.3	74.6	30.4	59.9	44.3	62.2	0.0	19.5	0.0	44.6	0.0	1672.1	66.2	72.5	0.0	0.0	70.3	45.9	55.6	0.0	0.0	57.6	13.7	59.0	126.1	41.9	30.1	19.6	59.0	71.8	59.2	64.5	38.2	39.0	28.1	57.7	0.0	82.5	52.8	65.9	21.6	42.3
NRDE2	"C14orf102, FLJ14051"	ENSG00000119720	"NRDE-2, necessary for RNA interference, domain containing"	Q9H7Z3	14	90267860-90331969	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, DNA damage, Mitosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.3"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 111.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047050, HPA050583"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA047050: AB_2679917, HPA050583: AB_2681182"	"unprognostic (1.24e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.27e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-2)"	1.0	1.0	2.1	1.4	3.0	3.5	1.2	7.3	2.9	1.3	2.3	1.3	2.5	1.6	1.3	1.1	1.2	0.9	1.2	2.1	2.8	1.1	1.7	1.2	1.2	2.5	2.1	1.5	1.2	1.4	1.8	1.1	2.4	1.3	1.0	3.1	1.4	0.9	1.6	2.0	1.5	1.1	1.8	1.6	1.3	0.9	2.8	1.7	1.7	1.0	1.1	1.1	1.2	3.6	0.7	1.4	2.0	1.2	0.3	1.0	1.4	1.4	0.9	1.0	1.1	1.8	1.3	1.3	0.7	1.4	1.3	1.9	1.1	1.9	1.9	2.5	1.7	1.7	5.0	1.3	0.5	4.6	2.2	1.8	1.3	1.0	0.6	2.1	0.9	3.3	0.8	2.0	0.9	1.4	2.1	1.9	0.7	0.6	1.1	1.8	2.9	0.5	0.6	2.9	1.8	2.1	0.6	3.8	1.0	0.7	1.7	1.9	1.2	1.5	0.7	0.9	0.6	1.6	1.9	1.3	1.4	0.8	1.8	1.6	0.8	1.0	0.8	0.5	0.6	0.8	0.5	0.6	0.4	1.0	0.5	0.6	1.3	0.7	0.4	1.1	0.5	0.2	2.1	3.0	7.3	2.9	2.1	2.8	2.5	2.1	2.4	1.8	2.8	3.6	18.2	35.3	29.7	11.4	21.6	5.9	7.0	13.3	17.1	79.4	19.7	14.9	13.2	37.1	18.8	18.4	87.6	19.1	26.4	23.3	7.9	16.6	8.6	15.2	23.8	20.8	24.7	13.7	10.0	14.6	13.0	16.7	18.8	18.0	38.6	24.7	28.2	42.1	11.8	53.8	12.2	24.2	14.2	17.6	6.7	9.7	23.6	12.8	8.8	4.7	25.1	30.4	30.9	15.1	18.8	14.0	17.7	33.1	9.4	8.0	36.5	18.6	11.4	111.3	0.0	26.6	16.5	24.3	39.4	9.3	6.3	25.2	18.6	18.3	23.7	5.5
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611720-129757082	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 127.0;Excitatory neurons: 115.4;Inhibitory neurons: 109.4;Microglial cells: 75.9;Oligodendrocyte precursor cells: 143.2;Oligodendrocytes: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	8.3	5.6	9.2	7.9	9.9	16.7	7.9	13.3	11.1	10.8	11.5	8.8	6.4	9.9	6.4	7.2	12.8	5.5	9.4	9.3	10.7	9.0	6.1	8.0	12.3	11.1	10.6	16.6	7.3	8.5	7.7	7.0	10.1	8.0	6.8	12.7	7.5	6.2	15.6	9.3	8.3	7.7	9.1	10.3	6.7	5.6	10.2	18.0	9.7	8.8	11.1	8.7	8.0	13.0	15.9	12.8	18.1	15.9	10.7	8.5	14.4	10.9	11.2	16.3	12.6	15.6	10.4	18.3	7.8	12.3	10.2	11.9	19.7	11.0	16.5	17.5	14.1	15.1	11.0	10.3	7.8	18.7	14.5	7.3	10.2	16.1	15.5	9.4	12.1	17.4	18.6	13.7	10.1	14.5	36.9	17.6	16.9	14.5	11.3	23.2	14.6	16.2	9.2	11.5	15.6	17.1	16.4	16.8	11.0	14.7	10.5	17.4	9.4	9.2	12.6	10.8	20.3	14.7	15.7	32.0	9.7	17.0	18.1	5.6	4.2	10.6	8.2	5.2	9.8	5.5	6.3	7.7	5.5	5.9	6.8	6.0	8.8	5.0	5.8	3.6	7.2	5.8	9.2	9.9	13.3	11.1	9.3	10.7	11.1	10.6	10.1	9.1	10.2	13.0	6.8	3.2	6.5	127.0	15.8	6.6	3.2	3.4	4.6	10.8	5.4	5.1	6.2	2.8	4.8	3.7	10.4	2.8	11.3	5.5	0.0	2.3	0.4	8.9	6.4	7.1	6.7	3.0	115.4	3.6	4.1	6.0	7.1	5.7	5.1	6.9	7.1	4.1	3.1	10.1	109.4	5.3	4.1	7.7	9.5	1.9	5.3	5.4	5.4	75.9	4.0	6.4	12.3	143.2	122.3	3.0	10.2	4.5	14.2	6.8	3.7	2.3	13.1	11.2	6.6	10.0	6.4	9.0	6.6	6.2	7.7	3.4	13.8	2.3	4.2	5.4
NRG1	"GGF, HGL, HRG, NDF, NRG1-IT2"	ENSG00000157168	"Neuregulin 1"	Q02297	8	31639222-32855666	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4"	"Group enriched"	"Detected in many"	17	"Excitatory neurons: 1466.4;Inhibitory neurons: 411.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"classical monocyte: 55.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 55.3"	"Cell line enhanced"	"Detected in many"		"A549: 132.5;BJ: 91.3;fHDF/TERT166: 98.1;GAMG: 95.4;U-2197: 84.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010964	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA010964: AB_1854641"	"unprognostic (5.76e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.96e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.94e-4)"	"unprognostic (4.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.40e-2)"	"unprognostic (7.83e-2)"	0.5	1.2	3.5	6.1	3.2	1.4	5.7	8.7	13.2	8.0	3.2	3.2	2.9	1.2	0.6	2.8	1.1	2.3	1.9	0.4	12.7	8.6	17.0	3.7	0.4	35.4	8.0	1.9	0.7	0.6	3.8	0.2	35.3	2.6	3.2	11.6	2.6	1.0	0.1	4.9	2.5	1.0	2.7	1.6	2.5	5.3	2.6	0.8	9.9	0.0	2.1	9.4	3.4	8.2	0.4	132.5	1.8	0.0	0.9	2.5	0.2	91.3	60.0	65.3	55.8	0.0	2.9	0.0	16.4	98.1	95.4	76.7	0.3	34.5	69.4	0.2	0.7	1.3	1.8	2.0	0.4	0.1	0.2	1.3	3.4	81.1	74.6	5.7	41.2	0.1	0.0	0.7	24.4	0.1	0.0	0.1	2.5	0.0	0.0	0.1	0.9	0.0	52.9	3.6	3.4	4.0	7.5	0.0	0.1	5.0	0.0	0.3	34.7	50.7	15.8	84.4	53.6	0.1	0.0	0.9	28.2	0.1	6.6	0.2	55.3	0.9	0.2	4.7	0.2	0.1	0.1	0.0	12.1	0.1	0.0	0.0	2.0	0.2	0.2	0.2	0.0	14.2	3.5	3.2	8.7	13.2	0.4	12.7	35.4	8.0	35.3	2.7	2.6	8.2	0.1	38.5	2.7	29.7	0.8	26.0	48.0	5.1	21.1	11.0	4.3	18.2	2.0	8.6	7.9	3.7	8.4	0.0	1.3	0.0	9.8	1.8	41.5	0.1	1.9	5.7	0.0	0.0	1466.4	0.2	0.0	10.5	0.0	0.2	1.3	3.2	7.1	5.3	0.5	28.6	411.8	0.0	2.0	10.2	1.9	23.5	0.3	22.1	1.8	36.5	49.2	5.0	0.0	54.3	19.2	0.9	0.0	0.4	0.0	42.9	0.0	18.7	2.4	3.1	0.0	0.1	9.3	11.3	5.0	3.2	6.1	0.0	0.6	0.0	0.0	6.5
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.5;Excitatory neurons: 89.9;Inhibitory neurons: 136.6;Oligodendrocyte precursor cells: 142.2;Oligodendrocytes: 50.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;HDLM-2: 4.0;Karpas-707: 4.4;PC-3: 11.1;RPTEC TERT1: 5.8;SCLC-21H: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted in other tissues"	No	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: AB_2680226"	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	2.3	3.4	2.9	0.5	2.8	0.0	3.3	8.5	3.1	5.8	0.0	2.1	0.2	1.2	1.1	1.6	3.3	1.2	1.2	2.0	2.4	0.8	0.1	0.4	0.8	3.2	2.6	7.5	2.7	8.1	3.5	0.3	3.0	3.1	0.1	1.3	6.5	1.9	5.0	3.6	0.7	0.3	1.5	1.7	0.8	2.1	2.6	0.5	0.7	0.1	0.4	3.1	1.8	2.3	0.0	1.6	0.1	6.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.3	0.0	2.8	2.1	0.3	0.1	0.1	4.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.1	0.1	0.0	4.4	0.0	0.2	0.0	0.0	0.1	0.0	11.1	0.1	0.0	0.0	5.8	1.5	4.2	2.5	0.0	2.7	2.6	0.0	0.0	0.0	0.1	1.9	0.3	0.0	1.3	0.8	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.8	8.5	3.1	2.0	2.4	3.2	2.6	3.0	1.5	2.6	2.3	15.9	0.0	0.0	71.5	1.6	2.8	9.7	0.9	29.0	16.6	4.0	16.0	2.2	0.0	0.5	1.8	0.0	0.1	3.2	0.1	1.9	0.4	0.6	2.6	8.2	2.6	0.0	0.0	89.9	2.2	0.0	2.7	0.5	0.4	0.0	1.3	1.8	0.0	0.1	6.7	136.6	0.1	0.0	0.3	1.3	0.6	9.6	0.6	3.6	8.4	0.3	11.2	5.2	142.2	50.8	0.5	0.0	10.1	2.7	2.6	0.0	1.7	1.0	1.0	6.6	10.9	2.2	2.7	9.4	1.0	0.3	0.0	2.8	4.0	0.1	6.2
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 219.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193"	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	30.4	10.2	5.8	10.2	5.2	26.4	14.2	14.9	6.9	24.7	6.5	18.2	16.8	18.2	13.4	9.4	21.4	10.3	5.4	6.4	8.1	15.9	26.9	8.9	8.7	4.8	4.5	13.3	14.4	7.4	3.2	14.6	5.3	10.3	18.1	31.8	6.1	8.4	22.3	4.1	18.3	20.1	6.4	13.1	8.9	8.1	6.7	17.0	5.6	23.8	7.2	14.1	8.4	8.3	22.1	43.5	34.6	0.0	17.4	11.3	12.6	26.1	11.7	16.0	12.5	8.7	17.3	0.1	14.5	23.3	7.9	11.0	2.2	15.6	33.9	0.0	10.0	33.4	15.3	27.2	10.5	16.7	6.7	14.1	21.3	17.6	20.5	17.8	12.6	4.8	24.1	17.4	11.4	11.8	7.8	0.1	14.5	8.8	13.9	92.4	28.0	0.8	9.8	35.8	3.2	0.1	21.7	11.3	8.8	27.7	27.2	12.9	22.0	13.7	9.1	21.4	10.8	8.5	0.2	0.1	29.0	0.0	6.8	0.0	0.4	0.2	0.3	0.2	1.8	0.3	0.3	0.4	0.6	1.0	0.5	0.2	0.1	0.5	0.5	0.6	0.2	0.2	5.8	5.2	14.9	6.9	6.4	8.1	4.8	4.5	5.3	6.4	6.7	8.3	33.2	48.1	37.6	60.7	27.4	18.6	122.6	16.2	22.8	33.9	52.9	26.8	18.3	21.5	40.9	29.5	50.1	16.4	20.7	50.1	9.8	23.0	15.8	60.9	99.1	43.0	37.7	24.2	123.7	27.6	120.8	42.3	26.5	130.9	31.5	94.0	27.1	44.7	45.7	21.9	95.0	41.6	18.3	50.4	21.9	19.3	37.6	57.9	8.8	219.2	40.4	56.2	27.8	102.1	78.2	31.4	42.6	27.1	10.1	49.5	43.0	36.5	15.9	63.1	32.9	112.1	38.6	12.1	6.3	23.1	18.8	14.1	19.9	71.0	47.7	99.8
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Rod photoreceptor cells: 8.8;Sertoli cells: 26.3;Smooth muscle cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	3.9	7.7	3.6	12.4	4.0	5.1	23.4	10.2	7.0	4.8	5.3	2.4	7.4	7.2	2.4	4.8	5.9	5.2	5.8	10.6	12.0	1.6	1.8	4.1	12.4	10.0	8.4	3.0	0.6	2.8	2.6	12.9	4.1	3.0	3.9	3.6	4.9	4.9	2.6	4.7	4.9	8.1	9.1	3.6	2.1	12.0	3.0	5.5	7.5	2.6	4.3	4.7	13.3	0.4	0.9	1.5	0.8	0.0	0.0	1.8	1.1	0.0	0.0	0.0	2.3	1.1	1.2	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.9	1.3	2.0	2.9	0.2	0.0	2.4	1.4	0.0	0.0	0.0	0.0	2.2	0.0	1.3	1.1	2.7	0.0	1.0	1.5	1.2	1.5	0.9	0.4	0.9	1.6	0.7	0.0	1.5	1.1	1.7	0.8	1.2	0.3	2.7	0.8	0.4	1.2	0.6	0.7	0.9	1.6	0.4	0.1	1.8	1.5	1.1	0.8	3.7	0.3	0.1	0.5	0.2	0.3	0.7	0.4	0.5	0.2	0.6	0.8	0.3	0.1	0.4	0.1	0.3	0.1	0.1	7.7	12.4	23.4	10.2	5.8	10.6	12.4	10.0	12.9	8.1	12.0	13.3	0.6	0.0	1.1	0.0	0.2	0.1	0.5	0.0	0.0	5.0	0.1	0.9	1.3	0.0	0.0	1.8	6.2	0.3	0.3	0.0	0.0	0.0	1.6	0.2	0.9	0.6	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.4	0.0	0.1	3.3	3.3	0.0	0.0	0.6	0.3	1.8	0.3	0.5	0.0	2.8	0.0	0.6	3.1	0.5	4.9	0.0	0.0	5.3	0.0	0.3	0.0	0.2	0.0	8.8	26.3	0.5	23.1	0.1	0.3	0.1	0.1	0.0	1.1	0.4	0.0	0.1
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822539-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.1;ovary: 32.5;placenta: 24.2"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 79.4;Leydig cells: 113.4;Syncytiotrophoblasts: 67.9;Theca cells: 70.2"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	11	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 58.1;HSkMC: 10.6;RH-30: 12.8;RPTEC TERT1: 34.8;SuSa: 40.5"	"Region enriched"	"Detected in single"	28	"cerebellum: 14.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.6"	HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	0.8	16.1	0.0	0.9	0.0	0.0	0.7	7.0	0.3	1.8	0.0	1.4	0.1	1.7	4.6	0.6	0.9	10.1	3.5	0.0	0.1	6.2	0.1	0.2	0.0	0.1	0.6	32.5	0.4	0.1	0.3	24.2	0.5	4.9	0.3	0.1	1.1	0.9	0.2	0.1	0.3	1.7	0.1	0.0	0.5	3.3	0.0	0.1	0.2	3.3	0.0	1.0	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	10.6	0.0	0.1	0.0	3.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.8	0.0	34.8	0.7	0.0	0.2	0.0	1.8	0.0	40.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.1	0.1	0.6	0.5	0.1	0.0	0.4	3.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	1.2	1.0	4.8	0.0	0.0	0.0	0.0	79.4	0.0	0.2	19.6	0.2	1.3	0.0	3.2	0.7	0.0	0.0	0.9	0.0	10.1	8.9	0.0	0.0	0.0	2.1	0.0	0.0	7.1	0.0	0.9	0.0	0.0	0.0	0.0	2.6	113.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.5	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.7	1.6	1.7	0.1	0.0	67.9	0.0	70.2	0.2	0.1
NRL	"D14S46E, NRL-MAF, RP27"	ENSG00000129535	"Neural retina leucine zipper"	P54845	14	24078662-24115010	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	75	"retina: 317.3"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 3720.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 4.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026066, HPA064599"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 79: Retina - Phototransduction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"CAB026066: , HPA064599: AB_2685295"	"unprognostic (2.71e-2)"	"unprognostic (8.17e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.88e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-5)"	"unprognostic (2.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-3)"	0.8	2.5	1.7	0.5	1.5	0.5	1.0	2.3	2.2	1.1	0.6	0.9	1.1	1.1	0.7	1.1	1.0	0.9	2.2	1.5	1.5	3.1	3.6	1.0	1.0	2.3	1.8	1.2	1.7	1.9	2.4	0.3	1.7	1.5	0.3	317.3	1.0	0.7	2.5	0.7	1.3	0.3	1.7	2.1	1.2	4.2	1.6	1.2	2.7	1.4	0.7	1.1	0.8	1.7	0.3	1.2	1.6	1.6	0.3	0.2	0.4	0.3	0.3	0.5	0.3	0.7	0.5	1.2	0.4	0.5	1.0	0.5	0.6	0.3	0.2	0.6	0.5	0.7	0.6	2.2	0.6	1.4	1.6	0.4	0.5	0.2	0.7	0.7	0.5	2.2	0.7	1.2	0.3	0.9	1.2	0.6	1.8	1.8	0.9	1.2	1.5	0.0	0.4	1.3	1.7	1.2	0.8	0.7	0.8	4.8	0.9	1.5	0.4	1.1	0.5	0.1	0.7	3.6	1.9	1.5	0.3	0.9	1.1	0.2	0.3	1.3	0.2	0.4	0.1	1.0	0.2	0.4	0.3	0.7	0.8	0.6	0.1	0.5	0.3	0.4	0.2	0.3	1.7	1.5	2.3	2.2	1.5	1.5	2.3	1.8	1.7	1.7	1.6	1.7	1.4	0.0	0.5	5.5	6.2	0.8	1.6	0.1	1.2	434.4	2.0	1.9	2.1	0.0	0.7	7.3	431.6	1.4	3.2	1.5	13.7	0.6	2.7	1.3	0.7	24.1	1.8	3.2	1.8	1.1	0.9	0.7	2.6	1.0	0.0	0.7	0.7	3.3	2.0	250.7	2.6	1.7	0.0	1.3	0.4	4.2	1.2	1.4	1.8	0.0	1.1	636.4	5.2	2.0	4.4	0.3	5.3	1.9	1.7	2.0	5.6	6.7	0.1	3720.7	0.0	1.2	0.7	9.7	4.3	2.2	0.4	2.5	2.6	2.3	1.0	2.1
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 78.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 134.4;Hepatic stellate cells: 137.8;Hofbauer cells: 141.3;Langerhans cells: 129.8;monocytes: 224.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 123.6;HUVEC TERT2: 105.7;TIME: 106.3;U-251 MG: 217.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039980, HPA054974"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA		29000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA039980: AB_10795517, HPA054974: AB_2682657"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (7.80e-5)"	18.8	22.2	18.0	17.8	13.8	4.6	12.6	9.3	11.7	18.8	7.0	78.7	5.3	51.8	3.7	13.3	21.1	31.1	6.3	21.7	42.5	4.9	9.6	24.3	8.2	30.4	23.9	46.8	1.9	2.5	9.6	47.0	19.6	13.0	10.5	3.6	3.3	30.9	2.3	4.8	14.9	54.8	13.2	7.5	25.9	1.4	33.9	6.1	10.8	3.4	4.5	38.3	15.9	12.4	2.5	50.4	32.2	0.2	30.1	9.6	9.3	8.5	14.8	10.0	9.5	48.0	123.6	0.0	11.9	25.3	20.5	19.2	1.5	15.9	16.8	0.1	6.8	0.5	2.4	0.4	80.7	0.0	2.1	68.5	12.2	14.4	12.3	64.5	105.7	0.2	0.2	0.1	6.8	0.2	0.0	0.0	41.5	0.1	9.2	0.2	2.0	12.0	21.7	0.0	29.0	1.0	1.1	0.3	75.4	84.9	0.1	0.8	106.3	43.1	0.4	11.3	217.0	0.0	0.2	3.2	96.9	0.3	88.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	13.8	9.3	11.7	21.7	42.5	30.4	23.9	19.6	13.2	33.9	12.4	88.7	89.8	57.5	2.0	3.8	19.4	19.5	30.8	97.9	36.5	1.3	11.3	4.5	5.7	53.2	1.8	0.0	89.7	0.1	0.6	0.0	6.4	6.3	8.8	8.1	134.4	1.2	2.7	4.1	3.8	8.7	47.0	1.5	13.2	3.8	2.7	137.8	1.8	141.3	0.0	9.4	1.1	4.1	28.0	129.8	18.9	2.8	53.7	19.6	53.4	224.8	4.8	0.0	4.0	8.1	53.2	0.0	4.9	0.2	9.1	0.0	0.6	48.1	2.7	0.0	4.6	32.2	1.4	1.4	17.8	12.6	25.7	2.4	48.1	0.4	51.5
NRSN2	"C20orf98, dJ1103G7.6"	ENSG00000125841	"Neurensin 2"	Q9GZP1	20	346782-359660	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 154.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015967	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Nucleoplasm, Cytosol"	"HPA015967: AB_1854647"	"unprognostic (5.67e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (1.73e-3)"	19.9	57.0	105.7	10.5	114.4	1.7	17.4	87.8	154.7	30.1	71.3	28.3	6.0	32.5	25.9	9.7	27.9	15.4	30.9	114.3	100.6	33.0	4.8	22.4	7.5	94.4	92.0	36.0	20.3	42.6	60.4	16.9	93.9	28.3	9.7	56.9	21.1	25.5	3.4	11.4	13.1	27.5	80.5	16.8	20.2	30.6	96.6	5.5	28.1	5.7	7.2	23.5	18.2	102.9	56.5	68.3	40.2	37.7	53.0	58.4	15.2	37.4	72.3	66.3	66.8	38.2	1.2	0.0	12.6	70.7	48.9	24.1	33.5	5.8	42.4	0.3	33.0	20.8	32.5	70.7	53.5	0.6	3.3	67.4	4.5	48.2	8.1	54.1	46.4	0.3	40.3	35.1	59.2	10.0	0.9	17.9	31.3	0.7	34.9	32.4	22.1	2.7	67.4	0.3	80.8	58.0	44.9	13.0	64.9	26.5	53.2	19.7	31.0	70.6	36.4	2.6	45.6	6.5	1.4	14.7	9.5	0.6	36.7	0.0	0.7	1.2	2.4	0.3	0.7	5.6	0.8	2.6	1.5	6.9	1.0	1.8	0.0	2.8	0.3	3.5	0.6	1.1	105.7	114.4	87.8	154.7	114.3	100.6	94.4	92.0	93.9	80.5	96.6	102.9	3.8	0.0	3.1	16.0	2.2	3.2	3.6	8.5	7.4	26.5	5.8	5.0	5.5	1.5	6.1	12.9	2.1	7.3	0.5	2.6	1.9	14.7	9.6	4.7	12.0	6.9	29.4	1.3	21.0	1.6	6.8	10.4	3.1	3.9	5.1	7.6	5.7	0.3	3.2	16.8	27.1	2.6	4.1	0.9	2.2	14.4	13.1	0.7	3.6	2.8	2.1	17.3	2.1	12.1	5.9	2.9	1.8	10.5	2.6	3.3	0.2	7.8	3.6	15.4	19.7	4.9	9.2	21.3	12.8	1.4	2.3	4.4	1.4	12.9	2.2	2.9
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2 ribosome biogenesis factor"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043487	Approved		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli"		"HPA043487: AB_2678507"	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	32.0	36.5	17.1	33.2	18.9	39.3	28.7	19.3	22.2	43.7	15.6	36.4	30.4	29.9	25.0	26.7	35.0	12.2	28.3	17.4	19.0	30.9	26.6	20.3	36.9	19.1	17.9	60.4	37.7	20.6	28.1	17.3	19.2	28.5	22.8	22.6	28.1	11.5	67.9	22.2	26.0	16.9	19.9	25.8	31.2	31.8	18.2	23.5	22.1	19.0	32.0	35.9	30.6	20.4	65.2	35.4	42.5	57.6	26.6	48.9	64.8	45.8	24.5	29.5	24.9	61.2	62.3	53.0	94.0	27.3	70.2	39.6	34.6	51.9	41.9	36.1	53.7	27.9	65.8	68.3	24.8	47.9	61.7	32.4	48.2	39.8	29.6	46.5	25.5	47.3	28.0	42.8	32.2	50.1	81.4	120.4	28.3	27.8	29.9	58.4	49.8	100.5	37.7	70.9	45.3	58.5	27.8	52.8	135.7	32.6	49.5	135.8	28.0	22.0	67.4	41.8	133.3	42.7	61.1	90.0	54.6	84.3	33.3	9.3	12.1	7.5	16.3	20.6	23.5	27.1	24.6	24.7	18.5	19.5	28.7	29.8	2.2	21.4	15.9	17.2	26.4	10.3	17.1	18.9	19.3	22.2	17.4	19.0	19.1	17.9	19.2	19.9	18.2	20.4	125.8	80.1	95.9	6.5	237.4	94.1	162.1	95.9	215.1	34.6	164.2	218.3	83.7	140.2	94.5	62.5	14.6	142.3	183.7	122.9	150.6	143.1	418.6	145.2	303.6	101.1	139.6	129.2	13.1	237.9	196.2	107.6	112.1	192.8	119.2	165.4	129.2	207.7	137.4	50.5	13.2	234.6	52.9	233.2	100.2	159.1	278.4	161.9	83.6	7.5	229.6	85.8	188.4	10.1	13.4	181.2	147.9	171.5	139.4	144.4	147.5	281.7	55.9	37.7	138.1	132.8	138.0	250.2	96.3	171.7	86.0	135.4	176.1	176.8	246.1	192.5
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300213	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239"	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	8.7	7.2	8.9	12.0	13.4	21.2	10.9	26.2	10.4	11.1	9.8	10.1	8.4	11.5	10.3	11.4	10.1	8.0	9.1	7.7	10.0	10.6	6.6	9.2	13.7	9.7	10.8	12.3	11.3	12.8	9.0	10.7	12.2	9.3	10.8	11.9	10.4	9.6	13.6	12.0	9.4	12.0	6.6	11.3	8.9	23.2	12.0	20.2	15.5	11.5	14.7	9.3	7.9	17.5	20.5	25.9	26.0	22.8	12.5	16.1	0.9	18.2	17.9	24.6	22.8	5.7	16.6	41.7	19.9	24.8	22.7	17.0	41.9	40.0	29.7	72.9	25.9	18.6	29.5	0.2	20.7	40.4	21.2	15.2	23.6	29.4	27.3	17.5	36.4	26.0	25.9	14.3	25.2	42.3	28.3	13.1	28.5	13.7	22.5	31.0	3.4	12.9	15.9	24.4	31.6	21.9	46.7	20.1	13.8	24.1	20.2	33.0	27.4	17.1	25.0	11.0	22.6	16.7	15.7	29.5	9.9	19.3	18.7	14.7	9.0	10.5	7.2	6.1	6.0	8.5	6.1	5.0	7.2	10.3	7.5	6.0	18.6	11.3	12.2	9.4	6.4	3.4	8.9	13.4	26.2	10.4	7.7	10.0	9.7	10.8	12.2	6.6	12.0	17.5	37.4	22.4	31.4	84.9	71.7	17.0	32.8	27.2	34.1	94.4	29.8	25.7	44.5	34.3	35.0	55.2	150.1	43.6	66.1	19.7	17.6	27.8	31.9	27.1	65.7	36.4	41.9	48.3	107.0	21.2	23.7	32.7	41.8	41.9	41.7	64.0	33.5	19.9	27.7	89.2	110.3	25.6	12.2	36.8	25.7	50.3	51.0	47.1	16.0	115.2	75.0	29.2	95.8	140.8	157.5	23.7	31.0	33.1	55.8	29.4	33.6	19.2	17.3	112.3	52.6	42.9	36.1	83.7	62.1	41.8	20.6	35.4	62.0	55.9	28.2	30.0
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871393-1982207	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 20.3;Granulosa cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	10.1	8.4	12.7	16.5	13.0	54.9	9.9	23.6	15.2	9.4	0.8	19.6	18.6	10.7	7.3	13.6	8.4	8.3	15.8	11.8	11.5	9.8	8.3	12.6	25.4	9.8	8.6	7.7	13.5	12.0	13.8	12.2	12.0	9.7	22.5	28.5	11.6	8.4	16.7	11.6	18.3	12.4	4.4	14.1	12.5	37.2	12.6	59.8	17.4	13.7	24.3	9.7	9.2	14.9	124.0	58.6	168.3	71.2	17.5	26.5	44.2	98.2	85.4	115.2	128.8	44.6	141.4	117.5	31.4	78.0	158.5	50.2	114.4	74.3	195.0	58.3	47.7	151.3	81.7	25.5	18.6	89.5	74.9	9.9	19.8	101.2	89.9	60.1	92.2	123.4	81.7	132.2	95.8	42.1	243.3	99.7	68.8	60.1	77.1	137.8	106.7	42.9	45.4	57.4	115.6	82.7	78.4	29.2	31.7	71.4	68.9	52.2	64.9	109.0	87.4	72.8	188.1	54.1	72.9	113.7	66.0	81.9	108.0	4.0	1.1	1.3	1.0	0.8	1.1	0.9	1.5	1.2	1.2	1.7	1.1	0.8	3.4	1.2	0.5	2.1	2.9	0.7	12.7	13.0	23.6	15.2	11.8	11.5	9.8	8.6	12.0	4.4	12.6	14.9	12.6	12.8	18.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	15.3	9.1	0.0	0.0	8.1	12.9	0.0	15.7	7.2	0.0	3.9	10.4	0.0	13.0	11.7	6.3	0.0	0.0	0.0	7.1	10.0	6.0	0.0	20.3	2.5	69.3	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	11.4	0.0	0.0	4.9	0.0	0.0	4.0	7.3	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	3.4	5.2	3.7	0.0	0.0
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269704-38382272	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 173.8;Syncytiotrophoblasts: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	22.4	14.4	10.0	24.8	13.7	60.2	23.4	28.4	20.5	24.0	0.7	22.4	24.1	22.9	17.4	22.9	23.5	24.5	13.7	12.8	22.3	20.0	16.6	20.6	35.3	3.1	4.8	36.4	20.1	24.8	17.3	33.5	5.3	20.9	26.6	23.3	19.9	24.3	14.4	19.8	26.7	19.8	0.1	26.9	29.0	14.4	10.4	38.3	27.6	16.0	31.0	23.3	23.1	18.7	62.1	34.9	58.7	39.9	40.3	46.0	43.4	50.8	55.9	43.1	49.7	18.8	33.6	73.5	45.5	35.0	41.7	36.4	47.0	40.6	61.0	29.4	27.6	93.6	28.6	22.1	41.2	41.7	32.5	24.9	40.4	39.0	78.6	40.3	50.1	79.8	67.9	47.4	41.5	22.3	122.8	35.4	40.0	48.0	16.4	55.5	64.1	23.4	30.3	47.3	33.0	44.6	41.4	35.8	35.3	37.5	45.1	31.4	48.3	44.5	46.0	67.0	30.3	41.9	53.8	69.2	37.6	41.3	33.0	37.4	11.8	21.9	17.2	5.6	11.0	43.1	25.5	15.5	9.3	60.7	31.9	13.7	57.9	19.6	3.6	12.6	43.4	7.3	10.0	13.7	28.4	20.5	12.8	22.3	3.1	4.8	5.3	0.1	10.4	18.7	75.1	67.3	57.3	0.0	57.8	0.0	0.0	0.0	0.0	0.0	73.4	69.1	0.0	0.0	30.3	51.5	0.0	101.6	101.9	0.0	23.5	73.0	0.0	109.1	81.3	28.0	0.0	0.0	0.0	61.0	173.8	33.1	0.0	97.5	8.8	99.7	0.0	0.0	44.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	49.7	0.0	0.0	0.0	0.0	64.7	0.0	0.0	48.9	0.0	0.0	31.7	34.2	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	130.8	55.6	81.7	0.0	0.0
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1900000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	22.8	37.7	38.3	13.5	39.5	27.8	21.5	37.0	45.9	23.2	41.6	23.0	14.9	22.5	26.8	28.5	26.1	13.5	29.1	39.7	38.6	21.4	26.3	18.0	15.2	39.0	39.0	25.7	15.5	23.9	14.1	21.1	39.8	20.9	18.4	22.6	19.3	26.4	69.0	36.6	17.6	22.9	36.4	19.8	18.0	14.8	38.6	21.0	20.0	43.3	18.6	22.4	21.6	39.7	55.6	64.4	35.9	32.0	30.5	31.4	28.7	21.0	41.8	57.7	41.3	53.9	43.1	31.6	16.6	47.8	47.2	50.4	25.9	70.3	40.8	12.3	25.1	29.8	10.3	61.4	33.8	30.7	16.4	23.5	33.3	55.3	20.3	30.8	46.8	23.4	42.5	26.5	36.2	29.1	31.4	54.7	40.7	42.5	65.4	14.7	41.1	29.8	68.6	37.1	20.5	23.4	29.6	59.8	26.7	18.8	36.5	22.0	37.8	38.7	29.4	23.9	40.2	21.9	41.8	24.7	28.9	43.0	29.3	31.4	21.3	80.3	20.0	26.6	19.7	35.0	21.2	19.5	29.7	36.0	23.4	20.7	69.1	16.7	28.1	23.1	28.2	25.5	38.3	39.5	37.0	45.9	39.7	38.6	39.0	39.0	39.8	36.4	38.6	39.7	34.6	22.4	23.2	17.3	36.1	89.2	63.5	106.3	44.3	60.2	28.6	26.0	35.4	24.3	57.8	31.3	22.9	150.7	29.7	68.2	56.7	104.7	23.0	51.0	29.6	44.3	43.6	41.0	24.0	94.5	146.0	41.1	30.5	54.9	40.5	49.1	31.1	42.2	81.1	70.7	24.8	42.5	61.1	43.7	43.6	38.8	39.1	43.8	42.7	14.0	52.9	61.7	32.0	17.6	31.2	123.4	65.7	46.3	41.8	76.0	66.4	73.8	43.2	44.5	78.9	44.2	64.7	106.1	103.2	55.1	75.7	151.6	31.6	48.9	44.0	88.5
NSMCE1	NSE1	ENSG00000169189	"NSE1 homolog, SMC5-SMC6 complex component"	Q8WV22	16	27224994-27268772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 275.5;Late spermatids: 420.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041567, HPA043091"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA041567: AB_10964260, HPA043091: AB_10962722"	"unprognostic (6.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	43.8	68.3	58.8	32.2	61.7	35.1	52.5	65.2	71.7	43.3	66.0	53.1	25.3	42.3	55.0	45.5	62.2	35.8	47.6	57.4	63.3	58.3	55.9	42.4	54.5	65.5	61.4	45.0	59.3	86.1	37.3	37.3	64.6	57.4	36.8	24.9	46.2	51.7	45.2	40.7	37.0	45.2	64.0	33.5	51.3	79.8	61.3	56.4	53.0	44.9	54.7	51.4	39.1	67.0	56.5	80.6	53.8	58.6	85.8	114.2	43.1	58.9	60.4	44.5	46.1	62.7	134.1	110.0	137.7	91.1	45.7	59.5	101.9	178.6	57.3	136.3	70.6	51.0	68.6	122.1	149.1	59.9	37.4	112.6	122.3	111.7	211.5	127.8	60.3	104.3	69.6	33.8	82.9	96.7	80.0	67.5	46.8	94.0	54.7	69.1	65.8	174.7	129.9	36.3	56.4	51.0	40.2	55.9	104.3	65.1	92.3	71.9	37.8	53.3	33.2	61.1	57.8	101.0	78.1	85.9	114.0	59.4	23.3	125.3	91.2	86.2	78.9	81.6	86.3	84.2	111.1	95.7	128.4	133.1	126.7	99.7	29.6	213.8	81.5	124.6	113.0	120.3	58.8	61.7	65.2	71.7	57.4	63.3	65.5	61.4	64.6	64.0	61.3	67.0	34.8	35.3	36.4	8.5	38.1	28.3	57.6	110.7	33.0	14.9	60.7	83.8	49.6	62.9	58.5	44.1	2.1	126.2	41.2	45.6	129.1	79.2	209.9	40.3	32.9	33.9	58.7	24.0	5.4	73.0	63.3	44.5	17.3	29.6	275.5	37.4	52.8	64.0	83.2	13.5	6.7	65.8	44.7	53.3	45.6	420.8	24.2	39.5	46.2	12.2	98.1	64.7	43.3	12.5	14.8	40.1	45.7	39.9	28.1	49.0	83.9	173.8	94.6	18.8	26.3	58.1	50.1	119.0	39.4	43.5	32.7	64.3	55.3	39.9	46.7	48.3
NSMCE2	"C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7"	ENSG00000156831	"NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase"	Q96MF7	8	125091679-125367120	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway"	Transferase	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 136.1;Excitatory neurons: 150.1;Inhibitory neurons: 156.8;Microglial cells: 157.4;Oligodendrocyte precursor cells: 139.2;Oligodendrocytes: 386.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051614, HPA065734"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA051614: AB_2681551, HPA065734: AB_2685549"	"unprognostic (1.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.65e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (7.54e-4)"	"unprognostic (3.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.85e-2)"	19.9	18.1	11.0	14.1	12.8	30.3	23.7	12.4	12.9	17.0	13.4	18.6	12.5	15.8	18.6	17.0	13.4	15.9	23.8	11.2	12.4	18.9	17.8	14.2	21.7	12.2	11.9	19.0	12.8	17.8	11.2	19.6	12.6	13.2	17.5	16.7	16.0	13.9	33.6	15.8	12.3	16.1	11.8	14.5	16.6	15.5	12.7	26.0	18.1	27.2	26.1	20.7	14.7	16.1	43.0	36.3	42.3	26.9	32.7	48.9	20.5	33.5	62.5	58.2	67.0	23.4	39.9	53.2	38.5	32.0	42.9	31.1	33.4	28.2	58.8	60.0	32.4	75.4	20.0	34.1	47.7	22.8	22.1	36.5	38.4	33.6	43.6	38.8	53.2	27.5	44.1	34.2	51.4	74.3	58.9	20.9	9.3	48.4	48.0	33.3	29.4	48.6	35.5	32.1	28.0	29.7	40.1	119.2	56.3	24.9	50.9	25.9	33.3	22.3	62.9	27.8	48.3	45.1	86.6	67.6	35.4	43.4	35.3	12.9	23.9	69.4	22.0	21.7	24.3	25.0	23.1	24.8	24.4	25.5	23.7	25.9	11.3	22.0	23.3	14.2	37.6	24.5	11.0	12.8	12.4	12.9	11.2	12.4	12.2	11.9	12.6	11.8	12.7	16.1	21.8	9.6	13.1	136.1	22.0	23.8	36.3	39.1	21.1	23.8	23.3	24.8	20.1	21.5	26.0	11.0	16.7	34.2	20.3	16.2	27.4	33.1	28.0	26.4	19.7	23.0	13.8	36.2	150.1	42.5	27.8	21.4	13.7	20.7	25.4	24.1	23.2	13.7	44.3	15.2	156.8	17.7	18.3	26.5	24.3	9.9	23.3	24.4	17.8	157.4	29.4	18.4	20.6	139.2	386.0	34.2	19.5	24.5	20.2	28.1	20.6	35.2	23.4	26.4	6.6	20.7	23.4	44.4	31.7	16.0	18.9	46.7	24.6	20.9	19.8	37.6
NSMCE4A	"bA500G22.3, C10orf86, FLJ20003, NSE4A"	ENSG00000107672	"NSE4 homolog A, SMC5-SMC6 complex component"	Q9NXX6	10	121957091-121975217	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037459, HPA038412, HPA044872"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 4: Stomach - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA037459: AB_10696932, HPA038412: AB_2676005, HPA044872: AB_2679124"	"unprognostic (1.16e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.16e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.64e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.01e-3)"	27.3	20.6	9.3	14.6	11.8	20.2	27.4	10.8	13.3	23.0	9.3	37.0	24.7	23.4	12.4	19.2	22.8	14.4	21.2	9.5	10.0	15.6	25.2	16.9	23.8	10.9	10.8	22.7	30.0	15.1	11.2	14.1	10.9	24.8	21.0	10.7	24.4	16.5	20.6	19.4	26.8	17.7	10.4	23.3	29.5	4.9	10.6	21.5	21.1	8.4	19.7	30.0	20.8	13.2	43.4	51.9	55.0	49.0	18.9	24.7	40.3	23.7	42.3	40.0	55.2	40.5	32.8	57.2	17.9	18.9	22.0	36.7	32.5	26.0	31.5	69.0	76.3	37.5	17.0	76.5	16.0	43.2	25.5	16.9	19.4	23.5	37.9	22.4	42.8	51.5	35.1	40.3	22.6	35.1	78.2	62.8	28.7	30.7	40.4	66.9	42.4	61.2	27.7	35.4	14.9	29.1	27.0	18.1	38.2	22.0	20.0	40.3	35.3	15.8	28.0	26.8	49.6	53.0	60.6	88.0	19.7	57.5	17.3	0.3	31.5	19.5	29.6	38.3	34.4	50.6	39.5	38.7	33.1	46.6	41.4	33.6	2.9	41.7	38.5	51.5	48.3	36.5	9.3	11.8	10.8	13.3	9.5	10.0	10.9	10.8	10.9	10.4	10.6	13.2	49.3	22.4	33.1	9.4	35.5	17.0	45.0	47.0	23.9	20.3	30.4	34.3	23.1	30.0	31.8	12.9	33.3	56.4	40.0	35.8	35.2	28.0	0.7	16.8	15.4	33.9	21.6	26.1	5.3	61.2	38.0	25.9	28.5	17.0	11.4	34.6	18.5	33.3	35.6	26.9	5.4	35.1	46.8	20.0	19.2	1.6	35.4	22.4	21.4	7.5	48.6	33.3	40.2	7.5	17.4	30.4	37.0	33.4	36.3	41.9	36.8	39.2	21.6	37.4	26.3	27.1	31.3	6.7	16.6	35.5	21.6	66.2	29.3	39.6	44.8	47.9
NSMF	NELF	ENSG00000165802	"NMDA receptor synaptonuclear signaling and neuronal migration factor"	Q6X4W1	9	137447570-137459334	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 361.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.5;Peritubular cells: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 3.5;intermediate monocyte: 13.8;myeloid DC: 6.3;non-classical monocyte: 12.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.3;granulocytes: 3.5;monocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044316	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA044316: AB_10964877"	"unprognostic (1.48e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.34e-3)"	"prognostic favorable (1.85e-6)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.97e-2)"	23.1	14.5	167.1	12.6	154.3	12.2	20.3	66.6	361.3	24.2	73.4	22.7	29.9	32.8	10.7	16.3	28.7	9.7	16.1	360.8	115.1	30.8	23.5	19.8	13.0	99.7	153.1	22.5	31.6	17.9	70.6	7.1	75.1	31.2	10.4	12.1	20.2	13.8	8.9	20.6	24.9	13.9	109.9	17.0	23.5	18.9	210.5	8.4	23.9	3.9	10.3	22.2	17.5	105.4	24.4	19.3	33.7	50.4	77.1	36.4	28.9	23.0	30.2	21.5	16.5	51.7	14.3	30.2	30.3	34.0	48.1	72.7	50.0	30.9	12.9	39.7	53.8	23.5	46.7	69.5	41.7	16.2	51.5	41.7	57.9	25.1	58.3	48.5	23.1	0.8	55.0	4.9	29.2	56.4	0.7	69.8	42.9	97.6	51.4	14.6	53.3	68.0	14.9	12.1	135.7	112.8	55.0	30.3	35.7	13.9	21.5	33.0	58.6	37.9	30.9	92.9	39.6	10.3	17.0	45.8	21.6	21.2	35.6	1.6	2.1	3.5	1.5	13.8	0.3	0.2	0.5	0.9	6.3	0.1	0.5	0.7	0.3	0.0	12.1	0.2	0.8	1.8	167.1	154.3	66.6	361.3	360.8	115.1	99.7	153.1	75.1	109.9	210.5	105.4	9.9	0.0	3.9	71.5	5.9	13.6	9.4	3.6	7.4	9.6	14.3	12.4	6.1	11.5	2.3	11.0	8.4	0.4	17.7	40.7	5.9	8.2	7.1	7.6	18.3	9.5	19.2	1.7	24.2	21.4	1.3	11.0	10.2	11.1	2.5	12.0	9.7	26.3	6.7	28.6	14.9	21.3	8.2	8.6	21.2	15.3	23.9	10.5	16.0	15.9	9.8	10.3	6.2	16.1	5.3	21.4	34.3	71.5	8.5	32.6	43.4	29.7	2.9	12.9	13.1	8.3	10.9	3.0	5.9	6.3	14.6	1.5	8.0	11.0	20.5	16.7
NSRP1	"CCDC55, DKFZP434K1421, NSrp70"	ENSG00000126653	"Nuclear speckle splicing regulatory protein 1"	Q9H0G5	17	30115521-30186475	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015593, HPA015603"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA015593: AB_2072217, HPA015603: AB_1846157"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.43e-1)"	23.1	18.8	25.0	18.8	28.4	25.0	21.9	34.0	34.4	18.6	32.5	25.0	16.8	22.9	22.5	19.5	19.6	19.6	25.8	21.7	28.5	21.4	20.2	18.8	22.3	29.8	25.5	22.8	20.3	24.2	17.9	22.0	27.9	20.5	18.3	19.5	18.0	17.9	25.2	25.0	17.9	21.1	25.0	19.4	19.1	19.3	26.9	17.6	25.5	20.8	19.9	21.1	18.0	34.7	30.9	27.3	26.3	21.0	35.0	33.0	18.6	41.8	42.6	31.4	33.5	28.3	19.6	56.1	32.6	39.8	38.5	44.4	41.1	32.2	50.8	13.5	55.7	25.6	43.8	21.1	56.5	40.0	29.8	38.3	41.5	50.1	64.6	36.5	29.7	20.3	41.0	35.6	43.8	22.1	26.9	39.0	17.4	33.8	22.0	30.8	43.3	37.8	32.5	32.9	24.8	21.6	32.1	84.2	38.6	26.4	44.1	44.3	32.4	37.7	26.7	40.0	67.1	25.8	36.9	44.1	46.5	35.5	44.1	66.1	39.7	33.1	32.2	38.2	36.0	62.1	35.8	32.1	21.5	57.9	34.6	31.5	59.5	32.8	44.4	62.4	35.6	14.5	25.0	28.4	34.0	34.4	21.7	28.5	29.8	25.5	27.9	25.0	26.9	34.7	97.5	76.9	91.0	49.0	59.2	67.6	95.9	124.0	88.8	62.6	51.4	64.1	147.3	72.9	80.6	84.6	35.5	58.3	54.0	57.5	97.8	71.7	259.2	79.2	89.6	91.9	31.3	68.0	30.6	75.2	69.5	76.3	37.8	76.6	83.4	43.6	94.9	143.7	53.6	74.0	41.9	65.1	59.0	63.1	46.5	137.0	77.0	52.3	49.8	69.3	70.6	78.7	63.8	52.8	88.5	71.1	54.1	71.5	48.2	75.8	57.9	90.6	84.9	56.8	72.3	113.1	97.1	186.9	105.8	40.7	52.0	110.8	52.5	56.1	54.3	63.2
NSUN2	"FLJ20303, Misu, MRT5, TRM4"	ENSG00000037474	"NOP2/Sun RNA methyltransferase 2"	Q08J23	5	6599239-6633291	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037896	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		110000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037896: AB_10670532"	"unprognostic (3.99e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.12e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.70e-2)"	21.6	16.0	10.4	29.1	10.9	28.2	38.6	11.3	13.4	16.2	12.0	24.7	20.8	18.2	19.5	24.1	17.7	17.8	23.0	10.8	11.3	16.4	36.7	19.5	34.3	11.2	10.6	18.0	20.0	24.9	11.5	19.8	11.2	20.7	27.7	10.9	17.9	17.0	39.0	22.7	20.4	22.4	10.4	23.0	21.4	18.9	11.8	26.5	18.0	30.2	36.8	29.3	15.0	13.2	97.6	85.8	49.9	45.4	31.7	36.1	112.9	72.5	48.6	84.4	71.5	113.0	75.6	170.6	74.0	63.8	101.6	70.7	102.1	90.6	114.6	115.1	73.4	100.8	199.0	67.0	44.8	176.8	77.4	40.2	67.5	91.8	80.5	33.6	60.6	70.3	132.3	66.3	79.9	71.1	93.2	89.3	80.0	69.3	101.3	121.1	50.5	54.7	61.7	112.1	45.8	65.4	184.4	101.2	79.1	65.0	85.0	84.2	66.6	66.8	82.0	68.4	111.1	51.2	100.1	159.9	52.9	143.9	77.6	16.2	18.6	21.2	21.1	22.4	27.9	22.4	22.1	25.0	21.5	20.6	23.2	23.5	3.9	24.4	21.2	20.2	17.0	17.0	10.4	10.9	11.3	13.4	10.8	11.3	11.2	10.6	11.2	10.4	11.8	13.2	13.2	19.2	17.6	27.7	26.3	37.7	16.4	15.7	21.6	6.2	15.5	14.2	18.7	17.2	30.3	18.4	14.6	20.1	17.1	16.2	9.8	19.6	3.1	11.2	12.9	16.2	14.9	22.3	37.2	15.3	21.2	14.5	17.9	14.1	20.8	17.8	10.0	33.9	14.4	3.3	30.2	16.5	16.2	18.5	21.1	2.9	13.1	16.4	16.0	20.6	21.9	7.2	21.6	24.1	45.4	24.8	14.8	14.3	23.0	18.9	10.2	9.8	17.4	7.3	6.6	20.2	15.4	14.9	17.7	30.1	30.5	23.1	20.7	17.2	19.8	17.0
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase 5"	Q96P11	7	73302516-73308826	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847"	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	13.9	11.6	9.8	9.7	11.3	33.4	14.1	11.7	12.9	15.3	9.1	18.6	8.9	18.7	3.2	17.7	15.5	4.2	17.7	9.8	10.9	17.4	16.2	12.1	14.2	12.8	10.8	13.0	24.0	6.6	12.8	6.1	11.7	15.5	4.3	3.2	14.6	6.3	37.9	19.7	17.7	6.2	11.6	24.4	16.3	20.7	11.0	13.0	13.6	8.1	9.4	18.6	14.7	13.3	34.7	46.4	12.3	29.3	4.8	6.3	48.4	15.3	9.1	23.6	25.3	63.0	24.3	55.3	10.6	7.7	34.6	28.9	23.7	15.2	8.1	36.6	57.0	20.7	35.8	36.4	20.0	45.9	26.0	8.3	25.7	20.0	17.3	5.2	3.1	40.4	71.0	12.7	10.8	83.2	39.3	91.6	52.1	24.9	34.9	48.9	9.5	79.8	10.1	17.1	33.2	54.6	27.9	72.5	36.4	12.8	47.9	37.1	5.3	0.2	34.8	34.7	11.1	49.6	73.8	80.8	0.5	65.6	2.5	23.7	21.5	24.0	19.6	19.6	15.7	32.2	22.3	20.4	25.0	46.2	31.0	26.5	27.4	26.8	14.8	31.5	26.9	23.2	9.8	11.3	11.7	12.9	9.8	10.9	12.8	10.8	11.7	11.6	11.0	13.3	11.1	6.4	7.4	14.4	38.2	17.0	20.0	32.8	14.8	27.5	23.0	25.0	20.4	27.1	21.3	36.8	12.5	37.7	27.3	18.3	37.2	35.8	17.4	18.1	12.7	8.9	3.6	19.1	9.2	33.0	48.9	17.2	21.4	15.5	26.6	50.5	5.3	21.0	36.6	32.0	9.3	18.3	26.4	21.0	10.8	21.6	29.2	20.2	21.4	3.7	39.9	13.2	36.0	10.1	12.1	29.1	20.5	20.7	24.9	12.6	28.4	25.1	21.8	23.1	6.6	20.8	16.8	64.2	56.7	15.1	21.3	21.8	24.9	16.2	23.1	14.3
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 35.5"	"Group enriched"	"Detected in some"	29	"Early spermatids: 159.5;Late spermatids: 300.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											HPA056683	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli, Plasma membrane"	Nucleoplasm	"HPA056683: AB_2683207"	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.5	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.1	2.6	0.1	0.7	0.1	0.0	1.0	0.1	0.7	0.6	0.1	0.1	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.4	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.0	0.0	1.1	0.2	0.0	0.1	0.2	0.8	35.5	0.4	0.0	0.7	0.0	0.0	0.3	0.1	0.2	1.2	0.2	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	1.2	0.5	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.4	0.1	0.0	1.0	0.0	0.1	0.2	0.2	0.6	0.1	0.2	0.3	0.0	1.1	0.8	0.4	0.9	0.1	0.5	0.1	0.2	0.2	0.6	0.5	0.3	1.0	0.1	0.3	0.2	0.7	0.9	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.4	0.4	0.1	0.3	0.8	0.7	0.0	0.2	0.0	1.2	0.1	0.1	0.2	0.3	0.2	0.2	0.1	0.1	0.3	0.5	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	159.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	300.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C1B-RDH14		ENSG00000250741	"NT5C1B-RDH14 readthrough"		2	18555545-18589564	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	126	"testis: 16.6"	"Group enriched"	"Detected in some"	97	"Early spermatids: 52.3;Late spermatids: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056683	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	"Nucleoli, Plasma membrane"	Nucleoplasm	"HPA056683: AB_2683207"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014114-33062797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 191.0;Paneth cells: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010520, HPA010630, HPA029058"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.4	14.3	11.4	26.1	11.4	32.6	21.3	15.2	15.6	12.6	10.8	51.9	40.0	16.9	14.3	18.6	15.9	23.4	16.6	11.5	11.5	22.4	11.8	17.6	30.8	11.1	11.8	13.4	21.4	9.7	7.5	16.3	11.5	12.3	51.0	20.4	9.7	10.0	87.4	28.7	37.3	13.2	12.7	22.9	27.0	9.5	12.0	22.5	17.1	51.0	45.8	23.8	14.4	13.1	42.2	27.6	25.2	29.6	21.2	16.1	20.3	44.8	30.5	29.2	38.9	19.9	115.1	100.4	27.7	29.6	48.3	63.8	28.3	30.8	40.4	16.2	36.2	54.7	36.5	28.7	23.3	55.6	36.9	21.7	23.8	35.9	63.0	16.4	22.2	33.2	43.3	24.8	37.3	29.9	25.0	87.8	27.8	47.1	31.2	25.9	22.9	60.0	87.8	39.8	28.1	37.0	31.1	52.4	66.6	24.5	35.2	33.5	19.8	25.1	20.9	42.6	55.7	50.6	69.0	54.8	20.6	34.9	42.5	112.5	25.9	82.5	26.6	32.7	30.6	64.0	34.2	30.8	22.1	63.6	34.5	29.1	103.8	28.2	39.2	20.6	56.2	37.9	11.4	11.4	15.2	15.6	11.5	11.5	11.1	11.8	11.5	12.7	12.0	13.1	39.1	22.4	13.7	30.7	85.1	46.8	40.9	85.3	47.8	23.9	22.6	18.9	16.9	32.9	40.4	16.5	41.7	36.9	42.5	191.0	29.4	34.4	5.7	40.9	21.0	40.8	119.6	127.1	45.3	79.0	31.6	35.2	42.8	21.4	17.7	38.3	30.0	18.9	25.0	1.7	49.4	98.9	40.7	31.2	23.5	5.0	33.8	111.4	26.6	29.0	37.0	23.4	55.6	48.2	52.4	48.3	186.6	22.2	43.8	45.7	91.8	84.8	53.7	27.1	13.1	30.7	24.9	46.4	24.0	35.5	38.9	28.3	53.7	23.3	71.0	65.9
NT5DC1	"dJ486I3.1, MGC24302, NT5C2L1"	ENSG00000178425	"5'-nucleotidase domain containing 1"	Q5TFE4	6	116100851-116249497	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 117.6"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 429.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030352, HPA079264"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		140000	"Cluster 37: B-cells - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA030352: AB_2154066, HPA079264: "	"unprognostic (1.30e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.61e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.49e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.63e-2)"	19.5	24.0	11.4	12.7	24.6	10.0	19.2	22.7	15.0	10.4	117.6	19.8	29.5	9.1	22.4	16.5	20.6	15.7	25.9	11.0	16.3	28.2	42.6	16.7	21.4	24.1	20.9	13.2	22.2	23.8	9.6	8.3	24.1	28.3	19.9	11.2	22.7	16.6	21.5	10.7	26.8	11.3	21.0	13.5	21.6	10.6	19.3	14.5	28.3	23.2	22.4	15.8	9.4	40.9	24.7	20.3	17.7	23.7	19.2	11.6	31.0	17.7	40.3	27.4	32.2	29.4	24.8	50.3	37.4	15.9	29.7	38.7	12.1	28.1	23.8	78.4	26.7	21.0	16.7	31.0	20.9	46.8	1.9	21.7	22.2	17.6	15.0	59.2	24.7	30.0	26.6	27.5	34.8	25.3	9.0	16.3	16.2	54.1	27.0	52.3	48.3	27.2	25.5	29.2	11.8	17.6	37.9	28.7	26.5	19.4	26.6	9.3	21.6	12.3	20.8	23.7	35.6	40.2	59.2	39.8	29.3	31.0	22.4	14.5	18.2	33.2	20.2	10.5	31.4	41.3	29.8	25.4	24.6	30.1	28.2	24.3	12.9	23.1	12.7	12.4	32.4	19.7	11.4	24.6	22.7	15.0	11.0	16.3	24.1	20.9	24.1	21.0	19.3	40.9	15.4	64.1	45.7	62.3	37.9	26.1	37.9	66.5	29.6	14.0	30.3	23.6	44.2	25.8	44.5	18.4	27.1	41.6	24.9	19.1	64.6	39.6	19.8	32.9	10.7	21.7	26.5	16.2	96.1	40.8	30.4	14.0	26.5	19.0	23.5	16.2	33.5	49.3	31.8	45.4	70.1	30.6	30.5	29.2	14.2	8.3	19.0	18.5	19.6	54.4	49.6	19.8	10.3	29.7	429.4	28.8	19.6	20.7	25.3	28.0	54.6	57.4	76.7	20.2	32.9	29.2	23.9	17.2	28.5	27.4	21.5	25.6	23.8	18.3	35.9	31.5
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 112.6;retina: 94.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.0;naive CD8 T-cell: 30.7"	"Group enriched"	"Detected in many"	41	"B-cells: 33.0;T-cells: 30.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	20.7	6.0	9.8	11.9	11.9	0.6	14.1	11.2	10.7	112.6	14.9	29.4	40.1	49.4	6.3	8.6	20.7	17.2	8.7	8.5	11.3	17.2	54.8	6.8	9.6	11.7	14.1	39.3	1.8	1.8	11.8	25.3	13.0	13.3	31.9	94.4	6.6	34.2	2.1	6.4	20.9	73.9	14.7	13.0	8.1	10.4	12.7	5.2	23.7	9.8	11.3	15.8	28.5	12.1	48.9	26.0	42.9	0.8	95.1	302.4	0.4	306.1	332.7	147.5	275.2	0.4	469.6	0.0	107.3	270.2	379.0	24.5	0.1	308.0	348.8	0.8	0.1	0.1	7.3	6.0	47.5	0.2	0.7	77.4	3.7	302.0	191.3	807.8	124.9	0.3	0.3	1.4	934.3	8.3	0.0	0.2	0.8	8.2	34.6	1.5	9.5	1.3	323.1	21.8	0.3	5.5	3.8	18.8	104.9	2.2	0.4	8.3	546.2	120.6	0.9	152.9	506.8	22.7	15.3	0.5	821.7	0.4	385.3	0.0	0.0	0.5	3.7	0.0	6.4	23.7	4.2	11.7	0.0	33.0	4.1	30.7	0.5	0.7	0.0	0.1	1.7	6.4	9.8	11.9	11.2	10.7	8.5	11.3	11.7	14.1	13.0	14.7	12.7	12.1	6.4	0.0	5.8	36.9	21.6	5.2	1.7	6.1	2.8	4.4	1.2	0.3	1.7	27.1	4.8	1.8	10.4	0.6	2.2	49.2	3.9	3.8	0.6	19.3	20.8	20.5	0.0	0.0	1.6	4.1	2.5	39.4	11.2	58.0	0.0	0.1	49.6	33.7	1.3	0.0	2.1	27.7	0.0	3.5	8.2	1.3	13.1	2.1	7.2	11.2	0.5	9.1	0.0	61.3	0.7	124.8	46.0	25.6	3.6	1.5	8.3	27.6	4.8	81.6	0.0	3.3	9.6	0.0	0.3	0.6	4.8	15.2	5.0	0.1	18.0	9.6
NTAN1		ENSG00000157045	"N-terminal asparagine amidase"	Q96AB6	16	15037854-15056079	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 17.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 18.5;REH: 9.2;U-266/84: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051418			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA051418: "	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (1.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (4.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	38.6	10.2	3.6	0.5	3.9	2.2	28.1	3.8	8.9	25.3	2.1	30.3	0.1	20.7	1.4	19.4	18.8	1.2	19.3	3.4	3.7	15.9	15.2	21.6	0.7	3.8	4.1	19.7	11.0	0.5	6.5	0.4	4.1	20.2	0.3	1.3	15.8	0.4	24.5	21.6	15.6	0.8	2.9	20.5	17.9	20.3	3.7	0.8	13.5	0.6	0.4	27.8	21.8	3.5	3.6	0.0	1.8	0.7	1.2	0.6	0.6	6.2	2.6	1.0	2.8	0.0	0.0	3.2	2.5	4.7	1.7	0.1	0.9	0.7	0.9	5.0	5.9	0.3	0.0	0.0	1.1	1.7	4.3	0.8	0.4	3.4	1.5	1.5	1.3	2.6	0.5	3.2	0.9	0.3	5.3	18.5	1.1	0.0	0.2	9.2	0.1	1.3	1.2	0.0	0.7	2.1	0.0	0.1	1.5	0.4	0.0	0.6	4.1	1.1	3.8	1.1	1.1	4.2	10.1	2.5	1.5	1.3	2.2	4.9	1.3	17.5	2.8	1.7	3.0	4.2	3.4	2.6	1.9	3.8	3.9	1.3	1.6	3.8	2.0	5.7	5.9	3.1	3.6	3.9	3.8	8.9	3.4	3.7	3.8	4.1	4.1	2.9	3.7	3.5	79.7	3.2	3.9	7.8	24.7	33.6	16.4	24.1	7.4	6.1	20.2	33.4	3.2	12.8	13.8	18.4	10.4	77.4	30.4	25.1	45.0	49.3	48.9	8.8	29.3	55.0	6.7	25.3	12.6	23.6	23.8	51.3	8.2	12.7	8.8	22.0	62.8	23.0	116.6	25.2	15.6	7.2	30.5	75.0	48.3	32.4	83.0	53.9	58.7	12.2	46.0	15.2	37.0	3.0	6.6	56.9	14.6	75.2	37.6	21.2	9.6	38.6	6.0	9.4	39.5	20.8	52.3	33.3	30.7	16.0	21.7	56.9	25.6	23.5	13.5	23.9
NTAQ1	"C8orf32, FLJ10204, WDYHV1"	ENSG00000156795	"N-terminal glutamine amidase 1"	Q96HA8	8	123416726-123470028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 21.9;Cytotrophoblasts: 13.9;Extravillous trophoblasts: 23.0;Hofbauer cells: 13.2;Syncytiotrophoblasts: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024823, HPA053680"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA024823: AB_1845773, HPA053680: AB_2682228"	"unprognostic (9.97e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.37e-1)"	7.1	10.9	16.2	5.1	16.7	5.9	13.5	16.3	24.0	12.8	15.5	7.5	4.3	8.1	8.9	6.9	7.5	6.7	20.1	14.8	17.8	13.0	6.8	6.8	7.4	17.0	17.9	18.2	9.6	11.0	10.5	6.8	17.4	10.2	7.9	14.9	6.9	8.8	16.0	7.7	4.4	9.5	15.8	5.2	8.5	12.7	20.0	7.1	12.8	17.6	10.1	8.8	7.2	17.7	26.6	26.9	39.2	18.1	15.3	40.9	14.5	19.1	21.3	23.4	26.1	15.8	17.8	19.7	19.8	23.8	32.7	12.8	25.8	29.7	31.4	53.1	15.8	25.6	13.2	22.4	21.2	12.7	10.9	24.1	16.0	29.3	32.8	27.1	22.6	41.2	18.8	29.0	33.5	84.3	30.2	14.4	12.3	65.6	20.5	13.5	20.0	20.4	31.1	22.6	18.6	34.1	20.7	109.0	35.8	44.5	17.6	12.2	9.8	26.5	46.2	19.7	26.4	17.4	38.1	24.1	18.8	14.1	19.1	16.3	5.7	2.1	6.2	8.7	7.4	5.0	7.3	7.7	9.0	4.1	6.2	6.9	1.5	16.0	3.8	5.2	10.6	4.6	16.2	16.7	16.3	24.0	14.8	17.8	17.0	17.9	17.4	15.8	20.0	17.7	5.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	13.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	23.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	10.0	0.3	0.0	0.0	0.0
NTMT1	"AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1"	ENSG00000148335	"N-terminal Xaa-Pro-Lys N-methyltransferase 1"	Q9BV86	9	129608884-129636135	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 391.4;Late spermatids: 761.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020092, HPA058420"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020092: AB_1853831, HPA058420: AB_2683713"	"unprognostic (4.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.50e-3)"	26.4	68.6	20.6	19.3	21.7	24.5	22.1	23.6	27.0	22.5	22.4	23.2	18.3	19.6	15.9	20.2	18.9	19.9	67.9	21.0	23.1	31.5	41.6	22.8	20.2	22.5	23.8	19.8	31.1	22.4	23.4	19.6	22.5	22.7	11.2	6.3	22.4	16.7	98.9	25.1	19.5	13.7	21.3	29.7	24.9	93.3	22.9	16.1	17.9	84.3	16.0	23.9	20.0	24.1	57.8	117.2	47.9	82.2	30.0	44.6	50.2	107.6	63.5	108.1	92.8	96.6	74.0	74.8	53.7	78.5	76.7	110.1	101.8	96.4	66.8	56.3	50.9	31.2	106.3	100.4	96.3	63.3	45.0	47.0	48.6	113.5	56.0	34.2	60.1	64.1	116.5	54.2	57.5	194.1	72.0	85.6	62.6	105.4	96.6	66.8	55.8	150.4	43.7	32.4	96.5	48.5	53.1	97.3	74.7	30.2	81.4	32.4	41.8	129.1	64.5	118.7	115.3	41.2	53.7	115.2	59.0	64.4	75.0	32.9	49.7	39.2	43.7	55.1	43.7	43.2	43.5	46.5	49.2	50.4	43.9	36.3	13.6	30.6	70.9	52.8	44.5	36.4	20.6	21.7	23.6	27.0	21.0	23.1	22.5	23.8	22.5	21.3	22.9	24.1	35.6	3.2	13.9	5.9	45.9	99.8	85.7	50.3	16.5	18.3	33.4	33.8	4.1	20.0	35.7	22.0	22.9	72.6	23.1	49.7	97.8	60.5	391.4	21.4	29.8	38.3	20.3	23.4	6.4	55.9	86.8	41.1	21.9	23.2	30.4	20.5	20.0	52.7	67.0	42.1	6.5	44.0	42.7	27.6	80.3	761.6	35.1	34.3	55.2	3.7	33.1	23.3	25.7	4.5	9.2	69.2	29.9	24.8	41.0	105.7	84.5	89.6	22.5	23.6	26.3	34.1	58.8	129.2	43.2	19.2	99.3	135.6	38.3	39.2	48.4	70.7
NTN1	NTN1L	ENSG00000065320	"Netrin 1"	O95631	17	9021510-9244000	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.1;heart muscle: 59.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 137.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 27.5;T-47d: 16.6;U-2 OS: 14.4;U-251 MG: 22.1;WM-115: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056419	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"	"Secreted to extracellular matrix"	NA	NA		110000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA056419: AB_2683124"	"unprognostic (2.72e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.33e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.07e-3)"	"unprognostic (8.31e-3)"	6.4	0.5	4.5	3.6	6.4	0.1	5.3	10.1	4.9	9.3	2.8	14.7	6.7	9.6	3.5	18.9	10.3	7.3	59.4	3.8	7.0	2.0	6.9	4.3	0.2	12.7	37.1	0.9	2.3	4.3	3.0	0.9	14.4	3.9	3.9	0.4	10.9	2.0	2.1	8.1	10.5	6.0	13.8	0.1	17.5	3.1	10.1	2.9	2.0	2.6	2.1	10.2	5.4	8.8	0.1	0.0	1.3	4.6	4.2	0.1	27.5	0.3	0.4	0.3	0.5	0.1	5.7	0.0	6.2	0.0	9.0	0.1	1.2	0.9	0.0	6.4	10.4	1.4	0.0	0.0	0.1	0.5	0.1	0.1	2.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	5.6	0.1	0.6	1.8	0.0	0.0	3.4	4.8	0.0	0.0	0.3	0.0	0.0	0.1	4.7	1.1	4.5	16.6	0.3	0.0	6.7	14.4	0.0	22.1	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	6.4	10.1	4.9	3.8	7.0	12.7	37.1	14.4	13.8	10.1	8.8	0.7	0.0	0.0	10.7	0.3	3.3	6.6	21.8	9.6	2.9	4.7	4.4	28.1	0.0	23.9	1.8	0.0	0.3	0.2	0.5	0.0	3.1	9.3	5.8	2.0	3.1	0.0	0.0	4.8	1.7	1.2	9.7	1.1	7.9	0.0	0.0	2.2	12.4	0.1	0.0	7.1	1.4	24.4	0.6	5.9	4.6	0.3	0.1	1.8	9.4	0.6	0.3	0.0	137.2	1.0	1.4	0.1	0.0	0.0	4.0	0.7	0.2	11.1	0.2	0.0	3.9	6.8	1.6	2.0	12.7	2.8	0.5	0.5	0.0	0.6	3.5
NUAK1	"ARK5, KIAA0537"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063345-106138954	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 111.7;Excitatory neurons: 150.5;Hepatic stellate cells: 136.3;Microglial cells: 93.7;Oligodendrocytes: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 58.0;EFO-21: 55.1;RH-30: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Microtubules"	"HPA057143: AB_2683349"	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	17.5	3.6	12.6	2.3	17.5	0.6	12.1	9.4	25.4	9.8	0.0	4.1	2.2	9.5	3.1	3.5	9.0	4.9	18.8	17.4	5.6	4.2	4.0	9.3	3.2	6.1	5.9	6.1	3.2	17.5	2.7	4.5	8.3	6.0	3.9	5.4	3.4	6.0	20.6	20.8	4.3	10.2	5.5	0.8	3.8	2.6	5.5	3.3	4.3	17.2	2.3	4.8	8.1	31.8	13.0	8.3	58.0	0.6	23.7	2.5	27.0	14.2	9.5	9.9	8.0	4.3	2.1	0.0	55.1	27.4	5.0	11.9	12.6	11.2	4.8	0.2	3.4	0.0	9.7	4.7	5.0	0.1	0.1	11.0	8.1	6.0	1.7	19.2	21.2	0.1	0.0	40.3	7.8	1.3	0.2	0.6	11.1	0.2	3.3	0.1	77.7	10.5	6.6	13.3	6.8	0.4	6.9	1.9	0.5	37.2	2.9	0.4	16.6	9.4	29.7	3.3	17.0	0.0	0.0	0.7	2.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.6	17.5	9.4	25.4	17.4	5.6	6.1	5.9	8.3	5.5	5.5	31.8	56.4	0.0	2.4	15.7	0.6	13.5	32.9	29.8	10.2	32.3	2.1	4.2	48.9	10.0	7.2	7.3	0.0	0.8	13.5	0.9	3.9	6.2	0.4	5.1	6.6	111.7	0.0	5.3	150.5	9.6	5.2	17.9	2.0	3.8	0.0	2.9	136.3	12.1	8.0	40.4	55.4	2.3	12.2	8.4	8.8	2.6	4.1	1.3	10.6	93.7	0.6	1.9	1.0	15.6	73.5	18.4	0.5	3.0	3.2	10.6	0.2	1.8	2.2	2.9	0.0	7.1	26.4	1.0	5.5	2.5	15.9	0.3	2.7	0.4	0.8	5.2
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302063-205321745	"Enzymes, Metabolic proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 56.7;vagina: 45.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 46.9;Endometrial ciliated cells: 45.3;Glandular and luminal cells: 52.4;Intestinal goblet cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 120.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.1;RPMI-8226: 36.1;RPTEC TERT1: 40.9;SuSa: 45.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	2.1	3.7	1.3	7.7	1.9	11.4	0.9	4.6	1.7	31.0	3.2	8.0	16.5	1.6	1.3	56.7	4.0	1.7	1.2	1.2	1.3	28.2	5.1	10.3	11.5	2.1	1.8	1.3	16.0	0.8	3.0	4.4	2.0	1.9	8.8	0.5	15.1	1.6	0.7	22.4	12.5	1.2	1.4	13.1	2.5	3.7	2.2	3.9	16.1	1.1	8.0	3.1	45.3	4.1	4.3	23.1	13.7	0.6	0.3	0.6	44.1	5.5	5.7	14.7	5.9	24.4	0.8	7.0	3.2	1.5	24.1	8.3	3.2	8.3	6.3	0.0	0.4	0.0	1.4	4.2	9.3	0.0	0.1	2.6	6.1	8.6	5.0	3.3	0.7	0.0	0.9	1.7	2.8	1.0	0.0	0.1	8.9	3.1	0.7	0.0	1.0	36.1	40.9	0.1	2.1	0.2	1.6	6.5	0.7	45.6	6.6	0.1	1.7	5.3	2.5	0.6	8.7	12.1	2.0	4.4	0.8	0.0	2.1	11.2	16.5	40.1	10.3	11.8	7.6	37.9	12.7	12.3	10.4	39.3	27.9	21.9	120.4	17.5	13.1	4.1	8.1	17.4	1.3	1.9	4.6	1.7	1.2	1.3	2.1	1.8	2.0	1.4	2.2	4.1	2.0	6.4	6.8	0.3	28.0	1.1	3.2	3.7	13.1	1.1	1.9	2.2	2.7	20.0	2.9	33.1	0.0	9.2	7.1	34.9	5.9	46.9	2.0	45.3	7.5	5.9	10.8	2.7	0.1	1.8	29.1	3.7	7.7	52.4	0.0	2.4	0.7	2.6	4.7	0.0	0.4	43.0	18.3	12.3	11.1	2.1	0.0	8.9	7.2	3.7	38.5	1.3	18.6	0.5	3.5	6.9	7.8	0.0	18.5	2.5	18.3	17.2	7.7	0.5	6.6	2.4	5.5	0.9	1.1	21.5	5.4	4.1	5.7	0.5	22.0	0.5
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341772-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.4;monocytes: 559.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"		"HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217"	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	36.7	33.2	23.5	47.0	24.3	30.7	31.3	24.5	23.0	32.5	23.2	36.0	62.1	32.7	18.1	27.7	31.6	33.8	33.6	21.1	24.1	28.9	35.5	36.4	62.8	25.9	24.8	35.2	40.1	40.7	25.8	30.7	25.3	31.4	30.2	31.7	41.8	28.5	52.8	29.3	56.9	21.1	24.2	54.7	36.6	52.0	24.5	46.2	47.3	32.4	40.6	30.2	28.0	26.7	78.0	34.8	45.9	26.9	47.0	56.6	38.7	61.2	55.8	45.5	52.2	34.2	67.3	84.5	78.5	38.8	58.3	38.0	27.9	40.0	29.2	74.2	46.4	30.8	32.1	21.9	65.2	72.0	38.0	36.4	46.4	32.9	31.3	56.4	30.6	41.4	81.5	2.5	37.3	42.0	126.9	55.0	73.0	79.4	45.6	69.4	47.9	12.8	33.3	37.9	42.9	71.8	116.3	48.7	60.4	31.7	33.9	40.6	62.7	38.2	13.7	51.8	58.9	78.5	64.0	73.7	77.9	60.6	64.4	18.2	20.5	28.5	25.9	27.1	30.8	26.9	22.6	26.6	18.1	26.0	24.5	23.5	37.6	33.6	34.9	25.2	19.8	23.8	23.5	24.3	24.5	23.0	21.1	24.1	25.9	24.8	25.3	24.2	24.5	26.7	61.0	73.7	66.4	14.0	52.7	24.9	33.8	36.4	39.9	38.4	31.0	32.3	57.4	34.3	51.4	25.8	12.5	49.3	91.8	53.4	60.7	52.1	249.4	59.5	46.5	45.8	29.3	17.1	13.6	69.8	43.0	42.3	29.0	47.9	72.2	45.1	33.2	40.5	30.0	48.8	19.4	40.9	18.3	37.1	45.8	34.2	44.1	46.7	16.0	18.7	559.4	57.7	74.2	11.1	23.0	52.3	20.5	41.0	22.3	48.7	56.5	37.8	55.7	41.4	26.3	39.5	43.3	160.4	12.5	25.8	29.0	50.1	60.0	40.2	26.0	33.1
NUBP2	"CFD1, CIAO6"	ENSG00000095906	"Nucleotide binding protein 2"	Q9Y5Y2	16	1782932-1789186	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041704	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA041704: AB_10804006"	"unprognostic (1.94e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.83e-2)"	19.4	34.3	18.2	10.6	19.7	16.6	17.6	19.5	25.5	21.6	26.5	21.9	14.5	18.7	3.8	30.8	17.1	5.9	20.8	17.6	17.1	26.4	53.2	18.0	16.0	21.3	18.4	17.7	34.2	8.3	18.7	10.9	18.9	25.6	4.2	3.4	22.4	10.4	27.9	25.8	20.5	6.7	18.9	26.8	27.2	10.1	19.7	14.0	18.9	8.2	6.4	20.8	20.1	19.8	28.6	91.4	16.2	49.6	12.1	9.2	50.9	32.2	14.8	20.7	23.3	56.1	41.5	45.0	38.1	7.4	15.2	32.6	10.8	31.6	3.8	39.6	85.7	19.6	67.2	83.0	23.6	30.2	38.2	13.1	26.6	16.9	12.1	13.0	26.2	54.9	49.4	29.6	8.7	109.1	58.8	53.7	44.2	26.4	52.6	80.0	33.4	106.1	16.7	21.1	58.4	70.4	31.9	50.4	38.1	4.2	75.5	35.9	29.8	33.8	42.6	31.9	34.1	65.1	44.9	54.4	20.4	36.0	44.2	72.3	58.1	59.8	64.9	61.6	59.2	48.5	56.5	57.7	62.3	47.6	47.1	45.0	29.7	57.9	60.7	87.5	84.2	67.9	18.2	19.7	19.5	25.5	17.6	17.1	21.3	18.4	18.9	18.9	19.7	19.8	41.0	16.0	30.9	9.4	38.4	35.8	39.4	75.8	24.5	36.0	52.2	65.9	24.9	42.9	43.7	31.3	20.9	103.9	55.5	40.2	66.5	64.7	33.1	23.1	32.7	35.1	38.2	36.4	6.2	74.3	83.0	38.0	32.6	24.5	20.3	48.6	31.8	65.0	62.2	23.5	7.4	51.7	54.9	39.3	28.8	90.9	36.7	27.9	58.7	7.5	55.1	54.4	68.0	6.0	11.0	63.7	30.4	30.9	38.0	45.0	65.4	67.1	22.2	42.5	46.0	28.2	43.3	34.0	30.6	44.7	41.5	41.3	42.0	49.6	58.2	32.2
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712822-205750182	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	63.3	57.2	88.6	43.3	98.3	33.4	72.8	86.2	102.7	70.8	53.7	52.5	29.5	83.4	62.0	54.4	71.8	46.7	98.3	80.7	88.8	70.4	104.2	48.7	61.2	93.8	87.8	108.9	41.2	96.1	39.0	49.6	94.1	71.7	48.1	81.4	46.8	71.1	113.7	51.4	33.2	69.8	94.6	56.5	43.0	25.8	87.9	97.4	98.1	101.6	60.7	47.8	45.2	115.8	223.5	134.6	354.2	140.8	96.0	131.7	166.1	157.3	161.3	215.6	172.6	74.4	250.0	246.1	89.0	154.2	68.2	160.0	272.6	131.9	245.7	118.6	135.8	160.3	113.2	81.8	70.6	255.0	54.9	105.1	116.9	128.6	221.7	115.6	171.4	156.3	261.9	76.7	170.7	258.1	233.2	128.0	363.0	88.9	99.4	239.1	436.4	141.1	121.4	135.4	146.9	270.9	232.2	183.3	127.5	272.4	280.3	189.9	172.8	164.5	144.8	190.0	282.8	69.9	88.0	192.6	112.8	140.5	226.2	5.6	3.2	3.9	9.1	4.9	8.8	5.6	8.3	8.0	4.6	6.9	10.1	10.7	0.6	10.7	4.2	7.3	5.5	3.8	88.6	98.3	86.2	102.7	80.7	88.8	93.8	87.8	94.1	94.6	87.9	115.8	258.4	214.7	283.4	73.4	179.5	258.1	277.4	212.9	282.9	356.2	221.2	229.7	412.4	318.8	241.8	303.5	73.0	301.5	174.5	125.5	385.4	202.5	61.3	227.0	410.3	254.5	179.0	324.2	85.9	171.5	381.3	356.5	131.0	299.5	215.4	329.0	258.5	668.2	264.1	316.3	88.7	219.2	116.0	216.8	266.4	52.6	512.0	164.0	174.3	71.2	162.1	546.9	195.7	56.8	126.2	117.2	113.2	485.2	128.2	295.3	49.4	384.5	187.8	200.2	315.5	458.0	358.1	70.0	104.1	321.4	243.9	177.2	190.5	443.9	265.1	220.8
NUDCD1	"CML66, FLJ14991"	ENSG00000120526	"NudC domain containing 1"	Q96RS6	8	109240919-109334121	"Predicted intracellular proteins"	Immunity	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023183	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		7300	"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA023183: AB_1854695"	"unprognostic (5.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (1.39e-5)"	"prognostic unfavorable (4.37e-5)"	"unprognostic (2.13e-1)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.65e-1)"	11.1	5.0	3.3	6.0	3.5	1.3	9.5	3.7	4.2	7.7	3.1	5.5	2.8	7.2	5.2	5.7	6.9	4.8	6.6	3.3	3.5	7.8	6.4	7.0	9.3	3.7	3.6	6.3	6.9	5.8	4.2	15.1	3.4	5.9	6.7	4.7	6.1	6.8	6.1	4.3	5.1	7.9	4.1	7.3	5.8	13.0	3.4	10.1	9.0	9.3	8.5	11.4	6.8	3.8	28.9	16.7	24.7	13.7	13.1	18.0	13.1	20.6	24.8	57.8	54.4	17.6	21.8	18.5	13.1	22.5	16.3	17.1	36.3	34.3	79.8	23.6	12.6	28.8	9.9	19.6	27.2	13.7	10.6	12.7	18.4	28.1	40.3	18.3	53.0	22.7	32.2	9.5	49.5	23.3	33.3	15.1	17.3	59.7	22.7	21.4	20.4	18.3	35.6	14.8	20.5	18.1	9.4	26.1	21.6	25.6	19.2	9.9	14.2	28.2	17.2	12.1	17.6	6.9	9.4	22.3	10.4	22.2	24.1	0.0	0.4	0.5	0.8	1.3	1.4	1.2	1.0	1.6	1.4	1.1	1.1	1.6	0.0	1.7	1.7	0.9	1.5	0.7	3.3	3.5	3.7	4.2	3.3	3.5	3.7	3.6	3.4	4.1	3.4	3.8	25.4	3.2	10.0	6.2	11.3	17.7	24.4	19.4	10.2	5.0	7.4	6.3	11.3	2.8	23.2	3.7	6.2	23.4	9.7	2.5	7.9	17.1	122.3	11.2	19.2	26.5	9.0	14.5	22.9	11.0	21.2	16.2	5.6	10.2	17.7	11.8	8.9	6.2	9.8	5.0	23.5	5.7	14.2	4.7	11.5	22.5	13.1	8.7	7.2	13.1	16.9	4.4	5.2	15.1	15.3	14.1	4.7	6.8	12.1	29.6	3.4	13.0	15.4	9.0	0.0	13.7	15.8	53.3	36.4	8.9	16.8	8.2	9.5	12.5	9.9	22.7
NUDCD3	"KIAA1068, NudCL"	ENSG00000015676	"NudC domain containing 3"	Q8IVD9	7	44379119-44490658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019136, HPA019528, HPA019529"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374"	"unprognostic (3.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.18e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.50e-2)"	2.9	2.8	6.8	1.3	9.0	2.8	2.8	3.2	7.2	2.5	0.0	2.4	1.2	2.2	2.4	2.7	3.5	2.2	7.5	6.6	5.1	2.2	1.8	2.4	2.2	4.4	5.5	3.1	3.3	3.7	1.8	1.7	5.6	2.8	1.8	4.8	2.4	3.3	8.2	3.1	2.0	3.0	3.9	1.9	2.7	3.9	5.6	2.1	2.7	5.7	2.2	2.3	1.8	6.3	2.6	4.9	3.4	6.3	4.2	3.4	1.3	4.1	4.0	4.8	4.9	3.3	1.8	8.1	3.0	5.5	6.6	3.0	4.8	5.6	2.8	4.8	4.9	2.2	2.9	2.3	3.8	3.9	1.3	3.1	3.7	3.6	4.1	2.8	5.9	2.4	6.1	2.6	3.6	2.3	1.6	3.7	4.3	2.5	6.3	2.3	3.7	3.0	2.7	4.0	3.6	10.6	2.4	4.5	1.8	3.4	3.4	5.7	5.7	3.3	3.4	2.2	3.3	7.3	8.1	4.0	3.6	4.5	5.9	0.6	0.8	0.9	1.0	0.8	1.1	1.0	0.9	0.9	0.7	1.0	0.9	0.9	0.5	0.8	1.0	0.6	1.0	0.9	6.8	9.0	3.2	7.2	6.6	5.1	4.4	5.5	5.6	3.9	5.6	6.3	30.5	12.8	19.2	35.9	26.4	11.3	13.0	16.5	20.5	40.9	29.3	25.3	44.5	17.2	16.0	38.6	54.2	19.6	21.9	22.7	23.5	29.6	87.7	27.4	34.4	25.3	17.4	22.3	59.6	21.6	18.1	23.9	23.9	30.9	9.5	35.8	22.5	32.8	18.3	48.8	58.8	25.1	26.4	17.9	9.5	98.3	30.4	13.9	16.0	46.9	21.2	24.8	34.0	36.2	61.2	27.4	18.8	28.2	14.3	15.9	27.2	26.8	21.9	40.2	32.9	17.8	25.2	106.6	21.1	25.5	16.2	14.4	26.2	18.9	27.8	13.3
NUDT15	"FLJ10956, MTH2"	ENSG00000136159	"Nudix hydrolase 15"	Q9NV35	13	48037726-48047221	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038968, HPA038969"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA038968: AB_10697402, HPA038969: AB_2676295"	"unprognostic (9.48e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.64e-2)"	"unprognostic (9.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.47e-3)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-3)"	12.2	13.0	7.1	10.1	7.2	18.0	16.4	8.6	8.3	12.9	6.9	20.2	20.8	9.7	13.8	16.3	11.6	9.0	11.0	6.9	8.5	17.2	14.1	9.2	7.5	7.2	7.7	8.6	9.4	8.2	9.4	12.6	7.8	15.1	22.1	10.3	12.1	10.0	11.9	8.7	16.3	10.5	6.8	5.5	13.0	10.7	7.6	10.7	13.4	18.7	10.3	12.9	10.3	7.8	47.5	28.4	52.4	23.1	21.2	30.3	37.8	37.7	35.8	41.3	39.7	42.1	45.2	34.6	20.7	30.3	36.7	54.3	51.3	56.1	63.4	18.3	41.8	34.1	28.0	46.2	19.8	52.0	31.2	20.9	35.3	33.3	46.7	18.4	45.3	34.5	30.7	13.5	67.2	23.2	40.5	48.4	83.0	72.8	32.2	27.6	33.8	22.7	46.2	35.8	31.4	33.1	25.6	43.8	30.3	44.7	22.5	38.7	23.0	28.5	34.7	36.2	53.3	6.9	12.5	43.6	14.8	40.1	47.4	1.6	4.8	3.5	2.9	6.9	2.9	3.1	4.6	3.6	4.9	2.6	5.3	5.8	1.0	2.8	4.8	3.7	3.4	2.7	7.1	7.2	8.6	8.3	6.9	8.5	7.2	7.7	7.8	6.8	7.6	7.8	12.0	12.8	15.7	0.7	14.7	16.6	34.6	18.1	19.9	9.2	14.0	11.6	12.5	12.8	20.7	7.3	2.1	36.2	12.6	30.4	49.0	17.3	16.7	45.7	20.4	15.1	8.4	10.5	3.9	17.6	79.4	12.8	18.3	39.5	9.5	8.7	7.5	17.4	16.8	38.7	3.1	23.5	26.4	7.8	10.5	9.3	16.8	11.4	10.6	1.9	10.3	10.8	6.2	0.5	3.0	16.4	18.3	12.4	16.8	41.9	18.9	40.8	13.6	9.0	0.0	9.5	17.1	8.9	34.4	34.9	20.5	38.0	13.2	15.3	31.9	42.0
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 179.8;Proximal enterocytes: 334.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 41.7;eosinophil: 47.0;intermediate monocyte: 54.6;myeloid DC: 32.4;neutrophil: 34.0;non-classical monocyte: 63.4"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.4;granulocytes: 47.0;monocytes: 63.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA		38000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 18: U-2197 - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"		"HPA060452: AB_2684279, HPA062492: AB_2684781"	"unprognostic (4.85e-3)"	"prognostic favorable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	30.6	19.0	39.3	15.2	40.1	10.4	22.9	35.9	49.3	17.1	28.6	25.6	22.2	19.4	11.0	11.1	22.7	9.8	32.9	34.1	38.3	27.7	33.8	26.2	12.3	40.7	39.6	25.2	14.7	48.6	15.8	8.1	40.9	17.8	19.5	18.8	16.1	13.6	24.7	11.6	57.6	12.6	41.7	36.0	21.3	12.2	41.2	6.7	24.4	24.5	10.1	20.9	14.0	40.8	20.8	10.8	17.5	9.2	34.3	31.0	8.1	16.5	15.1	10.9	11.3	16.8	9.0	3.4	14.1	15.4	21.5	14.8	15.7	10.4	17.3	10.4	11.5	8.7	15.3	16.4	22.0	14.9	15.4	27.8	9.0	7.2	19.5	9.7	17.2	0.0	10.2	17.4	10.7	21.5	0.0	4.0	13.6	20.6	16.0	11.6	12.6	26.1	10.8	16.6	8.6	15.0	9.9	9.9	15.6	14.7	21.6	11.7	17.1	17.7	7.6	32.8	13.0	17.1	18.1	0.5	11.5	11.2	10.0	7.2	41.7	47.0	6.0	54.6	6.2	11.2	6.0	5.5	32.4	10.5	5.3	5.4	34.0	9.8	63.4	4.3	10.7	17.4	39.3	40.1	35.9	49.3	34.1	38.3	40.7	39.6	40.9	41.7	41.2	40.8	56.1	16.0	41.1	4.6	13.0	8.4	12.3	21.1	10.8	22.8	22.2	20.2	85.2	44.3	23.9	20.2	8.4	21.0	11.5	58.8	68.4	24.7	77.8	27.2	25.5	33.0	25.3	17.9	5.6	36.9	26.1	27.8	36.2	33.1	19.6	23.0	78.1	107.5	65.1	43.7	3.0	74.7	18.3	179.8	25.3	37.5	26.4	73.6	17.8	3.7	64.6	14.2	17.5	3.0	4.6	31.1	66.7	39.5	14.3	19.5	334.3	109.4	19.8	19.2	26.3	22.1	30.7	28.2	6.3	15.4	5.4	7.3	15.1	68.2	48.5	16.0
NUDT18	"FLJ22494, MTH3"	ENSG00000275074	"Nudix hydrolase 18"	Q6ZVK8	8	22106874-22109419	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028581, HPA030125"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus"	"HPA028581: AB_10601381, HPA030125: AB_2673324"	"unprognostic (9.90e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (4.88e-3)"	"prognostic favorable (2.49e-6)"	"unprognostic (1.29e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.32e-1)"	7.4	6.4	5.1	4.8	5.2	4.4	6.7	5.4	5.5	4.9	4.3	5.7	6.5	5.4	12.9	8.0	5.3	4.2	4.8	5.4	4.8	6.8	5.6	6.1	8.8	5.3	4.8	2.3	17.0	2.7	9.1	2.7	5.7	7.8	4.7	1.2	8.5	4.6	2.3	7.1	7.6	3.6	4.4	10.4	8.9	7.7	5.4	6.8	8.2	1.2	6.3	5.7	5.5	4.6	8.1	16.8	0.5	3.6	12.4	4.6	9.0	4.8	12.6	6.1	7.0	4.0	6.3	6.0	7.5	5.7	15.5	13.8	2.3	7.7	2.0	7.5	2.3	5.1	4.9	3.9	8.3	1.7	15.2	8.5	7.2	2.4	6.4	7.9	7.7	13.0	3.8	9.9	6.0	8.6	6.9	4.6	0.9	4.8	4.1	3.0	1.5	6.5	9.0	7.1	1.8	2.8	3.3	4.0	4.2	3.7	9.4	8.3	6.4	4.0	2.2	5.4	2.5	4.4	0.5	1.9	7.0	4.5	9.8	0.0	1.5	3.0	2.2	1.6	2.1	1.4	1.8	1.3	1.0	2.0	2.0	1.1	0.3	4.0	1.3	1.9	0.7	0.9	5.1	5.2	5.4	5.5	5.4	4.8	5.3	4.8	5.7	4.4	5.4	4.6	5.6	3.2	2.2	1.0	7.3	2.0	3.4	5.2	1.2	3.3	5.9	4.6	1.9	8.6	3.0	5.5	0.0	6.7	6.8	12.5	5.9	9.5	14.6	5.9	2.4	4.7	3.0	5.2	1.6	13.6	9.6	5.9	6.1	4.1	0.0	6.3	5.7	4.0	14.5	3.3	1.7	10.9	2.0	16.8	1.3	15.1	3.1	9.0	5.4	2.8	15.3	4.1	19.6	0.5	1.6	10.1	14.6	3.4	6.2	4.6	41.2	13.6	7.0	1.2	0.0	3.1	3.7	3.5	2.7	6.3	1.8	3.1	7.9	5.3	7.0	2.3
NUDT19	RP2	ENSG00000213965	"Nudix hydrolase 19"	A8MXV4	19	32691961-32713796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042761			Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA042761: "	"unprognostic (1.20e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.35e-3)"	"unprognostic (6.61e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.35e-4)"	5.1	11.7	4.0	4.1	4.1	8.4	4.6	3.9	4.5	3.9	9.4	6.9	7.1	3.6	5.4	11.1	3.6	2.9	10.6	4.1	5.1	6.3	6.9	6.4	5.8	4.6	4.3	3.7	8.4	7.1	4.0	4.5	4.8	7.5	7.3	8.3	6.9	3.5	23.9	8.9	6.2	4.3	4.3	5.2	8.1	2.8	4.6	3.1	3.6	13.0	5.1	6.3	5.6	4.6	21.5	24.7	2.7	24.0	8.1	10.5	0.2	11.9	4.4	8.7	8.2	14.0	11.6	0.1	14.0	13.8	6.7	13.7	16.7	13.9	11.4	24.8	10.0	27.7	9.3	5.0	11.2	20.9	8.2	8.5	18.1	7.4	17.8	10.1	13.0	4.2	21.6	15.3	15.9	14.3	0.1	19.3	2.9	5.9	11.5	0.1	5.2	12.1	14.4	15.7	10.7	15.4	21.2	17.7	15.9	4.7	9.8	25.4	10.4	11.9	7.7	12.0	21.5	17.8	16.3	6.9	14.4	20.0	11.2	11.1	26.5	15.4	18.2	36.7	20.0	13.0	18.9	22.6	19.5	9.4	14.9	20.4	5.1	32.2	42.4	15.9	23.6	11.9	4.0	4.1	3.9	4.5	4.1	5.1	4.6	4.3	4.8	4.3	4.6	4.6	5.9	12.8	14.5	7.5	6.4	21.9	9.4	4.6	8.0	14.5	12.0	6.6	22.8	2.8	6.2	7.3	12.5	11.0	9.1	10.6	27.4	2.9	7.7	8.5	9.3	7.3	12.1	10.3	5.9	11.5	11.5	6.6	3.1	10.7	1.3	11.3	13.2	12.5	14.3	3.3	6.7	12.7	8.2	17.6	11.6	3.7	4.1	10.2	12.4	4.7	10.7	4.6	4.1	6.6	7.4	12.0	13.1	9.4	4.1	12.0	15.7	18.8	6.5	30.4	0.0	6.9	7.4	1.6	2.2	9.9	31.5	7.8	9.1	22.3	18.4	10.6
NUDT2	APAH1	ENSG00000164978	"Nudix hydrolase 2"	P50583	9	34329506-34343711	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004684, HPA044903, HPA058623, HPA067639"	Uncertain		Approved	Nucleoplasm		NA	NA		65000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877"	"unprognostic (2.74e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.55e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.91e-1)"	21.7	32.0	36.6	10.6	37.9	14.9	26.0	37.4	47.3	26.4	33.6	29.0	16.3	22.3	35.8	26.0	25.2	13.9	28.2	35.8	37.5	23.9	27.0	13.6	17.3	37.5	37.0	34.8	34.5	19.4	30.8	18.1	37.1	26.8	19.0	20.8	21.1	15.6	44.0	25.7	18.6	18.4	38.1	20.2	25.5	16.2	37.4	23.7	7.1	15.0	18.0	28.4	22.6	40.4	59.3	24.2	30.8	10.9	20.7	37.7	22.0	28.1	62.7	31.8	33.0	16.5	27.4	16.7	22.8	35.0	12.2	25.4	28.1	68.7	32.1	61.7	24.8	35.2	44.6	31.4	61.1	28.1	13.9	38.5	45.1	41.4	77.0	43.3	66.2	55.9	10.3	64.7	46.9	36.8	29.1	26.1	19.4	26.8	67.7	36.7	19.2	41.7	31.3	19.2	6.3	24.9	45.1	16.9	27.3	27.4	14.0	29.5	43.2	27.1	24.4	18.0	29.8	14.9	25.7	28.8	33.9	26.0	35.4	20.8	16.2	13.0	14.7	14.6	20.6	22.6	23.9	19.0	20.7	22.2	27.2	23.8	5.8	19.9	15.1	19.1	27.1	15.7	36.6	37.9	37.4	47.3	35.8	37.5	37.5	37.0	37.1	38.1	37.4	40.4	26.3	3.2	4.1	9.1	17.0	28.2	20.5	44.6	14.2	13.6	39.1	53.1	24.9	37.1	20.6	16.5	6.2	39.0	16.7	20.2	88.0	26.7	11.4	20.2	18.5	24.7	22.2	21.0	6.9	40.0	37.8	21.5	13.7	11.5	13.3	21.6	28.5	36.2	36.9	8.4	7.7	34.7	14.2	31.1	23.0	26.8	27.4	20.3	23.2	11.2	25.8	25.9	18.6	12.5	19.0	32.6	26.5	19.2	31.8	18.5	28.7	65.4	25.4	16.5	26.3	21.0	23.9	39.7	19.2	25.0	31.5	18.9	17.8	35.0	30.0	23.6
NUDT22	MGC13045	ENSG00000149761	"Nudix hydrolase 22"	Q9BRQ3	11	64225941-64230686	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039334, HPA053464"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA039334: AB_10795174, HPA053464: AB_2682160"	"unprognostic (2.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.61e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.76e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.54e-2)"	21.0	34.7	12.2	12.6	13.2	16.2	21.7	14.0	18.1	19.1	15.4	39.2	30.2	18.5	4.6	34.2	18.5	9.0	52.0	12.2	14.0	43.8	48.8	22.0	17.3	14.1	13.3	15.7	45.4	14.1	24.9	10.3	13.0	26.1	8.3	1.1	30.6	14.8	42.4	27.2	36.3	6.0	13.4	41.9	38.1	10.8	14.8	12.9	31.6	19.7	10.4	26.0	21.5	12.7	35.5	22.7	5.4	22.6	8.1	9.7	20.1	15.0	15.1	10.3	9.5	14.8	29.1	16.6	38.4	14.6	15.5	36.1	3.2	23.0	1.3	21.6	9.2	22.6	15.6	15.4	24.2	14.9	35.5	15.2	16.9	10.8	11.7	7.9	16.9	19.5	11.1	17.7	12.2	53.1	20.4	27.1	8.5	21.5	47.0	25.1	9.2	62.4	17.9	19.4	12.6	19.9	12.8	47.8	58.8	2.1	48.9	16.3	15.9	17.0	16.2	54.5	12.6	66.2	28.5	10.6	58.7	17.0	20.4	40.6	69.1	52.5	53.4	88.7	48.1	63.4	47.0	52.8	72.7	77.3	40.8	44.7	42.7	52.1	86.2	121.4	64.9	52.1	12.2	13.2	14.0	18.1	12.2	14.0	14.1	13.3	13.0	13.4	14.8	12.7	18.8	3.2	14.6	5.5	42.6	12.0	28.9	78.8	19.4	14.7	34.6	30.1	3.7	48.6	36.6	40.5	12.5	107.9	51.5	94.1	164.4	61.8	15.5	19.0	27.2	20.3	37.2	14.5	4.8	87.4	50.9	20.1	47.4	27.8	15.2	15.5	23.2	54.3	57.7	30.3	5.6	98.1	61.1	50.1	21.8	9.6	20.2	40.0	33.8	4.7	70.8	26.5	49.4	1.5	3.5	68.0	93.0	19.5	65.8	33.6	133.5	144.8	13.6	18.0	13.1	20.2	45.0	6.6	8.2	34.3	17.5	67.5	37.5	43.6	73.6	33.0
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165330-12196144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	35.1	32.4	23.0	30.6	26.4	24.1	26.7	27.5	30.5	24.6	29.5	32.0	27.5	14.3	23.7	40.7	24.6	18.4	14.9	23.4	26.0	36.3	88.8	26.0	39.3	27.3	24.9	18.0	25.9	33.1	35.5	31.1	27.4	21.0	36.0	27.4	25.1	14.0	6.2	33.2	25.4	17.6	25.0	34.2	22.6	13.1	25.4	53.5	27.8	7.6	47.4	28.9	27.8	31.8	136.4	98.0	114.6	107.1	107.5	105.6	100.8	96.9	61.5	111.9	119.1	142.5	125.9	134.2	82.4	79.2	70.0	133.1	162.0	150.6	102.1	110.8	160.8	111.9	114.3	209.3	112.0	77.1	75.2	111.7	88.4	122.3	61.7	86.3	144.9	209.4	153.5	88.9	103.2	123.8	143.5	87.0	100.4	215.0	60.1	128.0	42.4	157.2	106.0	46.1	56.6	82.3	117.4	90.8	142.2	132.0	155.9	77.9	91.6	47.0	90.6	134.3	121.9	74.3	141.6	179.3	99.7	97.3	36.0	29.6	60.8	115.2	69.9	65.7	80.4	72.7	73.9	82.6	87.6	64.6	50.4	68.4	163.8	57.4	52.2	149.2	123.4	71.6	23.0	26.4	27.5	30.5	23.4	26.0	27.3	24.9	27.4	25.0	25.4	31.8	42.1	25.6	55.1	23.2	43.8	43.0	57.8	121.2	28.5	21.1	28.6	30.7	4.5	32.9	72.3	23.9	16.7	82.6	49.8	35.0	74.3	82.2	35.3	61.1	44.4	42.6	38.3	43.5	34.6	82.9	150.6	40.3	33.1	31.9	31.7	41.4	41.7	131.8	128.7	21.9	38.2	41.2	79.3	41.8	32.2	11.7	39.4	39.7	30.2	12.2	85.0	37.4	62.8	34.2	41.2	73.8	35.2	29.0	66.1	33.7	52.6	130.6	103.9	25.5	32.9	21.2	40.1	20.2	33.6	52.4	60.5	58.1	49.7	54.4	57.4	46.9
NUDT7		ENSG00000140876	"Nudix hydrolase 7"	P0C024	16	77722492-77742260	"Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Proximal tubular cells: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 49.7;U-698: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042042	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	Nucleoplasm	"HPA042042: AB_10806232"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (5.36e-11)"	"unprognostic (1.19e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.42e-2)"	14.4	23.6	5.9	5.2	6.0	2.2	9.2	6.4	7.4	5.8	15.6	12.0	10.8	7.8	17.5	6.6	10.2	6.8	37.6	5.6	7.8	22.1	70.1	6.1	8.9	5.5	5.4	7.3	9.5	16.3	6.0	4.5	6.0	6.6	12.3	9.7	9.0	7.2	8.1	9.0	8.7	7.4	5.3	7.0	7.5	8.7	6.8	6.4	11.8	12.1	9.1	8.2	5.8	6.1	2.1	7.0	6.2	3.5	28.4	7.2	5.8	1.8	9.1	2.7	3.5	2.0	8.8	10.3	6.6	6.9	6.5	6.9	4.7	7.6	1.6	3.3	6.4	0.1	0.4	9.6	3.1	7.1	1.4	12.2	9.4	1.5	5.3	1.2	4.8	14.7	7.6	4.4	1.1	19.1	3.7	16.8	6.6	12.4	1.7	7.8	0.8	3.1	14.1	0.0	5.1	5.0	6.5	2.6	5.7	10.6	18.6	49.7	3.7	3.1	0.4	1.4	0.3	0.0	0.0	40.6	12.1	8.8	0.0	3.8	12.4	1.7	12.6	17.5	14.4	14.2	14.8	15.1	10.2	19.8	19.5	13.5	2.0	3.5	17.5	11.7	31.5	8.8	5.9	6.0	6.4	7.4	5.6	7.8	5.5	5.4	6.0	5.3	6.8	6.1	8.3	16.0	8.7	12.7	4.1	9.7	6.5	14.6	14.2	2.5	10.9	14.5	17.9	18.6	7.9	14.7	0.0	20.3	7.9	12.1	58.7	8.0	11.6	19.5	4.7	8.2	6.7	3.6	4.3	9.5	9.1	8.5	3.6	6.6	1.3	7.0	5.3	41.2	5.9	6.7	5.6	6.6	10.2	9.2	4.4	4.6	5.6	4.1	8.8	1.9	2.1	25.0	10.3	3.5	2.7	4.0	10.4	4.9	1.1	2.0	22.6	42.2	21.0	7.3	6.6	7.1	8.9	14.2	20.0	12.2	13.9	6.7	6.9	10.7	14.8	4.5
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2 component of NDC80 kinetochore complex"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 28.4;lymphoid tissue: 26.0;testis: 53.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 60.8;Spermatocytes: 208.2;Spermatogonia: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059692, HPA076604"			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.04e-5)"	"prognostic unfavorable (9.16e-4)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	0.8	0.6	0.5	6.9	0.8	28.4	1.2	0.5	0.8	1.0	0.4	4.2	4.3	1.1	0.3	5.8	0.4	1.0	0.3	0.6	0.6	0.3	0.7	0.9	18.2	0.9	0.8	0.4	0.2	0.6	0.2	4.7	0.9	0.4	5.3	1.5	0.9	0.3	0.1	4.1	4.3	2.3	0.7	3.6	2.6	53.5	0.8	26.0	0.5	0.2	16.7	1.8	1.8	1.0	90.8	30.8	80.5	33.9	2.5	8.1	43.6	55.9	39.3	88.9	77.3	23.7	77.7	77.4	45.5	22.6	37.0	51.6	49.6	21.0	111.5	81.4	35.6	30.3	34.8	34.4	0.3	53.0	60.2	1.0	2.0	45.0	31.6	16.8	41.1	74.5	58.1	103.9	85.0	17.6	97.3	70.6	43.9	66.1	47.0	65.0	70.3	68.4	25.3	12.4	59.9	68.9	29.9	32.2	30.6	49.7	49.3	109.5	29.4	65.9	73.8	50.1	115.1	73.9	111.5	148.9	22.0	42.9	74.7	1.4	0.1	1.3	1.2	0.0	0.5	0.6	1.8	1.2	0.2	0.7	1.2	1.0	0.4	1.8	0.1	0.3	4.3	0.4	0.5	0.8	0.5	0.8	0.6	0.6	0.9	0.8	0.9	0.7	0.8	1.0	0.5	0.0	0.5	1.3	5.3	5.9	1.9	4.2	1.2	1.2	1.3	2.7	0.9	0.0	3.3	0.0	0.0	21.7	3.6	2.6	0.0	0.8	17.7	2.5	2.5	1.8	0.0	60.8	1.1	0.2	29.7	3.4	5.6	3.0	4.5	18.3	3.3	0.4	14.0	0.0	1.4	3.3	0.0	5.2	3.6	21.4	2.5	3.1	0.0	1.0	0.9	2.0	6.2	0.5	3.6	0.2	0.1	2.2	17.8	0.8	0.9	0.2	0.7	2.3	6.6	0.9	4.2	208.2	40.3	10.6	2.4	4.0	5.0	1.7	9.0	3.8
NUFIP1	"NUFIP, Rsa1"	ENSG00000083635	"Nuclear FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989471	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	3.2	3.7	3.2	2.8	3.4	7.9	4.6	2.9	4.6	3.6	2.1	2.6	2.8	4.5	5.5	3.3	3.5	2.4	2.5	3.3	3.0	4.0	4.1	2.3	3.7	2.6	3.2	4.3	3.8	4.0	1.8	3.0	2.9	3.4	3.0	2.6	3.3	3.2	4.8	3.4	2.4	4.0	2.9	3.0	2.8	5.5	3.1	3.6	3.9	3.9	3.8	4.2	2.6	3.9	7.4	5.7	9.5	7.9	6.4	6.6	11.3	8.6	7.4	15.6	9.9	15.6	11.5	21.5	7.0	8.0	9.4	11.3	17.9	12.2	20.2	6.6	14.0	16.4	3.7	14.0	10.5	21.3	6.4	6.9	11.0	10.5	15.8	6.0	7.9	10.9	13.3	3.5	11.1	8.5	17.8	13.4	22.5	19.5	9.3	17.3	9.0	13.1	9.5	6.3	5.2	11.5	7.3	9.9	9.6	8.9	7.5	11.8	6.0	7.9	6.8	10.3	11.9	4.8	7.9	26.7	8.9	14.8	11.4	0.0	2.6	0.8	2.5	2.6	4.7	4.0	2.9	2.8	3.4	4.1	4.5	3.4	0.2	5.9	1.8	4.5	1.7	1.8	3.2	3.4	2.9	4.6	3.3	3.0	2.6	3.2	2.9	2.9	3.1	3.9	11.3	6.4	12.2	6.2	10.5	15.4	11.8	16.7	23.9	7.8	9.8	16.3	4.5	4.3	15.4	5.5	12.5	15.7	11.7	4.2	17.6	14.0	37.2	14.0	21.7	10.9	5.4	14.5	19.2	16.7	15.9	11.9	7.7	18.6	17.7	14.1	7.1	9.7	10.8	8.4	16.9	5.3	12.2	3.4	5.5	63.2	10.8	7.9	8.8	7.5	6.9	9.7	7.2	16.6	14.4	10.8	1.6	11.3	5.0	8.6	3.2	14.8	6.6	6.8	6.6	20.3	15.6	27.1	31.6	14.3	16.6	8.8	9.9	15.7	8.4	7.1
NUFIP2	"182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1"	ENSG00000108256	"Nuclear FMR1 interacting protein 2"	Q7Z417	17	29255839-29294148	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 79.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067443			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA067443: AB_2685841"	"unprognostic (6.51e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.04e-3)"	15.3	14.9	4.4	22.7	3.6	79.9	12.5	10.3	20.4	12.7	11.7	14.9	16.2	11.5	11.9	17.2	10.9	14.0	13.6	5.1	19.9	13.0	24.0	21.0	19.8	12.1	14.7	12.0	14.7	18.4	11.0	29.6	11.0	12.1	13.0	23.1	15.5	9.8	15.9	12.1	13.2	10.3	2.1	20.7	18.7	14.2	10.8	18.0	13.5	17.6	17.5	16.4	14.2	14.1	42.5	67.1	38.9	27.2	32.8	38.0	65.1	41.3	24.8	31.1	28.4	75.0	22.5	68.5	60.1	28.5	27.7	58.6	31.4	28.9	39.3	74.0	55.9	51.8	64.7	19.8	30.3	66.6	53.8	33.1	34.5	34.4	36.7	35.9	23.2	24.8	86.2	49.5	32.1	34.8	70.6	30.1	40.2	32.2	24.9	57.2	66.8	29.4	26.1	68.4	37.1	23.5	73.6	136.6	44.6	51.5	47.3	44.2	38.5	59.1	59.1	35.0	71.3	68.4	68.9	79.3	39.0	34.9	51.6	13.6	6.1	8.5	5.6	5.9	4.3	8.5	5.5	6.2	5.2	7.6	7.0	5.9	25.4	5.1	9.6	12.1	3.2	2.3	4.4	3.6	10.3	20.4	5.1	19.9	12.1	14.7	11.0	2.1	10.8	14.1	139.7	80.1	67.0	58.1	76.8	99.5	78.2	40.0	118.4	55.3	105.0	124.8	81.7	38.6	69.3	31.3	95.9	69.2	124.3	72.6	15.6	33.9	35.2	108.2	139.0	85.9	48.3	55.6	47.4	27.9	31.3	86.4	82.6	154.2	46.2	41.2	55.0	54.6	44.6	57.2	47.1	62.5	20.3	74.7	108.8	24.9	35.4	122.9	40.9	41.2	50.0	35.2	37.0	44.7	85.9	37.4	43.1	35.0	65.2	91.8	26.5	27.6	88.8	60.6	19.7	171.7	78.5	36.6	29.8	120.8	97.7	182.0	93.8	51.8	57.1	111.9
NUMA1		ENSG00000137497	"Nuclear mitotic apparatus protein 1"	Q14980	11	72002864-72080693	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019841, HPA019859, HPA029912"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		62000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811"	"unprognostic (1.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.39e-1)"	55.2	59.9	27.8	51.1	45.6	69.6	67.1	37.4	40.5	75.4	36.2	77.7	59.6	111.2	43.3	67.9	82.7	62.7	47.6	24.0	33.0	49.9	29.8	65.4	57.9	40.4	34.3	112.3	68.8	98.6	42.1	60.8	41.9	111.4	54.5	46.2	78.1	85.6	82.5	93.8	61.9	86.7	28.4	56.8	59.0	42.4	36.0	79.3	73.9	54.8	53.2	75.2	65.9	83.4	64.4	80.0	97.2	66.4	85.1	88.2	48.8	85.0	97.2	86.4	74.6	83.9	115.5	86.7	72.0	104.0	61.6	134.2	89.7	85.8	78.0	89.9	43.1	105.8	130.4	64.1	69.1	81.1	74.0	94.0	55.7	84.1	84.3	133.0	74.0	76.7	63.4	101.1	59.4	124.2	105.6	45.2	61.2	122.3	57.6	127.9	170.0	67.6	64.2	98.6	117.3	166.6	134.9	123.5	123.6	42.3	166.4	47.1	103.0	90.6	69.9	130.1	56.9	64.8	69.7	120.0	61.1	38.0	53.0	3.7	4.1	1.9	6.4	2.3	4.7	3.4	4.0	5.0	3.5	5.8	4.9	3.6	2.8	5.0	4.4	8.2	5.2	6.0	27.8	45.6	37.4	40.5	24.0	33.0	40.4	34.3	41.9	28.4	36.0	83.4	52.4	41.7	41.3	42.7	36.6	25.9	30.1	25.3	74.0	60.7	62.3	63.4	5.7	34.3	32.2	53.3	73.0	25.5	42.6	56.3	17.6	27.9	31.9	55.5	48.5	44.9	47.4	43.3	27.5	32.1	13.4	41.9	57.6	92.8	31.0	84.7	37.9	23.6	28.7	52.2	34.0	68.3	32.6	32.1	24.9	17.8	69.0	36.3	19.6	33.7	26.8	51.8	53.5	27.6	58.9	30.9	31.2	50.8	40.8	29.6	57.0	26.9	35.4	59.8	39.5	64.3	36.9	14.8	21.4	51.9	28.1	45.0	44.8	44.2	52.2	26.0
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686951-68745809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: AB_2673992"	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	15.4	11.1	5.0	17.9	6.3	24.0	17.8	8.2	6.0	12.9	6.3	13.0	10.3	16.7	14.3	10.7	13.5	9.3	11.4	4.6	5.0	10.6	11.8	12.8	25.8	5.6	5.7	16.3	9.3	11.8	6.8	13.8	5.5	12.0	16.2	14.7	10.3	12.2	11.7	15.8	12.9	14.0	5.4	15.8	11.0	20.9	5.5	25.6	10.3	12.1	25.5	12.4	10.7	7.6	53.1	66.8	77.8	56.7	22.6	28.6	84.1	56.6	32.4	83.0	68.9	67.6	43.7	96.3	53.7	27.2	36.9	59.4	88.4	41.7	109.8	90.8	65.6	110.1	46.2	57.4	14.2	97.9	35.6	15.2	19.4	66.5	43.2	29.0	50.3	54.9	133.7	67.3	52.8	64.3	81.3	85.2	85.8	20.3	64.6	81.9	93.6	57.8	36.1	55.3	45.7	46.9	62.7	46.5	34.4	60.4	69.8	46.7	31.1	45.0	45.8	53.0	69.9	29.2	62.2	115.2	34.7	70.2	54.2	10.5	9.2	14.4	17.7	12.5	23.4	18.7	17.5	19.3	10.2	18.7	21.5	19.5	2.4	30.5	23.2	8.1	20.0	11.8	5.0	6.3	8.2	6.0	4.6	5.0	5.6	5.7	5.5	5.4	5.5	7.6	18.3	12.8	17.7	13.7	38.1	17.3	18.4	28.1	25.0	23.8	12.5	11.4	13.5	12.8	18.9	9.2	18.8	30.7	30.3	12.2	11.7	22.8	45.3	12.6	18.2	20.6	8.5	64.4	23.8	17.6	30.8	19.6	16.3	10.2	15.8	35.6	15.4	7.0	17.5	13.5	20.1	12.6	42.7	13.9	16.2	9.6	38.8	18.3	19.6	15.9	27.0	16.7	36.0	21.6	34.3	22.1	9.9	21.8	22.9	19.4	10.5	6.4	21.9	29.6	13.1	18.4	18.2	89.4	51.9	18.7	17.6	14.1	27.0	24.5	16.8	12.5
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Spermatocytes: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: AB_2684602, HPA063942: AB_2685156"	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	13.1	15.5	9.5	16.2	10.9	21.4	11.9	13.1	10.0	15.6	10.0	14.8	7.5	13.1	8.0	23.7	11.9	9.4	13.6	9.0	9.7	10.4	9.9	16.7	18.0	11.4	11.1	11.4	12.0	13.1	14.9	11.8	11.8	13.5	11.5	13.7	13.9	9.8	15.7	21.4	13.4	13.9	9.3	16.8	13.6	56.6	10.9	27.3	12.6	10.3	20.4	16.1	15.6	11.7	33.6	62.6	50.8	69.7	37.7	37.2	45.4	45.9	35.9	82.1	54.4	76.3	26.2	58.2	16.7	50.7	52.9	96.6	115.2	56.8	61.0	47.1	55.5	51.9	113.3	60.8	23.9	89.6	50.2	26.0	26.3	86.5	43.8	24.1	47.8	74.1	116.0	40.3	58.8	84.6	77.3	36.5	68.2	63.8	59.4	69.9	109.8	59.2	25.5	37.3	71.2	34.3	118.8	44.7	17.1	37.2	49.3	32.7	39.0	67.7	48.2	69.2	83.5	34.1	67.9	76.9	39.5	56.3	51.2	8.2	4.8	1.7	7.5	8.9	9.7	4.9	6.4	7.4	6.8	4.3	6.4	7.0	0.6	5.4	5.2	2.9	8.3	6.8	9.5	10.9	13.1	10.0	9.0	9.7	11.4	11.1	11.8	9.3	10.9	11.7	9.6	0.0	12.6	15.7	10.4	6.5	6.6	6.4	5.7	16.2	7.6	7.6	3.5	10.0	5.9	5.5	45.9	8.0	8.6	6.0	1.9	6.1	14.5	7.9	13.2	9.4	9.1	8.6	11.3	6.5	6.5	9.5	9.7	12.2	6.3	24.0	11.0	5.0	8.4	20.2	13.1	7.2	6.1	4.7	6.1	5.7	9.6	8.1	1.8	12.2	5.3	6.8	9.2	12.5	13.0	9.0	2.3	11.7	8.3	10.1	3.3	2.5	6.3	24.4	26.3	18.2	7.1	52.9	37.8	13.6	11.2	8.6	9.4	12.5	7.4	8.2
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 151.6;Late spermatids: 424.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	7.7	8.9	5.9	6.9	7.3	4.6	13.1	8.9	7.8	8.5	5.0	7.6	6.3	8.1	7.7	8.7	8.9	6.9	6.2	6.1	5.9	10.2	14.4	5.9	9.1	5.5	5.9	10.4	10.2	8.9	6.3	7.8	5.5	7.8	9.1	9.0	8.4	7.0	7.4	9.0	6.5	8.9	6.6	5.7	7.2	24.2	5.5	10.4	8.2	8.7	11.0	9.2	8.0	6.4	19.7	19.7	32.5	20.5	11.8	11.5	23.2	23.0	18.8	35.3	33.5	37.6	24.7	34.6	22.0	12.4	40.9	17.4	45.4	26.7	57.8	29.6	27.8	32.6	16.4	43.9	8.2	23.6	21.8	8.2	13.8	29.9	28.9	7.9	20.8	20.5	28.7	25.3	27.8	23.7	28.7	29.1	57.9	31.6	61.9	34.3	25.2	25.0	34.0	24.7	29.4	20.3	21.6	26.6	26.0	24.4	17.0	16.2	10.6	28.6	19.7	23.3	26.5	16.4	38.3	37.9	19.3	16.8	39.2	0.0	4.1	1.4	4.9	5.5	8.6	7.2	6.3	6.0	3.2	6.5	7.5	6.7	0.2	5.6	6.6	3.1	6.7	4.1	5.9	7.3	8.9	7.8	6.1	5.9	5.5	5.9	5.5	6.6	5.5	6.4	9.6	9.6	6.8	6.5	10.3	26.0	20.7	17.5	12.5	10.8	9.3	8.9	4.7	14.3	13.8	16.5	18.8	23.6	8.5	3.3	11.7	15.5	151.6	5.3	8.1	10.2	3.6	12.6	11.5	12.7	20.2	10.8	5.1	6.4	8.2	8.1	12.8	12.6	8.4	6.7	12.0	7.5	16.2	4.4	9.9	424.7	9.6	3.6	21.4	2.8	5.0	11.4	7.2	17.1	12.8	11.1	5.1	8.2	7.5	12.8	4.2	14.5	6.9	19.1	13.1	18.7	11.6	39.8	21.1	11.3	27.4	9.4	11.5	9.0	9.6	11.2
NUP37	"FLJ22618, MGC5585"	ENSG00000075188	"Nucleoporin 37"	Q8NFH4	12	102073103-102120120	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056300, HPA073708"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA056300: AB_2683092, HPA073708: AB_2686629"	"unprognostic (1.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.72e-4)"	"prognostic unfavorable (7.70e-6)"	"unprognostic (2.48e-3)"	"unprognostic (2.37e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.67e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-1)"	11.3	14.2	4.1	17.1	4.4	22.7	19.5	5.1	7.8	12.8	2.4	20.1	13.0	11.9	21.5	18.9	19.0	10.9	17.6	4.8	4.5	15.2	13.0	11.6	28.1	3.5	2.8	12.1	8.7	17.4	5.9	16.9	3.4	13.7	23.8	10.9	11.7	13.8	17.5	13.4	14.9	17.7	2.4	12.0	12.9	15.1	4.3	25.7	16.4	15.5	33.5	17.7	9.6	6.3	105.5	74.5	64.2	29.6	51.7	68.4	144.6	64.8	61.0	99.8	68.0	97.4	55.5	70.1	45.4	50.9	68.9	76.2	113.5	101.2	124.4	98.5	65.2	75.6	37.2	86.4	66.0	107.5	22.8	53.4	43.5	78.3	57.3	66.7	83.3	91.2	135.5	25.8	93.9	71.6	79.9	87.9	63.4	96.8	117.2	51.9	92.0	52.8	79.0	76.1	33.6	24.0	49.8	52.7	50.3	72.1	90.7	61.7	27.2	35.7	39.4	51.0	91.1	38.5	78.9	119.4	41.9	86.1	61.8	67.8	24.0	28.3	21.4	29.3	23.2	31.2	25.7	21.9	30.2	28.2	23.0	26.1	7.0	23.9	24.9	25.3	45.4	22.5	4.1	4.4	5.1	7.8	4.8	4.5	3.5	2.8	3.4	2.4	4.3	6.3	12.3	6.4	14.3	8.8	22.6	11.3	20.9	63.8	17.1	8.0	10.5	11.7	9.5	14.3	28.2	16.5	8.4	68.1	17.7	9.1	25.4	24.0	2.9	21.6	17.6	17.2	6.0	38.7	5.8	20.0	92.3	19.9	12.2	11.8	7.6	21.2	13.6	10.0	35.6	3.3	7.3	16.0	22.4	15.2	8.4	6.3	19.6	13.5	7.2	5.6	20.5	18.9	13.4	11.1	12.6	17.2	10.6	18.8	34.1	10.7	11.5	24.6	39.3	20.1	19.7	8.6	18.3	49.0	42.4	25.5	9.5	40.2	18.8	31.9	26.5	16.8
NUP42	"CG1, H_RG271G13.9, hCG1, NLP_1, NUPL2"	ENSG00000136243	"Nucleoporin 42"	O15504	7	23181841-23201011	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;Cardiomyocytes: 20.3;Cytotrophoblasts: 17.1;dendritic cells: 10.5;Extravillous trophoblasts: 11.6;Hofbauer cells: 28.1;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049036, HPA057251"			Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA049036: , HPA057251: "	"unprognostic (3.81e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-2)"	10.8	14.7	12.9	10.8	8.8	20.6	11.4	21.2	13.8	11.2	18.0	11.1	14.9	14.2	15.1	13.6	12.9	13.1	19.7	11.2	10.4	15.1	13.9	10.0	21.6	11.6	9.9	12.0	6.2	17.1	6.4	8.6	8.9	12.1	14.3	8.2	10.7	10.1	11.6	16.4	12.4	15.0	3.6	15.8	11.6	18.9	10.7	19.4	14.4	9.0	18.3	13.2	7.7	22.6	31.1	14.0	21.5	44.5	21.3	25.0	17.8	23.1	16.6	25.2	26.4	21.2	31.9	52.4	22.0	16.1	54.1	41.6	37.9	17.2	32.6	15.9	39.0	32.0	36.5	21.7	24.6	67.4	47.1	11.6	25.5	21.8	14.5	20.4	29.0	22.0	58.9	31.4	25.5	7.7	32.5	54.6	45.1	38.4	21.9	31.6	19.0	40.5	27.1	21.6	33.2	31.2	22.9	14.0	44.9	41.2	17.0	86.3	21.6	16.5	21.8	28.3	39.7	44.9	64.8	52.3	17.6	46.7	44.4	33.2	10.3	8.1	11.0	10.1	10.7	18.8	12.8	12.1	15.0	13.6	10.6	12.7	8.0	17.8	9.3	14.4	16.2	11.1	12.9	8.8	21.2	13.8	11.2	10.4	11.6	9.9	8.9	3.6	10.7	22.6	7.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	17.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	11.6	5.2	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	6.6	1.3	0.0	0.0	0.0
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	8.4	8.6	6.2	11.4	7.5	6.2	13.6	7.2	6.9	9.7	6.5	9.4	8.7	9.8	7.5	9.5	8.2	6.4	10.8	5.6	6.6	9.9	9.6	8.0	15.9	6.6	6.6	9.1	12.2	8.9	5.6	11.4	6.9	10.3	9.7	9.8	8.8	9.2	14.2	13.5	10.9	9.4	6.6	13.6	9.8	7.9	6.5	12.8	11.1	11.6	17.0	9.0	9.1	8.3	21.1	34.9	31.1	49.6	20.0	23.7	48.9	36.3	20.3	34.0	43.0	49.5	19.5	61.4	36.6	20.2	32.1	33.5	54.6	31.6	58.3	27.8	38.2	70.9	35.5	49.6	13.4	73.2	44.1	15.3	16.4	49.9	33.1	13.0	27.5	34.6	71.4	33.6	29.6	20.7	52.2	30.4	28.3	24.1	21.0	50.2	43.2	20.6	23.2	28.9	12.9	21.2	43.4	27.1	14.2	25.6	28.7	30.9	21.3	28.3	30.2	41.2	53.9	20.5	43.3	63.9	25.2	49.3	40.5	2.9	4.9	3.4	3.5	5.4	3.8	4.3	4.2	3.5	2.6	6.2	4.3	5.5	1.9	3.7	4.8	5.0	4.9	2.2	6.2	7.5	7.2	6.9	5.6	6.6	6.6	6.6	6.9	6.6	6.5	8.3	5.8	3.2	7.8	9.1	11.5	7.9	5.5	4.7	2.8	11.9	4.5	5.0	14.3	11.5	5.2	3.7	6.2	10.9	11.3	4.7	3.9	9.0	33.3	4.3	8.7	5.7	10.2	7.6	4.8	7.8	12.2	6.4	6.1	6.0	0.0	12.8	8.2	4.4	7.8	6.7	5.1	6.9	2.0	11.9	6.9	78.9	10.2	6.5	8.8	9.4	15.1	10.5	9.2	11.1	17.4	6.6	2.3	10.5	8.7	6.2	3.9	5.4	4.2	9.5	13.1	6.9	22.1	7.1	9.2	5.5	8.5	6.6	7.6	7.4	8.4	6.7
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163925-45188017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047162, HPA048328"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA047162: AB_2679963, HPA048328: AB_2680360"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	14.1	14.8	8.6	23.3	9.9	54.4	13.5	11.9	12.1	14.3	11.2	18.7	16.6	10.1	18.7	20.5	18.1	14.3	7.2	10.7	10.2	13.7	23.5	14.6	33.7	8.1	8.3	13.9	15.9	15.8	6.7	15.5	7.8	12.2	16.7	10.9	11.7	13.4	7.8	19.0	16.3	11.4	8.0	25.5	24.2	29.8	9.2	46.6	15.2	12.7	35.3	19.3	12.3	9.7	75.8	35.5	67.1	43.7	31.0	31.8	70.9	61.9	41.1	46.9	47.1	77.6	32.9	82.7	28.1	41.0	35.1	52.0	83.4	50.5	67.3	44.3	87.4	72.6	54.8	47.7	32.2	193.7	73.7	38.8	34.1	60.1	45.2	22.7	52.4	71.4	76.5	84.3	49.0	50.8	88.2	50.5	50.4	50.0	36.3	91.8	40.7	58.0	37.0	72.5	41.7	40.4	61.5	37.9	74.0	50.9	23.6	50.3	48.3	99.1	88.6	51.6	52.7	58.4	51.3	119.0	37.1	49.2	70.4	55.1	39.1	80.5	20.3	40.2	27.8	19.5	24.5	23.5	25.5	18.1	28.4	19.6	92.7	30.6	24.2	13.9	25.8	34.2	8.6	9.9	11.9	12.1	10.7	10.2	8.1	8.3	7.8	8.0	9.2	9.7	42.7	9.6	27.9	6.2	32.7	85.5	51.9	26.4	48.3	14.6	26.2	16.3	10.8	22.8	29.6	33.1	12.5	22.6	47.5	34.2	13.7	18.9	46.3	56.3	34.7	29.7	17.4	72.4	16.4	20.9	39.8	21.8	59.1	47.3	34.7	23.9	33.2	38.5	28.1	13.5	15.3	24.4	20.3	47.5	32.8	83.3	14.6	33.4	24.9	11.2	56.9	11.1	42.2	11.6	12.5	29.8	33.5	13.9	49.0	60.8	16.9	22.8	50.0	16.3	26.3	15.9	17.1	45.9	44.3	60.6	89.4	56.6	47.1	23.5	26.3	95.3
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148444	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	17.5	13.1	6.4	15.8	7.1	35.0	23.4	11.9	9.3	22.4	6.2	19.2	16.5	23.5	18.8	18.1	20.0	15.8	12.2	6.6	7.7	15.2	22.2	16.1	22.1	6.4	6.4	24.3	16.6	15.7	7.5	24.4	6.6	18.5	20.6	12.4	14.7	18.4	12.7	19.3	16.0	20.4	7.1	16.6	16.3	21.8	6.3	28.7	20.6	14.2	24.5	21.7	15.0	9.2	42.6	14.2	52.3	37.1	44.2	40.8	45.0	42.1	61.1	62.1	63.1	36.9	58.4	64.4	34.5	42.3	33.4	27.5	57.0	47.6	76.5	42.5	31.1	38.5	19.1	36.7	41.1	75.8	44.1	37.4	33.6	48.8	50.7	27.1	52.8	41.4	67.1	38.9	44.4	35.9	81.0	39.9	81.3	51.2	14.2	61.6	81.0	25.0	37.3	39.1	31.7	26.6	38.6	45.2	35.4	39.5	18.7	47.2	35.5	48.2	43.0	58.8	52.8	25.1	10.0	60.8	35.1	44.5	44.0	10.1	8.8	9.3	13.3	10.7	18.4	9.7	14.0	13.1	12.9	10.9	14.7	14.1	4.1	26.6	12.6	9.5	14.9	8.5	6.4	7.1	11.9	9.3	6.6	7.7	6.4	6.4	6.6	7.1	6.3	9.2	26.1	22.4	16.7	25.5	31.3	35.2	42.8	29.4	32.5	13.8	18.8	19.3	11.8	14.3	17.8	11.0	20.9	41.3	30.5	13.5	29.4	25.1	12.5	24.9	31.6	23.7	14.4	35.7	42.8	27.7	47.5	26.8	17.3	34.4	24.1	23.0	19.2	13.6	21.7	8.4	42.0	20.8	16.2	16.4	24.2	7.4	27.4	20.2	17.8	18.7	28.6	12.8	35.0	34.2	54.2	19.2	17.1	25.9	30.5	34.1	14.4	20.4	19.2	22.2	32.9	24.8	26.5	46.8	39.9	30.2	29.1	39.1	31.8	21.6	24.4	36.1
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 119.2;Late spermatids: 315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes		31000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.9	29.4	14.2	37.3	13.2	27.1	18.9	18.4	15.9	22.5	14.0	22.5	23.7	27.6	11.0	25.0	24.8	18.4	20.4	13.9	15.7	18.5	31.7	19.4	38.3	15.5	14.2	29.8	21.0	18.0	22.8	22.4	15.8	19.9	21.1	11.1	21.8	17.5	33.7	23.4	24.3	27.7	13.6	29.8	19.4	50.4	14.7	41.9	16.3	24.5	37.7	24.6	20.1	16.9	126.7	115.5	88.8	74.0	26.0	30.0	79.7	92.8	65.8	99.3	98.8	79.8	71.9	141.2	51.7	60.8	65.9	73.6	108.3	62.1	96.1	211.6	112.0	109.8	59.4	72.6	30.9	108.8	106.8	28.6	44.8	62.0	54.8	44.1	71.5	82.7	138.6	135.5	69.2	59.7	196.7	83.6	82.0	117.4	102.8	170.3	99.9	120.3	46.9	93.7	96.2	68.8	88.2	103.8	46.3	63.8	78.8	51.5	53.0	150.2	85.3	49.1	155.4	96.3	295.9	132.5	62.2	90.1	113.9	12.3	33.4	6.7	17.7	34.7	24.1	15.1	17.6	19.6	33.1	14.9	11.9	15.4	5.2	22.0	20.1	29.0	17.2	22.1	14.2	13.2	18.4	15.9	13.9	15.7	15.5	14.2	15.8	13.6	14.7	16.9	16.8	25.6	22.4	0.0	28.4	34.2	16.5	16.0	21.1	11.4	23.7	26.0	15.4	21.5	18.3	9.2	6.2	37.0	24.4	24.9	9.8	23.7	113.5	19.2	23.9	27.7	21.6	39.1	0.0	16.3	48.4	19.5	20.4	25.6	23.4	30.4	30.4	13.3	49.5	63.9	0.0	27.0	16.2	36.1	119.2	315.1	24.8	41.5	21.4	0.0	77.1	19.1	22.6	0.0	0.0	22.9	22.8	23.0	23.3	24.1	20.6	16.1	19.2	16.3	19.7	18.0	16.0	71.0	39.3	20.0	32.0	21.8	24.4	17.2	33.4	16.6
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	20.9	12.9	15.2	18.6	15.7	20.8	20.0	21.8	17.0	21.5	15.4	18.7	15.8	20.8	16.1	20.5	20.9	11.6	16.4	15.6	14.7	18.9	22.1	18.7	26.5	15.8	15.1	20.8	18.7	12.1	12.7	19.0	16.0	18.9	21.0	11.2	16.7	14.3	16.7	23.9	20.5	19.6	14.9	25.3	16.9	22.2	15.3	33.2	18.0	14.1	27.0	17.9	19.5	17.0	66.5	74.0	53.4	37.3	20.3	31.5	74.0	47.3	37.4	108.5	101.7	63.2	61.4	61.1	26.6	41.1	70.5	55.9	88.8	50.6	96.1	19.3	70.1	51.0	83.3	56.3	16.6	52.8	40.7	30.3	30.5	76.1	32.8	24.9	84.7	49.0	63.3	38.1	53.8	73.0	100.2	64.8	40.0	82.2	67.4	68.9	115.1	55.5	42.1	47.5	40.6	38.5	58.2	73.7	42.5	59.4	83.3	59.1	30.8	80.2	74.4	52.5	76.3	23.6	21.0	79.2	41.4	47.3	50.6	8.1	24.9	21.5	16.1	22.6	22.9	16.1	17.5	15.9	20.5	21.5	17.0	12.8	8.2	16.7	16.5	22.5	16.6	17.3	15.2	15.7	21.8	17.0	15.6	14.7	15.8	15.1	16.0	14.9	15.3	17.0	13.2	6.4	12.5	7.2	13.9	6.1	8.9	19.1	6.2	7.8	10.3	7.5	9.0	8.6	15.0	7.3	10.4	23.0	11.7	9.1	7.9	16.0	3.7	11.1	13.6	15.0	7.7	16.2	13.5	19.4	22.1	13.8	9.7	10.3	11.4	13.0	21.0	23.1	23.0	6.7	9.9	11.0	16.2	13.3	7.2	3.9	14.3	13.7	8.8	10.3	15.8	4.8	22.6	3.5	10.6	18.3	7.5	9.8	8.6	7.9	8.8	11.7	11.8	8.8	32.9	7.9	19.2	24.9	29.3	7.3	7.1	12.7	10.9	7.4	13.3	8.0
NUP88	MGC8530	ENSG00000108559	"Nucleoporin 88"	Q99567	17	5360963-5419676	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.0;Spermatocytes: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002209, HPA021816"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB002209: AB_564128, HPA021816: AB_1854725"	"unprognostic (3.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	11.8	12.0	4.2	16.3	3.8	20.8	15.2	7.5	6.0	10.8	3.3	13.2	9.9	10.4	16.4	12.1	12.4	8.0	12.2	3.9	3.9	15.2	27.3	9.4	26.4	4.1	4.0	8.5	10.2	15.3	9.0	10.9	4.3	11.5	19.3	9.6	13.2	10.3	31.2	12.9	11.7	13.7	3.6	14.8	12.3	49.3	3.8	24.1	14.6	21.6	32.9	15.1	9.0	4.2	46.2	50.0	44.0	33.3	18.3	20.0	40.2	35.8	29.0	58.7	52.0	41.5	17.8	88.6	13.3	33.1	38.1	43.5	73.6	39.6	74.7	22.7	48.6	40.0	42.7	32.5	24.8	31.8	34.6	14.3	28.2	43.7	71.3	24.5	41.0	34.3	42.3	22.2	46.5	24.3	46.7	23.4	41.2	46.4	23.9	44.1	48.5	38.7	30.7	22.3	17.5	33.9	44.0	20.4	28.1	33.7	22.9	37.3	26.8	26.4	28.3	27.1	66.9	15.0	19.4	39.5	31.3	36.3	37.4	5.4	7.6	4.3	12.4	12.2	12.3	39.1	13.3	15.0	10.9	35.7	14.3	15.9	0.9	21.1	14.3	12.2	17.6	11.5	4.2	3.8	7.5	6.0	3.9	3.9	4.1	4.0	4.3	3.6	3.8	4.2	6.9	12.8	17.8	10.1	38.0	22.2	31.5	13.5	14.2	13.3	8.9	6.2	10.7	11.5	18.1	16.5	16.7	30.1	19.3	15.2	11.7	27.9	146.0	26.1	15.0	11.5	13.8	28.6	22.9	25.4	24.8	12.2	15.3	47.2	7.6	14.9	9.3	16.5	11.4	10.1	20.4	10.1	14.2	7.9	12.3	38.0	15.2	10.6	3.6	11.2	19.4	7.8	26.8	13.0	17.8	23.3	15.4	10.9	9.4	21.7	9.9	7.5	11.5	11.0	13.1	19.5	20.5	147.5	61.8	15.8	17.0	36.0	17.9	13.6	17.6	42.8
NUPR1	"COM1, p8"	ENSG00000176046	"Nuclear protein 1, transcriptional regulator"	O60356	16	28532708-28539008	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 1157.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 14.3"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 14.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 280.6;hTCEpi: 446.5;SK-MEL-30: 344.9;T-47d: 199.1;U-87 MG: 173.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006349			Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Cytokinetic bridge"	"HPA006349: "	"unprognostic (2.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.72e-3)"	"unprognostic (5.77e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.80e-2)"	190.1	270.7	66.9	32.2	71.3	1.2	185.8	70.4	83.7	148.5	55.3	221.1	12.3	137.8	81.8	110.1	146.3	70.7	108.8	64.7	82.8	87.8	345.4	164.4	29.9	83.9	77.0	188.9	1157.3	26.4	39.5	54.5	81.0	204.1	59.9	9.0	255.3	124.3	87.9	205.1	71.3	63.4	76.6	35.8	130.6	67.9	72.9	23.3	354.6	17.3	13.9	178.0	152.4	75.8	1.4	10.5	0.0	73.3	108.0	94.7	58.6	66.5	57.3	2.3	54.6	0.2	0.2	0.2	37.2	101.2	8.8	1.9	0.4	2.1	2.3	0.4	3.7	0.1	6.2	52.1	280.6	0.3	0.5	90.2	446.5	31.2	148.5	76.8	0.4	0.1	0.1	3.5	34.0	13.7	0.3	1.4	0.4	0.2	38.7	0.2	0.2	3.1	0.0	6.9	0.6	0.5	19.6	78.5	344.9	1.5	199.1	12.0	0.2	21.3	51.7	55.2	10.5	0.5	0.6	0.6	173.1	0.3	2.6	14.3	0.4	3.6	0.3	0.3	0.3	0.3	0.3	0.2	0.1	0.5	0.3	0.3	2.4	0.8	0.4	0.6	0.2	0.1	66.9	71.3	70.4	83.7	64.7	82.8	83.9	77.0	81.0	76.6	72.9	75.8	179.9	288.4	336.2	11.1	9.7	316.9	318.4	1162.8	253.8	3.5	379.6	348.1	146.1	121.5	639.3	323.7	2.1	142.3	5.2	276.3	21.5	242.0	14.8	186.4	291.8	165.4	61.1	53.5	0.2	567.2	73.6	407.5	58.6	597.3	20.3	198.3	262.3	734.9	296.8	1.7	0.5	464.9	225.9	45.2	115.2	61.0	528.8	100.6	154.7	3.7	6.3	200.2	1.0	0.5	4.7	222.5	71.1	704.5	7.7	374.2	0.9	272.6	514.1	5.3	203.8	129.5	368.3	9.8	4.9	211.2	531.8	707.8	20.0	66.3	376.1	483.8
NUSAP1	"ANKT, BM037, FLJ13421, LNP, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41320794-41381050	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 88.6;lymphoid tissue: 101.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 266.7;Extravillous trophoblasts: 121.2;Granulosa cells: 93.3;Spermatocytes: 99.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 10.7;T-reg: 7.7"	"Group enriched"	"Detected in many"	15	"granulocytes: 10.7;T-cells: 7.7"	"Low cell line specificity"	"Detected in many"											"HPA042904, HPA074847"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	1.8	14.1	0.2	7.8	0.2	88.6	1.5	0.3	0.4	3.6	0.3	6.1	7.0	1.1	0.1	17.7	1.1	1.0	1.1	0.2	0.2	2.6	5.0	3.8	28.7	0.3	0.4	4.4	1.3	0.0	0.6	6.5	0.3	1.1	8.0	0.1	3.6	0.6	5.4	9.4	7.4	2.7	0.2	7.8	4.5	10.9	0.3	101.5	0.9	0.1	31.5	1.9	6.4	0.3	146.0	38.3	165.1	64.6	3.5	5.9	37.0	107.4	74.6	138.9	130.6	58.4	67.0	63.5	42.5	44.4	99.1	107.6	104.2	46.2	132.4	98.5	62.3	149.6	102.0	50.7	0.2	67.3	57.2	0.9	1.3	69.1	37.3	21.7	72.0	104.2	70.1	237.5	105.7	30.7	147.5	82.2	59.8	139.8	55.0	136.5	156.5	67.5	42.4	29.3	85.7	55.2	129.8	88.5	25.7	46.0	106.2	76.1	33.7	89.9	104.8	101.5	206.2	81.3	145.8	200.5	42.1	163.6	171.2	10.7	0.1	0.5	0.1	0.0	0.0	0.3	0.5	0.5	0.3	0.6	0.0	0.3	0.2	0.4	0.0	0.3	7.7	0.5	0.2	0.2	0.3	0.4	0.2	0.2	0.3	0.4	0.3	0.2	0.3	0.3	1.9	0.0	1.5	1.3	14.2	38.5	10.3	21.2	31.9	0.9	9.9	13.7	1.1	17.2	5.0	0.0	0.0	72.2	13.4	14.4	3.9	2.3	33.2	10.7	11.6	7.3	3.0	266.7	1.4	0.5	121.2	14.6	25.5	21.8	7.0	93.3	10.8	3.9	36.7	0.0	1.5	15.5	24.4	13.8	22.7	14.6	0.3	17.5	3.6	1.9	6.1	1.9	4.1	1.0	1.3	1.5	0.4	1.9	57.2	5.3	2.6	5.4	1.1	1.0	0.0	2.8	12.1	99.6	59.9	69.5	24.9	19.3	22.9	38.8	30.0	10.3
NXF1	"DKFZp667O0311, Mex67, TAP"	ENSG00000162231	"Nuclear RNA export factor 1"	Q9UBU9	11	62792123-62806302	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016327, HPA061593"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB016327: AB_627608, HPA061593: AB_2684565"	"unprognostic (2.45e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (4.33e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.25e-2)"	90.2	103.4	57.2	47.9	56.8	204.6	81.8	61.6	71.9	100.1	66.8	106.0	39.4	94.6	55.2	80.2	86.8	51.8	78.0	57.3	59.0	100.3	130.0	82.0	69.9	56.6	57.2	97.3	98.3	63.8	136.7	58.9	56.1	107.2	45.6	49.9	77.3	57.8	75.7	110.6	96.1	66.6	55.2	143.8	97.1	59.5	58.2	75.5	123.1	41.5	56.1	83.1	78.8	59.9	44.6	48.5	82.8	56.5	69.6	50.2	50.2	67.5	60.5	89.0	52.6	66.8	35.1	70.0	39.1	54.4	35.7	54.1	89.9	42.3	80.2	55.5	61.3	52.9	82.1	56.4	52.8	66.3	73.6	74.5	59.9	65.6	31.5	66.5	58.9	60.7	69.3	50.7	64.4	61.1	81.3	85.1	50.4	54.8	41.6	77.5	46.0	74.6	61.7	51.7	43.6	36.5	66.4	52.8	49.8	59.9	60.3	57.9	60.3	51.2	41.5	64.6	61.3	61.4	56.8	70.2	39.6	55.2	52.1	7.6	21.3	23.5	18.9	26.0	20.5	16.0	18.4	18.5	23.6	12.8	19.6	18.4	16.1	20.2	23.6	18.3	24.0	17.1	57.2	56.8	61.6	71.9	57.3	59.0	56.6	57.2	56.1	55.2	58.2	59.9	53.2	38.5	45.3	14.7	40.2	83.4	27.0	29.4	42.7	13.2	45.9	74.7	24.6	21.5	23.4	22.0	31.3	50.4	44.1	42.2	9.8	17.6	32.6	30.4	36.8	36.8	31.6	17.7	11.0	12.3	25.9	35.1	43.3	51.7	49.9	19.8	26.0	18.6	28.6	5.0	13.0	35.9	22.4	33.8	43.2	12.3	36.7	62.5	32.0	11.2	21.8	12.7	21.6	7.1	10.1	14.7	28.6	25.9	29.7	22.0	24.0	10.2	18.6	17.2	26.3	48.6	40.4	28.2	19.9	53.4	70.0	99.2	42.3	15.4	30.4	15.2
NXF3		ENSG00000147206	"Nuclear RNA export factor 3"	Q9H4D5	X	103075810-103093143	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 25.0;testis: 57.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Early spermatids: 2.4;Endometrial ciliated cells: 8.4;Hepatic stellate cells: 2.9;Kupffer cells: 2.6;Late spermatids: 4.2;Paneth cells: 3.9;Undifferentiated cells: 2.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 48.6;HL-60: 46.6;NB-4: 43.0;THP-1: 33.0;U-2197: 135.9;U-937: 101.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003132, HPA046757"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003132: AB_1079514, HPA046757: AB_2679789"	"unprognostic (1.20e-3)"	"unprognostic (6.72e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.75e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.86e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-10)"	"unprognostic (1.90e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	0.6	0.8	0.0	0.1	0.0	3.9	0.2	0.0	0.1	1.4	0.1	0.3	0.6	0.1	10.9	0.1	25.0	7.2	0.4	0.0	0.0	1.1	1.1	4.9	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.9	0.0	1.1	0.1	0.0	0.1	3.0	0.0	0.0	0.6	0.1	57.8	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.2	0.0	0.0	0.1	0.5	0.2	0.0	48.6	0.5	0.0	0.0	46.6	0.0	0.0	0.0	1.9	0.0	0.6	0.0	2.2	0.0	8.6	1.0	0.0	0.2	43.0	0.0	0.4	0.2	0.0	0.9	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.0	0.0	0.0	0.1	135.9	0.1	0.1	0.0	0.0	0.7	101.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	2.4	8.4	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.9	0.0	0.5	0.0	0.1	0.9	0.0	2.6	0.0	4.2	0.3	1.4	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.1	0.8	1.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0
NXPE3	"FAM55C, MGC15606"	ENSG00000144815	"Neurexophilin and PC-esterase domain family member 3"	Q969Y0	3	101779202-101828231	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.2;tongue: 50.5"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 177.7;Plasma cells: 59.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 92.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036259	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA		12000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"HPA036259: AB_10671838"	"unprognostic (3.30e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-5)"	"unprognostic (4.98e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (2.89e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.75e-3)"	7.8	6.4	13.6	11.7	23.2	12.5	6.0	20.1	18.7	7.6	1.3	5.3	3.5	8.1	3.3	6.1	7.4	6.5	18.4	12.4	21.0	3.3	3.5	9.4	16.7	21.6	21.3	7.1	2.5	20.7	6.8	6.7	24.2	8.3	4.6	11.3	3.5	9.8	73.2	2.0	5.0	10.6	16.5	12.5	5.0	7.4	23.7	13.1	5.9	50.5	14.2	7.2	4.5	34.8	19.8	29.9	25.1	9.2	26.6	26.9	5.7	21.7	27.2	25.4	36.6	7.0	2.0	29.3	62.6	24.4	30.4	4.1	28.3	23.2	31.2	36.7	8.9	22.7	19.0	19.3	35.0	19.4	19.9	15.6	3.9	21.1	7.8	33.1	27.8	27.3	4.7	92.0	42.5	10.6	26.2	4.6	14.6	1.0	18.6	11.5	30.7	12.7	18.8	5.1	19.6	23.4	9.3	2.2	16.7	14.9	4.3	27.2	24.5	28.0	33.7	3.3	23.0	43.0	47.5	34.0	23.9	83.7	5.4	8.0	16.5	20.1	14.6	13.0	10.0	10.8	16.0	15.2	14.2	6.4	21.6	17.6	8.6	8.9	12.7	8.8	20.8	14.1	13.6	23.2	20.1	18.7	12.4	21.0	21.6	21.3	24.2	16.5	23.7	34.8	24.1	25.6	5.1	11.4	19.2	3.7	2.2	2.3	6.2	26.1	9.8	9.0	49.4	4.3	2.3	0.0	8.4	0.7	12.8	1.0	0.0	2.6	1.4	2.9	11.8	17.2	7.2	0.0	34.1	2.6	1.6	10.0	1.5	1.9	13.3	46.0	40.4	1.8	6.8	48.8	35.2	0.6	4.1	19.1	10.0	1.8	9.3	11.0	7.2	9.4	26.3	22.7	23.7	44.2	177.7	2.9	0.1	7.5	59.6	1.0	0.8	0.8	3.1	17.1	19.7	14.9	8.3	11.8	15.1	3.8	3.0	0.7	16.2	20.0	0.9	1.1
NXT1	"MTR2, P15"	ENSG00000132661	"Nuclear transport factor 2 like export factor 1"	Q9UKK6	20	23350791-23354771	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 235.3;Suprabasal keratinocytes: 253.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 200.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047471			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Cytosol	"HPA047471: AB_2680061"	"unprognostic (6.44e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.15e-7)"	"unprognostic (2.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.11e-3)"	"unprognostic (9.31e-2)"	26.4	14.2	10.4	12.4	10.4	46.8	20.6	11.0	11.7	18.7	11.0	16.0	6.9	17.8	16.7	19.6	22.8	10.1	15.7	9.9	11.0	19.8	13.7	18.9	13.7	11.1	11.1	23.9	12.5	9.6	17.9	13.0	11.3	14.9	10.1	9.4	12.8	11.6	11.6	22.7	13.8	14.9	11.2	17.6	15.2	17.6	11.2	18.3	14.4	9.5	18.3	21.5	16.9	11.1	46.3	50.6	29.9	31.4	20.7	20.0	27.9	27.7	31.0	44.3	44.5	33.7	44.2	55.0	40.3	27.7	73.0	52.8	35.6	72.6	43.3	26.5	33.2	40.5	10.4	60.4	30.9	43.6	29.5	17.9	47.6	42.8	60.4	17.5	35.7	39.5	54.7	52.6	34.7	60.1	90.7	76.4	25.2	82.3	110.9	61.9	48.4	64.7	27.0	38.5	48.4	28.4	25.4	66.7	53.3	18.2	37.5	50.1	22.7	44.6	36.9	37.7	54.1	35.9	37.2	64.0	12.6	200.8	33.9	43.6	46.7	34.5	80.2	68.7	99.2	141.5	80.4	84.3	69.5	131.4	97.9	88.3	11.5	107.9	51.1	113.5	62.1	87.8	10.4	10.4	11.0	11.7	9.9	11.0	11.1	11.1	11.3	11.2	11.2	11.1	63.4	16.0	13.1	1.0	67.0	235.3	141.0	82.9	132.1	10.1	73.1	91.4	7.6	17.2	36.1	20.2	4.2	75.4	64.7	8.2	41.1	39.7	20.3	34.0	39.3	62.1	18.7	41.9	1.5	31.2	77.1	63.7	5.6	37.8	76.2	23.5	27.5	13.4	45.3	11.8	2.2	23.9	59.0	16.6	141.2	12.8	51.6	36.9	108.5	1.9	23.9	24.5	35.0	2.5	2.8	41.3	11.0	40.3	46.0	111.3	8.3	24.1	24.0	18.3	6.6	89.5	70.5	89.6	76.4	87.4	253.5	40.2	66.7	27.8	27.9	118.1
NXT2	P15-2	ENSG00000101888	"Nuclear transport factor 2 like export factor 2"	Q9NPJ8	X	109535781-109544698	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 157.3;U-937: 166.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024199, HPA072010"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA024199: AB_1854738, HPA072010: AB_2686483"	"unprognostic (1.72e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.59e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.90e-2)"	7.6	4.8	5.3	8.0	5.6	17.5	15.2	6.0	6.8	9.2	4.0	7.8	9.2	5.6	7.2	8.9	7.0	6.1	2.7	4.8	5.8	9.3	11.9	8.0	12.3	6.0	5.8	6.5	4.3	7.3	1.2	8.4	6.4	6.4	8.5	2.2	7.7	4.3	1.9	12.2	7.5	4.5	6.8	7.5	8.7	27.6	5.4	14.8	7.9	3.4	14.1	8.8	4.4	6.9	14.2	12.2	11.6	20.3	17.1	13.5	25.6	8.8	14.9	11.1	14.4	9.6	19.5	18.1	27.1	11.1	30.0	10.5	15.4	13.8	16.9	23.5	9.5	15.1	10.6	15.8	7.0	157.3	60.9	9.9	11.8	10.6	6.6	8.3	10.0	18.7	16.1	72.2	11.0	14.6	23.9	16.6	18.6	19.8	18.0	9.4	16.4	21.6	10.4	13.9	4.6	14.6	37.7	21.2	12.0	10.1	9.0	52.1	7.5	15.9	9.0	21.2	9.3	14.8	19.5	27.7	13.9	166.9	16.6	4.7	7.2	3.6	9.2	9.8	6.0	6.3	6.7	7.5	9.7	6.2	6.6	6.5	1.4	10.8	8.1	5.9	8.4	8.0	5.3	5.6	6.0	6.8	4.8	5.8	6.0	5.8	6.4	6.8	5.4	6.9	4.8	3.2	6.5	2.0	10.1	19.2	21.0	10.4	9.6	1.4	18.0	11.3	30.0	2.8	12.8	3.7	0.0	15.1	12.9	7.9	21.5	12.5	21.5	9.3	6.0	5.4	1.2	12.4	0.5	14.0	24.8	7.5	7.1	15.0	5.7	6.0	4.6	5.4	11.4	0.0	0.4	4.4	10.2	10.1	20.0	5.9	4.7	9.9	1.8	1.0	31.9	9.2	26.8	1.5	2.5	9.0	7.6	4.5	12.3	20.3	7.6	16.6	10.5	1.4	13.1	5.3	5.2	31.7	33.7	17.0	23.3	29.1	9.4	6.6	6.4	21.3
NYNRIN	"CGIN1, FLJ11811, KIAA1305"	ENSG00000205978	"NYN domain and retroviral integrase containing"	Q9P2P1	14	24399003-24419283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 18.2;Squamous epithelial cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.4;HEL: 14.7;HUVEC TERT2: 35.6;RT4: 29.8;TIME: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018945	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA018945: AB_1859538"	"unprognostic (9.41e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.43e-1)"	8.7	3.7	4.3	3.1	3.9	0.4	6.3	16.3	4.6	16.8	5.4	7.6	4.0	11.5	28.0	11.6	16.9	8.6	7.5	3.2	6.6	6.3	4.5	8.1	1.9	5.8	5.4	35.1	3.8	5.8	5.8	12.8	6.3	7.5	5.5	1.8	7.4	14.9	3.8	13.3	5.3	10.5	3.2	4.4	6.0	5.1	7.8	4.5	7.8	4.2	2.9	9.5	14.0	2.8	0.2	0.1	4.6	0.0	6.3	13.0	0.3	2.2	2.3	1.5	1.6	3.3	14.4	0.4	0.6	8.6	0.2	0.0	7.5	0.2	1.5	0.0	0.8	14.7	2.0	0.3	4.7	0.0	0.0	13.3	0.6	1.0	0.0	2.6	35.6	0.1	2.4	0.0	0.2	0.6	0.0	0.8	2.7	1.0	0.0	1.9	0.0	0.0	0.0	29.8	0.6	10.0	0.0	1.3	0.2	11.2	2.5	2.1	17.4	0.1	8.2	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.3	3.9	16.3	4.6	3.2	6.6	5.8	5.4	6.3	3.2	7.8	2.8	15.2	3.2	1.7	4.9	0.1	4.6	3.9	9.5	15.4	0.5	1.8	3.6	3.1	8.6	15.6	9.2	0.0	1.1	1.6	2.7	0.0	4.1	0.8	1.4	10.8	15.0	5.4	3.6	1.0	3.0	1.0	10.1	10.7	1.7	0.0	12.0	18.2	2.7	10.7	0.0	3.9	9.0	4.1	9.0	1.4	0.2	2.5	1.4	3.6	3.7	0.7	5.4	0.0	0.5	0.1	4.8	5.1	0.4	1.2	1.2	1.0	0.3	10.8	0.2	0.0	1.2	7.3	0.3	1.2	18.0	3.8	1.1	0.3	1.5	8.8	4.5
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120211032-120230334	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 396.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.9;Fibroblasts: 135.9;Hepatocytes: 218.8;Muller glia cells: 279.4;Theca cells: 149.0;Urothelial cells: 192.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.3;intermediate monocyte: 1.6;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 2.4;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 115.5;Hep G2: 190.1;NB-4: 139.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		69000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	66.0	91.5	47.7	18.0	56.8	10.8	42.6	35.8	57.1	66.7	40.5	61.9	47.7	54.2	16.0	22.8	54.6	34.5	55.1	48.1	36.5	51.4	396.6	19.2	5.8	39.0	37.8	61.0	74.1	6.7	27.4	8.1	37.1	33.5	36.5	30.7	53.9	13.7	13.2	12.0	57.3	29.1	35.9	54.4	33.5	3.7	45.0	4.6	25.9	12.2	3.7	42.6	40.4	44.6	24.9	7.5	30.9	14.4	47.8	53.4	1.7	47.7	53.8	20.5	30.0	7.5	37.3	0.0	115.5	35.6	33.7	25.7	8.9	13.2	8.2	18.7	21.1	21.1	4.7	190.1	42.4	46.7	7.9	66.8	7.9	19.8	54.8	39.9	59.7	12.7	14.0	22.7	5.0	9.4	0.3	139.9	11.6	7.3	40.8	11.8	0.9	23.7	31.8	13.4	1.5	10.0	14.0	15.2	40.2	8.6	4.8	74.7	32.7	39.3	14.7	40.8	4.6	0.8	0.7	0.4	30.3	76.2	14.1	0.0	3.3	0.0	0.1	1.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.1	0.0	0.3	0.5	0.1	0.8	47.7	56.8	35.8	57.1	48.1	36.5	39.0	37.8	37.1	35.9	45.0	44.6	19.4	0.0	0.6	102.2	3.7	9.4	33.6	7.3	12.5	3.2	6.0	7.0	5.5	34.3	3.5	71.7	2.1	2.1	1.1	135.9	27.4	14.8	0.2	4.7	70.9	40.0	22.8	12.8	0.6	28.7	5.5	135.9	11.7	12.2	1.3	2.6	12.5	218.8	6.0	0.0	2.3	56.5	4.1	11.5	20.9	1.1	16.8	11.0	16.0	23.4	10.2	279.4	0.0	5.5	11.0	28.2	56.5	4.5	14.5	31.3	111.1	79.3	0.4	10.6	52.6	8.6	40.8	0.7	6.9	11.3	10.2	6.2	3.1	149.0	45.8	192.5
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 193.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 294.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	20.9	25.5	26.4	20.3	30.5	26.3	30.1	28.5	32.3	19.5	26.5	28.8	31.4	17.6	38.3	23.3	30.1	19.3	22.0	26.0	28.4	44.3	59.2	17.3	28.5	29.7	28.3	35.7	40.6	34.9	22.6	20.0	30.4	25.0	31.1	43.8	25.6	22.0	25.5	21.6	30.2	15.0	28.8	23.0	39.5	58.6	28.2	39.7	30.9	37.1	33.4	20.0	20.1	35.6	44.2	25.0	55.8	40.6	32.1	37.6	36.9	28.0	36.5	29.1	31.4	39.7	33.1	61.7	29.3	15.4	32.1	33.4	38.1	33.1	41.0	53.2	18.6	73.8	28.0	75.4	29.1	50.1	47.6	28.7	45.6	28.1	102.2	26.5	20.3	77.4	95.4	48.8	32.2	59.0	88.1	55.1	51.4	294.4	17.3	36.8	52.4	54.7	58.0	21.4	60.5	38.7	25.5	25.2	88.6	43.2	41.9	42.3	21.9	32.0	39.3	20.0	43.6	65.8	72.7	140.1	25.2	48.5	27.1	49.1	21.8	42.4	26.2	23.3	34.3	45.7	30.6	26.6	26.8	43.2	37.2	36.9	20.8	45.0	28.2	26.0	37.2	22.7	26.4	30.5	28.5	32.3	26.0	28.4	29.7	28.3	30.4	28.8	28.2	35.6	30.5	16.0	40.9	7.8	49.8	28.6	40.3	51.8	38.7	63.2	47.5	41.1	43.4	52.9	40.6	60.7	45.9	89.5	44.1	28.5	86.1	42.9	164.2	43.3	19.6	34.2	22.1	56.4	2.9	48.0	60.2	23.5	37.8	29.8	48.2	21.7	35.0	69.5	45.6	42.1	3.9	52.2	50.8	53.4	37.0	153.8	28.3	33.4	35.6	3.7	42.1	75.9	59.8	4.0	13.1	34.6	44.0	25.9	29.3	37.1	63.0	112.9	56.6	70.5	26.3	23.9	26.7	193.0	148.0	43.4	29.3	45.6	47.5	34.2	61.7	32.4
OAS1	"IFI-4, OIAS, OIASI"	ENSG00000089127	"2'-5'-oligoadenylate synthetase 1"	P00973	12	112905856-112933219	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 91.0;urinary bladder: 111.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 151.0;Hofbauer cells: 105.6;Paneth cells: 127.9;Urothelial cells: 171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 572.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 247.1;BJ hTERT+ SV40 Large T+ RasG12V: 336.6;OE19: 307.6;U-266/70: 272.9;U-266/84: 210.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003657, CAB021104"	Uncertain		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB021104: AB_10057722, HPA003657: AB_1854747"	"unprognostic (1.03e-1)"	"unprognostic (6.59e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.67e-2)"	"prognostic favorable (6.12e-6)"	17.0	11.5	6.8	27.3	7.3	14.3	13.1	6.5	9.7	29.6	6.1	49.0	51.7	8.0	8.1	57.1	10.0	22.5	9.5	6.6	6.9	22.3	38.6	23.1	27.2	15.4	8.0	8.1	4.4	9.0	8.3	20.4	11.5	9.1	45.1	1.5	91.0	7.3	2.4	10.3	39.8	14.6	21.2	50.5	43.6	4.8	8.4	28.1	7.7	7.4	25.6	111.1	22.7	9.9	4.7	24.4	0.0	0.1	9.4	6.6	1.5	0.1	38.8	247.1	336.6	18.5	34.1	42.3	12.2	0.3	121.8	10.8	0.2	4.2	2.2	21.0	0.0	0.7	35.2	4.6	2.9	0.6	1.4	0.5	7.2	8.0	0.0	3.1	13.5	0.7	0.0	17.4	0.2	0.4	0.6	17.0	0.7	307.6	22.5	5.8	0.2	20.5	11.6	89.4	0.2	0.9	3.7	4.2	85.2	0.4	0.9	5.1	50.4	0.0	0.5	3.2	0.4	272.9	210.3	23.9	2.9	6.6	1.4	6.3	253.6	3.2	26.5	403.9	25.3	108.8	36.3	34.3	153.9	93.1	14.3	18.8	24.4	24.9	572.0	144.5	108.7	217.8	6.8	7.3	6.5	9.7	6.6	6.9	15.4	8.0	11.5	21.2	8.4	9.9	23.0	3.2	2.2	0.0	21.1	3.4	16.6	24.0	10.8	0.2	6.0	8.1	3.1	14.3	35.4	5.5	0.0	12.6	31.5	151.0	5.9	19.5	0.4	1.9	3.6	17.2	4.2	3.6	0.6	12.0	36.4	11.1	28.5	4.1	5.1	15.4	14.3	11.9	105.6	0.0	1.0	59.3	26.4	36.9	11.4	1.2	7.2	52.9	5.4	13.1	36.2	15.0	18.6	3.5	0.1	19.5	127.9	10.5	24.1	7.4	50.9	25.4	17.5	0.4	6.6	3.0	7.5	0.0	0.5	18.3	2.3	5.7	9.1	12.7	14.6	171.9
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938051-112976460	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 15.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 202.5;BJ hTERT+ SV40 Large T+ RasG12V: 224.5;GAMG: 89.8;RT4: 62.6"	"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No		21000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	8.1	4.1	3.2	11.5	3.1	20.9	6.0	2.3	2.5	11.0	1.1	7.1	7.1	3.9	1.5	15.8	5.2	11.3	7.0	2.2	2.4	5.6	4.4	12.6	6.0	8.7	3.6	3.8	3.8	3.2	3.5	11.1	6.4	3.4	6.2	0.6	27.7	2.7	3.0	5.4	6.5	9.3	11.8	17.9	11.0	2.3	4.1	16.1	4.1	5.9	6.4	14.4	7.8	3.0	23.2	34.4	0.3	5.5	1.0	4.6	2.1	2.6	25.3	202.5	224.5	24.1	20.5	0.7	7.3	8.1	89.8	15.7	3.3	22.7	11.2	9.7	1.2	15.9	16.3	4.0	3.9	4.5	6.6	0.9	7.2	32.8	1.3	4.0	11.7	3.9	0.5	3.1	2.0	13.3	8.0	2.7	1.4	33.7	22.8	13.5	11.6	0.1	7.0	62.6	0.6	0.1	19.8	5.5	14.8	0.2	25.7	1.1	9.5	4.6	4.0	5.5	6.5	0.8	21.0	0.2	4.9	12.9	16.7	1.0	7.8	0.8	1.4	7.4	1.7	2.3	2.0	2.3	4.1	1.0	1.8	1.7	9.7	2.7	15.3	0.3	2.6	3.5	3.2	3.1	2.3	2.5	2.2	2.4	8.7	3.6	6.4	11.8	4.1	3.0	19.9	3.2	3.9	0.7	3.8	3.4	5.6	13.5	5.2	0.4	3.1	2.7	1.7	0.0	5.1	3.7	0.0	5.4	1.8	14.7	3.9	11.2	5.9	1.8	4.1	20.8	1.8	0.8	0.3	9.8	20.9	5.5	16.3	5.6	1.3	21.9	9.3	1.7	18.7	0.0	0.4	6.8	8.2	5.8	7.0	10.8	10.2	16.7	1.8	5.6	30.2	3.0	8.2	3.5	0.0	21.2	8.2	15.1	1.4	11.8	4.5	2.0	2.3	0.5	0.0	2.5	5.0	0.8	0.7	14.4	4.7	1.9	6.5	9.2	5.4	26.8
OASL	"OASL1, p59OASL, TRIP14"	ENSG00000135114	"2'-5'-oligoadenylate synthetase like"	Q15646	12	121017763-121039242	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.7;stomach 1: 22.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 54.1;Distal enterocytes: 82.3;Gastric mucus-secreting cells: 97.9;Paneth cells: 71.4;T-cells: 43.9;Urothelial cells: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 132.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 126.9;BJ hTERT+ SV40 Large T+ RasG12V: 66.2;GAMG: 35.3;hTEC/SVTERT24-B: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001474	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA001474: AB_1079518"	"unprognostic (2.39e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.93e-3)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (4.61e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.17e-2)"	2.3	0.8	0.7	4.2	0.8	35.7	2.4	0.7	0.8	3.3	0.6	7.5	2.7	0.5	0.5	4.0	0.7	3.6	1.1	0.6	0.5	2.3	11.8	11.9	3.6	1.4	0.7	0.4	0.7	0.1	0.6	1.4	1.4	0.5	3.4	0.2	4.1	0.4	0.4	0.9	2.0	1.3	3.3	5.3	22.3	2.1	1.1	3.3	1.1	0.6	1.7	7.8	1.4	0.9	2.6	0.6	0.2	0.9	1.0	1.6	0.1	0.2	0.9	126.9	66.2	0.3	13.0	0.6	4.0	0.1	35.3	6.4	0.1	0.9	7.2	25.2	0.1	0.1	13.8	0.0	0.7	0.2	1.8	0.8	0.6	50.7	0.1	0.3	0.3	1.0	0.1	5.3	1.1	1.7	0.1	3.1	0.1	4.5	3.7	0.1	0.2	1.4	0.1	13.7	0.1	0.2	1.1	0.6	18.5	0.1	0.4	1.7	0.1	0.7	1.2	2.1	0.2	4.9	10.1	0.3	19.9	1.3	0.4	12.3	29.6	65.8	53.1	32.5	14.3	2.5	36.2	62.1	8.9	0.8	9.9	38.5	132.8	20.3	23.5	0.5	27.8	33.2	0.7	0.8	0.7	0.8	0.6	0.5	1.4	0.7	1.4	3.3	1.1	0.9	28.6	0.0	4.2	0.7	4.6	2.2	5.0	2.7	1.8	0.0	3.3	4.7	0.6	1.5	3.9	0.0	0.0	0.2	54.1	82.3	0.0	2.5	6.6	2.0	0.6	4.5	1.8	0.8	0.2	3.8	1.3	2.4	97.9	2.8	11.4	1.0	2.2	4.5	12.6	0.0	0.2	30.7	4.1	3.1	7.2	3.4	0.3	16.7	0.0	1.0	6.0	0.0	9.2	0.0	0.0	12.7	71.4	0.0	14.3	2.2	2.4	0.3	3.8	0.0	0.0	0.7	2.8	2.4	0.1	14.6	1.0	0.1	43.9	0.2	5.1	96.3
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 781.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343"	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	60.0	119.6	69.4	40.8	71.2	106.4	150.1	74.6	97.4	99.7	75.4	75.6	750.0	82.5	63.7	105.0	56.0	68.7	52.3	71.2	78.7	114.6	162.5	42.7	38.1	76.5	72.0	77.0	36.1	46.1	53.5	65.0	85.2	74.3	67.2	51.1	225.4	94.6	58.2	71.6	781.8	97.8	73.6	34.1	70.1	56.2	73.3	30.2	67.7	60.0	69.1	58.9	63.8	81.7	241.5	42.8	27.5	98.7	272.4	260.8	93.4	142.2	288.0	124.2	135.2	110.5	30.8	0.5	101.0	241.8	118.0	249.4	126.5	265.7	134.0	42.4	174.9	268.1	28.1	82.7	139.9	0.4	169.3	172.1	134.5	111.9	129.5	204.9	147.1	48.4	470.8	50.0	175.5	62.6	72.1	15.3	55.1	73.2	59.6	66.3	104.5	65.3	119.8	3.9	57.3	60.9	89.7	235.1	209.5	156.6	78.6	65.8	114.3	70.5	65.3	117.9	90.2	42.4	47.6	64.6	97.4	72.0	34.4	38.0	39.6	36.0	28.8	35.3	31.2	15.2	24.0	30.5	44.3	16.2	29.5	29.8	40.0	16.9	37.2	9.4	24.6	29.6	69.4	71.2	74.6	97.4	71.2	78.7	76.5	72.0	85.2	73.6	73.3	81.7	49.0	19.2	49.7	37.9	44.7	151.3	144.0	362.8	185.5	35.2	154.2	163.7	21.8	18.6	182.7	35.0	27.1	120.8	80.3	38.2	90.1	34.6	30.4	37.0	90.4	37.7	43.1	317.0	31.8	13.4	90.5	124.2	55.5	40.6	43.8	32.2	37.5	152.2	66.2	43.7	33.4	104.1	197.4	31.8	68.1	15.2	104.1	56.7	85.4	17.8	34.8	37.4	18.6	22.1	41.9	12.6	74.6	120.0	32.9	82.6	1222.6	196.4	76.4	24.4	78.9	106.1	115.1	46.3	33.2	161.8	126.0	48.2	65.0	92.4	214.5	82.2
OAZ3		ENSG00000143450	"Ornithine decarboxylase antizyme 3"	Q9UMX2	1	151762899-151771334	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"testis: 244.7"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 12007.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 3.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030136, HPA045808"			Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA030136: AB_2673331, HPA045808: "	"unprognostic (2.12e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.05e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.36e-2)"	1.5	1.6	2.3	1.6	2.3	0.6	2.4	4.2	2.7	0.6	1.5	1.3	0.7	0.5	2.6	1.7	0.9	0.8	1.1	2.6	2.3	1.6	2.8	1.4	1.5	2.7	2.2	0.3	2.1	4.3	2.7	0.6	2.8	15.3	1.6	2.7	8.2	1.3	2.9	1.2	1.2	0.5	1.9	1.3	1.4	244.7	2.3	0.6	3.3	0.9	0.6	1.1	1.0	2.3	0.9	1.8	1.0	2.5	0.8	2.4	2.3	1.9	0.4	1.7	0.7	1.0	2.3	0.8	1.5	0.6	1.2	0.9	1.0	1.7	0.5	5.8	5.3	0.8	3.2	1.5	1.0	0.4	0.9	3.8	1.0	1.9	2.3	1.1	2.6	2.3	1.2	2.8	1.9	7.7	0.7	1.3	2.5	3.6	1.9	0.4	0.8	1.3	0.3	2.3	1.2	2.8	0.8	3.7	3.6	2.3	8.2	2.1	2.3	1.0	0.5	1.9	1.0	4.0	7.5	2.0	1.3	1.2	2.7	0.6	0.8	0.1	0.3	0.4	0.3	0.3	0.3	0.6	1.0	0.2	0.3	0.6	0.4	0.7	1.5	0.3	0.7	0.4	2.3	2.3	4.2	2.7	2.6	2.3	2.7	2.2	2.8	1.9	2.3	2.3	2.3	0.0	1.7	0.3	0.3	0.8	2.6	1.8	1.8	0.5	16.0	6.2	1.4	0.0	2.2	0.0	2.1	1.7	0.9	4.2	1.9	2.4	2386.5	3.4	0.6	5.3	3.6	0.4	0.4	3.1	3.0	1.0	1.5	1.5	1.3	0.5	1.8	3.1	4.8	0.0	0.3	7.4	2.0	4.2	1.6	12007.9	46.0	5.1	1.8	0.0	1.8	1.7	0.0	0.0	0.3	3.3	4.9	42.5	1.6	20.4	5.7	7.4	3.2	1.6	0.0	0.4	0.8	67.6	31.8	1.2	0.6	1.5	0.6	1.4	2.7	3.2
OBI1	"C13orf7, FLJ13449, RNF219"	ENSG00000152193	"ORC ubiquitin ligase 1"	Q5W0B1	13	78614289-78659155	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.5;Cardiomyocytes: 19.5;Cytotrophoblasts: 15.8;dendritic cells: 8.0;Extravillous trophoblasts: 12.2;Hofbauer cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034785, HPA034786"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034785: AB_10601496, HPA034786: AB_2674331"	"unprognostic (2.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (6.87e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-2)"	5.8	4.8	5.4	6.1	5.8	2.4	6.7	6.6	6.7	5.9	3.0	4.8	4.8	7.1	4.5	5.0	5.6	4.5	7.1	5.6	6.1	4.6	4.4	5.2	9.9	5.5	5.9	7.6	4.1	4.1	2.9	7.4	5.0	5.5	5.3	9.6	4.2	6.1	4.8	5.5	4.7	6.5	6.1	7.3	4.5	14.8	7.2	13.3	5.9	6.4	11.3	6.0	4.5	5.9	23.7	9.1	39.1	23.1	13.5	12.9	17.8	19.3	14.5	18.7	23.3	18.3	17.3	39.8	9.2	12.4	12.2	23.0	31.2	15.3	32.6	24.9	22.8	61.0	11.4	16.1	11.3	59.6	18.2	12.4	16.7	15.7	16.8	10.6	15.6	19.9	16.1	5.3	24.6	6.6	36.5	20.2	0.0	25.1	10.0	42.0	32.2	15.4	12.7	12.5	28.4	15.9	13.4	16.9	14.8	22.2	8.6	47.3	12.9	16.2	14.7	10.7	16.3	5.5	6.6	37.9	25.9	35.6	17.8	4.9	5.4	7.5	7.9	8.8	9.5	8.8	8.8	9.8	6.3	8.9	10.8	9.8	1.8	11.1	10.3	5.3	9.6	6.6	5.4	5.8	6.6	6.7	5.6	6.1	5.5	5.9	5.0	6.1	7.2	5.9	14.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	15.8	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	12.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.1	1.1	0.0	0.0	0.0
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	Biomineralization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"salivary gland: 371.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 4.2;Breast glandular cells: 10.3;Ductal cells: 6.5;Exocrine glandular cells: 8.2;Gastric mucus-secreting cells: 6.6;Glandular and luminal cells: 10.5;Theca cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"Hep G2: 31.7;OE19: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA036279: , HPA036543: AB_10669797, HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.8	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.3	0.1	3.6	1.0	0.1	0.6	0.2	0.1	0.5	0.0	0.0	0.8	1.2	0.0	2.4	0.3	1.2	0.7	0.0	0.5	3.6	0.5	0.3	0.0	1.8	0.8	0.0	371.5	1.4	0.0	0.0	0.7	7.3	0.0	0.0	9.8	0.0	0.2	0.0	4.1	0.0	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.7	0.0	0.0	0.2	0.0	0.1	3.2	4.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	10.3	0.4	0.0	1.5	1.3	1.8	0.0	0.4	0.0	0.0	0.0	6.5	0.0	2.3	0.9	0.1	0.0	0.0	0.0	8.2	0.0	0.0	6.6	10.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	4.2	0.5	0.4
ODF3L2	"C19orf19, FLJ40059"	ENSG00000181781	"Outer dense fiber of sperm tails 3 like 2"	Q3SX64	19	463346-474983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 8.2;testis: 23.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 1184.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA067065, HPA067973"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA067065: , HPA067973: AB_2685937"	"unprognostic (3.75e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.02e-5)"	"unprognostic (3.13e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.99e-1)"	0.3	0.3	0.7	0.0	0.7	0.0	0.3	0.4	0.9	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.5	0.5	0.2	0.3	0.2	0.0	0.7	0.6	0.1	0.1	0.0	0.1	0.2	0.7	0.2	0.0	0.1	0.0	0.0	8.2	0.1	0.2	0.0	0.5	0.7	0.1	23.4	0.8	0.0	0.3	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.4	0.9	0.5	0.5	0.7	0.6	0.7	0.5	0.8	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.8	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1184.9	8.4	0.6	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	7.6	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ODR4	"C1orf27, FLJ20505, odr-4, TTG1"	ENSG00000157181	"Odr-4 GPCR localization factor homolog"	Q5SWX8	1	186375838-186421378	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 37.8;Glandular and luminal cells: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015988, HPA031352"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Plasma membrane"		"HPA015988: AB_1845644, HPA031352: AB_2673838"	"unprognostic (1.19e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.20e-2)"	11.9	14.4	7.5	7.2	9.2	15.0	14.0	10.4	10.1	13.3	8.4	10.8	13.4	9.4	17.2	7.8	8.8	10.6	10.0	7.6	8.2	16.7	21.8	9.5	6.7	8.9	8.6	10.3	29.1	32.4	12.4	14.2	9.2	16.6	12.7	15.2	21.7	12.2	9.0	10.3	13.6	8.8	8.7	8.5	13.1	8.3	8.2	6.4	19.9	9.5	7.1	11.5	8.2	11.9	12.6	13.9	15.1	12.1	17.5	16.3	28.8	19.9	12.2	12.7	12.8	28.2	29.7	8.7	23.5	9.9	11.6	32.3	11.4	10.9	12.5	7.1	10.9	8.2	17.7	15.9	16.4	13.8	9.6	12.5	21.3	15.4	24.1	13.2	13.8	9.0	32.1	17.3	15.3	13.5	9.7	14.3	21.6	46.0	5.0	11.2	10.5	25.0	26.1	12.9	11.0	17.2	15.1	33.0	24.5	26.9	29.1	12.4	13.2	18.1	11.5	12.2	18.9	20.2	13.3	13.3	9.8	7.4	16.7	1.4	9.0	2.5	3.0	8.9	4.5	3.6	3.8	4.2	7.6	2.3	4.7	3.6	3.9	10.0	11.4	4.8	5.7	3.9	7.5	9.2	10.4	10.1	7.6	8.2	8.9	8.6	9.2	8.7	8.2	11.9	28.1	28.9	37.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	18.8	16.5	0.0	0.0	29.7	25.8	0.0	22.0	12.6	0.0	9.8	22.8	0.0	26.8	27.0	9.8	0.0	0.0	0.0	25.4	25.7	12.3	0.0	38.6	12.6	26.4	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	6.7	0.0	0.0	0.0	0.0	24.7	0.0	0.0	4.0	0.0	0.0	10.7	15.3	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	28.0	6.9	29.0	0.0	0.0
OGFOD1	"FLJ10826, KIAA1612, TPA1"	ENSG00000087263	"2-oxoglutarate and iron dependent oxygenase domain containing 1"	Q8N543	16	56451521-56479104	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003215, HPA003722"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	Cytosol	"HPA003215: AB_1078881, HPA003722: "	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.48e-3)"	"prognostic unfavorable (6.65e-4)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (5.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.49e-2)"	"unprognostic (7.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-2)"	9.6	12.3	5.2	8.8	6.5	3.9	9.5	5.5	7.3	10.4	4.1	7.7	8.8	9.8	7.6	19.4	10.6	6.7	14.5	5.3	7.2	9.3	9.1	8.0	8.9	6.5	6.3	8.1	5.7	12.0	6.1	9.2	6.5	8.4	9.6	9.6	6.4	9.5	31.5	6.3	5.1	16.7	5.1	7.5	6.1	9.5	6.3	10.5	10.2	23.5	14.5	9.1	5.7	9.0	25.4	27.4	25.7	32.5	28.6	34.5	26.0	39.1	29.9	52.4	38.5	34.5	16.5	44.7	19.0	29.3	21.7	34.9	57.2	25.5	57.3	14.1	29.6	32.4	21.6	32.8	21.4	34.9	36.2	23.2	29.0	38.7	31.2	23.1	45.3	29.3	44.3	8.2	46.2	15.6	27.4	19.2	45.0	19.8	47.2	51.2	41.0	51.9	22.9	16.7	20.4	24.1	46.3	29.0	25.2	26.9	26.4	30.1	28.9	28.1	23.2	22.9	36.7	18.0	37.1	67.5	22.9	26.5	22.7	13.4	4.6	4.5	7.7	6.4	10.1	7.1	9.5	9.4	6.4	5.6	10.7	8.4	1.5	8.5	8.6	6.8	9.0	5.9	5.2	6.5	5.5	7.3	5.3	7.2	6.5	6.3	6.5	5.1	6.3	9.0	8.9	3.2	16.0	9.8	14.1	17.7	13.8	11.2	17.6	11.3	13.1	10.7	21.4	20.0	15.0	9.2	10.4	18.3	11.7	5.8	25.4	13.7	22.2	11.6	20.0	12.2	2.4	19.6	14.4	14.1	20.5	22.3	12.2	19.1	45.7	13.0	9.7	17.6	12.0	13.5	16.6	7.9	4.1	6.9	10.2	15.6	12.2	10.9	10.6	4.7	16.1	13.6	10.3	9.0	14.5	17.4	5.5	15.8	16.1	11.0	4.6	13.8	8.0	15.2	13.1	16.7	19.0	26.0	29.6	21.2	18.9	11.6	18.4	19.1	10.6	9.0
OGFOD2	"FLJ13491, FLJ37501"	ENSG00000111325	"2-oxoglutarate and iron dependent oxygenase domain containing 2"	Q6N063	12	122974580-122980043	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 431.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039448, HPA040306"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA039448: AB_10795035, HPA040306: AB_10794026"	"unprognostic (2.14e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	6.5	15.0	10.8	7.7	11.1	8.4	7.5	10.9	14.0	9.1	12.4	9.9	13.8	6.8	5.9	10.7	10.2	4.8	10.3	10.6	10.9	14.1	21.2	7.7	11.0	12.3	11.4	9.4	20.9	6.5	13.2	5.6	11.5	12.0	5.5	4.9	14.7	7.8	10.9	11.9	12.7	3.3	10.8	14.4	13.0	29.1	11.6	9.3	11.8	4.5	6.6	7.8	8.3	13.5	11.7	18.6	7.6	12.4	5.2	5.5	20.4	6.9	7.1	9.5	8.6	17.6	10.2	13.0	14.1	6.0	5.6	16.5	5.5	9.5	3.6	9.1	12.0	20.6	17.8	18.3	11.1	20.7	15.5	8.1	14.0	8.8	7.8	13.7	10.1	24.7	24.4	9.3	4.8	22.4	17.6	39.0	4.6	8.0	23.5	19.2	7.3	23.2	7.2	10.4	9.7	8.8	9.4	13.4	13.8	5.0	34.0	17.6	6.5	13.0	13.2	15.5	7.3	23.4	15.1	12.4	17.9	10.7	12.8	18.7	11.7	18.9	9.1	12.9	7.8	15.9	7.5	9.0	13.1	11.3	8.1	7.7	9.6	9.7	18.2	7.8	16.0	9.0	10.8	11.1	10.9	14.0	10.6	10.9	12.3	11.4	11.5	10.8	11.6	13.5	4.1	0.0	7.0	4.6	10.0	2.9	6.5	10.3	8.0	3.6	9.2	8.6	0.4	10.0	8.6	12.9	2.1	25.9	5.6	9.2	9.8	11.8	97.3	13.0	5.2	5.9	2.4	17.2	3.2	15.0	14.0	5.4	8.6	5.3	0.0	8.6	7.9	21.1	12.5	11.8	3.6	8.0	16.2	11.9	3.4	431.0	8.7	6.4	7.2	1.0	7.7	7.8	10.3	3.0	2.6	12.7	7.8	4.5	18.4	4.6	32.4	34.1	30.5	6.4	13.1	4.1	5.7	36.8	16.2	7.3	4.5	16.4	7.2	11.5	10.1	4.3
OGFOD3	"C17orf101, FLJ22222"	ENSG00000181396	"2-oxoglutarate and iron dependent oxygenase domain containing 3"	Q6PK18	17	82389210-82418637	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052099	Uncertain		Approved	Nucleoplasm		NA	NA		9700	"Cluster 26: Non-specific - Mitochondria"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA052099: AB_2681725"	"unprognostic (1.12e-2)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.95e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.02e-1)"	14.6	19.6	4.3	9.0	4.7	10.1	14.0	6.1	6.9	14.2	9.7	13.5	9.9	16.0	6.4	12.5	13.3	8.1	24.0	3.8	4.3	15.4	20.5	13.7	8.4	5.3	4.5	14.6	25.7	15.3	22.0	8.9	4.6	15.5	5.4	2.7	18.9	10.2	24.3	13.0	11.1	5.7	3.7	11.4	15.8	8.5	4.1	5.4	19.0	9.0	5.4	14.4	11.5	5.1	23.0	28.6	9.4	31.5	17.8	22.4	16.1	22.9	21.4	23.5	24.0	30.8	30.9	15.7	17.8	18.0	23.9	16.9	8.1	19.4	9.7	12.5	24.5	23.6	22.6	39.7	15.9	27.8	27.0	18.1	14.0	10.9	9.3	17.1	24.8	17.2	30.4	12.0	6.9	21.7	19.1	29.1	8.9	24.3	33.5	12.4	18.0	24.4	13.5	21.3	20.2	40.1	39.4	36.1	18.8	7.9	21.4	36.2	19.4	44.0	27.3	17.5	30.0	20.9	2.0	14.6	27.5	15.9	23.2	0.2	13.8	4.5	6.5	12.9	7.4	13.6	9.4	13.0	23.6	11.9	11.1	9.3	1.6	7.0	8.5	12.3	3.9	8.0	4.3	4.7	6.1	6.9	3.8	4.3	5.3	4.5	4.6	3.7	4.1	5.1	13.9	25.6	16.5	3.3	21.6	11.3	23.8	27.1	13.1	23.1	26.0	29.7	18.6	18.6	19.1	22.0	10.4	37.9	12.7	19.8	9.8	27.3	28.2	23.1	17.0	18.4	28.8	21.8	6.3	31.4	59.2	25.3	19.4	16.8	9.5	20.8	8.9	28.0	37.1	30.3	7.7	24.0	12.2	22.4	16.4	45.7	20.8	19.9	14.2	3.7	27.1	12.4	34.0	8.5	6.9	20.1	32.4	18.8	53.1	35.1	42.3	27.8	18.2	16.1	6.6	30.2	23.1	16.1	10.3	19.9	12.8	31.7	15.9	27.0	28.6	28.1
OGFR	7-60	ENSG00000060491	"Opioid growth factor receptor"	Q9NZT2	20	62804835-62814000	"Predicted intracellular proteins"	"Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 12.5;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017899	Supported		Approved	Nucleoplasm		NA	NA		20000	"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA017899: AB_1854774"	"unprognostic (1.33e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (5.19e-4)"	33.4	25.7	25.9	26.8	28.1	34.5	31.7	21.0	45.4	37.1	21.7	38.4	28.5	30.7	5.3	27.3	34.6	11.5	29.1	28.4	22.8	38.5	79.4	54.5	26.6	25.4	22.7	41.4	33.4	13.1	36.8	13.4	22.9	42.3	8.6	17.2	30.9	14.1	29.5	32.5	42.9	10.5	21.8	68.3	34.3	21.1	23.9	15.2	39.3	9.9	15.2	35.1	34.1	27.7	51.5	34.2	19.8	26.5	16.4	16.5	56.1	30.9	25.3	91.3	41.0	77.3	36.9	58.6	57.2	21.5	56.8	58.8	20.2	32.8	25.9	19.3	37.5	29.4	42.9	71.1	28.7	36.9	69.6	23.4	23.6	24.9	10.4	30.9	20.4	37.9	29.0	30.6	13.5	76.4	78.9	69.8	13.3	24.5	65.1	62.1	34.5	27.5	14.2	25.5	19.8	30.2	42.5	59.5	49.6	17.9	29.7	56.5	34.8	61.1	54.1	48.1	45.6	38.8	11.5	30.9	47.9	39.6	24.5	1.8	1.5	12.5	0.7	1.4	0.4	1.0	0.9	0.8	1.0	1.5	0.9	0.5	3.1	0.6	1.4	0.7	0.6	0.4	25.9	28.1	21.0	45.4	28.4	22.8	25.4	22.7	22.9	21.8	23.9	27.7	25.2	9.6	15.0	19.6	52.8	27.0	35.7	20.2	35.3	59.5	18.6	16.8	5.9	40.0	12.6	16.5	93.8	27.8	47.0	35.5	11.7	35.7	1.9	19.9	24.4	25.1	18.0	26.1	29.1	32.9	52.1	25.3	28.5	20.2	0.0	24.5	28.9	49.2	57.5	43.7	23.5	30.4	12.2	79.5	37.6	3.5	32.6	51.7	16.0	11.2	70.3	35.7	74.2	19.1	10.2	31.4	39.7	18.8	44.2	36.5	60.4	27.4	19.4	42.3	19.7	18.2	22.1	5.7	8.9	19.2	23.3	27.9	44.7	20.5	24.2	32.3
OGFRL1	dJ331H24.1	ENSG00000119900	"Opioid growth factor receptor like 1"	Q5TC84	6	71288811-71309059	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 175.3;Langerhans cells: 144.0;Macrophages: 155.7;monocytes: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027122			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA027122: AB_2156775"	"unprognostic (8.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (9.62e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.58e-3)"	25.2	11.2	32.9	16.1	28.1	26.7	51.0	40.5	26.3	7.9	7.8	9.3	3.6	10.4	13.7	33.2	6.5	10.8	6.8	40.9	47.7	7.1	6.4	11.5	14.5	50.8	60.5	6.6	8.0	6.2	7.6	13.5	51.5	8.4	5.3	13.2	46.3	12.8	5.1	20.1	6.8	33.4	55.3	16.8	6.3	2.8	47.9	11.4	5.3	12.1	25.5	7.4	12.5	69.6	9.7	2.9	10.0	0.0	26.5	24.1	3.6	42.2	26.5	16.9	17.0	3.7	1.8	59.1	56.3	18.5	15.6	4.7	7.8	29.4	59.5	12.5	6.1	13.0	10.0	1.5	21.4	6.2	4.4	24.4	24.7	12.5	38.8	14.2	13.7	0.0	0.8	4.5	58.8	8.1	0.0	9.7	4.0	3.8	2.3	4.2	30.4	13.8	38.8	0.7	33.8	15.3	12.6	7.8	2.8	14.3	13.4	48.0	21.1	41.3	20.5	4.3	14.1	6.0	0.4	7.6	13.8	41.0	7.2	3.4	2.6	0.1	0.4	1.7	0.4	0.3	0.3	0.4	2.1	0.5	0.0	0.3	11.1	0.5	1.3	0.8	0.1	0.6	32.9	28.1	40.5	26.3	40.9	47.7	50.8	60.5	51.5	55.3	47.9	69.6	40.3	6.4	18.6	175.3	17.4	38.9	22.3	18.4	22.8	42.8	79.4	86.4	8.7	11.5	14.1	11.0	25.0	23.2	31.7	1.4	1.9	17.0	0.5	8.0	14.2	30.2	14.4	11.1	29.1	32.9	11.0	50.8	5.6	19.1	6.3	6.6	8.9	5.1	61.7	38.7	28.0	2.2	8.2	95.5	144.0	1.2	16.4	155.7	32.0	71.2	133.5	87.0	18.6	13.0	4.0	19.3	2.4	33.1	11.6	16.2	0.1	4.9	3.2	6.0	26.3	26.8	31.3	0.6	1.2	57.9	46.5	19.0	19.3	3.4	4.4	19.3
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	12.6	13.8	18.6	13.2	18.3	12.2	12.8	20.5	19.6	18.2	12.5	14.8	18.9	17.1	10.3	9.6	16.9	8.4	11.8	19.6	15.8	30.3	20.7	10.7	26.2	18.8	16.7	22.5	10.6	6.6	10.8	8.6	17.9	15.7	8.1	12.1	12.2	10.1	7.2	9.6	17.2	9.8	16.2	15.2	12.4	8.6	17.5	13.5	13.1	8.0	21.2	15.3	14.3	17.4	11.3	20.7	20.3	13.1	19.9	22.3	38.4	14.5	14.8	21.6	25.6	19.9	10.8	68.5	9.5	18.3	34.1	10.8	12.1	15.9	9.0	25.1	17.6	33.9	32.5	29.3	20.7	13.3	20.9	22.3	20.0	37.4	16.0	17.4	27.3	9.6	11.0	10.9	20.9	21.3	10.7	13.2	11.0	10.3	29.3	7.8	13.7	22.4	12.4	5.7	9.0	15.9	18.4	15.2	11.5	10.4	23.7	22.9	17.5	21.9	22.7	17.2	24.0	10.7	16.9	35.9	17.4	37.9	13.7	15.1	10.9	20.7	18.7	9.0	18.4	13.9	15.8	15.3	9.8	16.5	12.1	11.5	2.9	27.0	7.3	15.9	21.0	10.9	18.6	18.3	20.5	19.6	19.6	15.8	18.8	16.7	17.9	16.2	17.5	17.4	9.5	0.0	3.4	15.3	16.7	5.5	8.9	8.3	9.1	20.9	6.7	7.4	2.3	10.0	4.9	9.2	35.5	6.4	16.5	9.0	11.7	7.7	0.9	5.0	12.2	10.4	18.0	22.3	11.2	6.7	10.1	11.7	6.1	4.4	2.5	10.0	10.0	11.8	18.0	8.4	9.2	8.8	6.1	9.0	5.8	1.8	14.3	9.3	7.2	10.3	15.8	11.3	27.8	13.0	9.9	8.8	11.0	13.5	10.0	5.2	47.1	86.3	4.1	34.7	26.3	11.1	10.3	10.2	21.5	5.0	4.5	4.0	12.9	12.0	14.0	5.4
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533104-71575892	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	59.3	55.9	39.7	38.3	42.4	61.5	62.7	43.3	51.6	72.7	40.1	62.5	30.6	56.0	62.2	52.8	76.4	26.4	55.5	43.9	35.5	61.6	45.8	70.7	71.9	36.1	35.8	85.5	102.4	24.3	46.9	26.4	37.9	75.4	39.6	36.9	64.1	27.1	62.8	68.6	86.4	24.5	36.1	122.8	67.4	19.0	36.2	57.2	70.7	39.2	57.8	55.7	67.4	44.3	40.5	37.0	47.1	41.5	49.6	45.6	31.6	30.3	54.3	32.1	49.1	39.3	45.4	47.9	20.7	37.3	33.3	49.1	52.0	29.5	39.4	41.1	53.4	30.4	98.6	28.5	37.6	62.9	48.1	43.6	59.2	35.1	65.7	55.5	30.5	100.7	31.1	160.4	31.1	34.3	48.9	75.2	31.6	35.5	49.8	47.8	52.7	62.1	50.0	45.9	24.1	21.2	46.9	30.9	30.2	35.5	22.8	42.4	35.5	34.6	27.9	36.6	17.9	43.5	33.5	56.5	24.4	65.0	21.6	2.8	4.6	2.0	7.5	5.7	6.8	7.4	6.3	6.2	6.1	6.2	7.2	7.4	1.9	10.4	5.7	6.2	6.2	5.6	39.7	42.4	43.3	51.6	43.9	35.5	36.1	35.8	37.9	36.1	36.2	44.3	31.1	35.3	85.2	52.9	67.2	88.1	37.9	23.5	58.6	26.5	49.6	34.0	42.8	20.0	31.1	49.7	8.4	15.8	130.7	31.1	9.8	14.4	2.4	32.1	49.8	39.8	34.9	51.3	110.7	14.4	8.5	47.5	54.6	53.3	27.8	26.4	45.7	27.5	16.1	40.4	94.6	37.3	22.4	60.9	69.7	4.8	53.4	45.8	35.6	71.2	51.6	11.3	51.5	92.0	97.9	17.6	34.9	29.7	147.2	53.8	34.8	15.1	28.0	21.8	32.9	44.8	42.2	2.5	6.1	63.3	84.1	10.9	82.1	62.0	34.0	50.8
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121180	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 555.7;choroid plexus: 246.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 193.1;Hepatic stellate cells: 78.1;Inhibitory neurons: 70.0"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.8;myeloid DC: 2.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 2.6;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 96.0;MCF7: 84.1;NTERA-2: 104.9;OE19: 78.9;SCLC-21H: 155.6;SiHa: 131.8;T-47d: 200.2;U-2197: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"	NA	NA		200000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: AB_2683443"	"unprognostic (6.77e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	36.7	25.4	410.4	13.0	427.0	0.2	36.8	309.6	555.7	29.9	246.9	24.0	5.0	29.0	70.4	12.1	30.3	8.6	20.7	474.7	309.0	20.3	4.8	15.0	14.5	296.6	301.7	19.4	12.3	4.9	82.8	1.0	293.9	19.3	13.8	47.3	14.0	18.1	17.5	15.3	16.5	17.9	279.9	35.1	15.4	6.8	317.0	11.5	17.5	23.0	19.1	25.0	26.7	372.3	0.0	6.1	12.1	0.2	1.7	1.4	0.5	3.6	0.0	0.0	0.0	0.1	2.7	0.1	0.8	5.2	49.2	2.3	2.6	0.0	0.0	14.4	0.9	0.2	96.0	0.0	0.5	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.3	84.1	0.5	0.3	104.9	78.9	0.0	0.1	0.3	48.3	0.0	0.1	155.6	20.5	131.8	0.4	8.6	7.9	200.2	0.0	0.1	7.7	16.6	87.1	0.2	0.2	0.1	0.3	0.7	0.1	4.3	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	410.4	427.0	309.6	555.7	474.7	309.0	296.6	301.7	293.9	279.9	317.0	372.3	44.2	0.0	7.9	43.8	0.1	9.7	3.3	0.0	3.4	21.6	3.1	3.0	5.9	11.5	1.8	0.0	43.8	0.0	0.1	2.4	0.0	9.7	5.8	0.5	20.4	50.0	2.4	0.0	193.1	2.7	0.0	17.3	0.0	0.7	2.5	14.4	78.1	1.1	0.4	38.7	70.0	2.5	0.0	3.2	7.3	11.9	44.4	2.8	21.4	32.8	2.7	38.6	0.0	48.7	17.3	2.5	2.5	29.3	0.4	5.1	0.0	0.1	0.0	15.7	0.0	13.3	8.8	0.6	3.7	1.3	6.3	0.0	0.7	12.9	4.2	1.4
OLFM2	"NOE2, OlfC"	ENSG00000105088	"Olfactomedin 2"	O95897	19	9853718-9936552	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 202.6;skin 1: 94.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.4;Basal keratinocytes: 125.0;Muller glia cells: 91.1;Oligodendrocyte precursor cells: 124.7;Suprabasal keratinocytes: 118.1"	"Cancer enhanced"	"Detected in all"		"glioma: 96.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 49.7"	"Group enriched"	"Detected in many"	26	"granulocytes: 49.7;T-cells: 17.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;ASC diff: 23.4;BJ hTERT+: 18.5;SH-SY5Y: 24.3;U-2 OS: 28.7;WM-115: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049961, HPA057771"	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA		2700000	"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA049961: AB_2680972, HPA057771: AB_2683524"	"unprognostic (1.42e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	36.8	30.7	130.8	3.4	134.5	0.2	25.0	118.5	202.6	17.2	80.7	4.8	2.1	16.7	4.5	5.6	11.1	6.7	10.1	134.0	127.3	9.2	41.9	10.1	7.9	152.5	168.8	9.7	11.2	9.6	19.1	7.1	162.0	10.1	1.1	24.6	10.0	13.4	1.8	94.8	3.8	6.7	130.0	2.5	2.2	10.7	123.2	16.5	13.2	1.0	4.8	3.0	14.1	120.7	0.0	3.7	3.0	25.6	23.4	14.3	1.7	5.6	18.5	1.2	1.5	0.3	2.4	0.1	2.3	4.2	2.1	1.5	9.8	1.7	0.1	0.1	2.1	0.0	0.2	0.3	0.1	0.0	4.3	7.5	1.5	0.1	0.2	0.7	0.1	4.8	0.3	0.3	0.0	8.2	0.3	0.2	15.8	2.5	0.0	0.1	0.0	0.0	0.0	0.9	0.1	24.3	0.9	0.1	5.2	9.7	0.9	0.0	0.3	10.5	28.7	0.1	0.1	0.0	0.0	0.0	0.3	0.0	25.6	21.2	0.0	49.7	6.2	0.0	6.6	0.0	7.0	5.5	0.0	0.0	13.5	8.9	0.5	1.2	0.0	0.1	17.0	2.9	130.8	134.5	118.5	202.6	134.0	127.3	152.5	168.8	162.0	130.0	123.2	120.7	12.9	0.0	0.0	108.4	0.3	125.0	4.7	5.9	8.6	4.9	6.9	13.8	0.8	7.2	0.4	7.3	0.0	0.1	1.0	0.1	1.9	0.9	8.6	0.9	2.2	4.3	1.2	0.4	27.3	2.4	0.0	17.2	0.0	1.0	4.5	6.5	1.4	24.7	0.3	1.7	51.0	0.2	2.0	0.3	32.6	52.8	13.7	0.6	17.8	15.0	0.4	91.1	7.2	124.7	3.5	4.1	0.0	9.8	0.5	7.9	0.0	0.2	0.2	3.7	0.0	7.4	24.3	3.0	10.4	1.4	118.1	0.1	7.7	0.6	0.1	2.9
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028813-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1296.1;pancreas: 671.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 497.1;Exocrine glandular cells: 900.9;Intestinal goblet cells: 791.9;Pancreatic endocrine cells: 933.7;Paneth cells: 556.9;Undifferentiated cells: 2419.9;Urothelial cells: 1989.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;BJ hTERT+: 18.8;HaCaT: 26.4;OE19: 10.4;RPMI-8226: 6.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted to digestive system"	Yes	NA		9300		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: AB_2732358"	"prognostic favorable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	1.9	0.1	0.2	195.4	0.5	126.0	6.8	0.1	0.5	7.9	0.2	451.6	1211.9	5.5	3.5	0.8	8.3	10.4	0.8	0.2	0.4	26.9	0.9	3.8	1.4	0.1	0.2	0.2	671.4	0.0	0.5	0.6	0.2	92.4	568.7	0.4	16.2	0.9	0.6	0.4	1296.1	52.6	0.2	18.0	16.1	0.3	0.2	4.2	0.4	2.1	0.2	127.0	285.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	5.4	2.4	18.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	26.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	10.4	0.0	0.0	0.8	6.2	0.2	0.0	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.6	0.9	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.5	0.2	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.3	3.8	0.1	168.5	0.3	0.0	0.0	9.8	2.5	0.5	0.0	11.9	139.8	0.0	0.0	0.0	98.7	1.9	497.1	0.2	13.5	0.5	1.4	92.3	0.8	1.0	900.9	0.0	1.5	0.0	17.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	791.9	2.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	10.3	4.0	0.0	0.0	0.2	933.7	556.9	0.0	0.4	209.4	300.6	0.0	0.5	0.2	0.0	2.1	9.2	0.0	0.1	0.0	0.0	0.0	3.1	0.2	2419.9	1989.0
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777133-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 40.1;Endothelial cells: 21.2;Fibroblasts: 29.0;Skeletal myocytes: 63.0;Smooth muscle cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 160.0;GAMG: 34.0;HeLa: 39.8;hTERT-RPE1: 38.0;WM-115: 64.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		240000		"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	15.4	2.9	2.6	2.7	3.1	0.3	11.1	2.2	4.6	25.0	3.3	29.9	3.3	25.3	2.8	8.2	6.4	4.8	16.4	2.2	2.4	4.3	0.7	10.5	2.4	2.8	2.1	12.0	4.8	4.6	2.8	7.0	2.8	7.4	6.2	2.2	7.0	12.2	10.8	16.0	6.9	16.0	2.1	32.8	5.5	1.1	2.6	3.1	19.1	10.0	3.7	17.6	14.6	2.1	0.8	14.6	1.2	0.4	16.8	160.0	0.1	1.8	8.2	3.5	3.5	0.2	2.2	0.0	3.4	0.1	34.0	25.5	0.4	0.8	4.0	0.0	0.1	0.0	39.8	0.1	0.9	0.0	0.1	11.3	2.7	10.2	1.4	38.0	0.0	0.0	0.0	0.2	1.8	0.4	0.0	0.3	3.4	0.0	0.9	0.0	9.5	0.0	0.0	1.2	0.0	0.1	2.9	0.2	4.3	28.6	3.9	0.5	0.1	5.2	4.6	5.5	0.7	1.9	0.0	0.1	15.2	0.8	64.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	2.6	3.1	2.2	4.6	2.2	2.4	2.8	2.1	2.8	2.1	2.6	2.1	40.1	0.0	1.3	0.7	0.4	12.0	5.9	17.5	6.2	0.6	2.9	8.3	13.8	1.5	5.5	0.0	2.1	0.3	0.5	0.0	0.0	0.1	0.7	0.2	1.5	21.2	0.0	0.0	0.4	0.6	0.3	29.0	0.5	0.2	0.0	0.9	3.6	0.1	0.1	0.0	0.6	0.0	4.1	1.5	7.9	1.4	2.8	0.9	10.6	8.4	0.1	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.1	4.0	0.0	0.1	11.5	4.0	13.1	63.0	36.4	0.4	0.7	4.5	8.4	0.0	0.6	4.2	0.0	3.5
OLIG2	"BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17"	ENSG00000205927	"Oligodendrocyte transcription factor 2"	Q13516	21	33025935-33029196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 87.2"	"Group enriched"	"Detected in some"	22	"Oligodendrocyte precursor cells: 124.1;Oligodendrocytes: 39.9"	"Cancer enriched"	"Detected in some"	52	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"eosinophil: 19.0"	"Lineage enriched"	"Detected in single"	190	"granulocytes: 19.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 56.2;NB-4: 41.8;THP-1: 35.9;WM-115: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003254, CAB019381"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Plasma membrane"	"CAB019381: , HPA003254: AB_1854795"		"unprognostic (5.14e-1)"	"unprognostic (4.56e-1)"		"unprognostic (1.44e-2)"	"unprognostic (8.27e-2)"		"unprognostic (3.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.41e-2)"		"unprognostic (1.39e-1)"	"unprognostic (5.78e-5)"	"unprognostic (2.76e-1)"			0.0	0.0	46.4	0.0	58.3	0.0	0.0	52.7	54.4	0.0	21.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	48.1	49.8	0.0	0.0	0.0	0.0	58.0	54.6	0.0	0.0	0.0	0.1	0.0	51.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	48.0	0.0	0.1	0.0	50.9	0.0	0.0	0.2	0.0	0.0	0.0	87.2	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.5	0.0	0.0	0.0	1.1	8.2	0.0	0.0	0.0	1.7	56.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	41.8	3.6	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	35.9	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	1.4	0.0	11.7	2.8	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	58.3	52.7	54.4	48.1	49.8	58.0	54.6	51.4	48.0	50.9	87.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	124.1	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
OLR1	"CLEC8A, LOX-1, SCARE1"	ENSG00000173391	"Oxidized low density lipoprotein receptor 1"	P78380	12	10158301-10172138	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.6;lung: 100.2;placenta: 114.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 399.0;Hofbauer cells: 202.1;Macrophages: 202.6;Syncytiotrophoblasts: 463.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 125.4;HaCaT: 64.9;HHSteC: 125.1;hTCEpi: 58.4;SiHa: 248.8;SK-BR-3: 96.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050798			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA	1060000		"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050798: AB_2756318"	"unprognostic (2.30e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (6.34e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.42e-1)"	3.0	3.3	9.0	29.1	13.1	23.8	3.6	18.9	16.9	3.3	8.8	0.7	1.3	1.6	1.3	0.5	2.1	7.4	1.5	9.4	13.3	8.2	3.1	100.2	0.7	25.5	15.6	0.3	2.2	4.1	2.7	114.5	26.0	2.3	1.0	5.1	3.8	1.0	0.5	0.6	1.2	2.1	27.6	0.8	2.3	4.7	24.0	2.8	2.5	0.0	0.8	6.0	0.3	52.6	7.3	0.5	0.1	0.3	0.3	0.0	16.8	12.1	2.2	7.3	2.6	125.4	0.1	1.6	0.0	15.8	0.5	64.9	0.0	0.7	4.9	0.0	0.0	0.0	6.1	0.0	125.1	0.1	0.3	1.0	58.4	0.3	0.0	0.0	0.3	0.1	0.1	0.7	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.2	0.3	0.2	13.3	0.4	0.2	248.8	96.9	0.0	17.4	27.1	0.0	0.1	0.2	1.4	0.0	0.0	0.4	0.3	0.4	0.1	0.1	0.1	0.6	0.6	1.3	0.1	0.1	0.1	0.1	0.1	0.0	2.8	0.2	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.6	9.0	13.1	18.9	16.9	9.4	13.3	25.5	15.6	26.0	27.6	24.0	52.6	1.9	28.9	27.4	0.0	4.0	1.5	0.4	0.5	0.0	0.4	1.1	4.6	0.1	1.5	4.4	0.0	0.0	399.0	0.3	0.0	0.0	0.1	13.4	0.1	0.0	10.8	0.0	0.4	2.3	0.0	14.6	10.9	0.5	0.1	15.2	0.0	0.0	0.5	202.1	0.0	0.2	0.0	0.0	18.9	79.5	11.6	0.3	202.6	0.0	40.3	21.3	0.1	0.0	0.5	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.2	6.6	0.2	0.0	0.2	0.4	0.1	0.2	0.8	0.6	463.1	1.6	0.1	0.0	0.3
OMA1	"FLJ33782, MPRP-1, YKR087C, ZMPOMA1"	ENSG00000162600	"OMA1 zinc metallopeptidase"	Q96E52	1	58415384-58546802	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055120	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"		"HPA055120: AB_2682702"	"prognostic favorable (1.63e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (8.22e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.54e-3)"	"unprognostic (2.52e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.24e-3)"	11.4	18.7	15.1	14.0	22.8	12.8	19.7	23.1	14.9	16.7	14.9	20.8	14.9	13.5	17.8	13.3	19.4	15.1	19.8	13.0	19.5	28.4	31.1	11.9	23.4	18.8	17.9	13.5	17.9	18.1	10.4	11.5	21.1	20.8	20.0	20.5	19.5	16.7	28.2	12.8	14.2	12.4	15.6	20.2	17.3	8.2	18.3	20.2	20.1	29.9	21.5	14.8	10.5	27.3	31.2	13.0	8.3	7.9	41.7	39.0	24.6	12.7	13.9	10.9	13.7	4.0	18.7	69.8	26.3	13.1	37.8	31.2	31.1	31.3	13.3	55.1	17.9	22.0	10.4	16.1	20.3	54.3	14.7	37.3	33.6	10.4	22.4	24.1	9.3	34.3	42.7	20.1	29.2	19.5	18.0	19.4	12.4	47.4	28.5	22.1	27.7	29.1	23.6	20.5	8.7	4.3	26.0	41.9	37.6	38.4	19.5	20.1	5.4	5.6	10.8	27.8	13.5	16.3	23.4	46.2	16.8	42.2	14.1	20.1	14.4	32.1	19.4	24.1	25.6	35.6	23.7	23.1	15.4	35.0	33.9	31.5	17.2	30.9	35.1	8.2	23.6	15.9	15.1	22.8	23.1	14.9	13.0	19.5	18.8	17.9	21.1	15.6	18.3	27.3	8.4	19.2	11.5	37.9	25.7	6.0	18.2	35.6	13.6	7.8	15.0	12.3	27.2	8.6	33.0	25.8	12.5	22.9	14.4	8.4	25.4	11.2	5.8	31.6	10.8	6.3	6.0	15.6	18.3	5.5	10.0	12.0	5.6	18.4	6.3	10.9	6.4	18.7	15.8	1.7	31.7	17.7	36.7	10.1	9.7	12.7	9.9	12.9	7.2	29.0	11.3	10.9	15.5	52.8	106.5	3.8	10.9	8.6	16.8	12.3	8.5	32.4	63.1	20.5	6.6	12.0	8.6	14.3	13.6	17.3	6.8	18.3	20.7	17.1	14.6	17.1
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435374-57491298	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.1;gallbladder: 10.1;intestine: 10.1;liver: 8.5;retina: 5.4"	"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 964.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.1;cerebral cortex: 2.3;hypothalamus: 4.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.3;HeLa: 14.1;RT4: 6.7;SCLC-21H: 10.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.7;cerebellum: 4.7;cerebral cortex: 5.6;hippocampal formation: 3.2;hypothalamus: 2.5"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Actin filaments"	"HPA057058: AB_2683323"	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.0	0.1	0.4	0.0	9.1	0.0	0.0	0.8	2.3	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	10.1	0.0	0.3	4.2	0.1	8.5	0.0	0.0	0.6	0.3	0.0	2.3	0.8	0.8	0.0	0.8	0.0	0.0	5.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	1.2	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.4	0.0	3.4	0.0	0.1	20.3	3.1	0.7	14.1	3.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.3	4.0	0.7	0.0	0.5	1.9	0.0	0.1	1.6	0.7	0.0	1.2	0.0	1.6	6.7	10.1	1.7	0.1	0.0	0.2	0.1	0.5	0.7	0.0	1.0	1.3	0.2	0.2	0.3	3.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	9.1	0.8	2.3	0.3	4.2	0.6	0.3	0.8	0.0	1.0	0.2	0.3	0.0	0.0	2.3	0.0	0.1	0.2	0.0	0.0	4.5	0.4	1.1	2.8	184.5	0.0	7.3	14.6	0.0	0.0	2.0	0.0	79.7	4.9	0.2	0.1	0.5	8.9	0.0	38.7	8.8	0.1	0.3	0.0	0.3	0.0	0.5	5.3	47.0	1.0	964.0	1.8	0.6	0.0	1.3	0.0	3.2	0.3	0.1	0.0	1.0	0.0	3.0	0.0	3.5	1.0	38.7	3.3	0.0	0.0	0.4	0.1	0.1	0.0	5.6	0.0	0.9	0.7	1.9	2.0	0.0	0.1	0.0	0.1	0.2	0.5	0.0
ONECUT3		ENSG00000205922	"One cut homeobox 3"	O60422	19	1753506-1780988	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 2.1;stomach 1: 4.3"	"Group enriched"	"Detected in some"	28	"Cardiomyocytes: 89.7;Horizontal cells: 312.9"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HaCaT: 8.1;OE19: 10.9;PC-3: 18.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059936			Supported	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA059936: AB_2684172"	"unprognostic (9.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.08e-10)"	"unprognostic (1.18e-1)"	"unprognostic (9.86e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.21e-2)"	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.2	0.2	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	4.3	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.9	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.2	1.1	0.7	0.5	0.6	0.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	1.0	0.2	0.5	89.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.9	0.2	0.4	2.9	0.0	0.0	0.1	0.2	0.0	1.3	7.1	0.8	0.0	0.0	0.0	0.1	0.1	312.9	0.1	1.3	0.0	0.0	0.8	1.5	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	6.4	0.0	0.4	0.0	0.4	0.2	0.0	0.0	2.6	0.0	0.4	2.1	3.2	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.5
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1 mitochondrial dynamin like GTPase"	O60313	3	193593144-193697811	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		10000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	15.0	12.0	14.3	7.6	17.4	25.6	12.8	15.2	19.5	10.4	9.4	18.9	16.8	10.9	9.1	14.6	8.1	10.2	39.3	18.6	17.4	18.3	20.9	8.5	11.8	16.4	15.4	8.4	10.1	23.1	3.8	11.7	16.8	12.3	16.6	9.6	11.7	13.3	24.2	11.9	13.8	13.5	12.4	9.3	14.6	6.3	15.2	12.7	13.9	44.5	12.4	13.0	5.1	13.7	58.9	18.8	18.2	20.2	15.8	25.0	19.3	27.5	26.2	30.0	29.0	45.2	19.3	38.6	58.1	27.0	27.3	37.3	32.7	31.7	53.5	46.5	25.7	67.9	16.7	23.1	24.9	55.8	29.8	28.4	27.6	30.0	40.9	18.5	26.2	15.7	28.4	37.0	30.2	46.5	21.9	30.9	25.8	33.9	59.9	27.8	40.1	41.6	22.7	36.1	39.8	24.2	41.8	46.3	29.5	14.1	60.3	43.5	26.3	27.7	20.8	29.3	58.7	33.1	41.3	74.0	30.5	43.7	28.4	9.7	7.3	7.1	5.8	8.2	5.5	6.8	5.5	5.6	7.8	5.1	5.6	6.0	2.7	4.7	17.3	4.0	6.6	5.2	14.3	17.4	15.2	19.5	18.6	17.4	16.4	15.4	16.8	12.4	15.2	13.7	24.8	16.0	24.0	72.1	27.5	15.9	16.4	17.4	24.5	19.5	20.9	13.5	135.2	22.8	20.1	18.4	31.3	19.0	24.6	31.4	17.6	19.3	7.7	20.3	25.2	23.8	23.4	86.3	106.8	24.0	14.9	24.6	31.1	26.1	19.6	25.6	14.3	39.1	17.9	21.9	106.7	20.6	10.2	25.6	14.7	13.5	15.8	28.1	21.4	58.1	22.9	14.6	11.3	87.4	98.1	28.9	12.1	14.7	29.3	18.7	24.6	34.1	19.6	23.4	6.6	21.3	26.2	15.1	16.6	34.3	22.4	17.9	22.3	28.2	26.7	22.1
OPA3	"FLJ22187, MGA3"	ENSG00000125741	"Outer mitochondrial membrane lipid metabolism regulator OPA3"	Q9H6K4	19	45527427-45602212	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044881	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA044881: AB_10964052"	"unprognostic (3.37e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (3.14e-3)"	"unprognostic (4.53e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.72e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.30e-12)"	"unprognostic (5.85e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-1)"	4.8	7.2	3.3	4.7	3.4	4.0	3.5	4.4	5.2	3.0	3.7	4.6	4.0	4.9	3.0	5.8	3.4	3.3	10.5	3.2	3.1	7.4	7.8	4.4	4.7	4.9	4.0	3.4	4.4	12.0	6.0	4.4	5.0	3.8	3.9	6.4	4.0	4.1	11.1	5.8	5.0	4.7	2.5	5.8	4.9	8.9	5.5	4.6	4.6	12.9	4.7	4.1	3.5	3.2	15.2	18.9	7.4	7.3	4.8	5.9	11.3	9.7	8.9	10.1	10.7	8.8	10.5	13.0	6.9	9.8	11.5	12.0	12.5	13.3	8.9	24.0	12.6	20.1	10.8	9.1	8.8	14.1	25.0	8.9	10.1	11.2	12.2	5.8	7.3	7.6	17.5	14.2	6.9	9.3	11.3	5.8	6.5	12.6	12.9	10.9	6.7	7.1	8.0	26.9	5.5	6.6	12.4	11.3	5.2	6.6	6.3	8.0	15.9	8.5	9.7	7.1	16.7	9.5	19.1	10.6	8.2	10.1	13.1	5.6	5.3	2.9	3.6	7.8	3.6	4.4	3.2	3.1	5.6	3.9	3.9	4.0	4.7	7.8	10.5	5.1	4.8	3.6	3.3	3.4	4.4	5.2	3.2	3.1	4.9	4.0	5.0	2.5	5.5	3.2	11.0	12.8	11.7	8.5	23.0	18.7	22.4	14.6	13.1	22.8	9.2	7.9	25.4	17.2	11.6	11.0	52.1	25.6	15.7	18.8	25.4	18.4	18.5	12.8	13.8	15.2	13.8	5.7	9.5	21.1	29.8	10.6	14.3	20.1	15.9	8.9	11.4	21.9	16.3	20.2	10.2	14.5	16.2	11.4	28.3	20.2	6.2	17.4	14.2	4.7	19.0	15.1	11.3	3.0	8.1	18.2	19.2	6.4	11.9	15.8	21.2	16.8	10.7	36.0	0.0	23.3	23.6	23.9	13.1	11.2	19.6	36.3	14.4	19.5	16.6	16.7
OPHN1	"ARHGAP41, MRX60, OPN1"	ENSG00000079482	"Oligophrenin 1"	O60890	X	67949349-68433913	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Neurogenesis"	"GTPase activation"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 383.9;Oligodendrocyte precursor cells: 600.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002919	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA002919: AB_1079526"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-3)"	4.1	5.1	20.8	1.8	18.6	3.9	4.5	14.2	19.5	6.0	1.0	3.4	2.5	5.6	3.7	3.8	3.2	2.7	3.1	18.0	14.6	4.3	1.3	4.4	1.9	9.5	11.9	4.5	3.1	3.6	2.7	5.6	5.8	10.1	3.4	11.5	5.4	5.0	6.5	6.4	2.9	4.0	6.1	2.3	3.8	2.6	16.3	1.2	4.7	4.8	1.4	2.3	3.8	11.5	23.6	5.1	3.2	7.3	7.1	6.8	5.0	4.2	5.6	8.3	10.1	3.3	4.5	1.5	13.7	4.9	3.4	5.7	3.1	2.9	12.6	0.9	2.1	5.2	6.9	3.7	2.4	2.1	5.2	4.6	4.8	6.9	6.4	10.6	5.6	1.1	3.2	3.1	4.3	10.1	0.8	1.8	7.5	10.0	4.8	0.9	7.3	1.3	8.5	7.6	1.7	2.8	7.2	9.1	13.7	7.1	6.2	1.6	6.0	5.0	7.3	18.1	4.5	2.9	3.4	1.0	4.0	2.8	3.5	1.0	1.0	0.4	0.5	0.4	0.4	0.5	0.4	0.3	0.4	0.8	0.4	0.5	4.6	0.5	0.6	1.6	0.3	0.2	20.8	18.6	14.2	19.5	18.0	14.6	9.5	11.9	5.8	6.1	16.3	11.5	13.8	16.0	19.3	383.9	0.0	3.2	5.4	2.0	10.2	5.4	6.7	5.0	3.3	2.8	6.4	18.4	6.2	23.0	2.3	3.9	0.0	1.2	2.0	7.2	4.3	8.1	4.2	1.3	84.6	0.8	11.7	18.0	14.8	12.9	8.8	36.3	5.0	0.2	4.6	0.0	78.8	3.0	2.0	2.1	9.5	1.7	21.1	5.9	8.8	54.4	1.2	16.0	3.1	600.2	41.7	1.3	2.4	12.0	0.1	8.5	3.8	1.8	10.9	5.1	0.0	24.1	5.4	0.3	1.9	8.9	5.1	66.9	1.4	4.2	4.1	4.2
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772485-128775794	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"retina: 41.0"	"Cell type enriched"	"Detected in some"	12	"Cone photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"LHCN-M2: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (9.33e-4)"	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	41.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPN3	"ECPN, encephalopsin, ERO, NMO-1, PPP1R116"	ENSG00000054277	"Opsin 3"	Q9H1Y3	1	241590102-241677376	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 133.9;Extravillous trophoblasts: 252.9;Langerhans cells: 206.8;Syncytiotrophoblasts: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 10.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 72.4"	"Low region specificity"	"Detected in all"							"CAB013682, HPA064443"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB013682: , HPA064443: AB_2685267"	"unprognostic (2.41e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.10e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.96e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.13e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.44e-3)"	2.6	2.2	5.0	3.4	5.5	1.1	3.1	4.1	9.6	2.7	3.2	6.4	1.6	3.8	4.4	4.2	4.5	3.1	2.1	5.8	4.3	4.2	11.0	8.4	4.4	3.5	6.4	2.1	1.9	1.4	2.7	18.7	3.4	1.0	5.5	0.5	2.3	1.3	1.8	2.2	2.9	1.8	3.5	4.5	3.3	2.5	7.1	4.9	3.2	4.0	5.1	4.2	2.9	5.3	4.5	15.0	10.7	0.8	38.3	72.4	8.2	8.0	6.0	5.6	5.6	1.1	12.5	0.6	0.4	9.7	6.3	25.9	3.4	5.7	5.6	16.7	0.8	0.0	3.2	9.5	19.4	3.9	8.3	37.0	15.5	3.5	8.4	37.7	11.5	13.4	7.6	2.3	9.1	2.4	1.4	5.0	29.1	19.3	8.0	6.3	0.6	14.6	38.5	6.7	2.8	10.9	5.0	15.6	4.6	21.5	0.8	14.9	13.9	1.3	1.0	2.2	8.6	5.3	8.7	0.7	4.3	12.4	16.7	0.0	0.8	0.7	0.0	1.1	0.0	1.8	0.1	0.1	2.2	1.7	0.2	0.3	0.3	0.5	1.1	10.0	0.2	0.5	5.0	5.5	4.1	9.6	5.8	4.3	3.5	6.4	3.4	3.5	7.1	5.3	3.7	6.4	5.4	4.9	35.5	14.7	13.5	12.7	18.8	3.3	12.4	10.5	0.8	15.7	7.0	12.9	0.0	80.6	60.1	41.4	13.7	16.8	133.9	10.5	5.8	5.9	4.2	15.1	56.7	10.5	252.9	7.7	12.8	22.2	2.5	22.4	8.6	26.3	26.6	0.0	15.7	8.8	20.3	31.9	206.8	89.7	11.1	56.9	28.4	9.4	30.2	4.3	5.2	10.1	7.2	19.3	10.8	16.6	18.4	20.1	7.6	21.5	2.7	2.1	0.0	5.4	13.3	7.8	8.3	29.7	12.4	171.6	6.4	6.6	7.1	15.2
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225724-53251637	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 14.5"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 4.5;Excitatory neurons: 6.7;Extravillous trophoblasts: 8.0;Glandular and luminal cells: 9.8;Inhibitory neurons: 10.1;Leydig cells: 4.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: AB_2732770"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.1	0.1	7.3	0.0	14.5	0.0	0.0	1.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	5.4	0.0	0.0	0.1	0.0	5.8	1.7	0.0	0.0	0.0	0.0	0.2	5.1	1.6	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	6.9	0.1	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	21.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.5	1.3	8.3	3.9	5.4	5.8	1.7	5.1	0.3	6.9	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	4.5	0.6	0.1	0.0	0.0	6.7	0.0	8.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	10.1	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0
OR13C2		ENSG00000276119	"Olfactory receptor family 13 subfamily C member 2"	Q8NGS9	9	104604671-104605627	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA078297			Supported	"Nucleoplasm,Plasma membrane"		NA	NA							"Plasma membrane"	Nucleoplasm	"HPA078297: "																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.8	0.3	0.9	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13C5		ENSG00000277556	"Olfactory receptor family 13 subfamily C member 5"	Q8NGS8	9	104598457-104599413	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA078297			Supported	"Nucleoplasm,Plasma membrane"		NA	NA							"Plasma membrane"	Nucleoplasm	"HPA078297: "																"unprognostic (4.88e-2)"		0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.2	0.5	0.5	0.4	0.8	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13C9		ENSG00000136839	"Olfactory receptor family 13 subfamily C member 9"	Q8NGT0	9	104617248-104618204	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA078297			Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA							"Plasma membrane"	Nucleoplasm	"HPA078297: "																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.1	0.3	0.4	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ORAI2	"C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B"	ENSG00000160991	"ORAI calcium release-activated calcium modulator 2"	Q96SN7	7	102433106-102456825	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 140.4;Endometrial ciliated cells: 77.2;Glandular and luminal cells: 76.9;Plasma cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 75.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 149.0;RPMI-8226: 160.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055137, HPA065937"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA055137: AB_2682712, HPA065937: AB_2685581"	"unprognostic (5.09e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.07e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (8.49e-5)"	"unprognostic (7.16e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.46e-1)"	8.8	10.7	18.7	30.9	13.7	39.4	7.2	16.5	21.2	8.0	25.3	7.1	7.9	11.9	6.9	3.3	10.6	9.4	4.4	24.4	26.2	13.5	2.1	9.9	31.0	21.0	20.0	6.0	7.1	39.6	38.9	5.5	24.5	6.8	3.9	3.3	7.3	9.4	1.4	2.5	17.8	6.4	13.7	27.7	11.3	3.0	27.5	12.0	16.0	1.6	22.1	10.7	3.8	12.2	22.1	52.2	20.0	38.3	17.2	17.2	1.3	21.4	24.3	24.6	20.7	28.9	24.1	149.0	59.7	38.9	47.9	8.8	7.6	6.2	8.6	17.1	11.7	23.0	24.2	9.1	26.1	56.6	29.2	16.2	3.6	39.4	5.8	24.4	39.6	21.3	27.8	130.7	18.1	44.9	77.4	25.1	23.8	8.1	18.6	33.0	15.3	160.8	14.4	18.0	32.1	78.5	20.5	9.4	11.8	10.2	13.3	22.7	36.3	57.0	55.5	39.3	29.9	115.9	94.8	116.4	40.6	30.8	28.5	13.2	6.8	75.9	4.9	5.8	5.1	29.2	4.1	3.6	3.9	29.4	2.6	3.2	58.9	18.3	3.3	6.4	2.4	7.0	18.7	13.7	16.5	21.2	24.4	26.2	21.0	20.0	24.5	13.7	27.5	12.2	29.0	3.2	9.6	5.2	140.4	4.0	9.7	5.3	5.2	33.5	10.0	6.7	4.2	8.6	11.1	16.5	66.7	1.3	55.4	1.0	5.9	20.9	3.6	77.2	39.8	27.0	17.3	27.1	13.2	11.6	1.6	13.9	1.5	76.9	26.0	14.9	23.9	0.7	14.9	43.7	14.7	2.4	2.0	19.1	12.5	7.4	8.1	33.0	10.6	7.5	37.6	12.1	39.1	7.1	1.2	10.7	0.3	10.1	76.3	10.3	0.2	8.9	31.2	19.1	0.0	17.9	15.2	5.3	9.1	1.2	3.1	3.0	28.8	12.8	2.0	7.0
ORAI3	"MGC13024, TMEM142C"	ENSG00000175938	"ORAI calcium release-activated calcium modulator 3"	Q9BRQ5	16	30949068-30956461	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 77.3;Hofbauer cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 94.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA015022: AB_1854807"	"unprognostic (1.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.60e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (2.30e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.43e-3)"	"unprognostic (9.17e-3)"	17.3	34.1	18.0	8.2	16.5	17.6	15.2	16.9	17.1	24.4	26.0	22.7	9.2	18.3	16.3	15.4	19.2	9.9	16.7	15.3	16.3	19.3	70.2	14.2	11.9	18.6	18.5	18.9	17.7	18.9	18.0	14.9	17.1	26.3	8.6	4.0	14.6	17.0	7.9	14.3	16.1	9.8	17.4	22.5	17.1	15.6	20.5	11.2	16.4	8.1	10.6	27.2	20.2	17.7	2.8	15.8	8.1	10.7	68.1	60.7	0.6	9.3	62.3	6.8	17.2	1.5	26.1	3.9	20.7	17.9	27.5	12.7	1.4	17.6	4.6	12.3	5.2	10.2	4.9	16.1	94.9	11.2	30.5	65.5	45.9	13.1	25.5	63.8	11.7	2.2	11.7	20.6	22.1	10.8	0.7	42.6	6.6	9.1	4.3	8.6	6.3	30.8	26.2	6.8	2.0	13.5	8.4	2.6	14.9	19.5	19.7	45.5	8.5	5.1	3.5	11.4	2.2	50.4	4.0	3.1	25.3	26.4	7.9	23.2	8.7	26.6	3.4	9.2	3.6	7.1	1.8	2.7	8.5	6.7	2.2	2.9	15.3	11.7	12.6	9.5	2.7	3.3	18.0	16.5	16.9	17.1	15.3	16.3	18.6	18.5	17.1	17.4	20.5	17.7	12.1	6.4	10.8	0.0	23.9	7.9	24.5	25.6	32.5	1.5	11.1	19.6	6.9	5.7	11.6	16.5	2.1	28.1	25.9	11.1	13.7	21.4	61.1	16.5	21.8	16.5	15.0	16.2	0.0	11.4	2.7	25.9	4.1	10.5	7.0	17.9	23.6	77.3	93.8	35.3	0.0	11.3	10.2	43.7	11.5	36.7	53.1	31.4	21.4	0.0	39.1	24.4	17.5	0.0	0.0	9.5	18.4	43.2	18.1	14.0	9.5	48.2	14.7	3.6	26.3	11.0	14.0	26.5	2.5	17.0	4.5	4.4	9.7	61.0	5.8	20.4
ORC1	"HSORC1, ORC1L, PARC1"	ENSG00000085840	"Origin recognition complex subunit 1"	Q13415	1	52372829-52404423	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 29.0;lymphoid tissue: 11.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.5;Early spermatids: 5.6;Erythroid cells: 14.1;Extravillous trophoblasts: 9.9;Plasma cells: 6.3;Spermatogonia: 6.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027439, HPA027450"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027439: , HPA027450: AB_10602041"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-3)"	"prognostic favorable (1.74e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (3.77e-3)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.70e-3)"	"unprognostic (8.39e-2)"	"unprognostic (1.25e-10)"	"unprognostic (4.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	0.4	0.6	0.2	3.5	0.1	29.0	1.1	0.6	0.2	0.6	0.0	3.4	1.7	0.6	0.1	2.7	0.3	0.4	0.2	0.1	0.2	0.5	0.6	0.6	6.7	0.3	0.0	0.5	0.3	0.3	0.3	1.9	0.2	0.4	4.0	1.0	0.6	0.1	0.5	2.0	2.3	0.9	0.0	2.0	1.0	5.2	0.2	11.6	0.3	0.1	7.7	0.9	1.0	0.3	19.3	20.8	33.0	21.7	0.8	2.7	31.8	13.5	12.2	38.9	40.0	25.8	10.7	44.2	11.6	8.5	17.8	25.9	48.9	16.9	33.8	19.0	28.1	53.2	30.2	25.8	0.2	71.9	29.2	1.4	0.8	38.1	4.3	2.7	11.7	27.6	63.0	20.9	12.8	14.4	56.9	34.0	73.1	11.7	29.5	60.2	51.3	43.1	6.8	25.0	18.5	15.6	31.0	18.8	10.3	30.5	10.2	28.7	5.4	15.8	22.5	24.9	34.0	10.9	31.1	54.4	15.6	52.6	19.5	0.0	0.1	0.0	0.2	0.1	0.2	0.2	0.4	0.4	0.6	0.8	0.1	0.3	0.4	3.4	0.2	0.0	1.2	0.3	0.2	0.1	0.6	0.2	0.1	0.2	0.3	0.0	0.2	0.0	0.2	0.3	0.6	0.0	0.0	0.3	1.7	0.9	0.3	0.4	1.2	0.7	0.7	1.1	0.5	0.0	0.1	0.0	0.0	5.5	0.7	1.2	0.0	0.3	5.6	0.5	0.6	0.5	0.0	14.1	0.7	0.2	9.9	0.7	0.5	0.6	0.0	2.8	0.0	0.2	2.9	0.0	0.7	1.3	0.0	0.3	0.4	3.8	0.6	0.6	0.0	1.0	0.3	0.2	0.0	0.5	0.5	0.2	0.8	0.4	6.3	0.2	0.2	3.9	0.1	0.9	0.0	0.6	0.7	4.1	6.5	2.5	1.1	1.8	1.1	0.9	3.7	0.4
ORC2	ORC2L	ENSG00000115942	"Origin recognition complex subunit 2"	Q13416	2	200908977-200963680	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003693, HPA073881"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB003693: AB_425574, HPA073881: AB_2686640"	"unprognostic (3.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (9.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-3)"	5.9	4.9	2.8	6.7	3.1	5.7	8.0	7.6	4.6	5.8	4.6	7.2	9.1	6.0	6.0	5.8	5.1	4.3	8.8	2.7	3.3	5.6	5.2	4.9	8.5	2.4	2.6	6.8	6.9	7.2	5.1	5.6	2.6	6.4	6.8	7.8	7.1	5.8	6.7	8.4	7.7	4.8	1.4	6.5	7.0	20.8	2.6	9.4	8.3	6.0	8.4	5.4	5.8	5.0	17.8	12.3	13.9	13.9	5.6	9.5	23.4	18.1	11.4	16.3	16.1	26.3	14.2	11.2	12.6	10.7	18.3	14.3	30.6	20.6	24.7	24.9	28.2	26.1	22.1	32.4	11.0	20.7	17.7	8.9	12.0	16.7	20.4	12.8	19.1	18.3	42.5	13.3	14.6	16.9	29.1	19.5	33.6	17.2	29.6	20.6	14.1	16.3	17.2	14.1	22.0	16.5	15.9	14.0	10.4	27.2	10.0	10.2	14.7	14.2	14.6	12.3	18.3	9.4	24.1	17.9	11.3	19.9	13.6	0.3	2.5	3.9	3.2	1.0	4.3	5.5	4.5	3.2	2.1	4.6	5.7	4.1	1.2	3.2	1.9	4.9	3.3	1.6	2.8	3.1	7.6	4.6	2.7	3.3	2.4	2.6	2.6	1.4	2.6	5.0	12.9	9.6	18.5	30.7	16.5	19.1	9.0	7.7	23.9	14.6	12.3	7.6	18.0	14.3	14.8	9.2	25.0	20.6	17.5	12.8	7.9	10.0	56.0	11.5	14.1	12.7	4.2	26.7	54.6	12.3	18.5	10.0	14.8	13.3	10.8	27.5	13.2	10.9	8.9	6.7	61.4	13.1	4.1	7.0	7.1	11.6	12.2	7.0	10.6	24.4	11.4	7.0	20.6	41.7	55.9	10.5	9.0	8.2	16.3	9.7	15.2	9.1	12.1	14.9	19.7	13.1	9.1	107.2	22.1	16.1	15.5	10.8	14.7	6.9	14.7	8.4
ORC3	"IMAGE50150, LATHEO, ORC3L"	ENSG00000135336	"Origin recognition complex subunit 3"	Q9UBD5	6	87590067-87667453	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039553, HPA053748"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA039553: AB_2676566, HPA053748: AB_2682247"	"unprognostic (9.38e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (8.63e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.09e-1)"	11.8	17.9	13.5	9.8	14.0	8.8	15.8	18.3	17.9	11.1	11.1	10.0	6.8	13.6	16.3	9.0	15.3	9.5	20.3	14.0	13.6	14.5	15.8	10.8	13.8	14.2	12.7	20.1	9.6	19.4	13.2	12.7	13.9	12.3	10.6	33.8	9.0	11.5	21.7	10.6	8.8	10.9	14.3	10.8	8.4	25.8	13.5	20.5	16.1	20.5	13.2	10.8	9.5	17.0	16.5	22.9	39.1	30.6	31.0	32.2	29.4	32.9	30.4	38.5	53.0	31.6	20.0	32.3	44.6	22.9	33.0	28.5	45.1	27.3	52.4	40.6	31.3	30.8	30.5	33.3	16.9	34.6	9.7	29.6	20.1	43.5	38.6	21.4	23.7	34.2	71.5	33.8	37.5	22.2	13.7	18.4	28.5	24.3	24.3	33.5	53.5	20.4	30.8	24.6	27.8	20.4	25.9	15.7	26.2	41.4	20.9	29.9	19.6	19.1	18.5	39.1	39.7	16.1	38.0	22.4	25.3	34.7	29.9	22.5	10.1	11.5	12.6	17.1	18.7	17.7	17.7	15.7	8.6	15.2	21.9	18.5	7.0	19.4	22.4	11.0	18.8	12.7	13.5	14.0	18.3	17.9	14.0	13.6	14.2	12.7	13.9	14.3	13.5	17.0	17.8	12.8	13.4	36.2	21.6	5.0	11.0	16.0	5.7	18.7	9.2	11.0	36.3	11.5	15.7	7.3	12.5	23.4	13.6	14.2	21.5	10.8	61.2	21.2	19.8	10.9	10.3	12.0	56.2	10.3	24.5	17.5	11.7	15.1	12.0	23.7	12.1	9.5	20.0	6.7	68.0	12.5	10.2	8.8	3.9	26.7	18.6	13.1	8.8	37.5	12.4	20.2	10.3	41.7	44.8	10.5	12.1	15.4	23.9	10.0	58.3	31.4	21.4	28.1	13.1	21.6	17.1	67.8	34.6	8.7	4.4	14.6	17.0	20.0	14.2	8.3
ORC4	"HsORC4, ORC4L, Orc4p"	ENSG00000115947	"Origin recognition complex subunit 4"	O43929	2	147930396-148021604	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015124, HPA064562"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"		"CAB015124: AB_2157883, HPA064562: AB_2685287"	"unprognostic (5.04e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (4.98e-8)"	"unprognostic (5.55e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.10e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.95e-3)"	9.7	11.2	11.5	10.1	13.1	19.3	14.6	21.6	16.3	9.0	8.7	12.6	12.0	12.0	11.0	10.6	14.2	9.7	11.6	12.8	10.8	20.5	12.8	9.3	10.9	9.6	7.9	16.7	8.2	16.2	7.6	10.1	10.0	12.1	13.8	19.7	13.4	10.3	15.0	9.3	11.4	11.5	7.6	8.9	9.4	15.5	10.9	15.7	15.6	10.9	11.9	10.2	6.6	14.4	22.8	19.3	37.2	20.4	14.2	13.9	39.9	25.2	21.3	31.3	31.0	47.9	22.6	29.3	26.8	15.1	27.7	22.4	43.4	25.2	32.4	20.6	36.1	40.2	19.0	32.8	18.8	25.9	14.5	11.9	29.4	34.0	13.9	23.3	21.4	27.5	38.8	14.9	21.2	23.8	20.1	20.9	42.3	18.9	28.0	21.6	24.9	26.5	34.5	46.3	35.0	27.4	22.6	24.7	30.1	33.6	18.9	12.2	15.5	23.5	23.2	17.3	23.4	14.7	37.9	27.5	19.1	20.0	14.6	24.1	13.1	18.3	13.6	17.5	13.9	14.1	12.9	13.9	16.4	14.5	13.4	13.5	18.8	19.3	14.0	8.3	15.1	11.7	11.5	13.1	21.6	16.3	12.8	10.8	9.6	7.9	10.0	7.6	10.9	14.4	21.5	83.3	62.5	53.5	26.0	26.0	21.8	47.1	27.3	48.7	20.3	24.0	25.9	11.5	66.1	12.9	39.6	40.3	27.3	21.7	45.0	31.6	34.0	47.9	17.6	23.8	22.9	46.5	88.4	17.2	48.2	27.7	14.3	26.1	45.5	28.3	19.2	17.1	23.8	53.8	91.4	18.9	28.5	18.8	20.7	15.7	22.4	19.7	21.4	34.7	22.0	33.8	24.7	69.9	71.3	18.3	15.4	21.4	12.8	24.4	23.2	55.4	85.8	37.5	32.9	23.2	31.5	61.2	26.8	22.6	24.9	32.7	25.6	16.9	21.8	20.6
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.4;Inhibitory neurons: 48.8;Oligodendrocytes: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	9.7	9.8	10.5	7.8	11.5	5.8	13.2	14.3	12.5	10.2	7.8	12.0	8.4	10.8	13.7	10.6	8.9	6.6	6.3	11.2	10.5	10.4	17.4	6.4	12.2	10.3	10.0	10.7	14.5	10.1	7.5	9.5	9.7	16.9	12.8	14.1	8.9	10.6	9.0	11.6	7.5	10.9	9.3	9.0	10.3	19.3	11.6	13.3	10.2	7.9	13.4	11.0	10.0	11.2	37.1	39.2	21.2	38.1	21.8	21.5	18.8	31.0	30.8	34.2	28.5	25.9	23.7	55.4	26.9	19.5	37.9	33.1	42.4	29.9	40.8	32.3	30.5	20.2	19.1	24.8	30.8	37.9	16.5	22.3	27.9	39.4	36.2	14.4	32.8	30.1	65.0	29.3	30.8	52.6	52.4	38.7	23.2	48.6	37.9	21.6	38.0	53.4	26.4	26.4	28.9	23.5	30.2	58.7	41.3	16.5	19.7	28.4	19.2	32.8	36.0	51.8	41.6	33.7	75.8	69.3	22.2	49.7	39.8	14.2	10.6	8.4	20.2	12.7	26.5	24.0	21.6	23.9	12.3	18.7	25.7	28.9	1.4	20.6	10.9	11.4	18.4	13.7	10.5	11.5	14.3	12.5	11.2	10.5	10.3	10.0	9.7	9.3	11.6	11.2	6.7	3.2	7.2	22.2	11.2	4.5	3.6	11.4	10.8	6.6	6.6	5.7	6.2	8.6	9.8	3.7	0.0	22.1	2.6	4.4	1.9	10.3	5.7	3.8	9.8	9.1	5.4	12.8	54.4	9.0	14.3	8.6	9.7	4.5	5.1	11.6	4.6	9.7	8.8	3.3	48.8	8.9	6.1	4.8	4.2	5.7	6.2	6.0	1.8	35.6	7.8	3.4	7.2	31.2	55.9	7.4	5.4	7.9	13.9	4.9	5.9	7.2	12.9	12.5	0.0	4.1	10.9	40.1	24.6	12.6	8.5	10.5	9.5	10.3	8.1	2.0
ORC6	ORC6L	ENSG00000091651	"Origin recognition complex subunit 6"	Q9Y5N6	16	46689643-46698394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.3;lymphoid tissue: 7.4;testis: 9.6"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 56.7;Spermatocytes: 102.6;Spermatogonia: 108.9;Theca cells: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016330, HPA072587"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB016330: AB_670295, HPA072587: AB_2686537"	"unprognostic (3.47e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.15e-6)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (3.53e-4)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.50e-4)"	"unprognostic (3.97e-2)"	"unprognostic (3.90e-14)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.98e-2)"	0.3	0.7	2.0	2.2	1.6	10.3	0.6	1.5	1.9	0.7	1.0	1.7	1.5	0.8	1.1	4.1	0.4	0.6	1.5	1.9	1.8	0.4	0.9	0.6	7.4	1.5	1.9	0.4	0.3	0.7	0.6	3.3	1.7	0.3	1.9	0.3	0.7	0.2	0.1	1.1	1.5	1.0	1.6	2.4	0.8	9.6	1.8	6.2	0.5	0.3	7.3	1.2	1.3	1.8	28.6	27.4	43.7	33.9	5.4	6.8	31.6	54.2	20.2	59.3	30.9	39.3	18.0	35.6	27.1	10.5	29.1	29.9	57.9	15.1	50.4	17.2	46.4	27.9	13.2	40.1	6.6	46.5	23.7	1.8	2.6	32.4	17.1	9.3	20.0	30.1	36.0	17.4	35.9	26.9	65.6	60.7	48.1	20.7	76.0	78.6	80.6	35.8	14.9	9.8	52.2	30.4	24.5	29.8	18.1	34.9	15.6	37.9	11.6	53.7	34.6	33.6	51.8	12.5	18.9	123.2	22.2	29.5	40.1	0.0	0.3	0.3	0.9	0.7	0.4	0.7	0.5	0.5	0.6	1.4	0.8	0.3	0.0	0.8	0.8	1.0	1.2	0.7	2.0	1.6	1.5	1.9	1.9	1.8	1.5	1.9	1.7	1.6	1.8	1.8	1.6	3.2	14.5	1.0	8.8	6.6	2.2	3.6	8.6	6.6	4.1	5.8	3.7	1.5	6.3	5.5	4.2	39.3	6.0	9.5	1.9	2.5	13.2	6.5	7.5	4.3	1.8	45.4	6.3	0.7	40.9	8.0	7.1	9.4	1.3	56.7	0.7	9.9	15.7	11.8	2.7	12.4	6.1	3.8	11.9	8.9	2.8	7.7	33.8	2.8	1.2	2.5	2.1	0.0	2.0	2.1	1.4	3.4	18.5	2.6	2.3	1.0	10.7	10.2	0.0	5.1	7.3	102.6	108.9	16.9	6.0	10.9	7.5	47.5	14.4	2.7
OSBP	OSBP1	ENSG00000110048	"Oxysterol binding protein"	P22059	11	59574398-59615774	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039227, HPA043625"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		70000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039227: AB_2676401, HPA043625: AB_2678587"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"prognostic favorable (2.08e-5)"	"unprognostic (7.80e-3)"	"unprognostic (7.32e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.08e-7)"	"unprognostic (1.25e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	19.6	41.7	14.1	15.5	15.2	27.2	27.4	15.3	18.9	24.7	18.4	26.8	29.4	20.0	31.6	19.6	22.4	19.5	25.5	15.0	15.6	42.8	57.6	18.5	17.8	15.4	16.7	22.4	37.3	44.9	16.1	22.9	16.7	25.9	28.3	15.9	30.1	27.0	57.7	26.6	25.5	21.2	14.0	15.6	27.8	18.0	15.7	24.0	32.3	43.8	23.7	19.6	17.1	15.1	40.9	33.6	24.7	33.2	56.5	52.4	26.8	32.9	42.3	38.4	34.4	38.1	40.2	41.1	42.7	37.9	47.2	41.4	45.4	43.5	43.0	40.0	20.9	28.1	25.1	25.8	60.2	36.2	52.9	40.4	52.8	36.2	94.4	40.0	41.7	38.3	48.6	37.3	34.5	19.0	34.0	26.2	28.0	59.5	32.7	32.5	39.8	28.6	45.6	47.0	28.5	20.3	38.6	47.7	46.0	33.6	66.9	22.7	45.8	32.7	22.8	49.5	22.3	51.9	45.2	41.4	37.0	25.6	26.8	1.7	1.6	1.5	2.8	1.4	2.6	2.2	2.9	2.3	1.6	1.6	2.6	2.1	1.5	2.2	1.3	4.0	1.3	1.1	14.1	15.2	15.3	18.9	15.0	15.6	15.4	16.7	16.7	14.0	15.7	15.1	29.2	25.6	9.0	14.7	18.9	39.6	16.4	13.7	29.6	23.8	38.0	27.1	34.1	32.9	19.0	27.6	22.9	14.2	31.1	34.0	7.9	14.0	8.8	37.9	52.7	21.8	30.0	10.5	25.6	18.6	14.7	21.1	22.4	43.8	27.9	21.8	15.4	67.1	16.0	26.9	22.9	40.0	8.2	12.9	16.9	14.5	15.8	17.9	14.2	12.2	9.6	15.7	18.6	18.1	23.3	20.2	20.5	19.9	32.2	31.2	34.6	21.0	27.8	21.7	6.6	28.4	19.3	25.1	14.5	27.0	47.3	30.8	20.0	43.5	28.4	26.4
OSBPL11	"FLJ13012, FLJ13164, ORP-11, ORP11"	ENSG00000144909	"Oxysterol binding protein like 11"	Q9BXB4	3	125528858-125595497	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 57.3;tongue: 80.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 74.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039144			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA039144: AB_10794086"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.73e-3)"	"unprognostic (6.38e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.13e-1)"	10.0	5.4	11.6	10.9	13.3	7.0	6.0	8.6	10.5	6.3	4.4	8.2	6.8	7.6	5.6	8.4	5.7	6.5	6.6	9.1	15.2	8.5	28.9	14.0	13.1	11.0	14.1	5.5	3.7	13.3	3.9	10.9	12.6	5.6	8.1	6.0	4.2	7.7	57.3	7.5	6.2	8.8	9.9	15.4	5.2	10.3	12.3	12.4	7.4	80.1	12.2	8.4	4.9	12.3	21.2	10.9	20.4	11.7	22.4	12.0	27.5	15.6	11.9	18.7	21.3	21.3	7.2	34.2	19.2	12.5	15.5	15.5	22.7	13.3	24.7	9.6	10.2	15.6	12.5	14.0	12.6	11.9	20.8	9.7	15.8	15.6	13.6	7.5	13.8	16.2	16.5	15.0	17.1	12.2	24.4	5.8	28.8	15.1	10.0	21.1	11.8	40.4	15.5	12.6	4.6	12.4	18.9	10.6	16.3	13.9	11.2	6.1	14.8	15.2	13.9	22.4	12.2	9.8	11.1	41.5	10.7	4.1	14.9	16.5	12.3	3.1	2.1	12.1	1.8	4.3	1.3	2.2	14.9	3.3	1.4	1.6	18.2	2.5	10.1	6.2	2.9	4.5	11.6	13.3	8.6	10.5	9.1	15.2	11.0	14.1	12.6	9.9	12.3	12.3	14.4	9.6	14.4	33.3	16.0	9.9	7.3	3.9	10.8	18.7	12.1	11.6	9.4	7.2	9.9	9.2	12.5	12.4	22.8	29.1	5.9	8.5	1.3	34.5	13.7	9.7	4.2	9.4	14.8	6.9	10.3	9.4	6.6	24.3	3.8	10.6	10.8	37.6	26.6	8.4	18.6	6.0	0.0	74.0	27.5	4.0	6.5	40.3	12.4	38.4	48.6	12.2	13.4	15.1	18.1	11.4	21.3	7.2	10.5	7.8	10.7	9.7	8.9	33.8	6.6	18.0	10.5	13.0	18.6	9.2	15.8	23.1	11.1	5.3	9.5	10.4
OSBPL1A	"ORP-1, ORP1, OSBPL1B"	ENSG00000141447	"Oxysterol binding protein like 1A"	Q9BXW6	18	24162045-24397880	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 214.3;Oligodendrocytes: 433.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	22	"basophil: 93.4"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040959, HPA043401"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA040959: AB_10964295, HPA043401: AB_10960208"	"unprognostic (1.75e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.53e-2)"	"prognostic favorable (4.98e-13)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.56e-1)"	72.0	27.8	77.1	9.4	105.6	15.4	47.9	99.6	136.0	52.4	114.0	34.9	20.7	48.0	17.2	30.8	29.6	21.1	52.0	77.3	90.6	43.5	13.3	24.2	10.4	89.7	95.0	27.3	16.5	62.8	18.7	8.3	94.5	23.0	22.7	82.2	51.5	26.2	170.9	17.5	20.2	41.1	79.2	9.9	21.3	14.3	91.3	9.6	29.0	123.1	7.9	25.4	20.0	136.8	38.2	11.4	26.3	49.1	60.0	48.7	24.5	14.0	40.4	12.4	10.2	7.1	38.9	0.1	16.0	25.1	19.7	37.9	10.4	24.4	11.4	0.2	19.6	12.1	7.8	0.2	29.9	30.4	6.0	63.4	34.4	9.5	38.4	54.0	15.9	10.4	0.0	0.3	15.5	16.1	7.0	9.1	21.7	19.5	36.8	0.0	21.0	3.2	3.3	27.7	16.9	16.6	32.6	37.5	46.1	24.5	13.7	21.7	3.4	45.9	9.4	14.9	13.6	0.4	5.3	1.0	22.3	8.7	26.8	93.4	4.2	1.1	0.2	2.2	0.1	0.0	0.8	0.6	4.1	0.4	0.6	0.5	1.6	0.2	0.7	4.1	0.8	1.5	77.1	105.6	99.6	136.0	77.3	90.6	89.7	95.0	94.5	79.2	91.3	136.8	214.3	16.0	21.6	142.0	5.4	20.1	43.4	16.6	29.6	66.6	73.6	64.3	78.0	41.5	20.0	20.2	22.9	12.1	11.1	23.6	64.6	13.3	67.7	27.6	55.3	89.9	4.8	18.7	180.3	7.4	8.1	59.9	16.3	17.0	17.2	137.9	37.5	12.4	26.6	25.2	166.4	40.0	40.7	27.4	17.9	76.4	42.9	34.3	58.7	67.5	11.0	124.8	0.0	75.9	433.0	10.7	19.1	54.9	2.5	27.1	29.8	71.7	21.7	112.3	32.9	44.7	65.8	6.7	9.9	27.2	10.2	6.4	3.8	103.7	16.2	26.4
OSBPL7	"MGC71150, ORP7"	ENSG00000006025	"Oxysterol binding protein like 7"	Q9BZF2	17	47807372-47821834	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 29.5;Gastric mucus-secreting cells: 118.7;Paneth cells: 29.9;Proximal enterocytes: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036076, HPA053083, HPA073967"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: "	"unprognostic (3.88e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (1.19e-5)"	5.0	3.7	10.6	4.9	10.4	7.2	5.4	9.5	14.0	11.1	7.3	22.7	22.3	8.6	1.6	3.4	7.6	5.3	6.5	10.3	9.9	9.9	2.2	8.5	7.5	10.6	10.2	9.6	17.3	2.6	10.1	2.3	10.7	14.3	8.7	3.1	9.0	6.1	20.2	1.7	22.7	3.5	9.2	17.2	34.0	1.4	10.5	4.9	11.3	3.5	3.8	9.1	7.0	10.9	6.0	6.9	3.0	3.4	3.3	4.6	2.5	2.2	3.2	3.7	4.2	7.1	17.8	6.0	8.7	3.2	1.3	43.2	1.7	4.8	1.2	20.8	2.4	4.4	15.0	4.8	3.0	9.4	0.1	7.4	0.9	2.4	1.7	11.5	7.7	10.5	4.4	8.1	5.8	7.8	9.5	10.0	1.8	23.8	8.9	8.6	4.7	8.3	5.0	4.5	3.1	7.0	3.7	1.2	3.3	3.7	6.4	5.9	8.9	5.6	4.9	0.0	1.8	14.6	5.8	5.8	6.1	7.9	2.2	0.0	0.6	0.6	1.8	0.4	0.8	1.0	0.7	1.1	0.6	0.4	0.5	0.8	0.3	0.4	0.0	1.0	0.9	0.9	10.6	10.4	9.5	14.0	10.3	9.9	10.6	10.2	10.7	9.2	10.5	10.9	5.5	0.0	3.9	10.4	4.5	0.1	1.1	2.5	1.2	6.1	2.9	2.5	2.7	1.5	7.4	3.7	6.2	0.2	15.4	29.5	0.0	2.7	0.1	2.1	2.7	4.3	6.0	3.2	7.3	14.7	0.1	2.0	118.7	1.7	2.5	7.1	5.3	0.5	2.7	11.8	6.3	25.8	4.1	3.4	0.8	0.3	2.8	2.3	1.8	1.0	2.7	7.1	8.2	3.5	9.3	9.3	29.9	2.6	11.4	1.7	34.5	1.2	3.4	8.2	0.0	2.5	1.9	0.0	0.3	1.3	0.1	0.5	10.0	3.3	17.6	1.3
OSCAR		ENSG00000170909	"Osteoclast associated Ig-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 13.6;lung: 28.4;lymphoid tissue: 29.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 35.6;Kupffer cells: 27.8;Macrophages: 42.9;monocytes: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	36	"classical monocyte: 43.0;eosinophil: 26.6;intermediate monocyte: 28.8;myeloid DC: 20.3;neutrophil: 40.0;non-classical monocyte: 27.0"	"Group enriched"	"Detected in many"	79	"dendritic cells: 20.3;granulocytes: 40.0;monocytes: 43.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.9;HHSteC: 9.4;hTERT-HME1: 5.0;NB-4: 5.9;U-937: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	3.7	1.8	0.9	2.3	0.7	13.6	1.8	0.1	1.6	2.2	0.0	1.5	0.0	1.3	0.0	1.5	3.2	1.3	1.9	0.1	0.7	1.5	2.4	28.4	0.3	1.3	0.7	1.1	1.3	0.1	1.0	0.6	0.9	1.7	0.3	0.0	2.2	0.3	0.5	2.1	1.6	1.7	0.7	29.8	1.2	0.9	0.8	0.2	1.1	0.6	0.6	2.2	2.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	13.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.4	0.6	0.0	0.0	0.2	0.6	5.0	0.8	0.0	0.0	0.0	0.4	0.1	0.1	0.0	5.9	0.3	0.1	1.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.5	17.9	0.0	0.0	43.0	26.6	0.3	28.8	0.1	0.0	0.2	0.4	20.3	0.0	0.1	0.0	40.0	0.0	27.0	0.8	0.2	16.8	0.9	0.7	0.1	1.6	0.1	0.7	1.3	0.7	0.9	0.7	0.8	1.7	0.2	3.2	5.9	0.3	0.3	0.8	0.6	0.7	0.6	0.0	0.7	0.4	0.3	1.5	2.1	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.1	0.3	0.9	0.0	1.7	1.9	0.0	0.4	0.6	0.0	0.1	1.3	0.3	0.0	0.0	35.6	0.0	1.0	0.3	0.0	27.8	11.6	0.2	0.0	42.9	0.0	1.0	66.4	0.0	1.0	0.0	0.3	0.4	0.0	0.0	0.4	0.3	0.1	0.2	3.7	0.4	0.0	0.2	0.1	0.6	0.5	0.4	0.1	0.3	0.7	0.4	0.1	0.3
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 58.0;testis: 76.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 453.5;Endometrial ciliated cells: 88.6;Respiratory ciliated cells: 199.1;Spermatocytes: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	6.8	8.2	9.7	2.4	10.4	2.0	9.4	7.4	10.5	9.5	31.3	7.3	2.9	10.0	22.0	5.0	58.0	8.8	7.9	11.1	13.0	19.1	2.8	11.0	1.9	11.3	14.7	9.1	8.2	30.2	23.1	5.6	10.9	9.9	3.9	23.1	8.7	8.9	4.9	6.8	2.7	7.9	9.9	1.4	6.3	76.1	13.5	3.6	17.9	5.2	1.5	5.9	4.8	8.3	6.7	6.3	7.6	8.9	8.9	8.6	1.4	4.0	9.7	9.7	6.6	0.1	5.8	1.5	7.3	7.3	7.1	5.1	0.2	7.5	6.2	1.1	5.9	0.1	3.9	0.7	10.9	0.8	1.2	9.8	12.0	13.7	5.9	14.1	6.7	6.3	0.1	1.7	7.7	4.8	3.6	2.5	7.8	2.6	2.6	3.8	3.1	1.2	16.0	2.3	20.4	9.0	7.5	3.5	5.4	7.2	7.6	1.1	5.8	7.0	2.6	12.7	6.9	2.8	3.1	0.8	13.4	0.2	4.7	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	0.2	0.6	0.2	0.6	1.0	0.1	0.1	0.0	1.2	0.7	0.2	9.7	10.4	7.4	10.5	11.1	13.0	11.3	14.7	10.9	9.9	13.5	8.3	3.0	9.6	10.9	4.6	0.4	1.5	5.5	21.3	3.4	5.4	7.9	7.5	5.5	5.7	21.3	12.9	16.7	12.2	0.0	2.0	23.5	15.1	453.5	88.6	5.8	3.3	4.9	1.7	8.1	9.3	3.4	6.4	6.1	7.7	0.0	4.8	2.2	2.3	4.2	5.0	6.9	2.3	32.6	0.8	1.2	66.8	12.5	1.4	3.6	1.0	0.1	12.9	0.0	5.0	2.6	7.2	4.0	9.1	0.4	3.5	0.5	26.1	199.1	21.3	0.0	4.7	7.7	163.7	20.6	3.6	3.1	20.1	0.7	13.9	2.3	5.2
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446401-20455089	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favorable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	5.7	6.3	6.1	3.8	6.2	6.1	7.0	6.4	7.3	6.8	6.8	7.6	3.8	6.4	8.5	6.0	6.1	6.6	8.1	6.0	6.3	5.8	11.1	6.2	9.3	6.4	6.1	5.3	5.6	7.4	5.2	6.7	6.4	4.9	7.0	4.1	5.3	8.3	10.5	4.7	6.2	5.6	6.5	8.4	6.4	2.4	6.3	9.9	7.6	9.9	10.1	8.2	4.9	6.9	10.3	17.2	5.6	16.2	9.9	6.6	17.6	8.0	11.3	21.1	20.1	21.5	12.3	21.1	10.3	11.0	9.0	8.6	17.9	17.6	14.1	16.8	19.1	14.8	12.2	32.1	7.4	24.3	19.7	5.3	5.2	26.1	14.0	4.6	14.3	18.8	14.0	12.1	17.6	21.0	25.0	11.8	9.1	31.5	31.8	35.3	10.3	12.4	12.8	11.7	21.3	4.2	15.4	16.0	11.9	3.3	9.7	23.7	6.1	8.7	21.2	11.3	10.7	3.4	18.0	31.7	5.0	36.1	11.0	9.3	29.2	38.5	18.8	27.9	17.4	28.7	19.7	17.2	44.5	38.1	15.9	17.4	13.8	20.9	23.3	16.9	19.2	24.6	6.1	6.2	6.4	7.3	6.0	6.3	6.4	6.1	6.4	6.5	6.3	6.9	27.1	35.3	34.9	16.3	46.0	11.5	20.9	26.2	14.2	37.8	24.0	25.1	17.2	15.7	29.1	23.9	37.5	66.3	31.8	22.5	35.2	24.7	3.1	19.2	18.3	24.1	26.9	19.6	23.0	29.8	47.0	23.4	28.1	16.3	25.9	24.6	25.7	19.3	65.8	10.1	24.1	24.2	22.4	30.7	32.8	3.0	19.3	34.2	21.4	7.5	28.4	31.0	32.0	16.6	17.0	20.0	30.6	21.4	26.2	10.9	42.2	39.7	25.5	51.5	13.1	24.6	23.9	7.8	16.9	22.0	11.5	46.1	26.8	37.3	31.6	17.4
OSGIN1	"BDGI, OKL38"	ENSG00000140961	"Oxidative stress induced growth inhibitor 1"	Q9UJX0	16	83931311-83966332	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 147.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.2;Hepatocytes: 78.4;Late spermatids: 261.1;Proximal enterocytes: 99.0"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 65.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 12.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.2;monocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"A549: 66.8;Hep G2: 103.7;T-47d: 73.3;WM-115: 62.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA019239			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA019239: AB_1854779"	"unprognostic (8.36e-2)"	"unprognostic (9.44e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (4.89e-5)"	"unprognostic (3.31e-3)"	"unprognostic (9.14e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.89e-1)"	8.5	26.5	7.0	4.8	8.3	0.8	7.1	7.6	7.0	4.0	4.3	7.4	31.3	3.3	1.2	12.3	4.5	8.4	10.1	5.2	7.3	14.1	147.4	9.3	1.3	10.1	9.0	4.3	8.5	3.0	3.7	1.6	10.2	5.6	2.5	2.0	5.2	2.2	22.4	3.3	18.7	1.6	5.5	10.5	13.9	15.2	9.3	0.8	13.2	9.6	1.2	12.8	5.7	9.3	4.7	66.8	0.8	2.9	4.1	5.9	5.0	7.7	7.5	7.0	2.5	16.9	24.0	0.1	18.0	6.7	31.5	12.6	3.2	4.9	2.6	1.1	0.8	1.2	15.5	103.7	15.0	2.3	25.7	3.6	3.9	18.1	4.1	3.9	7.2	4.8	6.5	6.5	9.1	31.9	0.9	0.9	0.6	16.5	15.8	2.3	6.7	3.3	4.8	5.9	0.4	1.5	16.0	5.1	32.6	1.7	73.3	2.7	23.1	10.6	16.0	15.7	5.3	2.7	1.2	0.2	35.6	3.6	62.8	0.1	2.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.2	0.0	12.6	0.0	0.0	1.0	7.0	8.3	7.6	7.0	5.2	7.3	10.1	9.0	10.2	5.5	9.3	9.3	2.2	16.0	3.9	0.0	0.6	1.5	8.1	15.7	5.2	0.8	7.9	4.3	9.0	8.6	18.5	1.8	0.0	1.4	0.5	41.8	5.9	11.3	56.2	6.1	1.0	5.4	4.2	0.0	0.1	6.6	0.4	5.4	26.0	5.3	1.3	2.7	6.1	78.4	10.5	0.0	0.1	12.9	12.2	9.4	3.0	261.1	4.1	7.3	7.2	0.0	3.0	8.6	0.0	0.0	0.2	13.2	23.5	12.0	1.3	11.8	99.0	11.7	5.0	0.6	13.1	4.7	5.1	2.3	1.3	6.0	1.7	1.4	0.6	4.6	10.5	5.9
OSR2	FLJ90037	ENSG00000164920	"Odd-skipped related transciption factor 2"	Q8N2R0	8	98944403-98952104	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 166.1;endometrium 1: 155.1;fallopian tube: 155.3"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 243.1;Leydig cells: 784.1;Peritubular cells: 758.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	16	"ASC diff: 542.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052425, HPA063486"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane"	Nucleoplasm	"HPA052425: AB_2681826, HPA063486: AB_2685022"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.73e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.57e-7)"	"unprognostic (1.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.54e-3)"	45.0	9.9	0.0	2.4	0.0	0.6	26.0	0.2	0.2	166.1	0.0	9.2	0.6	155.1	53.7	15.1	155.3	12.9	4.2	0.0	0.0	1.3	0.3	3.6	2.4	0.0	0.0	93.2	4.2	3.0	2.7	8.2	0.0	40.2	3.8	0.0	6.8	72.2	5.6	27.9	24.9	47.1	0.0	0.2	5.1	35.6	0.0	0.8	5.6	5.1	1.1	27.2	83.8	0.0	32.3	4.5	0.0	4.4	542.4	17.2	4.3	17.6	33.1	13.7	13.6	3.4	3.9	0.0	2.9	26.7	0.8	12.4	2.7	4.7	6.7	1.5	13.0	0.6	3.3	1.6	8.9	0.9	0.6	17.0	9.8	2.3	1.6	0.8	0.0	4.8	4.0	0.4	0.6	14.6	2.9	5.7	0.0	2.6	2.8	13.8	1.6	1.1	1.1	2.7	1.4	0.1	1.9	7.5	0.4	0.3	4.3	7.5	0.2	2.1	0.1	13.9	1.0	0.7	0.5	0.3	0.9	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.9	14.1	6.6	3.4	1.2	0.0	7.9	5.3	0.7	0.0	3.3	0.0	0.0	17.2	0.9	0.7	0.0	0.0	5.8	7.8	243.1	3.7	0.0	0.0	0.0	0.0	138.4	71.7	0.5	5.9	0.0	0.2	0.0	0.0	9.3	0.0	0.0	18.4	10.2	1.9	21.9	24.1	784.1	2.7	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	758.3	4.6	3.6	103.9	0.1	1.7	0.0	32.9	8.8	21.3	5.1	4.5	0.3	9.1	24.2	2.3	95.6	22.3	2.2
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteoclastogenesis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Melanocytes: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		210000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.1	19.1	4.7	17.9	5.2	5.7	9.8	5.1	5.8	10.4	33.1	12.2	7.9	13.7	9.0	12.7	9.5	12.5	19.2	5.3	9.2	15.6	13.1	16.2	14.7	6.0	7.6	7.5	5.8	15.3	8.3	14.1	7.9	13.8	11.1	17.6	8.9	16.7	11.8	9.8	9.0	23.3	5.3	18.3	8.5	10.1	7.4	13.7	10.7	11.5	13.5	16.9	7.0	8.3	6.0	17.2	20.1	29.4	59.0	19.0	28.6	42.8	42.7	30.7	50.4	10.0	9.8	13.7	34.4	30.0	82.5	11.1	20.2	14.6	47.0	31.6	15.7	28.9	10.9	12.8	45.6	32.1	64.6	28.1	35.7	37.7	30.0	28.2	15.8	15.2	23.3	48.7	50.3	8.4	7.1	7.3	8.0	7.1	13.0	11.4	29.1	7.5	22.0	15.7	2.2	11.8	34.7	8.7	79.9	26.6	10.0	45.8	19.3	26.7	9.8	59.7	61.4	18.6	34.4	11.9	78.9	21.3	60.3	31.4	20.2	22.8	20.3	29.4	21.5	14.7	16.9	22.3	17.8	8.6	15.6	19.8	29.8	22.0	43.5	12.9	22.6	27.0	4.7	5.2	5.1	5.8	5.3	9.2	6.0	7.6	7.9	5.3	7.4	8.3	28.5	9.6	19.0	26.4	26.0	46.7	19.8	11.7	21.6	28.3	10.0	7.0	24.8	12.8	9.4	12.9	10.4	21.7	32.3	21.9	1.9	12.4	12.0	7.5	15.7	20.7	4.2	4.6	36.6	22.9	33.9	24.4	15.8	9.6	24.1	6.9	26.7	13.2	52.8	28.6	40.1	5.8	6.1	46.5	29.5	5.4	14.3	43.1	151.2	20.6	25.6	23.7	40.2	21.1	36.6	16.8	17.0	28.6	25.0	17.9	7.6	25.5	9.8	17.5	26.3	18.5	29.6	28.0	18.7	12.4	31.1	61.2	29.5	23.7	3.3	16.0
OTP		ENSG00000171540	"Orthopedia homeobox"	Q5XKR4	5	77628712-77638713	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"brain: 28.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Sertoli cells: 6.6;Spermatocytes: 2.2;Spermatogonia: 1.5"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 28.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"hypothalamus: 20.0"	"Region enhanced"	"Detected in some"		"hypothalamus: 15.5"	HPA059342	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies"	"HPA059342: AB_2732635"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-2)"		"unprognostic (6.25e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.16e-1)"		"unprognostic (7.77e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.39e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.76e-14)"	"unprognostic (3.38e-2)"	"unprognostic (1.84e-1)"		"unprognostic (9.49e-3)"	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.1	0.0	9.2	1.7	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.4	0.0	28.7	9.2	1.7	6.6	0.8	8.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	2.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	44.8	57.0	69.9	43.0	78.0	63.5	47.3	53.0	93.4	54.1	39.7	51.9	42.0	49.0	37.4	85.4	55.8	35.9	62.4	79.3	62.5	61.3	47.0	47.1	59.8	65.0	58.0	44.5	43.9	47.1	48.6	49.3	66.1	53.5	39.3	25.6	54.3	42.6	70.2	78.1	51.9	38.0	51.2	58.6	54.0	57.1	65.0	56.0	51.9	48.4	57.1	52.5	56.7	67.7	113.4	198.9	107.2	95.7	70.7	77.8	83.0	66.0	97.1	143.6	105.1	138.1	104.5	59.3	122.0	106.6	124.4	138.1	140.4	165.4	88.1	69.9	111.7	99.3	114.1	172.9	98.8	99.2	104.3	83.4	106.4	110.2	69.8	74.4	137.2	54.6	71.2	65.3	97.9	237.2	109.2	133.0	126.5	95.4	94.1	88.3	41.8	102.5	151.1	162.1	81.5	117.5	74.6	114.1	123.3	72.9	178.2	86.3	100.1	75.8	74.2	103.3	88.4	76.2	51.7	86.4	98.4	64.0	74.5	228.8	186.8	189.9	165.5	244.2	131.2	149.6	152.1	153.6	203.1	139.3	117.1	130.4	184.6	161.8	218.9	140.7	224.7	313.4	69.9	78.0	53.0	93.4	79.3	62.5	65.0	58.0	66.1	51.2	65.0	67.7	37.0	19.2	56.5	15.0	67.2	48.3	70.9	137.8	83.6	44.4	42.5	48.8	31.9	37.1	82.5	46.0	39.6	146.2	56.5	104.7	74.3	80.7	72.6	55.4	36.2	43.4	87.8	35.5	17.8	85.5	109.2	50.0	71.9	44.3	48.7	54.6	35.7	33.2	90.4	30.3	16.9	70.8	101.7	57.4	65.9	87.1	34.2	61.0	51.6	8.4	98.0	43.2	78.2	12.5	18.8	90.1	92.0	25.6	80.8	51.8	90.8	85.2	89.2	55.7	26.3	28.1	62.0	48.0	71.4	77.7	52.6	194.8	73.7	51.7	62.7	71.6
OTUD1	"DUBA7, OTDC1"	ENSG00000165312	"OTU deubiquitinase 1"	Q5VV17	10	23439075-23442377	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 149.0;Langerhans cells: 219.1;Macrophages: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.1;HaCaT: 36.5;SiHa: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038503, HPA038504"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA038503: AB_2676049, HPA038504: AB_10672712"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.61e-7)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-2)"	13.0	11.7	8.0	10.2	8.4	60.4	10.3	9.5	10.2	8.4	8.4	8.7	6.8	10.2	6.8	7.8	11.2	9.7	43.4	8.7	9.0	19.7	7.6	19.7	14.4	8.3	8.0	13.6	6.9	19.4	8.0	12.1	7.6	8.8	7.6	5.9	6.7	7.6	29.4	20.9	8.2	9.4	8.4	13.7	22.9	7.5	9.2	6.8	13.3	22.6	12.5	11.9	7.6	9.2	4.8	2.3	2.4	1.1	9.3	4.6	3.2	1.9	4.2	4.4	4.0	0.9	38.1	2.2	4.1	2.4	1.5	36.5	2.5	4.5	2.9	17.4	7.1	0.1	5.7	1.5	8.0	0.4	3.2	4.8	19.4	1.3	6.1	3.9	1.5	2.2	0.5	15.1	2.5	2.3	1.5	1.4	1.9	2.7	1.3	2.4	10.8	2.2	5.8	4.0	1.1	2.6	23.4	4.1	11.3	6.3	1.7	3.3	2.7	2.5	3.7	7.0	0.8	7.6	15.0	1.1	3.8	1.5	1.0	2.5	0.5	1.0	0.3	0.6	0.3	0.7	0.5	0.3	0.3	1.2	0.4	0.6	1.3	0.0	1.9	0.2	1.3	0.2	8.0	8.4	9.5	10.2	8.7	9.0	8.3	8.0	7.6	8.4	9.2	9.2	17.3	67.3	11.5	3.3	55.9	32.0	7.1	5.0	13.6	20.1	12.3	9.1	149.0	7.2	4.9	5.5	2.1	3.3	9.6	47.2	11.7	6.0	8.0	35.0	44.5	25.6	6.0	13.5	4.3	7.1	3.2	20.8	47.4	33.8	5.7	10.4	16.4	10.1	51.0	53.8	4.8	77.9	10.2	68.2	219.1	7.6	6.5	105.7	33.8	8.4	9.3	33.8	10.3	4.0	6.5	10.1	16.3	13.2	50.0	7.7	8.0	25.1	9.8	26.2	6.6	82.2	19.4	7.2	4.7	15.1	30.5	7.9	16.5	7.5	24.3	10.9
OTUD3	"DUBA4, KIAA0459"	ENSG00000169914	"OTU deubiquitinase 3"	Q5T2D3	1	19882395-19912945	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028543, HPA028544"	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA028543: AB_10599302, HPA028544: AB_10602277"	"unprognostic (6.45e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.15e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-2)"	3.3	5.7	4.8	3.3	5.0	6.4	4.7	5.2	5.9	6.2	2.2	6.4	5.0	7.7	6.0	3.8	5.6	3.3	3.4	4.9	3.2	4.6	3.1	4.9	3.6	2.8	3.1	6.7	4.6	4.1	5.5	2.4	2.8	5.9	3.8	9.3	3.9	4.1	4.9	6.4	5.8	5.6	2.2	4.8	4.8	10.7	3.6	3.7	3.9	4.3	3.0	4.5	4.9	5.2	5.8	2.2	9.5	11.4	4.0	3.5	9.3	6.1	3.5	3.0	3.0	10.2	5.4	9.2	4.8	13.5	2.2	5.6	8.9	3.5	5.9	6.0	11.9	8.8	13.4	7.2	2.2	6.5	7.8	2.9	3.4	4.8	6.2	6.4	4.1	9.2	6.3	3.8	5.3	3.2	5.0	6.5	4.5	4.6	5.6	11.5	24.2	3.4	5.1	6.3	8.4	5.9	4.4	3.5	4.6	9.2	5.2	4.8	5.0	7.3	9.3	8.2	5.3	4.4	4.0	5.6	5.1	8.6	3.4	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.3	0.3	0.1	0.1	0.0	0.1	0.2	0.0	4.8	5.0	5.2	5.9	4.9	3.2	2.8	3.1	2.8	2.2	3.6	5.2	5.0	16.0	7.5	11.4	5.6	14.1	5.9	2.4	4.6	14.9	10.2	9.1	4.7	4.3	2.0	9.2	16.7	2.7	6.5	4.7	0.0	5.1	16.0	11.7	7.8	5.1	12.0	6.1	32.6	4.5	5.4	7.0	5.1	8.3	1.3	16.4	7.9	2.2	1.9	26.9	28.5	7.0	4.1	2.6	8.9	16.4	5.6	5.2	5.4	6.5	4.1	8.9	5.2	21.1	16.6	5.0	6.7	6.0	8.6	9.8	4.7	4.2	9.7	15.5	6.6	7.8	6.1	23.5	21.4	5.7	8.8	2.5	7.0	4.7	7.0	4.8
OTUD5	"DKFZp761A052, DUBA"	ENSG00000068308	"OTU deubiquitinase 5"	Q96G74	X	48922024-48958386	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"U-266/70: 1503.3;U-266/84: 407.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017375	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli fibrillar center"	"HPA017375: AB_1854844"	"unprognostic (9.73e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.20e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.05e-3)"	37.7	44.8	42.9	36.9	44.9	56.7	36.6	39.2	45.5	40.6	33.6	45.8	39.6	43.0	29.9	37.5	41.4	24.7	29.9	44.8	46.1	41.1	39.5	39.6	43.4	44.2	42.8	46.8	37.7	35.6	46.1	26.4	46.0	43.1	21.7	30.2	36.3	32.0	39.7	44.6	47.3	27.0	38.3	60.7	37.5	24.2	44.9	47.0	42.3	25.2	35.8	39.9	36.7	43.9	53.0	77.8	36.0	88.9	59.2	52.3	41.4	45.7	52.9	55.9	59.8	39.7	57.3	58.9	29.2	56.8	49.1	63.3	54.2	45.7	51.7	69.1	65.0	44.5	79.4	45.0	49.3	43.4	48.7	58.1	41.2	58.2	39.5	61.4	44.7	47.8	56.9	90.7	40.0	52.3	67.7	89.2	64.9	19.5	60.4	53.0	52.5	77.4	38.9	46.4	34.7	60.7	60.2	38.7	61.7	82.7	51.6	39.2	64.2	36.5	46.2	97.2	38.1	1503.3	407.1	56.5	56.3	58.9	25.7	5.5	3.3	7.6	6.6	5.2	5.6	8.6	5.1	5.7	4.8	5.3	4.8	7.1	8.5	20.3	5.1	6.2	7.3	3.6	42.9	44.9	39.2	45.5	44.8	46.1	44.2	42.8	46.0	38.3	44.9	43.9	21.3	9.6	22.3	17.3	33.3	22.2	21.2	13.7	13.1	35.5	23.7	19.7	11.5	15.7	16.3	27.6	27.1	13.3	38.2	28.4	9.8	13.6	1.9	24.5	23.2	19.6	48.2	32.6	15.5	18.3	16.3	18.4	21.4	33.1	7.0	28.5	22.1	24.3	16.7	28.6	15.7	28.5	10.2	22.9	33.9	2.9	20.8	25.7	26.6	15.9	22.6	18.0	30.9	14.1	14.1	21.5	19.0	23.7	38.1	27.5	28.1	21.7	21.6	27.9	13.1	19.9	20.1	10.4	12.6	15.9	25.6	30.8	33.3	28.6	20.1	27.4
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU deubiquitinase 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	6.6	6.2	5.7	6.3	6.1	5.9	7.2	5.9	8.6	5.2	5.0	5.3	4.2	6.0	4.6	6.4	4.2	3.9	6.5	5.4	6.1	5.4	5.4	4.7	7.4	6.2	6.2	5.3	4.6	4.0	3.5	8.0	6.3	5.8	5.4	3.1	4.3	4.7	10.2	6.4	4.4	5.5	6.3	5.0	4.3	6.4	5.9	5.7	6.0	9.2	6.1	6.3	5.4	7.5	27.6	11.1	12.8	10.4	6.4	5.6	14.5	19.1	7.4	19.1	12.6	8.6	16.6	25.6	9.0	10.2	7.6	9.1	26.4	16.1	31.6	21.6	16.9	34.5	11.7	8.3	13.3	18.7	21.0	7.2	9.8	14.0	35.5	11.6	17.5	19.4	36.5	19.1	18.9	9.6	31.7	17.5	8.1	20.3	27.3	19.4	11.2	28.9	18.9	15.1	3.5	14.6	2.6	55.9	22.7	16.3	25.5	11.8	15.8	12.3	17.2	20.6	20.5	17.1	29.5	37.2	16.8	26.2	23.1	1.7	1.9	1.1	1.5	2.7	2.0	2.0	1.4	1.7	2.6	1.8	2.1	1.9	0.2	3.4	2.1	4.0	0.8	1.0	5.7	6.1	5.9	8.6	5.4	6.1	6.2	6.2	6.3	6.3	5.9	7.5	11.9	9.6	11.3	9.8	13.7	23.2	6.5	4.0	10.8	13.0	6.5	5.2	14.3	8.6	9.2	1.8	33.3	10.8	16.5	5.1	9.8	4.8	0.9	10.6	9.9	10.9	10.8	8.2	18.0	4.9	10.0	9.0	7.7	8.6	18.4	10.7	8.9	11.7	8.1	11.8	15.5	4.9	4.1	8.7	12.5	2.2	9.6	8.3	3.6	12.2	10.2	12.2	11.3	18.6	21.6	6.6	3.7	4.1	12.0	8.9	2.8	8.2	8.8	15.3	0.0	8.2	9.6	3.2	7.0	12.5	18.2	6.7	10.7	9.9	6.4	5.9
OTX1		ENSG00000115507	"Orthodenticle homeobox 1"	P32242	2	63050057-63057836	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"salivary gland: 18.0;skin 1: 8.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.8;Basal respiratory cells: 6.3;Club cells: 4.1;Ionocytes: 6.1;Respiratory ciliated cells: 6.8;Suprabasal keratinocytes: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	95	"neutrophil: 9.4"	"Lineage enriched"	"Detected in single"	95	"granulocytes: 9.4"	"Cell line enriched"	"Detected in many"	9	"THP-1: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052122	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA052122: AB_2681736"	"unprognostic (2.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.71e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.64e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.80e-4)"	"unprognostic (3.67e-3)"	0.1	0.0	2.1	0.0	1.7	0.0	0.2	0.1	2.5	0.0	3.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.1	0.0	0.2	2.5	0.0	0.2	0.0	0.0	0.0	0.7	0.7	0.0	0.0	18.0	0.0	0.0	8.4	0.0	0.0	0.0	0.1	0.2	0.3	2.8	0.0	0.0	0.0	0.5	0.0	0.1	1.8	2.3	1.3	4.2	2.5	0.0	0.1	5.9	0.0	0.3	0.3	0.4	4.4	2.2	0.1	0.8	0.0	1.1	3.0	2.7	1.9	0.5	1.1	2.5	2.7	2.2	5.0	0.0	1.9	2.0	0.0	0.7	0.0	0.7	0.8	0.0	2.6	2.4	0.0	0.2	2.1	2.6	4.6	0.0	2.2	1.6	2.3	3.6	0.7	1.2	0.8	0.4	0.5	1.8	0.2	1.5	0.0	1.0	54.1	0.1	0.9	1.7	0.0	0.9	1.5	1.1	4.0	0.3	2.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	2.1	1.7	0.1	2.5	1.9	1.4	0.2	2.5	0.7	0.0	2.8	1.8	0.2	0.0	0.0	9.8	0.1	1.7	0.0	6.3	0.6	0.0	0.8	1.0	0.8	0.0	4.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.2	0.6	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	6.8	0.0	0.0	0.7	0.3	0.3	0.5	1.1	2.6	0.1	0.0	0.1	0.2	0.1
OTX2		ENSG00000165588	"Orthodenticle homeobox 2"	P32243	14	56799905-56816693	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"choroid plexus: 108.8;retina: 279.9"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 170.6;Cone photoreceptor cells: 168.9;Rod photoreceptor cells: 202.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 11.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 249.6;hTERT-RPE1: 57.0;NTERA-2: 199.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000633, HPA001123"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA000633: AB_1079538, HPA001123: "					"unprognostic (3.82e-1)"			"unprognostic (2.56e-2)"							"unprognostic (9.28e-2)"			0.0	0.0	4.1	0.0	1.3	0.0	0.0	8.5	0.5	0.0	108.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	2.6	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	2.5	0.0	2.0	0.0	0.0	279.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	12.8	0.0	0.0	0.8	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	249.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	199.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.3	8.5	0.5	5.9	2.6	0.2	8.7	2.0	0.1	12.8	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	170.6	0.0	0.0	0.3	0.0	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVCA2		ENSG00000262664	"OVCA2 serine hydrolase domain containing"	Q8WZ82	17	2042022-2043425	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"B-cells: 10.3;Basal squamous epithelial cells: 19.9;Erythroid cells: 11.3;Gastric mucus-secreting cells: 21.9;Macrophages: 8.4;Plasma cells: 31.0;Squamous epithelial cells: 32.2;T-cells: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059002			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA059002: AB_2683875"																		27.0	39.4	35.9	20.8	35.9	32.2	23.6	36.5	42.0	16.7	36.9	26.1	26.1	18.1	22.3	36.4	17.6	22.3	30.2	36.3	36.7	36.4	42.0	21.0	30.9	36.3	36.2	16.6	37.8	23.4	33.0	17.9	36.5	24.7	21.5	18.2	26.8	16.4	33.0	32.1	26.5	16.6	36.1	30.0	31.3	29.6	37.4	22.5	21.6	26.6	24.6	30.2	21.1	36.8	57.7	64.6	24.1	49.5	30.2	40.5	39.3	39.2	49.1	51.1	44.7	70.1	39.6	19.3	41.4	63.9	32.7	44.5	36.2	62.8	35.7	28.5	74.1	28.9	34.4	31.2	79.1	20.6	54.5	54.9	59.0	48.8	34.6	27.1	68.9	28.7	21.8	60.3	62.4	47.1	32.7	33.5	20.3	48.7	38.5	27.6	22.3	26.9	62.7	39.6	17.2	55.9	26.9	44.0	57.1	23.9	55.3	37.3	53.3	66.2	20.8	49.2	75.4	36.6	39.9	13.0	58.5	44.9	56.7	21.7	84.6	35.7	71.5	77.5	72.3	75.6	69.5	75.9	75.8	66.0	49.3	47.3	23.9	89.9	59.7	87.8	124.7	87.7	35.9	35.9	36.5	42.0	36.3	36.7	36.3	36.2	36.5	36.1	37.4	36.8	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.3	0.0	11.3	0.0	0.0	0.0	3.8	21.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	32.2	0.0	0.0	10.4	0.1	0.0	0.0
OVOL1	HOVO1	ENSG00000172818	"Ovo like transcriptional repressor 1"	O14753	11	65787063-65797214	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 57.2;skin 1: 51.0;testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 113.2;Squamous epithelial cells: 130.8;Syncytiotrophoblasts: 348.9;Urothelial cells: 114.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 52.2;CACO-2: 13.6;HaCaT: 31.4;MCF7: 12.6;RT4: 31.2;SK-BR-3: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003984	Uncertain		Approved	Nucleoplasm		Yes	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA003984: AB_1854854"	"unprognostic (4.26e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.00e-13)"	"unprognostic (4.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.04e-3)"	0.1	0.0	0.0	1.0	0.1	0.1	2.8	0.2	0.1	13.6	0.0	10.3	15.5	0.5	0.1	57.2	0.6	0.9	0.0	0.1	0.0	7.4	0.2	0.3	0.0	0.0	0.0	0.0	9.1	15.0	0.1	6.9	0.0	1.4	8.3	0.1	8.8	1.0	0.1	51.0	9.1	0.3	0.0	0.1	1.6	35.5	0.0	0.4	1.3	0.0	5.5	27.4	21.3	0.1	19.0	0.0	0.0	0.0	0.0	0.0	52.2	0.0	0.0	0.0	0.0	13.6	5.0	0.0	0.1	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	9.7	0.1	0.3	0.0	0.1	1.4	31.2	0.2	0.1	0.0	24.0	0.2	5.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.3	2.3	26.6	62.6	14.5	54.1	0.0	59.4	25.4	0.5	7.2	13.0	3.7	0.0	19.5	1.3	57.6	0.0	2.5	81.9	76.2	11.7	1.8	31.6	0.0	0.1	3.8	14.0	0.9	0.0	113.2	2.5	0.0	0.0	0.1	2.1	0.0	0.1	54.9	20.3	0.0	1.4	87.2	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	44.5	1.9	3.0	34.1	39.1	6.7	11.3	0.0	0.0	0.0	1.1	83.9	4.8	130.8	57.4	348.9	1.7	0.0	52.0	114.9
OVOL2	"bA504H3.3, CHED, CHED1, HOVO2, ZNF339"	ENSG00000125850	"Ovo like zinc finger 2"	Q9BRP0	20	17956979-18059188	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 7.1;stomach 1: 7.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 24.4;Spermatocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.6;CACO-2: 4.1;CAPAN-2: 7.3;HaCaT: 5.4;OE19: 10.0;SCLC-21H: 8.3;SK-BR-3: 5.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 10.3"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.9;hippocampal formation: 3.3"	HPA038531	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA038531: AB_10673012"	"unprognostic (2.85e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-4)"	"unprognostic (4.77e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.76e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	2.8	0.0	0.1	1.5	0.0	3.5	2.9	0.3	0.5	5.3	1.0	0.3	0.0	0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	4.5	0.4	1.2	0.1	0.0	4.1	1.3	0.0	7.1	0.7	0.0	6.7	2.3	0.0	0.0	0.0	7.9	1.4	0.0	0.1	3.3	0.0	0.2	1.2	3.7	0.0	5.6	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.1	7.3	0.0	1.0	0.0	0.3	5.4	1.0	1.3	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	10.0	0.1	0.0	0.0	2.1	0.1	2.6	8.3	0.0	0.0	5.4	0.0	0.1	2.8	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.4	8.4	0.3	0.1	8.3	11.4	4.8	4.0	0.0	14.6	11.7	1.4	8.6	8.8	1.8	0.0	1.7	0.2	17.1	0.0	8.4	18.6	24.4	1.3	0.3	3.6	0.0	3.3	10.9	3.2	0.2	17.9	18.4	0.0	0.0	0.0	0.0	0.1	1.7	1.7	15.5	10.2	0.0	0.7	7.4	0.3	0.5	0.0	0.0	0.0	0.7	0.0	1.0	0.3	16.9	10.5	0.4	0.0	12.9	12.0	1.6	6.4	0.0	0.0	0.0	0.7	37.9	0.7	4.9	9.8	0.1	0.4	0.0	12.3	15.1
OXNAD1	MGC15763	ENSG00000154814	"Oxidoreductase NAD binding domain containing 1"	Q96HP4	3	16265160-16350299	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.0;Inhibitory neurons: 62.8;T-cells: 90.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 81.0"	"Lineage enriched"	"Detected in all"	4	"T-cells: 81.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036830, HPA059160"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA036830: AB_2675338, HPA059160: AB_2683936"	"unprognostic (4.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.38e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (1.00e-7)"	"unprognostic (2.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-3)"	"prognostic favorable (7.63e-4)"	5.8	4.0	2.0	11.4	3.3	8.9	4.8	2.4	3.7	2.7	3.7	8.5	12.2	3.0	2.5	5.4	3.4	5.0	9.0	1.8	2.4	8.7	16.9	4.2	17.0	2.3	2.4	3.0	3.7	7.3	2.4	3.6	2.5	2.9	7.2	4.6	4.4	2.6	14.9	4.1	14.1	2.8	1.3	7.1	7.3	4.4	2.8	18.1	5.6	10.1	12.1	5.4	3.3	3.4	8.3	12.0	7.6	12.0	8.8	7.8	29.7	8.8	6.5	11.8	9.5	17.2	8.2	11.8	5.4	5.5	6.5	5.9	15.9	14.3	11.2	21.6	10.5	17.4	9.6	9.3	9.1	28.3	10.2	5.8	10.5	19.2	9.2	3.7	9.3	12.0	24.1	27.3	5.2	14.7	16.6	14.8	16.3	12.4	13.8	14.6	9.3	20.7	8.0	9.9	5.4	7.5	9.8	16.3	14.0	8.2	10.4	16.1	4.2	7.7	9.8	8.5	14.4	9.9	19.0	19.0	9.1	24.3	10.5	0.1	3.8	3.1	22.6	5.4	30.3	5.5	34.6	24.5	6.0	4.3	81.0	61.8	3.4	19.3	5.4	4.6	20.4	19.3	2.0	3.3	2.4	3.7	1.8	2.4	2.3	2.4	2.5	1.3	2.8	3.4	4.9	0.0	8.6	35.6	8.9	2.4	5.4	7.9	6.2	5.8	5.7	3.4	12.8	7.2	4.7	7.3	6.2	10.2	29.4	8.9	31.3	9.8	40.2	3.9	5.5	4.4	3.0	16.2	67.0	6.2	8.1	5.1	11.2	3.9	20.8	5.8	3.9	23.3	8.5	3.3	62.8	7.6	6.1	5.2	3.6	31.7	3.1	6.3	5.4	17.8	10.2	5.8	41.2	36.2	42.1	7.5	2.9	1.9	20.8	5.0	21.2	15.7	7.2	11.7	6.6	6.1	6.8	9.0	11.7	7.5	3.4	5.1	90.0	7.8	11.5	6.5
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	22	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in single"	90	"dendritic cells: 28.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Vesicles, Cytosol"	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	4.9	41.6	2.8	4.9	3.1	1.0	6.5	3.0	3.1	17.0	1.8	24.0	2.7	17.6	18.5	11.0	8.0	4.8	8.8	3.3	4.8	51.3	7.0	28.7	2.4	7.6	4.7	16.1	3.6	2.3	8.2	9.2	6.7	37.6	10.4	19.3	4.9	26.5	1.2	17.8	6.7	32.4	5.2	54.8	23.9	4.2	4.9	5.2	3.0	1.7	2.0	11.9	19.9	8.3	46.9	18.2	35.1	0.2	0.6	1.4	42.1	48.7	19.3	7.8	12.6	15.0	18.0	0.1	27.1	8.6	120.2	109.9	0.1	65.3	16.3	0.4	6.2	0.1	12.1	0.3	35.4	0.2	0.3	16.9	21.4	15.2	5.4	73.5	1.4	0.1	0.1	0.4	12.3	1.1	0.1	0.4	11.0	31.3	3.7	0.1	7.1	2.8	109.8	77.5	2.5	0.3	66.1	3.7	29.3	51.1	0.1	0.7	24.4	45.9	16.8	0.4	8.9	3.4	0.2	0.5	10.6	0.2	60.2	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.1	0.0	28.9	0.0	0.2	2.8	3.1	3.0	3.1	3.3	4.8	7.6	4.7	6.7	5.2	4.9	8.3	5.7	48.1	80.3	19.2	1.0	0.0	7.7	0.0	13.6	2.3	1.6	9.9	1.0	2.8	3.1	44.1	4.2	42.0	9.5	19.8	5.9	4.7	19.6	2.0	27.3	10.5	0.0	2.7	55.6	0.8	14.7	10.3	8.6	1.5	1.3	124.1	32.5	0.8	11.4	10.1	60.4	0.5	0.0	3.2	0.0	14.9	4.7	5.6	0.0	91.8	0.8	44.5	0.0	43.7	4.4	30.6	1.9	0.0	0.2	15.1	0.0	26.2	0.0	1.2	0.0	10.9	45.2	0.5	0.9	13.5	0.0	38.6	0.7	74.3	2.1	3.9
PAAF1	"FLJ11848, Rpn14, WDR71"	ENSG00000175575	"Proteasomal ATPase associated factor 1"	Q9BRP4	11	73876699-73931114	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 130.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 112.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039952, HPA040020"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA039952: AB_10793925, HPA040020: AB_2676802"	"unprognostic (3.13e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.42e-1)"	17.3	29.0	85.2	11.3	92.6	9.0	17.6	82.3	130.1	19.4	68.8	25.0	11.8	16.6	23.8	14.4	19.6	12.0	25.2	80.3	85.9	23.9	21.9	12.6	12.6	88.0	88.6	24.6	22.2	19.1	25.8	11.7	87.3	22.0	16.3	46.4	15.4	19.8	19.8	19.2	14.3	15.5	85.4	16.3	18.5	30.3	85.7	15.9	18.8	7.5	17.2	21.7	16.3	101.2	13.5	30.6	27.2	21.3	28.9	29.6	15.5	22.6	25.9	35.3	25.0	60.2	10.4	40.4	34.4	23.2	32.8	30.2	33.5	27.2	52.2	30.4	20.8	41.4	28.0	50.3	34.6	39.1	15.3	30.5	41.7	38.8	47.2	28.4	27.0	32.1	50.7	33.7	33.2	26.3	34.5	40.5	12.7	71.0	23.7	31.6	72.6	66.5	26.5	22.9	28.8	33.8	26.8	17.7	70.6	25.4	53.1	21.8	19.7	24.8	15.7	35.3	22.3	41.3	50.3	82.2	17.4	25.0	26.5	53.4	26.2	32.3	26.8	17.2	29.5	40.8	28.7	27.3	34.4	36.1	37.0	31.7	2.2	32.4	6.3	24.8	36.8	27.9	85.2	92.6	82.3	130.1	80.3	85.9	88.0	88.6	87.3	85.4	85.7	101.2	9.0	3.2	12.5	40.1	11.5	4.7	11.6	27.3	6.8	50.4	6.8	9.1	19.6	8.6	15.6	16.5	112.6	33.5	9.5	5.5	13.7	15.9	38.4	10.7	12.2	9.8	3.6	20.2	17.4	13.8	4.8	11.5	6.6	9.4	19.6	30.1	11.7	13.6	18.8	47.1	23.7	7.7	20.3	9.5	6.6	22.6	16.8	9.5	14.2	14.0	16.3	37.6	18.6	24.6	55.5	7.3	5.7	18.0	15.3	9.6	12.0	53.5	14.1	51.7	6.6	18.2	12.5	48.9	28.6	9.6	8.1	18.3	9.8	29.9	10.3	8.0
PABPN1	"OPMD, PAB2, PABP2"	ENSG00000100836	"Poly(A) binding protein nuclear 1"	Q86U42	14	23321289-23326185	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA000637	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553"	"unprognostic (5.11e-3)"	"unprognostic (2.65e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.66e-4)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.25e-3)"	133.2	178.7	187.0	86.4	183.9	136.9	127.7	193.4	249.3	165.6	184.5	184.1	107.6	176.0	130.3	151.0	175.6	63.4	138.1	185.8	196.6	187.7	194.8	130.0	103.9	186.0	182.2	176.3	138.8	101.0	199.0	79.7	181.6	179.4	101.5	126.6	130.4	85.8	131.5	136.9	167.8	97.4	175.6	174.3	159.3	230.1	186.3	147.6	189.8	94.1	116.5	146.3	144.0	190.4	127.2	133.9	298.3	216.6	125.5	143.1	191.4	120.4	121.6	168.4	157.4	168.0	223.0	229.7	67.0	157.0	180.6	186.4	337.7	169.7	230.7	195.2	116.7	173.5	208.1	435.5	145.2	273.5	220.2	157.1	164.7	125.0	149.1	240.9	188.1	196.0	164.5	174.6	159.8	239.6	296.1	334.5	328.6	151.2	149.3	289.1	114.8	136.2	196.1	256.2	205.6	159.9	161.4	143.2	129.6	196.9	114.2	196.3	153.2	112.1	153.8	110.4	161.8	207.3	153.0	276.5	51.4	221.4	138.7	15.7	7.6	8.5	6.0	5.8	4.9	7.4	6.1	5.5	6.1	9.3	7.5	7.0	10.0	10.1	7.2	13.8	7.6	2.5	187.0	183.9	193.4	249.3	185.8	196.6	186.0	182.2	181.6	175.6	186.3	190.4	66.3	35.3	49.4	0.0	83.3	157.8	84.4	74.0	158.2	120.1	110.2	89.5	14.3	77.2	51.2	126.9	146.0	70.0	102.5	85.5	13.7	52.6	55.6	71.8	80.8	75.0	161.4	94.2	0.0	57.2	67.4	72.4	68.8	78.6	24.1	169.3	66.0	121.6	63.2	77.4	0.0	107.2	54.9	84.7	119.0	45.9	81.1	85.5	53.4	0.0	104.4	55.8	65.9	0.0	0.0	59.2	91.6	59.8	102.2	88.7	88.9	40.3	49.8	80.2	72.3	57.5	85.0	41.8	33.3	187.4	179.9	62.8	67.3	107.6	108.1	114.6
PACRGL	"C4orf28, MGC29898"	ENSG00000163138	"Parkin coregulated like"	Q8N7B6	4	20696282-20752907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 211.7;Late spermatids: 88.4;Oligodendrocytes: 66.9;Spermatocytes: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054666			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Vesicles"		"HPA054666: AB_2682564"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.90e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.74e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (4.85e-4)"	7.6	8.5	9.6	5.7	10.1	4.0	16.0	3.6	11.9	8.2	16.6	8.5	6.6	12.9	14.3	9.2	13.5	9.6	9.2	11.9	11.4	8.2	4.5	7.3	7.9	6.5	7.3	13.5	7.0	11.1	8.0	7.4	5.4	10.5	8.6	15.0	7.0	10.1	7.2	14.7	7.8	10.1	6.5	7.1	7.7	28.1	12.1	5.4	15.1	8.1	6.3	9.2	7.7	12.1	12.5	8.9	16.8	12.1	23.7	21.9	8.0	15.9	11.9	13.4	17.5	8.9	28.2	11.9	11.5	8.7	24.1	6.4	9.3	10.9	24.3	4.3	8.6	8.4	16.1	13.7	11.8	17.6	8.9	14.4	18.8	17.9	17.4	14.5	14.9	12.2	13.9	7.6	12.7	9.1	18.1	17.0	20.3	11.0	12.3	9.4	18.4	7.4	12.9	7.8	25.4	17.9	12.5	5.6	12.2	9.4	11.5	10.0	12.0	14.4	13.5	20.0	22.6	8.0	2.5	11.3	21.7	10.9	25.5	0.0	1.5	0.7	1.3	2.4	2.9	2.0	1.4	1.3	2.7	1.8	2.2	1.5	0.6	2.3	2.0	3.5	1.9	1.4	9.6	10.1	3.6	11.9	11.9	11.4	6.5	7.3	5.4	6.5	12.1	12.1	6.7	9.6	6.4	37.9	4.9	13.6	10.6	6.8	13.1	5.8	8.2	7.0	5.4	8.6	8.6	7.3	4.2	5.5	4.9	5.5	7.9	9.7	211.7	15.8	8.6	7.4	9.0	5.7	48.0	9.1	6.9	9.7	6.6	4.8	2.5	7.9	7.5	3.1	4.2	5.0	44.9	5.9	6.1	4.9	4.0	88.4	13.1	4.6	5.4	31.9	3.3	9.7	3.1	35.7	66.9	8.7	9.1	12.4	2.1	9.7	5.5	6.2	27.1	12.1	13.1	9.2	7.3	90.6	30.3	9.0	10.5	5.9	3.6	9.3	6.7	8.0
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535229	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 149.3;retina: 64.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 76.1;Cone photoreceptor cells: 81.3;dendritic cells: 24.9;Excitatory neurons: 49.9;Horizontal cells: 69.0;Inhibitory neurons: 47.6;Rod photoreceptor cells: 89.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 12.1;RPMI-8226: 14.0;T-47d: 21.5;U-266/84: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834"	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	0.2	0.7	40.9	1.2	72.9	0.8	0.2	0.0	149.3	0.3	0.0	0.8	0.5	0.5	0.1	0.1	0.6	0.3	5.4	64.4	0.0	1.4	0.2	0.2	3.6	58.8	10.0	0.6	5.1	1.7	6.3	0.0	55.4	0.7	0.2	64.3	1.0	0.4	0.2	0.3	1.4	0.1	0.0	1.3	1.3	0.8	3.9	1.3	0.2	0.1	2.2	0.4	0.3	59.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	4.5	0.8	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.4	1.1	0.1	0.0	12.1	0.7	0.0	2.8	0.1	0.1	0.1	0.0	14.0	0.0	0.4	4.2	0.3	0.0	2.2	0.0	0.4	21.5	2.4	0.0	0.0	0.3	0.0	0.0	3.5	16.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	15.8	0.0	0.1	40.9	72.9	0.0	149.3	64.4	0.0	58.8	10.0	55.4	0.0	3.9	59.5	0.2	0.0	0.0	2.3	0.3	0.0	0.1	0.0	0.0	76.1	0.2	0.1	4.5	0.0	0.0	0.0	81.3	0.1	24.9	0.1	0.0	0.3	0.2	1.3	0.2	0.6	0.0	0.0	49.9	0.7	0.0	0.1	0.5	2.0	0.0	0.2	0.0	0.0	0.0	69.0	47.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	6.5	0.0	12.7	1.0	1.0	2.0	0.1	0.0	0.0	0.2	0.1	0.0	2.3	0.0	89.4	0.0	0.2	0.2	0.4	1.7	0.0	0.0	0.0	0.6	0.1	0.1	0.1
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205128-17246007	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"esophagus: 109.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.8;Extravillous trophoblasts: 14.0;Squamous epithelial cells: 5.6;Urothelial cells: 22.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.2;EFO-21: 2.1;HaCaT: 1.5;RPTEC TERT1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	0.0	109.5	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.2	0.0	0.0	11.5	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.4	1.4	18.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	4.2	0.0	2.1	0.1	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.6	0.9	0.0	0.0	14.8	0.0	3.9	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	14.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.8	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.2	0.1	5.6	0.0	0.7	0.0	0.1	0.6	22.5
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 17.0;urinary bladder: 25.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Ionocytes: 6.1;Squamous epithelial cells: 1.1;Urothelial cells: 7.9"	"Cancer enriched"	"Detected in many"	4	"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 14.0;RT4: 17.4;T-47d: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	17.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.9	3.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	25.6	3.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.0	0.0	1.4	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.5	0.1	0.1	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	7.9
PAF1	"F23149_1, FLJ11123, PD2"	ENSG00000006712	"PAF1 homolog, Paf1/RNA polymerase II complex component"	Q8N7H5	19	39385629-39391154	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041875, HPA043637"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041875: AB_2677720, HPA043637: AB_2678592"	"unprognostic (5.33e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.73e-1)"	36.9	45.4	32.3	26.1	36.4	36.9	37.5	35.1	36.3	40.7	32.4	41.4	22.9	36.9	28.0	44.8	38.9	23.6	45.2	32.8	38.8	35.4	49.5	33.5	29.3	36.4	34.9	50.1	31.9	38.3	48.5	21.0	35.6	40.6	20.2	26.5	38.2	27.7	62.3	34.3	37.3	23.2	33.0	46.9	39.4	68.5	35.7	31.0	41.4	30.9	31.5	37.9	37.4	40.0	92.1	114.9	74.9	40.3	46.7	39.5	30.5	75.0	69.4	86.1	82.7	95.3	48.3	72.6	51.0	61.6	51.3	31.4	81.3	62.1	70.2	82.4	95.2	71.6	77.0	62.6	50.4	61.5	65.6	39.9	42.0	72.0	46.4	54.3	63.8	63.0	56.7	59.0	71.5	103.3	70.7	40.5	26.5	76.2	38.7	70.8	73.4	51.7	64.7	102.3	63.2	42.6	80.5	52.8	41.6	37.1	50.4	52.5	60.8	51.6	68.1	54.5	84.0	63.2	61.2	61.9	51.6	53.0	49.0	32.3	20.0	33.7	29.4	28.0	30.9	40.1	24.4	29.4	21.8	36.6	27.3	25.3	31.3	30.5	26.6	20.4	26.0	21.6	32.3	36.4	35.1	36.3	32.8	38.8	36.4	34.9	35.6	33.0	35.7	40.0	26.6	22.4	46.2	9.4	49.9	53.5	63.0	29.9	63.2	14.1	28.9	27.1	37.5	21.5	35.9	22.0	8.4	38.4	33.2	26.0	13.7	27.3	40.4	48.4	25.3	24.4	26.4	16.4	3.8	27.3	30.0	33.0	43.3	62.8	50.7	19.0	18.2	24.1	24.8	8.4	4.8	22.4	26.4	12.9	62.4	30.6	35.1	28.1	23.2	1.9	20.4	23.4	12.3	6.6	8.8	23.3	22.1	27.8	54.2	24.5	22.9	25.9	64.0	16.8	13.1	22.5	29.8	96.0	26.8	41.0	49.2	64.0	48.7	24.6	21.9	34.8
PAGE1	"CT16.3, GAGE-9, GAGEB1, PAGE-1"	ENSG00000068985	"PAGE family member 1"	O75459	X	49687447-49695984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	151	"testis: 17.2"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 166.9;Spermatogonia: 206.5"	"Group enriched"	"Detected in many"	4	"liver cancer: 10.5;melanoma: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 188.0;Karpas-707: 139.8;U-266/84: 230.7"									HPA003473	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Mitochondria"	"HPA003473: AB_1079558"				"unprognostic (3.00e-1)"										"unprognostic (1.99e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.7	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	139.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	0.3	0.2	0.3	1.6	0.6	2.8	230.7	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	166.9	206.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAGE3	"CT16.6, GAGED1, PAGE-3"	ENSG00000204279	"PAGE family member 3"	Q5JUK9	X	55258412-55264846	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 7.6"	"Group enriched"	"Detected in some"	63	"Early spermatids: 107.9;Late spermatids: 312.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA045032, HPA062248"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"	Nucleoplasm	"HPA045032: , HPA062248: AB_2684725"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	312.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1700000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	31.8	18.1	21.2	34.6	24.9	28.1	19.5	25.0	21.7	21.1	19.8	25.6	23.0	21.9	16.0	26.5	20.5	23.8	24.0	19.5	24.6	22.1	33.8	26.3	40.9	26.7	23.4	19.8	18.5	32.6	8.4	33.3	27.7	20.1	26.6	17.4	14.5	18.9	28.3	16.6	22.5	27.0	24.8	43.5	20.9	15.1	23.0	45.1	19.7	25.9	39.4	34.1	16.0	34.1	140.7	49.1	67.6	49.8	47.1	61.9	100.0	69.1	57.0	73.7	66.8	117.5	70.1	89.4	192.7	70.8	75.1	70.2	72.5	66.2	113.6	39.9	35.2	132.2	52.1	92.5	95.0	130.2	122.0	49.6	53.1	66.2	139.2	78.1	74.3	97.3	65.0	107.5	72.9	146.7	124.8	67.2	40.5	74.7	73.4	112.4	38.6	80.9	64.8	96.7	39.6	44.7	92.8	64.7	52.7	51.9	227.0	92.6	76.9	60.9	33.6	64.3	103.1	72.5	138.9	216.4	50.4	127.6	59.1	37.3	20.0	48.0	10.9	23.2	14.7	11.2	12.7	12.6	25.4	11.3	9.1	10.9	47.6	12.2	21.2	9.3	20.7	14.9	21.2	24.9	25.0	21.7	19.5	24.6	26.7	23.4	27.7	24.8	23.0	34.1	164.9	80.1	40.2	37.9	142.8	97.4	89.2	41.8	96.2	42.6	59.7	47.5	59.3	62.9	45.1	82.8	52.1	50.3	135.1	69.6	33.2	71.5	57.1	107.9	112.6	104.0	44.9	72.3	32.2	59.0	101.4	68.9	58.1	96.1	148.8	70.9	66.0	138.6	104.3	55.5	38.9	46.4	57.0	160.5	115.9	75.5	60.9	169.6	33.8	46.9	183.2	63.7	140.1	37.2	61.3	100.4	52.1	45.5	100.0	149.4	58.2	85.2	76.4	45.0	39.5	86.0	75.9	24.5	43.0	103.2	86.2	34.9	139.1	96.3	51.0	124.1
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537370-9839076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 12.0;retina: 4.7"	"Group enriched"	"Detected in some"	4	"Breast myoepithelial cells: 6.5;Glandular and luminal cells: 2.0;Granulosa cells: 5.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 4.6;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.0	1.9	3.6	0.0	4.8	0.0	0.4	12.0	8.4	0.1	0.0	0.0	0.0	0.2	0.6	0.2	0.0	1.2	0.0	5.5	0.7	0.2	0.7	0.0	0.0	0.3	1.4	0.0	1.3	0.0	1.2	0.0	0.4	0.4	0.0	4.7	0.3	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.2	2.1	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.8	12.0	8.4	5.5	0.7	0.3	1.4	0.4	0.2	2.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40217428-40277487	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 25.6;skin 1: 28.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;NK-cells: 16.5;Suprabasal keratinocytes: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.5;HaCaT: 32.2;hTCEpi: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.2	8.2	11.6	0.4	15.9	0.9	2.1	8.5	16.6	4.5	0.0	1.3	1.5	0.9	1.0	25.6	4.3	1.1	8.3	17.6	3.0	4.7	0.3	2.5	0.9	1.4	1.1	0.6	8.0	8.0	12.1	7.6	1.9	4.4	1.1	0.8	6.1	3.8	4.5	28.2	1.5	0.3	1.8	0.9	3.9	17.7	3.0	0.5	7.5	1.3	1.9	3.5	9.4	5.4	3.9	0.0	0.2	0.0	0.0	0.0	6.0	0.0	0.2	0.7	0.7	26.5	2.9	0.1	3.6	0.0	1.3	32.2	4.5	6.9	0.3	0.2	1.0	0.0	3.0	0.2	0.0	0.1	0.3	0.0	19.4	0.3	4.5	0.2	0.0	5.5	1.8	0.3	0.0	4.5	0.0	0.5	0.5	3.9	2.9	0.2	0.2	2.9	1.5	8.4	7.3	2.0	2.6	10.9	0.3	1.7	1.7	10.3	0.0	0.3	0.6	0.0	0.3	0.1	0.3	0.1	0.7	0.6	0.2	1.2	0.1	1.2	2.3	0.1	0.8	0.6	0.1	1.9	0.3	0.1	0.1	0.4	0.5	0.9	0.1	0.1	0.0	0.6	11.6	15.9	8.5	16.6	17.6	3.0	1.4	1.1	1.9	1.8	3.0	5.4	0.0	0.0	4.2	0.7	0.3	9.8	9.6	4.8	8.6	3.5	2.8	2.9	0.0	4.3	5.4	5.5	0.0	52.7	2.1	0.3	13.7	4.4	8.6	3.3	0.4	0.3	4.9	0.0	8.9	4.3	3.0	0.7	0.5	5.1	0.0	0.7	0.0	0.0	4.1	0.0	7.3	1.1	2.0	0.6	0.9	5.8	1.8	0.3	1.8	1.0	0.0	1.3	16.5	0.5	0.3	2.5	1.0	1.9	0.1	5.2	0.2	0.2	3.9	0.2	0.0	0.3	0.4	1.9	3.3	13.9	19.0	9.0	1.0	0.8	2.0	11.3
PALB2	"FANCN, FLJ21816"	ENSG00000083093	"Partner and localizer of BRCA2"	Q86YC2	16	23603160-23641310	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB014895, HPA057000"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB014895: , HPA057000: AB_2683307"	"unprognostic (1.11e-1)"	"unprognostic (5.67e-3)"	"prognostic favorable (2.83e-5)"	"unprognostic (1.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.21e-1)"	5.8	5.6	6.2	4.4	6.5	3.5	6.4	9.8	10.7	7.1	6.2	6.1	6.5	5.6	5.6	10.1	5.4	3.3	4.7	6.2	6.1	7.9	9.9	4.8	6.3	6.0	6.2	6.2	6.0	5.8	5.1	3.8	6.2	5.3	5.3	8.6	6.0	4.0	5.4	9.0	7.0	4.0	5.7	7.8	5.7	9.8	6.6	6.4	5.3	4.8	6.9	6.6	7.2	7.0	17.3	13.1	15.4	10.8	12.6	9.4	13.9	12.0	18.4	19.7	23.6	11.2	17.3	18.2	8.7	8.6	15.0	15.2	13.9	19.8	23.4	10.8	8.1	11.2	18.2	31.8	11.7	20.5	17.3	11.2	20.3	18.7	20.7	10.9	10.6	17.1	23.4	9.4	17.2	17.4	21.2	21.3	34.3	12.5	7.6	24.2	18.9	24.7	15.2	15.2	11.2	11.3	12.5	13.5	16.7	13.4	12.9	13.9	7.7	23.1	8.7	11.2	13.2	11.2	19.0	18.3	15.4	14.8	14.3	6.4	1.8	1.8	2.1	2.3	2.6	1.8	2.4	2.7	2.0	1.4	2.6	2.1	0.1	2.1	4.5	1.5	1.7	1.1	6.2	6.5	9.8	10.7	6.2	6.1	6.0	6.2	6.2	5.7	6.6	7.0	4.7	12.8	4.2	8.5	5.1	0.9	3.5	5.4	2.2	4.8	4.0	3.7	4.8	2.8	8.2	3.7	4.2	2.9	3.8	2.4	3.9	5.8	6.8	2.3	5.1	4.8	1.2	4.6	7.4	5.0	2.0	4.4	4.1	2.6	5.1	7.7	3.3	4.7	3.7	1.7	8.0	3.4	2.0	5.0	1.5	3.6	4.7	5.1	1.8	5.6	8.4	4.8	5.2	7.1	5.9	8.6	2.5	6.4	4.2	5.3	4.6	5.4	8.3	7.5	6.6	4.7	3.0	30.0	17.7	5.4	2.7	1.2	3.7	6.9	4.8	4.1
PALM	"KIAA0270, PALM1"	ENSG00000099864	Paralemmin	O75781	19	708935-748329	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 257.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 85.2;Distal tubular cells: 52.8;Hepatic stellate cells: 63.1;Leydig cells: 48.4;Muller glia cells: 92.8;Proximal tubular cells: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 1.9"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.6;EFO-21: 20.7;REH: 34.3;SH-SY5Y: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041713, HPA049578"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA041713: AB_10794305, HPA049578: AB_2680822"	"unprognostic (9.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (2.74e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.00e-2)"	89.0	23.1	158.4	2.0	140.7	0.7	66.0	86.1	257.8	60.3	54.5	54.4	7.4	43.3	3.3	14.4	47.0	2.8	41.1	165.1	97.0	52.7	7.3	30.0	0.6	106.4	103.6	65.7	5.8	1.2	62.5	6.6	96.9	42.6	0.6	4.6	12.9	8.3	9.6	33.4	20.8	2.4	95.0	23.4	18.0	19.6	112.1	0.6	21.0	1.7	0.2	29.4	41.8	110.5	0.0	7.6	14.6	16.6	0.6	0.2	2.2	0.9	0.0	1.0	0.2	1.9	0.1	0.0	20.7	0.0	0.0	2.7	8.0	0.0	0.4	0.0	14.1	0.0	4.3	9.3	9.4	0.0	0.3	3.0	0.0	0.9	0.0	0.4	0.4	1.6	4.6	0.1	1.1	15.9	1.1	9.4	5.9	1.0	3.2	34.3	0.0	0.2	0.6	0.0	1.7	28.0	7.5	0.1	0.2	4.6	1.8	4.5	0.0	0.0	13.4	16.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	158.4	140.7	86.1	257.8	165.1	97.0	106.4	103.6	96.9	95.0	112.1	110.5	27.2	0.0	1.7	85.2	2.7	7.1	7.2	6.3	1.8	11.4	5.7	5.3	5.8	1.5	4.9	5.5	12.5	0.9	0.2	1.3	52.8	1.4	1.4	3.8	27.0	25.6	0.0	1.3	26.9	0.2	7.2	37.6	1.1	5.9	0.0	1.4	63.1	0.4	1.0	25.2	15.1	0.1	12.2	2.4	5.4	6.6	48.4	1.1	17.8	10.3	0.1	92.8	0.0	16.6	9.8	0.2	1.4	45.1	0.1	10.1	7.2	57.9	0.5	5.7	0.0	2.3	14.1	0.8	7.3	1.1	7.0	1.9	1.1	0.1	0.4	7.2
PALM2AKAP2	PALM2-AKAP2	ENSG00000157654	"PALM2 and AKAP2 fusion"	"Q8IXS6, Q9Y2D5"	9	109498325-110172512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 10.6;naive B-cell: 10.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	97.0	13.5	21.8	37.3	21.1	9.9	17.5	6.9	22.7	28.5	0.0	17.4	14.8	28.8	8.5	26.5	14.7	37.4	93.8	15.7	18.5	30.8	38.2	69.1	32.2	18.1	26.6	9.3	13.1	14.0	0.1	97.9	20.3	14.9	18.1	3.3	38.0	25.1	17.0	10.1	13.3	48.5	10.5	38.4	18.5	4.6	38.8	45.4	25.6	24.3	31.7	43.0	0.4	26.3	20.6	7.7	112.5	0.1	110.8	93.0	33.4	116.0	141.3	101.6	93.4	134.6	17.9	92.1	30.6	129.6	146.2	28.9	9.5	98.8	185.4	68.9	12.5	9.2	30.4	11.0	75.9	12.4	256.2	109.8	24.7	183.3	280.4	62.5	150.9	14.5	0.3	76.2	204.7	1.2	61.9	31.1	47.2	9.1	62.6	5.5	98.2	25.3	72.4	2.8	25.2	1.5	10.3	9.5	26.4	87.8	4.1	22.2	240.0	94.0	77.9	137.5	108.8	52.5	89.1	52.5	81.4	51.3	73.9	2.9	0.1	1.3	1.0	0.2	0.2	10.6	1.2	1.4	1.2	10.3	0.7	0.8	0.5	2.2	0.0	2.4	3.9	1.4	21.8	21.1	6.9	22.7	15.7	18.5	18.1	26.6	20.3	10.5	38.8	26.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PALM3		ENSG00000187867	"Paralemmin 3"	A6NDB9	19	14053363-14062076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 46.9;liver: 55.7;stomach 1: 30.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 40.9;Cholangiocytes: 22.8;Collecting duct cells: 38.6;Exocrine glandular cells: 27.9;Hepatocytes: 40.5;Spermatogonia: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AN3-CA: 17.6;CACO-2: 20.2;GAMG: 5.5;HAP1: 15.8;NTERA-2: 10.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052794, HPA056119"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA052794: AB_2681952, HPA056119: AB_2683042"	"unprognostic (3.67e-2)"	"unprognostic (9.08e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.72e-3)"	0.1	0.2	1.3	0.1	1.4	0.0	0.6	1.3	1.5	2.0	1.0	0.8	1.6	1.0	6.7	0.3	1.8	1.0	0.4	1.3	1.8	46.9	55.7	4.3	0.0	2.9	1.7	0.2	24.5	6.5	0.4	0.4	2.6	4.0	0.2	0.5	3.7	4.5	0.1	0.5	1.1	0.0	1.7	0.1	30.5	15.2	1.8	0.0	12.7	0.0	0.0	4.7	1.6	1.7	1.4	1.3	2.9	17.6	0.3	0.0	3.3	0.3	0.0	0.7	0.5	20.2	0.3	0.0	0.2	0.4	5.5	0.0	15.8	0.0	0.3	0.0	0.9	0.1	0.5	2.3	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.5	0.0	0.0	3.4	0.0	0.0	3.2	0.2	0.0	10.3	1.6	0.8	0.0	0.0	0.0	0.0	1.7	1.9	2.3	0.1	0.0	0.0	3.2	1.3	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	1.3	1.5	1.3	1.8	2.9	1.7	2.6	1.7	1.8	1.7	0.1	57.7	40.9	0.3	0.5	0.0	0.6	0.1	0.0	0.7	1.0	1.4	0.3	22.8	10.1	38.6	0.0	0.3	0.0	0.7	1.9	9.4	0.0	3.2	1.0	0.2	1.2	0.0	0.3	27.9	3.1	1.7	7.1	6.3	1.3	0.1	1.8	40.5	0.1	0.0	0.5	3.0	0.0	1.3	0.3	0.5	0.9	0.2	1.8	0.0	1.0	0.8	0.0	0.0	0.1	5.5	1.3	2.6	0.0	1.0	3.2	9.5	2.1	0.6	0.0	0.1	0.2	0.0	18.8	0.0	0.0	2.2	0.3	0.0	1.0	1.0
PAM16	"Magmas, Tim16, TIMM16"	ENSG00000217930	"Presequence translocase associated motor 16"	Q9Y3D7	16	4331549-4355607	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 109.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 67.2;Gastric mucus-secreting cells: 36.2;Plasma cells: 39.5;Squamous epithelial cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 184.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062721			Approved	Nucleoplasm,Microtubules,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Microtubules	"HPA062721: AB_2684849"	"unprognostic (2.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (7.25e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"prognostic favorable (1.33e-4)"	26.2	44.3	16.2	6.4	16.9	14.4	24.5	14.8	29.0	21.8	15.6	23.8	14.9	20.5	7.0	25.9	22.3	3.9	70.7	16.4	16.2	28.7	66.4	22.4	7.6	15.5	15.9	20.0	39.2	7.4	27.7	6.2	15.6	20.6	4.8	4.7	19.1	8.2	109.3	21.5	19.6	5.1	14.9	22.4	26.8	34.5	15.9	5.8	17.9	17.6	6.1	26.2	20.7	16.2	20.7	41.2	13.8	41.1	5.2	15.2	44.1	34.3	9.8	23.3	15.5	39.0	28.5	49.4	43.7	10.6	22.6	28.5	12.0	16.3	5.5	56.1	87.8	44.8	26.0	20.4	23.4	33.0	34.6	17.7	27.6	17.2	13.0	12.5	13.2	44.1	68.9	24.8	13.2	57.1	40.1	92.8	41.6	16.2	71.5	54.5	18.6	61.5	10.0	12.8	61.8	49.6	32.7	31.7	52.4	8.3	25.7	54.0	13.2	26.0	41.9	184.8	49.7	34.0	46.7	71.1	15.3	30.3	34.8	0.3	25.0	3.2	17.9	16.2	17.0	26.0	16.3	16.4	17.5	23.2	20.0	20.7	14.3	18.3	18.1	33.2	21.7	18.9	16.2	16.9	14.8	29.0	16.4	16.2	15.5	15.9	15.6	14.9	15.9	16.2	2.6	3.2	4.8	0.0	12.8	4.0	1.4	6.9	67.2	0.8	9.8	7.7	0.5	10.0	5.0	0.0	0.0	2.3	3.7	1.8	7.9	4.0	3.3	14.3	11.9	4.4	0.0	18.5	0.0	3.1	2.8	7.0	36.2	10.0	1.3	12.0	3.3	14.6	1.6	1.7	0.0	2.6	2.0	4.3	1.5	2.2	5.0	6.9	1.8	0.0	4.5	0.4	0.0	0.0	0.0	4.8	2.5	3.8	39.5	1.2	5.5	7.3	5.1	0.6	6.6	2.0	5.1	9.7	13.7	81.3	5.8	1.2	8.8	1.7	3.5	1.3
PAOX	PAO	ENSG00000148832	"Polyamine oxidase"	Q6QHF9	10	133379261-133391694	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 143.4;Late spermatids: 456.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.7;K-562: 3.9;U-266/70: 13.7"									HPA047782			Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Nucleoplasm	"HPA047782: "	"unprognostic (3.67e-3)"	"prognostic favorable (6.07e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.96e-2)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.39e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.20e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (9.49e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.29e-3)"	1.9	2.3	0.6	0.5	1.1	0.0	1.9	0.9	1.5	2.8	1.1	2.6	1.8	2.5	0.0	6.2	2.7	0.1	1.5	0.6	0.5	3.4	7.7	1.5	0.5	0.8	0.6	2.4	2.5	0.3	1.6	0.1	0.8	2.7	0.0	0.0	3.1	1.1	3.1	2.8	4.4	0.3	0.9	4.8	2.5	27.4	0.5	0.1	1.6	0.0	0.4	2.8	3.3	1.6	5.7	0.0	0.3	1.2	0.0	0.5	0.4	1.5	1.1	1.7	0.1	0.5	0.1	0.0	0.4	0.7	0.4	1.8	0.0	0.7	0.3	2.7	0.0	0.4	0.0	0.0	1.3	0.0	0.3	0.0	0.1	0.4	0.1	0.0	0.0	0.0	3.9	0.4	0.0	0.1	0.0	0.2	0.6	0.0	1.9	3.3	0.0	0.0	0.1	0.0	0.1	1.3	1.1	0.0	0.0	0.0	1.4	0.0	1.8	0.0	0.6	1.1	0.0	13.7	2.8	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.6	1.1	0.9	1.5	0.6	0.5	0.8	0.6	0.8	0.9	0.5	1.6	3.8	0.0	4.6	4.2	17.5	3.7	8.5	3.4	8.6	4.0	4.2	5.0	1.7	8.6	1.9	1.8	0.0	1.1	5.8	4.3	5.9	5.4	143.4	4.0	3.0	3.3	0.0	1.3	3.3	3.3	2.3	3.6	5.6	3.9	5.7	2.5	3.3	13.5	4.6	5.0	1.7	4.0	4.1	14.5	2.3	456.3	9.6	9.0	0.0	3.7	12.3	9.2	2.1	3.0	9.7	3.4	3.4	7.9	22.0	8.7	29.9	18.0	3.3	3.0	19.7	2.4	3.6	46.9	6.0	12.8	3.7	0.3	5.4	3.7	4.1	10.5
PAPLN	MGC50452	ENSG00000100767	"Papilin, proteoglycan like sulfated glycoprotein"	O95428	14	73237497-73274640	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 119.8;Endometrial stromal cells: 37.9;Leydig cells: 34.5;Peritubular cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 5.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.4;granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 16.1;HSkMC: 30.6;hTCEpi: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA048682, HPA053453"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		76000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA048682: AB_2680492, HPA053453: AB_2682155"	"unprognostic (1.97e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.56e-3)"	"unprognostic (7.42e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.46e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.58e-2)"	16.1	6.6	15.7	8.4	17.0	2.3	10.7	12.1	23.5	30.3	15.7	13.4	3.0	20.4	14.9	7.1	23.0	5.6	8.0	14.4	13.3	42.6	3.2	13.4	15.2	14.1	14.6	16.8	4.0	0.4	16.4	4.0	13.1	13.6	4.5	9.5	7.5	7.5	2.1	15.7	17.8	6.3	12.3	29.1	11.3	6.4	14.4	5.1	24.8	1.8	13.6	5.1	9.1	12.3	2.7	2.6	1.0	0.4	1.9	2.3	5.8	0.5	0.0	0.1	0.2	3.4	0.8	0.5	2.7	0.0	0.1	4.3	2.7	2.0	0.3	3.0	3.9	1.2	4.7	0.3	16.1	0.4	2.1	30.6	11.4	0.5	1.7	0.2	0.6	2.5	0.8	0.3	0.0	1.4	0.3	3.0	0.6	0.3	0.8	0.4	0.3	2.8	2.3	0.6	0.3	0.5	6.2	7.0	1.3	7.9	0.2	4.8	0.5	0.7	2.3	0.2	0.3	1.3	0.1	0.3	1.4	1.4	0.6	0.8	0.5	0.3	0.2	0.3	0.1	0.4	0.1	0.2	0.1	0.5	0.2	0.2	2.5	0.3	0.2	5.4	0.3	0.1	15.7	17.0	12.1	23.5	14.4	13.3	14.1	14.6	13.1	12.3	14.4	12.3	0.4	0.0	2.6	119.8	0.3	2.0	0.7	5.1	0.6	1.2	1.8	1.4	1.9	7.2	4.8	5.5	8.4	0.5	5.7	0.4	0.0	4.0	0.3	11.8	37.9	3.4	0.0	0.0	0.3	0.0	1.1	8.3	0.5	16.1	0.0	0.2	3.3	0.1	1.2	0.0	0.9	0.4	2.0	0.3	1.6	1.7	34.5	1.8	1.8	10.3	1.6	15.7	0.0	3.0	0.3	0.4	0.0	44.0	0.2	1.4	0.2	10.2	3.7	3.0	6.6	1.4	1.8	0.6	0.1	0.8	3.0	0.4	0.7	0.1	1.0	0.4
PAPOLA	PAP	ENSG00000090060	"Poly(A) polymerase alpha"	P51003	14	96501433-96567111	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1036.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001788	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA001788: AB_1079564"	"unprognostic (3.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.05e-1)"	52.6	60.5	62.7	66.6	65.1	96.9	62.7	71.7	87.4	61.7	70.1	70.5	57.1	68.5	72.5	59.6	57.9	56.1	61.0	59.9	64.4	60.7	81.6	50.0	77.8	63.0	61.7	76.1	71.6	73.2	53.0	85.3	64.3	54.2	71.8	92.4	63.8	54.0	46.7	57.9	67.6	61.6	62.8	69.3	65.9	75.8	62.1	93.0	68.9	56.4	82.8	66.4	53.5	80.7	126.6	119.4	150.5	152.6	107.2	119.4	331.6	112.9	120.4	132.1	125.8	132.9	125.6	170.9	125.3	134.1	115.2	104.4	50.1	156.9	235.0	141.1	81.1	131.9	88.9	138.5	110.6	166.2	133.4	110.6	134.1	148.0	131.1	127.8	150.5	79.5	128.2	146.5	128.9	184.6	140.5	91.1	102.9	205.0	135.3	146.7	183.5	98.7	132.0	192.7	154.0	102.0	151.4	115.8	111.6	167.9	165.3	158.3	119.0	91.3	72.6	104.1	140.7	114.3	186.7	138.6	144.5	137.5	158.9	73.5	32.0	56.1	23.8	39.3	29.0	38.9	30.2	34.2	38.8	42.7	35.3	33.9	41.3	41.3	37.7	25.1	32.7	36.6	62.7	65.1	71.7	87.4	59.9	64.4	63.0	61.7	64.3	62.8	62.1	80.7	126.3	80.1	122.4	64.6	171.4	229.7	406.3	196.6	126.9	78.2	140.0	101.6	157.2	88.6	160.1	84.6	95.9	346.2	139.6	124.1	183.9	121.4	634.7	326.1	145.4	150.7	117.2	126.8	87.9	137.0	440.7	129.9	95.3	371.7	136.4	113.8	85.6	112.3	155.6	63.9	111.5	154.9	168.9	141.3	239.4	275.3	96.3	153.2	168.9	104.9	171.8	93.4	135.9	105.1	115.2	129.6	118.9	80.5	197.4	373.0	122.5	136.5	253.1	107.2	105.2	131.6	185.0	256.8	203.0	146.0	247.6	1036.0	167.8	131.2	166.1	540.3
PAPOLB	PAPT	ENSG00000218823	"Poly(A) polymerase beta"	Q9NRJ5	7	4857738-4862030	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 29.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 94.8;Late spermatids: 89.7;Smooth muscle cells: 18.5;Spermatocytes: 37.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA047285			Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA047285: "					"unprognostic (7.58e-2)"					"unprognostic (1.25e-1)"				"unprognostic (1.68e-2)"	"unprognostic (1.78e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.4	1.2	0.2	0.0	0.9	0.2	0.1	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.8	0.2	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	89.7	2.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.8	0.0	0.7	18.5	37.4	4.0	0.0	0.9	0.3	0.1	0.1	0.0	0.3
PAPOLG	FLJ12972	ENSG00000115421	"Poly(A) polymerase gamma"	Q9BWT3	2	60756253-60802086	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017795, HPA035349, HPA035350"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.72e-4)"	"unprognostic (2.49e-1)"	"unprognostic (6.97e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.62e-2)"	3.7	3.0	2.2	2.2	2.3	1.4	3.4	3.2	3.1	4.2	1.7	3.2	1.3	4.1	1.2	3.5	3.2	1.4	3.1	2.3	2.3	2.5	2.3	3.2	3.0	2.5	2.1	4.9	3.5	1.7	3.1	2.0	2.5	2.6	1.5	4.0	3.8	1.2	4.2	3.7	3.6	1.5	1.9	4.1	3.4	3.5	2.6	3.7	6.2	1.7	2.5	3.2	4.1	3.0	1.8	1.5	3.4	2.0	3.1	3.7	2.4	1.5	1.9	1.4	1.2	2.4	1.3	2.6	1.7	1.3	1.4	2.8	3.7	1.8	2.3	4.0	2.1	4.0	1.7	1.7	1.9	4.4	2.4	2.2	2.5	1.7	3.7	2.9	2.6	2.6	3.2	1.9	1.4	1.4	5.0	3.6	5.3	2.9	1.1	3.4	4.9	2.7	1.9	1.4	1.6	2.4	2.2	2.7	1.9	3.2	1.3	2.7	2.4	1.8	1.8	1.3	1.7	2.4	1.5	5.4	2.2	4.8	1.4	3.7	0.8	1.5	1.3	1.0	1.7	1.1	1.2	1.2	0.7	1.4	1.7	1.5	2.2	1.4	1.2	0.8	2.2	0.8	2.2	2.3	3.2	3.1	2.3	2.3	2.5	2.1	2.5	1.9	2.6	3.0	11.5	12.8	12.2	13.1	13.9	12.5	13.5	4.6	12.0	6.8	8.4	8.6	7.9	7.2	8.8	9.2	25.0	6.0	21.0	6.9	3.9	4.8	4.7	6.1	13.2	10.9	2.4	13.3	29.5	4.3	4.6	11.0	6.6	6.6	13.3	14.6	11.7	5.0	7.4	5.0	24.8	5.7	10.2	10.4	22.7	4.3	7.5	17.8	12.4	25.3	12.0	5.1	8.2	19.1	22.1	4.9	6.0	8.6	12.7	15.4	4.3	3.5	7.1	10.3	26.3	9.3	11.3	30.3	17.3	13.2	15.9	8.8	20.8	10.6	4.0	16.2
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720234	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 444.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 321.8;eosinophil: 359.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 359.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		13000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (9.14e-4)"	"prognostic favorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	26.3	14.2	36.8	30.8	43.9	26.0	49.9	46.4	50.0	49.6	26.5	20.4	16.0	47.1	43.0	36.2	48.4	26.4	15.9	41.9	40.8	31.7	10.3	44.4	32.9	53.2	41.4	29.2	49.3	26.9	15.8	17.2	51.8	41.1	24.7	22.3	66.0	25.9	6.1	49.7	15.8	33.6	51.1	17.4	62.8	17.0	41.8	35.4	20.3	9.9	51.7	31.7	23.7	66.3	33.6	29.7	49.1	62.1	59.1	74.0	39.6	42.4	77.2	39.4	53.1	45.7	46.7	51.3	26.0	76.1	30.4	40.7	46.8	81.6	50.5	124.2	35.5	60.4	62.6	103.0	32.3	93.0	99.8	61.7	41.2	45.7	37.1	95.2	88.7	63.9	13.6	97.0	111.6	50.7	77.3	28.2	52.6	35.3	33.1	62.4	78.0	15.0	59.6	45.6	55.5	81.4	42.9	63.3	51.9	61.9	37.9	14.1	52.9	49.3	51.0	33.6	35.4	76.9	57.2	48.7	60.1	69.3	79.2	321.8	49.9	359.8	15.6	56.2	18.8	44.8	21.2	18.0	51.4	26.4	13.2	14.9	55.5	27.6	60.8	9.8	39.9	36.7	36.8	43.9	46.4	50.0	41.9	40.8	53.2	41.4	51.8	51.1	41.8	66.3	19.7	96.1	20.2	41.4	25.4	32.0	36.3	73.2	33.6	19.9	48.4	41.5	7.4	50.1	92.3	57.0	10.4	20.6	7.0	10.5	17.6	36.8	6.2	124.2	84.6	25.1	23.4	15.3	112.2	44.7	48.7	35.2	62.2	444.3	42.5	25.0	20.3	10.2	55.1	30.3	64.7	17.5	32.6	46.5	27.8	6.7	18.0	53.5	60.5	29.0	37.4	35.0	10.3	100.0	150.3	33.6	9.1	25.6	86.4	29.1	6.9	28.8	110.0	13.3	26.3	45.2	29.1	19.6	14.7	62.9	40.9	8.9	22.2	19.2	14.8	29.4
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: AB_2682014"	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	5.3	6.5	3.7	6.2	3.8	3.2	7.1	7.5	4.8	6.1	1.4	7.3	8.8	6.1	4.7	7.0	5.8	5.4	8.5	4.0	4.3	12.7	6.9	5.2	9.1	3.6	3.2	5.4	4.0	8.9	4.3	7.7	4.0	6.7	7.8	5.8	5.3	6.3	12.0	7.3	7.0	6.3	3.0	6.9	6.4	7.8	3.7	9.1	6.7	9.0	9.0	6.2	5.2	4.3	15.3	9.5	20.0	17.8	11.2	13.6	14.9	13.6	17.2	17.0	16.1	9.8	15.2	10.5	10.7	13.3	7.8	17.7	17.3	10.2	19.8	15.5	16.6	11.6	7.7	13.2	13.8	16.5	8.9	8.4	21.0	12.3	22.4	13.4	10.6	14.0	18.8	11.1	14.9	9.2	18.0	20.0	22.4	10.5	26.8	21.1	20.7	13.9	16.1	8.4	16.0	19.7	10.6	21.6	17.1	21.2	23.8	10.9	10.0	11.5	12.4	11.8	15.9	10.4	16.2	21.9	18.9	18.8	8.8	6.1	2.5	1.4	2.3	2.2	3.2	3.0	3.0	2.8	2.7	2.9	3.7	3.5	1.3	3.9	3.5	2.9	2.8	2.3	3.7	3.8	7.5	4.8	4.0	4.3	3.6	3.2	4.0	3.0	3.7	4.3	8.2	9.6	15.3	22.2	12.2	6.1	5.2	4.3	12.0	13.9	9.5	7.4	28.6	14.3	9.2	12.9	27.1	7.7	8.9	10.4	9.8	7.3	6.1	17.7	14.8	11.1	6.6	12.8	42.5	6.5	6.2	12.0	11.2	11.8	14.5	17.0	6.8	13.6	9.7	5.0	37.9	10.0	2.0	12.0	4.3	4.6	7.5	11.6	3.6	35.6	12.4	7.3	24.7	26.7	41.4	8.1	3.7	8.2	9.9	5.3	8.7	40.3	21.5	20.7	0.0	11.3	12.0	17.1	13.3	13.8	6.0	4.7	12.0	20.0	11.2	4.4
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		35000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	249.4	373.6	283.5	213.7	290.0	205.0	235.7	292.9	403.4	201.1	327.7	252.5	145.8	212.2	278.0	161.0	203.2	162.9	388.0	285.5	296.6	311.0	397.6	181.6	269.2	289.6	286.0	234.2	308.5	387.6	283.6	174.1	291.7	234.9	194.9	273.8	240.9	185.6	771.4	127.1	170.5	199.1	295.2	188.2	234.2	139.6	288.1	217.9	286.3	541.8	249.7	226.5	171.2	299.7	537.0	452.5	467.1	523.2	459.8	442.6	218.4	476.7	434.4	450.4	360.3	419.9	549.4	633.1	534.2	505.1	328.6	367.1	483.2	625.3	579.3	574.5	526.2	683.0	678.6	674.5	403.8	662.9	418.6	421.3	262.4	459.8	547.4	359.2	478.2	340.1	676.8	471.7	633.0	485.0	474.3	868.7	376.1	653.6	465.4	366.7	598.0	888.7	714.7	269.7	527.7	447.4	470.4	728.0	798.4	370.1	414.9	503.7	459.3	412.8	344.6	395.5	539.5	452.8	788.4	938.8	551.5	1002.9	606.4	298.4	590.2	394.0	484.7	553.7	459.2	483.6	478.2	577.3	717.4	374.6	406.8	466.8	202.5	551.1	456.9	1378.2	874.4	1060.8	283.5	290.0	292.9	403.4	285.5	296.6	289.6	286.0	291.7	295.2	288.1	299.7	243.6	131.4	157.1	23.2	211.8	208.9	402.4	677.7	200.9	196.2	342.0	381.8	453.3	257.4	318.5	248.3	79.2	553.0	382.3	131.1	851.0	504.3	32.1	272.1	263.9	241.7	238.0	177.1	19.5	478.4	612.1	302.3	146.3	195.9	206.5	291.2	183.1	368.1	435.1	186.7	22.9	279.6	484.2	204.5	304.5	53.6	358.2	258.9	359.3	21.5	605.4	816.4	327.5	18.1	36.0	378.9	186.9	378.7	269.7	523.4	227.1	941.5	327.8	235.5	276.1	277.8	342.6	288.2	302.2	220.4	143.8	469.6	244.4	535.3	312.2	433.1
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 181.9;Distal enterocytes: 398.3;Intestinal goblet cells: 109.7;Paneth cells: 132.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	15	"memory B-cell: 8.1;myeloid DC: 4.0;naive B-cell: 5.6"	"Group enriched"	"Detected in many"	15	"B-cells: 8.1;dendritic cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.6;Karpas-707: 44.9;U-266/70: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	45.1	51.8	4.1	27.7	5.4	0.4	29.3	0.0	19.3	43.3	2.1	91.3	7.0	34.7	14.0	13.5	23.3	28.6	103.6	10.4	26.0	55.9	1.3	33.7	18.2	1.3	3.9	19.6	34.1	73.1	41.0	40.7	21.2	83.8	113.4	6.0	39.4	64.5	21.0	11.1	15.7	48.2	0.0	15.3	13.4	12.0	4.1	17.3	123.7	18.1	20.9	44.9	25.0	0.0	1.1	1.9	1.7	0.0	44.6	0.3	0.2	0.0	0.2	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.1	0.1	15.1	0.0	0.0	0.2	3.3	0.0	0.0	0.0	7.4	0.0	1.3	1.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	44.9	0.8	0.5	5.2	0.2	4.3	0.0	2.7	0.0	4.1	11.8	0.2	9.5	2.8	0.1	0.1	0.3	0.0	1.8	0.0	0.0	0.0	2.7	2.9	0.3	4.2	49.8	5.1	12.9	4.7	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.0	8.1	0.0	0.0	4.0	5.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	4.1	5.4	0.0	19.3	10.4	26.0	1.3	3.9	21.2	0.0	4.1	0.0	44.8	16.0	84.1	2.9	11.6	3.2	27.2	6.5	4.0	7.0	4.0	3.4	181.9	31.5	10.4	0.0	0.0	0.3	0.1	398.3	3.9	0.5	10.1	3.0	73.5	6.4	19.9	2.7	51.3	49.2	0.7	13.2	2.0	2.8	1.3	61.9	2.9	0.0	1.5	0.0	77.8	109.7	14.2	0.3	34.7	28.6	36.7	4.9	8.8	1.0	0.7	0.1	0.0	6.0	3.6	23.5	132.1	74.4	42.9	32.6	2.5	27.7	7.2	1.7	46.0	5.4	61.5	1.6	3.2	0.3	1.8	0.8	1.9	14.9	81.6	9.1
PARP1	"ADPRT, ARTD1, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360210-226408154	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		150000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	32.0	26.4	33.9	63.9	41.9	29.4	29.5	46.2	33.2	26.2	20.6	43.5	29.3	30.2	19.8	31.3	28.9	20.4	55.1	30.3	36.2	22.4	37.1	27.4	125.5	48.4	39.7	27.5	50.8	94.7	38.0	58.2	47.7	40.7	37.2	44.9	28.9	46.4	94.5	21.1	36.8	45.6	41.9	57.7	29.6	40.5	40.9	64.6	28.4	70.2	150.8	38.7	24.6	58.1	182.4	108.9	295.4	209.3	75.9	61.3	137.1	101.3	119.1	178.2	144.9	175.4	98.1	559.3	147.2	80.9	77.9	135.1	411.6	132.4	144.4	204.1	396.6	216.2	135.9	114.5	44.6	372.2	93.3	61.7	50.5	144.2	101.3	49.3	140.5	132.2	346.9	291.8	94.1	99.6	114.7	110.0	476.2	290.5	165.1	334.2	484.5	533.4	76.4	144.5	264.0	229.2	165.2	190.3	100.1	205.3	159.6	225.8	99.3	93.3	140.9	120.6	235.1	110.9	151.8	472.6	78.2	125.7	214.3	11.1	11.7	12.3	31.2	20.5	45.3	72.2	37.3	36.7	28.2	69.9	28.2	32.5	2.2	22.0	42.3	16.2	49.3	25.7	33.9	41.9	46.2	33.2	30.3	36.2	48.4	39.7	47.7	41.9	40.9	58.1	33.4	54.5	73.6	13.7	169.1	72.3	83.9	56.4	51.2	96.1	58.8	43.3	115.0	44.3	69.8	57.0	141.8	469.2	53.8	27.7	72.4	88.9	34.1	53.3	66.5	62.0	75.0	100.5	16.5	107.0	111.7	49.8	37.8	55.2	122.1	116.2	34.2	69.4	139.6	90.9	17.5	50.0	57.0	47.8	35.7	20.5	40.0	48.3	62.2	16.9	76.9	80.1	95.8	10.1	31.9	48.5	24.2	35.0	186.9	82.8	25.6	48.5	56.4	118.1	46.0	58.7	48.0	88.8	199.6	77.2	48.2	137.6	85.0	103.5	61.9	41.7
PARP11	"ARTD11, C12orf6"	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.5;Granulosa cells: 72.0;Late spermatids: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	3.4	5.0	2.7	5.0	2.9	3.2	5.3	2.0	2.9	4.2	2.0	3.6	3.7	6.5	5.4	3.1	4.1	4.0	2.3	2.5	3.4	3.9	4.5	3.8	10.2	3.4	3.2	8.2	2.5	7.8	1.8	3.2	3.3	8.6	4.1	3.3	4.0	4.2	1.8	2.2	3.7	5.2	2.8	6.2	3.3	9.4	3.5	10.4	9.1	2.9	9.4	5.0	1.9	3.5	2.7	2.3	14.0	2.3	4.4	7.2	4.1	3.3	5.5	5.6	5.7	8.7	2.2	8.0	2.0	6.4	6.6	2.2	4.8	4.8	9.0	16.1	4.9	12.0	0.0	6.5	5.1	8.1	4.4	5.9	3.8	4.4	12.4	0.0	4.4	15.3	3.1	6.5	8.1	4.0	4.2	3.1	5.2	2.9	0.3	8.3	9.8	1.8	2.6	6.3	0.9	2.9	3.1	2.8	4.2	15.1	0.5	7.1	8.5	4.9	4.8	7.3	4.4	3.1	7.3	11.7	4.6	4.4	1.2	20.3	8.9	9.2	7.4	7.4	10.0	10.0	8.3	5.5	8.9	8.8	9.2	7.5	8.5	7.7	6.1	7.8	3.7	6.2	2.7	2.9	2.0	2.9	2.5	3.4	3.4	3.2	3.3	2.8	3.5	3.5	8.6	9.6	9.5	16.0	18.3	1.9	4.4	6.7	7.4	10.6	5.7	4.1	3.8	2.8	4.5	1.8	2.1	4.2	17.7	2.6	0.0	3.4	61.5	2.1	9.6	5.3	3.6	12.0	30.8	3.1	1.6	8.4	1.1	1.9	14.7	72.0	6.8	4.1	7.1	3.3	30.8	4.7	2.0	9.8	5.8	45.1	10.5	9.7	1.8	18.7	10.3	5.4	17.5	32.6	18.8	3.3	7.6	8.6	3.7	6.6	2.6	4.1	6.0	6.4	6.6	7.0	9.8	9.9	10.9	3.6	1.8	2.6	15.0	8.9	5.0	3.4
PARP12	"ARTD12, FLJ22693, PARP-12, ZC3H1, ZC3HDC1"	ENSG00000059378	"Poly(ADP-ribose) polymerase family member 12"	Q9H0J9	7	140023749-140062951	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003584, HPA063872"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA003584: AB_1079568, HPA063872: AB_2685139"	"unprognostic (1.46e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (3.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.01e-2)"	6.4	4.7	4.1	12.3	4.3	15.8	6.6	3.6	5.3	4.0	5.2	12.1	18.3	7.6	9.6	4.8	8.1	9.3	5.9	3.6	4.2	5.0	7.8	15.4	13.4	8.3	4.4	6.3	9.2	10.2	2.3	9.9	5.4	7.0	11.6	1.8	17.2	4.8	2.9	15.0	18.1	7.9	6.3	17.1	13.1	10.4	4.9	10.7	5.8	2.5	9.5	8.7	2.4	5.0	20.8	7.6	0.6	0.8	2.4	5.7	15.1	4.7	10.4	36.3	42.5	4.9	12.6	8.6	11.5	3.9	28.0	9.3	5.4	17.6	6.0	33.4	8.7	9.2	4.9	6.8	15.2	2.4	6.2	5.7	6.7	12.7	15.5	9.9	28.2	10.4	19.0	6.0	2.7	8.4	25.7	14.3	1.3	10.7	18.0	15.2	0.0	2.7	7.1	7.9	4.6	0.0	14.2	7.7	11.2	0.7	9.2	5.6	31.0	4.3	10.2	0.3	14.5	0.5	1.5	2.0	7.9	12.2	5.2	1.2	3.0	4.3	1.5	5.5	1.3	1.7	2.1	1.6	2.1	2.4	0.9	0.7	1.0	2.5	6.4	0.2	5.8	1.2	4.1	4.3	3.6	5.3	3.6	4.2	8.3	4.4	5.4	6.3	4.9	5.0	24.1	6.4	10.6	2.6	17.9	6.5	7.2	4.4	8.0	2.9	6.2	5.5	5.4	7.2	5.8	11.0	2.1	6.0	13.0	48.9	1.9	13.9	0.7	7.0	6.4	18.1	24.0	4.8	1.2	26.0	19.1	6.9	18.3	6.3	19.7	38.2	7.9	10.9	24.2	0.0	2.6	19.4	4.1	13.6	9.7	0.9	7.2	20.5	7.2	26.2	17.5	2.9	11.3	9.5	3.1	35.2	37.0	7.2	8.3	12.4	44.2	6.9	9.0	2.5	0.0	7.3	7.9	35.0	15.6	8.7	9.9	2.1	15.6	8.4	11.6	10.6
PARP2	"ADPRTL2, ARTD2"	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343615-20357904	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA052003: AB_2681689"	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	17.7	21.1	21.1	10.7	22.0	26.8	17.5	21.4	31.4	18.1	16.4	19.3	12.8	20.9	17.8	14.6	17.5	10.0	17.1	22.5	21.0	15.5	17.2	13.5	14.5	19.5	18.9	22.9	17.9	11.1	21.0	12.9	19.8	13.9	14.0	26.4	14.2	13.4	32.4	19.2	14.2	15.8	19.0	16.5	16.3	23.8	19.8	11.9	16.7	27.1	17.9	13.8	15.3	22.1	55.5	39.5	59.7	45.3	19.4	18.4	43.4	60.2	32.5	74.8	91.8	36.8	51.3	40.4	26.5	19.0	64.8	50.1	78.3	27.5	87.8	32.4	38.3	37.2	46.6	63.3	17.3	77.9	20.4	12.5	23.0	45.5	51.1	20.5	38.5	48.0	39.2	53.4	52.3	33.5	40.1	33.0	33.0	62.8	60.0	49.7	79.7	26.5	30.0	28.2	41.3	28.3	65.3	36.8	17.9	37.4	34.2	25.8	26.6	45.3	68.1	31.5	48.1	49.3	67.7	53.4	19.0	33.3	51.4	1.9	5.0	0.5	8.9	4.8	11.7	6.8	8.4	7.9	5.5	4.1	9.0	8.6	0.1	7.6	2.6	5.6	5.3	4.8	21.1	22.0	21.4	31.4	22.5	21.0	19.5	18.9	19.8	19.0	19.8	22.1	12.1	25.6	6.5	7.2	9.5	6.5	10.5	16.1	18.8	29.2	7.4	10.0	14.0	5.7	19.9	7.3	12.5	25.8	10.2	4.5	7.9	12.8	9.3	9.9	13.3	11.0	4.8	30.3	17.6	8.7	22.2	11.6	7.7	11.3	8.2	18.4	6.8	10.1	11.9	30.3	15.5	5.0	14.2	4.6	5.1	9.8	11.5	6.6	8.8	9.4	4.2	20.7	6.2	6.0	9.3	10.1	4.5	17.0	19.1	4.5	5.3	7.4	28.0	23.2	6.6	9.8	18.5	20.9	41.5	11.3	4.8	14.9	6.2	16.7	7.4	7.0
PARP3	"ADPRT3, ADPRTL3, ARTD3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"prognostic favorable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	16.0	33.4	12.7	9.9	13.5	3.1	15.3	12.9	14.6	9.6	14.4	17.1	28.1	11.4	5.9	10.4	11.2	11.3	13.6	11.6	14.2	21.2	29.2	13.4	10.9	13.8	14.9	8.9	4.4	35.8	10.9	5.9	13.7	14.6	10.2	4.7	14.5	15.5	15.8	7.5	25.2	9.3	12.9	14.8	16.4	5.4	14.9	8.2	19.6	17.6	8.0	15.4	10.8	12.4	10.0	6.6	2.0	17.3	17.8	30.0	4.8	15.4	29.0	23.1	24.9	3.9	28.1	14.1	4.5	29.4	12.6	1.6	5.0	14.5	9.1	34.8	1.2	7.8	15.1	13.2	18.8	5.3	10.9	24.4	12.4	16.2	9.1	35.7	10.8	10.2	3.5	14.7	19.9	3.4	4.6	12.5	2.4	4.2	16.4	7.3	2.8	13.9	14.0	13.5	2.0	6.4	16.3	4.8	10.7	1.4	6.5	5.9	24.0	42.5	9.9	7.4	10.4	22.5	26.0	6.0	27.2	14.4	13.6	0.0	1.6	1.2	2.4	3.0	2.2	6.3	2.6	1.8	2.6	2.5	3.6	3.5	0.1	5.7	1.6	0.9	3.2	1.8	12.7	13.5	12.9	14.6	11.6	14.2	13.8	14.9	13.7	12.9	14.9	12.4	5.3	6.4	10.0	6.2	8.1	2.7	10.6	15.9	21.1	2.0	8.6	8.9	7.4	8.6	8.6	0.0	0.0	0.6	2.1	13.1	7.9	9.7	7.8	2.4	3.8	5.3	3.0	1.7	2.6	6.3	0.4	4.7	17.3	2.7	4.5	0.8	2.5	9.5	3.7	0.0	3.0	11.3	6.1	3.2	2.2	15.3	4.7	3.7	7.2	3.7	5.0	3.8	0.0	1.0	1.8	11.5	6.5	1.5	4.9	4.3	33.4	20.6	9.5	2.1	6.6	4.1	5.7	3.4	3.3	7.8	1.4	0.5	5.9	1.6	13.8	9.3
PARP4	"ADPRTL1, ARTD4, p193, VAULT3, VPARP, VWA5C"	ENSG00000102699	"Poly(ADP-ribose) polymerase family member 4"	Q9UKK3	13	24420931-24512778	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Ribonucleoprotein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011739	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA011739: AB_1854986"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.21e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.84e-3)"	18.6	22.8	8.4	24.2	11.9	22.1	16.7	11.2	8.2	24.3	12.1	38.7	38.9	17.9	18.0	22.0	21.1	29.5	12.7	7.5	10.4	26.9	24.9	28.7	23.6	15.6	11.3	18.6	14.8	18.5	5.8	15.9	15.2	13.1	39.5	8.3	16.8	18.6	6.4	11.0	39.1	19.5	11.3	26.3	34.4	9.0	11.8	21.6	21.2	11.3	25.2	28.3	14.0	15.6	42.9	37.7	18.1	32.7	48.7	68.8	15.3	48.7	63.5	41.8	37.1	15.5	108.5	32.0	47.3	44.5	46.3	48.5	27.2	49.4	34.1	73.7	19.0	45.9	33.0	35.9	27.8	59.3	43.3	39.9	16.3	34.6	18.3	81.4	69.7	24.5	13.2	13.8	50.2	19.9	37.6	28.5	20.5	100.6	45.9	35.0	33.8	45.0	77.6	86.7	16.4	20.9	35.7	14.2	33.5	23.4	7.1	48.2	99.7	18.9	19.8	24.4	50.4	15.6	19.3	41.4	34.3	30.6	42.1	50.0	21.1	45.9	20.4	25.7	20.4	14.2	16.8	20.5	27.9	8.0	12.2	14.8	24.0	21.1	34.6	10.4	21.9	20.1	8.4	11.9	11.2	8.2	7.5	10.4	15.6	11.3	15.2	11.3	11.8	15.6	20.5	51.3	51.8	21.2	20.5	2.8	6.9	29.2	6.2	6.3	10.2	5.8	17.6	17.2	52.6	25.8	2.1	5.0	33.8	74.2	5.9	26.1	5.4	35.9	19.4	19.8	4.9	13.9	1.5	22.5	8.9	18.3	42.8	50.9	99.2	30.7	31.1	16.0	17.7	1.7	2.1	27.0	18.3	23.4	6.9	4.7	11.8	35.3	8.8	36.5	37.1	6.7	36.0	21.1	40.8	30.9	53.8	8.2	27.0	10.6	59.7	18.2	69.7	7.4	6.6	12.2	10.4	2.5	8.9	13.5	3.8	1.9	28.9	24.1	30.8	20.5
PARP8	"ARTD16, FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846519	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 124.9;Excitatory neurons: 197.9;Inhibitory neurons: 139.3;Microglial cells: 112.4;Oligodendrocyte precursor cells: 158.3;T-cells: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 91.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: AB_2680667"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (1.12e-4)"	11.7	13.1	4.6	26.8	8.8	78.2	9.2	0.0	7.9	8.3	0.3	8.8	14.5	6.6	4.2	7.7	9.9	25.7	6.9	14.7	12.6	7.0	8.0	19.8	42.0	3.4	4.5	11.6	12.2	13.8	4.9	12.4	0.1	11.3	9.3	4.6	10.3	7.4	4.8	7.6	15.0	8.4	2.7	43.6	20.2	9.1	7.7	19.2	43.1	2.1	22.5	14.5	5.4	2.0	24.8	0.1	12.2	18.8	3.2	5.7	18.0	4.3	15.7	4.1	12.0	0.9	33.5	14.8	16.9	0.5	43.3	12.4	2.1	13.1	10.0	20.2	15.9	10.6	9.2	1.1	6.3	28.1	0.2	6.8	10.9	8.5	6.0	24.6	0.2	23.1	1.6	9.1	5.9	8.8	31.8	32.5	12.3	0.4	6.0	15.4	24.0	17.1	7.6	12.8	13.0	19.0	13.8	21.6	3.7	17.6	1.0	91.2	0.0	1.0	15.4	1.2	12.6	6.9	0.2	29.5	13.8	7.6	17.7	27.4	13.7	31.9	43.6	4.0	70.6	13.4	34.3	50.5	9.2	16.7	20.9	34.9	28.6	39.5	2.9	4.2	22.5	22.7	4.6	8.8	0.0	7.9	14.7	12.6	3.4	4.5	0.1	2.7	7.7	2.0	6.2	32.1	21.1	29.4	51.7	8.0	5.2	12.7	26.2	13.6	10.4	6.5	5.6	14.3	19.1	22.0	0.0	22.5	124.9	17.2	7.9	14.2	28.7	11.8	8.4	3.9	15.0	7.4	197.9	10.2	6.4	13.4	46.9	10.6	14.5	12.6	6.8	5.0	14.3	6.7	139.3	4.2	8.2	26.1	16.9	15.3	1.2	27.1	8.8	112.4	43.4	0.7	93.7	158.3	7.3	18.7	8.4	3.0	65.0	7.7	8.2	4.3	25.6	2.1	6.6	12.3	13.0	12.8	6.0	14.3	4.0	24.8	157.3	6.5	9.6	13.7
PARP9	"ARTD9, BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 95.8;BJ hTERT+ SV40 Large T+ RasG12V: 113.4;SK-MEL-30: 93.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: AB_2685707"	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	20.1	29.4	14.0	35.8	15.1	20.8	17.6	13.8	17.4	20.3	14.8	22.5	21.2	19.6	19.1	24.8	20.1	28.8	18.3	13.5	15.1	22.0	68.3	36.5	30.5	21.3	15.5	12.9	22.0	23.7	18.5	20.1	16.8	18.9	19.5	5.8	39.9	12.6	13.6	11.6	21.4	29.1	17.6	44.3	20.0	6.4	17.4	30.6	16.8	17.3	25.9	26.0	16.5	16.1	23.1	7.7	2.8	1.9	16.9	34.6	2.6	7.6	41.0	95.8	113.4	12.0	24.9	5.2	16.4	15.3	60.2	24.8	6.6	13.4	19.9	40.3	4.5	24.9	7.6	6.4	18.0	8.1	15.9	28.4	12.9	13.6	3.4	19.1	20.8	15.7	2.3	20.7	3.9	10.2	26.0	10.1	1.1	4.7	21.1	27.3	27.2	1.7	37.0	13.1	1.7	6.6	20.2	3.3	93.8	1.5	10.7	9.0	12.6	4.1	11.8	0.9	4.7	12.8	7.1	9.5	14.1	8.7	7.7	41.9	29.9	36.9	19.8	41.1	18.5	15.9	20.6	22.3	27.5	11.4	15.6	19.3	87.5	30.2	45.2	3.3	24.9	23.3	14.0	15.1	13.8	17.4	13.5	15.1	21.3	15.5	16.8	17.6	17.4	16.1	37.0	41.7	44.2	13.4	18.9	7.1	10.8	13.8	12.5	0.8	10.5	6.3	5.8	10.0	35.1	20.2	0.0	5.2	14.0	32.5	1.9	30.4	1.6	23.6	28.1	37.4	10.7	19.0	0.3	39.9	19.3	19.9	22.4	23.2	10.1	19.5	21.8	50.1	42.0	0.0	1.3	11.5	10.2	32.3	9.2	4.5	18.3	41.2	7.2	45.0	50.2	12.1	32.0	17.1	3.9	36.8	11.7	24.0	13.6	8.9	17.5	19.3	48.8	1.0	19.7	18.9	16.3	0.9	1.9	15.7	6.7	1.6	23.5	17.0	8.6	14.4
PARPBP	"C12orf48, FLJ20641, PARI"	ENSG00000185480	"PARP1 binding protein"	Q9NWS1	12	102120183-102197520	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.3;lymphoid tissue: 7.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 20.0;Spermatogonia: 17.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039677	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039677: AB_10673426"	"unprognostic (7.84e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.54e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.83e-1)"	"unprognostic (5.61e-8)"	"unprognostic (3.50e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.16e-3)"	"unprognostic (6.14e-2)"	0.8	0.6	0.2	3.1	0.2	9.3	1.8	0.3	0.4	1.2	0.1	3.0	2.3	1.2	0.5	3.6	0.6	1.1	0.4	0.3	0.4	0.8	0.6	0.6	4.2	0.3	0.4	0.7	0.2	0.3	0.2	2.3	0.3	1.0	3.8	0.2	0.9	0.9	0.4	1.9	2.7	1.7	0.3	1.2	1.8	3.9	0.3	7.5	0.5	0.3	5.1	1.9	1.1	0.3	13.5	27.2	23.6	13.7	3.8	3.4	16.7	19.9	11.0	32.0	27.9	14.8	10.4	25.4	11.4	7.8	16.2	14.5	38.5	11.7	34.2	25.7	22.6	31.9	15.7	13.9	1.1	33.5	9.1	3.3	2.8	22.3	14.4	8.3	21.6	18.9	31.0	15.3	21.1	10.7	30.5	31.1	31.7	17.8	26.6	20.4	38.9	16.7	10.3	21.1	15.9	14.7	13.8	16.6	11.8	24.0	27.1	12.1	8.5	16.5	15.7	20.2	25.3	11.3	24.8	22.8	11.4	33.7	22.4	2.6	0.4	1.0	0.5	0.6	0.1	1.1	0.9	0.8	0.7	0.7	0.5	0.6	0.0	0.5	0.4	0.7	1.8	0.7	0.2	0.2	0.3	0.4	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0.3	1.1	0.0	0.0	2.9	4.3	3.7	1.5	3.6	0.6	1.9	2.4	2.4	0.7	1.5	2.5	1.8	0.0	11.3	2.3	1.5	5.9	1.6	2.5	3.0	11.6	2.5	1.8	20.0	4.1	1.3	13.9	4.8	6.1	3.0	5.7	15.0	2.2	0.1	6.5	3.3	5.3	3.1	10.2	5.7	4.3	2.6	1.2	3.1	0.0	3.7	1.7	0.2	2.1	3.5	4.1	1.2	0.8	0.4	14.2	0.7	1.3	1.8	1.4	0.9	0.0	1.1	2.8	16.0	17.7	9.8	1.6	3.6	4.1	9.3	7.8	1.6
PATZ1	"dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG"	ENSG00000100105	"POZ/BTB and AT hook containing zinc finger 1"	Q9HBE1	22	31325804-31346346	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047893, HPA048315"	Approved		Supported	Nucleoplasm		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA047893: AB_2680201, HPA048315: AB_2680353"	"unprognostic (3.25e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-3)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (9.22e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.79e-6)"	10.2	10.5	16.0	11.4	18.1	15.8	12.1	16.4	16.1	14.5	11.1	14.8	9.9	18.7	14.2	6.1	22.2	9.3	10.8	14.7	16.0	11.6	11.8	11.2	20.3	18.4	16.7	27.3	13.5	21.0	10.5	9.3	17.6	13.1	6.9	14.9	18.7	17.0	10.5	7.9	12.7	12.2	17.1	15.7	11.1	8.1	16.4	24.0	19.3	8.5	14.8	15.7	9.7	20.4	19.0	23.3	46.7	27.7	12.1	11.1	24.5	5.7	14.2	22.6	20.6	16.5	17.7	40.1	20.1	10.6	7.9	14.5	32.0	17.3	11.5	23.7	29.5	16.9	16.7	33.8	19.7	57.4	21.9	17.4	20.5	14.4	16.0	17.8	18.0	19.4	7.3	15.7	14.6	57.7	37.1	39.3	31.4	34.4	27.1	61.9	19.9	13.3	15.3	39.4	60.8	48.7	14.2	17.1	31.4	15.4	33.8	36.2	12.8	15.1	28.3	9.5	19.5	20.3	14.4	36.5	6.3	7.5	26.3	0.0	1.0	2.8	1.8	0.6	1.8	2.5	1.3	2.3	1.4	1.8	2.9	2.2	0.4	2.1	0.3	4.0	2.2	1.2	16.0	18.1	16.4	16.1	14.7	16.0	18.4	16.7	17.6	17.1	16.4	20.4	6.6	3.2	14.9	11.4	12.8	1.7	7.1	7.6	8.0	16.8	22.0	16.0	13.7	17.2	11.7	20.2	8.4	5.2	17.0	3.3	19.6	14.3	0.6	14.9	8.8	7.6	20.4	8.0	2.4	6.2	2.0	6.4	5.6	16.7	6.3	19.3	7.1	16.2	9.4	21.9	5.0	9.7	20.3	8.1	2.6	1.7	9.6	6.6	3.6	7.5	7.7	14.4	12.3	11.1	8.8	6.4	6.0	8.6	5.5	7.4	5.0	7.1	10.5	14.3	6.6	7.1	8.5	0.7	8.1	2.3	1.6	0.8	10.4	8.4	11.8	7.3
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735396-100829944	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 29.6;kidney: 85.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 145.3;Distal tubular cells: 49.0;Endometrial ciliated cells: 129.5;Glandular and luminal cells: 246.0"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"AN3-CA: 14.4;EFO-21: 22.6;RPTEC TERT1: 16.0"	"Group enriched"	"Detected in some"	9	"cerebellum: 1.3;pons and medulla: 3.4"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.6;medulla oblongata: 5.6;spinal cord: 4.9"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305"	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.4	5.4	0.2	0.0	0.0	1.8	29.6	0.0	8.4	0.0	0.0	0.5	0.4	85.3	0.1	0.0	0.0	6.8	1.6	0.2	0.4	5.9	0.8	0.0	3.3	0.2	0.0	1.2	0.0	11.5	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	14.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.6	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	16.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.4	0.5	0.4	6.8	1.6	3.3	6.3	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	5.9	0.0	0.0	145.3	0.0	0.0	0.0	0.0	49.0	0.0	9.4	129.5	14.8	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	246.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.5	0.0	1.1	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	27.6	0.0	0.5	0.0	0.0	0.6	1.1	1.2	0.0	0.0	0.0	1.2	0.0	0.1	0.0
PAX3	"HUP2, WS1"	ENSG00000135903	"Paired box 3"	P23760	2	222199887-222298998	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Deafness, Disease variant, Proto-oncogene, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5;salivary gland: 4.8;skeletal muscle: 3.6;skin 1: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 14.4;Late spermatids: 34.8;Melanocytes: 33.8;Skeletal myocytes: 12.8"	"Cancer enriched"	"Detected in some"	24	"melanoma: 20.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 9.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;HBF TERT88: 8.0;RH-30: 17.5;SK-MEL-30: 29.1"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.4;midbrain: 1.4;pons and medulla: 1.3"	"Region enhanced"	"Detected in many"		"midbrain: 7.7"	"HPA063659, HPA069000"			Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA063659: AB_2685080, HPA069000: AB_2686067"	"unprognostic (2.57e-2)"				"unprognostic (1.48e-2)"	"unprognostic (1.27e-2)"		"unprognostic (1.65e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.70e-1)"		"unprognostic (6.18e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.26e-1)"		"unprognostic (9.70e-2)"	0.5	0.0	0.4	0.0	0.1	0.0	1.0	4.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.3	1.9	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	4.8	0.0	3.6	2.9	0.0	0.0	2.0	0.0	0.0	1.1	1.2	0.0	0.0	0.8	0.1	0.0	0.1	5.5	0.0	0.0	4.9	0.0	0.0	0.0	0.0	6.0	6.5	9.0	10.6	0.0	0.7	0.0	0.0	4.4	0.2	0.0	0.0	0.0	8.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	6.9	0.1	0.0	0.0	0.0	17.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	29.1	7.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.5	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.6	0.1	0.0	0.1	3.3	1.9	2.8	2.0	1.2	5.5	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.8	34.8	0.9	0.1	33.8	1.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.4	5.6	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833269-37034268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 39.7"	"Cell type enriched"	"Detected in some"	29	"B-cells: 91.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 6.5"	"Group enriched"	"Detected in some"	43	"memory B-cell: 39.0;naive B-cell: 26.0"	"Lineage enriched"	"Detected in single"	52	"B-cells: 39.0"	"Group enriched"	"Detected in some"	9	"Daudi: 66.6;REH: 194.1;U-698: 87.1"	"Region enriched"	"Detected in single"	11	"midbrain: 3.9"	"Low region specificity"	"Detected in all"			"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.3	0.1	0.4	14.9	0.3	9.4	0.1	0.5	0.5	0.0	0.2	0.8	0.5	0.2	0.1	0.2	0.0	0.8	0.2	0.3	0.6	0.1	0.2	0.3	39.7	1.1	6.5	0.0	0.0	0.0	0.2	0.1	4.1	0.3	0.8	0.5	1.0	0.0	3.1	0.0	6.6	0.0	0.8	18.7	1.6	0.6	1.9	2.8	0.2	0.0	36.2	1.1	0.0	0.3	0.1	0.3	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	66.6	0.1	0.0	0.1	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.1	0.3	1.9	0.3	0.4	194.1	0.4	0.3	0.0	0.0	13.2	2.9	0.1	0.7	0.0	0.0	0.0	7.5	0.2	0.0	0.2	0.1	0.0	0.2	0.1	87.1	0.0	1.5	0.1	0.7	0.0	0.1	0.0	0.1	0.1	39.0	0.0	0.0	0.1	26.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.7	0.4	0.3	0.5	0.5	0.3	0.6	1.1	6.5	4.1	0.8	1.9	0.3	0.0	0.0	0.0	0.7	91.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.3	0.0	3.1	0.0	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.3	0.0	0.1	0.0	2.7	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.2	0.0	0.0	2.0	0.0	0.0	0.3
PAX6	"AN, AN1, AN2, D11S812E, WAGR"	ENSG00000007372	"Paired box 6"	P26367	11	31784779-31817961	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 61.6;retina: 68.9"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 264.2;Muller glia cells: 462.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;AN3-CA: 20.1;HEK 293: 18.0;HeLa: 14.9;hTERT-RPE1: 50.6;U-251 MG: 16.5"	"Region enhanced"	"Detected in all"		"cerebellum: 54.3"	"Low region specificity"	"Detected in all"			"HPA030775, CAB034143"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB034143: AB_1127044, HPA030775: AB_10601243"	"unprognostic (2.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	0.0	0.6	21.7	0.0	22.9	0.2	0.1	61.6	34.1	0.0	16.5	0.2	1.7	0.0	0.6	0.0	0.0	0.0	0.0	23.6	20.7	0.8	0.1	0.0	0.0	22.0	18.1	0.0	9.2	0.0	4.3	0.0	21.7	0.0	0.3	68.9	0.1	0.0	0.8	0.5	0.9	0.0	21.4	0.0	9.4	1.6	19.6	0.4	0.0	0.0	0.1	0.1	0.1	25.8	0.0	0.2	15.1	20.1	4.6	6.6	5.9	0.0	0.0	0.2	0.0	1.3	3.7	0.1	6.3	2.3	9.0	0.4	1.8	0.0	0.3	0.0	18.0	8.9	14.9	8.4	0.0	0.5	0.0	0.1	0.7	0.1	0.5	50.6	0.0	5.2	7.6	0.0	0.2	0.0	3.7	0.6	0.3	0.0	10.1	0.0	7.3	0.1	0.8	0.6	0.7	0.0	0.4	0.1	0.0	0.0	4.7	0.0	0.0	5.3	0.4	0.0	16.5	0.1	0.2	0.1	8.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.7	22.9	61.6	34.1	23.6	20.7	22.0	18.1	21.7	21.4	19.6	25.8	0.2	0.0	0.0	76.7	0.1	0.5	0.0	0.0	0.0	78.8	0.5	0.0	3.8	0.0	0.0	0.0	12.5	0.1	0.1	0.2	0.0	0.0	0.7	0.2	0.5	1.0	74.6	0.0	3.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	264.2	1.6	3.1	0.0	0.0	0.4	0.6	0.0	0.2	0.0	3.7	0.6	462.6	0.0	3.5	0.6	2.5	1.3	0.0	0.0	0.0	0.1	0.2	0.0	30.6	0.0	0.9	0.5	21.4	7.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278921	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 267.9;thyroid gland: 565.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 246.5;Endometrial ciliated cells: 114.0;Glandular and luminal cells: 228.2;Proximal tubular cells: 128.1"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"EFO-21: 79.7;GAMG: 50.0;RPTEC TERT1: 193.2"	"Region enriched"	"Detected in some"	4	"pons and medulla: 5.5"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283"	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	2.0	6.0	1.4	0.6	0.9	0.5	1.7	0.1	1.1	14.5	1.7	1.8	0.6	8.8	32.9	2.2	37.5	3.6	2.1	1.0	1.9	267.9	1.2	1.6	1.7	5.2	1.3	1.7	1.0	1.4	1.4	1.9	3.0	1.1	0.9	1.5	1.9	26.1	0.5	1.8	2.4	0.8	3.7	0.8	1.4	2.4	2.3	0.5	565.5	0.3	1.0	2.1	1.0	1.9	9.4	0.8	0.4	0.0	0.4	0.2	3.0	2.6	8.0	0.7	1.2	5.7	1.6	1.7	79.7	0.6	50.0	0.1	1.6	2.6	0.7	3.9	0.0	1.5	0.7	3.4	0.9	0.0	0.0	2.3	0.3	0.6	1.9	9.9	0.1	0.0	1.3	6.2	2.5	1.8	1.0	3.8	0.5	2.2	5.5	0.0	0.6	2.1	193.2	14.4	1.5	0.0	10.4	0.1	5.6	0.0	0.0	3.5	2.7	13.8	0.5	2.6	7.2	1.2	4.6	0.6	11.9	2.0	0.0	0.7	1.0	0.0	0.1	0.6	0.4	1.3	0.4	0.3	0.9	0.5	0.7	0.4	0.2	0.6	0.4	0.3	0.2	0.4	1.4	0.9	0.1	1.1	1.0	1.9	5.2	1.3	3.0	3.7	2.3	1.9	1.3	3.2	2.0	0.7	4.1	0.6	1.9	1.8	7.4	0.6	2.0	1.4	0.9	5.7	3.4	246.5	0.0	2.4	1.6	9.5	46.9	8.5	1.6	114.0	21.8	1.4	4.8	3.0	0.8	2.9	2.4	1.6	4.1	228.2	0.0	1.0	1.1	0.3	5.2	0.0	0.8	3.2	2.0	2.6	2.1	3.9	5.0	5.6	0.0	0.0	2.0	4.0	1.0	0.5	0.2	29.2	7.4	0.4	0.5	1.6	6.3	128.1	0.6	0.9	6.6	3.6	1.7	6.2	7.3	12.5	0.9	0.8	3.1	0.4	3.7	2.2
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679362	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"esophagus: 81.0;lymphoid tissue: 20.5;parathyroid gland: 43.0;salivary gland: 51.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 45.3;Basal squamous epithelial cells: 174.8;Ionocytes: 40.7;Squamous epithelial cells: 172.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.3;HDLM-2: 58.3;PC-3: 18.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001572, CAB016239"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoli	Nucleoplasm	"CAB016239: AB_2159984, HPA001572: "	"unprognostic (3.09e-1)"	"prognostic favorable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.0	7.3	0.1	0.7	0.0	0.2	0.3	81.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.1	43.0	2.2	0.0	0.0	3.7	0.1	0.0	51.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	20.5	0.7	0.0	8.5	0.7	7.1	0.0	5.3	2.3	0.0	2.5	2.1	3.8	2.0	0.0	0.3	0.0	0.0	1.6	1.8	1.6	0.8	0.0	0.5	11.4	2.1	12.3	0.0	58.3	7.3	0.9	1.2	0.0	0.0	0.0	4.2	0.7	6.0	0.0	1.9	0.0	0.0	5.3	2.3	0.3	0.2	7.3	0.9	0.0	0.1	1.9	18.9	0.0	0.0	0.0	0.0	6.9	3.4	0.0	1.3	7.0	1.4	0.9	5.1	0.0	0.0	0.0	0.6	2.2	1.0	0.0	0.1	4.4	0.7	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	8.4	45.3	174.8	0.0	1.6	1.3	0.4	0.0	25.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.6	0.0	0.4	0.0	0.2	0.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	40.7	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	20.9	0.0	0.0	26.8	0.0	0.0	0.1	2.0	2.4	0.9	172.0	0.3	0.1	0.1	0.0	0.6	12.1
PAXBP1	"C21orf66, fSAP105, GCFC, GCFC1"	ENSG00000159086	"PAX3 and PAX7 binding protein 1"	Q9Y5B6	21	32733899-32771792	"Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 155.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003757	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA003757: AB_10600796"	"unprognostic (8.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.38e-3)"	"unprognostic (2.54e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.43e-4)"	"prognostic unfavorable (1.50e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	5.8	6.2	7.3	6.4	8.4	28.6	7.2	10.1	9.8	7.4	8.5	6.8	10.2	8.3	7.2	5.8	7.4	4.9	4.6	7.0	9.2	6.7	6.6	6.3	9.4	8.5	8.1	10.9	6.9	4.7	5.8	6.3	8.5	5.8	7.6	13.0	5.7	5.2	9.3	8.0	7.9	5.3	7.7	7.4	5.5	8.3	8.0	10.1	6.2	6.7	8.0	6.3	6.0	10.5	14.5	11.5	24.4	19.7	9.2	7.4	32.0	10.4	7.0	13.7	10.0	24.3	12.8	16.9	7.9	6.2	10.9	14.1	23.7	9.8	14.5	14.0	18.2	29.6	19.7	17.9	4.5	33.6	17.1	3.9	14.5	16.0	7.5	9.7	9.5	18.4	34.3	15.9	10.3	12.6	23.1	19.8	64.5	16.4	11.0	21.1	22.0	25.0	11.0	13.1	19.3	11.2	15.2	17.3	12.1	15.1	11.3	18.7	8.2	10.5	13.7	11.8	16.5	15.5	19.8	31.0	7.8	30.0	10.7	0.0	0.3	0.1	0.6	0.1	0.8	0.5	0.7	0.5	0.4	0.6	0.7	0.7	0.0	0.2	0.2	0.3	0.4	0.1	7.3	8.4	10.1	9.8	7.0	9.2	8.5	8.1	8.5	7.7	8.0	10.5	28.9	12.8	21.6	62.3	22.0	25.5	21.5	5.6	31.3	50.6	26.0	20.2	12.3	21.5	15.3	20.2	62.6	16.7	39.2	19.4	5.9	7.4	36.8	47.8	51.6	22.3	22.1	17.9	61.6	8.0	12.1	27.1	30.1	45.6	12.0	42.4	15.4	12.7	10.2	21.9	66.1	23.7	6.1	13.9	19.3	32.8	14.6	24.3	21.4	55.3	14.1	28.6	24.7	117.6	155.4	6.8	12.8	17.0	29.1	25.1	17.4	7.9	24.5	81.6	32.9	51.5	23.5	32.2	18.2	26.5	25.4	17.8	29.4	26.3	21.7	32.4
PAXIP1	"CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2"	ENSG00000157212	"PAX interacting protein 1"	Q6ZW49	7	154943687-155003124	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 12.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006694, HPA016950"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA006694: AB_1855011, HPA016950: AB_2669489"	"unprognostic (2.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.30e-1)"	4.3	3.9	2.3	5.8	2.5	9.8	5.4	12.0	2.6	4.8	2.7	4.9	4.8	4.6	4.8	5.4	4.2	4.4	3.9	2.3	2.4	4.6	5.7	4.2	8.8	2.8	2.6	5.7	4.4	6.2	3.8	6.1	2.9	4.4	4.9	3.9	5.7	3.6	5.9	6.5	5.7	3.7	2.5	5.6	5.2	8.7	2.6	26.6	5.5	4.6	6.0	5.3	4.7	2.8	17.7	14.2	18.4	31.2	7.8	6.5	16.4	7.6	8.0	10.3	11.9	15.7	13.6	22.9	9.4	9.1	21.3	13.6	23.7	12.1	12.7	23.0	18.4	17.4	10.7	13.6	5.5	23.9	22.3	6.3	9.0	10.3	4.2	5.8	9.9	22.8	24.3	15.1	10.4	24.3	51.1	19.9	29.8	17.1	9.5	28.8	18.7	24.8	10.7	14.6	14.6	9.4	20.3	14.9	9.5	16.6	11.4	20.1	5.1	8.6	1.5	12.3	18.6	15.2	9.5	31.0	21.1	27.7	23.6	0.2	0.9	0.5	0.9	1.1	1.4	0.5	1.5	1.1	1.0	0.9	2.4	0.7	0.5	1.3	1.3	1.2	1.2	0.9	2.3	2.5	12.0	2.6	2.3	2.4	2.8	2.6	2.9	2.5	2.6	2.8	5.2	6.4	6.3	18.9	5.8	6.4	5.1	4.7	4.0	18.9	8.9	6.6	6.9	7.2	7.1	9.2	10.4	9.0	3.8	6.8	5.9	3.9	2.3	5.5	6.9	5.2	2.4	10.3	21.4	3.3	8.0	6.9	5.6	6.5	2.5	8.8	5.0	9.2	4.4	3.3	24.2	8.4	2.0	6.1	7.1	2.8	8.7	4.8	3.6	15.9	6.3	8.0	7.2	27.2	27.4	4.4	4.3	9.4	4.9	8.0	5.2	4.2	4.3	12.3	0.0	11.1	5.1	22.6	18.7	8.9	7.0	6.2	4.9	6.3	9.8	4.5
PAXX	"C9orf142, XLS"	ENSG00000148362	"PAXX non-homologous end joining factor"	Q9BUH6	9	136992422-136993984	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.1;dendritic cells: 198.4;Distal tubular cells: 131.0;Extravillous trophoblasts: 216.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045268	Uncertain		Supported	Nucleoplasm		NA	NA		95000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045268: AB_10963079"	"unprognostic (1.85e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.66e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.97e-3)"	24.1	24.9	15.9	8.1	16.3	17.6	23.6	18.0	27.3	27.9	9.6	25.5	11.8	23.5	1.7	29.5	24.7	4.3	29.3	13.9	15.0	37.3	44.7	28.4	11.8	21.9	18.8	21.5	37.7	5.5	37.4	7.5	19.1	34.5	2.0	1.2	20.2	7.4	14.9	34.7	28.8	1.9	19.4	48.3	31.2	14.8	17.1	10.1	32.4	2.1	4.0	25.7	25.5	21.8	27.6	30.3	4.8	18.4	8.5	7.6	70.5	20.7	12.3	13.7	7.4	13.5	19.8	24.6	35.3	5.4	5.4	43.5	1.7	15.6	1.1	63.3	42.7	19.3	16.2	11.4	12.7	27.6	41.2	5.6	14.6	4.7	6.3	2.4	12.5	44.1	29.4	7.1	3.1	61.2	29.0	45.6	28.7	32.6	91.5	37.7	9.8	70.4	9.5	14.2	22.6	28.2	17.8	44.0	24.9	0.8	52.5	23.4	16.6	6.5	19.9	31.2	25.1	13.1	12.5	16.9	11.6	31.6	24.8	25.9	44.3	18.7	142.3	54.9	122.5	33.8	78.3	123.9	46.2	30.5	42.4	99.1	14.9	87.7	29.0	238.2	66.0	62.2	15.9	16.3	18.0	27.3	13.9	15.0	21.9	18.8	19.1	19.4	17.1	21.8	65.5	16.0	27.6	0.0	20.2	0.0	0.0	0.0	0.0	0.0	76.8	95.0	0.0	0.0	7.4	40.5	0.0	147.1	198.4	0.0	131.0	54.3	0.0	45.3	34.0	22.6	0.0	0.0	0.0	43.4	216.7	25.0	0.0	44.4	12.6	66.5	0.0	0.0	77.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	35.2	0.0	0.0	0.0	0.0	40.0	0.0	0.0	21.5	0.0	0.0	82.4	11.7	0.0	0.0	0.0	24.1	0.0	0.0	0.0	0.0	88.7	72.3	59.1	0.0	0.0
PBDC1	"CXorf26, MGC874"	ENSG00000102390	"Polysaccharide biosynthesis domain containing 1"	Q9BVG4	X	76173040-76178314	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003155	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003155: AB_1078592"	"unprognostic (6.95e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-3)"	"unprognostic (8.82e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.98e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (1.62e-1)"	24.2	31.0	12.4	22.6	11.8	46.6	23.1	12.7	19.9	22.6	12.9	27.2	40.3	24.0	23.6	33.3	19.3	19.2	21.1	12.1	13.5	29.4	31.8	22.4	26.3	13.3	14.0	20.2	19.5	20.8	19.8	22.8	13.1	25.2	28.2	20.1	21.4	18.9	24.3	26.4	33.2	26.1	12.6	25.6	23.8	6.5	13.7	20.6	19.0	19.3	26.7	33.1	21.9	12.5	35.3	50.9	41.5	28.2	53.5	52.3	36.0	62.5	51.2	53.9	46.3	48.9	46.8	47.1	40.3	62.3	68.6	49.7	70.3	68.1	69.5	36.1	45.2	36.0	30.1	72.4	82.0	104.6	49.2	42.2	55.4	74.9	63.2	33.3	69.6	17.0	50.7	22.9	67.8	41.6	49.1	75.3	116.1	87.0	78.9	41.3	43.7	6.0	79.8	64.9	24.3	30.9	27.6	44.0	0.2	53.0	26.8	39.1	60.8	39.9	40.8	48.6	56.7	40.6	77.3	27.8	44.7	35.7	32.3	17.6	41.1	42.6	68.3	62.8	50.6	70.7	61.0	67.8	53.5	57.3	61.9	59.4	7.7	69.6	71.8	56.0	57.0	44.0	12.4	11.8	12.7	19.9	12.1	13.5	13.3	14.0	13.1	12.6	13.7	12.5	32.8	35.3	29.1	2.6	32.9	52.9	84.4	119.6	50.7	21.0	29.3	35.3	38.5	31.5	64.3	40.5	14.6	55.5	57.5	46.9	49.0	71.0	0.9	51.9	49.1	34.4	27.6	17.5	2.3	62.5	60.4	42.9	28.1	45.7	51.4	33.5	25.7	47.9	69.8	8.4	2.4	50.3	77.3	30.5	31.5	3.8	47.8	38.1	46.2	1.9	68.0	26.4	45.3	2.5	2.8	58.7	44.7	38.7	25.7	58.3	105.5	84.1	49.1	25.0	52.6	35.9	47.0	4.4	18.9	59.4	70.5	55.0	49.2	82.0	51.9	82.1
PBOV1	"UC28, UROC28"	ENSG00000254440	"Prostate and breast cancer overexpressed 1"	Q9GZY1	6	138215986-138218491	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"brain: 3.1"	"Cell type enhanced"	"Detected in single"		"Bipolar cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063021, HPA069649"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA063021: AB_2684923, HPA069649: "	"unprognostic (3.32e-3)"							"unprognostic (8.23e-2)"		"unprognostic (9.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.77e-2)"		"unprognostic (2.51e-1)"			"unprognostic (1.35e-4)"	0.0	0.0	0.7	0.0	1.1	0.2	0.0	2.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.1	0.0	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	1.1	2.7	0.9	1.2	0.7	0.9	0.6	0.7	0.3	0.8	3.1	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2
PBRM1	"BAF180, PB1"	ENSG00000163939	"Polybromo 1"	Q86U86	3	52545352-52685917	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015629, HPA059373"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA015629: AB_1855012, HPA059373: AB_2683994"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.06e-1)"	21.4	12.9	6.4	20.8	11.0	24.6	16.6	18.5	8.9	21.1	13.2	17.9	15.4	22.1	16.4	22.5	19.4	16.9	18.5	6.0	11.9	11.2	18.2	17.6	22.1	10.7	9.9	29.4	12.0	14.3	8.7	20.9	11.8	18.6	18.5	20.2	13.1	17.4	15.5	17.3	14.2	25.4	8.6	18.9	16.0	14.1	10.3	42.0	26.7	22.8	22.0	20.0	12.0	19.8	32.5	20.5	71.9	35.4	34.7	35.0	50.4	44.5	29.9	49.5	43.0	23.3	21.5	78.7	6.2	51.8	40.8	21.8	63.1	33.1	59.6	85.5	34.6	74.6	38.1	18.1	49.6	62.7	54.6	33.2	37.3	55.4	35.4	38.9	48.4	60.6	43.7	41.7	50.3	11.0	103.9	18.8	43.8	22.0	34.4	53.8	45.1	40.1	20.4	62.5	48.7	53.8	52.7	12.4	41.6	43.4	23.4	35.7	56.5	46.1	34.8	40.1	54.4	30.0	51.3	73.6	28.5	49.8	46.9	9.0	4.0	9.9	3.6	2.6	3.8	2.9	3.6	4.0	4.0	5.3	5.7	3.6	2.3	3.6	8.0	8.7	3.9	1.6	6.4	11.0	18.5	8.9	6.0	11.9	10.7	9.9	11.8	8.6	10.3	19.8	49.1	41.7	61.3	95.3	44.0	40.5	35.8	28.3	43.9	45.6	40.7	30.4	61.7	30.0	39.8	23.9	47.9	36.0	67.7	36.8	19.6	37.7	39.1	61.4	54.5	47.7	35.2	82.9	76.4	46.2	36.9	39.8	42.8	46.8	29.1	61.9	33.5	47.9	53.0	30.3	84.5	35.3	28.5	61.7	47.7	17.1	34.2	65.6	48.0	80.6	67.6	29.1	49.4	87.9	135.5	49.7	29.2	58.3	76.9	37.5	18.7	18.4	58.2	44.3	26.3	54.3	69.2	48.6	35.8	43.7	51.6	50.9	50.4	45.8	39.8	37.0
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 382.3;Excitatory neurons: 475.9;Inhibitory neurons: 405.0;Oligodendrocyte precursor cells: 327.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 93.0;NTERA-2: 111.5;SK-BR-3: 186.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	24.3	32.1	16.5	11.8	22.3	3.1	36.1	10.7	18.0	88.3	1.9	52.3	22.4	136.8	21.6	30.1	74.6	37.6	24.0	15.3	14.1	29.4	7.7	20.7	4.5	8.8	32.7	52.1	48.1	29.5	14.3	19.5	6.7	38.0	19.8	17.1	43.8	53.8	36.3	10.2	19.9	125.2	13.7	10.2	21.9	6.8	12.6	10.9	35.1	26.5	8.1	40.2	41.5	12.1	2.9	74.4	82.4	19.1	50.8	23.3	3.4	25.2	20.9	8.4	6.1	14.2	11.8	0.0	5.5	47.8	4.3	22.8	31.7	8.1	3.6	3.1	31.3	93.0	56.5	0.3	34.7	0.0	22.2	24.4	0.0	5.4	2.1	19.2	0.3	0.0	0.2	0.0	2.2	47.1	0.2	0.6	111.5	3.8	4.5	0.0	21.6	27.0	6.3	44.1	2.5	39.6	27.8	186.1	0.1	71.4	73.2	0.0	0.5	3.7	8.6	24.2	8.1	8.5	61.2	0.1	0.4	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	16.5	22.3	10.7	18.0	15.3	14.1	8.8	32.7	6.7	13.7	12.6	12.1	28.6	22.4	18.6	382.3	2.8	22.8	115.0	39.8	70.6	39.9	129.9	87.8	50.0	98.7	25.3	33.1	110.5	101.3	1.5	29.2	33.2	47.9	91.3	47.7	144.3	47.0	90.9	30.3	475.9	68.7	7.3	126.7	32.1	38.5	71.7	57.6	68.9	18.7	9.7	5.0	405.0	38.2	50.8	1.9	17.5	124.4	63.6	12.1	16.0	125.5	1.6	33.5	1.0	327.2	227.4	31.7	72.5	103.8	2.8	41.5	40.4	57.9	37.3	30.6	39.5	142.0	70.9	2.3	17.5	83.6	28.1	104.7	7.6	168.0	43.7	75.9
PBX2	"G17, HOX12, PBX2MHC"	ENSG00000204304	"PBX homeobox 2"	P40425	6	32184733-32190202	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061478	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061478: AB_2684535"	"unprognostic (9.73e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (4.98e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.27e-1)"	30.3	39.6	4.9	14.2	4.5	9.0	27.6	3.9	5.5	47.4	5.0	51.2	10.6	47.8	30.4	33.5	47.1	4.9	32.1	4.5	4.7	37.9	31.0	43.9	16.7	5.1	4.6	52.3	28.2	4.5	52.0	25.2	4.8	39.3	12.2	8.5	27.6	12.3	29.8	34.1	39.8	13.0	4.3	64.5	36.7	23.9	5.0	23.9	55.2	2.3	17.8	42.4	39.2	4.6	4.8	7.9	32.3	17.7	23.5	29.4	13.9	3.7	8.9	9.7	10.0	6.5	7.8	21.9	23.5	13.7	3.8	13.4	8.1	26.8	10.6	19.5	30.3	20.5	7.1	3.8	20.7	13.2	18.7	43.2	14.9	7.4	24.8	16.6	19.1	38.8	26.5	11.1	3.7	18.1	13.6	29.7	0.6	2.9	2.2	18.8	5.0	26.1	21.2	7.7	9.4	12.6	3.0	6.8	26.5	18.3	16.9	25.0	6.5	8.5	19.8	3.4	4.2	54.1	36.9	27.2	17.3	9.9	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.9	4.5	3.9	5.5	4.5	4.7	5.1	4.6	4.8	4.3	5.0	4.6	27.7	6.4	11.0	14.4	18.5	18.2	18.5	11.8	15.4	19.2	17.0	12.2	3.7	31.5	10.1	16.5	8.4	32.2	29.4	9.6	3.9	17.1	1.0	12.3	24.5	24.8	30.5	19.1	7.8	14.0	25.6	16.0	12.2	16.6	15.2	21.8	28.9	23.0	19.0	26.9	7.0	15.5	10.2	34.5	55.5	4.2	20.2	25.3	8.8	9.4	23.9	21.0	35.0	6.0	9.1	13.9	12.5	19.5	17.7	19.4	12.5	10.2	9.6	4.9	6.6	19.7	19.8	1.6	6.1	19.7	19.5	47.2	16.7	22.8	13.2	18.1
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 153.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 13.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 90.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 167.4"	"Group enriched"	"Detected in all"	5	"basal ganglia: 46.3;olfactory bulb: 161.9"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	10.9	56.0	10.4	12.9	14.6	6.9	10.0	17.4	13.2	27.2	7.0	47.9	6.8	9.8	20.0	11.8	14.2	22.5	38.0	7.2	15.0	7.1	18.1	13.0	8.0	19.7	21.0	58.2	18.8	153.1	12.6	6.7	19.4	30.9	13.7	28.0	11.8	28.0	8.5	19.4	14.3	22.6	18.8	12.8	21.5	8.2	15.3	16.7	35.1	5.7	6.9	20.7	21.9	21.7	11.6	11.0	50.0	43.1	13.1	19.1	8.5	29.9	16.8	19.2	14.5	14.3	21.1	11.3	3.6	22.1	20.8	8.5	28.3	12.3	38.3	12.4	20.5	9.7	7.9	5.8	17.2	9.6	15.5	9.5	13.7	14.5	10.0	45.3	23.1	7.2	0.4	10.3	43.5	5.9	10.0	4.9	35.8	14.2	7.4	18.9	73.3	1.5	15.6	6.4	25.9	45.1	20.2	3.8	9.4	18.8	15.7	90.1	26.6	40.0	10.2	23.8	57.1	7.2	12.8	11.5	19.7	15.2	20.6	2.3	1.7	2.2	0.8	1.4	0.9	1.0	0.9	0.7	1.9	1.5	1.7	0.7	1.4	3.2	1.3	13.9	0.8	1.0	10.4	14.6	17.4	13.2	7.2	15.0	19.7	21.0	19.4	18.8	15.3	21.7	7.3	9.6	16.7	17.9	10.0	22.7	10.3	3.0	6.8	7.5	11.5	8.3	60.3	2.8	8.6	12.9	37.5	0.6	20.7	1.3	7.9	13.5	15.2	1.1	14.0	11.9	11.5	6.3	44.3	2.5	0.9	23.4	5.6	1.5	16.5	9.4	9.7	12.6	15.3	42.1	19.3	5.7	6.1	29.0	23.7	11.4	19.9	22.9	7.2	91.8	13.6	11.5	6.2	136.2	192.2	3.1	12.1	11.3	3.8	13.0	0.9	2.8	8.5	43.1	0.0	5.3	13.0	33.7	16.0	10.4	26.3	0.4	10.5	8.7	3.4	8.7
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 429.5"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 453.9;Hepatocytes: 603.7;Proximal tubular cells: 877.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 527.8;Hep G2: 527.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		170000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: AB_2684594"	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	77.3	102.9	115.0	31.0	111.8	21.8	67.9	111.9	140.7	58.0	114.1	83.9	54.4	48.2	91.2	54.3	111.5	47.4	152.3	109.3	136.9	165.1	429.5	57.9	31.1	125.4	138.5	64.2	174.9	135.1	61.5	33.4	139.4	73.8	88.3	48.6	49.9	78.4	109.7	25.7	64.0	75.6	119.7	25.6	84.8	20.0	131.8	25.8	86.3	109.1	35.8	69.3	39.2	118.9	158.3	374.3	21.4	223.8	80.9	76.0	29.4	50.0	84.5	77.7	61.6	527.8	270.3	32.2	141.4	56.3	57.9	101.7	138.9	81.3	53.2	86.2	251.9	28.6	57.5	527.1	84.9	28.5	99.2	74.1	88.5	76.5	35.8	114.1	212.3	19.9	57.1	2.8	55.2	270.2	3.5	94.7	30.1	420.5	346.0	15.1	29.7	103.6	328.6	164.7	94.0	158.8	41.5	277.1	111.5	59.9	81.1	53.8	86.2	12.7	102.9	18.9	123.8	1.1	6.7	1.1	68.3	93.1	19.5	0.2	24.8	8.7	19.6	47.1	15.3	25.7	25.8	28.3	49.6	10.9	8.4	17.1	1.6	19.6	34.4	35.8	41.1	18.7	115.0	111.8	111.9	140.7	109.3	136.9	125.4	138.5	139.4	119.7	131.8	118.9	25.5	41.7	91.5	8.5	25.9	49.8	169.1	88.2	103.0	39.0	197.9	249.6	151.5	138.7	86.0	187.6	6.2	124.6	18.5	113.8	453.9	185.0	2.3	138.7	49.3	40.8	176.4	36.2	4.9	169.9	81.6	82.2	86.6	175.3	31.1	64.6	37.9	603.7	180.3	35.3	8.5	313.3	65.1	79.9	55.7	11.2	67.4	73.1	78.2	5.6	68.0	153.0	22.6	9.0	4.6	154.8	164.7	95.5	35.1	212.7	232.1	877.7	78.4	33.2	85.5	57.2	63.3	4.4	12.3	147.8	45.7	77.6	32.6	95.9	230.2	187.5
PCBP2	"hnRNP-E2, HNRNPE2, HNRPE2"	ENSG00000197111	"Poly(rC) binding protein 2"	Q15366	12	53452102-53481162	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038356, HPA073145"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		970000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA038356: AB_10697248, HPA073145: "	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.20e-2)"	467.6	429.4	213.6	263.0	232.5	863.1	396.1	260.1	240.3	385.9	238.8	318.2	334.8	345.0	366.4	314.4	407.8	301.5	340.3	197.9	232.9	534.9	509.0	350.9	380.4	228.2	223.5	507.3	501.5	437.3	220.7	299.7	232.8	265.5	325.5	665.2	322.1	264.5	481.1	416.6	324.5	333.8	227.4	323.8	390.4	363.6	228.8	543.6	414.9	401.7	455.6	313.3	323.5	263.2	527.6	809.2	755.8	614.7	1068.5	809.3	582.3	547.0	722.3	844.6	605.4	951.9	760.5	916.9	518.6	796.7	398.6	501.2	830.1	720.1	830.0	579.1	617.4	917.3	597.0	946.0	1071.1	922.5	592.1	937.8	593.9	719.6	1147.1	1451.3	819.3	583.5	810.8	1621.9	762.9	1444.3	856.8	1030.1	975.1	447.8	559.7	690.0	686.4	1098.4	667.5	814.6	742.4	655.6	736.2	656.2	553.9	767.2	918.2	791.8	615.9	443.9	614.0	412.7	561.7	908.2	666.0	840.7	523.9	572.6	494.4	19.1	34.5	25.9	27.7	34.0	44.6	38.1	42.3	35.7	41.6	34.3	48.1	41.8	30.8	23.9	33.3	57.2	52.3	30.1	213.6	232.5	260.1	240.3	197.9	232.9	228.2	223.5	232.8	227.4	228.8	263.2	306.1	115.4	179.2	64.9	433.6	390.7	302.9	352.6	569.1	88.0	361.5	389.9	73.7	253.1	193.0	296.1	110.5	329.2	313.6	242.9	493.1	233.0	68.3	264.2	289.3	285.1	206.5	525.1	54.6	240.0	365.1	285.8	326.2	298.1	155.0	360.3	283.4	302.2	368.2	102.6	58.1	279.1	223.8	437.6	473.8	65.6	309.1	376.0	233.1	74.0	476.5	152.9	292.5	58.8	101.4	250.8	266.5	229.0	483.8	256.3	446.8	714.4	159.5	188.3	190.7	346.6	435.1	292.8	183.4	511.3	382.3	443.3	341.6	240.4	325.7	345.0
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.6;retina: 81.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 159.4;Cone photoreceptor cells: 50.1;Horizontal cells: 116.1;Late spermatids: 79.8;Muller glia cells: 49.3;Rod photoreceptor cells: 83.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.0;HDLM-2: 56.9;HSkMC: 40.8;SH-SY5Y: 46.9;U-87 MG: 25.0;U-937: 31.3"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 229.1"					"HPA030247, HPA073145"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244, HPA073145: "	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	7.3	7.1	8.9	7.5	6.8	8.9	4.5	34.6	11.9	8.2	2.8	13.7	1.7	8.7	7.5	1.4	5.3	2.6	3.4	13.5	8.1	4.8	1.3	2.8	3.3	32.3	12.0	3.9	2.7	0.1	22.6	1.2	31.3	2.3	1.6	81.5	1.8	0.8	0.4	2.1	8.7	7.8	8.9	10.0	4.7	14.8	17.9	18.9	1.0	1.7	2.9	4.1	2.8	9.5	0.0	0.0	0.5	0.0	13.7	29.0	0.2	1.8	0.4	3.1	1.4	0.0	0.0	0.0	0.7	8.2	3.9	0.1	1.7	0.0	0.5	56.9	0.2	0.0	0.0	0.0	13.7	0.0	0.0	40.8	0.2	0.5	0.8	0.0	0.0	2.0	0.0	0.2	1.8	0.7	16.5	3.3	0.8	0.1	2.8	0.0	0.1	2.4	0.0	0.0	4.9	46.9	1.2	0.0	0.0	1.3	0.0	8.7	0.0	0.0	0.1	12.3	0.0	0.7	3.1	0.0	25.0	31.3	1.1	2.1	0.2	3.0	0.7	0.1	0.1	1.3	0.4	0.0	0.0	1.4	0.7	0.1	0.7	0.3	0.1	0.0	0.4	0.2	8.9	6.8	34.6	11.9	13.5	8.1	32.3	12.0	31.3	8.9	17.9	9.5	0.6	0.0	0.0	2.3	6.2	0.3	0.1	0.3	0.0	159.4	0.1	0.5	3.6	0.0	0.7	1.8	50.1	0.1	0.3	0.0	0.0	0.1	36.5	0.2	8.9	2.2	3.0	0.0	3.8	0.2	0.1	2.3	0.5	0.3	0.0	0.2	2.2	0.0	0.4	116.1	4.6	0.1	0.0	0.0	0.7	79.8	8.4	0.9	3.6	1.0	0.0	49.3	0.0	0.5	5.5	0.9	0.1	12.8	4.1	1.3	0.0	0.4	0.0	83.1	0.0	1.1	3.9	34.1	21.2	0.0	0.0	0.0	2.5	0.2	0.2	0.5
PCDH1	pc42	ENSG00000156453	"Protocadherin 1"	Q08174	5	141853090-141879246	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.5;Distal enterocytes: 66.4;Exocrine glandular cells: 46.3;Pancreatic endocrine cells: 65.2;Urothelial cells: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 86.1;HaCaT: 108.0;HUVEC TERT2: 56.2;OE19: 77.8;RT4: 74.2;TIME: 74.5;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047720, HPA050538"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA		2500000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cell Junctions"	Nucleoli	"HPA047720: AB_2680130, HPA050538: AB_2681162"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.43e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.91e-1)"	24.0	4.0	11.7	7.7	15.9	1.2	22.8	3.3	15.1	11.6	0.0	23.1	21.4	9.2	6.4	41.7	9.1	6.6	19.3	17.0	2.3	21.3	19.3	27.7	2.0	0.0	0.8	2.5	13.8	3.8	6.5	19.2	0.0	10.8	14.3	3.4	28.8	11.2	8.2	27.4	17.1	7.2	1.1	1.8	23.6	1.1	2.7	1.0	12.6	11.1	9.1	9.8	19.2	5.7	18.9	1.0	7.7	8.5	0.3	0.0	5.5	0.2	0.2	0.1	0.0	4.5	86.1	0.1	43.7	0.6	1.0	108.0	9.9	7.9	0.0	0.1	0.3	0.0	0.4	0.1	6.9	0.0	0.3	0.0	17.8	0.1	1.2	18.1	56.2	0.0	0.1	9.2	0.0	15.1	0.3	0.0	32.5	77.8	14.6	0.3	0.1	13.2	6.3	74.2	0.9	1.8	0.5	23.3	20.0	21.6	18.8	0.4	74.5	0.1	0.7	0.1	6.9	0.0	0.1	0.2	0.5	0.0	52.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	11.7	15.9	3.3	15.1	17.0	2.3	0.0	0.8	0.0	1.1	2.7	5.7	61.5	0.0	5.3	3.6	0.2	1.0	12.0	4.6	0.0	9.6	9.5	4.7	4.4	20.0	8.6	12.9	0.0	0.7	2.0	66.4	3.9	15.3	1.3	10.1	2.1	34.2	7.7	2.7	12.3	46.3	0.3	2.6	21.9	21.3	0.0	0.0	7.5	30.1	0.2	26.9	6.1	21.3	12.2	1.4	2.3	2.5	0.6	0.5	0.0	6.5	0.0	4.8	7.2	5.5	7.2	65.2	30.3	0.4	1.4	25.8	36.4	5.2	7.1	0.5	13.1	0.9	18.5	0.3	0.2	7.4	2.6	20.1	0.9	0.5	18.9	54.5
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149294-133208606	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 35.4;placenta: 25.9;prostate: 10.6;seminal vesicle: 17.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.1;Endometrial ciliated cells: 26.5;Excitatory neurons: 64.9;Glandular and luminal cells: 29.1;Inhibitory neurons: 57.7;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 59.6"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.5;HUVEC TERT2: 27.4;MOLT-4: 24.1;TIME: 55.4;U-138 MG: 14.5;U-251 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA		88000		"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA011220: AB_1855041, HPA073462: AB_2686605"	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	0.5	5.1	20.5	0.2	35.4	0.0	0.1	0.9	23.9	1.5	0.0	0.5	0.1	1.6	0.5	0.3	1.2	0.5	1.2	19.6	15.2	2.1	0.1	0.7	0.0	7.7	24.9	2.3	0.2	0.0	1.4	25.9	11.3	10.6	0.2	3.0	0.5	17.3	0.0	0.0	0.4	0.7	3.7	0.0	0.4	1.4	16.8	0.1	0.5	0.0	0.0	1.8	2.8	19.1	0.0	0.7	8.7	0.0	0.3	0.0	0.0	8.6	4.6	0.7	0.4	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.9	0.0	4.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	11.5	27.4	0.0	0.3	0.0	4.2	0.0	24.1	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.3	55.4	14.5	0.0	0.1	12.9	0.0	0.0	0.0	1.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	35.4	0.9	23.9	19.6	15.2	7.7	24.9	11.3	3.7	16.8	19.1	1.4	0.0	0.6	58.1	0.0	0.1	0.5	0.1	1.2	15.0	1.2	2.7	2.3	0.0	0.7	0.0	0.0	0.8	0.0	0.9	1.9	0.0	5.6	26.5	4.6	4.0	0.0	0.0	64.9	0.0	0.9	15.5	0.0	29.1	0.0	5.0	0.0	0.0	1.8	0.0	57.7	0.2	0.0	0.0	0.0	1.7	0.0	0.5	0.0	6.5	0.0	8.6	0.0	46.8	59.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.1	2.7	0.0	4.3	11.5	17.4	0.9	0.0	0.3	2.9	0.2	3.9	0.1	0.4
PCDH9		ENSG00000184226	"Protocadherin 9"	Q9HC56	13	66302834-67230445	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 159.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 4339.5;Excitatory neurons: 5259.8;Inhibitory neurons: 2489.4;Oligodendrocyte precursor cells: 6313.8;Oligodendrocytes: 14117.8"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 4.5;memory B-cell: 5.3;naive B-cell: 17.3"	"Group enriched"	"Detected in many"	9	"B-cells: 17.3;granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"AF22: 25.1;LHCN-M2: 41.6;TIME: 48.9;U-698: 64.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015581			Approved	Nucleoplasm,Centrosome		NA	NA		2900000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Centrosome"		"HPA015581: AB_1855048"	"unprognostic (1.77e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.42e-5)"	"unprognostic (7.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.47e-4)"	"unprognostic (6.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.35e-4)"	3.8	2.2	37.1	0.4	84.0	3.3	1.0	41.5	53.2	0.9	0.0	1.2	0.2	0.2	1.2	0.3	0.4	1.5	4.9	37.8	51.3	2.5	1.5	1.5	0.7	49.9	52.1	0.6	1.3	0.0	2.0	0.0	56.8	1.6	0.5	9.4	0.3	4.2	1.3	0.2	0.5	0.5	27.1	0.9	1.9	0.9	76.1	2.2	1.0	1.1	0.6	0.7	1.0	159.3	0.0	19.3	25.1	0.0	6.6	5.1	0.0	3.8	0.2	2.7	1.0	0.1	0.1	5.7	0.1	2.9	0.9	0.0	2.1	0.6	1.2	0.0	10.1	0.3	0.2	0.0	6.3	0.7	0.3	12.1	0.7	3.1	5.0	0.6	2.1	2.2	0.6	0.3	41.6	1.6	12.2	0.0	0.2	0.5	2.5	18.2	0.8	0.0	0.5	0.0	3.2	1.3	0.0	0.1	0.3	0.6	0.0	0.1	48.9	1.4	1.2	5.9	2.0	7.3	0.0	64.2	10.6	0.0	5.0	4.5	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	17.3	0.1	0.1	0.1	0.9	0.0	1.2	0.0	0.2	37.1	84.0	41.5	53.2	37.8	51.3	49.9	52.1	56.8	27.1	76.1	159.3	5.6	19.2	68.0	4339.5	29.1	1.9	2.5	0.0	1.8	318.8	9.2	14.7	152.5	0.0	4.4	5.5	20.9	0.2	4.3	0.9	9.8	1.9	3.6	0.3	6.4	4.7	62.4	2.5	5259.8	0.0	0.2	76.3	11.7	0.3	1.3	1.0	19.2	8.6	0.3	198.5	2489.4	1.4	0.0	1.9	1.4	3.0	29.5	3.7	10.6	237.0	0.3	87.8	2.1	6313.8	14117.8	0.3	1.2	14.7	1.4	2.0	0.0	0.8	0.0	27.1	6.6	27.9	25.4	6.8	5.4	1.2	0.3	0.0	2.7	3.7	0.8	0.8
PCDHA4	"CNR1, CNRN1, CRNR1, PCDH-ALPHA4"	ENSG00000204967	"Protocadherin alpha 4"	Q9UN74	5	140806929-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;granulocytes: 3.8;Respiratory ciliated cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.6;AF22: 5.6;EFO-21: 5.1;T-47d: 5.4"	"Not detected"	"Not detected"							"HPA043180, HPA073478"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA043180: AB_10806381, HPA073478: AB_2686608"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.90e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.00e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.94e-5)"	"unprognostic (5.01e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.29e-3)"	"unprognostic (4.79e-2)"	0.2	0.2	0.9	0.2	1.2	0.9	0.4	2.9	1.1	0.5	0.0	0.3	0.3	0.6	0.4	0.1	0.3	1.3	0.1	0.9	0.5	0.4	0.1	0.4	0.3	0.6	0.5	0.2	1.2	0.1	0.4	0.1	0.6	0.4	0.2	0.9	0.2	0.3	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.4	0.4	0.1	0.3	0.1	0.2	0.2	0.1	1.5	0.1	6.6	5.6	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	1.1	0.1	5.1	0.1	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.2	0.1	0.2	0.3	0.3	1.1	0.1	0.1	0.3	0.3	0.2	0.1	0.7	0.1	0.1	0.1	0.2	1.7	1.2	0.9	0.1	0.1	0.2	0.1	0.2	0.2	2.3	0.0	1.4	0.5	0.8	5.4	0.1	0.6	1.2	0.8	0.5	0.1	0.3	0.1	0.1	0.2	0.2	0.5	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.9	1.2	2.9	1.1	0.9	0.5	0.6	0.5	0.6	0.3	0.4	1.5	0.1	3.2	2.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.2	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.3	0.6	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.3	3.8	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.2	2.9	1.1	0.0	0.4	0.5	1.0	0.5	0.0	0.0	0.0	0.2	0.1	0.1	0.4
PCDHAC1		ENSG00000248383	"Protocadherin alpha subfamily C, 1"	Q9H158	5	140926299-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 29.8"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;EFO-21: 2.5;hTCEpi: 5.9;PC-3: 4.2;SCLC-21H: 2.9"	"Low region specificity"	"Detected in all"							HPA052775			Approved	Nucleoplasm,Nucleoli,Vesicles		No	No				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"	Vesicles	"HPA052775: AB_2681942"	"unprognostic (2.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.29e-2)"	0.4	0.4	0.6	0.5	0.7	0.0	0.1	4.5	1.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.0	0.0	0.5	0.5	0.2	0.1	0.7	1.2	2.0	3.1	0.0	1.2	29.8	0.7	0.0	2.3	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.7	0.7	0.0	0.9	0.0	0.6	0.0	0.0	0.6	0.0	5.7	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.7	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	4.2	0.0	0.0	0.0	0.1	0.3	2.9	1.7	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	4.5	1.0	0.5	0.5	2.0	3.1	2.3	0.0	0.7	0.6	0.1	6.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.2	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHAC2	PCDH-ALPHA-C2	ENSG00000243232	"Protocadherin alpha subfamily C, 2"	Q9Y5I4	5	140966470-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;parathyroid gland: 42.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 1.3;Hepatic stellate cells: 2.2;Respiratory ciliated cells: 1.6;Rod photoreceptor cells: 1.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076190			Approved	Nucleoplasm,Mitochondria		NA	NA		1100000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Mitochondria	"HPA076190: AB_2686785"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.31e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.46e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-3)"	0.6	1.1	4.0	0.5	4.6	0.0	0.1	3.5	6.6	0.9	0.0	0.3	0.1	0.6	0.1	0.0	0.2	2.6	0.7	4.9	1.7	0.4	0.7	2.2	2.1	0.8	16.9	0.1	0.4	42.9	1.6	1.8	6.0	0.3	0.3	9.7	0.6	0.1	0.0	0.1	0.2	1.0	0.0	1.7	0.5	1.6	2.8	0.0	1.2	0.0	0.6	0.2	0.0	2.3	0.0	13.1	1.2	58.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	3.7	0.0	2.5	0.1	1.3	6.9	0.0	0.0	0.2	0.0	13.7	0.0	0.8	0.0	0.0	0.2	8.8	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.5	0.0	2.3	0.0	0.0	0.0	1.7	0.1	2.7	10.6	0.0	0.0	0.1	1.2	2.6	0.4	0.0	1.1	1.2	0.0	0.6	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.6	3.5	6.6	4.9	1.7	0.8	16.9	6.0	0.0	2.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	1.4	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PCDHB1	PCDH-BETA1	ENSG00000171815	"Protocadherin beta 1"	Q9Y5F3	5	141051374-141059346	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Cardiomyocytes: 2.7;Respiratory ciliated cells: 2.2;Skeletal myocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA053921	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"		"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"HPA053921: AB_2682310"	"unprognostic (5.54e-2)"	"unprognostic (1.60e-2)"		"unprognostic (9.01e-4)"	"unprognostic (8.65e-2)"			"unprognostic (8.00e-2)"		"unprognostic (7.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-5)"	"unprognostic (3.38e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-4)"	0.1	0.2	0.4	0.1	0.4	0.4	0.0	0.9	0.5	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.4	0.1	0.1	0.4	0.2	0.3	0.1	0.1	0.2	0.4	0.3	0.1	0.4	0.3	0.5	0.1	0.4	0.1	0.0	0.5	0.2	0.0	1.4	0.3	0.2	0.0	0.1	0.2	0.3	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.4	0.4	0.9	0.5	0.4	0.2	0.4	0.3	0.4	0.1	0.3	0.4	0.0	0.0	1.1	0.0	0.4	0.0	0.9	0.0	0.0	0.3	0.1	0.0	2.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.2	0.4	0.0	1.2	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7
PCDHB2	PCDH-BETA2	ENSG00000112852	"Protocadherin beta 2"	Q9Y5E7	5	141094606-141098703	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.1;Endometrial stromal cells: 7.2;Spermatocytes: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 23.7;AN3-CA: 51.0;EFO-21: 28.7;U-138 MG: 22.2"	"Low region specificity"	"Detected in many"							HPA007548	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA007548: AB_2667859"	"unprognostic (2.94e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.03e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.84e-4)"	2.7	0.9	0.7	0.4	1.2	0.1	2.6	0.9	2.6	1.8	0.0	2.3	0.6	2.3	0.6	0.9	1.3	1.4	1.9	2.4	1.0	1.0	0.2	2.2	0.2	0.9	0.9	1.7	1.0	0.1	1.8	0.7	0.7	1.5	0.9	1.4	1.7	0.4	1.0	2.0	0.9	1.4	0.9	0.6	0.8	5.5	0.8	0.2	1.3	1.3	0.1	1.2	1.3	1.8	0.4	3.4	23.7	51.0	6.7	3.1	10.8	0.9	3.7	0.0	0.0	0.6	0.2	0.9	28.7	1.7	5.6	0.0	1.2	0.3	0.0	0.3	0.8	0.0	0.1	6.9	0.0	0.0	2.4	1.6	0.0	0.0	0.4	1.0	0.5	2.9	0.8	0.7	7.1	0.2	6.9	0.0	10.5	0.3	6.7	0.0	17.6	0.2	2.6	0.0	13.1	3.6	0.0	3.4	7.6	13.2	14.6	4.3	2.8	22.2	6.6	10.5	3.4	0.3	0.1	0.2	4.8	0.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.9	2.6	2.4	1.0	0.9	0.9	0.7	0.9	0.8	1.8	5.1	0.0	0.5	0.0	0.0	0.8	1.1	0.6	4.0	3.1	1.8	1.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	1.6	2.1	7.2	2.5	1.2	0.0	0.0	0.4	0.0	3.7	0.5	1.3	0.0	0.7	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.3	1.0	1.2	0.1	3.6	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.1	1.5	0.0	0.8	0.0	0.3	0.8	1.4	0.0	3.0	1.9	9.9	4.0	0.7	0.4	0.0	0.1	0.1	0.1	0.7
PCDHB6	PCDH-BETA6	ENSG00000113211	"Protocadherin beta 6"	Q9Y5E3	5	141150057-141153287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 16.6;SH-SY5Y: 7.1;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5"	"Low region specificity"	"Detected in many"							"HPA029566, HPA075308"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA029566: AB_10601385, HPA075308: "	"unprognostic (3.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.65e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.64e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.60e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.52e-2)"	0.8	0.7	0.9	0.2	0.9	0.0	1.1	0.4	1.6	1.2	0.0	0.7	0.0	1.9	1.1	0.2	1.0	0.3	0.7	1.4	0.3	0.6	0.1	0.7	0.1	0.8	0.7	1.2	0.5	1.8	1.0	0.4	0.8	0.5	0.1	0.9	0.7	0.3	0.4	0.7	0.3	0.9	0.6	0.2	0.4	1.9	0.8	0.1	0.4	0.3	0.1	0.7	0.7	1.3	0.0	0.4	0.3	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	16.6	0.2	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.1	0.0	0.1	3.7	0.4	5.4	2.3	0.0	0.6	1.2	7.6	0.0	0.0	0.0	0.0	3.8	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.4	1.6	1.4	0.3	0.8	0.7	0.8	0.6	0.8	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.4	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	1.0	0.7	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	1.5	0.8	7.6	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 2.4;Cardiomyocytes: 1.8;Horizontal cells: 3.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.5;T-47d: 7.3;WM-115: 3.3"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 37: Myocytes - Muscle contraction"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	0.3	0.2	1.1	0.2	2.3	0.2	0.2	3.2	2.0	0.5	0.0	0.5	0.2	0.6	0.9	0.2	0.4	0.1	1.2	2.2	0.9	0.2	0.1	0.3	0.1	1.5	1.4	0.6	0.5	0.5	0.9	0.5	0.9	0.3	0.2	1.0	0.2	0.2	0.7	0.3	0.1	0.4	1.7	0.2	0.1	0.7	1.4	0.1	0.2	0.4	0.1	0.4	0.3	1.3	0.0	0.2	0.3	1.1	0.7	1.3	0.1	1.1	0.7	0.3	0.6	0.3	0.1	0.2	1.8	0.7	0.5	0.1	0.1	0.2	0.7	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.1	1.1	0.3	0.0	0.4	2.1	0.0	0.1	0.1	0.5	4.5	0.0	0.1	0.5	0.1	0.0	0.2	2.0	1.6	0.2	0.2	0.2	1.0	1.3	0.1	0.6	1.1	0.3	7.3	0.2	0.5	2.0	0.3	1.0	0.2	0.1	0.6	0.1	2.4	0.1	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	2.3	3.2	2.0	2.2	0.9	1.5	1.4	0.9	1.7	1.4	1.3	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.7;Cone photoreceptor cells: 16.7;Horizontal cells: 23.5;Skeletal myocytes: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 14.6;HSkMC: 16.1;T-47d: 19.7;U-2197: 11.6"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	1.6	1.6	3.5	0.4	3.2	0.1	1.1	4.1	2.4	1.3	0.8	1.0	0.8	1.3	0.7	1.7	1.3	1.4	1.0	2.7	3.8	0.5	1.5	1.3	0.4	3.3	3.1	1.3	0.6	2.1	0.8	3.6	3.4	1.4	0.9	2.5	1.8	1.8	1.1	2.0	1.0	1.1	4.2	0.9	2.0	0.5	3.9	0.4	2.1	0.3	0.5	0.8	1.3	3.8	0.0	0.0	14.6	7.5	6.3	2.7	6.9	2.6	0.1	3.6	5.6	0.3	0.9	0.8	9.6	3.7	0.2	0.4	3.5	2.4	2.8	0.9	0.1	0.0	0.3	0.0	2.5	1.5	0.3	16.1	0.4	2.4	1.0	0.4	1.4	0.3	0.0	0.1	9.0	0.1	0.1	0.4	1.4	0.0	0.1	0.2	1.2	0.0	2.4	0.1	2.0	0.7	0.4	0.1	0.4	3.5	19.7	1.9	3.3	6.7	0.4	11.6	0.1	0.2	1.2	0.1	3.4	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	3.2	4.1	2.4	2.7	3.8	3.3	3.1	3.4	4.2	3.9	3.8	5.8	0.0	2.0	0.0	0.9	0.1	2.3	0.6	1.2	27.7	2.2	2.2	3.4	1.5	1.6	1.8	16.7	2.1	1.3	0.7	0.0	1.0	0.0	1.3	7.7	4.8	1.2	0.4	0.0	1.4	1.3	4.8	1.5	2.0	1.3	1.0	4.6	1.7	1.0	23.5	0.0	1.6	0.0	0.0	0.0	0.2	3.4	0.7	1.8	0.0	0.0	5.7	0.0	0.0	0.0	3.1	0.4	2.2	0.5	2.8	0.4	0.5	0.0	6.7	6.6	14.9	3.7	0.4	0.7	1.2	0.4	0.4	0.5	3.0	1.3	1.5
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512975	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Bipolar cells: 2.5;Hepatic stellate cells: 1.1;Horizontal cells: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;ASC TERT1: 25.9;GAMG: 47.4;hTERT-RPE1: 69.8;WM-115: 43.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	0.8	0.7	1.4	0.7	1.8	0.0	0.6	5.1	1.3	0.8	0.7	1.0	0.2	0.7	0.3	0.7	0.9	0.5	1.6	2.1	2.3	0.5	0.4	0.6	0.4	1.8	1.2	1.1	0.5	0.3	0.6	2.2	2.1	0.5	0.3	3.1	0.7	0.7	1.1	1.7	0.4	0.8	2.4	0.3	0.4	0.8	1.9	0.3	0.8	0.5	0.3	0.6	0.8	2.9	0.0	0.0	0.7	2.4	24.3	25.9	0.9	5.5	10.6	4.2	6.6	0.1	0.2	0.6	9.1	5.6	47.4	3.7	0.1	0.6	6.6	0.2	2.4	0.1	0.1	0.0	4.0	0.4	0.0	19.0	0.3	7.4	0.1	69.8	6.5	1.2	0.0	0.1	0.1	0.0	0.0	0.3	2.9	0.0	0.1	17.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	21.3	9.9	0.5	3.2	7.9	0.8	0.1	0.6	0.1	0.0	0.4	0.0	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	1.8	5.1	1.3	2.1	2.3	1.8	1.2	2.1	2.4	1.9	2.9	0.5	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.1	0.5	0.8	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.1	0.0	0.2	1.1	0.0	0.4	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.6	0.3	0.1	0.1	0.7	0.0	0.1	0.0	0.2	0.1	0.1
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430507-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.2;Bipolar cells: 3.8;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.3;Endothelial cells: 2.2;Fibroblasts: 3.2;Skeletal myocytes: 2.0"	"Group enriched"	"Detected in many"	5	"glioma: 1.7;melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 9.3;BJ hTERT+: 15.4;fHDF/TERT166: 23.3;HHSteC: 7.2;HSkMC: 16.5;TIME: 7.5"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		21000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	3.0	4.3	5.3	0.8	6.8	0.0	1.5	5.5	3.7	2.0	0.8	1.3	0.2	2.6	0.4	1.0	1.9	3.9	4.2	5.1	8.4	1.0	0.7	3.1	0.4	10.0	4.2	1.9	1.1	0.3	1.4	2.2	4.5	1.0	0.3	1.4	0.9	1.5	1.3	1.7	0.8	1.7	5.5	1.2	1.0	0.3	5.2	0.9	1.6	1.1	0.4	1.2	2.0	4.6	0.0	0.0	0.1	1.9	0.8	1.4	0.1	9.3	15.4	0.0	0.0	0.0	0.0	0.5	0.0	23.3	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.0	16.5	0.0	4.5	0.0	0.0	5.4	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	2.6	7.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	6.8	5.5	3.7	5.1	8.4	10.0	4.2	4.5	5.5	5.2	4.6	2.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.8	0.2	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.3	2.2	0.0	0.0	0.0	0.2	0.0	3.2	1.1	0.1	0.0	0.1	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.7	0.0	2.0	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Bipolar cells: 3.2;Cardiomyocytes: 1.8;Fibroblasts: 1.5;Leydig cells: 1.2;Peritubular cells: 2.6;Skeletal myocytes: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.4;BJ: 3.9;fHDF/TERT166: 4.4;HSkMC: 3.4;hTERT-RPE1: 3.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480"	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	2.2	1.6	1.8	0.7	1.4	0.0	1.9	2.7	2.5	3.0	0.7	1.5	0.1	2.9	1.9	0.8	3.1	1.4	4.9	2.9	1.5	1.1	0.7	2.0	0.2	3.8	3.2	6.3	1.8	3.8	2.6	0.7	2.6	1.9	0.3	2.3	1.2	2.2	1.0	1.0	0.6	2.1	3.5	0.6	0.9	2.3	2.6	0.8	1.6	1.1	0.2	1.4	1.7	2.2	0.0	0.7	0.3	0.2	2.8	6.4	0.0	3.9	1.3	0.3	0.5	0.0	0.0	0.1	0.4	4.4	0.5	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.4	0.1	0.0	0.2	3.9	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.5	0.0	0.2	0.5	0.0	2.3	0.1	0.3	0.4	0.0	2.3	0.6	0.3	0.2	0.0	0.0	0.3	0.0	1.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.4	2.7	2.5	2.9	1.5	3.8	3.2	2.6	3.5	2.6	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.2	0.3	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	1.1	0.9	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.5	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.4;Cardiomyocytes: 1.6;Endometrial stromal cells: 1.9;Fibroblasts: 1.3;Horizontal cells: 3.3;Skeletal myocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 7.1;BJ: 2.3;EFO-21: 5.7"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	1.2	1.2	2.6	0.2	1.7	0.0	0.9	2.2	2.6	1.6	0.1	0.7	0.0	1.4	0.9	0.2	1.2	0.9	3.7	2.5	1.8	0.5	0.6	0.9	0.0	3.8	2.9	2.5	0.9	0.6	1.2	1.7	2.2	0.7	0.2	1.8	0.7	0.8	0.8	0.5	0.2	0.9	3.4	0.2	0.4	1.5	2.9	0.2	0.8	0.9	0.1	0.8	0.9	2.5	0.0	0.0	7.1	0.0	0.0	0.9	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	5.7	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.7	2.2	2.6	2.5	1.8	3.8	2.9	2.2	3.4	2.9	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.1	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.9	0.1	0.5	0.0	0.0	0.1	0.0	0.4	0.0	0.0
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355021-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Skeletal myocytes: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.4;BJ: 4.3;HSkMC: 4.3;HUVEC TERT2: 4.3;U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	1.7	1.3	1.6	0.4	1.8	0.0	0.9	3.7	1.7	1.3	0.0	0.9	0.2	1.6	0.8	0.4	0.9	0.8	1.5	2.9	1.5	0.4	0.3	1.0	0.1	2.1	2.4	1.6	2.1	2.3	1.0	0.8	1.7	1.1	0.3	1.5	0.8	1.1	0.7	0.5	0.3	1.5	2.0	0.3	0.4	0.7	2.1	0.2	0.7	1.0	0.1	0.7	0.8	2.5	0.0	0.1	0.8	0.4	3.3	7.4	0.0	4.3	3.4	0.2	0.8	0.0	0.1	0.7	1.4	3.7	1.3	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.3	4.3	0.1	0.0	0.0	2.6	4.3	0.0	0.1	0.2	1.8	0.6	0.2	0.2	0.1	0.0	0.2	0.3	1.2	0.1	0.2	0.0	0.6	1.3	0.2	0.2	0.9	0.3	1.6	0.0	2.8	1.8	0.5	2.4	0.3	0.1	0.2	0.1	6.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.8	3.7	1.7	2.9	1.5	2.1	2.4	1.7	2.0	2.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 4.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.5;Endometrial stromal cells: 9.2;Horizontal cells: 10.1;Sertoli cells: 6.6;Skeletal myocytes: 5.7"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 15.8;ASC TERT1: 6.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	1.0	0.6	1.0	0.3	1.6	0.1	1.2	4.9	1.1	2.5	0.0	1.1	0.1	2.0	0.6	0.8	1.4	1.1	1.9	1.2	1.2	0.3	0.2	1.1	0.2	2.2	2.1	2.0	0.6	0.6	0.9	0.6	1.0	1.4	0.3	1.2	0.8	0.9	0.6	0.7	0.4	1.0	1.2	0.2	0.5	0.3	1.2	0.3	0.5	0.7	0.1	1.0	1.3	2.0	0.0	0.4	0.2	0.1	15.8	6.2	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.8	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	1.5	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.5	0.6	0.3	0.5	0.6	0.1	0.0	0.3	0.8	0.6	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.2	1.4	0.0	0.9	0.5	0.1	0.9	0.6	0.1	0.9	0.1	0.3	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	1.0	1.6	4.9	1.1	1.2	1.2	2.2	2.1	1.0	1.2	1.2	2.0	1.8	0.0	1.1	0.0	0.2	0.1	0.8	0.1	0.6	11.5	0.3	0.4	2.6	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.4	9.2	1.9	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.2	1.3	0.6	1.4	0.3	0.1	10.1	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.5	0.0	0.1	0.1	1.3	6.6	5.7	1.7	0.0	0.3	0.3	0.0	0.0	0.6	0.9	0.0	0.4
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373891-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.6;Cardiomyocytes: 5.0;Endometrial stromal cells: 4.6;Hepatic stellate cells: 3.6;Skeletal myocytes: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 9.6;T-47d: 5.6;WM-115: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	1.4	1.1	1.6	0.7	1.8	0.1	1.3	7.2	1.6	2.7	0.0	2.0	0.2	3.2	1.4	0.8	2.0	1.1	2.7	1.7	1.8	0.8	0.5	1.5	0.4	1.8	1.7	3.5	1.2	1.1	1.8	2.3	0.9	1.2	0.4	2.0	1.5	1.6	0.9	1.5	0.8	2.0	0.8	0.9	0.7	0.8	2.0	0.5	1.2	1.0	0.4	1.6	1.5	1.9	0.0	0.3	2.7	0.4	1.3	4.7	0.1	2.1	0.7	1.1	1.1	0.0	0.1	2.0	2.6	3.3	1.0	0.4	0.1	0.4	0.7	0.0	0.2	0.0	0.3	0.2	0.7	0.1	0.1	4.9	0.3	0.2	0.1	1.0	1.6	0.1	0.2	1.1	0.3	0.4	0.7	1.7	0.3	0.0	0.1	1.4	0.4	0.0	0.3	0.1	9.6	0.7	0.1	0.3	0.6	0.6	5.6	0.1	4.8	0.7	0.3	0.7	0.7	0.4	1.7	0.4	0.8	0.7	12.2	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.6	1.8	7.2	1.6	1.7	1.8	1.8	1.7	0.9	0.8	2.0	1.9	2.8	0.0	2.2	0.0	0.4	0.0	0.8	0.0	0.0	10.6	0.3	1.0	5.0	1.5	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.5	0.4	4.6	1.8	0.0	0.4	0.0	1.5	0.1	2.2	0.0	0.4	0.0	0.6	3.6	0.7	0.1	1.7	0.0	0.2	0.0	0.3	0.0	0.3	1.2	0.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.1	2.2	1.6	0.4	0.0	0.3	0.7	0.9	0.0	5.2	1.9	0.3	0.3	0.5	0.0	0.3	0.2	0.5	0.2	0.2
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.3;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.2;Skeletal myocytes: 2.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.3;BJ hTERT+: 20.8;hTERT-RPE1: 10.9;SH-SY5Y: 18.6;T-47d: 8.1"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	0.5	0.4	1.0	0.2	0.9	0.0	0.6	5.9	1.0	1.2	0.0	1.1	0.1	1.3	1.1	0.5	1.0	0.4	1.5	1.1	0.6	0.6	0.4	0.7	0.1	1.5	1.2	1.5	0.7	2.2	0.8	1.3	0.9	0.9	0.3	1.6	0.8	0.8	0.7	1.0	0.4	0.8	1.0	0.4	0.3	0.5	1.3	0.2	1.9	0.5	0.1	0.9	0.7	1.5	0.0	1.6	2.3	0.0	6.6	11.3	0.0	3.3	20.8	4.2	6.1	0.0	0.0	0.5	5.2	0.7	0.2	0.2	0.0	0.1	3.4	0.0	0.3	0.0	0.4	0.2	1.1	0.0	0.0	5.0	0.1	0.0	0.7	10.9	1.7	0.0	0.0	0.1	0.1	0.1	0.6	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.4	18.6	0.0	0.1	0.1	3.7	8.1	0.0	6.7	0.1	0.1	3.1	0.1	0.1	1.9	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	5.9	1.0	1.1	0.6	1.5	1.2	0.9	1.0	1.3	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.3	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.6	0.0	2.8	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.3
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"brain: 3.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.4;Cardiomyocytes: 3.5;Horizontal cells: 3.3;Skeletal myocytes: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.1	0.1	0.6	0.1	0.6	0.4	0.1	3.9	0.8	0.2	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.5	0.8	0.5	0.0	0.1	0.1	0.1	1.1	0.7	0.3	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.5	0.1	0.0	0.3	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.9	0.1	0.4	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.3	0.1	0.2	0.6	0.1	0.6	0.4	0.4	0.1	0.0	0.1	0.3	0.2	0.4	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.6	0.2	0.4	0.6	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.6	0.6	3.9	0.8	0.8	0.5	1.1	0.7	0.7	0.3	0.9	1.2	1.2	0.0	0.6	0.0	0.1	0.0	0.9	0.0	0.0	11.4	0.3	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.1	2.1	1.2	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.3	0.4	0.7	0.1	3.3	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.2	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.1	0.1	1.5	0.0	0.7	0.0	0.2	0.0	1.7	0.0	5.2	0.9	0.7	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.5
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.5;Cardiomyocytes: 1.3;Endometrial stromal cells: 1.5;Horizontal cells: 3.3;Skeletal myocytes: 2.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.6;HSkMC: 4.0;hTERT-RPE1: 16.9;TIME: 4.6;U-87 MG: 5.1"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	1.8	1.6	3.3	0.7	3.5	0.1	1.3	6.6	3.2	2.0	0.4	1.2	0.5	2.5	1.1	1.4	1.9	2.0	1.1	3.7	2.6	0.8	0.4	1.5	0.5	3.6	3.4	2.8	0.8	1.1	0.9	1.0	3.8	1.5	0.7	4.4	1.1	2.2	0.8	1.7	0.6	1.8	3.7	1.1	0.8	0.4	3.6	0.5	1.4	1.2	0.7	1.2	1.4	5.7	0.0	0.1	0.6	1.6	0.1	0.2	0.2	0.7	0.0	0.6	0.6	0.2	0.4	1.3	3.6	2.0	0.3	0.1	0.1	0.2	0.7	0.0	0.3	0.0	0.1	0.0	1.1	0.0	0.2	4.0	0.1	0.4	0.3	16.9	1.0	0.0	0.1	0.2	0.3	0.3	0.1	0.5	0.2	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.4	1.1	0.4	0.1	0.5	0.4	0.9	0.4	4.6	0.3	0.3	0.1	2.5	0.2	0.0	0.0	5.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.5	6.6	3.2	3.7	2.6	3.6	3.4	3.8	3.7	3.6	5.7	0.6	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.6	4.5	0.2	0.3	1.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.4	0.2	0.1	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	2.3	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.1
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.7;Late spermatids: 7.6;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.9;ASC TERT1: 6.6;hTERT-RPE1: 7.1;T-47d: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"		Yes	No				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	0.6	0.7	1.8	0.1	1.2	0.0	0.5	2.1	1.6	0.6	0.0	0.3	0.0	1.2	0.4	0.3	0.4	0.5	0.5	2.9	1.6	0.4	0.1	0.6	0.0	1.9	3.3	1.4	0.8	2.3	1.0	0.2	2.4	0.6	0.1	1.6	0.3	0.9	0.2	0.2	0.1	0.9	2.4	0.1	0.1	0.4	1.8	0.0	0.6	0.3	0.0	0.3	0.3	3.5	0.1	1.9	1.6	0.0	12.9	6.6	0.1	1.2	3.2	0.5	0.7	0.2	0.5	0.5	4.2	0.5	3.1	0.6	0.3	0.2	0.4	0.0	0.8	0.0	0.2	1.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	7.1	0.1	0.0	0.2	0.2	3.0	1.7	0.4	0.3	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.0	1.0	0.7	0.0	0.8	0.1	1.2	8.6	0.0	1.0	0.2	1.3	1.1	0.0	0.0	2.4	0.3	2.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.2	2.1	1.6	2.9	1.6	1.9	3.3	2.4	2.4	1.8	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.2;Cardiomyocytes: 1.4;Endometrial stromal cells: 1.0;Fibroblasts: 1.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.5;ASC TERT1: 9.8;LHCN-M2: 8.2;REH: 7.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350"	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	1.5	1.0	2.6	0.6	3.6	0.1	1.1	6.3	2.8	2.1	0.0	1.1	0.2	3.0	0.9	0.9	1.6	1.9	1.8	3.1	3.2	0.7	0.7	1.7	0.3	3.7	3.3	2.8	0.8	1.2	0.9	1.1	3.6	1.3	0.8	1.6	0.8	1.2	0.8	0.8	0.5	1.5	3.0	0.6	0.6	0.5	2.2	0.4	0.7	0.9	0.3	0.9	1.1	5.5	0.1	0.3	2.0	0.2	13.5	9.8	0.1	2.1	2.9	0.6	3.2	0.0	0.3	3.7	1.0	1.7	7.1	0.5	0.4	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.5	0.2	0.2	2.5	0.5	0.2	0.1	4.7	1.7	0.1	0.2	1.2	8.2	0.5	2.9	0.7	0.1	0.9	0.9	7.8	2.6	0.2	0.2	0.3	1.5	1.6	0.2	0.4	0.4	1.5	3.0	0.2	5.9	2.9	0.6	4.4	3.9	0.2	2.2	0.6	3.1	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.6	6.3	2.8	3.1	3.2	3.7	3.3	3.6	3.0	2.2	5.5	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.6	2.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370242-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.4;ASC TERT1: 8.4;fHDF/TERT166: 3.5;TIME: 5.5"									"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802"	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	0.7	0.3	0.4	0.2	0.8	0.0	0.5	3.8	0.8	0.8	0.0	0.8	0.0	1.0	0.6	0.3	0.7	0.4	1.2	0.9	0.5	0.3	0.2	0.5	0.2	1.3	1.4	1.2	0.7	1.1	0.7	0.4	0.6	0.4	0.3	0.8	0.8	0.4	0.5	0.6	0.3	0.7	0.6	0.4	0.4	0.4	0.8	0.3	0.6	0.5	0.2	0.6	0.6	1.4	0.0	0.6	0.4	0.3	10.4	8.4	0.2	1.2	2.0	0.7	0.8	0.0	0.0	1.8	0.3	3.5	0.6	0.5	0.0	0.2	0.5	0.0	0.2	0.0	0.2	0.1	0.4	0.1	0.0	2.1	0.4	0.2	0.1	0.2	1.0	0.0	0.2	0.8	0.2	0.4	0.6	0.9	0.1	0.0	0.1	1.5	0.6	0.0	0.2	0.1	2.4	0.5	0.0	0.0	0.2	0.3	0.6	0.0	5.5	0.5	0.1	0.5	0.6	0.2	1.8	0.2	0.4	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	3.8	0.8	0.9	0.5	1.3	1.4	0.6	0.6	0.8	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.1;Horizontal cells: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.3;SuSa: 15.5;TIME: 22.7"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	1.3	1.1	1.3	0.4	1.5	0.0	0.9	4.4	1.4	1.5	1.8	1.1	0.2	1.6	1.5	0.7	1.3	0.5	1.5	2.0	3.2	1.4	1.6	1.1	0.1	2.0	2.0	2.4	1.0	1.9	1.2	3.0	1.5	1.2	0.4	1.4	1.6	1.4	1.0	1.7	0.5	1.0	1.4	0.4	0.4	0.5	2.5	0.7	1.7	0.8	0.2	1.0	1.1	1.5	0.0	1.1	11.1	0.1	6.9	8.5	1.3	10.8	43.3	4.4	3.0	0.0	0.0	0.4	8.3	0.3	0.2	3.3	0.0	0.0	4.6	0.0	0.0	0.0	0.2	2.4	2.8	0.0	0.0	8.4	0.1	4.1	0.0	0.1	6.7	0.0	0.4	0.1	0.0	0.0	1.1	0.2	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	15.5	5.6	4.2	22.7	6.0	1.8	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	1.5	4.4	1.4	2.0	3.2	2.0	2.0	1.5	1.4	2.5	1.5	0.2	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Bipolar cells: 1.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 66.3;ASC TERT1: 49.6;BJ hTERT+ SV40 Large T+: 29.2;BJ hTERT+ SV40 Large T+ RasG12V: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.8	2.7	3.6	1.1	3.6	0.0	1.8	5.8	3.1	2.0	3.3	1.7	0.7	3.1	2.0	1.9	2.8	1.6	2.9	3.9	6.4	2.2	2.1	2.7	0.4	5.1	4.7	5.7	3.8	20.3	1.7	4.8	5.4	3.0	0.9	3.1	4.7	3.9	2.1	3.8	0.8	2.8	5.3	1.3	1.5	1.9	4.9	1.3	4.5	1.9	0.8	1.9	2.1	6.1	0.0	2.4	0.3	0.0	66.3	49.6	1.3	18.3	0.0	29.2	32.5	2.9	10.0	10.6	23.4	20.5	0.0	13.9	0.0	7.6	16.4	0.0	3.1	0.0	0.0	0.1	6.9	0.0	6.5	17.6	1.5	1.7	9.4	12.6	9.0	0.0	0.2	0.0	1.0	8.1	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	1.6	5.5	0.0	0.1	0.0	0.1	0.0	2.0	19.1	0.1	9.2	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.6	5.8	3.1	3.9	6.4	5.1	4.7	5.4	5.3	4.9	6.1	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.2	1.5	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.8	0.5	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.1
PCDHGB6	PCDH-GAMMA-B6	ENSG00000253305	"Protocadherin gamma subfamily B, 6"	Q9Y5F9	5	141408021-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.9;Cone photoreceptor cells: 6.2;Horizontal cells: 10.1;Skeletal myocytes: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.0;EFO-21: 5.4;HSkMC: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.71e-4)"	3.1	3.1	3.0	0.9	3.6	0.4	2.2	5.0	2.4	2.9	2.9	2.4	0.5	3.2	2.0	1.2	2.9	1.7	2.4	2.5	3.5	1.1	1.3	2.0	0.7	3.6	3.5	6.0	1.2	2.8	1.8	3.1	3.2	1.4	0.7	2.8	2.2	2.4	2.9	2.1	1.0	1.9	3.3	1.5	1.1	0.6	3.7	0.6	2.6	1.5	0.6	1.8	2.3	3.9	0.0	0.1	16.0	0.1	0.5	0.6	0.8	1.4	0.0	0.4	0.9	0.2	0.2	1.4	5.4	0.9	0.2	0.3	0.0	0.3	1.0	0.0	0.3	0.0	0.2	0.1	1.3	0.1	0.1	3.6	1.8	0.8	0.1	0.1	0.5	0.3	0.1	0.2	0.1	0.3	0.1	1.1	0.6	0.0	0.0	0.2	0.0	0.1	2.5	0.2	0.2	0.3	0.0	0.1	0.1	0.4	1.2	0.3	2.6	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	3.0	3.6	5.0	2.4	2.5	3.5	3.6	3.5	3.2	3.3	3.7	3.9	3.6	3.2	0.5	0.0	1.0	0.0	1.5	0.0	0.0	6.9	0.6	0.4	3.9	0.0	1.3	0.0	6.2	0.2	0.6	0.4	0.0	0.7	0.0	0.6	3.8	2.6	0.0	0.0	0.0	1.2	0.1	3.3	1.1	0.5	0.0	0.4	1.4	0.7	0.3	10.1	0.0	0.4	0.0	0.0	0.0	0.2	1.8	0.2	0.0	0.0	0.1	2.7	0.0	0.0	0.0	2.0	0.1	1.2	1.5	0.8	0.1	0.3	0.7	2.5	0.0	5.2	3.2	0.2	0.5	0.3	0.1	0.1	0.7	0.8	0.4	0.8
PCDHGB7	"ME6, PCDH-GAMMA-B7"	ENSG00000254122	"Protocadherin gamma subfamily B, 7"	Q9Y5F8	5	141417645-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 7.9;Fibroblasts: 3.4;Horizontal cells: 3.3;Skeletal myocytes: 5.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"AN3-CA: 86.7;HSkMC: 26.7;hTERT-RPE1: 72.4"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.22e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-2)"	5.2	4.6	4.6	1.8	4.7	0.1	4.2	10.8	3.5	4.9	5.0	5.0	0.9	5.7	2.2	3.0	4.4	4.4	4.3	4.5	7.0	2.4	1.5	5.8	1.2	6.0	6.0	8.1	1.7	4.3	2.2	5.5	5.3	3.8	1.7	5.8	3.7	5.5	3.0	3.3	2.1	5.1	7.7	2.7	2.4	1.9	5.0	1.5	4.0	4.1	0.9	3.3	3.8	7.3	0.0	0.0	2.9	86.7	1.9	0.3	0.9	5.7	0.7	2.1	4.3	0.1	5.3	0.7	4.6	11.7	0.8	1.4	0.2	1.0	2.0	0.1	0.6	0.0	0.2	0.0	6.4	0.5	0.1	26.7	0.7	1.7	0.9	72.4	4.6	0.2	0.0	0.0	0.3	0.0	0.0	0.1	1.0	0.0	0.6	10.1	1.9	0.0	0.2	0.0	9.3	12.8	0.2	0.0	0.0	1.0	1.0	0.9	11.5	10.3	0.2	0.9	0.1	0.1	0.2	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.6	4.7	10.8	3.5	4.5	7.0	6.0	6.0	5.3	7.7	5.0	7.3	2.2	3.2	1.3	0.0	0.3	0.4	0.8	0.0	0.0	7.9	0.3	0.5	1.4	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.0	0.2	0.1	0.4	2.1	2.2	0.0	0.0	0.0	0.5	0.1	3.4	0.0	0.3	1.3	0.5	0.4	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.0	1.9	0.1	0.4	0.0	0.3	0.0	0.7	0.0	5.9	2.2	0.0	0.1	0.5	0.4	0.0	0.0	1.2	0.1	0.2
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 31.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.1;Horizontal cells: 3.3"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 9.1;SCLC-21H: 7.3;SH-SY5Y: 14.2;SuSa: 10.0"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.2	1.1	17.3	0.1	12.2	0.0	0.2	19.3	14.6	0.3	0.1	0.6	0.0	0.4	0.2	0.2	0.3	0.2	2.2	12.7	13.9	0.1	0.1	0.4	0.1	12.9	21.9	0.3	0.3	0.0	1.1	0.1	10.3	0.2	0.1	6.6	0.3	0.1	0.7	0.5	0.1	0.2	22.4	0.1	0.2	0.9	14.3	0.0	0.1	0.3	0.2	0.2	0.3	31.4	0.0	0.0	0.9	0.2	0.2	0.7	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.8	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	1.3	0.0	0.0	9.1	0.5	0.0	0.0	0.1	7.3	14.2	0.1	0.0	0.1	10.0	0.1	0.3	0.1	0.8	0.1	0.2	0.6	0.2	0.0	0.2	0.6	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	12.2	19.3	14.6	12.7	13.9	12.9	21.9	10.3	22.4	14.3	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489081-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 28.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 4.6;SuSa: 7.4;U-138 MG: 14.4;U-251 MG: 6.5;U-87 MG: 8.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA076140"	Supported		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"		"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	0.3	0.5	5.6	0.1	8.6	0.0	0.3	0.0	11.7	0.8	0.0	1.3	0.0	1.2	0.2	0.3	0.7	0.2	5.3	28.4	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.7	0.4	0.0	1.2	0.1	0.0	0.5	0.0	1.2	0.4	0.5	1.2	0.5	0.2	0.7	0.0	0.1	0.3	0.6	0.3	0.1	0.2	0.2	0.0	0.5	0.6	0.0	0.0	0.0	0.3	0.3	0.3	1.5	0.1	0.8	0.5	0.4	0.5	0.0	0.0	0.4	1.4	2.2	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	4.6	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	7.4	0.1	0.2	0.1	14.4	0.2	0.2	6.5	0.0	0.0	0.0	8.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.6	0.0	11.7	28.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCED1A	"bA12M19.1, C20orf81, FAM113A, FLJ22376"	ENSG00000132635	"PC-esterase domain containing 1A"	Q9H1Q7	20	2835314-2841190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Cytosol"		"HPA050816: AB_2681246"	"unprognostic (3.20e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.97e-3)"	45.4	44.2	64.8	30.8	66.1	22.2	35.5	60.6	74.1	62.1	72.0	34.7	24.6	40.0	27.2	31.8	53.4	26.0	27.5	61.7	63.0	70.9	57.8	42.6	36.8	67.4	63.7	63.4	41.2	40.2	63.3	23.3	62.9	65.9	12.6	18.2	35.0	19.8	13.5	21.4	47.7	21.0	61.4	81.9	41.2	25.9	66.6	23.5	86.3	9.0	24.2	40.5	42.5	72.8	31.2	39.1	39.4	21.6	39.8	54.5	29.1	29.2	32.5	29.7	32.2	27.3	54.5	9.1	20.0	19.5	49.5	50.3	9.3	27.1	13.7	45.4	31.0	36.0	49.9	38.7	32.2	6.8	11.6	73.0	56.0	36.3	48.4	42.7	21.7	45.3	28.9	40.1	22.2	20.9	4.9	45.5	44.3	23.3	25.4	24.7	13.3	18.9	33.7	24.7	37.2	57.4	29.8	37.1	51.7	24.9	48.0	23.2	21.6	29.1	20.4	30.4	14.0	69.0	36.5	2.6	7.1	24.8	35.1	3.6	8.2	3.5	11.0	7.3	10.9	9.8	6.7	9.8	9.2	9.8	12.1	11.0	0.6	16.1	7.7	8.0	4.8	8.3	64.8	66.1	60.6	74.1	61.7	63.0	67.4	63.7	62.9	61.4	66.6	72.8	9.9	16.0	19.8	16.0	13.8	4.0	10.6	8.6	30.1	11.9	12.7	13.2	4.9	8.6	10.5	9.2	10.4	5.1	12.8	6.0	13.7	5.0	0.7	12.4	32.3	11.7	8.4	7.2	4.8	2.1	2.5	15.4	22.4	10.1	0.0	18.1	11.0	14.0	6.9	11.8	6.9	9.1	6.1	9.5	6.8	3.0	9.0	12.8	1.8	8.4	5.1	9.6	5.2	8.0	11.6	4.0	8.5	2.2	11.4	6.6	8.6	12.4	8.5	12.4	6.6	7.1	12.3	13.2	7.4	15.1	3.7	3.4	12.2	17.6	7.5	8.3
PCF11	KIAA0824	ENSG00000165494	"PCF11 cleavage and polyadenylation factor subunit"	O94913	11	83156988-83187451	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 227.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 124.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040779			Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA040779: AB_2677133"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (3.74e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.03e-5)"	20.1	13.9	9.8	23.5	15.0	42.5	23.7	29.1	13.6	19.2	6.0	19.6	16.3	22.4	15.2	19.5	17.7	17.2	13.5	9.3	10.9	14.9	16.9	22.8	32.4	13.1	12.7	28.3	17.0	16.6	10.4	16.7	14.0	18.7	19.9	26.6	15.4	16.2	26.3	27.8	20.8	23.8	10.9	28.7	16.4	24.7	12.1	33.4	24.3	19.5	29.6	17.0	13.5	17.9	26.3	18.4	29.4	25.3	34.4	33.4	23.5	24.7	18.2	23.2	17.7	31.5	25.7	58.9	18.1	18.0	21.9	25.8	43.2	17.0	22.3	42.1	14.8	34.5	26.3	22.4	19.4	40.9	36.8	23.9	32.1	17.7	25.6	31.2	23.8	38.8	40.9	27.9	21.9	27.9	38.7	45.2	30.7	44.6	20.5	36.4	37.1	35.2	20.2	38.4	24.4	27.0	30.1	23.7	24.3	26.9	23.7	28.0	24.6	33.0	16.9	24.5	16.6	25.0	45.2	124.6	14.5	26.8	26.0	14.8	7.2	14.9	10.1	6.8	8.5	10.9	6.9	7.3	6.9	9.9	7.8	8.2	17.1	13.5	5.5	7.1	5.5	5.8	9.8	15.0	29.1	13.6	9.3	10.9	13.1	12.7	14.0	10.9	12.1	17.9	96.4	41.7	63.5	58.1	90.6	53.7	79.8	30.7	101.9	48.4	84.4	81.0	42.7	35.8	43.4	46.0	33.3	30.2	90.1	49.8	25.4	22.9	203.3	55.5	70.8	66.8	31.8	62.5	32.0	18.1	26.9	58.8	40.2	83.6	37.2	48.0	56.7	21.7	37.6	55.5	37.9	51.0	26.4	57.8	41.0	40.3	60.3	87.4	28.4	45.0	52.5	34.5	58.7	40.7	72.0	19.2	46.2	45.1	69.0	71.6	83.4	14.2	29.0	55.3	39.5	227.3	66.8	46.7	17.9	100.4	62.7	39.4	81.7	42.7	50.3	71.1
PCGF1	"MGC10882, NSPC1, RNF68"	ENSG00000115289	"Polycomb group ring finger 1"	Q9BSM1	2	74505043-74507695	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011356, HPA069156"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA011356: AB_1855063, HPA069156: AB_2686095"	"unprognostic (2.41e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.13e-1)"	9.9	10.4	13.7	8.6	14.5	17.8	15.2	14.6	17.3	12.8	13.0	11.5	11.2	12.5	14.4	9.7	14.4	10.0	12.3	14.1	13.9	10.9	13.0	12.3	14.1	13.9	13.8	14.8	11.0	17.6	2.3	11.4	14.7	9.3	12.3	18.1	11.0	8.8	12.1	14.8	10.8	11.2	13.7	8.5	11.7	11.0	14.5	14.4	14.2	17.6	14.7	10.7	2.1	15.1	18.9	11.6	12.3	19.0	15.4	19.0	19.0	17.8	23.8	16.2	10.9	25.5	12.8	16.9	7.6	16.5	38.0	11.4	20.7	23.5	14.6	16.3	24.7	12.0	15.7	25.6	24.9	31.7	16.5	25.5	33.3	10.5	57.4	26.0	12.8	21.8	25.0	23.0	17.8	27.8	22.6	42.0	16.3	23.5	12.3	18.0	27.3	14.1	24.8	21.0	14.0	27.8	13.8	27.1	30.1	12.1	10.1	21.4	11.7	26.2	17.5	14.5	24.1	12.5	9.7	18.3	22.1	22.6	16.3	11.1	24.2	10.4	15.5	20.1	18.3	18.1	20.7	19.8	26.9	17.9	16.3	16.8	8.7	14.4	23.3	13.1	24.2	14.2	13.7	14.5	14.6	17.3	14.1	13.9	13.9	13.8	14.7	13.7	14.5	15.1	7.0	3.2	1.8	2.3	8.7	12.5	9.0	23.8	31.3	5.0	10.5	10.9	3.5	12.8	10.6	3.7	4.2	12.2	6.5	9.5	31.3	11.0	19.0	11.3	11.5	8.5	1.2	10.3	1.7	10.4	19.5	13.1	6.1	10.4	10.2	2.9	7.1	6.2	13.6	5.0	1.6	12.8	18.3	9.9	14.0	4.9	7.8	10.8	7.2	0.0	15.0	6.7	19.6	0.5	2.3	11.3	15.9	4.9	11.4	9.4	14.2	17.5	9.5	9.5	6.6	10.4	14.0	19.3	8.0	24.3	18.9	18.3	9.6	5.0	9.4	8.5
PCGF2	"MEL-18, RNF110, ZNF144"	ENSG00000277258	"Polycomb group ring finger 2"	P35227	17	38733898-38749817	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047732, HPA063531"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA047732: AB_2680138, HPA063531: AB_2685031"	"unprognostic (1.56e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.10e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	33.6	38.3	3.3	4.6	3.2	0.0	33.0	7.7	5.5	44.7	4.3	24.4	3.7	40.6	2.4	21.4	35.9	6.1	37.3	3.2	5.2	56.5	12.9	33.4	2.1	2.6	3.0	40.5	22.9	2.9	55.6	6.8	2.9	37.5	1.6	7.2	22.6	2.7	9.3	21.6	22.7	2.1	1.2	28.3	25.3	13.3	4.1	0.2	41.7	0.9	0.8	27.3	30.8	3.1	16.9	38.2	9.2	34.5	7.2	2.3	11.7	13.1	6.2	6.2	7.4	21.1	17.6	1.3	14.3	4.2	16.3	26.2	3.4	6.1	2.5	10.4	20.1	7.9	20.7	52.4	2.3	1.2	9.4	2.5	2.8	9.0	6.1	9.6	7.5	7.9	14.9	21.2	3.9	37.8	1.5	0.2	11.7	7.4	15.3	12.6	14.7	3.3	3.2	22.5	16.4	26.8	12.6	9.0	20.8	9.0	35.4	1.6	22.0	24.8	27.1	24.8	23.2	12.5	4.1	4.3	13.3	2.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.2	7.7	5.5	3.2	5.2	2.6	3.0	2.9	1.2	4.1	3.1	49.6	3.2	16.0	2.0	1.1	14.1	11.2	19.7	23.9	59.9	20.6	17.0	2.1	15.7	10.1	20.2	10.4	13.3	0.8	23.7	52.8	24.9	15.1	8.0	22.1	46.4	13.2	0.0	6.5	13.7	26.7	21.9	12.8	12.8	1.3	14.0	51.0	2.9	4.8	35.3	7.0	12.5	22.4	2.9	5.5	5.0	37.0	2.9	14.2	6.5	3.2	26.4	2.1	9.5	2.4	18.9	10.3	29.3	3.8	15.4	22.3	59.6	5.0	16.5	0.0	16.8	16.7	6.1	15.7	9.6	16.9	22.2	0.9	13.3	13.2	11.1
PCGF3	"DONG1, FLJ36550, MGC40413, RNF3, RNF3A"	ENSG00000185619	"Polycomb group ring finger 3"	Q3KNV8	4	705748-770640	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061879	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA061879: AB_2684631"	"unprognostic (1.24e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.25e-4)"	32.7	45.1	17.9	15.5	18.5	30.1	34.7	30.6	19.5	41.9	16.7	31.7	22.6	35.3	8.7	35.5	33.6	14.0	27.2	18.9	17.0	31.7	29.7	34.7	18.3	18.1	17.2	50.4	27.8	7.8	31.4	19.8	17.5	38.3	10.3	13.3	37.4	9.7	18.4	53.3	36.2	10.7	16.2	51.0	32.1	23.3	17.9	18.6	34.6	11.4	11.8	27.2	39.4	24.1	22.1	19.6	35.3	40.4	15.8	16.2	43.3	29.2	15.9	23.5	23.7	21.5	23.8	15.7	19.1	28.3	23.8	14.9	16.5	23.7	17.8	20.8	17.9	22.6	24.2	38.4	19.3	15.5	28.9	20.5	31.0	20.5	9.3	15.4	30.5	28.2	31.5	12.6	23.3	24.6	41.8	54.6	23.4	14.9	35.0	41.0	22.4	10.1	14.1	35.6	50.2	37.9	15.2	16.1	16.1	22.7	31.5	21.8	36.9	22.8	18.4	19.2	38.1	30.1	27.6	24.6	18.0	24.5	43.0	3.4	7.1	3.1	3.3	5.1	2.8	4.2	2.0	2.1	3.2	5.0	2.5	1.7	4.5	4.7	2.2	4.6	3.3	2.3	17.9	18.5	30.6	19.5	18.9	17.0	18.1	17.2	17.5	16.2	17.9	24.1	29.5	12.8	28.8	19.6	12.5	25.4	17.3	17.2	25.0	12.3	28.3	21.3	21.7	17.2	21.8	9.2	12.5	13.4	13.5	21.4	3.9	20.6	52.0	17.7	28.7	27.8	19.2	9.1	18.1	19.8	30.0	17.8	35.2	21.2	16.5	22.4	25.4	15.3	12.2	6.7	18.6	21.7	20.3	15.1	21.0	54.4	16.4	20.1	23.2	23.4	14.3	9.1	16.5	27.2	22.8	32.7	19.3	15.4	22.9	24.0	19.1	9.4	14.0	8.5	6.6	18.8	18.8	19.0	25.6	22.5	28.7	23.7	13.3	20.8	20.2	38.2
PCGF5	"MGC16202, RNF159"	ENSG00000180628	"Polycomb group ring finger 5"	Q86SE9	10	91163012-91284337	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 345.7;Oligodendrocytes: 252.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038349, HPA059071"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038349: AB_10669523, HPA059071: "	"unprognostic (1.34e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.98e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.90e-4)"	13.7	21.8	17.8	13.1	18.9	5.8	11.9	17.4	20.0	12.0	10.9	15.3	17.6	12.5	10.7	12.8	12.1	12.7	28.3	14.2	25.2	23.4	26.2	13.1	16.9	21.8	21.2	14.9	16.2	19.9	7.2	15.9	17.7	13.7	14.1	16.3	17.6	14.0	15.2	11.2	21.0	11.9	17.6	17.8	14.7	11.4	21.1	19.4	24.2	16.7	15.7	12.2	8.5	23.0	32.9	14.2	11.6	5.0	16.5	25.7	8.3	18.2	37.3	16.2	22.5	2.2	18.7	43.2	8.3	22.9	13.3	6.3	12.6	12.5	28.4	50.1	9.5	20.4	9.0	22.2	21.8	16.0	31.0	11.7	22.6	12.1	16.8	33.2	13.7	19.0	11.1	23.5	25.4	6.1	36.2	4.1	1.7	7.5	8.1	17.8	21.5	11.7	29.6	5.1	5.5	7.8	8.9	9.4	15.6	4.1	7.6	7.1	35.9	19.0	13.4	11.8	21.8	40.8	26.9	38.2	26.7	11.4	6.0	6.4	1.6	2.7	2.6	4.0	4.7	4.0	3.9	2.7	2.1	3.9	3.9	3.9	2.1	5.1	7.7	0.5	2.4	2.6	17.8	18.9	17.4	20.0	14.2	25.2	21.8	21.2	17.7	17.6	21.1	23.0	35.8	6.4	24.0	135.8	60.1	34.4	48.7	34.8	38.7	20.2	26.8	30.6	81.2	28.6	28.3	29.5	16.7	16.5	49.7	82.8	49.0	33.9	127.8	25.2	38.7	33.8	21.6	124.8	99.0	63.9	5.0	32.7	33.1	29.0	23.4	14.0	35.3	58.6	50.5	50.5	159.5	65.4	20.3	73.1	64.9	345.7	19.6	65.9	42.7	56.2	74.0	79.9	40.2	107.1	252.6	54.3	55.1	29.7	72.3	61.2	83.7	59.0	27.9	19.3	13.1	59.1	39.4	78.2	14.4	34.4	31.3	5.6	55.9	10.9	49.0	67.2
PCID2	FLJ11305	ENSG00000126226	"PCI domain containing 2"	Q5JVF3	13	113177536-113208715	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 204.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069107, HPA073074"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA069107: AB_2686088, HPA073074: AB_2686568"	"unprognostic (2.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (1.73e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.24e-6)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	22.2	29.0	16.6	15.8	17.4	15.5	22.9	19.0	18.8	27.0	18.3	25.2	12.1	23.0	23.0	19.3	25.9	17.1	37.7	16.8	17.3	20.1	23.8	18.6	25.8	16.4	16.6	33.7	23.9	19.1	22.6	15.5	16.4	24.7	18.5	10.7	23.8	19.2	29.1	18.9	20.2	21.8	16.5	24.7	24.4	45.3	17.6	24.4	20.8	24.4	23.0	23.9	22.4	18.8	62.9	26.3	39.1	34.7	70.2	52.3	27.4	47.2	70.7	64.4	59.1	51.9	57.7	50.2	30.7	64.5	81.6	38.8	62.9	42.8	71.2	44.3	62.1	64.8	68.1	45.9	70.0	110.4	25.5	43.3	46.6	40.4	71.1	51.4	51.3	68.5	50.4	19.9	73.6	30.3	59.4	77.9	38.9	115.1	33.2	53.4	43.4	48.0	58.8	31.3	52.0	31.9	29.5	72.2	55.9	39.3	39.9	133.4	33.5	19.0	68.7	27.9	36.2	30.4	30.4	70.4	65.3	74.1	44.2	28.2	25.5	20.0	68.9	34.4	81.6	39.7	58.0	72.5	26.0	39.5	52.2	54.6	3.9	22.6	33.2	24.8	64.7	54.7	16.6	17.4	19.0	18.8	16.8	17.3	16.4	16.6	16.4	16.5	17.6	18.8	26.5	19.2	16.7	16.3	28.4	21.5	29.1	37.8	17.6	23.6	25.5	32.3	27.8	21.5	23.7	14.7	16.7	30.2	38.5	7.8	27.4	22.8	52.8	26.8	35.7	26.2	7.8	32.8	43.6	13.8	24.7	33.8	18.8	21.7	10.8	39.0	18.9	18.4	20.2	37.0	33.7	15.6	16.2	18.2	14.0	18.1	41.3	17.2	16.0	26.2	24.0	19.0	38.1	25.1	40.4	18.1	15.8	40.6	16.8	46.3	13.6	23.6	30.4	23.8	19.7	37.4	30.9	204.4	72.7	17.6	24.7	31.1	43.7	33.0	20.1	25.3
PCIF1	"bA465L10.1, C20orf67, CAPAM, PPP1R121"	ENSG00000100982	"Phosphorylated CTD interacting factor 1"	Q9H4Z3	20	45934683-45948023	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049517	Enhanced		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Microtubules, Cytokinetic bridge"	"HPA049517: AB_2680801"	"unprognostic (5.42e-3)"	"unprognostic (7.76e-2)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.24e-1)"	28.7	28.0	20.7	18.6	23.0	33.9	28.7	30.2	24.2	36.1	17.6	30.7	16.5	39.7	10.8	24.4	35.3	16.3	31.9	20.4	20.2	23.4	19.5	28.2	27.3	22.7	21.6	41.7	29.5	22.8	26.0	17.0	22.1	26.2	11.7	15.9	23.6	21.3	41.7	36.7	27.2	21.3	20.9	34.7	25.4	18.1	21.7	34.4	32.0	27.6	19.6	28.6	29.3	24.9	21.2	29.0	22.0	27.2	15.3	18.2	24.2	8.3	25.1	24.9	24.2	49.3	27.7	22.7	27.4	22.6	28.7	23.4	15.8	29.0	10.8	14.1	11.4	29.1	23.1	33.4	28.2	26.4	28.1	25.5	29.9	15.3	24.5	22.3	21.0	37.1	20.8	30.9	17.9	44.6	52.3	48.3	7.8	25.5	24.9	32.2	20.4	28.0	20.1	21.8	30.2	30.0	31.5	29.5	16.1	11.6	31.0	30.7	18.1	30.7	24.1	27.3	16.8	35.4	22.1	21.0	37.7	23.8	18.2	75.5	47.5	80.2	54.5	47.2	43.0	51.6	47.3	50.2	50.3	56.2	48.6	43.0	74.6	74.3	48.0	40.4	54.4	64.0	20.7	23.0	30.2	24.2	20.4	20.2	22.7	21.6	22.1	20.9	21.7	24.9	19.7	3.2	14.2	4.6	33.7	8.7	26.4	7.9	26.2	9.9	17.0	19.7	21.9	20.0	7.1	11.0	2.1	19.5	32.4	14.6	15.6	21.4	9.6	13.3	10.7	16.1	26.5	25.4	2.5	38.6	22.6	15.4	17.3	13.5	14.5	14.9	9.7	12.4	16.9	13.5	3.6	14.0	4.1	16.0	8.7	8.1	11.5	21.5	17.8	1.0	24.9	12.0	33.0	3.0	3.9	28.3	13.1	12.8	35.5	25.4	14.8	23.2	11.0	13.4	0.0	20.2	19.3	14.4	11.9	23.8	10.7	27.8	30.8	15.1	12.0	38.8
PCMTD1	FLJ10883	ENSG00000168300	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1"	Q96MG8	8	51817575-51899186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025696, HPA061444"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA025696: AB_1855077, HPA061444: AB_2684519"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.11e-3)"	36.5	35.2	18.2	23.3	20.2	16.8	38.2	25.2	21.9	33.8	23.2	38.8	25.9	35.3	47.5	28.0	30.8	29.0	35.5	16.4	19.9	38.3	30.4	28.3	28.8	19.1	19.2	42.6	73.9	77.9	25.5	26.3	19.9	36.1	25.8	25.4	57.6	32.0	83.4	33.5	26.8	28.3	18.9	46.3	29.5	14.9	18.9	35.1	53.3	67.1	27.3	32.6	31.0	21.6	11.7	5.7	24.3	5.4	34.1	28.4	14.0	13.4	22.8	5.5	9.0	3.1	23.6	12.0	18.0	17.3	8.4	27.2	4.7	15.8	9.3	11.9	8.5	12.6	11.7	8.3	43.9	5.2	12.4	30.4	31.7	6.9	17.4	35.8	24.4	16.0	9.5	36.0	12.0	4.2	24.5	13.7	8.9	16.7	3.0	8.0	4.5	13.8	24.7	21.7	16.2	15.0	10.9	14.8	17.1	18.5	14.2	7.6	22.2	6.8	5.9	8.8	5.2	21.6	15.6	3.9	16.4	11.4	7.0	18.7	8.4	23.2	8.6	11.0	10.4	13.1	11.5	9.4	8.1	13.0	13.5	12.4	29.4	21.6	12.7	14.7	13.2	9.1	18.2	20.2	25.2	21.9	16.4	19.9	19.1	19.2	19.9	18.9	18.9	21.6	98.4	115.4	68.1	78.7	78.1	54.0	66.0	49.7	58.6	80.7	66.7	61.0	92.7	48.6	52.0	84.6	10.4	38.1	80.7	28.7	64.6	32.9	4.7	66.6	63.9	79.3	46.7	51.4	144.7	39.8	37.2	79.2	45.9	92.2	53.0	107.2	76.4	37.1	25.1	58.9	159.7	39.0	61.1	51.8	56.8	10.4	104.1	62.7	71.2	144.3	52.5	120.8	55.6	106.1	122.3	43.8	32.2	120.0	101.8	98.0	45.5	92.8	56.7	24.0	39.5	73.2	68.2	16.4	24.2	38.3	59.2	68.5	62.1	87.6	30.9	94.6
PCMTD2	"C20orf36, FLJ10883"	ENSG00000203880	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2"	Q9NV79	20	64255695-64287821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 180.5"	"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 138.2;Rod photoreceptor cells: 181.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057849	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria	Nucleoplasm	"HPA057849: AB_2683544"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.05e-3)"	31.4	33.6	27.2	22.9	31.0	17.8	37.5	40.2	40.7	36.7	28.3	25.3	23.3	39.2	49.2	22.8	29.0	32.5	42.5	27.1	30.5	34.2	32.1	24.0	41.6	27.1	25.9	57.0	27.0	27.7	31.8	41.2	25.3	29.5	20.3	180.5	32.3	18.3	44.6	66.0	25.0	19.0	24.9	36.3	21.7	24.7	28.4	39.5	27.1	32.9	29.6	20.6	28.1	38.9	22.9	8.5	32.0	25.0	30.1	37.1	30.1	13.6	15.1	19.7	12.0	19.4	35.9	33.8	23.5	16.6	15.6	27.6	17.6	22.4	26.5	7.4	23.0	16.4	42.1	32.9	25.3	16.9	24.0	52.7	30.5	10.4	17.9	35.1	29.1	34.0	30.4	29.8	16.3	14.8	39.8	56.7	23.5	31.6	31.7	32.6	12.6	41.1	30.0	26.1	50.0	58.9	26.1	30.1	37.2	49.4	32.2	34.1	21.2	29.4	10.3	18.9	11.3	35.8	31.3	32.9	19.5	17.9	16.1	10.1	7.9	9.4	9.4	5.4	11.2	10.2	14.0	10.7	9.0	10.7	19.2	14.2	10.2	17.4	5.3	5.4	22.6	9.8	27.2	31.0	40.2	40.7	27.1	30.5	27.1	25.9	25.3	24.9	28.4	38.9	40.8	22.4	26.9	25.8	21.0	20.4	15.6	10.2	31.3	118.5	27.5	18.0	67.4	28.6	17.5	29.5	93.8	33.7	21.9	6.7	23.5	8.4	13.2	21.3	23.2	36.6	22.8	35.3	34.8	9.1	7.0	34.8	17.9	26.4	12.7	33.5	45.0	36.7	14.4	37.0	29.5	15.9	14.2	28.8	10.7	9.5	42.9	17.3	48.0	21.5	19.2	61.3	20.6	138.2	64.6	9.9	15.7	30.9	20.2	14.6	12.0	23.3	24.3	181.9	26.3	25.0	27.7	51.7	37.7	24.9	21.3	21.9	21.6	63.1	15.2	11.3
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	DNA-binding	"Cancer-related genes, Deafness, Disease variant, Dwarfism, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 383.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm		No	Yes		170000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	31.2	47.2	23.2	85.2	26.0	383.2	51.0	26.8	29.7	41.5	26.8	89.0	70.7	38.1	30.9	81.2	39.1	34.8	30.6	23.0	24.4	43.7	55.3	37.5	168.8	25.1	24.0	37.7	32.8	42.4	25.1	69.8	26.0	32.2	93.7	94.1	40.3	38.3	27.9	62.8	72.9	47.9	26.8	54.0	53.9	62.3	23.3	219.9	42.0	26.8	137.3	51.0	42.3	30.0	769.1	591.4	585.0	253.7	136.1	126.6	409.5	491.6	288.3	453.7	640.0	465.3	594.2	773.4	155.7	177.5	395.2	558.8	350.7	594.4	413.2	231.7	386.8	543.7	207.8	1098.3	57.8	753.7	233.0	92.6	138.2	387.2	91.7	95.3	263.3	503.6	493.9	631.2	449.7	278.3	1450.6	829.3	439.9	592.0	322.9	787.9	514.1	622.5	208.5	441.1	500.8	339.4	345.1	524.6	351.9	213.9	371.2	378.0	177.2	324.3	373.3	461.5	572.0	317.2	981.6	1313.9	145.9	707.4	426.2	5.0	23.2	18.5	36.5	23.3	45.7	33.5	45.7	37.1	32.6	29.2	41.6	37.3	7.7	43.6	24.7	29.9	48.1	36.7	23.2	26.0	26.8	29.7	23.0	24.4	25.1	24.0	26.0	26.8	23.3	30.0	32.4	44.8	26.0	2.9	40.6	67.7	44.4	121.4	44.3	42.1	27.5	45.2	14.5	21.5	60.5	58.8	27.1	171.5	44.3	42.9	60.7	51.6	176.0	30.2	21.4	34.8	19.9	189.0	4.3	39.6	175.6	38.7	21.9	27.7	22.7	53.1	29.6	27.1	96.7	32.0	5.9	53.9	75.3	24.2	33.4	109.1	36.1	32.7	37.4	3.7	47.6	74.0	23.7	4.0	13.5	28.3	20.3	40.3	56.6	23.3	33.3	46.1	44.1	97.1	52.6	29.2	46.1	149.1	101.1	65.5	49.7	66.4	48.6	29.6	84.5	40.4
PCNP		ENSG00000081154	"PEST proteolytic signal containing nuclear protein"	Q8WW12	3	101574180-101594465	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035011, HPA063861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No		38000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA035011: AB_10601386, HPA063861: "	"unprognostic (4.34e-2)"	"unprognostic (9.65e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-1)"	47.0	47.6	42.6	43.5	45.3	58.7	53.5	48.6	69.1	48.2	54.5	47.8	38.8	53.8	52.6	48.1	43.8	41.0	57.7	43.1	50.6	51.9	49.6	41.0	57.3	43.7	43.9	69.7	33.3	50.0	39.3	50.5	44.0	47.6	45.2	58.3	42.5	49.1	66.5	39.0	36.1	53.4	45.8	39.8	34.8	28.4	45.8	58.0	49.8	66.4	57.5	50.7	40.0	52.9	135.0	71.1	105.2	82.9	96.1	136.8	113.4	90.0	126.3	94.1	105.1	85.8	73.1	139.4	66.5	100.0	92.8	71.4	138.0	119.6	196.9	102.6	76.6	151.1	84.9	103.4	73.6	141.1	72.1	82.4	115.5	78.0	109.6	134.8	129.6	64.1	143.7	82.6	117.2	55.8	123.8	120.2	162.4	110.8	113.9	71.8	93.2	110.0	123.7	76.7	136.1	108.0	83.4	82.0	132.6	119.3	76.7	105.4	81.5	86.5	113.8	44.1	97.1	62.1	100.2	174.0	84.1	150.9	107.4	58.3	22.4	38.6	22.1	27.0	29.1	29.8	28.9	26.9	23.9	24.1	29.1	27.3	20.2	36.4	36.0	18.9	35.9	40.9	42.6	45.3	48.6	69.1	43.1	50.6	43.7	43.9	44.0	45.8	45.8	52.9	94.9	60.9	101.4	25.5	124.2	232.6	235.2	171.7	126.9	89.5	90.3	65.8	111.5	75.8	106.2	64.4	39.6	120.3	75.0	46.6	266.1	130.3	30.1	89.1	80.4	111.0	81.9	195.9	50.4	95.0	205.7	126.9	55.5	114.6	102.6	53.8	90.3	51.7	90.3	97.6	51.3	70.8	187.2	87.3	242.1	15.0	130.8	105.0	250.8	39.4	131.0	128.4	102.0	36.2	49.1	111.2	51.6	134.6	77.8	207.5	72.2	182.6	85.8	90.5	131.5	110.8	170.3	105.7	70.1	100.6	238.5	235.9	125.1	60.9	78.8	196.3
PCNX1	"KIAA0805, KIAA0995, PCNX, PCNXL1, pecanex"	ENSG00000100731	"Pecanex 1"	Q96RV3	14	70907405-71115382	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 31.5;Alveolar cells type 2: 27.9;dendritic cells: 31.6;Endometrial stromal cells: 35.3;Granulosa cells: 57.2;Theca cells: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048970, HPA053532"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA048970: , HPA053532: AB_2682180"	"unprognostic (1.96e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.56e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (9.01e-3)"	"unprognostic (2.90e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.37e-2)"	14.1	20.0	8.1	15.3	10.4	17.5	10.7	8.2	9.9	9.6	11.1	11.5	7.9	11.0	5.1	7.8	10.5	10.0	11.5	9.5	8.3	11.8	11.5	12.8	14.4	5.7	6.3	20.0	7.0	15.8	8.2	9.0	7.1	9.1	7.6	16.6	6.7	8.8	15.2	7.3	11.8	13.2	6.2	13.4	8.2	20.7	9.0	16.9	12.3	21.8	12.5	15.5	7.4	8.8	22.3	15.5	17.4	10.9	28.7	19.3	9.6	23.3	23.2	17.9	24.9	15.4	9.8	15.8	7.8	24.0	14.0	21.9	18.8	18.8	26.8	49.0	7.3	3.0	9.7	17.0	17.4	24.5	8.0	20.0	16.4	17.8	31.9	22.0	18.0	16.1	1.3	22.5	20.9	18.0	11.6	22.0	8.8	9.9	8.4	10.5	20.0	4.7	12.2	16.3	7.2	11.3	17.6	10.5	13.0	17.7	9.5	22.7	21.5	32.7	36.5	10.7	17.1	13.5	7.4	13.4	20.2	19.7	11.6	3.3	1.8	1.7	3.4	1.0	4.6	1.3	5.9	3.6	0.4	2.8	2.5	4.0	9.8	1.9	0.7	3.7	10.3	1.7	8.1	10.4	8.2	9.9	9.5	8.3	5.7	6.3	7.1	6.2	9.0	8.8	31.5	16.0	27.9	0.0	8.3	0.0	0.0	0.0	0.0	0.0	11.4	19.7	0.0	0.0	6.2	9.2	0.0	5.9	31.6	0.0	1.9	8.2	0.0	14.1	35.3	9.2	0.0	0.0	0.0	5.3	6.9	9.6	0.0	14.1	15.2	57.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	8.4	0.0	0.0	24.3	0.0	0.0	7.5	9.5	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	5.1	24.0	50.0	0.0	0.0
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889206	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 87.6;heart muscle: 123.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 138.0;Extravillous trophoblasts: 63.1;Fibroblasts: 225.8;Syncytiotrophoblasts: 241.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.5;RPMI-8226: 36.8;U-2197: 77.9;U-266/70: 68.6;U-266/84: 34.3"	"Low region specificity"	"Detected in many"							HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		580000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavorable (1.08e-4)"	87.6	2.8	0.8	4.0	0.9	14.9	29.1	0.4	1.0	21.5	0.8	6.9	0.1	4.2	2.2	7.8	3.9	1.5	123.2	1.3	1.9	17.9	18.3	16.4	2.3	0.7	1.1	3.9	1.4	0.7	23.7	48.1	0.6	21.5	5.1	0.7	3.1	8.9	2.4	5.3	2.8	8.7	0.5	3.0	3.4	2.4	1.5	0.7	6.4	22.1	1.9	25.7	26.0	0.8	1.4	11.0	3.4	0.0	65.5	18.1	0.0	1.0	0.2	2.9	3.6	0.7	1.2	0.0	3.3	4.9	14.8	0.1	13.7	0.0	3.4	0.0	21.0	2.5	6.8	0.0	0.0	1.5	0.0	6.9	0.0	6.9	1.7	14.5	0.2	2.2	0.5	0.0	1.4	2.0	4.5	1.2	5.5	0.2	21.9	0.0	8.1	36.8	3.2	0.1	7.6	4.6	17.8	0.0	6.5	4.7	0.0	4.5	0.0	5.8	12.8	77.9	6.0	68.6	34.3	0.0	16.6	1.9	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	1.3	1.9	0.7	1.1	0.6	0.5	1.5	0.8	17.3	0.0	3.2	0.7	0.2	7.4	0.7	0.9	0.6	18.0	0.5	0.6	37.3	0.0	0.9	12.9	25.0	138.0	0.2	0.2	0.0	0.0	0.6	2.1	2.2	4.5	0.0	0.0	1.6	0.0	63.1	225.8	0.5	3.7	1.3	29.0	0.4	11.8	15.3	6.7	2.2	0.2	0.0	0.6	12.4	1.0	0.6	6.7	3.6	1.9	0.0	13.8	0.0	29.7	1.6	0.5	0.4	0.0	0.0	2.1	0.0	0.0	0.0	12.6	0.0	6.1	16.9	25.8	47.7	1.0	7.4	241.6	1.1	19.1	0.0	0.4
PCP4	PEP-19	ENSG00000183036	"Purkinje cell protein 4"	P48539	21	39867438-39929397	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 647.3;seminal vesicle: 1280.1"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 600.9;Distal tubular cells: 645.6;Horizontal cells: 1398.2;Proximal tubular cells: 941.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 41.7;thyroid cancer: 48.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 215.9;T-47d: 64.7"					"Low region specificity"	"Detected in all"			HPA005792	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA005792: AB_1855086"	"unprognostic (6.82e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (5.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (9.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	5.2	52.9	197.6	2.0	647.3	0.0	8.4	166.2	202.0	180.9	509.6	135.5	5.1	126.9	365.6	228.2	10.2	4.2	4.6	121.8	175.9	52.1	0.5	0.6	0.2	75.6	299.1	3.5	6.2	19.7	8.8	2.0	70.2	323.4	32.4	385.3	21.3	1280.1	0.6	14.8	6.0	54.6	64.1	2.6	7.1	0.9	491.1	7.9	227.7	0.0	1.0	468.0	128.6	85.5	0.0	0.0	3.1	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	2.3	1.9	0.0	0.0	0.0	0.0	215.9	0.5	0.0	0.3	0.3	0.0	34.8	0.0	0.2	64.7	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.6	647.3	166.2	202.0	121.8	175.9	75.6	299.1	70.2	64.1	491.1	85.5	0.0	0.0	1.5	15.3	2.9	3.1	0.4	0.0	0.0	600.9	0.4	0.4	8.8	2.8	0.0	77.3	62.6	0.3	0.0	0.1	645.6	0.4	1.3	0.0	0.2	5.0	1.2	0.0	71.3	0.2	0.3	1.5	0.0	0.0	0.0	0.4	0.0	0.1	0.2	1398.2	21.5	0.2	0.0	0.0	7.5	0.4	9.6	7.0	21.4	8.4	0.0	68.4	0.0	7.5	11.9	0.8	0.2	0.4	0.0	4.4	0.0	941.2	0.0	200.0	0.0	0.0	77.4	3.4	9.5	0.0	6.0	2.9	2.2	0.5	0.5	1.0
PCP4L1	IQM1	ENSG00000248485	"Purkinje cell protein 4 like 1"	A6NKN8	1	161258745-161285450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.7;pituitary gland: 84.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 35.8;Bipolar cells: 82.8;Inhibitory neurons: 34.0;Sertoli cells: 19.7;Squamous epithelial cells: 23.5;Urothelial cells: 39.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 21.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RT4: 13.8;T-47d: 8.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 206.6"	HPA052833	Enhanced	Supported	Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"		"HPA052833: AB_2681968"	"unprognostic (1.81e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.63e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-2)"	2.7	0.4	14.1	0.8	71.7	0.1	1.8	19.6	33.2	4.0	0.9	5.6	1.7	1.8	2.6	18.8	2.1	2.0	0.8	6.8	14.7	0.9	4.0	4.6	0.2	39.7	23.3	2.2	0.5	0.4	84.3	0.3	39.8	11.0	2.5	39.2	1.9	16.4	0.4	5.6	2.8	6.6	28.1	0.3	2.0	1.8	15.2	2.0	0.7	1.5	2.6	35.6	17.1	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	13.8	1.9	0.0	0.0	0.2	0.0	0.2	8.9	0.3	0.2	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	14.1	71.7	19.6	33.2	6.8	14.7	39.7	23.3	39.8	28.1	15.2	13.9	0.0	3.2	6.4	2.0	0.0	0.0	35.8	8.3	12.5	82.8	3.2	1.0	0.2	0.0	7.6	0.0	6.2	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	3.1	1.3	1.9	0.2	4.6	0.3	1.3	0.0	0.0	0.9	0.1	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.0	3.5	0.0	5.0	1.4	0.2	0.0	1.9	0.0	2.5	0.0	0.6	0.9	5.9	19.7	0.0	10.0	1.3	1.5	23.5	0.3	1.8	0.0	0.0	0.0	39.9
PCTP	STARD2	ENSG00000141179	"Phosphatidylcholine transfer protein"	Q9UKL6	17	55751051-55842830	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.0"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 68.5;Hepatocytes: 72.8;Syncytiotrophoblasts: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 241.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 94.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA022979	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"		"HPA022979: AB_2671018"	"unprognostic (1.14e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.27e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (9.35e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.93e-1)"	"unprognostic (6.89e-3)"	"unprognostic (3.04e-1)"	15.3	8.5	8.0	10.4	8.0	11.4	12.4	8.1	8.9	10.7	8.3	23.1	18.1	7.4	28.3	10.7	9.0	9.7	19.0	7.7	9.2	29.7	98.0	18.8	9.9	8.7	9.5	8.3	11.8	13.4	7.9	28.7	8.7	9.6	23.8	4.2	10.8	23.1	18.9	6.4	16.5	10.7	8.1	15.5	19.0	13.3	9.9	5.9	8.5	19.3	8.9	13.4	7.9	8.0	21.2	19.3	13.9	5.1	18.4	17.7	36.6	8.1	10.3	12.5	12.1	22.0	26.7	5.9	61.0	12.7	11.8	11.5	8.2	13.7	11.2	94.8	19.5	51.9	5.7	40.2	16.3	20.0	39.5	14.7	17.3	7.6	13.5	15.2	24.8	17.7	38.4	20.2	13.7	18.7	16.0	16.1	15.4	0.0	16.9	8.1	20.5	4.9	13.4	15.6	7.1	16.1	4.2	8.7	34.6	30.4	23.6	33.8	18.2	14.7	10.4	16.2	10.9	57.9	19.4	3.6	13.2	32.7	25.5	77.3	60.9	241.1	9.4	52.6	5.6	8.6	6.1	9.7	49.0	5.3	3.6	8.2	63.3	27.5	58.9	3.9	11.8	29.3	8.0	8.0	8.1	8.9	7.7	9.2	8.7	9.5	8.7	8.1	9.9	8.0	13.1	3.2	8.1	25.5	4.2	1.0	2.4	6.6	2.8	4.0	5.4	4.8	15.7	15.7	3.2	9.2	2.1	51.6	5.2	17.8	11.7	13.0	18.3	6.4	6.0	10.3	13.1	12.2	16.5	13.7	68.5	8.2	7.7	6.3	15.2	7.1	10.4	72.8	22.1	1.7	26.4	17.1	8.2	25.2	5.1	20.0	16.4	20.1	12.4	9.4	15.1	4.0	11.3	19.6	4.2	9.5	10.1	25.9	5.3	1.7	13.9	40.6	3.8	2.3	13.1	4.3	8.9	17.9	7.7	6.6	1.4	67.2	5.6	8.2	16.2	2.6
PCYOX1L	MGC3265	ENSG00000145882	"Prenylcysteine oxidase 1 like"	Q8NBM8	5	149358037-149369653	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 17.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 50.2;RPMI-8226: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037463, HPA038402"	Approved		Approved	Nucleoplasm,Mitochondria	"Secreted to blood"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Mitochondria"		"HPA037463: AB_10673632, HPA038402: AB_2675997"	"unprognostic (1.34e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.83e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.77e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.28e-1)"	3.2	4.6	2.3	5.3	2.4	3.9	3.3	2.4	4.5	5.1	0.2	3.2	1.8	4.9	0.6	3.5	5.3	4.7	3.9	2.9	4.4	2.0	0.5	3.4	6.6	3.7	2.5	5.7	3.1	17.5	4.9	4.2	5.0	3.9	0.7	7.6	2.9	4.5	0.8	5.4	4.8	5.2	1.0	4.0	3.7	6.4	2.3	4.6	2.7	1.8	3.2	3.8	3.8	2.3	4.3	2.7	9.2	20.3	7.8	7.9	4.9	9.0	4.0	7.8	13.2	0.8	7.6	17.9	27.1	6.7	36.1	7.7	8.8	20.3	0.7	8.4	8.2	8.4	0.0	0.7	17.3	7.3	9.1	14.9	3.0	10.7	12.6	9.4	17.3	16.6	4.9	50.2	0.4	17.9	8.1	11.2	4.7	15.8	16.3	10.7	6.7	50.8	4.9	2.0	13.3	13.6	17.9	11.9	14.6	10.0	20.0	12.4	8.2	6.8	5.5	14.7	4.2	20.1	29.2	10.6	11.2	38.3	14.6	3.0	7.1	4.0	2.8	9.6	3.7	1.6	5.3	2.1	13.2	1.0	6.3	4.4	1.2	4.8	9.6	0.9	7.3	4.7	2.3	2.4	2.4	4.5	2.9	4.4	3.7	2.5	5.0	1.0	2.3	2.3	4.5	9.6	1.7	2.9	2.3	1.0	1.0	3.2	2.8	5.2	2.4	1.8	5.3	4.3	3.6	1.8	0.0	6.0	1.9	0.6	0.0	3.0	3.3	3.2	2.4	4.6	0.0	2.5	10.5	2.3	6.6	5.0	2.0	2.3	2.5	9.6	2.5	0.4	7.6	11.8	12.4	1.8	6.1	8.2	1.4	1.5	3.4	6.9	1.8	4.7	7.0	7.8	1.0	5.5	4.9	2.1	1.7	2.6	1.3	0.8	2.6	0.6	2.8	14.2	0.0	2.5	2.7	1.2	3.5	1.9	1.6	1.2	5.6	9.7	2.3	0.9
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	31.4	24.4	15.2	30.0	16.0	45.3	21.0	16.6	15.8	16.7	17.8	25.7	60.3	19.1	13.9	31.0	15.6	20.7	46.4	15.5	21.1	18.3	20.7	22.5	22.9	18.8	18.0	15.8	16.8	22.7	12.9	20.1	18.5	16.6	22.9	14.4	19.3	18.6	73.8	43.0	49.1	23.0	17.5	25.9	24.2	22.4	18.1	18.1	17.2	42.1	26.8	21.0	19.8	17.1	92.6	36.6	25.8	37.2	52.2	53.9	37.0	68.2	47.1	59.2	51.8	92.3	32.8	23.9	215.2	78.1	60.2	71.4	40.5	52.1	50.4	42.1	28.6	68.6	40.6	39.5	45.2	34.3	56.7	47.4	40.0	55.9	39.6	35.4	63.0	21.0	38.3	53.3	58.1	79.6	19.9	17.3	21.4	55.7	53.0	34.5	31.0	37.5	35.7	53.6	25.4	18.3	44.5	79.5	44.2	32.8	114.1	37.2	88.5	45.5	25.2	61.8	92.7	45.8	101.1	44.1	69.6	43.8	56.9	9.6	9.2	10.4	8.8	9.3	7.5	7.2	6.5	9.7	9.1	6.3	4.2	6.3	21.0	9.4	11.0	5.9	14.9	5.2	15.2	16.0	16.6	15.8	15.5	21.1	18.8	18.0	18.5	17.5	18.1	17.1	24.7	16.0	25.7	15.3	19.9	14.5	9.4	19.7	14.2	15.9	14.1	9.4	70.1	20.0	17.5	14.7	25.0	11.9	27.3	36.4	13.7	24.8	76.3	17.8	22.9	23.2	22.1	12.2	20.4	22.9	17.7	17.0	23.4	15.6	20.8	16.1	26.7	35.6	37.4	8.4	22.7	24.2	6.1	34.6	27.1	67.6	19.9	33.9	19.6	20.6	39.4	13.1	39.1	16.1	17.6	24.6	21.1	28.2	27.2	12.0	67.2	23.2	33.9	12.8	26.3	15.0	19.0	46.0	13.2	30.0	21.5	18.6	25.6	25.5	23.8	12.2
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900958-81911432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.7;testis: 261.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 763.2;Late spermatids: 2829.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 218.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		84000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	29.7	16.8	40.0	9.5	40.1	12.1	25.2	44.4	45.8	14.9	30.4	25.5	63.9	18.0	13.5	26.3	23.9	9.9	47.7	41.2	37.7	44.0	165.7	21.3	12.0	47.0	43.0	20.9	25.3	20.2	14.4	12.0	47.3	24.2	16.7	8.6	22.3	12.1	33.5	16.3	43.0	9.6	41.3	12.8	35.4	261.7	41.0	13.5	16.2	29.3	11.9	21.2	15.1	44.0	42.6	23.9	18.8	53.1	91.8	48.0	27.9	29.9	63.2	40.7	48.0	94.0	43.0	14.8	16.0	31.1	75.3	34.5	28.6	55.1	23.5	4.5	24.3	32.1	33.3	218.2	97.8	32.5	26.0	39.8	31.4	36.8	28.4	14.5	38.6	44.0	60.6	29.6	30.8	35.7	39.3	40.1	15.1	147.2	25.9	25.4	20.2	52.4	49.2	78.8	23.9	21.9	22.4	121.7	29.0	36.5	33.9	75.3	26.1	30.0	19.7	22.9	25.0	19.3	9.1	15.3	31.2	42.8	29.9	1.5	2.4	0.9	4.6	2.6	3.0	4.2	5.5	4.7	4.5	5.6	4.5	4.6	0.7	3.3	2.1	4.4	3.6	3.1	40.0	40.1	44.4	45.8	41.2	37.7	47.0	43.0	47.3	41.3	41.0	44.0	11.5	0.0	17.3	15.0	11.1	5.4	8.1	11.7	6.8	12.5	25.1	11.0	17.0	62.9	9.6	25.8	0.0	73.1	21.0	41.6	119.3	19.5	763.2	29.0	7.5	8.7	13.9	47.8	5.3	18.3	39.7	7.7	36.2	15.8	9.5	39.6	21.8	166.0	24.1	16.8	4.6	29.1	20.3	11.8	3.3	2829.0	27.7	8.1	33.8	0.0	14.7	26.7	22.6	3.5	12.2	17.8	18.8	25.9	13.4	11.4	144.4	130.3	29.4	10.6	26.3	6.2	11.5	253.1	18.1	16.5	5.7	50.8	13.6	34.4	48.7	7.7
PDCD2	"RP8, ZMYND7"	ENSG00000071994	"Programmed cell death 2"	Q16342	6	170575295-170584692	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026713, HPA075534"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Cytokinetic bridge"	"HPA026713: AB_1855103, HPA075534: AB_2686754"	"unprognostic (3.80e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	26.3	25.6	18.9	30.0	19.1	35.4	43.0	20.2	23.7	27.1	18.4	31.1	32.4	25.9	39.9	32.6	33.7	23.4	22.8	19.3	20.2	33.2	32.7	23.4	43.2	19.2	20.0	29.8	45.4	29.6	16.9	28.4	19.3	25.9	38.4	17.7	31.7	30.3	36.4	25.8	25.9	28.7	19.0	27.5	30.6	19.9	19.5	42.3	34.6	27.0	50.6	32.8	21.6	19.3	50.5	36.2	53.8	126.7	75.8	82.6	59.3	58.6	66.7	67.9	75.3	65.2	43.1	90.6	46.6	64.8	90.8	70.5	116.5	97.1	98.9	74.7	127.2	128.6	46.2	119.3	91.9	161.6	83.3	75.6	93.4	86.2	138.7	71.2	95.8	123.9	260.3	57.7	84.1	109.5	113.0	116.6	77.5	161.6	54.9	79.4	41.5	117.8	103.7	29.3	98.4	102.4	66.7	107.8	71.6	58.1	54.8	162.8	73.0	33.3	71.4	80.1	105.1	76.5	96.4	97.9	62.1	154.9	87.0	4.1	12.4	11.5	14.1	12.0	16.5	14.2	15.9	14.9	17.3	13.8	15.5	14.8	5.3	18.8	15.2	15.9	20.3	12.0	18.9	19.1	20.2	23.7	19.3	20.2	19.2	20.0	19.3	19.0	19.5	19.3	47.2	12.8	15.3	9.4	54.1	49.5	76.4	14.6	40.5	36.9	58.0	59.7	27.4	52.9	14.0	29.5	12.5	63.9	82.2	29.2	78.2	55.3	17.0	36.1	38.5	38.8	47.2	64.1	13.2	74.1	71.6	32.2	32.1	33.5	15.9	59.8	44.6	28.2	49.2	16.8	12.7	44.0	22.4	41.9	33.2	15.0	49.0	40.9	35.6	8.4	62.8	34.7	84.5	8.0	12.4	58.6	36.4	40.6	58.0	103.9	47.8	83.6	16.0	35.3	19.7	43.8	55.5	33.0	85.8	58.7	46.0	46.7	60.7	60.8	68.0	84.1
PDCD4	H731	ENSG00000150593	"Programmed cell death 4"	Q53EL6	10	110871795-110900006	"Predicted intracellular proteins"	Apoptosis	RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 505.4"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 786.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 295.6;U-266/70: 320.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001032, HPA027214, CAB037024"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107"	"unprognostic (4.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.25e-1)"	45.7	30.7	15.0	53.2	15.7	74.0	146.6	18.1	16.9	49.3	24.7	157.6	90.7	67.0	36.2	151.3	57.7	43.4	22.4	13.7	17.2	26.2	36.2	32.8	60.7	15.7	18.5	133.6	505.4	283.9	40.3	97.0	15.4	55.3	130.4	50.4	255.0	60.4	11.8	104.2	100.2	51.3	15.5	67.6	102.3	29.9	16.6	73.9	154.5	18.7	95.4	42.2	61.8	17.3	26.5	25.4	40.6	43.7	61.6	110.7	23.8	29.9	89.7	14.7	25.7	16.0	65.0	252.3	81.7	43.5	11.4	118.8	26.1	79.4	32.4	219.7	50.6	127.5	146.9	27.9	26.9	65.2	135.8	88.0	247.4	15.7	84.0	67.6	28.2	40.1	35.3	119.6	37.6	69.7	24.2	76.4	10.6	19.0	46.3	10.4	71.6	138.7	24.8	36.8	17.8	73.6	58.7	31.6	109.1	44.6	295.6	121.3	71.8	22.6	16.8	17.1	11.0	320.1	163.8	143.6	22.2	87.4	24.5	186.1	19.5	52.4	54.0	27.0	96.0	54.1	49.7	59.8	23.0	39.5	43.0	53.2	38.3	84.7	29.6	38.5	29.0	40.4	15.0	15.7	18.1	16.9	13.7	17.2	15.7	18.5	15.4	15.5	16.6	17.3	85.3	19.2	50.0	16.3	132.0	133.1	88.1	104.6	113.3	61.8	148.1	113.9	16.8	42.9	90.3	25.8	31.3	229.5	246.1	348.0	35.2	70.8	20.2	66.7	132.5	79.1	33.6	94.2	26.2	101.4	78.4	72.1	82.0	59.4	132.9	111.7	97.1	23.6	56.5	21.9	44.4	150.6	81.4	84.1	49.7	11.0	145.1	66.1	291.7	46.9	57.4	40.9	75.2	36.7	70.6	45.0	244.3	222.7	134.7	51.3	292.1	28.1	47.8	206.1	39.5	69.4	48.6	63.3	72.2	200.8	165.2	786.0	229.2	176.8	190.3	73.3
PDCD5	"MGC9294, TFAR19"	ENSG00000105185	"Programmed cell death 5"	O14737	19	32581190-32587453	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018471	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		47000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA018471: AB_1855108"	"unprognostic (1.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.02e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.54e-2)"	95.7	96.1	86.2	73.8	87.0	46.8	82.0	85.4	110.2	73.2	80.8	100.1	65.8	68.8	50.8	109.3	70.9	34.8	170.9	86.7	91.1	97.8	101.2	68.0	58.6	87.1	87.7	71.8	102.4	52.6	95.1	61.2	88.4	64.3	55.7	39.2	70.1	41.9	224.2	60.5	62.0	65.8	85.8	56.8	78.9	144.4	94.6	41.8	60.6	132.2	59.5	91.1	80.3	89.9	499.0	630.0	168.8	163.7	223.8	334.0	190.0	353.2	225.6	295.2	252.2	525.0	188.3	272.6	498.7	177.1	286.3	133.2	213.6	281.7	254.4	493.1	333.6	412.4	303.9	382.8	284.0	587.0	157.3	219.7	253.8	195.9	315.0	145.1	198.8	214.9	381.0	298.8	247.2	332.0	243.6	298.6	164.9	410.5	211.6	238.9	248.8	323.6	231.9	167.6	326.0	178.4	338.1	351.8	283.4	125.2	152.6	294.6	299.4	272.6	291.7	274.2	602.7	270.6	413.0	504.4	302.3	459.8	244.2	40.7	93.4	50.9	106.4	149.0	134.3	147.3	167.4	132.1	120.6	116.3	115.3	114.3	13.7	116.9	197.6	123.6	217.8	122.7	86.2	87.0	85.4	110.2	86.7	91.1	87.1	87.7	88.4	85.8	94.6	89.9	115.4	73.7	62.7	16.6	70.4	121.6	174.0	292.0	97.3	43.2	129.1	216.4	336.1	94.4	119.4	75.4	27.1	194.7	69.0	94.6	189.8	245.3	469.7	94.0	166.4	121.3	71.3	44.8	24.0	247.3	216.5	150.4	64.2	115.0	46.9	84.9	83.6	151.1	146.7	50.5	29.3	113.6	140.4	48.3	93.1	481.2	142.6	67.4	124.5	11.2	113.8	104.0	66.9	17.6	16.8	292.2	100.4	123.0	124.4	392.4	125.1	216.8	107.9	45.3	72.3	126.8	218.4	487.0	413.1	170.9	119.9	143.0	78.4	164.9	157.8	140.4
PDCD6	"ALG-2, PEF1B"	ENSG00000249915	"Programmed cell death 6"	O75340	5	271621-314974	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047221			Supported	Nucleoplasm,Cytosol		No	No		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA047221: "	"unprognostic (1.32e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.47e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (2.19e-4)"	63.3	108.3	89.0	48.7	90.4	42.1	74.8	95.4	102.6	73.4	88.1	83.0	71.6	63.4	98.2	134.8	64.8	48.4	53.5	91.1	92.9	114.6	85.0	53.1	59.9	92.2	88.9	61.7	65.5	77.3	76.4	61.4	90.5	64.3	85.4	29.6	73.9	54.4	42.3	72.7	71.8	52.8	94.9	77.0	69.0	50.3	90.3	81.2	72.8	27.3	74.5	72.7	86.9	100.1	151.8	208.6	88.4	133.5	156.1	141.9	185.6	115.5	151.9	144.2	134.6	147.3	186.4	119.6	283.2	155.4	187.2	112.9	137.3	288.2	116.0	409.9	170.9	105.9	508.7	194.0	193.3	155.7	129.5	128.1	175.0	117.4	208.9	148.3	137.9	81.2	136.8	90.3	130.7	237.7	125.7	270.1	95.6	183.8	295.1	102.0	83.8	171.5	344.7	192.6	86.3	117.5	297.2	309.4	224.7	91.9	215.1	210.7	108.5	94.0	76.9	82.8	100.0	121.4	163.4	141.8	138.9	198.9	128.9	172.8	209.7	284.4	158.2	206.0	199.7	251.9	196.4	179.6	229.3	224.6	217.8	175.5	231.0	260.7	206.6	183.2	236.7	356.2	89.0	90.4	95.4	102.6	91.1	92.9	92.2	88.9	90.5	94.9	90.3	100.1	134.6	64.1	57.4	9.4	99.5	82.1	129.6	250.6	85.4	47.9	140.1	182.1	50.4	78.6	146.7	103.0	37.5	239.1	104.4	146.4	252.4	172.0	55.4	130.9	91.6	110.7	79.7	83.9	10.7	129.1	321.6	104.3	68.8	99.9	82.5	101.3	69.9	77.7	140.4	63.9	11.3	187.5	219.7	84.1	75.5	55.5	117.4	90.0	124.5	10.3	175.3	136.8	137.0	5.5	11.0	164.0	136.7	116.6	57.7	170.7	175.6	205.1	181.9	42.0	85.5	85.3	109.5	100.8	137.8	123.8	92.5	356.7	92.6	173.3	192.3	176.6
PDCL	"DKFZp564M1863, PhLP"	ENSG00000136940	"Phosducin like"	Q13371	9	122798389-122828588	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021571, HPA021647, CAB026473"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	Nucleoplasm	"CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115"	"unprognostic (3.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-1)"	11.0	8.7	6.8	10.4	9.5	19.4	13.0	8.5	8.7	12.1	7.3	10.2	9.3	13.4	7.7	9.8	10.3	9.5	8.8	6.5	9.2	8.8	6.4	13.1	13.1	8.8	8.4	9.9	6.8	11.0	5.0	14.1	9.2	11.1	10.5	12.4	12.8	9.2	5.9	10.6	9.1	11.3	7.4	12.7	10.7	6.7	8.5	13.1	11.6	6.9	12.3	9.2	7.5	10.6	16.9	23.2	38.4	14.4	34.1	22.5	21.4	23.1	23.8	20.9	21.2	15.2	21.9	28.1	18.7	27.5	23.0	32.3	24.1	22.6	22.7	28.0	12.1	29.2	30.1	25.3	17.4	24.6	55.3	19.7	15.8	20.7	10.3	19.3	43.3	17.6	29.7	16.1	23.1	25.8	27.1	22.2	28.4	28.8	17.6	27.8	36.5	20.9	25.6	0.0	30.8	27.4	31.3	17.3	13.8	25.1	26.5	16.8	48.4	19.4	23.0	28.4	22.8	12.0	26.7	30.5	16.6	19.6	19.0	30.4	13.8	23.9	15.2	12.5	16.2	12.7	18.2	14.1	14.5	16.0	18.5	16.4	11.4	19.8	21.8	17.0	31.3	13.4	6.8	9.5	8.5	8.7	6.5	9.2	8.8	8.4	9.2	7.4	8.5	10.6	43.0	9.6	9.2	5.2	16.7	24.2	14.7	25.4	25.6	42.6	19.9	16.0	5.7	14.3	13.4	20.2	22.9	27.6	29.1	12.9	9.8	20.7	5.5	29.9	22.3	37.5	12.6	50.5	5.8	18.0	27.3	26.7	9.7	36.3	57.1	14.4	31.8	7.6	24.9	40.4	8.2	19.0	24.4	22.6	15.7	4.1	23.0	19.3	19.6	10.3	30.4	36.1	20.6	6.6	15.4	16.5	13.2	17.0	18.2	15.8	9.1	15.3	21.9	38.2	19.7	15.8	21.6	14.5	21.9	25.8	23.2	31.9	25.9	19.9	13.5	16.5
PDCL3	VIAF1	ENSG00000115539	"Phosducin like 3"	Q9H2J4	2	100562993-100576739	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018469, HPA027094"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018469: AB_1855116, HPA027094: AB_10601387"	"unprognostic (1.34e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (1.44e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.22e-2)"	"prognostic favorable (4.23e-4)"	20.8	22.0	19.1	27.1	21.6	22.9	23.0	21.6	24.3	18.9	16.6	27.3	17.0	24.1	37.2	36.8	22.5	21.3	30.6	18.4	21.3	28.4	18.5	18.4	25.3	21.8	24.7	21.1	11.4	23.4	10.5	23.4	21.7	27.0	28.9	21.1	16.9	23.2	58.8	36.8	17.3	38.6	20.8	17.0	17.6	22.8	22.1	22.4	21.4	34.3	34.0	33.1	17.5	22.2	41.8	58.7	59.9	52.2	19.3	27.4	67.5	51.3	32.5	92.9	58.1	74.2	25.5	68.6	74.0	62.3	122.3	34.2	76.0	50.2	74.0	110.6	65.8	72.0	31.8	89.7	50.8	77.3	73.2	29.8	92.0	82.0	52.3	24.2	58.9	52.8	61.1	43.8	70.7	74.6	75.8	117.7	77.9	45.6	86.6	72.5	63.2	48.0	58.2	98.7	55.9	49.6	41.0	54.7	59.0	48.6	42.3	53.0	45.8	56.4	60.1	44.8	72.2	26.4	54.1	68.3	34.4	90.5	45.7	82.3	64.8	80.2	63.1	124.4	72.8	92.5	95.0	70.4	114.9	78.1	97.7	75.4	7.0	93.9	161.7	64.0	113.6	87.3	19.1	21.6	21.6	24.3	18.4	21.3	21.8	24.7	21.7	20.8	22.1	22.2	37.4	19.2	25.2	1.6	39.5	65.6	36.6	79.2	52.9	13.0	24.8	36.2	40.9	18.6	46.1	14.7	6.2	70.8	61.5	16.0	60.7	50.6	37.0	38.9	26.6	30.2	19.8	21.7	2.3	39.1	51.2	22.6	19.4	34.6	92.9	25.4	12.5	17.0	59.7	11.8	2.0	24.0	89.5	17.8	80.7	14.3	14.6	54.4	35.6	3.7	104.3	19.7	40.2	2.0	4.5	31.8	18.6	33.4	27.7	33.2	19.7	77.9	28.1	16.5	52.6	23.8	54.1	5.5	66.9	63.2	57.5	52.4	91.8	24.5	31.3	32.4
PDE1A		ENSG00000115252	"Phosphodiesterase 1A"	P54750	2	182140036-182523192	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 46.6;thyroid gland: 45.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 396.3;Excitatory neurons: 764.9;Late spermatids: 592.1;Oligodendrocytes: 1178.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 37.2;HHSteC: 22.0;HSkMC: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022151	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA022151: AB_1855118"	"unprognostic (3.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.40e-3)"	10.5	4.4	16.9	4.6	20.4	0.0	5.0	35.5	23.4	17.2	2.4	11.8	3.0	8.7	8.0	5.6	10.3	23.7	15.6	30.3	8.4	46.6	3.9	3.6	2.1	2.6	4.2	10.9	2.1	2.2	2.7	1.2	5.4	3.6	6.7	1.4	2.0	5.4	2.8	2.2	5.7	12.9	3.7	3.1	5.6	35.6	16.5	8.4	45.8	5.0	0.9	9.7	9.8	18.2	0.0	0.2	3.9	0.0	37.2	3.1	0.1	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	4.7	0.0	5.1	0.0	22.0	0.0	0.0	47.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.5	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.7	0.0	5.4	0.1	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.9	20.4	35.5	23.4	30.3	8.4	2.6	4.2	5.4	3.7	16.5	18.2	6.7	0.0	2.6	15.3	0.0	1.3	2.0	0.1	8.0	20.0	0.3	0.3	5.9	1.5	1.4	27.6	0.0	0.1	0.0	0.1	185.9	0.5	396.3	0.3	0.4	8.9	0.0	0.0	764.9	0.4	0.0	18.6	0.0	0.8	0.0	0.1	5.0	0.0	0.1	0.0	185.8	1.0	0.0	0.0	1.8	592.1	14.9	0.4	0.0	30.0	0.0	0.3	0.0	18.1	1178.0	0.2	0.1	8.2	0.2	2.6	0.1	1.5	0.0	1.2	52.6	21.0	45.1	9.1	4.9	1.0	1.3	0.0	0.2	7.6	0.1	0.7
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32428131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 68.9;heart muscle: 58.5"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 1071.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 44.4;fHDF/TERT166: 148.3;hTERT-RPE1: 44.9;U-251 MG: 77.9;WM-115: 105.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.4	1.8	19.2	2.5	43.0	0.0	4.3	21.4	39.9	0.7	0.0	3.0	1.4	2.4	6.0	6.4	10.5	1.5	58.5	18.9	24.2	4.2	0.1	4.9	0.6	29.4	27.9	3.8	2.6	0.3	1.3	3.2	27.7	2.0	1.8	7.4	1.8	3.2	0.6	0.4	3.3	5.0	16.4	0.6	4.0	3.8	28.6	1.6	3.1	4.0	0.1	9.8	1.4	68.9	0.3	5.8	15.5	0.0	0.6	0.4	0.2	44.4	18.3	20.8	17.1	0.0	0.0	0.0	0.2	148.3	0.0	1.2	0.0	0.0	27.1	0.0	0.0	1.3	1.4	0.0	0.1	0.0	31.9	1.9	0.0	4.3	0.2	44.9	7.1	0.0	0.1	0.1	1.7	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.0	22.5	0.0	6.8	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	22.8	8.6	0.4	77.9	0.4	0.0	0.0	2.4	0.5	105.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	43.0	21.4	39.9	18.9	24.2	29.4	27.9	27.7	16.4	28.6	68.9	1.2	0.0	0.0	7.5	0.1	0.0	0.7	0.1	1.2	69.5	2.8	17.1	136.0	0.0	0.7	1.8	52.1	0.0	0.1	0.0	0.0	4.8	53.4	0.2	0.1	3.9	0.0	0.0	70.8	0.4	0.0	8.7	0.0	0.4	8.8	0.2	0.0	0.0	0.1	3.3	169.2	0.0	59.0	0.0	0.2	50.3	0.3	0.5	0.0	15.9	0.0	0.9	0.0	196.6	1071.4	0.2	0.0	0.4	0.1	0.2	0.0	0.0	2.2	4.7	0.0	0.9	9.4	1.3	1.2	0.2	0.0	0.0	0.1	1.2	0.0	0.0
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469630	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 190.8;Late spermatids: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.5;NB-4: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	13.7	5.6	10.9	5.9	12.5	5.4	9.7	3.0	32.3	12.4	0.0	11.0	2.7	9.8	1.4	4.1	7.5	6.6	12.5	11.8	7.9	7.0	2.5	13.0	3.2	21.9	7.1	1.5	12.7	22.2	3.9	6.5	20.8	8.4	4.0	5.3	9.8	4.8	37.9	5.4	6.5	6.2	1.1	8.2	12.9	24.5	13.0	1.6	11.0	16.9	2.6	8.2	8.2	15.7	0.1	2.5	0.5	6.7	18.7	11.1	3.7	5.6	11.1	0.7	1.9	6.0	5.4	2.6	16.1	14.6	0.4	0.6	3.9	0.7	0.4	6.7	5.5	23.7	8.1	6.7	12.3	3.9	36.5	8.3	0.8	6.2	0.0	0.7	5.3	2.1	18.9	5.5	4.0	1.7	2.3	43.3	2.9	6.7	4.7	15.6	3.7	20.3	0.9	1.4	4.2	1.5	0.4	0.2	6.2	1.0	0.8	7.8	11.2	8.3	10.5	5.7	3.7	10.9	0.9	12.4	3.5	0.3	6.7	4.1	1.7	3.4	0.8	2.5	0.4	0.1	0.3	1.1	2.0	0.0	0.0	0.4	0.1	3.0	2.7	0.1	0.7	1.1	10.9	12.5	3.0	32.3	11.8	7.9	21.9	7.1	20.8	1.1	13.0	15.7	9.4	3.2	11.6	6.2	10.8	10.1	2.6	2.5	1.8	25.6	6.4	4.3	7.7	8.6	5.5	9.2	0.0	0.5	58.9	7.1	0.0	3.1	48.9	2.1	20.7	8.6	0.0	1.7	39.4	12.9	4.8	12.1	7.1	3.6	31.8	0.3	10.4	0.9	10.2	55.5	43.5	5.1	6.1	22.1	190.8	197.0	17.4	53.9	14.2	12.2	15.4	1.2	22.6	12.5	1.5	12.3	3.8	18.0	27.0	3.0	0.1	0.2	6.9	3.6	6.6	9.0	10.2	8.6	8.5	0.5	8.1	0.4	37.0	1.0	6.8	1.3
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851701-136195574	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 346.4;Excitatory neurons: 136.7;Inhibitory neurons: 166.0;Oligodendrocyte precursor cells: 343.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;ASC TERT1: 10.2;EFO-21: 16.2;HeLa: 9.6;HSkMC: 22.4;HUVEC TERT2: 10.8;U-2197: 11.4"	"Region enriched"	"Detected in all"	5	"basal ganglia: 125.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.2	2.3	6.5	2.2	22.1	0.1	2.6	3.6	8.1	3.9	2.8	2.5	1.9	7.8	2.2	1.3	2.8	3.4	6.6	2.6	8.7	5.5	3.7	1.7	1.5	6.2	11.6	13.0	0.8	6.2	4.8	1.0	6.0	4.3	2.7	2.4	2.9	10.3	4.7	0.8	2.2	7.6	4.6	1.1	3.6	1.5	15.8	3.8	4.7	8.9	0.8	6.0	3.6	2.8	0.0	5.7	0.2	0.0	8.7	10.2	0.1	0.5	2.9	2.1	1.1	0.0	0.1	0.1	16.2	3.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	9.6	0.0	3.7	0.1	0.0	22.4	0.0	4.2	0.0	0.9	10.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.8	0.7	3.9	3.7	0.1	0.2	0.0	0.0	1.8	0.0	2.3	0.0	11.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.8	1.3	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.1	6.5	22.1	3.6	8.1	2.6	8.7	6.2	11.6	6.0	4.6	15.8	2.8	8.3	0.0	0.5	346.4	11.9	0.4	0.3	0.5	0.0	4.4	0.9	0.4	8.4	2.8	0.2	22.0	0.0	0.1	0.7	0.1	0.0	0.2	0.5	3.1	1.4	23.1	7.3	0.8	136.7	1.6	0.0	9.8	4.6	2.1	10.2	31.1	35.3	3.8	0.3	6.7	166.0	0.0	0.0	1.9	4.8	0.9	12.2	3.2	0.0	70.3	0.7	11.5	0.0	343.8	10.4	0.1	0.0	7.9	0.2	0.4	0.0	1.6	1.6	0.9	13.1	30.6	9.1	0.3	0.1	0.2	1.4	0.0	2.9	4.4	0.0	0.3
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77428256	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.9;Excitatory neurons: 183.1;Horizontal cells: 69.0;Inhibitory neurons: 276.5;Muller glia cells: 86.5;Oligodendrocyte precursor cells: 190.5"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.6;HeLa: 34.8;SK-BR-3: 11.1"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	20.9	4.8	24.2	1.0	28.6	0.4	14.0	4.8	24.6	17.4	0.0	5.6	2.0	26.4	6.3	2.0	28.7	4.3	23.7	25.5	32.5	15.6	2.3	5.2	1.2	20.5	15.9	4.2	7.9	0.8	12.5	23.8	18.8	19.0	1.2	22.5	10.5	11.9	0.7	2.0	3.3	17.7	9.9	0.8	5.5	3.0	36.7	0.3	124.7	0.8	1.0	4.0	4.9	17.2	0.1	4.9	0.8	0.3	1.5	0.0	0.5	1.5	13.6	0.2	0.1	1.4	0.1	0.3	0.1	0.1	0.2	0.6	0.2	0.0	0.2	0.2	0.7	0.4	34.8	0.3	0.0	0.4	0.5	0.8	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.2	0.0	0.2	0.5	0.8	0.8	0.2	0.1	0.6	0.9	0.4	0.0	0.2	5.4	1.0	2.3	11.1	0.7	0.7	1.8	0.9	0.5	0.3	0.3	0.2	0.5	0.7	0.5	0.4	1.2	0.5	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	24.2	28.6	4.8	24.6	25.5	32.5	20.5	15.9	18.8	9.9	36.7	17.2	0.8	3.2	2.8	64.9	0.3	0.4	2.0	0.1	0.0	10.8	5.8	3.0	28.0	2.8	1.6	1.8	54.2	0.0	0.2	0.1	0.0	2.3	6.8	15.3	2.1	4.5	4.9	0.0	183.1	0.0	0.1	3.8	0.0	7.9	1.3	1.8	2.9	0.1	0.4	69.0	276.5	1.0	0.0	1.0	1.6	5.1	5.9	0.9	1.8	10.3	0.1	86.5	0.0	190.5	45.5	0.2	0.4	0.0	0.3	29.1	0.2	0.7	0.7	5.8	6.6	1.8	7.7	1.1	2.6	0.5	1.1	0.0	0.1	8.8	1.2	4.2
PDE9A		ENSG00000160191	"Phosphodiesterase 9A"	O76083	21	42653621-42775509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 74.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 90.8;Paneth cells: 105.3;Proximal enterocytes: 233.5"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 31.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 29.7;EFO-21: 30.0;MCF7: 23.2;NB-4: 34.7;NTERA-2: 41.2;SCLC-21H: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011380, HPA011978"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA011380: AB_1855132, HPA011978: "	"unprognostic (5.75e-2)"	"unprognostic (9.92e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.79e-1)"	9.4	11.1	12.3	3.9	15.1	0.5	10.8	14.0	12.9	7.2	8.6	74.7	2.9	5.1	19.4	3.7	10.6	6.8	4.3	10.6	12.6	29.8	4.2	4.9	4.8	12.4	14.4	3.5	4.1	6.5	9.9	10.3	12.7	38.5	16.4	10.7	12.7	15.8	2.4	7.0	47.3	8.8	11.0	18.3	13.4	1.9	15.0	7.8	6.5	4.8	3.1	18.9	6.2	12.0	0.0	2.8	29.7	3.7	0.0	0.8	0.5	0.0	0.0	0.0	0.0	3.2	18.2	0.0	30.0	0.0	2.2	0.0	2.7	9.8	0.0	0.0	10.4	0.0	0.0	6.4	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	23.2	1.5	34.7	41.2	14.6	0.0	0.0	0.0	1.2	20.4	7.6	22.5	13.5	5.2	0.0	0.5	7.0	0.2	19.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.1	0.2	3.1	0.6	0.4	0.9	0.0	0.4	1.0	0.3	12.3	15.1	14.0	12.9	10.6	12.6	12.4	14.4	12.7	11.0	15.0	12.0	18.6	3.2	5.0	43.4	1.6	1.0	10.9	4.2	6.2	26.4	13.4	12.6	1.6	5.7	2.4	18.4	0.0	0.0	1.0	90.8	29.4	7.3	0.6	18.1	8.5	11.9	13.1	3.2	5.6	2.4	0.1	5.9	1.5	26.8	1.3	6.1	5.7	0.9	7.5	35.3	10.8	25.8	8.2	1.3	0.8	2.2	11.8	1.6	28.4	31.9	1.1	11.0	0.0	29.1	16.6	5.3	105.3	6.0	0.2	28.1	233.5	8.9	1.3	2.8	13.1	0.5	6.4	0.4	2.3	0.5	0.6	0.4	3.8	16.9	24.4	15.0
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69326913-69330588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 8.0;Erythroid cells: 4.6;Gastric mucus-secreting cells: 8.6;Plasma cells: 14.7;Squamous epithelial cells: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	5.9	8.7	1.0	0.9	1.3	1.4	5.5	1.9	1.8	4.4	1.5	5.6	2.1	5.8	0.4	10.2	4.7	0.5	5.3	2.2	0.8	19.0	27.8	4.4	1.1	1.4	0.8	3.1	8.8	1.6	4.3	0.6	1.0	5.0	0.8	0.3	7.2	0.6	12.4	7.7	5.2	0.4	0.8	5.1	5.6	4.8	0.9	0.6	5.9	0.8	0.7	4.8	4.8	1.5	6.3	4.8	1.3	4.1	1.1	0.8	7.7	6.0	1.0	2.9	2.4	8.6	5.7	13.1	6.2	1.6	2.2	11.5	1.8	2.1	1.3	3.5	23.3	6.6	5.3	12.6	1.8	10.8	5.7	1.7	4.3	2.5	1.2	0.8	1.5	7.2	16.1	2.4	1.9	7.6	9.2	8.3	6.4	2.6	7.1	20.8	2.1	11.0	2.2	5.4	9.3	7.1	10.8	2.9	5.2	0.3	11.0	3.3	4.6	3.9	6.4	5.8	6.8	12.1	9.4	15.2	3.1	6.9	5.9	1.4	0.7	1.0	0.4	0.3	0.9	1.2	1.0	1.2	0.6	4.1	1.5	0.7	0.0	0.4	0.4	1.3	0.9	0.3	1.0	1.3	1.9	1.8	2.2	0.8	1.4	0.8	1.0	0.8	0.9	1.5	0.2	3.2	0.0	0.0	3.0	0.0	0.1	0.0	8.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.5	0.3	0.6	0.0	4.6	0.0	0.2	0.3	1.2	8.6	0.5	0.0	0.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	14.7	0.1	0.4	1.1	0.0	0.0	0.0	0.1	0.8	0.2	0.1	17.7	0.4	0.3	1.4	0.1	0.0	0.1
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229280-54298245	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 190.2"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 423.9;Fibroblasts: 256.4;Leydig cells: 449.8;Oligodendrocyte precursor cells: 499.6;Peritubular cells: 408.9"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 468.1;ASC TERT1: 216.1;BJ hTERT+: 279.4;fHDF/TERT166: 195.9;HHSteC: 156.3;HSkMC: 392.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		300000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	46.0	28.9	13.9	40.4	13.7	1.6	40.1	8.1	12.8	50.8	18.1	37.7	22.4	44.3	21.8	22.5	50.9	38.5	32.1	11.9	11.0	26.5	16.0	37.9	8.5	16.7	11.9	190.2	13.4	3.0	3.7	62.7	15.1	15.0	35.2	5.3	16.6	18.9	9.6	14.8	31.3	48.1	12.1	46.2	29.4	13.6	8.9	7.6	16.5	41.9	7.2	63.9	38.0	20.0	0.1	0.0	1.0	0.8	468.1	216.1	0.5	25.4	279.4	0.1	0.7	67.6	0.5	0.5	0.5	195.9	0.8	0.6	19.6	0.2	0.1	2.6	1.0	0.7	0.7	1.2	156.3	0.3	0.4	392.0	0.0	31.4	0.0	5.4	0.0	0.7	0.6	0.9	1.1	0.1	0.4	1.2	3.5	0.3	1.1	0.5	0.1	0.1	0.0	0.4	0.6	37.9	0.0	0.5	0.2	2.0	0.7	0.1	0.8	84.9	3.2	93.9	0.2	0.4	0.1	0.8	2.6	0.1	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	13.7	8.1	12.8	11.9	11.0	16.7	11.9	15.1	12.1	8.9	20.0	11.1	0.0	0.5	0.3	0.6	17.1	0.6	2.4	1.2	5.5	4.3	3.2	4.8	0.0	0.8	0.0	0.0	1.4	0.9	0.1	1.9	4.2	2.2	11.7	423.9	5.7	0.0	0.0	1.1	6.7	2.0	256.4	5.1	9.0	0.0	2.6	26.0	1.0	3.1	0.0	19.5	0.2	10.2	0.6	27.3	17.2	449.8	5.4	23.2	39.4	4.7	17.5	0.0	499.6	0.4	20.0	0.0	408.9	0.2	0.9	0.0	0.1	0.5	0.6	0.0	25.7	13.9	1.0	3.4	8.1	15.8	1.4	2.5	49.6	0.0	1.0
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Fibroblasts: 186.2;Leydig cells: 74.6;Peritubular cells: 70.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"AN3-CA: 189.4;BJ hTERT+: 159.1;HSkMC: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA052801: AB_2681956"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	34.1	4.2	2.5	3.9	3.5	0.2	51.9	2.8	3.0	27.8	1.9	9.0	0.9	15.8	10.3	3.0	23.3	13.4	11.1	2.3	2.3	1.3	0.7	4.7	1.2	2.7	2.6	42.9	6.9	9.0	7.4	9.0	2.5	5.4	3.1	0.6	13.1	6.7	18.4	11.0	2.6	26.0	2.4	0.8	6.2	6.5	2.9	3.8	33.0	38.0	2.0	6.5	12.0	3.3	0.0	17.7	1.0	189.4	5.6	2.5	13.8	4.6	159.1	7.5	31.3	1.0	0.2	0.0	0.9	2.5	24.7	0.0	11.6	0.9	3.7	0.2	14.5	0.0	5.3	4.1	14.6	0.0	0.0	86.9	0.1	9.2	0.1	0.0	13.0	1.6	0.0	2.4	1.1	12.5	0.2	0.4	9.9	0.7	3.6	0.0	0.2	0.4	1.0	11.4	0.6	1.2	1.4	1.7	3.3	11.4	0.6	0.0	2.6	0.2	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.5	2.8	3.0	2.3	2.3	2.7	2.6	2.5	2.4	2.9	3.3	15.5	0.0	3.6	2.3	0.3	13.3	0.5	4.3	0.6	0.6	2.9	3.3	4.5	1.5	2.8	0.0	0.0	14.9	0.7	0.4	0.0	4.1	36.0	2.4	5.4	4.1	1.2	0.0	1.1	7.1	19.9	186.2	0.5	4.7	0.0	0.3	1.4	0.2	3.5	0.0	3.5	1.3	2.0	0.0	14.6	6.7	74.6	1.6	10.6	1.9	1.6	1.4	0.0	3.0	1.3	3.1	0.1	70.7	0.2	1.9	0.4	0.1	0.2	0.4	0.0	8.0	10.7	0.8	1.9	0.6	9.9	9.7	1.7	1.5	0.4	0.5
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 subunit beta"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 299.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 300.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		61000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	59.9	76.5	48.7	42.2	50.2	25.7	42.9	53.9	62.7	43.3	63.6	56.8	42.5	38.5	44.6	57.4	37.7	35.9	175.0	49.7	52.3	100.8	110.7	36.4	53.1	51.7	49.4	26.5	36.4	88.8	44.1	57.0	51.5	48.5	60.4	30.7	45.9	52.1	272.6	36.8	37.6	63.8	51.6	42.8	53.9	42.3	53.1	53.1	40.8	299.4	56.0	49.7	35.9	54.3	66.5	90.9	92.3	69.8	91.7	111.1	110.4	81.6	101.3	117.9	120.6	165.1	62.6	140.3	44.9	103.8	109.0	37.6	113.2	74.9	90.0	81.7	83.0	125.4	163.7	126.0	92.5	103.0	67.9	97.9	67.7	95.5	55.8	137.5	103.1	114.2	65.9	61.5	129.5	63.1	98.2	107.8	127.2	69.2	101.3	46.3	71.8	136.1	188.1	89.1	63.7	70.2	75.6	107.2	85.4	131.3	159.0	108.7	76.3	62.9	83.7	66.8	94.2	85.2	129.9	99.2	96.2	120.8	60.7	57.8	98.9	98.7	83.2	115.1	87.9	102.2	81.7	80.5	141.1	103.4	90.9	82.4	19.6	129.4	109.7	94.7	113.2	124.1	48.7	50.2	53.9	62.7	49.7	52.3	51.7	49.4	51.5	51.6	53.1	54.3	57.8	60.9	34.5	5.9	45.3	27.9	40.7	142.0	26.7	31.8	29.4	31.6	300.6	48.6	96.0	35.0	25.0	174.1	35.3	41.0	230.9	95.9	76.3	37.0	37.3	58.0	58.0	22.5	10.9	72.2	101.6	54.1	29.6	34.2	39.3	48.5	46.1	76.1	84.6	57.2	13.3	50.4	162.8	37.9	26.6	16.9	60.3	37.2	56.9	9.4	76.5	61.7	70.0	9.0	13.6	55.9	43.0	51.1	38.8	19.1	45.8	146.8	70.7	45.9	65.7	30.8	72.3	98.2	88.3	42.8	29.8	157.2	44.7	224.4	53.0	37.7
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.6;tongue: 125.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 115.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	23.5	21.6	16.5	12.2	19.9	7.4	16.6	21.6	21.9	13.3	9.4	22.8	20.1	14.2	13.3	17.2	10.0	12.3	77.8	21.1	14.5	21.5	31.0	12.7	11.9	16.6	17.2	11.7	21.5	21.0	15.4	24.4	16.5	18.9	20.6	27.1	20.4	16.0	138.6	14.6	15.0	17.8	13.4	11.1	23.1	27.8	19.7	13.2	14.3	125.2	14.8	15.0	11.7	21.1	20.4	54.3	29.9	11.9	20.7	25.5	28.5	38.9	30.1	40.3	38.9	69.3	18.8	27.2	24.7	31.4	49.1	39.4	58.9	31.9	41.1	25.8	47.2	26.9	54.6	82.3	45.0	50.7	30.7	25.6	37.9	23.2	31.5	23.8	31.1	23.9	57.9	25.4	33.1	35.7	32.2	29.9	25.2	54.2	30.5	27.0	53.5	23.8	62.1	54.7	32.0	23.3	33.8	48.1	52.2	29.3	54.8	29.9	21.0	30.4	35.5	32.3	42.7	24.4	53.3	35.7	23.9	24.2	32.5	14.0	19.4	17.5	15.4	21.4	14.3	18.8	14.4	12.7	27.5	16.0	17.2	12.6	3.9	22.1	34.6	7.4	22.1	14.7	16.5	19.9	21.6	21.9	21.1	14.5	16.6	17.2	16.5	13.4	19.7	21.1	9.0	35.3	24.6	34.3	14.5	26.0	21.4	26.7	15.4	25.8	15.1	11.4	115.3	20.0	26.0	5.5	29.2	62.9	9.0	14.4	64.6	21.4	52.6	15.1	12.2	13.0	9.0	13.5	85.4	14.3	34.9	20.6	16.3	16.6	5.7	16.5	11.7	23.6	26.4	20.2	80.3	17.2	42.7	18.6	13.6	54.0	10.8	14.7	21.4	24.4	23.2	21.0	9.2	40.2	53.4	16.7	15.9	13.5	14.1	22.4	15.0	30.7	19.8	26.7	0.0	14.5	18.8	57.2	36.1	17.9	25.4	83.0	13.4	27.5	20.0	19.7
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067025-123225227	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 133.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA		4700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	17.9	23.6	0.3	15.2	0.3	17.9	13.8	0.2	1.4	14.5	2.7	20.1	13.9	12.4	30.2	6.1	14.0	19.6	9.9	0.6	0.8	14.5	80.2	17.7	11.1	0.5	0.6	11.5	26.6	10.7	12.7	47.4	0.4	32.3	25.0	4.2	13.7	7.9	4.2	8.8	12.8	17.0	0.3	10.1	33.4	15.3	0.9	4.5	30.8	4.3	12.0	17.9	9.5	0.7	24.0	14.6	17.7	21.5	80.3	71.9	95.0	44.9	74.5	24.5	66.9	47.8	21.6	0.0	57.6	69.9	15.7	12.5	7.8	27.4	25.7	1.1	8.8	10.4	3.9	56.7	33.2	26.5	1.4	62.3	40.2	16.6	34.5	26.1	84.0	10.1	13.6	60.4	16.9	29.6	7.2	31.3	13.1	54.5	15.6	6.7	13.0	67.5	20.7	13.9	19.3	11.4	22.0	24.0	40.4	28.7	21.4	32.3	47.2	6.2	19.5	29.4	12.3	18.1	5.0	10.8	20.2	21.0	21.5	0.0	9.3	0.3	1.4	2.4	2.3	3.5	1.0	0.8	5.5	1.1	0.6	0.6	0.2	0.5	0.5	12.8	0.0	2.3	0.3	0.3	0.2	1.4	0.6	0.8	0.5	0.6	0.4	0.3	0.9	0.7	17.2	19.2	30.7	2.6	5.6	5.0	6.0	6.4	3.4	13.1	6.9	4.7	2.7	35.8	11.3	5.5	39.6	41.8	3.1	5.4	0.0	32.2	1.6	5.4	13.1	24.3	8.4	5.5	9.6	28.6	133.6	20.7	30.5	21.1	3.8	7.3	37.5	50.1	12.1	0.0	7.1	36.9	0.0	7.8	5.5	2.0	24.2	4.4	8.8	5.6	5.0	2.3	0.0	1.0	2.5	11.9	7.6	22.2	40.1	18.1	3.5	5.3	6.4	28.4	13.1	3.6	17.6	1.3	1.5	3.4	4.1	50.2	3.1	23.3	15.1	4.5
PDIK1L	CLIK1L	ENSG00000175087	"PDLIM1 interacting kinase 1 like"	Q8N165	1	26111165-26125555	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064157			Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA064157: "	"unprognostic (1.09e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.99e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.47e-1)"	"unprognostic (1.78e-2)"	3.2	3.4	4.4	4.5	4.0	16.6	8.2	6.6	5.1	5.9	2.7	6.9	7.1	4.4	4.6	4.9	5.4	3.9	3.3	4.1	5.2	6.0	8.1	4.6	6.5	3.9	4.0	6.5	7.8	7.0	2.6	3.4	4.8	4.7	7.3	8.3	6.3	5.0	4.8	5.5	5.6	3.6	3.8	4.6	7.3	5.0	4.9	8.6	15.4	5.2	6.3	4.6	3.2	4.9	7.9	2.9	7.5	9.8	2.7	3.8	2.6	2.3	2.7	5.2	3.3	2.0	11.2	17.8	6.3	2.6	4.0	5.6	11.2	4.0	4.4	6.1	7.7	15.3	4.3	2.2	4.7	15.6	9.0	2.2	5.9	4.6	8.5	3.5	4.8	15.3	18.0	16.8	1.8	4.8	23.5	7.4	3.5	9.5	4.7	12.7	7.3	19.2	3.7	6.1	13.3	10.8	8.2	10.0	10.5	2.0	5.4	5.4	4.4	5.5	5.2	7.0	6.9	23.8	26.5	12.0	5.9	19.2	5.0	10.5	3.8	3.3	4.8	3.6	4.5	4.9	6.6	5.3	7.3	4.2	7.0	5.6	0.3	4.4	5.1	2.8	7.9	4.0	4.4	4.0	6.6	5.1	4.1	5.2	3.9	4.0	4.8	3.8	4.9	4.9	6.4	9.6	4.2	5.9	6.2	3.2	1.7	3.5	7.4	18.6	8.6	3.9	2.3	7.2	7.0	1.8	0.0	3.9	2.7	6.5	0.0	3.7	1.3	3.2	5.7	5.0	13.1	6.3	13.7	4.0	0.7	3.8	7.1	4.9	7.0	6.3	5.0	11.1	4.1	23.5	15.4	8.0	4.1	6.3	5.9	0.5	2.5	4.6	3.6	5.6	3.1	11.0	0.0	10.1	12.1	2.9	3.3	3.0	14.0	3.5	4.5	7.5	8.4	11.7	0.0	2.9	3.6	14.0	11.7	14.5	7.4	1.6	5.4	3.0	8.7	3.0
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 216.2;tongue: 285.0"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 123.0;Proximal tubular cells: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Mitochondria"		"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	40.8	63.8	49.9	8.7	51.2	5.0	26.4	65.7	58.2	30.5	37.1	42.7	28.1	29.4	124.4	21.8	24.3	18.0	116.6	50.6	41.8	62.7	50.8	15.3	10.1	40.8	44.0	48.2	44.3	40.7	17.0	14.7	41.8	23.5	21.5	14.7	25.7	27.4	216.2	26.0	32.5	25.7	40.8	18.4	33.7	13.7	44.6	12.6	27.3	285.0	9.2	30.9	22.2	44.6	12.4	17.5	20.6	18.5	21.2	16.5	2.2	13.2	19.3	19.3	18.5	1.7	13.2	15.5	21.7	37.0	13.0	6.4	13.7	5.3	18.8	30.6	19.3	14.0	17.1	13.2	11.3	0.0	15.0	33.6	19.6	12.5	0.9	33.7	17.2	20.0	5.7	15.0	11.0	15.8	11.8	0.0	4.5	37.2	17.1	17.5	45.8	21.1	10.4	10.4	13.8	20.7	18.7	5.9	9.0	25.0	35.0	13.7	8.8	22.5	18.4	16.0	10.1	29.4	29.9	8.2	33.3	4.9	15.4	14.3	16.2	8.9	16.2	12.9	12.8	12.9	14.8	18.0	18.4	13.8	17.2	18.0	2.6	22.9	14.1	25.8	22.4	17.4	49.9	51.2	65.7	58.2	50.6	41.8	40.8	44.0	41.8	40.8	44.6	44.6	17.9	9.6	10.3	18.3	12.1	15.2	12.3	12.4	17.6	19.0	16.0	26.8	5.4	12.8	11.7	20.2	6.2	19.6	16.7	38.6	58.7	11.7	8.8	6.5	12.1	11.8	13.8	10.8	18.6	9.1	3.6	17.7	13.7	7.8	1.3	19.0	18.2	52.0	19.9	43.7	15.6	50.2	16.2	13.6	9.1	18.9	24.2	12.0	24.9	8.4	14.5	37.3	7.2	6.0	11.3	6.2	55.2	52.6	25.9	6.7	123.0	131.9	6.5	11.0	19.7	15.0	20.5	3.3	11.7	14.6	18.8	7.9	12.9	29.0	36.9	11.3
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 629.5;skeletal muscle: 1163.5;tongue: 576.0"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 1844.2"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 219.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		1200000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Focal adhesion sites"	"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	41.7	26.0	20.5	25.6	25.2	59.7	39.5	22.4	22.4	27.4	84.9	34.1	33.3	94.8	11.3	72.3	40.5	47.5	629.5	21.4	27.7	34.9	82.7	22.0	16.2	30.9	30.1	27.2	30.2	12.2	17.5	67.7	25.0	88.5	30.8	18.2	40.2	68.9	1163.5	21.5	34.4	105.9	22.7	24.1	31.0	12.7	26.3	10.9	25.5	576.0	21.1	45.8	27.6	21.0	31.4	87.2	33.6	13.0	71.7	51.3	13.0	71.6	59.9	40.1	32.6	80.8	66.3	12.0	72.0	72.3	21.0	31.8	46.5	68.2	65.9	24.1	19.3	43.7	53.8	32.2	103.7	14.6	38.3	66.4	58.4	96.1	74.0	177.9	93.5	13.2	19.2	12.5	86.2	29.8	15.0	4.8	11.4	66.7	36.6	7.2	24.7	11.1	45.0	94.6	16.5	21.8	38.9	88.7	20.3	26.7	10.3	5.2	113.7	103.7	17.3	46.1	44.1	9.5	13.0	12.7	56.5	10.3	24.9	219.7	23.4	21.0	12.1	40.6	9.7	10.5	12.0	12.8	19.5	7.6	7.9	10.4	22.6	9.2	44.6	6.6	11.8	15.2	20.5	25.2	22.4	22.4	21.4	27.7	30.9	30.1	25.0	22.7	26.3	21.0	107.4	44.8	23.6	184.1	22.1	194.4	380.3	92.1	63.7	4.7	90.2	67.4	1844.2	62.9	82.9	49.7	31.3	13.7	18.5	180.0	13.7	95.0	19.2	68.7	11.8	117.2	109.4	27.6	4.9	95.1	96.5	97.8	84.6	108.7	52.0	29.1	137.8	207.0	38.8	1.7	20.7	107.4	36.7	60.6	75.3	9.1	41.3	59.8	62.2	104.0	41.6	86.2	12.3	181.5	43.1	139.2	166.8	66.5	23.2	300.7	117.5	73.6	70.0	35.8	78.9	96.7	134.7	23.8	34.4	107.3	157.0	23.8	31.1	6.8	74.0	217.5
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 80.0;Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 14.2;basal ganglia: 20.1;cerebral cortex: 41.7;hippocampal formation: 23.4;white matter: 18.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 117.8;hTERT-RPE1: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	10.6	62.6	14.2	10.5	20.1	14.4	16.1	0.0	41.7	14.2	1.2	8.9	7.2	15.5	17.0	14.2	12.2	19.4	49.2	23.4	0.0	12.8	4.2	12.6	12.9	0.0	2.3	19.3	19.9	29.9	5.4	13.8	0.0	10.3	12.4	14.1	11.7	9.4	72.9	4.3	7.6	11.2	0.0	13.2	11.7	26.7	3.0	11.6	18.8	16.9	12.4	14.0	6.8	18.5	25.7	12.0	25.9	10.9	21.0	37.9	8.6	19.3	21.7	22.1	25.8	12.7	90.3	13.9	63.8	30.8	117.8	54.4	11.0	16.1	32.8	1.5	5.6	6.6	15.7	4.5	23.9	3.3	9.0	24.5	31.5	37.7	59.8	117.1	50.9	12.4	2.4	22.8	27.6	6.0	20.3	10.3	12.1	26.8	15.4	4.8	15.5	2.6	15.3	17.0	2.4	11.4	12.7	1.4	61.8	20.9	4.0	3.9	90.9	27.5	17.2	63.8	23.3	12.6	5.8	12.1	34.2	11.7	25.1	6.4	27.9	14.5	9.2	25.3	8.9	15.6	15.1	12.0	22.5	17.9	8.9	7.8	3.1	5.4	41.1	3.7	34.9	18.0	14.2	20.1	0.0	41.7	23.4	0.0	0.0	2.3	0.0	0.0	3.0	18.5	10.7	12.8	7.8	15.0	18.0	13.0	12.7	36.3	68.9	38.3	11.6	7.0	80.0	14.3	35.6	16.5	8.4	4.3	13.7	27.5	5.9	33.3	144.2	33.3	14.9	15.0	10.2	1.3	73.6	14.0	3.9	20.8	16.3	70.2	6.3	3.7	12.5	3.3	6.3	10.1	23.4	5.5	10.2	19.2	19.1	28.1	11.5	19.9	10.6	19.7	22.4	18.8	10.3	13.0	8.5	24.5	9.6	13.5	8.1	15.6	4.9	11.4	30.5	11.5	6.6	35.4	13.1	10.1	11.4	26.5	10.9	4.4	19.3	7.1	10.7	23.9
PDS5A	"KIAA0648, PIG54, SCC-112"	ENSG00000121892	"PDS5 cohesin associated factor A"	Q29RF7	4	39822863-39977956	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036661, HPA036662"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA036661: AB_2675233, HPA036662: AB_10696783"	"unprognostic (4.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.81e-2)"	19.4	16.2	13.3	23.2	15.0	29.4	24.3	19.7	18.1	20.6	17.0	23.0	19.7	19.9	20.2	25.8	15.9	16.5	14.5	13.4	13.9	22.0	33.4	22.7	33.2	15.1	13.6	23.6	21.0	29.7	10.6	22.9	15.5	18.5	23.9	20.9	20.1	15.9	17.7	24.3	19.4	19.4	14.2	21.4	20.6	14.0	14.2	42.0	28.5	19.6	34.7	22.8	15.9	23.5	54.8	40.0	50.3	53.4	47.5	47.5	40.2	43.4	40.9	50.1	49.6	39.2	60.2	106.6	46.5	51.6	79.5	29.4	86.9	50.5	71.7	36.1	33.2	73.1	47.6	41.3	47.5	90.2	60.1	31.5	55.9	53.3	78.2	44.5	64.7	62.1	88.0	43.8	52.0	38.5	113.2	78.8	28.6	51.4	26.7	104.3	89.6	38.9	48.2	54.6	69.5	41.2	59.9	40.7	39.0	37.5	41.4	78.7	61.5	56.4	58.6	41.2	74.3	37.0	69.7	112.3	40.1	90.6	45.3	2.3	1.2	1.9	2.3	1.6	3.0	2.0	2.2	2.5	1.8	2.5	2.6	2.1	0.4	3.0	1.1	2.2	2.0	1.0	13.3	15.0	19.7	18.1	13.4	13.9	15.1	13.6	15.5	14.2	14.2	23.5	36.2	86.6	70.3	75.7	52.3	56.6	37.0	29.3	51.8	32.7	42.6	30.1	40.5	32.9	45.8	22.0	60.5	32.4	50.8	39.2	7.9	22.0	9.7	34.9	50.0	40.7	30.5	69.6	120.5	25.8	39.1	36.8	41.3	52.8	29.1	45.1	40.0	58.2	30.9	13.5	115.3	36.3	28.5	46.6	54.5	10.0	32.9	44.6	46.2	119.9	38.7	13.3	42.2	98.5	138.0	38.9	28.2	33.1	52.8	53.7	28.5	27.4	25.5	27.9	32.9	36.3	31.1	44.2	48.5	66.9	68.2	38.7	49.9	30.9	40.4	59.6
PDS5B	"APRIN, AS3, CG008, FLJ23236, KIAA0979"	ENSG00000083642	"PDS5 cohesin associated factor B"	Q9NTI5	13	32586452-32778019	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 185.5;Inhibitory neurons: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039513, HPA040015"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA039513: AB_10671999, HPA040015: AB_10671047"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.62e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.91e-2)"	11.8	8.1	3.8	9.4	6.2	23.3	12.6	7.6	14.3	18.5	0.0	13.5	6.1	19.0	13.2	7.1	12.8	7.8	7.4	7.5	8.3	9.8	9.6	10.9	13.3	0.7	0.4	15.9	7.5	9.3	9.8	10.1	0.0	12.8	8.2	11.1	8.5	9.8	11.4	10.4	10.6	11.7	0.3	13.4	9.8	12.1	0.9	20.9	10.4	8.0	10.7	10.2	11.4	10.5	12.4	7.3	32.7	17.6	15.3	11.0	9.2	20.5	13.7	17.1	17.1	10.1	20.2	45.0	7.2	10.1	17.2	16.1	23.9	12.9	20.2	36.1	9.0	40.7	13.1	14.2	9.0	37.6	24.0	8.6	6.4	14.3	12.8	11.2	13.1	17.8	14.4	29.6	15.8	15.9	45.3	28.2	24.2	25.9	8.9	45.7	45.2	15.5	11.0	10.2	8.5	20.4	23.6	23.0	9.2	19.7	22.2	24.8	26.0	16.3	15.7	11.8	12.4	9.0	10.7	37.4	7.0	25.1	24.1	3.0	2.7	4.0	3.0	2.4	3.5	3.4	3.5	3.2	3.5	4.5	3.4	3.3	3.3	2.8	3.3	2.3	2.8	1.6	3.8	6.2	7.6	14.3	7.5	8.3	0.7	0.4	0.0	0.3	0.9	10.5	50.3	16.0	30.2	86.8	33.9	28.9	23.8	14.6	34.1	42.3	24.3	17.0	26.7	21.5	24.6	27.6	25.0	24.9	35.9	17.4	5.9	14.8	14.5	24.2	79.7	42.2	31.8	22.9	185.5	16.0	18.5	46.4	19.4	19.9	23.5	55.3	23.9	28.0	18.5	47.1	222.6	21.8	16.2	39.0	38.1	13.7	67.1	31.3	35.6	131.2	39.4	15.8	34.0	154.8	155.1	14.7	17.9	62.4	43.8	23.4	15.9	12.9	31.3	20.8	72.3	46.9	51.4	49.5	60.6	17.0	29.3	6.2	37.1	41.8	21.1	17.0
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920000-27926313	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 41.8;pancreas: 13.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Ductal cells: 13.3;Enteroendocrine cells: 13.8;Exocrine glandular cells: 9.8;Gastric mucus-secreting cells: 4.6"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 8.4;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;HEK 293: 2.3;HeLa: 5.9;OE19: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB025873: , HPA059146: AB_2683927"		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	41.8	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	13.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.0	2.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	15.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	13.8	0.0	0.0	9.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0
PDXK	"C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79"	ENSG00000160209	"Pyridoxal kinase"	O00764	21	43719094-43762307	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 87.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1717.4;Late spermatids: 4366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030196, HPA030197, HPA030198, CAB033918"	Enhanced		Enhanced	Nucleoplasm		NA	NA		830000	"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570"	"unprognostic (1.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.51e-3)"	25.6	21.8	79.4	7.6	62.2	12.9	18.4	23.9	87.0	14.3	17.5	17.1	14.1	12.3	10.2	19.7	14.0	7.0	15.5	62.5	51.7	50.4	21.5	20.9	7.0	48.8	59.7	19.1	21.3	17.8	37.3	7.8	54.7	17.2	9.4	10.0	22.7	10.6	6.7	13.9	19.7	6.9	34.4	12.5	16.6	23.9	70.5	10.2	19.1	5.4	9.3	10.9	12.6	57.6	43.4	51.9	8.1	15.5	19.4	27.3	9.9	15.2	23.8	14.5	12.1	42.5	65.7	14.4	15.7	21.9	20.0	31.9	15.8	43.4	9.5	16.2	13.4	14.7	60.9	31.7	38.1	14.0	20.6	38.9	40.7	15.3	16.9	23.6	6.9	6.3	26.2	31.9	13.8	29.1	2.0	24.9	22.3	41.9	19.7	16.7	4.8	40.4	62.9	51.9	7.8	9.3	63.3	57.7	23.2	3.3	19.0	19.4	12.5	10.5	20.3	14.2	14.4	19.3	9.8	8.4	43.2	39.9	10.3	0.6	2.4	0.1	0.8	2.2	1.5	0.6	0.8	0.9	1.3	1.7	0.8	0.6	0.6	0.9	4.3	0.6	0.7	1.4	79.4	62.2	23.9	87.0	62.5	51.7	48.8	59.7	54.7	34.4	70.5	57.6	15.8	80.1	66.6	44.1	37.7	28.4	142.4	72.2	27.3	46.3	74.8	53.5	48.0	34.3	73.2	101.2	22.9	42.9	23.6	97.6	180.0	146.4	1717.4	66.9	28.3	36.1	30.1	15.8	49.3	196.6	86.3	39.4	63.2	73.2	31.8	23.8	17.2	54.2	207.6	52.2	48.7	55.4	12.2	58.2	101.0	4366.5	50.1	118.7	42.7	61.8	38.4	14.9	20.6	16.6	13.5	223.4	36.4	54.2	146.4	184.7	108.4	95.7	71.1	43.3	6.6	17.0	35.0	678.1	30.4	60.7	28.4	124.1	27.3	22.1	57.5	239.8
PDZD7	"bA108L7.8, DFNB57, FLJ23209, PDZK7"	ENSG00000186862	"PDZ domain containing 7"	Q9H5P4	10	101007679-101032295	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 21.5;intestine: 20.0;pituitary gland: 6.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 15.9;Cone photoreceptor cells: 22.9;Excitatory neurons: 32.3;Inhibitory neurons: 16.5;Proximal enterocytes: 56.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 7.5;SCLC-21H: 11.7;THP-1: 18.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074542			Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA074542: "	"unprognostic (1.46e-1)"	"unprognostic (2.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.54e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.80e-1)"	1.5	1.3	5.8	1.0	8.0	1.3	0.5	10.2	15.4	0.7	0.7	0.4	12.8	1.4	0.9	0.3	0.4	1.9	0.6	5.7	4.5	1.5	0.1	1.0	0.9	21.5	7.7	0.6	0.9	1.1	6.0	1.0	21.0	0.7	0.2	2.3	1.1	0.5	0.9	2.4	20.0	1.0	2.7	1.6	1.0	1.2	8.8	0.7	1.2	0.2	0.1	0.4	0.8	9.9	7.5	0.9	0.5	0.7	0.9	0.1	2.3	1.2	0.6	0.0	0.3	1.5	1.7	3.7	3.5	0.3	1.0	2.2	0.2	0.7	0.0	1.0	2.5	0.2	3.8	2.3	0.6	0.5	3.1	0.3	0.1	0.2	0.1	4.2	0.2	3.3	0.6	0.7	0.1	1.8	0.5	1.2	0.6	1.5	2.4	1.6	1.0	0.4	1.8	0.6	11.7	5.4	0.8	0.3	1.2	1.0	2.4	18.2	0.5	1.1	2.4	1.4	1.0	1.5	0.1	0.2	6.4	1.2	0.6	0.6	0.4	0.5	0.3	0.4	0.3	0.3	0.2	0.4	0.1	0.3	0.4	0.2	1.6	0.8	0.3	0.1	0.1	0.3	5.8	8.0	10.2	15.4	5.7	4.5	21.5	7.7	21.0	2.7	8.8	9.9	0.8	0.0	0.0	1.3	0.1	0.5	0.5	0.2	0.0	15.9	0.5	0.9	1.4	2.8	0.2	1.8	22.9	0.2	0.1	0.2	1.9	0.7	1.7	2.1	0.3	0.7	0.0	0.0	32.3	0.4	5.2	0.8	1.1	0.3	0.0	1.6	0.7	0.0	2.1	1.7	16.5	1.5	0.0	1.3	2.7	2.6	0.3	1.0	0.0	5.6	0.3	0.9	1.0	0.5	6.9	1.3	1.2	1.2	0.3	0.4	56.7	1.6	1.3	8.3	0.0	1.4	1.7	2.9	3.7	0.2	0.4	1.9	0.8	0.1	1.0	0.2
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 595.8"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 280.0;Proximal tubular cells: 1113.8"	"Group enriched"	"Detected in many"	4	"liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 14.7"	"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.2"	"Group enriched"	"Detected in many"	4	"RPTEC TERT1: 250.0;T-47d: 653.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.6	3.5	0.7	0.5	0.9	0.6	19.6	14.7	2.0	2.4	1.9	4.7	74.8	0.7	15.8	0.2	1.0	22.0	0.4	1.0	0.5	595.8	128.1	0.3	0.7	1.4	0.8	0.3	16.6	0.0	0.6	0.5	1.8	0.3	8.2	3.0	0.4	0.8	0.3	2.6	124.9	0.8	0.4	0.7	2.8	0.6	0.8	0.3	0.3	0.1	0.2	0.2	0.3	1.5	7.6	1.2	0.8	0.8	0.3	0.4	3.0	1.2	0.3	0.2	1.0	106.6	1.0	0.7	1.3	5.9	0.5	3.4	0.2	0.6	0.6	10.3	2.0	0.9	2.8	45.7	0.0	1.1	0.9	0.3	0.7	0.4	0.2	0.8	0.0	0.4	0.8	1.6	0.8	6.0	0.7	1.4	1.2	1.5	3.6	0.4	7.3	1.6	250.0	0.3	0.6	6.7	1.7	1.8	0.2	6.4	653.8	0.9	0.5	1.3	1.3	0.9	1.1	8.8	1.2	0.6	1.0	0.6	0.5	0.1	0.1	0.0	0.7	0.1	0.2	0.6	0.2	0.8	0.0	0.4	0.2	0.3	0.1	4.2	0.0	0.5	0.0	0.3	0.7	0.9	14.7	2.0	1.0	0.5	1.4	0.8	1.8	0.4	0.8	1.5	0.2	0.0	0.0	2.0	4.1	0.1	0.0	0.1	0.0	0.4	20.2	3.3	0.5	72.9	0.0	57.0	0.0	0.0	0.9	27.4	138.9	1.2	8.6	1.1	0.5	0.4	6.6	0.0	2.8	2.0	0.1	0.5	0.5	4.9	0.0	0.2	1.1	47.9	0.2	0.0	1.9	7.8	0.0	0.9	0.3	9.0	0.0	4.9	0.0	1.9	0.0	0.3	2.1	3.0	0.7	1.5	7.4	0.0	0.0	0.1	280.0	1113.8	0.1	0.5	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.1	4.1	4.3	6.5	0.1
PDZRN3	"KIAA1095, LNX3, SEMACAP3, SEMCAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382431-73624941	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 256.0;Excitatory neurons: 183.1;Inhibitory neurons: 258.3;Microglial cells: 329.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AF22: 32.1;ASC diff: 57.0;ASC TERT1: 29.6;BJ hTERT+: 42.0;HSkMC: 41.4;U-87 MG: 30.4"	"Group enriched"	"Detected in many"	4	"amygdala: 15.1;basal ganglia: 8.1;cerebral cortex: 19.5;hippocampal formation: 16.1;white matter: 7.2"	"Low region specificity"	"Detected in many"			"HPA038822, HPA061420"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA038822: AB_10675952, HPA061420: AB_2684512"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	29.9	35.7	14.9	10.2	16.3	0.0	24.0	8.5	20.9	45.2	58.0	84.0	9.2	64.1	24.5	27.8	26.7	27.4	48.0	16.7	10.6	10.7	2.1	14.9	4.5	13.0	11.8	69.4	6.9	0.8	4.6	17.5	11.0	31.7	13.9	6.3	20.9	29.0	91.8	17.3	24.4	38.4	13.1	2.4	38.7	6.4	17.1	2.9	3.6	22.4	1.4	46.7	32.0	13.2	0.0	0.0	32.1	0.1	57.0	29.6	0.1	16.9	42.0	5.0	3.2	16.2	0.0	0.1	0.1	22.8	0.8	0.0	0.0	0.0	4.8	0.0	2.2	0.0	0.0	0.0	9.5	0.0	0.1	41.4	0.0	13.8	0.1	6.0	0.0	0.0	0.0	0.0	4.9	2.1	0.0	0.2	4.6	0.0	0.2	0.0	8.4	0.1	0.0	0.0	3.7	10.5	0.0	7.8	12.7	9.2	4.5	0.0	0.0	20.6	1.5	23.6	2.2	0.7	0.0	0.2	30.4	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	14.9	16.3	8.5	20.9	16.7	10.6	13.0	11.8	11.0	13.1	17.1	13.2	5.9	0.0	0.0	256.0	0.5	2.4	9.7	0.0	1.8	19.3	7.5	7.6	65.0	0.0	0.0	5.5	6.2	0.5	2.7	1.0	1.9	0.0	0.4	2.1	45.2	2.3	21.1	0.0	183.1	0.4	0.5	25.2	2.0	3.3	0.0	35.0	0.0	0.0	0.8	0.0	258.3	9.1	0.0	0.0	2.9	1.3	23.3	0.7	16.0	329.8	0.0	22.5	0.0	21.6	5.5	0.3	0.9	28.2	0.1	10.9	0.1	7.1	0.0	1.9	0.0	4.6	19.6	0.5	6.2	2.9	1.8	0.8	0.5	12.4	3.9	6.3
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205380-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1106.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 246.3;monocytes: 267.6;Muller glia cells: 315.8"	"Cancer enhanced"	"Detected in all"		"glioma: 466.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 78.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	Nucleoplasm	"HPA028356: AB_10602814, HPA070820: AB_2732166"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	190.2	82.2	863.3	121.7	900.6	16.6	142.7	908.1	949.4	110.1	612.5	146.5	31.7	124.5	83.4	119.2	104.2	88.2	241.9	884.6	939.2	112.0	41.2	147.9	75.5	1028.2	1010.2	80.4	39.6	85.4	80.0	102.3	981.5	112.2	58.5	461.4	80.8	119.4	61.1	105.6	64.8	194.6	933.0	103.2	75.8	80.5	915.2	40.7	83.5	84.5	96.9	133.4	110.2	1106.4	139.2	46.8	190.5	82.5	344.5	191.5	63.6	593.2	503.3	471.6	328.5	103.7	72.3	63.4	210.9	729.4	226.6	146.4	71.5	181.7	365.3	34.4	40.2	52.4	32.5	26.7	423.9	17.8	62.0	161.8	100.7	260.2	328.5	259.6	360.7	45.7	55.1	111.8	640.6	68.3	21.0	41.1	127.0	160.9	134.3	34.4	200.6	43.8	173.0	71.0	38.0	100.0	310.4	207.6	179.9	409.4	128.1	122.6	487.7	311.3	246.4	234.4	254.5	88.1	59.5	118.7	287.1	33.2	450.8	1.3	39.3	5.2	8.4	78.2	6.5	18.9	6.2	6.9	56.7	13.5	3.8	4.2	1.8	7.9	38.7	25.0	7.9	14.9	863.3	900.6	908.1	949.4	884.6	939.2	1028.2	1010.2	981.5	933.0	915.2	1106.4	137.8	16.0	29.9	40.5	38.6	80.2	124.2	21.8	33.6	172.1	76.9	60.2	246.3	11.5	24.7	5.5	73.0	21.8	13.7	12.7	29.4	74.7	65.4	36.4	33.7	125.1	12.0	7.4	24.8	46.3	61.1	81.5	17.9	85.9	31.1	17.2	89.3	6.5	63.3	92.5	19.1	12.0	8.2	42.6	234.6	55.4	66.8	68.9	74.7	14.0	267.6	315.8	8.2	12.1	48.3	102.5	4.7	109.9	14.8	119.4	5.4	18.3	13.8	129.2	46.0	69.4	78.3	16.5	4.1	42.7	73.3	45.3	19.4	18.5	12.8	178.8
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.6;Endothelial cells: 30.6;Hepatic stellate cells: 40.0;Leydig cells: 44.4;Peritubular cells: 35.7;Sertoli cells: 26.3;Smooth muscle cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 19.5;HBEC3-KT: 29.9;HHSteC: 21.6;HUVEC TERT2: 52.2;TIME: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		62000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	19.0	5.0	2.5	2.3	3.0	2.3	12.9	1.2	4.1	12.3	2.0	4.5	1.6	10.0	1.1	2.6	9.1	7.4	8.7	1.2	1.7	4.8	2.1	11.8	3.8	2.0	2.3	9.1	2.3	1.7	3.4	11.7	2.3	4.7	0.9	0.4	2.9	3.7	5.7	4.2	4.1	4.6	1.1	7.0	3.7	3.0	2.9	1.4	9.7	7.6	1.1	6.0	7.3	1.4	0.5	2.9	0.8	0.0	0.0	3.7	0.1	11.7	19.5	4.8	2.8	0.3	0.5	0.0	0.6	8.7	0.4	0.2	0.0	29.9	1.3	0.2	0.0	14.8	0.7	0.8	21.6	0.1	0.0	11.3	0.1	6.5	1.5	1.0	52.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	6.9	0.0	0.0	85.2	0.1	6.4	2.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	3.0	1.2	4.1	1.2	1.7	2.0	2.3	2.3	1.1	2.9	1.4	44.6	0.0	3.2	0.0	0.4	0.9	0.1	0.7	1.2	2.4	0.6	1.3	7.5	1.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.2	0.2	2.5	30.6	1.8	5.7	0.0	0.4	0.1	10.1	1.5	0.4	1.3	0.1	40.0	0.4	0.5	0.0	0.0	2.3	0.0	1.6	1.5	3.5	44.4	3.0	5.4	12.2	0.4	0.2	0.0	0.0	0.0	1.2	0.0	35.7	0.0	0.2	0.0	0.1	0.2	0.2	26.3	1.7	34.2	1.5	1.5	0.2	1.1	0.3	0.3	1.1	0.3	0.2
PEDS1-UBE2V1	"CROC-1B, Kua-UEV, TMEM189-UBE2V1"	ENSG00000124208	"PEDS1-UBE2V1 readthrough"		20	50081124-50153637	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"brain: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"					"HPA052535, HPA053186"			Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"		Nucleoplasm		"HPA052535: AB_2681863, HPA053186: AB_2682073"	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.41e-3)"	"unprognostic (2.71e-2)"		"unprognostic (1.52e-1)"	"unprognostic (6.05e-3)"					"unprognostic (2.40e-1)"			"unprognostic (8.19e-2)"	2.1	1.6	3.0	1.7	8.4	0.0	1.5	11.3	5.7	2.3	1.3	1.1	0.2	1.7	0.0	4.1	0.9	0.4	1.6	3.6	6.7	0.7	1.2	1.8	0.7	9.2	7.0	0.8	2.1	2.9	1.0	3.5	10.9	0.7	0.1	0.1	1.7	0.5	2.9	2.9	0.9	0.9	8.0	0.9	1.5	2.7	6.1	1.1	1.0	1.3	0.2	1.6	2.5	12.3	3.8	6.9	2.2	6.5	9.7	6.4	6.8	6.8	4.5	9.1	5.1	15.7	8.3	2.0	8.5	3.7	8.0	16.3	3.6	7.5	1.5	1.0	1.3	2.8	12.2	9.3	4.4	5.2	5.0	6.6	13.6	6.7	2.4	0.6	9.2	0.8	4.9	6.1	4.2	5.3	3.9	0.7	1.8	1.4	1.6	3.5	1.9	3.4	2.5	10.9	3.5	1.4	3.0	13.5	2.3	0.0	3.1	4.5	13.7	10.6	3.8	3.0	4.2	1.5	2.1	0.8	4.6	1.3	7.1	7.7	8.7	11.0	7.6	12.5	6.6	3.6	6.8	7.4	8.4	6.0	6.1	6.6	1.2	7.8	15.2	5.0	7.8	10.8	3.0	8.4	11.3	5.7	3.6	6.7	9.2	7.0	10.9	8.0	6.1	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PEF1	PEF1A	ENSG00000162517	"Penta-EF-hand domain containing 1"	Q9UBV8	1	31629866-31644896	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061608			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		570000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles, Cytosol"		"HPA061608: AB_2684567"	"unprognostic (2.92e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-3)"	57.3	67.1	76.4	28.5	78.6	37.9	56.4	80.1	81.3	56.3	77.8	59.0	31.3	63.3	84.4	62.1	54.6	38.6	63.8	77.9	81.6	69.4	71.3	61.3	38.5	81.9	78.6	50.2	40.9	69.1	52.1	61.4	84.7	59.4	45.1	26.6	39.9	59.1	42.5	85.7	44.0	60.0	79.9	55.9	51.3	40.1	78.9	56.6	110.9	39.3	61.6	61.9	52.2	81.4	56.9	65.0	53.1	41.3	61.2	63.8	51.0	52.8	89.8	124.4	109.0	38.7	83.2	60.2	71.9	118.3	63.9	58.1	103.9	134.5	100.1	76.0	112.6	49.9	49.4	78.6	107.9	49.0	45.3	66.3	152.6	122.0	113.2	79.2	122.2	72.6	52.4	60.6	90.4	67.1	75.6	47.5	74.3	69.7	72.9	72.5	51.7	66.2	98.6	60.8	75.8	43.9	60.2	56.1	81.0	82.9	50.0	35.5	65.7	54.0	46.0	92.7	71.3	38.7	42.2	65.4	67.7	71.8	65.9	147.3	75.6	93.0	90.2	69.4	86.8	70.9	75.5	81.4	77.5	76.4	70.2	70.6	76.2	87.4	67.2	71.4	84.0	104.8	76.4	78.6	80.1	81.3	77.9	81.6	81.9	78.6	84.7	79.9	78.9	81.4	58.2	41.7	37.7	5.9	31.6	36.2	66.6	70.8	29.6	41.2	34.7	36.2	20.4	21.5	35.3	69.9	12.5	160.0	33.9	36.6	113.5	72.0	81.3	17.4	20.0	60.3	44.3	40.0	8.0	61.9	106.1	34.0	21.9	19.8	72.9	34.3	35.3	24.4	61.9	53.8	7.4	49.8	50.8	18.5	21.8	87.5	45.1	27.8	49.8	7.5	81.6	59.6	46.4	6.0	13.8	59.1	44.0	58.6	23.6	65.4	48.9	57.8	23.5	26.5	19.7	25.8	38.8	44.1	44.2	24.6	51.4	182.8	33.6	50.9	39.5	58.3
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 172.1;brain: 348.9;placenta: 467.0"	"Group enriched"	"Detected in many"	11	"Cytotrophoblasts: 2015.8;Syncytiotrophoblasts: 2856.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 773.3;HAP1: 1015.3;Hep G2: 805.0;SCLC-21H: 488.6"	"Region enhanced"	"Detected in all"		"hypothalamus: 110.7"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	3.2	172.1	101.2	2.6	111.9	0.9	24.6	43.7	46.4	7.5	0.0	5.5	0.8	5.6	1.9	2.3	10.0	3.2	1.6	43.5	331.8	7.3	2.4	15.4	5.1	55.2	122.0	65.1	11.4	2.1	88.3	467.0	136.0	2.7	2.0	23.0	9.1	2.6	2.2	0.6	1.5	3.9	32.2	2.0	2.8	41.1	348.9	13.2	11.4	3.3	3.2	3.6	1.6	23.0	22.8	111.6	773.3	329.0	16.0	28.5	45.0	60.7	35.3	42.8	57.3	187.6	37.0	2.5	2.2	70.2	87.5	6.9	1015.3	43.1	58.9	2.9	107.0	0.1	121.8	805.0	12.0	129.6	0.2	63.9	13.9	105.7	73.0	37.1	25.8	0.0	0.5	243.7	84.5	5.8	0.5	0.1	355.4	19.1	70.5	48.5	247.6	67.4	194.3	83.2	488.6	28.2	0.4	16.9	59.9	192.8	105.8	0.3	0.0	33.7	2.0	4.2	46.9	65.2	46.4	97.1	76.3	0.1	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	101.2	111.9	43.7	46.4	43.5	331.8	55.2	122.0	136.0	32.2	348.9	23.0	4.0	153.8	82.4	11.4	37.1	0.8	9.1	2.5	0.6	87.5	49.4	74.3	42.8	5.7	69.8	16.5	8.4	2015.8	3.3	0.9	64.6	18.1	4.5	9.7	3.0	8.4	60.4	0.0	15.8	5.3	205.1	45.3	2.0	15.4	2.5	24.2	4.2	4.7	175.8	37.0	21.9	0.6	8.2	0.0	0.6	18.9	9.0	1.7	14.2	4.7	0.0	109.0	0.0	10.1	12.8	5.2	0.0	4.1	1.5	9.6	0.0	22.0	8.9	29.7	6.6	173.1	23.0	52.9	51.5	2.5	0.9	2856.1	2.6	68.9	0.7	0.6
PEG3	"KIAA0287, ZKSCAN22, ZNF904, ZSCAN24"	ENSG00000198300	"Paternally expressed 3"	Q9GZU2	19	56810077-56840728	"Predicted intracellular proteins, Transcription factors"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 76.9;brain: 218.4;choroid plexus: 177.0;ovary: 260.1;placenta: 135.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 345.8;Granulosa cells: 224.1;Horizontal cells: 148.0;Syncytiotrophoblasts: 477.1;Theca cells: 395.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 103.6;Hep G2: 218.1;RH-30: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026070	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA026070: AB_10603328"	"unprognostic (1.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.48e-5)"	"unprognostic (6.92e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.68e-3)"	2.4	76.9	76.5	1.5	56.5	0.1	10.9	4.4	41.2	8.7	177.0	5.1	0.6	22.8	5.8	2.2	12.9	1.9	3.5	28.7	218.4	3.4	4.5	1.8	0.5	51.9	105.8	260.1	2.5	9.9	28.8	135.1	95.6	3.0	1.7	17.9	5.4	4.9	0.7	1.5	1.4	9.2	27.4	0.8	2.1	33.6	130.4	1.0	5.7	1.8	6.2	3.5	3.3	42.8	0.0	0.0	4.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	218.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.6	0.0	71.7	0.1	0.1	0.1	0.2	6.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	76.5	56.5	4.4	41.2	28.7	218.4	51.9	105.8	95.6	27.4	130.4	42.8	4.1	0.0	4.6	0.0	0.2	4.8	1.9	0.0	4.0	31.0	10.9	17.8	17.2	1.5	1.8	1.8	8.4	345.8	1.6	0.0	1.9	0.9	32.0	1.3	35.0	3.5	0.0	0.0	0.0	0.0	45.4	56.9	0.0	1.6	0.0	224.1	4.6	4.3	34.3	148.0	0.0	0.0	0.0	0.6	1.7	19.4	58.7	1.2	14.2	0.0	0.0	17.0	0.0	0.0	0.0	0.3	0.0	109.9	0.0	2.0	0.0	1.1	2.2	13.7	13.1	29.5	17.0	53.0	36.2	2.0	2.6	477.1	0.2	395.9	0.0	0.7
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144420	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 228.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 224.1;Plasma cells: 318.8;Squamous epithelial cells: 208.0;Suprabasal keratinocytes: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 76.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 76.9;monocytes: 23.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 58.8;U-698: 146.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Approved		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	27.6	7.9	10.2	28.1	14.4	228.5	25.7	11.9	13.5	17.9	9.2	18.6	17.6	17.3	8.6	42.9	12.7	26.1	11.8	13.8	11.2	10.6	13.5	31.0	24.7	12.2	11.2	5.5	9.3	37.9	15.8	15.6	12.2	8.9	20.1	5.1	18.9	7.7	7.1	29.7	23.2	13.9	12.6	21.8	18.1	10.7	10.9	28.3	9.7	10.0	29.0	22.4	23.7	15.6	3.6	2.8	36.5	24.6	4.2	3.2	8.3	4.8	5.4	4.3	6.8	58.8	4.1	48.3	11.3	1.7	1.6	5.8	11.1	10.5	8.6	12.2	8.9	4.4	1.7	9.5	12.4	4.8	8.3	4.2	8.1	6.4	21.6	4.5	24.3	18.2	2.7	11.7	3.7	0.3	10.6	6.9	23.8	11.1	1.7	13.2	12.6	28.1	17.7	10.8	16.7	23.3	3.6	5.5	12.9	11.3	3.0	3.3	17.5	4.0	5.7	4.0	7.1	27.0	2.8	146.7	2.1	4.3	10.9	15.0	15.6	15.0	0.9	14.1	1.7	8.5	4.8	1.9	5.4	6.6	5.6	2.5	76.9	3.0	23.2	0.5	11.6	6.6	10.2	14.4	11.9	13.5	13.8	11.2	12.2	11.2	12.2	12.6	10.9	15.6	94.5	28.9	49.2	4.6	84.4	224.1	74.6	48.2	105.9	1.7	60.9	50.3	5.7	15.7	52.0	5.5	0.0	1.7	16.9	57.9	1.9	5.3	10.6	34.6	26.4	52.1	25.7	3.4	23.4	26.7	8.6	24.5	75.4	58.7	15.2	6.3	37.5	7.5	22.8	3.3	19.1	23.4	30.5	67.6	103.7	11.2	1.5	107.0	112.1	119.9	30.6	5.5	3.1	82.9	67.9	20.9	45.9	1.9	318.8	44.7	32.7	9.6	43.6	2.0	0.0	10.1	51.9	8.4	9.6	208.0	217.5	4.0	49.4	3.2	32.4	145.8
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301524	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.3;Microglial cells: 100.2;Oligodendrocyte precursor cells: 150.8;Oligodendrocytes: 77.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.3;JURKAT: 43.8;MOLT-4: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	11.6	3.0	8.1	4.3	7.8	18.6	7.7	27.9	5.9	6.7	5.4	7.0	11.0	6.7	2.5	4.4	6.3	10.0	2.9	5.6	6.6	9.2	2.8	6.7	4.0	8.8	10.9	15.0	28.6	1.9	2.7	3.1	9.3	4.7	3.9	15.1	7.7	3.5	2.4	5.9	9.2	3.3	8.0	6.8	14.4	10.0	10.4	19.1	4.1	3.8	2.0	10.6	5.7	9.2	0.1	3.1	8.8	0.0	4.8	7.2	0.2	1.2	4.2	0.9	0.1	0.2	0.7	0.2	4.2	2.5	0.0	0.9	6.9	0.0	0.4	2.3	2.4	7.9	13.0	0.0	4.1	1.1	33.3	4.5	0.4	0.0	0.0	4.8	1.6	43.8	6.0	0.1	0.9	0.0	39.5	0.4	14.5	0.1	1.2	19.2	0.5	1.8	3.6	15.4	17.5	0.0	0.8	0.1	10.2	5.5	0.0	6.3	0.5	2.6	4.4	0.8	4.4	0.7	0.1	1.0	4.6	5.4	2.6	0.9	1.9	2.4	0.3	1.0	0.5	0.1	0.3	0.2	1.3	0.4	0.2	0.1	5.6	0.3	0.8	0.3	0.0	0.7	8.1	7.8	27.9	5.9	5.6	6.6	8.8	10.9	9.3	8.0	10.4	9.2	13.9	0.0	10.0	114.3	7.7	14.3	10.4	1.7	9.6	30.7	7.1	7.7	2.7	8.6	6.7	12.9	29.2	0.1	11.8	15.0	3.9	5.9	3.7	23.7	14.5	18.0	7.2	5.5	13.5	14.1	0.1	13.5	34.1	21.2	5.7	5.7	17.5	1.0	1.2	21.9	22.1	7.9	2.0	19.7	14.0	5.7	17.1	20.3	17.8	100.2	22.9	9.7	10.3	150.8	77.5	9.1	6.0	18.0	5.6	7.8	12.4	10.1	8.8	19.7	13.1	5.4	22.0	2.0	24.0	4.7	18.3	0.1	6.2	5.6	3.1	12.6
PELI3	MGC35521	ENSG00000174516	"Pellino E3 ubiquitin protein ligase family member 3"	Q8N2H9	11	66466327-66477337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 26.5;Horizontal cells: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033750, HPA038875, HPA062281"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Vesicles"	Nucleoli	"CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735"	"unprognostic (1.15e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.01e-2)"	7.5	10.2	19.1	2.6	18.7	1.2	7.7	21.1	33.2	12.4	4.4	15.3	3.2	13.9	5.6	6.9	11.2	6.8	8.8	20.5	15.0	6.2	4.2	5.5	3.2	22.7	17.2	13.5	8.2	11.7	13.4	2.4	23.6	14.6	1.7	5.5	8.7	14.8	18.3	7.7	6.3	5.6	13.9	5.1	9.4	7.6	19.5	1.0	6.3	4.6	1.5	14.7	9.1	19.8	20.2	8.1	6.5	5.0	10.2	4.0	5.6	6.2	8.0	5.7	4.9	11.8	4.3	5.0	6.1	6.9	10.3	10.2	4.0	7.8	2.4	9.6	4.1	1.3	7.2	3.5	6.4	1.0	9.2	3.8	8.6	5.8	2.1	8.3	1.2	6.4	2.3	7.2	2.5	11.5	4.2	3.0	3.9	10.2	8.4	13.6	4.7	5.2	3.2	6.3	7.9	4.4	3.2	8.8	21.6	2.8	10.3	5.3	3.4	5.0	7.6	21.7	5.4	6.9	4.2	2.7	10.6	3.1	4.1	0.5	1.0	0.2	1.0	0.8	0.8	1.2	0.8	1.2	1.4	1.5	0.9	0.7	0.0	0.5	3.4	0.4	1.0	0.6	19.1	18.7	21.1	33.2	20.5	15.0	22.7	17.2	23.6	13.9	19.5	19.8	5.0	6.4	2.0	2.0	0.7	1.7	3.8	0.9	4.0	13.3	3.0	4.4	8.1	4.3	0.6	0.0	10.4	2.5	0.4	0.6	1.9	3.2	5.0	0.4	2.6	2.7	26.5	0.0	7.1	2.5	2.1	4.2	2.0	1.1	0.0	2.9	3.3	2.8	3.3	21.9	7.7	1.4	2.0	1.9	1.4	10.4	7.5	2.9	0.0	1.9	2.8	7.5	0.0	2.0	2.5	1.8	1.4	9.8	1.0	2.5	0.9	2.9	0.2	9.7	6.6	3.1	4.9	3.0	3.5	1.8	0.3	0.3	1.3	1.5	0.8	1.5
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"		"HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355"	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.2	17.8	34.9	13.4	34.1	10.9	14.9	29.9	33.1	19.9	21.2	18.3	11.8	21.5	6.2	19.5	19.8	8.8	23.1	33.4	30.7	16.8	17.7	13.1	16.3	34.2	33.3	21.9	17.5	15.5	23.5	11.4	33.8	20.5	7.5	8.7	15.3	12.2	46.8	18.7	17.4	10.8	31.8	20.5	17.5	32.8	33.6	12.5	17.2	18.1	12.0	19.5	17.0	33.9	41.8	89.8	34.8	55.3	26.5	19.5	77.9	29.6	20.5	40.1	42.7	88.1	30.0	100.0	44.4	23.4	28.5	62.6	65.1	46.3	22.6	52.1	93.2	44.6	45.1	72.0	34.2	36.4	57.5	23.9	28.2	49.5	41.3	20.7	30.2	52.9	54.7	42.6	22.4	57.2	68.9	42.7	57.3	40.2	29.7	71.7	30.8	49.3	28.2	31.2	34.8	46.5	50.8	36.9	39.4	33.1	44.6	24.3	30.7	30.9	43.5	47.3	57.9	22.7	42.5	41.6	34.9	37.1	40.6	0.2	0.7	2.0	0.9	1.0	0.9	0.8	0.9	0.7	0.8	1.3	0.9	1.3	0.2	1.3	1.2	1.1	0.6	0.7	34.9	34.1	29.9	33.1	33.4	30.7	34.2	33.3	33.8	31.8	33.6	33.9	10.4	22.4	30.1	11.1	18.5	14.8	14.8	15.7	21.1	24.0	13.5	12.4	22.6	8.6	20.9	9.2	16.7	30.9	15.3	11.8	1.9	15.9	64.7	16.6	17.3	13.7	12.6	14.1	10.6	14.6	28.3	16.6	16.8	17.6	30.9	21.1	5.0	10.6	16.9	35.3	13.0	18.6	12.2	6.0	20.4	27.0	9.3	10.4	10.6	5.6	65.1	10.7	5.2	5.0	11.5	11.4	11.7	19.2	23.6	19.3	8.3	4.7	22.3	17.8	6.6	16.8	14.8	31.3	67.5	20.0	16.3	21.2	17.4	16.6	21.9	13.0
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 209.5;kidney: 277.7"	"Group enriched"	"Detected in all"	4	"Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		860000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	53.2	56.0	28.5	26.9	35.5	14.3	43.6	35.6	30.5	36.9	33.5	44.2	180.5	49.7	9.9	42.8	34.2	31.2	24.3	28.7	30.9	277.7	117.8	38.1	30.7	36.2	30.8	35.9	27.1	29.3	42.5	21.9	36.3	23.6	14.8	11.8	33.6	22.9	35.6	43.1	209.5	24.5	34.6	38.2	33.6	18.3	33.4	20.8	37.0	23.2	21.3	40.1	28.2	43.4	43.2	118.7	26.4	53.1	114.9	44.9	80.6	37.4	65.3	45.6	52.7	104.7	34.2	18.8	53.5	73.2	33.9	11.2	39.5	28.5	23.4	51.3	50.4	107.7	24.6	108.3	91.6	29.6	128.8	63.6	29.0	38.2	18.3	27.8	56.4	34.4	22.7	49.4	44.2	54.3	19.0	11.7	46.2	79.6	48.8	45.3	41.0	51.2	39.4	108.8	40.3	106.4	64.2	31.3	62.5	18.2	25.1	36.3	56.6	48.3	46.6	62.3	41.8	45.2	59.1	13.1	49.5	48.2	65.8	113.7	117.2	8.3	75.5	123.6	65.5	49.6	74.0	69.8	100.6	50.5	47.1	55.6	6.1	55.6	92.5	31.0	76.1	119.6	28.5	35.5	35.6	30.5	28.7	30.9	36.2	30.8	36.3	34.6	33.4	43.4	56.9	22.4	27.4	11.4	29.0	19.4	32.9	36.0	11.4	33.3	16.2	24.4	13.3	52.9	23.8	73.5	4.2	21.4	32.6	17.6	197.6	77.2	8.0	15.0	20.1	50.7	17.3	25.4	19.9	44.2	67.3	38.6	18.3	13.0	57.6	41.9	52.8	180.3	227.2	62.2	14.9	35.6	30.5	59.7	40.9	13.2	49.4	75.3	67.6	15.9	102.2	73.6	34.0	21.6	24.3	33.8	79.3	60.5	31.5	22.9	833.0	1278.3	27.1	33.7	39.5	37.0	43.1	10.2	44.5	34.3	20.3	30.4	33.7	48.7	44.6	22.2
PER1	"PER, RIGUI"	ENSG00000179094	"Period circadian regulator 1"	O15534	17	8140472-8156506	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 49.8;hTCEpi: 56.6;hTERT-HME1: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047947, HPA067064"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA047947: AB_2680219, HPA067064: AB_2685774"	"unprognostic (7.64e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.21e-3)"	"unprognostic (6.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-2)"	128.3	73.3	17.6	36.6	19.1	53.3	113.2	25.5	27.3	85.1	25.9	99.2	10.4	63.9	6.2	61.9	101.8	36.6	88.2	18.9	21.4	56.2	73.5	95.5	18.3	19.4	20.6	168.5	103.7	49.5	103.3	20.5	17.7	83.9	11.7	22.0	62.5	27.9	211.8	182.2	58.0	30.6	16.1	54.6	82.5	35.8	18.0	12.8	100.1	67.3	11.5	81.0	90.6	25.7	2.2	8.2	9.4	13.4	29.8	21.7	5.2	3.4	5.9	4.1	4.8	8.3	5.4	15.6	2.5	4.7	4.4	6.7	9.4	49.8	2.9	4.9	11.7	8.4	18.5	2.6	40.7	3.3	11.9	33.8	56.6	7.0	54.9	5.4	9.0	11.9	10.9	21.0	7.5	7.6	9.6	6.8	7.9	2.6	5.4	13.2	5.3	8.3	9.7	1.8	4.0	9.9	6.9	7.9	6.6	3.8	5.8	2.5	15.5	4.7	8.7	1.8	2.8	12.7	5.1	5.3	6.3	4.1	3.3	0.0	1.2	0.6	0.6	0.9	0.7	0.3	0.5	0.4	1.8	0.6	0.5	0.3	1.2	0.2	0.4	0.2	0.4	0.5	17.6	19.1	25.5	27.3	18.9	21.4	19.4	20.6	17.7	16.1	18.0	25.7	88.8	54.5	78.5	24.8	47.6	53.2	38.9	31.5	118.9	37.7	39.2	37.5	24.4	51.5	37.7	27.6	98.0	5.9	63.9	16.8	5.9	6.5	28.2	48.3	23.6	39.4	50.2	50.9	18.7	4.0	4.0	50.5	60.1	54.4	70.2	11.9	40.7	48.8	19.7	20.2	9.9	22.9	16.2	59.2	70.1	52.4	41.0	91.5	48.0	15.0	12.1	40.0	3.1	8.0	5.6	8.5	21.7	33.8	55.4	34.4	38.9	6.3	48.7	49.2	32.9	89.3	47.1	6.6	10.0	63.0	59.8	13.5	84.4	12.8	16.4	19.9
PER2	KIAA0347	ENSG00000132326	"Period circadian regulator 2"	O15055	2	238244044-238290102	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053136, HPA060510"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA053136: , HPA060510: AB_2684298"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.22e-2)"	12.2	3.3	4.7	5.0	5.2	8.4	14.2	7.2	5.8	11.9	2.4	7.6	5.1	10.2	5.7	13.6	7.9	12.3	5.7	5.7	5.1	3.9	12.4	7.1	4.7	5.2	5.7	7.8	14.4	4.2	9.0	2.9	4.4	9.3	6.2	5.1	14.1	8.9	11.4	17.0	8.0	4.9	5.4	4.8	13.4	11.8	4.7	4.1	8.8	7.6	6.2	8.7	8.2	4.7	1.6	11.7	2.4	4.2	0.1	1.2	8.2	1.1	4.1	1.5	1.4	1.8	5.8	10.3	1.2	2.7	1.5	8.6	2.4	3.5	2.2	2.9	1.7	9.1	6.2	8.2	2.0	13.8	9.2	1.6	8.3	1.8	6.1	1.5	0.8	4.2	4.5	6.3	1.3	7.7	6.9	15.2	3.5	7.6	2.3	16.5	5.5	3.3	1.5	3.3	9.7	1.2	2.9	6.3	1.8	0.7	5.9	8.5	2.1	3.6	4.2	2.8	4.1	7.1	1.8	12.3	6.7	5.9	4.5	2.1	1.2	0.3	1.0	2.2	1.6	1.5	1.6	1.2	1.4	1.5	1.5	1.6	1.0	1.2	2.1	1.8	1.2	0.3	4.7	5.2	7.2	5.8	5.7	5.1	5.2	5.7	4.4	5.4	4.7	4.7	24.9	16.0	30.1	18.6	9.9	73.9	61.7	21.3	38.1	20.6	67.8	33.8	5.7	31.5	46.9	27.6	2.1	9.2	27.0	22.5	7.9	7.5	9.6	69.7	30.1	15.6	24.6	6.9	20.9	10.4	6.3	39.8	52.5	86.1	9.5	3.3	11.4	35.8	3.9	11.8	13.9	35.1	18.3	10.1	25.3	4.7	11.1	12.4	24.9	5.6	5.3	13.5	2.1	9.0	7.2	7.6	35.3	18.4	10.9	15.0	10.9	5.5	44.2	7.8	6.6	110.1	32.2	31.3	17.0	38.4	85.4	13.0	13.6	3.7	36.9	33.9
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavorable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	33.3	41.0	26.3	29.2	28.6	35.5	32.2	26.7	30.5	31.8	27.1	29.6	21.7	35.5	21.2	43.6	29.4	20.2	28.8	26.9	26.2	38.7	48.2	26.2	32.3	27.1	27.2	34.2	57.3	30.1	21.8	21.5	27.6	32.9	19.6	9.2	29.3	21.5	48.8	45.3	28.2	22.5	25.8	34.4	35.7	40.0	27.0	23.8	27.1	20.0	27.3	35.0	31.9	30.0	132.2	146.6	53.0	113.7	59.9	58.4	81.6	84.7	69.6	141.6	110.0	170.6	55.2	177.2	74.4	97.0	110.3	89.4	163.9	153.5	103.1	76.4	159.8	85.9	80.8	149.0	149.3	209.6	86.8	82.7	94.7	148.3	147.3	68.3	93.0	62.4	144.6	69.9	87.7	164.3	102.6	209.8	103.1	128.3	106.7	129.0	91.7	173.3	78.9	88.7	91.4	94.6	84.2	94.6	117.8	42.0	66.8	106.1	74.2	165.9	126.1	85.3	145.1	88.1	81.0	178.6	116.2	94.9	109.0	7.5	24.9	6.4	18.9	29.8	23.2	20.2	17.4	18.1	26.8	20.0	19.4	18.0	0.9	20.0	22.3	23.2	14.3	29.3	26.3	28.6	26.7	30.5	26.9	26.2	27.1	27.2	27.6	25.8	27.0	30.0	23.6	3.2	18.9	4.9	17.4	22.6	23.4	32.7	22.2	6.5	14.1	12.2	3.8	24.3	22.1	25.8	8.4	34.9	7.8	19.6	25.4	48.0	44.4	11.7	13.8	23.2	23.4	24.6	4.3	43.9	40.0	15.4	22.4	10.6	18.3	24.4	27.8	22.8	38.4	3.3	4.3	22.4	22.4	27.8	12.6	14.3	19.9	21.2	21.4	2.8	29.0	13.5	16.5	6.6	5.1	38.7	16.2	20.3	28.3	26.4	31.3	55.1	24.6	8.9	19.7	23.2	20.7	28.7	20.9	25.9	22.9	28.5	13.5	19.9	29.7	15.1
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 194.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA049458: AB_2680775, HPA049755: AB_2680867"	"prognostic favorable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.9	28.9	22.2	2.2	24.3	3.1	13.9	23.5	25.7	10.8	19.7	11.3	6.7	11.4	8.5	17.2	10.0	4.2	16.1	20.6	21.6	18.1	22.0	8.8	4.3	25.4	22.6	12.8	19.8	10.4	18.5	3.8	22.1	16.1	4.4	4.6	14.3	6.9	18.6	14.0	9.6	4.1	23.4	10.2	12.7	22.0	23.3	3.7	13.1	10.2	3.4	12.9	11.3	25.3	18.6	16.9	13.2	7.4	7.9	9.7	11.5	9.6	10.9	14.2	11.3	27.2	13.9	10.8	27.1	11.9	8.7	12.1	11.6	16.3	8.1	16.8	21.9	8.5	17.2	55.3	16.4	14.2	4.2	9.0	9.3	10.8	16.0	10.4	13.9	12.5	9.9	7.4	14.7	26.2	9.1	6.0	9.6	8.0	31.3	7.8	13.8	18.9	17.8	6.3	18.2	15.3	13.0	8.2	29.2	7.1	8.3	3.5	14.8	6.7	5.9	17.2	10.8	19.0	7.6	8.6	17.6	10.9	6.1	1.6	5.8	1.7	3.8	8.7	4.4	5.9	3.3	5.1	9.4	4.9	3.8	3.0	0.6	3.6	7.6	7.8	2.1	4.2	22.2	24.3	23.5	25.7	20.6	21.6	25.4	22.6	22.1	23.4	23.3	25.3	12.8	3.2	4.4	3.3	9.5	8.8	13.7	15.4	15.9	16.8	16.4	15.4	1.1	11.5	8.9	14.7	0.0	26.7	6.7	8.3	35.2	26.8	51.7	8.5	9.0	11.2	13.2	9.2	5.1	30.3	25.2	11.5	12.8	10.3	0.0	22.8	7.5	10.5	22.9	13.5	5.6	10.3	12.2	11.2	7.2	194.7	10.5	9.6	23.2	2.8	18.7	45.2	8.2	8.0	6.7	21.0	7.7	13.5	14.9	14.6	17.5	27.8	8.6	14.8	0.0	15.5	10.9	28.9	22.8	22.4	6.1	27.5	6.9	30.2	14.6	14.1
PEX11B		ENSG00000131779	"Peroxisomal biogenesis factor 11 beta"	O96011	1	145911350-145918717	"Disease related genes, Predicted membrane proteins"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017150, HPA050104"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA017150: , HPA050104: AB_2681017"	"unprognostic (4.59e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.67e-4)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.62e-3)"	"unprognostic (4.28e-1)"	17.5	25.1	34.7	19.0	35.8	13.3	31.2	32.5	42.5	24.6	33.3	24.9	24.6	23.4	33.1	34.3	25.7	17.0	28.0	36.3	38.1	32.4	27.1	20.1	27.4	33.3	33.0	24.6	27.2	33.5	24.5	23.1	35.1	24.3	27.6	20.2	28.7	25.6	39.8	28.1	25.9	21.0	31.6	27.7	28.3	30.8	34.1	30.2	26.4	34.9	34.7	23.2	22.2	34.2	27.1	24.4	21.0	21.1	48.6	37.9	21.9	26.8	35.3	34.4	26.5	11.3	30.7	25.2	28.1	38.3	16.6	31.9	18.6	40.0	24.0	28.4	14.1	15.6	14.8	29.2	68.3	46.9	27.5	49.9	49.3	23.3	22.8	43.9	44.5	34.8	28.7	40.5	54.7	43.1	35.8	43.5	7.5	57.4	29.5	33.0	31.5	55.5	58.8	19.1	14.7	24.0	20.2	38.4	24.7	20.5	53.2	72.0	39.7	23.1	18.2	30.3	19.8	43.1	54.0	35.1	38.5	26.3	16.0	89.6	64.7	47.3	58.5	60.9	64.8	93.2	67.5	65.4	70.8	84.1	74.7	67.9	32.4	71.1	60.5	94.9	79.6	82.7	34.7	35.8	32.5	42.5	36.3	38.1	33.3	33.0	35.1	31.6	34.1	34.2	5.0	16.0	10.3	9.8	17.0	19.4	9.2	41.3	26.7	8.0	16.8	17.0	12.8	17.2	20.7	40.5	0.0	37.9	19.6	20.2	45.0	13.7	12.2	8.2	7.0	12.3	12.7	14.1	13.0	13.8	13.9	11.1	19.4	7.4	3.8	9.3	18.2	32.9	23.0	5.0	13.5	16.0	20.3	18.3	10.7	21.1	14.0	12.9	21.4	4.7	27.1	12.6	25.7	9.5	12.9	16.0	11.4	19.9	17.4	10.1	20.1	34.5	22.9	5.1	6.6	5.8	10.3	41.1	24.3	34.0	22.0	20.0	13.8	11.6	15.8	9.4
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450805-143490616	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	8.7	38.4	4.4	7.6	4.8	3.2	11.8	4.5	5.6	11.7	7.3	7.5	6.0	9.8	12.5	17.8	9.6	7.3	12.6	4.2	5.3	18.3	24.4	7.9	8.8	3.6	3.4	10.7	6.7	24.4	9.0	9.4	3.9	11.7	6.2	10.0	10.6	11.2	11.6	12.8	7.4	8.9	3.9	7.2	9.7	12.2	3.6	8.3	15.5	9.6	9.5	8.9	13.4	7.5	21.4	4.6	11.0	21.1	17.8	15.6	12.2	17.8	13.8	23.7	28.3	31.5	12.8	31.7	21.1	17.4	27.8	17.3	14.4	23.9	30.8	19.4	16.5	22.8	10.2	20.0	15.0	38.7	9.6	18.1	16.6	22.4	17.2	10.3	13.0	18.5	21.1	15.7	24.0	14.1	20.2	15.3	6.1	12.6	18.2	15.3	22.2	14.0	28.0	9.2	15.3	5.3	23.0	19.3	14.7	9.5	10.2	12.7	10.3	16.7	15.9	26.9	20.9	10.7	16.4	36.1	21.1	26.0	13.3	12.9	6.3	6.4	15.5	10.1	17.2	23.2	16.3	15.5	9.9	18.6	21.1	20.7	1.0	15.6	13.4	10.6	21.2	9.8	4.4	4.8	4.5	5.6	4.2	5.3	3.6	3.4	3.9	3.9	3.6	7.5	13.1	16.0	14.4	23.8	19.7	26.6	12.7	19.2	14.8	14.5	9.9	11.8	14.8	5.7	19.0	9.2	4.2	41.7	9.0	4.1	19.6	12.3	12.6	15.2	10.4	12.0	6.0	5.9	61.0	9.5	11.6	13.5	10.2	13.1	25.3	9.6	13.6	20.5	11.5	16.8	67.4	5.4	16.2	7.6	6.6	4.9	13.7	6.0	8.8	28.1	8.0	15.4	10.3	40.7	59.6	9.6	2.3	11.3	18.1	6.6	8.2	28.8	27.2	12.1	6.6	12.2	13.6	80.0	18.5	20.2	34.8	58.7	13.7	20.9	7.6	8.5
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963865-42979181	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	11.6	20.5	24.9	9.2	25.2	9.5	12.1	23.9	27.7	19.1	25.5	16.3	9.3	15.5	7.7	16.4	22.7	9.6	18.7	25.1	25.5	16.5	27.7	10.0	14.5	27.2	25.5	26.1	76.2	15.2	24.3	9.6	24.2	21.6	7.8	9.9	14.8	11.4	23.4	14.0	16.3	9.6	23.9	17.5	16.3	16.2	25.1	14.7	19.8	15.0	10.4	17.3	15.7	25.2	35.0	16.4	8.1	30.6	29.6	28.3	8.4	6.0	9.4	4.8	10.0	10.5	10.1	14.1	8.2	14.3	20.5	32.2	28.7	31.1	5.0	27.6	15.2	4.7	24.4	6.2	20.0	4.8	9.4	35.5	35.5	19.9	5.5	39.1	24.7	18.9	25.2	14.1	10.7	3.9	12.7	15.8	10.0	78.8	14.3	26.8	14.3	5.8	12.3	10.0	25.4	11.1	5.6	21.9	32.7	13.1	43.2	21.2	14.0	15.2	2.9	7.5	14.0	21.0	19.8	19.7	5.2	24.6	12.4	1.3	1.3	2.1	1.2	1.1	2.1	1.0	1.8	2.5	1.9	1.9	2.2	2.1	0.8	2.0	0.7	1.0	0.9	1.1	24.9	25.2	23.9	27.7	25.1	25.5	27.2	25.5	24.2	23.9	25.1	25.2	5.6	6.4	2.6	19.9	5.6	5.0	10.2	6.2	10.8	15.2	11.8	12.7	4.1	10.0	5.6	7.3	2.1	11.4	5.4	10.2	13.7	2.8	2.5	17.6	10.6	5.8	5.4	1.7	24.6	1.5	6.7	9.2	11.2	9.1	0.0	19.8	8.6	14.1	5.8	21.9	22.4	8.5	6.1	9.7	3.2	3.6	14.6	5.4	8.8	9.4	4.5	11.8	9.2	13.0	16.6	1.9	10.4	9.4	3.1	6.3	15.1	13.9	14.3	7.0	0.0	13.0	6.6	7.3	2.6	6.3	5.5	7.4	7.8	26.1	10.5	6.6
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913934	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.2	14.8	4.6	2.0	4.8	3.8	11.9	6.0	5.2	6.8	5.1	7.9	5.3	4.2	17.2	7.3	8.7	4.5	11.7	4.2	4.2	15.6	9.1	4.9	3.2	4.3	4.4	5.0	26.9	17.1	6.0	4.1	4.5	10.4	8.4	6.9	10.6	6.4	10.7	11.2	4.7	3.3	4.4	3.3	15.6	10.0	4.7	3.7	11.0	9.8	3.3	5.4	6.7	5.5	4.4	4.3	4.4	6.2	6.6	9.8	2.4	6.1	8.9	7.5	7.4	4.9	6.0	1.5	11.3	8.3	8.5	5.3	3.3	13.8	9.8	5.7	7.5	6.4	4.3	0.9	13.9	8.1	5.3	9.6	13.1	5.4	7.9	8.7	5.4	12.0	13.0	5.2	10.6	13.4	3.5	7.9	5.0	13.9	8.3	4.8	3.4	5.7	17.4	6.4	8.3	10.6	6.5	9.0	8.4	4.9	5.8	7.7	2.5	4.8	1.7	7.3	5.3	6.9	5.1	0.0	4.2	6.4	4.9	2.9	1.3	2.2	0.7	1.0	0.7	1.5	1.3	1.6	2.3	1.0	2.4	1.5	0.9	1.6	1.9	1.8	2.3	0.9	4.6	4.8	6.0	5.2	4.2	4.2	4.3	4.4	4.5	4.4	4.7	5.5	4.9	3.2	9.4	10.7	6.3	12.1	14.9	16.5	9.1	9.1	19.5	13.8	18.7	11.5	14.7	11.0	8.4	19.6	2.3	11.6	60.7	16.5	12.5	18.7	6.4	5.6	10.3	15.8	12.4	22.7	21.0	6.8	10.2	11.1	14.0	7.9	6.1	7.0	12.4	0.0	14.7	21.8	30.5	5.7	6.2	10.2	9.0	6.4	14.2	5.6	11.9	20.8	4.1	17.6	19.9	16.7	13.2	9.8	3.7	16.0	15.0	38.3	16.1	9.9	6.6	5.7	8.2	30.6	16.7	15.4	18.2	17.1	6.6	24.3	17.2	17.4
PFDN6	"H2-KE2, HKE2, KE-2, PFD6"	ENSG00000204220	"Prefoldin subunit 6"	O15212	6	33289302-33298401	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 220.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043032, HPA048123"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		89000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA043032: AB_2678278, HPA048123: AB_2680273"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (6.93e-2)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.68e-3)"	45.3	78.2	23.7	13.7	24.4	12.9	45.4	24.2	27.3	49.2	22.6	55.9	9.3	54.8	14.2	70.2	46.2	6.7	85.1	24.4	24.4	78.8	98.1	41.7	15.9	24.6	24.6	45.3	51.7	14.4	62.7	13.6	24.7	51.0	11.6	8.6	47.6	8.0	129.3	49.6	45.3	9.9	23.7	49.9	58.4	91.4	24.0	17.1	45.6	14.7	17.0	55.6	46.7	25.2	49.4	36.0	34.9	56.7	22.7	17.3	43.4	37.2	20.6	48.0	48.7	42.6	24.0	102.8	43.1	20.5	83.5	42.2	69.5	47.6	58.3	49.3	52.9	89.8	39.4	78.3	33.2	56.3	49.3	20.7	50.9	64.8	41.6	28.5	40.2	61.2	107.2	29.6	36.7	36.0	73.9	58.7	47.7	33.0	37.6	71.9	38.0	65.2	58.9	23.4	61.3	83.9	32.1	83.3	61.3	35.0	44.4	65.0	22.5	24.7	36.0	26.0	68.7	71.2	220.3	89.4	20.5	71.9	38.1	1.8	2.6	1.8	1.9	3.2	2.1	3.3	2.3	3.1	2.4	3.2	1.8	2.5	1.1	2.1	3.5	3.5	3.5	1.9	23.7	24.4	24.2	27.3	24.4	24.4	24.6	24.6	24.7	23.7	24.0	25.2	17.4	25.6	8.7	5.2	49.1	55.7	45.2	92.6	43.9	24.5	30.2	17.1	20.7	60.1	51.6	55.2	10.4	127.5	37.6	90.0	121.3	87.6	94.2	106.5	64.7	30.6	50.4	48.4	4.3	103.8	126.1	32.6	44.4	66.9	61.6	32.9	19.2	74.0	79.2	18.5	4.1	75.7	87.5	35.4	45.2	42.7	61.8	37.2	71.2	2.8	66.3	51.0	50.4	1.5	7.1	88.0	71.3	49.2	55.3	53.9	76.4	210.0	53.0	29.0	39.5	43.6	96.3	208.2	60.4	64.3	63.9	110.8	36.9	47.4	82.7	46.7
PFKFB2		ENSG00000123836	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2"	O60825	1	207034366-207081024	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 83.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.1;Cardiomyocytes: 79.0;Late spermatids: 158.2;Rod photoreceptor cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 20.8;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 23.8;granulocytes: 20.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049975, HPA063575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA049975: AB_2680977, HPA063575: AB_2685046"	"unprognostic (1.30e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.96e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.23e-7)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (1.86e-2)"	4.3	6.8	13.2	8.3	14.5	23.5	6.4	8.6	15.2	9.1	42.5	22.2	32.2	5.0	11.6	9.6	5.7	5.8	36.0	13.9	11.4	29.7	4.0	13.3	7.0	13.3	13.8	5.2	16.0	15.3	23.1	3.9	12.2	4.8	24.1	83.3	7.6	4.1	49.5	8.1	22.2	5.0	9.7	15.0	15.5	7.0	19.3	20.2	51.7	42.7	6.7	4.2	4.2	18.4	15.0	6.5	4.2	7.3	8.4	4.1	6.9	2.1	2.5	3.6	2.0	16.0	21.1	2.7	3.3	3.3	10.8	20.8	3.1	7.9	2.1	0.6	3.2	21.1	17.4	5.9	7.0	0.0	14.2	5.9	11.7	3.5	19.1	4.3	0.8	8.7	14.6	0.1	2.0	4.5	3.6	0.6	5.8	7.2	9.7	0.0	0.0	0.4	4.9	15.3	6.6	4.0	13.7	22.8	17.4	4.5	15.6	1.8	0.4	0.0	7.6	11.0	1.9	6.6	7.0	1.4	8.8	0.0	3.9	1.6	1.2	20.8	0.3	2.6	0.4	1.9	0.2	0.4	1.1	2.3	0.5	0.6	3.5	1.6	1.9	23.8	0.0	0.7	13.2	14.5	8.6	15.2	13.9	11.4	13.3	13.8	12.2	9.7	19.3	18.4	1.0	6.4	54.8	105.1	5.0	15.2	3.8	5.0	10.2	7.0	3.7	4.2	79.0	4.3	8.7	16.5	0.0	0.7	24.6	53.8	25.4	5.0	51.0	18.0	3.7	4.2	6.0	0.8	14.5	7.6	0.4	4.6	14.8	21.3	9.5	2.3	2.5	5.8	5.6	3.3	13.0	20.1	8.2	13.6	4.9	158.2	2.8	8.5	21.4	11.2	5.4	9.8	5.2	4.5	10.6	16.6	26.2	3.0	3.8	13.5	45.4	32.8	15.3	110.5	0.0	3.3	3.1	5.1	3.2	9.9	11.6	1.5	1.6	7.5	36.9	11.5
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 334.6;skeletal muscle: 621.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Collecting duct cells: 195.0;Langerhans cells: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 26.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 296.2;RPTEC TERT1: 181.8;T-47d: 192.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	334.6	22.7	66.1	72.2	81.2	246.0	153.8	75.4	66.6	30.2	22.1	22.2	19.4	24.0	11.1	51.3	37.7	59.9	21.9	62.8	105.8	243.9	32.8	67.7	24.5	145.7	100.9	24.2	21.0	10.1	39.6	20.0	100.9	20.2	8.9	31.5	40.4	49.5	621.3	53.6	22.9	16.9	90.1	50.2	26.1	13.9	91.8	15.1	10.9	30.4	28.2	63.9	40.3	105.6	22.0	296.2	23.1	18.8	85.2	10.5	12.2	31.6	22.5	22.9	35.5	14.1	78.0	37.2	20.2	13.8	18.0	69.0	24.9	50.2	26.3	44.6	17.3	22.1	16.2	5.2	7.2	21.6	32.2	7.6	16.4	39.5	9.5	58.3	44.9	25.6	16.6	13.6	18.6	35.7	15.3	20.3	22.5	31.1	20.5	34.3	11.3	14.7	181.8	11.1	21.9	8.9	22.9	24.7	45.8	39.5	192.0	25.2	57.0	23.9	22.0	3.1	38.7	27.8	10.4	33.7	65.8	25.0	37.4	2.9	7.5	7.7	2.2	9.2	5.7	1.8	4.2	2.9	4.7	1.6	3.0	3.0	26.4	1.2	5.5	2.9	4.3	4.3	66.1	81.2	75.4	66.6	62.8	105.8	145.7	100.9	100.9	90.1	91.8	105.6	37.1	76.9	55.1	153.8	27.2	102.6	16.7	21.5	37.5	6.4	37.1	36.8	19.5	22.8	32.1	195.0	52.1	0.4	37.0	14.9	0.0	54.7	5.0	41.1	18.9	32.9	8.5	1.3	42.8	25.7	6.9	30.8	33.1	64.3	44.2	72.5	8.9	15.8	20.6	6.7	19.4	6.6	18.3	88.0	132.3	9.5	2.8	122.2	46.2	41.2	19.6	0.3	4.1	14.1	31.9	59.6	5.2	7.2	25.3	4.2	5.4	2.4	19.2	1.9	0.0	58.5	24.4	0.6	2.5	20.9	63.9	1.0	61.7	12.4	8.1	14.7
PGAM1	"PGAM-B, PGAMA"	ENSG00000171314	"Phosphoglycerate mutase 1"	P18669	10	97426191-97433444	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 791.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042528, HPA060483"	Approved		Supported	Nucleoplasm		NA	NA		120000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.64e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.74e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.61e-3)"	149.0	294.7	228.7	153.6	249.7	180.0	122.1	252.9	265.0	184.3	275.1	162.9	151.5	153.7	98.6	436.7	117.2	106.6	275.7	256.1	266.0	167.6	182.5	121.7	165.7	241.7	242.7	133.3	81.8	191.3	150.8	156.6	280.9	107.3	141.9	420.7	164.7	156.5	56.5	206.9	141.4	177.9	228.3	139.6	133.2	87.5	278.8	124.9	86.9	70.2	229.7	186.6	233.3	224.7	1160.6	538.9	364.0	697.9	336.7	307.7	494.1	722.4	938.4	830.2	1148.3	589.4	335.4	609.1	482.7	619.2	333.4	706.8	639.8	1051.4	998.1	567.2	611.7	393.6	386.4	667.5	248.4	570.0	503.9	303.2	422.5	552.7	408.7	1118.9	610.8	447.2	262.0	334.0	884.8	478.3	514.7	697.8	559.0	331.8	637.8	384.2	333.6	484.0	646.0	431.1	79.1	370.1	388.6	229.2	381.2	564.9	625.0	472.9	463.8	441.5	385.2	394.8	844.0	499.0	593.1	556.1	1023.3	937.5	209.3	242.5	433.5	572.7	217.0	366.6	192.3	134.8	183.8	216.9	309.7	114.7	117.5	164.9	312.6	149.4	422.7	110.5	265.6	580.2	228.7	249.7	252.9	265.0	256.1	266.0	241.7	242.7	280.9	228.3	278.8	224.7	92.9	44.8	44.4	23.8	122.2	187.0	173.1	394.2	124.1	403.5	77.8	76.7	22.9	85.8	140.8	106.7	77.2	495.8	122.3	233.9	358.1	321.8	15.1	50.2	113.7	145.9	48.1	71.1	29.4	205.8	791.9	146.0	68.8	72.0	103.4	109.5	96.8	193.7	395.1	387.0	35.7	116.7	152.5	170.0	129.1	27.0	149.5	174.6	131.6	16.9	376.9	404.4	174.0	14.1	19.9	295.7	132.9	234.3	254.9	175.2	283.0	274.8	72.1	300.5	203.8	73.1	199.9	38.0	114.7	253.3	204.7	372.6	138.0	257.8	176.4	269.6
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 1132.9;skeletal muscle: 4350.5;tongue: 1754.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 539.1;Late spermatids: 1891.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		38000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		4.1	3.7	32.9	0.1	37.7	0.1	2.9	40.9	43.1	2.8	28.9	2.1	2.0	1.8	0.7	58.9	2.3	2.4	1132.9	29.3	45.0	10.6	1.8	2.0	0.3	33.8	39.8	2.0	2.1	4.0	13.5	0.1	46.0	16.5	0.3	4.3	33.6	0.6	4350.5	1.8	1.3	0.5	30.8	1.2	1.7	193.9	46.8	23.9	5.1	1754.5	0.5	0.7	1.9	39.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	65.8	7.0	0.0	0.3	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	32.9	37.7	40.9	43.1	29.3	45.0	33.8	39.8	46.0	30.8	46.8	39.8	0.7	0.0	0.0	6.8	1.2	1.1	0.3	0.1	0.6	15.6	0.2	0.6	0.0	0.0	0.3	0.0	10.4	0.0	0.0	0.2	80.3	0.1	539.1	4.0	0.4	1.5	22.9	0.0	0.1	0.5	0.0	0.6	1.5	5.6	0.0	0.4	0.0	0.3	0.0	0.0	0.7	0.4	4.1	0.3	1.4	1891.7	7.8	1.5	1.8	1.9	0.0	5.6	0.0	1.0	0.5	0.3	1.2	6.0	1.4	0.2	0.4	9.2	0.1	4.6	26.3	78.3	18.6	187.6	7.0	0.2	0.6	0.0	0.6	0.1	0.2	0.5
PGAM4	"dJ1000K24.1, PGAM-B, PGAM1, PGAM3"	ENSG00000226784	"Phosphoglycerate mutase family member 4"	Q8N0Y7	X	77967949-77969638	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 2.3;Basal respiratory cells: 1.6;Langerhans cells: 1.5;Melanocytes: 3.6;Suprabasal keratinocytes: 2.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 1.3"									"HPA042528, HPA060483"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"		"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"unprognostic (3.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.52e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-3)"	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	1.3	0.4	0.1	0.4	0.0	0.0	0.6	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.8	1.0	0.3	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.0	0.6	0.2	0.1	0.5	0.2	0.2	0.2	0.0	0.2	0.4	0.4	1.0	0.5	0.4	0.3	1.0	0.7	0.1	0.5	1.0	1.5	0.5	1.0	0.4	0.3	0.5	0.5	0.8	0.3	0.3	0.5	0.6	0.4	1.1	0.2	0.9	1.7	0.1	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.6	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.1	0.1	0.0	0.0	0.0
PGAP6	"M83, TMEM6, TMEM8, TMEM8A"	ENSG00000129925	"Post-glycosylphosphatidylinositol attachment to proteins 6"	Q9HCN3	16	370788-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 63.7;Hofbauer cells: 29.2;Syncytiotrophoblasts: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 36.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 129.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	23.5	25.5	13.5	18.0	15.1	30.0	20.1	11.8	17.7	17.7	14.5	39.6	31.4	19.2	24.8	31.9	17.7	16.4	37.7	12.8	11.0	59.4	57.6	36.2	17.0	14.6	12.6	12.2	102.8	19.3	28.8	34.8	13.5	30.3	10.3	5.6	40.8	12.5	36.1	11.3	38.5	8.8	11.9	36.0	53.9	63.3	16.0	11.7	28.0	10.1	7.9	23.4	14.3	14.6	12.7	32.8	18.4	33.9	24.7	22.1	36.7	35.5	36.6	17.7	25.3	129.2	57.9	13.4	47.1	34.5	27.3	17.8	8.4	39.2	4.9	38.5	31.1	22.1	23.1	74.8	56.9	16.9	40.4	25.7	11.6	27.4	7.9	18.0	41.4	14.8	36.2	20.1	22.6	78.2	23.9	33.2	29.2	20.1	12.9	51.0	21.0	31.2	28.8	32.0	21.9	25.2	19.8	19.7	106.3	9.6	35.7	33.4	61.1	50.2	53.6	35.2	19.2	40.3	21.6	27.0	25.5	17.8	32.5	7.1	7.6	10.1	10.7	8.6	8.3	2.5	8.1	8.3	3.9	2.6	10.7	8.0	36.0	1.5	6.1	4.2	6.6	5.7	13.5	15.1	11.8	17.7	12.8	11.0	14.6	12.6	13.5	11.9	16.0	14.6	11.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	63.7	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	7.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	100.2	1.4	0.0	0.0	0.0
PGBD1	"dJ874C20.4, HUCEP-4, SCAND4"	ENSG00000137338	"PiggyBac transposable element derived 1"	Q96JS3	6	28281572-28302549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 33.4;Inhibitory neurons: 26.7;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.7;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007267	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA007267: AB_1079601"	"unprognostic (2.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.28e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (6.79e-4)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.68e-1)"	2.9	2.9	5.8	1.9	6.2	1.6	2.9	5.9	7.3	3.8	2.9	5.9	1.4	4.4	2.6	2.1	3.4	1.9	3.2	6.8	4.5	3.2	2.6	2.5	1.6	4.1	4.2	3.1	2.1	2.4	3.1	2.0	4.5	3.5	2.1	6.2	2.1	3.2	2.1	1.4	2.7	5.4	4.0	3.2	3.2	3.1	4.4	2.3	2.5	1.6	1.6	3.3	2.8	6.7	6.4	3.5	10.9	15.5	8.6	6.1	3.6	8.2	5.6	10.2	11.5	3.9	2.6	4.2	5.1	5.7	11.6	2.8	11.9	6.7	13.2	4.7	6.8	7.8	6.9	4.9	4.0	9.7	0.9	5.0	3.1	10.1	3.5	5.8	12.7	8.1	10.2	0.5	11.5	2.0	8.2	12.1	4.1	0.1	6.9	14.0	13.9	0.1	5.1	3.4	7.5	14.3	5.6	1.0	6.5	10.8	3.1	5.9	9.1	15.2	10.2	1.0	13.2	4.0	4.3	5.5	3.4	5.5	7.3	1.7	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.3	0.0	0.1	0.0	0.5	0.0	1.5	0.1	0.1	5.8	6.2	5.9	7.3	6.8	4.5	4.1	4.2	4.5	4.0	4.4	6.7	6.1	6.4	1.1	12.7	1.4	0.3	3.0	0.7	1.8	6.2	2.3	2.9	7.5	0.0	0.2	0.0	2.1	0.8	3.6	0.5	0.0	1.1	1.4	1.1	4.4	4.6	1.2	5.2	33.4	2.5	3.7	4.1	0.5	1.0	3.8	4.7	3.6	0.2	1.7	5.0	26.7	0.7	2.0	4.0	1.4	1.0	1.8	1.2	3.6	7.5	2.1	4.4	0.0	20.6	22.3	1.1	0.3	3.4	1.5	0.8	0.6	3.9	4.2	4.4	0.0	6.2	4.3	5.0	9.7	1.8	0.3	0.4	1.3	3.1	1.1	0.5
PGBD4	"FLJ32638, FLJ37497"	ENSG00000182405	"PiggyBac transposable element derived 4"	Q96DM1	15	34102083-34108686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.9"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.9"	"Low cell line specificity"	"Detected in many"											"HPA040896, HPA059823"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Centrosome	"HPA040896: AB_10805831, HPA059823: AB_2684134"	"unprognostic (9.54e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.47e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.70e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.73e-2)"	0.8	0.8	2.5	1.6	2.4	2.8	1.1	3.1	3.2	0.6	2.2	0.9	1.1	0.7	1.3	0.8	1.1	0.7	1.5	2.4	2.6	1.1	1.3	0.7	2.0	3.5	2.4	0.9	1.0	1.5	0.6	0.6	3.5	0.9	1.1	2.4	0.7	0.8	5.3	1.6	1.1	0.6	1.9	1.4	1.4	1.8	2.4	1.3	1.1	1.3	1.5	0.6	0.6	3.1	1.0	1.9	1.3	2.2	3.9	2.5	0.8	1.7	1.6	1.0	1.3	1.3	1.4	2.2	1.3	1.3	2.1	3.0	0.8	1.9	1.3	2.4	2.0	3.7	4.2	1.0	1.6	1.2	3.2	1.9	2.2	1.4	2.5	1.8	1.1	4.1	2.6	2.6	2.2	0.8	2.1	2.9	0.5	2.2	1.4	3.1	1.8	1.1	1.4	2.3	1.9	1.7	0.8	1.9	0.6	1.6	1.8	1.9	1.3	3.2	1.8	1.7	1.1	3.1	2.1	1.2	2.8	2.9	1.9	3.9	0.5	0.6	0.4	0.4	0.3	0.5	0.6	0.4	0.3	0.9	0.9	0.8	1.1	0.6	0.3	0.6	0.5	0.2	2.5	2.4	3.1	3.2	2.4	2.6	3.5	2.4	3.5	1.9	2.4	3.1	1.4	0.0	3.2	2.0	4.1	0.8	2.5	1.8	3.4	5.6	1.9	1.3	5.8	2.8	2.9	0.0	6.2	2.0	5.6	3.1	9.8	1.2	11.6	2.0	3.8	2.1	0.0	2.5	2.7	0.7	0.6	1.8	3.6	2.3	1.3	1.8	3.6	2.2	1.3	10.1	3.1	2.5	4.1	2.8	0.4	11.5	1.2	2.2	0.0	1.0	2.1	2.1	3.1	2.0	3.9	2.1	2.5	0.4	1.6	2.0	3.6	1.4	3.9	6.9	13.1	3.9	1.9	7.6	1.6	2.3	0.3	3.3	4.6	2.7	2.9	1.5
PGBD5	"DKFZp761A0620, FLJ11413"	ENSG00000177614	"PiggyBac transposable element derived 5"	Q8N414	1	230314490-230426332	"Disease related genes, Predicted intracellular proteins"	Transposition	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;pancreas: 20.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.6;Excitatory neurons: 83.3;Inhibitory neurons: 78.4;Oligodendrocytes: 48.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 17.7;basal ganglia: 18.5;cerebral cortex: 35.9;hippocampal formation: 41.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 30.7;GAMG: 15.0;NTERA-2: 30.3;RH-30: 16.4;SCLC-21H: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065010			Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA065010: AB_2685402"	"unprognostic (2.00e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (8.78e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.51e-1)"	0.4	9.4	17.7	0.4	18.5	0.1	0.4	1.1	35.9	18.1	0.0	1.0	0.5	4.6	0.0	1.2	4.9	1.7	13.1	41.8	0.0	1.0	3.1	1.3	0.5	0.9	0.0	0.3	20.3	1.3	5.8	2.1	1.4	0.8	0.7	6.9	5.2	0.7	2.6	0.7	0.5	2.4	0.0	2.2	1.1	5.2	0.1	3.0	5.2	5.1	4.6	0.9	2.6	6.6	0.0	0.0	7.6	0.1	0.1	0.0	0.6	0.5	0.0	0.2	0.0	6.8	0.0	30.7	2.8	0.1	15.0	5.7	2.4	0.0	0.0	0.1	2.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.2	1.5	0.3	6.2	30.3	0.0	0.2	0.0	16.4	4.9	3.5	0.0	41.4	7.7	1.0	0.1	0.4	0.6	0.4	10.5	0.0	0.0	2.5	0.0	2.5	12.7	10.3	0.0	0.1	2.6	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.7	18.5	1.1	35.9	41.8	0.0	0.9	0.0	1.4	0.0	0.1	6.6	0.3	0.0	1.9	18.9	0.3	0.1	0.7	0.1	0.0	26.6	1.3	0.6	9.0	4.3	0.4	0.0	20.9	0.1	0.3	0.4	0.0	10.3	0.9	1.4	3.0	0.3	9.1	0.0	83.3	5.8	0.2	0.8	0.0	2.9	10.8	1.9	0.4	4.1	11.5	21.9	78.4	0.4	0.0	3.8	0.3	0.9	0.0	0.9	1.8	4.7	0.1	2.8	0.0	16.1	48.0	5.5	0.3	0.0	0.0	2.1	0.0	0.8	0.9	10.8	0.0	6.4	0.8	0.7	1.8	0.0	0.0	0.3	0.5	2.8	0.6	1.9
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"stomach 1: 59821.1"	"Group enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 5737.5;Pancreatic endocrine cells: 1449.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 253.1;OE19: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	19.4	7.0	0.0	0.3	0.1	0.2	6.6	1.2	0.5	6.7	0.0	26.4	1327.3	2.8	0.9	85.5	9.2	2.3	6.2	0.1	0.0	4.9	11.0	378.8	0.3	0.0	0.0	3.9	136.3	0.0	7.4	2.8	0.0	83.9	0.3	0.1	4.6	437.7	2.5	3.4	3.2	0.0	0.0	7.7	59821.1	4.2	0.0	0.1	2.2	0.0	0.3	3.8	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.6	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	253.1	0.0	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.9	5.7	152.2	0.0	2.9	0.0	6.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	3.7	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.6	335.2	0.0	4.4	0.4	2.8	0.0	0.0	0.0	0.3	0.8	0.3	87.2	5.0	0.0	0.0	1.2	0.0	0.3	0.0	4.6	0.0	0.4	0.0	1.1	0.0	0.0	0.3	131.2	1.5	0.9	5737.5	0.1	10.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.0	0.0	2.0	0.0	0.0	0.0	0.1	1449.1	2.1	0.0	2.4	85.2	0.1	0.2	3.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	4.1	2.6	0.0	0.2	4.2
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955626	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.5;thyroid gland: 52.5"	"Group enriched"	"Detected in many"	11	"Extravillous trophoblasts: 1604.4;Syncytiotrophoblasts: 2122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"BEWO: 422.4;HUVEC TERT2: 199.1"	"Low region specificity"	"Detected in all"							HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	No	No	20800		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	11.8	4.9	7.4	7.8	7.6	0.1	11.3	7.3	11.7	22.4	20.2	7.0	2.4	7.6	1.4	10.0	21.8	5.9	18.8	8.7	20.6	8.1	6.0	7.2	6.4	9.5	15.7	6.4	4.9	8.4	5.5	50.5	9.3	19.3	2.0	1.2	10.5	10.3	9.9	15.7	12.5	7.8	7.0	3.3	4.8	3.2	8.6	3.9	52.5	5.9	3.3	13.6	14.8	7.8	1.4	1.5	1.3	1.3	2.0	0.2	422.4	4.0	3.6	1.8	2.2	10.9	0.6	0.3	9.1	2.8	0.2	0.5	1.8	19.2	1.6	0.2	2.4	0.0	0.1	11.3	1.5	0.2	11.0	4.7	4.5	7.5	1.8	0.5	199.1	0.0	0.0	0.1	55.6	0.9	0.0	0.5	2.1	0.1	3.4	0.2	51.3	0.0	0.5	1.0	31.0	17.0	0.0	0.8	7.7	25.0	0.1	0.5	40.6	0.3	10.2	0.1	17.0	0.4	0.2	0.7	6.3	0.5	0.5	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	7.4	7.6	7.3	11.7	8.7	20.6	9.5	15.7	9.3	7.0	8.6	7.8	32.4	9.6	4.6	1.0	1.0	24.6	10.3	111.4	34.7	1.3	8.9	16.0	3.6	0.0	26.0	0.0	14.6	83.8	2.4	2.0	0.0	2.7	0.1	1.1	3.3	169.4	7.1	2.7	0.1	0.5	1604.4	30.8	1.1	0.8	6.3	0.2	5.3	0.3	37.4	0.0	0.2	2.1	18.3	0.6	8.9	0.8	13.1	2.1	21.4	0.0	0.0	1.9	0.0	0.0	0.2	0.5	1.2	19.5	0.2	3.2	0.6	1.1	12.1	7.8	105.2	7.1	86.4	0.2	6.8	8.1	19.6	2122.6	3.0	3.0	2.3	5.8
PGGT1B	"BGGI, GGTI"	ENSG00000164219	"Protein geranylgeranyltransferase type I subunit beta"	P53609	5	115204012-115262877	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030646	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Endoplasmic reticulum"	Cytosol	"HPA030646: AB_10602019"	"unprognostic (2.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (7.34e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.15e-2)"	9.4	8.1	4.6	11.1	6.1	12.8	9.6	6.1	4.2	7.6	5.6	14.6	13.0	8.0	3.6	9.6	7.5	7.4	6.7	4.2	5.9	8.1	12.8	7.4	9.8	5.3	5.9	7.3	9.6	12.6	3.2	8.3	6.4	8.4	15.1	12.0	6.6	5.9	7.8	4.9	11.1	9.8	5.8	10.3	11.7	5.6	5.6	9.4	8.6	9.1	11.0	11.3	5.4	6.8	14.7	15.6	17.5	22.7	10.0	8.3	8.6	17.7	10.4	14.5	14.8	17.1	15.3	29.6	23.4	12.4	14.9	11.2	23.3	23.3	21.5	32.9	12.9	17.1	21.0	13.9	13.3	23.7	24.2	12.5	14.0	14.3	14.8	9.2	14.7	17.2	14.1	12.3	16.7	22.8	20.9	7.9	13.0	16.4	12.0	22.6	23.3	30.3	15.2	27.3	17.0	13.0	21.0	15.8	17.6	10.4	21.2	17.4	17.0	14.8	14.0	10.3	20.9	20.4	24.5	15.5	10.7	24.1	20.9	13.7	19.0	34.1	7.0	25.3	8.0	9.7	7.8	8.9	17.2	11.3	7.4	6.8	19.5	10.5	27.0	15.5	7.6	10.3	4.6	6.1	6.1	4.2	4.2	5.9	5.3	5.9	6.4	5.8	5.6	6.8	21.8	12.8	20.8	24.8	26.2	9.9	11.8	12.2	9.1	23.3	18.3	10.4	17.1	5.7	18.3	16.5	47.9	15.3	27.2	29.0	27.4	19.3	49.2	15.8	21.3	20.3	30.1	9.5	30.5	21.6	14.9	15.5	19.9	13.5	23.5	17.2	20.7	25.7	22.6	23.5	27.6	22.4	10.2	21.9	13.2	10.2	13.4	24.8	10.6	33.7	26.8	27.8	24.7	38.2	38.0	24.0	27.2	15.4	12.0	15.6	20.7	22.8	20.3	111.2	13.1	20.5	16.7	14.7	13.9	10.7	12.4	13.5	16.1	19.6	23.9	20.3
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511636-17521288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 244.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7200000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	65.0	85.9	31.6	20.0	33.8	40.6	60.9	33.8	41.8	53.2	33.9	53.9	26.2	42.6	13.2	107.4	44.6	16.9	32.1	30.1	33.3	64.7	75.6	46.5	27.2	36.5	32.4	59.7	88.2	28.5	43.0	17.1	35.2	57.3	16.1	3.7	66.1	19.0	18.0	83.6	49.0	15.9	34.5	73.6	54.7	23.2	34.6	26.2	58.3	11.6	20.6	50.1	62.6	38.5	68.7	62.2	38.7	26.3	57.6	94.8	70.6	45.4	76.5	46.4	59.5	29.7	104.0	74.4	50.0	74.9	33.1	46.6	21.9	73.6	14.5	37.3	80.9	35.3	28.0	54.1	97.8	38.7	38.6	111.8	100.5	27.9	83.9	48.3	63.3	29.4	40.7	18.7	58.5	77.2	84.6	108.6	50.6	72.9	244.0	57.3	23.3	49.9	64.3	56.3	47.3	56.0	28.3	33.2	70.3	21.1	47.9	69.7	57.2	47.9	12.9	96.0	26.6	31.4	23.9	32.2	68.2	97.5	48.0	73.0	163.5	194.6	55.3	185.4	44.9	61.5	49.5	50.1	185.0	71.4	45.4	46.1	158.8	72.5	180.2	137.2	57.3	102.7	31.6	33.8	33.8	41.8	30.1	33.3	36.5	32.4	35.2	34.5	34.6	38.5	93.7	28.9	38.3	7.2	84.8	64.5	94.5	132.5	100.2	22.2	128.9	177.8	8.9	110.1	89.4	47.8	16.7	122.4	98.8	194.0	111.6	177.5	35.5	89.4	99.7	72.0	133.0	48.4	3.5	208.8	169.6	94.2	82.0	90.9	25.4	163.7	99.2	94.0	263.4	26.9	4.9	147.0	75.3	306.5	142.4	70.8	90.7	208.2	74.7	8.4	325.3	79.4	139.0	8.0	11.8	175.7	211.6	69.2	40.4	107.6	263.1	211.1	66.7	28.1	52.6	51.4	103.9	28.7	25.8	210.7	96.2	105.2	85.2	178.3	173.4	143.5
PGLYRP1	"PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L"	ENSG00000008438	"Peptidoglycan recognition protein 1"	O75594	19	46019153-46023053	"Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 629.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.2;Excitatory neurons: 1.7;Inhibitory neurons: 1.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.4"	"Group enriched"	"Detected in some"	202	"eosinophil: 443.7;neutrophil: 494.6"	"Lineage enriched"	"Detected in many"	213	"granulocytes: 494.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.1;HEK 293: 1.8;HeLa: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045702, HPA070227"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		35000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles	"Nucleoplasm, Cytosol"	"HPA045702: AB_10960204, HPA070227: "	"unprognostic (2.87e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.37e-3)"	1.5	0.3	0.3	1.8	1.1	629.4	0.3	3.4	1.5	0.1	0.0	0.3	0.6	0.2	0.0	0.5	0.6	0.2	1.7	0.6	0.0	0.8	2.5	8.7	0.5	0.0	0.1	0.1	0.5	0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.5	0.0	0.3	1.0	0.7	0.1	0.0	42.5	0.4	1.0	0.0	3.3	0.5	2.3	0.0	0.4	0.2	0.0	0.3	3.1	0.5	0.3	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	0.2	0.8	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.8	1.8	0.3	1.7	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.3	0.0	0.2	0.2	0.9	0.2	0.0	1.2	0.7	0.1	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.7	0.6	0.3	0.4	0.7	0.0	0.2	0.4	443.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	494.6	0.0	2.3	0.0	0.1	3.9	0.3	1.1	3.4	1.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	23.6	21.0	12.0	18.1	12.9	9.3	18.0	20.2	15.2	24.4	19.6	18.0	15.8	17.1	34.5	12.3	13.4	24.6	14.3	9.7	10.5	13.6	38.3	16.8	11.2	10.9	10.2	22.7	46.1	13.3	28.2	47.5	13.1	51.0	23.4	26.8	35.8	20.3	6.7	10.9	18.2	18.5	6.6	11.5	24.9	32.3	11.1	8.2	25.6	8.6	15.2	19.0	12.3	15.9	35.1	23.4	41.8	51.0	68.9	72.9	48.9	118.1	82.9	55.2	83.3	60.1	16.1	18.3	24.7	112.3	53.0	20.1	38.4	49.5	104.6	14.6	37.8	22.7	41.9	105.0	77.6	22.6	11.2	46.2	40.1	96.6	120.0	55.5	64.6	12.1	74.9	19.6	61.0	39.1	3.7	14.7	18.8	31.8	31.6	16.2	92.5	11.3	42.0	36.0	16.9	26.3	34.8	28.5	20.9	61.8	27.0	25.5	94.2	38.3	21.2	74.9	60.5	36.5	16.1	13.0	29.7	17.7	58.4	10.8	4.1	2.7	2.6	3.5	3.9	4.6	2.8	3.4	3.6	2.5	4.5	4.7	1.8	3.5	4.5	4.2	2.1	2.3	12.0	12.9	20.2	15.2	9.7	10.5	10.9	10.2	13.1	6.6	11.1	15.9	14.3	28.9	27.7	14.4	13.0	15.8	29.2	28.5	5.7	16.4	19.9	15.0	6.8	15.7	36.1	11.0	10.4	32.4	12.7	15.9	7.9	31.7	67.7	17.0	35.1	13.8	16.1	6.9	25.1	49.6	71.1	46.1	23.9	36.4	5.1	25.4	14.3	32.6	17.6	8.4	29.4	35.5	18.3	6.0	8.7	20.9	33.5	8.6	10.6	15.9	10.1	25.9	2.1	41.2	36.8	37.9	19.7	18.4	44.1	56.5	16.1	23.2	22.2	21.1	6.6	22.1	26.6	75.5	34.2	11.6	15.6	64.4	10.1	12.2	17.6	25.6
PHACTR3	"C20orf101, PPP1R123"	ENSG00000087495	"Phosphatase and actin regulator 3"	Q96KR7	20	59577509-59847711	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 104.4;choroid plexus: 36.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 205.7;Excitatory neurons: 100.4;Inhibitory neurons: 88.7;Oligodendrocyte precursor cells: 218.1;Oligodendrocytes: 241.1"	"Group enriched"	"Detected in some"	5	"glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 85.4;HBEC3-KT: 64.6;PC-3: 113.2;THP-1: 131.3;U-937: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051834, HPA054847"			Enhanced	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA051834: AB_2681629, HPA054847: "	"unprognostic (7.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.43e-7)"	"unprognostic (1.99e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.83e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.32e-1)"	0.9	1.2	90.4	0.5	92.4	0.5	0.4	82.0	93.4	0.3	36.5	0.8	0.7	1.0	0.7	1.1	8.6	1.9	4.0	82.3	75.4	2.2	0.6	5.9	0.1	78.5	82.4	6.2	0.2	0.0	1.7	0.6	76.1	0.1	0.8	3.3	0.1	0.0	0.2	1.1	1.0	0.3	74.7	5.5	0.5	0.5	93.7	1.9	0.1	1.0	0.1	0.5	0.1	104.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	85.4	0.0	6.2	1.3	0.0	0.2	0.3	64.6	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	1.4	0.1	10.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	17.9	0.3	0.4	113.2	0.0	0.0	0.7	25.1	1.4	2.1	6.5	0.5	0.0	0.1	0.0	0.5	131.3	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	90.4	92.4	82.0	93.4	82.3	75.4	78.5	82.4	76.1	74.7	93.7	104.4	0.3	12.8	0.5	205.7	0.3	0.6	1.3	2.1	0.0	13.8	0.2	0.0	8.9	10.0	8.4	3.7	0.0	0.0	0.0	0.0	1.9	1.1	1.0	7.1	3.7	0.3	1.2	0.0	100.4	0.0	0.0	4.2	0.0	2.1	0.0	0.5	3.3	0.0	0.2	5.0	88.7	0.9	44.7	0.3	1.1	0.9	0.0	3.7	0.0	7.5	0.0	0.8	0.0	218.1	241.1	2.9	0.1	0.0	0.9	2.9	4.3	0.1	1.3	1.9	0.0	2.9	0.9	0.3	1.0	0.1	0.4	0.0	0.1	0.9	4.5	3.2
PHAX	"FLJ13193, RNUXA"	ENSG00000164902	"Phosphorylated adaptor for RNA export"	Q9H814	5	126600925-126627252	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059630, HPA070326"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA059630: AB_2684088, HPA070326: AB_2686253"	"unprognostic (1.06e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.91e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.07e-2)"	8.2	8.9	9.5	7.1	9.5	4.4	8.1	11.8	10.3	6.9	7.9	6.3	5.0	9.1	7.5	9.0	7.9	7.1	9.7	9.8	8.9	7.6	8.2	6.4	10.9	8.8	9.0	11.4	7.1	8.8	5.1	7.3	9.1	8.4	6.2	8.4	7.3	6.2	12.1	10.6	5.4	8.3	9.0	7.1	6.3	5.6	9.8	7.2	8.7	10.0	10.4	7.7	5.5	10.9	15.5	15.9	13.5	25.6	19.0	18.3	14.9	21.4	16.0	17.6	16.4	21.8	15.1	15.2	19.0	27.7	21.2	12.2	19.1	29.7	25.7	24.7	20.4	13.0	18.5	8.8	11.3	10.8	13.5	18.6	16.4	17.2	15.6	16.5	15.0	8.7	10.4	17.2	27.4	13.3	15.2	13.4	16.9	10.3	12.4	12.1	19.1	12.4	16.4	18.1	17.3	19.9	19.3	16.4	22.7	13.0	22.0	14.7	23.2	29.0	16.1	16.3	32.7	13.3	13.6	17.0	20.8	17.4	21.3	8.7	4.8	6.6	7.1	5.7	8.1	8.2	7.1	7.4	4.8	7.1	7.9	8.3	3.8	10.7	6.1	6.4	6.5	5.5	9.5	9.5	11.8	10.3	9.8	8.9	8.8	9.0	9.1	9.0	9.8	10.9	34.6	25.6	40.2	10.7	36.1	28.6	31.6	72.1	26.7	60.0	27.7	42.2	56.6	20.0	47.3	35.0	39.6	51.5	42.4	29.5	74.3	53.6	37.2	32.8	44.6	36.8	27.5	26.9	14.2	33.3	50.3	41.8	16.3	28.3	46.9	35.0	28.2	28.5	30.1	75.7	14.8	26.9	65.1	17.2	17.6	9.7	42.0	21.9	21.4	5.6	43.4	86.9	37.0	8.0	11.8	40.3	23.1	41.3	29.7	31.9	16.5	56.1	63.3	72.3	46.0	50.3	51.7	64.5	86.4	32.3	25.9	51.4	34.2	43.2	27.7	27.8
PHC1	"EDR1, HPH1, RAE28"	ENSG00000111752	"Polyhomeotic homolog 1"	P78364	12	8913896-8941467	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein, DNA-binding"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"BEWO: 141.8;NTERA-2: 492.6;SuSa: 178.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006973	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA006973: AB_1855278"	"unprognostic (4.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.63e-2)"	20.1	18.1	22.9	17.7	21.1	7.5	23.1	26.1	21.8	46.8	31.3	32.1	6.9	42.0	13.3	20.7	44.6	15.7	20.4	21.7	21.4	24.9	6.9	21.4	16.1	20.5	22.9	47.2	25.5	26.4	75.7	14.1	19.3	31.7	9.4	40.0	23.6	20.2	16.1	10.7	21.0	22.4	19.2	22.2	22.3	43.3	20.8	28.1	44.3	10.3	14.6	28.0	26.9	19.8	6.6	11.1	46.5	43.0	13.8	14.5	141.8	6.6	13.7	11.3	14.7	7.4	10.5	17.4	5.7	11.3	17.4	5.8	12.9	15.4	15.2	60.8	7.5	22.8	14.5	7.5	15.0	12.4	38.5	18.0	8.0	18.1	18.1	36.2	13.7	19.8	4.6	6.4	11.5	8.2	15.8	22.1	492.6	2.5	3.7	25.1	31.3	0.9	12.3	29.0	9.0	32.1	10.4	23.4	17.4	178.3	3.4	12.4	7.8	20.8	34.5	13.2	9.6	12.8	8.9	24.9	9.3	6.7	14.4	0.6	0.2	0.0	0.8	1.1	0.5	1.1	1.2	1.5	0.1	0.9	1.2	0.9	0.0	0.8	2.8	1.2	0.8	0.8	22.9	21.1	26.1	21.8	21.7	21.4	20.5	22.9	19.3	19.2	20.8	19.8	11.9	16.0	19.8	48.3	7.7	2.4	5.5	4.6	9.1	24.2	10.8	11.2	0.5	11.5	13.1	9.2	27.1	5.9	10.1	0.8	1.9	5.4	26.4	20.0	17.4	11.0	11.4	9.5	36.4	5.2	11.5	11.8	5.1	10.6	19.0	15.5	8.6	2.0	4.4	16.8	44.0	2.7	4.1	5.4	3.9	17.6	14.3	6.0	7.2	12.2	3.2	17.7	7.2	23.1	13.0	4.6	1.9	12.0	3.0	4.5	0.7	5.3	19.2	36.8	0.0	15.8	12.2	17.7	25.1	10.2	2.4	5.1	11.2	8.7	2.0	4.9
PHC2	"EDR2, HPH2"	ENSG00000134686	"Polyhomeotic homolog 2"	Q8IXK0	1	33323623-33431052	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"neutrophil: 93.4"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047403	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA047403: AB_10964220"	"unprognostic (8.58e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.28e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	114.4	87.1	57.1	52.1	66.9	50.6	103.8	62.5	64.3	87.1	73.5	104.3	26.0	86.3	27.9	50.7	86.2	49.2	113.1	56.0	63.6	141.7	124.9	135.0	31.3	79.7	67.7	66.9	54.8	33.4	70.5	46.2	68.9	79.9	27.9	51.1	68.8	44.6	260.0	68.2	64.2	60.2	64.5	118.9	92.7	62.2	67.1	40.4	81.7	74.7	23.9	97.2	63.5	72.5	53.0	34.0	145.3	56.0	149.3	169.9	43.2	51.4	111.1	70.0	76.5	21.5	115.2	47.2	42.4	81.3	56.7	27.4	29.2	88.0	67.2	22.9	26.6	31.5	15.7	54.9	229.2	38.8	29.1	279.3	53.4	126.3	99.0	133.2	93.9	44.9	28.3	35.1	185.1	21.8	84.8	39.7	33.1	89.4	97.8	95.0	60.4	26.3	128.4	39.5	88.3	81.0	40.2	39.9	204.7	60.7	19.9	49.5	93.8	69.5	35.0	59.9	98.1	24.3	18.0	35.6	165.5	40.7	195.3	10.5	6.6	3.4	2.0	6.7	1.6	1.4	2.2	1.8	3.4	1.2	2.6	1.4	93.4	2.1	8.3	3.9	1.6	2.2	57.1	66.9	62.5	64.3	56.0	63.6	79.7	67.7	68.9	64.5	67.1	72.5	89.3	16.0	13.9	24.2	5.6	14.1	28.9	16.2	4.6	75.9	24.1	30.9	31.8	25.8	13.2	35.0	68.8	11.3	17.4	19.5	17.6	34.4	58.2	18.7	40.2	43.0	37.7	17.4	60.7	44.4	9.2	32.9	14.8	28.5	6.3	39.4	47.8	55.6	21.4	62.2	82.0	21.9	18.3	75.7	14.1	72.9	29.2	55.3	21.4	61.8	18.4	58.5	8.2	91.0	117.2	85.8	11.0	29.7	2.5	23.8	11.2	31.7	14.8	78.5	13.1	24.2	48.7	14.2	8.6	7.9	10.9	11.5	11.4	30.0	20.0	30.9
PHC3	"EDR3, FLJ12729, FLJ12967, HPH3"	ENSG00000173889	"Polyhomeotic homolog 3"	Q8NDX5	3	170086732-170181749	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 156.5;Rod photoreceptor cells: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039162, HPA062031"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA039162: AB_10671038, HPA062031: AB_2684666"	"unprognostic (4.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.76e-2)"	9.1	7.4	3.7	12.7	9.1	50.8	10.5	29.3	8.9	9.0	6.3	10.5	11.2	12.2	8.1	12.4	10.2	12.9	8.1	2.0	14.3	9.7	8.7	9.7	18.1	6.5	2.9	14.9	11.3	15.1	5.4	8.4	7.8	11.6	11.3	42.0	8.9	8.6	8.7	8.5	12.3	13.5	0.0	13.9	11.8	11.5	5.5	16.8	16.6	14.0	14.1	11.8	7.4	14.0	35.0	32.3	6.9	11.6	19.2	19.4	12.8	14.6	16.5	14.8	18.2	21.6	17.0	16.5	34.8	20.5	19.7	17.1	15.3	14.1	26.6	38.3	14.2	28.5	30.2	10.0	11.3	35.4	14.8	14.0	8.1	22.1	31.0	10.9	11.1	12.7	6.9	45.0	14.6	32.3	16.2	7.4	7.2	11.3	11.9	12.0	29.5	24.0	7.4	38.7	7.5	4.6	48.1	29.8	9.8	4.5	34.6	27.0	22.3	20.5	12.1	17.1	25.4	43.0	37.6	48.1	12.8	13.1	12.6	9.5	7.0	25.7	16.2	11.2	13.8	16.8	15.2	14.1	7.8	21.6	15.6	13.8	10.2	13.3	7.3	26.0	20.2	7.5	3.7	9.1	29.3	8.9	2.0	14.3	6.5	2.9	7.8	0.0	5.5	14.0	26.8	22.4	31.9	77.4	46.2	14.1	16.9	16.1	19.9	36.3	16.4	12.1	22.7	18.6	18.7	27.6	60.5	15.5	45.9	11.1	0.0	8.9	5.5	18.7	34.5	21.3	7.8	28.8	108.2	7.5	9.6	25.1	25.0	19.0	12.7	35.9	19.6	17.8	11.1	53.8	103.2	14.1	16.2	21.6	22.6	3.8	29.5	22.5	19.6	105.9	25.5	21.9	32.0	103.0	156.5	10.4	16.7	27.8	45.6	22.8	16.4	10.7	24.1	126.2	6.6	29.8	26.4	21.0	19.3	17.8	15.9	18.3	40.4	25.7	14.4	19.6
PHF1	"MTF2L2, PCL1, TDRD19C"	ENSG00000112511	"PHD finger protein 1"	O43189	6	33410399-33416453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 25.9;HMC-1: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031038	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA031038: AB_10671365"	"unprognostic (1.96e-3)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.43e-3)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (1.72e-4)"	35.0	31.9	0.3	4.6	0.2	11.2	37.6	0.2	1.1	65.8	0.4	49.6	5.9	51.8	18.1	19.4	57.8	4.2	41.6	0.3	0.2	38.2	22.8	41.1	6.3	0.6	0.2	89.6	41.5	2.1	76.6	1.8	0.3	49.9	2.3	6.1	32.8	4.2	42.2	25.5	38.6	2.6	0.3	47.3	39.7	70.2	0.3	5.5	58.4	13.1	10.3	49.1	40.6	0.6	1.4	2.0	4.5	2.8	1.9	1.1	10.3	3.1	4.8	2.5	2.6	2.8	1.3	0.5	2.0	7.4	25.9	0.4	0.9	1.6	0.6	1.8	0.9	4.3	3.6	1.2	0.3	2.5	20.0	2.2	2.0	4.6	4.0	3.3	1.5	1.4	1.7	3.6	1.9	1.1	0.8	1.5	1.9	0.4	1.4	1.8	0.6	1.5	0.3	1.9	2.9	3.3	1.6	1.6	2.6	1.0	1.2	3.0	3.0	4.5	1.2	2.7	3.4	2.9	4.5	8.3	3.3	2.6	2.7	0.2	0.2	1.0	0.7	0.2	2.1	0.6	1.6	1.9	0.3	0.9	1.6	0.9	1.5	0.7	0.2	0.1	0.6	0.7	0.3	0.2	0.2	1.1	0.3	0.2	0.6	0.2	0.3	0.3	0.3	0.6	32.9	19.2	24.8	19.2	70.5	33.9	89.0	26.8	34.1	74.4	36.0	37.1	19.6	15.7	20.5	23.9	37.5	16.9	53.3	16.7	35.2	13.1	153.8	14.9	15.3	29.9	12.0	3.8	19.1	17.9	16.3	32.6	15.3	20.3	69.2	21.4	33.2	7.6	11.8	45.4	30.3	16.0	34.6	14.1	43.1	88.6	43.2	20.9	37.4	13.1	11.4	34.7	27.8	26.2	18.0	17.9	14.5	41.0	54.8	59.0	29.6	22.9	22.1	73.6	78.9	28.9	42.3	80.9	51.2	15.9	24.0	37.5	71.4	19.1	10.1	75.1
PHF10	"BAF45a, FLJ10975, XAP135"	ENSG00000130024	"PHD finger protein 10"	Q8WUB8	6	169703902-169725566	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055649	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA055649: AB_2682875"	"unprognostic (1.74e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.76e-3)"	"prognostic unfavorable (3.42e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.63e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.76e-2)"	41.9	78.5	49.1	39.0	55.4	53.4	40.9	52.2	53.9	43.1	46.3	49.2	32.3	40.0	39.2	46.7	39.7	34.6	46.5	43.0	54.2	38.4	52.4	40.4	61.7	52.5	56.2	80.7	41.0	47.7	36.3	43.7	54.8	48.4	34.6	59.1	44.5	44.7	81.3	50.9	40.7	33.4	56.6	49.8	42.7	41.7	55.0	53.2	48.6	63.7	61.3	42.3	41.9	57.4	31.2	30.7	119.2	125.5	40.7	24.5	49.0	41.2	37.3	49.8	54.3	88.9	31.4	91.1	24.4	29.2	31.7	38.4	92.5	45.3	72.0	73.3	82.1	91.1	54.8	116.9	41.5	134.2	5.4	18.5	46.7	32.1	29.4	82.3	80.2	64.4	102.7	57.5	36.0	53.4	25.6	115.0	37.6	68.3	18.9	121.0	84.4	73.7	62.1	32.5	56.7	75.9	56.4	18.4	41.5	49.7	36.3	158.6	54.0	28.1	46.6	36.3	53.2	50.7	46.1	112.3	36.7	88.6	45.6	1.6	1.4	3.2	1.5	1.5	1.4	2.6	2.7	2.1	1.4	1.7	2.6	2.8	0.2	1.2	1.6	1.2	1.8	0.8	49.1	55.4	52.2	53.9	43.0	54.2	52.5	56.2	54.8	56.6	55.0	57.4	42.5	25.6	30.1	17.9	24.5	29.8	22.7	13.3	13.1	12.1	38.1	31.8	59.3	35.8	23.7	11.0	41.7	14.8	25.9	11.0	13.7	12.5	15.3	32.1	27.4	28.2	25.9	7.4	14.9	12.6	8.9	27.6	12.8	42.1	6.3	38.1	29.3	27.5	11.6	11.8	19.0	22.8	18.3	13.9	28.7	9.7	22.4	21.5	19.6	28.1	11.8	33.4	10.3	17.6	33.6	17.1	19.4	21.1	16.4	27.6	18.6	12.4	22.7	26.8	19.7	27.9	53.1	18.9	22.0	21.2	23.4	17.4	21.2	33.2	20.0	27.4
PHF11	"BCAP, IGER, NY-REN-34"	ENSG00000136147	"PHD finger protein 11"	Q9UIL8	13	49495610-49528981	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA016566			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nuclear membrane"	"HPA016566: AB_2669387"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.98e-6)"	"unprognostic (3.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (4.46e-7)"	"unprognostic (9.81e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.46e-4)"	28.3	39.5	17.2	33.4	18.8	37.0	32.3	17.6	23.6	29.1	18.2	28.9	25.3	24.0	28.5	23.2	23.0	26.4	21.3	16.4	19.6	33.1	22.4	28.9	43.4	21.2	19.9	22.6	25.1	16.5	16.1	23.9	20.3	26.3	22.0	9.1	39.7	24.6	13.4	27.2	27.6	27.3	20.5	39.3	28.9	13.4	19.4	31.6	34.3	11.3	39.4	28.4	27.4	20.5	12.0	4.9	1.7	0.0	23.5	44.4	14.7	28.5	32.5	40.0	42.1	0.0	28.3	29.2	7.7	32.1	26.5	8.2	10.4	9.8	23.6	59.2	8.8	14.5	9.5	12.8	29.1	10.5	21.5	27.0	15.4	16.2	9.0	16.4	26.0	23.6	3.1	12.4	30.3	9.8	33.7	24.8	5.6	7.8	3.3	32.2	0.0	8.9	36.5	21.8	1.0	0.2	7.6	15.9	0.4	2.1	9.3	23.6	23.2	9.7	3.8	14.0	8.2	8.9	4.9	18.1	20.0	14.9	14.9	26.3	42.4	31.0	42.3	54.1	49.1	40.7	53.6	50.6	39.9	35.0	43.1	48.5	51.3	30.0	51.4	34.8	78.0	42.6	17.2	18.8	17.6	23.6	16.4	19.6	21.2	19.9	20.3	20.5	19.4	20.5	48.0	16.0	28.7	15.7	48.2	22.6	35.1	41.0	29.0	4.4	26.8	25.4	19.5	27.1	40.3	36.8	0.0	26.1	54.6	15.2	35.2	41.1	35.9	38.3	48.9	35.0	4.2	18.5	11.1	42.3	46.4	32.6	23.0	34.9	24.0	30.3	31.1	22.3	41.9	11.8	11.7	15.6	26.4	40.9	31.5	56.3	32.0	46.6	12.4	27.2	66.8	17.0	58.7	16.1	23.9	38.5	8.5	31.6	35.7	35.4	21.4	29.2	63.4	5.0	46.0	26.5	28.7	24.2	6.0	27.1	20.2	21.1	60.4	23.1	15.8	35.8
PHF12	"KIAA1523, PF1"	ENSG00000109118	"PHD finger protein 12"	Q96QT6	17	28905250-28951771	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 40.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 40.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021410, HPA021452"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021410: AB_1855287, HPA021452: AB_2670708"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.16e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-3)"	13.7	11.0	11.6	15.6	12.6	39.9	14.4	14.1	12.1	17.9	7.2	18.2	11.5	18.7	14.0	10.6	17.2	11.0	11.0	10.7	11.9	12.3	14.7	16.7	18.2	11.5	11.1	17.9	19.1	13.8	16.9	10.9	9.1	21.8	11.4	14.9	15.7	17.0	15.7	15.2	17.7	14.6	7.2	22.9	14.8	9.9	11.3	25.3	17.0	14.2	17.2	16.8	13.8	14.0	15.0	24.4	33.1	19.8	18.6	13.8	15.0	14.6	22.0	23.0	21.2	16.9	14.3	17.3	17.9	17.4	19.0	15.9	21.5	13.0	21.8	27.9	22.5	18.8	27.2	13.2	16.8	20.5	22.7	15.8	13.8	20.9	19.0	21.3	16.7	23.0	16.0	18.6	14.2	16.6	38.3	26.7	19.0	33.6	10.4	38.2	26.8	17.6	15.2	19.3	22.8	18.7	22.6	35.7	17.6	17.5	19.6	26.6	9.9	18.9	16.8	18.2	18.4	21.9	19.9	20.2	14.7	15.2	19.5	25.2	4.4	7.2	6.3	3.6	6.1	4.4	4.9	6.6	2.5	6.5	4.4	5.2	40.1	6.3	4.3	8.2	3.1	2.9	11.6	12.6	14.1	12.1	10.7	11.9	11.5	11.1	9.1	7.2	11.3	14.0	13.1	16.0	8.6	27.1	24.7	15.3	8.5	7.5	26.7	22.7	17.6	15.1	6.9	8.6	12.2	3.7	14.6	7.9	24.5	12.0	1.9	9.1	9.5	17.5	16.4	14.4	10.7	27.0	16.3	10.4	7.6	11.9	12.8	23.8	14.5	14.4	14.3	11.7	9.2	25.2	18.6	16.5	12.2	15.7	18.9	7.4	17.1	16.5	12.4	27.2	20.0	12.9	17.5	30.2	31.3	9.7	6.5	16.6	31.4	27.1	8.9	5.9	8.1	21.3	26.3	11.2	17.2	13.5	12.6	22.2	16.3	6.0	35.3	11.4	10.8	14.0
PHF14	KIAA0783	ENSG00000106443	"PHD finger protein 14"	O94880	7	10973336-11169623	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000538, HPA017376"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Nucleoplasm, Cytosol"	"HPA000538: AB_1079604, HPA017376: AB_2732420"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.73e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.33e-1)"	9.9	8.0	17.2	8.6	15.6	5.5	13.7	17.5	26.9	9.1	12.7	9.8	8.2	13.1	7.8	8.4	8.8	9.3	5.3	17.0	16.1	10.0	11.4	8.6	9.9	16.5	16.7	14.5	7.1	9.5	7.9	8.4	17.3	10.0	10.4	6.7	7.9	8.1	6.0	8.5	8.2	11.0	14.2	10.3	10.3	9.3	16.0	17.8	9.2	7.8	10.2	9.2	7.6	16.9	16.4	32.8	46.4	49.2	16.2	15.6	23.1	12.6	10.0	14.5	15.9	29.5	28.9	62.4	22.7	11.7	32.7	22.8	42.4	14.6	16.0	23.1	17.3	31.1	28.1	38.0	14.8	70.2	28.8	14.2	15.0	17.3	30.9	20.4	21.2	24.2	42.4	21.6	17.6	21.6	28.0	30.4	39.3	68.1	24.4	45.9	30.3	19.8	15.0	30.6	42.2	58.3	19.5	64.6	21.1	33.6	34.6	50.1	20.6	20.3	27.1	13.6	25.0	27.7	51.1	43.2	14.4	57.8	48.6	1.0	0.9	0.6	1.3	0.8	1.0	1.8	1.4	1.6	0.5	1.4	1.9	1.7	0.0	1.4	0.8	2.7	1.9	0.4	17.2	15.6	17.5	26.9	17.0	16.1	16.5	16.7	17.3	14.2	16.0	16.9	80.6	41.7	41.6	141.0	66.9	57.5	68.6	27.5	68.9	92.7	80.3	91.3	22.7	37.1	44.2	33.1	58.4	68.8	58.4	54.6	27.4	92.0	23.9	40.9	82.7	77.4	92.2	46.9	223.8	84.3	80.9	65.9	55.5	48.1	56.5	103.7	64.2	43.6	42.1	79.1	260.6	72.3	42.7	39.6	24.7	16.2	102.9	39.1	37.4	116.2	58.0	36.5	87.6	263.4	200.8	90.4	45.9	116.9	34.3	82.0	46.0	35.9	28.0	63.3	52.6	71.0	67.6	142.3	133.7	56.5	52.4	39.8	58.6	73.7	72.0	54.2
PHF2	"CENP-35, JHDM1E, KDM7C, KIAA0662"	ENSG00000197724	"PHD finger protein 2"	O75151	9	93576584-93679587	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 155.2;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010831	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"	Nucleoplasm	"HPA010831: AB_1855294"	"unprognostic (9.42e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.89e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.19e-2)"	22.6	15.8	27.6	11.6	30.7	17.3	23.5	32.1	28.1	31.1	23.2	28.8	10.1	29.6	13.2	19.4	27.4	11.9	28.1	25.9	28.2	16.5	14.3	24.0	13.5	30.4	30.0	34.2	21.7	17.2	29.7	15.9	29.2	24.9	9.3	13.8	21.1	17.8	28.7	23.2	18.7	14.6	27.5	23.9	22.9	15.1	28.6	18.6	25.7	21.2	10.0	24.5	26.3	34.4	16.1	13.6	27.9	22.6	17.4	13.5	14.0	12.8	17.0	18.2	12.9	6.4	9.3	11.7	9.0	16.7	16.3	30.6	17.7	12.3	9.6	31.8	11.5	9.6	15.9	9.7	15.0	18.8	31.3	13.7	20.2	8.6	14.4	17.7	14.6	17.7	14.2	19.6	12.5	36.1	35.9	20.3	7.2	28.3	11.5	40.4	21.4	4.6	11.4	20.5	36.4	17.6	13.4	21.1	11.7	8.0	14.4	31.9	17.2	16.9	14.3	18.6	18.3	15.3	2.7	8.6	9.3	11.3	19.6	0.4	0.8	0.8	0.9	0.4	0.9	0.5	1.0	0.6	0.8	0.8	1.0	1.2	1.6	0.3	0.6	1.2	0.6	0.7	27.6	30.7	32.1	28.1	25.9	28.2	30.4	30.0	29.2	27.5	28.6	34.4	18.4	16.0	13.7	13.7	7.5	7.6	6.6	7.1	4.6	14.4	13.3	11.0	15.5	4.3	16.0	5.5	8.4	7.3	9.8	7.5	0.0	5.6	155.2	13.2	14.0	15.0	16.3	9.9	11.9	5.6	3.5	13.3	10.2	13.3	17.1	8.4	13.2	7.6	5.8	10.1	16.0	7.3	8.2	12.4	10.0	575.3	19.9	10.2	3.6	12.2	9.0	9.6	5.2	20.1	28.8	6.1	3.8	20.3	3.9	8.7	4.1	3.2	16.4	7.9	19.7	15.0	13.4	1.8	3.4	7.8	8.0	6.0	9.6	4.9	7.6	8.2
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950370	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 452.5;Late spermatids: 661.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	12.9	8.2	10.4	12.0	11.5	11.8	12.5	15.4	13.0	10.8	9.4	10.9	6.0	11.8	7.3	11.9	9.2	10.8	11.5	11.2	10.4	7.8	8.2	10.0	14.2	11.6	11.1	13.2	6.8	12.1	5.4	11.7	11.1	10.3	8.4	14.4	9.5	10.8	32.3	8.1	7.8	11.6	9.5	14.7	8.2	11.8	11.8	14.7	10.2	17.6	13.9	10.5	8.5	14.7	18.1	14.2	24.4	36.0	17.3	19.7	22.5	20.2	19.1	19.8	17.2	41.4	13.1	30.1	17.9	27.1	24.4	10.7	22.6	28.2	24.1	13.7	9.6	55.8	26.3	15.6	17.3	27.2	20.8	15.6	38.8	21.0	32.2	23.5	22.1	21.0	23.3	18.8	23.1	10.8	27.6	15.9	12.0	11.9	17.5	20.0	35.9	17.9	15.9	12.4	21.9	17.9	36.0	41.0	18.4	21.8	32.6	20.0	31.1	43.7	9.9	23.0	21.0	17.2	22.0	21.5	32.2	19.5	22.9	17.3	11.2	33.1	12.4	11.5	13.6	15.0	12.5	14.6	10.6	11.1	14.0	14.7	25.9	16.0	16.9	9.9	7.2	9.0	10.4	11.5	15.4	13.0	11.2	10.4	11.6	11.1	11.1	9.5	11.8	14.7	51.2	38.5	41.8	28.4	131.1	34.8	76.6	52.5	31.3	77.4	49.8	53.5	62.2	31.5	43.5	38.6	98.0	106.7	191.0	16.3	37.2	29.8	452.5	39.8	41.6	46.3	36.0	37.6	49.7	19.9	52.5	53.6	23.0	34.7	142.4	41.2	47.2	18.2	54.5	114.4	49.5	27.9	30.5	62.7	84.3	661.6	35.8	87.1	39.2	62.8	62.6	50.0	105.0	34.2	55.2	24.1	26.5	53.4	76.9	60.0	14.0	24.8	50.2	80.7	19.7	65.5	50.6	60.4	47.0	29.8	28.3	22.3	127.8	30.1	28.8	55.4
PHF20L1	"CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B"	ENSG00000129292	"PHD finger protein 20 like 1"	A8MW92	8	132775358-132848807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025060, HPA028417"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"HPA025060: AB_10599822, HPA028417: AB_10602278"	"unprognostic (9.12e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.83e-2)"	12.1	14.0	8.0	13.5	9.6	24.9	10.9	10.4	11.3	11.6	9.9	9.2	9.4	11.4	10.0	11.6	7.9	10.7	17.5	8.0	6.4	10.7	13.4	10.3	11.8	6.5	6.7	11.3	8.9	15.7	8.7	12.4	6.7	9.9	10.1	12.5	9.6	8.0	16.7	7.7	9.9	11.5	5.7	11.5	9.3	13.5	7.2	25.6	22.7	18.5	12.4	12.8	8.9	9.8	20.9	20.6	33.1	19.1	25.3	29.9	11.9	30.1	23.4	20.2	19.7	11.5	14.0	23.8	25.6	30.3	17.4	12.0	22.5	16.0	24.9	40.4	16.1	25.5	24.3	8.2	26.6	20.7	17.6	22.5	19.4	21.1	31.1	19.5	22.6	37.2	32.1	36.4	30.4	21.0	67.6	9.2	14.7	23.8	27.1	32.6	22.1	20.6	16.5	17.8	81.4	23.8	19.1	13.5	24.5	13.8	26.5	23.0	29.6	32.6	25.9	21.5	29.1	21.5	29.9	30.3	28.8	35.8	29.6	3.5	3.8	7.0	2.1	2.4	2.1	2.1	1.9	2.5	3.6	2.2	2.8	2.2	12.6	3.0	3.6	2.9	2.5	1.5	8.0	9.6	10.4	11.3	8.0	6.4	6.5	6.7	6.7	5.7	7.2	9.8	65.9	25.6	51.6	74.4	51.1	33.6	52.6	48.2	40.9	55.7	40.5	38.0	88.5	25.8	57.2	36.8	43.8	29.7	92.9	35.1	23.5	37.3	81.2	39.8	73.4	55.2	43.7	37.9	133.9	31.3	32.0	51.6	41.8	48.9	60.2	60.1	36.0	33.4	36.6	53.8	192.2	29.0	44.7	39.6	49.3	49.5	40.0	84.2	23.2	83.4	67.5	50.9	78.2	104.5	117.5	40.6	26.4	42.9	66.6	40.4	41.5	25.7	30.8	54.1	46.0	68.1	58.9	115.1	45.9	44.9	36.2	45.0	65.8	61.4	30.9	66.7
PHF21A	"BHC80, BM-006, KIAA1696"	ENSG00000135365	"PHD finger protein 21A"	Q96BD5	11	45929319-46121454	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 172.4;Excitatory neurons: 171.0;Inhibitory neurons: 140.0;Microglial cells: 138.7;Oligodendrocyte precursor cells: 250.3;Oligodendrocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 34.9;neutrophil: 31.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 34.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023253, HPA023580"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA023253: , HPA023580: AB_10962727"	"unprognostic (5.30e-3)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (2.59e-8)"	"unprognostic (1.89e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.21e-1)"	13.1	17.4	18.5	20.5	25.1	28.8	11.0	39.1	23.8	12.9	5.4	18.5	7.0	17.2	10.7	11.4	12.9	12.6	17.4	13.2	20.7	7.9	8.0	17.3	16.8	17.0	17.9	24.1	8.6	16.5	12.8	13.1	15.8	12.1	9.5	16.7	9.9	11.3	15.3	13.5	10.4	16.7	12.0	17.4	10.0	23.7	26.8	17.8	12.8	12.8	14.8	14.0	11.6	27.3	7.3	19.1	36.8	35.6	14.8	22.5	4.9	14.6	25.4	12.3	20.5	3.7	11.2	30.4	10.3	14.2	19.3	8.2	22.0	9.4	12.4	34.0	15.3	17.2	19.9	7.7	17.6	12.5	25.9	20.6	21.3	7.1	20.2	30.2	18.4	21.1	21.0	48.2	14.5	6.9	13.6	20.6	31.9	9.3	11.3	22.8	18.2	10.4	12.6	12.2	24.1	31.7	21.6	10.9	16.0	23.6	19.7	23.5	18.8	20.2	16.3	16.9	12.0	52.5	46.2	20.8	16.1	13.6	16.3	34.9	7.8	4.1	6.1	3.9	5.1	5.0	4.7	5.4	4.3	4.2	2.8	4.8	31.3	5.6	7.2	2.9	6.0	4.1	18.5	25.1	39.1	23.8	13.2	20.7	17.0	17.9	15.8	12.0	26.8	27.3	13.9	12.8	17.7	172.4	25.2	10.3	8.8	11.2	22.2	25.5	11.8	12.1	25.7	10.0	10.5	3.7	27.1	4.3	26.1	4.8	1.9	10.0	9.0	10.3	26.8	15.0	23.4	18.7	171.0	6.3	3.4	18.3	12.8	11.1	16.5	30.1	12.5	5.5	10.0	15.2	140.0	6.8	4.1	25.4	12.4	8.2	26.1	23.9	10.6	138.7	35.6	7.9	37.0	250.3	231.3	5.5	6.5	14.7	21.8	7.6	5.6	3.9	15.4	23.3	13.1	18.6	18.8	16.9	16.9	19.0	8.8	4.2	19.5	19.2	6.2	5.7
PHF21B	"BHC80L, FLJ34161, PHF4"	ENSG00000056487	"PHD finger protein 21B"	Q96EK2	22	44881162-45010005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 96.6;Cone photoreceptor cells: 22.9;Horizontal cells: 28.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 29.1;Rod photoreceptor cells: 23.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.2;AN3-CA: 10.0;JURKAT: 8.8;SCLC-21H: 8.7;SH-SY5Y: 37.5;U-2 OS: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053834, HPA074665"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA053834: AB_2682276, HPA074665: "	"unprognostic (1.04e-1)"	"unprognostic (7.76e-2)"		"unprognostic (2.00e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.37e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.02e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.22e-1)"	0.2	1.2	6.7	0.1	7.9	0.0	0.4	4.8	6.1	9.0	1.5	0.2	0.1	3.2	0.4	0.4	2.5	0.1	0.9	5.1	5.1	2.6	0.0	0.1	0.0	8.5	8.3	4.0	0.5	0.9	18.9	0.0	5.2	5.2	0.0	6.1	0.3	0.5	0.2	0.1	0.2	0.7	4.4	0.1	0.6	5.4	6.8	0.2	2.0	0.3	0.0	0.2	3.2	4.7	0.0	0.0	11.2	10.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.0	0.1	2.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.6	0.0	0.0	8.8	0.0	0.0	0.1	0.9	1.3	0.0	6.7	0.0	0.4	0.0	2.6	0.2	0.0	0.1	8.7	37.5	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.5	8.5	0.0	0.2	0.4	0.0	5.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.9	4.8	6.1	5.1	5.1	8.5	8.3	5.2	4.4	6.8	4.7	0.0	0.0	0.0	96.6	0.0	0.1	0.6	0.0	0.0	14.1	0.0	0.3	2.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	1.9	0.0	16.2	0.1	3.2	0.4	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.3	0.0	0.6	0.0	0.0	0.1	28.6	9.1	0.0	0.0	0.0	0.0	41.9	0.6	0.1	0.0	5.6	0.0	5.0	0.0	29.1	9.3	0.1	0.0	1.9	0.0	1.7	0.0	0.0	0.7	23.3	0.0	1.1	0.5	1.2	2.9	0.0	0.0	0.0	0.3	1.9	0.0	0.1
PHF23	"FLJ16355, MGC2941"	ENSG00000040633	"PHD finger protein 23"	Q9BUL5	17	7235029-7239722	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052410	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA052410: AB_2681822"	"unprognostic (1.76e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.72e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	22.0	39.6	21.3	24.5	21.0	10.1	19.1	21.6	25.1	22.3	20.7	24.2	22.8	23.6	23.3	35.3	20.2	20.2	18.0	22.7	23.1	22.5	26.3	18.3	30.4	25.4	30.3	19.0	17.9	24.3	20.8	23.0	25.1	24.0	17.7	15.2	19.1	22.8	22.6	19.3	21.4	22.9	21.8	28.4	19.7	24.8	23.1	36.7	24.3	21.9	34.2	29.1	23.3	22.9	49.6	78.1	85.2	56.0	54.4	54.7	33.4	65.8	72.2	78.5	66.7	42.5	34.2	72.5	39.7	71.2	55.4	46.6	81.1	54.1	64.6	73.7	67.4	54.6	51.5	47.8	87.5	26.4	82.7	75.9	51.5	68.4	45.6	82.3	75.6	34.8	61.1	17.4	92.7	37.9	45.7	53.5	80.7	35.7	34.3	61.5	41.5	35.4	83.9	27.4	28.0	89.0	47.0	37.9	75.2	50.9	46.0	30.7	69.5	69.0	47.9	41.2	82.8	32.0	35.2	37.6	62.0	42.9	60.6	23.1	8.2	15.5	16.2	6.6	13.9	12.0	12.3	17.9	9.3	15.6	10.0	12.5	15.9	10.7	9.5	16.7	11.2	7.9	21.3	21.0	21.6	25.1	22.7	23.1	25.4	30.3	25.1	21.8	23.1	22.9	22.3	6.4	9.2	2.0	21.9	84.1	22.7	21.6	56.9	13.6	36.5	17.7	18.7	15.7	17.2	22.0	6.2	32.1	31.2	24.0	39.2	39.2	19.8	20.2	25.7	26.0	18.6	33.6	3.7	21.5	21.0	20.0	8.6	22.1	17.7	15.2	17.5	13.8	37.0	16.8	2.8	18.5	26.4	20.9	40.3	24.8	24.8	20.8	33.8	4.7	37.3	14.5	35.0	3.5	2.5	35.1	26.0	17.3	23.7	28.9	16.6	30.1	11.4	11.0	39.5	14.8	29.1	30.9	22.4	39.2	83.3	76.8	21.3	30.5	16.5	27.1
PHF3		ENSG00000118482	"PHD finger protein 3"	Q92576	6	63635802-63779336	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024676, HPA025763"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA024676: AB_10599736, HPA025763: AB_10600987"	"unprognostic (4.33e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.37e-1)"	19.6	18.2	12.5	16.9	18.9	39.5	21.4	32.2	15.3	20.6	11.7	16.7	16.0	22.8	17.5	12.8	16.7	16.1	13.7	11.0	15.4	19.7	28.0	16.0	21.6	17.4	13.7	32.2	18.4	23.8	12.2	24.3	19.4	18.2	17.6	27.7	15.2	15.9	20.3	16.5	16.1	15.5	14.5	21.3	18.3	14.3	14.7	30.6	26.1	22.9	18.1	15.4	16.8	30.5	35.8	17.5	28.1	17.0	27.3	29.6	28.6	23.0	32.5	16.9	22.3	24.0	16.6	44.0	19.3	20.7	24.4	15.3	27.7	23.9	27.8	35.2	23.3	52.5	21.7	38.2	24.7	45.3	20.7	21.4	21.2	24.0	34.1	29.1	19.8	23.0	58.4	39.9	17.4	21.2	19.5	23.9	16.3	22.9	10.4	33.7	25.6	21.2	20.5	21.0	30.8	22.7	27.7	12.5	20.1	30.7	21.3	41.2	28.2	25.9	30.4	20.0	27.6	33.9	37.6	41.0	11.9	35.6	20.3	15.5	6.2	7.1	7.6	8.0	7.4	7.3	7.1	6.1	5.5	8.9	10.0	7.6	14.4	5.0	11.5	6.7	5.5	4.4	12.5	18.9	32.2	15.3	11.0	15.4	17.4	13.7	19.4	14.5	14.7	30.5	87.9	157.0	133.2	76.0	108.0	54.9	62.1	42.2	71.7	67.9	49.4	56.8	95.2	34.3	88.6	46.0	47.9	47.6	91.2	50.1	15.6	48.4	40.5	68.8	93.7	61.1	43.1	63.1	71.1	37.6	31.5	77.2	60.6	84.3	103.0	85.5	41.7	47.1	28.8	50.5	80.5	46.1	28.5	46.2	33.2	26.5	81.1	65.3	23.2	70.3	69.6	47.4	74.2	76.9	129.8	29.8	40.5	56.8	92.4	64.1	55.5	36.4	72.9	66.8	59.2	103.7	58.5	103.0	69.3	48.4	42.9	31.2	97.1	114.2	49.4	51.0
PHF5A	"bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7"	ENSG00000100410	"PHD finger protein 5A"	Q7RTV0	22	41459717-41468692	"Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028885	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028885: AB_10602079"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.91e-2)"	26.0	21.1	26.5	23.0	29.7	58.2	27.7	30.0	30.6	23.3	28.9	25.1	22.7	22.9	26.0	29.0	22.8	19.6	20.9	26.7	28.5	25.5	30.9	20.1	35.5	28.9	28.5	20.7	26.2	25.1	21.5	25.6	29.7	19.7	28.8	24.5	21.0	19.1	35.8	27.7	22.4	22.6	28.8	26.4	26.0	18.8	28.2	52.2	19.7	29.0	41.9	30.6	23.7	33.9	80.5	56.8	95.0	62.8	68.7	51.7	65.9	80.1	65.5	102.9	86.4	78.4	46.5	115.4	45.7	60.1	72.1	60.7	130.2	95.3	115.6	71.7	136.5	71.8	86.9	92.2	71.9	190.3	54.9	50.4	72.9	81.3	100.5	41.7	73.8	80.6	97.5	71.8	74.9	107.5	154.8	124.3	96.1	220.8	82.2	115.4	84.9	81.5	68.6	63.1	46.6	38.9	87.9	57.4	90.0	66.6	45.9	96.8	50.7	54.0	95.6	44.1	97.9	58.9	112.3	194.9	52.2	82.6	59.0	32.8	47.0	57.9	36.0	45.2	47.2	47.6	41.1	45.6	49.2	42.6	40.2	39.5	55.6	47.6	44.1	41.7	47.8	59.3	26.5	29.7	30.0	30.6	26.7	28.5	28.9	28.5	29.7	28.8	28.2	33.9	36.4	22.4	13.9	2.3	52.3	77.2	78.1	81.1	58.1	24.6	35.1	35.4	10.6	41.5	33.5	11.0	4.2	93.0	42.3	27.2	46.9	58.5	14.7	26.6	20.7	43.7	15.0	56.1	3.5	56.2	115.0	36.2	20.4	25.5	33.7	20.9	37.5	24.7	58.7	13.5	3.7	32.1	63.1	38.8	55.9	9.1	42.3	37.3	33.8	2.8	67.5	47.3	59.8	5.5	8.2	64.5	32.5	41.8	41.6	84.4	41.1	42.1	24.3	28.2	98.6	32.3	38.6	63.5	88.1	59.0	91.6	109.2	42.3	20.2	41.9	95.7
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373312-134428791	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	6.7	18.0	6.6	14.2	7.9	8.4	10.8	10.3	9.3	8.3	6.2	9.1	8.9	9.7	32.7	8.2	7.9	6.6	6.7	7.1	8.4	10.2	7.7	6.8	25.3	8.3	7.8	33.3	9.5	16.3	6.2	9.3	8.4	9.2	10.3	12.0	13.2	11.0	5.0	8.3	8.8	8.1	8.6	13.3	9.3	9.2	7.7	20.8	13.2	6.8	29.8	8.6	7.1	11.5	28.2	22.9	98.7	40.8	17.9	22.9	18.7	27.6	22.1	29.1	35.6	13.9	28.5	45.1	61.8	16.9	28.3	24.6	69.4	31.3	48.6	37.2	32.1	44.3	37.7	16.1	19.2	44.2	23.3	15.3	23.2	31.7	39.2	29.1	41.1	43.1	32.6	21.8	35.8	18.7	71.3	21.8	30.1	38.3	31.0	69.6	36.0	34.5	30.7	33.8	34.1	39.9	21.2	19.3	29.5	29.0	18.0	24.0	31.5	26.8	19.2	34.0	42.9	11.1	27.3	60.5	17.7	51.4	34.3	5.9	6.3	4.1	8.0	6.6	8.7	18.7	8.2	7.3	9.5	12.4	9.6	8.2	2.6	11.0	8.4	11.7	9.1	5.5	6.6	7.9	10.3	9.3	7.1	8.4	8.3	7.8	8.4	8.6	7.7	11.5	25.5	22.4	18.4	13.1	42.7	13.0	14.3	28.7	22.2	22.4	17.5	20.3	16.3	11.5	17.8	16.5	18.8	11.8	27.1	9.9	23.5	14.2	3.7	13.0	29.1	18.7	11.4	31.3	27.8	13.8	7.6	17.2	14.8	18.7	24.6	149.5	20.0	15.2	15.1	18.5	23.4	12.5	10.2	15.5	10.2	3.1	20.8	20.2	7.2	29.0	25.3	27.9	21.6	33.2	46.7	14.4	18.7	15.4	23.1	12.3	9.5	19.8	16.5	19.7	26.3	21.0	21.9	10.3	22.0	25.7	11.5	4.7	22.6	69.3	17.7	11.5
PHF7	"HSPC226, NYD-SP6"	ENSG00000010318	"PHD finger protein 7"	Q9BWX1	3	52410660-52423641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	212	"testis: 1216.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 2630.6;Late spermatids: 8698.5;Spermatocytes: 1456.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.8;U-266/70: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA036283, HPA070305"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA036283: AB_10795026, HPA070305: AB_2686248"	"prognostic favorable (7.38e-5)"	"unprognostic (4.57e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (9.44e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.61e-3)"	"unprognostic (7.44e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (2.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.34e-2)"	"unprognostic (6.79e-2)"	4.8	2.8	0.6	1.3	0.6	4.1	5.0	0.9	1.3	2.1	0.6	4.3	2.7	1.6	3.3	2.6	2.0	1.1	1.9	0.6	0.7	2.9	4.7	2.4	2.1	0.8	0.8	1.4	4.4	5.7	1.7	2.0	0.8	4.3	4.6	0.6	3.5	1.7	2.3	5.0	4.2	1.4	0.7	3.2	2.5	1216.7	0.7	2.8	2.2	0.9	2.2	2.4	2.3	0.8	2.2	0.6	1.6	6.8	1.1	1.6	2.8	2.1	2.2	1.7	2.1	1.1	0.9	3.6	0.2	1.6	1.0	1.2	1.2	3.4	2.9	4.5	1.6	4.1	0.6	2.5	1.1	4.6	7.5	1.0	3.7	1.6	3.5	0.5	2.5	8.3	2.5	14.8	1.3	1.0	5.4	1.7	0.7	0.7	4.6	2.4	1.5	4.5	1.8	0.9	1.1	1.3	2.0	0.1	1.6	2.0	1.0	2.3	1.8	2.8	1.9	3.0	4.5	17.4	9.0	2.1	1.2	10.4	1.7	0.3	1.1	1.8	0.9	1.2	1.1	3.4	1.0	1.6	0.5	1.8	0.7	1.5	0.2	1.1	0.6	1.1	2.5	0.9	0.6	0.6	0.9	1.3	0.6	0.7	0.8	0.8	0.8	0.7	0.7	0.8	4.3	3.2	4.6	15.7	7.8	4.6	4.8	3.5	13.6	11.2	6.2	5.0	9.7	4.3	1.3	7.3	8.4	3.5	5.8	7.7	13.7	3.6	2630.6	5.3	3.1	6.7	11.5	14.7	10.9	2.8	2.0	5.7	6.1	2.1	7.0	3.7	3.3	4.5	4.2	13.5	12.4	4.2	2.0	4.1	2.3	8698.5	77.0	7.9	8.8	1.9	4.4	8.1	7.2	5.5	16.3	3.7	2.4	63.2	7.6	1.7	12.7	7.3	6.0	15.3	52.6	6.0	4.5	1456.7	71.6	7.6	3.0	0.5	5.5	7.2	10.2	2.2
PHF8	"JHDM1F, KDM7B, KIAA1111, ZNF422"	ENSG00000172943	"PHD finger protein 8"	Q9UPP1	X	53936676-54048958	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 70.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 57.9;Spermatogonia: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038779, HPA062015"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038779: AB_10675950, HPA062015: AB_2684658"	"unprognostic (6.35e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (3.74e-5)"	11.6	8.1	8.3	13.3	11.1	16.2	13.8	9.5	10.3	13.9	20.0	11.6	10.3	14.1	70.6	13.4	14.1	9.2	9.8	7.8	11.2	9.7	28.7	13.5	16.3	10.1	9.4	19.3	17.8	10.8	13.9	13.2	11.2	16.0	9.6	14.6	12.8	18.3	11.0	13.1	14.2	9.4	8.1	13.9	12.7	40.1	10.2	18.6	13.2	7.8	15.8	14.1	13.5	13.3	16.1	14.0	20.4	19.9	12.2	9.6	33.3	12.0	10.4	12.9	11.4	15.7	12.8	23.4	6.9	10.8	13.9	16.5	51.1	10.3	13.7	36.4	23.8	14.2	18.1	15.8	9.6	22.4	25.6	10.9	14.0	15.0	20.2	9.7	12.0	24.3	18.7	33.2	7.6	16.1	30.6	16.9	37.2	11.0	19.6	29.7	22.5	22.9	8.9	19.2	29.2	14.5	31.6	20.5	10.5	31.2	20.5	15.5	14.3	10.3	14.5	19.2	10.0	25.1	25.4	28.3	12.2	27.9	11.3	6.1	2.7	4.4	3.2	4.8	5.1	2.3	3.3	3.9	2.9	3.1	2.5	2.8	4.4	3.5	3.2	2.3	5.3	3.4	8.3	11.1	9.5	10.3	7.8	11.2	10.1	9.4	11.2	8.1	10.2	13.3	9.5	9.6	10.3	17.3	11.2	8.9	9.4	4.5	15.4	13.7	13.9	8.1	7.8	5.7	5.4	9.2	12.5	13.9	14.1	8.3	0.0	5.1	54.9	34.5	11.3	11.3	5.4	5.2	19.7	4.6	4.7	6.9	10.7	40.2	14.0	15.0	7.9	39.4	6.8	8.4	22.0	8.8	10.2	11.8	6.4	31.4	9.3	11.6	3.6	20.6	9.2	6.1	9.2	27.2	30.0	4.4	9.4	6.4	14.4	10.9	9.2	3.7	16.5	15.3	6.6	11.6	9.2	57.9	58.7	15.2	9.8	12.2	13.5	6.3	8.3	14.7
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744218	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 135.0;Exocrine glandular cells: 136.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 25.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 975.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	51.4	3.0	113.6	9.4	125.3	11.4	30.1	130.7	125.9	46.1	89.1	27.2	7.6	25.4	79.6	56.6	49.3	7.6	22.4	108.8	128.8	40.9	126.0	18.0	14.9	121.8	113.9	46.1	171.1	103.9	23.7	13.2	122.4	52.6	7.0	7.5	156.2	33.5	2.6	92.5	13.3	15.0	117.0	6.5	41.7	40.3	115.8	34.0	29.5	4.3	13.3	35.8	62.9	153.6	156.8	35.2	148.0	444.6	64.9	82.8	286.1	101.0	209.3	132.9	257.6	195.7	28.6	0.1	58.1	270.5	16.6	205.6	216.8	224.6	83.9	1.1	162.1	29.1	151.3	153.3	135.7	214.3	1.7	147.6	338.6	146.8	142.2	83.0	100.1	519.7	71.4	443.9	66.8	380.9	222.8	90.1	440.0	93.3	274.6	228.0	181.1	24.8	9.6	120.4	160.8	146.0	65.9	63.9	975.9	103.9	164.8	505.7	0.9	38.3	172.1	207.3	134.8	294.0	79.9	246.1	456.9	328.2	302.7	5.3	1.1	0.2	4.7	0.3	0.2	11.1	2.4	8.2	5.3	4.0	13.0	25.2	2.2	1.8	0.3	2.6	4.5	6.3	113.6	125.3	130.7	125.9	108.8	128.8	121.8	113.9	122.4	117.0	115.8	153.6	5.3	3.2	12.6	31.6	10.0	51.9	118.1	24.2	42.7	0.7	29.7	38.0	2.1	128.7	12.5	20.2	2.1	49.9	2.2	1.6	135.0	60.2	51.2	15.6	3.8	6.9	1.8	5.5	0.3	136.1	54.0	58.7	8.6	12.2	5.7	30.9	3.6	96.1	9.2	0.0	0.6	3.6	18.3	2.2	4.3	116.9	67.7	6.5	56.9	2.8	11.0	82.4	0.0	14.1	32.3	35.6	2.0	127.9	27.4	62.1	0.2	118.4	24.7	3.4	13.1	11.2	48.8	20.0	19.4	57.5	77.1	25.3	5.9	71.4	3.2	56.8
PHIP	"BRWD2, DCAF14, FLJ20705, ndrp, WDR11"	ENSG00000146247	"Pleckstrin homology domain interacting protein"	Q8WWQ0	6	78934419-79078254	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019140, HPA019838"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA019140: AB_2670073, HPA019838: AB_2670287"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-2)"	8.5	5.7	7.6	8.4	9.9	29.4	12.0	18.8	9.3	11.0	6.0	8.5	5.8	11.1	8.4	6.2	9.8	6.3	6.6	6.6	9.0	6.1	4.8	8.8	11.0	8.8	8.7	11.7	8.4	8.5	9.4	7.9	9.2	8.7	7.7	20.5	8.5	7.0	9.7	8.9	7.9	7.1	8.3	9.9	8.1	6.4	8.5	13.1	7.8	8.4	9.1	8.4	9.2	14.0	13.6	10.8	25.2	24.6	9.6	13.7	14.6	14.3	11.3	12.0	15.1	13.4	8.2	22.3	11.1	9.0	10.1	12.2	19.1	9.1	20.1	32.2	13.9	25.0	20.7	10.0	4.4	28.2	15.4	8.4	7.9	14.4	14.3	10.1	12.9	14.0	25.5	20.8	11.7	9.1	11.0	21.0	15.9	7.0	11.8	18.9	32.3	9.7	12.9	18.0	24.7	15.8	19.0	14.4	9.2	16.0	11.2	37.6	15.2	13.9	9.8	6.8	23.8	14.2	14.9	12.3	5.9	17.9	21.2	10.0	4.2	7.7	4.4	3.0	4.7	6.1	5.3	5.0	2.9	6.6	5.8	4.6	14.4	4.6	5.7	5.3	4.8	2.1	7.6	9.9	18.8	9.3	6.6	9.0	8.8	8.7	9.2	8.3	8.5	14.0	64.4	70.5	109.9	181.8	92.5	63.2	88.9	56.7	48.9	183.4	53.7	52.2	58.6	54.3	95.9	55.2	152.2	85.4	95.3	52.1	1.9	71.6	33.8	94.6	75.1	74.5	72.7	80.4	168.9	47.2	91.0	77.3	59.7	58.4	115.2	76.6	71.0	21.3	51.0	181.7	196.4	58.2	71.2	83.8	75.6	17.2	101.2	83.3	49.8	154.6	134.7	84.4	83.4	154.3	346.1	58.1	49.1	87.6	124.8	81.5	46.7	19.0	148.4	174.1	52.6	97.9	87.4	127.3	53.6	50.1	56.4	102.1	92.9	50.5	62.1	104.5
PHKA2	"PHK, PYK"	ENSG00000044446	"Phosphorylase kinase regulatory subunit alpha 2"	P46019	X	18892298-18984114	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 42.7;Hepatocytes: 57.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002912	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA002912: AB_10961321"	"unprognostic (3.90e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.07e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.16e-2)"	"prognostic favorable (2.96e-5)"	12.7	9.6	4.6	6.8	6.3	15.0	7.6	6.6	5.5	9.0	6.9	6.8	12.5	10.5	6.5	6.3	9.9	8.1	12.6	5.6	5.4	6.7	34.3	6.4	7.7	6.9	5.6	16.8	15.2	8.1	12.8	10.5	6.7	9.7	6.5	10.6	9.5	7.1	7.8	8.8	10.1	6.2	5.5	9.3	8.6	9.7	6.0	12.6	10.1	14.3	7.4	6.2	8.1	7.3	11.3	10.6	6.1	10.2	8.2	7.5	16.6	4.9	4.1	7.1	7.7	11.3	7.3	13.3	3.6	6.4	11.2	10.3	11.0	12.8	7.6	6.5	11.2	15.9	17.6	13.8	5.8	15.2	19.7	12.6	8.3	8.7	12.5	11.8	7.4	13.8	5.3	8.0	5.0	12.0	16.0	25.2	7.5	5.2	11.2	12.4	12.5	14.9	4.6	5.0	5.2	8.0	14.8	15.3	6.8	20.3	18.9	8.8	13.2	9.6	5.3	10.3	7.6	7.6	6.7	10.1	5.4	8.1	5.2	4.3	3.2	7.2	2.0	3.8	2.1	1.6	1.7	1.5	2.1	1.7	1.9	1.9	5.4	3.0	2.5	1.1	2.3	1.9	4.6	6.3	6.6	5.5	5.6	5.4	6.9	5.6	6.7	5.5	6.0	7.3	6.1	9.6	12.9	27.7	5.7	6.5	5.4	6.0	8.6	11.1	8.0	7.4	20.1	12.8	5.1	9.2	10.4	16.8	3.4	9.6	0.0	7.5	7.2	6.4	11.8	7.3	4.2	14.5	15.2	5.1	17.5	5.3	4.1	7.2	1.3	42.7	20.3	57.4	8.0	5.0	19.9	7.4	4.1	18.9	3.8	5.3	7.5	10.5	5.4	13.1	8.3	17.0	7.2	16.6	16.9	6.3	12.6	7.9	7.4	6.9	12.4	4.8	4.1	13.3	0.0	7.4	5.9	7.9	7.9	8.6	4.7	10.5	7.4	12.1	10.7	3.6
PHLDA1	"DT1P1B11, PHRIP, TDAG51"	ENSG00000139289	"Pleckstrin homology like domain family A member 1"	Q8WV24	12	76025447-76031776	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 159.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1438.7;Basal squamous epithelial cells: 582.8;Urothelial cells: 760.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"monocytes: 1.1;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 296.3;RPTEC TERT1: 233.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016160, HPA019000, HPA063520"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028"	"unprognostic (9.09e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.55e-3)"	21.3	31.0	9.9	17.3	10.1	21.8	28.1	8.9	11.0	23.1	6.2	8.9	6.5	13.4	4.4	59.8	7.8	39.3	20.6	10.3	11.3	14.8	67.6	27.1	5.9	10.8	16.9	19.2	17.9	5.3	8.2	14.3	11.3	8.9	10.2	13.8	159.1	8.2	5.8	11.5	8.6	14.8	9.6	19.5	22.5	3.1	11.5	7.4	27.2	1.5	7.5	60.9	33.7	11.3	60.9	71.5	54.9	30.4	25.0	51.6	3.9	50.5	134.7	22.4	30.8	39.7	72.2	0.3	14.8	21.2	73.8	30.7	1.5	84.2	47.9	9.3	1.2	1.5	3.8	68.2	36.3	1.4	15.1	16.2	60.6	93.2	182.6	296.3	54.4	0.1	5.0	1.7	115.8	7.8	0.2	7.9	20.1	36.3	108.7	0.2	14.3	1.8	233.7	135.1	4.0	10.4	8.8	0.8	169.5	67.8	35.5	0.7	50.8	75.8	7.2	89.3	50.4	0.8	0.3	0.2	127.9	0.8	96.7	0.2	0.0	0.0	0.9	0.1	1.5	0.0	0.9	1.0	0.0	0.0	0.1	0.2	0.2	0.0	1.1	0.0	1.6	0.2	9.9	10.1	8.9	11.0	10.3	11.3	10.8	16.9	11.3	9.6	11.5	11.3	98.5	12.8	12.4	7.2	13.0	195.3	1438.7	249.6	582.8	5.2	136.2	140.3	34.8	11.5	44.4	31.3	2.1	4.7	42.9	11.6	84.1	74.8	2.2	11.5	111.2	162.5	117.7	0.0	7.8	43.1	11.5	203.2	55.0	20.4	79.5	7.1	21.4	127.8	94.7	1.7	14.6	41.0	384.5	14.0	123.4	2.1	9.3	110.8	286.4	8.4	24.0	97.8	0.0	142.2	2.7	208.4	27.7	15.4	19.0	116.1	0.2	39.3	12.4	5.2	269.5	59.8	276.3	0.7	3.2	66.3	75.6	7.4	132.8	20.7	18.0	760.3
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.0;retina: 32.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 104.3;Distal enterocytes: 75.5;Excitatory neurons: 69.5;Proximal enterocytes: 73.7;Rod photoreceptor cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040761, HPA041837, HPA048598"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA040761: , HPA041837: , HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	4.2	2.8	6.6	2.8	7.5	6.5	2.7	5.8	7.4	3.5	0.1	11.7	11.1	3.7	2.9	1.4	3.2	2.4	2.8	7.8	4.8	3.4	3.0	3.1	3.5	4.6	3.9	4.2	3.1	4.5	4.0	2.7	4.7	2.7	12.2	32.2	1.7	3.4	1.9	1.8	22.0	4.5	0.6	2.5	2.4	6.8	5.3	1.9	6.6	2.6	3.2	3.3	2.4	5.1	6.0	7.8	8.3	9.3	6.5	7.8	4.8	8.8	8.0	12.5	10.1	7.2	1.9	11.8	3.4	14.6	9.0	12.4	12.1	4.5	16.1	4.2	6.5	3.3	7.3	4.8	5.1	2.9	5.0	5.8	2.5	17.7	5.7	5.2	4.7	4.1	3.0	3.2	8.7	12.7	3.9	2.3	6.5	1.9	2.1	6.3	7.3	3.9	5.9	4.5	7.2	3.8	18.9	5.1	3.1	6.4	6.3	1.6	6.5	12.5	9.0	5.3	7.4	7.1	5.4	11.9	7.7	2.3	2.8	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.7	0.1	0.5	0.3	0.1	6.6	7.5	5.8	7.4	7.8	4.8	4.6	3.9	4.7	0.6	5.3	5.1	4.0	9.6	2.2	26.1	7.4	9.3	5.1	3.5	7.4	20.6	6.9	5.6	3.3	0.0	3.6	3.7	104.3	4.3	3.8	75.5	0.0	2.7	12.0	2.9	6.1	5.3	6.0	22.9	69.5	2.3	0.4	7.7	1.1	5.1	10.2	11.3	2.9	4.1	1.5	23.5	45.9	6.7	4.1	7.0	12.7	6.3	5.3	2.7	14.2	10.3	3.2	6.5	1.0	30.7	32.7	2.5	31.4	5.3	4.0	8.2	73.7	5.1	3.1	68.6	6.6	7.8	7.9	31.6	20.4	1.9	9.1	1.4	4.9	1.7	9.2	2.2
PHOSPHO2	MGC22679	ENSG00000144362	"Phosphatase, orphan 2"	Q8TCD6	2	169694454-169701708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 158.7;Spermatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034726, HPA034727"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA034726: AB_10602191, HPA034727: AB_2674302"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (4.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.53e-2)"	5.0	2.8	1.9	2.4	1.9	2.9	10.6	4.1	1.6	4.7	3.7	5.8	6.4	5.3	4.2	3.2	6.0	4.0	2.7	1.6	2.8	5.6	3.6	3.3	3.0	1.4	1.8	6.0	5.1	7.2	4.6	3.0	1.5	13.0	5.8	7.2	8.5	4.7	3.4	3.5	6.4	3.1	1.7	2.5	4.7	13.7	2.4	3.0	9.8	1.6	3.0	3.8	2.8	1.9	6.6	1.8	4.6	6.2	8.5	2.7	17.8	2.8	1.9	4.3	4.7	6.3	4.9	6.4	6.1	2.1	8.9	5.0	6.2	3.4	3.5	9.5	7.0	6.4	6.1	11.0	5.6	5.3	5.6	4.9	6.3	4.9	6.5	3.6	3.9	8.9	10.8	6.4	2.7	6.0	3.7	6.8	6.0	4.2	2.3	3.6	2.8	5.1	6.8	19.6	19.1	6.5	5.8	3.1	6.8	5.5	8.4	3.2	2.3	4.7	4.3	4.2	3.1	6.2	6.0	5.7	5.5	3.2	5.1	0.1	0.7	1.0	3.3	0.9	4.6	6.5	3.6	3.2	0.9	8.8	4.7	4.6	1.3	9.8	0.9	4.2	4.4	1.4	1.9	1.9	4.1	1.6	1.6	2.8	1.4	1.8	1.5	1.7	2.4	1.9	6.1	3.2	3.6	0.0	6.8	2.5	10.3	5.4	2.8	8.7	15.2	11.0	4.1	5.7	4.7	3.7	6.2	8.8	2.5	7.0	9.8	7.6	158.7	10.6	5.0	4.3	15.0	6.9	0.0	11.1	9.3	6.9	15.3	3.3	0.0	5.7	2.5	3.7	2.8	6.7	0.0	6.6	12.2	0.6	1.6	35.9	4.7	2.0	3.6	0.0	1.0	6.4	1.0	0.0	0.0	6.4	6.8	4.9	3.8	6.5	12.7	12.2	13.4	10.2	0.0	6.7	9.3	68.9	13.9	4.5	4.3	5.5	5.7	8.8	7.5	5.5
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2A"	O14813	11	72239077-72245664	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 19.9;brain: 18.3"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in some"	9	"pons: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	226	"SH-SY5Y: 569.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA053810, HPA065621, HPA078004"	Enhanced		Supported	Nucleoplasm		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367"			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.3	19.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	0.0	0.2	0.0	0.5	0.0	18.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.3	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	569.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	18.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHOX2B	"NBPhox, PMX2B"	ENSG00000109132	"Paired like homeobox 2B"	Q99453	4	41744082-41748725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 8.6;brain: 15.2"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"medulla oblongata: 10.1;pons: 15.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	89	"SH-SY5Y: 132.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.6"	"Group enriched"	"Detected in some"	18	"medulla oblongata: 1.4;pons: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	0.0	0.1	0.0	0.0	0.0	15.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	15.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 953.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		590000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	71.5	109.2	196.7	54.5	200.5	64.6	62.4	206.2	245.6	76.0	192.2	74.0	54.0	44.7	103.0	70.6	99.3	62.0	267.2	192.3	203.3	82.6	47.9	57.3	57.4	199.3	191.9	65.0	153.4	160.9	85.2	49.8	200.3	89.2	50.5	26.3	144.0	86.6	432.6	45.8	62.9	78.1	198.8	41.6	61.5	56.9	199.1	68.5	86.7	441.5	40.0	71.8	41.4	216.2	53.6	452.5	225.6	199.1	153.4	266.0	412.8	147.6	170.8	158.8	138.6	165.7	138.0	145.1	142.8	168.6	180.0	155.0	51.2	293.9	50.2	116.9	132.5	45.4	276.8	380.3	177.5	82.6	176.4	322.8	248.7	91.8	109.5	145.8	218.8	93.1	102.9	129.7	257.2	328.2	156.9	176.7	216.0	372.5	206.6	106.5	106.6	196.7	255.6	113.3	137.6	132.8	146.7	155.8	75.1	107.0	127.2	226.4	177.0	390.6	130.8	91.5	166.5	60.5	93.4	94.0	174.3	59.7	235.8	38.2	290.0	31.0	197.6	318.4	170.7	241.3	173.9	184.6	321.8	178.9	126.0	175.8	13.7	196.7	231.7	425.4	223.6	324.1	196.7	200.5	206.2	245.6	192.3	203.3	199.3	191.9	200.3	198.8	199.1	216.2	125.7	96.1	159.8	24.8	111.8	150.3	187.7	659.2	204.9	43.9	223.1	317.7	384.8	178.7	326.5	217.0	22.9	322.1	111.8	337.1	747.4	196.1	271.3	122.2	168.1	111.9	265.1	80.2	8.1	252.4	489.5	213.1	140.6	170.3	123.5	367.4	83.6	201.9	286.5	67.3	12.5	370.9	309.3	97.2	197.1	953.5	205.0	133.6	334.4	5.6	273.2	194.7	146.2	10.6	25.0	185.3	359.8	223.4	187.8	257.5	540.1	817.4	250.6	77.7	85.5	137.1	249.6	141.8	143.8	140.3	161.8	264.1	106.4	352.5	336.0	199.5
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.7;tongue: 57.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.1;Inhibitory neurons: 94.6;Oligodendrocyte precursor cells: 91.5;Oligodendrocytes: 144.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 25.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA012312: AB_2668649"	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (5.53e-2)"	7.9	4.8	3.7	13.1	4.6	12.3	7.1	5.0	6.3	8.7	2.7	6.0	4.0	8.7	5.2	8.6	5.4	10.7	13.0	4.6	3.8	5.7	6.3	7.6	18.1	4.1	3.2	8.2	4.5	26.3	4.6	11.0	3.7	6.7	6.6	7.2	5.0	8.0	112.7	6.8	8.0	11.9	3.9	12.8	4.4	10.0	3.9	9.1	6.5	57.7	17.6	11.7	5.8	7.2	34.6	15.5	20.9	42.6	17.8	19.5	17.3	59.6	54.1	34.9	39.3	26.6	27.3	31.0	4.8	46.4	37.8	27.9	30.1	15.5	49.3	20.9	24.0	12.7	16.7	7.8	19.3	16.9	33.5	11.6	14.5	20.4	30.4	22.4	12.6	17.1	21.0	53.1	37.7	21.7	14.0	10.9	18.9	9.6	18.2	13.8	42.3	25.4	9.6	45.9	20.0	27.9	33.4	37.5	21.9	30.5	39.7	13.0	12.9	59.7	31.9	34.0	35.5	24.9	31.1	38.3	18.9	26.7	52.5	14.1	2.7	4.6	1.8	11.7	3.7	8.2	5.6	1.7	2.8	5.3	1.7	1.8	1.6	5.1	25.4	1.2	8.2	2.7	3.7	4.6	5.0	6.3	4.6	3.8	4.1	3.2	3.7	3.9	3.9	7.2	12.8	6.4	15.2	31.6	54.0	15.9	20.9	9.0	21.1	8.7	13.2	10.0	23.8	14.3	10.8	7.3	12.5	13.7	18.4	8.9	0.0	4.4	27.4	8.1	20.9	9.6	5.4	8.4	109.1	6.7	8.6	18.3	7.7	12.5	39.2	26.7	18.9	5.7	11.7	3.3	94.6	6.6	22.4	32.7	32.6	4.5	12.2	39.7	10.6	47.8	11.1	4.7	10.3	91.5	144.4	5.7	5.6	13.5	34.8	9.0	2.3	2.2	9.7	9.0	13.1	15.1	15.3	47.6	39.2	14.4	17.8	14.8	54.2	14.7	4.8	21.5
PHYHIP	"DYRK1AP3, KIAA0273, PAHX-AP"	ENSG00000168490	"Phytanoyl-CoA 2-hydroxylase interacting protein"	Q92561	8	22219703-22232101	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 217.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 14.8;Excitatory neurons: 48.5;Inhibitory neurons: 15.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.3;thyroid cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 9.3;SH-SY5Y: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 101.1;basal ganglia: 300.5;cerebellum: 251.7;cerebral cortex: 256.5;hippocampal formation: 296.8"	"HPA068030, HPA069318"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Nucleoplasm	"HPA068030: AB_2685944, HPA069318: AB_2686117"	"unprognostic (1.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-5)"	"unprognostic (8.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.09e-3)"	11.3	33.1	106.0	1.5	183.9	0.0	9.3	98.1	217.1	11.6	0.0	14.1	1.3	14.5	2.8	9.8	25.6	6.7	5.2	210.3	21.9	9.4	0.7	2.5	0.2	63.7	11.5	7.1	1.6	0.2	35.7	2.5	58.1	11.9	0.6	2.2	1.8	5.9	0.9	55.8	5.1	8.1	2.0	11.5	3.7	10.7	30.7	0.2	3.9	0.3	0.2	12.1	15.1	137.4	0.6	1.6	0.3	0.0	0.2	0.5	0.8	0.2	0.9	0.2	0.2	0.1	1.4	0.0	1.5	0.5	1.0	2.6	0.0	0.4	0.0	0.0	0.1	0.0	3.0	1.0	1.1	0.0	0.0	0.6	0.0	0.6	0.0	2.5	1.7	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.2	9.3	0.0	0.0	2.9	3.5	2.0	0.0	2.4	0.2	0.0	0.2	0.7	0.0	1.4	1.1	0.5	0.6	0.1	0.0	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.0	183.9	98.1	217.1	210.3	21.9	63.7	11.5	58.1	2.0	30.7	137.4	1.1	0.0	0.0	7.2	0.0	18.9	5.5	5.6	14.8	1.5	0.7	1.3	1.4	1.5	1.9	3.7	0.0	0.1	0.1	0.2	0.0	0.2	0.8	0.4	3.6	1.5	0.0	0.0	48.5	2.1	0.4	5.6	0.5	0.2	0.0	0.0	1.4	1.0	0.2	0.0	15.4	0.7	0.0	0.0	1.4	1.8	3.1	0.1	1.8	5.6	0.0	0.6	0.0	7.5	5.8	0.8	0.0	3.8	0.0	1.3	2.6	3.5	0.3	1.1	0.0	0.2	8.0	0.4	0.4	8.2	10.9	2.2	0.2	0.1	0.1	5.0
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 209.1;Inhibitory neurons: 127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: AB_2686753"	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	18.8	21.6	45.2	19.2	61.0	24.1	16.8	2.1	74.4	20.4	9.6	23.7	15.8	24.2	9.9	14.3	19.5	13.5	21.5	65.3	9.0	21.3	25.2	19.1	20.5	14.6	4.8	21.4	18.7	34.5	25.2	17.9	14.5	19.5	14.9	27.7	16.5	16.9	23.6	15.1	22.9	21.9	0.0	21.0	26.0	25.7	8.6	34.3	18.0	15.9	18.0	22.2	16.9	43.3	24.5	20.2	17.4	26.3	48.7	29.1	24.9	21.6	32.6	31.3	30.4	15.9	10.2	45.6	12.6	43.9	30.7	21.1	33.4	20.9	19.0	38.9	50.9	47.1	27.1	18.3	24.3	47.0	36.1	26.2	12.9	26.7	14.7	20.4	25.8	13.8	130.2	37.6	24.6	33.8	41.6	16.0	13.8	43.4	20.6	41.1	38.1	8.5	17.3	38.3	42.6	31.0	28.4	32.6	22.6	24.3	27.6	21.3	26.2	56.4	29.1	21.1	18.5	28.6	31.3	35.8	37.4	33.2	24.1	2.1	3.7	5.3	3.2	3.8	3.1	3.4	3.6	3.9	2.5	3.4	3.6	5.0	5.1	7.0	3.3	8.5	4.3	2.2	45.2	61.0	2.1	74.4	65.3	9.0	14.6	4.8	14.5	0.0	8.6	43.3	13.0	12.8	30.4	65.6	14.7	10.1	6.5	7.6	9.6	35.8	17.2	14.4	30.2	20.0	10.5	7.3	47.9	17.8	21.5	19.7	1.9	9.7	36.5	10.3	17.9	15.5	19.2	12.4	209.1	6.3	19.6	15.6	38.7	15.8	12.0	13.8	11.4	19.7	20.1	37.0	127.4	16.7	10.2	21.0	12.6	25.3	19.9	20.2	10.6	39.4	10.9	23.1	16.5	50.3	88.4	8.9	9.7	24.0	15.5	10.1	23.8	10.3	9.6	25.4	26.3	14.5	19.3	35.3	29.6	14.1	9.8	20.0	15.3	26.1	14.3	8.9
PIANP	"C12orf53, DKFZp547D2210, PANP"	ENSG00000139200	"PILR alpha associated neural protein"	Q8IYJ0	12	6693791-6700815	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 90.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 16.1;Excitatory neurons: 24.4;Horizontal cells: 18.5;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 16.1;Peritubular cells: 13.9;Spermatogonia: 6.7"	"Group enriched"	"Detected in many"	4	"glioma: 14.7;testis cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.9;HAP1: 9.8;hTERT-RPE1: 16.2;NTERA-2: 20.8;SH-SY5Y: 19.4;U-2 OS: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010631	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA010631: AB_10603680"	"unprognostic (1.82e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.30e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	0.4	5.4	66.0	0.9	54.9	0.0	0.8	14.6	90.4	17.8	0.0	4.8	0.6	21.1	2.2	0.8	7.5	1.7	1.0	59.8	56.9	0.9	0.2	1.0	1.1	12.1	36.1	3.3	0.7	5.4	15.6	0.3	23.1	5.5	0.6	7.9	0.8	5.5	0.2	0.5	3.0	5.1	7.3	0.6	2.3	4.0	40.6	0.0	0.9	0.4	0.4	3.7	10.1	52.9	0.0	0.5	7.4	1.4	0.2	0.4	0.2	2.0	9.9	5.1	4.6	0.1	0.2	0.2	0.0	3.5	0.8	0.2	9.8	0.3	2.4	0.3	1.3	0.4	0.3	0.0	0.3	0.4	0.3	1.2	0.0	2.0	0.0	16.2	0.0	3.0	0.0	0.3	0.5	0.2	0.3	0.3	20.8	0.0	0.1	1.4	0.1	0.2	0.1	0.1	2.6	19.4	0.1	0.1	0.0	1.3	0.1	0.0	0.0	5.2	10.5	5.5	1.4	0.2	0.0	0.3	7.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.0	54.9	14.6	90.4	59.8	56.9	12.1	36.1	23.1	7.3	40.6	52.9	0.2	0.0	0.0	3.6	0.1	0.3	0.0	0.0	0.0	16.1	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.8	0.3	3.5	0.2	0.0	0.0	24.4	0.0	0.0	1.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	18.5	23.9	0.0	0.0	0.0	0.2	1.1	2.1	0.0	0.0	3.7	0.0	3.9	0.0	16.1	3.1	0.0	0.0	13.9	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	1.6	0.1	6.7	0.0	0.1	0.1	0.3	0.0	0.0	0.1
PIAS2	"ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4"	ENSG00000078043	"Protein inhibitor of activated STAT 2"	O75928	18	46803218-46920160	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 521.4;Late spermatids: 519.5;Spermatocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068792	Enhanced		Supported	Nucleoplasm		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA068792: AB_2686037"	"unprognostic (9.59e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.71e-1)"	4.8	5.4	7.3	4.1	8.1	7.4	5.1	16.9	9.8	4.9	6.4	4.9	2.8	5.0	7.5	3.7	4.5	4.6	6.8	8.7	6.2	6.4	5.9	4.3	6.2	4.7	6.9	5.0	4.2	11.8	5.6	3.9	5.4	6.5	7.0	10.9	5.5	4.4	16.1	7.7	4.2	4.7	3.7	6.0	4.5	67.2	7.9	4.6	8.2	10.2	5.2	4.1	4.4	8.0	13.7	5.5	6.1	8.7	6.0	7.5	2.9	7.0	5.6	6.0	5.5	6.5	5.1	13.7	3.7	5.3	6.1	4.5	12.3	7.5	8.5	6.6	4.6	8.5	5.4	7.7	5.9	14.3	5.8	7.7	4.5	5.3	5.6	9.7	5.5	11.9	6.4	3.5	12.0	7.4	8.2	8.3	6.7	2.5	3.5	15.0	13.1	0.1	5.5	10.4	11.7	9.0	6.4	4.1	4.7	6.8	6.1	6.3	6.9	12.8	5.5	4.5	5.3	10.1	5.4	17.7	9.5	15.1	12.8	0.7	1.7	1.2	2.0	1.3	1.3	1.6	1.8	2.4	2.0	3.0	2.5	2.1	1.0	1.9	1.3	2.1	1.9	0.8	7.3	8.1	16.9	9.8	8.7	6.2	4.7	6.9	5.4	3.7	7.9	8.0	26.3	19.2	21.9	60.4	25.0	20.6	19.9	15.2	23.9	57.7	21.8	13.2	30.7	12.8	12.6	25.8	89.6	2.6	32.8	18.1	19.6	13.5	521.4	16.6	25.4	26.0	28.5	16.6	137.9	8.9	2.3	20.6	19.4	15.9	14.5	48.4	34.2	22.3	28.1	32.0	134.9	18.0	16.2	50.3	15.7	519.5	33.5	24.2	12.4	73.1	34.7	21.9	40.2	133.7	94.0	7.9	17.1	35.0	30.3	28.4	11.8	23.1	13.9	36.0	6.6	42.5	18.2	238.7	72.4	24.7	15.3	1.4	19.2	35.6	25.5	18.0
PIAS3	"FLJ14651, ZMIZ5"	ENSG00000131788	"Protein inhibitor of activated STAT 3"	Q9Y6X2	1	145848522-145859836	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006389, HPA067383"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA006389: AB_2667576, HPA067383: AB_2685828"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.06e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (5.14e-2)"	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-2)"	21.9	11.5	11.3	12.8	10.8	4.9	23.3	10.2	12.2	35.2	13.5	24.5	7.6	32.0	7.9	37.3	37.2	12.1	18.1	10.9	12.8	13.7	7.2	17.9	9.1	11.7	12.2	23.4	13.1	14.4	15.4	10.7	11.7	21.6	8.0	9.8	29.2	21.1	25.8	34.4	14.6	23.6	11.3	13.3	21.7	11.1	13.9	13.5	14.9	14.5	17.9	29.1	34.9	10.7	34.6	23.5	23.8	21.1	35.9	67.3	14.5	31.8	43.6	35.5	39.3	19.3	22.2	17.8	33.6	54.8	15.0	35.0	12.4	50.4	29.9	19.4	18.3	8.2	15.9	10.4	35.8	14.7	38.8	55.2	32.3	32.9	18.6	45.6	52.0	15.8	13.2	24.0	74.7	57.6	15.8	7.8	37.0	97.3	37.7	24.6	16.2	11.7	28.2	20.5	8.1	37.9	30.7	16.9	15.5	27.0	78.0	22.1	80.7	47.2	34.8	31.7	20.9	32.6	15.7	11.5	45.8	10.9	23.9	8.9	9.1	10.7	10.6	8.7	11.4	5.4	6.7	11.6	6.8	3.6	6.2	6.0	2.2	15.2	12.5	8.4	8.1	7.0	11.3	10.8	10.2	12.2	10.9	12.8	11.7	12.2	11.7	11.3	13.9	10.7	14.7	22.4	11.5	8.5	8.6	10.7	7.9	15.4	19.4	10.2	16.2	16.5	0.9	4.3	22.8	16.5	12.5	3.7	10.0	2.1	1.9	7.9	2.3	29.4	14.8	12.3	4.2	2.1	4.2	7.7	7.3	11.9	13.3	19.1	10.8	4.9	13.2	3.8	5.2	10.1	3.9	6.2	12.2	4.4	7.0	3.9	14.3	4.1	5.4	7.5	13.1	4.2	8.2	6.6	7.4	12.7	2.0	13.2	4.8	9.2	2.1	1.8	37.6	11.8	26.3	7.0	13.6	4.0	11.4	19.9	16.3	4.0	8.6	6.0	2.8	10.4
PIAS4	"FLJ12419, Piasg, PIASY, ZMIZ6"	ENSG00000105229	"Protein inhibitor of activated STAT 4"	Q8N2W9	19	4007736-4039386	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 103.7;Late spermatids: 264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010598, HPA076008"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA010598: AB_1079616, HPA076008: "	"unprognostic (1.23e-1)"	"unprognostic (8.94e-3)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (2.45e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.33e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.52e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.67e-3)"	8.0	10.7	9.2	6.0	11.8	4.7	9.0	11.6	11.4	11.0	3.8	15.4	6.6	10.5	2.3	11.1	8.8	2.9	10.1	8.5	7.4	8.7	15.5	7.9	5.6	12.2	11.5	10.6	13.9	3.5	10.4	5.3	10.3	11.4	2.4	3.7	9.8	3.9	10.6	12.7	9.9	3.8	8.5	11.6	12.1	37.2	10.4	5.9	7.5	4.8	4.0	10.4	9.7	17.4	15.1	10.6	9.7	9.3	4.7	4.2	15.4	9.0	4.9	9.2	8.4	16.7	6.8	11.4	7.9	4.8	10.1	15.5	10.0	7.1	4.0	18.5	15.8	8.2	7.8	13.1	9.6	12.0	13.8	4.9	7.8	8.3	5.1	5.1	11.1	11.6	15.5	15.2	4.5	15.5	21.9	13.9	21.6	7.3	9.7	19.3	9.9	15.0	6.1	8.3	17.8	19.8	12.8	12.4	10.3	7.3	11.5	11.0	8.2	9.2	13.2	19.4	14.2	28.3	22.8	14.4	7.7	14.6	11.5	10.5	13.2	19.8	15.2	15.3	10.8	16.1	10.8	14.0	11.0	14.6	9.3	10.6	15.8	17.1	19.5	11.0	13.0	10.3	9.2	11.8	11.6	11.4	8.5	7.4	12.2	11.5	10.3	8.5	10.4	17.4	12.8	3.2	15.0	15.0	10.1	18.4	8.4	15.8	7.4	18.8	14.5	11.2	3.6	11.5	11.5	9.2	12.5	24.3	12.3	13.2	7.9	17.1	103.7	13.9	10.7	12.3	22.1	9.9	7.3	17.6	16.9	9.1	11.7	12.4	7.0	15.2	11.4	12.3	14.6	26.9	5.7	15.6	20.3	8.3	9.2	264.3	14.0	10.6	7.2	2.8	12.8	11.3	10.3	6.6	18.0	13.5	7.8	18.4	12.0	11.9	14.0	12.5	15.6	23.1	6.6	8.1	9.3	69.1	42.1	7.4	15.5	36.4	10.1	13.3	12.4	9.0
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.3;Erythroid cells: 17.7;Granulosa cells: 15.1;NK-cells: 15.5;Theca cells: 18.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	0.7	1.0	0.8	2.6	0.8	3.8	0.4	0.7	1.3	0.9	0.7	2.4	1.9	0.8	0.1	3.1	0.7	0.8	0.9	0.7	1.2	0.6	0.6	1.0	4.6	1.4	1.0	0.4	0.2	0.2	0.5	0.9	1.1	1.7	1.0	0.1	0.6	0.7	0.3	1.0	2.6	1.2	0.9	4.8	1.8	2.5	1.2	3.6	0.5	0.1	3.3	1.5	1.4	0.8	7.7	8.7	21.1	8.6	3.7	4.3	7.8	7.4	3.9	7.3	5.6	14.0	12.6	9.3	3.0	3.6	6.8	20.9	21.8	6.2	2.7	14.8	8.0	10.8	28.5	10.2	1.9	4.3	8.4	2.5	0.0	3.2	2.6	1.8	7.5	13.6	7.2	18.0	7.0	6.7	4.7	17.9	17.2	9.7	6.0	9.7	7.0	13.0	4.1	4.3	8.7	5.6	5.7	6.3	3.3	9.2	7.0	4.7	5.2	4.4	22.6	7.0	14.0	14.3	14.3	9.0	4.2	18.8	6.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.8	0.7	1.3	0.7	1.2	1.4	1.0	1.1	0.9	1.2	0.8	1.2	0.0	1.1	3.6	6.5	1.9	0.8	0.6	0.0	0.5	0.6	0.6	1.9	0.0	0.1	0.0	0.0	5.1	7.5	3.2	0.0	0.0	21.3	0.4	4.4	2.3	0.0	17.7	2.6	0.0	6.5	5.6	3.6	0.7	0.0	15.1	5.3	0.5	5.8	0.0	1.0	2.4	0.0	5.1	2.0	2.3	1.5	4.5	0.0	1.9	0.1	0.8	15.5	3.5	0.1	0.2	0.1	2.2	9.7	1.1	0.2	0.1	0.1	1.2	6.6	4.2	3.5	0.8	2.0	1.6	1.0	1.1	7.5	18.3	6.2	1.3
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.57e-4)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	9.6	8.6	8.0	6.3	8.4	5.6	10.1	9.7	10.4	8.6	8.5	8.8	10.6	8.3	11.8	8.1	8.9	6.1	5.6	7.8	8.5	9.0	14.3	7.7	7.8	7.8	7.8	10.4	10.2	6.1	10.4	6.3	8.2	9.8	8.4	6.3	8.2	6.1	5.3	11.4	10.1	5.9	7.6	7.8	10.5	8.7	8.2	6.4	10.1	3.3	8.3	7.8	8.1	9.4	12.5	16.3	11.4	9.3	16.0	15.2	4.6	6.3	8.0	10.8	19.5	17.2	15.4	6.6	13.7	6.7	6.9	17.4	14.7	8.2	15.0	13.1	38.3	12.3	13.6	21.9	17.3	5.0	7.4	12.5	20.3	19.1	22.0	10.9	13.0	20.1	14.6	7.3	8.6	11.1	9.3	11.6	4.5	25.2	8.3	9.0	9.7	15.6	12.3	6.6	6.0	8.5	6.7	4.9	14.6	29.9	5.4	4.5	7.6	9.1	6.0	6.6	19.8	5.5	0.2	10.3	12.2	12.5	6.2	0.0	2.7	4.7	4.6	2.6	4.1	3.7	6.3	3.7	2.0	2.8	6.4	5.5	0.0	4.8	1.8	5.3	5.4	2.5	8.0	8.4	9.7	10.4	7.8	8.5	7.8	7.8	8.2	7.6	8.2	9.4	8.5	9.6	21.0	19.2	10.0	4.5	9.2	9.1	11.4	11.5	9.8	9.8	2.4	7.2	13.0	12.9	10.4	15.6	9.3	7.3	5.9	6.3	3.0	7.7	11.4	6.6	7.8	11.6	46.7	7.5	8.0	8.8	11.7	6.9	5.1	14.0	5.0	10.5	5.2	6.7	45.3	11.2	10.2	3.5	4.3	2.9	7.8	5.9	3.6	26.2	3.6	5.2	9.2	24.6	34.9	9.4	9.7	11.3	12.2	8.3	9.8	5.9	10.6	12.2	0.0	9.1	7.3	16.1	8.3	7.5	6.0	9.6	11.8	9.4	12.6	10.4
PIGO	"DKFZp434M222, FLJ00135"	ENSG00000165282	"Phosphatidylinositol glycan anchor biosynthesis class O"	Q8TEQ8	9	35088688-35096601	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014905			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli	Nucleoplasm	"HPA014905: AB_1855369"	"unprognostic (1.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.81e-2)"	8.6	12.9	5.4	9.2	7.5	5.9	10.9	7.6	6.1	9.8	9.6	11.7	14.5	10.5	11.2	10.5	15.5	9.5	7.7	5.3	6.0	14.7	15.3	10.0	9.1	7.8	6.8	12.5	16.4	33.2	9.4	12.3	7.6	12.5	12.9	10.5	13.0	11.9	6.8	10.0	11.3	8.6	6.8	11.3	13.1	12.2	6.2	11.4	20.0	4.7	10.2	9.4	8.6	9.8	30.5	51.5	14.4	20.8	12.5	13.8	25.6	12.7	22.0	30.0	24.5	19.0	30.2	17.1	22.7	15.4	41.8	21.6	24.2	39.6	18.0	19.0	15.7	10.3	31.2	14.5	24.5	13.9	17.1	17.1	42.8	26.8	43.7	23.9	15.8	25.1	11.4	23.7	24.9	16.8	16.5	15.9	9.2	18.9	20.8	16.9	11.6	18.8	32.9	20.8	11.9	16.1	17.5	42.8	10.0	15.7	32.2	9.1	9.7	21.8	19.1	11.8	23.6	14.4	22.9	7.1	23.4	10.3	27.8	5.3	5.1	6.3	6.4	6.7	6.6	3.5	3.5	7.3	10.4	4.8	4.5	5.4	1.8	5.7	4.6	7.3	6.0	3.5	5.4	7.5	7.6	6.1	5.3	6.0	7.8	6.8	7.6	6.8	6.2	9.8	6.3	3.2	13.9	4.6	7.9	2.5	4.5	7.9	8.6	9.1	6.1	3.8	3.1	14.3	12.2	16.5	2.1	21.0	10.2	13.3	0.0	13.6	1.2	11.3	5.5	5.2	3.0	2.1	1.7	14.0	16.0	5.6	11.7	10.1	7.0	7.9	4.2	11.7	11.6	11.8	1.9	7.4	8.2	6.6	4.2	1.0	4.4	5.8	3.6	2.8	6.7	14.3	5.2	1.5	3.9	8.4	7.7	3.0	8.7	3.7	11.4	7.4	16.1	11.8	6.6	5.1	4.8	20.0	10.4	6.7	2.0	22.6	7.2	7.2	10.8	4.0
PIGQ	"GPI1, hGPI1"	ENSG00000007541	"Phosphatidylinositol glycan anchor biosynthesis class Q"	Q9BRB3	16	566995-584109	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 78.9;Late spermatids: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039105, HPA039828, HPA061414"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: AB_2684508"	"unprognostic (1.23e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (2.53e-6)"	"unprognostic (2.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	13.3	23.9	7.1	3.8	8.0	30.4	15.0	2.0	12.0	15.4	8.6	16.2	7.5	18.3	1.4	13.2	16.5	2.8	13.3	9.6	5.2	30.7	19.0	17.9	2.5	6.6	9.7	15.6	21.9	9.4	25.4	3.3	6.5	19.4	1.1	1.2	19.3	5.8	18.4	15.7	12.6	1.6	3.5	15.0	17.0	28.1	6.0	2.7	31.1	1.7	1.2	15.8	12.1	4.3	14.2	21.9	7.3	10.3	4.6	2.7	13.9	14.7	5.6	6.3	6.6	14.6	12.9	7.6	18.6	3.3	5.5	22.2	3.3	6.4	1.3	21.9	30.4	11.4	23.8	10.8	8.9	10.1	10.2	5.2	9.8	10.2	2.0	4.0	6.1	13.7	26.1	4.1	2.1	20.7	18.3	11.4	10.0	3.0	21.9	36.6	6.4	17.7	5.6	5.6	13.2	21.4	16.8	7.6	10.8	2.3	17.3	6.9	14.5	10.4	13.7	11.7	10.4	15.8	5.0	6.0	4.8	5.4	10.4	0.9	2.8	1.6	2.8	3.1	2.4	2.3	2.3	2.6	2.7	2.5	2.5	1.6	3.0	3.3	3.7	5.6	2.4	2.6	7.1	8.0	2.0	12.0	9.6	5.2	6.6	9.7	6.5	3.5	6.0	4.3	9.7	16.0	20.3	14.0	6.9	4.8	6.6	8.4	5.2	12.1	15.8	11.0	8.4	4.3	10.6	40.5	4.2	10.5	8.8	31.5	3.9	19.3	33.6	21.0	7.8	9.0	20.3	78.9	19.3	17.4	8.4	9.4	16.3	11.4	8.2	19.7	6.4	16.4	9.5	10.1	13.8	13.0	8.2	9.1	4.4	61.4	7.5	8.2	16.0	3.7	7.7	14.6	10.3	7.5	6.6	14.1	11.6	7.2	9.1	6.9	7.6	12.4	23.3	13.7	0.0	7.7	9.9	30.1	13.6	6.2	4.8	5.9	7.8	11.1	16.9	5.0
PIGU	"bA346K17.2, CDC91L1, GAB1"	ENSG00000101464	"Phosphatidylinositol glycan anchor biosynthesis class U"	Q9H490	20	34560542-34698790	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041706, HPA046766"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA041706: AB_2677627, HPA046766: AB_2679794"	"unprognostic (1.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-3)"	"unprognostic (7.94e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.86e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.27e-2)"	"unprognostic (4.21e-3)"	11.0	14.8	20.8	9.7	25.3	10.6	13.5	23.4	25.3	13.6	18.0	20.0	12.2	16.3	19.8	18.6	25.1	11.4	16.2	21.2	22.0	16.0	13.8	10.3	11.8	24.5	22.5	20.9	11.5	28.9	14.3	15.9	24.7	12.3	22.3	16.5	12.3	13.5	16.2	12.9	13.3	17.6	23.3	9.6	10.9	19.1	22.7	14.7	13.2	20.5	15.8	14.2	13.8	31.7	30.2	37.2	47.0	34.4	30.0	36.1	46.8	30.0	35.8	50.3	43.9	69.3	61.9	38.4	48.0	30.0	65.1	54.5	43.1	57.0	50.6	16.5	23.2	87.3	22.6	78.9	27.9	53.4	20.0	32.1	36.2	28.9	32.8	23.2	36.7	37.9	44.4	33.4	43.0	33.5	45.6	54.0	23.7	68.8	55.9	32.7	58.5	61.8	44.5	27.4	30.0	28.2	56.6	101.0	38.0	26.0	55.8	37.1	21.7	82.0	29.1	44.8	30.8	22.2	33.3	25.4	49.9	54.8	36.0	14.0	5.6	2.4	16.2	8.4	14.4	10.7	14.5	17.8	13.6	12.6	14.4	14.5	1.0	16.7	6.8	13.2	14.1	8.8	20.8	25.3	23.4	25.3	21.2	22.0	24.5	22.5	24.7	23.3	22.7	31.7	5.2	9.6	4.8	26.8	6.4	4.5	11.8	32.7	7.4	8.9	4.9	4.7	6.6	8.6	21.6	11.0	16.7	40.1	5.7	15.4	1.9	19.2	17.8	14.4	7.2	9.1	10.2	9.1	30.4	17.6	29.3	10.1	4.6	11.5	8.2	19.5	7.1	8.5	15.8	1.7	39.0	15.3	22.4	6.5	2.2	16.7	5.6	4.7	1.8	16.9	5.7	8.5	5.2	46.3	78.5	10.4	19.0	7.9	7.6	10.6	9.0	9.2	28.5	9.5	19.7	8.3	13.7	34.6	12.8	9.5	5.8	21.2	6.8	9.8	24.3	8.7
PIGX	FLJ20522	ENSG00000163964	"Phosphatidylinositol glycan anchor biosynthesis class X"	Q8TBF5	3	196639775-196736007	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 87.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 87.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029409, HPA073301"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029409: AB_10610280, HPA073301: "	"unprognostic (8.83e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.25e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.45e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-1)"	10.5	10.3	14.4	10.4	15.6	9.0	9.9	14.7	16.7	7.5	19.5	10.8	9.1	8.3	12.4	10.3	7.9	8.3	9.6	15.2	16.7	12.2	8.2	7.2	7.1	15.1	15.8	6.8	9.0	19.6	12.7	8.3	14.8	12.8	10.1	17.4	9.9	10.5	17.1	10.4	9.1	11.2	16.0	6.8	7.6	6.0	16.2	11.6	9.2	14.1	10.9	8.7	7.6	16.7	39.4	18.7	21.4	18.1	22.7	15.3	12.6	18.1	20.7	19.3	20.5	13.7	25.6	20.3	63.6	15.4	25.1	22.2	19.5	16.6	23.1	18.6	19.6	21.0	12.8	12.6	19.2	20.6	34.6	15.1	25.7	17.1	15.7	16.3	12.7	36.5	11.7	38.6	21.0	30.1	59.2	32.1	12.8	30.7	18.3	31.1	27.6	29.5	24.6	11.5	24.4	29.2	31.8	23.9	29.7	16.9	71.8	20.3	8.2	18.1	9.2	25.6	29.5	57.0	70.4	41.1	20.7	26.9	21.5	39.6	7.5	87.5	3.3	10.8	3.0	4.6	3.1	4.6	7.7	5.5	3.7	3.2	18.8	8.7	11.6	3.3	4.4	4.1	14.4	15.6	14.7	16.7	15.2	16.7	15.1	15.8	14.8	16.0	16.2	16.7	14.2	19.2	16.3	13.7	16.4	17.1	30.1	5.5	31.9	34.9	28.3	19.2	12.6	21.5	8.4	29.5	47.9	21.4	31.6	20.8	35.2	7.9	30.5	17.2	23.5	16.9	15.7	15.8	17.7	5.6	20.9	22.0	9.2	17.9	12.0	19.3	17.5	16.6	20.1	33.7	23.7	17.0	8.2	21.4	25.4	22.7	28.0	18.1	21.4	15.9	25.0	50.0	32.0	12.1	14.5	5.2	12.5	35.0	20.1	33.8	27.1	32.5	10.2	39.1	26.3	23.6	28.1	27.1	36.0	29.3	15.9	11.6	21.2	22.7	25.7	23.0
PIH1D2		ENSG00000150773	"PIH1 domain containing 2"	Q8WWB5	11	112063218-112074274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 66.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 425.9;Endometrial ciliated cells: 68.8;Late spermatids: 157.5;Respiratory ciliated cells: 115.3;Spermatocytes: 215.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039496			Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA039496: AB_10959385"	"unprognostic (8.74e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.82e-2)"	"unprognostic (9.05e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	0.8	1.0	1.8	0.5	1.8	0.4	1.9	1.6	1.8	1.8	9.6	0.9	0.5	1.7	4.8	1.2	14.8	1.6	1.3	1.9	2.0	3.9	0.7	2.9	0.4	4.0	4.6	1.2	1.1	4.1	3.3	0.7	3.4	0.9	0.8	12.4	1.3	1.4	1.0	1.2	0.4	0.6	3.5	0.3	1.0	66.5	2.1	0.6	5.3	0.4	0.4	0.8	0.8	2.5	1.9	1.1	3.1	1.6	0.7	0.8	2.3	0.7	2.2	1.8	2.3	3.0	6.4	0.9	2.4	1.8	2.5	2.6	0.6	1.8	1.9	0.9	2.1	1.3	1.4	1.6	1.3	1.8	0.3	1.2	2.3	4.7	2.6	1.6	0.9	1.3	2.0	0.6	1.3	0.7	0.7	2.5	1.0	1.0	1.6	1.1	2.0	2.6	5.6	0.9	3.6	1.0	2.9	0.5	1.0	0.7	8.0	0.5	0.1	1.6	1.4	0.8	0.6	0.4	0.3	1.3	1.9	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	1.8	1.6	1.8	1.9	2.0	4.0	4.6	3.4	3.5	2.1	2.5	1.4	6.4	0.5	10.1	0.0	0.6	1.6	7.8	1.8	2.6	1.9	2.2	3.1	5.7	9.9	3.7	2.1	0.9	0.0	0.5	15.6	3.8	425.9	68.8	2.8	1.3	3.0	0.0	5.1	2.3	0.7	1.5	0.0	2.6	1.3	1.5	1.1	0.2	0.7	1.7	5.8	0.5	10.2	0.3	0.4	157.5	2.8	0.8	3.6	1.9	0.6	5.6	0.0	4.0	3.9	1.6	0.4	1.5	0.0	0.6	0.2	10.4	115.3	16.9	0.0	0.7	3.3	215.5	8.4	0.4	1.0	0.3	0.6	1.6	0.4	0.9
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593315-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 83.2;lymphoid tissue: 62.3;salivary gland: 73.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;Hepatocytes: 70.7;Kupffer cells: 127.0;Macrophages: 89.8;Microglial cells: 60.9;monocytes: 57.4;NK-cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 44.7;memory B-cell: 48.3;naive B-cell: 44.5;non-classical monocyte: 123.0"	"Group enriched"	"Detected in all"	6	"B-cells: 48.3;monocytes: 123.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;NB-4: 62.1;REH: 183.5;THP-1: 92.9;U-698: 114.7;U-937: 95.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	8.1	4.5	2.1	51.1	2.0	47.5	4.7	2.4	3.2	2.8	2.7	7.3	6.8	2.1	1.7	2.4	2.2	24.8	2.5	1.9	2.9	11.8	83.2	16.7	61.2	6.5	4.6	6.0	22.8	2.0	1.4	14.1	5.3	2.8	8.6	3.1	73.6	2.4	0.7	1.0	7.7	8.3	4.7	62.3	6.9	3.0	5.7	8.7	4.1	3.1	57.8	15.2	0.6	7.6	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.2	2.8	1.5	85.3	8.5	0.0	1.3	0.1	17.7	0.0	0.6	48.0	3.0	13.0	0.0	1.7	0.1	36.1	6.7	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.9	0.1	0.1	0.4	1.1	62.1	0.8	24.3	1.0	183.5	4.3	20.0	0.2	0.1	3.6	2.0	0.2	0.2	1.1	0.3	0.2	92.9	0.0	0.0	2.8	0.1	0.7	0.7	0.2	114.7	0.0	95.2	0.0	6.1	16.0	10.5	13.3	44.7	4.7	48.3	0.3	4.1	12.9	44.5	0.1	3.3	13.5	14.0	123.0	11.3	0.5	14.4	2.1	2.0	2.4	3.2	1.9	2.9	6.5	4.6	5.3	4.7	5.7	7.6	0.5	3.2	3.9	1.3	53.7	1.5	0.1	0.1	0.6	0.6	2.2	2.3	2.6	32.9	2.2	1.8	2.1	0.5	41.5	8.1	1.9	40.0	4.3	0.3	0.1	1.8	1.8	10.3	0.8	29.1	0.9	0.7	0.0	0.2	14.0	0.2	5.7	70.7	47.7	0.0	0.8	2.8	4.1	127.0	32.5	1.0	1.2	89.8	5.4	60.9	57.4	0.2	58.7	1.0	0.3	16.4	21.2	2.2	9.4	0.4	1.6	18.3	1.1	3.4	0.0	0.6	0.8	0.8	0.2	0.3	1.1	2.3	18.3	0.4	3.8	0.3
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.5	13.7	16.3	12.3	25.9	9.4	15.9	22.5	14.6	16.1	17.4	13.2	14.9	18.0	15.7	15.4	14.5	19.0	12.4	10.5	14.0	23.5	15.5	16.6	11.3	16.6	16.1	14.1	12.3	43.6	10.3	23.1	17.0	16.4	13.0	22.4	11.8	14.8	6.4	12.3	11.8	18.3	13.8	13.0	18.0	19.3	19.6	9.4	30.7	12.1	10.9	14.9	12.0	15.8	53.8	24.1	39.6	24.8	28.0	28.3	35.3	33.2	35.7	23.9	33.2	58.9	6.0	15.6	16.2	28.6	39.1	34.8	31.9	25.4	42.1	13.5	27.6	9.8	28.4	23.3	30.6	12.3	14.9	22.2	17.5	23.6	45.8	22.2	57.7	9.9	23.4	14.7	18.6	16.6	6.6	7.7	22.6	30.1	18.5	6.9	41.1	11.0	29.6	47.0	23.2	20.5	50.6	21.4	23.2	33.0	12.7	12.3	72.5	19.1	27.4	50.1	20.4	5.9	14.1	12.8	22.8	11.3	22.6	1.7	1.5	1.1	1.7	1.0	1.1	1.4	1.3	1.3	2.1	1.5	1.7	1.0	2.3	1.8	3.2	1.4	0.9	0.6	16.3	25.9	22.5	14.6	10.5	14.0	16.6	16.1	17.0	13.8	19.6	15.8	93.2	76.9	62.0	217.4	25.0	35.3	26.1	18.7	24.5	49.1	34.7	25.0	29.7	25.8	33.1	36.8	70.9	29.6	29.5	22.6	19.6	19.8	35.9	51.8	35.1	87.6	28.7	11.2	57.0	25.1	17.9	28.6	45.3	72.4	32.2	22.8	106.7	32.4	19.2	35.3	81.1	23.5	18.3	46.3	33.1	18.6	25.7	27.0	19.6	69.3	19.6	73.0	17.5	62.8	79.4	26.1	13.1	31.2	29.9	42.7	15.2	22.4	26.4	40.4	39.5	33.7	35.1	52.6	26.8	23.5	34.0	143.5	25.3	25.1	20.7	37.3
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 70.3;RT4: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: AB_2681104"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.16e-4)"	12.0	3.6	10.4	15.2	23.6	5.0	9.7	8.5	23.3	7.4	0.0	15.8	14.4	8.4	4.8	12.9	6.5	8.0	10.6	11.2	18.8	10.2	4.9	17.2	23.4	19.2	20.4	3.0	5.2	3.2	3.3	12.8	17.1	6.2	12.9	2.9	7.2	5.4	20.9	21.2	14.9	9.9	7.3	13.6	18.9	1.9	28.0	22.3	8.1	10.8	22.1	10.9	10.7	44.2	7.5	14.8	12.9	11.9	7.4	0.6	70.3	0.9	2.9	2.8	2.1	8.8	19.2	12.7	2.7	1.7	2.5	18.3	7.7	5.2	1.1	7.7	2.1	0.3	30.1	3.3	0.4	4.5	9.3	0.9	5.4	0.7	0.4	1.1	19.1	12.6	4.7	8.3	0.2	16.7	15.4	12.8	11.8	29.3	9.3	16.6	3.3	2.4	3.5	75.6	14.1	7.8	26.0	35.9	8.4	4.7	16.1	2.4	0.7	0.4	4.5	1.3	0.2	8.9	2.6	16.4	0.5	6.7	1.9	0.0	0.1	0.0	0.5	0.0	0.5	1.5	0.6	0.4	0.1	3.2	0.3	0.3	0.2	0.8	0.0	0.0	1.2	0.2	10.4	23.6	8.5	23.3	11.2	18.8	19.2	20.4	17.1	7.3	28.0	44.2	26.7	0.0	12.2	16.0	15.3	3.8	2.1	7.9	1.2	16.6	5.3	4.4	6.9	5.7	6.9	3.7	0.0	4.4	3.3	29.2	0.0	1.8	0.6	2.0	2.5	26.1	9.6	0.0	14.3	3.4	4.4	4.5	28.5	2.4	32.4	8.5	31.1	5.5	4.2	15.2	22.8	23.8	2.0	1.6	5.1	0.7	1.2	2.9	3.6	27.2	2.3	2.7	4.1	23.6	111.5	4.7	14.5	7.5	4.9	2.4	14.6	2.1	9.1	1.0	0.0	7.7	3.3	0.1	1.5	8.1	8.0	2.2	5.0	9.4	15.5	13.8
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652698-138834928	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.5;Inhibitory neurons: 92.4;Oligodendrocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 115.2;HMC-1: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	11.6	7.4	4.3	12.4	5.0	23.7	11.9	8.6	8.6	12.4	14.4	17.8	17.8	8.2	7.0	18.0	12.1	10.3	15.8	5.4	4.4	26.4	11.0	11.2	12.3	5.1	3.3	9.2	22.3	19.3	2.7	18.6	6.1	15.0	18.1	23.0	19.8	12.0	19.5	23.7	17.9	9.1	3.5	10.8	13.0	8.0	4.0	17.0	43.2	13.2	13.2	9.9	5.4	7.9	64.1	21.9	11.7	9.4	10.6	13.0	79.2	14.2	14.5	15.1	16.7	26.0	25.2	25.0	38.0	13.7	29.1	27.5	15.1	24.1	27.3	31.8	12.5	115.2	14.8	17.3	11.8	30.1	185.1	12.4	17.6	10.2	21.9	26.4	21.5	12.3	43.0	19.0	18.1	28.6	17.8	20.7	16.6	49.2	19.5	11.5	12.2	19.6	24.5	35.5	9.8	7.4	37.6	18.0	56.2	34.7	44.8	73.0	20.3	8.4	11.7	21.2	21.1	30.3	22.1	23.7	22.8	27.7	14.0	4.4	5.1	6.9	2.4	2.8	1.6	2.8	2.8	1.8	5.9	2.6	3.5	2.4	6.4	0.8	2.8	1.0	1.5	2.0	4.3	5.0	8.6	8.6	5.4	4.4	5.1	3.3	6.1	3.5	4.0	7.9	19.7	9.6	21.3	40.1	12.1	19.1	18.7	12.5	14.2	16.2	13.1	7.7	37.3	12.8	18.3	18.4	25.0	35.5	6.9	30.3	5.9	11.1	1.1	18.3	4.0	13.9	16.3	8.0	96.5	19.4	61.1	7.3	21.4	18.8	14.5	6.7	9.7	19.1	14.4	21.9	92.4	17.1	4.1	33.3	23.1	1.7	3.7	28.1	7.2	37.5	29.5	8.9	11.3	48.2	88.2	20.0	25.9	6.8	10.2	25.8	21.9	23.4	17.4	19.5	6.6	8.6	5.9	16.0	19.9	22.1	23.3	47.9	11.6	4.2	15.1	17.5
PIK3R3	p55	ENSG00000117461	"Phosphoinositide-3-kinase regulatory subunit 3"	Q92569	1	46040140-46133036	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 199.0;Endothelial cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 5.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 5.8;monocytes: 2.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"RT4: 76.1"					"Low region specificity"	"Detected in all"			"HPA005751, HPA071988"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Nucleoplasm	"HPA005751: AB_1855350, HPA071988: AB_2686479"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.32e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (4.88e-2)"	"unprognostic (3.33e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.99e-3)"	"unprognostic (2.87e-2)"	"unprognostic (9.74e-2)"	"unprognostic (6.71e-2)"	"unprognostic (8.22e-3)"	31.2	12.2	13.0	7.2	11.2	0.7	28.0	35.9	14.8	15.3	14.0	7.5	3.2	15.9	10.3	7.1	10.1	10.7	35.2	11.4	14.9	16.2	4.0	18.5	6.2	16.7	17.3	4.1	4.7	12.1	8.5	13.3	16.8	12.0	4.9	17.9	12.5	6.1	12.0	6.4	8.6	11.5	15.5	11.2	9.9	25.4	15.9	10.8	14.2	18.5	5.3	14.8	7.4	11.4	10.9	3.6	47.4	24.4	4.6	2.0	15.2	6.3	4.6	8.2	10.1	2.1	3.2	14.3	18.9	2.5	9.9	6.4	16.9	5.8	5.3	11.1	15.0	9.3	41.8	1.6	1.5	8.3	11.8	5.8	3.3	8.7	3.2	7.8	17.3	32.8	3.5	10.0	11.8	16.7	33.4	5.1	16.9	3.1	9.6	42.0	12.7	17.0	20.4	76.1	34.4	24.9	20.5	53.5	5.7	28.5	14.9	7.3	32.4	8.7	8.0	1.5	6.2	14.1	15.8	8.5	6.9	10.9	4.5	0.0	0.2	5.8	2.0	0.3	1.9	0.3	0.4	1.8	0.0	0.0	0.1	1.1	0.0	0.0	2.4	0.3	2.3	0.6	13.0	11.2	35.9	14.8	11.4	14.9	16.7	17.3	16.8	15.5	15.9	11.4	199.0	0.0	8.4	15.7	3.1	2.5	5.4	42.1	14.8	48.3	32.0	30.1	21.1	0.0	28.8	18.4	45.9	4.4	13.9	21.7	0.0	0.6	11.8	13.9	21.0	83.3	7.8	5.9	26.2	1.2	1.1	16.2	55.5	26.2	9.5	6.1	0.0	0.0	1.7	3.3	55.9	8.6	38.7	0.0	4.4	19.9	1.2	8.4	5.4	60.9	0.9	33.5	3.1	22.1	7.1	1.4	1.5	7.9	10.1	7.2	4.5	4.2	26.7	42.8	0.0	13.3	18.0	35.9	31.7	8.0	1.8	1.4	15.7	19.2	6.6	5.0
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802722-8867677	"Metabolic proteins, Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;granulocytes: 47.4;Hofbauer cells: 7.6;Late spermatids: 20.6;Microglial cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 21.9;eosinophil: 75.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 75.8"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 148.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	0.4	0.0	1.1	1.8	1.6	2.2	0.4	0.9	1.1	0.6	0.8	0.8	1.5	0.9	0.1	0.5	0.2	1.2	1.3	1.0	1.1	0.0	0.3	1.2	2.1	1.4	1.5	0.0	0.4	0.1	0.0	0.6	1.6	0.3	0.6	0.0	0.2	0.3	0.5	0.8	2.2	0.7	1.1	2.9	1.0	0.4	1.9	2.1	0.0	0.3	1.5	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	19.4	0.0	0.0	0.0	0.0	148.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	2.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	21.9	7.2	75.8	0.5	9.6	0.4	2.7	0.1	0.3	10.8	0.3	0.1	0.2	1.1	1.5	7.8	0.0	0.0	3.3	1.1	1.6	0.9	1.1	1.0	1.1	1.4	1.5	1.6	1.1	1.9	1.6	0.2	0.0	1.3	0.3	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	11.5	0.0	0.1	2.6	0.0	0.4	0.6	0.0	0.1	0.2	0.5	0.0	47.4	0.0	0.4	0.0	7.6	0.0	0.5	0.0	0.0	4.4	1.6	20.6	0.0	3.9	1.8	7.5	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	1.6	0.1	0.0	0.0
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170152-37175428	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 219.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 368.2;Suprabasal keratinocytes: 228.6;Urothelial cells: 455.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 321.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 321.3"	"Cell line enhanced"	"Detected in all"		"HEL: 219.9;HMC-1: 391.5;K-562: 192.7;U-698: 735.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	152.8	14.4	8.5	42.3	8.6	219.0	46.2	10.5	10.7	82.9	10.0	45.8	39.2	46.3	2.6	201.5	66.4	52.6	65.4	7.9	11.6	27.0	58.0	49.8	38.5	15.1	12.2	60.4	20.4	3.4	14.8	28.9	12.8	22.5	17.8	8.2	41.1	7.5	36.3	109.8	44.4	38.1	12.3	61.7	40.3	10.7	11.6	26.6	22.7	5.8	26.8	101.6	113.3	12.1	19.1	7.9	12.1	6.7	27.2	14.5	141.9	6.7	20.3	13.5	21.5	28.3	26.2	38.3	10.4	8.0	30.2	21.7	12.7	20.1	12.3	174.4	8.4	219.9	8.7	37.0	27.9	3.8	391.5	49.0	24.5	12.4	8.3	14.9	4.0	9.2	192.7	59.7	2.2	5.0	12.3	19.9	22.7	35.4	12.1	29.7	22.0	45.7	3.9	114.4	58.8	11.9	14.7	1.7	3.8	27.9	3.2	6.5	7.4	7.8	23.3	35.6	8.5	28.0	15.9	735.7	3.4	55.3	8.1	321.3	8.0	113.5	60.3	7.3	77.7	7.1	53.4	53.8	6.3	5.2	47.1	36.9	61.7	39.8	4.2	1.9	41.3	42.1	8.5	8.6	10.5	10.7	7.9	11.6	15.1	12.2	12.8	12.3	11.6	12.1	41.1	22.4	16.0	2.9	35.1	127.8	166.5	63.3	26.7	4.9	9.6	5.3	36.0	18.6	37.6	9.2	0.0	36.5	55.0	50.4	5.9	40.6	4.8	40.3	125.8	33.3	37.1	368.2	2.4	17.2	121.8	67.4	26.0	92.0	49.3	27.5	11.0	33.8	53.6	15.2	2.2	12.4	44.7	44.3	47.4	12.4	8.1	53.9	44.4	4.7	72.3	7.6	112.3	1.0	0.9	60.7	34.2	3.0	190.1	109.6	51.1	17.2	12.9	1.7	0.0	34.2	41.3	14.5	33.9	92.8	228.6	80.7	118.0	1.1	7.8	455.2
PIMREG	"CATS, FAM64A, FLJ10156, FLJ10491, RCS1"	ENSG00000129195	"PICALM interacting mitotic regulator"	Q9BSJ6	17	6444441-6451469	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.9"	"Group enriched"	"Detected in some"	6	"Fibroblasts: 5.5;Granulosa cells: 21.5;Hofbauer cells: 7.2;Smooth muscle cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 161.8"	"Region enhanced"	"Detected in many"		"white matter: 5.7"	"Low region specificity"	"Detected in single"			"HPA043783, HPA049934"	Uncertain		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043783: AB_2678669, HPA049934: AB_2680959"	"unprognostic (5.32e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	0.5	2.5	0.3	1.3	0.0	2.5	0.8	1.1	0.4	0.9	0.0	3.3	3.0	0.8	0.0	3.3	0.3	0.7	0.3	0.1	0.1	0.3	0.3	0.7	1.5	0.2	0.0	0.8	0.2	0.1	0.1	0.6	0.0	0.3	4.1	0.4	0.7	0.1	0.0	2.7	3.1	2.0	0.0	6.0	1.2	0.3	0.1	13.9	0.4	0.0	2.1	1.3	1.3	0.2	42.1	54.1	161.8	73.1	1.5	4.5	12.6	47.9	29.8	78.6	52.5	32.8	17.9	0.0	18.8	39.8	39.9	29.9	82.6	21.6	41.9	64.6	33.9	0.1	33.8	41.2	0.2	1.7	48.9	2.4	1.5	32.2	12.4	8.0	24.8	36.8	10.1	23.0	49.9	30.5	9.2	0.5	70.9	34.0	37.8	74.9	64.8	29.6	12.9	6.4	36.5	51.3	41.7	42.5	39.1	20.4	19.9	4.0	11.9	59.9	48.4	36.0	80.7	8.2	31.5	0.2	23.6	20.4	94.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.1	0.2	1.0	0.1	0.0	0.3	0.3	0.3	0.0	1.1	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.4	1.2	0.6	0.0	0.0	0.0	0.0	0.6	5.5	0.0	0.7	1.3	21.5	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.0	0.0
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849689	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 782.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004528, CAB009326, HPA068650, HPA070887"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favorable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	55.3	90.1	130.7	31.2	140.6	48.1	52.3	132.5	201.4	59.4	99.9	83.2	36.4	61.7	7.2	59.5	63.7	13.0	105.5	149.6	141.4	70.1	63.2	49.0	26.4	152.6	134.4	54.6	43.5	28.2	69.2	20.5	156.7	74.7	9.3	20.6	39.6	22.0	90.4	54.3	49.0	16.7	113.9	53.8	61.1	98.4	133.8	42.3	44.8	33.4	12.4	67.4	52.4	132.7	116.8	104.5	75.4	70.8	25.8	22.9	45.1	85.3	35.7	60.9	58.3	97.5	36.1	72.0	132.0	31.7	63.8	58.4	52.2	49.6	19.3	153.9	223.5	187.0	137.2	85.5	41.9	88.0	105.0	31.5	33.5	39.5	18.7	45.7	49.9	124.1	86.1	105.4	37.3	81.0	133.7	338.6	72.8	47.8	156.8	120.6	79.4	121.2	44.5	56.4	95.1	112.4	82.0	40.5	96.6	30.8	51.9	104.3	87.3	85.6	68.3	133.6	139.1	135.0	137.0	97.1	90.9	111.3	107.2	280.9	181.0	397.6	170.1	202.0	159.8	165.5	165.5	171.8	171.4	176.5	130.5	146.0	114.0	192.2	195.8	316.9	245.5	214.7	130.7	140.6	132.5	201.4	149.6	141.4	152.6	134.4	156.7	113.9	133.8	132.7	73.8	28.9	20.5	11.1	48.8	48.3	65.7	153.9	23.3	77.3	56.1	62.0	79.6	44.3	67.4	62.5	12.5	119.4	81.3	82.3	164.4	101.5	270.5	75.9	57.6	65.6	99.9	78.9	41.3	108.6	98.1	66.5	38.7	40.6	63.5	83.6	56.4	45.8	140.7	60.6	39.2	70.6	160.7	54.7	75.2	782.4	90.1	60.6	124.5	20.6	131.6	87.9	138.0	11.6	24.3	113.7	81.2	129.8	74.3	68.9	97.0	143.8	104.5	76.0	65.7	52.3	98.6	186.7	94.7	54.0	65.9	55.0	77.8	81.8	69.2	58.5
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.1	14.8	23.5	10.4	24.0	8.7	16.9	25.2	36.3	15.2	24.0	16.2	11.5	14.7	21.5	14.4	12.9	7.3	19.0	23.6	24.8	19.7	28.6	10.6	10.5	24.4	24.2	16.1	13.1	20.4	13.9	11.8	24.2	15.6	12.7	18.3	16.1	10.1	19.4	10.6	12.7	10.8	24.0	13.9	15.8	5.7	23.8	17.5	16.5	20.4	11.1	13.2	14.9	25.4	36.8	41.2	42.5	29.9	28.1	23.4	23.1	24.6	26.8	28.7	29.1	20.8	26.4	11.2	68.6	25.2	39.2	25.8	38.6	43.0	35.6	26.9	83.3	18.8	51.1	55.3	14.9	29.9	14.8	15.7	22.5	32.0	11.1	32.4	29.1	32.5	32.1	46.6	20.4	43.4	25.3	49.9	30.3	42.4	36.7	25.8	34.7	32.3	37.1	24.7	27.0	48.1	28.5	13.3	27.0	32.0	20.3	25.9	30.7	13.4	19.9	36.8	17.7	15.4	18.5	17.9	38.5	28.3	14.7	42.7	37.1	40.6	41.8	41.1	41.7	49.2	43.7	40.3	38.0	45.6	44.1	44.8	15.7	41.1	39.4	44.6	58.1	39.6	23.5	24.0	25.2	36.3	23.6	24.8	24.4	24.2	24.2	24.0	23.8	25.4	68.3	67.3	48.2	14.0	44.4	43.2	63.3	167.9	36.5	26.7	67.2	94.5	84.9	78.6	89.4	119.5	8.4	162.8	44.5	99.2	181.9	125.0	13.5	78.6	66.7	71.5	92.7	71.7	17.8	117.9	89.0	59.9	45.3	56.6	57.6	46.3	92.4	288.5	110.3	28.6	17.8	93.7	128.1	72.9	44.9	9.3	74.6	50.7	60.5	7.5	69.6	90.7	80.3	16.6	27.3	136.3	114.9	81.3	38.7	51.5	162.0	296.1	95.9	42.9	85.5	65.9	94.6	19.6	42.6	51.3	46.9	120.7	44.8	53.9	88.5	54.8
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1"	ENSG00000254093	"PIN2 (TERF1) interacting telomerase inhibitor 1"	Q96BK5	8	10764961-10839884	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 20.0;Extravillous trophoblasts: 13.0;Hofbauer cells: 16.1;Syncytiotrophoblasts: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023139, HPA023146"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoli	"Nucleoplasm, Mitochondria"	"HPA023139: AB_1855384, HPA023146: "	"unprognostic (4.01e-1)"	"prognostic favorable (2.45e-5)"	"unprognostic (7.80e-3)"	"unprognostic (3.35e-2)"	"unprognostic (4.10e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.40e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	9.9	7.7	7.2	8.9	8.4	9.1	9.9	8.9	8.9	9.7	6.1	9.9	6.2	9.3	4.5	12.1	8.8	4.0	8.2	7.4	7.1	11.6	11.7	8.0	11.5	7.2	7.1	9.8	9.0	6.1	6.4	7.2	7.4	8.1	6.1	12.0	7.3	4.2	13.5	14.4	7.7	8.5	7.0	9.3	8.2	9.7	7.4	13.0	8.2	9.3	11.1	10.2	10.5	7.7	14.5	18.9	20.1	19.2	16.6	13.5	23.1	21.5	9.7	23.2	15.6	20.0	12.4	38.5	7.4	11.7	28.3	28.6	51.4	39.9	29.8	15.7	15.3	16.2	13.3	22.0	18.8	17.4	9.7	11.3	24.9	18.3	34.0	8.2	32.7	25.8	52.3	23.1	22.9	17.1	57.7	21.8	46.3	62.6	21.0	46.5	24.5	35.2	17.5	17.5	16.6	17.3	14.5	17.0	48.3	24.3	18.1	21.7	20.0	13.9	30.3	18.0	28.1	10.3	29.0	71.2	14.4	32.6	32.1	1.9	8.4	6.1	14.6	10.7	18.9	12.9	12.8	15.6	11.1	10.8	17.1	13.5	0.5	12.5	9.9	8.6	16.1	10.4	7.2	8.4	8.9	8.9	7.4	7.1	7.2	7.1	7.4	7.0	7.4	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	13.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	48.2	0.0	0.0	0.0	0.0
PIP4K2B	"PIP5K2B, PIP5KIIB, PIP5KIIbeta"	ENSG00000276293	"Phosphatidylinositol-5-phosphate 4-kinase type 2 beta"	P78356	17	38765691-38800126	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062220			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA062220: AB_2684715"	"unprognostic (7.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.79e-1)"	"unprognostic (4.82e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.48e-1)"	19.9	27.0	82.5	15.5	85.6	7.3	20.8	62.3	93.9	30.1	43.3	24.2	10.3	28.8	23.3	15.4	29.1	16.3	30.2	90.7	75.2	20.1	14.4	21.4	20.5	65.9	65.7	49.8	16.4	16.6	25.2	22.8	67.1	22.2	14.0	36.0	16.9	25.3	99.0	24.6	17.3	29.5	63.2	23.2	16.4	13.0	80.4	23.4	20.3	75.6	20.4	22.9	20.9	81.4	18.1	40.2	66.0	69.9	56.7	45.5	12.2	31.6	38.2	43.1	35.0	28.2	18.4	44.8	17.2	59.8	36.3	35.9	44.9	28.7	41.4	27.8	17.2	38.4	27.3	40.7	26.2	43.7	23.5	40.0	34.2	33.7	24.2	59.2	36.3	48.6	34.2	22.3	46.8	14.2	44.0	34.0	32.0	20.7	15.8	44.6	63.7	25.6	31.3	22.3	34.0	46.1	30.9	13.9	34.5	68.5	43.6	44.5	33.4	35.8	21.6	29.4	28.9	27.4	36.5	19.7	42.0	36.8	32.9	1.3	1.9	0.6	3.4	1.6	3.5	2.3	2.9	3.3	2.4	2.3	3.2	2.9	1.8	2.8	1.4	2.2	3.0	3.3	82.5	85.6	62.3	93.9	90.7	75.2	65.9	65.7	67.1	63.2	80.4	81.4	15.8	19.2	11.4	21.5	6.7	6.1	3.5	4.6	7.4	31.6	11.5	13.3	23.4	4.3	7.5	5.5	10.4	7.0	14.8	3.7	1.9	5.3	9.2	10.8	17.7	17.3	11.5	9.0	33.5	4.9	5.0	13.8	5.6	9.0	1.3	22.6	18.2	12.7	8.8	43.7	29.1	7.4	2.0	11.3	4.9	21.1	15.2	8.6	1.8	18.7	6.9	14.8	10.3	22.1	24.0	6.0	4.1	16.6	6.2	4.9	5.4	7.7	6.4	14.0	6.6	13.8	13.2	4.6	7.4	9.9	4.4	2.5	8.1	17.3	7.2	2.7
PIP4K2C	"FLJ22055, PIP5K2C"	ENSG00000166908	"Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma"	Q8TBX8	12	57591174-57603418	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028658	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028658: AB_10601245"	"unprognostic (7.84e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (3.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.06e-6)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.42e-1)"	13.6	17.2	18.4	11.6	24.0	26.5	20.0	13.4	32.8	18.4	20.7	24.1	16.0	18.5	81.6	28.2	26.6	16.1	15.0	22.3	11.5	36.0	14.8	19.7	13.5	14.9	13.0	16.0	21.0	39.1	18.7	12.1	16.0	21.6	26.3	29.1	25.6	18.4	14.0	27.1	19.2	15.9	11.9	14.6	39.8	28.1	15.7	11.4	22.4	10.5	18.8	18.2	20.5	20.9	52.0	36.4	14.8	17.6	0.0	0.1	47.0	21.4	40.6	38.7	35.1	46.7	73.4	11.3	44.1	25.6	47.4	46.1	24.2	42.2	30.3	15.9	26.1	20.0	17.5	33.7	32.8	19.3	35.0	12.9	70.0	14.7	26.9	46.4	19.6	12.1	26.8	33.3	20.0	52.6	16.5	16.7	28.1	32.1	31.2	0.5	130.9	17.2	39.6	91.1	23.7	30.0	45.8	30.4	29.7	49.3	83.2	17.8	4.2	18.5	26.1	27.7	22.8	25.1	31.5	25.6	36.0	16.0	32.1	58.8	8.2	25.8	24.3	10.5	16.1	8.7	14.8	18.4	8.6	11.0	13.8	16.7	16.3	16.2	14.6	3.8	19.9	11.0	18.4	24.0	13.4	32.8	22.3	11.5	14.9	13.0	16.0	11.9	15.7	20.9	4.1	9.6	8.6	4.9	6.9	12.4	6.2	11.7	10.8	14.3	13.2	8.0	121.7	12.8	11.9	35.0	18.8	11.3	7.4	33.7	21.5	17.7	25.7	14.2	4.2	8.8	22.2	5.2	28.0	19.7	15.2	5.4	26.0	20.3	3.8	4.0	9.3	12.6	8.9	8.4	11.8	18.4	10.2	6.0	2.2	47.9	6.8	5.7	12.4	2.8	5.9	7.5	5.2	5.0	11.5	40.5	12.8	5.3	9.4	10.1	14.2	13.3	15.3	8.1	19.7	3.8	13.1	12.0	9.0	14.3	12.8	17.4	11.9	5.5	10.4	9.2
PIP5K1A		ENSG00000143398	"Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	Q99755	1	151197949-151249536	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029366	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029366: AB_10602116"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.16e-7)"	"unprognostic (1.44e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.59e-1)"	20.1	19.1	16.0	16.1	17.3	9.7	19.5	17.8	19.2	18.9	20.8	17.2	16.2	18.8	21.1	20.4	18.9	19.7	19.8	16.8	17.3	21.9	18.6	21.8	18.7	15.1	15.7	18.7	13.6	23.0	21.5	25.9	14.7	16.7	15.1	30.1	16.9	14.1	29.2	21.0	16.9	20.3	14.2	19.0	16.6	35.1	16.9	24.7	18.4	25.4	20.1	20.5	17.4	18.4	49.3	37.4	57.7	67.6	37.5	38.8	56.7	63.5	89.3	116.6	103.7	68.7	46.8	43.9	66.8	67.9	52.7	42.0	75.7	42.6	101.2	68.8	54.0	36.0	48.4	33.9	70.1	64.9	43.8	51.1	40.3	72.7	90.7	52.1	48.8	69.4	35.6	36.7	60.4	69.9	63.6	32.4	86.0	38.2	58.3	60.5	50.7	34.1	61.2	27.1	38.6	49.4	87.1	66.6	57.4	96.4	69.2	59.4	47.4	46.6	64.7	42.6	77.0	50.5	93.6	99.3	44.7	18.6	56.6	0.1	3.9	5.7	3.7	4.7	2.8	6.6	3.3	4.1	6.4	3.0	3.7	2.9	8.9	3.9	3.8	6.7	3.1	4.7	16.0	17.3	17.8	19.2	16.8	17.3	15.1	15.7	14.7	14.2	16.9	18.4	11.6	32.1	12.2	43.8	21.3	66.2	23.2	17.0	39.9	34.1	31.3	22.0	18.4	17.2	15.3	31.3	98.0	25.9	18.3	12.7	9.8	13.5	4.9	64.0	26.2	15.6	6.0	12.4	59.6	8.7	29.3	19.8	19.4	71.0	12.0	19.9	14.3	14.3	12.8	26.9	51.2	9.7	18.3	10.7	29.5	4.8	13.4	14.9	12.4	44.0	12.2	12.5	9.2	54.8	64.0	19.4	8.9	10.9	16.8	20.9	21.0	10.1	18.4	43.0	13.1	17.4	20.9	52.1	24.6	38.4	50.0	63.5	15.9	18.4	10.7	39.4
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705240-69009176	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 97.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 127.4;Early spermatids: 100.0;Inhibitory neurons: 270.1;Muller glia cells: 120.2"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 10.1;pancreatic cancer: 3.4;stomach cancer: 9.4;testis cancer: 3.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"eosinophil: 34.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 34.5"	"Cell line enhanced"	"Detected in some"		"AF22: 43.8;HEL: 17.0;Hep G2: 13.4;OE19: 73.1;U-266/70: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	4.2	11.9	5.6	6.0	5.3	16.1	4.9	18.4	8.1	6.3	97.3	31.2	34.8	7.5	1.7	1.2	6.0	4.0	32.2	12.3	10.7	7.8	0.3	12.9	2.6	7.9	11.2	1.0	8.6	13.7	6.6	6.5	6.3	3.1	29.1	38.0	16.4	9.6	2.9	2.3	30.8	2.9	4.0	2.6	26.1	24.7	11.4	1.0	1.2	5.1	3.6	3.3	2.5	3.7	0.0	0.0	43.8	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	4.6	0.0	3.6	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.8	17.0	0.3	13.4	0.0	0.9	4.4	0.0	2.0	0.0	0.0	0.0	0.1	0.5	0.9	9.3	0.3	1.1	0.1	0.2	2.3	73.1	1.4	1.4	0.1	0.3	0.3	3.4	0.9	0.1	0.0	0.1	0.5	1.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	17.0	3.5	2.3	0.0	3.1	0.0	5.6	0.5	34.5	0.0	0.0	0.0	4.7	0.3	0.1	0.1	5.4	0.7	0.1	1.7	0.0	0.2	1.4	1.6	0.3	5.6	5.3	18.4	8.1	12.3	10.7	7.9	11.2	6.3	4.0	11.4	3.7	3.6	35.3	34.4	28.7	19.2	0.6	3.2	0.5	0.6	5.1	4.7	3.3	61.6	2.8	2.8	5.5	2.1	21.3	0.0	127.4	27.4	1.6	100.0	12.8	13.6	3.3	37.0	53.6	84.7	14.0	1.3	3.1	40.2	27.5	5.7	3.8	1.4	0.0	3.9	0.0	270.1	32.6	14.2	1.0	1.3	47.6	2.5	5.6	5.4	60.0	2.6	120.2	0.0	80.9	6.4	5.2	46.6	1.5	43.2	2.5	39.2	1.4	6.5	3.3	26.3	2.5	32.2	39.0	4.5	0.7	0.3	8.8	2.1	0.9	29.7	9.8
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700468	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"U-2197: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	22.1	15.6	30.7	11.5	36.6	3.4	19.2	19.4	66.4	24.0	0.0	62.2	8.6	44.9	7.6	20.3	29.8	8.2	32.2	40.2	5.0	15.8	8.7	22.6	6.5	13.3	7.7	22.2	18.0	10.7	20.6	11.2	12.9	33.9	4.5	13.2	18.1	25.1	17.7	16.0	24.1	16.0	0.0	22.4	29.7	61.4	19.5	5.3	21.1	4.8	4.2	39.4	24.7	33.2	18.9	18.0	13.4	18.0	25.5	21.0	20.3	36.1	22.4	15.2	12.3	16.1	5.2	7.8	13.6	39.0	16.5	16.4	6.5	11.7	6.2	28.7	11.9	9.0	15.0	13.1	22.0	9.4	26.7	23.7	9.9	12.4	4.1	9.9	25.6	11.5	14.1	13.5	14.4	15.7	11.2	6.6	14.4	6.8	24.6	21.4	7.2	11.2	11.5	15.9	13.7	12.0	18.7	10.1	11.1	16.6	7.9	14.1	57.3	21.3	11.8	75.1	17.0	16.0	14.3	3.5	27.6	19.2	15.0	1.0	0.7	0.0	0.7	0.5	0.2	0.6	0.5	0.4	0.8	0.3	0.2	0.4	0.5	0.5	0.8	0.5	0.4	0.6	30.7	36.6	19.4	66.4	40.2	5.0	13.3	7.7	12.9	0.0	19.5	33.2	20.3	6.4	5.0	8.8	6.2	5.4	3.0	6.1	7.4	56.8	9.6	6.6	7.5	7.2	3.0	16.5	37.5	7.8	10.6	12.2	1.9	7.9	11.6	6.4	29.0	22.1	8.4	2.1	30.6	7.1	7.4	10.7	7.1	11.6	1.3	10.7	16.1	4.0	15.7	30.3	17.9	9.7	6.1	19.6	13.2	24.0	14.9	15.5	5.4	22.5	15.0	14.3	11.3	9.0	6.8	12.1	13.2	24.0	5.7	4.4	7.2	6.4	4.1	26.8	13.1	8.4	10.4	18.6	11.8	7.8	6.8	16.4	8.0	11.9	7.2	5.3
PITPNC1	"RDGB-BETA, RDGBB, RDGBB1"	ENSG00000154217	"Phosphatidylinositol transfer protein cytoplasmic 1"	Q9UKF7	17	67377281-67697261	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1255.9;Inhibitory neurons: 330.9;Oligodendrocyte precursor cells: 281.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA026563, HPA031250"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	Nucleoplasm	"HPA026563: AB_1855409, HPA031250: AB_2673808"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.17e-2)"	"prognostic favorable (4.85e-5)"	"unprognostic (6.57e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-2)"	25.7	8.9	27.2	5.6	30.1	3.8	18.6	23.5	26.9	8.7	13.2	7.6	1.5	7.8	3.8	9.8	10.9	3.8	13.3	22.7	31.2	21.8	9.8	15.1	8.8	38.4	41.0	15.2	23.1	1.8	13.7	6.0	28.2	11.9	2.2	15.0	14.1	4.4	5.4	4.9	8.7	3.5	28.7	9.4	12.6	2.5	42.7	8.4	9.0	5.0	7.4	12.0	9.2	20.1	4.2	1.0	4.5	6.8	2.8	5.1	3.9	6.0	2.9	0.8	0.4	0.0	6.4	4.6	1.4	3.6	1.7	2.0	6.7	6.0	1.1	9.3	3.0	0.7	7.6	3.4	0.7	1.4	9.8	3.6	2.2	0.9	2.5	0.5	3.2	6.5	0.3	16.9	2.3	7.0	10.9	2.8	6.6	1.8	7.7	15.2	0.9	4.2	9.7	5.4	4.7	13.0	1.7	3.3	4.1	4.8	3.0	4.7	3.7	1.8	1.0	2.4	2.9	13.2	6.2	3.7	14.4	4.6	1.6	0.7	1.4	10.3	11.1	2.6	5.7	0.5	6.9	9.2	0.9	1.3	8.2	8.3	1.7	5.2	4.1	0.1	2.8	4.1	27.2	30.1	23.5	26.9	22.7	31.2	38.4	41.0	28.2	28.7	42.7	20.1	102.6	9.6	1.1	1255.9	9.6	5.4	55.6	4.6	8.0	15.2	7.7	4.1	6.9	21.5	4.6	0.0	2.1	7.9	84.0	5.8	21.5	43.3	0.2	13.7	5.7	59.8	6.0	4.0	88.4	49.1	13.6	18.9	8.2	30.9	5.1	7.7	21.4	10.1	13.8	74.0	330.9	1.3	4.1	21.4	22.3	1.4	5.0	17.7	10.6	103.0	20.2	34.6	84.5	281.5	9.7	38.7	4.4	14.7	28.0	32.9	0.1	21.2	3.4	21.8	26.3	66.5	25.7	0.4	3.8	9.0	4.3	3.4	75.7	2.7	3.8	54.3
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.0;skeletal muscle: 43.2;urinary bladder: 29.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 19.2;Fibroblasts: 69.6;Paneth cells: 20.6;Proximal enterocytes: 39.7;Skeletal myocytes: 49.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"hypothalamus: 17.8;thalamus: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.8;HEK 293: 10.5;LHCN-M2: 25.1;RH-30: 20.5"					"Group enriched"	"Detected in some"	25	"hypothalamus: 5.4;midbrain: 1.5"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA050074: AB_2681005, HPA062728: AB_2684851"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.2	0.0	0.0	7.8	0.2	0.0	0.4	0.0	0.0	1.6	0.0	3.8	0.0	0.1	0.0	2.6	0.2	1.1	2.0	0.0	17.8	0.2	0.0	0.0	0.0	0.1	2.8	0.0	0.5	0.0	16.1	42.0	0.2	0.9	0.2	0.0	13.5	0.1	43.2	1.5	3.1	0.5	0.2	0.0	0.5	0.5	6.8	0.0	0.0	12.3	0.0	29.8	3.8	0.0	1.4	2.6	0.0	1.0	2.4	2.1	4.0	0.8	0.4	2.6	2.0	24.8	0.0	0.0	5.2	5.1	3.2	0.4	0.1	0.0	1.4	0.0	10.5	0.0	2.0	0.0	8.8	0.0	5.0	2.5	0.2	0.5	0.0	0.8	0.0	2.7	0.6	0.0	25.1	0.7	2.7	0.0	0.4	0.0	0.5	0.0	20.5	0.0	0.4	3.4	0.0	0.0	2.0	3.3	0.3	0.4	0.2	0.0	0.0	3.1	7.5	0.0	4.1	0.1	0.1	1.0	1.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	17.8	0.1	2.8	0.2	0.2	6.8	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.2	0.0	0.1	0.3	19.2	0.0	0.1	0.0	0.0	5.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.4	5.7	69.6	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	9.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.2	39.7	2.3	0.0	0.0	0.0	49.8	5.4	2.3	7.0	1.7	0.1	10.5	0.0	0.0	14.1	0.1
PIWIL4	"FLJ36156, HIWI2, Miwi2"	ENSG00000134627	"Piwi like RNA-mediated gene silencing 4"	Q7Z3Z4	11	94543840-94621421	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.3"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 8.7;Spermatogonia: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"NB-4: 93.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036587, HPA036588, HPA057508"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Mitochondria"		"HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.80e-2)"	3.3	1.1	5.5	2.8	5.3	24.3	3.6	4.9	5.0	4.4	3.4	5.8	5.8	3.7	2.3	1.6	3.6	4.6	2.8	5.6	4.7	3.2	1.3	2.7	3.9	4.5	4.4	3.4	11.3	0.4	2.2	2.0	4.5	2.5	6.0	6.7	8.8	2.6	1.0	1.7	6.3	2.0	4.5	3.7	5.1	13.3	4.9	3.0	2.0	1.0	2.7	3.3	3.0	5.4	0.2	0.1	0.4	0.0	6.6	4.3	0.5	0.5	0.3	0.2	0.9	0.7	0.6	0.0	0.4	2.8	0.2	0.0	0.9	0.0	0.2	2.7	0.3	0.2	0.6	0.0	2.5	6.5	0.1	1.5	0.0	0.5	0.0	0.1	0.1	0.5	0.3	0.0	1.1	0.4	0.3	93.2	0.1	9.2	0.6	0.4	0.0	0.0	2.1	0.0	0.4	0.3	0.4	0.9	0.4	0.3	0.0	20.7	1.2	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.1	9.9	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	5.5	5.3	4.9	5.0	5.6	4.7	4.5	4.4	4.5	4.5	4.9	5.4	1.1	0.0	0.5	3.3	0.2	1.3	0.2	0.4	0.0	0.6	1.3	1.3	3.5	7.2	1.4	0.0	0.0	4.0	0.2	4.1	1.9	6.2	4.7	0.7	0.7	0.6	0.0	0.4	5.4	2.0	0.5	1.6	7.7	1.3	0.0	0.9	0.7	0.0	1.7	0.0	4.9	8.7	0.0	3.0	1.7	2.1	0.3	1.7	0.0	3.7	2.0	0.7	1.0	5.0	6.0	3.0	4.9	1.2	0.1	0.5	4.4	0.6	1.7	3.3	0.0	2.2	1.3	1.2	12.0	0.6	0.1	1.0	0.3	0.3	5.3	0.1
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165521	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 160.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	22.9	14.5	46.8	8.7	50.5	3.6	19.4	37.2	78.0	19.9	33.0	15.4	6.4	16.4	160.0	12.3	16.0	11.1	15.0	47.1	48.9	19.2	9.4	13.8	10.0	38.9	41.7	25.8	14.5	38.7	28.1	17.3	40.6	15.3	7.6	17.6	10.6	32.4	7.9	14.6	11.1	16.0	40.1	13.3	14.0	26.4	49.0	10.0	22.7	8.8	12.1	17.4	15.1	43.5	27.3	19.6	62.9	43.7	21.3	22.5	18.7	17.8	22.0	16.7	22.3	17.1	25.8	4.4	26.7	28.1	39.2	24.0	99.0	34.9	21.2	20.2	33.0	8.1	16.0	10.9	25.7	4.9	14.4	23.1	23.6	28.6	17.0	15.8	19.0	13.2	7.8	3.0	16.9	14.1	2.1	8.4	43.4	23.1	32.0	20.0	28.2	6.9	23.4	22.6	46.4	30.7	28.6	4.9	22.2	50.1	7.7	7.0	17.8	13.9	22.6	41.7	8.3	0.0	0.2	9.1	15.3	13.1	19.4	6.6	6.8	2.1	29.6	9.2	34.3	16.4	26.1	27.5	7.3	22.8	26.5	31.3	2.3	30.0	6.5	8.9	17.5	19.4	46.8	50.5	37.2	78.0	47.1	48.9	38.9	41.7	40.6	40.1	49.0	43.5	4.7	16.0	4.8	2.9	9.7	41.0	19.4	30.8	23.9	16.8	5.0	6.2	7.1	4.3	14.8	3.7	8.4	35.6	5.9	1.0	15.6	24.9	74.7	3.9	10.4	6.6	5.4	10.8	8.1	11.7	15.3	18.2	7.1	5.8	4.5	27.9	6.8	1.7	7.0	5.0	8.3	3.6	6.1	2.9	9.9	32.7	27.1	5.7	5.4	2.8	2.9	30.6	14.4	5.0	3.7	18.0	1.7	19.5	7.7	17.0	0.5	6.5	4.4	6.1	6.6	9.4	16.3	1.4	1.5	11.2	29.5	20.8	11.2	27.0	2.6	22.5
PKIG		ENSG00000168734	"CAMP-dependent protein kinase inhibitor gamma"	Q9Y2B9	20	44531785-44624247	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 233.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"memory B-cell: 370.6;naive B-cell: 377.4"	"Lineage enriched"	"Detected in all"	11	"B-cells: 377.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 540.5;HSkMC: 211.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042703, HPA063690"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042703: AB_10797018, HPA063690: AB_2685091"	"unprognostic (3.15e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.90e-5)"	"unprognostic (6.26e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.96e-2)"	90.3	76.6	77.4	59.0	80.0	20.7	74.2	70.9	95.6	105.2	78.0	189.1	30.3	111.4	37.8	76.4	101.7	73.8	289.9	82.7	82.5	104.5	44.5	162.9	49.4	80.9	77.0	57.5	32.3	66.8	69.1	82.3	72.5	102.4	31.5	26.9	45.9	75.3	104.8	31.4	72.2	92.6	73.1	42.7	81.8	68.3	83.4	19.3	68.4	91.1	46.7	169.0	68.9	73.4	27.8	27.9	44.7	28.8	67.0	135.7	6.2	66.0	540.5	73.6	55.4	64.7	12.5	108.3	52.7	58.5	61.2	10.6	9.0	14.4	23.9	54.8	16.3	16.7	4.1	45.7	61.7	2.1	1.1	211.7	28.5	35.8	7.9	36.4	167.5	29.3	13.4	2.6	6.8	35.0	17.2	27.5	23.7	0.2	39.4	2.8	1.2	2.6	40.7	5.5	18.0	58.7	16.9	7.9	45.6	19.3	21.0	13.6	108.5	99.9	44.2	44.8	32.3	13.9	41.9	76.3	49.5	1.9	43.8	2.9	1.8	0.7	1.5	1.7	1.3	370.6	1.9	1.8	9.1	377.4	5.4	8.8	2.2	4.4	1.6	35.8	1.0	17.8	77.4	80.0	70.9	95.6	82.7	82.5	80.9	77.0	72.5	73.1	83.4	73.4	93.3	9.6	6.1	26.8	82.9	25.2	14.4	20.3	10.2	24.6	37.6	45.1	233.6	24.3	15.7	46.0	20.9	15.1	6.2	44.2	127.2	70.6	110.1	104.2	91.5	122.3	44.2	34.9	65.9	30.8	17.8	93.2	5.1	18.5	47.5	27.8	65.0	37.8	8.2	10.1	42.7	15.7	32.6	3.8	20.4	40.1	73.0	14.2	49.8	22.5	8.1	94.1	3.1	25.6	25.4	39.1	46.9	61.3	11.8	11.6	19.3	156.6	78.3	28.7	118.3	19.5	153.0	155.9	27.4	5.3	30.0	36.7	8.5	80.8	29.1	10.2
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980479	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.6;testis: 56.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 29.0;Extravillous trophoblasts: 52.0;Plasma cells: 22.9;Spermatocytes: 114.7;Spermatogonia: 46.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	6	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA068860: AB_2686050"	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.33e-4)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	1.1	1.0	0.4	6.8	0.5	27.6	0.6	1.6	1.4	2.2	0.2	3.9	2.8	0.6	0.3	11.5	0.4	0.6	0.9	0.5	0.2	0.9	1.6	2.0	8.0	0.7	0.6	0.3	1.8	0.1	1.0	3.1	0.8	1.0	1.3	17.4	1.9	0.1	2.4	4.4	4.0	1.0	0.5	5.6	3.3	56.9	0.7	9.6	0.5	0.0	4.5	0.7	3.3	0.8	84.2	57.0	22.0	31.2	0.3	0.9	64.0	65.5	15.1	40.0	38.4	45.0	49.3	54.2	29.2	7.9	24.2	106.7	15.7	20.7	7.2	71.7	56.7	27.9	52.7	40.0	0.0	31.2	73.6	0.7	1.8	24.0	6.5	5.0	8.4	57.6	80.6	87.0	13.5	127.5	83.6	88.0	37.9	39.3	34.4	93.7	51.2	100.7	7.8	17.7	42.6	46.7	31.9	77.7	23.9	12.1	44.7	56.9	7.7	53.2	69.7	77.3	68.0	67.6	54.2	94.0	19.4	40.0	61.2	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.3	0.4	0.5	1.6	1.4	0.5	0.2	0.7	0.6	0.8	0.5	0.7	0.8	0.0	0.0	1.1	0.0	1.9	2.5	1.3	2.1	0.6	0.4	1.5	1.3	0.6	1.5	1.6	1.8	6.2	16.0	1.3	5.0	0.0	0.8	20.0	0.6	0.8	0.8	1.8	29.0	0.4	0.6	52.0	2.5	3.1	1.9	0.0	4.5	0.0	0.4	11.8	0.0	0.2	3.6	6.1	2.1	1.8	8.6	0.3	1.9	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.6	0.3	0.4	22.9	0.7	0.3	0.1	0.2	7.1	0.0	0.1	2.6	114.7	46.1	11.2	0.6	7.4	4.2	0.5	8.6	2.0
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 80.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 80.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	19.3	16.5	9.3	17.6	14.2	48.7	24.1	20.7	10.9	16.4	17.0	23.9	30.5	23.6	25.0	24.7	18.1	17.1	14.1	9.5	9.7	16.9	20.5	20.4	18.2	12.3	10.4	31.2	15.5	22.3	10.1	24.7	12.7	20.3	30.0	26.7	16.3	15.4	9.8	20.3	30.8	18.5	10.1	19.0	20.9	10.5	12.6	17.8	26.1	13.4	17.4	21.3	15.4	17.6	61.1	23.8	45.2	27.3	29.8	33.6	29.6	35.3	32.2	38.5	39.8	25.3	42.5	23.9	41.0	33.6	47.3	46.7	44.7	26.6	52.4	8.6	33.0	17.7	49.3	21.4	26.2	17.6	5.1	27.7	27.1	30.2	36.3	30.6	44.7	18.6	29.9	16.8	42.2	12.2	20.5	15.2	22.8	23.1	27.1	19.3	68.8	9.8	34.3	117.9	22.0	14.5	52.7	29.8	45.7	33.9	22.5	15.7	42.2	32.5	29.2	42.1	37.2	9.2	8.6	16.6	13.6	17.1	12.6	15.3	9.9	16.6	5.7	5.9	5.1	8.0	5.1	5.3	5.0	9.3	6.6	5.6	80.5	3.5	8.0	8.6	4.6	2.7	9.3	14.2	20.7	10.9	9.5	9.7	12.3	10.4	12.7	10.1	12.6	17.6	104.7	41.7	57.8	102.5	52.5	48.4	44.3	33.3	75.1	85.4	60.2	67.9	50.8	38.6	47.9	69.9	89.6	42.9	48.1	101.5	11.7	61.2	2.6	63.7	68.7	59.5	44.3	57.7	134.2	60.7	33.1	53.1	85.6	84.6	15.8	107.0	47.5	39.4	24.2	65.6	130.8	64.3	32.6	35.8	27.9	6.6	54.3	44.9	32.0	178.0	57.3	50.5	22.6	117.1	146.4	77.6	98.1	48.2	54.8	64.7	84.0	26.7	49.1	150.5	39.5	62.8	55.5	43.6	34.6	83.0	52.4	37.4	44.8	90.2	65.0	124.2
PKNOX1	PREP1	ENSG00000160199	"PBX/knotted 1 homeobox 1"	P55347	21	42974510-43033931	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 106.8;Early spermatids: 121.1;Spermatocytes: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004285, HPA057215, HPA065017"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004285: AB_2164128, HPA057215: AB_2683372, HPA065017: AB_2685405"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (4.54e-8)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (3.67e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (9.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.16e-2)"	"unprognostic (4.31e-3)"	4.8	4.2	6.6	4.0	6.6	2.5	3.9	9.6	6.9	8.1	5.5	6.5	2.8	8.3	5.4	4.1	6.5	4.7	3.5	6.7	6.7	6.7	4.4	4.5	5.0	6.9	6.6	8.6	3.9	3.4	4.6	5.3	6.6	5.0	3.8	4.7	4.2	6.6	7.6	5.4	4.3	6.0	7.5	4.7	4.4	8.2	7.3	5.2	11.5	5.9	4.5	7.0	4.6	7.6	8.8	3.0	3.9	3.8	7.3	11.0	4.8	11.0	7.6	6.5	5.6	5.2	6.6	12.2	8.9	9.7	5.1	4.6	9.1	7.0	8.6	8.4	7.3	7.2	5.7	4.9	7.5	6.6	5.4	8.3	11.3	8.1	6.6	6.8	6.3	4.1	5.8	8.8	15.1	5.2	6.2	7.3	6.1	12.4	6.5	9.8	17.7	6.7	13.0	6.9	12.6	7.5	7.8	5.6	7.6	4.5	4.7	8.4	7.5	10.2	5.0	5.7	7.1	5.1	6.1	6.2	12.9	11.6	5.5	0.3	2.1	1.7	3.9	2.9	4.1	2.8	2.8	3.2	1.9	2.2	3.3	3.0	5.7	2.3	1.9	1.7	3.3	2.4	6.6	6.6	9.6	6.9	6.7	6.7	6.9	6.6	6.6	7.5	7.3	7.6	18.4	6.4	15.7	28.1	12.5	17.5	106.8	13.7	17.1	23.7	12.4	11.7	7.4	12.8	18.2	16.5	4.2	14.9	11.1	12.3	9.8	17.1	121.1	15.1	37.7	16.0	14.9	11.0	30.3	12.6	28.8	22.3	3.6	23.8	6.3	17.3	10.0	8.4	12.6	13.5	27.2	11.8	14.2	8.4	22.5	40.8	18.6	15.3	14.2	16.9	20.8	9.5	11.3	27.6	40.8	14.5	7.0	29.3	8.6	32.2	8.5	7.5	16.3	11.5	32.9	27.3	20.8	99.7	26.4	17.1	13.8	29.0	17.1	24.2	10.8	45.2
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.3;Early spermatids: 46.8;Excitatory neurons: 132.9;Inhibitory neurons: 137.4;Oligodendrocyte precursor cells: 85.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 39.1;AN3-CA: 9.6;hTEC/SVTERT24-B: 7.8;LHCN-M2: 11.6;SK-MEL-30: 7.8;WM-115: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	3.6	3.3	2.6	2.0	5.8	0.0	1.2	1.4	12.7	3.2	8.1	2.8	0.9	3.3	2.7	1.4	6.1	1.8	7.3	4.8	0.6	3.0	0.5	10.0	1.4	3.0	0.3	14.9	3.9	0.9	5.6	8.4	1.3	6.3	1.4	2.8	2.5	5.1	15.0	2.4	1.7	2.6	2.6	2.3	2.3	4.8	0.8	3.1	12.1	36.3	1.1	3.1	2.7	3.1	0.0	0.0	39.1	9.6	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	11.6	0.3	0.0	0.0	3.9	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	6.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.8	1.4	12.7	4.8	0.6	3.0	0.3	1.3	2.6	0.8	3.1	0.6	0.0	0.0	31.3	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	1.4	46.8	0.0	1.1	0.5	0.0	0.0	132.9	0.2	0.0	3.1	0.0	0.0	0.0	12.2	1.8	0.0	0.3	8.4	137.4	0.0	0.0	0.0	0.3	9.6	5.0	0.0	8.8	22.5	0.0	2.9	0.0	85.5	3.8	0.1	0.0	17.7	0.0	1.9	0.0	0.1	0.0	0.3	6.6	8.8	2.9	1.2	0.4	0.0	0.4	0.1	0.0	6.9	0.0	0.0
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 416.7;skin 1: 699.9;vagina: 200.4"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 139.7;Squamous epithelial cells: 234.5;Suprabasal keratinocytes: 409.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 125.5;head and neck cancer: 295.4;lung cancer: 79.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 234.6;HBEC3-KT: 144.2;hTCEpi: 501.4;hTERT-HME1: 132.5;PC-3: 192.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		2500000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Plasma membrane"		"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	9.7	0.2	0.3	0.2	0.2	0.2	31.7	0.0	1.1	102.9	0.0	0.4	0.2	0.2	3.3	416.7	1.0	0.1	0.6	0.2	0.0	0.4	0.3	5.0	0.2	0.0	1.1	0.2	0.5	0.0	0.6	5.5	0.5	32.3	0.2	32.4	60.5	9.1	6.6	699.9	0.6	0.0	0.0	0.1	0.4	0.2	0.0	23.7	0.5	2.9	48.0	3.2	200.4	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	1.1	0.0	0.2	0.1	0.0	234.6	0.0	144.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	501.4	5.6	132.5	0.0	0.0	0.1	0.0	0.2	0.0	38.4	0.0	0.1	0.0	0.0	192.6	0.0	0.4	0.0	0.0	1.1	0.0	0.0	18.3	4.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.1	0.2	0.0	0.0	1.1	0.5	0.0	0.0	0.0	39.9	0.0	0.0	0.3	0.0	139.7	58.2	57.1	63.7	34.7	7.7	17.9	1.9	0.0	20.0	0.0	2.1	0.1	0.1	0.1	0.0	2.5	0.1	0.2	0.1	4.1	0.0	0.0	0.6	1.1	0.1	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.0	0.1	1.6	4.1	0.0	16.5	0.8	0.0	0.4	16.0	0.0	0.0	5.2	0.0	0.0	0.1	16.1	0.1	0.0	0.0	25.7	0.2	0.1	2.8	37.4	0.0	6.1	2.0	0.0	0.1	234.5	409.0	0.1	1.1	0.0	0.1	47.5
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790755-32896777	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 188.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 393.9;Distal enterocytes: 105.5;Extravillous trophoblasts: 185.9;Undifferentiated cells: 135.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 198.8;OE19: 72.7;SuSa: 149.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 20.2"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	5.5	2.6	1.6	6.5	2.0	5.8	11.2	3.1	3.8	20.3	8.2	49.8	23.6	5.0	3.9	5.3	73.0	7.4	188.2	8.7	1.0	7.8	25.9	1.3	4.5	1.4	0.3	15.1	16.4	33.6	9.9	20.5	0.6	9.1	45.2	2.6	58.5	6.9	6.0	2.9	26.5	5.5	0.7	2.0	17.8	6.4	1.6	12.4	0.3	1.7	10.6	5.3	3.4	1.6	56.5	10.8	0.4	0.3	0.2	0.0	0.5	0.0	0.0	0.2	0.1	198.8	49.6	0.0	32.9	0.0	7.1	48.8	6.8	43.3	0.0	0.2	15.7	0.3	2.3	52.6	29.5	3.1	0.6	0.2	40.2	0.1	46.2	21.4	1.8	0.1	10.4	15.3	4.8	14.9	0.2	0.4	29.7	72.7	9.5	0.0	23.6	16.8	14.3	26.3	5.9	5.3	2.3	11.4	0.1	149.0	24.7	0.7	0.3	0.1	21.1	0.0	13.5	12.6	0.2	0.4	0.1	0.2	2.6	5.8	0.9	8.1	0.2	1.1	0.6	0.1	0.4	0.3	2.9	0.3	0.5	0.3	0.6	1.0	1.7	0.5	0.4	0.4	1.6	2.0	3.1	3.8	8.7	1.0	1.4	0.3	0.6	0.7	1.6	1.6	0.4	0.0	0.0	0.3	2.2	7.0	48.1	20.7	32.5	3.2	22.1	13.1	393.9	21.5	17.7	1.8	4.2	57.9	0.9	105.5	3.9	12.7	4.0	61.2	11.6	3.7	27.1	2.1	1.3	10.1	185.9	12.9	43.3	52.1	4.5	23.2	5.0	46.0	8.6	1.7	58.8	67.0	26.4	17.0	20.4	1.8	11.8	28.6	10.6	4.7	1.4	14.3	0.0	2.0	1.0	23.6	65.5	2.2	1.6	32.8	30.8	11.0	14.2	1.1	0.0	13.0	9.8	6.9	5.7	12.1	3.3	41.5	2.7	1.0	135.6	28.2
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 294.4;skin 1: 223.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0"	"Region enriched"	"Detected in single"	37	"cerebellum: 8.9"	"Low region specificity"	"Detected in all"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	1.1	0.1	0.3	3.7	0.2	0.0	9.1	0.2	0.6	50.2	0.1	34.3	31.1	1.4	4.7	294.4	7.5	4.9	0.8	0.3	0.3	4.2	0.8	9.7	0.1	0.6	0.2	0.3	27.4	9.1	15.8	10.9	0.6	19.8	10.2	0.0	52.8	5.0	1.0	223.0	28.6	0.5	0.2	0.2	29.1	0.7	0.3	2.5	12.8	0.1	8.8	9.2	104.3	0.3	151.3	28.8	0.0	0.6	0.1	0.2	60.3	1.2	1.0	3.1	1.6	59.2	102.6	0.1	6.0	1.1	6.4	199.1	0.0	75.1	0.5	0.1	36.9	0.1	18.0	41.7	0.6	0.0	0.3	0.5	126.9	0.5	30.8	0.5	0.5	0.0	45.3	0.9	0.4	94.9	0.5	0.2	0.3	75.6	49.1	0.8	0.3	0.6	1.6	29.9	41.1	0.7	42.7	148.0	0.2	1.8	53.8	0.4	5.4	1.0	5.2	2.7	0.8	0.2	0.4	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.6	0.3	0.3	0.6	0.2	0.6	0.2	0.3	0.3	0.2	16.0	13.0	0.0	1.1	72.1	52.0	56.1	54.7	0.2	27.7	26.5	1.1	11.5	36.8	12.9	0.0	133.8	0.4	345.0	0.0	83.8	0.0	16.1	1.8	1.8	21.7	0.0	0.2	62.9	176.8	2.3	91.3	27.4	13.4	0.4	0.0	0.3	13.2	0.0	0.0	95.1	36.7	0.3	6.5	0.4	0.9	0.9	1.8	0.0	2.0	0.6	0.0	0.0	0.0	140.2	248.9	0.0	0.2	63.5	195.6	0.9	17.9	0.2	0.0	0.0	2.8	0.2	1.7	114.1	88.7	109.7	1.6	0.0	142.9	60.4
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597875-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 138.4;parathyroid gland: 65.8;seminal vesicle: 67.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 14.7;Endothelial cells: 14.3;Hepatocytes: 26.0;Langerhans cells: 15.6;Peritubular cells: 14.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"	NA	NA		420000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cytoplasmic bodies"	Nucleoplasm	"HPA059740: AB_2684118"	"unprognostic (1.35e-1)"	"prognostic favorable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	4.9	0.7	12.1	3.5	11.3	0.3	3.4	11.6	16.3	4.7	26.8	2.7	1.1	4.7	138.4	1.5	5.7	2.8	4.9	12.5	12.0	7.7	39.6	21.2	15.6	13.2	12.3	1.1	3.7	65.8	1.7	9.8	13.2	9.1	2.5	1.0	3.5	67.2	16.2	0.8	3.5	8.8	13.4	1.0	4.4	3.7	14.7	1.6	6.9	3.1	8.7	3.9	1.9	12.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.8	0.3	0.5	0.1	0.0	0.2	0.0	0.0	25.0	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	12.1	11.3	11.6	16.3	12.5	12.0	13.2	12.3	13.2	13.4	14.7	12.4	6.5	0.0	1.7	0.0	0.0	0.6	0.5	0.4	0.6	0.0	0.1	0.1	2.8	2.8	1.0	14.7	0.0	0.2	0.1	0.0	1.9	4.7	6.6	0.1	0.1	14.3	1.8	0.0	0.2	2.2	0.0	1.6	0.0	0.9	1.3	0.7	7.9	26.0	1.6	0.0	0.1	0.1	0.0	1.0	15.6	3.2	0.3	5.4	1.8	4.7	4.2	0.0	0.0	0.0	0.0	1.3	0.6	14.3	0.0	0.5	0.0	5.1	7.5	0.1	0.0	0.9	5.9	0.0	0.2	0.0	0.6	1.9	0.1	0.0	0.1	0.2
PLA2G15	"GXVPLA2, LLPL, LYPLA3"	ENSG00000103066	"Phospholipase A2 group XV"	Q8NCC3	16	68245304-68261058	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 116.0;Horizontal cells: 38.7;Kupffer cells: 37.1;Syncytiotrophoblasts: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041702, HPA041727"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		38000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"		"HPA041702: AB_10794486, HPA041727: AB_10793931"	"unprognostic (3.47e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.47e-2)"	15.1	11.5	12.9	7.6	12.5	7.0	9.8	12.8	18.1	6.6	9.2	8.0	6.9	6.2	8.7	6.2	7.4	9.3	35.5	13.1	14.2	33.4	17.3	17.5	13.6	13.1	14.1	7.7	7.4	11.4	11.4	27.3	14.6	8.1	5.9	4.4	9.1	5.7	58.3	13.9	6.5	8.8	12.4	20.3	8.4	10.8	15.9	11.7	13.2	22.4	5.1	8.8	6.4	16.1	10.0	10.0	7.9	25.5	36.7	26.8	19.0	24.6	31.6	35.7	30.2	26.1	18.6	17.4	31.2	34.1	28.5	15.2	8.5	10.4	15.9	6.0	16.4	5.0	10.4	19.0	19.6	4.6	25.0	19.0	11.2	35.2	5.5	44.6	22.5	8.9	7.9	9.8	23.0	21.3	7.2	14.5	5.1	9.4	12.1	9.9	11.3	55.3	17.7	8.7	3.0	5.1	31.2	9.6	19.2	6.6	25.2	23.7	18.8	31.5	15.0	41.1	16.5	34.6	33.5	22.1	28.6	13.8	12.0	19.6	24.1	16.0	4.7	27.5	4.8	5.0	5.2	7.0	14.1	5.3	6.5	5.5	1.0	2.3	32.4	12.2	5.1	14.6	12.9	12.5	12.8	18.1	13.1	14.2	13.1	14.1	14.6	12.4	15.9	16.1	4.4	6.4	3.3	3.6	3.0	4.8	2.4	6.8	2.8	12.1	7.0	6.0	22.5	1.5	5.1	9.2	8.4	20.9	4.9	8.1	5.9	10.1	1.9	4.3	4.8	5.9	0.0	1.7	7.0	7.2	7.6	8.2	8.6	9.0	15.2	6.6	9.3	13.7	116.0	38.7	6.7	8.5	2.0	37.1	6.8	6.1	2.1	21.4	12.4	10.3	7.7	4.4	3.1	5.5	3.9	6.3	5.0	1.5	2.6	2.6	3.0	19.5	2.7	6.1	0.0	5.5	6.7	3.4	2.8	4.1	3.4	50.8	3.9	3.1	4.1	2.0
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 78.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 74.5;Distal enterocytes: 21.7;Gastric mucus-secreting cells: 18.3;Glandular and luminal cells: 17.1;Suprabasal keratinocytes: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 11.1;RT4: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.0	0.0	0.1	0.4	0.3	0.3	2.4	0.1	0.1	5.7	0.0	6.4	6.7	0.0	1.6	5.7	0.1	0.1	0.3	0.1	0.0	7.8	0.2	12.2	0.1	0.0	0.0	0.0	0.1	2.9	1.7	0.1	0.0	4.3	3.8	0.2	2.6	0.4	2.9	78.1	4.2	0.1	0.0	0.1	2.4	0.1	0.0	4.4	1.9	0.5	0.3	1.2	11.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.1	0.1	0.0	0.0	0.0	0.0	8.3	0.4	0.0	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	74.5	0.0	0.0	5.5	2.7	1.3	0.6	0.0	1.2	0.3	2.9	0.0	0.5	5.5	0.0	1.7	0.0	21.7	3.9	0.4	0.0	7.3	1.0	0.1	0.0	0.0	0.0	1.3	0.7	0.1	18.3	17.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	7.7	4.1	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	0.0	0.3	3.1	10.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	5.6	13.8	1.2	0.6	0.0	6.7	2.0
PLAA	"DOA1, FLJ11281, FLJ12699, PLA2P, PLAP"	ENSG00000137055	"Phospholipase A2 activating protein"	Q9Y263	9	26903372-26947242	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005035, HPA020994, HPA020996"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.50e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.54e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.10e-1)"	16.0	16.9	8.5	16.2	9.0	42.0	12.6	9.3	11.2	11.3	9.6	15.2	13.6	17.5	13.4	18.8	9.8	13.0	18.8	9.5	9.7	15.4	21.5	12.8	15.0	8.1	8.3	11.0	12.0	16.9	8.0	16.0	9.0	12.9	15.9	14.1	10.9	12.5	50.3	12.1	12.6	19.3	8.3	13.3	12.7	20.4	8.1	18.0	15.9	29.1	18.1	14.7	11.2	10.2	64.6	37.0	46.1	46.3	30.4	38.2	34.6	58.4	33.1	43.9	42.2	13.1	29.8	56.9	48.0	45.0	30.6	25.1	45.8	46.0	47.7	75.7	19.1	35.2	57.9	25.5	30.9	28.8	46.3	34.4	27.0	53.2	38.8	33.0	44.3	41.7	22.1	56.6	47.6	26.6	56.3	28.1	66.8	33.2	31.6	39.4	28.7	34.4	33.5	37.6	29.2	49.9	31.3	36.5	19.1	44.8	25.5	22.5	54.3	0.2	53.8	28.5	48.3	18.4	43.7	59.5	30.8	40.4	23.4	21.9	12.7	21.0	11.0	18.2	12.6	14.3	11.5	11.4	13.1	11.9	10.3	12.0	11.4	14.9	21.2	6.6	18.0	9.6	8.5	9.0	9.3	11.2	9.5	9.7	8.1	8.3	9.0	8.3	8.1	10.2	10.8	16.0	11.2	18.3	18.8	11.0	11.3	14.6	17.1	9.1	7.5	6.6	23.8	5.7	16.1	9.2	0.0	24.9	14.9	11.9	9.8	17.6	27.7	10.2	12.3	17.1	9.6	25.9	31.9	16.2	26.6	11.5	15.8	14.7	40.6	13.2	12.5	10.7	20.7	5.0	30.8	8.6	14.2	15.8	8.2	6.6	8.7	17.5	1.8	21.5	15.9	9.5	16.5	24.6	32.1	15.2	8.7	8.2	23.1	10.6	11.0	12.3	12.7	6.7	19.7	13.0	34.1	28.1	24.9	20.9	9.5	49.3	18.3	21.5	12.6	11.6
PLAC8L1		ENSG00000173261	"PLAC8 like 1"	A1L4L8	5	146084313-146105577	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	8	"testis: 18.4"	"Group enriched"	"Detected in some"	35	"Early spermatids: 456.8;Late spermatids: 300.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA074266			Approved	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA074266: AB_2686676"	"unprognostic (6.38e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.62e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-6)"	"unprognostic (9.72e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.18e-2)"	0.3	0.3	1.5	0.1	1.7	0.1	0.3	2.1	1.9	0.6	0.6	0.3	0.1	0.6	0.1	0.2	0.6	0.0	0.3	1.6	1.6	0.4	0.9	0.2	0.1	1.2	1.2	0.4	0.5	0.0	0.7	0.0	1.4	0.7	0.1	0.7	0.3	0.1	0.5	0.8	0.3	0.1	1.2	0.6	0.2	18.4	1.4	0.1	0.4	0.1	0.0	0.4	0.3	1.9	0.2	0.5	0.7	2.3	0.1	0.4	0.3	0.3	0.2	0.5	0.6	0.1	0.1	0.4	0.5	0.2	0.2	0.3	1.3	0.1	0.6	0.7	1.0	0.3	0.4	0.2	0.2	0.3	0.5	0.1	1.3	0.7	0.6	0.1	0.2	0.8	0.1	0.4	0.1	0.0	0.4	0.6	0.2	0.0	0.8	0.3	0.3	0.0	0.0	0.0	0.7	0.3	0.1	0.2	0.8	0.2	0.0	0.5	0.2	0.1	0.8	0.3	0.6	0.4	0.7	0.3	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.5	1.7	2.1	1.9	1.6	1.6	1.2	1.2	1.4	1.2	1.4	1.9	0.2	0.0	0.0	2.3	0.3	0.0	0.3	0.1	0.0	0.6	0.3	0.5	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	456.8	0.1	0.3	0.3	0.0	0.0	10.7	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	0.1	0.1	1.7	7.2	0.0	2.0	0.0	0.4	300.4	4.4	0.3	0.0	3.7	0.5	0.4	0.0	5.0	10.4	0.0	0.0	1.5	0.0	0.3	0.0	0.1	0.1	0.6	0.0	0.8	0.3	5.7	2.3	0.0	0.0	0.1	0.1	0.3	0.4	0.0
PLAG1	ZNF912	ENSG00000181690	"PLAG1 zinc finger"	Q6DJT9	8	56160909-56211324	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 32.0;Microglial cells: 28.1;Rod photoreceptor cells: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;ASC TERT1: 20.9;hTERT-HME1: 15.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA072290			Supported	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA072290: AB_2686508"	"unprognostic (1.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.63e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.14e-2)"	0.7	1.4	0.8	1.0	1.2	0.9	0.9	2.5	1.1	3.0	0.6	0.8	1.4	1.4	4.1	0.7	3.1	0.7	3.1	0.7	1.0	1.3	0.3	1.9	1.8	1.5	1.4	4.9	0.8	1.2	3.8	1.6	1.8	1.3	0.6	7.7	3.0	1.8	0.4	1.4	2.3	0.4	1.2	2.6	1.3	2.4	1.3	2.8	1.3	1.4	2.3	1.3	3.0	2.0	2.0	0.0	11.9	0.1	16.0	20.9	3.7	5.4	6.9	2.5	1.1	0.8	6.2	0.2	5.1	2.9	0.7	0.4	3.4	7.1	2.5	0.2	7.4	8.0	0.8	1.8	3.3	2.5	2.3	14.9	3.9	1.4	15.6	6.9	4.7	5.3	3.4	0.1	5.3	0.1	0.7	4.7	3.4	0.5	1.8	6.1	0.8	4.9	3.2	0.7	0.1	0.0	0.1	0.1	0.4	8.0	0.1	2.4	7.2	3.6	4.6	5.9	1.4	1.8	1.5	2.9	4.1	0.9	1.0	0.6	0.0	0.4	0.1	0.0	0.1	1.3	0.4	0.2	0.0	0.7	1.8	1.8	0.4	0.3	0.2	0.1	0.1	0.4	0.8	1.2	2.5	1.1	0.7	1.0	1.5	1.4	1.8	1.2	1.3	2.0	2.6	6.4	3.2	2.9	13.0	1.0	2.5	6.2	1.8	23.6	1.6	0.6	12.2	4.3	6.7	5.5	25.0	8.3	2.0	1.0	0.0	0.7	6.2	3.0	2.3	3.7	5.4	5.0	16.8	1.3	4.2	4.0	2.6	4.2	1.3	0.4	15.7	0.7	5.8	32.0	12.3	3.6	6.1	2.9	2.2	6.7	15.2	2.8	16.0	28.1	1.2	16.3	4.1	2.0	19.2	1.4	4.1	10.1	6.3	5.0	5.1	0.8	9.1	27.8	0.0	2.4	1.4	9.0	8.8	1.1	0.9	7.1	4.5	0.9	3.6	12.9
PLAGL2	ZNF900	ENSG00000126003	"PLAG1 like zinc finger 2"	Q9UPG8	20	32192504-32207743	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.7;Glandular and luminal cells: 47.7;Late spermatids: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"intermediate monocyte: 18.3;non-classical monocyte: 34.8"	"Lineage enriched"	"Detected in many"	15	"monocytes: 34.8"	"Cell line enhanced"	"Detected in all"		"CACO-2: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005900	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA005900: AB_1079629"	"unprognostic (9.40e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.09e-1)"	4.4	3.2	4.4	6.6	5.2	32.2	4.6	5.0	5.0	4.8	7.4	7.8	10.4	6.0	5.2	12.8	9.4	4.1	5.2	5.1	4.0	4.9	4.3	6.6	7.7	4.3	4.1	7.7	6.0	8.5	5.5	3.9	3.6	5.3	8.0	13.0	6.8	5.4	10.2	7.5	12.9	7.2	3.7	6.2	7.2	16.4	4.2	8.9	4.8	8.3	10.7	5.6	6.1	4.2	19.4	10.9	28.5	10.4	10.4	8.0	17.8	7.5	11.9	16.0	14.5	82.3	9.5	19.8	10.1	7.8	22.4	18.6	35.7	17.3	21.0	11.9	16.1	80.3	9.4	39.8	12.7	35.5	17.0	9.7	15.1	12.9	9.1	7.5	11.7	20.7	28.7	17.5	8.5	10.8	39.2	24.4	13.4	14.8	12.4	25.0	36.8	12.6	6.9	14.6	12.9	14.2	18.5	9.9	16.1	16.5	14.9	42.8	8.8	19.3	20.5	14.0	15.5	47.5	28.5	25.1	11.2	73.5	12.1	2.2	3.6	0.9	0.7	18.3	1.4	1.4	1.0	1.5	2.2	1.0	1.2	0.7	0.9	0.5	34.8	0.6	0.8	2.5	4.4	5.2	5.0	5.0	5.1	4.0	4.3	4.1	3.6	3.7	4.2	4.2	4.3	12.8	21.1	2.0	6.0	7.5	13.5	6.2	10.8	7.4	8.6	6.5	4.2	2.8	12.2	1.8	31.3	3.2	8.1	13.1	3.9	3.8	56.7	26.1	9.1	5.2	10.7	10.3	4.5	5.2	3.1	5.7	8.2	47.7	2.5	6.4	7.1	3.8	6.0	3.3	3.8	12.4	2.0	8.9	7.8	159.8	2.5	11.9	0.0	4.7	11.1	6.3	0.0	1.5	4.9	6.2	8.9	7.2	7.9	15.0	29.3	3.4	6.8	21.3	6.6	7.1	4.1	11.8	10.8	21.2	11.6	4.1	7.4	6.2	16.7	21.7
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251530-64269150	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 113.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.3;Proximal enterocytes: 161.7;Undifferentiated cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		210000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus"	"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	12.8	19.1	6.8	9.7	7.3	7.4	11.2	8.2	8.0	19.7	7.0	22.8	113.8	17.8	3.6	35.3	16.5	7.1	11.5	6.5	7.3	11.7	6.4	15.6	4.4	9.2	7.6	15.8	8.6	10.0	5.8	10.3	8.1	13.1	12.5	1.4	13.5	10.4	6.7	20.3	101.6	11.4	7.7	14.5	14.7	9.5	9.2	3.9	10.3	4.2	5.3	13.8	18.8	7.7	45.2	24.9	24.0	36.0	24.6	18.9	23.8	35.3	26.4	29.5	17.9	22.1	33.5	3.2	20.8	44.4	25.4	75.9	27.2	33.0	10.1	21.8	15.1	35.1	54.9	16.7	17.0	8.6	22.3	16.0	21.5	32.1	23.6	32.2	43.5	13.4	17.6	3.8	37.9	54.5	10.9	17.9	38.8	56.9	26.9	23.5	54.0	13.3	18.2	46.8	6.4	26.4	52.0	64.4	25.2	14.8	33.9	16.4	76.4	27.1	32.0	62.7	23.2	4.6	2.4	3.6	44.8	19.9	25.5	0.0	0.4	0.0	0.2	0.4	0.2	0.0	0.2	0.1	0.4	0.0	0.1	0.1	0.2	0.1	0.4	1.2	0.0	0.1	6.8	7.3	8.2	8.0	6.5	7.3	9.2	7.6	8.1	7.7	9.2	7.7	11.2	3.2	7.9	7.5	1.8	13.0	6.0	6.4	6.2	1.2	6.1	4.6	3.3	8.6	6.3	16.5	0.0	9.2	8.3	52.3	1.9	7.8	1.3	3.5	8.7	13.2	2.4	7.8	0.6	7.7	19.1	7.6	28.5	7.1	5.7	20.2	18.2	3.4	9.8	3.3	0.9	46.2	12.2	10.1	13.5	1.4	9.9	8.8	8.8	8.4	22.1	4.7	2.1	1.5	0.6	17.3	23.8	12.4	2.6	7.4	161.7	4.0	2.8	1.1	26.3	6.0	9.8	3.1	8.3	19.4	11.8	14.6	2.7	6.8	65.5	8.3
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.6;salivary gland: 57.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 105.9;Horizontal cells: 164.9;Inhibitory neurons: 113.8;Microglial cells: 183.6;Oligodendrocyte precursor cells: 168.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Region enhanced"	"Detected in all"		"cerebellum: 55.6"	"Immune cell enriched"	"Detected in single"	18	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 91.4;hTERT-HME1: 45.9;LHCN-M2: 77.6;OE19: 48.2;RPTEC TERT1: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	6.3	7.2	8.6	3.4	3.7	0.5	7.0	55.6	6.3	4.6	31.0	20.5	2.6	8.2	24.4	9.0	15.0	5.9	17.9	2.5	10.8	3.0	0.3	5.4	1.7	13.4	17.8	2.1	2.1	0.7	8.2	6.5	12.0	9.7	17.9	15.1	57.4	6.1	2.7	4.6	4.2	9.1	5.3	1.3	14.4	2.4	23.3	4.5	32.7	6.8	2.3	8.2	5.3	6.5	0.0	15.1	7.9	0.0	0.0	0.4	0.1	35.8	9.5	10.9	6.1	3.4	2.6	0.0	0.6	91.4	39.0	0.1	2.3	7.6	14.7	0.0	5.3	3.8	5.7	0.0	1.6	0.0	0.0	2.3	3.0	12.7	45.9	18.7	0.1	0.0	4.3	0.4	77.6	5.0	0.0	0.0	8.8	48.2	10.4	0.0	0.0	0.7	96.9	5.8	25.5	18.4	0.0	23.8	15.1	10.5	19.2	0.2	0.5	11.2	0.9	1.2	14.2	0.0	0.0	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	8.6	3.7	55.6	6.3	2.5	10.8	13.4	17.8	12.0	5.3	23.3	6.5	37.8	6.4	0.5	60.1	0.3	2.4	3.8	1.5	2.2	82.9	5.7	5.3	72.6	0.0	8.9	5.5	0.0	0.0	4.5	17.9	0.0	0.7	1.4	46.2	4.6	40.4	42.0	0.0	105.9	0.2	0.0	9.0	18.8	53.5	0.0	36.6	1.8	0.0	0.1	164.9	113.8	36.4	14.2	0.0	2.1	1.2	1.5	0.8	7.2	183.6	0.6	2.9	0.0	168.9	2.9	7.1	9.7	20.7	0.2	8.5	2.1	1.2	39.5	6.6	13.1	10.5	36.0	1.5	2.0	0.5	1.0	0.1	1.4	4.8	40.4	2.5
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962685	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 706.3;choroid plexus: 347.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		8200	"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	9.0	4.2	69.4	33.0	141.3	30.3	8.5	706.3	105.2	5.0	347.5	8.6	17.3	8.6	22.5	4.6	5.5	13.4	4.3	40.1	122.6	23.4	14.3	9.4	66.8	301.3	122.7	1.6	3.9	2.8	1.2	8.2	207.3	2.8	7.0	0.5	7.1	3.4	1.9	4.0	19.4	8.8	241.5	34.8	8.7	2.0	283.3	10.0	6.9	3.6	72.0	10.1	3.9	437.2	1.4	3.2	0.6	2.9	0.2	0.2	4.0	0.3	0.4	2.3	0.8	0.9	8.1	183.3	30.1	0.2	7.4	4.2	4.0	0.5	1.4	1.4	2.1	22.1	0.4	0.3	1.2	22.3	84.2	0.3	1.8	1.3	1.0	0.3	4.2	8.1	2.5	15.0	0.4	5.7	2.6	55.5	3.1	2.3	1.3	75.1	0.1	23.7	0.5	3.9	1.4	0.4	5.0	1.6	1.5	3.9	3.3	67.7	1.1	0.4	3.2	0.4	0.6	35.2	61.4	403.4	0.3	30.0	1.6	9.4	12.1	76.2	1.9	16.1	0.9	51.1	0.6	2.9	10.7	49.6	0.8	1.9	65.7	41.3	36.8	7.0	0.5	6.9	69.4	141.3	706.3	105.2	40.1	122.6	301.3	122.7	207.3	241.5	283.3	437.2	187.0	12.8	54.0	0.0	138.3	2.9	1.6	2.3	1.8	224.8	139.5	113.0	7.2	28.6	13.1	16.5	104.3	13.6	94.0	0.4	13.7	2.6	20.5	65.5	88.0	61.7	21.5	23.2	0.7	0.0	2.2	30.6	16.8	86.6	40.4	29.0	37.1	43.2	27.7	101.0	0.8	2.7	65.1	47.4	9.4	30.7	11.1	46.7	8.8	95.5	21.8	221.7	47.4	2.0	1.3	0.1	9.8	4.9	138.6	3.5	5.5	5.9	6.9	196.2	6.6	28.0	51.9	4.8	2.9	3.0	2.3	11.1	48.2	8.7	1.9	6.5
PLCXD2	FLJ31579	ENSG00000240891	"Phosphatidylinositol specific phospholipase C X domain containing 2"	Q0VAA5	3	111674676-111846447	"Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;retina: 14.8"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 60.7;Distal tubular cells: 160.4;Hepatocytes: 168.6;Proximal tubular cells: 196.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;NK-cells: 1.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 7.1"	"Low region specificity"	"Detected in all"							HPA055947	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055947: AB_2682981"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.23e-7)"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (2.99e-4)"	0.3	0.3	2.6	1.6	2.9	4.6	0.2	0.7	7.3	0.3	0.0	1.2	2.8	0.3	0.2	0.5	0.2	0.7	0.3	3.9	1.6	0.6	1.0	0.6	2.9	4.1	4.5	0.2	0.6	0.1	1.4	1.0	4.1	0.3	1.5	14.8	0.9	0.2	0.2	0.6	2.7	0.3	2.2	1.6	0.9	1.0	3.5	2.7	1.3	0.1	2.2	0.5	0.3	1.9	2.3	2.1	2.0	0.9	0.0	0.1	0.6	4.0	1.9	3.7	3.2	1.4	1.1	1.7	2.0	0.2	1.2	5.6	0.8	3.7	7.1	0.5	1.0	0.4	4.1	1.3	0.3	0.5	2.0	0.0	0.7	1.2	2.2	3.4	2.0	2.1	0.0	4.0	0.4	0.2	1.2	0.4	0.7	1.5	5.1	1.1	2.8	1.6	1.7	2.3	0.4	3.4	0.8	0.5	0.8	2.2	0.3	0.1	2.0	0.8	5.0	0.4	0.8	4.8	0.7	0.3	0.4	0.3	0.2	0.3	0.0	0.0	1.8	0.0	1.8	0.3	0.9	1.8	0.1	0.4	0.4	0.9	0.1	1.1	0.0	3.8	0.9	0.3	2.6	2.9	0.7	7.3	3.9	1.6	4.1	4.5	4.1	2.2	3.5	1.9	0.4	19.2	2.2	3.3	2.3	0.1	9.9	17.1	7.4	0.8	2.9	1.8	3.7	22.8	3.5	60.7	4.2	0.0	8.4	1.6	160.4	44.2	11.9	0.9	0.2	0.7	25.1	0.0	11.7	50.1	0.0	0.4	7.1	1.5	0.0	5.4	0.4	168.6	0.0	6.7	6.0	7.8	2.0	1.6	0.0	12.0	0.3	1.8	0.0	3.7	0.0	0.0	2.1	7.5	0.9	50.1	0.2	0.4	3.9	7.9	1.0	196.6	1.0	3.5	0.0	0.0	1.7	0.5	0.5	2.2	0.1	0.0	5.3	0.5	1.5	14.1
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600404-171810950	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 86.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 519.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004527, HPA042396, HPA066938"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: "	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.8	26.4	9.2	6.6	24.7	7.8	7.5	18.4	13.6	10.4	4.5	14.6	46.9	6.2	2.8	33.0	6.4	86.8	24.4	10.5	14.3	12.0	33.7	4.7	9.1	24.8	22.0	24.2	21.2	1.6	2.3	10.7	23.5	3.4	14.7	0.5	13.8	6.0	2.5	29.2	43.9	4.8	14.7	15.7	8.2	5.0	19.0	4.1	3.7	6.8	10.8	5.1	12.4	41.4	4.5	7.2	3.7	1.4	11.2	12.6	7.7	2.3	9.9	3.5	4.3	1.1	6.4	0.0	17.0	0.9	24.0	15.2	0.6	2.0	5.7	3.6	3.2	4.2	11.5	26.1	4.9	7.3	18.9	4.9	10.9	4.2	2.0	10.0	57.5	1.2	2.8	0.0	0.9	1.3	0.0	6.4	0.8	11.9	5.1	0.2	1.5	0.1	8.9	1.8	0.1	0.1	7.9	4.7	31.1	5.1	9.0	9.7	50.7	1.5	5.7	4.0	2.5	9.6	8.2	0.1	6.7	8.6	1.9	8.3	1.8	2.3	0.3	1.1	2.6	0.0	0.2	0.6	0.6	0.0	0.0	0.1	1.0	2.2	0.4	0.0	0.8	0.6	9.2	24.7	18.4	13.6	10.5	14.3	24.8	22.0	23.5	14.7	19.0	41.4	7.7	0.0	4.7	2.0	0.9	7.1	3.4	11.0	10.8	0.4	4.9	5.6	33.6	57.2	11.1	1.8	0.0	3.0	1.9	37.5	3.9	8.4	13.1	1.0	4.8	7.4	4.2	6.3	8.9	3.4	3.7	15.7	27.0	1.3	27.9	10.4	6.4	15.9	20.0	0.0	12.1	23.6	6.1	13.2	2.4	9.5	10.5	10.2	12.4	98.4	5.4	0.0	1.0	12.5	519.6	2.4	18.3	4.5	3.4	0.7	38.3	48.0	9.9	0.1	19.7	3.8	8.4	6.1	5.3	93.5	34.9	2.3	2.3	12.1	17.8	4.7
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 711.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 688.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 1727.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1727.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		450000	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	169.3	200.0	143.3	78.4	159.7	48.3	138.4	46.0	229.7	139.4	54.0	131.4	71.7	155.7	84.7	84.9	133.5	96.7	206.1	202.5	294.4	130.2	121.3	181.5	98.1	132.4	128.5	199.0	151.0	105.9	711.9	123.4	137.9	133.4	49.2	51.4	138.7	106.2	105.1	120.5	105.3	79.1	63.8	197.0	126.5	77.7	197.7	44.3	120.8	82.3	41.4	126.2	126.0	129.6	85.6	257.8	163.7	259.1	444.2	210.2	124.5	206.5	208.6	146.4	166.6	49.4	93.8	36.9	211.0	180.9	47.8	39.3	39.9	81.2	63.5	138.4	145.3	39.9	82.1	63.2	302.7	16.8	435.1	402.5	167.0	112.1	76.6	244.2	125.0	59.3	142.5	144.5	106.7	111.5	29.5	79.6	107.4	138.7	52.8	37.0	124.5	154.2	75.2	63.2	116.7	193.9	99.0	60.6	113.8	169.5	83.6	283.2	222.3	122.8	58.5	105.6	47.0	148.9	173.3	38.8	197.7	66.2	77.9	1727.4	256.7	378.7	75.0	129.5	62.0	34.4	59.5	67.7	235.0	28.1	60.8	61.3	25.7	102.3	64.2	34.7	64.5	208.6	143.3	159.7	46.0	229.7	202.5	294.4	132.4	128.5	137.9	63.8	197.7	129.6	66.7	32.1	69.6	59.4	27.0	35.4	93.6	263.1	39.9	101.5	45.9	61.2	22.0	45.8	90.4	57.0	33.3	158.2	27.2	42.5	21.5	52.5	8.7	32.0	49.8	53.9	72.8	18.7	99.1	58.3	107.2	158.8	38.2	31.5	60.3	134.7	88.2	43.1	688.4	121.1	113.4	41.3	126.1	280.9	59.1	15.7	151.6	261.3	92.5	50.6	54.2	94.1	35.0	53.3	70.2	54.3	42.6	143.7	85.8	57.9	78.8	37.1	35.2	47.6	19.7	73.1	59.7	24.2	67.9	32.4	33.4	195.9	28.8	114.1	41.6	68.2
PLEKHA1	TAPP1	ENSG00000107679	"Pleckstrin homology domain containing A1"	Q9HB21	10	122374696-122442602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 10.3;NK-cells: 21.3;T-cells: 27.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 203.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002043, HPA064795"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA002043: AB_1079632, HPA064795: AB_2685354"	"unprognostic (1.79e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.23e-2)"	18.0	10.4	21.2	13.9	25.5	4.4	19.6	10.7	42.0	18.6	5.0	21.4	25.9	25.9	20.5	39.4	12.7	24.0	29.2	25.9	14.8	39.1	38.7	36.6	14.9	12.4	14.9	19.2	27.3	27.6	21.8	37.3	13.3	17.9	20.1	19.8	25.2	18.8	31.8	66.5	25.1	23.6	13.2	13.7	21.2	40.7	13.7	15.6	27.3	57.4	18.0	24.9	21.7	36.9	25.9	23.5	23.3	16.1	33.1	37.5	28.0	28.2	49.1	16.8	18.0	20.0	31.8	16.1	13.3	25.6	17.0	55.4	22.3	86.1	15.4	11.4	21.8	0.0	22.6	23.6	21.8	2.9	7.3	20.5	69.7	13.9	58.3	27.5	56.8	33.2	24.3	0.1	15.6	9.9	14.8	2.5	18.1	39.3	15.5	4.0	33.1	3.2	203.2	28.3	31.6	15.5	36.4	26.8	28.9	32.7	14.9	0.3	54.6	14.1	11.5	15.4	14.3	0.1	0.0	5.4	21.6	0.1	8.8	0.3	2.7	2.3	27.1	2.4	17.5	5.1	16.3	21.9	3.2	10.3	25.4	21.9	0.8	21.3	2.9	1.6	11.9	11.6	21.2	25.5	10.7	42.0	25.9	14.8	12.4	14.9	13.3	13.2	13.7	36.9	48.6	144.2	42.0	19.9	28.0	72.8	54.7	51.6	97.9	46.5	25.6	19.2	55.9	55.8	46.0	57.0	75.0	58.4	47.6	39.1	41.1	63.1	202.0	50.2	30.6	70.8	22.3	6.9	133.8	85.3	53.9	34.3	28.1	83.7	5.1	20.8	32.5	45.1	37.2	26.9	92.9	19.6	22.4	23.7	23.6	336.5	44.1	20.4	24.9	35.6	28.5	20.2	147.2	35.2	161.9	71.4	26.9	36.1	7.4	91.4	64.4	118.1	29.1	49.5	26.3	32.2	28.9	119.4	86.1	71.6	84.8	39.7	39.7	14.7	27.5	83.5
PLEKHA2	TAPP2	ENSG00000169499	"Pleckstrin homology domain containing A2"		8	38901235-38973912	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.1;dendritic cells: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 164.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004706	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA004706: AB_1079633"	"unprognostic (2.78e-1)"	"unprognostic (8.80e-3)"	"unprognostic (4.15e-3)"	"unprognostic (3.03e-1)"	"unprognostic (8.61e-2)"	"unprognostic (9.07e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.60e-3)"	17.5	15.7	13.6	35.3	11.1	39.7	10.6	6.1	18.3	16.9	13.1	16.9	10.1	15.0	10.6	14.0	15.8	17.7	42.8	25.3	10.2	17.1	9.4	20.1	78.7	10.7	6.9	19.1	6.6	21.2	8.7	17.8	11.8	10.2	12.4	5.4	7.4	18.8	4.5	8.4	16.0	18.9	10.1	43.0	12.6	5.9	10.1	17.9	19.3	8.0	66.1	17.3	10.3	16.3	30.0	6.5	4.1	10.0	10.2	20.1	4.6	35.7	27.2	25.9	21.5	3.7	19.4	164.7	41.3	31.9	22.9	17.9	10.8	21.6	38.4	42.8	1.0	84.7	54.4	4.0	36.9	28.0	32.9	46.3	14.7	13.2	23.6	60.1	4.4	26.3	8.7	45.0	24.1	3.7	56.0	12.8	3.9	23.2	10.2	14.1	22.4	34.6	31.3	24.9	0.5	6.5	41.9	7.4	27.9	6.1	16.9	13.0	6.5	18.5	14.5	3.2	28.5	14.7	14.8	76.3	29.3	28.7	4.2	6.9	1.5	8.1	1.9	2.0	2.0	10.0	2.2	2.3	1.8	12.7	1.4	2.6	3.3	3.9	2.2	5.4	1.9	1.0	13.6	11.1	6.1	18.3	25.3	10.2	10.7	6.9	11.8	10.1	10.1	16.3	8.8	3.2	17.9	15.0	94.1	8.8	15.7	17.1	6.8	1.8	7.2	5.2	40.7	12.8	17.3	40.5	0.0	7.7	132.0	9.0	1.9	7.4	1.0	17.8	28.7	10.9	13.1	12.2	21.2	5.5	17.7	22.2	9.2	25.4	36.8	21.3	19.6	10.2	48.8	58.9	7.7	11.8	6.1	79.6	55.3	2.5	22.7	49.7	16.0	35.6	48.4	12.1	64.9	52.3	4.7	24.5	4.7	25.2	56.4	9.9	15.9	16.3	23.5	1.4	13.1	35.8	24.8	0.7	7.9	5.1	6.7	4.5	53.9	4.4	12.8	35.7
PLEKHA5	"FLJ10667, KIAA1686, PEPP2"	ENSG00000052126	"Pleckstrin homology domain containing A5"	Q9HAU0	12	19129733-19376400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 555.7;Inhibitory neurons: 506.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 22.6;MAIT T-cell: 5.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 22.6;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 65.5;NTERA-2: 64.4;SuSa: 61.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035923, HPA035924, HPA041455"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: AB_2677490"	"unprognostic (3.16e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.85e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.07e-2)"	10.5	61.3	7.2	5.2	15.7	3.7	15.3	3.9	15.8	30.7	1.3	12.1	13.0	29.8	32.3	20.7	20.0	18.5	35.2	12.6	7.7	42.7	16.2	12.8	3.1	13.6	16.1	32.7	14.9	21.9	12.6	12.7	11.5	17.3	13.6	35.1	15.5	28.0	2.4	17.7	13.3	15.3	11.8	3.4	18.6	20.5	10.4	8.6	14.6	5.1	4.9	23.5	25.0	14.7	25.8	12.5	45.2	0.4	14.9	20.1	15.8	10.8	23.7	6.5	10.2	19.1	22.8	0.5	3.5	12.1	13.2	10.9	30.8	20.3	13.5	65.5	10.8	15.4	28.1	9.1	14.0	0.3	2.0	11.8	20.4	18.6	35.2	35.5	7.1	12.9	6.7	0.7	7.0	8.0	10.2	1.8	64.4	21.1	6.5	0.2	21.0	0.2	45.6	30.5	4.1	9.1	10.6	5.9	40.3	61.0	7.4	3.5	10.8	4.0	17.3	0.9	0.4	0.6	0.5	0.3	9.8	0.2	8.3	22.6	0.3	0.3	2.4	0.4	5.7	0.2	2.2	2.1	1.8	0.3	0.3	1.6	0.8	1.6	0.2	2.5	2.1	0.4	7.2	15.7	3.9	15.8	12.6	7.7	13.6	16.1	11.5	11.8	10.4	14.7	19.9	25.6	28.2	145.9	3.2	20.5	46.6	42.2	25.0	86.2	27.8	49.7	157.9	57.2	49.5	46.0	137.6	26.8	9.0	25.6	35.2	33.7	25.8	84.2	187.3	17.2	32.4	7.8	555.7	33.1	38.7	79.8	37.8	98.8	3.8	11.3	20.3	38.9	6.6	126.2	506.4	17.9	22.4	10.5	94.1	15.3	40.4	11.4	117.4	178.0	168.2	97.5	0.0	158.8	82.0	52.6	30.9	28.2	4.9	33.4	30.4	115.3	60.6	139.7	32.9	24.7	38.1	45.5	48.8	39.4	25.7	26.4	12.0	75.3	36.9	47.2
PLEKHA7	DKFZp686M22243	ENSG00000166689	"Pleckstrin homology domain containing A7"	Q6IQ23	11	16777297-17014414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.0;Gastric mucus-secreting cells: 40.8;Microglial cells: 48.7;Oligodendrocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 3.7;MAIT T-cell: 2.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.7;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 116.4;HaCaT: 75.2;OE19: 58.6;RT4: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038610, HPA066103"	Approved		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA038610: AB_10671746, HPA066103: AB_2732738"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.13e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (9.74e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.65e-2)"	10.3	1.7	10.0	5.5	11.9	0.6	13.3	9.6	7.0	11.2	26.5	18.3	27.3	4.1	3.8	46.0	9.1	7.3	24.0	7.5	14.3	26.4	16.7	8.0	2.3	11.5	17.9	12.7	15.2	17.6	4.2	9.0	11.8	7.0	16.9	27.4	21.5	5.3	2.2	14.1	25.4	3.6	7.3	1.8	23.7	10.1	21.2	4.0	10.9	2.2	6.6	14.0	18.3	10.3	14.2	12.7	11.9	5.5	0.7	0.0	20.7	0.1	0.4	4.9	9.0	22.6	116.4	0.2	5.4	1.9	0.7	75.2	16.9	0.2	3.5	4.2	16.2	39.7	11.2	13.5	0.3	0.1	0.5	0.6	6.4	0.0	0.4	10.7	0.0	14.3	1.7	0.4	2.0	8.7	8.8	0.3	6.1	58.6	12.4	11.5	0.0	3.0	10.9	109.9	8.3	0.9	16.7	44.3	0.6	22.3	11.3	4.1	3.3	0.2	4.1	3.2	2.8	7.6	2.4	16.2	0.1	0.8	0.1	0.1	0.1	3.7	0.3	0.0	2.0	0.1	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.2	10.0	11.9	9.6	7.0	7.5	14.3	11.5	17.9	11.8	7.3	21.2	10.3	8.2	3.2	17.0	111.0	0.6	0.6	1.1	1.4	0.6	2.3	6.9	6.1	8.7	7.2	8.6	11.0	25.0	6.7	0.2	12.0	3.9	6.1	16.3	20.5	2.3	4.7	0.0	1.3	19.3	6.0	0.9	1.0	40.8	22.9	2.5	16.1	2.2	2.9	1.8	0.0	26.2	6.5	0.0	1.0	1.4	6.1	0.6	2.7	0.0	48.7	0.8	4.3	1.0	15.6	37.9	10.7	4.1	0.4	1.8	0.8	9.2	10.6	8.0	9.7	0.0	1.0	1.2	0.5	0.5	12.3	0.4	6.0	1.2	2.1	3.1	6.4
PLEKHA8	"FAPP2, MGC3358"	ENSG00000106086	"Pleckstrin homology domain containing A8"	Q96JA3	7	30027404-30130483	"Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072314			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA072314: AB_2686511"	"unprognostic (5.49e-3)"	"unprognostic (8.62e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.07e-2)"	3.6	2.4	3.7	3.2	3.7	1.5	3.6	5.2	4.4	5.0	3.6	4.0	3.7	3.7	4.2	4.1	3.1	3.0	2.8	4.0	3.1	6.1	3.0	3.5	4.3	4.2	3.5	4.1	3.6	4.2	3.2	8.0	3.3	3.6	3.6	11.8	4.0	3.7	2.4	3.9	4.2	3.8	3.2	2.4	3.4	3.5	4.0	2.8	2.8	2.4	4.7	3.8	4.3	4.3	11.4	7.8	34.5	35.3	9.4	7.3	23.2	8.2	6.6	6.3	8.3	14.1	4.9	25.8	10.5	7.4	16.4	8.2	18.2	9.1	8.9	5.0	12.5	15.1	12.8	13.4	7.9	6.9	5.2	3.8	7.3	8.6	12.4	7.8	13.6	12.3	14.3	9.3	9.1	7.2	13.2	4.6	22.7	5.5	8.6	0.0	9.4	18.2	7.1	9.0	4.4	25.2	8.8	28.9	11.5	30.5	10.2	7.0	11.5	5.7	22.8	5.6	9.4	18.9	35.6	15.4	10.8	4.4	12.8	0.3	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.3	0.0	0.2	0.1	0.0	0.1	0.0	3.7	3.7	5.2	4.4	4.0	3.1	4.2	3.5	3.3	3.2	4.0	4.3	8.9	3.2	2.6	32.7	6.6	11.2	6.3	2.3	10.8	14.8	7.0	4.7	3.7	1.5	2.8	12.9	25.0	21.6	4.4	7.2	3.9	11.7	2.0	11.4	10.3	5.8	2.4	3.8	36.0	7.1	19.6	6.0	2.6	14.8	4.5	10.0	3.9	4.6	6.7	10.1	30.2	5.0	8.2	3.4	4.6	1.1	3.4	4.7	10.6	14.0	6.5	6.3	10.3	33.7	24.2	10.2	23.9	4.9	15.8	8.7	9.6	12.2	4.4	18.7	6.6	4.9	10.3	14.0	12.4	7.6	12.6	20.2	4.7	4.9	4.8	10.2
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 91.2;Astrocytes: 98.6;Endothelial cells: 58.4;Microglial cells: 131.2;Oligodendrocytes: 168.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 23.9;naive B-cell: 22.9"	"Lineage enriched"	"Detected in single"	31	"B-cells: 23.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 26.4;Karpas-707: 23.4;U-698: 16.6"	"Region enhanced"	"Detected in all"		"thalamus: 51.3"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	15.1	1.6	9.8	9.4	12.3	2.4	13.7	15.5	8.9	7.5	3.9	5.9	4.9	5.6	10.8	9.4	8.7	7.9	6.9	5.8	8.7	7.7	4.9	10.4	14.7	19.5	16.2	3.1	2.7	6.7	3.6	14.2	18.3	2.7	5.9	4.7	3.5	4.9	3.5	7.4	6.6	5.6	18.2	31.2	4.5	6.3	19.1	22.4	5.7	5.0	13.9	9.1	5.3	21.5	0.0	0.2	17.6	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	10.1	4.4	7.2	6.8	0.0	1.6	2.5	26.4	2.4	0.0	11.4	2.9	0.4	1.4	0.0	0.0	0.0	1.9	1.1	6.7	0.0	0.2	0.0	11.0	5.9	0.0	23.4	0.0	0.3	2.3	0.1	1.3	7.0	0.7	1.2	0.0	0.0	5.1	11.9	0.5	0.1	0.1	3.1	2.2	1.9	0.0	0.1	11.2	0.1	2.4	0.0	4.9	0.0	0.0	16.6	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.7	23.9	0.4	0.6	0.0	22.9	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.7	9.8	12.3	15.5	8.9	5.8	8.7	19.5	16.2	18.3	18.2	19.1	21.5	91.2	0.0	6.2	98.6	50.3	4.2	0.5	5.5	2.8	0.9	2.0	3.3	2.1	1.5	6.8	7.3	0.0	5.5	0.7	7.2	3.9	2.6	3.8	20.7	6.2	58.4	5.4	5.0	12.8	1.1	1.6	11.8	7.1	19.2	0.0	7.9	35.0	4.3	0.6	0.0	5.8	8.2	8.2	5.9	3.8	1.6	0.3	2.0	5.4	131.2	4.7	11.3	0.0	14.1	168.5	9.4	12.4	0.4	5.2	1.1	3.9	3.6	9.6	0.7	0.0	2.0	3.0	0.7	1.5	6.2	3.7	2.9	5.1	1.1	5.5	3.6
PLEKHG2	"ARHGEF42, CLG, FLJ00018"	ENSG00000090924	"Pleckstrin homology and RhoGEF domain containing G2"	Q9H7P9	19	39412669-39428415	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Leukodystrophy, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 86.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017973, HPA048054"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA017973: AB_2669719, HPA048054: AB_2680241"	"unprognostic (3.55e-1)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (3.79e-8)"	"unprognostic (8.01e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	32.6	10.7	4.6	22.8	3.8	22.1	20.3	4.6	7.5	28.2	11.3	24.5	8.1	31.2	4.4	10.1	24.9	17.4	25.6	4.3	3.7	27.7	8.0	42.2	20.7	7.1	4.4	20.1	7.1	5.2	12.2	23.0	5.1	21.0	5.2	4.6	8.4	15.1	6.3	9.0	18.9	18.5	4.7	33.4	15.6	15.7	9.3	21.1	19.1	4.9	18.3	20.9	17.4	5.2	8.5	40.8	73.0	39.9	6.9	9.0	10.6	21.9	17.3	14.9	12.8	26.5	14.9	14.7	15.8	28.8	12.4	2.8	11.1	19.4	7.9	49.3	10.2	19.3	23.5	12.4	11.9	2.2	23.1	20.7	3.3	17.9	8.7	25.8	19.3	41.7	13.2	16.9	24.1	17.0	24.2	7.5	17.3	7.8	3.9	86.1	8.9	4.6	12.7	15.4	2.0	23.6	4.9	1.8	7.0	25.2	21.9	21.8	24.8	38.8	30.0	14.5	14.4	12.6	4.1	21.4	21.6	8.7	22.0	1.3	0.5	0.1	1.4	0.2	0.9	1.2	0.7	0.8	0.3	1.1	1.0	1.2	0.8	0.4	0.7	1.4	1.3	1.1	4.6	3.8	4.6	7.5	4.3	3.7	7.1	4.4	5.1	4.7	9.3	5.2	30.4	6.4	27.4	1.6	9.7	4.0	5.5	2.9	6.8	0.6	4.6	11.7	6.4	2.8	6.4	0.0	0.0	0.8	8.7	5.0	0.0	5.6	14.2	11.9	20.1	17.7	1.2	1.7	0.5	4.9	2.9	16.9	13.3	30.4	2.5	6.9	8.2	0.8	9.9	0.0	0.8	3.7	0.0	12.8	21.1	19.8	7.2	25.6	5.4	2.8	5.4	1.1	4.1	2.5	0.3	4.2	2.1	8.2	9.1	3.0	2.6	0.2	2.2	2.4	6.6	64.5	26.8	2.5	4.1	6.5	2.8	1.1	12.2	2.4	3.1	1.9
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 179.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 24.0;NK-cells: 9.4;T-cells: 16.2"	"Cell line enhanced"	"Detected in many"		"A-431: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favorable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	25.2	3.5	44.0	10.7	92.5	16.3	23.4	47.2	74.1	33.9	53.0	39.0	13.0	67.5	5.0	45.8	38.1	22.6	17.2	44.5	46.7	36.0	36.3	14.3	5.6	65.8	66.3	33.8	33.0	17.0	6.8	29.3	60.9	24.2	15.5	2.9	29.2	37.5	9.7	44.9	13.2	26.4	37.9	26.6	22.3	5.7	74.1	4.6	23.7	7.4	4.9	32.2	39.1	179.2	78.4	36.5	29.8	45.3	3.1	0.0	49.0	8.7	10.4	13.8	11.0	38.9	34.3	0.0	15.3	8.6	4.8	74.6	20.3	69.7	4.7	0.2	16.7	35.1	48.3	9.2	4.0	1.3	16.1	3.9	39.6	2.9	24.4	22.9	9.1	0.3	0.0	0.4	4.6	37.5	0.1	32.0	10.0	21.2	37.0	0.4	14.7	5.5	37.0	58.0	9.9	18.0	17.7	26.7	25.1	27.5	29.0	8.0	16.6	6.0	59.8	0.3	12.3	0.1	0.2	0.1	0.6	3.7	10.7	9.0	3.0	18.2	16.2	1.5	11.1	0.0	5.0	7.3	1.0	0.0	0.5	3.6	24.0	9.4	1.0	0.0	1.7	5.3	44.0	92.5	47.2	74.1	44.5	46.7	65.8	66.3	60.9	37.9	74.1	179.2	3.1	3.2	6.2	15.0	0.7	19.4	19.4	15.1	21.6	5.5	16.0	9.8	7.8	12.8	6.0	47.8	0.0	7.9	14.5	24.7	11.7	26.7	0.9	18.6	18.5	4.0	34.7	0.4	1.0	20.6	9.5	7.4	14.3	23.6	1.3	1.9	3.6	10.1	5.5	0.0	3.2	26.9	18.3	6.5	8.0	1.5	7.5	2.7	5.4	6.5	4.6	9.1	45.3	10.6	90.9	35.3	16.7	25.6	2.8	16.1	2.3	9.5	4.0	0.8	26.3	5.1	25.3	0.2	1.6	25.6	21.5	2.6	9.0	10.5	13.2	32.2
PLEKHG4B	KIAA1909	ENSG00000153404	"Pleckstrin homology and RhoGEF domain containing G4B"	Q96PX9	5	92151-189972	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.2"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 6.3;Club cells: 11.2;Collecting duct cells: 11.0;Glandular and luminal cells: 9.5;Respiratory ciliated cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	20	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.2;HAP1: 13.7;NTERA-2: 14.1;REH: 33.0;SCLC-21H: 14.0;SH-SY5Y: 12.6;SK-BR-3: 13.5;SuSa: 13.2;T-47d: 19.1"					"Low region specificity"	"Detected in all"			"HPA036274, HPA058157"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA036274: AB_10669668, HPA058157: AB_2683625"	"unprognostic (3.60e-2)"	"unprognostic (8.52e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.59e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (5.96e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.98e-7)"	"unprognostic (1.43e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-3)"	0.1	0.1	1.9	0.1	1.1	0.6	1.5	0.5	0.5	1.0	9.2	0.4	0.2	0.8	0.1	0.3	1.1	0.0	0.0	0.9	1.1	2.5	0.0	0.6	0.2	0.8	1.2	1.0	0.4	0.1	3.5	1.4	0.4	1.8	0.0	0.2	2.6	0.3	0.1	0.5	0.1	0.2	0.8	0.1	1.0	2.9	2.8	1.0	3.1	0.0	0.1	0.0	0.4	1.6	0.0	1.4	10.1	15.2	0.0	0.0	0.2	1.1	0.3	1.0	2.2	1.8	0.2	0.2	3.3	1.4	0.9	0.6	13.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	4.1	0.0	0.0	0.1	0.4	0.2	0.0	14.1	0.0	0.2	33.0	7.1	8.6	1.2	0.0	14.0	12.6	7.9	13.5	0.0	13.2	19.1	0.0	0.1	0.4	3.7	0.0	0.3	0.2	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.9	1.1	0.5	0.5	0.9	1.1	0.8	1.2	0.4	0.8	2.8	1.6	0.1	0.0	3.4	0.3	0.0	0.4	3.8	0.1	0.0	0.4	6.1	6.3	1.6	0.0	11.2	11.0	0.0	4.6	2.8	0.0	0.0	0.4	0.3	4.8	3.7	0.7	0.0	0.0	1.0	0.2	3.7	1.0	0.0	9.5	1.3	4.4	0.0	0.0	0.7	0.0	0.6	0.2	0.0	0.0	0.8	0.3	0.3	0.4	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.1	14.0	0.2	0.0	0.1	0.9	2.4	5.9	0.0	0.3	1.8	0.3	0.4	0.0	1.0
PLEKHG5	"GEF720, KIAA0720, Syx, Tech"	ENSG00000171680	"Pleckstrin homology and RhoGEF domain containing G5"	O94827	1	6467122-6520074	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.4;skin 1: 102.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 57.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 32.1;TIME: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049570	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA049570: AB_2680818"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.50e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.85e-2)"	18.7	15.0	4.4	2.9	2.6	0.6	12.0	57.4	16.6	14.0	0.0	7.3	6.4	7.5	1.9	21.6	8.6	7.3	16.4	13.0	0.0	6.5	1.8	6.0	5.0	0.0	0.0	7.5	5.1	4.4	43.3	12.4	1.8	9.9	3.5	3.4	9.3	7.2	6.8	102.5	8.4	3.9	0.0	50.9	4.4	5.4	0.0	2.0	7.2	3.0	3.3	5.9	14.3	0.0	7.1	2.7	11.9	9.4	1.5	4.2	3.1	8.4	7.0	3.2	2.1	6.9	18.8	0.3	22.6	2.8	4.9	22.6	2.2	23.7	1.3	16.5	3.0	0.0	15.1	2.9	1.9	0.0	1.3	5.5	10.2	8.1	12.5	17.4	24.9	1.7	0.0	1.5	0.6	5.0	0.5	32.1	4.9	2.3	23.8	0.1	2.7	2.3	6.3	3.1	10.5	25.2	1.1	8.2	1.5	5.3	8.2	0.5	30.3	8.1	5.0	0.0	6.6	0.1	0.0	2.4	9.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	2.6	57.4	16.6	13.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.6	0.0	1.5	1.0	0.2	7.4	2.3	4.7	8.0	1.4	1.4	2.2	4.1	1.5	3.6	3.7	2.1	2.6	0.1	4.2	0.0	1.3	8.6	2.5	5.9	9.8	3.5	0.4	17.4	1.3	4.0	1.9	3.1	3.2	0.0	4.0	7.5	0.3	5.3	1.7	9.6	6.4	6.1	0.8	1.3	5.7	1.8	2.4	0.0	7.5	0.0	9.7	0.0	2.0	1.2	5.1	5.6	8.6	0.4	3.8	4.1	0.4	2.7	1.5	13.1	2.1	1.7	2.1	5.1	10.8	14.5	1.9	0.7	2.5	2.8	5.8
PLEKHH2	"KIAA2028, PLEKHH1L"	ENSG00000152527	"Pleckstrin homology, MyTH4 and FERM domain containing H2"	Q8IVE3	2	43637260-43767987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 66.2;Endometrial stromal cells: 150.5;Oligodendrocyte precursor cells: 191.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 7.4;RPTEC TERT1: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077225			Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA077225: AB_2686828"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.82e-2)"	13.1	3.0	2.8	1.7	2.7	0.1	8.9	3.6	2.8	20.9	8.8	11.8	3.7	19.8	4.4	4.6	15.9	7.3	4.8	2.3	2.8	15.9	1.7	27.6	2.9	3.0	3.4	23.0	2.9	5.4	2.0	3.8	3.1	5.1	4.3	1.7	4.8	5.0	1.8	8.4	6.5	9.8	2.7	5.4	5.0	3.9	2.7	0.4	5.5	2.5	1.8	6.2	8.5	2.5	0.5	4.0	1.6	0.0	3.1	7.4	0.3	0.5	2.0	0.8	2.0	0.0	1.3	1.0	0.2	0.6	3.3	2.6	0.5	0.6	1.5	0.0	1.1	0.1	0.6	0.1	0.5	0.0	0.5	2.2	0.6	1.9	0.1	1.1	1.7	1.6	3.9	0.1	0.7	1.1	0.8	0.1	0.9	0.6	3.9	0.0	4.6	0.0	6.3	0.2	1.2	0.6	0.4	0.0	3.9	1.1	0.5	0.1	0.2	4.5	1.3	0.2	1.4	0.9	0.2	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	2.7	3.6	2.8	2.3	2.8	3.0	3.4	3.1	2.7	2.7	2.5	4.6	38.5	8.7	19.2	0.9	8.7	17.5	5.8	6.8	1.0	5.3	8.3	2.9	11.5	12.9	66.2	6.2	0.3	1.3	0.1	5.9	6.2	1.6	5.9	150.5	3.8	0.0	0.0	15.6	1.4	0.3	57.4	3.1	8.8	1.3	42.6	2.2	0.0	0.8	0.0	4.3	0.3	2.0	0.3	8.6	3.3	35.8	1.2	12.4	15.9	0.2	5.8	0.0	191.0	52.7	7.2	0.0	50.4	0.4	9.2	0.3	4.1	7.3	4.1	46.0	40.7	24.6	10.8	5.9	2.6	8.4	0.5	3.6	13.1	0.6	8.7
PLEKHO2	"DKFZp761K2312, PLEKHQ1, PP1628, pp9099"	ENSG00000241839	"Pleckstrin homology domain containing O2"	Q8TD55	15	64841883-64868002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 103.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 63.2;Kupffer cells: 52.3;Macrophages: 46.5;Muller glia cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 27.1;granulocytes: 77.3;monocytes: 73.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 68.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040055	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		200000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA040055: AB_10793954"	"unprognostic (4.32e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.85e-3)"	37.9	31.8	23.1	30.5	26.9	52.0	22.7	25.0	25.0	17.0	16.7	23.6	10.0	19.8	5.7	13.9	22.4	26.0	16.5	21.7	24.4	14.2	11.8	42.2	34.3	31.8	26.2	14.9	8.2	7.4	10.3	25.4	26.6	17.4	7.8	14.4	9.9	13.9	5.8	10.6	17.8	22.9	27.6	103.2	16.3	8.3	28.0	16.0	29.9	8.2	21.1	25.8	16.7	25.5	6.5	4.2	7.9	7.8	68.0	38.8	18.4	18.5	27.4	19.2	19.6	5.1	4.0	17.1	9.5	37.7	19.5	2.2	9.0	7.4	11.2	26.6	2.7	17.2	1.9	6.0	52.2	19.4	24.7	28.3	6.5	24.0	7.8	16.6	27.0	3.5	5.2	59.5	25.9	1.9	4.1	20.9	15.0	3.2	3.7	14.9	19.0	12.2	3.1	4.4	0.6	6.7	7.7	2.6	25.4	12.9	2.7	26.1	35.3	14.8	13.4	14.1	7.8	22.0	37.1	5.8	16.0	24.8	8.8	22.2	43.2	25.6	13.2	52.3	11.9	9.8	7.4	12.2	27.1	6.8	3.1	6.5	77.3	7.0	73.0	3.1	10.7	36.0	23.1	26.9	25.0	25.0	21.7	24.4	31.8	26.2	26.6	27.6	28.0	25.5	24.9	0.0	5.6	17.3	9.1	5.6	2.3	2.3	0.6	0.6	6.4	8.3	3.6	2.8	2.4	9.2	0.0	4.2	15.9	0.5	3.9	2.4	5.0	1.4	5.9	26.1	0.0	2.1	0.2	1.5	5.9	8.6	0.5	2.3	18.4	2.5	34.2	2.1	63.2	0.0	0.2	0.3	4.1	52.3	24.3	2.9	18.3	46.5	14.2	8.4	18.9	56.8	16.5	2.5	2.7	2.0	0.0	25.6	2.7	3.5	0.0	2.2	2.1	3.8	13.1	10.2	5.9	0.9	2.3	1.9	4.4	6.0	10.5	4.6	0.4	3.4
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460139	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 380.7;Extravillous trophoblasts: 257.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"NK-cell: 9.1"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1060.6;T-47d: 396.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	24.3	8.4	25.6	7.4	35.7	9.3	40.6	6.4	31.2	37.9	16.4	11.8	9.3	29.0	9.3	35.5	21.0	32.1	54.7	44.4	10.4	15.7	31.1	32.3	7.2	8.1	12.3	19.3	23.4	5.9	6.3	47.6	8.4	17.7	14.6	2.1	42.9	10.5	7.4	47.3	12.9	26.6	7.3	83.6	10.4	38.1	11.8	7.2	18.0	13.6	7.6	29.8	32.1	16.8	131.1	115.6	38.3	3.1	19.9	31.9	15.1	27.1	44.8	86.3	49.8	8.6	112.1	0.0	176.3	95.2	208.3	159.8	1.7	61.5	75.6	0.3	3.5	0.0	50.8	9.7	106.1	0.6	3.6	18.7	82.0	33.3	90.9	1060.6	175.4	0.0	0.1	4.4	169.8	47.5	0.3	0.2	7.6	12.4	18.5	6.3	106.5	0.0	221.6	25.4	2.3	5.1	82.4	16.0	76.0	66.1	396.9	2.0	231.9	24.3	63.8	11.0	217.8	0.1	0.3	0.3	18.8	0.3	110.7	2.2	0.5	1.9	0.1	1.2	0.0	0.8	0.5	0.0	2.2	0.6	0.9	0.4	1.5	9.1	0.5	1.5	0.4	0.4	25.6	35.7	6.4	31.2	44.4	10.4	8.1	12.3	8.4	7.3	11.8	16.8	144.6	19.2	15.8	5.9	23.4	141.7	194.1	116.1	380.7	3.8	108.5	203.7	128.9	30.0	134.9	18.4	4.2	66.5	22.7	66.3	9.8	109.8	10.9	132.7	67.8	178.7	84.3	2.7	44.3	77.9	257.3	107.8	136.6	165.4	9.5	4.1	89.3	7.7	14.9	0.0	22.8	39.9	124.1	8.1	19.3	5.0	12.8	39.5	24.9	15.9	3.2	3.3	0.0	3.5	4.9	103.2	44.6	10.9	8.2	76.1	38.5	5.5	31.6	2.9	0.0	74.0	106.6	65.1	10.4	184.9	103.4	129.8	21.2	7.4	45.6	63.1
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 236.8;Sertoli cells: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.43e-4)"	58.1	34.6	46.3	35.2	51.2	16.1	41.2	48.6	56.6	65.4	46.4	47.3	37.7	65.0	30.5	21.3	51.1	42.0	71.2	44.5	47.4	45.5	78.1	44.4	15.4	49.6	50.8	54.4	39.0	36.9	29.6	83.8	52.4	34.7	23.2	10.6	75.9	40.6	40.5	27.2	35.6	78.4	44.8	31.5	35.5	11.6	52.2	7.9	34.9	41.6	12.9	42.4	36.0	53.1	112.5	91.4	51.3	239.7	343.4	190.6	39.0	330.4	436.1	170.4	287.1	105.2	71.5	63.1	339.5	367.3	125.9	93.4	75.6	115.6	115.6	66.2	78.3	34.0	136.6	137.3	212.5	21.9	162.7	234.0	59.7	206.2	81.9	573.3	305.0	14.8	97.6	30.9	180.2	71.1	5.7	58.6	22.9	115.4	131.6	25.8	100.0	141.0	98.7	24.3	19.2	77.7	137.3	97.4	164.8	80.4	48.3	55.9	298.7	190.1	141.6	236.3	161.9	71.4	123.7	38.7	425.1	75.5	316.8	0.0	40.3	2.0	17.3	34.4	3.1	1.7	3.0	8.4	32.7	3.4	1.2	6.4	35.5	5.4	32.3	4.9	2.0	22.6	46.3	51.2	48.6	56.6	44.5	47.4	49.6	50.8	52.4	44.8	52.2	53.1	19.4	0.0	7.9	9.4	3.7	7.0	8.0	22.8	8.0	5.7	17.9	17.5	18.3	8.6	8.6	11.0	2.1	39.7	8.7	14.8	3.9	30.3	1.0	11.0	62.2	33.9	8.4	3.0	4.2	9.8	236.8	47.5	17.3	24.8	0.0	20.4	36.8	37.1	46.3	6.7	5.8	12.5	4.1	26.5	8.3	2.4	44.4	16.3	10.6	15.9	17.9	7.9	15.5	3.0	9.8	22.4	15.4	24.5	19.4	8.0	41.5	16.7	4.5	3.1	105.2	77.2	47.3	0.5	3.3	7.4	5.1	33.7	5.5	37.1	16.6	3.9
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120457227-120592065	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 12.2"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 11.5;Distal tubular cells: 7.9;Early spermatids: 10.9;Erythroid cells: 9.7;Late spermatids: 10.7;Leydig cells: 19.3;Peritubular cells: 7.9;Proximal tubular cells: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 14.2;U-251 MG: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA045188: AB_2679246"	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.0	0.0	2.9	0.1	3.5	0.4	0.1	6.4	2.8	0.2	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	5.3	8.9	0.8	0.1	0.0	0.0	11.0	5.3	0.0	0.0	0.0	0.0	0.0	12.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.1	4.3	0.0	0.0	0.9	3.7	0.1	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.2	0.0	0.3	0.1	0.0	1.7	1.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	14.2	1.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.9	0.2	0.0	2.8	1.7	1.2	0.1	10.4	0.0	0.0	0.0	2.3	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.9	3.5	6.4	2.8	5.3	8.9	11.0	5.3	12.2	4.3	3.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	3.7	0.0	0.0	0.0	0.0	7.9	0.3	10.9	0.1	2.5	0.0	0.0	9.7	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.2	1.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	19.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	7.9	0.0	0.5	0.0	9.0	0.0	0.0	0.0	0.0	4.9	1.5	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4
PLPP6	"FLJ46512, FLJ90191, PDP1, PPAPDC2"	ENSG00000205808	"Phospholipid phosphatase 6"	Q8IY26	9	4662294-4665258	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.2;Late spermatids: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"HDLM-2: 99.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018096	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA018096: AB_1855609"	"unprognostic (2.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.88e-2)"	3.6	6.6	3.8	6.2	4.0	1.5	7.3	7.0	5.0	5.0	8.7	9.3	10.5	4.0	12.7	7.4	3.3	4.6	2.8	4.3	3.3	5.4	18.9	3.4	8.2	3.4	3.6	4.0	17.2	7.7	4.7	7.1	3.6	16.4	9.9	5.1	7.7	4.8	1.9	8.2	11.4	3.4	3.3	6.0	11.3	5.9	3.3	6.1	7.1	1.5	8.4	5.2	5.1	3.5	8.2	8.3	8.8	10.9	6.9	7.7	8.8	5.5	7.1	4.4	5.0	2.2	5.3	7.9	2.2	5.5	10.9	10.0	6.2	7.8	4.6	99.2	5.9	15.7	8.7	11.3	6.3	5.7	11.4	8.5	6.2	3.4	7.5	5.8	6.6	8.8	2.7	8.1	5.6	8.8	5.4	15.0	8.1	8.2	2.9	5.3	0.0	6.1	7.6	9.3	22.0	11.1	6.5	5.8	3.5	10.8	8.2	12.7	7.8	3.9	3.3	5.3	3.6	1.7	6.4	2.0	6.1	4.1	3.7	6.8	4.1	3.5	3.1	3.7	3.6	2.6	5.6	4.8	4.2	3.3	9.6	6.9	1.8	4.2	4.4	3.2	8.6	4.1	3.8	4.0	7.0	5.0	4.3	3.3	3.4	3.6	3.6	3.3	3.3	3.5	2.8	6.4	2.7	0.0	2.6	0.0	2.5	0.0	2.8	7.5	4.2	2.7	0.0	5.7	1.3	1.8	2.1	18.6	2.9	9.7	1.9	11.0	82.2	2.1	3.4	3.0	10.9	2.1	0.0	13.9	2.9	2.3	7.1	5.3	0.0	4.1	4.2	15.3	6.5	3.3	0.0	7.3	0.0	4.7	0.0	46.3	2.8	1.7	0.0	0.0	3.0	4.6	3.1	0.0	0.0	10.8	6.5	4.9	1.5	7.5	13.4	2.8	0.0	4.9	0.0	1.7	1.8	0.5	1.1	4.6	0.0	10.4	3.4	3.5	5.1	3.1
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 91.2;skeletal muscle: 210.1;tongue: 74.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 18.8;Horizontal cells: 8.4;Leydig cells: 5.0;Skeletal myocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.1;ASC diff: 11.4;ASC TERT1: 8.6;SCLC-21H: 11.3;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	4.8	9.7	10.0	1.1	11.5	0.4	4.9	16.4	13.9	6.3	1.4	9.6	0.7	6.4	0.6	2.5	5.1	2.1	91.2	10.6	9.1	4.2	0.3	2.1	0.5	11.0	10.7	8.7	2.3	1.2	4.7	0.5	11.1	4.9	0.5	4.0	3.4	2.5	210.1	1.4	3.1	2.7	8.8	2.4	3.1	5.0	11.7	0.4	1.8	74.4	0.3	6.7	4.0	11.0	0.0	0.0	2.2	11.1	11.4	8.6	2.3	1.7	1.2	0.3	0.0	0.0	0.0	0.0	0.3	4.5	2.4	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.6	2.8	0.0	0.0	2.9	0.0	3.1	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	11.3	8.7	0.0	0.1	0.0	0.3	0.3	2.8	0.1	0.1	0.7	0.5	0.0	0.0	0.4	0.0	1.9	0.0	1.8	0.0	2.6	0.0	0.0	1.7	0.0	0.4	0.0	0.0	2.3	0.5	0.2	0.2	0.0	1.3	1.5	1.0	0.0	0.9	10.0	11.5	16.4	13.9	10.6	9.1	11.0	10.7	11.1	8.8	11.7	11.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.0	1.8	2.1	0.1	0.1	0.0	1.9	0.0	1.4	0.1	1.7	1.4	0.0	1.3	0.0	0.6	0.7	4.1	0.0	0.1	0.0	0.8	1.1	0.0	0.5	8.4	0.0	0.0	0.0	0.3	0.0	1.7	5.0	2.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.3	0.0	3.8	0.7	0.0	0.0	2.3	0.0	3.7	0.0	7.0	3.0	0.0	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.0
PLPPR1	"FLJ20300, LPPR1, MGC26189, PRG-3"	ENSG00000148123	"Phospholipid phosphatase related 1"	Q8TBJ4	9	101028727-101325135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;kidney: 15.6"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 37.2;Early spermatids: 12.3;Proximal tubular cells: 39.0"	"Group enriched"	"Detected in some"	5	"glioma: 11.1;liver cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 3.7;SCLC-21H: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014760, HPA014968, HPA014979"	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130"	"unprognostic (1.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-6)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.83e-2)"	0.0	0.1	9.7	0.0	12.8	0.0	0.7	7.1	12.7	0.1	5.2	0.2	0.0	0.0	2.8	0.0	0.2	0.0	0.0	10.4	9.3	15.6	3.6	1.4	0.0	10.2	9.1	0.0	0.3	0.0	0.1	0.0	9.8	0.2	0.1	1.5	0.3	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.1	0.6	10.9	0.4	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	9.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	12.8	7.1	12.7	10.4	9.3	10.2	9.1	9.8	9.6	10.9	11.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	2.3	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	37.2	0.0	12.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	39.0	0.0	1.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0
PLPPR2	"LPPR2, PRG-4"	ENSG00000105520	"Phospholipid phosphatase related 2"	Q96GM1	19	11355386-11365698	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 72.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 72.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 95.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048973	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA048973: AB_2680580"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.82e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (7.46e-11)"	"unprognostic (1.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.17e-1)"	21.9	35.8	80.2	10.6	62.7	15.8	21.1	28.5	80.9	39.4	22.3	41.9	5.6	32.9	7.5	16.0	35.4	13.3	32.5	111.3	70.5	18.9	25.9	29.9	5.2	39.4	44.0	40.4	17.0	13.0	73.5	11.1	44.6	40.8	4.4	10.6	22.3	13.6	33.0	24.7	17.4	16.5	32.0	28.9	26.5	17.4	75.3	3.0	26.0	5.4	2.8	32.3	27.5	41.2	23.6	14.3	7.8	32.2	31.8	30.3	2.1	40.8	37.7	24.7	25.2	2.8	4.3	4.5	23.6	52.5	5.2	4.2	4.4	12.3	13.3	12.3	8.4	1.4	9.5	2.8	16.5	1.4	45.3	27.3	21.7	21.4	4.2	35.8	17.0	7.2	22.9	36.0	21.1	34.6	0.8	6.4	8.5	7.9	78.6	0.5	1.1	12.9	11.7	11.0	8.3	27.6	17.1	14.6	9.0	2.4	20.9	29.6	19.8	55.7	11.8	95.2	21.8	22.4	14.7	1.6	54.1	21.2	22.4	2.0	17.7	9.1	0.6	15.3	0.1	0.1	0.2	0.0	6.7	0.0	0.3	0.1	72.3	0.0	10.8	0.2	0.6	6.7	80.2	62.7	28.5	80.9	111.3	70.5	39.4	44.0	44.6	32.0	75.3	41.2	9.5	6.4	8.3	0.0	1.5	0.0	6.9	0.0	11.4	7.0	9.9	10.7	0.0	8.6	1.3	3.7	12.5	0.6	1.5	0.1	1.9	6.2	11.7	2.0	11.0	10.1	17.0	0.4	0.0	8.7	2.3	12.7	3.1	3.4	2.5	3.6	11.4	8.3	4.2	8.4	0.0	2.0	0.0	11.1	0.0	13.5	14.3	7.9	0.0	0.0	12.1	16.0	6.2	0.0	0.0	9.6	0.4	16.6	1.3	11.6	0.6	1.5	1.5	6.9	6.6	5.7	13.0	2.3	7.4	2.6	0.0	2.9	1.5	11.2	0.7	5.3
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821955	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 9.8;brain: 21.1;fallopian tube: 11.1"	"Cell type enriched"	"Detected in some"	7	"Endometrial ciliated cells: 37.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 61.8;THP-1: 128.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.0	0.0	16.8	0.2	14.1	9.8	2.2	0.0	21.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	11.1	0.1	0.1	14.2	11.5	0.0	0.0	2.3	0.1	4.1	8.2	0.3	0.0	0.2	0.4	0.0	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	2.3	0.2	0.1	3.2	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.5	12.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.7	0.1	0.1	8.4	0.1	0.1	0.3	2.3	0.0	0.0	0.0	5.2	0.0	1.6	0.0	0.5	4.4	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	12.0	0.3	0.0	1.1	0.0	61.8	9.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	15.5	0.3	0.0	0.0	6.3	5.4	128.9	0.1	0.2	0.2	0.3	0.1	0.2	0.5	0.2	0.0	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	14.1	0.0	21.1	14.2	11.5	4.1	8.2	1.5	2.3	13.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	37.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.1	5.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544856	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Host-virus interaction"	"DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 291.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.6	23.0	11.4	86.7	12.5	64.4	45.9	12.7	17.6	25.9	11.9	65.0	39.8	28.2	31.0	47.9	40.0	66.1	24.3	12.1	13.5	71.9	49.2	49.3	40.6	17.4	14.2	34.9	38.3	16.8	15.4	56.3	15.3	23.7	59.5	9.8	49.1	49.6	10.8	13.6	45.4	41.9	16.2	64.5	44.0	17.1	14.7	30.0	27.8	17.6	39.4	68.1	29.5	14.0	106.2	41.5	26.4	12.1	40.9	65.0	40.5	32.6	88.4	319.8	418.6	34.0	88.1	8.4	75.6	20.6	245.9	86.2	21.2	32.7	56.6	32.9	21.6	66.1	12.5	25.2	292.9	40.3	35.4	106.3	53.3	36.6	182.3	52.6	49.4	19.1	44.7	104.0	66.9	41.0	30.6	16.1	25.8	71.6	37.6	27.4	28.1	2.9	95.9	29.6	16.3	0.0	42.6	20.9	569.9	35.8	20.7	46.8	30.6	26.9	22.7	59.1	55.8	79.2	15.6	0.4	27.0	29.0	23.3	41.1	157.6	44.3	20.8	159.6	30.0	25.2	13.5	18.5	105.8	19.7	9.3	13.9	100.0	57.8	94.8	28.5	8.3	79.3	11.4	12.5	12.7	17.6	12.1	13.5	17.4	14.2	15.3	16.2	14.7	14.0	191.4	35.3	43.0	12.7	28.2	37.0	106.5	92.1	26.2	0.7	36.0	22.6	7.3	124.4	110.4	95.6	0.0	53.7	25.4	134.2	74.3	291.6	2.0	56.1	24.5	135.2	33.1	18.3	7.1	217.4	114.1	74.8	47.9	58.2	28.4	60.5	100.6	29.7	139.9	0.0	9.0	71.5	79.3	86.2	162.9	6.8	114.9	185.5	48.0	35.6	72.3	64.3	32.0	7.1	0.3	157.6	110.3	45.9	18.2	79.6	40.7	75.0	133.5	1.6	39.5	63.4	59.2	1.5	2.4	21.8	28.6	44.5	25.9	42.6	69.4	211.9
PLSCR2		ENSG00000163746	"Phospholipid scramblase 2"	Q9NRY7	3	146391421-146495991	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 13.2"	"Group enriched"	"Detected in some"	30	"Early spermatids: 195.5;Late spermatids: 246.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051352			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA051352: "	"unprognostic (1.11e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.94e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.23e-2)"	0.2	0.1	0.4	0.3	0.2	1.1	0.3	0.2	0.7	0.1	0.2	0.3	0.2	0.1	1.8	0.2	0.7	0.5	0.0	0.1	0.7	0.6	0.2	0.2	0.1	0.9	0.6	0.1	0.9	0.2	0.1	0.2	0.7	0.3	0.4	0.5	0.3	0.5	0.0	0.0	0.2	0.2	0.6	0.1	0.4	13.2	0.6	0.2	0.5	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.2	0.7	0.1	0.7	0.9	0.6	0.7	0.6	0.6	0.6	0.4	0.0	0.0	0.3	0.2	0.3	0.1	0.1	0.6	0.0	1.3	0.6	0.0	1.5	0.2	7.3	0.0	0.2	1.5	0.7	1.9	1.6	195.5	1.4	0.1	0.4	1.8	0.0	1.0	0.6	0.1	0.5	1.5	0.7	0.0	0.4	0.4	0.1	0.1	0.0	1.1	0.3	2.0	0.0	1.1	246.0	1.8	0.6	0.0	1.0	0.0	1.2	0.0	0.0	0.2	0.5	1.0	1.5	0.0	0.3	0.1	1.5	1.4	0.3	0.0	0.7	0.3	5.4	2.6	0.1	0.1	0.0	0.2	0.2	0.9	0.3
PLSCR4		ENSG00000114698	"Phospholipid scramblase 4"	Q9NRQ2	3	146192335-146251179	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 77.3;Astrocytes: 151.1;Endothelial cells: 63.4;Hepatic stellate cells: 110.3;Oligodendrocyte precursor cells: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 60.5;ASC TERT1: 48.2;hTERT-RPE1: 62.1;HUVEC TERT2: 50.8;TIME: 106.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002276	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA002276: AB_1855479"	"unprognostic (3.73e-3)"	"unprognostic (4.03e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.97e-3)"	60.2	43.8	30.2	9.4	28.2	2.3	41.9	30.9	32.5	28.9	11.6	27.4	6.8	30.1	15.7	23.2	41.2	45.6	28.0	28.7	38.5	25.3	69.0	37.4	10.5	39.3	44.0	36.4	20.5	4.3	11.2	56.4	32.6	13.8	25.2	13.7	23.6	25.8	7.4	16.1	13.6	33.7	36.9	30.1	14.4	21.6	41.8	6.6	31.2	18.8	6.7	19.8	25.5	32.2	0.0	9.9	1.7	0.0	60.5	48.2	0.3	11.5	15.7	5.0	10.9	1.0	12.6	0.0	12.3	21.0	5.0	1.4	2.4	1.1	2.8	0.1	0.1	5.0	7.9	1.3	28.1	0.1	1.3	29.6	1.6	10.4	3.0	62.1	50.8	0.0	0.2	0.9	7.4	0.3	0.0	0.1	2.1	5.1	3.4	0.0	0.8	0.0	0.1	0.0	0.6	0.0	20.1	0.1	3.9	2.5	0.7	0.6	106.4	10.4	2.6	23.6	2.1	0.3	0.0	0.0	2.6	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.2	28.2	30.9	32.5	28.7	38.5	39.3	44.0	32.6	36.9	41.8	32.2	77.3	3.2	10.3	151.1	1.0	10.8	5.6	0.8	12.0	0.6	10.2	8.6	4.1	25.8	6.0	3.7	0.0	0.7	0.3	27.4	0.0	8.2	1.1	3.6	11.6	63.4	10.3	15.6	1.7	11.6	0.5	57.1	2.0	1.5	1.3	7.0	110.3	44.1	0.8	0.0	0.6	11.7	0.0	7.1	11.8	3.8	42.9	1.1	3.6	40.3	0.1	51.4	0.0	61.3	0.6	4.7	13.3	32.4	2.8	2.6	6.4	28.3	6.4	1.5	0.0	18.9	23.6	1.2	0.9	4.8	8.7	0.8	1.8	20.0	8.1	2.7
PLXNA1	"NOV, PLXN1"	ENSG00000114554	"Plexin A1"	Q9UIW2	3	126988594-127037392	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007499, CAB012483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		10000000		"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012483: , HPA007499: AB_1079637"	"unprognostic (1.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.79e-2)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.77e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.64e-5)"	"unprognostic (4.50e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	11.2	7.6	13.9	7.0	13.0	1.0	9.6	0.6	16.4	11.6	0.5	9.1	3.4	10.9	2.3	11.3	10.2	4.8	15.8	14.0	7.9	8.6	3.2	14.7	6.3	5.5	5.6	13.8	9.3	24.0	5.5	8.2	5.6	9.3	1.9	1.7	12.9	6.3	10.9	15.1	7.9	5.2	1.3	13.2	7.9	9.0	14.8	6.3	9.6	6.1	4.2	9.8	10.0	5.5	45.3	21.1	22.8	18.1	29.3	32.7	36.3	26.3	22.2	14.8	14.7	70.2	20.6	5.0	38.6	28.4	20.0	68.2	11.7	51.6	6.1	7.2	18.6	0.7	13.4	18.3	19.2	5.4	3.6	32.8	35.4	27.4	21.2	14.9	7.5	14.7	26.3	9.1	16.1	26.3	10.6	9.9	22.0	14.2	18.5	14.0	58.0	14.1	12.9	89.4	20.2	22.1	19.1	17.9	24.7	14.7	28.8	33.9	28.0	23.6	30.0	43.4	28.1	5.5	3.9	9.8	33.9	10.2	25.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.9	13.0	0.6	16.4	14.0	7.9	5.5	5.6	5.6	1.3	14.8	5.5	1.9	48.1	4.1	8.8	1.8	15.8	5.6	23.4	6.2	6.7	6.6	7.4	13.0	1.5	18.6	12.9	4.2	21.8	0.8	3.6	0.0	8.9	4.4	5.0	10.0	3.8	9.6	0.4	22.1	6.9	2.5	13.8	7.1	5.6	0.0	20.8	2.2	0.9	13.1	20.2	11.3	4.0	0.0	7.4	12.8	1.0	7.8	7.4	8.8	5.6	1.0	2.5	1.0	13.6	3.6	17.0	2.3	6.4	3.1	21.3	7.4	1.5	11.2	3.3	6.6	6.4	9.9	5.3	9.5	6.7	16.1	7.3	2.2	4.7	5.1	9.5
PLXNA3	"6.3, Plxn3, PLXN4, SEX, XAP-6"	ENSG00000130827	"Plexin A3"	P51805	X	154458281-154477779	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058989			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		94000	"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA058989: AB_2683872"	"unprognostic (2.79e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	6.5	7.0	5.7	3.5	6.4	1.7	6.0	7.5	7.2	10.7	5.3	7.5	3.6	8.1	4.3	5.3	8.7	3.9	7.1	5.5	8.6	5.8	2.8	8.4	3.8	6.4	7.3	17.0	7.6	2.0	24.8	3.6	7.2	10.5	2.2	1.5	12.0	3.4	1.7	10.1	7.8	2.6	4.6	8.0	5.5	3.7	9.0	2.2	10.2	1.1	2.6	7.4	9.7	8.6	11.2	2.2	6.3	16.1	6.5	8.3	8.4	15.6	3.3	3.6	4.9	8.2	4.6	2.0	8.2	16.9	8.4	9.6	6.4	7.6	1.3	0.9	4.8	2.0	29.0	4.5	5.2	1.0	8.8	11.3	5.5	5.4	0.4	12.4	4.1	3.2	5.2	1.6	5.7	13.8	1.9	8.4	2.0	3.4	4.9	7.2	0.5	0.7	4.8	7.2	13.2	6.8	5.7	10.3	2.6	4.4	6.2	2.4	10.4	7.8	7.0	0.8	6.7	1.2	0.2	2.9	14.5	1.5	2.1	0.7	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.3	0.0	0.0	0.1	0.0	5.7	6.4	7.5	7.2	5.5	8.6	6.4	7.3	7.2	4.6	9.0	8.6	5.2	12.8	7.7	13.4	9.8	8.7	9.0	7.3	9.6	18.7	13.9	10.3	6.5	2.8	6.8	11.0	12.5	3.0	10.3	15.9	0.0	11.5	0.1	14.4	23.2	3.9	7.2	0.0	6.5	5.8	7.2	11.0	17.9	30.4	8.8	21.3	2.9	1.6	8.5	5.0	5.4	15.1	0.0	3.5	9.2	0.8	11.5	10.5	14.2	6.5	4.7	6.5	4.1	6.0	4.1	13.6	11.4	8.6	8.5	10.3	9.4	1.5	10.9	7.8	13.1	26.5	9.4	0.9	2.3	8.1	7.4	9.3	13.2	2.5	9.6	8.2
PM20D2	"ACY1L2, bA63L7.3"	ENSG00000146281	"Peptidase M20 domain containing 2"	Q8IYS1	6	89146055-89165565	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030325, HPA030326, HPA030327"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129"	"unprognostic (3.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	5.4	6.0	4.5	8.6	4.8	9.2	9.4	7.3	5.2	9.4	10.1	13.6	8.8	11.8	8.2	8.9	12.9	6.5	8.2	4.5	6.1	9.2	4.8	4.9	11.2	4.6	4.0	22.3	10.7	9.2	8.2	4.8	3.3	25.4	10.1	14.1	7.8	8.5	29.1	12.6	8.9	10.4	3.4	6.1	8.5	3.0	5.9	13.6	12.5	16.3	10.8	10.9	8.1	3.9	30.7	13.4	11.8	18.3	3.8	2.3	0.8	15.1	15.0	22.1	28.2	15.7	14.6	88.3	18.0	3.3	18.8	11.5	24.3	12.1	49.9	27.8	30.8	18.0	8.0	14.9	4.2	52.4	13.9	3.8	8.8	8.4	17.7	18.0	5.4	26.2	7.0	46.3	6.9	4.7	33.3	41.3	4.8	26.4	13.2	54.5	58.5	65.1	24.8	5.7	33.1	23.0	9.1	14.5	15.1	15.3	0.1	45.5	8.8	0.4	13.3	4.6	32.0	24.5	38.3	19.0	6.1	44.3	2.1	0.8	0.3	1.2	0.7	0.2	1.2	1.5	0.9	1.3	0.6	1.0	1.4	1.2	1.0	1.9	0.2	0.9	0.1	0.6	4.5	4.8	7.3	5.2	4.5	6.1	4.6	4.0	3.3	3.4	5.9	3.9	7.3	9.6	10.3	21.5	14.3	30.2	23.8	7.4	17.1	28.5	21.6	16.5	23.4	27.1	11.5	16.5	31.3	2.8	7.1	6.8	5.9	11.9	5.5	15.1	13.6	8.8	10.8	18.3	29.5	10.4	2.4	12.0	15.3	20.6	6.3	17.3	8.9	9.2	3.4	8.4	38.9	21.4	6.1	6.7	17.9	9.0	24.5	6.8	17.8	26.2	14.6	11.1	4.1	32.2	27.3	18.1	7.9	19.2	15.5	44.4	5.2	15.6	12.2	24.3	6.6	26.9	20.3	5.3	6.6	24.4	31.7	1.2	10.5	5.3	28.4	17.4
PMF1		ENSG00000160783	"Polyamine modulated factor 1"	Q6P1K2	1	156212993-156240042	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (1.17e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.62e-2)"	39.3	39.6	33.5	29.6	35.9	73.7	42.8	35.1	39.5	47.2	33.0	38.3	30.6	42.6	24.4	50.0	34.8	26.0	69.7	33.3	34.7	56.6	62.3	38.8	46.8	37.1	34.9	42.9	39.4	56.3	34.9	29.9	36.5	47.2	26.8	16.8	42.9	27.1	113.3	54.2	36.7	28.6	35.0	52.5	43.6	15.1	34.9	45.6	50.7	89.7	39.7	39.4	41.7	38.6	68.2	82.5	86.8	66.1	16.1	33.5	67.3	34.6	48.7	91.4	75.4	101.6	95.3	62.2	73.3	44.5	31.6	44.4	88.1	57.7	47.0	44.6	104.6	46.3	59.3	91.8	33.3	65.8	61.3	30.2	57.2	41.2	43.0	36.3	69.9	44.7	69.9	70.1	45.0	138.2	69.2	84.7	151.5	99.6	72.2	75.2	46.3	123.6	97.2	50.5	79.0	99.5	57.4	65.4	45.6	63.2	106.1	79.7	40.7	39.4	50.5	44.4	69.4	52.0	58.1	123.7	31.9	63.1	55.7	18.4	85.7	40.5	43.9	60.6	39.6	54.0	43.0	41.4	70.0	45.6	41.5	42.0	59.9	49.5	55.2	95.9	75.5	77.7	33.5	35.9	35.1	39.5	33.3	34.7	37.1	34.9	36.5	35.0	34.9	38.6	25.5	19.2	25.1	0.0	38.2	49.8	87.2	108.6	3.4	12.3	39.5	33.4	11.9	51.5	57.4	75.4	12.5	136.3	63.4	21.5	176.1	98.0	5.3	22.1	26.3	41.5	49.1	13.2	0.0	99.0	115.7	34.7	8.6	36.5	45.0	50.3	47.2	56.7	80.5	8.4	0.0	46.6	61.1	40.3	43.9	6.0	39.1	34.2	85.4	0.0	59.6	71.2	43.3	0.0	0.0	81.6	52.1	28.2	11.7	51.5	44.7	120.1	15.6	28.8	26.3	36.6	35.7	14.7	33.4	7.6	51.0	157.5	47.3	66.1	52.5	83.8
PMF1-BGLAP		ENSG00000260238	"PMF1-BGLAP readthrough"		1	156212982-156243332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Proximal tubular cells: 2.5;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (8.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.65e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.85e-4)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.36e-1)"	7.0	9.0	6.8	2.2	7.1	4.6	5.0	7.6	11.5	10.8	7.3	9.5	2.8	6.7	5.1	5.2	7.3	3.6	16.2	6.8	7.3	8.6	7.6	4.9	3.4	6.8	6.7	10.0	5.7	3.8	10.3	4.7	6.8	11.0	1.6	4.9	7.7	4.1	13.3	4.3	4.6	2.9	6.8	6.5	6.5	3.5	6.9	3.0	8.7	10.0	2.5	6.8	7.2	8.4	8.9	8.4	11.6	7.8	3.0	7.4	5.2	7.8	5.0	7.5	6.0	6.6	7.9	7.7	12.8	7.0	3.1	6.0	10.8	10.1	3.5	13.4	18.4	5.3	8.5	12.5	14.5	5.3	9.3	9.7	9.3	7.0	6.2	6.9	7.3	7.0	5.4	12.4	5.0	11.1	4.7	11.3	23.7	5.9	16.1	8.7	4.5	11.4	4.8	4.2	7.9	10.3	5.2	2.0	13.6	10.0	11.8	20.9	7.9	3.7	3.8	4.6	7.0	7.4	9.4	11.5	4.7	6.9	7.5	2.3	5.7	3.1	2.8	3.9	2.9	2.7	4.6	4.3	4.2	7.7	6.2	3.6	6.4	3.0	4.3	4.4	5.6	5.7	6.8	7.1	7.6	11.5	6.8	7.3	6.8	6.7	6.8	6.8	6.9	8.4	0.6	0.0	1.5	0.3	1.3	0.0	0.5	0.1	1.8	0.0	0.5	0.4	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	3.9	0.4	0.0	0.4	1.1	0.3	0.0	1.3	0.2	0.0	0.2	1.1	0.5	0.4	0.0	0.6	0.7	0.5	0.4	0.0	0.3	0.3	0.0	0.6	0.0	0.1	1.5	0.8	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.1	0.1	0.4	2.4	0.1	0.4	2.5	1.5	0.0	6.6	0.3	0.6	0.3	0.5	2.2	0.0	1.0	1.3	0.2	0.6	0.3
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"basophil: 210.5"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 210.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		21000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	18.5	18.3	3.3	15.1	4.6	6.4	16.7	3.3	4.2	13.7	8.4	26.0	25.0	10.6	11.9	29.0	10.7	10.6	13.2	3.8	3.5	16.7	51.8	13.8	13.7	3.6	3.7	7.5	36.5	10.2	12.1	15.5	3.5	14.2	26.0	1.5	22.6	7.4	9.7	16.2	21.3	12.5	3.5	14.0	19.6	4.5	3.9	9.6	11.3	5.9	14.2	21.7	15.7	3.6	26.1	56.5	12.3	32.7	21.8	33.7	27.4	39.8	47.3	38.8	41.6	42.5	31.5	41.0	16.3	69.4	20.2	35.1	25.3	48.5	39.2	30.7	29.0	13.6	33.0	73.8	40.4	36.9	31.6	50.4	33.7	41.1	37.9	18.1	40.1	24.5	18.9	39.6	26.0	68.3	37.9	33.9	52.8	60.0	35.8	47.2	27.4	82.8	43.5	45.0	23.5	43.7	32.7	71.4	23.9	19.5	46.4	31.7	47.7	27.8	31.5	76.6	39.5	48.2	43.3	51.5	23.4	45.5	38.0	210.5	16.5	3.2	7.9	13.0	11.7	9.5	7.0	10.2	12.1	7.8	7.7	7.5	26.5	6.2	8.4	10.9	5.7	10.9	3.3	4.6	3.3	4.2	3.8	3.5	3.6	3.7	3.5	3.5	3.9	3.6	16.5	16.0	24.1	12.7	18.4	3.8	11.6	7.7	14.8	4.7	10.6	9.5	3.1	4.3	28.8	0.0	14.6	8.9	11.9	11.2	9.8	16.3	0.9	15.9	32.0	11.7	7.7	9.0	29.3	28.5	11.9	16.6	23.9	38.5	22.8	12.9	2.5	12.8	5.5	1.7	26.1	21.2	2.0	4.7	1.7	0.9	6.2	10.4	1.8	21.5	9.6	2.5	9.2	22.6	21.6	23.3	9.7	2.2	49.5	12.6	12.3	17.4	16.8	9.0	0.0	13.5	9.8	2.0	4.2	27.0	4.1	10.7	16.0	13.1	12.6	14.9
PMS1	"MLH2, PMSL1"	ENSG00000064933	"PMS1 homolog 1, mismatch repair system component"	P54277	2	189784085-189877629	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 474.4;Late spermatids: 570.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031013			Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA031013: AB_2673696"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (5.31e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.29e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.92e-2)"	"prognostic favorable (3.73e-4)"	9.2	9.0	9.6	12.0	8.2	12.1	11.6	14.7	9.7	10.8	7.6	7.7	7.4	13.3	15.7	6.3	9.7	8.3	7.0	7.8	10.0	6.3	7.7	8.0	13.7	7.5	8.2	11.9	8.3	7.3	9.8	8.7	8.7	9.5	9.1	18.4	9.9	10.2	9.4	11.5	8.4	10.2	7.2	13.2	13.0	48.4	9.5	8.0	10.6	6.6	10.7	7.4	7.5	11.4	13.8	11.8	29.9	23.8	16.1	24.3	26.6	25.3	12.3	21.2	25.4	19.6	18.1	39.7	14.0	10.6	15.1	19.2	29.9	18.7	29.5	30.3	17.4	39.5	24.1	30.3	22.5	23.3	17.3	15.6	18.4	19.3	39.7	18.8	22.4	27.6	34.0	20.8	26.1	9.7	27.6	32.2	31.6	14.1	27.6	31.9	19.5	38.8	20.9	19.6	27.8	19.3	18.5	12.5	19.6	36.2	13.4	20.1	17.3	22.8	15.4	14.7	23.2	16.6	21.9	34.4	13.1	20.4	14.7	2.9	6.4	3.7	13.6	4.2	13.3	14.4	10.1	15.5	6.4	15.9	10.6	13.0	3.0	12.0	5.2	10.0	10.8	4.8	9.6	8.2	14.7	9.7	7.8	10.0	7.5	8.2	8.7	7.2	9.5	11.4	18.5	16.0	14.4	45.1	22.7	6.9	8.9	12.9	21.6	30.8	13.7	14.6	16.3	10.0	15.8	5.5	8.4	16.4	18.7	3.6	0.0	7.6	474.4	17.3	26.6	14.8	12.0	10.9	68.6	8.0	11.7	18.5	13.7	11.7	13.3	27.7	8.2	9.6	9.2	10.1	80.2	7.3	16.2	16.0	5.1	570.1	21.8	14.9	7.2	43.1	9.8	11.2	22.6	80.9	64.8	6.4	4.3	19.5	30.1	7.5	4.9	6.1	27.0	28.0	13.1	16.3	15.0	25.3	25.9	19.3	7.0	5.2	20.9	22.2	11.1	4.3
PMS2	"H_DJ0042M02.9, HNPCC4, MLH4, PMSL2"	ENSG00000122512	"PMS1 homolog 2, mismatch repair system component"	P54278	7	5970925-6009106	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010235, HPA066490, HPA070310"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250"	"unprognostic (5.13e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.23e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-2)"	5.3	5.1	6.7	5.3	7.2	5.8	6.5	6.3	7.6	4.8	2.8	4.8	5.7	4.9	5.0	5.3	5.7	4.0	4.1	7.4	5.8	10.4	4.7	4.4	8.4	5.3	5.6	5.7	3.9	11.0	4.6	4.8	5.5	5.2	4.7	8.4	5.7	5.5	4.5	11.9	5.3	5.3	4.4	5.9	5.0	4.0	5.2	8.8	9.2	3.5	8.9	5.1	4.9	7.0	15.1	16.7	12.9	32.2	9.0	13.6	10.9	7.8	5.8	6.6	5.6	14.0	9.9	28.2	8.7	10.9	17.2	19.6	19.2	6.6	8.0	11.3	7.2	12.0	12.5	10.1	15.9	15.8	9.4	15.1	14.8	5.4	22.3	11.4	13.7	15.2	22.9	12.6	11.9	15.5	5.2	17.1	13.3	7.6	9.6	16.3	15.3	14.0	16.4	11.0	11.9	25.7	13.3	23.0	16.2	18.0	27.1	11.8	12.4	9.3	21.2	14.2	14.6	19.8	32.8	27.5	7.2	15.3	22.9	5.0	2.9	1.9	4.5	4.1	4.9	3.4	3.5	3.8	3.0	3.4	4.4	3.4	1.4	2.3	1.8	3.1	3.4	3.4	6.7	7.2	6.3	7.6	7.4	5.8	5.3	5.6	5.5	4.4	5.2	7.0	12.2	12.8	8.2	11.4	13.6	5.0	9.3	10.9	15.9	13.2	10.7	11.3	3.2	12.8	9.7	11.0	22.9	9.4	15.2	1.8	35.2	5.5	9.9	11.0	14.6	10.1	5.4	8.4	14.0	3.3	6.3	6.6	8.2	11.8	5.1	11.4	7.9	7.6	5.2	30.3	12.2	2.2	10.2	7.1	5.9	6.6	12.8	6.3	7.2	5.6	8.7	7.8	20.6	3.5	8.3	4.7	2.6	10.1	9.6	12.6	2.2	39.5	9.3	14.3	26.3	10.0	8.0	34.5	11.7	10.5	8.1	12.7	11.4	11.9	2.6	11.1
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	18.9	45.1	12.0	21.0	12.9	26.4	21.2	12.8	16.2	21.1	24.2	21.6	16.0	21.3	13.5	19.4	22.9	10.6	23.9	14.4	11.9	27.3	22.4	22.2	17.5	14.0	14.0	23.7	28.6	16.7	36.8	11.1	14.3	25.3	13.1	10.1	21.6	12.4	18.5	17.8	22.8	11.5	12.8	37.2	25.0	21.2	13.3	12.3	31.9	7.8	15.3	19.4	18.0	14.1	27.5	17.4	19.1	27.2	15.8	13.4	28.6	43.4	21.2	18.7	17.7	17.5	34.2	18.4	13.6	13.6	11.3	23.5	6.1	25.9	10.9	22.3	27.2	30.0	36.7	14.8	12.2	25.8	36.3	13.2	13.0	17.9	11.0	16.9	26.3	23.4	14.9	34.3	24.7	18.8	28.7	23.5	16.0	28.3	37.4	24.3	15.9	34.7	21.0	68.5	20.6	33.4	19.3	52.5	9.2	14.5	10.2	14.8	36.0	37.6	24.9	9.6	35.8	38.7	16.5	13.0	33.8	12.3	30.8	1.8	12.3	16.7	9.2	11.5	7.9	9.1	7.8	7.3	9.8	12.2	5.7	5.0	23.4	3.9	18.1	5.5	9.1	5.8	12.0	12.9	12.8	16.2	14.4	11.9	14.0	14.0	14.3	12.8	13.3	14.1	23.6	16.0	23.6	5.9	47.2	13.4	35.4	29.9	25.6	40.9	28.1	23.7	11.1	21.5	19.1	20.2	81.3	44.5	37.7	40.0	23.5	42.5	15.0	25.2	28.5	26.6	30.5	17.1	6.0	39.9	35.1	19.1	31.6	28.0	29.1	54.6	35.0	20.1	39.5	33.7	6.0	31.7	24.4	27.7	19.0	32.9	59.4	26.8	14.2	8.4	46.1	18.4	96.8	6.0	5.7	44.6	22.3	44.8	40.4	33.6	27.1	36.1	33.8	73.9	19.7	17.9	20.1	19.4	28.9	23.3	13.1	49.3	39.2	83.0	34.1	35.6
PNMA1	MA1	ENSG00000176903	"PNMA family member 1"	Q8ND90	14	73711783-73714384	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 84.2;Peritubular cells: 84.7;Spermatocytes: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA003817, HPA015007"	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Focal adhesion sites"	"HPA003817: AB_1079646, HPA015007: AB_1855502"	"unprognostic (2.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (7.49e-5)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.90e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (4.51e-5)"	35.5	30.2	75.0	20.3	80.5	8.8	20.6	55.5	85.6	37.6	34.7	56.7	13.9	46.3	54.6	23.4	38.1	24.6	23.3	77.3	90.0	27.8	4.9	15.5	16.4	62.1	62.5	53.4	9.2	8.0	53.1	21.4	62.9	48.8	16.5	59.9	10.9	89.3	12.0	9.8	24.9	52.3	66.9	19.2	26.0	71.0	78.4	19.0	18.5	10.4	12.5	41.7	26.6	70.3	48.2	42.8	72.3	54.1	53.1	56.0	29.9	49.8	27.8	44.5	32.5	40.6	29.2	1.1	33.8	60.7	42.4	31.6	56.0	29.4	45.7	45.7	34.7	27.2	35.8	30.7	56.8	15.3	41.6	49.8	35.1	53.4	33.5	87.4	68.1	28.7	23.9	29.3	61.2	117.6	30.5	37.1	21.8	24.6	149.0	47.5	45.0	1.1	58.8	1.5	85.4	65.5	87.5	19.9	40.4	43.6	97.0	25.6	66.5	89.3	71.7	54.9	41.1	25.7	42.9	14.2	88.3	21.4	30.3	2.9	1.8	4.7	8.5	3.5	5.8	2.8	10.9	8.7	3.9	3.1	10.4	10.0	1.6	5.6	5.3	0.6	14.2	7.3	75.0	80.5	55.5	85.6	77.3	90.0	62.1	62.5	62.9	66.9	78.4	70.3	13.1	6.4	3.0	21.9	8.8	3.8	6.8	5.0	6.2	48.6	7.0	7.5	19.9	2.8	4.1	14.7	12.5	7.5	10.4	6.7	15.6	10.1	84.2	32.2	30.6	13.5	18.7	3.0	31.4	6.7	11.3	20.5	14.3	10.2	16.5	16.6	20.0	1.6	15.6	58.9	28.9	5.4	14.2	6.8	25.9	57.6	32.6	18.8	19.6	12.2	14.1	65.2	10.3	17.1	21.7	30.2	1.4	84.7	10.9	7.4	1.6	26.6	23.1	49.1	72.3	31.2	44.1	87.2	44.4	4.7	3.8	6.0	20.0	43.8	2.5	3.7
PNMA8A	"FLJ10781, KIAA1183L, PNMAL1"	ENSG00000182013	"PNMA family member 8A"	Q86V59	19	46466491-46471563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Endometrial ciliated cells: 8.4;Granulosa cells: 13.5;Respiratory ciliated cells: 10.9;Theca cells: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 32.9;K-562: 36.3;LHCN-M2: 35.9;SH-SY5Y: 31.3"	"Low region specificity"	"Detected in all"							"HPA012956, HPA077702"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA012956: AB_1844328, HPA077702: "	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.76e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.48e-3)"	1.1	22.8	45.8	0.9	44.8	0.7	4.7	16.2	54.3	5.8	13.9	3.6	0.7	12.5	16.2	1.2	22.1	5.2	15.0	45.4	53.9	8.7	0.4	1.7	0.3	27.0	30.1	17.2	6.3	15.8	36.7	2.6	35.3	8.8	0.7	35.6	6.0	9.6	1.6	1.2	1.3	7.2	23.3	0.6	1.8	22.5	39.8	30.1	15.4	1.1	0.6	3.1	1.6	34.6	0.0	13.9	19.7	19.6	5.6	12.7	3.5	1.3	0.2	2.4	1.2	0.2	1.6	0.1	18.1	0.9	6.8	0.2	32.9	5.3	1.6	0.1	12.2	0.0	0.5	0.5	9.4	0.2	0.2	3.3	6.5	8.2	0.0	1.8	2.0	11.9	36.3	0.2	35.9	0.1	0.2	0.2	16.5	0.0	0.0	0.0	21.5	0.0	8.2	0.1	16.0	31.3	0.1	0.3	0.0	18.0	0.2	0.3	1.2	0.0	0.2	0.2	6.8	0.1	0.1	0.2	0.3	0.1	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	0.0	0.0	45.8	44.8	16.2	54.3	45.4	53.9	27.0	30.1	35.3	23.3	39.8	34.6	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.9	0.0	0.0	1.8	11.0	0.0	1.9	0.0	0.0	3.9	0.9	0.0	8.4	2.3	0.3	0.0	0.0	0.0	0.0	0.5	2.8	0.0	1.3	0.0	13.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	10.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.0
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157888-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056928			Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	15.1	14.2	6.4	12.1	8.0	19.5	11.6	7.0	11.8	7.6	6.9	9.7	7.6	9.8	11.2	11.1	8.8	9.9	10.2	12.0	7.3	14.1	12.6	8.6	12.6	6.7	6.9	7.0	12.7	12.5	7.1	12.7	6.8	10.0	9.1	19.0	7.1	10.8	20.1	9.1	6.7	11.5	6.7	8.2	8.8	8.9	6.9	8.1	12.5	12.6	12.2	19.8	7.6	7.4	37.8	40.1	18.5	30.5	22.5	18.3	46.0	34.7	23.0	39.1	27.8	77.9	21.9	51.4	28.5	23.6	54.0	31.6	60.6	41.9	61.3	35.2	40.6	49.7	17.4	58.2	34.6	40.2	22.4	24.1	30.2	39.4	45.0	11.3	29.1	32.7	69.7	27.3	35.7	27.4	39.9	38.1	52.0	68.7	43.1	33.3	45.2	54.8	29.8	31.7	32.7	24.0	26.1	32.4	57.8	29.7	22.9	22.4	21.2	44.2	48.0	40.1	97.9	21.6	33.1	78.1	36.3	59.1	62.1	0.9	12.6	2.8	12.2	18.1	19.1	19.2	13.8	14.4	16.8	14.5	16.0	14.6	2.4	15.0	13.0	11.8	16.0	21.3	6.4	8.0	7.0	11.8	12.0	7.3	6.7	6.9	6.8	6.7	6.9	7.4	23.7	16.0	13.2	3.3	29.9	83.2	62.8	29.5	25.6	22.7	18.6	18.4	11.9	18.6	36.2	7.3	12.5	39.5	20.2	7.9	19.6	36.7	33.5	28.7	37.7	25.5	17.3	21.4	10.6	29.8	43.5	28.3	9.7	20.9	31.6	13.6	12.5	15.8	26.0	18.5	9.0	12.1	30.5	10.4	38.7	7.7	12.5	20.7	12.4	4.7	18.9	21.0	14.4	7.1	10.4	29.1	5.8	16.6	27.8	56.6	4.6	34.7	28.6	51.3	6.6	40.4	29.6	28.9	41.7	21.0	56.1	47.6	25.7	20.5	20.2	37.6
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818914-825573	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 508.1;breast: 361.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	508.1	75.3	11.9	9.2	14.0	43.1	361.4	13.6	18.8	42.2	13.4	58.1	19.3	49.2	2.8	39.9	50.8	9.5	171.3	11.9	14.0	61.9	58.4	57.3	8.1	17.5	11.8	50.5	75.4	9.6	46.3	8.4	16.8	46.6	4.8	1.3	81.1	16.7	194.6	71.8	74.7	6.4	12.6	51.2	71.3	32.1	12.8	10.9	55.3	64.3	4.1	64.8	44.5	15.3	33.9	26.0	5.3	14.0	194.4	17.2	34.1	35.3	28.1	21.6	19.1	22.3	33.3	19.9	20.4	26.7	13.6	30.0	8.1	14.6	6.6	25.9	71.5	27.6	11.2	36.3	63.3	19.2	33.4	33.9	18.7	14.5	16.7	22.3	17.7	14.5	23.8	19.9	19.5	20.0	25.8	42.3	15.2	34.3	55.1	24.6	11.5	45.7	21.4	7.7	19.6	26.0	65.3	55.0	21.9	3.4	23.7	22.0	32.5	19.3	15.0	12.7	16.3	75.2	49.8	16.7	48.4	27.0	13.8	11.5	9.5	22.1	3.7	6.1	3.6	4.7	4.8	5.4	6.1	4.1	5.4	4.4	8.2	4.0	7.1	7.0	4.2	4.7	11.9	14.0	13.6	18.8	11.9	14.0	17.5	11.8	16.8	12.6	12.8	15.3	78.1	6.4	11.8	12.7	63.5	44.2	69.2	34.2	42.1	14.0	79.5	67.1	45.5	61.5	65.2	51.5	8.4	70.2	50.8	151.8	33.2	65.1	22.1	58.0	31.8	51.8	51.5	52.6	8.9	65.3	32.0	37.4	204.4	114.3	11.4	42.2	100.6	50.6	29.2	11.8	7.5	96.1	20.3	27.6	29.0	6.2	48.4	46.6	42.7	16.9	29.6	32.2	21.6	5.5	13.8	142.2	170.7	39.1	92.0	78.5	166.8	45.0	31.3	9.0	65.7	64.4	50.7	33.5	23.9	53.7	41.2	169.4	53.3	182.2	43.6	195.5
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470417-108569666	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	27.8	47.3	23.6	17.9	25.1	82.9	20.2	21.6	29.6	19.4	22.1	14.1	11.8	17.9	17.7	21.1	11.6	21.4	25.3	24.0	26.5	30.0	34.6	17.5	18.0	23.5	23.3	14.7	13.9	28.4	16.5	26.6	23.4	18.0	15.1	24.4	11.9	17.7	35.9	15.0	10.7	20.9	24.9	17.7	15.6	15.5	22.9	18.6	24.3	34.7	22.1	29.1	12.7	26.5	28.6	12.8	22.1	19.7	47.7	32.7	32.4	26.6	47.2	21.6	35.8	12.4	16.0	15.9	33.1	26.4	43.4	10.6	37.9	17.1	32.6	24.2	10.1	11.0	19.3	9.1	34.8	7.6	21.7	29.8	31.7	29.2	26.9	23.4	29.5	17.7	13.0	44.5	27.2	18.9	18.0	18.3	9.8	17.9	17.8	6.5	23.3	34.3	25.9	35.9	18.3	25.3	25.8	27.4	32.7	27.7	11.6	12.6	24.2	35.1	15.7	52.8	15.0	37.4	41.5	23.9	33.4	11.4	23.2	21.9	29.8	26.2	14.6	32.8	17.8	28.6	14.2	14.6	29.2	27.3	15.4	14.7	24.5	22.9	43.4	11.6	19.1	22.9	23.6	25.1	21.6	29.6	24.0	26.5	23.5	23.3	23.4	24.9	22.9	26.5	64.5	41.7	49.3	66.3	91.3	92.9	124.0	42.2	55.2	64.0	45.7	35.9	49.7	8.6	51.2	23.9	18.8	58.0	72.7	44.3	93.9	32.0	52.3	124.9	67.3	57.1	57.1	50.7	42.4	37.8	37.5	76.6	45.3	236.1	71.7	19.0	23.2	44.3	32.2	32.0	42.9	27.8	67.1	45.5	90.0	47.4	32.0	113.8	55.2	23.4	43.5	42.9	18.6	38.2	41.3	29.6	38.6	39.5	76.8	80.1	16.7	41.0	62.0	32.5	19.7	88.9	63.9	18.6	23.1	60.5	135.7	130.2	69.1	43.7	22.9	122.7
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Hepatocytes: 53.4;Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	7.3	15.8	16.5	6.2	15.9	3.5	10.6	16.7	22.0	7.0	12.9	8.8	10.2	5.0	11.6	10.7	10.1	6.6	13.2	16.0	21.9	35.1	88.8	6.4	6.9	19.1	21.2	5.8	10.9	26.6	9.2	7.0	20.6	8.0	8.6	5.4	10.4	7.8	21.1	6.7	9.6	6.1	16.5	7.2	8.6	6.6	20.6	5.8	17.8	19.6	7.7	6.7	7.3	14.3	37.9	30.9	2.4	5.8	15.3	11.7	0.0	12.2	7.7	14.0	11.9	51.1	27.6	35.2	57.4	12.7	5.5	22.0	19.4	34.7	20.3	43.4	16.4	24.6	13.9	53.6	16.3	22.6	16.6	15.4	26.9	25.8	32.7	13.1	18.0	26.1	24.4	12.2	16.5	28.3	25.3	7.8	4.5	37.4	37.1	18.8	10.4	26.2	40.2	19.5	12.1	9.5	11.2	18.6	10.7	8.5	32.4	9.1	19.1	22.6	12.8	22.2	26.2	27.8	34.0	19.0	18.4	19.2	11.7	2.5	12.3	2.8	7.2	17.7	8.2	6.7	6.3	7.6	13.5	5.3	8.2	8.1	1.1	7.9	11.9	9.8	7.0	10.3	16.5	15.9	16.7	22.0	16.0	21.9	19.1	21.2	20.6	16.5	20.6	14.3	7.6	12.8	13.9	7.5	3.9	1.5	6.7	5.0	5.7	1.1	16.2	14.4	1.9	18.6	6.8	12.9	4.2	8.4	7.8	7.3	62.6	18.2	0.8	11.2	6.4	5.9	3.6	7.4	4.2	15.6	1.9	5.3	4.6	13.3	12.7	8.8	6.4	53.4	17.2	3.3	6.2	11.6	2.0	11.4	2.4	0.9	9.9	10.6	1.8	2.8	8.6	7.1	3.1	2.5	3.2	15.0	8.9	6.0	4.9	9.0	20.2	86.3	5.9	1.9	0.0	4.1	3.8	0.7	1.3	7.2	2.3	6.3	4.7	19.5	15.4	5.0
PNRC1	"B4-2, PROL2, PRR2"	ENSG00000146278	"Proline rich nuclear receptor coactivator 1"	Q12796	6	89080751-89085160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1848.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 212.8;hTCEpi: 234.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029839, HPA066513"	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli"		"HPA029839: AB_10601247, HPA066513: AB_2685684"	"unprognostic (9.02e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (6.88e-6)"	"unprognostic (8.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.09e-2)"	232.7	171.7	61.6	145.9	66.3	368.1	135.4	84.0	67.5	93.8	47.9	158.4	70.2	100.6	80.4	91.4	204.4	139.3	132.5	58.3	74.2	103.5	318.1	159.6	134.1	87.7	65.7	222.5	89.2	86.8	78.5	122.6	73.0	95.0	77.5	129.8	91.9	84.3	460.6	147.5	94.3	130.3	69.5	139.6	104.6	50.1	57.4	165.9	105.6	163.4	111.2	141.4	98.5	80.4	12.1	12.0	25.3	42.4	96.7	166.6	16.9	16.0	110.6	29.5	69.0	10.2	34.5	25.9	71.2	19.4	116.3	40.5	13.3	23.9	45.6	31.8	36.3	4.7	69.8	31.9	212.8	25.0	57.9	117.6	234.4	19.6	90.1	107.9	49.4	30.3	4.1	81.0	33.3	11.5	6.8	124.7	7.0	13.9	23.1	29.1	30.0	21.5	70.2	21.1	15.7	42.2	40.3	56.3	44.0	73.6	27.9	119.4	44.8	23.1	13.2	16.2	5.9	118.3	64.0	9.0	46.3	20.6	14.9	32.8	17.3	103.8	18.3	19.0	19.0	20.7	22.1	19.7	11.3	23.0	24.9	25.9	100.9	19.2	17.9	18.7	19.0	10.5	61.6	66.3	84.0	67.5	58.3	74.2	87.7	65.7	73.0	69.5	57.4	80.4	405.7	141.1	149.8	36.2	747.6	968.9	776.8	98.9	1286.2	130.6	412.5	381.5	188.6	230.2	65.2	90.1	50.1	235.8	662.8	158.1	234.8	203.5	103.4	528.4	655.3	356.1	248.0	284.1	10.0	238.2	78.6	720.1	225.8	955.1	164.6	153.2	238.5	207.6	229.4	72.3	15.5	200.7	34.6	452.6	1848.0	41.5	481.9	898.3	439.4	39.4	763.5	403.3	440.8	20.1	41.5	143.0	184.6	377.3	530.6	738.5	211.1	319.2	61.5	134.8	420.7	731.3	725.6	51.9	64.6	840.2	1250.8	274.5	735.8	214.3	136.9	472.8
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23956839-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favorable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (4.05e-4)"	82.7	82.5	49.5	80.6	52.1	141.0	78.5	53.4	62.0	69.6	56.1	98.1	99.5	87.4	68.6	62.8	58.3	80.5	75.2	49.6	51.9	99.6	66.8	76.0	137.0	52.6	50.7	79.3	52.2	94.3	34.8	103.3	54.4	70.5	92.2	56.2	55.0	56.9	49.8	46.1	84.2	71.8	50.9	87.5	81.9	33.7	51.9	133.5	122.2	63.6	109.5	100.1	51.4	57.8	107.8	42.0	179.5	124.9	121.5	110.7	68.6	116.7	103.7	132.7	106.1	122.7	132.5	291.7	111.5	74.8	49.9	93.5	121.6	101.8	146.7	208.6	78.7	277.5	131.8	130.2	103.3	272.1	122.3	83.9	125.8	109.2	101.0	86.8	130.3	148.4	239.6	159.5	79.0	87.5	169.4	103.3	243.8	101.7	76.5	189.7	116.7	125.0	134.8	113.8	107.4	93.5	101.0	85.7	123.7	130.9	93.6	168.6	105.3	85.6	82.2	84.6	75.4	133.7	164.8	197.6	58.0	259.0	89.8	230.8	112.7	126.8	103.5	115.0	108.8	129.1	112.5	112.2	109.1	131.1	124.9	106.8	74.2	108.6	112.2	77.4	129.4	178.3	49.5	52.1	53.4	62.0	49.6	51.9	52.6	50.7	54.4	50.9	51.9	57.8	119.0	185.9	109.2	11.4	122.5	13.3	231.7	2.0	99.0	33.6	110.5	109.6	84.8	58.6	62.2	62.5	18.8	129.8	104.7	160.5	238.7	90.5	6.9	86.0	96.1	97.3	100.4	157.0	7.9	127.8	101.4	128.7	66.3	130.9	76.5	84.1	86.7	30.0	68.6	20.2	6.4	109.3	0.0	82.3	10.9	14.2	78.9	109.0	1.8	13.1	81.8	66.9	127.7	6.0	11.8	119.2	157.7	81.3	48.8	187.6	90.3	112.0	56.1	28.7	46.0	104.3	104.5	21.2	24.4	97.8	12.6	141.7	104.0	203.9	110.2	314.0
POC5	"C5orf37, FLJ35779, hPOC5, MGC120442, MGC120443, MGC120444"	ENSG00000152359	"POC5 centriolar protein"	Q8NA72	5	75674124-75717448	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 102.7;Late spermatids: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037509, HPA037510, HPA061521"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA037509: AB_2797227, HPA037510: AB_10672349, HPA061521: AB_2797263"	"unprognostic (1.33e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.60e-7)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.62e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.09e-4)"	5.8	6.1	5.3	6.1	7.6	10.2	9.5	6.9	8.1	7.6	4.3	5.1	4.6	7.6	8.3	3.8	8.9	4.4	3.8	5.2	5.8	5.2	4.5	6.0	11.4	6.8	6.5	11.2	5.1	5.7	3.3	5.9	6.9	6.9	6.3	29.2	4.3	5.2	3.8	6.0	5.9	7.3	5.9	9.7	5.5	20.1	6.1	14.3	5.7	3.5	11.0	5.6	5.5	10.5	16.1	12.4	20.5	20.4	8.7	7.0	15.0	14.9	8.9	25.9	19.4	18.3	14.3	21.5	27.9	8.4	34.8	14.8	18.3	14.8	19.3	23.3	12.7	14.1	9.3	10.2	11.7	16.2	26.3	7.8	14.3	19.6	32.4	8.7	10.5	21.6	13.8	38.1	12.2	19.1	26.3	20.5	8.9	3.6	10.9	16.5	17.0	25.8	11.9	7.8	16.1	17.7	14.0	7.6	15.7	10.3	14.5	18.5	4.5	8.7	19.2	15.3	30.5	23.4	53.1	31.6	13.2	21.3	21.1	8.1	10.0	23.1	14.6	11.2	12.9	15.1	14.5	15.5	15.2	18.0	14.8	14.4	10.0	18.5	9.0	17.1	21.5	8.7	5.3	7.6	6.9	8.1	5.2	5.8	6.8	6.5	6.9	5.9	6.1	10.5	5.9	6.4	11.1	6.2	8.3	2.7	3.0	8.2	5.2	12.3	5.2	6.2	3.9	8.6	6.3	7.3	12.5	7.4	12.2	3.6	9.8	7.7	102.7	12.3	8.4	5.8	4.9	13.5	18.4	6.9	7.7	6.1	6.1	5.7	2.5	8.1	6.1	3.6	6.3	10.1	9.4	4.0	10.2	5.4	4.8	53.3	6.2	6.0	3.6	14.0	4.0	5.9	10.3	9.0	32.1	5.5	2.5	7.2	10.5	2.5	3.2	5.1	19.9	39.0	6.6	3.8	6.0	36.8	15.7	6.4	2.8	4.1	10.8	9.6	5.5	1.7
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B actin binding protein"	Q8WVV4	X	85277396-85379717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.2;skin 1: 123.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.8;Gastric mucus-secreting cells: 48.9;Intestinal goblet cells: 61.1;Paneth cells: 62.5;Proximal enterocytes: 73.6;Squamous epithelial cells: 39.2;Undifferentiated cells: 51.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Group enriched"	"Detected in some"	5	"OE19: 179.0;RT4: 78.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		200000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.7	0.3	0.1	6.1	0.1	0.2	11.0	0.8	0.3	6.4	0.0	54.2	34.4	0.2	0.5	33.1	6.2	9.0	10.6	0.1	0.0	1.4	0.4	1.8	0.5	0.0	0.0	0.1	6.9	0.0	0.3	1.0	0.0	2.9	50.9	0.4	8.5	1.3	0.8	123.9	43.4	2.0	0.0	3.5	23.7	0.2	0.0	0.5	0.5	0.0	12.0	14.3	14.7	0.0	3.7	22.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.5	23.9	12.0	3.3	0.0	0.1	23.7	5.1	0.4	0.0	2.4	0.1	4.4	0.1	0.1	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.3	0.7	3.9	0.0	9.6	0.1	0.2	0.0	179.0	0.0	0.2	1.0	0.1	0.0	78.2	0.1	0.1	0.0	6.0	0.0	1.8	2.4	1.0	0.2	0.1	0.1	0.2	0.3	2.0	4.8	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	1.2	9.1	4.9	7.9	12.0	0.0	2.5	0.8	24.2	8.6	10.2	5.5	0.0	3.2	0.0	129.8	0.0	13.8	0.0	0.3	0.0	1.7	22.8	0.0	0.4	15.6	0.6	3.4	48.9	0.2	0.0	0.0	0.4	0.2	0.3	0.0	0.4	61.1	6.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.4	24.8	62.5	0.0	0.2	3.9	73.6	0.1	9.5	0.0	0.0	0.1	0.9	0.0	0.1	39.2	28.6	5.3	0.3	0.0	51.1	17.1
POGK	"BASS2, KIAA15131, KRBOX2, LST003"	ENSG00000143157	"Pogo transposable element derived with KRAB domain"	Q9P215	1	166839447-166856359	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007838, HPA031630, HPA075919"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: "	"unprognostic (3.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (4.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	11.3	9.1	33.8	13.5	38.4	11.0	14.2	32.4	39.2	14.9	25.0	12.3	9.5	15.7	10.9	14.7	11.9	11.2	10.5	30.4	30.8	13.9	11.1	19.5	13.5	34.2	36.5	17.3	13.7	19.5	8.3	14.1	34.8	10.5	13.7	26.5	11.6	13.0	6.8	18.8	11.3	15.2	34.2	14.3	14.0	6.3	34.7	12.3	11.7	9.5	16.9	17.5	11.5	43.4	33.4	27.4	29.5	36.5	30.5	25.2	17.1	22.6	22.7	28.1	21.2	21.0	27.4	37.3	33.1	23.3	23.8	32.6	37.1	29.7	25.6	46.3	25.4	14.9	25.2	15.0	26.0	52.8	39.7	19.2	46.1	31.7	44.9	24.8	25.4	33.9	51.0	24.3	27.0	15.7	33.0	13.2	48.5	38.5	32.2	37.2	16.5	32.9	29.4	79.4	38.4	46.5	32.1	43.6	41.7	43.5	41.7	48.3	24.1	29.7	29.7	23.9	41.2	34.2	47.7	47.8	16.7	25.9	28.7	2.2	6.0	5.1	4.7	7.5	5.1	6.7	4.6	5.1	7.8	3.9	4.2	4.6	0.8	7.5	9.0	3.7	4.3	4.9	33.8	38.4	32.4	39.2	30.4	30.8	34.2	36.5	34.8	34.2	34.7	43.4	11.7	54.5	19.5	12.4	20.2	21.9	26.2	13.0	18.8	30.7	17.8	12.8	10.1	11.5	19.4	12.9	10.4	10.8	15.3	9.8	1.9	16.9	2.8	9.8	19.9	16.0	9.0	5.9	14.7	16.3	12.3	15.4	13.3	15.2	24.1	23.4	15.0	13.4	16.0	48.8	15.7	11.9	4.1	20.1	17.5	1.6	10.8	18.7	8.8	8.4	21.6	16.5	10.3	23.1	27.8	15.0	11.9	18.0	11.6	31.9	9.2	7.3	11.1	29.5	13.1	19.8	17.1	1.0	3.3	25.4	24.0	9.0	13.7	7.8	15.6	28.0
POGLUT2	"EP58, KDELC1, MGC5302"	ENSG00000134901	"Protein O-glucosyltransferase 2"	Q6UW63	13	102784281-102798976	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.0;Extravillous trophoblasts: 23.3;Fibroblasts: 3.8;Hofbauer cells: 3.3;Syncytiotrophoblasts: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.9;T-cells: 2.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020780, HPA043946, HPA064398"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		44000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB020780: , HPA043946: AB_2678743, HPA064398: AB_2685256"	"unprognostic (1.97e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (4.81e-4)"	"unprognostic (4.34e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.60e-3)"	4.6	2.3	1.5	3.1	2.2	1.6	3.3	2.2	2.4	5.6	1.6	3.5	1.3	11.1	4.3	2.6	4.3	8.1	4.8	1.5	1.5	4.6	7.7	3.4	2.4	1.8	1.7	6.5	1.6	2.8	2.1	12.2	1.9	2.7	2.7	3.4	1.8	4.2	0.8	2.3	2.1	12.5	1.7	3.6	2.4	1.5	1.9	1.9	2.9	2.5	1.9	6.0	3.2	2.7	8.1	6.0	36.8	35.5	37.0	28.5	9.0	21.4	16.4	19.5	33.5	17.1	11.5	0.0	16.7	17.6	10.0	13.3	26.6	10.9	19.5	3.4	22.1	9.8	16.3	18.8	32.1	25.4	34.5	27.0	12.3	14.8	14.2	29.1	43.0	12.3	16.3	0.0	10.5	9.0	11.4	20.8	23.5	11.5	17.9	0.0	26.3	9.5	53.7	0.7	5.5	33.7	21.0	5.6	12.3	30.5	16.1	10.9	13.3	12.8	9.3	14.7	21.6	7.4	14.4	0.0	25.2	0.0	22.6	0.0	0.0	0.0	1.4	0.0	2.4	0.2	0.7	1.1	0.6	0.0	0.2	0.7	0.0	3.9	0.0	0.0	0.9	0.2	1.5	2.2	2.2	2.4	1.5	1.5	1.8	1.7	1.9	1.7	1.9	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	23.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0
POGLUT3	"KDELC2, MGC33424"	ENSG00000178202	"Protein O-glucosyltransferase 3"	Q7Z4H8	11	108472112-108498384	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.8;Cardiomyocytes: 13.1;Cytotrophoblasts: 27.6;Extravillous trophoblasts: 14.5;Fibroblasts: 14.7;Hofbauer cells: 18.0;Syncytiotrophoblasts: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039315, HPA039817, HPA066134"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Vesicles	"HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624"	"unprognostic (1.29e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.00e-3)"	"unprognostic (4.08e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (6.27e-5)"	24.6	13.2	5.0	17.3	5.0	7.6	16.2	4.6	5.4	33.6	7.0	16.8	9.4	35.0	27.3	21.0	23.0	21.7	15.2	4.2	5.9	15.6	13.2	16.0	10.4	5.5	6.1	36.5	8.3	25.2	5.4	32.7	5.4	28.4	16.9	5.8	13.9	28.4	5.5	13.7	11.2	37.1	5.3	12.4	11.3	5.8	5.5	16.4	12.1	13.9	9.5	22.5	18.8	6.0	10.9	12.4	46.5	47.8	76.5	88.5	44.8	47.0	43.7	66.0	71.1	58.9	78.1	0.1	28.6	61.6	73.1	7.9	35.6	1.2	69.3	19.4	27.4	18.1	12.1	27.2	30.8	47.7	0.2	51.1	14.6	35.0	1.0	40.1	56.6	0.3	41.5	0.3	101.0	7.9	30.9	27.2	20.3	11.5	34.8	1.5	72.5	0.2	12.3	30.3	9.7	29.5	89.1	6.2	13.3	21.4	42.3	18.0	56.8	127.0	24.9	10.8	49.7	0.4	0.1	0.3	32.6	48.9	103.1	0.1	0.1	0.0	2.0	0.7	1.7	0.2	1.0	1.7	0.5	0.3	1.0	1.5	0.1	1.9	0.4	1.0	0.9	0.5	5.0	5.0	4.6	5.4	4.2	5.9	5.5	6.1	5.4	5.3	5.5	6.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	27.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	14.5	14.7	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	21.2	0.5	0.0	0.0	0.0
POGZ	"KIAA0461, ZNF280E, ZNF635"	ENSG00000143442	"Pogo transposable element derived with ZNF domain"	Q7Z3K3	1	151402724-151459494	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division"	DNA-binding	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 347.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006800, HPA008781"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA006800: AB_1855516, HPA008781: AB_1855517"	"unprognostic (2.87e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.00e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (4.40e-4)"	27.0	32.4	29.4	15.6	42.8	40.2	29.0	51.0	42.9	42.7	20.9	45.4	15.2	36.5	56.2	22.5	45.5	23.7	26.9	27.3	27.9	36.3	29.1	26.4	21.1	44.5	29.0	66.5	29.2	34.5	61.6	16.0	36.2	40.4	21.4	55.3	27.3	25.0	26.1	36.7	29.1	28.2	23.6	32.5	29.8	33.6	34.9	27.3	46.9	20.1	21.7	35.8	32.5	79.1	22.1	28.0	68.4	38.8	29.8	28.7	23.3	18.9	17.3	21.1	21.9	31.3	22.2	45.4	31.5	23.6	16.7	18.6	40.9	20.0	27.5	38.4	22.4	27.8	41.1	18.4	21.8	38.5	26.9	25.7	16.0	23.4	27.8	39.3	34.2	33.4	26.3	42.2	21.5	55.7	42.7	24.4	48.4	22.8	16.5	41.2	33.1	22.8	22.9	34.8	36.6	37.8	31.5	26.3	31.2	56.0	34.3	49.9	28.3	25.2	29.8	21.0	27.2	30.6	27.6	86.1	18.0	20.3	21.7	3.3	1.0	2.5	1.8	0.9	1.5	2.1	1.7	2.4	1.0	2.0	1.8	1.8	2.1	1.3	1.2	1.8	1.4	0.8	29.4	42.8	51.0	42.9	27.3	27.9	44.5	29.0	36.2	23.6	34.9	79.1	42.7	60.9	41.6	167.8	60.6	45.2	26.8	25.2	54.1	83.7	48.4	34.9	18.8	37.1	30.0	64.4	83.4	17.1	34.4	31.8	3.9	22.3	17.0	31.5	40.9	45.0	58.2	29.3	147.8	14.7	11.3	40.2	34.7	43.6	27.8	87.6	47.2	44.4	21.3	79.1	142.4	32.4	20.3	30.0	49.2	12.2	53.7	32.8	51.6	112.4	30.7	37.8	26.8	155.8	347.4	23.7	26.3	73.7	58.9	31.4	29.3	13.7	29.7	60.1	65.7	55.8	41.3	32.3	49.9	40.3	34.1	11.5	39.9	44.0	36.4	28.8
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693873-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Excitatory neurons: 42.3;Inhibitory neurons: 65.7;Microglial cells: 57.1;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	3.7	2.0	1.9	4.8	2.5	7.3	5.1	2.2	1.8	4.3	0.8	4.1	2.4	4.2	1.4	3.9	3.7	2.1	3.5	1.3	1.9	2.9	2.0	3.1	6.8	2.3	2.3	5.8	2.8	3.4	1.8	5.6	2.4	3.1	5.2	3.7	3.0	3.5	4.9	4.0	3.5	4.8	2.2	3.5	3.7	2.6	2.1	11.9	3.1	3.1	7.7	3.7	3.8	2.6	32.7	24.6	30.3	24.1	5.2	6.5	6.9	23.6	12.7	25.0	28.3	20.4	17.0	41.1	7.7	9.6	23.4	26.0	59.7	18.7	33.6	21.1	24.8	31.0	42.8	13.5	2.4	41.6	15.5	4.1	3.6	31.2	8.4	5.8	13.0	20.8	28.7	20.0	16.8	22.4	45.2	7.2	30.7	20.3	19.1	39.0	81.5	30.7	7.1	21.1	27.9	16.7	28.1	11.2	11.6	33.0	25.7	11.5	10.1	21.3	14.9	42.4	22.6	11.6	18.1	32.7	12.4	18.3	24.9	0.0	0.2	0.2	0.6	1.4	0.8	1.0	0.8	1.0	0.7	0.4	0.4	0.5	0.0	0.8	0.2	0.2	0.9	0.5	1.9	2.5	2.2	1.8	1.3	1.9	2.3	2.3	2.4	2.2	2.1	2.6	5.8	9.6	6.5	38.5	5.2	2.8	4.6	1.8	5.7	3.9	4.7	4.3	11.8	0.0	7.2	1.8	2.1	6.1	3.2	2.5	3.9	3.2	0.2	3.2	4.7	6.3	4.2	24.2	42.3	3.0	4.9	4.6	4.6	3.8	9.5	8.3	3.3	3.4	4.4	1.7	65.7	4.2	4.1	4.4	1.5	1.7	6.2	4.5	0.0	57.1	3.7	4.8	5.2	59.3	97.7	1.4	1.2	3.4	8.6	2.0	2.3	1.6	6.1	7.4	6.6	9.2	6.0	6.4	4.5	5.5	2.3	2.3	4.9	5.0	4.2	2.4
POLA2	FLJ21662	ENSG00000014138	"DNA polymerase alpha 2, accessory subunit"	Q14181	11	65261920-65305589	"Metabolic proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.2;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037570	Supported		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA037570: AB_10672280"	"unprognostic (2.28e-1)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.09e-8)"	"unprognostic (1.60e-3)"	"unprognostic (8.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.25e-3)"	3.3	2.6	1.9	5.3	2.9	6.9	3.5	4.8	3.3	4.5	1.7	5.3	3.6	5.0	3.3	4.5	3.8	1.8	2.9	1.9	1.5	3.5	3.7	3.5	10.0	4.5	2.8	5.1	3.3	3.2	1.9	2.1	3.7	3.0	4.9	3.6	4.2	3.1	3.1	5.1	4.2	4.1	3.1	5.7	3.8	5.2	2.6	15.9	3.3	3.4	13.2	3.2	3.2	7.0	32.6	21.9	47.3	20.4	3.7	3.6	19.5	25.6	15.9	64.4	43.3	6.9	24.0	48.1	20.4	11.0	35.5	18.9	38.8	25.1	61.1	21.3	14.7	32.4	39.4	10.4	0.9	33.5	25.6	3.7	2.9	47.4	8.5	10.3	14.6	20.2	30.2	25.3	44.4	34.9	62.6	13.2	38.6	16.1	16.2	33.4	29.9	40.7	14.1	21.8	32.5	18.1	14.9	15.9	7.9	29.7	28.6	14.1	3.9	25.4	18.7	19.8	16.0	12.0	14.7	45.0	14.9	18.8	33.7	10.0	5.2	2.3	3.8	3.2	4.5	3.9	4.2	4.2	7.4	3.9	3.5	3.1	1.4	3.8	1.7	5.9	4.6	5.3	1.9	2.9	4.8	3.3	1.9	1.5	4.5	2.8	3.7	3.1	2.6	7.0	2.6	0.0	3.4	1.0	5.1	1.7	4.2	5.7	2.2	2.2	3.0	2.3	2.9	7.2	3.7	5.5	2.1	15.6	4.3	3.0	3.9	5.3	2.7	1.8	2.9	3.7	3.0	23.2	4.3	3.4	19.0	7.7	5.6	2.5	0.0	11.0	5.3	2.1	9.7	3.3	3.6	3.5	2.0	2.8	3.7	4.0	7.5	5.3	0.0	12.2	8.0	2.2	5.2	1.5	8.7	4.9	2.2	7.5	10.4	3.4	1.7	2.0	3.2	5.4	6.6	19.6	5.0	23.7	17.7	4.3	1.4	7.3	5.5	4.0	6.3	3.7
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418018	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 51.3;Spermatogonia: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004375: AB_675487, HPA046524: AB_2679684"	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	5.6	5.1	3.2	9.2	3.7	26.3	6.3	4.5	3.8	7.6	2.5	8.9	5.4	8.4	0.4	10.7	6.5	2.1	5.8	2.7	2.7	6.5	6.4	9.5	11.2	5.1	3.7	7.1	7.9	2.3	4.7	5.9	4.1	6.1	2.2	1.9	7.4	2.6	5.6	9.2	10.1	2.3	3.5	12.8	6.2	13.3	4.1	11.0	9.8	1.5	5.2	5.9	7.7	4.4	52.1	77.9	27.9	22.4	3.0	2.8	45.6	34.0	9.6	30.0	34.9	42.4	39.2	84.6	19.4	7.1	13.9	45.1	27.4	25.1	6.8	64.4	145.0	66.1	73.0	54.6	3.7	67.0	57.7	6.4	7.1	26.1	6.5	6.0	14.2	58.2	77.4	54.3	9.1	40.6	92.2	110.6	48.7	25.3	55.4	105.4	62.2	67.7	7.4	44.9	39.3	38.6	33.0	35.9	8.8	10.1	21.1	50.7	17.4	21.4	70.7	22.0	56.5	60.0	91.3	76.3	21.2	66.9	20.8	1.3	4.3	1.5	4.3	5.6	4.0	6.0	4.0	3.5	3.9	5.4	4.0	3.9	0.6	4.2	6.9	7.1	3.1	4.0	3.2	3.7	4.5	3.8	2.7	2.7	5.1	3.7	4.1	3.5	4.1	4.4	3.5	3.2	3.9	0.7	8.7	6.4	2.3	3.5	3.4	4.0	4.3	5.3	3.4	2.8	3.8	3.7	6.2	19.2	3.8	12.2	0.0	4.8	1.9	2.8	1.6	3.4	7.2	15.2	1.2	4.0	15.0	4.1	3.1	3.0	0.0	9.5	1.1	2.2	15.1	0.0	0.9	7.4	0.0	5.7	5.3	1.9	3.1	5.8	5.4	1.0	4.8	1.2	6.2	1.5	2.2	4.7	51.3	5.3	10.6	2.8	6.3	2.8	3.0	4.3	0.0	3.5	4.0	11.5	25.6	5.5	5.3	7.7	5.4	3.4	14.3	1.3
POLD2		ENSG00000106628	"DNA polymerase delta 2, accessory subunit"	P49005	7	44114680-44124358	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026745	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026745: AB_1855520"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.94e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-3)"	48.4	58.8	48.9	35.0	46.7	44.6	44.4	46.4	53.8	53.4	52.0	39.0	32.4	47.3	14.0	86.6	75.8	18.5	86.8	46.5	47.6	51.6	113.5	36.2	36.9	49.0	49.3	59.3	73.4	62.0	53.0	27.1	49.3	46.8	28.9	22.6	46.6	30.1	118.8	59.9	32.9	32.4	46.9	35.9	48.0	48.7	56.7	46.2	40.6	77.5	33.4	48.2	54.3	45.6	162.2	209.3	114.1	240.5	99.5	105.5	112.9	97.2	97.5	130.6	97.4	178.0	151.4	371.1	121.2	141.1	261.0	218.3	188.9	265.6	84.4	105.9	222.1	82.2	216.3	152.3	112.8	253.4	96.1	96.8	159.6	202.4	195.1	136.3	110.7	245.8	305.4	173.2	146.3	262.7	310.5	476.0	180.0	231.0	203.0	206.4	153.4	528.9	114.0	102.7	225.0	176.2	121.5	430.6	83.7	73.5	249.7	321.6	88.0	171.7	215.8	213.3	310.5	269.3	430.3	359.1	154.1	252.7	248.6	1.7	41.2	10.4	51.6	38.9	77.3	82.2	61.7	52.5	70.8	80.2	81.4	60.5	3.3	44.9	38.8	112.7	54.1	69.7	48.9	46.7	46.4	53.8	46.5	47.6	49.0	49.3	49.3	46.9	56.7	45.6	25.6	6.4	31.8	11.8	35.3	49.3	83.0	111.8	42.7	41.6	57.1	62.7	58.2	44.3	54.1	29.5	31.3	69.9	24.3	31.0	103.7	71.9	108.9	53.5	52.4	33.6	41.9	52.2	5.0	59.5	84.1	49.3	40.2	24.9	26.6	65.6	19.2	95.6	46.8	53.8	5.1	53.6	30.5	14.4	26.6	288.0	41.7	15.0	49.8	4.7	13.0	58.1	18.6	5.0	7.8	44.5	25.0	53.4	38.0	127.6	10.0	95.2	69.7	52.0	19.7	55.4	78.6	48.2	52.4	70.5	60.5	35.4	25.7	103.9	81.5	71.3
POLD3	"KIAA0039, P66, P68, PPP1R128"	ENSG00000077514	"DNA polymerase delta 3, accessory subunit"	Q15054	11	74493851-74669117	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA058846	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA058846: AB_2683833"	"unprognostic (3.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.99e-3)"	"unprognostic (1.54e-3)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (7.92e-3)"	"unprognostic (2.65e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.23e-1)"	7.9	6.2	6.1	14.6	6.0	10.1	11.1	6.0	7.3	10.6	7.6	17.2	15.7	16.5	12.0	12.9	16.3	14.9	8.9	5.9	6.1	44.5	7.1	11.5	14.5	4.9	5.6	16.0	11.4	7.8	4.6	11.5	5.6	8.3	17.9	14.9	6.8	10.1	7.7	11.6	14.4	15.3	5.1	11.4	15.4	19.6	5.5	15.7	15.0	12.5	15.2	12.7	7.5	7.4	32.2	28.6	43.6	29.8	13.2	22.5	30.9	42.7	23.9	43.7	37.0	37.8	40.8	45.7	30.9	20.5	25.3	41.2	36.3	28.0	54.6	34.5	23.3	29.1	44.3	12.8	9.5	56.4	25.3	10.0	17.3	51.1	27.3	13.8	17.1	39.8	26.7	35.5	25.6	25.3	63.4	25.3	26.4	95.3	29.1	60.0	109.4	37.9	20.2	30.6	29.0	19.5	50.7	25.3	49.7	26.2	29.5	35.7	16.4	42.9	30.8	48.8	34.2	24.8	56.6	102.4	24.5	35.1	33.2	7.3	22.6	15.9	9.2	18.5	9.1	10.1	11.7	8.2	17.7	8.0	11.6	9.6	19.4	10.8	19.0	5.2	13.7	13.0	6.1	6.0	6.0	7.3	5.9	6.1	4.9	5.6	5.6	5.1	5.5	7.4	14.8	12.8	20.0	13.1	9.7	5.9	7.0	11.4	12.5	12.3	10.5	12.8	7.8	7.2	17.7	9.2	8.4	19.7	11.1	17.9	5.9	17.2	28.3	24.8	17.1	14.2	5.4	24.2	20.1	32.1	26.7	13.1	16.8	14.4	19.0	20.9	8.2	4.9	15.6	23.5	15.3	12.7	12.2	12.9	7.2	23.1	12.5	16.9	3.6	15.0	25.3	15.3	9.2	6.6	18.7	17.4	13.4	8.6	11.4	11.4	10.7	39.1	45.2	19.1	6.6	13.7	12.4	60.3	37.7	11.2	5.4	13.0	11.8	10.0	19.9	10.5
POLE	POLE1	ENSG00000177084	"DNA polymerase epsilon, catalytic subunit"	Q07864	12	132623753-132687376	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 46.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebellum: 4.1;cerebral cortex: 1.1;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA058210, HPA067385"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Plasma membrane"	"HPA058210: AB_2683639, HPA067385: AB_2685830"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.19e-8)"	"unprognostic (8.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	6.0	2.9	0.2	6.1	0.2	24.7	6.0	4.1	1.1	6.4	0.3	7.3	6.5	5.4	2.1	7.0	6.2	3.1	4.3	1.6	0.0	3.0	8.6	5.0	7.2	0.3	0.1	7.8	6.5	2.6	2.7	5.3	0.3	6.4	6.3	2.4	6.1	3.3	7.5	13.2	8.5	3.7	0.1	16.2	8.0	16.2	0.5	15.7	4.7	3.0	7.1	6.1	6.2	0.3	25.3	33.3	48.7	22.0	10.2	7.6	39.9	26.0	11.7	30.3	21.8	38.3	14.5	28.7	10.2	14.1	11.6	33.6	35.4	16.7	18.8	13.3	41.2	45.4	45.7	15.2	1.9	37.2	24.9	5.5	6.0	31.8	10.5	8.1	10.8	35.1	53.4	15.7	14.9	33.3	61.8	46.8	36.9	9.3	18.5	48.0	27.6	13.0	6.9	40.8	40.6	22.0	30.0	22.7	4.7	23.4	35.0	19.1	9.9	26.5	24.7	20.6	25.9	20.3	14.5	44.8	14.7	26.3	19.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	4.1	1.1	1.6	0.0	0.3	0.1	0.3	0.1	0.5	0.3	3.2	0.0	6.7	7.5	4.0	5.7	3.8	3.0	4.0	8.7	7.8	6.7	6.9	1.5	1.6	1.8	0.0	8.8	5.6	18.8	0.0	2.3	8.2	3.2	3.8	4.9	7.2	14.9	13.6	3.3	10.8	5.1	11.2	6.8	2.5	16.2	8.9	10.5	13.2	0.0	7.6	9.1	2.0	6.9	5.4	9.7	6.8	2.9	5.4	4.7	1.6	2.6	2.1	3.5	2.9	2.6	6.0	3.4	6.3	4.0	4.1	1.0	1.9	6.1	26.3	7.0	6.1	46.6	18.2	5.8	7.7	4.0	5.8	2.9	10.9	2.8
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 21.0;Spermatogonia: 24.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	0.9	0.9	0.5	5.1	0.3	18.2	3.0	0.5	0.6	2.1	0.0	3.8	2.5	2.5	0.7	3.7	1.0	0.9	0.6	0.2	0.2	0.7	3.1	1.2	5.1	0.2	0.4	1.0	0.8	0.7	0.5	3.0	0.2	1.4	4.5	3.0	1.0	0.7	0.5	3.5	3.6	2.3	0.3	1.5	2.1	4.1	0.2	5.5	0.9	0.9	6.2	1.4	1.9	0.6	37.2	18.6	34.3	16.3	1.7	9.9	18.2	20.4	10.4	31.9	36.7	19.3	27.5	23.6	11.6	11.6	17.5	22.3	35.3	12.8	36.9	27.4	19.6	35.4	20.6	23.9	0.8	41.2	14.6	2.8	0.8	18.5	2.9	4.1	19.0	30.5	30.9	14.3	31.6	32.7	43.6	28.4	20.2	30.9	42.6	35.9	31.7	21.0	11.6	20.6	24.8	14.3	20.5	11.9	6.7	16.5	24.5	15.8	6.7	5.3	38.5	21.4	16.9	10.7	22.7	52.7	9.8	30.1	20.9	0.0	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.0	0.2	0.0	0.9	0.0	0.2	0.7	0.1	0.5	0.3	0.5	0.6	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	2.0	3.2	0.5	4.2	2.4	4.8	2.1	1.9	2.2	0.8	1.5	1.1	1.2	1.5	1.3	0.0	0.0	9.1	1.0	2.2	0.0	1.3	1.2	0.8	2.6	1.5	1.2	21.0	9.5	1.5	10.6	2.7	1.1	1.5	0.0	4.3	5.0	5.5	5.5	0.0	11.9	2.8	0.0	1.9	1.6	0.8	1.5	1.1	1.8	7.5	1.0	2.0	4.1	12.1	11.5	0.8	0.5	3.0	5.7	1.9	1.1	1.2	0.9	3.1	0.0	2.1	7.4	5.3	24.4	6.0	3.7	3.4	1.7	1.8	4.7	1.5
POLE3	"CHARAC17, CHRAC17, CHRAC2, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410675	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA047945: AB_2680218"	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	25.4	32.9	20.3	34.9	20.9	113.5	31.7	24.7	24.2	25.8	17.3	29.6	25.4	25.2	26.0	39.7	28.2	18.0	26.4	21.2	19.7	23.6	38.1	23.7	53.6	21.9	19.6	22.6	27.4	26.7	11.2	26.6	21.5	23.0	32.8	16.4	27.2	22.8	79.1	37.3	26.3	27.8	20.8	33.0	24.9	41.1	19.8	55.1	21.8	56.4	56.7	28.5	24.8	21.5	85.0	103.3	71.2	107.6	39.8	35.3	62.5	110.3	56.0	122.1	95.6	96.5	75.0	305.5	66.9	65.0	74.5	141.4	140.3	121.4	112.0	58.8	84.7	158.9	97.7	99.5	42.4	333.5	92.2	40.5	82.2	106.3	135.5	44.3	86.0	152.7	225.7	165.6	85.9	215.1	230.6	178.4	92.1	180.7	184.8	232.4	296.3	171.8	53.4	79.8	153.8	88.7	160.2	100.0	89.4	43.0	149.7	148.1	71.3	90.0	122.3	115.2	191.2	86.0	301.5	407.4	82.2	193.5	110.1	77.4	85.4	90.4	83.8	87.0	104.2	86.3	78.9	79.8	83.3	82.4	84.8	79.3	17.5	77.4	71.6	83.6	102.0	135.2	20.3	20.9	24.7	24.2	21.2	19.7	21.9	19.6	21.5	20.8	19.8	21.5	37.2	38.5	30.2	2.0	61.4	93.8	30.8	37.0	66.0	15.0	51.9	49.9	43.6	21.5	35.8	31.3	6.2	60.7	73.9	28.9	43.0	35.7	5.1	45.4	53.7	33.9	24.6	101.6	4.7	45.4	62.5	37.6	22.4	44.1	57.5	41.4	25.7	43.1	49.3	13.5	3.9	36.9	28.5	36.5	66.4	16.4	35.8	44.7	40.9	1.9	60.3	29.9	48.4	3.5	3.6	37.6	13.9	42.5	67.8	36.0	18.3	34.4	35.5	18.3	13.1	47.9	45.7	40.2	93.1	87.6	94.9	34.9	65.5	36.3	42.5	22.6
POLE4	p12	ENSG00000115350	"DNA polymerase epsilon 4, accessory subunit"	Q9NR33	2	74958643-74970128	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 110.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054979, HPA071815"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 47: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA054979: AB_2682661, HPA071815: AB_2686453"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.64e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	19.7	17.1	16.0	5.4	16.1	23.3	19.9	14.5	25.3	14.7	13.9	16.4	5.9	12.0	2.7	11.4	11.9	7.7	15.0	15.8	14.9	14.5	15.2	12.1	12.5	15.4	15.2	13.6	8.6	3.0	3.1	6.5	15.8	10.7	6.0	7.1	12.2	6.7	29.0	10.5	13.2	7.3	15.1	12.1	14.6	6.8	15.5	5.3	10.3	16.9	7.3	15.0	12.0	17.2	37.4	33.5	3.3	3.3	11.2	23.4	0.0	24.3	29.1	36.6	30.7	43.1	16.2	33.3	19.9	26.6	10.1	16.0	15.6	19.5	39.6	15.5	42.2	28.0	20.3	46.7	38.8	40.4	41.5	23.8	37.0	15.3	33.3	12.6	16.1	4.8	33.9	21.2	28.1	35.6	12.0	110.1	24.2	23.0	59.1	14.1	28.8	29.4	30.3	1.0	10.8	15.9	33.5	13.9	19.1	1.9	10.4	13.6	18.4	8.7	9.6	6.0	24.7	7.3	5.0	12.8	31.2	58.8	43.4	7.0	53.6	19.1	13.3	32.7	14.5	35.2	19.2	16.1	29.7	33.3	20.5	14.7	3.5	10.6	30.2	33.8	20.4	31.8	16.0	16.1	14.5	25.3	15.8	14.9	15.4	15.2	15.8	15.1	15.5	17.2	156.9	25.6	40.4	3.9	83.9	84.5	96.6	82.4	62.0	33.9	89.9	80.4	40.3	48.6	52.6	73.5	43.8	156.3	69.5	116.4	148.7	53.6	12.1	37.3	34.2	96.0	12.2	50.9	6.2	80.7	154.7	66.4	30.5	33.4	61.6	53.9	94.2	147.1	115.6	18.5	6.6	100.8	44.7	113.7	111.5	24.0	67.1	91.9	97.8	9.4	134.1	174.9	87.6	4.0	11.1	83.5	157.5	54.5	55.8	100.3	190.7	182.3	49.2	126.8	78.9	99.4	68.8	45.9	91.5	57.8	97.7	94.0	70.3	108.1	88.3	95.4
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576185-43620523	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	5.0	3.8	2.3	6.9	2.7	4.2	4.8	5.1	2.9	5.9	5.3	7.0	4.6	4.2	3.6	5.5	5.5	4.3	3.7	2.2	2.2	4.7	5.6	5.7	12.9	2.7	2.2	4.7	5.4	3.7	3.2	4.0	2.7	4.7	7.2	7.4	4.0	3.8	8.5	8.5	4.4	6.3	1.8	5.6	4.6	10.6	2.5	12.9	6.8	4.7	14.2	4.8	4.3	3.6	46.7	9.7	13.5	19.9	17.6	29.1	33.0	48.6	13.9	26.2	29.2	12.0	7.9	48.9	12.0	17.6	7.6	11.4	13.1	28.6	31.5	25.9	10.0	15.3	31.6	35.5	13.4	26.8	19.2	19.5	33.4	21.5	11.3	10.6	24.3	14.5	24.0	29.6	33.0	15.0	23.9	6.4	4.2	33.2	7.2	25.1	14.3	11.8	9.9	34.6	15.1	5.4	14.5	12.9	7.3	15.4	17.9	10.8	36.2	23.6	24.4	12.2	25.2	28.0	21.3	91.1	11.8	14.5	27.3	4.1	1.7	2.7	4.2	1.6	3.8	5.0	3.5	3.1	1.3	4.9	2.8	3.0	1.7	4.2	1.6	2.6	4.6	2.0	2.3	2.7	5.1	2.9	2.2	2.2	2.7	2.2	2.7	1.8	2.5	3.6	3.1	12.8	8.2	12.1	15.1	4.7	3.2	4.8	19.4	6.3	3.4	3.3	2.3	5.7	6.5	3.7	10.4	2.4	5.2	6.3	5.9	2.1	11.4	10.2	4.8	2.8	5.4	5.7	14.8	0.9	2.8	5.3	8.2	9.0	0.0	6.1	1.4	2.4	1.7	0.0	15.3	2.2	4.1	2.2	2.2	7.3	3.4	3.0	1.8	6.5	3.2	2.6	2.1	10.1	13.4	1.9	4.5	3.0	12.7	2.2	3.1	2.3	5.4	9.4	0.0	7.0	5.0	25.9	6.7	13.0	3.0	1.9	8.8	5.6	3.0	2.3
POLK	"DINB1, DINP, POLQ"	ENSG00000122008	"DNA polymerase kappa"	Q9UBT6	5	75511756-75601144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 236.8;Oligodendrocytes: 159.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012035, HPA057303, HPA068117, HPA069375"			Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131"	"unprognostic (9.66e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.02e-1)"	4.7	4.3	2.3	3.7	5.0	2.7	5.4	7.0	4.5	6.8	1.9	3.2	2.4	6.3	4.6	3.4	4.0	3.7	4.6	3.1	5.4	4.7	4.9	4.9	4.0	5.6	4.2	6.0	4.3	5.5	3.2	6.3	5.7	4.3	3.1	5.2	4.2	3.9	4.6	4.1	3.1	4.1	3.6	5.6	3.7	3.1	4.7	3.9	7.6	3.3	3.6	3.2	3.9	10.5	6.7	6.7	4.1	5.3	5.3	10.5	3.5	12.5	8.8	9.5	9.8	4.3	5.2	6.9	10.0	8.3	6.2	2.5	3.8	4.3	11.4	7.6	4.5	6.3	5.7	2.1	10.1	4.0	4.9	5.0	5.1	7.7	5.3	7.6	8.0	4.4	5.6	3.9	9.1	0.5	7.9	3.2	1.5	0.7	3.9	3.3	10.6	4.8	5.7	2.2	4.1	4.6	9.4	2.5	3.4	2.8	3.7	3.8	10.4	6.9	3.6	3.3	7.2	4.5	4.4	6.0	4.6	6.2	12.2	5.8	5.3	2.7	2.4	6.0	2.0	5.1	2.6	3.0	4.8	4.1	3.2	2.2	4.6	3.9	11.5	5.8	3.4	2.0	2.3	5.0	7.0	4.5	3.1	5.4	5.6	4.2	5.7	3.6	4.7	10.5	45.8	32.1	44.6	65.6	36.3	14.7	21.8	22.1	20.5	32.9	19.5	15.0	21.8	24.3	26.1	29.5	20.9	17.3	37.5	8.3	23.5	20.3	236.8	19.5	32.1	34.4	14.9	29.2	63.5	15.8	13.0	33.7	17.3	21.0	51.9	33.8	57.1	25.0	21.8	65.6	60.0	11.3	24.4	39.2	25.0	58.7	37.6	33.3	23.2	73.1	55.8	19.6	25.7	84.4	159.6	19.1	15.1	38.4	26.4	14.6	17.8	21.2	20.8	38.8	6.6	38.5	27.8	61.3	23.6	14.5	12.9	6.7	27.6	48.8	12.2	11.6
POLL		ENSG00000166169	"DNA polymerase lambda"	Q9UGP5	10	101578882-101588270	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076828			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA076828: "	"unprognostic (3.71e-3)"	"unprognostic (6.93e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.64e-3)"	17.4	22.4	17.3	12.4	18.0	12.8	19.6	15.9	19.0	21.1	18.2	21.8	16.8	19.4	22.6	18.1	22.1	15.6	19.9	17.5	16.0	24.8	26.9	15.6	17.0	16.3	16.3	26.3	45.6	21.3	28.5	13.7	17.2	26.0	17.1	17.4	20.8	15.4	34.4	16.1	18.7	14.2	14.1	22.7	27.6	41.4	17.1	7.4	26.1	18.2	17.1	20.9	17.7	17.4	23.5	21.0	16.2	23.0	16.2	30.0	22.7	15.3	26.4	22.9	23.9	15.5	27.8	5.7	23.5	13.9	12.6	28.8	18.4	22.6	18.4	20.8	24.8	18.1	23.1	17.7	29.8	19.0	16.2	27.5	30.3	25.0	51.8	64.1	24.7	11.1	20.4	19.2	14.7	18.8	0.0	20.8	8.6	13.0	12.4	0.1	14.6	9.9	19.2	14.1	11.2	16.6	9.4	15.7	26.5	23.8	47.3	11.0	13.5	8.1	16.4	9.8	16.8	28.4	15.3	8.9	17.5	16.6	6.3	0.6	9.2	1.3	6.5	6.6	10.6	8.4	7.4	6.8	11.6	6.8	11.7	8.0	1.0	9.5	6.7	0.2	10.2	7.6	17.3	18.0	15.9	19.0	17.5	16.0	16.3	16.3	17.2	14.1	17.1	17.4	7.5	6.4	12.9	13.7	11.4	3.7	6.7	9.7	7.4	16.9	14.7	19.0	8.6	11.5	7.4	7.3	47.9	16.9	7.5	9.1	5.9	9.6	25.2	7.3	7.5	7.6	13.1	25.9	10.4	21.5	9.8	9.6	20.9	6.6	14.0	20.9	8.6	10.9	11.2	21.9	7.9	13.6	18.3	17.7	6.0	51.6	14.0	9.6	10.6	2.8	18.0	10.1	13.4	8.5	9.9	13.7	9.2	11.3	10.9	6.5	13.7	11.6	7.2	24.0	13.1	10.8	9.6	35.5	11.0	8.4	2.0	11.5	9.4	14.4	15.6	5.6
POLM	Tdt-N	ENSG00000122678	"DNA polymerase mu"	Q9NP87	7	44072062-44082530	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 63.0"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 63.0"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058900, HPA066007"			Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA058900: AB_2683848, HPA066007: AB_2685595"	"unprognostic (2.44e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-3)"	8.0	5.9	4.0	4.4	4.0	4.5	7.8	4.4	4.1	8.8	4.0	6.6	5.6	6.1	3.7	8.4	6.4	4.4	7.5	3.5	3.7	10.2	9.7	5.9	7.6	4.4	5.2	8.9	8.5	4.4	6.0	2.8	4.5	8.4	3.4	4.3	7.5	6.7	7.9	8.9	9.0	3.5	3.9	13.1	9.1	3.8	5.1	9.8	10.5	4.9	7.2	7.6	7.8	4.0	1.8	2.5	2.6	5.8	3.6	4.2	7.5	6.1	6.2	4.5	2.5	3.2	4.2	18.1	5.6	4.7	5.5	5.3	2.7	67.0	2.6	6.3	6.0	2.3	2.8	1.1	4.8	5.8	7.7	6.1	6.0	3.7	4.4	8.6	8.1	18.5	2.7	9.2	3.8	4.1	10.5	4.7	5.4	5.5	14.2	9.6	1.6	7.3	4.7	2.9	2.7	4.8	2.9	11.3	5.6	4.0	6.7	10.2	5.7	3.1	4.4	3.2	8.6	14.1	7.5	13.9	5.6	5.2	6.9	23.9	3.5	10.7	6.3	4.3	6.5	7.9	5.5	5.6	3.3	11.1	7.9	6.3	63.0	7.4	3.3	9.5	5.8	2.9	4.0	4.0	4.4	4.1	3.5	3.7	4.4	5.2	4.5	3.9	5.1	4.0	8.3	3.2	7.8	13.1	33.4	4.5	11.2	8.3	11.4	24.5	10.3	6.2	5.6	15.7	11.4	12.9	29.2	12.3	19.9	11.1	1.9	7.6	0.6	5.0	7.1	8.7	5.4	3.0	4.0	9.4	9.4	7.1	27.5	6.0	24.1	11.1	12.5	9.2	10.2	18.5	4.3	8.5	10.2	11.1	5.0	0.7	14.0	9.9	10.6	6.5	14.4	11.9	23.7	3.5	5.7	8.3	22.5	10.1	15.6	16.6	19.4	5.6	7.4	48.3	0.0	6.9	9.0	17.5	14.3	6.5	5.1	9.7	18.8	13.5	12.1	15.0
POLN		ENSG00000130997	"DNA polymerase nu"	Q7Z5Q5	4	2071918-2242121	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.4;testis: 2.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.3;Excitatory neurons: 77.7;Inhibitory neurons: 42.7;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 26.8;Spermatocytes: 23.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"ASC diff: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035939, HPA035940"			Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA035939: AB_2674875, HPA035940: AB_2674876"	"unprognostic (8.52e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	2.4	0.6	0.3	0.0	0.4	0.0	1.0	0.2	0.5	0.3	0.0	0.3	0.1	0.3	0.7	0.1	0.4	0.3	0.3	0.3	0.0	0.4	0.4	0.2	0.2	0.0	0.0	0.2	0.4	0.1	0.4	0.1	0.0	0.6	0.0	0.2	0.5	0.2	0.4	0.3	0.3	0.1	0.0	0.3	0.3	2.6	0.1	0.1	0.3	0.1	0.1	0.2	0.2	0.4	0.0	0.6	0.0	0.3	1.7	0.5	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.2	0.7	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	0.0	32.3	1.0	0.9	1.0	0.6	0.6	4.2	3.0	1.5	3.6	1.5	1.7	0.0	0.0	0.2	0.6	0.2	3.9	0.4	8.3	4.2	2.0	1.9	4.8	0.8	77.7	1.0	0.3	2.0	1.5	2.1	0.0	5.5	3.3	1.1	0.7	3.3	42.7	0.0	2.0	1.3	1.0	14.1	4.4	1.3	0.0	15.0	0.7	2.5	1.0	22.1	26.8	0.5	1.1	3.8	1.5	1.0	0.3	0.8	1.9	3.8	0.0	2.9	1.1	23.4	10.4	0.5	1.6	0.0	1.8	4.1	0.3	1.3
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 16.4;Excitatory neurons: 9.5;Granulosa cells: 12.6;Inhibitory neurons: 7.8;Plasma cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 2.5"	HPA053359			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.1	0.2	0.0	1.6	0.1	6.0	0.4	1.0	0.2	0.2	0.0	1.2	1.2	0.2	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	2.0	0.0	0.3	0.0	0.0	1.4	0.9	0.4	0.0	0.8	0.5	2.2	0.0	4.5	0.0	0.0	2.3	0.3	0.5	0.0	18.2	12.1	10.2	7.2	0.9	1.2	9.2	8.5	3.2	9.7	12.9	9.8	6.6	21.5	3.7	4.6	11.7	14.0	12.2	5.4	16.4	6.3	6.7	13.8	8.0	6.1	0.1	15.1	12.1	0.2	0.4	8.9	5.4	1.7	4.9	7.9	9.3	15.9	10.3	7.1	13.7	8.8	9.7	5.5	5.9	11.4	12.2	7.6	3.1	10.3	5.5	5.0	9.8	5.2	3.4	8.8	4.8	14.8	3.8	8.6	11.2	3.4	11.1	8.0	6.9	21.8	4.1	11.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	1.6	0.7	0.9	0.5	0.6	0.0	0.9	0.6	0.6	1.6	0.0	2.0	0.0	0.0	3.1	0.6	1.6	0.0	0.1	0.4	0.9	1.0	0.5	0.0	16.4	9.5	0.0	3.3	1.2	4.6	1.0	0.0	12.6	0.0	0.2	2.3	0.0	7.8	1.6	2.0	1.3	1.2	0.7	0.3	1.7	0.0	1.0	0.6	0.4	0.0	1.5	1.3	0.2	1.2	0.0	12.2	0.5	0.2	0.1	2.4	0.2	0.0	0.1	1.0	6.8	3.4	4.9	0.1	0.3	1.8	0.9	3.2	0.8
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	5.4	5.7	3.7	5.8	4.0	4.9	4.5	3.1	4.7	4.9	4.0	4.9	4.1	8.2	3.0	6.0	5.2	2.9	5.8	3.9	3.6	4.6	5.0	4.0	4.6	3.4	3.6	5.2	5.2	7.1	4.9	5.0	3.3	4.5	5.0	3.5	3.9	5.1	10.8	5.5	3.8	6.9	2.7	3.8	4.5	6.2	4.4	6.2	4.5	7.4	4.9	5.2	4.2	4.3	18.5	41.1	18.0	34.7	17.2	13.7	25.9	16.6	10.9	23.2	14.4	51.9	14.2	41.9	17.2	17.0	22.7	20.9	46.6	24.4	20.6	17.6	24.0	36.2	18.0	35.1	12.1	34.8	18.7	10.5	15.0	34.6	26.7	8.8	18.2	19.0	48.8	10.3	16.2	16.4	25.8	15.1	32.7	24.4	26.8	30.7	39.5	19.6	10.5	29.7	27.7	14.6	18.3	23.8	12.7	12.3	14.0	12.0	29.3	28.0	22.2	24.3	33.8	14.5	15.3	35.7	14.6	29.3	25.3	0.5	0.4	0.0	0.7	0.6	0.9	0.5	0.3	0.6	0.4	0.6	0.3	0.4	0.1	0.5	0.5	0.7	0.1	0.4	3.7	4.0	3.1	4.7	3.9	3.6	3.4	3.6	3.3	2.7	4.4	4.3	4.9	3.2	9.1	13.4	8.8	4.2	4.9	5.3	12.0	12.4	6.2	5.5	11.1	8.6	4.7	9.2	16.7	6.3	7.2	5.1	3.9	6.0	3.0	5.4	13.8	6.5	9.6	10.9	19.7	4.9	5.4	7.7	8.2	6.9	6.3	11.0	4.2	8.3	12.5	11.8	18.1	6.7	2.0	3.1	3.5	1.7	6.2	5.5	5.4	6.5	3.3	4.2	6.2	20.1	18.2	6.6	3.0	5.3	10.1	9.1	3.5	3.4	5.2	9.7	0.0	14.3	6.2	5.0	7.2	13.4	2.7	3.8	7.5	12.4	10.4	4.0
POLR1C	"AC40, RPA39, RPA40, RPA5, RPAC1, RPC40"	ENSG00000171453	"RNA polymerase I and III subunit C"	O15160	6	43509702-43562419	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 306.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031010			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA031010: AB_10603131"	"unprognostic (2.84e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (1.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	15.5	19.2	16.0	12.3	16.0	7.7	20.3	15.7	20.9	15.3	19.8	18.4	13.1	15.1	15.7	21.3	21.0	9.5	13.3	16.0	16.4	17.6	17.7	11.0	13.9	15.9	15.9	14.4	15.5	17.1	13.8	12.2	16.2	14.4	15.5	6.6	15.8	12.0	15.3	20.5	10.9	14.8	16.0	12.7	14.6	20.1	16.3	12.5	16.1	13.4	20.8	23.4	15.5	17.1	76.0	61.7	26.6	72.3	40.0	43.0	42.1	45.3	33.5	49.7	42.2	82.5	25.2	85.2	48.3	44.2	42.5	45.2	64.7	57.6	57.6	45.4	67.7	58.3	57.2	115.7	50.1	90.0	39.1	38.7	54.8	67.9	85.4	29.4	39.6	35.4	136.9	24.5	44.0	106.4	47.4	65.0	49.2	306.8	52.9	31.9	41.8	57.6	60.7	104.1	49.0	32.8	39.6	34.1	62.2	19.4	36.9	77.9	47.6	35.3	48.1	38.4	72.3	35.1	85.0	146.0	24.1	60.9	40.0	5.7	30.0	4.6	34.1	24.0	46.5	51.1	40.4	34.1	42.4	55.0	55.1	49.6	2.7	41.7	20.5	38.6	32.7	34.0	16.0	16.0	15.7	20.9	16.0	16.4	15.9	15.9	16.2	16.0	16.3	17.1	13.0	12.8	17.7	9.8	24.9	61.8	50.6	34.3	42.1	8.2	24.0	23.6	5.2	17.2	30.4	5.5	6.2	29.7	15.3	11.3	15.6	26.7	13.5	23.4	15.9	18.6	13.1	12.8	13.6	24.4	18.9	21.5	25.0	14.2	14.0	14.4	15.7	11.9	13.3	5.0	12.3	17.4	28.5	5.2	17.0	8.3	11.5	8.5	21.4	11.2	8.3	7.1	14.4	14.1	10.2	21.0	11.5	11.7	13.1	29.2	5.0	27.5	48.5	15.4	6.6	29.1	45.6	34.4	43.3	26.4	40.9	13.5	17.4	21.5	19.9	37.0
POLR1D	"AC19, MGC9850, RPA16, RPA9, RPAC2, RPO1-3"	ENSG00000186184	"RNA polymerase I and III subunit D"	"P0DPB5, P0DPB6"	13	27620742-27744237	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 819.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039337	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Golgi apparatus"		"HPA039337: AB_10672961"	"unprognostic (1.33e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	72.1	124.8	56.0	57.4	58.5	150.8	90.6	77.5	75.5	102.5	67.2	98.7	86.2	67.5	78.1	142.3	75.7	55.8	90.7	58.4	57.3	84.4	81.2	76.5	90.8	53.4	54.7	118.7	267.3	54.2	69.3	62.3	54.9	88.6	87.4	58.5	112.5	65.7	119.9	143.4	86.6	66.4	52.7	75.6	132.9	76.0	55.3	117.5	62.2	85.0	87.3	91.7	111.7	56.3	103.2	94.8	106.8	110.5	121.6	213.4	143.4	99.2	171.2	129.2	127.7	155.0	203.9	331.3	73.2	113.9	215.7	155.4	200.4	319.8	152.3	102.5	119.0	236.0	97.4	262.9	181.4	215.7	178.0	195.5	330.2	106.0	194.6	143.9	180.9	187.9	132.3	56.6	126.8	106.7	213.2	257.7	259.1	320.2	100.4	144.0	182.6	151.1	204.7	157.2	182.2	142.3	67.3	132.0	381.4	133.9	81.3	198.6	124.9	56.5	90.1	97.9	110.3	92.2	113.1	188.4	49.5	152.3	112.9	80.0	115.9	56.3	71.0	124.4	94.5	83.9	114.9	91.8	130.9	83.8	121.8	98.4	42.0	88.8	113.5	95.9	179.0	83.8	56.0	58.5	77.5	75.5	58.4	57.3	53.4	54.7	54.9	52.7	55.3	56.3	122.5	89.8	108.8	13.7	147.4	336.6	303.0	247.7	385.3	56.6	171.4	241.4	73.5	118.7	123.8	29.5	16.7	155.0	133.9	104.5	74.3	137.2	464.1	100.9	98.4	111.8	124.4	182.4	30.0	309.2	273.2	100.5	126.4	106.3	95.7	125.8	112.5	81.2	165.7	45.4	22.2	203.5	65.1	205.2	148.2	819.5	116.5	142.5	80.0	19.7	260.9	56.5	151.4	13.6	22.3	232.1	124.6	79.0	105.9	256.2	210.1	152.1	58.5	44.0	78.9	105.2	164.4	268.0	81.9	307.8	317.0	145.8	148.5	179.8	197.2	345.7
POLR1E	"FLJ13390, FLJ13970, PAF53, PRAF1, RPA49"	ENSG00000137054	"RNA polymerase I subunit E"	Q9GZS1	9	37485948-37503697	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022527, HPA052400"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA022527: AB_1854924, HPA052400: AB_2681815"	"prognostic favorable (2.27e-4)"	"unprognostic (2.09e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.24e-2)"	20.8	15.3	9.4	14.6	9.7	13.1	24.0	9.7	9.0	22.7	7.0	17.9	8.5	24.3	14.8	13.9	20.0	12.6	18.4	8.8	10.6	8.4	29.7	11.9	19.3	9.0	9.5	42.4	27.9	11.5	9.4	8.3	9.4	14.0	10.9	8.9	18.0	17.4	19.1	15.7	10.9	22.5	10.2	10.9	15.0	9.1	9.6	17.0	13.7	10.5	21.6	17.9	17.0	10.4	58.5	53.7	29.0	46.2	53.2	67.8	18.9	50.6	19.5	51.2	45.0	46.4	18.9	84.1	23.8	58.5	34.9	23.8	71.5	60.0	64.2	81.9	33.6	40.4	68.0	33.3	39.7	78.2	27.5	72.7	20.9	100.4	85.7	32.2	26.5	46.0	107.5	36.0	45.6	28.0	54.5	26.8	51.7	39.7	43.5	47.8	26.7	40.5	26.7	21.4	41.3	33.9	33.7	26.7	43.8	23.8	26.0	51.4	18.3	60.3	91.9	52.3	102.2	19.5	29.6	87.7	20.8	48.8	51.2	0.0	3.5	2.2	14.2	6.0	22.7	10.1	13.5	14.5	5.6	11.5	16.6	14.7	1.1	13.1	5.2	3.9	8.0	7.5	9.4	9.7	9.7	9.0	8.8	10.6	9.0	9.5	9.4	10.2	9.6	10.4	7.2	0.0	8.4	1.6	20.4	28.3	23.7	10.9	21.1	7.0	13.2	15.2	8.6	14.3	7.4	0.0	4.2	15.6	20.0	4.3	7.9	13.8	5.6	5.4	20.1	7.1	1.8	15.4	1.8	21.6	21.4	16.1	8.6	6.7	8.8	14.0	3.9	18.7	7.4	3.3	2.4	7.7	6.1	10.3	8.0	10.7	14.9	8.1	5.4	3.7	9.2	9.2	12.3	1.5	2.1	14.1	3.0	15.1	28.3	23.6	3.1	5.9	4.1	6.9	0.0	22.1	15.9	20.6	23.5	14.0	17.8	8.3	23.7	31.9	11.9	12.7
POLR1F	"A43, RPA43, TWISTNB"	ENSG00000105849	"RNA polymerase I subunit F"	Q3B726	7	19695461-19709037	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 21.6;Cardiomyocytes: 23.1;Cytotrophoblasts: 40.3;dendritic cells: 24.9;Extravillous trophoblasts: 34.1;Hofbauer cells: 34.7;Macrophages: 16.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019071, HPA022416"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA019071: AB_1858465, HPA022416: AB_1858466"	"unprognostic (5.66e-3)"	"unprognostic (3.43e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.02e-2)"	"unprognostic (4.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.96e-1)"	8.6	7.9	5.8	8.0	6.4	17.2	10.2	6.1	9.2	8.9	5.6	7.3	5.6	11.9	5.1	9.5	6.6	6.2	7.8	6.2	6.8	8.0	8.7	6.3	10.5	6.1	6.8	8.8	7.5	9.1	2.7	10.8	6.1	9.7	7.0	3.2	6.1	8.9	7.1	7.6	5.3	11.8	6.6	7.8	5.8	6.2	6.5	8.6	8.7	8.3	12.9	12.2	4.6	7.6	28.0	20.9	15.1	22.6	17.1	21.1	11.7	15.7	11.8	17.9	20.7	17.2	23.9	31.0	44.6	19.6	22.7	24.6	30.9	29.2	33.3	9.9	23.7	28.8	15.9	13.3	26.2	59.4	20.0	19.2	20.3	19.7	23.4	12.1	29.7	21.3	45.0	27.2	26.1	10.1	32.9	55.3	39.3	28.9	23.4	26.3	26.0	32.6	29.7	14.2	10.9	16.4	14.3	38.3	20.0	24.6	15.5	52.5	25.0	37.0	19.8	34.5	38.4	34.4	22.8	77.5	25.0	86.9	55.5	5.7	4.5	1.4	7.9	6.0	12.0	12.5	9.4	10.5	7.0	13.0	10.7	12.6	0.4	17.4	5.9	9.0	9.3	5.8	5.8	6.4	6.1	9.2	6.2	6.8	6.1	6.8	6.1	6.6	6.5	7.6	21.6	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	40.3	24.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	34.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	16.6	3.0	0.0	0.0	0.0
POLR1G	"A34.5, ASE-1, CAST, CD3EAP, PAF49, RPA34"	ENSG00000117877	"RNA polymerase I subunit G"	O15446	19	45406644-45410737	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 15.8;Extravillous trophoblasts: 26.3;Hofbauer cells: 11.5;Syncytiotrophoblasts: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.5"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 14.5"	"Cell line enhanced"	"Detected in all"		"U-251 MG: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041664, HPA041734"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA041664: AB_10795693, HPA041734: AB_10794489"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (4.79e-9)"	"unprognostic (1.62e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-9)"	"unprognostic (1.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.53e-2)"	3.2	2.4	2.9	3.3	3.0	2.1	3.1	4.1	4.3	2.4	1.1	2.5	2.4	2.7	1.4	4.3	3.0	2.8	3.5	2.9	2.4	2.7	2.6	2.0	3.5	3.4	2.6	3.5	3.8	2.9	1.9	2.2	3.6	2.2	2.1	2.7	2.8	1.9	6.7	4.4	1.9	3.0	1.1	2.1	1.8	1.8	3.4	2.1	2.3	4.5	4.0	4.1	2.4	3.8	31.4	29.0	5.3	20.6	7.5	6.5	20.3	15.3	5.2	26.2	15.1	32.5	21.5	48.3	14.8	11.3	20.6	29.5	46.4	43.0	18.4	22.1	28.7	24.3	11.0	23.9	12.8	25.3	8.9	9.4	27.3	38.2	20.7	7.0	19.2	16.0	63.0	8.9	25.6	37.0	18.7	9.3	37.0	34.6	27.3	25.1	19.5	32.2	10.5	22.7	30.8	9.6	30.9	40.6	6.4	10.6	19.9	15.4	18.2	36.5	36.7	20.4	200.5	16.1	74.0	51.6	16.8	37.6	25.9	1.5	2.7	0.3	1.4	3.5	3.1	2.7	2.0	2.2	4.2	3.0	2.9	3.5	1.3	3.3	2.8	14.5	1.3	2.0	2.9	3.0	4.1	4.3	2.9	2.4	3.4	2.6	3.6	1.1	3.4	3.8	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	15.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	26.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0
POLR2A	"POLR2, POLRA, RPB1"	ENSG00000181222	"RNA polymerase II subunit A"		17	7484366-7514616	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 2.4;lymphoid tissue: 1.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012226, CAB016388, HPA021563, HPA053012"			Enhanced	Nucleoplasm,Cytosol		NA	Yes			"Cluster 27: Non-specific - Gene expression"		"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB012226: AB_304749, CAB016388: AB_677353, HPA021563: AB_1855526, HPA053012: AB_2682017"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.43e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.70e-2)"	0.1	0.7	0.4	1.6	0.2	0.2	0.1	0.3	1.9	0.0	0.8	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.1	0.7	0.4	0.1	0.0	0.2	0.2	2.4	0.7	0.1	0.0	0.1		0.2	1.1	0.2	0.2	0.3	0.0	0.0	0.5	0.1	0.4	0.0	0.4	0.2	0.0	0.7	1.1	0.2	0.0	0.1	0.0	0.0		1.6	1.0	1.7	0.5	1.5	0.4	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.4	0.0	0.6	1.0	2.1	0.0	0.0	0.3	0.0	0.5	0.0	0.9	0.0	1.6	2.9	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	1.0	0.4	2.1	0.0	0.0	2.5	2.3	1.0	0.0	2.7	3.5	2.8	1.2	0.8	0.0	0.0	0.8	1.6	0.0	1.0	0.5	1.1	2.0	0.4	0.2	1.6	1.1	0.8	1.0	0.0	2.2	0.8	2.0	0.9	2.5	1.1	0.3	0.8	2.2	0.5	1.3	1.0	0.0	2.0	4.2	0.0	3.2	10.1	0.4	0.2	0.3	1.9	0.7	0.4	2.4	0.7	1.1	0.4	1.1	1.6	124.2	22.4	41.6	13.4	68.0	42.8	40.7	33.8	64.3	90.4	56.5	187.1	26.9	38.6	30.3	23.9	110.5	35.9	153.5	55.0	3.9	27.0	25.0	74.9	64.4	57.7	76.7	43.3	18.1	30.2	28.7	53.3	103.0	67.3	42.5	46.0	40.4	29.9	45.4	55.5	14.9	43.9	26.4	42.1	38.3	7.4	37.0	65.7	37.4	19.7	38.2	27.3	26.8	17.6	17.8	32.0	35.9	41.8	62.0	27.9	42.5	13.2	38.4	90.5	6.6	94.4	53.9	58.5	120.2	73.8	41.2	53.8	89.2	49.8	32.6	30.8
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031158	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	28.2	29.1	11.8	38.3	14.0	34.1	34.1	21.0	17.6	32.9	16.9	34.7	32.6	34.9	26.5	30.0	32.9	30.2	48.1	14.2	16.0	35.7	30.0	27.7	49.9	14.1	11.8	31.6	28.3	50.3	17.8	32.9	15.4	32.5	36.3	36.8	30.6	32.4	64.7	28.0	30.9	38.3	12.8	36.5	31.1	39.8	12.8	61.2	37.6	56.7	51.3	42.4	19.8	17.6	78.9	64.3	110.5	98.2	89.3	80.3	61.2	94.6	101.3	98.3	91.1	82.9	80.1	126.5	86.1	94.3	71.4	52.2	140.5	77.2	139.8	54.2	66.3	96.9	70.0	71.5	102.2	156.0	100.6	86.8	76.1	114.3	68.5	81.0	119.5	95.0	145.4	100.0	115.9	56.8	142.3	60.5	92.0	101.5	77.9	105.9	75.7	68.4	66.8	90.7	95.3	106.8	67.5	120.3	89.6	90.7	65.8	88.3	91.2	74.4	95.2	75.8	132.2	77.3	75.5	172.8	82.4	83.1	92.4	51.9	17.0	22.8	27.7	17.0	29.5	27.9	26.6	28.8	22.2	18.9	25.9	30.8	14.4	26.5	19.8	17.6	30.9	19.8	11.8	14.0	21.0	17.6	14.2	16.0	14.1	11.8	15.4	12.8	12.8	17.6	39.5	28.9	52.0	26.8	61.5	41.3	60.9	60.3	39.9	45.5	31.5	26.5	35.7	35.8	56.3	36.8	43.8	49.2	77.1	36.9	19.6	60.9	5.9	53.4	52.7	39.5	29.9	50.5	31.1	55.0	30.7	42.8	59.1	45.8	58.2	36.8	30.7	30.8	29.1	45.4	32.0	36.9	50.8	45.8	36.8	8.8	57.5	42.5	44.4	33.7	74.3	26.7	115.4	23.6	40.4	54.0	36.2	38.0	50.5	59.4	36.6	32.7	80.6	49.0	72.3	46.5	45.7	74.0	63.6	32.7	39.9	41.0	75.2	46.2	35.4	74.6
POLR2C	RPB3	ENSG00000102978	"RNA polymerase II subunit C"	P19387	16	57462660-57472009	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040919, HPA041826"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA040919: AB_10795483, HPA041826: AB_10793935"	"unprognostic (2.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.03e-6)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.43e-3)"	35.1	41.6	49.9	30.4	51.2	43.9	39.6	52.3	60.3	36.8	49.4	36.0	33.1	39.2	67.1	31.2	47.0	31.3	52.1	51.0	52.0	59.8	62.3	47.7	38.7	50.5	51.0	54.3	45.1	55.1	46.9	39.5	51.8	40.4	40.0	59.3	39.0	45.9	74.2	34.5	31.8	40.6	52.4	30.8	36.4	25.4	50.4	47.7	40.8	61.4	44.9	39.1	31.2	54.5	59.3	94.0	81.2	72.7	72.7	62.9	67.6	75.4	84.9	126.0	82.3	121.7	74.7	65.8	86.4	89.3	75.6	60.5	111.9	83.5	134.2	30.2	77.0	51.1	53.5	142.0	81.8	95.0	94.4	57.8	66.4	96.7	88.7	66.6	74.8	90.0	90.2	37.3	81.6	78.6	106.9	98.6	118.4	72.1	138.0	151.4	94.4	120.5	99.7	56.7	102.5	117.4	122.9	69.8	81.4	74.0	51.6	85.2	54.4	76.3	76.3	56.8	89.0	82.2	76.2	135.0	75.3	79.5	102.5	79.8	38.3	70.3	44.6	37.8	49.2	52.4	50.6	42.8	38.1	48.4	60.4	57.4	96.9	64.6	49.5	31.2	54.9	60.5	49.9	51.2	52.3	60.3	51.0	52.0	50.5	51.0	51.8	52.4	50.4	54.5	49.5	25.6	43.0	11.1	49.2	31.0	46.0	51.3	30.1	81.6	39.4	52.5	11.0	41.5	31.9	27.6	56.3	78.8	49.8	38.2	92.0	62.9	5.6	25.0	25.4	39.0	38.2	35.6	13.3	65.8	80.8	40.5	15.8	22.3	61.0	46.1	23.2	25.1	41.2	52.2	13.9	34.5	48.8	22.9	30.3	8.4	51.6	22.7	40.9	8.4	49.1	102.7	58.7	8.0	9.6	59.5	44.6	51.9	40.0	43.9	63.8	120.4	29.4	93.9	46.0	30.0	49.1	50.4	66.4	30.0	30.0	92.9	52.9	49.0	38.4	43.5
POLR2D	RPB4	ENSG00000144231	"RNA polymerase II subunit D"	O15514	2	127843553-127858155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 170.2;Spermatocytes: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034694, HPA046092"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"		"HPA034694: AB_2674284, HPA046092: AB_10963049"	"unprognostic (3.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (2.51e-1)"	"unprognostic (7.95e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.66e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.38e-1)"	12.3	10.4	7.2	14.4	9.8	32.4	11.9	9.6	8.3	9.4	7.3	12.0	9.7	10.3	8.0	12.3	10.6	8.4	10.0	7.5	8.7	8.8	19.2	10.2	19.7	8.0	8.9	15.0	14.7	10.4	8.3	15.9	8.3	9.5	14.7	8.1	8.4	9.2	29.3	11.3	9.3	15.0	8.4	12.8	9.4	74.3	8.1	28.3	9.1	27.1	26.9	15.3	8.4	11.0	63.4	40.6	73.9	51.9	26.8	29.2	59.0	59.1	27.9	69.6	61.9	92.0	50.9	97.7	49.6	40.0	39.8	32.7	107.0	51.2	107.3	57.7	58.3	96.6	37.9	85.4	31.4	104.9	51.6	20.8	37.8	93.3	53.2	19.3	46.1	70.4	137.1	84.8	40.4	50.1	105.0	47.5	103.6	65.9	46.4	99.3	77.8	88.0	23.1	42.6	45.7	60.9	39.9	48.9	50.7	54.7	54.6	71.4	47.0	60.1	84.4	34.4	69.0	99.4	173.4	173.0	52.4	51.2	60.5	9.9	22.8	17.3	26.3	31.7	25.0	22.8	21.0	23.2	29.9	20.2	27.6	23.7	7.3	25.8	35.0	19.5	20.6	21.3	7.2	9.8	9.6	8.3	7.5	8.7	8.0	8.9	8.3	8.4	8.1	11.0	10.9	3.2	11.7	2.6	22.0	10.8	22.0	7.6	15.9	15.1	9.8	6.2	10.4	11.5	10.1	12.9	8.4	33.0	23.4	7.6	11.7	20.3	70.8	13.2	16.1	12.5	8.4	31.1	4.7	17.5	31.0	15.2	9.7	10.4	18.4	23.1	11.4	17.0	21.7	33.7	5.2	11.9	8.2	11.1	14.1	170.2	17.7	13.3	8.8	2.8	23.4	13.2	16.5	2.5	7.5	18.4	8.4	18.4	46.6	26.2	10.2	11.1	6.8	13.7	13.1	18.5	15.5	86.1	48.9	19.3	10.1	26.7	17.1	31.5	14.0	18.9
POLR2E	"hRPB25, hsRPB5, RPABC1, RPB5, XAP4"	ENSG00000099817	"RNA polymerase II, I and III subunit E"	P19388	19	1086574-1095380	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Host-virus interaction, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063030, HPA068992"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA063030: AB_2684926, HPA068992: AB_2686065"	"unprognostic (2.52e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (3.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.77e-2)"	30.8	16.7	25.5	16.3	22.9	15.4	18.1	23.0	28.9	13.0	16.0	18.7	13.7	12.8	14.4	22.8	17.3	7.9	14.6	25.9	23.5	23.6	41.1	17.0	18.6	28.1	24.7	14.0	13.2	20.3	12.2	10.3	28.6	12.5	19.5	17.5	14.8	12.1	16.4	16.2	17.0	16.7	23.4	19.3	15.9	13.0	26.6	13.8	17.0	22.6	26.6	14.0	11.2	24.1	33.6	30.8	41.6	33.4	55.6	34.5	19.5	24.2	34.1	39.5	23.1	36.1	11.9	27.5	10.7	72.1	6.1	26.5	79.1	26.9	73.1	29.2	23.9	36.3	36.2	33.9	22.3	54.3	26.4	25.5	17.5	27.7	51.0	40.6	36.7	14.7	42.3	31.0	44.3	27.6	30.0	17.1	33.6	23.9	23.1	31.9	40.7	27.0	39.5	38.3	21.0	23.9	40.2	27.8	17.5	37.2	29.5	24.7	49.9	19.6	21.7	36.0	28.4	47.6	70.9	50.9	32.3	34.6	23.2	24.2	50.2	29.5	25.5	33.7	26.5	18.2	23.2	26.0	44.3	19.6	18.5	18.4	25.2	28.7	38.7	31.2	24.5	38.4	25.5	22.9	23.0	28.9	25.9	23.5	28.1	24.7	28.6	23.4	26.6	24.1	67.7	32.1	63.0	8.1	80.1	104.3	83.9	152.1	59.7	55.7	80.9	82.9	78.2	60.1	79.9	55.2	41.7	234.3	67.4	103.1	174.1	156.7	21.0	64.0	64.4	77.8	70.6	77.4	13.0	141.1	264.1	95.1	66.3	57.2	71.0	74.9	68.9	96.6	259.7	55.5	13.9	91.8	107.8	93.6	221.7	37.8	69.3	103.7	99.6	6.5	361.7	78.1	103.0	4.5	10.6	162.5	84.6	62.1	93.8	111.7	163.1	188.4	72.3	48.9	26.3	50.5	96.9	125.4	82.5	104.1	109.7	234.6	73.4	110.6	130.5	106.9
POLR2F	"HRBP14.4, RPB6"	ENSG00000100142	"RNA polymerase II, I and III subunit F"	P61218	22	37952607-38041915	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	4	"melanoma: 1.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000827, CAB009882"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB009882: AB_2299942, HPA000827: AB_1079834"	"unprognostic (8.27e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.11e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.86e-2)"	52.5	61.1	73.4	34.6	92.3	38.9	50.8	77.5	90.2	59.5	56.9	64.9	37.7	53.2	24.8	58.7	50.2	19.5	91.8	74.2	91.2	58.2	118.6	41.6	31.0	87.9	83.9	60.9	47.5	76.5	62.7	30.2	82.6	47.7	28.7	16.8	56.1	39.6	111.0	45.8	42.3	28.8	75.3	36.4	57.6	48.8	86.8	36.7	54.7	68.4	26.3	53.1	52.7	123.7	150.7	176.2	120.6	128.7	141.1	81.7	109.4	138.0	81.0	141.4	130.5	210.0	51.8	117.4	99.1	120.3	138.3	106.4	166.9	135.7	67.1	143.0	303.7	107.3	181.3	289.1	125.9	213.6	67.0	112.4	99.8	186.3	72.1	71.2	118.7	130.4	208.9	93.7	101.9	220.2	168.4	258.2	174.3	175.4	134.7	162.3	110.4	134.5	77.4	94.8	180.6	67.2	129.5	88.9	215.3	69.6	62.9	144.3	110.5	119.8	173.9	150.4	158.1	106.0	178.0	247.9	122.4	107.9	138.4	118.9	92.9	140.8	83.8	90.4	78.5	95.8	71.9	81.8	86.3	71.3	63.1	63.7	122.8	113.7	78.5	123.3	103.4	85.3	73.4	92.3	77.5	90.2	74.2	91.2	87.9	83.9	82.6	75.3	86.8	123.7	82.6	38.5	85.9	9.4	73.2	204.3	113.9	205.4	63.7	26.7	133.8	168.7	0.3	101.5	122.5	121.4	25.0	243.5	70.5	148.7	193.7	160.0	117.0	96.0	117.2	94.8	117.2	109.6	9.9	159.5	303.4	97.4	58.1	82.4	90.0	90.0	98.6	304.4	178.5	28.6	10.7	143.1	116.0	94.2	102.9	42.0	159.7	65.9	225.9	2.8	102.3	99.4	111.2	9.5	99.0	182.4	152.9	151.2	65.7	137.3	196.6	306.5	114.3	33.3	157.8	90.1	197.1	237.0	241.0	106.0	224.3	211.9	82.4	82.7	145.7	121.2
POLR2G	"hRPB19, hsRPB7, RPB7"	ENSG00000168002	"RNA polymerase II subunit G"	P62487	11	62761565-62766710	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053000	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA053000: AB_2682010"	"unprognostic (7.58e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (6.02e-5)"	"unprognostic (8.50e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.21e-1)"	63.1	69.5	75.5	48.3	79.7	70.6	75.3	82.0	101.1	54.8	72.3	53.9	37.3	52.5	85.8	59.2	64.3	41.5	53.5	75.1	80.7	67.7	67.9	49.1	89.1	85.0	76.6	54.6	41.1	57.9	41.1	60.7	84.5	55.2	66.1	76.0	41.9	51.8	45.4	60.9	44.1	66.2	83.8	62.7	49.9	32.6	79.2	112.2	53.6	47.3	106.2	53.1	50.1	90.1	124.4	212.7	225.1	142.9	114.0	111.7	56.7	85.7	107.8	199.8	159.9	129.3	141.4	173.9	192.5	129.8	86.2	118.9	103.6	159.8	176.4	342.3	129.7	116.6	157.2	156.5	159.6	159.7	103.2	108.8	161.2	93.0	185.9	105.6	157.9	160.5	148.5	115.4	143.4	389.4	230.6	209.4	142.3	130.7	218.2	185.6	207.0	234.8	150.8	103.8	95.7	162.1	143.8	112.8	226.2	84.6	318.6	132.6	62.7	101.7	109.0	199.1	101.0	89.0	177.6	192.8	103.7	99.8	139.1	169.9	147.5	164.1	127.2	160.7	124.2	150.4	109.0	126.0	174.9	146.7	103.5	129.6	64.0	154.6	175.3	184.5	151.0	230.5	75.5	79.7	82.0	101.1	75.1	80.7	85.0	76.6	84.5	83.8	79.2	90.1	50.9	38.5	60.7	3.3	69.1	44.9	46.6	209.0	43.3	43.5	47.0	56.3	46.4	55.8	102.3	77.3	8.4	222.1	79.3	27.5	140.8	120.3	7.4	51.3	66.4	73.3	58.6	59.3	1.9	111.3	138.4	69.5	30.5	61.2	90.0	69.6	73.5	73.8	191.6	38.7	2.2	55.1	148.5	74.5	80.7	14.9	70.8	86.4	88.9	2.8	149.2	147.2	118.4	2.5	8.5	93.1	48.3	62.1	39.3	35.1	44.1	150.4	58.0	55.9	78.9	51.8	65.7	36.4	38.9	62.9	60.4	139.0	79.7	91.7	77.6	41.4
POLR2H	RPB8	ENSG00000163882	"RNA polymerase II, I and III subunit H"	P52434	3	184361718-184368596	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037745, HPA055813"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA037745: AB_10672914, HPA055813: AB_2797254"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.61e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.82e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.02e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-3)"	41.6	60.6	50.4	32.5	51.0	31.1	42.2	53.5	60.1	48.8	51.8	54.4	57.6	36.3	39.7	52.1	39.8	30.0	34.8	50.7	49.9	77.5	63.8	37.6	41.1	50.8	50.6	40.2	52.1	35.5	32.9	34.9	50.9	42.9	57.8	14.6	44.2	26.3	37.3	37.8	55.5	35.0	49.8	41.9	51.2	32.3	51.3	39.8	48.3	30.0	40.8	43.4	41.5	52.9	225.2	77.3	81.7	121.4	89.0	62.8	101.2	82.8	86.3	110.8	141.6	199.6	104.6	126.0	201.7	65.0	168.4	88.8	147.4	148.7	98.1	124.4	194.7	121.4	89.8	126.2	80.1	129.3	67.9	81.6	83.3	72.6	129.8	99.4	116.3	124.6	95.3	81.0	89.0	265.6	128.7	172.3	89.0	279.0	159.3	74.3	74.9	171.2	133.9	100.3	122.8	87.3	69.7	214.0	126.9	78.6	267.9	102.4	61.5	52.5	82.9	70.9	224.3	161.7	181.3	237.3	83.4	136.2	71.5	8.3	17.6	15.9	26.8	30.7	32.9	32.9	31.6	29.1	34.0	33.9	45.8	34.8	1.3	29.8	19.2	34.7	36.7	21.6	50.4	51.0	53.5	60.1	50.7	49.9	50.8	50.6	50.9	49.8	51.3	52.9	45.1	38.5	43.8	23.8	39.4	113.4	74.1	113.7	61.5	22.0	70.1	77.0	17.4	47.1	70.2	44.1	16.7	103.2	45.8	132.8	140.8	73.0	21.0	62.3	62.3	57.9	55.7	53.8	12.9	91.2	146.0	52.8	53.5	83.7	31.1	50.4	43.2	58.5	61.4	25.2	15.8	80.2	93.6	21.4	57.5	14.3	46.0	29.9	51.6	9.4	29.0	26.7	32.0	8.5	11.5	97.6	90.9	27.8	52.1	139.7	94.5	150.5	55.1	24.9	39.5	48.0	69.6	92.9	111.0	66.0	74.2	122.3	38.0	71.6	83.1	92.5
POLR2I	"hRPB14.5, RPB9"	ENSG00000105258	"RNA polymerase II subunit I"	P36954	19	36113709-36115213	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1145.8;Late spermatids: 2796.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035632, HPA045156"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035632: AB_2674711, HPA045156: AB_10964748"	"unprognostic (1.95e-2)"	"unprognostic (7.88e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	32.6	41.0	97.6	23.3	104.3	44.4	34.8	104.2	118.6	30.6	85.8	35.0	28.9	28.4	39.7	40.2	55.7	27.2	78.9	94.6	100.8	32.9	40.2	25.5	31.5	98.5	98.6	50.0	83.9	61.3	26.1	21.8	101.0	30.2	20.2	25.9	66.9	35.9	195.2	41.5	29.9	21.7	98.5	29.7	31.5	66.8	97.4	30.4	37.2	119.7	24.2	28.3	15.7	120.6	96.7	364.7	61.9	103.8	38.5	44.6	67.7	35.5	47.5	80.5	67.5	179.0	62.0	61.6	80.4	38.2	46.8	49.6	60.4	82.5	42.1	107.8	115.5	59.1	88.8	180.9	70.0	88.7	53.1	47.5	71.4	51.7	75.1	51.1	52.8	112.2	66.6	117.1	48.5	292.1	124.6	111.0	74.5	201.6	151.7	130.4	51.6	114.0	94.0	121.3	145.0	74.0	60.1	172.5	59.5	53.7	81.3	92.7	35.7	88.6	91.6	60.3	128.2	83.2	88.4	99.6	102.3	88.0	94.7	130.7	109.5	128.4	113.9	115.2	130.6	168.7	148.3	134.1	90.2	134.8	150.4	117.2	72.5	111.0	113.0	223.8	176.5	114.0	97.6	104.3	104.2	118.6	94.6	100.8	98.5	98.6	101.0	98.5	97.4	120.6	108.2	83.3	66.3	2.9	62.9	79.0	94.9	156.4	75.1	63.1	203.5	279.4	253.5	133.0	124.7	163.7	25.0	144.5	76.3	141.5	352.1	178.2	1145.8	380.4	114.9	101.6	106.2	199.9	2.9	240.5	166.2	96.9	71.4	126.0	82.4	150.0	111.0	282.5	124.3	33.7	3.2	163.3	126.1	72.9	63.8	2796.6	139.1	68.7	168.9	0.0	122.5	183.2	77.2	1.5	7.9	196.8	196.8	154.2	88.5	127.9	221.4	528.2	386.6	73.6	111.7	111.1	125.1	378.2	183.1	155.9	109.0	103.8	68.1	133.7	167.7	90.1
POLR2J	"hRPB14, POLR2J1, RPB11, RPB11A, RPB11m"	ENSG00000005075	"RNA polymerase II subunit J"	P52435	7	102473118-102478907	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA046970			Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA046970: AB_2679882"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	54.8	87.0	85.3	36.5	87.4	90.0	51.7	88.2	108.0	48.3	83.2	59.1	46.4	48.1	54.7	60.0	46.5	32.7	125.8	85.3	89.6	71.2	99.4	43.3	46.1	89.2	87.2	59.3	58.6	62.9	66.4	32.5	87.4	59.7	33.9	17.8	58.6	38.2	195.7	56.5	51.1	28.3	88.3	59.1	63.6	43.6	90.2	53.2	56.0	127.7	40.1	51.1	48.1	88.4	143.4	143.0	96.2	127.5	89.2	68.5	70.4	77.4	82.3	111.2	94.2	131.1	108.4	65.7	145.9	108.7	160.2	74.8	89.8	95.6	67.8	123.3	160.4	65.9	101.2	129.1	108.9	128.5	94.6	89.6	117.4	100.1	55.8	72.5	100.8	138.3	156.8	190.0	92.5	439.6	212.9	228.5	89.5	141.4	182.2	100.1	94.4	194.0	91.2	93.6	81.4	135.6	93.5	176.1	113.9	97.3	79.1	155.3	82.3	125.0	160.0	198.4	154.5	116.5	183.6	171.0	111.3	157.8	149.1	180.3	116.5	199.5	90.5	122.5	86.2	137.6	96.0	101.0	93.8	122.9	81.4	81.8	174.6	84.7	115.5	127.5	140.8	128.9	85.3	87.4	88.2	108.0	85.3	89.6	89.2	87.2	87.4	88.3	90.2	88.4	87.9	35.3	46.7	17.9	91.1	95.0	113.5	190.7	79.1	37.0	149.6	195.2	193.2	81.5	107.4	125.0	12.5	197.7	93.0	241.7	273.9	139.0	53.1	84.1	64.4	86.8	103.0	128.2	5.6	199.6	195.5	94.4	78.0	73.2	43.7	90.7	86.0	203.5	202.5	35.3	6.2	164.0	146.5	111.0	107.6	43.2	127.1	99.5	142.3	4.7	154.0	171.3	127.7	8.5	10.8	191.8	281.6	110.6	111.4	128.9	236.3	242.0	107.0	46.7	52.6	76.9	113.2	117.1	229.3	114.3	116.1	182.1	91.4	114.5	131.2	153.9
POLR2J2	RPB11b1	ENSG00000228049	"RNA polymerase II subunit J2"	Q9GZM3	7	102665368-102671629	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.3"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 20.0;RT4: 14.0;U-2 OS: 13.6"									HPA046970			Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA046970: AB_2679882"																		1.7	1.9	0.5	3.8	0.7	2.2	2.5	0.8	5.3	2.2	0.3	2.4	3.1	1.8	2.3	3.1	1.7	2.7	1.8	0.7	0.0	2.9	2.6	2.6	3.1	0.6	0.2	2.3	3.0	3.3	2.4	1.2	1.1	2.4	1.8	4.1	2.3	1.1	4.7	3.8	4.5	0.6	0.0	4.7	2.5	1.4	1.0	1.2	3.1	1.0	4.3	1.9	2.6	1.3	2.7	2.2	1.6	1.9	3.5	5.0	3.1	3.0	0.7	1.7	1.8	1.8	5.4	2.8	0.5	2.0	1.0	2.5	1.1	0.8	4.8	2.0	3.1	1.5	4.0	1.1	1.7	6.5	2.8	0.9	0.5	1.3	2.6	0.8	0.7	1.7	2.9	6.9	1.3	1.0	20.0	2.0	1.2	0.9	0.6	2.5	0.5	2.5	1.1	14.0	1.5	1.8	2.5	1.4	1.2	2.4	0.8	1.0	1.1	3.9	13.6	0.6	2.3	3.1	2.4	2.4	1.8	2.8	1.4	11.0	2.8	2.2	3.9	1.6	2.6	4.1	4.0	2.9	1.3	5.2	4.3	3.3	2.2	2.2	2.5	4.3	2.6	1.0	0.5	0.7	0.8	5.3	0.7	0.0	0.6	0.2	1.1	0.0	1.0	1.3	2.0	6.4	2.6	8.1	4.6	1.7	4.0	1.6	0.6	6.9	2.1	1.5	0.0	5.7	1.1	9.2	10.4	6.9	8.8	2.2	5.9	4.4	0.1	1.2	2.4	3.8	3.6	5.7	15.9	0.8	4.2	2.5	4.6	1.3	1.3	5.6	6.4	2.2	3.6	5.0	12.9	2.7	4.1	5.9	1.5	0.4	9.0	3.6	0.0	6.5	7.5	2.4	15.5	9.5	10.0	1.6	1.2	3.4	2.9	2.3	8.5	4.0	2.5	11.9	0.0	5.4	3.1	8.2	11.9	0.5	1.3	7.8	4.8	5.4	2.0	3.4
POLR2J3		ENSG00000168255	"RNA polymerase II subunit J3"		7	102537918-102572653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 87.4;Extravillous trophoblasts: 65.6;Hofbauer cells: 42.5;Syncytiotrophoblasts: 110.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.5"									"HPA011403, HPA046970"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA011403: AB_2668503, HPA046970: AB_2679882"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.55e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-2)"	2.4	2.3	1.0	1.7	1.1	2.1	1.7	1.5	3.1	3.9	0.9	2.2	2.9	3.2	0.4	1.9	3.6	0.6	1.4	1.0	1.3	2.0	2.5	1.9	1.2	1.2	1.1	3.2	1.6	1.5	2.0	1.5	1.2	2.3	1.8	0.7	3.3	0.5	1.0	3.8	3.0	1.6	1.1	3.2	2.2	0.9	1.3	1.4	3.1	2.7	2.9	2.3	1.8	1.2	10.3	4.8	1.9	0.1	0.2	0.8	0.9	6.0	1.7	3.8	4.3	3.8	2.8	1.4	0.4	0.0	5.5	4.8	3.1	2.4	4.1	25.5	5.5	2.9	3.8	1.2	1.1	3.7	2.5	0.4	2.1	1.9	1.9	7.4	6.0	2.4	3.2	2.0	0.6	8.0	8.9	0.5	0.0	3.6	6.0	0.4	3.3	2.4	0.9	1.3	2.0	0.4	10.9	1.0	5.5	2.3	0.0	1.7	4.9	3.4	9.1	0.0	1.5	0.3	0.8	4.6	5.9	2.9	3.9	9.6	4.1	6.5	2.2	1.7	1.3	3.5	2.2	3.2	4.6	3.9	2.7	2.7	9.4	3.9	3.1	3.1	3.3	3.0	1.0	1.1	1.5	3.1	1.0	1.3	1.2	1.1	1.2	1.1	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	65.6	7.2	0.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.0	0.0	0.0	0.0	0.0
POLR2J3		ENSG00000285437	"RNA polymerase II subunit J3"		7	102562133-102572583	"Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 243.5;Cone photoreceptor cells: 354.5;Rod photoreceptor cells: 343.4"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA046970			Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"		"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA046970: AB_2679882"																		9.7	16.7	21.2	16.0	18.9	37.8	11.5	28.4	74.7	2.1	15.3	26.2	15.8	18.2	22.0	14.0	3.5	8.0	3.4	21.3	24.8	18.4	19.8	8.0	15.9	26.0	21.1	11.5	7.2	17.7		8.6	18.5	8.6	14.7	44.3	5.2	8.1	84.7	15.6	14.3	4.0	11.2	16.6	12.8	12.2	22.3	34.6	8.1	40.6	11.9	12.9		25.6	49.6	6.2	67.8	60.6	3.3	13.7	26.1	68.1	2.6	14.4	4.2	22.9	37.9	22.2	32.4	11.9	35.0	31.0	8.9	16.7	44.1	2.9	10.5	52.2	90.5	69.1	9.4	89.4	49.4	15.1	19.6	7.7	5.7	38.7	19.8	40.9	46.4	128.3	6.2	25.0	126.1	38.9	20.6	62.5	1.9	58.7	60.9	64.4	19.4	62.0	32.5	48.6	53.6	53.1	53.2	76.1	20.7	50.0	21.3	89.9	40.8	79.2	56.0	57.5	93.7	143.0	49.7	60.0	55.4	41.9	24.9	36.9	20.6	22.4	18.8	29.4	27.0	23.8	22.2	25.3	23.1	22.5	24.9	20.9	33.1	33.7	27.9	22.6	21.2	18.9	28.4	74.7	21.3	24.8	26.0	21.1	18.5	11.2	22.3	25.6	2.6	6.4	2.6	49.0	58.0	12.2	97.8	32.5	21.6	243.5	4.0	1.3	15.9	105.8	19.9	7.3	354.5	0.0	63.3	55.3	1.9	0.4	8.3	2.2	2.4	43.1	58.4	65.0	43.4	0.4	0.0	23.6	46.9	1.9	13.4	0.3	137.0	43.9	0.0	178.4	40.4	44.1	26.4	85.9	19.0	11.2	90.7	24.6	24.9	30.0	58.9	53.0	178.2	29.1	35.6	0.9	46.5	51.6	25.7	69.3	79.3	3.5	16.6	343.4	26.3	97.3	33.9	84.4	111.1	22.3	14.8	0.0	59.1	0.4	42.5	105.0
POLR2L	"hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6"	ENSG00000177700	"RNA polymerase II, I and III subunit L"	P62875	11	837356-842529	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1813.6;Proximal tubular cells: 1989.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 569.0;PC-3: 706.8"	"Low region specificity"	"Detected in all"							HPA073614			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA073614: "	"unprognostic (2.65e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (5.56e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.73e-1)"	112.1	101.2	68.2	21.5	69.9	27.2	91.0	69.0	98.3	48.0	90.5	63.5	26.1	48.9	16.5	87.1	43.3	16.4	161.8	72.9	75.3	112.7	107.6	68.3	20.4	68.3	71.0	37.3	111.5	30.4	71.7	21.1	70.1	67.9	15.4	11.9	62.6	31.3	101.0	65.3	46.2	24.9	67.9	68.4	63.3	34.3	70.1	21.0	72.5	43.1	17.6	63.3	54.1	69.7	106.4	569.0	52.9	66.5	150.1	107.8	45.6	134.5	94.1	129.6	86.5	166.2	97.6	64.4	35.6	166.6	110.4	69.5	79.7	160.8	39.9	59.9	381.6	63.4	160.7	216.6	88.3	62.3	49.3	178.9	71.6	74.2	36.6	79.2	101.7	63.9	67.0	71.3	156.1	268.4	59.7	63.1	82.6	124.7	706.8	58.8	41.9	99.3	160.7	81.1	104.1	32.1	133.3	135.2	107.3	28.2	81.2	36.7	117.9	87.5	69.1	48.3	83.8	40.0	50.0	62.3	130.8	58.3	78.2	93.3	119.5	121.7	92.9	109.0	100.1	75.5	86.0	92.0	114.0	73.6	71.8	89.3	32.1	123.7	76.6	141.1	92.5	134.7	68.2	69.9	69.0	98.3	72.9	75.3	68.3	71.0	70.1	67.9	70.1	69.7	364.4	410.3	390.2	9.8	265.9	611.8	245.0	767.6	279.4	68.1	491.1	412.0	500.6	584.8	415.4	526.0	25.0	625.4	305.0	669.3	1287.4	444.0	84.2	388.4	377.2	400.3	501.7	363.4	5.0	684.1	467.7	392.3	283.4	301.7	266.2	194.4	649.6	1813.6	700.2	50.5	5.3	641.6	323.5	434.5	582.0	235.7	305.7	307.3	658.1	11.2	493.6	368.5	389.3	3.5	9.0	751.1	589.2	255.1	382.8	300.0	813.6	1989.1	329.9	82.5	157.8	195.2	340.8	182.6	268.6	459.8	696.6	449.6	286.1	284.9	553.1	289.7
POLR2M	"GCOM1, Gdown, Gdown1, GRINL1A"	ENSG00000255529	"RNA polymerase II subunit M"	"P0CAP2, Q6EEV4"	15	57706695-57782762	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068141			Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA068141: AB_2685962"	"unprognostic (3.07e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.80e-2)"	"unprognostic (7.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.07e-1)"	19.4	20.0	24.6	10.6	34.0	17.0	18.4	28.6	27.0	21.8	13.6	15.5	12.3	34.7	19.6	15.3	19.5	16.1	29.2	22.1	30.0	20.1	15.4	14.3	19.2	30.7	37.6	31.3	16.2	25.5	9.1	18.1	28.0	26.1	15.0	12.7	16.1	24.1	36.0	15.3	13.1	27.0	31.1	21.3	15.0	10.4	31.6	21.4	24.1	38.9	17.3	15.2	13.3	39.0	18.4	21.8	20.9	52.2	38.6	38.4	15.8	29.4	49.0	33.3	30.4	19.5	14.8	27.7	25.9	22.3	25.2	33.1	26.2	24.3	44.5	24.3	27.9	37.9	21.5	15.6	42.1	33.4	31.0	36.3	38.3	19.0	54.2	37.5	26.1	29.5	34.6	20.7	28.5	8.8	38.2	22.7	31.9	27.7	19.0	37.8	49.1	22.0	25.2	19.5	14.6	26.6	21.2	25.1	35.9	29.2	28.4	49.0	24.7	47.0	47.2	68.4	30.7	26.5	27.1	36.1	28.4	52.4	32.2	26.6	14.7	12.1	17.4	13.3	16.2	16.1	15.1	16.4	13.9	17.1	19.6	14.6	1.5	24.4	11.6	12.4	19.0	15.6	24.6	34.0	28.6	27.0	22.1	30.0	30.7	37.6	28.0	31.1	31.6	39.0	19.5	22.4	11.5	0.0	25.7	16.8	20.2	12.4	26.7	14.9	16.9	12.6	27.7	10.0	14.5	25.8	4.2	12.8	25.3	11.8	25.4	13.3	48.5	13.9	22.7	23.2	23.4	24.0	0.0	15.3	19.1	24.3	16.8	32.4	12.6	11.0	25.0	15.4	18.2	11.8	0.0	16.6	18.3	27.4	15.8	14.6	22.1	17.9	24.9	0.0	18.9	24.9	29.9	0.0	0.0	19.5	15.8	28.2	13.3	30.3	13.6	17.2	13.3	9.8	19.7	17.2	20.8	21.2	24.2	22.7	14.3	12.0	22.9	16.9	20.0	23.7
POLR3A	"C160, hRPC155, RPC1, RPC155"	ENSG00000148606	"RNA polymerase III subunit A"	O14802	10	77969251-78029515	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037926	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA037926: AB_10672400"	"unprognostic (6.83e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.64e-6)"	"unprognostic (3.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.11e-2)"	4.3	6.0	6.6	5.2	7.1	3.9	6.2	6.7	7.9	5.1	4.7	4.8	5.1	5.5	7.5	5.0	4.8	3.7	4.9	8.1	3.7	5.2	5.6	4.0	5.7	5.5	3.4	6.5	5.4	6.8	10.4	6.1	5.5	5.8	5.7	12.8	5.0	4.5	11.5	6.7	4.7	5.6	2.2	5.1	4.7	6.0	4.0	7.6	5.6	8.7	6.3	5.0	4.8	6.5	14.2	16.3	17.4	28.8	11.2	14.2	11.6	16.0	20.7	20.2	19.8	22.1	10.0	17.6	9.7	14.0	11.5	15.7	30.3	17.5	24.4	13.0	22.2	14.2	13.6	26.6	10.5	24.6	11.5	12.2	12.3	35.9	33.0	19.4	18.0	14.1	26.8	10.6	19.9	10.6	18.7	15.6	19.0	11.0	75.1	17.5	11.0	11.5	10.0	8.6	15.5	20.0	15.4	28.3	16.6	15.5	21.0	12.7	19.8	12.9	12.5	14.2	32.0	16.4	18.6	21.0	23.0	25.4	6.4	5.4	2.6	1.5	3.5	3.1	3.5	2.6	2.8	3.4	2.4	3.2	2.5	3.0	1.5	3.4	2.9	2.6	4.6	1.9	6.6	7.1	6.7	7.9	8.1	3.7	5.5	3.4	5.5	2.2	4.0	6.5	8.5	0.0	9.1	17.0	8.7	9.9	5.1	5.3	11.4	28.3	9.6	8.3	11.7	8.6	9.5	0.0	64.6	8.0	12.6	6.1	1.9	7.0	1.6	8.3	14.4	8.1	7.2	11.6	26.4	6.2	6.9	8.2	8.2	8.9	6.3	15.7	5.3	9.5	5.5	15.2	26.3	10.2	0.0	6.9	3.7	1.2	13.1	5.9	1.8	10.3	7.8	13.0	12.3	16.1	18.7	8.1	8.3	8.2	11.2	4.7	8.0	5.0	10.4	31.5	6.6	13.6	8.3	12.5	18.0	10.1	9.1	4.1	7.8	13.7	8.6	3.6
POLR3C	"C82, RPC3, RPC62"	ENSG00000186141	"RNA polymerase III subunit C"	Q9BUI4	1	145824088-145844402	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	16	"Early spermatids: 288.2;Late spermatids: 574.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027508, HPA027516"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA027508: AB_10600091, HPA027516: AB_10600894"	"unprognostic (1.43e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.34e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.38e-1)"	16.9	8.5	5.0	10.5	5.3	14.7	15.1	8.7	6.5	14.1	4.6	12.0	8.0	13.4	9.3	11.1	12.3	10.9	10.1	5.5	4.9	10.3	10.7	9.7	14.1	4.6	4.6	16.0	14.6	11.9	6.3	10.4	5.1	9.6	11.2	7.9	12.4	8.3	14.7	15.9	11.8	13.1	4.7	12.6	11.3	24.8	5.3	15.3	11.4	10.3	15.6	13.0	12.2	6.5	29.9	23.7	19.0	17.6	23.0	29.3	19.8	30.6	31.5	36.2	34.9	32.6	16.4	51.6	28.9	37.2	19.5	31.6	30.6	30.5	34.9	22.7	24.9	27.9	26.5	17.6	42.1	58.4	35.2	29.3	18.9	42.4	61.7	20.8	21.8	22.0	36.3	30.9	35.6	37.2	27.7	22.1	29.0	29.3	29.7	30.1	23.6	34.1	19.7	20.6	18.2	26.4	26.0	37.5	36.7	28.5	29.5	49.6	26.7	34.0	27.4	19.6	41.9	42.9	48.1	58.8	12.4	28.4	28.3	63.0	31.7	31.9	22.5	36.9	29.5	30.4	24.2	23.3	33.9	33.8	25.1	22.7	2.7	34.0	27.0	35.6	23.3	26.1	5.0	5.3	8.7	6.5	5.5	4.9	4.6	4.6	5.1	4.7	5.3	6.5	12.6	6.4	10.8	12.1	15.6	5.0	8.3	8.8	13.1	3.6	5.5	5.2	23.8	2.8	10.1	3.7	4.2	11.7	18.5	3.5	11.7	14.8	288.2	7.8	7.3	11.2	4.2	19.1	13.0	21.3	12.5	11.0	9.2	7.5	8.2	6.9	9.3	5.2	14.3	1.7	12.4	7.5	8.2	12.6	6.2	574.5	10.2	9.4	1.8	10.3	13.3	5.1	10.3	14.1	12.9	16.5	6.8	14.7	12.2	8.4	8.9	12.8	8.1	3.8	19.7	11.0	9.9	26.1	22.5	10.9	4.3	9.6	13.4	11.1	8.5	9.5
POLR3D	"BN51T, C53, RPC4, TSBN51"	ENSG00000168495	"RNA polymerase III subunit D"	P05423	8	22245133-22254601	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061331, HPA067875, HPA068461, HPA069089"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081"	"unprognostic (2.33e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.15e-6)"	"unprognostic (1.15e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.12e-4)"	15.0	11.9	3.4	4.4	3.3	6.5	10.6	3.0	3.9	14.1	3.8	11.3	2.5	10.4	3.3	15.2	11.3	4.1	14.1	3.0	3.6	11.7	10.0	11.1	4.7	3.7	3.6	14.9	17.5	4.0	13.7	6.6	3.6	12.8	4.5	4.0	10.6	3.8	32.8	11.2	8.6	5.8	3.5	11.4	10.6	19.3	3.9	3.4	10.6	8.3	4.3	15.1	14.4	4.3	5.1	10.7	11.0	7.8	10.0	16.6	11.3	18.9	9.1	10.7	8.7	10.5	3.6	27.8	10.2	12.5	8.9	9.1	16.9	9.2	11.0	6.9	9.4	20.7	10.5	11.2	13.6	5.0	9.5	13.8	12.9	13.4	21.8	13.1	8.9	14.9	28.9	9.5	8.7	7.2	22.2	10.4	18.9	13.0	9.0	14.7	12.2	18.0	6.1	6.0	7.8	24.2	8.5	5.9	17.7	11.9	5.4	8.0	13.0	9.4	9.1	18.8	11.4	17.0	22.7	18.9	9.2	10.1	14.0	0.1	1.4	0.3	1.8	1.1	2.5	2.4	2.3	2.6	1.6	2.2	3.0	1.9	0.1	2.9	1.6	3.5	1.8	1.3	3.4	3.3	3.0	3.9	3.0	3.6	3.7	3.6	3.6	3.5	3.9	4.3	15.0	9.6	6.5	4.6	15.8	19.5	43.6	21.2	13.6	12.8	15.2	14.5	10.9	4.3	13.3	11.0	16.7	16.2	18.5	6.9	11.7	20.2	42.7	11.6	37.7	15.6	21.5	10.3	2.4	11.8	33.2	21.3	12.8	14.8	18.4	18.7	11.7	3.8	13.7	3.3	2.8	19.1	12.2	8.8	8.2	40.5	15.8	8.6	8.8	1.0	13.4	4.5	14.4	2.5	3.5	22.5	6.7	12.8	20.5	52.3	6.7	12.6	11.2	12.2	19.7	22.1	21.3	44.2	52.0	12.1	19.2	27.0	15.0	25.1	12.3	41.8
POLR3E	"C37, FLJ10509, RPC5, SIN"	ENSG00000058600	"RNA polymerase III subunit E"	Q9NVU0	16	22297375-22335101	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041419, HPA041477"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041419: AB_2677468, HPA041477: AB_10796345"	"unprognostic (3.09e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.41e-2)"	12.2	17.0	2.8	6.6	4.5	7.8	12.0	4.3	3.7	10.7	16.1	12.9	6.3	12.7	2.4	13.0	11.8	4.5	15.4	4.1	4.4	8.4	13.3	10.2	5.3	4.8	5.5	11.3	16.1	10.7	12.8	4.6	4.5	11.3	3.0	3.1	12.2	8.2	62.6	14.8	10.0	4.9	3.7	8.9	14.2	11.2	4.2	8.5	12.8	15.5	5.7	12.0	10.4	5.3	21.1	29.0	6.9	19.5	12.1	9.7	27.5	16.1	6.1	9.4	4.2	36.3	14.8	41.7	21.8	11.1	7.9	18.7	35.6	20.6	7.6	28.7	52.3	21.0	31.8	70.9	15.1	34.4	23.0	8.7	19.5	22.1	25.8	3.5	25.9	17.1	63.1	17.0	10.9	34.5	33.6	11.8	37.5	20.2	22.8	45.0	16.7	54.2	8.0	12.4	28.9	20.6	15.6	29.2	14.0	4.2	17.2	16.3	17.3	11.0	12.4	9.2	18.3	23.6	45.6	40.3	11.1	23.0	21.1	0.0	4.7	2.8	8.6	4.8	9.1	7.4	9.1	8.7	7.7	6.0	8.4	7.3	0.5	7.4	4.5	4.4	10.0	6.9	2.8	4.5	4.3	3.7	4.1	4.4	4.8	5.5	4.5	3.7	4.2	5.3	9.4	3.2	14.7	14.4	20.3	32.5	23.0	10.9	12.5	24.0	16.4	19.7	18.9	11.5	13.4	18.4	31.3	25.2	27.3	8.9	5.9	12.0	34.9	21.0	13.3	13.3	15.0	10.5	12.8	12.8	20.2	14.1	13.7	28.5	27.9	23.1	8.9	11.1	13.1	20.2	16.3	13.7	10.2	10.1	22.2	20.9	12.5	11.0	14.2	11.2	9.7	10.4	21.6	18.6	17.9	15.0	11.7	9.1	26.0	28.5	13.6	11.8	16.6	40.9	13.1	21.0	12.2	19.7	16.1	16.5	39.6	28.3	30.3	20.5	16.2	26.3
POLR3F	"C34, RPC39, RPC6"	ENSG00000132664	"RNA polymerase III subunit F"	Q9H1D9	20	18467389-18484646	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049441, HPA050173, HPA072298"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA049441: AB_2680768, HPA050173: AB_2681042, HPA072298: AB_2686510"	"unprognostic (4.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (8.87e-9)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.98e-3)"	6.6	6.5	10.1	6.4	10.9	9.8	9.5	13.1	12.6	6.1	9.7	5.2	5.0	8.0	9.5	7.0	6.8	5.7	9.8	11.1	10.5	8.5	6.4	6.2	7.3	10.1	10.0	8.2	6.0	7.6	3.2	7.5	10.5	7.0	6.1	21.2	5.7	6.6	10.9	7.4	4.4	7.2	9.9	6.3	5.5	9.1	9.9	6.9	11.0	9.5	7.2	6.9	3.0	10.9	12.9	12.6	14.9	15.9	9.5	11.7	22.7	19.0	13.2	23.8	19.3	14.0	12.1	12.0	10.0	14.2	21.3	20.0	20.8	21.2	27.2	8.1	11.0	8.5	7.1	18.6	12.4	22.8	11.9	10.6	14.0	32.2	18.0	13.1	12.9	9.4	19.4	11.7	19.0	15.8	17.3	21.1	17.2	14.3	29.1	11.8	29.4	12.7	13.0	9.1	27.3	17.2	13.9	24.2	32.2	14.0	13.6	15.5	10.1	26.0	13.4	16.2	27.8	11.2	38.0	11.7	10.7	11.0	19.5	0.4	3.0	1.3	2.7	3.7	4.5	3.1	3.6	2.7	3.7	1.7	3.5	3.6	0.8	3.7	3.0	2.7	3.7	2.7	10.1	10.9	13.1	12.6	11.1	10.5	10.1	10.0	10.5	9.9	9.9	10.9	7.3	9.6	4.8	9.8	8.0	8.9	3.7	5.7	10.2	18.3	6.6	5.8	8.3	2.8	5.1	1.8	10.4	10.7	8.5	3.5	9.8	8.8	42.7	8.5	6.7	9.0	6.7	8.2	21.7	6.8	12.1	7.0	4.6	4.8	5.7	8.8	7.1	4.6	7.6	11.8	19.4	4.4	4.1	9.2	6.7	7.7	6.2	5.9	5.4	10.3	10.4	17.5	12.3	15.1	13.0	7.7	1.9	10.1	9.0	4.3	2.9	12.2	11.3	19.3	13.1	8.3	8.3	28.1	22.9	8.4	11.4	7.3	8.0	11.3	4.3	3.2
POLR3G	"C31, RPC32, RPC7"	ENSG00000113356	"RNA polymerase III subunit G"	O15318	5	90471748-90514557	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.8;Inhibitory neurons: 21.2;Oligodendrocytes: 70.8;Spermatogonia: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 84.5"									"CAB010109, HPA052658, HPA074330"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: "	"unprognostic (4.31e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.19e-6)"	"unprognostic (2.17e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.21e-14)"	"unprognostic (3.86e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.17e-5)"	1.8	0.6	3.5	2.4	4.5	3.0	2.0	6.3	5.9	1.3	0.7	1.6	1.8	1.5	4.7	4.3	1.2	1.3	1.8	3.6	6.0	0.9	2.2	1.6	4.7	5.7	4.4	1.9	2.4	2.0	0.9	1.8	6.8	1.7	1.5	3.3	2.3	0.5	3.0	4.3	1.4	0.8	1.9	1.8	1.2	4.5	4.2	0.8	3.2	0.8	1.9	2.0	1.7	6.3	24.1	13.0	18.8	5.3	5.9	8.2	7.7	11.9	4.3	19.8	16.8	9.0	18.8	63.7	4.2	5.3	20.0	11.6	20.8	23.2	69.2	29.6	19.6	26.2	8.1	15.1	9.5	19.4	6.2	6.7	8.1	32.7	25.8	4.6	27.2	26.5	35.8	6.4	8.3	13.2	19.1	14.1	78.1	4.0	63.2	16.5	7.4	40.2	5.9	3.2	22.0	6.4	3.7	9.6	35.1	7.7	5.4	6.2	29.1	10.3	21.2	13.2	48.3	13.5	36.7	50.0	22.1	23.7	84.5	3.3	0.2	0.2	1.5	0.4	0.7	1.7	0.5	0.9	0.4	0.9	1.1	1.2	0.7	2.9	1.5	1.0	0.2	0.3	3.5	4.5	6.3	5.9	3.6	6.0	5.7	4.4	6.8	1.9	4.2	6.3	3.2	6.4	2.2	11.8	2.8	3.6	1.6	1.5	1.8	3.0	2.8	3.7	5.2	0.0	0.7	1.8	8.4	0.8	0.7	0.9	3.9	2.4	4.5	1.6	2.3	2.0	6.7	8.8	24.8	4.4	5.4	3.8	0.5	1.2	7.0	1.6	4.6	2.6	1.7	3.3	21.2	1.4	0.0	0.3	0.3	1.0	0.3	1.2	1.8	5.6	0.0	1.1	1.0	14.6	70.8	4.1	3.0	1.2	5.4	6.1	0.4	1.5	3.0	0.8	0.0	1.1	1.8	7.2	26.6	6.3	8.5	0.8	1.7	6.5	2.0	0.8
POLR3H	"C25, KIAA1665, RPC8"	ENSG00000100413	"RNA polymerase III subunit H"	Q9Y535	22	41525799-41544606	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046787	Approved		Supported	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Centrosome"	"HPA046787: AB_2679806"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.43e-2)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.70e-1)"	16.6	21.0	40.4	8.5	38.9	5.4	15.1	38.0	49.5	11.0	33.3	13.4	4.8	14.0	9.0	16.4	15.8	7.9	18.3	39.5	38.6	13.5	26.7	14.2	10.0	41.1	41.7	18.5	12.2	11.9	18.2	6.5	38.1	15.4	5.2	7.0	11.5	10.7	13.8	12.1	9.7	11.7	40.1	10.9	13.4	16.2	41.3	8.0	14.1	9.0	7.7	14.2	9.8	39.4	36.4	23.8	21.4	32.7	23.0	20.9	14.8	30.5	27.3	49.0	39.3	47.9	12.0	30.8	21.9	49.9	27.8	17.8	39.8	48.1	30.6	26.3	50.1	18.4	37.1	23.7	23.9	75.3	30.8	26.3	30.8	64.9	17.4	18.8	23.5	29.3	39.5	19.9	28.0	34.4	19.3	20.1	15.6	49.8	28.1	30.0	16.9	32.6	22.9	21.7	21.2	12.5	37.0	39.7	19.3	13.7	15.6	21.1	22.7	29.8	30.7	49.8	39.8	16.7	28.6	46.6	49.5	26.8	28.9	0.1	12.5	0.2	8.8	18.3	12.6	16.6	8.7	10.4	14.2	13.9	11.6	9.7	0.6	5.4	18.6	13.3	5.8	9.9	40.4	38.9	38.0	49.5	39.5	38.6	41.1	41.7	38.1	40.1	41.3	39.4	6.1	0.0	32.0	15.7	14.8	17.7	12.0	19.0	13.6	18.8	24.9	23.4	6.4	14.3	19.8	16.5	16.7	32.9	7.9	5.0	46.9	30.4	42.6	12.7	15.4	10.3	14.3	19.1	10.0	29.6	30.9	14.8	13.3	8.9	11.4	13.1	9.7	33.3	30.5	21.9	7.1	4.8	14.2	9.5	11.0	163.9	16.8	10.2	24.9	1.9	19.6	24.1	18.6	2.0	6.7	27.6	6.6	20.3	21.8	16.8	4.1	40.7	12.7	20.9	0.0	17.9	16.8	51.6	50.9	21.2	25.6	17.9	10.3	21.2	9.5	11.8
POLR3K	"C11, RPC11"	ENSG00000161980	"RNA polymerase III subunit K"	Q9Y2Y1	16	46407-53608	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 183.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005891	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA005891: AB_1079653"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.03e-3)"	"unprognostic (9.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.63e-2)"	6.9	10.4	12.5	13.1	13.0	11.6	7.0	12.3	13.5	6.4	11.0	8.1	8.3	6.8	7.3	8.7	7.4	5.2	10.3	12.6	12.8	8.2	9.0	6.5	18.4	11.8	11.9	7.1	6.9	12.3	6.1	6.7	12.5	8.0	7.6	5.1	8.4	6.8	20.5	5.3	8.5	6.7	11.5	11.9	8.4	2.6	13.6	13.1	9.5	12.6	16.3	8.8	5.8	13.2	36.1	60.9	37.7	39.4	15.2	9.4	30.3	50.2	16.0	43.4	28.7	79.4	38.2	93.1	37.1	17.7	17.3	35.0	88.5	23.0	31.0	56.5	82.1	68.2	44.5	56.6	11.6	62.1	64.3	9.2	20.4	48.3	24.3	9.9	21.7	40.9	99.0	29.0	28.4	89.9	75.1	41.2	62.3	44.8	57.4	89.9	43.7	96.7	25.0	25.7	55.1	32.5	34.7	63.2	30.8	15.9	37.2	55.2	20.9	28.1	34.5	37.8	61.6	18.5	47.5	183.8	12.1	45.1	42.5	30.5	36.3	93.2	40.4	54.7	42.1	114.6	51.3	46.5	34.4	109.9	45.8	42.6	27.7	41.2	51.8	70.2	87.6	53.1	12.5	13.0	12.3	13.5	12.6	12.8	11.8	11.9	12.5	11.5	13.6	13.2	23.3	3.2	11.3	2.0	31.8	33.3	19.9	34.4	17.6	16.4	29.7	33.8	28.9	18.6	30.3	18.4	4.2	42.5	28.2	17.6	49.0	34.0	0.7	21.6	15.6	20.0	18.0	38.3	5.1	35.0	51.1	16.9	9.2	14.9	22.2	29.7	20.7	27.5	43.7	10.1	4.6	21.8	71.2	15.1	24.3	1.8	21.1	23.2	23.2	3.7	44.1	23.5	34.0	1.0	3.4	37.0	16.2	16.6	28.1	29.6	17.1	43.4	30.6	10.8	13.1	12.0	25.2	4.5	18.9	23.4	44.2	12.9	23.1	58.8	29.3	22.1
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	25.4	20.4	10.3	18.8	10.1	44.7	21.0	7.2	14.3	18.3	3.4	19.5	21.6	19.6	9.4	20.1	18.7	13.6	16.0	11.9	9.7	16.6	23.5	17.4	21.3	6.8	8.5	23.8	25.5	16.1	21.4	17.0	6.4	19.2	12.1	17.5	19.3	11.2	25.7	21.6	22.8	13.0	2.3	22.9	21.8	18.7	8.8	17.8	20.0	16.0	17.1	18.8	18.1	9.1	49.6	35.4	43.5	98.0	23.0	18.8	36.0	34.6	29.2	33.8	29.3	63.0	30.6	67.7	11.0	30.1	37.5	37.0	43.5	33.6	37.6	59.2	86.5	50.6	36.6	42.4	23.5	106.1	61.8	24.8	23.3	44.9	41.0	21.9	25.5	38.5	141.2	49.3	33.7	37.8	63.7	67.0	45.5	27.4	42.3	57.4	33.8	57.1	17.2	42.8	61.7	54.3	30.3	57.3	31.1	28.8	48.1	55.0	36.2	60.2	36.8	48.0	70.5	58.8	58.8	96.0	35.2	66.6	61.0	0.0	0.8	1.4	1.7	0.5	1.0	1.0	1.1	1.3	0.9	1.1	0.9	1.4	0.9	1.6	1.4	1.5	0.6	1.1	10.3	10.1	7.2	14.3	11.9	9.7	6.8	8.5	6.4	2.3	8.8	9.1	31.8	38.5	28.9	33.0	28.6	25.2	10.1	17.5	29.0	34.6	19.5	19.7	4.4	20.0	19.9	18.4	98.0	17.1	30.6	19.7	5.9	12.3	13.2	14.6	24.7	18.3	18.0	30.7	55.6	17.1	13.2	19.2	32.1	21.3	16.5	31.1	17.2	24.9	16.2	40.4	58.9	21.7	16.2	18.9	21.7	6.3	14.9	23.3	19.6	23.4	13.8	18.2	32.0	30.2	38.6	21.8	14.1	17.7	37.6	22.2	19.1	8.4	17.6	26.6	13.1	27.0	17.6	19.2	13.1	29.6	31.0	19.4	27.9	24.7	23.2	21.9
POM121C		ENSG00000272391	"POM121 transmembrane nucleoporin C"	A8CG34	7	75416786-75486299	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043809, HPA049817"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (9.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.00e-2)"	14.9	14.0	3.5	15.5	3.8	28.9	14.2	8.0	9.3	13.8	2.4	14.2	12.0	16.6	9.0	15.9	14.1	12.0	13.9	7.0	4.9	13.1	13.2	12.9	18.2	2.2	3.1	18.7	18.1	16.8	13.4	16.4	2.0	13.0	12.9	26.3	14.3	11.5	19.6	17.7	14.0	15.1	0.3	15.5	14.0	12.5	5.2	17.6	16.7	10.7	19.9	14.3	14.3	5.5	41.8	34.1	46.3	89.0	17.1	19.0	30.4	29.7	27.3	23.7	22.8	41.2	26.5	73.4	12.0	32.6	37.2	36.7	39.6	36.7	38.9	49.9	55.1	36.4	39.6	27.8	22.5	97.0	49.5	16.2	22.8	36.3	26.8	34.5	24.6	29.9	103.8	39.8	38.9	41.8	59.5	49.3	36.9	32.0	38.4	53.0	30.7	37.6	13.1	56.0	51.4	67.4	34.3	54.0	23.8	41.5	47.1	34.2	27.4	57.4	30.6	42.2	62.3	42.4	54.4	88.2	37.3	49.1	53.9	0.2	0.4	0.5	1.1	0.5	1.0	0.8	0.9	0.3	0.3	1.0	0.5	0.6	1.2	0.9	0.3	1.1	0.2	0.6	3.5	3.8	8.0	9.3	7.0	4.9	2.2	3.1	2.0	0.3	5.2	5.5	23.1	35.3	26.2	29.4	27.8	18.0	11.8	13.4	33.6	30.7	21.3	23.4	12.6	21.5	21.4	12.9	68.8	13.4	27.2	12.3	5.9	11.8	2.1	14.2	21.3	20.7	28.7	33.9	59.2	17.1	10.2	21.0	31.6	18.3	7.6	28.6	16.8	15.1	12.0	25.2	60.2	17.4	14.2	16.4	15.8	3.8	18.0	21.7	7.2	35.6	17.1	21.3	37.0	28.1	45.6	18.8	8.0	15.4	37.8	24.6	10.0	9.6	18.7	29.4	13.1	26.1	17.4	19.2	12.4	32.9	18.5	17.0	34.0	22.0	17.0	19.7
POMT2	LGMD2N	ENSG00000009830	"Protein O-mannosyltransferase 2"	Q9UKY4	14	77274956-77320883	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.1;Oligodendrocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003663	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003663: AB_1079655"	"unprognostic (2.15e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (7.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.94e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.46e-2)"	5.8	12.4	13.2	4.1	14.9	2.5	5.7	13.5	13.4	8.0	12.5	6.7	2.6	6.7	9.8	5.5	5.8	4.0	7.9	12.7	13.1	10.8	9.3	5.6	1.8	14.6	14.6	6.1	8.8	8.6	12.6	7.0	13.4	7.8	3.3	5.6	6.3	6.9	19.1	4.7	4.9	4.6	13.7	5.6	5.9	37.5	14.4	2.9	10.9	8.4	1.9	7.9	5.3	15.4	15.6	19.4	18.6	21.1	13.0	10.3	14.8	13.4	10.8	19.3	16.6	9.6	13.6	4.6	10.6	12.6	27.1	17.1	8.8	13.3	13.5	6.9	12.1	2.8	8.9	7.9	15.8	3.2	8.9	10.5	13.9	18.3	17.8	13.6	11.5	4.5	7.4	10.5	13.0	30.7	5.4	15.0	5.3	21.4	16.2	5.3	18.0	4.1	20.4	11.3	15.6	15.2	8.7	14.6	11.3	12.0	15.1	6.5	9.6	14.6	22.8	17.1	12.0	6.8	14.5	2.1	7.4	4.8	13.2	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.1	13.2	14.9	13.5	13.4	12.7	13.1	14.6	14.6	13.4	13.7	14.4	15.4	3.2	6.4	2.8	27.1	2.0	3.1	2.7	3.4	2.8	7.5	7.2	7.6	4.3	4.3	1.6	1.8	16.7	6.0	1.2	6.5	0.0	7.6	14.3	5.8	6.7	3.1	18.0	0.0	12.9	7.5	10.2	6.1	4.1	7.0	2.5	6.4	2.5	5.7	5.5	8.4	14.5	3.2	2.0	2.2	2.6	17.2	1.8	2.4	1.8	9.4	2.3	5.9	0.0	20.1	30.5	5.5	3.2	4.1	2.1	5.2	2.5	3.6	5.1	15.1	0.0	6.2	5.0	11.3	8.2	5.2	1.8	5.7	1.2	13.9	3.6	1.9
POMZP3	"POM-ZP3, POM121"	ENSG00000146707	"POM121 and ZP3 fusion"	Q6PJE2	7	76609986-76627261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.3;Late spermatids: 60.8;Spermatocytes: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA049817, HPA071198"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA049817: AB_2680896, HPA071198: "	"unprognostic (2.23e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (4.31e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (4.94e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.99e-2)"	13.7	10.6	5.8	3.6	5.6	6.8	13.2	8.2	9.7	15.3	4.7	15.9	2.4	16.2	4.6	10.7	12.3	2.2	14.7	5.8	6.1	11.3	5.5	10.4	3.3	6.1	5.6	16.6	12.9	2.5	10.1	1.8	5.8	14.4	3.5	6.2	9.4	4.4	19.8	12.2	9.4	6.2	3.9	9.0	12.6	29.5	5.7	4.7	11.3	0.9	3.6	13.9	12.3	6.4	2.8	11.1	17.7	22.7	11.4	4.4	2.6	3.9	6.2	2.7	3.7	6.5	5.0	1.7	1.0	3.6	6.2	1.5	4.1	1.9	2.7	7.0	6.4	7.6	6.2	4.0	2.6	3.4	4.8	3.8	7.3	9.8	3.2	1.4	1.7	2.8	4.2	12.8	12.8	3.5	6.2	14.2	7.9	4.1	5.6	2.4	12.9	2.9	2.1	4.2	9.1	16.7	3.6	16.2	6.1	18.6	6.1	4.5	7.0	8.9	1.2	22.2	9.5	3.2	3.0	12.3	1.7	13.7	12.7	0.6	1.2	2.3	0.8	0.5	1.2	0.8	1.4	1.4	1.2	1.6	1.7	0.9	1.3	1.0	0.6	1.2	1.4	0.4	5.8	5.6	8.2	9.7	5.8	6.1	6.1	5.6	5.8	3.9	5.7	6.4	5.5	3.2	4.1	4.2	8.1	7.0	7.3	11.5	21.1	5.0	8.0	8.4	6.7	2.8	3.5	5.5	12.5	6.9	7.7	8.1	0.0	1.4	45.3	5.8	5.7	4.3	13.1	9.4	8.2	2.2	3.2	8.1	25.5	7.0	5.7	4.7	2.5	1.7	3.2	3.3	8.6	4.8	2.0	4.9	3.3	60.8	6.2	6.5	10.6	2.8	0.8	5.0	2.1	6.6	8.1	1.8	9.3	7.9	15.2	4.7	4.3	5.9	4.1	5.3	13.1	2.9	5.6	33.0	8.0	18.3	7.0	10.4	9.1	2.0	6.3	11.1
POP4	RPP29	ENSG00000105171	"POP4 homolog, ribonuclease P/MRP subunit"	O95707	19	29606283-29617237	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042748, HPA064577"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA042748: AB_10964774, HPA064577: "	"unprognostic (5.88e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.50e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.08e-3)"	11.3	13.6	8.9	5.2	9.4	6.3	10.6	10.0	9.5	8.8	8.5	11.1	4.7	9.7	3.8	13.3	7.7	2.5	14.1	9.1	9.6	13.4	14.4	8.1	5.9	10.1	9.5	7.8	9.5	3.9	8.3	3.7	9.8	8.8	2.9	3.6	10.5	3.2	18.8	11.6	10.5	3.5	9.7	11.4	11.6	12.8	9.8	5.0	9.2	4.0	4.7	9.6	9.3	10.5	44.5	61.9	5.3	5.4	7.8	3.9	26.5	42.1	4.9	9.3	9.3	28.6	10.5	35.2	72.1	7.3	10.1	20.6	10.8	10.0	5.3	79.9	65.1	42.0	19.4	18.2	7.5	51.4	21.6	4.4	8.0	7.9	4.8	5.0	8.2	18.5	34.8	8.0	8.2	36.9	29.7	8.6	10.3	13.6	39.5	19.0	44.7	18.0	5.6	17.1	15.1	16.6	44.4	15.4	18.5	5.0	15.5	12.5	30.0	13.4	40.5	23.1	37.1	30.3	59.7	44.1	17.1	24.8	13.5	73.1	39.7	40.3	35.5	52.1	26.1	48.1	34.2	37.5	39.9	36.4	27.1	32.4	23.3	36.5	43.0	33.2	53.0	45.8	8.9	9.4	10.0	9.5	9.1	9.6	10.1	9.5	9.8	9.7	9.8	10.5	26.4	22.4	20.0	4.9	29.8	12.6	20.0	61.0	15.9	16.6	18.5	21.0	26.1	27.1	29.6	33.1	8.4	53.4	25.8	29.5	80.3	59.5	18.2	29.8	21.5	27.1	17.4	21.4	4.6	78.3	45.0	22.8	17.3	22.6	26.0	22.1	25.4	40.2	62.1	11.8	4.3	27.5	46.8	26.2	18.3	15.3	16.4	27.3	24.9	0.0	57.4	34.1	52.5	4.0	5.8	66.2	26.6	28.2	33.6	20.3	39.4	72.4	38.0	15.5	26.3	18.6	27.8	71.0	15.4	21.4	16.1	47.3	27.4	31.7	26.2	19.5
POP5		ENSG00000167272	"POP5 homolog, ribonuclease P/MRP subunit"	Q969H6	12	120578764-120581402	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047598, HPA069204"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA047598: AB_2680096, HPA069204: "	"unprognostic (1.50e-2)"	"prognostic favorable (2.68e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.68e-2)"	27.0	51.3	5.2	5.6	6.1	9.5	25.6	6.0	8.9	20.7	6.1	24.6	6.0	21.8	2.4	25.9	20.1	5.1	42.5	5.5	5.9	38.3	40.5	19.0	10.8	6.1	5.7	17.2	25.2	7.3	26.2	2.1	6.4	24.3	2.8	1.2	25.2	4.8	22.9	22.4	24.6	3.5	6.2	31.8	25.4	10.2	5.8	7.9	27.4	3.6	4.3	24.3	21.0	6.4	22.2	43.4	3.8	8.7	10.1	4.5	14.7	14.2	5.7	13.6	11.2	36.6	6.6	13.4	26.9	7.8	6.1	15.7	8.0	30.1	1.1	41.4	42.1	13.5	20.3	26.5	12.1	11.7	11.3	14.1	11.2	13.5	2.4	3.4	8.9	30.2	18.2	5.6	7.5	45.0	18.9	11.2	8.0	14.6	36.5	20.5	9.8	28.5	11.5	18.5	7.4	8.7	27.7	6.5	15.7	2.8	27.5	20.7	11.8	8.1	13.2	13.6	19.8	16.1	35.8	16.7	20.5	21.6	13.3	4.5	12.7	3.1	17.7	14.9	16.4	25.2	14.2	16.2	16.8	18.0	17.6	16.3	0.9	16.0	14.1	26.6	15.8	20.8	5.2	6.1	6.0	8.9	5.5	5.9	6.1	5.7	6.4	6.2	5.8	6.4	24.2	12.8	27.6	10.1	47.8	19.6	38.6	83.7	34.1	22.0	37.5	50.4	60.5	37.1	59.3	77.3	14.6	51.7	49.3	21.6	154.6	44.9	1.7	39.9	30.5	25.4	22.1	30.1	6.4	44.9	42.9	33.8	32.6	24.8	54.6	24.0	24.3	58.3	53.2	18.5	6.9	30.5	54.9	19.8	21.7	5.0	36.1	35.7	49.8	7.5	33.4	79.3	52.5	10.6	8.2	40.0	21.9	37.6	56.8	23.6	31.2	136.2	45.2	34.4	19.7	27.5	39.4	22.7	43.8	53.3	24.7	17.6	46.1	106.3	44.2	33.5
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 313.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 489.2;Proximal enterocytes: 274.2;Theca cells: 647.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 328.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		12000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	53.4	197.4	19.9	32.1	20.7	17.9	44.7	14.1	18.6	42.0	15.5	35.9	105.2	32.1	29.4	53.6	50.2	37.0	43.3	20.7	30.2	38.1	313.3	55.0	19.9	22.2	24.5	52.2	44.5	77.6	71.4	46.3	20.9	31.8	21.9	12.7	29.9	113.1	56.2	43.8	92.4	28.2	16.9	43.8	41.5	25.5	34.7	38.0	131.3	68.1	23.2	36.6	42.3	15.3	59.6	133.0	57.0	106.3	212.9	79.8	98.0	24.4	79.3	44.7	62.3	100.7	257.0	56.1	21.9	53.1	151.8	28.3	76.0	38.4	19.6	48.1	57.9	26.0	36.9	189.4	146.5	26.2	45.5	163.9	47.4	59.2	43.2	36.3	42.3	27.1	79.1	24.0	40.8	90.9	29.0	49.4	71.7	92.9	74.8	41.0	37.6	61.1	50.0	72.8	59.3	57.4	65.4	328.4	91.0	32.6	94.0	44.2	38.6	41.7	45.8	63.6	48.7	23.8	38.3	39.0	59.3	39.8	54.9	65.9	42.6	60.4	20.6	39.6	17.1	11.0	17.5	19.4	45.6	11.2	17.1	14.7	53.8	25.9	30.2	12.5	19.3	36.6	19.9	20.7	14.1	18.6	20.7	30.2	22.2	24.5	20.9	16.9	34.7	15.3	34.3	38.5	39.7	23.2	17.1	17.1	29.4	172.3	13.1	31.4	20.5	14.0	10.9	54.3	201.4	73.5	12.5	99.9	26.0	97.7	1.9	65.0	27.6	62.1	28.0	27.1	19.8	11.8	10.1	29.4	95.0	40.1	67.8	46.6	24.7	121.4	32.2	489.2	67.8	15.2	17.1	41.7	124.1	35.2	16.1	9.5	75.8	47.3	12.4	11.2	20.5	25.9	12.3	11.6	8.8	27.9	102.0	112.5	17.0	20.7	274.2	31.7	178.6	23.0	65.7	32.7	46.9	21.3	30.8	18.2	14.6	193.2	25.4	647.6	44.5	45.9
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 207.2;stomach 1: 174.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 295.7;Breast myoepithelial cells: 158.1;Endothelial cells: 134.6;Fibroblasts: 191.5;Smooth muscle cells: 151.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 490.2;SuSa: 440.5;U-138 MG: 619.3;U-2197: 427.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"spinal cord: 87.9"	HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		660000000		"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	71.4	5.2	4.5	23.8	0.1	0.3	84.0	0.0	4.4	20.3	2.9	61.3	5.1	53.2	13.0	20.5	83.5	64.3	83.2	3.0	0.0	28.1	13.0	45.1	12.8	0.9	0.0	3.6	2.2	21.6	2.4	60.9	2.0	16.1	84.9	0.0	17.7	44.8	10.6	207.2	15.0	66.6	0.0	1.1	174.6	3.4	0.1	5.8	19.1	29.9	3.9	91.4	10.7	0.4	0.0	0.0	71.0	1.6	85.0	51.0	0.2	23.1	0.0	5.5	0.7	0.0	1.4	0.1	0.0	18.7	0.1	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.1	90.8	0.0	490.2	1.9	15.9	0.7	0.0	0.0	0.0	11.8	0.0	0.3	0.4	4.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.6	0.0	440.5	0.9	0.0	0.0	619.3	0.3	427.2	3.4	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	4.4	3.0	0.0	0.9	0.0	2.0	0.0	0.1	0.4	46.7	6.4	10.6	0.7	0.3	295.7	1.3	51.5	0.0	0.0	2.9	158.1	22.8	0.0	18.7	0.0	0.0	2.5	1.0	0.0	0.0	0.0	0.5	0.5	9.8	134.6	0.0	0.0	1.5	0.0	0.2	191.5	0.0	0.3	3.8	0.0	22.5	0.6	3.7	0.0	36.8	0.0	24.4	0.0	27.0	1.1	6.5	0.8	30.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	0.4	0.4	0.0	0.0	5.6	0.0	0.0	0.7	151.5	1.3	0.9	0.2	48.4	3.4	2.3	49.3	0.0	0.3
POT1	"DKFZp586D211, hPot1"	ENSG00000128513	"Protection of telomeres 1"	Q9NUX5	7	124822386-124929983	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 41.5;Oligodendrocytes: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068538			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA068538: AB_2686001"	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.42e-2)"	5.6	5.7	3.2	5.7	3.8	4.1	10.4	3.7	3.6	7.9	4.0	5.6	4.5	9.5	6.1	4.5	8.1	6.0	6.2	3.2	4.2	9.7	9.9	6.1	8.8	3.9	3.4	10.1	5.3	9.8	6.4	6.9	4.1	7.1	6.4	9.9	3.9	6.7	3.2	4.1	4.2	7.2	3.8	8.1	5.8	13.8	3.2	13.0	12.9	4.4	9.6	7.7	4.5	6.1	24.0	6.9	14.0	9.9	9.2	16.2	10.3	12.1	14.9	14.3	19.7	7.3	25.9	24.4	8.5	11.1	23.6	9.5	14.8	15.0	21.7	21.4	17.5	18.9	10.3	3.2	15.4	22.6	12.4	13.1	13.6	12.8	21.8	14.5	16.6	10.1	38.1	51.9	15.0	4.1	29.8	12.5	17.4	13.2	14.1	19.1	14.0	27.5	9.9	9.8	13.9	16.6	18.7	19.8	15.6	20.3	8.0	12.3	8.4	14.3	5.5	19.1	17.1	23.2	27.0	39.8	20.4	23.6	22.7	0.6	2.2	1.0	2.3	2.3	4.3	3.2	2.6	3.0	2.5	2.5	4.3	3.0	0.4	3.7	1.8	2.2	2.8	1.9	3.2	3.8	3.7	3.6	3.2	4.2	3.9	3.4	4.1	3.8	3.2	6.1	9.7	6.4	4.1	36.9	10.1	4.6	6.7	5.5	13.1	9.2	7.1	7.1	8.8	8.6	3.6	12.9	10.4	7.0	8.0	1.5	19.6	5.0	19.3	4.3	6.9	7.1	9.0	16.0	34.7	4.5	8.0	6.9	8.2	4.2	3.8	9.4	7.1	10.5	6.3	8.4	41.5	4.0	2.0	10.9	7.0	8.3	8.7	8.7	16.0	24.4	5.6	12.6	4.1	37.2	66.8	3.8	1.7	4.5	7.6	2.8	0.8	11.2	4.9	10.0	0.0	5.4	6.3	35.2	14.4	7.6	2.6	4.5	8.5	4.8	4.9	3.5
POU1F1	"GHF-1, PIT-1, PIT1, POU1F1a"	ENSG00000064835	"POU class 1 homeobox 1"	P28069	3	87259404-87276584	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	137	"pituitary gland: 59.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041646, HPA050624"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"			"Nucleoplasm, Cytosol"		"HPA041646: AB_10794672, HPA050624: AB_2681192"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.05e-4)"	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
POU2F1	"OCT1, OTF1"	ENSG00000143190	"POU class 2 homeobox 1"	P14859	1	167220876-167427345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 270.6;Excitatory neurons: 187.6;Inhibitory neurons: 184.0;Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002608, HPA058559, HPA064323"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-3)"	"unprognostic (4.26e-2)"	"unprognostic (5.67e-6)"	"unprognostic (4.47e-2)"	"unprognostic (5.14e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.17e-2)"	4.0	2.5	5.0	2.2	5.8	3.9	3.4	7.3	5.2	3.6	2.9	3.7	1.3	4.0	2.6	2.7	3.4	1.4	2.6	4.8	3.8	2.9	2.3	3.5	3.0	4.1	4.2	4.1	2.4	3.4	3.6	2.4	3.9	3.2	2.1	12.9	3.0	2.0	4.1	3.5	3.6	1.4	3.8	4.2	2.6	4.3	5.0	3.8	3.3	2.6	3.4	3.4	3.2	4.4	7.4	4.0	14.8	4.5	1.7	1.7	6.1	0.9	1.6	1.7	1.7	8.1	4.2	8.3	3.8	1.5	1.7	5.6	8.8	2.7	2.6	3.3	3.5	5.9	3.9	7.1	1.1	6.5	3.8	1.2	1.6	2.0	3.6	2.1	2.3	5.7	6.4	4.3	2.3	3.7	6.0	4.3	17.4	4.0	2.3	8.7	5.4	3.7	3.1	4.0	9.0	6.9	5.6	4.1	3.7	7.4	4.6	7.9	3.8	3.4	5.3	2.0	3.5	4.4	2.1	18.3	1.6	3.9	4.4	4.6	0.3	0.3	0.2	0.3	0.3	2.0	0.2	0.0	0.4	0.7	0.3	0.2	0.4	0.2	0.3	0.9	0.2	0.4	5.0	5.8	7.3	5.2	4.8	3.8	4.1	4.2	3.9	3.8	5.0	4.4	19.9	12.8	17.2	270.6	25.2	13.4	11.3	9.7	9.6	58.7	12.5	11.8	15.8	14.3	11.6	20.2	102.2	17.8	20.2	12.3	5.9	10.5	26.2	17.7	18.7	19.8	24.1	14.5	187.6	11.6	18.5	17.5	10.2	18.9	19.7	18.7	15.0	13.3	13.3	47.1	184.0	14.3	8.2	52.5	12.4	44.1	25.7	19.9	7.2	114.3	21.7	43.8	14.4	186.0	202.1	16.5	8.0	20.7	33.5	16.1	5.3	8.3	11.5	101.7	26.3	28.4	16.4	17.6	35.7	12.7	11.1	51.7	14.1	11.0	14.5	21.0
POU2F2	"OCT2, OTF2"	ENSG00000028277	"POU class 2 homeobox 2"	P09086	19	42086110-42196585	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 225.5;Kupffer cells: 119.6;Langerhans cells: 104.4;Macrophages: 105.0;monocytes: 137.6;Plasma cells: 96.7;Spermatocytes: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 94.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 52.3;Daudi: 113.0;hTEC/SVTERT24-B: 42.7;U-266/70: 75.5;U-266/84: 80.2;U-698: 88.4;U-87 MG: 41.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002513, HPA049056, HPA062096, HPA064404, HPA073998"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: "	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (7.57e-11)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.54e-1)"	2.6	2.8	6.1	28.0	5.9	8.4	1.7	15.5	10.6	1.1	3.8	4.3	3.1	1.2	1.5	2.0	1.6	3.4	0.8	5.8	15.4	1.4	2.0	3.8	52.1	8.0	9.1	0.8	1.7	0.3	2.0	3.8	9.4	3.0	3.0	1.9	2.6	3.1	1.1	1.4	14.0	2.9	5.8	27.5	5.0	9.2	14.0	6.5	1.5	0.5	48.3	7.1	1.2	6.7	0.9	1.5	1.8	0.1	0.0	2.9	0.5	8.2	52.3	5.1	10.0	0.5	1.4	113.0	2.8	2.9	0.9	1.0	0.6	8.6	23.2	0.3	0.5	2.7	0.3	0.1	0.6	1.1	2.2	2.2	1.6	42.7	2.8	0.4	3.2	2.4	1.3	25.4	1.1	0.8	0.3	6.1	0.4	0.2	0.6	1.3	0.2	0.4	0.2	0.5	1.8	0.8	0.4	0.7	0.8	0.7	0.1	14.1	3.9	22.0	2.3	0.2	1.1	75.5	80.2	88.4	41.3	2.8	3.1	2.6	28.3	0.5	3.1	51.5	2.7	29.3	4.4	4.0	20.9	33.0	2.3	3.3	4.3	1.7	94.9	3.4	7.2	14.4	6.1	5.9	15.5	10.6	5.8	15.4	8.0	9.1	9.4	5.8	14.0	6.7	2.7	0.0	7.0	0.7	225.5	7.8	8.3	14.1	4.6	63.5	7.2	7.6	3.7	2.8	3.2	0.0	6.2	0.9	29.3	2.8	0.0	1.4	15.2	4.0	1.1	7.3	9.5	10.7	19.7	2.8	0.8	2.7	1.5	8.5	6.3	0.5	4.2	1.1	49.5	1.7	10.0	1.6	4.1	119.6	104.4	9.8	0.9	105.0	8.8	32.8	137.6	1.9	37.0	4.5	1.0	3.5	0.1	0.4	96.7	3.8	2.8	0.4	2.4	6.6	0.0	1.7	5.0	75.1	28.8	13.3	8.8	3.7	31.7	0.6	1.0	5.0
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 48.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 20.9;Pancreatic endocrine cells: 20.8;Suprabasal keratinocytes: 37.6;Urothelial cells: 14.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;CAPAN-2: 3.6;EFO-21: 1.3;SK-BR-3: 2.5;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.1	0.1	0.2	0.1	0.1	0.2	2.0	0.3	0.4	0.8	0.0	0.6	0.9	0.0	1.7	1.3	0.5	0.7	0.1	0.1	0.1	0.3	0.1	1.0	0.2	0.1	0.1	0.1	0.2	6.3	0.4	0.3	0.1	0.6	0.2	0.1	1.1	2.0	0.2	48.0	0.7	0.3	0.0	0.2	0.7	0.1	0.1	0.2	0.7	0.0	0.5	0.4	2.1	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	3.6	0.1	1.3	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	2.5	0.0	0.3	3.9	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	8.2	0.3	0.0	20.9	10.6	5.0	1.8	0.0	3.0	1.5	0.8	0.0	3.9	11.0	0.0	1.5	0.1	0.9	0.0	5.3	2.2	1.3	0.7	0.3	3.0	0.0	0.4	1.3	0.4	0.6	10.2	4.8	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.2	8.2	0.0	2.2	5.5	0.0	0.1	5.4	0.0	0.0	0.4	0.0	0.0	0.5	20.8	1.1	0.0	0.0	5.0	0.4	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.1	7.0	37.6	7.9	0.5	0.2	0.6	14.2
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38043829-38046793	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 10.3;skin 1: 32.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 27.3;Breast myoepithelial cells: 39.1;Cone photoreceptor cells: 22.9;Suprabasal keratinocytes: 55.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.8;head and neck cancer: 4.4;melanoma: 4.8;testis cancer: 1.3;urothelial cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.1;HDLM-2: 23.9;NTERA-2: 7.5;SCLC-21H: 5.7;SK-MEL-30: 28.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055980, HPA073824"			Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055980: AB_2682995, HPA073824: AB_2686635"	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.2	1.5	2.3	0.2	7.0	0.0	0.3	0.9	10.3	0.2	0.1	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.1	9.7	1.9	0.0	0.0	0.0	1.0	1.4	2.6	0.1	0.1	0.2	0.0	0.0	1.3	0.2	0.0	0.3	0.3	0.1	0.9	32.6	0.0	0.0	0.6	0.1	0.1	0.8	2.0	0.3	0.0	0.5	1.0	0.8	0.3	2.5	0.0	0.0	24.1	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	23.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.7	0.0	0.1	0.0	28.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.0	0.9	10.3	9.7	1.9	1.4	2.6	1.3	0.6	2.0	2.5	12.2	0.0	0.0	2.3	8.3	27.3	2.9	1.4	20.5	7.8	9.9	39.1	5.2	0.0	0.2	0.0	22.9	0.2	13.4	13.8	0.0	0.0	0.2	0.5	2.3	1.9	1.8	2.7	6.4	0.0	0.1	5.2	7.1	1.4	0.0	0.5	0.0	0.0	0.3	1.7	1.1	11.0	0.0	0.0	1.3	0.0	0.3	4.3	7.2	1.0	0.0	14.0	0.0	0.5	0.2	0.0	0.1	0.0	2.7	0.7	0.3	0.1	0.0	21.1	0.0	8.5	7.2	0.2	4.1	20.2	55.8	0.1	5.2	8.3	5.7	3.2
POU3F2	"BRN2, OCT7, OTF7, POUF3"	ENSG00000184486	"POU class 3 homeobox 2"	P20265	6	98834574-98839458	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"brain: 17.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 77.4;Excitatory neurons: 8.8;Muller glia cells: 11.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 13.4"	"Cancer enriched"	"Detected in some"	11	"glioma: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 125.4;SK-MEL-30: 18.3;U-251 MG: 39.9;WM-115: 33.8"	"Low region specificity"	"Detected in all"							"HPA047081, HPA056261"		Approved	Supported	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA047081: , HPA056261: AB_2683081"	"unprognostic (5.94e-4)"	"unprognostic (7.80e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.77e-1)"	"unprognostic (9.38e-11)"	"unprognostic (4.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.04e-1)"	0.0	0.0	9.7	0.0	9.6	0.0	0.0	11.4	15.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	13.0	0.0	0.0	0.0	0.0	9.8	17.3	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.1	10.6	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	125.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	5.6	0.0	0.0	0.2	7.6	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	5.5	4.3	1.0	0.0	0.0	0.0	6.9	3.6	0.0	0.0	18.3	0.1	1.0	0.1	0.0	0.7	0.0	0.2	39.9	0.1	0.0	0.0	0.2	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	9.6	11.4	15.5	7.6	13.0	9.8	17.3	9.3	10.5	10.6	12.2	0.1	0.0	0.0	77.4	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	8.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.8	0.0	11.1	0.0	27.2	13.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.4	0.3	1.4	0.0	0.1	0.0	0.4	0.0	0.1	0.3
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104853287-104858574	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 45.6;epididymis: 32.4;kidney: 58.8;seminal vesicle: 15.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal tubular cells: 27.4;Proximal tubular cells: 13.2"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 59.6;AN3-CA: 53.9;HEK 293: 21.2;RPTEC TERT1: 57.3;SH-SY5Y: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			1.5	0.1	22.5	0.1	36.9	0.0	0.3	34.6	36.2	0.0	0.0	0.7	0.0	0.0	32.4	0.0	0.0	0.0	0.1	26.3	18.9	58.8	0.0	0.0	0.0	31.0	35.5	0.1	0.0	0.0	0.1	0.0	25.3	0.2	0.2	0.3	1.3	15.2	0.0	1.7	0.1	0.0	22.7	0.0	0.6	0.2	30.6	0.2	0.0	0.0	0.1	0.0	0.0	45.6	0.0	0.0	59.6	53.9	0.6	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	0.0	6.5	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	1.8	1.7	0.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.1	0.0	6.4	1.4	0.0	57.3	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	36.9	34.6	36.2	26.3	18.9	31.0	35.5	25.3	22.7	30.6	45.6	0.0	0.0	0.0	1.0	0.5	0.8	0.1	0.0	0.0	3.8	0.0	0.6	1.0	0.0	0.0	58.8	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.2	5.4	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	13.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
POU3F4	"BRN4, DFN3, DFNX2, OTF9"	ENSG00000196767	"POU class 3 homeobox 4"		X	83508290-83512127	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	7	"brain: 11.9"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 11.0"	"Cancer enriched"	"Detected in single"	21	"glioma: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	99	"AF22: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062295			Supported	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA062295: AB_2732681"					"unprognostic (5.73e-2)"										"unprognostic (2.00e-1)"			0.0	0.0	2.3	0.0	11.9	0.0	0.0	2.6	4.5	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	2.5	1.6	0.0	0.0	0.0	2.9	5.5	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	11.9	2.6	4.5	1.5	2.5	2.9	5.5	2.5	2.6	3.4	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU4F3	"BRN3C, DFNA15, DFNA42, DFNA52"	ENSG00000091010	"POU class 4 homeobox 3"	Q15319	5	146338839-146341728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038215	Uncertain		Supported	Nucleoplasm		NA	NA							Nucleoplasm		"HPA038215: AB_10697245"	"unprognostic (8.41e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.12e-1)"		"unprognostic (1.03e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (7.82e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.9;Glandular and luminal cells: 67.8"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	51	"SuSa: 287.4"	"Not detected"	"Not detected"							"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.04e-5)"	1.1	0.3	1.2	1.0	1.0	1.5	1.2	1.5	1.2	6.3	0.4	4.9	4.3	2.3	2.4	1.8	7.1	2.1	3.3	1.0	0.7	16.5	8.0	3.7	1.0	1.3	0.8	0.5	13.0	0.0	0.3	0.2	1.1	7.6	1.1	0.7	0.8	2.4	1.0	2.2	8.0	0.3	0.2	2.0	10.1	1.3	1.3	0.2	0.9	0.3	0.3	10.2	2.0	1.9	3.6	1.8	0.4	0.7	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	1.3	0.3	5.6	0.1	0.4	2.9	0.7	3.1	0.0	0.6	1.4	0.6	3.3	2.5	0.2	0.9	0.8	0.3	0.6	0.3	0.9	0.2	0.0	0.7	0.1	1.0	1.0	0.2	0.3	1.0	2.9	0.6	0.1	0.8	0.6	0.7	4.8	3.8	0.6	0.1	1.0	0.2	0.3	287.4	0.6	0.4	0.0	0.7	0.5	1.8	0.3	1.3	1.3	1.6	0.5	1.3	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	1.2	1.0	1.5	1.2	1.0	0.7	1.3	0.8	1.1	0.2	1.3	1.9	1.0	0.0	1.1	0.0	0.9	5.2	2.7	5.3	2.8	0.5	0.7	0.8	0.4	10.0	2.3	9.2	2.1	0.0	0.1	9.2	0.0	6.7	0.0	27.9	5.9	1.2	1.2	0.0	0.2	6.6	0.1	0.7	11.2	67.8	0.0	0.1	0.4	2.4	0.1	0.0	0.1	6.4	2.0	0.0	1.5	0.2	0.0	0.7	1.8	1.0	0.7	0.1	1.0	0.5	0.1	12.6	12.5	0.7	0.2	5.6	10.1	2.0	1.6	1.0	0.0	1.4	1.2	0.1	0.8	0.8	3.8	0.1	0.8	0.0	4.1	4.3
POU5F1B	"OTF3C, OTF3P1, POU5F1P1"	ENSG00000212993	"POU class 5 homeobox 1B"	Q06416	8	127322183-127420066	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"choroid plexus: 3.1"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Distal enterocytes: 3.2;Endometrial ciliated cells: 5.5;Glandular and luminal cells: 10.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.1;EFO-21: 1.5;hTERT-HME1: 3.7;NTERA-2: 1.9"									HPA058267			Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA058267: AB_2683659"	"unprognostic (1.74e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.85e-2)"	"unprognostic (9.31e-4)"	"unprognostic (2.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.56e-2)"	"unprognostic (5.11e-2)"	"unprognostic (5.60e-10)"	"unprognostic (1.21e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.33e-3)"	0.2	0.1	0.2	0.1	0.2	0.2	0.7	0.7	0.3	0.3	3.1	0.4	0.1	0.5	0.6	0.2	0.5	0.2	0.0	0.5	0.2	0.5	0.2	0.2	0.3	0.3	0.5	0.2	0.2	0.4	0.1	0.2	0.3	0.6	0.5	0.2	1.7	0.3	0.1	0.6	0.1	0.1	0.0	0.2	0.3	0.2	0.2	0.2	0.5	0.0	0.2	0.1	0.2	0.2	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.0	1.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.7	0.3	0.5	0.2	0.3	0.5	0.3	0.0	0.2	0.2	1.0	0.0	0.5	0.0	0.2	0.3	0.3	0.3	0.0	0.0	1.0	0.9	0.7	0.0	0.4	0.0	4.2	0.0	0.1	3.2	1.9	1.5	0.3	5.5	0.9	1.4	0.0	0.0	0.0	1.8	0.0	0.4	0.0	10.6	0.0	0.0	0.4	0.1	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	2.3	0.0	0.1	0.2	2.7	0.4	0.9	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.6	0.0	0.4	0.0	1.3	0.4
POU5F2	"FLJ25680, SPRM-1"	ENSG00000248483	"POU domain class 5, transcription factor 2"	Q8N7G0	5	93733220-93741600	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7;testis: 1.9"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 16.8;Rod photoreceptor cells: 14.4;Spermatocytes: 22.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 1.4"	"Not detected"	"Not detected"							HPA077615	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA077615: "	"unprognostic (1.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.03e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.16e-9)"	"unprognostic (1.87e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-3)"	0.0	0.0	0.6	0.1	0.8	0.4	0.2	1.7	0.9	0.0	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.1	0.0	0.2	1.0	0.5	0.1	0.0	0.0	0.0	0.1	1.0	0.1	0.1	1.0	0.1	0.1	0.1	0.4	0.2	0.0	0.3	0.1	0.2	1.9	1.0	0.1	0.2	0.0	0.1	0.0	0.0	1.7	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	1.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.1	0.2	0.0	0.6	0.8	1.7	0.9	0.5	0.3	1.0	0.5	1.0	0.3	1.0	1.7	2.3	3.2	2.2	0.0	4.3	2.2	2.6	1.8	0.0	10.7	2.8	1.5	0.4	1.5	1.0	1.8	6.2	1.0	4.7	1.3	0.0	1.6	2.7	3.0	3.2	2.5	3.0	3.2	0.0	0.9	0.9	2.1	1.1	3.3	8.2	5.8	2.5	0.9	1.1	16.8	0.0	0.3	0.0	2.4	6.2	7.6	4.7	2.4	1.8	0.0	3.3	2.9	11.3	0.0	0.0	2.1	1.2	1.5	1.8	2.1	1.8	0.5	2.1	14.4	0.0	3.4	1.8	22.3	2.3	0.7	2.7	0.5	4.8	4.6	1.2	2.3
PP2D1	"C3orf48, FLJ25449"	ENSG00000183977	"Protein phosphatase 2C like domain containing 1"	A8MPX8	3	19979961-20012267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 2.0;testis: 7.4"	"Group enriched"	"Detected in some"	106	"Early spermatids: 420.0;Late spermatids: 301.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036870, HPA066083"	Enhanced		Uncertain	"Nucleoplasm,Intermediate filaments"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA036870: AB_10671246, HPA066083: AB_2685611"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.04e-1)"	0.2	0.1	0.0	0.1	0.0	2.0	0.1	0.5	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.1	7.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.4	0.0	0.6	0.3	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.4	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	420.0	0.2	0.3	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	301.8	2.5	0.2	0.0	0.0	0.0	0.1	0.0	2.0	0.9	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.1	3.4	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1
PPARA	"hPPAR, NR1C1, PPAR"	ENSG00000186951	"Peroxisome proliferator activated receptor alpha"	Q07869	22	46150521-46243756	"FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 44.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 99.4;Hepatocytes: 144.5;Proximal enterocytes: 93.2;Rod photoreceptor cells: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 10.3;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;granulocytes: 10.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058901, HPA067049, CAB075701"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB075701: , HPA058901: AB_2683849, HPA067049: AB_2685770"	"unprognostic (1.96e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.39e-9)"	"unprognostic (4.84e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.18e-2)"	7.9	6.3	9.6	4.5	12.7	6.6	3.8	9.5	6.9	4.1	23.5	11.8	18.4	3.8	3.6	7.7	4.1	4.4	26.3	7.7	8.8	22.4	33.2	4.0	3.4	11.0	11.2	11.2	8.2	7.4	2.6	4.3	10.0	6.2	9.1	18.2	7.8	5.7	26.2	7.7	18.4	4.3	8.6	4.4	6.1	1.3	11.7	3.7	7.0	44.6	3.9	5.1	4.0	10.5	7.8	1.9	2.4	8.4	13.0	8.3	5.3	6.7	13.2	7.0	7.2	3.8	3.7	2.8	3.3	15.6	6.5	3.5	7.1	8.7	6.3	8.1	8.9	8.7	4.8	8.0	8.1	6.0	14.3	6.6	6.9	5.2	11.8	6.0	1.5	6.3	3.2	6.4	6.6	2.0	6.8	2.2	0.3	6.5	1.9	8.0	8.6	3.6	4.7	4.6	2.4	7.0	2.6	2.4	8.0	3.2	2.7	4.6	2.6	7.3	7.7	6.7	2.9	6.3	4.0	1.2	11.4	6.6	2.3	1.4	0.8	10.3	1.0	1.0	0.8	0.8	0.5	0.5	0.6	1.0	0.6	0.4	0.7	0.7	0.7	3.1	1.4	0.2	9.6	12.7	9.5	6.9	7.7	8.8	11.0	11.2	10.0	8.6	11.7	10.5	15.0	3.2	13.6	49.6	8.0	23.3	15.0	7.8	9.1	15.0	14.3	11.4	99.4	22.8	8.9	7.3	62.6	8.0	18.4	58.8	9.8	10.3	0.6	9.4	26.4	15.5	19.9	32.0	1.4	16.6	6.7	16.0	14.8	18.4	5.1	19.1	22.5	144.5	8.8	5.0	13.8	31.4	0.0	24.8	10.2	1.1	19.6	10.4	3.6	10.3	12.2	16.0	8.2	19.6	27.2	13.0	24.5	30.1	10.6	19.1	93.2	40.8	5.0	148.0	6.6	31.0	15.8	0.7	1.7	19.3	34.2	3.0	9.6	14.6	37.9	19.9
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 165.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 284.1;Extravillous trophoblasts: 217.8;Granulosa cells: 232.9;Urothelial cells: 239.6"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 198.7;ASC TERT1: 113.7;BEWO: 247.5;CAPAN-2: 111.6;HSkMC: 118.9;PC-3: 112.0;RT4: 157.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081"	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favorable (5.52e-5)"	165.1	3.9	4.0	8.7	3.0	3.0	74.3	3.2	4.7	9.7	0.6	48.7	23.6	7.0	1.2	6.2	7.0	10.5	14.6	4.0	2.7	14.3	17.1	28.5	4.9	3.7	3.5	14.5	2.8	7.9	0.5	43.6	3.4	5.5	40.6	1.0	5.7	1.7	5.2	6.2	15.1	8.7	3.2	12.0	35.5	6.9	3.5	4.1	13.2	8.1	2.1	67.7	9.1	5.0	44.0	38.6	0.0	0.2	198.7	113.7	247.5	3.7	44.7	5.4	2.1	7.8	111.6	0.0	0.1	4.0	72.9	17.3	14.4	0.7	1.0	106.4	20.3	0.0	8.1	10.3	51.8	0.2	0.1	118.9	9.7	9.8	37.5	20.6	0.7	1.0	0.0	0.0	8.3	11.0	0.1	0.8	0.7	99.2	112.0	0.0	0.0	0.2	30.6	157.5	0.1	1.2	18.8	6.7	2.2	6.7	0.0	34.2	35.0	7.8	10.6	4.6	0.2	0.0	0.1	0.3	3.2	0.5	1.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	3.0	3.2	4.7	4.0	2.7	3.7	3.5	3.4	3.2	3.5	5.0	284.1	3.2	7.2	1.6	0.6	1.0	50.5	0.4	4.6	0.9	1.9	2.8	9.2	1.5	2.5	5.5	0.0	110.4	1.8	93.4	1.9	1.1	4.9	5.2	1.4	26.1	8.4	0.0	39.3	0.7	217.8	12.3	83.1	20.8	8.9	232.9	25.7	3.4	49.9	0.0	74.1	21.3	0.0	19.4	4.8	2.2	4.1	19.1	3.6	38.4	1.8	0.6	0.0	6.6	1.2	17.3	84.1	0.0	1.6	42.1	17.0	14.3	1.5	0.2	13.1	1.9	31.3	10.9	22.8	4.6	1.1	88.9	2.2	0.8	24.5	239.6
PPARGC1A	"PGC-1alpha, PGC1, PGC1A, PPARGC1"	ENSG00000109819	"PPARG coactivator 1 alpha"	Q9UBK2	4	23755041-23904089	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.6"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 1098.2;Inhibitory neurons: 1704.4;Oligodendrocyte precursor cells: 890.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"A-431: 88.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063136			Supported	Nucleoplasm		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA063136: AB_2684948"	"unprognostic (1.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.28e-6)"	"unprognostic (5.00e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.35e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (1.49e-14)"	"unprognostic (3.62e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.07e-3)"	2.3	2.9	4.2	0.6	3.2	0.0	1.6	7.6	13.0	3.3	33.9	7.4	7.6	0.9	1.5	3.3	1.5	2.6	36.3	3.1	10.7	29.0	44.6	3.1	0.2	4.1	4.1	1.2	3.8	38.5	4.8	0.1	2.6	3.3	9.1	4.2	29.3	3.0	29.5	8.2	6.6	1.9	2.4	0.8	4.3	4.5	7.2	2.3	17.7	37.2	0.4	1.1	1.0	4.1	88.6	0.0	1.6	0.0	2.6	0.0	0.0	0.0	1.9	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	4.5	10.7	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.7	0.0	12.3	0.1	4.0	0.2	2.8	0.0	3.5	4.2	0.5	1.4	0.0	0.7	0.7	0.0	1.6	8.1	0.1	0.1	1.6	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.2	7.6	13.0	3.1	10.7	4.1	4.1	2.6	2.4	7.2	4.1	2.5	19.2	2.6	240.6	0.9	0.9	4.1	7.4	1.2	7.0	2.7	1.5	90.9	47.1	6.3	36.8	39.6	0.0	0.0	36.0	52.8	12.0	78.3	7.2	1.3	0.8	26.7	0.0	1098.2	0.0	0.0	2.4	4.1	9.7	1.3	0.2	1.1	88.8	0.0	0.0	1704.4	17.0	38.7	2.5	0.3	69.7	0.9	0.6	7.2	24.4	0.1	6.4	0.0	890.2	28.8	0.6	7.3	2.2	1.8	1.4	32.0	26.8	4.8	1.9	0.0	37.1	5.1	0.8	0.6	2.6	1.1	0.0	1.0	1.9	21.9	1.5
PPARGC1B	"PERC, PGC1B"	ENSG00000155846	"PPARG coactivator 1 beta"	Q86YN6	5	149730298-149855022	"Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 12.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 111.8;Cone photoreceptor cells: 135.5;Rod photoreceptor cells: 72.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.7"	"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050543			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA050543: AB_2681165"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.51e-3)"	"unprognostic (6.55e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.01e-6)"	"unprognostic (8.45e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.77e-3)"	2.2	0.9	2.1	2.4	2.2	2.0	1.4	9.7	3.1	1.4	0.0	7.0	7.0	2.1	1.1	4.1	2.2	1.2	6.3	1.6	0.4	0.8	1.6	3.6	1.4	1.9	0.2	1.3	1.0	4.4	0.6	1.5	2.0	1.8	6.0	12.4	1.4	3.3	6.2	3.3	6.4	2.8	0.4	2.1	3.8	0.8	0.3	0.9	0.4	2.5	1.8	3.7	2.6	0.5	0.5	1.9	0.7	4.5	1.8	0.6	7.3	0.3	0.0	0.5	0.7	8.5	1.8	9.2	1.3	0.0	2.1	5.5	6.9	3.5	0.6	0.5	5.9	8.6	3.6	1.8	0.5	12.0	3.2	0.9	4.6	1.8	3.0	0.2	1.0	4.0	6.0	2.9	0.4	2.3	4.4	5.4	2.9	2.6	4.8	8.3	5.0	5.1	1.4	11.2	2.4	0.5	1.2	9.8	1.5	1.3	2.5	3.9	1.3	1.0	1.6	3.6	1.8	3.6	2.8	5.3	2.2	7.4	0.9	0.5	0.9	0.1	0.1	1.7	0.3	0.8	0.1	0.1	1.1	0.3	0.2	0.2	0.6	0.3	3.1	0.1	0.1	0.3	2.1	2.2	9.7	3.1	1.6	0.4	1.9	0.2	2.0	0.4	0.3	0.5	6.1	0.0	1.1	1.6	3.0	5.1	3.9	17.9	12.0	111.8	2.5	3.2	22.3	1.5	7.4	1.8	135.5	1.8	0.7	15.4	1.9	0.5	0.3	1.7	4.1	5.4	5.4	5.7	29.2	0.8	1.6	2.7	18.8	2.5	1.3	2.1	4.2	3.5	7.6	8.4	26.2	10.3	0.0	12.5	4.7	0.2	1.5	12.1	3.6	12.2	6.1	4.0	2.1	12.1	0.9	0.5	6.7	0.4	5.5	5.1	19.6	3.0	2.9	72.0	6.6	3.0	8.9	0.2	3.2	23.1	10.7	4.9	2.0	2.1	24.9	6.1
PPDPF	"C20orf149, dJ697K14.9, exdpf"	ENSG00000125534	"Pancreatic progenitor cell differentiation and proliferation factor"	Q9H3Y8	20	63520765-63522206	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2997.4;Paneth cells: 2752.7;Proximal enterocytes: 2849.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"eosinophil: 26.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 26.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040929			Approved	Nucleoplasm,Nucleoli,Microtubules		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Microtubules"	Nucleoli	"HPA040929: AB_10794155"	"unprognostic (3.75e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.09e-2)"	215.1	72.2	192.7	71.1	203.3	79.6	237.4	194.7	262.1	312.4	108.7	298.3	81.3	217.8	43.8	622.2	185.6	40.8	412.9	164.7	189.8	421.8	134.9	243.4	42.2	220.9	217.1	197.5	197.9	47.1	196.8	30.3	221.9	365.0	60.6	25.6	432.4	93.4	438.3	461.5	167.1	53.4	201.1	117.0	298.8	129.3	202.5	32.1	249.8	64.2	47.3	264.0	410.7	253.9	287.2	87.8	57.9	118.5	65.4	107.9	185.4	169.1	54.1	217.5	85.2	162.8	166.3	60.7	222.8	115.2	83.2	294.3	29.5	196.0	35.5	110.5	58.5	24.8	83.0	31.9	175.3	0.2	124.3	106.5	384.9	55.3	76.4	72.7	86.5	74.9	104.5	138.9	81.1	394.9	288.7	2.7	63.3	228.1	494.5	132.0	132.2	125.7	159.8	117.4	197.1	150.9	170.3	272.6	124.4	39.1	390.7	168.8	147.3	184.1	206.9	245.8	143.5	108.9	93.3	41.1	130.7	70.9	122.6	2.3	3.0	26.0	5.7	3.6	4.7	5.0	5.1	5.4	3.4	5.8	4.3	5.2	1.2	3.0	5.7	4.0	5.7	5.7	192.7	203.3	194.7	262.1	164.7	189.8	220.9	217.1	221.9	201.1	202.5	253.9	328.1	314.1	220.3	15.7	462.8	574.5	714.7	1076.0	375.6	51.8	1282.8	1173.8	70.1	906.5	763.6	960.0	12.5	428.4	422.5	2528.3	2997.4	916.1	222.0	440.1	449.6	294.2	796.4	399.0	15.4	755.9	761.0	430.8	1120.8	520.2	337.8	293.3	376.3	224.2	600.6	50.5	12.5	1549.5	850.4	390.4	755.8	1154.3	371.9	366.4	1191.7	6.5	831.8	236.9	435.6	6.6	67.2	971.0	2752.7	288.5	280.4	1021.9	2849.8	1715.5	542.0	60.0	197.2	216.3	541.5	129.0	261.6	1559.8	932.1	414.1	541.7	158.5	1132.9	1492.7
PPHLN1		ENSG00000134283	"Periphilin 1"	Q8NEY8	12	42238447-42459715	"Predicted intracellular proteins"	"Keratinization, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 337.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038902, HPA038903"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA038902: AB_10674844, HPA038903: AB_2676263"	"unprognostic (4.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.28e-7)"	"unprognostic (2.85e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.04e-2)"	26.0	30.5	21.9	34.9	23.2	51.9	33.2	23.4	26.6	27.7	22.1	29.0	23.2	31.0	31.9	28.2	28.3	28.6	35.7	23.3	22.9	30.1	30.5	28.0	58.4	17.7	19.7	34.1	19.2	25.9	22.9	29.8	20.4	26.0	31.7	25.8	25.9	28.3	34.1	25.9	28.8	33.9	18.9	36.2	25.7	56.1	23.5	52.8	27.4	31.2	59.1	37.0	22.4	23.3	60.7	54.7	63.5	53.4	56.0	61.3	55.8	68.3	79.1	71.8	59.1	89.1	74.3	99.0	86.4	74.6	33.9	53.6	66.2	72.4	87.6	87.3	68.9	159.5	53.8	81.9	58.8	190.4	88.0	74.4	71.9	57.5	54.6	80.3	89.5	87.3	79.2	76.0	78.9	46.3	107.8	111.7	55.0	166.0	54.2	90.4	73.7	93.3	111.7	50.7	44.7	66.0	61.1	48.7	60.1	60.7	75.1	90.7	63.1	41.5	74.5	39.9	60.7	87.4	129.9	163.3	69.8	337.5	27.7	51.7	23.9	44.1	32.7	26.7	39.4	44.3	41.9	44.5	43.8	35.8	37.9	38.1	14.9	44.6	25.9	41.5	61.5	22.6	21.9	23.2	23.4	26.6	23.3	22.9	17.7	19.7	20.4	18.9	23.5	23.3	28.9	41.7	51.8	46.0	78.4	75.8	68.1	116.9	44.9	60.2	30.8	31.0	32.5	40.0	70.7	42.3	29.2	88.1	77.4	31.8	37.2	62.3	243.3	47.5	56.1	48.1	33.6	58.5	128.7	68.3	75.4	47.0	24.5	60.7	57.0	238.1	36.0	35.5	52.9	37.0	93.2	35.8	71.2	40.6	65.4	76.7	58.4	49.1	64.0	49.6	92.9	46.3	72.1	64.3	85.0	71.4	42.1	52.3	63.4	46.4	45.8	55.6	58.6	60.5	52.6	44.6	47.9	120.3	58.8	50.3	59.1	44.2	81.8	84.0	42.4	50.7
PPIB	"B, CYP-S1, CYPB, OI9, PPIase, SCYLP"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155740-64163134	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease variant, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1473.7;Plasma cells: 2242.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		33000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	375.5	377.5	230.7	449.5	240.3	571.9	361.9	247.9	259.2	611.5	257.2	401.0	365.0	383.9	899.0	298.8	401.5	379.2	262.0	229.7	256.9	312.3	737.4	351.1	344.5	258.1	241.4	386.2	644.2	345.4	416.8	515.2	255.1	375.7	411.3	72.3	513.1	488.6	62.2	205.5	334.3	482.4	247.0	360.5	375.0	110.0	254.9	315.6	672.8	91.1	346.4	510.9	295.6	262.6	675.6	847.9	736.7	1666.7	2577.0	1492.3	641.9	1570.3	2108.3	1248.7	1472.3	1242.6	1223.1	653.6	1227.4	2513.0	1235.3	1067.7	1384.6	1080.4	641.1	406.2	491.0	914.5	915.3	1643.7	2682.9	915.0	778.1	1374.2	1149.4	725.9	1751.3	1516.7	1539.2	301.1	645.9	2174.7	966.0	1102.6	280.6	1404.9	625.1	1879.0	529.5	520.6	784.1	3347.9	1312.7	1062.6	410.5	647.7	726.0	1224.5	1194.2	1086.0	727.6	2767.0	927.6	1213.7	975.8	679.2	1079.4	1152.5	1269.5	693.4	1129.0	1478.0	1238.2	716.7	712.5	491.7	929.6	547.3	931.8	827.8	645.0	762.4	930.9	541.4	411.3	558.0	347.5	668.1	369.3	2643.5	569.3	1512.3	230.7	240.3	247.9	259.2	229.7	256.9	258.1	241.4	255.1	247.0	254.9	262.6	389.3	125.0	209.0	16.6	375.3	160.2	426.2	614.6	234.5	34.5	264.3	303.8	0.8	270.2	328.7	272.2	31.3	625.9	560.0	271.0	90.1	665.1	19.0	295.8	910.1	285.0	297.0	172.6	10.2	566.4	1473.7	627.8	441.4	494.2	181.2	540.4	322.7	473.2	630.1	45.4	15.8	603.9	205.4	216.9	333.4	29.5	456.3	316.6	281.1	19.7	299.1	149.1	368.7	35.2	37.0	435.1	338.9	393.1	2242.6	569.3	338.6	287.4	168.2	43.7	230.1	204.3	445.6	38.4	76.6	337.0	144.8	1118.9	352.3	674.0	477.2	422.3
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709127-158723396	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		480000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	26.8	38.3	38.0	24.4	40.2	25.1	22.8	40.4	77.6	25.4	46.4	33.9	50.6	24.2	19.0	27.7	24.1	18.8	49.6	40.1	44.2	39.5	87.6	19.8	28.6	39.0	39.4	24.2	31.7	17.0	28.6	21.6	40.2	23.5	20.3	36.2	23.3	18.7	88.9	36.1	45.3	18.9	39.6	29.1	29.0	24.1	42.2	24.3	23.9	45.5	25.8	27.4	24.0	46.9	46.7	42.3	41.8	57.7	60.7	45.2	63.1	44.9	24.3	40.3	30.4	55.4	30.9	48.9	19.7	42.0	63.4	35.1	127.9	51.5	48.8	162.9	44.4	87.5	36.5	76.9	46.8	55.6	63.0	28.9	41.2	34.6	51.5	52.0	44.6	81.9	111.0	84.4	45.5	44.6	80.0	49.9	57.9	75.5	55.8	35.9	20.7	41.7	44.6	23.0	70.2	47.1	33.8	69.2	65.6	60.0	31.9	52.2	43.7	40.1	45.3	44.7	60.2	48.3	107.2	62.0	51.1	59.4	41.1	68.8	23.9	55.2	31.1	35.4	36.0	22.3	30.2	29.1	26.4	25.4	30.9	32.0	32.9	40.5	37.7	26.9	37.0	28.0	38.0	40.2	40.4	77.6	40.1	44.2	39.0	39.4	40.2	39.6	42.2	46.9	29.2	6.4	13.4	13.1	24.8	10.1	29.7	17.5	9.1	30.2	19.1	20.8	59.7	25.8	27.9	27.6	22.9	41.5	38.7	17.1	37.2	39.2	39.0	66.1	39.9	25.1	19.6	17.4	24.3	23.0	49.5	24.3	14.3	28.5	32.3	24.4	17.2	18.5	41.9	75.7	28.6	28.3	22.4	17.0	14.7	23.1	20.5	26.0	14.2	9.4	51.6	23.3	48.4	15.1	28.3	29.5	27.4	22.6	22.3	31.6	39.7	33.7	62.3	32.3	6.6	17.7	58.2	96.0	77.5	16.9	11.8	47.6	33.7	33.7	32.0	20.2
PPIL2	"CYC4, Cyp-60, UBOX7"	ENSG00000100023	"Peptidylprolyl isomerase like 2"	Q13356	22	21666000-21700015	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"K-562: 190.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035344, HPA055637"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA035344: AB_10672863, HPA055637: AB_2682869"	"unprognostic (1.97e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.77e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.46e-2)"	"unprognostic (5.39e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-3)"	8.9	14.2	4.7	12.8	5.7	6.3	9.5	4.0	7.0	11.6	2.1	12.1	8.1	12.0	9.3	16.4	10.7	9.5	13.9	5.8	4.8	12.6	15.0	10.1	16.4	3.5	2.9	10.7	19.2	16.4	14.3	9.1	3.9	12.4	10.6	9.0	14.7	9.5	18.8	12.3	13.3	9.9	3.6	14.0	13.9	10.1	3.1	15.8	18.8	13.0	16.4	11.7	12.1	4.8	20.4	17.1	18.1	20.1	19.2	17.6	15.8	19.3	17.9	28.0	24.5	21.3	10.3	34.0	12.7	27.2	13.9	22.9	28.6	23.6	16.2	19.2	28.2	26.7	14.2	32.4	14.7	42.5	21.5	17.4	21.2	19.4	14.0	15.1	25.1	18.5	190.3	17.9	19.6	28.6	20.5	13.7	20.2	35.7	14.9	23.7	31.1	5.7	14.2	14.1	30.8	18.4	21.2	32.7	9.7	11.3	27.1	20.3	27.5	15.8	25.1	17.5	12.7	19.2	17.5	24.7	21.6	22.6	24.9	1.5	9.7	5.1	9.6	15.3	12.2	7.2	11.5	12.6	13.7	8.3	10.5	9.4	2.3	14.1	22.6	11.9	15.6	12.1	4.7	5.7	4.0	7.0	5.8	4.8	3.5	2.9	3.9	3.6	3.1	4.8	9.8	9.6	29.5	15.0	21.5	3.2	7.9	10.9	10.8	26.3	13.4	10.2	5.7	27.1	16.6	14.7	33.3	15.8	39.4	23.9	13.7	12.8	66.8	15.4	14.8	8.0	11.4	17.7	19.9	16.7	13.3	10.3	39.3	19.5	17.1	16.6	10.4	18.9	15.3	18.5	24.2	20.6	14.2	21.0	5.3	90.9	12.2	15.5	1.8	8.4	16.6	11.5	52.5	12.5	17.4	18.5	17.4	13.5	23.8	10.9	14.2	9.1	11.9	31.4	0.0	11.2	9.4	23.6	17.3	12.3	5.7	22.2	24.5	14.8	20.8	12.6
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA040765: AB_2677125, HPA062187: AB_2684706"	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	13.0	16.4	15.2	19.8	14.9	35.1	25.4	17.0	22.3	15.7	13.9	19.0	14.6	20.2	28.4	18.6	22.5	13.0	18.2	14.6	16.8	18.4	21.9	15.0	32.2	15.7	15.5	35.4	12.1	14.0	14.9	17.7	16.8	15.1	19.5	25.8	17.1	18.2	18.0	18.0	18.1	12.4	15.4	17.5	19.0	21.1	15.5	30.1	20.8	11.1	32.5	16.2	12.5	18.2	19.9	18.3	53.0	23.5	42.5	90.8	17.5	32.0	35.3	37.1	37.2	13.0	37.5	19.5	32.0	35.4	41.9	24.6	19.3	38.1	33.2	41.4	43.8	84.0	48.3	90.6	21.3	79.7	39.8	32.7	37.7	30.3	47.1	62.0	25.3	38.4	67.4	46.3	46.3	32.4	61.7	67.2	32.9	19.8	28.9	23.3	30.5	29.1	49.6	30.4	22.2	21.1	31.3	29.9	51.7	62.3	24.6	36.9	34.2	51.4	28.8	31.2	26.2	45.5	51.0	94.2	39.6	36.2	33.7	36.2	17.5	19.7	17.5	16.4	25.5	35.2	20.9	17.7	30.9	26.7	25.3	27.6	4.5	31.8	23.1	25.6	30.3	14.6	15.2	14.9	17.0	22.3	14.6	16.8	15.7	15.5	16.8	15.4	15.5	18.2	12.5	0.0	11.5	16.0	33.6	31.7	43.1	71.5	37.5	12.0	23.7	28.2	18.5	15.7	30.4	16.5	10.4	50.3	24.8	9.7	56.7	26.0	44.1	16.1	21.4	16.2	9.5	25.5	19.3	16.1	51.6	22.1	16.3	13.4	26.0	17.2	13.6	19.4	47.0	3.3	18.1	25.3	48.8	32.1	59.1	9.5	36.7	26.8	28.4	9.4	30.2	23.1	37.0	15.1	19.7	18.2	18.1	28.2	24.5	15.9	25.4	59.7	28.7	11.9	19.7	18.2	39.6	45.7	22.6	34.5	46.3	30.8	31.1	8.9	29.4	35.6
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504495-149546043	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	19.6	19.2	12.3	15.6	15.0	36.4	20.3	19.8	18.3	18.1	9.6	15.4	14.2	20.1	25.7	13.7	16.5	18.9	15.9	13.1	18.0	17.9	22.9	16.1	17.2	10.6	12.8	27.3	14.8	18.8	18.8	22.7	10.9	19.2	16.0	13.1	15.8	15.2	10.7	14.4	14.6	14.7	11.1	17.4	16.4	16.3	17.0	18.5	25.7	11.5	17.1	20.9	16.9	15.8	22.7	12.0	41.0	34.7	23.8	30.9	38.1	43.8	41.1	46.4	49.2	25.1	22.8	23.8	29.4	33.9	27.9	20.1	31.5	16.5	73.1	34.7	29.7	26.4	27.0	43.9	37.3	49.2	21.6	24.3	27.8	47.6	39.7	26.2	25.7	17.1	58.1	14.0	36.5	24.2	28.1	41.8	32.6	22.6	18.5	37.2	37.7	11.9	35.6	17.0	24.1	18.4	52.0	22.4	31.7	28.2	26.5	35.1	31.0	30.8	24.3	55.1	42.3	18.4	9.9	37.0	26.3	38.7	45.5	34.1	17.1	20.4	15.1	19.9	21.0	23.7	19.5	17.5	18.2	17.9	24.5	18.8	14.5	32.0	19.3	17.9	23.7	16.5	12.3	15.0	19.8	18.3	13.1	18.0	10.6	12.8	10.9	11.1	17.0	15.8	54.8	67.3	70.7	25.1	49.7	48.8	56.4	49.0	30.7	46.2	29.5	34.9	45.6	18.6	59.7	46.0	8.4	50.4	48.4	16.9	43.0	42.0	24.4	57.6	55.7	43.2	23.3	25.4	37.3	26.3	46.2	76.2	20.9	48.2	77.1	30.9	33.5	21.3	37.3	28.6	34.7	22.9	48.8	25.2	43.8	12.0	61.8	38.3	40.9	21.5	45.5	42.0	28.8	27.2	41.1	32.2	21.9	56.1	29.4	33.8	19.7	37.6	71.9	37.1	52.6	66.1	70.5	75.9	59.3	22.5	45.3	65.3	53.4	47.7	22.3	43.0
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 35.6;testis: 18.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 374.4;Endometrial ciliated cells: 226.5;Late spermatids: 75.1;Respiratory ciliated cells: 228.6;Spermatocytes: 101.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;ASC diff: 9.2;ASC TERT1: 11.5;hTERT-RPE1: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.1	0.9	4.7	0.6	5.2	0.2	3.0	5.7	5.3	3.8	12.2	1.3	1.4	3.0	9.0	1.4	35.6	1.1	2.1	4.8	5.2	4.3	0.6	4.7	0.6	7.5	8.2	5.3	2.3	5.2	2.7	1.1	5.5	1.2	1.0	7.4	2.3	2.7	4.3	1.3	0.7	2.0	7.2	0.8	1.7	18.9	5.1	0.8	11.1	1.7	0.6	1.5	1.2	7.6	1.4	1.2	1.1	6.0	9.2	11.5	0.6	0.0	2.2	0.5	0.1	0.1	1.6	0.0	0.4	0.6	0.8	0.9	1.0	0.0	0.3	0.4	0.4	0.5	0.1	0.0	4.6	0.5	0.2	2.4	5.6	0.2	3.5	8.6	0.7	1.3	0.6	0.4	0.4	0.6	0.1	0.7	0.2	4.0	0.8	0.6	0.0	0.5	4.7	0.1	1.3	2.1	0.1	0.3	3.9	0.3	0.4	0.9	0.3	0.1	0.2	1.0	0.2	0.2	0.1	0.1	1.9	0.1	0.4	0.8	0.1	0.2	0.1	0.1	0.1	1.5	0.2	0.1	0.3	0.5	0.1	0.1	0.4	0.4	0.1	0.4	0.1	0.2	4.7	5.2	5.7	5.3	4.8	5.2	7.5	8.2	5.5	7.2	5.1	7.6	2.6	6.4	6.9	11.8	1.8	2.2	3.7	18.2	2.8	2.4	5.7	7.0	3.7	2.8	22.1	3.7	2.1	0.8	0.4	0.9	25.4	1.9	374.4	226.5	7.3	1.8	3.0	0.4	15.0	1.2	0.8	3.9	2.6	5.8	0.0	4.1	1.1	0.2	0.4	1.7	6.1	2.0	22.4	0.0	0.3	75.1	5.3	1.1	3.6	3.7	0.6	7.8	0.0	8.5	6.2	0.7	0.8	5.3	0.8	3.8	1.5	13.0	228.6	13.4	0.0	5.2	5.6	101.4	21.5	1.9	3.0	0.7	1.2	3.0	2.0	1.5
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 728.1;vagina: 288.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Squamous epithelial cells: 138.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 86.5;HaCaT: 191.1;MCF7: 71.5;SiHa: 102.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		80000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	56.3	4.9	2.5	1.0	3.2	0.2	39.8	0.3	4.2	163.0	3.3	10.4	6.5	5.7	7.3	728.1	11.5	7.1	5.7	3.6	0.0	13.2	13.3	18.6	0.4	0.0	2.8	5.9	10.6	4.1	14.3	6.4	1.1	17.3	3.4	2.4	149.5	11.5	12.0	188.4	12.3	1.7	0.0	0.3	11.1	1.9	0.0	3.5	22.1	5.3	57.0	22.0	288.6	0.5	24.0	8.6	0.1	0.1	60.0	86.5	29.6	0.1	1.6	0.2	0.6	39.5	59.5	0.4	13.5	1.2	3.4	191.1	1.3	23.0	0.0	0.0	1.3	0.1	46.3	7.1	3.8	0.1	0.1	4.2	20.7	0.2	7.1	4.6	0.1	0.2	0.2	0.2	0.1	71.5	0.1	0.2	6.0	31.3	18.1	0.1	0.1	30.0	44.6	37.5	30.9	0.3	102.5	33.8	0.3	8.9	17.4	0.5	0.3	0.2	0.3	0.3	0.1	0.4	1.1	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.2	0.3	4.2	3.6	0.0	0.0	2.8	1.1	0.0	0.0	0.5	4.1	73.7	29.1	1.6	1.2	35.1	32.5	30.5	35.9	8.4	18.8	13.8	5.1	35.8	42.6	57.0	6.2	2.1	2.0	3.6	1.9	18.4	0.7	31.6	4.1	8.0	39.4	0.0	6.6	4.5	1.6	38.0	9.2	28.0	0.0	0.8	2.9	12.7	0.7	1.7	2.5	3.8	18.3	0.9	9.0	1.3	55.3	1.4	17.8	1.0	1.2	3.7	2.1	1.0	1.7	23.4	8.3	4.1	0.2	35.1	13.5	1.2	32.5	12.5	0.0	28.7	4.3	3.9	3.1	138.0	51.3	1.4	2.7	0.4	4.8	53.2
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	4.4	2.4	2.7	2.2	5.2	5.9	3.9	14.8	4.6	4.5	5.0	3.1	2.9	4.3	2.9	3.5	3.7	3.1	2.9	3.3	3.4	2.8	2.8	3.6	2.7	4.0	3.5	6.3	3.3	2.3	2.4	5.9	4.7	3.1	3.5	6.4	3.1	2.2	4.0	2.9	2.7	3.0	3.4	3.8	2.7	5.5	3.7	4.4	2.9	3.1	2.3	2.8	4.0	9.1	3.8	6.9	7.5	6.4	5.0	3.1	10.7	5.8	3.6	3.4	4.9	7.1	2.0	9.9	4.5	3.7	1.3	3.4	4.9	2.2	4.6	1.9	11.1	7.4	6.7	8.1	4.2	2.9	5.3	2.7	3.6	5.1	3.0	2.8	7.9	4.1	5.4	4.0	3.7	34.4	8.1	4.4	3.5	3.4	5.2	9.5	9.6	6.6	3.1	4.2	10.5	7.4	7.1	2.4	1.6	8.0	2.8	3.9	5.7	4.7	12.5	3.5	3.3	6.7	7.7	7.3	1.7	2.9	3.8	9.9	16.1	18.0	7.6	12.5	6.8	8.9	6.3	7.0	16.0	6.2	6.8	7.0	24.7	8.6	8.1	7.0	10.6	9.8	2.7	5.2	14.8	4.6	3.3	3.4	4.0	3.5	4.7	3.4	3.7	9.1	40.9	32.1	7.7	15.0	23.1	21.0	6.2	3.3	52.3	13.1	14.2	9.8	6.3	8.6	4.6	5.5	4.2	17.6	19.4	15.0	3.9	6.6	68.9	14.0	15.5	25.2	14.4	14.1	19.6	6.6	6.4	14.7	10.2	15.6	1.3	7.2	23.6	4.2	8.8	3.3	20.8	11.4	6.1	21.4	19.2	12.8	13.7	16.1	3.6	28.1	12.3	7.0	6.2	20.6	38.6	5.4	10.2	7.5	24.5	7.8	8.7	5.1	3.6	10.4	0.0	12.1	14.0	43.8	15.0	34.4	18.0	38.6	18.1	6.0	11.5	7.7
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755854-58985179	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 39.2;retina: 22.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;prostate cancer: 3.0"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 31.6;hippocampal formation: 39.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.1	5.5	5.3	0.1	4.8	0.0	0.1	1.0	31.6	0.2	0.0	0.1	0.1	0.3	0.9	0.0	1.5	0.1	1.0	39.2	7.3	0.7	1.0	0.2	0.2	1.9	4.2	0.2	0.6	0.3	1.3	0.0	3.2	1.4	0.0	22.3	0.2	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.5	6.7	8.0	0.2	0.1	0.1	0.2	0.1	0.1	2.3	0.0	0.1	12.2	0.6	0.0	0.0	0.9	0.0	0.0	0.9	1.4	0.0	0.0	8.0	0.1	0.1	2.7	0.0	19.9	0.0	0.5	0.2	5.9	0.0	0.2	0.0	1.3	0.6	2.6	0.3	1.6	0.1	0.0	0.6	0.0	4.9	2.1	0.0	0.0	3.6	9.9	0.0	3.5	0.0	1.0	0.0	1.5	0.0	0.0	0.0	9.1	18.7	0.3	0.0	1.3	0.1	0.0	8.7	0.0	0.0	2.2	0.0	2.9	0.1	0.1	5.4	0.3	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.8	1.0	31.6	39.2	7.3	1.9	4.2	3.2	0.3	8.0	2.3	0.1	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.4	3.3	0.0	1.8	0.0	31.3	0.0	0.0	0.1	0.0	0.0	30.8	3.9	0.1	0.3	3.0	0.0	220.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.4	0.1	77.4	288.4	0.0	0.0	0.3	0.0	17.6	0.0	0.1	0.0	5.6	0.0	4.2	0.0	109.1	38.4	0.0	0.2	0.4	0.0	1.3	0.0	0.1	0.0	13.8	0.0	0.0	0.5	12.1	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919425-21952848	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endothelial cells: 42.2;Hepatic stellate cells: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 28.6"	"Group enriched"	"Detected in all"	7	"dendritic cells: 8.9;granulocytes: 28.6;monocytes: 24.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 109.1;K-562: 173.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		510000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	24.1	18.1	14.9	21.6	13.9	26.8	17.6	11.6	15.7	18.5	11.8	17.1	8.9	19.9	3.8	22.1	15.0	12.2	16.8	14.5	19.4	18.4	8.0	26.1	15.2	16.8	16.4	12.5	12.3	6.4	8.5	26.6	17.3	15.8	4.2	3.7	10.9	14.3	17.0	14.8	13.8	12.1	15.3	35.8	12.0	6.3	17.1	7.8	12.4	10.5	7.8	22.0	15.9	15.4	28.9	30.1	19.0	18.6	10.4	18.1	23.9	32.1	18.9	27.7	19.0	13.8	11.3	17.3	39.0	22.7	11.8	33.9	8.3	19.9	9.8	24.7	27.1	66.8	14.5	13.2	17.1	25.0	17.4	17.1	5.9	27.1	12.6	19.6	109.1	16.9	173.4	7.2	35.9	26.2	15.0	19.3	8.0	9.2	32.7	21.9	49.0	5.2	9.4	12.1	7.7	29.6	30.4	10.0	25.7	7.4	12.5	17.2	93.1	33.1	33.4	30.5	31.1	14.1	12.2	19.6	33.5	46.7	64.7	0.0	12.8	5.9	1.7	21.0	1.0	1.1	1.1	0.9	8.9	0.9	1.0	1.3	28.6	3.1	24.4	2.2	2.4	5.4	14.9	13.9	11.6	15.7	14.5	19.4	16.8	16.4	17.3	15.3	17.1	15.4	32.1	6.4	6.0	11.8	5.5	8.2	5.2	4.9	8.6	8.3	7.4	9.9	11.9	8.6	4.1	1.8	2.1	16.6	5.1	1.4	3.9	5.2	2.0	3.0	9.4	42.2	6.0	5.5	11.6	5.1	10.0	8.4	3.1	3.8	3.8	10.4	56.4	6.5	20.6	8.4	12.7	4.2	6.1	37.0	22.0	1.5	7.2	23.4	7.2	18.7	30.9	4.1	6.2	12.5	6.8	7.4	1.1	6.8	5.0	7.4	2.6	4.4	4.0	6.5	6.6	17.2	8.2	14.2	13.1	8.5	5.7	3.0	6.4	7.1	4.5	6.6
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381195-27409591	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 233.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1540.4;Late spermatids: 3492.8;Spermatocytes: 793.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm		NA	NA		19000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	46.0	49.6	34.7	45.1	35.1	73.5	43.6	35.4	37.8	38.4	36.9	48.3	39.9	45.6	26.1	62.6	39.0	28.0	44.9	35.0	37.0	40.7	45.3	40.6	59.6	35.4	36.0	34.9	53.0	41.4	43.4	37.6	35.3	36.0	51.3	20.0	45.1	38.8	95.7	41.2	43.0	44.9	35.1	47.1	47.8	233.9	36.0	64.9	36.8	53.0	75.3	47.0	39.6	35.3	302.0	243.1	174.0	134.8	108.7	88.0	160.6	182.8	119.8	214.8	170.9	377.7	154.4	352.7	130.9	130.9	181.8	160.3	296.4	205.6	191.4	148.4	241.1	343.6	172.9	404.0	97.9	343.5	139.2	95.7	116.9	219.2	175.1	101.7	209.1	171.1	293.3	106.0	165.5	269.4	256.7	370.5	254.1	207.1	173.1	261.1	365.0	185.3	145.9	206.4	233.2	264.0	164.4	178.9	135.9	137.4	99.4	111.3	169.5	159.3	192.6	141.6	281.8	229.0	277.0	545.5	124.8	275.6	122.5	67.3	41.5	59.0	57.5	52.3	56.8	44.7	61.1	60.3	65.4	37.9	45.1	47.4	20.9	55.0	71.4	91.9	88.9	48.0	34.7	35.1	35.4	37.8	35.0	37.0	35.4	36.0	35.3	35.1	36.0	35.3	72.9	64.1	51.3	9.8	76.7	81.1	88.7	71.9	83.6	40.8	63.1	59.3	37.9	52.9	63.7	69.9	29.2	93.9	114.2	81.0	33.2	135.7	1540.4	102.7	75.8	80.8	80.7	119.6	19.5	139.3	163.8	56.6	69.3	89.8	59.1	76.1	40.4	44.7	85.4	48.8	21.1	78.9	54.9	59.7	75.7	3492.8	70.2	68.2	24.9	17.8	127.3	69.7	112.3	17.1	15.9	156.7	52.7	71.1	137.8	152.1	52.6	61.4	61.8	41.7	46.0	54.9	80.5	793.3	298.9	108.7	80.6	53.1	89.7	123.7	106.4	122.6
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643994-62935150	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;parathyroid gland: 42.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 123.5;Glandular and luminal cells: 81.6;Inhibitory neurons: 162.1;Microglial cells: 89.9;Oligodendrocytes: 341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 80.6;HMC-1: 62.7;SK-BR-3: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816"	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.2	1.5	12.0	1.2	12.7	3.1	4.9	30.0	16.0	7.5	5.7	2.4	3.1	6.2	6.7	0.6	6.5	6.7	2.4	13.3	15.7	10.6	3.4	2.7	1.2	11.1	11.3	9.6	3.9	42.4	8.2	6.5	14.9	13.4	3.0	26.7	11.4	6.0	1.1	0.8	1.7	1.5	7.8	0.9	5.7	0.9	16.5	4.3	3.2	1.3	1.7	2.1	0.3	16.2	1.2	12.4	2.2	0.2	0.5	0.0	26.5	2.9	2.9	1.8	0.6	80.6	5.7	0.0	2.7	1.4	1.8	1.6	8.7	0.2	1.1	0.2	4.3	15.2	2.4	18.4	0.1	4.6	62.7	0.1	0.3	0.0	0.7	1.9	0.3	2.7	4.0	0.0	1.3	9.5	1.5	2.2	15.9	4.1	5.9	2.1	5.6	23.0	18.1	28.3	6.9	0.0	5.0	35.6	12.1	8.5	19.6	2.7	0.2	0.5	1.5	0.2	0.9	3.3	21.4	4.1	0.2	0.1	1.2	2.9	0.7	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.1	12.0	12.7	30.0	16.0	13.3	15.7	11.1	11.3	14.9	7.8	16.5	16.2	4.6	6.4	4.7	25.5	1.0	0.1	0.3	3.0	0.0	9.4	9.5	3.4	2.4	12.8	5.9	16.5	27.1	22.2	0.0	0.7	3.9	4.2	8.5	27.6	25.3	6.5	9.0	3.8	123.5	6.3	2.1	1.3	7.7	81.6	14.5	0.3	9.7	6.1	6.1	11.8	162.1	2.0	6.1	1.6	2.1	10.1	0.9	2.1	3.6	89.9	2.1	6.4	0.0	41.7	341.4	4.5	2.1	1.5	0.5	4.3	0.1	8.5	14.0	10.9	0.0	0.6	1.7	0.0	0.5	0.5	0.1	6.8	1.3	2.8	2.4	0.5
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078902	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.7;Excitatory neurons: 344.6;Inhibitory neurons: 175.7;Oligodendrocyte precursor cells: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 4.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"HDLM-2: 79.8;U-266/70: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavorable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	6.0	5.9	7.6	2.2	8.5	2.4	3.2	11.0	13.4	7.3	0.0	5.9	1.9	4.2	1.9	6.2	4.1	5.9	6.6	9.2	5.6	5.8	3.2	3.0	1.0	11.3	7.6	2.2	3.7	15.5	10.1	8.6	13.1	4.0	3.9	11.3	15.2	2.2	21.8	6.0	2.5	4.1	0.0	2.2	6.1	1.7	12.7	3.5	10.7	17.8	2.2	10.8	4.0	0.8	2.6	1.7	8.7	4.6	5.1	0.1	5.4	0.3	0.2	0.9	0.3	0.5	0.6	0.5	0.8	0.4	2.0	8.1	7.4	0.5	0.3	79.8	7.9	7.7	7.0	0.9	0.2	4.7	8.6	0.9	3.5	0.2	0.5	0.6	0.5	3.8	0.3	12.0	0.1	4.2	1.8	0.5	5.1	14.2	1.7	9.5	1.5	1.8	0.4	8.4	10.5	9.0	4.5	5.2	0.3	3.0	5.7	4.7	0.4	0.9	0.9	0.7	2.9	75.6	0.3	4.3	1.1	3.9	1.9	0.4	1.6	3.2	1.5	3.5	0.1	0.1	0.3	1.0	0.8	0.6	0.5	1.0	0.1	0.6	4.9	0.4	0.0	1.6	7.6	8.5	11.0	13.4	9.2	5.6	11.3	7.6	13.1	0.0	12.7	0.8	2.6	6.4	2.7	126.7	1.5	8.7	5.7	3.0	8.6	59.4	4.7	3.0	33.9	8.6	10.9	1.8	35.5	3.8	11.6	12.5	0.0	2.1	1.2	3.2	17.5	5.3	13.8	3.4	344.6	4.3	3.4	6.5	11.7	6.8	0.0	2.2	2.5	18.1	7.1	6.7	175.7	8.0	14.2	15.4	7.2	1.2	5.0	14.0	3.6	53.4	6.6	10.2	26.8	111.6	77.4	2.2	8.3	5.3	2.9	5.9	2.2	3.7	9.5	10.4	0.0	42.5	21.4	2.6	3.4	13.1	8.7	2.6	3.8	2.6	5.6	21.2
PPME1	"ABDH19, PME-1"	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171267-74254703	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 432.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		45000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear bodies"	"CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254"	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	14.7	25.1	16.8	10.0	18.1	16.9	14.9	8.5	21.3	17.3	7.8	15.2	11.0	16.8	29.1	20.8	24.1	14.0	21.4	18.8	19.4	18.6	10.1	13.0	9.3	12.7	14.5	18.3	15.4	62.5	14.5	14.9	17.5	23.8	15.7	23.8	20.1	24.9	29.7	28.7	11.5	21.4	9.8	8.1	13.4	31.9	13.4	18.8	23.1	24.1	14.7	22.3	13.9	14.0	50.5	62.3	42.4	45.9	45.4	36.0	41.3	71.8	48.4	134.8	103.6	139.1	32.3	26.3	47.7	55.1	73.6	79.9	63.4	50.3	123.1	36.4	23.8	38.7	66.6	64.1	96.7	28.9	33.2	34.6	41.8	69.7	32.7	54.8	39.1	37.5	93.0	22.5	236.6	34.1	38.0	36.1	34.4	71.2	50.3	39.9	432.4	39.9	56.7	33.9	57.2	49.2	85.1	38.7	108.4	46.2	72.7	29.1	23.5	52.1	67.6	51.5	55.2	41.4	54.6	46.9	39.2	26.7	43.4	1.4	8.7	11.3	10.4	10.5	13.2	7.2	13.4	12.6	11.2	8.3	13.3	10.9	4.9	13.7	9.5	11.8	10.9	9.2	16.8	18.1	8.5	21.3	18.8	19.4	12.7	14.5	17.5	9.8	13.4	14.0	16.1	28.9	12.8	28.7	10.8	20.3	24.4	30.5	23.3	31.3	18.5	17.7	18.0	7.2	28.5	35.0	37.5	14.1	11.2	15.4	17.6	16.9	51.4	44.9	32.8	15.0	25.7	96.4	65.3	13.4	38.9	19.1	23.9	24.2	8.2	21.2	10.8	9.7	13.6	33.7	59.3	13.5	34.6	6.7	14.8	13.4	13.7	11.1	3.6	20.6	10.8	15.2	16.5	35.7	40.5	16.6	12.0	25.2	8.2	19.2	10.3	11.6	40.9	18.8	6.6	19.0	33.0	61.9	45.6	21.5	24.9	15.5	12.4	18.8	13.4	17.3
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398181-67421183	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: AB_2679829"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (7.60e-2)"	70.0	102.4	61.2	102.6	70.8	127.8	63.5	64.0	70.7	62.1	61.2	110.8	95.9	50.5	66.8	184.0	61.1	51.2	122.0	63.5	63.6	121.8	128.2	78.9	147.8	68.3	62.4	33.1	105.1	64.2	59.8	83.5	63.8	81.1	89.6	21.6	100.4	51.0	123.2	105.8	107.1	56.1	63.9	148.7	102.7	34.6	65.8	113.7	88.7	81.3	155.6	74.9	80.6	68.2	283.1	305.6	181.1	270.3	88.4	108.9	185.6	136.1	158.4	267.4	202.3	445.8	328.5	237.2	227.3	208.1	198.4	238.7	213.9	280.2	169.6	256.3	139.9	227.5	129.3	232.7	195.2	295.2	281.1	123.3	181.1	225.7	130.7	125.4	272.2	226.0	217.4	191.1	220.5	619.4	378.2	562.2	303.5	526.7	241.1	262.7	254.0	209.8	262.2	220.7	142.5	236.7	159.2	283.0	439.8	135.3	338.5	201.2	196.4	208.5	208.9	245.3	179.0	190.1	193.2	271.8	244.6	199.9	224.3	921.6	735.9	1234.1	779.2	962.9	604.3	733.4	679.9	792.5	705.3	779.6	412.6	584.2	853.8	688.8	1186.1	500.4	1098.7	2042.5	61.2	70.8	64.0	70.7	63.5	63.6	68.3	62.4	63.8	63.9	65.8	68.2	49.2	76.9	92.2	8.8	165.8	99.9	143.5	305.9	64.3	35.5	81.7	79.1	8.4	102.9	157.8	86.5	10.4	360.4	151.2	377.5	213.2	265.6	2.5	63.1	67.2	101.6	96.9	108.8	8.8	311.1	507.0	68.8	132.0	107.1	109.6	87.1	89.3	113.9	377.1	43.7	7.7	241.3	181.0	219.8	138.5	7.7	49.0	186.5	136.9	9.4	353.0	53.8	408.8	6.0	13.1	318.4	308.4	28.6	206.5	139.0	341.3	297.4	70.5	30.5	98.6	67.1	100.7	13.6	94.6	142.0	121.6	427.3	176.3	100.1	231.7	205.4
PPP1CB	"MP, PP-1B, PP1B, PP1beta, PP1c, PPP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 985.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022558: , CAB069426: , HPA065425: AB_2685489"	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	90.9	75.2	55.8	74.7	73.5	119.1	110.5	55.6	74.9	148.6	67.8	109.2	84.8	138.4	104.0	245.7	113.5	103.1	185.2	54.3	73.8	84.4	70.5	73.3	60.4	73.9	61.2	92.7	76.2	126.9	45.9	74.8	74.5	149.1	92.9	70.8	114.6	123.4	386.0	73.7	76.0	159.7	71.8	65.8	81.7	47.6	63.5	71.3	78.8	262.8	91.1	118.0	104.1	88.2	186.0	114.6	391.1	121.7	130.8	121.0	227.0	97.7	110.6	92.2	91.0	102.6	106.9	147.5	119.2	101.5	102.7	111.4	112.6	129.9	109.8	235.9	58.2	111.3	130.1	111.5	284.3	127.8	50.5	93.5	181.3	100.1	207.8	97.4	113.8	77.0	103.6	140.4	123.3	93.2	136.9	110.3	128.3	141.8	89.8	132.2	344.9	112.7	304.3	220.6	106.7	131.3	151.4	166.2	136.2	111.4	80.4	70.6	137.6	122.6	134.6	89.3	119.0	100.4	171.0	299.8	130.1	135.0	93.5	72.4	59.4	84.9	39.8	96.7	50.8	38.6	59.3	46.8	65.4	31.6	51.8	58.8	103.6	61.4	115.2	49.8	74.3	52.8	55.8	73.5	55.6	74.9	54.3	73.8	73.9	61.2	74.5	71.8	63.5	88.2	172.2	93.0	80.6	59.4	147.8	492.1	176.7	101.5	64.9	62.4	208.0	117.0	352.1	112.9	124.1	310.8	27.1	129.6	210.4	324.5	244.6	297.0	514.0	330.2	245.7	129.3	283.0	200.2	68.5	210.5	202.1	147.8	78.5	258.9	146.6	91.2	137.8	108.7	114.7	163.2	71.8	144.2	111.9	182.6	985.1	406.2	196.7	238.1	336.2	59.0	137.9	116.6	55.6	64.3	68.4	236.8	181.3	302.0	100.9	364.9	106.6	227.4	213.3	65.2	631.1	225.8	264.8	55.2	66.6	135.6	458.0	392.9	237.7	65.8	154.4	498.9
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600413-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	20.9	27.5	0.2	12.0	0.1	1.0	15.8	0.2	1.3	23.3	0.1	21.8	8.9	21.2	1.1	23.1	22.0	10.7	14.6	0.5	0.4	22.8	33.6	17.4	5.0	1.2	1.3	22.8	28.0	4.8	26.3	5.0	0.6	22.8	6.4	5.2	20.1	7.9	23.0	21.1	21.0	7.0	0.3	25.1	25.2	21.7	0.3	10.1	22.9	1.2	5.6	22.5	21.8	0.2	9.1	20.0	30.9	16.8	17.0	2.2	8.9	15.9	7.0	5.6	23.3	5.0	9.7	11.5	9.6	16.0	10.5	23.6	24.3	35.7	9.7	13.1	0.0	19.8	14.1	0.2	7.6	16.3	27.3	14.2	4.0	28.0	30.9	13.2	9.7	3.9	18.4	3.7	14.4	5.4	5.5	2.4	9.1	1.9	2.3	25.4	39.3	19.8	1.4	8.0	19.3	9.1	29.5	28.3	8.8	13.0	13.8	21.8	2.6	12.7	9.0	18.5	10.7	26.9	5.1	11.3	15.8	19.9	15.8	7.9	1.2	2.0	0.9	2.1	1.6	2.9	0.4	1.7	3.3	0.7	0.5	1.1	1.0	1.0	0.8	1.2	1.9	0.4	0.2	0.1	0.2	1.3	0.5	0.4	1.2	1.3	0.6	0.3	0.3	0.2	243.9	32.1	40.3	20.5	152.7	69.8	64.9	41.1	167.9	72.7	165.1	163.8	59.1	28.6	34.2	27.6	131.3	44.0	178.9	120.5	35.2	27.2	32.0	138.2	103.8	102.6	71.3	30.5	26.1	23.0	21.8	103.2	107.0	151.4	44.9	143.0	38.2	33.6	33.1	35.3	27.0	102.2	54.9	35.5	70.6	11.3	46.3	123.4	37.4	30.0	46.4	59.0	72.1	21.1	29.7	29.8	58.3	30.1	140.1	51.9	88.1	40.3	46.9	102.2	32.9	211.5	114.9	45.9	23.4	125.7	77.9	88.5	144.1	99.9	77.0	34.5
PPP1R13B	"ASPP1, KIAA0771, p53BP2-like, p85"	ENSG00000088808	"Protein phosphatase 1 regulatory subunit 13B"	Q96KQ4	14	103733195-103847575	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 106.1;Granulosa cells: 83.4;Inhibitory neurons: 105.9;Late spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006394, CAB015454"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"CAB015454: AB_2252775, HPA006394: AB_1079668"	"unprognostic (1.20e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (3.22e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.62e-3)"	"prognostic favorable (3.28e-11)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.23e-1)"	7.0	4.7	3.4	3.2	4.2	0.7	7.4	6.6	8.5	6.8	4.0	7.7	7.1	7.6	2.1	11.6	9.8	4.7	21.2	7.6	3.9	6.9	5.0	9.9	2.7	1.2	2.0	10.9	8.3	7.8	6.5	6.0	1.7	10.7	5.6	8.0	10.2	5.3	7.5	12.5	7.6	5.2	0.3	11.3	10.1	19.1	3.8	2.0	23.4	6.2	5.1	8.0	7.1	4.2	4.9	4.2	0.5	5.4	0.9	0.4	1.9	3.2	2.3	4.0	1.8	3.3	4.4	1.1	11.7	2.2	4.9	9.8	5.8	3.7	3.5	2.2	4.0	0.0	1.3	5.7	3.6	0.5	4.4	1.0	4.4	0.3	4.7	1.7	7.9	2.8	0.7	1.7	2.7	20.3	0.0	0.5	1.0	12.3	5.1	11.3	3.2	2.7	7.8	12.7	6.6	16.9	9.9	7.3	2.5	2.6	18.4	0.7	7.1	2.9	4.0	2.4	3.0	4.0	5.8	8.4	1.8	2.9	1.4	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	4.2	6.6	8.5	7.6	3.9	1.2	2.0	1.7	0.3	3.8	4.2	35.1	19.2	39.5	31.0	7.1	13.5	16.6	6.9	18.8	15.8	31.3	20.6	45.4	14.3	11.8	7.3	12.5	2.9	11.9	26.9	3.9	7.9	58.0	37.9	7.9	30.3	15.6	2.7	106.1	6.4	1.0	7.7	37.8	48.5	0.0	83.4	14.3	9.0	2.9	15.2	105.9	14.2	6.1	1.6	5.7	78.4	4.4	3.0	3.6	49.6	0.4	5.8	1.0	31.7	33.2	6.8	18.7	20.3	6.3	13.1	14.6	7.8	8.3	12.9	6.6	10.9	6.7	17.8	15.1	24.1	12.9	2.2	9.0	8.7	15.8	13.7
PPP1R14A	"CPI-17, PPP1INL"	ENSG00000167641	"Protein phosphatase 1 regulatory inhibitor subunit 14A"	Q96A00	19	38251237-38256532	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 492.0;intestine: 450.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 332.5;Granulosa cells: 435.0;Leydig cells: 341.1;Peritubular cells: 656.0;Sertoli cells: 979.5;Smooth muscle cells: 465.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 299.4;naive B-cell: 283.9;plasmacytoid DC: 246.9"	"Group enriched"	"Detected in many"	24	"B-cells: 299.4;dendritic cells: 246.9"	"Group enriched"	"Detected in some"	4	"A549: 164.1;EFO-21: 112.2;K-562: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005044, CAB009803, HPA042097, HPA054534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		880000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518"	"unprognostic (5.40e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.25e-5)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (4.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.22e-2)"	134.0	144.2	175.2	22.1	347.5	2.9	111.9	321.5	226.5	149.7	63.2	450.3	18.6	273.5	5.2	47.6	153.7	14.8	94.6	175.2	219.6	53.3	17.9	163.1	2.6	402.3	322.9	125.1	31.1	2.8	12.6	34.1	336.3	142.0	12.6	0.3	19.0	86.1	27.5	28.6	82.1	57.2	222.0	101.2	140.3	77.6	365.3	1.7	25.8	12.3	1.4	301.6	106.1	492.0	0.0	164.1	0.4	0.0	1.0	0.0	6.1	10.8	0.0	0.1	0.0	12.8	0.2	0.0	112.2	1.0	0.0	0.5	13.6	0.2	0.0	1.4	0.0	25.5	0.0	0.0	4.6	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	64.5	0.3	0.0	0.8	0.0	0.3	4.9	0.0	0.0	0.2	2.4	0.4	0.4	0.0	3.5	0.2	0.0	0.0	0.1	9.2	0.0	0.4	0.4	0.0	0.8	0.4	0.0	0.4	0.0	0.5	0.2	0.0	0.1	11.3	0.6	1.2	0.1	0.7	0.2	299.4	0.2	0.4	44.3	283.9	0.6	0.1	1.7	8.7	0.2	246.9	0.2	21.6	175.2	347.5	321.5	226.5	175.2	219.6	402.3	322.9	336.3	222.0	365.3	492.0	332.5	0.0	1.1	1.3	29.9	9.6	3.0	1.2	3.4	0.4	8.8	209.8	19.6	2.8	0.7	0.0	0.0	48.3	48.7	32.7	0.0	0.7	14.1	15.4	239.5	108.5	1.8	34.7	0.5	10.9	7.4	66.8	2.0	10.8	3.8	435.0	224.5	2.3	9.5	0.0	0.6	0.4	0.0	5.6	24.6	42.1	341.1	41.4	8.8	14.0	66.1	0.5	4.1	3.5	155.6	2.2	2.6	656.0	4.8	2.4	3.8	0.3	0.0	1.6	979.5	8.7	465.2	9.9	46.2	0.6	8.0	26.4	3.7	66.0	0.4	1.2
PPP1R18	"KIAA1949, phostensin"	ENSG00000146112	"Protein phosphatase 1 regulatory subunit 18"	Q6NYC8	6	30676389-30687895	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 208.4;Kupffer cells: 164.4;Langerhans cells: 179.3;monocytes: 212.8;NK-cells: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 215.8;neutrophil: 169.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 215.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044745, HPA051000"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		11000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA044745: AB_2679070, HPA051000: AB_2681304"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.33e-2)"	"unprognostic (4.76e-2)"	35.4	16.7	9.5	42.5	9.1	56.0	25.9	9.9	12.8	30.2	7.0	38.0	8.8	36.8	3.5	18.1	28.6	25.6	23.2	9.4	12.1	14.2	16.8	51.5	75.5	17.8	12.6	26.8	10.1	2.7	7.0	21.4	15.5	19.7	7.7	2.6	15.4	11.5	10.8	21.6	33.7	17.3	13.7	80.4	19.5	5.9	15.6	53.5	17.6	9.0	38.2	36.1	24.4	13.9	63.2	9.4	34.4	37.3	28.0	80.4	1.7	48.4	63.6	43.3	29.9	6.6	11.2	64.7	25.0	77.3	73.7	35.8	21.6	44.7	29.6	74.8	2.2	79.3	20.7	6.6	59.1	28.6	116.3	44.0	44.0	97.9	89.8	64.5	60.0	53.3	27.2	58.2	57.8	6.9	40.8	43.5	3.2	1.6	13.8	162.8	28.8	33.9	18.0	3.4	3.8	19.2	30.1	10.9	65.9	18.8	9.4	26.8	90.8	139.4	29.2	29.4	103.3	11.6	57.3	77.3	40.7	131.9	155.9	43.0	16.4	215.8	43.4	21.8	31.8	20.9	23.1	42.5	9.5	22.0	16.7	32.5	169.6	37.8	25.2	14.9	39.7	22.6	9.5	9.1	9.9	12.8	9.4	12.1	17.8	12.6	15.5	13.7	15.6	13.9	39.1	3.2	15.7	1.6	89.7	109.0	29.6	15.7	79.6	2.3	14.2	14.6	3.1	8.6	4.6	9.2	0.0	3.1	116.5	0.8	0.0	25.1	24.2	4.4	24.4	67.8	1.8	35.4	0.8	8.2	20.4	34.1	7.1	6.7	53.2	5.9	32.9	8.2	208.4	3.3	1.3	0.8	8.2	164.4	179.3	19.9	27.7	123.3	39.2	19.7	212.8	1.0	332.7	11.1	0.1	20.8	0.0	23.3	52.9	23.8	0.4	2.5	4.4	3.1	26.3	28.6	53.5	1.2	1.3	38.3	59.7	4.0	141.6	6.8	0.7	22.5
PPP1R1C	Inhibitor-1-like	ENSG00000150722	"Protein phosphatase 1 regulatory inhibitor subunit 1C"	Q8WVI7	2	181954241-182131398	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"heart muscle: 21.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 168.5;Late spermatids: 219.8;Spermatocytes: 145.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055043			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA055043: AB_2797251"	"unprognostic (1.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.07e-2)"	"unprognostic (9.75e-3)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	21.1	0.3	1.0	0.0	0.8	0.1	0.0	0.7	0.8	0.0	0.3	0.0	0.4	0.0	1.4	1.0	0.0	1.8	0.0	0.0	3.7	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.7	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.4	0.4	0.3	1.0	0.7	0.8	1.4	0.1	0.1	0.3	0.1	12.8	8.7	6.2	0.0	0.3	0.6	1.2	2.8	1.1	0.3	0.3	40.6	17.2	8.1	3.7	0.0	3.1	0.0	0.5	1.9	2.5	168.5	1.7	0.1	0.6	6.1	0.0	1.1	11.0	6.6	2.4	4.6	0.8	0.0	0.0	0.0	18.5	0.6	0.0	19.4	0.4	10.2	0.8	0.0	219.8	5.9	0.3	3.6	1.9	3.6	12.0	0.0	3.5	0.7	23.1	0.1	0.7	0.0	0.3	0.0	0.7	1.6	1.7	0.0	0.4	0.8	145.1	2.6	1.3	0.3	2.5	0.0	0.8	0.6	1.0
PPP1R2	"IPP2, PPP1R2A"	ENSG00000184203	"Protein phosphatase 1 regulatory inhibitor subunit 2"	P41236	3	195514428-195543386	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 431.9;Spermatocytes: 354.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 142.1;U-266/70: 224.2"	"Low region specificity"	"Detected in all"							"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.13e-1)"	18.3	15.0	15.4	21.3	16.2	68.1	22.6	12.9	16.9	18.0	16.5	22.8	25.8	21.2	25.2	22.4	18.3	19.7	24.7	16.6	21.0	21.0	15.0	17.4	29.1	15.1	15.4	13.9	13.5	16.8	15.6	17.5	17.2	20.9	19.8	16.0	16.9	19.1	85.8	17.2	22.3	21.6	14.3	21.5	17.7	29.2	15.2	28.2	23.1	56.2	25.2	21.1	18.2	15.0	43.8	9.8	14.7	17.0	24.1	25.8	29.1	25.8	36.6	26.4	22.6	142.1	18.0	17.3	99.2	31.1	27.8	18.1	15.1	25.6	32.1	33.0	30.3	18.6	14.0	47.5	37.2	20.5	18.8	31.4	19.4	19.7	39.6	20.8	23.0	17.1	14.7	33.4	23.4	32.3	34.4	22.9	15.6	49.2	42.1	16.6	25.6	50.4	31.8	32.1	34.9	20.0	31.6	33.1	46.5	27.0	52.5	19.9	27.9	16.9	19.3	28.8	36.7	224.2	105.7	79.5	23.9	37.0	33.3	120.6	64.7	257.5	71.8	68.2	98.2	100.3	149.3	99.1	68.8	95.8	178.6	122.8	152.3	94.2	69.0	103.5	168.4	129.2	15.4	16.2	12.9	16.9	16.6	21.0	15.1	15.4	17.2	14.3	15.2	15.0	106.9	22.4	47.8	13.1	165.7	94.2	138.6	70.1	89.4	51.5	80.6	61.5	53.5	38.6	56.3	22.0	58.4	67.7	148.2	48.6	125.2	69.5	431.9	119.5	65.0	99.6	57.4	33.6	30.8	66.3	43.0	62.5	45.3	67.9	111.0	26.7	51.0	27.1	61.0	52.2	41.7	48.5	69.2	73.3	170.6	243.8	51.6	103.4	97.8	25.3	120.9	50.5	74.2	23.1	19.1	74.5	65.1	63.6	188.4	123.0	77.3	106.0	80.3	91.1	26.3	48.7	71.1	354.3	92.4	88.2	77.6	103.2	230.1	58.0	54.7	186.2
PPP1R21	"CCDC128, FLJ16566, KLRAQ1"	ENSG00000162869	"Protein phosphatase 1 regulatory subunit 21"	Q6ZMI0	2	48440598-48515391	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 99.6;Oligodendrocytes: 190.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036791, HPA036792"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"HPA036791: AB_10671713, HPA036792: AB_2675317"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.44e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (4.59e-6)"	"unprognostic (9.23e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (6.60e-2)"	9.3	10.6	10.6	10.5	13.4	9.9	8.5	8.2	13.4	8.5	10.7	8.8	7.9	12.7	19.6	12.1	14.5	10.8	10.1	9.7	9.4	28.1	11.6	11.2	13.3	11.1	11.0	13.4	8.1	33.5	9.6	12.8	10.2	11.4	10.6	12.0	5.7	10.6	5.7	10.5	9.9	13.0	8.7	13.0	9.0	9.4	11.7	13.9	21.4	4.8	12.2	9.5	7.6	18.9	17.3	8.2	6.8	8.5	17.1	12.5	18.3	10.0	11.0	6.1	7.2	4.5	10.6	11.8	16.4	14.2	11.7	9.3	5.8	9.1	12.4	15.1	4.8	12.6	7.2	10.8	11.6	5.5	9.8	15.9	8.1	11.0	13.2	15.1	15.3	5.9	5.2	19.2	16.7	9.5	10.9	9.5	17.7	12.3	8.4	9.1	18.8	13.1	11.9	10.8	9.2	5.7	19.0	4.8	18.1	18.2	8.6	9.0	13.9	6.4	7.8	5.6	8.0	14.3	4.1	10.5	10.2	12.5	8.6	18.6	4.7	8.1	3.7	5.4	2.9	5.4	4.3	4.4	5.0	6.8	6.4	5.5	11.6	3.8	4.8	3.1	4.6	2.3	10.6	13.4	8.2	13.4	9.7	9.4	11.1	11.0	10.2	8.7	11.7	18.9	14.5	22.4	16.5	37.5	23.6	10.5	32.9	8.6	13.6	9.1	6.9	6.7	11.0	14.3	9.2	25.8	2.1	21.7	8.5	11.7	5.9	11.0	3.9	10.2	11.5	10.9	18.7	10.3	99.6	8.4	16.3	15.0	25.5	12.3	12.0	12.4	10.8	13.6	35.2	28.6	49.6	10.7	10.2	26.1	12.2	5.7	12.2	19.3	12.4	44.0	24.3	21.2	19.6	69.9	190.3	12.2	9.3	20.7	19.4	17.0	10.7	59.3	20.0	6.8	13.1	9.6	14.2	9.8	10.8	17.4	14.1	27.1	20.5	12.1	8.4	27.2
PPP1R26	KIAA0649	ENSG00000196422	"Protein phosphatase 1 regulatory subunit 26"	Q5T8A7	9	135479079-135488893	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044686, HPA063817"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA044686: AB_10795987, HPA063817: "	"unprognostic (1.79e-1)"	"unprognostic (8.80e-3)"	"prognostic unfavorable (3.98e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (9.23e-2)"	"prognostic favorable (6.20e-13)"	"unprognostic (4.46e-3)"	"unprognostic (8.31e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.07e-3)"	5.0	8.2	10.3	2.4	9.9	0.8	6.0	6.2	12.8	6.8	8.2	8.9	6.2	6.3	3.3	7.0	7.2	3.6	12.8	10.7	10.3	11.9	10.2	9.3	1.7	8.8	9.6	7.2	12.9	14.4	15.6	4.1	8.4	9.5	3.3	4.6	10.5	7.1	6.1	4.5	6.4	2.5	7.6	5.6	11.5	7.4	11.2	1.4	10.6	5.1	2.1	9.0	5.7	7.8	12.0	17.9	9.2	9.6	3.9	3.3	0.1	6.5	8.7	8.6	5.6	17.5	20.3	0.0	12.0	6.3	21.9	43.7	8.5	8.3	2.7	0.6	9.7	0.2	28.0	13.0	9.1	5.8	21.3	2.4	15.3	4.3	10.2	9.3	5.4	0.0	12.2	0.1	4.9	27.5	0.2	1.9	13.6	24.4	24.3	0.0	16.3	19.9	8.1	15.8	14.2	20.8	11.4	15.7	12.2	7.0	12.1	5.3	6.7	3.2	14.4	15.5	7.4	8.8	22.3	0.4	6.7	1.2	8.3	0.0	0.3	0.8	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.1	10.3	9.9	6.2	12.8	10.7	10.3	8.8	9.6	8.4	7.6	11.2	7.8	3.1	3.2	7.7	10.1	0.7	2.2	1.9	4.9	2.8	10.0	8.4	5.7	10.4	15.7	3.8	7.3	8.4	0.6	0.3	8.9	5.9	5.7	0.3	7.5	2.9	3.1	6.6	1.7	3.5	3.3	0.9	2.2	4.1	9.0	2.5	13.6	3.9	5.9	6.0	1.7	4.8	8.9	4.1	3.5	1.6	0.9	1.2	2.3	3.6	1.0	0.9	8.3	2.1	3.5	1.4	7.4	7.1	1.9	1.0	4.7	6.4	5.1	5.8	7.1	0.0	3.4	3.6	0.5	4.0	4.6	1.7	0.3	0.4	5.1	8.3	2.6
PPP1R2B	"MGC87149, PPP1R2P3"	ENSG00000231989	"PPP1R2 family member B"	Q6NXS1	5	156850295-156852528	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	121	"testis: 21.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"U-266/84: 1.2"									"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PPP1R35	"C7orf47, MGC22793"	ENSG00000160813	"Protein phosphatase 1 regulatory subunit 35"	Q8TAP8	7	100435282-100436497	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.7"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021604, HPA051607"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021604: AB_2670774, HPA051607: AB_2681548"	"unprognostic (2.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.77e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.97e-4)"	8.8	16.7	7.8	11.9	7.7	8.7	9.7	9.6	13.8	12.3	8.7	10.6	11.5	10.9	2.2	11.1	11.0	3.1	9.4	7.7	8.0	12.4	12.9	9.4	14.5	8.2	7.7	13.5	10.5	7.8	11.9	6.8	7.8	11.2	2.4	2.4	9.9	5.4	6.3	7.8	12.0	2.8	8.0	22.1	10.9	48.7	8.2	15.3	12.0	3.5	5.5	10.3	10.3	7.7	41.0	14.7	11.1	19.4	3.3	4.9	14.5	11.6	10.5	8.2	9.4	6.8	36.2	14.0	22.2	6.4	39.3	17.4	5.9	9.4	1.8	30.9	18.3	11.6	11.8	14.1	14.5	12.2	16.4	6.8	17.0	7.3	12.0	14.1	17.2	38.8	21.1	24.1	9.9	34.1	36.2	64.6	23.0	17.1	20.1	14.6	4.7	37.9	11.4	9.5	11.8	35.0	8.9	62.5	35.0	6.9	18.0	28.8	13.9	12.2	18.4	16.4	28.9	37.9	23.1	20.2	13.3	19.6	25.0	17.1	2.3	5.7	5.8	1.0	6.2	4.3	5.9	6.6	1.7	5.4	3.3	3.2	10.5	3.8	0.7	7.6	7.6	2.7	7.8	7.7	9.6	13.8	7.7	8.0	8.2	7.7	7.8	8.0	8.2	7.7	47.7	16.0	9.6	13.1	30.8	21.0	39.9	13.9	28.5	35.7	51.3	60.6	2.0	27.1	7.8	47.8	8.4	66.5	47.8	23.6	52.8	9.1	17.3	34.6	22.7	22.1	18.6	17.2	10.2	10.0	40.2	16.5	20.4	24.9	8.2	28.3	15.4	16.1	16.8	48.8	11.8	32.0	18.3	12.0	15.4	8.7	18.0	17.4	17.8	12.2	11.6	26.8	27.8	12.1	12.5	10.7	30.2	9.4	24.2	55.2	26.2	39.5	16.5	37.7	13.1	12.4	17.8	106.1	29.8	36.7	33.4	33.9	37.6	35.2	28.1	43.9
PPP1R3F	Hb2E	ENSG00000049769	"Protein phosphatase 1 regulatory subunit 3F"	Q6ZSY5	X	49269793-49301461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 27.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 38.6;Horizontal cells: 48.8;Oligodendrocytes: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 9.4"	"Lineage enriched"	"Detected in single"	12	"T-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 13.6;HDLM-2: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000244, HPA000918"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Vesicles"		"HPA000244: AB_2665949, HPA000918: AB_2268692"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.83e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (5.99e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.55e-1)"	3.1	4.0	13.9	2.4	14.9	1.5	3.2	14.0	18.3	5.7	8.1	7.4	1.3	5.8	5.8	4.2	7.1	1.5	18.1	15.2	14.1	4.1	3.4	3.3	2.7	14.7	13.5	8.2	2.6	1.1	15.5	1.0	17.2	5.6	0.6	9.7	3.1	1.4	27.5	3.3	3.5	1.3	12.5	4.0	3.4	4.2	14.1	1.3	5.3	12.8	1.4	6.7	4.6	19.1	2.1	4.7	2.9	3.6	2.4	1.8	2.3	2.8	1.8	1.3	2.2	3.0	1.8	2.2	0.6	0.6	13.6	3.6	0.9	0.5	0.9	13.2	4.4	0.2	4.0	0.3	1.5	0.6	1.5	1.4	1.4	1.5	0.5	2.2	0.1	2.8	0.6	0.9	0.9	6.2	1.2	2.5	9.8	0.1	5.8	6.1	3.2	1.1	1.4	1.1	3.8	3.7	0.9	0.1	6.2	4.5	3.3	2.3	2.5	4.1	1.0	3.0	2.0	3.6	4.4	1.5	1.6	5.2	4.8	0.0	0.2	0.0	0.2	0.3	0.6	0.3	1.8	0.6	0.2	0.0	1.5	0.6	0.0	0.3	0.7	0.2	9.4	0.3	13.9	14.9	14.0	18.3	15.2	14.1	14.7	13.5	17.2	12.5	14.1	19.1	2.1	0.0	0.5	14.0	2.8	1.9	2.4	1.0	4.0	38.6	2.5	3.4	16.8	0.0	0.7	3.7	8.4	1.1	1.7	0.3	7.9	0.3	0.1	3.6	2.8	2.2	3.0	0.8	9.6	0.2	0.1	3.8	0.0	2.0	0.0	4.3	3.3	1.1	0.7	48.8	10.7	0.1	0.0	0.6	1.8	0.7	4.7	1.5	0.0	3.7	0.2	11.9	0.0	12.5	34.3	0.4	0.1	3.0	2.0	2.2	0.0	7.6	2.6	17.8	0.0	4.0	3.9	2.0	8.5	7.3	1.3	1.2	5.6	2.4	0.2	2.3
PPP1R8	"ard-1, ARD1, NIPP-1, NIPP1, PRO2047"	ENSG00000117751	"Protein phosphatase 1 regulatory subunit 8"	Q12972	1	27830782-27851676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027406, HPA027417, HPA027452"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Nucleoplasm	"HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490"	"unprognostic (5.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.58e-2)"	24.0	17.1	23.7	23.8	26.3	38.8	27.2	26.0	27.8	25.1	20.8	23.3	19.6	28.4	21.3	26.1	26.7	20.8	23.8	22.9	25.1	19.6	21.5	21.1	35.5	25.0	25.0	33.0	20.7	25.2	15.8	25.2	25.7	21.0	25.1	28.0	18.9	25.7	25.3	23.2	21.4	30.6	26.0	25.9	19.7	24.0	24.2	41.0	25.2	37.0	36.4	29.5	20.5	30.5	57.8	40.0	85.3	55.8	52.6	54.7	48.9	60.5	63.3	101.5	81.6	45.2	64.5	81.9	41.6	69.3	39.5	50.9	101.3	56.6	73.2	69.3	61.7	107.2	53.3	67.2	52.9	99.9	73.0	48.0	60.7	92.4	81.8	45.4	61.3	68.9	92.4	54.3	61.2	37.6	109.6	58.6	105.9	50.7	46.2	88.4	70.5	78.2	54.9	52.2	59.5	54.0	74.5	57.5	73.4	43.5	50.5	61.7	50.9	49.6	45.3	78.9	57.2	50.0	82.2	102.8	48.5	127.6	65.0	17.2	9.1	8.5	12.4	9.5	14.3	9.8	9.7	13.7	8.8	9.9	10.5	10.2	5.4	14.3	11.4	6.7	10.8	13.2	23.7	26.3	26.0	27.8	22.9	25.1	25.0	25.0	25.7	26.0	24.2	30.5	11.3	16.0	10.0	2.9	21.3	17.3	21.4	33.4	7.4	22.0	12.0	9.8	13.4	8.6	24.2	5.5	2.1	47.6	19.6	15.4	31.3	30.6	33.7	9.8	15.2	17.8	11.5	20.6	8.4	25.9	41.2	17.1	12.2	11.1	26.0	16.8	19.6	20.2	26.3	8.4	8.6	15.0	28.5	18.0	11.5	30.0	23.9	14.1	10.6	4.7	35.6	21.5	25.7	10.6	16.0	31.9	14.7	17.0	14.3	24.6	14.3	25.7	18.1	16.9	26.3	16.2	20.0	35.4	43.2	16.5	14.1	43.9	17.4	28.8	16.2	21.2
PPP2CB	PP2Abeta	ENSG00000104695	"Protein phosphatase 2 catalytic subunit beta"	P62714	8	30774457-30814314	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Peritubular cells: 264.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018600, HPA043236"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB018600: AB_675841, HPA043236: AB_2678379"	"unprognostic (9.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.70e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (5.82e-7)"	"unprognostic (9.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.65e-3)"	89.9	66.6	190.2	42.2	196.1	10.5	68.4	189.1	220.1	84.0	147.9	79.3	72.9	112.1	117.1	95.1	87.8	74.2	94.7	191.6	190.7	131.9	118.6	90.6	32.5	199.7	184.1	147.4	75.7	93.3	52.5	91.0	190.4	74.9	76.2	77.9	68.6	87.1	105.7	63.7	87.0	122.3	195.1	52.9	71.2	64.7	204.4	41.4	126.7	122.7	47.4	76.8	70.0	200.1	96.5	82.7	136.4	54.4	134.6	120.0	78.0	124.0	114.0	123.1	129.5	86.6	68.3	45.6	118.7	165.4	117.9	56.5	84.4	142.1	167.3	28.5	44.2	61.8	52.7	86.9	157.3	28.1	34.2	108.6	157.4	105.2	115.9	124.2	152.5	73.6	97.7	47.6	212.4	48.4	77.1	34.9	102.6	139.3	47.0	53.9	55.7	34.5	168.5	73.6	134.3	55.0	57.8	61.1	127.0	150.5	34.1	47.8	164.0	109.1	81.7	36.1	105.5	24.0	33.6	53.7	93.4	26.0	141.4	3.4	2.5	1.7	1.8	3.1	2.3	2.9	1.7	1.9	1.7	1.1	1.7	2.1	2.3	3.8	1.5	3.8	1.3	0.8	190.2	196.1	189.1	220.1	191.6	190.7	199.7	184.1	190.4	195.1	204.4	200.1	81.0	70.5	60.7	68.6	13.0	104.1	115.9	44.4	44.9	36.6	64.9	51.8	80.2	45.8	54.3	86.5	31.3	41.1	23.6	186.1	46.9	40.6	21.8	98.5	109.8	60.9	32.3	16.6	41.0	48.9	52.8	79.0	34.7	89.2	17.7	95.4	87.8	95.5	58.4	47.1	59.1	65.3	28.5	55.4	60.4	20.3	73.3	36.0	40.9	52.5	27.4	127.2	17.5	37.7	60.4	81.1	78.9	264.0	15.8	125.4	115.6	95.9	68.2	26.5	46.0	93.1	73.0	37.2	40.4	50.3	95.6	70.6	17.4	75.3	41.2	149.9
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333933-386955	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 73.0;skeletal muscle: 103.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"PC-3: 18.5;U-698: 29.9"									HPA026606			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.90e-5)"	4.4	4.7	1.2	0.2	1.2	1.9	4.9	0.8	1.6	8.3	0.8	4.0	0.5	6.9	0.0	9.5	9.3	0.3	73.0	1.0	1.6	4.0	3.7	3.9	0.6	1.5	1.7	7.6	4.5	0.2	10.3	0.6	1.5	9.1	0.0	0.1	7.1	0.3	103.4	16.5	4.7	0.3	1.2	7.2	4.6	16.3	1.4	1.3	5.0	2.6	0.0	11.8	7.7	1.8	1.0	5.0	0.6	1.9	0.1	0.1	8.1	7.6	1.3	4.7	6.0	5.4	0.0	1.8	4.0	5.4	0.7	0.0	0.1	0.0	1.0	5.6	6.3	1.1	1.8	0.3	0.0	2.3	3.1	0.2	0.1	0.0	3.7	0.4	0.1	3.3	1.6	0.2	0.7	3.1	11.8	8.6	3.1	0.1	18.5	5.3	3.7	0.4	1.0	1.4	0.0	11.1	0.0	0.6	5.3	4.0	0.0	1.7	0.4	2.5	3.6	0.0	2.0	0.2	0.4	29.9	0.0	2.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	0.8	1.6	1.0	1.6	1.5	1.7	1.5	1.2	1.4	1.8	6.7	0.0	1.7	11.4	3.8	6.8	8.6	1.7	4.6	13.5	8.5	10.7	72.3	4.3	2.1	0.0	27.1	5.2	5.7	3.8	0.0	2.5	0.6	12.1	4.6	5.4	4.8	4.8	2.8	4.0	7.3	8.0	4.6	7.4	0.0	25.6	2.9	1.8	3.7	6.7	3.7	3.9	0.0	2.8	4.5	2.0	4.1	5.8	5.4	5.6	3.1	8.6	6.2	17.6	10.4	2.4	0.6	3.0	3.3	3.7	1.8	1.7	4.3	19.0	0.0	12.2	6.5	16.7	27.1	6.1	7.5	4.0	5.0	7.8	3.6	4.5
PPP2R3C	"C14orf10, FLJ20644, G4-1, G5PR"	ENSG00000092020	"Protein phosphatase 2 regulatory subunit B''gamma"	Q969Q6	14	35085467-35122517	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040835, HPA058834"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA040835: AB_10794152, HPA058834: AB_2683831"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.32e-3)"	"unprognostic (5.33e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.10e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.85e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.55e-2)"	"unprognostic (8.29e-2)"	19.9	15.5	23.5	23.9	25.0	42.8	17.1	24.4	41.6	18.1	23.3	18.6	21.0	16.2	16.4	12.5	14.0	18.6	22.9	23.8	25.6	14.4	16.1	17.7	31.0	25.3	24.4	15.9	10.2	17.0	17.6	18.8	25.6	17.1	20.3	15.4	13.5	14.1	24.9	7.1	22.5	21.0	24.9	24.4	16.2	71.6	24.4	26.4	12.4	25.7	25.9	22.3	10.4	27.5	41.2	21.8	41.7	33.9	32.4	54.5	29.6	33.0	32.0	41.0	48.0	18.1	32.2	47.2	13.4	33.9	15.5	17.6	20.0	13.8	60.5	47.8	19.3	26.2	11.9	65.2	43.3	51.2	51.7	41.9	14.4	29.0	19.7	24.0	55.7	26.2	25.7	46.3	57.4	28.4	46.4	43.1	37.1	27.4	24.3	50.2	27.1	32.8	15.8	24.1	39.9	37.5	41.7	27.6	57.8	19.9	17.9	57.0	47.9	41.3	17.3	36.0	34.9	44.8	52.4	92.8	22.8	47.9	48.1	66.5	41.6	86.9	23.4	52.5	27.0	31.0	24.8	29.5	36.1	33.1	22.0	26.9	76.9	33.1	42.7	16.3	40.8	34.0	23.5	25.0	24.4	41.6	23.8	25.6	25.3	24.4	25.6	24.9	24.4	27.5	35.5	16.0	24.7	32.7	40.2	11.5	23.3	31.7	9.6	15.9	18.8	14.7	26.3	17.2	25.8	20.2	4.2	19.4	48.1	29.1	33.2	31.2	489.7	23.1	28.1	33.8	31.2	69.7	28.3	36.1	26.2	26.5	19.9	21.7	33.7	31.3	34.6	22.8	61.3	8.4	30.4	26.8	32.6	49.7	36.3	233.5	28.3	42.6	28.4	24.4	71.5	28.7	46.4	36.2	58.8	49.2	22.3	30.5	37.4	24.8	37.8	43.2	25.1	21.5	32.9	24.0	43.1	239.2	58.6	19.6	13.5	34.8	45.2	36.2	24.6	30.5
PPP2R5C	"B56G, B56gamma, PR61G"	ENSG00000078304	"Protein phosphatase 2 regulatory subunit B'gamma"	Q13362	14	101761798-101927989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 525.3;T-cells: 323.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027553	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA027553: AB_10602081"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.72e-1)"	54.7	58.4	72.7	77.6	75.1	129.2	62.0	67.3	81.2	59.2	55.1	70.7	52.4	53.8	63.5	73.8	49.2	57.7	112.6	89.3	72.5	58.6	89.3	66.8	136.9	73.1	71.1	61.2	59.6	64.1	43.2	45.6	72.4	50.5	74.4	56.2	69.2	55.8	79.2	67.3	57.3	60.8	74.2	72.0	53.8	66.5	71.9	114.4	66.5	73.0	124.6	67.3	44.1	72.8	100.6	67.4	111.8	108.6	99.5	138.8	107.9	92.7	121.5	113.5	107.9	68.2	169.8	272.1	86.9	120.8	79.7	102.7	103.6	98.2	146.6	123.2	48.3	79.0	74.8	66.7	73.3	122.7	162.4	91.9	124.4	78.2	72.1	100.7	103.3	145.3	167.5	111.7	109.7	153.2	124.1	135.1	65.0	200.7	111.2	103.7	125.8	67.8	109.3	112.1	87.2	163.3	125.6	82.2	161.1	78.0	150.2	92.9	103.0	71.1	67.3	276.4	93.0	154.8	249.3	449.4	106.6	89.5	81.0	97.5	72.7	72.6	217.2	94.3	140.0	74.8	139.8	172.3	65.4	68.8	98.4	153.5	133.7	68.2	104.6	95.8	156.2	91.3	72.7	75.1	67.3	81.2	89.3	72.5	73.1	71.1	72.4	74.2	71.9	72.8	51.0	83.3	93.9	61.4	94.4	58.6	45.7	35.0	26.2	30.8	51.7	35.8	133.9	47.1	52.4	36.8	58.4	49.8	525.3	69.3	46.9	38.3	79.6	104.2	39.2	45.9	47.4	45.3	124.6	46.9	46.6	43.4	33.6	54.9	69.6	38.7	59.3	78.5	73.2	26.9	92.2	78.9	38.7	122.9	84.5	69.5	52.5	78.4	85.4	84.3	128.2	49.9	280.2	71.4	89.8	50.6	69.7	45.5	193.9	48.9	51.0	62.8	76.5	43.3	39.5	34.3	54.1	47.1	27.5	36.2	70.3	52.4	323.4	42.7	62.6	71.6
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984553-43012342	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	23.2	20.2	29.9	17.5	32.5	18.3	20.2	25.7	38.1	30.9	17.2	27.2	29.7	28.7	4.3	24.3	28.5	15.2	30.3	33.1	26.8	18.2	20.8	18.7	19.9	31.0	26.6	28.6	19.1	24.5	15.9	18.1	30.8	24.8	23.5	29.7	19.8	21.2	40.6	27.8	35.8	30.6	21.1	18.7	22.3	28.6	29.6	44.4	18.3	41.2	24.0	24.7	27.4	31.2	71.3	38.0	72.6	88.2	61.0	63.6	32.6	38.3	39.9	108.5	86.6	58.7	24.9	55.8	36.3	71.8	67.3	38.6	108.6	66.4	94.6	45.3	67.5	62.9	51.2	81.8	33.5	51.4	43.6	45.6	47.3	88.5	35.1	54.1	87.2	68.7	67.4	41.1	63.0	44.0	114.9	40.0	26.2	228.1	36.3	86.3	73.8	37.3	45.3	39.0	77.9	45.7	56.2	38.7	47.3	63.2	47.9	55.5	57.1	57.2	50.9	55.8	61.4	39.6	54.6	109.0	21.2	48.0	51.6	18.4	13.8	21.9	18.4	11.6	19.2	10.1	16.9	21.2	13.7	9.2	12.8	15.6	8.1	14.3	8.9	14.4	23.9	20.1	29.9	32.5	25.7	38.1	33.1	26.8	31.0	26.6	30.8	21.1	29.6	31.2	6.2	9.6	6.7	6.8	7.6	8.4	2.9	5.1	13.1	12.9	6.9	6.6	4.9	4.3	6.3	7.3	10.4	7.5	10.1	15.7	5.9	6.9	6.4	7.7	19.9	7.4	9.0	12.4	10.5	7.8	11.0	9.7	7.1	9.5	8.2	10.8	6.4	11.3	9.2	3.3	10.3	8.3	8.2	6.2	5.2	7.0	9.6	6.9	10.6	3.7	6.8	8.1	3.1	3.0	5.3	9.8	9.0	14.7	7.7	3.7	35.7	5.2	5.1	7.5	6.6	8.7	10.8	8.3	10.2	13.3	9.5	4.5	11.1	6.1	13.0	2.5
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease variant, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.1"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 933.8;Inhibitory neurons: 403.0;Oligodendrocyte precursor cells: 348.3"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		94000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	24.7	17.5	48.5	15.7	144.1	17.2	20.5	63.2	125.6	17.0	0.0	19.5	11.6	11.8	13.1	14.4	13.8	13.3	9.2	97.4	25.0	11.2	17.0	19.9	14.7	14.6	11.0	17.9	9.4	8.9	9.0	13.0	15.7	66.0	16.1	27.6	22.2	38.4	51.2	22.9	12.9	15.5	24.7	14.5	22.4	10.6	23.9	12.8	13.2	29.0	18.3	20.7	16.0	54.3	48.3	33.8	9.3	18.0	50.4	37.9	15.8	51.9	47.8	19.8	21.6	18.3	59.0	22.4	20.9	47.6	25.6	23.5	33.3	69.6	34.9	56.0	15.1	35.4	45.8	25.2	36.8	59.0	17.8	39.6	35.6	45.3	51.4	39.1	38.8	14.5	14.4	61.1	33.5	58.0	12.2	44.2	15.4	55.7	20.7	22.1	83.2	26.5	20.0	38.3	71.5	26.2	43.1	35.4	24.6	12.5	32.3	33.4	42.1	48.7	54.8	44.7	34.7	28.5	31.5	40.1	26.6	31.5	13.1	82.5	31.0	73.5	35.7	33.1	41.6	74.1	33.2	34.8	28.2	62.8	15.5	31.0	123.7	65.1	45.1	51.9	25.3	21.1	48.5	144.1	63.2	125.6	97.4	25.0	14.6	11.0	15.7	24.7	23.9	54.3	143.3	76.9	58.6	284.1	96.8	168.8	36.2	29.5	34.7	89.8	93.8	51.8	25.0	38.6	21.9	31.3	39.6	39.6	81.4	60.0	33.2	21.3	3.2	39.3	56.2	100.8	127.4	32.0	933.8	31.6	84.0	75.6	59.1	42.8	35.4	22.1	53.2	39.7	38.3	18.5	403.0	44.2	14.2	61.8	135.3	8.4	65.0	58.2	92.5	281.1	64.3	21.2	56.7	348.3	139.1	53.3	115.4	60.9	63.8	127.6	23.9	51.9	25.3	82.9	13.1	66.9	67.5	12.7	26.5	27.9	172.0	27.5	69.1	76.2	55.9	39.5
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085376	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: AB_2678695"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	44.3	57.9	34.8	43.2	34.7	63.2	42.5	35.9	38.7	42.8	41.0	49.8	47.0	39.6	47.1	88.3	35.9	32.5	45.6	34.0	35.7	49.9	83.2	46.2	58.6	35.5	34.9	29.4	41.0	46.4	33.5	49.6	35.3	37.8	35.2	18.1	44.0	28.5	60.8	60.8	49.0	32.8	35.6	62.5	49.2	65.4	38.4	61.2	35.4	30.2	63.7	56.3	48.9	36.4	132.7	145.9	95.5	134.0	88.4	73.8	148.5	115.8	127.7	148.7	163.8	129.5	167.9	102.7	145.2	137.0	95.5	105.9	119.3	143.2	87.0	130.1	213.0	70.5	86.0	290.4	133.5	100.1	126.8	107.9	124.7	135.9	85.5	88.4	174.9	130.5	139.6	91.0	115.1	382.2	174.4	180.7	182.2	104.7	77.1	190.9	99.4	180.4	142.5	134.5	91.9	136.8	57.1	169.1	101.8	79.4	156.0	166.0	113.3	86.4	90.4	70.6	90.8	155.4	183.8	122.4	123.1	126.9	107.0	100.6	103.5	236.1	66.5	113.2	47.7	68.5	69.6	74.2	115.8	88.3	62.0	54.1	215.2	51.7	100.1	90.6	95.1	48.3	34.8	34.7	35.9	38.7	34.0	35.7	35.5	34.9	35.3	35.6	38.4	36.4	87.8	51.3	33.4	10.7	85.8	147.2	121.7	206.9	71.2	23.3	94.2	82.8	11.1	82.9	133.5	77.3	29.2	313.7	106.0	217.0	158.5	226.9	156.9	80.5	55.5	91.7	125.6	89.2	8.0	193.3	335.3	66.7	106.0	85.2	69.2	66.7	74.6	94.2	239.3	35.3	8.6	159.3	193.3	105.4	138.4	143.8	62.7	124.4	80.0	9.4	221.1	61.1	118.4	8.0	12.9	345.5	220.8	52.3	97.6	161.3	191.0	198.6	119.7	29.5	72.3	43.4	85.9	228.5	157.8	113.2	172.5	421.0	93.0	61.7	175.9	227.2
PPP4R1	PP4R1	ENSG00000154845	"Protein phosphatase 4 regulatory subunit 1"	Q8TF05	18	9546791-9615240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 36.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040905, HPA041089"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA040905: AB_10794869, HPA041089: AB_10805836"	"unprognostic (1.76e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.14e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.13e-3)"	"unprognostic (4.15e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	20.7	16.2	16.7	16.8	19.1	32.0	18.8	18.7	17.8	27.2	19.1	24.7	23.2	20.8	17.1	70.7	21.1	20.7	20.7	15.6	17.4	19.6	15.3	34.6	13.0	17.7	17.2	17.0	19.9	23.5	11.7	29.0	17.7	16.6	19.7	13.3	23.3	16.9	16.2	26.1	26.1	23.3	16.9	18.4	24.4	35.7	17.0	19.9	18.7	17.4	24.9	40.7	35.7	20.6	70.3	48.5	115.0	31.6	22.3	33.7	58.3	66.9	44.7	64.9	62.3	44.1	39.6	34.0	47.6	66.1	55.0	29.4	54.0	99.4	87.0	39.8	21.8	32.2	35.0	32.0	34.7	83.0	46.7	30.3	62.8	56.1	52.9	48.5	75.3	22.6	47.5	29.8	70.9	34.5	58.1	31.7	46.1	97.5	30.3	71.5	69.2	21.4	54.6	96.5	33.6	39.5	79.3	35.3	26.4	73.3	19.3	31.5	81.3	113.6	70.2	59.3	83.5	26.5	39.7	60.7	42.5	34.0	52.5	14.6	6.1	10.9	3.9	4.7	5.0	3.8	4.3	3.9	7.0	1.8	1.4	3.2	36.1	4.1	4.7	2.9	4.6	3.5	16.7	19.1	18.7	17.8	15.6	17.4	17.7	17.2	17.7	16.9	17.0	20.6	26.4	99.3	76.1	35.9	11.9	40.4	26.5	30.8	42.7	19.6	20.7	14.7	21.4	7.2	55.4	22.0	10.4	27.0	12.0	31.2	5.9	23.8	77.3	48.1	26.7	29.5	17.4	15.6	43.0	34.9	15.9	19.3	45.3	54.0	3.8	27.0	26.0	12.2	16.8	33.7	54.9	16.4	8.2	19.6	16.7	57.2	17.4	20.7	14.2	34.7	20.5	10.6	13.4	61.9	66.5	49.8	16.2	11.7	10.8	21.0	23.7	10.0	58.9	19.3	13.1	16.5	22.1	20.4	12.3	52.0	42.5	23.0	12.9	9.2	13.6	68.4
PPP4R2		ENSG00000163605	"Protein phosphatase 4 regulatory subunit 2"	Q9NY27	3	72996803-73069198	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034695, HPA039837, HPA073758"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632"	"unprognostic (4.60e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.62e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.35e-1)"	27.2	23.2	16.9	26.8	22.9	101.2	22.7	22.6	25.3	27.9	21.7	26.9	24.7	24.7	19.0	23.0	27.7	23.3	25.8	17.3	17.7	23.6	53.6	18.0	26.3	19.7	19.1	22.9	23.0	25.4	11.0	28.6	21.5	18.3	23.8	24.4	20.7	15.7	25.8	16.7	22.3	18.8	18.9	21.6	21.4	27.1	20.1	36.2	24.8	24.8	25.8	24.0	15.3	38.7	33.6	38.5	80.9	48.2	41.7	35.9	48.8	66.2	46.7	59.0	61.3	56.1	39.8	63.3	37.3	39.7	56.0	23.6	63.6	36.8	76.0	96.6	23.8	71.1	43.6	67.8	45.8	105.7	70.6	40.9	53.6	71.3	58.3	40.9	41.4	62.9	63.6	70.6	49.5	49.3	88.3	45.8	74.8	50.0	31.8	82.0	45.9	58.9	50.0	89.4	18.1	47.7	77.3	49.9	62.1	57.9	45.9	58.7	47.0	52.4	62.4	61.3	57.3	43.1	97.4	125.5	36.9	79.9	60.4	7.9	5.9	14.8	12.5	3.4	13.8	6.9	12.9	13.1	5.1	7.8	11.1	10.0	21.3	11.3	5.7	18.0	17.6	4.3	16.9	22.9	22.6	25.3	17.3	17.7	19.7	19.1	21.5	18.9	20.1	38.7	56.8	57.7	32.4	19.2	58.5	117.1	110.1	115.8	69.4	50.1	53.2	55.5	54.7	47.1	74.0	27.6	14.6	74.8	62.8	72.4	19.6	63.4	58.1	86.3	76.0	61.9	53.8	61.0	45.6	53.1	72.0	61.6	38.2	142.7	30.9	49.1	40.4	76.4	43.1	50.5	34.8	55.5	77.3	39.2	78.1	12.7	53.4	61.6	56.9	41.2	52.6	53.9	54.6	42.3	101.8	71.4	58.3	48.5	69.7	115.7	44.3	45.8	64.0	39.0	39.5	73.9	60.4	100.6	77.1	54.6	109.1	138.3	69.4	59.1	54.5	128.1
PPP4R3A	"FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1"	ENSG00000100796	"Protein phosphatase 4 regulatory subunit 3A"	Q6IN85	14	91457508-91510554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002568, HPA063917"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA002568: AB_1079207, HPA063917: AB_2685153"	"unprognostic (5.51e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.34e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.53e-2)"	19.3	13.5	14.4	18.2	14.5	50.0	19.6	16.6	15.2	19.1	16.2	21.2	17.2	20.0	15.9	21.4	20.4	12.3	16.2	12.6	13.3	18.3	23.7	20.2	28.3	13.6	14.2	22.0	19.8	16.8	14.8	17.5	13.7	18.4	18.5	10.9	20.8	13.1	24.5	25.4	24.4	15.0	12.7	24.1	20.6	22.3	14.5	27.4	17.7	16.7	25.4	19.5	19.4	16.9	24.5	41.4	34.1	27.1	22.5	20.9	60.9	23.2	21.4	24.5	24.6	35.2	32.1	63.1	30.2	19.2	15.0	27.8	36.6	28.9	39.8	52.0	19.7	32.5	25.7	24.5	26.3	59.1	33.1	15.1	50.4	19.7	31.1	20.1	26.7	29.4	33.5	36.2	33.1	52.1	42.8	38.0	31.2	46.5	29.8	54.0	40.6	26.5	30.3	41.5	41.6	25.4	35.3	77.0	32.5	33.6	39.4	37.8	28.0	19.2	20.6	21.1	26.8	36.0	67.0	69.3	25.2	31.8	34.7	6.2	1.9	2.9	4.9	2.6	6.6	4.6	4.5	4.4	2.1	7.4	5.6	4.8	2.5	9.0	3.7	5.0	6.9	2.6	14.4	14.5	16.6	15.2	12.6	13.3	13.6	14.2	13.7	12.7	14.5	16.9	44.1	32.1	48.3	0.0	83.0	0.0	46.7	0.0	58.1	27.9	35.9	23.5	0.0	32.9	30.3	46.0	20.9	33.9	91.8	21.1	29.4	21.2	13.0	86.9	46.5	33.3	13.3	47.5	0.0	25.1	29.0	27.3	45.3	70.7	20.2	39.8	28.9	51.8	25.8	32.0	0.0	28.2	0.0	48.7	0.0	8.5	37.6	70.7	0.0	0.0	41.8	21.0	44.3	0.0	0.0	27.8	25.7	42.5	75.8	56.6	37.3	23.5	16.8	27.3	26.3	45.9	27.1	91.0	59.9	58.0	0.0	44.3	80.1	33.0	25.8	75.2
PPP4R3B	"FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2"	ENSG00000275052	"Protein phosphatase 4 regulatory subunit 3B"	Q5MIZ7	2	55547292-55618880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001233, CAB017185"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Centrosome"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	Centrosome	"CAB017185: , HPA001233: AB_1080033"	"unprognostic (9.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	29.0	27.4	14.8	28.2	15.1	25.8	29.1	20.9	16.9	26.8	20.0	28.1	31.6	23.7	19.3	31.7	32.3	24.7	14.3	13.8	16.9	33.4	48.0	23.4	38.1	15.0	16.3	25.7	32.1	27.4	12.5	24.5	16.2	24.9	27.7	35.3	28.1	23.2	14.7	29.6	32.1	21.8	15.9	28.7	30.8	23.7	15.1	42.2	33.0	20.3	38.7	26.7	16.9	18.7	42.8	33.0	35.6	30.0	37.2	38.9	49.1	34.0	35.9	28.2	24.0	39.5	40.9	57.7	67.5	32.7	44.8	36.4	39.9	27.5	41.4	84.6	16.7	56.7	30.0	52.9	60.3	66.0	45.6	29.8	64.9	34.1	60.1	36.9	45.0	31.6	55.2	57.4	37.7	50.9	42.8	43.7	35.1	55.9	25.3	40.1	53.6	44.6	39.3	43.8	43.4	26.9	36.8	49.9	54.8	23.5	31.6	52.0	36.3	43.3	56.8	21.6	47.2	59.1	47.3	22.3	40.8	61.3	47.2	25.6	16.5	26.9	20.4	20.9	23.2	18.1	21.2	21.6	18.4	18.6	24.5	21.5	19.6	22.5	23.0	9.9	24.0	23.9	14.8	15.1	20.9	16.9	13.8	16.9	15.0	16.3	16.2	15.9	15.1	18.7	46.8	44.8	41.3	0.0	61.8	0.0	48.9	0.0	44.3	44.1	42.7	27.9	0.0	31.5	29.1	16.5	33.3	30.6	51.4	25.3	39.2	32.4	9.5	85.1	43.2	32.9	18.2	46.7	0.0	41.0	28.5	33.9	43.8	39.6	30.3	39.0	26.0	52.5	26.2	53.8	0.0	29.4	0.0	37.7	0.0	7.6	28.0	44.9	0.0	0.0	47.9	53.1	49.4	0.0	0.0	35.4	24.1	36.1	57.2	57.4	46.1	52.9	62.7	38.5	6.6	54.9	28.4	39.1	25.7	53.3	0.0	47.7	56.3	44.6	29.0	57.2
PPP6R3	"C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3"	ENSG00000110075	"Protein phosphatase 6 regulatory subunit 3"	Q5H9R7	11	68460731-68615334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 213.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017183, HPA038467, HPA038468"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		6600	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030"	"unprognostic (9.46e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (1.54e-2)"	"unprognostic (6.43e-2)"	28.7	28.0	20.4	31.1	26.7	53.0	31.1	35.0	23.1	27.2	29.4	33.4	27.3	30.9	23.3	32.6	26.2	30.7	32.9	20.0	21.9	29.2	31.9	28.1	37.0	24.2	23.4	38.4	22.7	42.9	24.1	34.7	24.8	32.4	33.5	33.8	28.3	26.1	48.8	29.9	31.0	34.5	21.8	32.9	30.0	36.9	23.1	44.4	43.9	49.0	36.6	32.7	26.4	34.6	72.8	83.6	85.0	59.6	44.5	44.9	66.3	62.0	59.7	70.7	64.2	148.3	71.3	83.4	59.4	58.1	74.3	66.6	94.6	70.2	92.3	81.4	40.6	96.1	83.0	49.8	42.6	92.3	82.5	44.8	46.1	72.6	78.0	39.6	65.3	65.4	83.1	59.7	51.1	96.5	92.8	70.8	42.9	142.1	49.5	86.1	116.0	80.9	46.9	103.8	47.8	57.4	88.5	68.8	128.7	70.4	102.4	48.5	65.3	69.1	65.0	74.4	53.4	47.1	71.2	107.0	50.1	40.1	75.1	14.5	9.9	13.2	11.8	13.3	11.4	11.3	12.6	11.7	6.4	12.8	13.7	12.8	14.1	10.1	15.8	13.2	13.2	6.8	20.4	26.7	35.0	23.1	20.0	21.9	24.2	23.4	24.8	21.8	23.1	34.6	41.5	44.8	37.6	134.8	39.6	33.1	25.4	17.6	25.6	49.8	32.1	24.9	42.3	25.8	33.1	27.6	56.3	19.4	36.6	40.9	15.6	15.4	65.8	33.3	33.1	31.0	30.5	35.6	133.3	16.7	17.0	29.8	36.7	43.1	27.8	31.6	29.6	25.3	17.5	26.9	155.0	29.6	16.2	24.9	27.6	24.8	31.1	29.4	21.4	163.9	22.1	28.6	17.5	186.0	213.6	23.9	36.2	31.6	35.9	37.9	29.4	16.1	25.9	50.2	19.7	29.0	30.2	33.8	31.0	29.2	35.5	32.8	38.6	28.6	26.5	42.2
PPRC1	"KIAA0595, MGC74642, PRC"	ENSG00000148840	"PPARG related coactivator 1"	Q5VV67	10	102132994-102150333	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038511, HPA057571"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA038511: AB_10672521, HPA057571: AB_2683472"	"unprognostic (2.27e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (4.29e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (8.65e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.93e-2)"	31.0	19.2	10.3	13.1	10.9	19.0	19.3	9.8	10.7	20.3	12.0	23.2	8.1	21.8	8.1	25.2	21.7	11.9	19.2	10.2	12.0	21.2	19.4	26.3	13.7	11.7	11.4	25.0	24.9	9.4	17.9	13.4	11.2	19.2	8.2	5.1	16.3	8.0	28.8	29.2	16.1	14.2	10.3	19.8	20.4	14.2	11.2	11.0	16.0	12.1	13.7	21.0	20.2	11.5	30.7	44.3	27.0	54.5	23.6	24.2	34.7	26.7	35.9	37.9	31.2	51.1	34.1	66.4	21.8	40.5	23.8	56.7	55.4	52.8	32.6	27.5	43.4	63.5	33.9	48.7	31.4	50.6	26.3	31.9	46.9	44.3	82.8	24.9	23.9	26.5	48.0	38.4	29.9	52.4	40.5	70.0	46.6	29.0	26.7	55.9	38.6	28.2	32.7	30.1	18.6	26.9	23.3	25.2	32.7	25.9	40.8	26.4	26.1	30.1	38.0	30.9	61.2	31.8	24.3	59.6	33.8	61.7	15.4	0.0	1.2	0.1	1.8	1.3	2.3	1.5	1.4	2.3	2.6	1.8	1.7	2.1	0.0	4.1	1.3	1.0	0.9	1.3	10.3	10.9	9.8	10.7	10.2	12.0	11.7	11.4	11.2	10.3	11.2	11.5	16.4	28.9	13.2	6.5	13.4	44.4	33.1	6.1	48.9	4.7	17.5	12.4	9.1	8.6	9.5	5.5	4.2	7.6	9.2	7.9	1.9	8.0	1.1	16.3	16.1	15.6	8.4	10.7	6.8	9.6	12.9	13.7	32.1	31.3	10.8	9.5	6.8	7.2	8.7	1.7	6.2	11.2	6.1	5.3	15.9	2.4	6.2	9.7	8.8	2.8	3.9	2.2	9.2	5.5	5.3	14.0	5.8	6.4	21.4	26.0	2.8	2.4	3.8	4.1	6.6	35.6	18.2	6.3	14.8	36.0	43.5	5.1	10.8	7.8	11.4	30.0
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	12	"intestine: 206.4;prostate: 109.0"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 326.1;Enteroendocrine cells: 908.1;Intestinal goblet cells: 717.3;Paneth cells: 328.7;Undifferentiated cells: 624.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	32	"PC-3: 379.0"									HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA047871: AB_2680195"			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.2	0.3	4.4	0.1	106.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	109.0	206.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	12.4	12.8	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	379.0	11.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.4	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	110.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	326.1	0.0	0.0	0.7	0.0	0.0	0.4	908.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	717.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	328.7	0.0	0.0	101.9	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.9	0.0	624.3	63.1
PRAME	"CT130, MAPE"	ENSG00000185686	"PRAME nuclear receptor transcriptional regulator"	P78395	22	22547701-22559361	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 105.1"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 249.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 139.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"K-562: 834.1"					"Not detected"	"Not detected"			"HPA045153, HPA068562"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA045153: AB_10797259, HPA068562: "	"unprognostic (9.36e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.48e-9)"	"unprognostic (1.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-1)"	0.2	3.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.2	0.0	3.4	10.0	0.0	0.5	0.0	0.3	0.0	0.1	1.8	0.1	0.2	0.1	0.1	0.0	4.7	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.1	105.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.9	53.3	0.0	126.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.4	0.7	3.5	88.8	0.0	0.5	0.1	4.3	0.0	0.0	61.5	14.8	36.0	21.7	0.6	0.0	2.9	172.6	0.0	0.0	0.0	0.0	0.0	0.0	14.9	834.1	15.6	0.0	8.1	0.3	0.2	0.0	27.2	3.5	5.0	0.0	0.2	0.0	0.2	1.1	185.0	0.0	0.6	0.2	0.0	27.8	24.3	5.0	0.1	159.6	0.0	0.2	3.0	14.6	1.3	0.2	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	37.8	22.3	1.1	0.3	0.0	0.0	0.0	0.0	0.9	2.0	0.0	13.0	0.0	60.9	0.0	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	41.4	5.6	0.4	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	1.8	0.0	0.4	6.6	0.0	2.7	41.8	249.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0
PRAMEF12		ENSG00000116726	"PRAME family member 12"	O95522	1	12773738-12777906	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045286, HPA051704"	Uncertain		Uncertain	Nucleoplasm		NA	NA							Nucleoplasm		"HPA045286: AB_10794782, HPA051704: AB_2681581"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966040-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.9;testis: 55.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 34.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 34.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	7.4	6.2	6.4	10.0	6.1	89.9	6.4	10.3	8.4	8.1	5.0	16.3	10.6	5.7	2.3	37.6	6.0	3.0	6.9	5.6	4.9	5.6	4.8	9.0	16.9	4.8	5.2	8.1	8.9	2.6	3.6	15.3	5.2	4.9	16.5	4.9	9.5	1.5	4.1	20.1	13.0	9.4	4.9	12.5	11.7	55.0	4.2	43.0	4.3	2.3	24.9	4.8	13.7	5.6	167.9	199.9	164.8	113.6	16.8	28.7	87.5	237.8	139.3	257.2	195.3	134.6	158.5	65.5	91.4	151.9	156.9	220.9	188.8	101.2	240.6	118.7	206.4	135.6	263.5	123.5	4.1	71.4	109.0	7.7	12.8	145.8	146.9	56.6	146.4	100.5	114.0	132.4	241.1	144.4	66.9	98.5	66.6	216.4	84.9	69.7	205.1	86.3	115.3	123.6	151.2	118.9	225.4	121.9	82.7	112.3	149.1	127.1	91.2	168.2	146.0	140.5	345.1	43.5	127.7	80.0	74.5	162.0	265.3	34.4	0.6	2.9	0.6	0.1	0.4	1.1	1.3	1.3	2.4	0.5	1.2	0.4	0.4	3.0	0.3	2.6	8.0	1.0	6.4	6.1	10.3	8.4	5.6	4.9	4.8	5.2	5.2	4.9	4.2	5.6	2.5	0.0	3.1	1.3	6.8	16.6	6.6	8.0	2.2	6.4	3.4	4.3	3.2	0.0	7.6	3.7	0.0	45.5	2.8	16.5	0.0	3.2	41.5	4.5	4.0	4.7	5.4	142.9	5.0	2.9	68.3	7.2	16.3	6.8	8.9	13.2	9.3	2.1	21.5	3.3	5.2	17.0	10.2	8.7	15.0	15.4	3.7	5.2	3.6	1.9	5.5	3.8	4.1	2.0	1.7	2.3	3.2	1.9	17.5	5.9	2.0	0.1	3.2	4.6	6.6	7.4	10.9	136.4	74.2	38.0	14.2	14.6	6.8	0.4	24.1	6.7
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	105993463-106109939	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 199.8;Langerhans cells: 199.2;Plasma cells: 786.9;T-cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 11.1;gdT-cell: 22.1;MAIT T-cell: 34.0;memory CD4 T-cell: 20.5;memory CD8 T-cell: 20.2;naive CD8 T-cell: 11.3;neutrophil: 12.5;T-reg: 29.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.5;T-cells: 34.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 212.1;RPMI-8226: 42.4;U-266/70: 81.5;U-266/84: 57.0"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 3.6"	"Low region specificity"	"Detected in many"			"HPA030033, HPA075427"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli	Nucleoplasm	"HPA030033: AB_10601050, HPA075427: "	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	6.6	2.1	1.6	20.0	1.6	20.3	6.8	5.5	1.8	15.7	3.1	15.2	9.2	17.2	1.3	55.2	5.5	12.7	1.7	1.5	2.8	2.5	4.5	10.1	15.9	3.2	1.8	4.9	1.9	2.5	1.4	5.1	2.7	3.4	17.2	1.3	9.3	2.4	4.3	9.1	12.6	5.5	2.4	13.6	15.2	1.2	2.9	4.2	9.0	2.2	27.8	19.6	20.2	3.4	1.4	0.5	1.1	0.0	1.6	2.1	0.2	7.2	23.3	2.3	3.7	1.4	9.2	2.0	0.4	13.8	0.3	0.5	0.0	3.6	2.5	21.7	0.1	0.4	4.9	0.0	3.6	0.8	1.6	2.3	11.6	3.3	9.7	0.7	2.9	1.0	1.4	212.1	0.4	0.0	0.1	0.5	0.8	1.4	0.0	0.5	0.0	42.4	2.1	0.3	0.0	0.3	1.0	0.9	0.0	1.6	1.0	2.4	1.5	3.1	1.8	2.1	7.2	81.5	57.0	4.9	5.1	1.3	2.1	2.4	0.8	11.1	22.1	1.2	34.0	2.5	20.5	20.2	0.5	1.0	1.8	11.3	12.5	4.7	0.3	0.4	29.4	2.6	1.6	1.6	5.5	1.8	1.5	2.8	3.2	1.8	2.7	2.4	2.9	3.4	93.1	0.0	5.1	0.3	42.1	19.5	8.6	15.0	3.4	0.6	2.8	3.4	1.5	0.0	19.1	3.7	52.1	0.7	199.8	129.8	0.0	0.3	0.9	15.9	101.0	41.1	1.8	6.1	1.8	0.2	0.7	18.5	19.4	62.6	3.8	9.9	6.4	2.5	19.8	0.0	19.2	15.0	10.2	38.0	199.2	0.3	0.0	64.5	37.4	23.4	30.4	0.5	89.6	0.5	0.1	7.8	103.7	1.2	786.9	4.0	3.2	0.3	13.0	1.1	0.0	5.3	30.1	0.5	2.3	43.9	41.5	0.7	184.3	1.6	8.7	91.9
PRDM10	"KIAA1231, MGC131802, PFM7"	ENSG00000170325	"PR/SET domain 10"	Q9NQV6	11	129899706-130002835	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Excitatory neurons: 21.3;Inhibitory neurons: 21.2;Oligodendrocytes: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026997, HPA061749"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"HPA026997: AB_1855681, HPA061749: "	"unprognostic (4.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.32e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.88e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.51e-1)"	2.8	2.4	2.5	3.1	2.5	7.9	4.2	7.4	3.3	3.2	2.8	3.4	3.4	3.0	3.3	4.0	2.6	2.8	2.0	2.9	3.4	2.2	3.5	3.0	3.9	1.8	1.8	3.4	3.1	3.4	4.6	2.6	1.9	3.4	3.9	4.7	3.1	2.5	6.7	6.2	3.7	2.5	0.9	3.1	4.0	2.4	3.3	6.7	3.0	3.8	4.0	2.6	3.4	4.0	4.7	6.1	7.7	5.1	3.4	4.1	5.1	3.9	5.0	3.2	4.1	6.2	4.8	17.8	4.5	4.6	4.4	6.1	6.4	3.2	5.2	6.6	5.5	12.3	7.5	5.0	2.2	10.9	44.8	2.9	7.1	4.8	3.1	4.9	5.7	5.0	7.0	6.6	4.7	5.2	6.7	5.7	5.9	6.3	4.4	6.5	4.8	2.9	4.7	8.0	8.3	4.3	5.7	6.4	1.7	4.3	4.5	4.8	5.7	7.2	3.4	3.8	5.1	1.7	3.0	25.1	3.2	6.1	5.9	2.4	2.2	6.0	2.6	2.5	2.6	6.8	2.1	2.2	2.1	3.6	3.1	1.4	6.3	4.4	2.7	2.1	2.9	1.4	2.5	2.5	7.4	3.3	2.9	3.4	1.8	1.8	1.9	0.9	3.3	4.0	2.7	3.2	2.7	22.5	3.2	6.1	2.6	1.8	6.8	3.7	3.5	2.2	2.7	1.5	2.0	0.0	0.0	1.5	2.5	6.3	0.0	1.2	3.0	2.9	2.7	1.8	1.8	8.6	21.3	1.1	1.2	2.7	4.6	3.2	1.3	2.7	1.1	2.3	1.6	1.7	21.2	3.1	2.0	3.1	2.9	4.1	2.5	2.8	0.0	13.1	2.1	1.0	1.0	13.6	21.6	0.9	3.2	1.9	2.4	4.6	3.1	1.0	2.3	2.7	0.0	3.9	3.4	0.8	0.8	7.2	5.1	0.5	3.5	1.7	2.7	5.8
PRDM12	PFM9	ENSG00000130711	"PR/SET domain 12"	Q9H4Q4	9	130664594-130682986	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 2.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Excitatory neurons: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"RH-30: 19.1"	"Region enriched"	"Detected in some"	7	"basal ganglia: 10.9"	"Group enriched"	"Detected in some"	26	"basal ganglia: 3.8;hypothalamus: 1.3"	HPA043143	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA043143: AB_10806379"	"unprognostic (3.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.81e-4)"	"unprognostic (7.90e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.01e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.30e-4)"	"unprognostic (1.40e-1)"	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.7	0.0	0.1	0.1	0.0	19.1	0.4	0.0	0.0	0.8	0.2	0.3	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.2	0.4	0.2	1.9	0.2	0.2	0.2	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0
PRDM14		ENSG00000147596	"PR/SET domain 14"	Q9GZV8	8	70051651-70071693	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	658	"testis cancer: 34.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	93	"NTERA-2: 49.4;SuSa: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019094, HPA057070"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 5: NTERA-2 - Transcription"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA019094: AB_1855686, HPA057070: AB_2683327"					"unprognostic (5.86e-2)"					"unprognostic (9.32e-2)"			"unprognostic (6.14e-3)"	"unprognostic (1.37e-2)"	"unprognostic (8.62e-2)"			0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.6	0.4	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.4	0.3	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.6	0.4	0.1	0.0	0.3	0.1	0.3	0.0	0.2	0.8	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2
PRDM15	"C21orf83, ZNF298"	ENSG00000141956	"PR/SET domain 15"	P57071	21	41798225-41879482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 12.5;Plasma cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"Daudi: 31.1;U-266/70: 32.2;U-698: 76.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024268, HPA029255, HPA029256"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear bodies"	Nucleoplasm	"HPA024268: AB_1855688, HPA029255: AB_2672970, HPA029256: AB_2672971"	"unprognostic (8.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.85e-4)"	"unprognostic (4.22e-4)"	"unprognostic (6.50e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.86e-3)"	2.0	1.8	1.8	4.5	1.7	1.7	2.1	1.3	1.9	2.2	1.2	2.3	2.8	2.2	1.6	2.5	2.4	1.4	1.7	1.7	1.4	1.5	2.1	1.9	8.3	1.4	1.4	2.4	2.3	1.8	2.1	1.2	1.4	2.4	1.8	1.6	2.3	1.5	4.5	3.9	2.9	1.4	1.0	3.7	2.2	2.0	1.3	3.2	2.2	1.7	7.4	1.9	2.2	1.6	2.8	6.0	4.4	5.8	1.9	2.4	4.4	2.2	1.8	2.2	1.6	4.1	3.0	31.1	2.5	2.7	2.1	4.1	3.9	2.9	2.1	3.3	5.5	6.5	15.1	5.0	1.3	5.6	3.9	1.1	3.9	2.7	1.8	2.4	3.3	3.4	5.6	2.0	3.0	6.4	5.5	3.7	5.1	3.1	3.1	8.5	3.5	2.5	2.3	4.8	7.5	4.3	10.1	5.1	1.5	1.7	3.8	2.7	3.3	3.8	2.1	2.9	4.3	32.2	3.5	76.0	3.6	6.5	5.3	0.0	0.4	0.5	0.2	0.8	0.2	0.6	0.1	0.3	0.4	0.2	0.2	0.3	0.0	0.1	0.1	0.1	0.2	0.4	1.8	1.7	1.3	1.9	1.7	1.4	1.4	1.4	1.4	1.0	1.3	1.6	2.4	3.2	12.5	6.2	5.1	2.9	1.8	1.6	2.2	3.4	2.8	2.4	4.4	1.5	7.8	1.8	6.2	1.4	2.0	2.3	0.0	1.3	2.2	2.6	2.5	2.5	0.0	2.5	9.0	2.6	0.9	2.6	3.1	2.0	3.8	3.3	1.1	2.2	1.9	3.3	6.4	1.3	2.0	2.8	2.2	4.3	1.2	3.3	1.8	6.5	2.9	1.1	4.1	3.5	8.0	1.7	0.8	0.4	15.9	2.3	1.1	0.8	5.3	3.1	0.0	3.1	2.3	2.3	2.9	3.2	3.4	0.7	2.7	1.3	2.2	1.8
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 16.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 173.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HHSteC: 2.0;hTERT-RPE1: 6.7;MCF7: 1.6;OE19: 3.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 15.7"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	1.6	0.2	3.7	0.5	4.8	0.0	1.1	0.1	4.1	1.3	16.2	1.1	7.4	1.0	2.1	0.3	1.4	1.1	5.4	2.8	0.6	6.8	0.2	2.5	0.5	0.5	1.7	1.5	5.8	0.9	0.6	0.1	0.9	0.7	0.2	0.0	0.4	2.2	0.4	0.5	2.6	0.2	0.0	2.1	9.3	0.7	4.1	0.1	8.0	0.6	0.3	0.9	1.1	1.5	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.1	1.8	0.0	0.0	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	3.7	4.8	0.1	4.1	2.8	0.6	0.5	1.7	0.9	0.0	4.1	1.5	4.5	35.3	10.5	173.7	0.1	0.6	0.3	2.1	0.6	0.1	0.2	0.3	5.2	22.8	6.3	7.3	0.0	0.0	0.1	0.2	5.9	10.0	0.3	0.2	0.0	2.1	5.4	0.8	1.2	4.9	4.2	0.6	30.5	0.4	0.0	0.3	0.0	0.0	0.0	1.7	1.0	0.9	0.0	0.0	0.4	0.2	1.5	0.1	0.0	14.0	0.0	1.4	0.0	6.6	1.8	7.1	0.8	1.9	0.1	0.8	0.5	0.2	1.9	0.3	0.0	3.3	9.0	0.3	1.8	0.2	0.0	0.0	0.4	0.0	1.5	0.2
PRDM2	"HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2"	ENSG00000116731	"PR/SET domain 2"	Q13029	1	13700198-13825079	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005809	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA005809: AB_1079673"	"unprognostic (2.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.85e-3)"	21.7	15.2	19.4	19.3	21.2	79.4	21.9	27.5	38.7	27.8	7.6	27.1	13.0	24.2	16.4	21.9	20.9	17.0	19.9	21.5	18.2	14.2	13.1	21.4	27.3	18.5	16.6	34.3	14.9	14.7	16.3	16.7	18.7	24.3	13.8	18.1	21.2	17.6	43.8	27.2	23.6	15.0	12.9	20.2	19.2	18.7	16.9	22.6	24.3	30.0	25.0	27.0	26.8	34.7	15.3	8.5	30.3	11.8	23.5	18.0	14.6	19.5	11.8	13.0	14.5	13.5	16.9	46.4	16.7	18.9	11.0	18.5	22.8	11.4	14.4	28.9	16.3	31.2	10.6	6.4	12.9	10.5	25.8	19.1	19.7	13.8	11.4	12.4	13.0	18.0	28.2	52.0	16.5	7.7	16.9	16.6	9.0	12.1	11.4	23.3	16.4	13.9	7.4	17.0	26.3	17.0	15.7	9.8	21.4	18.0	13.9	16.8	23.2	16.7	18.1	15.3	10.9	75.8	55.4	65.5	14.8	24.1	21.9	4.7	4.9	7.5	5.5	3.2	3.5	18.5	4.4	5.2	3.0	13.4	4.9	4.4	9.9	6.2	6.0	5.6	4.4	2.8	19.4	21.2	27.5	38.7	21.5	18.2	18.5	16.6	18.7	12.9	16.9	34.7	41.3	38.5	39.7	34.3	182.9	62.1	54.8	17.1	61.5	49.5	43.8	33.8	41.3	27.1	33.0	23.9	45.9	25.6	77.7	26.9	17.6	17.3	21.7	84.5	62.5	35.1	37.8	21.7	114.5	13.8	16.2	47.6	25.5	121.2	40.5	50.0	26.0	18.8	16.6	70.7	97.0	24.1	14.2	45.6	39.9	15.6	44.1	42.1	30.2	75.9	41.5	21.2	59.8	70.4	122.5	15.5	25.7	45.1	71.7	54.5	34.2	9.0	43.8	39.7	26.3	86.3	34.4	52.7	49.4	65.4	52.1	18.3	74.4	25.8	19.6	64.5
PRDM4	PFM1	ENSG00000110851	"PR/SET domain 4"	Q9UKN5	12	107732871-107761272	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024322, HPA067437"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA024322: AB_1855691, HPA067437: AB_2685839"	"unprognostic (4.64e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (9.64e-2)"	"unprognostic (9.06e-3)"	"unprognostic (5.31e-2)"	"prognostic favorable (3.15e-7)"	"unprognostic (9.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.62e-3)"	12.8	8.6	12.8	11.9	13.3	16.9	11.7	14.5	13.5	12.0	13.1	15.0	13.2	15.2	13.4	15.6	11.8	11.2	8.9	12.3	12.8	21.0	7.0	12.9	12.4	13.2	12.8	15.0	10.2	44.5	8.1	12.5	13.5	11.5	16.4	20.9	11.5	12.1	12.5	12.3	13.8	13.9	11.1	12.3	12.7	11.6	14.7	11.4	12.6	12.8	14.0	11.5	13.2	14.3	19.2	20.9	22.4	23.4	23.7	24.3	17.1	25.6	33.2	25.4	19.2	14.7	8.1	24.6	10.6	27.2	23.7	13.4	23.5	18.7	27.4	18.1	24.1	19.5	15.5	15.8	30.5	28.1	19.3	29.8	35.3	28.7	49.1	27.6	33.5	22.7	24.0	29.0	30.6	20.1	15.9	24.9	11.7	12.4	28.2	12.8	22.4	24.2	26.2	29.0	27.6	25.8	19.3	13.5	23.5	15.2	16.5	14.1	34.1	19.4	14.0	26.1	21.7	20.3	21.5	17.2	14.2	13.1	14.7	1.1	0.8	1.4	1.9	3.0	1.3	2.6	1.0	1.7	2.3	2.1	1.6	2.0	0.3	1.2	4.2	1.2	2.2	0.8	12.8	13.3	14.5	13.5	12.3	12.8	13.2	12.8	13.5	11.1	14.7	14.3	10.6	9.6	6.4	4.9	38.3	14.5	9.0	4.2	8.0	13.6	7.6	6.7	7.3	4.3	6.3	12.9	14.6	6.3	9.8	13.3	9.8	14.8	23.4	12.3	19.8	11.2	12.6	6.9	12.0	11.4	7.5	9.7	10.2	21.8	3.8	11.0	11.0	4.6	11.4	33.7	12.2	10.3	2.0	10.3	7.2	28.4	6.2	9.0	8.8	15.0	12.1	7.5	12.3	9.5	12.9	16.6	8.1	4.9	8.2	12.4	14.6	9.7	7.2	11.7	6.6	12.4	10.6	6.3	12.5	12.5	16.9	4.8	11.1	6.4	12.0	10.2
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 51.2;Early spermatids: 75.6;Inhibitory neurons: 31.9;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"eosinophil: 7.5;neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: AB_2681472"	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	3.0	4.0	1.8	1.6	2.0	3.5	3.0	3.2	2.0	5.2	4.2	3.2	1.3	6.0	2.8	2.2	4.6	2.4	3.0	1.6	3.2	1.9	0.4	4.2	0.9	4.1	4.0	10.3	4.8	8.6	3.9	3.5	4.0	4.1	2.9	4.7	1.8	4.3	1.6	1.5	1.8	4.4	4.7	2.4	2.1	3.6	2.9	1.4	5.8	3.0	0.8	2.9	3.3	4.4	2.2	3.4	7.8	0.1	4.5	9.3	9.2	4.7	9.9	4.7	4.2	4.4	1.2	0.4	1.2	6.2	4.5	0.1	0.0	1.0	6.0	0.0	1.4	2.9	3.1	0.3	4.9	10.0	0.1	6.6	2.9	3.3	4.1	4.3	3.4	1.2	0.0	14.2	5.7	0.4	1.5	0.1	5.7	0.8	2.7	0.0	9.3	6.1	1.6	0.0	1.4	6.2	0.0	0.1	0.9	4.0	6.4	4.1	1.4	0.2	2.7	4.8	4.6	13.0	19.7	0.1	3.6	0.1	3.6	0.1	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	1.8	2.0	3.2	2.0	1.6	3.2	4.1	4.0	4.0	4.7	2.9	4.4	7.1	12.8	5.6	51.2	0.5	1.7	2.7	2.4	9.1	9.1	1.1	2.4	8.2	2.8	3.8	1.8	8.4	1.0	0.2	1.5	1.9	2.3	75.6	1.4	9.4	6.3	3.6	0.0	25.0	2.5	2.6	9.6	2.6	1.4	2.5	15.5	3.6	0.0	0.8	0.0	31.9	3.6	4.1	0.3	0.7	31.0	8.7	0.6	1.8	23.4	0.2	7.6	0.0	52.8	8.0	1.5	0.8	9.4	0.7	2.6	0.1	0.2	1.8	7.5	6.6	10.1	6.6	8.2	3.5	4.6	1.7	0.5	1.2	14.9	3.0	0.7
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089241-123194266	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.9;urinary bladder: 9.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.0;Endometrial stromal cells: 6.5;Excitatory neurons: 7.9;Fibroblasts: 10.7;Late spermatids: 7.1;Oligodendrocytes: 11.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;HEK 293: 5.2;HEL: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	HPA030324	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	0.7	0.1	0.2	0.3	0.2	0.0	0.6	0.2	0.3	0.9	0.6	4.9	0.2	0.7	0.1	0.6	0.4	3.3	0.5	0.1	0.2	0.3	0.1	2.9	0.0	0.3	0.4	1.9	0.3	0.1	0.3	4.2	0.4	1.3	1.0	0.2	0.1	0.1	0.1	0.2	0.6	0.7	0.3	0.0	0.6	0.3	0.2	0.0	0.8	0.2	0.2	9.0	0.6	0.3	0.0	0.0	0.0	0.3	0.3	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.1	5.2	1.1	0.5	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.2	0.3	0.4	0.4	0.3	0.2	0.3	0.5	0.0	0.0	15.0	0.0	1.9	0.1	0.0	0.0	1.0	0.6	0.3	1.4	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.1	3.3	0.6	6.5	0.5	0.0	0.0	7.9	0.2	0.3	10.7	0.0	0.5	0.0	2.4	0.0	0.5	0.8	0.0	6.4	0.1	0.0	0.8	3.5	7.1	2.1	0.4	3.6	4.7	0.8	0.2	0.0	3.0	11.0	0.1	0.0	1.2	0.1	0.2	0.0	0.8	0.2	1.0	0.0	0.7	2.2	2.3	4.4	0.2	1.3	0.4	0.4	6.1	0.0	0.1
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.1;seminal vesicle: 27.2"	"Cell type enriched"	"Detected in many"	9	"Bipolar cells: 271.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 17.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 27.3;LHCN-M2: 41.7;NB-4: 48.2;SCLC-21H: 99.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.7"	"Low region specificity"	"Detected in all"			HPA057253			Supported	"Nucleoplasm,Nuclear bodies"		No	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	Nucleoplasm	"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	4.8	2.3	5.1	5.0	10.2	4.0	4.0	0.0	17.0	11.7	0.0	11.4	1.1	9.3	1.9	1.7	5.2	1.7	1.7	13.7	0.0	1.3	0.3	1.6	5.1	0.0	0.0	5.2	0.9	0.0	5.4	4.3	0.0	26.1	1.5	24.1	1.4	27.2	2.2	2.7	5.7	3.8	0.6	1.8	5.0	1.1	0.1	0.7	1.2	0.9	2.4	10.2	9.8	3.2	2.3	0.2	0.7	0.0	2.1	7.2	0.1	5.8	20.5	2.8	3.2	0.0	2.2	0.0	0.0	7.2	1.8	0.7	0.1	2.4	12.1	8.8	1.8	0.8	0.0	0.0	4.1	9.1	2.5	4.4	0.2	11.1	3.2	27.3	0.4	2.4	0.0	3.7	41.7	0.0	4.2	48.2	0.0	0.2	17.0	1.6	0.0	0.2	1.2	0.3	99.3	13.8	0.3	0.0	0.1	0.1	0.0	4.5	8.8	7.1	1.0	5.2	0.4	1.7	0.0	0.0	17.8	4.2	1.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1	0.5	0.5	0.1	0.7	0.3	0.1	0.5	0.2	0.0	0.1	0.2	0.1	5.1	10.2	0.0	17.0	13.7	0.0	0.0	0.0	0.0	0.6	0.1	3.2	0.9	0.0	0.5	2.3	8.2	0.6	3.4	0.4	0.0	271.5	0.1	0.4	1.8	0.0	5.2	1.8	2.1	0.0	2.5	0.0	0.0	0.0	1.5	0.3	6.5	2.2	0.0	2.5	29.9	0.2	0.2	8.8	0.0	0.5	0.0	0.1	0.0	0.0	0.5	3.3	2.0	0.2	2.0	1.2	6.2	6.7	3.1	5.9	1.8	3.7	0.9	6.1	2.1	7.1	17.0	0.7	0.0	3.4	2.7	3.7	0.0	0.2	5.0	11.6	0.0	4.2	2.9	0.3	0.4	0.0	0.1	0.1	5.0	0.1	0.0	0.6
PRELID1	"CGI-106, PRELI, PX19"	ENSG00000169230	"PRELI domain containing 1"	Q9Y255	5	177303799-177306949	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005701	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria	Nucleoplasm	"HPA005701: AB_1079721"	"unprognostic (1.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (7.63e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.89e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	89.1	106.5	63.6	89.2	63.5	90.7	78.9	64.0	70.5	69.9	64.6	121.8	109.3	69.3	37.5	146.9	61.4	37.1	70.6	63.8	65.2	140.1	182.3	76.0	79.0	64.3	65.8	64.0	262.3	48.1	67.4	58.6	66.2	74.9	85.8	24.4	95.7	29.8	32.2	108.3	121.8	47.2	66.6	117.4	103.2	43.0	69.0	30.9	65.9	13.7	87.4	81.5	78.7	62.8	221.4	193.8	116.1	307.1	103.3	111.0	400.6	154.5	106.6	214.6	206.1	443.2	232.5	181.4	181.6	143.7	236.0	118.1	212.5	400.0	145.8	826.0	291.9	154.9	195.7	291.1	109.6	243.6	215.1	102.7	142.2	170.6	144.9	89.1	269.0	129.2	181.4	247.7	210.5	556.7	160.5	362.5	242.1	251.6	319.7	52.7	232.1	324.5	140.0	171.5	186.3	237.7	136.8	266.9	267.5	144.4	172.5	293.4	148.5	189.3	174.9	157.4	365.5	155.4	270.9	267.4	162.2	328.0	200.4	411.1	764.6	1198.6	248.0	988.0	238.5	276.0	202.6	245.4	775.1	238.7	175.7	195.7	553.7	327.4	989.8	281.9	246.6	614.3	63.6	63.5	64.0	70.5	63.8	65.2	64.3	65.8	66.2	66.6	69.0	62.8	174.4	22.4	23.4	8.1	198.3	348.3	297.0	331.8	152.5	60.8	339.3	415.4	0.4	168.7	159.0	104.8	22.9	756.9	231.4	572.7	303.3	382.9	6.6	114.1	111.2	171.5	157.5	128.9	9.7	563.3	552.7	134.0	110.6	129.9	108.1	145.9	120.3	247.5	352.2	60.6	10.0	311.3	219.7	271.0	337.1	24.6	114.0	293.8	256.1	7.5	410.1	117.1	325.4	4.0	12.2	752.9	664.0	109.1	393.9	612.4	853.7	567.0	60.5	68.9	46.0	126.6	177.3	81.5	218.6	246.7	420.8	883.6	169.7	221.0	433.6	480.2
PRELID2	"FLJ38376, MGC21644"	ENSG00000186314	"PRELI domain containing 2"	Q8N945	5	145471799-145835369	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.6;retina: 15.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 400.3;Inhibitory neurons: 422.9;Proximal enterocytes: 113.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	4	"basophil: 24.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042486	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA042486: AB_10797498"	"unprognostic (9.45e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-3)"	"unprognostic (2.71e-5)"	"unprognostic (1.96e-3)"	"unprognostic (6.53e-4)"	"unprognostic (6.62e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (9.65e-6)"	"unprognostic (2.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-4)"	"unprognostic (6.42e-3)"	3.4	1.4	0.4	3.4	1.3	5.0	3.8	0.0	2.5	2.9	0.0	18.2	11.7	2.0	2.4	1.8	2.8	5.6	4.4	1.2	0.1	1.6	2.4	2.1	1.5	0.7	0.2	4.2	6.2	1.2	1.2	0.7	1.1	1.8	17.4	15.4	2.1	1.9	0.8	2.3	25.6	3.6	0.7	2.0	8.8	1.8	1.2	1.6	4.4	1.4	1.9	2.9	2.6	2.7	16.7	5.4	4.9	8.0	1.1	2.8	0.0	5.5	9.5	10.0	13.9	17.8	26.6	0.0	9.1	6.6	23.0	4.9	3.9	12.3	14.7	4.8	6.3	19.3	5.9	9.3	3.0	2.3	19.3	1.6	5.1	11.5	10.2	13.9	11.4	0.1	10.6	7.3	4.9	2.8	0.0	2.9	2.6	19.4	3.7	0.1	0.0	2.8	4.8	2.5	2.2	4.4	6.9	0.9	10.9	2.3	8.0	3.8	10.7	8.3	4.6	15.4	12.4	0.4	0.1	0.0	15.4	0.0	3.5	24.5	1.3	0.4	0.8	2.2	0.3	1.7	1.5	1.2	5.6	1.6	0.2	1.1	0.3	2.1	1.5	0.6	2.3	1.0	0.4	1.3	0.0	2.5	1.2	0.1	0.7	0.2	1.1	0.7	1.2	2.7	12.3	0.0	2.7	47.7	2.7	4.1	12.3	15.1	11.4	43.7	8.5	8.0	10.3	14.3	8.1	0.0	400.3	0.4	1.5	87.1	0.0	13.6	8.8	1.5	2.4	7.3	9.6	19.1	65.3	12.9	2.8	8.2	29.0	2.5	17.7	10.8	8.2	1.9	2.7	5.0	422.9	27.0	2.0	2.5	7.4	2.1	3.4	4.3	0.0	67.5	2.9	7.9	0.0	36.7	90.7	17.4	50.9	4.5	4.1	4.3	113.1	2.8	3.5	48.9	0.0	6.5	6.0	2.4	2.9	4.4	3.3	0.3	3.6	9.9	39.3	8.7
PRELID3B	"C20orf45, dJ543J19.5, SLMO2"	ENSG00000101166	"PRELI domain containing 3B"	Q9Y3B1	20	59033145-59042809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 229.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047721	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA047721: AB_2680131"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (5.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.20e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.96e-2)"	30.0	33.4	17.7	30.8	19.5	37.4	32.3	20.2	24.1	19.0	16.1	68.8	92.5	20.9	18.4	43.1	19.6	22.6	28.4	16.8	21.0	34.2	33.6	23.2	34.5	19.4	19.9	14.9	26.2	43.3	27.3	28.2	20.5	19.9	64.8	17.7	28.3	13.3	18.7	25.0	83.4	24.8	19.4	25.1	44.4	25.5	19.3	34.4	37.0	38.9	40.1	49.4	19.9	21.9	118.6	54.2	53.5	71.6	36.8	51.0	75.6	87.4	70.2	147.1	77.3	152.4	98.4	187.1	138.2	61.2	115.3	123.5	106.2	127.5	154.3	106.9	68.2	132.1	87.3	33.0	77.7	174.5	114.9	46.4	162.1	85.6	196.3	49.9	47.3	143.0	51.6	77.1	61.6	145.3	186.9	71.0	26.3	187.8	149.6	101.5	125.9	107.8	72.7	98.8	97.2	92.7	139.5	218.5	208.1	37.3	116.2	125.6	64.0	54.8	54.5	101.2	45.4	51.2	77.7	149.5	61.9	81.7	65.1	52.1	22.1	23.3	32.7	30.2	40.6	41.1	40.1	37.7	28.9	30.1	35.4	38.1	19.5	45.6	37.7	24.6	46.5	36.9	17.7	19.5	20.2	24.1	16.8	21.0	19.4	19.9	20.5	19.4	19.3	21.9	25.5	22.4	36.0	0.0	43.2	0.0	67.0	0.0	52.9	9.8	53.0	32.1	0.0	17.2	15.5	22.0	6.2	64.2	47.1	62.6	68.4	60.8	68.5	43.6	20.6	26.8	27.9	55.2	0.0	56.8	113.2	21.6	45.9	64.7	16.4	26.1	18.5	27.8	54.5	11.8	0.0	46.8	0.0	38.9	0.0	24.7	14.9	37.6	0.0	0.0	49.5	16.6	35.0	0.0	0.0	77.8	45.9	15.8	51.5	113.0	137.5	51.3	22.6	10.6	26.3	31.9	21.5	79.3	39.5	69.5	0.0	124.1	47.0	43.3	59.9	229.4
PRICKLE1	"EPM1B, FLJ31937, RILP"	ENSG00000139174	"Prickle planar cell polarity protein 1"	Q96MT3	12	42456757-42590355	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8;Excitatory neurons: 307.7;Inhibitory neurons: 122.2;Microglial cells: 64.6;Oligodendrocyte precursor cells: 114.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.6;naive B-cell: 11.5"	"Lineage enriched"	"Detected in many"	4	"B-cells: 11.5"	"Cell line enriched"	"Detected in many"	18	"HBEC3-KT: 1015.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001379, HPA050037"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA001379: AB_1855703, HPA050037: "	"unprognostic (2.44e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.29e-4)"	"unprognostic (1.12e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.33e-4)"	6.3	3.0	3.7	5.2	5.0	1.7	5.0	0.0	7.2	12.5	0.0	4.2	2.6	12.1	1.6	2.4	6.4	10.0	13.8	4.2	0.0	5.0	1.7	9.5	4.6	0.1	1.3	12.5	2.0	1.4	2.0	5.3	0.0	5.1	2.2	4.2	7.8	5.6	3.9	4.7	2.4	12.7	0.0	14.8	2.9	6.0	3.9	1.6	7.9	4.6	3.4	5.5	6.3	1.0	7.7	4.4	17.0	0.5	12.4	13.1	0.5	11.0	5.2	3.0	5.1	0.5	16.0	0.5	31.4	1.6	0.0	2.9	12.5	1015.4	3.5	0.6	6.4	17.5	0.9	0.4	1.7	0.3	0.2	19.3	7.5	12.7	1.7	1.8	39.7	0.3	1.8	3.1	2.9	0.3	0.1	0.5	56.1	0.1	18.0	0.2	0.7	0.1	21.1	0.7	4.4	3.0	0.3	0.7	0.7	13.7	0.3	35.1	2.9	0.9	13.4	14.0	14.2	0.9	0.6	6.1	0.2	10.7	0.6	2.6	1.8	0.4	0.2	1.0	0.7	7.6	0.2	0.2	1.0	11.5	0.4	0.2	2.4	0.5	0.6	1.6	0.2	0.9	3.7	5.0	0.0	7.2	4.2	0.0	0.1	1.3	0.0	0.0	3.9	1.0	6.9	16.0	8.2	8.8	13.2	2.7	5.3	7.3	4.0	13.5	4.0	2.2	5.7	14.3	2.6	1.8	2.1	0.6	0.2	0.0	0.0	3.8	72.8	5.2	43.0	8.1	0.0	0.4	307.7	2.6	0.2	19.2	3.6	8.6	1.3	59.1	14.6	0.1	0.6	8.4	122.2	0.0	2.0	0.9	2.3	25.4	9.9	1.2	7.2	64.6	1.1	2.7	0.0	114.6	5.3	3.9	0.1	24.8	3.1	1.0	0.0	3.3	0.3	4.5	0.0	3.8	7.9	5.1	4.8	1.9	1.4	0.7	1.1	18.6	0.0	0.8
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646850	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 30.6"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 70.3;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA046566: AB_2679701"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.00e-5)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	4.3	3.3	3.9	6.6	4.6	15.0	6.9	6.0	4.3	5.6	6.9	6.9	6.0	7.2	6.9	4.3	6.2	4.3	3.3	3.9	5.6	3.9	5.0	4.8	10.6	4.2	4.7	7.2	4.0	3.9	1.9	7.5	4.4	30.6	8.4	4.0	4.2	5.6	2.3	5.8	5.2	8.0	2.8	5.5	4.8	6.5	4.5	15.3	4.4	2.4	11.8	5.8	4.1	7.1	44.8	17.7	34.1	37.6	16.8	29.5	27.3	53.1	48.8	57.0	74.7	26.6	21.1	39.4	27.7	66.6	39.6	27.9	30.2	29.2	71.6	35.1	24.2	47.6	22.7	43.0	7.3	43.5	27.4	12.1	12.0	61.0	20.3	14.2	26.9	44.1	46.2	38.9	48.3	28.2	49.8	37.6	22.0	37.1	17.2	34.7	46.9	31.2	21.0	20.7	24.5	19.2	31.5	15.9	21.3	38.9	33.3	47.4	17.9	54.7	55.5	106.2	44.2	14.4	29.3	47.2	26.6	50.5	30.4	0.7	1.9	1.8	4.1	3.7	4.3	3.5	3.5	5.4	3.0	4.0	2.8	5.7	1.4	5.2	4.2	5.1	4.7	2.1	3.9	4.6	6.0	4.3	3.9	5.6	4.2	4.7	4.4	2.8	4.5	7.1	5.9	0.0	2.7	30.0	11.2	4.0	6.7	4.1	11.4	5.6	6.2	4.2	1.1	2.8	4.6	3.7	12.5	17.0	15.1	4.3	3.9	5.1	10.3	4.9	7.1	5.0	1.2	26.5	38.0	5.2	22.0	6.9	4.1	6.0	12.0	13.7	4.2	3.5	9.3	6.7	32.6	6.5	10.2	6.6	6.4	3.7	6.5	7.0	0.0	70.3	7.3	4.8	17.5	56.8	54.5	4.9	5.3	6.8	12.7	7.1	4.4	1.8	4.1	5.6	19.7	4.9	6.8	10.1	11.2	8.7	3.0	5.7	13.6	8.0	8.6	5.3
PRIMPOL	"CCDC111, FLJ33167"	ENSG00000164306	"Primase and DNA directed polymerase"	Q96LW4	4	184649667-184694963	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 24.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054372	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Nucleoplasm	"HPA054372: AB_2682466"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.02e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.05e-1)"	7.2	8.0	4.0	6.0	4.9	5.5	8.9	7.6	4.2	8.5	4.4	7.9	4.7	10.7	8.2	7.0	8.9	6.9	7.0	3.6	4.1	5.7	6.8	7.5	7.9	4.3	4.1	12.1	4.8	6.8	4.6	6.6	4.3	7.1	8.6	7.2	4.7	8.2	4.7	6.6	6.7	9.2	4.2	8.6	5.9	5.5	4.3	8.6	7.6	5.3	6.4	6.4	5.3	5.6	13.1	5.7	13.2	15.0	17.5	23.2	8.9	13.8	21.8	22.9	19.9	4.4	13.3	7.5	5.0	10.6	12.6	7.9	11.3	14.6	24.0	15.9	5.3	7.8	7.8	5.3	11.4	6.4	11.5	14.5	11.4	21.2	13.7	13.4	12.6	20.7	16.5	24.0	16.5	4.4	13.3	5.4	4.3	5.8	4.6	12.3	9.4	9.0	11.8	7.8	9.4	11.9	8.3	2.1	15.2	10.4	6.6	12.3	6.8	7.5	9.7	5.9	8.9	13.4	10.2	3.8	11.1	8.5	18.6	11.2	2.5	24.0	3.8	2.4	5.6	3.6	3.6	3.9	3.2	3.7	3.0	3.0	1.2	4.7	5.6	2.7	4.6	3.1	4.0	4.9	7.6	4.2	3.6	4.1	4.3	4.1	4.3	4.2	4.3	5.6	7.7	6.4	8.6	23.5	6.7	9.6	9.5	10.0	9.1	6.2	10.1	6.3	2.6	7.2	10.4	5.5	0.0	14.3	8.1	5.9	5.9	7.7	5.5	9.0	11.1	7.3	6.7	17.5	13.9	5.2	10.0	9.7	8.2	6.3	15.2	12.0	8.9	7.5	9.7	8.4	26.9	58.8	6.1	14.8	6.4	5.7	12.5	9.5	8.8	19.7	6.5	11.1	6.2	27.2	28.1	3.7	10.4	9.1	8.6	4.0	7.2	5.7	15.4	8.2	13.1	11.1	9.0	18.8	13.1	6.9	9.8	4.9	8.9	5.7	8.0	5.4
PRKAB1		ENSG00000111725	"Protein kinase AMP-activated non-catalytic subunit beta 1"	Q9Y478	12	119667864-119681624	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004247, CAB005058"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"CAB005058: AB_562038, HPA004247: AB_1078149"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.42e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (5.40e-9)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.32e-2)"	16.8	16.9	11.9	13.9	13.1	44.0	15.3	12.8	13.2	25.3	12.6	34.8	32.5	16.8	16.3	21.4	17.2	14.5	12.2	11.7	13.0	53.3	17.3	25.3	18.1	14.6	13.5	14.3	33.4	18.9	10.7	27.6	14.1	11.9	33.4	19.4	16.0	15.6	12.6	10.6	22.7	17.0	12.7	24.1	29.0	21.4	13.1	19.7	20.8	10.5	23.9	15.1	10.7	15.7	11.4	30.8	22.1	21.5	17.8	16.7	29.7	18.3	22.7	28.2	20.4	39.9	24.0	36.6	21.8	23.6	12.6	15.2	22.6	32.1	24.9	22.4	36.5	57.8	17.1	51.5	35.6	26.7	66.0	22.4	29.9	24.4	29.7	30.0	21.2	54.5	89.4	13.5	21.6	33.0	60.4	35.4	32.3	16.5	50.1	33.9	20.8	22.7	32.7	33.7	18.7	31.8	22.1	8.6	25.3	26.7	27.2	34.1	25.0	16.9	20.2	13.3	17.8	45.8	45.7	26.8	16.5	19.7	25.5	50.6	28.5	70.3	28.5	32.6	34.4	47.1	30.0	31.0	30.8	39.5	32.3	29.7	34.7	42.0	38.6	27.8	36.1	36.4	11.9	13.1	12.8	13.2	11.7	13.0	14.6	13.5	14.1	12.7	13.1	15.7	20.6	48.1	49.7	3.3	11.9	3.3	6.5	15.3	15.4	16.2	10.0	6.3	5.3	8.6	16.6	22.0	4.2	18.4	7.5	27.0	46.9	8.3	1.2	12.7	7.7	13.2	19.7	34.5	7.1	30.2	10.9	8.6	12.8	15.4	12.0	18.5	5.3	7.1	12.3	21.9	6.2	15.3	14.2	7.0	5.2	2.2	5.6	9.6	3.6	8.4	10.3	13.4	11.3	7.5	7.6	11.7	17.9	6.4	6.4	5.2	16.2	38.2	12.7	17.9	6.6	4.8	8.2	25.6	13.2	13.7	4.3	15.1	9.9	26.3	23.7	8.3
PRKAB2		ENSG00000131791	"Protein kinase AMP-activated non-catalytic subunit beta 2"	O43741	1	147155106-147172550	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.2;tongue: 103.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044342	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"HPA044342: AB_10966508"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.59e-3)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (6.78e-7)"	"unprognostic (4.78e-2)"	12.4	10.8	9.4	7.8	10.1	9.0	11.8	12.5	13.1	14.8	6.0	23.4	32.0	18.7	8.5	10.3	12.9	7.1	25.8	10.1	9.5	9.5	56.3	10.0	6.5	10.8	10.1	11.7	34.8	64.7	6.7	12.3	11.0	12.7	10.7	14.7	8.2	19.4	97.2	15.4	20.8	19.8	10.8	8.5	18.1	6.7	10.6	5.9	6.3	103.8	5.6	18.6	14.0	11.2	7.8	4.2	11.1	8.6	25.7	22.1	39.7	14.3	7.9	9.5	10.3	17.1	15.1	13.9	7.1	11.6	5.5	20.2	13.1	16.1	9.2	5.5	9.0	6.2	15.2	27.8	17.7	7.4	2.6	17.4	31.7	9.9	46.0	14.1	9.4	10.6	8.9	5.6	8.2	7.8	5.5	4.1	23.3	13.4	18.4	8.5	14.8	6.9	6.8	6.1	7.1	13.2	10.8	12.1	52.8	39.6	11.4	9.1	10.8	10.6	23.3	9.9	23.6	8.9	10.1	7.1	11.0	6.4	14.1	0.9	0.3	0.6	0.4	0.4	0.7	0.3	0.4	0.3	0.5	0.3	0.5	0.3	0.1	1.5	0.5	0.2	0.2	0.2	9.4	10.1	12.5	13.1	10.1	9.5	10.8	10.1	11.0	10.8	10.6	11.2	10.4	3.2	2.0	14.0	10.6	16.6	11.8	11.4	18.2	14.5	6.7	8.1	66.2	20.0	5.3	18.4	14.6	21.9	10.3	22.7	1.9	6.1	0.8	5.4	15.1	8.2	11.4	3.4	23.2	7.0	42.1	13.6	13.7	10.4	1.3	11.8	6.8	44.9	5.7	11.8	18.8	12.6	10.2	8.9	12.5	1.8	9.6	7.3	16.0	10.3	12.2	6.4	11.3	25.1	21.3	9.9	12.0	16.1	9.0	7.2	55.1	5.4	7.0	19.5	19.7	11.3	20.4	13.9	11.2	13.1	14.1	20.5	9.7	43.4	10.1	4.8
PRKAG1		ENSG00000181929	"Protein kinase AMP-activated non-catalytic subunit gamma 1"	P54619	12	49002274-49018807	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 339.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077805			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA077805: AB_2686855"	"unprognostic (3.24e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (2.84e-7)"	"unprognostic (1.45e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.49e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (3.40e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.57e-2)"	42.8	54.5	36.4	29.8	40.5	47.4	50.5	39.9	46.3	37.6	41.9	40.7	32.6	32.9	59.1	44.2	33.4	31.3	80.9	38.2	38.6	50.5	49.4	30.8	38.7	34.5	35.5	25.6	37.4	59.1	33.9	35.1	36.5	37.7	47.8	42.3	36.1	39.9	122.7	43.0	29.9	44.8	33.5	28.6	33.5	33.5	34.9	41.8	37.7	112.4	50.8	40.1	30.8	41.5	79.8	45.8	50.5	76.3	157.8	141.6	33.2	85.5	117.4	84.4	55.7	50.9	66.1	50.4	72.9	98.9	53.9	65.4	42.5	115.6	80.4	69.6	57.1	70.4	66.5	34.2	120.2	97.7	54.6	110.0	94.6	65.9	141.4	123.6	90.3	67.6	60.1	70.0	108.6	52.8	45.8	31.5	29.1	339.6	96.8	24.1	53.3	59.7	114.0	67.6	42.1	57.7	61.0	99.1	142.5	39.7	134.1	49.5	72.5	44.4	52.3	87.7	63.5	109.1	113.3	36.0	89.3	69.9	34.5	87.3	59.8	59.9	53.0	58.7	50.0	51.9	46.1	47.6	68.7	51.3	41.3	43.0	70.9	71.8	56.0	45.2	66.8	73.0	36.4	40.5	39.9	46.3	38.2	38.6	34.5	35.5	36.5	33.5	34.9	41.5	20.2	9.6	22.7	16.6	31.2	20.0	30.3	64.5	11.4	29.2	24.3	20.8	49.8	18.6	29.9	36.8	37.5	65.6	30.5	24.5	76.3	48.3	11.3	11.4	21.3	21.9	21.0	30.3	18.1	46.4	57.7	26.7	15.8	12.9	21.5	31.4	30.4	23.2	52.2	15.2	24.1	31.6	63.1	36.2	26.5	15.7	36.7	26.7	37.4	9.4	55.5	41.6	55.6	23.1	21.1	47.8	16.5	27.1	25.0	24.2	38.6	69.3	19.2	30.1	19.7	18.5	27.5	49.3	43.9	19.1	26.0	67.0	26.3	33.6	32.2	23.6
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556124-151877125	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 143.0"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 208.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 178.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	27.1	7.7	21.7	12.8	20.3	8.1	18.4	16.7	22.8	16.2	11.1	25.8	24.4	19.8	14.3	16.2	17.9	12.8	143.0	23.7	21.1	22.5	36.1	14.2	11.6	19.3	17.4	10.9	10.9	9.2	9.5	16.1	19.7	25.3	18.9	2.9	15.0	19.5	15.0	13.5	26.2	16.5	15.8	17.6	26.7	12.8	18.5	7.9	16.6	21.7	9.8	47.9	17.5	19.6	46.6	13.6	9.1	10.6	36.4	28.6	14.4	21.5	19.5	22.7	22.3	8.6	52.5	0.0	34.0	28.9	178.2	13.9	5.7	22.4	30.0	15.8	6.2	11.5	1.8	0.9	60.8	8.5	11.4	16.5	49.7	21.8	21.0	34.1	40.2	14.9	4.1	5.6	66.2	17.2	3.5	6.7	9.7	18.8	37.5	5.6	6.9	9.7	39.2	10.9	38.5	6.7	10.7	19.9	10.0	22.9	4.0	13.6	52.8	5.0	4.3	2.8	13.1	3.5	5.1	0.0	63.5	29.8	45.9	26.2	9.3	10.9	5.3	7.0	4.1	9.6	4.9	4.8	6.5	4.0	4.8	7.3	11.1	4.4	6.4	6.0	2.9	5.3	21.7	20.3	16.7	22.8	23.7	21.1	19.3	17.4	19.7	15.8	18.5	19.6	19.2	6.4	19.8	37.5	24.8	10.6	39.9	25.0	19.9	22.3	20.6	14.5	122.3	8.6	22.9	46.0	8.4	3.9	43.8	29.5	64.6	14.1	49.3	75.1	16.9	20.4	13.1	3.8	208.5	22.7	31.2	24.9	21.9	98.1	22.2	4.6	18.9	76.8	17.7	3.3	85.2	34.5	105.8	57.2	48.2	35.8	7.5	50.9	16.0	73.1	62.9	14.7	37.0	39.2	4.4	27.5	21.9	7.9	23.4	45.7	77.7	19.7	14.2	6.1	13.1	6.9	27.3	4.0	32.3	12.8	10.9	50.6	27.3	5.0	28.0	45.2
PRKCB	"PKCβ, PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835983-24220611	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;lymphoid tissue: 47.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 185.1;Bipolar cells: 208.6;Excitatory neurons: 877.7;Inhibitory neurons: 320.2;Kupffer cells: 221.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	95	"amygdala: 28.9;basal ganglia: 53.9;cerebral cortex: 84.0;hippocampal formation: 35.3;white matter: 36.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 161.8;HMC-1: 154.8;K-562: 234.9;THP-1: 72.7;U-937: 64.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		380000	"Cluster 6: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.4	1.6	28.9	30.8	53.9	32.1	1.5	0.5	84.0	4.2	0.0	9.7	5.9	3.8	0.6	3.5	3.8	4.4	1.1	35.3	0.0	2.8	4.2	7.8	47.1	0.0	0.0	0.6	1.0	0.2	1.4	2.7	0.0	7.3	5.1	18.2	1.5	10.2	0.8	5.5	19.4	7.2	0.0	46.2	5.7	8.4	0.0	47.2	4.5	1.0	40.0	8.7	1.7	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	1.0	0.0	0.3	0.5	0.5	0.0	0.0	0.0	3.2	161.8	7.5	0.0	0.0	23.6	154.8	0.0	0.7	0.0	0.0	0.0	0.0	27.3	234.9	0.6	0.0	0.0	52.1	51.4	1.5	0.0	0.0	49.0	0.4	9.5	0.5	14.1	27.2	0.0	0.2	0.2	2.4	0.8	0.0	72.7	1.1	0.0	0.3	0.1	0.0	4.1	0.0	1.4	0.2	64.4	0.3	39.3	13.3	27.8	24.8	20.0	11.5	44.2	15.9	29.9	11.3	40.0	13.0	32.0	39.1	39.9	28.6	33.8	12.7	15.5	28.9	53.9	0.5	84.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	36.6	1.1	3.2	4.9	21.5	185.1	6.0	4.1	0.1	0.6	208.6	0.9	0.8	2.0	2.8	1.8	1.8	2.1	0.2	166.3	1.4	0.0	0.0	26.5	0.1	0.1	4.1	0.0	26.3	877.7	0.2	0.3	1.7	1.5	0.1	71.5	1.9	11.4	3.1	50.5	79.1	320.2	1.5	0.0	221.9	20.5	11.7	0.0	100.9	3.6	110.5	154.4	10.8	120.5	102.1	132.5	0.0	9.6	0.4	61.8	1.0	6.7	0.8	1.6	9.9	0.0	4.4	1.6	3.4	3.6	0.5	14.3	0.8	68.1	0.2	3.8	4.5
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (9.15e-4)"	29.0	11.5	7.2	23.6	7.3	29.4	29.3	5.4	7.7	26.6	12.5	20.3	17.1	21.8	4.7	27.5	24.1	11.2	13.8	6.1	6.0	19.2	13.8	34.3	31.1	10.0	6.3	21.8	19.1	8.3	24.0	11.1	6.8	23.9	7.1	4.4	24.7	10.0	8.0	46.8	29.9	6.0	6.0	54.3	20.3	6.6	7.7	25.6	28.9	4.8	21.2	19.5	26.9	6.6	19.6	34.5	12.8	16.6	7.3	6.4	15.1	11.5	13.2	19.6	19.7	19.7	21.0	22.3	16.3	13.2	13.2	27.5	9.5	26.0	5.9	19.8	17.5	25.9	11.5	10.2	12.8	21.2	34.7	11.0	15.8	12.7	9.8	12.8	30.1	21.5	14.6	35.4	7.0	23.8	32.7	53.1	9.7	27.4	17.4	25.8	5.8	37.5	11.4	32.7	7.7	22.4	18.8	18.8	4.6	10.6	11.6	7.5	17.6	8.7	18.8	7.1	10.0	31.8	149.1	13.5	8.5	17.7	11.0	0.6	0.7	2.6	3.9	0.7	3.3	4.3	3.9	4.3	0.3	4.1	3.3	3.3	5.3	2.2	0.5	0.0	2.9	1.5	7.2	7.3	5.4	7.7	6.1	6.0	10.0	6.3	6.8	6.0	7.7	6.6	37.8	9.6	9.9	5.9	46.5	22.0	32.0	13.2	22.8	6.4	13.9	11.3	17.2	12.8	13.0	9.2	0.0	13.8	17.5	43.6	7.9	18.6	1.2	15.3	6.7	37.2	21.6	4.0	6.5	28.2	13.8	9.6	23.4	15.0	14.5	14.1	37.1	8.5	9.0	1.7	2.8	21.7	4.1	12.3	11.4	3.1	11.8	8.3	12.4	11.2	9.3	6.5	42.2	4.0	3.1	29.5	35.1	6.8	47.0	22.9	34.1	9.3	15.6	4.4	13.1	6.1	7.6	2.9	17.9	21.2	26.7	29.7	31.9	6.6	15.3	30.2
PRKD3	"EPK2, PRKCN"	ENSG00000115825	"Protein kinase D3"	O94806	2	37250502-37324833	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 152.1;U-266/84: 159.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029529	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA029529: AB_10602082"	"unprognostic (1.39e-1)"	"unprognostic (7.34e-2)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-1)"	15.1	19.9	6.1	18.1	6.8	8.7	14.4	7.8	7.3	19.3	3.9	16.4	8.2	18.9	13.8	10.7	9.9	13.3	9.8	6.0	7.5	12.0	10.1	14.7	29.1	7.2	7.1	18.0	9.1	11.7	6.5	14.9	7.8	11.7	11.0	41.6	10.5	12.5	14.9	12.2	10.3	16.2	7.6	23.4	12.4	23.3	8.1	20.7	13.4	12.1	28.9	15.5	9.5	7.1	38.8	14.3	44.4	36.1	33.2	55.1	31.5	25.0	48.8	29.1	28.7	23.4	14.0	58.5	20.1	39.6	43.2	15.0	31.1	31.9	39.0	72.3	38.7	39.2	24.4	17.8	13.8	26.2	21.5	26.0	16.2	46.2	29.7	26.6	52.6	19.9	32.3	70.9	33.8	6.1	11.6	21.6	45.4	0.4	14.2	40.8	67.9	51.8	18.9	42.1	32.5	81.0	24.6	13.9	152.1	22.8	15.1	25.1	47.7	80.0	40.5	31.5	28.5	78.1	159.7	68.2	27.8	11.2	48.7	6.9	7.7	6.1	9.5	6.7	8.1	10.6	8.5	8.1	7.7	14.6	9.6	10.8	1.4	6.9	3.6	8.1	4.4	3.6	6.1	6.8	7.8	7.3	6.0	7.5	7.2	7.1	7.8	7.6	8.1	7.1	41.4	41.7	17.8	21.9	60.2	37.9	32.1	24.1	14.8	47.6	14.7	15.5	9.1	27.1	16.6	18.4	68.8	11.2	37.7	7.3	3.9	13.1	57.1	8.3	38.5	48.0	18.8	12.0	24.8	10.6	37.0	33.0	20.4	14.1	76.9	26.8	44.3	12.2	12.8	43.7	18.7	6.9	22.4	31.2	91.2	100.6	33.5	24.4	49.8	68.4	32.7	15.9	27.8	37.7	12.6	16.1	4.3	30.9	60.2	34.3	6.6	8.6	10.3	118.8	26.3	27.5	24.0	54.7	39.9	10.6	23.9	9.7	33.5	29.1	12.3	34.1
PRKDC	"DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC, HYRC1, p350, p460, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic subunit"	P78527	8	47773111-47960178	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: AB_2674504"	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	17.3	16.8	8.6	14.1	10.7	19.2	16.1	9.8	11.9	18.2	10.8	16.2	7.0	20.1	8.0	24.0	18.3	7.4	16.7	10.6	9.3	14.8	14.0	14.8	17.9	10.4	10.0	19.8	18.0	14.0	16.3	10.9	9.8	13.5	11.6	23.8	16.0	9.2	26.4	19.8	17.2	12.1	10.6	18.8	16.6	18.3	9.6	27.8	13.4	15.0	17.1	18.7	17.5	14.3	123.5	103.4	98.4	93.9	59.9	63.0	41.6	51.2	49.9	70.3	68.9	68.0	39.6	117.1	43.1	63.3	52.3	68.5	131.3	70.2	109.3	26.3	81.8	230.2	92.1	83.7	25.8	88.6	46.0	45.9	22.5	111.3	115.3	27.1	73.4	79.5	156.6	48.0	78.8	57.7	125.8	72.3	108.6	85.6	31.2	60.8	77.3	41.2	35.5	104.4	49.2	62.5	158.1	50.6	51.1	60.2	72.6	60.1	86.2	91.5	78.0	73.0	104.2	41.3	56.7	162.8	51.7	97.9	75.6	11.4	8.1	4.1	8.7	6.8	11.0	13.1	10.8	9.2	6.5	16.7	11.2	10.3	7.7	12.8	13.7	15.3	8.3	2.9	8.6	10.7	9.8	11.9	10.6	9.3	10.4	10.0	9.8	10.6	9.6	14.3	73.4	38.5	36.1	56.8	67.9	38.4	48.3	59.7	77.4	103.4	63.1	64.0	82.1	22.8	44.1	42.3	125.1	61.1	81.9	17.5	17.6	41.9	29.0	66.0	166.5	59.7	25.8	147.6	85.5	36.0	60.6	73.2	55.0	72.6	45.6	105.1	32.5	41.2	35.9	104.3	77.1	31.2	38.7	45.5	20.1	15.5	56.8	54.6	19.6	61.8	63.6	73.1	57.7	82.0	76.0	34.9	16.6	69.6	69.3	57.1	13.2	23.5	50.1	111.6	52.6	91.2	69.3	100.7	106.3	85.3	40.6	33.0	71.0	143.2	55.2	36.4
PRKRA	"DYT16, HSD14, PACT, RAX"	ENSG00000180228	"Protein activator of interferon induced protein kinase EIF2AK2"	O75569	2	178431292-178451512	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	RNA-binding	"Disease variant, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 307.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004648, HPA034996, HPA034997"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-3)"	"unprognostic (8.99e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.78e-2)"	28.7	21.9	22.1	13.8	22.6	18.2	26.4	24.6	31.3	23.6	25.3	36.4	13.7	28.7	25.7	22.8	23.4	17.5	37.2	22.8	24.9	29.7	20.2	21.2	16.9	25.0	22.5	23.4	25.4	26.2	22.5	11.5	24.2	23.4	20.1	30.9	22.6	24.3	100.7	31.2	19.7	29.4	25.2	15.9	26.0	24.3	23.1	20.4	22.1	72.7	20.4	32.1	22.0	27.1	24.6	18.4	48.2	20.8	49.2	56.7	39.6	35.4	37.7	46.4	50.8	50.9	33.8	51.0	39.8	43.6	30.9	21.0	42.0	28.5	50.9	43.9	25.0	29.2	17.0	46.7	58.6	21.2	16.1	32.2	69.3	44.0	49.7	46.0	46.8	32.8	26.7	34.9	62.9	25.3	46.3	52.2	46.7	42.3	33.5	38.5	89.0	46.6	52.4	25.5	30.2	39.4	21.9	20.2	48.3	36.3	30.6	27.4	20.8	32.0	42.6	33.8	29.9	52.5	33.7	62.6	40.8	35.1	20.7	5.4	24.7	25.9	18.1	25.5	26.2	34.3	28.4	22.7	37.2	26.4	31.4	25.8	5.1	25.2	26.3	49.7	38.3	30.9	22.1	22.6	24.6	31.3	22.8	24.9	25.0	22.5	24.2	25.2	23.1	27.1	35.1	16.0	33.4	23.2	37.7	63.1	90.0	89.3	30.1	53.6	48.1	40.3	43.5	20.0	39.9	25.8	43.8	37.7	49.3	16.9	125.2	51.4	149.5	43.6	36.2	34.5	47.9	19.1	39.5	41.6	53.2	42.7	19.4	27.0	28.5	40.5	21.8	18.5	30.4	10.1	46.4	35.5	93.6	19.8	69.4	307.9	39.4	26.4	69.4	21.5	38.6	49.2	9.2	30.7	47.1	36.0	25.1	37.2	42.5	94.7	30.8	89.0	30.6	86.2	46.0	45.6	66.7	78.7	57.6	43.7	78.4	43.4	33.6	47.0	39.6	73.0
PRKX	PKX1	ENSG00000183943	"Protein kinase X-linked"	P51817	X	3604340-3713649	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 33.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 108.3;Endometrial ciliated cells: 164.0;Glandular and luminal cells: 179.5;NK-cells: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015324	Supported		Supported	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	5.5	1.6	10.0	9.8	12.9	7.7	7.9	12.6	8.8	7.8	12.7	6.5	5.1	4.6	9.6	13.9	19.4	4.4	3.7	8.3	14.3	15.6	1.8	9.0	12.8	18.1	13.8	4.0	4.4	3.1	2.0	5.3	15.8	3.8	6.1	1.7	6.1	5.9	2.2	12.0	6.3	3.7	14.5	12.4	4.0	6.8	15.3	15.4	33.8	3.2	9.9	4.5	12.4	17.1	9.1	8.3	22.4	16.7	4.2	5.6	20.5	5.3	2.1	2.6	3.5	12.4	6.1	0.7	5.3	4.3	5.4	6.2	21.1	16.1	4.5	10.2	14.7	10.0	6.7	0.2	4.4	13.0	74.7	3.8	16.8	2.8	10.3	7.1	25.7	12.3	11.8	12.7	8.6	8.0	15.0	11.7	15.0	7.0	9.4	27.7	21.5	17.2	20.6	7.6	14.9	9.6	5.6	3.6	5.5	35.1	2.8	10.3	14.2	2.2	3.8	3.7	3.6	0.3	0.7	11.6	1.3	11.6	5.8	11.0	2.0	1.2	2.3	2.4	2.4	1.6	2.4	2.2	1.6	1.5	1.9	2.1	0.5	2.4	3.2	1.9	1.8	1.2	10.0	12.9	12.6	8.8	8.3	14.3	18.1	13.8	15.8	14.5	15.3	17.1	32.0	3.2	9.4	7.8	35.5	21.4	22.3	9.7	21.6	1.8	14.4	9.1	1.6	30.0	10.1	5.5	0.0	30.8	108.3	8.8	13.7	10.8	11.9	164.0	23.8	19.7	4.8	7.2	1.3	3.1	5.8	10.4	6.1	179.5	85.1	11.8	13.2	2.3	16.9	1.7	20.2	13.5	24.4	19.4	24.1	49.2	19.9	29.0	5.4	39.4	53.4	2.2	139.0	11.1	7.0	5.6	13.1	21.8	38.2	29.0	10.7	6.1	18.0	0.6	32.9	46.4	12.4	1.3	21.6	34.1	26.9	7.8	63.5	10.6	23.6	20.4
PRM1	CT94.1	ENSG00000175646	"Protamine 1"	P04553	16	11280841-11281330	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1099	"testis: 14115.0"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 776887.9"	"Cancer enriched"	"Detected in single"	161	"testis cancer: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.4;U-2197: 1.7"					"Not detected"	"Not detected"			"HPA055150, HPA059371"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA055150: AB_2682718, HPA059371: "															"unprognostic (2.10e-2)"			2.3	2.2	0.0	0.5	0.0	0.0	9.9	0.0	0.0	2.1	0.0	2.1	1.5	1.0	0.0	1.9	1.2	0.0	2.2	0.0	0.2	2.7	4.4	1.3	0.4	0.1	0.0	1.6	3.0	0.0	1.9	0.0	0.1	12.8	0.0	0.0	2.1	1.3	5.8	3.7	4.0	0.0	0.0	1.4	2.4	14115.0	0.0	0.0	4.3	0.0	0.1	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126844.3	0.0	0.0	80.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	776887.9	1855.9	161.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1689.6	0.0	0.0	0.0	0.0	0.0	0.0	1157.0	0.0	0.0	2054.0	1211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRMT1	"ANM1, HCP1, HRMT1L2"	ENSG00000126457	"Protein arginine methyltransferase 1"	Q99873	19	49675786-49689029	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 444.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022550, HPA069769, HPA072136"	Supported		Supported	Nucleoplasm		NA	NA		8500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB022550: , HPA069769: AB_2686193, HPA072136: AB_2686490"	"unprognostic (1.88e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.04e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.10e-2)"	79.7	102.2	62.5	76.2	63.2	65.0	76.7	68.1	74.7	107.0	59.4	87.2	55.1	115.4	44.5	90.7	109.7	49.8	149.2	65.7	71.1	77.9	61.8	76.5	94.0	66.5	65.2	106.7	66.3	65.6	101.1	65.3	68.8	77.1	45.5	71.3	67.6	73.9	242.6	74.8	71.8	74.0	66.3	91.6	69.4	78.4	71.3	79.6	70.9	163.2	84.5	92.6	81.6	68.7	262.5	584.9	396.5	481.7	105.4	118.7	208.4	163.7	283.1	461.8	394.0	439.5	202.2	425.9	119.0	193.4	181.1	188.0	337.3	345.8	200.1	333.7	580.5	311.5	156.4	484.6	256.8	378.7	214.2	166.7	169.3	259.2	369.0	154.8	277.1	338.3	334.0	293.2	182.5	394.1	493.2	467.0	420.5	324.9	375.6	344.8	319.9	388.8	264.0	540.9	440.0	342.4	188.9	193.2	103.4	126.9	146.8	220.6	173.9	269.9	262.5	125.4	398.6	280.0	457.4	429.3	165.7	271.0	289.8	25.0	76.8	37.5	104.0	93.8	129.6	198.9	95.4	111.0	131.5	171.6	105.2	103.3	14.8	162.3	71.9	158.9	97.7	132.5	62.5	63.2	68.1	74.7	65.7	71.1	66.5	65.2	68.8	66.3	71.3	68.7	169.7	3.2	10.3	15.7	112.4	207.0	228.7	444.9	123.5	228.9	71.3	96.8	17.2	40.0	117.3	44.1	106.3	195.6	74.4	45.1	127.2	204.0	5.4	88.9	124.5	167.8	115.2	38.3	9.8	135.2	177.5	101.7	51.5	87.5	54.7	154.2	109.6	22.1	104.1	129.5	15.8	74.5	227.9	27.0	125.7	19.4	104.1	52.9	112.1	15.9	149.4	119.3	57.7	14.6	20.2	125.6	45.6	89.1	117.8	263.0	35.2	87.5	62.8	168.7	92.1	89.7	236.3	66.8	121.8	94.9	158.8	235.2	76.8	200.7	105.0	183.2
PRMT2	"HRMT1L1, MGC111373"	ENSG00000160310	"Protein arginine methyltransferase 2"	P55345	21	46635595-46665124	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 451.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018976, HPA029591"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA018976: AB_1855719, HPA029591: AB_10601250"	"unprognostic (1.82e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.76e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.23e-1)"	37.4	25.4	84.3	42.3	88.4	37.3	39.0	90.1	84.0	43.5	79.6	50.2	27.0	43.2	26.8	55.2	47.0	42.5	56.3	81.4	105.6	36.8	14.4	40.7	57.1	100.7	123.9	82.6	27.4	29.9	27.9	49.3	104.7	38.1	30.4	23.1	38.6	48.3	20.4	51.1	36.7	50.4	91.8	49.8	32.1	16.4	100.0	45.2	36.0	21.8	52.7	44.4	38.2	106.5	75.7	63.4	130.2	48.1	94.0	90.1	31.1	70.6	79.0	77.4	70.2	88.8	60.4	44.5	85.6	126.9	104.3	22.0	59.3	87.4	44.7	110.1	57.2	115.8	55.0	67.4	43.3	34.9	51.7	56.1	85.0	93.4	66.6	87.6	114.5	61.2	74.5	80.4	121.0	84.1	50.3	63.9	69.3	47.5	73.6	63.2	33.2	29.6	61.1	63.3	89.4	56.6	73.8	33.0	135.0	18.5	44.1	35.2	104.8	75.2	50.5	40.4	47.4	21.2	21.0	28.6	70.4	92.4	115.3	256.5	91.9	314.2	261.8	128.4	192.0	93.6	176.3	227.2	131.5	82.7	215.9	248.8	122.3	262.0	135.3	112.7	142.3	223.2	84.3	88.4	90.1	84.0	81.4	105.6	100.7	123.9	104.7	91.8	100.0	106.5	71.5	93.0	36.2	54.5	74.4	46.1	69.8	79.1	66.6	47.7	93.2	103.5	69.5	67.2	61.8	75.4	29.2	64.3	192.9	49.4	90.1	79.1	3.5	51.9	60.2	82.9	35.8	27.3	39.2	52.9	43.5	68.0	48.9	46.1	117.0	132.0	142.8	42.1	107.2	37.0	42.6	32.6	52.9	133.7	102.1	9.0	55.6	109.3	87.2	74.0	182.9	61.1	451.1	69.4	160.6	74.9	40.0	62.1	64.6	94.0	44.0	113.5	71.4	57.7	65.7	53.2	77.2	22.0	39.0	75.0	45.0	69.2	167.1	55.0	38.3	72.9
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920525-22929408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		45000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330"	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (1.82e-4)"	"prognostic unfavorable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.04e-4)"	27.6	31.0	19.9	27.9	21.6	21.7	34.9	21.0	25.9	33.3	24.4	38.4	24.0	36.9	30.6	49.0	44.6	19.4	35.1	20.9	21.8	37.0	28.3	23.2	26.6	20.2	22.2	45.3	32.9	47.3	24.5	30.6	22.0	27.9	35.6	30.8	27.7	33.3	65.8	34.4	23.3	35.5	20.4	26.3	29.2	30.3	21.6	33.1	37.9	42.1	34.3	31.4	33.5	22.8	161.7	169.2	114.2	112.9	62.3	67.7	125.6	104.1	91.6	192.7	156.6	159.2	160.1	171.3	83.2	88.5	108.3	135.8	246.4	212.8	213.9	98.5	119.3	104.5	108.3	256.3	111.4	221.7	85.7	69.3	113.2	143.1	264.8	72.7	91.0	128.5	160.0	91.7	108.5	171.4	151.3	102.9	103.1	160.8	221.8	176.0	140.3	122.7	98.8	110.7	126.0	79.8	125.7	132.3	65.5	94.3	91.3	82.6	70.9	75.1	103.1	103.0	145.9	116.6	246.0	207.2	46.1	109.2	116.0	3.0	31.3	0.4	14.2	31.7	22.9	30.6	19.0	23.0	42.8	27.9	24.4	20.4	7.7	19.8	25.1	25.9	17.6	29.1	19.9	21.6	21.0	25.9	20.9	21.8	20.2	22.2	22.0	20.4	21.6	22.8	8.5	19.2	15.1	5.5	11.4	26.5	26.5	33.8	15.4	10.8	13.9	15.4	1.1	28.6	19.4	7.3	8.4	41.7	8.6	11.1	23.5	32.0	2.3	18.5	21.4	12.3	6.1	24.4	6.1	27.0	33.4	16.7	12.8	12.6	7.0	21.9	10.4	15.1	19.6	16.8	5.8	17.5	20.3	4.4	11.7	3.7	16.4	8.0	26.6	0.0	11.8	18.2	3.1	5.5	4.0	92.8	12.7	21.1	12.4	23.6	7.4	24.6	31.1	11.2	6.6	25.9	19.5	43.1	47.3	20.3	27.8	33.4	8.2	27.5	21.1	17.9
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056674-107067636	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 308.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA059424: AB_2684012"	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	4.9	10.0	5.7	7.2	5.6	4.2	8.0	5.6	5.7	6.1	13.8	7.9	6.1	7.0	8.0	6.8	8.8	6.0	3.9	5.2	6.9	12.0	7.1	4.6	9.6	6.1	6.5	8.6	10.9	9.6	8.4	7.3	5.3	8.5	7.2	6.4	6.5	7.8	1.8	5.6	7.2	5.9	5.5	8.3	7.4	6.6	8.2	10.3	7.0	3.1	8.7	7.9	5.0	6.0	13.6	0.2	25.7	11.3	16.6	18.4	7.0	17.8	13.2	16.9	17.2	17.2	9.2	33.1	24.1	16.5	9.2	18.9	23.9	26.2	13.3	0.0	25.4	20.0	35.6	25.0	16.5	41.6	11.9	17.4	14.2	15.2	15.5	11.4	14.8	18.5	27.1	5.0	15.4	308.1	24.5	14.6	11.1	10.6	24.6	30.8	56.0	12.6	41.3	27.1	47.8	58.3	24.2	34.5	12.1	15.5	24.0	30.7	17.2	12.5	25.5	26.3	26.8	5.4	4.0	5.7	18.4	19.3	10.2	2.1	10.4	1.9	7.9	11.9	9.5	7.4	8.3	7.6	14.1	10.3	11.5	11.9	0.6	17.4	12.0	17.2	9.2	9.3	5.7	5.6	5.6	5.7	5.2	6.9	6.1	6.5	5.3	5.5	8.2	6.0	3.0	0.0	4.4	1.3	6.2	4.5	6.9	9.7	8.6	14.2	8.9	5.0	2.6	5.7	5.8	14.7	0.0	18.3	8.5	3.3	27.4	10.3	1.2	5.2	6.2	4.7	17.5	15.8	1.5	7.4	14.6	6.7	4.6	4.9	1.3	9.4	7.5	2.4	10.0	15.2	2.2	7.4	8.2	7.0	1.6	3.0	8.7	3.8	1.8	3.7	3.9	6.9	3.1	2.0	2.2	4.7	8.5	9.1	2.0	5.1	4.1	18.4	7.4	5.1	13.1	5.9	6.3	9.1	8.1	8.9	6.1	7.1	5.0	13.7	10.3	5.4
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358584	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	9.7	11.9	8.1	6.2	8.3	4.7	10.5	8.4	10.2	9.8	12.0	10.8	3.2	9.4	3.3	7.5	10.7	4.3	13.2	8.3	8.3	8.6	10.2	5.9	9.4	8.9	8.4	12.1	9.7	4.8	11.1	6.3	8.8	10.5	3.0	4.6	10.0	7.0	21.8	9.8	8.8	4.5	8.3	9.7	8.8	9.8	8.4	14.4	8.6	13.5	5.8	9.7	8.3	8.4	18.1	24.7	13.2	36.1	7.1	7.0	50.8	13.8	6.8	19.5	15.6	79.4	16.1	42.4	29.8	14.0	8.4	22.6	20.4	13.8	12.6	12.7	24.5	8.6	30.8	36.8	7.8	24.3	15.8	11.3	4.9	15.2	14.0	9.3	11.8	18.7	28.1	0.8	10.3	28.2	25.8	36.3	25.3	16.5	18.8	43.7	19.3	25.7	10.7	17.7	19.8	13.2	53.5	16.2	15.7	11.9	25.2	22.2	16.0	14.7	12.9	19.9	17.6	9.6	22.5	41.6	17.1	23.4	16.8	12.3	8.2	7.1	17.4	10.6	20.2	10.9	11.6	14.9	11.8	12.8	16.7	15.4	0.8	21.4	9.5	32.9	14.7	14.3	8.1	8.3	8.4	10.2	8.3	8.3	8.9	8.4	8.8	8.3	8.4	8.4	7.1	19.2	10.6	16.6	12.1	6.9	8.9	12.8	9.1	21.2	10.8	8.8	13.3	8.6	10.0	9.2	54.2	25.4	12.6	28.3	5.9	12.3	4.4	12.9	8.7	7.6	13.2	7.8	25.0	16.1	8.4	10.5	23.4	5.9	7.0	24.9	6.8	8.4	12.2	30.3	25.9	32.4	10.2	7.7	20.6	4.3	11.8	6.2	8.8	12.2	9.1	9.7	13.4	18.6	20.4	23.6	29.8	13.2	6.9	6.7	24.7	7.7	14.5	18.2	13.1	9.9	8.6	6.9	19.3	6.1	6.0	11.6	16.5	10.0	24.1	12.7
PRMT9	"FLJ46629, PRMT10"	ENSG00000164169	"Protein arginine methyltransferase 9"	Q6P2P2	4	147637785-147684163	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Rod photoreceptor cells: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036844, HPA042537"	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Microtubules	"Nucleoplasm, Cytosol"	"HPA036844: AB_10672341, HPA042537: AB_2678043"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.30e-2)"	3.2	9.9	1.4	2.8	1.8	8.5	4.1	3.1	2.4	2.8	1.8	2.3	1.4	4.6	3.1	2.9	3.3	3.0	2.8	2.0	1.8	4.3	3.4	3.2	3.5	1.4	1.6	11.3	3.3	6.1	3.6	3.0	1.5	3.4	2.6	5.2	2.7	3.3	3.3	2.8	1.8	2.7	1.6	2.8	3.1	7.1	1.7	4.5	5.7	2.5	3.0	2.5	2.3	1.6	2.8	1.8	4.3	3.3	3.3	5.6	3.8	3.1	4.9	4.6	4.8	1.4	3.1	9.8	1.3	2.7	2.3	1.9	5.1	2.6	6.3	3.5	3.0	5.4	3.6	2.3	2.5	8.0	2.8	3.9	2.7	2.8	2.5	3.7	3.9	4.8	5.4	5.5	3.9	1.6	6.8	3.1	2.2	2.7	3.2	4.5	3.7	3.6	3.7	2.2	2.7	4.1	4.9	3.8	2.5	2.8	1.6	1.7	3.3	2.9	2.4	3.3	3.4	6.2	5.3	6.1	3.3	4.8	2.2	6.1	4.2	8.6	4.7	4.7	4.6	7.4	5.7	5.8	3.0	7.2	7.1	6.2	2.8	4.3	3.5	4.4	5.5	2.1	1.4	1.8	3.1	2.4	2.0	1.8	1.4	1.6	1.5	1.6	1.7	1.6	8.7	0.0	5.3	9.8	40.4	0.0	4.2	0.0	26.7	56.5	11.7	21.8	5.9	7.2	0.6	35.0	112.6	14.5	51.6	6.2	5.9	7.0	73.1	9.2	9.5	8.4	17.4	10.3	29.8	6.5	14.8	12.9	11.2	13.0	33.7	15.6	12.8	6.9	17.2	50.5	29.8	7.2	0.0	36.5	0.0	13.4	18.0	63.7	0.0	17.8	10.9	48.1	16.5	20.6	16.3	7.4	6.2	17.0	18.4	4.1	7.4	5.5	1.5	81.1	13.1	6.2	18.5	36.5	19.6	4.3	0.0	15.2	61.2	18.5	6.3	2.0
PROB1	C5orf65	ENSG00000228672	"Proline rich basic protein 1"	E7EW31	5	139390592-139395104	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.3;skeletal muscle: 81.0"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"HDLM-2: 104.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA053354, HPA060103"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA053354: , HPA060103: AB_2684205"	"unprognostic (4.14e-2)"	"prognostic favorable (9.26e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.84e-4)"	"unprognostic (7.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.89e-2)"	"unprognostic (8.24e-2)"	1.4	4.8	4.2	0.9	3.3	0.4	1.5	3.5	2.5	1.4	2.2	1.9	1.2	1.7	0.4	1.0	2.1	0.4	23.3	3.3	4.5	1.7	0.6	0.9	1.0	6.4	7.8	0.6	0.4	2.3	2.9	0.6	4.9	3.3	0.1	0.3	2.4	1.3	81.0	0.7	1.6	0.5	6.1	1.6	1.2	0.8	5.0	0.7	1.0	18.4	0.6	1.6	1.0	2.9	1.5	0.6	0.3	0.3	0.1	0.3	0.5	1.2	0.3	1.3	1.1	4.3	2.6	5.7	1.1	3.9	0.1	0.7	0.5	0.1	0.3	104.7	1.4	1.4	2.7	0.5	3.0	0.0	3.2	0.9	0.7	2.8	0.6	0.7	0.1	3.7	0.5	5.7	4.1	1.2	4.9	2.6	1.4	0.6	2.7	15.4	0.4	12.5	0.2	0.1	1.3	0.7	6.0	4.5	0.2	1.3	2.1	3.0	0.4	0.1	0.4	0.2	0.4	1.0	1.8	9.2	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.2	3.3	3.5	2.5	3.3	4.5	6.4	7.8	4.9	6.1	5.0	2.9	2.4	0.0	0.0	0.0	0.7	0.0	0.3	0.0	1.2	0.0	0.4	0.1	29.7	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.2	2.4	1.5	2.5	0.0	0.4	0.0	0.0	0.3	1.2	1.1	0.9	0.0	0.7	2.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	0.1	1.2	3.0	0.3	0.0	2.4	0.0	0.2	6.6	5.6	2.9	0.4	0.8	0.3	0.0	2.6	0.4	2.4	0.6	0.3
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 49.2;skin 1: 39.8"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 183.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 91.3;RPTEC TERT1: 35.9"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	7.9	0.7	5.8	0.4	6.4	0.0	8.5	3.1	9.0	5.0	34.0	3.1	5.6	1.5	0.1	11.6	5.8	0.1	18.6	6.5	2.8	16.7	15.6	20.6	0.2	7.3	4.7	0.5	1.4	0.0	5.4	0.2	2.5	3.2	0.3	0.6	4.2	0.2	49.2	39.8	32.5	0.0	3.3	0.5	3.5	1.7	7.6	0.3	7.4	6.2	0.8	4.2	8.5	3.4	0.0	0.8	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.0	0.0	2.9	3.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	4.5	91.3	0.0	0.0	0.0	0.4	35.9	0.9	0.1	0.2	0.8	1.4	0.3	5.2	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	6.4	3.1	9.0	6.5	2.8	7.3	4.7	2.5	3.3	7.6	3.4	0.1	16.0	25.6	183.1	0.0	5.1	0.3	13.1	0.0	0.0	0.2	0.1	1.8	0.0	11.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.6	1.2	0.2	0.4	3.5	0.0	0.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	2.0	0.0	1.5	0.1	0.0	0.1	21.4	17.8	0.0	0.6	0.0	14.1	2.1	0.0	2.3	0.0	0.0	0.0	8.0	0.1	21.0	0.1	0.0	1.1	0.6	0.2	0.4	1.0	15.2	0.0	0.3	0.0	1.6	0.2
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"kidney: 140.1;liver: 173.6"	"Group enriched"	"Detected in some"	13	"Hepatocytes: 157.6;Proximal tubular cells: 559.9"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 28.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"Hep G2: 33.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.1	173.6	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.9	1.5	0.0	12.9	0.0	0.0	0.0	0.0	27.4	0.0	2.8	0.3	0.0	0.3	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	157.6	0.1	0.0	0.1	0.0	0.0	4.7	0.0	0.9	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	559.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0
PROM2		ENSG00000155066	"Prominin 2"	Q8N271	2	95274449-95291308	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.1;skin 1: 60.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Club cells: 39.9;Collecting duct cells: 33.1;Squamous epithelial cells: 37.2;Urothelial cells: 37.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 79.5;CAPAN-2: 135.9;HaCaT: 73.2;hTCEpi: 78.4;MCF7: 62.1;RT4: 83.8;SK-BR-3: 117.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB046005, HPA063728"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB046005: AB_2284371, HPA063728: AB_2685104"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.59e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-2)"	0.7	0.3	1.1	1.5	1.3	0.3	10.3	1.0	2.1	16.6	0.2	11.4	10.5	1.9	27.9	88.1	5.5	27.0	1.1	0.9	0.6	32.4	0.8	1.7	0.1	1.4	0.7	1.1	10.2	25.5	1.5	4.5	1.2	24.7	9.8	0.4	35.2	27.7	0.7	60.0	4.8	0.8	0.3	0.6	26.3	0.6	1.4	2.0	11.9	0.2	7.9	25.7	37.9	2.1	79.5	0.1	0.2	0.8	0.3	0.1	38.5	0.1	0.2	0.3	0.4	0.8	135.9	0.0	0.0	0.1	0.1	73.2	0.0	42.4	0.4	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.3	0.0	78.4	0.1	0.4	1.9	0.0	0.1	0.0	0.1	0.0	62.1	0.4	0.5	0.1	3.7	0.5	0.2	0.0	0.1	0.2	83.8	0.6	0.2	0.0	117.7	0.1	0.9	37.2	0.1	0.0	0.2	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	1.0	2.1	0.9	0.6	1.4	0.7	1.2	0.3	1.4	2.1	0.4	3.2	4.2	1.3	0.1	6.6	25.2	27.6	14.2	0.4	29.1	14.9	1.7	37.1	39.9	33.1	4.2	19.0	0.1	8.0	11.7	15.6	0.5	2.7	0.6	0.9	3.6	0.0	0.6	11.0	3.5	0.6	25.5	5.5	0.0	0.7	0.0	0.0	2.4	0.0	1.2	10.4	12.2	0.0	0.8	1.4	0.3	0.2	7.2	0.0	0.6	0.1	0.0	1.5	3.2	17.5	12.4	0.7	0.0	14.1	0.7	0.1	12.3	1.1	0.0	0.4	2.2	0.6	0.1	37.2	12.8	11.2	0.2	0.8	17.4	37.5
PRORP	"KIAA0391, MRPP3"	ENSG00000100890	"Protein only RNase P catalytic subunit"	O15091	14	35121846-35277622	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.8;dendritic cells: 1.1;Hofbauer cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA020459	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	Nucleoplasm	"HPA020459: AB_2670449"	"unprognostic (6.44e-3)"	"unprognostic (8.10e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.67e-5)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.65e-2)"	11.3	17.0	11.0	17.0	12.2	12.2	13.9	12.4	16.1	13.6	16.6	19.9	15.3	8.4	16.7	19.2	11.8	10.4	13.7	11.4	12.1	25.0	24.9	12.5	21.2	13.2	12.5	7.0	10.6	19.3	9.7	11.0	12.8	10.6	20.8	6.2	13.1	9.6	15.1	17.3	14.5	11.9	11.6	13.6	13.6	12.1	13.1	31.1	15.6	17.1	22.5	15.4	11.9	14.4	47.5	34.9	23.6	33.1	25.1	21.0	22.7	31.1	25.3	35.9	26.1	35.8	26.3	53.0	39.0	27.2	9.9	33.9	43.8	47.3	36.5	39.2	12.9	22.6	24.9	77.9	25.2	27.2	23.0	28.3	37.7	33.9	31.6	30.2	50.0	41.3	38.4	13.6	42.5	54.9	46.0	33.3	26.8	30.4	33.4	42.9	40.4	28.1	52.6	44.6	24.0	25.0	40.0	43.3	26.8	29.0	55.4	23.9	44.5	30.7	25.7	22.1	25.8	15.5	40.4	53.9	14.5	32.0	32.5	30.9	10.3	7.2	30.3	9.6	43.9	20.1	47.3	32.8	13.8	14.4	41.6	30.1	14.4	24.7	8.2	20.4	56.1	24.3	11.0	12.2	12.4	16.1	11.4	12.1	13.2	12.5	12.8	11.6	13.1	14.4	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0
PROSER1	"bA50D16.2, C13orf23, FLJ12661"	ENSG00000120685	"Proline and serine rich 1"	Q86XN7	13	39009865-39038089	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034225, HPA055687"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB034225: AB_1564157, HPA055687: AB_2682886"	"unprognostic (6.75e-3)"	"unprognostic (9.56e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.95e-1)"	9.0	7.7	4.7	11.1	5.1	25.5	9.1	7.0	6.2	7.6	4.4	12.8	10.6	9.0	9.0	11.6	7.2	6.0	8.9	4.8	4.3	9.0	9.5	12.2	13.4	6.7	5.2	6.9	15.5	5.7	7.7	21.0	5.9	10.6	13.7	9.9	13.6	6.2	10.1	15.8	12.4	7.8	5.1	12.8	10.9	12.7	5.0	14.0	10.0	7.2	14.6	8.5	9.4	6.9	16.0	12.2	37.3	25.9	12.5	10.0	59.1	14.8	13.0	14.6	15.5	39.0	24.3	37.1	11.7	14.5	19.7	26.9	40.5	26.6	23.8	56.6	33.1	54.7	13.4	27.1	28.5	57.7	32.4	13.3	31.4	23.2	52.3	9.0	24.2	41.9	27.6	21.8	15.7	27.8	35.2	30.6	55.8	31.4	13.0	36.6	39.6	23.3	14.6	24.6	21.0	24.2	10.4	26.8	21.7	28.9	28.8	32.9	22.2	8.4	13.5	16.7	18.9	20.2	22.6	39.7	13.6	31.5	16.8	4.6	1.9	0.4	2.8	1.6	3.1	2.0	2.8	3.0	2.2	1.4	2.4	2.6	0.5	4.2	2.5	2.5	1.7	2.7	4.7	5.1	7.0	6.2	4.8	4.3	6.7	5.2	5.9	5.1	5.0	6.9	9.5	3.2	15.3	13.7	11.7	7.0	5.2	4.6	8.0	11.7	8.4	7.6	6.2	5.7	5.6	0.0	8.4	19.3	19.4	12.7	1.9	7.3	16.8	9.0	9.4	10.0	11.4	6.3	16.8	13.5	18.5	6.4	11.2	12.1	12.0	12.5	8.6	6.0	10.4	16.8	12.7	16.3	0.0	16.3	8.0	5.6	6.5	9.9	5.4	12.2	9.9	4.5	13.4	14.1	27.3	15.0	19.2	4.9	16.9	11.2	6.5	3.6	6.0	9.5	0.0	7.8	7.2	14.0	11.6	10.5	7.2	26.8	11.5	5.2	14.8	8.1
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;liver: 86.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 196.4;Hepatocytes: 285.9;Horizontal cells: 523.3;Paneth cells: 130.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 31.4;RH-30: 15.9;SH-SY5Y: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	1.6	10.0	11.0	1.4	21.4	0.0	1.8	24.6	18.2	1.0	0.0	2.6	2.1	1.1	1.2	0.6	2.2	1.9	15.7	23.1	12.4	4.7	86.8	1.2	2.8	18.7	17.3	7.4	15.5	0.1	4.0	0.4	13.9	0.5	2.7	21.2	0.3	0.4	3.6	0.7	2.6	0.8	10.6	7.1	2.1	5.4	30.0	0.2	7.6	2.1	0.7	1.0	0.7	38.2	0.0	0.0	0.6	0.0	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.3	0.2	2.3	0.0	0.1	0.0	1.0	0.6	0.0	31.4	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.1	3.5	2.3	5.7	0.0	0.4	0.0	0.4	0.0	1.7	2.0	1.3	0.0	15.9	2.5	0.2	0.5	2.3	77.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.2	0.7	0.2	0.9	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.4	24.6	18.2	23.1	12.4	18.7	17.3	13.9	10.6	30.0	38.2	14.3	0.0	2.3	1.3	1.9	5.9	1.1	0.3	5.7	196.4	4.8	4.7	105.9	102.9	1.3	9.2	2.1	0.0	0.1	3.2	15.6	34.7	52.7	0.1	1.0	36.5	66.9	5.3	2.9	2.7	0.1	8.7	8.6	0.3	0.0	9.3	11.0	285.9	0.9	523.3	66.8	16.5	12.2	4.4	6.6	10.4	1.2	2.2	10.6	8.4	0.0	36.0	0.0	27.2	114.0	3.4	130.6	1.2	0.1	3.9	3.3	0.4	0.9	11.7	0.0	113.6	3.7	2.9	0.4	0.4	4.5	0.0	1.9	29.6	10.5	0.9
PRPF3	"hPrp3, Prp3, RP18, SNRNP90"	ENSG00000117360	"Pre-mRNA processing factor 3"	O43395	1	150321479-150353233	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027226, HPA067116"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA027226: AB_1855770, HPA067116: AB_2685783"	"unprognostic (2.75e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (7.89e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.78e-3)"	26.0	24.7	18.1	22.3	20.2	44.8	27.0	23.2	23.1	27.5	22.8	25.2	16.9	25.0	26.7	22.2	25.7	13.8	19.5	17.8	21.4	29.0	30.4	24.3	28.6	19.7	18.9	34.1	23.8	17.6	27.0	20.9	19.3	27.5	19.6	43.5	21.7	19.5	22.2	23.8	24.6	18.7	17.3	33.8	19.1	20.1	19.7	30.9	32.0	14.9	28.5	24.3	24.3	21.6	44.8	47.5	47.1	30.3	31.0	33.5	63.8	45.6	31.9	69.1	47.5	36.6	40.8	58.7	29.7	37.6	64.4	51.5	86.1	32.2	61.7	29.7	38.3	50.7	72.1	35.2	30.7	62.5	31.6	24.6	43.7	59.0	50.5	32.9	42.7	39.0	61.3	34.8	50.0	66.5	52.3	55.0	67.6	114.3	41.9	75.1	38.5	38.8	28.5	26.7	40.3	35.7	37.9	44.2	34.9	63.3	52.9	150.5	34.3	43.2	33.3	36.7	75.8	33.1	62.8	64.7	28.8	56.2	45.9	9.3	9.0	13.3	14.9	11.8	14.6	13.0	10.8	9.8	9.5	10.0	11.0	11.4	5.3	11.5	21.8	7.6	9.1	8.3	18.1	20.2	23.2	23.1	17.8	21.4	19.7	18.9	19.3	17.3	19.7	21.6	26.1	35.3	23.4	31.6	26.1	11.7	13.1	13.0	10.8	30.4	10.8	10.8	13.2	11.5	19.7	11.0	18.8	16.1	22.9	15.8	13.7	15.6	11.5	13.2	20.0	22.5	2.4	19.0	19.5	11.9	16.0	16.3	17.9	17.8	22.8	25.5	14.6	11.0	12.1	32.0	17.5	17.5	4.1	8.6	11.8	5.3	20.2	14.5	10.6	15.0	14.2	27.8	17.5	18.1	28.4	13.4	9.5	18.4	12.4	12.6	12.6	5.0	20.6	42.6	13.1	19.1	21.2	44.3	23.5	11.6	10.1	20.0	24.0	11.3	11.6	10.0
PRPF31	"hPrp31, NY-BR-99, PRP31, RP11, SNRNP61"	ENSG00000105618	"Pre-mRNA processing factor 31"	Q8WWY3	19	54115410-54131719	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041939, HPA061873"	Supported		Supported	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA041939: AB_10793938, HPA061873: AB_2684630"	"unprognostic (1.32e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (9.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.04e-2)"	35.1	36.0	26.1	24.3	27.5	33.2	35.1	26.6	31.3	39.6	26.9	42.3	23.1	39.7	12.5	37.8	35.3	18.9	38.8	26.7	26.1	34.2	44.5	29.7	33.2	27.0	26.3	39.0	29.3	28.6	33.7	23.1	26.7	37.6	13.9	8.1	33.9	23.6	48.2	40.2	34.6	19.0	25.5	39.7	35.7	33.0	27.2	26.3	36.5	23.7	23.4	38.3	35.6	28.5	83.7	169.4	55.0	89.8	34.6	33.0	59.4	68.3	53.1	74.6	72.5	82.4	63.8	89.1	54.2	49.9	36.0	49.8	64.6	78.6	46.4	82.4	298.4	66.6	108.3	97.0	51.7	120.9	59.7	54.2	36.0	62.3	43.1	39.4	79.4	74.4	96.8	46.2	49.9	82.8	103.3	64.1	53.4	78.5	187.1	89.2	71.7	81.5	51.8	120.8	61.6	72.8	88.0	83.2	44.7	24.5	52.3	62.5	81.2	100.4	84.7	43.6	109.0	58.6	97.7	98.5	75.7	81.9	71.0	25.0	44.3	30.1	47.9	53.1	51.8	43.5	47.2	51.4	52.9	44.5	39.7	40.5	9.1	54.4	48.6	45.6	61.0	51.1	26.1	27.5	26.6	31.3	26.7	26.1	27.0	26.3	26.7	25.5	27.2	28.5	38.7	35.3	26.7	17.0	35.0	42.7	38.9	96.1	46.7	31.4	31.3	37.6	35.9	32.9	54.2	25.8	14.6	95.0	40.2	29.3	60.7	74.6	5.9	34.9	34.9	47.3	34.8	32.4	13.4	62.9	90.8	42.0	33.6	31.0	31.7	53.5	27.8	27.3	66.4	30.3	12.4	38.9	57.0	22.2	43.2	7.4	38.2	33.7	40.9	9.4	61.2	51.1	48.4	13.6	14.9	63.2	30.1	48.9	34.0	37.6	46.9	62.0	43.6	32.2	39.5	36.1	53.4	125.2	77.9	33.9	42.1	76.2	41.5	54.3	46.3	32.8
PRPF38A	"FLJ14936, Prp38"	ENSG00000134748	"Pre-mRNA processing factor 38A"	Q8NAV1	1	52404602-52420836	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053099, HPA058407"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA053099: AB_2682044, HPA058407: AB_2683709"	"unprognostic (1.29e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.83e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.82e-1)"	9.0	8.1	11.8	10.7	12.2	19.3	13.3	16.2	14.2	12.1	10.5	11.2	8.4	14.1	9.8	9.5	11.4	7.1	7.4	11.3	12.3	10.4	7.9	9.7	15.7	12.2	12.5	17.3	7.9	8.9	9.6	9.9	12.1	10.1	12.1	17.6	8.4	9.0	6.7	11.4	10.7	9.0	11.6	11.2	8.2	8.9	11.8	21.1	12.2	8.1	15.0	8.7	10.3	13.5	17.6	8.5	29.8	14.3	11.5	11.3	17.6	11.8	8.0	19.1	18.3	15.5	8.5	36.2	12.0	8.1	14.8	12.8	42.6	12.8	24.7	19.8	32.4	48.7	31.1	16.3	14.2	54.8	17.2	8.7	11.2	20.9	20.0	14.5	16.3	25.9	45.4	9.2	11.5	9.9	42.5	32.8	36.6	18.6	19.7	41.3	44.8	30.3	16.9	10.4	19.7	24.0	23.8	19.3	23.8	20.0	13.6	43.8	12.9	10.8	16.2	16.3	23.5	17.4	26.6	35.7	15.9	47.0	14.0	12.3	6.2	8.9	7.4	7.1	10.2	7.2	8.3	9.1	7.9	6.5	11.3	8.8	4.8	11.1	7.5	4.3	8.9	5.7	11.8	12.2	16.2	14.2	11.3	12.3	12.2	12.5	12.1	11.6	11.8	13.5	37.5	41.7	32.1	8.5	49.1	53.0	92.7	48.8	33.6	35.9	34.4	32.1	29.9	22.8	41.1	16.5	93.8	60.5	52.6	69.9	35.2	36.9	84.6	36.8	34.3	47.6	35.8	44.6	6.7	29.4	77.9	33.8	20.4	31.6	60.1	43.1	34.6	19.3	40.0	25.2	7.2	42.7	32.6	35.8	40.0	18.6	25.7	34.4	30.2	1.9	40.4	49.4	70.0	7.1	7.4	27.0	49.1	33.4	47.3	47.0	61.2	34.9	28.3	47.8	52.6	53.8	33.2	109.8	55.1	38.1	56.0	103.4	57.6	44.7	62.2	67.9
PRPF39	"FLJ11128, FLJ20666"	ENSG00000185246	"Pre-mRNA processing factor 39"	Q86UA1	14	45084107-45116282	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001176, HPA078403"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA001176: AB_2171026, HPA078403: "	"unprognostic (1.79e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.84e-5)"	"unprognostic (9.51e-3)"	"prognostic unfavorable (6.51e-4)"	"prognostic favorable (8.48e-4)"	"unprognostic (4.34e-3)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (2.99e-4)"	4.8	4.0	1.4	0.7	1.6	2.7	4.8	1.3	2.0	5.5	0.2	5.1	1.5	5.2	1.7	3.9	6.3	1.3	3.7	1.1	1.0	5.6	3.4	3.2	1.5	1.3	0.7	5.5	4.4	1.7	4.1	1.7	1.5	3.5	1.0	2.0	4.4	1.5	7.6	4.8	4.3	1.5	0.2	3.8	5.1	3.0	1.0	1.8	3.6	1.7	1.2	5.3	4.3	2.2	7.8	8.5	7.0	3.4	2.7	2.4	7.0	6.2	3.4	4.9	4.3	5.1	5.2	4.9	6.2	4.5	3.6	5.1	9.0	4.1	7.3	8.9	6.2	6.8	11.5	4.8	3.2	6.5	1.9	1.5	2.5	2.7	3.2	2.6	3.5	6.2	9.8	5.2	5.4	7.0	7.2	3.1	6.5	5.2	8.9	9.5	6.0	6.3	2.8	10.4	6.8	1.8	2.9	3.9	4.9	3.5	3.7	5.2	7.8	4.3	4.0	3.1	8.3	5.1	12.9	11.2	1.8	6.6	2.4	5.2	2.7	4.7	4.5	4.9	6.4	5.6	4.0	4.7	4.9	5.0	5.2	6.1	2.1	4.3	5.2	2.0	5.4	3.2	1.4	1.6	1.3	2.0	1.1	1.0	1.3	0.7	1.5	0.2	1.0	2.2	14.3	25.6	22.5	21.2	18.2	27.3	15.6	6.5	18.8	19.5	10.6	7.4	14.9	7.2	13.5	7.3	14.6	12.1	21.5	7.0	9.8	8.5	1.3	9.2	19.5	12.8	9.6	15.8	36.6	9.3	10.6	15.5	12.2	11.2	16.4	16.7	10.8	7.5	7.5	16.8	37.1	9.1	6.1	5.1	14.6	4.9	14.9	9.5	14.2	25.3	8.4	10.8	5.2	31.2	55.5	8.0	6.6	14.7	19.1	14.2	14.2	5.4	6.1	24.2	6.6	13.5	16.7	11.6	11.8	18.3	25.3	12.0	19.7	13.4	9.2	10.0
PRPF40B	HYPC	ENSG00000110844	"Pre-mRNA processing factor 40 homolog B"	Q6NWY9	12	49568218-49644666	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 61.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038426, HPA038599"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Aggresome,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Aggresome, Cytosol"	"HPA038426: AB_10674684, HPA038599: AB_10674689"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.50e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.80e-2)"	8.3	16.3	16.3	3.2	15.6	0.7	11.5	13.3	18.8	23.9	13.7	15.6	4.0	17.9	10.4	10.4	19.1	6.4	15.6	16.6	16.5	23.9	9.2	7.4	3.1	16.4	14.5	25.4	16.0	20.3	26.2	6.5	15.9	17.5	3.4	12.3	13.3	11.7	25.2	11.4	7.6	7.8	13.3	9.5	14.5	33.7	14.7	3.5	29.2	13.5	3.4	14.6	14.6	15.3	7.2	10.5	10.3	10.0	8.4	5.4	9.5	5.8	8.1	6.1	3.0	12.2	15.8	5.8	12.0	7.7	8.6	4.2	6.3	20.1	3.1	4.4	2.5	6.1	4.2	4.4	10.6	2.0	7.8	7.7	16.8	6.1	22.0	13.2	4.9	11.7	3.0	3.0	7.3	6.7	1.4	4.2	4.4	8.2	3.9	5.1	1.6	4.8	13.0	6.6	10.9	13.1	4.7	12.8	7.2	9.4	24.5	5.7	2.0	3.7	14.9	4.9	2.5	7.1	4.3	2.4	11.2	1.5	3.5	0.0	0.1	0.0	0.8	0.1	1.1	0.3	0.8	0.3	0.2	0.6	0.8	0.9	0.0	1.3	0.0	0.5	0.3	0.3	16.3	15.6	13.3	18.8	16.6	16.5	16.4	14.5	15.9	13.3	14.7	15.3	5.3	12.8	20.3	15.7	4.1	3.6	8.7	10.2	11.4	19.1	6.6	9.7	1.2	5.7	17.5	18.4	10.4	21.9	1.2	1.5	7.9	13.8	28.9	8.6	7.5	5.2	7.7	3.0	19.3	11.1	7.4	7.2	4.1	5.6	2.5	15.6	8.2	3.1	5.4	11.8	22.9	3.2	12.2	1.6	2.1	23.1	11.8	1.5	3.6	6.5	4.9	8.3	2.1	20.6	17.2	6.8	1.1	12.0	1.1	6.7	1.4	5.6	24.5	19.8	13.1	9.8	9.7	61.3	26.6	8.0	6.0	26.4	3.1	9.2	5.2	5.0
PRPF8	"hPrp8, Prp8, PRPC8, RP13, SNRNP220"	ENSG00000174231	"Pre-mRNA processing factor 8"	Q6P2Q9	17	1650629-1684867	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 252.3;Rod photoreceptor cells: 293.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009941, CAB015457"	Supported		Enhanced	Nucleoplasm		NA	NA		120000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009941: AB_2171185, CAB015457: AB_831685"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	78.5	128.7	82.6	45.7	85.0	70.5	78.6	93.2	121.3	98.5	98.7	93.5	33.0	94.5	44.1	85.3	94.2	30.8	100.9	84.4	84.0	78.2	91.2	84.2	52.8	83.6	82.1	131.6	78.3	82.7	130.4	44.7	86.2	89.7	44.5	115.6	78.1	49.1	146.7	92.6	84.2	51.7	80.9	98.2	80.5	100.1	81.5	83.9	89.0	80.1	61.6	96.9	84.3	88.0	104.0	240.7	149.0	116.1	120.8	90.4	107.9	78.2	109.5	160.3	122.4	208.2	50.0	150.0	73.2	150.5	113.4	152.9	356.3	139.5	181.6	99.4	170.0	124.3	187.1	161.0	73.5	145.4	138.9	86.0	91.2	194.8	146.7	84.5	146.1	106.2	121.1	126.6	117.9	112.7	114.4	117.4	97.0	97.7	74.4	218.4	82.3	80.7	63.1	121.1	71.0	103.8	145.0	61.5	69.3	121.6	87.4	91.3	122.1	91.7	78.3	130.2	176.1	46.6	46.7	101.9	81.6	108.1	121.6	23.1	8.9	10.1	19.1	14.4	23.6	17.5	17.7	20.9	15.7	18.3	16.7	20.0	9.0	14.2	21.7	25.2	23.2	11.2	82.6	85.0	93.2	121.3	84.4	84.0	83.6	82.1	86.2	80.9	81.5	88.0	45.7	60.9	84.3	24.5	72.8	30.1	30.0	42.5	56.9	128.0	31.8	34.4	39.4	42.9	53.9	47.8	252.3	43.3	66.6	42.9	7.9	35.5	11.8	45.4	38.8	46.3	36.5	73.0	23.6	40.9	26.7	48.3	56.1	40.3	52.6	55.9	37.9	38.7	39.8	72.3	29.3	40.2	32.6	40.1	26.5	11.2	73.3	42.6	19.6	19.7	48.3	55.9	46.4	21.6	19.0	42.7	36.5	52.3	70.0	31.4	48.7	18.3	51.3	293.2	72.3	65.4	44.8	100.4	99.1	57.3	27.8	39.5	62.8	50.2	50.3	31.5
PRPSAP2	PAP41	ENSG00000141127	"Phosphoribosyl pyrophosphate synthetase associated protein 2"	O60256	17	18840085-18931287	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 274.7"	"Low region specificity"	"Detected in all"							HPA021881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		84000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021881: AB_1855782"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (4.57e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.08e-2)"	10.4	17.8	21.5	21.4	25.7	23.6	16.1	39.6	25.3	16.0	18.9	20.6	26.3	21.2	17.8	16.7	21.0	21.4	19.0	25.3	25.2	29.9	21.5	18.4	51.3	27.3	23.5	25.8	16.0	21.0	22.0	13.9	27.7	16.5	24.5	46.3	14.5	14.5	10.3	20.7	20.7	17.4	26.5	19.5	23.1	31.7	25.2	30.5	26.6	10.8	57.3	14.8	14.4	38.7	40.6	44.2	63.1	46.1	26.8	16.2	64.4	30.4	23.7	38.8	35.7	56.2	19.3	104.3	30.7	26.4	38.4	49.2	75.0	38.4	42.2	47.4	60.1	32.8	37.0	46.8	37.5	21.0	29.1	19.5	24.7	49.2	36.6	39.2	36.5	57.0	49.4	17.0	34.5	45.5	45.4	23.9	45.8	80.3	29.0	63.0	103.4	46.4	24.4	25.7	37.7	47.7	45.4	18.5	48.5	274.7	49.7	31.0	24.8	15.8	31.5	53.8	38.7	26.9	34.8	43.5	33.3	30.0	33.1	23.2	23.2	28.5	25.9	23.5	29.4	43.7	32.9	27.2	31.9	40.4	46.0	34.5	9.5	36.9	26.1	21.4	36.3	30.0	21.5	25.7	39.6	25.3	25.3	25.2	27.3	23.5	27.7	26.5	25.2	38.7	16.6	16.0	31.7	21.5	31.7	15.8	19.7	26.9	16.5	38.5	14.2	18.2	10.2	25.8	18.6	11.0	29.2	12.4	22.6	12.3	27.4	23.4	54.3	14.6	13.0	18.3	26.5	23.5	17.6	22.1	37.9	14.8	16.3	13.1	46.3	18.4	18.9	17.6	24.5	16.8	21.5	17.6	16.2	14.0	11.0	67.9	14.0	19.5	12.4	14.0	24.6	26.3	19.6	27.2	37.8	21.1	14.8	13.5	48.0	20.3	21.5	32.2	25.3	34.4	19.7	13.7	14.3	69.8	54.0	19.5	20.9	14.0	23.8	24.7	21.3	15.6
PRR13	"DKFZP564J157, FLJ23818"	ENSG00000205352	"Proline rich 13"	Q9NZ81	12	53441678-53446645	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 884.9;Distal tubular cells: 1365.6;Paneth cells: 858.1;Proximal enterocytes: 1642.7;Proximal tubular cells: 1097.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039396, HPA046219"	Uncertain		Supported	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA039396: AB_2676484, HPA046219: AB_10963936"	"unprognostic (1.09e-1)"	"prognostic favorable (9.08e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.55e-4)"	143.8	207.8	110.8	159.2	110.1	279.1	139.2	112.6	147.7	118.9	109.7	316.1	451.6	104.6	110.8	143.4	139.2	147.1	110.6	105.8	147.8	457.9	192.8	164.3	185.3	126.6	132.1	118.8	133.3	76.0	114.6	95.2	126.3	139.6	265.7	44.0	115.5	86.6	131.6	108.7	432.6	91.4	114.3	230.2	247.8	46.4	118.4	139.0	131.8	59.6	190.4	143.7	111.7	117.1	171.7	339.6	82.6	89.4	135.3	185.3	178.4	142.5	213.0	185.6	179.4	623.1	373.6	265.1	453.5	206.8	225.4	146.6	167.8	225.0	217.9	263.1	124.6	382.4	166.4	294.6	340.7	573.2	489.5	232.6	221.2	326.5	223.6	192.6	195.3	166.1	340.1	254.6	285.1	472.5	325.8	563.8	127.5	229.2	230.7	287.6	67.8	273.9	406.2	283.8	72.3	56.5	202.5	276.7	237.2	169.5	394.0	436.2	196.3	117.2	114.0	201.3	138.0	190.7	241.6	386.4	153.3	345.1	220.2	851.3	824.0	1620.1	511.1	941.9	503.0	888.2	563.7	545.8	649.3	855.6	520.6	557.7	2095.7	584.5	1014.6	539.0	824.8	1573.1	110.8	110.1	112.6	147.7	105.8	147.8	126.6	132.1	126.3	114.3	118.4	117.1	66.8	83.3	110.4	6.8	219.1	47.5	147.8	204.8	82.6	11.1	114.3	95.2	26.4	198.8	145.1	187.6	29.2	225.3	159.1	884.9	1365.6	228.0	12.6	182.7	67.1	80.3	169.8	99.2	6.3	253.9	337.7	76.6	263.0	127.4	186.7	53.4	78.1	152.8	355.2	18.5	7.1	346.9	193.3	345.0	174.4	8.7	58.1	266.8	108.5	9.4	384.7	85.3	297.6	4.5	12.9	332.3	858.1	45.9	120.9	174.7	1642.7	1097.6	215.9	20.9	78.9	33.6	67.1	29.7	22.8	107.1	56.0	291.0	212.7	88.4	340.0	193.1
PRR14	MGC3121	ENSG00000156858	"Proline rich 14"	Q9BWN1	16	30650717-30656413	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052022, HPA060265, HPA075914"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: "	"unprognostic (1.57e-1)"	"prognostic favorable (8.19e-5)"	"unprognostic (3.74e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.54e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.31e-3)"	20.5	20.2	17.1	13.9	16.8	23.6	20.3	19.0	21.7	26.6	12.8	30.8	13.8	29.8	7.1	22.4	26.1	6.6	16.4	16.0	15.3	22.1	21.3	24.1	14.1	18.5	16.6	25.1	24.9	13.0	21.2	8.3	16.1	26.2	7.8	9.4	19.1	13.7	15.1	26.2	25.6	10.9	15.0	32.5	26.0	12.6	18.3	18.7	23.4	9.6	10.6	24.5	22.7	17.9	18.2	20.3	17.1	18.2	15.2	11.7	11.9	17.6	11.8	18.1	17.2	9.3	17.3	30.5	15.3	12.9	8.4	17.7	14.4	20.4	9.8	41.5	36.0	17.9	19.6	21.4	23.6	16.1	43.3	9.8	23.1	13.0	13.7	18.9	23.1	8.2	22.8	24.3	10.0	42.2	36.7	28.4	6.2	12.4	10.3	29.4	8.4	44.2	13.7	7.3	14.5	32.4	7.1	26.8	18.2	5.3	29.9	13.1	18.1	16.3	17.7	17.0	18.4	44.1	29.4	21.3	11.0	33.0	14.7	11.4	6.0	23.7	9.6	6.5	7.4	7.0	8.0	9.7	5.7	10.5	7.3	7.2	22.5	8.6	10.9	7.6	10.3	5.5	17.1	16.8	19.0	21.7	16.0	15.3	18.5	16.6	16.1	15.0	18.3	17.9	18.1	9.6	10.4	13.7	23.2	22.8	26.1	28.8	33.6	13.9	19.1	18.7	6.6	25.8	13.2	12.9	14.6	15.8	31.9	24.1	15.6	22.3	6.7	8.8	13.0	20.9	12.6	15.4	7.5	22.2	15.3	15.3	27.5	15.1	12.0	15.4	18.9	10.1	18.2	1.7	7.7	18.3	20.3	16.0	34.1	2.5	19.3	20.2	8.8	8.4	30.2	13.1	33.0	5.5	8.7	20.4	14.6	21.1	17.3	23.6	23.6	15.1	10.0	14.2	19.7	12.8	19.9	17.2	27.2	28.5	23.0	14.1	26.5	11.7	19.8	17.3
PRR14L	"C22orf30, MGC50372"	ENSG00000183530	"Proline rich 14 like"	Q5THK1	22	31676256-31750140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062645	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA062645: AB_2684817"	"unprognostic (2.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.14e-3)"	3.8	3.6	3.1	5.4	4.1	8.6	5.6	5.8	3.8	4.5	8.5	6.3	4.3	4.3	4.2	5.7	5.1	3.3	3.2	3.5	2.4	4.3	4.2	4.5	6.9	2.0	2.1	6.9	4.1	6.6	4.7	5.3	1.9	4.0	7.0	4.9	4.2	3.7	2.8	6.9	4.7	5.0	0.6	5.6	5.9	5.5	3.7	7.6	5.3	4.6	7.2	4.8	4.0	6.5	11.4	10.8	11.6	11.5	10.4	9.7	12.0	6.1	7.2	9.4	8.7	9.9	4.1	12.9	5.8	12.0	7.0	11.0	22.9	9.1	9.7	17.3	9.7	7.8	9.7	8.0	8.8	24.3	16.2	8.7	9.0	13.0	11.2	8.1	13.3	10.1	12.0	8.3	9.9	10.8	8.6	7.7	13.4	16.3	4.1	12.8	18.5	7.4	7.8	12.8	16.0	9.4	14.2	8.5	7.8	13.6	7.5	9.6	12.7	5.7	11.4	7.7	8.4	12.8	16.4	9.5	8.9	11.7	8.9	9.1	4.3	5.4	2.9	5.1	2.6	3.5	1.8	2.4	3.3	3.1	2.6	2.8	8.1	2.9	11.8	3.7	2.7	1.8	3.1	4.1	5.8	3.8	3.5	2.4	2.0	2.1	1.9	0.6	3.7	6.5	18.1	22.4	20.3	31.0	18.1	7.5	13.4	18.5	16.5	11.9	16.0	12.3	22.2	10.0	28.7	11.0	20.9	19.0	21.1	29.5	9.8	19.3	7.4	25.9	27.3	16.2	10.2	14.3	48.0	17.1	14.2	15.6	25.0	24.4	26.6	56.6	11.7	18.4	14.6	15.2	38.8	19.4	10.2	21.3	9.2	5.9	14.9	21.2	1.8	35.6	24.7	12.1	20.6	21.6	46.7	24.6	13.9	8.2	12.4	19.3	20.3	11.9	23.2	11.7	13.1	21.9	15.6	14.0	18.4	19.9	9.7	22.2	14.4	27.9	18.5	20.3
PRR16	DSC54	ENSG00000184838	"Proline rich 16"	Q569H4	5	120464300-120687332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 30.4"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 171.6;Inhibitory neurons: 188.9"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.3;BJ hTERT+: 83.9;fHDF/TERT166: 102.1;HSkMC: 62.5;hTERT-RPE1: 103.0;LHCN-M2: 97.9;U-138 MG: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049254	Approved		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Midbody, Cytosol"	"HPA049254: AB_2680693"	"unprognostic (1.71e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.61e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-8)"	"unprognostic (3.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.38e-3)"	11.0	2.8	2.0	5.2	2.1	0.2	7.9	6.1	3.5	14.9	0.0	5.1	1.7	11.8	1.5	1.8	7.0	5.7	12.7	2.2	5.1	3.0	0.9	9.8	1.1	3.4	1.8	5.6	2.0	1.1	1.7	9.7	3.2	9.3	4.5	7.0	2.6	2.4	26.4	4.0	5.0	8.2	0.7	2.5	4.0	2.4	2.3	0.7	4.4	30.4	0.9	9.5	10.0	1.4	3.7	0.0	8.0	0.0	22.2	77.3	0.0	37.0	83.9	51.5	39.1	0.0	0.2	0.0	0.0	102.1	9.3	0.0	8.1	0.9	53.8	0.0	1.9	0.0	1.2	0.0	21.5	0.2	0.1	62.5	8.9	15.4	48.0	103.0	1.7	0.0	0.1	0.1	97.9	0.0	0.0	0.0	0.9	0.0	1.4	0.0	6.2	0.0	4.3	0.0	0.3	16.1	0.1	0.0	1.1	6.1	0.1	0.1	0.5	117.9	13.3	3.8	19.4	0.3	0.0	0.0	6.7	0.2	4.1	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.3	2.0	2.1	6.1	3.5	2.2	5.1	3.4	1.8	3.2	0.7	2.3	1.4	1.4	0.0	0.0	14.0	0.4	1.3	6.2	0.0	0.0	7.5	1.5	1.9	3.2	0.0	0.0	0.0	14.6	0.1	0.1	0.0	0.0	0.1	16.8	0.9	18.9	0.8	0.0	0.0	171.6	0.0	0.0	13.5	0.0	0.8	0.0	0.2	0.4	0.0	0.5	15.2	188.9	0.0	0.0	1.8	2.7	11.6	2.8	1.0	1.8	9.4	0.1	2.6	0.0	7.5	3.9	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.7	0.0	1.4	9.6	0.9	1.4	0.5	0.6	0.5	0.4	3.1	0.0	0.7
PRR19	MGC70924	ENSG00000188368	"Proline rich 19"	A6NJB7	19	42302098-42310814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 21.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 26.7;Late spermatids: 60.1;Spermatocytes: 37.9;Spermatogonia: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA070350			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"HPA070350: AB_2686259"	"unprognostic (2.05e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.02e-2)"	"unprognostic (7.55e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.44e-5)"	"unprognostic (3.57e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-2)"	0.4	1.1	1.9	0.7	2.5	2.3	0.5	2.1	2.4	0.7	1.3	0.4	0.4	0.6	0.4	1.1	0.5	0.5	0.2	1.9	1.7	0.7	0.6	0.3	0.5	1.8	1.5	0.5	0.4	0.4	0.9	0.4	1.9	0.7	0.2	0.5	0.7	0.4	0.3	0.7	0.5	0.3	1.4	0.5	0.4	21.6	2.0	0.6	0.4	0.1	0.5	0.4	0.7	2.0	2.7	3.9	2.2	2.9	0.1	0.2	2.2	1.2	1.2	3.5	3.5	1.6	2.5	0.5	4.5	1.3	2.6	0.8	1.0	1.0	0.7	1.8	1.0	2.8	2.0	1.0	0.8	0.7	1.6	1.1	1.6	2.3	0.4	0.7	0.6	2.9	1.5	1.3	1.6	6.2	2.7	1.3	2.3	2.5	0.0	1.0	0.4	0.2	1.1	2.1	4.9	1.9	2.1	1.5	0.6	0.6	2.0	1.0	0.8	2.3	3.4	0.5	2.1	0.2	1.0	0.8	2.4	2.0	2.4	0.4	0.4	0.1	0.4	0.4	0.1	0.6	0.3	0.5	0.5	0.4	0.4	0.2	0.4	0.5	0.1	0.3	0.5	0.2	1.9	2.5	2.1	2.4	1.9	1.7	1.8	1.5	1.9	1.4	2.0	2.0	1.2	0.0	0.5	0.0	0.7	0.6	0.9	1.9	4.0	0.4	2.7	2.8	0.5	0.0	0.6	0.0	0.0	0.9	0.3	0.8	1.9	0.9	26.7	1.0	0.7	1.2	0.0	0.0	0.4	1.2	0.6	0.6	1.1	1.5	0.0	0.3	0.0	0.4	0.8	1.7	0.4	0.1	0.0	0.0	0.3	60.1	1.2	0.4	0.0	1.0	0.1	0.0	1.0	1.0	0.3	0.4	1.2	1.2	0.6	0.4	0.6	0.6	2.3	0.2	0.0	0.8	0.7	37.9	22.5	2.1	0.9	0.5	0.4	0.6	0.4	0.7
PRR22	MGC24975	ENSG00000212123	"Proline rich 22"	Q8IZ63	19	5782960-5784746	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 50.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 194.8;Late spermatids: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 17.3"	"Not detected"	"Not detected"							HPA044157	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA044157: AB_10960694"	"unprognostic (8.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.19e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.42e-3)"	"unprognostic (9.37e-3)"	"unprognostic (4.18e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-3)"	1.9	2.7	1.6	1.5	1.9	1.9	3.0	1.6	2.8	3.4	0.9	3.9	2.5	2.2	0.6	4.9	5.5	0.6	2.5	1.6	1.4	7.1	11.8	2.3	1.4	2.0	1.5	3.3	6.3	0.5	3.8	0.9	1.6	7.1	0.3	0.8	5.0	0.4	1.4	5.9	5.9	0.3	1.3	6.4	4.0	50.1	2.0	0.9	6.1	0.1	0.5	2.4	3.0	2.2	2.1	3.5	1.5	7.3	0.0	0.2	7.2	1.5	0.6	1.1	1.7	3.6	2.0	3.3	4.0	0.3	0.8	2.6	1.1	1.5	0.2	5.1	11.3	1.5	1.8	1.3	0.6	3.4	17.3	0.8	1.2	1.6	0.5	0.1	0.3	3.9	8.4	0.0	0.9	7.9	4.1	4.3	8.9	0.3	3.6	4.0	1.4	5.2	0.3	2.4	1.9	3.6	0.3	2.6	4.4	0.3	3.0	2.8	1.1	2.6	7.2	9.5	1.8	10.0	8.6	6.4	0.2	7.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.6	2.8	1.6	1.4	2.0	1.5	1.6	1.3	2.0	2.2	0.7	3.2	0.5	1.6	0.8	0.3	0.5	1.3	0.0	5.9	1.8	2.2	0.3	1.5	2.5	3.7	0.0	2.2	1.8	2.3	0.0	1.0	194.8	1.5	1.1	0.9	2.4	0.0	1.6	0.7	1.0	0.9	1.5	2.0	0.0	2.9	1.1	2.6	1.1	5.0	2.1	2.5	0.0	1.3	0.2	87.6	2.1	0.6	0.0	2.8	0.0	2.4	1.0	1.5	2.0	0.8	1.8	0.4	0.1	1.2	4.3	1.5	1.2	6.3	6.6	0.8	0.5	20.4	7.4	1.2	1.1	1.8	0.5	1.6	3.3	0.5
PRR23A		ENSG00000206260	"Proline rich 23A"	A6NEV1	3	139003962-139006268	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.48e-1)"			0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR23B	FLJ46116	ENSG00000184814	"Proline rich 23B"	Q6ZRT6	3	139019031-139020926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 1.3"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 6.4;Spermatogonia: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (7.57e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4
PRR23C	FLJ46210	ENSG00000233701	"Proline rich 23C"	Q6ZRP0	3	139042102-139044892	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.5;Late spermatids: 2.0;Spermatocytes: 1.6;Spermatogonia: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"			"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.00e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PRR3	"CAT56, Em:AB014077.1, Em:AB023052.2"	ENSG00000204576	"Proline rich 3"	P79522	6	30557280-30563723	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.6;HAP1: 20.1;HEL: 15.1;JURKAT: 14.7;U-266/84: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064061			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA064061: AB_2685185"	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.25e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (6.49e-6)"	"prognostic favorable (5.61e-5)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (7.84e-7)"	"unprognostic (2.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.21e-3)"	3.9	5.3	0.7	0.1	0.7	0.0	3.5	0.7	3.0	6.5	0.6	3.4	0.0	6.9	1.1	2.5	5.9	0.0	3.6	0.7	0.7	3.5	3.1	3.3	0.3	0.7	0.9	10.6	3.2	0.1	5.8	0.0	0.8	4.3	0.2	0.6	2.6	0.2	1.5	3.1	3.6	0.0	0.6	5.0	3.1	4.8	0.7	0.8	3.9	0.0	0.6	4.5	4.1	0.7	0.1	3.9	7.7	16.6	5.2	1.3	0.0	0.0	0.0	0.0	0.0	6.6	0.1	7.0	8.6	2.1	4.4	0.6	20.1	1.5	0.0	4.1	3.7	15.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.6	0.0	0.0	0.0	14.7	7.8	0.0	3.6	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.0	1.7	0.3	0.1	10.6	4.8	0.5	0.0	0.0	0.0	4.3	0.5	6.4	0.1	0.0	0.0	9.2	13.1	8.8	0.0	5.8	3.6	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.5	0.0	0.1	0.0	0.2	0.0	1.2	0.0	0.1	0.7	0.7	0.7	3.0	0.7	0.7	0.7	0.9	0.8	0.6	0.7	0.7	10.6	9.6	19.1	11.4	18.2	5.7	6.4	8.6	12.5	11.3	11.0	22.9	3.6	11.5	10.7	3.7	14.6	14.2	11.2	14.0	7.9	5.8	0.6	8.7	14.2	8.0	7.8	7.6	18.8	9.5	8.7	10.9	24.5	8.4	12.0	16.3	9.3	5.9	7.9	6.7	16.4	10.2	14.2	6.0	7.9	2.6	10.2	8.8	10.6	9.4	12.7	6.4	12.3	17.1	12.2	5.7	5.7	10.1	14.5	5.7	9.9	9.4	11.3	19.2	6.6	11.9	9.8	10.3	6.6	9.1	5.7	9.9	12.0	15.9	8.3	3.9
PRR36		ENSG00000183248	"Proline rich 36"	Q9H6K5	19	7868719-7874390	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.0;pituitary gland: 29.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.4;Breast glandular cells: 9.2;Cone photoreceptor cells: 12.5;Horizontal cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 21.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 28.7;SCLC-21H: 8.0;SH-SY5Y: 17.9;T-47d: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062741	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Golgi apparatus"		Yes	No				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 14: REH - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Nuclear speckles"	"HPA062741: AB_2684860"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (3.56e-1)"	"unprognostic (8.52e-3)"	0.1	0.9	3.5	0.1	4.0	0.0	2.5	3.0	21.0	0.8	0.0	0.3	0.2	0.6	0.3	0.3	1.2	0.1	0.2	7.5	0.0	3.3	0.2	0.9	0.0	0.0	0.0	0.7	2.8	2.0	29.6	0.0	0.0	2.5	0.0	5.0	4.1	0.3	0.0	0.7	0.2	0.0	0.0	0.1	0.8	0.8	0.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	0.1	0.9	6.6	5.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	2.9	0.0	1.9	0.0	0.6	0.1	5.1	0.0	0.0	0.0	6.4	0.0	0.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	3.2	0.1	0.1	0.0	3.0	0.3	0.3	2.5	0.4	0.6	28.7	0.0	0.3	3.7	5.4	8.0	17.9	0.0	0.3	0.0	0.5	9.1	0.0	0.0	0.0	3.2	0.1	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.0	3.0	21.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.8	0.0	2.2	13.4	9.2	7.7	1.3	2.8	0.0	5.5	12.5	0.2	0.2	0.2	5.9	3.0	5.4	4.5	0.7	0.2	3.6	0.0	6.9	0.9	0.4	0.3	2.6	6.7	0.0	1.1	0.0	0.5	0.1	10.1	5.8	0.7	0.0	0.0	0.0	0.7	0.6	0.4	0.0	3.7	0.0	5.4	0.0	4.5	0.8	0.9	0.1	0.0	0.6	1.3	0.1	1.5	0.0	4.5	0.0	0.3	1.1	0.3	3.7	3.1	0.0	0.3	0.3	0.5	0.3	1.0
PRR7	MGC10772	ENSG00000131188	"Proline rich 7, synaptic"	Q8TB68	5	177446445-177456286	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 24.7;SK-MEL-30: 26.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046636	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046636: AB_2679730"	"unprognostic (3.69e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (8.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.69e-1)"	1.3	4.0	10.7	0.8	11.9	5.8	1.6	1.2	18.7	1.8	6.3	1.3	0.7	2.5	0.0	3.7	4.8	0.1	1.8	17.9	6.7	2.3	2.3	2.0	1.0	2.7	2.1	0.7	2.9	0.4	10.4	0.1	0.7	1.8	0.1	0.3	2.7	0.2	1.2	6.0	1.8	0.1	1.9	3.1	1.3	4.4	7.4	0.5	1.2	0.0	0.5	1.0	2.0	2.8	10.7	4.1	1.1	8.1	0.0	0.6	3.5	4.9	0.9	1.3	1.8	0.9	5.6	10.2	12.6	0.7	4.1	8.8	0.7	4.5	0.5	9.0	12.8	3.1	4.3	3.1	0.9	6.2	7.2	0.9	1.8	0.6	0.3	1.2	0.6	3.9	1.6	7.1	1.3	14.3	5.2	15.8	1.9	1.6	24.7	14.5	3.6	10.5	1.7	0.8	19.8	14.1	1.9	4.8	26.2	0.0	4.3	1.0	3.8	8.0	13.5	7.1	12.0	3.9	2.3	5.1	7.7	9.8	5.9	1.9	0.1	9.7	2.3	0.4	5.5	1.5	2.5	3.9	0.1	2.8	2.4	3.1	3.7	1.7	0.5	2.4	2.0	1.2	10.7	11.9	1.2	18.7	17.9	6.7	2.7	2.1	0.7	1.9	7.4	2.8	11.8	3.2	0.0	4.9	27.9	43.3	28.0	6.8	46.7	13.6	17.2	20.3	1.6	17.2	3.7	7.3	0.0	0.8	55.9	7.4	9.8	10.6	10.6	50.2	12.3	9.2	43.0	3.4	8.6	10.8	0.9	4.8	14.3	22.3	26.7	1.0	4.6	3.1	1.5	6.7	7.0	12.3	16.2	1.9	36.5	13.8	0.9	16.7	28.4	1.0	2.3	19.7	22.6	4.0	5.7	8.6	9.8	2.2	27.3	26.7	11.6	14.2	7.0	16.6	0.0	7.8	8.1	3.3	10.7	33.2	66.9	1.4	37.0	1.5	12.3	17.3
PRR9		ENSG00000203783	"Proline rich 9"	Q5T870	1	153217584-153219310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"skin 1: 59.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 4.1;Late spermatids: 10.2;Syncytiotrophoblasts: 8.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SuSa: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027714	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Nucleoplasm, Vesicles"	"HPA027714: AB_10602194"		"unprognostic (1.45e-1)"	"unprognostic (1.46e-1)"			"unprognostic (4.17e-1)"			"unprognostic (3.48e-1)"	"unprognostic (7.02e-2)"					"unprognostic (8.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-2)"	1.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	17.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0
PRRC2A	"BAT2, D6S51E, G2"	ENSG00000204469	"Proline rich coiled-coil 2A"	P48634	6	31620715-31637771	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 81.9;HEK 293: 148.3;U-266/70: 75.3;U-266/84: 86.8;U-698: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026383, HPA046791, HPA066501"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		5600		"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747"	"unprognostic (2.07e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.10e-1)"	37.2	36.5	0.2	6.8	0.2	0.1	36.3	0.2	0.4	48.8	0.0	47.9	0.5	53.7	12.2	42.0	47.3	0.0	41.5	0.6	0.2	37.4	23.0	36.4	3.4	0.6	1.0	55.7	35.1	0.0	50.4	0.8	0.1	47.5	0.6	2.9	31.8	0.3	54.9	37.6	37.3	0.1	0.2	41.7	37.1	84.3	0.2	4.3	41.9	0.0	0.0	44.1	40.3	0.2	4.4	19.3	0.2	0.7	35.5	33.6	3.3	2.0	0.0	0.0	0.2	0.9	0.2	4.2	24.5	41.8	0.0	1.8	0.0	81.9	0.0	8.1	148.3	4.6	0.2	0.3	0.1	2.0	1.4	14.9	0.0	0.2	0.0	0.0	0.0	30.7	2.0	0.0	0.2	0.7	0.9	0.2	0.4	0.1	1.7	2.2	0.6	0.9	6.9	0.5	2.6	1.3	1.5	0.1	0.7	0.0	0.3	1.5	0.7	0.5	17.6	1.3	0.9	75.3	86.8	78.7	25.7	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.6	0.2	0.6	1.0	0.1	0.2	0.2	0.2	39.3	0.0	5.5	25.5	39.2	32.9	28.4	26.1	67.7	36.1	41.6	39.0	6.7	18.6	14.5	40.5	60.5	26.9	38.0	48.4	5.9	24.8	58.7	33.3	37.1	33.4	38.9	47.9	19.2	25.6	22.2	32.9	52.0	35.9	10.8	55.5	33.5	22.5	34.6	37.0	19.7	39.1	26.4	28.2	30.9	23.7	49.0	31.4	19.6	15.9	28.7	20.9	39.1	23.1	15.3	34.5	37.8	44.8	47.2	39.1	27.0	16.0	20.1	35.9	19.7	57.0	44.8	58.0	43.2	64.1	28.4	18.3	38.2	45.3	48.0	28.4
PRRG1	PRGP1	ENSG00000130962	"Proline rich and Gla domain 1"	O14668	X	37349309-37457292	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.4"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078129			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA078129: AB_2686878"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (8.34e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (8.21e-2)"	"prognostic favorable (2.05e-7)"	"unprognostic (1.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.48e-1)"	8.6	3.7	12.3	2.1	24.9	0.2	5.2	21.6	19.7	4.4	4.7	4.0	2.9	4.3	1.5	4.1	2.6	8.8	6.4	12.9	15.9	10.5	7.9	5.5	1.7	26.7	21.3	4.2	1.6	1.2	1.4	8.1	25.3	3.4	4.1	1.5	2.9	7.8	15.9	2.2	3.0	5.4	18.4	2.9	2.4	1.5	18.4	1.5	8.3	7.8	1.0	5.6	3.8	39.4	32.3	7.2	5.6	5.6	18.7	15.4	2.4	14.1	17.6	4.7	8.2	17.1	20.2	0.0	21.8	10.4	8.9	10.7	15.6	10.0	8.3	0.1	5.2	5.2	7.7	5.7	22.6	0.0	7.2	23.2	8.1	9.1	7.7	9.4	24.8	0.0	2.6	0.1	16.5	2.4	0.1	0.1	6.8	5.1	13.4	0.0	13.1	0.0	79.2	1.7	0.0	0.1	9.7	15.6	6.1	15.3	0.1	3.5	17.6	7.5	4.2	14.2	4.1	0.0	0.1	0.0	7.3	0.0	7.3	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.3	24.9	21.6	19.7	12.9	15.9	26.7	21.3	25.3	18.4	18.4	39.4	29.7	6.4	4.2	15.7	0.0	11.3	4.8	7.6	5.2	2.2	5.3	5.3	8.1	15.7	2.7	33.1	0.0	7.0	0.2	7.6	7.9	6.8	0.7	3.3	12.9	18.4	3.0	0.0	23.3	3.1	14.9	9.6	4.6	9.2	1.3	3.9	17.9	16.3	4.8	18.5	10.8	5.7	14.2	4.1	5.3	0.4	4.7	1.4	3.6	31.9	0.8	2.2	0.0	12.5	229.8	18.7	7.5	2.6	0.0	9.1	4.3	9.4	2.9	0.5	6.6	8.3	8.4	2.5	4.2	5.2	6.3	10.4	0.4	3.5	4.8	8.1
PRRG2	PRGP2	ENSG00000126460	"Proline rich and Gla domain 2"	O14669	19	49580646-49591004	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 28.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 47.2;Proximal enterocytes: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.9;OE19: 18.0;RT4: 11.7;SK-BR-3: 13.3;T-47d: 14.4;U-266/84: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010702	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA010702: AB_1079693"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (3.82e-9)"	"unprognostic (4.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.68e-2)"	1.2	0.4	0.9	1.2	0.9	0.1	7.0	1.3	2.6	4.9	0.6	8.4	12.0	1.5	12.9	13.5	4.9	4.3	1.2	0.9	1.0	11.8	6.4	3.9	0.9	1.2	0.9	0.3	13.1	28.4	15.6	2.1	1.1	6.2	7.7	0.1	11.3	9.0	0.9	12.9	11.0	1.1	0.9	1.0	9.8	0.9	1.1	2.3	13.4	0.1	3.9	6.7	5.5	1.0	11.1	0.4	0.3	0.9	1.3	0.0	4.6	0.2	0.0	0.4	0.4	2.2	14.9	0.7	1.6	0.1	0.3	8.5	0.3	8.5	0.4	1.1	1.2	0.5	0.8	0.7	0.9	0.4	1.1	0.9	7.4	0.3	0.3	0.7	3.4	0.9	0.2	0.8	0.0	2.4	0.2	0.7	0.6	18.0	1.4	0.2	0.3	8.7	6.5	11.7	2.4	0.3	1.3	13.3	0.1	1.0	14.4	0.2	0.6	0.8	0.7	0.4	0.1	5.1	18.7	0.5	0.2	0.3	0.4	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.2	0.5	0.0	0.2	1.2	0.2	0.1	0.9	0.9	1.3	2.6	0.9	1.0	1.2	0.9	1.1	0.9	1.1	1.0	6.4	6.4	13.4	0.7	3.4	4.1	11.6	20.2	29.6	2.2	21.5	22.6	0.9	8.6	14.2	12.9	2.1	13.0	4.1	47.2	3.9	31.9	0.7	10.8	4.1	6.4	16.2	1.3	0.5	33.2	6.5	1.6	16.8	16.1	2.5	2.3	1.1	6.8	2.3	5.0	0.4	18.0	8.2	1.9	1.2	0.4	0.3	3.3	1.8	1.9	8.2	0.9	2.1	2.0	0.4	27.4	29.4	0.0	4.4	14.5	46.3	15.5	8.8	4.1	0.0	0.8	3.9	1.9	2.1	23.3	4.7	12.7	4.1	4.6	20.7	14.6
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952408	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.6;fallopian tube: 7.6;parathyroid gland: 15.3;pituitary gland: 11.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.2;MCF7: 23.1;SK-BR-3: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		83000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	0.9	1.8	3.9	1.1	5.0	1.5	1.2	10.1	11.6	1.3	0.3	1.3	0.4	1.2	1.2	1.2	7.6	1.1	1.1	4.4	1.1	1.3	0.4	0.9	1.2	5.1	1.9	1.3	1.8	15.3	11.0	0.3	5.3	2.5	0.3	2.2	2.3	1.7	1.4	2.3	0.9	0.9	0.0	0.9	1.1	2.1	3.6	1.3	2.2	0.2	1.3	1.8	1.1	4.8	0.4	1.0	3.6	4.7	17.2	2.3	1.2	1.8	3.4	2.0	4.5	0.3	3.4	2.0	0.4	4.2	2.1	0.3	1.3	4.5	0.9	9.8	2.0	0.7	1.9	0.2	1.7	0.4	1.7	4.4	0.3	1.7	0.7	9.7	0.8	6.0	1.0	4.7	2.5	23.1	4.4	0.4	8.5	0.1	2.1	2.8	0.4	1.9	1.0	0.4	6.6	4.4	1.8	33.6	0.7	1.4	9.1	0.4	0.7	0.4	4.6	0.9	1.3	6.1	6.6	0.6	10.9	0.3	1.3	0.5	0.2	0.2	1.2	0.1	1.4	0.5	1.3	1.2	0.0	0.6	1.4	1.3	0.3	0.7	0.1	0.6	0.2	0.4	3.9	5.0	10.1	11.6	4.4	1.1	5.1	1.9	5.3	0.0	3.6	4.8	3.3	0.0	2.0	3.9	2.9	2.7	3.8	3.7	3.4	22.8	7.4	6.2	3.0	7.2	3.4	11.0	14.6	0.7	4.4	4.5	3.9	2.9	4.3	5.0	5.4	3.3	11.3	2.1	14.7	5.0	0.5	5.2	5.6	4.9	1.3	7.9	2.2	2.9	3.8	15.2	10.8	5.4	2.0	2.5	2.6	3.5	5.6	2.2	1.8	2.8	11.3	8.6	11.3	5.5	3.7	3.1	1.0	2.6	2.2	4.2	6.4	8.0	12.4	21.6	0.0	7.2	5.3	10.4	6.4	3.4	2.3	0.4	5.6	7.8	4.7	3.0
PRRT4		ENSG00000224940	"Proline rich transmembrane protein 4"	C9JH25	7	128350325-128361685	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 16.3;bone marrow: 57.7"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 4.8;Horizontal cells: 10.1;Inhibitory neurons: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 225.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA046373, HPA052681"	Uncertain		Approved	"Nucleoplasm,Peroxisomes,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Peroxisomes, Plasma membrane"	"HPA046373: AB_2679642, HPA052681: AB_2681912"	"unprognostic (1.72e-1)"	"unprognostic (4.55e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.20e-4)"	"unprognostic (2.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.28e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.27e-2)"	16.3	1.3	3.2	0.4	2.7	57.7	8.5	3.2	2.9	2.5	0.7	1.3	0.1	0.5	0.0	2.7	1.1	0.7	1.5	2.0	6.3	0.1	0.4	0.9	0.1	4.7	4.8	1.1	0.3	0.3	0.2	0.0	4.0	0.4	0.2	1.0	1.1	0.8	4.5	2.3	1.2	0.4	3.6	2.1	2.1	0.4	5.1	0.6	0.5	4.5	0.0	0.5	3.0	2.1	0.0	0.1	0.3	0.5	1.3	0.1	3.8	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.2	8.8	0.1	1.3	0.0	0.0	0.1	0.0	0.0	12.8	0.0	0.0	0.0	1.0	2.6	46.6	1.2	0.0	0.1	12.9	0.6	1.0	0.0	0.1	0.5	225.3	0.4	0.2	0.3	1.5	0.1	6.1	0.0	0.0	1.0	0.5	0.1	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.7	3.2	2.9	2.0	6.3	4.7	4.8	4.0	3.6	5.1	2.1	0.4	0.0	0.0	1.0	0.0	0.6	0.1	0.2	0.6	4.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.1	0.2	10.1	12.6	0.0	0.0	0.0	0.7	0.0	0.9	0.1	0.0	0.0	0.1	1.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.8	1.2	0.3	0.3	0.1	0.0	0.0	0.1
PRRX1	"PHOX1, PMX1"	ENSG00000116132	"Paired related homeobox 1"	P54821	1	170662728-170739421	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 351.7;Endometrial stromal cells: 158.6;Fibroblasts: 180.2;Late spermatids: 390.0;Leydig cells: 256.3;Oligodendrocyte precursor cells: 288.5;Smooth muscle cells: 206.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 367.0;ASC TERT1: 290.5;BJ: 109.7;BJ hTERT+: 213.2;HSkMC: 150.6;U-138 MG: 146.0;U-2197: 140.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051084, HPA063566"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA051084: AB_2681338, HPA063566: AB_2732702"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (6.60e-10)"	"unprognostic (4.23e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.69e-3)"	96.3	10.2	14.5	17.7	15.2	0.0	42.9	15.4	13.4	92.0	5.4	5.6	1.1	68.6	20.3	20.1	42.3	34.1	44.2	12.6	26.2	2.3	0.4	21.7	34.6	17.4	18.5	28.2	3.8	7.5	4.9	6.3	16.8	33.5	5.7	0.1	38.5	75.6	51.7	24.1	3.6	52.4	7.9	1.9	3.4	14.2	16.5	18.7	41.6	73.9	36.3	33.0	58.8	15.0	0.0	0.0	2.1	0.0	367.0	290.5	0.1	109.7	213.2	15.0	14.8	0.0	0.1	0.1	0.0	90.2	0.0	0.0	18.5	0.0	4.7	0.0	0.2	0.0	1.6	0.0	1.2	0.0	0.0	150.6	0.0	73.4	0.4	25.7	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.8	0.0	0.0	0.1	146.0	2.6	140.4	16.9	0.0	0.0	0.0	77.3	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	15.2	15.4	13.4	12.6	26.2	17.4	18.5	16.8	7.9	16.5	15.0	49.8	0.0	0.5	114.3	0.3	16.3	0.6	0.1	4.0	0.0	1.3	10.2	29.8	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	1.2	351.7	4.9	158.6	11.4	0.0	0.0	17.4	0.2	0.1	180.2	0.5	3.5	0.0	0.6	0.0	0.0	0.8	0.0	5.5	0.0	0.0	0.0	27.9	390.0	256.3	2.8	14.2	124.6	0.0	0.5	0.0	288.5	0.9	0.7	0.0	104.6	0.4	1.7	0.0	0.1	0.0	0.2	52.6	59.1	206.5	15.4	1.9	1.2	11.8	0.1	2.3	0.6	0.0	1.2
PRRX2	"PMX2, PRX2"	ENSG00000167157	"Paired related homeobox 2"	Q99811	9	129665647-129722674	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 23.3;skin 1: 25.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 27.4;Early spermatids: 78.7;Fibroblasts: 44.2;Langerhans cells: 28.0;Smooth muscle cells: 21.2;Suprabasal keratinocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.9;BJ: 28.7;BJ hTERT+: 20.3;fHDF/TERT166: 41.6;U-2197: 34.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"spinal cord: 1.3"	"HPA006607, HPA026808"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA006607: AB_2667623, HPA026808: AB_10603228"	"unprognostic (4.02e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.47e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-10)"	"unprognostic (6.66e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.47e-3)"	14.2	2.4	0.5	1.2	0.5	0.0	11.7	0.4	0.7	23.3	1.0	2.2	0.2	3.9	0.2	5.4	3.4	1.3	9.5	0.6	1.2	1.2	0.1	4.6	1.1	0.5	0.5	1.3	0.9	0.5	4.5	1.4	0.6	14.1	0.3	0.0	7.5	2.7	1.6	25.5	1.6	0.6	0.4	0.1	2.8	10.7	0.5	0.3	9.5	0.6	0.8	10.7	18.3	0.5	0.0	0.7	0.0	1.1	3.3	12.9	0.1	28.7	20.3	3.6	4.0	0.0	0.0	0.0	10.2	41.6	1.5	0.3	0.8	0.0	0.3	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	1.1	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.6	0.0	0.0	4.4	2.1	6.4	0.0	0.0	0.0	0.9	0.0	0.0	2.7	1.3	0.1	0.0	1.4	2.7	0.5	0.0	0.0	8.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.7	0.6	1.2	0.5	0.5	0.6	0.4	0.5	0.5	3.9	0.0	0.0	0.7	0.1	27.4	1.1	16.0	0.6	0.0	6.0	6.0	0.3	0.0	10.1	0.0	0.0	0.2	0.1	0.0	1.9	0.1	78.7	1.0	6.3	3.0	0.0	0.0	0.4	0.0	0.4	44.2	0.5	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	2.0	0.0	28.0	10.2	2.8	0.3	8.8	0.0	0.0	0.0	0.0	5.0	0.1	0.9	0.0	3.4	0.0	4.0	0.0	0.1	7.9	0.0	0.0	0.4	21.2	3.6	6.8	0.5	29.7	0.4	0.8	0.0	0.0	6.2
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Club cells: 34.3;Cytotrophoblasts: 48.0;Respiratory ciliated cells: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 70.2;SH-SY5Y: 215.4;THP-1: 100.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.6	0.5	1.4	1.6	0.9	0.1	2.2	0.6	1.3	14.5	14.4	6.7	2.7	1.9	0.6	3.2	10.5	9.8	0.0	2.7	0.5	0.8	0.6	7.6	0.1	0.5	1.9	1.6	7.7	0.1	0.6	10.6	0.7	1.4	6.4	0.3	2.5	2.0	0.2	5.9	4.8	1.3	0.5	0.0	9.2	10.0	1.2	1.0	0.2	1.2	5.7	3.8	12.6	0.5	5.2	0.2	1.8	0.0	0.2	13.3	0.1	46.0	41.5	9.7	16.1	0.1	18.7	0.0	0.2	70.2	4.9	0.8	31.1	9.5	12.7	0.2	7.2	0.0	3.6	0.0	1.4	0.0	0.2	4.1	17.5	3.4	9.9	31.2	0.1	0.6	0.0	0.0	8.0	0.3	0.5	9.6	2.2	36.4	2.9	0.0	38.7	0.0	0.0	7.0	5.1	215.4	0.0	0.2	3.0	30.9	0.0	100.6	0.0	19.2	2.8	12.2	9.1	1.0	0.1	0.0	1.0	3.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.6	1.3	2.7	0.5	0.5	1.9	0.7	0.5	1.2	0.5	0.3	6.4	4.6	0.7	0.2	8.4	0.8	16.4	2.2	0.6	0.8	0.8	1.4	10.0	34.3	1.8	0.0	48.0	0.0	26.8	0.0	0.4	9.9	19.7	16.8	0.9	5.3	0.0	10.5	10.2	4.5	7.1	17.9	2.6	7.0	3.3	0.0	0.4	3.8	0.0	14.3	2.7	10.2	0.0	4.2	18.3	0.0	0.4	5.4	7.5	0.0	0.0	0.0	0.5	0.2	8.1	12.8	0.0	0.2	0.4	9.4	0.6	76.1	0.2	0.0	0.6	4.9	10.1	13.3	3.6	4.3	11.9	0.7	21.8	5.3	4.7
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852730-2858170	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 79.6;salivary gland: 26.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 221.0;Club cells: 343.9;Ionocytes: 207.5;Pancreatic endocrine cells: 380.6;Urothelial cells: 479.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 17.3;MCF7: 14.6;RT4: 10.4;SK-BR-3: 22.9"	"Region enhanced"	"Detected in some"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	23.4	0.0	0.5	0.3	0.7	0.4	79.6	1.3	0.8	0.0	0.0	0.0	16.7	0.5	2.9	0.0	0.0	0.0	0.0	5.8	1.5	2.4	1.1	0.0	6.0	0.5	0.0	26.9	0.3	0.0	3.2	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.3	0.0	2.2	2.5	23.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	17.3	0.0	0.0	0.0	0.0	1.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	22.9	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	4.2	0.0	0.2	23.2	221.0	128.8	28.5	0.0	42.8	23.7	0.3	38.6	343.9	16.5	0.0	36.7	1.9	18.5	1.9	113.1	0.0	28.4	4.6	1.8	3.6	0.0	0.0	98.3	37.1	1.3	52.5	56.6	0.0	0.0	0.0	0.1	2.3	0.0	0.0	7.5	207.5	0.0	1.4	0.0	0.0	0.9	7.2	0.0	1.0	0.0	0.0	0.0	0.0	380.6	32.3	0.0	0.3	75.4	0.6	0.2	108.0	0.0	0.0	0.0	13.7	0.1	0.2	22.7	27.6	10.5	2.7	0.0	6.9	479.5
PRTFDC1	HHGP	ENSG00000099256	"Phosphoribosyl transferase domain containing 1"	Q9NRG1	10	24848614-24952606	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 136.1;Oligodendrocyte precursor cells: 111.6;Oligodendrocytes: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 4.4"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 4.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 75.9;CAPAN-2: 94.3;HEL: 56.2"					"Low region specificity"	"Detected in all"			HPA021458	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA021458: AB_1855793"	"unprognostic (2.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (9.49e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.94e-2)"	5.4	22.2	21.7	4.5	28.7	0.9	7.6	24.9	27.2	12.9	16.1	9.9	17.7	15.8	7.4	5.5	9.8	14.8	10.9	22.4	24.6	4.8	2.8	4.3	4.2	26.7	24.0	20.2	4.6	13.4	11.4	2.9	28.0	7.8	11.3	16.5	9.7	8.2	1.3	1.8	17.1	9.8	25.8	3.2	17.5	2.2	23.7	6.8	5.3	2.8	3.2	7.4	6.3	37.1	19.5	41.3	30.2	12.4	4.9	24.4	0.0	20.2	15.1	14.2	19.3	75.9	94.3	0.0	3.1	23.7	1.2	10.7	34.7	0.0	22.0	0.0	1.4	56.2	7.6	0.1	14.6	0.0	0.0	7.1	0.2	7.7	0.0	13.3	22.6	2.2	18.6	10.5	6.8	0.5	8.8	0.1	20.9	3.3	0.7	9.7	0.1	0.2	12.7	0.5	21.5	0.9	19.3	0.1	0.0	0.6	1.1	4.3	12.2	6.3	15.5	23.1	12.2	0.9	0.0	0.0	16.8	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	4.4	0.0	0.1	0.0	0.9	21.7	28.7	24.9	27.2	22.4	24.6	26.7	24.0	28.0	25.8	23.7	37.1	3.5	0.0	0.5	136.1	0.7	2.7	4.6	5.4	2.8	10.2	1.1	5.8	8.6	7.2	3.9	3.7	2.1	1.0	0.8	3.8	5.9	5.8	1.4	1.5	27.3	2.8	5.4	3.0	38.2	0.5	4.9	20.6	12.2	2.2	0.0	25.1	7.5	0.1	7.2	6.7	43.0	7.3	0.0	0.9	3.1	1.0	12.2	7.8	3.6	24.4	1.5	45.8	0.0	111.6	148.2	2.3	2.1	9.8	1.3	1.1	12.2	0.1	1.1	15.9	0.0	16.4	10.4	3.4	6.3	0.4	2.8	0.8	1.0	22.7	11.6	1.5
PRUNE2	"A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367"	ENSG00000106772	"Prune homolog 2 with BCH domain"	Q8WUY3	9	76611376-76906114	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 120.6;intestine: 110.9"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 918.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.1;LHCN-M2: 83.2;RH-30: 71.5;RPTEC TERT1: 40.1"	"Low region specificity"	"Detected in all"							"HPA022470, HPA031079"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA022470: AB_1845832, HPA031079: AB_10603230"	"unprognostic (1.21e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.60e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.80e-4)"	11.3	23.2	26.9	11.9	82.9	2.9	5.2	49.5	54.7	16.6	0.0	110.9	7.1	50.6	18.5	34.0	29.4	16.4	8.9	26.9	48.4	15.4	1.9	5.1	2.8	90.0	52.8	4.7	4.3	4.0	30.9	4.0	76.4	47.6	18.5	39.0	14.6	64.8	16.7	5.4	27.7	55.3	31.7	4.4	37.1	4.9	53.1	0.9	2.6	56.8	2.5	69.2	14.4	120.6	0.0	0.0	1.5	0.0	51.1	25.8	0.2	1.8	3.6	6.6	14.7	0.4	0.0	0.3	3.9	4.5	13.6	0.0	0.1	0.0	18.0	0.4	2.9	6.3	3.7	0.0	8.5	0.1	0.3	28.7	0.1	26.7	0.7	15.1	14.4	0.4	0.0	20.8	83.2	0.1	4.6	1.8	4.0	0.0	0.0	0.5	71.5	0.3	40.1	0.0	17.4	0.0	0.0	0.3	4.9	2.8	0.1	0.7	11.9	14.2	0.7	34.9	1.2	22.2	3.2	0.0	11.5	0.3	0.0	0.3	0.5	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.3	0.2	0.1	0.0	0.2	26.9	82.9	49.5	54.7	26.9	48.4	90.0	52.8	76.4	31.7	53.1	120.6	0.4	0.0	1.1	27.7	0.0	2.3	0.4	0.5	0.0	47.5	1.2	3.4	11.1	0.0	1.0	11.0	0.0	0.0	1.6	3.5	1.9	0.0	12.6	37.7	4.7	3.7	54.3	0.0	152.4	0.5	0.2	2.9	3.1	34.7	0.0	0.1	21.8	0.2	3.2	15.2	65.4	36.4	4.1	3.1	3.1	30.0	0.9	2.3	5.4	13.1	1.7	9.9	2.1	134.7	918.7	0.4	8.8	1.5	0.1	5.1	9.9	20.3	17.0	6.5	0.0	27.2	9.6	4.3	4.2	0.0	1.4	0.0	0.7	0.5	5.2	0.6
PRXL2B	"C1orf93, FAM213B, MGC26818"	ENSG00000157870	"Peroxiredoxin like 2B"	Q8TBF2	1	2586491-2591469	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 5.0;Endothelial cells: 2.1;Hofbauer cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 51.8;U-2197: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006403	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA006403: AB_1853870"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.76e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (5.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.20e-2)"	8.3	18.6	11.0	4.8	12.0	3.2	9.2	5.5	16.4	9.4	2.3	24.4	18.7	9.3	1.4	12.3	10.9	6.0	6.4	12.1	10.2	15.6	7.0	11.7	5.0	9.4	10.1	6.3	6.8	5.4	8.7	6.7	11.7	10.0	5.9	2.8	7.8	5.6	1.3	7.8	20.5	3.6	7.3	15.2	14.3	6.6	11.1	4.1	8.1	0.7	3.9	11.7	8.1	8.3	15.8	8.7	9.8	9.1	3.8	4.6	1.2	5.4	6.2	13.6	5.6	6.7	18.0	4.2	13.9	9.5	5.4	12.6	8.2	9.5	4.5	11.8	3.8	9.9	6.1	11.3	10.3	5.3	3.0	6.4	5.2	9.8	3.2	6.7	19.0	6.8	13.3	6.4	13.9	7.7	12.2	2.5	10.4	19.8	31.6	14.2	12.8	10.1	14.2	8.3	11.7	18.0	12.2	51.8	16.8	2.2	9.3	2.2	28.1	11.2	12.7	46.3	5.4	5.2	8.1	3.0	11.0	19.9	2.8	1.9	1.5	0.8	2.5	1.5	4.2	1.2	2.8	2.9	1.6	0.9	2.5	3.7	1.1	4.8	1.4	0.7	4.4	2.4	11.0	12.0	5.5	16.4	12.1	10.2	9.4	10.1	11.7	7.3	11.1	8.3	5.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0
PRY	"PRY1, PTPN13LY"	ENSG00000169789	"PTPN13 like Y-linked"	O14603	Y	22490397-22514637	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059887			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"			"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA059887: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRY2	PTPN13LY2	ENSG00000169807	"PTPN13 like Y-linked 2"	O14603	Y	22071756-22096007	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059887			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"				"Nucleoplasm, Nucleoli"	Cytosol	"HPA059887: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRYP3		ENSG00000169763	"PTPN13 like Y-linked pseudogene 3"	O14603	Y	23681440-23694579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 1.7;epididymis: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"A549: 4.5;HDLM-2: 7.7"									HPA059887			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 44: HDLM-2 - Immune response"		"Nucleoplasm, Nucleoli"	Cytosol	"HPA059887: "																		0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.0		0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.7	1.5	0.9	1.2	1.7	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSD	"EFA6, EFA6A, KIAA2011, PSD1, TYL"	ENSG00000059915	"Pleckstrin and Sec7 domain containing"	A5PKW4	10	102402617-102421539	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 233.9;intestine: 261.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.7;Cone photoreceptor cells: 95.9;Endometrial stromal cells: 47.7;Excitatory neurons: 41.1;Inhibitory neurons: 29.9;Rod photoreceptor cells: 70.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 7.7;MOLT-4: 4.4;SCLC-21H: 7.4;SH-SY5Y: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059237	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA059237: AB_2683954"	"unprognostic (2.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	1.2	9.1	159.5	3.8	151.7	0.7	1.5	7.8	233.9	53.8	0.0	261.8	6.1	78.3	1.4	1.6	46.2	8.9	4.4	220.9	63.9	2.8	2.4	1.2	0.9	23.8	25.4	15.3	5.0	1.5	99.4	0.8	27.3	4.3	3.5	36.8	1.0	1.2	0.4	1.6	41.4	17.7	14.9	1.5	44.2	12.4	70.2	1.4	1.1	0.0	0.4	105.7	14.7	87.6	0.2	0.0	3.0	2.7	1.1	0.6	0.3	0.2	0.0	0.1	0.0	2.1	0.3	0.2	1.8	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.2	0.1	0.1	0.1	1.6	0.0	0.1	7.7	0.2	0.5	0.1	1.2	0.0	1.0	0.4	0.7	0.0	1.7	4.4	0.2	0.4	0.3	0.0	1.2	0.0	0.1	0.0	0.1	7.4	6.4	0.1	0.1	0.2	0.2	0.5	0.4	0.0	2.2	3.5	0.2	0.0	1.9	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	159.5	151.7	7.8	233.9	220.9	63.9	23.8	25.4	27.3	14.9	70.2	87.6	0.7	3.2	0.5	6.8	1.0	0.6	0.3	0.3	0.0	50.7	1.1	0.5	1.5	2.8	1.5	0.0	95.9	0.2	0.6	0.8	1.9	0.2	6.6	4.8	47.7	1.0	18.0	0.0	41.1	1.9	0.2	4.0	2.6	1.8	0.0	0.4	0.0	1.3	0.7	13.5	29.9	0.9	0.0	0.6	0.7	2.7	3.7	0.5	0.0	3.7	0.1	13.2	0.0	9.0	2.4	0.7	1.4	4.1	0.1	0.4	1.3	1.2	0.5	70.8	0.0	2.0	1.1	4.0	3.7	0.7	0.1	0.7	1.9	8.8	1.3	0.1
PSD3	"DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942"	ENSG00000156011	"Pleckstrin and Sec7 domain containing 3"	Q9NYI0	8	18527303-19084730	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.3;Early spermatids: 686.7;Excitatory neurons: 284.7;Oligodendrocyte precursor cells: 488.1;Oligodendrocytes: 584.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.8;hTERT-RPE1: 48.0;LHCN-M2: 47.3;U-87 MG: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002455	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA002455: AB_2666597"	"unprognostic (3.87e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (7.55e-4)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.45e-1)"	2.4	17.8	24.8	3.1	46.2	1.2	5.9	62.4	46.1	11.9	0.0	6.7	4.8	8.8	3.8	5.3	2.5	7.4	27.5	51.9	4.0	1.9	18.9	4.6	2.5	3.3	10.0	18.0	9.9	18.4	7.3	6.6	1.8	3.9	7.3	19.9	4.1	5.8	1.3	4.4	5.0	5.8	0.0	10.4	9.8	16.4	7.8	2.2	6.1	2.3	3.4	5.8	4.3	17.2	11.0	5.7	25.0	0.1	8.8	53.8	1.3	5.7	8.9	5.1	10.5	3.3	4.3	6.5	3.6	23.8	22.3	0.9	7.3	10.1	9.7	0.0	6.6	0.6	4.6	0.5	15.9	0.2	0.4	14.2	6.2	28.2	4.9	48.0	6.8	1.6	0.8	4.9	47.3	3.7	0.0	1.2	4.9	9.6	14.7	5.2	21.4	3.0	12.7	14.0	10.7	11.8	2.5	1.1	3.8	5.4	0.3	2.6	28.0	15.7	10.8	37.5	5.1	0.4	0.7	14.8	49.5	2.7	5.4	0.7	0.2	0.2	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.5	0.1	0.1	0.3	0.3	0.2	0.1	0.4	0.1	24.8	46.2	62.4	46.1	51.9	4.0	3.3	10.0	1.8	0.0	7.8	17.2	8.1	3.2	2.7	558.3	3.3	21.9	13.7	26.4	13.6	191.9	14.4	10.7	119.2	7.2	23.9	9.2	118.9	3.2	0.1	48.5	1.9	13.5	686.7	12.5	69.9	8.2	6.1	0.0	284.7	8.7	1.7	44.3	43.8	6.6	0.0	87.2	4.2	42.9	13.1	18.5	121.6	20.0	44.7	16.0	25.9	217.9	33.2	9.0	1.8	148.9	59.7	78.0	0.0	488.1	584.6	27.0	13.5	53.8	0.1	11.2	20.3	0.3	41.0	52.0	13.1	29.3	17.7	16.5	17.7	32.4	9.9	1.1	1.1	114.9	17.2	23.7
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	25.1	22.6	44.3	26.5	80.7	39.6	28.2	62.4	56.0	28.1	48.9	49.5	50.2	25.3	26.9	35.2	22.9	31.7	18.0	47.4	51.6	35.5	31.9	32.1	22.4	73.0	63.8	22.0	22.9	35.1	11.6	43.1	71.5	24.3	46.3	23.4	22.9	23.4	18.4	38.2	49.0	27.1	55.7	22.6	31.0	32.5	60.8	26.2	36.9	23.3	30.7	35.0	19.2	119.1	37.1	55.9	50.6	20.0	68.9	49.9	46.7	52.5	60.1	52.6	66.7	69.9	88.9	23.7	34.1	50.5	43.0	94.9	43.2	40.1	57.3	54.6	26.7	27.1	35.1	34.4	63.8	27.7	50.7	50.4	71.9	44.3	54.4	48.5	43.2	26.2	31.0	46.6	50.0	72.8	21.0	35.7	22.0	64.5	40.4	26.4	42.7	30.2	73.7	76.5	28.1	38.3	57.4	53.0	47.1	45.4	66.3	60.7	45.7	53.1	43.5	44.1	25.3	30.3	47.9	23.7	44.9	32.8	33.3	126.8	94.5	96.3	23.1	106.0	22.6	23.1	22.3	19.0	83.4	31.8	20.7	20.1	129.3	42.8	125.0	43.6	37.0	70.3	44.3	80.7	62.4	56.0	47.4	51.6	73.0	63.8	71.5	55.7	60.8	119.1	22.2	28.9	30.5	35.9	25.8	28.6	24.6	24.7	12.0	17.1	25.0	17.7	12.5	15.7	30.2	23.9	39.6	27.1	30.7	79.1	5.9	27.1	22.9	26.3	26.4	22.3	16.2	12.0	38.9	26.7	29.2	23.7	32.1	47.4	18.3	29.6	15.7	24.6	30.5	13.5	40.2	39.5	24.4	50.5	40.8	12.9	16.4	52.3	16.0	39.4	51.8	13.8	14.4	48.7	395.8	38.2	58.8	15.4	23.6	38.8	76.2	13.0	29.0	28.0	26.3	20.0	19.0	40.2	14.4	20.4	33.0	49.9	21.6	18.6	41.3	51.5
PSIP1	"DFS70, LEDGF, p52, p75, PSIP2"	ENSG00000164985	"PC4 and SFRS1 interacting protein 1"	O75475	9	15464066-15510995	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 279.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013718, HPA019697"	Enhanced		Enhanced	Nucleoplasm		NA	NA		24000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB013718: , HPA019697: AB_1852779"	"unprognostic (8.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.10e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.39e-1)"	32.9	40.9	67.8	46.9	72.1	62.0	27.4	83.9	89.1	45.8	52.6	40.8	23.1	57.5	36.0	26.2	42.9	30.8	34.4	71.5	79.2	32.6	22.3	32.8	80.7	65.2	66.4	86.0	17.1	30.3	52.2	39.5	64.4	36.3	30.9	154.4	19.1	41.0	38.6	26.0	34.4	43.2	65.1	54.7	28.5	81.6	68.1	129.7	37.1	29.5	69.3	31.2	32.3	72.2	117.5	76.5	254.7	187.4	54.0	65.2	56.7	138.3	98.1	121.7	143.6	32.1	59.5	248.1	31.4	73.5	68.2	32.0	160.1	75.0	174.9	164.8	96.6	860.4	194.9	60.8	65.1	101.7	91.7	54.8	21.0	102.1	74.4	121.0	108.0	115.2	144.4	134.1	80.2	42.8	211.5	250.9	395.2	2.7	117.2	194.7	138.8	50.7	68.3	40.5	161.1	176.7	123.7	54.0	67.1	157.5	54.5	134.9	76.7	88.0	88.6	66.7	133.2	57.1	85.3	221.8	70.2	100.8	51.6	13.7	2.6	5.4	6.1	2.0	7.7	11.0	12.5	8.8	3.0	17.5	18.7	11.6	8.4	9.5	5.7	3.1	12.9	2.4	67.8	72.1	83.9	89.1	71.5	79.2	65.2	66.4	64.4	65.1	68.1	72.2	93.7	54.5	31.9	27.4	98.1	31.9	49.1	8.1	48.9	231.0	22.0	35.6	57.8	31.5	23.1	47.8	66.7	122.7	82.1	24.7	62.6	9.5	95.5	92.9	62.5	84.8	38.1	160.1	73.4	8.5	76.2	74.8	23.0	35.1	15.2	104.2	65.3	18.0	32.1	138.0	76.9	34.1	2.0	36.5	45.9	58.5	125.9	45.8	40.9	20.6	47.9	162.2	83.4	49.8	67.6	3.6	20.6	134.3	60.4	19.6	14.1	54.5	42.1	279.1	124.9	85.2	89.8	217.9	243.8	34.5	21.2	41.3	111.6	68.6	45.8	20.3
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86047109-86088621	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"retina: 2.4"	"Cell type enhanced"	"Detected in single"		"Rod photoreceptor cells: 2.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 9.4"									"HPA015095, HPA056839"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PSMA1	"HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30"	ENSG00000129084	"Proteasome 20S subunit alpha 1"	P25786	11	14504874-14643635	"Enzymes, Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033765, HPA037646, HPA043891, CAB079995"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Centrosome"		NA	NA		20000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Nuclear bodies, Centrosome"	"CAB033765: AB_2253026, CAB079995: , HPA037646: AB_10670386, HPA043891: AB_2678718"	"unprognostic (1.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.66e-3)"	"prognostic unfavorable (3.79e-5)"	"unprognostic (3.28e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.27e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (4.03e-11)"	"unprognostic (1.93e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.23e-2)"	87.2	85.5	55.1	94.9	57.8	135.8	96.2	55.4	68.2	76.8	58.7	92.5	96.4	80.7	108.0	94.7	79.4	79.6	140.5	59.4	64.4	98.4	139.2	77.5	114.9	55.8	56.6	79.4	54.6	78.5	50.4	113.0	58.8	81.7	101.9	63.2	74.4	85.8	168.7	80.5	86.1	96.1	56.6	75.6	75.7	56.2	60.2	122.2	88.4	152.6	109.9	111.2	56.0	58.6	408.8	279.8	227.8	275.7	223.7	225.5	193.3	232.9	305.2	348.3	283.9	244.2	500.1	349.5	262.1	248.6	315.4	303.1	259.3	290.1	328.3	344.0	389.6	220.4	190.5	326.1	291.0	355.3	277.5	217.8	171.6	188.9	390.7	252.7	347.0	271.6	398.9	283.4	315.2	277.8	334.0	319.5	191.6	340.5	414.1	223.3	336.1	217.5	313.0	304.7	188.2	119.3	246.6	273.9	229.0	233.8	164.4	222.9	272.0	226.2	222.9	402.7	295.4	123.3	366.1	319.9	334.8	291.1	296.6	115.5	191.2	47.5	97.7	139.8	128.0	104.1	110.8	109.7	243.3	95.3	98.5	94.4	36.3	145.1	137.5	138.7	154.9	235.8	55.1	57.8	55.4	68.2	59.4	64.4	55.8	56.6	58.8	56.6	60.2	58.6	119.0	83.3	90.2	64.3	101.7	142.9	231.2	365.7	76.2	50.3	105.7	125.9	0.0	82.9	176.1	88.3	18.8	469.5	135.3	49.2	256.3	228.5	75.5	84.0	94.0	135.5	40.1	163.9	56.8	233.1	370.6	128.5	66.8	79.8	78.2	134.7	95.3	127.9	292.9	57.2	66.3	63.6	231.9	161.8	170.5	36.3	116.5	153.6	144.1	122.7	263.7	111.6	168.9	64.8	35.3	223.2	88.6	127.5	112.1	209.1	135.0	257.1	115.1	54.8	85.5	99.2	129.8	174.9	80.1	114.3	151.9	627.3	130.7	137.2	97.1	248.1
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome 20S subunit alpha 4"	P25789	15	78540405-78552417	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		No	No		13000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332"	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	92.9	105.0	62.5	106.3	64.4	107.6	87.5	66.2	98.8	78.9	65.6	105.1	108.9	89.6	74.5	118.2	71.6	66.0	108.4	64.7	69.1	98.1	152.1	87.9	136.9	67.6	65.5	64.6	67.3	73.4	54.4	85.8	67.5	97.2	109.6	50.3	70.3	64.2	180.6	78.3	101.3	99.3	69.3	115.3	88.5	109.9	65.6	156.5	70.6	121.6	128.7	118.8	81.2	69.9	274.2	386.9	327.7	290.8	202.1	189.5	256.3	250.2	199.9	301.4	320.6	404.9	386.9	590.8	359.7	232.5	337.4	363.9	669.1	271.8	289.1	244.2	465.7	497.6	271.6	330.1	326.9	512.6	294.5	154.6	166.8	255.0	250.9	185.4	330.7	319.1	544.2	225.0	249.6	392.3	347.5	477.4	309.7	315.3	224.5	297.7	432.9	198.9	309.5	469.4	287.6	209.9	401.3	289.5	327.5	402.2	267.8	414.7	265.8	223.7	298.6	249.3	434.2	204.0	517.9	556.2	209.9	756.7	252.6	126.0	251.9	172.9	136.2	403.9	140.3	156.0	142.0	144.7	327.4	119.9	111.7	137.0	112.8	209.4	394.8	185.4	216.8	405.6	62.5	64.4	66.2	98.8	64.7	69.1	67.6	65.5	67.5	69.3	65.6	69.9	119.0	128.2	118.5	17.3	124.1	231.6	269.6	765.7	84.2	57.8	88.5	95.8	163.7	105.8	327.0	121.4	10.4	478.9	128.4	145.3	311.0	296.2	689.4	158.0	183.6	162.5	146.2	153.2	18.0	292.7	450.6	159.9	78.0	126.0	174.2	152.9	114.9	178.9	320.4	72.3	19.6	216.2	506.6	143.2	201.7	399.0	151.0	176.9	133.4	23.4	308.6	63.5	149.3	11.1	21.5	256.0	165.7	147.4	108.0	249.3	195.8	367.2	280.0	39.8	151.2	95.4	241.1	417.1	181.0	106.4	212.8	447.1	128.6	166.7	234.7	258.4
PSMA6	"IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27"	ENSG00000100902	"Proteasome 20S subunit alpha 6"	P60900	14	35278633-35317493	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 156.3;Late spermatids: 474.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003049	Approved		Supported	Nucleoplasm		NA	NA		18000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA003049: AB_1079703"	"unprognostic (9.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.27e-4)"	"unprognostic (1.29e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.08e-2)"	118.4	141.3	88.3	117.3	92.4	155.5	131.1	88.9	140.7	81.3	86.6	128.6	115.1	82.4	98.7	126.0	84.0	69.7	169.1	92.2	97.6	98.0	172.8	123.6	137.6	92.6	90.5	71.3	91.9	82.8	83.2	120.7	96.0	74.7	130.0	63.9	87.8	81.1	350.1	107.5	114.8	94.4	92.8	114.4	95.9	247.9	94.7	290.1	82.3	203.9	139.7	132.6	85.7	92.4	502.2	367.2	257.6	264.9	209.8	214.5	523.1	252.2	300.3	368.2	329.0	338.8	341.7	322.9	492.1	244.4	220.4	337.5	306.6	280.0	434.5	337.9	170.1	257.6	233.6	1011.6	235.8	542.0	225.8	166.7	229.4	256.6	324.7	178.2	312.2	548.1	284.2	220.4	298.7	522.9	838.2	458.2	249.3	391.0	407.0	1249.4	261.3	256.9	312.8	634.9	275.1	230.8	285.5	402.2	274.7	211.9	473.8	351.4	267.1	235.8	231.8	245.7	283.6	234.0	576.3	605.9	192.4	335.7	272.0	232.1	364.6	242.2	241.0	344.8	243.0	212.8	230.9	248.9	373.6	171.5	182.5	217.5	131.9	300.6	343.7	385.3	317.0	711.5	88.3	92.4	88.9	140.7	92.2	97.6	92.6	90.5	96.0	92.8	94.7	92.4	20.8	44.8	40.7	20.2	37.7	33.3	14.9	37.2	69.4	13.7	16.5	15.0	1.4	22.8	45.7	14.7	25.0	32.2	24.8	22.4	21.5	34.2	156.3	21.2	14.9	30.5	18.0	56.8	32.7	36.7	26.0	28.4	46.4	28.2	54.5	10.1	29.6	20.0	22.6	25.2	31.2	18.3	22.4	36.7	89.5	474.9	22.7	62.2	24.9	22.5	34.1	8.6	34.0	20.6	29.4	32.8	19.5	17.3	114.6	15.9	43.1	25.4	59.5	19.4	13.1	17.8	31.3	35.1	20.0	89.8	33.1	41.3	53.7	9.2	22.2	17.1
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome 20S subunit beta 1"	P20618	6	170535120-170553307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1197.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm		NA	NA		15000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"unprognostic (2.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (3.63e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.62e-2)"	214.3	191.2	127.8	138.1	131.9	206.8	186.4	129.8	150.7	146.1	131.9	175.9	147.4	174.9	279.4	175.2	157.1	114.5	222.3	127.7	139.0	179.7	308.6	158.3	175.8	129.2	127.5	136.6	153.1	169.2	151.8	173.8	133.2	130.9	166.9	98.5	141.7	151.3	355.2	192.2	149.1	164.3	137.6	165.7	156.8	114.3	132.9	180.5	142.4	239.2	206.8	168.8	143.4	143.0	309.8	284.9	396.2	514.9	347.3	271.2	421.6	288.3	422.7	471.6	478.5	628.9	259.3	449.1	366.2	390.0	430.8	303.7	446.0	459.8	488.7	460.2	502.1	384.4	277.6	799.6	406.3	455.8	327.1	311.5	277.6	455.6	293.1	322.4	409.9	278.1	774.3	373.2	436.9	835.1	343.5	633.0	362.7	558.1	387.9	326.9	314.1	571.6	495.1	183.6	394.5	321.6	277.1	424.5	231.5	351.1	290.9	648.4	313.3	190.4	304.8	466.9	543.2	315.8	454.8	565.8	443.7	510.9	417.5	258.4	431.9	290.2	265.2	416.1	313.5	386.4	306.0	290.7	523.1	305.7	288.1	279.8	249.3	408.2	384.4	297.4	442.6	652.5	127.8	131.9	129.8	150.7	127.7	139.0	129.2	127.5	133.2	137.6	132.9	143.0	242.7	112.2	148.5	19.9	182.1	217.2	351.4	750.7	117.8	120.2	168.2	236.3	232.3	208.8	335.5	141.6	41.7	876.6	175.0	222.0	401.1	498.3	332.4	224.6	190.2	243.8	165.3	223.9	23.5	651.4	790.8	245.5	109.6	215.1	189.5	226.1	168.8	349.8	394.3	119.5	25.1	251.6	417.1	165.3	222.3	81.9	256.3	207.3	231.3	20.6	364.5	237.8	206.0	19.6	43.3	525.5	240.1	235.9	253.4	334.9	327.6	537.0	310.0	135.9	190.7	181.2	500.2	247.8	196.3	153.3	215.8	1197.8	182.1	283.7	276.7	365.4
PSMB2	HC7-I	ENSG00000126067	"Proteasome 20S subunit beta 2"	P49721	1	35599541-35641526	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm		NA	NA		9700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (3.54e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.49e-7)"	"unprognostic (2.81e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.80e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	26.4	29.3	10.0	13.9	10.3	21.7	25.0	9.7	11.6	23.6	9.4	24.3	12.9	26.9	11.5	31.8	21.9	9.1	27.3	10.6	10.4	22.6	45.9	25.6	15.8	9.9	9.7	21.0	25.2	11.3	19.6	15.2	11.0	20.0	12.7	12.1	22.3	10.8	63.1	30.9	23.2	13.4	9.9	25.4	24.2	15.6	9.5	20.5	18.7	14.8	16.7	22.9	23.9	11.8	68.8	42.4	45.5	32.2	23.3	27.9	55.5	31.8	36.6	63.2	51.1	51.6	79.3	68.8	71.3	37.6	38.6	41.2	59.3	53.4	54.5	54.5	54.1	63.4	44.5	50.1	41.4	66.1	34.7	30.4	33.4	77.0	36.8	25.9	50.8	54.1	76.6	37.7	41.9	30.7	85.5	50.1	59.3	29.7	44.0	52.3	47.5	48.7	45.3	35.9	39.8	30.1	36.0	34.5	52.1	50.3	24.9	29.3	35.2	32.0	37.5	30.9	76.5	31.8	55.0	66.9	49.9	70.4	55.6	20.5	23.6	18.2	19.6	30.3	19.9	22.3	19.3	20.6	26.4	18.5	14.0	17.3	8.8	23.6	35.4	27.4	26.3	26.1	10.0	10.3	9.7	11.6	10.6	10.4	9.9	9.7	11.0	9.9	9.5	11.8	110.8	64.1	68.9	6.2	80.4	111.1	145.2	298.5	50.7	48.0	65.8	95.1	59.8	67.2	145.0	66.2	16.7	406.6	83.6	72.4	144.8	286.2	118.0	95.4	78.8	115.9	98.3	78.7	20.8	227.3	341.0	101.3	61.2	75.9	35.4	109.6	85.6	158.1	222.6	58.9	20.9	96.9	187.2	92.7	70.3	22.8	100.6	94.1	76.5	15.9	184.1	68.4	87.6	17.1	23.4	252.0	76.6	91.4	141.7	186.0	108.5	221.7	126.8	50.4	92.1	66.8	291.4	224.4	144.0	80.4	111.5	442.1	81.4	123.9	111.7	178.9
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome 20S subunit beta 4"	P28070	1	151399560-151401937	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006700, HPA073499"	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA		12000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA006700: AB_1079704, HPA073499: "	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	189.5	242.7	200.2	156.7	202.1	172.9	174.2	210.6	212.4	167.0	201.9	194.3	150.0	195.5	225.6	170.4	178.3	139.1	241.8	201.7	212.9	196.6	269.5	143.2	214.0	206.8	203.9	179.5	164.0	218.6	168.0	187.1	211.7	162.4	166.4	94.3	169.6	190.6	299.1	186.6	152.8	191.7	210.5	173.8	171.8	69.0	205.8	233.5	156.1	237.5	235.4	196.7	151.3	218.4	428.3	451.9	373.0	447.8	412.9	392.3	507.8	247.6	549.2	719.3	503.1	608.6	569.5	384.1	730.7	424.3	379.1	419.7	383.2	472.7	407.6	535.6	391.1	268.6	320.8	463.3	444.4	377.0	355.7	431.7	444.8	672.5	276.2	364.8	506.1	419.1	434.3	740.0	512.7	1174.2	463.5	452.0	952.8	638.6	576.2	433.8	266.9	688.2	594.4	354.2	408.6	488.0	283.6	626.5	879.8	459.1	564.1	594.6	320.7	310.4	326.1	333.8	557.0	726.9	902.5	769.1	459.5	337.8	667.8	291.8	343.4	227.0	265.0	342.2	314.8	293.6	303.7	301.0	421.7	257.5	260.4	272.8	251.5	347.3	270.5	468.1	405.1	395.2	200.2	202.1	210.6	212.4	201.7	212.9	206.8	203.9	211.7	210.5	205.8	218.4	72.2	153.8	127.4	10.1	82.2	76.6	81.9	131.5	82.0	56.3	62.0	71.6	128.0	68.6	123.2	71.7	16.7	209.8	79.7	87.8	103.7	127.9	16.0	118.1	107.5	97.7	66.4	87.1	10.4	195.8	146.7	91.9	47.4	110.0	111.1	81.1	92.8	151.7	125.0	48.8	11.5	80.5	89.5	108.1	88.8	15.6	104.4	89.4	96.0	12.2	186.2	89.5	64.9	6.6	14.7	131.7	75.0	105.3	89.1	75.5	117.5	148.9	141.5	62.8	65.7	86.0	127.5	54.5	49.7	80.0	75.9	267.3	80.2	124.5	96.0	89.1
PSMB5	MB1	ENSG00000100804	"Proteasome 20S subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1146.8"	"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		6200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	84.0	116.0	129.1	58.7	134.2	32.0	81.0	141.4	134.3	71.3	141.1	80.8	61.1	71.0	129.5	102.3	93.3	61.0	136.8	136.4	141.1	98.5	119.1	64.7	49.0	137.9	138.4	61.6	80.9	143.5	80.1	90.1	145.2	76.8	88.7	59.7	73.5	78.6	332.4	76.0	53.0	103.4	141.3	50.3	81.0	57.8	136.5	79.5	72.3	274.1	68.6	92.1	68.4	146.5	181.0	398.9	250.6	245.5	360.4	318.9	261.8	252.0	307.3	446.1	376.1	329.2	282.2	228.0	228.1	352.1	298.4	239.7	428.4	320.2	401.9	139.9	311.4	146.9	260.3	1146.8	287.3	170.2	162.1	354.2	292.0	331.8	264.1	289.7	475.5	190.5	218.6	121.5	376.0	557.2	97.6	218.4	285.7	341.6	631.4	133.8	197.7	150.7	349.9	256.6	336.0	251.0	179.9	354.8	245.4	322.2	175.0	217.7	254.1	212.4	210.1	197.3	247.8	99.7	218.4	158.8	164.9	140.8	274.6	97.8	127.6	58.0	89.4	125.6	103.5	103.8	101.1	85.1	137.6	99.7	135.0	102.5	48.1	67.4	92.7	172.4	91.3	147.8	129.1	134.2	141.4	134.3	136.4	141.1	137.9	138.4	145.2	141.3	136.5	146.5	94.2	76.9	69.2	16.0	47.3	140.2	174.1	461.5	100.7	61.0	130.4	135.5	157.6	112.9	240.4	95.6	29.2	400.1	40.2	75.0	275.9	277.7	93.0	149.0	109.5	150.0	154.6	82.5	17.6	231.3	435.2	139.9	73.9	88.0	31.0	162.6	89.6	171.6	221.6	70.7	18.0	109.2	329.6	57.5	80.9	106.4	118.7	64.0	115.6	15.9	138.2	170.8	25.7	11.6	29.4	285.7	88.0	122.2	78.2	185.1	81.2	437.8	268.9	71.8	98.6	87.1	355.1	174.4	81.6	144.7	157.1	430.2	43.4	215.7	148.9	215.3
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome 20S subunit beta 6"	P28072	17	4796144-4798502	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: AB_2685078"	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	92.7	107.8	130.1	82.2	133.7	126.9	107.0	138.1	141.2	92.6	137.4	116.3	76.9	101.9	150.9	140.6	99.2	68.3	201.6	132.8	138.1	134.8	184.6	86.2	90.1	135.7	134.1	63.7	99.3	173.3	82.5	119.8	138.7	84.8	118.3	62.6	100.0	114.2	358.6	114.9	77.0	135.3	136.0	90.4	103.8	76.6	133.5	147.4	88.7	339.5	140.5	110.6	89.2	140.3	279.8	478.2	251.6	216.4	209.9	188.1	289.7	144.1	300.1	431.3	336.0	358.7	220.5	215.0	277.9	348.1	246.5	273.8	388.0	404.4	418.0	281.9	409.7	128.0	315.3	422.7	242.0	133.5	194.4	178.3	305.1	377.4	355.7	241.5	426.5	335.8	199.4	316.6	336.1	331.8	237.4	221.8	214.1	356.2	328.2	261.9	178.7	284.6	326.6	185.3	146.9	179.9	206.6	158.9	148.6	261.4	194.5	147.2	205.1	210.8	158.9	286.4	355.2	130.8	191.8	132.9	301.3	242.1	259.3	410.6	603.3	343.2	347.5	589.9	355.9	668.6	373.1	384.0	624.9	640.8	319.8	329.3	210.5	424.4	549.4	585.5	556.2	817.2	130.1	133.7	138.1	141.2	132.8	138.1	135.7	134.1	138.7	136.0	133.5	140.3	156.3	134.6	113.3	8.5	118.3	229.2	184.1	410.8	112.1	65.5	124.6	153.4	454.8	141.5	253.9	134.3	16.7	587.3	142.8	178.0	358.1	321.6	245.2	110.9	108.1	164.7	148.4	183.7	7.6	349.9	418.2	171.5	105.5	116.0	105.2	156.1	99.6	235.4	346.3	32.0	7.2	173.0	311.3	111.7	272.1	52.9	109.6	159.8	236.5	4.7	298.9	183.4	109.2	9.0	16.9	351.3	163.4	123.0	244.7	191.7	188.6	564.6	193.3	81.3	111.7	119.8	486.8	175.1	84.7	178.6	277.2	664.5	125.9	172.6	177.7	217.3
PSMB7	Z	ENSG00000136930	"Proteasome 20S subunit beta 7"	Q99436	9	124353465-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		2100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA052408: AB_2681820, HPA054902: AB_2682635"	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	115.7	180.4	129.4	103.9	136.9	189.7	122.6	132.7	144.8	99.8	119.6	103.5	98.7	102.9	147.0	139.1	94.6	87.2	212.0	135.8	137.0	150.9	222.9	91.4	112.7	138.2	139.5	101.6	142.2	143.4	74.7	120.2	138.2	94.8	107.8	81.0	114.3	75.0	277.8	166.2	98.3	92.7	131.5	91.7	115.3	155.2	137.8	147.6	91.3	205.3	124.6	110.5	104.2	135.0	344.4	411.7	275.8	336.4	190.4	224.8	396.1	325.3	447.6	461.7	315.1	546.3	327.1	389.2	256.8	307.4	457.2	480.2	346.7	345.4	420.0	375.0	299.3	245.3	673.3	460.0	428.5	491.6	234.3	270.8	299.6	483.7	478.5	355.1	394.3	345.5	507.9	269.8	362.4	600.0	355.9	329.5	409.7	519.6	581.5	309.8	411.4	457.2	331.5	221.9	323.7	263.6	310.4	394.0	498.4	268.7	454.8	212.7	315.9	297.5	240.7	384.9	499.0	289.9	873.7	394.9	498.1	297.8	429.1	162.7	201.5	154.5	128.3	211.4	138.9	177.8	145.7	142.5	221.1	159.7	138.2	135.9	87.0	185.3	206.8	187.5	226.0	264.8	129.4	136.9	132.7	144.8	135.8	137.0	138.2	139.5	138.2	131.5	137.8	135.0	73.1	76.9	77.6	26.1	88.0	194.1	184.4	309.1	39.9	41.5	113.9	97.5	147.3	134.4	150.0	69.9	22.9	441.4	83.0	146.9	330.6	351.3	404.6	105.7	93.8	123.8	141.2	93.8	38.4	392.7	356.7	112.3	52.5	90.3	104.6	130.8	107.1	277.3	237.2	33.7	31.9	162.5	160.7	122.1	148.4	472.8	139.1	92.5	199.3	33.7	168.5	119.7	113.3	30.7	44.8	393.6	143.7	125.3	69.9	158.0	173.6	484.7	135.7	61.6	85.5	133.8	221.2	330.6	190.4	60.4	218.9	488.7	81.4	135.8	181.2	201.3
PSMC1	"p56, S4"	ENSG00000100764	"Proteasome 26S subunit, ATPase 1"	P62191	14	90256527-90275429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 308.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 593.2;Late spermatids: 549.5;Syncytiotrophoblasts: 469.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000872, HPA016885"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA000872: AB_1079705, HPA016885: "	"unprognostic (4.10e-1)"	"unprognostic (9.70e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-2)"	76.7	61.3	47.6	48.0	50.3	86.3	64.9	50.8	63.3	51.7	47.6	72.4	35.7	67.3	71.6	71.5	53.4	37.5	114.9	49.5	53.6	62.2	83.3	55.0	49.5	50.5	51.3	45.6	52.7	69.3	37.0	69.6	53.0	49.7	60.4	40.1	55.3	57.5	308.0	74.1	54.5	61.5	49.4	57.5	61.1	82.2	50.3	62.5	48.1	142.5	72.2	64.7	54.1	50.8	141.6	131.1	147.5	154.8	126.6	115.4	154.9	133.5	185.7	287.9	215.4	122.3	154.7	119.4	198.4	162.3	132.2	142.8	182.2	155.8	334.2	143.9	80.0	93.8	84.6	105.9	109.1	143.7	120.4	104.3	120.7	187.9	137.1	120.2	176.2	130.3	134.8	69.9	200.6	267.9	108.0	186.7	130.6	180.7	160.4	127.5	190.8	97.6	163.0	144.6	154.6	103.2	109.0	279.6	118.0	121.8	175.9	125.2	134.9	110.1	98.8	119.6	196.3	120.0	204.3	178.3	159.8	129.1	172.1	95.1	101.4	160.1	67.1	93.7	66.4	57.7	68.5	69.0	101.1	56.8	62.5	60.7	109.9	82.0	110.7	70.8	101.2	116.5	47.6	50.3	50.8	63.3	49.5	53.6	50.5	51.3	53.0	49.4	50.3	50.8	63.1	102.5	80.4	11.4	51.4	65.0	90.3	175.3	30.1	51.3	48.6	45.7	39.2	88.6	136.0	55.2	52.1	304.2	48.2	91.2	119.3	180.8	593.2	68.9	56.1	90.1	57.0	80.6	21.0	197.7	178.9	71.4	30.1	70.1	98.2	82.4	75.7	196.6	150.2	79.1	21.2	68.7	111.9	91.8	82.2	549.5	76.4	74.7	67.6	14.0	146.0	88.1	72.1	10.6	22.3	210.3	71.5	82.0	50.7	75.5	104.2	160.4	123.9	65.8	85.5	67.5	139.5	198.1	48.7	44.1	50.2	469.4	55.4	82.5	74.4	92.7
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	85.3	86.1	106.8	64.7	117.3	96.1	77.9	105.3	131.0	73.7	105.8	110.2	52.2	89.9	62.5	88.7	69.0	44.0	172.1	107.8	106.3	73.8	117.7	76.2	65.3	108.6	114.7	58.2	81.4	74.1	55.4	78.8	111.0	74.2	59.1	30.9	73.0	69.8	292.0	103.4	64.0	77.5	104.6	67.8	87.7	74.7	115.2	90.6	69.4	162.9	76.5	80.8	71.7	107.0	223.7	248.2	233.5	173.3	109.6	117.3	226.5	181.5	267.4	445.7	313.8	223.3	126.8	179.5	110.1	230.1	195.7	218.3	206.7	237.7	199.0	269.4	268.1	173.1	301.1	218.5	141.4	203.7	177.0	131.4	126.1	181.6	202.5	98.4	253.8	182.7	249.2	164.7	276.0	497.0	259.5	258.4	229.5	280.7	296.1	269.3	458.8	157.3	209.5	165.2	170.0	147.1	148.7	206.9	116.2	98.2	255.7	209.8	181.3	253.7	321.1	363.8	474.7	176.5	220.0	209.2	262.4	201.7	325.1	111.5	154.3	121.8	160.8	194.6	146.7	146.8	132.9	147.8	160.6	122.4	116.5	118.6	33.9	173.3	211.6	160.0	191.0	254.7	106.8	117.3	105.3	131.0	107.8	106.3	108.6	114.7	111.0	104.6	115.2	107.0	81.5	57.7	42.0	3.9	59.5	86.3	112.8	198.5	50.7	41.2	61.4	64.1	217.6	81.5	103.7	68.0	16.7	265.9	60.0	143.9	152.6	199.2	152.5	72.0	75.7	96.0	64.5	136.6	6.4	202.6	257.9	100.4	54.0	70.1	75.3	79.2	77.1	144.2	158.2	37.0	5.3	111.5	75.3	62.4	80.0	217.6	88.6	62.5	99.6	1.9	132.0	120.2	74.2	3.0	5.2	214.2	110.8	100.1	96.3	102.8	127.7	191.3	76.9	47.4	118.3	75.1	193.3	147.0	63.6	51.3	77.3	352.9	61.8	74.1	117.6	101.6
PSMC3IP	"GT198, Hop2, HUMGT198A, TBPIP"	ENSG00000131470	"PSMC3 interacting protein"	Q9P2W1	17	42572310-42577831	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA recombination, Meiosis"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 113.3;Spermatogonia: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA044439	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA044439: AB_10964210"	"unprognostic (2.98e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-7)"	"unprognostic (6.22e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (9.41e-4)"	"unprognostic (6.03e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.82e-1)"	3.3	1.4	8.3	2.5	8.9	8.2	3.8	8.7	10.3	3.5	7.9	4.2	1.3	3.7	3.8	3.0	6.2	1.4	1.8	7.8	8.5	2.8	0.8	2.3	3.9	9.4	8.9	3.4	2.1	7.6	1.5	4.2	9.2	3.6	3.0	7.3	1.5	3.9	1.5	3.1	1.6	5.2	9.0	1.9	2.4	23.7	8.8	7.4	1.8	2.3	5.5	2.9	2.9	8.9	21.1	29.0	48.3	34.9	11.0	15.0	11.0	80.4	23.7	63.4	78.3	28.6	12.9	21.1	17.6	22.2	27.6	29.9	36.9	28.8	73.0	31.0	30.0	13.5	66.1	35.0	1.6	46.3	14.4	5.3	6.4	101.5	34.2	9.4	18.8	28.3	44.5	38.2	56.6	21.8	33.3	28.0	30.0	23.9	26.8	32.3	50.7	20.6	14.8	16.6	65.1	40.6	32.1	11.8	34.7	24.3	28.3	20.3	8.8	70.5	41.1	55.2	128.6	30.0	54.1	30.8	32.8	21.2	79.7	0.0	0.0	0.9	0.7	0.2	0.9	1.1	0.4	0.7	0.0	0.3	0.1	0.4	0.9	0.1	0.3	2.8	0.7	0.1	8.3	8.9	8.7	10.3	7.8	8.5	9.4	8.9	9.2	9.0	8.8	8.9	6.0	3.2	3.7	2.3	6.4	5.4	2.7	3.7	0.0	5.9	4.8	5.2	0.9	4.3	2.8	3.7	10.4	15.6	3.7	1.4	0.0	4.5	12.8	11.1	5.8	4.4	0.0	19.8	1.1	3.3	19.1	5.5	1.5	5.0	1.3	7.7	2.9	2.2	7.4	0.0	1.2	1.2	4.1	3.0	2.6	13.1	5.3	2.4	5.4	2.8	5.8	4.6	3.1	1.0	1.5	2.0	0.3	8.6	6.5	2.0	0.2	2.2	14.9	13.9	19.7	8.6	16.0	113.3	44.6	3.2	4.1	5.2	2.7	2.5	2.5	1.7
PSMC4	"MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7"	ENSG00000013275	"Proteasome 26S subunit, ATPase 4"	P43686	19	39971165-39981764	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002044, HPA005471"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002044: AB_1079707, HPA005471: AB_1855838"	"unprognostic (1.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-1)"	41.3	54.8	21.8	21.0	22.5	14.5	38.2	24.1	24.8	38.0	21.3	41.6	20.4	50.9	26.9	54.8	38.2	16.7	58.9	22.9	25.4	48.4	69.1	35.9	18.2	24.1	23.5	32.0	32.5	30.9	37.1	19.3	25.8	35.2	19.0	13.8	36.5	20.3	112.7	48.1	39.0	20.8	24.6	40.3	43.6	43.2	22.7	22.3	41.1	30.2	23.1	41.6	38.0	26.1	68.7	221.3	43.8	53.5	38.0	31.3	47.0	38.6	50.4	87.0	66.4	129.0	46.8	33.0	72.7	49.2	50.5	35.6	61.6	52.7	72.1	60.6	63.0	46.9	39.2	110.4	52.5	52.2	54.7	31.3	46.0	69.1	48.6	25.8	60.5	42.3	63.0	48.5	57.2	108.3	62.4	32.1	80.5	88.3	66.8	54.6	49.7	48.2	64.3	105.7	56.9	74.8	42.3	69.3	38.9	41.9	47.8	45.5	36.2	53.2	54.9	52.2	97.1	62.2	114.6	51.9	69.7	54.0	62.8	38.0	41.5	33.5	44.8	64.8	39.0	35.8	39.8	46.6	66.9	34.7	32.6	32.8	22.3	43.8	89.8	34.8	59.8	61.9	21.8	22.5	24.1	24.8	22.9	25.4	24.1	23.5	25.8	24.6	22.7	26.1	52.5	32.1	19.8	8.1	53.6	64.0	84.8	191.9	40.9	50.1	31.2	31.9	38.1	52.9	96.2	44.1	14.6	174.7	53.7	119.7	92.0	143.3	203.9	70.3	46.3	63.2	59.2	48.8	8.5	110.9	118.9	55.8	53.5	57.1	41.2	41.9	29.6	50.9	163.7	42.1	8.5	41.7	126.1	42.7	66.3	120.0	55.0	57.4	44.4	12.2	91.6	59.5	63.8	6.6	10.7	127.0	103.1	70.0	58.3	65.4	95.2	179.2	88.0	49.9	92.1	49.0	152.1	114.6	45.7	44.7	58.2	399.5	57.5	69.5	69.1	79.8
PSMC6	p42	ENSG00000100519	"Proteasome 26S subunit, ATPase 6"	P62333	14	52707178-52728590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042823	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042823: AB_2678188"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.14e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.67e-1)"	43.4	48.4	38.8	47.3	39.2	44.1	58.1	41.2	54.0	44.0	37.4	52.2	50.0	47.6	49.2	65.1	49.2	36.5	78.7	39.8	42.1	65.9	87.1	39.6	55.4	41.1	41.0	51.0	43.7	59.9	5.5	54.9	42.0	45.3	54.3	60.1	37.9	45.6	118.1	44.6	46.6	56.8	41.5	38.8	46.5	31.4	41.0	56.3	54.3	106.7	67.0	57.2	7.9	44.1	182.0	115.0	135.4	99.0	92.4	95.8	146.0	139.3	133.1	220.8	165.1	142.6	143.5	156.8	169.8	121.6	111.5	134.0	173.9	121.9	230.6	151.2	74.5	115.0	91.3	153.5	111.0	164.9	106.8	71.8	118.4	112.1	111.6	120.1	141.2	77.4	174.2	64.7	161.8	163.2	129.5	111.8	108.7	170.1	153.8	108.4	237.2	70.7	144.6	178.5	96.0	71.2	123.8	76.5	122.3	120.8	156.4	117.0	108.9	121.2	171.0	95.8	145.2	45.6	127.0	175.8	79.1	110.5	112.9	77.5	62.4	67.0	51.2	71.9	59.5	63.4	62.7	56.4	73.9	56.4	59.6	59.0	52.7	55.6	73.0	38.5	85.4	75.4	38.8	39.2	41.2	54.0	39.8	42.1	41.1	41.0	42.0	41.5	41.0	44.1	81.2	70.5	58.9	23.5	74.2	86.2	141.9	187.1	50.1	65.5	55.3	51.3	76.6	62.9	140.6	57.0	68.8	162.2	69.4	73.5	135.0	131.0	30.4	92.8	75.3	78.2	70.4	85.2	37.4	106.9	139.9	72.1	38.7	96.3	67.7	68.7	50.0	84.4	92.1	62.2	39.0	58.9	109.9	71.3	67.9	19.9	67.1	61.4	80.0	20.6	90.9	64.6	52.5	38.2	46.7	116.2	46.2	65.5	64.0	85.2	72.5	140.2	116.4	107.6	72.3	66.5	130.6	63.4	82.8	48.9	72.0	237.5	65.0	79.7	73.4	116.6
PSMD1	"P112, Rpn2, S1"	ENSG00000173692	"Proteasome 26S subunit, non-ATPase 1"	Q99460	2	231056845-231173116	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021092, HPA036736, HPA036737"	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA		230000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Actin filaments"	"CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279"	"unprognostic (9.32e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (8.63e-12)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.70e-3)"	37.3	38.2	21.9	31.7	26.1	20.1	29.0	21.9	33.7	26.3	20.9	34.8	35.5	37.4	25.6	41.5	24.3	20.3	51.3	27.5	28.5	34.1	42.1	27.0	28.8	26.9	24.9	19.2	17.3	72.7	32.9	36.8	28.3	29.7	36.8	25.4	25.8	33.4	136.3	34.9	29.3	44.9	24.5	25.2	27.9	29.0	24.5	36.6	27.4	81.6	38.3	37.3	27.8	24.4	103.9	113.1	120.6	93.8	122.2	88.7	115.4	135.3	139.4	133.4	134.0	136.5	97.6	80.0	123.3	150.5	138.0	95.0	169.4	125.0	174.3	124.3	93.3	148.7	81.6	155.5	62.9	133.3	119.4	76.5	57.8	142.4	73.9	73.4	159.6	70.3	212.1	56.8	158.7	100.3	103.0	68.3	157.8	100.1	89.3	86.0	190.4	77.7	96.5	104.0	78.8	74.1	108.7	94.1	65.7	120.6	75.3	74.7	152.3	101.4	110.8	126.0	129.8	48.6	80.2	140.4	162.7	100.0	123.4	34.6	27.8	18.8	25.1	39.0	27.3	21.0	25.8	23.8	30.9	17.2	19.2	22.9	12.5	35.9	42.5	18.9	32.3	25.7	21.9	26.1	21.9	33.7	27.5	28.5	26.9	24.9	28.3	24.5	24.5	24.4	51.9	51.3	48.5	77.7	32.9	33.1	37.7	57.0	19.9	46.4	23.0	25.8	125.4	31.5	53.0	33.1	41.7	119.2	27.0	63.6	17.6	83.9	6.2	51.2	67.5	51.7	39.4	61.6	100.0	102.2	101.4	54.6	42.3	60.9	103.9	67.8	30.0	86.9	72.3	90.9	96.0	30.0	57.0	44.2	23.5	9.9	34.8	49.8	17.8	54.4	62.6	46.6	29.9	67.3	93.1	98.6	26.2	45.9	49.4	46.5	46.9	32.1	66.9	53.2	72.3	54.6	128.2	247.9	158.8	39.2	33.1	167.5	36.6	65.5	42.9	38.8
PSMD11	"MGC3844, p44.5, Rpn6, S9"	ENSG00000108671	"Proteasome 26S subunit, non-ATPase 11"	O00231	17	32444379-32483319	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 308.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042275, HPA067433"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		95000	"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA042275: AB_10794793, HPA067433: AB_2685838"	"unprognostic (1.16e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.64e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (9.39e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.17e-2)"	26.9	26.5	25.6	29.4	26.4	34.5	22.6	24.6	29.5	22.8	20.3	27.3	27.2	28.8	23.1	36.3	21.8	22.7	37.0	26.0	25.6	30.1	37.7	24.3	30.2	27.0	25.3	20.6	25.9	35.0	18.5	34.1	28.1	25.0	32.0	23.8	23.3	21.8	96.0	33.8	23.2	35.0	24.4	24.0	22.9	34.2	25.9	38.4	21.6	58.6	39.1	34.0	24.8	31.2	127.0	136.8	98.4	106.2	65.4	48.4	103.8	71.5	90.0	151.9	122.0	139.9	111.5	99.1	110.7	77.0	145.9	143.0	114.5	98.5	147.8	50.9	81.2	81.0	68.7	108.3	63.3	95.5	81.6	43.7	51.0	134.3	91.8	49.0	108.7	87.0	155.5	110.9	90.8	78.0	143.1	57.4	134.5	67.4	68.8	89.2	127.2	132.4	75.2	92.2	86.3	58.8	89.8	63.4	71.0	100.3	154.2	45.1	77.8	84.3	99.5	105.6	166.5	62.2	105.0	129.1	122.5	74.8	145.2	48.3	41.2	26.7	40.2	41.8	44.2	36.3	39.1	40.6	46.6	34.2	34.5	36.4	19.1	47.7	45.6	38.2	51.5	45.6	25.6	26.4	24.6	29.5	26.0	25.6	27.0	25.3	28.1	24.4	25.9	31.2	62.7	48.1	31.5	36.6	56.3	126.9	108.7	116.3	44.9	44.5	47.8	40.8	71.9	41.5	78.0	25.8	31.3	178.2	57.8	87.5	80.3	117.8	205.4	45.8	46.2	69.7	48.8	100.8	36.0	107.3	146.1	63.8	43.8	59.9	45.7	79.8	55.3	107.0	92.3	37.0	36.4	58.7	77.3	48.4	72.6	48.0	49.0	61.1	26.6	15.9	77.5	63.1	40.2	33.2	55.6	117.2	48.0	48.5	79.3	131.9	66.4	120.6	52.6	43.3	52.6	68.0	189.7	152.7	98.4	85.3	117.5	308.9	54.8	52.0	67.6	109.5
PSMD12	"p55, Rpn5"	ENSG00000197170	"Proteasome 26S subunit, non-ATPase 12"	O00232	17	67337916-67366605	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023119	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		73000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Nucleoplasm, Cytosol"	"HPA023119: AB_1855845"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.63e-1)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (1.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	14.8	13.9	11.2	11.4	12.2	12.5	11.9	15.0	19.4	9.4	9.7	10.4	8.2	10.5	10.9	12.5	7.6	9.7	13.7	12.6	17.2	14.9	28.0	9.4	10.8	17.8	17.8	9.1	15.6	14.8	7.6	11.0	18.9	10.7	11.6	8.9	10.0	7.7	35.8	10.3	8.7	11.3	12.9	9.4	11.2	14.4	16.0	12.1	10.3	29.1	15.1	14.7	8.0	12.5	63.8	38.5	29.2	32.2	21.9	26.3	40.6	44.2	27.9	47.8	42.0	40.4	27.4	36.6	28.0	35.9	37.4	37.0	51.1	45.1	70.7	17.8	38.5	43.2	29.9	41.1	28.6	44.7	25.0	29.6	29.4	45.3	35.2	21.2	47.6	27.8	57.4	21.0	45.0	43.5	41.0	42.6	35.7	30.0	50.1	20.9	75.6	32.5	36.1	52.0	28.0	40.6	32.9	62.6	45.2	34.1	45.0	36.9	49.5	50.5	34.4	38.6	81.4	21.4	35.2	30.5	59.8	46.5	29.9	14.0	9.9	8.9	8.7	16.7	12.3	8.0	11.5	9.9	10.3	8.9	10.1	10.7	7.3	10.9	19.6	7.0	12.1	8.7	11.2	12.2	15.0	19.4	12.6	17.2	17.8	17.8	18.9	12.9	16.0	12.5	59.6	48.1	58.8	9.8	37.9	112.3	119.5	109.0	43.3	40.8	37.9	33.0	108.1	25.8	97.7	46.0	25.0	88.3	47.9	29.7	70.5	80.7	158.1	99.1	62.3	73.8	32.9	67.3	21.0	78.7	88.8	64.0	33.1	125.3	50.6	39.9	41.0	84.1	56.0	92.5	22.0	28.6	65.1	44.7	90.6	197.0	46.3	50.6	48.0	10.3	59.8	58.6	37.0	14.6	15.0	84.9	22.7	44.0	58.2	93.4	26.0	77.2	68.1	44.6	26.3	78.6	146.8	126.2	108.0	52.9	94.8	123.0	53.8	53.8	34.1	123.2
PSMD14	"pad1, POH1, Rpn11"	ENSG00000115233	"Proteasome 26S subunit, non-ATPase 14"	O00487	2	161308425-161411717	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002114, HPA003828"	Approved		Supported	Nucleoplasm		NA	NA		26000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA002114: AB_1855850, HPA003828: AB_2667057"	"unprognostic (3.50e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.61e-3)"	"prognostic unfavorable (2.66e-8)"	"unprognostic (3.11e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.84e-3)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.66e-1)"	35.2	38.3	38.6	39.7	40.0	38.8	36.4	42.5	47.5	26.2	36.7	35.2	29.1	24.7	30.1	40.7	27.3	23.7	44.6	40.7	43.3	44.4	48.4	26.9	37.8	42.1	41.7	14.5	25.6	51.1	21.4	42.0	43.7	31.0	41.0	37.9	20.8	29.9	98.0	33.2	26.4	39.6	43.8	22.9	27.2	38.7	41.1	49.7	34.7	76.0	52.0	42.5	19.6	46.6	170.3	145.8	158.8	140.8	113.9	97.0	194.2	173.6	168.2	246.1	198.6	216.2	140.2	200.2	258.0	128.7	144.3	126.5	176.8	185.6	244.6	210.3	133.1	200.8	110.8	245.9	139.7	196.7	113.8	74.4	138.8	277.4	256.8	94.0	185.5	117.1	222.1	139.6	207.7	164.1	145.0	148.0	220.5	124.3	218.2	123.6	154.4	196.0	218.6	145.0	138.4	101.3	117.8	131.7	167.5	131.4	90.2	124.3	147.2	162.7	152.4	111.6	193.8	82.5	242.7	186.7	174.1	129.6	182.2	47.4	48.2	25.2	65.3	69.6	68.7	64.2	69.4	71.0	75.4	57.4	55.4	66.5	4.9	70.2	56.2	74.5	83.7	73.3	38.6	40.0	42.5	47.5	40.7	43.3	42.1	41.7	43.7	43.8	41.1	46.6	40.1	51.3	38.2	35.3	49.4	49.5	48.1	146.8	25.0	43.7	40.2	36.2	89.8	52.9	80.3	23.9	18.8	159.5	60.4	47.7	90.1	124.3	82.5	52.4	51.8	49.9	52.5	56.2	64.0	118.3	154.6	48.1	29.6	58.4	51.2	59.0	31.8	125.3	104.7	47.1	56.1	53.5	118.0	41.1	40.0	36.0	27.7	46.1	48.0	25.3	61.1	87.7	44.3	50.3	64.6	155.0	48.0	34.3	60.2	57.0	36.5	106.1	55.4	60.6	32.9	36.6	64.5	137.0	77.7	34.3	56.0	220.3	47.8	63.6	64.5	50.8
PSMD3	"P58, Rpn3, S3, TSTA2"	ENSG00000108344	"Proteasome 26S subunit, non-ATPase 3"	O43242	17	39980807-39997959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 252.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 247.0;Syncytiotrophoblasts: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 842.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017038, HPA048972"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB017038: , HPA048972: AB_2680579"	"unprognostic (3.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.36e-3)"	"unprognostic (5.75e-3)"	"unprognostic (7.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (4.47e-7)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.45e-2)"	56.5	64.2	44.5	47.6	45.4	48.1	53.6	44.1	50.0	54.6	40.7	60.3	43.3	61.8	35.0	69.6	51.6	25.3	76.5	47.4	47.0	47.8	93.6	51.0	45.7	45.9	43.0	52.7	57.1	55.4	48.3	47.4	48.0	47.7	46.1	31.3	54.2	37.2	252.5	86.1	48.9	45.2	42.9	49.3	52.7	52.9	44.2	56.9	45.9	103.3	51.1	53.6	53.2	46.6	203.7	247.8	133.2	192.9	106.3	68.2	158.3	146.2	150.7	257.3	198.3	206.4	170.0	242.3	357.7	157.6	172.5	310.2	238.6	190.7	172.9	245.5	266.2	140.4	120.5	207.2	96.5	191.3	151.0	91.5	160.0	272.7	118.8	86.4	147.6	166.0	291.5	146.9	121.2	148.0	298.2	131.2	185.5	130.9	145.2	216.2	184.7	227.7	130.5	135.3	174.9	132.5	139.7	842.6	124.3	160.9	190.2	162.7	132.9	110.7	195.8	165.6	266.2	158.2	217.2	269.3	169.4	142.2	182.6	8.1	22.4	19.0	17.6	21.3	17.2	16.6	17.0	20.4	29.8	17.7	15.3	19.1	6.3	16.6	18.3	20.4	16.3	17.9	44.5	45.4	44.1	50.0	47.4	47.0	45.9	43.0	48.0	42.9	44.2	46.6	32.4	44.8	40.1	16.6	43.3	46.7	57.2	71.5	33.0	70.8	31.7	25.7	21.3	15.7	48.6	16.5	20.9	165.3	38.0	98.3	46.9	101.4	247.0	30.7	35.9	46.5	26.4	44.6	18.0	106.3	131.6	50.6	34.7	28.5	25.3	70.2	32.2	50.9	96.3	60.6	17.6	59.2	69.2	27.4	37.0	51.8	62.7	39.1	65.8	4.7	57.4	89.9	35.0	11.1	16.5	101.4	68.3	54.2	57.2	76.3	75.3	54.8	32.0	56.9	26.3	51.1	50.7	87.3	54.0	38.7	44.6	271.7	32.4	78.8	77.2	53.7
PSMD4	"AF, AF-1, Rpn10, S5A"	ENSG00000159352	"Proteasome 26S subunit, non-ATPase 4"	P55036	1	151254709-151267479	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038807, HPA039252, CAB047300"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		69000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418"	"unprognostic (3.83e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (6.66e-10)"	"unprognostic (9.80e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.91e-1)"	108.8	118.0	198.8	77.8	203.8	89.4	97.9	203.0	288.1	88.7	195.2	136.9	68.9	99.5	114.3	115.5	91.0	58.2	191.2	202.8	205.8	110.2	170.5	81.7	95.7	208.5	215.3	85.8	114.0	91.6	79.4	91.1	209.3	91.3	82.1	64.5	83.9	86.4	404.1	103.3	91.3	91.0	204.2	109.6	115.4	152.0	203.7	114.3	76.7	188.0	114.0	118.6	88.2	203.4	251.4	294.8	213.4	175.2	227.4	167.0	231.9	166.0	202.1	258.6	205.1	388.3	278.2	202.2	396.2	235.4	178.7	255.4	277.1	250.6	219.6	331.9	236.6	197.8	256.2	396.6	250.8	234.7	220.5	182.5	204.2	296.3	271.4	193.3	229.5	222.4	313.6	247.9	220.2	723.5	217.4	276.7	406.0	384.3	293.4	181.6	207.7	364.7	252.7	210.6	166.7	283.8	184.5	266.3	222.7	313.0	278.9	452.3	203.4	128.1	201.2	159.2	288.2	295.1	397.7	430.3	212.6	218.1	238.7	439.4	439.0	713.9	247.3	478.1	281.2	399.0	287.4	274.4	398.4	426.1	261.0	258.1	580.2	351.2	502.3	240.3	476.6	651.0	198.8	203.8	203.0	288.1	202.8	205.8	208.5	215.3	209.3	204.2	203.7	203.4	90.1	57.7	62.9	15.7	78.5	88.6	111.9	249.0	58.1	50.9	60.9	69.3	245.2	82.9	125.0	60.7	27.1	328.6	74.0	104.1	168.3	177.3	279.1	91.5	63.0	95.8	84.2	107.3	25.3	186.9	234.1	88.5	46.9	59.1	83.6	88.8	83.2	116.0	184.5	33.7	24.2	94.1	156.6	104.0	98.0	243.2	105.3	90.3	104.9	11.2	256.6	91.9	115.4	16.1	23.2	172.2	129.1	98.6	67.0	121.4	168.6	206.6	148.3	54.6	118.3	79.0	221.1	234.8	83.5	66.7	86.5	414.6	77.7	105.6	114.5	107.2
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842951	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol		No	No		250000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	15.0	16.5	8.8	13.4	8.4	20.4	23.4	12.0	9.8	15.9	8.5	14.5	12.6	16.4	13.9	16.6	14.1	12.5	9.4	8.4	10.2	13.5	20.5	14.6	15.9	9.3	9.4	15.2	14.3	10.7	9.8	12.7	9.5	18.1	14.3	11.7	17.9	14.3	9.1	19.7	12.5	18.6	8.9	12.0	14.3	13.8	9.7	14.5	14.3	11.2	19.0	17.1	12.1	12.8	35.0	44.3	20.7	38.6	44.9	44.1	24.4	49.4	38.1	45.3	41.5	38.7	21.7	35.4	22.1	50.2	36.1	50.5	0.0	48.9	52.5	33.1	5.3	29.7	59.2	21.6	33.9	10.2	10.6	37.3	30.6	44.2	47.4	22.7	26.9	37.7	110.2	22.6	42.8	42.9	31.5	21.0	30.6	82.6	31.4	28.0	45.0	28.0	42.1	30.0	28.8	18.3	61.8	50.2	24.7	15.2	60.5	24.5	41.5	0.1	25.0	19.3	45.3	13.0	14.8	38.0	28.6	33.4	41.1	19.3	18.1	15.6	19.8	20.9	21.6	22.2	22.7	23.9	17.7	17.8	21.9	16.9	9.7	18.7	23.7	12.7	32.7	18.1	8.8	8.4	12.0	9.8	8.4	10.2	9.3	9.4	9.5	8.9	9.7	12.8	14.3	9.6	17.0	20.2	16.7	12.4	11.8	11.7	21.1	11.6	18.9	13.5	8.1	11.5	17.5	9.2	12.5	12.1	15.3	13.6	11.7	12.9	7.7	8.1	20.6	13.7	7.8	17.2	28.4	13.4	11.7	18.4	14.8	11.9	14.5	11.8	17.2	24.9	11.8	5.0	24.5	14.1	8.2	16.1	13.9	4.7	13.1	12.7	14.2	15.0	12.3	9.9	10.3	34.2	29.0	17.1	10.1	16.1	16.0	14.1	10.5	16.8	8.1	10.3	6.6	11.7	16.3	22.4	21.3	27.0	13.5	10.9	17.3	17.7	11.0	9.7
PSMD7	"MOV34, P40, Rpn8, S12"	ENSG00000103035	"Proteasome 26S subunit, non-ATPase 7"	P51665	16	74296814-74306288	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 596.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019379, HPA049824, HPA056069"	Enhanced		Enhanced	Nucleoplasm		NA	NA		190000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025"	"unprognostic (4.75e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (6.64e-5)"	"prognostic unfavorable (7.71e-6)"	"unprognostic (1.97e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-2)"	68.9	78.8	51.6	52.1	52.9	126.7	57.5	54.5	69.3	50.1	50.9	75.8	47.3	59.5	59.3	85.8	44.0	41.2	124.8	53.0	54.2	57.3	75.1	52.6	62.3	54.3	54.1	37.8	49.0	49.0	41.7	70.2	55.6	68.3	65.4	47.3	59.7	59.2	265.8	85.5	55.6	62.4	54.3	56.5	58.0	42.0	55.0	71.9	42.0	159.5	71.2	73.1	62.2	56.7	140.1	226.2	170.6	89.0	120.1	122.1	209.8	191.6	166.2	236.2	212.7	301.9	189.8	190.1	207.7	156.7	103.2	176.3	135.0	175.1	215.4	113.3	146.3	147.2	169.1	235.9	156.0	241.3	241.3	112.4	176.3	213.4	213.0	106.0	207.0	119.2	222.2	82.1	153.5	345.4	147.0	232.1	184.9	145.0	113.8	198.8	106.9	251.6	125.1	207.3	106.9	119.3	185.7	70.4	114.9	130.5	148.7	166.6	187.5	137.5	116.0	152.5	146.5	174.6	241.4	560.2	186.6	174.1	145.2	152.4	163.6	193.4	133.2	176.2	130.5	149.7	131.8	141.2	201.9	110.5	126.6	131.2	98.7	139.5	187.4	172.2	168.2	187.8	51.6	52.9	54.5	69.3	53.0	54.2	54.3	54.1	55.6	54.3	55.0	56.7	74.4	67.3	59.4	16.6	84.2	104.4	183.5	167.8	64.3	59.6	47.0	47.5	53.3	57.2	114.9	46.0	8.4	337.1	69.5	120.4	80.3	158.5	153.8	76.3	80.6	96.2	85.5	121.0	22.7	190.9	229.8	87.7	67.8	80.3	103.9	76.7	66.0	147.6	188.5	57.2	21.3	100.1	122.1	75.1	91.2	25.3	56.5	95.1	99.6	9.4	119.5	86.0	81.4	15.6	25.7	164.0	104.1	65.5	121.4	259.6	93.9	109.4	88.1	59.9	92.1	68.4	186.1	184.2	88.7	103.6	129.3	596.1	86.2	114.0	110.3	197.8
PSME2	PA28beta	ENSG00000100911	"Proteasome activator subunit 2"	Q9UL46	14	24143362-24147570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1063.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062661			Approved	Nucleoplasm		NA	NA		5900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA062661: AB_2684825"	"prognostic favorable (1.27e-4)"	"unprognostic (7.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.90e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.43e-3)"	"unprognostic (3.07e-3)"	81.3	204.5	25.7	86.6	26.0	42.8	79.7	25.5	40.1	93.7	28.8	104.6	165.9	68.6	48.6	112.5	75.0	30.6	105.3	25.7	28.2	142.0	228.1	107.9	89.6	30.7	26.5	71.7	102.1	27.7	123.7	30.7	27.5	94.1	79.2	18.1	84.0	33.8	63.7	72.6	152.9	44.0	28.1	204.6	101.6	56.9	28.7	52.1	92.2	26.6	80.2	74.0	80.6	27.8	95.2	93.2	59.5	140.6	42.8	59.9	85.6	47.7	108.4	145.7	182.4	72.7	183.9	111.0	30.7	59.8	166.5	79.1	32.1	92.0	87.6	198.6	28.9	75.2	45.8	277.1	135.9	103.4	100.1	61.2	26.3	115.1	44.1	65.6	79.3	78.2	37.2	165.2	61.5	188.6	204.2	140.0	19.8	142.3	112.1	189.2	93.2	119.2	108.9	209.4	36.8	47.7	101.6	168.8	70.3	31.0	89.0	110.7	63.4	80.7	75.1	38.2	102.5	143.7	215.1	140.7	52.9	110.0	99.7	110.3	605.5	217.5	421.1	1217.1	431.5	432.6	412.2	415.9	504.7	357.2	305.7	373.8	192.3	543.4	801.7	375.6	447.3	1562.7	25.7	26.0	25.5	40.1	25.7	28.2	30.7	26.5	27.5	28.1	28.7	27.8	185.3	51.3	113.7	5.2	198.5	154.9	174.3	754.8	126.3	39.7	104.5	120.8	69.5	140.2	287.7	117.7	22.9	296.6	223.6	316.1	299.3	370.5	12.6	113.0	147.3	159.7	98.0	74.2	1.7	567.1	296.6	128.6	132.5	109.9	141.5	83.4	69.7	236.6	332.1	28.6	2.2	288.5	319.4	143.7	224.9	15.5	74.0	237.8	136.9	2.8	763.7	69.8	326.5	2.5	1.3	303.1	324.5	77.8	389.3	282.8	1063.1	373.6	293.7	19.2	46.0	62.0	453.3	54.6	24.8	144.5	139.8	228.2	228.6	229.0	338.5	224.4
PSME3	"Ki, PA28-gamma, PA28G, REG-GAMMA"	ENSG00000131467	"Proteasome activator subunit 3"	P61289	17	42824385-42843760	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 253.8;Late spermatids: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008388, HPA012510"	Supported		Enhanced	Nucleoplasm		NA	NA		460000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB008388: AB_592552, HPA012510: AB_1855752"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (6.02e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	46.9	45.2	27.9	43.4	29.1	51.7	40.3	27.9	32.1	32.6	27.0	43.6	38.0	39.8	28.1	67.3	33.8	29.3	52.0	30.2	29.7	49.7	41.8	36.2	49.2	28.2	35.0	25.4	43.8	49.9	25.2	36.2	29.2	31.2	45.3	34.6	42.1	35.7	80.8	50.7	39.6	41.6	27.9	37.5	46.7	46.4	30.6	43.1	39.5	50.1	57.8	61.9	39.0	26.7	153.1	211.4	124.3	125.3	97.6	101.7	158.6	199.6	134.3	238.7	168.6	180.7	116.5	224.8	137.0	155.3	134.9	142.1	186.2	180.9	268.2	114.6	159.0	131.1	114.8	151.1	111.0	306.1	139.6	97.4	116.1	187.5	175.8	66.3	140.4	123.8	220.7	75.3	154.4	75.8	268.0	101.1	166.0	227.8	114.1	171.4	228.0	173.8	115.4	217.8	140.4	139.5	113.5	92.2	140.6	174.1	193.2	111.0	131.2	187.0	132.9	156.0	259.8	119.7	217.5	316.3	133.6	156.9	181.9	52.0	78.1	73.6	55.2	86.6	59.6	51.4	44.2	54.4	75.7	49.4	41.5	47.6	101.5	66.3	74.9	41.6	59.4	87.5	27.9	29.1	27.9	32.1	30.2	29.7	28.2	35.0	29.2	27.9	30.6	26.7	15.1	19.2	19.3	5.9	29.2	30.2	38.1	34.6	35.3	13.2	26.9	18.4	35.1	22.8	28.2	29.5	14.6	43.6	21.2	31.1	27.4	58.7	253.8	24.4	24.5	21.1	24.7	30.3	10.5	52.9	71.4	21.6	31.6	31.1	22.2	19.2	18.9	28.0	49.5	13.5	10.6	25.2	44.7	30.8	21.3	143.8	15.5	29.6	16.0	4.7	42.6	17.0	24.7	11.1	7.3	63.6	26.8	19.9	38.5	58.8	28.5	43.3	23.9	18.5	19.7	17.7	35.9	43.8	41.5	49.0	47.2	76.2	22.6	25.3	30.7	52.7
PSME3IP1	"C16orf94, FAM192A, NIP30, PIP30"	ENSG00000172775	"Proteasome activator subunit 3 interacting protein 1"	Q9GZU8	16	57152466-57186116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 82.3;Cytotrophoblasts: 56.7;Extravillous trophoblasts: 59.5;Hofbauer cells: 64.6;Syncytiotrophoblasts: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054382, HPA059652"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA054382: AB_2682469, HPA059652: AB_2684095"	"unprognostic (1.69e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-3)"	48.8	50.2	80.5	72.9	93.9	151.0	66.7	85.8	99.0	52.4	83.8	75.4	67.6	54.1	64.7	63.5	54.1	47.3	59.2	78.4	89.7	66.3	62.6	57.6	94.8	91.7	87.3	54.6	55.3	76.7	65.3	56.0	87.3	64.7	87.5	75.2	55.2	50.3	79.0	90.3	76.1	52.3	87.9	93.3	62.6	96.8	85.8	85.0	71.5	66.0	96.5	53.3	56.1	103.7	119.3	148.6	163.6	109.8	70.3	86.2	153.4	138.3	102.3	166.3	107.1	141.3	122.5	179.2	150.6	105.8	84.2	155.9	114.4	137.9	167.1	80.3	92.1	125.0	141.6	148.3	101.0	154.8	170.8	86.6	134.8	158.2	127.4	101.8	121.0	134.4	170.1	56.5	110.8	88.2	169.4	143.2	105.1	88.0	111.3	205.6	236.9	174.5	113.1	96.4	116.3	133.9	250.2	105.2	92.7	113.0	87.1	105.9	120.2	122.0	102.3	90.2	103.7	133.2	113.1	228.6	125.0	109.7	119.6	170.3	78.3	124.1	47.6	93.0	46.8	83.1	45.8	44.7	90.0	77.8	47.0	49.1	107.6	57.1	123.4	62.4	69.2	68.1	80.5	93.9	85.8	99.0	78.4	89.7	91.7	87.3	87.3	87.9	85.8	103.7	16.9	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.3	0.0	0.0	0.0	0.0	56.7	10.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	59.5	16.8	0.0	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	53.1	1.5	0.0	0.0	0.0
PSME4	"KIAA0077, PA200"	ENSG00000068878	"Proteasome activator subunit 4"	Q14997	2	53864069-53970993	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.8"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 238.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060922	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060922: AB_2684386"	"unprognostic (2.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.26e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (4.76e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-1)"	7.4	8.6	5.3	8.1	8.8	16.1	12.1	5.7	7.4	15.4	11.1	9.8	5.9	16.1	6.2	8.8	8.0	11.9	16.9	6.4	7.1	7.0	16.6	8.0	11.1	7.1	7.0	6.7	7.9	8.3	6.8	8.5	6.4	10.0	8.4	8.9	14.5	7.4	59.8	7.2	7.1	15.0	5.0	9.5	10.6	33.6	8.1	10.7	14.4	45.2	12.2	13.2	8.1	12.6	28.0	18.3	27.6	8.5	9.1	19.4	18.1	29.1	25.6	29.3	23.6	28.3	10.6	38.7	26.1	29.4	14.1	18.1	32.1	23.5	52.7	29.4	18.8	59.8	18.3	38.5	11.7	32.1	17.1	14.8	14.2	33.1	26.6	12.1	30.4	10.1	48.1	24.0	26.3	10.9	19.5	15.4	26.7	13.7	15.4	22.8	41.9	25.3	15.7	27.1	20.6	23.1	18.2	23.9	14.8	17.4	18.1	12.7	39.6	25.5	21.4	19.7	27.0	17.1	16.6	24.9	20.1	26.4	16.1	0.5	0.1	0.5	0.7	0.3	0.4	0.6	0.4	0.4	0.3	0.9	0.5	0.7	0.4	0.6	0.2	0.4	0.3	0.1	5.3	8.8	5.7	7.4	6.4	7.1	7.1	7.0	6.4	5.0	8.1	12.6	20.0	16.0	35.0	58.1	33.1	75.8	72.4	37.4	60.9	20.6	40.0	19.6	63.5	20.0	45.4	22.0	45.9	16.1	51.0	20.1	3.9	20.8	99.7	60.0	49.6	27.3	40.6	28.8	100.3	37.1	12.8	27.2	41.3	97.0	28.5	34.9	18.5	34.3	19.5	25.2	83.5	19.5	30.5	28.7	47.7	92.5	21.1	35.1	28.4	71.2	28.0	15.7	36.0	64.3	238.5	43.6	9.3	10.5	61.3	92.5	8.7	10.3	39.0	27.8	13.1	48.9	26.5	36.0	18.0	79.3	66.1	29.7	42.6	14.0	18.8	107.3
PSMG1	"c21-LRP, DSCR2, LRPC21, PAC1"	ENSG00000183527	"Proteasome assembly chaperone 1"	O95456	21	39174769-39183488	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 673.8;Spermatocytes: 544.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057193, HPA070225"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA057193: AB_2683363, HPA070225: AB_2686236"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.38e-2)"	"unprognostic (5.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.84e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.17e-3)"	7.5	9.8	4.0	9.1	4.0	17.3	6.8	2.7	5.5	7.3	2.5	10.5	8.9	7.8	4.8	11.8	6.4	5.4	8.3	4.6	3.8	9.7	15.9	5.7	8.9	2.2	2.4	7.2	10.8	5.1	8.0	7.7	3.2	5.5	9.9	4.9	7.3	3.2	13.8	7.1	8.2	5.1	2.1	6.3	7.1	40.3	3.7	6.3	10.8	5.6	6.2	7.8	7.4	4.0	104.0	34.7	23.5	32.9	12.3	15.1	65.0	55.3	25.9	44.8	28.2	66.6	26.9	113.7	28.9	17.1	38.1	28.5	40.3	30.3	30.2	48.9	61.6	209.6	52.4	83.6	21.9	101.0	40.4	18.9	24.6	46.2	46.5	9.8	24.9	47.0	160.4	61.9	27.2	58.2	63.0	54.7	82.2	38.9	53.5	99.6	29.8	115.8	19.1	30.4	77.6	22.7	70.4	39.1	57.4	4.0	36.6	51.4	26.7	50.1	16.8	66.7	79.9	46.4	79.3	96.8	42.0	170.4	38.6	10.6	6.8	3.9	10.5	9.0	12.3	12.0	14.7	12.4	12.2	10.6	11.5	10.3	0.6	7.5	9.1	11.3	13.7	7.9	4.0	4.0	2.7	5.5	4.6	3.8	2.2	2.4	3.2	2.1	3.7	4.0	23.7	6.4	17.6	5.2	17.8	136.0	44.1	68.6	43.9	14.2	31.3	39.0	24.8	22.8	39.9	20.2	4.2	108.9	12.6	14.7	66.5	50.8	673.8	20.8	36.5	26.3	29.9	63.3	7.5	49.7	118.6	31.8	18.8	21.6	36.1	26.2	18.9	32.7	59.5	8.4	8.0	45.7	69.2	17.7	35.5	88.4	31.7	25.0	46.2	3.7	24.4	18.0	12.3	3.5	5.9	32.4	20.0	33.1	31.7	41.5	30.6	89.4	20.8	19.7	26.3	29.5	31.3	544.1	98.7	51.7	97.7	54.5	20.1	54.7	56.9	27.9
PSMG2	"CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1"	ENSG00000128789	"Proteasome assembly chaperone 2"	Q969U7	18	12658043-12725740	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 537.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 436.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041517, HPA046741"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA041517: AB_2677530, HPA046741: AB_2679780"	"unprognostic (2.28e-2)"	"unprognostic (9.44e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.75e-3)"	65.6	50.3	43.5	44.8	43.4	91.9	65.2	47.0	54.8	53.0	43.2	56.3	48.3	49.0	67.5	63.5	47.7	53.2	47.3	43.5	44.9	57.2	65.6	44.3	65.1	44.7	42.8	60.6	55.9	31.1	31.8	52.9	44.4	42.5	60.5	25.1	46.6	47.9	50.9	56.0	47.8	53.0	46.9	43.8	53.7	89.7	42.9	67.6	49.6	39.5	63.7	63.8	52.0	49.2	82.6	51.3	58.2	74.0	100.1	142.5	75.0	81.3	115.7	131.1	147.8	89.1	84.6	90.6	64.6	86.2	108.3	49.8	93.7	99.9	112.2	48.6	52.4	50.1	43.0	101.8	100.7	170.7	78.7	116.8	76.0	80.7	107.6	81.3	92.5	78.7	77.4	112.9	102.4	83.0	109.9	226.1	46.2	436.4	67.8	78.8	87.5	130.2	121.0	106.3	69.6	52.5	77.5	88.1	78.1	56.3	75.8	136.2	63.5	148.9	203.3	131.3	89.4	101.1	142.9	111.1	90.1	88.5	63.3	84.9	89.3	87.6	65.3	95.1	77.6	70.3	84.0	74.8	80.5	62.5	74.6	72.2	30.9	73.9	111.6	65.7	108.2	91.7	43.5	43.4	47.0	54.8	43.5	44.9	44.7	42.8	44.4	46.9	42.9	49.2	96.1	51.3	50.1	42.7	76.4	91.0	98.8	145.2	80.8	25.1	81.4	99.2	36.0	82.9	80.9	82.8	22.9	183.0	80.9	70.8	154.6	110.5	537.7	59.8	75.8	83.9	68.6	97.2	50.1	110.8	140.3	99.3	59.1	53.3	60.9	74.9	101.7	53.1	147.6	25.2	50.3	87.8	54.9	133.0	88.7	140.8	134.2	100.2	72.9	26.2	130.7	63.8	50.4	34.7	38.5	103.2	84.2	97.0	67.1	126.1	120.6	193.8	68.7	21.4	85.5	78.4	89.8	344.9	216.8	119.5	90.1	186.3	78.8	122.3	103.6	130.7
PSMG4	"C6orf86, PAC4"	ENSG00000180822	"Proteasome assembly chaperone 4"	Q5JS54	6	3231403-3303373	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067652, HPA074376, HPA075846"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA067652: AB_2685880, HPA074376: , HPA075846: "	"unprognostic (3.13e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.40e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.48e-2)"	20.3	18.3	12.8	8.2	15.7	13.8	20.0	19.8	13.7	16.9	5.0	24.1	14.1	18.9	18.6	19.9	18.4	6.9	15.1	11.5	14.6	20.1	26.9	13.7	10.2	17.6	16.0	16.6	33.4	12.0	22.2	7.0	18.1	19.3	6.9	9.9	20.2	13.4	37.1	20.8	16.8	9.5	13.5	14.4	21.4	16.2	15.9	9.3	21.1	11.1	7.7	19.8	16.8	23.8	61.8	29.0	17.5	42.8	15.3	23.1	29.5	27.2	20.0	25.9	41.4	25.1	20.6	21.0	73.1	16.4	20.2	28.9	15.0	18.9	16.9	34.7	65.2	16.9	33.4	66.6	19.2	48.7	16.9	19.8	20.1	18.8	27.8	14.8	32.4	39.9	65.0	15.1	14.0	58.2	27.6	88.9	21.4	31.3	57.7	36.5	9.5	116.2	21.1	24.0	74.3	21.3	12.9	16.7	61.4	16.5	22.0	21.0	31.7	21.4	20.4	24.6	26.6	48.7	76.4	39.4	15.2	34.1	29.3	16.2	35.5	24.4	25.3	36.9	29.4	50.2	42.1	30.8	28.4	52.1	40.9	35.7	8.9	32.3	36.3	33.9	39.4	23.9	12.8	15.7	19.8	13.7	11.5	14.6	17.6	16.0	18.1	13.5	15.9	23.8	45.2	22.4	21.2	18.6	25.3	27.9	29.1	44.2	38.7	32.0	53.1	88.4	21.9	37.1	26.9	44.1	8.4	39.3	15.2	23.6	84.1	43.9	31.4	23.6	25.9	35.2	22.8	18.5	9.6	87.5	37.8	30.4	15.8	17.1	22.2	38.8	28.2	64.5	35.1	25.2	17.8	31.1	28.5	19.2	21.1	13.3	37.0	18.4	30.2	5.6	35.7	22.0	32.0	21.6	15.7	57.8	25.8	23.0	18.9	47.0	47.3	67.2	22.6	29.4	46.0	45.5	54.0	29.6	78.2	39.6	38.2	12.0	23.7	30.0	35.4	27.1
PSORS1C1	"C6orf16, SEEK1"	ENSG00000204540	"Psoriasis susceptibility 1 candidate 1"	Q9UIG5	6	31114750-31140092	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 109.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 358.6;Late spermatids: 1285.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.5"									HPA045049			Uncertain	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA045049: "	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.72e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.30e-1)"	0.7	0.4	0.1	0.0	0.1	0.0	0.8	0.0	0.1	0.8	0.0	1.5	0.0	0.9	2.3	0.9	0.5	0.0	0.4	0.1	0.0	1.0	0.0	1.7	0.0	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.9	0.1	0.0	3.3	1.8	0.0	0.0	0.2	1.4	109.9	0.0	0.0	1.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.5	0.1	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	19.2	3.2	0.7	0.0	8.8	3.8	5.4	3.4	0.0	7.5	3.4	3.3	12.8	2.7	9.2	0.0	0.2	0.1	55.1	0.0	17.7	358.6	3.6	3.3	4.6	3.0	0.0	0.4	2.2	0.6	5.8	20.9	11.6	0.0	0.0	3.6	0.1	0.4	0.0	0.3	4.9	0.0	0.0	3.0	1285.1	9.3	0.4	3.6	0.0	0.6	0.7	0.0	2.0	2.4	12.2	131.7	6.8	0.0	2.7	26.0	1.0	0.6	0.0	6.6	0.9	1.3	170.3	31.8	3.5	10.5	0.1	0.4	0.2	6.9	2.4
PSPC1	"FLJ10955, PSP1"	ENSG00000121390	"Paraspeckle component 1"	Q8WXF1	13	19674752-19783019	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 173.4;Inhibitory neurons: 164.7;Spermatocytes: 171.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038904	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA038904: AB_10673291"	"unprognostic (2.13e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.13e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.69e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.61e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (7.72e-2)"	10.9	13.0	11.5	13.2	11.5	53.7	16.2	12.8	13.9	12.5	9.9	14.9	12.4	14.8	21.7	14.0	16.2	12.1	11.1	11.8	10.6	12.2	8.9	9.9	20.8	12.1	9.0	13.7	9.5	9.5	10.3	13.8	10.6	11.0	15.5	17.4	10.0	8.3	20.9	14.4	12.4	12.6	8.7	11.1	12.0	25.0	10.5	23.1	12.2	12.7	21.9	20.4	10.0	15.8	50.5	20.4	46.6	23.3	18.9	19.8	60.3	26.1	34.0	48.3	43.6	68.4	27.8	67.8	27.7	27.9	25.4	24.6	54.7	32.2	50.0	28.9	27.3	76.4	14.1	83.1	37.4	55.3	46.7	31.6	6.5	29.8	32.9	19.2	41.7	65.9	42.8	26.1	43.2	54.1	65.5	52.8	65.5	27.3	28.0	43.7	46.8	34.6	50.8	74.6	42.7	22.0	35.8	59.1	23.1	44.9	34.5	56.6	25.1	28.9	27.7	28.0	25.4	22.5	14.5	115.1	13.2	32.7	35.2	14.8	21.3	14.5	11.8	22.7	12.0	23.3	15.1	11.0	19.1	22.5	15.4	11.2	16.9	11.9	18.1	20.9	21.8	15.7	11.5	11.5	12.8	13.9	11.8	10.6	12.1	9.0	10.6	8.7	10.5	15.8	21.0	19.2	29.5	79.3	36.4	33.3	24.9	16.4	23.3	43.2	24.6	21.0	28.6	21.5	18.9	16.5	58.4	70.0	41.0	16.4	21.5	31.3	17.4	40.0	33.9	24.0	25.2	23.1	173.4	34.1	104.7	25.1	25.5	39.4	9.5	28.0	23.9	11.1	27.2	30.3	164.7	20.0	12.2	25.7	25.3	21.4	31.4	27.7	19.6	92.8	45.2	25.5	27.8	115.6	156.4	26.8	22.2	26.7	31.8	16.5	16.1	23.8	25.9	69.1	32.9	27.2	27.4	171.5	75.4	24.0	34.1	80.4	38.9	48.1	27.2	26.2
PSRC1	DDA3	ENSG00000134222	"Proline and serine rich coiled-coil 1"	Q6PGN9	1	109279556-109283186	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 101.5;choroid plexus: 47.9;retina: 41.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 30.1;Oligodendrocytes: 95.2;Peritubular cells: 44.8;Rod photoreceptor cells: 71.0"	"Cancer enriched"	"Detected in all"	4	"glioma: 50.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 12.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 5.4;granulocytes: 7.1;monocytes: 12.0"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 3.5;cerebral cortex: 7.7;hippocampal formation: 5.7;white matter: 3.4"	"Low region specificity"	"Detected in all"			HPA056561			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Nucleoplasm	"HPA056561: AB_2683175"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.36e-9)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	2.0	1.9	64.7	3.8	84.0	7.9	2.4	76.5	84.1	5.1	47.9	3.9	4.3	3.1	2.6	7.6	3.5	3.0	3.0	69.7	71.2	2.7	4.5	5.3	3.6	78.0	79.9	3.3	1.5	3.2	4.2	4.0	83.0	5.5	2.7	41.6	2.4	4.5	0.9	5.2	4.5	3.9	67.9	3.9	3.4	13.3	74.1	14.2	2.3	0.9	4.3	3.2	5.8	101.5	56.0	28.2	112.9	55.1	4.4	8.7	31.0	43.1	34.7	57.6	55.1	43.7	22.7	28.2	15.4	21.4	27.1	38.9	61.4	35.4	48.1	11.0	29.6	17.7	40.5	36.2	5.0	19.0	19.3	10.0	3.3	22.8	16.2	21.5	28.7	32.9	40.9	12.5	46.8	50.5	29.2	12.9	46.9	25.4	31.8	44.4	108.7	9.5	19.6	14.4	47.2	27.3	24.3	36.8	43.6	40.8	22.3	18.0	14.9	35.4	57.9	25.1	72.5	9.7	6.9	9.8	28.6	44.9	100.9	0.0	12.0	1.9	0.6	4.8	0.4	0.0	0.7	0.2	5.4	0.0	0.4	0.3	7.1	0.3	2.7	0.0	0.7	3.4	64.7	84.0	76.5	84.1	69.7	71.2	78.0	79.9	83.0	67.9	74.1	101.5	0.7	0.0	3.9	9.8	0.5	2.0	1.8	2.3	0.6	6.7	2.1	5.6	1.3	1.5	0.5	1.8	25.0	17.6	1.0	2.0	0.0	0.9	1.1	0.5	3.2	2.3	0.0	0.8	19.3	0.9	30.1	4.4	0.5	1.1	1.3	12.9	2.9	1.2	10.9	3.3	3.8	3.9	4.1	4.4	1.8	2.6	5.9	4.9	1.8	2.8	2.2	10.0	0.0	18.1	95.2	0.5	0.6	44.8	0.6	1.0	0.6	2.9	0.9	71.0	0.0	5.5	4.7	5.0	1.5	6.5	1.1	2.9	1.5	1.1	5.4	1.3
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 72.4;lymphoid tissue: 63.4;skeletal muscle: 33.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 44.6;Erythroid cells: 46.7;Macrophages: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 112.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 102.0;HMC-1: 108.3"	"Low region specificity"	"Detected in all"							"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		No	No		1500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.4	4.6	0.9	11.1	0.9	72.4	8.5	0.8	1.5	4.2	1.8	4.4	3.6	2.9	1.4	5.1	4.0	5.3	2.1	0.8	1.1	3.7	10.0	11.4	6.3	1.8	1.2	3.6	3.5	3.8	2.9	12.1	1.5	8.0	5.1	2.8	5.9	2.7	33.0	8.8	4.5	4.6	1.1	63.4	6.4	1.3	1.2	3.9	2.1	5.8	4.9	9.6	4.3	1.4	2.9	0.0	3.8	0.1	0.9	6.7	20.6	15.0	7.4	5.3	4.5	11.6	4.0	0.1	0.9	5.0	0.0	36.2	20.3	28.1	6.6	0.0	3.2	102.0	4.6	0.2	5.9	6.0	108.3	5.0	34.4	5.0	16.3	4.8	10.6	0.2	24.8	0.1	23.1	3.6	0.9	0.1	2.3	0.0	0.1	0.1	7.5	4.9	11.2	37.0	0.3	2.1	2.4	10.3	0.5	28.2	32.6	12.0	7.6	0.6	8.2	0.8	0.2	0.1	0.3	0.1	1.3	0.2	0.4	77.3	25.3	112.8	10.4	35.0	3.6	0.1	6.2	7.7	25.3	0.1	7.2	8.8	13.5	2.9	36.4	0.9	4.1	20.0	0.9	0.9	0.8	1.5	0.8	1.1	1.8	1.2	1.5	1.1	1.2	1.4	1.7	12.8	11.6	0.7	2.4	13.8	19.4	44.6	15.4	0.7	11.1	17.1	3.5	2.8	24.9	0.0	0.0	26.6	21.8	0.6	3.9	9.6	2.0	4.1	2.6	3.1	1.2	46.7	1.6	3.9	3.3	4.2	11.2	11.2	43.6	20.6	7.1	17.3	14.6	0.0	1.4	4.2	6.1	42.5	5.5	7.3	2.8	58.7	7.2	2.8	37.4	10.9	25.7	2.0	0.9	17.7	0.3	2.2	3.6	39.7	0.5	4.1	13.0	0.4	6.6	3.1	7.7	1.1	1.6	7.3	10.2	8.8	17.8	7.1	2.4	21.8
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.1;lymphoid tissue: 30.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 75.4;Hofbauer cells: 71.7;Kupffer cells: 93.0;Langerhans cells: 67.8;Macrophages: 64.5;monocytes: 52.8;Pancreatic endocrine cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 256.7;eosinophil: 906.5;neutrophil: 747.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 906.5;monocytes: 256.7"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 36.6;HMC-1: 131.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	10.4	2.4	4.3	30.8	4.7	41.1	3.4	4.7	5.6	3.4	4.1	5.5	4.1	1.7	1.2	7.2	2.6	7.2	2.0	3.8	5.1	2.7	4.1	17.8	13.5	8.9	6.6	1.3	2.0	1.6	0.6	7.3	7.7	1.5	6.7	0.5	2.3	1.5	0.7	5.4	6.3	7.9	8.1	14.4	3.8	1.3	7.2	3.6	1.9	2.6	18.0	14.4	1.9	11.8	20.1	0.2	0.1	0.4	0.2	0.0	0.5	0.0	0.0	0.7	0.2	0.2	5.7	1.3	0.1	0.1	0.3	13.5	0.5	36.6	0.8	0.4	0.6	7.7	0.2	0.9	0.1	1.9	131.3	0.0	6.0	0.4	0.4	0.0	0.2	0.1	0.5	0.4	0.0	1.3	0.2	19.3	0.6	0.5	0.2	0.3	0.1	0.1	8.7	2.1	0.3	0.1	0.1	18.1	0.2	0.4	0.4	5.4	0.1	0.2	0.7	0.0	0.2	1.2	1.1	5.6	0.1	2.4	0.6	61.7	256.7	906.5	0.6	77.9	1.2	12.5	0.4	0.4	116.1	6.7	0.5	0.7	747.1	0.7	34.1	1.3	1.2	112.4	4.3	4.7	4.7	5.6	3.8	5.1	8.9	6.6	7.7	8.1	7.2	11.8	2.1	6.4	6.7	0.0	4.1	6.5	2.0	37.9	5.2	1.5	0.8	0.5	2.2	1.5	20.9	1.8	2.1	0.6	2.9	0.4	0.0	18.1	0.4	0.5	0.2	7.3	0.0	4.0	0.9	5.1	0.5	1.3	1.1	0.5	75.4	2.0	2.9	1.0	71.7	0.0	0.7	0.0	18.3	93.0	67.8	0.2	0.6	64.5	0.0	15.0	52.8	0.2	0.0	1.5	6.6	89.8	0.6	0.0	0.5	0.6	0.3	0.2	20.2	0.9	0.0	0.6	1.0	2.3	0.7	3.2	2.8	1.5	2.0	0.0	0.4	9.4
PTBP1	"HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4"	ENSG00000011304	"Polypyrimidine tract binding protein 1"	P26599	19	797075-812327	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013507	Supported		Supported	Nucleoplasm		NA	NA		4500000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB013507: AB_2533082"	"unprognostic (2.82e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (4.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.28e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.72e-2)"	101.5	84.7	29.9	104.7	33.4	138.2	94.9	33.5	34.9	92.7	51.7	95.9	91.4	90.5	48.9	137.7	86.9	54.0	64.7	29.9	33.6	111.8	123.5	102.3	90.1	38.1	35.5	99.5	100.8	66.4	80.9	79.0	36.7	86.3	56.0	11.8	90.7	45.6	35.2	123.8	96.6	49.7	34.4	117.2	86.0	45.5	36.2	91.9	98.0	19.7	79.2	80.3	101.5	34.8	517.8	377.1	242.8	224.3	70.1	90.3	385.1	299.7	128.8	230.2	169.2	394.1	243.6	428.0	192.5	188.9	88.0	299.8	342.7	260.0	239.3	433.8	361.2	352.9	362.6	429.8	141.8	479.4	355.1	83.5	179.0	265.5	164.2	84.4	232.2	201.3	523.0	223.0	385.6	434.8	610.4	258.5	446.4	190.2	245.2	648.8	182.0	254.2	140.4	467.5	272.9	317.4	358.4	213.4	174.8	168.5	228.9	286.4	335.4	247.5	286.9	306.0	557.4	238.0	500.7	591.2	153.2	357.7	307.9	12.9	32.5	23.1	31.8	38.6	32.3	23.7	26.3	30.0	36.0	23.7	25.1	26.2	13.4	33.5	36.7	22.3	29.1	38.3	29.9	33.4	33.5	34.9	29.9	33.6	38.1	35.5	36.7	34.4	36.2	34.8	99.8	41.7	66.9	11.8	88.7	76.7	91.8	47.0	84.8	19.6	114.5	91.9	39.1	82.9	44.3	47.8	35.5	116.5	96.1	134.3	35.2	73.3	22.3	62.2	62.2	92.1	101.1	87.7	12.4	87.5	172.7	70.4	70.3	80.5	90.8	92.0	74.6	87.9	78.7	33.7	12.1	145.0	36.7	60.6	62.7	20.6	79.9	75.1	39.2	20.6	59.8	29.9	59.8	10.1	12.9	99.4	107.5	65.8	90.0	90.5	89.9	46.9	49.9	21.3	59.2	74.8	71.1	40.5	54.3	97.2	82.0	133.4	89.7	68.7	144.9	100.7
PTBP2	"brPTB, nPTB, PTB, PTBLP"	ENSG00000117569	"Polypyrimidine tract binding protein 2"	Q9UKA9	1	96721665-96823738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 126.2;Inhibitory neurons: 125.8;Oligodendrocyte precursor cells: 203.1;Oligodendrocytes: 625.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RH-30: 72.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047420	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA047420: AB_10962353"	"unprognostic (2.14e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.26e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.31e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.27e-2)"	14.8	8.0	19.2	6.0	20.6	15.7	13.5	19.1	25.8	20.8	11.2	33.4	4.2	18.0	5.2	7.9	15.4	5.8	7.8	20.5	21.0	10.7	7.5	8.6	6.0	18.6	21.6	13.1	7.1	2.4	11.4	4.1	19.4	12.4	6.5	14.7	8.2	9.6	11.3	8.6	12.9	13.1	20.4	11.5	12.2	23.7	22.0	10.5	11.9	9.0	4.8	17.5	14.3	25.2	6.6	3.5	27.2	15.4	6.3	6.8	15.1	5.7	6.5	9.7	9.1	4.3	5.7	22.4	6.6	3.4	22.1	3.9	17.8	4.0	14.1	4.1	5.1	12.6	8.4	5.9	3.8	5.9	6.1	4.6	2.7	12.2	4.6	7.5	4.9	10.9	9.3	5.2	13.0	2.1	21.0	18.0	17.2	2.7	7.9	11.3	72.0	3.2	9.6	3.2	16.7	16.8	7.4	4.4	9.5	13.4	4.5	13.4	4.8	5.8	12.6	5.0	7.5	4.5	4.0	25.7	2.9	9.5	2.8	0.3	0.5	0.3	0.8	0.6	0.7	1.2	1.1	0.8	0.3	1.3	1.3	0.9	0.5	1.4	0.7	0.6	1.1	0.2	19.2	20.6	19.1	25.8	20.5	21.0	18.6	21.6	19.4	20.4	22.0	25.2	26.1	9.6	13.9	116.2	16.9	13.9	9.6	4.1	14.2	27.4	14.4	13.8	10.9	10.0	6.0	20.2	14.6	5.6	13.9	3.8	13.7	6.8	4.8	11.5	27.9	16.7	24.5	16.2	126.2	5.1	4.2	20.5	10.7	18.3	7.6	21.4	8.2	8.4	3.3	30.3	125.8	6.2	6.1	13.0	13.9	7.1	9.0	8.5	14.2	102.1	7.1	47.6	10.3	203.1	625.1	4.9	3.9	7.9	14.4	7.3	4.5	9.1	8.1	22.6	6.6	15.0	33.1	79.0	35.4	12.1	7.1	2.1	13.7	11.0	5.5	6.3
PTBP3	"DKFZp781I1117, ROD1"	ENSG00000119314	"Polypyrimidine tract binding protein 3"	O95758	9	112217716-112333664	"Predicted intracellular proteins"	"Differentiation, Erythrocyte maturation, mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048374			Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA048374: AB_2680376"	"unprognostic (6.12e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.38e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.39e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.10e-2)"	14.7	11.6	5.5	31.0	9.6	40.9	21.7	5.6	6.3	15.3	5.7	31.8	28.6	13.3	15.1	37.1	12.3	20.9	7.6	5.7	10.7	25.6	15.6	21.5	36.7	5.4	5.8	10.9	14.3	11.1	7.4	24.8	5.3	11.5	34.1	8.6	17.7	9.3	5.9	28.7	31.1	12.5	4.6	28.5	33.3	23.7	7.0	46.2	19.6	7.1	39.5	37.0	17.6	5.9	62.3	64.3	24.2	21.0	20.9	22.8	123.0	24.8	20.1	29.9	30.9	74.3	90.7	70.3	26.9	32.5	23.8	86.5	34.0	71.0	39.6	79.7	11.7	71.5	25.1	52.6	26.6	95.7	83.7	25.8	47.2	40.3	55.1	19.1	51.9	53.2	97.6	64.6	34.7	57.8	93.7	25.9	38.3	95.6	21.7	60.6	82.0	35.9	44.4	81.6	30.0	19.4	49.3	63.9	24.1	51.6	75.4	42.9	40.5	26.3	35.3	38.2	31.3	32.6	86.6	62.9	22.7	47.6	26.4	23.0	8.8	16.7	10.8	10.3	11.3	7.0	7.8	8.8	9.9	8.6	6.2	7.3	32.5	5.8	14.4	16.1	9.1	6.8	5.5	9.6	5.6	6.3	5.7	10.7	5.4	5.8	5.3	4.6	7.0	5.9	75.5	28.9	68.6	18.6	76.8	80.2	52.2	47.8	87.0	7.7	49.9	31.0	9.5	45.8	65.1	114.0	18.8	39.0	129.1	111.1	29.4	41.6	71.2	83.1	53.1	53.1	90.4	75.1	54.2	71.2	107.3	32.5	90.7	115.3	65.8	31.6	46.8	31.4	57.5	8.4	37.5	76.8	24.4	110.8	89.4	131.0	21.8	104.1	28.4	89.0	116.7	3.6	62.8	45.2	26.5	115.9	66.6	18.8	54.6	81.7	62.3	31.5	86.2	16.1	19.7	34.5	36.9	25.1	20.6	110.5	104.0	35.0	77.8	21.6	84.7	190.7
PTDSS1	"KIAA0024, PSS1, PSSA"	ENSG00000156471	"Phosphatidylserine synthase 1"	P48651	8	96261902-96336995	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016852	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"	Nucleoplasm	"HPA016852: AB_1855878"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (1.08e-5)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.55e-2)"	1.6	2.2	1.6	3.4	2.0	4.9	3.1	1.2	2.6	3.5	0.8	3.4	4.1	2.1	2.8	3.7	2.5	3.1	7.2	1.8	1.0	3.7	4.6	2.6	5.6	0.5	0.6	3.6	2.7	8.0	0.6	4.6	1.3	1.9	2.9	0.9	2.0	3.5	2.9	3.2	3.2	3.6	0.2	2.6	1.4	1.9	2.0	3.6	4.5	3.0	5.2	2.6	1.1	1.4	14.9	11.6	2.0	5.5	4.2	8.5	3.4	10.6	15.5	10.6	7.5	4.6	4.2	24.9	9.5	10.5	2.1	6.0	14.1	11.1	16.1	12.5	10.3	24.5	19.8	2.5	4.3	17.8	8.1	7.2	10.9	14.4	10.2	2.7	7.0	7.6	12.5	12.3	9.7	4.4	14.0	3.0	3.1	5.1	11.1	10.9	10.1	18.8	5.7	12.5	8.6	3.5	3.9	3.4	1.4	2.3	8.2	6.3	11.8	9.1	5.5	6.3	12.3	2.5	13.3	11.8	5.7	19.3	7.5	10.5	2.6	1.5	1.7	1.6	2.5	1.7	2.8	2.2	4.0	2.2	2.5	1.8	0.9	3.2	1.7	1.2	1.7	6.7	1.6	2.0	1.2	2.6	1.8	1.0	0.5	0.6	1.3	0.2	2.0	1.4	12.4	19.2	9.1	8.8	50.5	31.6	18.9	22.6	42.7	10.2	22.9	18.4	94.5	14.3	15.6	11.0	10.4	78.4	23.6	11.9	1.9	20.5	60.1	6.6	9.1	22.9	5.4	38.3	29.3	44.9	54.1	18.0	14.8	9.3	32.4	17.6	34.2	32.1	45.9	5.0	29.2	17.1	10.2	45.3	31.5	52.2	23.3	36.0	19.6	15.9	39.3	4.7	29.9	21.1	8.7	23.9	11.9	25.9	45.5	21.4	16.6	19.0	5.2	4.7	0.0	13.8	15.8	12.1	18.8	33.1	33.5	80.9	34.3	14.6	34.8	16.3
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863625-87971930	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 60.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	64.0	25.4	17.8	18.6	19.3	12.9	47.6	34.5	23.4	54.8	15.6	28.1	12.9	27.4	18.6	28.3	35.2	15.6	29.7	20.4	18.4	22.6	39.2	39.5	21.4	16.6	17.8	28.0	33.2	11.9	17.3	30.5	16.4	26.3	14.6	30.0	19.6	16.5	23.7	25.9	24.5	22.2	14.5	40.0	25.6	28.2	19.7	31.8	26.1	14.0	16.5	28.1	38.4	17.6	23.5	10.8	12.3	11.2	28.5	19.7	10.9	12.5	28.0	14.5	20.4	10.9	28.0	28.1	8.0	20.9	8.3	14.1	16.6	14.3	22.8	14.1	4.7	9.3	28.5	13.8	30.1	31.9	15.3	13.5	38.7	18.0	23.7	60.3	20.8	17.7	7.0	72.6	13.5	18.1	17.8	56.3	4.6	19.9	0.0	27.6	6.4	20.8	22.9	13.4	4.5	19.9	16.6	7.9	23.0	9.7	21.9	45.2	17.9	44.6	10.8	18.3	10.1	23.9	32.9	30.7	14.6	29.2	2.9	21.3	14.2	25.8	6.8	21.8	7.2	7.9	7.2	6.6	10.3	6.8	8.3	8.3	60.5	8.9	15.6	8.2	7.0	4.5	17.8	19.3	34.5	23.4	20.4	18.4	16.6	17.8	16.4	14.5	19.7	17.6	67.2	35.3	63.3	83.6	48.3	56.1	57.4	31.5	47.3	113.0	49.4	41.9	46.5	57.2	31.2	29.5	39.6	25.8	64.4	57.7	33.2	24.7	70.1	40.0	114.5	56.0	31.2	52.0	141.0	30.0	62.2	79.3	39.8	33.6	25.4	39.6	53.9	64.1	35.0	45.4	132.4	44.7	12.2	206.1	97.2	92.1	56.8	105.2	62.2	196.8	101.5	61.6	44.3	139.2	95.7	30.6	39.7	54.5	39.3	45.1	50.1	38.0	31.2	61.2	92.1	66.4	170.7	33.5	25.4	45.2	60.1	57.3	46.3	44.7	46.1	64.0
PTER		ENSG00000165983	"Phosphotriesterase related"	Q96BW5	10	16436943-16513745	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.5"	"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 190.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 6.9;basal ganglia: 16.5;cerebral cortex: 8.7;hippocampal formation: 14.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038044, HPA038045"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8600	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA038044: AB_2675803, HPA038045: AB_10672616"	"unprognostic (5.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (6.52e-6)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.36e-3)"	6.8	5.5	6.9	5.6	16.5	2.3	10.3	1.0	8.7	5.9	0.0	8.3	12.7	4.9	4.4	4.5	5.1	5.3	7.1	14.1	1.3	31.5	14.0	6.0	7.9	0.0	0.0	2.0	7.5	9.2	1.3	5.6	0.0	7.1	8.0	11.8	8.3	4.6	9.2	5.4	10.0	3.3	0.0	6.9	14.1	1.1	0.8	7.3	10.6	10.0	7.9	9.0	3.7	0.0	26.9	11.7	0.1	4.8	7.0	13.0	14.7	6.9	0.7	2.6	3.5	10.7	20.9	25.0	5.9	4.5	1.2	11.4	8.3	4.3	4.3	30.2	9.9	24.9	6.1	5.6	7.2	8.2	8.0	8.2	17.0	8.0	1.3	0.1	1.5	22.9	17.5	8.4	4.1	7.8	17.8	9.5	5.7	15.9	2.5	13.7	2.4	13.1	43.2	6.4	22.7	1.4	12.5	3.7	23.3	5.2	8.6	30.4	3.4	0.2	6.3	5.5	0.1	6.3	7.6	25.2	3.3	14.7	8.7	3.4	7.2	4.7	7.5	11.6	8.1	9.2	8.8	8.1	7.6	5.8	6.8	7.1	2.2	5.6	10.3	6.7	14.2	5.9	6.9	16.5	1.0	8.7	14.1	1.3	0.0	0.0	0.0	0.0	0.8	0.0	12.1	28.9	26.3	2.9	13.5	11.0	14.7	7.7	9.6	0.9	13.6	9.4	29.5	15.7	20.6	29.5	0.0	19.6	10.2	19.5	52.8	22.5	0.3	10.7	5.5	8.3	11.5	9.4	0.5	34.4	18.7	10.2	41.8	17.8	24.1	5.1	11.4	24.3	15.6	0.0	0.2	13.1	18.3	17.1	6.5	0.3	0.9	12.3	8.8	10.3	14.6	13.9	33.0	0.0	0.2	26.8	26.7	0.0	8.1	11.4	19.8	190.5	14.4	9.9	6.6	7.7	16.0	1.1	6.5	7.6	12.4	12.0	13.2	3.0	19.2	22.2
PTF1A	"bHLHa29, p48, PTF1-p48"	ENSG00000168267	"Pancreas associated transcription factor 1a"	Q7RTS3	10	23192312-23194245	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"pancreas: 104.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2.1;Exocrine glandular cells: 4.8;Spermatocytes: 3.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.6;pancreatic cancer: 1.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022612			Approved	Nucleoplasm		NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB022612: "										"unprognostic (2.02e-1)"	"unprognostic (1.85e-1)"			"unprognostic (4.49e-1)"	"unprognostic (1.80e-1)"			0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.6	1.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.6	0.4	0.0	0.0	0.0	0.0	0.8	0.6	0.1	104.2	0.0	0.2	0.0	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.5	0.0	1.9	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.6	1.4	0.6	0.4	0.8	0.6	0.8	0.5	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.4	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		660000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	141.7	128.0	198.0	137.2	210.0	150.2	171.2	217.0	454.6	168.2	185.5	169.9	151.7	172.9	159.0	161.3	217.6	114.9	122.8	195.5	215.6	180.5	218.6	133.9	157.2	214.9	213.0	250.0	121.9	133.7	111.7	164.9	218.5	141.6	172.8	118.0	124.0	147.6	208.6	123.5	155.4	138.8	213.0	125.0	117.1	135.0	204.3	167.2	162.3	158.5	185.0	158.7	145.8	278.0	616.6	528.8	416.5	249.8	300.2	270.3	634.3	392.8	298.5	494.5	366.9	452.5	629.6	676.0	588.5	338.3	331.7	385.4	790.0	514.2	621.8	509.8	529.8	529.7	309.5	524.4	219.4	637.9	367.2	197.0	367.3	375.1	450.3	468.5	518.1	425.7	866.0	628.2	490.4	385.3	636.5	602.1	714.7	538.3	609.3	549.2	392.3	914.4	436.8	473.2	538.4	313.8	401.7	570.1	355.8	546.5	658.3	526.9	314.0	294.7	341.8	358.3	552.8	262.8	777.5	540.4	321.1	516.7	543.8	141.1	166.1	107.1	130.9	261.6	172.3	172.3	170.6	156.7	160.2	127.0	167.3	147.7	64.7	132.2	346.2	135.3	191.6	316.1	198.0	210.0	217.0	454.6	195.5	215.6	214.9	213.0	218.5	213.0	204.3	278.0	265.8	179.5	137.1	39.5	251.0	386.6	826.7	248.5	272.6	128.3	208.5	197.1	166.0	178.7	161.4	189.4	77.2	457.2	245.6	246.5	373.7	310.4	42.5	493.7	221.5	242.1	261.3	452.0	43.4	214.8	676.3	268.7	143.2	291.3	234.2	224.5	188.8	187.0	349.9	112.7	41.3	295.9	201.4	209.5	363.6	107.9	238.9	261.7	282.8	47.8	283.3	244.1	178.2	38.7	71.4	220.8	207.1	213.3	299.8	657.6	218.9	343.8	345.5	128.0	144.7	185.1	337.7	558.4	348.4	350.4	377.6	566.0	359.3	219.0	358.9	556.3
PTHLH	"HHM, PLP, PTHR, PTHRP"	ENSG00000087494	"Parathyroid hormone like hormone"	P12272	12	27958084-27972733	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 254.0;Basal squamous epithelial cells: 93.9;Breast glandular cells: 105.4;Breast myoepithelial cells: 56.3;Club cells: 77.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HaCaT: 291.3;HBEC3-KT: 359.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035982	Approved	Approved	Supported	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA035982: AB_10794631"	"unprognostic (1.67e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (1.82e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.87e-3)"	3.1	0.8	1.8	1.2	2.3	0.0	20.1	0.6	3.2	13.6	10.2	3.3	2.3	10.7	1.1	16.2	1.5	7.5	4.2	4.1	3.2	0.4	0.2	1.2	1.1	4.0	8.1	1.8	1.7	22.8	2.9	3.0	0.4	5.2	1.6	0.2	8.5	2.4	0.7	2.0	1.6	3.0	0.2	3.6	1.8	1.3	8.6	0.4	1.8	1.7	1.0	9.2	15.2	0.8	1.7	9.9	0.0	0.0	2.9	2.8	0.1	0.3	1.0	0.5	1.3	0.3	7.9	0.0	0.5	2.6	9.1	291.3	1.3	359.8	0.1	7.4	1.7	0.5	1.8	0.1	0.8	0.1	0.4	0.2	19.7	9.1	34.4	0.9	11.2	0.1	0.0	0.4	0.2	0.1	0.1	0.0	1.4	0.4	16.7	0.1	1.5	0.6	34.3	0.3	0.2	0.1	16.4	0.1	2.1	11.5	0.5	0.1	5.6	1.6	8.9	5.1	77.8	4.7	0.1	12.1	7.5	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	2.3	0.6	3.2	4.1	3.2	4.0	8.1	0.4	0.2	8.6	0.8	1.4	0.0	0.0	0.7	0.4	4.6	1.9	254.0	93.9	0.3	105.4	56.3	0.4	0.0	77.5	0.0	0.0	0.0	0.5	0.0	0.0	3.5	5.9	0.9	4.7	4.5	0.0	0.0	0.6	8.9	0.0	13.6	0.0	0.8	0.0	2.6	0.4	0.2	0.0	0.0	11.2	0.0	4.1	0.3	1.3	2.7	0.9	0.6	23.2	1.0	0.6	1.8	0.0	0.0	0.2	8.6	0.0	0.0	6.2	0.5	0.0	0.3	14.8	0.5	6.6	8.0	6.7	3.6	0.2	7.9	1.4	0.0	0.5	0.2	0.0	0.2
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537376	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 109.4;skin 1: 53.9;vagina: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 132.1;Gastric mucus-secreting cells: 59.1;Intestinal goblet cells: 42.5;Paneth cells: 97.6;Proximal enterocytes: 80.2;Squamous epithelial cells: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 22.1;CAPAN-2: 41.4;HaCaT: 33.9;hTCEpi: 45.0;OE19: 57.0;RT4: 26.4;T-47d: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.5	0.1	0.6	3.6	1.7	0.8	3.8	2.9	1.7	19.8	0.0	26.5	28.9	0.4	0.1	109.4	0.4	3.5	0.2	0.6	0.9	0.8	5.2	2.6	0.6	1.6	1.0	0.3	3.6	0.0	0.2	0.3	1.7	3.1	15.7	0.8	19.1	0.6	0.6	53.9	22.2	0.8	0.6	0.8	26.2	0.3	1.1	0.3	0.2	0.0	6.4	9.8	43.2	5.4	22.1	2.6	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	41.4	0.1	7.2	0.0	0.1	33.9	0.0	0.1	0.0	5.4	0.4	0.0	10.2	0.1	0.1	0.0	6.7	0.0	45.0	0.0	0.2	0.2	0.0	0.1	0.2	2.5	0.2	12.5	0.0	0.2	0.2	57.0	15.5	0.1	1.2	0.5	0.0	26.4	0.3	2.2	2.6	8.1	0.0	0.1	25.2	1.6	0.2	0.3	0.4	0.8	0.3	0.5	0.1	0.1	0.4	0.5	1.1	0.4	0.7	0.1	0.1	0.5	0.5	0.3	0.1	0.0	1.3	0.3	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.3	0.6	1.7	2.9	1.7	0.6	0.9	1.6	1.0	1.7	0.6	1.1	5.4	0.3	12.8	25.6	0.3	1.4	5.9	2.6	7.7	5.2	2.2	7.0	4.3	0.4	12.8	14.9	0.0	2.1	0.2	0.2	132.1	0.0	1.4	0.2	0.4	0.5	3.2	5.4	0.0	0.1	1.6	0.2	1.4	59.1	1.3	9.5	0.2	0.4	1.7	0.6	0.0	0.1	42.5	2.0	2.2	2.0	0.0	0.3	2.6	0.0	0.0	1.0	1.6	1.0	0.0	0.8	17.6	97.6	0.0	0.1	1.5	80.2	0.2	8.9	3.7	0.0	2.3	1.1	0.2	0.3	48.0	15.5	0.1	2.0	0.2	32.1	15.9
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713551	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047183	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA047183: AB_2679972"	"unprognostic (1.49e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	1203.7	522.8	832.1	1028.5	1020.8	2322.6	1026.6	865.2	1035.4	1185.1	644.5	1045.1	703.0	1110.9	698.4	1186.1	1022.9	565.9	541.0	779.9	898.4	1203.7	652.1	933.2	1396.2	952.9	933.7	1078.5	1090.3	481.3	398.6	688.1	919.2	722.6	985.0	437.1	765.6	604.7	305.9	1425.4	935.1	699.4	875.4	896.2	873.2	237.1	929.1	2059.3	1002.8	246.4	1523.2	896.5	999.1	1137.2	2436.8	1416.4	1990.8	1788.7	592.5	783.4	2037.5	1614.2	1346.2	1379.8	1436.6	1380.8	2759.6	3811.5	1795.4	1271.0	948.1	1252.2	2830.6	1992.5	1738.6	3027.0	2228.9	4906.7	1096.2	2266.8	732.6	5621.1	2018.0	1143.7	733.1	1226.2	1002.6	1307.0	2286.8	3049.7	2910.9	1573.5	1222.0	3433.7	7998.5	7671.0	3004.9	2381.4	1180.4	5426.1	1408.4	2601.9	1719.2	2116.3	4041.8	2483.3	1851.0	1833.5	1507.1	1552.9	1383.9	4430.2	1704.1	1154.2	2052.5	1429.4	1769.7	1887.9	999.3	7614.4	790.8	3401.9	1897.3	2067.1	1713.8	1146.7	1346.2	1695.8	1945.2	2776.6	1928.5	1640.8	1828.0	2438.2	2109.4	1808.0	321.7	1782.3	1957.1	1944.4	2506.6	4661.6	832.1	1020.8	865.2	1035.4	779.9	898.4	952.9	933.7	919.2	875.4	929.1	1137.2	3907.5	971.2	1529.2	49.6	4518.0	7745.0	3851.3	5347.3	5459.5	703.1	3534.0	3673.7	259.7	1974.5	2483.8	2273.2	294.0	2599.4	4054.7	1741.3	3785.9	3474.2	103.3	2713.9	3364.3	4186.4	1695.3	3942.3	37.4	4190.1	5153.9	2404.0	2340.5	3092.6	2928.1	2349.3	1940.1	1347.6	3134.5	812.6	40.9	3178.6	3733.2	3492.4	8474.1	201.4	1306.3	3470.5	3689.1	78.7	3334.5	2195.9	2988.7	40.7	282.0	3669.3	2492.8	1404.5	3523.3	4524.2	1624.2	3136.2	1925.7	934.2	1926.2	2766.5	4571.8	1157.6	2467.8	5778.6	7944.4	2734.1	4276.7	1312.4	3381.3	4052.2
PTMS	ParaT	ENSG00000159335	Parathymosin	P20962	12	6765516-6770952	"Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 565.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 25.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 25.6"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 672.8"									HPA038186	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	Yes		300000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA038186: AB_10673042"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (6.18e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.55e-2)"	138.4	78.4	115.9	37.0	105.9	14.3	121.4	103.2	122.3	188.2	48.6	293.9	33.0	243.9	29.0	128.0	145.3	28.9	98.7	117.0	74.3	186.6	565.2	173.5	22.7	45.9	43.5	239.9	50.3	82.4	96.3	49.4	48.0	194.3	28.9	64.6	94.4	86.8	56.3	116.8	101.1	98.8	31.6	61.4	109.5	32.6	86.0	16.3	109.5	16.2	20.1	176.6	137.5	72.5	49.2	250.8	324.8	320.3	149.8	126.2	127.5	210.9	189.2	157.6	130.1	153.8	190.2	19.5	151.8	321.7	143.2	104.6	178.7	159.3	61.9	672.8	219.1	27.5	160.6	58.1	174.1	7.7	56.6	123.7	68.8	121.4	245.6	237.7	175.3	8.6	175.5	50.6	139.8	144.1	9.2	40.7	347.6	92.2	180.8	4.2	99.8	39.6	124.7	12.5	107.4	363.6	254.7	86.9	186.1	230.0	75.9	23.4	296.7	239.6	344.2	36.6	195.2	42.4	19.3	25.4	196.5	18.1	183.6	25.6	0.4	3.6	1.3	0.1	0.6	0.1	0.1	1.1	0.3	0.0	0.0	0.1	1.3	0.1	0.0	4.4	0.5	0.4	115.9	105.9	103.2	122.3	117.0	74.3	45.9	43.5	48.0	31.6	86.0	72.5	370.5	0.0	14.1	9.4	22.8	289.5	328.0	44.6	257.8	325.5	239.2	275.5	10.4	88.6	16.7	154.5	200.1	153.6	88.4	99.8	234.8	61.9	6.6	73.1	494.8	342.7	513.3	248.6	28.7	34.0	404.0	292.4	66.3	117.5	52.8	216.3	325.2	710.0	491.3	116.1	15.2	229.4	22.4	100.4	309.4	23.1	489.6	136.8	227.7	12.2	76.7	512.6	4.1	13.0	3.1	38.3	141.3	692.1	38.8	399.9	244.2	547.6	11.4	357.7	598.2	232.0	411.7	7.4	32.8	259.4	249.2	163.2	81.3	122.5	198.9	206.7
PTOV1		ENSG00000104960	"PTOV1 extended AT-hook containing adaptor protein"	Q86YD1	19	49850735-49860744	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 326.5;Late spermatids: 631.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051812, HPA075125"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA051812: , HPA075125: AB_2732280"	"unprognostic (2.70e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (9.20e-4)"	"unprognostic (4.65e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.70e-2)"	46.1	107.3	123.8	24.1	122.9	29.8	46.8	122.4	161.5	76.3	129.3	65.8	23.7	65.8	15.0	43.7	62.1	17.8	65.6	124.4	132.6	69.5	67.8	40.0	23.6	133.8	126.5	91.0	61.5	27.5	106.0	23.1	125.7	73.5	5.8	19.0	55.0	23.2	106.6	51.2	43.0	11.5	131.5	47.6	58.7	66.4	126.0	18.7	62.4	16.6	8.7	53.9	52.2	136.4	43.5	88.0	87.5	94.4	12.1	19.7	53.7	52.3	45.7	47.8	50.1	48.1	73.1	46.7	49.0	26.4	32.8	47.1	32.5	40.6	11.5	122.5	218.8	30.3	72.2	76.1	31.0	25.1	59.2	37.6	25.7	20.2	8.2	32.2	40.2	64.9	71.9	54.9	22.5	53.2	113.3	113.1	56.6	31.2	79.6	135.8	35.5	65.8	42.2	75.1	113.1	123.4	44.8	51.6	23.9	21.9	50.5	27.3	58.6	56.6	93.5	34.1	43.3	57.5	37.4	63.7	58.5	35.2	73.7	8.8	2.6	4.3	2.7	2.4	3.6	7.1	3.0	2.4	1.9	6.3	3.8	3.5	7.4	4.7	1.4	7.7	1.3	1.1	123.8	122.9	122.4	161.5	124.4	132.6	133.8	126.5	125.7	131.5	126.0	136.4	42.9	38.5	25.7	18.3	43.3	36.6	82.3	21.5	55.2	50.5	56.2	60.1	32.6	65.8	26.4	44.1	18.8	110.6	29.9	69.8	90.1	28.9	326.5	87.4	68.5	37.4	99.8	46.3	14.7	26.8	91.4	62.7	56.6	78.9	15.2	92.7	38.2	57.2	52.1	35.3	17.1	72.7	20.3	28.9	39.1	631.4	64.3	28.8	44.4	10.3	18.6	75.0	18.6	17.1	23.7	35.8	61.2	80.5	72.0	74.8	68.4	141.0	38.4	44.1	59.2	44.2	56.2	30.3	93.3	40.1	36.2	153.6	34.0	88.0	55.3	70.2
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 51.9;Collecting duct cells: 53.3;Cytotrophoblasts: 49.5;Distal tubular cells: 54.8;Ductal cells: 70.3;Exocrine glandular cells: 62.3;Hofbauer cells: 53.9;Pancreatic endocrine cells: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		4300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	47.2	118.0	157.8	56.2	154.0	52.9	60.9	136.2	185.0	73.5	124.6	105.2	49.6	87.4	55.8	116.8	77.3	49.3	176.7	158.5	141.6	125.5	154.2	72.6	49.9	151.3	148.8	63.8	70.4	146.7	73.1	49.8	147.6	119.0	51.3	43.4	97.1	86.8	340.8	73.7	57.1	92.1	143.2	82.8	83.5	124.5	162.7	59.1	75.3	206.2	54.9	71.1	62.2	148.5	108.9	183.9	111.0	219.9	74.4	94.5	118.3	115.5	120.2	144.8	100.1	103.4	135.4	113.9	83.3	187.3	173.1	184.1	110.9	138.2	100.6	198.6	68.1	64.6	193.6	101.7	229.1	113.1	147.2	114.6	133.1	109.8	101.8	230.9	146.5	120.3	102.0	124.7	117.1	293.8	103.0	76.6	186.8	301.0	193.0	108.3	93.7	216.2	159.0	119.8	120.6	86.9	220.4	237.3	147.3	99.4	253.4	55.0	101.7	127.6	113.8	129.9	165.2	114.9	284.1	96.8	153.2	79.1	180.7	7.6	19.2	9.8	20.8	18.4	19.9	10.8	15.8	18.5	23.0	13.4	13.8	13.9	6.1	20.4	18.3	16.4	16.9	20.4	157.8	154.0	136.2	185.0	158.5	141.6	151.3	148.8	147.6	143.2	162.7	148.5	19.8	3.2	8.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	51.9	38.6	0.0	0.0	3.1	53.3	0.0	49.5	9.2	0.0	54.8	70.3	0.0	33.7	21.8	19.0	0.0	0.0	0.0	62.3	44.2	12.2	0.0	32.9	8.8	24.8	0.0	0.0	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	61.8	0.0	0.0	0.9	0.0	0.0	41.9	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	37.9	4.0	31.8	0.0	0.0
PTPDC1	"FLJ37312, PTP9Q22"	ENSG00000158079	"Protein tyrosine phosphatase domain containing 1"	A2A3K4	9	94030794-94109856	"Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 36.1;Oligodendrocytes: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016747, HPA026832"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016747: AB_1855908, HPA026832: AB_10602917"	"unprognostic (3.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-2)"	3.7	5.7	7.8	2.2	14.1	0.7	3.1	9.7	12.4	3.1	2.5	4.3	1.4	3.1	2.2	2.0	3.3	2.2	7.0	8.0	8.9	3.3	1.5	4.4	1.9	10.9	11.5	3.0	5.9	3.6	6.7	1.7	10.8	3.2	2.8	4.4	2.9	2.0	4.8	3.1	2.3	4.1	6.7	1.8	4.3	7.8	10.2	1.8	3.3	6.7	1.9	2.5	2.7	18.3	6.1	2.7	4.7	6.1	5.8	7.9	6.2	4.4	3.0	4.4	3.7	2.6	5.0	5.1	2.9	3.4	10.1	4.7	4.9	2.8	4.3	6.8	1.3	1.2	7.7	2.8	7.4	1.4	3.8	7.9	10.0	6.7	9.2	2.6	4.7	8.3	3.0	0.0	8.4	3.3	5.2	2.2	3.3	5.0	4.8	5.6	9.3	0.0	2.4	1.5	4.1	5.1	6.1	5.7	9.5	6.2	3.1	2.5	6.7	5.8	3.5	9.1	5.4	7.2	8.4	0.7	4.3	2.5	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	14.1	9.7	12.4	8.0	8.9	10.9	11.5	10.8	6.7	10.2	18.3	5.7	0.0	7.7	19.2	4.7	4.8	3.0	2.2	5.7	10.7	2.3	3.3	11.3	5.7	1.4	5.5	10.4	0.4	2.6	2.1	3.9	3.1	11.7	2.3	7.3	5.8	3.5	0.8	36.1	2.9	2.0	8.1	14.3	3.1	5.7	6.7	4.2	1.0	3.1	5.0	27.0	2.6	4.1	1.0	4.6	6.2	3.7	3.6	3.6	14.0	0.5	2.2	0.0	18.6	82.6	6.1	2.9	14.3	2.0	1.4	1.1	1.7	2.1	9.8	19.7	7.4	5.5	21.0	20.8	4.7	4.3	0.3	4.0	2.3	2.3	1.8
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase non-receptor type 11"	Q06124	12	112418351-112509918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol"		NA	NA		74000	"Cluster 6: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli rim"	"Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	62.9	36.6	74.6	34.7	91.7	46.3	37.6	72.7	115.7	37.9	38.4	32.5	27.6	37.8	28.7	38.9	24.3	29.4	68.7	66.1	85.6	39.7	53.0	34.4	35.6	79.0	84.1	26.2	31.6	53.4	16.1	38.0	85.7	35.2	30.6	51.8	25.9	42.4	75.1	32.1	26.1	45.7	83.4	26.7	30.4	18.2	81.7	35.5	46.8	64.0	32.5	40.1	23.5	106.3	116.9	107.6	77.0	73.4	109.7	106.1	92.7	136.4	148.2	105.5	78.5	107.7	43.4	124.5	69.4	127.4	66.7	68.1	100.1	121.6	173.8	93.1	85.0	181.5	102.6	59.8	109.2	145.8	108.0	86.6	119.6	113.6	159.8	101.3	88.7	92.0	140.2	41.3	103.3	83.2	101.0	69.7	94.1	112.3	73.4	102.4	114.6	70.5	97.3	126.7	53.3	66.1	133.7	99.8	85.2	77.6	114.8	97.8	108.1	122.9	110.0	74.2	121.8	79.4	141.6	120.2	102.2	99.7	117.7	32.2	11.7	16.8	14.8	10.2	14.0	18.1	13.3	12.4	13.6	20.8	15.3	11.9	10.7	12.6	13.7	18.3	10.9	7.2	74.6	91.7	72.7	115.7	66.1	85.6	79.0	84.1	85.7	83.4	81.7	106.3	49.0	60.9	68.2	27.7	25.8	25.6	39.9	25.3	20.5	29.9	40.5	32.4	131.6	24.3	41.8	36.8	16.7	23.5	34.2	25.4	33.2	37.5	63.1	31.3	92.6	46.2	13.1	21.7	67.6	42.8	25.3	35.8	21.9	40.9	28.4	33.1	26.0	101.5	26.8	13.5	54.7	22.0	18.3	33.3	21.6	28.5	51.6	31.8	14.2	40.3	31.1	59.8	29.9	32.6	73.0	59.3	19.6	79.7	37.0	73.4	16.6	39.8	23.5	22.2	32.9	58.2	49.2	7.1	6.6	37.5	27.4	35.2	31.7	30.5	22.2	66.8
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 124.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 223.1;Astrocytes: 165.2;Oligodendrocytes: 200.2;Rod photoreceptor cells: 179.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 117.6;RT4: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	14.0	6.7	9.9	3.0	16.6	0.3	11.7	8.1	10.8	18.8	22.4	5.2	0.8	13.1	25.5	22.2	13.0	7.7	6.1	14.2	10.6	26.6	1.4	22.9	5.2	16.7	13.1	28.7	4.9	17.5	16.8	3.3	10.5	11.0	2.4	124.3	6.6	10.6	1.0	55.9	2.6	7.9	8.2	4.0	4.1	15.8	13.8	7.6	20.8	5.0	11.5	20.7	22.7	20.4	13.8	6.8	117.6	11.5	48.2	41.9	0.0	25.0	51.0	9.4	11.7	0.1	6.8	0.0	5.3	28.0	3.3	44.4	20.6	37.9	18.0	0.3	15.1	11.4	14.6	0.0	5.9	20.5	0.1	27.2	11.8	6.8	22.4	19.7	0.0	0.0	0.0	19.2	0.0	6.2	1.8	7.4	26.5	0.0	5.1	4.1	0.0	0.0	35.6	57.2	6.8	9.8	7.4	16.4	13.3	18.8	9.6	0.7	0.0	9.1	6.9	0.2	3.3	19.8	0.0	0.0	9.5	0.0	4.0	0.0	0.1	0.0	0.1	1.3	0.9	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	9.9	16.6	8.1	10.8	14.2	10.6	16.7	13.1	10.5	8.2	13.8	20.4	5.3	48.1	223.1	165.2	0.6	109.4	25.6	26.3	79.1	11.6	11.2	8.9	1.8	11.5	52.0	47.8	91.8	0.2	0.3	0.1	3.9	5.0	23.2	16.9	49.4	3.7	4.8	0.8	67.0	3.7	0.1	28.8	4.1	7.7	5.1	7.5	3.6	0.1	0.3	1.7	39.3	1.1	8.2	1.4	10.6	20.8	45.7	4.5	19.6	51.5	0.5	20.3	0.0	75.4	200.2	6.2	2.7	32.7	3.0	16.0	0.1	10.9	27.3	179.0	13.1	10.1	20.8	25.4	20.5	97.8	99.4	0.3	6.6	14.0	0.7	52.5
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase non-receptor type 14"	Q15678	1	214348700-214552449	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281"	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	7.5	8.0	3.7	1.8	1.5	0.2	10.6	1.5	3.7	5.2	13.4	7.6	0.9	8.2	2.5	6.0	7.3	3.3	6.0	3.3	0.8	8.2	0.7	4.6	1.3	2.4	2.4	6.6	4.3	3.3	1.8	7.8	2.1	6.7	2.3	0.6	6.5	6.6	19.8	16.2	2.8	7.9	1.4	3.5	4.5	3.9	4.2	2.1	5.3	10.2	1.8	5.6	5.6	1.9	21.1	9.2	7.2	10.6	12.3	20.9	21.6	23.2	21.3	17.3	14.4	18.8	10.7	0.1	25.3	53.6	10.0	18.1	10.0	25.7	29.0	0.2	7.7	1.9	26.6	3.5	22.2	0.2	1.0	15.6	26.1	30.0	47.4	28.1	33.8	0.6	0.1	0.2	41.8	2.3	0.2	0.2	16.2	3.7	9.9	0.3	36.3	0.1	30.6	10.5	0.1	1.7	28.7	18.4	11.6	25.1	18.4	0.7	61.4	40.3	15.9	14.6	33.3	1.2	0.1	0.2	21.6	0.3	34.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.7	1.5	1.5	3.7	3.3	0.8	2.4	2.4	2.1	1.4	4.2	1.9	60.3	73.7	12.6	47.3	1.3	56.5	32.1	39.4	45.5	0.6	20.3	29.8	20.5	14.3	32.7	29.5	0.0	38.8	1.3	1.0	7.9	12.9	8.8	42.5	25.9	53.5	3.5	0.0	47.9	11.0	14.2	20.8	9.2	55.2	1.3	13.5	40.0	0.9	4.5	0.0	6.0	4.1	4.1	1.5	7.7	4.4	26.1	2.4	10.6	91.8	0.3	3.9	3.1	39.2	2.1	31.2	0.3	29.3	1.6	30.6	0.3	14.4	18.5	1.3	19.7	38.0	20.1	1.2	10.6	18.3	36.1	24.2	3.7	46.3	2.9	28.9
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	23.4	15.2	10.0	32.8	10.8	57.2	23.7	21.0	17.1	19.9	15.6	22.2	18.9	16.0	20.4	20.0	17.4	22.4	14.7	11.0	10.4	17.3	25.8	26.3	44.4	12.3	10.4	26.8	33.1	14.1	18.3	19.5	11.8	17.6	24.1	20.2	29.4	13.5	16.7	21.0	19.5	16.9	10.7	28.5	18.0	13.6	10.0	99.8	17.5	11.9	43.5	37.2	19.9	14.3	34.8	20.7	23.7	7.9	26.5	47.4	23.0	22.7	50.2	47.5	42.2	45.4	48.8	54.3	37.2	23.6	53.2	20.4	39.0	62.2	62.1	21.2	23.5	38.4	17.7	47.6	36.4	91.1	35.1	40.2	57.6	43.3	85.1	29.2	24.6	58.1	37.9	71.6	38.6	39.9	91.3	74.5	28.5	141.7	24.0	30.4	37.3	61.9	40.2	54.6	42.3	22.0	46.0	26.7	41.8	25.1	22.4	51.5	18.8	59.8	58.0	45.1	49.8	22.6	24.5	77.8	28.3	49.3	25.7	23.7	52.6	39.2	37.0	47.7	50.4	54.4	43.7	41.4	62.5	39.5	31.6	34.9	19.0	64.1	46.7	53.0	57.3	40.7	10.0	10.8	21.0	17.1	11.0	10.4	12.3	10.4	11.8	10.7	10.0	14.3	25.8	35.3	77.0	38.5	82.4	59.9	106.0	88.0	61.5	44.1	37.0	50.5	15.0	47.1	84.4	14.7	104.3	54.1	130.4	32.2	13.7	55.1	24.3	51.0	44.8	32.0	32.3	40.8	81.1	68.8	52.5	38.1	24.5	78.7	56.4	53.1	20.3	27.9	51.3	15.2	60.5	35.0	69.2	99.2	92.5	23.2	29.2	93.4	23.2	44.0	137.0	17.6	128.8	22.6	55.0	40.0	45.1	25.6	120.2	126.4	29.9	23.1	55.4	84.5	19.7	35.4	33.8	23.3	61.3	40.0	50.2	81.1	84.2	65.2	39.5	152.4
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	4	"B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	2.0	1.5	0.2	11.5	0.2	38.0	2.3	0.4	0.5	1.8	0.6	4.0	6.4	1.0	1.1	1.7	0.9	4.8	0.6	0.1	0.2	0.6	2.0	7.5	20.3	0.5	0.2	0.6	1.3	0.3	0.3	0.8	0.4	1.0	4.3	0.4	1.3	0.6	0.3	0.9	8.6	1.6	0.2	13.2	5.2	1.4	0.6	20.0	0.7	0.2	13.5	4.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.4	0.0	0.7	0.0	0.4	69.3	0.1	0.2	0.0	0.0	0.0	0.1	0.5	6.5	0.0	10.0	0.0	0.0	0.2	27.7	21.1	5.7	0.0	2.8	0.2	5.1	10.6	17.2	0.1	15.7	10.3	0.2	20.1	15.7	0.0	0.1	0.0	1.2	6.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	5.0	16.0	0.3	0.4	0.5	29.2	6.6	37.5	11.1	28.4	0.1	15.8	4.8	25.0	17.0	1.3	20.1	9.9	8.4	13.6	8.7	7.4	5.0	12.1	2.4	11.0	0.6	5.2	14.5	7.3	0.2	0.2	0.4	0.5	0.1	0.2	0.5	0.2	0.4	0.2	0.6	0.8	2.2	0.0	6.5	0.7	67.4	2.5	0.2	0.0	1.2	0.7	2.2	2.4	0.8	0.0	0.2	1.8	2.1	0.1	176.0	2.2	0.0	0.1	0.4	0.7	0.5	1.7	0.0	16.6	3.2	0.6	0.3	2.2	12.8	1.0	27.8	0.0	0.4	0.5	7.1	0.0	2.5	1.2	0.0	17.3	26.8	1.0	0.0	26.4	3.6	2.8	14.4	0.0	108.1	0.0	1.7	0.5	0.8	0.0	79.6	0.3	4.3	0.1	2.2	0.5	13.1	0.6	1.4	0.4	0.6	0.3	2.7	0.1	151.2	0.0	2.2	0.3
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase non-receptor type 23"	Q9H3S7	3	47381011-47413435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	18.5	19.1	6.2	12.6	9.2	14.7	17.4	5.8	10.5	23.3	5.1	16.3	14.3	20.9	7.5	19.0	19.2	8.4	13.2	7.1	7.2	17.5	14.0	18.7	9.1	8.8	7.2	23.5	20.2	23.5	30.9	11.6	8.5	18.7	6.5	8.5	20.0	11.4	30.0	26.4	18.4	8.8	5.5	20.0	16.1	15.6	7.7	8.0	27.1	8.9	7.3	18.5	20.4	14.4	21.5	29.9	16.4	21.4	21.0	16.0	15.8	19.2	18.9	17.5	14.8	25.0	20.7	15.1	17.2	21.9	31.2	19.0	14.3	20.8	8.5	14.3	15.1	21.0	22.2	24.0	23.0	12.3	27.5	21.4	20.9	22.9	23.2	12.4	21.7	12.5	15.9	20.3	19.0	30.2	11.5	10.4	17.5	14.9	20.1	7.2	7.9	18.5	13.2	40.9	8.6	20.6	17.1	35.6	13.6	9.8	20.3	12.0	22.4	26.7	22.2	37.7	27.5	28.8	20.4	8.7	29.0	11.6	19.5	0.8	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.3	0.3	6.2	9.2	5.8	10.5	7.1	7.2	8.8	7.2	8.5	5.5	7.7	14.4	11.1	9.6	7.0	17.0	8.2	8.0	5.2	6.9	13.6	11.7	9.5	8.0	8.7	8.6	9.5	5.5	14.6	10.6	11.0	15.7	1.9	10.5	2.1	10.3	13.7	12.4	7.3	2.5	9.8	8.9	7.9	9.1	26.5	21.1	2.5	14.9	11.4	12.7	13.9	16.8	12.0	16.3	20.3	10.4	5.5	3.1	19.3	9.5	12.4	7.5	8.7	8.8	6.2	9.5	14.3	13.5	10.4	13.5	15.4	9.3	14.6	9.4	12.6	14.2	6.6	10.2	8.8	13.6	13.3	13.2	10.9	9.3	8.9	9.4	12.8	8.2
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase non-receptor type 4"	P29074	2	119759922-119984899	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 224.3;Horizontal cells: 161.5;Inhibitory neurons: 187.5;NK-cells: 247.2;Oligodendrocyte precursor cells: 200.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 37.3"	"Group enriched"	"Detected in many"	4	"gdT-cell: 35.0;MAIT T-cell: 28.1;memory CD4 T-cell: 16.9;memory CD8 T-cell: 27.9;naive CD8 T-cell: 19.2;NK-cell: 24.4;T-reg: 11.0"	"Group enriched"	"Detected in many"	16	"NK-cells: 24.4;T-cells: 35.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	4.5	3.8	5.9	3.6	5.0	5.1	4.7	37.3	10.1	5.7	0.0	3.4	5.1	4.1	4.2	4.1	5.5	3.7	5.7	5.2	2.7	7.4	4.2	5.2	5.4	0.1	9.6	5.2	2.8	6.3	3.5	2.5	1.4	3.5	2.4	12.1	4.1	2.5	8.0	3.0	2.8	2.8	0.0	5.9	5.7	4.9	12.6	8.1	14.0	12.8	4.2	3.2	2.6	5.9	7.4	4.3	5.0	7.3	4.8	5.0	9.1	3.2	9.3	1.8	4.9	6.2	10.9	4.1	7.6	3.5	5.2	5.3	4.4	5.1	4.8	12.6	3.6	3.7	3.5	6.1	3.2	3.9	2.6	4.5	9.6	8.5	3.7	6.0	8.2	4.8	5.7	4.8	5.0	5.0	5.2	4.4	7.3	4.0	6.9	3.4	9.6	6.9	6.7	10.0	6.8	8.5	4.2	5.8	4.0	4.0	2.8	2.4	10.7	0.0	6.1	1.9	4.0	8.9	13.7	6.6	4.7	0.1	3.0	0.3	0.2	1.8	35.0	0.5	28.1	0.6	16.9	27.9	0.5	0.6	5.2	19.2	0.6	24.4	0.7	0.3	11.0	10.4	5.9	5.0	37.3	10.1	5.2	2.7	0.1	9.6	1.4	0.0	12.6	5.9	20.5	3.2	14.6	128.9	24.4	8.2	15.5	8.5	27.3	55.7	13.9	11.2	17.9	10.0	8.3	16.5	104.3	10.5	95.5	7.3	7.9	8.0	5.4	18.2	15.7	15.0	9.1	35.4	224.3	7.3	11.8	11.3	16.8	15.8	11.4	47.9	15.0	11.0	4.0	161.5	187.5	9.9	12.2	8.6	7.6	8.8	17.4	9.0	8.8	38.4	11.8	24.9	247.2	200.6	113.6	6.3	9.6	14.3	30.1	12.7	10.6	13.6	8.8	79.8	0.0	25.5	9.0	31.4	26.4	12.8	6.7	3.7	79.4	23.3	11.5	9.5
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 131.8;lymphoid tissue: 153.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 214.6;granulocytes: 137.3;Hofbauer cells: 191.6;Kupffer cells: 146.5;Langerhans cells: 118.2;Macrophages: 152.1;NK-cells: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 170.9;HL-60: 154.3;HMC-1: 648.7;THP-1: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		6000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	14.4	15.6	3.7	102.5	3.9	131.8	11.0	4.3	4.2	11.1	6.0	21.9	30.4	6.2	10.2	12.8	13.9	20.3	4.9	3.6	5.2	12.2	19.3	49.7	153.5	7.0	4.6	2.9	11.9	13.7	10.0	19.8	6.3	11.7	21.3	0.7	17.0	9.0	2.0	18.8	42.0	12.3	5.9	128.0	28.0	3.1	6.3	71.3	12.6	4.5	127.3	27.0	7.5	10.6	16.4	30.8	0.2	0.1	0.1	0.0	28.5	0.0	0.0	0.0	0.0	16.5	36.0	11.9	8.4	0.0	0.0	18.3	0.3	21.6	0.0	7.3	6.5	170.9	3.4	13.9	0.0	154.3	648.7	0.1	15.4	0.0	6.5	0.0	0.0	60.0	0.3	1.3	0.0	34.5	55.4	92.2	8.3	38.0	5.1	50.4	0.2	86.5	16.7	30.2	2.7	0.0	5.2	24.9	0.2	20.9	7.7	259.8	0.4	0.0	0.2	0.1	0.2	0.4	0.2	5.5	0.4	66.3	0.5	676.7	368.3	1112.5	263.4	728.6	169.3	595.0	125.3	195.9	377.0	650.0	142.7	182.6	674.8	238.6	1117.7	98.7	146.8	789.3	3.7	3.9	4.3	4.2	3.6	5.2	7.0	4.6	6.3	5.9	6.3	10.6	10.5	6.4	13.8	0.7	214.6	9.1	8.2	18.8	29.6	0.0	8.6	10.0	2.1	11.5	15.3	5.5	0.0	25.6	77.7	16.0	15.6	15.8	50.4	12.1	1.5	7.5	24.7	22.9	0.9	15.4	18.3	3.0	25.0	11.8	137.3	10.9	8.9	11.6	191.6	0.0	0.9	13.2	18.3	146.5	118.2	10.5	0.9	152.1	14.2	3.7	99.7	0.5	154.5	2.0	0.1	12.6	16.9	0.0	53.5	3.9	22.8	14.3	17.2	0.5	6.6	1.6	4.0	0.3	1.3	14.6	8.7	18.5	86.2	24.5	15.6	7.8
PTPRA	"HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA"	ENSG00000132670	"Protein tyrosine phosphatase receptor type A"	P18433	20	2864184-3039076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029412, CAB034366, HPA069480"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.43e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.24e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.29e-6)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-1)"	48.8	36.6	83.9	31.9	89.3	39.6	47.4	84.2	96.1	56.4	59.5	41.6	31.0	53.0	36.7	46.1	52.7	43.7	29.5	87.7	83.5	44.2	28.6	45.4	38.9	74.7	81.9	55.8	31.2	81.9	44.8	60.8	78.3	46.3	40.6	61.5	36.3	41.9	16.9	45.8	32.7	52.4	76.3	39.4	34.5	43.4	92.6	59.6	65.5	30.7	44.3	46.6	38.9	81.1	74.0	44.2	124.7	38.4	134.4	243.3	26.5	54.1	105.1	65.5	79.6	53.1	99.5	48.1	41.6	73.1	66.1	77.2	51.0	77.4	73.4	74.7	32.7	68.5	18.3	68.0	48.1	69.5	31.1	109.8	78.2	54.4	56.8	80.3	92.0	67.7	69.9	59.7	65.8	30.4	80.8	78.3	48.3	66.0	35.0	61.0	60.5	60.3	55.1	56.2	68.7	65.7	52.3	87.8	81.4	54.0	55.2	58.7	66.5	58.1	28.6	65.6	48.5	43.4	64.7	62.7	26.9	64.5	55.7	5.7	2.8	4.8	6.1	2.9	4.9	5.3	4.0	4.4	2.1	2.6	4.0	4.8	3.3	4.0	4.3	3.2	4.9	2.3	83.9	89.3	84.2	96.1	87.7	83.5	74.7	81.9	78.3	76.3	92.6	81.1	87.0	22.4	19.2	128.6	46.7	15.8	34.0	15.0	34.7	88.9	49.0	43.9	10.1	54.3	24.5	46.0	31.3	35.3	111.7	39.8	27.4	14.8	17.0	62.0	109.0	39.7	44.3	42.3	138.2	15.8	40.5	67.5	25.0	55.3	22.9	60.3	43.5	33.6	39.4	70.7	136.4	27.9	24.4	37.6	20.4	17.2	60.3	40.1	37.4	52.5	29.9	88.3	110.2	102.5	147.5	16.6	30.2	48.9	58.6	32.9	27.1	23.6	26.6	60.5	39.5	53.3	61.8	68.7	84.1	32.9	17.2	32.7	59.7	41.4	30.4	31.5
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase receptor type D"	P23468	9	8314246-10612723	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.8"	"Group enriched"	"Detected in many"	12	"Excitatory neurons: 4579.7;Inhibitory neurons: 1152.9;Oligodendrocyte precursor cells: 1170.2;Oligodendrocytes: 3151.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.1;HAP1: 4.3;HSkMC: 6.3;RH-30: 8.1;SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		20000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.1	0.6	10.8	0.3	24.7	0.1	0.9	12.2	26.2	5.6	0.0	3.3	1.8	2.4	0.2	0.6	2.2	1.0	2.5	14.4	7.2	6.6	3.6	4.6	0.0	14.6	10.1	12.1	1.3	18.7	4.3	5.3	19.1	1.9	2.5	6.4	0.5	0.6	0.9	0.7	5.0	1.0	10.4	0.4	0.9	1.6	17.6	0.7	3.4	0.8	0.0	2.2	3.4	70.8	0.0	0.1	21.1	0.0	0.3	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	2.7	3.6	0.5	0.0	0.0	0.0	0.1	6.3	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.6	0.0	3.4	0.0	3.2	2.3	8.1	0.0	1.8	0.0	4.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.7	12.2	26.2	14.4	7.2	14.6	10.1	19.1	10.4	17.6	70.8	0.5	0.0	3.2	199.2	0.1	0.5	0.4	3.2	6.2	134.2	0.3	0.1	6.5	27.1	1.8	5.5	16.7	0.3	0.0	16.4	0.0	3.6	15.8	0.8	15.0	1.2	35.4	0.0	4579.7	0.0	0.3	15.5	0.5	1.0	0.0	9.2	1.4	13.5	1.3	5.0	1152.9	13.2	0.0	0.8	0.0	6.5	15.8	1.6	0.0	85.3	0.1	36.1	0.0	1170.2	3151.1	0.2	9.2	0.0	2.7	2.1	18.3	26.3	0.2	7.8	0.0	4.0	5.8	2.4	3.2	0.4	0.9	0.3	0.8	6.0	8.7	0.1
PTRHD1	"C2orf79, LOC391356"	ENSG00000184924	"Peptidyl-tRNA hydrolase domain containing 1"	Q6GMV3	2	24789728-24793391	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019951	Approved		Approved	Nucleoplasm		NA	NA		100000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA019951: AB_1853109"	"unprognostic (1.28e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.99e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	10.6	26.0	11.7	4.3	11.8	16.1	11.0	12.2	17.5	8.7	13.7	12.8	10.6	7.2	3.5	17.6	6.4	4.2	16.4	12.5	12.6	14.9	14.9	10.2	8.4	12.4	11.9	10.2	13.7	3.6	10.8	6.4	12.6	10.6	5.8	3.0	15.1	4.0	23.9	14.8	11.9	3.3	12.5	11.2	12.3	9.1	12.8	7.1	14.5	8.5	6.2	9.4	10.3	13.0	18.2	40.2	12.7	5.5	6.9	15.2	22.1	12.2	11.3	15.4	9.9	39.7	15.9	14.2	5.2	12.7	10.3	11.7	10.4	11.1	5.1	20.1	70.0	25.7	18.2	43.2	14.2	21.8	23.5	14.6	8.9	7.1	7.9	12.3	14.4	12.8	26.4	11.2	11.4	36.6	17.7	39.0	26.8	10.6	23.7	14.9	38.9	23.9	18.1	31.2	19.9	30.9	13.6	18.1	16.4	5.9	17.7	15.9	24.2	13.6	21.4	6.7	11.2	8.7	28.1	15.4	12.4	13.3	9.3	34.8	90.6	20.7	52.6	66.9	26.8	96.4	51.4	46.2	144.5	81.2	46.6	54.8	10.4	52.8	50.1	149.0	84.4	97.0	11.7	11.8	12.2	17.5	12.5	12.6	12.4	11.9	12.6	12.5	12.8	13.0	27.8	51.3	61.5	1.0	65.0	119.8	79.4	123.3	72.3	10.5	171.4	239.4	81.0	60.1	83.8	66.2	6.2	200.0	87.9	127.0	115.4	91.0	130.9	53.5	37.5	46.9	88.1	68.1	1.9	142.0	153.7	57.4	50.4	48.8	41.2	121.1	62.4	101.5	134.5	1.7	2.2	158.2	79.3	112.5	154.3	157.1	47.2	79.9	67.6	3.7	154.6	78.7	65.9	1.0	2.3	124.2	128.8	39.9	46.6	74.3	120.9	199.2	107.1	12.2	72.3	34.5	56.0	135.6	78.6	133.6	141.8	167.7	52.5	110.4	162.2	125.3
PTTG1IP	"C21orf1, C21orf3, PBF"	ENSG00000183255	"PTTG1 interacting protein"	P53801	21	44849585-44873903	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034146, HPA061827"	Uncertain		Supported	Nucleoplasm		NA	Yes		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB034146: AB_1568894, HPA061827: AB_2684620"	"unprognostic (1.78e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (5.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.90e-1)"	127.8	131.8	147.6	98.4	158.9	92.0	114.0	150.8	146.8	131.1	131.1	132.7	123.2	132.4	118.5	89.1	109.4	141.8	164.3	138.1	168.7	157.6	130.5	160.5	75.3	178.8	152.9	110.7	85.6	84.1	68.8	180.1	169.9	108.5	111.5	29.7	118.3	151.4	70.7	88.9	127.3	145.0	152.0	97.7	169.9	66.9	175.3	57.9	127.4	63.2	62.0	139.6	93.3	157.5	245.3	134.6	155.3	148.2	300.6	174.8	127.0	212.9	309.8	174.1	166.6	290.0	323.9	32.9	789.8	344.4	417.0	109.8	73.0	140.2	161.1	56.3	81.0	254.3	80.0	260.1	293.8	97.6	83.5	269.9	225.1	189.1	130.8	346.3	376.6	88.6	131.7	83.1	539.5	106.0	71.0	99.5	166.8	352.9	169.8	70.4	158.4	162.0	735.6	82.7	117.2	182.0	240.0	262.5	482.0	188.7	203.7	163.7	511.8	216.9	126.5	170.6	340.0	78.5	79.4	42.2	146.7	220.6	199.8	336.2	181.2	109.1	48.4	146.7	79.5	25.5	62.7	51.3	203.3	23.6	59.7	41.0	248.8	67.3	167.0	92.5	87.3	223.7	147.6	158.9	150.8	146.8	138.1	168.7	178.8	152.9	169.9	152.0	175.3	157.5	140.9	394.2	169.6	39.8	28.0	50.7	84.1	181.3	61.5	14.6	102.0	96.8	173.0	75.8	248.9	145.3	6.2	218.6	56.8	321.4	49.0	323.0	51.5	115.0	115.0	191.6	79.3	37.8	8.5	120.6	72.7	117.1	140.6	187.7	81.5	181.3	124.2	102.2	109.3	11.8	10.7	89.1	130.2	88.0	69.6	98.7	72.1	136.3	87.2	22.5	91.1	78.8	51.5	20.1	31.9	294.3	255.2	98.9	36.4	112.8	268.1	71.2	192.3	15.2	65.7	61.1	127.9	73.7	43.4	92.4	42.9	366.7	45.6	54.6	100.3	169.9
PUDP	"DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A"	ENSG00000130021	"Pseudouridine 5'-phosphatase"	Q08623	X	6667865-7148158	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000292, HPA072672"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA000292: , HPA072672: AB_2732208"	"unprognostic (1.84e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.00e-3)"	"unprognostic (3.22e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (3.42e-2)"	8.3	9.1	8.3	12.4	8.8	3.5	8.8	9.2	8.6	9.3	10.6	17.4	18.0	6.4	4.8	8.4	19.9	8.2	20.4	8.0	10.3	15.1	9.8	11.9	16.8	9.0	8.7	10.4	6.7	8.4	3.7	20.1	9.7	6.9	12.3	7.4	11.1	7.7	33.0	5.1	12.3	10.9	8.8	8.9	19.3	4.4	10.1	13.3	10.3	20.2	14.1	9.2	7.2	9.6	48.0	42.1	68.4	28.3	34.7	34.0	11.8	14.8	15.7	18.6	18.7	64.2	28.7	21.9	31.5	16.5	61.5	14.4	31.7	37.9	28.1	20.1	60.4	23.4	15.7	35.7	16.3	20.7	24.4	16.5	14.6	50.7	23.0	12.1	56.2	27.2	45.3	17.8	29.3	23.3	22.5	30.6	29.1	19.9	21.1	16.2	26.0	60.8	26.7	18.0	15.4	16.1	12.7	24.4	25.5	59.6	27.2	18.9	17.4	10.4	6.6	43.7	13.0	55.6	0.2	33.8	15.9	11.5	21.5	2.6	17.8	2.2	7.4	18.9	7.6	8.1	7.8	7.1	13.6	5.9	5.8	6.5	1.9	6.8	19.3	4.3	12.2	10.1	8.3	8.8	9.2	8.6	8.0	10.3	9.0	8.7	9.7	8.8	10.1	9.6	6.6	12.8	4.6	0.0	7.8	0.0	4.1	0.0	5.7	3.9	5.2	3.9	0.0	15.7	3.7	18.4	4.2	48.0	2.4	20.8	9.8	21.1	0.4	10.7	5.3	7.0	0.0	3.4	0.0	16.9	27.6	4.6	10.2	6.1	1.3	10.7	6.8	11.1	22.1	5.0	0.0	10.7	0.0	19.8	0.0	1.6	6.2	8.3	0.0	0.0	13.2	11.9	1.0	0.0	0.0	19.7	20.8	4.9	14.6	8.0	23.5	24.6	5.1	3.9	6.6	6.1	4.0	11.1	15.9	6.0	0.0	28.2	4.8	9.4	14.6	6.1
PUF60	"FIR, RoBPI, SIAHBP1"	ENSG00000179950	"Poly(U) binding splicing factor 60"	Q9UHX1	8	143816344-143829352	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 332.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045733, HPA052096, HPA059714"	Enhanced		Enhanced	Nucleoplasm		NA	NA		70000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110"	"unprognostic (3.49e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.42e-2)"	71.6	73.5	7.9	11.0	7.6	39.6	75.5	8.1	22.9	71.4	5.3	84.8	22.3	84.9	5.9	84.9	76.3	7.3	88.5	7.8	15.4	82.8	124.3	64.0	17.7	12.2	11.6	57.2	62.9	11.7	71.0	19.2	14.1	67.2	5.8	1.3	63.3	17.8	125.5	108.7	69.5	10.5	7.3	72.3	73.2	70.8	14.5	15.9	59.8	9.0	9.7	74.5	68.6	12.4	95.7	211.5	36.7	31.3	16.6	15.6	62.7	74.4	27.4	70.3	75.1	95.4	103.9	89.4	71.2	58.9	52.8	83.0	86.5	91.4	3.6	91.4	147.7	110.2	117.0	106.3	60.4	38.5	70.0	45.4	61.8	89.8	26.9	21.1	69.0	92.1	88.7	37.4	20.5	332.5	156.1	26.4	77.8	63.3	191.6	84.2	42.9	91.8	19.5	91.8	71.5	80.3	101.6	40.4	77.7	9.1	116.7	21.4	79.0	72.9	176.2	85.7	98.6	66.7	103.9	109.7	70.7	73.3	71.9	90.8	112.6	99.8	129.0	133.7	139.3	116.8	103.1	128.6	127.1	135.9	98.6	113.1	58.8	132.6	137.6	76.8	139.0	193.9	7.9	7.6	8.1	22.9	7.8	15.4	12.2	11.6	14.1	7.3	14.5	12.4	70.2	38.5	46.4	21.5	64.7	107.7	102.1	197.4	65.4	62.8	51.3	67.9	63.7	51.5	103.0	29.5	29.2	146.6	56.4	98.0	92.0	110.7	20.5	65.6	55.3	67.3	66.9	65.0	8.2	89.8	134.3	68.4	74.9	60.3	55.8	75.0	41.7	76.8	101.1	43.7	8.3	75.9	118.0	44.0	62.3	47.8	64.0	52.3	90.7	6.5	105.2	182.6	81.4	9.5	23.7	98.2	91.4	59.0	52.7	83.0	91.9	118.1	85.4	64.8	65.7	57.1	122.9	104.2	128.5	63.1	107.1	173.3	74.2	99.3	97.7	81.2
PUM1	"KIAA0099, PUMH1"	ENSG00000134644	"Pumilio RNA binding family member 1"	Q14671	1	30931506-31065991	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	RNA-binding	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027424, HPA027449"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoplasm	"HPA027424: AB_10602918, HPA027449: AB_2672281"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.62e-8)"	"unprognostic (1.57e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.74e-1)"	27.8	26.0	33.4	22.5	34.3	52.0	31.9	37.5	37.8	28.0	28.5	26.7	22.5	32.2	29.3	25.7	35.0	22.7	28.6	33.7	42.5	28.7	25.9	25.6	26.2	27.0	30.0	40.3	27.5	39.3	19.2	32.4	28.0	27.3	29.4	38.4	30.3	28.0	46.1	32.7	22.6	31.6	27.8	25.7	26.3	18.4	45.5	35.1	34.9	38.3	26.1	27.1	26.0	31.5	33.7	43.7	70.4	44.7	54.1	46.5	48.2	39.3	47.9	40.3	45.5	46.0	56.6	39.3	40.2	53.8	25.2	48.2	58.3	43.4	51.4	33.2	50.8	42.8	50.7	56.0	37.9	52.6	39.2	50.0	53.3	53.5	56.1	52.8	55.6	36.9	60.0	36.1	46.5	28.1	51.6	37.8	72.2	42.0	30.2	53.1	48.0	42.3	58.7	50.0	58.0	44.0	54.5	41.7	47.6	77.6	42.1	39.3	58.5	33.2	29.8	44.7	39.7	28.8	28.3	42.5	29.7	38.3	43.0	44.1	31.3	24.8	31.0	30.3	31.7	23.9	27.5	30.3	32.0	21.1	31.0	32.0	19.6	37.9	34.5	18.5	35.9	31.0	33.4	34.3	37.5	37.8	33.7	42.5	27.0	30.0	28.0	27.8	45.5	31.5	66.6	73.7	58.8	85.2	56.9	90.2	53.8	41.2	56.3	54.6	63.2	58.7	80.7	61.5	46.3	36.8	79.2	52.6	66.4	56.4	23.5	44.0	32.2	139.8	98.0	61.5	104.7	34.3	87.0	36.4	42.4	56.8	55.0	154.6	18.3	105.1	43.2	61.0	34.0	33.7	87.5	65.6	24.4	78.3	49.8	21.5	72.1	50.4	17.8	102.1	56.6	41.6	69.0	111.6	101.7	58.1	45.0	80.5	41.7	84.6	28.8	49.2	42.7	59.2	32.9	81.6	65.5	36.4	24.4	62.9	93.6	78.0	50.5	63.6	75.8	95.5
PURB	PURBETA	ENSG00000146676	"Purine rich element binding protein B"	Q96QR8	7	44876299-44885530	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048766			Supported	Nucleoplasm		NA	NA		150000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA048766: "	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.22e-2)"	10.6	7.8	8.2	10.7	9.5	13.5	11.7	17.4	10.7	10.4	7.4	12.7	7.5	10.7	7.5	11.3	9.3	7.8	8.1	9.7	7.0	9.2	8.6	10.4	10.2	6.9	8.1	9.9	8.4	10.9	7.5	13.1	6.9	10.3	7.4	25.0	9.0	9.1	12.2	14.1	8.9	9.7	7.3	9.8	8.9	5.9	7.9	13.4	11.5	9.2	10.4	9.7	9.3	11.1	16.4	9.0	15.9	30.0	14.5	22.9	10.6	22.1	17.3	16.3	15.7	13.6	12.4	24.4	18.9	25.7	38.6	29.6	15.0	19.6	32.1	20.0	12.2	12.2	23.2	7.7	14.5	19.4	18.7	18.9	24.6	31.2	22.7	17.3	17.5	19.8	21.8	22.2	34.6	22.7	16.2	24.2	24.7	11.0	15.7	13.2	48.0	16.0	13.5	27.7	15.7	22.2	22.1	45.5	14.0	19.0	30.5	21.9	29.7	28.4	31.2	18.6	37.7	38.8	36.6	7.7	21.2	22.3	38.5	0.4	0.2	0.3	0.3	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.1	8.2	9.5	17.4	10.7	9.7	7.0	6.9	8.1	6.9	7.3	7.9	11.1	50.1	38.5	40.9	17.0	20.1	69.8	39.5	21.5	35.9	65.3	40.1	29.6	19.8	27.1	28.1	18.4	33.3	19.0	38.9	19.1	9.8	19.6	21.3	45.4	59.1	41.7	20.4	9.2	24.0	22.5	12.0	26.9	23.9	53.7	36.8	33.0	36.0	14.6	16.4	53.8	23.9	18.1	30.5	25.7	108.3	16.9	20.8	53.8	17.8	20.6	21.9	40.2	21.6	18.6	42.4	28.9	12.3	19.9	16.0	46.0	13.5	12.0	28.3	57.0	46.0	61.0	44.6	25.6	11.8	43.4	86.1	18.9	23.8	21.6	23.3	44.1
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;retina: 4.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 61.0;Excitatory neurons: 57.2;Inhibitory neurons: 69.5;Late spermatids: 22.0;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 27.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.1;JURKAT: 4.3;NTERA-2: 4.8;SH-SY5Y: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: AB_2680145"	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	0.3	0.4	7.7	0.2	8.3	0.0	0.2	10.5	9.0	1.3	0.5	0.3	0.1	2.0	0.6	0.2	0.4	0.8	0.4	8.7	7.7	0.4	0.0	0.2	0.2	6.6	6.7	0.5	0.0	0.0	3.0	0.2	7.4	0.5	0.1	4.1	0.3	0.6	0.1	0.0	0.2	1.3	6.1	0.6	0.2	2.6	7.3	0.1	0.2	0.2	0.1	0.2	0.8	6.5	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.1	0.3	0.5	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	2.0	0.0	0.7	0.0	3.1	1.1	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.9	0.0	0.7	3.0	4.3	0.3	0.4	0.1	0.0	0.6	0.0	4.8	0.0	0.2	1.6	0.8	0.0	0.0	0.0	0.8	5.7	0.0	0.0	0.0	2.2	0.0	0.0	1.9	2.0	2.5	0.0	0.3	0.2	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.3	10.5	9.0	8.7	7.7	6.6	6.7	7.4	6.1	7.3	6.5	0.5	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	13.3	0.1	0.3	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	17.3	0.2	3.2	0.5	0.0	0.0	57.2	0.0	0.0	1.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	20.2	69.5	0.0	0.0	0.0	0.3	22.0	0.6	0.1	0.0	12.2	0.0	10.8	0.0	49.3	27.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	1.3	4.2	1.5	0.0	0.0	0.0	0.1	1.8	0.0	0.0
PUS1		ENSG00000177192	"Pseudouridine synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA051636: AB_2681560, HPA057593: AB_2683479"	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.5	14.9	10.1	14.9	8.4	23.0	10.4	8.2	10.2	9.7	7.6	11.9	9.7	12.5	14.0	16.5	11.2	7.1	8.7	8.9	5.9	13.0	21.6	9.0	18.5	7.1	5.1	8.6	14.8	5.4	8.7	6.4	6.2	10.9	7.9	5.0	9.3	6.8	14.2	14.4	14.0	7.4	4.4	15.8	12.7	13.0	6.9	8.6	9.5	4.8	10.6	14.2	10.7	9.2	45.3	58.1	13.7	24.0	13.0	21.5	82.2	34.5	14.2	25.4	16.3	64.5	28.7	53.2	38.3	18.6	19.9	56.0	44.4	32.2	16.3	24.0	90.6	54.0	30.9	56.9	34.0	93.5	47.4	21.7	25.6	28.9	24.8	12.3	25.0	36.8	68.0	15.6	14.9	77.9	61.9	83.4	71.5	36.7	87.3	57.8	19.2	55.4	20.8	61.7	37.5	20.8	28.6	38.9	32.5	13.1	42.5	99.3	22.7	20.2	43.3	43.1	50.0	43.5	35.5	64.5	20.7	73.6	28.4	1.0	1.3	0.2	2.0	1.0	1.5	4.6	1.7	2.1	1.1	4.2	2.4	1.3	1.1	5.6	0.9	3.0	1.8	0.9	10.1	8.4	8.2	10.2	8.9	5.9	7.1	5.1	6.2	4.4	6.9	9.2	7.0	0.0	6.1	9.8	10.7	29.6	22.3	8.4	6.2	6.2	10.7	10.5	5.3	8.6	6.2	5.5	22.9	13.9	11.7	10.9	5.9	12.3	0.9	6.6	10.1	11.1	14.4	13.2	11.9	9.6	19.1	8.3	15.3	7.7	16.5	11.7	6.1	12.9	15.2	0.0	8.4	20.1	10.2	7.3	8.1	3.0	7.8	7.2	7.2	9.4	8.8	4.4	6.2	5.0	7.1	16.3	6.9	9.4	8.8	35.4	4.0	13.7	4.9	10.0	6.6	15.9	9.3	18.5	19.7	14.7	22.7	8.6	9.5	14.3	18.8	21.4
PUS10	"CCDC139, FLJ32312"	ENSG00000162927	"Pseudouridine synthase 10"	Q3MIT2	2	60940222-61018259	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044736, HPA049582"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies, Mitochondria"		"HPA044736: AB_2679066, HPA049582: AB_2680824"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.15e-3)"	3.6	3.7	2.7	4.1	2.7	5.1	5.4	2.9	3.4	3.0	3.2	3.6	7.5	3.3	6.4	2.7	3.7	4.1	3.7	2.7	2.5	4.8	15.0	4.9	6.8	2.7	2.6	4.8	4.0	3.9	2.9	3.2	3.0	4.8	4.4	3.9	3.8	2.6	3.1	4.9	9.3	2.7	2.9	4.8	3.4	4.5	2.9	4.5	6.9	1.8	6.8	2.6	1.6	3.6	3.2	1.7	4.9	8.4	4.1	4.6	5.3	6.1	5.5	6.0	5.6	4.8	4.4	12.8	6.3	3.4	5.4	4.2	5.7	4.9	7.4	10.0	2.9	9.0	2.5	15.9	7.6	10.6	5.8	5.3	6.0	4.2	9.4	7.7	7.9	9.1	9.2	6.4	4.6	2.7	8.0	8.7	4.4	3.0	3.5	7.7	6.6	4.7	4.3	6.3	2.8	3.9	5.0	9.7	9.9	3.5	3.4	6.3	5.9	5.7	4.6	3.9	4.7	8.1	3.8	23.6	5.0	6.8	6.5	9.1	1.2	1.1	2.3	1.3	2.5	3.0	1.4	1.6	0.9	1.7	1.7	1.9	2.3	3.1	4.8	3.0	1.0	1.1	2.7	2.7	2.9	3.4	2.7	2.5	2.7	2.6	3.0	2.9	2.9	3.6	6.6	0.0	14.3	20.5	6.8	2.4	3.5	3.3	1.8	6.6	5.9	2.8	5.1	1.5	4.3	3.7	0.0	7.0	8.1	11.9	7.9	3.7	1.6	6.2	4.3	5.8	1.2	5.9	28.3	5.1	4.7	3.1	5.1	8.5	0.0	9.9	4.6	16.3	5.8	1.7	21.7	2.5	4.1	5.7	2.1	1.8	3.1	4.6	1.8	14.0	9.0	7.0	7.2	19.1	24.4	3.5	3.0	1.5	4.6	3.8	26.7	6.3	7.7	7.1	6.6	3.1	3.0	13.9	13.4	3.9	2.3	12.4	6.6	8.2	4.5	10.6
PUS3	FKSG32	ENSG00000110060	"Pseudouridine synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: AB_2685126"	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.3	8.4	7.1	8.2	7.8	3.3	9.4	8.4	11.6	7.7	6.7	8.5	10.9	7.8	9.7	9.0	7.4	6.5	7.1	7.1	8.7	9.0	33.2	6.1	9.2	7.8	7.8	7.3	17.8	7.0	8.5	6.7	7.3	8.7	7.9	8.4	7.7	5.4	15.0	9.5	6.8	9.7	7.0	7.6	10.1	7.2	8.5	11.0	9.3	15.2	10.5	10.1	6.3	7.6	6.5	7.9	23.2	24.9	24.3	29.7	11.0	21.1	17.0	11.6	13.2	24.0	23.2	31.4	33.3	9.2	17.1	22.5	37.6	19.7	11.5	28.2	18.2	31.2	9.5	18.6	24.6	20.5	9.2	23.1	23.4	13.7	29.8	16.2	21.0	23.5	34.0	16.1	13.0	4.0	23.7	23.6	19.8	47.0	15.8	4.8	20.5	18.4	20.3	9.5	27.1	25.7	13.1	21.4	11.7	16.5	43.2	13.8	15.3	24.0	10.1	11.9	17.3	12.4	20.1	33.6	6.7	31.9	17.1	14.2	10.5	9.9	13.4	10.8	15.3	13.3	13.1	12.8	9.2	14.8	17.0	16.0	4.2	14.9	14.0	8.0	15.0	8.3	7.1	7.8	8.4	11.6	7.1	8.7	7.8	7.8	7.3	7.0	8.5	7.6	8.5	9.6	11.5	3.6	9.5	12.9	12.2	10.6	8.0	9.3	7.3	9.4	5.4	11.5	13.6	5.5	29.2	9.7	7.4	3.6	5.9	17.8	7.7	4.4	8.9	10.5	4.8	14.5	2.9	27.2	12.7	6.1	9.2	4.4	12.7	6.1	10.4	33.0	8.2	5.0	3.4	4.6	10.2	5.0	2.9	6.3	7.8	5.5	1.8	1.9	9.9	9.8	6.2	2.5	3.8	15.0	3.9	7.9	6.7	9.1	10.2	16.9	6.2	10.9	6.6	9.9	10.1	7.8	7.2	6.7	11.8	14.0	7.9	12.8	6.5	10.9
PUS7	FLJ20485	ENSG00000091127	"Pseudouridine synthase 7"	Q96PZ0	7	105439661-105522271	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024116	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024116: AB_1848754"	"unprognostic (3.07e-1)"	"unprognostic (1.52e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (4.89e-6)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (7.58e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (1.03e-8)"	"unprognostic (2.76e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (4.90e-2)"	7.1	3.5	3.6	5.5	3.9	3.2	7.4	4.7	4.1	5.9	3.0	5.3	4.0	5.6	3.0	7.7	5.2	3.2	4.8	3.6	3.2	4.4	6.3	4.6	4.3	3.5	3.2	4.3	6.0	6.5	2.7	5.1	3.6	4.4	5.7	2.3	4.7	3.9	11.0	7.8	3.4	6.5	3.0	2.8	4.2	4.6	3.1	3.0	7.6	4.8	5.3	7.2	6.2	4.1	32.1	18.2	18.0	29.4	13.6	14.9	19.9	14.7	13.0	25.5	20.9	24.5	12.7	17.5	24.7	15.6	22.0	25.0	33.0	17.9	39.6	12.9	26.4	26.2	17.2	25.8	16.1	42.1	9.9	15.2	20.9	21.5	27.9	9.5	27.2	16.2	59.8	14.6	17.9	39.8	48.4	39.4	44.6	39.5	23.6	29.1	26.5	81.5	31.0	23.3	30.2	28.5	29.3	53.0	21.3	20.5	19.2	9.9	16.6	37.4	25.1	49.3	32.5	11.0	24.4	46.9	13.1	35.7	33.1	0.0	0.8	0.2	0.9	2.0	2.1	2.0	1.3	1.0	1.2	1.3	1.1	1.2	0.1	1.4	2.0	0.0	0.9	0.7	3.6	3.9	4.7	4.1	3.6	3.2	3.5	3.2	3.6	3.0	3.1	4.1	8.5	6.4	9.0	13.1	4.8	13.4	13.9	5.0	13.1	4.0	8.2	6.5	3.8	1.5	6.0	1.8	2.1	5.6	2.8	3.6	1.9	9.5	1.7	7.0	14.3	10.4	7.2	8.4	43.2	7.2	10.2	8.6	8.6	5.5	11.4	4.3	4.2	5.1	4.4	0.0	27.9	4.1	2.0	2.8	6.0	1.8	4.1	3.3	0.0	11.2	4.0	1.5	3.1	8.5	23.8	7.6	3.2	1.9	6.7	18.3	1.0	5.6	4.3	3.2	0.0	14.3	10.4	1.8	9.7	13.7	9.8	3.4	3.9	15.6	8.0	8.2
PVALB	D22S749	ENSG00000100362	Parvalbumin	P20472	22	36800684-36819479	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 2129.3"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 641.8;Horizontal cells: 1527.7"	"Cancer enriched"	"Detected in many"	4	"renal cancer: 59.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Cell line enriched"	"Detected in some"	291	"RPMI-8226: 1561.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 2120.1"	"Low region specificity"	"Detected in all"			"CAB002515, HPA048536"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		No	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB002515: AB_563948, HPA048536: AB_2680433"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (8.99e-3)"	0.4	1.0	82.5	0.7	40.2	0.1	15.0	255.6	86.5	0.1	8.6	0.3	0.2	1.4	0.8	0.1	0.1	0.3	0.2	9.3	100.5	82.1	5.7	2.2	2.4	127.4	85.7	0.5	0.2	2129.3	1.2	2.4	105.7	0.3	0.3	373.5	2.7	0.7	13.6	0.1	0.3	0.5	50.9	3.2	0.8	1.5	275.5	0.3	5.0	0.4	3.1	3.8	0.2	51.8	0.0	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.1	0.4	1561.0	0.0	5.3	2.3	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	4.6	0.0	0.0	0.9	0.3	15.1	82.5	40.2	255.6	86.5	9.3	100.5	127.4	85.7	105.7	50.9	275.5	51.8	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	0.0	51.3	2.4	2.0	0.6	0.0	0.0	38.6	10.4	0.3	0.0	0.0	641.8	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	11.4	0.2	30.0	0.2	53.8	1527.7	29.7	0.0	0.0	2.9	0.0	0.1	0.6	15.7	0.0	2.8	0.1	37.4	0.0	3.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	150.5	0.0	1.0	0.0	0.0	3.6	0.0	0.0	0.4	0.9	0.0	0.0	0.1
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"PVR cell adhesion molecule"	P15151	19	44643798-44666162	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.5;intermediate monocyte: 4.5;myeloid DC: 3.8;non-classical monocyte: 5.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"TIME: 175.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012568, HPA064739"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA		720000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248, HPA064739: "	"unprognostic (2.90e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (2.75e-4)"	13.9	17.5	10.2	7.1	9.1	5.1	9.6	9.0	10.0	8.7	9.3	10.3	12.5	13.9	5.2	8.4	11.8	6.2	28.5	9.0	16.6	13.6	30.7	19.4	2.7	9.7	11.0	12.5	14.0	10.3	17.3	12.5	12.4	9.7	8.8	5.4	9.9	6.4	19.0	7.1	11.1	10.5	7.4	4.6	12.3	5.8	14.9	2.5	10.6	6.2	2.8	9.1	8.5	7.9	58.8	52.1	5.6	25.0	8.6	9.7	7.4	96.7	38.8	40.7	45.8	31.9	28.2	0.1	50.6	43.7	60.2	44.4	24.3	51.1	31.7	7.8	27.1	8.8	40.3	23.3	43.7	4.1	22.2	10.6	28.0	40.9	82.5	49.7	50.7	6.6	4.3	0.5	23.4	7.8	4.2	5.8	12.5	30.1	31.7	0.1	23.2	5.0	111.8	25.5	21.2	22.9	66.3	54.3	14.7	7.2	22.8	12.5	175.3	39.0	52.8	33.7	78.2	0.3	6.3	0.2	35.3	23.4	24.6	0.2	4.5	0.0	0.1	4.5	0.0	0.0	0.0	0.2	3.8	0.0	0.2	0.1	1.1	0.7	5.5	0.5	0.0	1.7	10.2	9.1	9.0	10.0	9.0	16.6	9.7	11.0	12.4	7.4	14.9	7.9	11.1	16.0	25.2	2.3	1.6	3.6	16.0	6.9	4.0	5.7	4.7	3.4	14.4	14.3	12.2	1.8	2.1	2.9	0.2	18.5	3.9	37.9	10.5	5.4	6.3	20.4	13.1	2.1	11.4	35.3	34.8	7.7	13.7	11.6	1.3	6.5	7.9	41.1	8.4	1.7	13.7	11.3	2.0	8.9	7.5	14.3	5.6	6.8	1.8	5.6	17.2	1.8	2.1	6.0	4.6	69.6	18.0	15.8	0.2	14.4	10.8	5.7	2.8	3.4	0.0	23.8	10.4	10.4	1.5	5.8	5.5	1.0	0.9	10.8	12.7	7.4
PWWP2A	KIAA1935	ENSG00000170234	"PWWP domain containing 2A"	Q96N64	5	160061801-160119450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046733, HPA058233"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Focal adhesion sites"	"HPA046733: AB_2679777, HPA058233: AB_2683647"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (7.25e-2)"	"unprognostic (8.24e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.51e-4)"	6.7	7.0	9.6	7.4	14.8	10.3	6.8	22.8	10.9	10.3	8.2	10.5	7.5	7.9	5.3	6.6	7.6	6.2	5.9	7.8	8.6	8.5	7.1	7.6	10.1	12.2	12.2	7.6	8.0	5.9	8.1	8.7	11.9	8.6	10.8	14.2	7.1	6.0	6.1	11.3	8.5	7.0	9.5	9.4	9.3	5.1	11.6	12.4	7.2	6.0	9.0	8.2	7.9	24.2	13.4	6.3	16.1	13.7	17.5	13.6	22.5	10.4	8.4	9.1	9.1	20.5	25.3	21.4	15.6	8.0	14.9	9.4	14.1	16.2	14.8	22.3	15.6	15.4	11.9	10.6	13.3	15.6	11.2	9.7	7.9	18.3	13.8	20.4	14.8	11.9	12.0	13.5	15.5	11.1	13.5	15.1	19.0	11.3	8.1	20.9	14.3	13.7	11.2	9.4	18.8	13.1	17.6	17.3	19.4	12.9	13.4	17.1	19.9	15.7	10.9	11.9	20.6	15.4	14.7	18.9	10.4	15.6	15.9	3.2	2.0	1.1	1.1	0.9	0.9	3.3	1.2	1.4	1.3	1.6	2.0	1.1	2.1	0.4	1.2	1.2	1.2	0.4	9.6	14.8	22.8	10.9	7.8	8.6	12.2	12.2	11.9	9.5	11.6	24.2	16.8	9.6	22.7	42.7	25.0	31.9	13.0	10.8	27.3	102.0	15.8	13.2	13.9	11.5	15.6	20.2	73.0	12.3	22.0	30.2	17.6	13.7	2.1	18.2	33.8	18.7	32.9	30.3	47.2	11.0	12.4	20.4	20.9	17.3	23.5	29.0	18.2	8.8	9.2	94.2	61.8	25.9	20.3	13.7	17.6	3.8	55.9	16.9	10.6	52.5	25.7	28.8	22.6	92.0	228.5	16.5	17.8	38.4	19.5	19.4	11.2	7.2	14.4	57.6	26.3	23.5	25.1	20.4	22.0	18.3	25.9	9.3	23.8	34.0	25.2	11.2
PWWP2B	"bA432J24.1, FLJ46823, PWWP2"	ENSG00000171813	"PWWP domain containing 2B"	Q6NUJ5	10	132397168-132417859	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 56.2;MCF7: 44.5;SK-BR-3: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038056, HPA038502, HPA078118"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038056: AB_10697093, HPA038502: AB_2676048, HPA078118: "	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (5.75e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-2)"	10.4	31.0	9.5	3.2	15.1	2.4	10.1	3.6	10.8	9.8	9.1	19.1	4.8	10.4	1.0	22.1	9.3	2.0	14.0	10.6	7.1	11.6	5.9	11.0	2.9	8.5	7.2	8.3	38.1	6.5	14.5	4.2	7.9	11.3	2.3	1.9	15.4	3.9	22.3	16.1	10.6	1.2	4.7	27.2	16.3	17.4	7.8	1.0	13.5	5.1	1.6	12.1	12.2	5.2	21.9	12.9	1.6	8.2	1.2	1.0	56.2	2.6	2.6	1.5	1.4	5.8	12.4	0.0	8.8	1.6	3.2	22.9	2.3	3.1	0.2	16.5	6.4	2.5	12.4	5.7	5.8	7.2	9.3	0.8	8.0	0.9	2.3	1.3	1.2	2.9	4.3	1.8	1.0	44.5	0.2	27.0	2.5	8.5	9.5	5.2	0.1	5.0	0.7	16.3	10.4	12.9	1.7	33.1	6.9	1.6	10.2	17.5	4.3	0.8	4.4	4.0	1.8	0.4	0.2	4.5	5.0	6.4	1.6	0.0	1.6	2.6	1.3	3.5	1.0	0.9	0.7	0.8	1.5	3.3	0.5	0.5	0.3	5.4	5.3	0.9	0.0	0.8	9.5	15.1	3.6	10.8	10.6	7.1	8.5	7.2	7.9	4.7	7.8	5.2	5.8	22.4	11.0	2.3	18.0	17.6	14.0	5.8	9.1	7.3	13.5	11.0	5.4	14.3	10.2	9.2	8.4	31.8	12.1	33.5	13.7	15.0	33.0	29.5	4.7	7.1	25.3	2.1	4.3	22.0	47.4	4.1	16.3	19.9	2.5	13.6	13.2	1.6	13.1	15.2	3.8	29.1	10.2	12.6	17.2	70.8	3.7	13.3	14.2	5.6	7.3	3.1	6.2	2.0	0.2	10.6	25.5	2.2	2.2	16.3	5.5	1.5	29.4	14.9	0.0	3.9	5.0	1.2	1.6	8.8	20.3	52.9	7.8	17.4	19.4	31.8
PWWP3A	"EXPAND1, MUM-1, MUM1"	ENSG00000160953	"PWWP domain containing 3A, DNA repair factor"	Q2TAK8	19	1354711-1378431	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.7;Cardiomyocytes: 31.4;Cytotrophoblasts: 18.8;Extravillous trophoblasts: 24.5;Fibroblasts: 14.5;Hofbauer cells: 16.9;Smooth muscle cells: 13.0;Syncytiotrophoblasts: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048063, HPA054491"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA048063: AB_2680243, HPA054491: "	"unprognostic (2.50e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.84e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (1.60e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-3)"	16.3	13.8	28.2	5.2	26.2	3.1	16.2	21.4	27.3	20.5	14.9	17.7	4.9	23.1	5.8	10.0	22.6	5.4	13.0	24.9	28.4	14.0	22.6	12.1	5.1	31.5	29.6	29.4	11.8	6.3	30.4	6.6	27.7	15.8	4.8	8.0	13.2	9.1	13.1	13.1	14.6	10.1	23.7	16.6	13.3	36.4	30.8	4.9	15.5	5.9	4.4	16.3	13.8	26.4	7.9	12.3	11.4	15.8	7.7	10.2	18.5	11.1	6.9	8.8	7.7	8.2	5.5	14.9	5.3	13.4	3.1	9.1	9.4	7.2	7.5	17.2	10.3	6.9	12.9	12.4	9.1	5.8	20.5	7.8	5.0	5.2	2.9	12.6	9.3	9.7	14.4	7.5	8.9	9.6	10.1	8.7	16.4	6.7	5.9	18.4	11.6	6.6	6.9	12.3	9.9	24.6	8.7	14.8	8.7	10.0	7.7	16.8	11.4	12.2	16.2	9.5	13.0	15.8	11.5	5.2	14.8	10.6	17.2	9.6	0.8	4.8	2.9	1.8	2.5	2.8	1.7	2.1	1.4	2.5	2.3	2.4	1.4	3.1	1.6	2.6	0.8	0.9	28.2	26.2	21.4	27.3	24.9	28.4	31.5	29.6	27.7	23.7	30.8	26.4	20.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	18.8	6.2	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	24.5	14.5	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	14.2	0.8	0.0	0.0	0.0
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319577-51809445	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"heart muscle: 45.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 42.2;Early spermatids: 43.8;Excitatory neurons: 25.2;Inhibitory neurons: 68.8;Microglial cells: 16.9;Muller glia cells: 18.6;Spermatocytes: 24.2"	"Group enriched"	"Detected in some"	4	"breast cancer: 1.7;glioma: 0.7;renal cancer: 0.8;testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 7.7;Daudi: 5.9;SH-SY5Y: 6.1"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA007919: AB_1855966"	"prognostic unfavorable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.6	0.1	0.2	0.2	0.1	0.0	0.2	0.2	0.6	0.1	0.0	0.1	0.0	0.1	9.4	0.2	0.0	0.1	45.3	0.2	0.3	1.6	0.0	0.2	0.3	0.5	0.6	0.1	0.0	0.2	0.0	0.0	0.8	0.2	0.1	2.9	0.3	0.0	1.4	0.2	0.2	0.0	0.1	0.4	0.0	5.0	0.2	0.5	0.3	2.1	0.5	0.0	0.0	0.4	0.5	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.6	0.2	0.3	0.5	0.6	0.8	0.1	0.2	0.4	0.3	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	1.2	3.7	0.1	42.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.9	0.0	43.8	0.0	0.0	0.3	0.0	0.0	25.2	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	68.8	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	16.9	0.0	18.6	0.0	14.1	14.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.8	24.2	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
PYCARD	"ASC, CARD5, TMS-1"	ENSG00000103490	"PYD and CARD domain containing"	Q9ULZ3	16	31201486-31203450	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 84.7;skin 1: 90.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 425.8;Kupffer cells: 555.8;Macrophages: 344.2;Paneth cells: 360.0;Proximal enterocytes: 504.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 585.7;classical monocyte: 1098.3;eosinophil: 948.1;intermediate monocyte: 1138.3;myeloid DC: 829.2;neutrophil: 1638.4;non-classical monocyte: 1152.8;plasmacytoid DC: 769.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 829.2;granulocytes: 1638.4;monocytes: 1152.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 148.9;NB-4: 237.0;THP-1: 186.9;U-937: 112.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006853, CAB015948, HPA049074, HPA054496"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		640000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506"	"unprognostic (1.00e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.88e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (4.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.97e-2)"	25.6	11.4	4.1	32.9	4.0	43.4	20.4	4.6	8.6	22.1	5.0	48.1	63.9	10.7	0.0	56.1	17.4	4.9	9.7	3.7	5.2	10.9	10.4	32.8	19.1	7.8	5.1	14.9	11.3	1.7	7.7	6.1	6.7	19.9	9.5	0.1	24.6	8.7	3.4	90.5	48.5	5.8	7.6	84.7	22.1	2.3	6.7	9.5	9.1	1.2	12.7	19.8	33.1	11.3	23.9	54.8	0.5	0.2	9.2	18.9	0.6	12.6	22.6	8.8	6.5	0.1	31.7	10.6	0.1	17.6	0.0	69.7	2.9	57.4	0.3	73.0	0.0	9.3	7.9	18.3	25.6	86.9	65.7	24.7	30.3	4.0	1.2	0.2	18.4	0.1	42.9	17.5	2.9	148.9	0.2	237.0	15.7	13.2	0.1	75.5	0.0	35.2	1.3	22.3	0.7	0.2	10.4	0.0	12.4	0.3	15.5	186.9	11.8	0.4	0.7	9.9	0.3	0.6	0.1	0.2	6.4	112.1	0.1	585.7	1098.3	948.1	178.4	1138.3	112.2	213.7	146.5	183.3	829.2	210.7	102.1	139.6	1638.4	219.2	1152.8	769.2	206.4	814.2	4.1	4.0	4.6	8.6	3.7	5.2	7.8	5.1	6.7	7.6	6.7	11.3	35.7	22.4	28.9	0.0	58.5	74.1	66.3	237.0	100.7	0.2	92.2	131.7	2.5	41.5	84.3	25.8	0.0	62.5	158.8	184.5	5.9	90.5	0.8	18.6	16.8	39.2	58.9	42.9	0.1	56.5	11.3	39.3	50.4	7.3	110.9	60.2	48.9	3.3	425.8	0.0	0.1	144.6	75.3	555.8	280.2	2.9	47.2	344.2	97.8	13.1	277.8	0.0	132.8	0.0	0.1	60.4	360.0	22.6	54.1	22.6	504.8	3.6	88.2	0.7	26.3	10.5	28.5	0.3	1.4	83.9	163.7	17.8	70.8	119.9	287.1	70.6
PYGO1		ENSG00000171016	"Pygopus family PHD finger 1"	Q9Y3Y4	15	55538884-55588947	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.5;Endometrial stromal cells: 18.2;Inhibitory neurons: 30.4;Oligodendrocyte precursor cells: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-698: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042248	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA042248: AB_10794272"	"unprognostic (5.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-6)"	"unprognostic (3.36e-4)"	"unprognostic (4.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.80e-2)"	1.8	2.3	2.6	0.9	3.0	0.2	1.7	7.3	2.3	3.7	2.9	3.2	0.4	5.6	2.0	1.8	2.5	2.3	1.3	2.6	4.6	0.9	0.1	1.9	0.5	3.3	4.5	6.1	1.4	13.2	3.0	2.0	3.1	4.5	1.0	4.5	0.9	4.8	11.7	0.7	0.9	4.7	3.3	0.3	1.4	3.2	4.9	0.4	6.8	9.1	0.4	2.2	1.7	2.4	3.7	6.3	12.2	6.2	4.4	10.0	4.6	7.8	8.9	6.2	7.1	4.5	0.0	0.0	2.4	5.3	8.9	0.0	12.4	0.1	8.3	0.0	3.9	1.8	1.8	0.4	5.9	6.6	0.0	5.5	6.2	5.5	0.9	6.9	3.2	1.0	0.1	0.0	10.3	0.1	0.3	0.0	3.3	0.9	3.4	0.0	14.8	0.0	2.1	2.7	6.5	7.3	7.6	0.0	5.6	1.7	2.3	2.1	0.0	15.8	6.9	0.3	9.5	0.2	0.2	33.6	4.9	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	7.3	2.3	2.6	4.6	3.3	4.5	3.1	3.3	4.9	2.4	0.6	9.6	6.3	23.5	0.0	1.7	5.9	0.1	4.6	5.6	2.4	3.6	6.1	0.0	1.9	9.2	0.0	1.5	0.1	0.0	0.0	0.5	2.9	1.6	18.2	1.1	0.0	0.0	1.8	0.0	0.2	9.3	0.0	1.9	0.0	7.1	1.1	0.0	0.5	0.0	30.4	0.0	0.0	0.6	1.4	2.6	9.9	0.3	7.2	4.7	0.0	7.0	0.0	59.8	1.9	0.5	0.0	12.0	0.0	5.7	0.0	0.2	1.8	4.5	0.0	12.7	6.1	11.6	2.8	1.4	0.9	0.3	0.6	2.0	0.0	0.7
PYGO2		ENSG00000163348	"Pygopus family PHD finger 2"	Q9BRQ0	1	154957026-154963853	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023689, HPA074813"	Supported		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA023689: AB_1855974, HPA074813: "	"unprognostic (1.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.76e-4)"	14.6	30.6	30.0	16.7	30.3	6.5	15.3	29.3	29.8	21.4	21.1	23.5	19.0	19.1	23.5	24.2	20.3	12.7	15.5	29.9	34.0	24.7	20.1	15.7	26.5	30.5	30.8	27.2	18.1	27.5	32.4	16.3	29.1	23.5	15.3	12.7	23.2	23.3	18.9	22.4	24.4	15.7	29.8	28.2	21.6	16.1	35.3	22.5	26.2	15.9	27.8	21.2	20.0	32.3	28.1	19.4	40.4	36.0	39.8	19.5	37.0	17.1	23.0	26.5	22.7	26.1	34.2	34.9	26.4	19.9	28.7	37.2	35.6	23.7	17.4	34.7	25.1	27.9	32.7	23.6	18.5	25.8	23.9	16.2	33.8	23.9	20.0	30.0	16.5	52.5	37.1	57.6	25.2	42.8	36.0	30.0	43.3	55.7	34.2	40.2	25.7	55.6	27.1	26.1	48.4	71.8	27.0	48.5	34.9	39.1	59.7	45.9	14.1	23.5	35.1	25.6	25.1	56.8	54.3	37.1	19.6	32.4	31.8	2.3	3.9	10.9	8.0	6.5	10.0	6.9	10.3	10.7	4.1	7.5	11.0	8.7	3.8	6.3	8.4	3.9	5.8	6.2	30.0	30.3	29.3	29.8	29.9	34.0	30.5	30.8	29.1	29.8	35.3	32.3	7.0	9.6	4.9	5.5	12.6	5.5	3.8	5.8	7.4	11.8	14.3	10.0	5.3	5.7	7.4	12.9	2.1	15.5	14.1	10.3	19.6	6.2	3.4	5.7	7.5	6.8	5.4	12.4	6.3	5.9	12.6	5.8	9.7	7.4	0.0	9.3	7.1	9.4	6.5	21.9	4.3	10.6	6.1	6.6	3.5	2.2	9.0	5.6	5.4	6.5	6.4	10.6	8.2	5.5	4.7	9.7	9.1	9.1	11.5	4.9	12.0	9.8	4.0	6.0	6.6	5.4	6.9	5.9	12.2	9.8	5.3	11.6	11.7	9.3	8.4	3.7
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 23.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 165.9;NK-cells: 324.4;T-cells: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 97.3;MAIT T-cell: 56.3;memory CD4 T-cell: 40.8;memory CD8 T-cell: 74.7;naive CD8 T-cell: 45.1;NK-cell: 36.8;T-reg: 67.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 36.8;T-cells: 97.3"	"Cell line enriched"	"Detected in some"	6	"U-698: 49.1"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	2.3	0.6	0.2	8.3	0.3	5.5	1.2	0.2	0.4	1.0	0.4	1.7	1.6	1.1	0.8	0.8	0.9	3.8	0.6	0.3	0.4	0.7	3.2	3.7	23.1	0.7	0.3	0.8	0.3	0.2	0.3	0.9	0.6	1.0	2.1	0.1	1.6	0.5	0.3	0.5	5.4	0.7	0.2	13.9	2.7	0.4	0.5	3.7	1.4	0.6	12.5	3.3	0.8	1.2	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.1	0.1	0.0	0.0	0.9	0.0	49.1	0.0	7.7	0.0	1.5	0.3	0.4	97.3	0.4	56.3	14.8	40.8	74.7	0.3	8.7	13.5	45.1	3.5	36.8	0.5	0.6	67.3	21.0	0.2	0.3	0.2	0.4	0.3	0.4	0.7	0.3	0.6	0.2	0.5	1.2	1.3	12.8	2.8	1.0	17.0	0.4	0.6	0.0	0.0	0.5	1.2	0.9	0.6	0.0	2.0	3.7	0.0	0.1	165.9	0.1	0.0	0.1	0.3	0.5	0.3	1.2	0.0	7.4	0.5	0.0	0.0	2.7	2.6	0.2	2.5	0.1	3.9	1.2	2.7	0.0	0.5	0.0	0.0	5.0	1.5	0.3	0.0	3.5	1.8	6.5	2.3	0.5	324.4	0.0	0.2	0.0	0.0	0.0	37.9	0.6	0.0	0.6	5.3	1.1	0.0	0.7	0.7	0.1	0.2	0.1	0.6	0.1	104.7	0.0	0.2	0.4
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		No	No		27000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.34e-4)"	24.5	30.8	19.8	24.0	20.2	22.5	27.9	21.5	24.8	26.1	22.9	31.1	31.6	22.1	41.5	72.3	22.7	19.8	21.8	19.5	20.7	26.3	43.0	20.8	35.4	20.5	20.6	17.1	28.0	26.3	22.3	22.8	20.5	31.2	30.0	17.4	34.0	15.9	29.8	41.9	29.5	19.8	20.1	31.1	24.1	25.9	20.1	33.2	27.0	29.0	42.1	24.8	31.4	20.2	50.3	39.1	56.1	31.4	33.4	43.2	92.6	36.1	43.1	33.3	28.0	57.7	57.9	62.9	53.6	35.1	15.4	38.6	43.6	77.1	26.7	48.6	32.7	51.0	35.1	71.8	40.7	59.7	44.7	39.2	48.8	37.7	56.0	42.2	35.9	27.3	44.5	67.4	39.7	75.3	38.6	105.7	98.3	56.7	20.2	34.3	22.3	72.5	69.5	69.8	37.7	43.4	46.2	61.1	33.1	51.8	74.5	124.0	28.2	20.0	28.3	31.5	26.6	35.5	58.2	97.2	34.2	40.9	31.9	17.5	79.8	75.8	58.5	92.2	72.3	98.1	105.4	82.2	120.2	88.2	68.7	69.5	19.1	53.1	66.5	65.6	186.0	87.2	19.8	20.2	21.5	24.8	19.5	20.7	20.5	20.6	20.5	20.1	20.1	20.2	16.2	19.2	17.3	0.0	28.6	0.0	29.4	0.0	21.1	12.7	41.7	38.4	0.0	25.8	14.2	23.9	8.4	84.3	21.1	29.8	78.2	40.6	15.2	21.1	17.0	16.3	7.3	32.2	0.0	50.6	76.3	17.6	22.4	21.1	18.9	14.5	22.9	44.3	55.2	6.7	0.0	32.1	0.0	47.7	0.0	11.7	23.3	42.8	0.0	0.0	110.4	55.7	48.4	0.0	0.0	54.1	33.7	23.7	21.9	34.7	66.8	61.3	16.8	13.6	13.1	18.0	15.7	23.8	25.6	63.1	0.0	62.0	29.6	16.5	29.3	34.3
PYURF	PreY	ENSG00000145337	"PIGY upstream reading frame"	Q96I23	4	88520998-88523776	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA036455	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA036455: AB_10673388"	"unprognostic (8.25e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	71.2	72.2	35.1	23.1	37.0	44.5	70.4	38.7	43.4	69.0	33.8	72.0	30.7	74.8	45.6	64.1	65.5	22.5	58.6	34.0	37.3	84.9	81.7	56.4	27.8	36.7	35.6	65.2	59.0	41.9	66.2	28.5	36.5	61.9	31.2	22.9	55.4	33.9	66.9	67.0	53.9	36.2	39.2	54.4	56.8	42.3	36.2	27.3	54.5	42.3	29.4	61.7	62.5	39.3	60.1	19.8	39.1	46.4	76.7	78.3	26.2	43.2	60.6	53.1	44.6	15.5	46.3	0.2	47.3	61.7	36.4	25.2	35.6	54.4	66.6	73.4	61.8	66.2	24.8	59.9	58.0	110.7	40.9	54.4	80.8	34.5	69.5	50.4	88.5	20.4	75.9	64.9	77.8	45.5	68.5	67.6	32.7	70.5	37.5	68.0	36.3	69.8	44.4	33.4	46.7	45.7	54.9	49.4	119.9	38.4	23.0	54.8	60.6	56.1	51.9	55.3	40.6	45.6	40.1	7.5	49.3	55.7	63.1	82.4	92.1	79.0	90.4	94.9	102.2	98.9	103.2	98.3	111.0	80.5	105.4	101.6	18.1	108.9	95.3	68.3	116.8	186.1	35.1	37.0	38.7	43.4	34.0	37.3	36.7	35.6	36.5	39.2	36.2	39.3	136.2	51.3	71.3	0.0	92.0	230.4	176.0	167.2	158.8	28.7	207.2	205.2	5.8	84.4	98.8	86.5	10.4	232.3	106.8	65.5	287.6	118.0	44.0	69.7	103.9	127.0	114.6	98.2	0.0	129.5	120.6	119.6	53.5	51.2	105.8	97.7	114.2	147.3	139.4	26.9	0.0	99.4	101.7	115.9	124.7	98.3	125.9	100.0	348.6	0.0	129.2	113.3	176.1	0.0	0.0	103.4	102.7	120.0	84.6	208.7	128.0	236.9	79.1	33.0	59.2	107.3	109.2	108.1	62.3	189.9	289.0	163.9	119.6	136.5	132.8	142.3
QKI	QK3	ENSG00000112531	"QKI, KH domain containing RNA binding"	Q96PU8	6	163414000-163578592	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport"	"Developmental protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 628.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1140.0;Microglial cells: 713.0;Oligodendrocyte precursor cells: 1421.0;Oligodendrocytes: 4573.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 42.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 250.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019123, CAB022602"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB022602: , HPA019123: AB_1855980"	"unprognostic (2.42e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.09e-2)"	76.3	24.2	208.2	36.8	437.7	69.7	27.8	355.8	207.9	29.2	2.5	22.2	7.9	28.4	8.7	34.4	25.3	33.8	149.3	211.1	301.1	22.7	41.1	55.9	27.4	431.2	367.9	38.2	16.0	15.0	6.9	53.0	451.4	15.3	16.7	26.9	15.3	22.3	157.0	18.6	11.9	46.3	304.5	39.8	12.1	47.3	365.7	28.5	22.1	222.1	25.3	38.2	16.4	628.6	17.8	72.0	250.8	83.7	74.3	81.9	58.4	46.8	109.0	74.5	89.4	49.3	15.8	21.3	38.6	117.2	50.8	25.9	134.4	48.4	120.2	43.7	43.3	83.4	38.4	55.3	90.4	44.8	24.9	96.8	19.5	80.0	125.8	72.4	104.4	30.9	124.3	48.2	48.6	32.8	30.1	9.5	32.4	17.3	36.0	45.9	156.5	42.3	40.5	54.4	5.2	28.7	49.9	26.7	19.2	101.2	10.5	71.8	107.2	51.3	42.7	55.9	86.1	30.9	40.9	26.3	44.2	38.7	122.8	3.6	7.1	3.4	1.8	4.7	3.0	1.2	1.3	1.6	3.7	1.2	1.1	2.0	9.2	6.3	5.1	6.2	1.0	1.1	208.2	437.7	355.8	207.9	211.1	301.1	431.2	367.9	451.4	304.5	365.7	628.6	180.6	150.6	51.5	1140.0	35.4	153.7	34.1	25.3	43.9	60.4	42.8	47.2	355.5	37.1	30.5	20.2	58.4	51.1	77.7	0.2	21.5	21.8	53.0	60.7	156.7	130.0	0.0	40.4	58.4	12.0	51.3	92.2	10.2	71.1	60.9	64.8	131.0	72.9	86.8	32.0	471.4	0.0	14.2	221.9	188.0	102.5	86.6	165.7	113.8	713.0	107.9	113.5	32.0	1421.0	4573.8	19.8	0.1	98.6	34.4	46.5	0.0	33.2	23.7	31.5	46.0	197.7	83.5	46.1	19.7	47.4	136.1	55.1	32.2	69.9	0.2	46.4
QRICH1	"AB-DIP, FLJ20259, VERBRAS"	ENSG00000198218	"Glutamine rich 1"	Q2TAL8	3	49029707-49094363	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Unfolded protein response"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037677, HPA037678"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037677: AB_10671883, HPA037678: AB_2675603"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.94e-2)"	"unprognostic (2.82e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-1)"	29.8	27.9	15.4	30.5	17.0	61.0	27.8	25.3	20.2	25.8	16.0	25.9	26.3	28.6	25.9	30.0	27.6	25.2	26.0	16.9	14.8	21.3	23.5	27.8	40.1	14.7	13.2	34.0	26.0	33.2	24.8	27.0	14.6	25.8	25.2	30.4	28.3	26.3	34.8	35.4	31.0	28.9	13.2	35.8	25.9	44.5	13.3	51.9	25.7	32.4	41.9	26.8	23.7	16.9	41.4	39.6	78.6	35.6	48.2	45.8	48.2	48.4	60.3	75.6	70.7	44.3	50.8	65.6	29.1	58.9	62.8	33.5	69.0	63.0	64.8	57.8	45.1	65.5	52.9	37.8	43.1	57.9	75.0	53.3	47.4	74.8	46.6	46.2	60.3	62.7	45.0	58.6	51.6	31.8	84.9	41.4	62.3	43.7	48.9	43.3	40.3	55.4	47.6	63.2	29.9	58.9	54.9	47.7	39.7	59.3	42.4	65.5	52.5	49.0	55.1	43.7	69.8	54.2	66.6	82.2	44.0	55.2	57.2	21.3	15.6	19.1	18.1	18.9	21.5	16.6	17.3	20.6	18.5	16.6	18.3	22.0	11.7	18.1	33.0	13.5	19.8	14.3	15.4	17.0	25.3	20.2	16.9	14.8	14.7	13.2	14.6	13.2	13.3	16.9	21.8	9.6	18.9	19.6	30.5	22.2	13.7	16.0	17.1	13.6	20.6	17.7	21.1	14.3	17.9	20.2	22.9	25.7	28.2	16.6	1.9	15.9	15.8	19.8	20.7	19.6	25.9	22.5	37.9	14.0	27.8	20.3	23.9	27.5	16.5	20.0	18.9	20.4	19.7	11.8	39.1	20.6	10.2	25.3	18.3	10.9	22.4	19.5	12.4	14.0	22.3	12.5	15.5	24.6	25.5	18.6	10.5	30.9	39.7	18.0	14.4	10.1	15.2	17.6	6.6	21.9	25.3	52.4	27.8	24.5	22.6	36.8	28.5	17.0	16.8	15.5
QRICH2	DKFZP434P0316	ENSG00000129646	"Glutamine rich 2"	Q9H0J4	17	76274049-76307998	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 18.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.8;Excitatory neurons: 9.8;Inhibitory neurons: 14.5;Late spermatids: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052219	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA052219: AB_2681766"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.82e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-3)"	1.0	0.7	3.9	0.7	3.7	1.7	1.1	6.3	7.0	1.8	2.5	1.6	0.3	1.1	0.7	2.1	1.6	0.3	1.6	3.6	3.6	2.0	2.3	1.7	0.6	6.3	3.8	1.3	1.9	0.6	1.8	1.0	6.4	2.1	0.6	2.7	3.6	0.5	1.2	1.3	1.1	0.4	3.2	1.1	1.2	18.3	4.5	0.5	4.4	0.5	0.5	1.0	1.7	4.4	0.8	1.6	2.9	3.3	1.5	1.4	1.4	1.4	0.3	1.0	0.3	0.5	0.3	4.2	0.5	0.9	0.8	0.3	4.0	0.7	1.3	1.1	2.2	0.4	1.2	3.7	0.8	0.6	1.9	1.3	0.6	1.2	0.1	2.0	1.3	1.2	2.3	0.8	0.3	2.5	2.3	0.5	1.2	1.0	3.2	4.9	2.5	0.1	0.5	1.5	2.7	2.7	0.7	0.4	1.7	2.9	1.2	1.7	1.2	0.8	3.1	4.1	1.7	1.1	1.1	0.4	0.9	2.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.7	6.3	7.0	3.6	3.6	6.3	3.8	6.4	3.2	4.5	4.4	0.8	0.0	0.0	6.5	0.8	0.1	0.4	0.2	0.0	0.7	1.5	1.8	1.7	5.7	0.3	1.8	0.0	0.7	0.1	0.7	0.0	0.9	33.8	1.4	0.9	0.9	0.0	0.4	9.8	0.0	1.1	0.3	2.0	1.6	0.0	3.7	0.0	0.5	0.2	1.7	14.5	0.5	0.0	0.6	0.4	9.1	0.9	0.3	1.8	5.6	0.6	1.9	1.0	5.5	5.4	0.4	0.2	0.7	0.9	0.3	0.2	0.8	1.1	2.3	0.0	0.9	1.0	5.0	1.5	0.6	0.3	0.4	0.4	0.1	0.6	0.3
QSER1	FLJ21924	ENSG00000060749	"Glutamine and serine rich 1"	Q2KHR3	11	32892811-32993316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005682	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA005682: AB_1855985"	"unprognostic (2.94e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (7.94e-5)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.96e-2)"	5.4	4.5	5.3	5.5	6.5	4.1	8.9	15.1	5.3	7.5	10.0	5.1	3.5	8.3	6.7	7.6	6.1	5.9	5.9	5.1	5.8	5.5	5.8	4.4	5.5	5.6	5.7	12.7	6.9	6.5	3.9	5.7	5.6	4.6	5.5	7.1	10.0	5.1	4.6	11.8	4.1	6.4	5.7	6.1	5.5	9.0	5.4	8.6	8.8	7.0	6.5	6.3	6.1	6.6	23.4	28.7	32.4	30.5	12.2	23.2	15.7	20.0	17.9	14.0	17.3	24.5	10.8	24.2	12.5	23.9	23.5	29.4	30.9	17.6	30.3	10.7	19.5	22.9	26.7	21.0	9.8	27.7	11.9	11.6	18.9	17.7	29.5	16.8	19.9	14.2	35.2	10.6	22.2	20.5	14.3	10.8	34.1	14.4	17.9	22.5	64.6	10.1	14.5	24.6	16.7	23.9	37.8	19.4	12.3	23.7	20.2	14.3	20.3	34.0	34.2	62.9	44.0	6.8	10.3	22.5	21.9	12.7	22.6	0.0	0.2	0.0	0.2	0.4	0.1	0.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.4	0.1	0.4	0.0	0.1	5.3	6.5	15.1	5.3	5.1	5.8	5.6	5.7	5.6	5.7	5.4	6.6	22.0	19.2	13.4	35.6	10.6	27.9	12.0	14.2	35.9	17.7	21.6	18.7	31.0	14.3	15.9	7.3	14.6	12.9	7.7	5.9	3.9	10.6	14.0	9.9	37.0	19.5	0.0	17.7	51.6	12.1	12.2	27.2	15.8	17.1	3.8	39.3	15.7	10.5	14.5	10.1	50.6	11.7	14.2	16.0	16.1	11.0	24.5	19.1	16.0	54.4	15.9	12.9	5.2	50.3	48.6	10.7	9.3	21.1	23.1	15.0	5.3	8.9	12.2	15.0	6.6	37.9	17.8	21.3	20.5	43.1	27.6	4.2	8.4	21.5	13.6	14.3
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245812	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		9600000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.5	7.6	7.3	11.2	7.6	15.9	5.9	12.9	8.1	7.3	5.9	6.7	5.1	8.3	10.6	5.3	8.6	4.6	7.6	7.3	7.6	7.5	8.6	7.0	17.5	7.3	7.6	9.5	18.8	8.1	32.3	4.9	6.9	6.4	5.4	12.3	5.9	3.7	5.6	11.1	11.8	6.7	6.0	15.7	7.1	10.8	8.0	8.1	11.7	3.4	14.6	6.3	5.8	7.3	14.7	35.0	28.6	38.2	15.8	19.0	35.9	18.3	20.4	34.9	31.9	26.4	31.1	22.6	29.5	24.7	64.1	46.7	34.2	26.5	28.0	33.5	17.2	12.1	59.8	29.3	22.5	36.4	17.8	15.3	26.3	34.8	41.8	15.4	25.9	23.3	29.8	59.1	18.8	25.0	13.6	24.2	34.0	44.2	22.3	24.8	37.1	37.2	12.0	13.1	30.5	23.1	28.9	22.6	15.9	18.5	16.3	21.1	15.0	42.2	30.4	35.1	42.6	20.9	29.9	49.7	28.3	18.9	40.5	0.4	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	7.3	7.6	12.9	8.1	7.3	7.6	7.3	7.6	6.9	6.0	8.0	7.3	8.8	9.6	7.9	13.7	17.7	5.7	2.8	2.2	1.8	24.4	2.3	2.9	4.3	0.0	4.4	5.5	18.8	1.3	5.8	1.6	1.9	3.4	6.7	5.7	7.4	6.6	16.3	14.5	10.1	4.0	2.8	5.2	4.1	5.6	1.3	7.1	2.9	4.4	2.3	5.0	11.1	3.8	0.0	3.7	8.2	7.3	5.9	3.3	0.0	8.4	4.3	2.6	4.1	6.0	10.7	3.4	0.7	7.2	5.4	7.9	0.9	2.3	9.0	8.8	6.6	9.2	4.7	19.4	24.2	1.8	11.5	1.0	5.1	7.3	3.9	3.6
QTRT2	"FLJ12960, QTRTD1"	ENSG00000151576	"Queuine tRNA-ribosyltransferase accessory subunit 2"	Q9H974	3	114005833-114088422	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 20.3;Endometrial stromal cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036827, HPA036828"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Intermediate filaments"	"HPA036827: AB_2675336, HPA036828: AB_10696788"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.41e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-3)"	6.9	6.5	3.6	9.4	3.9	11.2	10.1	3.2	4.0	7.4	9.0	8.4	7.7	8.4	6.4	7.0	7.5	5.3	3.4	4.3	3.6	7.5	7.2	8.6	12.0	3.8	3.6	8.1	6.7	7.3	4.4	8.5	3.8	6.9	8.9	11.3	5.9	5.9	3.8	8.2	7.6	7.4	3.4	11.8	6.9	7.1	3.7	7.7	8.9	3.9	11.6	9.6	5.2	4.4	26.8	27.1	22.2	24.6	9.6	11.7	20.9	13.7	8.6	22.9	20.9	26.0	18.8	49.4	19.5	12.7	27.3	25.9	43.5	20.6	29.9	9.4	19.6	22.2	15.9	18.6	13.7	40.8	20.0	9.3	18.2	20.8	29.4	9.3	24.0	22.5	23.7	17.1	13.1	21.4	34.3	15.9	42.6	37.6	29.3	30.6	15.6	26.6	18.0	18.2	30.1	14.2	19.9	19.4	25.1	18.4	21.6	20.4	15.9	19.9	21.6	7.9	26.9	12.0	18.7	68.1	17.4	29.6	40.9	0.6	15.3	3.8	6.4	15.8	6.0	16.8	5.4	6.3	19.4	11.0	7.4	6.0	6.5	8.6	11.4	8.1	7.6	6.5	3.6	3.9	3.2	4.0	4.3	3.6	3.8	3.6	3.8	3.4	3.7	4.4	14.0	19.2	20.3	0.0	8.4	0.0	0.0	0.0	0.0	0.0	13.8	12.4	0.0	0.0	10.5	3.7	0.0	10.9	10.0	0.0	1.9	15.7	0.0	16.3	19.7	9.9	0.0	0.0	0.0	12.4	10.9	6.2	0.0	15.1	15.2	15.7	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	16.7	0.0	0.0	3.3	0.0	0.0	8.9	4.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	4.9	4.3	17.4	0.0	0.0
R3HCC1	DKFZp564N123	ENSG00000104679	"R3H domain and coiled-coil containing 1"	Q9Y3T6	8	23270120-23296279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 113.2;Rod photoreceptor cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023073, HPA023153"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Nucleoplasm	"HPA023073: AB_1855987, HPA023153: AB_2237834"	"unprognostic (5.80e-2)"	"unprognostic (4.70e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (7.46e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.02e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (7.65e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (1.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.43e-1)"	20.5	21.9	41.2	15.2	52.7	29.0	19.6	53.7	43.8	23.4	36.4	33.6	19.7	23.9	14.8	16.1	22.5	16.2	33.1	39.9	42.3	20.1	28.2	16.7	22.5	60.9	49.8	27.2	42.8	29.0	22.6	13.7	63.6	22.7	15.3	62.7	35.7	19.9	54.5	22.5	20.4	22.2	49.3	20.2	28.4	30.8	48.6	20.3	17.6	31.5	18.8	22.2	17.8	73.7	38.2	48.7	36.7	35.9	15.2	20.6	25.2	24.7	23.4	41.0	29.7	35.0	17.6	38.1	25.6	30.2	28.0	28.3	38.9	45.8	27.5	24.7	41.6	35.7	33.4	29.2	36.0	24.7	25.6	24.8	35.5	35.0	16.4	30.1	31.7	42.9	41.8	31.0	24.3	33.1	55.6	43.8	29.8	40.4	35.8	37.9	44.8	22.8	20.3	41.9	47.2	41.1	28.1	32.8	41.8	25.0	30.3	29.2	27.4	37.9	31.8	32.2	51.1	23.8	22.2	39.3	29.5	34.3	48.5	38.4	50.5	82.5	64.8	44.1	56.5	56.5	52.7	55.0	56.7	42.1	40.5	47.0	31.3	59.5	50.3	52.9	61.5	51.4	41.2	52.7	53.7	43.8	39.9	42.3	60.9	49.8	63.6	49.3	48.6	73.7	25.2	25.6	14.7	4.9	15.5	14.9	16.5	35.9	10.2	28.0	22.8	32.9	24.1	24.3	20.5	5.5	27.1	18.8	19.8	17.9	56.7	32.3	36.4	15.2	17.0	21.1	19.2	17.9	5.1	50.9	21.3	25.4	20.9	10.2	22.8	24.7	20.0	21.6	30.2	18.5	5.0	21.5	22.4	18.2	12.3	113.2	17.7	16.2	21.4	5.6	18.8	59.3	42.2	4.5	9.5	37.0	22.1	21.8	34.7	11.4	41.7	38.5	22.0	115.7	13.1	19.9	31.1	49.8	32.4	13.6	16.2	7.7	18.3	30.7	22.8	13.6
R3HCC1L	"C10orf28, GIDRP86, PSORT"	ENSG00000166024	"R3H domain and coiled-coil containing 1 like"	Q7Z5L2	10	98134624-98244897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 51.5;Oligodendrocytes: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037367	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA037367: AB_10696930"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-2)"	12.8	8.5	8.8	7.8	10.0	17.4	11.6	10.9	11.1	14.2	9.1	12.1	6.4	8.9	9.7	13.1	9.2	5.9	8.3	8.5	8.9	11.8	13.5	10.9	12.2	9.7	9.3	8.7	11.0	10.5	8.6	8.3	9.7	12.7	10.1	10.0	11.8	6.6	9.9	15.1	12.3	6.5	9.4	15.3	9.5	31.1	9.5	13.7	10.1	8.0	13.0	12.4	13.1	10.9	14.6	9.4	13.9	12.4	11.7	12.4	11.5	16.1	22.4	15.4	17.0	12.8	10.0	20.4	8.5	9.6	8.7	16.0	14.2	9.7	17.4	15.4	9.6	12.1	7.3	14.4	14.4	16.7	14.1	11.4	10.9	13.6	20.0	13.6	10.1	12.6	10.6	12.4	12.2	14.0	13.2	17.3	10.1	6.9	12.1	13.4	15.9	8.2	11.2	8.5	4.8	10.2	8.3	6.0	32.9	17.7	10.8	10.4	11.2	10.3	11.0	11.6	12.2	12.5	14.1	34.4	14.8	17.1	7.7	12.2	6.3	17.8	8.6	8.8	7.8	9.2	8.9	8.9	5.0	8.6	7.7	7.7	7.6	10.4	13.4	5.5	13.4	5.5	8.8	10.0	10.9	11.1	8.5	8.9	9.7	9.3	9.7	9.4	9.5	10.9	11.8	16.0	15.1	30.0	13.2	3.3	4.8	3.9	6.8	6.7	5.9	5.0	8.9	10.0	6.5	7.3	6.2	9.8	15.6	13.5	5.9	7.8	28.4	10.8	10.5	9.5	6.0	11.8	39.9	6.9	9.8	8.3	14.3	10.1	17.1	9.7	6.1	4.5	6.9	5.0	35.8	12.2	2.0	8.7	5.1	13.1	5.3	13.5	12.4	51.5	9.5	6.5	13.4	34.2	59.8	10.5	5.4	5.7	11.9	5.4	9.6	3.4	13.0	14.2	0.0	7.6	7.1	36.6	23.9	6.3	3.8	13.0	12.8	8.7	9.5	7.5
R3HDM1	"KIAA0029, R3HDM"	ENSG00000048991	"R3H domain containing 1"	Q15032	2	135531455-135725270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 1088.8;Inhibitory neurons: 296.7;Oligodendrocyte precursor cells: 198.0;Oligodendrocytes: 173.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	5	"cerebral cortex: 53.0"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030936			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA030936: AB_10670835"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.00e-3)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (5.83e-7)"	"unprognostic (1.16e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.47e-1)"	10.3	10.5	0.0	13.6	7.7	23.2	8.2	0.0	53.0	9.5	0.0	11.8	7.2	10.1	9.6	9.5	8.2	9.6	7.9	10.5	0.0	9.0	9.7	7.9	18.1	0.0	0.0	7.7	13.0	22.8	20.1	6.7	0.0	8.0	15.1	17.7	7.0	8.8	22.7	8.4	9.1	13.1	0.0	10.8	8.6	22.8	0.0	43.6	13.2	15.6	20.9	12.0	7.2	0.0	50.7	30.5	42.1	49.0	22.2	30.0	24.8	31.1	32.2	30.5	33.2	54.7	34.2	79.8	24.0	44.3	22.2	22.3	55.6	57.5	53.3	50.4	27.9	64.3	37.0	55.1	26.5	55.4	39.9	28.5	25.2	53.7	68.5	27.7	49.8	85.2	67.9	66.4	35.4	52.0	96.5	38.0	32.6	37.6	35.4	56.8	29.1	47.6	30.3	43.9	42.9	33.3	49.9	20.2	22.0	36.5	27.1	29.4	37.0	28.1	27.8	35.7	39.3	52.7	78.8	74.1	31.6	44.7	36.7	3.5	6.9	2.8	5.1	7.3	4.9	5.5	5.3	7.6	9.9	3.6	5.1	5.9	1.0	9.1	6.7	11.2	8.5	4.4	0.0	7.7	0.0	53.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	6.4	3.1	125.7	20.1	7.9	7.2	9.9	10.8	39.3	11.0	9.7	16.0	14.3	14.1	7.3	20.9	8.1	31.2	5.4	19.6	8.8	46.7	6.8	27.0	15.6	22.9	30.7	1088.8	7.4	10.4	11.5	15.8	12.6	18.3	25.9	11.7	14.2	12.2	26.9	296.7	11.7	14.2	19.5	13.8	44.7	13.7	18.8	7.2	98.4	21.9	8.6	22.6	198.0	173.5	8.3	6.3	11.3	33.7	10.0	5.3	13.4	4.3	40.5	0.0	14.7	25.3	26.5	24.5	20.3	9.7	3.1	23.4	36.6	11.5	6.8
R3HDM2	KIAA1002	ENSG00000179912	"R3H domain containing 2"	Q9Y2K5	12	57253762-57431005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 274.9;Inhibitory neurons: 204.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038327, HPA038328"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA038327: AB_10674681, HPA038328: AB_2675962"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.49e-2)"	19.8	18.4	11.2	20.0	14.5	24.2	18.4	12.9	26.7	20.1	0.8	18.7	22.4	23.7	11.0	20.4	23.5	20.2	34.3	14.5	7.2	17.3	22.0	18.0	23.2	4.5	6.9	32.4	20.2	24.2	19.4	17.9	2.2	28.2	16.9	34.9	15.8	15.9	42.8	24.0	20.9	17.9	2.3	24.5	20.2	19.4	8.8	28.6	20.6	29.3	18.4	16.6	17.7	19.8	20.4	28.0	22.7	28.4	36.5	51.2	15.2	20.9	25.3	14.4	13.2	9.2	23.4	22.5	25.3	29.6	16.1	26.1	13.7	24.8	16.7	31.4	17.7	27.6	11.1	12.0	27.0	18.4	33.9	35.0	38.7	23.8	52.5	62.1	20.5	38.3	19.5	28.6	24.8	25.1	25.9	13.6	5.8	12.4	20.3	15.7	16.8	14.8	12.8	21.9	23.0	25.0	19.8	26.1	21.3	13.0	23.0	33.5	24.3	15.0	11.4	34.4	21.3	17.1	9.0	9.1	31.4	19.0	27.4	4.6	2.2	1.8	1.6	2.1	2.0	4.7	2.9	1.5	1.3	1.9	3.0	1.8	4.9	3.1	5.7	2.0	0.9	0.8	11.2	14.5	12.9	26.7	14.5	7.2	4.5	6.9	2.2	2.3	8.8	19.8	53.2	32.1	27.7	82.6	60.0	43.5	28.1	13.3	46.1	112.2	50.1	43.2	33.8	32.9	12.7	38.6	79.2	22.9	60.9	28.5	50.9	13.3	18.2	44.9	83.9	28.5	24.7	22.7	274.9	11.1	19.2	39.7	41.3	51.5	25.9	53.2	31.8	79.6	19.3	109.4	204.6	31.3	10.2	63.1	34.7	33.6	59.7	46.7	26.6	65.6	26.5	40.0	57.7	114.1	130.7	11.7	42.2	48.2	27.6	25.1	38.2	68.3	19.4	77.5	32.9	71.5	43.9	42.3	47.1	40.2	51.4	24.4	55.7	56.0	29.8	27.9
R3HDM4	"C19orf22, MGC16353"	ENSG00000198858	"R3H domain containing 4"	Q96D70	19	896503-913245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 586.7"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 586.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043025, HPA048638"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA043025: AB_2678275, HPA048638: AB_2680472"	"unprognostic (9.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (7.33e-6)"	"unprognostic (4.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.74e-2)"	37.7	26.3	34.5	50.1	31.2	98.0	37.0	33.7	38.5	42.0	29.3	39.4	23.9	34.1	13.4	81.8	36.9	28.4	32.4	32.1	28.0	58.8	47.8	55.7	54.3	31.3	29.4	23.7	50.8	19.2	33.1	25.1	28.9	42.2	17.5	22.0	48.1	15.8	55.8	58.8	45.5	18.7	25.6	93.9	39.1	9.1	29.7	39.6	32.4	23.8	36.5	43.2	49.4	37.0	44.2	25.4	26.1	36.5	16.6	28.9	43.7	29.3	23.2	28.8	25.4	27.6	36.7	31.5	23.9	33.4	6.1	39.6	15.4	34.7	12.9	49.2	33.0	43.7	19.7	48.3	49.3	24.6	73.0	38.7	65.9	18.7	39.1	26.3	33.4	35.7	82.2	62.8	27.1	79.0	34.7	46.5	34.5	53.3	41.2	33.9	12.5	60.8	48.2	45.7	46.6	45.4	25.8	56.2	48.9	20.0	49.1	57.8	34.3	52.3	29.1	62.0	30.0	69.1	39.1	47.6	33.5	34.9	45.9	117.4	13.1	111.0	14.9	10.1	23.1	38.5	30.3	20.5	14.3	21.5	28.1	20.1	586.7	8.6	14.0	6.0	49.3	26.5	34.5	31.2	33.7	38.5	32.1	28.0	31.3	29.4	28.9	25.6	29.7	37.0	23.2	19.2	21.5	0.7	59.6	35.1	49.0	24.9	25.0	17.5	30.7	20.6	6.8	20.0	26.3	18.4	8.4	38.1	29.0	34.7	7.9	57.7	1.3	20.1	20.1	22.8	32.8	106.5	4.0	55.4	46.7	20.0	30.5	33.5	23.5	10.3	12.1	13.3	26.2	28.6	3.0	31.3	34.6	27.5	37.0	2.6	11.1	59.0	24.9	1.9	51.4	8.0	29.9	1.5	3.1	68.4	31.9	11.7	37.3	48.9	13.1	16.0	19.9	12.4	26.3	13.6	20.6	0.8	4.0	34.3	31.7	69.0	48.1	15.2	22.6	70.9
RAB11FIP2	"KIAA0941, nRip11, Rab11-FIP2"	ENSG00000107560	"RAB11 family interacting protein 2"	Q7L804	10	118004916-118046941	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037726	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"HPA037726: AB_10672390"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (9.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.17e-1)"	8.6	6.6	5.2	6.6	7.0	13.8	6.9	4.8	8.5	10.2	2.4	8.2	3.6	18.8	28.5	6.3	11.8	8.3	6.1	7.1	3.4	12.2	5.4	7.6	6.9	2.8	4.6	9.9	5.6	6.3	4.3	8.2	2.2	10.8	4.9	10.3	4.8	24.7	5.0	5.9	5.5	19.5	3.7	6.6	17.2	7.8	5.3	6.2	11.4	7.5	5.5	7.6	6.2	6.1	7.1	8.8	7.3	9.3	11.9	15.0	7.8	13.8	15.8	8.3	8.6	7.4	7.4	14.5	10.8	14.0	6.1	4.8	10.1	6.1	12.8	3.8	10.9	5.1	9.1	5.1	17.2	9.7	5.5	14.8	11.3	11.6	25.4	11.0	5.1	9.3	3.9	12.1	10.9	2.5	7.5	7.3	6.2	3.1	6.2	6.4	26.0	4.9	12.4	5.6	1.7	13.5	9.8	3.9	17.3	8.7	3.0	8.9	7.7	11.2	8.9	13.3	13.8	8.9	7.8	9.4	11.5	16.4	7.0	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.4	0.4	0.2	0.3	0.1	0.1	0.5	0.1	0.0	5.2	7.0	4.8	8.5	7.1	3.4	2.8	4.6	2.2	3.7	5.3	6.1	16.7	57.7	31.5	79.7	17.7	10.3	8.8	4.4	12.5	28.1	10.1	10.7	25.8	24.3	6.0	42.3	29.2	11.6	15.1	5.5	7.9	12.6	16.5	13.1	31.0	14.1	14.5	17.4	63.8	18.7	7.9	29.1	14.8	15.7	3.8	28.0	11.4	8.6	11.4	38.7	57.9	6.6	4.1	23.0	12.2	6.6	33.5	16.2	23.2	34.7	19.4	26.0	15.5	53.8	82.9	16.6	4.7	28.6	17.0	11.1	5.4	18.1	7.3	31.4	26.3	34.0	25.8	14.9	21.2	9.2	9.5	5.2	12.9	19.2	6.5	6.4
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425649-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 151.1"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	27.9	32.3	18.0	5.3	18.9	7.0	19.5	21.3	22.6	29.6	7.6	35.1	9.0	31.3	5.5	12.3	27.5	7.4	31.4	21.7	14.0	151.1	37.3	25.2	5.8	14.4	15.8	33.8	47.4	15.9	41.5	6.5	15.2	29.9	3.1	6.1	19.3	7.8	52.2	19.5	27.5	7.1	12.7	26.4	22.2	34.6	16.8	5.3	24.8	15.8	3.2	31.7	19.9	19.0	5.9	14.9	14.6	11.9	20.2	13.2	10.0	10.6	11.6	10.7	7.6	11.5	3.0	15.3	11.0	18.7	8.9	5.5	8.9	13.4	3.9	10.8	14.9	7.9	14.8	31.7	20.9	9.5	8.6	12.7	8.8	11.6	9.9	11.7	17.3	10.7	3.5	6.0	14.4	22.5	10.2	15.9	11.7	5.0	6.8	22.8	10.8	4.6	11.3	4.0	13.8	12.0	11.5	13.6	7.5	5.0	7.6	13.9	29.9	14.8	8.8	13.6	7.0	6.9	6.7	18.8	6.5	5.8	11.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	18.0	18.9	21.3	22.6	21.7	14.0	14.4	15.8	15.2	12.7	16.8	19.0	9.4	3.2	1.7	36.9	3.8	3.7	0.7	1.1	2.2	7.7	3.5	4.3	12.4	7.2	4.3	5.5	6.2	1.0	5.7	5.9	27.4	1.6	1.2	6.4	8.7	7.1	3.0	1.7	73.5	1.2	0.2	5.5	2.0	13.1	1.3	8.4	17.9	15.9	0.8	21.9	60.3	3.0	0.0	3.7	1.6	2.6	0.6	4.7	0.0	19.7	0.6	7.2	2.1	46.8	40.7	1.4	3.9	1.9	3.4	0.9	8.1	384.2	3.1	7.6	6.6	5.3	5.4	4.0	2.8	0.3	2.3	0.8	4.4	6.1	5.9	0.3
RAB3A		ENSG00000105649	"RAB3A, member RAS oncogene family"	P20336	19	18196784-18204042	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 290.7;retina: 77.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.4;Distal tubular cells: 39.2;Excitatory neurons: 34.0;Horizontal cells: 92.5;Inhibitory neurons: 41.0;Rod photoreceptor cells: 46.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 290.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 20.8;SCLC-21H: 37.5;SH-SY5Y: 18.0;U-2197: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, CAB009949, CAB078998"	Enhanced	Supported	Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731"	"unprognostic (1.82e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (6.14e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.14e-2)"	2.6	15.6	41.0	1.7	56.7	0.9	2.1	6.8	290.7	3.3	0.0	6.4	3.1	2.7	1.5	2.5	5.2	2.0	25.7	53.4	32.5	5.9	3.8	2.5	1.5	26.8	4.6	25.8	2.0	12.8	38.4	1.4	23.3	3.9	1.8	77.5	4.0	3.9	9.9	4.1	3.2	2.1	0.0	2.8	4.5	2.2	29.4	1.3	2.3	8.9	0.9	2.6	3.6	90.5	1.4	1.6	3.5	4.9	5.7	1.4	2.2	3.2	1.9	2.2	2.9	1.4	0.9	5.2	3.4	2.6	2.0	4.2	16.6	2.0	1.0	1.1	5.3	2.1	6.3	6.0	1.4	3.6	6.2	4.6	2.0	1.2	0.6	4.2	0.6	6.4	1.1	1.8	2.0	5.2	8.0	1.0	2.9	4.4	20.8	5.5	0.3	4.4	2.3	0.8	37.5	18.0	1.6	6.6	3.7	1.4	1.4	0.6	0.7	1.8	1.4	26.2	1.8	3.2	7.4	1.3	4.9	2.7	1.7	0.0	1.3	1.8	1.3	0.9	1.8	1.9	1.3	1.3	2.9	0.9	1.7	1.8	2.2	0.3	1.3	2.6	0.8	1.3	41.0	56.7	6.8	290.7	53.4	32.5	26.8	4.6	23.3	0.0	29.4	90.5	2.3	0.0	0.0	8.5	4.7	3.2	2.5	3.7	8.6	102.4	4.8	4.8	1.3	2.8	2.2	16.5	8.4	1.6	7.4	1.6	39.2	2.3	2.4	1.0	1.3	2.6	9.6	0.0	34.0	0.9	5.2	3.1	2.0	1.4	0.0	1.6	2.5	1.6	5.2	92.5	41.0	2.8	4.1	2.2	15.3	0.2	4.4	4.5	10.6	13.1	2.9	15.4	1.0	7.5	10.1	1.0	2.0	5.7	1.1	1.1	5.3	8.3	1.2	46.5	0.0	1.8	8.2	0.4	3.6	6.0	4.8	1.8	5.3	4.5	4.2	2.1
RAB3GAP1	"KIAA0066, RAB3GAP, RAB3GAP130, WARBM1"	ENSG00000115839	"RAB3 GTPase activating protein catalytic subunit 1"	Q15042	2	135052292-135176394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034494, HPA034495"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		6300	"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA034494: AB_2674188, HPA034495: AB_10670158"	"unprognostic (1.02e-2)"	"unprognostic (2.43e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.15e-1)"	23.4	21.1	22.5	24.3	24.1	37.5	25.6	18.7	23.1	27.5	22.0	23.7	19.1	29.2	30.6	26.2	22.9	21.6	35.2	24.5	24.1	23.2	20.5	20.4	25.9	23.3	23.2	35.2	35.4	34.0	18.9	23.6	24.3	29.5	27.9	34.1	35.6	28.3	36.9	26.2	21.4	30.9	19.7	21.3	26.1	18.7	23.1	30.3	30.8	36.0	30.4	26.0	22.4	22.0	51.2	20.4	34.8	29.0	67.3	57.0	32.4	76.6	62.6	59.5	58.4	45.3	40.7	75.5	46.2	78.5	22.8	42.2	37.4	70.6	72.1	36.2	37.9	34.3	24.8	39.9	46.9	46.8	39.3	50.2	91.2	54.8	98.2	53.6	43.6	33.7	49.5	42.5	54.7	30.1	24.1	18.2	27.1	30.7	33.8	40.9	45.0	31.9	35.0	44.9	28.3	22.4	52.0	30.7	36.8	30.5	27.2	33.6	53.0	60.0	45.7	26.0	32.5	30.1	18.2	55.8	39.2	27.8	34.3	10.3	4.3	6.7	1.5	5.3	1.3	5.5	3.8	2.1	4.5	6.8	7.9	4.2	1.7	3.1	6.0	2.3	5.4	2.1	22.5	24.1	18.7	23.1	24.5	24.1	23.3	23.2	24.3	19.7	23.1	22.0	34.3	25.6	26.7	86.8	50.4	30.2	46.8	28.8	27.9	28.9	30.2	27.8	58.0	32.9	32.6	31.3	50.1	23.6	15.3	39.4	11.7	20.0	34.8	31.8	33.0	28.5	34.6	24.4	137.8	26.9	17.1	35.5	46.9	31.5	46.3	27.2	32.9	25.7	22.4	30.3	106.8	31.2	28.5	26.7	28.1	23.2	30.7	32.4	23.2	112.4	24.2	18.0	6.2	107.1	123.3	34.6	24.3	35.7	40.0	42.5	29.9	21.1	36.0	33.8	46.0	31.8	34.4	41.8	25.8	37.5	29.7	39.1	28.3	35.0	24.7	51.0
RAB5A	RAB5	ENSG00000144566	"RAB5A, member RAS oncogene family"	P20339	3	19947097-19985175	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Endocytosis, Phagocytosis, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004567, HPA049354"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"		"CAB004567: AB_628191, HPA049354: AB_2680725"	"unprognostic (2.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	35.7	27.3	39.2	27.0	39.9	41.4	33.2	42.1	49.5	30.5	36.6	29.7	29.6	22.7	42.4	42.3	21.1	32.2	36.3	38.6	43.1	33.6	42.8	29.5	24.3	42.7	42.5	19.9	27.2	53.8	20.5	49.2	42.2	30.7	30.5	35.4	35.8	28.8	29.1	36.0	28.2	28.0	44.0	24.2	32.6	18.0	41.1	28.9	41.1	30.3	29.1	35.4	29.7	46.1	29.8	26.8	38.5	26.4	65.8	57.8	38.9	51.3	59.7	47.8	55.0	31.9	45.7	21.8	30.3	56.7	27.6	18.4	29.0	38.2	55.7	37.9	24.1	31.9	24.9	31.1	82.2	45.0	38.1	53.6	71.0	56.1	81.9	59.9	61.6	28.5	37.1	34.1	57.9	46.2	34.8	31.9	48.4	40.8	42.6	25.8	27.2	32.2	98.9	38.8	12.0	39.6	36.9	45.3	60.3	57.0	35.4	35.8	61.6	34.5	30.1	44.4	44.2	42.0	73.5	28.6	55.0	40.4	57.1	28.7	18.0	31.3	7.9	19.6	10.6	7.9	9.3	9.6	18.1	5.8	8.5	8.1	36.0	20.3	26.3	11.8	10.9	11.5	39.2	39.9	42.1	49.5	38.6	43.1	42.7	42.5	42.2	44.0	41.1	46.1	114.8	60.9	45.1	33.0	43.6	170.0	129.5	48.8	62.0	34.0	57.0	35.9	57.0	27.1	52.6	42.3	31.3	74.7	44.2	68.7	103.7	52.2	21.2	45.9	44.4	72.4	62.0	55.3	33.7	45.3	67.2	65.2	66.3	72.0	85.0	39.1	41.7	39.3	54.2	15.2	31.4	59.4	65.1	44.4	158.8	15.9	36.7	60.9	83.6	28.1	43.1	86.1	41.2	65.9	44.1	65.2	55.9	35.3	50.7	109.7	49.4	62.3	48.1	36.8	52.6	86.5	72.4	24.6	27.1	65.0	188.0	164.3	60.6	37.1	41.5	151.0
RAB8A	"MEL, RAB8"	ENSG00000167461	"RAB8A, member RAS oncogene family"	P61006	19	16111889-16134234	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041945			Approved	"Nucleoplasm,Plasma membrane"		No	No		4800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"HPA041945: "	"unprognostic (1.10e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (6.60e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (9.99e-2)"	21.3	24.5	17.4	40.4	17.5	61.3	18.7	19.5	17.6	24.6	20.7	37.4	58.5	18.5	18.9	25.9	27.8	22.0	11.5	17.2	19.1	20.8	51.5	28.6	44.3	21.1	19.5	21.5	23.4	17.7	15.3	25.0	21.6	21.7	32.8	8.7	30.7	21.2	7.0	27.5	58.7	22.8	20.3	40.4	32.4	15.4	19.0	34.3	16.3	8.1	45.1	25.9	21.2	23.3	94.2	62.6	50.5	43.0	42.7	36.7	77.9	56.0	48.8	74.2	76.8	76.1	105.7	66.1	61.9	58.6	63.5	60.6	71.2	69.1	50.9	132.6	39.9	135.9	57.1	75.6	46.7	119.4	129.3	36.6	37.6	69.5	32.1	38.9	63.5	65.0	64.4	97.0	63.4	111.6	100.1	113.7	63.3	114.3	100.5	111.6	56.2	115.6	58.2	71.9	46.9	45.3	56.6	68.0	35.9	34.2	53.8	44.2	61.7	61.4	39.2	119.2	96.6	51.4	113.4	97.3	58.7	121.5	67.0	244.5	278.6	315.0	164.3	387.5	145.7	190.5	143.3	147.5	247.5	190.0	112.5	131.7	292.2	225.9	485.1	177.8	150.9	514.1	17.4	17.5	19.5	17.6	17.2	19.1	21.1	19.5	21.6	20.3	19.0	23.3	47.2	25.6	29.1	2.3	70.2	47.7	47.4	53.5	31.3	15.2	37.0	34.7	3.0	17.2	35.7	31.3	14.6	95.7	97.9	115.9	82.2	70.7	31.0	33.7	29.7	37.3	30.4	47.5	4.2	51.5	98.6	36.3	29.6	45.0	48.7	36.2	26.0	50.3	88.9	6.7	3.5	55.3	48.8	50.6	81.5	19.0	27.7	100.9	33.8	2.8	124.8	34.9	131.8	3.0	8.8	76.8	90.0	24.8	96.5	30.7	130.7	62.6	35.4	13.9	32.9	22.0	38.1	33.3	23.4	30.4	52.6	79.6	64.8	43.4	52.0	38.4
RAB9A	RAB9	ENSG00000123595	"RAB9A, member RAS oncogene family"	P51151	X	13689128-13710504	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 345.3;Syncytiotrophoblasts: 370.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003094, CAB016411"	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"CAB016411: AB_630176, HPA003094: AB_1079736"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.68e-2)"	28.9	51.7	24.2	18.4	27.2	56.0	32.8	28.3	28.2	31.4	21.8	28.4	14.9	29.4	21.3	29.7	21.5	22.8	20.7	23.4	26.0	30.3	24.9	24.9	25.1	28.0	25.3	28.2	33.2	38.1	15.5	28.7	28.7	20.2	25.0	21.7	37.0	18.9	19.7	37.0	19.1	22.1	28.5	22.0	21.4	7.6	25.0	16.5	21.1	16.5	31.7	27.4	27.9	32.1	34.8	18.1	22.9	54.5	75.1	59.7	20.4	19.0	66.4	28.5	41.2	19.6	37.7	31.3	45.7	29.9	68.1	34.8	34.4	40.4	27.8	69.6	53.4	9.9	36.6	22.9	45.0	17.7	25.8	64.6	69.5	35.8	38.2	45.7	26.8	17.3	19.5	44.8	30.9	23.9	16.8	28.8	24.7	24.0	34.1	22.7	24.2	94.7	78.8	31.7	18.8	13.2	40.3	56.3	69.3	56.8	31.4	18.5	21.1	21.5	11.2	76.9	11.6	35.4	66.4	12.8	21.5	15.1	21.5	34.1	37.7	17.5	38.1	25.3	29.9	20.0	20.7	31.9	26.5	14.2	15.3	26.3	22.5	31.0	24.1	29.1	18.0	22.0	24.2	27.2	28.3	28.2	23.4	26.0	28.0	25.3	28.7	28.5	25.0	32.1	25.4	48.1	27.3	19.9	35.0	64.7	69.0	73.4	29.6	8.7	35.9	39.0	16.6	42.9	64.1	33.1	0.0	83.6	121.0	85.3	80.3	135.0	0.6	78.8	46.2	23.7	24.5	27.8	11.1	64.0	60.5	39.2	23.4	105.8	45.1	13.5	14.3	19.2	54.9	15.2	13.7	32.2	52.9	45.0	104.9	2.2	37.6	46.7	56.9	6.5	345.3	50.9	68.0	33.7	36.6	81.1	103.1	40.3	53.8	93.1	30.7	68.9	42.8	9.4	13.1	28.1	37.2	9.7	17.7	44.5	83.4	370.4	75.6	51.4	26.6	111.8
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374527-6403967	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 1980.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		3900000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: AB_2680167"	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (1.74e-5)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	157.4	108.0	237.0	96.8	250.4	94.5	146.4	242.4	290.7	154.8	206.5	190.5	167.4	150.7	149.9	316.9	145.1	125.9	129.4	240.2	240.6	150.5	136.2	147.5	96.4	249.4	244.8	135.8	92.2	151.1	77.5	180.2	249.2	122.8	199.6	52.2	137.9	145.0	179.5	189.2	161.9	179.3	260.2	96.6	160.6	51.6	241.1	115.3	127.2	141.1	169.6	205.3	188.6	262.9	519.9	230.9	233.0	255.1	270.1	341.8	138.6	284.9	348.0	371.6	375.8	227.3	474.8	145.5	179.7	400.9	384.2	359.4	251.5	345.9	471.9	68.3	207.8	146.6	171.7	166.5	323.7	134.0	114.6	229.7	302.8	268.4	297.6	281.7	333.4	141.3	266.2	111.7	406.4	377.3	74.0	312.4	419.1	261.9	272.3	129.2	236.9	214.6	481.7	322.7	175.8	295.9	201.7	726.1	241.4	264.7	409.6	396.3	341.8	242.4	364.3	300.7	334.5	84.1	99.5	135.4	223.9	250.9	470.6	31.0	117.3	63.0	23.8	83.0	15.1	46.8	26.8	30.9	112.8	49.9	33.0	21.8	168.6	26.1	83.5	64.5	46.1	47.0	237.0	250.4	242.4	290.7	240.2	240.6	249.4	244.8	249.2	260.2	241.1	262.9	755.4	147.4	123.6	28.7	155.9	934.1	981.6	232.1	429.2	90.4	485.3	593.8	200.6	484.7	164.8	356.8	25.0	802.8	224.1	920.9	536.1	183.5	77.6	388.7	362.9	641.2	336.7	313.3	43.3	174.2	1064.1	415.9	305.3	422.8	130.9	325.4	580.8	367.1	832.0	146.4	35.3	632.9	179.0	811.3	1066.7	58.8	476.3	705.7	458.9	66.5	607.2	341.1	191.6	23.1	56.7	299.1	754.4	472.8	212.2	1495.5	816.4	832.0	214.1	64.2	479.9	346.6	466.6	216.6	373.1	774.5	1148.6	845.4	180.0	353.6	573.7	1980.7
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.9;lymphoid tissue: 43.0;testis: 45.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 55.7;Extravillous trophoblasts: 49.4;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	5.0	2.5	5.5	13.7	8.2	38.9	7.1	6.9	6.3	5.2	3.2	16.7	10.5	5.3	1.5	21.3	4.4	6.4	2.8	5.0	6.0	9.2	4.7	6.2	23.9	6.7	7.1	2.4	2.7	5.8	1.4	14.0	6.5	3.3	18.7	5.3	4.8	3.4	4.9	14.4	11.6	12.5	5.5	6.5	9.8	45.5	7.6	43.0	3.3	4.8	30.2	7.7	8.0	7.0	193.0	174.5	135.8	86.8	24.8	29.7	113.0	195.0	97.0	207.3	140.3	174.6	144.7	107.5	86.0	108.3	99.9	127.1	137.7	93.6	219.9	203.0	85.4	137.9	165.8	58.1	8.4	146.1	109.0	16.2	17.2	140.7	111.4	60.3	71.7	96.4	101.6	159.6	197.0	136.8	122.5	72.6	96.2	108.9	112.9	113.9	163.5	78.3	54.9	95.7	113.9	97.5	161.7	102.7	53.0	68.8	199.7	64.8	64.9	136.2	119.1	86.8	144.7	83.3	225.2	126.6	67.7	97.0	81.1	24.1	3.2	4.7	6.5	4.1	5.7	8.2	7.9	9.2	2.8	4.3	4.6	6.1	0.7	11.0	2.6	1.8	19.1	5.8	5.5	8.2	6.9	6.3	5.0	6.0	6.7	7.1	6.5	5.5	7.6	7.0	2.0	6.4	6.4	2.9	4.2	12.9	2.5	4.9	6.2	1.5	4.8	5.1	1.5	2.8	3.3	5.5	4.2	21.8	4.4	3.1	19.6	1.9	15.2	2.2	3.1	2.7	0.0	55.7	7.5	2.2	49.4	5.9	7.7	4.0	2.5	14.2	5.3	2.7	13.1	1.7	8.0	5.7	20.3	11.3	8.0	17.7	1.5	7.1	1.8	1.0	4.5	2.7	6.2	6.0	12.3	2.0	1.0	3.8	10.9	2.8	1.1	2.1	2.3	0.8	13.1	3.1	5.5	79.6	32.2	19.5	12.9	8.6	6.9	2.2	11.6	2.9
RACK1	"Gnb2-rs1, GNB2L1, H12.3"	ENSG00000204628	"Receptor for activated C kinase 1"	P63244	5	181236897-181248096	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 3642.0;Breast myoepithelial cells: 3742.9;Cytotrophoblasts: 3252.2;Exocrine glandular cells: 3361.4;Extravillous trophoblasts: 4389.3;Syncytiotrophoblasts: 3206.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004288, HPA021676"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB004288: AB_2247471, HPA021676: AB_1849868"	"unprognostic (4.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (4.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.62e-1)"	873.7	718.9	473.2	701.4	488.1	1590.2	1435.8	482.6	527.4	1091.1	505.6	1033.5	747.7	884.8	989.4	1154.9	1366.8	732.8	676.4	457.2	487.8	641.2	817.0	631.4	1358.7	519.6	485.3	2527.6	1504.7	721.7	582.6	763.8	514.8	716.2	922.6	286.5	1204.1	638.1	1167.2	1242.9	788.2	823.6	514.0	821.7	753.6	230.4	490.2	1703.2	820.4	1152.2	1590.1	1026.2	896.4	532.7	1606.0	1783.0	1498.7	2930.0	2671.8	4139.8	2576.4	1409.8	2832.1	2364.7	2463.4	3845.9	1671.3	3592.6	1735.5	2068.5	1668.5	1216.3	1867.9	6501.5	1729.1	3457.2	3068.4	1205.2	1939.5	2508.6	3610.1	3145.0	1193.1	4375.7	3664.7	1935.6	3427.8	2880.2	2705.8	2328.3	1610.6	2717.9	2117.6	3742.7	2435.7	2703.6	1535.1	1487.1	1504.9	2218.3	1536.5	3279.6	2733.5	2152.4	1969.8	2163.4	865.3	2682.2	4446.4	1015.6	1882.1	2802.9	2089.8	1297.4	1032.1	1029.1	2315.5	1767.8	2293.6	2063.5	1242.5	2470.7	1440.5	577.1	1163.9	290.3	829.2	908.1	1333.4	1732.3	1391.2	1062.0	1405.6	1689.0	1597.5	1348.6	138.6	1092.2	861.8	1037.0	1465.0	3377.9	473.2	488.1	482.6	527.4	457.2	487.8	519.6	485.3	514.8	514.0	490.2	532.7	896.6	576.9	935.7	0.0	698.1	0.0	0.0	0.0	0.0	0.0	3642.0	3742.9	0.0	0.0	452.5	498.4	0.0	3252.2	821.7	0.0	1749.1	1773.1	0.0	590.9	1560.3	523.7	0.0	0.0	0.0	3361.4	4389.3	783.3	0.0	818.8	671.1	1822.8	0.0	0.0	1964.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.4	0.0	0.0	1169.6	0.0	0.0	0.0	0.0	2097.2	0.0	0.0	200.2	0.0	0.0	2538.2	253.6	0.0	0.0	0.0	689.9	0.0	0.0	0.0	0.0	3206.0	503.5	2464.9	0.0	0.0
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905260-34918989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA006692: AB_2667645"	"prognostic unfavorable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.5	8.1	3.2	4.8	3.5	8.4	5.8	3.9	4.6	6.8	5.3	4.1	4.9	5.6	5.4	4.9	3.9	4.6	8.9	3.8	4.6	5.1	4.3	7.5	8.9	3.5	2.7	5.7	4.4	5.1	3.5	8.1	3.2	6.8	4.3	8.7	4.9	4.8	10.9	6.7	4.8	4.6	1.9	4.9	4.8	7.9	3.4	6.3	6.3	8.6	6.2	5.2	4.7	3.8	8.5	10.2	12.3	20.5	7.9	9.4	17.2	15.1	12.0	13.0	10.6	12.2	12.3	25.0	5.2	11.2	15.7	8.4	12.6	7.6	14.4	10.1	12.7	12.9	34.0	8.0	11.9	16.5	11.9	7.8	7.3	13.9	9.3	6.1	6.2	11.0	22.7	13.2	11.2	10.2	19.6	13.9	15.4	6.0	15.7	17.1	24.0	8.6	6.7	9.0	12.4	13.3	30.0	19.9	13.3	7.6	12.5	14.8	6.2	17.9	13.3	9.7	14.4	7.9	13.8	20.3	11.1	28.6	12.5	7.4	2.9	6.5	5.3	2.8	6.9	8.6	5.8	7.6	3.1	9.1	8.2	6.8	1.6	4.5	2.8	6.9	4.9	2.6	3.2	3.5	3.9	4.6	3.8	4.6	3.5	2.7	3.2	1.9	3.4	3.8	11.5	22.4	43.2	5.9	18.3	29.2	20.2	29.3	13.1	25.3	23.9	18.4	25.7	14.3	21.3	20.2	27.1	82.3	20.4	11.9	19.6	18.1	22.0	13.1	16.6	14.1	13.1	28.2	6.6	22.5	54.4	18.7	6.1	12.0	21.5	39.1	10.0	14.8	23.4	23.5	9.0	12.7	30.5	12.0	19.3	16.8	25.1	13.1	17.8	6.5	12.7	23.9	9.2	7.5	9.1	17.8	13.8	21.8	18.0	21.9	13.4	16.4	14.6	35.6	13.1	19.6	19.4	72.5	58.6	15.6	28.6	80.6	22.3	27.4	13.0	25.8
RAD17	"CCYC, RAD17Sp, Rad24"	ENSG00000152942	"RAD17 checkpoint clamp loader component"	O75943	5	69369293-69414801	"Predicted intracellular proteins"	"Cell cycle, DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 121.6;Spermatocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004551, HPA005448"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004551: AB_628195, HPA005448: AB_1079738"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.74e-2)"	"prognostic favorable (5.79e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-2)"	9.6	11.5	6.3	8.5	6.8	8.0	11.7	7.3	8.8	9.7	7.2	10.8	4.8	10.1	8.1	9.5	9.1	5.4	12.5	7.1	7.9	16.1	13.4	8.2	19.4	6.8	7.3	10.3	16.5	12.9	16.2	8.2	6.9	9.6	9.3	16.5	10.7	8.5	13.3	9.9	11.7	5.6	6.5	13.3	11.8	41.2	7.2	14.8	11.1	8.3	13.0	9.5	8.9	7.9	16.2	7.0	21.7	25.7	0.0	0.2	26.5	15.7	19.8	21.0	29.5	16.9	17.3	70.7	16.6	9.1	41.9	7.4	21.8	9.1	32.3	0.0	11.8	17.3	17.0	16.9	25.3	0.5	21.7	15.1	14.9	15.6	15.2	0.0	18.4	18.3	16.9	21.0	26.7	0.0	32.2	11.8	13.4	6.7	8.8	27.7	19.8	15.9	25.1	14.5	22.7	15.8	14.4	4.5	0.6	22.8	21.2	21.1	5.6	0.0	19.1	9.8	10.3	26.9	44.6	24.4	21.3	33.7	14.2	1.4	2.3	4.0	4.3	2.9	4.2	7.5	3.9	4.6	3.4	5.5	5.4	4.7	0.9	6.5	1.4	1.7	5.8	2.5	6.3	6.8	7.3	8.8	7.1	7.9	6.8	7.3	6.9	6.5	7.2	7.9	17.5	32.1	17.9	20.2	20.2	5.5	6.5	10.3	12.0	17.9	13.6	15.1	33.5	8.6	19.9	5.5	20.9	18.0	20.5	9.5	25.4	12.8	121.6	19.4	23.7	13.9	15.1	24.4	16.5	12.9	17.3	11.5	12.8	16.0	30.9	20.2	10.8	12.6	10.1	6.7	17.8	11.1	14.2	10.4	4.3	72.3	14.3	11.9	5.4	11.2	15.6	20.8	16.5	23.1	28.1	12.2	7.5	10.9	31.7	9.3	11.1	24.3	29.3	45.4	6.6	20.1	16.5	172.7	70.1	12.5	5.8	14.1	17.2	16.7	10.8	6.4
RAD18	RNF73	ENSG00000070950	"RAD18 E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	2.7	2.3	1.2	3.3	1.5	5.2	5.3	1.3	1.7	3.2	0.5	3.8	10.1	2.8	1.9	3.4	2.3	3.1	1.8	1.5	0.9	1.6	2.7	2.7	4.6	1.6	1.0	2.8	1.7	2.0	1.3	3.0	1.5	3.2	4.9	2.6	3.2	1.6	1.3	4.5	6.5	2.8	1.2	3.5	2.2	2.9	1.1	5.8	3.7	1.0	4.4	2.5	2.9	2.3	16.2	15.2	12.3	7.4	3.0	6.4	14.9	25.0	8.5	23.5	16.1	13.7	10.1	19.8	4.7	14.2	13.8	5.6	13.1	13.0	23.8	12.2	17.2	16.9	16.1	8.2	1.9	22.7	13.9	2.4	4.6	23.3	15.7	6.3	7.7	17.1	18.2	19.0	20.9	18.6	22.9	15.9	17.2	12.7	28.5	18.0	13.6	15.6	6.9	12.2	5.1	11.5	11.2	10.5	8.2	9.7	11.0	9.8	6.4	19.4	10.5	16.8	21.7	9.6	16.1	43.7	14.3	24.5	14.6	6.4	1.6	5.1	1.5	1.7	2.8	1.9	2.1	2.7	2.0	1.9	2.2	1.6	0.7	2.8	1.1	3.6	3.0	0.8	1.2	1.5	1.3	1.7	1.5	0.9	1.6	1.0	1.5	1.2	1.1	2.3	5.7	16.0	9.8	6.2	7.7	11.1	7.5	6.4	5.7	4.6	7.3	11.7	2.2	4.3	7.5	3.7	2.1	9.0	8.6	5.2	1.9	9.6	4.2	4.0	5.8	4.6	1.8	7.2	20.9	8.2	12.4	6.8	3.6	4.9	13.9	14.8	6.1	3.1	7.1	3.3	15.7	6.5	2.0	5.2	5.6	3.0	4.1	4.6	3.6	14.0	7.1	3.2	8.2	16.1	14.3	10.2	4.3	2.6	8.7	6.4	4.0	3.1	4.1	2.3	6.6	4.3	6.9	26.2	14.0	6.0	11.8	6.7	7.5	9.3	6.3	3.6
RAD21	"hHR21, KIAA0078, SCC1"	ENSG00000164754	"RAD21 cohesin complex component"	O60216	8	116845934-116874776	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 424.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020044, CAB022065, HPA073277"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB022065: , HPA020044: AB_1856035, HPA073277: "	"unprognostic (7.85e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.43e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.86e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.58e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	75.4	80.5	62.9	74.0	74.5	206.0	71.9	74.7	75.7	50.5	56.7	73.1	57.3	67.6	54.6	71.2	50.6	49.4	89.8	58.1	74.3	68.2	64.7	67.9	122.8	70.0	69.3	67.8	41.9	82.3	33.8	90.1	75.2	57.5	82.5	114.2	56.9	65.0	76.6	54.0	60.4	60.2	71.9	75.5	56.4	88.7	67.2	177.2	80.9	95.5	119.5	59.7	44.5	97.1	301.6	143.9	277.3	156.7	136.5	117.0	124.2	202.1	191.4	220.8	202.4	119.8	275.2	438.6	109.4	146.0	117.4	162.4	238.5	132.1	257.6	589.1	153.1	447.6	167.2	153.7	85.5	145.7	253.1	100.2	106.0	129.4	156.0	146.1	176.4	625.8	183.6	595.6	193.1	181.1	665.4	86.2	163.6	385.4	179.2	241.8	201.5	223.4	133.5	173.3	348.2	179.1	212.2	569.4	140.6	144.5	238.3	178.5	128.5	154.6	223.5	164.4	217.1	313.3	383.9	391.9	132.8	206.7	189.7	35.3	7.9	28.0	17.4	8.7	17.5	14.4	20.3	20.6	9.0	12.8	20.8	20.6	29.7	14.3	12.7	7.6	43.7	11.4	62.9	74.5	74.7	75.7	58.1	74.3	70.0	69.3	75.2	71.9	67.2	97.1	115.7	256.4	157.1	24.5	111.2	95.6	77.5	62.5	78.0	75.4	65.8	53.0	155.2	51.5	101.0	55.2	31.3	142.4	118.1	90.4	43.0	54.0	258.0	67.0	86.7	97.0	84.4	249.8	39.3	44.9	157.0	89.4	57.1	88.2	153.5	112.9	75.0	72.1	67.9	67.3	48.1	72.7	69.2	93.1	100.0	424.9	116.5	93.4	69.4	45.9	110.8	112.5	77.2	41.2	58.3	63.5	66.3	106.5	124.0	100.0	35.7	59.4	70.5	67.9	72.3	88.6	85.3	33.2	88.6	103.7	100.4	113.7	134.1	85.5	94.1	95.5
RAD23A	"HHR23A, MGC111083"	ENSG00000179262	"RAD23 homolog A, nucleotide excision repair protein"	P54725	19	12945855-12953642	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 984.0;tongue: 447.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 901.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026418, HPA053901, HPA057003, HPA065599"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.32e-3)"	"unprognostic (9.99e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.59e-3)"	79.2	63.4	77.8	49.4	79.8	85.8	71.0	78.1	95.7	59.2	71.0	91.6	48.4	65.0	31.2	70.0	64.1	38.2	132.4	80.5	79.8	54.1	70.4	66.4	55.9	80.5	76.7	56.2	76.7	66.1	47.7	55.5	80.1	57.5	35.8	24.5	68.0	52.5	984.0	72.6	52.8	54.8	77.0	54.5	66.4	48.7	79.4	53.0	54.9	447.9	44.0	78.5	57.1	82.0	138.0	52.6	55.7	57.4	91.5	104.1	94.7	66.1	130.2	152.6	137.2	59.8	95.3	117.3	150.0	99.4	104.4	102.7	78.0	137.7	55.9	170.0	109.8	47.2	57.3	58.3	181.7	102.1	130.7	107.9	199.6	110.1	208.9	89.7	105.4	188.0	124.1	102.1	138.2	139.8	126.6	124.2	76.5	124.6	135.6	65.4	59.4	189.6	118.9	53.8	104.3	81.8	75.4	129.1	145.8	40.2	100.4	173.7	82.5	214.9	57.4	263.3	203.9	148.2	133.8	86.0	177.9	193.3	183.2	31.3	76.3	64.9	81.1	102.4	87.3	77.5	66.8	69.1	68.3	73.5	63.3	73.4	9.2	79.1	105.3	86.0	82.0	69.1	77.8	79.8	78.1	95.7	80.5	79.8	80.5	76.7	80.1	77.0	79.4	82.0	120.2	86.6	56.2	11.8	127.6	120.4	176.8	165.2	122.3	51.7	110.3	121.3	59.5	108.7	108.4	55.2	20.9	212.0	99.6	95.7	166.3	179.5	193.1	74.3	76.9	120.4	87.3	901.4	22.0	191.0	240.1	101.4	101.9	74.1	111.5	77.7	86.4	96.2	175.3	52.2	22.9	138.5	136.3	88.3	170.3	44.1	118.4	119.6	142.3	12.2	182.5	73.9	94.7	15.6	25.8	184.1	119.0	114.0	159.0	351.3	139.9	163.3	91.1	56.1	111.7	138.3	129.3	263.6	179.6	153.3	146.5	244.8	113.0	117.8	154.8	211.1
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332192	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 420.5;Late spermatids: 1201.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		5900000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	73.8	47.8	26.6	44.4	27.0	82.8	48.5	40.4	37.4	42.8	22.0	47.7	41.9	41.9	68.8	63.6	40.9	34.1	48.7	29.0	29.2	44.4	140.8	39.3	39.4	26.9	27.0	37.8	64.5	50.4	30.5	77.7	26.3	48.2	47.7	42.1	38.4	43.5	153.0	64.7	40.6	55.0	22.5	36.2	41.5	59.4	27.7	58.4	42.6	123.5	49.9	67.5	42.8	30.7	132.9	114.9	158.6	102.9	107.5	166.6	179.9	200.6	162.3	172.8	116.9	190.1	140.5	184.8	79.3	218.6	156.4	181.2	221.0	175.9	172.9	126.4	73.0	96.2	112.0	147.6	140.3	174.2	79.3	141.1	161.3	165.3	248.0	136.0	124.3	79.6	158.3	133.6	159.5	215.0	169.6	88.3	170.5	231.2	133.0	125.3	209.6	87.8	149.8	122.1	144.9	98.2	138.8	193.1	125.8	237.5	197.7	70.5	114.3	129.0	127.0	161.6	152.5	91.9	181.2	98.5	138.0	101.7	138.0	0.9	1.1	1.1	1.9	1.2	2.1	1.8	1.1	1.6	1.0	2.1	1.7	1.5	2.9	2.3	0.8	1.1	2.2	0.6	26.6	27.0	40.4	37.4	29.0	29.2	26.9	27.0	26.3	22.5	27.7	30.7	49.7	44.8	40.4	32.3	54.7	195.5	148.1	40.5	79.1	40.5	65.3	36.6	117.4	68.6	42.2	35.0	27.1	269.7	37.1	82.9	50.9	89.2	420.5	69.8	80.8	68.7	101.0	76.1	54.9	77.4	259.7	79.3	60.6	90.8	36.2	83.0	55.6	209.9	99.5	50.5	47.2	83.8	38.7	65.6	131.1	1201.4	75.5	70.7	74.7	38.4	83.7	40.4	39.1	50.3	54.1	81.0	50.5	87.3	89.3	146.0	51.2	95.9	47.6	43.9	78.9	71.6	88.5	45.3	74.7	126.9	240.9	291.8	50.5	91.1	74.9	141.2
RAD50	"hRad50, RAD50-2"	ENSG00000113522	"RAD50 double strand break repair protein"	Q92878	5	132556019-132646349	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB022103, CAB024979, HPA052291"	Supported		Supported	Nucleoplasm		NA	NA		12000	"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB022103: , CAB024979: , HPA052291: AB_2681786"	"unprognostic (3.46e-3)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.50e-3)"	"unprognostic (4.22e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.40e-1)"	6.3	8.0	5.8	2.8	6.9	5.9	6.6	7.6	8.6	6.9	4.0	8.7	2.5	8.1	10.3	7.6	7.3	3.5	7.1	6.8	4.9	6.1	6.2	5.0	2.5	5.0	4.4	9.2	9.2	8.8	8.1	3.6	5.7	6.2	4.6	8.5	7.1	4.2	11.3	10.4	8.0	3.8	3.4	5.4	8.6	5.5	5.4	4.0	6.0	4.7	3.5	7.9	6.9	8.6	9.1	22.8	2.1	12.1	13.3	20.0	9.8	6.3	11.2	11.0	12.8	20.4	14.8	20.6	3.7	10.3	19.7	8.8	17.6	14.2	16.5	11.7	13.4	9.5	13.3	12.5	10.8	10.2	7.6	10.8	24.1	13.4	36.7	7.2	5.4	6.5	17.9	3.2	10.1	8.6	7.7	13.9	11.7	9.0	6.8	7.2	3.7	10.1	8.8	16.9	11.5	14.9	11.7	4.7	2.8	5.6	11.5	7.0	9.5	4.7	5.5	14.5	8.3	5.7	7.7	24.2	8.4	12.5	6.7	7.0	3.3	1.1	4.1	3.8	5.6	7.0	5.4	5.4	3.6	5.8	4.9	4.5	0.3	9.3	4.8	2.5	4.0	2.7	5.8	6.9	7.6	8.6	6.8	4.9	5.0	4.4	5.7	3.4	5.4	8.6	3.5	38.5	27.1	65.6	34.6	26.0	37.3	33.7	31.9	56.8	6.6	4.8	130.0	44.3	31.6	7.3	89.6	69.6	22.9	31.0	1.9	6.3	26.4	8.2	15.8	16.6	37.1	38.5	65.9	6.0	49.2	37.6	37.2	7.6	30.4	8.5	22.1	38.5	37.4	37.0	79.7	44.1	18.3	27.2	12.2	12.6	60.6	16.5	16.0	49.6	22.4	38.0	48.4	65.9	92.4	4.8	35.6	53.4	33.0	32.1	53.7	4.4	40.8	60.8	32.9	50.9	39.9	108.4	87.2	39.2	26.7	33.1	25.2	11.5	52.3	25.1
RAD51AP1	PIR51	ENSG00000111247	"RAD51 associated protein 1"	Q96B01	12	4538798-4560047	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Meiosis"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.9;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.4;Erythroid cells: 47.8;Extravillous trophoblasts: 34.1;Hofbauer cells: 40.8;Late spermatids: 68.1;Spermatocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051499			Approved	Nucleoplasm		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051499: AB_2681508"	"unprognostic (1.03e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (6.30e-2)"	"unprognostic (5.25e-3)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.29e-3)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.44e-15)"	"unprognostic (2.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.88e-2)"	"unprognostic (3.75e-2)"	0.9	0.8	0.3	4.8	0.4	16.9	2.7	0.4	0.7	0.9	0.3	5.2	5.2	1.2	0.6	3.2	1.0	1.1	0.5	0.3	0.3	0.8	1.8	1.4	8.9	0.4	0.4	0.5	0.4	0.6	0.3	3.8	0.4	1.3	6.5	1.5	1.0	1.0	0.5	3.2	4.8	1.9	0.4	3.4	2.7	6.3	0.4	14.4	1.0	0.6	7.9	1.7	1.3	0.5	37.5	13.0	45.3	22.7	2.7	5.7	53.0	48.2	21.2	52.6	68.9	35.4	35.4	48.6	7.0	10.4	24.7	23.1	31.8	14.5	80.0	38.7	27.0	61.4	21.6	24.8	0.6	56.6	29.9	1.2	1.5	31.6	30.4	7.5	21.4	33.0	39.2	54.4	33.7	13.6	46.5	20.5	110.4	36.3	14.4	46.0	54.3	19.2	16.1	18.3	15.1	16.6	35.9	27.7	11.6	45.5	11.3	32.6	9.5	35.5	36.5	38.8	52.4	7.8	10.0	93.3	13.3	40.0	29.4	0.0	0.5	0.7	0.1	2.3	0.5	3.1	0.4	1.0	0.4	3.4	0.1	0.2	0.0	1.4	2.0	6.9	1.0	0.6	0.3	0.4	0.4	0.7	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.5	1.4	0.0	0.5	0.7	6.1	5.2	2.3	6.6	1.2	3.1	3.4	5.7	1.4	2.8	4.5	0.0	4.2	20.3	11.3	5.7	0.0	3.0	33.4	3.3	2.9	2.9	2.4	47.8	2.7	2.7	34.1	5.2	6.1	3.6	1.3	22.6	2.5	1.2	40.8	0.0	1.1	6.4	16.2	6.2	5.6	68.1	1.2	10.1	0.0	3.7	6.8	2.7	3.1	0.5	2.4	1.5	0.8	1.5	15.5	1.0	1.2	1.5	0.9	4.8	0.0	2.4	4.2	35.9	25.0	10.0	2.6	4.7	4.6	2.0	14.6	2.7
RAD51B	"hREC2, R51H2, RAD51L1, REC2"	ENSG00000182185	"RAD51 paralog B"	O15315	14	67819779-68730218	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Astrocytes: 150.8;Microglial cells: 263.3;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 375.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB016191, HPA051869"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Nucleoplasm	"CAB016191: AB_2238209, HPA051869: AB_2681644"	"unprognostic (9.10e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.47e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.13e-3)"	3.1	2.3	3.0	2.9	5.7	7.3	5.5	3.8	3.3	5.8	5.8	3.0	1.1	4.4	9.0	3.7	3.9	4.3	1.7	3.4	3.7	2.7	2.1	2.7	4.8	5.7	4.7	6.3	2.1	4.9	2.0	4.1	5.7	2.5	2.6	3.0	13.1	2.3	1.2	4.2	2.4	4.4	4.3	2.6	2.6	1.8	5.0	5.9	2.5	1.2	4.3	3.6	4.5	7.3	15.3	5.9	6.5	3.9	5.9	10.0	4.0	7.6	5.8	8.2	10.5	4.2	20.1	18.6	4.8	4.7	9.4	13.4	4.1	12.1	11.1	8.4	4.2	8.9	5.4	3.3	3.2	7.6	8.6	5.1	9.0	9.4	9.9	3.8	7.4	13.5	7.3	8.4	6.7	11.9	14.9	2.7	3.8	14.6	5.9	16.6	7.7	6.8	6.3	4.3	4.4	2.9	6.0	2.2	13.1	7.6	10.1	6.8	2.0	9.9	9.6	7.8	6.3	4.0	4.4	14.9	5.5	13.1	5.7	17.4	5.7	5.7	8.1	4.8	6.6	14.2	7.6	8.6	6.5	11.8	9.4	8.9	0.7	8.5	4.7	6.4	9.4	4.5	3.0	5.7	3.8	3.3	3.4	3.7	5.7	4.7	5.7	4.3	5.0	7.3	5.1	0.0	1.1	150.8	13.3	6.6	5.1	6.4	5.7	1.8	8.4	5.1	1.6	0.0	4.0	1.8	8.4	5.4	3.5	1.1	3.9	1.9	3.0	5.3	3.7	4.5	4.8	4.6	21.5	1.4	6.7	4.2	3.1	3.6	4.5	6.8	1.8	0.8	6.5	1.7	22.0	3.8	2.0	3.4	3.5	1.9	3.7	4.2	8.8	263.3	6.8	5.8	3.1	157.3	375.2	1.0	0.6	4.5	8.9	2.4	2.7	1.8	8.4	6.0	0.0	3.6	7.0	6.2	3.2	5.6	7.0	4.0	7.0	4.4	1.8	4.6
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 117.7;Spermatocytes: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 319.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: AB_2679250"	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	10.8	20.2	15.5	10.0	15.7	23.1	15.3	19.0	18.4	10.8	13.4	12.4	7.5	12.6	22.0	13.0	11.2	11.0	25.7	16.4	15.0	12.8	13.3	8.8	22.0	14.9	13.8	12.5	10.6	20.1	10.5	15.1	16.0	17.4	14.5	13.5	10.7	12.0	18.3	10.6	8.7	13.8	13.2	12.2	11.6	20.2	14.6	21.2	12.3	17.3	19.1	10.9	8.6	18.2	63.7	72.1	43.3	48.5	22.9	19.6	100.1	34.2	14.5	43.5	55.3	31.0	39.3	37.4	48.9	23.5	58.8	23.3	59.5	46.6	81.7	91.6	123.0	53.0	84.6	119.4	23.3	69.1	45.0	12.1	42.2	47.8	38.6	24.0	50.0	60.9	83.6	48.5	37.0	319.1	96.8	95.3	12.1	42.5	66.5	62.1	69.5	69.8	26.9	39.6	54.3	49.6	27.3	12.0	53.5	11.1	39.2	71.6	16.5	37.6	100.1	34.3	42.4	44.1	187.2	111.5	38.3	67.1	42.0	27.6	9.2	12.5	15.6	14.3	15.2	18.0	16.9	17.2	15.9	17.3	18.2	17.4	5.1	15.0	12.5	14.3	27.1	11.0	15.5	15.7	19.0	18.4	16.4	15.0	14.9	13.8	16.0	13.2	14.6	18.2	20.5	19.2	13.9	10.1	20.5	11.9	18.7	42.9	15.9	15.0	25.1	34.0	63.7	7.2	20.9	16.5	6.2	67.8	15.0	7.1	58.7	25.7	117.7	17.3	13.0	19.3	6.7	43.8	21.5	18.6	94.1	19.8	7.1	13.0	22.9	23.3	15.7	15.7	33.4	16.8	17.7	11.7	32.6	16.1	47.7	65.4	17.4	21.8	24.9	13.1	18.7	31.3	21.6	23.1	22.8	13.0	10.4	15.4	28.5	17.2	5.7	24.6	14.1	26.9	32.9	14.7	23.9	140.7	98.3	15.9	10.7	36.3	20.5	28.2	15.3	13.9
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46246461-46278480	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 7.2;Extravillous trophoblasts: 9.4;Glandular and luminal cells: 8.0;Spermatocytes: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028954: AB_2672840, HPA051537: AB_2681525"	"unprognostic (2.12e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	0.5	0.7	3.0	4.1	3.8	8.7	1.0	4.3	3.9	1.3	2.1	3.2	2.0	0.7	0.1	5.4	0.4	0.5	0.7	2.9	2.5	1.4	0.5	1.2	5.5	3.2	3.0	0.5	0.5	0.3	0.4	3.4	3.8	1.0	4.6	0.4	0.9	0.4	1.2	2.3	2.8	1.7	2.8	2.8	1.5	15.6	3.1	15.4	1.8	0.0	8.3	0.8	1.8	3.7	22.2	16.1	46.8	29.1	3.3	2.4	43.9	25.8	11.3	42.8	43.3	33.3	14.2	42.5	19.1	11.0	38.5	22.2	44.6	14.5	36.8	23.7	43.0	53.0	49.7	32.1	0.1	54.0	29.3	1.6	1.2	42.1	12.5	6.9	13.5	49.7	38.2	41.7	23.1	20.4	68.9	60.0	42.5	19.4	25.2	52.8	26.8	19.0	9.4	17.5	22.4	16.3	18.4	25.2	5.7	38.0	9.1	37.7	5.7	43.9	26.1	23.6	43.7	17.6	10.6	46.9	11.5	35.1	18.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.2	3.0	3.8	4.3	3.9	2.9	2.5	3.2	3.0	3.8	2.8	3.1	3.7	0.0	0.0	0.0	1.0	0.7	0.3	0.7	0.5	1.8	0.0	0.5	0.5	0.8	0.0	0.1	0.0	0.0	4.3	0.4	1.8	0.0	0.3	2.7	2.3	0.8	0.5	0.0	7.2	2.8	0.0	9.4	1.1	0.5	8.0	4.5	5.6	0.4	0.0	2.6	0.0	1.1	1.3	0.0	0.3	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.0	1.0	1.0	2.9	0.3	0.1	0.0	4.7	0.4	0.4	0.0	0.1	0.0	0.0	0.4	4.0	12.4	5.6	3.1	0.3	1.6	1.1	0.2	2.9	1.0
RAD54L2	"ARIP4, KIAA0809, SRISNF2L"	ENSG00000164080	"RAD54 like 2"	Q9Y4B4	3	51541144-51668667	"Enzymes, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035004, HPA039992, HPA077351"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: "	"unprognostic (1.46e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.63e-2)"	4.6	4.8	5.6	3.7	6.1	6.1	4.6	6.5	5.6	4.8	2.9	5.8	2.5	5.6	4.2	4.0	4.6	2.7	4.4	5.0	5.2	4.0	7.8	4.9	4.2	5.5	5.7	5.3	5.3	3.8	4.5	4.8	5.5	4.4	3.4	7.5	4.5	3.9	7.1	5.5	5.0	4.1	5.3	5.2	5.2	5.0	6.3	6.2	4.6	5.3	5.2	4.8	4.3	6.2	6.6	5.1	12.8	12.7	7.0	5.0	6.7	5.5	7.8	7.4	6.9	9.1	3.8	17.4	1.5	9.7	7.8	5.0	20.5	6.8	9.1	9.2	4.6	14.9	11.5	6.0	6.4	16.8	8.5	5.8	5.4	11.3	10.9	4.6	8.3	14.8	10.3	9.1	5.9	5.1	15.0	7.6	10.2	3.2	5.5	6.9	9.9	2.3	3.8	8.4	5.2	10.0	8.7	8.2	5.7	7.7	5.4	9.9	10.9	7.7	8.9	8.0	10.8	9.8	10.7	16.8	8.3	9.2	10.0	3.1	2.2	2.2	3.3	2.6	3.5	1.8	2.9	2.8	2.3	2.9	1.9	2.3	0.9	3.0	3.5	2.3	2.9	2.2	5.6	6.1	6.5	5.6	5.0	5.2	5.5	5.7	5.5	5.3	6.3	6.2	10.8	9.6	14.4	31.3	11.3	9.2	8.6	6.7	3.4	33.8	8.7	8.0	11.0	15.7	7.8	9.2	31.3	19.3	12.2	7.7	1.9	9.3	7.5	9.5	12.0	15.1	16.3	3.8	54.9	10.4	8.7	9.6	9.2	19.8	18.3	14.2	10.4	21.9	8.9	47.1	54.3	8.1	4.1	9.1	8.4	3.1	15.2	9.4	14.2	26.2	13.2	9.1	30.9	42.7	42.3	13.9	9.7	17.0	11.3	12.4	4.6	4.4	9.5	29.9	13.1	17.1	11.6	43.9	36.4	5.5	8.9	29.7	12.5	10.1	7.9	12.5
RAD9A	RAD9	ENSG00000172613	"RAD9 checkpoint clamp component A"	Q99638	11	67317871-67398410	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006725, HPA048155, CAB079979"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB079979: , HPA006725: AB_1856041, HPA048155: AB_2680290"	"unprognostic (7.64e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (2.82e-5)"	"unprognostic (6.16e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.52e-6)"	5.8	5.0	3.3	6.9	3.6	10.2	6.9	2.1	6.0	9.2	2.9	7.3	10.9	7.4	2.1	9.0	10.9	5.7	4.2	3.8	2.4	7.1	6.6	6.7	8.3	2.9	3.6	8.0	8.0	3.4	10.1	4.4	2.2	10.8	3.0	1.8	9.8	6.1	5.2	11.4	11.1	2.4	2.2	9.4	8.4	8.6	2.5	6.1	9.7	2.1	3.7	6.5	8.5	2.2	10.8	15.8	9.5	13.8	2.8	1.1	12.0	5.7	4.9	8.0	7.1	23.2	20.9	11.1	12.4	1.8	13.0	18.7	6.0	5.5	0.9	13.0	16.3	16.8	8.5	10.4	3.8	12.3	20.3	3.2	5.3	7.2	3.5	6.1	5.5	23.2	14.7	15.6	2.3	33.2	21.9	21.8	13.2	15.9	12.1	18.8	12.5	13.6	2.2	9.0	9.8	10.6	9.9	27.2	21.1	2.4	19.1	10.9	4.2	11.7	14.3	23.3	8.7	14.6	14.2	11.5	7.5	11.6	9.6	5.3	1.8	6.0	5.2	2.3	3.8	4.3	4.1	4.3	1.2	3.1	2.9	3.2	2.8	3.1	2.5	3.4	2.4	1.5	3.3	3.6	2.1	6.0	3.8	2.4	2.9	3.6	2.2	2.2	2.5	2.2	16.0	22.4	17.1	10.1	31.0	17.1	17.7	17.9	23.3	19.6	19.7	18.4	1.1	12.8	22.2	20.2	70.9	27.9	31.3	54.2	13.7	11.3	27.3	32.1	13.4	16.3	14.3	17.7	8.5	13.1	22.4	13.8	27.0	14.9	20.3	26.0	11.0	6.6	15.1	21.9	6.0	48.9	10.2	10.3	31.4	13.2	10.5	14.0	19.6	11.2	8.9	15.0	56.7	2.5	5.3	11.6	31.6	12.4	38.5	16.6	61.8	10.9	44.0	32.1	13.1	10.5	14.5	32.0	17.6	18.3	17.3	40.6	30.3	15.3	38.7	18.0
RADIL	"FLJ10324, KIAA1849, RASIP2"	ENSG00000157927	"Rap associating with DIL domain"	Q96JH8	7	4797055-4883716	"Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.1;Early spermatids: 9.2;Horizontal cells: 13.5;Microglial cells: 14.0;Spermatocytes: 17.0;Spermatogonia: 11.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.8;HEK 293: 6.5;NTERA-2: 7.3;SCLC-21H: 8.9;SH-SY5Y: 19.0;U-2197: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051776	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA051776: AB_2681605"	"unprognostic (6.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.89e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-4)"	"unprognostic (5.10e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.28e-3)"	3.4	0.5	2.2	0.2	1.9	0.0	3.3	11.0	3.6	4.1	0.4	3.4	0.2	3.2	0.2	0.8	3.7	0.7	4.8	1.8	4.0	0.4	0.1	4.5	0.1	3.3	3.7	1.5	3.3	0.3	2.9	2.6	3.4	2.0	0.2	0.3	1.1	1.2	2.8	1.2	1.3	1.0	2.8	0.5	1.3	8.2	2.7	0.2	2.5	2.0	0.1	2.3	2.9	1.7	0.0	2.1	4.4	7.8	0.2	1.9	0.0	1.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.8	1.5	0.0	3.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.7	4.2	0.0	0.4	1.9	0.0	0.0	7.3	0.1	1.6	5.0	0.5	0.0	0.0	0.0	8.9	19.0	0.0	0.0	0.0	1.8	3.2	0.6	0.0	0.0	0.0	6.1	1.9	0.2	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	11.0	3.6	1.8	4.0	3.3	3.7	3.4	2.8	2.7	1.7	1.8	3.2	1.5	10.1	0.0	0.8	0.0	0.0	0.6	2.1	3.4	1.8	2.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.2	1.1	2.6	2.2	0.0	0.0	2.6	1.7	0.0	3.9	0.0	0.1	0.0	0.2	0.4	0.0	0.1	13.5	3.6	0.3	0.0	0.6	1.2	5.1	3.4	1.0	7.2	14.0	0.0	4.7	0.0	7.1	3.5	0.3	0.1	3.8	0.0	0.4	0.0	0.0	1.5	0.9	6.6	4.7	4.1	17.0	11.7	0.0	0.6	0.1	2.1	0.3	0.0	0.0
RAE1	"Gle2, Mnrp41"	ENSG00000101146	"Ribonucleic acid export 1"	P78406	20	57351223-57379211	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Spermatocytes: 256.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048795			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048795: AB_2680523"	"unprognostic (1.20e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.55e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.01e-1)"	14.0	13.9	18.6	13.5	19.1	50.5	17.0	18.5	19.1	15.5	17.6	14.2	11.9	16.6	18.2	20.5	17.4	9.0	13.3	18.3	19.9	14.1	16.5	10.0	20.8	16.3	15.9	16.3	10.8	19.1	13.3	14.6	17.0	12.4	16.2	20.1	12.8	15.0	15.0	22.9	13.6	16.3	17.2	17.0	12.8	103.0	21.4	29.2	12.1	15.8	26.5	14.5	16.0	19.6	43.5	52.6	52.8	29.3	30.1	29.0	46.1	33.9	47.2	172.2	70.3	166.1	33.8	69.2	46.8	52.8	63.8	56.6	101.6	88.3	142.1	20.8	45.2	47.0	46.0	74.9	59.0	57.1	41.3	41.3	74.0	75.8	83.1	29.1	49.9	47.2	84.8	32.5	53.0	114.8	88.3	53.2	32.9	86.3	93.3	47.6	49.4	46.0	37.3	45.5	55.2	47.6	58.4	129.4	61.0	41.2	71.5	54.0	29.7	70.6	63.0	41.7	57.7	34.9	83.9	81.8	48.3	36.1	35.6	21.2	42.0	77.0	27.0	36.8	32.9	31.2	26.0	26.8	32.3	28.1	33.9	30.7	36.2	24.7	37.9	23.8	24.6	40.4	18.6	19.1	18.5	19.1	18.3	19.9	16.3	15.9	17.0	17.2	21.4	19.6	17.5	19.2	16.7	8.5	21.0	17.2	16.3	42.0	15.9	15.9	12.6	19.3	10.4	11.5	24.1	18.4	14.6	52.8	20.8	11.6	27.4	30.3	113.6	16.5	16.7	17.9	6.6	18.7	10.2	14.3	39.3	18.6	12.2	15.3	38.0	25.6	11.0	13.5	38.3	3.3	9.5	15.2	18.3	59.5	14.5	63.9	21.8	33.5	10.6	14.0	40.0	19.9	27.8	5.5	13.1	22.2	24.3	22.6	15.9	14.0	10.1	20.6	24.1	17.9	19.7	11.6	19.9	256.9	83.1	19.2	21.0	70.5	24.2	34.9	20.1	16.2
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"lymphoid tissue: 395.0"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Hepatic stellate cells: 8.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MOLT-4: 283.5;REH: 266.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA043939			Supported	Nucleoplasm		NA	NA				"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA043939: AB_2732512"	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.4	0.5	0.1	0.2	0.1	4.3	0.2	0.1	0.2	0.4	0.2	0.4	0.8	0.2	0.8	0.1	0.3	0.4	0.3	0.1	0.1	1.3	0.8	0.6	0.1	0.1	0.1	0.3	0.3	0.6	0.1	0.6	0.1	0.3	0.3	0.6	0.4	0.3	0.1	0.1	1.0	0.1	0.1	2.6	0.5	0.3	0.1	395.0	2.4	0.3	0.6	0.3	0.1	0.1	0.4	0.0	0.5	0.1	0.2	0.6	0.0	0.3	0.3	0.1	0.5	0.0	0.4	0.5	0.0	0.0	0.1	0.2	0.0	0.4	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.3	0.2	0.5	54.0	0.2	0.0	0.5	0.0	283.5	0.0	2.2	0.2	0.0	266.4	0.0	1.3	0.9	0.0	0.1	0.3	0.1	0.7	0.1	1.2	1.0	0.1	1.0	0.2	0.2	0.2	0.1	2.3	1.9	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.1	1.4	0.7	0.0	1.0	1.0	0.8	0.9	0.0	0.4	1.8	0.0	0.2	0.5	1.3	3.9	0.8	2.3	0.3	0.3	1.6	0.0	0.4	1.8	0.5	0.1	0.7	0.0	0.4	0.0	0.3	8.2	2.1	0.4	0.0	1.7	0.8	0.0	0.6	0.7	1.7	0.0	0.1	0.0	1.0	1.1	0.5	2.1	1.0	1.3	1.1	0.4	0.0	0.0	0.5	3.0	2.9	0.4	0.9	0.0	0.2	0.7	1.0	1.0	0.2	0.4	0.4	0.4	0.5	0.6	0.6
RAG2		ENSG00000175097	"Recombination activating 2"	P55895	11	36575574-36598279	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA recombination"	"Chromatin regulator"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 152.3"	"Group enriched"	"Detected in some"	19	"Astrocytes: 1.3;Early spermatids: 2.3;Excitatory neurons: 2.9;Inhibitory neurons: 1.5;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.3;Spermatocytes: 1.5"	"Cancer enriched"	"Detected in single"	21	"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 40.0;MOLT-4: 46.8;REH: 183.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065704			Approved	Nucleoplasm		NA	NA				"Cluster 63: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA065704: AB_2732737"				"unprognostic (4.30e-2)"					"unprognostic (9.09e-2)"	"unprognostic (1.21e-1)"		"unprognostic (1.77e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.68e-3)"		0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	152.3	23.9	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	0.0	46.8	0.0	0.1	0.0	0.0	183.8	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAI1	"DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS"	ENSG00000108557	"Retinoic acid induced 1"	Q7Z5J4	17	17681458-17811453	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023898, HPA054906"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA023898: AB_10971089, HPA054906: AB_2682637"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.28e-2)"	6.8	10.5	5.9	7.4	5.2	4.9	9.3	5.7	13.0	17.2	1.4	13.1	6.3	16.4	3.4	11.6	15.1	7.4	12.7	3.9	2.4	9.2	5.3	10.8	5.8	4.9	0.4	15.9	10.1	10.2	18.0	4.6	1.2	16.1	2.7	8.9	15.3	9.5	5.7	12.5	8.4	6.3	0.1	11.8	10.9	6.4	0.8	7.1	14.5	1.8	4.3	15.6	14.4	4.3	29.3	39.0	24.2	20.0	3.2	6.5	4.2	9.9	10.5	8.1	7.9	20.4	12.1	9.4	13.3	12.9	6.9	33.8	8.5	19.7	3.4	9.3	19.0	17.2	24.4	10.4	10.5	6.9	10.4	7.5	9.4	7.4	11.0	9.6	10.1	11.8	7.5	7.5	4.2	25.9	14.7	6.7	1.7	15.1	11.4	34.2	18.9	13.4	6.6	34.6	16.8	30.0	15.6	13.6	32.2	27.8	18.3	8.6	19.6	12.8	16.3	20.7	14.1	6.6	1.6	5.9	12.5	8.4	35.7	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.6	0.3	0.7	0.0	0.2	5.9	5.2	5.7	13.0	3.9	2.4	4.9	0.4	1.2	0.1	0.8	4.3	6.1	12.8	20.5	24.8	4.7	12.1	10.8	11.7	12.0	28.7	14.1	10.2	4.0	11.5	14.0	14.7	22.9	0.1	10.0	4.8	0.0	18.4	2.5	9.4	9.6	11.0	11.4	4.6	37.3	9.0	0.8	8.0	12.8	10.5	14.0	7.7	15.4	6.2	2.4	23.5	35.9	7.1	4.1	3.5	8.7	4.9	6.8	4.5	8.8	14.0	5.9	6.8	7.2	26.2	17.1	13.5	2.5	6.0	1.7	11.6	2.2	1.8	7.3	13.1	6.6	5.0	7.6	1.2	11.7	10.5	8.8	0.4	6.8	12.4	8.5	12.9
RAI14	"DKFZp564G013, KIAA1334, NORPEG, RAI13"	ENSG00000039560	"Retinoic acid induced 14"	Q9P0K7	5	34656328-34832612	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 208.2;Early spermatids: 210.1;Late spermatids: 364.3;Syncytiotrophoblasts: 156.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 267.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 23.8"	"HPA036949, HPA036950"	Supported		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Actin filaments, Cytosol"	"HPA036949: AB_10670568, HPA036950: AB_10669721"	"unprognostic (7.63e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.75e-2)"	"unprognostic (5.49e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (9.75e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.81e-2)"	"unprognostic (4.34e-2)"	10.6	9.0	10.1	21.6	14.5	2.4	9.8	13.3	9.8	51.2	17.5	22.1	7.0	53.6	6.2	10.0	13.8	18.7	6.8	8.0	9.4	18.9	27.5	26.2	14.7	18.1	13.9	9.5	7.9	10.8	4.9	34.6	17.1	11.4	10.3	10.2	16.5	25.4	1.9	19.5	7.5	58.0	15.6	39.4	10.8	39.2	12.7	6.3	10.1	2.3	10.2	43.0	14.3	20.0	12.5	48.5	55.2	37.1	29.0	100.9	70.3	147.0	118.3	83.3	83.0	36.7	15.6	2.9	57.0	72.5	90.5	8.2	64.0	109.0	179.2	0.2	30.5	20.6	43.3	22.9	90.0	0.5	1.9	94.8	34.0	149.4	118.1	136.7	267.4	4.6	29.4	1.0	110.1	10.0	2.3	0.7	43.3	7.8	47.0	18.2	84.1	0.6	97.4	70.1	14.4	7.9	86.8	12.8	39.5	80.5	14.9	2.3	173.2	134.1	71.7	33.5	65.1	3.1	0.1	0.4	113.5	0.4	53.5	0.9	0.2	0.1	0.9	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.0	0.0	10.1	14.5	13.3	9.8	8.0	9.4	18.1	13.9	17.1	15.6	12.7	20.0	16.2	105.8	208.2	33.3	0.9	12.0	32.2	46.7	23.9	3.2	27.8	9.9	5.2	7.2	81.8	35.0	68.8	32.3	0.6	17.9	7.9	36.1	210.1	35.7	36.1	96.1	1.8	2.7	6.6	28.5	75.3	25.0	11.2	36.1	3.8	22.7	17.2	23.0	7.2	15.2	6.0	1.1	16.2	1.6	4.3	364.3	72.1	4.6	5.4	15.0	1.0	19.3	0.0	31.2	60.1	53.3	5.1	31.6	0.1	26.6	6.3	25.3	24.8	5.1	0.0	6.0	33.4	9.0	9.2	6.4	15.8	156.1	3.4	11.4	2.6	61.5
RALGDS	"RalGEF, RGDS, RGF"	ENSG00000160271	"Ral guanine nucleotide dissociation stimulator"	Q12967	9	133097720-133149334	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 24.0;MAIT T-cell: 9.7;memory CD4 T-cell: 10.9;memory CD8 T-cell: 17.6;naive CD8 T-cell: 9.1;NK-cell: 9.0;T-reg: 20.8"	"Group enriched"	"Detected in many"	7	"NK-cells: 9.0;T-cells: 24.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 152.4;SH-SY5Y: 92.0"									"HPA025961, CAB032582"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB032582: AB_2238105, HPA025961: AB_2671795"	"unprognostic (1.01e-1)"	"prognostic favorable (4.19e-4)"	"unprognostic (1.35e-2)"	"unprognostic (7.92e-3)"	"unprognostic (8.20e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.91e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.03e-2)"	"unprognostic (9.54e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	36.8	29.7	68.3	20.2	88.1	41.8	35.5	76.3	75.8	22.2	34.7	28.2	17.3	19.0	12.8	40.5	23.9	31.3	26.8	66.8	66.5	14.8	13.4	35.7	27.6	91.3	87.5	33.0	22.9	16.6	68.5	10.9	84.4	25.0	10.1	7.3	31.8	20.3	32.5	62.3	25.2	13.6	73.5	22.2	21.4	6.1	86.1	15.8	23.5	16.3	16.9	38.8	29.6	117.9	7.5	10.9	22.2	27.8	8.3	12.1	18.7	8.8	13.0	8.8	5.7	9.5	16.1	11.3	8.0	15.1	13.4	33.8	22.7	16.1	2.9	152.4	16.3	9.6	22.0	13.8	10.8	15.6	16.9	14.2	22.1	4.7	9.7	23.7	18.2	21.7	19.3	68.4	8.3	24.6	22.2	15.0	15.3	33.3	27.6	22.2	5.4	18.9	10.8	13.0	70.1	92.0	10.5	15.4	14.0	8.6	16.0	15.9	9.5	9.8	10.3	7.4	6.1	3.2	9.2	14.0	8.6	17.4	11.2	2.3	0.6	0.9	24.0	0.3	9.7	1.7	10.9	17.6	0.8	0.5	2.4	9.1	0.4	9.0	0.3	0.8	20.8	6.1	68.3	88.1	76.3	75.8	66.8	66.5	91.3	87.5	84.4	73.5	86.1	117.9	83.9	32.1	11.3	43.4	17.2	55.4	46.3	19.5	40.5	16.6	55.5	40.5	7.2	12.8	21.4	9.2	12.5	5.5	45.7	40.6	3.9	11.4	0.6	100.2	11.7	54.1	37.0	14.3	34.1	6.7	4.5	21.8	26.0	93.1	15.8	26.9	36.4	3.8	12.5	62.2	29.8	14.4	22.4	9.8	51.1	1.8	13.4	33.6	23.2	12.2	4.9	16.3	46.4	32.2	86.4	11.5	31.5	9.1	26.5	43.9	26.7	2.5	34.5	9.3	0.0	43.7	15.4	2.5	5.1	47.6	101.4	5.9	41.6	19.6	17.6	116.6
RALGPS2	"FLJ10244, FLJ25604, KIAA0351"	ENSG00000116191	"Ral GEF with PH domain and SH3 binding motif 2"	Q86X27	1	178725147-178921841	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Alzheimer disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.2;testis: 77.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 263.1;Cone photoreceptor cells: 206.4;Late spermatids: 185.9;Rod photoreceptor cells: 397.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 26.7;naive B-cell: 21.0"	"Lineage enriched"	"Detected in many"	11	"B-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"U-266/84: 250.4;U-698: 194.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027143, HPA028328"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA027143: AB_10602071, HPA028328: AB_10601889"	"unprognostic (8.13e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.45e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.97e-2)"	5.5	8.5	3.5	24.0	5.0	13.2	8.1	4.9	4.6	6.5	3.3	13.4	11.5	9.4	5.4	16.3	8.0	8.1	4.6	7.1	5.8	6.7	32.0	2.8	52.4	3.0	2.4	18.3	5.7	7.8	2.9	9.2	2.6	7.3	12.1	52.5	5.4	5.5	1.4	19.6	16.4	11.8	3.4	28.3	13.7	77.0	5.5	15.2	6.8	4.8	56.2	12.6	7.6	2.1	39.9	12.7	38.7	0.4	42.3	61.6	15.2	34.0	74.8	27.1	24.3	15.1	38.3	83.7	11.2	100.8	13.5	32.2	17.2	8.6	35.4	0.1	10.3	0.0	8.7	14.6	7.1	11.1	0.4	27.5	7.5	35.1	24.6	18.8	23.7	15.3	20.6	3.1	17.8	6.3	17.0	3.5	26.5	15.3	13.4	23.5	39.9	0.7	9.3	24.9	6.0	17.2	22.2	24.5	48.4	26.3	29.3	5.6	17.9	12.4	11.8	45.4	16.4	91.8	250.4	194.3	7.2	5.7	14.2	0.8	0.1	2.4	0.3	0.1	0.3	26.7	0.2	0.1	0.4	21.0	0.7	0.2	1.3	0.4	0.1	0.8	0.0	1.1	3.5	5.0	4.9	4.6	7.1	5.8	3.0	2.4	2.6	3.4	5.5	2.1	5.4	12.8	6.9	29.4	263.1	14.8	16.3	5.4	14.8	97.4	27.9	15.1	17.5	15.7	8.7	14.7	206.4	7.5	11.6	39.5	21.5	15.2	123.0	23.3	25.6	4.9	35.9	22.7	84.0	12.0	10.1	18.7	48.9	33.0	8.8	60.3	2.9	55.2	6.3	13.5	92.3	22.5	0.0	8.5	4.8	185.9	50.1	7.3	8.8	41.2	5.1	27.8	10.3	107.5	4.0	31.0	52.4	46.6	105.2	26.0	22.7	9.7	23.9	397.3	19.7	41.5	18.6	146.6	34.8	29.1	34.1	3.3	10.3	20.7	15.6	72.0
RALY	"HNRPCL2, P542"	ENSG00000125970	"RALY heterogeneous nuclear ribonucleoprotein"	Q9UKM9	20	33993646-34108308	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040971, HPA043614"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA		9400	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA040971: AB_2677230, HPA043614: AB_2678581"	"unprognostic (2.06e-1)"	"unprognostic (9.54e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.80e-2)"	109.7	65.4	72.1	90.4	83.2	189.2	98.2	82.6	79.3	108.9	81.8	127.2	109.8	96.9	41.6	119.6	84.8	70.7	143.2	67.6	77.4	104.4	68.3	117.4	116.9	87.8	81.9	101.2	78.2	62.1	55.6	77.6	84.2	88.3	87.6	55.0	105.3	64.3	178.4	114.6	117.7	70.1	83.7	109.6	101.9	116.5	80.9	161.7	125.5	106.0	99.9	99.3	98.4	100.7	250.4	138.1	247.6	193.9	115.3	110.3	210.1	172.9	136.0	215.1	183.0	375.8	204.0	204.3	238.7	140.6	290.9	259.4	135.8	252.7	119.2	132.2	119.3	468.3	81.4	375.4	147.8	236.2	215.0	122.4	141.6	161.9	175.4	160.7	203.0	245.6	201.7	300.9	135.8	185.9	589.3	266.6	137.5	306.0	277.2	344.4	360.6	250.7	126.7	135.4	235.8	266.6	271.8	248.4	376.6	125.8	256.2	234.4	167.5	414.4	270.7	212.3	206.6	310.7	308.3	353.5	213.0	169.9	201.3	139.3	110.7	221.3	138.8	137.1	100.2	96.5	122.2	150.4	135.3	99.6	107.8	104.0	173.3	186.1	195.5	110.0	141.4	165.3	72.1	83.2	82.6	79.3	67.6	77.4	87.8	81.9	84.2	83.7	80.9	100.7	91.8	54.5	61.3	23.2	98.3	79.2	126.9	102.3	74.6	24.2	74.9	67.8	63.4	58.6	61.7	55.2	18.8	161.3	118.3	287.4	127.2	149.1	48.1	36.4	48.5	92.1	93.0	87.9	19.3	160.5	227.7	78.2	70.8	66.9	59.7	69.7	76.8	39.8	159.6	8.4	14.6	143.2	95.6	112.2	118.1	46.7	65.6	96.9	115.6	50.6	151.3	62.6	163.7	15.6	57.1	190.3	270.7	62.1	206.4	157.5	220.7	107.3	38.8	36.3	111.7	47.7	97.7	106.6	121.1	103.7	80.7	171.4	117.2	51.6	178.6	176.2
RALYL	HNRPCL3	ENSG00000184672	"RALY RNA binding protein like"	Q86SE5	8	84182787-84921844	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 19.8;brain: 68.1;kidney: 19.2"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 2828.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055868, HPA059112"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055868: AB_2682950, HPA059112: AB_2683908"				"unprognostic (1.13e-5)"	"unprognostic (1.62e-1)"		"unprognostic (7.48e-2)"		"unprognostic (1.36e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"			0.1	19.8	31.9	0.2	35.2	0.2	0.1	68.1	40.2	0.0	0.0	0.7	0.3	0.1	0.7	0.0	0.6	5.0	2.3	27.0	27.5	19.2	0.3	0.1	0.1	12.3	17.3	0.0	2.3	0.0	6.1	1.2	22.7	0.2	0.4	9.0	0.6	2.0	0.2	0.2	0.6	0.1	7.6	2.4	0.5	0.4	26.5	0.0	0.1	0.3	0.1	0.1	0.1	28.5	0.1	0.0	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	31.5	0.2	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	35.2	68.1	40.2	27.0	27.5	12.3	17.3	22.7	7.6	26.5	28.5	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	38.5	1.0	0.6	5.0	21.5	0.0	7.3	2.1	0.0	0.0	0.0	178.1	1.0	2.2	0.0	0.0	0.9	1.8	0.0	2828.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	33.7	531.4	0.6	0.0	0.0	0.0	1.5	0.3	0.0	0.0	68.4	0.0	32.8	0.0	495.6	36.3	0.1	0.0	0.0	0.0	0.0	11.7	19.4	0.0	5.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	4.0	0.1	0.1
RAMAC	"C15orf18, FAM103A1, HsT19360, MGC2560, RAM, RAMMET"	ENSG00000169612	"RNA guanine-7 methyltransferase activating subunit"	Q9BTL3	15	82986210-82991057	"Predicted intracellular proteins"	"mRNA capping, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 108.2;Extravillous trophoblasts: 82.2;Hofbauer cells: 69.4;Syncytiotrophoblasts: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041923, HPA041948"	Supported		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041923: AB_10796467, HPA041948: AB_10797270"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.09e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.45e-1)"	12.9	14.8	10.9	16.4	11.4	30.1	26.1	12.9	14.8	16.6	11.6	18.4	14.5	18.2	30.1	24.1	19.5	13.4	14.8	11.6	12.2	16.8	24.2	13.0	23.0	11.6	11.3	20.6	16.4	18.8	12.9	25.9	11.3	18.0	19.3	19.9	18.2	15.2	29.1	21.5	13.4	16.8	11.6	14.1	19.0	15.6	11.1	23.3	18.2	20.2	28.9	20.8	15.6	11.6	34.1	44.7	44.3	27.1	23.5	15.9	32.7	33.7	33.5	37.6	30.4	49.4	42.9	16.8	45.8	29.2	45.4	37.9	77.1	32.4	40.6	42.0	49.7	52.7	22.7	58.7	33.3	38.0	44.9	34.9	61.4	30.6	38.5	28.7	23.6	28.5	62.8	33.9	39.8	35.7	29.5	48.3	52.0	45.0	21.1	33.4	38.2	26.0	49.0	64.6	41.1	42.0	34.6	36.7	87.0	71.5	58.6	47.9	16.8	27.5	34.9	26.1	48.8	53.1	104.0	41.8	25.2	50.7	34.5	138.6	59.2	98.2	47.9	57.0	51.8	64.8	54.1	52.3	56.1	61.1	53.9	53.4	117.4	70.4	62.8	51.6	69.9	65.9	10.9	11.4	12.9	14.8	11.6	12.2	11.6	11.3	11.3	11.6	11.1	11.6	18.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	82.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	92.9	2.7	0.0	0.0	0.0
RAMACL	"C6orf119, dJ427A4.2, FAM103A2P, RAMMETL"	ENSG00000235272	"RNA guanine-7 methyltransferase activating subunit like (pseudogene)"		6	166585604-166587594	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"brain: 2.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.5;ASC TERT1: 2.8;HEK 293: 5.9;HeLa: 2.2;HHSteC: 4.9;TIME: 1.8"									"HPA041923, HPA041948"	Uncertain		Approved	Nucleoplasm		No	NA			"Cluster 8: Neutrophils - Inflammatory response"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA041923: AB_10796467, HPA041948: AB_10797270"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.33e-2)"	0.0	0.4	1.3	0.0	1.2	0.7	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0		0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.7	0.3	0.0	0.0	1.6	0.7	0.4	0.0	0.0	0.0		2.9	0.0	0.0	0.0	0.2	3.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	2.2	0.0	4.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.3	3.9	1.7	2.1	1.9	2.9	2.0	1.9	2.6	2.8	1.9	1.7	4.4	2.2	1.1	1.7	2.6	2.1	1.3	1.2	0.2	0.8	0.7	1.0	1.8	0.9	1.5	0.7	1.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAMP1		ENSG00000132329	"Receptor activity modifying protein 1"	O60894	2	237858893-237912106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 706.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 190.0;Endometrial stromal cells: 546.4;Exocrine glandular cells: 278.2;monocytes: 433.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 152.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	18	"NK-cell: 70.1"	"Lineage enriched"	"Detected in many"	18	"NK-cells: 70.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4;HDLM-2: 146.0;PC-3: 173.8;SH-SY5Y: 201.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057814			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"		"HPA057814: AB_2683536"	"unprognostic (1.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (7.61e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.46e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.08e-3)"	18.7	29.2	170.9	21.0	171.2	0.9	7.4	168.7	253.4	362.4	153.7	349.6	57.5	706.0	25.0	9.4	256.6	28.5	287.6	176.0	181.8	26.0	82.7	32.5	6.6	198.8	164.5	45.2	225.0	1.4	15.2	8.6	163.0	142.2	6.4	0.8	10.0	54.6	212.3	11.6	73.5	125.4	171.7	12.3	103.4	5.1	183.5	2.9	6.8	68.8	2.9	171.4	75.1	173.2	29.8	0.0	0.5	0.0	12.4	17.9	1.1	2.1	3.6	1.7	1.5	0.0	47.4	0.3	0.4	0.9	0.1	0.2	7.6	0.1	0.2	146.0	4.0	0.1	0.0	1.2	40.6	0.0	0.2	15.6	22.3	0.1	0.3	0.2	0.0	0.0	0.0	0.3	3.7	2.7	0.1	1.3	0.4	0.1	173.8	0.0	1.5	0.8	0.0	0.0	1.5	201.7	3.5	0.0	0.1	1.8	1.3	0.1	0.0	0.8	0.6	0.4	0.5	0.3	0.3	0.0	0.6	0.1	2.7	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.6	0.1	1.0	0.0	0.5	0.2	0.4	70.1	0.0	0.2	0.0	3.4	170.9	171.2	168.7	253.4	176.0	181.8	198.8	164.5	163.0	171.7	183.5	173.2	1.0	0.0	1.5	64.9	3.1	11.6	13.2	26.9	10.2	2.0	4.4	4.4	190.0	78.6	43.8	11.0	0.0	3.0	44.0	2.1	0.0	62.7	0.2	26.5	546.4	6.2	115.4	4.4	14.2	278.2	5.5	41.7	31.1	11.3	1.3	0.6	30.7	104.0	22.7	1.7	19.2	73.7	10.2	3.1	50.3	0.6	8.4	20.3	64.0	13.1	433.5	6.9	61.8	71.9	11.5	63.5	87.7	11.3	1.9	66.1	96.8	0.2	97.0	2.7	6.6	16.6	78.6	0.3	5.8	2.6	5.8	2.3	7.3	0.5	105.8	28.5
RAN	"ARA24, Gsp1, TC4"	ENSG00000132341	"RAN, member RAS oncogene family"	P62826	12	130872037-130877678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063353			Enhanced	Nucleoplasm		No	No		4000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA063353: "	"unprognostic (2.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (9.99e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (7.86e-5)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (6.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.16e-2)"	285.3	333.2	207.7	340.1	222.3	406.0	220.5	212.1	265.0	193.6	204.5	269.1	177.8	207.6	238.1	445.6	180.6	148.9	256.9	220.6	260.3	249.0	208.2	225.9	416.4	207.2	213.3	180.7	192.9	210.6	180.1	243.0	231.0	149.7	266.6	213.3	200.4	155.5	415.0	231.2	220.0	250.1	228.5	255.9	223.4	308.6	236.5	577.6	166.8	383.7	480.6	380.9	244.7	230.2	1391.5	1850.5	1580.8	921.6	707.0	868.2	1219.5	1770.2	926.2	1695.1	1163.1	2003.5	1434.2	2260.7	1169.3	1290.0	1067.9	877.0	2327.1	1854.5	1830.8	766.9	1831.5	1331.9	1318.9	2068.9	864.1	2347.9	1100.3	821.9	1129.3	1470.6	2111.6	1119.9	1671.0	1593.5	2013.6	656.5	1686.3	1688.2	2306.9	2810.1	1857.8	1429.2	2936.2	1773.9	1347.2	1274.4	1608.2	2377.1	1441.5	875.0	1018.5	920.7	1334.4	1299.9	1817.9	1666.5	1157.6	975.6	1495.0	998.8	1694.1	905.2	1605.1	3245.4	1002.2	1410.7	1390.4	285.0	398.0	275.5	501.5	489.3	614.6	726.4	682.5	581.4	531.7	593.3	611.5	585.9	80.7	500.4	481.0	506.9	768.0	1005.0	207.7	222.3	212.1	265.0	220.6	260.3	207.2	213.3	231.0	228.5	236.5	230.2	321.3	182.7	141.5	18.6	337.4	635.3	693.4	702.0	406.3	155.3	239.0	316.0	112.6	165.8	310.5	169.2	37.5	734.2	273.6	157.0	387.4	642.1	90.2	212.9	280.8	306.2	201.9	540.9	27.8	452.8	1266.0	379.6	181.0	201.3	194.0	273.1	143.8	181.6	624.5	139.7	25.8	300.5	349.9	171.7	424.1	148.1	213.4	239.7	332.6	9.4	417.0	287.5	219.4	19.6	23.5	596.4	189.1	230.9	418.2	954.8	167.2	423.2	214.3	141.6	164.3	286.0	600.8	746.4	571.6	578.0	547.0	613.1	332.3	451.9	403.6	621.0
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 112.7;Excitatory neurons: 100.6;Glandular and luminal cells: 59.5;Inhibitory neurons: 152.9;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 87.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 4.0;SK-BR-3: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	0.2	0.8	0.3	0.1	0.2	0.1	0.2	2.3	0.6	0.2	0.8	0.2	0.2	0.5	0.2	0.0	0.4	0.5	0.2	0.1	1.1	0.4	0.3	0.8	0.3	0.9	0.9	0.2	1.4	0.8	0.4	0.8	1.3	0.4	0.4	0.8	0.8	0.5	0.0	0.1	0.3	0.3	0.6	0.0	0.3	1.4	0.6	0.2	1.0	0.0	0.1	0.1	0.1	1.1	0.0	0.7	4.0	3.3	1.3	0.3	2.4	2.6	1.2	1.8	1.1	1.5	0.0	0.1	2.0	2.5	0.0	0.0	0.0	1.2	3.5	0.0	2.4	0.7	1.4	0.0	1.1	0.0	0.0	2.6	0.2	0.2	0.0	0.2	1.7	0.0	0.3	0.0	1.0	1.7	0.0	0.0	0.3	0.6	0.2	0.0	2.4	0.0	0.6	1.0	0.2	1.4	0.0	3.9	1.5	1.7	0.7	1.2	2.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.3	0.6	0.1	1.1	0.9	0.9	1.3	0.6	0.6	1.1	9.4	9.6	2.0	12.7	0.0	0.3	6.2	5.8	1.8	24.8	6.1	2.8	1.3	7.2	4.8	0.0	14.6	10.4	1.7	2.3	0.0	7.3	112.7	22.4	17.5	7.9	5.4	5.5	100.6	1.4	3.2	4.9	5.1	59.5	0.0	15.6	4.2	1.6	1.9	0.0	152.9	3.7	2.0	0.6	1.4	46.5	2.8	1.0	1.8	9.4	1.2	5.5	5.2	65.4	87.1	5.3	2.9	3.0	0.8	13.0	3.9	0.9	2.4	26.9	0.0	3.0	5.1	27.2	26.7	1.4	0.0	2.5	0.8	7.5	6.3	7.6
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719482-108785809	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA		160000	"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.3	24.3	8.6	16.3	11.6	42.1	19.7	14.4	17.1	18.1	20.3	15.6	13.4	17.7	20.5	14.3	14.6	13.7	14.9	11.8	9.4	18.1	17.4	14.0	18.6	9.2	8.1	24.4	20.2	30.1	21.5	16.5	9.5	20.9	15.2	26.5	16.4	17.2	30.3	17.2	13.4	15.2	8.6	15.0	17.6	21.3	8.2	23.3	28.4	23.6	18.0	16.9	12.1	12.2	40.5	24.2	34.1	31.0	38.7	34.5	32.9	35.5	28.0	28.7	25.1	60.7	18.9	63.2	26.8	37.2	35.3	33.1	58.9	36.9	41.5	38.9	28.5	65.9	30.3	43.2	22.5	77.9	21.3	29.1	27.5	44.9	34.7	28.3	44.5	27.1	71.9	34.0	38.4	22.3	34.8	31.6	43.0	20.3	28.7	32.3	52.3	30.7	25.3	49.6	49.4	22.6	31.5	26.7	34.7	20.4	17.2	35.4	53.5	29.8	39.6	21.2	40.2	27.9	44.4	55.8	23.1	34.4	23.5	5.4	2.6	2.7	3.7	1.7	4.1	2.7	3.0	3.4	2.2	2.7	2.9	3.3	3.9	2.2	3.6	2.6	2.7	1.4	8.6	11.6	14.4	17.1	11.8	9.4	9.2	8.1	9.5	8.6	8.2	12.2	54.5	76.9	85.3	48.6	91.5	55.7	34.5	39.1	61.5	51.2	34.1	25.8	103.9	38.6	63.0	58.8	73.0	28.8	96.1	28.9	1.9	34.7	77.3	83.6	65.3	55.7	106.4	50.5	125.5	50.9	17.5	56.5	68.3	142.1	84.9	52.2	31.4	56.6	47.9	32.0	92.2	59.5	44.7	44.9	80.7	32.9	38.5	114.0	48.0	55.3	57.0	20.0	34.0	44.2	80.0	41.5	29.9	56.1	118.4	44.1	28.8	15.6	67.0	40.5	46.0	56.9	59.0	78.3	65.4	53.3	67.8	40.6	104.8	25.3	38.3	38.7
RANBP3		ENSG00000031823	"RAN binding protein 3"	Q9H6Z4	19	5916139-5978142	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043375, HPA043389"	Enhanced		Enhanced	Nucleoplasm		NA	NA		17000	"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA043375: AB_10959889, HPA043389: AB_10963696"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.22e-5)"	"unprognostic (4.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.15e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.06e-2)"	25.1	40.3	30.0	24.0	30.6	21.5	24.7	30.4	33.7	30.5	25.0	43.1	22.2	35.1	10.6	26.6	29.0	17.8	35.3	30.0	30.3	24.6	24.4	25.2	26.5	33.0	34.9	28.2	29.6	20.7	32.0	16.7	31.7	32.2	12.1	19.3	25.6	22.9	36.6	29.2	27.6	19.0	30.5	30.1	32.0	44.7	31.5	26.2	25.8	21.3	17.9	36.6	27.9	31.1	73.8	50.4	42.3	47.6	31.2	31.3	30.0	45.9	43.1	52.7	56.7	64.9	25.4	69.0	50.4	35.8	33.1	44.8	38.2	44.8	32.0	71.0	62.3	37.1	38.8	77.6	33.7	54.9	52.2	30.9	30.4	33.0	37.3	24.5	38.9	37.0	68.4	63.6	30.3	30.7	91.8	26.6	77.6	31.8	64.3	67.0	40.6	63.3	34.3	56.3	46.4	52.1	41.1	42.9	41.1	24.7	32.7	41.0	40.6	44.2	32.2	78.2	68.4	65.4	72.1	59.2	55.9	68.0	55.6	14.5	23.1	29.2	23.2	23.2	24.1	17.6	22.7	23.5	23.4	24.5	19.5	25.8	26.0	17.9	24.3	22.3	32.1	24.5	30.0	30.6	30.4	33.7	30.0	30.3	33.0	34.9	31.7	30.5	31.5	31.1	14.0	25.6	26.6	9.8	18.4	12.2	20.5	27.1	9.6	16.7	12.0	10.2	16.4	18.6	19.9	7.3	25.0	29.2	18.6	16.9	43.0	28.8	59.5	14.3	12.6	19.2	13.2	8.6	9.4	20.8	29.5	17.1	17.3	15.4	17.7	14.1	9.3	10.8	25.0	23.5	11.7	20.2	32.6	14.9	16.8	73.3	16.8	16.5	21.4	8.4	31.5	21.9	25.7	13.6	17.5	22.7	11.4	24.8	21.7	18.8	20.2	21.0	21.4	20.8	19.7	13.5	15.8	86.8	40.8	10.4	11.8	35.4	20.6	19.1	15.1	23.0
RANBP3L	FLJ25422	ENSG00000164188	"RAN binding protein 3 like"	Q86VV4	5	36246913-36302114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;kidney: 24.6"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 355.9"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;glioma: 3.7;prostate cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037471, HPA037472, HPA061526"	Approved		Uncertain	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.52e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.76e-4)"	"unprognostic (1.68e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.71e-2)"	3.8	1.7	25.2	0.3	27.0	0.0	7.6	4.6	29.9	1.2	5.4	0.8	0.2	0.7	1.8	0.5	1.2	1.8	1.5	25.1	12.2	24.6	9.9	2.0	0.2	9.9	18.9	2.1	0.4	0.2	2.9	5.0	7.4	13.5	0.4	5.3	0.6	2.9	0.4	0.4	0.4	0.6	12.6	0.2	1.8	4.7	18.6	0.1	2.2	2.9	0.6	6.9	0.8	15.2	0.0	0.0	0.1	0.2	12.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	27.0	4.6	29.9	25.1	12.2	9.9	18.9	7.4	12.6	18.6	15.2	0.3	0.0	0.0	355.9	0.0	0.0	0.1	0.0	0.6	0.4	4.1	2.3	0.3	0.0	0.0	9.2	0.0	0.0	1.3	0.0	46.9	0.0	0.1	0.1	0.7	0.4	0.0	0.0	5.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.4	1.3	1.9	0.0	4.5	0.0	0.0	0.0	0.3	0.8	2.1	0.2	1.8	23.4	0.0	16.1	0.0	5.5	2.8	0.0	0.0	2.2	0.0	1.3	0.0	0.2	0.0	0.6	13.1	0.6	8.3	0.0	0.1	0.0	0.0	0.1	0.0	3.0	0.0	0.1
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Excitatory neurons: 132.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007, HPA076784"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	21.8	20.3	23.3	16.7	25.2	57.3	18.3	22.2	32.4	28.3	21.5	27.5	13.2	20.6	22.2	69.1	15.3	24.6	20.0	25.5	22.6	18.7	26.4	17.9	18.5	20.3	24.3	19.7	17.4	24.1	16.7	20.0	22.7	21.3	18.0	21.0	24.3	17.2	60.5	27.7	15.5	23.5	22.0	15.1	17.9	106.4	21.7	29.7	16.5	39.5	30.8	21.6	38.2	25.4	38.1	16.3	38.7	39.3	51.9	47.8	41.0	45.6	51.6	47.2	49.5	24.8	21.9	33.4	73.0	54.0	35.7	20.3	30.5	26.8	64.6	58.0	27.5	33.6	29.9	45.9	71.7	53.0	24.5	48.7	33.8	56.0	45.9	37.4	39.0	58.3	73.3	26.2	53.1	38.5	62.1	42.0	17.1	36.2	22.6	49.1	30.2	47.1	37.7	43.2	47.9	33.7	36.9	66.3	67.0	73.4	35.6	44.6	38.3	42.3	30.2	34.7	47.4	63.5	82.3	44.9	19.4	32.8	80.1	0.3	0.5	1.8	0.7	0.7	1.4	0.7	1.5	0.7	0.5	0.7	1.3	0.9	0.8	1.2	0.8	0.8	3.6	0.4	23.3	25.2	22.2	32.4	25.5	22.6	20.3	24.3	22.7	22.0	21.7	25.4	17.2	19.2	30.5	58.1	12.5	24.9	7.8	13.5	13.1	25.1	23.3	15.0	40.1	12.8	19.2	18.4	14.6	17.9	22.3	21.7	1.9	8.2	113.6	23.5	21.8	24.0	13.2	11.6	132.9	10.8	9.1	19.8	10.2	29.6	10.1	19.5	16.8	18.3	18.0	6.7	78.3	14.5	12.2	28.0	32.3	99.9	15.8	21.8	17.8	73.1	14.9	22.8	15.5	74.9	75.6	16.6	7.3	24.8	18.3	15.5	12.2	11.4	19.8	17.5	6.6	16.5	18.5	85.4	41.9	19.3	26.1	28.5	22.9	14.3	12.0	17.7
RANGRF	"HSPC165, HSPC236, MOG1, RANGNRF"	ENSG00000108961	"RAN guanine nucleotide release factor"	Q9HD47	17	8288654-8290092	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 435.1;Late spermatids: 1448.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057280, HPA057888"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA057280: AB_2683393, HPA057888: AB_2683549"	"unprognostic (2.87e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	28.3	27.6	40.9	18.8	42.4	20.5	29.2	39.9	43.8	47.4	40.6	38.1	15.8	36.9	31.9	15.7	35.1	16.9	41.6	40.6	42.5	44.2	18.6	25.3	33.0	40.6	41.3	36.3	15.1	43.8	32.7	22.7	41.1	35.5	15.9	34.8	13.1	27.6	24.1	19.4	28.1	27.1	41.4	33.3	39.0	78.4	43.1	34.0	25.1	26.0	32.3	34.7	23.3	41.0	52.8	59.5	41.0	42.7	30.0	41.0	35.4	29.7	59.9	75.3	72.7	30.4	20.3	98.4	31.7	35.9	29.7	58.0	77.7	39.3	53.7	71.2	97.6	46.6	45.0	46.6	72.9	30.7	66.2	39.6	75.1	66.4	66.4	38.9	65.5	93.4	21.2	27.1	48.9	1.3	91.7	98.4	29.7	29.8	22.7	81.1	32.0	61.8	44.4	21.3	15.7	45.2	23.5	36.2	65.0	25.9	2.8	28.3	36.3	16.4	29.5	33.0	58.4	47.5	40.0	121.4	35.1	60.8	24.1	17.2	47.6	81.5	68.2	50.7	64.4	74.7	82.8	78.1	51.5	82.0	72.3	61.6	5.9	70.1	41.0	67.8	129.9	57.5	40.9	42.4	39.9	43.8	40.6	42.5	40.6	41.3	41.1	41.4	43.1	41.0	21.2	9.6	26.1	6.2	35.8	18.1	24.3	23.5	25.0	26.2	31.4	36.2	4.7	12.8	17.5	25.8	12.5	93.2	25.4	9.4	68.4	25.5	435.1	19.0	18.8	26.0	19.8	15.4	6.2	18.3	46.4	25.3	14.8	19.3	27.8	19.0	23.9	17.3	49.3	20.2	9.0	17.4	26.4	16.4	19.2	1448.8	28.3	18.9	17.8	1.9	29.5	33.6	58.7	3.0	9.5	21.1	21.2	31.6	37.5	22.9	14.3	66.7	14.3	38.4	19.7	16.3	34.0	180.6	23.0	10.6	19.6	112.9	35.6	28.1	21.8	16.1
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118236-22357154	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 152.1;parathyroid gland: 387.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 504.6;Inhibitory neurons: 193.4;Microglial cells: 138.7;Oligodendrocytes: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 21.1;HUVEC TERT2: 45.0;SCLC-21H: 34.1;TIME: 25.8;U-698: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA057821: AB_2683538, HPA076772: AB_2686814"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	21.0	12.7	30.7	7.0	82.9	0.9	16.4	76.1	58.5	8.9	2.9	9.5	7.5	8.8	4.8	13.9	8.3	16.8	16.8	45.7	46.9	16.7	21.8	37.5	14.3	115.3	71.8	6.5	20.1	387.8	7.4	67.2	107.1	5.1	11.0	4.2	7.6	5.7	5.1	9.2	8.3	12.1	82.0	50.9	7.0	6.4	59.8	15.7	11.7	11.1	10.7	9.3	11.9	152.1	2.8	0.0	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	5.5	1.4	21.1	1.1	0.3	0.7	13.0	2.8	1.9	0.0	0.0	4.2	0.3	0.0	5.4	0.1	0.0	0.1	0.5	2.4	1.3	0.7	0.7	45.0	5.9	4.8	0.1	0.0	1.2	3.0	0.1	3.6	5.4	4.0	5.2	0.0	7.4	4.2	1.9	34.1	9.0	0.5	6.0	0.1	0.7	3.0	0.1	25.8	0.0	1.0	0.4	1.1	10.9	2.5	37.4	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	82.9	76.1	58.5	45.7	46.9	115.3	71.8	107.1	82.0	59.8	152.1	125.5	9.6	16.5	13.4	3.1	11.0	4.2	2.4	86.0	30.6	8.8	5.5	10.0	15.7	3.8	0.0	0.0	0.3	0.6	16.0	1.9	6.5	61.5	3.3	1.2	70.1	7.2	0.4	504.6	7.0	0.1	5.3	16.3	10.8	8.2	0.1	86.0	6.3	0.2	23.5	193.4	18.3	2.0	3.1	2.0	65.2	1.8	0.9	7.2	138.7	0.0	0.6	0.0	28.1	640.8	5.0	20.3	4.9	12.9	3.0	18.1	0.3	0.5	1.6	85.5	1.4	21.5	1.2	1.6	19.8	11.2	0.3	2.4	1.9	10.1	4.4
RAPGEFL1	Link-GEFII	ENSG00000108352	"Rap guanine nucleotide exchange factor like 1"	Q9UHV5	17	40177010-40195656	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 199.1;skin 1: 237.7;vagina: 113.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 87.7;Excitatory neurons: 47.8;Proximal enterocytes: 55.3;Squamous epithelial cells: 95.4;Suprabasal keratinocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HaCaT: 92.4;hTCEpi: 45.8;T-47d: 80.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022895			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Microtubules"	"Cytokinetic bridge"	"HPA022895: AB_1856071"	"prognostic favorable (8.43e-4)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.84e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	6.3	4.4	38.4	6.8	36.1	4.4	9.1	12.1	58.3	48.7	1.8	53.8	48.3	4.6	9.9	199.1	6.6	8.8	6.8	55.1	12.9	3.8	10.5	8.0	2.2	12.0	11.4	3.7	7.9	1.1	14.2	2.3	10.9	17.7	44.5	6.1	27.4	6.9	12.6	237.7	40.6	4.0	8.3	7.3	31.8	10.2	15.2	3.3	4.5	2.8	20.7	21.9	113.2	30.6	5.3	2.6	13.7	10.2	1.5	3.3	6.6	1.9	1.4	2.7	3.2	6.0	7.6	4.2	1.9	2.7	2.4	92.4	2.7	3.3	3.8	7.7	6.9	2.5	3.6	6.0	1.7	5.2	8.5	3.9	45.8	2.8	1.3	4.0	4.1	13.9	1.9	2.8	2.1	14.6	4.9	6.3	4.3	26.1	2.6	8.8	1.6	2.6	1.7	27.6	26.2	5.3	3.3	31.2	1.3	11.5	80.7	3.9	7.9	3.3	6.8	3.5	3.2	4.6	4.7	3.4	7.8	3.2	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	38.4	36.1	12.1	58.3	55.1	12.9	12.0	11.4	10.9	8.3	15.2	30.6	1.9	0.0	1.1	7.5	1.0	45.5	9.7	14.0	13.1	5.7	2.6	3.7	2.4	11.5	10.9	1.8	6.2	0.2	0.7	87.7	0.0	0.9	2.7	5.9	2.1	2.2	4.9	2.7	47.8	0.8	0.3	1.4	32.6	9.4	5.7	1.7	3.9	4.4	0.5	1.7	32.1	31.9	6.1	1.2	5.2	2.2	3.4	1.9	5.4	1.0	2.4	2.9	1.0	8.0	5.0	1.6	44.6	3.8	0.1	10.9	55.3	0.1	6.5	4.4	0.0	2.1	1.9	12.0	15.0	95.4	97.0	0.7	1.1	1.8	44.1	39.2
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309180-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 52.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 221.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058282, HPA071548"			Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli, Actin filaments, Cytosol"	"HPA058282: AB_2683666, HPA071548: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	47.6	21.1	3.2	28.3	4.4	59.6	37.2	7.2	16.5	43.7	5.1	31.0	28.4	32.2	10.7	14.9	40.7	41.3	40.8	7.0	5.7	24.1	42.3	58.4	16.4	5.3	2.7	40.8	14.7	11.3	30.6	25.7	2.8	29.8	13.2	18.3	20.6	21.3	62.6	24.8	32.2	28.6	1.8	41.7	22.9	28.8	4.9	10.0	26.9	17.4	11.8	30.3	30.2	4.3	18.0	41.9	11.8	20.5	23.4	35.9	12.5	14.9	21.8	21.5	13.6	28.6	15.1	9.6	22.7	33.2	18.9	51.1	14.2	33.9	12.0	77.5	21.4	26.6	21.2	29.8	37.0	9.4	81.3	48.2	10.0	22.7	29.2	75.8	30.9	8.4	17.6	20.2	23.7	221.5	6.4	34.2	10.7	16.2	13.3	12.9	71.3	37.0	12.2	14.4	5.4	40.5	31.0	124.8	42.1	11.7	119.1	36.6	35.8	25.3	45.3	44.2	15.4	48.7	16.9	8.3	38.4	18.7	77.1	26.3	8.9	34.6	3.2	14.6	5.1	2.0	3.6	3.8	12.4	1.7	1.5	2.8	52.6	5.9	19.5	3.8	3.1	5.0	3.2	4.4	7.2	16.5	7.0	5.7	5.3	2.7	2.8	1.8	4.9	4.3	35.6	3.2	7.0	2.3	43.4	19.5	25.6	8.4	18.8	23.2	35.4	17.5	3.8	10.0	5.5	7.3	6.2	2.2	36.9	41.2	13.7	16.7	60.5	20.7	22.0	28.4	9.6	5.7	5.4	19.2	5.8	28.5	10.7	18.4	35.5	13.9	26.0	28.8	12.3	3.3	2.6	13.1	6.1	45.4	65.5	66.2	41.7	56.9	28.4	2.8	26.1	11.8	6.2	4.0	0.3	22.0	33.1	23.0	21.0	13.4	70.9	17.7	4.9	10.2	32.9	42.1	26.7	3.6	7.6	7.1	18.9	5.2	31.7	6.5	16.5	19.3
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 41.4;Excitatory neurons: 66.8;Inhibitory neurons: 92.6;Microglial cells: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.7;HEK 293: 16.0;hTERT-RPE1: 82.3;WM-115: 36.5"	"Region enriched"	"Detected in all"	9	"basal ganglia: 109.2"					"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	4.1	7.0	3.5	2.6	15.0	0.0	6.9	2.2	6.6	9.3	7.2	6.0	1.7	7.4	6.7	7.9	6.0	5.3	14.0	3.5	1.4	15.1	6.5	5.3	6.7	3.4	1.7	11.5	1.3	6.0	7.5	14.4	0.9	12.5	2.2	13.6	13.1	11.2	2.4	1.1	2.0	5.9	1.4	4.9	3.9	0.6	2.4	1.2	9.1	5.3	4.2	7.2	6.1	3.7	0.0	1.9	1.2	6.4	13.7	3.6	0.0	1.6	0.8	0.0	0.6	0.3	0.1	0.1	0.2	2.5	0.3	0.4	0.0	0.3	0.0	0.1	16.0	0.1	0.1	1.1	0.3	0.2	0.1	7.1	0.0	0.0	0.0	82.3	13.4	0.1	0.1	5.6	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.6	8.3	0.0	0.2	0.1	9.1	0.0	0.1	0.0	1.1	0.1	2.1	7.0	0.2	0.0	0.1	5.6	0.2	36.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	15.0	2.2	6.6	3.5	1.4	3.4	1.7	0.9	1.4	2.4	3.7	2.4	0.0	0.5	41.4	0.3	0.1	18.0	6.4	1.8	4.5	1.7	7.5	12.0	12.8	14.9	11.0	25.0	0.2	0.8	0.0	0.0	1.6	1.5	8.3	4.2	10.5	0.0	0.0	66.8	0.9	0.1	6.8	7.7	3.0	0.0	0.1	22.1	2.1	0.4	5.0	92.6	0.0	2.0	1.9	0.4	1.2	0.0	0.3	0.0	29.0	0.0	24.8	0.0	19.6	2.9	1.4	0.0	0.0	0.2	10.2	0.6	0.6	9.2	6.3	0.0	2.9	9.7	0.2	1.0	6.6	0.1	0.3	0.5	0.2	0.2	9.7
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 141.6;skin 1: 121.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7;Squamous epithelial cells: 69.9;Suprabasal keratinocytes: 55.8;Urothelial cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 6.7;T-cells: 18.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 101.0;MCF7: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053883	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	17.4	16.2	10.2	5.7	9.7	3.7	19.4	13.0	10.9	55.0	10.8	22.7	2.5	23.3	6.0	141.6	27.2	15.7	17.3	9.7	9.5	12.5	3.2	15.2	5.9	10.3	10.0	20.5	8.5	7.2	8.7	9.5	9.3	26.9	7.8	3.9	30.6	16.2	6.9	121.4	10.4	13.0	10.0	10.2	14.5	4.8	9.5	5.1	22.6	10.6	22.5	26.2	69.3	10.0	22.8	24.7	5.5	50.9	55.0	46.8	1.7	23.2	50.0	29.7	23.3	8.3	101.0	0.5	12.5	93.6	16.2	74.3	18.4	44.6	7.4	5.7	9.4	3.3	18.6	7.4	23.2	0.0	9.1	34.8	63.9	28.5	6.4	74.7	12.7	4.6	0.8	9.8	11.9	110.3	1.3	1.1	16.3	30.4	42.7	7.3	1.9	18.1	8.9	37.1	4.4	22.9	47.0	50.6	32.1	6.8	43.9	1.4	13.8	35.4	16.5	23.6	1.5	4.2	2.6	1.8	43.4	3.8	51.3	1.8	3.1	0.9	7.4	0.9	18.8	2.0	6.5	5.4	6.7	0.6	5.2	4.7	0.0	2.3	0.0	0.6	1.8	4.0	10.2	9.7	13.0	10.9	9.7	9.5	10.3	10.0	9.3	10.0	9.5	10.0	10.7	3.2	7.0	21.2	2.5	34.2	24.1	21.6	42.7	0.5	18.0	15.6	3.7	11.5	11.1	3.7	2.1	7.5	6.2	3.2	0.0	10.5	0.1	3.6	14.4	11.0	1.8	0.8	2.5	5.1	1.2	19.6	13.7	3.4	1.3	0.3	20.3	0.1	2.7	0.0	3.0	2.1	12.2	4.1	13.3	0.5	5.3	4.9	8.8	6.5	1.8	3.6	5.2	7.1	0.7	14.3	4.4	5.3	3.0	19.2	0.2	0.5	3.9	5.2	6.6	9.5	22.0	0.8	5.6	69.9	55.8	1.8	7.2	0.4	5.5	45.7
RARS1	"DALRD1, RARS"	ENSG00000113643	"Arginyl-tRNA synthetase 1"	P54136	5	168486451-168519301	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 50.8;Cytotrophoblasts: 104.2;Extravillous trophoblasts: 96.8;Hofbauer cells: 57.2;Syncytiotrophoblasts: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		74000	"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.59e-5)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	27.5	25.6	12.7	31.5	12.3	12.8	36.3	19.6	15.6	22.9	9.4	37.6	54.8	26.7	33.5	38.2	25.8	23.4	29.5	12.8	11.2	33.2	43.5	22.0	31.0	9.0	10.7	23.0	34.4	32.7	16.6	36.5	9.8	27.9	43.0	17.2	32.9	23.5	31.1	41.8	48.7	32.8	5.4	21.8	32.8	23.2	12.1	23.5	30.2	34.6	40.6	41.1	25.2	21.4	100.2	115.6	82.5	94.2	113.4	128.9	143.9	143.4	122.3	145.7	168.7	198.4	105.6	104.3	114.2	137.2	149.3	93.9	111.0	192.7	188.5	110.1	76.5	71.2	103.1	126.5	96.8	169.2	72.6	99.7	100.8	159.0	76.0	89.3	118.5	56.4	107.7	51.9	158.1	92.4	70.7	68.7	138.1	86.7	77.8	30.3	122.0	99.7	129.7	110.8	79.6	97.7	109.1	124.7	152.7	101.1	113.4	69.9	118.7	104.7	96.3	81.9	169.4	51.8	100.3	105.7	114.3	118.0	101.9	5.2	21.5	8.2	17.4	27.3	20.2	15.5	17.2	18.8	32.1	9.5	21.2	22.6	5.8	26.6	26.7	14.7	19.3	18.2	12.7	12.3	19.6	15.6	12.8	11.2	9.0	10.7	9.8	5.4	12.1	21.4	10.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.0	0.0	0.0	104.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	96.8	12.8	0.0	0.0	0.0	0.0	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	84.3	1.4	0.0	0.0	0.0
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464544	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 23.5;intestine: 19.8;lung: 10.6;lymphoid tissue: 39.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 39.4;dendritic cells: 70.9;granulocytes: 39.3;NK-cells: 139.0;T-cells: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.6;HEL: 25.5;HMC-1: 46.7;Karpas-707: 52.5;NB-4: 27.8;RPMI-8226: 23.5;TIME: 35.5;U-937: 34.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	3.7	2.6	2.8	17.3	2.9	23.5	1.9	3.1	3.6	1.8	2.9	4.2	4.5	1.5	0.7	2.8	2.2	3.6	1.4	2.9	3.2	3.7	3.6	10.6	32.8	4.2	3.3	0.9	1.4	1.2	1.5	1.0	3.9	2.8	2.3	0.1	3.5	0.9	0.7	1.5	19.8	1.2	4.1	39.4	5.4	0.5	4.2	23.8	3.8	0.4	19.4	4.2	2.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	30.6	0.0	25.5	0.0	0.0	0.4	20.4	46.7	0.1	0.0	0.0	0.0	0.0	0.2	8.0	0.0	52.5	0.0	0.4	10.9	27.8	0.0	0.0	0.0	3.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.7	35.5	0.0	0.0	0.0	0.0	0.4	10.1	15.1	0.0	34.1	0.1	6.4	2.3	12.9	18.4	4.7	10.7	3.1	11.7	20.4	3.4	3.5	9.7	11.8	3.4	12.4	12.8	4.2	9.2	5.5	2.8	2.9	3.1	3.6	2.9	3.2	4.2	3.3	3.9	4.1	4.2	5.2	4.1	3.2	5.6	0.0	39.4	0.3	0.0	0.3	0.0	0.0	2.0	2.2	2.5	2.8	1.4	0.0	0.0	0.2	70.9	0.0	0.0	0.2	0.7	5.4	0.4	5.4	0.0	7.4	0.1	0.6	0.2	1.0	2.6	0.4	39.3	0.0	3.9	4.6	11.3	0.0	0.1	0.0	0.0	11.6	3.5	1.7	0.0	17.2	0.0	13.1	14.2	0.1	139.0	0.5	0.1	0.2	0.0	1.2	23.7	0.2	0.0	1.5	5.7	0.1	0.0	0.5	1.5	0.4	0.6	0.3	0.6	0.4	76.7	1.0	0.2	0.1
RASD1	"AGS1, DEXRAS1"	ENSG00000108551	"Ras related dexamethasone induced 1"	Q9Y272	17	17494437-17496395	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 371.9"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 425.1;Muller glia cells: 375.3;Peritubular cells: 469.8;Sertoli cells: 565.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	46	"plasmacytoid DC: 160.1"	"Lineage enriched"	"Detected in many"	46	"dendritic cells: 160.1"	"Group enriched"	"Detected in some"	4	"ASC diff: 70.2;REH: 71.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 75.6;hippocampal formation: 54.9;thalamus: 53.2"	"Low region specificity"	"Detected in all"			HPA047896	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"HPA047896: AB_10960535"	"unprognostic (1.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	244.7	53.5	48.7	5.9	63.7	9.3	153.3	31.1	83.6	69.2	13.4	16.1	5.4	22.8	11.9	11.7	32.7	12.6	91.0	60.8	61.9	181.7	271.3	25.4	3.0	71.6	49.8	53.7	30.1	4.2	371.9	1.3	39.4	32.7	6.5	47.7	97.8	55.7	183.1	44.1	12.2	3.4	45.7	18.6	42.2	47.7	40.4	13.1	88.4	103.0	1.2	16.6	26.3	53.6	0.0	0.3	0.3	0.0	70.2	3.8	0.3	0.9	1.4	0.1	0.2	3.0	0.0	0.0	8.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	0.9	0.3	0.3	8.3	0.5	0.1	0.3	17.1	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.2	7.5	13.8	1.3	1.4	1.3	4.5	71.0	0.1	0.1	1.5	0.0	12.9	0.4	1.1	0.9	16.3	2.1	0.1	0.1	4.1	0.1	0.7	0.5	0.2	14.5	0.6	0.2	0.4	0.0	0.5	0.0	0.4	0.0	0.4	3.5	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.8	160.1	0.1	1.0	48.7	63.7	31.1	83.6	60.8	61.9	71.6	49.8	39.4	45.7	40.4	53.6	172.2	28.9	36.8	21.2	11.0	17.2	96.2	46.6	27.3	51.4	106.9	147.2	71.2	20.0	33.5	149.0	4.2	3.3	45.8	42.9	13.7	93.5	2.7	150.9	264.2	31.1	222.4	0.4	15.0	1.3	2.2	191.1	86.6	425.1	8.8	40.3	9.7	21.6	3.6	6.7	5.2	262.7	260.4	3.1	22.2	8.1	109.6	27.3	30.2	1.9	2.2	375.3	0.0	17.1	1.6	9.0	21.8	469.8	56.1	73.3	16.8	13.8	7.2	23.8	565.4	228.1	191.7	1.7	3.0	54.8	13.2	6.7	27.0	73.7	32.9	20.0
RASGEF1B	"FLJ31695, GPIG4"	ENSG00000138670	"RasGEF domain family member 1B"	Q0VAM2	4	81426393-82044244	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 118.7;granulocytes: 107.0;Langerhans cells: 282.6;Macrophages: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 11.9;memory B-cell: 9.7;naive B-cell: 12.4;non-classical monocyte: 20.6;plasmacytoid DC: 28.0"	"Group enriched"	"Detected in all"	5	"B-cells: 12.4;dendritic cells: 28.0;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.4;Daudi: 16.1;Karpas-707: 11.1;NTERA-2: 7.9;OE19: 9.2;SCLC-21H: 7.3;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044574	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA044574: AB_10794292"	"unprognostic (3.24e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (4.42e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-2)"	"prognostic favorable (4.21e-6)"	"unprognostic (4.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.04e-2)"	13.8	6.4	8.9	11.0	20.1	32.5	8.3	12.8	9.4	8.8	17.0	6.5	13.6	3.5	12.3	11.3	8.0	12.0	4.3	8.0	9.3	9.4	41.8	19.8	10.7	37.6	12.5	2.5	2.8	5.4	7.5	13.0	39.0	4.2	7.1	12.5	9.9	2.1	2.9	24.3	13.9	5.9	10.0	11.2	14.7	2.4	18.4	14.2	3.4	2.3	9.8	6.0	5.3	20.2	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	13.4	0.3	16.1	0.0	0.0	0.1	0.3	1.1	0.1	0.0	0.1	2.5	1.4	1.0	0.6	0.5	0.3	0.7	0.2	0.6	0.0	0.5	0.1	0.0	2.8	0.2	11.1	0.0	0.6	5.5	0.5	7.9	9.2	3.6	1.6	0.1	6.4	0.5	0.2	7.3	0.1	0.0	2.3	0.1	7.3	1.1	0.0	0.0	0.0	0.5	0.5	0.1	0.1	0.0	5.1	1.2	0.2	0.2	0.8	3.0	0.4	1.9	11.9	2.1	9.7	1.6	1.6	2.7	12.4	2.8	2.7	1.1	3.8	20.6	28.0	0.5	1.2	8.9	20.1	12.8	9.4	8.0	9.3	37.6	12.5	39.0	10.0	18.4	20.2	9.6	28.9	15.9	1.3	118.7	58.9	7.9	4.4	23.9	11.7	22.7	13.2	9.1	15.7	11.1	14.7	37.5	33.2	71.2	13.2	13.7	3.1	0.5	44.5	4.8	10.8	26.8	0.0	3.6	4.0	2.4	9.1	30.1	38.0	107.0	0.6	102.1	45.9	39.5	3.3	2.8	12.8	16.2	64.2	282.6	1.5	0.9	141.4	62.2	10.3	2.9	1.0	2.1	26.7	25.5	3.0	9.6	1.9	33.5	10.2	9.2	12.9	34.0	4.9	0.0	5.9	17.7	0.8	3.2	10.4	56.7	11.2	56.3	0.5	8.1	11.5
RASGRP3	"CalDAG-GEFIII, GRP3, KIAA0846"	ENSG00000152689	"RAS guanyl releasing protein 3"	Q8IV61	2	33436324-33564750	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;skeletal muscle: 42.0"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 186.5;Plasma cells: 64.8;Urothelial cells: 106.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 13.9;memory B-cell: 12.3;naive B-cell: 15.2"	"Group enriched"	"Detected in many"	16	"B-cells: 15.2;granulocytes: 13.9"	"Group enriched"	"Detected in many"	7	"Daudi: 88.7;HEL: 92.0;U-266/70: 143.5;U-266/84: 59.1;U-698: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058937			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA058937: AB_2683858"	"unprognostic (2.64e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.82e-2)"	7.8	2.9	17.7	15.1	35.2	4.8	5.3	29.8	21.6	3.7	10.2	4.7	7.3	2.5	1.1	2.4	2.5	6.5	34.2	15.1	20.2	6.5	5.5	7.7	27.9	37.4	27.1	1.0	3.4	6.8	2.4	11.0	34.6	1.6	6.6	1.0	6.1	2.0	42.0	1.8	4.7	4.7	25.0	14.8	7.4	0.9	30.7	4.2	6.7	17.6	33.6	6.7	1.2	56.4	0.1	0.0	0.0	0.0	0.0	0.5	0.2	1.2	0.7	4.3	12.4	2.3	0.5	88.7	0.4	0.7	1.0	0.1	0.0	0.0	1.1	9.0	0.8	92.0	0.6	0.0	1.3	0.4	12.4	0.1	0.0	0.1	0.2	1.8	5.3	0.8	0.3	4.8	2.0	0.0	0.7	7.2	0.4	0.5	0.1	0.2	4.1	0.1	1.0	5.3	0.6	0.0	0.0	0.3	4.6	0.1	0.1	0.4	1.7	0.3	0.3	0.4	0.8	143.5	59.1	38.7	0.2	0.4	0.3	13.9	0.0	0.0	0.3	0.0	0.4	12.3	0.6	0.6	0.3	15.2	0.9	0.2	0.0	0.3	0.1	0.0	0.8	1.1	17.7	35.2	29.8	21.6	15.1	20.2	37.4	27.1	34.6	25.0	30.7	56.4	41.4	0.0	5.8	2.0	46.7	5.4	31.2	0.9	0.0	1.6	4.8	2.8	50.8	1.5	3.7	5.5	0.0	0.5	3.6	1.1	11.7	21.1	1.6	10.0	3.9	57.9	0.0	7.4	4.9	54.6	1.3	4.4	3.6	31.0	17.8	2.4	60.7	6.0	44.5	0.0	3.5	0.0	2.0	9.4	26.1	0.8	0.9	29.1	40.9	34.7	13.8	0.2	0.0	2.5	186.5	44.8	0.1	1.9	64.8	37.0	0.2	14.3	3.9	1.3	0.0	5.5	4.1	1.4	2.1	0.4	3.7	0.5	8.1	3.8	0.4	106.4
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 20.8;lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 18.1;granulocytes: 26.6;Hofbauer cells: 15.1;Kupffer cells: 32.9;Langerhans cells: 11.6;Macrophages: 19.1;monocytes: 25.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 39.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;HMC-1: 24.0;U-937: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	3.2	0.8	0.3	6.7	0.3	20.8	0.7	0.3	0.9	1.1	0.4	1.2	1.2	0.5	0.1	1.0	1.0	1.9	0.6	0.2	0.3	0.3	0.7	3.3	1.1	0.9	0.4	0.4	1.1	0.3	0.2	2.3	0.6	0.5	0.8	0.0	0.4	0.5	0.8	0.5	1.8	2.0	0.7	8.9	0.9	0.2	1.1	1.1	0.2	1.4	0.7	2.5	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	12.5	13.5	20.1	0.0	15.4	0.0	0.1	0.3	0.0	9.4	0.1	0.0	0.0	39.4	0.0	17.9	0.7	1.4	4.4	0.3	0.3	0.3	0.9	0.2	0.3	0.9	0.4	0.6	0.7	1.1	1.0	0.2	0.0	0.6	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.3	18.1	0.0	1.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.7	0.0	0.2	0.4	0.0	0.0	26.6	0.0	1.4	0.0	15.1	0.0	0.4	0.0	0.0	32.9	11.6	0.0	0.0	19.1	1.8	0.0	25.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.1
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823608	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 217.0;retina: 162.8"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 87.1;Langerhans cells: 75.8;monocytes: 148.5;Oligodendrocytes: 106.7;Peritubular cells: 149.7;Rod photoreceptor cells: 160.3"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 56.8;BEWO: 59.2;Daudi: 62.7;HL-60: 74.7;NB-4: 96.3;U-937: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: AB_2681386"	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	16.4	9.7	76.1	47.1	135.2	91.2	6.9	155.5	113.5	27.9	40.0	8.4	5.3	25.4	22.5	10.0	22.1	15.6	4.2	68.9	94.7	4.0	5.9	25.4	58.6	217.0	148.8	7.0	3.1	1.5	5.0	9.1	186.4	7.3	9.6	162.8	3.0	9.3	1.2	4.2	14.5	38.7	135.8	32.7	7.0	20.6	120.0	19.5	4.7	5.0	73.6	20.7	4.9	197.0	0.1	14.5	34.9	56.8	0.4	0.0	59.2	3.5	10.0	0.6	0.2	3.4	0.1	62.7	5.6	3.1	1.4	0.2	5.1	0.0	0.8	22.7	2.1	41.1	0.0	0.7	0.0	74.7	40.1	0.1	0.0	1.3	0.0	1.3	23.4	7.0	0.2	24.0	0.0	0.1	11.0	96.3	7.8	0.0	1.1	17.1	3.9	23.8	0.0	29.0	0.4	2.8	0.0	1.0	1.7	7.4	0.0	47.0	0.7	1.5	7.4	0.7	4.6	0.3	5.9	37.8	0.3	116.8	0.4	85.6	61.5	101.3	7.7	50.1	14.6	24.3	12.0	10.4	46.8	16.4	7.8	6.5	139.5	8.5	59.9	30.7	11.8	42.1	76.1	135.2	155.5	113.5	68.9	94.7	217.0	148.8	186.4	135.8	120.0	197.0	5.5	0.0	8.7	7.5	49.3	4.7	0.0	0.1	0.0	39.2	4.1	1.7	1.9	1.5	1.9	0.0	27.1	3.0	43.0	0.1	1.9	1.2	6.0	3.2	19.6	18.6	0.0	6.1	1.5	0.9	5.1	10.9	1.1	1.0	54.3	4.5	11.4	1.2	27.1	6.7	1.3	0.7	0.0	87.1	75.8	25.1	33.2	64.6	8.8	26.2	148.5	19.3	7.2	33.7	106.7	0.6	0.0	149.7	14.3	1.2	0.0	0.3	0.1	160.3	0.0	9.4	3.5	0.7	1.0	0.3	2.6	1.4	20.8	0.8	0.0	2.3
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 77.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.0;monocytes: 258.7;Muller glia cells: 260.3;Proximal tubular cells: 128.0;Skeletal myocytes: 186.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 84.8;intermediate monocyte: 63.9;myeloid DC: 84.2;non-classical monocyte: 37.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 84.2;monocytes: 84.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;RH-30: 162.7;RPMI-8226: 54.9;U-937: 85.4;WM-115: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	35.3	7.1	57.4	21.7	67.9	8.3	22.7	64.3	58.6	6.5	43.8	18.5	13.6	3.0	8.6	4.7	6.0	10.8	44.8	53.9	58.9	77.3	17.1	11.9	19.7	63.4	64.0	3.6	39.5	5.0	13.0	12.7	65.9	7.9	6.0	26.9	16.7	10.9	14.8	4.8	13.8	8.7	55.8	20.1	9.4	9.0	65.3	10.4	40.7	17.6	9.1	11.4	7.0	69.7	1.4	0.3	6.0	11.4	17.9	1.0	4.1	0.7	1.1	2.0	3.5	5.0	0.6	0.1	2.3	0.8	3.9	0.0	2.6	2.8	2.8	37.8	0.0	0.1	0.2	39.7	19.0	2.6	0.0	13.1	0.0	1.9	0.2	10.9	3.0	1.6	0.0	64.3	2.9	0.0	3.0	43.1	1.2	0.2	1.2	8.1	162.7	54.9	0.4	1.2	1.0	0.8	0.0	0.5	2.0	10.7	1.1	32.4	0.0	0.4	3.6	3.0	6.5	0.7	0.7	0.1	18.9	85.4	54.8	0.0	84.8	0.1	8.7	63.9	0.2	0.0	0.6	3.7	84.2	0.0	0.6	2.6	3.0	6.9	37.9	2.2	0.3	48.9	57.4	67.9	64.3	58.6	53.9	58.9	63.4	64.0	65.9	55.8	65.3	69.7	8.9	19.2	17.2	77.4	3.7	3.7	1.4	3.2	1.2	22.5	9.7	7.0	47.9	37.1	13.1	16.5	4.2	1.2	20.3	10.1	17.6	45.3	1.4	6.4	13.7	9.2	11.5	0.0	17.0	3.8	1.2	28.6	1.5	14.8	1.3	4.2	6.1	20.1	157.0	37.0	33.6	7.4	12.2	84.7	94.3	4.4	10.5	91.0	8.8	35.6	258.7	260.3	54.6	37.7	38.2	4.0	11.3	2.2	4.1	1.0	45.0	128.0	5.9	13.3	26.3	186.4	25.9	0.6	1.9	0.8	1.7	2.6	8.0	4.9	15.0	0.7
RASSF6		ENSG00000169435	"Ras association domain family member 6"	Q6ZTQ3	4	73571550-73620631	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.6;stomach 1: 34.9"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 120.3;Gastric mucus-secreting cells: 171.8;Ionocytes: 103.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 2.7"	"Lineage enriched"	"Detected in single"	13	"B-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 76.0;hTERT-HME1: 21.5;RPTEC TERT1: 23.5;RT4: 70.2;U-266/70: 20.2;U-698: 61.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037712	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA037712: AB_2675625"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.09e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.03e-2)"	0.2	0.1	0.0	4.9	0.0	0.1	8.4	0.0	0.2	2.3	5.0	11.9	9.8	0.5	2.8	1.9	2.7	4.4	0.0	0.1	0.2	6.0	2.2	1.3	5.7	0.0	0.8	1.3	16.6	0.7	0.4	7.4	0.0	5.7	12.7	1.6	3.5	3.7	0.0	5.3	12.3	0.3	0.0	0.2	34.9	0.1	0.7	30.6	5.7	0.4	6.9	9.2	1.8	0.1	0.3	1.9	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.2	12.0	76.0	1.1	0.0	0.3	3.8	0.0	6.0	0.0	1.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	5.8	0.0	21.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	11.1	0.2	0.0	0.1	0.5	23.5	70.2	2.8	0.0	0.2	1.8	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	20.2	0.1	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.0	0.7	0.1	0.3	12.8	5.1	0.0	25.0	9.8	38.5	70.5	18.8	0.1	25.1	42.2	1.2	21.5	37.7	7.3	0.0	55.7	0.1	81.1	17.6	18.2	0.3	45.4	2.0	0.8	120.3	0.4	0.3	80.9	23.0	1.7	171.8	22.8	1.3	2.2	0.4	4.0	4.4	0.0	0.1	57.9	103.7	0.3	1.0	0.0	0.0	1.2	1.8	0.0	0.6	18.7	0.0	0.0	0.3	67.1	65.8	0.0	21.3	24.6	30.1	37.8	29.8	0.5	0.0	0.0	1.6	0.0	0.2	11.9	1.4	47.2	3.5	0.7	23.2	60.5
RAVER1	KIAA1978	ENSG00000161847	"Ribonucleoprotein, PTB binding 1"	Q8IY67	19	10316212-10333638	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 15.2;Enteroendocrine cells: 16.3;Plasma cells: 15.3;Proximal enterocytes: 14.0;Undifferentiated cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 255.5"					"Low region specificity"	"Detected in all"			"HPA043575, HPA049457"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA043575: AB_2678562, HPA049457: AB_2680774"	"unprognostic (2.04e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.97e-1)"	12.4	12.9	4.1	11.8	4.9	19.0	12.6	3.9	5.5	17.9	6.2	20.4	17.7	22.8	0.7	15.1	19.8	3.3	9.7	3.7	4.4	12.0	8.3	13.1	11.1	6.9	5.0	19.3	11.7	4.4	17.5	6.0	4.4	15.2	3.2	1.1	13.1	7.5	8.5	11.8	22.6	4.0	3.8	21.7	13.9	11.5	5.0	11.4	14.3	2.2	5.2	16.8	14.0	4.5	62.0	38.9	14.1	21.6	5.6	7.0	31.0	31.9	14.0	24.7	21.8	42.7	17.3	65.0	43.7	10.4	19.9	31.5	15.8	21.1	4.9	55.2	93.5	100.3	25.7	48.6	12.6	63.5	62.4	8.2	7.2	16.6	6.2	8.2	16.2	48.6	80.9	56.2	7.6	57.8	85.6	255.5	55.1	13.1	73.9	78.3	20.5	57.2	6.9	24.4	40.3	46.7	34.7	22.3	18.3	4.8	32.0	30.5	22.5	63.7	32.4	56.7	54.5	122.1	109.0	54.9	42.1	44.2	42.5	0.2	1.3	1.8	3.3	1.5	1.7	1.4	2.8	4.6	2.1	2.0	1.9	1.7	1.2	1.9	3.3	0.9	1.1	2.2	4.1	4.9	3.9	5.5	3.7	4.4	6.9	5.0	4.4	3.8	5.0	4.5	1.2	0.0	1.1	6.5	7.8	0.8	0.3	0.5	10.2	0.8	2.0	1.1	0.7	0.0	0.4	0.0	0.0	2.0	2.3	15.2	0.0	4.5	0.4	1.6	2.2	1.1	16.3	12.0	4.8	4.3	1.9	1.6	6.1	1.2	4.5	0.6	0.4	0.3	1.3	0.0	4.5	9.3	0.0	0.0	0.8	0.0	0.0	2.0	0.0	6.5	6.8	0.3	0.0	4.0	4.2	5.4	10.2	0.7	15.3	0.3	14.0	0.6	1.1	1.0	0.0	0.8	2.4	0.7	0.3	6.1	0.1	1.5	5.5	0.6	14.3	0.2
RAVER2	"FLJ10770, KIAA1579"	ENSG00000162437	"Ribonucleoprotein, PTB binding 2"	Q9HCJ3	1	64745095-64833232	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 72.8;Distal enterocytes: 60.1;Inhibitory neurons: 40.4;Oligodendrocyte precursor cells: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045785	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA045785: AB_10964058"	"unprognostic (8.02e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (5.14e-6)"	"unprognostic (1.74e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-2)"	4.7	8.2	12.8	4.2	12.1	9.5	8.2	15.0	12.4	7.7	12.6	23.6	24.2	7.8	5.7	9.4	7.5	11.3	12.6	13.3	10.9	7.7	1.6	8.3	2.0	9.7	12.2	6.4	7.3	16.2	12.3	7.3	10.3	12.0	26.8	15.1	15.5	10.3	22.2	6.7	26.1	9.3	10.4	4.3	12.5	2.7	13.3	8.3	6.1	17.7	4.1	6.5	7.4	9.3	16.7	5.1	15.2	16.7	2.7	2.3	4.1	3.6	6.5	7.3	8.2	13.6	7.3	0.1	8.2	3.8	16.6	12.4	15.7	10.9	8.9	0.1	17.3	20.2	13.7	12.2	5.1	27.5	0.2	6.8	9.8	0.5	7.5	16.9	12.2	16.6	4.5	16.3	0.6	6.2	9.2	5.6	18.8	13.1	13.3	31.1	23.9	6.7	8.0	12.3	11.5	25.6	16.4	0.0	16.0	14.3	12.6	4.3	4.6	6.8	10.9	6.8	13.1	12.3	14.9	7.0	4.1	0.1	6.4	6.2	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	12.8	12.1	15.0	12.4	13.3	10.9	9.7	12.2	10.3	10.4	13.3	9.3	9.2	6.4	13.5	72.8	0.6	8.0	7.0	3.9	8.0	7.1	7.2	6.0	24.4	11.5	8.3	1.8	14.6	0.2	1.1	60.1	0.0	3.4	9.8	5.7	2.5	10.6	18.0	4.2	29.0	5.2	0.3	6.3	11.2	6.5	1.3	7.1	6.8	0.3	0.6	0.0	40.4	30.7	4.1	4.8	3.3	16.8	6.5	2.0	3.6	22.5	0.3	26.1	0.0	40.2	1.8	2.7	20.5	8.2	2.3	6.6	26.9	2.1	6.1	3.7	0.0	6.2	5.5	3.1	3.2	8.5	5.8	0.3	1.5	1.7	27.8	7.3
RAX2	"ARMD6, CORD11, MGC15631, RAXL1"	ENSG00000173976	"Retina and anterior neural fold homeobox 2"	Q96IS3	19	3769089-3772228	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	DNA-binding	"Age-related macular degeneration, Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"retina: 64.5"	"Group enriched"	"Detected in some"	9	"Cone photoreceptor cells: 123.0;Rod photoreceptor cells: 217.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA052533	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA052533: AB_2681862"										"unprognostic (5.53e-2)"				"unprognostic (1.39e-2)"	"unprognostic (4.48e-1)"			0.0	0.0	0.2	0.1	0.4	0.4	0.0	0.6	0.6	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.3	1.6	0.0	0.4	0.0	0.0	64.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.6	0.4	0.3	0.3	0.3	0.4	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	14.3	0.0	0.1	0.6	0.0	0.0	0.0	123.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	217.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
RB1	"OSRC, PPP1R130, RB"	ENSG00000139687	"RB transcriptional corepressor 1"	P06400	13	48303744-48599436	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 187.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000095, CAB016687, HPA050082"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008"	"unprognostic (4.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	20.7	18.7	8.9	22.8	9.7	19.3	17.8	12.0	13.0	18.8	10.9	15.1	14.6	15.7	21.2	21.9	13.1	17.3	17.8	8.5	10.9	18.4	14.5	18.1	30.7	13.9	10.3	11.5	9.2	20.5	6.5	24.9	13.4	15.1	17.1	12.5	16.9	15.9	19.0	23.6	15.6	18.3	11.6	24.8	16.3	12.9	9.3	34.2	22.4	21.2	30.1	19.8	10.6	15.1	29.1	15.8	40.9	44.2	19.8	22.8	18.5	56.6	45.9	57.4	48.3	13.4	49.8	37.3	12.8	37.4	31.7	39.6	53.7	44.8	86.6	53.0	20.8	68.5	29.4	22.7	21.1	59.5	62.0	12.9	27.0	37.3	47.1	47.8	40.1	90.1	23.4	29.6	66.4	13.7	187.2	29.8	20.0	65.6	17.3	79.8	41.1	43.0	59.6	27.6	2.0	41.8	55.1	27.3	46.2	36.2	29.8	76.3	32.1	35.3	23.3	43.7	51.2	13.1	3.9	0.4	18.8	36.7	48.9	23.8	14.9	8.8	6.9	19.9	5.6	30.2	5.7	6.9	15.2	29.4	4.8	5.6	20.6	5.9	20.9	16.9	7.4	7.1	8.9	9.7	12.0	13.0	8.5	10.9	13.9	10.3	13.4	11.6	9.3	15.1	59.2	3.2	19.6	75.4	97.3	28.4	23.3	27.6	63.2	17.3	26.9	21.0	18.3	14.3	19.2	31.3	29.2	7.1	50.1	17.8	15.6	19.3	28.1	40.1	36.2	46.4	17.5	50.7	99.5	11.9	9.6	22.2	29.0	40.4	12.0	25.9	35.7	17.3	77.4	18.5	98.9	20.0	8.2	105.3	198.9	13.9	26.1	104.2	26.6	152.7	93.7	20.4	22.6	101.0	98.3	17.4	10.7	28.6	69.9	24.0	15.7	23.6	25.3	19.6	19.7	28.5	32.3	33.0	21.3	72.1	38.2	4.4	38.3	21.2	16.6	18.0
RBAK	ZNF769	ENSG00000146587	"RB associated KRAB zinc finger"	Q9NYW8	7	5045821-5069487	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071231			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA071231: AB_2686370"	"unprognostic (2.82e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.04e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.12e-3)"	"unprognostic (5.75e-2)"	4.3	3.8	4.1	4.4	4.0	3.7	5.8	6.7	5.4	4.7	3.7	4.6	4.5	5.2	4.7	5.8	4.4	3.7	4.3	3.8	4.5	4.4	6.5	4.0	6.4	4.5	5.0	4.8	5.5	6.9	3.9	4.5	4.4	4.7	4.9	8.4	4.6	4.7	4.2	6.0	5.1	4.4	4.2	5.1	5.0	2.9	4.8	5.6	5.5	6.1	6.7	4.1	4.6	4.8	8.9	6.7	9.2	17.0	6.6	6.1	7.5	5.5	4.3	5.3	6.3	8.3	5.4	10.5	4.5	6.4	10.0	10.8	10.4	8.5	8.2	2.3	7.4	7.7	9.2	6.9	7.0	12.9	8.9	5.9	9.9	5.3	11.8	7.7	5.3	6.1	16.2	3.7	6.7	15.7	3.2	11.9	14.5	3.0	7.0	5.3	14.9	7.7	6.1	11.3	9.4	15.4	7.7	12.6	11.5	11.7	7.7	15.3	4.5	6.3	10.0	7.3	9.1	11.4	9.7	9.2	6.3	9.5	8.2	0.0	0.2	0.4	0.5	0.4	0.7	0.3	0.4	0.3	0.3	0.3	0.5	0.4	0.0	0.5	0.1	0.4	0.3	0.1	4.1	4.0	6.7	5.4	3.8	4.5	4.5	5.0	4.4	4.2	4.8	4.8	7.4	0.0	8.2	0.0	6.5	4.2	3.4	4.7	5.2	8.2	6.1	3.9	13.4	7.2	7.3	0.0	10.4	2.8	7.9	5.1	1.9	5.9	1.1	7.5	10.1	6.1	4.9	11.6	0.0	5.8	2.2	6.7	8.6	6.9	5.7	11.7	7.9	5.3	3.7	21.9	0.0	5.6	2.0	8.2	4.0	1.4	8.1	5.2	3.6	0.0	5.7	6.0	5.2	0.0	0.0	6.0	3.8	8.6	6.7	5.9	5.6	3.7	8.8	8.2	0.0	8.8	7.0	5.0	3.2	7.5	7.0	1.9	6.4	9.1	6.1	4.2
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	32.0	38.8	19.9	33.5	21.8	34.8	38.5	24.7	21.1	40.3	21.5	33.3	27.0	42.4	35.1	32.1	45.5	25.3	31.7	18.7	21.8	31.9	30.6	28.8	62.9	21.4	21.1	46.9	38.5	34.0	31.1	34.6	23.0	30.0	45.9	56.2	38.3	30.7	42.9	33.2	35.7	42.1	22.9	32.7	37.1	75.5	21.3	58.0	45.8	21.1	91.5	35.2	31.2	30.1	68.8	59.1	166.2	120.1	49.9	47.4	66.7	55.3	44.9	103.0	99.7	85.5	135.6	206.9	54.8	61.4	62.7	42.9	184.7	53.6	110.0	80.9	88.3	194.3	112.0	111.9	72.3	183.9	79.9	52.2	66.8	78.1	50.3	83.6	77.2	139.8	138.0	142.1	89.0	48.0	239.4	57.6	185.4	67.0	67.8	228.3	173.8	181.0	72.4	143.4	156.7	94.7	122.1	41.9	83.8	161.3	71.9	83.3	64.3	63.8	61.6	80.4	70.2	113.4	128.0	229.5	75.2	146.9	99.3	79.1	99.9	68.5	74.4	99.8	77.4	79.6	69.8	75.2	115.0	60.1	61.2	67.3	24.8	87.7	95.4	95.7	77.9	151.8	19.9	21.8	24.7	21.1	18.7	21.8	21.4	21.1	23.0	22.9	21.3	30.1	61.6	41.7	53.7	32.3	115.8	71.5	68.3	76.8	120.1	106.1	105.2	57.3	22.2	77.2	59.1	73.5	143.9	129.2	132.0	55.4	84.1	84.7	26.3	51.2	89.0	65.7	97.1	201.4	38.0	58.3	87.6	81.3	70.3	71.6	49.4	93.3	64.6	76.5	80.6	106.0	41.5	83.9	79.3	78.8	74.3	17.5	79.6	80.8	49.8	22.5	90.7	77.4	91.6	44.2	49.7	76.1	42.1	88.4	201.8	59.5	44.3	65.9	50.5	109.2	98.6	47.6	76.9	154.2	88.8	132.5	77.4	85.5	95.4	79.5	86.9	58.7
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	6.3	8.2	4.7	7.2	5.3	9.5	7.9	6.4	6.4	7.8	2.7	7.0	7.1	8.1	7.5	7.0	7.5	6.1	6.4	5.7	5.3	12.4	11.0	6.6	11.3	3.4	3.8	9.5	8.2	9.4	6.1	6.5	3.8	6.9	8.0	9.8	7.6	6.9	8.7	8.5	6.7	7.1	4.3	9.3	6.7	6.1	4.5	13.2	9.8	9.9	12.8	7.5	5.2	6.4	16.3	16.9	16.0	19.0	21.8	12.5	17.3	15.2	12.9	19.0	18.8	17.9	19.1	25.3	11.3	11.1	15.5	18.2	26.9	10.1	22.4	21.6	14.5	21.2	16.4	14.6	14.1	26.9	16.6	10.1	12.9	17.6	15.0	12.7	15.4	17.9	41.6	25.2	16.0	15.0	26.1	11.3	26.1	14.2	27.9	22.9	33.9	31.6	13.2	11.7	25.0	20.1	21.3	22.3	19.2	19.0	24.2	14.9	11.8	15.6	16.6	23.1	20.2	12.2	18.3	30.6	13.9	16.5	24.5	22.0	4.9	7.9	8.0	6.4	8.5	7.8	7.4	8.1	5.4	6.2	7.1	8.7	11.6	8.2	8.3	6.0	8.1	3.5	4.7	5.3	6.4	6.4	5.7	5.3	3.4	3.8	3.8	4.3	4.5	6.4	14.7	19.2	12.2	11.4	31.0	26.9	9.7	5.9	15.9	14.5	18.9	14.6	7.1	8.6	13.4	22.0	29.2	9.1	25.2	15.8	9.8	12.1	7.3	13.1	14.0	13.2	12.1	23.1	19.9	11.6	10.7	13.5	9.7	21.0	13.9	25.6	17.2	21.8	10.9	16.8	15.7	14.0	10.2	15.6	25.9	3.2	12.8	17.9	19.6	8.4	15.6	12.6	15.5	14.6	21.2	13.6	9.8	16.1	25.9	13.5	14.7	28.8	13.2	18.3	19.7	21.9	14.1	10.2	20.4	14.6	33.8	10.8	27.9	12.6	15.8	13.4
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870362	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 440.4;Syncytiotrophoblasts: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	47.1	280.4	28.9	57.0	35.7	99.8	63.8	27.7	39.8	133.1	40.1	73.0	55.0	90.5	293.7	67.1	96.3	49.8	86.5	32.0	31.0	60.9	56.7	42.9	89.8	29.4	25.9	132.8	46.8	194.2	42.5	96.4	28.8	81.9	73.0	61.4	62.1	166.4	132.8	61.2	57.2	101.0	30.1	47.7	64.4	94.5	27.4	88.7	57.9	90.0	106.5	67.9	51.7	34.2	298.0	219.5	159.5	212.2	99.8	116.6	103.0	143.7	144.7	207.7	233.9	128.6	190.4	328.0	215.2	141.6	236.3	153.1	291.5	214.4	275.2	186.2	400.6	138.9	247.7	153.1	83.8	212.1	160.3	91.3	77.8	240.6	174.9	133.3	211.9	134.6	141.5	167.2	166.9	200.2	236.1	194.0	181.7	141.5	199.5	204.3	295.3	386.7	151.9	197.6	149.3	110.7	271.9	128.3	133.9	225.8	426.8	126.5	99.0	99.5	102.1	265.7	162.8	116.6	178.6	429.3	127.7	140.8	123.3	50.9	45.3	62.3	85.1	79.5	82.6	92.0	70.6	89.4	63.6	80.0	73.3	82.9	18.2	89.2	111.7	74.1	72.1	77.2	28.9	35.7	27.7	39.8	32.0	31.0	29.4	25.9	28.8	30.1	27.4	34.2	52.0	51.3	65.0	18.6	69.5	74.8	105.7	98.0	33.6	31.4	53.5	51.1	105.1	42.9	80.8	55.2	29.2	440.4	89.8	41.9	78.2	87.3	14.5	55.0	58.0	50.7	60.7	70.2	26.6	74.3	170.8	87.7	44.9	54.8	57.7	101.8	41.4	36.4	109.3	25.2	20.7	57.4	81.4	33.5	39.6	31.2	113.7	43.7	83.6	16.9	60.4	79.4	72.1	46.3	24.7	75.7	39.0	187.3	89.6	75.3	48.6	64.2	63.8	43.6	138.1	73.8	134.3	109.9	121.1	52.5	61.1	532.2	67.8	81.9	79.3	74.2
RBBP8	"COM1, CtIP, RIM, SCKL2"	ENSG00000101773	"RB binding protein 8, endonuclease"	Q99708	18	22798261-23026488	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 125.9;Spermatocytes: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 36.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039890, HPA052946"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA039890: AB_10794756, HPA052946: AB_2681996"	"unprognostic (1.55e-3)"	"unprognostic (4.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.91e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.48e-1)"	10.1	8.7	6.8	10.0	6.8	18.2	29.4	9.2	11.3	20.9	41.6	14.5	9.3	20.1	23.4	22.1	28.0	12.7	7.0	7.4	9.2	42.2	14.4	13.5	14.0	6.3	7.3	6.4	18.5	22.1	17.5	8.5	6.4	10.8	12.9	6.2	19.5	23.3	2.3	28.5	12.9	16.4	6.2	7.6	13.1	28.7	8.5	32.4	18.2	3.5	17.3	18.3	18.0	7.3	32.9	24.8	36.0	41.9	18.2	19.4	28.2	44.2	31.1	40.3	56.5	45.7	36.3	95.4	19.9	27.9	38.5	67.3	41.2	89.9	78.5	68.3	33.2	41.8	32.0	44.0	22.2	151.5	43.7	13.9	86.0	61.0	105.3	23.6	16.6	65.7	25.0	69.2	41.6	49.1	112.8	50.6	34.2	60.1	41.5	57.6	65.9	58.9	117.4	34.7	84.1	39.8	74.1	22.4	39.0	20.5	129.1	39.4	12.0	107.2	49.3	52.4	78.0	92.9	108.4	105.3	49.1	72.2	58.8	17.0	6.5	3.9	1.2	24.0	0.5	6.6	1.7	2.1	8.2	5.3	0.9	1.5	2.4	7.9	36.7	8.1	4.7	3.8	6.8	6.8	9.2	11.3	7.4	9.2	6.3	7.3	6.4	6.2	8.5	7.3	13.1	35.3	42.8	10.1	22.9	27.4	44.7	125.9	76.8	4.3	22.6	72.6	10.4	35.8	41.9	29.5	4.2	12.7	25.0	14.5	43.0	30.5	17.7	56.0	19.5	14.2	7.7	37.0	20.3	33.0	9.4	13.2	23.0	67.3	66.1	22.3	5.7	16.4	11.7	1.7	15.5	9.3	16.2	11.4	23.5	14.5	6.5	27.5	23.2	8.4	9.0	2.1	4.1	9.5	2.7	44.9	8.6	5.3	53.8	37.5	17.5	26.1	28.2	7.9	0.0	20.4	14.0	116.6	83.4	36.2	19.7	15.2	13.6	9.8	14.9	45.5
RBBP9	Bog	ENSG00000089050	"RB binding protein 9, serine hydrolase"	O75884	20	18486540-18497225	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015830, HPA049005"	Approved		Supported	Nucleoplasm		NA	NA		40000	"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA015830: AB_1845410, HPA049005: AB_2680597"	"unprognostic (1.17e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.21e-2)"	7.2	10.3	5.3	6.6	5.8	3.3	9.5	6.2	5.9	13.4	8.2	6.3	6.7	7.6	6.6	7.7	5.8	9.5	5.4	4.5	5.8	17.7	25.7	8.5	7.1	5.7	5.9	6.9	5.4	15.9	5.4	5.5	5.7	8.6	7.5	8.1	8.8	8.8	3.5	11.0	6.5	7.9	5.6	5.6	7.2	3.8	6.6	7.3	24.3	3.9	9.1	8.3	4.6	6.6	12.2	14.1	12.8	18.2	8.9	14.6	13.0	13.7	13.3	17.4	17.7	10.2	10.8	15.2	5.5	9.6	12.1	13.5	10.2	22.5	20.7	4.6	12.5	8.0	4.3	31.4	5.6	11.8	4.7	7.6	8.7	14.3	8.4	8.7	22.2	12.5	5.1	11.6	15.2	6.9	12.2	8.1	8.5	16.9	26.4	11.9	38.0	9.6	15.7	13.2	10.9	18.7	18.2	21.8	9.7	8.7	17.6	3.2	12.8	29.0	9.5	18.5	12.3	13.1	34.5	10.4	11.4	5.5	9.5	9.3	2.0	0.6	1.9	2.5	2.9	2.2	2.3	1.4	2.1	1.7	2.0	1.6	0.3	1.8	2.0	0.4	3.0	2.0	5.3	5.8	6.2	5.9	4.5	5.8	5.7	5.9	5.7	5.6	6.6	6.6	6.7	22.4	18.3	3.9	5.5	7.4	3.4	7.7	10.2	4.3	7.8	4.6	8.1	4.3	9.3	11.0	0.0	3.3	5.8	5.1	15.6	5.9	5.1	4.9	6.5	6.6	5.4	2.5	3.4	2.8	4.0	5.5	6.6	6.2	0.0	6.2	6.1	17.9	5.7	3.3	4.9	3.6	4.1	6.8	5.2	1.6	5.3	4.4	5.4	1.0	5.9	8.6	3.1	5.0	4.7	4.7	2.5	7.2	4.3	3.3	9.2	21.3	10.5	6.8	0.0	5.7	5.7	1.3	4.1	8.5	6.1	2.5	6.1	7.3	6.4	3.8
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713340	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 73.9;heart muscle: 25.2;skeletal muscle: 95.3;tongue: 45.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 5800.8;Inhibitory neurons: 5921.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Group enriched"	"Detected in many"	10	"basal ganglia: 28.1;cerebral cortex: 73.9;hippocampal formation: 26.6;white matter: 22.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746, HPA075862"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA040809: AB_10796228, HPA066746: , HPA075862: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		0.3	1.5	3.7	0.4	28.1	0.5	0.1	2.5	73.9	0.6	0.0	0.8	0.2	0.2	3.1	1.1	1.1	0.1	25.2	26.6	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	1.1	0.1	0.0	1.7	0.5	5.7	2.2	4.1	95.3	0.3	0.2	0.0	2.7	0.0	0.2	1.1	2.2	0.2	0.1	45.3	0.0	0.4	0.4	22.6	0.1	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	25.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.0	0.7	0.1	0.4	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.3	0.2	0.7	0.2	0.1	0.1	0.2	0.0	3.7	28.1	2.5	73.9	26.6	0.0	0.0	0.0	0.0	2.7	2.2	22.6	0.0	0.0	0.5	97.9	0.0	0.0	0.0	0.0	0.0	10.9	0.4	0.0	98.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	6.6	0.3	1.8	0.9	0.0	0.0	5800.8	0.2	0.0	3.5	0.0	0.1	0.0	47.8	0.0	0.0	0.1	0.0	5921.8	0.5	0.0	0.0	0.3	4.9	1.2	0.5	1.8	132.1	0.6	6.6	0.0	597.6	689.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.7	2.8	0.0	17.0	1.2	0.6	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0
RBFOX2	"FOX-2, HNRBP2, HRNBP2, RBM9"	ENSG00000100320	"RNA binding fox-1 homolog 2"	O43251	22	35738736-36028824	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 378.7;Inhibitory neurons: 418.1;Oligodendrocyte precursor cells: 237.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006240, HPA006455, HPA075862"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA006240: AB_1079750, HPA006455: , HPA075862: "	"unprognostic (3.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.08e-2)"	28.4	21.9	16.4	12.3	21.7	0.2	27.0	38.8	41.9	49.0	0.0	59.2	11.7	67.5	21.6	34.7	40.4	25.2	37.0	24.3	11.7	18.7	25.8	25.6	5.9	6.9	3.3	63.0	18.7	26.2	27.5	32.6	5.2	31.4	21.4	15.5	23.7	29.7	77.1	23.7	23.4	52.7	1.1	9.9	28.9	25.7	7.3	10.0	28.5	44.3	8.5	43.1	36.5	17.8	46.2	27.4	110.3	64.8	62.4	111.2	36.8	89.9	123.6	67.1	72.0	60.1	21.3	28.2	41.2	108.9	41.9	46.5	40.2	41.7	95.9	19.2	36.6	16.7	26.5	22.3	18.8	4.4	11.6	77.3	53.1	59.6	73.3	64.8	86.8	7.0	13.7	3.9	80.3	14.0	4.5	2.7	40.5	19.7	42.0	7.6	92.0	7.9	50.1	47.5	34.1	106.0	110.3	15.5	31.0	57.0	16.9	6.8	105.5	96.4	54.4	54.7	41.2	2.8	9.4	38.3	42.7	6.8	51.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.4	21.7	38.8	41.9	24.3	11.7	6.9	3.3	5.2	1.1	7.3	17.8	34.3	67.3	38.5	189.4	1.0	37.1	50.6	57.3	57.5	20.8	31.4	34.5	62.2	31.5	40.4	27.6	0.0	69.9	0.9	17.9	35.2	53.0	24.8	17.8	60.8	45.9	57.0	0.8	378.7	32.1	89.1	67.8	15.8	25.0	2.5	30.6	40.7	26.0	10.5	117.8	418.1	24.7	18.3	1.3	14.7	9.4	79.6	1.8	16.0	183.6	2.6	16.9	0.0	237.2	130.0	77.4	10.7	93.3	1.4	57.4	22.5	18.7	20.9	6.7	52.6	74.5	93.3	42.2	25.6	31.0	33.8	29.0	2.5	48.2	23.8	61.1
RBFOX3	"FOX-3, HRNBP3, NeuN"	ENSG00000167281	"RNA binding fox-1 homolog 3"	A6NFN3	17	79089345-79516148	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 217.2;intestine: 97.4;urinary bladder: 80.5"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 320.4;Inhibitory neurons: 163.9;Skeletal myocytes: 124.4"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Group enriched"	"Detected in many"	4	"cerebellum: 217.2;cerebral cortex: 118.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 16.1;NTERA-2: 14.2;SCLC-21H: 22.4;U-2 OS: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030790, HPA075862, CAB078782"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB078782: , HPA030790: AB_10602305, HPA075862: "	"unprognostic (2.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.22e-15)"	"unprognostic (8.92e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-1)"	0.5	0.9	11.8	0.4	29.7	0.6	0.3	217.2	118.3	3.0	0.0	97.4	1.5	39.9	3.1	9.6	3.6	0.0	0.3	23.6	0.0	0.3	0.2	0.6	0.1	12.3	1.1	1.3	0.5	0.9	7.5	0.0	13.4	22.3	2.4	3.4	0.2	24.4	0.5	0.5	9.1	9.5	0.0	0.5	4.2	7.5	0.0	0.0	0.3	0.0	0.0	80.5	8.2	40.2	0.0	16.1	0.2	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	14.2	0.0	0.2	0.3	0.7	0.1	0.0	0.0	22.4	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	11.1	0.6	0.0	0.9	0.0	0.4	0.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.8	29.7	217.2	118.3	23.6	0.0	12.3	1.1	13.4	0.0	0.0	40.2	0.5	0.0	0.0	5.9	0.2	2.0	8.1	0.0	0.0	11.5	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	5.7	0.3	0.4	7.5	0.0	0.0	320.4	0.0	0.1	11.8	0.0	0.7	0.0	0.1	0.0	0.2	0.1	5.0	163.9	0.0	0.0	0.6	5.5	10.1	0.3	7.6	5.4	10.3	0.0	1.2	2.1	11.1	4.8	0.0	0.0	10.5	0.0	15.2	0.0	0.1	0.0	3.1	0.0	124.4	7.5	2.4	26.4	0.0	1.4	0.1	2.3	0.1	0.0	2.8
RBIS	C8orf59	ENSG00000176731	"Ribosomal biogenesis factor"	Q8N0T1	8	85214048-85220421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 56.0;Cytotrophoblasts: 105.8;dendritic cells: 39.1;Extravillous trophoblasts: 123.8;Hofbauer cells: 102.1;Syncytiotrophoblasts: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044805, HPA071903"			Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA044805: AB_2679095, HPA071903: AB_2686469"	"unprognostic (1.61e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.84e-3)"	74.4	69.3	55.7	51.0	56.1	83.2	95.2	57.4	72.4	85.3	57.0	81.0	60.6	67.0	91.1	90.2	72.2	42.8	101.1	54.6	58.2	88.5	86.2	52.3	70.8	56.9	55.6	82.7	103.1	60.6	68.9	45.6	57.5	71.6	56.8	45.8	75.2	41.4	78.0	63.9	66.3	48.8	58.5	75.4	99.0	41.5	56.1	75.1	61.3	68.6	71.3	73.9	73.5	59.8	166.6	83.1	122.6	79.4	73.4	140.2	94.8	107.6	102.7	123.1	120.5	97.2	140.0	42.1	86.8	71.8	116.2	112.9	84.8	118.2	138.1	116.6	92.5	242.1	74.2	145.8	87.0	92.5	105.7	120.0	137.0	79.4	99.7	133.3	106.4	145.3	111.9	97.8	103.7	131.0	205.8	173.1	36.1	372.8	143.3	86.9	100.6	188.2	121.2	104.7	40.7	87.1	81.7	132.8	161.0	145.5	154.4	135.9	81.8	78.1	164.9	87.5	104.2	114.1	144.8	197.4	155.8	116.8	88.9	76.6	55.2	39.2	63.5	71.7	76.7	89.3	83.7	78.9	96.9	77.7	95.8	95.0	14.1	104.7	64.4	118.7	90.8	71.0	55.7	56.1	57.4	72.4	54.6	58.2	56.9	55.6	57.5	58.5	56.1	59.8	56.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	105.8	39.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	123.8	27.8	0.0	0.0	0.0	0.0	0.0	0.0	102.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	76.9	7.6	0.0	0.0	0.0
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781379-27890681	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 79.0;Proximal tubular cells: 110.9;Respiratory ciliated cells: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 17.8;RPTEC TERT1: 40.8;U-266/84: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		11000	"Cluster 22: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	5.8	24.8	3.9	2.0	4.3	1.8	3.9	5.2	5.1	3.5	5.0	6.1	25.2	2.8	10.9	3.1	15.5	2.7	5.2	4.1	4.4	27.5	46.5	3.1	1.7	4.4	4.6	8.1	4.6	9.3	11.0	1.8	4.3	2.4	5.2	13.8	2.1	3.4	8.2	1.5	25.6	2.2	3.9	1.7	2.8	9.2	3.9	3.1	9.8	5.9	2.2	2.2	2.3	4.4	6.4	4.9	0.5	0.6	0.4	1.7	3.9	1.3	1.7	1.5	1.1	9.3	2.9	2.4	17.8	3.6	3.0	2.3	0.6	2.7	2.1	0.9	0.3	0.1	0.7	8.2	2.7	1.7	0.2	2.4	3.3	5.8	7.8	1.5	1.2	3.8	0.5	4.0	3.6	8.2	1.5	4.6	0.8	4.6	4.3	1.8	0.3	1.4	40.8	0.5	1.7	2.5	6.1	7.7	2.8	2.3	3.9	9.3	0.2	1.2	0.9	4.3	2.7	13.6	18.2	3.8	3.6	5.6	0.2	1.6	2.5	1.4	1.9	0.9	4.2	4.4	2.7	4.8	3.5	3.7	3.1	2.3	1.0	4.5	0.2	0.4	4.2	2.3	3.9	4.3	5.2	5.1	4.1	4.4	4.4	4.6	4.3	3.9	3.9	4.4	9.9	6.4	5.0	14.7	24.0	2.0	3.1	11.7	26.7	10.7	5.1	7.1	7.1	5.7	9.7	18.4	4.2	4.2	10.5	12.2	46.9	12.6	36.9	35.2	2.4	7.8	3.6	3.0	13.9	12.3	1.3	10.9	8.6	7.4	2.5	4.6	2.9	29.5	6.5	8.4	18.3	4.7	6.1	4.4	3.4	26.4	1.5	50.8	1.8	2.8	2.4	15.5	3.1	15.6	10.3	7.0	14.9	2.6	21.2	1.0	79.0	110.9	59.0	25.6	0.0	3.3	11.2	23.8	20.0	5.2	1.6	1.5	19.6	9.5	10.7	1.9
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095997	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.3;Inhibitory neurons: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	2.0	1.6	1.2	4.8	2.6	14.5	2.8	8.3	1.8	2.3	0.7	2.8	2.4	2.8	1.3	2.9	1.9	2.0	1.8	1.0	1.9	1.6	1.4	2.2	7.3	2.0	1.9	4.4	2.4	2.6	1.1	3.4	2.2	2.0	3.5	4.0	1.5	1.4	6.9	3.1	2.5	2.8	1.4	3.4	2.7	3.1	2.0	8.8	2.7	7.9	6.7	2.0	2.2	3.4	24.8	15.8	19.4	13.1	4.9	6.4	12.4	28.2	12.6	23.9	24.6	16.8	13.5	27.5	7.9	11.8	14.0	23.8	17.5	18.2	39.7	9.7	9.4	27.2	18.1	14.3	3.0	35.3	18.2	3.0	2.5	31.6	11.1	4.0	13.6	17.9	20.1	25.8	13.7	10.5	33.1	11.7	5.7	12.5	15.3	21.3	57.7	20.9	5.5	12.2	4.6	11.5	30.8	17.6	8.2	6.2	11.3	25.3	9.1	42.0	15.9	38.9	24.8	8.6	16.4	27.7	30.2	24.4	21.1	0.9	0.7	1.4	2.7	0.8	2.3	3.0	3.0	2.5	1.3	2.1	3.2	2.7	0.3	2.2	1.2	3.0	4.5	0.9	1.2	2.6	8.3	1.8	1.0	1.9	2.0	1.9	2.2	1.4	2.0	3.4	3.5	6.4	11.0	10.4	8.7	2.4	1.5	1.7	4.0	5.9	2.5	1.7	2.9	1.5	6.1	0.0	2.1	5.9	6.5	1.8	0.0	1.8	1.5	2.2	4.3	3.3	1.2	23.3	14.7	1.1	5.1	4.6	2.6	2.9	8.8	9.0	2.2	1.4	4.5	3.3	22.8	1.9	0.0	3.0	3.2	0.6	2.1	6.8	1.8	6.5	4.7	3.1	7.2	19.6	18.5	0.9	3.6	3.0	14.1	0.8	1.0	0.7	0.9	12.2	6.6	8.5	4.1	17.5	8.7	5.3	1.3	3.8	11.7	6.4	3.5	0.9
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491648	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 468.3;Late spermatids: 209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli rim, Mitotic chromosome"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	32.5	25.4	11.1	32.3	13.6	19.1	31.7	12.5	10.4	33.5	14.8	26.6	23.3	32.2	20.2	25.0	31.8	27.7	25.6	8.7	10.5	39.2	59.5	38.9	49.7	12.3	12.0	37.8	39.0	62.7	17.7	19.3	13.0	42.9	29.3	23.1	34.2	39.9	32.4	26.3	26.1	30.7	11.7	41.0	32.6	48.4	11.4	66.6	40.2	37.7	51.2	30.9	28.9	16.9	25.9	18.1	20.7	20.6	61.2	57.9	9.4	17.8	26.4	23.1	7.9	10.1	30.9	39.0	28.4	32.8	22.3	29.6	17.9	30.1	36.0	12.5	22.4	15.9	14.7	22.0	27.3	23.4	49.0	35.6	34.0	15.3	22.4	43.0	36.3	39.6	12.7	23.2	26.6	7.1	48.6	22.0	7.8	30.8	15.0	33.6	41.8	46.1	25.4	25.3	16.9	14.3	42.2	17.2	19.1	16.8	22.7	30.0	28.3	27.5	14.3	24.1	13.7	35.7	22.9	42.4	34.4	28.2	19.0	53.9	22.5	56.5	53.4	16.2	60.5	22.5	59.7	62.8	21.7	22.0	85.5	75.3	41.8	74.4	28.8	13.1	48.2	76.2	11.1	13.6	12.5	10.4	8.7	10.5	12.3	12.0	13.0	11.7	11.4	16.9	37.9	41.7	101.1	51.2	49.5	23.1	30.1	15.3	40.9	27.8	27.0	15.5	13.5	45.8	32.5	27.6	20.9	6.0	77.0	26.3	17.6	13.4	468.3	38.9	25.8	31.4	19.8	26.5	55.1	10.2	13.0	35.8	24.5	45.9	55.1	27.9	40.7	46.1	11.2	35.3	54.1	30.0	34.6	43.6	23.7	209.1	42.0	35.4	10.6	58.1	44.9	38.3	79.3	63.3	85.7	10.8	19.0	42.9	48.7	31.4	29.2	25.3	38.3	22.5	39.5	36.2	26.1	161.4	61.3	33.7	27.6	4.1	118.9	25.2	21.7	35.6
RBM11		ENSG00000185272	"RNA binding motif protein 11"	P57052	21	14216130-14228372	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"epididymis: 45.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6;Excitatory neurons: 13.0;Inhibitory neurons: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HEL: 1.4;REH: 1.0;SuSa: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045885			Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA045885: AB_10963937"	"unprognostic (1.95e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.44e-4)"	"unprognostic (2.18e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.92e-4)"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.24e-3)"	0.2	0.7	2.4	0.3	2.1	0.5	0.4	1.8	2.9	0.3	1.5	0.3	0.2	0.7	45.2	0.6	0.9	0.2	0.6	2.2	2.2	1.2	0.0	0.3	0.3	2.2	2.4	2.0	0.3	1.2	1.6	0.1	2.5	0.5	0.1	2.4	0.4	1.1	0.0	0.1	0.3	0.4	2.2	0.4	0.3	1.5	2.3	0.6	1.1	0.0	0.2	0.4	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.3	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.9	0.0	1.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	1.8	2.9	2.2	2.2	2.2	2.4	2.5	2.2	2.3	2.5	0.3	3.2	2.7	2.0	2.9	1.8	6.5	0.7	1.8	7.0	2.8	3.7	0.1	0.0	0.8	1.8	0.0	2.3	1.5	0.2	15.6	2.5	9.3	0.7	0.7	0.8	7.7	0.8	13.0	1.2	0.8	1.5	2.6	0.6	2.5	1.3	0.0	0.0	0.8	5.0	14.7	0.9	2.0	0.0	0.4	5.2	0.6	0.3	0.0	0.0	0.8	9.4	2.1	4.0	6.3	0.8	0.4	0.7	0.3	5.1	0.0	0.8	0.8	4.4	0.0	2.1	2.4	7.2	9.8	2.8	1.1	1.2	1.6	1.8	0.4	5.6
RBM12	"HRIHFB2091, KIAA0765, SWAN"	ENSG00000244462	"RNA binding motif protein 12"	Q9NTZ6	20	35648925-35664956	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043258, HPA043621"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA043258: AB_2678395, HPA043621: AB_2678584"	"unprognostic (8.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (7.96e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (4.44e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.87e-2)"	24.5	20.2	2.6	28.7	3.5	30.2	22.6	23.2	8.0	18.2	7.6	24.5	20.3	28.6	12.4	23.4	26.6	23.7	18.4	2.9	9.6	17.7	18.5	22.9	39.9	4.1	4.1	39.0	19.9	25.2	13.9	30.2	3.7	23.4	24.1	27.4	19.3	19.3	19.2	17.6	20.2	28.5	0.9	27.0	22.2	23.0	6.2	50.6	23.0	17.2	44.8	36.4	17.0	10.4	87.9	57.6	121.3	74.5	29.1	57.0	74.5	47.7	56.1	65.5	64.0	80.4	60.3	157.5	51.8	96.0	68.3	60.7	144.8	121.9	83.3	74.8	52.2	132.0	56.6	54.2	50.0	145.1	67.9	82.0	61.7	75.2	49.7	41.8	73.9	84.0	128.1	73.9	58.0	64.3	172.8	40.8	88.4	56.7	59.2	104.2	149.0	77.0	47.0	142.2	63.9	82.9	85.1	66.0	64.3	99.2	85.1	52.4	104.9	54.8	81.0	54.3	71.7	79.7	93.4	165.3	48.3	55.3	72.9	6.7	10.5	8.9	11.7	11.6	13.6	12.2	10.4	13.7	12.7	11.5	10.7	9.8	7.5	9.9	9.8	8.1	10.1	11.5	2.6	3.5	23.2	8.0	2.9	9.6	4.1	4.1	3.7	0.9	6.2	10.4	22.6	25.6	24.1	0.0	28.7	29.6	23.8	17.4	19.4	15.8	19.4	19.3	22.5	17.2	19.2	3.7	27.1	21.5	35.8	17.1	1.9	14.9	4.8	20.7	24.0	18.7	24.6	25.2	0.0	17.8	18.5	22.6	11.2	24.9	26.6	31.5	20.0	14.0	18.5	8.4	0.0	20.4	20.3	24.6	20.6	4.8	14.6	25.7	16.0	0.0	23.7	13.5	21.6	0.0	0.0	21.0	14.6	16.6	22.9	18.5	15.0	9.8	25.3	14.4	6.6	28.0	22.6	15.1	17.4	21.8	29.5	17.5	29.7	18.7	19.8	27.8
RBM12B		ENSG00000183808	"RNA binding motif protein 12B"	Q8IXT5	8	93729356-93741017	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 15.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024398, HPA053050"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA024398: AB_1856109, HPA053050: AB_2682026"	"unprognostic (4.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.15e-2)"	"unprognostic (4.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.62e-2)"	6.6	7.2	3.2	14.8	4.3	9.2	11.7	15.2	5.2	11.4	3.5	8.9	9.1	14.3	8.9	8.5	11.7	8.4	9.3	3.1	6.6	8.9	6.4	8.5	19.8	4.0	2.1	21.8	7.8	9.4	5.6	13.4	2.8	13.0	9.4	24.7	10.2	8.4	5.5	8.5	9.0	8.3	1.5	13.6	10.6	17.6	2.5	16.3	15.9	6.2	16.9	8.4	7.1	10.8	26.0	19.3	48.3	34.4	11.7	22.3	23.4	21.4	15.8	23.9	24.9	14.6	34.6	45.5	33.2	12.0	25.4	26.0	42.3	11.3	26.7	32.3	21.8	59.0	48.2	12.6	13.7	22.2	28.7	14.6	14.2	15.7	15.5	15.8	16.4	26.6	49.4	37.0	21.3	15.0	41.3	17.3	0.2	19.6	20.4	30.2	34.2	15.0	12.3	21.9	31.6	25.0	23.0	7.2	17.8	33.0	27.5	16.7	32.0	22.2	33.3	16.3	22.3	43.0	34.2	38.3	15.8	31.0	38.0	15.0	2.3	4.4	2.3	2.0	3.5	1.5	3.0	2.4	2.2	2.1	4.1	3.5	3.3	3.0	2.4	2.9	3.8	2.1	3.2	4.3	15.2	5.2	3.1	6.6	4.0	2.1	2.8	1.5	2.5	10.8	16.8	6.4	8.1	23.2	17.9	4.0	7.1	7.2	11.4	31.8	9.9	9.1	11.8	10.0	6.6	12.9	43.8	7.9	13.7	5.5	3.9	6.9	1.4	11.3	21.4	12.8	15.7	17.7	23.7	4.8	4.8	13.5	7.7	12.8	0.0	30.3	11.4	8.4	4.7	45.4	26.6	9.2	8.2	11.1	5.8	2.4	12.5	8.9	5.4	21.5	15.9	21.9	17.5	32.6	40.2	6.8	7.1	10.1	8.7	8.8	5.9	5.0	12.5	32.1	19.7	23.2	13.1	19.1	10.9	7.3	4.3	4.0	11.8	13.5	8.0	4.9
RBM14-RBM4		ENSG00000248643	"RBM14-RBM4 readthrough"		11	66616626-66646469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.5;Club cells: 5.0;Excitatory neurons: 8.7;Inhibitory neurons: 8.7;Microglial cells: 5.6;Oligodendrocytes: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 10.0"									HPA047849	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA047849: AB_2680180"	"unprognostic (2.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-4)"	"unprognostic (3.92e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.77e-4)"	"unprognostic (5.74e-7)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.10e-2)"	0.6	0.8	3.5	0.4	2.5	3.0	0.5	3.4	3.4	0.6	2.9	1.3	0.1	0.8	0.8	1.0	0.7	0.6	2.7	2.6	3.6	1.0	3.0	0.7	0.6	2.9	1.9	0.6	1.1	0.3	1.0	0.4	1.8	1.1	0.4	0.7	0.9	0.5	1.0	0.6	1.0	0.5	1.3	1.1	1.0	0.5	2.6	0.8	1.0	0.4	0.4	1.1	0.7	3.4	1.6	0.9	0.7	1.3	1.0	0.1	0.8	0.9	0.5	1.6	0.3	2.6	0.5	0.9	1.3	0.7	1.2	2.5	1.8	0.6	0.6	0.8	0.7	2.7	1.8	2.0	0.5	1.7	1.5	0.4	0.5	0.8	0.2	0.6	0.0	1.4	3.8	1.4	1.0	3.2	2.5	10.0	1.7	1.9	4.4	2.8	3.4	1.5	0.7	1.8	2.2	1.0	0.7	2.3	5.9	0.5	1.4	1.2	0.7	2.1	1.5	1.7	1.1	1.1	1.0	1.7	1.8	1.2	1.8	4.8	4.3	5.9	4.6	4.8	2.7	5.9	2.9	3.1	4.3	5.9	1.9	2.5	2.8	3.5	5.0	8.4	2.1	3.6	3.5	2.5	3.4	3.4	2.6	3.6	2.9	1.9	1.8	1.3	2.6	3.4	0.5	0.0	1.1	5.5	1.1	0.0	0.5	0.1	1.2	1.1	0.4	0.4	0.0	1.5	5.0	0.0	4.2	0.5	2.0	0.3	0.0	0.5	1.7	1.4	0.9	0.6	0.0	0.4	8.7	0.2	0.4	0.8	1.1	1.1	0.0	0.7	0.0	0.5	0.2	0.0	8.7	0.5	0.0	0.3	0.3	0.9	0.0	1.2	0.0	5.6	0.0	0.1	0.0	4.0	10.3	0.4	0.1	0.0	1.0	0.5	0.0	0.4	3.6	0.8	0.0	0.8	0.4	1.0	0.9	1.0	0.1	1.1	1.0	0.5	0.2	0.8
RBM15	"OTT, OTT1"	ENSG00000162775	"RNA binding motif protein 15"	Q96T37	1	110338506-110346681	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015201, HPA019824, HPA049642"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.57e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.37e-4)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	4.7	4.0	3.3	7.0	4.0	44.7	4.2	10.9	4.1	3.2	4.5	4.3	5.3	3.4	3.4	3.2	3.8	4.2	4.6	4.5	2.5	3.2	7.2	4.2	11.3	3.1	3.0	5.9	4.3	3.7	1.6	5.0	3.3	3.6	3.8	4.9	4.6	2.6	7.0	2.9	4.8	3.6	2.7	7.2	5.4	8.6	3.4	8.6	4.6	6.6	9.6	4.5	2.2	5.6	11.8	12.7	11.2	11.6	7.0	7.2	17.6	6.2	8.1	9.5	12.4	15.7	10.6	22.4	9.7	7.0	7.8	16.4	17.6	15.5	13.9	23.4	16.3	18.1	21.0	11.4	9.6	19.9	18.4	6.6	10.5	13.2	12.3	5.0	10.2	16.6	26.1	38.0	9.6	12.1	18.0	15.4	24.0	10.4	7.1	21.1	17.0	15.3	7.8	11.8	13.4	6.8	13.5	16.7	13.1	11.9	11.6	23.5	7.2	9.1	16.2	9.9	11.4	28.8	15.9	48.0	13.6	19.7	11.4	6.3	3.9	5.6	3.7	3.4	5.3	6.1	4.2	3.3	2.8	5.1	3.5	4.3	5.4	3.1	3.9	2.7	4.5	3.3	3.3	4.0	10.9	4.1	4.5	2.5	3.1	3.0	3.3	2.7	3.4	5.6	9.1	6.4	3.7	21.5	18.3	33.1	9.3	7.3	6.2	5.7	10.8	5.0	12.3	5.7	4.8	3.7	14.6	8.7	12.8	9.1	0.0	4.1	9.6	15.9	14.5	8.4	9.6	10.7	30.0	3.5	7.9	8.1	10.2	18.8	28.6	10.6	11.0	18.5	6.5	0.0	26.2	8.4	0.0	6.8	11.4	6.7	4.1	7.7	8.8	39.4	6.1	3.9	7.2	29.1	31.2	4.3	3.9	5.3	15.5	9.6	8.8	4.5	10.6	7.3	0.0	11.2	12.4	30.6	13.9	9.4	33.8	4.7	14.3	6.5	9.9	8.6
RBM15B	"HUMAGCGB, OTT3"	ENSG00000259956	"RNA binding motif protein 15B"	Q8NDT2	3	51391285-51397908	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036645, HPA058136"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA036645: AB_10671965, HPA058136: AB_2683618"	"unprognostic (2.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.84e-1)"	13.0	10.3	10.2	10.6	9.5	11.1	12.3	8.8	10.5	12.0	7.4	14.4	10.4	16.9	10.6	17.0	12.0	9.3	10.4	9.9	9.5	9.7	9.9	11.5	11.2	9.9	10.1	14.6	17.8	13.8	10.7	8.0	8.9	10.9	11.9	8.2	12.3	11.0	6.1	16.5	13.0	12.2	9.3	11.4	14.6	11.4	9.7	19.7	10.8	7.0	12.2	13.0	10.5	9.6	19.2	16.7	38.2	40.1	33.7	26.2	23.3	17.4	32.2	27.2	22.3	20.8	13.6	27.5	14.1	31.5	30.0	17.3	22.0	31.3	13.1	22.2	17.3	23.9	26.2	17.9	19.7	31.4	13.0	28.6	38.2	25.0	29.5	29.6	28.5	44.3	18.1	18.2	23.6	20.4	54.8	19.8	30.5	17.6	25.9	19.4	16.8	23.5	24.5	45.5	24.7	35.5	22.4	29.5	20.6	25.2	23.4	36.7	26.0	27.7	24.1	23.6	33.3	26.6	25.9	30.3	22.6	24.8	30.2	0.0	1.9	0.7	1.8	2.7	1.9	1.0	2.2	1.9	2.1	2.4	2.2	1.3	0.4	1.7	2.7	2.3	1.1	1.6	10.2	9.5	8.8	10.5	9.9	9.5	9.9	10.1	8.9	9.3	9.7	9.6	16.7	3.2	5.4	4.2	15.2	25.4	38.9	12.6	16.5	18.2	24.9	20.2	17.3	20.0	12.5	14.7	10.4	15.2	19.8	19.9	11.7	19.4	22.4	17.6	17.2	19.1	12.6	19.0	4.4	23.2	20.7	16.7	21.4	19.6	5.1	31.0	17.9	20.5	18.4	15.2	5.1	21.0	12.2	33.1	20.9	10.6	15.8	15.1	7.2	2.8	16.3	14.2	22.6	3.5	5.0	28.2	13.4	15.1	16.4	32.8	15.2	16.5	11.2	15.5	26.3	26.0	21.1	14.9	7.9	28.0	28.1	19.7	16.3	21.0	24.4	36.7
RBM17	"MGC14439, SPF45"	ENSG00000134453	"RNA binding motif protein 17"	Q96I25	10	6089034-6117457	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037477, HPA037478"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037477: AB_10671372, HPA037478: AB_2675494"	"unprognostic (8.55e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.57e-8)"	"unprognostic (3.78e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-2)"	72.4	47.0	46.3	75.3	51.6	139.5	64.4	47.2	53.5	50.2	40.1	57.6	63.8	63.5	38.7	51.9	55.3	52.6	60.8	46.9	52.3	54.6	44.6	78.0	87.4	53.5	49.5	54.7	62.9	45.5	35.8	75.7	52.7	41.5	65.2	41.6	49.9	39.4	95.4	47.0	70.5	60.4	47.3	77.6	51.6	61.9	52.5	87.7	63.3	72.1	85.4	63.5	49.4	52.4	195.9	113.0	141.1	122.7	76.5	69.4	175.5	128.4	58.0	130.2	139.8	184.7	151.2	234.1	89.3	94.4	48.5	188.1	130.3	136.4	138.6	233.7	132.1	199.3	120.4	158.5	96.7	110.0	93.6	71.7	104.0	132.4	72.4	67.9	159.6	168.1	219.0	112.1	84.1	223.6	198.8	66.2	90.3	227.8	81.3	211.4	79.9	120.8	93.5	117.3	60.5	78.9	124.1	110.1	99.0	119.5	146.3	111.3	97.3	76.9	153.4	169.0	138.1	110.2	135.6	386.7	72.0	140.3	51.7	79.7	78.2	102.6	71.6	79.0	75.2	101.8	71.8	73.4	69.9	110.2	71.8	68.1	38.7	77.8	62.3	77.0	101.1	59.8	46.3	51.6	47.2	53.5	46.9	52.3	53.5	49.5	52.7	47.3	52.5	52.4	152.3	89.8	56.0	24.8	107.7	129.2	97.4	72.7	108.7	71.3	68.5	85.3	86.0	65.8	68.1	66.2	50.1	125.6	83.3	80.8	90.1	92.0	90.2	74.7	99.5	123.9	72.7	100.5	42.2	70.9	188.5	89.5	58.6	83.9	96.8	79.7	69.7	65.3	98.8	92.5	41.4	87.1	63.1	73.6	128.6	26.3	66.2	93.9	51.6	38.4	161.5	77.9	96.8	23.6	40.7	88.0	86.4	60.5	153.8	122.3	79.8	75.7	41.3	62.2	72.3	115.6	117.4	266.4	233.3	114.4	108.7	97.0	97.4	78.9	106.5	112.6
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237622-122264840	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA057281: AB_2683394, HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favorable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	9.0	9.5	7.4	6.4	7.9	11.7	16.4	8.0	10.1	8.9	7.3	7.5	7.0	8.8	10.3	7.7	7.4	7.6	13.5	7.8	8.8	11.4	8.4	7.2	8.1	8.2	7.9	9.5	6.9	11.9	5.7	10.4	8.6	11.1	8.1	11.5	7.9	8.3	20.7	6.8	6.1	8.7	8.0	8.0	8.5	3.6	8.0	9.5	10.0	23.1	7.6	8.7	5.4	8.4	8.1	8.3	11.2	12.4	16.1	19.8	9.7	18.0	14.7	12.1	11.2	9.6	7.8	14.1	7.7	11.8	13.3	18.5	17.6	18.7	15.1	14.5	8.0	10.5	12.6	8.2	18.1	21.1	14.0	17.0	20.8	12.7	25.8	12.1	17.6	11.3	14.6	10.7	18.3	8.8	11.1	13.0	8.7	27.2	13.7	9.7	23.2	19.3	16.9	9.0	23.3	12.3	13.6	18.9	21.3	8.8	11.0	11.8	9.8	11.3	6.4	18.3	18.0	15.5	30.7	11.7	18.6	12.9	13.8	4.5	6.2	11.4	6.3	7.2	6.1	5.8	5.5	6.2	6.5	4.0	5.7	6.0	6.5	5.4	9.7	4.6	6.4	5.8	7.4	7.9	8.0	10.1	7.8	8.8	8.2	7.9	8.6	8.0	8.0	8.4	19.7	32.1	12.8	2.0	18.3	21.7	11.7	28.5	19.9	12.4	27.2	20.7	51.6	10.0	23.1	25.8	2.1	32.8	23.3	17.2	27.4	23.2	75.0	14.7	19.9	21.6	19.7	28.4	9.1	16.2	44.7	15.9	13.3	16.4	17.7	14.1	13.6	13.7	27.7	3.3	12.9	16.5	34.6	21.0	17.2	76.9	13.4	18.4	19.6	4.7	20.6	16.9	27.8	6.0	10.7	23.0	18.7	17.0	16.4	20.8	14.8	26.6	19.8	14.7	19.7	15.2	25.4	19.7	22.1	16.5	25.9	56.9	23.5	16.7	14.2	20.7
RBM20		ENSG00000203867	"RNA binding motif protein 20"	Q5T481	10	110644336-110839468	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.8;pancreas: 20.2"	"Cell type enriched"	"Detected in many"	8	"Cardiomyocytes: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.0;HEL: 5.2;K-562: 5.0;RH-30: 16.2;SH-SY5Y: 15.0;SuSa: 4.9;T-47d: 9.2"	"Low region specificity"	"Detected in single"							"HPA035806, HPA070358"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge"		Yes	No				"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus"	"Nucleoli, Cytokinetic bridge"	"HPA035806: AB_10672097, HPA070358: "	"unprognostic (2.43e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.46e-2)"	1.5	0.1	0.8	0.2	2.6	0.1	2.5	0.4	0.8	1.5	1.8	4.1	0.1	2.9	0.6	5.6	2.6	0.4	40.8	0.8	0.4	0.7	0.1	0.9	0.1	0.8	0.9	2.7	20.2	1.2	1.7	1.6	0.6	1.3	0.4	1.2	7.3	0.7	15.6	1.2	0.8	2.2	0.5	0.1	1.0	0.8	0.8	0.5	1.0	3.8	0.6	1.0	5.5	0.7	0.0	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.0	2.5	6.0	5.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	16.2	0.0	0.0	0.0	0.1	15.0	0.1	0.0	0.6	4.9	9.2	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	0.4	0.8	0.8	0.4	0.8	0.9	0.6	0.5	0.8	0.7	0.3	0.0	0.0	0.7	0.2	0.1	0.2	0.4	1.2	1.4	0.8	0.5	151.5	0.0	0.1	0.0	2.1	1.6	0.0	0.7	1.9	0.0	0.8	0.5	1.2	1.5	0.0	0.0	14.8	0.2	0.2	3.3	0.0	0.1	0.0	14.6	1.4	0.0	0.1	0.0	15.4	0.7	2.0	0.0	0.0	0.8	4.4	0.0	0.0	17.8	0.0	0.1	0.0	1.5	0.6	0.0	0.1	13.5	1.0	0.0	2.0	1.5	12.4	2.7	6.6	3.7	5.4	0.5	0.8	3.7	0.0	3.1	0.2	1.7	0.2	0.3
RBM22	"Cwc2, FLJ10290, fSAP47, ZC3H16"	ENSG00000086589	"RNA binding motif protein 22"	Q9NW64	5	150690792-150701077	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001634	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA001634: AB_1079746"	"unprognostic (1.94e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (5.50e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (7.29e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.87e-3)"	20.3	15.8	18.8	19.3	21.1	64.5	22.2	21.8	28.5	21.3	17.4	22.5	19.7	23.5	19.8	16.8	25.4	22.7	20.9	18.9	19.7	21.8	21.3	22.7	29.2	21.0	18.9	30.7	18.1	23.9	10.9	22.6	20.6	17.7	23.4	23.6	16.4	19.6	27.3	18.8	19.0	21.3	20.3	26.7	19.1	11.6	19.6	41.6	22.2	34.3	32.3	26.1	16.0	26.0	34.9	37.3	56.0	66.2	37.2	34.3	79.4	35.0	39.1	68.4	75.7	61.3	50.7	51.7	54.5	33.6	65.1	36.1	73.0	63.3	71.0	57.6	55.6	41.4	35.1	26.3	35.4	74.4	47.0	29.1	50.1	56.5	37.0	30.2	48.9	41.7	44.3	50.7	43.2	41.3	68.4	50.6	33.8	42.2	37.6	69.8	46.4	45.9	34.0	35.6	52.4	39.1	39.3	64.4	65.2	33.4	67.2	64.9	33.0	55.5	43.7	24.3	64.4	46.8	56.0	74.2	44.0	66.3	42.6	27.0	30.6	51.8	33.9	36.7	38.2	37.9	31.4	32.5	36.5	35.9	33.2	31.8	52.8	43.8	46.9	19.7	37.4	33.4	18.8	21.1	21.8	28.5	18.9	19.7	21.0	18.9	20.6	20.3	19.6	26.0	69.4	28.9	28.2	8.5	51.3	26.0	52.9	33.9	42.1	33.3	29.3	25.9	28.2	27.1	35.9	16.5	25.0	54.9	56.6	34.2	25.4	36.3	8.4	48.4	44.1	50.5	25.9	34.9	7.4	34.3	43.6	39.3	24.5	101.6	63.4	37.3	27.8	16.6	44.3	30.3	7.6	33.2	44.7	31.1	30.3	3.6	43.2	45.8	23.2	6.5	48.5	35.9	58.7	7.5	13.7	29.1	37.1	45.5	32.1	25.6	29.4	22.5	23.1	19.0	32.9	40.2	37.6	32.0	28.5	22.8	21.7	72.7	56.9	34.4	33.4	39.4
RBM23	"CAPERbeta, FLJ10482, RNPC4"	ENSG00000100461	"RNA binding motif protein 23"	Q86U06	14	22893204-22919182	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA004144	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"	Nucleoplasm	"HPA004144: AB_1079747"	"unprognostic (5.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-1)"	"prognostic favorable (8.06e-9)"	"unprognostic (4.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.81e-1)"	31.8	37.9	35.8	34.1	38.5	53.2	40.7	55.0	42.0	46.0	48.4	38.3	30.7	53.4	39.3	39.6	59.4	39.1	33.6	35.8	42.9	44.2	40.7	42.0	44.8	38.6	38.5	57.9	39.2	83.2	40.6	46.7	37.0	39.0	41.7	52.2	38.0	40.1	29.1	36.3	37.3	45.9	37.7	45.4	39.2	31.3	43.4	57.9	54.5	40.7	50.6	43.5	37.7	45.0	55.9	86.3	86.6	45.4	46.5	39.6	36.1	59.9	81.3	114.0	88.8	39.6	66.6	93.0	45.8	55.8	54.8	77.3	98.3	50.3	92.2	73.1	81.2	43.7	65.8	2.8	72.9	84.6	68.9	51.0	68.3	65.8	43.4	63.4	64.4	45.5	56.5	58.3	56.6	71.1	93.8	38.0	38.7	84.8	80.3	80.1	71.8	56.6	44.0	78.0	59.5	66.3	89.8	68.8	38.6	56.6	50.8	49.6	59.8	19.3	33.3	47.5	56.1	55.1	77.0	87.6	32.4	48.2	71.7	40.1	47.7	50.7	37.1	37.0	25.1	29.3	26.3	32.2	49.5	34.7	31.5	28.2	136.6	59.7	49.7	24.6	30.0	32.0	35.8	38.5	55.0	42.0	35.8	42.9	38.6	38.5	37.0	37.7	43.4	45.0	36.8	44.8	48.3	12.1	82.3	18.4	44.7	28.4	27.9	66.4	38.7	35.9	24.3	68.6	42.7	33.1	116.7	53.0	53.8	48.8	45.0	36.3	9.5	55.1	36.8	39.5	65.4	54.1	13.5	33.5	48.0	32.0	36.7	41.4	70.9	27.2	53.2	37.2	31.5	50.5	16.1	39.3	20.3	54.9	33.6	11.9	35.4	40.4	16.0	19.7	70.8	52.4	102.0	18.6	15.3	39.7	55.1	28.2	42.2	29.1	57.3	33.1	64.0	164.2	32.9	47.8	32.1	52.0	64.3	22.0	21.0	101.4	64.0	28.1	42.3	27.8
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281361-17293871	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 142.1;skeletal muscle: 313.0;tongue: 105.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 193.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	5.4	0.5	3.7	1.7	4.1	0.1	3.7	0.1	5.7	13.9	2.5	9.7	1.6	31.2	16.8	7.4	24.0	2.6	142.1	4.5	4.9	0.9	1.1	1.3	0.5	1.6	1.9	2.1	0.2	2.1	5.5	0.6	0.7	9.9	7.4	0.4	4.1	5.8	313.0	1.4	3.6	29.3	0.6	1.2	2.1	4.2	3.0	0.8	2.1	105.7	0.3	8.8	3.6	2.2	1.5	9.3	12.0	0.0	0.0	0.0	0.0	18.7	6.8	12.4	13.0	0.0	1.1	0.0	5.7	13.4	19.5	0.0	11.5	0.4	22.3	0.0	0.4	0.0	1.0	6.4	0.5	0.0	1.1	6.4	0.0	2.4	0.5	15.8	1.6	0.0	0.0	0.0	58.7	2.8	0.0	0.2	4.1	0.0	1.4	0.1	59.7	0.0	0.0	0.0	7.8	0.9	0.2	0.0	0.2	9.3	28.2	0.4	0.0	4.2	10.0	0.0	16.2	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.1	0.1	5.7	4.5	4.9	1.6	1.9	0.7	0.6	3.0	2.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	1.1	0.0	2.3	3.2	0.8	193.2	0.0	1.8	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.6	33.5	13.6	1.5	4.8	0.0	11.6	0.0	13.4	6.4	0.0	9.9	1.3	0.5	0.4	0.0	0.3	1.7	6.6	4.5	0.0	0.0	0.7	1.9	0.0	0.3	1.8	1.9	0.0	0.7	0.0	0.5	0.4	0.3	2.2	0.7	0.0	0.3	0.0	0.6	21.9	0.0	6.6	23.9	19.7	0.4	7.3	0.2	1.0	0.8	0.5	0.0	3.0	0.1
RBM3	IS1-RNPL	ENSG00000102317	"RNA binding motif protein 3"	P98179	X	48574449-48581162	"Predicted intracellular proteins"	"Stress response"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 1442.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			"HPA003624, CAB062559"	Enhanced		Enhanced	Nucleoplasm		NA	NA		130000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"CAB062559: AB_2665621, HPA003624: AB_10602123"	"unprognostic (1.07e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.07e-7)"	"unprognostic (1.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	246.8	129.7	21.7	143.2	23.7	301.8	200.9	23.0	33.2	82.3	27.5	122.4	102.1	118.2	89.4	147.1	101.7	71.9	100.7	22.3	27.9	89.2	71.1	130.5	158.5	27.9	24.0	99.3	167.2	94.2	80.1	104.0	26.5	75.7	146.0	51.4	126.0	81.8	112.3	195.3	102.6	114.9	28.7	128.5	114.2	55.9	23.4	156.9	90.1	38.3	206.1	135.0	101.7	29.3	128.2	168.7	172.5	187.3	42.4	226.3	117.2	156.0	272.3	381.6	273.6	173.7	322.5	241.4	50.0	302.3	75.9	107.1	153.2	209.1	304.1	236.5	206.7	126.2	270.5	164.0	153.0	360.8	248.0	168.1	143.8	129.7	124.3	46.2	320.4	131.7	69.8	194.6	268.6	215.9	304.9	209.3	100.5	33.3	230.1	280.7	181.4	196.5	177.7	201.8	70.1	179.1	152.2	206.9	187.5	83.7	272.2	363.6	440.7	127.0	213.0	425.8	278.2	93.7	114.0	279.1	176.5	208.0	263.0	33.0	187.0	30.7	118.4	211.9	141.7	147.5	120.6	119.7	264.1	101.5	120.6	119.5	28.7	150.9	187.0	185.0	137.5	256.3	21.7	23.7	23.0	33.2	22.3	27.9	27.9	24.0	26.5	28.7	23.4	29.3	336.2	166.7	172.1	18.6	391.7	519.4	182.9	379.4	157.6	58.9	326.1	260.5	76.8	154.4	196.7	53.3	47.9	459.9	392.1	165.8	176.1	482.2	6.0	114.6	193.8	292.9	247.4	287.0	18.4	1442.0	726.9	274.2	164.1	234.3	265.2	144.9	195.9	74.6	433.2	42.1	17.7	360.2	136.3	439.5	783.6	17.1	245.7	339.3	522.9	18.7	571.7	181.8	358.4	15.1	18.0	915.3	235.9	147.4	317.7	119.0	143.3	164.3	84.6	87.0	131.5	378.4	299.4	43.6	200.8	285.2	507.8	489.3	352.5	178.2	368.0	202.6
RBM33	"DKFZp434D1319, DKFZp686F102, MGC20460, PRR8"	ENSG00000184863	"RNA binding motif protein 33"	Q96EV2	7	155644451-155781485	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019232, HPA021497, HPA021768"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA019232: AB_1856121, HPA021497: AB_2176261, HPA021768: AB_1856123"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (3.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.89e-2)"	"unprognostic (8.90e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (4.29e-4)"	25.4	19.3	14.4	15.2	14.4	62.2	23.3	39.8	18.9	26.8	6.7	24.8	14.0	22.3	17.1	24.3	20.5	8.8	20.1	11.9	20.3	22.7	32.1	30.1	18.8	16.6	11.6	26.1	30.1	8.1	28.3	10.6	14.7	23.0	12.7	33.7	23.0	9.4	30.9	30.5	31.1	9.5	3.7	30.2	26.9	16.9	16.7	31.5	24.5	10.1	15.6	19.4	28.2	23.8	31.9	37.0	22.7	21.1	12.0	15.6	22.9	19.8	14.0	12.0	17.3	34.2	30.0	35.1	25.9	14.7	32.5	22.5	20.8	16.7	15.9	33.3	29.0	33.5	41.7	22.7	13.2	47.7	32.5	15.3	19.3	19.2	27.3	17.4	21.4	38.8	43.6	28.3	17.2	31.1	49.4	40.8	24.4	21.4	23.3	39.2	25.4	29.4	17.4	34.1	23.0	23.5	33.2	21.7	18.0	17.0	16.6	24.8	24.8	20.2	11.9	36.6	26.6	48.8	40.7	52.4	32.7	30.5	26.4	33.5	10.4	23.1	6.6	10.5	5.4	9.5	6.6	8.2	9.1	7.7	6.1	7.8	37.2	9.1	8.3	9.0	9.3	4.2	14.4	14.4	39.8	18.9	11.9	20.3	16.6	11.6	14.7	3.7	16.7	23.8	36.3	32.1	36.4	68.2	52.3	19.6	20.4	19.7	33.6	57.6	22.2	19.8	30.2	14.3	17.0	3.7	83.4	18.1	60.3	32.4	7.9	20.1	25.6	25.9	43.7	27.6	26.3	37.2	86.8	18.0	17.4	26.0	45.3	43.0	39.2	38.9	17.5	30.0	15.9	132.9	85.5	28.1	16.2	28.3	24.4	42.0	26.1	39.3	12.4	87.1	42.9	23.0	42.2	97.0	115.0	23.5	28.5	17.7	93.1	33.3	37.1	18.2	19.2	91.5	13.1	37.5	31.5	29.5	24.4	26.3	23.4	26.1	53.0	33.9	24.0	36.5
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161283	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoli	"Nucleoplasm, Mitotic chromosome"	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	12.2	10.3	11.7	15.0	12.5	35.5	17.0	12.1	13.7	10.0	12.3	12.4	17.9	11.5	15.6	13.9	10.9	12.2	15.5	11.8	12.6	17.1	14.8	11.9	23.2	13.3	12.5	12.8	13.1	9.2	8.7	13.2	13.1	12.0	14.1	6.3	19.9	7.4	19.7	18.2	15.8	11.6	13.1	12.7	14.3	21.3	12.5	16.3	15.6	12.3	20.6	15.7	9.6	13.5	28.6	20.9	23.8	28.8	17.9	33.3	52.8	29.3	24.6	29.4	30.1	26.9	33.7	49.4	29.9	21.0	22.1	40.5	29.0	28.9	28.2	44.4	47.8	35.7	17.0	20.1	35.1	60.4	34.5	28.0	33.2	26.5	19.6	26.5	26.8	50.5	54.5	23.7	38.7	18.0	49.9	48.3	65.3	43.8	15.8	48.0	23.2	57.3	29.5	22.7	26.2	47.1	39.2	27.0	66.4	17.0	55.2	63.5	21.0	26.2	23.0	36.1	59.9	27.8	47.5	47.4	30.8	38.0	40.8	113.9	36.0	44.1	46.1	42.5	55.6	74.1	53.0	59.8	37.2	54.5	49.0	57.4	18.3	58.2	46.4	59.5	77.5	51.5	11.7	12.5	12.1	13.7	11.8	12.6	13.3	12.5	13.1	13.1	12.5	13.5	4.3	19.2	12.8	12.1	11.9	3.2	10.0	7.3	10.2	2.6	6.3	3.7	3.4	7.2	9.1	3.7	10.4	6.2	19.3	4.1	5.9	6.6	7.2	3.2	5.1	6.9	7.8	3.8	10.6	6.2	4.5	10.3	4.6	6.0	23.4	8.0	6.1	3.6	3.3	0.0	11.5	2.7	8.2	5.4	3.2	7.9	4.1	7.1	3.6	15.9	9.4	4.0	23.7	10.1	11.9	8.6	9.6	5.7	10.2	5.3	5.3	12.8	10.7	5.7	0.0	5.0	4.4	7.1	5.3	8.0	3.8	6.2	16.2	3.3	4.5	7.7
RBM38	"dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D"	ENSG00000132819	"RNA binding motif protein 38"	Q9H0Z9	20	57391396-57409333	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 136.4;skeletal muscle: 221.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 110.9;dendritic cells: 156.9;Erythroid cells: 280.4"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 95.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 140.6;U-698: 150.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB017036	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB017036: "	"unprognostic (1.03e-1)"	"prognostic favorable (3.64e-7)"	"unprognostic (3.71e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.04e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.13e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.83e-1)"	11.7	10.7	6.7	26.6	9.4	136.4	12.8	13.3	10.3	18.8	15.1	96.6	8.7	38.4	0.9	16.8	28.9	5.1	72.6	5.9	6.4	16.3	16.4	21.0	43.4	8.6	11.5	27.8	10.8	1.9	12.2	5.5	8.0	27.0	4.1	0.6	19.7	11.9	221.7	9.1	39.8	8.7	6.6	65.8	23.0	38.1	9.4	26.6	9.4	32.7	12.2	42.9	13.6	7.9	20.1	20.4	9.7	25.1	0.0	1.6	56.3	6.5	1.6	13.5	3.5	84.2	20.6	140.6	54.1	1.9	13.2	18.3	8.0	8.0	2.1	29.0	34.5	118.0	7.6	52.6	6.0	57.8	54.2	1.9	3.8	5.7	1.1	1.9	9.2	52.5	100.9	24.6	1.6	87.8	42.7	58.5	36.9	10.7	25.5	82.0	23.6	114.2	10.1	9.2	40.9	26.3	15.2	50.5	24.7	8.7	28.3	79.4	17.0	4.4	42.6	6.0	27.6	60.1	86.8	150.7	1.1	40.3	4.2	0.0	0.5	2.2	3.1	1.8	1.9	3.2	2.5	2.1	1.0	3.3	3.0	2.8	0.7	3.5	1.7	1.3	4.7	2.1	6.7	9.4	13.3	10.3	5.9	6.4	8.6	11.5	8.0	6.6	9.4	7.9	13.9	3.2	5.2	10.1	110.9	9.1	28.3	7.9	13.6	1.0	15.8	21.0	42.5	8.6	6.6	1.8	0.0	1.9	156.9	41.6	9.8	6.2	4.2	54.2	5.2	11.9	62.8	280.4	2.5	5.0	5.8	8.8	12.2	21.5	8.8	31.5	10.4	6.0	9.6	0.0	1.3	56.4	12.2	8.1	18.9	4.0	4.4	27.6	1.8	2.8	5.8	12.8	54.6	4.5	4.6	5.9	35.4	6.0	52.8	18.8	2.8	16.4	22.5	1.4	6.6	20.6	7.6	2.4	13.2	9.1	8.4	2.3	81.0	13.3	34.0	18.5
RBM39	"CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2"	ENSG00000131051	"RNA binding motif protein 39"	Q14498	20	35701347-35742312	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001591	Supported		Supported	"Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite"		NA	NA		19000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Microtubules, Centriolar satellite"	"HPA001591: AB_1079749"	"unprognostic (1.37e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.28e-3)"	70.1	55.8	18.4	37.7	17.6	172.0	44.6	33.5	28.0	57.8	22.2	56.0	35.1	54.5	9.2	62.3	61.4	40.8	57.3	16.5	25.0	52.2	47.7	62.2	42.3	24.2	24.0	71.1	41.2	27.3	50.0	40.9	19.4	50.2	16.9	49.5	53.4	22.3	70.3	51.2	46.9	19.2	16.0	56.4	49.7	34.3	16.9	51.1	54.2	33.1	24.1	50.7	62.1	26.5	98.8	87.6	77.0	78.5	48.8	53.8	78.8	131.0	50.6	59.6	60.2	109.3	78.5	137.5	90.6	38.9	67.9	91.2	122.3	67.9	66.5	94.6	96.7	174.6	80.7	101.2	23.4	158.6	99.9	14.4	97.6	68.9	38.4	63.7	57.8	46.4	195.5	117.6	46.3	72.2	194.5	87.9	103.2	87.5	96.8	104.9	136.2	91.7	41.5	56.2	77.9	63.4	91.1	94.7	78.4	109.3	70.6	94.6	91.4	100.8	92.5	90.5	115.8	71.6	164.3	204.0	64.7	123.2	79.2	250.9	120.4	197.5	104.7	111.1	103.6	131.1	91.5	97.6	111.8	140.5	85.7	82.1	427.7	127.2	102.2	160.9	114.7	95.7	18.4	17.6	33.5	28.0	16.5	25.0	24.2	24.0	19.4	16.0	16.9	26.5	302.0	233.9	280.9	144.3	441.7	616.4	521.0	283.0	284.0	258.5	339.1	295.4	189.2	191.6	267.6	200.5	316.9	375.2	624.9	278.1	189.8	203.8	48.1	359.2	496.0	299.7	295.3	214.2	130.1	186.0	389.6	337.9	254.9	540.8	525.8	304.4	215.3	202.1	199.8	220.4	120.9	331.3	215.7	207.7	469.5	41.9	262.5	335.5	270.3	129.3	274.3	208.7	400.6	136.2	160.5	221.3	254.8	214.4	391.0	453.6	271.8	150.6	248.0	386.5	164.3	504.0	410.2	263.5	228.1	215.8	586.9	561.6	490.8	218.2	282.8	532.1
RBM4	"LARK, RBM4A, ZCCHC21, ZCRB3A"	ENSG00000173933	"RNA binding motif protein 4"	Q9BWF3	11	66638667-66668374	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042174, HPA047849"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (8.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.07e-3)"	82.6	111.5	60.8	71.0	63.3	131.5	75.8	81.1	66.7	90.8	69.4	96.1	67.8	87.1	90.3	100.3	79.4	59.0	75.6	61.5	67.1	119.8	82.3	77.4	97.5	59.0	58.5	103.6	115.5	77.2	86.1	72.8	58.9	95.9	62.6	74.4	89.1	60.0	96.6	80.9	83.6	69.1	61.1	104.8	98.4	74.3	69.5	109.8	85.7	72.4	99.1	84.2	84.1	65.4	127.2	163.6	246.5	136.4	90.1	95.6	153.9	128.6	106.1	134.1	97.3	281.5	160.9	161.1	174.4	132.3	120.5	136.4	263.5	159.1	142.9	162.1	138.4	220.7	163.5	170.3	173.1	152.8	91.9	138.8	134.3	158.6	213.9	136.4	184.3	155.0	180.1	115.0	147.3	263.3	252.9	157.9	309.7	246.8	176.0	234.2	224.6	181.7	180.7	199.5	204.5	149.5	227.1	168.6	379.9	163.8	315.3	154.4	180.9	140.4	124.0	86.5	107.3	143.9	162.5	258.8	109.9	118.3	205.8	210.0	119.4	131.3	135.5	123.2	122.3	119.3	139.8	149.9	116.2	130.4	147.5	149.8	137.5	155.4	144.0	103.6	194.3	159.1	60.8	63.3	81.1	66.7	61.5	67.1	59.0	58.5	58.9	61.1	69.5	65.4	19.7	28.9	42.2	8.1	64.0	17.8	61.4	36.3	112.7	58.2	24.2	12.7	4.6	15.7	36.5	20.2	93.8	36.2	48.7	16.6	15.6	25.1	39.8	26.6	28.0	28.5	34.7	42.5	23.9	23.1	30.1	33.6	53.0	30.7	36.8	38.1	25.7	11.1	14.5	62.2	21.4	15.5	32.6	18.8	29.2	9.3	27.4	27.5	19.6	7.5	28.8	15.9	69.0	15.1	18.8	19.6	23.6	20.3	60.2	62.6	32.9	10.6	41.1	90.0	19.7	29.7	28.3	41.1	40.1	68.6	22.3	43.8	66.3	42.4	24.8	65.5
RBM42	MGC10433	ENSG00000126254	"RNA binding motif protein 42"	Q9BTD8	19	35629030-35637686	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 384.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043671	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA043671: AB_10794890"	"unprognostic (4.77e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.26e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.33e-2)"	57.6	48.0	34.9	24.5	39.8	38.2	54.3	41.3	41.5	56.1	30.9	60.6	27.5	65.2	12.0	58.5	53.8	11.8	60.8	35.1	36.3	57.5	54.0	46.5	24.1	43.8	38.0	54.8	39.6	23.1	41.4	23.2	38.7	55.2	10.7	9.1	44.2	24.9	76.0	67.3	46.3	14.5	37.6	51.7	49.7	41.5	38.0	25.9	49.9	21.6	15.5	58.0	50.8	42.9	115.6	176.5	38.8	52.9	34.6	27.0	104.8	77.2	41.8	88.3	69.0	105.0	72.8	63.7	137.8	49.4	48.2	46.6	44.8	54.0	26.0	165.6	80.0	87.8	57.7	87.5	88.8	78.5	81.1	38.6	42.3	65.4	36.0	28.4	48.8	65.3	92.9	50.8	40.5	130.5	99.9	103.1	44.4	103.1	71.9	107.7	52.9	63.8	43.0	52.6	50.5	73.3	87.8	71.5	62.4	21.1	57.0	122.0	76.2	63.1	86.4	84.4	136.6	123.0	140.7	99.1	60.9	73.8	90.2	98.8	79.6	124.5	82.8	95.6	70.9	76.2	67.8	83.1	94.3	81.3	59.4	67.1	73.9	79.3	94.5	87.6	82.6	73.3	34.9	39.8	41.3	41.5	35.1	36.3	43.8	38.0	38.7	37.6	38.0	42.9	56.5	38.5	24.6	4.6	38.4	51.9	52.6	94.3	43.9	23.3	31.2	37.5	14.7	40.0	57.4	53.3	12.5	197.9	47.0	67.2	74.3	78.0	38.4	41.0	35.4	50.9	52.1	43.8	2.3	90.4	101.5	47.0	38.7	41.6	51.4	46.0	46.8	31.6	91.2	10.1	2.6	56.4	54.9	31.1	60.9	16.3	58.1	40.9	53.4	2.8	63.0	46.5	27.8	3.5	5.8	80.6	48.9	63.2	43.7	31.8	72.3	78.0	44.5	19.8	52.6	34.5	92.4	71.9	52.9	36.2	43.5	384.3	44.9	44.3	64.7	45.4
RBM43	"C2orf38, FLJ45645"	ENSG00000184898	"RNA binding motif protein 43"	Q6ZSC3	2	151247940-151261863	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.4;HSkMC: 18.5"	"Low region specificity"	"Detected in all"							HPA038204	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Nucleoplasm	"HPA038204: AB_10669520"	"unprognostic (3.50e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.94e-2)"	5.2	8.7	2.4	4.2	2.3	6.7	6.9	1.6	2.3	7.5	3.5	4.2	3.0	7.6	9.4	3.2	12.3	6.8	3.2	2.1	2.7	7.0	6.7	6.1	6.9	2.9	2.9	15.4	4.0	5.1	2.9	5.7	2.3	6.5	4.4	1.8	5.2	7.7	3.4	4.7	3.9	5.7	2.8	7.9	4.6	3.6	2.9	7.0	12.3	2.5	4.7	3.8	3.1	3.0	3.5	2.2	3.5	4.7	9.4	20.4	2.3	4.0	9.2	5.0	7.2	0.1	5.7	2.7	1.5	7.3	2.7	1.7	1.1	4.6	2.5	4.2	2.5	6.6	1.0	0.2	9.1	8.2	2.2	18.5	5.0	4.0	3.0	7.4	10.7	2.9	2.7	3.0	6.8	3.5	4.7	3.9	1.3	0.1	4.2	3.2	4.1	1.6	8.4	3.0	1.3	4.2	3.8	2.8	7.8	0.6	4.1	5.2	6.1	3.7	3.3	3.2	1.7	1.1	0.8	0.0	9.7	3.3	2.3	1.0	0.7	3.0	1.2	0.9	2.0	1.2	1.6	1.5	0.5	1.3	2.0	1.5	0.8	2.7	2.4	0.2	0.8	0.6	2.4	2.3	1.6	2.3	2.1	2.7	2.9	2.9	2.3	2.8	2.9	3.0	26.5	3.2	8.9	2.9	9.6	3.3	3.2	5.8	5.7	6.7	8.6	14.9	2.6	11.5	5.7	18.4	0.0	6.8	8.4	1.7	27.4	6.8	3.0	30.9	17.2	16.9	6.1	8.8	1.0	5.9	4.7	21.8	5.6	9.4	3.8	13.4	20.7	9.1	5.1	6.7	1.3	6.9	4.1	10.4	4.3	2.4	28.0	8.2	3.6	2.8	12.3	22.1	13.4	4.0	0.9	4.6	5.6	29.0	5.5	2.8	5.5	18.2	26.3	1.3	0.0	18.4	13.0	0.5	3.6	7.3	3.1	1.4	13.5	30.4	3.7	2.2
RBM45	"DRB1, FLJ44612"	ENSG00000155636	"RNA binding motif protein 45"	Q8IUH3	2	178112424-178139011	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020448	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA020448: AB_1856133"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (5.74e-9)"	"unprognostic (1.66e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (5.34e-9)"	"unprognostic (3.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-1)"	4.8	6.5	12.5	5.5	12.9	4.1	8.5	12.4	18.4	5.6	12.7	8.3	5.9	6.3	9.2	6.1	7.3	4.7	6.4	12.6	12.9	6.5	8.1	5.4	8.1	12.9	12.5	5.7	7.9	8.8	6.4	3.3	12.8	5.8	9.3	9.8	6.2	5.2	4.8	8.2	6.7	5.7	12.6	7.8	6.5	6.6	12.6	8.9	7.0	3.2	9.9	5.6	5.1	13.3	9.5	10.1	15.7	6.5	13.6	15.7	9.8	12.8	14.5	12.9	14.2	10.7	7.7	15.8	8.4	15.3	12.9	8.4	13.1	16.7	15.7	12.7	11.2	12.2	6.3	16.1	14.3	14.9	11.6	12.7	13.7	13.2	11.0	12.5	13.7	8.7	11.5	12.6	16.2	15.1	15.5	10.0	11.1	14.2	12.8	12.4	11.1	15.7	19.0	21.8	9.7	10.1	9.0	8.8	11.8	17.7	12.9	13.9	11.7	9.1	8.6	10.7	12.7	11.7	14.4	20.3	8.9	11.9	12.8	3.8	5.3	1.9	6.2	8.6	7.1	12.5	6.5	6.8	7.2	8.6	5.9	7.3	1.0	11.3	10.2	7.7	10.9	5.3	12.5	12.9	12.4	18.4	12.6	12.9	12.9	12.5	12.8	12.6	12.6	13.3	5.2	3.2	4.2	8.5	6.3	2.5	3.5	11.3	5.2	7.1	4.3	3.6	4.2	8.6	6.6	1.8	10.4	5.6	8.1	5.0	7.9	7.3	3.8	4.8	5.4	5.9	6.0	8.6	10.2	6.6	10.3	5.7	7.7	3.5	8.2	8.2	3.3	5.1	8.2	10.1	13.1	7.6	4.1	8.1	3.3	4.3	4.4	5.3	1.8	6.5	8.1	7.6	6.2	15.1	13.7	5.2	6.5	5.7	8.0	1.7	6.1	7.0	9.6	9.1	6.6	6.1	6.1	11.4	5.6	6.2	3.4	1.8	6.2	9.1	4.9	2.7
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 442.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 136.2"	"Group enriched"	"Detected in many"	12	"dendritic cells: 34.4;granulocytes: 136.2;monocytes: 45.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 134.0;CAPAN-2: 63.5;OE19: 56.7;SK-BR-3: 58.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA006347	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	9.3	49.7	2.2	20.3	1.9	9.6	24.7	1.8	3.0	15.3	44.9	61.0	68.4	3.5	23.1	42.2	17.7	17.9	1.3	2.8	2.3	67.6	34.5	21.0	8.2	6.0	3.2	2.2	25.9	27.8	3.2	20.1	4.9	33.2	50.5	0.4	59.4	13.4	0.5	9.0	64.1	4.7	4.1	14.7	64.6	6.7	5.7	4.4	49.5	1.1	11.4	22.6	15.5	6.8	31.9	47.8	0.0	1.8	0.2	0.0	134.0	0.8	1.6	0.1	0.6	28.3	63.5	0.2	23.0	1.2	3.8	14.2	0.9	11.8	0.3	0.2	7.6	0.0	3.1	7.9	0.6	0.3	0.3	0.8	6.0	0.1	0.1	1.8	0.0	0.0	1.8	7.0	0.1	18.1	0.2	1.1	13.5	56.7	2.4	0.2	0.0	34.7	46.8	41.6	1.6	0.3	17.3	58.4	0.3	14.8	23.9	9.0	0.0	0.5	1.9	0.3	1.0	23.5	37.7	4.1	5.0	3.9	0.2	0.5	45.5	0.5	0.2	33.1	0.3	5.9	0.2	0.1	34.4	5.4	0.4	0.1	136.2	0.5	26.2	14.1	0.2	16.9	2.2	1.9	1.8	3.0	2.8	2.3	6.0	3.2	4.9	4.1	5.7	6.8	1.1	80.1	116.6	0.7	21.2	58.9	75.2	42.9	95.0	0.1	145.7	63.5	1.9	75.8	92.2	112.2	0.0	99.6	16.3	442.8	64.6	90.6	1.3	132.6	9.5	6.0	121.9	2.5	2.5	115.4	84.3	7.7	174.8	143.7	7.0	8.7	23.6	140.4	92.6	1.7	1.9	234.2	59.0	138.8	92.8	2.6	2.5	119.9	37.4	82.4	80.6	0.3	1.0	2.5	0.8	108.0	228.1	1.2	40.1	164.7	218.1	143.6	118.3	0.1	0.0	1.4	5.1	2.6	10.4	178.1	75.4	262.6	4.8	16.9	203.8	295.4
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92540481	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	8.3	8.6	8.2	5.6	9.4	14.1	8.2	10.1	12.1	9.0	6.5	8.0	5.3	8.2	4.8	7.6	8.4	3.8	10.0	8.5	7.5	7.4	9.0	6.4	8.4	9.0	7.7	9.8	8.5	4.6	7.5	4.6	9.1	8.2	4.6	6.5	8.3	3.3	13.5	8.0	9.0	3.7	7.3	11.3	8.0	8.9	8.5	6.5	8.4	7.0	6.4	7.3	8.3	12.1	5.5	4.0	6.8	11.1	6.5	7.3	5.4	6.5	5.2	6.4	6.1	4.9	6.9	8.0	11.8	4.4	9.9	6.2	6.6	4.6	7.9	7.8	9.4	5.3	12.0	5.8	5.2	10.2	7.1	5.2	8.5	7.2	6.5	8.9	6.9	10.1	11.5	13.1	6.9	5.6	12.1	10.1	6.1	6.9	5.8	6.5	6.1	9.8	5.9	5.9	7.6	9.9	5.7	11.6	8.6	8.3	3.7	8.5	4.4	11.7	6.3	9.1	8.9	8.6	11.1	13.3	5.3	8.6	11.0	67.8	12.4	30.3	23.2	16.3	25.7	28.5	25.1	23.7	12.3	28.7	32.1	27.3	19.2	26.2	13.3	14.3	25.7	16.0	8.2	9.4	10.1	12.1	8.5	7.5	9.0	7.7	9.1	7.3	8.5	12.1	13.5	12.8	7.5	8.1	23.5	8.5	13.2	11.9	12.5	12.7	8.7	7.7	16.7	5.7	10.9	3.7	0.0	10.9	18.8	6.9	7.9	9.2	9.4	9.5	12.3	13.8	0.0	8.6	20.5	6.0	5.8	11.7	6.6	12.9	30.4	11.9	7.9	3.7	6.2	11.8	15.8	4.0	14.2	6.8	6.4	5.9	5.9	8.1	5.4	5.6	9.8	11.5	26.8	11.1	34.3	5.5	6.2	6.4	16.6	10.5	7.0	9.6	7.8	13.2	13.1	15.0	13.7	24.0	15.5	9.9	11.4	15.3	18.9	8.4	5.7	11.8
RBM4B	"MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B"	ENSG00000173914	"RNA binding motif protein 4B"	Q9BQ04	11	66664998-66677887	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042174, HPA047849"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.71e-2)"	8.1	16.2	25.9	11.1	26.2	4.9	10.7	36.5	31.5	21.9	23.2	15.2	10.0	19.8	20.4	13.7	18.7	10.4	10.9	25.7	27.7	15.2	14.3	9.4	16.1	25.2	24.9	30.0	13.6	13.1	23.6	13.1	25.3	18.6	12.0	34.5	15.3	14.9	16.3	18.8	14.5	14.5	24.7	15.6	12.6	16.2	26.2	13.3	16.1	15.3	17.3	14.0	15.5	29.9	21.3	21.0	45.1	37.7	21.7	22.3	15.3	19.9	20.0	21.9	22.3	29.5	21.9	23.8	27.9	25.5	21.5	27.2	30.1	27.7	23.2	23.0	20.4	25.7	26.6	31.9	15.9	26.4	24.4	23.3	18.6	22.5	19.1	25.1	21.5	19.0	20.0	23.1	29.8	34.3	16.5	20.4	26.7	47.8	27.9	33.4	35.8	24.4	20.2	21.1	27.7	25.2	23.9	12.1	47.3	28.8	32.3	24.7	20.1	24.1	24.6	23.7	18.3	11.2	20.5	24.2	22.2	18.4	21.7	26.4	15.1	43.9	16.1	22.6	15.7	34.6	14.9	15.8	18.2	28.9	18.1	13.5	9.8	22.6	25.9	15.1	12.2	13.8	25.9	26.2	36.5	31.5	25.7	27.7	25.2	24.9	25.3	24.7	26.2	29.9	7.5	12.8	5.9	15.3	25.9	8.0	14.7	29.8	24.5	36.3	14.4	13.6	6.9	12.8	15.9	18.4	33.3	36.5	11.5	8.1	11.7	11.9	26.5	13.4	12.8	9.5	19.2	12.0	20.0	5.8	16.5	14.9	11.2	11.7	8.9	17.0	12.8	9.0	13.0	25.2	25.8	11.7	26.4	9.8	6.1	53.9	18.3	9.8	16.0	11.2	10.5	23.3	13.4	29.1	31.1	4.7	12.4	13.5	13.4	7.0	21.2	13.4	22.6	60.4	6.6	12.0	14.2	50.8	42.8	13.6	7.1	22.2	14.6	12.2	10.9	5.7
RBM5	"H37, LUCA-15, LUCA15"	ENSG00000003756	"RNA binding motif protein 5"	P52756	3	50088919-50119021	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017335, HPA018011"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA017335: AB_1856134, HPA018011: AB_1856135"	"unprognostic (4.11e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.61e-3)"	"prognostic unfavorable (9.77e-4)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.58e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.89e-3)"	70.6	53.9	42.2	44.2	45.4	63.5	69.8	48.4	49.6	96.2	47.9	74.8	37.4	74.6	64.0	57.5	85.8	40.1	58.0	41.1	52.5	66.2	58.1	61.8	66.8	46.5	42.5	120.2	73.1	45.2	84.7	60.1	46.2	85.2	47.7	90.5	63.9	47.2	63.6	81.6	72.1	53.7	40.9	95.2	64.8	62.9	44.1	62.5	80.8	36.4	69.5	66.6	73.2	62.5	31.1	37.3	132.6	58.2	54.3	78.1	31.3	91.9	54.8	67.0	46.9	37.6	34.7	72.4	31.0	60.3	65.6	26.8	90.4	44.5	71.5	67.5	33.2	91.0	136.5	34.2	66.7	84.1	71.0	70.1	49.8	72.7	71.3	114.5	71.9	72.5	63.3	47.4	63.7	27.3	85.6	56.9	47.9	52.3	42.3	46.3	57.9	37.6	48.7	152.1	19.0	43.8	75.6	32.8	46.2	89.5	30.2	79.9	82.0	44.3	45.9	61.7	53.7	64.8	103.2	76.4	32.9	50.8	52.3	54.3	21.4	29.2	24.8	22.2	23.3	20.5	22.2	25.9	18.4	19.6	27.9	22.3	39.0	22.9	22.6	13.9	28.5	17.0	42.2	45.4	48.4	49.6	41.1	52.5	46.5	42.5	46.2	40.9	44.1	62.5	70.1	70.5	103.3	108.7	69.9	32.0	39.8	31.1	27.3	94.4	43.9	44.2	44.5	25.8	68.2	38.6	183.5	52.5	77.0	51.3	11.7	27.3	128.2	52.4	67.9	67.9	73.5	40.2	100.8	20.9	26.2	54.4	74.5	47.8	68.9	85.1	60.3	40.0	32.4	94.2	107.1	53.7	50.8	42.2	48.4	246.2	64.3	56.4	44.4	96.5	66.9	43.2	75.2	117.6	136.0	30.8	45.8	57.9	64.5	49.5	42.4	11.3	84.0	126.1	32.9	62.4	57.1	57.8	33.0	31.1	34.0	81.7	68.1	52.2	44.7	55.5
RBM7		ENSG00000076053	"RNA binding motif protein 7"	Q9Y580	11	114400030-114414203	"Predicted intracellular proteins"	Meiosis	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 196.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013993, HPA048003"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA013993: AB_1856137, HPA048003: AB_2680231"	"unprognostic (2.90e-3)"	"unprognostic (8.21e-3)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.38e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	18.5	9.1	3.4	6.5	5.3	39.8	15.3	7.6	7.8	12.9	3.6	13.1	6.2	13.9	4.9	13.3	13.9	10.5	9.9	4.0	5.1	12.7	18.0	13.7	6.8	6.3	5.0	16.4	10.0	9.6	7.2	11.3	5.0	10.1	11.2	6.8	12.7	8.7	12.2	10.8	11.3	10.9	5.2	10.1	12.1	11.5	4.0	15.2	10.4	14.6	9.3	12.6	13.2	6.6	13.1	13.4	17.0	11.5	21.9	27.6	11.3	31.1	43.5	34.6	37.8	30.7	28.1	24.2	34.5	28.0	26.0	11.0	19.7	23.6	40.4	15.3	8.4	27.5	14.5	27.3	36.7	18.9	15.3	32.2	25.0	31.2	41.7	32.6	30.1	17.1	19.8	2.9	20.8	6.4	23.0	9.5	13.9	13.1	19.7	14.5	29.5	18.2	26.1	22.2	13.1	12.5	18.8	10.4	8.9	27.5	6.8	5.0	26.6	9.1	17.2	10.2	22.8	10.8	12.4	18.8	7.3	22.7	14.9	53.0	15.3	17.8	11.5	13.7	15.2	11.9	11.6	10.5	15.2	9.7	14.8	11.6	14.0	17.3	16.5	14.0	14.7	10.6	3.4	5.3	7.6	7.8	4.0	5.1	6.3	5.0	5.0	5.2	4.0	6.6	49.4	16.0	25.7	2.0	44.0	67.4	78.4	48.4	41.5	11.5	47.4	31.9	15.1	30.0	34.2	29.5	12.5	51.0	52.4	30.8	66.5	49.8	196.4	37.6	38.8	45.0	47.4	26.1	5.4	35.1	78.0	51.7	26.0	51.3	40.0	20.1	37.9	27.5	29.8	8.4	5.6	30.9	40.7	27.4	55.3	29.5	31.4	30.8	42.7	7.5	32.2	24.5	28.8	8.5	10.2	39.0	37.6	17.0	18.0	71.2	38.1	46.5	27.8	13.0	0.0	49.1	47.6	35.3	16.9	32.8	68.6	92.5	46.6	18.7	38.4	82.6
RBMS2	SCR3	ENSG00000076067	"RNA binding motif single stranded interacting protein 2"	Q15434	12	56521820-56596193	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039225, HPA058784"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA039225: AB_10963056, HPA058784: AB_2683819"	"unprognostic (1.35e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.63e-2)"	19.4	7.1	12.5	5.7	11.5	3.6	17.4	9.3	13.1	14.7	15.1	12.9	4.7	13.7	9.3	8.2	13.7	9.5	15.6	9.2	10.0	14.7	3.4	37.3	3.2	14.5	11.7	12.6	7.0	8.6	6.1	23.5	13.4	11.2	8.8	6.0	10.1	8.7	8.4	8.3	9.0	12.1	9.8	10.5	8.5	4.3	15.2	3.5	18.3	10.8	3.9	10.3	13.9	11.7	28.8	24.3	10.5	14.9	23.7	22.7	9.3	34.8	37.0	26.9	23.9	18.7	50.2	0.2	42.1	36.6	11.1	20.4	7.8	57.8	30.1	8.3	6.7	3.7	19.0	4.8	15.4	3.8	6.5	20.9	13.9	28.1	33.5	31.4	51.1	6.1	1.8	6.5	47.0	3.7	4.1	4.9	6.2	0.0	7.5	2.4	11.5	0.3	34.1	6.4	0.8	6.9	39.6	14.9	5.1	22.2	16.0	6.3	78.2	16.7	35.8	9.5	8.4	6.1	2.5	1.7	6.1	0.9	23.6	0.6	4.7	1.6	0.8	1.3	0.9	0.3	0.3	1.2	2.7	0.5	0.9	0.6	1.6	1.0	0.3	0.6	0.5	0.8	12.5	11.5	9.3	13.1	9.2	10.0	14.5	11.7	13.4	9.8	15.2	11.7	74.4	41.7	20.5	34.6	1.5	3.7	9.7	6.8	11.4	4.2	11.4	9.4	7.9	12.8	14.2	12.9	10.4	19.8	7.0	19.7	1.9	23.6	12.6	16.4	16.9	47.9	5.4	3.2	7.2	16.9	38.5	16.9	6.1	21.8	8.2	10.4	52.1	1.0	10.5	8.4	10.0	5.9	4.1	22.7	5.5	24.2	17.4	11.2	0.0	53.4	6.2	5.4	4.1	30.7	9.6	37.8	11.5	24.8	0.8	13.4	1.6	13.4	6.8	1.7	26.3	11.2	15.5	0.9	1.8	5.4	2.0	23.7	2.5	8.7	7.0	17.3
RBMX	"hnRNP-G, HNRNPG, RNMX"	ENSG00000147274	"RNA binding motif protein X-linked"	P38159	X	136848004-136880764	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057707	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA057707: AB_2683508"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (5.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.64e-3)"	81.0	57.0	35.7	80.8	39.3	172.5	119.7	40.5	39.7	108.8	36.9	82.9	77.8	142.0	85.9	64.5	116.5	68.2	72.2	33.9	36.2	77.7	66.5	71.8	117.8	40.7	36.4	242.9	86.8	76.6	48.9	80.4	40.8	83.9	101.6	82.0	68.5	82.1	126.2	69.6	75.5	118.2	38.8	89.1	71.8	34.8	35.1	210.8	92.5	103.9	145.6	89.1	77.9	51.9	235.0	250.2	448.6	201.0	109.6	184.3	261.2	227.7	246.3	308.4	324.6	268.8	228.3	422.9	229.2	163.9	193.3	152.9	481.9	238.3	353.6	184.2	226.8	324.6	240.9	289.9	95.9	358.0	285.6	152.5	113.1	240.6	333.6	236.3	252.7	392.0	296.6	210.3	254.4	297.9	526.3	240.5	285.7	248.1	207.0	430.9	300.2	262.0	229.6	275.2	260.8	281.7	181.9	162.4	213.8	263.6	186.8	237.7	161.7	173.5	188.0	121.7	294.8	149.2	214.9	444.3	123.9	256.7	242.6	131.6	158.5	90.6	142.1	192.8	199.7	194.5	184.8	170.4	175.6	187.4	231.9	192.5	25.3	173.9	178.9	106.4	203.9	302.6	35.7	39.3	40.5	39.7	33.9	36.2	40.7	36.4	40.8	38.8	35.1	51.9	112.1	112.2	139.0	55.2	223.0	151.9	209.0	151.6	128.1	112.4	229.8	208.0	100.5	153.0	167.3	88.3	95.9	187.2	200.3	80.1	154.6	157.2	10.9	83.5	147.4	130.5	202.9	195.7	33.2	148.8	269.4	156.6	75.4	84.3	268.8	212.7	204.5	119.3	117.0	92.5	41.2	170.9	81.4	223.2	112.2	10.5	171.8	109.0	96.0	27.2	176.9	99.4	157.6	57.3	56.5	108.0	99.1	133.2	124.0	108.2	140.0	120.3	123.3	137.9	92.1	159.7	161.6	33.8	81.2	94.6	122.3	111.5	195.5	135.0	216.4	157.4
RBMXL1	KAT3	ENSG00000213516	"RBMX like 1"	Q96E39	1	88979456-88992960	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA057707	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA057707: AB_2683508"	"prognostic favorable (7.60e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	7.7	5.1	10.2	6.6	11.0	15.6	7.7	9.4	10.2	9.0	7.0	5.4	5.5	9.7	5.7	10.2	8.6	6.4	7.6	8.8	10.9	6.1	9.7	7.3	8.2	10.7	11.0	12.3	8.3	8.2	3.4	7.3	10.7	9.3	5.1	10.5	6.5	6.7	5.0	5.7	5.2	8.6	10.2	7.5	6.0	8.6	10.8	8.6	7.7	5.9	8.0	8.1	5.6	12.8	15.3	4.5	12.0	14.7	13.8	14.6	22.2	6.3	12.5	12.2	14.2	7.0	10.1	13.2	11.7	7.2	26.6	8.7	21.3	15.5	14.2	11.9	10.7	15.2	14.4	9.6	9.2	12.1	7.9	8.4	9.1	11.1	9.8	5.7	7.3	9.3	20.3	8.1	7.0	5.6	12.7	6.6	22.3	9.1	9.5	11.8	27.8	6.6	8.9	18.4	8.4	14.7	7.4	14.1	16.3	16.3	11.5	13.2	6.2	7.6	15.5	9.9	10.6	13.6	13.3	13.5	5.6	7.2	7.4	2.3	4.8	4.4	4.6	6.2	5.9	4.7	6.2	4.7	6.1	5.9	6.9	4.3	8.8	4.4	7.8	3.2	5.4	6.8	10.2	11.0	9.4	10.2	8.8	10.9	10.7	11.0	10.7	10.2	10.8	12.8	12.6	35.3	36.9	0.0	14.7	30.7	55.2	18.5	22.2	20.2	18.9	16.0	21.3	18.6	24.9	12.9	14.6	30.2	11.9	11.7	3.9	9.5	1.4	12.7	12.5	17.5	28.8	8.2	0.0	8.7	29.4	16.4	15.3	21.3	34.8	16.9	15.7	32.9	11.8	25.2	0.0	10.7	10.2	22.4	15.5	2.3	17.1	13.8	21.4	0.0	20.2	28.5	12.3	0.0	0.0	10.8	4.6	15.1	10.0	24.6	9.1	5.9	21.6	18.0	6.6	20.4	19.7	12.1	18.6	28.1	24.3	34.1	18.5	14.6	12.0	34.6
RBMY1A1	"RBM1, RBM2, YRRM1, YRRM2"	ENSG00000234414	"RNA binding motif protein Y-linked family 1 member A1"	P0DJD3	Y	21511372-21549326	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	96	"testis: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"U-266/84: 15.1"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"		Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1B		ENSG00000242875	"RNA binding motif protein Y-linked family 1 member B"	A6NDE4	Y	21511338-21549094	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"			Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1D		ENSG00000244395	"RNA binding motif protein Y-linked family 1 member D"	P0C7P1	Y	21880076-21894526	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1E		ENSG00000242389	"RNA binding motif protein Y-linked family 1 member E"	A6NEQ0	Y	21903618-21918067	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 2.6"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 1.7;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"U-266/84: 2.3"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1F	MGC33094	ENSG00000169800	"RNA binding motif protein Y-linked family 1 member F"	Q15415	Y	22168542-22182982	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"testis: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	325	"U-266/70: 29.7;U-266/84: 35.2"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		"Nucleoplasm, Nucleoli"		"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBMY1J		ENSG00000226941	"RNA binding motif protein Y-linked family 1 member J"	Q15415	Y	22403461-22417881	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"testis: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	193	"U-266/70: 25.2;U-266/84: 13.3"									"HPA001534, HPA053147, HPA057723"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoplasm	Nucleoli	"HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 1366.7;pancreas: 632.7"	"Group enriched"	"Detected in many"	4	"Granulosa cells: 5988.6;Theca cells: 3228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"SH-SY5Y: 835.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 64.4"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		41000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	23.7	377.1	64.6	18.4	65.2	1.3	49.5	64.9	72.7	53.8	251.4	30.3	32.3	180.2	64.2	35.4	390.2	182.9	60.1	65.5	67.8	46.9	140.8	26.8	18.6	83.1	69.0	1366.7	632.7	46.8	257.8	63.6	64.7	44.8	14.2	23.2	50.2	41.3	15.2	31.3	26.2	119.3	68.2	47.0	29.3	56.1	75.2	9.4	23.0	15.5	12.0	65.7	24.3	67.5	7.8	2.9	7.4	164.2	0.3	0.0	0.9	0.1	0.0	0.0	0.1	0.4	76.1	0.0	53.8	0.1	2.6	0.1	38.2	0.5	0.0	0.1	5.3	0.1	2.7	75.5	155.1	0.2	0.1	3.0	0.0	0.1	0.0	160.9	0.0	0.0	0.2	29.9	0.2	0.0	0.2	0.5	18.4	0.2	0.0	0.1	32.0	0.5	0.1	0.1	19.6	835.4	35.3	0.1	0.1	13.9	3.2	1.1	0.0	0.3	120.0	0.2	0.3	0.6	0.5	0.5	1.3	0.0	2.3	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	64.6	65.2	64.9	72.7	65.5	67.8	83.1	69.0	64.7	68.2	75.2	67.5	24.8	32.1	5.9	8.8	3.5	17.6	53.5	91.9	2.8	26.3	70.4	47.8	21.4	77.2	30.3	23.9	2.1	3.2	1.0	0.1	13.7	1013.0	4.8	199.6	961.4	103.8	43.1	13.5	0.5	1042.7	6.2	158.8	19.9	58.1	0.0	5988.6	343.7	6.9	16.5	3.3	0.3	2.3	42.7	10.6	3.4	16.2	27.1	25.1	8.8	5.6	13.5	159.9	0.0	4.0	16.0	563.0	0.0	4.5	2.9	56.6	2.6	4.7	10.3	7.2	26.3	220.9	534.7	11.6	4.9	6.2	34.9	3.8	10.2	3228.5	2.7	32.7
RBPJ	"CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH"	ENSG00000168214	"Recombination signal binding protein for immunoglobulin kappa J region"	Q06330	4	26163455-26435131	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 422.1;Oligodendrocytes: 378.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000251, HPA060647"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA000251: , HPA060647: AB_2684337"	"unprognostic (2.68e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.15e-3)"	40.9	18.3	28.1	33.0	44.2	51.3	28.4	34.2	38.5	31.9	27.7	33.2	20.2	36.4	18.0	28.5	23.6	25.5	21.8	29.0	37.6	21.4	17.9	31.3	27.5	41.7	38.5	34.2	22.3	26.2	12.9	54.4	39.0	28.0	28.1	33.1	19.3	22.5	21.7	26.0	22.7	38.0	32.2	25.7	25.4	28.7	36.4	27.8	24.8	28.9	26.5	31.8	21.7	58.9	68.2	19.1	60.0	39.0	91.5	138.8	44.9	54.4	47.0	50.9	60.1	14.5	36.4	56.0	34.1	36.2	39.5	12.2	51.9	33.4	98.1	30.4	28.4	42.5	24.2	27.9	47.9	76.9	35.9	64.0	28.5	104.9	39.7	70.3	28.5	34.3	43.0	21.5	93.2	20.1	54.5	76.4	163.5	20.3	30.3	48.0	112.4	25.4	26.8	22.4	84.5	36.5	28.0	20.6	24.3	54.4	22.0	53.3	38.5	50.5	25.2	86.3	51.9	40.2	51.9	55.7	132.3	86.3	43.4	23.8	94.6	112.9	31.4	77.8	42.6	37.2	49.8	34.1	136.4	33.4	41.4	35.9	220.5	70.9	77.1	31.5	68.1	68.6	28.1	44.2	34.2	38.5	29.0	37.6	41.7	38.5	39.0	32.2	36.4	58.9	72.5	48.1	66.8	62.0	54.6	152.8	86.2	104.6	55.8	94.6	48.9	51.2	44.2	62.9	83.3	46.0	129.3	102.7	47.3	26.6	74.3	64.3	44.4	54.5	96.3	73.2	78.4	46.9	81.7	65.4	74.4	129.0	29.0	62.8	57.0	130.7	65.3	53.1	365.2	85.8	85.9	51.0	59.0	208.5	422.1	56.7	135.5	234.2	80.0	60.9	125.1	95.0	44.3	215.1	378.1	76.5	35.1	84.2	54.9	113.7	44.9	55.4	67.5	102.9	85.5	71.7	95.8	134.7	158.4	45.9	109.3	83.9	102.8	57.0	47.0	75.7
RBPMS	HERMES	ENSG00000157110	"RNA binding protein, mRNA processing factor"	Q93062	8	30384511-30572256	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 324.1;RPTEC TERT1: 232.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056999	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA056999: AB_2683306"	"unprognostic (1.65e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.23e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.47e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.16e-3)"	238.3	96.7	22.3	43.8	28.0	1.4	194.8	20.2	24.1	196.9	26.7	350.6	25.2	200.7	90.0	99.9	200.5	95.4	174.7	17.3	25.2	218.7	108.9	119.6	23.3	23.1	27.6	190.0	68.8	68.6	33.0	105.0	28.7	182.6	46.6	10.4	92.1	193.7	31.2	56.6	107.7	171.9	18.7	56.7	159.8	45.4	33.2	23.5	140.7	31.6	20.0	323.4	134.0	18.9	0.7	54.5	58.5	0.4	324.1	96.4	145.8	74.8	101.8	90.2	74.6	76.2	31.2	0.5	39.3	96.7	82.5	29.9	68.0	54.4	107.9	0.1	14.6	1.8	24.7	80.5	139.4	0.5	12.0	112.8	13.8	86.7	11.5	100.8	52.8	2.5	0.5	0.4	44.6	32.6	0.3	1.2	150.9	62.3	34.6	3.5	16.2	4.7	232.2	88.9	1.1	11.6	7.7	55.2	37.7	192.3	11.7	0.0	48.8	44.3	4.2	77.3	12.8	0.1	0.2	0.4	72.8	0.2	20.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	22.3	28.0	20.2	24.1	17.3	25.2	23.1	27.6	28.7	18.7	33.2	18.9	104.0	54.5	98.9	36.6	4.5	9.3	61.8	22.7	14.2	6.7	45.8	64.3	114.4	75.8	48.5	141.6	2.1	108.7	4.1	1.8	113.5	100.0	104.7	31.2	86.3	69.7	1.8	5.0	6.4	94.8	184.8	66.7	18.8	48.2	10.1	18.0	44.3	55.2	39.9	0.0	5.2	0.1	20.3	1.9	10.2	31.5	171.2	4.3	14.2	71.2	2.1	1.0	1.0	2.0	1.6	67.0	0.0	180.2	0.5	101.5	2.0	242.2	30.9	5.7	111.7	6.6	149.9	35.3	22.0	27.8	8.0	41.2	4.4	28.1	1.0	151.7
RBX1	"BA554C12.1, RNF75, ROC1"	ENSG00000100387	"Ring-box 1"	P62877	22	40951347-40973309	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003038			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA003038: AB_1079827"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (5.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	37.8	46.8	82.3	33.4	85.6	63.4	45.1	88.4	105.1	38.5	79.7	36.6	26.3	34.3	59.2	53.5	31.4	22.3	72.7	82.9	86.5	49.4	38.9	37.5	44.5	88.2	84.1	26.9	24.7	38.3	34.5	40.9	87.3	32.8	32.8	45.3	33.1	26.9	83.2	43.3	33.1	32.7	89.7	39.8	37.5	24.8	84.1	59.3	35.8	100.5	51.6	36.4	37.7	93.6	111.1	62.2	114.4	57.9	79.9	94.9	64.3	86.6	80.0	128.2	112.9	101.4	52.5	96.7	57.3	86.3	50.8	62.3	110.6	100.2	135.1	113.9	174.7	60.4	84.0	126.1	68.2	148.3	74.8	79.1	79.1	93.0	66.6	73.3	110.5	57.8	72.2	95.6	115.1	136.7	90.2	170.1	63.7	216.3	64.8	116.8	80.0	122.5	149.3	71.0	54.1	34.9	76.5	76.3	82.7	63.8	65.8	99.5	74.8	77.9	81.1	66.4	84.5	80.0	78.9	146.5	98.0	74.7	88.6	151.8	128.1	108.7	79.9	133.9	76.0	114.7	99.2	85.7	129.7	102.4	85.5	93.8	42.3	89.2	154.6	211.1	137.6	250.2	82.3	85.6	88.4	105.1	82.9	86.5	88.2	84.1	87.3	89.7	84.1	93.6	224.9	230.8	144.8	23.5	173.6	300.9	207.2	567.7	129.1	90.4	189.6	237.9	515.4	171.6	300.0	224.3	25.0	507.3	238.6	181.8	508.7	346.8	41.1	227.4	170.6	222.1	162.1	638.3	29.9	333.6	637.9	211.2	107.6	180.4	129.8	140.0	167.4	254.8	431.3	89.2	29.7	205.1	349.9	236.7	334.2	79.4	185.8	270.7	341.5	15.0	532.3	264.5	228.6	18.6	49.6	377.7	229.8	177.1	180.8	269.5	300.5	586.5	314.3	163.7	118.3	160.0	256.3	220.2	242.9	237.5	370.7	675.9	175.3	185.7	207.1	248.8
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 199.5;tongue: 180.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 255.4;Excitatory neurons: 261.4;Inhibitory neurons: 254.4;Muller glia cells: 183.1;Oligodendrocytes: 294.6;Smooth muscle cells: 138.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 25.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"gdT-cell: 1.8;memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 63.3;HDLM-2: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Nucleoplasm	"HPA053880: AB_2682290"	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	38.1	12.6	35.7	7.7	41.2	0.0	17.1	31.7	106.3	20.3	0.0	20.1	9.8	17.5	51.5	25.9	17.0	35.1	199.5	34.0	65.0	32.4	4.9	16.3	4.1	69.6	76.0	24.0	11.1	85.5	17.5	0.6	68.8	25.3	22.6	61.6	9.6	27.0	73.3	17.2	19.1	14.0	20.6	7.1	36.5	5.7	65.5	4.7	20.1	180.1	7.0	44.0	21.4	62.3	0.0	0.0	1.6	0.0	0.7	0.2	0.1	1.1	15.1	1.1	0.1	0.0	0.0	0.0	0.8	63.3	0.0	0.1	0.0	0.0	0.3	129.7	0.8	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.1	5.1	0.0	0.0	0.2	2.7	0.4	0.4	0.4	13.6	0.1	0.2	0.3	4.9	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.8	0.1	0.2	6.8	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.1	2.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	35.7	41.2	31.7	106.3	34.0	65.0	69.6	76.0	68.8	20.6	65.5	62.3	7.6	6.4	5.8	13.7	0.6	6.2	4.6	0.0	0.0	24.8	1.8	1.4	255.4	8.6	0.0	3.7	4.2	0.1	0.8	1.0	70.5	5.5	40.2	0.8	0.4	17.1	25.1	0.0	261.4	2.5	0.0	22.2	1.5	0.8	0.0	0.3	0.4	1.2	0.1	30.3	254.4	1.5	34.6	0.3	8.0	14.2	29.2	0.9	32.0	46.9	0.0	183.1	0.0	76.9	294.6	2.9	0.3	50.4	0.4	3.3	0.0	1.9	0.0	9.7	98.6	16.4	138.4	1.5	1.4	0.5	7.4	0.0	4.0	0.8	0.3	1.4
RCBTB1	"CLLD7, CLLL7, FLJ10716"	ENSG00000136144	"RCC1 and BTB domain containing protein 1"	Q8NDN9	13	49531946-49585558	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Cone photoreceptor cells: 64.6;Oligodendrocyte precursor cells: 75.4;Oligodendrocytes: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056783			Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA056783: AB_2683234"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.52e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.17e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.49e-2)"	10.9	22.7	24.3	9.9	30.5	14.4	13.2	26.8	30.1	9.2	21.3	7.5	6.5	16.7	20.1	5.6	13.1	9.8	16.2	22.5	30.6	19.0	8.9	13.2	14.8	28.1	28.3	7.7	11.3	48.6	14.5	13.1	27.4	11.2	8.6	49.6	7.9	19.1	7.7	8.3	8.0	14.7	27.1	14.9	10.7	9.2	28.5	19.5	44.2	16.0	11.3	9.5	6.8	31.2	5.7	12.9	27.8	25.3	36.2	31.4	16.2	21.2	21.0	15.7	16.1	10.9	14.0	19.3	4.6	17.5	13.6	7.9	20.8	32.6	26.9	28.5	16.2	23.1	10.7	28.1	43.5	18.6	17.6	28.1	19.6	13.1	20.8	20.7	27.7	37.3	10.4	8.2	31.9	5.3	27.1	10.8	29.0	19.1	7.8	34.8	20.9	12.3	19.6	15.3	14.6	19.4	10.8	8.2	21.7	23.4	11.0	13.3	19.7	11.8	9.5	24.8	10.5	8.4	10.9	31.1	10.5	18.3	16.9	17.1	6.0	6.4	2.7	7.4	3.3	4.5	4.5	2.2	7.6	2.8	2.8	2.7	3.0	2.8	8.9	1.0	9.1	3.5	24.3	30.5	26.8	30.1	22.5	30.6	28.1	28.3	27.4	27.1	28.5	31.2	6.9	44.8	10.8	11.8	6.7	3.7	2.5	2.8	20.5	10.2	7.4	4.4	18.9	8.6	9.3	1.8	64.6	3.0	5.3	1.5	7.9	7.4	0.4	6.3	16.3	10.4	16.2	8.0	13.0	5.0	3.5	4.7	3.6	5.8	2.5	12.1	6.4	7.8	8.8	10.1	13.9	2.9	2.0	14.1	5.5	0.7	3.4	9.0	8.8	23.4	8.3	6.0	3.1	75.4	76.8	5.0	0.7	5.7	6.3	3.5	0.7	12.8	10.3	37.7	39.5	3.1	10.2	1.9	6.0	2.3	2.4	1.1	6.4	35.4	2.1	2.3
RCBTB2	CHC1L	ENSG00000136161	"RCC1 and BTB domain containing protein 2"	O95199	13	48488963-48533256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	9	"MOLT-4: 278.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040242	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA040242: AB_10795362"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.60e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.98e-1)"	12.9	11.1	10.0	12.9	11.2	5.2	10.8	11.1	13.9	15.6	17.4	8.9	5.3	15.0	12.3	13.0	12.9	12.3	12.5	9.5	13.2	16.6	9.5	10.5	11.3	11.9	11.7	19.9	6.8	6.6	13.4	17.7	12.5	13.5	8.0	8.3	23.3	19.9	7.0	5.4	7.2	13.7	13.0	17.4	8.8	7.1	10.8	11.8	27.5	10.8	10.7	11.5	12.4	14.4	1.5	1.2	22.0	1.4	17.1	15.1	0.0	6.8	8.4	4.0	3.0	0.8	1.4	4.7	5.0	10.7	2.7	3.1	3.2	2.8	4.6	5.7	4.3	12.2	3.2	1.2	6.6	5.6	7.4	15.6	6.5	5.3	2.6	9.2	12.3	29.8	0.9	7.1	14.6	0.5	278.7	15.6	12.3	0.5	3.7	23.9	2.2	20.3	7.5	3.7	5.1	4.3	5.3	1.1	8.7	9.1	0.5	14.2	10.3	4.6	2.0	1.2	2.7	0.3	0.4	5.7	2.7	12.5	9.1	4.6	39.8	4.6	14.0	28.8	8.7	1.1	11.4	14.2	27.1	1.1	6.6	10.2	55.0	15.5	27.9	0.5	15.5	20.5	10.0	11.2	11.1	13.9	9.5	13.2	11.9	11.7	12.5	13.0	10.8	14.4	23.1	3.2	3.3	9.1	5.5	6.1	11.6	9.5	21.1	1.9	4.9	9.3	16.1	4.3	9.8	5.5	2.1	1.4	20.7	1.3	7.9	1.2	9.0	5.1	6.6	19.7	8.3	6.1	12.3	0.8	1.4	11.6	2.6	5.0	8.8	9.9	24.7	5.2	25.0	1.7	17.0	2.2	2.0	26.6	24.4	8.1	9.3	30.6	8.8	66.5	38.3	33.7	24.7	6.6	13.2	1.3	1.6	14.3	17.4	6.0	0.7	11.2	6.9	4.9	13.1	14.9	14.1	9.6	4.4	12.6	5.7	1.0	24.0	11.9	2.4	6.7
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 789.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		47000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	14.2	12.1	5.5	31.0	6.1	58.5	17.2	7.3	7.6	14.7	6.5	24.4	27.2	14.2	10.3	32.2	18.9	12.9	6.6	5.8	6.1	9.0	23.9	12.3	37.4	6.8	6.2	16.1	16.1	5.8	3.8	17.7	6.8	10.9	28.1	6.1	20.6	9.2	13.3	14.6	23.4	19.3	6.1	16.1	18.6	57.9	7.6	44.3	11.7	8.0	38.0	23.6	15.8	6.9	263.2	109.7	94.8	112.9	68.4	86.5	106.2	100.2	60.2	158.5	122.9	111.9	206.2	331.0	60.0	99.2	65.3	155.0	306.6	158.1	125.1	133.7	185.0	295.0	140.0	147.2	51.6	329.0	171.5	111.6	106.0	150.0	125.6	100.7	110.6	194.5	222.8	101.1	66.0	140.8	260.5	118.0	205.3	117.8	106.4	252.9	163.3	164.0	60.5	119.9	150.6	76.7	105.3	171.5	87.6	52.7	72.6	99.8	84.5	81.6	162.5	102.0	198.2	60.9	91.2	248.8	80.5	469.7	89.5	5.1	7.7	3.3	5.0	7.9	9.4	7.1	7.8	8.2	14.0	7.2	6.8	7.6	1.8	5.9	5.7	7.7	7.6	6.3	5.5	6.1	7.3	7.6	5.8	6.1	6.8	6.2	6.8	6.1	7.6	6.9	8.9	0.0	10.3	2.0	57.4	36.7	12.4	13.6	92.2	0.8	18.9	15.4	4.6	5.7	16.2	7.3	2.1	25.6	10.7	10.7	3.9	34.0	176.5	12.7	21.1	16.6	5.4	118.1	4.5	23.7	43.5	17.4	68.8	17.4	1.3	14.8	2.9	6.6	20.8	13.5	5.0	16.0	12.2	11.3	20.0	789.4	17.1	21.3	14.2	1.9	16.6	0.5	15.5	2.0	2.9	39.5	7.0	10.5	75.5	21.6	9.6	5.7	14.1	0.3	6.6	15.0	16.6	19.2	18.4	185.3	33.8	24.5	31.7	12.5	25.0	18.4
RCC1L	WBSCR16	ENSG00000274523	"RCC1 like"	Q96I51	7	75027122-75074228	"Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 56.0;Distal tubular cells: 49.0;Extravillous trophoblasts: 42.3;Granulosa cells: 46.2;Proximal tubular cells: 37.0;Syncytiotrophoblasts: 54.5;Theca cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052184, HPA060643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA052184: AB_2681752, HPA060643: AB_2684335"	"unprognostic (9.73e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (8.91e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.28e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-1)"	27.4	46.3	19.6	17.3	21.4	14.0	25.2	19.5	22.5	24.0	22.9	35.0	19.0	28.2	6.8	30.7	21.9	12.7	53.1	18.5	19.6	40.1	59.8	20.2	18.7	21.4	20.2	28.8	28.8	18.2	27.2	15.4	19.3	30.6	10.3	5.3	22.8	17.5	103.1	22.0	23.2	12.7	20.8	25.3	28.8	21.6	22.0	12.4	25.9	45.9	12.7	32.0	23.1	20.5	44.8	59.2	34.8	54.0	24.5	19.8	45.3	42.9	30.5	36.1	29.5	64.6	53.5	47.2	18.9	34.8	46.9	51.9	29.8	28.8	15.0	52.0	47.7	35.1	41.5	61.3	34.6	56.6	53.7	24.7	23.1	31.4	24.9	24.2	32.4	7.7	113.8	29.5	28.3	92.8	1.5	84.6	80.0	53.2	52.1	24.5	27.4	98.6	31.5	38.9	34.5	55.3	57.1	119.0	54.4	24.3	83.8	58.3	35.8	46.9	38.5	40.7	56.5	32.4	26.7	73.6	35.8	58.3	63.6	3.5	2.3	1.4	4.2	3.1	3.4	3.6	4.6	3.7	3.3	4.2	4.3	5.3	0.8	4.6	2.3	3.3	3.7	1.7	19.6	21.4	19.5	22.5	18.5	19.6	21.4	20.2	19.3	20.8	22.0	20.5	15.9	0.0	7.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	15.2	15.5	0.0	0.0	2.5	22.0	0.0	56.0	13.0	0.0	49.0	24.3	0.0	11.7	17.7	8.0	0.0	0.0	0.0	20.6	42.3	10.5	0.0	13.8	5.1	46.2	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	18.1	0.0	0.0	1.8	0.0	0.0	37.0	2.9	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	54.5	6.6	53.8	0.0	0.0
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.89e-5)"	8.6	7.0	9.5	7.9	10.2	17.0	16.8	12.6	13.0	9.0	7.7	12.1	8.7	9.6	6.9	7.2	11.9	6.8	16.8	9.4	10.6	16.2	12.3	10.0	9.5	8.9	10.4	14.5	8.3	12.6	5.8	10.0	9.9	10.9	13.2	14.8	12.9	10.1	16.5	5.6	8.6	11.6	9.9	11.5	8.9	13.6	10.7	12.7	18.9	23.6	12.6	7.6	4.7	10.7	9.8	5.0	14.6	13.8	15.1	13.1	8.4	6.5	15.1	13.2	15.4	13.8	11.9	16.2	12.0	9.4	13.1	5.8	37.6	11.5	19.9	13.4	12.3	21.2	9.2	17.9	13.0	28.9	11.2	12.2	14.1	15.2	14.2	15.9	27.0	20.8	19.9	16.2	30.9	15.8	26.7	11.5	24.5	26.9	8.7	14.2	34.4	13.9	20.4	16.7	22.6	12.4	10.7	24.8	28.2	15.9	14.0	12.9	10.8	8.6	8.5	7.8	11.1	17.0	13.0	22.8	10.5	20.2	14.0	27.5	9.2	9.7	4.3	5.7	7.6	4.6	5.4	5.2	8.0	2.1	3.9	5.5	4.0	5.5	5.6	4.1	5.7	4.7	9.5	10.2	12.6	13.0	9.4	10.6	8.9	10.4	9.9	9.9	10.7	10.7	22.2	19.2	10.3	28.4	25.4	40.7	32.3	47.1	39.3	35.0	38.5	25.9	56.8	24.3	23.5	23.9	20.9	31.6	31.2	21.9	68.4	30.3	37.3	11.9	17.1	22.3	13.8	21.8	31.2	22.5	23.2	24.6	21.9	17.3	5.1	23.8	25.4	23.0	19.0	23.5	32.3	23.4	38.7	37.5	26.8	59.8	22.4	27.4	28.4	22.5	23.9	32.0	24.7	31.7	41.0	26.5	22.6	25.2	19.7	36.6	24.6	69.4	13.5	21.7	32.9	20.9	27.3	72.8	41.7	28.1	31.0	33.8	32.9	35.2	27.6	26.3
RCL1	"RNAC, RPCL1"	ENSG00000120158	"RNA terminal phosphate cyclase like 1"	Q9Y2P8	9	4792944-4885917	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 245.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 74.1;Hepatocytes: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HDLM-2: 145.5;HEL: 375.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071308			Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA071308: AB_2686384"	"prognostic favorable (5.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (7.55e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (2.40e-7)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.66e-2)"	37.2	13.4	5.8	9.0	7.8	44.3	21.7	6.5	7.3	9.4	8.2	7.5	4.1	8.3	9.9	10.4	10.6	6.3	6.6	5.9	8.0	12.3	245.8	13.1	15.0	8.4	7.9	17.6	64.6	8.7	7.0	13.8	8.8	7.0	7.5	3.8	6.8	7.1	14.4	21.1	8.0	7.7	8.3	9.2	10.4	13.8	8.1	9.7	8.2	8.6	12.5	12.5	10.6	10.2	23.3	27.6	10.3	16.5	15.0	10.1	27.3	10.8	12.0	19.9	16.8	13.9	13.4	45.2	7.4	9.7	22.1	14.4	48.0	32.5	22.8	145.5	24.2	375.0	33.5	28.1	21.5	34.1	28.9	22.4	18.2	19.0	28.7	11.2	19.7	32.4	38.9	28.0	12.0	30.4	27.8	57.8	35.7	27.7	11.0	34.2	13.8	24.2	24.3	25.9	29.6	24.3	13.6	20.0	15.8	20.4	18.9	39.8	13.9	11.6	13.3	16.6	34.0	11.5	35.3	48.1	21.3	20.8	8.1	16.2	1.6	4.3	5.7	2.5	7.0	8.7	6.5	7.7	4.3	11.5	8.7	9.0	0.6	12.1	1.3	7.4	5.9	3.7	5.8	7.8	6.5	7.3	5.9	8.0	8.4	7.9	8.8	8.3	8.1	10.2	10.9	6.4	6.8	18.9	14.7	25.5	21.8	11.9	25.0	5.4	9.3	8.0	10.6	11.5	7.8	3.7	0.0	39.8	8.5	3.0	25.4	12.4	74.1	8.3	8.8	12.1	3.0	68.4	14.1	11.5	16.6	11.9	8.6	5.7	14.5	16.7	16.1	183.4	17.7	5.0	15.9	6.4	6.1	11.3	6.2	39.7	23.0	7.6	3.6	36.5	9.7	9.2	5.2	18.1	34.3	10.6	3.7	37.6	14.3	18.1	3.2	13.7	14.0	7.0	13.1	19.1	10.2	18.2	18.4	18.6	21.2	35.4	8.9	12.1	8.9	16.6
RCOR1	"COREST, KIAA0071, RCOR"	ENSG00000089902	"REST corepressor 1"	Q9UKL0	14	102592649-102730561	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 117.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001956, HPA049327, HPA054241"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB001956: , HPA049327: AB_2680715, HPA054241: AB_2682426"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.05e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.72e-4)"	11.2	5.8	3.3	11.2	3.1	46.1	9.0	4.6	4.1	14.2	3.3	11.0	12.0	9.5	13.3	33.2	9.5	8.7	6.7	5.0	3.6	6.7	9.4	12.9	11.9	3.4	3.5	9.0	7.9	10.4	5.2	20.8	3.6	8.8	11.1	6.3	10.2	5.8	11.8	16.6	12.6	8.8	3.5	8.6	13.4	13.7	4.3	14.5	6.3	10.6	14.7	10.2	19.1	4.2	21.3	19.5	17.2	19.0	13.5	18.6	36.1	21.5	15.2	19.7	18.7	18.0	25.2	23.8	17.1	18.7	9.9	32.6	26.2	15.4	29.4	10.1	9.6	44.2	17.4	17.6	18.4	44.3	38.2	13.1	23.6	17.4	26.5	21.1	21.8	22.1	35.7	17.5	20.1	34.6	27.8	29.9	8.5	23.2	33.1	70.4	17.4	10.6	24.1	25.9	22.2	13.8	48.1	21.9	13.9	21.5	30.0	34.6	23.8	13.6	10.2	43.8	14.2	12.9	16.6	25.0	16.3	32.0	14.6	3.1	1.4	2.2	0.2	1.5	0.3	0.3	0.3	0.6	1.5	0.3	0.3	0.3	3.7	0.7	1.8	0.6	0.5	0.5	3.3	3.1	4.6	4.1	5.0	3.6	3.4	3.5	3.6	3.5	4.3	4.2	15.8	48.1	40.0	32.3	27.3	57.6	27.7	12.0	30.7	8.4	25.6	20.7	16.7	10.0	19.7	3.7	2.1	31.1	39.1	31.5	5.9	6.7	5.1	55.7	36.1	15.9	21.0	32.2	39.3	7.4	20.4	20.2	32.6	58.3	24.1	18.0	11.0	11.7	15.1	10.1	33.8	16.8	10.2	38.8	65.6	4.9	24.2	43.6	24.9	52.5	33.1	9.5	12.3	22.1	23.5	16.7	15.2	21.1	14.8	25.4	18.2	8.0	16.3	5.4	0.0	18.9	19.6	22.5	18.6	46.9	117.6	43.1	26.2	20.3	22.8	72.3
RCOR2		ENSG00000167771	"REST corepressor 2"	Q8IZ40	11	63911230-63917164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 20.7;Excitatory neurons: 5.9;Extravillous trophoblasts: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 35.7;NTERA-2: 47.0;SCLC-21H: 72.6;SH-SY5Y: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021638	Uncertain		Approved	Nucleoplasm,Vesicles,Midbody		Yes	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Vesicles, Midbody"	"HPA021638: AB_10960885"	"unprognostic (1.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.33e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (6.06e-3)"	0.3	0.5	1.8	0.2	3.2	0.0	0.4	1.3	3.7	1.4	0.1	1.1	0.8	2.7	1.0	0.4	1.5	0.4	2.8	2.5	1.1	0.6	0.1	0.3	0.0	1.2	1.0	1.2	0.5	1.4	3.5	0.7	0.8	0.9	0.6	3.4	0.9	0.6	1.5	0.3	0.6	1.0	1.1	0.1	0.7	3.2	1.0	0.9	0.2	0.7	0.0	1.2	0.6	2.4	0.0	1.0	35.7	2.5	0.5	2.9	10.9	0.2	0.6	0.5	1.2	1.4	0.3	0.3	0.4	0.8	0.7	0.4	15.8	0.0	0.3	0.6	2.0	0.5	0.3	11.9	5.9	0.0	0.3	3.5	0.0	0.6	0.0	0.0	0.3	4.8	2.0	0.0	0.0	3.3	3.4	13.2	47.0	4.8	0.1	12.4	2.1	1.0	0.1	0.1	72.6	48.7	0.3	3.2	1.8	8.7	2.7	4.5	0.3	0.1	2.3	0.1	0.1	0.3	0.1	0.4	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.2	1.3	3.7	2.5	1.1	1.2	1.0	0.8	1.1	1.0	2.4	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	20.7	0.6	0.4	2.2	0.0	0.1	0.0	0.0	0.5	0.0	1.0	0.0	0.1	0.1	0.3	3.3	0.6	1.2	0.0	5.9	0.2	4.4	1.1	0.0	0.6	0.0	1.2	0.0	0.0	0.2	3.3	1.5	1.2	2.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	2.1	1.0	1.0	1.5	0.2	0.2	0.4	0.0	0.0	0.3	0.1	0.2	2.2	0.0	0.3	0.7	0.7	2.9	0.0	0.3	0.8	0.1	1.2	0.8	0.1
RCOR3	FLJ10876	ENSG00000117625	"REST corepressor 3"	Q9P2K3	1	211258377-211316385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007413, HPA007621, HPA071997"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (4.02e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (5.75e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-3)"	16.9	15.6	11.3	10.7	16.1	31.7	19.7	21.8	16.6	20.3	9.2	19.6	12.1	19.1	21.4	14.5	18.2	12.4	22.7	11.1	14.3	15.7	15.9	14.5	15.2	13.4	12.0	26.7	19.7	20.8	16.9	14.9	14.6	23.9	13.8	30.5	19.5	24.5	65.2	19.2	18.7	14.0	11.5	18.6	16.2	33.7	12.6	19.2	31.9	51.7	14.6	18.8	18.0	22.3	15.5	13.9	25.1	14.4	21.3	20.2	26.4	18.3	18.3	20.0	20.2	12.0	20.9	22.8	11.6	23.7	13.9	23.4	20.6	18.2	15.4	21.5	10.9	21.4	22.6	17.0	23.4	34.2	19.8	22.0	16.6	21.9	27.3	22.4	11.8	23.2	21.0	29.2	29.9	11.2	16.8	18.8	27.2	11.3	14.4	17.8	49.6	27.3	17.2	28.5	16.0	32.5	46.7	24.3	33.6	24.1	29.9	23.3	17.1	17.5	19.7	23.2	20.4	23.5	18.4	30.1	15.2	19.6	15.9	27.2	12.4	45.9	8.8	12.5	11.8	15.4	9.4	9.7	13.7	11.4	16.0	11.6	20.8	19.8	14.3	14.5	12.7	8.8	11.3	16.1	21.8	16.6	11.1	14.3	13.4	12.0	14.6	11.5	12.6	22.3	23.1	38.5	44.4	67.6	23.0	14.5	10.7	16.4	29.6	43.7	29.0	25.9	73.4	24.3	24.9	14.7	35.5	26.7	30.2	16.6	21.5	10.4	70.4	22.0	37.4	17.7	34.2	29.8	121.9	15.4	14.8	24.0	28.1	26.6	19.6	21.7	21.8	20.8	20.5	23.5	101.1	17.3	16.2	22.3	14.2	122.6	22.4	24.6	23.2	49.6	22.2	24.1	14.4	87.9	131.6	10.4	15.8	27.1	28.1	12.5	24.1	22.8	22.2	47.7	0.0	33.2	24.8	65.4	35.1	33.1	16.9	25.4	22.6	22.7	17.5	9.0
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560679	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056686, HPA078577"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA056686: AB_2683209, HPA078577: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	14.4	14.5	10.6	8.3	10.8	5.4	12.6	11.0	12.4	10.1	15.7	14.6	11.6	14.2	12.2	9.8	11.9	9.4	29.8	10.5	10.8	14.0	18.5	11.8	12.5	10.8	10.5	10.0	14.1	18.7	11.3	13.0	11.3	13.3	10.4	8.3	10.7	11.0	28.1	9.6	11.4	12.0	11.1	11.5	14.6	11.5	10.7	12.5	11.1	27.1	9.5	15.5	10.2	11.7	28.6	8.9	7.3	6.0	21.8	22.9	24.7	16.8	17.7	15.2	15.0	6.9	14.6	28.2	9.7	10.3	19.7	15.3	10.8	19.9	17.6	15.6	28.8	10.8	10.6	21.4	18.6	13.7	14.1	17.5	19.9	14.8	22.9	21.2	14.2	11.2	19.9	9.2	25.2	9.2	11.8	23.7	19.9	21.9	24.1	16.5	20.1	12.1	29.9	18.4	11.2	19.3	9.3	20.4	25.8	15.4	10.1	7.2	14.4	21.5	13.1	16.6	20.6	26.0	23.1	20.8	15.1	9.0	17.1	1.4	1.4	6.5	3.3	1.7	5.5	7.3	3.9	4.9	1.9	11.6	5.5	4.5	0.5	3.1	1.7	6.1	5.1	1.3	10.6	10.8	11.0	12.4	10.5	10.8	10.8	10.5	11.3	11.1	10.7	11.7	21.7	16.0	12.8	0.0	36.1	24.5	31.0	27.9	31.3	23.5	20.1	24.5	55.6	32.9	20.9	16.5	6.2	44.6	34.8	20.6	31.3	37.8	27.4	27.4	19.7	19.4	13.2	18.7	0.0	35.3	50.3	38.5	20.4	19.7	12.7	16.4	20.3	30.0	24.2	15.2	0.0	27.1	20.3	17.2	14.6	13.6	66.8	15.4	23.2	0.0	23.2	31.3	29.9	0.0	0.0	27.0	36.3	44.8	15.6	45.1	23.3	38.1	18.8	22.4	32.9	28.5	29.6	79.5	30.6	18.9	18.6	45.7	27.1	30.9	29.2	27.3
RDH8	"PRRDH, SDR28C2"	ENSG00000080511	"Retinol dehydrogenase 8"	Q9NYR8	19	10013249-10022279	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"retina: 114.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.3;Cone photoreceptor cells: 54.2;Early spermatids: 72.6;Muller glia cells: 22.1;Rod photoreceptor cells: 203.4"	"Cancer enriched"	"Detected in some"	4	"melanoma: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064473			Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Midbody ring, Cytosol"	"HPA064473: "			"unprognostic (4.12e-1)"		"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.98e-3)"		"unprognostic (4.58e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-1)"			"unprognostic (1.02e-1)"	"unprognostic (3.86e-1)"		"unprognostic (2.63e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	114.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.2	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	0.0	72.6	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	203.4	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RDX	DFNB24	ENSG00000137710	Radixin	P35241	11	109864295-110296712	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 155.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, HPA000763, CAB037312"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		38000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.93e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-3)"	40.3	155.0	38.0	17.4	57.7	12.0	16.4	50.0	42.7	32.1	32.8	15.2	6.8	28.8	12.9	27.4	19.7	27.2	41.0	35.1	44.7	50.2	68.5	48.8	11.4	52.7	48.2	52.8	52.7	33.2	7.6	35.3	54.3	25.4	11.1	19.2	20.8	26.0	82.1	11.9	7.4	35.0	45.1	26.6	15.0	33.7	47.7	14.3	45.7	59.7	14.6	27.1	10.1	77.6	69.6	35.3	137.3	54.8	78.8	87.4	79.3	85.8	47.6	54.3	59.2	99.7	115.4	0.1	127.4	104.7	84.9	61.5	77.3	80.4	80.5	41.9	44.2	51.5	107.7	74.1	73.6	19.0	33.2	89.7	45.6	68.0	120.1	89.3	149.8	11.1	73.5	29.5	127.0	120.0	11.0	15.6	44.0	4.0	58.4	31.2	96.8	30.1	68.1	33.5	37.2	40.5	148.5	65.9	52.7	102.5	85.0	29.9	92.6	89.5	66.8	43.9	67.4	9.5	17.3	65.9	34.2	11.3	210.9	29.5	14.8	22.0	11.6	12.5	15.5	11.5	10.2	8.8	12.8	8.3	6.8	5.8	2.0	17.6	9.9	10.3	22.0	8.4	38.0	57.7	50.0	42.7	35.1	44.7	52.7	48.2	54.3	45.1	47.7	77.6	248.8	484.0	98.8	53.5	30.0	56.1	51.8	124.6	56.9	85.9	47.4	45.7	159.3	70.1	77.9	75.4	43.8	122.1	21.6	17.7	109.5	128.1	15.5	109.1	117.2	289.2	22.2	104.8	27.1	423.4	189.8	88.4	19.9	135.3	67.2	132.0	319.2	260.1	85.1	101.0	57.6	7.3	61.1	103.2	59.9	43.6	275.2	71.6	72.9	42.2	135.4	77.0	36.0	68.3	229.4	134.3	22.1	266.7	36.1	65.9	0.1	236.9	52.2	94.8	124.9	74.0	143.8	73.9	257.4	52.8	40.5	227.3	29.2	229.9	11.8	45.9
REC8	"kleisin-alpha, REC8L1, Rec8p"	ENSG00000100918	"REC8 meiotic recombination protein"	O95072	14	24171853-24180257	"Plasma proteins, Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 68.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.6;Gastric mucus-secreting cells: 73.9;Late spermatids: 74.5;Respiratory ciliated cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 10.8;HHSteC: 8.7;MOLT-4: 11.7;SH-SY5Y: 47.4;SuSa: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031727, HPA031729"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA031727: AB_10602920, HPA031729: AB_10669915"	"prognostic favorable (2.19e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (5.57e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.41e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.40e-3)"	9.8	6.1	3.3	2.1	3.2	6.6	2.5	5.2	3.9	6.3	5.3	8.5	1.3	7.1	0.1	2.7	14.9	8.8	2.8	3.4	4.5	12.4	3.3	9.5	3.1	8.9	4.8	3.9	2.7	0.2	68.9	0.6	8.9	7.3	0.4	1.9	4.7	6.2	0.9	1.7	7.3	2.4	3.6	13.6	25.7	29.9	5.3	10.1	3.5	0.3	3.1	4.0	3.7	4.4	0.1	0.2	10.8	0.1	0.4	0.5	0.6	0.4	0.5	1.0	0.8	0.1	1.2	0.2	0.1	0.0	0.6	0.5	0.3	0.0	0.7	1.0	0.2	0.4	0.7	0.0	8.7	0.2	1.5	4.8	0.5	0.4	0.1	4.1	1.9	0.4	0.1	1.4	0.0	0.2	11.7	1.8	3.4	0.0	0.1	0.2	0.0	0.1	0.4	0.4	0.2	47.4	0.0	0.1	0.4	26.0	0.2	0.5	0.4	0.0	0.2	0.3	0.1	1.7	0.5	0.1	0.0	0.2	0.2	2.2	0.1	9.7	4.7	1.1	5.4	1.6	1.7	2.7	3.2	1.7	0.7	2.4	0.1	2.8	5.8	5.2	2.9	1.2	3.3	3.2	5.2	3.9	3.4	4.5	8.9	4.8	8.9	3.6	5.3	4.4	9.5	12.8	10.8	3.6	6.8	1.9	4.4	15.8	8.6	14.9	2.8	2.0	2.0	25.8	14.8	27.6	0.0	1.4	10.2	5.1	5.9	2.9	150.6	43.5	10.6	4.8	4.8	25.9	3.8	2.7	3.2	10.0	73.9	21.9	3.8	7.9	3.6	2.1	2.3	6.7	5.1	2.5	10.2	5.7	3.9	74.5	4.7	6.6	1.8	2.8	4.0	21.1	2.1	5.5	4.6	5.0	0.7	3.0	11.0	1.5	4.1	24.7	51.4	2.0	0.0	3.7	3.9	8.3	43.4	1.3	2.0	0.4	11.3	33.8	2.4	4.0
RECQL	"RecQ1, RecQL1"	ENSG00000004700	"RecQ like helicase"	P46063	12	21468910-21501669	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009743, HPA030960, HPA064259"	Enhanced		Enhanced	Nucleoplasm		NA	NA		25000	"Cluster 15: NK-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230"	"unprognostic (9.70e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.89e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (3.77e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.69e-2)"	28.9	17.1	5.8	33.9	7.4	18.7	18.6	6.9	7.1	19.1	7.5	14.9	11.4	22.3	13.7	19.8	14.9	20.6	26.9	5.7	7.1	14.9	15.7	22.9	40.9	8.9	7.3	14.8	9.9	10.8	5.3	22.2	8.5	15.9	18.2	9.9	10.1	17.8	12.5	18.5	13.5	30.4	7.7	31.6	14.5	10.5	8.0	34.3	16.6	19.7	38.4	26.1	10.3	9.1	61.6	61.1	46.5	34.7	94.3	116.1	52.3	119.9	101.6	76.2	88.7	68.5	49.9	73.6	43.5	83.7	94.0	44.3	51.2	60.4	108.5	122.1	31.9	89.8	65.6	30.0	35.9	62.3	66.1	64.8	30.1	109.0	79.1	67.6	87.2	50.6	33.0	36.1	102.3	31.2	70.0	73.6	77.1	18.3	41.6	56.8	184.7	57.2	29.6	42.5	12.8	35.7	86.9	23.6	62.0	159.0	58.3	37.4	115.6	105.9	67.4	93.9	111.6	14.3	46.3	161.3	88.9	35.9	80.2	21.4	18.6	18.0	31.2	32.3	31.5	30.3	29.3	30.9	24.0	26.6	19.1	26.7	8.7	36.9	31.0	17.8	44.8	24.0	5.8	7.4	6.9	7.1	5.7	7.1	8.9	7.3	8.5	7.7	8.0	9.1	56.1	22.4	18.8	6.2	45.0	23.6	15.4	23.3	22.2	11.8	14.7	14.7	8.7	10.0	22.1	14.7	14.6	13.0	59.0	5.8	9.8	20.3	1.4	15.9	41.0	45.7	9.7	30.3	15.1	24.8	27.5	45.6	7.7	17.6	52.6	23.1	30.7	15.9	27.9	15.2	9.4	6.5	12.2	35.3	26.1	2.2	22.1	50.8	30.2	12.2	50.6	16.9	64.9	10.1	19.1	31.8	4.2	37.6	33.5	7.3	4.3	12.4	25.1	10.8	13.1	33.1	34.9	7.6	12.7	20.8	42.9	3.6	53.6	31.8	8.0	10.5
RECQL4	RecQ4	ENSG00000160957	"RecQ like helicase 4"	O94761	8	144511288-144517845	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Cancer-related genes, Cataract, Craniosynostosis, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;testis: 22.4"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.5;Spermatogonia: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"CAB017800, HPA025821"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB017800: , HPA025821: AB_1856168"	"unprognostic (5.92e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.12e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	1.7	1.8	3.0	5.8	3.7	25.4	2.0	7.7	7.0	2.9	0.1	4.7	6.0	2.5	0.4	13.3	2.1	2.1	1.8	2.6	1.6	2.5	2.7	2.3	6.8	6.9	2.3	2.7	3.1	0.7	3.1	2.5	7.4	8.6	1.6	1.5	5.8	0.8	2.5	10.1	5.2	1.0	1.7	6.5	3.2	22.4	4.1	7.4	3.4	0.5	2.5	2.5	3.1	3.6	33.7	58.8	27.0	57.1	1.6	2.6	47.1	33.2	5.9	24.2	20.2	58.4	48.4	22.8	21.5	5.6	14.2	40.1	18.0	14.2	6.6	40.3	68.6	82.4	118.5	44.3	0.5	21.2	65.7	3.3	2.1	27.1	5.5	3.4	6.8	45.4	83.3	28.9	8.5	104.1	77.3	56.9	18.8	27.8	69.5	80.0	21.2	37.9	6.7	35.8	52.9	32.0	45.2	37.3	12.1	7.4	45.5	45.7	9.2	38.9	117.4	47.3	62.6	16.0	18.1	39.3	22.4	64.6	39.9	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.7	7.7	7.0	2.6	1.6	6.9	2.3	7.4	1.7	4.1	3.6	0.7	0.0	0.0	2.0	2.2	1.5	0.7	0.9	1.2	2.7	3.7	2.7	1.8	1.5	0.5	0.0	4.2	3.9	1.0	5.9	0.0	0.5	3.9	2.1	0.9	0.7	0.0	6.1	2.0	0.4	8.1	1.8	4.6	2.0	0.0	8.8	0.0	0.7	3.6	0.0	1.6	4.1	0.0	0.6	1.1	7.4	1.2	1.0	0.0	0.0	0.3	0.3	1.0	0.0	0.8	0.3	0.2	1.5	9.1	0.7	0.7	0.5	0.7	1.7	0.0	1.4	1.2	23.5	20.6	6.6	1.0	1.5	1.2	0.5	7.0	0.7
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.8	12.0	8.4	12.8	10.3	10.9	9.5	8.1	11.5	11.0	8.2	10.8	22.4	10.4	10.0	20.6	11.4	12.2	7.3	8.1	8.0	18.4	16.4	8.1	18.2	9.9	9.2	13.0	10.9	16.3	20.7	10.2	9.0	12.3	9.6	8.9	14.9	8.7	7.5	21.7	22.9	7.1	7.5	16.1	23.4	19.1	10.9	12.7	20.6	6.4	14.4	10.3	13.4	15.1	19.1	34.6	14.0	19.3	19.1	13.7	31.5	14.1	12.0	18.2	16.1	15.1	19.7	22.8	14.8	12.5	23.7	17.8	14.4	17.2	16.6	12.2	26.7	40.4	46.7	22.0	20.0	13.7	19.5	19.7	20.7	17.9	23.9	21.0	23.4	25.9	21.7	19.4	13.3	16.8	27.5	18.1	8.8	18.6	26.4	21.8	32.3	22.7	15.3	22.0	16.3	16.1	14.9	26.2	19.6	19.3	47.2	10.5	12.1	22.0	25.2	12.5	14.8	27.6	16.8	22.6	18.4	13.0	16.3	6.0	3.3	4.5	3.9	4.1	2.4	3.3	2.5	2.9	3.9	4.3	3.7	2.7	1.9	4.0	2.0	15.7	2.2	3.6	8.4	10.3	8.1	11.5	8.1	8.0	9.9	9.2	9.0	7.5	10.9	15.1	4.9	0.0	11.3	9.1	8.3	1.0	3.3	4.4	3.4	8.3	4.9	5.8	7.3	7.2	6.1	27.6	18.8	8.6	16.2	12.5	5.9	6.1	4.6	13.1	8.1	5.6	4.8	13.0	6.9	3.3	5.2	4.5	42.8	23.9	1.3	11.9	5.7	7.2	5.1	10.1	5.8	9.6	10.2	6.0	0.8	2.2	4.1	9.0	3.6	4.7	3.6	5.1	5.2	8.0	13.3	6.7	9.7	2.6	9.2	3.2	15.0	4.9	14.2	12.9	0.0	4.5	3.8	13.2	11.6	5.4	2.0	11.6	4.0	10.2	6.7	10.0
RELB	REL-B	ENSG00000104856	"RELB proto-oncogene, NF-kB subunit"	Q01201	19	45001449-45038198	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 108.5;monocytes: 112.5;Plasma cells: 108.8;Prostatic glandular cells: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 61.9;HDLM-2: 79.5;U-698: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB007753, HPA040506"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB007753: AB_562340, HPA040506: AB_2677011"	"prognostic favorable (1.55e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.02e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.20e-2)"	17.2	13.1	3.5	18.7	2.9	40.1	12.6	2.9	4.4	9.1	3.1	13.3	10.8	14.1	0.8	8.7	9.2	7.4	12.7	3.1	3.4	21.3	13.0	23.0	19.2	4.9	3.5	6.4	16.5	2.1	4.0	4.8	4.1	15.3	3.9	0.2	12.1	5.2	14.0	16.5	17.7	4.9	3.6	29.1	12.0	4.3	4.6	9.2	10.0	1.4	15.6	13.8	8.1	4.1	22.2	13.0	1.3	5.7	2.8	9.1	4.5	3.9	27.5	5.9	9.6	4.5	23.6	61.9	11.0	6.4	20.8	9.8	0.5	9.0	5.1	79.5	2.0	2.2	0.8	2.5	23.8	4.9	35.3	15.0	3.7	12.3	14.4	5.4	3.9	1.7	0.5	39.2	2.1	5.3	1.1	14.9	2.0	6.3	2.4	4.8	3.2	7.7	10.0	33.7	0.1	2.0	4.1	11.4	11.6	1.4	4.0	11.8	12.6	14.4	7.1	5.3	14.4	49.0	31.2	67.0	15.6	1.7	8.1	0.0	5.1	2.5	1.4	3.4	2.0	9.2	2.2	1.9	3.8	8.0	1.7	0.8	15.2	2.1	2.8	4.1	1.1	2.0	3.5	2.9	2.9	4.4	3.1	3.4	4.9	3.5	4.1	3.6	4.6	4.1	16.4	6.4	12.4	2.3	64.4	37.9	108.5	20.3	40.9	0.0	17.6	11.3	1.8	24.3	15.7	3.7	0.0	4.2	35.0	53.0	9.8	33.1	5.2	15.1	15.2	30.8	22.8	22.5	3.0	31.5	7.3	35.4	65.2	29.1	50.9	3.8	5.0	3.5	18.4	3.3	1.7	33.3	8.2	15.1	74.9	3.4	4.7	44.7	24.9	3.7	112.5	0.8	7.2	1.5	2.5	37.4	90.3	2.6	108.8	145.3	48.0	19.4	7.4	0.3	6.6	28.9	27.3	1.1	1.7	27.7	31.8	9.9	53.8	4.1	16.8	89.7
RELCH	"FLJ33841, HsT3308, HsT885, KIAA1468"	ENSG00000134444	"RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing"	Q9P260	18	62187255-62310249	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.0;Cardiomyocytes: 9.4;Cytotrophoblasts: 6.5;dendritic cells: 8.2;Extravillous trophoblasts: 4.4;Hofbauer cells: 7.2;Plasma cells: 5.2;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039708, HPA040038"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA039708: AB_10794753, HPA040038: AB_10793860"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.44e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.71e-2)"	8.3	8.8	8.7	9.6	10.8	14.2	11.9	11.1	10.0	11.8	7.2	11.5	9.5	8.5	11.8	25.4	7.7	7.9	7.5	9.7	9.3	9.6	7.9	8.0	11.8	7.9	7.6	8.2	8.3	10.3	11.0	8.1	8.2	12.1	14.4	16.3	12.5	8.8	6.8	20.6	10.8	6.2	7.6	11.2	12.7	5.3	8.8	10.8	9.5	5.9	13.2	10.0	16.2	9.4	9.7	8.7	10.4	10.0	10.8	12.7	11.1	17.0	14.1	15.0	16.5	4.5	8.8	6.6	8.6	15.1	9.8	19.7	14.9	10.2	18.3	6.0	9.3	5.6	9.7	10.4	9.6	10.8	7.4	9.4	12.3	12.8	7.8	12.3	10.3	6.2	4.2	6.5	15.9	5.7	6.7	9.3	6.0	6.5	7.3	8.2	13.0	7.9	17.1	19.1	14.7	7.8	10.2	14.9	8.9	13.4	7.7	11.6	12.9	15.9	5.0	6.9	8.6	19.0	3.7	6.4	11.2	11.4	13.0	1.4	1.0	1.2	1.1	0.8	0.8	0.8	1.0	1.0	1.0	0.9	1.1	1.3	1.7	1.1	0.7	0.7	1.3	0.6	8.7	10.8	11.1	10.0	9.7	9.3	7.9	7.6	8.2	7.6	8.8	9.4	7.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	6.5	8.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.6	1.1	0.0	0.0	0.0
RELT	"FLJ14993, TNFRSF19L"	ENSG00000054967	"RELT TNF receptor"	Q969Z4	11	73376399-73397474	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 154.7"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 43.9;Macrophages: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062824, HPA071518"			Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA062824: AB_2684875, HPA071518: AB_2686408"	"unprognostic (3.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.42e-2)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (4.07e-11)"	"unprognostic (1.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-1)"	4.9	2.2	3.4	12.9	6.5	154.7	2.5	6.7	7.7	1.4	0.4	2.3	2.3	1.4	0.5	3.9	1.9	4.5	6.2	3.6	7.0	3.7	2.1	10.9	11.9	8.9	6.8	1.8	0.8	1.1	3.5	4.6	8.1	2.1	1.4	2.2	1.9	0.4	24.3	3.2	7.1	2.6	7.0	20.8	2.2	3.2	6.9	4.6	2.2	6.4	6.9	4.8	2.3	12.6	9.1	8.9	7.0	6.8	0.8	1.0	7.5	9.6	6.2	11.1	6.7	8.5	3.9	16.4	30.9	6.4	8.8	13.1	4.4	4.7	4.3	9.9	8.3	15.4	12.4	3.1	1.8	15.6	26.3	1.1	2.0	11.9	3.5	2.6	4.1	8.4	11.8	21.0	3.1	8.5	11.5	16.5	6.1	6.9	11.0	21.9	11.7	14.2	2.3	3.9	8.9	8.5	8.3	7.5	10.0	1.7	4.1	13.9	5.4	13.8	9.7	23.1	17.6	7.5	6.1	18.2	8.5	15.5	14.8	0.7	12.5	22.2	0.9	25.4	2.0	7.6	1.0	1.7	11.8	5.8	1.3	0.6	19.9	0.4	35.3	11.7	0.5	6.3	3.4	6.5	6.7	7.7	3.6	7.0	8.9	6.8	8.1	7.0	6.9	12.6	5.7	6.4	2.2	3.6	24.2	26.5	15.4	2.8	2.8	3.5	6.1	5.5	2.7	1.5	3.4	0.0	12.5	1.6	33.0	4.7	0.0	3.6	0.9	5.4	5.2	7.2	3.5	5.7	3.1	0.9	10.7	10.1	11.2	10.8	24.8	6.8	1.8	0.2	23.0	30.3	4.5	2.8	6.1	24.2	43.9	1.2	0.0	43.9	5.4	2.8	32.8	8.9	3.1	1.5	4.8	6.7	2.4	0.0	19.2	9.9	1.0	0.5	1.4	2.8	6.6	7.2	14.5	11.7	10.5	4.6	18.3	21.1	16.1	0.6	3.1	17.8
REPIN1	"AP4, H_DJ0584D14.12, RIP60, Zfp464, ZNF464"	ENSG00000214022	"Replication initiator 1"	Q9BWE0	7	150368189-150374044	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 7.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 246.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036022	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA036022: AB_10610417"	"unprognostic (2.73e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.50e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.88e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.59e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (5.56e-4)"	"prognostic favorable (1.61e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-3)"	"prognostic favorable (6.41e-4)"	28.7	77.2	45.1	25.2	43.6	44.1	35.1	43.1	46.4	31.7	54.6	68.4	42.2	37.5	31.8	37.4	40.9	14.6	65.3	37.9	40.0	51.5	86.6	31.7	35.7	52.3	46.7	37.3	67.7	35.5	69.7	12.1	45.5	49.2	28.3	23.7	41.7	23.9	134.5	31.8	56.5	15.4	41.1	56.2	53.1	18.2	49.5	41.0	45.0	66.2	24.8	42.5	25.0	42.1	59.4	71.3	66.1	81.5	15.8	11.3	40.2	28.7	35.2	27.6	23.8	55.5	37.6	65.5	70.9	20.6	48.0	43.4	36.4	11.4	13.9	72.0	54.8	38.4	40.3	70.4	52.3	68.4	60.1	14.7	34.1	15.2	3.5	26.1	39.4	39.1	93.5	39.9	23.1	76.7	95.1	77.4	69.5	39.7	69.9	51.8	76.4	246.3	29.4	103.7	96.9	123.7	43.3	107.5	75.8	27.2	52.8	54.2	42.1	21.2	17.4	23.6	58.7	115.4	46.1	59.8	37.1	59.9	53.3	0.0	1.4	2.7	0.8	0.7	1.3	2.5	1.8	1.5	2.2	2.4	2.3	1.1	1.4	1.8	0.3	7.8	0.8	0.9	45.1	43.6	43.1	46.4	37.9	40.0	52.3	46.7	45.5	41.1	49.5	42.1	21.1	35.3	18.6	17.9	26.9	9.4	18.3	11.5	14.8	57.9	39.3	33.1	46.5	45.8	15.0	14.7	41.7	28.0	49.5	53.7	62.6	37.3	7.8	53.4	14.3	24.3	68.1	14.5	13.0	50.3	12.9	16.1	23.4	35.8	24.7	56.3	26.0	69.7	32.0	80.8	15.8	68.6	32.6	14.8	23.9	9.8	22.1	21.8	16.0	9.4	88.4	101.3	40.2	17.6	16.6	34.3	37.1	19.9	26.4	31.6	47.0	32.8	36.2	55.8	6.6	28.0	20.1	10.2	3.1	17.6	17.8	25.6	16.0	33.5	109.7	19.9
RERG	MGC15754	ENSG00000134533	"RAS like estrogen regulated growth inhibitor"	Q96A58	12	15107783-15348675	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 104.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 202.7;Breast glandular cells: 80.1;Inhibitory neurons: 94.3;Sertoli cells: 92.1;Smooth muscle cells: 80.2"	"Cancer enhanced"	"Detected in all"		"breast cancer: 19.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.2;BEWO: 34.1;T-47d: 66.0;U-2 OS: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041387	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA041387: AB_10796669"	"unprognostic (5.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (8.72e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.61e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	30.7	45.4	8.9	6.8	21.0	0.0	42.5	5.9	16.3	32.0	3.5	37.0	4.1	104.7	50.3	15.1	72.7	11.2	14.0	10.2	12.3	37.0	2.5	16.5	4.3	20.7	12.8	29.0	9.8	4.8	1.4	33.3	21.2	17.0	9.3	0.8	10.2	77.5	5.4	10.2	18.0	83.9	7.7	31.4	20.1	9.0	12.8	2.6	5.8	5.8	2.7	17.4	20.0	9.0	0.0	1.6	0.3	15.2	6.0	0.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.0	0.1	0.0	0.2	0.2	0.0	0.0	4.3	0.1	5.9	0.0	4.7	0.0	1.9	0.8	1.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	1.4	0.7	0.2	0.3	1.7	0.0	0.9	0.1	0.0	0.2	5.8	0.3	0.1	2.2	2.5	2.6	0.0	1.0	66.0	0.0	0.0	0.9	21.5	0.4	0.0	0.1	5.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	21.0	5.9	16.3	10.2	12.3	20.7	12.8	21.2	7.7	12.8	9.0	10.7	0.0	2.2	202.7	0.4	3.8	8.6	0.9	6.2	1.3	80.1	36.2	1.0	5.7	4.0	7.3	0.0	12.0	0.7	0.0	15.6	9.8	20.9	6.5	9.8	6.0	1.8	0.0	20.2	9.8	14.6	28.7	2.6	1.0	0.0	0.1	2.2	0.0	2.1	3.3	94.3	0.0	18.3	0.0	2.3	16.1	22.1	1.1	7.2	41.2	0.0	5.0	0.0	3.0	1.1	2.2	0.0	32.0	0.0	3.5	0.0	33.7	0.1	0.5	92.1	8.2	80.2	8.3	15.0	12.6	5.5	14.0	1.2	16.1	0.0	5.8
RERGL	FLJ22655	ENSG00000111404	"RERG like"	Q9H628	12	18080869-18320107	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	37	"Sertoli cells: 164.3;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	719	"REH: 230.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041740	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041740: AB_10795694"	"unprognostic (3.53e-2)"	"unprognostic (7.03e-4)"	"unprognostic (6.29e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"		"unprognostic (5.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.66e-2)"	43.5	5.4	14.3	2.5	14.8	0.0	29.1	14.7	41.0	25.3	14.6	14.4	3.0	25.2	37.9	7.2	25.8	10.2	6.6	14.3	16.1	15.9	2.1	4.4	1.2	15.4	15.1	19.8	1.8	1.1	1.6	0.0	15.3	7.1	16.8	0.2	3.8	19.4	6.0	11.9	13.4	16.0	14.6	2.7	7.8	2.9	15.7	1.2	13.4	30.2	1.4	11.2	14.7	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	14.8	14.7	41.0	14.3	16.1	15.4	15.1	15.3	14.6	15.7	15.0	6.9	0.0	0.0	2.0	0.1	4.5	0.3	0.0	4.0	0.0	2.8	5.2	4.1	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.7	7.2	0.0	0.0	0.1	0.0	0.5	2.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	6.5	0.4	0.3	0.6	5.4	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.3	0.0	0.6	0.0	0.1	164.3	0.6	381.7	0.1	1.1	0.8	2.4	0.1	0.9	0.3	0.1	0.4
REST	"DFNA27, NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966808	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB068222: AB_2665651, HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	6.9	5.5	5.7	9.4	6.5	24.8	9.8	6.3	7.5	8.8	9.4	6.9	6.4	9.3	8.9	8.2	7.8	7.9	7.6	5.0	5.2	10.9	11.5	8.0	13.4	8.0	6.6	11.2	7.7	13.8	0.5	9.9	7.8	10.0	7.0	7.5	7.8	8.1	5.2	8.9	6.3	8.0	6.6	10.7	8.2	12.3	6.8	18.1	10.9	6.5	13.6	8.7	2.1	7.4	10.8	13.0	17.4	18.2	13.2	16.0	22.7	15.6	13.8	16.0	14.7	11.5	16.5	24.5	23.5	16.8	10.7	9.8	13.2	16.3	24.4	12.6	8.1	22.0	9.4	12.5	16.2	29.0	13.5	16.5	14.6	15.1	16.0	20.5	20.1	19.0	14.3	26.3	19.0	17.3	31.5	21.3	15.2	12.3	8.9	30.0	14.5	8.1	19.0	18.3	0.3	8.1	17.8	18.8	14.6	24.8	19.3	20.3	28.7	20.4	18.1	12.4	14.2	10.8	7.8	15.1	13.2	16.7	10.8	7.4	2.5	7.2	6.2	3.9	6.2	11.6	6.9	5.9	5.2	21.1	10.8	4.4	2.8	6.1	7.9	6.0	9.4	2.5	5.7	6.5	6.3	7.5	5.0	5.2	8.0	6.6	7.8	6.6	6.8	7.4	38.1	70.5	60.2	18.6	51.1	57.1	51.9	33.3	99.6	1.6	42.6	35.2	50.2	42.9	43.3	29.5	81.3	58.0	65.2	21.4	23.5	58.4	9.7	67.3	64.3	50.5	3.6	54.7	0.1	38.2	57.1	40.8	23.9	63.4	51.4	56.3	47.2	31.0	32.2	0.0	0.2	23.5	44.7	36.2	37.9	11.9	39.4	44.0	21.4	12.2	78.0	45.1	71.1	11.1	21.1	45.8	29.0	36.9	44.3	44.3	22.1	24.4	43.3	36.1	32.9	56.5	56.0	58.3	53.8	55.0	45.7	66.4	66.6	62.3	26.1	48.7
RETREG3	"DKFZp686B1036, FAM134C, FLJ33806"	ENSG00000141699	"Reticulophagy regulator family member 3"	Q86VR2	17	42579513-42610623	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 29.8;Collecting duct cells: 31.3;Pancreatic endocrine cells: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016492	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA016492: AB_1853027"	"unprognostic (6.79e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (5.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.43e-2)"	16.2	21.7	17.3	13.2	16.6	6.9	16.9	16.4	18.9	23.0	18.7	19.0	14.2	18.5	21.3	29.2	16.8	10.9	16.2	17.0	17.4	19.5	33.4	17.4	19.5	16.9	18.0	19.6	39.9	18.9	20.4	20.9	17.7	25.5	16.8	31.4	23.2	14.0	22.4	33.9	20.7	15.1	16.8	30.1	22.8	38.7	19.1	20.6	16.3	16.4	21.6	19.4	23.1	15.0	12.0	36.6	15.8	25.8	39.6	21.9	22.5	16.9	22.7	19.6	22.9	17.5	25.3	26.3	23.1	27.5	20.1	45.9	20.5	25.3	18.9	28.2	19.3	10.7	22.2	31.0	27.2	18.6	26.5	33.6	34.2	21.5	21.8	21.7	21.3	19.0	22.3	25.4	15.7	20.7	27.5	26.9	10.0	22.5	9.0	14.7	24.2	27.2	22.5	38.2	28.2	19.3	18.1	14.6	26.1	28.9	41.5	14.2	27.2	21.0	12.8	21.1	16.2	43.4	55.3	22.7	19.3	11.6	16.2	54.9	16.2	36.4	44.5	19.2	39.1	23.7	36.5	42.9	15.1	24.8	35.1	40.4	13.8	28.2	24.1	15.0	57.0	36.4	17.3	16.6	16.4	18.9	17.0	17.4	16.9	18.0	17.7	16.8	19.1	15.0	16.7	25.6	29.8	0.0	8.8	0.0	0.0	0.0	0.0	0.0	21.7	18.3	0.0	0.0	6.2	31.3	0.0	22.4	24.7	0.0	7.9	16.4	0.0	14.5	16.7	7.4	0.0	0.0	0.0	25.4	16.0	7.4	0.0	20.0	7.6	26.8	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.8	0.0	0.0	8.8	0.0	0.0	13.4	5.1	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	20.4	8.1	17.3	0.0	0.0
REV3L	"POLZ, REV3"	ENSG00000009413	"REV3 like, DNA directed polymerase zeta catalytic subunit"	O60673	6	111299028-111483715	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.8"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 290.6;Endometrial stromal cells: 610.1;Inhibitory neurons: 360.2;Oligodendrocyte precursor cells: 594.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064853, HPA069382"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA064853: AB_2685369, HPA069382: AB_2686134"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.59e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-3)"	6.1	3.6	11.2	6.4	9.2	7.2	3.1	28.8	11.9	16.6	11.3	4.8	4.3	10.3	2.3	4.6	6.2	4.9	4.4	7.2	10.0	4.1	3.5	4.4	5.6	3.6	7.9	7.6	4.2	3.2	0.9	6.8	4.4	4.8	3.5	26.2	3.2	5.0	5.0	4.7	3.6	8.0	1.8	4.6	4.5	7.5	8.4	6.0	6.6	12.2	2.5	4.8	1.0	10.7	9.2	6.3	11.4	13.3	35.2	35.0	11.9	13.6	16.7	6.4	9.6	8.1	5.0	17.0	9.3	15.9	12.0	9.4	17.6	5.7	10.7	13.9	10.0	13.9	13.9	13.3	9.1	13.5	6.9	21.0	3.2	12.0	15.4	10.3	10.2	10.0	18.3	13.9	10.8	7.2	16.7	3.6	3.2	3.8	10.2	11.6	12.7	6.6	2.5	7.9	15.7	11.8	17.5	3.2	12.4	8.5	7.1	14.2	13.7	9.6	9.6	47.0	15.4	14.0	17.1	17.6	9.1	10.5	12.4	0.6	0.6	1.2	1.0	0.5	1.6	1.0	0.8	1.0	0.6	1.6	0.5	1.0	1.9	0.4	0.9	0.9	0.7	0.3	11.2	9.2	28.8	11.9	7.2	10.0	3.6	7.9	4.4	1.8	8.4	10.7	133.4	48.1	82.4	290.6	65.7	30.5	19.5	12.8	45.5	117.5	20.2	17.9	34.5	11.5	29.1	20.2	56.3	27.2	35.3	11.8	3.9	17.3	40.0	151.1	610.1	57.4	59.8	27.5	161.7	11.5	11.9	82.7	41.3	107.5	46.9	61.5	21.8	16.0	11.8	35.3	360.2	18.6	10.2	19.9	87.4	16.3	50.4	57.2	21.4	105.9	23.7	59.6	33.0	594.7	190.3	8.5	12.3	39.1	41.3	21.3	18.4	15.9	43.5	57.6	39.5	122.3	62.3	68.5	70.4	26.1	26.9	33.0	46.4	30.3	21.5	8.2
REXO1	"EloA-BP1, KIAA1138, TCEB3BP1"	ENSG00000079313	"RNA exonuclease 1 homolog"	Q8N1G1	19	1815248-1848483	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.2;Late spermatids: 214.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042155, HPA042552"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA042155: AB_10806233, HPA042552: AB_10794280"	"unprognostic (1.36e-1)"	"unprognostic (3.86e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.70e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-2)"	13.3	27.8	15.0	10.4	21.3	18.9	12.7	2.2	18.5	10.5	0.0	14.5	9.9	14.0	2.5	12.8	11.7	6.2	12.7	16.8	1.6	12.2	16.4	12.5	13.1	3.7	2.3	13.5	13.3	5.6	9.5	10.0	2.0	11.7	4.2	4.8	10.5	5.2	16.2	18.6	14.0	4.5	0.3	23.6	12.2	30.1	7.2	9.2	11.4	6.2	5.6	12.3	10.9	8.4	20.8	13.1	11.8	18.4	4.6	6.0	23.7	14.7	7.8	10.5	9.4	17.1	11.2	17.6	9.7	10.3	6.8	17.9	9.0	16.5	4.6	28.2	13.8	18.6	15.3	10.1	10.4	16.5	29.3	10.6	9.3	13.9	9.2	6.0	9.7	24.8	28.4	29.8	5.5	13.0	27.5	18.6	26.6	8.3	12.8	24.3	9.8	16.7	7.0	11.6	17.3	19.0	9.2	15.3	19.3	7.8	13.4	24.1	16.9	16.6	14.3	27.9	24.8	47.9	24.8	15.1	13.3	19.7	21.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	15.0	21.3	2.2	18.5	16.8	1.6	3.7	2.3	2.0	0.3	7.2	8.4	17.1	0.0	5.9	7.2	12.6	15.9	8.0	6.9	14.2	19.5	11.3	9.1	1.3	5.7	7.3	18.4	8.4	21.9	20.8	27.9	1.9	7.3	161.2	14.2	13.8	13.2	18.4	10.8	7.9	8.5	10.6	9.7	23.4	23.8	5.7	20.1	13.2	14.2	11.0	47.1	6.2	16.4	2.0	8.8	10.5	214.3	7.5	12.7	7.2	10.3	7.3	7.3	11.3	6.6	6.9	14.0	17.2	7.5	15.9	11.8	11.4	8.7	3.9	20.0	0.0	15.1	10.2	14.8	18.3	17.9	16.8	20.5	14.6	33.7	18.9	12.0
REXO4	"hPMC2, XPMC2H"	ENSG00000148300	"REX4 homolog, 3'-5' exonuclease"	Q9GZR2	9	133406059-133418096	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047006	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA047006: AB_2679900"	"unprognostic (2.69e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (2.15e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.20e-1)"	12.6	15.7	8.6	6.7	8.9	5.1	12.3	9.0	9.4	16.0	8.1	14.8	5.7	12.7	3.8	18.2	12.2	4.5	16.3	8.7	8.6	15.6	22.6	10.5	8.7	8.7	8.7	18.0	21.4	5.1	13.0	5.8	8.9	15.7	3.9	3.5	13.1	4.7	35.4	17.0	14.3	3.9	8.7	18.8	14.1	18.2	8.8	8.3	12.8	9.7	6.6	16.2	15.1	9.2	9.8	22.2	10.3	15.1	10.5	10.7	18.2	16.4	9.3	17.0	11.2	26.8	12.3	31.5	11.0	9.0	13.9	26.0	21.5	17.2	9.7	20.5	19.8	17.2	23.7	21.1	13.0	39.4	16.1	10.1	14.4	17.9	24.4	13.0	12.6	16.8	38.3	13.5	11.0	28.1	27.9	23.7	20.8	35.0	32.2	19.7	16.7	31.5	10.8	9.1	29.1	15.9	17.4	20.2	19.4	10.1	24.7	15.7	11.1	30.9	16.1	14.7	20.3	8.8	11.5	21.6	11.5	22.5	18.7	0.4	1.3	2.0	1.9	1.3	2.2	2.4	2.0	2.0	1.1	2.8	2.5	2.7	0.1	3.9	1.1	1.8	2.0	1.0	8.6	8.9	9.0	9.4	8.7	8.6	8.7	8.7	8.9	8.7	8.8	9.2	16.8	22.4	15.0	4.9	29.7	25.0	22.3	12.9	10.2	26.6	27.0	23.5	9.9	21.5	8.5	25.8	22.9	37.5	27.8	24.2	19.6	29.2	38.2	36.6	34.5	17.4	13.2	7.6	4.4	28.7	36.2	14.7	7.1	32.7	17.7	24.2	19.6	26.8	21.3	16.8	4.6	22.2	4.1	22.4	11.5	83.3	28.9	13.2	7.2	1.9	37.9	17.6	51.5	1.5	5.0	30.6	21.7	24.0	18.4	25.3	30.8	28.2	10.4	34.1	19.7	13.1	16.9	51.6	65.9	10.7	27.6	31.5	24.9	16.4	35.8	13.7
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115"	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	15.6	19.0	13.7	16.7	19.2	33.1	22.2	15.4	15.6	16.9	12.0	15.3	13.3	19.2	17.4	13.8	14.6	12.2	16.5	13.5	14.9	20.8	25.5	18.2	30.2	16.5	15.6	26.1	29.0	31.4	14.7	14.6	18.0	17.8	14.8	24.3	16.6	16.1	11.6	14.9	13.8	17.1	15.4	17.0	14.9	11.8	14.8	28.0	23.1	15.9	30.2	13.5	14.1	25.5	43.5	19.4	53.7	44.1	25.4	32.0	27.5	49.1	44.6	49.2	58.2	37.8	43.1	106.5	32.4	33.2	52.8	20.7	49.8	42.6	78.5	19.5	33.9	48.0	35.6	34.7	30.6	67.5	30.7	24.6	33.8	49.9	55.3	39.1	38.8	52.1	48.0	22.1	37.9	17.5	99.7	43.4	33.0	26.8	24.2	78.1	97.8	33.7	21.4	30.1	37.6	36.4	29.1	11.3	37.6	33.4	29.8	37.5	30.0	40.3	49.6	37.8	63.1	31.0	45.8	101.3	33.1	69.3	41.2	8.2	8.6	3.8	13.7	6.9	10.1	14.6	11.7	11.9	6.9	16.1	13.8	12.2	3.9	12.6	8.9	14.3	11.5	5.5	13.7	19.2	15.4	15.6	13.5	14.9	16.5	15.6	18.0	15.4	14.8	25.5	65.5	64.1	120.6	33.0	62.9	20.6	37.9	26.5	47.3	67.8	60.5	62.4	86.1	45.8	37.0	57.0	60.5	43.1	83.8	30.6	72.4	54.8	73.0	45.9	79.1	56.1	30.0	57.9	22.0	66.0	48.5	54.9	28.1	60.0	25.9	82.2	57.8	82.0	30.7	85.8	32.1	58.2	12.2	44.3	16.6	32.3	82.0	35.1	16.0	22.5	58.1	82.7	107.1	38.7	95.7	51.1	34.2	91.7	75.0	50.0	36.1	124.2	32.6	83.3	59.2	61.6	54.6	49.0	66.5	38.2	21.3	32.2	63.7	70.8	49.1	44.5
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	12.2	9.5	10.6	13.4	10.9	27.4	15.5	11.4	11.5	12.6	11.1	13.4	9.0	9.6	8.4	18.6	10.1	8.6	10.1	10.5	10.9	14.7	21.2	11.3	23.5	11.7	11.3	11.3	13.3	11.8	7.9	18.4	11.4	11.5	15.0	8.8	12.2	7.6	18.8	20.3	11.2	12.6	11.5	14.2	13.6	10.0	10.7	20.2	9.2	12.2	30.8	11.5	12.6	11.8	74.3	55.6	65.2	64.6	13.1	15.2	29.4	42.5	46.7	85.2	101.4	62.6	67.3	69.2	11.5	30.7	78.7	49.7	53.3	69.2	87.5	49.6	91.5	42.9	76.4	46.7	10.1	64.6	25.3	15.4	15.9	79.8	55.0	18.5	46.0	63.9	89.4	41.9	66.4	87.2	65.1	124.7	74.1	116.3	47.4	95.0	72.0	85.8	45.7	58.1	52.4	65.5	50.7	94.8	34.7	79.2	68.7	58.0	17.4	83.4	54.9	64.6	96.3	25.1	35.1	120.6	42.4	98.4	89.3	33.4	36.7	27.3	18.0	42.3	18.1	31.6	15.5	16.5	31.9	36.8	19.5	14.3	46.4	42.9	40.1	17.1	23.9	29.1	10.6	10.9	11.4	11.5	10.5	10.9	11.7	11.3	11.4	11.5	10.7	11.8	15.4	12.8	11.1	2.6	19.0	23.8	24.3	24.3	19.9	13.2	12.6	17.4	6.1	5.7	16.5	5.5	2.1	68.6	17.5	12.4	5.9	21.0	2.8	8.1	13.3	13.5	4.8	38.3	3.0	19.0	65.0	17.4	10.7	11.5	23.4	25.1	13.6	14.0	37.7	3.3	2.6	13.1	20.3	14.4	28.2	2.5	8.7	18.2	21.4	1.9	26.3	16.1	23.7	1.5	2.2	13.8	6.9	10.9	17.5	11.0	13.2	13.8	8.8	9.5	6.6	14.6	17.5	33.8	44.6	20.1	17.0	46.1	16.9	12.9	19.1	15.3
RFC3	"MGC5276, RFC38"	ENSG00000133119	"Replication factor C subunit 3"	P40938	13	33818069-33966558	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 285.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030149	Approved		Supported	Nucleoplasm,Vesicles		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"		"HPA030149: AB_10602921"	"unprognostic (3.86e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.02e-3)"	"unprognostic (4.49e-1)"	"unprognostic (6.46e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.86e-1)"	5.3	13.8	2.6	12.9	2.4	19.5	12.8	8.7	2.6	5.7	1.7	9.0	8.5	10.6	4.3	6.7	8.3	4.6	6.1	2.7	2.5	5.1	7.4	5.4	24.3	2.7	2.2	7.8	4.8	5.1	2.6	10.8	2.8	6.3	11.6	5.9	5.5	4.1	3.5	7.5	7.9	7.6	3.7	6.6	6.5	12.8	2.6	24.1	6.5	4.4	23.4	5.7	4.6	2.5	49.0	51.1	86.4	69.5	6.5	10.0	47.5	66.6	29.2	85.5	73.7	63.0	72.2	179.8	26.8	25.3	53.2	72.5	111.6	45.9	112.0	71.5	68.9	105.0	54.4	68.0	7.5	127.2	48.3	9.8	5.8	74.5	49.9	14.1	28.9	63.7	75.1	44.2	51.4	56.1	108.8	58.1	104.2	101.2	42.1	40.3	103.4	41.1	25.4	42.7	45.1	79.2	49.4	65.3	33.4	45.7	52.2	66.8	15.5	45.1	49.7	57.1	70.9	24.9	36.7	285.3	32.4	73.7	86.6	1.5	4.4	7.2	3.2	6.1	3.7	5.8	3.9	3.3	6.1	5.5	5.0	4.5	0.9	2.5	5.3	2.5	6.3	3.1	2.6	2.4	8.7	2.6	2.7	2.5	2.7	2.2	2.8	3.7	2.6	2.5	9.3	9.6	6.2	5.9	11.2	12.2	6.9	6.9	7.4	16.5	8.9	10.5	7.5	1.5	8.6	3.7	8.4	29.6	5.1	3.0	3.9	7.3	8.4	7.0	7.9	9.4	6.1	43.8	30.2	8.9	39.3	7.5	3.1	7.7	1.3	17.8	8.9	7.2	11.9	8.4	20.3	4.3	4.1	6.7	4.0	7.9	6.2	6.5	8.8	34.7	6.4	5.4	1.0	33.7	18.0	5.4	1.5	4.5	21.0	2.7	1.1	5.4	3.8	12.2	6.6	7.9	29.8	52.6	43.2	9.2	7.0	16.4	6.6	9.2	10.1	3.3
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 55.7;Spermatocytes: 86.7;Spermatogonia: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favorable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.0	6.0	7.3	19.3	7.6	41.5	13.8	8.9	11.9	8.8	7.4	15.4	10.9	14.1	6.6	11.8	10.8	7.7	9.1	7.5	7.5	7.3	10.7	7.2	31.5	7.3	7.4	15.0	11.0	8.0	5.7	14.5	7.6	7.7	20.4	11.2	8.6	7.0	8.3	11.7	11.7	17.6	7.5	14.3	10.4	22.7	8.1	35.7	7.3	6.7	34.5	7.8	8.2	8.3	167.3	56.2	130.8	83.6	18.8	20.1	103.0	78.9	49.9	123.6	135.8	84.8	77.9	119.5	177.4	38.0	118.0	86.1	116.5	77.5	151.1	180.5	102.5	123.3	86.3	86.3	14.6	131.8	79.5	17.3	27.5	84.9	66.1	27.6	42.0	183.8	97.9	165.4	85.3	79.7	167.2	122.8	116.0	148.1	76.0	129.9	112.5	164.3	44.9	60.7	126.3	63.3	97.3	107.6	90.3	97.6	183.0	123.7	19.6	74.4	93.3	125.8	239.9	91.9	216.9	398.9	65.3	142.8	100.0	0.0	2.8	9.7	11.5	4.2	11.1	13.1	11.4	12.0	5.0	15.1	11.2	10.2	0.6	9.8	14.7	9.6	21.8	7.7	7.3	7.6	8.9	11.9	7.5	7.5	7.3	7.4	7.6	7.5	8.1	8.3	5.1	0.0	2.2	3.3	14.0	6.0	15.3	18.1	5.2	16.1	4.1	8.1	7.5	5.7	9.3	11.0	0.0	43.0	9.7	4.4	5.9	15.3	27.3	5.6	7.0	6.1	1.2	46.3	5.2	16.6	55.7	8.3	6.6	6.0	8.2	25.3	6.1	3.0	23.9	8.4	4.4	7.1	10.2	2.6	4.9	10.0	10.5	6.2	1.8	4.7	12.2	14.9	9.2	2.5	4.3	9.2	4.1	7.9	23.8	3.8	2.8	7.9	7.9	14.4	6.6	10.2	13.1	86.7	50.5	7.9	3.0	11.2	9.6	8.8	13.9	4.7
RFC5	RFC36	ENSG00000111445	"Replication factor C subunit 5"	P40937	12	118013588-118033130	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041037	Supported		Approved	Nucleoplasm		NA	NA		6500	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA041037: AB_10805834"	"unprognostic (9.63e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (5.12e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.06e-1)"	5.9	5.8	3.7	10.5	4.4	33.8	10.7	5.9	4.9	8.6	4.2	10.3	9.8	11.1	5.4	9.3	9.5	6.7	5.4	6.0	2.9	8.7	13.0	6.8	16.4	3.3	3.2	15.6	7.6	7.1	4.7	7.3	3.2	7.9	12.6	11.5	5.8	8.0	5.6	12.9	9.1	7.7	3.8	8.0	7.2	8.3	3.7	23.4	10.3	4.7	16.1	6.3	7.1	4.3	52.8	49.3	49.1	28.1	12.2	14.7	58.3	38.4	24.0	66.6	49.9	50.2	21.4	56.4	25.9	18.1	42.0	47.2	66.9	34.0	63.2	42.1	58.1	43.9	40.7	36.5	7.6	70.7	38.1	7.8	12.2	50.0	16.8	30.4	28.6	70.3	62.6	21.6	33.3	50.3	93.2	59.2	40.5	29.8	46.1	68.1	61.2	55.3	30.7	47.7	67.5	30.7	62.2	18.2	24.1	30.4	64.4	30.0	13.7	36.9	42.5	50.4	69.5	36.2	51.7	76.9	36.4	51.7	66.1	16.6	5.0	3.6	8.6	8.4	7.6	10.7	10.3	7.4	7.2	9.1	8.0	6.9	5.6	7.9	4.9	6.0	11.4	6.5	3.7	4.4	5.9	4.9	6.0	2.9	3.3	3.2	3.2	3.8	3.7	4.3	4.0	0.0	3.3	4.6	5.6	8.4	6.9	7.1	4.0	4.2	5.2	4.7	3.1	4.3	4.6	9.2	2.1	21.0	4.7	3.6	9.8	8.9	3.0	6.0	6.3	4.3	4.2	45.7	11.8	6.3	25.2	6.4	4.1	6.5	5.7	14.0	3.3	6.0	9.1	1.7	7.3	6.9	4.1	3.2	3.1	2.7	4.1	4.9	0.0	3.7	3.8	9.5	2.1	2.5	5.5	4.1	4.0	8.2	16.4	2.3	3.2	6.6	11.0	6.0	0.0	5.3	8.4	13.4	9.1	9.5	5.4	8.9	7.9	18.7	10.6	4.2
RFESD		ENSG00000175449	"Rieske Fe-S domain containing"	Q8TAC1	5	95646754-95684773	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 26.9"	"Cell type enriched"	"Detected in many"	7	"Erythroid cells: 278.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 41.3;K-562: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016546	Uncertain		Approved	Nucleoplasm		NA	NA		48000	"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB016546: AB_630417"	"unprognostic (1.15e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.09e-1)"	1.7	2.3	1.3	1.1	1.7	26.9	2.8	2.1	3.4	2.2	1.8	1.8	1.2	2.0	4.4	2.4	2.0	1.2	3.5	1.4	1.6	2.5	2.5	1.5	3.1	1.8	1.6	2.9	3.6	3.9	2.8	1.6	1.7	3.1	1.4	3.6	4.7	1.4	5.8	7.6	1.4	1.4	1.6	2.4	2.5	12.2	1.7	4.9	3.3	3.5	3.2	2.3	1.9	2.2	3.6	5.5	1.0	3.5	3.4	6.2	0.0	1.9	2.9	3.1	3.1	4.4	3.8	5.8	3.8	1.6	7.3	5.2	3.8	3.0	3.3	8.7	3.3	41.3	5.2	1.6	4.3	3.8	4.2	2.8	5.5	4.0	3.6	2.8	3.1	17.1	78.3	4.5	4.9	2.4	12.4	16.4	4.4	1.6	5.2	6.0	0.7	2.6	1.1	2.1	5.3	3.8	5.4	2.4	0.0	0.3	2.8	2.0	1.6	3.9	3.1	2.9	3.4	3.9	10.1	4.7	3.4	4.5	2.1	0.0	0.7	0.4	3.6	0.9	9.6	3.9	8.7	6.2	1.6	3.3	12.7	7.5	0.0	6.1	0.9	1.9	5.4	2.7	1.3	1.7	2.1	3.4	1.4	1.6	1.8	1.6	1.7	1.6	1.7	2.2	2.0	12.8	3.3	1.6	2.8	3.2	4.5	6.0	3.4	2.1	2.3	3.4	7.8	0.0	5.5	1.8	0.0	3.5	4.2	0.5	1.9	2.4	18.2	2.3	2.4	1.4	0.0	278.7	1.6	1.8	12.1	3.2	2.0	1.8	3.8	2.0	2.9	2.1	3.8	1.7	1.9	1.1	14.2	1.6	0.8	8.5	1.8	1.2	0.0	2.8	2.3	3.8	3.1	0.0	1.7	1.7	0.3	1.2	1.0	2.5	0.9	2.9	5.3	1.9	6.6	2.8	2.7	37.2	14.3	4.5	6.8	2.1	4.6	2.5	1.2	2.5
RFLNA	"Cfm2, FAM101A, FLJ44614, RefilinA"	ENSG00000178882	"Refilin A"	Q6ZTI6	12	123973241-124316024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 94.7"	"Cell type enriched"	"Detected in some"	22	"Pancreatic endocrine cells: 113.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 13.8;HUVEC TERT2: 19.8;LHCN-M2: 34.8;OE19: 37.0;RH-30: 11.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA058911, HPA078021"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA058911: AB_2683853, HPA078021: AB_2732368"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.78e-4)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (8.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-8)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	3.4	1.1	3.2	2.2	3.8	0.0	1.8	5.7	3.2	10.2	5.4	15.2	13.9	1.7	0.4	0.6	2.9	0.6	0.7	2.7	3.4	2.4	0.1	1.2	0.2	19.1	4.2	2.9	0.3	0.3	2.1	0.6	19.4	4.3	10.4	0.3	2.2	0.3	5.5	1.3	15.2	0.5	3.9	0.1	94.7	0.2	3.7	0.2	0.1	3.2	0.1	0.5	1.3	3.4	0.0	0.0	2.7	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.4	1.8	1.3	0.0	0.1	4.9	0.2	0.0	2.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.2	0.8	0.0	13.8	0.1	0.8	19.8	2.1	0.0	0.0	34.8	0.0	0.1	0.0	2.9	37.0	0.0	0.0	11.1	0.2	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.8	5.7	3.2	2.7	3.4	19.1	4.2	19.4	3.9	3.7	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.0	0.1	0.5	0.1	0.0	0.0	0.0	2.6	0.1	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RFNG		ENSG00000169733	"RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q9Y644	17	82047902-82051831	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HHSteC: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011564, HPA031673"	Uncertain		Approved	Nucleoplasm		No	No		1100000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA011564: AB_1079803, HPA031673: AB_2673989"	"unprognostic (4.17e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.14e-2)"	28.3	24.3	9.9	3.8	9.7	10.2	24.6	8.5	11.8	25.5	7.8	26.5	11.1	25.3	1.6	24.1	23.0	10.9	19.5	8.7	9.0	22.9	78.5	18.7	5.4	10.4	9.3	29.7	42.6	11.1	20.0	5.9	9.5	23.5	3.2	1.4	22.0	6.9	45.4	27.1	16.7	7.7	9.0	14.9	27.7	23.2	9.6	4.6	19.8	10.5	2.7	24.0	18.6	9.7	20.3	19.2	5.6	19.1	13.9	11.8	24.4	18.5	10.1	8.2	6.2	11.6	13.7	4.5	13.0	29.1	17.4	10.8	3.9	15.8	1.5	6.0	19.7	6.7	4.4	48.5	69.3	2.4	14.2	22.5	9.9	14.7	24.9	16.5	15.8	15.2	8.5	16.9	6.6	24.1	15.1	6.5	5.5	13.5	20.1	10.2	7.0	10.6	9.5	11.8	9.7	24.9	7.1	10.7	54.7	6.2	32.1	13.7	6.1	13.1	17.9	12.7	10.2	22.9	4.5	5.0	16.8	4.4	11.7	1.0	1.9	2.0	1.7	0.5	0.6	1.0	1.1	1.6	1.4	1.2	1.1	0.6	0.7	0.2	0.7	1.1	2.5	0.6	9.9	9.7	8.5	11.8	8.7	9.0	10.4	9.3	9.5	9.0	9.6	9.7	24.3	6.4	12.4	30.7	7.6	9.7	11.9	8.3	6.8	26.9	33.3	35.4	12.8	18.6	5.6	23.9	25.0	5.5	14.2	20.9	7.9	7.8	3.7	14.9	24.4	12.1	11.4	5.7	20.7	15.1	3.3	27.2	18.8	19.0	1.3	52.5	21.8	47.1	9.6	11.8	20.3	14.0	12.2	15.2	6.3	13.3	21.8	14.7	10.6	16.9	6.2	29.8	3.1	20.6	13.5	12.4	16.3	19.9	4.9	15.9	14.0	31.3	6.8	27.8	0.0	28.0	19.4	14.4	6.2	9.0	10.2	3.7	10.4	32.8	13.5	8.7
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621399-74666877	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 47.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	5.2	3.9	2.5	9.9	3.5	47.7	7.6	4.0	3.2	6.4	4.4	8.0	6.5	6.2	5.3	9.4	6.8	6.5	2.9	2.3	2.9	6.7	5.8	6.1	15.4	3.3	3.1	7.0	10.2	6.8	3.8	8.0	3.2	4.9	9.3	6.2	5.8	5.1	3.3	12.6	6.1	6.1	2.8	8.1	6.2	25.2	3.4	27.1	6.6	2.7	16.7	7.2	6.8	4.7	46.1	57.5	42.6	31.2	8.8	11.9	47.8	40.5	30.9	63.0	54.5	75.4	46.8	63.6	32.1	31.8	31.6	53.9	70.3	42.1	76.9	20.0	42.1	56.3	46.0	43.0	7.6	57.3	56.3	8.6	13.2	79.6	48.7	16.3	27.3	53.2	86.7	27.7	48.1	72.8	84.0	52.2	84.0	26.8	27.7	128.7	28.8	55.9	22.7	47.8	31.5	33.6	65.2	22.8	28.8	38.2	41.7	48.4	26.7	46.0	43.9	26.2	51.4	37.4	75.1	188.3	32.8	43.5	57.0	12.1	4.4	6.5	5.5	4.1	6.1	4.9	4.5	5.1	4.6	5.4	6.7	4.8	4.9	6.2	7.7	3.5	7.2	4.4	2.5	3.5	4.0	3.2	2.3	2.9	3.3	3.1	3.2	2.8	3.4	4.7	6.0	0.0	5.9	4.2	13.2	10.8	6.8	4.0	10.2	6.6	8.4	8.3	3.9	2.8	5.4	1.8	10.4	12.1	15.3	7.6	11.7	6.2	5.4	6.9	5.7	7.2	9.5	22.5	8.9	7.6	8.3	5.9	5.1	6.6	4.5	13.5	11.7	7.4	8.9	3.3	7.1	9.7	2.0	12.2	6.0	6.3	3.7	7.8	16.0	15.0	7.6	3.0	10.3	6.6	15.2	10.0	2.7	4.1	11.6	12.7	4.3	4.6	5.9	6.7	6.6	6.4	5.6	48.5	31.7	9.5	9.2	7.5	10.6	3.6	9.5	11.4
RFX1	EF-C	ENSG00000132005	"Regulatory factor X1"	P22670	19	13961530-14007039	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 144.2;Late spermatids: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048722, HPA052966"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA048722: AB_2680500, HPA052966: "	"unprognostic (6.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (5.45e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.56e-2)"	5.8	6.1	1.2	2.0	1.2	2.4	6.4	4.3	2.4	9.8	0.5	6.0	2.3	7.0	0.8	7.7	7.4	1.3	7.4	1.3	1.6	7.2	8.7	6.6	1.7	1.1	1.1	8.8	7.8	2.2	16.6	1.5	0.7	8.0	0.5	1.1	7.3	1.6	7.9	7.4	7.1	0.6	0.5	9.2	6.7	22.1	2.0	1.7	9.9	0.8	1.0	5.9	7.7	0.8	3.3	3.2	1.7	2.1	1.0	1.2	5.1	1.8	1.1	2.0	1.7	3.3	3.2	1.8	3.6	0.9	1.7	4.2	1.2	1.2	0.7	2.0	7.0	2.1	3.8	3.0	1.8	2.1	4.3	0.9	1.3	1.8	1.0	1.7	1.5	1.5	5.5	1.9	1.0	4.8	3.9	4.6	3.9	1.7	4.8	3.4	1.8	2.6	1.9	1.7	6.9	3.7	3.0	2.6	2.6	0.9	2.9	2.2	1.8	3.4	2.8	3.8	3.1	4.7	2.3	1.2	2.7	2.0	3.1	0.2	1.1	0.6	0.4	0.4	0.4	1.0	0.5	0.5	0.6	1.1	0.5	0.6	3.7	1.1	0.7	1.2	0.3	0.4	1.2	1.2	4.3	2.4	1.3	1.6	1.1	1.1	0.7	0.5	2.0	0.8	26.1	16.0	8.9	3.6	25.9	5.6	8.8	8.7	10.8	29.6	25.9	21.1	11.2	14.3	11.3	22.0	35.5	9.7	34.4	24.0	9.8	11.9	144.2	14.3	31.2	13.4	16.7	29.9	12.0	9.6	12.7	14.5	14.3	25.2	11.4	10.2	20.3	17.5	10.7	23.5	10.2	19.5	10.2	24.5	12.0	119.2	25.7	17.2	1.8	10.3	15.4	13.4	14.4	4.5	4.9	9.7	14.0	27.8	19.9	6.8	13.8	17.4	4.6	46.7	13.1	25.8	13.1	33.9	20.5	7.8	7.5	19.0	20.4	8.3	15.6	6.7
RFX2	FLJ14226	ENSG00000087903	"Regulatory factor X2"	P48378	19	5993164-6199572	"Predicted intracellular proteins, Transcription factors"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 56.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.2;Early spermatids: 163.7;Late spermatids: 196.2;Respiratory ciliated cells: 103.8;Spermatocytes: 113.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"neutrophil: 23.6"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 19.4;SCLC-21H: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048969	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA048969: AB_2680577"	"unprognostic (1.31e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.72e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.07e-1)"	9.8	2.0	9.0	2.2	8.0	9.5	6.9	12.1	8.1	5.9	35.2	19.4	3.3	16.2	1.2	8.0	20.8	5.0	7.8	10.4	8.7	2.2	1.7	10.5	1.5	15.5	21.2	6.7	4.4	1.8	10.4	0.9	12.7	6.0	1.8	1.3	3.2	2.3	2.0	11.2	8.8	5.3	15.4	2.9	7.0	56.9	12.7	4.2	3.5	0.6	1.6	9.6	6.3	11.7	5.3	3.9	6.2	12.3	3.2	1.9	3.9	3.3	4.3	2.6	4.1	1.8	6.0	5.7	3.4	4.1	5.7	7.6	1.6	6.2	3.6	1.4	0.9	8.8	4.0	1.8	3.6	4.1	19.4	2.2	5.3	5.8	3.0	3.1	4.0	7.7	6.0	0.2	2.6	2.6	7.7	5.5	1.7	6.8	2.6	2.1	3.9	0.6	3.3	9.5	24.2	3.4	3.0	2.4	1.7	0.6	4.2	4.3	6.1	1.1	5.6	4.3	3.3	8.2	2.9	3.3	3.2	14.4	2.3	0.0	2.7	1.1	0.1	0.5	0.0	0.4	0.5	0.3	2.1	0.2	0.5	0.6	23.6	0.7	1.6	0.0	0.1	0.8	9.0	8.0	12.1	8.1	10.4	8.7	15.5	21.2	12.7	15.4	12.7	11.7	12.0	25.6	31.6	84.2	2.6	26.4	33.7	11.5	12.5	3.6	8.5	10.9	7.6	15.7	26.0	3.7	2.1	5.9	2.0	4.1	3.9	5.6	163.7	69.0	9.5	13.2	13.8	6.5	5.2	1.8	8.8	23.0	2.6	4.7	46.2	14.7	12.1	2.8	7.0	0.0	5.5	4.4	2.0	6.2	17.3	196.2	8.1	13.0	7.2	8.4	5.1	5.7	5.2	3.0	1.8	3.5	1.6	4.1	2.4	7.9	4.6	2.1	103.8	3.5	26.3	49.2	11.4	113.2	13.5	6.3	22.0	5.6	5.6	2.6	5.1	22.0
RFX3		ENSG00000080298	"Regulatory factor X3"	P48380	9	3218297-3526004	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.3;choroid plexus: 40.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 394.4;Early spermatids: 182.8;Excitatory neurons: 333.6;Inhibitory neurons: 208.8;Microglial cells: 188.3;Oligodendrocyte precursor cells: 256.9;Oligodendrocytes: 179.6;Respiratory ciliated cells: 150.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 26.4;HDLM-2: 16.2;SCLC-21H: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035689	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA035689: AB_10671224"	"prognostic favorable (1.47e-4)"	"unprognostic (8.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.49e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.52e-1)"	"unprognostic (8.89e-3)"	3.0	1.9	10.0	2.0	14.6	6.3	3.3	21.7	31.3	4.2	40.7	2.6	2.2	3.2	2.7	1.4	11.5	2.2	2.0	27.6	11.0	2.1	1.6	4.2	3.4	14.0	21.3	3.7	2.4	3.3	4.4	2.7	8.2	3.0	2.4	9.0	2.2	1.8	3.2	2.4	2.8	1.5	17.6	3.0	3.1	21.2	13.2	6.3	2.7	1.5	3.7	2.2	2.9	11.8	2.5	3.3	26.4	6.4	1.0	1.1	2.6	1.0	2.9	2.3	1.7	1.0	3.1	3.9	1.1	1.4	1.8	1.4	6.5	2.8	3.9	16.2	1.8	7.3	3.6	2.2	1.3	1.5	1.0	1.6	1.3	2.7	4.4	4.4	4.0	5.0	1.4	3.9	2.4	1.9	4.7	5.4	7.0	2.1	1.4	4.9	1.8	1.0	3.6	1.9	14.1	6.2	1.5	0.8	2.4	5.1	1.3	3.9	2.5	1.7	3.8	0.9	1.6	1.3	0.6	7.8	1.8	1.7	1.8	2.4	2.2	4.7	5.9	3.3	3.6	4.1	5.3	4.7	2.2	5.1	3.6	4.5	6.1	4.0	1.0	3.2	7.2	2.7	10.0	14.6	21.7	31.3	27.6	11.0	14.0	21.3	8.2	17.6	13.2	11.8	15.7	6.4	7.7	394.4	20.9	5.0	8.0	6.4	6.2	24.7	7.7	6.2	6.9	2.8	23.2	3.7	25.0	2.0	11.3	2.4	0.0	3.9	182.8	89.4	16.1	18.5	141.1	7.4	333.6	2.5	2.7	7.3	7.1	11.2	6.3	8.4	15.0	1.0	3.1	38.7	208.8	9.4	6.1	7.3	5.7	120.8	7.2	8.6	1.8	188.3	5.4	14.5	5.2	256.9	179.6	4.2	4.9	7.5	8.1	6.1	2.9	2.2	150.3	24.7	0.0	22.8	11.4	8.9	5.2	4.9	6.3	1.4	12.2	5.9	6.0	3.9
RFX4		ENSG00000111783	"Regulatory factor X4"	Q33E94	12	106583004-106762803	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 54.1;testis: 75.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 346.7;Spermatocytes: 98.7"	"Cancer enriched"	"Detected in single"	54	"glioma: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"AF22: 48.0"	"Low region specificity"	"Detected in all"							HPA050527	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050527: AB_2681158"	"unprognostic (3.67e-1)"		"unprognostic (4.86e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.97e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.46e-2)"		0.1	0.0	32.0	0.0	36.0	0.0	0.0	32.8	27.6	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.8	54.1	0.0	0.0	0.0	0.0	52.7	46.7	0.0	0.1	0.0	9.9	0.0	40.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	0.0	75.0	38.8	0.0	0.1	0.0	0.0	0.0	0.0	34.0	0.0	0.3	48.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.0	36.0	32.8	27.6	28.8	54.1	52.7	46.7	40.2	40.5	38.8	34.0	0.0	0.0	0.0	346.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	41.8	0.0	0.1	0.2	0.0	0.0	13.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	13.4	0.0	0.0	0.0	0.0	29.2	2.1	0.0	0.0	7.5	0.1	0.1	0.0	27.6	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.1	98.7	2.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0
RFX5		ENSG00000143390	"Regulatory factor X5"	P48382	1	151340640-151347326	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018519, HPA079241"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Vesicles	"HPA018519: AB_1856209, HPA079241: "	"unprognostic (1.17e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	18.4	25.6	13.3	43.3	13.7	24.0	14.9	17.8	13.2	18.2	11.7	22.7	31.6	22.0	13.1	18.3	18.4	23.4	18.3	12.3	16.8	18.3	13.1	27.9	67.7	17.1	17.6	10.1	9.6	22.1	18.1	12.4	18.5	20.4	28.1	14.6	16.0	25.1	17.0	13.1	26.1	31.8	15.4	50.7	19.6	15.5	15.7	50.5	23.7	23.8	71.8	26.5	11.4	13.3	37.7	41.8	57.6	32.8	27.6	24.0	12.6	17.8	30.0	43.6	57.7	13.7	50.9	145.2	63.9	21.5	42.6	59.5	24.9	34.4	31.9	177.4	39.7	54.8	89.4	23.0	17.7	48.9	59.4	25.2	18.8	28.8	13.2	35.7	39.9	92.0	26.8	88.3	33.8	34.2	78.7	36.2	41.9	30.5	21.2	97.1	32.3	80.1	42.0	49.1	20.4	60.0	35.7	55.0	52.8	69.2	51.6	114.3	39.9	23.8	25.1	11.8	33.7	110.9	118.2	168.6	37.8	26.4	31.3	5.6	22.6	11.5	17.4	28.2	15.3	47.9	13.9	17.4	47.4	53.3	10.9	12.2	3.1	31.4	30.8	25.1	28.5	21.5	13.3	13.7	17.8	13.2	12.3	16.8	17.1	17.6	18.5	15.4	15.7	13.3	8.4	9.6	7.5	4.9	32.0	6.6	12.5	11.4	14.2	7.6	9.4	6.5	5.1	8.6	12.1	7.3	0.0	8.8	16.9	3.8	9.8	15.7	8.4	7.5	6.3	9.9	4.2	16.6	3.2	9.2	3.4	6.1	5.6	12.8	24.1	9.4	10.8	7.3	12.4	1.7	7.0	5.1	10.2	18.5	15.7	17.9	5.0	13.3	5.4	8.4	40.8	7.2	21.6	3.0	2.4	8.6	2.7	9.8	9.5	14.1	11.2	10.7	7.4	2.7	6.6	5.3	5.7	15.5	7.5	14.2	6.1	3.4	13.7	15.7	7.3	14.6
RFX7	"FLJ12994, RFXDC2"	ENSG00000181827	"Regulatory factor X7"	Q2KHR2	15	56087280-56245082	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 108.4;Excitatory neurons: 149.4;Inhibitory neurons: 164.0;Microglial cells: 91.8;Oligodendrocyte precursor cells: 187.0;Oligodendrocytes: 169.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035462, HPA057957"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear membrane"		"HPA035462: AB_10602152, HPA057957: "	"unprognostic (2.36e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.24e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	3.4	5.9	3.9	5.6	3.5	8.5	5.2	11.6	4.0	5.2	1.3	4.0	5.3	5.6	5.3	4.7	5.7	4.0	3.2	3.0	4.4	3.5	4.0	4.8	8.9	3.5	3.3	6.3	3.2	5.7	2.7	5.4	3.7	4.6	5.0	11.0	3.8	5.3	8.8	9.9	4.5	5.7	3.0	7.4	4.8	8.7	3.5	15.2	5.1	9.8	9.3	5.7	2.9	4.2	7.7	15.6	31.3	22.0	11.0	13.9	7.6	6.6	9.1	8.3	13.1	8.4	6.3	24.0	9.7	9.9	7.7	20.9	18.7	14.7	11.1	13.3	6.6	31.5	19.0	17.6	11.6	24.1	4.6	12.0	21.7	9.0	19.5	12.2	14.7	24.1	14.2	12.7	11.9	9.8	21.3	6.9	13.4	5.9	4.5	23.1	20.0	19.8	9.2	24.0	16.4	18.8	8.2	8.3	9.4	21.5	7.1	15.3	11.9	21.8	11.3	5.1	13.2	10.2	11.4	27.6	7.8	22.2	9.7	2.0	0.2	0.5	0.5	0.3	0.6	0.5	0.6	0.7	0.4	0.4	0.4	0.6	0.0	0.5	0.2	0.5	1.1	0.3	3.9	3.5	11.6	4.0	3.0	4.4	3.5	3.3	3.7	3.0	3.5	4.2	8.6	6.4	13.4	108.4	9.7	13.4	4.4	9.5	20.5	16.2	9.9	7.5	6.5	2.8	6.2	7.3	10.4	4.2	7.3	5.3	3.9	3.4	19.9	7.2	10.3	9.4	4.8	17.1	149.4	4.7	1.4	6.8	4.6	6.4	12.6	14.2	7.9	8.9	5.6	16.8	164.0	5.7	10.2	9.5	8.8	15.9	6.5	8.8	5.4	91.8	8.4	5.1	2.1	187.0	169.7	3.7	6.0	10.5	7.9	6.6	4.3	4.2	8.5	9.1	0.0	13.2	7.0	6.6	6.8	16.8	17.6	1.6	9.0	10.6	6.8	5.6
RFX8	FLJ42986	ENSG00000196460	"Regulatory factor X8"	Q6ZV50	2	101397359-101475112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.6;Excitatory neurons: 11.5;Inhibitory neurons: 4.5;Late spermatids: 10.2;Spermatocytes: 8.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.6;hTEC/SVTERT24-B: 16.8;LHCN-M2: 6.9;U-87 MG: 9.6;U-937: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059745			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nuclear bodies"	"HPA059745: AB_2684120"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.56e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-5)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	0.6	0.1	0.0	0.1	0.0	3.7	0.8	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.7	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	5.6	0.0	2.1	1.7	1.3	1.7	0.0	3.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	2.0	0.0	16.8	0.1	0.0	0.0	0.6	0.0	0.0	6.9	0.0	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.2	0.2	0.0	1.9	3.1	0.0	0.0	0.0	9.6	4.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.7	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	16.6	1.4	0.1	1.0	0.0	0.0	11.5	0.0	0.7	2.6	0.0	0.5	0.0	0.1	0.7	0.0	0.1	0.0	4.5	0.0	0.0	0.3	1.6	10.2	0.3	0.4	0.0	2.8	0.0	0.0	0.0	0.5	1.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	1.3	8.5	1.5	0.0	0.0	1.4	0.1	0.0	0.0	0.1
RFXANK	"ANKRA1, BLS, F14150_1, MGC138628, RFX-B"	ENSG00000064490	"Regulatory factor X associated ankyrin containing protein"	O14593	19	19192229-19201869	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049157, HPA053330"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA049157: AB_2680658, HPA053330: AB_2682114"	"unprognostic (3.16e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.04e-3)"	30.2	20.2	27.3	21.4	30.2	41.1	29.6	29.4	34.8	28.6	25.8	30.5	21.4	28.4	14.1	40.2	34.8	13.6	27.4	27.1	29.3	36.6	20.6	25.8	31.1	31.1	28.1	27.1	29.6	23.1	24.3	18.2	29.0	32.3	11.1	8.7	34.1	14.2	31.6	34.9	27.6	13.0	28.6	38.9	31.8	12.7	28.7	28.4	38.0	15.0	22.1	26.1	27.1	29.9	60.0	36.6	25.6	50.2	8.7	24.2	64.5	29.0	30.3	48.8	47.7	30.7	121.4	58.2	72.9	30.2	20.8	43.6	21.9	56.2	21.5	40.4	33.7	46.7	36.7	45.1	89.4	66.8	94.6	44.7	32.4	42.8	31.0	29.8	49.1	56.8	94.4	64.2	27.1	119.3	88.0	88.3	30.7	62.6	82.0	73.5	26.1	101.9	41.5	39.8	21.0	43.6	30.3	38.2	70.4	17.1	54.1	134.8	49.1	25.4	27.9	63.3	47.6	73.5	86.9	87.7	37.6	82.3	52.2	48.5	29.4	52.2	23.9	32.7	20.4	41.7	27.2	26.5	34.2	41.4	27.1	26.6	13.4	33.3	24.6	54.2	40.5	29.0	27.3	30.2	29.4	34.8	27.1	29.3	31.1	28.1	29.0	28.6	28.7	29.9	33.4	32.1	36.9	6.5	28.9	22.0	33.8	77.9	28.5	10.0	30.5	33.5	3.4	31.5	39.5	31.3	2.1	63.5	24.9	46.2	76.3	44.0	6.4	48.4	29.7	35.7	37.2	45.8	1.2	57.4	61.3	26.8	35.2	37.7	31.8	31.4	33.2	16.7	63.1	15.2	1.4	40.0	40.7	44.5	27.8	11.1	30.4	34.1	21.4	8.4	57.8	27.6	36.0	3.5	3.3	59.3	44.4	19.2	27.9	27.0	56.5	70.7	57.6	12.3	39.5	14.6	37.5	6.3	20.1	35.4	24.6	45.6	29.4	28.5	46.9	27.1
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457550-41470871	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 415.4;lung: 694.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1286.2;Basal prostatic cells: 676.2;Langerhans cells: 590.1;Prostatic glandular cells: 1415.5;T-cells: 532.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 159.9;T-reg: 90.9"	"Lineage enriched"	"Detected in many"	15	"T-cells: 159.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.5;BJ hTERT+: 316.0;Daudi: 105.1;U-698: 111.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		910000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA035638: AB_10670152, HPA063701: AB_2685096"	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	197.6	21.5	186.3	27.7	226.9	415.4	132.6	218.8	236.7	36.1	148.2	34.7	16.9	43.6	7.6	18.6	31.1	42.2	145.9	195.8	196.6	56.9	25.0	694.9	38.1	209.1	204.8	9.1	41.3	48.1	35.3	150.7	205.3	61.5	9.2	5.7	111.5	19.0	47.3	58.0	29.1	33.5	186.7	37.0	37.8	24.8	198.2	70.5	144.0	61.8	21.0	47.5	39.6	241.0	1.1	0.5	34.9	0.0	6.7	57.5	1.4	0.8	316.0	0.2	1.2	44.8	0.7	105.1	0.9	4.0	0.1	1.0	1.2	2.1	0.4	11.1	5.1	0.0	7.9	3.5	3.3	3.7	1.2	4.5	6.7	1.2	43.1	0.6	36.1	24.0	8.3	0.1	1.0	0.3	24.0	2.3	0.5	4.7	0.8	0.1	0.0	0.1	0.3	0.0	1.3	0.4	0.3	0.0	0.7	3.0	0.9	20.1	24.6	0.2	3.8	2.2	0.4	0.2	0.1	111.9	0.3	2.4	0.8	0.0	0.8	0.1	5.6	0.5	5.6	5.3	46.5	14.7	6.1	10.7	159.9	35.0	0.6	0.4	0.1	1.8	90.9	10.2	186.3	226.9	218.8	236.7	195.8	196.6	209.1	204.8	205.3	186.7	198.2	241.0	1286.2	246.8	39.8	57.5	131.8	86.5	676.2	15.2	14.2	1.0	269.9	314.7	25.8	1.5	37.5	3.7	2.1	6.4	249.2	3.0	35.2	0.6	42.3	103.0	47.2	474.6	84.8	322.7	2.5	0.0	9.3	205.1	65.2	69.0	48.9	0.3	31.8	2.5	349.1	0.0	1.2	22.1	14.2	32.0	590.1	13.2	8.1	315.9	193.9	36.5	6.4	1.5	4.1	51.8	115.3	0.3	4.5	2.2	371.2	1415.5	0.1	0.8	33.7	3.1	124.9	45.4	116.0	155.3	5.0	11.2	65.1	11.1	532.4	43.8	7.8	159.7
RGL1	RGL	ENSG00000143344	"Ral guanine nucleotide dissociation stimulator like 1"	Q9NZL6	1	183636085-183928532	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.5;Excitatory neurons: 176.1;Inhibitory neurons: 141.8;Kupffer cells: 109.1;Oligodendrocytes: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;HSkMC: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019788	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA019788: AB_1856215"	"unprognostic (3.08e-1)"	"unprognostic (5.25e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.49e-5)"	"prognostic favorable (4.32e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.88e-2)"	24.7	16.8	22.7	19.9	25.3	1.6	17.1	17.3	27.0	18.6	21.5	11.3	8.7	18.0	6.3	10.6	15.2	22.5	17.0	27.1	21.7	28.6	16.2	20.9	22.9	23.7	20.7	19.2	6.8	8.9	9.5	16.1	17.4	13.2	12.8	15.7	7.7	11.6	2.7	8.9	10.6	22.2	21.1	45.4	6.9	14.7	23.9	8.7	9.1	7.7	10.1	18.7	8.9	28.5	0.3	1.5	26.3	4.0	35.0	16.1	26.7	12.4	20.6	5.5	6.8	12.2	0.7	0.3	11.3	8.8	4.3	0.6	1.8	3.1	5.4	0.4	1.9	0.2	2.6	12.6	9.3	0.4	1.5	54.9	0.7	14.0	3.3	26.2	20.8	2.7	0.0	19.6	11.8	0.1	2.9	0.2	9.6	0.9	0.7	23.7	1.7	24.3	1.5	7.5	3.3	7.9	3.9	4.2	2.1	8.5	0.2	0.3	15.3	7.9	3.1	24.7	6.8	2.0	0.5	0.1	8.3	0.3	22.2	0.0	0.8	0.0	0.0	2.1	0.1	0.0	0.3	0.0	0.9	0.0	0.4	0.2	0.0	0.0	0.8	0.0	0.2	0.5	22.7	25.3	17.3	27.0	27.1	21.7	23.7	20.7	17.4	21.1	23.9	28.5	9.4	9.6	12.3	133.5	1.6	8.2	2.2	2.5	5.2	5.1	6.7	4.6	8.7	5.7	9.0	5.5	0.0	5.1	0.6	2.6	5.9	4.0	13.8	7.9	23.2	19.7	0.0	0.4	176.1	0.9	2.6	22.0	3.6	24.1	3.8	11.0	41.4	2.6	43.3	8.4	141.8	0.8	4.1	109.1	50.4	17.6	13.1	43.7	5.4	76.8	1.7	23.0	0.0	38.7	184.3	1.0	0.1	20.7	0.1	3.5	2.8	30.1	14.2	2.0	26.3	1.2	9.7	4.0	2.5	5.8	4.7	5.2	2.2	13.1	0.6	2.9
RGL2	"HKE1.5, KE1.5, RAB2L"	ENSG00000237441	"Ral guanine nucleotide dissociation stimulator like 2"	O15211	6	33291654-33298942	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;SK-MEL-30: 20.4;TIME: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047039, HPA053444"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA047039: AB_2732538, HPA053444: AB_2682153"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-2)"	10.4	8.7	2.6	0.6	2.8	2.3	9.1	2.7	1.6	13.0	8.9	10.0	2.2	11.0	0.0	5.4	12.5	2.0	8.9	2.1	3.7	8.9	2.5	11.4	0.8	6.0	3.0	12.9	6.9	2.7	20.7	5.6	2.5	9.5	0.6	0.1	7.5	3.0	18.5	5.7	8.0	4.0	2.5	24.2	9.9	5.4	4.0	1.0	16.0	8.5	0.2	9.3	7.4	2.2	15.7	2.8	0.2	1.0	2.1	7.2	0.0	1.5	6.0	2.4	1.5	0.2	2.5	2.7	14.0	2.8	5.4	0.3	0.6	5.8	1.4	0.9	0.6	6.5	0.0	2.8	12.9	1.8	5.3	5.4	6.0	5.0	3.6	2.6	19.0	0.0	4.0	0.1	2.4	0.0	1.9	7.9	1.6	1.0	9.7	4.4	0.4	4.1	4.8	3.5	2.9	11.8	0.1	0.0	20.4	0.0	0.0	4.9	22.6	5.1	5.1	3.0	14.8	2.8	1.9	1.6	3.4	4.1	10.4	4.3	4.2	8.8	2.0	3.1	1.7	1.6	1.3	1.5	3.3	2.1	0.7	1.1	9.6	2.4	1.1	0.4	1.3	2.8	2.6	2.8	2.7	1.6	2.1	3.7	6.0	3.0	2.5	2.5	4.0	2.2	75.5	16.0	41.5	52.2	20.6	28.4	36.5	30.3	37.0	30.4	58.8	40.4	28.7	20.0	38.6	22.0	22.9	30.4	18.4	8.4	13.7	21.2	5.1	19.9	13.6	60.8	28.6	7.8	13.0	14.5	39.0	20.1	16.3	21.1	11.4	21.4	75.7	10.7	32.3	32.0	18.2	10.8	22.4	27.0	23.4	17.4	16.8	23.0	17.8	30.9	13.4	22.5	19.6	17.6	11.1	22.4	25.5	14.7	7.8	30.5	5.6	11.7	39.9	30.9	26.3	20.4	26.9	26.2	18.9	20.0	24.3	102.2	16.5	28.3	10.0	39.2
RGL3	FLJ32585	ENSG00000205517	"Ral guanine nucleotide dissociation stimulator like 3"	Q3MIN7	19	11384341-11419328	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.1;parathyroid gland: 45.9;thyroid gland: 64.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.3;Collecting duct cells: 51.5;Gastric mucus-secreting cells: 48.4;Sertoli cells: 39.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 26.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;CACO-2: 10.4;RT4: 22.0;SK-BR-3: 9.7;T-47d: 15.9"	"Region enriched"	"Detected in many"	6	"cerebellum: 9.0"	"Low region specificity"	"Detected in many"			"HPA042763, HPA043615, HPA064578"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: "	"prognostic favorable (7.35e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.19e-3)"	"unprognostic (5.99e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.12e-3)"	7.3	11.5	1.8	0.7	1.6	0.0	7.4	1.9	2.5	13.3	6.9	2.9	1.4	4.8	9.5	1.1	9.5	2.1	9.2	2.2	2.2	41.1	10.6	8.9	0.6	2.7	2.4	2.5	21.0	45.9	15.4	5.6	2.8	6.5	1.3	0.8	5.9	9.4	2.0	1.3	1.8	0.8	1.7	8.2	13.8	0.6	2.9	0.2	64.9	0.6	0.3	5.3	5.7	2.3	0.0	0.6	0.0	0.1	1.1	0.2	17.7	1.1	1.4	0.6	2.0	10.4	7.4	0.0	6.5	1.3	2.6	4.6	0.0	0.0	0.1	0.0	0.0	0.1	4.2	3.3	2.7	0.0	0.0	0.0	0.1	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.9	1.4	0.0	0.7	2.2	6.3	22.0	1.0	5.2	0.2	9.7	3.3	3.7	15.9	0.0	0.0	3.3	0.0	2.5	0.9	0.0	0.6	1.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	1.6	1.9	2.5	2.2	2.2	2.7	2.4	2.8	1.7	2.9	2.3	3.1	19.2	21.0	32.3	1.1	0.1	2.1	0.4	1.8	0.3	3.3	4.6	4.6	12.8	12.4	51.5	0.0	12.9	0.0	2.2	11.7	8.6	0.0	14.8	9.6	5.8	10.3	0.0	0.5	4.2	11.9	4.1	48.4	18.4	1.3	3.1	26.0	5.8	3.0	0.0	0.6	7.7	2.0	7.4	0.3	0.2	3.7	1.5	5.4	4.7	0.0	16.9	0.0	1.5	0.5	5.7	5.3	0.4	0.6	1.4	0.0	4.6	1.7	0.6	39.5	9.9	18.7	0.6	1.7	0.0	0.0	12.0	0.2	0.8	2.4	2.0
RGMA	RGM	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3;skeletal muscle: 199.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.3;Leydig cells: 119.0;Peritubular cells: 116.9;Prostatic glandular cells: 61.3;Skeletal myocytes: 69.3;Squamous epithelial cells: 58.3"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 50.0;BEWO: 14.6;MOLT-4: 15.5;NTERA-2: 22.2;REH: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		2000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861"	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	30.2	3.2	62.1	22.5	73.8	0.4	30.3	72.5	59.1	55.9	7.7	79.4	9.9	50.9	2.9	57.4	39.9	7.7	29.4	60.4	68.0	3.6	0.6	4.6	2.4	126.3	113.9	38.5	11.4	0.8	6.9	1.3	70.4	12.8	6.2	1.0	24.2	6.4	199.1	17.1	42.9	60.6	91.5	1.3	73.6	33.5	120.6	2.6	10.0	45.0	3.4	10.0	29.2	62.8	2.1	0.3	50.0	0.8	10.3	5.7	14.6	0.3	0.0	0.0	0.0	0.6	0.6	0.1	0.2	0.4	0.0	3.4	8.4	0.2	0.0	0.0	9.2	0.1	0.3	0.0	0.0	0.1	0.2	6.1	0.2	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.0	1.0	15.5	0.2	22.2	0.1	0.0	13.1	11.4	0.1	0.0	0.5	5.1	3.0	0.5	0.2	0.0	2.6	4.0	2.7	0.0	0.1	10.4	0.3	0.1	0.1	0.0	0.2	0.2	0.2	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	62.1	73.8	72.5	59.1	60.4	68.0	126.3	113.9	70.4	91.5	120.6	62.8	4.2	0.0	1.5	143.3	0.5	5.5	20.4	10.2	40.5	1.9	7.5	4.4	4.4	0.0	3.9	0.0	2.1	4.4	0.5	0.3	0.0	6.5	1.2	0.6	10.9	2.7	0.0	0.4	16.8	0.7	1.2	40.5	1.5	2.3	0.0	0.6	1.8	0.3	2.1	0.0	2.8	0.0	12.2	2.5	2.3	6.4	119.0	1.6	3.6	9.4	0.6	4.5	0.0	11.1	1.6	0.4	0.0	116.9	0.1	61.3	0.0	0.1	1.3	1.2	13.1	69.3	20.3	0.9	43.8	58.3	2.8	2.5	1.4	0.1	0.1	29.2
RGMB	"DRAGON, FLJ90406"	ENSG00000174136	"Repulsive guidance molecule BMP co-receptor b"	Q6NW40	5	98768650-98798643	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 63.9;Undifferentiated cells: 88.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 3.3"	"Group enriched"	"Detected in many"	12	"B-cells: 1.6;T-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"BJ: 285.8;BJ hTERT+: 142.9;fHDF/TERT166: 178.0;HBF TERT88: 222.5;LHCN-M2: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016993			Approved	Nucleoplasm		NA	NA		560000	"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA016993: AB_1856216"	"unprognostic (1.50e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-3)"	8.8	7.7	14.8	7.2	18.4	0.3	9.1	11.4	17.4	9.3	5.7	20.5	21.4	9.2	6.0	11.8	11.1	7.5	10.2	17.4	15.1	4.7	6.0	8.1	3.7	12.9	16.0	21.8	11.2	9.3	11.4	5.5	27.1	20.7	33.3	3.8	21.8	13.9	24.8	33.8	26.2	10.9	12.2	6.0	41.7	10.5	22.3	2.6	11.5	16.1	4.5	10.8	9.5	14.9	7.3	5.2	87.8	8.1	26.2	44.5	9.1	285.8	142.9	138.5	97.6	4.4	3.5	4.2	10.2	178.0	9.7	7.5	10.4	26.0	222.5	12.5	10.2	0.0	7.1	4.9	12.6	0.9	0.1	37.1	9.4	71.1	28.2	37.6	26.3	13.6	0.0	3.5	167.1	8.1	0.1	0.1	6.0	3.3	14.0	11.4	50.7	7.9	5.4	8.4	35.6	18.0	3.9	9.4	14.1	4.4	7.5	0.4	57.4	86.7	14.2	54.1	133.5	6.0	9.1	5.8	31.9	0.1	19.1	0.0	0.0	0.2	0.1	0.0	0.7	1.1	1.5	0.6	0.0	1.6	3.3	1.5	0.1	0.1	0.0	0.0	2.4	0.8	14.8	18.4	11.4	17.4	17.4	15.1	12.9	16.0	27.1	12.2	22.3	14.9	8.6	16.0	4.1	7.5	12.7	31.0	15.3	6.0	44.3	5.7	17.8	12.4	14.3	7.2	5.3	9.2	16.7	4.5	0.4	12.8	1.9	5.0	63.9	10.2	12.7	10.3	21.8	0.0	20.8	5.3	6.2	19.1	18.8	18.0	0.0	4.0	9.3	8.2	2.1	0.0	23.6	44.6	4.1	1.0	7.2	16.9	9.0	2.4	12.4	5.6	0.7	1.7	0.0	35.2	6.6	8.4	16.3	7.2	1.7	16.1	11.9	1.6	6.1	4.0	0.0	20.3	13.1	7.4	17.5	27.0	24.4	1.8	2.9	5.4	88.9	17.4
RGS10		ENSG00000148908	"Regulator of G protein signaling 10"	O43665	10	119499817-119542719	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 222.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 291.2;Hofbauer cells: 528.1;Kupffer cells: 297.2;Langerhans cells: 358.3;Macrophages: 529.3;monocytes: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 474.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004559, HPA021305, HPA058485"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"		NA	NA		840000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732"	"unprognostic (1.64e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (7.98e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (5.21e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.20e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.92e-3)"	25.1	20.6	20.0	59.3	20.2	74.5	40.7	22.3	30.4	63.9	22.3	114.3	34.2	38.5	15.8	51.5	28.5	38.3	13.4	20.7	24.5	18.8	11.4	28.1	119.0	28.6	24.5	22.5	7.0	6.9	13.8	45.6	28.9	43.2	49.7	2.6	41.0	20.3	31.5	22.9	58.3	42.8	26.1	48.7	30.0	4.9	26.1	222.9	33.0	11.6	96.5	50.3	45.8	37.2	165.2	31.2	2.4	294.7	41.4	262.6	25.9	74.9	118.1	45.3	73.5	9.8	38.7	66.8	38.1	60.9	45.7	35.4	44.3	48.2	123.8	32.0	42.8	183.1	8.9	24.2	63.1	40.0	474.0	100.7	63.1	88.3	84.4	159.4	88.2	65.4	47.6	58.5	55.0	79.2	221.9	134.8	13.5	21.2	71.1	43.8	0.3	26.1	24.7	40.4	10.8	9.3	14.4	192.6	285.3	36.3	35.1	71.7	108.3	25.4	21.9	36.1	67.8	2.7	46.0	27.0	7.6	166.5	11.4	184.8	116.0	1.4	77.9	151.4	82.9	36.0	169.6	134.9	224.3	21.7	397.5	303.3	52.5	44.3	130.4	133.2	202.3	372.5	20.0	20.2	22.3	30.4	20.7	24.5	28.6	24.5	28.9	26.1	26.1	37.2	10.4	0.0	13.1	2.6	60.3	36.8	25.7	104.5	27.9	0.2	68.9	96.6	1.1	1.5	39.7	1.8	0.0	14.0	70.1	7.1	60.7	0.8	2.1	89.8	25.1	12.7	18.7	156.6	0.2	6.4	34.8	68.6	11.2	53.6	291.2	101.2	13.2	1.5	528.1	0.0	1.8	85.7	32.6	297.2	358.3	5.1	50.1	529.3	94.3	67.5	294.5	1.8	50.4	0.5	0.2	9.9	10.0	9.4	32.1	88.8	3.3	5.2	24.6	0.8	13.1	14.4	31.8	0.3	9.3	39.6	28.1	10.1	164.7	3.5	19.3	41.4
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 142.0;Inhibitory neurons: 170.1;Suprabasal keratinocytes: 110.0;Urothelial cells: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: AB_2682555, HPA067421: AB_2685836"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	8.4	6.5	13.6	2.9	46.6	2.3	8.7	10.2	20.5	16.1	10.5	8.3	4.8	8.6	4.7	30.4	9.9	3.9	6.7	12.9	8.5	11.1	17.3	10.6	3.5	9.5	8.5	12.5	4.9	3.3	13.8	3.7	8.2	16.6	1.9	3.8	9.4	4.7	12.3	20.7	6.2	2.6	7.8	6.0	6.7	10.3	8.7	3.6	8.0	4.6	3.3	10.4	20.2	10.5	4.8	6.0	11.9	8.6	3.9	3.1	4.9	5.1	4.1	5.2	3.8	4.9	2.8	1.1	3.1	4.5	7.6	4.6	2.3	16.3	1.7	0.1	1.9	0.5	3.6	12.0	3.5	0.3	6.5	2.6	10.9	2.7	3.6	4.6	11.5	4.2	5.6	0.2	4.8	4.1	0.8	13.1	5.6	2.7	5.7	12.3	4.6	4.0	2.7	14.1	13.3	13.8	3.2	2.2	11.4	2.9	5.4	8.2	8.7	10.0	6.5	2.0	5.5	5.9	4.9	2.7	5.9	7.2	7.3	0.4	0.3	0.0	0.2	1.1	0.0	0.0	0.2	0.1	0.4	0.2	0.3	0.1	0.4	0.0	1.1	0.2	0.2	0.2	13.6	46.6	10.2	20.5	12.9	8.5	9.5	8.5	8.2	7.8	8.7	10.5	16.1	6.4	6.4	66.9	2.6	84.4	142.0	69.3	71.2	17.3	11.0	14.9	8.6	8.6	28.6	5.5	29.2	6.2	1.3	6.4	3.9	10.4	5.0	22.8	13.3	26.6	14.9	4.8	44.3	10.4	1.3	14.6	7.7	11.8	14.0	57.7	27.8	28.8	20.8	10.1	170.1	10.8	8.2	12.4	11.3	5.5	14.9	21.7	17.8	47.8	7.8	29.3	2.1	71.4	25.5	14.7	2.7	7.9	0.8	53.9	6.0	23.9	34.6	18.9	0.0	12.5	12.7	24.0	15.3	84.4	110.0	6.7	4.3	11.8	9.0	153.8
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357924-177372596	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 72.8;Proximal tubular cells: 113.7;Squamous epithelial cells: 95.8;Suprabasal keratinocytes: 115.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 110.4;cerebral cortex: 67.9;hippocampal formation: 56.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 112.5;HMC-1: 95.4;NB-4: 44.8;RPMI-8226: 57.9"	"Group enriched"	"Detected in many"	10	"amygdala: 66.0;basal ganglia: 57.9;cerebral cortex: 46.8;hippocampal formation: 93.6;white matter: 23.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 102.1"	"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: AB_2679836, HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	3.5	2.8	16.0	13.9	110.4	22.4	2.9	0.0	67.9	3.1	1.8	3.7	6.3	2.3	0.4	10.0	7.7	4.3	1.3	56.4	4.5	8.5	28.7	5.5	18.1	0.0	0.4	1.1	3.7	1.5	2.4	1.4	0.1	3.5	0.9	0.0	6.2	2.1	2.6	6.1	11.0	1.8	0.1	27.7	4.9	1.9	15.2	16.3	6.1	0.9	6.6	4.1	5.0	3.2	5.4	1.1	2.3	1.4	0.1	0.0	3.7	0.2	0.0	0.5	0.6	3.7	10.4	13.3	7.3	0.4	1.3	10.6	0.2	3.8	0.0	112.5	0.5	20.7	1.0	4.7	0.9	16.3	95.4	1.8	1.1	0.6	0.7	1.4	0.6	14.9	3.5	26.5	0.2	0.4	21.7	44.8	1.7	5.4	2.8	10.2	0.3	57.9	1.5	1.6	0.4	1.9	0.4	0.4	8.8	0.0	3.5	25.2	1.1	0.2	1.9	0.0	9.7	13.9	7.1	5.8	1.6	30.3	2.4	70.6	39.9	148.8	62.4	37.9	63.0	27.7	57.9	57.8	39.8	26.6	47.4	43.1	140.0	23.6	41.2	17.6	60.9	43.9	16.0	110.4	0.0	67.9	56.4	4.5	0.0	0.4	0.1	0.1	15.2	3.2	5.3	6.4	4.4	2.6	27.3	68.8	23.9	15.4	72.8	0.7	8.9	11.8	2.3	37.1	5.6	11.0	2.1	3.9	41.4	4.2	31.3	11.4	0.6	19.5	2.0	6.5	4.8	7.4	4.6	16.7	10.4	5.4	12.2	8.1	24.7	2.8	8.2	64.0	26.1	0.0	1.5	10.0	10.2	17.0	23.3	1.5	2.8	18.2	21.4	6.5	18.1	9.9	48.4	0.5	0.3	12.8	17.2	2.2	18.0	14.1	16.8	113.7	11.7	2.0	0.0	1.6	4.6	0.1	20.3	95.8	115.1	3.3	51.2	1.1	4.4	20.0
RGS6		ENSG00000182732	"Regulator of G protein signaling 6"	P49758	14	71932429-72566530	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 97.3;Early spermatids: 173.5;Excitatory neurons: 652.7;Inhibitory neurons: 256.1;Late spermatids: 298.0"	"Group enriched"	"Detected in some"	7	"glioma: 3.1;thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 11.5;Karpas-707: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003067	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA003067: AB_1079807"	"unprognostic (7.18e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.24e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.68e-2)"	4.7	0.2	1.1	0.6	2.2	1.4	4.0	0.6	8.6	4.9	0.0	1.0	0.3	1.4	2.6	0.4	2.2	1.2	11.2	3.5	2.8	2.6	0.1	0.9	0.1	19.2	16.0	1.2	0.2	8.1	1.7	3.0	20.2	0.4	1.0	1.7	0.8	1.4	1.1	0.9	0.8	1.3	5.4	0.9	0.4	10.6	6.4	0.3	5.7	0.8	0.5	0.7	0.9	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	40.1	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.5	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.3	1.2	1.1	2.2	0.6	8.6	3.5	2.8	19.2	16.0	20.2	5.4	6.4	3.4	5.8	0.0	0.0	97.3	0.2	0.3	0.0	0.0	0.0	2.2	2.1	2.4	22.6	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	173.5	2.8	0.9	2.6	0.0	5.3	652.7	0.2	0.1	3.1	0.0	7.1	0.0	0.4	0.0	0.0	0.2	0.0	256.1	0.0	0.0	0.0	0.0	298.0	1.8	8.3	0.0	44.0	5.1	0.0	0.0	36.2	8.9	0.0	0.0	7.5	0.2	0.0	0.0	0.4	0.0	0.4	13.1	0.4	18.6	2.3	1.3	0.2	0.1	0.8	0.5	0.1	0.0	0.7
RGS9	"MGC111763, MGC26458, PERRS, RGS9L"	ENSG00000108370	"Regulator of G protein signaling 9"	O75916	17	65100812-65227703	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 325.2;Rod photoreceptor cells: 480.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 9.7;MAIT T-cell: 2.5;memory CD8 T-cell: 6.8;naive CD8 T-cell: 3.2;NK-cell: 4.0"	"Group enriched"	"Detected in many"	42	"NK-cells: 4.0;T-cells: 9.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.9;HEL: 11.7;hTERT-RPE1: 4.7;SuSa: 4.1"	"Region enriched"	"Detected in all"	9	"basal ganglia: 248.1"	"Region enriched"	"Detected in all"	10	"basal ganglia: 110.0"	"HPA013550, HPA014137"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"HPA013550: , HPA014137: AB_2668943"	"unprognostic (4.43e-3)"	"unprognostic (7.49e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.09e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.49e-1)"	0.8	1.5	6.2	1.2	23.5	0.2	0.8	4.3	9.4	1.6	3.8	8.5	1.1	1.7	2.5	1.5	10.3	1.0	0.8	5.1	9.3	2.4	2.3	5.1	2.1	5.3	5.9	2.6	1.4	5.5	12.1	1.2	6.9	4.6	1.3	1.3	1.3	3.3	0.1	1.4	3.8	1.4	5.2	1.7	3.8	0.4	7.4	0.6	0.6	0.3	3.0	2.9	2.8	4.6	0.4	0.0	1.3	0.1	0.1	0.2	0.0	0.1	2.6	0.0	0.3	0.2	0.0	1.2	1.8	0.0	0.0	0.1	0.0	0.1	0.1	25.9	0.6	11.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	4.7	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.2	4.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.7	0.0	2.5	0.0	0.8	6.8	0.0	0.0	0.0	3.2	0.1	4.0	0.0	0.1	0.0	1.7	6.2	23.5	4.3	9.4	5.1	9.3	5.3	5.9	6.9	5.2	7.4	4.6	1.3	3.2	1.5	33.3	0.4	0.4	1.4	0.9	0.6	25.0	7.8	14.5	0.4	0.0	1.3	1.8	325.2	0.0	27.5	0.1	3.9	8.9	0.6	2.5	1.8	2.6	59.7	0.0	2.3	3.1	0.1	5.8	1.1	4.2	0.0	3.3	1.1	0.0	0.1	52.2	2.3	2.3	0.0	0.0	3.0	2.4	0.9	2.9	1.8	1.9	19.4	39.2	18.6	2.5	1.2	2.7	0.1	4.9	6.3	0.1	0.1	14.2	0.8	480.2	0.0	0.5	1.9	0.1	0.4	0.0	0.1	0.1	10.3	12.8	0.6	0.3
RHBDL1	"RHBDL, RRP"	ENSG00000103269	"Rhomboid like 1"	O75783	16	675671-678268	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.6;Excitatory neurons: 30.1;Inhibitory neurons: 27.1;Ionocytes: 18.3;Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.8;MCF7: 9.2;U-266/70: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030359, HPA030360, HPA046593"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711"	"prognostic favorable (8.12e-4)"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.63e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.49e-2)"	0.8	5.0	9.2	0.4	9.7	1.0	1.0	9.1	17.7	2.0	0.0	2.2	2.4	1.0	0.6	1.2	1.6	0.4	2.4	7.9	6.1	4.1	2.0	1.1	0.4	5.5	4.8	2.1	2.6	0.6	8.3	0.3	4.9	2.7	0.3	2.1	2.4	0.9	0.5	2.6	2.5	0.2	3.2	0.9	2.7	4.2	7.4	1.4	0.9	0.0	0.1	1.5	1.5	7.7	1.7	2.1	1.2	1.8	0.9	2.3	6.1	0.7	1.1	0.4	0.1	4.4	1.2	0.6	1.4	0.4	0.2	1.1	0.1	0.3	0.0	1.5	7.7	0.8	9.8	1.8	0.8	1.6	1.1	1.6	2.8	0.3	0.0	0.9	0.1	2.8	1.3	1.2	0.1	9.2	0.4	4.4	1.1	2.3	0.6	7.6	1.1	1.6	0.1	1.5	1.5	2.0	0.9	0.4	2.2	0.7	3.2	4.5	0.5	2.5	2.2	0.8	0.6	10.5	1.5	2.2	0.9	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	9.2	9.7	9.1	17.7	7.9	6.1	5.5	4.8	4.9	3.2	7.4	7.7	0.6	0.0	0.0	15.3	2.8	2.2	3.8	10.3	12.5	17.6	2.5	4.2	0.9	0.0	2.4	0.0	12.5	0.2	0.3	2.7	0.0	0.7	2.7	1.4	1.1	0.3	2.4	0.0	30.1	0.5	0.2	1.1	3.1	1.0	0.0	1.9	0.4	0.7	0.3	15.2	27.1	6.1	18.3	0.9	1.2	1.4	1.5	0.4	0.0	1.9	0.2	2.9	0.0	10.6	4.1	1.4	3.8	2.6	0.9	1.6	17.3	9.9	10.8	31.8	0.0	0.4	1.2	1.5	1.7	1.4	1.8	0.3	0.6	3.0	5.5	2.8
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein"	Q9H310	1	156369211-156385219	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 9.8"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 89.9;Theca cells: 91.3"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in single"	17	"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 2.9;Hep G2: 3.0;RT4: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.8	1.9	0.0	0.0	0.1	0.0	2.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	22.0	0.0	0.0	0.0	0.0	19.6	0.3	10.3	0.3	0.0	0.1	0.0	0.0	0.2	0.6	0.1	1.3	0.0	0.1	0.0	89.9	0.0	10.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.8	2.3	0.4	0.0	0.4	0.0	0.0	91.3	0.0	0.1
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 48.5"	"Cell type enriched"	"Detected in some"	67	"Erythroid cells: 511.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HEL: 81.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.3	0.6	1.5	0.1	1.9	48.5	0.3	1.6	3.3	0.3	1.2	0.2	0.2	0.2	4.2	0.6	1.0	0.3	1.2	1.5	1.4	0.4	1.7	0.4	0.5	1.9	1.6	0.5	1.2	0.1	3.4	1.1	1.9	1.0	0.3	2.2	5.5	0.2	1.5	0.6	0.1	0.0	1.5	1.1	0.4	2.2	1.6	0.8	0.6	0.9	0.3	0.1	0.5	2.2	0.2	0.1	0.2	0.5	0.9	0.6	0.1	0.3	0.3	0.4	0.1	0.1	1.5	0.7	1.1	1.0	0.1	0.3	0.0	0.2	0.2	0.4	0.1	81.3	0.0	0.0	1.1	0.0	0.6	1.9	1.5	0.6	0.5	0.0	0.0	0.6	17.5	0.4	0.5	0.8	0.0	0.6	1.7	0.7	0.5	0.2	0.2	2.6	0.0	0.0	0.7	0.8	0.3	0.3	1.0	0.8	0.5	0.0	0.1	0.2	0.0	0.9	0.0	5.1	1.4	1.0	2.9	0.9	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	1.9	1.6	3.3	1.5	1.4	1.9	1.6	1.9	1.5	1.6	2.2	0.8	0.0	0.0	5.5	0.8	0.5	0.5	0.3	0.6	4.2	1.1	2.5	0.7	1.5	0.2	0.0	0.0	0.8	1.2	0.5	0.0	0.3	1.1	1.2	0.7	0.4	0.0	511.8	2.9	0.2	0.7	0.4	3.6	0.8	4.5	0.6	0.0	0.7	0.2	6.7	2.3	0.0	0.0	0.6	0.4	0.5	0.6	1.7	0.0	0.0	0.0	4.7	1.0	2.0	2.7	0.5	0.0	0.7	3.0	0.3	0.1	0.0	0.9	2.4	6.6	0.5	0.5	3.0	7.6	0.6	1.4	0.8	0.8	0.7	0.3	0.7
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 15.8"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 153.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.3"	"Group enriched"	"Detected in some"	7	"HEL: 43.0;K-562: 13.0"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.1	0.4	0.4	0.5	1.0	15.8	0.1	1.4	0.7	0.3	0.1	0.1	0.3	0.4	0.1	0.3	0.2	0.4	0.3	0.4	0.1	0.1	0.1	0.2	0.7	0.3	0.1	0.5	0.4	0.0	0.2	0.3	0.2	0.3	0.1	1.9	2.4	0.0	3.8	2.0	0.3	0.0	0.0	0.6	0.2	0.5	0.5	0.1	0.3	0.0	0.1	0.1	0.1	1.2	0.2	0.0	0.3	0.3	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.3	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.2	43.0	1.0	0.2	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.2	13.0	0.9	0.1	0.2	0.2	0.3	4.0	0.0	0.2	0.3	0.2	0.1	0.0	0.1	0.6	0.4	0.1	0.2	0.1	0.1	0.2	0.6	0.4	0.7	0.2	0.5	0.2	0.4	0.2	0.2	0.6	0.2	0.2	4.3	0.9	2.0	0.6	0.4	0.7	1.0	0.8	0.5	0.1	1.3	0.9	0.8	6.3	1.0	0.6	0.4	0.7	0.6	0.4	1.0	1.4	0.7	0.4	0.1	0.3	0.1	0.2	0.0	0.5	1.2	0.2	0.0	0.5	1.0	0.6	0.1	0.2	0.0	0.0	0.3	0.1	0.1	1.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.3	1.0	0.0	153.0	5.2	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.4	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.0	0.0	3.0	0.0	3.7	0.0	0.4	0.0	7.1	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	1.2	0.4	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.0	0.1
RHEBL1	"FLJ25797, MGC34869, RHEB2"	ENSG00000167550	"RHEB like 1"	Q8TAI7	12	49064676-49070025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 10.6;Granulosa cells: 12.2;NK-cells: 14.4;Plasma cells: 8.2;Respiratory ciliated cells: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 16.1;T-cells: 10.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.8;U-266/84: 61.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA053111, HPA061001"	Uncertain		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Centrosome"		"HPA053111: AB_2682047, HPA061001: AB_2684409"	"unprognostic (2.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (9.81e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.03e-5)"	"unprognostic (9.13e-2)"	"unprognostic (9.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-10)"	"unprognostic (4.67e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.07e-1)"	0.8	0.2	2.2	1.5	2.3	2.1	0.8	2.1	4.1	0.3	1.7	0.5	0.5	1.4	1.0	0.4	2.6	0.5	0.5	2.2	2.2	0.3	0.3	1.2	3.6	2.3	2.1	0.3	0.2	0.2	0.3	0.6	2.1	0.2	0.8	0.8	0.4	0.2	0.2	2.6	0.9	0.5	1.9	2.5	0.6	1.5	2.1	1.6	0.3	1.1	1.9	0.4	0.4	2.4	1.7	3.4	2.2	4.8	1.2	0.2	2.1	1.4	4.8	9.1	9.9	3.2	2.9	4.7	1.5	0.4	4.7	1.8	1.5	1.8	3.9	30.8	0.4	4.9	2.9	1.9	1.0	2.4	10.1	0.5	0.8	4.5	1.4	0.6	3.5	8.3	6.1	14.8	3.3	1.7	2.3	13.3	3.0	6.0	3.9	4.7	3.2	7.9	0.7	0.2	1.0	2.9	1.4	1.3	8.4	2.6	0.5	3.5	1.3	2.7	4.4	5.3	1.7	17.8	61.0	3.0	2.3	7.2	1.2	16.1	0.3	0.7	7.6	1.8	10.4	2.0	3.2	4.1	0.8	2.9	1.0	3.8	0.7	1.4	1.7	1.0	6.7	1.4	2.2	2.3	2.1	4.1	2.2	2.2	2.3	2.1	2.1	1.9	2.1	2.4	2.8	0.0	0.0	0.3	6.8	1.3	0.5	1.9	4.0	1.8	1.2	1.7	1.5	1.5	1.8	0.0	0.0	0.1	10.6	0.1	0.0	0.5	0.5	2.8	0.3	2.6	0.0	8.0	6.9	0.2	0.5	1.4	0.5	0.4	0.0	12.2	1.8	0.1	1.8	3.3	2.3	0.2	0.0	0.3	2.0	0.6	0.0	3.7	0.0	0.0	4.5	0.6	14.4	0.5	0.3	0.2	0.0	0.0	8.2	0.4	0.1	0.1	12.0	0.4	0.0	1.3	1.8	0.9	5.4	4.8	2.0	0.1	5.7	0.2	0.4	0.2
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 144.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Horizontal cells: 334.8;Oligodendrocytes: 155.5;Syncytiotrophoblasts: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA040205: AB_2676883, HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.8	13.9	5.6	4.1	6.6	0.9	7.1	5.2	7.8	15.7	5.3	8.1	6.6	14.5	2.4	3.0	10.9	11.5	13.5	4.6	4.7	30.8	6.8	10.6	2.8	6.1	6.1	10.2	9.2	8.6	3.2	37.1	6.3	7.7	4.8	24.3	2.1	9.9	144.2	3.6	5.6	12.1	4.9	14.9	20.8	15.1	7.6	1.9	3.3	19.6	1.2	7.4	7.5	7.8	0.2	12.0	17.8	0.0	8.3	7.3	0.0	5.3	4.8	4.3	6.4	0.6	0.2	0.0	21.9	28.0	2.0	0.3	5.3	1.6	5.0	0.0	4.8	1.1	8.8	67.3	9.0	1.4	0.4	10.6	3.0	2.6	2.7	16.5	20.6	3.8	10.2	0.0	19.1	0.4	5.2	0.0	7.7	0.2	7.9	4.5	24.9	6.4	14.1	0.7	4.9	19.0	6.3	6.9	6.9	11.1	1.4	2.4	18.5	8.2	21.1	0.2	5.9	0.0	0.0	0.0	4.1	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	5.6	6.6	5.2	7.8	4.6	4.7	6.1	6.1	6.3	4.9	7.6	7.8	13.7	16.0	8.7	3.6	1.0	1.8	1.0	0.5	0.6	3.4	3.7	2.5	29.5	1.5	2.3	1.8	135.5	66.1	0.2	0.7	1.9	3.8	75.2	11.0	14.7	13.6	8.3	3.8	74.3	16.0	3.4	8.6	34.1	4.5	0.0	59.0	17.9	9.6	11.3	334.8	23.1	7.7	4.1	21.5	1.4	35.3	8.1	14.1	1.8	57.1	0.4	16.0	0.0	14.1	155.5	16.4	2.5	4.9	0.1	1.2	1.5	36.4	10.2	25.1	6.6	16.7	11.8	2.8	1.4	0.6	1.4	302.4	0.8	15.2	4.3	0.4
RHOF	"ARHF, FLJ20247, RIF"	ENSG00000139725	"Ras homolog family member F, filopodia associated"	Q9HBH0	12	121777754-121803403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 273.9;Langerhans cells: 224.9;monocytes: 241.2;Pancreatic endocrine cells: 191.7;Paneth cells: 279.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 129.0;HDLM-2: 177.1;PC-3: 147.3;RPTEC TERT1: 127.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045912, HPA076019"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA045912: , HPA076019: AB_2732299"	"unprognostic (1.26e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-5)"	"unprognostic (1.38e-3)"	"unprognostic (2.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.14e-1)"	6.5	13.3	11.5	26.6	9.9	47.4	5.5	21.6	12.0	14.3	10.6	24.3	31.8	13.2	21.8	11.7	10.0	9.8	15.0	10.4	11.0	16.2	3.9	20.6	41.0	13.0	12.2	8.9	6.1	7.7	5.1	5.7	13.4	9.2	19.3	9.9	11.5	9.8	11.8	9.2	32.3	11.5	8.7	33.3	28.2	9.0	10.6	25.6	14.6	2.8	31.4	9.1	7.3	11.7	58.3	69.2	12.4	15.3	4.4	6.4	5.6	5.3	5.2	2.5	4.4	28.8	129.0	6.3	42.6	6.0	1.4	8.6	23.2	33.7	2.2	177.1	8.0	37.9	47.5	27.7	10.1	38.6	25.8	9.0	7.5	5.4	2.9	23.8	17.6	44.7	5.6	9.9	1.4	41.7	50.7	56.7	10.4	13.6	147.3	26.5	0.7	10.8	127.9	4.9	9.9	9.4	38.5	4.5	2.6	5.6	19.9	15.0	21.4	4.0	40.1	12.5	1.5	12.3	7.6	20.0	5.0	42.9	2.6	23.8	10.9	41.5	97.0	36.5	92.7	55.5	77.2	82.5	31.0	45.2	59.5	73.2	24.4	61.4	69.8	74.3	90.2	43.3	11.5	9.9	21.6	12.0	10.4	11.0	13.0	12.2	13.4	8.7	10.6	11.7	3.1	38.5	10.7	1.0	54.1	8.7	1.9	5.5	3.4	8.1	9.3	3.8	1.5	15.7	11.3	23.9	0.0	2.7	111.8	273.9	41.1	34.0	20.2	16.5	5.6	3.5	6.7	12.2	5.3	55.3	3.9	5.3	50.4	37.1	20.8	13.1	10.0	4.0	14.4	0.0	3.9	28.6	2.0	10.9	224.9	53.8	4.1	40.3	21.4	3.7	241.2	4.7	103.0	1.0	1.2	191.7	279.6	2.2	39.4	3.8	121.6	15.1	13.5	9.7	6.6	2.6	4.5	17.7	2.9	2.5	13.2	5.5	99.2	23.4	17.3	44.3
RHOJ	"ARHJ, FLJ14445, RASL7B, TCL"	ENSG00000126785	"Ras homolog family member J"	Q9H4E5	14	63204114-63293508	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 41.0;Astrocytes: 176.0;Endothelial cells: 72.5;Hepatic stellate cells: 41.4;Microglial cells: 35.6;Oligodendrocyte precursor cells: 43.2;Skeletal myocytes: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 63.8;HUVEC TERT2: 375.4;TIME: 100.9;WM-115: 106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003050	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA003050: AB_1079812"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (3.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.06e-3)"	19.6	3.3	12.5	8.5	14.6	0.1	17.4	10.8	16.9	12.9	8.5	14.2	7.5	27.9	17.3	15.5	18.5	25.3	17.9	14.0	11.1	11.7	4.2	21.5	9.6	10.9	11.0	14.2	4.4	3.5	6.4	9.3	11.0	11.8	10.7	5.5	8.4	13.8	7.9	7.6	9.8	31.4	8.3	12.6	9.3	2.8	14.5	3.1	13.8	13.4	4.9	19.7	9.4	13.0	0.0	0.0	63.8	0.0	0.0	0.0	0.0	10.6	42.6	3.6	6.2	0.0	0.0	0.0	5.9	0.8	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.3	0.0	0.1	8.0	35.8	375.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	5.1	0.0	0.4	0.0	0.1	0.1	0.0	0.0	14.6	1.1	0.1	0.0	100.9	0.1	1.1	0.8	6.1	0.0	0.0	0.0	0.0	0.0	106.5	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.5	14.6	10.8	16.9	14.0	11.1	10.9	11.0	11.0	8.3	14.5	13.0	41.0	0.0	1.3	176.0	0.3	5.9	0.3	0.1	0.0	0.3	1.2	5.2	3.8	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.5	0.3	6.7	72.5	0.0	0.0	11.1	0.9	0.0	31.0	0.0	0.3	0.0	0.5	41.4	0.5	0.1	0.0	2.2	0.0	0.0	1.9	7.7	1.6	11.8	1.0	3.6	35.6	0.0	11.1	0.0	43.2	0.4	0.1	0.0	16.1	2.5	0.6	0.0	0.0	0.0	0.4	6.6	34.6	17.0	0.1	0.4	0.9	4.8	0.1	0.6	6.9	0.0	1.4
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109051-120115913	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 15.1"	"Cell type enriched"	"Detected in some"	14	"Spermatogonia: 123.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"T-reg: 4.9"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.9"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052560, HPA056506"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA052560: , HPA056506: AB_2683157"	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	1.7	1.2	2.3	0.1	2.3	0.1	1.4	3.7	3.4	1.5	2.7	1.7	0.0	0.8	0.0	0.5	2.4	0.2	0.6	2.3	2.7	1.8	0.9	0.5	0.3	2.7	2.7	3.5	0.3	0.1	1.7	0.0	2.7	1.4	0.0	2.5	0.6	0.2	0.2	1.2	1.0	0.1	2.4	1.3	0.7	15.1	2.6	0.2	1.1	0.0	0.1	1.0	0.8	2.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.9	0.0	2.3	2.3	3.7	3.4	2.3	2.7	2.7	2.7	2.7	2.4	2.6	2.7	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.0	1.3	0.3	0.5	1.3	0.0	0.0	0.0	4.2	0.1	0.2	0.1	1.9	0.2	1.5	0.2	0.1	0.5	0.0	0.0	0.8	0.4	0.4	0.2	0.0	0.1	0.0	8.3	0.0	0.2	0.1	0.0	1.5	0.3	0.0	0.0	0.0	3.8	0.6	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.1	0.0	0.1	2.4	1.3	0.0	0.0	0.3	3.3	123.8	0.0	0.3	0.0	0.2	0.7	0.2	0.0
RHOXF2	"CT107, PEPP-2, PEPP2, THG1"	ENSG00000131721	"Rhox homeobox family member 2"	Q9BQY4	X	120158613-120165630	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.0"	"Group enriched"	"Detected in some"	22	"Spermatocytes: 6.6;Spermatogonia: 7.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"K-562: 100.5;NB-4: 69.9;THP-1: 27.9;U-266/84: 47.2"									"HPA003314, CAB020794"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB020794: , HPA003314: AB_1855193"					"unprognostic (1.60e-1)"										"unprognostic (5.04e-2)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.0	11.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.5	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.5	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	2.1	0.5	0.1	0.7	0.9	0.7	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHOXF2B		ENSG00000203989	"Rhox homeobox family member 2B"	P0C7M4	X	120072264-120077690	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 21.2"	"Cell type enriched"	"Detected in single"	6	"Spermatogonia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HL-60: 596.6;K-562: 903.3;NB-4: 1129.0"									HPA003314	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA003314: AB_1855193"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	596.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	903.3	0.0	0.0	0.0	0.0	1129.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	94.3	3.0	0.0	0.0	0.6	0.2	0.0	156.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHPN1	"KIAA1929, ODF5, RHPN"	ENSG00000158106	"Rhophilin Rho GTPase binding protein 1"	Q8TCX5	8	143368876-143384221	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.1;thyroid gland: 20.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.0;Collecting duct cells: 38.6;Cone photoreceptor cells: 31.3;Respiratory ciliated cells: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 28.3;MOLT-4: 25.8;RPMI-8226: 19.0;T-47d: 44.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024288, HPA024671"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA024288: AB_1856274, HPA024671: AB_1856275"	"unprognostic (2.04e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.12e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-2)"	2.6	1.6	11.8	0.9	9.1	2.1	4.7	6.7	12.9	3.3	8.5	2.0	0.1	1.3	1.3	2.4	5.0	0.7	1.1	13.5	8.2	13.6	1.3	3.5	1.1	7.5	9.3	0.7	4.2	2.9	20.1	0.1	7.2	4.0	0.1	0.6	3.6	1.9	0.3	2.7	3.0	0.3	5.9	5.3	3.0	4.0	9.9	8.8	20.4	0.0	0.5	2.6	1.9	7.1	2.9	4.9	1.2	3.8	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.7	1.9	0.2	9.8	0.0	0.2	1.3	0.0	0.0	0.0	0.6	4.4	0.0	3.5	0.3	0.4	0.3	3.1	0.0	0.8	0.0	0.0	0.9	1.0	11.5	1.1	5.8	0.0	28.3	25.8	2.6	1.7	5.9	13.4	7.0	0.0	19.0	3.9	4.6	7.2	2.7	1.5	8.1	1.8	0.0	44.2	0.0	0.0	0.0	5.1	0.1	0.2	1.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	9.1	6.7	12.9	13.5	8.2	7.5	9.3	7.2	5.9	9.9	7.1	6.7	6.4	7.5	47.0	2.0	2.5	2.7	3.9	3.4	3.4	13.4	8.9	1.0	2.8	5.9	38.6	31.3	1.6	3.3	2.4	11.7	8.7	5.1	21.9	1.2	5.7	22.7	1.7	20.2	2.8	0.2	1.1	11.7	4.1	0.0	6.6	5.3	1.4	3.2	6.7	10.2	3.1	6.1	1.3	6.0	11.2	0.3	1.6	7.2	3.7	1.4	11.5	0.0	15.1	3.6	3.3	1.2	1.5	1.4	3.2	0.0	15.8	38.6	25.2	0.0	0.7	1.5	7.6	7.2	2.5	1.4	1.9	5.5	1.1	4.3	3.7
RIF1	"FLJ10599, FLJ12870"	ENSG00000080345	"Replication timing regulatory factor 1"	Q5UIP0	2	151409883-151508013	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036887, HPA036888"	Supported		Uncertain	"Nucleoplasm,Nuclear bodies,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies, Plasma membrane"		"HPA036887: AB_2675361, HPA036888: AB_2675362"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.41e-2)"	6.1	5.0	4.4	7.4	8.4	21.7	10.0	13.8	7.0	6.5	2.6	5.6	4.3	8.2	4.0	5.6	5.6	5.6	3.5	4.6	5.1	5.5	6.7	5.1	8.5	4.4	5.1	11.2	7.0	6.8	3.5	8.0	5.4	6.0	6.1	8.2	7.7	5.0	7.5	7.2	4.6	6.2	4.9	6.5	6.1	11.0	4.5	10.7	9.1	9.5	7.9	7.3	4.6	13.8	20.8	17.4	26.8	20.5	10.7	13.8	25.9	24.8	18.0	21.6	25.5	28.9	16.4	39.2	21.7	17.3	17.9	21.3	41.2	17.1	36.1	27.8	19.8	63.4	21.4	21.0	11.2	64.7	20.2	10.3	11.3	38.8	28.7	12.3	21.3	23.5	52.2	32.6	22.1	13.8	38.3	22.9	43.2	11.2	22.9	38.4	42.1	26.1	11.6	24.9	24.2	18.8	32.0	14.6	16.5	18.8	12.9	23.1	27.0	32.9	22.8	20.3	26.7	16.0	29.6	55.4	15.3	25.5	22.5	6.3	2.5	3.0	4.3	1.7	4.9	4.0	3.6	3.2	1.8	3.1	4.8	3.7	2.8	7.7	3.5	1.6	2.8	1.7	4.4	8.4	13.8	7.0	4.6	5.1	4.4	5.1	5.4	4.9	4.5	13.8	53.1	96.1	49.7	41.1	43.5	49.3	47.5	21.9	33.0	48.2	30.4	29.8	38.2	28.6	38.0	14.7	31.3	39.2	40.3	19.6	1.9	38.5	22.6	38.0	61.7	48.0	25.0	84.3	68.5	21.9	35.9	51.3	34.7	65.0	34.1	88.6	27.1	19.7	23.0	47.1	72.4	30.9	14.2	26.4	27.0	14.0	43.8	37.6	30.2	48.7	44.1	35.8	32.0	73.9	126.3	29.9	23.5	34.3	45.1	53.2	14.9	12.9	21.3	42.8	85.5	106.5	51.2	122.8	113.1	28.9	41.6	40.9	45.3	58.9	34.6	45.4
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 24.9;pituitary gland: 34.7;testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.9;Endometrial ciliated cells: 133.2;Enteroendocrine cells: 46.2;Late spermatids: 57.1;Respiratory ciliated cells: 73.9;Spermatocytes: 30.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;SCLC-21H: 1.6;SH-SY5Y: 2.7"	"Low region specificity"	"Detected in all"							HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.0	1.6	1.9	0.0	2.5	0.0	0.0	3.5	2.5	1.4	0.4	1.0	0.0	0.8	0.1	0.1	24.9	0.0	0.4	2.2	2.5	0.8	0.0	2.4	0.0	1.2	0.9	0.1	0.8	0.1	34.7	0.0	0.5	0.4	0.3	4.8	0.0	0.4	0.1	0.0	0.3	0.3	0.3	0.0	0.9	16.9	2.3	0.0	0.0	0.0	0.0	0.3	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	2.7	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	3.5	2.5	2.2	2.5	1.2	0.9	0.5	0.3	2.3	1.1	0.0	19.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	8.5	1.1	0.4	15.7	0.0	9.3	5.5	16.7	0.0	0.0	0.1	3.9	3.8	88.9	133.2	0.8	0.4	46.2	0.0	1.8	0.9	0.0	1.2	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	1.1	3.2	0.0	0.0	0.0	57.1	0.6	0.2	3.6	0.0	0.0	0.8	0.0	1.0	0.2	0.4	0.1	1.5	0.0	0.1	0.1	3.0	73.9	3.0	0.0	0.5	1.8	30.1	8.9	0.0	0.0	0.0	0.2	0.1	0.8	0.0
RILPL1	FLJ39378	ENSG00000188026	"Rab interacting lysosomal protein like 1"	Q5EBL4	12	123470054-123533719	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 62.4;skeletal muscle: 88.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Oligodendrocytes: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041314	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041314: AB_10795587"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.81e-1)"	7.8	9.0	17.1	3.1	21.1	2.6	7.5	18.6	18.3	10.7	17.9	10.5	1.3	12.0	4.1	5.1	9.5	3.4	62.4	15.2	16.7	6.8	4.2	6.8	1.8	19.0	19.7	8.5	3.7	6.6	6.4	7.3	18.6	9.1	1.4	3.0	6.8	7.4	88.9	6.8	4.2	6.3	15.9	4.4	5.5	4.1	18.0	1.5	13.3	41.1	1.0	9.5	7.5	27.1	8.3	11.4	10.1	7.9	11.1	10.4	10.6	14.6	8.1	7.8	6.9	7.1	1.9	0.3	7.1	14.3	5.6	8.9	7.5	7.0	3.1	8.4	13.8	1.1	8.1	10.6	19.4	0.4	3.0	11.9	13.6	8.7	12.5	19.5	8.0	1.5	6.6	0.4	8.0	13.8	0.9	2.7	7.4	2.4	11.9	1.3	5.5	0.4	5.6	8.5	1.6	9.3	7.8	6.7	17.9	5.5	9.0	0.2	16.0	10.2	5.1	14.8	9.4	1.7	0.9	0.2	10.4	0.0	6.5	0.4	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.5	0.4	1.1	0.3	0.3	0.3	0.2	0.2	17.1	21.1	18.6	18.3	15.2	16.7	19.0	19.7	18.6	15.9	18.0	27.1	13.0	38.5	11.7	32.3	0.7	4.6	5.1	3.4	6.2	14.1	4.6	14.7	9.8	4.3	7.2	11.0	6.2	9.1	0.7	0.2	1.9	2.2	1.8	6.3	18.0	8.5	0.0	0.0	28.8	2.2	6.2	9.4	1.1	7.4	1.3	18.9	9.7	1.6	5.7	23.5	16.4	1.3	0.0	1.3	2.4	1.6	15.5	3.3	5.4	18.7	0.9	21.4	0.0	13.6	64.9	2.2	0.5	8.2	0.3	5.1	0.1	2.6	4.1	6.4	6.6	14.4	9.9	0.9	2.9	2.3	3.8	9.3	2.0	21.5	0.7	3.3
RIMBP2	"KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2"	ENSG00000060709	"RIMS binding protein 2"	O15034	12	130396137-130716281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;parathyroid gland: 24.6;pituitary gland: 32.2"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 75.5;Excitatory neurons: 128.2;Inhibitory neurons: 191.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 28.9;SH-SY5Y: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041494, HPA044114"			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041494: , HPA044114: AB_2678815"	"unprognostic (4.15e-4)"	"unprognostic (9.77e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.86e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.73e-2)"	0.6	14.5	6.3	0.9	11.3	0.2	0.2	0.0	17.5	7.2	17.3	1.5	2.9	2.7	2.5	0.5	7.8	0.9	0.0	25.9	19.2	5.9	0.2	0.4	0.1	1.7	19.6	2.1	2.5	24.6	32.2	0.0	20.6	1.1	1.8	11.2	0.3	1.3	0.2	2.7	2.5	2.4	0.1	1.0	5.9	2.6	0.9	0.3	0.6	3.9	0.1	0.3	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.0	0.4	7.3	0.0	0.0	28.9	55.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	11.3	0.0	17.5	25.9	19.2	1.7	19.6	20.6	0.1	0.9	2.7	0.4	0.0	0.0	5.9	0.0	2.0	0.1	0.0	0.6	19.4	0.0	0.1	1.4	0.0	0.0	0.0	31.3	0.0	0.0	0.4	0.0	0.0	3.8	3.0	1.4	0.4	75.5	0.0	128.2	0.0	0.0	0.7	4.1	6.4	0.0	0.0	0.0	0.0	0.0	10.1	191.4	2.6	6.1	0.0	0.5	2.1	0.9	0.0	0.0	1.0	0.0	3.2	0.0	19.6	5.3	0.1	0.1	0.7	0.0	0.1	0.0	0.1	0.7	14.0	0.0	0.0	0.2	1.7	1.5	0.1	0.6	0.0	0.1	0.0	0.8	0.0
RIMKLB	"FAM80B, KIAA1238, NAAGS, NAAGS-I"	ENSG00000166532	"Ribosomal modification protein rimK like family member B"	Q9ULI2	12	8681600-8783095	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 184.2;Endometrial ciliated cells: 191.3;Glandular and luminal cells: 1012.9;Late spermatids: 300.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 17.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 145.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059552			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Centriolar satellite"		"HPA059552: "	"unprognostic (5.29e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-5)"	"unprognostic (2.40e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.52e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.99e-1)"	27.6	10.9	20.1	8.0	23.0	21.0	24.1	23.9	18.6	29.5	19.9	30.5	5.4	40.1	15.9	11.1	29.4	14.9	14.4	20.9	23.7	11.8	3.1	19.4	9.1	27.5	24.8	30.1	8.1	22.2	12.8	24.5	22.3	14.1	7.0	19.1	11.8	14.1	13.7	13.0	12.8	27.6	26.7	13.5	11.0	32.4	24.9	13.7	20.0	9.4	7.0	15.4	21.7	21.0	3.7	18.1	43.5	44.9	5.7	5.4	63.0	19.6	8.8	16.1	10.5	1.5	20.6	27.9	16.2	11.7	17.9	6.3	21.5	23.9	17.1	0.5	13.9	13.3	52.4	0.2	6.6	4.1	13.3	11.7	10.4	14.4	24.2	10.1	21.0	22.9	18.0	0.0	9.4	11.8	27.0	2.0	53.2	0.0	1.0	42.0	60.5	0.1	22.8	10.2	1.4	28.2	17.5	24.9	19.4	70.9	6.0	13.4	41.2	15.7	51.0	8.6	6.4	0.2	0.0	145.9	13.3	2.9	10.9	2.1	1.2	0.3	0.8	0.3	1.0	0.7	0.8	1.3	0.5	1.3	1.4	0.5	0.1	1.2	0.5	0.4	0.0	1.0	20.1	23.0	23.9	18.6	20.9	23.7	27.5	24.8	22.3	26.7	24.9	21.0	69.8	28.9	42.9	99.6	13.3	15.2	23.3	16.6	27.9	25.5	10.9	11.4	15.6	7.2	25.7	12.9	0.0	61.0	4.2	1.0	15.6	12.8	184.2	191.3	99.5	38.5	9.0	30.9	33.0	3.0	18.6	27.3	4.1	1012.9	12.0	72.3	22.9	0.0	19.9	13.5	52.7	2.1	16.2	8.8	8.0	300.3	23.3	12.4	33.8	41.2	2.0	34.2	5.2	78.9	9.5	5.8	3.7	30.9	3.8	23.4	6.7	9.1	33.9	3.6	13.1	15.6	29.6	77.1	38.3	17.8	13.4	136.5	11.0	27.7	1.5	21.5
RIMS3	"NIM3, RIM3"	ENSG00000117016	"Regulating synaptic membrane exocytosis 3"	Q9UJD0	1	40620680-40665682	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 105.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 12.6;Excitatory neurons: 37.7;Inhibitory neurons: 21.1;Late spermatids: 34.4;Muller glia cells: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 77.4;JURKAT: 26.7;SH-SY5Y: 35.2;U-87 MG: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055285			Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA055285: AB_2682771"	"unprognostic (3.51e-3)"	"unprognostic (7.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-4)"	"unprognostic (3.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.19e-2)"	1.0	6.2	33.4	1.9	63.8	3.6	2.5	0.0	80.2	1.6	0.0	4.4	0.6	3.5	1.6	2.3	2.7	0.9	2.1	27.0	29.3	1.4	0.4	3.5	1.7	0.7	38.1	1.8	0.7	2.9	1.0	3.2	0.4	2.5	3.1	6.5	1.6	3.3	0.3	2.2	2.2	4.1	2.8	1.2	3.4	3.7	105.9	4.3	2.2	0.5	2.3	2.5	1.5	30.2	4.1	1.6	5.8	6.2	0.3	0.0	0.9	0.1	0.1	1.0	1.2	0.7	1.2	77.4	0.1	0.1	2.8	0.7	3.8	0.7	0.6	13.5	1.9	4.4	0.5	2.1	0.2	0.7	3.5	0.1	3.1	0.2	0.2	0.2	0.3	26.7	3.8	2.9	0.0	7.0	11.7	0.4	3.8	0.7	0.4	5.3	5.3	14.3	1.1	1.0	19.9	35.2	0.8	3.7	2.6	7.7	0.9	21.4	0.1	0.6	5.9	0.1	1.1	0.7	5.9	16.8	32.2	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	33.4	63.8	0.0	80.2	27.0	29.3	0.7	38.1	0.4	2.8	105.9	30.2	0.0	6.4	0.0	2.6	0.4	0.5	0.2	0.1	0.6	6.1	1.5	2.5	1.8	0.0	0.1	1.8	0.0	0.1	7.3	6.0	0.0	0.9	12.6	0.0	0.0	0.5	0.0	1.3	37.7	1.5	0.1	0.5	0.0	0.1	1.3	10.7	0.0	0.0	2.7	5.0	21.1	4.2	0.0	2.6	1.4	34.4	0.0	1.5	0.0	3.7	0.9	13.4	0.0	4.0	4.5	2.3	1.4	0.7	0.2	0.4	0.0	0.7	0.0	0.7	0.0	1.5	2.5	2.7	2.0	0.1	0.1	0.3	0.9	0.7	1.6	0.2
RIMS4	"C20orf190, dJ781B1.3"	ENSG00000101098	"Regulating synaptic membrane exocytosis 4"	Q9H426	20	44751808-44810546	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.9"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 110.3;Horizontal cells: 38.7;Inhibitory neurons: 14.4;Sertoli cells: 26.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 6.6;glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 19.3;MCF7: 13.4;SCLC-21H: 39.9;SH-SY5Y: 20.4;SiHa: 14.0;U-2 OS: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060928	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA060928: AB_2684387"	"unprognostic (1.54e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-2)"		"unprognostic (4.63e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.60e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.94e-2)"	0.4	1.1	17.6	0.2	22.8	0.0	1.1	6.9	35.9	7.2	0.0	0.6	0.1	1.9	0.4	0.5	8.1	0.6	0.6	22.5	12.1	0.1	0.0	0.9	0.1	15.5	9.2	6.1	0.0	0.0	12.0	0.0	10.6	2.5	0.5	2.9	1.1	0.9	1.0	0.4	0.4	2.6	7.7	0.0	1.8	10.5	10.9	0.2	5.0	1.6	0.4	0.1	1.5	20.1	0.0	0.5	0.5	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.9	0.1	2.0	0.0	19.3	0.2	0.0	0.0	8.2	0.0	0.8	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	13.4	0.1	0.0	3.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	39.9	20.4	14.0	0.0	0.2	0.5	6.1	0.7	0.0	0.0	9.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	22.8	6.9	35.9	22.5	12.1	15.5	9.2	10.6	7.7	10.9	20.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	7.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.1	1.8	0.0	11.3	0.0	0.0	0.4	0.0	0.4	0.0	110.3	0.0	0.0	0.1	38.7	14.4	0.8	0.0	0.0	0.0	2.9	7.2	0.2	0.0	0.0	0.0	1.0	0.0	2.0	0.6	0.1	0.1	13.2	0.0	0.0	0.0	0.0	0.0	1.4	26.3	0.2	1.2	1.2	5.7	0.0	0.1	0.0	0.0	0.5	0.5	0.0
RIN1		ENSG00000174791	"Ras and Rab interactor 1"	Q13671	11	66330241-66336840	"Predicted intracellular proteins, RAS pathway related proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 26.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 25.7;Basal squamous epithelial cells: 23.3;Squamous epithelial cells: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 9.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 44.3;U-2197: 40.7"	"Low region specificity"	"Detected in many"							HPA035491	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"	Nucleoplasm	"HPA035491: AB_10601608"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (9.34e-7)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.46e-1)"	4.8	4.3	3.7	2.3	4.9	1.1	4.4	3.3	5.7	8.3	1.5	5.2	2.7	4.4	0.2	20.4	5.6	1.4	3.4	6.3	1.6	4.3	1.3	4.9	0.5	1.0	1.2	3.7	5.2	0.4	7.2	1.4	1.1	7.1	1.0	0.2	5.1	0.8	7.5	26.6	4.3	0.6	0.8	6.1	6.8	3.7	2.0	0.5	2.4	0.5	0.4	5.4	11.3	2.6	2.3	5.7	2.3	5.3	2.8	14.5	1.2	13.7	18.0	14.4	6.8	3.3	9.3	0.5	5.0	13.6	5.2	12.9	0.0	24.3	1.8	1.1	0.0	0.8	4.4	4.1	5.5	0.1	4.2	15.9	44.3	12.4	8.0	17.1	2.8	0.6	0.3	0.1	6.1	0.5	0.3	11.0	0.6	3.9	12.6	0.1	5.4	0.1	3.9	3.0	10.9	2.3	3.2	2.5	20.5	0.6	1.8	1.3	6.5	18.7	7.9	40.7	3.3	0.3	0.9	0.0	26.9	3.5	6.3	0.1	2.7	0.0	0.2	4.7	0.6	0.1	0.4	0.2	1.7	0.0	0.5	0.2	0.0	0.1	9.7	0.0	0.1	1.8	3.7	4.9	3.3	5.7	6.3	1.6	1.0	1.2	1.1	0.8	2.0	2.6	3.9	0.0	0.5	1.3	0.8	13.4	9.3	25.7	23.3	3.8	3.5	4.3	0.8	4.3	4.8	0.0	0.0	0.8	0.5	9.6	0.0	4.1	0.5	2.4	5.1	5.3	3.0	0.0	6.0	6.9	4.8	5.6	5.6	1.8	4.5	0.1	7.9	0.2	4.7	0.0	2.3	4.5	2.0	8.7	6.5	2.0	4.4	6.4	1.8	1.0	8.1	0.7	1.0	0.5	0.5	8.9	7.8	1.9	1.4	4.0	9.1	0.1	3.4	1.2	0.0	4.2	3.4	1.2	0.9	18.6	15.2	0.3	2.2	1.6	9.2	5.8
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208500-33212722	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	38.6	42.4	39.2	21.6	42.7	18.1	36.8	39.7	45.6	60.2	42.2	45.4	21.3	51.5	20.8	37.4	51.8	19.3	37.0	38.7	41.4	50.7	51.2	39.3	20.9	39.4	42.7	59.4	44.7	34.2	80.8	19.4	40.6	55.8	7.2	15.7	37.0	23.2	37.3	34.7	37.0	29.6	39.9	41.2	37.5	46.9	43.4	34.4	67.1	25.4	17.3	41.3	42.2	47.5	38.8	24.9	38.2	33.3	35.0	13.2	15.5	36.5	55.1	32.7	40.5	35.2	22.9	30.1	19.0	41.2	45.8	21.0	31.6	29.7	24.5	69.5	16.5	60.2	50.4	40.2	75.9	37.7	57.0	0.0	26.7	34.4	53.6	38.1	16.5	30.4	49.2	37.2	37.2	0.0	6.3	22.1	13.6	24.5	17.0	18.1	27.1	59.6	42.9	41.5	43.6	32.4	26.3	34.8	62.9	11.6	40.2	56.7	26.1	37.6	29.7	5.6	43.8	56.4	37.1	32.6	25.5	36.0	28.7	0.0	0.4	1.6	0.0	0.2	0.6	0.8	0.5	0.6	0.4	0.2	0.6	1.3	0.6	0.5	0.5	1.1	0.8	0.4	39.2	42.7	39.7	45.6	38.7	41.4	39.4	42.7	40.6	39.9	43.4	47.5	27.5	0.0	20.2	22.5	23.6	27.5	40.6	28.6	51.2	32.1	26.8	25.3	23.9	21.5	22.1	22.0	16.7	41.9	30.8	23.7	15.6	32.8	34.7	28.4	29.0	26.8	30.6	16.8	23.2	34.7	35.2	32.2	31.6	29.5	19.7	19.7	35.0	36.9	29.1	25.2	23.0	24.1	8.2	26.5	23.5	21.5	40.0	22.3	17.8	12.2	21.0	44.8	21.6	12.5	20.3	31.2	25.1	29.7	32.2	29.4	36.6	34.8	25.9	21.6	26.3	38.3	30.9	33.4	18.9	32.7	30.5	63.1	27.6	32.6	21.8	30.2
RINL	FLJ45909	ENSG00000187994	"Ras and Rab interactor like"	Q6ZS11	19	38867830-38878275	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 32.5;NK-cells: 45.3;Skeletal myocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 14.2;Karpas-707: 24.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042083, HPA042103"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Vesicles"		"HPA042083: AB_10793977, HPA042103: AB_10797380"	"unprognostic (1.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (7.38e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.05e-2)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.40e-3)"	5.3	2.5	2.2	5.3	2.7	2.8	4.2	2.6	2.8	2.8	2.9	3.9	1.6	2.0	0.9	6.3	3.3	1.7	3.5	2.1	2.3	6.1	7.8	4.3	9.7	2.6	2.1	1.5	13.2	2.7	7.2	1.6	2.9	2.5	1.4	2.5	5.3	1.1	2.3	3.6	8.4	1.0	1.9	15.8	4.2	1.1	2.2	3.9	5.1	0.9	7.6	4.6	3.7	2.2	0.0	1.8	0.4	0.2	0.7	0.3	2.8	0.4	0.3	0.4	0.4	1.9	9.2	9.1	3.1	0.4	0.1	0.2	1.7	2.4	0.5	1.7	0.6	10.1	2.6	4.8	1.9	6.4	14.2	2.0	0.4	1.2	0.5	0.3	3.5	5.1	1.8	24.6	0.0	1.6	1.6	4.3	0.8	5.2	0.3	1.2	0.1	6.5	1.7	0.2	3.2	1.3	4.2	6.7	3.6	0.4	0.8	7.7	2.6	0.1	1.9	0.5	0.1	9.1	9.3	6.3	0.7	2.8	0.5	5.3	1.1	1.6	10.3	2.5	6.5	17.4	6.9	7.7	2.0	21.9	5.3	6.4	3.0	5.2	2.5	16.0	8.1	3.6	2.2	2.7	2.6	2.8	2.1	2.3	2.6	2.1	2.9	1.9	2.2	2.2	6.7	3.2	7.7	0.0	22.4	3.2	5.3	2.9	4.6	4.0	5.8	4.7	3.5	8.6	2.3	3.7	8.4	13.9	32.5	0.6	7.9	7.3	0.5	2.8	1.6	6.9	7.2	9.0	2.2	7.3	7.1	4.3	5.1	6.3	15.2	1.3	8.2	7.5	9.3	0.0	1.6	0.7	14.2	6.8	2.7	1.3	3.1	4.3	10.6	1.0	10.5	6.2	45.3	3.5	0.6	5.1	1.7	2.6	14.8	2.3	0.6	12.7	1.3	10.6	0.0	30.3	2.3	2.7	4.4	6.4	3.8	4.1	24.6	5.0	1.3	3.6
RIOX2	"FLJ14393, JMJD10, mdig, MINA, MINA53, NO52"	ENSG00000170854	"Ribosomal oxygenase 2"	Q8IUF8	3	97941818-97972457	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.7;Distal tubular cells: 49.0;Endometrial ciliated cells: 25.7;Extravillous trophoblasts: 43.5;Syncytiotrophoblasts: 31.2;Theca cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007603, HPA008080, CAB013458"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960"	"prognostic unfavorable (4.41e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.68e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.56e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.76e-1)"	14.6	9.7	9.8	14.5	11.3	2.2	13.9	9.5	11.2	11.6	8.3	12.4	6.9	10.7	10.6	22.3	10.4	7.3	10.1	9.5	12.3	14.4	14.3	11.0	14.2	12.4	12.4	10.4	18.2	10.8	10.2	15.6	12.0	10.4	12.3	16.8	19.8	9.6	32.0	17.8	10.3	10.4	12.9	8.4	12.8	6.7	10.9	6.9	46.4	11.3	15.0	16.4	15.5	13.6	42.6	27.8	9.1	17.4	20.5	30.3	22.8	20.1	14.3	22.0	18.5	18.6	22.8	59.7	21.2	25.1	34.3	24.3	28.9	28.2	32.5	109.9	13.8	19.2	13.5	19.1	33.4	37.1	7.0	24.5	38.8	17.6	44.4	13.1	23.9	26.4	26.2	23.3	22.1	11.5	29.7	14.5	19.9	47.3	34.4	0.0	32.2	58.7	21.4	24.1	49.6	17.6	25.7	28.7	34.4	10.1	24.7	15.3	16.3	22.9	24.0	13.7	39.9	37.7	18.3	55.5	29.1	37.8	23.8	1.9	13.2	0.7	10.3	11.9	15.8	15.9	14.9	12.0	16.9	13.3	15.0	12.5	0.8	10.8	15.8	26.0	15.2	10.5	9.8	11.3	9.5	11.2	9.5	12.3	12.4	12.4	12.0	12.9	10.9	13.6	18.3	9.6	14.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	14.9	11.2	0.0	0.0	10.5	7.3	0.0	33.7	5.7	0.0	49.0	16.4	0.0	25.7	14.9	5.8	0.0	0.0	0.0	13.2	43.5	7.3	0.0	12.6	2.5	20.2	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	7.2	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.5	0.0	0.0	11.6	13.8	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	31.2	2.2	24.8	0.0	0.0
RIPOR3	"C20orf175, C20orf176, dJ530I15.2, dJ530I15.3, FAM65C"	ENSG00000042062	"RIPOR family member 3"	Q96MK2	20	50586108-50691542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Collecting duct cells: 3.7;Endometrial stromal cells: 6.5;Fibroblasts: 3.8;monocytes: 2.0;Proximal tubular cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 16.7;HEL: 55.9;HSkMC: 33.0;K-562: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051823, HPA054759"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA051823: AB_2681626, HPA054759: AB_2682596"	"unprognostic (7.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.66e-5)"	"unprognostic (4.96e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.98e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.58e-2)"	19.4	13.3	2.7	3.4	3.0	22.4	11.7	2.7	3.5	38.5	5.1	8.5	2.5	18.2	1.0	5.3	27.7	3.2	16.6	2.7	2.6	28.9	14.1	5.3	4.7	3.0	2.9	8.3	3.0	0.8	9.1	1.9	2.9	6.0	1.5	0.1	6.9	0.6	7.8	5.5	11.3	4.4	2.6	7.5	5.8	6.1	2.8	4.7	7.5	3.8	1.3	8.2	16.6	2.6	0.0	0.0	0.9	0.0	36.0	16.7	0.1	0.0	11.6	0.0	0.2	0.3	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.2	4.3	0.0	0.0	33.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.9	0.0	3.2	0.0	0.0	5.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	2.7	3.0	2.7	3.5	2.7	2.6	3.0	2.9	2.9	2.6	2.8	2.6	1.1	3.2	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.6	3.7	0.0	0.6	0.4	0.0	0.0	0.5	0.0	0.8	6.5	0.2	0.0	0.0	0.0	0.4	0.4	3.8	0.0	1.6	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0
RIT2	"RIBA, RIN"	ENSG00000152214	"Ras like without CAAX 2"	Q99578	18	42743227-43115691	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 225.8;Oligodendrocyte precursor cells: 202.5"	"Cancer enriched"	"Detected in single"	49	"glioma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA072174, HPA072526"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA072174: AB_2732195, HPA072526: "					"unprognostic (1.37e-2)"							"unprognostic (4.15e-1)"			"unprognostic (2.14e-1)"			0.0	1.9	9.3	0.1	10.6	0.0	0.0	25.9	16.8	0.1	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	13.3	0.0	0.0	0.0	0.0	12.8	9.2	0.0	0.0	0.0	0.5	0.0	17.4	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	8.9	0.0	0.0	0.2	11.6	0.0	0.0	0.0	0.0	0.0	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	10.6	25.9	16.8	8.8	13.3	12.8	9.2	17.4	8.9	11.6	8.8	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	225.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	42.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	3.7	0.0	1.0	0.0	202.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	1.4	0.2	0.0	0.0	2.1	0.0	0.5	0.0	0.0
RITA1	"C12orf52, FLJ14827, RITA"	ENSG00000139405	"RBPJ interacting and tubulin associated 1"	Q96K30	12	113185526-113192368	"Predicted intracellular proteins"	"Neurogenesis, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 49.0;Proximal enterocytes: 62.0;Proximal tubular cells: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039094, HPA039095, HPA061531"	Supported		Supported	Nucleoplasm		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA039094: AB_10671037, HPA039095: AB_2676345, HPA061531: AB_2684554"	"unprognostic (7.10e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	6.8	25.4	17.0	7.1	17.4	7.1	7.7	16.0	20.2	8.7	14.6	9.7	13.1	8.1	6.4	14.3	14.0	5.9	15.0	17.5	15.7	15.9	29.6	6.9	11.1	15.1	15.3	10.6	10.6	9.5	12.6	4.7	15.2	10.1	5.9	4.4	13.7	8.3	31.7	10.8	14.2	4.6	12.6	9.5	8.8	7.4	16.9	9.7	10.4	27.2	8.2	8.5	8.1	15.3	27.0	34.3	8.7	23.0	11.5	8.8	15.6	17.2	35.3	24.9	19.8	40.7	13.0	50.8	26.0	14.6	21.4	20.0	20.0	22.3	14.4	31.3	28.4	17.4	16.6	26.6	18.7	23.4	14.0	13.6	20.2	24.6	13.8	34.5	20.7	24.7	34.0	9.2	14.9	38.6	26.1	63.1	29.2	22.9	41.8	23.2	9.3	43.2	20.3	37.8	28.9	16.6	21.7	45.2	38.2	10.6	38.2	35.5	13.7	15.7	22.3	18.2	24.7	31.6	28.6	56.0	23.4	19.4	22.5	43.7	14.6	9.9	15.3	6.6	15.3	11.0	13.5	13.9	16.5	11.8	13.2	14.6	0.3	20.7	8.6	22.5	16.1	13.5	17.0	17.4	16.0	20.2	17.5	15.7	15.1	15.3	15.2	12.6	16.9	15.3	8.1	0.0	11.3	2.9	11.1	6.4	7.1	14.0	7.4	7.4	14.7	14.7	6.6	12.8	9.1	14.7	4.2	19.3	9.8	17.0	49.0	19.2	10.8	16.7	7.3	9.3	11.4	8.8	6.5	16.4	16.9	7.0	8.2	7.3	0.0	8.7	8.6	37.5	14.2	15.2	6.7	12.5	8.2	7.8	2.4	29.6	9.9	6.3	5.4	2.8	5.9	11.0	19.6	2.0	3.7	15.2	12.9	8.2	14.7	10.1	62.0	51.9	17.1	6.0	6.6	7.7	7.5	4.5	7.8	13.8	6.5	10.1	9.0	17.2	12.7	7.5
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221614	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 265.6"	"Cell type enriched"	"Detected in some"	34	"Muller glia cells: 3148.2"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	53	"SK-MEL-30: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: AB_2732495, HPA044083: AB_2678802"	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.0	0.2	14.9	0.1	16.9	0.1	0.0	15.0	20.8	0.0	16.7	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.0	15.7	14.5	0.0	0.0	0.0	0.0	14.5	14.2	0.0	0.0	0.0	2.6	0.0	14.3	0.0	0.1	265.6	0.0	0.0	0.1	0.0	0.4	0.1	14.0	0.0	0.2	0.9	14.9	0.0	0.0	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.9	16.9	15.0	20.8	15.7	14.5	14.5	14.2	14.3	14.0	14.9	14.9	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.3	0.0	0.0	0.0	39.6	4.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	2.0	3148.2	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	20.0	0.0	0.0	0.0	0.0
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"RLF zinc finger"	Q13129	1	40161387-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA054653: AB_2682557, HPA057300: AB_2683404"	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	8.7	4.9	5.5	6.2	6.0	32.8	8.3	12.0	7.9	8.4	2.5	7.6	5.1	7.9	4.7	7.3	7.0	6.6	7.5	6.0	5.6	4.9	7.7	8.2	7.7	4.1	4.3	8.3	5.6	6.5	5.1	7.3	4.2	6.6	5.2	15.4	5.7	5.4	8.5	12.2	6.2	6.1	4.3	6.2	5.7	10.3	5.2	10.2	5.8	7.1	8.5	7.8	8.4	8.2	18.3	6.9	13.3	13.9	11.6	9.4	15.8	6.7	9.9	11.3	14.9	14.0	9.4	18.1	8.6	8.6	8.4	16.8	16.9	11.8	20.4	8.5	11.4	14.9	8.0	8.7	9.2	12.5	8.7	9.3	12.1	12.0	13.5	13.5	7.8	9.8	23.0	10.8	10.4	5.8	10.6	7.5	17.8	6.7	7.9	8.2	21.8	10.6	7.2	18.2	9.4	13.1	12.5	16.5	12.0	20.5	7.8	44.6	6.7	13.2	14.1	11.0	12.6	9.8	9.8	16.6	11.5	11.4	8.4	6.9	1.5	3.0	1.8	2.0	2.4	2.3	1.8	1.9	1.9	2.1	2.3	2.0	3.2	2.4	2.4	0.8	1.8	1.3	5.5	6.0	12.0	7.9	6.0	5.6	4.1	4.3	4.2	4.3	5.2	8.2	36.7	32.1	15.1	52.2	55.8	65.6	50.3	12.7	30.7	17.8	25.5	18.4	16.9	2.8	23.9	3.7	16.7	8.9	40.6	10.4	5.9	13.8	41.3	43.8	41.6	24.9	20.2	11.3	87.1	6.7	10.6	34.9	29.6	56.0	26.6	23.0	16.1	9.0	9.7	26.9	84.7	8.8	14.2	13.8	45.2	8.7	9.0	39.9	17.8	60.9	17.5	14.1	9.2	71.9	89.0	10.1	15.5	7.9	44.6	28.7	8.9	5.5	26.0	17.2	13.1	52.8	36.1	32.2	20.8	29.3	61.1	17.2	45.8	17.0	10.8	33.0
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74582976-74614624	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.20e-1)"	11.3	11.8	10.6	10.4	11.7	41.2	10.5	5.9	9.9	10.0	10.0	6.8	5.9	9.5	5.6	8.7	8.4	9.6	8.8	11.2	15.1	10.0	8.3	12.1	8.9	8.5	10.3	10.6	7.5	11.7	10.3	9.8	10.3	9.8	6.6	10.7	7.4	7.1	9.6	9.4	6.1	9.3	7.3	9.3	7.4	6.5	12.6	11.0	11.7	8.6	9.5	8.5	8.0	8.2	23.7	24.2	22.8	18.7	20.1	22.5	22.4	22.4	26.0	19.9	24.4	18.9	24.4	12.8	25.4	28.6	26.7	19.9	45.9	26.7	30.1	11.7	23.9	22.7	43.2	10.7	17.4	34.6	38.6	21.7	14.4	28.2	46.5	15.6	23.3	20.9	19.9	22.9	24.6	18.1	26.0	16.8	35.0	12.9	22.5	24.3	48.0	21.5	16.1	28.6	16.4	19.5	42.3	19.0	24.5	20.4	11.2	24.9	31.0	23.4	23.1	24.8	19.6	12.0	24.6	20.3	25.5	33.1	23.2	22.8	6.0	5.9	3.1	7.5	3.1	3.0	3.9	3.8	4.9	3.3	4.2	3.8	11.5	5.3	5.6	2.6	4.8	3.2	10.6	11.7	5.9	9.9	11.2	15.1	8.5	10.3	10.3	7.3	12.6	8.2	44.8	16.0	17.0	13.4	22.4	35.8	29.6	16.1	23.3	13.8	18.3	13.5	30.5	18.6	20.4	25.8	14.6	16.3	27.6	10.3	11.7	13.7	7.9	32.3	35.3	30.1	23.2	12.8	19.2	10.7	21.5	27.7	27.0	41.0	38.0	24.6	21.0	14.8	18.2	21.9	18.9	10.6	10.2	20.7	34.1	4.4	9.9	29.1	17.8	15.9	12.7	13.2	12.3	11.1	16.4	14.8	8.5	18.8	16.3	25.5	6.8	12.0	25.2	14.6	6.6	31.1	24.1	9.7	18.2	21.6	38.8	26.3	22.0	19.0	11.4	37.2
RMC1	"C18orf8, HsT2591, MIC1, WDR98"	ENSG00000141452	"Regulator of MON1-CCZ1"	Q96DM3	18	23503470-23531822	"Cancer-related genes, Predicted intracellular proteins"	Autophagy		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 14.5;Proximal tubular cells: 19.9;Syncytiotrophoblasts: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043589	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA043589: AB_2678568"	"unprognostic (6.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.13e-2)"	12.8	9.8	4.9	11.2	6.0	27.4	11.2	5.5	7.3	10.9	8.5	11.1	16.7	11.2	9.3	11.7	10.6	10.3	8.8	6.2	6.6	13.0	19.1	14.4	21.3	5.3	4.8	9.6	11.7	11.4	16.6	8.5	5.7	9.3	10.9	25.4	12.2	10.6	13.4	12.5	17.1	10.6	5.1	15.6	14.6	17.2	5.3	15.8	9.8	7.4	19.1	14.8	10.5	7.2	13.9	13.9	10.3	18.1	23.0	16.6	13.5	21.5	22.8	28.2	33.6	12.9	8.1	20.8	17.5	18.7	40.9	26.6	27.1	12.0	24.8	21.6	15.4	10.2	8.7	13.1	30.1	27.7	36.0	14.9	18.6	35.2	19.8	16.2	16.9	17.7	16.7	21.9	18.8	18.1	23.8	13.0	5.6	19.7	21.4	18.3	15.4	20.4	14.7	13.0	13.8	17.9	28.1	13.7	18.2	14.2	10.5	17.6	16.2	23.6	6.0	9.8	18.6	34.1	27.4	23.6	24.5	18.7	18.4	50.5	16.4	37.7	23.8	31.0	24.5	32.5	20.7	23.3	20.0	29.5	14.0	17.2	15.2	32.9	44.5	44.5	30.5	18.7	4.9	6.0	5.5	7.3	6.2	6.6	5.3	4.8	5.7	5.1	5.3	7.2	9.1	9.6	13.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.6	5.8	0.0	0.0	3.7	7.3	0.0	10.7	13.4	0.0	5.9	11.6	0.0	11.4	5.9	2.9	0.0	0.0	0.0	12.1	7.6	3.4	0.0	14.5	3.8	8.7	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.8	0.0	0.0	0.0	0.0	11.3	0.0	0.0	1.9	0.0	0.0	19.9	1.5	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	19.2	6.3	8.3	0.0	0.0
RMI1	"BLAP75, C9orf76, FLJ12888"	ENSG00000178966	"RecQ mediated genome instability 1"	Q9H9A7	9	83980798-84004074	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.0;Late spermatids: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021661			Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA021661: "	"unprognostic (9.59e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.24e-2)"	2.5	8.3	2.9	6.0	3.2	3.9	4.5	4.6	3.4	3.2	6.0	6.6	6.2	3.5	5.6	4.9	5.8	2.8	3.4	2.4	5.8	4.4	5.8	3.3	10.2	3.3	3.3	4.4	5.8	7.7	3.7	3.6	3.5	4.8	7.4	7.0	6.0	3.1	3.7	5.1	6.8	3.3	3.2	6.4	6.2	8.9	3.8	10.2	6.0	3.9	9.6	3.6	2.4	3.8	25.2	14.9	33.6	12.4	5.5	7.7	33.9	24.1	13.6	20.7	19.4	7.5	17.0	55.4	8.5	12.4	21.7	36.9	22.0	12.3	25.3	29.2	6.1	23.0	12.1	11.8	7.7	42.6	23.1	7.4	7.8	17.6	12.6	6.7	11.1	28.2	16.7	26.3	23.2	18.1	54.4	17.4	31.3	31.6	15.7	47.8	33.9	21.0	10.8	10.4	30.4	19.3	21.3	18.6	9.8	15.4	19.4	20.8	6.6	22.9	14.7	23.2	20.1	11.6	25.6	20.2	14.6	19.7	26.4	14.2	4.5	8.8	1.8	5.5	2.2	2.8	2.1	1.9	7.2	2.6	2.2	2.5	7.8	2.8	6.5	2.2	3.0	2.6	2.9	3.2	4.6	3.4	2.4	5.8	3.3	3.3	3.5	3.2	3.8	3.8	5.4	9.6	5.1	10.1	5.9	2.7	3.2	4.3	4.0	4.1	4.3	3.3	8.5	2.8	9.0	1.8	4.2	7.9	2.1	6.1	5.9	5.5	70.0	13.9	6.5	3.8	6.7	24.4	7.1	3.0	16.2	3.3	8.2	10.2	4.5	9.0	5.0	13.3	8.1	10.1	11.2	9.8	0.0	10.7	4.3	62.1	2.1	7.4	12.4	8.4	8.5	7.7	5.2	26.2	12.6	2.7	5.6	2.2	7.8	4.2	8.9	4.9	11.1	5.2	0.0	3.3	3.4	34.0	22.6	6.9	4.8	4.2	4.4	7.7	10.1	2.4
RMND5A	"FLJ13910, GID2, GID2A, p44CTLH, RMD5"	ENSG00000153561	"Required for meiotic nuclear division 5 homolog A"	Q9H871	2	86720291-86778041	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046795, HPA060843"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA046795: AB_10963573, HPA060843: AB_2684378"	"unprognostic (4.54e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.32e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.56e-1)"	17.8	11.2	19.4	9.3	24.3	31.2	16.2	54.5	25.2	13.4	20.0	19.7	16.4	13.0	13.3	31.3	12.9	6.8	38.2	21.6	17.5	18.2	42.9	10.5	11.6	18.4	20.6	11.1	11.6	20.8	7.9	11.6	18.3	12.4	21.2	18.9	11.4	11.1	63.6	22.4	15.5	13.7	20.4	14.3	12.1	7.8	18.7	31.4	13.0	37.0	14.0	10.0	17.0	28.8	19.4	10.2	17.6	10.5	22.9	10.1	36.3	7.5	6.1	9.7	11.0	37.6	20.3	66.7	22.4	6.9	11.3	22.6	45.1	15.8	15.0	19.4	34.4	58.7	21.8	34.2	23.1	43.2	18.6	15.4	30.5	10.2	35.2	11.0	17.0	48.7	37.7	37.3	7.9	12.6	40.1	36.9	29.8	23.1	13.0	47.3	54.2	42.3	20.1	22.8	32.6	25.1	16.9	33.5	27.9	24.8	16.8	36.8	16.3	6.7	12.9	12.2	11.7	16.7	18.8	45.0	5.6	51.3	7.8	37.5	11.9	8.1	8.1	10.1	9.7	4.7	6.2	9.1	9.4	6.4	8.4	11.6	27.5	8.8	12.5	7.4	4.7	8.6	19.4	24.3	54.5	25.2	21.6	17.5	18.4	20.6	18.3	20.4	18.7	28.8	32.8	12.8	15.9	15.3	27.0	41.9	23.4	10.4	46.7	26.3	25.5	15.6	93.2	24.3	10.5	11.0	6.2	21.0	36.2	73.3	23.5	13.1	13.7	33.8	28.7	26.0	39.5	105.2	27.3	14.1	18.6	20.1	24.5	35.3	8.2	16.3	25.0	76.7	15.1	23.5	27.2	57.4	14.2	34.4	42.7	5.6	19.3	26.3	32.0	14.0	23.7	15.3	30.9	10.6	42.3	21.9	30.9	17.3	30.1	34.8	38.1	34.4	26.6	16.3	6.6	22.7	20.1	17.9	27.8	50.0	54.8	24.6	31.4	24.6	28.7	34.0
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20802855	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"pancreas: 9121.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 826.6;Alveolar cells type 1: 929.5;Alveolar cells type 2: 818.4;Gastric mucus-secreting cells: 821.1;Hepatic stellate cells: 650.3;Hofbauer cells: 1583.4;Intestinal goblet cells: 663.8;Macrophages: 632.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 9.7;myeloid DC: 20.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 20.3;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 286.8;OE19: 67.4;RT4: 114.2;TIME: 179.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1100000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	694.2	501.3	336.6	131.3	466.1	6.2	353.3	404.4	556.1	203.9	294.9	378.4	176.7	139.4	112.0	194.0	232.0	406.4	377.7	351.3	380.9	253.0	54.5	775.9	187.8	438.9	408.3	190.6	9121.6	60.6	43.9	897.4	403.7	83.9	425.2	3.1	168.0	149.7	127.6	118.1	201.8	285.6	357.3	353.1	1003.5	977.5	465.4	177.6	119.7	280.6	68.8	374.7	107.9	533.7	0.0	1.4	0.5	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	0.0	0.3	1.7	0.0	2.2	0.6	0.0	1.4	0.0	0.1	0.1	5.3	0.1	0.8	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	286.8	0.0	31.4	0.4	0.0	0.0	0.3	2.0	1.2	67.4	0.0	0.2	0.1	1.5	0.2	114.2	1.2	1.4	0.0	0.8	0.3	2.0	0.3	0.1	179.3	0.0	2.7	1.8	0.3	0.6	0.1	0.1	4.6	0.1	3.8	1.6	9.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.0	5.0	0.0	2.4	336.6	466.1	404.4	556.1	351.3	380.9	438.9	408.3	403.7	357.3	465.4	533.7	826.6	929.5	818.4	1.6	11.1	35.6	1.0	1.9	15.9	0.1	6.2	11.7	59.8	27.1	174.0	16.5	0.0	12.9	5.7	261.8	0.0	8.8	20.0	3.8	1.9	581.7	48.7	28.0	0.5	315.2	14.6	58.4	821.1	3.4	25.2	103.8	650.3	7.9	1583.4	1.7	0.8	663.8	8.2	267.9	197.5	57.1	32.0	632.8	40.9	36.5	3.4	0.8	0.0	1.0	232.3	286.8	246.7	10.9	7.5	1.4	81.7	0.9	34.9	2.7	98.6	20.7	31.4	16.4	6.6	16.6	28.1	25.9	10.6	392.8	162.9	3.8
RNASEH1		ENSG00000171865	"Ribonuclease H1"	O60930	2	3541430-3558333	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA034817, HPA043037"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA034817: , HPA043037: AB_2678280"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.81e-3)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (9.43e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-3)"	10.6	8.7	9.7	9.5	10.6	11.4	9.7	8.2	12.3	8.5	6.8	7.8	7.2	11.7	11.3	9.6	7.8	7.5	13.0	11.1	11.2	7.1	8.1	7.9	10.2	10.1	9.1	8.2	8.7	9.1	3.3	7.9	10.1	9.3	9.5	8.7	7.7	11.8	15.3	9.9	7.8	13.3	9.2	9.0	6.9	7.0	11.7	10.3	9.5	15.0	10.9	8.5	4.7	10.5	11.9	21.4	22.1	22.5	24.9	23.2	17.2	29.0	30.6	24.8	16.5	19.4	13.0	33.6	13.7	31.5	18.8	14.7	32.6	23.2	30.9	12.4	17.5	33.1	18.9	27.5	35.5	42.0	23.3	23.5	24.9	24.2	29.3	18.5	21.5	54.8	33.0	19.4	31.1	9.3	32.7	27.3	34.7	20.6	17.0	26.9	32.0	34.3	21.0	19.7	33.3	48.9	17.8	15.9	27.5	16.7	10.3	22.9	24.8	24.1	11.5	24.7	40.7	36.1	37.5	43.9	43.2	35.1	37.5	0.1	0.6	1.3	1.3	1.2	2.2	1.1	1.0	1.7	0.7	0.6	1.0	2.1	0.5	0.4	1.2	1.5	0.4	0.7	9.7	10.6	8.2	12.3	11.1	11.2	10.1	9.1	10.1	9.2	11.7	10.5	15.6	22.4	6.9	9.1	30.7	7.5	26.1	21.0	13.6	25.7	14.9	12.6	25.9	11.5	14.7	3.7	20.9	32.7	25.4	14.4	37.2	44.3	5.1	9.6	20.8	20.1	15.0	13.5	11.8	48.7	44.3	20.2	17.9	11.0	27.3	17.9	16.8	18.0	30.8	35.3	10.7	16.4	14.2	18.8	8.9	3.4	13.7	16.2	10.6	10.3	32.3	17.5	30.9	7.5	9.8	48.3	9.9	26.4	41.7	50.2	16.6	28.6	14.1	18.8	19.7	23.6	23.4	21.0	27.5	17.8	12.1	36.5	18.9	27.7	15.9	37.9
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806584-12813640	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 62.3;Extravillous trophoblasts: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	8.9	6.8	7.0	11.8	7.2	28.0	9.0	10.4	9.1	10.8	6.2	10.5	10.3	8.5	4.9	18.3	10.6	4.9	7.6	7.2	6.1	7.4	6.9	7.3	17.1	7.3	6.5	8.9	9.2	5.3	5.4	10.4	7.4	6.0	10.7	8.4	8.6	5.0	8.9	13.9	10.0	8.2	6.0	14.5	9.4	19.8	6.8	24.4	7.5	6.6	18.7	8.2	10.8	9.5	130.0	103.8	94.8	75.7	12.3	23.4	76.2	68.4	40.0	126.3	136.0	76.2	58.7	126.9	106.2	36.6	59.6	79.4	82.6	89.2	83.5	82.7	118.1	67.7	112.9	89.9	7.1	70.6	60.5	10.4	19.7	110.7	43.9	21.4	47.3	114.8	91.2	46.8	82.0	251.4	132.8	83.0	56.4	79.1	167.4	146.1	102.0	113.7	39.6	63.8	119.8	76.7	67.0	39.8	46.7	39.8	76.1	78.4	29.3	129.2	55.7	197.0	126.1	97.6	130.3	108.5	77.4	129.4	105.5	9.4	19.1	17.2	23.9	27.6	23.3	36.8	19.6	22.5	19.0	36.3	15.9	19.6	4.4	44.8	27.7	21.0	25.8	19.1	7.0	7.2	10.4	9.1	7.2	6.1	7.3	6.5	7.4	6.0	6.8	9.5	5.3	0.0	2.6	1.3	15.3	14.0	15.7	22.9	6.8	16.2	2.8	11.7	2.7	12.8	7.6	0.0	4.2	62.3	9.1	11.3	0.0	5.4	16.1	0.8	1.6	9.0	8.4	38.7	2.2	6.0	117.4	10.3	10.7	1.1	3.8	2.5	11.7	4.4	48.9	8.4	3.0	13.9	22.4	9.1	13.2	18.8	8.4	9.3	12.4	1.9	8.5	10.4	14.4	1.0	2.4	2.1	6.8	4.9	33.0	5.3	6.2	1.0	9.5	13.9	6.6	15.6	9.8	51.2	44.9	23.8	13.2	22.7	10.2	0.8	24.8	16.1
RNASEH2B	"AGS2, DLEU8, FLJ11712"	ENSG00000136104	"Ribonuclease H2 subunit B"	Q5TBB1	13	50909747-51024120	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 132.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 351.0;NB-4: 259.8;REH: 286.0;THP-1: 258.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040084, HPA041469"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA040084: AB_10697714, HPA041469: AB_2677496"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.50e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (2.54e-8)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	17.7	14.8	13.2	28.6	13.5	58.4	19.5	14.5	15.2	16.0	8.7	22.3	16.7	18.8	14.1	17.6	24.9	17.1	25.2	11.9	11.5	14.8	15.0	20.5	45.7	12.2	12.1	21.2	25.7	17.1	8.3	19.6	12.0	19.2	22.0	4.7	20.2	21.6	23.8	13.5	19.8	26.8	12.4	26.3	19.2	17.3	13.7	132.6	27.4	6.0	38.4	22.9	9.4	15.4	41.1	33.1	17.6	37.5	22.9	45.9	41.7	28.6	32.4	40.6	34.0	43.1	61.2	114.4	17.8	29.4	38.4	38.2	55.8	26.1	48.4	42.2	47.1	102.7	22.4	25.4	31.2	191.2	66.0	17.9	33.4	35.9	31.8	36.8	36.3	238.0	58.7	52.7	55.4	19.2	351.0	259.8	57.9	87.2	25.7	286.0	51.4	77.7	30.6	23.6	38.8	56.8	34.4	12.6	38.0	22.8	19.7	258.7	25.6	36.0	30.1	42.7	64.3	69.8	50.3	135.6	9.5	140.6	43.1	3.5	37.5	17.8	31.6	43.3	35.7	104.2	61.9	51.4	55.1	86.4	54.4	51.9	6.1	38.0	38.3	94.0	107.5	54.1	13.2	13.5	14.5	15.2	11.9	11.5	12.2	12.1	12.0	12.4	13.7	15.4	21.2	38.5	23.8	17.6	85.8	18.7	30.5	43.7	22.2	14.1	31.1	35.8	47.4	18.6	27.4	16.5	6.2	40.7	92.3	9.7	29.4	41.7	74.0	30.1	33.2	14.9	12.1	107.7	31.1	50.5	55.7	26.7	13.7	18.2	52.6	62.0	16.4	15.1	97.3	1.7	35.4	21.8	24.4	59.0	22.0	38.2	27.7	50.4	16.0	45.0	86.4	11.7	45.3	44.2	59.5	24.7	9.9	29.7	75.6	34.5	12.1	28.4	37.3	6.2	13.1	21.8	28.9	91.4	44.3	26.9	21.0	17.9	56.5	36.9	35.4	29.3
RNASEH2C	"AGS3, AYP1"	ENSG00000172922	"Ribonuclease H2 subunit C"	Q8TDP1	11	65714005-65720818	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 388.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065375	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA065375: AB_2685481"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	17.4	23.8	15.7	9.6	16.4	19.6	16.8	16.8	19.4	30.6	16.4	35.0	8.5	27.3	6.5	14.6	28.2	6.3	18.9	15.9	15.5	27.5	16.8	16.4	13.9	15.3	15.7	34.0	16.9	7.5	32.3	5.5	16.1	34.4	3.9	7.7	16.5	9.6	10.1	11.9	25.0	6.1	14.5	33.1	23.1	13.3	15.8	9.8	22.1	3.6	8.0	27.9	22.2	17.6	13.5	12.9	16.6	13.1	13.3	6.3	5.4	7.4	4.6	18.6	15.4	15.8	15.4	19.9	7.7	6.8	24.1	19.5	14.0	10.3	12.2	13.5	30.2	20.2	40.9	7.4	2.3	3.5	17.7	7.3	3.6	16.7	4.7	11.0	8.0	21.4	10.9	22.7	7.8	19.9	33.9	19.0	10.3	6.4	15.6	27.1	11.3	27.4	4.9	7.8	20.6	20.4	3.5	14.5	8.1	5.1	17.6	7.1	8.2	17.9	15.7	18.3	11.7	20.6	6.3	6.7	26.6	16.8	14.8	3.3	14.6	3.7	9.2	10.7	9.9	12.7	6.2	6.8	9.2	12.8	7.6	5.7	3.0	11.2	8.0	23.3	6.9	9.8	15.7	16.4	16.8	19.4	15.9	15.5	15.3	15.7	16.1	14.5	15.8	17.6	94.0	25.6	39.9	8.5	90.6	31.6	109.5	59.8	23.9	26.7	82.2	102.7	69.8	94.4	44.5	68.0	8.4	73.5	89.5	64.6	105.7	62.6	40.0	34.1	75.5	77.7	128.4	124.2	14.3	46.6	107.8	89.5	32.6	36.7	65.4	168.7	104.6	103.6	128.0	23.5	12.5	52.7	42.7	93.6	51.4	138.2	135.8	73.1	64.0	7.5	90.7	47.5	145.2	8.5	16.9	43.4	83.1	100.1	119.0	74.5	132.5	271.4	37.5	23.5	111.7	66.1	101.7	66.5	68.5	44.1	36.9	208.0	68.6	388.0	53.9	95.9
RNASEK-C17orf49		ENSG00000161939	"RNASEK-C17orf49 readthrough"		17	7012635-7017520	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 64.1;Alveolar cells type 2: 59.4;Club cells: 31.1;granulocytes: 60.5;Respiratory ciliated cells: 56.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 2.9;THP-1: 3.7;U-87 MG: 3.7"									"HPA022961, HPA024457"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (4.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.37e-5)"	"unprognostic (4.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.26e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-1)"	1.9	4.1	0.0	0.2	0.0	0.6	1.6	0.1	0.2	2.4	0.0	1.7	0.0	1.4	0.0	2.1	1.4	0.0	2.4	0.2	0.0	5.5	2.1	2.5	0.0	0.1	0.0	1.6	1.5	0.1	3.5	0.0	0.0	1.5	0.0	0.0	1.8	0.1	2.2	1.9	1.6	0.1	0.0	2.7	1.9	1.7	0.0	0.0	1.8	0.0	0.1	1.2	1.6	0.0	0.7	2.0	0.2	0.3	0.0	0.0	0.6	1.3	1.0	1.5	1.1	1.3	0.6	1.0	0.1	0.0	0.1	0.3	0.4	2.9	0.4	0.0	2.4	0.0	1.3	0.5	1.4	0.0	0.3	0.0	0.0	0.9	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.7	1.1	1.3	1.2	0.3	0.6	0.8	0.0	0.0	0.4	0.4	0.2	1.0	0.0	0.0	0.2	0.1	0.3	3.7	0.0	0.0	0.1	1.9	0.5	0.0	0.4	0.2	3.7	0.3	0.0	2.4	2.3	1.9	0.5	1.6	0.8	1.0	0.7	0.4	2.0	0.9	0.6	0.6	3.8	0.5	1.8	2.1	0.5	1.7	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	64.1	59.4	0.0	2.6	0.4	0.0	0.3	0.6	0.0	0.9	0.3	0.0	0.0	31.1	0.0	0.0	0.3	0.7	3.2	3.9	8.3	0.0	0.3	0.2	6.5	5.4	1.3	0.0	8.2	0.2	5.3	0.0	0.3	60.5	0.0	0.7	0.1	0.6	0.0	0.0	3.2	0.0	1.2	0.8	0.0	0.3	14.8	0.0	0.0	4.8	0.0	0.0	0.0	0.0	7.7	6.1	0.4	2.8	0.1	3.9	0.5	56.2	0.0	0.0	0.1	1.3	0.2	0.1	2.0	1.0	0.8	5.9	0.1	2.6	0.1
RNF10	"KIAA0262, RIE2"	ENSG00000022840	"Ring finger protein 10"	Q8N5U6	12	120533480-120577588	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 286.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052643	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Mitochondria	"HPA052643: AB_2681897"	"unprognostic (1.54e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.58e-2)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (5.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.40e-1)"	79.5	104.3	99.0	52.7	101.2	184.8	68.1	97.2	135.0	63.9	108.8	90.1	58.8	61.6	96.1	103.0	58.5	50.1	191.2	101.7	98.4	108.3	81.7	74.4	53.6	99.0	102.9	65.6	75.2	75.8	71.3	65.9	97.8	69.0	65.8	76.6	68.1	61.7	307.2	77.8	61.2	77.8	99.3	78.7	81.0	96.8	100.9	57.9	60.7	208.8	69.5	73.2	69.3	107.2	109.7	141.6	68.3	109.3	130.9	103.0	80.6	100.7	113.9	81.8	86.4	117.1	49.3	129.5	89.4	167.3	64.0	73.9	126.6	136.5	116.0	127.5	71.0	132.1	77.5	123.0	175.3	120.0	89.5	105.5	155.0	115.1	156.8	141.8	168.5	95.7	134.2	86.7	124.3	125.3	79.4	131.1	104.0	101.7	139.9	69.8	87.5	185.4	164.4	221.1	66.9	72.7	140.0	89.5	78.9	94.2	144.2	68.6	134.8	59.3	65.7	95.5	65.9	74.7	146.8	90.8	97.5	80.2	65.0	154.2	53.8	173.8	45.5	45.8	48.9	35.7	44.7	52.4	60.0	31.2	39.5	40.6	118.0	46.1	54.3	30.7	60.7	52.9	99.0	101.2	97.2	135.0	101.7	98.4	99.0	102.9	97.8	99.3	100.9	107.2	56.2	25.6	32.6	30.3	54.0	61.9	51.1	27.1	52.3	39.9	63.8	42.9	99.3	32.9	28.4	47.8	22.9	62.1	58.9	93.5	164.4	49.7	72.7	54.1	53.2	45.9	49.2	286.5	43.1	58.7	69.4	47.8	64.7	78.9	36.8	42.0	42.8	48.8	36.9	55.5	42.9	50.3	34.6	52.5	63.1	41.7	56.8	54.7	56.9	16.9	48.7	43.3	56.7	32.2	52.4	59.8	49.1	54.9	71.2	63.1	73.8	70.0	21.6	54.5	52.6	52.3	55.0	118.0	55.2	74.5	65.8	111.8	59.1	74.1	47.3	77.8
RNF111	"ARK, Arkadia, DKFZP761D081, FLJ38008"	ENSG00000157450	"Ring finger protein 111"	Q6ZNA4	15	58865175-59097419	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 81.6;Inhibitory neurons: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038576, HPA038577"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA038576: AB_10964492, HPA038577: AB_10960052"	"unprognostic (7.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.21e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.74e-2)"	8.2	7.5	2.0	11.8	3.1	17.3	7.8	8.7	5.3	8.6	1.4	7.2	8.4	9.0	6.7	11.4	8.7	9.3	7.3	3.5	4.7	8.8	10.5	8.4	10.8	1.4	1.7	11.4	9.2	11.9	4.3	11.4	2.1	8.7	7.2	12.5	8.1	8.3	9.5	8.2	8.0	8.3	1.2	11.0	9.0	9.4	3.2	11.5	11.6	11.8	13.3	10.3	7.2	4.3	13.8	31.3	19.6	16.8	16.6	18.5	16.7	17.6	20.6	17.2	22.0	13.9	8.9	16.8	19.4	24.8	14.7	26.3	5.3	13.1	21.3	17.6	11.1	20.9	12.6	10.7	18.0	12.3	22.6	14.7	14.0	18.6	20.4	15.6	19.5	15.4	19.7	16.4	21.5	6.7	16.3	7.9	16.1	4.3	12.0	16.2	27.9	13.8	13.1	24.2	16.0	23.3	15.8	15.5	14.7	22.7	12.2	14.9	22.6	27.4	22.8	14.5	17.1	11.8	17.3	19.9	16.7	19.5	21.1	11.4	15.0	15.7	7.0	11.0	7.1	11.8	7.2	6.5	8.3	10.9	7.9	6.3	41.0	5.6	13.0	7.9	10.0	3.4	2.0	3.1	8.7	5.3	3.5	4.7	1.4	1.7	2.1	1.2	3.2	4.3	11.7	3.2	14.4	34.6	31.9	20.1	12.3	7.3	26.7	12.2	13.0	10.2	19.7	7.2	10.6	12.9	8.4	9.0	12.8	10.0	3.9	12.6	27.6	14.4	15.1	15.3	16.2	11.6	81.6	6.9	10.5	15.0	17.3	15.8	15.8	12.3	17.9	11.2	13.4	10.1	80.4	10.0	12.2	19.8	15.7	7.5	7.8	21.2	12.4	56.2	22.7	8.4	16.5	65.4	66.2	12.9	11.4	14.7	19.5	14.5	11.6	9.9	14.9	13.6	26.3	15.1	13.6	13.8	8.9	27.3	19.9	32.0	21.4	11.8	9.2	21.2
RNF113A	"Cwc24, RNF113, ZNF183"	ENSG00000125352	"Ring finger protein 113A"	O15541	X	119870475-119871733	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000160, HPA076658"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA000160: AB_1079821, HPA076658: AB_2732319"	"unprognostic (2.85e-1)"	"unprognostic (4.38e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (7.93e-4)"	"unprognostic (7.99e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.23e-4)"	11.0	9.6	11.5	13.0	12.1	35.3	10.2	13.0	14.4	10.5	11.3	11.4	13.2	9.8	9.6	11.3	10.2	8.2	12.7	11.7	13.9	9.2	17.7	11.0	24.7	12.7	13.0	13.4	19.1	9.2	10.0	9.0	13.1	8.9	9.5	15.6	14.4	8.8	12.3	17.1	17.5	7.5	11.9	24.3	12.1	3.4	13.1	24.7	9.9	10.6	19.0	10.8	10.3	12.6	16.9	22.9	11.0	17.7	20.7	14.9	22.3	14.8	25.0	17.6	21.0	19.7	14.1	28.0	28.1	13.8	25.1	20.4	24.4	19.1	13.1	21.9	18.0	17.0	25.8	23.5	28.3	33.7	28.3	18.4	20.6	17.7	26.0	20.7	17.1	19.4	12.2	38.4	17.3	47.5	23.5	39.9	16.1	29.5	32.8	21.7	23.2	45.3	18.5	20.6	14.7	12.9	23.1	35.5	33.1	12.9	8.7	32.9	13.1	18.6	6.6	26.7	29.7	43.2	36.0	27.9	16.8	44.1	12.3	96.4	59.5	109.5	73.9	60.3	74.4	83.6	78.3	79.0	63.4	88.6	81.3	73.1	27.5	65.9	72.6	53.3	96.6	73.6	11.5	12.1	13.0	14.4	11.7	13.9	12.7	13.0	13.1	11.9	13.1	12.6	14.8	9.6	14.8	2.6	42.8	24.3	17.2	26.6	30.7	11.5	13.6	21.1	8.9	18.6	21.4	14.7	14.6	18.5	51.6	10.8	9.8	18.3	0.5	13.1	18.8	17.4	4.2	10.3	3.0	16.8	37.6	15.2	16.3	16.5	26.5	14.4	18.2	13.1	24.4	13.5	4.1	16.8	14.2	17.6	23.1	1.4	12.2	17.0	26.6	5.6	17.2	16.5	39.1	2.0	6.2	15.5	17.8	9.8	59.6	12.3	34.9	25.1	19.6	17.7	6.6	8.3	19.3	2.9	5.8	20.9	24.4	26.4	50.2	15.9	15.5	14.3
RNF121	FLJ11099	ENSG00000137522	"Ring finger protein 121"	Q9H920	11	71929018-71997597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046041	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA046041: AB_10965850"	"unprognostic (1.36e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.72e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.70e-1)"	7.2	9.5	8.8	6.6	8.7	5.8	11.3	8.5	9.2	9.8	9.7	8.1	15.9	8.4	20.0	7.4	11.6	7.8	10.0	8.8	9.0	16.4	11.5	7.6	8.1	8.8	9.1	11.2	10.9	24.3	9.5	11.1	8.8	10.6	10.3	15.7	15.1	13.6	17.2	8.3	13.9	11.8	9.0	6.7	9.2	8.7	9.1	7.7	12.9	14.9	10.4	9.1	7.1	8.7	10.9	22.7	20.5	14.6	19.1	15.2	13.8	16.7	17.7	25.4	26.9	46.0	20.9	9.2	14.9	18.5	26.7	22.1	22.7	21.2	26.7	13.8	13.1	14.0	21.5	21.9	14.3	12.8	11.5	14.8	17.9	28.7	18.2	27.9	46.7	13.5	23.2	8.6	22.7	23.5	9.0	14.1	13.7	43.4	21.9	11.0	44.5	7.9	28.3	18.4	13.7	14.6	22.9	20.4	30.4	20.6	22.5	9.5	32.8	19.0	17.2	11.8	14.6	9.6	10.2	9.4	16.5	8.3	17.1	4.4	2.2	2.2	3.0	2.9	3.5	3.2	2.3	2.4	2.3	1.3	2.7	2.9	1.2	3.2	2.1	3.7	2.1	2.9	8.8	8.7	8.5	9.2	8.8	9.0	8.8	9.1	8.8	9.0	9.1	8.7	9.6	6.4	9.6	12.7	9.4	8.8	11.2	22.8	10.2	16.1	12.1	10.9	9.7	12.8	13.3	20.2	20.9	32.0	17.9	15.2	7.9	26.0	6.3	8.9	10.3	6.5	9.6	13.0	19.3	32.3	26.5	11.8	9.2	10.9	7.0	11.6	8.9	14.4	14.2	10.1	16.9	13.2	26.4	6.6	12.9	3.0	13.1	7.6	10.6	15.0	15.0	19.0	10.3	18.1	19.0	29.0	11.0	12.4	17.1	10.3	31.0	20.9	10.3	21.1	19.7	10.0	14.2	25.1	19.6	6.4	5.8	31.1	10.0	13.4	9.4	9.9
RNF126	FLJ20552	ENSG00000070423	"Ring finger protein 126"	Q9BV68	19	647526-663233	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043050	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA043050: AB_10794768"	"unprognostic (2.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.96e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	21.2	23.4	11.8	16.0	13.0	21.8	21.7	10.8	19.4	19.1	3.8	26.6	21.6	20.8	2.7	42.3	19.1	4.6	25.9	13.4	9.7	20.7	40.2	19.3	14.1	13.2	10.3	16.8	23.0	6.8	20.2	8.8	13.1	20.2	4.9	4.3	21.0	7.0	61.6	45.3	27.2	4.9	10.2	30.6	24.3	49.4	11.9	10.1	14.7	12.8	5.8	21.6	24.0	16.6	79.7	26.5	21.0	30.6	4.8	6.7	38.5	40.6	15.0	22.5	21.2	52.1	26.9	64.2	25.9	16.5	8.9	51.7	12.6	30.0	6.2	43.8	98.8	32.7	24.5	47.0	18.2	64.9	46.0	11.3	22.9	18.5	14.3	9.0	20.6	51.8	68.5	63.4	12.0	62.9	67.7	35.0	62.4	22.5	50.6	48.9	18.1	102.0	17.0	43.6	52.0	42.1	30.1	39.8	42.4	7.2	25.3	51.5	28.6	40.6	30.6	62.1	71.1	112.3	59.5	77.6	52.1	39.2	43.0	3.7	14.7	12.3	25.1	18.4	21.1	23.9	23.1	24.7	19.0	25.5	17.7	16.6	3.7	27.7	22.6	21.5	28.3	14.8	11.8	13.0	10.8	19.4	13.4	9.7	13.2	10.3	13.1	10.2	11.9	16.6	34.2	12.8	7.4	9.1	66.9	137.9	61.2	44.3	45.5	31.4	35.7	39.6	27.6	27.1	23.2	9.2	16.7	72.8	74.8	60.9	54.8	60.6	146.4	20.2	17.8	31.0	21.7	37.8	11.9	75.6	139.2	29.3	40.2	22.7	14.7	23.1	22.9	22.9	43.2	32.0	9.9	39.3	26.4	26.7	58.9	36.8	21.5	32.9	42.7	3.7	47.5	32.7	112.3	7.1	15.7	136.2	70.0	19.5	76.5	98.2	68.1	40.8	14.8	24.6	59.2	22.0	40.5	153.6	65.3	74.4	144.8	88.1	60.7	43.2	58.1	87.0
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812770-149962139	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 591.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 462.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	48.2	41.2	58.1	40.4	95.2	19.9	53.9	88.1	91.5	33.6	63.7	35.0	28.9	33.3	57.2	32.6	30.2	40.6	34.4	55.0	77.3	67.9	73.8	64.1	38.0	101.8	83.9	35.6	36.1	52.3	18.3	64.1	100.8	46.6	37.1	40.4	75.5	39.3	36.5	32.5	30.5	36.9	85.6	53.0	34.3	25.2	75.9	32.0	64.0	42.6	33.2	42.3	28.9	131.0	60.6	39.4	24.4	29.0	92.2	55.2	40.3	32.2	86.2	32.3	47.4	33.4	84.4	26.6	48.7	42.0	58.7	58.0	37.5	41.5	42.9	34.1	24.6	35.8	17.3	31.2	61.5	35.0	41.8	59.9	73.1	26.5	71.8	37.3	37.0	24.9	10.1	49.7	28.0	34.5	26.2	18.8	16.8	58.6	29.1	19.0	26.7	108.5	54.2	29.6	12.6	37.6	28.5	39.9	110.3	19.2	79.2	34.0	37.8	40.8	16.5	45.6	23.4	89.9	61.9	51.5	35.9	30.1	23.6	98.2	130.1	106.5	37.4	153.8	48.8	51.9	41.5	44.8	93.1	48.4	38.0	42.4	462.3	46.3	207.8	68.3	48.7	104.5	58.1	95.2	88.1	91.5	55.0	77.3	101.8	83.9	100.8	85.6	75.9	131.0	100.9	109.0	72.3	78.7	55.3	73.5	68.2	84.3	74.0	44.5	54.5	51.1	27.3	48.6	68.1	47.8	29.2	101.2	61.9	30.2	43.0	63.0	2.5	32.5	34.5	69.4	20.3	32.4	122.1	70.6	83.5	84.8	31.6	39.7	60.8	14.6	80.3	53.7	201.2	21.9	98.8	27.7	67.1	183.9	173.7	6.7	76.1	177.6	103.2	92.8	93.5	98.5	38.1	115.6	591.2	58.7	33.6	88.0	62.4	71.9	38.5	71.5	40.4	37.2	92.1	76.3	55.5	23.6	32.5	52.3	72.5	52.5	49.8	38.2	27.7	55.8
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990292	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 257.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008716, HPA064746"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA008716: AB_1856337, HPA064746: "	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.06e-2)"	48.4	51.8	31.5	26.0	32.7	20.2	45.6	32.7	42.8	36.6	30.6	40.7	33.2	33.6	43.2	32.6	29.7	32.6	71.2	33.3	35.6	65.3	67.6	30.2	32.3	35.3	38.2	32.3	37.2	104.0	23.7	39.8	36.3	44.0	41.2	40.4	37.1	40.2	66.7	23.5	36.4	43.3	33.4	28.9	35.4	74.5	36.5	36.7	55.1	85.8	33.7	32.1	23.4	33.7	38.3	62.5	43.1	85.1	75.7	78.8	29.0	76.8	42.6	52.8	58.1	52.4	43.4	67.1	87.5	79.3	79.4	20.6	55.6	75.4	47.0	51.1	48.5	42.9	30.2	24.0	83.2	47.7	36.9	59.7	64.9	70.3	87.6	45.6	66.2	46.0	53.0	91.7	109.4	45.7	46.6	15.3	18.3	46.2	71.0	30.2	47.8	73.8	71.7	65.2	47.5	38.3	67.3	121.3	133.2	47.8	85.0	36.7	69.3	69.6	22.6	33.2	74.0	56.8	72.1	61.8	59.7	57.4	87.9	79.6	22.0	23.2	26.9	26.9	26.0	19.5	23.2	26.9	27.4	18.1	17.6	25.9	5.5	30.1	33.9	28.9	29.1	19.7	31.5	32.7	32.7	42.8	33.3	35.6	35.3	38.2	36.3	33.4	36.5	33.7	18.1	9.6	19.3	12.7	12.5	10.7	15.9	19.6	11.4	20.2	18.4	15.0	45.4	11.5	18.1	22.0	16.7	29.1	13.3	22.9	68.4	29.2	257.1	14.1	20.8	21.7	15.0	59.1	25.1	24.9	26.1	18.2	18.3	16.4	22.2	32.0	20.7	33.1	24.5	23.5	22.9	14.9	24.4	29.7	10.4	39.3	19.3	17.1	32.0	13.1	14.8	28.7	29.9	15.6	18.6	26.3	14.0	33.4	13.5	19.2	28.3	50.5	15.8	16.3	39.5	15.8	23.0	38.7	25.8	15.6	10.5	60.5	16.4	25.0	15.0	15.0
RNF141	"ZFP26, ZNF230"	ENSG00000110315	"Ring finger protein 141"	Q8WVD5	11	10511673-10541230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 1045.8;Late spermatids: 666.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 176.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018133	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	Microtubules	Nucleoplasm	"HPA018133: AB_1859142"	"unprognostic (7.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.88e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-2)"	24.0	28.3	41.2	26.8	61.9	19.8	26.9	56.4	61.6	17.6	22.9	17.3	21.7	13.7	19.7	56.3	16.3	14.5	22.7	34.0	51.6	23.5	21.8	21.7	17.9	61.3	52.7	10.9	14.5	30.6	10.0	14.9	63.4	22.6	16.8	18.6	38.3	14.2	43.4	42.9	30.0	13.3	52.1	27.7	21.6	82.7	48.4	18.8	22.9	35.7	25.6	21.0	22.9	79.7	48.3	24.6	34.5	21.1	51.7	50.2	24.6	32.2	26.1	12.6	15.1	38.3	176.3	19.9	28.3	25.0	22.3	34.8	15.3	38.4	19.0	21.7	20.1	13.3	15.8	19.9	20.0	22.2	15.2	33.0	44.0	6.7	41.1	45.8	33.9	25.2	38.4	18.7	31.6	20.6	21.2	8.3	17.5	32.3	14.0	27.3	14.8	22.9	20.4	52.9	11.0	21.5	31.1	36.8	20.6	29.5	23.4	11.3	36.3	30.1	18.5	24.6	10.4	8.2	16.5	22.7	37.7	31.3	37.3	34.2	52.3	92.7	8.3	106.8	13.9	67.6	9.6	8.1	28.9	69.9	10.5	7.3	152.4	9.2	103.9	26.6	12.8	33.9	41.2	61.9	56.4	61.6	34.0	51.6	61.3	52.7	63.4	52.1	48.4	79.7	15.1	19.2	49.2	14.4	39.4	40.8	39.7	47.7	37.0	20.3	31.7	22.0	46.7	18.6	36.9	20.2	12.5	14.4	18.8	16.6	41.1	21.2	1045.8	18.5	14.0	18.4	21.0	15.4	10.7	24.7	15.1	15.9	16.8	23.0	13.3	18.8	21.0	28.0	41.6	37.0	11.8	28.2	16.2	107.4	10.5	666.5	19.6	52.6	19.6	4.7	41.7	27.8	4.1	12.1	67.9	41.6	11.2	19.5	15.2	53.3	58.8	33.5	48.0	11.0	6.6	19.1	18.6	83.4	39.4	49.1	40.1	17.9	11.7	23.3	21.1	74.8
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 11.4;granulocytes: 16.0;T-cells: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	27.4	39.3	13.7	39.4	15.9	20.4	28.2	16.2	16.1	24.7	18.6	26.4	12.2	21.0	30.9	53.1	16.9	48.3	18.8	15.6	19.8	19.5	15.3	73.6	38.7	11.1	13.1	29.0	12.3	47.7	19.4	52.4	11.6	25.9	29.3	33.8	25.6	32.7	9.0	22.3	16.6	27.4	14.3	29.2	26.7	12.1	20.3	26.5	33.8	13.7	48.4	68.1	24.4	14.7	65.5	63.5	95.2	115.1	98.5	43.6	18.6	51.3	88.9	46.3	74.6	22.2	52.9	22.4	89.7	45.3	87.9	83.1	75.9	67.3	80.9	92.7	27.2	47.2	68.5	18.4	42.1	31.4	43.2	27.0	118.8	43.2	63.0	64.7	46.2	53.6	47.7	83.6	44.1	1.9	36.1	9.8	41.3	20.5	32.0	47.3	41.6	44.8	61.4	22.3	34.5	63.9	51.8	54.7	86.5	64.7	38.5	28.4	49.7	51.6	47.0	41.9	92.1	18.4	27.6	20.6	60.3	38.4	113.1	3.5	2.5	16.0	3.0	2.6	3.5	11.4	4.4	3.6	1.9	5.1	5.8	4.0	9.5	2.3	2.3	2.7	6.3	1.3	13.7	15.9	16.2	16.1	15.6	19.8	11.1	13.1	11.6	14.3	20.3	14.7	34.1	112.2	244.1	25.1	62.9	122.7	102.0	90.0	73.4	106.7	97.2	77.3	12.7	65.8	114.0	36.8	58.4	2.8	55.1	98.4	19.6	75.0	28.9	27.5	37.1	75.7	54.1	67.5	89.2	114.4	24.3	45.7	52.0	36.7	69.1	30.2	127.8	19.5	45.5	114.4	74.2	41.8	32.6	115.0	240.8	39.5	46.3	69.4	65.8	52.5	153.9	56.1	47.4	40.2	38.9	108.6	53.7	51.9	38.1	123.8	16.9	10.6	65.6	53.4	46.0	25.4	46.5	19.2	34.8	81.9	99.4	10.9	69.3	19.0	72.0	163.1
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266682-127288567	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	52.9	37.0	49.5	32.4	56.0	10.6	42.7	79.4	61.2	48.1	36.2	40.5	21.9	57.4	60.8	25.3	42.4	38.6	46.9	50.7	51.6	37.1	31.8	38.7	35.1	53.2	52.1	49.5	23.3	40.0	33.3	51.8	56.8	31.7	30.9	48.1	31.2	34.5	114.9	29.5	31.1	45.9	55.2	47.1	29.9	31.3	52.5	24.3	47.1	91.5	33.3	36.9	34.3	61.5	13.2	16.2	60.3	53.6	54.7	54.3	22.2	43.5	69.0	22.8	32.4	21.3	19.3	23.6	30.3	35.7	36.2	16.4	18.1	20.4	32.9	27.6	16.0	30.3	21.8	30.0	54.0	18.0	20.6	47.6	42.1	26.1	51.1	52.5	40.6	23.2	33.0	22.5	50.7	25.2	17.9	32.0	22.1	8.1	17.1	22.6	15.7	12.1	32.4	14.3	36.0	36.6	17.1	23.6	27.7	35.5	16.1	60.8	48.3	39.7	13.1	41.8	31.7	32.3	22.0	15.6	30.5	31.0	38.5	27.5	30.0	26.6	14.3	32.4	14.7	17.4	12.2	16.3	22.8	17.9	11.0	15.5	37.0	19.8	40.1	11.7	15.0	16.1	49.5	56.0	79.4	61.2	50.7	51.6	53.2	52.1	56.8	55.2	52.5	61.5	24.6	35.3	29.3	35.6	23.7	17.7	14.3	15.1	18.8	34.7	16.9	14.7	38.9	31.5	16.7	9.2	4.2	29.0	14.7	13.5	41.1	28.0	52.5	15.7	29.5	30.5	20.4	12.8	53.5	15.8	27.2	50.6	7.1	11.5	22.2	28.1	31.4	30.5	26.3	30.3	54.5	12.1	38.7	68.4	24.6	45.4	69.6	29.9	46.2	42.2	31.1	41.1	28.8	56.3	76.5	18.0	17.0	66.5	9.3	26.3	15.7	51.7	23.9	20.9	32.9	36.2	31.9	41.7	24.9	15.0	20.0	38.4	20.8	36.0	10.9	25.9
RNF165	"Ark2C, ARKL2, RNF111L2"	ENSG00000141622	"Ring finger protein 165"	Q6ZSG1	18	46326809-46463140	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.6;retina: 18.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 44.0;Cone photoreceptor cells: 100.1;Excitatory neurons: 47.4;Horizontal cells: 80.8;Inhibitory neurons: 34.4;NK-cells: 41.2;Oligodendrocyte precursor cells: 35.7;Rod photoreceptor cells: 49.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 10.1;HaCaT: 7.3;HeLa: 7.5;RPMI-8226: 6.4;SCLC-21H: 13.9;SH-SY5Y: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041615, HPA047798"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"HPA041615: AB_2677582, HPA047798: AB_2680158"	"unprognostic (6.46e-3)"	"unprognostic (7.25e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-5)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-5)"	"unprognostic (3.53e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	0.6	0.5	3.1	0.3	3.7	0.3	0.7	7.6	6.4	0.6	0.0	0.4	0.0	0.2	1.9	1.2	1.2	0.3	1.0	4.7	0.2	1.6	5.2	0.3	0.2	0.0	0.3	0.0	0.3	2.4	4.1	0.2	0.0	2.2	0.1	18.2	0.8	1.3	1.5	1.2	0.3	0.1	0.1	2.0	0.2	0.5	1.3	0.9	4.0	0.8	0.4	0.3	0.5	1.9	1.6	0.1	10.1	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	7.3	0.5	1.0	0.0	0.0	1.1	0.1	7.5	0.0	0.0	3.4	0.0	0.0	0.8	0.0	0.0	0.4	0.0	2.3	0.0	0.2	0.0	0.0	2.6	0.9	1.7	0.4	1.3	2.7	0.6	6.4	0.7	2.2	13.9	13.2	2.0	0.0	0.0	0.9	0.3	0.5	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	3.8	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	3.1	3.7	7.6	6.4	4.7	0.2	0.0	0.3	0.0	0.1	1.3	1.9	9.1	3.2	1.7	1.6	0.3	2.7	9.5	12.9	28.5	44.0	2.9	7.2	8.4	1.5	2.8	0.0	100.1	0.2	10.0	0.2	3.9	0.0	3.8	1.5	9.3	5.0	0.0	0.0	47.4	0.0	0.3	2.4	0.0	0.6	0.0	0.0	1.8	8.9	0.1	80.8	34.4	0.0	2.0	1.9	1.3	5.1	2.5	0.4	1.8	1.9	0.3	5.0	41.2	35.7	1.8	0.1	0.0	4.1	0.4	5.0	0.1	0.1	0.6	49.1	0.0	4.5	0.7	0.4	0.9	3.7	2.0	0.3	3.2	3.2	0.0	2.4
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696499-88706408	"Enzymes, Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 91.2;lymphoid tissue: 101.6"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 132.3;NK-cells: 111.2;T-cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 108.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	22.7	18.4	16.1	28.8	16.2	91.2	16.0	14.4	24.5	18.3	13.9	18.3	14.1	16.6	3.2	11.8	20.0	14.0	21.3	15.5	15.0	20.7	23.4	48.3	40.4	19.4	16.8	17.8	19.5	5.4	17.6	8.2	17.6	19.7	4.9	3.4	14.8	5.8	21.3	11.8	37.2	6.3	16.9	101.6	17.8	12.8	20.9	18.0	18.8	8.2	21.1	18.1	14.4	20.0	10.3	15.9	12.5	18.4	5.8	5.0	23.3	10.3	6.5	11.8	5.3	11.1	6.4	12.4	13.0	6.0	6.8	11.1	7.2	6.8	4.7	6.4	21.7	16.7	12.4	18.7	15.9	16.7	20.4	6.0	6.4	9.4	8.2	6.9	12.4	20.6	28.6	8.8	5.0	20.3	38.9	108.0	20.3	4.4	21.5	36.3	7.8	32.2	5.3	4.5	11.8	12.3	23.9	4.8	12.1	5.9	13.4	53.3	18.6	8.7	13.4	13.5	12.5	19.9	13.5	31.6	7.8	62.8	12.4	7.0	25.6	61.3	31.6	19.1	27.7	4.2	19.3	27.6	23.8	3.9	15.7	22.9	40.4	11.3	22.7	14.8	21.8	21.6	16.1	16.2	14.4	24.5	15.5	15.0	19.4	16.8	17.6	16.9	20.9	20.0	15.2	9.6	3.6	7.8	23.5	4.8	4.6	2.4	6.2	10.1	6.0	7.1	2.8	4.3	3.1	7.3	6.2	8.8	132.3	2.3	9.8	6.5	1.4	5.2	7.4	11.0	4.9	13.7	6.5	9.2	9.6	8.8	8.2	4.9	21.0	12.3	8.6	4.8	38.8	8.4	4.8	3.1	2.0	46.7	32.4	2.5	9.3	52.4	10.6	15.0	41.5	11.7	111.2	3.5	4.5	5.5	1.0	7.9	55.1	4.5	1.8	7.0	4.7	9.6	6.6	8.9	10.0	9.1	9.9	4.8	5.8	3.7	73.1	12.2	3.7	1.9
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 199.9;Late spermatids: 459.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA046109: AB_2679540"	"unprognostic (6.15e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	8.6	4.8	3.9	6.0	4.2	20.6	6.8	5.9	4.3	9.3	4.4	6.1	6.1	6.0	4.0	7.9	5.9	4.5	6.8	3.2	6.3	4.7	10.4	8.1	7.2	6.1	5.2	7.4	4.8	4.0	3.5	5.4	6.5	5.3	5.7	4.9	5.8	4.1	13.1	11.5	5.6	5.3	4.9	6.8	5.8	10.7	6.0	7.7	4.9	8.3	8.7	6.7	9.3	6.0	21.6	8.5	14.8	19.5	13.6	9.8	21.1	12.9	8.1	8.5	13.3	16.6	10.4	22.7	29.1	10.8	11.9	21.3	21.0	15.4	13.0	10.9	10.3	43.0	22.2	20.7	7.0	13.3	10.3	9.8	5.8	13.3	11.7	6.0	12.6	18.4	13.1	23.1	8.7	36.4	44.6	7.8	17.6	11.6	10.8	19.7	17.2	18.4	7.2	29.2	12.3	12.4	14.6	17.7	11.1	10.9	26.8	11.7	12.4	14.6	11.4	15.7	17.2	19.6	19.7	33.2	14.3	15.8	11.9	30.0	7.3	8.8	12.2	8.0	10.9	6.3	10.1	8.8	6.6	6.6	8.8	9.4	8.0	8.7	12.2	6.2	7.0	7.5	3.9	4.2	5.9	4.3	3.2	6.3	6.1	5.2	6.5	4.9	6.0	6.0	34.4	16.0	37.5	16.0	37.7	100.1	49.8	30.8	52.3	36.0	17.3	15.0	21.7	12.8	20.0	14.7	60.5	14.6	76.4	25.3	17.6	14.0	199.9	17.0	20.8	33.3	14.4	14.1	33.5	8.9	26.6	27.9	23.9	24.0	50.1	24.0	24.3	25.9	17.9	15.2	36.0	18.5	28.5	32.4	98.8	459.7	20.2	33.9	26.6	28.1	38.2	12.7	42.2	25.1	27.4	10.5	17.3	20.7	37.9	27.7	11.4	10.3	17.1	39.8	13.1	23.6	25.7	13.8	54.9	55.5	126.6	10.7	63.7	20.3	22.4	50.3
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748849-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA047952"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Nucleoli rim, Cytosol"	"HPA038505: , HPA046138: AB_2679553, HPA047952: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	4.2	2.8	3.8	6.7	6.2	14.4	5.6	6.2	4.4	5.5	5.4	4.4	4.0	7.6	4.2	10.1	5.6	4.8	3.2	4.0	4.4	4.6	5.0	5.9	6.3	5.4	5.0	7.6	4.4	5.6	2.1	4.7	5.4	5.2	5.3	6.1	4.5	4.3	6.8	5.5	4.4	7.6	4.4	7.3	4.6	2.9	4.6	7.7	5.8	5.8	6.7	5.2	5.4	9.2	10.2	7.7	9.1	9.0	5.8	7.7	3.7	7.9	7.4	8.6	7.4	13.0	7.5	18.2	7.9	9.5	5.8	9.6	12.4	9.3	11.2	9.1	8.0	12.6	15.3	5.1	6.6	6.8	10.1	7.1	7.2	9.8	22.1	9.6	14.0	12.2	11.4	14.1	8.7	8.6	11.6	12.0	3.6	12.9	5.0	10.7	21.7	9.9	5.5	10.6	4.1	7.4	10.6	8.0	16.6	7.3	9.9	8.6	9.4	14.2	11.8	9.0	7.1	10.2	5.8	21.1	2.8	7.3	8.4	1.2	0.5	0.4	0.4	0.3	0.3	0.0	0.4	0.2	0.2	0.1	0.3	0.2	1.4	0.3	0.3	0.2	0.3	0.2	3.8	6.2	6.2	4.4	4.0	4.4	5.4	5.0	5.4	4.4	4.6	9.2	18.8	9.6	11.4	51.6	18.4	19.9	30.6	7.1	20.5	58.2	12.6	9.8	3.0	17.2	8.3	3.7	52.1	5.5	24.6	9.8	5.9	10.2	2.8	30.5	26.7	17.2	12.0	18.3	40.8	11.1	6.4	16.0	14.8	30.1	7.0	24.4	10.8	12.3	8.5	37.0	43.2	8.7	2.0	15.6	19.9	3.1	7.5	16.6	10.6	25.3	12.6	22.9	26.8	42.7	68.7	10.1	6.8	10.5	18.5	49.7	6.3	12.1	8.9	33.7	26.3	31.9	18.7	9.4	11.7	16.4	18.6	8.1	22.2	14.0	10.4	42.2
RNF181	HSPC238	ENSG00000168894	"Ring finger protein 181"	Q9P0P0	2	85595725-85597708	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 851.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046112, HPA062121"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA046112: AB_2679542, HPA062121: AB_2684687"	"unprognostic (3.79e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (3.24e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.49e-2)"	110.4	135.0	87.6	60.2	92.4	76.7	109.8	93.3	101.9	105.5	85.7	101.3	75.1	85.2	85.0	118.0	87.4	50.2	141.1	88.9	93.2	174.3	169.5	114.0	69.1	92.8	91.5	90.7	168.5	80.1	61.9	82.9	91.8	111.0	69.0	36.0	110.0	73.0	172.1	102.6	91.4	65.2	93.7	101.2	121.8	107.6	94.5	59.5	93.8	105.1	89.6	107.5	98.7	97.7	125.7	120.4	96.3	103.8	94.3	113.4	152.2	104.7	195.4	207.7	199.7	185.2	132.2	118.8	196.8	150.6	206.2	117.5	83.5	164.8	223.8	133.9	104.0	91.6	58.5	224.7	168.0	104.8	122.1	122.0	208.5	144.5	237.1	166.2	175.4	110.8	109.1	119.7	282.7	193.0	97.8	235.6	68.6	164.9	180.2	105.1	202.5	171.7	200.8	109.3	57.2	74.5	88.4	126.2	171.7	114.8	125.4	136.2	160.1	104.9	77.2	218.4	149.6	170.3	143.5	143.1	166.4	144.9	95.5	213.9	418.5	339.7	176.1	326.0	164.6	251.9	181.4	169.2	321.4	214.8	156.4	153.0	356.6	195.5	254.9	360.4	262.0	439.0	87.6	92.4	93.3	101.9	88.9	93.2	92.8	91.5	91.8	93.7	94.5	97.7	89.3	147.4	104.8	7.8	89.3	116.9	102.5	343.7	75.7	27.1	92.8	95.4	122.8	124.4	200.2	150.8	2.1	237.1	104.2	148.1	416.7	236.5	365.7	70.5	63.6	102.8	70.2	85.2	2.2	290.4	260.2	113.7	55.0	93.2	102.7	59.0	99.6	214.4	263.4	18.5	2.2	138.4	185.1	154.0	182.3	250.6	88.3	147.6	170.7	3.7	188.7	80.4	94.7	2.0	6.9	304.0	201.5	78.2	113.8	123.8	271.9	851.7	141.7	29.1	59.2	66.3	108.8	121.3	33.1	97.9	118.6	221.2	86.7	62.6	102.0	115.6
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980310	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;choroid plexus: 12.7"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 81.3;RPTEC TERT1: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.1	0.1	12.2	0.1	13.3	8.4	0.6	22.5	17.7	0.8	12.7	0.2	0.2	0.6	1.1	0.3	1.2	0.2	0.3	17.6	12.2	1.1	0.0	3.3	0.2	16.9	17.7	0.3	1.7	5.8	1.8	1.3	16.5	0.4	0.1	8.8	1.3	2.1	0.2	0.4	0.3	0.3	14.2	0.2	0.2	3.7	24.7	1.5	1.3	0.1	0.0	0.3	0.4	12.2	0.2	6.5	12.0	0.0	4.1	5.0	0.7	6.3	8.6	17.0	16.4	0.3	0.1	0.0	0.1	6.8	18.5	0.0	14.3	0.1	30.9	0.0	4.7	0.4	81.3	0.0	0.0	0.1	0.0	2.8	0.0	26.3	0.2	19.5	0.3	3.5	0.5	0.0	11.9	0.2	0.1	2.2	6.9	0.1	23.9	3.8	2.9	1.0	67.3	0.0	14.2	13.7	0.6	0.0	24.8	4.4	0.0	2.4	6.5	20.7	4.4	0.2	14.3	0.0	0.0	0.0	14.1	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	13.3	22.5	17.7	17.6	12.2	16.9	17.7	16.5	14.2	24.7	12.2	0.2	0.0	0.0	85.2	0.1	0.3	0.1	0.0	0.0	19.3	0.2	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	0.4	0.1	0.2	0.0	9.7	8.6	0.0	0.1	0.4	0.0	0.1	0.0	5.4	0.0	0.1	0.1	15.2	1.5	0.1	0.0	0.0	0.3	1.4	0.3	0.0	0.0	5.6	0.0	14.7	0.0	2.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.1	1.3	6.6	0.0	1.3	5.7	3.2	0.0	0.0	0.3	0.3	0.0	0.1	0.1
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487382-228496188	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 189.0"					"Low region specificity"	"Detected in all"			HPA030098	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	26.8	66.6	16.2	7.5	16.2	11.3	25.8	14.8	24.3	40.5	3.4	28.1	8.6	31.8	4.3	59.1	28.7	5.6	35.4	15.9	16.9	40.7	52.0	23.6	7.3	19.4	15.2	39.3	34.5	22.5	47.7	5.5	18.4	33.5	3.7	9.0	39.7	8.2	64.2	45.0	22.5	5.6	15.6	37.0	27.6	20.8	18.5	8.5	36.1	19.8	6.1	29.9	41.2	19.8	26.7	23.1	14.8	28.9	16.8	12.5	26.6	21.5	17.3	15.6	12.7	12.8	19.2	65.9	43.1	28.9	11.4	20.9	19.1	22.1	5.8	25.9	28.5	20.8	13.2	12.6	46.1	22.1	34.4	20.4	44.7	11.6	15.8	18.3	14.0	52.6	35.6	115.2	12.4	17.7	35.2	20.8	30.7	19.1	24.0	27.8	12.5	61.5	11.4	17.2	29.9	30.0	21.9	44.1	62.3	4.3	34.6	50.2	27.8	18.3	16.9	19.6	19.3	189.0	56.7	36.4	46.7	22.7	28.7	0.0	0.5	3.6	0.6	1.0	0.7	0.5	0.7	1.0	0.6	1.0	0.6	0.7	0.1	0.4	1.4	0.7	0.6	0.3	16.2	16.2	14.8	24.3	15.9	16.9	19.4	15.2	18.4	15.6	18.5	19.8	54.0	25.6	15.5	8.1	47.2	36.2	42.9	10.6	38.7	85.2	59.5	58.5	70.8	65.8	14.2	40.5	18.8	19.7	52.2	39.8	113.5	15.2	0.8	35.5	47.2	32.1	40.0	118.4	16.6	24.5	27.1	54.4	34.7	32.0	44.5	45.0	41.7	67.4	27.4	55.5	17.2	36.6	2.0	40.1	30.5	4.2	24.5	35.8	39.2	12.2	29.7	145.3	62.8	7.1	12.6	21.4	23.4	25.9	35.4	44.0	32.9	126.4	10.3	47.7	19.7	52.2	38.4	4.2	21.5	57.0	55.3	17.6	54.6	217.5	38.6	31.7
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045526-185102603	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	9.5	8.1	5.4	10.2	6.7	13.8	12.5	6.1	7.0	10.3	3.7	9.3	8.4	10.7	8.5	8.4	8.6	9.4	7.4	7.0	7.5	9.6	8.3	8.3	11.5	4.0	4.8	9.3	9.6	8.7	5.6	21.7	4.8	8.5	9.7	11.8	9.6	10.4	8.2	6.4	6.5	10.9	4.5	10.4	9.6	21.9	7.9	12.3	10.8	9.0	12.3	16.5	8.7	5.1	34.0	18.6	62.8	25.4	17.8	30.3	65.3	24.0	28.4	35.5	28.3	29.9	53.3	10.2	29.2	29.0	24.4	11.5	43.7	32.7	41.7	31.1	28.4	54.9	10.2	25.8	27.5	56.1	29.7	29.7	19.6	29.6	36.4	27.9	36.6	34.4	44.7	22.5	25.1	21.2	48.5	17.6	86.3	27.4	11.0	55.1	41.3	9.8	25.7	23.6	18.9	33.4	17.3	9.9	46.7	67.8	19.7	27.5	28.4	25.4	33.6	25.1	29.8	39.0	26.2	36.3	16.1	25.7	28.9	31.0	22.4	27.7	17.1	27.7	24.4	20.1	15.5	15.8	25.7	21.9	15.1	15.6	9.8	24.4	29.9	13.4	17.8	16.3	5.4	6.7	6.1	7.0	7.0	7.5	4.0	4.8	4.8	4.5	7.9	5.1	22.6	3.2	6.4	11.4	23.6	23.2	27.6	10.2	26.7	10.3	18.2	11.8	8.4	7.2	6.6	9.2	4.2	25.4	24.5	11.2	23.5	11.5	6.1	11.2	10.8	20.3	29.5	29.4	23.1	12.6	53.0	17.9	12.8	10.3	12.7	16.9	23.2	8.8	20.1	6.7	20.5	9.2	8.2	21.4	55.2	5.6	9.6	22.0	21.4	20.6	25.4	13.3	10.3	18.6	15.1	11.3	16.9	11.7	15.5	30.2	4.1	16.4	8.8	7.2	0.0	11.7	13.4	35.6	83.1	15.8	20.3	28.5	20.7	15.6	11.3	38.0
RNF20	"BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779"	ENSG00000155827	"Ring finger protein 20"	Q5VTR2	9	101533853-101563344	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012478, HPA051773"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB012478: , HPA051773: AB_2681604"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (2.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.54e-3)"	17.8	17.8	21.3	16.3	24.6	14.8	19.0	22.0	22.8	17.0	21.4	17.7	11.1	19.0	19.2	21.6	19.8	14.1	26.4	20.4	23.2	21.4	15.7	16.3	18.6	22.8	23.7	21.5	21.3	28.1	10.3	14.6	23.7	20.9	16.9	30.4	16.7	17.9	29.7	17.3	12.3	18.9	22.0	17.6	14.5	32.5	22.6	19.9	23.4	24.9	21.0	15.0	15.0	26.8	25.8	64.2	36.4	40.0	43.8	34.4	31.0	44.1	35.3	43.1	37.6	39.2	26.8	56.8	23.2	34.3	36.0	64.0	42.6	37.5	44.1	59.7	19.8	30.5	55.9	39.7	32.2	53.0	35.2	34.0	39.4	38.2	49.2	32.4	25.7	20.7	29.5	32.5	47.4	33.6	41.4	14.0	80.5	57.8	32.3	39.4	125.7	28.3	17.8	24.5	38.7	48.6	62.1	32.9	36.1	36.3	29.7	24.7	36.6	39.8	39.7	28.6	37.3	35.1	118.0	30.4	35.1	19.6	49.2	24.5	15.2	23.7	20.4	20.3	15.5	15.3	16.7	15.4	14.6	12.4	17.3	16.4	15.7	17.1	30.0	9.2	14.7	13.4	21.3	24.6	22.0	22.8	20.4	23.2	22.8	23.7	23.7	22.0	22.6	26.8	15.9	25.6	31.2	10.7	16.8	6.4	9.7	13.7	17.1	32.4	11.6	11.4	49.5	8.6	23.9	22.0	6.2	16.7	10.2	17.9	5.9	18.3	54.5	20.3	18.5	18.7	24.6	22.3	16.3	13.8	11.5	16.9	10.2	11.5	22.1	19.7	11.7	18.1	16.4	43.7	18.7	12.1	16.2	27.4	4.3	21.4	18.0	20.0	10.6	8.4	31.4	31.4	33.0	11.1	21.9	11.0	13.0	23.7	13.1	9.3	10.1	11.5	28.5	26.5	32.9	21.8	17.5	76.0	16.7	18.3	5.8	7.7	16.1	15.4	15.3	6.4
RNF208	DKFZP761H1710	ENSG00000212864	"Ring finger protein 208"	Q9H0X6	9	137220247-137221581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 25.4;Horizontal cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 23.5;MCF7: 55.7;REH: 44.9;RPMI-8226: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021256, HPA021429"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA021256: AB_1844331, HPA021429: AB_2180654"	"unprognostic (2.97e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.12e-8)"	"unprognostic (3.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.40e-2)"	6.1	23.1	29.0	0.8	27.1	0.6	6.8	5.0	83.0	8.9	0.0	9.4	1.6	4.9	0.6	32.5	8.1	0.8	42.3	36.9	7.5	15.6	22.6	5.0	0.8	21.1	8.4	5.0	9.0	5.6	19.8	0.5	20.0	14.2	0.4	2.6	13.1	4.1	15.4	15.3	5.1	0.6	2.2	5.2	10.0	5.8	19.8	0.4	14.4	3.7	0.9	7.8	13.4	36.9	1.5	2.8	1.9	3.3	1.3	0.3	5.8	0.8	1.1	1.4	1.2	8.3	5.2	0.7	4.1	0.9	0.3	4.4	4.6	0.2	0.3	2.1	1.7	5.9	10.1	23.5	4.2	1.2	2.0	1.0	1.5	1.3	0.6	5.1	1.4	8.4	8.3	0.4	0.5	55.7	3.0	2.8	2.4	5.5	6.1	44.9	0.4	25.1	1.4	0.2	5.4	19.0	0.6	1.7	1.2	1.0	19.5	4.3	0.6	0.9	1.2	2.0	0.1	0.7	0.8	0.3	2.6	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.0	27.1	5.0	83.0	36.9	7.5	21.1	8.4	20.0	2.2	19.8	36.9	1.9	6.4	2.2	2.9	1.2	0.4	1.0	2.0	0.6	9.3	7.7	5.8	9.3	4.3	1.7	7.3	12.5	0.3	0.4	5.5	25.4	5.3	0.6	4.4	1.2	1.4	7.8	0.4	13.1	2.2	0.2	1.4	1.5	5.9	0.0	13.0	1.4	9.1	1.3	16.8	13.4	4.4	0.0	0.6	0.8	1.1	1.2	1.8	1.8	5.6	1.6	8.7	0.0	1.5	2.9	3.6	5.1	3.4	0.3	1.9	4.4	9.4	3.9	5.6	0.0	2.5	1.8	1.5	2.4	2.7	1.8	0.3	0.5	2.7	3.8	1.6
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.5;Late spermatids: 257.6;Spermatocytes: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	14.3	12.3	14.3	12.8	15.9	15.6	13.1	12.6	14.6	13.2	10.0	25.5	8.1	21.9	8.2	12.3	15.8	8.7	21.7	13.8	17.5	10.0	10.1	12.8	17.0	14.9	15.4	16.5	14.9	13.9	15.4	7.7	14.8	14.6	5.8	7.2	11.4	13.7	19.6	13.3	17.9	15.0	12.8	19.2	14.6	30.1	16.2	12.8	12.7	11.9	11.5	16.4	10.9	14.3	22.0	23.6	17.0	32.8	21.6	14.6	11.5	20.7	19.3	17.6	15.8	16.7	12.3	17.3	11.4	22.0	38.7	17.1	13.6	15.3	10.3	11.4	19.3	12.5	13.6	18.0	27.7	19.5	25.3	21.4	20.4	16.2	14.6	18.4	15.0	19.2	28.4	12.9	18.9	35.2	8.8	44.7	25.7	13.1	20.0	26.1	23.4	12.2	13.9	13.9	14.1	25.3	11.8	33.9	13.2	15.3	14.2	28.2	20.5	24.9	39.9	25.2	22.8	11.4	9.0	16.0	19.6	21.7	37.4	3.5	7.7	24.2	10.1	8.3	9.4	8.3	9.3	8.7	6.3	8.8	10.9	11.3	13.2	12.7	8.7	7.1	8.3	6.9	14.3	15.9	12.6	14.6	13.8	17.5	14.9	15.4	14.8	12.8	16.2	14.3	33.4	6.4	23.9	34.9	33.6	16.6	20.8	11.9	15.9	36.4	16.1	17.8	33.3	8.6	13.6	12.9	52.1	14.1	47.7	10.3	25.4	17.6	145.5	14.6	33.7	29.7	6.0	8.8	50.2	13.7	12.9	26.7	16.3	16.9	19.6	34.0	26.4	15.1	22.9	28.6	61.7	15.4	6.1	23.0	29.3	257.6	37.3	23.1	12.4	49.6	37.0	30.2	56.7	46.3	64.2	15.6	7.0	30.1	20.3	24.2	13.0	14.9	13.7	48.5	26.3	46.0	30.0	159.8	124.2	12.9	16.2	15.2	40.2	22.8	11.8	15.2
RNF220	"C1orf164, FLJ10597"	ENSG00000187147	"Ring finger protein 220"	Q5VTB9	1	44405194-44651724	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 121.3"	"Cell type enriched"	"Detected in all"	7	"Oligodendrocytes: 2136.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-937: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027577, HPA027578"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027577: AB_2672339, HPA027578: AB_10601482"	"unprognostic (3.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.46e-2)"	7.5	5.9	37.9	7.3	67.0	10.8	6.8	49.1	49.3	7.4	0.4	9.1	7.8	8.9	5.9	6.6	8.1	2.9	8.7	36.2	45.1	6.6	5.2	5.7	5.9	64.1	53.3	7.6	7.0	5.7	7.1	6.2	63.0	5.9	3.9	7.5	7.4	4.5	24.3	8.6	7.7	5.5	38.1	6.9	6.6	8.2	68.3	7.1	6.3	10.1	5.8	7.0	7.0	121.3	11.6	5.4	22.9	7.8	8.7	7.9	17.1	13.4	12.3	10.1	14.9	9.3	11.2	22.3	11.6	10.8	14.4	7.5	25.8	11.0	13.7	28.0	22.9	30.9	17.9	16.3	14.1	22.0	15.2	8.7	24.7	11.3	17.9	8.4	5.9	11.6	23.1	10.7	6.3	8.1	21.8	16.7	24.9	12.6	12.2	18.3	13.5	15.9	6.5	7.1	10.3	12.7	11.4	7.8	17.4	7.9	5.8	38.1	9.1	10.7	11.4	10.2	25.1	24.4	25.2	16.0	8.7	69.5	6.5	0.9	0.8	1.2	1.2	0.7	0.9	0.8	0.3	1.6	1.3	1.2	0.7	0.6	0.6	0.8	0.5	2.5	1.3	0.6	37.9	67.0	49.1	49.3	36.2	45.1	64.1	53.3	63.0	38.1	68.3	121.3	16.2	9.6	13.4	66.3	26.9	15.2	13.4	13.2	30.1	25.1	24.7	20.8	22.0	25.8	10.4	23.9	25.0	17.3	33.7	29.0	17.6	17.9	13.1	23.4	20.7	17.2	18.0	41.9	21.9	28.7	24.5	16.7	19.4	20.5	10.8	18.8	17.9	31.4	25.7	23.5	12.9	24.3	22.4	29.3	9.8	16.2	19.3	21.3	12.4	298.9	23.9	19.2	15.5	7.1	2136.9	25.3	20.9	13.9	26.1	22.5	26.5	35.6	8.2	18.3	6.6	23.5	14.8	30.6	31.3	25.1	17.5	10.1	26.1	17.6	26.7	20.5
RNF224		ENSG00000233198	"Ring finger protein 224"	P0DH78	9	137227502-137229640	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"esophagus: 3.4;pituitary gland: 5.8"	"Cell type enhanced"	"Detected in single"		"Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.5;HeLa: 4.3;MCF7: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA079078			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"		"HPA079078: "	"unprognostic (2.45e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.01e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	0.2	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.2	0.5	0.0	0.3	0.3	0.2	0.0	3.4	1.4	0.3	0.5	0.1	0.1	2.1	0.0	0.8	0.1	0.8	1.2	0.1	0.8	0.0	5.8	0.0	0.3	1.0	0.0	0.2	1.4	0.0	0.1	0.6	0.5	0.0	0.5	0.2	0.6	1.2	0.5	0.0	0.9	0.0	0.1	0.4	0.9	0.2	0.6	1.0	0.4	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	5.5	0.1	0.2	0.0	0.3	2.7	0.0	0.1	0.0	1.8	0.2	0.0	4.3	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.2	0.4	0.0	9.8	0.1	0.0	0.4	0.7	1.3	0.6	0.2	0.1	0.1	0.6	0.0	1.1	0.5	2.0	0.0	0.7	1.9	0.2	0.2	0.2	0.1	1.1	0.0	0.6	0.2	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.8	1.2	0.3	0.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.9	2.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663892-218672002	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA036420: AB_2675114, HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	10.9	11.4	18.5	8.9	18.6	7.3	10.9	18.3	21.0	12.2	17.1	12.0	6.2	12.7	15.8	11.7	12.4	10.8	13.9	18.6	19.7	10.4	11.1	10.4	14.5	18.4	18.4	14.5	11.5	15.1	11.4	11.4	19.0	11.8	8.2	7.0	11.0	13.9	15.0	14.5	7.9	13.6	18.5	10.3	9.4	14.3	19.2	15.1	14.1	17.1	11.9	14.0	9.7	19.0	18.8	20.4	22.1	24.6	27.6	17.5	20.4	27.3	43.5	58.0	53.6	32.4	13.2	11.6	17.6	42.3	35.2	19.5	22.1	33.9	31.0	16.4	27.3	22.7	21.3	34.6	33.6	19.3	20.6	33.9	30.9	55.5	44.7	21.4	31.0	40.9	27.4	24.3	41.1	45.3	20.6	20.4	32.9	16.2	23.4	23.2	15.5	15.9	36.3	21.8	19.5	23.8	18.1	17.2	28.4	21.9	20.6	25.6	26.6	40.2	20.5	19.2	31.1	23.7	13.7	23.5	33.4	19.1	25.7	58.6	21.5	32.6	26.0	21.3	24.8	25.7	25.7	27.2	17.1	30.4	29.0	23.2	17.1	30.5	25.2	15.0	25.9	24.8	18.5	18.6	18.3	21.0	18.6	19.7	18.4	18.4	19.0	18.5	19.2	19.0	4.2	0.0	0.5	5.2	7.8	6.2	4.8	16.3	6.8	7.7	3.4	3.7	4.0	10.0	8.9	1.8	8.4	12.3	4.5	7.4	15.6	12.3	16.8	6.3	8.1	7.6	1.2	2.1	6.2	12.9	9.7	7.5	9.7	4.8	7.0	5.9	8.9	7.1	13.2	5.0	5.8	5.5	8.2	5.0	4.0	5.3	7.2	5.5	8.8	2.8	8.9	7.9	9.2	3.5	4.9	12.7	9.6	12.8	8.5	3.8	7.2	14.8	8.2	5.0	26.3	5.6	9.2	19.3	12.8	5.9	6.8	10.0	8.0	8.5	6.1	3.6
RNF26	MGC2642	ENSG00000173456	"Ring finger protein 26"	Q9BY78	11	119334527-119337309	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027620	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Vesicles, Cytosol"	"HPA027620: AB_1856356"	"unprognostic (9.23e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.24e-3)"	"unprognostic (6.22e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (9.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.73e-4)"	14.3	15.8	12.7	11.5	12.6	22.0	13.3	13.7	15.1	15.4	10.6	19.2	14.5	23.5	10.3	20.9	16.6	10.5	13.2	12.7	12.5	13.6	23.6	12.4	11.8	15.2	13.1	17.1	13.8	18.5	10.4	14.2	15.5	14.8	12.6	8.4	14.9	18.6	8.5	15.7	17.0	19.0	12.7	14.6	19.1	15.1	14.7	13.3	13.2	7.1	12.8	18.9	14.2	13.1	43.8	47.4	43.4	51.4	41.8	32.8	46.0	46.3	49.7	52.8	41.5	80.6	88.9	38.3	62.5	55.5	80.1	77.2	61.9	69.8	33.0	46.0	34.2	101.0	21.8	67.3	31.9	42.8	40.4	34.3	35.2	66.1	59.0	34.7	40.8	58.1	50.0	58.4	36.9	94.9	39.5	44.3	43.5	50.2	59.8	40.5	44.5	30.4	32.7	31.1	30.8	29.9	37.4	46.8	12.5	41.4	106.1	35.4	27.0	63.5	41.8	33.7	43.0	14.0	24.6	0.4	21.3	71.0	50.6	9.5	21.6	5.6	20.8	19.2	13.4	11.1	15.7	18.4	19.0	16.7	17.5	15.5	1.5	14.0	20.2	11.0	8.7	24.9	12.7	12.6	13.7	15.1	12.7	12.5	15.2	13.1	15.5	12.7	14.7	13.1	5.1	3.2	9.4	1.0	9.1	6.9	13.3	15.4	12.5	9.2	10.9	9.8	0.8	22.8	11.1	11.0	2.1	44.0	6.2	9.3	5.9	20.8	6.6	5.9	7.9	8.6	13.8	18.5	3.2	17.0	66.0	11.5	9.2	5.9	7.6	16.9	11.4	23.4	21.5	5.0	2.9	13.0	8.2	14.8	5.9	8.6	14.0	6.6	1.8	1.0	11.6	11.6	15.5	4.5	2.7	14.1	7.5	17.7	4.3	14.2	15.6	12.5	4.8	9.4	6.6	6.5	10.6	19.9	10.5	14.3	8.5	24.4	8.3	8.8	18.6	9.8
RNF34	"FLJ21786, RIF, RIFF"	ENSG00000170633	"Ring finger protein 34"	Q969K3	12	121400041-121430623	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074151			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA074151: AB_2686668"	"unprognostic (3.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (6.72e-8)"	"unprognostic (3.39e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.55e-3)"	"prognostic favorable (3.02e-4)"	13.7	10.8	25.5	23.6	29.7	13.4	13.4	31.6	32.2	11.6	21.8	19.2	19.5	13.7	13.5	14.9	12.5	17.3	18.4	26.8	28.6	11.3	13.0	12.9	34.3	26.0	26.6	14.7	13.8	13.3	13.7	11.5	26.7	10.5	15.6	19.0	13.9	13.5	59.5	15.7	18.3	16.7	24.7	23.3	18.4	24.6	26.6	26.8	13.9	36.8	26.4	19.0	11.9	32.7	45.4	53.8	34.7	36.3	26.8	24.5	43.2	47.5	42.2	46.3	35.3	67.3	16.9	64.9	35.3	51.3	24.6	31.8	52.6	29.8	41.0	95.3	30.8	75.4	37.7	62.5	32.1	65.7	50.4	21.9	39.6	40.2	34.7	26.4	49.3	37.9	58.0	29.3	46.0	35.7	57.5	95.7	44.5	26.6	48.4	54.0	45.1	38.1	32.0	53.2	50.7	33.0	59.4	21.8	36.6	31.6	38.0	49.1	39.5	39.5	28.4	34.6	37.8	51.2	92.8	70.5	28.2	45.4	40.6	83.7	42.1	91.2	72.4	48.4	74.1	77.1	83.2	76.8	40.4	65.0	71.1	71.1	65.2	76.2	53.3	34.3	106.3	68.3	25.5	29.7	31.6	32.2	26.8	28.6	26.0	26.6	26.7	24.7	26.6	32.7	14.5	16.0	16.2	15.3	22.9	17.5	18.7	23.4	13.6	13.9	16.5	13.2	22.0	27.1	18.9	9.2	4.2	26.1	30.9	19.0	37.2	32.7	23.5	13.7	15.3	17.3	40.8	24.8	34.3	27.3	38.8	16.1	15.8	13.9	17.7	19.0	17.2	11.2	21.2	13.5	32.7	15.8	30.5	18.0	14.9	10.7	17.1	14.0	17.8	13.1	35.0	23.6	46.4	9.5	45.5	26.2	17.2	18.0	27.9	17.0	20.5	19.9	18.7	21.4	19.7	11.1	25.0	134.0	73.9	15.3	16.1	24.2	34.3	18.5	21.2	25.7
RNF38		ENSG00000137075	"Ring finger protein 38"	Q9H0F5	9	36336396-36487548	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	11	"Early spermatids: 503.1;Late spermatids: 1314.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015853	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA015853: AB_1856365"	"unprognostic (2.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.30e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"prognostic favorable (2.90e-6)"	"unprognostic (3.88e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.39e-2)"	15.8	11.9	10.5	13.2	10.9	37.8	17.2	15.6	15.1	17.3	5.2	19.9	10.5	23.4	19.6	15.9	17.8	11.8	15.8	11.0	10.7	19.2	11.3	18.9	18.4	9.2	11.5	36.7	20.5	15.7	6.6	20.5	9.7	17.6	15.8	23.9	14.1	19.1	12.7	12.1	13.3	22.9	8.6	19.5	10.7	68.4	11.4	21.3	22.5	19.6	18.5	16.7	12.9	9.4	14.4	8.0	30.5	18.2	13.7	12.6	29.8	8.8	11.0	10.6	13.8	13.8	7.8	21.6	9.1	17.1	14.0	5.5	19.6	10.3	16.3	19.3	8.4	26.2	11.6	13.6	10.6	19.4	22.9	13.0	10.9	13.4	12.9	17.6	27.4	21.0	5.5	20.2	17.4	5.0	20.1	10.2	20.5	9.5	5.7	18.3	13.8	12.0	18.1	16.4	12.7	13.6	10.0	9.9	10.0	35.5	9.6	19.6	27.2	10.1	15.2	6.0	10.6	13.2	29.6	15.0	9.2	16.1	13.2	10.7	2.9	5.0	4.4	2.7	3.6	3.5	4.0	4.7	2.7	3.7	4.2	4.3	5.3	5.9	2.8	2.2	5.9	3.1	10.5	10.9	15.6	15.1	11.0	10.7	9.2	11.5	9.7	8.6	11.4	9.4	32.8	12.8	11.7	80.6	16.8	17.3	10.9	8.7	14.8	16.5	21.9	15.2	15.9	10.0	11.5	7.3	18.8	13.2	29.9	19.6	9.8	11.2	503.1	13.1	14.6	25.0	16.8	9.0	71.2	12.0	11.9	14.4	14.8	16.7	6.3	20.5	24.7	16.6	11.4	26.9	72.8	12.8	10.2	27.0	23.7	1314.3	32.9	19.0	19.6	82.4	19.5	19.3	20.6	53.3	81.5	14.5	6.8	39.9	18.6	23.9	10.4	16.5	10.1	23.2	13.1	19.3	20.9	40.4	20.2	14.4	14.9	14.9	23.3	13.2	14.3	17.5
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: AB_2680726"	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavorable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	30.2	30.9	24.0	36.0	24.9	46.4	29.2	26.0	25.1	29.4	26.5	27.9	29.0	29.5	28.3	30.7	28.5	28.3	27.0	24.5	25.5	32.6	25.9	27.8	49.9	26.0	25.9	31.0	31.2	33.6	26.8	28.4	25.2	28.2	27.4	24.0	28.0	28.1	27.7	29.7	30.4	33.1	23.9	40.3	30.1	31.9	26.3	50.1	30.7	23.2	50.0	35.0	26.8	25.5	60.9	57.0	57.9	42.0	50.6	52.2	65.6	73.3	83.4	77.3	70.0	65.1	56.8	77.6	42.0	76.0	101.5	39.7	63.5	58.6	72.7	37.6	38.5	92.4	54.6	62.6	76.6	66.7	77.8	61.0	69.7	72.3	59.4	53.6	73.1	64.8	50.0	103.2	80.4	43.5	105.0	92.5	89.8	52.3	70.9	76.6	55.3	40.8	52.6	74.5	54.3	51.0	50.5	40.4	52.1	62.9	63.1	50.6	60.0	65.8	32.0	64.2	115.4	131.3	189.5	82.6	64.6	72.7	69.5	44.7	70.0	104.6	97.7	95.4	97.2	85.0	82.2	97.0	84.1	59.1	78.8	80.3	77.2	99.2	103.8	56.5	98.8	128.6	24.0	24.9	26.0	25.1	24.5	25.5	26.0	25.9	25.2	23.9	26.3	25.5	31.1	22.4	17.5	17.0	36.0	27.5	18.4	17.7	31.3	11.9	24.0	16.0	20.7	12.8	21.3	22.0	16.7	21.3	45.9	16.5	21.5	22.2	14.0	17.0	22.8	21.7	12.1	15.4	15.9	23.3	35.0	19.5	23.0	23.9	14.5	22.7	16.4	20.4	19.7	13.5	17.8	16.8	8.2	34.0	28.5	22.4	17.1	27.8	7.2	18.7	35.1	11.5	43.3	13.0	16.3	29.8	14.3	20.7	47.8	27.1	23.1	21.2	17.6	17.7	26.3	18.2	22.0	31.2	48.6	27.0	32.1	21.8	39.7	16.4	18.9	32.9
RNF40	"BRE1B, KIAA0661, RBP95, STARING"	ENSG00000103549	"Ring finger protein 40"	O75150	16	30761745-30776307	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041330, HPA054227"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 14: REH - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA041330: AB_10793872, HPA054227: AB_2682422"	"unprognostic (1.61e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (8.11e-8)"	"unprognostic (9.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.60e-3)"	24.4	28.7	23.4	26.7	25.9	55.3	21.5	25.5	24.8	26.7	26.2	26.0	24.9	29.3	15.5	31.8	25.4	26.0	16.3	25.8	22.4	19.9	20.9	22.5	26.9	25.9	24.3	35.2	29.8	35.2	21.7	21.4	23.0	22.6	17.6	18.1	33.7	22.5	17.5	27.4	24.7	21.5	22.3	24.7	23.4	38.0	26.1	24.6	29.0	16.0	22.3	21.4	22.7	28.8	58.5	87.9	53.0	52.7	41.9	43.3	58.6	58.7	47.4	66.8	52.4	72.4	53.7	46.5	82.9	50.5	45.5	62.1	99.2	55.5	53.0	66.7	120.9	45.2	99.9	77.2	53.3	79.8	54.0	41.3	43.5	83.3	48.8	44.2	57.7	40.6	101.3	46.1	42.5	98.3	76.4	74.4	55.6	47.7	55.4	149.9	58.8	91.6	29.8	52.0	89.9	65.0	45.0	58.7	41.8	27.9	88.9	88.5	60.8	74.6	37.4	53.8	67.7	66.1	87.2	93.0	62.3	70.6	77.1	6.5	13.6	17.1	13.1	14.1	13.1	8.1	7.1	10.0	13.9	5.9	5.3	8.8	16.1	11.1	17.1	6.6	6.7	16.2	23.4	25.9	25.5	24.8	25.8	22.4	25.9	24.3	23.0	22.3	26.1	28.8	13.5	12.8	24.9	18.3	17.2	13.9	12.3	10.2	16.5	12.8	18.9	15.6	3.2	28.6	11.5	22.0	4.2	16.0	20.7	27.7	88.0	15.2	23.7	24.7	20.8	14.9	13.9	37.4	10.3	13.3	16.9	14.5	26.0	29.2	4.5	19.3	10.8	22.9	21.5	5.0	11.2	23.2	10.2	23.0	12.6	22.0	18.0	16.9	17.8	4.7	16.7	16.5	11.3	13.0	8.7	16.3	15.4	17.7	21.8	15.8	24.2	26.5	12.4	13.7	13.1	15.8	13.3	27.1	11.3	20.6	19.7	22.7	16.0	22.2	25.8	11.2
RNF41	"NRDP1, SBBI03"	ENSG00000181852	"Ring finger protein 41"	Q9H4P4	12	56202179-56221933	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016812	Approved		Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nuclear bodies"	"Midbody ring"	"HPA016812: AB_1856370"	"unprognostic (1.14e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (6.93e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	32.2	24.6	22.5	18.0	23.3	19.6	21.4	15.7	23.8	21.2	13.0	23.8	12.4	22.3	13.2	23.1	24.3	25.5	32.7	24.6	24.8	19.7	15.1	23.8	23.4	16.8	19.1	22.9	23.0	27.4	22.8	21.3	21.2	33.9	19.0	23.8	15.0	20.7	34.0	15.0	16.1	28.5	15.3	20.6	17.0	15.9	23.5	26.5	28.6	40.8	25.1	28.2	17.0	19.2	21.6	32.6	34.7	55.2	71.0	51.3	25.8	70.8	69.5	62.2	50.2	40.0	27.6	41.6	36.7	60.2	20.6	24.3	47.4	34.1	44.9	43.8	25.7	55.8	22.3	23.2	148.3	61.6	58.3	66.0	78.6	52.0	91.0	81.7	61.3	34.5	40.4	41.3	35.1	34.9	35.6	27.6	41.9	21.6	37.8	38.2	24.9	25.3	33.3	31.3	62.9	38.1	61.9	35.0	55.4	34.3	49.2	71.3	37.3	31.3	32.9	40.6	27.8	29.6	36.6	37.5	37.2	36.4	38.0	59.1	27.2	99.9	27.6	26.7	24.9	50.3	23.0	24.3	30.6	55.1	23.4	24.0	36.2	33.1	28.3	23.7	29.4	31.0	22.5	23.3	15.7	23.8	24.6	24.8	16.8	19.1	21.2	15.3	23.5	19.2	18.9	44.8	22.6	11.1	42.2	12.0	19.9	8.6	19.9	30.7	22.2	21.1	24.6	24.3	18.8	16.5	22.9	15.2	17.0	10.2	17.6	15.3	92.8	13.9	14.2	20.7	20.4	11.1	15.0	21.3	18.5	22.7	9.7	14.2	25.9	16.8	30.0	16.7	19.3	28.6	15.7	13.9	8.2	34.9	22.7	58.0	23.0	25.0	7.2	9.4	33.5	26.2	15.5	14.6	12.3	20.8	20.3	25.9	14.6	33.5	12.3	19.6	18.0	18.3	26.3	23.2	27.4	10.4	14.2	14.4	16.6	16.8	16.6	17.1	14.3	23.1
RNF44	KIAA1100	ENSG00000146083	"Ring finger protein 44"	Q7L0R7	5	176526712-176538025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 105.1;Late spermatids: 398.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038981	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038981: AB_10674846"	"unprognostic (1.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.57e-7)"	"unprognostic (1.50e-1)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (1.61e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.15e-2)"	16.7	17.8	15.9	28.9	14.0	42.7	18.1	8.6	19.3	18.3	6.1	26.3	20.2	16.3	5.4	25.9	19.1	9.1	17.0	14.2	14.4	21.7	14.6	22.0	37.7	12.5	12.0	24.9	19.5	10.3	15.7	13.1	9.9	19.5	12.6	8.4	23.2	9.3	11.8	30.5	34.6	7.8	8.5	54.7	20.4	20.2	15.0	30.9	25.1	7.5	24.2	18.0	21.1	11.4	9.3	20.9	32.7	30.6	6.4	5.3	87.6	5.3	4.6	3.5	4.5	31.9	20.2	17.7	32.0	3.0	16.0	24.8	14.8	31.8	4.0	69.0	26.1	18.9	20.1	29.8	8.1	22.1	25.0	10.3	25.1	3.9	11.7	11.4	9.8	33.8	21.4	25.9	4.8	32.1	51.6	49.3	43.4	12.1	25.5	21.0	8.6	25.8	12.0	21.4	40.1	48.8	8.0	21.7	31.2	21.5	24.0	43.9	16.0	8.8	13.1	7.1	10.0	32.6	26.3	24.1	4.3	44.7	11.7	0.0	1.5	2.9	3.0	1.8	2.2	1.9	2.3	2.5	1.0	2.3	2.2	2.7	5.3	2.1	1.6	1.1	3.1	1.8	15.9	14.0	8.6	19.3	14.2	14.4	12.5	12.0	9.9	8.5	15.0	11.4	18.3	12.8	28.6	22.9	39.0	40.3	10.5	24.4	43.3	17.1	30.7	25.4	13.3	20.0	18.2	12.9	10.4	10.5	46.6	41.7	7.9	12.3	105.1	15.3	13.7	19.9	40.7	10.1	20.5	16.2	11.7	11.1	21.4	20.2	15.8	13.7	15.7	10.5	15.3	28.6	24.7	40.7	18.3	56.5	19.6	398.5	19.9	26.8	5.4	21.5	38.4	9.2	40.2	13.0	12.2	21.2	24.3	12.4	17.0	22.2	27.1	10.8	13.9	8.5	6.6	14.1	13.0	3.6	12.0	35.0	49.6	12.0	40.3	12.9	35.7	15.3
RNF7	"CKBBP1, ROC2, SAG"	ENSG00000114125	"Ring finger protein 7"	Q9UBF6	3	141738249-141747560	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 898.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036995	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA036995: AB_10673627"	"unprognostic (5.68e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.17e-3)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (1.54e-9)"	"unprognostic (4.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.36e-2)"	67.1	114.5	62.7	40.8	65.6	65.0	63.5	63.4	80.0	69.5	72.2	98.2	69.7	58.7	70.8	86.5	61.0	46.1	102.8	64.2	67.2	92.3	83.9	58.4	44.5	64.4	64.8	73.8	80.3	44.0	81.5	51.2	65.7	77.6	59.8	37.6	59.8	43.8	142.0	72.0	64.1	47.8	65.1	58.7	68.3	71.2	66.3	45.4	52.6	113.1	44.1	77.9	71.9	65.9	172.6	67.4	98.1	80.0	91.6	125.7	65.5	94.6	87.5	78.2	82.6	79.4	82.5	57.7	214.5	104.7	192.7	80.8	61.5	88.1	98.3	56.0	119.1	56.6	64.8	116.4	122.6	89.7	52.9	118.2	96.9	63.4	105.5	104.3	112.3	96.1	61.6	77.0	117.2	131.0	56.6	100.1	105.1	170.7	113.3	61.1	63.1	124.0	169.2	74.0	54.8	68.1	108.7	108.8	161.4	126.4	102.4	114.8	86.2	78.1	75.6	139.2	80.5	73.7	66.5	121.2	122.4	98.4	90.3	119.0	128.2	87.7	78.0	116.4	77.7	82.6	82.8	83.2	112.9	74.1	79.6	83.7	45.5	61.8	125.7	103.4	108.8	121.6	62.7	65.6	63.4	80.0	64.2	67.2	64.4	64.8	65.7	65.1	66.3	65.9	128.7	60.9	55.2	7.5	81.4	132.4	143.0	290.5	150.2	34.3	159.7	207.3	104.1	105.8	151.1	101.2	27.1	183.8	133.2	262.0	254.3	225.1	348.9	99.3	112.0	134.9	125.7	41.4	12.9	247.3	249.1	114.2	73.9	100.0	72.9	206.4	129.9	132.0	214.4	28.6	12.6	195.2	134.3	126.7	123.5	898.4	117.8	137.6	144.1	18.7	174.1	111.7	140.1	10.6	19.6	233.2	261.4	121.9	102.0	181.8	295.1	324.1	105.7	56.7	85.5	84.3	126.2	212.2	129.1	183.7	144.6	129.8	112.7	281.4	174.5	185.9
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353979-37394734	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 76.0"	"Not detected"	"Not detected"							"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA050731: AB_2681222, HPA064925: AB_2685385"	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	5.0	7.8	10.0	3.5	10.1	4.6	5.2	11.8	14.3	7.7	9.3	6.3	3.1	7.0	2.1	10.6	6.0	4.0	8.6	10.1	10.5	8.8	4.8	5.9	4.2	10.2	10.6	7.6	4.5	7.4	6.6	4.8	10.3	6.0	3.6	9.0	6.2	5.2	8.1	7.6	5.0	4.9	9.4	4.7	5.2	11.2	11.2	5.8	4.5	10.6	6.6	6.5	7.8	9.9	12.5	7.3	17.3	20.7	13.7	19.6	4.9	12.6	15.5	23.4	25.6	11.0	6.8	15.3	7.5	12.4	20.1	11.4	24.4	16.0	24.4	16.2	23.7	26.5	12.0	16.6	7.8	14.3	18.7	9.8	15.2	14.0	16.2	14.3	22.9	17.9	18.1	5.2	13.6	8.3	17.4	17.5	12.1	6.3	9.4	13.5	16.0	10.6	12.1	8.7	34.0	11.4	9.5	10.6	18.0	11.3	9.5	13.6	10.4	15.4	13.5	14.7	18.8	15.2	21.8	76.0	7.5	20.1	18.0	1.0	4.3	2.5	9.5	5.8	8.8	8.1	7.0	9.2	7.8	4.9	6.1	8.1	0.5	7.9	8.8	3.3	9.1	5.2	10.0	10.1	11.8	14.3	10.1	10.5	10.2	10.6	10.3	9.4	11.2	9.9	21.0	19.2	25.9	13.4	15.0	18.2	22.2	26.0	26.2	26.7	16.5	20.4	31.1	12.8	18.5	25.8	39.6	24.8	18.2	10.3	15.6	24.7	41.1	68.5	32.2	19.2	22.2	18.7	17.0	18.9	25.8	28.0	16.3	52.3	28.5	37.0	27.8	16.5	17.5	50.5	15.9	16.5	14.2	13.9	17.7	30.2	26.8	24.0	10.6	11.2	19.6	25.4	37.0	12.5	20.5	28.8	18.1	30.9	13.7	31.8	11.8	20.6	23.8	32.3	13.1	23.2	20.8	46.5	34.5	34.2	22.0	5.9	19.3	22.0	18.0	21.9
RNFT2	"FLJ14627, TMEM118"	ENSG00000135119	"Ring finger protein, transmembrane 2"	Q96EX2	12	116738178-116853631	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.8;pituitary gland: 5.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.9;Early spermatids: 49.3;Excitatory neurons: 22.7;Inhibitory neurons: 28.7;Late spermatids: 56.4;Oligodendrocyte precursor cells: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/84: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064161	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064161: AB_2685202"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.14e-5)"	"unprognostic (8.62e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.36e-3)"	"unprognostic (4.01e-4)"	0.4	1.0	9.8	0.5	9.8	1.0	0.2	5.7	13.8	0.2	2.9	0.3	0.5	0.2	0.8	0.4	0.3	0.4	0.4	10.6	8.4	0.7	0.1	0.3	1.1	11.8	7.6	0.4	0.2	0.4	5.1	1.0	11.9	0.2	0.3	4.9	0.6	0.2	0.6	0.6	0.5	0.2	4.2	0.8	0.3	3.7	7.9	1.4	0.5	0.1	1.2	0.2	0.1	9.3	1.3	7.3	2.9	9.8	0.1	0.1	6.8	0.5	0.5	1.6	1.2	3.3	1.2	6.5	1.9	0.1	2.2	1.3	7.8	0.6	0.9	7.0	4.6	1.1	5.5	2.4	1.1	0.5	4.9	0.2	0.1	3.6	0.8	0.9	0.3	4.4	8.0	2.1	0.1	4.0	7.6	1.1	4.5	1.9	1.3	4.1	1.5	3.4	2.0	1.2	5.0	4.8	1.8	0.8	1.9	2.6	5.0	1.7	0.4	1.0	4.5	2.2	2.5	3.6	14.9	8.5	4.0	0.5	0.6	1.1	0.2	0.2	0.3	0.1	0.1	0.7	0.3	0.3	0.1	0.8	0.6	0.7	0.7	0.5	0.3	0.7	0.2	0.2	9.8	9.8	5.7	13.8	10.6	8.4	11.8	7.6	11.9	4.2	7.9	9.3	0.9	0.0	0.5	11.8	2.2	0.0	0.3	0.2	0.0	17.9	0.7	0.3	1.2	1.5	0.2	7.3	16.7	3.1	0.3	0.5	0.0	0.9	49.3	0.7	0.3	1.9	4.2	0.4	22.7	0.2	3.0	0.6	1.1	0.6	0.0	3.8	0.4	0.2	2.2	10.1	28.7	0.8	2.0	1.9	0.8	56.4	0.6	0.7	1.8	3.7	1.0	5.5	0.0	18.6	7.0	0.6	0.1	1.5	2.0	0.2	0.6	1.0	1.4	10.3	0.0	0.7	0.9	3.8	5.2	0.2	0.0	1.6	0.5	1.1	0.8	0.2
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88609897-88963618	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.6;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 96.5;Oligodendrocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	5.3	6.7	4.9	8.2	4.9	9.5	5.6	9.1	5.7	5.2	2.6	4.6	4.2	5.2	3.6	7.2	4.1	3.7	5.3	5.1	7.0	5.3	6.9	4.4	17.2	4.6	5.2	4.8	2.9	6.4	4.9	5.0	5.1	5.3	5.4	10.6	3.5	4.9	5.2	4.4	5.2	6.1	4.6	7.6	4.2	9.3	7.3	14.7	5.6	6.4	17.3	6.2	4.8	5.3	9.2	14.0	21.1	26.2	12.0	12.6	12.4	20.2	13.4	16.4	20.4	15.9	6.8	23.1	16.2	14.9	21.5	11.1	24.7	16.5	29.7	31.8	19.0	30.5	11.4	12.2	9.5	33.2	16.6	7.7	13.8	16.8	15.9	13.6	14.7	12.7	30.9	18.1	23.8	12.0	14.6	22.8	12.5	15.0	11.7	28.6	32.0	13.3	14.0	14.2	12.3	17.3	16.8	9.8	11.1	19.7	10.8	31.8	11.5	13.0	12.0	14.7	27.9	16.1	31.6	13.2	18.9	23.8	24.1	5.2	4.1	7.6	7.8	5.9	7.8	22.9	8.6	9.7	5.8	22.8	9.7	10.1	3.4	10.9	5.5	4.0	9.0	5.4	4.9	4.9	9.1	5.7	5.1	7.0	4.6	5.2	5.1	4.6	7.3	5.3	8.9	0.0	16.2	54.5	60.4	8.3	10.7	6.0	10.8	22.4	6.5	6.1	10.7	7.2	12.9	12.9	39.6	10.4	19.7	8.0	0.0	6.3	17.9	7.9	12.1	7.0	9.1	7.6	108.6	4.9	9.9	9.7	15.8	12.4	8.8	11.0	7.5	10.3	7.8	15.2	110.2	7.0	4.1	9.1	7.3	5.2	5.9	13.6	3.6	69.3	9.8	7.2	18.6	96.5	94.3	7.2	5.1	7.9	42.3	8.6	4.6	6.3	10.1	43.4	6.6	15.8	9.5	23.3	20.1	10.7	8.7	11.8	24.6	8.0	6.7	7.4
RNH1	"RAI, RNH"	ENSG00000023191	"Ribonuclease/angiogenin inhibitor 1"	P13489	11	494512-507300	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 262.3;monocytes: 299.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039223, HPA040781"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		22000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA039223: AB_10795581, HPA040781: AB_10796227"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.48e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.35e-2)"	163.5	137.2	27.3	29.0	41.8	46.3	133.7	42.4	33.9	156.4	28.9	123.0	27.1	140.8	10.0	215.0	119.5	29.7	198.0	26.3	32.5	118.6	111.9	146.7	30.8	48.6	39.7	119.1	89.5	25.6	80.6	27.3	38.2	100.9	8.8	5.6	112.5	31.0	145.9	257.4	91.1	25.3	35.3	113.3	101.1	90.1	38.3	15.6	106.6	21.8	13.9	144.5	160.3	49.4	86.5	123.9	13.2	39.8	66.3	93.8	43.9	70.6	51.3	68.9	58.3	61.9	92.9	41.8	54.3	175.1	41.9	72.7	20.6	76.5	10.4	51.3	104.9	28.2	28.5	65.7	243.3	39.8	90.0	77.1	108.2	40.2	46.7	29.2	47.9	27.7	36.2	71.3	37.7	86.6	30.5	78.4	19.8	45.3	112.6	37.7	22.3	55.8	40.7	34.6	35.7	23.2	41.8	59.1	73.7	7.4	44.6	122.2	77.3	109.3	32.8	39.8	49.5	44.9	53.0	32.2	117.5	81.9	74.3	37.6	246.2	57.3	51.1	298.9	59.9	63.0	55.3	51.1	262.3	48.4	49.8	45.1	17.1	54.2	299.1	71.7	58.4	236.5	27.3	41.8	42.4	33.9	26.3	32.5	48.6	39.7	38.2	35.3	38.3	49.4	156.0	112.2	83.5	18.9	92.3	202.1	239.0	265.0	89.4	102.4	82.0	105.5	83.3	88.6	138.6	79.1	110.5	222.2	85.3	126.6	225.0	188.8	105.1	72.8	132.4	136.1	57.4	59.7	10.9	164.4	217.4	194.9	64.2	82.8	140.2	93.8	101.7	68.6	374.0	168.2	14.5	115.6	148.5	191.8	323.0	42.7	211.6	230.3	193.9	12.2	334.2	144.6	79.3	10.1	70.8	171.6	120.5	179.8	101.7	161.0	139.4	242.3	97.9	146.4	177.5	99.1	178.0	153.4	157.8	140.0	260.0	305.5	96.5	199.7	114.4	217.4
RNMT	RG7MT1	ENSG00000101654	"RNA guanine-7 methyltransferase"	O43148	18	13726660-13764556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039409	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA039409: AB_10795289"	"unprognostic (3.02e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.78e-1)"	10.9	9.6	11.8	12.6	12.1	43.3	15.3	12.2	13.0	11.3	17.2	11.6	8.5	14.0	11.5	11.3	11.2	9.0	20.3	12.1	14.2	11.6	11.2	9.5	14.4	13.6	15.2	17.2	12.1	13.0	13.9	15.2	14.8	11.6	10.4	27.4	12.1	10.5	18.4	14.2	10.5	12.5	10.9	12.1	10.6	16.7	11.7	14.9	17.5	15.6	15.2	11.4	10.7	12.6	24.9	14.4	27.4	20.9	20.0	25.1	19.2	19.9	24.7	20.3	27.4	17.3	11.7	27.7	23.9	20.6	31.6	9.8	32.7	28.6	34.0	15.4	17.6	21.0	14.8	16.4	21.9	54.9	17.1	19.4	30.5	21.4	59.9	26.6	15.9	31.1	31.8	26.9	23.3	15.4	35.2	19.7	21.0	50.1	11.2	22.7	29.0	37.9	18.6	19.2	21.1	31.7	22.5	16.4	38.1	27.8	14.3	22.6	16.5	40.6	56.8	33.3	21.5	53.8	63.6	56.9	29.9	20.8	20.6	45.1	17.6	12.8	16.7	14.6	13.6	23.9	15.8	14.2	11.8	25.7	20.5	16.2	9.8	14.1	17.3	29.5	19.0	5.6	11.8	12.1	12.2	13.0	12.1	14.2	13.6	15.2	14.8	10.9	11.7	12.6	62.5	73.7	29.9	48.6	148.5	70.4	67.3	97.9	75.1	115.6	50.7	56.1	56.5	35.8	56.5	46.0	123.0	66.3	143.4	46.5	68.4	51.0	75.4	85.2	88.3	43.7	74.8	37.4	75.3	48.0	59.2	71.6	66.3	113.9	34.9	85.6	40.7	38.5	39.8	106.0	83.9	56.3	85.5	59.4	63.6	21.1	72.7	78.8	49.8	45.0	68.0	51.0	60.8	56.8	78.9	56.1	47.0	60.9	99.7	72.3	49.0	64.8	48.0	148.3	39.5	85.6	60.0	111.4	115.1	50.7	68.3	126.4	113.1	48.8	50.0	50.3
RNPC3	"FLJ20008, KIAA1839, RBM40, SNRNP65"	ENSG00000185946	"RNA binding region (RNP1, RRM) containing 3"	Q96LT9	1	103525691-103555239	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 133.5;Rod photoreceptor cells: 143.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052434			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA052434: AB_2681832"	"unprognostic (1.87e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.34e-5)"	"unprognostic (9.00e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (7.82e-4)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (5.25e-4)"	31.4	24.8	9.6	22.7	9.5	24.4	30.7	21.3	24.2	35.7	0.7	30.8	23.4	33.8	54.0	16.2	35.6	21.2	30.1	8.1	3.4	29.8	17.0	26.0	33.9	3.4	1.0	37.9	44.9	24.7	33.4	12.5	2.2	25.2	22.2	63.6	37.3	21.4	44.0	37.7	29.2	16.0	0.9	30.0	22.2	15.9	5.8	20.0	55.0	16.9	26.0	26.7	27.4	23.0	10.7	8.7	17.8	8.8	10.4	18.8	11.6	14.4	9.7	11.3	17.1	9.3	17.9	20.0	22.8	7.4	6.7	20.9	11.5	11.1	13.7	13.0	20.3	21.1	52.0	9.5	7.7	28.2	17.4	17.8	16.8	9.9	6.8	16.2	10.4	17.3	13.4	22.4	12.8	5.8	16.8	13.7	11.5	9.8	12.5	22.1	16.7	15.9	14.7	11.7	18.8	9.0	9.9	13.7	14.6	9.7	9.4	12.5	13.9	12.3	12.2	6.5	9.5	17.2	6.4	18.1	21.4	21.5	6.3	249.7	91.0	70.0	53.7	46.1	39.5	109.3	65.0	50.2	28.9	127.7	75.9	69.6	252.6	40.0	53.4	111.9	48.2	15.6	9.6	9.5	21.3	24.2	8.1	3.4	3.4	1.0	2.2	0.9	5.8	23.0	28.8	28.9	43.5	108.0	31.3	7.5	17.4	13.3	30.1	104.6	21.0	26.5	20.2	12.8	30.8	27.6	133.5	7.9	31.1	23.9	15.6	10.6	44.4	20.7	22.1	18.8	16.9	13.9	89.1	10.5	4.1	19.0	34.1	18.5	20.8	22.3	16.1	9.9	7.6	62.2	76.2	19.5	14.2	23.0	10.8	6.5	24.8	22.3	16.0	44.0	37.3	40.5	25.7	64.8	71.2	10.8	19.0	21.4	26.0	10.5	19.9	7.3	41.8	143.1	26.3	35.2	23.4	22.8	11.9	18.9	8.9	10.9	26.3	16.5	14.3	14.0
RNPEPL1		ENSG00000142327	"Arginyl aminopeptidase like 1"	Q9HAU8	2	240565804-240581372	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036772, HPA036773"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA036772: AB_10670848, HPA036773: "	"unprognostic (3.92e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (7.43e-4)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (3.72e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.86e-2)"	40.3	31.4	29.1	14.1	29.6	21.7	32.0	29.0	38.7	15.6	27.0	39.6	20.2	16.8	5.6	52.4	17.0	12.1	79.4	27.9	27.8	42.7	50.6	35.9	23.8	31.5	30.0	12.0	64.2	10.9	9.1	10.6	30.3	34.7	9.5	0.8	28.9	13.1	63.7	35.3	39.8	9.4	31.0	56.4	48.4	9.9	31.4	15.9	19.2	17.1	12.1	34.1	23.2	31.1	13.7	22.4	4.9	13.2	17.6	18.1	16.6	8.6	21.1	9.5	11.6	6.3	39.3	3.9	4.3	21.8	13.3	14.6	5.5	16.1	0.9	23.9	7.7	9.0	7.3	37.2	44.1	5.9	15.5	21.6	25.5	4.9	9.6	15.1	32.8	15.2	6.8	25.7	6.5	19.3	7.5	22.4	6.5	26.5	9.0	15.5	7.4	33.3	39.3	18.5	4.6	9.8	5.8	19.7	39.9	5.6	13.9	26.8	22.7	10.2	10.4	14.4	10.0	24.1	3.9	4.8	20.9	16.6	15.7	9.2	11.2	30.5	14.8	9.9	12.7	8.2	11.3	13.4	8.2	8.7	6.4	9.5	20.0	10.7	10.1	9.5	14.7	7.9	29.1	29.6	29.0	38.7	27.9	27.8	31.5	30.0	30.3	31.0	31.4	31.1	27.9	22.4	25.7	10.4	27.8	7.8	15.0	8.4	2.8	6.4	18.8	9.1	35.6	24.3	12.9	12.9	0.0	7.1	80.4	138.9	17.6	24.6	3.1	12.1	11.0	22.7	26.4	22.3	9.5	49.6	6.8	12.3	104.5	27.4	34.2	31.8	30.0	42.2	43.8	3.3	8.6	58.7	8.2	74.3	21.0	5.9	8.7	47.1	23.2	9.4	52.0	15.9	79.3	5.5	10.3	65.0	70.0	13.5	20.5	20.2	77.1	35.6	7.2	6.9	13.1	14.8	16.4	1.3	8.2	13.0	9.2	5.1	47.9	17.4	60.5	23.0
RNPS1		ENSG00000205937	"RNA binding protein with serine rich domain 1"	Q15287	16	2253116-2268397	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044014	Approved		Supported	Nucleoplasm		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044014: AB_10966286"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.27e-1)"	82.8	78.7	91.9	55.1	96.1	144.9	83.4	82.6	112.6	89.0	60.5	108.8	51.3	98.8	51.1	98.0	84.6	39.9	101.0	99.1	93.0	81.4	63.8	73.5	76.5	96.0	84.5	92.6	71.8	52.5	101.4	53.5	94.9	95.0	43.9	47.4	70.0	54.9	229.7	97.3	84.0	52.4	72.5	94.9	76.8	88.4	88.5	69.8	74.2	105.2	71.3	94.1	83.6	90.7	119.6	154.5	167.7	163.9	89.0	78.6	194.2	125.2	88.4	170.6	147.0	306.1	142.8	251.1	124.0	103.2	108.6	160.0	217.3	152.5	128.9	175.2	283.2	172.8	133.9	198.3	150.2	185.5	159.0	99.3	168.3	149.1	207.1	80.8	134.8	144.6	302.1	195.3	143.3	259.7	296.2	363.6	340.1	135.2	128.4	441.4	196.6	322.3	122.5	66.6	354.8	218.3	172.3	157.6	166.4	77.1	152.7	187.7	102.2	155.4	155.2	143.0	182.1	199.7	282.5	582.9	63.3	168.0	185.6	48.1	144.0	123.2	169.5	170.5	167.7	177.9	162.2	172.9	153.8	205.5	153.3	162.0	43.4	182.9	187.8	131.6	196.1	290.2	91.9	96.1	82.6	112.6	99.1	93.0	96.0	84.5	94.9	72.5	88.5	90.7	90.6	44.8	62.7	29.7	148.2	206.6	208.7	148.9	119.5	119.7	99.5	95.9	36.3	65.8	85.5	51.5	139.7	182.3	138.5	90.8	70.5	115.5	16.3	76.5	88.9	102.1	122.0	130.4	72.1	93.2	237.4	90.7	79.0	108.4	103.4	114.9	77.1	37.5	104.7	97.6	61.1	100.6	124.1	71.3	117.0	21.4	94.1	80.1	97.8	23.4	123.9	98.0	180.2	31.7	37.3	121.7	76.5	68.8	117.2	209.5	81.1	64.3	50.2	132.8	85.5	103.9	102.3	132.9	267.4	117.6	212.4	162.0	131.7	101.7	125.7	203.5
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;retina: 15.4"	"Group enriched"	"Detected in many"	24	"Excitatory neurons: 3438.7;Inhibitory neurons: 4706.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 29.8;HEL: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013371, HPA013975"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA		1900000		"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA013371: AB_1856391, HPA013975: "	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	0.7	2.4	10.1	0.5	13.6	0.0	0.6	0.0	14.2	2.4	0.0	0.8	0.5	2.1	0.4	4.8	0.1	2.3	0.6	10.4	1.7	1.8	1.2	10.0	1.5	14.8	13.1	7.0	1.6	2.8	1.5	5.2	14.3	1.2	0.4	15.4	1.6	5.7	0.1	2.3	0.7	1.4	16.7	2.9	0.7	3.7	4.9	9.3	0.1	0.4	2.2	1.2	1.7	8.1	0.0	0.0	2.2	0.0	7.5	8.1	0.1	0.3	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	9.8	83.9	1.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	5.1	9.1	0.0	0.0	1.1	5.1	12.2	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	13.6	0.0	14.2	10.4	1.7	14.8	13.1	14.3	16.7	4.9	8.1	0.7	0.0	0.5	164.6	0.0	1.8	2.0	0.4	19.4	30.8	0.2	1.0	2.4	1.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.2	1.0	1.7	1.1	0.0	0.0	3438.7	0.0	0.1	10.6	0.0	3.2	0.0	2.3	3.3	0.7	0.1	52.2	4706.0	3.0	0.0	0.0	2.8	3.4	3.1	0.1	0.0	54.4	0.0	2.0	0.0	63.3	52.4	0.2	0.0	6.0	0.0	0.8	0.3	0.1	0.1	5.6	0.0	0.1	0.9	2.9	1.1	15.7	1.1	0.1	0.2	40.5	0.5	0.2
RORB	"NR1F2, ROR-BETA, RZRB"	ENSG00000198963	"RAR related orphan receptor B"	Q92753	9	74497335-74693177	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0;retina: 55.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 393.7;Endometrial stromal cells: 436.8;Excitatory neurons: 190.0;Horizontal cells: 1399.8;Muller glia cells: 390.7;Rod photoreceptor cells: 190.3"	"Group enriched"	"Detected in some"	5	"glioma: 2.1;prostate cancer: 2.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 18.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HHSteC: 22.5;HSkMC: 12.4;JURKAT: 23.3;MOLT-4: 6.9;SH-SY5Y: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008393	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA008393: AB_1079830"	"unprognostic (6.89e-3)"	"unprognostic (4.06e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.81e-8)"	"unprognostic (5.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.00e-2)"	1.1	3.4	0.0	0.1	1.3	0.0	0.3	0.0	18.0	9.8	0.0	0.2	0.1	3.9	0.0	0.4	0.3	1.7	1.6	3.7	0.7	0.5	0.0	0.6	0.0	0.0	0.3	0.2	0.1	0.3	1.7	2.0	0.0	4.6	0.3	55.6	0.1	5.0	0.0	0.2	0.1	0.3	0.0	0.0	0.3	0.6	0.4	0.4	0.3	0.1	0.3	0.7	0.8	5.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	22.5	0.0	0.7	12.4	0.0	0.0	0.0	0.0	0.0	23.3	0.0	3.6	0.0	0.1	6.9	0.0	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.1	0.0	0.0	0.0	0.5	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	18.0	3.7	0.7	0.0	0.3	0.0	0.0	0.4	5.1	0.1	0.0	4.8	393.7	0.4	1.7	0.8	0.0	6.8	156.4	0.4	0.6	14.1	0.0	0.0	0.0	120.9	0.2	2.7	0.1	0.0	0.0	6.6	11.9	436.8	4.2	0.0	0.0	190.0	0.0	0.4	10.7	0.0	6.9	1.3	0.2	0.7	0.0	0.6	1399.8	6.4	0.0	0.0	0.3	2.1	1.9	0.0	1.8	1.8	10.3	0.1	390.7	1.0	12.5	28.6	0.1	0.0	0.0	0.8	2.8	0.0	8.9	0.7	190.3	0.0	8.7	9.9	3.0	0.7	1.4	0.4	0.1	3.0	0.3	0.1	0.9
RP2	"NM23-H10, NME10, TBCCD2"	ENSG00000102218	"RP2 activator of ARL3 GTPase"	O75695	X	46837043-46882358	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.5"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 62.8;Langerhans cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000234, HPA000909"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA000234: AB_1079831, HPA000909: AB_2666140"	"unprognostic (2.26e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.76e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.79e-3)"	"unprognostic (9.75e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.96e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.28e-3)"	10.9	8.9	1.9	15.6	2.3	49.5	7.2	2.6	2.3	7.9	3.6	10.1	10.6	6.9	4.0	12.9	6.8	12.7	4.8	1.7	2.7	6.7	13.2	11.8	12.9	3.3	2.8	6.5	4.6	7.4	1.7	25.2	3.5	6.7	10.5	4.2	4.4	5.3	2.0	5.3	11.0	9.0	3.5	13.2	8.1	4.0	2.3	9.8	6.1	3.6	11.2	10.4	4.2	4.6	21.8	10.3	20.4	11.0	15.7	19.4	48.0	27.4	21.5	23.8	23.9	44.6	18.2	25.8	10.7	29.3	20.1	14.0	19.8	20.0	32.1	11.5	11.5	13.9	11.7	10.7	17.9	29.2	46.4	15.1	13.0	18.8	10.1	13.3	30.5	11.4	6.2	13.1	27.0	1.9	18.1	26.8	12.5	14.8	19.5	22.9	27.9	13.8	15.3	22.0	7.4	10.0	24.4	14.9	12.4	36.2	16.8	27.1	27.1	18.3	13.6	29.1	9.8	4.9	6.8	15.4	9.5	20.4	19.5	62.6	22.6	35.5	6.1	30.8	5.0	10.3	4.9	5.3	22.6	9.6	6.0	5.7	43.5	7.6	36.3	7.6	6.1	12.2	1.9	2.3	2.6	2.3	1.7	2.7	3.3	2.8	3.5	3.5	2.3	4.6	9.6	9.6	7.4	3.9	18.9	15.8	3.2	6.1	15.4	3.1	7.8	6.1	1.7	7.2	5.1	9.2	2.1	23.2	12.0	28.6	0.0	4.7	2.8	15.8	14.5	8.6	3.6	10.3	3.1	5.3	6.4	10.3	12.8	14.9	12.0	4.0	12.5	20.1	24.3	0.0	4.0	9.4	2.0	62.8	72.9	1.7	5.6	44.7	21.4	6.5	36.6	3.6	6.2	12.1	5.9	11.6	13.4	5.7	13.2	8.2	9.8	3.6	14.5	5.5	6.6	7.7	10.5	7.8	4.6	36.4	14.9	38.2	11.4	4.7	10.5	13.6
RP9	PAP-1	ENSG00000164610	"RP9 pre-mRNA splicing factor"	Q8TA86	7	33094797-33109404	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031523, HPA050778"	Uncertain		Enhanced	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Vesicles, Cytosol"	"HPA031523: AB_10603235, HPA050778: AB_2681233"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (4.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.61e-1)"	12.6	15.0	26.3	8.7	26.1	21.6	12.6	28.0	51.2	17.0	26.7	16.7	9.0	14.4	15.5	10.1	14.0	6.2	29.2	25.8	26.3	17.2	13.8	12.0	15.6	26.6	26.3	16.2	20.2	10.5	10.3	10.2	26.7	14.4	9.8	16.7	11.5	11.7	36.3	13.8	15.9	8.4	25.8	20.8	13.5	18.1	26.9	13.8	16.0	34.3	16.7	14.3	13.1	27.4	20.9	28.8	29.7	34.1	18.5	17.2	14.3	26.4	21.6	28.9	23.0	25.6	14.6	26.2	17.0	21.1	35.4	20.4	36.4	22.0	36.8	11.9	25.1	19.2	22.8	24.4	32.4	26.0	13.0	17.5	20.2	32.8	64.5	23.3	24.0	27.1	35.2	23.0	29.1	42.6	27.7	69.6	25.4	27.2	21.9	28.2	26.4	17.1	21.1	19.3	28.7	39.5	18.7	39.6	46.2	35.1	20.8	35.0	19.4	28.4	40.9	25.6	42.8	38.1	37.2	51.7	20.0	36.3	56.1	21.9	12.0	21.6	15.2	9.8	14.1	57.8	16.3	17.4	13.2	77.3	19.1	18.0	2.0	15.7	12.5	28.4	15.8	8.8	26.3	26.1	28.0	51.2	25.8	26.3	26.6	26.3	26.7	25.8	26.9	27.4	21.3	12.8	10.1	4.9	35.6	21.0	15.1	11.3	29.0	15.8	17.7	27.9	41.7	17.2	10.9	14.7	14.6	20.2	16.8	12.6	21.5	16.0	5.6	14.6	28.2	24.1	10.2	19.4	6.5	15.8	20.0	20.4	20.4	16.6	3.8	26.8	15.4	16.4	18.4	8.4	7.5	19.3	24.4	10.1	14.9	3.2	18.0	12.0	23.2	5.6	10.1	21.9	21.6	3.0	8.7	14.6	8.0	16.1	24.4	22.9	16.1	18.6	8.5	16.4	26.3	19.4	30.3	31.6	54.3	24.4	18.0	10.4	19.9	22.9	18.4	12.0
RPA1	"HSSB, REPA1, RF-A, RP-A, RPA70"	ENSG00000132383	"Replication protein A1"	P27694	17	1829702-1900082	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004563, HPA006914, HPA046497"	Supported		Enhanced	Nucleoplasm		NA	NA		82000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: AB_2679675"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (9.00e-9)"	"unprognostic (9.59e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.52e-2)"	21.1	17.7	14.1	22.5	15.7	22.0	20.6	18.1	16.3	21.8	15.6	21.8	20.8	22.8	17.5	23.4	25.4	15.5	26.7	14.4	17.1	14.6	17.1	17.1	35.8	15.0	15.2	31.8	15.3	18.9	14.8	16.9	17.2	22.2	17.2	22.4	21.8	21.8	52.4	25.9	20.6	21.9	16.6	21.8	17.0	14.4	16.3	37.6	23.2	34.3	37.8	22.1	19.7	19.0	93.5	90.7	77.9	76.2	35.3	35.9	88.1	73.5	40.7	85.1	87.7	132.0	41.2	128.4	68.1	41.3	34.9	83.4	93.4	58.3	93.5	86.3	116.3	77.8	113.6	51.0	23.4	57.7	65.5	29.9	37.0	84.1	36.2	30.1	62.9	77.0	75.8	72.4	60.2	47.8	127.3	33.7	63.5	58.2	53.2	173.8	44.0	72.1	37.3	62.3	34.9	54.7	103.9	35.1	63.8	52.0	75.1	43.4	56.2	66.5	56.7	75.3	113.9	19.8	56.5	76.0	46.5	88.6	82.2	43.2	25.0	54.5	53.1	36.4	54.2	51.2	55.1	53.0	30.2	35.8	53.0	48.4	11.9	80.8	47.8	31.7	56.7	60.5	14.1	15.7	18.1	16.3	14.4	17.1	15.0	15.2	17.2	16.6	16.3	19.0	14.9	9.6	14.7	12.4	24.3	29.6	16.3	22.4	17.6	19.2	25.1	21.0	23.7	22.8	14.4	40.5	4.2	69.4	27.0	13.5	5.9	20.6	18.9	13.4	16.6	21.7	15.6	67.6	12.2	19.8	68.9	23.2	7.7	14.2	33.7	25.0	25.4	24.2	46.1	37.0	14.0	19.3	26.4	49.1	14.6	42.4	32.3	35.1	28.4	14.0	37.6	39.7	35.0	12.1	18.2	15.0	7.2	34.6	23.0	14.1	24.6	11.7	19.4	19.5	0.0	19.2	21.5	14.7	21.8	24.3	29.1	43.5	30.3	15.6	23.1	11.7
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 162.3;Spermatogonia: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	28.4	25.0	33.3	39.7	35.1	40.7	43.8	33.4	42.4	32.0	37.4	26.6	18.5	33.7	43.4	32.3	49.1	30.6	39.2	34.5	36.1	32.4	31.8	28.7	75.1	33.7	33.2	52.0	21.0	40.7	31.3	30.2	33.9	28.7	30.2	43.8	24.0	31.3	72.3	40.3	26.1	30.7	36.7	42.3	25.6	63.7	34.0	53.4	52.9	63.2	67.6	30.3	24.9	36.7	60.9	57.4	86.4	68.5	59.3	52.8	57.2	106.1	70.3	130.0	113.5	80.2	72.7	148.9	69.4	41.1	48.4	55.8	126.5	60.3	122.4	121.0	126.0	174.3	73.0	71.3	30.9	229.7	115.1	24.6	33.2	123.8	62.3	40.3	59.1	133.1	196.2	127.1	75.7	63.6	163.9	105.1	181.7	115.1	122.0	115.0	128.7	74.2	49.1	65.2	78.3	75.8	123.3	47.3	100.7	68.1	50.9	71.8	36.6	32.2	73.0	186.2	76.3	105.8	251.0	135.8	81.4	213.5	64.3	322.3	97.4	290.0	279.7	80.0	304.4	272.5	252.9	257.4	112.1	232.0	287.4	282.7	100.1	294.1	106.5	172.3	255.5	435.5	33.3	35.1	33.4	42.4	34.5	36.1	33.7	33.2	33.9	36.7	34.0	36.7	26.5	22.4	15.7	10.4	64.0	21.0	28.5	47.1	16.5	28.4	25.7	27.8	29.0	24.3	30.4	22.0	2.1	95.2	77.8	10.1	35.2	35.0	49.0	14.6	18.8	27.9	13.8	39.1	8.8	20.6	67.3	34.8	7.1	15.1	60.9	33.3	26.4	16.6	51.9	8.4	8.4	14.0	71.2	31.5	27.6	22.6	41.3	34.1	37.4	7.5	86.7	100.0	95.8	9.5	14.3	29.5	10.4	46.3	32.6	19.3	11.2	23.6	28.8	34.5	32.9	48.0	24.7	162.3	183.5	20.6	22.4	55.7	59.9	33.9	19.3	20.1
RPA4	HSU24186	ENSG00000204086	"Replication protein A4"	Q13156	X	96883908-96885467	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 1.8;testis: 1.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.6;Syncytiotrophoblasts: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"									HPA066010	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA066010: AB_2685596"	"unprognostic (6.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.66e-6)"	"unprognostic (1.33e-1)"	"unprognostic (6.33e-2)"	"unprognostic (9.75e-4)"	"unprognostic (3.15e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.47e-12)"	"unprognostic (8.95e-3)"	"unprognostic (6.05e-3)"	"unprognostic (8.17e-2)"	"unprognostic (4.59e-2)"	0.4	0.1	0.3	0.0	0.5	0.2	0.2	0.0	0.4	0.5	1.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.6	0.2	0.1	0.4	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	1.6	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.4	0.1	0.4	0.0	0.1	0.7	0.0	0.7	0.0	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.9	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.7	0.6	0.1	0.3	0.4	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.5	0.3	0.0	0.5	0.7	0.4	0.2	0.4	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.4	0.3	0.3	0.0	0.3	0.5	0.0	0.4	0.6	0.2	0.1	0.0	0.1	0.1	0.2	0.2	3.3	0.0	3.3	0.0	0.7	0.8	0.3	0.7	0.6	0.3	0.4	0.5	0.1	2.8	0.8	0.0	0.0	4.6	1.6	2.1	0.0	0.8	1.1	0.9	1.5	2.0	3.6	0.0	0.0	0.6	1.1	1.3	2.6	1.7	0.0	3.4	0.4	1.9	1.9	0.0	0.0	2.5	4.1	2.2	1.1	1.0	1.5	2.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	1.4	2.9	1.5	0.3	0.4	1.1	0.1	0.1	1.6	6.6	3.5	1.0	20.6	6.7	1.1	1.3	9.9	0.8	1.1	1.7	0.2
RPAIN	"hRIP, MGC4189, RIP"	ENSG00000129197	"RPA interacting protein"	Q86UA6	17	5419641-5432877	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023924, HPA031526"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA023924: AB_10601890, HPA031526: AB_10601555"	"unprognostic (1.68e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (5.20e-4)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.00e-3)"	18.1	24.5	38.4	14.7	38.6	21.0	27.8	38.5	52.6	17.5	38.0	18.7	15.9	18.8	27.1	17.1	22.2	16.7	33.2	38.8	39.7	23.3	28.6	16.0	22.2	38.6	38.3	20.9	20.9	20.8	21.7	16.5	39.3	18.7	20.1	24.4	17.1	15.8	51.1	17.1	13.6	18.4	38.5	15.4	21.1	15.1	39.0	35.9	16.8	38.0	22.3	19.6	11.4	39.7	31.5	65.5	65.1	57.0	50.2	35.8	32.0	31.9	54.9	59.8	55.3	39.9	13.9	37.7	41.9	19.4	47.3	35.5	75.1	27.6	52.2	38.3	71.1	30.4	38.0	54.0	60.6	33.2	57.6	31.7	53.5	38.7	77.6	73.6	53.2	117.1	31.7	20.9	33.9	25.1	78.8	65.9	39.4	42.7	34.0	40.3	44.7	32.7	51.2	35.1	40.9	82.6	27.3	23.7	76.0	50.8	31.9	45.3	26.8	20.2	28.0	18.5	62.7	21.7	35.5	34.7	30.8	39.8	34.4	40.9	37.3	59.2	31.6	33.4	39.3	75.3	43.5	40.4	34.2	57.3	53.2	46.0	6.4	36.1	32.1	55.6	62.4	32.4	38.4	38.6	38.5	52.6	38.8	39.7	38.6	38.3	39.3	38.5	39.0	39.7	58.0	70.5	61.7	22.9	67.2	63.2	78.4	120.4	76.2	47.9	79.6	97.3	38.2	57.2	91.7	40.5	52.1	77.8	65.1	50.3	103.7	72.1	92.1	103.7	68.6	48.6	110.2	65.6	32.7	57.6	46.5	53.8	55.0	129.3	62.0	99.3	47.8	39.8	56.0	47.1	31.2	49.8	134.3	48.1	47.1	18.2	70.8	43.4	48.0	24.4	58.9	80.9	48.4	32.6	40.7	75.2	58.8	71.8	33.0	86.9	42.1	82.0	89.2	62.1	72.3	71.2	65.1	100.4	34.1	59.2	74.9	59.7	62.4	71.9	67.0	98.9
RPAP1	"DKFZP727M111, FLJ12732, KIAA1403, MGC858"	ENSG00000103932	"RNA polymerase II associated protein 1"	Q9BWH6	15	41517176-41544269	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041739	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA041739: AB_2677647"	"unprognostic (8.83e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (4.30e-3)"	7.0	5.7	4.9	6.1	5.4	3.5	5.1	4.4	5.2	5.4	3.7	7.2	5.7	6.4	3.2	8.1	6.7	3.9	6.7	5.1	4.2	4.0	4.9	4.7	7.2	5.0	5.1	8.0	5.9	7.2	3.9	5.9	4.8	6.1	4.6	2.8	7.0	5.6	19.0	7.0	5.2	6.6	4.7	6.5	6.1	6.5	5.0	6.9	5.2	11.6	6.8	6.9	5.3	5.9	13.3	15.3	20.8	21.9	17.1	12.3	17.7	12.8	11.0	16.4	15.8	42.3	11.7	10.3	20.6	14.2	26.1	30.5	37.9	18.7	13.8	18.3	18.5	19.6	21.2	18.8	10.7	16.3	11.9	12.6	23.3	19.2	13.3	11.0	18.4	23.1	46.4	11.5	15.2	8.3	17.6	10.0	36.9	20.3	14.3	31.4	18.0	11.2	7.2	30.5	19.0	25.4	16.4	16.9	8.8	18.0	28.1	20.0	16.9	25.3	16.4	25.5	20.6	19.2	57.5	11.6	18.1	17.4	24.4	0.0	1.9	0.0	4.6	2.4	4.0	2.9	2.6	2.8	2.9	3.3	3.7	3.4	0.0	3.1	4.4	1.9	3.1	2.5	4.9	5.4	4.4	5.2	5.1	4.2	5.0	5.1	4.8	4.7	5.0	5.9	4.1	3.2	5.4	10.4	7.7	2.8	4.4	4.6	8.6	10.2	5.1	5.2	9.0	2.8	4.7	5.5	12.5	6.5	6.1	3.9	1.9	5.5	1.5	3.7	6.5	5.8	2.4	11.2	7.7	5.3	5.8	6.1	8.6	5.2	2.5	11.9	5.0	9.6	4.8	16.8	6.7	5.6	6.1	5.2	2.8	1.7	3.7	3.5	1.8	6.5	6.0	5.0	5.2	7.5	9.3	5.3	2.7	9.4	4.4	6.7	4.1	3.0	5.2	7.4	0.0	6.5	4.6	10.6	9.5	6.1	4.1	2.7	7.0	10.8	7.5	3.1
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022260	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		130000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	21.9	27.6	15.9	20.1	20.0	19.4	25.4	18.3	21.7	19.7	11.9	24.0	21.8	22.6	22.3	29.1	21.0	19.8	14.5	16.2	14.7	30.0	27.4	17.9	25.1	11.0	13.3	25.4	15.1	21.0	17.2	29.4	12.8	22.5	31.8	17.8	20.6	31.1	11.0	19.7	19.8	29.3	14.6	19.2	24.2	15.3	16.5	22.9	29.5	27.4	29.4	27.4	17.4	23.1	62.4	81.0	47.5	47.9	71.3	68.0	85.4	80.2	60.9	67.9	93.1	118.7	92.1	39.9	50.6	58.8	104.1	59.9	69.7	81.9	103.3	49.7	47.8	78.2	112.3	112.3	98.8	80.7	56.1	51.7	75.4	83.2	107.5	60.2	94.8	39.1	79.7	57.2	55.5	106.7	43.5	63.5	68.2	121.4	59.8	52.4	58.4	56.7	78.6	94.7	56.6	31.4	70.2	63.7	52.3	85.6	54.4	85.2	80.0	96.7	66.9	47.5	73.8	31.9	49.5	88.6	69.6	76.0	62.5	20.2	40.2	19.1	23.1	51.0	19.8	20.2	17.7	21.7	69.5	21.6	23.4	21.0	3.7	77.2	34.8	25.4	26.7	28.8	15.9	20.0	18.3	21.7	16.2	14.7	11.0	13.3	12.8	14.6	16.5	23.1	14.9	6.4	7.5	14.4	13.1	16.6	15.2	21.6	13.1	13.2	13.2	10.3	6.2	10.0	20.1	18.4	20.9	35.4	18.1	14.0	31.3	24.5	10.7	13.5	17.4	14.3	10.2	17.2	61.9	17.5	42.8	17.4	14.3	11.2	6.3	18.1	18.2	17.5	37.0	10.1	44.7	14.6	14.2	19.4	45.8	11.8	11.1	17.2	14.2	15.0	19.7	8.9	26.8	27.2	39.2	19.4	11.6	14.7	12.2	19.9	14.2	48.6	15.9	12.7	6.6	11.1	16.1	14.7	17.4	20.1	20.3	25.6	10.5	24.8	21.3	14.8
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.1;Cone photoreceptor cells: 8.4;Ionocytes: 2.0;Rod photoreceptor cells: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA						"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.0	3.1	0.0	0.0	1.9	0.0	0.7	0.0	8.4	0.3	1.3	0.5	0.0	0.5	0.1	0.1	0.0	0.3	1.8	0.0	0.6	0.2	0.5	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.5	2.0	0.0	1.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.5	0.1	0.2	4.4	0.0	0.0	0.4	0.1	0.3	0.0	0.3	0.4	0.1	0.0	0.7	0.0
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 234.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	16.4	12.2	6.6	9.5	7.4	10.8	14.9	7.3	8.7	12.9	7.2	11.9	6.6	11.2	5.4	15.2	12.5	9.1	15.3	7.0	7.1	15.8	17.2	9.7	10.4	6.9	6.9	13.2	19.9	9.7	8.1	10.2	7.0	11.4	8.8	5.6	9.9	7.1	22.2	13.9	8.1	8.1	6.9	9.3	11.7	13.5	7.1	7.6	13.0	14.0	10.9	15.3	12.5	7.9	23.3	16.6	12.7	50.5	26.4	34.7	32.6	32.5	23.6	32.3	32.6	39.2	18.5	50.2	29.4	22.8	38.8	27.0	51.5	37.6	84.2	19.4	38.7	29.5	14.2	27.4	35.9	45.9	16.6	26.5	31.4	46.5	83.5	20.3	24.9	22.1	99.0	29.9	52.2	23.4	39.2	45.5	45.2	37.7	20.2	40.2	22.4	43.6	37.4	22.9	20.3	28.7	14.1	23.7	61.3	16.8	18.8	47.3	17.5	24.7	21.2	234.1	81.4	13.4	22.0	65.0	36.4	60.8	55.2	0.2	4.4	0.7	4.1	5.5	8.5	6.6	6.1	5.0	5.8	5.7	6.8	7.0	0.3	8.8	3.5	5.8	5.0	4.0	6.6	7.4	7.3	8.7	7.0	7.1	6.9	6.9	7.0	6.9	7.1	7.9	40.0	19.2	26.9	6.5	25.0	78.4	119.6	90.1	35.9	14.1	33.6	52.3	71.9	47.1	67.6	18.4	0.0	44.9	18.0	15.8	68.4	48.2	105.7	49.8	57.6	35.2	11.4	26.1	15.7	47.4	53.8	50.0	17.3	60.9	46.2	18.9	23.6	83.6	56.0	18.5	14.0	30.3	36.7	27.7	19.5	32.1	34.5	28.2	37.4	5.6	21.8	21.0	19.6	9.0	13.5	42.2	18.7	27.1	18.8	80.4	15.2	87.2	55.0	8.9	13.1	61.7	49.9	76.8	28.4	33.0	66.2	34.6	22.9	29.8	44.0	70.2
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691673-88750929	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.6"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 234.3;Erythroid cells: 167.9;Syncytiotrophoblasts: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		2500000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: AB_2683563"	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	17.2	11.0	7.4	19.6	7.6	89.6	16.0	8.3	8.9	13.4	8.0	22.7	22.1	13.2	9.5	24.1	14.6	11.7	16.0	7.3	8.2	10.6	7.8	12.2	28.0	7.8	7.5	13.7	17.9	7.4	8.2	33.8	7.5	8.9	23.0	4.1	15.9	8.1	29.9	11.9	18.9	12.5	7.8	19.2	18.9	9.6	8.0	40.4	9.7	17.1	32.4	16.5	12.5	7.9	29.7	17.0	33.7	26.9	23.4	23.9	73.8	16.1	15.1	26.1	17.8	61.1	38.2	150.1	34.3	18.7	35.8	17.7	42.4	13.5	40.9	71.9	55.3	60.2	11.0	60.7	23.7	111.5	42.4	22.1	11.2	23.3	35.9	13.0	37.4	78.7	65.7	25.3	24.8	46.5	123.4	97.2	30.7	97.6	27.7	63.5	40.1	36.8	21.7	47.1	24.0	27.4	19.4	24.8	39.3	18.3	13.5	45.3	21.4	15.5	40.7	51.2	46.7	19.7	17.2	149.3	15.9	99.4	22.5	10.6	16.0	36.4	16.9	16.7	21.4	31.4	23.5	25.1	22.7	23.5	33.4	27.8	3.9	21.9	21.9	10.9	22.0	20.6	7.4	7.6	8.3	8.9	7.3	8.2	7.8	7.5	7.5	7.8	8.0	7.9	38.9	12.8	13.2	4.6	43.2	37.3	21.3	31.2	21.6	8.7	22.2	18.2	13.7	14.3	22.7	20.2	2.1	234.3	37.1	20.6	9.8	21.7	8.1	28.0	23.3	35.0	19.2	167.9	13.3	34.2	98.9	23.5	31.1	43.2	21.6	30.7	24.3	7.1	43.8	13.5	15.7	26.9	26.4	23.1	33.9	4.0	19.9	23.7	40.9	11.2	32.4	5.2	60.8	13.6	13.3	22.8	28.1	18.8	35.8	41.7	20.6	18.7	10.1	4.8	19.7	19.8	18.0	28.4	33.4	37.6	40.9	225.6	38.8	37.8	58.5	43.7
RPL22	"EAP, L22"	ENSG00000116251	"Ribosomal protein L22"	P35268	1	6185020-6209389	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA068294			Approved	Nucleoplasm,Nucleoli		NA	NA		860000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoli	Nucleoplasm	"HPA068294: AB_2732781"	"unprognostic (3.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.98e-1)"	579.0	489.0	252.3	511.9	262.0	1064.4	599.4	258.1	400.1	716.0	257.9	573.4	475.0	513.3	313.9	621.7	590.5	220.4	390.9	243.7	261.0	473.0	480.3	396.9	659.8	256.3	250.3	1096.7	690.5	312.2	331.9	308.3	259.9	487.3	320.3	316.6	589.4	218.3	912.3	686.8	461.4	247.4	263.7	501.7	500.7	137.8	255.5	484.9	400.4	398.8	509.7	551.5	600.5	274.7	1443.4	400.8	836.4	858.6	576.1	897.0	659.0	1224.2	488.1	440.4	372.9	802.5	1213.4	2217.7	981.3	458.1	304.2	810.7	636.9	638.2	576.9	1093.6	1033.3	2159.0	948.8	1016.3	569.4	2893.0	828.4	799.9	516.3	393.5	808.6	907.3	560.1	610.3	1817.3	1301.1	512.9	634.7	1274.0	2340.3	522.1	953.0	880.1	1207.4	1731.8	1731.8	656.1	490.4	1149.9	1051.9	996.9	2846.8	2387.4	721.1	918.2	2247.5	1380.1	623.1	689.2	833.9	1170.4	1037.2	1544.9	3289.7	413.0	2911.2	395.5	109.0	297.7	71.2	268.2	270.0	474.9	547.1	502.6	373.2	451.6	500.6	679.0	560.8	22.0	337.5	227.9	472.2	416.3	664.1	252.3	262.0	258.1	400.1	243.7	261.0	256.3	250.3	259.9	263.7	255.5	274.7	1090.2	445.5	731.5	5.9	2372.5	1821.1	2035.3	1455.3	2241.2	217.6	1764.0	2190.8	277.9	1225.3	883.4	584.9	131.3	1816.1	1450.8	669.0	1905.6	1332.1	442.9	736.9	1377.2	1104.5	912.5	1508.9	15.3	1823.0	2751.0	1022.5	940.9	944.1	921.5	1256.6	1457.4	1491.7	1504.9	141.3	14.2	2032.2	449.6	1997.8	2098.8	320.1	2027.4	1440.8	1076.1	14.0	2435.3	890.1	1442.9	8.0	10.7	1575.3	1413.5	1234.1	1218.7	1837.3	1182.5	2505.6	437.3	390.8	775.7	1773.9	1169.1	358.6	473.0	2759.8	1935.8	1851.9	1791.5	1289.9	2231.0	2084.3
RPL22L1		ENSG00000163584	"Ribosomal protein L22 like 1"	Q6P5R6	3	170864875-170870208	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 651.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 912.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048060, HPA056207, HPA068294"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (5.13e-12)"	"unprognostic (5.12e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.96e-2)"	41.4	32.0	10.4	64.2	12.0	93.6	46.7	10.7	20.6	25.6	9.8	36.1	19.0	24.8	17.8	75.3	32.3	17.2	23.5	10.4	11.6	27.4	47.9	25.9	75.3	11.9	11.5	34.0	47.5	8.3	22.4	17.2	12.1	25.1	33.0	7.7	34.2	15.7	9.9	46.6	32.9	26.5	11.4	67.4	38.6	13.7	11.8	39.8	16.9	6.2	63.2	61.3	38.0	16.4	153.8	169.2	54.4	632.1	156.8	912.4	165.5	152.9	349.5	121.7	78.4	72.8	34.8	472.8	34.5	143.1	379.6	39.3	136.4	390.2	67.7	28.8	24.7	43.2	21.4	166.4	632.4	88.7	60.1	670.6	775.2	38.9	409.7	189.0	418.9	257.7	30.4	29.8	672.0	194.3	650.6	49.7	849.1	58.6	31.0	857.7	19.4	72.7	305.4	337.4	9.2	45.7	15.4	75.6	72.1	29.2	105.6	77.2	196.3	23.3	175.9	47.2	216.8	47.1	36.0	76.2	420.5	53.7	489.4	2.2	9.5	4.3	13.2	12.6	26.9	47.1	19.4	17.9	10.7	34.8	12.9	14.5	2.1	28.8	17.8	51.2	13.1	6.9	10.4	12.0	10.7	20.6	10.4	11.6	11.9	11.5	12.1	11.4	11.8	16.4	153.2	9.6	43.7	4.6	379.6	197.6	240.2	260.8	198.6	13.9	185.1	397.2	18.1	55.8	111.4	20.2	4.2	89.8	241.9	111.5	66.5	160.8	37.6	128.4	279.6	138.5	144.6	266.7	3.3	232.3	297.4	169.0	146.3	116.8	106.5	202.8	103.9	129.5	184.7	8.4	4.5	240.7	93.6	187.4	101.4	36.3	139.4	148.9	78.2	2.8	108.7	54.2	69.0	7.5	10.1	400.8	137.1	89.1	651.0	421.5	99.1	94.1	60.5	21.0	46.0	189.5	472.0	67.2	58.9	511.7	247.8	98.4	173.7	260.4	197.5	356.3
RPL27	L27	ENSG00000131469	"Ribosomal protein L27"	P61353	17	42998273-43002959	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes, Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA002649	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		170000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoli	Nucleoplasm	"HPA002649: AB_1079840"	"unprognostic (8.53e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.91e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (7.80e-8)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	1871.8	1549.8	1111.3	1009.9	1116.5	2929.2	1962.9	1098.5	1512.7	2052.8	1111.9	1884.1	802.3	1550.5	994.9	1984.2	1652.8	740.8	1495.4	1092.8	1126.1	1276.4	1316.9	1278.5	1999.4	1122.6	1109.6	2598.8	2232.2	850.4	894.8	951.0	1119.0	1483.8	894.1	394.5	1530.7	749.8	2544.6	2726.6	1467.8	854.4	1124.4	1802.0	1559.6	409.4	1127.1	1682.4	1067.7	1510.1	1378.5	1650.9	1820.8	1132.8	2288.0	2867.0	1701.7	2480.6	2983.9	4422.4	2741.5	2594.6	2162.4	2777.2	1979.1	4107.0	1751.0	4309.7	2143.3	2087.9	1477.4	1948.8	2000.9	3363.7	2670.5	1996.4	4741.8	1694.3	2147.4	4431.8	3669.4	4908.1	1698.9	4175.7	2847.4	1867.0	2381.3	2795.0	2356.9	2241.9	3237.8	2584.2	2618.6	2253.4	4127.7	4153.0	2577.8	2634.0	1821.4	2841.1	4775.1	4927.8	2374.2	3092.9	1909.6	2094.8	1016.8	1982.1	4341.5	2299.8	3341.2	5076.5	2617.1	2021.7	1988.7	2497.2	3885.7	2219.6	4004.7	4327.4	1816.5	3030.7	2107.7	1007.1	1762.8	553.5	1773.1	1633.6	2518.3	3055.1	2633.3	2095.8	2115.1	2792.7	2987.8	2673.6	358.7	2155.7	1284.9	2726.2	2059.6	4601.4	1111.3	1116.5	1098.5	1512.7	1092.8	1126.1	1122.6	1109.6	1119.0	1124.4	1127.1	1132.8	770.3	734.0	1103.9	11.1	2217.2	2530.2	2296.2	1759.2	941.8	138.9	1779.8	1725.0	725.8	1302.6	1175.0	518.6	89.6	2093.8	1873.8	948.5	1496.7	1822.6	435.6	524.0	1202.0	1245.7	912.0	1291.4	9.9	3028.9	3551.3	1025.1	510.7	660.9	991.3	983.7	1689.1	1859.0	2118.7	65.6	10.7	2016.4	671.4	2560.1	2977.0	1070.0	2434.3	1522.8	1426.5	22.5	3232.7	722.9	2669.4	7.5	16.3	2450.0	1585.4	1279.6	957.2	2462.7	1301.2	2383.0	574.6	230.6	867.8	1669.6	1874.7	384.8	476.4	1644.1	3371.3	2184.8	1833.0	1266.3	2175.4	2628.2
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306245-58324695	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.8;tongue: 39.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	5.1	5.7	3.1	4.6	3.2	4.8	5.0	5.9	4.1	4.6	2.0	6.8	6.8	5.5	3.7	5.9	4.9	4.2	10.9	3.2	2.9	9.1	11.5	4.1	4.0	3.0	2.2	5.5	6.1	7.7	5.9	4.0	3.1	4.7	6.4	5.1	4.9	4.4	40.8	5.3	6.9	7.1	1.7	5.8	5.4	5.1	3.1	6.5	5.5	39.0	6.0	5.2	5.0	3.4	12.3	10.4	11.5	8.2	6.6	9.0	12.3	9.9	11.7	14.5	17.1	15.9	8.0	13.8	2.4	14.4	13.7	7.2	17.6	15.8	14.8	10.6	8.5	12.0	11.9	8.4	7.8	24.4	10.7	8.4	12.1	18.6	16.3	5.2	12.1	18.2	12.0	7.8	14.3	6.5	16.2	7.9	11.9	10.5	17.9	6.8	8.4	14.0	9.6	18.9	6.9	11.8	10.2	9.8	11.9	7.3	11.0	8.6	11.1	10.4	11.7	10.5	20.4	13.0	28.3	22.3	11.2	17.1	6.7	2.1	3.4	2.6	2.1	2.8	3.0	2.1	2.7	3.2	3.9	3.0	3.2	3.5	4.0	5.5	6.0	3.9	1.8	2.1	3.1	3.2	5.9	4.1	3.2	2.9	3.0	2.2	3.1	1.7	3.1	3.4	9.0	9.6	11.9	6.2	8.2	31.2	8.1	21.1	17.1	26.3	8.2	7.6	28.4	7.2	11.8	3.7	25.0	8.4	9.4	14.9	11.7	5.7	0.8	8.2	12.4	10.6	9.6	7.6	18.4	6.2	5.9	11.5	13.3	8.2	3.8	11.5	11.4	21.3	6.2	18.5	18.2	11.8	16.2	11.0	20.0	1.7	12.5	9.7	23.2	13.1	9.2	13.2	7.2	10.6	11.2	7.8	7.6	9.8	14.2	8.1	16.2	11.4	9.7	28.3	0.0	14.1	13.7	11.9	15.3	20.4	43.0	10.3	9.2	15.0	13.7	6.5
RPP25	FLJ20374	ENSG00000178718	"Ribonuclease P and MRP subunit p25"	Q9BUL9	15	74954418-74956772	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 95.1;Hofbauer cells: 77.0;Rod photoreceptor cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 25.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 25.8;monocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.0;SCLC-21H: 42.9;SK-MEL-30: 67.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"olfactory bulb: 23.0"	HPA046900	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Centriolar satellite"	"HPA046900: AB_10962049"	"unprognostic (9.36e-2)"	"unprognostic (7.17e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (7.18e-2)"	"unprognostic (5.73e-3)"	"unprognostic (5.50e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.50e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.53e-1)"	6.0	13.2	7.4	2.7	8.9	0.4	4.5	14.6	8.5	7.1	6.5	7.9	7.2	3.7	1.8	6.9	4.4	4.5	5.5	4.9	10.8	5.1	3.1	5.8	3.9	16.5	12.7	15.4	7.6	23.0	5.2	7.2	16.4	4.2	4.8	12.8	4.6	1.7	1.4	4.9	5.7	2.5	10.8	10.8	7.1	3.0	12.8	2.4	8.9	1.5	3.4	7.7	5.4	12.7	23.6	17.5	4.4	0.1	1.5	0.9	7.4	4.3	5.2	1.3	1.2	24.1	21.0	0.0	19.4	4.4	1.2	6.9	13.7	0.8	0.3	8.9	0.7	0.1	19.9	0.5	46.0	0.0	13.3	5.9	0.6	8.5	0.0	0.9	20.4	5.5	16.1	0.0	4.6	9.1	3.8	6.3	20.8	40.9	7.0	0.1	0.0	15.8	4.2	0.4	42.9	32.1	32.6	28.8	67.4	2.2	5.7	18.7	4.6	0.0	1.4	3.8	0.2	0.4	0.1	0.1	2.3	36.6	25.1	0.0	5.2	0.0	2.3	10.1	1.3	3.4	1.5	1.8	5.1	3.7	3.8	3.0	0.4	0.5	7.7	25.8	0.7	2.5	7.4	8.9	14.6	8.5	4.9	10.8	16.5	12.7	16.4	10.8	12.8	12.7	5.3	3.2	1.1	0.3	4.9	11.0	7.5	9.1	11.4	95.1	11.8	9.9	1.6	14.3	6.4	9.2	4.2	2.3	17.0	24.4	13.7	13.7	0.3	1.6	4.7	8.9	10.2	0.8	0.7	19.3	4.3	23.9	14.8	3.6	0.0	3.4	31.8	1.6	77.0	21.9	10.0	12.5	14.2	14.8	8.6	2.6	39.4	9.3	14.2	1.0	16.1	13.4	4.1	0.0	6.3	13.8	20.5	30.1	8.2	19.1	27.5	16.6	1.3	72.3	13.1	4.3	10.4	1.4	6.5	18.2	11.5	2.3	2.1	26.6	20.7	10.5
RPP25L	"bA296L22.5, C9orf23, MGC29635"	ENSG00000164967	"Ribonuclease P/MRP subunit p25 like"	Q8N5L8	9	34610486-34612104	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 118.4"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 132.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052187, HPA059698"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA052187: AB_2681755, HPA059698: AB_2684106"	"unprognostic (1.56e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-1)"	"prognostic favorable (3.01e-9)"	"unprognostic (4.63e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.40e-1)"	"prognostic favorable (8.21e-4)"	17.2	23.2	30.5	13.8	31.7	9.7	18.3	32.7	36.2	20.6	28.4	26.4	27.5	19.9	12.5	28.2	20.1	14.5	46.8	30.5	31.5	30.6	51.4	11.8	20.7	31.9	30.6	19.5	23.0	24.0	17.4	12.2	32.3	24.5	14.4	4.8	23.1	15.1	118.4	17.5	26.4	10.5	30.8	26.5	21.9	16.0	33.0	22.5	18.5	103.1	13.9	20.5	18.5	30.2	42.6	54.0	21.9	21.4	21.4	20.2	21.5	18.1	18.5	28.9	33.1	24.3	28.2	32.8	27.1	11.0	13.5	28.1	33.2	44.2	10.4	66.1	44.5	19.5	37.9	36.2	46.1	20.5	28.3	35.2	42.4	24.3	55.3	25.1	30.8	44.5	31.6	34.1	22.7	45.8	42.9	76.4	20.1	43.4	48.7	37.2	23.0	33.2	31.9	22.1	14.6	8.5	32.9	36.6	21.6	10.8	33.6	35.7	14.5	9.1	26.3	22.3	15.1	16.4	30.8	38.6	27.6	41.3	44.7	71.2	55.6	56.4	38.2	48.5	47.3	57.1	44.5	40.3	47.8	67.3	51.8	49.8	51.9	56.6	57.5	39.3	68.4	39.6	30.5	31.7	32.7	36.2	30.5	31.5	31.9	30.6	32.3	30.8	33.0	30.2	12.9	0.0	15.1	6.5	20.7	11.1	50.4	61.9	24.5	7.8	30.9	39.9	34.4	22.8	30.5	20.2	2.1	61.8	14.4	55.7	99.7	31.0	3.3	10.3	21.5	17.5	33.6	12.6	3.0	19.8	38.1	18.4	17.9	13.7	10.2	16.4	27.1	77.5	32.0	0.0	3.9	44.7	38.7	33.6	10.4	6.0	22.4	18.4	12.4	3.7	33.1	25.6	51.5	2.0	3.4	18.9	61.6	15.4	14.7	40.8	132.7	82.2	21.0	12.3	6.6	18.2	18.8	50.3	24.0	30.6	14.8	41.9	17.4	47.7	50.1	44.4
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871952-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	19.2	13.9	7.8	12.9	8.8	25.9	17.3	8.2	10.6	14.1	7.3	15.3	9.3	15.8	14.1	18.0	14.9	12.7	22.6	8.8	8.4	16.3	15.1	13.1	21.0	7.1	7.3	18.1	11.0	23.0	8.0	18.5	7.6	12.1	15.1	13.2	14.5	12.2	31.1	17.9	12.4	16.4	8.3	15.0	14.3	28.6	7.7	21.7	12.2	22.2	22.4	17.0	14.2	10.6	82.2	53.2	55.0	66.5	34.4	37.6	19.4	57.0	51.1	93.3	98.3	90.6	64.1	48.1	42.6	36.4	60.9	56.0	73.9	50.5	95.3	77.2	51.3	32.7	31.1	73.0	33.0	66.7	39.1	30.9	32.4	70.5	79.1	39.6	54.1	43.5	65.7	42.6	62.6	50.8	77.4	89.8	33.9	46.4	59.8	42.9	46.7	50.4	35.6	38.2	29.9	29.9	33.1	23.8	68.2	50.0	64.8	41.3	31.2	46.3	46.3	26.5	119.6	28.7	79.4	104.4	57.9	35.4	36.4	9.2	30.0	27.1	25.2	30.7	27.5	31.7	28.7	28.0	35.1	28.1	24.6	27.0	3.5	25.4	26.2	32.8	33.0	27.6	7.8	8.8	8.2	10.6	8.8	8.4	7.1	7.3	7.6	8.3	7.7	10.6	31.4	32.1	16.9	14.0	28.7	34.4	27.5	51.8	23.9	19.2	16.7	28.2	45.7	27.1	31.4	14.7	18.8	60.6	33.7	9.4	31.3	41.9	95.9	18.9	26.1	25.2	19.8	38.5	18.0	35.0	68.1	28.0	13.3	17.9	23.5	33.3	21.4	14.3	58.1	16.8	19.4	21.0	30.5	23.9	29.3	49.9	28.9	24.7	23.2	11.2	32.2	23.3	15.5	17.6	19.6	31.3	12.5	29.3	20.6	18.8	12.5	36.5	21.6	24.3	39.5	30.1	36.9	77.9	54.2	20.2	34.0	33.8	23.7	28.6	17.6	27.6
RPP40	"bA428J1.3, RNASEP1"	ENSG00000124787	"Ribonuclease P/MRP subunit p40"	O75818	6	4994717-5004063	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Theca cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035685, HPA035686"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA035685: AB_2674734, HPA035686: AB_10670153"	"unprognostic (2.93e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.10e-6)"	"unprognostic (8.00e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (7.54e-8)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.19e-1)"	5.2	11.4	4.4	4.3	4.4	4.9	6.7	4.2	5.7	5.1	3.7	3.4	2.9	4.1	3.6	8.6	3.2	2.9	3.4	4.4	5.3	3.5	7.4	2.0	5.8	4.4	4.5	3.6	3.9	3.8	3.5	3.4	4.6	2.8	3.1	0.7	2.6	2.7	5.6	6.1	2.4	4.6	4.6	4.6	3.0	6.0	5.4	4.7	3.4	3.3	5.4	8.0	5.3	4.7	13.0	21.2	6.6	18.7	11.9	15.1	20.7	12.5	6.3	23.4	18.4	29.0	9.7	27.8	53.6	13.1	32.2	13.4	13.7	19.3	20.9	10.6	27.4	17.5	12.8	39.5	14.0	22.8	9.6	11.8	16.2	23.5	23.0	5.2	23.4	25.2	28.1	5.4	17.3	36.8	11.6	39.0	10.9	15.2	34.0	24.4	12.5	51.0	12.2	13.8	23.5	6.8	11.7	11.1	13.2	17.3	20.2	18.7	11.2	30.6	20.7	20.9	29.1	9.7	43.7	22.0	5.8	37.8	16.1	0.0	7.1	0.0	3.3	11.9	4.9	8.1	5.7	4.1	12.9	7.2	7.6	7.1	0.0	8.6	3.9	6.4	9.1	5.2	4.4	4.4	4.2	5.7	4.4	5.3	4.4	4.5	4.6	4.6	5.4	4.7	7.3	0.0	1.1	2.0	5.3	12.4	10.4	20.6	6.8	0.2	6.3	9.3	4.5	0.0	9.5	1.8	0.0	13.3	3.6	2.2	11.7	7.9	8.1	9.1	13.7	10.9	3.0	2.5	3.6	9.4	14.5	5.8	4.6	4.6	0.0	11.7	6.4	5.5	11.5	0.0	3.1	4.2	6.1	2.5	4.7	3.7	5.6	3.2	8.8	1.9	3.7	1.2	3.1	3.5	3.1	4.3	2.1	4.9	5.7	7.7	0.7	15.1	10.6	0.5	0.0	8.3	8.4	15.1	24.1	12.6	14.8	9.6	3.6	30.8	7.4	7.7
RPRD1A	"FLJ10656, HsT3101, P15RS"	ENSG00000141425	"Regulation of nuclear pre-mRNA domain containing 1A"	Q96P16	18	35984387-36067576	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 233.0;Late spermatids: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040602	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA040602: AB_10673137"	"unprognostic (2.06e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.92e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.95e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.30e-1)"	23.3	34.8	40.6	16.4	44.4	11.3	24.7	40.7	59.9	21.1	34.6	29.6	19.0	25.7	115.2	23.6	25.3	18.5	29.1	45.5	43.2	26.7	21.8	19.2	19.5	39.5	40.3	24.1	23.4	26.1	27.8	17.8	40.0	29.6	20.5	41.5	28.3	28.9	54.7	20.9	19.0	21.3	41.4	22.3	21.3	28.0	42.6	19.9	32.1	46.5	19.3	27.6	20.0	44.4	31.6	34.1	57.0	60.8	30.6	35.8	35.5	55.6	54.5	31.7	44.5	9.4	34.2	44.1	57.2	40.7	16.9	51.2	64.1	56.3	44.7	39.2	36.6	46.9	48.9	37.0	53.9	78.9	24.3	27.6	73.7	30.2	85.4	39.8	46.0	51.5	42.8	46.7	41.1	39.3	42.4	33.3	45.9	16.2	24.4	34.7	18.3	70.8	48.4	66.9	99.1	83.4	46.5	25.7	48.3	46.2	35.2	55.9	56.4	33.0	20.6	17.7	46.0	52.5	77.6	45.0	33.6	64.1	33.9	0.7	4.7	2.2	2.9	6.3	4.4	5.0	4.0	3.4	7.8	5.4	5.0	4.0	3.5	7.0	4.2	5.4	2.3	3.3	40.6	44.4	40.7	59.9	45.5	43.2	39.5	40.3	40.0	41.4	42.6	44.4	19.0	32.1	20.7	54.9	40.6	34.4	35.9	23.6	54.7	49.6	29.9	22.2	39.4	17.2	21.0	35.0	31.3	17.1	28.7	13.6	27.4	21.0	233.0	36.3	30.2	23.1	28.8	24.6	105.0	19.9	17.6	19.0	25.0	52.5	13.3	50.7	20.7	29.3	9.8	37.0	91.0	16.7	22.4	20.1	24.2	362.4	22.1	18.8	30.2	58.1	18.1	32.2	18.6	84.9	98.5	20.4	25.2	23.0	33.1	41.5	17.8	26.2	20.3	50.8	13.1	26.1	27.0	39.5	42.2	45.2	38.2	14.6	21.9	51.9	22.2	38.2
RPRD1B	"C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60"	ENSG00000101413	"Regulation of nuclear pre-mRNA domain containing 1B"	Q9NQG5	20	38033725-38127780	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 72.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066290, HPA070590, HPA072645"	Enhanced		Supported	Nucleoplasm		NA	NA		28000	"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA066290: AB_2685650, HPA070590: , HPA072645: "	"unprognostic (3.14e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.47e-1)"	13.3	12.4	8.9	12.3	10.7	35.2	14.1	11.8	10.4	14.5	9.1	12.3	10.2	16.3	12.4	14.5	16.5	10.8	23.6	7.6	11.7	14.5	72.5	12.0	21.7	9.5	9.0	13.7	12.8	17.3	10.9	11.9	10.1	15.1	12.8	18.1	12.2	12.1	34.8	14.4	13.3	12.7	7.4	13.8	12.4	13.3	9.4	16.3	15.0	25.9	29.8	17.5	12.5	13.6	29.6	14.4	28.4	13.0	18.8	25.2	28.3	21.3	20.4	27.9	23.7	70.7	30.8	27.0	27.5	17.0	26.1	34.2	26.3	40.3	33.3	11.1	13.3	44.1	18.6	39.0	22.6	35.0	13.9	20.1	40.0	27.9	34.0	19.0	17.3	28.8	36.9	20.4	21.6	23.0	49.3	27.5	14.1	37.0	29.6	28.3	56.7	26.7	15.0	27.5	28.0	19.7	38.0	60.0	27.8	18.1	29.7	33.7	17.0	46.0	28.8	18.5	24.8	26.8	26.9	48.1	27.8	21.1	15.3	0.6	5.8	5.8	4.6	6.6	5.7	3.4	4.4	4.1	6.0	3.2	5.5	5.1	4.6	3.9	9.0	2.9	2.9	5.0	8.9	10.7	11.8	10.4	7.6	11.7	9.5	9.0	10.1	7.4	9.4	13.6	13.6	16.0	21.9	20.5	16.2	15.8	12.0	9.8	13.1	16.4	22.7	16.9	49.3	17.2	11.8	18.4	18.8	14.7	12.8	15.7	15.6	7.6	9.4	11.9	17.9	16.2	23.4	17.4	28.6	8.6	12.4	18.0	16.8	14.8	13.3	18.5	24.3	87.9	12.3	18.5	26.3	20.7	4.1	22.7	9.5	10.3	10.5	18.4	10.6	21.5	9.7	10.3	4.1	30.7	41.1	9.8	11.6	13.2	17.4	23.7	17.1	17.4	22.4	19.1	6.6	19.1	14.7	15.2	12.3	19.1	18.6	15.6	14.8	18.3	14.5	19.8
RPRD2	"FLJ32145, HSPC099, KIAA0460"	ENSG00000163125	"Regulation of nuclear pre-mRNA domain containing 2"	Q5VT52	1	150363091-150476566	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 132.9;Inhibitory neurons: 133.8;Oligodendrocyte precursor cells: 136.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061693	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		66000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA061693: AB_2684587"	"unprognostic (1.68e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.38e-1)"	10.8	11.4	6.1	10.8	7.4	13.7	12.0	17.4	11.0	16.0	3.2	13.2	10.6	18.9	14.2	14.0	21.1	10.7	13.2	7.3	8.1	16.0	11.4	12.9	13.6	4.2	5.3	29.8	14.5	19.2	10.7	9.8	4.3	14.3	14.5	17.4	14.0	16.2	24.5	12.8	12.1	17.8	3.8	14.0	11.9	14.1	7.7	19.5	23.0	22.8	15.7	12.7	11.3	7.9	24.6	18.4	23.9	24.3	24.3	20.5	22.6	17.4	20.7	18.8	18.4	16.1	29.4	38.8	19.5	21.4	10.4	26.6	34.0	25.9	20.4	17.9	14.2	22.3	21.2	19.5	17.4	33.8	26.3	21.8	19.3	26.2	34.4	20.9	23.5	23.2	22.1	40.9	19.3	35.4	29.8	10.9	30.0	30.9	20.6	27.0	17.7	39.4	27.7	22.4	25.4	25.6	35.6	30.0	22.6	21.2	23.7	29.5	21.7	17.3	17.8	14.6	24.9	24.9	29.5	28.7	17.2	24.8	17.4	5.8	2.9	3.5	5.6	1.8	5.1	5.4	5.3	4.5	2.6	5.2	6.1	6.2	1.4	3.9	7.3	3.1	7.0	2.4	6.1	7.4	17.4	11.0	7.3	8.1	4.2	5.3	4.3	3.8	7.7	7.9	18.7	19.2	25.9	97.3	30.8	15.4	10.5	17.1	25.0	35.0	22.0	19.8	27.6	17.2	24.5	33.1	16.7	14.0	27.2	20.6	7.9	14.6	11.0	31.8	30.1	21.6	25.8	16.8	132.9	12.9	9.1	23.4	16.8	33.5	17.7	28.5	26.0	27.1	14.7	11.8	133.8	22.1	18.3	22.6	10.5	6.6	37.9	16.6	10.6	56.2	18.6	22.9	27.8	136.2	112.2	14.1	17.7	39.9	29.6	16.4	21.6	30.8	29.9	29.8	32.9	37.1	20.6	21.1	21.3	26.4	14.6	10.0	27.6	27.3	22.3	16.9
RPS19	"DBA, eS19, LOH19CR1, S19"	ENSG00000105372	"Ribosomal protein S19"	P39019	19	41860255-41872925	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063217			Supported	Nucleoplasm		NA	NA		260000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA063217: AB_2732699"	"unprognostic (8.02e-3)"	"unprognostic (9.04e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.96e-2)"	"prognostic unfavorable (2.32e-8)"	"unprognostic (1.16e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	1929.6	1900.6	1567.9	1417.3	1592.2	2933.3	2052.3	1529.9	2038.1	2531.8	1544.4	2004.3	1389.8	1628.2	679.3	3488.9	2151.1	766.0	1349.4	1501.4	1560.9	1424.1	2262.6	1640.4	2271.7	1631.4	1548.2	3787.9	3981.7	585.6	1015.9	818.9	1606.1	2231.8	1105.1	370.4	1748.9	760.8	1573.4	3885.1	2168.6	767.5	1626.1	2909.0	2099.7	639.3	1585.0	1825.5	1516.5	728.6	1869.1	2025.4	2512.4	1619.6	3536.2	4978.2	3109.1	2770.4	3924.8	5205.4	3456.4	2731.6	3132.5	3378.6	2982.1	3854.2	2341.3	5185.2	2985.2	2483.1	1670.6	1819.8	2701.4	4647.3	1563.5	2183.2	5098.9	2626.1	1471.5	4029.3	6775.6	4355.4	2564.0	7419.1	8959.5	2132.0	3942.4	5453.7	3421.0	4849.8	2911.6	3476.5	2845.7	4010.8	3975.9	3021.3	3619.2	9954.1	2087.6	4372.0	2503.1	2511.1	3188.1	3714.9	2216.7	2693.9	1539.3	4915.7	3951.2	4649.7	2787.7	6840.6	2694.1	2157.5	3396.5	1451.9	4383.8	3886.3	4520.6	5054.3	2348.3	3672.5	2498.9	1309.9	5303.2	586.8	9147.6	9536.3	13783.0	18138.6	13464.4	11872.3	8174.5	17813.4	15114.7	13788.0	724.9	12054.7	12053.9	11257.8	11367.1	30500.3	1567.9	1592.2	1529.9	2038.1	1501.4	1560.9	1631.4	1548.2	1606.1	1626.1	1585.0	1619.6	2154.8	1644.2	2318.8	17.6	7536.2	13338.7	9463.4	12098.6	8008.7	295.5	11387.2	17068.7	680.0	2778.1	4886.7	1430.8	127.2	6635.1	4648.2	1753.9	2641.3	4446.2	482.4	1178.2	3145.6	3665.9	2227.6	2708.0	15.4	8576.4	9609.3	2834.8	2442.4	1645.3	1825.2	4566.6	3793.4	3258.5	4591.9	136.3	20.2	4777.7	3497.2	6041.3	8631.8	1752.6	4036.7	4053.7	4557.0	52.5	5989.0	991.8	4541.7	13.6	42.4	7669.3	4181.6	1892.7	4036.1	8714.9	4183.2	3284.5	1889.5	479.3	1584.3	3428.0	5508.3	608.5	1952.5	7919.1	16952.4	6534.4	6030.8	3718.5	6131.8	8160.5
RPS19BP1	"FLJ21770, MGC52010"	ENSG00000187051	"Ribosomal protein S19 binding protein 1"	Q86WX3	22	39529093-39532761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042874	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA042874: AB_10793988"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.65e-1)"	"unprognostic (5.68e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.32e-2)"	98.5	123.0	122.2	43.1	124.5	61.7	94.6	126.7	159.0	73.5	115.9	117.1	43.5	65.5	31.5	94.2	65.6	19.3	114.6	121.2	119.7	123.1	158.5	80.4	48.0	126.5	124.2	68.9	109.6	47.1	66.5	30.2	123.7	108.1	19.2	23.9	94.4	42.8	104.7	80.0	78.3	19.7	124.8	100.5	101.5	65.8	128.4	40.5	96.7	45.4	34.6	99.9	73.7	123.9	94.8	117.6	54.5	80.4	60.7	39.7	110.8	102.0	87.3	92.5	74.0	131.1	62.1	118.9	107.4	64.5	74.8	73.8	87.8	111.3	32.2	163.8	261.5	110.0	105.5	118.0	88.2	166.8	142.3	60.1	83.1	80.3	96.8	49.4	64.9	87.6	128.0	83.8	61.0	108.0	80.6	164.1	95.1	210.9	209.5	127.3	70.0	182.0	99.7	95.8	121.2	66.9	85.8	137.3	203.1	33.6	98.8	134.8	74.0	77.5	168.8	85.7	141.7	140.3	145.4	188.4	103.3	116.8	183.1	126.8	147.4	187.3	133.0	141.6	123.5	159.7	135.1	140.6	122.4	173.9	129.9	132.8	168.7	128.9	119.4	193.1	165.1	138.3	122.2	124.5	126.7	159.0	121.2	119.7	126.5	124.2	123.7	124.8	128.4	123.9	113.6	44.8	51.4	13.1	109.5	137.1	94.3	124.3	84.2	98.0	178.6	205.7	73.8	105.8	83.0	97.5	52.1	152.9	114.7	205.5	217.2	174.9	23.6	68.6	69.8	121.0	142.6	83.5	8.7	192.2	231.9	92.0	76.0	81.6	69.8	62.0	116.0	184.8	204.3	35.3	10.9	207.5	130.2	116.4	233.3	40.3	137.0	110.8	108.5	8.4	147.8	139.1	162.7	5.5	18.7	233.5	202.2	126.0	193.3	206.8	274.9	362.2	54.0	103.7	78.9	74.4	100.9	61.6	138.0	87.6	147.9	131.6	115.2	103.1	165.9	132.4
RPS6KA1	"HU-1, MAPKAPK1, p90Rsk, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.1;monocytes: 81.2;NK-cells: 88.6;Proximal enterocytes: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.6;U-937: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	7.4	17.0	7.8	17.5	9.1	23.8	8.3	9.2	9.3	6.0	11.2	37.9	33.1	3.0	1.2	16.9	7.9	5.5	3.8	7.9	9.1	26.2	10.5	33.7	20.2	10.8	9.5	1.9	19.4	12.5	13.4	4.0	10.1	17.2	20.7	1.4	21.5	4.5	1.7	17.8	51.4	3.6	9.4	47.1	20.6	5.4	10.4	11.4	24.5	1.9	20.7	9.0	9.6	11.6	27.1	9.3	7.5	9.9	0.4	0.1	9.9	2.2	4.2	11.0	10.6	10.8	21.9	50.2	11.9	1.3	13.3	31.0	16.9	61.0	7.8	41.8	11.0	55.3	21.6	19.5	3.4	65.8	77.6	1.8	22.1	10.1	18.0	5.0	4.9	19.7	9.6	17.7	0.6	15.0	2.4	64.3	19.1	52.2	29.2	34.8	9.5	22.0	31.7	7.3	10.7	4.4	18.7	17.5	8.4	7.8	11.2	55.5	3.2	0.5	13.9	1.8	9.2	10.9	14.0	27.5	6.5	86.8	10.8	37.6	57.9	131.2	24.2	52.1	20.3	14.2	17.9	21.6	68.8	15.7	11.3	15.8	108.2	26.4	58.4	26.9	19.0	65.2	7.8	9.1	9.2	9.3	7.9	9.1	10.8	9.5	10.1	9.4	10.4	11.6	2.8	16.0	25.0	0.0	23.7	18.6	8.1	19.9	16.5	1.5	12.0	10.4	1.3	11.5	7.7	9.2	4.2	1.6	53.9	91.1	7.9	16.3	1.9	19.9	2.2	6.9	16.3	29.5	1.4	18.7	17.5	1.8	18.3	20.7	31.8	3.3	7.9	3.4	47.5	0.0	2.6	41.6	12.2	53.0	14.2	1.4	0.0	44.1	1.8	12.2	81.2	0.6	88.6	1.0	12.3	28.1	41.9	0.0	14.2	18.8	93.3	17.2	13.6	1.8	6.6	0.8	2.7	1.6	3.4	10.9	11.6	4.1	36.3	2.0	43.6	9.1
RPS6KA2	"HU-2, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.6;Excitatory neurons: 204.1;Horizontal cells: 287.7;Inhibitory neurons: 552.3;Oligodendrocyte precursor cells: 244.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 26.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"eosinophil: 22.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 214.5;ASC TERT1: 156.1;HHSteC: 158.5;HSkMC: 141.4;hTERT-HME1: 173.0;hTERT-RPE1: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	34.2	9.0	40.3	8.0	41.0	10.5	27.8	35.0	35.2	18.1	8.6	16.6	6.1	26.0	7.1	20.1	18.7	18.2	61.8	37.8	42.1	13.6	6.6	45.1	7.5	48.3	41.7	29.2	19.4	49.6	27.2	17.9	42.0	14.9	10.3	28.9	14.7	14.2	24.1	16.4	16.5	22.7	35.3	26.0	21.4	7.7	47.3	5.9	36.3	30.5	7.3	24.5	14.9	49.3	9.1	0.0	17.9	26.0	214.5	156.1	0.4	19.3	37.4	10.6	14.6	0.0	5.8	1.1	6.2	68.2	8.4	8.2	9.4	41.8	9.4	4.2	2.3	0.1	40.2	0.4	158.5	0.6	7.2	141.4	29.4	56.6	173.0	316.2	58.0	19.2	0.2	0.2	43.6	1.9	0.8	2.1	4.5	9.1	10.5	3.0	9.2	27.3	11.1	10.1	9.8	68.8	6.7	17.9	24.8	4.4	0.5	14.3	21.7	37.3	3.7	103.8	5.6	5.2	8.4	2.6	24.8	1.2	36.0	0.2	0.6	22.4	0.6	0.8	0.3	0.3	0.6	0.3	0.8	0.5	0.7	0.3	0.5	4.4	2.2	4.7	0.5	0.4	40.3	41.0	35.0	35.2	37.8	42.1	48.3	41.7	42.0	35.3	47.3	49.3	60.9	22.4	46.2	399.6	2.7	4.7	5.4	4.6	3.4	37.1	7.1	5.0	60.0	15.7	11.6	36.8	8.4	0.2	8.0	1.9	11.7	15.2	14.8	20.6	4.6	58.2	5.4	0.0	204.1	24.0	0.3	16.3	16.8	20.3	2.5	10.5	45.3	11.9	7.2	287.7	552.3	5.3	2.0	6.0	6.7	69.3	5.3	8.0	19.6	144.3	3.5	10.1	1.0	244.8	97.7	26.8	1.7	4.5	2.4	9.9	0.3	7.0	9.4	17.1	13.1	10.0	14.5	3.5	2.3	1.2	3.4	0.3	2.0	9.5	1.4	6.6
RPS6KA3	"CLS, HU-3, MRX19, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 236.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	21.1	18.8	6.9	33.7	10.2	16.2	14.8	12.7	12.8	16.1	8.5	32.8	24.1	17.5	8.5	18.7	15.1	26.9	21.1	8.7	9.4	19.5	45.0	32.3	31.3	8.4	10.0	10.6	17.2	59.4	5.9	19.5	8.5	19.9	31.8	15.7	13.2	18.0	51.8	15.0	27.6	27.8	8.7	29.2	21.1	5.5	10.6	32.9	21.2	40.3	32.6	34.2	8.5	8.0	44.9	77.0	28.4	14.8	27.1	47.3	8.6	38.0	57.4	27.8	37.7	87.7	56.2	29.3	12.8	40.0	40.5	30.9	32.8	32.2	51.1	24.8	26.1	34.6	46.2	236.8	27.7	67.8	34.2	30.3	25.1	43.5	54.4	24.3	101.9	30.4	23.1	81.0	29.4	21.2	44.2	20.7	20.6	57.8	45.9	23.3	60.0	33.8	23.9	36.9	13.1	12.8	51.1	15.3	54.4	35.3	0.1	20.0	57.3	30.1	20.8	96.3	21.7	64.3	42.1	32.1	56.9	33.1	72.6	11.9	3.8	7.9	4.7	5.3	8.3	2.4	5.4	5.2	5.6	3.2	3.7	4.5	5.8	6.6	6.0	6.7	2.9	2.2	6.9	10.2	12.7	12.8	8.7	9.4	8.4	10.0	8.5	8.7	10.6	8.0	60.6	44.8	67.5	31.6	34.8	54.4	37.0	21.2	10.2	37.8	20.4	10.8	22.9	34.3	41.1	16.5	22.9	4.0	70.0	63.5	3.9	26.3	0.4	10.8	24.0	61.1	25.0	19.1	142.2	30.5	6.7	31.6	24.5	26.1	44.3	8.3	34.6	65.4	22.6	13.5	108.4	59.1	28.5	40.8	104.3	1.5	13.1	62.6	37.4	126.5	53.7	27.5	46.4	116.6	27.0	37.4	57.9	21.1	25.5	56.6	33.5	25.1	23.3	9.7	19.7	41.5	21.3	6.4	8.7	13.8	55.5	3.6	66.0	14.2	61.1	63.8
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.0;dendritic cells: 75.0;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 10.5;monocytes: 2.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	15.0	13.1	14.8	11.8	16.1	10.9	12.5	17.0	17.9	13.7	10.5	16.8	9.8	16.5	2.8	31.0	12.0	4.7	16.2	15.3	13.7	14.2	12.0	16.4	12.0	14.7	14.7	8.5	12.2	3.3	6.8	11.7	14.7	13.1	5.6	2.1	12.5	5.6	16.0	22.8	17.1	6.8	14.4	25.0	15.8	3.5	15.1	5.7	10.2	5.0	9.5	16.6	14.6	14.3	76.1	41.5	5.9	15.0	12.8	11.9	84.0	39.4	20.6	30.2	14.9	41.7	38.8	7.9	44.9	22.9	38.6	69.1	7.1	32.1	14.7	24.1	14.0	17.8	36.8	21.6	12.8	18.0	32.0	12.0	29.7	25.7	20.9	10.9	18.4	14.2	7.4	10.6	15.6	69.2	16.6	28.4	6.5	29.2	88.1	31.8	24.4	25.3	21.1	34.4	8.7	6.9	40.7	24.8	35.6	8.5	28.6	22.3	37.0	41.0	51.7	74.7	35.9	12.5	10.4	7.8	27.0	20.6	21.2	1.3	2.7	1.4	0.7	2.1	0.7	0.4	0.5	0.6	2.2	0.2	0.3	0.3	0.2	0.2	1.3	10.5	0.5	2.6	14.8	16.1	17.0	17.9	15.3	13.7	14.7	14.7	14.7	14.4	15.1	14.3	11.8	3.2	3.0	8.5	6.4	12.1	6.8	8.6	8.6	7.3	5.4	4.8	15.2	7.2	5.4	3.7	4.2	70.0	75.0	25.2	5.9	20.1	0.8	3.5	8.7	9.9	8.4	9.9	6.6	25.2	38.2	9.3	26.0	7.6	19.1	5.7	10.8	7.8	29.6	8.4	5.3	14.3	2.0	30.5	13.2	1.5	11.1	25.8	8.8	11.2	26.6	3.6	10.3	4.5	5.4	65.1	12.8	6.8	5.7	10.2	16.2	8.4	3.1	2.1	0.0	6.0	10.2	0.7	6.5	13.9	10.7	46.7	11.3	7.5	19.9	9.6
RPS6KA5	"MSK1, RLPK"	ENSG00000100784	"Ribosomal protein S6 kinase A5"	O75582	14	90847861-91060641	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 162.0;Oligodendrocytes: 156.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001274, HPA001780, CAB025458"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (4.20e-4)"	"unprognostic (3.70e-2)"	"unprognostic (5.80e-4)"	"unprognostic (6.70e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.38e-4)"	"unprognostic (5.73e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.75e-1)"	2.6	0.9	2.4	2.9	7.8	3.3	7.5	14.7	3.7	3.1	1.0	6.6	3.7	4.9	0.3	5.3	4.1	2.8	2.6	1.6	3.0	1.9	1.7	2.8	3.4	4.1	3.8	4.6	1.5	3.0	2.6	3.4	4.1	3.1	5.1	3.0	4.9	4.3	9.0	3.7	4.9	3.9	2.9	3.1	5.4	2.4	4.5	5.0	4.0	9.9	3.5	5.4	4.1	8.0	1.3	2.1	2.7	1.4	0.0	0.5	9.4	0.9	1.3	2.9	4.1	1.2	2.7	6.7	2.8	2.8	1.8	4.7	2.2	1.8	5.1	1.0	3.5	7.5	1.8	0.4	0.0	7.1	31.8	0.8	4.3	1.7	1.3	0.7	3.2	5.1	0.7	7.1	2.9	3.1	2.0	2.2	0.9	4.6	3.4	3.3	11.2	3.2	3.2	2.9	10.4	3.2	2.7	14.8	8.1	1.8	3.0	1.9	0.6	0.8	1.5	0.6	3.4	2.8	3.5	5.9	1.7	5.0	10.6	16.9	3.0	9.0	3.7	2.5	6.1	4.5	4.6	3.5	2.7	5.8	5.5	3.0	19.8	10.4	3.5	1.2	7.9	2.6	2.4	7.8	14.7	3.7	1.6	3.0	4.1	3.8	4.1	2.9	4.5	8.0	13.2	19.2	26.5	80.3	53.7	40.4	45.2	20.4	53.5	32.9	41.4	42.9	20.7	14.3	22.7	7.3	16.7	43.7	21.0	36.7	0.0	11.1	9.1	96.2	19.0	21.4	16.3	22.5	65.4	5.1	6.5	21.8	13.3	162.0	92.2	32.5	20.3	6.5	7.1	26.9	32.5	17.3	4.1	17.6	13.4	3.1	14.0	21.8	19.6	53.4	21.2	10.5	23.7	36.7	156.1	3.5	13.0	11.7	26.0	29.3	41.9	3.7	31.3	32.1	13.1	51.9	22.3	21.2	23.7	35.5	46.3	111.8	48.6	7.2	20.8	52.7
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84188199	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.3;Inhibitory neurons: 70.7;Oligodendrocyte precursor cells: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.1;PC-3: 7.9;RH-30: 9.9;SH-SY5Y: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.4	2.0	2.6	0.5	3.1	0.1	1.7	3.2	3.0	2.0	2.6	2.9	1.2	1.7	3.1	0.8	2.2	1.1	0.6	2.7	3.4	5.7	0.6	0.6	0.2	2.7	2.4	2.6	0.9	7.0	5.8	0.3	2.2	2.8	2.3	7.0	1.7	2.7	1.6	2.0	1.3	1.0	1.5	0.4	1.7	1.5	2.4	1.0	8.1	0.4	0.3	1.3	1.4	2.0	0.0	2.4	2.6	0.0	2.4	2.2	0.0	5.2	2.7	2.3	1.9	1.9	2.0	0.0	0.0	2.6	0.0	0.1	6.4	4.6	5.1	0.0	3.5	0.0	0.1	0.0	2.7	0.0	0.0	1.4	0.0	0.0	2.4	3.0	0.6	0.0	0.0	0.1	2.0	0.0	1.1	0.1	8.1	0.0	7.9	0.0	9.9	0.0	0.5	5.4	0.0	9.4	0.0	3.4	0.0	3.8	1.4	0.0	0.0	0.1	2.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.0	2.6	3.1	3.2	3.0	2.7	3.4	2.7	2.4	2.2	1.5	2.4	2.0	0.3	9.6	2.7	6.2	0.7	0.3	5.3	0.3	3.4	21.1	3.6	3.4	2.6	12.8	1.9	18.4	25.0	2.6	0.1	6.7	1.9	0.5	0.7	1.9	1.2	1.2	25.0	2.7	75.3	1.2	0.7	2.2	2.0	0.9	0.0	21.8	1.1	1.3	0.2	1.7	70.7	3.6	0.0	0.0	0.0	0.4	4.4	0.5	0.0	3.7	0.1	2.1	1.0	31.2	5.8	1.3	3.4	6.0	0.0	9.2	1.8	4.3	3.7	18.2	0.0	4.9	1.5	8.4	6.2	2.5	0.4	2.3	0.9	2.0	6.5	5.2
RPS6KB1	"p70(S6K)-alpha, PS6K, S6K, S6K1, STK14A"	ENSG00000108443	"Ribosomal protein S6 kinase B1"	P23443	17	59893046-59950574	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"MCF7: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003838, CAB018346, HPA039442"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510"	"unprognostic (2.25e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.35e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.09e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.52e-3)"	14.0	11.3	7.1	11.9	7.8	18.0	13.3	11.8	9.8	11.8	9.4	10.7	10.0	13.8	10.1	16.3	10.2	9.4	10.6	7.2	6.6	9.8	15.2	9.9	14.2	7.3	7.0	14.9	16.9	14.9	7.4	15.4	7.5	10.6	11.0	10.9	9.4	10.2	22.7	10.6	9.3	14.3	6.2	12.4	11.1	6.9	7.5	15.2	11.9	18.3	17.3	14.9	11.0	9.6	34.5	33.5	27.5	26.2	18.1	26.2	20.8	31.2	28.3	26.3	29.3	27.6	16.8	41.7	37.9	25.4	32.1	17.3	36.0	27.3	42.7	23.3	41.5	28.7	21.2	31.2	26.9	44.5	27.1	26.7	20.7	31.0	22.8	21.9	35.0	26.0	38.5	25.9	19.7	243.6	53.2	18.4	18.6	29.8	24.9	30.8	46.7	38.8	21.9	25.1	20.1	23.8	26.2	15.2	16.6	31.7	29.7	24.2	31.1	25.8	42.9	21.2	42.0	46.2	42.0	46.3	19.4	26.7	21.2	43.8	12.1	11.4	12.7	12.2	15.5	10.4	11.6	14.7	15.3	9.4	13.5	14.3	11.5	11.9	14.4	9.5	11.9	10.3	7.1	7.8	11.8	9.8	7.2	6.6	7.3	7.0	7.5	6.2	7.5	9.6	22.8	22.4	34.2	29.0	32.6	33.0	21.4	13.0	30.7	18.0	23.1	17.8	16.8	12.8	30.4	3.7	18.8	24.3	33.5	12.4	3.9	12.9	5.1	24.0	31.7	25.5	13.2	11.8	47.3	16.4	18.2	24.8	26.0	37.7	23.4	20.0	13.6	15.1	12.1	18.5	45.2	14.1	4.1	15.2	20.4	3.8	15.8	19.0	10.6	28.1	20.0	12.8	18.6	25.6	54.8	15.1	10.9	18.0	34.6	27.9	9.3	9.2	21.1	18.9	26.3	33.4	32.6	13.0	13.7	34.5	32.0	30.5	29.9	26.0	13.9	25.4
RPS6KL1	"MGC11287, RSKL2"	ENSG00000198208	"Ribosomal protein S6 kinase like 1"	Q9Y6S9	14	74903951-74923302	"Enzymes, Predicted intracellular proteins"		"Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.3;Cone photoreceptor cells: 83.4;Horizontal cells: 40.4;Rod photoreceptor cells: 73.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 17.5;SCLC-21H: 25.1;SK-BR-3: 19.7;U-266/70: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027451, HPA027794"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA027451: AB_10599304, HPA027794: AB_10602098"	"unprognostic (2.71e-2)"	"unprognostic (9.33e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.49e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.52e-2)"	3.7	4.5	22.4	1.1	23.1	3.0	4.1	21.6	29.4	1.9	17.6	6.7	2.2	4.1	4.8	2.9	2.5	1.8	13.7	23.4	21.2	4.8	4.2	2.5	1.4	20.8	21.3	0.9	7.9	1.3	18.8	0.5	20.5	3.8	3.2	20.6	3.1	3.0	19.1	2.3	3.1	4.0	19.3	3.2	2.5	13.9	21.7	0.6	4.3	4.2	1.1	3.4	1.7	22.9	3.3	0.5	1.3	4.4	0.2	0.0	6.3	0.7	0.2	1.6	0.4	5.8	2.4	0.1	4.5	1.1	0.7	0.4	1.9	0.1	1.6	0.0	0.6	2.7	1.2	4.8	5.7	3.2	17.5	0.5	3.5	2.3	0.0	0.0	7.9	0.0	3.2	0.9	0.1	10.7	0.1	1.1	1.3	1.0	5.1	2.0	0.1	9.7	2.3	0.0	25.1	3.8	0.4	19.7	3.4	2.7	1.5	2.1	5.8	0.1	0.2	4.0	0.0	13.8	8.1	6.9	1.8	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.3	0.7	0.8	0.0	0.0	0.0	2.3	0.0	0.1	22.4	23.1	21.6	29.4	23.4	21.2	20.8	21.3	20.5	19.3	21.7	22.9	2.6	0.0	0.0	10.4	0.9	0.8	2.7	1.2	0.6	72.3	4.3	3.9	6.1	0.0	0.8	3.7	83.4	1.7	2.0	2.4	1.9	1.3	7.7	0.8	0.6	2.6	6.7	5.2	24.5	6.2	1.7	1.0	0.5	0.7	0.0	0.7	1.1	2.6	3.7	40.4	19.7	2.1	4.1	0.3	1.3	7.4	2.1	1.0	3.6	3.7	0.0	5.0	3.1	15.6	15.1	3.8	1.6	2.6	0.5	2.1	1.5	1.9	4.5	73.6	6.6	3.8	3.1	27.0	22.9	1.2	1.3	1.4	1.0	1.5	3.1	1.6
RPUSD1	"C16orf40, MGC19600, RLUCL"	ENSG00000007376	"RNA pseudouridine synthase domain containing 1"	Q9UJJ7	16	784974-788397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041144, HPA041938"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions, Cytosol"	"HPA041144: AB_10794265, HPA041938: AB_10795601"	"unprognostic (1.51e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.07e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.25e-2)"	"unprognostic (8.07e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-1)"	11.8	12.9	12.3	9.7	11.9	13.5	12.0	11.2	21.1	11.0	6.8	14.9	9.8	13.1	3.1	18.7	10.6	4.7	12.0	12.5	10.0	13.0	15.3	9.5	11.3	12.9	10.7	9.2	16.1	4.5	11.2	4.2	10.9	14.6	2.5	2.2	15.2	5.1	11.2	18.1	15.6	3.6	9.7	21.9	17.0	7.2	12.4	8.3	11.0	3.1	5.3	13.1	11.8	11.6	28.2	32.5	7.8	35.7	6.8	7.9	36.2	22.9	13.0	29.4	21.3	76.4	25.8	38.9	24.3	11.1	20.6	47.2	18.1	23.1	5.3	35.7	74.0	19.2	52.1	28.0	10.9	35.8	31.1	11.7	21.9	25.4	6.7	8.7	20.4	22.6	45.7	17.1	10.2	89.2	44.8	37.4	40.0	13.0	55.4	79.0	21.0	80.5	10.9	17.0	40.8	29.4	26.4	42.7	26.1	4.6	22.0	43.9	23.3	29.1	37.9	30.9	33.6	27.2	29.6	45.7	14.1	27.8	24.5	16.5	14.8	13.7	12.7	13.7	12.6	10.2	10.7	14.1	17.0	12.0	10.7	11.1	9.2	13.4	13.6	15.8	14.8	13.1	12.3	11.9	11.2	21.1	12.5	10.0	12.9	10.7	10.9	9.7	12.4	11.6	9.4	3.2	3.3	3.6	12.9	15.9	3.5	13.2	10.8	42.0	12.8	13.3	4.4	5.7	5.2	9.2	2.1	20.5	13.7	23.0	7.9	19.5	0.4	4.7	7.1	8.1	13.2	6.3	6.0	26.9	25.7	6.8	17.9	8.2	0.0	10.9	9.3	5.1	19.6	1.7	4.2	11.5	10.2	5.7	7.0	1.8	6.8	9.0	14.2	1.9	19.2	11.1	23.7	1.5	3.5	29.9	16.6	6.4	19.5	6.3	21.1	10.2	3.4	3.8	13.1	3.6	9.4	3.6	11.4	11.5	16.8	14.6	11.9	13.3	20.7	5.0
RPUSD2	"C15orf19, C18B11, FLJ31409, PUS9"	ENSG00000166133	"RNA pseudouridine synthase domain containing 2"	Q8IZ73	15	40569299-40574949	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042079, HPA042194"	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Microtubules"		"HPA042079: AB_10794643, HPA042194: AB_10794416"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.63e-7)"	"unprognostic (7.27e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.75e-2)"	5.1	8.9	5.7	4.8	6.2	9.7	5.8	5.8	6.4	6.6	6.2	7.5	4.8	9.2	5.3	7.1	7.2	2.4	9.5	5.6	5.6	8.0	8.9	4.5	6.7	5.4	5.6	7.7	5.3	5.3	7.9	3.7	5.8	6.5	4.0	2.5	7.7	4.7	14.5	9.5	7.0	3.6	4.9	8.0	6.3	6.1	5.5	6.1	6.1	7.6	6.2	6.2	5.2	6.0	10.4	11.5	9.6	16.0	8.1	6.1	18.2	9.0	10.8	15.4	12.2	14.3	6.4	9.9	12.8	10.5	14.1	27.7	22.3	15.9	8.7	11.5	15.3	17.1	15.9	17.1	12.1	14.7	12.1	8.6	14.7	10.1	13.8	7.1	9.7	16.1	21.9	11.4	7.7	12.3	17.7	18.6	12.4	15.0	12.4	22.3	10.7	15.3	10.0	8.9	10.9	12.6	12.3	13.8	7.6	7.9	13.2	19.9	6.0	10.5	12.3	13.7	10.5	11.8	25.2	27.3	9.2	22.9	8.4	0.1	6.4	5.6	23.4	8.0	21.3	28.2	22.6	24.9	12.5	35.5	26.8	22.5	0.7	33.6	18.4	16.5	26.3	14.4	5.7	6.2	5.8	6.4	5.6	5.6	5.4	5.6	5.8	4.9	5.5	6.0	5.7	6.4	2.6	2.3	10.4	10.6	16.4	11.5	10.8	11.7	6.4	8.6	8.2	8.6	7.0	7.3	16.7	15.7	9.3	5.4	25.4	9.6	2.1	5.4	5.7	5.7	13.2	8.2	2.8	10.9	9.3	7.6	6.6	4.6	4.5	9.0	3.6	9.1	7.1	18.5	2.9	6.2	12.2	2.2	3.1	1.7	7.2	2.6	3.6	1.0	3.4	15.6	7.2	4.0	3.1	6.5	5.0	10.1	8.9	9.0	4.9	13.2	9.9	16.0	13.1	11.6	8.1	7.1	15.1	9.6	10.7	5.6	7.3	12.4	8.5	8.0
RPUSD3	MGC29784	ENSG00000156990	"RNA pseudouridine synthase D3"	Q6P087	3	9837849-9844602	"Predicted intracellular proteins"	"mRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 249.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037551, HPA037552"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA037551: AB_2675538, HPA037552: AB_10672600"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.83e-2)"	18.8	28.8	25.1	13.2	25.4	21.3	19.8	24.3	31.3	20.3	22.0	25.3	17.6	21.5	14.7	32.3	20.0	8.7	37.2	26.5	25.4	24.7	30.7	16.1	17.4	23.8	24.1	17.8	24.5	26.1	20.3	16.7	23.8	19.9	16.5	15.5	19.9	17.4	72.7	27.4	20.1	16.7	21.6	21.0	22.8	54.3	25.3	15.2	16.0	48.2	21.3	24.2	21.0	26.0	30.5	44.8	33.6	21.7	55.1	40.5	249.3	25.9	36.7	41.9	44.3	39.4	30.6	52.4	31.6	29.0	61.7	25.6	75.2	46.3	33.2	40.7	78.9	69.8	39.6	42.5	43.1	43.5	42.3	50.0	63.3	48.9	56.5	34.2	55.9	69.3	52.7	35.4	41.9	72.0	59.6	78.9	36.4	44.4	66.3	41.5	27.5	88.5	46.2	23.0	25.9	21.5	32.6	41.0	69.9	47.9	70.3	46.3	33.6	16.7	30.0	29.8	38.4	52.3	67.4	70.0	35.1	81.3	39.5	35.4	51.0	26.5	44.1	38.2	45.7	50.3	41.4	42.3	46.8	41.9	46.3	41.7	12.3	84.9	26.7	45.0	64.9	41.5	25.1	25.4	24.3	31.3	26.5	25.4	23.8	24.1	23.8	21.6	25.3	26.0	11.8	19.2	9.6	10.1	19.5	8.0	21.4	27.8	13.1	22.8	17.1	21.5	25.4	21.5	20.8	14.7	20.9	44.3	19.8	16.4	46.9	31.1	80.3	6.9	13.7	15.8	13.2	24.6	9.9	31.6	48.6	16.3	15.8	9.7	21.0	20.1	22.1	28.3	39.1	11.8	10.6	17.0	12.2	14.7	7.3	59.5	21.5	15.2	16.0	3.7	27.2	20.6	54.6	8.0	6.3	25.8	20.6	21.4	18.8	19.5	28.1	55.4	12.9	22.2	6.6	13.3	17.2	100.7	20.6	22.3	12.8	17.2	20.5	33.9	28.6	16.2
RPUSD4	FLJ14494	ENSG00000165526	"RNA pseudouridine synthase D4"	Q96CM3	11	126202096-126211692	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.5;tongue: 75.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039689	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Nucleoplasm	"HPA039689: AB_10673537"	"unprognostic (2.02e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (3.16e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.47e-2)"	14.8	12.7	10.2	9.8	10.4	10.6	14.0	10.5	11.2	13.8	10.7	12.1	10.4	12.6	7.7	15.1	12.9	8.1	27.2	10.5	10.4	11.8	20.5	9.4	13.8	10.2	10.2	18.3	26.8	7.8	8.8	6.8	10.5	11.5	10.1	6.1	14.4	7.0	135.5	17.1	12.1	9.2	10.6	14.4	20.0	8.8	10.5	13.2	10.1	75.2	15.5	12.4	13.4	10.5	15.6	14.0	17.0	19.7	24.5	34.3	12.5	16.2	22.7	16.6	15.1	46.4	27.3	35.7	16.8	14.1	23.7	25.1	40.3	25.8	17.3	32.4	23.9	84.1	15.0	40.5	18.3	42.5	17.1	29.8	35.0	18.4	22.9	24.8	33.4	28.8	51.8	25.1	20.2	13.5	26.6	46.3	18.4	49.3	29.1	31.0	25.2	33.3	25.7	19.8	29.3	20.5	21.5	29.7	16.7	17.0	46.2	21.9	20.9	18.6	13.3	15.4	19.9	10.1	12.4	30.7	8.8	47.2	19.7	1.6	12.7	1.4	15.9	11.7	19.6	14.4	18.0	14.3	16.3	14.5	20.4	16.8	0.9	14.3	14.0	7.0	18.1	13.3	10.2	10.4	10.5	11.2	10.5	10.4	10.2	10.2	10.5	10.6	10.5	10.5	10.0	3.2	8.4	6.8	15.3	27.5	20.4	13.2	17.1	9.9	13.1	9.1	35.4	12.8	7.4	7.3	8.4	14.0	12.3	7.2	9.8	12.3	1.8	6.7	7.1	11.9	15.5	6.7	7.0	19.6	17.1	10.2	10.7	7.4	5.7	15.2	13.6	11.3	13.3	11.8	8.4	10.7	2.0	15.9	8.7	2.3	9.6	8.6	10.6	8.4	21.0	5.3	14.4	6.6	7.8	13.5	7.4	8.6	12.4	17.4	15.6	14.5	7.0	8.2	6.6	15.6	9.9	10.3	16.7	13.2	24.0	13.3	13.1	18.3	18.8	14.7
RRAD	"RAD, REM3"	ENSG00000166592	"RRAD, Ras related glycolysis inhibitor and calcium channel regulator"	P55042	16	66921679-66925536	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 305.8;skeletal muscle: 769.7"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 302.0;Endometrial ciliated cells: 477.6;Glandular and luminal cells: 245.5;Respiratory ciliated cells: 214.9;Skeletal myocytes: 179.2;Smooth muscle cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HDLM-2: 194.2;U-87 MG: 51.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041755	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA041755: AB_2677655"	"unprognostic (1.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-3)"	"unprognostic (3.46e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.80e-3)"	56.5	18.1	4.1	5.5	6.4	4.7	24.4	16.8	14.6	34.6	12.0	16.3	3.4	21.0	1.7	101.2	35.2	11.9	305.8	5.0	5.3	45.0	5.1	52.3	4.0	4.2	6.0	18.8	2.5	1.7	14.4	32.6	4.2	18.4	1.1	2.5	29.4	3.5	769.7	19.9	10.9	6.3	4.9	2.8	13.9	6.7	5.6	1.7	13.7	28.3	3.2	27.4	32.9	6.3	0.1	8.5	0.2	0.1	0.0	0.8	0.3	4.9	0.5	0.8	4.2	2.2	5.9	0.2	4.8	0.3	1.5	0.4	0.2	0.3	0.7	194.2	0.3	0.0	0.3	2.1	8.0	0.0	0.6	2.3	0.9	14.3	0.2	3.3	0.0	0.1	0.2	3.8	0.6	0.2	0.0	0.5	0.7	0.0	0.3	0.6	0.2	0.0	0.9	0.1	0.3	0.6	4.5	0.0	0.0	0.7	0.0	0.5	0.0	0.4	0.5	0.3	0.4	6.2	0.2	0.5	51.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	6.4	16.8	14.6	5.0	5.3	4.2	6.0	4.2	4.9	5.6	6.3	17.0	70.5	150.0	3.3	33.6	9.4	3.7	11.3	4.0	21.4	10.7	15.9	302.0	0.0	18.9	68.0	10.4	4.1	22.5	9.7	23.5	47.4	1.6	477.6	36.7	18.1	10.7	0.0	0.8	3.2	8.2	39.4	10.7	245.5	34.2	26.4	0.7	0.0	1.4	1.7	1.0	7.8	14.2	1.9	36.2	0.7	0.6	24.6	23.2	1.9	0.6	2.4	0.0	0.5	0.6	55.3	5.0	5.3	59.5	30.7	3.4	11.3	214.9	3.2	111.7	179.2	232.6	1.7	5.2	148.1	10.1	5.6	12.4	0.5	6.9	2.6
RRAGC	"FLJ13311, GTR2"	ENSG00000116954	"Ras related GTP binding C"	Q9HB90	1	38838198-38859772	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 224.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018247, HPA055489"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Vesicles"		"HPA018247: AB_1856475, HPA055489: AB_2682832"	"unprognostic (2.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (9.97e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-2)"	37.0	16.9	18.0	16.6	19.2	30.2	25.2	20.0	19.4	17.1	16.4	21.5	18.7	16.1	14.0	24.9	13.9	17.7	21.6	17.6	20.4	24.5	18.5	19.3	20.5	20.4	21.3	21.6	14.2	24.0	10.0	28.5	21.3	14.9	17.0	16.1	14.2	16.9	17.4	29.8	16.2	21.9	19.5	17.3	15.1	17.5	19.8	18.8	16.7	18.9	21.8	19.0	18.1	21.3	37.0	16.6	21.3	23.3	110.7	74.6	33.0	33.7	68.6	44.8	47.2	12.7	23.9	23.0	18.9	52.6	71.8	21.7	40.1	22.2	36.8	37.6	28.3	22.1	19.2	14.7	135.6	26.0	23.9	66.7	55.2	48.0	61.9	35.4	47.5	24.5	22.9	44.9	65.7	10.2	19.0	14.7	27.2	15.9	28.0	18.1	37.6	15.6	31.6	42.5	11.1	16.5	27.0	20.0	73.2	47.5	18.3	19.5	42.5	54.3	22.4	60.0	29.2	35.0	60.5	26.8	50.5	29.1	28.8	0.5	2.4	5.5	1.7	2.3	2.9	3.3	2.6	2.2	2.3	3.6	2.2	2.1	5.9	1.7	1.8	8.4	2.5	1.6	18.0	19.2	20.0	19.4	17.6	20.4	20.4	21.3	21.3	19.5	19.8	21.3	31.2	32.1	28.0	6.5	42.1	111.9	47.1	19.2	40.9	20.0	31.0	25.0	22.2	24.3	16.1	12.9	12.5	84.9	38.4	30.3	11.7	55.7	56.3	32.0	26.6	34.3	14.4	24.0	7.4	48.1	57.7	39.4	12.2	42.9	16.5	16.9	35.7	14.2	72.1	38.7	8.3	10.3	20.3	34.4	65.0	49.8	30.7	49.2	53.4	9.4	63.3	43.4	10.3	7.5	15.8	47.0	14.0	37.2	20.1	47.3	21.5	30.4	15.0	22.8	19.7	28.1	37.5	24.7	28.5	46.1	140.5	224.1	23.3	18.6	12.2	51.1
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364616-89412273	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 129.1;Distal tubular cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 63.9;SCLC-21H: 33.1;U-266/70: 80.0;U-266/84: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Centrosome"	"HPA068664: AB_2686016"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	9.8	9.1	14.0	2.3	18.9	11.6	8.2	31.8	16.1	9.4	17.9	4.0	1.7	1.5	6.9	13.8	13.7	3.6	38.4	15.9	13.9	26.5	4.4	7.0	2.8	16.4	12.2	1.6	6.4	22.7	11.4	3.2	17.2	6.1	1.8	21.8	52.2	2.8	84.5	6.7	2.0	2.1	21.5	4.8	1.7	6.9	14.8	5.5	28.1	60.3	2.5	5.8	6.2	23.8	0.1	1.7	4.4	3.3	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.1	0.1	0.0	1.5	0.0	22.6	0.1	24.5	0.1	0.0	0.0	12.1	5.8	0.1	0.1	1.8	16.9	19.0	0.4	1.5	0.0	0.1	0.0	0.0	16.9	0.5	63.9	0.1	1.8	8.2	8.4	3.6	0.0	1.8	16.8	23.1	0.2	5.8	0.6	33.1	1.8	0.6	2.2	28.8	1.3	0.7	13.2	0.0	1.8	2.8	11.5	3.0	80.0	39.8	0.0	6.1	12.5	1.9	2.6	0.6	1.4	0.0	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.3	3.3	0.1	2.4	0.3	0.0	0.1	14.0	18.9	31.8	16.1	15.9	13.9	16.4	12.2	17.2	21.5	14.8	23.8	1.4	9.6	16.7	5.2	3.7	16.2	17.0	5.8	4.0	21.7	17.4	9.7	129.1	17.2	13.9	14.7	31.3	0.6	4.7	0.1	117.4	20.2	25.6	10.4	2.5	4.8	1.2	5.0	17.6	16.9	1.5	10.0	1.1	15.0	4.5	2.9	2.5	9.7	51.9	47.1	20.6	0.5	42.7	25.8	9.2	15.5	3.1	23.2	39.2	3.7	10.4	29.6	0.0	13.0	17.2	8.1	0.0	4.1	8.0	28.4	0.0	18.6	19.4	16.3	0.0	11.8	7.0	21.7	30.3	32.4	22.6	0.7	3.9	0.2	0.2	30.2
RRAS2	TC21	ENSG00000133818	"RAS related 2"	P62070	11	14277922-14364506	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010420, HPA050942"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB010420: AB_2253855, HPA050942: AB_2681285"	"unprognostic (6.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (7.80e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.50e-2)"	"unprognostic (4.15e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	30.8	14.1	8.0	16.1	8.0	5.2	21.2	9.7	10.7	21.7	14.9	22.3	20.8	19.7	9.2	15.4	14.2	11.9	44.4	12.0	10.5	39.3	39.1	22.9	28.3	7.0	8.1	18.3	18.2	17.2	8.5	29.4	8.0	20.1	18.7	12.1	18.0	19.3	40.8	12.1	39.5	18.0	6.3	16.3	17.7	25.1	10.4	14.4	29.0	34.0	37.7	23.4	14.0	6.3	89.3	38.2	35.7	30.8	122.0	121.1	52.8	309.1	160.7	260.5	328.1	78.0	108.7	102.2	46.8	209.0	84.3	97.1	61.0	110.8	260.5	88.7	49.6	6.8	21.5	62.4	133.6	0.3	0.7	129.5	205.0	104.2	331.2	106.5	131.7	24.8	45.9	0.2	229.3	43.5	21.5	5.6	98.3	18.2	31.4	19.0	118.5	1.9	133.7	48.8	9.7	18.4	74.7	46.0	42.5	119.9	30.6	6.2	303.1	139.6	74.0	272.1	85.1	0.2	0.2	48.4	56.0	0.1	29.0	2.1	0.0	0.0	5.5	0.0	2.4	11.8	1.0	2.8	0.0	6.6	0.5	2.1	0.4	3.8	0.0	0.2	0.0	0.9	8.0	8.0	9.7	10.7	12.0	10.5	7.0	8.1	8.0	6.3	10.4	6.3	6.6	19.2	18.9	14.4	57.8	69.3	76.2	17.7	23.9	5.5	22.6	13.7	31.5	40.0	20.6	18.4	0.0	36.5	31.2	30.5	23.5	46.5	55.2	25.8	16.0	15.2	19.1	3.2	32.8	18.4	58.0	29.7	12.8	34.7	8.9	15.6	13.6	33.4	8.2	13.5	35.4	16.0	14.2	2.4	12.0	45.2	16.4	2.3	26.6	9.4	2.0	21.7	56.7	28.6	4.9	57.1	30.1	11.3	22.0	120.3	89.9	112.9	15.0	10.1	19.7	20.7	21.4	39.5	42.1	20.3	49.9	29.0	29.5	13.3	20.8	96.5
RRM2B	p53R2	ENSG00000048392	"Ribonucleotide reductase regulatory TP53 inducible subunit M2B"	Q7LG56	8	102204502-102238961	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, DNA replication"	Oxidoreductase	"Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006854, HPA028812"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"CAB006854: , HPA028812: AB_10602246"	"unprognostic (7.76e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.17e-2)"	11.5	21.2	10.5	11.5	12.1	7.1	12.1	13.6	11.5	12.5	26.5	15.3	15.0	11.6	15.1	11.2	13.5	11.9	16.7	10.1	13.7	24.4	22.6	22.0	20.1	13.6	12.4	12.0	13.5	45.0	10.3	13.8	13.9	15.7	15.5	21.9	10.9	13.8	30.4	11.0	10.1	11.7	14.1	14.3	9.5	9.7	12.6	10.1	39.9	34.9	19.6	11.2	5.4	16.8	15.3	26.5	30.7	18.3	43.7	41.3	24.6	34.8	41.4	18.1	21.0	9.6	11.9	97.5	31.8	38.7	18.5	5.7	15.1	35.2	25.3	15.8	16.2	24.4	10.3	20.9	35.3	7.6	50.0	53.1	66.1	20.2	30.5	43.0	51.8	16.3	18.2	14.6	59.1	15.2	13.1	14.6	17.7	16.5	19.2	8.2	12.7	20.1	43.1	17.1	7.8	15.4	17.9	9.7	21.1	76.3	25.5	17.1	39.4	27.8	53.7	19.6	9.6	15.3	15.3	88.0	41.0	11.5	30.2	15.7	6.3	7.0	2.7	5.4	3.8	6.6	2.3	3.2	7.7	8.6	2.6	2.8	23.1	4.1	11.5	2.2	1.8	3.3	10.5	12.1	13.6	11.5	10.1	13.7	13.6	12.4	13.9	14.1	12.6	16.8	16.2	57.7	29.3	10.1	33.5	19.4	8.2	11.8	34.1	13.5	17.0	9.4	22.8	20.0	23.9	40.5	14.6	13.8	13.9	7.3	25.4	6.8	2.3	36.2	11.1	14.9	29.4	3.8	14.6	8.2	5.9	14.8	6.1	11.8	11.4	11.2	18.5	23.6	12.6	10.1	17.6	9.7	10.2	26.2	39.5	1.4	14.3	23.8	17.8	20.6	18.2	24.5	7.2	16.1	12.1	5.7	5.7	14.7	9.3	10.7	8.1	22.7	39.9	18.3	6.6	16.2	16.8	13.2	14.5	26.2	18.5	4.8	12.2	8.6	12.1	6.7
RRP15	"CGI-115, KIAA0507"	ENSG00000067533	"Ribosomal RNA processing 15 homolog"	Q9Y3B9	1	218285293-218337983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024639	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Mitochondria"	"HPA024639: AB_1844368"	"unprognostic (2.68e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.65e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-2)"	4.0	2.6	1.7	3.3	1.7	4.1	4.7	2.5	2.4	3.0	1.4	3.0	2.1	3.7	2.7	3.0	2.9	1.9	4.9	1.8	1.9	3.4	3.5	2.8	3.7	1.4	2.0	3.8	2.9	4.5	1.8	3.6	1.6	3.1	2.9	2.2	2.6	2.4	9.6	3.5	2.4	3.4	1.5	2.9	2.6	2.4	1.8	2.6	3.5	7.7	3.5	3.9	2.8	1.9	9.8	7.2	7.9	5.7	5.6	7.8	6.7	9.8	7.3	10.0	7.2	14.1	8.8	14.0	13.1	7.6	6.7	8.7	13.5	13.0	16.6	5.7	10.1	10.9	6.6	7.8	11.6	17.0	5.6	5.4	7.8	13.1	17.4	4.4	6.6	6.5	22.7	4.4	11.4	8.9	11.3	8.3	15.7	7.8	14.8	7.8	4.9	13.8	8.0	8.9	9.0	13.1	8.3	15.3	15.0	9.3	11.0	12.1	9.3	8.0	7.6	14.3	18.3	5.4	8.9	14.4	9.1	8.1	13.1	0.3	0.8	0.1	1.6	1.3	2.3	2.4	2.0	1.4	1.2	2.3	2.6	2.6	0.2	1.6	1.1	1.7	1.3	0.7	1.7	1.7	2.5	2.4	1.8	1.9	1.4	2.0	1.6	1.5	1.8	1.9	33.7	32.1	28.1	7.5	36.0	65.3	33.6	28.7	24.5	31.1	32.6	31.0	68.4	22.8	25.0	36.8	10.4	38.1	32.7	13.5	27.4	39.7	17.0	22.6	47.3	27.9	12.1	41.0	18.4	52.2	59.1	32.2	19.9	28.5	31.0	18.6	21.8	44.2	33.6	26.9	16.1	20.8	6.1	17.3	18.5	4.6	37.6	17.4	21.4	7.5	20.8	21.2	24.7	7.5	9.0	36.8	9.0	24.8	13.0	34.9	5.2	37.2	11.7	23.6	26.3	72.1	33.0	59.7	69.1	24.3	47.6	18.1	26.4	20.4	32.1	23.0
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659560-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 131.3;Early spermatids: 213.2;Late spermatids: 222.8;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	8.8	5.9	7.9	12.2	8.9	6.2	9.1	7.0	7.8	7.2	5.9	7.2	6.7	9.1	5.5	8.6	9.1	6.1	4.9	7.4	7.2	4.9	8.7	6.7	17.4	7.8	7.9	13.1	10.2	7.2	4.3	5.8	7.2	7.5	7.3	28.4	10.2	6.8	12.1	8.8	6.4	8.8	7.4	11.0	7.8	12.0	7.8	16.1	6.5	8.8	14.8	9.8	6.5	8.6	52.5	30.4	31.8	48.1	20.2	21.5	26.0	27.0	19.3	29.3	24.0	69.4	22.2	101.9	17.2	21.5	33.9	22.8	78.9	46.5	34.6	34.6	62.8	60.3	34.8	43.9	27.9	95.0	22.9	22.4	29.2	35.1	40.3	18.1	33.1	43.2	96.0	29.1	26.1	27.4	76.1	28.9	108.4	33.7	33.4	98.7	32.1	71.2	21.2	24.8	62.7	33.6	50.6	36.9	37.9	11.7	24.2	29.4	29.7	9.0	28.3	24.0	49.8	39.1	53.8	119.3	28.5	100.7	30.1	2.0	2.5	0.7	6.2	2.5	7.3	5.6	7.9	7.5	3.0	4.3	7.2	8.6	0.1	5.8	2.2	2.4	6.6	5.5	7.9	8.9	7.0	7.8	7.4	7.2	7.8	7.9	7.2	7.4	7.8	8.6	15.5	32.1	16.4	8.8	32.7	22.8	17.7	15.0	28.5	30.3	13.8	11.0	13.4	17.2	21.0	5.5	131.3	8.6	27.1	5.7	1.9	17.0	213.2	10.5	28.8	19.1	5.4	23.7	19.0	15.6	17.0	18.9	14.8	10.8	36.0	25.5	12.8	18.4	18.7	25.2	20.0	9.2	6.1	13.9	12.7	222.8	22.4	13.4	8.8	21.5	17.0	17.9	35.0	18.6	22.2	20.9	3.7	26.7	48.5	23.6	6.8	9.9	16.7	143.5	0.0	29.9	18.1	26.3	33.6	32.0	31.7	4.4	35.7	32.6	16.5	17.4
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021623-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	30.0	34.6	19.4	27.4	19.7	28.7	28.7	21.5	23.2	26.0	19.8	29.0	20.8	25.5	22.9	37.8	23.2	19.0	30.1	20.3	22.3	35.1	37.3	25.5	32.3	21.3	20.9	18.4	35.8	34.7	31.9	24.2	22.0	28.5	24.3	16.6	27.1	25.0	51.3	34.3	25.9	29.7	20.8	33.3	30.6	17.7	21.0	31.1	23.4	34.8	35.2	30.0	26.4	20.8	141.5	77.9	75.8	111.3	79.7	74.0	63.6	108.9	97.7	136.1	132.6	141.9	59.8	64.7	86.3	113.8	100.1	73.5	127.7	131.8	149.3	82.5	129.9	104.1	82.7	153.2	92.3	87.5	77.7	75.6	79.0	163.0	69.1	48.7	112.2	57.6	128.2	68.4	127.8	148.1	106.0	95.6	84.3	249.7	79.6	98.7	74.7	74.9	83.2	130.5	96.4	84.5	80.1	72.8	129.1	70.6	100.1	106.0	91.2	125.1	95.1	83.4	173.8	63.8	103.9	172.0	54.5	108.6	119.1	2.4	2.2	2.0	3.3	3.0	2.7	4.5	2.4	4.2	2.3	1.4	2.2	4.5	2.5	2.0	2.4	6.0	1.4	0.8	19.4	19.7	21.5	23.2	20.3	22.3	21.3	20.9	22.0	20.8	21.0	20.8	26.8	0.0	15.6	4.6	14.7	13.4	11.2	13.5	5.7	16.1	19.7	22.1	15.1	20.0	14.1	20.2	16.7	29.3	33.1	12.7	13.7	33.7	10.1	18.3	26.5	18.5	13.9	4.6	8.1	44.8	41.8	18.0	12.8	18.0	6.3	27.3	21.0	36.0	29.1	18.5	8.1	12.6	12.2	16.6	11.7	23.0	11.8	20.0	14.2	2.8	26.1	36.9	20.6	6.6	9.6	44.0	7.4	18.8	18.8	17.7	12.4	20.5	10.0	20.3	6.6	19.3	24.7	9.5	10.6	16.5	18.6	33.7	16.5	61.5	14.2	14.3
RRP7A	"CGI-96, Rrp7"	ENSG00000189306	"Ribosomal RNA processing 7 homolog A"	Q9Y3A4	22	42508344-42519796	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001586, HPA046768"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA001586: AB_1078506, HPA046768: AB_2679796"	"unprognostic (8.46e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.96e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.73e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.53e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	14.0	16.5	15.8	9.8	18.0	12.3	15.4	14.3	17.0	13.9	11.6	13.9	6.2	13.7	28.2	18.7	13.9	4.7	15.6	16.4	14.1	22.3	18.4	13.0	14.2	15.0	15.3	17.3	14.5	11.1	11.2	6.6	15.5	22.3	6.1	5.2	15.6	7.5	13.8	15.7	13.8	6.4	13.1	18.4	15.0	12.8	14.6	10.3	13.6	5.2	10.2	14.8	14.0	15.7	23.9	34.6	21.1	24.7	13.7	8.8	35.9	21.0	13.7	27.0	22.8	47.4	14.3	41.4	10.6	15.5	13.4	29.3	25.4	28.1	11.1	11.2	50.3	21.8	26.4	23.6	11.2	57.1	19.4	12.1	16.4	35.6	17.7	10.5	15.6	21.6	30.7	12.1	15.9	51.5	54.8	23.0	17.9	20.5	25.5	88.9	19.9	17.6	13.7	31.5	9.8	8.4	14.8	50.5	20.7	8.9	18.2	23.9	12.4	22.9	25.1	16.4	21.1	18.5	16.0	48.8	18.2	20.3	31.2	16.1	28.0	22.4	21.2	33.2	20.4	26.1	18.4	19.7	21.8	32.5	20.0	18.8	5.7	20.4	37.2	37.6	17.1	26.2	15.8	18.0	14.3	17.0	16.4	14.1	15.0	15.3	15.5	13.1	14.6	15.7	32.2	22.4	36.6	5.9	48.6	43.8	95.1	41.4	12.5	26.6	28.6	28.3	16.0	31.5	37.2	22.0	16.7	93.0	50.3	48.4	17.6	71.3	55.8	24.2	25.4	38.6	26.4	64.6	7.5	27.2	133.8	31.0	34.7	28.8	47.5	46.3	37.5	32.6	94.8	26.9	6.8	39.8	28.5	43.3	47.4	118.3	22.1	39.5	33.8	6.5	116.5	24.8	68.0	1.0	7.9	52.1	46.0	18.4	51.4	94.3	38.5	42.1	34.4	28.5	6.6	30.2	37.0	33.5	24.7	27.3	37.8	120.4	40.2	45.2	59.4	106.3
RRP8	"KIAA0409, NML"	ENSG00000132275	"Ribosomal RNA processing 8"	O43159	11	6595072-6603616	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038487, HPA057562"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA038487: AB_10672518, HPA057562: AB_2683468"	"unprognostic (9.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.10e-7)"	"unprognostic (4.64e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.87e-2)"	10.8	10.2	10.9	5.8	10.6	18.4	10.5	10.6	14.9	12.7	9.3	21.8	6.7	11.0	9.8	11.4	10.5	3.4	15.4	10.0	9.9	13.3	21.5	9.2	8.6	10.3	10.7	9.3	10.0	5.3	8.2	6.1	10.4	15.8	6.5	7.6	7.4	8.8	9.5	12.6	10.3	6.2	10.9	14.2	12.1	10.7	10.6	6.8	10.6	4.1	8.4	16.8	11.1	12.1	12.3	12.0	4.7	6.1	9.6	8.3	6.7	6.2	7.7	14.0	13.1	12.4	14.1	17.1	6.0	5.9	10.3	12.1	13.6	10.9	14.7	8.3	19.5	8.1	14.0	14.3	11.0	14.8	10.8	7.1	14.0	6.7	12.1	9.2	14.7	8.0	16.3	9.7	11.2	15.2	14.5	22.0	11.6	21.4	10.7	12.8	3.8	3.9	13.4	9.7	7.2	8.4	8.9	18.0	10.7	7.7	9.8	12.9	7.6	13.2	6.1	13.0	12.2	10.8	10.5	16.7	11.2	14.8	8.7	26.3	10.0	10.4	11.5	10.7	11.2	9.1	11.3	10.7	13.0	11.9	11.0	11.7	3.9	13.6	11.8	9.9	11.9	9.0	10.9	10.6	10.6	14.9	10.0	9.9	10.3	10.7	10.4	10.9	10.6	12.1	17.0	22.4	15.0	37.2	19.6	23.2	18.5	13.3	14.2	17.3	14.1	11.7	20.7	8.6	14.7	9.2	14.6	23.5	20.7	12.2	11.7	19.0	7.4	13.7	22.8	16.4	7.2	37.7	45.0	15.9	21.2	15.5	21.4	14.0	17.7	14.7	12.5	23.5	18.9	3.3	32.6	16.2	12.2	9.4	13.4	13.6	13.1	13.1	8.8	21.5	18.4	14.2	22.6	27.2	34.6	22.7	18.2	9.8	15.2	15.8	13.7	29.8	10.3	30.5	0.0	15.3	20.0	23.7	18.0	18.3	27.1	20.0	17.7	25.2	17.3	15.0
RRP9	"RNU3IP2, U3-55K"	ENSG00000114767	"Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein"	O43818	3	51933429-51941904	"Predicted intracellular proteins"	"rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038798	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA038798: AB_10672653"	"unprognostic (5.57e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.92e-2)"	20.5	20.1	9.8	13.7	10.7	12.4	17.3	9.9	12.1	17.1	8.2	13.2	10.9	16.4	5.3	17.7	15.8	6.8	14.5	10.4	9.8	17.7	16.2	13.9	15.7	10.1	10.0	15.8	14.2	10.4	10.5	9.1	9.5	14.6	7.6	5.6	11.6	9.0	28.9	17.8	12.5	9.1	9.3	14.6	13.1	10.8	10.5	9.2	12.6	13.2	10.5	19.1	15.5	10.6	35.8	50.0	23.5	56.2	33.8	18.8	59.5	38.4	20.9	63.7	40.3	85.5	39.6	102.7	15.9	27.3	86.5	32.3	81.9	59.4	25.5	47.1	35.8	69.5	30.6	77.5	67.9	76.6	55.6	39.0	43.0	80.1	75.3	15.5	24.9	35.8	67.0	25.2	28.5	56.7	65.3	76.2	92.6	54.7	126.9	39.7	26.7	78.6	31.4	52.1	28.9	34.1	34.8	38.5	38.8	20.0	20.1	49.2	24.1	44.3	59.4	111.0	160.8	43.0	75.6	96.2	39.5	94.2	71.4	2.1	9.1	0.5	16.4	13.2	17.5	16.4	14.1	14.5	17.0	13.5	10.9	13.2	0.6	18.8	6.5	18.0	12.5	10.0	9.8	10.7	9.9	12.1	10.4	9.8	10.1	10.0	9.5	9.3	10.5	10.6	9.2	0.0	10.5	3.6	15.2	66.8	27.1	29.7	13.1	12.9	11.2	10.3	4.1	10.0	14.0	5.5	4.2	26.8	14.8	8.3	15.6	24.3	8.1	11.2	12.7	12.7	8.4	7.2	1.9	13.4	40.5	12.6	9.7	9.3	15.2	14.4	5.0	7.0	23.4	16.8	1.3	7.2	22.4	5.3	13.4	6.6	8.7	8.7	21.4	1.0	12.9	10.6	16.5	2.0	1.6	20.0	10.3	9.1	11.6	34.2	6.2	22.2	11.9	10.7	6.6	15.6	36.7	8.0	23.8	15.0	50.4	16.7	12.5	16.4	18.9	14.6
RSBN1	"FLJ11220, ROSBIN"	ENSG00000081019	"Round spermatid basic protein 1"	Q5VWQ0	1	113761832-113812476	"Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042124, HPA049484"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA042124: AB_10794644, HPA049484: AB_2680787"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-3)"	6.4	6.0	4.6	7.7	4.7	34.4	8.2	12.7	6.1	7.9	2.8	8.4	6.2	10.3	6.5	7.3	7.9	6.4	5.2	4.2	5.3	8.0	6.4	7.5	10.6	3.1	3.7	14.2	11.0	11.0	5.1	6.6	3.2	7.9	8.6	13.7	6.8	6.9	8.0	7.5	7.5	7.0	3.9	9.2	6.8	10.7	4.3	12.3	9.0	7.9	10.5	6.4	5.5	5.2	14.6	4.1	13.7	8.2	8.0	9.2	6.6	5.1	10.9	10.1	10.5	4.9	4.3	12.7	7.9	6.3	4.6	6.2	9.8	6.2	16.4	12.3	7.1	9.6	4.4	5.6	6.0	18.1	9.9	7.0	6.7	8.6	8.2	8.6	8.1	14.0	14.7	7.7	7.5	14.9	14.7	10.8	11.6	4.6	6.9	26.3	13.4	6.6	6.0	6.2	13.8	11.0	9.7	9.4	8.7	6.8	4.5	12.1	9.7	9.0	9.7	13.5	8.3	10.3	8.2	15.9	9.3	10.9	15.4	53.3	14.5	25.6	29.1	11.7	29.3	32.2	31.2	27.2	12.8	33.1	31.9	26.2	29.0	25.4	13.4	27.3	30.6	12.6	4.6	4.7	12.7	6.1	4.2	5.3	3.1	3.7	3.2	3.9	4.3	5.2	37.4	35.3	20.1	16.0	52.7	74.7	39.2	26.9	45.5	90.0	35.0	46.7	21.5	24.3	29.6	25.8	66.7	26.3	68.0	55.5	19.6	22.3	25.6	26.2	39.4	38.9	49.4	37.5	34.3	26.0	24.1	41.5	17.9	28.8	36.1	23.4	32.5	18.7	19.2	97.6	34.2	58.5	28.5	26.3	37.7	9.0	50.4	25.7	40.9	30.9	35.0	56.7	62.8	33.7	34.6	21.2	54.0	49.7	34.7	44.3	40.2	17.2	27.8	106.5	39.5	43.8	54.9	96.8	37.0	34.3	65.1	31.5	84.8	24.2	52.7	37.8
RSC1A1	RS1	ENSG00000215695	"Regulator of solute carriers 1"	Q92681	1	15659869-15661722	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027813, HPA028676"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Cell Junctions"	"HPA027813: AB_10600308, HPA028676: AB_10600895"																		3.0	1.5	0.1	2.6	0.3	4.1	1.9	0.4	1.1	1.3	1.1	1.4	0.5	1.9	0.3	4.2	1.9	1.9	3.0	0.4	0.0	4.6	8.3	2.3	2.9	0.6	0.0	1.9	1.1	2.9	0.5	3.2	0.6	2.0	2.0	2.4	0.2	1.4	0.2	0.8	1.4	3.7	0.3	0.8	1.3	2.4	0.6	2.0	2.4	4.9	4.1	2.2	1.0	1.7	4.1	4.7	5.7	3.8	6.9	4.8	7.5	3.4	5.6	9.2	8.5	7.8	6.5	9.2	3.2	7.6	4.6	2.8	14.9	4.8	11.2	6.0	3.8	8.5	9.1	8.4	1.6	12.6	4.2	3.8	0.0	15.8	8.7	2.2	5.9	6.1	23.6	8.3	6.8	4.1	6.7	0.0	6.2	2.4	2.7	5.6	8.0	3.8	2.2	7.5	4.6	1.9	6.3	2.9	4.9	4.8	4.0	1.1	5.8	4.7	8.5	4.2	2.5	2.6	5.2	15.6	1.9	3.4	3.4	0.0	0.4	0.1	0.1	0.9	0.4	0.3	0.1	0.6	0.9	0.0	0.2	0.1	0.0	0.4	0.0	0.2	0.7	0.5	0.1	0.3	0.4	1.1	0.4	0.0	0.6	0.0	0.6	0.3	0.6	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RSF1	"HBXAP, p325, RSF-1, XAP8"	ENSG00000048649	"Remodeling and spacing factor 1"	Q96T23	11	77659996-77821017	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022626, HPA046129, HPA057547, HPA064567"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289"	"unprognostic (2.67e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.00e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.19e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	12.5	17.9	10.8	16.5	12.9	25.7	15.4	43.9	13.7	17.1	1.5	12.8	9.4	20.0	8.9	14.1	14.5	16.6	14.0	8.7	15.4	14.3	11.7	13.2	15.3	8.3	8.5	26.3	16.9	17.3	6.5	18.5	8.5	15.4	12.6	25.9	10.2	13.4	11.7	9.3	10.8	17.5	8.0	16.3	13.5	23.8	12.0	22.6	22.3	13.4	13.5	17.0	8.4	15.5	27.7	18.2	62.0	33.3	20.6	25.9	23.3	31.7	31.0	25.5	31.4	48.0	37.5	46.7	33.2	22.3	39.4	28.1	36.8	23.8	47.7	33.4	16.3	43.9	25.1	13.0	19.6	42.2	30.0	21.8	17.5	35.0	55.8	29.7	32.7	15.2	72.8	43.0	29.7	18.7	29.7	23.4	36.1	32.9	24.8	49.1	107.5	30.6	13.5	35.5	37.3	37.6	48.8	19.1	18.5	32.2	34.3	20.6	41.2	45.0	38.8	71.0	23.1	25.7	35.7	106.3	11.9	28.1	34.5	49.3	17.8	32.8	27.4	16.9	18.8	34.3	16.6	17.6	14.2	35.0	22.7	22.9	46.4	23.7	30.1	32.0	17.0	7.5	10.8	12.9	43.9	13.7	8.7	15.4	8.3	8.5	8.5	8.0	12.0	15.5	100.3	118.6	113.5	99.6	98.0	90.5	69.3	89.7	93.9	123.0	68.8	85.1	97.1	54.3	84.3	73.5	75.0	57.8	85.1	53.0	46.9	79.2	112.4	72.9	95.2	96.5	85.6	71.8	129.4	55.3	50.6	90.5	51.0	86.0	95.5	132.5	79.9	46.2	45.6	146.4	129.3	64.7	71.2	62.9	68.5	40.3	126.8	66.5	56.9	98.4	93.9	124.6	120.5	157.8	144.7	73.1	63.4	118.1	74.8	97.6	44.1	38.2	69.7	97.6	105.2	99.3	100.4	114.8	109.4	57.2	84.0	67.5	99.9	141.7	58.1	91.6
RSKR	"FLJ25006, SgK494"	ENSG00000167524	"Ribosomal protein S6 kinase related"		17	28601827-28614197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"retina: 5.8"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 7.1;Extravillous trophoblasts: 2.4;Hofbauer cells: 4.1;Syncytiotrophoblasts: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"							HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: AB_2679710"	"unprognostic (1.83e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.33e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.62e-4)"	"unprognostic (2.09e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.45e-5)"	"unprognostic (1.20e-7)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-3)"	0.2	0.5	1.2	0.8	1.2	1.6	0.2	1.4	1.7	0.4	1.2	0.2	0.3	0.3	0.1	0.1	0.4	0.0	0.2	1.1	1.2	0.9	0.2	0.2	0.3	1.3	1.2	0.5	0.1	0.1	0.4	0.3	1.4	0.3	0.3	5.8	0.1	0.1	0.5	0.7	0.3	0.1	1.1	0.4	0.2	1.1	1.3	0.4	0.3	0.1	0.3	0.3	0.2	1.5	0.4	0.5	0.6	0.8	0.2	0.1	0.2	0.0	0.0	0.6	0.2	0.9	0.1	1.2	0.1	0.0	0.4	0.6	0.8	0.1	0.6	0.3	0.6	1.0	0.4	0.4	0.0	0.2	0.8	0.0	0.4	0.3	0.4	0.1	0.2	1.2	0.6	0.2	0.1	1.3	0.4	1.0	1.2	1.2	0.1	0.8	2.2	0.7	0.5	1.3	0.4	0.4	0.4	0.1	0.9	0.9	0.5	0.5	0.4	0.3	0.8	0.7	0.5	0.6	0.4	0.6	0.4	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.4	1.7	1.1	1.2	1.3	1.2	1.4	1.1	1.3	1.5	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	24.8	0.2	0.0	0.0	0.0
RSL24D1	"C15orf15, HRP-L30-iso, L30, RPL24, RPL24L"	ENSG00000137876	"Ribosomal L24 domain containing 1"	Q9UHA3	15	55180806-55197049	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062724, HPA063392"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA062724: AB_2684850, HPA063392: AB_2685002"	"unprognostic (3.40e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.19e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.41e-1)"	67.0	62.0	47.9	60.2	50.4	238.6	121.8	59.7	71.1	69.6	43.9	57.9	48.2	89.8	68.7	55.2	59.8	55.2	66.1	50.0	51.9	64.2	73.0	48.3	88.0	49.1	49.1	138.6	77.0	52.5	34.2	45.8	50.1	55.1	53.0	54.1	65.2	49.0	91.2	51.6	48.7	61.8	51.3	52.0	60.3	51.0	49.0	82.2	74.3	74.5	76.6	75.0	46.1	59.9	122.0	115.2	130.2	168.5	95.7	172.4	104.6	126.1	127.5	95.6	117.0	112.2	70.8	361.8	110.5	86.5	100.9	141.4	165.3	137.2	125.9	183.6	104.1	191.3	89.1	148.7	219.6	365.0	121.7	154.1	282.4	98.9	286.0	162.6	120.5	275.2	352.0	256.2	114.3	122.5	202.5	324.3	159.8	246.9	105.9	156.7	162.8	565.2	148.3	108.8	181.0	218.7	57.6	159.2	430.1	100.6	152.3	524.9	90.4	82.1	98.5	99.3	181.6	249.5	420.2	382.3	129.3	353.9	142.4	61.3	99.2	51.1	76.9	101.5	124.8	123.6	115.9	98.2	116.9	98.1	173.9	134.8	24.9	103.3	108.9	90.0	142.4	229.9	47.9	50.4	59.7	71.1	50.0	51.9	49.1	49.1	50.1	51.3	49.0	59.9	146.9	99.3	79.8	6.8	259.2	580.6	425.7	437.4	275.4	85.4	258.9	299.5	69.0	140.2	177.6	84.6	22.9	150.2	219.9	51.2	285.7	182.2	100.6	127.2	177.7	154.9	140.2	189.9	14.8	271.1	247.6	191.9	99.4	126.3	152.8	103.6	114.5	64.0	143.1	15.2	15.2	128.0	197.4	212.2	414.4	40.8	203.5	164.2	284.6	11.2	247.2	91.0	170.0	8.5	13.9	218.9	118.2	149.3	174.8	347.4	114.6	355.1	105.0	62.8	157.8	274.6	215.6	116.9	151.8	173.3	522.2	174.4	251.7	118.3	144.3	332.5
RSPH4A	"CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B"	ENSG00000111834	"Radial spoke head component 4A"	Q5TD94	6	116616479-116632985	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 21.0;fallopian tube: 37.2"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 92.4;Respiratory ciliated cells: 260.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 3.3;U-266/84: 2.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 14.5"	"HPA031196, HPA031197, HPA031198"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025"	"unprognostic (9.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.69e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.56e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.21e-2)"	0.6	0.5	1.5	0.3	1.6	0.9	0.6	1.3	0.6	1.7	21.0	0.3	0.3	1.6	0.5	0.2	37.2	0.5	0.4	1.5	2.0	0.7	0.5	4.6	0.3	6.1	6.2	0.8	0.8	2.0	4.3	0.1	3.8	0.5	0.2	6.0	0.4	0.2	0.9	0.5	0.5	0.4	4.5	0.9	0.5	2.8	2.4	0.5	0.8	0.2	0.3	0.3	0.3	2.8	0.0	0.1	0.6	1.4	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.3	0.5	0.4	0.1	0.0	0.5	0.1	0.1	0.2	0.2	0.3	0.5	0.2	0.2	0.5	0.0	0.3	0.4	0.1	0.1	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.7	3.3	1.3	0.2	1.2	0.5	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	2.4	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	1.3	0.6	1.5	2.0	6.1	6.2	3.8	4.5	2.4	2.8	0.8	3.2	3.4	7.2	0.3	0.0	0.1	4.9	0.0	3.3	0.4	0.8	0.6	0.0	22.9	0.0	2.1	0.0	0.1	0.1	1.9	0.4	33.1	92.4	1.6	2.2	0.0	0.0	10.6	0.4	0.1	1.1	0.5	1.4	2.5	0.7	1.8	0.0	0.1	1.7	12.9	0.0	10.2	0.0	0.0	9.3	0.3	0.4	1.8	0.0	0.0	2.0	0.0	3.5	5.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	260.6	3.7	0.0	2.0	2.4	9.3	1.6	0.0	0.1	0.3	0.5	5.7	0.0	0.1
RSRP1	"C1orf63, DJ465N24.2.1"	ENSG00000117616	"Arginine and serine rich protein 1"	Q9BUV0	1	25242249-25338213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058992, HPA067651"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA058992: AB_2683873, HPA067651: AB_2685879"	"unprognostic (1.03e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.81e-2)"	"unprognostic (5.77e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.73e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.87e-2)"	"prognostic favorable (2.91e-5)"	31.1	31.2	19.6	3.5	27.1	12.8	18.6	25.7	29.4	54.5	25.8	34.0	4.7	29.6	4.4	39.3	38.9	16.3	42.9	20.7	18.1	53.5	35.1	42.4	5.8	37.3	23.6	47.8	19.6	0.9	59.9	8.8	26.0	56.3	2.0	8.5	39.1	18.2	18.8	22.4	26.0	2.1	22.9	37.6	27.2	24.4	25.0	24.4	41.3	21.2	11.4	33.4	52.7	34.8	7.7	16.8	2.2	2.4	18.3	2.7	6.6	7.1	1.3	8.2	9.2	13.7	8.5	6.1	23.0	1.0	3.0	11.4	14.7	1.3	2.8	14.4	8.9	21.0	20.5	17.9	3.9	9.7	11.3	1.8	8.9	3.8	0.0	3.2	4.8	6.3	17.7	49.9	2.3	7.6	2.2	18.5	9.1	17.1	9.7	9.2	6.9	9.1	6.1	0.3	8.9	1.9	4.7	4.7	5.1	1.4	3.9	10.6	10.7	5.7	5.6	5.0	4.1	29.1	24.0	6.3	4.3	24.1	4.5	149.6	57.0	87.4	25.5	38.0	26.7	24.8	26.8	21.6	60.4	23.5	25.3	17.3	130.4	36.6	54.5	37.9	37.6	30.9	19.6	27.1	25.7	29.4	20.7	18.1	37.3	23.6	26.0	22.9	25.0	34.8	351.6	60.9	77.0	121.1	332.7	0.0	229.7	0.0	338.6	86.9	200.1	217.0	47.7	45.8	37.8	93.8	141.8	80.3	456.5	385.9	21.5	43.0	29.8	115.2	142.0	150.0	130.6	140.9	172.6	21.1	82.8	169.0	183.0	146.4	217.1	140.1	71.4	19.6	61.9	84.1	125.4	200.1	0.0	72.2	0.0	16.5	140.1	197.5	0.0	140.5	160.6	69.3	200.8	93.0	278.8	43.6	340.3	90.3	248.4	130.3	397.9	15.2	59.0	138.8	124.9	214.1	141.8	107.6	102.8	283.0	0.0	121.2	346.7	123.8	159.6	196.8
RTCA	"RPC, RTC1, RTCD1"	ENSG00000137996	"RNA 3'-terminal phosphate cyclase"	O00442	1	100266216-100292769	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027982, HPA027990, HPA028151, HPA028331"	Uncertain		Enhanced	Nucleoplasm		NA	NA		38000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: "	"unprognostic (4.79e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (9.55e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.94e-2)"	21.7	20.8	14.1	20.4	15.0	31.9	17.1	14.7	17.0	13.1	15.7	22.2	34.5	12.9	26.6	23.8	12.7	16.7	28.4	15.4	16.3	34.5	22.4	15.8	26.3	15.6	14.0	11.0	24.1	23.7	14.3	23.2	16.2	21.6	23.3	22.3	18.7	14.5	39.3	15.8	31.6	15.5	14.0	21.7	23.9	12.5	15.0	19.2	18.0	35.4	23.4	18.5	15.7	15.7	56.8	28.6	27.8	37.4	34.5	55.4	75.7	65.7	32.0	41.9	35.9	47.0	27.7	57.6	48.4	42.0	51.4	28.0	34.3	31.1	50.2	57.8	28.5	38.0	32.8	59.9	52.9	70.2	57.3	45.5	48.0	54.9	72.5	41.3	52.9	41.1	66.6	84.7	64.1	18.6	36.4	54.3	42.7	40.0	54.8	25.7	49.6	25.5	51.7	45.5	22.2	27.6	42.3	60.5	93.3	43.3	13.2	88.5	45.7	39.2	27.5	62.0	80.1	48.7	51.9	46.3	82.5	60.0	23.7	11.8	10.9	9.4	11.8	14.4	15.5	10.6	11.1	14.2	9.6	9.0	10.2	11.6	5.3	13.5	26.1	9.3	24.7	9.3	14.1	15.0	14.7	17.0	15.4	16.3	15.6	14.0	16.2	14.0	15.0	15.7	20.5	6.4	16.2	15.0	27.1	13.6	13.7	23.2	17.6	24.2	19.8	14.0	52.8	11.5	20.4	18.4	12.5	56.7	30.9	30.5	25.4	42.1	19.3	23.0	17.2	20.7	19.2	25.0	20.7	34.5	85.9	18.8	18.8	24.0	13.3	19.8	21.0	17.4	80.9	21.9	22.2	26.2	20.3	48.8	14.5	9.0	19.3	29.5	16.0	21.5	46.2	25.5	25.7	21.1	33.5	57.3	31.9	12.8	36.0	16.1	79.4	73.9	21.0	29.7	6.6	14.3	20.2	43.0	23.2	21.7	14.6	46.4	32.1	25.7	33.0	20.2
RTCB	"C22orf28, FAAP, HSPC117"	ENSG00000100220	"RNA 2',3'-cyclic phosphate and 5'-OH ligase"	Q9Y3I0	22	32387582-32412248	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000535, HPA001103"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		73000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Cytosol"	"HPA000535: AB_2666021, HPA001103: AB_1078351"	"unprognostic (1.84e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (4.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	43.5	44.5	33.3	39.0	36.0	31.4	51.2	37.5	40.8	37.7	35.6	56.1	93.9	43.9	43.7	49.4	46.5	32.6	45.8	33.5	38.1	75.9	75.2	36.3	45.6	36.7	37.0	45.6	45.8	73.0	39.8	45.5	39.1	45.9	73.8	44.1	47.2	47.4	71.1	76.9	79.1	56.0	38.3	43.7	48.4	32.0	36.3	72.9	41.5	63.6	87.9	53.9	39.2	40.2	116.1	101.9	125.0	94.3	106.8	79.1	99.3	98.8	118.5	154.6	145.9	133.2	45.9	28.5	64.6	116.1	95.2	76.7	144.7	143.5	198.6	144.3	144.8	81.4	83.0	122.1	73.4	192.4	71.2	78.3	93.7	153.3	147.8	85.1	141.3	78.5	98.2	78.7	114.3	96.4	82.5	66.4	71.7	133.4	91.7	126.0	134.7	147.1	106.0	99.0	128.3	71.1	107.2	68.5	129.2	130.6	75.5	73.8	107.3	84.8	124.8	74.7	96.5	54.4	46.6	102.1	87.8	85.6	113.4	112.5	135.3	89.2	93.0	151.3	104.4	143.5	96.6	97.4	161.4	150.4	114.8	99.1	13.2	125.7	118.7	90.4	131.7	156.3	33.3	36.0	37.5	40.8	33.5	38.1	36.7	37.0	39.1	38.3	36.3	40.2	32.0	32.1	33.4	15.3	40.3	60.5	54.9	84.9	47.8	51.6	35.4	27.6	35.8	47.1	60.6	35.0	20.9	112.6	43.0	74.8	66.5	108.4	4.8	46.3	28.6	45.4	46.7	36.4	22.4	95.6	87.9	35.8	45.9	53.8	42.6	50.5	41.0	58.3	85.4	52.2	19.6	62.2	116.0	47.4	45.9	10.8	35.1	43.2	30.2	25.3	80.0	66.9	34.0	28.6	35.1	106.5	62.1	47.8	36.0	64.3	178.2	146.9	48.2	56.9	26.3	35.4	43.0	67.0	65.1	52.7	76.0	97.8	34.1	59.3	61.3	73.8
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006714, CAB079946, CAB079947"	Supported		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB079946: , CAB079947: , HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	17.8	23.2	24.7	18.8	26.3	45.1	22.4	26.8	42.7	24.3	19.2	21.6	19.2	25.1	19.5	21.4	17.1	20.3	24.6	27.1	24.0	19.0	19.9	19.4	28.2	21.0	21.3	29.4	16.6	36.9	11.4	24.5	20.9	23.4	22.4	26.4	16.7	22.8	49.4	25.9	19.8	26.3	20.0	23.8	20.8	29.8	23.9	28.8	29.5	34.8	25.0	23.1	17.5	24.6	32.0	20.6	66.5	54.2	37.0	43.4	31.2	41.8	46.8	56.0	46.5	40.4	19.8	30.2	33.0	43.9	24.9	55.3	38.9	34.8	47.6	46.2	36.1	63.5	45.2	30.4	25.8	57.2	35.5	31.4	34.3	30.0	30.1	41.6	45.8	54.0	49.2	34.0	46.5	24.2	55.1	35.1	35.9	39.6	28.0	59.0	51.8	28.9	36.5	67.5	34.0	44.9	37.6	47.4	19.0	35.9	38.9	54.5	37.9	54.6	34.4	54.8	46.5	38.9	65.0	49.6	39.4	53.5	34.1	5.4	3.1	6.9	3.4	2.1	3.1	6.9	3.3	2.9	2.2	5.3	4.0	3.2	8.5	6.2	2.7	5.5	4.3	1.1	24.7	26.3	26.8	42.7	27.1	24.0	21.0	21.3	20.9	20.0	23.9	24.6	118.0	128.2	80.1	23.8	109.0	145.0	98.7	120.4	102.4	213.5	152.6	129.7	94.3	111.5	89.7	123.2	93.8	168.3	117.1	129.6	164.4	103.0	333.7	103.9	162.6	116.4	87.8	85.0	40.3	110.5	119.1	103.5	71.9	126.2	91.2	127.9	129.5	193.2	95.5	148.0	43.6	145.4	109.9	86.7	94.4	348.5	145.1	83.0	108.5	15.9	116.1	106.2	128.8	16.6	23.5	127.0	105.1	159.9	104.1	141.9	112.6	186.4	70.7	188.2	85.5	115.4	146.9	198.3	59.9	83.4	163.0	219.3	113.0	126.1	133.2	99.2
RTF2	"C20orf43, CDAO5, HSPC164, RTFDC1"	ENSG00000022277	"Replication termination factor 2"	Q9BY42	20	56468585-56519449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 162.8;Distal tubular cells: 156.5;Proximal tubular cells: 149.9;Syncytiotrophoblasts: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053986	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA053986: AB_2682333"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (8.90e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.48e-3)"	73.8	72.7	101.4	65.9	113.3	128.5	65.7	117.4	106.7	66.2	88.3	79.2	60.5	70.6	48.9	64.2	64.8	49.2	85.9	97.2	106.7	68.7	63.8	58.1	70.7	113.7	109.6	71.1	59.3	63.0	67.8	55.4	115.0	58.2	54.2	61.3	51.2	62.2	181.4	69.6	60.8	65.4	111.1	67.8	59.3	57.0	108.4	79.2	60.6	111.1	76.2	73.8	57.5	123.5	132.8	93.3	91.1	91.3	111.1	97.9	85.9	198.5	148.1	280.0	158.5	192.6	125.2	110.4	232.0	161.5	139.7	144.9	92.4	153.8	190.7	52.6	72.9	138.9	97.4	150.8	127.9	201.3	186.6	88.1	156.5	126.0	106.9	119.7	121.3	118.1	109.6	114.3	139.1	253.9	171.6	173.0	68.8	185.2	175.9	116.3	247.2	149.5	119.1	86.1	95.1	103.1	208.2	355.0	199.0	66.7	165.0	191.7	131.5	242.2	156.0	133.0	165.1	94.6	116.1	156.9	190.7	134.7	135.1	309.4	205.4	562.3	125.6	192.8	106.2	115.7	106.4	122.5	223.6	134.0	119.7	110.6	580.4	197.4	200.5	189.6	152.2	254.1	101.4	113.3	117.4	106.7	97.2	106.7	113.7	109.6	115.0	111.1	108.4	123.5	87.2	51.3	61.2	0.0	20.9	0.0	0.0	0.0	0.0	0.0	54.1	56.9	0.0	0.0	34.0	66.2	0.0	162.8	50.9	0.0	156.5	104.5	0.0	47.8	51.2	38.8	0.0	0.0	0.0	96.3	109.5	37.3	0.0	47.7	90.8	57.9	0.0	0.0	110.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	92.0	0.0	0.0	0.0	0.0	101.9	0.0	0.0	5.3	0.0	0.0	149.9	34.2	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	182.9	26.4	89.8	0.0	0.0
RTKN	B5	ENSG00000114993	Rhotekin	Q9BST9	2	74425835-74442422	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 149.6;liver: 124.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NK-cell: 2.3;plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.6;NK-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 96.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030259	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA030259: AB_10601484"	"unprognostic (4.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.43e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-3)"	9.8	8.3	69.5	5.0	104.1	0.6	11.3	85.4	84.6	13.5	51.9	20.3	31.8	8.7	3.5	20.8	12.7	14.2	17.3	72.0	84.3	54.4	124.7	10.3	3.1	100.4	95.5	7.7	30.8	20.7	14.7	11.8	95.7	19.1	12.6	1.9	26.0	9.5	12.8	32.0	25.3	6.3	73.4	5.2	15.3	3.3	93.5	6.3	19.5	7.5	5.3	8.3	16.6	149.6	50.4	15.5	19.5	56.3	11.8	13.7	82.1	7.6	9.9	11.0	8.0	76.3	26.8	0.3	21.2	7.4	13.6	67.2	7.3	48.6	5.3	9.9	31.3	12.0	2.8	96.7	7.2	0.0	0.1	8.4	37.7	9.5	30.0	20.2	5.5	0.7	6.2	0.3	16.5	35.8	1.9	10.1	20.9	70.9	30.3	11.1	60.6	7.6	52.4	0.3	19.0	18.8	20.7	79.3	45.2	17.5	44.6	4.4	0.6	20.5	14.0	9.3	10.6	4.8	3.7	1.8	19.6	0.1	19.5	0.0	0.0	0.0	0.2	0.0	0.2	0.7	0.1	0.2	0.6	1.0	0.0	0.1	0.0	2.3	0.0	6.6	0.0	0.4	69.5	104.1	85.4	84.6	72.0	84.3	100.4	95.5	95.7	73.4	93.5	149.6	4.3	9.6	11.8	4.9	2.0	20.0	22.1	37.2	19.4	0.1	14.4	12.2	3.1	28.6	18.3	11.0	2.1	46.7	4.5	21.7	21.5	43.0	0.7	12.6	6.1	8.8	30.7	1.3	0.5	20.1	8.3	8.9	15.8	26.0	1.3	4.9	5.3	40.1	10.1	0.0	0.9	20.1	18.3	2.2	3.8	1.5	12.8	1.1	28.4	3.7	0.7	6.9	5.2	34.7	48.2	30.5	31.0	8.6	1.4	35.4	44.7	54.7	5.8	0.4	6.6	36.9	3.9	1.1	5.6	12.9	21.6	33.4	2.5	3.1	30.5	15.6
RTKN2	"bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1"	ENSG00000182010	"Rhotekin 2"	Q8IZC4	10	62183035-62268844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lung: 77.5"	"Group enriched"	"Detected in many"	10	"Alveolar cells type 1: 1753.2;Early spermatids: 480.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.6"	"Immune cell enriched"	"Detected in some"	8	"T-reg: 16.7"	"Lineage enriched"	"Detected in single"	72	"T-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"A-431: 45.2;HaCaT: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037946, HPA038446"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 19: Lung - Lung function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Mitochondria	"HPA037946: AB_10795398, HPA038446: AB_10796218"	"unprognostic (2.33e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-3)"	"unprognostic (6.66e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.48e-4)"	"unprognostic (3.70e-11)"	"unprognostic (3.95e-2)"	"unprognostic (9.34e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.55e-1)"	0.2	0.1	0.1	1.7	0.4	0.8	1.1	0.6	1.6	1.5	0.0	1.6	1.3	0.9	0.1	7.1	0.2	0.7	0.1	0.2	0.0	0.4	0.2	77.5	3.5	0.0	0.0	0.2	0.1	0.4	0.8	1.3	0.0	1.1	2.0	0.9	1.4	0.2	0.0	1.2	1.5	0.4	0.0	1.4	1.2	7.6	0.1	3.9	0.6	0.0	3.4	1.2	3.1	0.5	45.2	2.6	23.2	10.8	0.0	0.1	5.6	6.4	7.4	7.2	11.2	18.7	8.9	0.1	2.8	2.6	7.3	35.3	13.1	1.0	7.4	6.4	8.9	7.5	5.4	7.8	0.1	9.9	5.6	0.3	0.6	8.8	0.9	3.8	1.1	11.8	0.5	0.2	9.7	5.6	19.8	13.1	9.8	6.7	8.7	16.9	24.9	0.1	4.6	19.5	12.6	14.5	4.3	14.8	6.0	6.8	13.4	5.6	0.1	3.3	20.8	0.2	16.5	0.1	0.1	17.2	4.2	0.0	5.2	0.1	0.0	0.0	1.1	0.0	0.0	0.0	2.0	0.4	0.1	0.1	0.6	0.3	0.2	0.1	0.0	0.1	16.7	0.2	0.1	0.4	0.6	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	1753.2	45.8	0.3	1.5	4.7	10.2	3.0	0.0	0.7	5.0	3.6	0.5	1.5	10.9	0.0	0.0	9.0	2.0	1.9	0.0	1.6	480.3	5.6	1.4	0.7	1.8	1.7	21.5	1.6	7.2	2.9	7.1	10.8	3.8	12.9	1.1	0.0	2.4	0.0	2.5	8.5	6.1	0.6	2.9	102.8	2.1	2.1	1.8	1.0	0.4	0.3	0.0	0.5	1.0	15.4	0.7	1.9	3.3	9.7	0.5	1.9	2.8	0.5	0.0	0.6	3.4	23.5	24.6	26.2	1.8	2.1	17.4	2.9	7.0	97.3
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656068-78659328	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 1.8;GAMG: 1.4;HBF TERT88: 2.4;hTEC/SVTERT24-B: 1.7;RH-30: 2.1;U-251 MG: 1.6"	"Region enriched"	"Detected in single"	9	"hippocampal formation: 2.8"					"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA					"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737"	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.0	1.1	0.0	0.0	0.0	0.0	1.8	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 15: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	1.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.3	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL5	"KIAA2001, Mar5, Mart5, RGAG4, SIRH8"	ENSG00000242732	"Retrotransposon Gag like 5"	Q5HYW3	X	72127110-72131901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 7.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast myoepithelial cells: 5.0;Endometrial ciliated cells: 3.8;Endometrial stromal cells: 8.9;Theca cells: 7.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 13.4"	"Region enhanced"	"Detected in many"		"cerebellum: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.7;AN3-CA: 4.2;SCLC-21H: 5.0;SH-SY5Y: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003652	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003652: AB_1079805"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (4.23e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	1.3	1.3	1.0	0.3	1.0	0.2	1.2	3.4	0.8	2.3	1.8	2.2	0.4	2.6	2.0	0.5	2.2	1.1	0.8	0.5	1.2	1.4	0.8	1.4	0.3	0.1	0.0	2.8	0.6	1.1	7.2	1.0	0.2	1.5	0.4	0.7	0.8	1.3	0.3	0.4	1.0	1.2	0.0	0.8	1.9	1.4	1.2	0.1	3.8	0.4	0.1	1.7	1.5	0.1	0.0	0.1	3.7	4.2	0.9	1.1	0.2	1.4	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.3	0.6	0.0	0.8	0.1	0.7	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	7.0	0.2	0.0	0.0	1.5	0.1	0.0	0.4	0.5	0.4	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	3.4	0.8	0.5	1.2	0.1	0.0	0.2	0.0	1.2	0.1	2.9	3.2	3.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.0	1.8	0.0	0.0	0.1	2.7	0.0	1.9	0.1	0.0	3.8	8.9	0.6	0.0	0.0	0.0	0.0	0.4	2.0	0.0	2.3	2.5	0.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	2.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.3	1.1	7.0	0.0	0.0
RTN4RL1	"DKFZp547J144, NgR3, NGRH2"	ENSG00000185924	"Reticulon 4 receptor like 1"	Q86UN2	17	1934677-2025334	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 20.6;Cone photoreceptor cells: 37.5;Excitatory neurons: 43.5;Horizontal cells: 33.7;Inhibitory neurons: 18.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 12.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.9;HaCaT: 10.8;hTCEpi: 10.1;T-47d: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044428	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Midbody"	"Intracellular and membrane"	Yes	NA		35000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Midbody"	"HPA044428: AB_10963229"	"unprognostic (5.23e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.97e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.32e-3)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.15e-2)"	4.0	3.1	4.6	0.3	4.0	0.0	6.4	0.0	9.2	2.1	0.0	0.4	0.1	0.8	0.2	1.3	1.5	0.6	2.3	12.3	0.3	1.6	2.6	1.6	0.1	0.0	0.5	0.9	1.8	1.3	5.9	0.3	0.0	3.4	0.1	8.5	4.4	2.0	1.8	9.6	0.5	0.3	0.0	1.1	0.7	0.8	1.9	0.2	1.4	0.4	0.1	1.5	2.2	0.0	1.4	1.6	1.8	2.5	2.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.1	10.9	0.2	10.8	4.6	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.1	0.0	3.6	0.0	0.0	2.5	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.3	0.8	0.3	1.2	0.0	0.0	2.2	0.0	0.3	0.8	1.7	0.2	13.3	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	0.0	9.2	12.3	0.3	0.0	0.5	0.0	0.0	1.9	0.0	1.0	0.0	2.2	1.6	0.1	2.7	0.2	0.0	1.8	20.6	5.4	4.3	3.0	1.5	1.3	3.7	37.5	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.7	0.0	0.0	43.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.1	3.3	1.8	33.7	18.6	0.0	0.0	0.3	0.4	1.1	0.0	0.1	3.6	7.5	0.0	1.8	0.0	8.5	1.7	0.1	0.0	0.0	0.1	0.9	0.0	0.1	1.5	10.0	0.0	0.0	0.6	0.0	0.2	0.5	2.8	0.0	0.2	0.0	0.0	0.3
RTP4	"IFRG28, Z3CXXC4"	ENSG00000136514	"Receptor transporter protein 4"	Q96DX8	3	187368385-187372076	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 33.2;Ductal cells: 46.4;Urothelial cells: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.9;GAMG: 14.2;HDLM-2: 12.3;Karpas-707: 9.7;REH: 9.9;SK-MEL-30: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064887, HPA071189"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA064887: AB_2685383, HPA071189: AB_2686357"	"unprognostic (1.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.95e-2)"	"prognostic favorable (4.35e-4)"	"prognostic favorable (1.45e-4)"	2.1	2.7	2.4	5.1	2.5	1.1	6.0	2.3	3.0	4.8	2.0	5.9	9.1	4.3	3.2	1.9	10.8	6.2	3.2	2.1	2.4	4.4	6.1	7.0	8.1	3.1	2.4	4.0	2.5	0.6	1.1	2.2	2.8	4.0	6.0	0.2	10.7	5.2	1.0	2.4	8.2	4.5	3.5	8.5	8.1	1.0	2.5	9.2	1.9	2.3	5.8	8.2	2.7	2.7	3.1	0.0	0.0	0.0	1.4	4.9	0.1	0.0	1.2	2.0	1.8	0.0	10.9	1.4	0.0	1.3	14.2	3.6	0.0	0.1	0.0	12.3	0.0	0.0	0.0	0.1	1.8	0.0	2.7	1.2	0.0	0.4	0.0	0.4	0.4	0.3	0.0	9.7	0.0	0.0	7.3	0.0	0.0	0.0	0.0	9.9	0.0	8.0	2.6	7.9	0.0	0.0	0.0	0.2	19.7	0.1	0.0	4.9	0.2	0.1	0.2	0.0	0.1	7.8	2.6	0.1	0.0	2.7	6.0	7.0	8.3	5.9	11.5	10.2	11.5	6.2	9.1	10.5	7.1	5.3	6.9	8.2	2.3	14.9	13.2	0.2	19.8	6.7	2.4	2.5	2.3	3.0	2.1	2.4	3.1	2.4	2.8	3.5	2.5	2.7	7.4	6.4	4.5	0.3	4.3	1.7	33.2	10.5	1.8	0.0	4.0	5.5	0.7	11.5	11.3	5.5	0.0	0.1	4.2	6.0	15.6	46.4	0.0	13.6	4.3	9.6	9.1	0.4	0.0	9.8	0.5	4.2	10.7	6.1	1.3	1.6	10.8	4.5	5.5	0.0	0.1	9.6	6.1	7.8	2.5	0.0	2.1	6.4	1.8	1.9	8.9	3.7	25.7	1.0	0.7	16.9	9.4	4.9	2.0	12.9	17.9	3.1	24.6	0.1	0.0	1.3	3.0	0.1	0.1	1.3	1.3	0.3	8.3	12.0	7.8	52.6
RTRAF	"C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1"	ENSG00000087302	"RNA transcription, translation and transport factor"	Q9Y224	14	51989514-52010694	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 316.0;Distal tubular cells: 309.1;Exocrine glandular cells: 289.7;Extravillous trophoblasts: 349.6;Proximal tubular cells: 303.7;Syncytiotrophoblasts: 261.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039824	Supported		Supported	Nucleoplasm		NA	NA		48000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA039824: AB_10793922"	"unprognostic (2.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-1)"	92.9	92.7	47.2	73.7	48.9	138.9	87.2	50.8	60.3	69.3	52.5	93.5	61.3	71.1	87.0	79.1	64.5	67.8	151.6	46.6	50.9	77.3	78.9	64.0	105.5	50.4	48.6	96.5	114.0	74.1	65.6	68.2	49.4	66.6	88.7	56.3	76.8	58.7	155.8	79.6	67.3	76.9	51.4	61.2	98.9	142.2	49.0	107.0	81.2	102.2	105.3	87.9	62.8	54.6	214.6	142.1	239.8	233.7	157.7	208.3	228.8	166.9	183.6	180.9	203.1	153.2	184.0	290.8	174.0	139.5	142.2	167.1	226.2	152.6	234.7	158.0	126.5	113.3	287.8	206.7	252.1	243.8	125.0	158.5	155.6	136.6	223.5	210.1	207.2	269.6	118.8	135.1	177.3	237.6	310.8	306.3	187.1	247.8	238.1	278.6	228.0	138.0	176.1	245.2	169.0	171.6	211.0	376.7	274.7	301.3	252.8	190.4	146.0	196.6	216.4	167.2	212.7	50.5	76.2	295.7	96.9	189.3	228.7	54.8	93.3	58.7	73.5	104.7	91.1	108.8	102.0	88.6	117.6	90.9	93.2	95.2	19.2	96.1	112.5	107.9	144.0	126.6	47.2	48.9	50.8	60.3	46.6	50.9	50.4	48.6	49.4	51.4	49.0	54.6	168.6	44.8	67.2	0.0	39.2	0.0	0.0	0.0	0.0	0.0	181.7	232.8	0.0	0.0	39.0	73.5	0.0	316.0	83.1	0.0	309.1	226.6	0.0	164.3	108.1	77.5	0.0	0.0	0.0	289.7	349.6	77.4	0.0	103.6	61.8	242.8	0.0	0.0	240.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.0	154.5	0.0	0.0	0.0	0.0	232.4	0.0	0.0	13.0	0.0	0.0	303.7	49.6	0.0	0.0	0.0	95.2	0.0	0.0	0.0	0.0	261.6	53.6	233.9	0.0	0.0
RUFY2	"FLJ10063, KIAA1537, RABIP4R, ZFYVE13"	ENSG00000204130	"RUN and FYVE domain containing 2"	Q8WXA3	10	68341107-68407294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 93.1;Oligodendrocytes: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039792	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA039792: AB_10673363"	"unprognostic (1.23e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.40e-2)"	5.8	4.7	8.4	3.8	12.7	1.9	6.5	13.5	18.7	5.9	3.7	4.9	3.3	8.4	4.6	4.9	5.7	5.0	4.5	9.6	10.5	5.6	1.8	5.4	4.1	13.7	10.9	9.8	4.4	6.9	3.6	5.5	12.9	6.3	5.4	10.0	4.7	4.9	5.1	5.0	4.0	7.0	11.3	4.9	4.9	4.2	12.3	5.6	6.4	4.4	4.2	5.7	5.2	19.0	11.7	4.5	7.3	9.8	9.2	13.5	4.5	9.8	12.1	10.2	10.2	6.9	10.8	3.8	7.2	16.0	4.5	8.3	3.2	10.9	10.2	1.6	8.2	2.6	3.6	3.7	9.7	3.7	1.7	12.0	11.4	12.1	12.4	16.2	11.5	3.2	4.9	5.6	10.9	4.8	3.1	5.0	3.2	3.6	13.1	4.3	5.9	2.3	10.8	7.1	8.4	7.9	7.0	9.3	6.0	9.1	13.8	4.6	13.2	12.7	9.6	7.6	13.8	5.6	3.2	1.9	12.0	3.6	5.6	0.6	0.5	1.1	0.8	0.6	0.8	0.8	1.1	1.1	0.3	0.9	1.1	1.4	0.5	2.6	0.8	0.5	0.4	0.3	8.4	12.7	13.5	18.7	9.6	10.5	13.7	10.9	12.9	11.3	12.3	19.0	22.8	32.1	15.1	40.1	15.9	6.6	15.2	14.8	8.0	47.7	11.7	11.2	11.4	4.3	20.7	25.8	60.5	9.3	13.0	7.2	1.9	16.1	8.5	24.1	30.2	20.3	10.2	13.5	93.1	12.9	6.0	24.8	14.3	20.2	7.6	24.2	22.5	6.5	6.5	32.0	84.7	12.0	10.2	10.0	7.7	5.5	24.2	11.2	12.4	45.0	13.1	20.2	12.3	58.8	153.7	17.9	5.4	17.7	12.0	15.6	6.3	10.1	21.7	62.0	13.1	31.7	24.7	11.1	24.4	15.9	8.1	9.6	11.8	22.8	7.7	10.7
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"RUNX family transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 175.5;Glandular and luminal cells: 155.8;Microglial cells: 195.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 23.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 251.3;HMC-1: 145.3;JURKAT: 226.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Vesicles	"HPA004176: AB_1078412, HPA037912: AB_2675733"	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	14.8	3.8	2.9	20.3	2.1	45.5	27.1	2.6	4.0	15.3	5.1	6.7	5.1	3.3	3.1	9.2	4.7	16.0	6.3	2.8	3.2	4.6	7.0	22.4	11.3	6.0	4.3	6.3	4.0	1.5	5.1	8.5	6.5	13.5	6.5	0.3	39.2	3.5	18.9	11.6	6.8	9.2	4.9	10.2	16.9	3.8	9.1	28.2	4.8	1.4	9.9	20.8	12.8	7.9	50.9	3.8	0.1	0.3	12.5	16.0	32.0	28.1	28.4	15.3	11.6	2.5	37.7	24.9	1.8	24.9	25.5	45.0	3.0	33.6	21.4	38.7	3.8	251.3	10.1	11.6	22.9	29.4	145.3	30.9	19.8	46.6	45.6	21.2	8.8	226.3	17.3	14.1	32.7	10.7	119.3	46.5	2.2	27.4	14.5	119.2	84.6	15.3	20.7	19.9	1.4	0.0	28.9	7.2	10.5	6.8	14.7	67.8	37.0	25.1	32.4	37.8	42.8	46.4	20.7	23.3	31.2	63.4	37.4	23.9	3.1	7.1	3.4	1.4	3.2	4.1	3.0	3.2	0.9	3.6	4.5	3.7	3.4	1.5	4.7	3.4	4.5	2.2	2.9	2.1	2.6	4.0	2.8	3.2	6.0	4.3	6.5	4.9	9.1	7.9	6.2	54.5	35.4	1.6	27.0	41.6	52.7	61.2	54.7	2.3	175.5	94.6	3.2	28.6	60.8	20.2	0.0	2.1	39.5	18.7	1.9	39.7	19.4	89.6	21.5	9.2	6.0	47.3	3.5	28.1	21.4	49.2	84.6	155.8	17.7	29.2	4.6	5.4	68.4	0.0	3.2	12.4	28.5	77.0	122.5	27.1	4.7	84.4	28.4	195.8	42.2	0.5	39.1	1.5	1.6	101.0	15.8	4.5	27.7	43.6	8.3	1.6	78.6	0.8	0.0	111.3	51.2	29.0	28.0	53.7	20.2	2.5	41.6	2.7	17.0	75.3
RUNX1T1	"AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2"	ENSG00000079102	"RUNX1 partner transcriptional co-repressor 1"	Q06455	8	91954967-92103286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 93.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 142.1;Excitatory neurons: 196.9;Hepatic stellate cells: 124.2;Inhibitory neurons: 326.3;Oligodendrocyte precursor cells: 262.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 93.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.6;fHDF/TERT166: 16.5;HEL: 35.9;HSkMC: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049852, HPA070951"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA049852: AB_2680914, HPA070951: AB_2686326"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-4)"	"unprognostic (2.29e-4)"	"unprognostic (5.56e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-4)"	"unprognostic (8.98e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.80e-3)"	7.0	2.8	9.4	2.1	13.2	0.2	5.1	93.1	8.7	8.4	0.0	6.5	1.2	7.4	3.6	2.5	4.7	5.0	8.2	13.1	2.3	1.4	0.6	3.8	1.3	1.4	12.8	4.7	1.0	1.0	3.0	5.8	4.6	2.5	2.4	5.2	3.1	2.4	3.9	2.4	2.5	6.5	4.2	1.9	2.7	3.6	3.6	0.5	3.7	4.8	1.1	3.8	3.9	1.2	0.0	0.0	0.4	1.9	5.0	7.2	0.0	7.6	11.6	5.0	7.6	0.0	0.0	19.6	0.0	16.5	0.0	0.0	4.0	0.5	3.3	0.0	3.2	35.9	0.0	0.0	1.9	0.0	0.0	13.6	0.0	8.4	0.4	0.0	10.8	0.0	0.1	0.0	1.3	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.1	6.0	0.0	0.0	0.0	7.8	0.0	0.0	1.2	0.4	0.0	0.9	0.0	3.8	0.0	6.3	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	13.2	93.1	8.7	13.1	2.3	1.4	12.8	4.6	4.2	3.6	1.2	44.9	0.0	1.1	90.8	0.1	6.2	0.2	0.0	0.6	142.1	1.2	5.1	46.0	0.0	0.6	0.0	16.7	1.1	0.5	0.2	1.9	0.0	2.6	1.1	65.8	64.3	47.7	2.7	196.9	0.2	0.3	77.7	0.5	1.1	1.3	2.1	124.2	1.5	1.9	35.3	326.3	0.6	0.0	4.1	9.4	7.5	96.3	1.2	10.6	103.0	0.0	3.9	0.0	262.4	17.3	0.2	0.0	98.9	0.0	0.3	0.0	0.1	0.0	7.2	65.7	24.4	43.1	3.3	16.8	0.9	4.8	1.1	1.1	20.7	0.0	0.1
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"RUNX family transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.8;Early spermatids: 128.3;Inhibitory neurons: 95.2;Microglial cells: 128.4;Plasma cells: 44.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 22.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 39.3;Karpas-707: 62.3;RH-30: 51.8;U-698: 55.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (3.97e-9)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (6.66e-5)"	1.7	0.7	1.1	4.3	1.0	9.7	2.8	1.2	1.4	6.7	0.9	3.7	2.0	1.5	0.8	1.4	0.9	3.4	0.7	1.3	1.5	1.5	0.7	2.7	4.5	1.9	1.8	2.2	0.6	0.6	1.6	1.5	1.9	4.8	3.9	0.1	10.7	2.6	0.8	2.4	6.0	1.6	1.6	3.6	3.2	0.5	2.0	4.5	1.8	0.9	5.6	3.6	4.9	1.9	3.6	1.1	0.8	0.0	3.2	8.3	0.0	3.3	7.9	10.9	15.2	0.0	1.9	0.0	3.8	4.7	4.9	4.3	0.0	3.1	19.7	13.7	1.5	0.0	2.4	0.0	16.7	14.2	0.1	22.5	2.5	9.7	10.9	39.3	0.2	5.6	0.0	62.3	19.7	1.0	0.4	24.7	0.7	3.2	0.5	0.1	51.8	0.0	10.7	7.0	0.0	0.0	2.4	0.1	4.1	9.2	3.6	1.2	0.5	11.1	8.8	17.2	12.1	19.6	0.0	55.2	12.5	5.3	5.0	8.6	0.9	4.5	1.5	0.2	12.9	0.2	3.5	4.0	2.4	0.2	0.6	1.8	6.5	22.1	0.1	15.4	3.2	1.0	1.1	1.0	1.2	1.4	1.3	1.5	1.9	1.8	1.9	1.6	2.0	1.9	0.9	0.0	2.7	4.6	5.7	2.8	16.6	5.3	1.2	0.0	2.0	1.4	2.7	0.0	4.9	3.7	0.0	0.0	55.8	0.3	0.0	0.6	128.3	0.7	3.5	0.8	0.0	3.8	17.4	0.2	0.0	7.0	4.1	0.5	2.5	0.1	1.1	0.8	3.7	0.0	95.2	1.0	20.3	6.7	20.8	20.0	1.2	16.3	7.2	128.4	18.6	0.0	7.2	6.6	5.2	0.4	0.1	2.2	44.4	16.5	0.0	3.3	5.1	0.0	6.6	1.5	6.2	0.8	0.5	1.2	1.6	0.1	21.4	0.2	0.2	28.0
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"RUNX family transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.8;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 336.4;Langerhans cells: 133.9;NK-cells: 251.3;Plasma cells: 87.1;T-cells: 215.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 124.9;Karpas-707: 155.6;SK-MEL-30: 92.4;U-266/70: 54.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	Cytosol	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.5	1.4	3.7	21.1	3.6	68.8	3.5	3.8	4.6	19.7	3.7	3.7	5.0	1.6	0.7	2.6	1.6	5.3	1.1	3.6	3.8	1.6	3.7	9.5	34.7	4.7	4.4	0.6	0.9	0.4	0.7	0.9	4.3	1.9	4.2	0.1	4.7	0.8	3.8	11.5	15.0	1.6	4.1	35.1	5.5	2.3	4.3	11.2	1.8	0.7	29.0	6.5	1.5	4.5	0.3	10.4	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.5	0.0	0.5	0.0	19.3	18.4	16.4	0.1	0.4	11.1	0.0	0.7	124.9	1.9	0.4	1.8	0.1	0.0	4.5	42.8	0.1	0.0	0.0	1.1	0.0	0.0	3.1	0.1	155.6	0.0	0.0	1.5	37.9	0.7	0.0	3.2	0.0	0.1	22.7	0.0	0.5	3.5	0.0	7.3	0.1	92.4	2.9	0.0	25.7	0.0	0.0	1.9	0.0	0.5	54.6	40.4	18.2	0.1	42.0	4.4	0.7	1.1	7.0	21.7	4.5	11.3	6.7	7.9	18.7	1.4	5.7	3.9	14.6	1.3	28.7	7.7	1.5	9.2	5.5	3.7	3.6	3.8	4.6	3.6	3.8	4.7	4.4	4.3	4.1	4.3	4.5	4.4	0.0	3.6	0.0	57.7	7.6	0.8	4.6	2.2	0.0	9.8	11.3	2.4	0.0	1.5	1.8	0.0	0.1	336.4	0.5	0.0	0.2	2.3	1.1	1.2	2.4	0.0	13.7	0.0	0.2	0.1	3.3	13.3	2.3	45.2	0.0	2.2	1.5	4.6	0.0	0.0	0.5	0.0	22.9	133.9	1.0	0.0	55.6	46.2	1.0	51.1	0.0	251.3	0.0	0.1	0.1	0.1	0.7	87.1	1.2	0.0	0.3	0.5	0.0	0.0	3.5	3.6	0.3	4.1	2.3	5.8	0.3	215.4	0.1	0.4	0.4
RUSF1	"C16orf58, FLJ13868"	ENSG00000140688	"RUS family member 1"	Q96GQ5	16	31489471-31509309	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.8;Cytotrophoblasts: 22.3;Extravillous trophoblasts: 21.0;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024406	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA024406: AB_1845580"	"unprognostic (1.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.22e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.24e-2)"	27.1	31.8	19.6	20.0	18.9	21.5	28.8	12.0	21.3	45.4	14.2	29.6	31.3	43.2	20.7	26.5	38.2	23.0	28.5	19.9	19.7	29.5	57.9	25.0	19.8	17.0	16.0	49.6	56.8	46.2	48.4	25.7	18.5	39.1	19.1	22.4	64.8	34.2	9.4	26.9	30.3	25.6	13.8	22.3	39.5	21.4	17.0	18.0	42.0	9.8	15.6	31.8	31.4	17.0	28.6	37.2	22.7	39.7	51.7	34.3	42.3	33.4	56.6	25.5	30.2	11.3	49.1	24.5	69.4	49.8	32.9	39.0	22.9	31.0	11.8	35.8	23.0	24.8	20.6	28.8	74.8	29.4	28.6	41.7	33.1	33.7	68.5	50.2	24.9	38.4	37.3	40.9	25.3	53.9	13.7	19.8	17.8	41.8	24.1	31.1	34.2	74.8	29.3	17.6	24.8	38.2	25.2	65.3	52.8	21.5	56.6	42.9	22.0	44.3	24.7	28.7	22.1	59.0	37.0	18.8	56.7	44.7	62.5	3.1	5.7	7.6	7.8	8.4	7.2	6.7	8.2	7.8	9.7	6.3	7.9	7.0	0.9	9.4	8.1	8.9	9.4	7.2	19.6	18.9	12.0	21.3	19.9	19.7	17.0	16.0	18.5	13.8	17.0	17.0	5.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	22.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	21.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	22.3	0.4	0.0	0.0	0.0
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 147.0;Respiratory ciliated cells: 221.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		81000	"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	20.2	18.7	6.4	10.1	6.3	8.6	18.5	6.1	7.0	17.7	9.8	16.2	5.1	23.1	5.8	26.0	27.5	5.0	25.8	6.2	6.3	24.6	17.2	17.2	13.1	7.3	8.7	15.3	13.9	14.6	17.3	12.7	7.5	13.1	8.5	7.4	14.0	6.9	19.1	17.7	15.2	10.0	6.4	22.3	14.8	29.4	6.5	15.7	15.4	6.0	16.1	19.2	18.5	6.8	75.1	66.2	40.1	65.6	30.5	29.4	52.2	35.8	30.5	67.3	45.9	69.7	43.2	105.0	34.8	34.2	52.2	58.4	107.2	75.6	77.6	43.4	52.3	87.8	36.3	47.4	31.4	82.9	27.0	30.2	39.1	56.5	72.1	25.6	45.6	39.4	72.9	24.4	38.7	105.9	89.7	64.6	101.1	83.5	55.8	72.4	48.4	73.4	40.7	27.6	66.8	60.1	39.6	32.4	55.9	36.8	58.5	61.8	29.8	30.5	37.2	46.4	55.2	24.3	41.6	103.0	37.4	50.2	39.2	1.3	7.3	2.5	15.6	11.9	20.1	15.6	18.7	19.6	11.3	15.7	15.6	17.6	0.3	15.9	11.9	12.6	30.5	11.0	6.4	6.3	6.1	7.0	6.2	6.3	7.3	8.7	7.5	6.4	6.5	6.8	26.1	22.4	15.3	12.7	22.7	20.0	23.7	61.6	25.0	17.4	17.4	21.8	20.9	21.5	37.3	22.0	2.1	53.7	31.3	7.8	46.9	40.9	21.2	147.0	50.8	27.4	16.9	20.4	12.6	30.1	65.4	22.9	17.3	23.8	26.0	35.7	12.8	14.6	29.9	23.5	14.6	14.0	28.5	8.8	8.2	67.1	15.2	14.6	10.6	4.7	13.3	28.1	11.3	9.0	10.0	27.1	11.1	18.4	27.3	34.5	4.6	59.2	221.3	19.7	13.1	16.1	32.3	94.8	75.0	27.9	16.9	24.1	29.1	84.7	23.4	15.6
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993562-49015970	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 614.5;Late spermatids: 945.1;Respiratory ciliated cells: 253.6;Spermatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		53000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	23.4	21.7	41.4	26.7	42.9	51.4	22.6	44.6	54.6	23.5	48.9	29.8	27.9	19.3	15.3	36.7	72.2	15.8	37.0	44.7	42.6	19.4	24.0	19.6	30.8	42.4	45.8	25.8	34.5	28.2	6.5	24.0	44.2	20.2	17.4	14.9	32.5	25.4	60.3	30.7	24.7	19.0	41.4	20.6	22.6	110.7	43.8	38.9	23.8	39.1	21.3	22.6	7.2	52.3	236.5	346.0	63.3	250.2	45.0	50.9	88.8	105.4	86.3	214.9	162.5	267.4	148.7	219.9	78.5	106.8	93.7	134.6	99.9	210.3	68.5	99.2	323.7	158.8	196.7	241.0	119.1	318.8	96.8	78.0	68.0	145.0	113.5	59.2	114.1	232.8	266.6	121.3	90.5	195.2	234.1	218.5	122.6	162.4	152.4	227.4	156.9	155.8	110.5	182.7	155.7	169.9	132.2	164.2	66.2	30.4	125.9	179.4	104.8	100.8	135.1	63.8	318.1	171.4	177.1	223.6	76.2	174.6	156.4	51.1	54.9	18.9	42.6	52.4	46.8	54.5	45.2	42.3	65.9	52.6	42.9	40.0	3.7	47.4	48.5	48.9	49.2	55.4	41.4	42.9	44.6	54.6	44.7	42.6	42.4	45.8	44.2	41.4	43.8	52.3	16.5	12.8	20.7	4.2	25.3	27.8	52.0	89.8	37.5	17.5	30.4	33.7	48.5	24.3	55.7	33.1	33.3	104.6	15.0	33.8	46.9	78.3	614.5	131.7	29.6	27.3	17.5	58.1	6.1	71.8	81.8	36.6	28.5	25.4	13.3	32.8	23.2	34.2	51.1	18.5	5.2	38.5	52.9	22.9	25.5	945.1	36.1	18.9	26.6	1.9	35.5	31.2	27.8	4.5	5.6	56.0	30.6	42.9	41.3	43.5	33.1	70.4	253.6	31.4	19.7	28.9	65.4	394.2	43.9	49.2	27.6	115.9	20.8	37.1	61.0	38.8
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 218.9;Kupffer cells: 134.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 19.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.5;monocytes: 12.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 105.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	40.5	22.7	33.5	14.5	36.4	18.9	11.2	25.5	29.4	12.2	16.9	16.6	25.8	13.5	8.7	28.5	16.5	13.6	19.4	27.1	30.2	16.0	32.9	18.8	8.2	32.9	31.3	21.7	25.4	45.1	3.5	14.5	30.8	15.6	10.0	5.4	21.7	17.1	106.5	88.1	28.0	11.1	30.4	25.1	14.7	7.9	42.7	6.0	17.6	51.9	7.6	16.2	8.2	22.6	19.6	36.4	14.7	21.9	42.8	19.1	66.7	14.1	16.1	9.6	6.5	20.7	28.0	0.0	25.8	22.5	15.1	105.5	7.7	32.8	2.9	26.3	7.2	0.1	47.5	30.0	20.4	18.8	4.8	29.0	52.1	11.5	10.6	12.9	12.8	1.6	26.0	1.1	8.7	61.8	1.1	59.5	17.5	63.4	16.9	7.4	30.3	36.7	12.2	64.3	17.2	10.5	37.3	46.9	10.6	7.1	44.9	78.8	16.5	16.2	23.4	17.4	9.7	1.7	0.2	0.4	11.6	33.9	12.7	1.3	8.1	6.6	1.4	12.9	0.2	0.3	0.9	1.0	3.2	0.1	0.2	1.2	19.5	2.2	11.2	0.7	1.2	3.2	33.5	36.4	25.5	29.4	27.1	30.2	32.9	31.3	30.8	30.4	42.7	22.6	32.1	32.1	22.9	36.2	4.6	34.5	16.5	21.1	12.5	6.0	16.7	14.4	38.8	72.9	26.2	9.2	25.0	30.1	11.0	72.3	1.9	13.9	4.3	19.8	16.6	28.9	9.6	30.9	9.1	14.1	29.5	23.7	17.9	17.4	1.3	21.3	71.0	218.9	31.9	33.7	17.6	21.2	10.2	134.2	30.0	18.8	32.3	50.4	12.4	10.3	80.4	36.5	14.4	29.1	6.0	15.9	32.4	21.1	7.4	17.7	55.6	19.9	34.4	19.9	19.7	34.6	30.6	0.9	9.4	34.4	46.9	23.9	12.6	15.5	27.5	32.8
RXRB	"H-2RIIBP, NR2B2, RCoR-1"	ENSG00000204231	"Retinoid X receptor beta"	P28702	6	33193588-33200665	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.0;RH-30: 14.4;RT4: 12.1;T-47d: 16.1;U-266/70: 11.1;U-266/84: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002003, HPA063653"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB002003: , HPA063653: AB_2685076"	"unprognostic (3.51e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-3)"	"unprognostic (8.13e-3)"	"unprognostic (9.53e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.53e-3)"	26.8	29.1	1.5	2.0	1.5	2.3	27.1	1.6	5.7	33.9	1.4	34.4	3.9	31.9	7.4	27.0	31.4	3.3	31.4	1.5	2.6	29.5	34.4	27.2	1.4	1.5	1.7	32.9	32.3	0.0	33.0	2.5	1.5	32.8	1.6	3.2	27.0	3.3	42.5	26.3	28.6	9.6	1.6	38.3	28.3	20.0	1.6	2.8	37.7	12.3	9.1	30.6	29.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	10.0	0.0	10.4	7.1	0.0	11.0	4.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	8.9	0.0	0.0	0.5	3.2	0.0	0.0	0.1	14.4	0.0	8.0	12.1	0.0	7.4	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	4.8	0.0	0.0	11.1	11.8	9.2	0.0	0.0	0.0	2.3	0.4	1.7	1.1	0.3	0.8	1.0	1.3	1.3	0.6	0.3	1.1	0.8	0.7	0.8	0.6	0.6	1.1	0.3	1.5	1.5	1.6	5.7	1.5	2.6	1.5	1.7	1.5	1.6	1.6	1.7	21.2	41.7	13.3	14.4	19.2	17.3	14.9	8.9	18.2	25.2	22.4	18.9	16.1	15.7	14.7	5.5	20.9	23.6	26.3	21.8	25.4	19.9	2.7	10.6	14.7	18.2	22.0	8.6	14.9	16.2	17.9	18.3	23.0	11.9	10.2	22.5	14.3	15.9	15.8	18.5	12.9	21.8	16.2	14.7	9.2	8.6	16.1	12.2	16.0	10.3	18.8	16.6	33.0	14.1	15.2	13.6	20.2	16.1	12.0	16.3	23.2	14.1	10.8	20.4	26.3	19.3	20.0	17.7	12.5	16.8	18.8	28.7	19.4	18.7	24.5	12.7
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400922-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;pituitary gland: 29.9;retina: 24.3;skeletal muscle: 49.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 13.4;Cone photoreceptor cells: 25.0;Melanocytes: 28.4;Muller glia cells: 16.8;Sertoli cells: 13.1;Skeletal myocytes: 35.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 39.4"	"Region enriched"	"Detected in many"	5	"basal ganglia: 100.2"	"Low region specificity"	"Detected in many"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	2.4	3.2	14.6	0.4	16.6	0.0	1.0	11.7	17.4	3.0	11.7	4.1	0.7	1.1	0.7	1.0	2.8	0.6	5.3	12.4	21.5	0.2	0.3	2.8	0.3	25.6	14.8	1.0	2.1	0.1	29.9	0.7	22.2	1.1	2.0	24.3	1.2	1.4	49.7	2.3	1.6	1.2	13.6	0.4	1.4	1.0	32.1	0.1	0.7	7.6	0.0	1.6	2.1	15.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	39.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	16.6	11.7	17.4	12.4	21.5	25.6	14.8	22.2	13.6	32.1	15.6	0.9	0.0	0.0	13.4	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	2.8	5.0	0.0	28.4	0.0	0.0	16.8	0.0	1.0	1.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.5	13.1	35.9	3.4	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
RXYLT1	"HP10481, TMEM5"	ENSG00000118600	"Ribitol xylosyltransferase 1"	Q9Y2B1	12	63779842-63809562	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transferase	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 37.2;Endometrial stromal cells: 34.5;Extravillous trophoblasts: 33.8;Syncytiotrophoblasts: 37.1;Theca cells: 45.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064014			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Golgi apparatus"		"HPA064014: AB_2685176"	"unprognostic (1.19e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.33e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	6.6	12.0	6.9	4.9	7.6	4.4	10.8	7.1	8.5	7.1	7.2	6.9	5.7	6.7	15.3	5.6	7.9	5.5	14.3	6.8	7.9	10.9	8.5	5.2	7.4	7.5	7.0	12.0	11.8	15.4	9.0	5.7	7.7	8.4	7.5	9.9	8.3	7.0	10.7	8.3	4.2	6.1	7.5	5.7	5.5	11.8	7.3	7.3	12.8	8.7	7.2	7.4	5.5	9.3	9.6	19.9	14.2	11.7	12.2	16.4	13.5	10.4	18.5	17.7	11.9	6.6	10.1	20.5	17.7	13.4	14.2	9.3	17.5	16.0	22.3	18.5	13.4	11.5	5.1	12.2	18.1	17.6	10.0	14.6	15.6	17.1	22.6	16.8	10.4	16.5	14.0	19.8	27.8	18.3	10.2	8.1	8.1	10.4	20.6	9.0	14.8	13.1	17.8	15.1	30.7	5.9	10.4	9.5	24.5	9.0	20.2	9.9	10.1	14.9	15.2	9.7	15.4	10.6	17.9	15.6	10.9	11.4	20.9	0.8	1.7	1.0	1.9	1.6	3.5	3.0	2.4	2.6	1.7	2.2	2.8	2.6	0.3	3.0	2.2	4.1	4.3	1.2	6.9	7.6	7.1	8.5	6.8	7.9	7.5	7.0	7.7	7.5	7.3	9.3	17.5	9.6	8.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	26.8	26.8	0.0	0.0	10.5	16.5	0.0	24.7	6.9	0.0	37.2	23.1	0.0	28.6	34.5	8.1	0.0	0.0	0.0	30.7	33.8	12.1	0.0	16.6	7.6	15.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	8.3	0.0	0.0	0.0	0.0	17.3	0.0	0.0	2.4	0.0	0.0	30.3	13.8	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	37.1	4.8	45.0	0.0	0.0
RYBP	"AAP1, DEDAF, YEAF1"	ENSG00000163602	"RING1 and YY1 binding protein"	Q8N488	3	72371825-72446623	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 524.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053357	Approved		Supported	Nucleoplasm		NA	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA053357: AB_2682124"	"unprognostic (6.80e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (2.50e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.22e-1)"	8.6	5.4	2.0	0.8	2.0	2.7	7.8	1.4	2.3	9.4	0.9	9.5	0.8	10.0	0.6	7.1	8.5	1.2	5.7	1.8	2.2	7.6	8.6	11.5	0.8	1.5	1.6	10.9	4.7	0.8	5.9	2.2	1.4	8.7	1.0	2.1	6.7	1.2	4.4	8.3	7.4	1.4	1.4	8.6	7.0	8.1	2.0	1.5	5.8	0.8	1.0	8.8	7.9	2.0	0.9	0.9	1.7	1.6	1.5	1.5	1.1	0.9	2.0	1.7	2.1	1.6	1.2	1.0	0.9	1.5	2.0	0.4	1.9	1.4	2.1	6.0	1.0	4.7	1.2	0.7	1.1	0.9	1.1	2.3	1.7	2.2	3.5	2.2	0.5	1.1	1.4	3.1	1.4	1.4	1.3	0.9	3.1	2.7	1.1	1.4	1.5	0.6	1.3	1.0	1.3	5.2	2.4	2.3	1.2	2.7	0.7	1.1	1.3	2.2	1.6	1.3	0.8	2.5	2.7	0.9	1.1	1.6	2.4	0.0	0.1	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.8	0.1	0.2	0.2	0.1	0.1	2.0	2.0	1.4	2.3	1.8	2.2	1.5	1.6	1.4	1.4	2.0	2.0	67.4	57.7	27.6	29.4	39.1	107.2	67.8	19.2	46.1	74.7	75.5	51.4	39.2	32.9	28.9	42.3	16.7	26.9	63.1	58.7	33.2	21.1	27.3	67.5	103.7	70.9	81.2	42.7	49.5	24.0	51.7	61.5	13.7	87.5	69.0	27.1	55.0	40.5	16.5	38.7	64.2	50.5	26.4	37.6	77.3	13.4	25.7	71.3	35.6	60.9	31.9	22.4	27.8	42.7	524.1	32.8	49.0	43.6	49.0	65.0	16.8	24.7	32.3	40.8	32.9	74.9	42.1	57.9	37.0	51.7	97.0	186.9	44.3	98.5	34.9	65.1
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042184-237833988	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 132.0"	"Group enriched"	"Detected in many"	10	"Cardiomyocytes: 2180.6;Excitatory neurons: 1320.5;Inhibitory neurons: 790.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.7;HEK 293: 8.5;K-562: 2.3;NB-4: 2.7;NTERA-2: 3.1;U-937: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	0.7	0.7	9.1	0.8	15.9	0.0	0.6	8.7	24.0	1.5	0.0	2.0	0.2	0.7	0.4	2.9	0.7	1.9	132.0	10.5	0.0	0.1	0.1	1.8	0.1	0.0	0.0	2.9	8.4	0.0	1.8	1.2	0.0	2.9	0.5	6.5	0.5	1.7	0.1	0.3	0.5	0.7	0.0	1.3	1.5	1.1	0.0	0.1	4.4	0.3	0.0	1.2	0.4	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.9	0.3	0.0	0.0	7.7	8.5	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.0	0.0	0.0	2.7	3.1	0.6	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	9.1	15.9	8.7	24.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.2	0.0	0.5	17.0	0.0	0.4	0.0	0.0	0.0	74.2	0.3	0.1	2180.6	0.0	1.3	1.8	10.4	0.1	0.1	0.0	0.0	0.0	21.1	0.2	3.4	10.6	3.5	0.0	1320.5	2.9	0.1	53.6	0.0	0.5	0.0	0.5	1.1	0.0	0.1	1.7	790.6	0.0	0.0	0.0	0.2	15.3	1.2	1.3	8.8	48.7	0.0	1.3	0.0	29.7	140.6	0.4	0.0	0.0	0.1	0.0	1.0	0.2	0.7	5.3	0.0	0.5	21.6	5.8	2.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 3076.8;skeletal muscle: 3060.2;tongue: 4911.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 1848.3"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Hep G2: 325.8;SK-MEL-30: 1130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		290000	"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	179.7	8.3	811.3	6.5	898.6	2.3	77.2	851.4	952.4	2.9	643.9	14.5	11.1	4.2	1.0	81.0	41.8	4.9	3076.8	779.4	813.6	194.9	4.5	3.9	5.1	907.6	894.8	2.0	16.8	160.9	54.6	18.1	871.2	29.0	1.2	36.5	622.1	9.3	3060.2	23.0	6.9	1.6	847.7	4.2	23.1	5.9	882.9	9.4	167.9	4911.5	4.0	4.3	2.9	967.6	6.0	3.4	3.9	33.7	0.5	0.2	2.9	7.7	0.2	0.6	0.2	6.6	3.4	3.7	137.7	0.6	2.7	10.3	0.3	0.4	0.0	4.2	3.3	8.2	5.4	325.8	0.4	3.0	2.3	0.7	0.0	0.0	0.1	7.9	0.0	1.5	27.2	3.7	0.1	10.6	1.2	4.9	1.8	4.3	2.6	22.5	3.3	8.0	6.0	12.1	6.1	1.9	3.5	10.6	1130.2	11.1	32.8	16.2	2.7	3.3	2.8	3.0	3.8	6.1	5.7	6.2	2.5	6.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	811.3	898.6	851.4	952.4	779.4	813.6	907.6	894.8	871.2	847.7	882.9	967.6	4.3	0.0	0.0	59.4	9.5	9.7	1.2	0.4	1.8	1.1	369.9	354.1	74.4	8.6	0.2	154.5	2.1	1.1	5.9	1.1	162.4	0.9	0.6	90.5	17.3	5.3	1.8	0.0	0.3	3.7	1.9	6.0	0.0	193.3	0.0	0.0	7.9	4.7	199.1	0.0	0.3	3.7	0.0	0.6	3.5	2.2	6.5	15.6	341.5	2.8	0.0	163.5	0.0	2.0	45.8	1.9	0.6	9.1	0.0	1.8	0.9	1848.3	0.2	2.7	0.0	67.0	4.2	3.8	2.8	1.0	2.3	3.4	8.2	2.3	1.8	0.7
S100A11	S100C	ENSG00000163191	"S100 calcium binding protein A11"	P31949	1	152032506-152047907	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 4751.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5473.4;Extravillous trophoblasts: 6093.0;Pancreatic endocrine cells: 6926.5;Urothelial cells: 6250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 17820.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034320, HPA042745"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA		7900000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB034320: AB_2183487, HPA042745: AB_2678142"	"unprognostic (1.85e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (3.34e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.24e-6)"	"unprognostic (2.91e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.86e-2)"	656.7	214.3	92.6	487.2	92.8	415.2	574.7	99.1	222.3	1070.5	106.8	303.0	181.6	297.7	675.4	4751.5	611.1	437.8	354.1	92.3	104.4	882.5	127.6	776.0	206.7	118.1	108.6	152.0	264.1	905.1	210.7	723.2	118.0	536.4	328.7	8.4	1247.1	544.1	91.0	894.7	239.5	468.3	110.2	713.7	482.6	68.9	124.1	303.5	325.3	150.9	959.9	1527.7	1771.1	126.8	1889.0	1483.7	70.5	542.1	1960.9	2451.3	1172.4	1796.3	2626.0	1439.7	1464.8	697.6	2066.0	2.5	1571.4	2355.4	1142.4	2595.4	73.7	3254.0	814.0	913.6	149.2	162.6	830.1	409.1	1511.3	149.6	1098.4	1867.2	3255.1	1577.8	1974.9	826.9	1116.1	0.3	340.9	352.1	2137.7	3058.8	19.8	694.0	513.9	4043.1	1491.9	2.5	757.1	1426.0	4361.1	3196.5	2.5	115.8	1367.7	1797.9	1255.3	1727.2	1378.9	1612.5	1584.8	757.0	533.1	1188.8	975.7	2.5	17.0	8.2	1713.0	490.9	915.2	7956.3	4682.6	7210.4	713.6	4560.1	939.4	354.9	1346.4	845.1	3020.5	252.7	391.5	437.0	17820.3	740.5	4871.8	1042.8	1269.9	5289.9	92.6	92.8	99.1	222.3	92.3	104.4	118.1	108.6	118.0	110.2	124.1	126.8	718.5	137.8	189.4	1.3	136.6	2210.3	3924.9	5473.4	1027.8	0.7	686.8	823.8	30.8	546.2	2673.9	2284.2	0.0	3257.0	384.0	421.7	1019.3	4344.5	277.6	1738.8	561.2	617.8	277.7	52.6	0.0	4330.2	6093.0	890.7	676.4	1503.0	437.6	251.1	372.6	11.6	3806.0	0.0	0.0	479.6	1485.2	1216.7	2054.0	634.0	320.9	1971.8	1243.3	15.9	2265.2	0.8	371.8	0.0	0.0	6926.5	690.2	258.4	153.8	4365.0	343.9	925.4	2674.2	2.4	210.4	536.2	1054.9	14.5	34.8	4207.9	2822.4	3753.1	470.4	334.8	500.2	6250.2
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 3084.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 28.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.9;NK-cells: 28.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 811.3;SuSa: 896.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		36000	"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	275.3	137.3	237.4	47.7	247.3	4.4	222.4	241.0	347.5	133.7	214.6	198.9	30.6	111.8	72.1	91.7	129.8	103.9	310.1	233.1	240.8	262.2	66.2	138.0	48.8	252.9	245.5	138.2	75.7	317.4	73.9	70.1	249.4	100.9	59.8	25.8	156.1	64.6	250.6	114.0	116.5	68.9	245.8	111.7	94.4	41.2	251.6	21.2	318.7	220.6	49.6	121.2	122.7	258.6	188.7	153.7	174.5	111.4	150.7	437.5	62.7	254.7	400.0	150.6	172.2	150.4	203.7	4.9	471.6	435.5	22.3	174.7	73.5	158.7	132.7	0.8	68.1	12.0	178.0	129.6	99.8	5.9	39.2	355.3	59.4	135.3	145.0	441.9	346.5	1.3	61.4	0.3	475.2	663.4	0.4	3.4	141.0	161.1	460.2	30.0	180.4	1.4	811.3	141.9	53.4	2.0	544.7	277.2	576.7	896.9	226.4	6.8	495.0	103.3	57.9	139.5	312.0	2.0	5.3	9.3	185.5	3.2	62.1	4.1	2.0	0.2	0.4	0.9	0.9	4.1	0.4	0.3	7.0	2.0	0.6	0.5	0.3	28.3	1.4	11.9	1.4	1.1	237.4	247.3	241.0	347.5	233.1	240.8	252.9	245.5	249.4	245.8	251.6	258.6	331.0	28.9	106.1	29.7	9.3	110.5	177.4	105.0	103.0	2.1	311.2	345.6	141.9	164.5	104.0	465.3	0.0	132.4	15.3	148.7	248.4	323.3	8.4	399.3	449.1	251.9	124.7	17.3	1.2	323.6	202.1	450.0	58.6	573.8	23.5	185.5	372.3	51.8	162.3	0.0	0.5	167.5	61.1	31.7	107.7	36.3	771.7	37.1	238.3	13.1	14.8	308.1	1.0	0.0	8.8	488.4	164.7	314.1	6.3	240.0	128.7	521.7	77.1	6.9	0.0	234.2	132.5	12.8	23.4	80.3	75.7	74.7	20.5	3084.7	100.6	244.3
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 3574.5;kidney: 1380.0;urinary bladder: 1097.4"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 11464.4;Basal prostatic cells: 4796.7;Basal respiratory cells: 10600.9;Basal squamous epithelial cells: 4741.9;Club cells: 3331.1;Prostatic glandular cells: 9446.4;Squamous epithelial cells: 9013.7;Suprabasal keratinocytes: 3626.5;Urothelial cells: 5382.7"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 848.8;head and neck cancer: 1229.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.1"	"Group enriched"	"Detected in many"	5	"HBEC3-KT: 21286.9;RT4: 8382.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA		27000	"Cluster 10: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	4.0	2.1	2.5	4.1	2.7	1.0	17.3	2.4	3.6	279.9	2.0	3.1	0.8	2.5	16.1	3574.5	5.6	1.8	3.9	2.3	3.2	1380.0	1.7	12.0	0.5	4.1	3.0	1.9	2.1	0.1	5.4	0.8	3.0	48.1	1.6	0.4	377.1	16.9	3.3	429.6	1.6	1.9	3.0	1.5	3.6	2.8	3.4	6.3	11.9	1.4	416.1	1097.4	747.3	3.5	827.0	9.3	1.1	0.9	10.8	4.2	1.2	10.4	11.5	9.0	7.8	2.1	26.8	1.2	418.3	17.8	18.3	2001.4	1.3	21286.9	9.9	5.4	3.7	3.8	56.2	5.0	4.5	0.7	1.9	8.8	2777.8	24.1	3135.5	21.7	13.2	0.0	0.8	1.5	47.7	3.4	0.2	0.2	2.2	22.3	155.4	1.3	497.9	2.1	502.4	8382.8	16.5	0.5	34.9	5.8	9.0	5.9	3.2	5.7	6.0	12.5	692.6	92.4	280.6	1.9	2.4	4.7	26.5	1.8	24.2	10.1	0.4	0.0	2.3	0.0	1.4	0.4	1.6	1.3	0.3	0.0	0.4	0.3	4.3	0.0	0.5	2.2	1.6	0.7	2.5	2.7	2.4	3.6	2.3	3.2	4.1	3.0	3.0	3.0	3.4	3.5	1.4	9.6	17.3	2.6	1.0	11464.4	4796.7	10600.9	4741.9	0.0	22.2	35.4	2.9	1.5	3331.1	218.8	0.0	0.7	0.8	3.2	1226.7	24.8	4.5	16.3	2.5	108.2	1.8	3.0	0.1	27.6	1.0	130.8	1.5	24.5	17.1	1.2	0.4	0.1	1.8	0.0	0.0	1.6	789.4	0.8	676.4	8.1	0.6	18.0	759.5	0.0	5.3	1.1	0.0	2.0	0.1	668.7	2.5	0.7	25.9	9446.4	0.8	11.8	560.8	0.1	0.0	5.5	207.0	0.6	3.0	9013.7	3626.5	0.3	37.8	8.9	2.0	5382.7
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 2708.8;Langerhans cells: 5952.7;Macrophages: 2786.0;monocytes: 3172.6;NK-cells: 2130.8;Skeletal myocytes: 2034.0;T-cells: 2111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 2614.3;ASC diff: 3300.1;BJ hTERT+: 6738.6;fHDF/TERT166: 4819.1;RPMI-8226: 2700.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.6"	"CAB002618, HPA007486, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		9600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007486: , HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	982.3	77.1	25.5	353.9	26.2	1090.8	561.9	27.5	53.1	566.3	32.0	301.7	91.7	177.8	124.5	224.0	217.6	167.6	268.5	24.7	27.4	247.0	64.3	874.2	221.0	31.7	26.4	51.0	53.8	18.1	24.8	182.9	29.8	223.7	331.5	10.0	245.4	155.8	163.0	371.5	234.3	297.7	27.8	443.0	133.3	32.2	33.7	112.6	191.9	424.6	315.4	391.6	455.2	34.1	11.8	2614.3	13.2	77.0	3300.1	2410.9	3.7	1664.4	6738.6	32.1	148.4	20.0	180.3	0.8	299.7	4819.1	3.5	65.3	8.8	20.9	23.6	405.2	2.3	1186.8	529.0	59.4	4.3	106.9	1924.6	364.2	21.5	62.2	13.0	4.9	2.6	0.7	9.9	4.2	2468.1	10.6	3.8	1273.9	7.2	189.7	1050.4	64.1	3.7	2700.2	103.5	71.3	108.5	11.6	24.9	1286.6	9.4	412.5	77.1	1493.7	3.1	8.5	13.7	2159.5	9.3	82.8	647.5	14.3	6.1	1367.9	127.2	2789.7	13536.2	1408.0	5800.5	9099.6	6077.0	761.6	5167.7	4700.0	9268.4	282.5	882.4	2641.3	12129.7	837.1	11862.4	1626.0	7406.7	24075.8	25.5	26.2	27.5	53.1	24.7	27.4	31.7	26.4	29.8	27.8	33.7	34.1	226.0	490.4	398.4	0.0	266.1	772.9	19.5	159.0	93.9	0.7	44.9	65.9	14.9	35.8	273.8	893.8	0.0	52.4	1345.4	8.9	111.6	21.9	7.3	53.0	473.0	209.1	4.8	730.9	0.0	23.5	255.5	1378.8	54.0	41.9	1395.8	0.6	96.4	18.6	1966.1	45.4	0.0	10.0	345.8	2708.8	5952.7	24.0	235.8	2786.0	1193.5	12.2	3172.6	3.6	2130.8	0.0	0.1	35.7	17.0	45.9	266.5	12.9	3.2	19.7	154.9	2.3	151.2	2034.0	1309.6	1.9	5.5	77.6	694.0	53.4	2111.1	32.5	11.3	73.1
S100A5	S100D	ENSG00000196420	"S100 calcium binding protein A5"	P33763	1	153537147-153541765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 3.6;thyroid gland: 5.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Distal tubular cells: 3.9;Extravillous trophoblasts: 8.5;Langerhans cells: 3.1;Theca cells: 6.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.0;granulocytes: 1.4;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"OE19: 34.3;RPTEC TERT1: 11.9;RT4: 19.9;SCLC-21H: 17.3"	"Region enriched"	"Detected in many"	86	"olfactory bulb: 980.0"	"Region enriched"	"Detected in single"	15	"olfactory bulb: 5.6"	HPA064184			Approved	Nucleoplasm		Yes	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA064184: AB_2685206"	"unprognostic (6.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.63e-5)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"		"unprognostic (1.52e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.68e-3)"	0.2	0.1	0.3	0.1	0.3	0.7	0.2	0.9	0.8	0.3	0.1	0.2	1.5	0.6	0.1	0.9	0.5	1.0	0.1	0.3	0.4	2.9	0.0	0.5	1.5	0.4	0.3	0.1	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.1	3.6	0.3	0.0	0.3	0.4	1.2	0.1	0.4	0.7	5.2	0.1	0.4	1.1	0.3	0.4	2.2	5.7	0.0	0.0	0.6	0.4	0.4	1.0	1.3	0.7	1.4	0.6	4.2	0.0	3.7	2.1	0.4	1.7	0.1	1.0	0.9	0.5	0.0	2.7	2.6	0.2	0.4	0.0	3.5	0.0	1.1	2.7	0.8	0.5	0.5	0.0	0.7	0.2	3.0	0.2	0.5	1.3	0.2	34.3	9.7	0.0	1.8	1.1	11.9	19.9	17.3	0.0	0.2	9.0	0.8	1.5	0.0	0.5	0.4	0.1	1.3	2.6	1.7	0.0	0.9	0.0	0.5	0.7	0.4	0.0	0.7	1.4	1.2	0.1	4.6	0.5	2.6	1.3	1.8	0.3	1.4	0.6	1.2	0.0	0.4	3.0	3.9	0.7	0.3	0.3	0.9	0.8	0.3	0.4	0.4	0.3	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.2	3.7	0.0	0.1	0.2	0.1	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	8.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.0	0.6	3.1	0.0	0.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.6	6.8	0.3	0.6
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361023	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32194.3;esophagus: 30581.7;vagina: 14027.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 24579.6;neutrophil: 33654.0"	"Group enriched"	"Detected in all"	6	"granulocytes: 33654.0;monocytes: 24579.6"	"Cell line enriched"	"Detected in many"	6	"SK-BR-3: 2398.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	706.4	126.1	19.7	1505.7	24.3	32194.3	189.8	21.4	67.8	7849.1	28.5	123.9	24.1	50.0	2.0	30581.7	486.1	147.4	208.5	19.4	21.9	171.7	284.0	1629.4	69.3	28.7	24.2	51.5	73.9	11.5	65.4	370.1	30.0	91.3	20.2	3.6	5790.0	9.6	92.2	416.7	120.6	480.7	22.0	5381.4	187.6	16.7	26.5	197.7	90.4	150.4	4378.8	955.1	14027.7	25.4	24.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.0	9.2	372.2	0.0	0.4	23.0	0.0	157.3	0.0	0.4	0.0	6.2	0.0	0.1	0.0	7.8	0.0	0.0	130.2	0.0	8.4	0.0	0.0	0.1	7.6	3.5	0.0	31.4	0.8	3.3	0.1	3.1	0.2	0.8	5.1	82.2	0.3	100.4	1.3	0.6	4.0	2398.2	1.7	1.2	38.1	312.3	6.8	0.0	3.3	0.4	0.4	0.7	1.6	3.3	0.5	71.7	0.0	373.8	24579.6	2626.3	30.5	1754.8	52.6	29.7	25.3	17.2	4664.8	24.8	17.7	15.4	33654.0	18.8	860.2	153.3	29.2	24461.7	19.7	24.3	21.4	67.8	19.4	21.9	28.7	24.2	30.0	22.0	26.5	25.4	1.8	230.8	392.4	0.0	92.1	20.0	123.1	5771.3	28.5	0.0	55.6	6.7	8.0	57.2	1685.0	36.8	0.0	126.1	115.1	7.7	5.9	102.6	1.7	1.2	1.9	26.9	0.0	92.8	0.0	39.4	52.9	50.9	3.6	9.4	164.0	0.2	70.6	54.5	1926.0	0.0	0.0	3.7	309.3	7537.0	13.4	4.0	5.9	3678.1	0.0	0.0	11103.1	0.0	483.0	0.0	0.0	15.3	1.4	0.0	13.1	55.6	0.8	25.2	262.8	0.3	0.0	13.3	60.4	0.3	1.2	3263.1	33.2	1236.0	79.9	0.0	12.5	551.3
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598604-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 1499.3;choroid plexus: 781.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.3;Breast myoepithelial cells: 124.8;Granulosa cells: 261.7;Langerhans cells: 206.8;Melanocytes: 99.6;Oligodendrocytes: 332.1"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 360.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 360.9"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 547.1;WM-115: 992.8"									"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		300000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	151.1	25.7	877.1	10.5	1072.5	2.3	87.0	1254.5	1191.2	28.6	781.0	121.0	7.4	2.4	12.1	14.6	6.9	14.3	28.1	858.4	989.0	3.6	3.2	6.4	21.4	1491.0	1054.2	5.6	5.0	0.3	44.7	0.8	1359.0	29.3	14.2	14.1	19.3	26.2	3.6	15.8	36.3	6.8	1162.2	26.2	23.6	2.4	998.8	18.4	5.2	6.4	20.3	15.9	26.9	1499.3	0.5	0.0	110.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	15.9	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.5	0.0	0.0	547.1	0.0	0.1	0.5	0.0	0.3	0.3	0.0	3.2	0.0	0.3	0.0	1.4	6.7	992.8	0.1	0.5	0.2	360.9	9.5	103.3	0.2	1.0	67.6	16.3	1.4	3.2	153.1	3.2	58.7	10.1	3.9	0.0	63.6	877.1	1072.5	1254.5	1191.2	858.4	989.0	1491.0	1054.2	1359.0	1162.2	998.8	1499.3	4.5	3.2	4.8	126.3	4.6	16.8	0.7	0.0	17.6	1.3	41.2	124.8	6.0	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.1	0.4	0.1	0.1	2.7	0.0	2.7	0.9	0.0	0.1	4.4	0.5	0.2	0.0	261.7	4.6	0.4	9.3	0.0	1.4	0.0	0.0	38.6	206.8	1.7	5.6	37.0	99.6	9.4	33.3	25.7	63.8	83.4	332.1	0.1	0.0	0.0	2.2	0.1	0.0	0.1	0.0	4.7	0.0	5.6	7.8	0.1	0.1	0.7	12.6	0.1	37.9	0.0	0.2	0.4
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693878-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 1410.7;stomach 1: 1742.0;urinary bladder: 1777.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 1088.3;Gastric mucus-secreting cells: 2306.9;Syncytiotrophoblasts: 2773.6;Urothelial cells: 4448.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 1789.3;eosinophil: 836.9;neutrophil: 2961.8"	"Lineage enriched"	"Detected in many"	73	"granulocytes: 2961.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 879.0;Hep G2: 1283.2;hTCEpi: 1185.6;OE19: 4335.4;RT4: 2619.8;SK-BR-3: 1057.4"									"HPA019502, HPA075251"	Enhanced		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA019502: AB_1856530, HPA075251: "	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	14.0	1.7	1.0	42.4	1.4	1410.7	7.4	1.6	6.3	15.0	1.4	155.6	13.2	5.9	0.0	340.6	6.9	52.1	2.7	1.4	0.9	2.1	8.8	14.7	1.0	1.1	1.1	0.5	4.7	0.4	1.7	474.7	3.2	25.5	176.0	0.1	8.2	0.5	0.4	20.9	23.8	16.6	0.6	34.3	1742.0	1.4	1.0	10.6	0.6	12.2	96.9	1777.0	34.5	1.1	115.2	89.1	0.0	0.1	0.0	0.5	879.0	0.0	1.0	0.0	0.0	5.2	17.6	0.7	40.1	0.6	1.2	137.6	0.5	1.1	0.0	54.7	0.0	1.9	106.7	1283.2	0.0	53.4	3.2	0.6	1185.6	0.0	1.1	0.2	0.2	0.8	3.1	0.0	0.0	214.5	1.6	126.5	1.5	4335.4	149.6	0.9	0.5	0.5	0.0	2619.8	1.1	0.7	156.8	1057.4	2.4	39.9	31.0	169.6	0.5	0.0	1.4	0.2	0.9	1.2	0.7	0.8	0.1	479.1	0.2	1789.3	40.6	836.9	1.4	9.5	1.1	0.4	1.7	1.1	1.6	0.5	0.3	0.8	2961.8	0.1	5.7	0.4	1.1	16.7	1.0	1.4	1.6	6.3	1.4	0.9	1.1	1.1	3.2	0.6	1.0	1.1	0.9	9.6	48.6	0.0	6.2	1.1	318.3	568.6	4.0	0.0	3.4	3.6	1.2	27.1	1088.3	1.8	0.0	550.7	2.2	322.2	0.0	4.8	12.3	37.5	38.9	8.7	16.6	0.0	0.0	31.1	783.4	13.8	2306.9	202.5	31.6	0.0	1.4	7.4	69.2	0.0	0.0	443.7	152.5	11.8	1.0	7.4	0.0	11.0	8.8	0.0	5.6	0.0	2.1	0.0	0.1	828.1	580.9	0.0	5.9	288.4	2.2	0.5	301.5	0.0	0.0	0.1	32.1	0.5	0.6	18.6	6.3	2773.6	9.8	0.1	173.2	4448.3
S100Z	"Gm625, S100-zeta"	ENSG00000171643	"S100 calcium binding protein Z"	Q8WXG8	5	76850001-76921650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;lymphoid tissue: 3.2"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 7.4;Kupffer cells: 8.7;Macrophages: 11.8;Microglial cells: 32.8;monocytes: 26.1"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 35.0;eosinophil: 31.8;intermediate monocyte: 34.0;myeloid DC: 19.5;neutrophil: 11.8;non-classical monocyte: 39.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 19.5;granulocytes: 31.8;monocytes: 39.6"	"Cell line enriched"	"Detected in some"	6	"U-698: 81.9"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.3"	"Low region specificity"	"Detected in all"			HPA051929	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA051929: AB_2732571"	"unprognostic (4.17e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.47e-5)"	"unprognostic (3.39e-4)"	"unprognostic (8.94e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.62e-1)"	0.3	0.2	1.1	2.0	0.6	2.4	0.2	0.4	1.1	0.0	0.1	0.3	0.4	0.1	0.1	0.3	0.1	0.7	0.1	0.5	0.5	0.1	0.3	0.7	0.9	0.6	0.6	0.0	0.9	0.1	0.1	1.2	0.6	0.2	0.4	0.0	0.2	0.1	0.2	0.0	0.8	0.6	0.5	3.2	0.4	0.2	1.0	0.8	0.1	0.0	2.5	0.5	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	2.7	0.1	0.2	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.1	1.0	0.1	81.9	3.3	0.0	0.0	2.5	35.0	31.8	0.8	34.0	0.2	4.7	0.5	0.1	19.5	2.1	0.0	0.0	11.8	0.7	39.6	0.1	0.7	10.5	1.1	0.6	0.4	1.1	0.5	0.5	0.6	0.6	0.6	0.5	1.0	1.1	0.2	0.0	0.0	0.3	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	2.1	2.1	0.0	0.2	0.2	0.5	0.2	0.0	0.5	0.4	0.0	7.4	0.0	2.0	0.0	0.0	8.7	1.1	0.0	0.0	11.8	3.6	32.8	26.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.1	1.4	0.0	0.0	0.0
SAAL1	FLJ41463	ENSG00000166788	"Serum amyloid A like 1"	Q96ER3	11	18069935-18106087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039003, HPA039004"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039003: AB_2676303, HPA039004: AB_10673602"	"unprognostic (1.13e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.75e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.87e-1)"	6.0	5.3	4.9	8.2	4.8	19.1	10.0	5.6	6.1	6.2	4.3	9.6	8.0	7.5	7.7	6.6	5.6	4.8	6.5	4.6	5.0	5.4	8.3	4.9	14.6	4.8	5.3	8.2	8.1	5.4	5.2	7.0	4.9	6.0	11.9	8.2	5.6	5.8	5.8	5.7	6.7	9.6	4.8	7.5	6.7	12.8	5.1	13.7	6.1	7.2	15.6	7.8	6.1	5.7	27.1	41.5	29.5	40.5	19.5	21.8	24.6	29.9	20.4	44.8	52.8	57.8	10.1	73.0	15.5	16.9	62.3	34.9	56.9	48.5	62.6	32.5	57.4	33.6	24.9	35.0	15.9	57.1	28.6	15.2	22.2	28.7	42.9	16.8	38.5	62.8	50.5	23.9	37.2	36.2	66.7	54.2	38.5	41.7	39.0	65.7	51.8	25.4	25.7	31.4	36.4	34.3	26.9	28.4	36.4	37.1	18.2	25.9	15.8	51.0	35.0	29.4	43.2	11.6	37.7	80.6	21.2	45.2	47.5	11.1	12.9	4.3	14.0	15.4	13.5	16.5	16.2	12.3	22.3	11.7	12.3	13.3	0.6	10.4	14.6	11.4	20.9	10.8	4.9	4.8	5.6	6.1	4.6	5.0	4.8	5.3	4.9	4.8	5.1	5.7	7.6	0.0	10.8	7.5	15.9	4.6	7.8	16.0	9.6	9.0	7.2	6.9	8.5	2.8	7.4	1.8	2.1	22.0	13.6	6.3	5.9	9.6	21.9	4.4	8.0	8.7	28.1	11.1	8.5	10.2	23.1	8.0	4.6	4.2	14.0	15.3	5.7	4.6	16.1	0.0	9.5	10.7	8.2	10.9	7.3	3.5	8.1	7.7	5.4	6.5	10.7	6.5	4.1	15.1	11.7	6.6	7.5	7.9	17.3	3.8	6.9	7.7	6.0	8.5	6.6	6.1	10.5	41.5	24.9	8.3	5.4	10.4	9.9	10.1	15.1	6.1
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745409	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	23.5	26.3	13.2	26.2	13.8	21.1	22.0	17.1	16.1	22.1	13.6	24.0	23.3	20.6	23.3	20.2	16.9	19.2	16.3	14.0	18.8	38.1	28.2	28.9	26.8	15.5	14.9	16.2	21.8	35.8	10.9	25.0	14.7	24.3	23.6	20.3	22.9	20.6	8.8	18.4	21.6	21.2	14.6	26.2	25.0	14.2	15.9	32.5	43.5	11.4	25.0	22.9	10.8	16.3	31.0	23.0	38.0	22.0	58.8	39.2	29.6	50.1	43.0	36.9	33.1	30.5	21.8	47.8	24.3	39.8	49.8	22.7	50.4	27.0	48.9	34.3	26.8	50.8	38.2	25.7	37.6	78.0	61.5	26.5	41.1	39.9	29.6	29.9	25.6	43.2	57.9	45.7	60.6	14.0	59.5	41.4	40.1	29.6	40.1	17.2	20.0	48.4	41.2	42.7	15.0	36.1	35.5	36.3	44.7	38.0	31.0	64.1	33.7	36.2	21.1	37.0	44.5	25.3	71.7	32.5	45.1	106.8	36.2	10.3	17.1	27.5	24.6	14.2	27.5	11.0	17.8	26.0	27.2	11.9	17.6	23.5	14.1	65.2	13.0	11.1	16.7	27.6	13.2	13.8	17.1	16.1	14.0	18.8	15.5	14.9	14.7	14.6	15.9	16.3	18.4	28.9	37.3	22.5	22.2	19.6	9.1	14.6	22.2	22.8	15.2	12.3	16.6	14.3	15.7	7.3	31.3	22.9	55.4	16.4	19.6	11.1	1.6	15.9	31.9	17.6	12.0	23.4	44.7	10.0	11.2	19.5	17.3	18.5	17.1	17.2	17.2	15.4	24.5	33.7	42.7	9.4	18.3	23.0	18.7	2.9	16.8	22.6	17.8	30.9	25.5	15.8	46.4	40.7	43.6	12.9	20.7	23.0	33.2	14.6	18.5	22.3	14.1	20.7	6.6	15.8	16.6	12.3	12.0	15.7	17.3	18.3	44.5	19.5	13.6	11.6
SAE1	"AOS1, FLJ3091, Sua1"	ENSG00000142230	"SUMO1 activating enzyme subunit 1"	Q9UBE0	19	47113274-47210636	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041906, HPA043552"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		37000	"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"HPA041906: AB_2677735, HPA043552: AB_2678548"	"unprognostic (9.69e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (9.86e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.27e-1)"	43.9	34.7	33.1	18.7	33.9	21.5	38.9	30.2	39.9	47.8	29.7	115.7	9.9	58.5	4.9	53.0	44.5	14.7	44.3	34.2	34.3	29.4	32.4	39.5	23.1	33.4	33.5	36.4	29.3	22.1	27.2	21.6	33.4	38.5	15.8	11.0	31.0	22.3	53.6	41.3	43.2	27.6	30.5	51.8	59.1	76.6	35.6	36.5	50.8	17.7	24.9	68.1	42.3	34.4	126.7	71.6	189.2	81.8	57.9	68.8	51.3	180.7	130.3	154.7	192.7	76.0	61.6	131.4	72.6	112.0	89.6	49.4	179.6	93.2	141.0	138.4	172.0	117.4	45.2	62.7	68.4	142.3	81.7	64.0	42.2	75.4	72.0	58.9	142.2	141.3	138.7	51.3	135.9	68.0	127.1	396.8	87.3	116.0	68.5	171.7	110.2	47.9	56.2	77.1	59.9	79.3	126.8	87.9	79.3	84.3	70.8	75.9	72.7	71.0	103.8	47.0	161.9	97.0	352.1	206.5	44.7	108.7	98.5	55.3	37.6	21.7	41.6	34.7	45.2	37.2	50.4	43.2	45.2	29.6	69.9	54.6	18.9	63.8	23.6	30.1	69.4	65.3	33.1	33.9	30.2	39.9	34.2	34.3	33.4	33.5	33.4	30.5	35.6	34.4	29.2	9.6	18.7	11.4	24.1	25.6	32.6	33.2	16.5	20.1	19.2	16.3	21.9	15.7	18.6	12.9	6.2	77.7	20.5	18.5	11.7	41.6	13.1	13.3	34.4	39.4	19.2	36.6	20.9	34.9	107.2	30.8	17.3	22.0	15.2	40.2	22.1	21.0	57.6	20.2	21.8	25.2	42.7	17.2	25.0	19.1	15.5	19.2	46.2	10.3	48.5	25.8	41.2	10.6	16.3	38.1	20.1	18.8	26.3	32.6	11.4	15.6	7.2	16.6	52.6	16.5	39.0	151.3	113.7	22.4	24.6	57.5	33.5	35.4	32.5	30.5
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	NA		67000	"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Midbody	"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.70e-4)"	43.4	40.1	27.9	34.5	31.6	55.6	44.2	37.1	33.8	52.5	24.0	50.4	28.8	49.7	14.0	45.2	45.2	17.3	46.0	27.6	31.4	39.3	42.6	45.8	39.0	32.0	29.2	54.4	44.3	22.7	43.4	27.7	31.0	46.4	17.7	32.1	42.8	19.6	85.3	60.9	48.4	20.6	23.9	58.9	43.2	43.4	32.4	43.4	42.6	30.2	29.4	43.4	47.6	44.6	94.1	81.8	95.3	62.0	41.6	36.4	111.5	68.0	43.7	56.8	47.4	124.2	52.0	149.7	52.9	33.8	48.3	86.4	92.7	55.7	58.1	101.6	94.6	109.9	75.1	118.0	39.4	136.7	93.6	33.6	50.9	50.8	53.2	40.4	45.5	65.9	156.7	75.0	43.5	84.7	146.2	109.9	128.3	63.7	81.1	144.4	105.1	104.8	44.4	76.6	88.2	76.4	76.3	61.2	76.2	54.3	56.3	74.4	71.4	57.6	71.6	72.2	106.2	121.5	112.0	133.3	55.4	112.6	77.7	65.4	47.4	84.1	55.9	47.8	57.1	53.1	55.1	54.9	53.2	47.6	56.8	55.1	53.1	54.6	79.8	44.6	58.6	55.4	27.9	31.6	37.1	33.8	27.6	31.4	32.0	29.2	31.0	23.9	32.4	44.6	34.8	32.1	21.0	33.3	59.1	65.6	50.2	41.0	51.2	41.3	28.9	30.2	43.4	17.2	47.6	16.5	35.5	53.6	47.7	41.0	25.4	44.0	10.0	56.6	55.6	38.9	29.8	29.6	28.6	35.0	55.2	42.6	33.1	46.4	50.6	52.6	23.2	28.1	38.0	50.5	29.8	43.4	32.6	23.0	52.6	8.2	35.8	37.0	30.2	30.9	55.6	30.0	50.4	34.2	41.5	32.3	29.9	25.9	50.9	44.8	33.7	28.1	72.9	47.2	19.7	44.5	45.1	89.7	94.3	37.2	65.4	62.5	52.2	44.0	40.5	38.9
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA		48000	"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: AB_2681266"	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.12e-4)"	26.8	35.8	23.3	22.4	23.8	35.2	25.8	28.0	30.3	48.4	21.0	35.3	22.2	38.2	21.0	23.1	44.0	15.6	30.8	21.7	29.6	40.6	30.7	27.8	24.4	24.2	23.9	56.2	30.5	18.0	48.6	14.2	23.1	43.0	16.1	34.7	27.6	18.6	41.5	25.8	34.3	19.3	17.5	39.9	27.8	32.5	23.9	22.3	38.9	20.4	21.2	31.5	35.0	27.5	44.9	54.8	38.8	30.4	36.7	23.7	47.6	40.9	21.3	24.4	23.3	69.9	31.4	84.9	36.9	19.9	19.6	39.9	47.2	24.9	39.2	59.8	53.5	64.4	59.5	54.6	21.2	53.0	58.2	23.5	25.4	35.2	26.9	23.9	24.6	29.3	63.6	40.6	28.7	48.9	65.7	53.1	69.9	33.1	59.9	82.2	34.2	47.6	27.7	70.5	37.6	35.3	54.7	25.3	35.3	24.4	36.5	33.0	40.5	30.7	32.7	39.3	57.6	55.2	52.2	58.6	31.2	47.1	52.2	42.8	12.6	22.0	14.6	10.8	16.8	13.9	13.2	11.7	11.3	14.9	14.5	11.7	23.4	9.4	12.3	12.5	13.4	7.9	23.3	23.8	28.0	30.3	21.7	29.6	24.2	23.9	23.1	17.5	23.9	27.5	40.6	41.7	45.1	79.7	69.7	46.7	58.1	41.4	47.3	70.2	39.1	30.6	28.7	20.0	39.3	33.1	75.0	46.8	63.0	46.4	23.5	49.7	7.6	44.5	92.6	49.0	43.0	45.8	36.2	44.4	44.7	47.3	44.4	58.3	42.3	45.4	26.7	23.3	30.6	43.7	42.7	46.5	57.0	27.6	49.5	13.3	72.4	46.6	26.6	32.8	52.2	77.5	52.5	29.7	34.6	42.2	48.6	65.8	70.0	50.3	54.1	61.5	55.3	78.4	46.0	75.4	47.9	68.3	78.8	37.3	41.9	32.3	79.1	59.7	44.8	54.2
SAGE1	"CT14, SAGE"	ENSG00000181433	"Sarcoma antigen 1"	Q9NXZ1	X	135889205-135913061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 4.8"	"Cell type enriched"	"Detected in some"	9	"Spermatogonia: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 20.5;K-562: 15.6;Karpas-707: 25.5;U-2 OS: 7.0;U-266/70: 8.9;U-266/84: 23.8"									"HPA003033, HPA003208"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003033: AB_1079865, HPA003208: AB_1079863"				"unprognostic (1.11e-1)"	"unprognostic (5.26e-2)"			"unprognostic (1.15e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.37e-1)"		"unprognostic (7.12e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	8.9	23.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.3	0.4	0.5	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0;kidney: 36.4;liver: 36.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Cone photoreceptor cells: 25.0;Endometrial stromal cells: 17.5;Glandular and luminal cells: 14.3;Hepatocytes: 30.1;Microglial cells: 26.2;Oligodendrocytes: 47.6;Proximal tubular cells: 20.3"	"Cancer enhanced"	"Detected in many"		"glioma: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 29.5;BJ hTERT+: 25.3;NTERA-2: 48.0;RPTEC TERT1: 40.4;U-87 MG: 46.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 52.6"	"Low region specificity"	"Detected in all"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.3	0.0	18.0	0.6	29.2	0.1	0.3	29.7	21.3	19.6	2.1	2.6	1.0	17.4	0.0	0.3	11.0	0.4	0.8	17.9	21.7	36.4	36.5	0.0	0.0	41.0	32.2	4.5	1.0	6.5	6.5	3.9	36.6	0.8	2.6	4.6	0.2	1.6	0.0	0.2	1.3	8.4	31.1	0.0	2.5	1.7	26.6	0.1	23.7	0.2	0.0	2.8	7.2	40.2	0.0	1.7	29.5	0.2	0.8	0.6	0.0	10.0	25.3	0.6	1.4	0.0	0.0	0.0	11.2	14.1	8.8	0.0	18.6	0.0	0.9	0.0	11.3	0.0	0.0	18.5	0.7	0.0	8.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.0	0.0	0.0	3.8	1.9	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	46.2	0.0	10.0	0.2	0.6	0.5	0.1	0.4	0.1	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.0	0.3	0.4	0.2	0.3	18.0	29.2	29.7	21.3	17.9	21.7	41.0	32.2	36.6	31.1	26.6	40.2	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	1.4	10.0	0.0	9.2	25.0	0.0	0.0	0.0	11.7	0.5	0.7	8.9	17.5	0.9	0.0	2.7	0.2	0.0	0.0	1.6	0.0	14.3	0.0	0.0	0.7	30.1	0.1	0.0	8.2	0.0	0.0	1.0	0.3	0.1	0.0	0.4	0.0	26.2	0.0	0.5	0.0	5.0	47.6	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	1.0	0.0	0.0	0.5	0.2	2.3	0.0	0.1	0.0	0.3	0.6	0.0	0.1
SALL2	"Hsal2, KIAA0360, ZNF795"	ENSG00000165821	"Spalt like transcription factor 2"	Q9Y467	14	21521080-21537216	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.4;Bipolar cells: 13.9;Horizontal cells: 13.5;Muller glia cells: 11.2;Oligodendrocyte precursor cells: 10.6"	"Cancer enhanced"	"Detected in many"		"glioma: 16.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 109.2;NTERA-2: 85.7;SuSa: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004162	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles	Nucleoplasm	"HPA004162: AB_2667155"	"unprognostic (5.73e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	3.9	5.4	40.2	1.4	37.7	0.2	5.5	43.2	31.0	13.1	16.6	13.3	1.7	13.5	6.3	2.9	12.7	3.2	5.4	29.4	43.7	6.2	0.9	4.5	1.7	41.3	45.2	17.2	4.3	20.6	27.0	1.2	36.9	7.0	2.1	16.9	3.1	9.2	1.5	2.6	6.7	9.5	39.2	2.8	6.0	1.6	49.1	6.5	10.5	2.8	1.7	8.7	6.3	28.7	0.1	2.4	109.2	24.2	1.9	1.6	0.0	2.1	2.7	7.1	7.2	2.3	1.2	0.1	2.2	3.2	3.1	0.2	24.5	2.7	10.0	2.0	12.5	0.0	0.7	2.2	3.2	0.0	0.1	7.3	0.9	3.4	0.0	18.4	2.2	10.9	16.6	0.0	6.2	2.1	16.0	0.1	85.7	0.1	0.5	14.3	2.3	0.0	8.3	11.6	30.4	17.3	0.0	0.6	0.3	36.2	9.2	0.2	0.0	0.9	11.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.5	1.1	0.0	0.1	0.0	0.5	0.5	0.1	40.2	37.7	43.2	31.0	29.4	43.7	41.3	45.2	36.9	39.2	49.1	28.7	0.8	3.2	3.6	13.4	0.0	0.6	0.6	1.1	8.0	13.9	3.4	2.8	0.9	2.8	1.5	5.5	8.4	0.1	0.2	0.0	1.9	1.8	0.3	0.5	3.2	1.0	0.0	0.4	2.5	0.0	0.1	3.9	0.0	0.4	0.0	7.2	2.5	0.1	0.1	13.5	9.3	0.0	4.1	0.0	0.3	0.7	5.0	0.2	0.0	0.0	0.0	11.2	0.0	10.6	2.6	0.3	0.0	6.0	0.2	0.4	0.0	0.8	0.0	2.8	0.0	3.9	3.0	0.0	0.5	1.0	0.6	0.1	0.8	3.9	0.0	0.1
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802521	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.9;thyroid gland: 5.8"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 26.9"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"NK-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 25.0;AN3-CA: 17.5;BEWO: 33.2;NTERA-2: 60.2;SiHa: 15.6;SuSa: 39.7"	"Not detected"	"Not detected"							"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.2	0.3	0.2	0.2	0.2	0.8	0.2	0.4	0.2	0.2	0.3	0.2	0.1	0.2	0.4	0.2	0.2	0.0	0.1	0.2	0.4	0.8	1.6	0.2	0.1	0.2	0.3	0.1	2.1	2.0	0.5	0.2	0.2	2.4	0.2	0.5	0.9	0.2	0.1	0.2	0.4	0.1	0.2	0.5	0.2	3.9	0.3	0.0	5.8	0.0	0.1	0.4	0.1	0.4	0.0	1.7	25.0	17.5	0.0	0.1	33.2	0.0	0.2	0.1	0.3	9.0	0.2	0.0	0.3	0.3	0.3	4.3	0.2	0.1	0.3	0.4	0.0	0.0	7.0	0.4	0.1	0.0	1.9	0.7	0.5	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.8	0.0	0.1	60.2	0.2	0.4	2.3	0.0	0.0	0.0	0.5	5.7	3.1	15.6	0.1	1.5	39.7	0.1	1.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.4	0.1	0.0	2.0	1.6	0.0	0.0	1.1	0.1	0.0	0.4	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.6	0.0	0.2	0.1	0.2	1.2	0.0	4.1	0.2	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.6	0.2	26.9	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	1.0	2.0	2.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.7	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2
SAMD10	C20orf136	ENSG00000130590	"Sterile alpha motif domain containing 10"	Q9BYL1	20	63974116-63980008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.6;T-cells: 3.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040973	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA040973: AB_10794258"	"unprognostic (5.89e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.94e-3)"	1.6	3.4	6.8	4.0	9.4	2.4	2.9	11.6	10.0	2.9	4.2	3.9	4.3	0.8	1.6	13.8	3.3	2.2	4.5	6.4	5.3	8.9	5.7	2.7	6.6	5.0	4.9	0.4	5.2	3.0	3.5	1.9	5.1	5.5	2.1	3.1	5.6	1.6	1.1	7.7	5.4	0.8	4.3	6.5	6.2	3.5	6.7	4.2	3.7	1.0	6.2	3.7	5.9	5.9	8.2	0.0	2.6	0.2	0.6	0.8	0.1	2.6	2.1	5.2	2.4	7.8	15.5	0.5	5.3	1.3	0.3	11.0	2.6	3.2	2.6	16.6	5.4	2.7	8.8	11.8	1.1	13.8	21.3	0.7	5.8	2.8	0.5	3.7	2.4	5.7	6.7	6.5	1.0	6.3	6.2	12.8	4.2	11.7	12.3	8.7	0.1	14.6	8.6	14.1	2.9	6.2	1.8	14.9	3.4	1.1	10.1	6.8	2.3	1.6	3.7	0.1	0.4	1.3	1.0	4.7	5.0	11.0	1.5	0.0	0.1	0.3	2.7	0.1	1.4	1.6	1.7	1.6	0.3	0.6	3.1	3.4	0.0	0.6	0.3	0.5	1.4	1.1	6.8	9.4	11.6	10.0	6.4	5.3	5.0	4.9	5.1	4.3	6.7	5.9	1.9	3.2	0.0	5.2	3.5	1.0	2.3	3.9	0.0	5.7	4.9	4.3	2.4	0.0	3.6	9.2	2.1	3.0	5.1	2.5	1.9	3.2	0.0	2.3	0.4	1.9	4.9	2.1	5.1	3.4	0.5	0.3	5.1	3.3	0.0	3.3	2.5	1.1	1.2	0.0	5.8	4.4	4.1	1.0	0.4	0.2	0.0	0.9	1.8	0.0	2.1	2.9	8.2	1.5	0.0	8.4	1.8	0.0	0.5	3.0	4.1	3.5	3.0	3.3	0.0	0.1	0.9	0.5	1.3	6.4	1.8	2.7	4.7	0.4	2.5	3.9
SAMD11	MGC45873	ENSG00000187634	"Sterile alpha motif domain containing 11"	Q96NU1	1	923923-944575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 266.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 87.6;HeLa: 142.1;SCLC-21H: 71.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030110			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"HPA030110: "	"unprognostic (9.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.18e-1)"	3.8	9.0	3.6	3.3	4.5	1.0	1.8	6.0	8.8	7.4	7.2	4.9	5.1	9.6	9.4	1.9	17.6	3.2	13.2	5.6	9.0	19.7	4.3	3.9	2.1	23.4	10.5	3.3	1.4	1.6	27.6	0.3	10.9	16.9	1.1	24.5	2.0	19.5	0.8	0.8	5.4	4.1	8.8	17.1	4.9	4.7	8.3	0.1	4.7	0.3	0.4	14.0	7.9	10.1	0.3	8.0	0.1	7.4	0.4	0.1	2.0	9.2	0.5	0.6	0.3	0.4	2.4	0.0	19.0	26.0	5.1	15.3	8.8	0.0	0.0	0.8	87.6	0.0	142.1	0.4	1.9	0.0	0.9	5.3	0.0	0.1	0.0	12.1	0.0	0.2	3.5	0.0	0.2	8.4	0.0	0.1	3.8	0.5	0.8	0.7	1.4	5.6	1.2	0.0	71.1	20.9	23.8	12.3	0.2	6.1	12.8	0.5	1.4	3.8	14.4	0.2	2.6	1.3	0.0	0.3	5.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	3.6	4.5	6.0	8.8	5.6	9.0	23.4	10.5	10.9	8.8	8.3	10.1	0.1	0.0	1.8	12.1	0.3	0.4	0.1	0.3	0.6	25.5	0.7	0.4	0.9	2.8	1.9	3.7	29.2	0.2	0.1	0.2	0.0	1.0	3.9	20.1	43.9	6.1	26.5	0.0	0.1	0.4	0.9	17.0	2.0	6.4	0.0	3.8	4.6	0.2	0.3	35.3	0.2	1.0	0.0	0.6	0.0	12.1	0.9	0.7	0.0	1.0	0.0	25.8	0.0	0.0	0.1	1.6	2.6	4.1	0.4	2.1	0.0	0.3	0.1	266.9	0.0	0.2	4.1	1.5	26.0	0.1	0.6	0.1	0.6	0.0	0.2	0.3
SAMD14	FLJ36890	ENSG00000167100	"Sterile alpha motif domain containing 14"	Q8IZD0	17	50110040-50130160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4"	"Cell type enriched"	"Detected in many"	4	"Bipolar cells: 56.1"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HEL: 8.6;HMC-1: 28.0;SH-SY5Y: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051916	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA051916: AB_2681662"	"unprognostic (2.33e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.48e-4)"	0.9	1.4	14.9	0.8	14.0	0.3	0.5	19.4	15.4	1.6	0.0	1.0	0.2	3.1	0.8	0.5	0.5	0.3	1.2	15.3	11.0	3.1	0.8	6.0	0.3	9.4	8.8	1.3	0.2	0.7	3.4	0.7	8.5	3.0	0.1	1.3	0.1	0.7	1.4	0.3	0.9	0.4	6.0	1.7	1.1	2.1	11.2	0.1	0.9	0.5	0.5	1.8	1.1	10.1	0.0	0.2	4.2	0.0	1.1	0.3	0.0	3.0	1.1	0.1	0.0	0.6	0.0	0.1	4.1	1.3	0.0	0.1	0.3	0.0	0.1	12.7	0.1	8.6	0.3	0.0	0.7	0.0	28.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.3	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	12.9	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.6	1.6	0.3	0.1	0.2	0.0	0.1	2.2	0.1	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	14.0	19.4	15.4	15.3	11.0	9.4	8.8	8.5	6.0	11.2	10.1	0.6	0.0	0.5	6.2	0.0	0.4	0.1	0.2	0.6	56.1	0.2	0.3	1.1	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.2	3.1	0.0	1.4	6.1	12.7	2.7	8.3	0.4	0.2	2.3	0.5	0.1	2.5	0.1	8.2	0.3	0.1	11.8	7.2	0.3	0.0	0.6	1.0	2.2	1.5	5.7	0.0	1.0	2.0	2.2	0.0	2.5	0.4	0.2	0.1	3.4	0.2	0.0	0.3	1.1	0.0	4.6	0.0	0.1	2.8	1.5	1.1	0.2	0.1	0.4	0.2	0.7	0.1	0.1
SAMD15	"C14orf174, FAM15A, FLJ35963"	ENSG00000100583	"Sterile alpha motif domain containing 15"	Q9P1V8	14	77376689-77391497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 15.3;testis: 17.7"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 62.6;Early spermatids: 81.8;Endometrial ciliated cells: 38.8;Late spermatids: 111.7;Respiratory ciliated cells: 41.5;Rod photoreceptor cells: 75.7;Spermatocytes: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030673, HPA030677"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear membrane, Nucleoli"		"HPA030673: AB_10600655, HPA030677: AB_10599938"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.83e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.76e-2)"	0.5	0.8	1.7	0.3	2.8	0.6	1.0	0.7	1.5	0.7	7.7	0.2	0.3	1.0	5.3	0.2	4.5	1.1	0.1	1.7	3.4	1.9	0.1	0.8	1.4	2.8	3.5	0.7	2.0	2.4	2.4	0.3	2.0	0.7	0.3	15.3	0.3	0.7	0.2	0.5	0.2	0.3	1.4	0.2	0.4	17.7	2.7	0.4	3.9	0.0	1.4	0.8	0.2	0.8	2.5	3.4	1.3	2.7	0.3	1.4	1.2	1.0	0.9	2.6	2.3	2.5	2.2	2.8	1.1	1.0	2.3	2.4	0.9	1.4	3.7	0.2	0.5	0.4	1.0	0.6	0.1	0.5	2.9	1.3	0.9	2.3	0.2	1.1	1.8	1.4	0.3	0.7	1.1	7.6	0.6	0.2	0.5	0.6	1.0	1.2	1.2	0.1	4.6	1.4	2.8	1.8	3.5	0.5	0.5	0.5	4.3	0.8	0.7	2.5	1.4	2.6	1.3	0.4	2.4	1.8	3.1	0.1	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.7	2.8	0.7	1.5	1.7	3.4	2.8	3.5	2.0	1.4	2.7	0.8	0.7	0.0	0.0	1.0	0.3	0.3	0.5	0.6	0.0	11.2	0.9	0.9	1.9	2.8	1.8	0.0	62.6	0.3	0.8	0.7	1.9	2.8	81.8	38.8	4.6	0.5	3.6	0.0	1.3	0.6	0.2	1.0	0.0	1.4	0.0	1.3	0.4	0.0	0.1	3.3	0.6	0.5	0.0	0.0	0.0	111.7	1.5	0.3	0.0	0.0	0.1	5.5	0.0	0.5	0.4	0.9	0.1	0.0	0.0	0.2	0.0	3.5	41.5	75.7	0.0	1.0	1.0	59.3	7.3	0.0	0.0	0.3	0.3	6.0	0.1	0.3
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36890229-36951843	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 214.2;Endometrial ciliated cells: 173.8;Kupffer cells: 280.2;Macrophages: 326.4;monocytes: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 510.8;BJ hTERT+ SV40 Large T+: 165.8;BJ hTERT+ SV40 Large T+ RasG12V: 187.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		91000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane"	"HPA047072: AB_2679921"	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	79.5	39.9	11.9	94.3	12.4	11.5	65.7	11.6	12.2	39.1	33.2	58.4	29.4	33.0	9.1	45.8	81.8	40.2	60.5	11.4	16.6	12.2	26.1	68.0	78.0	16.8	15.0	38.0	42.2	14.0	21.7	36.0	17.9	26.3	28.8	5.5	32.6	18.1	23.8	27.8	55.2	44.1	17.6	94.2	45.0	12.6	18.0	29.3	31.7	20.7	51.2	55.3	39.9	26.4	29.9	10.9	3.7	15.6	510.8	101.8	5.5	10.8	37.7	165.8	187.8	39.1	11.2	64.4	19.9	14.4	94.9	21.2	34.7	27.8	30.9	17.4	20.6	5.3	18.8	30.9	39.3	28.2	5.1	96.4	1.0	45.3	1.9	13.3	26.4	0.0	13.7	18.8	5.4	12.0	0.0	19.2	7.9	18.3	25.9	2.8	21.7	35.3	15.7	8.2	23.0	4.2	20.2	10.2	28.2	4.7	20.5	125.4	13.9	11.5	13.5	25.1	28.5	7.3	20.3	21.7	14.5	3.2	7.1	1.4	147.7	4.8	52.2	174.4	47.0	4.5	55.7	53.3	278.6	3.1	55.5	47.6	18.5	56.2	167.0	96.4	95.8	144.3	11.9	12.4	11.6	12.2	11.4	16.6	16.8	15.0	17.9	17.6	18.0	26.4	48.7	28.9	25.5	4.2	19.4	6.4	2.3	7.8	5.7	5.5	6.9	5.8	17.3	14.3	35.3	1.8	4.2	2.6	214.2	2.6	0.0	10.3	3.3	173.8	12.7	44.3	6.0	30.7	8.6	10.2	3.3	71.4	13.3	40.6	12.6	10.5	42.5	20.1	137.2	6.7	8.5	5.7	8.2	280.2	52.3	4.8	82.3	326.4	5.4	36.5	257.9	25.1	116.4	14.1	3.5	7.5	31.3	96.3	54.8	1.9	1.1	1.9	104.4	2.9	59.2	9.6	31.9	10.2	4.9	12.1	5.8	2.9	102.6	9.7	5.5	4.9
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 1174.1;Langerhans cells: 317.9;Macrophages: 414.6;monocytes: 829.9;T-cells: 332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 273.7;K-562: 331.6;Karpas-707: 137.3"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 20.7"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	32.3	6.7	2.4	80.1	2.8	192.9	4.7	3.3	4.9	5.7	4.2	11.0	7.0	3.4	1.9	5.3	6.3	22.7	4.5	2.5	3.5	4.2	17.5	22.9	35.4	6.2	4.5	1.3	3.1	2.0	2.1	15.5	6.1	3.9	15.3	12.7	2.8	2.2	0.7	1.5	15.1	10.8	5.1	32.0	9.3	1.2	4.6	22.4	2.2	1.2	41.0	39.7	2.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	0.0	1.8	0.0	14.0	0.0	273.7	0.0	0.0	0.0	32.5	12.7	0.1	0.0	0.0	37.9	10.2	3.6	4.8	331.6	137.3	0.0	0.0	15.9	39.5	0.1	0.0	0.2	26.8	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	35.0	0.0	0.0	0.0	0.0	58.2	0.5	0.3	1.4	20.7	0.0	314.2	38.7	234.6	22.1	52.3	15.4	27.3	42.8	33.3	25.0	15.4	26.8	19.1	49.4	18.0	83.0	0.9	60.3	33.6	2.4	2.8	3.3	4.9	2.5	3.5	6.2	4.5	6.1	5.1	4.6	8.9	4.8	22.4	54.9	0.7	127.5	15.6	1.1	0.0	1.8	64.9	2.7	3.0	1.2	1.5	11.2	36.8	0.0	0.5	147.9	0.7	0.0	0.6	0.0	0.8	0.2	8.0	0.0	13.7	1.0	6.5	0.7	11.3	10.7	0.6	1174.1	0.1	4.6	1.8	62.0	0.0	0.8	0.8	0.0	183.7	317.9	0.4	0.6	414.6	21.4	131.2	829.9	1.6	24.7	2.5	0.6	0.7	1.1	0.0	119.3	0.5	0.0	0.5	8.0	4.7	0.0	2.2	3.7	0.1	0.2	1.2	13.2	0.5	332.8	0.1	0.9	0.9
SAP18	"2HOR0202, MGC27131, SAP18p"	ENSG00000150459	"Sin3A associated protein 18"	O00422	13	21140514-21149084	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011352, CAB012273"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB012273: , HPA011352: AB_1856563"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.78e-2)"	125.7	164.3	140.9	122.9	152.2	242.3	121.6	149.6	198.9	120.4	137.8	141.8	137.4	123.8	97.5	159.2	112.9	82.4	195.8	147.4	160.7	190.4	171.1	106.5	118.0	154.7	153.8	109.5	134.6	114.2	129.6	111.7	157.7	109.7	58.5	89.5	126.3	73.0	297.9	119.5	127.5	51.7	164.1	107.6	119.5	194.3	155.7	115.5	110.7	156.3	64.8	131.7	118.5	170.7	182.1	99.3	159.5	173.1	169.0	140.5	246.9	227.1	167.2	205.5	151.3	181.1	342.4	187.3	272.0	189.1	223.4	186.5	198.1	142.4	231.5	288.0	100.4	267.6	121.2	305.9	191.8	367.1	207.5	143.0	159.7	157.5	187.1	158.4	157.3	223.1	128.8	103.6	188.2	231.0	417.0	599.0	200.7	501.5	109.7	261.1	251.4	187.1	295.7	160.7	185.0	161.1	145.7	213.8	296.5	176.5	206.8	528.0	192.6	126.0	141.9	230.1	268.9	159.6	243.6	536.7	122.5	214.9	236.4	433.0	431.5	540.0	344.1	485.0	349.3	493.7	418.2	410.9	427.8	443.6	405.9	402.9	430.5	395.3	547.4	568.8	517.5	909.3	140.9	152.2	149.6	198.9	147.4	160.7	154.7	153.8	157.7	164.1	155.7	170.7	638.0	134.6	143.5	15.0	291.7	458.6	336.3	640.9	310.7	101.5	298.9	594.9	592.9	194.5	383.8	233.6	41.7	566.2	397.4	353.6	759.2	396.5	1259.5	334.1	231.1	273.1	234.5	214.4	20.8	365.6	528.0	374.0	170.2	256.2	258.6	176.6	180.2	242.0	396.0	119.5	23.4	364.5	468.0	189.5	440.9	206.0	342.3	260.4	407.4	17.8	385.0	370.8	233.8	19.6	26.2	401.9	417.6	303.6	182.3	325.9	475.0	1100.6	446.8	132.3	203.8	362.5	438.3	547.7	319.9	271.7	422.2	908.3	338.8	254.2	344.7	419.9
SAP30		ENSG00000164105	"Sin3A associated protein 30"	O75446	4	173369969-173377532	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 77.2;Macrophages: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022627, HPA059012"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB022627: , HPA059012: AB_2683880"	"unprognostic (1.53e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.83e-2)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (4.95e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (3.97e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	17.4	12.9	17.4	13.3	19.7	23.4	12.8	18.4	21.6	13.9	16.1	25.6	9.5	13.2	9.6	9.9	16.9	8.6	20.4	17.0	18.2	6.2	9.0	12.8	8.0	19.3	18.2	14.6	7.3	4.5	8.1	7.1	19.2	11.4	7.0	16.3	11.6	9.7	10.5	8.5	12.5	12.4	18.7	15.7	18.4	24.7	17.6	10.3	10.6	7.4	6.6	19.5	12.6	25.3	49.0	16.3	46.3	45.2	29.0	17.9	10.1	22.5	19.3	24.7	30.4	7.0	19.4	43.9	10.3	26.3	31.1	12.0	37.8	19.1	18.9	49.6	35.9	58.7	39.6	20.0	27.5	34.0	35.9	29.8	9.2	21.1	21.2	34.7	29.3	31.5	30.8	181.4	32.2	20.9	48.4	38.0	20.5	21.7	31.3	38.9	16.5	31.6	15.1	7.8	37.5	79.1	31.8	31.9	14.9	11.8	13.5	20.0	29.1	17.6	23.9	41.4	52.8	101.5	39.1	41.8	56.8	81.6	51.2	0.4	1.3	0.0	0.6	0.7	0.2	0.1	0.3	0.4	1.0	0.2	0.0	0.2	0.5	0.0	0.4	0.0	0.4	0.2	17.4	19.7	18.4	21.6	17.0	18.2	19.3	18.2	19.2	18.7	17.6	25.3	42.1	0.0	2.3	11.1	7.2	51.7	6.6	3.9	16.5	26.2	25.5	29.3	28.9	4.3	3.7	7.3	22.9	2.1	22.5	4.8	0.0	2.2	23.1	23.6	34.3	27.3	19.7	20.2	12.5	3.5	9.3	19.9	19.4	7.4	7.0	13.5	14.6	9.0	9.3	25.2	14.6	10.5	0.0	77.2	13.8	6.2	10.2	77.0	33.8	3.7	15.2	57.7	2.1	7.1	15.4	2.4	2.7	6.4	17.6	8.6	6.4	6.2	9.9	46.3	52.6	12.5	31.7	63.7	15.2	16.1	53.0	1.2	27.0	12.3	11.1	4.1
SAP30BP	"HCNGP, HTRG, HTRP"	ENSG00000161526	"SAP30 binding protein"	Q9UHR5	17	75667251-75708062	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042382, HPA052943"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA042382: AB_10793881, HPA052943: AB_2681995"	"unprognostic (6.92e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.31e-3)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.06e-2)"	"unprognostic (6.58e-2)"	17.7	13.1	30.7	14.5	31.9	23.2	17.3	31.1	33.5	20.6	37.9	22.1	11.9	17.0	17.1	20.0	17.0	15.3	19.6	30.8	30.8	20.3	19.0	15.1	19.6	34.6	32.6	17.3	16.2	18.6	17.7	18.0	31.8	19.8	15.1	14.7	23.0	17.1	17.8	17.8	16.0	17.0	31.8	21.1	18.2	14.7	31.6	22.7	15.8	22.2	22.9	19.6	19.0	36.5	28.2	36.9	27.8	26.7	25.6	26.9	31.5	29.2	31.4	53.2	54.8	31.8	23.2	30.2	15.1	27.8	48.8	23.5	33.5	32.0	53.1	10.7	40.1	23.7	26.2	33.2	25.4	25.4	21.5	25.5	28.7	39.9	43.2	30.6	73.5	30.8	29.2	23.0	41.9	29.9	42.0	24.4	23.7	41.7	41.0	27.4	40.4	22.7	44.7	24.7	19.3	31.8	26.4	28.2	33.7	40.7	42.8	22.9	28.7	47.0	30.9	20.9	40.5	17.1	7.1	35.9	31.4	18.8	38.4	18.0	23.1	24.6	24.3	19.8	26.8	21.6	22.0	25.2	19.4	21.7	22.0	22.7	22.8	27.7	23.7	32.0	25.6	22.9	30.7	31.9	31.1	33.5	30.8	30.8	34.6	32.6	31.8	31.8	31.6	36.5	72.4	54.5	62.7	25.5	54.1	49.5	117.7	65.5	34.1	19.6	34.0	43.2	53.5	30.0	71.1	22.0	12.5	59.5	68.3	71.2	68.4	71.3	47.5	32.8	48.4	63.5	35.9	26.9	15.9	73.2	67.0	55.9	45.9	56.3	77.2	38.9	52.8	34.2	57.5	10.1	14.2	43.8	59.0	35.5	48.1	93.6	44.4	48.0	56.9	10.3	59.7	72.6	55.6	22.6	30.5	103.3	109.2	34.6	57.4	52.0	43.3	47.2	58.0	17.3	65.7	50.9	64.3	34.8	34.3	36.1	45.5	96.0	59.8	31.7	37.2	94.0
SAP30L	"FLJ11526, NS4ATP2"	ENSG00000164576	"SAP30 like"	Q9HAJ7	5	154445997-154461053	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048665, HPA078308"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048665: AB_2680486, HPA078308: "	"unprognostic (3.79e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.33e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.69e-4)"	10.0	8.4	12.2	5.3	13.7	1.6	11.3	13.0	13.2	14.0	10.2	14.9	10.5	13.4	9.0	7.1	12.9	6.7	9.8	11.1	12.9	13.1	8.0	9.3	6.8	13.2	13.4	19.7	6.4	13.8	5.0	7.7	12.7	10.6	8.7	6.1	7.3	12.4	14.1	11.4	11.0	11.6	13.7	8.9	8.9	7.7	13.1	9.9	9.3	15.3	8.3	10.9	10.0	13.8	9.0	7.3	13.3	8.8	28.4	22.5	6.5	9.2	19.9	10.4	11.2	4.9	5.0	9.7	7.2	14.0	12.1	7.1	10.1	7.5	11.6	4.9	9.9	7.9	6.8	3.6	8.5	10.5	5.7	8.2	13.4	4.6	11.3	16.0	8.5	9.1	3.3	6.0	8.8	4.5	9.9	6.7	3.3	8.2	5.0	9.4	13.3	4.8	6.0	4.4	8.0	10.5	7.3	15.6	17.6	12.4	5.6	12.8	12.1	7.2	5.3	9.6	6.6	5.6	8.6	5.0	10.6	8.1	4.2	0.0	0.3	0.3	0.5	0.4	0.6	0.2	0.6	0.6	0.3	0.5	0.6	0.4	0.2	1.4	1.2	0.4	0.6	0.3	12.2	13.7	13.0	13.2	11.1	12.9	13.2	13.4	12.7	13.7	13.1	13.8	25.7	19.2	6.9	7.8	7.1	17.3	8.7	4.2	8.0	4.5	17.0	14.1	19.8	17.2	6.3	3.7	6.2	7.7	15.5	26.5	3.9	4.8	22.4	15.6	18.4	17.6	7.2	11.0	6.6	8.2	12.3	18.1	4.6	9.8	1.3	16.4	15.7	16.3	8.5	10.1	6.5	11.4	0.0	9.7	12.4	18.0	20.5	11.3	10.6	9.4	10.7	21.4	14.4	6.0	12.1	10.6	13.9	18.0	7.8	16.9	32.7	10.5	9.5	5.8	0.0	14.9	16.0	16.1	17.2	5.5	18.2	6.3	8.9	10.5	12.1	13.3
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062127-137070557	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.1;esophagus: 8.5;skin 1: 6.2"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 10.8;Oligodendrocyte precursor cells: 29.7;Undifferentiated cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 122.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	0.5	0.3	6.9	2.4	5.1	2.0	1.3	4.7	5.4	1.2	1.3	3.7	4.3	0.4	0.0	8.5	0.3	0.2	0.2	5.4	4.5	1.2	0.2	0.5	2.7	7.1	6.8	0.1	0.4	0.0	0.5	0.9	5.7	3.1	1.8	0.1	4.1	0.1	0.1	6.2	4.3	0.4	5.0	2.2	2.4	0.5	6.8	2.3	0.3	0.0	2.5	0.4	2.3	7.0	52.1	27.5	10.7	32.0	0.3	0.7	57.1	8.4	5.7	8.8	4.1	52.5	23.2	53.8	26.5	4.1	8.2	72.3	33.6	9.7	2.0	37.4	38.9	23.6	32.7	59.6	0.2	27.0	39.2	0.1	1.5	3.0	5.8	2.3	14.4	27.1	33.1	23.7	2.6	122.1	7.8	72.7	19.9	119.2	61.9	82.9	40.7	60.1	10.9	14.8	55.2	32.7	32.2	89.1	12.2	2.4	71.9	51.1	9.4	7.9	26.6	24.0	41.9	8.2	25.5	26.3	18.4	31.8	25.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	5.1	4.7	5.4	5.4	4.5	7.1	6.8	5.7	5.0	6.8	7.0	0.5	0.0	0.0	0.7	1.9	4.2	0.7	0.5	0.6	0.2	5.0	5.2	1.3	0.0	1.1	0.0	0.0	2.8	1.6	5.4	1.9	0.3	0.0	1.6	0.8	0.9	0.0	3.6	0.2	0.0	3.5	1.1	6.1	6.0	0.0	3.3	1.4	0.0	3.1	0.0	0.2	10.8	0.0	2.8	1.5	0.1	0.0	2.2	0.0	0.0	1.5	0.5	0.0	29.7	5.6	0.6	4.0	0.0	1.8	2.1	0.5	0.0	0.1	0.6	0.0	0.2	1.0	0.0	1.4	5.8	2.7	0.5	1.3	0.6	12.1	1.1
SARS2	"FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS"	ENSG00000104835	"Seryl-tRNA synthetase 2, mitochondrial"	Q9NP81	19	38915266-38930763	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Late spermatids: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA052730, HPA056957"	Approved		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"	"unprognostic (3.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.62e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.69e-2)"	7.3	17.3	4.2	7.2	4.7	9.3	8.2	4.4	6.8	9.7	3.6	10.1	9.3	9.3	2.8	14.3	8.5	5.9	12.4	4.7	4.4	14.6	18.7	6.6	9.8	5.0	4.4	9.8	15.9	7.8	11.9	7.6	5.3	12.2	5.3	2.3	11.3	6.2	16.4	12.3	10.2	5.1	4.2	12.0	11.9	10.7	4.4	7.5	14.4	11.5	6.6	9.4	9.6	5.4	17.6	47.3	15.5	10.7	5.8	13.3	23.7	10.7	12.6	23.1	17.7	36.0	18.4	17.2	16.3	12.5	9.7	13.9	14.7	29.2	5.3	12.7	24.4	33.7	17.7	32.0	15.4	29.1	31.9	20.7	13.5	14.5	7.6	9.5	14.2	26.3	29.9	14.2	10.6	28.4	21.4	20.7	18.5	21.6	8.5	31.2	16.4	18.6	20.5	36.2	29.1	18.1	14.2	32.7	8.9	4.6	21.8	19.1	11.4	13.7	17.7	11.7	15.1	11.0	7.1	13.2	10.9	18.5	13.8	0.0	8.0	1.0	14.2	14.4	11.5	12.0	10.7	14.7	25.2	10.7	7.5	8.6	0.5	14.0	13.7	9.9	13.4	8.9	4.2	4.7	4.4	6.8	4.7	4.4	5.0	4.4	5.3	4.2	4.4	5.4	2.7	6.4	7.9	6.2	8.4	4.2	3.8	8.3	3.4	8.0	7.0	5.3	8.1	7.2	6.8	5.5	8.4	40.1	5.6	8.9	15.6	15.5	15.7	3.6	3.6	3.8	11.4	13.2	6.8	12.7	23.0	4.8	9.7	3.9	5.7	7.4	6.1	10.1	12.9	5.0	6.7	9.2	10.2	6.7	4.2	56.9	4.7	4.8	3.6	1.9	7.7	3.1	5.2	1.5	3.1	8.4	5.6	4.9	10.1	2.6	7.4	10.3	5.1	13.4	0.0	2.7	4.2	1.9	8.2	12.8	4.1	29.1	7.4	10.6	17.8	3.2
SART3	"KIAA0156, p110, RP11-13G14, TIP110"	ENSG00000075856	"Spliceosome associated factor 3, U4/U6 recycling protein"	Q15020	12	108522214-108561400	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028840, HPA044322"	Approved		Supported	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA028840: , HPA044322: AB_2678895"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.36e-2)"	14.6	15.1	14.0	18.5	14.0	25.5	14.8	17.6	15.1	18.8	12.2	15.9	12.6	19.3	13.7	19.2	17.4	11.9	13.9	13.7	14.6	13.9	16.1	14.5	26.3	12.5	12.9	23.8	13.2	18.3	18.9	15.4	13.0	16.5	15.2	20.3	14.1	14.5	17.8	19.0	17.2	13.9	13.5	19.8	15.1	16.8	14.5	25.7	18.8	15.1	23.2	15.5	16.0	16.8	34.5	61.5	45.4	53.8	24.2	18.9	43.6	29.3	35.8	50.1	37.2	51.5	23.4	51.3	20.1	26.4	32.2	32.0	68.2	33.9	44.1	61.8	43.0	74.1	40.9	47.9	39.2	74.0	44.4	26.4	31.4	31.9	46.8	38.1	30.8	42.1	85.7	33.7	30.9	34.6	69.9	57.5	90.2	27.6	59.9	67.3	44.7	59.3	26.1	57.5	56.8	40.3	45.0	17.0	30.7	38.7	49.0	51.1	26.0	39.0	21.0	30.1	30.7	42.6	68.3	75.6	34.1	42.2	46.2	6.9	6.2	6.4	8.3	5.1	9.9	7.7	6.3	8.3	9.0	7.1	9.4	6.0	1.6	8.6	7.6	6.1	10.5	7.9	14.0	14.0	17.6	15.1	13.7	14.6	12.5	12.9	13.0	13.5	14.5	16.8	14.7	19.2	24.5	16.0	25.9	14.7	16.3	15.4	16.5	42.0	11.5	11.4	19.9	10.0	23.4	18.4	35.5	21.4	21.1	12.0	7.9	14.7	53.6	15.1	21.6	20.0	12.5	23.1	22.1	12.7	14.0	17.1	15.3	15.9	17.7	21.9	11.7	12.5	13.2	35.3	22.2	9.3	24.4	14.1	13.8	30.8	10.2	17.0	16.0	16.9	18.6	23.4	14.4	19.1	24.9	13.5	7.7	17.7	29.6	16.1	9.5	8.2	27.4	39.1	32.9	22.0	18.0	27.2	31.1	19.6	18.0	23.7	24.2	19.1	14.0	17.0
SASH1	"dJ323M4.1, KIAA0790, SH3D6A"	ENSG00000111961	"SAM and SH3 domain containing 1"	O94885	6	148272304-148552048	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 194.8;Astrocytes: 426.7;Microglial cells: 179.9;Oligodendrocyte precursor cells: 186.5;Oligodendrocytes: 328.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"classical monocyte: 1.2;intermediate monocyte: 2.6;non-classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	26	"monocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 198.0;ASC TERT1: 74.7;fHDF/TERT166: 73.4;HUVEC TERT2: 75.0;WM-115: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029947, HPA029949"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA029947: AB_10598915, HPA029949: AB_10602280"	"unprognostic (9.71e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.79e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.53e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.54e-1)"	76.1	6.1	45.5	6.6	62.5	0.3	47.6	58.2	35.4	24.5	10.3	18.1	6.8	13.6	5.1	45.2	15.9	19.7	17.0	40.0	43.0	15.0	9.3	26.5	6.2	72.1	60.0	6.5	9.5	14.2	5.1	30.3	59.4	11.6	9.8	15.4	19.8	9.2	17.9	31.0	11.8	16.1	49.1	13.7	9.5	4.6	65.1	5.1	39.0	22.5	7.8	13.8	27.9	59.3	4.8	2.9	23.6	7.9	198.0	74.7	3.9	27.3	65.6	20.2	30.7	6.2	5.7	0.0	14.1	73.4	10.1	5.7	7.3	6.7	16.9	0.0	5.3	0.0	13.6	5.7	6.1	0.0	1.3	35.1	6.8	30.6	8.3	8.3	75.0	0.0	0.4	0.1	19.1	5.5	0.0	0.0	6.9	2.6	3.8	0.0	16.8	0.2	15.1	15.1	0.9	0.0	8.4	30.8	21.5	6.1	2.4	14.0	65.6	19.7	4.0	63.1	5.9	0.0	0.0	0.0	31.6	0.0	95.6	0.0	1.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	45.5	62.5	58.2	35.4	40.0	43.0	72.1	60.0	59.4	49.1	65.1	59.3	194.8	16.0	21.7	426.7	0.6	41.0	6.2	5.1	29.6	21.9	17.7	24.0	18.5	5.7	18.3	46.0	6.2	20.6	0.8	4.4	7.9	3.1	0.8	45.3	36.2	104.7	4.8	0.0	16.4	2.4	59.5	66.5	8.2	40.1	2.5	2.3	60.3	8.1	8.8	3.3	120.7	5.3	10.2	42.4	18.5	1.6	18.3	15.6	42.7	179.9	4.9	100.4	0.0	186.5	328.6	1.5	2.9	28.2	1.3	6.4	2.3	15.0	15.5	4.7	78.9	49.9	73.2	0.5	3.7	46.3	33.0	32.7	1.6	3.1	7.2	7.4
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779949-129795201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 108.1;intestine: 36.5;lymphoid tissue: 120.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 69.5;dendritic cells: 66.3;Hofbauer cells: 51.3;Kupffer cells: 58.9;Macrophages: 40.0;monocytes: 45.3;NK-cells: 101.0;Plasma cells: 39.8;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 164.1;JURKAT: 119.4;MOLT-4: 120.6;NB-4: 89.1;REH: 88.5;U-698: 150.2;U-937: 117.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA		14000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	8.6	5.6	5.2	61.8	5.6	108.1	4.3	5.4	7.4	3.2	5.1	9.4	11.6	3.1	1.8	3.6	4.9	10.2	2.7	4.8	6.4	3.7	5.9	21.3	120.6	9.6	7.0	1.8	2.5	1.5	2.2	7.5	8.4	4.2	9.9	0.2	7.9	2.2	1.3	2.1	36.5	7.5	7.5	100.3	13.6	1.3	8.4	120.7	3.9	1.7	108.2	15.4	3.0	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	58.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	119.4	0.2	13.6	0.0	0.0	120.6	89.1	0.0	0.0	0.0	88.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	24.0	0.3	0.0	0.3	0.1	0.1	0.1	35.0	150.2	0.0	117.2	0.0	41.6	135.4	245.5	192.2	195.3	159.1	79.1	108.2	178.9	121.5	90.8	76.9	120.9	128.0	153.3	209.9	55.1	145.6	343.7	5.2	5.6	5.4	7.4	4.8	6.4	9.6	7.0	8.4	7.5	8.4	10.2	0.8	0.0	3.6	0.0	69.5	0.5	0.1	0.0	0.0	0.0	0.5	1.1	1.0	1.5	0.0	0.0	0.0	0.5	66.3	0.1	0.0	0.1	0.1	0.2	0.2	1.2	0.0	13.5	0.2	0.0	0.6	0.9	2.6	0.3	22.2	0.0	3.3	0.9	51.3	0.0	0.2	0.1	0.0	58.9	19.1	0.0	0.3	40.0	0.0	7.5	45.3	0.0	101.0	0.0	0.1	0.0	0.0	0.0	39.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.1	1.3	0.5	60.6	0.0	0.1	0.0
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345377-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 374.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 180.2;Inhibitory neurons: 283.4;Oligodendrocyte precursor cells: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"naive CD4 T-cell: 113.7"	"Group enriched"	"Detected in all"	4	"NK-cells: 63.4;T-cells: 113.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 455.3;JURKAT: 213.3;MOLT-4: 107.7;REH: 126.5;THP-1: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144, HPA070534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favorable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	16.1	10.3	13.4	28.8	19.1	42.8	13.2	0.8	32.2	11.4	2.6	29.9	16.0	13.6	24.0	12.2	17.9	17.6	26.0	23.4	0.4	10.8	15.4	15.7	38.1	0.3	6.1	13.8	28.8	32.4	22.5	4.9	0.0	22.5	18.5	29.8	44.0	25.9	89.5	21.4	21.0	11.8	1.4	27.4	18.5	6.7	0.9	374.2	24.5	49.0	27.8	24.6	12.3	11.0	2.1	0.0	12.7	0.0	17.2	16.6	1.4	3.4	12.3	2.9	9.8	0.5	22.9	4.7	0.4	4.1	1.0	0.2	46.4	5.4	5.9	455.3	28.0	0.1	1.1	0.0	2.5	26.7	3.8	7.4	4.0	0.1	0.6	35.1	3.3	213.3	0.6	24.3	2.2	0.4	107.7	33.9	18.5	1.5	1.5	126.5	6.2	4.9	4.8	15.7	5.9	34.5	0.0	3.9	0.3	10.0	98.5	192.7	1.7	12.6	7.9	5.9	3.7	1.3	0.4	10.0	10.3	101.3	5.7	21.1	1.9	4.6	44.2	2.0	78.6	1.6	29.9	23.0	3.5	13.0	113.7	69.5	4.1	63.4	1.1	4.0	6.0	26.6	13.4	19.1	0.8	32.2	23.4	0.4	0.3	6.1	0.0	1.4	0.9	11.0	19.3	25.6	29.6	48.3	44.6	14.3	12.3	10.9	12.0	12.1	33.2	18.0	70.0	22.8	15.0	31.3	87.6	0.5	71.1	11.0	1.9	16.9	8.2	31.6	15.3	17.0	32.4	22.5	180.2	12.5	0.2	16.4	8.6	11.6	23.4	20.6	35.0	20.9	9.3	0.0	283.4	30.8	4.1	41.5	36.4	4.3	8.4	45.5	10.6	41.2	23.0	15.5	56.7	168.9	28.8	10.5	23.6	8.2	20.6	21.7	24.6	9.1	50.9	63.1	6.6	8.3	10.2	3.2	9.3	20.5	22.0	0.3	84.0	16.8	25.7	19.7
SATB2	"FLJ21474, KIAA1034"	ENSG00000119042	"SATB homeobox 2"	Q9UPW6	2	199269500-199471266	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 13.9;intestine: 39.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.7;Enteroendocrine cells: 99.7;Excitatory neurons: 363.9;Intestinal goblet cells: 66.9;Paneth cells: 70.0;Undifferentiated cells: 84.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.0"	"Group enriched"	"Detected in many"	84	"basal ganglia: 10.9;cerebral cortex: 13.9;hippocampal formation: 4.6;white matter: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 40.3;K-562: 45.1;THP-1: 59.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 29.2"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 46.4;hippocampal formation: 37.1"	"HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB023669: AB_1129287, CAB062562: AB_2665615, CAB067751: AB_2665629, CAB068229: AB_2665628, CAB068230: AB_2665630, CAB068231: AB_2665631, HPA001042: AB_10601711, HPA029543: AB_10959737"	"unprognostic (1.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.53e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.54e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.37e-8)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.95e-6)"	"unprognostic (1.08e-3)"	2.7	4.8	0.0	4.3	10.9	0.3	2.2	0.0	13.9	2.7	0.0	34.2	1.5	1.7	0.9	0.8	1.4	1.3	0.7	4.6	0.0	4.0	3.0	0.9	0.5	0.0	0.0	1.9	3.9	2.1	1.0	0.6	0.0	1.9	39.5	0.8	1.5	2.8	2.2	1.8	5.7	3.0	0.0	0.7	1.0	2.8	0.0	0.2	1.6	2.7	1.0	1.6	3.1	3.9	2.6	1.7	17.6	8.1	8.3	9.9	1.3	6.2	8.9	4.4	5.7	0.4	5.8	0.9	0.2	13.3	6.9	0.5	14.0	3.7	7.0	9.4	12.3	40.3	4.1	4.9	1.9	18.7	17.1	4.8	6.4	8.8	5.6	11.3	0.4	6.0	45.1	0.0	12.8	0.9	0.8	22.9	3.2	2.0	2.9	1.7	6.0	0.1	6.6	0.6	3.8	0.0	3.1	0.0	9.5	3.1	3.6	59.8	6.2	31.5	5.9	10.1	16.6	2.6	8.9	25.9	21.7	14.6	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	13.9	4.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.4	0.0	1.1	18.6	0.6	1.8	2.7	0.5	0.6	2.4	0.9	0.4	1.5	0.0	0.7	0.0	4.2	0.1	0.2	129.7	1.9	0.3	1.0	0.9	3.9	1.5	99.7	0.0	363.9	2.7	0.3	3.6	0.0	0.7	0.0	1.6	1.8	5.4	0.8	0.0	3.5	66.9	0.0	2.5	3.0	0.9	2.5	1.0	5.4	9.4	0.6	0.5	0.0	21.1	34.1	1.2	70.0	1.2	0.0	4.3	19.1	7.6	0.2	0.5	0.0	1.7	10.4	6.1	4.1	0.8	3.0	0.1	1.3	3.9	84.7	2.2
SATL1		ENSG00000184788	"Spermidine/spermine N1-acetyl transferase like 1"	Q86VE3	X	85092284-85243911	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 12.8;Alveolar cells type 2: 12.9;Club cells: 6.8;Distal tubular cells: 3.9;Early spermatids: 5.4;granulocytes: 6.3;Late spermatids: 14.0;Respiratory ciliated cells: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060369	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA060369: AB_2684265"					"unprognostic (1.77e-1)"	"unprognostic (2.06e-1)"				"unprognostic (4.69e-3)"			"unprognostic (7.88e-2)"					0.0	0.3	0.3	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.0	0.2	0.4	0.0	12.8	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	6.8	0.0	0.0	0.0	0.2	0.0	3.9	0.0	5.4	0.3	0.3	1.2	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.2	6.3	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	14.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.8	0.0	0.4	0.7	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.7	0.3	0.0	0.0
SAXO2	"DKFZp666G057, FAM154B"	ENSG00000188659	"Stabilizer of axonemal microtubules 2"	Q658L1	15	82262810-82284930	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 59.9;testis: 21.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 90.9;Endometrial ciliated cells: 71.5;Late spermatids: 175.4;Respiratory ciliated cells: 201.9;Spermatocytes: 57.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.5;K-562: 10.0;SCLC-21H: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040487, HPA040833"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA040487: AB_10796457, HPA040833: AB_10796561"	"unprognostic (3.03e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.13e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.87e-2)"	0.9	1.1	2.1	0.3	2.2	0.6	3.2	2.3	2.7	2.3	8.3	1.3	0.7	2.2	17.9	0.6	59.9	1.0	1.3	2.5	2.3	2.7	0.9	8.0	1.2	3.2	5.0	1.7	1.6	4.7	4.9	0.4	2.4	2.6	2.0	6.9	2.8	1.2	1.3	2.1	1.6	0.6	3.1	1.2	2.5	21.6	2.5	2.6	3.5	0.8	1.6	1.3	1.0	3.7	1.4	1.9	1.1	4.1	0.9	1.8	0.5	0.5	0.3	0.8	1.5	0.2	2.3	1.4	1.0	0.0	2.2	10.5	1.8	1.6	1.8	1.0	6.8	0.5	3.4	0.0	0.1	0.3	0.4	1.2	2.2	1.4	1.2	2.3	1.7	2.9	10.0	0.7	1.0	1.0	0.5	0.0	2.7	0.5	0.8	1.4	0.5	0.9	0.8	0.9	7.8	1.2	1.1	0.0	1.5	0.6	4.0	0.4	0.2	2.0	1.1	4.2	0.8	2.1	2.6	0.9	1.9	0.5	1.3	0.0	0.0	3.0	0.5	0.0	0.8	1.3	0.2	1.5	0.1	3.3	0.9	0.4	0.0	2.0	0.1	0.8	0.0	0.3	2.1	2.2	2.3	2.7	2.5	2.3	3.2	5.0	2.4	3.1	2.5	3.7	1.8	0.0	2.7	9.1	1.5	0.0	2.0	0.0	2.8	2.7	4.5	4.1	2.7	1.5	24.1	3.7	4.2	0.5	0.9	0.1	1.9	0.7	90.9	71.5	1.5	0.9	2.4	0.8	21.1	0.5	0.4	1.5	10.2	2.0	1.3	3.7	0.4	0.3	0.1	0.0	16.4	1.9	0.0	0.6	0.0	175.4	2.5	0.5	0.0	3.7	0.0	3.7	0.0	9.0	8.0	0.3	0.1	2.2	1.9	1.5	0.3	4.6	201.9	5.0	6.6	1.0	1.0	57.7	12.7	0.9	0.0	0.3	0.7	3.0	0.5	1.6
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS ribosome maturation factor"	Q9Y3A5	7	66987680-66995587	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		190000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	139.1	107.5	136.1	57.9	152.1	157.2	113.7	151.2	168.3	97.3	115.8	143.6	127.8	117.2	83.3	128.6	99.2	84.9	238.0	133.1	148.4	117.8	126.8	113.8	43.8	156.2	142.3	90.1	89.3	145.0	87.4	106.2	155.0	107.9	111.6	90.3	80.7	122.6	374.0	92.0	114.2	128.2	152.6	57.3	104.6	60.9	143.4	38.8	107.0	263.3	52.5	113.9	90.7	169.7	168.3	68.9	59.9	54.6	212.7	157.9	67.0	281.4	225.4	206.1	157.1	143.1	83.0	62.2	209.7	253.5	136.3	80.1	101.7	164.3	219.4	59.8	136.4	31.1	125.9	86.6	188.9	78.1	40.8	144.0	215.1	157.0	269.8	105.9	129.2	39.7	227.2	65.0	324.2	100.0	41.8	112.4	67.2	227.3	165.9	31.3	132.6	129.3	218.1	73.6	91.7	63.7	142.3	235.5	194.3	131.0	176.2	64.8	176.4	276.5	96.7	142.5	205.4	40.6	51.4	141.0	95.7	125.5	157.4	75.5	33.2	61.4	64.7	37.7	81.7	62.8	82.7	75.2	33.4	59.9	104.4	85.7	13.0	51.8	35.1	45.4	80.2	62.2	136.1	152.1	151.2	168.3	133.1	148.4	156.2	142.3	155.0	152.6	143.4	169.7	169.9	304.5	128.0	10.7	101.6	464.2	466.2	213.2	145.7	73.7	118.5	154.0	286.6	108.7	160.3	92.0	12.5	130.5	98.0	270.9	262.2	177.4	583.0	93.0	131.2	153.2	101.9	51.3	12.5	165.7	232.1	197.7	96.8	128.2	150.0	29.7	138.5	102.1	107.0	58.9	15.3	221.9	142.4	47.2	238.1	2042.9	127.1	74.8	256.1	11.2	66.5	161.9	30.9	7.5	36.0	300.0	242.2	168.5	117.5	267.2	359.3	264.6	75.6	56.8	164.3	512.9	266.2	86.3	47.9	129.9	430.0	398.5	144.5	132.2	165.4	318.5
SBF2	"CMT4B2, DENND7B, KIAA1766, MTMR13"	ENSG00000133812	"SET binding factor 2"	Q86WG5	11	9778667-10294219	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 224.6;Excitatory neurons: 244.9;Inhibitory neurons: 367.4;Microglial cells: 273.6;Oligodendrocyte precursor cells: 290.5;Oligodendrocytes: 228.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 105.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050933	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA050933: AB_2681280"	"unprognostic (2.26e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.36e-2)"	"unprognostic (5.55e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (3.66e-5)"	"unprognostic (3.72e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.11e-2)"	13.3	7.6	8.6	6.2	9.2	4.0	9.2	6.4	7.7	15.2	5.1	9.3	6.8	11.3	9.1	11.6	10.2	10.4	8.9	6.7	7.7	13.8	9.5	7.4	3.9	6.9	8.1	18.0	5.1	17.1	4.6	14.2	7.2	10.6	10.5	14.9	9.3	11.4	4.7	7.4	6.6	10.9	7.1	7.8	9.5	10.8	7.1	6.1	16.7	8.9	4.2	11.2	8.2	8.2	15.1	12.1	20.8	15.0	27.1	35.4	105.4	11.6	20.9	13.1	18.2	9.1	18.1	5.8	6.2	20.6	19.1	9.8	12.5	9.8	22.9	6.2	8.6	2.5	9.1	11.9	10.6	5.6	8.0	17.5	12.3	6.6	25.8	20.2	21.8	12.1	5.1	5.2	15.8	4.3	8.1	1.5	9.1	13.5	13.3	7.5	14.5	7.6	11.9	13.4	6.9	15.4	15.7	22.4	10.0	10.6	6.7	4.0	24.4	23.1	11.5	24.3	9.5	1.7	4.6	8.0	17.4	2.7	17.0	0.0	0.7	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	1.1	0.3	1.6	0.1	0.1	0.2	8.6	9.2	6.4	7.7	6.7	7.7	6.9	8.1	7.2	7.1	7.1	8.2	50.2	44.8	83.9	224.6	16.4	25.5	43.4	24.1	27.3	35.1	16.4	14.5	31.4	22.8	30.8	16.5	75.0	13.8	14.6	20.3	3.9	13.9	18.3	17.8	31.1	40.9	43.8	11.4	244.9	8.8	12.9	40.0	40.8	30.1	21.5	41.7	49.6	16.6	18.6	37.0	367.4	16.2	24.4	55.0	34.1	9.2	51.0	44.8	30.2	273.6	37.6	12.0	29.9	290.5	228.4	13.5	21.2	27.1	9.5	56.5	14.5	13.1	38.3	71.6	26.3	44.0	34.8	24.5	17.4	30.6	30.7	13.8	20.6	25.9	20.1	47.4
SBNO1	"FLJ10701, FLJ10833, MOP3, Sno"	ENSG00000139697	"Strawberry notch homolog 1"	A3KN83	12	123289109-123364847	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.6"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 265.4;Spermatogonia: 219.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042388	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA042388: AB_10795704"	"unprognostic (1.61e-2)"	"unprognostic (9.61e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.61e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-2)"	5.5	5.7	5.9	6.8	7.4	16.8	6.5	11.5	9.2	5.4	5.7	6.1	5.3	6.7	6.4	7.2	5.5	4.2	5.3	8.2	5.7	6.4	6.2	4.8	8.9	5.7	5.4	7.2	5.0	6.9	5.1	5.6	5.8	6.8	6.6	10.2	5.1	6.3	11.6	8.3	5.9	6.1	5.6	7.1	5.3	37.6	5.9	9.6	10.0	7.8	8.7	5.7	5.5	7.9	14.0	24.3	11.7	21.6	16.6	11.9	22.8	11.7	11.6	10.0	8.2	19.1	8.3	31.0	13.6	14.4	11.0	16.8	22.3	13.9	16.8	19.8	9.2	27.1	15.6	18.0	10.2	33.8	22.9	10.0	13.1	14.5	15.3	13.8	10.9	16.4	35.2	8.6	18.7	14.7	20.2	25.0	18.0	13.5	13.2	20.7	15.4	15.9	10.8	31.3	18.3	9.5	19.5	16.4	13.6	13.1	24.4	17.8	14.7	15.1	16.7	16.7	11.9	9.9	19.5	34.2	10.3	21.9	17.2	5.0	4.5	4.5	7.2	5.0	7.5	6.0	6.6	5.8	4.0	5.0	6.9	6.9	5.9	4.6	8.0	4.4	5.2	4.5	5.9	7.4	11.5	9.2	8.2	5.7	5.7	5.4	5.8	5.6	5.9	7.9	29.8	28.9	25.7	42.1	59.3	63.3	48.1	40.4	37.0	92.6	38.0	30.4	39.6	25.8	38.3	36.8	79.2	65.8	54.3	22.1	23.5	36.5	62.5	53.1	56.0	34.7	40.2	47.9	58.3	27.2	49.6	36.5	23.9	44.0	29.2	47.3	32.2	26.7	26.2	63.9	47.6	25.1	52.9	35.3	46.4	35.2	25.4	41.2	33.8	31.9	56.5	49.7	54.6	27.2	46.2	38.1	21.2	60.5	33.0	55.5	29.8	27.5	36.4	59.9	26.3	51.5	58.1	265.4	219.3	40.7	61.4	106.0	53.3	42.1	38.9	44.3
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292681-121313410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.6"	"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 141.0;Hepatocytes: 307.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	28.6	35.3	18.4	12.6	20.4	5.7	56.6	37.1	29.3	20.7	17.6	23.2	48.2	15.1	73.2	39.6	16.5	18.2	22.0	19.9	29.9	49.1	393.6	24.6	13.5	42.9	28.0	16.9	21.5	48.6	15.6	14.7	39.1	101.4	19.9	29.5	22.4	56.6	7.7	13.8	24.7	16.2	32.2	8.8	21.7	24.3	24.6	13.5	23.9	13.0	19.5	21.5	27.1	36.5	26.5	14.3	184.8	39.5	72.1	59.9	27.8	27.8	53.5	18.2	32.4	83.1	95.9	25.4	89.0	32.3	156.6	100.8	59.2	70.9	18.1	12.5	80.0	34.6	73.4	64.4	57.9	24.8	12.5	51.0	57.4	60.4	60.2	15.6	29.8	22.8	25.0	34.6	89.0	27.4	9.4	29.2	59.8	74.4	39.7	13.2	51.0	21.6	133.6	116.5	51.1	28.8	73.4	14.6	38.0	125.4	62.2	38.6	58.3	19.0	29.7	32.5	14.0	6.4	11.2	33.3	7.0	49.5	33.5	7.8	3.7	1.0	3.5	4.9	5.9	4.4	4.7	4.2	6.5	4.1	6.8	6.7	0.3	5.3	3.6	7.7	5.5	2.6	18.4	20.4	37.1	29.3	19.9	29.9	42.9	28.0	39.1	32.2	24.6	36.5	10.4	19.2	31.9	23.8	62.6	9.7	49.9	48.9	14.8	26.8	33.7	12.4	20.8	18.6	40.8	20.2	31.3	15.9	47.5	26.4	5.9	24.1	3.0	11.5	8.8	15.7	14.4	18.1	29.6	28.9	16.7	16.3	18.3	19.6	17.7	11.1	141.0	307.1	21.0	23.5	29.4	15.3	59.0	22.1	17.0	1.3	19.3	17.6	19.6	20.6	15.6	38.7	13.4	27.6	34.0	19.3	18.8	17.0	20.9	50.1	24.1	15.8	18.7	28.3	13.1	12.9	14.7	6.7	12.7	36.2	15.5	18.6	56.5	42.8	13.3	54.4
SCAF1	"FLJ00034, SR-A1"	ENSG00000126461	"SR-related CTD associated factor 1"	Q9H7N4	19	49642209-49658642	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046828, HPA054593"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA046828: AB_10961907, HPA054593: AB_2682536"	"unprognostic (1.16e-1)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.18e-2)"	25.4	22.6	24.5	19.0	22.8	17.4	23.7	11.2	31.1	27.2	0.0	30.3	19.3	32.2	6.9	28.1	26.5	18.0	28.3	29.5	13.6	21.1	26.2	21.5	20.4	31.1	21.7	28.9	22.2	17.8	29.4	16.0	22.7	26.7	8.7	11.2	23.2	11.3	47.3	28.3	22.3	15.1	10.7	23.5	23.0	28.2	22.5	17.3	24.7	16.9	13.9	28.7	24.9	21.3	84.1	143.1	38.7	64.0	18.0	17.1	47.2	61.9	20.0	28.4	23.8	78.2	50.6	48.5	41.4	22.9	42.8	63.2	28.0	37.9	8.3	75.4	80.5	54.6	72.9	40.1	30.8	52.1	52.0	28.7	23.5	34.1	24.0	27.4	23.1	19.5	71.6	48.1	22.6	53.4	53.2	28.3	49.6	37.8	86.1	64.7	53.6	50.1	18.7	118.5	57.2	62.7	63.5	66.0	23.4	23.4	46.2	29.0	63.9	102.0	59.1	37.0	91.6	68.5	110.2	46.3	61.6	32.8	59.1	2.0	1.4	1.4	1.9	1.2	1.2	2.8	1.0	1.3	1.1	2.1	1.0	1.1	3.6	1.0	1.1	2.4	0.2	1.8	24.5	22.8	11.2	31.1	29.5	13.6	31.1	21.7	22.7	10.7	22.5	21.3	16.4	6.4	0.0	7.8	17.0	12.1	8.8	12.4	22.2	12.3	15.7	12.7	3.0	12.8	6.0	22.0	4.2	14.6	13.4	32.1	7.9	13.0	31.8	18.6	14.1	10.8	14.4	9.4	7.0	13.1	14.7	12.9	17.3	21.1	5.7	22.1	18.2	14.7	14.5	10.1	8.4	21.1	12.2	9.1	6.9	97.4	22.1	12.3	10.6	8.4	9.5	10.6	10.3	9.0	8.7	19.0	22.7	23.7	18.0	13.4	22.9	13.1	10.6	8.0	13.1	16.5	17.1	24.9	17.8	23.0	11.9	22.0	12.6	17.5	19.8	11.1
SCAF11	"CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP"	ENSG00000139218	"SR-related CTD associated factor 11"	Q99590	12	45919131-45992120	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038862, HPA045456, HPA046345"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630"	"unprognostic (2.83e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.13e-2)"	31.1	21.2	22.3	41.7	29.6	89.6	40.1	38.7	23.7	28.0	36.5	31.6	29.4	34.5	41.2	26.7	26.6	30.9	30.0	19.7	25.2	29.9	42.4	31.0	54.7	30.2	26.5	37.7	23.5	39.8	17.2	31.5	32.5	29.4	34.9	60.8	27.0	24.9	35.2	40.3	31.7	29.2	25.9	43.0	29.6	29.0	26.3	44.4	34.7	38.6	49.8	31.8	23.6	38.3	56.4	49.4	60.6	50.7	41.0	55.7	56.0	64.7	52.6	54.8	39.3	180.3	60.1	116.7	71.0	69.3	32.3	54.0	62.4	52.2	61.9	62.1	42.1	108.8	64.5	47.0	32.3	115.6	70.4	46.4	54.7	47.2	71.1	62.9	57.1	50.0	85.1	62.3	70.3	51.9	87.2	63.4	47.0	0.6	67.4	70.2	81.7	57.9	52.4	70.5	34.2	35.0	71.9	60.8	35.0	47.6	56.4	123.4	71.6	55.9	46.3	42.5	34.9	44.4	36.0	187.9	47.0	245.0	21.8	39.4	19.6	29.5	21.7	19.9	19.9	28.6	20.6	21.3	16.0	28.2	22.2	20.0	51.5	21.3	23.5	30.2	20.8	12.9	22.3	29.6	38.7	23.7	19.7	25.2	30.2	26.5	32.5	25.9	26.3	38.3	180.2	176.3	164.0	91.4	200.4	128.5	127.6	87.4	132.1	134.9	101.8	96.8	187.4	88.6	131.7	79.1	127.2	86.3	229.6	96.1	54.8	117.8	57.7	133.3	148.7	146.2	103.3	118.4	75.3	107.9	72.5	135.3	69.3	152.4	222.7	224.7	114.5	138.9	109.8	107.7	81.7	123.3	67.1	158.0	160.9	39.2	121.8	157.3	67.6	141.5	211.7	105.2	185.3	119.6	122.4	103.4	103.4	103.8	126.4	121.6	97.2	83.5	149.6	198.4	124.9	176.3	129.7	157.6	82.5	116.4	120.5	61.0	170.6	114.2	107.5	145.0
SCAF4	"DKFZp434E098, KIAA1172, SFRS15, SRA4"	ENSG00000156304	"SR-related CTD associated factor 4"	O95104	21	31671000-31732118	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018319, HPA018668, HPA021504, HPA028807"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927"	"unprognostic (9.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-3)"	14.1	10.6	6.8	12.7	7.3	13.7	13.2	9.3	9.0	14.9	5.5	14.1	12.3	14.6	9.1	16.1	12.8	8.5	11.3	7.1	9.7	9.6	17.1	14.2	18.4	7.8	7.4	16.1	11.8	11.4	11.2	12.7	7.1	12.5	10.1	10.6	13.0	9.0	17.9	18.5	16.3	9.5	5.4	16.3	13.4	17.5	7.3	18.9	11.4	10.8	17.2	13.3	15.1	8.6	31.4	20.5	40.3	29.4	21.4	16.1	27.4	22.6	23.8	23.7	22.0	39.5	22.2	63.9	13.4	22.3	25.9	18.9	44.3	22.1	25.8	28.6	25.8	50.9	16.8	33.4	24.5	54.8	20.5	18.2	24.6	31.6	27.1	15.1	20.9	25.0	68.4	32.4	19.9	41.7	58.4	39.7	51.7	30.5	17.3	57.1	44.8	21.1	16.5	24.3	27.5	29.7	34.9	26.8	19.7	22.1	20.7	36.7	24.4	24.5	23.6	23.5	23.5	20.6	20.7	72.0	17.6	43.4	23.3	6.6	7.9	10.9	9.7	10.6	9.6	10.9	5.6	9.3	9.7	9.7	6.5	7.2	4.0	7.6	9.6	6.8	5.2	8.1	6.8	7.3	9.3	9.0	7.1	9.7	7.8	7.4	7.1	5.4	7.3	8.6	16.5	6.4	14.5	25.8	46.5	46.7	35.5	15.2	53.5	22.8	23.0	13.8	9.4	18.6	13.8	11.0	25.0	16.6	31.2	39.4	3.9	16.4	9.9	14.9	26.7	19.9	19.8	48.4	34.9	14.0	17.8	21.6	19.4	22.9	11.4	21.9	18.9	24.4	15.7	21.9	34.5	18.7	22.4	23.1	37.8	3.8	22.1	22.7	33.8	36.5	24.5	12.5	32.0	34.7	45.5	17.9	23.4	14.3	23.9	31.2	31.6	6.7	18.2	24.6	13.1	29.9	18.3	25.6	23.9	41.7	41.1	18.9	33.1	12.5	22.2	33.5
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733378-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 105.4;Inhibitory neurons: 114.2;Microglial cells: 119.9;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	19.2	11.8	7.9	15.6	10.3	37.2	18.9	17.8	9.9	18.2	2.7	14.9	12.7	22.1	16.4	13.2	17.4	13.6	14.8	6.9	8.5	16.6	15.4	16.2	22.6	7.3	8.5	27.0	14.9	21.3	10.2	18.9	6.2	16.9	17.6	23.2	15.6	15.6	18.7	18.3	14.3	20.3	6.8	19.1	15.2	23.5	8.7	26.8	21.3	19.1	20.8	15.3	14.7	10.4	16.2	15.3	44.6	27.1	29.3	29.8	27.2	25.7	35.8	33.1	33.4	24.2	16.0	49.7	20.4	29.6	29.4	21.1	39.5	33.8	44.2	21.7	19.7	44.6	16.0	29.8	33.8	41.7	28.8	32.3	35.0	29.0	45.0	25.7	28.6	21.6	52.6	29.4	30.8	29.1	44.6	28.2	31.0	24.4	11.3	42.3	24.4	27.1	28.1	29.0	27.4	32.3	26.7	34.7	19.9	32.1	22.8	47.8	26.3	18.8	23.0	24.6	26.2	27.2	21.7	54.0	23.4	25.6	30.0	0.6	1.5	1.8	2.8	2.0	2.8	2.4	3.0	2.9	1.7	2.6	3.0	2.7	1.9	3.1	3.8	1.6	4.0	1.4	7.9	10.3	17.8	9.9	6.9	8.5	7.3	8.5	6.2	6.8	8.7	10.4	23.1	25.6	18.1	89.8	22.6	12.6	12.2	11.9	17.6	19.5	14.6	12.4	33.9	7.2	11.7	12.9	25.0	11.1	23.2	15.8	1.9	11.3	3.6	18.8	25.4	16.6	13.1	18.7	105.4	11.8	8.8	17.5	23.0	25.0	34.2	29.3	18.5	11.6	13.3	13.5	114.2	14.1	6.1	20.8	9.7	5.4	16.4	16.6	10.6	119.9	13.5	16.1	8.2	121.2	145.8	13.6	11.8	12.4	13.7	13.7	11.7	6.5	15.8	21.4	26.3	24.5	16.3	21.4	21.2	14.8	10.7	10.7	19.2	19.5	16.1	15.4
SCAI	"C9orf126, FLJ36664, NET40"	ENSG00000173611	"Suppressor of cancer cell invasion"	Q8N9R8	9	124942608-125143528	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 200.1;Excitatory neurons: 327.4;Inhibitory neurons: 171.6;Rod photoreceptor cells: 136.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020632	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"		"HPA020632: AB_1845804"	"unprognostic (1.93e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-3)"	1.7	2.5	3.3	1.8	3.7	2.9	1.9	0.3	4.2	2.1	5.2	1.9	1.1	2.1	1.5	1.4	2.1	1.2	1.3	2.4	0.3	1.5	1.5	3.2	2.9	0.0	0.4	2.7	1.7	1.5	1.7	0.9	0.0	1.9	1.7	7.5	1.4	1.0	1.7	2.4	1.5	1.3	0.0	1.9	1.5	1.9	0.9	11.2	1.9	1.0	2.3	1.5	1.7	0.9	3.2	2.4	3.2	3.1	1.7	4.2	5.4	2.0	4.1	2.1	2.9	3.1	3.0	5.7	1.5	2.0	2.4	5.3	4.2	2.2	4.2	4.1	1.5	3.8	4.4	2.8	2.4	4.0	2.8	1.6	1.8	3.2	2.1	3.5	3.0	10.2	5.4	6.6	3.2	3.5	13.0	2.8	3.2	6.1	2.6	8.1	5.1	5.0	1.4	4.3	3.3	2.1	4.7	2.5	2.4	3.5	6.3	1.8	3.1	1.9	3.5	3.2	3.5	3.6	7.3	5.5	2.2	3.3	2.8	0.2	0.3	0.0	0.2	0.4	0.3	0.5	0.4	0.3	0.2	0.6	0.6	0.4	0.2	0.6	0.1	0.8	0.7	0.3	3.3	3.7	0.3	4.2	2.4	0.3	0.0	0.4	0.0	0.0	0.9	0.9	7.3	70.5	28.2	49.0	19.7	2.8	7.9	6.0	10.2	46.4	8.7	5.6	4.8	14.3	9.4	18.4	200.1	6.6	14.6	6.3	1.9	4.1	14.5	9.4	8.5	8.0	13.1	23.3	327.4	2.0	4.7	7.5	8.2	14.2	5.1	74.5	12.5	8.7	4.2	16.8	171.6	8.4	16.2	6.6	5.5	5.9	9.6	5.4	3.6	55.3	5.4	25.8	22.6	72.9	61.0	2.9	7.3	6.0	14.3	9.6	8.3	3.1	10.3	136.5	0.0	11.3	8.3	34.7	21.5	12.4	4.3	2.6	14.8	28.9	11.2	4.4
SCAMP1	SCAMP37	ENSG00000085365	"Secretory carrier membrane protein 1"	O15126	5	78360611-78480739	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044753, CAB079009"		Supported	Uncertain	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB079009: , HPA044753: "	"unprognostic (8.25e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.34e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (8.44e-3)"	"unprognostic (7.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.99e-2)"	17.9	22.4	18.4	12.7	20.5	8.5	28.2	24.5	29.1	23.9	23.9	19.6	16.0	25.0	23.2	24.7	29.6	20.2	24.7	20.4	22.4	28.6	17.8	17.8	12.1	18.4	21.5	22.8	25.2	47.1	15.7	23.4	21.4	34.3	22.3	40.2	31.5	29.8	10.6	17.7	15.6	26.6	20.0	13.6	27.9	14.1	23.3	14.6	39.8	16.3	13.4	25.0	11.4	19.0	32.7	23.9	23.4	76.1	35.5	45.5	40.8	30.0	46.1	26.5	56.1	9.3	61.1	48.1	31.4	45.5	65.7	26.2	34.9	57.0	45.9	17.4	32.5	20.5	17.8	20.1	22.7	13.6	16.5	28.6	54.5	27.3	41.2	62.5	41.3	25.0	8.4	33.6	50.9	39.2	25.2	26.7	19.9	14.3	26.0	29.5	38.3	55.3	43.5	38.6	70.9	40.6	27.6	38.5	26.7	24.9	52.5	26.1	36.6	26.3	19.3	30.0	24.2	20.9	29.4	27.6	50.1	50.4	22.6	20.3	11.4	13.2	7.5	12.7	9.3	7.6	8.7	9.2	14.8	6.5	7.1	6.3	6.8	10.3	16.6	4.5	9.1	8.0	18.4	20.5	24.5	29.1	20.4	22.4	18.4	21.5	21.4	20.0	23.3	19.0	59.5	25.6	22.4	45.7	20.3	39.1	31.5	33.6	38.7	72.1	33.4	22.7	36.1	21.5	30.4	40.5	70.9	13.8	21.7	19.1	13.7	24.2	42.2	34.9	30.2	31.4	35.4	12.0	80.0	30.5	24.8	34.3	36.7	34.1	12.0	41.7	27.1	15.7	19.2	32.0	100.1	34.2	20.3	33.7	33.1	15.3	20.2	25.1	30.2	45.0	19.1	47.4	19.6	76.4	60.3	29.8	14.9	28.6	23.9	44.6	14.2	24.7	65.4	68.2	13.1	33.5	25.4	25.6	23.1	30.8	45.3	10.5	21.2	30.8	18.8	33.7
SCAPER	"Zfp291, ZNF291"	ENSG00000140386	"S-phase cyclin A associated protein in the ER"	Q9BY12	15	76347904-76905444	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 55.4"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 252.3;Oligodendrocytes: 251.5;Rod photoreceptor cells: 710.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046253, HPA048077"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	No			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA046253: AB_2679600, HPA048077: "	"unprognostic (3.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.69e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.89e-3)"	5.5	7.9	9.7	4.0	12.2	7.4	6.9	18.2	10.4	6.2	6.5	6.0	6.5	7.4	7.7	8.9	6.4	5.3	13.8	9.0	12.8	9.0	7.5	6.3	4.7	11.5	10.5	12.1	8.3	14.5	8.2	6.5	11.3	7.0	4.4	55.4	7.9	6.2	13.6	6.9	6.3	6.3	9.2	5.9	6.1	21.0	10.7	8.6	12.2	12.0	6.0	5.0	6.5	16.3	6.3	5.8	7.8	4.5	3.9	7.0	6.5	8.3	5.9	3.8	5.4	6.1	5.0	6.3	7.2	2.8	10.0	6.7	18.5	3.5	5.7	14.7	9.1	3.3	6.8	3.0	4.9	9.0	7.6	5.9	6.0	4.5	7.3	8.2	5.2	12.6	4.8	17.5	6.6	2.6	8.8	2.7	2.3	5.5	3.3	7.9	12.4	2.2	3.5	6.3	18.4	8.9	11.2	3.9	9.0	9.4	5.8	7.3	6.3	8.7	8.1	4.1	7.4	10.5	23.7	8.9	5.1	11.1	5.9	40.8	6.3	17.4	11.4	3.5	13.1	16.3	11.5	10.3	3.6	17.0	18.8	12.1	10.7	17.1	4.2	9.3	9.7	4.2	9.7	12.2	18.2	10.4	9.0	12.8	11.5	10.5	11.3	9.2	10.7	16.3	28.5	99.3	61.5	190.7	33.2	20.6	28.9	10.6	18.8	91.5	13.9	15.5	191.3	12.8	27.4	12.9	252.3	33.8	26.6	17.1	1.9	14.6	59.1	10.6	13.8	23.5	16.2	1.7	151.5	6.0	11.8	22.1	17.3	18.4	22.1	41.9	21.8	9.3	14.3	77.4	201.8	9.0	6.1	13.6	11.3	24.9	20.5	14.4	10.6	135.9	12.8	51.3	34.0	203.1	251.5	6.5	11.4	19.2	28.6	15.9	72.6	7.8	12.3	710.6	19.7	39.1	23.5	143.9	68.9	15.1	18.8	52.0	30.5	26.7	13.4	19.7
SCARF2	"HUMZD58C02, SREC-II, SREC2"	ENSG00000244486	"Scavenger receptor class F member 2"	Q96GP6	22	20424584-20437826	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 44.8;Fibroblasts: 21.2;Leydig cells: 13.4;Peritubular cells: 17.7;Sertoli cells: 13.1;Smooth muscle cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 25.5;SH-SY5Y: 28.5;SK-MEL-30: 31.7;U-138 MG: 38.7;U-2 OS: 40.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035079	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		580000	"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035079: AB_10670287"	"unprognostic (2.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.38e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (4.28e-4)"	15.1	5.4	2.4	1.9	2.6	0.4	10.7	0.5	3.3	19.1	4.1	10.0	1.3	22.4	0.5	3.6	15.5	3.6	10.3	2.1	3.9	10.6	3.6	23.2	1.3	5.1	3.2	20.2	4.0	0.4	5.4	3.7	2.2	15.5	0.3	0.1	4.6	4.5	3.1	10.1	6.0	2.2	2.0	9.4	7.8	2.7	4.7	0.2	11.8	0.4	0.2	13.3	13.2	1.3	0.7	0.4	5.8	10.1	3.4	4.8	2.3	25.5	10.8	6.2	3.3	0.1	0.1	0.4	14.6	12.7	0.4	0.2	3.4	0.1	0.7	0.9	21.6	2.1	0.5	4.9	21.3	0.0	1.1	8.2	0.1	3.0	1.5	3.0	3.0	0.1	0.2	0.2	2.2	1.1	0.0	0.5	7.8	0.0	3.3	0.6	16.1	0.0	0.1	0.1	2.5	28.5	0.1	0.0	31.7	1.1	0.9	0.1	3.7	38.7	40.7	1.0	5.9	1.2	0.5	0.4	0.1	0.5	19.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	2.6	0.5	3.3	2.1	3.9	5.1	3.2	2.2	2.0	4.7	1.3	3.6	0.0	0.0	1.6	0.1	2.8	1.6	0.7	0.0	2.9	0.3	0.9	44.8	0.0	0.3	0.0	2.1	0.4	0.3	0.1	0.0	0.0	0.3	2.6	8.9	10.5	0.0	0.0	1.9	0.0	1.6	21.2	1.5	1.0	0.0	0.6	3.9	0.7	0.7	0.0	5.2	0.2	0.0	0.8	2.4	0.5	13.4	0.4	3.6	6.5	0.0	0.3	1.0	3.0	1.1	0.0	0.1	17.7	0.2	7.1	0.0	0.2	4.2	0.8	13.1	1.4	19.5	1.1	0.7	0.3	2.7	0.4	1.2	2.1	0.2	0.6
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 385.5;skin 1: 302.7"	"Cell type enriched"	"Detected in many"	12	"Alveolar cells type 1: 679.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 17.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	3.1	0.1	0.0	0.1	0.1	0.1	19.5	0.1	0.1	69.9	0.0	1.1	0.0	0.1	0.1	385.5	0.3	0.1	0.1	0.0	0.0	0.4	0.1	59.8	0.0	0.1	0.2	0.2	0.2	0.3	0.5	0.8	0.2	0.1	2.0	0.1	57.8	0.0	1.5	302.7	0.1	0.0	0.1	0.0	0.6	2.3	0.1	0.5	2.2	0.0	76.8	0.1	121.6	0.2	16.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	1.8	0.0	0.0	54.6	0.0	25.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	74.2	14.9	0.0	0.0	0.0	107.2	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	679.5	31.6	0.0	0.0	10.7	0.1	12.9	0.0	0.0	0.0	0.0	0.2	0.0	49.7	0.0	0.0	0.3	0.0	0.7	0.0	3.2	6.6	0.7	0.1	0.2	0.0	0.0	0.2	0.2	0.0	2.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	7.8	8.2	0.0	1.1	20.9	0.0	0.3	1.8	0.0	0.0	1.6	0.0	1.0	1.7	45.5	0.2	0.0	0.0	0.1	0.0	0.1	7.1	0.0	0.0	0.0	1.2	7.9	5.0	48.8	55.8	0.1	0.3	0.8	0.1	2.7
SCFD2	"FLJ39514, STXBP1L1"	ENSG00000184178	"Sec1 family domain containing 2"	Q8WU76	4	52872982-53366066	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 63.0;Excitatory neurons: 126.2;Inhibitory neurons: 131.6;Microglial cells: 82.4;Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036526, HPA036527"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA036526: AB_10673499, HPA036527: AB_2675175"	"unprognostic (1.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.81e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.51e-2)"	7.3	9.0	5.7	7.3	6.2	7.6	7.3	5.5	6.6	6.2	4.8	6.3	5.6	6.9	3.3	8.5	4.6	4.5	6.4	5.6	6.8	7.1	5.6	5.2	7.4	6.5	6.0	6.6	6.1	5.6	5.8	6.0	6.8	4.4	6.2	4.0	5.5	5.1	7.6	7.2	4.3	7.5	5.6	5.8	5.8	2.8	6.9	6.5	5.2	6.2	7.9	6.0	6.6	8.3	13.5	12.2	6.8	16.0	22.2	22.3	8.3	30.0	22.6	10.3	8.7	8.7	16.6	25.7	22.8	57.7	11.1	8.1	22.2	26.2	19.6	7.7	13.0	14.1	12.1	10.6	10.3	18.3	24.8	15.5	15.6	19.9	7.8	9.9	18.2	6.5	24.4	14.3	17.7	15.2	25.0	10.8	4.3	37.6	15.0	15.4	6.6	26.8	11.4	8.7	19.5	11.3	6.8	25.0	13.7	7.9	9.8	8.2	16.3	22.1	14.2	25.7	22.3	16.5	9.8	29.7	15.1	20.7	65.0	0.1	7.2	1.8	9.2	12.2	9.5	8.0	7.4	10.6	19.6	6.4	10.9	10.1	1.4	17.9	13.5	12.7	7.1	11.1	5.7	6.2	5.5	6.6	5.6	6.8	6.5	6.0	6.8	5.6	6.9	8.3	5.4	0.0	3.1	63.0	10.3	3.7	5.4	5.8	8.0	4.1	3.9	3.4	2.9	11.5	3.5	3.7	6.2	8.4	5.4	3.5	1.9	3.8	2.9	2.6	8.4	4.2	1.2	5.5	126.2	5.1	6.7	7.3	5.6	3.6	12.7	5.9	4.2	6.0	5.3	5.0	131.6	3.5	2.0	2.5	3.1	1.5	6.5	10.0	5.4	82.4	2.7	2.7	3.1	182.0	153.7	2.5	2.8	5.7	14.3	2.8	2.4	8.5	4.3	3.3	0.0	5.3	3.8	5.4	3.5	10.5	5.4	4.2	6.8	16.4	4.9	3.5
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 81.0;choroid plexus: 28.9;heart muscle: 80.4;skeletal muscle: 101.3;tongue: 92.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 14.2;Horizontal cells: 15.2;Skeletal myocytes: 7.0"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.9"	"Group enriched"	"Detected in many"	46	"dendritic cells: 6.9;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 27.0;AN3-CA: 49.2;HUVEC TERT2: 58.3;NTERA-2: 29.8;SH-SY5Y: 167.0"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	2.9	46.5	0.2	56.3	0.8	1.2	52.6	55.0	2.5	28.9	11.1	1.0	3.9	0.7	3.4	2.3	1.9	80.4	50.0	48.7	2.5	0.7	2.9	0.5	51.0	48.2	0.5	0.4	0.2	11.8	10.9	52.6	5.6	1.1	3.6	1.9	1.4	101.3	0.4	3.6	5.4	55.6	4.8	4.6	1.9	46.9	0.8	0.8	92.8	0.2	0.7	1.2	81.0	0.1	0.0	27.0	49.2	0.0	0.2	0.0	0.2	0.1	0.1	1.1	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	2.4	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.7	1.1	0.3	11.2	0.4	58.3	0.0	0.0	0.1	3.5	0.0	0.0	0.0	29.8	0.0	0.0	0.0	5.5	0.0	1.3	0.0	0.0	167.0	0.0	0.0	0.2	7.0	0.0	3.1	10.9	0.6	1.5	0.4	2.5	2.1	0.0	0.0	0.7	2.0	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	46.5	56.3	52.6	55.0	50.0	48.7	51.0	48.2	52.6	55.6	46.9	81.0	4.5	6.4	1.7	0.0	0.1	0.4	4.8	2.5	1.2	5.4	0.6	0.8	14.2	0.0	2.2	3.7	2.1	1.5	2.7	0.1	0.0	0.3	0.0	4.4	0.4	6.0	0.0	2.1	0.0	0.2	0.5	1.6	0.0	3.1	0.0	0.1	2.2	0.5	0.2	15.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	3.6	0.0	0.0	3.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.6	0.0	1.4	3.7	0.6	0.0	7.0	2.9	0.0	0.4	0.4	0.6	0.8	0.2	0.2	0.0	1.4
SCMH1	Scml3	ENSG00000010803	"Scm polycomb group protein homolog 1"	Q96GD3	1	41027200-41242154	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 125.4;Excitatory neurons: 161.3;Inhibitory neurons: 213.0;Microglial cells: 102.1;Oligodendrocyte precursor cells: 154.3;Oligodendrocytes: 77.9;Spermatocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048898, HPA053292"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA048898: , HPA053292: AB_2797246"	"unprognostic (6.02e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (5.80e-4)"	22.0	24.0	15.2	11.3	15.9	17.8	23.2	16.5	18.1	32.0	18.6	54.6	12.7	35.4	20.5	14.0	33.1	15.8	39.3	16.1	16.9	29.8	19.7	20.6	10.4	13.6	14.7	36.3	40.1	34.7	27.6	11.0	13.1	40.4	17.0	21.0	27.5	30.7	44.9	13.3	23.4	24.6	12.2	15.5	32.5	32.8	16.7	16.6	24.1	34.2	10.5	38.9	21.3	14.1	19.5	12.8	29.9	27.5	13.4	25.4	0.1	15.4	26.7	25.2	26.0	12.3	24.6	35.4	11.4	28.1	21.1	4.8	23.3	20.6	21.6	24.7	17.8	16.6	17.7	31.2	58.2	35.7	26.2	27.7	20.5	16.7	40.2	30.5	25.7	43.3	15.7	26.8	25.0	10.6	36.0	30.8	27.7	16.4	13.5	39.3	31.3	21.0	20.4	24.1	21.0	22.5	26.7	21.1	22.1	20.2	18.8	90.7	19.0	26.3	20.4	16.4	28.5	27.1	16.2	38.6	16.5	31.5	24.4	0.6	0.6	1.2	1.6	1.1	2.0	2.4	1.9	1.5	1.9	1.1	1.3	1.1	0.0	1.6	0.2	3.9	1.4	0.9	15.2	15.9	16.5	18.1	16.1	16.9	13.6	14.7	13.1	12.2	16.7	14.1	7.1	9.6	10.8	125.4	9.4	6.6	25.8	11.5	26.7	17.0	16.4	17.0	14.9	18.6	7.4	12.9	16.7	7.3	10.8	7.2	1.9	11.4	9.4	7.2	13.8	9.6	8.4	16.0	161.3	21.3	3.3	11.4	15.3	13.1	5.1	11.9	8.9	7.3	6.2	8.4	213.0	7.4	8.2	3.3	6.5	12.4	16.4	3.2	8.8	102.1	2.7	6.9	2.1	154.3	77.9	12.4	6.2	18.0	20.2	23.3	10.4	18.1	5.8	14.2	19.7	11.9	10.3	54.3	26.1	6.1	3.7	4.8	7.4	3.5	12.4	14.5
SCML1		ENSG00000047634	"Scm polycomb group protein like 1"	Q9UN30	X	17737449-17754988	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 581.3;Spermatogonia: 205.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 19.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 88.1"									"HPA035270, HPA035271, HPA061397"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA035270: AB_10672860, HPA035271: AB_10602795, HPA061397: AB_2684503"	"unprognostic (6.36e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-3)"	10.7	11.5	5.6	6.4	5.9	3.1	8.2	5.8	8.9	11.1	6.7	7.9	8.1	7.9	3.1	6.0	9.8	5.4	7.8	5.6	6.0	9.5	28.8	9.8	8.3	6.5	5.8	20.8	8.2	3.9	9.2	10.1	6.0	9.2	7.2	30.7	3.7	6.3	12.7	6.3	7.6	7.6	5.5	8.4	6.8	26.6	5.7	7.6	5.4	14.6	5.5	6.5	8.1	6.1	23.2	6.1	19.4	6.8	18.0	23.7	2.2	22.2	21.4	23.8	30.2	11.9	10.6	0.0	9.4	15.0	15.7	13.3	25.4	15.6	35.4	0.0	50.0	1.7	18.6	25.6	23.6	0.0	12.0	15.6	14.1	30.7	23.2	5.3	0.4	8.9	3.9	0.0	22.7	7.0	0.0	0.0	3.0	17.2	24.6	0.0	9.9	10.7	9.6	5.5	3.8	4.9	10.0	0.1	8.9	11.2	3.5	0.5	10.8	23.4	9.6	88.1	14.5	13.4	13.1	0.0	18.7	2.1	6.7	0.0	1.2	1.0	0.2	3.5	0.2	1.7	3.3	0.3	2.6	3.7	19.0	9.0	1.0	9.6	4.2	0.6	0.5	2.1	5.6	5.9	5.8	8.9	5.6	6.0	6.5	5.8	6.0	5.5	5.7	6.1	42.4	19.2	25.7	25.5	16.1	95.0	36.7	10.0	58.6	55.6	21.5	14.7	26.6	15.7	14.1	16.5	68.8	5.1	6.1	14.8	9.8	5.8	26.8	23.5	24.4	41.1	11.3	1.7	13.9	8.7	2.3	42.0	25.5	40.0	10.8	35.3	16.1	60.5	19.5	38.7	26.8	20.0	12.2	17.0	62.8	20.3	59.4	32.3	28.4	22.5	6.2	33.3	2.1	15.6	24.5	4.3	21.1	34.3	2.5	33.8	28.4	5.6	10.4	86.9	52.6	71.5	40.4	581.3	205.9	38.6	114.1	5.6	15.1	44.4	31.3	31.1
SCML4	dJ47M23.1	ENSG00000146285	"Scm polycomb group protein like 4"	Q8N228	6	107702154-107824317	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 10.1;lymphoid tissue: 12.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 31.7;Early spermatids: 72.1;Late spermatids: 168.4;NK-cells: 35.0;T-cells: 73.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 48.2;MAIT T-cell: 47.7;memory CD4 T-cell: 74.8;memory CD8 T-cell: 65.7;naive CD4 T-cell: 69.1;naive CD8 T-cell: 59.5;NK-cell: 53.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 53.2;T-cells: 74.8"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 65.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA063326, HPA065958"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA063326: AB_2684986, HPA065958: AB_2685587"	"unprognostic (4.00e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-4)"	"unprognostic (3.84e-3)"	"unprognostic (6.65e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.13e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.77e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-3)"	"unprognostic (5.09e-3)"	0.6	0.8	0.8	7.2	0.6	3.3	1.0	1.2	0.7	0.5	0.2	2.3	10.1	0.5	4.6	0.9	0.7	1.4	0.6	0.6	0.9	0.6	1.6	1.7	12.1	0.5	0.5	0.6	0.7	0.2	1.9	0.3	0.3	0.6	2.0	0.9	1.0	0.4	0.4	0.9	8.2	0.5	0.1	7.4	2.8	2.2	1.3	9.3	0.8	0.2	9.8	1.1	0.7	0.6	0.1	0.1	0.1	0.1	0.1	0.3	0.8	0.1	0.0	0.0	0.0	1.4	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.1	65.1	0.0	0.1	0.4	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.3	0.1	0.1	13.8	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.3	0.2	0.7	0.1	0.1	0.1	4.2	0.3	3.5	48.2	0.1	47.7	10.1	74.8	65.7	0.2	5.8	69.1	59.5	6.6	53.2	0.4	1.2	5.8	26.6	0.8	0.6	1.2	0.7	0.6	0.9	0.5	0.5	0.3	0.1	1.3	0.6	0.5	0.0	0.0	0.7	18.0	1.5	0.0	0.0	0.6	0.6	0.4	0.4	1.1	0.0	0.0	0.0	0.0	1.3	31.7	0.4	0.0	1.2	72.1	0.0	0.1	0.7	0.0	1.3	2.7	0.0	0.2	1.0	4.6	0.1	1.3	0.0	1.1	1.8	0.2	1.7	2.5	1.4	0.0	0.8	1.4	168.4	0.9	1.2	3.6	1.9	2.0	0.0	35.0	0.5	0.1	0.1	2.6	0.7	11.6	0.0	5.5	0.4	0.7	0.0	0.0	0.3	0.6	1.1	0.5	0.3	0.1	0.1	73.3	0.0	4.7	0.1
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 409.9;Inhibitory neurons: 494.6;Oligodendrocyte precursor cells: 692.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 6.1;Hep G2: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	0.0	0.0	4.2	0.0	4.2	0.0	0.0	2.1	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.1	6.9	0.0	0.0	1.4	0.0	14.2	6.2	0.0	0.0	0.0	2.0	0.0	18.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	2.1	24.7	2.1	6.9	14.2	6.2	18.5	2.2	10.9	10.9	0.0	6.4	33.9	27.4	0.0	0.0	0.0	0.0	0.0	47.4	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	0.0	0.3	1.8	0.0	409.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	494.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	18.7	0.0	2.8	0.0	692.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 137.4;tongue: 54.0"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 46.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"REH: 15.0;RH-30: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053992			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Centriolar satellite"	"HPA053992: AB_2797249"	"unprognostic (2.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.45e-2)"	17.9	0.7	0.0	0.2	0.1	0.0	16.0	0.3	0.1	0.1	0.0	1.1	0.0	0.1	0.0	1.1	0.2	0.3	0.8	0.0	0.0	0.7	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.7	1.5	0.1	0.0	0.5	0.1	0.0	1.8	0.0	137.4	0.7	0.3	0.0	0.0	0.8	0.5	1.7	0.0	0.2	4.3	54.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	15.0	45.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.8	1.4	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	1.1	2.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.1	5.9	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649687	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"heart muscle: 42.8"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 77.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 27.6;RH-30: 22.8"	"Group enriched"	"Detected in many"	5	"amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.2	0.1	1.9	0.1	1.2	0.2	0.2	0.0	0.7	1.7	0.0	0.2	0.2	0.7	0.0	0.1	0.3	0.1	42.8	0.2	1.5	0.0	0.0	0.1	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.2	0.0	0.3	0.1	2.0	0.2	0.5	1.6	0.1	0.2	0.3	0.2	0.1	0.1	0.3	2.6	0.0	0.2	1.0	0.0	0.4	0.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.4	0.1	0.0	0.2	3.6	0.0	0.0	0.0	1.0	0.5	2.7	0.0	0.4	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	0.0	2.1	2.8	0.4	0.0	0.0	27.6	1.4	0.0	0.0	2.6	0.0	0.0	0.0	22.8	0.0	0.0	3.2	0.4	3.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.7	0.2	1.5	0.0	0.7	0.0	0.2	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.7	0.0	0.3	77.1	0.0	0.1	0.0	14.6	0.2	0.0	0.0	0.0	0.1	1.2	0.1	3.2	2.8	0.0	0.0	0.5	0.0	0.3	3.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	6.3	0.3	0.6	0.2	0.0	3.7	0.0	0.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.9	0.0	7.3	3.1	0.2	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4
SCNM1	MGC3180	ENSG00000163156	"Sodium channel modifier 1"	Q9BWG6	1	151156664-151170296	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 269.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052439, HPA054324"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA052439: AB_2681834, HPA054324: AB_2682451"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.25e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (2.17e-13)"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.71e-2)"	27.6	19.9	37.6	27.5	37.7	46.1	24.3	38.6	40.6	24.4	34.3	25.8	20.1	25.2	17.3	25.8	21.8	18.7	23.2	36.6	38.0	22.8	16.8	21.6	39.9	38.7	37.9	20.8	15.0	17.6	16.4	21.1	38.1	23.7	17.4	13.7	20.2	17.2	65.0	29.1	23.4	21.6	37.9	34.1	21.3	18.3	38.4	35.0	18.0	34.3	34.7	29.8	23.0	40.0	46.5	32.0	35.0	41.4	47.9	35.9	58.3	35.9	41.5	85.7	66.5	69.9	44.2	73.3	57.1	39.0	22.4	61.5	41.3	33.1	41.4	46.6	45.7	63.5	44.5	45.5	69.2	85.2	60.0	37.8	63.3	60.3	53.4	40.2	52.4	50.5	51.7	54.7	42.6	114.0	61.2	132.0	89.0	72.1	49.2	82.3	41.7	91.7	46.7	30.6	43.0	69.0	40.5	65.4	83.5	43.2	60.5	269.9	38.7	40.8	38.3	42.5	78.1	70.7	104.3	117.4	42.5	89.5	53.6	286.7	189.1	203.3	80.4	146.0	77.6	125.9	97.4	92.0	254.9	112.7	89.0	76.9	190.5	131.6	95.1	260.8	131.4	182.3	37.6	37.7	38.6	40.6	36.6	38.0	38.7	37.9	38.1	37.9	38.4	40.0	21.0	3.2	15.2	0.0	33.7	26.6	17.8	47.8	33.0	19.9	20.2	26.3	32.9	17.2	34.1	29.5	18.8	36.6	52.3	21.4	54.8	34.0	33.5	24.0	23.1	26.9	14.4	34.7	0.0	31.9	33.6	26.5	26.0	15.2	40.5	15.8	27.5	11.9	74.1	8.4	0.0	20.4	54.9	57.2	62.0	25.3	31.1	55.1	21.4	0.0	67.6	25.7	64.9	0.0	0.0	41.9	31.2	21.4	23.2	16.6	36.3	37.1	38.5	16.9	32.9	14.2	43.9	27.9	15.1	33.6	18.3	27.5	37.8	14.7	16.8	22.0
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 subunit gamma"	P51170	16	23182745-23216883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.4"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 90.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in single"	6	"cerebellum: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"hTCEpi: 46.8;RT4: 21.7"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Not detected"	"Not detected"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	0.7	0.2	0.4	0.0	0.3	0.3	2.3	4.4	0.2	16.0	0.2	10.3	0.0	1.8	0.7	9.9	0.4	0.0	0.0	0.8	0.2	42.4	0.0	7.4	0.0	0.2	0.2	0.0	3.2	0.0	3.8	0.5	0.4	13.8	1.2	0.2	17.7	3.4	0.0	9.7	0.4	0.1	0.0	0.0	10.1	0.1	0.1	2.0	5.7	0.0	1.2	1.4	15.3	0.3	1.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.9	0.0	0.0	0.1	0.0	21.7	1.5	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.4	0.2	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.3	0.4	19.2	4.2	0.0	0.0	0.4	4.7	8.8	19.9	0.0	0.8	1.3	0.8	0.0	17.4	90.1	0.0	0.2	0.0	3.4	0.0	2.0	0.0	9.8	1.1	0.1	0.0	0.0	0.2	1.7	0.0	0.4	15.3	18.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	10.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.5	1.1	0.0	0.1	5.3	0.0	0.2	1.9	0.0	0.0	0.0	0.2	0.1	0.1	4.4	0.3	0.1	0.2	0.0	0.4	1.8
SCOC	"HRIHFB2072, SCOCO, UNC-69"	ENSG00000153130	"Short coiled-coil protein"	Q9UIL1	4	140257286-140385728	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 320.8;Early spermatids: 537.1;Proximal tubular cells: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061198, HPA070321"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		22000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA061198: AB_2684449, HPA070321: AB_2686252"	"unprognostic (2.27e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.37e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.82e-12)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-2)"	44.8	66.8	81.8	27.7	84.5	14.7	69.4	87.4	114.6	42.6	72.0	43.9	45.4	48.0	79.5	54.1	44.7	39.7	103.6	85.1	109.1	101.6	74.3	35.9	29.7	91.3	96.8	42.6	51.3	94.1	43.2	48.3	103.1	59.9	49.8	74.5	49.2	47.1	40.8	29.9	37.1	50.9	91.4	27.9	53.7	33.8	95.2	29.3	67.4	59.3	32.8	38.9	19.4	105.6	53.9	38.1	92.6	49.9	80.6	109.3	67.4	85.5	78.0	64.6	71.8	24.4	81.0	22.0	75.5	83.9	60.6	22.6	57.3	113.6	95.7	79.1	40.4	33.5	18.8	59.7	70.1	70.2	40.5	72.5	155.9	59.0	63.1	124.1	87.1	63.8	53.0	60.0	116.3	36.5	94.7	42.5	30.2	47.6	57.1	54.0	39.1	32.1	197.1	52.9	68.4	70.4	57.0	84.5	97.0	81.7	63.4	41.9	68.0	104.4	60.5	86.9	83.1	94.4	193.4	64.9	118.2	32.2	102.3	47.8	16.5	23.0	27.5	23.0	35.1	36.8	32.3	27.3	21.4	30.3	46.8	36.4	9.7	36.9	23.1	26.7	33.2	37.0	81.8	84.5	87.4	114.6	85.1	109.1	91.3	96.8	103.1	91.4	95.2	105.6	63.2	48.1	47.2	15.3	34.4	61.1	69.7	74.1	78.6	135.0	84.9	96.0	140.3	62.9	51.8	126.9	22.9	139.9	31.3	63.4	320.8	99.2	537.1	67.5	52.4	54.4	37.8	34.7	33.8	112.8	82.2	58.3	66.8	58.4	36.8	32.0	51.4	65.0	47.6	171.6	37.1	42.7	114.0	23.0	27.9	91.2	60.0	34.5	138.7	17.8	36.7	205.6	22.6	20.6	42.9	92.9	37.0	66.2	30.8	91.7	46.8	311.1	54.9	71.0	46.0	40.8	64.5	60.7	56.1	83.8	56.7	88.9	36.3	39.6	46.1	56.0
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927276-53051698	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1116.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1240.7;Proximal enterocytes: 769.0;Proximal tubular cells: 881.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	203.7	125.5	68.5	92.7	71.6	111.2	196.6	74.2	90.1	153.8	79.2	256.7	336.3	94.6	165.5	140.2	119.7	144.6	162.4	65.8	76.1	319.8	1116.8	140.6	106.0	75.4	72.3	94.5	119.2	130.9	64.7	79.0	77.9	150.9	270.5	76.6	114.0	97.3	142.0	130.6	305.7	112.9	75.6	83.9	234.4	63.4	74.7	131.9	140.9	152.8	125.5	139.2	76.9	78.9	120.6	64.8	85.5	157.9	273.6	232.6	92.7	140.0	208.9	90.1	129.2	58.7	127.5	114.7	147.6	206.6	105.3	82.5	59.6	131.0	136.5	168.2	86.4	123.4	88.8	122.1	182.0	179.9	197.5	190.2	175.0	107.1	52.9	196.2	260.0	132.6	111.5	58.2	184.7	70.1	200.7	155.2	94.6	304.4	126.0	101.9	150.9	158.3	252.2	192.2	70.9	85.3	122.0	246.3	121.6	189.6	125.9	201.4	203.8	122.4	63.4	213.2	114.9	95.9	131.0	134.2	159.0	175.7	113.8	285.6	193.7	286.0	185.9	208.8	152.1	150.8	144.9	184.6	230.5	132.6	120.8	171.4	29.4	176.8	204.2	150.9	195.2	289.5	68.5	71.6	74.2	90.1	65.8	76.1	75.4	72.3	77.9	75.6	74.7	78.9	167.0	134.6	198.4	52.2	91.1	150.4	123.8	222.2	110.4	37.5	189.8	86.0	157.4	258.7	166.2	185.8	31.3	182.7	128.3	512.7	473.5	168.1	57.4	150.4	81.6	126.8	235.1	93.4	45.0	162.4	156.5	124.3	180.4	125.3	138.4	54.0	146.7	1240.7	203.5	42.1	54.4	462.7	250.3	230.1	173.1	51.4	184.2	148.8	192.1	42.2	154.6	132.0	181.3	48.2	44.3	157.4	503.4	171.9	76.6	118.1	769.0	881.0	178.2	34.1	78.9	72.0	110.6	20.4	19.4	150.0	170.8	133.9	132.9	110.3	336.4	187.8
SCRIB	"KIAA0147, SCRB1, Vartul"	ENSG00000180900	"Scribble planar cell polarity protein"	Q14160	8	143790920-143815773	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 100.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015463, CAB022081, HPA023557, HPA064312"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Rods & Rings"	"CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.78e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-1)"	18.7	17.1	11.5	7.2	10.8	5.6	23.6	6.0	10.4	45.6	0.0	32.3	9.1	24.7	0.9	100.5	26.0	3.4	24.6	8.7	2.7	27.7	25.4	21.3	4.0	10.7	8.1	23.0	38.8	5.2	24.8	5.0	5.9	28.4	3.4	1.0	40.2	5.2	54.3	68.3	26.5	2.0	4.9	22.9	30.0	26.4	9.0	3.0	24.6	1.7	3.9	27.8	52.6	15.3	55.7	33.1	12.7	20.5	5.1	6.9	33.0	30.9	5.3	11.2	9.1	15.3	29.8	24.2	39.7	7.2	4.6	52.4	7.9	32.9	1.7	30.8	58.5	24.6	30.5	26.1	10.8	13.0	14.8	5.1	29.9	9.4	5.5	5.1	11.5	19.8	42.2	6.4	7.5	93.0	38.1	26.9	15.7	25.0	55.1	44.5	10.6	25.0	5.6	45.5	29.6	27.1	31.4	30.5	33.6	4.5	41.5	28.2	25.7	10.1	64.1	25.2	44.7	31.6	31.0	23.8	13.1	9.5	19.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.5	10.8	6.0	10.4	8.7	2.7	10.7	8.1	5.9	4.9	9.0	15.3	12.3	0.0	9.9	33.0	4.4	8.5	5.0	10.2	13.6	11.3	16.8	17.0	11.1	11.5	8.3	14.7	14.6	11.0	9.7	28.7	3.9	8.6	1.5	14.0	7.7	7.8	13.8	13.7	5.0	9.4	6.3	7.3	29.6	27.3	0.0	17.9	3.6	8.8	6.5	5.0	6.2	17.8	18.3	6.0	4.1	0.7	9.0	6.6	8.8	6.5	5.0	10.0	5.2	12.1	15.2	11.5	22.8	9.8	5.6	9.3	16.9	4.5	9.9	16.0	13.1	12.0	8.7	9.4	10.0	19.9	10.7	5.1	7.3	8.0	23.2	7.1
SCRN2		ENSG00000141295	"Secernin 2"	Q96FV2	17	47837692-47841289	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 149.7;Proximal tubular cells: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022934, HPA023434"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		370000	"Cluster 44: Non-specific - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA022934: AB_1856638, HPA023434: AB_1856639"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.28e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.83e-4)"	81.2	22.9	18.9	11.1	19.4	13.4	48.9	18.8	22.3	28.2	22.0	23.8	43.8	24.5	11.5	19.2	26.5	12.0	31.9	18.5	20.6	68.6	37.2	17.4	12.9	19.9	19.6	25.4	26.4	25.4	31.5	12.9	18.8	28.5	10.4	6.5	33.8	19.7	38.1	22.1	36.7	10.2	20.1	34.0	21.5	10.6	19.4	12.0	39.9	25.0	10.1	22.2	23.3	20.1	28.0	43.8	12.1	11.0	33.7	25.7	36.6	13.7	27.6	20.6	21.0	32.5	33.2	15.3	27.5	7.1	11.0	14.7	3.9	24.6	6.9	37.6	29.7	15.5	33.8	29.2	12.0	7.9	12.7	25.7	18.1	12.8	9.8	31.5	23.5	35.6	5.4	18.2	28.9	25.4	24.6	12.8	6.0	12.1	17.5	32.7	9.0	62.4	16.9	12.9	8.9	37.6	8.0	17.3	17.8	8.3	37.9	14.5	10.7	18.2	20.8	5.6	6.6	70.2	9.8	7.7	52.1	13.2	4.2	24.5	19.9	43.4	24.6	21.1	24.1	24.8	20.4	24.2	25.7	25.3	31.7	17.8	5.4	29.3	10.8	30.1	23.0	16.5	18.9	19.4	18.8	22.3	18.5	20.6	19.9	19.6	18.8	20.1	19.4	20.1	21.9	38.5	29.9	15.0	18.7	15.7	31.5	41.8	20.5	12.0	24.5	25.7	19.3	15.7	35.9	16.5	10.4	43.1	12.4	33.2	74.3	27.7	3.9	16.9	10.0	24.6	22.3	7.2	12.4	61.0	9.3	25.7	17.3	12.4	16.5	22.1	24.3	26.7	22.7	20.2	10.5	33.6	48.8	11.1	13.7	2.8	33.2	12.8	42.7	7.5	13.9	28.8	26.8	11.1	6.0	33.3	36.5	16.6	30.9	14.1	149.7	332.7	40.9	16.8	6.6	19.1	16.0	5.2	16.7	21.9	11.5	33.8	21.6	23.9	40.7	27.0
SCRT2	ZNF898B	ENSG00000215397	"Scratch family transcriptional repressor 2"	Q9NQ03	20	661596-675802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	44	"brain: 7.8;retina: 3.9"	"Cell type enriched"	"Detected in some"	11	"Horizontal cells: 60.6"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Karpas-707: 1.7;NTERA-2: 1.7;RPMI-8226: 3.4;SCLC-21H: 1.8;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA067697			Approved	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA067697: AB_2685890"					"unprognostic (9.71e-2)"					"unprognostic (2.03e-1)"	"unprognostic (6.97e-2)"			"unprognostic (9.70e-2)"	"unprognostic (1.70e-1)"			0.0	0.0	0.6	0.0	1.5	0.0	0.0	6.2	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.0	2.6	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.5	6.2	7.8	0.0	0.4	5.0	2.6	3.1	0.5	5.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	60.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Human disease related genes, Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	14.6	13.5	10.5	14.8	10.8	7.2	17.9	8.4	12.3	13.6	8.5	14.3	11.9	17.6	19.0	15.3	12.7	8.7	14.3	10.9	11.0	15.0	15.8	12.6	21.2	9.6	8.9	13.7	17.7	17.7	8.9	12.9	9.3	14.2	15.1	6.8	15.0	16.2	22.9	14.8	11.1	17.1	8.5	15.5	14.0	21.3	11.1	16.4	21.2	16.4	20.2	18.8	11.7	10.2	29.8	11.8	28.5	38.9	33.1	29.8	30.6	41.3	35.9	34.0	29.1	36.6	42.0	46.7	30.2	38.1	32.4	29.7	44.5	40.5	42.3	41.2	23.0	39.9	24.4	30.6	32.7	68.5	43.9	26.4	45.0	36.3	40.4	21.1	30.0	31.2	72.7	37.8	36.4	33.1	69.6	25.1	47.4	48.3	18.1	41.8	53.5	39.3	32.7	32.6	43.3	35.6	28.1	57.0	48.9	31.1	26.4	39.6	29.1	36.6	36.7	44.4	34.8	33.9	37.6	62.0	40.7	31.1	46.0	10.4	14.5	4.1	19.1	19.1	23.8	17.8	23.0	21.1	15.3	20.1	23.0	19.5	2.3	23.4	27.5	13.0	21.5	15.9	10.5	10.8	8.4	12.3	10.9	11.0	9.6	8.9	9.3	8.5	11.1	10.2	36.2	19.2	34.7	15.0	45.7	27.5	26.8	45.1	35.3	21.1	21.3	29.1	12.3	14.3	46.0	22.0	6.2	30.6	35.7	14.5	35.2	37.7	109.0	12.1	29.9	25.2	22.8	35.3	34.0	24.9	32.2	27.4	20.9	18.7	49.4	26.3	18.9	22.1	37.9	13.5	31.8	22.6	36.7	24.3	16.3	106.7	25.4	30.0	24.9	30.9	40.3	23.7	42.2	23.6	29.9	33.4	18.3	33.1	49.0	37.1	17.1	46.6	26.1	20.0	19.7	33.2	38.7	75.6	100.7	47.5	33.1	25.0	38.1	33.2	27.9	22.4
SDC3	"N-syndecan, SYND3"	ENSG00000162512	"Syndecan 3"	O75056	1	30869466-30908758	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 140.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.6;Endometrial stromal cells: 59.8;Kupffer cells: 174.8;Late spermatids: 82.4;Oligodendrocyte precursor cells: 108.6"	"Group enriched"	"Detected in all"	5	"glioma: 115.2;melanoma: 102.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 249.5;WM-115: 342.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017087, CAB025786, HPA048085"	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256"	"unprognostic (1.42e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.83e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (9.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (6.45e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.46e-1)"	33.9	99.1	103.9	22.9	123.9	3.0	17.9	97.0	105.4	36.5	38.1	57.3	12.3	62.3	12.3	17.6	29.8	30.0	22.7	91.6	111.1	10.4	22.3	22.5	36.4	140.3	121.2	9.3	7.5	13.2	11.8	18.1	107.9	26.9	14.6	27.2	15.9	52.7	27.1	10.1	16.5	66.2	112.4	91.0	19.7	3.3	124.4	6.4	9.8	9.1	7.6	32.7	13.4	91.9	12.9	10.4	80.4	36.5	60.6	14.8	13.8	31.4	48.0	15.0	9.5	2.0	12.3	0.9	68.6	95.3	21.8	16.3	8.7	7.6	10.0	5.7	6.3	0.0	4.1	1.8	56.9	0.3	8.2	35.4	35.9	1.0	15.4	86.6	20.1	3.6	6.2	0.5	30.6	15.0	0.3	0.2	36.4	10.2	9.4	0.8	75.2	2.8	19.7	14.9	28.9	17.5	40.3	5.7	249.5	50.8	5.7	6.1	19.3	18.6	28.2	2.0	7.5	0.1	0.5	0.9	1.9	0.2	342.9	1.1	0.3	0.2	0.1	0.6	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.4	0.2	0.2	0.2	103.9	123.9	97.0	105.4	91.6	111.1	140.3	121.2	107.9	112.4	124.4	91.9	37.3	0.0	2.2	64.6	0.5	2.5	3.4	4.7	4.0	9.6	14.9	25.5	4.9	14.3	2.6	47.8	0.0	2.1	0.2	0.8	0.0	10.7	17.7	14.1	59.8	17.9	3.0	0.0	14.7	3.1	3.4	16.6	3.1	28.6	0.0	17.5	20.3	1.0	14.3	0.0	13.9	1.1	6.1	174.8	3.1	82.4	2.1	24.4	19.6	18.7	4.0	2.5	1.0	108.6	6.8	6.0	1.3	7.9	1.5	8.5	0.0	0.6	0.4	27.8	0.0	1.1	9.1	0.7	0.4	1.3	2.3	3.6	2.3	15.4	1.6	5.7
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582859	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 959.8;Melanocytes: 889.4"	"Cancer enriched"	"Detected in all"	4	"melanoma: 244.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1908.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1908.0;monocytes: 562.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 787.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	228.5	126.4	94.1	160.8	111.8	245.6	167.1	102.0	130.1	160.9	112.2	119.6	83.1	109.8	83.6	88.8	95.7	194.8	120.6	103.7	112.6	126.6	174.0	223.9	121.2	113.7	103.8	89.1	80.8	132.9	45.8	264.3	113.5	70.8	134.7	26.8	124.9	78.3	65.9	84.8	92.8	151.2	107.4	203.0	130.0	41.1	110.8	129.9	120.7	113.7	92.8	248.8	91.9	123.7	123.5	185.9	194.2	101.4	711.7	607.1	86.1	122.9	439.6	175.3	228.9	74.8	250.7	0.4	194.8	166.4	321.2	49.7	106.0	142.4	215.7	22.6	91.3	184.3	156.0	60.6	787.9	47.7	287.1	417.9	188.1	176.5	525.2	273.0	428.0	125.2	92.3	104.6	403.4	32.4	104.1	55.9	122.2	478.6	52.3	49.6	59.4	24.3	282.1	127.0	84.9	153.5	133.8	56.1	630.0	213.8	51.0	127.9	382.3	168.8	72.5	200.8	81.5	31.4	45.6	74.8	428.9	0.5	155.1	777.4	562.9	528.1	61.2	349.6	78.0	69.4	82.0	67.3	251.8	61.0	103.9	80.2	1908.0	42.6	329.1	69.9	103.0	453.2	94.1	111.8	102.0	130.1	103.7	112.6	113.7	103.8	113.5	107.4	110.8	123.7	382.7	211.5	115.9	26.8	170.3	338.7	321.2	312.5	108.1	10.8	86.7	54.6	70.6	88.6	181.3	206.0	16.7	284.3	220.2	192.9	225.0	392.9	7.8	110.9	87.0	412.7	112.3	116.6	18.5	291.6	756.8	308.1	162.1	120.5	396.9	62.9	378.3	101.9	782.5	15.2	23.7	180.3	248.2	552.1	959.8	15.9	233.9	626.0	889.4	71.2	312.4	94.3	51.5	21.6	16.3	297.9	152.9	159.9	65.1	307.4	78.4	211.2	169.8	11.1	98.6	82.7	177.4	14.8	8.4	73.3	173.2	483.0	256.2	117.0	129.2	457.6
SDCBP2	"SITAC18, ST-2"	ENSG00000125775	"Syndecan binding protein 2"	Q9H190	20	1309909-1329139	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 141.8;intestine: 136.9;stomach 1: 101.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 782.5;Pancreatic endocrine cells: 755.4;Paneth cells: 948.5;Proximal enterocytes: 470.3;Urothelial cells: 641.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.6;OE19: 57.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005804, HPA064490"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA005804: , HPA064490: AB_2732713"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.78e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.37e-4)"	7.3	3.4	19.9	10.1	20.7	0.7	6.9	16.3	24.3	25.8	15.2	85.8	136.9	5.7	9.0	141.8	4.3	41.8	4.6	19.6	20.2	16.0	18.1	20.9	1.3	17.2	17.9	3.5	15.2	2.5	3.9	3.3	17.4	6.5	55.5	1.0	29.8	2.5	2.8	62.9	133.0	3.6	16.9	3.1	101.8	5.6	20.3	1.5	14.6	1.4	13.7	38.2	49.9	18.0	10.9	0.5	1.4	0.5	5.8	5.1	0.9	3.2	6.3	2.8	2.7	2.3	18.6	1.1	2.1	1.2	2.0	8.2	0.5	15.5	1.4	0.4	1.0	0.9	0.6	1.5	5.8	1.1	1.2	1.8	10.8	2.2	2.2	6.0	9.6	2.0	1.5	0.7	1.1	2.6	1.7	3.0	1.3	57.3	0.7	1.6	0.7	2.2	1.2	14.4	2.4	1.9	1.5	9.3	3.6	0.6	0.4	0.9	6.5	1.5	0.6	2.8	1.2	2.8	2.7	1.1	0.7	4.1	0.9	0.1	0.8	1.9	0.9	0.3	0.7	0.2	1.2	0.9	1.0	0.4	1.0	1.8	0.8	0.9	0.6	0.7	2.3	0.7	19.9	20.7	16.3	24.3	19.6	20.2	17.2	17.9	17.4	16.9	20.3	18.0	15.6	16.0	4.2	0.0	4.1	55.7	112.0	198.1	3.4	1.0	4.9	4.8	0.8	72.9	172.6	16.5	0.0	1.8	1.0	782.5	27.4	114.5	17.1	25.8	11.7	14.1	35.9	0.0	0.0	209.7	1.1	4.6	201.8	85.4	8.9	1.0	7.1	5.1	0.9	1.7	0.0	150.8	156.6	1.9	6.4	1.9	1.5	1.8	8.8	0.0	2.3	1.0	2.1	0.0	0.0	755.4	948.5	0.0	0.7	107.0	470.3	1.8	89.6	0.9	0.0	1.7	9.9	5.0	7.6	31.1	95.6	1.6	3.5	2.0	109.2	641.9
SDHAF4	"C6orf57, Sdh8"	ENSG00000154079	"Succinate dehydrogenase complex assembly factor 4"	Q5VUM1	6	70566917-70589569	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031824	Supported		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA031824: AB_10602113"	"unprognostic (8.72e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (2.45e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.94e-2)"	11.2	12.3	7.1	4.2	7.5	4.3	10.5	6.8	10.5	6.6	7.3	6.8	5.0	5.8	9.3	7.5	10.3	4.2	14.5	7.6	9.4	12.5	8.5	5.4	6.0	6.9	6.3	6.4	6.6	14.4	12.7	6.8	7.3	7.6	6.7	10.0	8.7	5.4	23.6	8.6	5.4	4.2	5.8	5.6	7.0	5.3	7.8	6.4	7.3	10.6	5.2	6.8	6.7	7.6	13.3	4.2	18.8	11.6	9.0	13.6	3.5	7.1	5.1	3.4	5.0	3.8	11.3	9.1	12.7	3.8	8.0	2.3	6.2	5.9	5.2	18.3	4.3	6.6	1.8	3.9	15.3	6.3	5.1	9.6	19.3	2.6	14.8	11.6	8.0	14.8	4.2	13.9	11.0	9.0	5.9	15.7	8.8	6.5	4.5	6.4	12.6	10.8	14.9	4.4	16.8	12.1	4.3	2.1	9.6	8.0	9.6	16.5	6.3	3.5	2.7	2.8	7.7	6.2	4.5	3.1	3.9	15.1	8.5	4.0	4.6	4.4	3.4	4.3	3.3	3.7	3.7	4.1	5.1	4.7	3.9	3.8	3.3	4.7	4.6	6.2	4.2	3.0	7.1	7.5	6.8	10.5	7.6	9.4	6.9	6.3	7.3	5.8	7.8	7.6	5.4	12.8	13.9	4.9	3.3	0.0	7.9	0.0	3.4	7.4	6.5	7.5	21.3	10.0	5.6	7.3	8.4	10.5	5.0	2.9	23.5	9.1	5.5	20.2	8.2	5.0	3.6	2.5	7.7	11.6	8.5	6.6	2.6	6.0	5.1	6.1	4.2	11.8	10.0	18.5	7.5	5.8	0.0	5.3	0.0	2.5	12.5	6.2	0.0	2.8	10.1	10.1	3.1	12.1	7.7	13.2	5.3	6.8	2.2	9.5	6.2	16.8	13.8	6.4	13.1	5.1	4.9	10.0	6.1	5.7	0.0	5.1	3.9	6.1	5.3	8.0
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054032	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 491.5;tongue: 580.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 405.5;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		7900	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	85.8	95.7	68.0	59.0	72.2	94.6	68.7	80.6	84.3	56.8	81.1	134.3	163.0	56.0	71.0	77.4	59.8	48.0	302.8	69.9	76.9	228.0	336.1	56.1	75.3	74.8	71.4	44.4	80.3	144.3	42.8	57.6	73.8	55.7	132.4	62.9	74.0	60.5	491.5	55.6	121.9	70.4	73.9	60.5	92.8	64.4	74.9	62.7	64.3	580.6	84.2	71.3	52.0	78.9	157.3	152.7	72.2	107.8	141.6	135.2	95.9	122.4	145.2	254.3	227.7	216.8	183.1	206.8	159.3	156.4	176.1	180.1	290.7	226.8	284.8	128.7	280.6	183.4	149.2	168.2	172.8	276.0	135.6	140.4	154.9	224.5	370.1	138.7	183.6	176.5	165.2	236.9	179.6	129.5	182.4	175.1	70.4	224.6	302.6	146.1	142.5	265.4	252.4	88.7	157.5	86.0	172.3	216.3	392.3	76.4	131.1	169.1	94.9	115.8	131.0	206.4	176.0	98.9	133.3	198.6	170.4	438.5	128.3	68.7	149.8	149.5	71.4	206.5	70.7	89.9	81.0	77.5	186.8	81.1	73.5	74.8	174.3	85.3	185.7	89.3	113.8	116.1	68.0	72.2	80.6	84.3	69.9	76.9	74.8	71.4	73.8	73.9	74.9	78.9	48.2	64.1	47.4	20.9	57.4	52.1	93.3	199.8	40.5	31.5	45.2	49.4	405.5	101.5	97.0	47.8	14.6	107.1	48.3	176.1	354.1	134.3	220.3	48.7	38.2	54.7	48.6	77.3	27.7	149.2	142.2	62.0	46.9	45.5	66.6	39.9	46.8	226.0	177.4	37.0	32.1	103.1	116.0	88.7	67.9	30.5	57.8	78.4	64.0	29.0	123.1	78.3	48.4	15.6	24.6	111.5	218.3	67.7	62.2	74.4	300.5	449.0	79.8	53.8	39.5	57.1	191.6	148.9	71.5	72.9	54.6	121.8	46.8	69.3	162.0	110.9
SDK2	"FLJ10832, KIAA1514"	ENSG00000069188	"Sidekick cell adhesion molecule 2"	Q58EX2	17	73334384-73644445	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.5;cervix: 5.5;testis: 9.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 16.0;Enteroendocrine cells: 14.9;Excitatory neurons: 18.9;Extravillous trophoblasts: 17.1;Horizontal cells: 20.2;Inhibitory neurons: 14.8;Late spermatids: 20.0;Syncytiotrophoblasts: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 13.8;BEWO: 11.4;RPMI-8226: 4.7;SuSa: 7.2;U-2 OS: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014725			Approved	Nucleoplasm		NA	NA		5300000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA014725: AB_2183303"	"unprognostic (7.22e-4)"	"unprognostic (5.57e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.62e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (7.69e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.64e-2)"	0.1	0.5	3.9	1.1	2.9	0.6	0.6	1.2	2.8	5.5	0.0	0.6	0.1	1.6	1.3	0.6	2.4	0.6	0.9	5.4	1.9	0.3	0.1	1.1	1.1	6.5	3.2	0.3	0.1	0.9	1.4	0.3	6.5	1.8	0.3	0.9	0.6	0.7	0.2	0.5	0.8	0.2	2.0	2.7	0.5	9.7	3.7	0.7	1.3	0.3	1.0	0.4	0.7	3.7	0.0	2.0	13.8	3.9	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	3.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.5	0.0	4.7	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	4.7	0.0	0.0	4.2	1.8	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	3.9	2.9	1.2	2.8	5.4	1.9	6.5	3.2	6.5	2.0	3.7	3.7	0.4	0.0	2.7	6.5	4.4	0.9	4.6	9.9	2.8	6.8	0.8	5.0	2.0	1.5	1.9	0.0	0.0	6.7	0.2	0.2	0.0	0.3	16.0	0.5	3.9	0.8	14.9	0.4	18.9	0.2	17.1	4.6	0.5	1.0	1.3	5.6	0.0	0.0	0.6	20.2	14.8	0.4	0.0	0.0	0.2	20.0	0.6	0.6	1.8	2.8	1.1	9.7	0.0	6.6	6.6	0.0	0.0	0.0	1.3	2.3	0.0	0.3	0.2	0.8	0.0	1.2	0.9	10.7	3.5	0.3	0.1	17.8	0.8	10.4	0.0	1.1
SDR39U1	"C14orf124, HCDI"	ENSG00000100445	"Short chain dehydrogenase/reductase family 39U member 1"	Q9NRG7	14	24439766-24442905	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044294, HPA075356"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA044294: AB_10961400, HPA075356: "	"unprognostic (2.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.87e-3)"	"prognostic favorable (2.34e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.32e-2)"	41.5	73.9	55.4	14.8	56.9	28.9	44.6	59.7	65.1	40.4	53.4	43.3	16.9	33.5	17.7	35.1	35.8	11.6	83.7	54.0	55.7	60.2	57.9	35.1	22.6	56.7	57.9	47.2	50.1	22.7	58.1	14.4	56.6	47.2	9.3	37.9	38.0	23.1	96.7	40.1	42.1	11.6	57.4	57.7	47.5	34.7	58.5	27.8	38.7	72.5	14.1	41.1	33.4	57.3	20.1	35.4	25.5	30.0	34.8	26.5	24.4	11.5	16.3	26.4	30.2	27.4	26.0	28.4	30.0	13.4	19.6	37.1	22.8	29.2	11.5	38.2	39.5	25.3	26.1	74.1	16.9	23.7	23.4	29.7	34.6	19.0	27.2	26.9	28.5	65.5	23.1	24.5	26.3	36.2	40.2	39.2	24.1	31.3	32.6	50.9	13.2	20.9	47.5	27.1	43.8	36.8	30.3	55.4	28.3	15.1	38.1	34.9	14.2	8.0	25.5	23.7	15.3	38.3	26.9	35.7	21.1	30.6	21.2	39.1	38.3	23.8	40.3	23.7	39.2	49.7	30.7	32.3	43.7	49.7	43.2	45.2	11.4	58.4	20.3	60.7	40.2	33.0	55.4	56.9	59.7	65.1	54.0	55.7	56.7	57.9	56.6	57.4	58.5	57.3	34.9	28.9	21.7	10.1	35.0	26.5	40.8	40.1	21.6	37.2	44.2	47.2	0.2	45.8	36.5	40.5	12.5	48.4	41.6	19.7	121.3	29.1	16.9	16.9	15.9	27.3	27.6	35.3	12.2	19.9	24.3	24.8	13.3	17.8	36.1	28.4	21.0	38.6	30.2	28.6	12.6	25.8	38.7	19.3	19.6	26.3	32.9	21.6	42.7	12.2	22.9	63.4	37.0	11.1	17.0	15.7	17.7	31.6	34.4	24.9	21.3	71.7	26.8	47.4	0.0	25.5	24.0	67.1	22.6	21.0	27.3	56.1	28.6	27.0	22.5	29.8
SEC13	"D3S1231E, npp-20, SEC13L1, SEC13R"	ENSG00000157020	"SEC13 homolog, nuclear pore and COPII coat complex component"	P55735	3	10293131-10321112	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035292, HPA057943"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		35000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA035292: AB_10959451, HPA057943: AB_2683560"	"unprognostic (3.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	62.1	71.5	51.0	61.8	55.6	58.4	58.9	55.9	57.6	83.7	59.2	68.8	114.7	66.4	59.4	72.6	57.4	47.5	71.1	52.2	57.2	67.4	92.1	64.3	54.6	54.6	54.6	52.6	85.2	64.6	109.2	68.5	55.2	53.8	65.7	21.2	96.2	64.9	111.5	62.7	96.6	76.6	54.3	59.4	67.3	39.4	54.2	70.3	57.6	87.3	65.4	69.9	59.2	58.2	122.6	182.1	142.9	55.2	228.0	251.6	474.4	243.8	296.1	279.3	319.8	150.3	97.6	110.7	109.6	390.1	156.8	49.0	186.4	218.3	142.4	97.8	194.5	136.2	137.3	363.7	311.8	156.7	115.5	224.7	173.1	292.6	181.5	205.6	337.0	146.2	148.4	159.8	219.5	250.2	153.8	169.9	160.9	158.0	218.7	148.1	102.4	198.2	172.4	90.2	80.3	99.4	107.3	98.7	101.3	119.3	127.5	150.8	253.6	114.2	130.2	172.6	213.3	131.7	198.4	258.6	215.5	217.5	193.0	127.3	163.2	106.6	84.4	144.9	94.6	96.5	83.6	82.1	222.5	82.6	68.0	71.2	105.8	93.9	116.4	198.3	106.1	176.5	51.0	55.6	55.9	57.6	52.2	57.2	54.6	54.6	55.2	54.3	54.2	58.2	23.9	48.1	61.9	14.0	45.8	39.4	50.4	73.6	31.3	16.2	29.5	26.4	40.2	30.0	68.3	27.6	10.4	119.9	36.5	60.1	66.5	79.3	25.6	31.8	44.0	51.0	41.4	33.0	17.3	109.2	166.6	74.1	73.9	47.1	43.1	35.5	33.9	57.3	104.9	11.8	13.7	108.2	50.8	33.0	46.7	10.2	53.4	45.0	26.6	12.2	64.2	37.4	35.0	11.6	12.6	81.8	56.1	52.6	203.2	52.4	187.5	112.0	64.5	21.1	13.1	37.7	63.6	54.9	38.9	43.7	40.2	168.6	36.5	35.8	74.2	62.3
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77088749-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 430.3;Hepatic stellate cells: 286.3;Late spermatids: 740.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 355.0"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 355.0"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 398.1;TIME: 251.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021463: AB_2670712, HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	66.7	54.2	42.6	44.6	63.3	65.5	57.6	75.4	60.7	39.5	36.3	19.5	21.8	24.6	28.2	31.5	27.3	34.3	50.2	49.5	57.5	42.0	25.3	66.9	49.7	64.0	63.0	20.7	30.8	25.1	27.9	76.7	54.6	18.3	19.8	19.0	35.0	16.8	94.1	20.5	21.7	27.1	46.2	49.9	31.7	51.9	63.6	24.1	41.6	54.7	46.2	26.0	20.6	50.9	55.0	45.4	65.6	105.0	27.4	36.3	24.1	47.4	42.0	57.8	49.5	55.7	39.6	143.1	93.3	65.0	71.1	26.3	36.0	47.8	72.6	27.3	50.1	81.1	42.4	75.9	44.4	26.8	39.8	46.6	20.7	47.8	47.8	69.1	398.1	24.3	55.8	136.0	79.2	36.2	28.5	22.4	25.0	25.7	43.7	20.3	104.2	112.2	91.2	26.2	59.5	44.8	51.1	31.3	32.1	58.3	27.9	20.7	251.1	65.4	60.6	35.0	37.7	71.1	64.8	79.9	27.9	22.1	21.6	33.8	19.4	48.9	7.1	28.3	8.9	14.6	6.9	5.3	12.7	10.8	10.9	5.9	355.0	10.0	33.3	18.9	12.5	11.5	42.6	63.3	75.4	60.7	49.5	57.5	64.0	63.0	54.6	46.2	63.6	50.9	430.3	41.7	18.6	55.8	69.4	29.3	23.5	22.5	37.0	31.5	86.5	37.8	17.6	15.7	28.9	27.6	18.8	10.8	77.5	20.3	99.7	18.0	242.6	114.8	46.7	205.9	19.7	86.5	33.0	20.7	10.8	34.0	35.2	240.5	34.7	104.3	286.3	11.1	51.6	37.0	54.6	14.0	61.1	127.2	48.1	740.3	26.4	115.1	35.6	62.8	76.1	31.4	34.0	23.1	44.4	41.8	15.2	17.3	269.1	39.5	9.6	24.8	69.5	17.2	39.5	36.4	36.3	45.1	42.5	25.1	30.4	13.3	51.6	64.3	11.5	39.1
SEC14L2	"C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1"	ENSG00000100003	"SEC14 like lipid binding 2"	O76054	22	30396941-30425303	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 86.0;liver: 243.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 146.3;Muller glia cells: 112.6;Pancreatic endocrine cells: 115.2;Proximal enterocytes: 52.8;Rod photoreceptor cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 93.9;hTCEpi: 47.3;hTERT-RPE1: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064466	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		580000	"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA064466: AB_2685270"	"prognostic favorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.59e-3)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.63e-6)"	"unprognostic (1.25e-3)"	"unprognostic (3.76e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.01e-1)"	2.8	1.4	33.1	2.6	43.3	4.1	44.4	35.8	37.1	6.0	35.4	3.4	21.6	3.4	86.0	20.6	3.1	7.4	2.4	34.3	39.7	8.0	243.8	2.7	3.1	45.4	39.5	2.6	2.6	11.0	11.1	1.5	33.2	52.3	1.3	64.2	9.3	13.7	0.7	7.0	24.3	3.4	30.4	1.1	5.9	1.3	41.4	4.2	9.0	0.5	4.5	3.2	7.7	32.2	24.8	5.5	5.0	6.4	6.5	16.8	0.4	18.0	15.5	12.0	13.1	1.6	15.9	0.5	5.6	22.7	20.5	20.0	3.0	93.9	13.8	2.2	4.1	0.4	5.4	8.0	9.2	0.0	7.1	11.5	47.3	11.5	20.8	55.5	29.7	4.2	0.1	0.5	22.2	4.0	3.0	0.5	0.1	13.9	7.6	1.2	8.0	0.6	20.7	7.8	2.8	3.1	13.3	3.2	11.2	0.6	14.7	0.5	41.2	15.8	10.4	6.8	12.7	0.3	0.2	0.8	32.4	0.1	12.6	0.0	0.1	0.2	0.5	0.1	0.2	0.4	1.4	0.3	0.0	0.3	3.7	2.7	0.3	0.0	0.0	0.5	0.7	0.8	33.1	43.3	35.8	37.1	34.3	39.7	45.4	39.5	33.2	30.4	41.4	32.2	1.1	3.2	5.8	33.6	1.1	4.1	18.0	25.2	6.8	9.2	36.5	21.7	1.2	12.8	10.3	0.0	16.7	4.2	3.2	0.6	5.9	22.9	8.3	2.9	2.3	2.4	1.2	17.2	9.8	18.7	0.3	5.1	5.6	5.8	5.7	0.7	7.1	146.3	0.5	13.5	6.7	2.0	4.1	4.4	0.4	10.7	1.2	2.6	7.2	1.9	0.2	112.6	0.0	21.6	13.2	115.2	0.0	0.7	2.5	15.3	52.8	8.7	3.9	56.0	0.0	2.8	4.0	0.6	1.2	5.6	2.0	3.0	7.4	0.1	2.1	7.8
SEC14L6		ENSG00000214491	"SEC14 like lipid binding 6"	B5MCN3	22	30522799-30546682	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"epididymis: 21.2;parathyroid gland: 30.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.5;Cholangiocytes: 11.5;Collecting duct cells: 12.9;Ductal cells: 6.6;Muller glia cells: 18.6"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"K-562: 12.3;RPTEC TERT1: 21.8;SiHa: 6.6"									HPA067695			Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA067695: AB_2685889"	"unprognostic (3.49e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.25e-2)"	"unprognostic (8.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.02e-2)"	1.4	1.4	5.3	0.3	4.6	2.1	3.9	4.5	4.7	3.5	5.9	0.5	0.6	3.2	21.2	0.3	1.7	4.5	0.3	4.4	5.0	8.4	0.4	11.9	0.4	8.6	6.2	2.4	5.5	30.5	2.5	0.5	8.8	1.7	0.3	5.0	0.4	2.6	0.2	10.0	0.5	2.2	5.2	0.4	1.2	5.4	8.7	0.3	0.3	0.8	0.6	0.4	0.4	4.9	0.2	0.1	0.9	0.3	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.2	0.5	0.3	1.1	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.0	3.0	0.3	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.7	0.0	0.1	12.3	0.2	0.0	0.5	0.1	0.4	0.5	0.0	0.1	0.2	0.0	0.1	21.8	0.2	0.2	0.1	6.6	0.1	0.0	0.2	1.8	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.1	0.1	0.5	0.0	5.3	4.6	4.5	4.7	4.4	5.0	8.6	6.2	8.8	5.2	8.7	4.9	0.0	12.8	10.5	0.3	0.2	0.1	0.5	0.0	0.0	0.2	0.4	0.5	0.3	11.5	3.7	12.9	0.0	0.0	0.0	0.0	1.9	6.6	0.0	0.3	0.4	1.0	0.0	0.0	0.7	0.8	0.0	0.2	0.0	1.5	1.3	0.2	0.7	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.6	18.6	0.0	1.5	0.6	1.8	0.0	0.7	0.0	0.1	0.0	2.9	0.0	0.5	0.0	2.7	0.1	0.9	0.4	0.0	0.0	0.1	0.9	0.0	0.0	0.2
SEC22C	"MGC13261, MGC5373, SEC22L3"	ENSG00000093183	"SEC22 homolog C, vesicle trafficking protein"	Q9BRL7	3	42547969-42601080	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031242			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA031242: "	"unprognostic (1.68e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (1.35e-7)"	"unprognostic (2.59e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-3)"	35.7	23.4	37.3	14.1	40.8	36.5	33.2	39.1	46.8	28.2	33.8	31.1	31.9	29.8	27.4	17.2	27.2	18.9	24.3	34.1	38.0	26.2	16.4	33.1	19.0	41.4	40.3	29.3	29.6	26.4	26.6	19.3	42.0	37.3	15.6	25.6	23.3	25.9	22.2	19.4	32.6	26.3	37.5	20.4	28.3	27.5	39.2	18.2	24.2	26.1	16.4	25.7	23.1	48.1	24.0	22.2	35.9	30.5	72.4	68.1	7.6	43.8	46.7	46.1	47.9	15.5	37.9	24.5	17.6	50.1	28.2	12.6	24.1	39.8	40.7	32.8	28.5	41.7	40.0	21.0	55.4	19.2	39.5	38.3	53.1	51.4	62.5	46.5	51.1	38.7	37.0	46.5	45.8	16.6	27.1	22.3	19.8	16.0	31.9	11.7	21.4	22.9	40.6	21.1	18.5	27.8	30.9	28.0	34.5	26.5	48.4	20.9	42.9	35.1	27.8	63.8	43.1	36.8	55.6	23.5	41.7	26.6	34.0	11.7	11.5	22.0	13.2	9.0	19.6	11.5	17.6	16.3	10.8	9.4	14.9	13.2	7.1	10.2	9.3	11.3	16.3	10.1	37.3	40.8	39.1	46.8	34.1	38.0	41.4	40.3	42.0	37.5	39.2	48.1	31.4	25.6	27.6	27.1	23.2	15.0	18.3	25.3	25.0	16.6	31.6	29.6	18.8	24.3	17.2	11.0	29.2	20.5	28.1	1.9	41.1	29.7	61.2	17.5	19.5	30.5	9.0	48.2	18.9	32.9	20.3	31.8	21.9	12.7	49.4	25.1	32.2	14.5	31.3	26.9	18.4	4.9	32.6	19.0	14.4	15.0	32.6	17.6	40.9	21.5	35.5	39.2	24.7	12.5	44.1	28.8	1.0	42.9	23.0	24.0	36.9	29.6	19.4	39.9	39.5	26.6	31.1	96.9	49.8	11.3	10.2	10.5	34.6	20.3	6.6	9.4
SEC23A		ENSG00000100934	"Sec23 homolog A, COPII coat complex component"	Q15436	14	39031919-39109646	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043806, HPA069974"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		83000	"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA043806: , HPA069974: AB_2686223"	"unprognostic (2.40e-1)"	"prognostic unfavorable (5.75e-4)"	"prognostic favorable (3.56e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.69e-4)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.41e-3)"	45.9	32.0	11.4	31.8	14.2	13.1	20.9	18.3	16.8	36.2	31.4	40.0	57.7	42.7	19.9	34.1	21.5	32.1	46.9	13.3	18.9	23.1	80.8	20.2	21.0	13.8	14.0	33.9	12.0	8.1	10.5	27.1	15.3	34.0	34.2	38.5	10.5	52.6	54.2	12.8	52.6	90.5	7.6	20.5	16.8	23.5	12.7	18.9	17.9	58.5	22.0	40.7	17.9	15.4	52.1	90.8	76.9	74.7	161.3	173.0	25.9	195.1	176.4	135.2	166.8	93.2	44.2	12.6	46.9	279.6	54.9	41.2	99.6	86.3	208.6	39.6	36.9	21.8	67.7	347.3	122.4	35.9	31.3	134.0	48.8	91.6	73.7	114.6	130.8	26.9	15.6	30.1	125.8	47.5	32.9	16.9	18.4	81.7	91.3	44.0	111.8	19.1	84.7	75.6	8.5	20.5	132.8	43.0	51.8	68.6	51.5	12.4	138.4	75.0	57.8	110.8	52.0	27.0	36.6	56.0	50.3	31.4	70.2	70.5	34.3	38.6	26.6	29.3	38.4	23.6	33.1	34.9	31.1	21.1	34.9	28.0	29.5	42.1	27.3	26.7	38.1	31.4	11.4	14.2	18.3	16.8	13.3	18.9	13.8	14.0	15.3	7.6	12.7	15.4	35.4	16.0	26.9	34.9	30.5	25.9	33.5	15.5	15.4	39.7	11.8	10.3	54.6	15.7	18.8	31.3	68.8	16.0	36.0	87.0	7.9	9.8	13.4	11.3	42.8	41.1	24.5	6.1	48.3	5.6	43.7	55.0	26.5	18.8	27.9	56.9	118.9	133.6	25.6	30.3	51.1	31.6	12.2	36.4	32.3	18.6	74.9	24.3	24.9	48.7	25.6	19.4	32.0	34.2	44.3	17.8	34.1	71.5	38.5	37.5	88.6	32.8	10.1	58.7	39.5	27.6	51.4	18.0	15.5	15.7	24.0	24.8	32.3	31.0	30.2	56.5
SEC24B		ENSG00000138802	"SEC24 homolog B, COPII coat complex component"	O95487	4	109433772-109540896	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 88.1;Oligodendrocytes: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038181	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA038181: AB_10672472"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.58e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	19.3	13.7	7.2	13.2	7.5	28.0	17.4	14.7	9.9	16.3	15.0	15.7	14.1	16.9	12.9	17.2	15.0	13.8	15.6	6.8	7.6	16.7	46.2	14.8	13.9	7.5	6.9	21.4	18.6	21.9	11.2	20.6	7.8	15.6	16.1	32.6	14.3	16.1	28.1	19.8	12.7	17.9	7.3	14.7	13.3	11.3	7.4	27.2	18.5	22.9	16.7	17.5	16.0	9.6	21.1	18.9	29.3	22.1	34.9	34.7	16.8	27.0	32.8	22.5	19.8	17.4	23.8	19.4	13.8	41.1	19.3	17.4	33.2	26.9	33.0	24.0	16.6	20.3	16.6	19.2	23.4	27.0	22.9	34.4	33.7	25.8	30.8	31.8	33.7	19.7	31.5	17.3	33.6	17.1	39.2	12.5	11.2	26.1	15.0	25.1	25.9	11.3	27.1	25.8	20.6	16.5	20.8	43.8	16.0	30.0	12.9	10.3	31.3	26.2	17.6	23.1	19.5	16.6	22.3	18.1	23.3	10.7	21.5	6.1	9.5	11.5	8.6	10.4	9.5	10.3	9.5	9.0	11.8	8.9	10.8	9.3	9.2	11.5	10.5	4.6	9.1	9.0	7.2	7.5	14.7	9.9	6.8	7.6	7.5	6.9	7.8	7.3	7.4	9.6	25.1	25.6	15.4	63.0	23.0	35.4	20.1	11.8	28.5	27.0	12.9	10.8	30.5	14.3	17.4	5.5	6.2	13.3	13.2	22.7	5.9	10.4	4.4	18.7	14.6	22.5	15.6	11.6	71.1	13.1	9.2	16.4	19.9	21.9	11.4	15.9	16.8	29.9	12.3	16.8	84.1	15.6	4.1	17.6	16.8	7.9	20.5	18.7	17.8	88.1	14.5	20.3	13.4	76.9	91.6	12.6	18.7	21.8	21.3	22.5	16.5	9.6	19.6	22.0	13.1	16.3	16.8	14.7	13.6	22.2	36.7	16.1	17.0	9.9	14.4	30.3
SEC31B	"DKFZP434M183, SEC31B-1, SEC31L2"	ENSG00000075826	"SEC31 homolog B, COPII coat complex component"	Q9NQW1	10	100486646-100519864	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Bipolar cells: 32.2;Cone photoreceptor cells: 39.6;Excitatory neurons: 38.1;Horizontal cells: 40.4;Inhibitory neurons: 40.7;Oligodendrocyte precursor cells: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.1;JURKAT: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035882, HPA040819, HPA060052"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Vesicles, Cytosol"		"HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: "	"unprognostic (1.23e-1)"	"unprognostic (3.13e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.10e-4)"	"unprognostic (8.23e-3)"	"prognostic unfavorable (6.41e-7)"	"unprognostic (2.31e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-4)"	2.2	1.5	2.0	1.1	2.0	2.5	2.0	2.3	2.9	2.6	1.2	2.5	0.3	2.1	1.0	0.8	2.6	0.8	2.8	1.8	1.9	2.2	2.0	1.7	1.6	1.9	1.7	2.8	0.6	1.7	3.7	0.7	1.8	2.3	0.8	1.5	1.6	0.8	5.9	1.3	2.3	0.8	1.5	3.0	1.7	2.7	1.9	2.9	2.0	8.3	1.3	1.8	1.5	2.2	0.1	0.0	2.0	0.5	0.6	1.0	0.1	0.4	0.9	0.2	0.6	0.1	0.0	0.4	0.6	0.0	0.1	0.0	1.1	0.2	0.5	2.5	0.5	1.0	1.5	0.2	0.9	0.8	0.8	1.8	1.0	0.1	1.2	9.1	0.3	8.9	0.1	1.3	0.0	0.0	1.4	2.3	0.0	0.2	0.4	2.0	0.0	0.9	0.6	0.0	0.1	0.7	0.2	0.0	0.4	1.5	0.4	0.2	0.0	0.1	0.2	0.1	0.1	0.9	0.5	0.6	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.0	2.3	2.9	1.8	1.9	1.9	1.7	1.8	1.5	1.9	2.2	2.5	6.4	4.5	28.7	2.4	1.1	0.9	1.7	1.2	32.2	2.9	2.0	8.0	4.3	2.3	11.0	39.6	1.2	4.5	3.8	0.0	0.4	2.3	1.3	3.4	2.6	5.4	0.4	38.1	0.2	0.3	2.4	3.1	1.6	1.3	7.7	2.9	6.1	2.2	40.4	40.7	3.3	0.0	4.8	1.7	1.7	3.4	3.5	1.8	7.5	5.2	3.6	1.0	32.6	21.5	0.2	2.0	4.1	2.5	1.2	2.4	1.0	2.2	5.8	0.0	1.9	2.2	7.7	3.2	1.8	1.1	0.8	4.6	4.7	4.0	1.1
SECISBP2	SBP2	ENSG00000187742	"SECIS binding protein 2"	Q96T21	9	89318500-89359663	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 332.4;Late spermatids: 440.3;Spermatocytes: 338.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044314, HPA054905"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA044314: AB_10964885, HPA054905: "	"unprognostic (1.07e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (8.98e-9)"	"unprognostic (5.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.55e-3)"	22.9	27.2	17.7	22.6	21.0	35.1	28.2	22.2	19.9	29.2	25.1	26.0	23.5	27.4	28.0	19.7	28.1	18.6	18.2	18.5	21.3	31.6	29.2	25.9	31.9	19.4	18.7	40.8	40.8	25.3	28.1	27.1	19.6	25.2	27.5	49.0	27.1	16.3	41.6	29.7	29.3	15.3	17.8	34.8	27.0	68.9	19.9	33.8	35.3	21.3	27.5	24.7	23.6	28.0	29.9	19.9	53.5	31.1	24.7	26.5	38.8	16.9	20.9	19.8	19.4	11.2	24.4	44.4	14.6	15.9	31.5	37.1	36.4	17.0	18.3	29.4	21.6	21.8	16.5	28.7	21.3	44.2	31.5	16.7	31.5	16.8	19.9	21.8	25.0	58.5	28.4	51.1	19.1	27.7	60.9	22.6	55.7	74.5	19.5	29.1	26.2	29.3	22.2	22.7	39.0	38.3	15.3	33.7	45.9	35.4	29.9	37.8	23.2	19.2	22.3	26.0	26.4	61.7	42.3	18.2	33.3	28.3	28.1	17.0	8.2	14.7	10.8	8.9	10.5	14.2	10.9	10.7	7.4	14.8	16.2	13.9	23.0	10.2	11.5	13.0	14.3	6.5	17.7	21.0	22.2	19.9	18.5	21.3	19.4	18.7	19.6	17.8	19.9	28.0	72.5	44.8	58.0	43.8	81.2	19.5	72.0	29.9	38.1	113.8	49.0	59.8	18.3	31.5	40.2	40.5	91.8	70.6	67.7	41.0	43.0	39.4	332.4	44.8	34.6	46.2	37.3	60.4	55.2	31.4	47.2	36.1	42.8	47.7	36.1	51.8	36.0	36.9	26.9	57.2	55.4	56.7	30.5	32.6	19.4	440.3	40.0	69.6	21.4	51.5	47.2	44.8	69.0	46.8	77.5	35.9	49.6	25.6	81.5	64.1	49.2	54.5	41.8	112.9	32.9	63.2	36.3	338.9	223.2	44.2	25.4	91.8	54.3	43.9	50.0	65.4
SECISBP2L	KIAA0256	ENSG00000138593	"SECIS binding protein 2 like"	Q93073	15	48988476-49046447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 119.4"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 248.6;Oligodendrocytes: 429.8;Syncytiotrophoblasts: 711.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039875	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA039875: AB_10673365"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-3)"	"unprognostic (9.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (5.65e-8)"	"unprognostic (1.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.28e-1)"	18.8	16.1	36.4	11.9	72.7	22.6	18.6	61.1	57.1	18.6	5.8	13.5	9.6	18.4	21.9	17.0	18.4	14.6	15.4	39.5	43.2	25.0	18.7	37.2	13.7	69.2	58.2	19.5	15.0	76.3	9.2	29.9	61.8	20.8	11.6	32.4	45.0	17.5	12.1	11.0	11.4	14.9	58.8	15.1	19.1	13.9	54.7	14.9	23.9	18.3	13.4	12.9	11.8	119.4	9.5	10.4	20.7	18.0	28.6	21.9	12.9	31.3	25.8	25.1	31.6	11.2	8.2	6.6	15.1	24.0	26.5	8.0	26.2	8.2	30.0	40.7	7.0	18.4	14.1	8.4	15.5	10.0	20.0	17.5	9.7	22.1	12.3	27.0	25.3	16.2	11.4	16.0	29.9	4.2	11.8	9.6	7.5	5.9	9.0	11.1	23.2	25.4	32.8	19.5	3.7	14.7	21.5	36.5	29.5	34.7	11.2	11.4	31.7	23.3	11.3	23.6	15.1	13.5	25.0	11.5	17.9	14.8	30.8	10.8	5.3	16.3	8.9	5.1	8.2	12.8	7.9	6.2	3.8	14.4	10.7	8.6	9.9	8.7	6.9	8.8	6.3	4.5	36.4	72.7	61.1	57.1	39.5	43.2	69.2	58.2	61.8	58.8	54.7	119.4	41.6	115.4	248.6	60.7	47.8	14.8	15.1	24.3	18.2	34.7	26.0	21.7	43.1	18.6	55.2	33.1	27.1	105.2	33.3	27.3	15.6	28.1	15.0	94.8	49.2	39.4	9.6	15.8	105.9	18.6	37.8	37.8	34.1	153.2	33.5	32.3	29.6	25.2	26.5	57.2	74.0	14.9	28.5	20.8	18.3	11.1	33.5	29.8	46.2	53.4	30.9	39.7	37.0	82.4	429.8	37.8	15.7	36.5	48.8	31.3	20.9	37.9	86.4	27.2	6.6	47.0	35.2	22.2	31.1	18.8	13.5	711.3	35.6	21.1	11.7	41.5
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747433-25863760	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 128.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 114.7;Oligodendrocyte precursor cells: 128.7;Plasma cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 82.1"	"Group enriched"	"Detected in many"	4	"memory B-cell: 42.0;naive B-cell: 41.8;plasmacytoid DC: 38.2"	"Group enriched"	"Detected in many"	4	"B-cells: 42.0;dendritic cells: 38.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 287.9;OE19: 217.9;U-698: 187.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 100.4"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA040045: AB_10796116, HPA058792: AB_2683822"	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	9.3	5.5	8.7	61.5	11.3	13.6	9.3	82.1	11.1	54.0	8.7	72.1	82.0	7.9	68.8	8.7	11.0	53.6	5.3	12.5	4.2	14.5	11.6	40.7	124.8	2.8	5.2	5.6	48.5	45.5	3.7	37.5	4.7	18.9	68.8	35.2	38.3	4.0	2.9	2.9	72.4	7.8	2.9	63.2	104.8	6.6	8.2	18.7	10.9	2.8	128.3	42.4	2.2	5.9	21.5	23.0	16.7	5.6	2.7	3.3	2.6	10.4	28.3	7.9	25.2	14.6	97.0	287.9	48.9	72.0	66.7	13.3	12.4	45.1	10.6	15.7	7.2	3.3	35.4	19.6	70.0	40.1	2.0	5.7	35.8	27.8	10.9	31.3	105.7	5.8	19.3	0.3	5.6	16.2	0.1	2.8	48.2	217.9	20.1	1.5	91.3	40.6	60.9	71.2	41.0	8.0	69.2	1.0	7.1	23.0	3.3	49.0	46.6	0.5	32.6	0.6	30.6	1.8	0.5	187.9	125.0	16.7	19.3	0.9	0.2	0.0	5.7	0.0	6.8	42.0	7.0	6.4	1.4	41.8	3.0	4.8	0.7	8.0	0.3	38.2	9.6	3.3	8.7	11.3	82.1	11.1	12.5	4.2	2.8	5.2	4.7	2.9	8.2	5.9	13.2	12.8	36.0	57.1	114.7	0.9	3.4	16.8	1.2	4.0	1.6	0.9	1.8	61.5	51.9	3.7	0.0	30.7	71.0	46.3	0.0	64.9	60.8	6.0	1.5	11.5	11.5	10.5	40.1	33.2	1.3	2.5	71.9	19.3	2.5	3.4	13.6	4.2	4.9	0.0	26.6	92.6	22.4	23.1	4.6	78.3	1.5	14.4	8.8	4.7	14.6	33.2	10.3	128.7	1.4	38.3	22.6	0.4	271.7	13.6	46.9	10.7	24.2	32.8	0.0	0.8	4.7	0.7	2.5	0.7	1.6	16.4	27.8	0.2	36.8	6.1
SELENOH	"C11orf31, SELH"	ENSG00000211450	"Selenoprotein H"	Q8IZQ5	11	57741250-57743554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 444.1;Exocrine glandular cells: 315.1;Hofbauer cells: 416.3;Proximal tubular cells: 588.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048362	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA048362: AB_2680370"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.60e-1)"	96.0	167.2	38.4	31.6	41.1	39.4	95.6	36.4	70.0	91.4	39.5	82.0	31.7	73.7	11.9	135.0	72.7	20.6	117.5	39.9	43.2	125.6	171.2	85.9	42.5	38.2	38.7	96.4	110.8	9.2	104.6	26.2	39.6	110.6	13.1	5.4	99.4	16.2	117.0	79.6	88.0	15.0	37.5	130.1	91.3	66.8	41.1	14.5	103.2	6.2	27.9	87.0	86.3	39.7	116.5	84.5	79.8	47.6	7.6	29.1	18.8	43.1	30.3	36.4	19.8	26.7	56.2	51.0	120.7	15.4	31.0	50.9	26.6	47.1	8.3	75.7	85.3	67.8	59.0	66.4	63.7	105.1	140.0	38.4	43.3	39.0	19.4	39.9	50.4	68.9	70.2	44.0	23.7	112.6	103.5	181.1	155.6	32.8	89.6	122.5	75.6	106.7	23.6	62.2	46.0	105.1	39.1	35.2	133.6	18.3	102.2	79.7	64.1	41.1	101.2	90.3	64.2	269.8	226.2	41.3	95.3	89.0	106.1	295.2	385.8	204.5	160.2	417.6	151.4	346.4	209.6	171.4	396.4	349.2	282.1	208.8	29.7	187.7	394.2	488.1	175.3	469.5	38.4	41.1	36.4	70.0	39.9	43.2	38.2	38.7	39.6	37.5	41.1	39.7	182.7	166.7	151.8	0.0	61.0	0.0	0.0	0.0	0.0	0.0	273.3	267.0	0.0	0.0	74.3	150.8	0.0	288.7	77.7	0.0	444.1	256.7	0.0	175.5	95.2	90.2	0.0	0.0	0.0	315.1	280.8	68.4	0.0	104.1	133.7	148.5	0.0	0.0	416.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	119.1	0.0	0.0	102.4	0.0	0.0	0.0	0.0	288.7	0.0	0.0	14.8	0.0	0.0	588.6	142.8	0.0	0.0	0.0	74.7	0.0	0.0	0.0	0.0	147.2	49.0	190.5	0.0	0.0
SELENOK	SELK	ENSG00000113811	"Selenoprotein K"	Q9Y6D0	3	53884417-53891962	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 373.5;Proximal tubular cells: 415.0;Syncytiotrophoblasts: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 471.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 471.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA008196	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA008196: AB_1856665"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.85e-1)"	"prognostic favorable (7.18e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.56e-3)"	39.6	51.9	52.3	27.0	53.0	70.1	35.8	55.2	67.9	29.8	52.3	35.9	23.3	29.1	64.4	27.8	33.9	23.4	90.1	52.0	55.8	42.1	74.2	38.3	23.7	55.0	53.7	48.6	51.7	55.7	62.8	26.5	55.5	34.6	29.3	86.5	29.7	28.5	86.7	24.1	30.4	18.7	55.7	32.3	39.6	32.0	53.3	26.7	43.0	61.2	29.4	35.5	26.1	58.4	22.4	14.9	34.3	23.3	52.1	32.8	36.8	32.0	40.5	43.4	48.9	33.4	33.1	33.8	13.8	23.4	48.7	13.8	40.7	24.5	37.8	59.6	50.3	21.1	61.4	77.6	49.1	28.3	48.6	19.8	40.3	30.1	39.4	25.2	35.3	25.1	20.1	86.3	38.5	24.7	18.5	33.5	33.4	27.5	55.1	11.5	20.9	61.9	51.3	37.1	17.5	49.5	21.9	29.4	32.7	37.5	19.6	44.0	20.6	24.4	28.7	62.2	45.7	62.8	76.3	31.4	36.8	37.3	38.2	471.4	41.7	110.7	69.5	47.2	67.5	60.3	63.0	70.0	36.6	49.0	55.0	63.0	94.1	52.2	56.6	66.3	72.1	82.6	52.3	53.0	55.2	67.9	52.0	55.8	55.0	53.7	55.5	55.7	53.3	58.4	223.1	134.6	103.9	0.0	173.5	0.0	0.0	0.0	0.0	0.0	233.7	237.5	0.0	0.0	53.9	149.0	0.0	162.3	373.5	0.0	189.8	258.5	0.0	150.1	113.5	62.7	0.0	0.0	0.0	199.6	239.6	86.9	0.0	237.9	237.1	59.1	0.0	0.0	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.6	0.0	0.0	74.9	0.0	0.0	0.0	0.0	282.5	0.0	0.0	110.6	0.0	0.0	415.0	53.9	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.0	350.1	155.9	94.7	0.0	0.0
SELENOM	"SELM, SEPM"	ENSG00000198832	"Selenoprotein M"	Q8WWX9	22	31104772-31120069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 373.6;Breast myoepithelial cells: 436.2;Collecting duct cells: 309.0;Distal tubular cells: 309.1;Endometrial stromal cells: 349.5;Exocrine glandular cells: 586.6;Smooth muscle cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 154.8;T-cells: 233.0"	"Cell line enhanced"	"Detected in many"		"BJ: 152.2;BJ hTERT+: 143.8;HHSteC: 183.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008667, HPA019601"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		170000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB008667: AB_1622762, HPA019601: AB_1856666"	"unprognostic (5.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.51e-3)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.19e-2)"	241.8	95.4	126.7	55.7	126.7	2.9	239.8	127.3	170.7	458.8	189.9	575.4	37.2	600.2	14.8	86.1	437.8	28.6	227.2	130.0	149.3	162.5	36.7	157.5	25.9	137.1	138.6	262.4	154.3	94.7	241.1	32.2	131.0	339.6	16.4	8.1	198.8	140.1	109.9	114.8	193.9	85.3	139.6	97.6	285.6	42.1	142.1	10.2	225.8	18.6	15.3	462.3	290.7	132.3	12.8	25.7	7.4	42.7	68.8	80.5	82.2	152.2	143.8	69.2	50.0	0.8	2.0	1.6	30.9	89.9	31.2	1.2	6.9	9.2	4.7	7.0	25.6	2.7	7.8	13.3	183.7	0.0	13.1	78.5	27.1	33.1	12.6	33.1	9.0	2.2	2.4	14.7	17.9	6.6	0.5	1.4	9.6	11.8	27.3	0.1	0.1	18.1	11.1	0.1	16.2	35.7	47.3	41.6	0.7	2.5	57.5	0.9	30.9	20.8	59.0	77.8	0.1	13.2	6.5	1.0	83.1	0.2	13.8	18.3	10.5	5.1	105.3	19.9	137.9	154.8	174.5	127.0	6.4	129.5	233.0	137.8	8.2	39.1	40.1	2.5	179.0	102.6	126.7	126.7	127.3	170.7	130.0	149.3	137.1	138.6	131.0	139.6	142.1	132.3	168.6	54.5	126.5	0.0	38.8	0.0	0.0	0.0	0.0	0.0	373.6	436.2	0.0	0.0	32.2	309.0	0.0	11.7	23.2	0.0	309.1	101.2	0.0	22.8	349.5	61.8	0.0	0.0	0.0	586.6	149.5	161.3	0.0	18.1	30.3	30.8	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	42.9	0.0	0.0	0.0	0.0	166.2	0.0	0.0	22.3	0.0	0.0	152.5	20.4	0.0	0.0	0.0	225.6	0.0	0.0	0.0	0.0	23.4	24.8	30.5	0.0	0.0
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 2087.6;liver: 6268.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 448.7;Alveolar cells type 2: 529.3;Granulosa cells: 458.1;Hofbauer cells: 858.5;Macrophages: 373.3;Proximal tubular cells: 1044.7"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Hep G2: 567.4;HSkMC: 451.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	2220000000	1800000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	719.1	424.3	164.8	179.9	345.6	40.1	617.5	386.0	290.0	460.0	145.5	644.0	620.0	335.8	459.7	240.7	376.5	670.5	237.2	156.3	231.3	853.7	6268.1	512.0	552.4	519.4	316.4	701.2	229.0	246.0	108.3	973.0	490.3	214.2	714.2	59.2	170.8	374.1	156.4	171.8	2087.6	233.2	310.3	948.8	257.0	87.8	284.7	170.4	147.0	265.6	177.4	414.3	213.1	524.3	0.7	1.7	7.7	1.0	43.6	12.2	7.3	4.1	10.9	0.0	0.0	12.5	65.3	2.0	36.3	1.5	1.4	1.7	0.2	0.1	0.0	2.4	52.7	3.1	0.2	567.4	25.9	3.2	0.4	451.1	0.7	0.0	0.1	1.9	0.1	1.5	6.4	12.9	23.5	1.3	1.1	6.4	30.6	17.0	0.9	1.3	2.0	100.8	12.5	8.0	2.2	2.7	2.7	16.7	1.6	54.6	125.4	0.7	0.7	3.2	1.7	5.2	1.0	8.4	1.5	2.0	1.7	5.9	1.5	0.1	0.1	0.5	0.5	0.1	0.6	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.5	0.6	0.2	0.9	0.3	0.3	164.8	345.6	386.0	290.0	156.3	231.3	519.4	316.4	490.3	310.3	284.7	524.3	312.7	448.7	529.3	0.0	15.2	0.0	0.0	0.0	0.0	0.0	312.0	271.1	0.0	0.0	102.1	125.0	0.0	223.4	9.4	0.0	197.6	73.4	0.0	83.8	231.0	75.8	0.0	0.0	0.0	52.8	17.5	358.7	0.0	116.1	26.5	458.1	0.0	0.0	858.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	373.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	4.9	0.0	0.0	1044.7	52.5	0.0	0.0	0.0	133.1	0.0	0.0	0.0	0.0	112.9	10.0	361.8	0.0	0.0
SEMA3A	"coll-1, Hsema-I, SEMA1, SEMAD, SemD"	ENSG00000075213	"Semaphorin 3A"	Q14563	7	83955777-84492724	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.4;Cone photoreceptor cells: 45.9;Excitatory neurons: 89.7;Rod photoreceptor cells: 66.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	16	"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 129.3;BJ: 102.9;fHDF/TERT166: 112.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029447, HPA052235"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		1600000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA029447: AB_10602302, HPA052235: AB_2681770"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.51e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-2)"	"unprognostic (6.18e-12)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.47e-4)"	6.8	0.2	3.8	3.8	5.8	0.1	1.5	0.6	3.0	4.4	0.0	9.8	1.4	1.0	2.2	5.8	1.6	5.6	2.5	2.0	0.7	0.4	0.4	2.3	3.3	3.8	0.2	0.4	0.4	0.5	2.1	10.4	4.6	2.9	5.7	22.6	0.4	0.4	0.1	1.1	2.4	4.7	0.6	3.8	2.0	1.2	0.3	0.5	1.7	0.5	1.6	5.4	0.6	4.4	11.8	32.8	129.3	0.1	3.8	3.1	8.4	102.9	60.0	8.5	5.3	11.4	30.7	0.0	4.8	112.0	1.1	57.0	0.3	24.6	11.8	0.0	4.2	0.0	6.0	0.0	3.3	2.6	0.0	3.9	0.0	18.1	4.4	26.2	32.1	0.1	0.1	0.2	3.4	0.6	0.0	0.0	48.6	0.5	11.6	2.3	55.3	3.4	18.5	0.8	9.8	5.2	0.8	0.2	1.1	20.7	0.6	1.1	18.3	11.2	11.6	32.6	15.1	7.6	5.5	0.0	11.5	4.5	22.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.8	5.8	0.6	3.0	2.0	0.7	3.8	0.2	4.6	0.6	0.3	4.4	1.0	3.2	1.7	58.4	0.0	0.9	0.0	15.4	0.0	15.1	0.2	0.3	6.0	0.0	22.4	0.0	45.9	0.4	0.3	0.1	0.0	0.1	0.2	2.0	0.7	7.3	0.0	0.0	89.7	2.0	0.2	9.3	0.0	9.0	1.3	3.5	1.8	0.1	1.0	3.3	10.0	0.0	2.0	0.3	2.7	0.2	2.5	0.5	1.8	7.5	0.0	19.6	0.0	9.5	5.8	5.5	0.0	0.0	0.0	0.3	0.0	0.0	15.6	66.3	0.0	1.5	2.1	1.7	1.9	0.4	1.3	0.3	1.1	18.6	0.0	0.2
SEMA3E	"coll-5, KIAA0331, M-SemaK, SEMAH"	ENSG00000170381	"Semaphorin 3E"	O15041	7	83363238-83649139	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 176.3;Alveolar cells type 2: 110.2;Bipolar cells: 75.7;Excitatory neurons: 84.9;Oligodendrocyte precursor cells: 250.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.9;SK-BR-3: 19.9;U-2 OS: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029419, HPA063804"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA029419: AB_10602090, HPA063804: AB_2685127"	"unprognostic (4.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.82e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (9.36e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-6)"	"unprognostic (1.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	1.2	0.1	3.1	0.2	2.8	0.0	2.8	0.6	2.3	1.8	0.1	2.1	0.6	1.9	0.3	1.2	0.6	2.3	0.1	5.0	5.3	0.1	0.1	2.2	0.0	1.6	4.3	0.1	0.4	0.0	0.2	0.2	1.3	4.3	1.7	3.9	2.2	3.3	0.2	0.5	1.2	1.1	3.2	0.0	1.3	0.0	4.3	1.7	0.6	1.0	0.1	3.2	0.7	3.7	0.2	1.1	0.2	0.0	0.5	3.1	0.0	0.0	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.5	0.0	3.4	0.0	1.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.9	0.0	0.0	0.5	0.4	1.1	0.0	2.0	0.0	0.0	0.8	0.1	0.0	0.0	19.9	0.0	3.2	1.6	0.0	0.0	0.7	6.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.8	0.6	2.3	5.0	5.3	1.6	4.3	1.3	3.2	4.3	3.7	10.5	176.3	110.2	2.9	0.2	1.1	1.3	1.6	0.0	75.7	19.0	7.5	1.7	18.6	43.2	1.8	0.0	0.8	0.2	0.1	0.0	3.9	1.1	3.8	1.2	10.7	0.0	0.0	84.9	1.1	0.4	21.3	3.1	9.3	24.0	0.2	0.0	0.3	0.1	0.0	12.3	0.0	4.1	1.0	2.1	0.0	0.9	3.6	1.8	1.0	1.0	29.6	0.0	250.3	6.0	6.2	0.0	0.0	0.3	2.6	0.1	0.5	35.7	3.6	0.0	0.8	1.0	0.3	0.6	0.3	0.4	0.3	2.8	0.0	0.0	2.5
SEMA4B	"KIAA1745, MGC131831, SEMAC, SemC"	ENSG00000185033	"Semaphorin 4B"	Q9NPR2	15	90160604-90229679	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 124.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 16.9;naive B-cell: 14.9;neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 182.4;RPTEC TERT1: 111.1;RT4: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013372	Approved		Approved	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA		61000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA013372: AB_1856670"	"unprognostic (3.33e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.09e-2)"	11.9	37.6	20.3	18.0	21.9	9.8	22.5	18.8	21.6	35.1	12.8	50.2	30.2	17.1	8.2	124.4	22.6	17.1	24.9	17.3	21.0	47.7	43.2	20.5	12.0	23.5	24.0	21.6	38.5	18.1	18.6	18.3	21.4	31.4	12.1	27.1	41.2	17.6	7.8	50.9	34.7	13.3	21.0	30.3	32.2	10.7	22.9	13.2	34.2	7.9	13.0	42.2	59.8	26.8	21.2	56.3	4.2	13.2	3.8	2.6	30.4	6.4	13.9	7.8	8.3	7.0	182.4	14.9	69.2	4.7	45.0	97.8	3.7	91.2	6.4	85.4	11.7	19.7	13.5	9.4	15.1	2.6	8.7	10.8	39.1	8.5	17.5	32.5	8.8	4.4	9.6	23.0	4.3	15.6	5.4	8.4	18.7	46.8	51.1	6.4	3.1	33.1	111.1	124.0	13.3	13.5	22.3	35.4	8.5	9.3	24.7	6.0	20.0	6.3	11.4	13.1	14.5	33.0	43.2	7.5	58.8	16.1	6.3	0.0	2.4	0.3	0.9	1.4	0.6	16.9	0.5	0.5	1.2	14.9	0.5	0.6	5.1	0.4	2.8	0.2	0.2	1.5	20.3	21.9	18.8	21.6	17.3	21.0	23.5	24.0	21.4	21.0	22.9	26.8	1.8	16.0	22.5	67.3	29.2	65.0	40.0	51.4	23.9	5.7	29.1	18.9	7.8	8.6	44.6	16.5	25.0	13.9	2.4	47.8	3.9	27.3	0.9	15.6	19.6	4.4	4.2	4.0	23.5	35.5	74.5	6.4	34.1	28.3	0.0	8.6	4.6	16.8	13.3	16.8	28.2	17.5	18.3	6.9	7.5	1.2	13.1	5.5	5.4	2.8	5.3	25.1	1.0	8.0	8.3	44.7	26.1	12.0	8.0	46.9	19.6	4.5	22.6	48.3	19.7	5.7	15.3	0.7	3.2	65.3	57.1	12.4	4.3	5.2	20.2	52.0
SEMA4F	"SEMAM, SEMAW"	ENSG00000135622	"Ssemaphorin 4F"	O95754	2	74654228-74683853	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.5;Inhibitory neurons: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064095, HPA065969"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane, Centrosome"	"HPA064095: AB_2732710, HPA065969: AB_2685590"	"unprognostic (9.69e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (5.94e-5)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.74e-6)"	"unprognostic (2.60e-2)"	"unprognostic (8.08e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (4.69e-2)"	3.2	2.3	5.4	0.9	7.0	0.4	3.2	3.2	8.2	4.1	0.1	2.5	0.5	3.6	1.7	1.3	3.3	0.8	2.7	8.0	6.3	3.5	1.0	2.5	1.5	4.2	2.1	5.3	2.6	3.0	7.2	0.9	3.9	3.1	1.0	4.7	2.7	1.4	1.4	1.9	2.1	1.6	1.5	2.6	2.2	4.1	8.1	1.2	3.1	1.3	1.4	2.6	3.2	3.8	6.1	3.4	3.7	5.5	5.8	3.3	2.6	3.9	8.9	7.4	6.5	1.4	3.3	2.3	5.0	6.2	14.4	1.9	6.7	5.7	7.5	5.3	7.0	4.4	1.4	3.8	2.3	1.0	5.4	2.6	6.0	4.9	2.4	14.1	2.9	4.4	0.2	0.2	4.8	2.1	3.3	0.8	2.6	2.7	4.0	0.0	5.4	0.0	6.0	2.6	2.9	5.8	7.0	1.8	6.5	5.0	2.6	0.7	4.9	11.5	5.8	2.9	7.1	5.2	5.6	0.3	13.4	0.3	5.6	0.3	0.1	0.7	1.9	0.0	1.2	1.1	1.1	1.7	0.0	0.8	1.1	1.3	0.3	1.0	0.2	0.0	0.9	0.8	5.4	7.0	3.2	8.2	8.0	6.3	4.2	2.1	3.9	1.5	8.1	3.8	2.2	0.0	6.5	4.9	2.7	0.4	1.8	1.8	2.2	8.8	1.8	2.5	2.4	5.7	4.8	5.5	12.5	0.8	1.4	0.7	1.9	2.1	3.2	0.6	0.6	2.2	7.2	0.8	44.5	1.6	2.4	3.3	1.5	1.0	2.5	3.0	3.3	0.6	0.8	11.8	22.7	0.6	2.0	0.0	0.7	3.7	0.9	0.7	0.0	4.7	1.5	3.3	4.1	4.5	5.8	2.7	1.4	1.5	0.7	1.3	0.4	0.3	1.3	6.7	6.6	3.1	1.4	5.6	11.2	0.5	0.4	0.4	3.5	0.5	1.0	1.6
SEMA6A	"HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ"	ENSG00000092421	"Semaphorin 6A"	Q9H2E6	5	116443555-116574823	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 60.1;brain: 75.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 128.9;Hepatic stellate cells: 145.6;Horizontal cells: 138.0;Oligodendrocyte precursor cells: 138.7;Oligodendrocytes: 311.3;Syncytiotrophoblasts: 348.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 20.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.3;HAP1: 52.0;NTERA-2: 115.2;SuSa: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031264, HPA031265, HPA031267"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"		NA	NA		620000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nuclear bodies, Intermediate filaments"	"HPA031264: , HPA031265: AB_10610423, HPA031267: "	"unprognostic (3.79e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-3)"	"unprognostic (7.32e-3)"	13.4	60.1	24.1	4.9	48.6	3.5	13.1	39.9	31.9	10.0	0.3	20.6	19.9	6.0	2.8	4.4	8.2	12.9	7.1	24.5	40.3	8.6	5.6	17.9	4.5	51.9	41.0	18.1	11.2	2.0	5.8	31.9	50.0	6.0	17.5	10.4	16.6	2.5	8.2	6.9	25.5	5.8	32.9	11.2	7.0	7.5	44.1	3.6	9.1	6.5	2.2	5.6	8.1	75.2	0.3	0.1	36.9	44.3	0.2	0.0	38.2	0.7	0.4	0.2	0.2	2.2	1.5	1.6	1.7	0.6	0.7	0.4	52.0	0.0	0.1	1.6	7.7	0.7	0.7	13.1	0.5	0.5	2.6	0.7	0.0	0.0	0.0	0.5	0.2	0.3	0.3	0.4	0.2	0.8	0.7	3.9	115.2	0.2	0.3	6.9	24.2	1.8	19.0	33.7	10.3	3.7	0.2	0.7	19.7	221.1	14.4	2.6	0.9	3.6	3.1	0.4	1.5	0.6	0.7	0.8	0.6	1.8	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.1	48.6	39.9	31.9	24.5	40.3	51.9	41.0	50.0	32.9	44.1	75.2	64.7	0.0	0.6	71.8	1.1	6.5	0.7	13.1	34.7	17.9	17.0	8.3	8.6	61.5	3.1	14.7	2.1	128.9	0.3	73.3	0.0	42.9	13.6	12.2	4.8	60.9	28.1	2.7	26.9	1.3	8.1	15.4	1.1	10.6	0.0	9.7	145.6	0.9	12.5	138.0	62.2	30.7	0.0	14.8	4.6	2.4	6.5	1.1	24.9	54.4	0.1	5.8	0.0	138.7	311.3	2.0	46.7	1.9	2.6	1.5	40.7	4.4	0.6	3.5	0.0	36.1	8.1	0.9	1.5	11.3	4.1	348.1	0.8	3.5	40.3	2.2
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 322.9;tongue: 96.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.9;Cardiomyocytes: 19.1;Cone photoreceptor cells: 20.9;Inhibitory neurons: 13.7;Skeletal myocytes: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 14.1;HUVEC TERT2: 24.8;TIME: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1500000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	8.8	2.8	7.7	1.8	6.7	1.2	7.9	21.9	9.4	12.0	1.0	7.6	13.7	10.5	1.4	5.5	10.7	3.7	38.8	7.9	5.4	12.1	12.4	5.1	1.7	5.0	5.0	14.8	3.6	2.1	13.4	1.9	4.9	8.3	1.8	5.2	8.5	2.3	322.9	8.9	10.8	6.2	2.2	3.0	5.4	32.2	7.3	2.2	4.7	96.9	0.9	8.4	8.8	5.3	0.9	1.0	14.1	5.4	5.8	1.9	1.3	1.0	0.5	0.9	1.3	0.3	0.6	0.7	4.0	3.3	2.0	1.4	1.3	0.5	0.8	1.3	4.2	7.7	0.7	1.2	0.8	0.1	2.7	3.3	1.7	1.2	0.6	2.8	24.8	4.1	0.7	0.7	2.3	0.5	1.3	1.0	6.3	0.2	1.7	9.0	3.1	0.3	0.5	0.4	7.1	9.3	1.3	0.6	1.2	3.5	1.6	1.3	11.8	2.3	3.3	3.5	0.6	5.9	1.2	6.1	0.6	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	6.7	21.9	9.4	7.9	5.4	5.0	5.0	4.9	2.2	7.3	5.3	12.9	0.0	2.8	3.9	1.0	1.7	0.8	0.3	0.6	5.7	1.9	3.0	19.1	1.5	0.8	0.0	20.9	0.2	0.6	0.1	0.0	0.3	0.6	0.4	2.8	10.2	0.0	0.8	6.7	0.4	0.6	4.4	0.5	0.4	0.0	9.9	6.8	5.3	0.4	6.7	13.7	0.3	0.0	2.5	0.7	3.1	5.6	0.5	1.8	4.7	0.4	1.9	1.0	5.5	1.5	0.4	0.0	2.6	1.9	0.5	3.3	2.9	0.3	7.5	0.0	12.0	2.9	3.3	1.2	0.5	1.0	0.1	0.8	0.5	0.8	0.5
SENP1		ENSG00000079387	"SUMO specific peptidase 1"	Q9P0U3	12	48042897-48106079	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 32.5;testis: 61.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011765, HPA046491"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Focal adhesion sites"	"HPA011765: AB_1079907, HPA046491: AB_2679672"	"unprognostic (2.66e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.20e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-1)"	5.0	3.6	3.1	9.1	3.9	14.4	5.6	8.3	3.7	6.2	1.9	4.9	4.8	7.5	5.1	7.5	4.7	5.5	3.8	2.7	5.0	3.8	3.8	4.6	12.0	3.0	3.6	5.5	4.4	6.3	3.3	6.5	3.7	4.8	6.8	6.5	32.5	4.7	3.7	6.8	4.7	7.0	2.2	6.3	4.8	61.8	3.4	12.2	5.8	4.3	12.9	6.1	3.9	5.0	13.8	17.7	22.4	16.3	6.4	9.8	15.7	14.9	17.1	25.8	20.7	22.2	22.3	38.0	12.8	13.9	9.9	13.0	28.0	13.0	25.7	34.6	11.4	33.9	17.9	10.9	10.1	32.2	22.4	7.4	10.4	22.7	20.1	11.4	13.7	25.2	30.2	15.9	13.4	12.0	40.1	11.2	20.0	9.5	12.8	36.6	23.6	19.1	7.2	17.3	22.8	15.4	21.9	13.2	8.8	12.7	20.6	14.4	12.2	21.1	18.4	12.5	16.4	18.4	32.5	36.7	13.3	71.4	10.0	0.8	0.8	2.9	1.6	1.1	2.1	1.0	1.6	1.6	1.4	1.8	1.4	1.5	1.6	1.6	0.8	1.5	1.9	1.0	3.1	3.9	8.3	3.7	2.7	5.0	3.0	3.6	3.7	2.2	3.4	5.0	11.2	9.6	8.9	18.9	14.3	3.7	4.7	4.7	6.8	7.9	6.7	4.7	3.2	4.3	7.6	3.7	4.2	4.0	9.1	3.6	3.9	3.9	16.7	5.6	11.6	9.1	3.5	11.1	14.0	6.5	3.4	7.3	7.7	5.0	6.3	9.8	6.8	6.6	4.5	15.2	15.9	4.2	8.2	9.5	4.2	6.0	6.2	7.7	1.8	15.0	7.2	5.2	5.2	17.6	17.8	5.8	1.9	6.8	13.5	4.4	2.8	3.7	4.6	8.7	0.0	9.8	8.3	86.5	31.0	8.5	6.1	2.7	12.2	7.4	4.2	3.8
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO specific peptidase 3"	Q9H4L4	17	7561919-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	24.2	24.0	43.7	21.0	42.6	25.4	23.7	38.5	47.9	23.7	38.5	32.4	21.2	26.7	27.4	25.4	25.9	19.3	25.2	42.6	39.8	34.1	20.5	28.6	26.5	40.4	42.2	26.8	26.4	38.1	26.4	22.5	41.1	23.0	25.4	24.7	24.8	26.0	33.5	28.6	25.2	28.9	39.5	28.3	27.0	29.0	44.0	33.8	23.9	30.9	31.2	29.7	21.8	42.0	76.4	90.8	52.7	82.5	58.6	42.8	54.8	54.8	56.0	93.4	87.2	54.9	32.5	90.3	52.6	72.7	62.3	72.0	114.4	85.8	78.0	63.7	105.0	46.7	74.8	56.9	79.1	44.0	57.9	55.1	86.5	107.1	103.5	53.3	76.0	102.1	61.5	24.7	73.0	51.4	107.9	33.6	64.2	70.9	54.5	97.1	48.8	52.4	62.9	44.0	52.5	67.6	55.3	52.7	60.0	66.6	44.1	28.5	40.5	53.0	45.9	51.3	119.0	36.3	40.4	57.3	53.9	45.7	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	43.7	42.6	38.5	47.9	42.6	39.8	40.4	42.2	41.1	39.5	44.0	42.0	4.5	3.2	5.4	0.0	4.9	8.5	6.4	1.6	10.2	6.1	6.7	11.0	7.1	7.2	3.6	1.8	22.9	3.0	4.8	2.6	0.0	2.3	1.4	4.0	4.2	4.7	6.6	1.3	0.0	2.4	2.3	3.8	3.6	4.7	1.3	5.2	8.2	2.7	1.5	6.7	0.0	3.0	2.0	6.0	6.4	0.7	4.1	4.9	3.6	0.0	4.7	5.5	4.1	0.0	0.0	2.1	0.8	2.2	6.4	6.1	4.0	1.1	2.1	7.3	0.0	5.2	4.4	3.7	4.0	7.4	11.6	4.1	4.9	3.0	3.7	6.4
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO specific peptidase 6"	Q9GZR1	6	75601509-75718281	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (1.72e-1)"	25.1	22.6	12.8	24.6	16.8	37.9	31.4	47.6	15.5	28.6	7.5	26.6	20.9	33.0	22.1	25.3	26.8	26.0	22.6	9.6	14.3	28.5	28.0	26.4	28.5	11.9	11.9	40.5	27.0	39.4	22.3	33.4	12.8	29.3	26.0	31.4	21.8	28.9	25.5	25.2	20.5	31.9	12.3	28.9	24.9	33.8	12.0	32.4	41.9	30.1	30.4	29.7	21.2	22.3	23.8	24.5	54.3	39.1	41.3	54.6	40.3	41.9	46.5	34.6	43.1	33.9	22.4	40.1	38.6	48.7	40.9	29.8	51.6	28.0	53.1	59.2	44.2	60.8	28.9	31.7	57.3	53.5	42.8	42.6	45.6	32.6	71.8	41.9	58.2	32.8	74.9	43.2	43.0	29.0	21.4	28.6	33.1	31.9	20.4	39.7	28.7	59.0	36.7	35.0	47.2	48.7	35.8	31.3	36.4	43.5	28.2	50.1	49.0	30.8	33.4	15.9	43.8	48.9	52.4	31.4	15.4	49.8	33.1	7.5	8.0	20.8	7.3	8.4	10.5	9.1	7.4	9.9	8.9	10.5	10.5	9.6	14.9	10.1	14.7	11.0	6.9	6.3	12.8	16.8	47.6	15.5	9.6	14.3	11.9	11.9	12.8	12.3	12.0	22.3	76.7	67.3	128.3	158.0	74.0	46.5	65.0	27.6	78.6	58.8	53.0	59.6	76.7	31.5	70.9	29.5	91.8	33.0	73.8	43.2	17.6	33.7	40.4	62.9	78.1	57.9	27.6	50.5	152.6	33.7	29.4	69.3	51.0	62.9	65.1	74.2	42.1	32.0	29.5	60.6	177.3	35.6	24.4	43.2	41.5	35.6	70.8	57.7	35.6	149.9	68.4	56.6	50.4	218.1	228.9	32.1	29.9	63.2	62.8	63.4	32.6	26.8	47.2	65.7	26.3	98.9	73.7	107.7	61.7	61.4	48.4	41.2	67.2	66.0	46.3	66.8
SENP7		ENSG00000138468	"SUMO specific peptidase 7"	Q9BQF6	3	101324205-101513241	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 109.6;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 44.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 44.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027259, HPA071998"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Centrosome,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Nuclear bodies, Centrosome, Cytosol"	"HPA027259: AB_1856679, HPA071998: "	"unprognostic (1.50e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.38e-3)"	"unprognostic (9.25e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.08e-3)"	"unprognostic (3.27e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.23e-2)"	15.1	9.7	9.7	13.7	12.7	24.7	16.9	21.8	11.8	15.8	9.7	12.5	7.3	26.8	14.7	7.8	16.1	14.2	9.5	9.3	12.3	11.4	8.7	12.8	23.1	13.9	11.7	26.3	12.8	16.9	10.2	19.4	14.0	12.7	10.8	26.0	8.9	11.5	11.2	20.8	12.4	14.7	10.1	16.9	14.1	9.1	11.5	20.5	17.5	11.2	17.7	11.8	11.4	20.3	9.2	6.1	29.4	16.4	5.6	8.2	5.3	5.2	3.8	8.5	10.4	4.0	8.3	7.0	7.9	5.1	7.8	9.1	9.4	4.8	17.0	13.0	2.7	12.7	5.1	5.5	4.5	7.4	12.2	6.4	8.5	4.3	9.6	7.6	12.2	13.4	10.5	17.6	8.1	6.1	13.7	8.6	6.0	4.8	6.3	15.2	8.0	6.4	10.1	5.2	11.3	8.8	4.8	4.8	6.5	15.0	8.0	9.8	10.2	11.8	7.1	3.9	5.2	12.2	7.8	16.4	4.1	9.7	9.8	44.1	5.9	5.9	5.8	5.4	7.3	6.4	7.8	5.8	4.8	9.0	10.3	7.1	17.3	9.3	6.3	4.1	6.9	6.1	9.7	12.7	21.8	11.8	9.3	12.3	13.9	11.7	14.0	10.1	11.5	20.3	44.5	16.0	24.9	78.4	33.0	9.1	8.4	7.4	21.1	48.3	14.4	12.2	21.6	2.8	18.4	16.5	20.9	5.8	30.8	5.4	5.9	8.1	4.1	33.1	48.5	28.4	13.1	18.7	62.4	5.2	2.7	23.4	21.4	34.1	37.2	28.6	32.9	10.3	8.2	52.2	109.6	6.5	12.2	20.5	9.5	4.0	18.3	19.1	10.6	80.6	13.6	16.7	35.0	157.3	134.4	6.9	4.1	19.5	23.5	4.8	7.0	8.5	27.5	33.8	46.0	29.7	23.3	22.8	19.9	13.4	9.9	2.5	41.0	21.1	5.9	6.1
SENP8	"DEN1, HsT17512, NEDP1, PRSC2"	ENSG00000166192	"SUMO peptidase family member, NEDD8 specific"	Q96LD8	15	72114258-72143692	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 15.6"	"Group enriched"	"Detected in many"	11	"Early spermatids: 86.5;Late spermatids: 222.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036273	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA036273: AB_10669985"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.85e-4)"	"unprognostic (5.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.46e-12)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.54e-2)"	1.1	1.7	2.7	1.1	2.4	2.8	2.0	1.1	3.1	1.7	0.0	1.9	1.8	1.7	3.3	2.3	2.5	1.9	4.0	2.2	2.1	4.4	2.5	1.5	1.5	1.4	1.7	2.4	1.5	2.4	2.1	1.7	1.9	2.1	1.9	4.6	1.6	1.7	6.3	1.6	1.5	1.6	0.4	1.5	2.0	15.6	1.7	1.5	5.0	5.7	1.2	1.7	1.0	2.6	1.5	2.7	4.7	3.8	5.6	6.9	2.7	4.1	2.5	2.2	2.0	2.1	3.4	1.5	5.7	2.4	4.0	3.4	7.4	5.9	3.3	1.6	4.0	2.5	3.7	1.9	3.9	2.8	1.3	3.3	5.8	1.4	6.2	2.9	2.1	4.4	3.7	2.7	5.4	3.8	2.9	3.7	4.0	3.4	2.5	1.9	4.2	3.3	6.0	2.6	5.8	2.0	4.4	3.3	4.2	5.6	5.1	2.1	2.2	4.5	1.7	7.8	2.0	2.2	2.9	1.8	2.1	4.0	3.3	1.1	0.9	0.7	0.8	2.2	1.1	1.9	1.3	1.2	2.9	0.6	1.5	1.8	0.3	3.5	3.2	0.8	1.1	1.0	2.7	2.4	1.1	3.1	2.2	2.1	1.4	1.7	1.9	0.4	1.7	2.6	1.2	6.4	5.3	3.9	0.4	0.3	1.4	2.5	1.2	4.5	2.4	2.4	5.4	1.5	4.5	1.8	4.2	6.7	0.3	1.5	13.7	3.3	86.5	2.5	2.7	1.8	1.2	3.2	4.6	1.7	3.4	2.6	4.1	2.6	0.0	3.4	1.8	1.5	2.1	1.7	6.1	1.5	2.0	2.6	0.6	222.9	1.8	1.7	0.0	2.8	3.8	10.6	0.0	6.0	4.0	1.4	3.2	1.2	0.2	1.7	2.3	8.1	6.0	4.0	0.0	2.3	1.3	10.7	12.6	1.4	0.4	7.8	1.0	3.0	2.2	1.0
SEPHS1	"SPS, SPS1"	ENSG00000086475	"Selenophosphate synthetase 1"	P49903	10	13317428-13348298	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037645, HPA062118"	Enhanced		Uncertain	Nucleoplasm		NA	NA		21000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA037645: AB_10671631, HPA062118: AB_2732676"	"unprognostic (8.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.61e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.11e-2)"	27.8	28.6	23.2	23.6	23.9	25.3	33.5	25.3	22.3	25.6	28.1	31.2	23.2	32.3	35.9	24.6	35.3	23.8	30.8	21.7	24.1	56.5	48.6	24.3	29.3	26.7	28.4	35.7	33.6	48.1	23.5	27.8	23.1	26.4	32.7	25.0	26.9	24.7	33.3	20.9	24.6	33.2	25.9	21.8	25.6	22.1	24.6	64.3	55.4	36.6	34.3	24.8	17.4	24.4	127.7	90.8	182.4	176.3	59.4	45.1	85.8	55.4	42.6	115.6	97.9	103.5	116.4	123.1	67.2	65.0	55.9	79.6	195.2	91.4	120.5	186.7	80.9	67.4	66.8	132.9	61.4	92.0	41.4	39.6	64.6	67.7	39.5	53.9	95.0	255.9	90.7	97.5	83.2	168.1	228.8	39.3	301.8	119.8	40.9	176.3	88.8	73.7	62.2	51.0	64.5	119.5	169.6	74.1	75.7	157.7	93.8	96.1	64.1	51.1	96.3	67.6	117.6	71.3	143.4	228.1	41.2	67.6	41.9	10.2	11.6	8.8	7.7	17.1	9.5	9.5	7.8	8.9	13.6	6.4	10.0	9.4	1.7	15.4	24.8	15.4	13.3	8.3	23.2	23.9	25.3	22.3	21.7	24.1	26.7	28.4	23.1	25.9	24.6	24.4	24.1	12.8	13.1	8.1	12.3	17.2	16.5	19.3	9.6	17.1	23.8	19.4	14.1	20.0	18.0	22.0	0.0	31.6	27.1	17.6	33.2	26.4	13.5	16.9	15.4	26.1	16.7	19.3	8.2	30.1	45.2	18.0	11.7	16.1	15.8	27.7	19.6	32.7	21.1	21.9	8.3	13.7	20.3	10.1	11.7	14.1	14.9	13.1	16.0	4.7	8.0	35.2	9.2	4.0	12.9	34.1	15.3	18.4	18.7	17.5	16.4	44.6	13.4	15.6	6.6	14.2	26.1	17.6	21.2	15.0	16.9	25.6	13.2	25.9	18.0	15.1
SEPHS2	"SPS2, SPS2b"	ENSG00000179918	"Selenophosphate synthetase 2"	Q99611	16	30443631-30445874	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 402.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 385.4;Proximal tubular cells: 384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 477.5"	"Low region specificity"	"Detected in all"							HPA047931	Approved		Approved	Nucleoplasm		No	No		29000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA047931: AB_2680216"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.86e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.35e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-2)"	27.5	30.6	16.8	33.7	17.5	26.0	33.8	18.5	19.9	24.8	21.2	75.5	136.0	19.9	23.9	20.4	20.5	34.0	27.8	18.5	20.5	158.5	402.6	28.8	44.8	18.5	18.9	14.9	35.2	48.9	20.4	25.1	19.5	28.7	65.9	19.7	33.6	23.2	41.7	21.1	105.8	25.9	18.6	29.8	62.5	11.5	20.2	43.5	37.7	32.3	41.9	27.7	14.2	19.8	77.6	68.9	23.8	83.1	71.7	45.7	62.5	52.3	64.5	50.5	62.2	42.9	57.7	110.8	79.0	56.0	45.7	42.1	44.5	47.9	51.0	71.2	137.5	110.8	35.9	204.0	90.5	62.0	477.5	58.4	100.5	47.6	87.7	31.6	47.0	80.1	91.1	69.7	45.4	114.5	93.9	127.8	59.3	58.0	51.4	90.2	41.8	85.3	62.6	68.9	50.5	43.1	44.8	129.3	179.7	47.8	113.7	204.2	39.6	52.2	37.1	50.9	32.0	59.6	103.4	57.6	45.3	114.3	59.7	8.7	19.4	30.2	14.8	16.1	22.2	17.8	20.9	21.4	21.6	20.2	25.0	17.2	17.6	31.9	20.5	15.4	22.8	14.8	16.8	17.5	18.5	19.9	18.5	20.5	18.5	18.9	19.5	18.6	20.2	19.8	76.2	44.8	40.3	3.9	34.3	37.5	1.4	47.6	58.6	0.5	66.2	52.7	49.4	1.5	39.4	64.4	0.0	1.3	41.5	108.9	385.4	112.2	0.1	34.2	25.1	32.4	35.5	20.8	6.7	82.7	1.1	30.4	68.8	59.2	31.0	20.5	0.7	9.1	1.4	0.0	8.6	31.0	63.1	2.9	34.9	0.1	0.0	42.5	44.4	5.6	37.1	0.2	1.0	5.5	4.6	57.4	42.4	0.0	30.6	1.6	11.1	384.9	27.2	1.1	0.0	2.0	49.4	0.8	0.8	45.4	42.6	1.2	35.7	52.6	46.0	0.9
SEPTIN2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	246.0	155.0	192.8	159.7	216.1	125.3	177.2	208.8	220.6	233.8	183.2	179.7	140.8	209.0	176.7	161.1	168.7	193.8	211.8	180.5	209.6	212.6	117.1	184.5	157.2	227.2	203.3	221.7	214.2	220.1	112.7	217.3	232.2	186.1	188.6	114.0	163.3	218.2	160.6	119.0	154.8	253.1	224.1	164.9	152.6	145.0	198.3	141.8	224.6	163.5	180.5	221.0	116.7	245.3	245.1	207.7	561.7	370.8	511.5	555.0	289.1	517.3	508.9	329.1	417.2	118.7	258.4	96.1	119.4	599.0	176.7	209.6	377.7	347.9	535.5	241.9	262.2	388.9	200.5	444.5	311.6	374.4	228.0	495.1	224.8	275.0	259.1	369.8	576.2	240.9	357.4	138.0	491.9	171.5	226.7	227.3	412.5	215.2	152.8	216.2	707.4	204.7	483.5	359.9	401.4	270.0	363.0	245.7	353.0	397.9	146.9	333.4	555.5	399.2	166.2	392.9	320.6	267.7	251.9	340.9	344.7	225.1	571.6	172.0	165.0	98.3	101.0	184.1	125.1	87.4	97.9	104.2	183.8	77.2	84.4	89.6	58.9	191.4	144.8	138.7	108.0	241.2	192.8	216.1	208.8	220.6	180.5	209.6	227.2	203.3	232.2	224.1	198.3	245.3	89.9	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	135.9	39.9	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	190.1	50.4	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	139.0	6.5	0.0	0.0	0.0
SEPTIN3	"SEP3, SEPT3"	ENSG00000100167	"Septin 3"	Q9UH03	22	41969475-41998221	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 233.7"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 27.9"	"Group enriched"	"Detected in many"	5	"glioma: 24.6;melanoma: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.6;Daudi: 22.3;SCLC-21H: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003548, CAB017633"	Supported	Supported	Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	"Actin filaments"	"CAB017633: AB_2301476, HPA003548: AB_1079908"	"unprognostic (2.10e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.67e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	0.2	4.6	134.7	0.4	160.5	0.1	1.3	82.4	233.7	0.2	30.5	0.8	0.3	0.2	1.4	0.2	0.1	0.4	0.2	167.0	89.5	0.3	0.1	0.7	0.5	86.2	73.4	0.2	1.2	18.6	7.8	5.7	83.8	1.3	0.5	28.4	0.4	0.0	0.1	1.6	0.4	0.3	56.9	0.2	0.7	2.1	91.4	0.9	0.8	0.2	0.5	0.3	0.4	150.7	1.5	1.7	26.6	20.1	0.3	0.0	13.3	0.3	0.3	1.8	0.8	0.4	3.1	22.3	0.7	0.2	11.4	0.1	14.0	0.1	0.7	9.2	4.6	0.1	0.5	0.0	0.2	0.0	0.9	0.2	1.0	0.1	0.0	0.0	0.0	12.1	0.0	3.4	0.0	2.4	3.7	0.2	18.2	0.2	0.7	17.9	0.0	1.3	0.0	2.7	71.4	14.8	10.9	0.1	18.2	2.5	2.6	6.7	0.0	0.0	9.2	0.9	1.0	14.1	13.1	0.2	0.3	9.0	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	134.7	160.5	82.4	233.7	167.0	89.5	86.2	73.4	83.8	56.9	91.4	150.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0
SEPTIN4	"ARTS, C17orf47, CE5B3, FLJ40121, H5, hCDCREL-2, hucep-7, MART, PNUTL2, SEPT4"	ENSG00000108387	"Septin 4"	"O43236, Q8NEP4"	17	58520250-58544368	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 1288.2;choroid plexus: 593.0;retina: 404.5"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 52.0;Smooth muscle cells: 38.9"	"Cancer enhanced"	"Detected in all"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 14.0;hTERT-RPE1: 19.4;SK-MEL-30: 32.8"									"CAB006855, HPA021587, HPA022905, HPA028424"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687, HPA028424: AB_10601690"	"unprognostic (1.12e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (6.40e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.75e-3)"	46.6	165.0	832.1	5.0	1011.1	0.5	33.5	861.9	1288.2	13.9	593.0	15.3	4.9	12.4	6.9	5.9	14.2	17.1	56.3	774.4	799.2	31.8	56.6	39.6	14.4	864.7	904.6	15.8	8.7	9.4	23.1	20.9	859.8	8.6	5.3	404.5	9.2	6.5	10.8	11.1	12.1	11.7	798.0	49.5	11.5	25.7	925.2	4.4	23.2	13.7	7.3	12.2	12.1	1080.0	0.0	0.6	1.2	3.6	1.4	0.2	0.6	0.2	0.5	2.1	2.4	0.2	0.5	0.0	5.1	0.8	3.2	0.4	1.8	1.4	0.5	0.3	0.9	1.3	0.3	7.6	14.0	0.1	0.7	7.2	2.9	0.5	2.6	19.4	0.6	1.9	0.0	3.8	0.2	0.5	0.0	0.1	0.6	0.0	0.9	0.2	0.0	1.6	0.0	0.1	3.9	2.1	0.1	0.2	32.8	1.6	0.8	0.4	0.0	0.3	1.6	0.0	1.4	1.0	0.6	0.0	1.1	0.0	0.4	0.0	3.6	0.8	4.9	0.5	1.5	1.6	1.0	1.3	3.7	0.3	1.8	1.4	1.9	1.0	0.0	0.2	0.7	3.6	832.1	1011.1	861.9	1288.2	774.4	799.2	864.7	904.6	859.8	798.0	925.2	1080.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
SEPTIN5	"H5, HCDCREL-1, PNUTL1, SEPT5"	ENSG00000184702	"Septin 5"	Q99719	22	19714503-19724224	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 321.9"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 3.4;Smooth muscle cells: 2.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	32	"eosinophil: 15.4;neutrophil: 5.8"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"K-562: 281.6;THP-1: 75.9"									"CAB016120, HPA029095, HPA063885"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		860000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Actin filaments, Cytosol"		"CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: AB_2685141"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.87e-6)"	"unprognostic (3.39e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.30e-2)"	17.7	17.7	152.8	5.7	215.6	41.0	16.4	49.2	321.9	54.1	61.9	19.8	5.2	28.1	46.2	62.1	38.8	14.7	165.4	233.6	49.3	12.7	5.2	17.4	8.4	40.9	45.2	29.3	17.0	127.3	82.7	12.0	39.4	20.1	6.3	30.3	15.9	9.9	10.8	126.5	8.8	17.3	24.7	14.3	16.3	29.1	73.1	15.9	33.4	16.2	8.1	13.5	42.8	168.6	0.4	10.6	42.0	64.0	3.9	13.1	0.3	15.8	20.1	17.9	10.5	0.7	5.6	1.5	6.1	35.8	26.0	6.0	30.2	6.0	8.8	9.6	3.4	0.7	2.4	0.2	16.2	0.8	47.2	17.4	7.4	6.0	2.5	5.1	7.5	23.1	281.6	0.6	28.2	4.2	4.6	31.2	5.4	1.0	10.4	41.4	1.3	7.2	1.3	1.4	62.3	49.2	2.4	3.5	2.8	10.2	17.3	75.9	3.0	46.4	55.6	2.0	3.2	4.5	0.0	0.4	5.8	2.2	15.2	0.0	0.1	15.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	5.8	0.0	0.0	0.3	0.0	6.0	152.8	215.6	49.2	321.9	233.6	49.3	40.9	45.2	39.4	24.7	73.1	168.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERF2	"4F5REL, FAM2C, H4F5rel, HsT17089"	ENSG00000140264	"Small EDRK-rich factor 2"	P84101	15	43777087-43804427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056613			Uncertain	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA056613: "	"unprognostic (3.29e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (5.33e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.42e-2)"	760.6	1067.4	704.4	446.7	726.4	944.9	619.4	750.2	906.3	650.8	1027.1	728.4	443.4	509.9	776.2	887.9	456.8	469.4	1187.9	698.1	712.2	1002.2	1328.7	700.8	686.4	737.1	725.3	474.3	795.1	490.9	569.3	484.2	734.7	794.5	631.9	72.8	823.7	312.8	636.9	631.1	593.2	507.4	739.4	745.3	784.3	400.2	759.4	450.7	706.6	723.6	628.9	595.0	634.1	758.8	497.5	770.8	573.8	792.9	1963.2	1431.3	438.9	844.8	1042.5	540.4	682.7	991.5	470.0	250.4	694.7	1429.2	698.7	641.1	454.6	623.8	271.1	699.6	526.2	610.9	1074.9	1936.8	934.7	581.8	1235.8	1349.9	810.5	425.8	452.1	836.1	783.5	680.7	630.2	1593.5	1067.4	1441.8	758.6	1337.2	501.5	1849.7	885.1	743.9	382.6	1147.2	1462.5	1695.7	450.6	481.1	458.9	1871.5	463.9	488.4	1574.7	2363.9	682.9	920.0	469.0	1409.4	669.3	593.3	886.2	1837.8	989.2	1032.8	980.4	4033.8	5391.9	5884.9	2716.6	5055.2	2481.3	3853.8	2938.5	2784.5	4649.4	3901.8	2713.3	2731.7	3154.6	2568.8	4495.9	6486.5	3793.5	12856.7	704.4	726.4	750.2	906.3	698.1	712.2	737.1	725.3	734.7	739.4	759.4	758.8	1269.2	506.4	789.0	0.0	1149.8	1151.3	1379.1	3393.0	861.6	53.9	2373.1	2483.2	2229.8	1338.2	2099.5	1736.1	54.2	2660.9	1475.6	2388.2	3897.3	1707.6	576.8	1243.6	1343.1	1283.3	1167.5	1310.8	0.5	2255.2	3410.2	1489.3	1403.7	1261.0	785.9	775.2	1532.4	2884.5	3545.2	47.1	0.5	2862.6	2278.6	2262.1	2298.5	319.2	1225.3	2102.8	1817.8	0.0	2626.4	544.5	1881.6	1.5	0.3	1804.7	2363.9	992.2	1546.7	2188.9	3013.2	5083.6	1950.6	148.4	604.8	680.1	1737.3	750.2	381.1	1725.5	1556.5	3275.8	1216.9	1446.6	2042.5	2819.5
SERGEF	"DelGEF, Gnefr"	ENSG00000129158	"Secretion regulating guanine nucleotide exchange factor"	Q9UGK8	11	17788048-18013047	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 155.4;Excitatory neurons: 114.9;Inhibitory neurons: 123.9;Late spermatids: 258.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037811, HPA037812, HPA074086"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658"	"unprognostic (2.67e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.82e-2)"	16.1	17.5	35.9	9.4	37.4	6.4	16.4	49.6	42.8	19.5	32.2	25.4	7.4	16.8	18.4	12.5	16.5	9.9	18.9	39.0	39.1	19.6	14.0	14.0	10.7	37.4	53.9	27.5	23.1	17.1	36.8	5.7	43.8	21.3	12.3	22.5	15.1	18.0	22.7	20.2	13.8	16.4	34.8	12.8	19.7	5.0	37.3	12.3	27.7	21.7	13.5	21.5	17.7	39.1	10.8	13.2	10.6	22.3	19.1	18.6	7.2	9.0	18.3	9.5	12.0	8.5	3.7	9.5	11.0	12.2	26.1	14.5	37.3	27.6	7.5	21.0	37.7	15.3	10.6	36.3	21.5	13.5	16.6	17.7	27.4	4.8	20.4	28.6	10.5	20.8	9.2	17.6	15.2	16.0	14.0	30.0	8.9	33.7	16.2	18.3	13.0	10.0	21.2	16.1	27.1	5.9	15.8	16.1	17.1	21.1	7.2	12.1	6.2	8.9	12.1	13.1	10.2	12.3	16.1	12.9	15.5	15.4	10.2	15.6	21.3	17.1	34.5	17.6	28.6	25.5	35.5	25.8	26.1	18.7	34.8	30.5	2.3	22.4	17.5	10.5	41.4	25.9	35.9	37.4	49.6	42.8	39.0	39.1	37.4	53.9	43.8	34.8	37.3	39.1	12.7	6.4	6.8	58.4	14.3	26.5	25.3	30.5	15.9	14.1	18.5	20.8	11.6	10.0	13.6	11.0	2.1	6.4	14.4	7.8	39.2	17.1	155.4	3.3	5.1	9.0	48.5	7.4	114.9	24.5	12.5	14.4	4.6	5.2	14.5	26.7	12.5	14.7	14.3	11.8	123.9	14.7	34.6	17.8	14.9	258.3	19.6	9.3	21.4	44.0	12.9	31.7	17.5	82.9	46.5	14.0	9.8	21.4	11.6	18.7	12.3	46.0	7.6	10.9	6.6	13.3	16.9	9.0	7.6	8.7	20.2	3.1	18.2	15.6	13.0	20.0
SERINC2	"FKSG84, PRO0899, TDE2, TDE2L"	ENSG00000168528	"Serine incorporator 2"	Q96SA4	1	31409565-31434680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 235.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.3;Distal enterocytes: 530.1;Ductal cells: 735.4;Pancreatic endocrine cells: 457.4;Paneth cells: 465.1;Proximal enterocytes: 422.0;Syncytiotrophoblasts: 446.6;Urothelial cells: 432.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 10.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 10.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 305.6;HaCaT: 349.2;HBEC3-KT: 553.0;hTCEpi: 307.8;RT4: 381.9;SK-BR-3: 311.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005974	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA005974: AB_10603239"	"unprognostic (1.41e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.78e-3)"	"prognostic favorable (1.69e-7)"	"unprognostic (6.78e-2)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (2.11e-4)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.63e-3)"	"unprognostic (2.67e-2)"	6.5	23.8	1.2	15.0	1.4	8.1	33.8	1.5	1.2	68.9	2.9	111.0	118.7	15.3	21.4	120.7	18.9	59.1	3.2	1.0	1.7	114.1	235.5	20.9	3.5	1.8	2.2	0.9	37.7	45.8	9.7	44.5	1.9	56.6	56.2	0.1	151.0	62.1	76.8	53.5	105.6	2.6	1.6	3.4	90.7	4.9	5.8	8.8	28.4	24.5	9.5	116.5	39.3	1.8	87.3	20.5	17.7	57.0	37.3	50.4	48.2	162.8	119.5	10.6	13.1	31.1	305.6	57.0	209.5	154.6	12.9	349.2	2.3	553.0	2.1	5.5	13.2	0.0	17.2	16.6	42.0	0.5	64.1	46.0	307.8	66.5	144.2	45.5	6.7	6.9	2.6	0.5	18.2	14.2	2.1	2.0	18.3	172.1	42.4	0.4	34.8	19.5	57.9	381.9	7.6	42.4	41.7	311.0	6.5	8.5	182.8	9.9	40.7	2.8	13.0	1.8	3.4	2.9	2.1	2.6	1.4	1.6	13.7	0.0	2.4	2.2	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	10.4	0.0	0.6	1.2	1.4	1.5	1.2	1.0	1.7	1.8	2.2	1.9	1.6	5.8	1.8	2.2	16.0	8.9	0.0	2.7	12.4	108.7	374.7	37.0	0.0	162.9	72.9	0.7	138.7	173.3	117.7	0.0	466.3	4.2	530.1	72.4	735.4	6.4	61.6	18.2	8.8	116.6	3.6	0.4	326.3	91.2	5.4	80.0	140.7	0.0	1.6	5.7	54.5	47.5	0.0	0.4	195.0	183.1	5.1	5.0	12.9	2.1	13.1	40.9	1.0	48.4	0.6	0.0	0.0	0.2	457.4	465.1	0.0	0.1	192.2	422.0	71.0	54.3	0.0	0.0	23.5	19.3	0.7	9.5	30.8	21.2	446.6	3.5	0.1	145.7	432.5
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280460-94293268	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	104	"liver: 346.9"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 259.1"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 21.2"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	3960000000	4700000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.4	0.4	0.4	0.6	0.7	3.3	0.6	3.2	1.4	0.6	0.4	0.7	0.7	0.7	0.5	0.4	0.3	0.5	0.6	0.4	0.4	0.5	346.9	0.4	0.8	1.5	0.5	0.9	0.5	0.2	0.2	0.5	0.8	0.4	0.7	3.1	0.4	0.4	0.5	1.7	0.7	0.6	0.4	0.7	0.7	0.6	0.7	1.3	0.7	0.4	0.4	0.2	0.1	2.5	0.6	0.2	1.8	0.7	0.7	0.6	0.4	0.5	0.5	0.9	0.8	2.7	0.6	2.1	0.3	0.4	0.2	0.4	2.2	0.5	1.3	0.8	1.4	2.0	0.8	21.2	0.4	1.6	1.1	0.6	0.5	0.3	0.7	1.1	1.0	1.1	0.5	1.3	1.0	0.3	1.4	0.8	0.8	0.2	0.6	0.9	1.2	0.9	0.5	0.7	0.9	0.8	0.4	0.4	0.2	1.0	0.9	0.9	0.6	0.7	0.4	0.7	0.6	1.1	0.5	0.9	0.9	1.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	3.2	1.4	0.4	0.4	1.5	0.5	0.8	0.4	0.7	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	2.8	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	6.6	8.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	3.3	259.1	0.0	0.0	0.0	0.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"bone marrow: 74.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.4;Club cells: 2.7;Erythroid cells: 1.3;Kupffer cells: 1.2;monocytes: 4.7;Respiratory ciliated cells: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.3;eosinophil: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"U-937: 104.1"					"Not detected"	"Not detected"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		59000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA015480: AB_1855456, HPA059582: AB_2684072"	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	0.3	0.1	0.1	0.1	0.2	74.7	0.0	0.5	0.4	0.3	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.1	0.1	0.1	0.7	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.7	0.1	1.5	0.1	0.0	0.0	0.1	0.1	104.1	0.1	0.1	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.3	0.1	0.2	0.5	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	4.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.2
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63970029-64019779	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 58.8"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 120.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		920000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	10.8	9.5	2.6	15.8	3.2	30.3	9.5	3.4	3.6	9.3	3.5	8.6	6.3	4.7	1.5	30.1	4.4	18.1	5.7	2.8	3.9	9.0	37.8	12.1	13.4	5.2	4.0	4.2	7.1	2.7	3.7	7.2	4.8	4.6	9.7	2.3	10.8	3.3	3.0	58.8	8.8	7.3	4.3	7.8	7.1	2.7	4.6	6.5	5.3	2.3	18.3	23.7	17.1	4.5	24.2	4.8	4.0	28.8	13.9	19.7	2.0	75.6	72.9	46.8	46.4	1.0	10.8	0.4	27.2	45.6	23.3	38.3	0.8	48.2	66.3	33.4	0.9	0.0	8.7	2.5	32.1	120.0	10.0	19.1	41.3	63.6	20.9	30.3	51.4	5.1	0.7	13.4	32.9	2.1	2.1	13.5	1.7	3.8	23.6	1.7	10.5	2.1	21.4	27.1	2.3	2.4	15.0	2.3	28.8	3.3	0.8	45.4	79.2	71.0	15.4	8.8	31.1	5.9	1.0	0.1	72.5	69.2	63.0	2.7	44.2	2.0	7.6	34.2	6.8	7.1	6.3	4.7	53.8	9.9	3.3	5.2	12.4	4.6	18.1	28.8	8.9	11.2	2.6	3.2	3.4	3.6	2.8	3.9	5.2	4.0	4.8	4.3	4.6	4.5	6.0	3.2	8.3	0.3	9.1	41.0	25.9	38.9	5.7	0.4	5.5	3.8	1.2	8.6	25.5	0.0	0.0	4.9	13.4	12.3	0.0	30.0	1.3	7.6	3.3	8.7	1.8	3.0	1.8	19.2	5.6	8.6	8.2	16.3	4.5	0.9	7.5	9.6	15.3	0.0	1.3	3.5	12.2	24.8	35.1	1.1	0.9	35.9	16.0	1.0	29.0	1.6	5.2	1.5	2.9	42.2	10.7	0.0	3.5	13.0	8.5	2.9	12.9	0.3	0.0	12.3	9.8	1.7	2.3	18.2	48.4	31.3	8.2	1.4	5.0	33.3
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887270-2903309	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.1;placenta: 52.3"	"Cell type enriched"	"Detected in many"	5	"Langerhans cells: 1527.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 225.3;SuSa: 227.6;U-698: 98.8"					"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		3400000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	11.6	11.0	6.4	35.4	6.7	18.9	5.3	7.5	7.9	7.8	5.9	5.3	4.4	4.4	3.1	9.2	8.3	11.3	9.1	6.3	8.0	5.2	16.3	26.4	40.9	8.8	7.8	3.0	2.4	6.7	8.8	52.3	8.7	5.2	6.5	4.7	4.3	2.8	2.4	2.7	10.8	5.9	8.4	28.2	5.0	8.7	7.2	13.8	7.6	1.8	41.1	17.0	7.4	8.2	0.2	9.8	0.3	0.1	0.7	0.3	225.3	1.9	0.5	2.3	3.4	2.9	18.8	38.2	22.8	2.1	0.1	0.1	27.6	0.0	2.0	12.4	2.7	3.8	3.3	5.5	12.9	0.0	0.1	10.1	0.1	4.1	0.0	0.2	50.2	3.4	17.8	0.3	1.9	0.9	0.0	0.3	31.7	0.1	0.1	3.7	0.1	0.4	1.6	0.1	1.5	0.5	22.7	0.1	0.0	227.6	0.1	0.6	52.5	0.0	0.4	0.1	0.1	0.2	49.5	98.8	0.0	0.1	0.1	4.7	48.6	0.3	43.6	100.8	36.3	22.4	31.3	41.7	16.1	24.9	28.7	41.4	7.6	51.3	62.7	17.0	35.7	37.9	6.4	6.7	7.5	7.9	6.3	8.0	8.8	7.8	8.7	8.4	7.2	8.2	26.2	19.2	17.6	12.1	105.1	35.3	2.2	4.2	1.8	1.5	13.8	6.7	5.3	1.5	12.1	5.5	0.0	83.1	100.8	4.7	0.0	15.8	1.0	68.0	10.8	44.1	15.5	11.6	21.4	0.2	143.7	35.6	3.6	82.2	46.3	2.2	66.4	7.1	17.9	8.4	23.1	2.7	2.0	59.6	1527.7	4.9	4.4	232.6	88.9	92.8	99.8	5.3	43.3	1.0	3.2	9.3	6.0	17.7	115.7	2.5	0.1	2.4	10.4	3.0	13.1	55.3	14.6	0.4	2.2	3.8	36.9	270.2	100.6	8.1	3.4	6.9
SERTAD1	"SEI1, TRIP-Br1"	ENSG00000197019	"SERTA domain containing 1"	Q9UHV2	19	40421589-40425992	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 480.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063323			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"	Nucleoplasm	"HPA063323: AB_2684984"	"unprognostic (2.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.08e-3)"	27.1	9.3	8.1	7.3	7.8	28.7	10.7	9.4	12.1	9.1	8.5	12.0	6.7	11.3	2.1	18.8	15.2	12.7	21.2	9.0	7.5	21.9	14.1	22.3	5.8	8.7	7.9	6.9	15.1	4.4	8.9	6.6	8.7	11.1	3.0	0.9	8.4	4.2	15.1	15.5	10.8	7.1	8.4	10.0	18.8	3.8	9.7	5.5	11.6	13.2	3.5	11.0	11.9	8.7	18.5	21.4	3.0	7.4	8.3	5.9	8.0	29.0	8.7	15.4	15.1	9.5	14.6	3.6	13.4	9.8	4.4	7.4	2.4	26.2	4.7	10.1	5.1	3.2	5.0	8.3	9.4	1.1	11.0	9.6	15.8	16.8	3.1	7.4	8.7	3.1	6.8	5.6	14.1	27.7	1.7	5.6	2.3	13.2	14.2	2.2	4.8	9.3	8.2	12.8	0.9	1.4	15.3	14.0	14.5	3.4	14.0	3.1	16.2	15.2	17.2	12.3	19.8	8.1	3.6	4.8	21.3	4.8	7.2	22.5	21.9	15.0	9.7	19.8	5.8	13.3	9.5	9.3	26.1	12.7	10.9	7.8	17.5	15.9	19.4	23.8	14.2	13.6	8.1	7.8	9.4	12.1	9.0	7.5	8.7	7.9	8.7	8.4	9.7	8.7	480.2	73.7	52.3	2.3	138.2	126.2	196.5	83.4	243.6	5.0	221.4	299.7	83.2	32.9	51.5	31.3	0.0	46.0	203.8	246.0	23.5	62.6	1.4	100.0	72.1	156.1	106.1	6.1	1.1	61.7	72.8	159.7	169.7	126.7	132.9	27.9	86.7	12.8	53.9	3.3	0.6	152.3	46.8	28.9	98.3	4.2	16.4	102.6	94.3	4.7	30.0	17.9	6.2	1.5	0.8	91.6	300.8	10.9	69.7	130.9	158.9	18.5	31.7	2.4	39.5	292.5	201.5	1.7	5.4	174.7	130.4	130.2	150.4	24.2	102.0	111.9
SERTAD2	"KIAA0127, Sei-2, TRIP-Br2"	ENSG00000179833	"SERTA domain containing 2"	Q14140	2	64631621-64751005	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 85.7"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 177.6;Basal squamous epithelial cells: 153.1;Suprabasal keratinocytes: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019021, HPA020904"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019021: AB_1856740, HPA020904: AB_1856741"	"unprognostic (1.40e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (2.15e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.55e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.21e-3)"	"unprognostic (6.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.84e-1)"	14.1	6.7	4.3	13.8	5.8	85.7	9.4	5.3	5.5	12.7	3.8	8.5	6.2	8.6	7.9	22.8	6.9	9.4	10.3	5.0	4.5	7.5	14.6	9.7	19.2	6.3	5.9	13.5	6.6	10.7	3.6	12.6	5.8	9.3	8.7	15.6	11.7	8.5	8.6	18.8	9.0	8.1	5.4	19.3	9.2	7.2	5.3	35.3	8.1	9.6	27.3	15.9	16.8	7.1	30.9	9.0	16.5	16.6	13.9	35.2	18.9	24.2	23.2	14.1	13.2	23.1	23.0	26.0	13.0	39.8	19.6	12.0	10.9	14.8	29.6	2.5	16.4	17.2	8.8	16.8	3.1	15.3	8.4	24.0	19.1	32.2	20.9	21.1	8.6	12.7	10.9	14.1	33.2	7.4	16.5	16.7	9.0	16.9	23.6	14.3	28.2	10.2	19.1	28.0	19.1	7.5	17.1	11.9	31.5	15.3	7.9	12.1	26.1	75.7	39.1	44.8	19.9	24.0	9.8	29.6	28.0	27.7	30.3	1.3	1.6	2.3	0.9	1.5	0.5	2.5	0.9	1.0	1.5	2.5	2.2	1.6	2.0	1.5	1.8	4.9	0.5	0.9	4.3	5.8	5.3	5.5	5.0	4.5	6.3	5.9	5.8	5.4	5.3	7.1	25.6	6.4	23.6	22.9	40.8	177.6	40.9	22.5	153.1	24.8	28.7	28.6	26.4	32.9	25.9	9.2	18.8	38.6	33.0	31.6	1.9	12.8	51.2	57.8	18.5	35.4	11.3	26.5	27.3	10.0	42.8	35.1	17.3	97.7	8.8	4.8	25.4	24.1	23.6	10.1	19.8	17.1	18.3	39.3	84.7	35.4	17.1	43.6	39.2	38.4	27.4	20.0	14.4	19.6	35.5	20.7	45.4	10.5	28.1	43.9	11.6	9.5	24.9	24.3	13.1	26.8	31.0	10.8	6.7	135.4	148.3	60.1	25.5	3.7	13.3	71.5
SERTAD4	DJ667H12.2	ENSG00000082497	"SERTA domain containing 4"	Q9NUC0	1	210232796-210246631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 28.5;Breast glandular cells: 23.1;Extravillous trophoblasts: 54.9;Ionocytes: 24.4;Squamous epithelial cells: 27.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.5;BEWO: 7.4;SCLC-21H: 7.4;SK-BR-3: 8.5;T-47d: 10.5;U-2 OS: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027344, HPA028514"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA027344: AB_10601770, HPA028514: AB_10611391"	"unprognostic (1.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.85e-2)"	"unprognostic (6.55e-2)"	"unprognostic (4.24e-1)"	1.1	0.3	0.6	0.3	1.6	0.0	3.6	1.0	1.1	2.0	0.2	4.8	0.4	3.8	0.6	4.2	1.7	0.7	3.0	0.6	1.0	1.9	0.0	1.5	0.1	0.9	1.4	1.0	0.1	0.6	0.9	1.0	1.0	1.8	1.4	0.1	5.9	1.4	0.2	3.3	0.8	2.7	1.2	0.1	1.4	0.2	0.8	0.6	1.4	0.7	0.7	0.6	1.8	1.1	7.5	0.1	1.6	0.0	0.8	0.7	7.4	1.8	1.8	1.4	2.4	0.3	0.8	0.0	0.2	0.4	1.1	3.6	0.2	0.6	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	1.7	0.2	0.0	0.0	0.0	0.3	1.8	0.0	0.0	5.2	6.0	0.3	0.0	2.4	0.0	1.2	1.3	7.4	6.3	1.2	8.5	0.1	2.9	10.5	0.0	2.3	2.0	8.7	0.1	5.6	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	1.0	1.1	0.6	1.0	0.9	1.4	1.0	1.2	0.8	1.1	5.0	6.4	3.9	1.6	0.0	16.7	9.6	16.0	28.5	2.5	23.1	9.3	0.7	1.5	10.9	9.2	0.0	14.2	0.0	1.5	7.9	2.1	0.5	4.8	1.2	5.2	1.2	0.0	10.1	3.9	54.9	7.5	2.6	5.8	0.0	9.3	2.5	0.0	1.4	0.0	3.7	5.6	24.4	0.0	5.0	0.6	0.6	0.3	10.6	3.7	0.0	0.5	0.0	1.0	9.4	8.1	1.3	1.5	0.0	2.5	0.0	0.4	13.9	0.3	0.0	1.8	3.7	0.1	1.7	27.4	4.7	4.4	0.3	0.1	6.5	3.4
SESN1	"PA26, SEST1"	ENSG00000080546	"Sestrin 1"	Q9Y6P5	6	108986437-109094819	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 137.2;Excitatory neurons: 134.9;Inhibitory neurons: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 48.0;NK-cells: 58.9;T-cells: 74.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 80.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073659			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA073659: AB_2686622"	"unprognostic (2.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.47e-5)"	"unprognostic (2.68e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-3)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.95e-2)"	30.7	26.6	29.1	23.2	30.7	50.2	42.3	29.8	35.9	29.9	29.8	31.6	20.2	31.7	26.6	22.7	32.5	18.5	36.2	31.1	29.4	16.7	29.2	25.6	33.8	27.9	27.9	62.6	31.6	50.3	25.8	53.4	28.7	25.1	23.9	25.0	18.3	23.6	151.2	43.1	38.1	32.9	28.7	37.0	31.0	42.0	29.9	21.9	32.1	140.0	33.8	28.3	28.2	30.8	3.5	5.7	25.7	12.2	32.1	40.6	80.5	13.8	15.7	4.7	9.0	10.9	3.6	29.3	11.4	10.2	3.7	4.1	7.0	27.6	5.8	2.6	34.7	13.0	6.9	40.9	19.7	5.1	12.7	44.2	43.0	8.5	13.7	20.5	24.7	8.3	9.7	20.5	23.3	6.9	11.3	16.4	10.6	5.7	3.6	9.0	7.3	13.7	10.1	17.4	6.3	12.7	7.5	4.7	5.7	41.3	4.5	33.5	15.3	3.6	7.1	3.3	4.5	20.5	12.5	12.0	7.9	12.8	7.9	11.9	2.7	3.4	34.4	6.3	74.6	13.3	32.4	27.3	2.7	48.0	39.6	20.8	10.0	58.9	8.7	5.4	15.1	20.3	29.1	30.7	29.8	35.9	31.1	29.4	27.9	27.9	28.7	28.7	29.9	30.8	13.9	64.1	22.4	79.0	37.3	6.5	4.9	7.4	25.0	23.8	14.2	14.5	30.0	17.2	15.2	14.7	45.9	57.8	22.9	12.7	9.8	4.3	137.2	10.3	15.2	9.8	15.5	24.2	134.9	5.3	13.7	21.9	28.5	8.2	3.8	17.4	10.8	14.7	44.9	26.9	127.7	10.0	2.0	43.1	11.3	104.8	34.5	56.5	16.0	71.2	9.4	39.1	25.7	64.3	119.1	3.1	11.9	35.3	26.2	9.4	7.8	9.3	26.4	44.3	26.3	43.9	15.9	18.4	16.2	25.4	8.4	44.6	41.8	102.9	13.6	4.3
SESN3	"MGC29667, SEST3"	ENSG00000149212	"Sestrin 3"	P58005	11	95165513-95232541	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 680.7;Late spermatids: 529.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.7;ASC TERT1: 50.7;SuSa: 110.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037935			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA037935: AB_10670534"	"unprognostic (2.72e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.09e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.34e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.42e-2)"	9.6	17.5	42.3	14.3	56.4	17.9	14.7	24.3	37.8	11.8	26.0	5.7	6.5	11.4	14.1	8.9	8.4	12.4	5.4	32.6	30.7	10.5	7.5	9.1	24.4	21.4	40.6	21.9	3.1	25.8	11.2	7.1	22.5	10.2	6.5	23.4	9.9	5.5	5.3	10.7	12.5	9.2	28.8	17.3	4.9	57.7	54.6	21.8	21.7	13.1	24.2	11.2	8.8	26.6	0.0	1.0	28.2	0.1	46.7	50.7	0.1	0.2	0.0	0.0	0.1	1.2	0.9	7.7	3.4	0.1	1.3	5.7	17.3	12.5	0.0	6.4	9.0	3.9	15.4	1.2	0.9	3.4	0.7	28.1	21.4	0.1	6.3	8.7	1.1	4.5	0.4	1.4	2.3	0.2	2.5	9.0	11.5	0.2	1.2	5.7	1.7	0.6	6.2	19.1	3.6	7.9	0.3	0.2	1.6	110.9	0.0	11.0	0.3	3.2	7.1	0.6	1.1	0.3	0.0	1.0	1.4	4.0	6.9	0.5	0.3	0.2	0.2	0.7	0.3	1.8	0.8	0.5	0.3	1.1	1.6	0.6	0.3	0.3	1.5	0.4	1.7	0.3	42.3	56.4	24.3	37.8	32.6	30.7	21.4	40.6	22.5	28.8	54.6	26.6	13.4	25.6	7.9	152.8	97.6	23.1	26.2	38.3	76.2	48.2	16.1	25.5	7.6	2.8	15.6	35.0	22.9	0.7	7.1	6.9	1.9	6.0	680.7	7.7	45.4	36.4	7.3	73.4	130.8	2.3	0.6	36.5	10.7	14.5	7.0	28.0	35.3	6.4	23.4	0.0	95.1	11.4	8.2	54.8	58.8	529.5	40.7	36.7	32.0	97.4	82.0	98.9	10.3	48.2	37.2	2.2	7.3	87.3	11.9	13.6	27.7	22.5	4.5	14.8	6.6	31.5	28.9	45.4	11.1	38.2	12.5	1.6	41.3	76.4	14.8	14.9
SET	"2PP2A, IGAAD, IPP2A2, PHAPII, TAF-I, TAF-IBETA"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA		880000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: AB_2685088"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	124.9	122.7	125.2	195.6	134.6	261.8	174.2	115.9	137.6	147.7	111.0	160.1	125.5	174.7	88.0	196.3	154.9	149.1	152.7	109.1	115.3	155.5	159.8	129.3	308.5	120.3	126.1	190.6	175.3	143.3	78.6	206.2	126.9	135.8	169.7	142.4	139.4	134.9	182.5	154.1	132.2	164.6	141.1	170.4	139.8	105.3	124.2	286.8	211.2	134.5	300.4	220.8	122.9	147.6	579.4	644.4	908.7	723.6	265.2	412.2	835.7	465.8	511.8	656.9	449.9	892.0	688.8	1483.4	383.1	482.8	513.6	1053.0	1358.8	700.1	745.2	681.2	577.8	855.2	968.5	734.5	591.3	1581.1	535.5	346.7	535.7	561.6	1114.6	526.1	626.1	781.8	1692.1	583.3	545.4	974.2	1333.9	580.0	1521.8	876.7	678.6	1198.7	1128.2	1198.7	506.5	640.5	921.0	576.5	1024.4	679.0	560.5	641.6	847.6	483.9	604.4	770.6	576.9	481.4	784.1	455.0	1417.0	1737.1	367.1	824.8	753.1	165.1	207.3	182.0	224.0	235.4	277.6	287.4	253.0	240.4	215.1	258.0	241.0	286.1	141.4	329.2	199.5	271.6	223.1	335.1	125.2	134.6	115.9	137.6	109.1	115.3	120.3	126.1	126.9	141.1	124.2	147.6	249.9	121.8	145.0	25.1	337.1	673.6	507.5	134.0	352.8	187.6	372.3	250.6	204.2	238.8	134.0	196.8	43.8	316.7	365.9	136.8	389.4	254.6	43.5	318.3	502.1	266.9	256.1	355.6	41.7	218.7	504.0	194.8	126.9	438.5	132.3	308.3	193.1	198.5	239.4	124.5	40.2	261.8	93.6	264.0	436.5	33.6	164.1	249.0	327.3	22.5	274.3	240.6	211.2	38.2	36.6	294.5	132.5	173.4	356.2	647.6	106.7	338.6	87.0	132.5	131.5	323.9	297.0	124.6	259.7	448.0	702.1	314.5	292.3	238.9	342.8	580.9
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.6"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.0;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Karpas-707: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		66000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: AB_2680602, HPA057259: AB_2683384"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favorable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	7.3	1.9	2.0	3.7	3.7	1.8	6.3	11.6	5.7	11.6	0.0	10.9	1.7	8.3	7.2	4.5	7.2	5.0	4.3	2.6	0.2	7.4	4.7	6.6	5.3	0.0	0.1	7.7	5.8	3.7	2.7	7.2	0.1	7.8	3.5	3.0	4.3	9.2	10.7	4.4	4.6	7.4	0.0	3.7	5.6	1.8	0.0	4.4	5.1	9.7	4.7	8.1	8.5	3.8	0.0	2.4	16.1	0.0	4.1	1.2	1.0	1.3	3.0	1.5	1.3	0.2	0.0	1.0	0.5	1.8	1.0	4.8	1.8	4.9	1.0	1.4	0.8	0.0	1.8	1.2	0.0	0.0	0.0	3.8	2.0	0.0	3.0	2.7	0.5	0.0	0.1	44.7	0.4	0.8	0.0	0.1	2.0	0.0	1.1	5.6	0.0	5.5	4.9	3.9	8.2	4.2	0.0	0.0	0.9	7.1	2.2	0.0	0.0	9.5	3.3	0.0	7.7	8.6	0.5	0.0	5.8	0.2	5.5	0.1	0.0	0.0	0.4	0.6	0.0	2.0	0.0	0.2	0.0	3.0	0.0	0.1	0.0	0.0	1.0	2.8	0.0	0.1	2.0	3.7	11.6	5.7	2.6	0.2	0.0	0.1	0.1	0.0	0.0	3.8	7.6	0.0	1.8	85.5	42.4	15.4	8.6	8.3	7.4	12.5	11.0	12.6	3.9	14.3	4.2	16.5	18.8	1.5	25.5	1.6	3.9	4.5	1.3	12.9	15.6	8.3	12.0	0.8	349.0	3.5	1.4	29.3	4.1	14.8	0.0	0.7	17.9	16.5	2.0	3.3	548.3	4.4	10.2	2.4	8.7	3.7	62.7	4.6	3.6	88.1	1.5	10.7	6.2	170.4	62.9	3.7	9.1	39.9	29.6	8.1	0.4	10.5	5.8	18.2	6.6	18.4	28.6	0.3	0.8	4.0	15.2	0.8	5.9	0.1	4.7	1.5
SETD1B	"KIAA1076, KMT2G, Set1B"	ENSG00000139718	"SET domain containing 1B, histone lysine methyltransferase"	Q9UPS6	12	121804009-121832656	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021667, HPA059412"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021667: AB_1856753, HPA059412: AB_2684006"	"unprognostic (1.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	14.3	8.9	2.8	8.6	2.5	15.1	12.1	7.6	4.4	19.4	1.3	28.5	7.5	26.0	4.7	14.0	19.6	4.5	8.0	2.7	0.7	8.4	11.3	9.2	6.9	1.7	1.4	15.8	12.5	5.5	9.2	5.5	0.7	15.6	3.7	3.4	11.4	10.0	9.0	11.6	15.6	7.1	0.5	13.1	16.7	9.4	1.6	8.4	13.9	4.2	4.8	22.0	14.1	1.5	7.4	14.8	7.4	12.5	6.9	4.7	11.2	6.8	5.4	5.1	2.9	8.1	4.4	5.4	6.1	7.6	3.2	11.3	8.6	5.3	3.0	9.7	10.5	16.3	20.3	7.1	5.9	15.3	14.0	5.7	6.4	7.0	5.6	6.2	5.6	10.6	17.1	3.7	3.9	17.1	22.5	21.5	10.6	3.6	8.5	17.3	4.8	7.9	5.0	15.1	9.0	6.9	15.0	10.5	5.7	5.5	12.8	13.8	9.5	7.6	9.4	10.8	7.7	7.3	4.0	3.2	6.3	9.7	8.8	1.4	0.2	0.6	0.4	0.5	0.3	0.3	0.3	0.4	0.2	0.3	0.5	0.3	1.0	0.3	0.2	0.5	0.3	0.2	2.8	2.5	7.6	4.4	2.7	0.7	1.7	1.4	0.7	0.5	1.6	1.5	10.1	3.2	7.3	9.8	11.2	11.7	3.2	5.7	26.2	13.8	12.7	9.5	9.7	10.0	6.7	5.5	8.4	7.9	17.6	8.5	0.0	5.1	9.8	13.9	14.5	9.5	7.3	7.8	10.6	7.2	7.0	8.5	8.6	20.3	3.8	10.1	12.1	13.8	6.5	11.8	11.7	7.8	4.1	17.7	14.8	21.4	11.5	10.8	1.8	5.6	13.9	5.0	9.2	5.0	6.8	6.5	10.5	10.1	11.2	9.1	6.8	3.2	5.4	10.0	6.6	10.6	12.9	11.3	3.5	29.4	12.9	13.1	13.3	8.1	6.6	9.1
SETD5	FLJ10707	ENSG00000168137	"SET domain containing 5"	Q9C0A6	3	9397615-9479240	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Autism, Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 263.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017093, HPA035574"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB017093: , HPA035574: AB_2674681"	"unprognostic (6.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (5.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.15e-3)"	24.9	28.1	22.3	19.3	22.0	14.9	25.4	33.7	24.9	29.5	20.9	30.5	15.2	27.6	30.2	25.0	30.2	18.8	23.0	23.5	22.3	18.3	27.6	33.5	23.1	20.5	20.3	33.2	28.5	18.0	26.5	24.0	21.1	25.6	20.9	33.9	28.3	20.4	23.9	32.8	25.6	23.2	18.6	26.1	23.9	17.8	22.2	25.5	30.5	21.5	26.7	26.5	28.1	24.2	25.3	28.6	57.8	27.0	36.5	33.6	138.5	24.9	30.2	31.6	35.4	29.1	30.2	53.5	14.3	33.4	29.8	20.0	50.6	29.8	35.5	38.4	27.6	50.6	56.4	29.8	36.7	42.0	31.9	35.0	52.2	49.3	55.1	37.3	35.7	35.6	50.0	40.0	32.6	36.4	35.7	38.1	42.2	19.5	23.9	37.7	47.6	26.2	29.6	37.7	22.3	34.6	34.2	29.8	22.6	52.6	39.7	30.8	41.6	35.3	41.6	21.0	28.9	27.4	34.2	83.6	26.9	30.4	33.2	0.4	0.4	0.2	0.9	0.2	0.8	0.7	0.6	0.7	0.3	0.7	0.5	0.5	1.1	1.1	0.2	0.8	0.1	0.1	22.3	22.0	33.7	24.9	23.5	22.3	20.5	20.3	21.1	18.6	22.2	24.2	51.5	41.7	50.6	136.1	53.6	93.9	54.4	28.5	86.6	110.6	45.1	26.2	25.5	41.5	50.0	42.3	114.7	38.9	50.4	39.1	3.9	37.3	7.9	45.9	60.3	62.5	62.4	34.3	175.0	34.0	41.3	62.2	45.9	49.4	48.1	60.6	63.1	50.1	24.4	55.5	188.5	51.9	26.4	32.4	70.7	11.7	66.8	30.8	44.4	108.7	39.7	33.4	39.1	263.9	131.7	44.2	46.2	53.8	67.7	88.2	39.4	12.8	52.9	60.9	13.1	65.3	52.8	50.6	37.8	75.2	91.5	57.3	49.6	56.2	47.8	84.2
SETD6	FLJ21148	ENSG00000103037	"SET domain containing 6, protein lysine methyltransferase"	Q8TBK2	16	58515479-58523842	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041481, HPA053546"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041481: AB_10804004, HPA053546: AB_2682182"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (3.74e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.73e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.55e-1)"	8.6	12.4	3.8	2.9	3.6	2.6	9.1	8.9	4.6	9.4	3.9	8.4	3.8	8.4	5.4	13.4	9.7	2.7	11.3	3.9	3.8	12.5	13.5	7.0	4.6	3.8	3.5	9.1	19.6	6.5	12.5	2.5	3.9	10.9	4.3	7.9	11.1	5.9	15.0	14.6	9.2	3.3	3.5	10.6	11.4	12.7	3.8	2.8	12.2	3.9	4.4	8.3	10.8	3.8	2.5	6.1	1.3	10.7	4.3	2.8	15.9	4.0	5.4	7.1	3.8	10.1	6.1	19.9	5.4	4.6	0.9	8.1	9.0	6.3	4.9	2.2	23.6	0.9	11.0	17.2	4.3	14.4	7.8	3.8	13.2	5.6	8.8	4.8	4.5	0.2	14.7	2.6	1.5	10.1	0.3	17.7	21.0	9.7	9.6	0.4	2.5	26.7	7.3	0.4	19.6	12.6	16.8	15.9	7.8	6.2	10.0	2.0	3.7	2.5	6.0	3.1	7.3	11.7	8.1	13.7	5.3	6.9	4.6	2.5	1.1	0.2	2.0	1.5	1.4	1.5	1.6	2.2	1.8	1.5	2.0	2.2	0.7	4.4	1.6	2.0	1.6	1.3	3.8	3.6	8.9	4.6	3.9	3.8	3.8	3.5	3.9	3.5	3.8	3.8	5.2	6.4	6.9	6.8	7.1	13.9	10.5	7.5	13.6	14.3	12.0	11.0	7.6	17.2	8.5	9.2	14.6	17.5	8.6	5.3	1.9	10.1	9.2	10.8	6.9	6.8	4.8	10.3	11.5	12.2	9.9	8.4	8.2	10.0	1.3	14.9	4.2	7.9	3.5	11.8	11.3	5.0	2.0	3.5	5.6	16.9	9.0	3.4	5.4	5.6	5.6	15.0	6.2	7.5	4.7	6.1	4.2	10.1	6.8	13.8	6.5	9.4	12.0	13.4	13.1	10.1	7.4	15.0	22.9	12.1	12.1	12.6	7.1	6.1	7.4	6.2
SETD9	"C5orf35, MGC33648"	ENSG00000155542	"SET domain containing 9"	Q8NE22	5	56909260-56925532	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 18.8"	"Group enriched"	"Detected in many"	7	"Early spermatids: 691.8;Late spermatids: 372.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.2;monocytes: 3.2"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA049936			Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA049936: "	"unprognostic (1.13e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.37e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	5.1	2.8	0.9	1.0	1.1	2.6	5.1	1.1	1.4	1.6	0.9	5.9	5.2	3.0	3.9	3.0	2.3	2.6	5.9	0.8	1.1	6.2	9.9	2.1	2.7	1.3	1.0	3.1	4.4	3.5	0.6	2.4	1.2	2.3	4.6	1.1	6.3	1.2	3.7	1.4	6.7	2.8	1.1	1.8	3.1	18.8	1.0	1.2	4.9	7.2	2.9	2.9	0.9	1.5	6.8	1.6	5.9	3.3	5.1	3.7	3.9	4.8	3.1	5.2	7.2	4.9	5.1	4.5	10.3	5.1	8.1	6.4	3.9	2.6	7.3	4.1	6.9	0.7	1.7	6.6	5.1	3.6	4.7	3.6	3.8	8.7	7.3	4.8	7.8	2.3	5.1	3.1	8.0	11.0	0.5	3.5	7.0	0.0	8.1	5.9	2.2	8.0	5.8	3.0	4.5	6.7	1.1	3.4	10.3	3.7	8.3	4.1	6.1	2.9	9.2	5.0	6.0	4.0	12.8	9.1	3.5	2.5	0.7	5.2	1.0	1.9	0.4	0.9	0.7	0.2	0.8	0.2	0.6	0.3	0.3	0.6	1.8	0.6	3.2	0.2	0.9	0.4	0.9	1.1	1.1	1.4	0.8	1.1	1.3	1.0	1.2	1.1	1.0	1.5	10.7	3.2	2.7	1.0	7.8	17.5	15.6	17.9	1.8	2.8	32.2	30.5	14.7	12.8	9.0	7.3	0.0	15.5	7.6	24.5	56.7	14.6	691.8	10.4	7.7	9.6	18.5	5.2	0.7	17.4	21.4	12.2	9.2	7.6	14.7	7.1	8.2	27.4	14.8	0.0	1.4	10.4	14.2	13.5	35.4	372.2	10.2	11.9	28.4	2.8	13.6	6.9	8.2	2.0	8.6	9.8	20.7	5.7	9.0	28.4	24.7	52.7	9.9	3.1	0.0	14.5	12.7	67.0	13.5	4.8	15.3	14.4	6.8	10.3	14.3	19.2
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated histone lysine methyltransferase 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 341.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	13.5	11.3	7.1	15.2	8.2	18.1	16.7	12.8	8.9	14.4	8.7	13.4	12.5	18.1	13.1	11.8	15.3	11.5	8.2	6.7	7.9	11.7	11.5	13.4	19.6	8.2	7.6	19.4	13.3	15.7	8.6	17.7	7.6	11.4	15.5	14.2	12.3	12.2	16.4	14.4	13.7	16.5	6.0	19.9	13.4	25.1	8.4	21.6	15.5	11.7	20.3	13.1	12.7	10.3	22.9	26.3	37.1	24.6	17.5	23.2	61.7	18.6	21.2	26.2	22.2	17.9	31.1	44.9	24.9	20.7	10.4	28.1	35.0	20.0	20.7	21.8	43.3	25.5	27.3	20.8	24.7	45.3	23.2	30.5	22.0	21.8	34.8	26.6	31.2	28.3	43.4	35.6	18.9	44.1	31.6	26.4	51.1	32.1	20.6	36.3	24.3	33.4	20.1	25.9	27.1	49.1	28.4	32.9	22.5	44.5	35.7	60.4	21.2	15.3	15.7	17.0	26.3	36.6	42.3	341.6	15.7	15.7	15.1	6.9	8.3	5.7	5.8	11.6	6.1	6.1	5.3	6.6	9.7	8.3	5.7	5.9	4.8	6.3	8.5	6.5	3.5	4.3	7.1	8.2	12.8	8.9	6.7	7.9	8.2	7.6	7.6	6.0	8.4	10.3	8.5	6.4	14.0	15.3	15.3	5.5	9.3	6.6	10.2	11.0	9.8	10.7	5.5	10.0	7.8	7.3	18.8	13.9	8.8	6.6	3.9	7.6	26.1	10.8	13.3	8.3	3.6	9.2	19.6	5.7	8.5	9.1	10.2	10.7	7.6	17.9	11.4	8.1	9.9	6.7	19.4	9.7	12.2	17.2	5.1	31.0	10.2	13.9	1.8	23.4	14.4	6.2	14.4	15.6	23.5	8.1	9.5	9.8	8.9	8.2	7.6	6.4	11.0	10.4	6.6	10.2	10.3	24.4	15.9	10.9	5.1	10.0	10.2	14.6	10.7	7.8
SETDB2	"C13orf4, CLLD8, CLLL8, KMT1F"	ENSG00000136169	"SET domain bifurcated histone lysine methyltransferase 2"	Q96T68	13	49444374-49495003	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Chromatin regulator, Developmental protein, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012190, HPA071677"	Approved		Approved	Nucleoplasm		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB012190: AB_2186195, HPA071677: AB_2686430"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.74e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.95e-2)"	"prognostic favorable (1.92e-7)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	5.3	8.9	4.2	10.4	4.6	8.2	11.1	5.7	5.2	7.4	6.2	7.5	6.4	9.0	6.1	5.9	6.3	7.7	10.5	4.7	4.1	8.1	8.0	8.1	16.7	3.4	3.9	16.0	7.1	7.8	3.9	6.3	3.6	7.6	9.3	9.5	8.2	6.9	2.5	7.8	7.2	7.5	3.8	13.1	8.0	15.3	4.7	10.1	11.1	5.3	13.9	6.4	4.7	5.5	3.0	2.0	6.0	6.2	8.3	9.3	3.0	8.4	10.5	7.4	6.9	12.5	7.1	37.1	1.6	5.5	5.5	6.0	6.4	5.7	7.2	8.5	5.6	12.9	5.7	7.6	11.7	19.9	7.1	7.3	10.2	5.6	18.5	8.0	6.3	11.8	5.7	5.0	6.8	2.6	7.6	14.8	3.2	7.9	4.8	14.6	7.5	8.0	6.8	2.8	3.1	3.5	3.7	5.2	18.2	5.1	4.4	17.0	3.8	7.0	2.5	9.4	3.4	6.1	8.9	19.4	2.2	15.9	3.3	3.0	2.7	3.3	4.2	3.6	3.6	5.4	4.4	4.4	4.9	5.5	6.1	4.7	0.9	5.1	3.0	3.4	6.5	2.8	4.2	4.6	5.7	5.2	4.7	4.1	3.4	3.9	3.6	3.8	4.7	5.5	7.8	28.9	13.3	18.6	26.9	6.9	5.7	3.9	7.4	14.4	8.0	7.4	23.2	10.0	8.0	5.5	27.1	5.6	17.0	9.7	9.8	4.0	22.1	8.6	14.7	8.8	11.5	8.8	32.9	4.2	3.3	8.5	9.7	6.8	6.3	18.8	6.4	7.6	17.1	13.5	30.4	7.0	6.1	21.5	19.8	16.5	9.9	26.4	14.2	15.9	13.8	11.0	20.6	24.1	21.5	3.6	3.7	8.2	28.9	3.5	6.7	5.5	9.8	28.1	0.0	7.5	7.7	25.5	13.1	9.2	6.0	2.9	17.3	30.7	8.6	2.5
SETSIP	SETP18	ENSG00000230667	"SET like protein"	P0DME0	1	92074533-92075441	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 1.4;Cardiomyocytes: 3.5;Early spermatids: 1.7;granulocytes: 3.8;NK-cells: 3.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA063683	Approved		Supported	"Nucleoplasm,Lipid droplets"		NA	NA						"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Lipid droplets"	"HPA063683: AB_2685088"	"unprognostic (2.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (7.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.88e-8)"	"unprognostic (3.43e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.35e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.6	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.7	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.1	3.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.6	0.3	0.0	0.0	0.1	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.1	0.7	0.0	0.0	0.5	0.4	0.0	0.0	0.9
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354986	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"HPA024105: AB_2671437, HPA057269: AB_2683389"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	13.7	9.5	6.2	19.9	8.8	16.8	13.9	9.8	6.3	13.2	7.7	13.1	10.6	12.7	11.1	10.6	10.9	12.7	10.5	5.1	7.8	11.9	16.7	15.4	27.4	8.7	7.0	13.0	9.2	18.3	6.0	14.3	9.6	13.0	12.8	13.2	9.0	12.7	12.9	12.3	13.2	12.8	8.0	27.6	12.9	31.9	7.7	25.4	33.0	12.8	26.3	15.7	8.5	13.2	15.1	19.9	22.5	24.4	28.3	34.1	13.5	19.6	21.9	15.6	14.6	21.1	16.8	25.6	9.4	36.9	38.3	30.2	22.8	17.0	17.0	24.6	9.9	26.9	22.7	18.4	26.5	41.8	31.2	24.0	26.2	26.6	23.6	19.1	25.4	17.8	31.7	20.0	18.3	21.8	25.9	15.8	24.2	25.4	15.4	24.2	32.6	17.2	17.1	19.5	14.0	21.4	32.4	14.2	18.2	29.7	19.7	21.2	29.3	32.5	14.0	22.1	19.0	12.2	22.0	38.6	14.9	16.3	17.8	10.5	4.4	4.7	5.3	4.1	5.6	5.5	3.9	4.1	3.3	6.9	4.2	3.7	15.1	5.2	4.9	5.0	3.2	2.3	6.2	8.8	9.8	6.3	5.1	7.8	8.7	7.0	9.6	8.0	7.7	13.2	76.2	60.9	45.7	75.1	85.6	30.2	34.6	26.6	38.7	31.2	24.1	22.7	61.3	17.2	43.9	20.2	29.2	13.7	96.8	37.6	3.9	20.0	7.6	62.7	68.0	58.7	14.5	25.5	73.7	14.7	10.6	52.9	44.4	89.7	58.2	38.3	51.4	33.0	28.8	67.3	64.8	30.6	16.2	73.1	37.6	13.8	30.7	75.5	12.4	131.2	75.8	20.7	87.6	65.9	113.0	23.2	31.9	36.1	61.8	49.3	25.6	18.5	54.4	28.7	13.1	44.9	42.5	145.2	38.5	35.1	33.5	9.4	65.9	53.7	26.9	46.4
SF1	"ZCCHC25, ZFM1, ZNF162"	ENSG00000168066	"Splicing factor 1"	Q15637	11	64764606-64778786	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018883	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA018883: AB_1856763"	"unprognostic (1.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (4.85e-5)"	"unprognostic (3.72e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.78e-1)"	111.7	89.1	47.2	73.1	47.9	230.4	100.8	70.8	73.7	106.8	39.7	112.6	62.3	110.5	46.3	98.2	118.7	53.8	93.0	44.2	64.4	97.9	100.4	85.0	95.8	51.5	40.2	142.4	103.3	52.0	97.7	53.4	42.2	105.7	42.5	46.3	87.4	58.4	149.2	96.3	110.5	63.4	27.7	133.6	104.5	110.2	53.3	91.2	99.6	73.3	80.4	98.4	92.3	57.9	141.2	165.4	151.1	131.0	82.4	65.5	178.8	98.9	83.6	130.3	100.3	142.0	154.8	223.6	120.2	111.4	119.4	163.8	172.2	171.0	110.3	167.1	115.0	144.6	107.6	107.0	130.7	155.0	143.7	86.0	87.1	165.2	172.3	77.0	118.9	145.0	216.4	141.5	100.8	145.1	294.2	217.9	206.5	126.2	117.5	253.2	104.7	177.7	87.5	151.8	119.6	157.4	138.1	118.8	138.3	95.6	182.7	163.6	104.6	145.1	131.7	134.5	158.2	163.6	139.4	205.6	129.1	132.2	180.2	3.4	9.7	10.7	12.9	10.8	12.9	9.3	9.6	12.7	9.6	7.3	11.2	11.9	13.7	9.2	9.7	10.9	10.5	9.4	47.2	47.9	70.8	73.7	44.2	64.4	51.5	40.2	42.2	27.7	53.3	57.9	131.9	60.9	88.7	82.3	326.5	184.2	205.1	121.4	350.0	267.2	158.4	127.8	63.5	107.2	87.2	55.2	225.2	118.6	194.5	133.6	37.2	80.4	156.9	156.6	180.5	134.3	209.8	115.7	60.6	73.8	116.8	126.1	138.6	170.1	107.8	212.6	164.2	120.7	98.2	175.0	52.1	115.6	109.9	137.2	167.6	67.1	157.5	122.0	96.0	72.1	146.4	121.9	166.9	62.4	141.0	88.3	106.3	113.2	188.1	192.8	118.5	56.0	83.1	325.8	78.9	145.3	132.0	116.8	84.3	246.9	183.8	148.7	250.2	249.6	129.6	194.3
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356919	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		87000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	36.2	29.7	14.1	45.4	19.0	58.0	35.0	19.2	20.5	33.4	12.6	31.2	29.8	36.3	20.5	34.0	31.8	21.3	28.0	15.3	12.7	25.5	27.5	31.0	44.1	16.6	14.8	46.4	32.9	42.8	24.3	29.0	14.1	29.4	27.0	36.4	33.3	28.1	51.1	40.5	32.8	29.9	13.3	42.0	31.8	49.2	15.9	42.6	31.6	25.8	41.4	33.2	32.8	20.7	86.2	58.9	79.4	77.6	46.4	41.3	94.8	66.5	42.7	71.4	52.8	78.8	55.9	106.4	44.6	47.7	55.9	80.4	101.6	70.8	77.7	97.4	88.4	99.3	69.1	65.3	41.8	202.1	106.3	41.7	49.6	89.5	72.4	40.1	52.1	56.6	112.5	108.0	52.8	49.1	99.4	46.2	132.0	65.7	48.4	139.5	99.4	86.8	40.9	93.6	82.2	74.9	84.4	50.8	78.4	52.5	62.3	65.4	72.9	90.2	80.0	65.1	124.4	83.2	108.2	106.9	69.4	73.8	95.0	6.7	8.9	14.1	10.9	9.8	11.2	10.4	11.0	11.8	9.2	11.0	12.0	11.2	14.1	11.0	13.0	5.6	14.5	8.0	14.1	19.0	19.2	20.5	15.3	12.7	16.6	14.8	14.1	13.3	15.9	20.7	32.4	57.7	66.5	12.1	60.8	26.1	25.4	19.0	37.0	17.6	25.7	24.4	27.6	34.3	30.5	31.3	16.7	32.5	49.2	30.8	17.6	25.7	106.1	30.5	23.1	32.6	25.1	36.1	7.5	29.4	39.7	29.1	35.2	29.1	52.6	76.3	28.2	28.4	40.6	26.9	9.4	30.7	16.2	37.2	28.3	116.8	35.1	39.8	17.8	5.6	58.5	27.1	46.4	6.0	7.1	28.8	31.3	37.6	45.5	26.4	31.8	17.0	39.4	20.3	46.0	29.0	27.3	64.3	41.6	37.8	27.3	34.6	55.8	26.7	33.9	25.8
SF3A2	"Prp11, PRPF11, SAP62, SF3a66"	ENSG00000104897	"Splicing factor 3a subunit 2"	Q15428	19	2236824-2248655	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042843, HPA049439"	Enhanced		Approved	Nucleoplasm		NA	NA		43000	"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA042843: AB_2678199, HPA049439: AB_2680766"	"unprognostic (5.29e-2)"	"prognostic favorable (7.16e-4)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (3.09e-3)"	"unprognostic (9.19e-2)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.73e-2)"	44.8	22.6	23.0	25.7	24.9	40.8	44.0	32.9	35.2	58.9	14.9	46.8	29.5	65.4	5.4	47.6	52.2	11.4	33.5	21.2	24.7	30.4	29.9	38.2	30.3	26.8	22.8	74.2	38.3	9.1	35.6	17.7	23.4	46.8	6.3	7.0	36.5	19.2	38.8	60.2	42.8	11.5	20.4	49.2	37.3	78.9	23.1	34.2	37.8	11.9	17.9	43.1	49.3	27.5	110.8	50.3	65.2	66.2	17.1	25.8	110.2	40.4	27.9	57.9	56.5	73.5	39.3	121.4	41.3	28.6	38.8	89.0	57.8	49.8	13.2	93.9	94.2	79.8	51.7	63.9	46.9	100.9	94.8	39.3	43.8	49.3	35.6	28.7	56.4	93.5	92.7	111.7	20.9	62.4	127.7	90.4	124.6	41.9	39.6	221.5	40.7	108.9	26.2	33.5	81.4	128.6	60.4	46.0	53.3	24.8	61.9	111.8	57.4	61.7	68.0	133.2	125.4	122.7	123.4	120.8	47.0	75.4	64.7	0.8	1.9	7.2	2.9	2.5	2.2	1.7	2.4	3.0	1.8	1.6	2.1	1.9	1.7	1.3	1.9	2.5	3.0	2.1	23.0	24.9	32.9	35.2	21.2	24.7	26.8	22.8	23.4	20.4	23.1	27.5	31.7	3.2	4.5	5.9	49.0	39.0	28.1	38.3	64.3	6.4	21.4	19.9	2.0	18.6	16.8	11.0	4.2	70.7	32.3	18.0	25.4	24.4	66.7	14.2	18.5	24.0	13.1	49.4	6.1	9.6	79.9	28.8	36.2	17.0	16.5	32.6	35.0	4.0	32.6	8.4	5.6	22.1	24.4	24.9	34.3	91.0	46.0	26.4	32.0	9.4	14.1	6.2	11.3	8.0	9.5	11.8	24.5	32.0	51.7	20.1	38.7	20.2	10.7	12.3	13.1	20.4	27.4	63.6	71.6	41.7	25.3	59.0	51.5	15.8	26.2	24.7
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990075	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA		57000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: AB_2674130"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	24.6	23.4	22.3	29.2	22.6	57.9	31.7	24.1	29.0	25.6	23.2	25.1	20.4	30.5	33.7	23.3	27.5	19.1	18.6	22.0	22.8	26.0	27.4	22.9	39.0	22.6	22.6	32.1	20.3	30.6	16.2	25.4	22.9	24.9	30.0	29.9	23.5	28.8	49.6	29.2	21.4	31.7	22.3	27.4	20.0	27.5	23.4	43.4	26.9	27.4	44.6	28.1	18.8	24.0	84.4	57.0	108.1	90.8	63.3	57.7	129.6	82.2	69.1	131.9	106.4	97.2	84.4	165.8	68.1	73.6	51.6	71.5	136.7	108.6	162.3	74.9	125.7	206.3	92.3	86.7	57.9	261.1	93.5	54.9	75.4	135.5	88.4	58.6	89.9	112.6	176.1	60.0	95.2	53.2	131.4	123.0	268.0	80.4	89.9	156.8	197.0	110.7	59.4	83.5	95.8	69.4	104.2	47.1	83.9	95.1	54.0	90.3	82.0	70.3	79.6	64.9	157.2	57.6	89.5	166.4	65.6	215.6	92.1	37.2	41.3	28.4	56.1	53.3	55.0	54.9	65.3	56.7	53.1	68.9	69.4	58.9	4.6	56.2	61.8	32.5	75.5	61.7	22.3	22.6	24.1	29.0	22.0	22.8	22.6	22.6	22.9	22.3	23.4	24.0	37.3	51.3	35.0	11.4	42.2	47.3	38.6	46.6	55.2	37.0	21.3	27.7	22.7	20.0	42.3	22.0	22.9	59.1	40.7	12.1	39.2	44.4	37.9	23.7	42.4	35.8	15.6	53.6	15.7	38.1	69.2	41.6	15.3	25.3	42.4	43.0	25.0	23.6	51.5	26.9	14.9	23.9	34.6	28.0	39.8	14.0	39.7	34.2	39.2	6.5	82.9	45.6	44.3	11.1	11.5	35.4	13.1	54.2	41.5	28.5	19.0	29.2	27.8	38.6	39.5	47.2	68.3	120.8	55.2	36.5	41.8	33.0	42.9	53.5	31.4	24.0
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523791-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA041134: AB_2677317, HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	15.7	11.2	7.9	19.2	8.2	22.2	13.8	15.9	9.6	16.3	11.4	17.1	13.6	17.0	10.2	19.9	16.4	11.6	12.1	8.8	9.7	12.5	12.3	11.7	24.3	7.0	6.9	22.3	13.8	16.8	7.9	14.1	7.5	11.6	13.2	16.3	12.6	10.7	23.6	19.9	12.9	16.0	6.5	13.9	13.2	10.2	10.4	23.7	14.5	11.7	26.6	14.2	14.4	12.0	72.4	72.6	93.4	65.3	45.5	41.6	74.0	66.3	55.5	84.5	67.3	75.6	55.8	97.1	52.6	51.8	49.9	81.4	98.0	55.7	133.0	31.5	71.1	75.1	56.7	81.0	30.6	106.1	83.9	39.8	40.1	93.9	68.8	54.1	50.9	55.3	104.6	34.2	67.4	87.5	92.9	51.6	85.2	44.8	41.9	163.2	73.3	109.7	26.9	96.4	81.4	59.8	217.7	33.8	33.8	39.2	73.9	53.0	52.7	61.9	67.8	49.2	71.6	37.4	90.4	260.7	40.9	66.9	61.3	23.4	26.1	28.1	35.8	30.8	39.3	28.4	33.1	37.5	35.3	34.3	38.8	33.7	8.3	35.5	31.2	19.1	40.2	37.4	7.9	8.2	15.9	9.6	8.8	9.7	7.0	6.9	7.5	6.5	10.4	12.0	18.9	25.6	25.7	16.6	33.0	22.4	23.2	23.4	13.1	35.5	20.5	18.3	29.3	14.3	25.4	23.9	14.6	33.6	21.6	19.7	7.9	20.7	6.3	17.8	31.9	25.4	21.1	36.8	23.2	23.2	34.7	24.2	20.4	17.5	17.7	52.3	17.5	23.6	23.6	40.4	26.5	21.8	24.4	20.6	12.8	10.3	33.8	19.2	17.8	24.4	22.7	19.4	25.7	26.2	26.7	24.9	14.0	33.1	25.1	30.2	18.1	15.7	18.8	26.7	6.6	30.2	18.8	28.7	33.3	37.6	26.1	25.4	28.3	48.2	31.6	24.7
SF3B5	"MGC3133, SF3b10, Ysf3"	ENSG00000169976	"Splicing factor 3b subunit 5"	Q9BWJ5	6	144094884-144095573	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054408	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054408: AB_2682479"	"unprognostic (1.22e-1)"	"unprognostic (7.12e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.49e-1)"	105.8	180.4	121.2	79.5	125.6	251.9	110.1	130.7	140.7	99.1	128.0	121.8	93.1	101.8	100.8	152.3	127.8	86.0	149.3	126.2	124.8	159.8	191.1	94.3	129.7	128.0	122.9	107.2	146.9	132.5	149.6	75.6	126.8	104.3	111.0	32.3	112.4	83.8	158.5	133.0	104.6	91.7	125.9	119.3	113.6	93.7	126.2	147.1	114.2	161.2	125.5	116.8	97.7	129.2	124.1	164.2	184.6	343.4	211.9	239.3	109.8	125.5	209.6	252.3	286.8	175.0	110.2	204.7	219.7	205.3	244.5	143.6	214.0	288.5	177.2	213.0	302.5	223.8	136.0	391.3	203.4	441.2	138.0	246.0	382.5	277.7	275.3	162.8	310.0	278.0	292.3	290.1	229.7	436.5	287.1	396.2	119.3	192.9	196.8	176.5	241.7	208.0	276.0	109.8	252.6	159.6	175.1	211.5	242.2	93.0	154.1	266.9	169.0	129.0	175.5	233.6	276.7	216.3	284.6	197.3	208.8	366.8	162.5	181.9	377.9	191.8	171.5	277.7	213.0	211.2	192.2	203.6	326.2	197.2	190.3	189.1	101.0	199.0	256.3	364.0	241.3	364.1	121.2	125.6	130.7	140.7	126.2	124.8	128.0	122.9	126.8	125.9	126.2	129.2	97.8	89.8	137.8	5.2	151.9	271.1	168.4	282.5	97.3	45.5	178.4	238.9	87.2	170.1	171.2	123.2	12.5	224.5	180.9	244.9	457.8	253.7	240.9	149.3	159.3	136.6	267.7	157.8	3.8	315.5	221.8	151.6	100.4	138.5	178.7	156.6	163.9	265.6	328.1	43.7	4.9	423.3	201.4	224.0	239.5	109.8	134.8	165.3	252.5	7.5	258.0	132.2	176.1	6.6	13.2	259.8	259.6	108.7	214.7	233.7	304.2	625.7	153.3	58.4	105.2	119.8	135.6	169.6	59.1	164.7	324.2	206.5	168.9	203.9	342.4	222.7
SF3B6	"CGI-110, Ht006, P14, SAP14a, SF3B14a"	ENSG00000115128	"Splicing factor 3b subunit 6"	Q9Y3B4	2	24067586-24076373	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034829, HPA034830"	Enhanced		Supported	Nucleoplasm		NA	NA		11000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA034829: AB_10673104, HPA034830: AB_10669680"	"unprognostic (6.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.35e-3)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.74e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-1)"	79.0	86.5	82.4	65.1	84.1	211.2	137.9	86.4	125.3	99.1	82.5	106.2	91.1	84.7	141.9	123.5	89.2	78.2	89.3	82.7	85.7	111.5	132.6	67.3	102.8	85.9	84.2	93.7	63.7	103.0	62.9	88.3	86.3	81.2	108.7	64.4	71.6	84.2	74.7	76.4	84.7	89.0	88.6	65.1	70.4	66.6	82.0	138.6	104.9	106.2	123.3	117.2	85.2	92.4	307.2	152.4	231.6	207.9	182.7	292.8	139.3	233.6	253.8	279.1	284.2	329.9	197.0	236.6	117.3	213.1	265.4	187.7	245.2	293.7	345.5	218.0	263.4	256.6	197.2	299.4	324.4	314.3	151.3	268.5	342.5	281.3	319.3	286.4	288.8	199.4	290.2	181.3	294.2	250.3	234.1	486.1	194.7	362.8	264.0	170.6	327.7	239.1	334.6	189.0	214.4	320.7	123.6	268.3	570.9	195.4	122.7	309.4	173.9	159.6	213.6	157.3	384.4	171.2	239.1	655.3	215.4	515.8	224.5	225.0	118.9	185.7	96.0	133.5	108.1	153.9	122.9	117.8	138.9	114.7	118.0	130.0	173.5	133.7	124.3	129.6	179.6	143.8	82.4	84.1	86.4	125.3	82.7	85.7	85.9	84.2	86.3	88.6	82.0	92.4	207.4	70.5	91.5	11.8	125.1	0.0	280.4	0.0	208.3	50.7	194.3	320.5	120.8	133.0	55.1	138.0	16.7	296.5	149.2	217.1	389.4	206.1	195.9	226.4	208.1	149.0	180.3	164.7	9.2	167.4	413.2	153.0	85.6	210.7	100.1	185.1	142.1	167.1	232.7	18.5	10.2	253.5	0.0	129.3	0.0	49.4	210.3	132.6	0.0	10.3	227.4	175.4	149.3	11.6	19.4	205.4	314.5	180.5	134.0	327.5	381.2	423.1	78.0	68.4	118.3	155.0	158.9	272.4	173.7	257.8	0.0	271.7	126.6	344.4	242.7	438.1
SFMBT1	"DKFZp434L243, RU1, SFMBT"	ENSG00000163935	"Scm like with four mbt domains 1"	Q9UHJ3	3	52903572-53046750	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 45.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 136.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036152, HPA064564"			Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA036152: AB_2674972, HPA064564: AB_2685288"	"unprognostic (2.78e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.39e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.57e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.55e-2)"	3.2	2.4	2.6	5.6	3.1	6.9	5.8	5.5	3.4	3.6	3.8	7.3	4.8	2.3	5.0	6.6	5.4	3.6	7.2	3.0	3.5	6.3	7.8	4.2	7.6	3.2	3.1	1.3	9.0	11.9	5.3	4.6	3.2	3.7	7.6	6.4	7.4	2.8	13.0	5.2	5.2	3.5	2.7	3.9	6.3	45.6	2.9	5.1	5.9	8.7	8.5	5.1	3.1	3.5	25.6	6.8	10.9	19.8	2.3	1.7	22.3	5.5	5.2	16.3	20.1	14.1	21.5	13.2	6.3	3.4	17.8	2.1	11.0	7.0	19.7	23.8	6.9	11.0	14.9	6.4	3.7	17.4	10.9	1.6	10.1	11.2	7.5	1.8	3.0	14.8	3.8	18.9	5.4	8.0	11.1	7.0	5.7	9.7	7.2	9.8	10.2	7.3	2.2	27.1	12.8	8.1	23.6	9.6	11.8	1.2	6.3	16.0	1.9	7.2	16.2	12.5	17.2	9.0	34.1	27.3	6.6	7.1	12.4	1.3	1.5	9.1	2.5	0.7	3.3	6.2	3.9	2.3	0.6	5.2	3.6	4.0	2.4	2.9	0.7	0.7	1.9	1.9	2.6	3.1	5.5	3.4	3.0	3.5	3.2	3.1	3.2	2.7	2.9	3.5	2.5	9.6	9.4	42.7	22.7	11.6	8.6	5.1	9.6	15.4	11.7	6.2	17.0	10.0	6.0	1.8	45.9	10.0	7.3	11.0	7.9	8.2	56.2	5.1	3.5	4.1	6.0	16.0	37.1	13.4	8.7	6.2	10.7	5.1	8.9	8.2	3.6	16.8	6.5	8.4	47.3	8.3	0.0	6.7	7.9	58.5	2.1	6.9	0.0	46.9	3.6	6.2	17.5	60.3	41.8	9.4	6.9	7.5	11.5	9.1	6.0	7.6	11.1	23.2	6.6	5.2	4.2	136.6	27.0	9.8	8.7	5.3	14.4	8.4	12.2	5.3
SFMBT2	KIAA1617	ENSG00000198879	"Scm like with four mbt domains 2"	Q5VUG0	10	7158624-7411486	"Predicted intracellular proteins"		Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 27.7"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 618.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.0;REH: 21.0;RPMI-8226: 20.2;SH-SY5Y: 16.6;THP-1: 25.0;U-937: 16.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035447, HPA035448, HPA070388"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear speckles"		"HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: "	"unprognostic (4.36e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.17e-3)"	"unprognostic (5.37e-3)"	"unprognostic (7.29e-2)"	3.8	4.1	13.0	5.9	13.1	6.6	5.5	10.2	9.8	3.4	5.1	2.8	2.0	4.0	3.7	1.1	4.0	3.5	4.0	7.5	17.6	3.0	1.3	4.7	7.3	20.4	15.0	9.1	1.3	5.7	6.4	3.4	17.1	6.6	3.2	18.0	2.3	3.1	4.2	1.7	4.0	3.3	12.7	9.0	3.1	1.8	27.7	4.5	6.8	2.6	5.8	4.1	4.2	19.0	0.0	4.0	0.3	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	1.1	7.6	0.0	0.0	0.0	1.9	7.6	0.0	0.0	0.4	7.9	0.0	13.0	0.0	0.7	8.0	1.1	1.1	0.4	0.0	0.3	0.0	0.1	10.0	11.5	23.0	0.0	3.5	7.0	14.3	1.6	0.0	0.0	21.0	2.2	20.2	0.0	0.8	2.0	16.6	0.0	0.1	0.0	2.1	1.3	25.0	0.0	0.0	2.6	0.4	0.2	10.1	13.3	0.0	1.1	16.5	0.3	0.1	0.2	1.1	0.7	2.3	0.4	0.0	0.2	0.5	0.4	0.0	1.0	0.6	0.1	0.9	4.6	3.1	0.0	0.2	13.0	13.1	10.2	9.8	7.5	17.6	20.4	15.0	17.1	12.7	27.7	19.0	8.2	0.0	5.2	148.2	10.2	1.5	1.5	0.0	1.2	8.1	9.3	8.6	9.7	1.5	0.6	0.0	81.3	7.7	22.1	0.1	0.0	0.4	0.2	0.8	15.8	10.1	4.2	6.1	77.3	0.2	2.5	4.2	2.0	3.5	4.5	7.1	5.7	1.1	15.5	0.0	103.9	0.0	0.0	15.7	9.9	0.8	5.0	26.3	5.4	618.3	11.4	12.4	15.5	26.2	113.7	0.1	0.0	2.2	25.8	11.4	0.0	0.3	0.7	34.1	0.0	4.4	2.6	0.3	3.9	0.2	1.3	4.4	25.8	2.5	0.2	0.6
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193145	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favorable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	62.9	46.7	25.1	62.1	26.0	215.1	53.2	38.5	32.3	54.0	23.4	46.9	44.6	60.2	51.0	59.8	54.6	39.9	43.8	24.8	30.7	48.8	50.6	40.8	76.4	30.2	27.2	74.4	52.8	44.9	34.4	51.8	25.2	49.8	54.4	47.4	52.8	35.6	63.9	60.0	47.6	52.9	23.0	54.1	48.0	45.8	24.9	85.5	44.8	27.4	94.5	58.1	52.5	44.6	180.5	147.3	251.1	142.9	60.5	90.0	234.7	96.1	97.1	160.4	116.3	161.5	126.4	325.6	130.1	111.8	100.6	160.4	276.1	188.3	217.0	175.2	183.0	245.5	156.2	193.6	81.5	258.2	140.1	72.4	71.7	139.4	67.3	70.9	142.3	169.1	282.6	150.9	158.3	156.8	304.2	220.1	299.7	107.8	140.7	304.5	170.4	213.6	156.2	214.4	180.1	200.3	138.6	106.3	147.1	174.4	125.0	181.7	152.3	127.7	188.3	84.7	208.9	171.2	156.5	327.6	91.1	168.6	185.9	2.6	4.1	3.0	4.7	5.8	5.4	4.1	4.6	3.8	3.8	4.5	4.3	4.8	2.1	3.4	4.7	7.3	5.6	2.3	25.1	26.0	38.5	32.3	24.8	30.7	30.2	27.2	25.2	23.0	24.9	44.6	286.7	169.9	237.7	149.8	317.4	357.5	239.3	80.6	234.5	230.0	231.6	191.0	149.6	82.9	146.2	110.3	191.8	206.5	339.0	149.7	82.2	120.1	126.8	230.1	318.9	222.2	219.6	198.9	127.3	138.4	222.9	255.8	267.6	333.1	155.8	450.5	123.5	109.1	141.4	171.6	143.4	189.5	59.0	129.4	216.9	361.9	142.9	258.5	140.5	104.9	146.2	152.6	127.7	248.8	183.1	162.0	126.7	116.6	291.8	159.9	94.8	87.6	114.8	223.6	52.6	530.6	259.2	199.1	171.9	287.9	327.3	305.5	313.7	223.7	220.0	167.7
SFSWAP	"SFRS8, SWAP"	ENSG00000061936	"Splicing factor SWAP"	Q12872	12	131711081-131799738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039362, HPA040063"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039362: AB_10794089, HPA040063: AB_10795413"	"unprognostic (1.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (7.50e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	26.9	18.3	18.5	10.1	20.8	28.1	26.3	18.5	24.8	27.1	13.7	25.9	10.1	24.6	4.0	23.2	24.5	4.8	20.2	18.2	19.0	24.9	19.4	20.3	11.3	20.4	19.3	29.0	21.9	7.4	21.7	8.1	19.8	21.8	4.3	9.3	20.2	6.8	29.5	32.6	24.6	5.6	16.9	28.4	20.8	16.3	21.2	12.6	24.5	6.7	7.6	22.3	24.3	25.1	26.1	23.0	16.0	17.0	12.6	10.3	35.8	19.7	13.6	22.9	15.6	22.6	12.3	31.9	18.0	14.8	11.9	23.9	22.7	18.1	13.2	9.9	36.0	29.0	12.9	27.0	13.4	37.8	27.4	11.7	20.4	20.8	24.9	18.2	14.3	24.3	40.9	12.3	10.4	32.7	31.9	57.1	41.9	14.0	38.0	36.7	16.2	25.2	13.3	18.8	25.1	28.3	18.7	15.6	25.1	12.5	22.5	29.1	18.6	19.0	24.8	14.8	22.3	35.0	41.2	31.7	18.7	25.5	25.9	2.0	4.1	1.9	3.0	2.7	3.0	2.1	2.8	2.6	2.9	3.7	3.0	3.4	5.6	5.4	3.4	7.2	2.4	1.8	18.5	20.8	18.5	24.8	18.2	19.0	20.4	19.3	19.8	16.9	21.2	25.1	46.4	73.7	44.5	48.6	37.9	38.9	41.5	19.0	42.1	49.7	25.4	25.9	19.3	21.5	38.6	14.7	66.7	30.4	52.6	22.1	0.0	23.1	21.4	27.0	48.8	39.3	21.6	38.7	55.1	26.6	31.8	39.2	37.8	39.7	38.0	47.1	21.4	16.7	22.1	42.1	43.2	24.9	14.2	27.4	21.4	12.9	30.1	30.3	23.2	36.5	35.4	33.7	50.4	58.3	85.1	28.6	24.1	29.7	43.6	44.7	20.8	11.8	30.7	62.4	46.0	52.1	38.1	39.5	42.8	39.7	46.9	43.6	45.9	48.4	22.9	48.2
SFT2D1	"C6orf83, MGC19825, pRGR1"	ENSG00000198818	"SFT2 domain containing 1"	Q8WV19	6	166319728-166342576	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014677	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA014677: AB_2238986"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (7.47e-4)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (4.20e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.75e-2)"	40.8	43.9	55.0	35.6	61.7	35.8	45.9	62.3	76.2	35.4	54.0	52.1	39.2	26.5	68.2	36.6	33.8	34.4	30.5	54.5	59.0	51.0	24.5	37.0	50.9	64.0	59.0	31.9	51.1	36.1	17.3	48.9	65.3	47.5	50.1	12.9	70.7	28.0	22.2	24.7	39.0	24.8	62.9	41.9	50.7	26.9	57.2	41.7	46.3	27.5	47.9	40.4	29.4	72.4	47.1	39.9	41.9	86.3	76.1	65.9	56.4	70.7	69.6	56.8	85.5	80.2	103.3	43.9	55.7	68.8	90.2	59.7	62.5	67.0	88.3	58.8	88.4	53.0	35.4	133.4	65.9	134.9	106.5	61.1	78.9	65.5	58.3	81.8	31.3	73.1	96.1	46.8	90.3	68.5	42.1	241.5	40.2	154.5	36.2	28.6	45.0	105.4	141.6	46.1	8.0	34.3	45.6	87.8	73.0	48.1	46.4	252.3	28.6	33.4	60.4	87.4	79.7	40.7	32.3	50.6	70.4	84.8	85.5	141.1	90.7	126.3	62.1	98.6	38.7	88.1	47.3	52.3	103.4	72.5	50.3	51.7	166.0	58.9	107.3	204.9	79.4	92.7	55.0	61.7	62.3	76.2	54.5	59.0	64.0	59.0	65.3	62.9	57.2	72.4	45.6	41.7	66.5	25.1	103.4	86.5	127.8	262.4	59.2	10.0	136.0	103.6	25.0	51.5	143.9	108.5	0.0	153.0	154.2	109.3	90.1	154.5	70.3	52.0	49.9	55.8	28.8	63.3	15.6	126.8	259.4	81.5	61.2	73.9	149.0	31.3	65.3	30.6	211.6	15.2	13.6	162.5	168.9	178.5	178.4	25.2	85.1	143.5	99.6	21.5	198.3	31.7	111.2	16.6	71.5	155.4	146.5	47.4	108.5	239.2	115.5	140.4	96.0	9.1	85.5	69.5	64.0	159.0	93.4	72.9	102.9	131.2	74.9	63.2	131.4	194.0
SFXN4	SLC56A4	ENSG00000183605	"Sideroflexin 4"	Q6P4A7	10	119140767-119165714	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018028, HPA020872"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA018028: AB_1856792, HPA020872: AB_1856793"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.70e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.07e-3)"	13.3	35.9	9.9	10.1	12.5	16.4	14.1	12.8	13.6	14.2	17.0	21.9	20.4	11.1	13.5	19.1	14.3	8.6	33.1	10.2	12.4	24.5	36.4	8.5	14.4	11.3	12.5	16.0	33.7	23.1	21.5	8.8	11.6	18.8	22.7	5.7	27.8	13.2	51.4	11.5	17.3	12.2	10.6	20.9	17.3	11.9	11.3	11.0	24.7	59.3	17.8	16.4	13.8	12.5	26.2	27.6	8.7	41.8	10.4	19.7	33.0	16.3	19.8	21.0	21.8	45.9	43.2	62.6	15.6	14.9	22.4	48.2	57.5	36.3	24.3	33.1	65.7	28.7	18.4	47.3	37.1	49.7	28.8	21.1	34.4	22.0	63.8	19.5	25.0	46.5	45.2	17.5	13.6	29.6	53.8	60.4	11.8	50.2	32.5	51.7	27.1	49.0	24.3	17.3	25.2	13.9	10.8	42.2	61.9	11.1	26.0	28.4	11.5	10.6	21.9	19.8	37.6	42.6	53.0	56.3	16.2	72.6	7.2	2.5	18.1	1.9	6.5	19.5	10.8	12.5	7.9	7.1	21.2	7.0	12.1	9.8	2.2	7.3	15.9	10.6	6.0	11.1	9.9	12.5	12.8	13.6	10.2	12.4	11.3	12.5	11.6	10.6	11.3	12.5	8.0	6.4	5.6	29.0	16.9	12.0	25.8	39.9	23.3	7.9	17.8	18.2	36.2	12.8	19.1	14.7	2.1	37.6	6.2	13.2	58.7	28.4	27.4	7.6	8.9	8.4	18.0	33.6	22.3	23.8	25.8	12.4	14.3	7.9	5.7	28.5	7.1	31.5	29.2	6.7	29.1	24.7	30.5	17.6	5.0	69.3	8.7	13.1	12.4	8.4	11.3	7.7	10.3	22.1	19.5	17.6	12.1	13.5	31.9	28.0	29.8	65.6	13.5	11.3	6.6	22.3	10.6	27.7	15.2	26.9	9.1	21.9	9.2	44.5	45.8	20.5
SFXN5	"BBG-TCC, SLC56A5"	ENSG00000144040	"Sideroflexin 5"	Q8TD22	2	72942036-73075619	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 405.2;Early spermatids: 96.4;Late spermatids: 168.4"	"Cancer enhanced"	"Detected in all"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015473, HPA056866"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Mitochondria"		"HPA015473: AB_1856794, HPA056866: AB_2683261"	"unprognostic (7.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.26e-6)"	"unprognostic (1.57e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-2)"	3.2	11.7	52.1	4.6	45.5	13.7	2.5	40.0	63.6	3.2	21.9	6.1	6.9	3.1	16.6	3.1	4.2	4.0	3.5	48.0	45.2	11.4	29.4	3.6	3.9	51.5	49.2	2.6	2.4	2.0	3.5	3.7	41.4	4.2	5.7	6.2	2.2	4.5	7.7	4.5	6.5	3.9	42.6	5.6	4.6	2.4	57.0	4.9	3.7	4.6	3.0	3.8	2.3	37.4	4.2	9.1	13.7	11.5	3.0	5.0	5.4	8.4	5.4	13.3	6.9	13.7	10.7	2.3	8.8	8.9	9.2	3.7	10.8	11.1	6.0	10.2	6.7	10.7	11.0	18.7	4.4	5.9	11.1	5.8	3.5	9.0	1.1	4.9	7.4	3.2	9.5	2.9	4.3	8.7	1.5	9.5	17.1	8.1	6.6	10.6	12.2	3.1	8.1	10.5	9.0	2.7	8.6	4.3	3.5	7.7	2.2	5.3	6.8	4.1	13.5	6.1	10.2	4.0	4.1	3.1	15.0	10.3	5.3	4.7	6.0	3.5	0.6	2.6	0.9	1.6	0.3	0.7	2.7	2.4	0.4	0.5	4.6	4.3	3.2	1.9	0.7	1.7	52.1	45.5	40.0	63.6	48.0	45.2	51.5	49.2	41.4	42.6	57.0	37.4	7.1	0.0	4.4	405.2	4.8	4.7	4.3	7.6	4.6	26.8	6.9	5.5	5.8	7.2	4.8	36.8	33.3	12.4	6.8	18.4	3.9	5.1	96.4	5.1	13.1	7.6	13.8	13.7	84.4	9.1	2.4	8.9	9.2	11.2	0.0	42.8	9.3	61.3	12.4	20.2	57.4	8.6	2.0	8.7	9.6	168.4	10.5	9.6	8.8	43.1	19.7	65.8	10.3	40.2	29.9	8.0	6.5	11.3	7.1	3.6	17.5	22.2	3.2	42.3	13.1	12.2	8.8	11.2	15.7	7.3	9.2	4.2	6.3	15.9	8.8	2.3
SGCE	DYT11	ENSG00000127990	"Sarcoglycan epsilon"	O43556	7	94524204-94656572	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 116.6;Oligodendrocyte precursor cells: 133.2;Oligodendrocytes: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 2.1;memory B-cell: 4.4;naive B-cell: 6.6"	"Group enriched"	"Detected in many"	4	"B-cells: 6.6;T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074790			Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane"		Yes	No		170000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA074790: AB_2686713"	"unprognostic (3.16e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.19e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	43.2	63.4	19.9	9.4	21.6	0.4	36.5	22.1	31.6	45.1	20.9	51.6	8.0	43.2	27.1	13.3	40.7	27.6	38.9	19.6	21.0	19.5	14.4	30.5	16.7	23.2	20.6	92.2	21.5	10.9	30.9	52.7	22.4	18.0	12.8	16.8	21.1	31.6	8.5	8.2	19.2	41.8	21.9	25.1	23.8	18.5	20.4	12.8	23.9	19.8	7.2	35.6	34.6	26.7	13.5	42.5	39.6	61.8	63.7	110.8	7.1	51.3	92.3	40.7	60.4	24.9	78.0	12.8	70.4	86.5	83.7	9.4	60.0	21.6	49.1	2.2	32.7	1.4	36.9	28.3	44.0	4.3	0.0	95.5	31.1	64.8	79.3	104.9	30.8	0.0	0.1	93.7	43.5	42.6	0.0	0.0	32.8	8.0	29.0	19.8	51.0	25.8	78.6	13.6	26.2	20.8	0.0	52.2	65.1	44.2	17.6	0.8	0.0	131.1	45.1	11.8	81.7	50.8	67.9	14.8	51.4	0.2	74.2	0.7	0.0	0.1	2.1	0.0	0.8	4.4	0.6	1.0	0.0	6.6	0.2	0.7	0.3	1.0	0.1	0.2	0.2	0.3	19.9	21.6	22.1	31.6	19.6	21.0	23.2	20.6	22.4	21.9	20.4	26.7	39.2	70.5	33.3	66.9	6.1	5.0	18.4	16.8	1.8	18.6	9.7	44.4	18.6	30.0	28.3	20.2	4.2	90.2	1.4	0.0	5.9	42.5	1.6	4.0	17.1	18.8	1.2	0.4	85.2	4.3	26.1	116.6	1.5	6.6	2.5	37.3	58.2	11.2	6.3	20.2	68.5	0.1	12.2	2.5	7.3	3.7	75.5	1.4	51.6	15.9	0.0	31.5	0.0	133.2	116.3	2.1	0.0	58.3	2.6	5.5	0.0	14.1	13.7	30.3	85.5	68.0	60.7	17.1	13.0	0.9	4.0	82.8	2.7	44.0	0.0	2.2
SGF29	"CCDC101, FLJ32446, TDRD29"	ENSG00000176476	"SAGA complex associated factor 29"	Q96ES7	16	28553915-28591790	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 222.2;Late spermatids: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052590, HPA053608"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoli	Nucleoplasm	"HPA052590: AB_2681875, HPA053608: AB_2682205"	"unprognostic (1.38e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.42e-3)"	16.8	16.1	13.6	11.2	15.6	12.4	16.5	16.7	14.6	26.8	13.8	28.0	12.8	29.1	9.5	12.0	27.6	9.1	15.3	13.4	14.9	11.1	19.9	14.0	16.9	15.2	14.4	33.3	25.6	10.7	10.3	7.1	15.4	16.4	7.2	7.8	16.6	16.7	51.1	16.0	18.8	12.0	14.9	16.2	19.8	43.0	14.6	14.1	17.6	19.8	10.2	23.5	16.4	16.8	13.1	21.3	16.3	10.5	10.6	10.9	29.5	8.5	9.6	21.7	20.2	24.6	11.5	39.1	21.1	6.7	13.2	15.0	12.4	15.4	6.1	12.8	24.0	24.3	12.9	33.7	27.1	22.1	26.1	11.5	20.0	13.1	13.2	11.7	8.3	24.5	20.8	19.4	7.9	43.4	25.5	43.2	22.7	9.6	20.5	38.9	10.6	34.2	11.3	19.5	26.3	12.2	13.3	25.3	15.0	5.8	20.7	18.4	5.9	15.4	12.9	9.2	15.3	22.4	35.7	22.7	10.9	36.9	12.5	20.6	47.0	50.0	53.6	41.8	65.2	57.9	74.2	65.8	47.6	65.9	84.1	66.3	13.4	55.1	33.7	71.4	78.3	58.7	13.6	15.6	16.7	14.6	13.4	14.9	15.2	14.4	15.4	14.9	14.6	16.8	11.2	16.0	16.7	0.0	20.0	0.0	18.1	0.0	32.5	5.5	12.5	21.1	0.0	12.8	7.4	18.4	14.6	17.3	27.1	7.9	9.8	12.6	222.2	8.5	10.1	8.7	3.6	17.1	0.0	12.9	11.8	12.7	10.2	7.7	6.3	16.9	11.0	17.3	14.2	0.0	0.0	8.8	0.0	12.9	0.0	384.4	30.7	13.5	0.0	0.0	17.1	11.8	22.6	0.0	0.0	10.1	15.7	21.8	16.7	9.5	40.1	23.7	6.6	14.1	19.7	18.3	13.0	10.5	30.9	17.0	0.0	21.1	21.0	14.8	11.9	12.0
SGK2		ENSG00000101049	"Serum/glucocorticoid regulated kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.5;kidney: 53.6;liver: 63.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 76.5;Distal tubular cells: 76.3;Hepatocytes: 32.8;Paneth cells: 21.7;Proximal enterocytes: 23.8;Proximal tubular cells: 25.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 20.5;CAPAN-2: 14.2;Hep G2: 18.7;OE19: 61.7;RPTEC TERT1: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA008859: AB_2668159, HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (5.65e-4)"	23.5	1.4	4.9	1.5	14.8	0.5	6.1	12.6	10.5	3.5	0.7	37.7	31.6	1.8	33.8	1.0	3.7	10.0	1.2	6.0	7.7	53.6	63.2	1.0	0.2	18.1	13.3	6.6	16.2	0.5	3.0	0.8	14.3	2.6	40.5	5.6	1.8	2.9	0.4	6.2	20.1	1.6	11.8	1.1	22.8	1.8	13.3	0.3	1.7	0.4	0.3	4.2	3.0	24.5	0.0	20.5	0.3	0.1	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.6	14.2	0.1	8.7	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.4	0.0	18.7	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.1	0.1	0.5	0.1	61.7	0.0	0.1	0.1	0.0	25.4	4.2	0.2	1.0	0.0	1.2	0.1	0.4	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	14.8	12.6	10.5	6.0	7.7	18.1	13.3	14.3	11.8	13.3	24.5	0.3	0.0	0.0	4.9	0.2	0.1	0.1	0.2	0.0	0.8	0.3	0.8	4.9	8.6	0.0	11.0	0.0	5.1	0.0	76.5	76.3	6.8	0.3	0.9	0.5	0.6	1.8	0.0	0.7	6.3	1.3	0.4	11.2	2.4	0.0	0.7	0.7	32.8	0.7	6.7	1.3	4.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	3.5	20.7	2.5	21.7	0.4	0.0	0.1	23.8	25.5	0.2	0.8	0.0	0.2	0.4	0.1	0.1	0.0	0.1	17.1	0.2	0.0	7.7	0.3
SGK3	"SGK2, SGKL"	ENSG00000104205	"Serum/glucocorticoid regulated kinase family member 3"	Q96BR1	8	66712734-66862022	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 49.0"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 56.0;monocytes: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 28.4"									"HPA006699, HPA027146"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	"prognostic favorable (5.52e-6)"	"prognostic favorable (8.28e-4)"	"unprognostic (8.52e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.95e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.29e-3)"	5.2	5.3	13.4	9.8	25.7	8.5	24.1	21.3	16.9	10.5	36.0	10.3	8.9	8.0	8.6	7.6	6.9	7.5	5.4	14.6	17.3	14.7	13.6	10.0	7.8	29.4	21.6	9.1	15.6	28.3	6.2	5.7	28.3	7.4	10.3	2.4	7.0	7.1	2.9	13.3	11.3	5.3	19.3	8.9	7.5	9.4	20.9	5.8	17.5	3.5	6.9	5.0	5.7	49.0	14.2	3.7	0.6	2.4	3.9	6.5	7.7	8.1	7.4	4.2	5.1	6.1	8.6	10.2	2.2	7.7	13.6	4.9	7.3	5.5	5.4	5.3	11.7	9.7	2.6	6.7	4.1	8.9	10.5	2.9	3.7	1.7	7.9	4.3	7.4	7.4	1.5	4.6	10.0	2.4	6.2	5.8	1.9	8.5	5.0	11.7	5.3	7.6	6.4	3.3	2.9	2.2	3.4	6.5	14.4	6.0	28.4	16.9	9.0	4.4	3.9	3.9	3.4	6.1	12.8	12.7	4.5	14.2	4.9	21.1	15.0	5.1	8.7	9.9	13.8	4.7	8.8	8.0	13.8	6.4	8.7	7.1	2.0	7.2	5.1	8.9	5.7	9.0	13.4	25.7	21.3	16.9	14.6	17.3	29.4	21.6	28.3	19.3	20.9	49.0	20.7	6.4	28.1	0.0	12.5	13.3	8.1	3.3	8.6	1.7	56.0	30.5	7.6	7.2	8.5	11.0	18.8	9.2	24.9	13.3	15.6	7.0	0.9	16.7	6.6	15.3	16.2	10.3	0.0	18.2	1.4	8.9	6.6	12.3	15.2	11.0	17.5	20.7	22.9	0.0	0.0	9.3	8.2	41.9	14.3	2.2	4.1	42.6	8.8	0.0	53.4	3.8	19.6	0.0	0.0	14.8	8.4	7.9	18.3	9.3	14.0	36.8	15.4	1.7	0.0	5.9	4.2	5.9	13.7	9.9	15.8	4.8	19.4	5.2	10.4	5.3
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"	Q86VZ5	10	50305586-50625163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.1;Microglial cells: 229.5;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 422.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	15.8	19.3	19.8	10.7	27.4	24.0	14.5	21.5	20.3	16.9	33.9	10.1	13.5	11.9	19.9	15.3	16.6	15.4	13.2	17.2	23.0	20.2	27.9	21.9	14.9	29.5	24.1	18.6	13.3	52.9	6.4	24.6	28.5	19.5	11.7	20.2	18.0	16.8	9.9	25.3	16.0	15.8	23.6	11.7	14.3	11.3	23.4	12.0	24.7	10.5	14.5	20.9	13.1	41.3	30.2	14.0	4.0	9.0	14.2	18.6	18.8	19.6	19.7	13.5	12.6	11.7	30.3	22.1	11.3	25.9	12.2	18.7	9.5	20.6	14.0	19.4	10.2	32.7	17.9	9.0	16.5	7.5	7.6	12.1	23.6	18.0	21.7	8.7	19.3	7.9	62.6	32.2	14.6	12.7	3.3	4.2	9.2	13.7	13.7	5.5	18.4	8.8	19.7	31.2	6.2	4.9	14.4	14.2	7.5	11.3	21.4	2.7	27.1	14.6	17.8	14.1	14.6	11.0	9.5	6.3	18.2	12.0	12.1	3.4	9.3	28.4	4.6	4.9	10.3	7.0	6.2	6.8	5.2	6.5	8.2	5.4	16.7	10.1	4.0	3.2	15.6	6.3	19.8	27.4	21.5	20.3	17.2	23.0	29.5	24.1	28.5	23.6	23.4	41.3	17.1	44.8	40.0	106.7	19.9	54.4	28.9	15.6	23.9	20.1	15.8	8.9	26.3	10.0	30.0	29.5	4.2	10.9	15.6	6.2	15.6	17.6	17.0	20.9	10.5	19.6	14.9	32.0	153.1	21.6	7.7	19.8	30.5	32.4	20.8	12.1	17.9	16.0	29.0	5.0	117.2	11.1	4.1	46.5	17.6	30.6	16.1	34.5	12.4	229.5	12.4	17.4	10.3	313.1	422.0	10.7	6.4	10.5	13.7	32.3	18.4	9.3	25.1	36.4	0.0	20.5	27.1	12.8	2.3	18.7	83.4	4.9	20.0	11.8	12.4	25.4
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.3	0.1	0.3	3.3	0.7	8.7	0.5	0.9	0.5	0.4	0.0	2.1	2.3	0.4	0.0	1.9	0.1	0.4	0.1	0.3	0.4	0.3	0.6	0.3	6.2	0.8	0.6	0.2	0.1	0.2	0.0	1.7	0.6	0.2	2.8	0.1	0.4	0.1	0.1	1.1	2.5	1.0	0.3	1.4	1.5	6.7	0.6	13.0	0.2	0.0	6.6	0.9	0.7	1.2	20.3	23.9	29.9	18.5	1.4	2.6	20.2	21.3	10.1	31.2	33.6	16.5	24.0	30.7	10.6	8.6	21.2	11.4	28.7	11.3	37.6	40.9	19.6	34.6	15.6	12.8	0.2	32.0	28.8	0.3	0.9	33.3	13.1	4.0	18.5	34.9	31.3	52.2	24.6	19.4	52.4	15.4	30.0	20.3	17.0	31.8	38.4	17.7	7.5	14.9	14.2	15.4	23.6	27.2	13.1	22.7	18.2	21.3	4.7	22.5	27.3	20.5	43.3	22.8	57.4	35.2	12.5	31.1	35.0	10.0	0.1	1.4	0.2	0.2	0.1	8.8	0.6	0.7	0.3	8.9	0.2	0.3	1.4	0.3	0.2	4.1	2.6	0.6	0.3	0.7	0.9	0.5	0.3	0.4	0.8	0.6	0.6	0.3	0.6	1.2	0.1	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.4	0.0	0.0	0.0	1.8	0.0	16.5	1.5	0.0	0.0	1.1	0.0	2.3	1.6	1.2	0.0	0.0	0.0	1.8	42.6	3.3	0.0	2.9	1.3	20.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.9	1.0	4.3	0.0	0.0
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200584096	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.9;testis: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.6;Endometrial ciliated cells: 12.1;Extravillous trophoblasts: 31.0;granulocytes: 11.4;Granulosa cells: 23.4;Hofbauer cells: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.7"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA035163: AB_10602397, HPA040817: AB_2677149"	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	3.3	0.9	0.6	4.4	0.9	6.8	1.9	0.8	0.9	0.9	0.3	3.1	2.5	1.8	0.7	2.4	1.4	1.2	1.0	0.5	0.9	0.9	0.8	1.5	7.9	0.9	0.9	1.9	0.5	1.1	0.3	2.6	0.9	1.4	3.2	0.9	0.7	0.7	0.4	2.3	2.6	2.0	0.7	2.0	1.8	32.6	0.9	14.9	1.2	0.6	8.1	1.5	0.9	1.2	34.6	16.2	37.0	17.4	5.2	7.9	23.7	38.7	16.6	32.0	33.1	24.3	23.5	22.5	18.6	18.1	34.4	25.3	33.6	20.1	54.5	48.0	16.9	43.5	21.6	17.5	1.6	43.9	33.1	3.4	2.5	32.9	17.3	8.0	29.4	31.3	33.1	31.6	61.4	15.4	35.9	17.9	26.7	24.9	41.2	28.8	49.1	21.3	13.3	13.6	22.2	15.4	28.6	13.3	16.3	29.2	14.1	25.2	18.1	33.9	34.0	31.6	34.0	14.3	33.5	49.8	21.4	28.9	49.4	16.7	1.4	4.5	2.2	1.4	1.4	2.7	2.4	2.2	0.8	3.2	1.8	2.2	1.0	2.0	1.7	1.7	3.6	1.2	0.6	0.9	0.8	0.9	0.5	0.9	0.9	0.9	0.9	0.7	0.9	1.2	9.4	3.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.8	7.1	0.0	0.0	6.2	0.0	0.0	11.6	7.8	0.0	3.9	3.9	0.0	12.1	5.3	3.3	0.0	0.0	0.0	2.7	31.0	6.7	0.0	3.6	11.4	23.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.0	1.7	0.0	0.0	2.5	8.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.4	3.8	4.0	0.0	0.0
SGPP1		ENSG00000126821	"Sphingosine-1-phosphate phosphatase 1"	Q9BX95	14	63684216-63728065	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 61.8;Oligodendrocytes: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.8;U-698: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053149, HPA064908"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA053149: AB_2682057, HPA064908: AB_2797270"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-3)"	7.9	10.6	5.3	6.0	6.0	3.0	6.4	5.8	7.9	6.4	3.6	7.0	3.8	7.4	6.2	4.9	5.7	5.5	4.9	5.3	5.9	15.9	19.5	6.9	13.3	6.6	6.2	5.8	12.7	10.2	5.6	12.0	6.6	7.4	5.3	4.1	4.8	4.0	4.2	3.8	8.8	4.8	7.3	9.3	5.5	5.4	5.8	5.8	5.8	2.6	12.9	5.8	6.8	8.0	19.7	6.2	3.0	8.6	10.7	9.9	35.9	15.7	10.9	9.6	10.7	2.7	10.9	43.8	4.5	8.0	8.0	20.3	4.8	9.3	15.3	17.3	5.7	4.0	3.4	4.4	13.1	7.3	12.2	7.3	14.7	8.4	13.2	9.7	4.6	8.2	2.3	1.2	14.1	7.3	8.6	0.1	2.1	3.2	13.1	2.1	8.4	3.5	15.2	9.7	1.8	5.0	11.0	10.2	8.4	9.2	13.3	2.6	5.2	13.2	9.1	9.5	7.9	10.1	6.5	57.4	9.7	0.0	5.8	6.9	0.2	1.7	0.5	1.4	0.5	1.8	0.5	0.3	0.3	0.4	0.8	0.6	0.2	0.3	2.1	0.1	1.3	0.3	5.3	6.0	5.8	7.9	5.3	5.9	6.6	6.2	6.6	7.3	5.8	8.0	5.3	12.8	16.2	22.2	22.6	9.7	6.1	4.1	8.0	4.0	9.4	5.2	3.8	24.3	3.2	51.5	0.0	23.4	10.9	11.9	0.0	6.0	2.4	6.3	12.1	6.5	18.6	9.7	32.6	9.1	27.0	12.8	3.1	10.1	11.4	5.0	6.1	43.6	23.7	10.1	38.5	10.2	2.0	61.8	20.1	1.2	6.2	18.6	17.8	21.5	6.8	8.2	2.1	31.7	60.0	13.2	13.5	17.0	5.7	8.1	3.2	22.7	2.6	5.4	6.6	8.1	11.3	7.4	3.5	4.6	13.5	33.0	10.4	10.3	10.3	5.6
SGSM2	"KIAA0397, RUTBC1"	ENSG00000141258	"Small G protein signaling modulator 2"	O43147	17	2337498-2381058	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 7.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021641, HPA024553"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA021641: AB_2188702, HPA024553: AB_1856512"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.84e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (9.00e-6)"	"unprognostic (2.78e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-2)"	22.2	30.2	84.3	20.2	83.0	28.4	31.0	52.5	102.7	32.1	53.8	37.0	15.5	26.3	51.7	36.0	27.4	21.2	27.1	83.0	81.3	36.5	19.3	28.2	24.3	64.0	67.5	28.9	27.9	27.4	80.7	15.8	62.6	53.7	10.1	15.7	41.9	21.6	21.6	33.3	32.6	17.9	58.4	37.6	33.6	30.0	76.9	17.5	41.4	13.9	14.1	31.8	28.7	68.4	20.7	31.1	27.9	39.0	15.5	18.6	41.4	17.4	20.4	23.6	23.9	31.2	38.6	9.9	18.5	25.3	8.7	28.4	17.2	20.6	8.2	14.5	35.3	17.2	55.6	33.8	13.3	10.4	25.0	20.1	13.4	24.1	13.7	34.1	24.9	26.4	10.5	14.4	14.3	43.5	22.4	14.0	13.7	14.7	13.5	48.5	14.2	8.0	30.5	42.5	13.5	31.9	21.7	16.2	13.4	17.1	41.9	12.3	29.3	18.9	21.5	28.1	23.4	11.8	1.9	9.5	16.4	13.6	17.0	7.0	0.3	1.3	0.9	0.1	0.8	0.1	0.3	0.5	0.4	0.3	1.1	0.6	0.1	0.9	0.0	0.5	0.6	0.4	84.3	83.0	52.5	102.7	83.0	81.3	64.0	67.5	62.6	58.4	76.9	68.4	9.4	6.4	24.7	52.9	5.4	6.8	8.3	13.8	5.7	59.6	31.9	24.0	15.6	11.5	23.5	12.9	135.5	13.8	9.3	7.1	0.0	6.7	18.2	9.9	11.0	11.8	13.8	5.7	39.7	4.5	8.8	10.0	14.3	14.7	20.3	18.1	14.3	8.3	7.8	30.3	38.2	9.9	16.2	7.6	9.9	38.1	8.1	9.2	5.4	16.9	6.3	11.9	7.2	22.6	10.3	6.4	4.5	12.0	4.6	15.0	7.0	4.0	16.5	51.2	19.7	9.6	11.0	4.1	6.7	11.9	7.7	14.1	11.6	15.2	8.2	13.5
SGTA	SGT	ENSG00000104969	"Small glutamine rich tetratricopeptide repeat containing alpha"	O43765	19	2754715-2783362	"Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056309	Approved		Approved	Nucleoplasm		NA	NA		81000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA056309: AB_2683096"	"unprognostic (2.31e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.99e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.58e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.04e-1)"	38.4	46.4	60.2	16.8	61.7	29.0	39.8	61.4	76.0	40.8	45.4	53.4	27.3	44.2	18.6	53.3	42.0	13.8	91.0	60.1	57.6	54.7	72.3	37.5	19.9	64.9	62.9	52.8	57.8	22.1	56.5	22.0	60.4	51.1	9.3	17.2	36.2	18.6	110.8	40.2	37.6	14.9	61.7	49.2	47.7	54.1	61.3	31.6	47.9	43.4	13.2	43.7	38.1	66.5	67.9	58.8	57.4	56.5	21.7	23.9	45.9	46.8	35.7	71.3	60.8	95.4	31.4	61.5	37.7	39.4	44.4	53.3	70.2	79.5	24.6	0.0	59.3	37.8	25.0	81.8	56.0	49.0	46.5	39.1	39.2	58.5	45.6	27.5	51.5	60.5	95.6	57.6	38.3	46.4	87.8	70.8	98.2	51.6	57.3	113.8	43.7	80.8	48.0	43.0	104.2	85.6	31.6	61.0	73.4	21.5	66.8	76.0	41.0	50.7	53.2	91.3	86.8	101.1	88.1	82.6	65.6	122.2	81.1	17.3	21.4	20.9	17.4	28.1	20.4	15.4	19.0	19.1	23.6	13.9	14.4	14.4	20.7	21.2	27.8	20.5	25.4	21.8	60.2	61.7	61.4	76.0	60.1	57.6	64.9	62.9	60.4	61.7	61.3	66.5	31.6	9.6	15.7	15.3	26.3	23.7	24.0	21.2	17.1	42.3	32.5	30.4	46.8	12.8	14.9	18.4	25.0	52.2	19.3	54.1	35.2	40.0	65.4	26.1	21.9	26.9	32.2	16.6	9.8	45.1	56.5	25.8	30.5	31.0	28.5	34.4	17.5	24.8	37.4	38.7	9.6	36.3	26.4	22.0	23.6	49.8	22.1	26.2	19.6	4.7	30.3	42.9	17.5	10.6	34.2	40.5	38.2	27.4	24.9	27.4	36.1	27.5	10.6	48.8	13.1	26.6	25.9	39.3	21.6	23.2	24.6	92.8	19.9	31.5	46.2	29.7
SGTB	"FLJ39002, Sgt2"	ENSG00000197860	"Small glutamine rich tetratricopeptide repeat containing beta"	Q96EQ0	5	65665928-65723035	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.5;Horizontal cells: 70.7;Langerhans cells: 40.0;Muller glia cells: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"granulocytes: 10.0;monocytes: 6.7;T-cells: 13.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044689, HPA063674"	Enhanced		Uncertain	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 58: Brain - Synaptic function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA044689: AB_10960838, HPA063674: AB_2685084"	"unprognostic (9.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.92e-5)"	"unprognostic (4.27e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.05e-3)"	4.4	2.6	5.9	7.5	9.0	10.0	2.5	3.0	18.0	3.0	0.0	2.7	1.4	4.7	2.0	2.9	2.4	3.0	4.2	10.4	6.1	2.5	2.5	3.9	7.0	6.8	5.0	2.9	1.8	2.6	3.1	3.7	6.8	4.8	2.5	16.4	1.7	2.1	2.7	2.0	2.1	5.4	1.8	4.7	1.8	1.9	5.3	4.1	4.2	4.6	4.9	3.9	2.3	8.0	7.6	4.8	9.0	9.2	13.3	17.3	8.9	31.4	9.7	10.3	14.0	6.5	3.2	10.3	16.5	24.5	18.1	7.6	12.9	11.9	16.7	7.7	12.7	4.6	13.0	13.2	34.3	3.4	7.3	13.0	10.3	22.3	29.3	7.2	10.0	8.0	7.9	6.9	16.3	2.8	7.5	5.4	6.0	0.6	2.5	8.7	15.7	10.7	4.6	2.8	14.1	7.5	12.9	2.2	14.8	8.9	3.1	5.0	15.2	13.5	14.5	14.5	7.0	5.4	8.8	13.9	6.9	9.7	5.4	10.0	5.5	1.4	2.6	6.7	2.5	1.4	6.3	3.6	2.3	1.2	6.7	3.9	5.9	1.0	5.7	0.5	13.6	3.1	5.9	9.0	3.0	18.0	10.4	6.1	6.8	5.0	6.8	1.8	5.3	8.0	11.3	16.0	5.5	10.4	7.4	6.4	3.3	2.7	4.6	8.8	2.0	2.8	4.3	2.8	4.1	1.8	0.0	1.5	8.5	0.4	0.0	3.5	2.0	2.7	8.0	8.5	1.8	7.0	43.5	2.0	5.1	9.7	3.6	5.8	21.0	4.4	3.3	3.9	23.5	70.7	38.0	1.4	2.0	19.9	40.0	1.7	4.1	18.5	12.4	3.7	27.3	67.5	4.1	10.6	16.3	4.9	1.7	4.1	9.9	3.7	0.1	2.9	1.9	5.2	13.1	18.5	10.4	4.4	5.3	3.4	4.5	1.2	24.0	2.4	0.4	1.8
SH2B1	"FLJ30542, SH2B"	ENSG00000178188	"SH2B adaptor protein 1"	Q9NRF2	16	28846600-28874212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060663, HPA076175"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA060663: , HPA076175: AB_2686782"	"unprognostic (3.60e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.27e-3)"	"unprognostic (6.10e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.38e-4)"	"unprognostic (1.39e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.60e-4)"	36.7	57.4	53.8	32.8	54.8	38.6	39.5	58.6	75.2	58.5	42.8	59.7	46.4	54.9	20.9	39.4	54.3	30.0	52.9	53.6	47.0	62.1	44.6	35.6	39.2	49.0	47.8	69.4	53.4	55.2	70.1	20.9	48.8	57.7	28.5	29.1	49.2	36.8	58.2	40.6	57.1	24.8	38.1	63.4	51.9	48.8	51.4	36.5	71.6	50.6	25.2	47.1	44.9	58.4	29.9	43.2	32.3	41.7	33.3	28.2	26.9	30.4	17.1	23.4	25.3	29.0	49.2	27.4	41.7	24.5	20.2	46.4	21.3	33.9	13.2	35.9	27.6	24.4	111.3	45.0	25.2	24.8	22.4	39.4	27.2	32.9	13.3	40.0	27.4	27.8	39.8	39.1	31.3	40.3	37.2	36.4	41.9	15.6	17.3	62.3	19.4	46.1	27.2	22.2	36.9	49.7	14.7	42.4	22.3	19.1	33.4	26.5	38.8	26.9	22.5	23.8	23.6	74.0	40.2	30.9	41.8	43.0	27.5	3.3	1.4	0.6	2.0	1.1	1.9	1.6	1.6	1.4	1.1	1.7	1.2	1.1	2.1	0.6	1.1	1.9	1.8	0.9	53.8	54.8	58.6	75.2	53.6	47.0	49.0	47.8	48.8	38.1	51.4	58.4	14.1	6.4	13.7	37.5	13.9	10.8	15.9	15.4	22.8	26.7	17.4	13.8	18.4	17.2	15.7	22.0	33.3	16.6	12.8	31.1	15.6	9.5	2.2	11.0	11.0	12.7	27.6	7.8	25.6	12.9	8.2	15.0	19.4	11.4	6.3	20.1	13.9	8.9	12.2	28.6	26.8	24.7	14.2	8.7	7.2	5.4	22.1	10.8	3.6	13.1	10.7	18.1	22.6	21.6	19.0	12.8	24.9	23.7	10.5	10.4	26.3	10.2	12.5	28.9	26.3	12.9	15.7	9.9	12.8	17.4	11.1	13.7	15.3	20.4	28.4	12.3
SH2B3	"IDDM20, LNK"	ENSG00000111252	"SH2B adaptor protein 3"	Q9UQQ2	12	111405923-111451623	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.7"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 113.6;Langerhans cells: 130.9;Macrophages: 84.1;monocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 122.2;hTEC/SVTERT24-B: 140.7;U-87 MG: 211.6;WM-115: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005483	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA005483: AB_1079260"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.65e-2)"	"unprognostic (8.17e-3)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (2.86e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.24e-2)"	22.2	10.9	10.2	21.9	6.8	60.7	13.3	3.5	9.3	8.6	8.5	11.4	8.1	8.5	3.3	7.7	8.1	18.6	23.4	5.8	6.5	14.3	17.4	20.5	21.0	12.0	7.3	5.5	10.2	5.8	8.0	24.4	10.0	7.3	13.5	3.7	5.3	5.9	9.6	4.1	12.5	13.6	10.1	37.1	7.1	9.5	12.1	10.5	11.1	9.5	15.8	15.7	6.0	14.7	9.2	5.5	7.0	7.3	23.9	35.5	4.8	29.2	79.5	21.9	23.3	8.4	5.2	15.6	20.3	44.6	73.6	1.7	5.5	16.9	35.2	13.3	2.7	53.2	2.6	6.2	23.3	23.5	122.2	21.2	3.8	140.7	12.7	48.4	119.1	12.8	38.9	6.1	80.2	3.2	9.7	46.7	11.0	2.4	21.0	9.5	15.9	10.2	10.5	3.7	4.6	4.9	5.4	0.6	42.2	6.2	3.5	33.4	93.0	20.0	11.3	17.4	48.1	13.9	15.8	17.6	211.6	16.6	165.3	0.9	3.5	1.2	1.2	8.4	1.0	1.5	1.1	1.3	4.8	0.5	0.7	1.0	3.0	1.8	6.6	4.9	0.4	1.8	10.2	6.8	3.5	9.3	5.8	6.5	12.0	7.3	10.0	10.1	12.1	14.7	26.8	3.2	22.0	2.6	26.2	6.8	1.5	4.2	1.2	4.6	4.3	3.8	17.5	4.3	4.3	1.8	2.1	0.4	40.6	15.0	1.9	3.6	13.1	1.0	2.2	39.2	3.5	11.2	11.0	9.0	1.4	8.1	0.5	1.2	38.6	0.8	46.1	11.1	40.4	3.3	7.3	3.0	6.1	113.6	130.9	5.3	2.8	84.1	16.0	38.4	67.1	1.1	18.6	11.1	9.0	7.2	5.9	4.1	4.9	3.0	0.8	1.5	3.5	3.4	0.0	4.0	12.7	12.5	4.5	0.7	4.1	1.0	12.1	4.4	3.2	1.2
SH2D3A	NSP1	ENSG00000125731	"SH2 domain containing 3A"	Q9BRG2	19	6752160-6767463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 117.9;Pancreatic endocrine cells: 81.3;Urothelial cells: 87.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 43.2;HaCaT: 34.2;HBEC3-KT: 67.4"					"Not detected"	"Not detected"			"HPA035722, HPA064382"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA035722: AB_10670024, HPA064382: AB_2685251"	"unprognostic (3.32e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.63e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.21e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (7.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.81e-3)"	0.9	0.4	0.2	4.6	0.2	3.4	7.5	0.1	0.6	8.0	0.5	12.8	14.3	1.2	1.0	32.5	4.3	3.5	0.6	0.1	0.1	19.6	2.6	10.8	5.2	0.4	0.2	0.8	19.7	5.9	2.8	5.9	0.2	18.1	5.4	0.9	18.7	4.1	1.5	27.6	14.4	0.3	0.2	5.7	14.2	4.4	0.3	3.3	13.0	0.0	4.1	9.1	17.0	0.5	43.2	6.2	0.1	0.2	0.0	0.0	22.6	0.3	0.0	0.0	0.0	20.3	30.8	6.6	19.6	0.0	0.0	34.2	2.3	67.4	0.0	3.6	6.6	0.3	6.9	2.6	0.1	0.6	8.6	0.0	30.3	0.0	5.9	0.8	0.0	14.8	7.3	14.3	0.0	15.3	3.2	0.2	1.6	21.5	12.0	1.2	0.1	24.8	11.5	31.4	0.0	0.2	2.3	31.7	0.1	1.0	22.0	0.4	0.7	0.7	2.2	0.5	0.4	14.1	15.8	9.2	0.2	4.8	0.3	0.1	0.0	0.0	2.6	0.1	4.2	3.6	5.9	5.2	0.1	5.6	7.7	4.2	0.1	1.8	0.1	0.4	3.2	0.9	0.2	0.2	0.1	0.6	0.1	0.1	0.4	0.2	0.2	0.2	0.3	0.5	0.7	19.2	14.2	0.3	25.8	30.7	117.9	51.4	25.0	4.1	13.6	11.4	1.9	40.0	43.9	40.5	10.4	23.8	7.7	46.6	1.9	54.1	1.6	15.4	2.9	2.8	12.1	7.8	0.1	37.1	52.8	2.6	50.0	24.9	5.7	0.3	1.8	2.9	3.6	0.0	0.2	37.9	28.5	0.6	10.3	0.8	0.6	2.2	3.6	0.0	4.2	0.8	14.4	0.0	0.1	81.3	69.7	0.0	8.0	58.6	53.9	13.1	27.0	4.6	0.0	2.2	3.5	8.7	11.4	17.6	39.9	10.8	18.0	1.1	32.0	87.9
SH2D7	LOC646892	ENSG00000183476	"SH2 domain containing 7"	A6NKC9	15	78077808-78104909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	7	"intestine: 2.1;testis: 3.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 21.1;Late spermatids: 35.1"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA051320, HPA058382, HPA076728"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA051320: AB_2681439, HPA058382: , HPA076728: "	"unprognostic (1.22e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	1.6	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.1	1.7	0.1	0.2	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.7	1.3	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	21.1	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	3.0	0.0	0.0	0.4	0.0
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631329-79703655	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 161.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.3;Excitatory neurons: 86.5;Intestinal goblet cells: 87.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 50.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 81.6;HEL: 41.8;OE19: 99.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA047486: AB_2680065"	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	26.4	6.9	18.8	7.5	18.6	1.7	21.6	15.6	27.5	22.3	15.1	50.5	35.2	9.9	24.7	55.1	17.8	23.2	6.8	21.4	21.8	15.7	53.1	12.7	5.5	26.7	22.0	4.1	23.3	31.5	16.6	24.0	28.1	26.2	47.9	26.0	161.7	11.4	4.8	11.3	35.6	15.8	24.1	6.6	68.9	2.1	24.2	4.8	59.1	10.1	10.7	12.7	19.7	22.5	8.5	1.5	7.6	1.6	6.7	5.6	18.0	0.5	5.6	1.9	4.0	81.6	16.3	0.1	11.4	0.5	1.6	3.9	7.0	9.2	6.7	0.0	10.2	41.8	1.8	15.8	2.8	1.7	1.1	3.1	7.3	5.8	3.3	2.7	23.8	0.0	16.8	0.0	0.7	1.3	0.0	0.2	6.5	99.7	2.8	0.0	2.2	0.2	2.0	27.3	20.3	22.3	0.5	2.4	0.6	10.3	0.4	3.5	13.6	5.2	3.4	0.1	4.9	12.0	6.0	0.0	0.9	0.0	1.6	11.1	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.0	2.2	0.0	0.0	0.1	0.0	8.8	18.8	18.6	15.6	27.5	21.4	21.8	26.7	22.0	28.1	24.1	24.2	22.5	83.2	6.4	24.8	20.9	0.9	2.2	4.6	3.3	2.2	13.5	14.8	9.9	6.1	52.9	21.4	22.0	8.4	40.4	1.7	156.3	0.0	14.8	18.1	14.3	3.7	33.8	12.6	7.4	86.5	13.0	3.7	4.6	81.1	21.0	0.0	2.0	44.6	69.6	4.1	13.5	38.1	87.8	4.1	2.9	2.1	20.3	0.6	21.6	16.0	11.2	4.6	8.6	0.0	33.7	24.9	15.0	76.0	4.5	1.3	19.7	48.7	11.3	24.6	12.2	0.0	3.7	4.7	2.5	1.2	21.5	0.9	52.7	1.0	1.8	67.2	29.9
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254353-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 200.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.9;Early spermatids: 192.2;Extravillous trophoblasts: 356.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 349.3;MCF7: 118.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: AB_2683572"	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	78.3	200.5	21.2	35.2	22.7	72.6	72.0	38.4	26.1	71.1	16.0	27.4	15.7	77.5	13.5	26.9	85.6	45.7	24.1	23.3	21.0	52.8	17.3	73.2	59.9	21.4	20.0	116.2	15.9	47.9	35.7	40.8	22.4	25.0	8.4	27.4	49.9	34.1	71.7	25.6	27.0	37.3	20.8	30.9	16.1	30.9	20.9	37.4	51.1	19.1	35.7	33.0	50.6	35.1	27.4	16.5	6.4	14.1	53.1	46.8	349.3	13.6	10.9	9.3	10.4	10.8	13.4	21.3	6.2	40.8	16.1	3.6	2.9	14.2	5.9	19.5	12.8	15.7	72.3	1.9	21.9	4.4	8.6	36.9	9.3	41.6	7.9	34.2	116.0	31.3	18.4	8.5	10.3	118.1	57.6	23.2	13.6	3.5	20.6	1.1	27.2	115.6	8.8	53.5	16.8	7.8	18.6	19.2	21.7	21.6	18.1	10.9	84.3	22.8	29.5	21.9	12.0	3.3	7.6	15.2	44.7	16.3	31.5	8.1	7.8	9.1	52.9	2.5	15.9	19.1	24.1	36.1	8.9	24.3	12.9	16.6	13.9	25.4	4.6	3.9	11.1	20.4	21.2	22.7	38.4	26.1	23.3	21.0	21.4	20.0	22.4	20.8	20.9	35.1	195.9	0.0	16.3	2.3	115.2	17.0	6.0	8.2	11.4	41.3	23.5	32.1	0.7	5.7	13.9	68.0	14.6	12.5	73.7	0.6	3.9	2.7	192.2	13.1	33.0	150.7	2.4	7.0	49.5	8.7	356.3	97.5	3.6	13.7	2.5	28.1	165.0	7.0	33.1	65.6	38.4	2.5	12.2	87.2	133.3	97.8	49.0	113.1	33.8	26.2	33.3	5.1	167.9	12.5	60.6	3.2	1.1	118.5	67.1	8.5	4.7	36.2	7.5	44.4	6.6	56.8	13.4	3.0	4.5	14.2	12.1	173.2	51.5	81.6	1.4	10.2
SH3BP5L	KIAA1720	ENSG00000175137	"SH3 binding domain protein 5 like"	Q7L8J4	1	248810446-248825915	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 7.7;eosinophil: 4.1;neutrophil: 4.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038067, HPA038068"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA038067: AB_2675814, HPA038068: AB_10670651"	"unprognostic (2.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (4.41e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.99e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.66e-2)"	9.6	10.5	18.0	10.1	18.7	9.0	7.7	17.3	21.0	8.8	13.9	12.2	13.5	10.5	7.8	15.8	10.0	8.0	14.1	19.4	15.8	9.5	10.5	9.2	11.3	17.0	16.7	8.6	10.0	12.0	5.9	11.4	16.9	9.1	7.3	5.3	11.9	11.6	30.6	18.4	12.4	9.9	15.8	12.3	9.9	9.5	17.1	13.8	8.1	17.8	10.2	9.0	9.1	18.3	23.2	14.7	18.5	21.2	25.7	17.1	24.6	51.1	17.4	29.2	21.8	14.3	20.0	11.6	29.7	44.1	7.3	24.6	17.9	22.1	15.0	25.4	6.3	18.6	16.4	11.9	15.8	20.4	21.9	14.4	23.4	33.0	12.9	20.7	19.6	21.4	33.0	12.0	20.2	7.9	19.7	16.5	32.4	25.5	36.9	21.9	13.0	23.5	20.5	10.6	21.1	29.2	15.6	19.3	17.9	14.0	21.0	42.4	27.5	36.9	15.7	14.7	80.2	30.5	34.3	10.5	26.8	23.5	15.4	7.7	1.2	4.1	0.7	0.8	0.7	0.6	1.0	0.6	1.1	0.6	0.3	0.3	4.6	0.3	0.3	0.4	0.2	0.8	18.0	18.7	17.3	21.0	19.4	15.8	17.0	16.7	16.9	15.8	17.1	18.3	5.2	0.0	2.0	5.9	4.3	4.6	2.1	2.9	4.0	8.3	6.1	5.0	9.4	1.5	2.3	11.0	0.0	9.6	4.7	15.1	1.9	8.8	1.3	10.5	5.4	6.0	7.7	6.9	6.5	6.0	5.2	4.9	7.7	6.1	0.0	9.0	6.1	10.0	6.0	8.4	5.7	8.4	2.0	5.3	4.5	1.0	4.4	5.6	3.6	3.7	7.1	4.7	6.2	6.0	6.4	10.6	8.1	5.7	5.4	3.0	13.8	9.2	5.1	3.5	0.0	3.7	5.8	8.8	7.0	7.0	4.7	11.4	6.3	5.4	7.3	3.3
SH3D19	"DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19"	ENSG00000109686	"SH3 domain containing 19"	Q5HYK7	4	151102751-151325605	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 360.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 190.3;ASC TERT1: 161.0;HSkMC: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016424, HPA058562"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA016424: AB_1856814, HPA058562: AB_2683758"	"unprognostic (1.09e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.64e-2)"	70.8	15.7	9.8	12.8	14.9	0.2	31.5	6.0	9.6	22.5	104.9	44.2	44.4	23.2	10.7	40.8	23.7	63.7	64.1	6.8	11.6	27.2	49.9	36.2	5.1	8.8	10.3	42.9	15.2	19.9	5.0	27.9	8.8	27.1	48.3	12.8	17.3	40.5	17.7	30.0	49.0	41.4	5.1	7.4	22.6	12.4	11.5	3.9	25.1	33.8	7.9	33.3	20.6	18.6	26.3	19.2	12.1	9.5	190.3	161.0	26.0	31.8	34.0	13.9	14.4	24.9	31.6	0.0	12.5	29.9	22.7	19.2	12.8	36.6	13.5	0.1	10.1	0.0	22.2	26.7	46.0	0.1	0.1	129.1	27.6	20.9	32.0	23.9	81.9	0.0	0.0	0.1	36.9	10.9	0.0	0.4	24.3	40.3	27.6	0.0	0.9	0.4	17.3	18.3	0.9	16.3	22.7	23.0	18.5	24.7	7.5	0.1	59.9	43.6	15.6	19.5	12.9	0.1	0.0	0.1	22.6	0.1	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	9.8	14.9	6.0	9.6	6.8	11.6	8.8	10.3	8.8	5.1	11.5	18.6	36.7	22.4	32.5	8.1	2.9	28.6	14.1	12.3	18.8	6.6	20.5	25.0	88.5	34.3	29.2	16.5	14.6	25.9	5.0	103.5	5.9	11.9	4.4	17.6	38.1	29.1	18.6	7.0	55.8	15.4	20.7	77.9	38.7	13.7	21.5	37.5	21.8	46.4	7.4	6.7	30.0	35.6	10.2	4.6	20.2	6.7	62.1	4.8	26.6	74.0	1.2	20.8	5.2	263.9	360.1	21.3	55.9	48.2	3.2	41.5	88.2	27.2	52.4	11.0	13.1	46.0	26.3	2.9	6.0	16.7	38.5	27.2	5.5	20.3	54.0	41.2
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306368-36329340	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;thyroid gland: 27.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 15.3;Late spermatids: 53.6;Proximal enterocytes: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.4;HaCaT: 21.1;hTERT-RPE1: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042212, HPA042456, HPA066168"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627"	"prognostic favorable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.1	0.7	2.4	2.5	1.1	1.3	10.8	0.2	6.8	4.4	0.0	3.4	14.0	2.2	1.4	6.9	1.2	2.0	2.0	0.8	0.0	8.8	0.8	3.9	2.0	1.1	0.2	3.5	0.5	0.3	1.7	3.1	1.0	6.7	3.7	3.2	13.4	1.4	0.8	17.4	20.9	1.1	0.0	2.2	2.0	6.8	0.8	0.7	27.8	0.3	3.0	1.3	7.2	0.2	11.2	0.3	2.0	2.2	0.5	1.3	14.4	6.1	0.9	2.8	1.3	7.1	4.3	2.2	5.5	1.6	0.3	21.1	1.4	3.3	2.1	0.9	2.1	2.1	4.8	5.3	1.1	1.2	3.2	0.9	3.0	1.9	1.4	21.7	1.0	4.3	0.4	2.6	1.6	7.3	1.4	1.1	1.2	2.6	2.4	2.3	0.3	1.2	3.7	1.8	4.4	2.1	1.1	11.0	3.4	10.3	0.7	0.3	3.2	1.6	1.2	4.3	1.0	3.3	1.0	2.2	3.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	2.4	1.1	0.2	6.8	0.8	0.0	1.1	0.2	1.0	0.0	0.8	0.2	1.1	0.0	2.0	0.3	1.7	3.1	1.7	3.0	1.8	6.9	6.2	4.3	1.4	0.0	1.9	5.5	0.0	2.9	1.9	15.3	1.9	0.6	14.2	2.5	2.0	1.6	0.0	0.0	1.6	0.4	2.2	1.9	4.6	7.7	1.3	2.6	1.1	0.3	7.7	11.8	1.2	2.9	2.0	6.1	7.7	53.6	1.2	5.0	3.6	0.0	2.2	1.2	1.0	0.0	0.2	4.3	5.8	2.6	2.9	2.6	14.9	1.1	2.3	1.2	0.0	0.7	2.1	2.6	1.2	2.4	3.1	5.7	1.3	3.2	1.6	1.3
SH3GLB2	KIAA1848	ENSG00000148341	"SH3 domain containing GRB2 like, endophilin B2"	Q9NR46	9	129007036-129028331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 127.9;Syncytiotrophoblasts: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 234.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021438, HPA024734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021438: AB_1856820, HPA024734: AB_1856821"	"unprognostic (2.59e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.88e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-3)"	"prognostic favorable (4.28e-4)"	32.7	49.1	86.7	19.2	93.6	59.4	46.0	69.4	127.6	60.5	63.5	56.3	42.1	47.9	17.1	101.4	52.7	22.0	32.4	95.0	74.5	63.9	25.3	35.4	24.9	81.3	71.1	45.2	71.5	69.1	88.4	37.7	82.2	71.8	16.1	11.7	60.8	50.2	50.0	116.7	47.9	18.5	68.8	42.1	71.2	24.4	78.0	37.2	45.9	19.0	22.6	72.6	66.8	93.1	49.7	41.2	19.9	27.1	11.7	14.8	59.2	17.0	37.8	33.0	30.0	25.8	83.2	51.9	13.3	30.1	25.5	119.2	6.3	36.7	9.3	34.0	27.5	13.2	70.5	22.9	24.4	11.9	30.7	10.6	41.1	16.8	14.9	36.2	28.0	66.8	17.8	67.2	16.9	121.5	68.4	31.5	17.8	83.2	28.7	136.3	37.2	234.3	36.7	59.1	62.0	50.3	24.7	62.6	26.3	16.4	90.5	17.5	25.8	15.3	26.1	39.3	37.7	65.6	34.0	33.8	35.6	14.7	8.3	2.1	1.6	3.5	1.9	0.8	2.3	3.5	2.2	1.8	1.3	2.0	1.6	1.3	1.3	2.6	2.5	3.7	2.0	1.5	86.7	93.6	69.4	127.6	95.0	74.5	81.3	71.1	82.2	68.8	78.0	93.1	36.3	16.0	28.4	28.1	20.3	20.8	27.5	11.6	9.6	26.9	59.7	62.9	10.6	18.6	19.8	47.8	8.4	127.9	29.4	58.2	15.6	14.5	11.2	36.3	19.6	15.6	25.3	29.5	24.4	26.0	19.2	23.3	84.6	63.6	6.3	29.9	12.1	9.9	20.7	47.1	14.2	35.9	12.2	11.9	11.6	24.4	19.0	14.3	14.2	17.8	6.9	36.0	6.2	23.6	95.6	24.6	50.3	20.3	25.9	23.0	39.4	7.6	21.5	20.6	13.1	32.0	39.7	8.6	6.6	27.6	53.6	149.5	16.3	18.3	34.6	58.3
SH3PXD2B	"FLJ20831, KIAA1295"	ENSG00000174705	"SH3 and PX domains 2B"	A1X283	5	172325000-172454525	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 91.1;Leydig cells: 39.7;Oligodendrocytes: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 95.2;ASC TERT1: 79.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036471	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036471: AB_10670799"	"unprognostic (3.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.84e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (5.38e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (8.45e-4)"	22.6	25.4	9.2	11.2	12.8	0.1	19.0	12.9	11.5	36.4	9.6	14.0	2.3	32.6	5.4	10.5	17.9	18.9	7.4	9.8	10.7	2.4	2.9	17.6	3.5	14.5	12.8	18.4	9.8	6.6	5.0	8.9	16.0	12.8	5.6	3.6	18.3	13.9	3.5	19.8	11.5	23.2	10.1	6.5	13.1	6.3	13.7	4.2	8.0	3.4	3.4	18.3	18.1	15.4	1.0	14.3	52.3	34.6	95.2	79.9	44.3	8.6	29.7	5.4	10.7	4.0	1.3	0.1	11.5	33.4	16.7	8.1	18.7	9.8	5.3	0.8	3.5	0.1	13.3	2.9	30.6	0.0	36.5	51.5	15.1	22.4	6.4	5.2	37.9	3.8	0.1	0.2	24.1	3.1	0.1	4.6	20.1	8.1	3.3	17.3	8.5	5.1	5.7	1.5	4.6	29.2	6.0	3.8	10.7	16.5	1.4	2.1	40.9	33.4	13.2	20.7	3.8	0.0	0.0	0.2	22.6	2.2	27.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	12.8	12.9	11.5	9.8	10.7	14.5	12.8	16.0	10.1	13.7	15.4	11.3	0.0	1.1	91.1	0.4	10.1	3.2	13.9	8.6	0.6	6.2	6.5	1.8	5.7	12.0	0.0	0.0	4.5	0.2	1.3	0.0	9.9	0.9	5.5	30.8	6.4	2.4	0.0	5.0	16.0	31.0	29.8	6.1	13.4	0.0	5.8	3.3	1.8	3.1	1.7	11.2	2.1	18.3	28.4	9.4	2.0	39.7	13.6	14.2	13.1	1.3	6.3	0.0	25.1	63.0	21.8	1.0	27.1	0.0	6.9	0.2	1.9	3.8	0.3	13.1	6.0	10.5	0.8	4.2	4.7	8.1	2.2	0.5	22.3	2.7	5.7
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936578-146081791	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 58.1;skeletal muscle: 42.4;skin 1: 56.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 7869.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 6.1;cerebral cortex: 4.1;thalamus: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 70.3;GAMG: 29.8;hTERT-RPE1: 33.5"	"Region enriched"	"Detected in many"	14	"basal ganglia: 26.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 9.7"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035903: AB_10696515, HPA058119: AB_2683611"	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	1.9	0.9	0.6	2.5	6.1	0.0	4.7	0.0	4.1	7.6	0.2	14.3	16.0	1.1	3.6	34.1	6.1	11.9	58.1	0.9	0.5	0.9	7.0	2.7	0.2	0.0	0.3	0.4	15.4	0.0	1.6	0.1	0.0	2.7	14.3	0.5	12.1	0.6	42.4	56.8	13.7	1.1	0.0	0.0	20.5	6.8	1.7	1.0	6.3	8.8	7.7	1.2	20.6	0.4	21.0	5.7	0.2	1.1	0.0	0.0	0.0	0.2	1.7	4.1	1.7	70.3	19.0	0.0	10.5	0.9	29.8	18.9	0.0	22.4	4.0	0.3	0.3	0.0	8.5	9.5	1.2	0.0	0.0	0.2	11.9	6.4	14.8	33.5	0.2	0.5	0.0	0.0	1.8	0.1	0.0	0.0	1.6	17.3	1.5	0.0	0.2	0.0	8.7	2.0	0.0	0.0	1.2	0.4	0.5	1.0	6.6	0.1	9.8	0.8	17.3	1.5	6.7	0.0	0.0	0.0	10.6	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	6.1	0.0	4.1	0.9	0.5	0.0	0.3	0.0	0.0	1.7	0.4	4.1	16.0	2.3	1.6	0.0	55.1	5.4	14.5	38.7	0.4	3.9	3.3	510.0	8.6	6.7	1.8	0.0	0.2	0.2	38.9	0.0	5.7	1511.3	11.9	0.9	9.7	1.2	0.0	10.5	8.7	0.0	15.4	50.4	26.7	1.3	0.1	0.7	8.4	0.2	0.0	2.2	16.1	8.2	0.0	4.9	7869.1	25.7	2.6	8.8	10.3	0.6	1.6	0.0	1.5	0.7	21.4	22.9	34.6	0.6	2.2	26.6	0.9	4.4	0.1	13.1	1.6	6.3	31.4	20.7	70.9	50.0	0.0	0.7	2.9	33.2	6.6
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129205-109504634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Astrocytes: 47.0;Excitatory neurons: 108.3;Inhibitory neurons: 160.9;Microglial cells: 164.9;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.8;RPMI-8226: 20.5;TIME: 23.2;U-266/84: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044822: AB_2679103, HPA048444: AB_2680396"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	6.1	6.7	4.7	3.0	6.1	0.8	4.3	1.3	6.5	5.5	1.6	5.6	1.1	3.7	0.7	2.8	4.8	4.4	6.0	6.3	3.2	6.8	1.1	7.2	2.1	3.0	4.5	3.2	2.0	0.5	1.9	5.2	2.8	4.7	1.4	0.6	1.6	4.4	5.7	3.1	3.3	3.8	3.1	2.1	2.9	4.2	3.9	3.2	2.5	7.3	1.2	5.5	4.2	3.5	0.0	0.1	0.1	2.2	9.0	6.9	0.0	4.2	12.2	3.1	1.1	1.1	0.0	0.0	3.1	3.1	0.7	0.0	0.2	1.8	1.3	0.0	4.2	0.0	0.2	0.0	19.8	0.1	0.0	12.0	2.9	14.1	6.3	1.8	11.4	2.2	0.0	11.7	7.3	0.0	0.0	6.5	1.1	0.0	12.0	2.6	0.0	20.5	0.0	0.0	0.7	2.5	0.0	0.0	0.4	0.1	0.2	0.0	23.2	4.0	12.0	11.5	5.5	4.0	28.6	0.0	0.0	6.3	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.7	6.1	1.3	6.5	6.3	3.2	3.0	4.5	2.8	3.1	3.9	3.5	5.3	0.0	0.0	47.0	0.2	1.9	0.4	0.2	1.8	0.5	0.6	0.5	10.7	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.0	1.1	2.6	9.4	9.6	6.7	1.8	0.0	108.3	0.2	0.2	4.8	0.0	1.1	0.0	0.2	7.5	0.0	4.7	10.1	160.9	0.8	0.0	2.5	1.5	5.2	2.1	1.2	5.4	164.9	0.0	1.7	0.0	42.3	1.9	0.1	0.0	3.0	1.6	0.2	0.0	0.6	2.1	0.0	13.1	3.2	6.8	0.7	9.6	0.8	0.9	0.1	0.5	2.3	0.1	0.0
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.0"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 32.6;Kupffer cells: 33.7;Macrophages: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.7"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;dendritic cells: 17.7;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.8;MOLT-4: 41.8;SK-MEL-30: 26.8;U-2197: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038132, HPA056807"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: AB_2683239"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	8.4	3.5	4.0	8.7	4.3	4.6	5.6	4.1	5.6	2.9	5.2	2.8	0.9	2.1	0.7	8.4	3.0	5.4	3.6	3.6	7.3	19.2	9.6	9.0	9.1	10.5	6.0	1.2	6.3	0.7	2.5	3.0	8.5	4.7	1.0	1.3	4.6	2.7	1.5	2.7	4.9	2.0	9.2	14.1	6.0	0.6	8.4	28.0	4.6	0.7	4.5	4.4	5.8	11.8	3.9	6.1	0.1	0.0	0.0	0.5	4.1	0.4	0.2	0.5	0.8	3.2	2.2	5.2	5.2	0.0	0.8	2.0	0.0	12.4	0.0	14.2	0.2	0.0	6.1	5.7	4.3	0.1	0.8	0.2	15.3	0.3	9.9	0.5	25.8	3.2	0.8	7.3	0.4	4.1	41.8	3.4	0.0	2.3	5.1	3.1	0.7	1.6	0.4	1.0	0.1	3.1	1.7	0.4	26.8	1.0	0.0	1.0	14.2	0.0	3.0	19.0	0.2	0.0	1.0	4.7	0.2	1.9	4.1	0.0	9.9	1.3	0.7	8.8	0.9	4.9	1.7	1.1	7.7	6.8	0.9	0.7	0.3	0.3	12.3	17.7	2.5	4.3	4.0	4.3	4.1	5.6	3.6	7.3	10.5	6.0	8.5	9.2	8.4	11.8	12.6	0.0	5.8	1.3	18.1	0.8	10.5	6.9	0.6	1.0	0.8	1.4	3.3	4.3	4.1	25.8	0.0	2.1	18.2	2.5	7.9	3.6	0.5	0.9	0.3	12.6	1.2	3.2	0.2	5.6	3.4	1.6	32.6	2.2	17.2	0.3	27.5	8.6	22.7	23.5	0.1	2.5	14.2	33.7	16.7	1.5	0.6	35.7	0.0	17.8	15.6	13.3	7.2	0.5	0.1	9.3	4.5	0.7	17.1	8.3	0.1	17.2	2.0	0.9	0.0	0.6	1.2	0.0	0.3	2.5	0.6	3.0	11.7	2.5	1.8	15.3
SH3TC2	"CMT4C, KIAA1985"	ENSG00000169247	"SH3 domain and tetratricopeptide repeats 2"	Q8TF17	5	148923639-149063163	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 12.6;retina: 3.9"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 270.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;HBEC3-KT: 2.2;RT4: 3.6;SK-MEL-30: 5.2;WM-115: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037683, HPA037684"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No				"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA037683: AB_2675608, HPA037684: AB_10672603"	"unprognostic (6.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.18e-2)"	"unprognostic (4.53e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.40e-1)"	0.1	0.0	4.7	0.0	8.0	0.1	0.1	5.1	5.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	3.6	5.1	0.0	0.0	0.0	0.0	7.1	6.9	0.0	0.0	0.0	0.0	0.4	7.3	0.0	0.0	3.9	0.1	0.1	0.2	0.1	0.0	0.0	5.8	0.0	0.0	1.5	7.1	0.0	0.0	0.1	0.0	0.1	0.0	12.6	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.3	0.1	2.6	1.5	0.0	1.8	0.1	0.6	1.9	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.1	1.6	0.0	1.3	0.0	0.7	3.6	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.2	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	8.0	5.1	5.0	3.6	5.1	7.1	6.9	7.3	5.8	7.1	12.6	1.9	3.2	3.7	0.3	0.1	0.9	0.8	1.0	0.0	1.4	0.7	0.4	1.7	1.5	3.8	0.0	4.2	0.8	0.0	0.6	0.0	0.6	6.4	0.3	0.1	2.8	0.0	0.0	0.4	0.2	0.4	0.5	0.0	0.5	2.5	0.1	1.4	0.3	0.4	0.0	0.4	0.0	2.0	1.8	0.7	2.3	0.3	2.2	0.0	4.7	0.1	2.3	0.0	0.0	270.4	1.6	0.0	0.0	0.1	1.2	0.0	0.1	4.1	25.4	0.0	0.3	0.4	2.3	0.9	1.0	0.9	11.9	0.3	0.1	0.2	8.8
SH3YL1	"DKFZP586F1318, Ray"	ENSG00000035115	"SH3 and SYLF domain containing 1"	Q96HL8	2	217730-266398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 606.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 223.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030926, HPA030927"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA030926: AB_10670148, HPA030927: AB_10669874"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-3)"	13.6	32.0	26.6	11.9	27.7	11.6	54.8	27.5	37.2	31.8	28.3	45.6	35.1	27.0	40.8	43.8	43.6	45.2	11.0	26.8	25.5	145.6	11.6	35.7	22.1	27.4	26.8	28.6	161.6	55.7	33.9	26.9	27.8	34.4	53.2	10.7	114.0	24.3	13.4	75.0	51.7	11.9	26.4	16.0	72.3	17.0	27.9	15.4	59.2	8.3	28.0	49.3	27.1	33.1	12.7	2.4	13.5	6.0	18.1	16.8	9.0	15.7	17.4	5.8	6.0	33.6	46.3	0.6	7.3	13.8	3.9	51.6	3.4	67.6	5.4	10.2	2.4	3.0	3.9	10.9	14.5	1.5	3.8	18.6	68.2	3.5	11.0	28.7	8.7	17.2	0.9	2.3	12.0	37.1	13.4	6.9	4.4	223.4	2.6	6.4	4.1	0.9	41.4	69.8	5.5	9.1	2.6	64.1	11.9	17.5	44.0	10.6	6.6	2.9	0.8	16.9	6.9	1.7	0.1	1.2	28.8	20.7	9.8	38.9	2.5	1.9	4.5	3.1	14.3	12.6	22.4	11.5	6.1	10.1	33.9	20.5	1.5	22.9	4.9	5.5	30.6	8.2	26.6	27.7	27.5	37.2	26.8	25.5	27.4	26.8	27.8	26.4	27.9	33.1	14.8	57.7	116.7	51.2	29.7	82.7	173.5	174.4	42.7	19.3	140.2	130.3	6.6	313.1	139.7	101.2	22.9	197.7	15.8	84.5	291.6	129.2	136.6	148.5	32.3	15.9	49.1	3.8	62.3	143.9	69.9	22.6	31.1	216.6	15.8	51.9	19.2	7.9	26.5	26.9	57.1	97.4	109.9	9.5	17.0	113.1	36.7	14.9	72.9	23.4	15.2	9.4	30.9	44.2	87.2	104.6	115.3	41.0	4.7	166.3	125.1	606.2	85.2	9.7	26.3	20.4	20.5	63.3	23.2	29.5	115.4	247.0	35.7	37.1	123.8	245.3
SHANK3	"KIAA1650, prosap2, PSAP2, SPANK-2"	ENSG00000251322	"SH3 and multiple ankyrin repeat domains 3"		22	50674415-50733298	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"brain: 73.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.3;Endothelial cells: 65.0;Hepatic stellate cells: 70.3;Microglial cells: 44.0;Oligodendrocytes: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 33.3;TIME: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003446	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA003446: AB_1079958"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.09e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-1)"	34.9	4.0	38.9	4.9	21.6	1.1	33.5	73.5	54.7	12.8	0.0	7.5	3.4	13.4	2.0	5.2	12.4	5.8	26.2	44.7	14.9	11.9	4.4	20.3	4.2	10.0	15.3	4.3	4.0	3.5	5.2	13.7	2.6	8.3	1.2	0.7	8.2	4.2	23.3	7.1	6.4	5.1	0.0	50.4	5.7	2.2	38.6	1.7	14.8	8.9	1.4	10.7	10.1	16.2	6.6	2.6	6.2	4.8	0.5	1.6	3.2	1.3	0.0	0.4	0.5	1.6	2.4	0.0	4.0	1.0	3.1	1.2	0.9	2.3	0.0	0.0	10.4	8.0	1.8	7.1	1.9	1.8	0.4	2.2	1.8	0.1	0.3	0.1	33.3	1.9	0.2	0.2	0.5	2.6	1.4	0.5	3.2	0.6	2.2	7.5	0.0	1.7	0.4	1.3	2.3	3.0	2.7	0.0	3.1	0.7	0.3	0.7	37.6	0.4	9.3	2.0	0.7	0.3	0.4	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	21.6	73.5	54.7	44.7	14.9	10.0	15.3	2.6	0.0	38.6	16.2	195.3	0.0	1.1	4.6	0.5	0.3	0.1	0.5	4.0	1.2	1.3	2.4	27.6	0.0	0.8	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.9	3.9	2.4	65.0	2.4	0.0	28.3	0.0	0.0	3.3	0.0	1.5	0.0	0.3	70.3	6.5	0.4	0.0	21.7	0.0	2.0	3.1	0.0	0.4	0.0	0.3	0.0	44.0	0.0	1.4	0.0	25.1	31.3	0.1	0.0	0.4	0.0	0.2	0.0	0.9	0.9	0.0	0.0	1.0	3.8	0.2	0.8	1.0	0.3	0.0	0.6	0.7	0.1	0.3
SHB		ENSG00000107338	"SH2 domain containing adaptor protein B"	Q15464	9	37915898-38069227	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	22	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"OE19: 35.3"	"Low region specificity"	"Detected in all"							"CAB010161, HPA049911, HPA052108"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Nucleoplasm, Cytoplasmic bodies"	"CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730"	"unprognostic (4.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.96e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-1)"	12.8	7.6	6.4	1.9	9.6	3.1	9.8	6.1	9.2	8.8	8.2	11.2	3.6	6.6	1.2	26.2	7.2	4.9	24.9	6.7	6.3	23.1	35.2	13.9	1.3	8.5	9.7	4.7	20.0	4.1	15.0	2.5	7.8	16.1	2.6	0.9	23.2	4.6	6.8	17.3	7.1	3.2	5.6	6.6	10.6	4.1	9.4	1.7	8.3	1.3	2.5	13.6	16.1	12.8	8.3	14.6	1.4	0.2	1.5	3.8	2.5	9.8	11.5	6.9	5.0	4.5	5.8	0.0	10.9	8.5	16.9	8.8	5.8	14.2	4.8	6.7	11.0	0.0	5.3	10.7	10.8	0.4	0.4	3.4	4.9	11.2	7.8	16.1	6.5	1.4	3.6	2.4	7.7	6.2	0.9	0.3	3.7	35.3	13.0	0.4	4.3	0.5	13.1	3.8	15.8	12.1	1.3	10.9	2.2	11.9	6.5	0.4	9.2	3.3	11.0	1.6	16.2	0.7	0.2	0.1	18.3	0.8	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.6	6.1	9.2	6.7	6.3	8.5	9.7	7.8	5.6	9.4	12.8	21.5	6.4	5.6	9.8	0.6	20.4	96.9	9.9	33.0	0.6	12.7	6.0	9.6	35.8	9.0	22.0	8.4	10.2	1.1	17.3	15.6	18.0	1.9	8.3	2.5	19.0	7.8	5.2	6.4	20.3	1.5	5.5	14.8	18.3	0.0	0.9	10.4	21.6	6.1	0.0	5.4	12.1	2.0	2.6	19.4	3.8	0.6	5.8	7.2	8.4	0.4	2.9	0.0	5.0	43.7	22.2	6.8	0.4	1.9	31.1	7.5	24.9	5.1	1.4	0.0	5.7	3.9	1.2	9.4	19.3	34.0	4.0	1.2	9.3	11.1	45.9
SHC3	"N-Shc, NSHC, SHCC"	ENSG00000148082	"SHC adaptor protein 3"	Q92529	9	89005771-89178818	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.1"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 155.2;Inhibitory neurons: 179.2;Oligodendrocyte precursor cells: 333.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.1"	"Group enriched"	"Detected in many"	9	"amygdala: 16.8;basal ganglia: 24.9;cerebral cortex: 28.1;hippocampal formation: 23.6;white matter: 11.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 20.7;hTERT-RPE1: 22.6;RT4: 7.9;SH-SY5Y: 7.6;U-87 MG: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031427, HPA046656, HPA072448"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521"	"unprognostic (6.22e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.07e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.53e-7)"	"unprognostic (8.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.84e-4)"	1.0	9.0	16.8	0.2	24.9	0.0	1.7	0.0	28.1	5.8	0.0	1.4	0.4	1.7	0.9	1.0	1.7	1.8	1.1	23.6	0.0	1.4	0.2	4.6	0.2	0.0	0.0	0.2	4.0	2.7	1.1	0.2	0.0	1.0	0.7	2.3	5.0	0.6	0.3	1.8	0.7	1.0	0.0	0.1	0.8	0.3	2.3	0.0	0.6	0.6	0.2	1.4	2.9	11.4	1.4	0.4	20.7	0.0	4.5	1.4	0.0	1.5	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.4	0.5	0.2	0.0	3.1	0.0	2.1	0.0	22.6	5.5	0.1	0.0	0.0	0.0	0.2	0.0	1.3	2.7	0.3	0.3	0.3	0.0	4.5	4.5	7.9	2.8	7.6	0.5	0.0	0.0	0.2	0.0	0.4	3.2	0.8	0.1	1.3	0.1	0.0	0.0	0.0	11.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	24.9	0.0	28.1	23.6	0.0	0.0	0.0	0.0	0.0	2.3	11.4	0.3	0.0	21.0	17.6	0.0	0.1	0.3	0.1	1.2	7.6	1.1	1.0	1.1	0.0	0.7	0.0	0.0	0.1	0.2	0.0	1.9	0.1	1.1	0.4	1.8	0.5	0.0	0.0	155.2	0.9	0.1	4.4	0.0	0.2	0.0	0.3	0.0	0.0	0.2	3.3	179.2	0.0	0.0	0.0	1.1	1.6	1.5	0.3	1.8	15.0	0.0	7.2	0.0	333.8	9.6	0.1	0.0	3.8	0.0	0.0	0.1	0.6	0.9	0.6	0.0	0.9	0.9	0.3	0.6	0.7	0.6	0.4	0.3	0.8	0.0	0.8
SHE		ENSG00000169291	"Src homology 2 domain containing E"	Q5VZ18	1	154469772-154502412	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.9;Alveolar cells type 2: 23.4;Endothelial cells: 64.4;Hepatic stellate cells: 85.3;Kupffer cells: 26.7;Late spermatids: 23.0;Microglial cells: 26.2;Spermatocytes: 30.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 49.1;TIME: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037417	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA037417: AB_10672384"	"unprognostic (3.24e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.33e-2)"	23.4	9.8	9.4	3.3	8.8	1.2	20.9	7.7	10.6	13.2	7.4	7.4	3.4	12.1	4.3	5.0	12.5	6.9	22.7	8.3	8.3	10.5	5.8	20.6	3.9	8.4	9.1	7.6	3.0	4.9	3.7	16.5	8.8	8.1	4.2	0.6	5.4	4.2	7.1	6.4	8.9	8.0	8.1	21.4	5.5	22.2	10.2	2.6	22.1	11.3	2.3	9.7	9.9	8.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.5	0.0	1.0	13.6	0.0	0.3	1.4	0.0	0.1	0.2	0.1	0.0	1.0	0.0	0.5	0.3	0.2	1.5	1.5	1.1	0.9	0.6	0.6	0.1	0.9	0.8	0.9	2.4	1.7	1.1	4.0	0.0	0.5	9.4	8.8	7.7	10.6	8.3	8.3	8.4	9.1	8.8	8.1	10.2	8.0	56.9	0.0	23.4	3.9	0.3	3.3	0.4	0.3	1.2	0.1	0.4	1.3	4.4	1.5	1.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	13.0	0.4	0.3	64.4	0.0	2.7	0.3	0.0	0.0	6.7	0.0	0.5	3.8	2.1	85.3	3.4	1.4	0.0	0.3	0.0	0.0	26.7	6.6	23.0	1.5	2.0	0.0	26.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.7	0.0	0.1	0.0	0.4	0.0	3.3	2.2	30.6	13.0	0.3	1.6	0.1	0.7	0.3	0.0	0.3
SHF		ENSG00000138606	"Src homology 2 domain containing F"	Q7M4L6	15	45167214-45201175	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 143.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.6;Granulosa cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 143.8"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 121.0;SH-SY5Y: 54.1"	"Region enriched"	"Detected in all"	5	"cerebellum: 240.6"	"Region enriched"	"Detected in all"	4	"cerebellum: 106.2"	HPA057381			Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA057381: AB_2683423"	"unprognostic (4.05e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.83e-2)"	6.1	22.7	21.9	4.3	20.5	1.0	6.3	143.8	27.8	14.4	0.2	13.4	13.1	11.9	4.7	5.0	10.5	6.6	9.0	21.5	19.5	4.4	38.6	5.6	2.7	12.8	16.9	23.7	3.1	4.4	8.3	1.9	15.9	10.1	5.3	7.1	6.7	5.9	3.8	12.7	8.4	7.5	9.4	4.3	6.7	8.4	21.4	2.4	7.5	4.7	1.9	10.2	11.7	13.4	0.1	1.4	24.0	0.7	1.8	0.9	11.2	3.0	2.1	6.7	9.5	3.6	11.6	1.3	9.5	4.2	6.6	2.1	9.2	0.7	3.2	2.2	4.2	0.8	2.2	24.8	1.0	0.1	8.0	2.2	0.6	0.9	0.2	5.0	5.2	12.0	5.0	0.5	9.5	4.1	5.5	0.9	9.6	4.5	0.6	15.0	19.1	0.5	2.3	0.5	121.0	54.1	0.7	0.8	0.4	7.4	1.2	2.4	0.3	0.8	10.0	0.7	0.4	1.1	0.9	1.1	0.3	0.6	3.8	0.1	0.6	0.5	1.3	0.6	1.4	0.8	0.5	0.8	0.6	1.5	0.7	0.5	0.8	2.0	0.6	0.9	0.1	0.5	21.9	20.5	143.8	27.8	21.5	19.5	12.8	16.9	15.9	9.4	21.4	13.4	4.1	0.0	0.6	3.3	4.2	3.6	5.8	1.7	0.0	50.6	3.6	5.5	2.8	0.0	1.3	0.0	0.0	1.1	2.6	2.1	0.0	0.8	7.9	1.1	3.5	5.7	13.1	0.0	5.9	1.3	0.5	5.8	1.5	2.2	2.5	58.8	5.3	11.7	0.6	10.1	6.9	10.9	2.0	1.0	15.0	15.3	4.4	2.9	8.8	5.6	0.1	5.9	2.1	9.0	1.8	0.7	5.6	4.1	0.7	3.5	18.0	1.1	0.8	5.0	6.6	6.7	9.6	5.4	2.9	1.4	2.6	0.7	2.8	1.8	4.6	9.7
SHFL	"C19orf66, FLJ11286, IRAV, RyDEN, SFL"	ENSG00000130813	"Shiftless antiviral inhibitor of ribosomal frameshifting"	Q9NUL5	19	10086122-10093252	"Predicted intracellular proteins"	"Antiviral defense"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;dendritic cells: 21.7;Fibroblasts: 6.8;Hofbauer cells: 32.6;Plasma cells: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 71.8;BJ hTERT+ SV40 Large T+ RasG12V: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042001	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042001: AB_10794167"	"prognostic favorable (4.04e-4)"	"unprognostic (1.21e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (8.96e-11)"	"unprognostic (5.92e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.41e-3)"	"prognostic favorable (1.35e-4)"	12.8	18.5	27.1	14.2	27.4	15.7	12.2	26.3	30.1	17.0	24.4	12.8	14.8	15.8	16.5	8.6	17.6	18.1	8.2	27.2	28.5	14.0	75.7	16.8	22.8	27.3	27.0	18.9	9.9	16.7	14.1	12.7	27.2	11.9	9.9	15.0	16.3	19.1	4.4	9.5	18.4	15.4	28.8	19.9	11.0	4.3	29.5	20.4	12.2	6.9	16.6	14.7	12.3	28.1	9.4	3.8	5.0	3.9	20.3	23.6	1.4	7.6	46.3	71.8	81.2	0.4	7.4	4.8	2.1	24.0	25.7	3.9	3.9	20.7	12.0	30.4	0.4	15.5	3.0	10.6	32.6	4.7	9.7	34.3	11.7	11.5	4.1	27.1	22.9	20.6	1.8	20.2	15.0	6.5	20.1	13.3	1.1	7.0	5.5	16.2	0.0	8.0	14.8	13.0	0.7	3.5	12.9	1.3	42.2	0.9	1.2	12.9	14.8	6.0	3.0	9.6	1.6	24.1	7.2	1.2	16.8	6.0	12.1	16.4	12.8	18.2	23.3	11.7	31.1	13.0	19.5	25.4	10.2	10.1	16.3	17.7	16.4	32.7	20.3	2.0	21.7	15.5	27.1	27.4	26.3	30.1	27.2	28.5	27.3	27.0	27.2	28.8	29.5	28.1	23.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.4	21.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	6.8	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.6	3.3	0.0	0.0	0.0
SHISA2	"bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166"	ENSG00000180730	"Shisa family member 2"	Q6UWI4	13	26044597-26052016	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 12.4;skeletal muscle: 14.2;thyroid gland: 21.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 13.1;Basal prostatic cells: 14.6;Breast glandular cells: 24.1;Oligodendrocytes: 10.9;Urothelial cells: 19.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 25.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 26.7;JURKAT: 20.8;LHCN-M2: 18.7;NTERA-2: 15.5;RH-30: 46.3;U-2197: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA049752, HPA050172"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA049752: , HPA050172: AB_2681041"	"unprognostic (2.08e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.51e-2)"	0.5	0.0	1.1	0.2	2.3	0.1	12.4	1.5	2.0	1.7	0.9	0.1	0.7	0.1	7.8	0.2	0.2	0.5	0.2	2.0	1.5	4.7	0.0	4.3	0.5	1.9	1.5	0.3	0.3	0.1	1.6	0.0	1.6	0.5	0.1	0.0	2.7	0.3	14.2	1.1	0.7	0.1	2.2	0.2	2.1	1.2	1.6	2.5	21.0	1.2	0.7	0.7	0.0	5.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.4	4.2	1.4	0.0	0.0	1.7	26.7	1.0	20.8	0.0	0.0	18.7	1.2	2.3	0.5	15.5	8.4	8.2	0.0	46.3	0.3	1.7	6.5	0.4	0.0	0.4	0.0	5.4	2.6	0.7	0.2	1.6	0.1	0.7	30.4	7.0	0.0	0.0	0.0	0.0	0.0	4.1	0.8	0.1	0.5	0.1	0.2	0.2	0.1	0.4	0.1	0.0	0.2	1.0	1.6	0.4	0.2	0.3	0.1	0.2	0.1	1.1	2.3	1.5	2.0	2.0	1.5	1.9	1.5	1.6	2.2	1.6	5.4	4.7	0.0	13.1	0.0	0.4	5.4	14.6	2.3	0.6	0.0	24.1	6.2	0.5	0.0	1.5	3.7	0.0	0.3	0.3	0.1	0.0	6.0	2.6	1.0	0.5	5.1	0.0	0.0	0.0	0.2	0.3	2.8	3.1	2.5	0.0	2.4	1.1	0.0	0.8	0.0	1.0	0.1	8.2	0.3	2.3	1.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.5	10.9	1.2	0.0	0.4	0.2	3.9	0.0	0.3	1.1	0.0	0.0	7.6	1.6	0.7	5.1	0.4	1.7	0.1	1.1	0.7	0.0	19.6
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241213-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.2;cervix: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.3;Excitatory neurons: 27.4;Inhibitory neurons: 181.4;Oligodendrocyte precursor cells: 77.4;Peritubular cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"OE19: 52.0"	"Low region specificity"	"Detected in all"							HPA023440	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	1.7	0.6	17.7	0.0	11.0	0.0	1.1	23.2	25.3	16.8	0.8	0.6	0.2	6.2	0.7	0.8	1.8	0.3	0.8	46.2	18.9	1.9	0.0	0.2	0.0	43.3	25.5	0.6	1.0	3.4	0.2	0.1	24.4	4.3	0.4	1.1	0.2	7.3	0.7	0.8	0.3	0.5	44.8	0.0	4.2	2.9	34.7	0.0	0.5	1.3	0.0	1.1	3.4	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	52.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	11.0	23.2	25.3	46.2	18.9	43.3	25.5	24.4	44.8	34.7	27.0	0.9	0.0	0.0	50.3	0.0	0.1	0.1	0.0	1.2	4.0	1.8	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.5	16.9	1.6	1.2	0.0	27.4	0.0	0.0	2.1	0.0	0.5	0.0	5.6	0.4	0.0	0.1	0.0	181.4	0.0	0.0	0.0	0.3	15.2	5.0	0.0	1.8	12.2	0.0	0.8	0.0	77.4	2.4	0.0	0.0	29.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.2	1.7	0.4	2.5	0.1	0.1	0.0	0.1	4.4	0.2	0.2
SHLD2	"bA163M19.1, FAM35A, FAM35A1, MGC5560, RINN2"	ENSG00000122376	"Shieldin complex subunit 2"	Q86V20	10	87094161-87191465	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 31.3;Endometrial stromal cells: 28.6;Glandular and luminal cells: 29.0;Proximal tubular cells: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036582	Uncertain		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Actin filaments"	"HPA036582: AB_10670233"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.44e-3)"	"unprognostic (3.61e-2)"	15.6	20.1	10.8	12.6	8.4	9.6	17.3	7.3	10.0	11.9	10.2	15.7	22.3	11.4	7.0	12.8	11.2	10.7	10.3	8.6	10.5	32.1	37.2	11.6	13.1	27.5	10.9	12.7	12.4	6.1	10.9	9.7	8.8	14.9	16.5	15.6	14.3	9.5	10.6	12.0	24.8	12.2	9.3	11.9	12.0	8.0	10.1	10.4	23.3	11.7	14.4	13.3	11.2	8.7	33.6	26.7	14.9	34.4	16.4	15.8	21.7	22.1	31.0	29.0	31.8	30.8	25.2	24.4	12.1	30.2	17.0	21.9	37.2	16.9	29.8	35.1	24.6	33.9	24.3	29.1	25.4	53.4	28.5	14.5	30.4	26.6	45.4	25.6	19.6	26.3	43.7	42.7	27.2	19.2	43.7	37.8	17.2	24.2	18.4	26.8	29.6	27.0	26.6	27.7	7.4	30.6	17.1	19.9	29.8	13.7	44.0	29.6	19.4	16.5	15.0	24.8	44.7	23.9	55.8	58.5	27.8	65.4	9.1	7.1	7.3	2.8	6.7	11.8	13.7	9.2	10.0	10.0	11.3	8.8	10.0	10.1	0.1	12.5	9.5	3.9	10.4	8.7	10.8	8.4	7.3	10.0	8.6	10.5	27.5	10.9	8.8	9.3	10.1	8.7	21.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	20.9	13.2	0.0	0.0	0.0	5.5	0.0	7.2	17.4	0.0	31.3	12.6	0.0	16.7	28.6	4.2	0.0	0.0	0.0	13.7	15.1	7.9	0.0	29.0	0.0	20.2	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	8.8	0.0	0.0	0.0	0.0	14.7	0.0	0.0	7.6	0.0	0.0	48.2	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	2.2	7.8	19.1	0.0	0.0
SHLD3	"AC008560.1, CTC-534A2.2, FLJ26957, RINN1"	ENSG00000253251	"Shieldin complex subunit 3"	Q6ZNX1	5	65625027-65630928	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 17.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.0;dendritic cells: 5.9;Distal tubular cells: 3.9;Pancreatic endocrine cells: 4.6;Proximal tubular cells: 5.3;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA066071: AB_2685609, HPA068764: AB_2686028"	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.17e-4)"	2.3	2.7	2.4	2.7	2.5	17.5	4.2	2.8	3.6	1.8	1.8	2.8	2.8	2.3	3.1	1.5	1.9	2.4	1.8	2.3	2.1	2.9	2.6	2.5	4.8	2.4	2.1	1.5	3.4	2.1	2.5	2.5	2.3	4.3	3.0	3.7	2.0	2.5	1.8	2.9	2.7	1.7	2.4	2.5	2.4	3.2	2.4	3.9	2.4	1.9	3.6	2.5	1.3	3.2	2.6	3.6	5.0	10.8	2.9	3.5	6.3	3.8	3.5	5.8	7.0	5.9	8.0	4.9	4.2	4.6	6.5	3.1	5.1	4.7	8.5	6.7	6.5	4.3	10.3	8.3	2.5	5.0	7.5	2.1	6.8	6.0	6.1	1.6	3.7	7.7	6.4	11.5	4.7	6.9	6.7	7.7	4.0	1.5	2.2	4.4	4.9	7.9	4.9	6.0	6.7	5.5	3.2	3.3	11.0	3.4	3.8	4.6	3.0	5.0	6.8	4.1	6.6	7.2	14.3	10.7	3.7	6.1	4.7	15.9	3.0	6.4	3.8	2.9	4.0	3.9	4.5	4.0	2.8	3.1	6.1	5.6	3.3	4.9	3.1	3.2	6.2	2.1	2.4	2.5	2.8	3.6	2.3	2.1	2.4	2.1	2.3	2.4	2.4	3.2	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	3.6	0.0	0.0	0.0	0.0	0.0	4.0	5.9	0.0	3.9	3.1	0.0	1.9	1.8	0.8	0.0	0.0	0.0	2.9	3.8	0.9	0.0	2.1	0.0	2.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.1	1.8	2.1	0.0	0.0
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 168.5;liver: 398.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 307.7;Proximal tubular cells: 435.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023314, HPA078682"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA023314: AB_1856830, HPA078682: "	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favorable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	37.5	9.4	8.1	4.0	9.4	9.5	36.3	12.6	9.5	13.6	7.1	17.5	13.8	7.6	4.9	59.2	13.1	7.7	5.7	8.8	8.5	168.5	398.7	10.3	9.0	10.8	9.3	11.7	8.8	85.7	4.1	7.7	10.7	10.1	6.1	3.1	30.0	10.0	18.8	22.6	24.4	3.7	8.0	21.7	13.3	12.8	9.4	21.1	23.5	18.6	17.6	11.5	19.3	16.0	39.6	28.9	5.5	34.5	29.9	15.8	63.0	11.3	10.3	30.8	31.2	22.1	22.5	26.8	27.8	3.6	16.4	18.8	32.4	39.7	24.3	17.3	30.6	13.0	39.9	21.6	7.2	4.4	11.0	21.1	13.6	23.1	7.2	10.9	9.7	32.3	10.0	10.9	11.3	12.4	46.0	13.9	17.4	43.6	5.1	29.7	48.5	34.7	69.3	17.0	24.0	5.3	82.7	14.9	21.4	50.2	64.5	19.4	2.6	5.7	14.0	71.4	17.6	10.7	20.5	7.1	10.3	12.7	16.5	10.2	4.7	5.2	5.3	5.9	8.1	4.4	6.6	5.5	3.5	3.7	6.8	6.4	0.2	8.5	5.2	1.1	11.2	4.3	8.1	9.4	12.6	9.5	8.8	8.5	10.8	9.3	10.7	8.0	9.4	16.0	11.2	12.8	31.0	3.3	10.4	10.3	21.7	16.5	18.8	3.1	22.7	13.8	2.7	42.9	11.2	36.8	4.2	23.7	5.2	8.9	82.2	13.7	10.9	6.2	1.9	7.4	1.2	28.0	5.2	7.7	76.1	8.0	9.2	10.1	8.2	9.9	13.6	307.7	39.6	0.0	4.8	12.9	4.1	36.8	3.5	5.5	5.9	17.2	12.4	9.4	4.4	33.8	5.2	2.0	11.4	5.3	9.7	3.0	20.3	5.9	53.7	435.7	3.5	4.2	19.7	8.1	4.4	30.0	21.4	35.4	10.5	8.5	10.1	4.9	32.2	10.9
SHOC2	"KIAA0862, SOC-2, SOC2, SUR-8, SUR8"	ENSG00000108061	"SHOC2 leucine rich repeat scaffold protein"	Q9UQ13	10	110919593-111013666	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009164, HPA048134"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA009164: AB_1079960, HPA048134: "	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.97e-3)"	"unprognostic (8.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.67e-1)"	25.0	16.3	16.4	22.5	17.8	45.7	19.3	19.3	22.1	20.3	12.0	20.4	16.4	20.7	21.0	21.6	16.4	20.1	19.5	19.4	22.3	21.9	23.7	17.9	29.9	16.6	21.7	19.8	20.4	30.3	14.6	20.8	22.0	18.0	21.5	19.7	14.2	17.5	21.3	15.4	18.4	23.3	16.4	22.2	17.3	36.4	18.2	26.9	25.2	26.8	31.2	25.0	14.8	15.5	29.2	17.8	22.7	38.2	50.9	51.2	14.5	35.0	51.9	31.9	38.5	16.5	25.8	63.1	17.1	62.8	19.9	24.1	27.8	25.0	46.2	34.7	16.5	28.8	25.7	16.2	37.0	49.6	49.4	57.3	38.6	36.9	69.1	43.6	32.8	22.1	18.3	43.8	45.7	15.6	24.7	38.9	14.1	15.6	18.6	34.8	45.2	18.1	33.3	19.4	11.7	23.4	30.7	15.0	34.9	25.8	77.2	41.5	33.3	25.6	22.6	32.5	24.3	40.2	44.0	100.1	30.6	50.3	18.6	52.3	22.8	33.5	12.6	26.8	15.5	30.3	14.8	15.0	22.3	24.4	15.6	15.2	65.8	19.5	27.8	15.2	19.2	23.9	16.4	17.8	19.3	22.1	19.4	22.3	16.6	21.7	22.0	16.4	18.2	15.5	73.8	54.5	48.1	35.6	95.4	55.8	35.2	37.5	27.9	27.6	51.4	39.1	83.6	45.8	42.3	31.3	16.7	22.2	77.5	80.8	64.6	48.5	44.2	65.1	54.6	63.5	26.3	67.5	59.9	59.2	23.0	50.7	49.5	54.9	73.4	20.2	53.2	69.0	29.4	30.3	53.1	36.2	46.8	78.3	67.3	89.7	65.6	76.0	49.8	57.1	116.5	31.5	57.7	46.3	61.0	64.0	51.6	80.9	53.4	37.1	51.7	67.7	57.0	32.7	72.3	59.9	58.7	108.8	69.3	38.1	69.9	60.6	65.8	17.0	30.1	49.7
SHOX	"GCFX, PHOG, SHOXY, SS"	ENSG00000185960	"Short stature homeobox"	O15266	X	624344-659411	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 7.6"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 2.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 7.6;pons: 7.5"	"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"BJ: 18.5;BJ hTERT+: 8.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"midbrain: 2.7;thalamus: 3.8"	"HPA035141, HPA060931"			Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA035141: AB_2674489, HPA060931: AB_2684388"	"unprognostic (7.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.82e-2)"			"unprognostic (2.45e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.67e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.38e-1)"	0.7	0.4	0.2	0.3	0.3	0.9	0.2	1.4	0.6	0.0	0.0	0.2	0.6	0.1	0.3	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.3	1.2	7.6	0.1	0.3	0.2	0.0	0.1	7.5	0.3	0.2	0.4	0.6	0.0	1.2	0.4	0.4	0.1	0.1	0.7	0.2	0.1	1.4	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.1	0.1	0.2	0.1	3.0	18.5	8.4	2.7	2.9	0.3	0.2	0.2	0.1	0.4	0.7	0.2	0.2	0.0	0.9	0.1	0.1	0.1	1.4	0.1	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.8	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.2	0.1	0.1	0.0	2.9	0.6	0.6	0.4	0.3	0.4	0.5	0.3	0.3	0.1	0.7	0.4	0.5	1.7	0.7	0.6	0.6	0.3	0.3	0.2	0.3	1.4	0.6	0.2	0.2	1.2	7.6	7.5	0.1	1.4	1.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2
SHPK	"CARKL, SHK"	ENSG00000197417	Sedoheptulokinase	Q9UHJ6	17	3608240-3636250	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 19.1;Proximal enterocytes: 18.9;Rod photoreceptor cells: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024361, HPA064939"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA		350000	"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear speckles"		"HPA024361: AB_1846030, HPA064939: AB_2685388"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	7.4	9.9	3.5	3.9	5.0	4.8	6.9	4.1	4.4	9.8	3.1	6.4	13.5	4.8	2.9	9.4	6.2	3.6	4.5	3.4	3.5	10.2	23.3	4.7	3.9	3.9	4.8	7.5	10.9	8.6	4.5	6.2	4.2	5.7	6.0	7.1	7.0	5.4	3.3	9.7	11.5	3.5	3.0	4.4	8.4	4.2	4.3	4.5	5.5	3.3	5.3	5.6	7.8	8.7	6.7	13.5	14.0	9.1	5.7	5.7	7.8	4.4	4.0	8.5	5.0	23.3	6.2	7.9	9.5	8.6	7.9	12.8	18.8	14.3	6.1	12.8	18.3	8.6	11.6	17.0	6.9	7.6	11.8	9.7	6.8	9.4	6.3	7.2	16.1	6.2	11.6	9.8	8.3	12.0	9.8	5.9	7.0	15.3	8.9	13.3	7.3	12.6	12.0	8.5	4.1	10.7	16.2	14.7	4.6	8.4	13.2	4.4	11.6	12.8	6.1	12.5	10.9	3.3	4.5	5.2	13.9	6.7	6.7	1.5	2.2	2.5	1.9	2.3	2.0	2.1	1.8	1.6	3.0	1.5	3.0	1.9	0.4	3.2	1.8	3.2	1.6	2.5	3.5	5.0	4.1	4.4	3.4	3.5	3.9	4.8	4.2	3.0	4.3	8.7	2.6	0.0	3.2	11.1	2.0	0.0	1.0	0.1	3.4	5.9	3.2	2.3	1.0	4.3	0.8	5.5	16.7	10.0	1.1	9.2	1.9	3.3	0.5	2.6	2.5	2.9	3.5	5.2	4.5	4.7	10.1	3.3	4.6	2.9	0.0	5.0	3.6	19.1	8.4	15.2	5.3	6.0	0.0	2.2	0.4	0.4	4.1	2.2	0.0	8.4	2.7	2.5	1.0	4.0	8.2	5.3	6.7	2.6	2.0	2.2	18.9	8.5	1.0	18.2	0.0	4.8	1.8	0.6	1.2	3.0	0.4	5.6	2.1	16.9	6.5	1.8
SHPRH	"bA545I5.2, FLJ90837, KIAA2023"	ENSG00000146414	"SNF2 histone linker PHD RING helicase"	Q149N8	6	145864245-145964423	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Helicase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 210.6;Oligodendrocytes: 164.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034854, HPA044852"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA034854: AB_10964488, HPA044852: "	"unprognostic (3.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (5.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.01e-1)"	4.9	4.2	3.1	4.7	3.7	4.2	7.2	18.4	5.1	5.4	3.2	4.3	4.2	7.7	6.0	4.3	5.2	4.6	3.5	3.0	2.5	5.5	4.6	4.2	6.9	2.8	2.6	12.2	3.9	6.7	2.0	4.5	4.5	5.5	5.0	16.3	5.8	5.1	4.2	9.7	4.5	5.7	2.5	6.4	5.4	7.6	2.9	7.2	8.4	5.2	5.8	4.3	3.3	5.5	4.2	3.2	15.3	9.1	7.0	7.3	7.2	4.9	3.9	5.9	7.6	7.0	2.9	14.5	5.9	3.7	4.6	7.0	9.5	6.9	7.7	6.5	10.9	14.6	7.6	6.1	5.2	31.2	8.6	5.2	7.8	5.6	8.0	5.8	6.4	10.0	20.3	7.9	5.1	3.7	19.8	11.6	10.3	6.9	5.4	14.1	23.6	5.0	8.0	4.1	12.6	8.8	8.7	7.9	5.4	10.5	4.2	14.6	7.2	3.7	7.0	7.4	5.8	6.4	9.4	17.1	3.9	13.0	6.0	0.7	0.9	1.9	1.7	0.9	1.5	1.5	1.4	1.1	1.1	2.5	1.5	1.3	0.0	1.5	1.0	2.0	1.4	0.5	3.1	3.7	18.4	5.1	3.0	2.5	2.8	2.6	4.5	2.5	2.9	5.5	31.4	28.9	23.4	106.7	31.0	21.2	17.9	14.5	19.4	117.2	21.5	20.3	17.2	20.0	20.7	22.0	210.6	16.1	34.6	9.1	7.9	18.6	20.4	20.9	52.8	26.0	19.2	15.3	131.0	12.9	7.0	25.9	23.9	18.1	13.3	145.7	15.7	20.5	12.0	94.2	140.3	14.7	6.1	21.4	9.8	8.0	50.7	19.8	14.2	93.7	30.6	40.7	36.0	143.7	164.6	15.9	8.8	34.3	23.5	18.8	17.2	7.5	14.9	158.5	72.3	47.1	39.1	83.2	65.0	16.5	19.7	6.6	26.4	61.5	18.0	12.5
SHQ1	"FLJ10539, Shq1p"	ENSG00000144736	"SHQ1, H/ACA ribonucleoprotein assembly factor"	Q6PI26	3	72749277-72861914	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042792	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA042792: AB_10959736"	"unprognostic (1.10e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.83e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.05e-1)"	"unprognostic (4.54e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.30e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	5.9	7.0	7.3	8.1	10.1	9.2	8.1	7.1	7.6	6.7	6.1	8.8	6.7	7.1	11.4	6.4	10.7	5.6	10.1	5.1	6.6	7.4	8.0	6.2	8.9	7.1	7.0	7.6	7.0	8.5	4.6	5.3	7.4	5.7	8.7	5.5	5.7	6.0	9.1	7.5	6.1	8.0	5.2	7.0	6.4	10.0	8.0	15.3	8.2	8.6	10.0	8.4	5.1	10.4	13.5	18.1	12.0	20.3	15.7	19.2	12.1	21.8	15.8	22.4	24.6	14.5	10.7	22.4	10.2	15.2	18.2	10.9	24.9	20.5	27.5	20.1	19.6	23.3	14.1	17.3	15.9	39.7	18.8	19.2	15.4	33.1	13.6	10.4	21.2	35.8	19.0	13.5	18.5	20.2	113.4	14.1	33.9	41.5	22.7	27.1	18.8	17.3	19.7	17.6	7.6	30.4	20.3	14.3	10.6	16.0	14.7	14.9	15.1	18.0	17.5	30.1	19.5	24.9	53.8	32.7	16.1	32.0	18.3	0.9	11.9	4.3	14.2	13.5	19.1	13.7	15.8	15.4	12.3	13.3	17.7	15.4	0.5	24.2	12.3	17.6	14.4	14.5	7.3	10.1	7.1	7.6	5.1	6.6	7.1	7.0	7.4	5.2	8.0	10.4	5.9	12.8	6.9	8.8	8.3	13.3	4.3	6.9	5.7	7.5	7.2	5.3	9.5	4.3	6.5	5.5	0.0	6.1	9.9	4.3	7.9	8.6	6.9	11.5	9.6	9.1	4.2	10.3	12.1	6.1	7.9	7.1	5.6	8.0	15.2	6.6	11.4	7.6	6.9	3.3	13.5	6.8	4.1	6.6	6.2	1.9	5.9	5.7	5.4	20.6	4.1	3.2	2.1	16.1	33.9	6.5	4.3	5.7	6.1	5.1	4.7	5.7	16.2	5.4	0.0	8.0	5.9	9.1	19.5	10.8	10.2	5.7	7.6	14.8	9.3	3.9
SHROOM4	KIAA1202	ENSG00000158352	"Shroom family member 4"	Q9ULL8	X	50591642-50814302	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 463.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.7;HUVEC TERT2: 26.7;RH-30: 5.0;RPTEC TERT1: 5.5;TIME: 10.0;WM-115: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010089, HPA010565"	Uncertain		Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites"	"Nucleoplasm, Vesicles"	"HPA010089: , HPA010565: AB_1079961"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.30e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (7.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	8.1	1.8	9.8	1.9	20.0	1.2	5.4	17.1	12.4	3.3	0.9	1.8	1.1	3.6	1.6	2.7	2.2	3.0	7.8	8.9	12.6	5.3	0.9	13.3	0.9	23.8	17.6	1.3	0.9	1.9	2.0	9.0	21.8	2.2	1.4	1.3	2.0	1.8	3.6	1.7	1.5	4.1	13.8	1.0	1.3	0.6	17.3	0.6	3.3	5.0	1.0	3.5	2.3	30.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	6.7	0.9	0.0	0.6	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.0	0.0	5.5	2.5	0.1	0.0	0.0	0.8	1.5	3.6	0.1	0.1	10.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	1.3	0.2	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	20.0	17.1	12.4	8.9	12.6	23.8	17.6	21.8	13.8	17.3	30.7	45.0	25.6	18.6	3.3	0.0	3.6	2.0	1.9	2.2	0.3	1.0	1.5	4.2	0.0	2.0	5.5	0.0	0.6	0.2	1.1	3.9	0.7	0.1	2.8	5.4	46.5	3.0	0.0	1.1	0.2	3.0	3.0	0.0	2.9	3.8	2.3	30.7	0.9	0.5	0.0	1.1	2.8	0.0	2.4	2.7	0.6	1.2	0.6	0.0	51.5	0.0	3.6	0.0	126.7	463.4	2.3	1.0	1.2	0.0	1.2	0.3	3.5	2.5	0.6	0.0	2.5	2.6	0.0	1.0	2.0	3.1	0.3	0.6	3.0	3.2	1.6
SHTN1	"KIAA1598, shootin-1, shootin1"	ENSG00000187164	"Shootin 1"	A0MZ66	10	116881477-117126586	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 128.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 19.7;intermediate monocyte: 12.9;myeloid DC: 19.3;non-classical monocyte: 6.6;plasmacytoid DC: 12.9"	"Group enriched"	"Detected in many"	42	"dendritic cells: 19.3;monocytes: 19.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037942, HPA037943"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA037942: AB_2675748, HPA037943: AB_10671637"	"unprognostic (1.00e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.08e-6)"	1.9	4.0	63.2	4.5	94.5	0.7	4.9	42.7	54.1	2.9	10.0	4.3	4.1	2.4	4.6	3.1	2.9	3.8	1.6	46.9	73.9	4.7	7.6	6.2	2.9	77.5	70.1	3.9	12.2	8.0	6.2	3.1	69.5	4.2	5.2	10.6	6.7	1.4	0.3	5.6	4.8	2.0	48.6	4.5	5.7	6.4	79.5	2.7	7.5	0.8	2.3	2.1	2.1	128.1	24.2	13.4	1.3	2.8	0.0	0.0	12.8	2.0	5.3	4.0	7.6	15.1	15.5	0.0	4.0	7.4	11.8	12.2	10.6	8.9	4.1	0.0	11.0	0.0	14.5	8.9	1.7	4.3	3.7	0.5	7.5	4.0	7.5	10.3	9.7	6.4	6.7	0.1	2.8	9.6	0.0	0.1	5.0	4.8	8.9	0.0	17.5	5.4	10.3	3.3	14.5	5.7	16.0	23.3	13.8	15.7	18.4	3.8	17.0	1.4	9.4	0.1	11.7	2.4	0.1	0.0	7.1	0.0	7.2	0.0	19.7	0.2	0.0	12.9	0.0	0.0	0.1	0.0	19.3	0.0	0.1	0.0	0.4	0.0	6.6	12.9	0.4	5.6	63.2	94.5	42.7	54.1	46.9	73.9	77.5	70.1	69.5	48.6	79.5	128.1	1.4	76.9	35.7	0.0	2.0	0.0	18.9	0.0	15.4	92.3	31.8	15.9	4.9	35.8	23.5	23.9	62.6	42.1	24.7	10.6	21.5	46.4	7.5	43.4	10.6	5.1	17.0	1.7	0.0	53.2	30.9	11.2	36.7	81.1	2.5	23.6	1.8	50.5	37.3	48.8	0.0	15.5	0.0	83.6	0.0	11.7	11.1	77.2	0.0	0.0	90.3	13.8	1.0	0.0	0.0	46.2	42.5	5.3	0.8	25.2	21.2	58.4	18.2	59.4	13.1	18.2	5.0	22.0	39.6	20.5	0.0	20.0	3.1	28.4	15.7	15.4
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 187.4;Syncytiotrophoblasts: 746.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	23.3	14.1	12.0	10.8	13.9	28.2	22.8	16.2	16.0	19.3	13.3	15.9	16.0	19.4	15.6	14.0	17.4	15.8	15.0	12.3	12.4	14.6	22.6	17.6	14.0	13.6	14.6	19.2	14.1	14.6	10.3	50.1	13.2	16.8	14.6	19.1	16.1	13.8	21.5	22.3	16.2	14.5	12.2	13.4	15.7	23.3	13.5	14.1	17.5	17.3	13.0	14.1	17.1	16.9	15.5	13.7	29.1	26.3	24.5	21.3	29.6	14.2	19.2	20.6	10.1	10.5	19.7	20.1	15.3	18.0	14.4	17.6	20.3	20.7	25.3	8.1	16.4	10.8	10.6	27.8	34.2	10.7	15.8	25.8	36.5	12.1	27.9	23.1	17.5	18.5	17.7	18.4	17.0	10.6	29.1	21.9	35.5	17.1	21.0	33.3	43.7	21.3	19.5	19.3	33.1	29.3	42.0	20.9	37.7	24.8	13.3	24.4	18.8	22.0	19.8	12.0	15.4	24.0	10.7	36.8	16.3	13.1	20.2	13.7	8.1	35.4	4.1	3.6	4.5	20.4	4.4	6.3	13.0	19.2	8.7	6.6	4.7	8.7	2.2	12.5	2.5	5.8	12.0	13.9	16.2	16.0	12.3	12.4	13.6	14.6	13.2	12.2	13.5	16.9	43.0	12.8	9.7	8.8	24.7	85.7	55.7	45.0	71.2	22.3	43.5	32.0	13.3	20.0	20.5	16.5	8.4	187.4	15.3	27.3	31.3	24.5	70.5	21.9	26.7	35.7	22.6	27.0	20.1	22.7	34.0	42.5	21.9	34.5	4.5	37.8	33.9	23.6	34.3	35.3	20.9	17.8	40.7	20.3	99.2	71.3	22.7	31.1	49.8	23.4	27.0	38.3	4.1	25.6	40.2	22.3	18.2	19.5	17.9	49.7	23.5	28.9	17.0	18.6	19.7	36.2	34.4	70.0	51.0	67.7	75.7	746.2	17.3	17.4	20.6	50.8
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741125-150763477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 226.7;Syncytiotrophoblasts: 389.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	15.8	78.6	16.4	20.8	19.0	44.7	17.1	17.4	24.9	48.0	17.3	17.7	13.5	33.4	18.6	46.1	27.2	14.3	16.2	16.9	16.7	12.1	61.2	13.2	35.8	15.8	15.5	24.4	20.9	15.9	11.0	43.1	17.9	19.4	15.4	7.8	16.4	34.7	12.3	30.4	12.9	29.4	15.5	24.4	17.9	8.0	16.5	25.1	8.0	12.8	45.3	23.5	39.6	26.0	54.0	13.4	10.5	20.1	35.4	26.4	41.7	22.9	26.5	27.3	32.4	28.4	24.7	31.3	31.0	24.1	22.8	31.4	28.6	20.7	25.6	24.4	19.5	61.5	16.0	94.7	50.4	34.3	16.0	24.1	47.0	16.3	36.9	21.7	21.5	60.2	15.5	110.8	17.4	66.4	58.7	17.4	33.1	52.3	26.0	44.0	22.7	110.4	17.4	17.9	38.4	19.1	17.4	15.4	39.8	23.8	99.5	50.0	15.0	17.7	15.8	40.1	31.0	130.6	55.9	42.0	17.6	48.6	9.2	8.9	2.2	8.6	1.6	1.2	2.5	2.2	2.8	2.5	2.0	2.2	1.4	1.4	4.7	1.4	1.3	2.6	1.6	0.9	16.4	19.0	17.4	24.9	16.9	16.7	15.8	15.5	17.9	15.5	16.5	26.0	15.9	6.4	4.8	6.8	99.0	146.7	82.3	11.8	153.1	47.0	32.3	22.2	17.8	25.8	11.7	22.0	37.5	192.0	62.6	30.2	13.7	8.5	3.4	56.0	29.2	22.5	38.3	226.7	14.1	6.6	23.4	28.8	44.4	96.5	10.2	18.7	20.7	54.4	32.6	35.3	11.0	39.9	14.2	115.5	102.7	2.1	44.1	70.4	44.4	14.0	22.7	32.7	32.0	5.0	11.5	10.5	17.9	30.9	128.7	56.7	20.7	17.9	16.5	2.8	13.1	11.8	29.9	0.7	10.8	154.1	142.4	389.4	86.1	28.6	34.5	81.8
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777242-45851753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;fallopian tube: 3.1"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 28.6;Inhibitory neurons: 35.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.5;ovarian cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"EFO-21: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060576	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA060576: AB_2684325"	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.0	0.2	0.7	0.1	0.9	0.1	0.0	2.3	0.8	0.9	0.0	0.0	0.0	0.3	0.3	0.0	3.1	0.0	0.0	0.6	0.7	0.6	0.0	0.0	0.0	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.3	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	2.3	0.8	0.6	0.7	0.8	3.0	0.8	0.6	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	1.8	2.1	0.0	0.0	0.0	1.9	0.0	0.0	28.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1
SIGLEC11		ENSG00000161640	"Sialic acid binding Ig like lectin 11"	Q96RL6	19	49948985-49961172	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 23.1;ovary: 65.5"	"Group enriched"	"Detected in some"	7	"Granulosa cells: 196.9;Theca cells: 192.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.4;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.4;monocytes: 1.3"	"Cell line enriched"	"Detected in single"	16	"HEL: 10.1"									"HPA052132, HPA060278"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA052132: , HPA060278: AB_2684240"	"unprognostic (1.07e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.38e-2)"	1.1	7.3	0.5	1.8	0.8	0.4	0.4	0.4	0.7	0.3	0.6	0.5	0.8	0.3	0.2	0.1	0.9	0.3	0.4	0.6	0.6	0.4	1.7	1.7	0.6	1.4	1.0	65.5	2.7	0.1	0.2	1.8	1.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	1.0	1.2	0.8	23.1	4.7	1.5	1.6	0.1	0.2	0.1	0.0	0.6	0.2	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	10.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.3	1.4	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.1	0.5	0.8	0.4	0.7	0.6	0.6	1.4	1.0	1.3	0.8	1.6	1.4	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	19.6	0.0	0.6	0.2	0.3	1.0	0.0	0.0	0.0	1.1	0.1	4.3	0.0	0.3	0.0	196.9	5.3	0.6	7.9	0.0	0.0	0.0	0.0	26.8	0.2	0.1	0.0	6.1	0.0	5.6	1.3	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	7.5	1.7	0.7	0.0	0.1	0.1	0.2	192.3	0.0	0.0
SIGLEC15	"CD33L3, HsT1361"	ENSG00000197046	"Sialic acid binding Ig like lectin 15"	Q6ZMC9	18	45825675-45844094	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 1.7;intestine: 3.0;urinary bladder: 1.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 3.6;Hofbauer cells: 10.1;Macrophages: 3.7;Pancreatic endocrine cells: 3.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.0;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.0;monocytes: 3.0"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 124.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053509			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA053509: "	"unprognostic (3.89e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (9.14e-5)"	0.0	0.4	0.1	0.3	0.4	0.0	1.7	0.6	0.3	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0	1.0	1.3	0.0	0.0	0.2	0.0	0.0	0.6	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.9	0.3	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	2.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.4	10.9	2.1	0.3	0.0	22.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	5.5	0.0	0.1	1.3	0.0	0.0	0.0	124.2	2.9	0.2	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.9	1.3	0.0	0.0	1.0	3.6	0.9	0.8	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.5	0.4	0.2	1.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.7	0.0	0.0	2.2	0.4	10.1	1.7	0.1	0.2	0.0	1.6	2.5	0.0	0.0	3.7	0.0	0.0	1.6	0.0	1.0	0.0	0.0	3.5	0.1	0.0	0.0	1.1	1.2	0.1	0.0	1.0	0.0	1.5	0.4	1.2	0.1	0.0	0.3	0.0	0.3	0.0	0.1	2.8
SIK1	"msk, SNF1LK"	ENSG00000142178	"Salt inducible kinase 1"	P57059	21	43414483-43427131	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell cycle, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 88.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 302.0;Basal respiratory cells: 123.5;Langerhans cells: 141.9;Suprabasal keratinocytes: 422.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.3;HeLa: 63.1;hTCEpi: 45.4;LHCN-M2: 45.5;U-266/84: 37.7"	"Low region specificity"	"Detected in all"							"CAB023801, HPA038211, HPA078064"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 61: Skin - Cornification"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Vesicles	"CAB023801: , HPA038211: AB_2675894, HPA078064: "	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.82e-1)"	24.5	8.3	0.7	6.2	0.4	10.5	19.5	0.5	1.8	17.5	0.8	7.0	0.4	4.4	0.0	18.5	18.6	15.1	16.0	0.3	1.1	5.1	20.9	12.7	4.3	1.0	1.0	26.9	11.8	5.9	12.5	12.5	0.8	9.2	0.7	8.5	12.1	13.3	13.0	88.0	5.4	5.3	0.0	7.2	12.2	3.0	0.7	11.0	6.2	1.3	4.6	16.9	14.4	0.5	1.2	3.4	4.3	0.1	0.3	1.6	1.7	2.0	0.7	3.5	2.7	5.1	0.1	5.4	1.5	0.4	19.8	23.6	3.5	35.3	2.0	0.3	1.1	1.6	63.1	2.0	4.8	1.7	0.2	2.1	45.4	0.9	10.7	20.7	0.7	0.1	0.2	0.2	45.5	0.3	0.9	3.9	1.9	0.0	3.4	0.1	0.8	5.7	4.0	13.3	0.1	0.0	24.2	4.0	0.8	0.7	2.3	0.6	8.1	0.9	4.2	0.4	0.1	9.5	37.7	1.0	10.0	4.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.5	1.8	0.3	1.1	1.0	1.0	0.8	0.0	0.7	0.5	23.7	28.9	77.3	0.0	18.4	302.0	0.8	123.5	26.7	0.3	8.6	6.3	11.7	7.2	68.4	12.9	0.0	0.8	13.4	16.4	0.0	3.2	0.0	23.2	4.8	18.4	27.6	0.0	0.0	2.1	1.3	11.1	15.3	29.1	19.6	2.3	4.2	7.7	1.7	0.0	0.0	16.5	85.5	3.8	141.9	0.1	0.0	10.1	96.0	0.0	1.6	1.3	0.0	0.0	0.0	7.3	24.3	0.0	36.3	0.5	23.8	0.2	50.7	0.2	0.0	2.4	27.4	0.1	0.4	35.1	422.7	2.5	16.4	0.8	20.3	1.2
SIK1B		ENSG00000275993	"Salt inducible kinase 1B (putative)"	A0A0B4J2F2	21	6111131-6123778	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 243.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.9;Alveolar cells type 1: 25.6;Alveolar cells type 2: 27.2;Endometrial ciliated cells: 17.1;Glandular and luminal cells: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 95.3;hTERT-RPE1: 117.7;Karpas-707: 120.6;LHCN-M2: 83.0;SiHa: 87.2"									"HPA038211, HPA078064"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"HPA038211: AB_2675894, HPA078064: "	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.58e-3)"	"unprognostic (2.62e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.69e-3)"	"unprognostic (7.41e-2)"	67.6	52.0	6.5	16.1	5.6	42.4	53.5	5.3	12.3	21.8	7.4	22.2	7.6	16.2	0.4	32.0	31.0	30.4	49.9	6.1	11.2	21.8	71.2	38.1	9.8	10.7	8.0	93.5	47.0	8.0	39.5	14.2	8.3	33.5	12.3	20.9	41.5	41.6	40.1	243.9	17.4	10.5	6.2	18.0	37.5	7.3	7.1	8.2	17.9	4.3	4.7	44.3	46.7	5.7	9.5	47.5	3.5	3.0	0.7	0.4	8.3	1.1	0.6	1.7	1.0	53.3	7.0	3.2	1.4	0.2	7.1	0.8	5.5	0.0	0.6	8.9	1.7	7.4	95.3	10.3	3.1	1.2	0.7	1.2	39.6	4.8	26.5	117.7	2.0	1.5	3.0	120.6	83.0	4.7	0.9	2.3	4.9	8.8	5.1	2.0	21.1	14.3	4.6	16.4	4.4	2.1	87.2	5.5	5.0	2.3	0.9	4.1	2.3	1.4	4.4	2.0	19.9	15.9	37.7	1.6	12.6	3.0	5.6	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.6	1.8	0.0	0.0	6.5	5.6	5.3	12.3	6.1	11.2	10.7	8.0	8.3	6.2	7.1	5.7	11.9	25.6	27.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	4.0	2.7	0.0	0.0	3.7	1.8	0.0	0.7	4.1	0.0	0.0	0.5	0.0	17.1	3.4	1.4	0.0	0.0	0.0	0.2	0.9	1.5	0.0	30.0	6.3	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.1	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.5	2.4	0.0	0.0	0.0
SIK2	"DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2"	ENSG00000170145	"Salt inducible kinase 2"	Q9H0K1	11	111602449-111730855	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.3;Excitatory neurons: 217.6;Inhibitory neurons: 132.4;Oligodendrocytes: 191.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC diff: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016026, HPA071049"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"	"Nuclear speckles, Intermediate filaments, Cytosol"	"HPA016026: AB_1857321, HPA071049: "	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.17e-9)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.13e-2)"	29.7	9.3	9.2	5.3	12.4	3.1	20.7	7.9	11.1	7.6	11.0	7.9	5.9	7.3	5.0	5.9	8.1	10.0	12.3	9.5	14.7	11.4	22.7	11.7	4.4	11.9	11.9	14.9	31.8	21.3	16.6	5.8	10.6	6.7	6.2	30.7	13.8	6.2	33.1	8.9	7.5	5.9	5.5	4.6	17.6	3.0	9.3	5.4	8.7	23.2	4.3	7.7	6.1	11.6	9.2	6.0	10.3	11.1	50.3	14.8	6.1	7.9	11.2	5.9	6.7	20.5	9.6	7.2	10.7	9.2	6.9	12.7	8.2	5.9	7.6	5.4	3.4	7.9	5.2	10.1	10.9	7.7	4.9	14.5	8.6	8.7	11.1	11.7	7.1	7.1	7.4	10.3	9.4	4.3	8.0	7.0	3.5	7.6	5.9	10.6	11.0	8.7	13.1	8.2	4.8	11.3	11.6	4.7	4.5	9.4	11.5	6.2	9.9	12.9	7.7	8.3	10.9	2.9	2.4	14.8	4.2	10.6	8.8	0.3	0.7	0.6	0.7	0.7	0.3	0.4	0.5	0.5	0.6	0.4	0.2	0.4	0.3	0.5	0.6	0.3	0.5	0.5	9.2	12.4	7.9	11.1	9.5	14.7	11.9	11.9	10.6	5.5	9.3	11.6	22.1	19.2	24.8	113.3	14.1	14.7	6.2	5.2	18.2	15.7	10.5	9.9	21.3	27.1	10.0	16.5	66.7	4.4	11.4	15.6	5.9	10.4	16.5	27.7	14.9	18.8	18.0	12.4	217.6	7.9	4.6	20.1	27.5	45.3	9.5	24.3	9.3	38.7	5.4	32.0	132.4	11.3	4.1	12.4	16.9	14.1	11.5	13.3	19.6	73.1	6.0	14.5	4.1	86.0	191.9	8.4	10.3	14.7	8.9	6.9	8.3	23.1	13.4	60.9	0.0	19.1	19.0	3.9	6.4	10.3	11.9	5.2	12.6	5.0	11.5	7.1
SIK3	"FLJ12240, KIAA0999, L19, QSK"	ENSG00000160584	"SIK family kinase 3"	Q9Y2K2	11	116843402-117098437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 375.5;Excitatory neurons: 384.4;Inhibitory neurons: 399.6;Oligodendrocyte precursor cells: 457.9;Oligodendrocytes: 1679.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045245, HPA048161"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA045245: AB_2679270, HPA048161: AB_2680293"	"unprognostic (3.19e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.82e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	10.1	7.2	19.3	11.4	36.6	12.7	9.2	15.0	34.3	9.6	0.0	11.7	8.5	12.6	7.2	10.4	12.4	9.8	12.8	19.7	19.4	10.3	13.8	9.7	9.9	22.0	23.1	16.5	15.4	17.7	10.0	12.1	22.5	8.2	8.8	19.1	9.8	11.3	19.5	7.5	8.7	14.1	11.5	11.8	9.7	21.4	36.1	12.3	17.1	14.4	10.4	10.1	7.5	41.1	11.8	8.9	13.9	14.7	11.7	12.6	22.2	8.8	15.7	6.8	7.6	21.8	13.3	13.9	14.0	16.3	15.0	18.1	11.6	12.7	9.4	38.5	7.4	31.2	9.7	13.6	10.9	11.2	11.8	13.9	7.2	14.5	23.3	8.7	9.2	9.0	15.2	10.1	9.4	4.0	10.2	12.1	7.7	8.0	6.6	12.9	8.0	11.1	9.3	2.2	13.5	10.8	23.7	10.3	4.4	10.5	6.8	11.8	10.6	8.3	10.4	14.0	8.9	7.1	5.6	17.5	7.7	18.2	11.4	2.0	0.4	0.0	0.3	0.5	0.5	0.1	0.3	0.1	0.6	1.0	0.0	0.0	0.9	0.6	1.5	0.0	0.0	0.2	19.3	36.6	15.0	34.3	19.7	19.4	22.0	23.1	22.5	11.5	36.1	41.1	25.8	9.6	22.1	375.5	34.9	26.5	26.0	6.8	7.4	42.6	26.1	21.5	22.2	10.0	12.4	5.5	112.6	8.7	47.3	12.5	5.9	7.6	89.2	64.4	27.9	20.4	17.3	12.4	384.4	7.3	2.8	22.1	12.8	71.5	17.2	37.4	17.2	26.3	7.7	47.1	399.6	11.1	6.1	21.7	45.1	214.9	10.2	31.4	16.0	161.1	25.6	36.3	12.3	457.9	1679.9	9.2	8.2	14.3	28.1	22.0	9.7	6.9	20.5	63.9	0.0	35.0	23.2	18.0	14.8	7.4	24.3	29.7	44.2	14.8	11.4	30.0
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"SIM bHLH transcription factor 2"	Q14190	21	36699115-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 31.1;kidney: 61.3"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 100.7;Squamous epithelial cells: 68.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 24.9;PC-3: 43.0;RPTEC TERT1: 54.3;RT4: 33.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (2.88e-4)"	0.3	0.3	1.8	0.0	1.1	0.0	0.4	0.7	1.4	2.3	0.4	0.5	0.0	0.5	0.8	31.1	0.6	0.0	0.2	1.5	2.5	61.3	0.4	0.2	0.0	0.7	1.4	0.2	0.3	1.8	1.6	0.0	0.5	6.6	0.0	0.0	0.6	0.0	10.6	0.5	0.3	0.0	0.5	0.3	9.5	0.4	2.4	0.0	0.4	0.0	3.5	0.7	0.7	0.7	6.4	9.6	0.0	0.3	0.0	0.0	9.4	0.0	0.0	0.9	0.0	5.0	14.7	0.0	8.6	0.2	17.0	3.2	4.8	0.0	0.5	7.8	15.0	0.0	14.3	0.3	0.0	0.0	0.0	1.6	1.4	0.0	2.6	24.9	0.0	0.0	0.0	0.0	16.0	3.7	0.0	0.0	0.0	6.4	43.0	0.0	0.0	0.0	54.3	33.5	0.4	0.0	15.7	0.0	0.9	1.6	4.1	0.0	0.6	0.0	2.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	0.7	1.4	1.5	2.5	0.7	1.4	0.5	0.5	2.4	0.7	0.2	0.0	0.0	0.0	0.0	0.3	19.1	0.0	100.7	0.2	0.1	0.1	2.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	9.8	0.1	2.2	0.3	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.8	12.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	5.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	7.1	1.1	0.0	0.0	0.0	1.3	9.5	0.1	0.2	0.0	0.5	0.0	1.5	0.9	0.5	0.2	68.3	0.4	0.0	0.4	0.0	0.2	4.0
SIMC1	"C5orf25, FLJ44216, OOMA1, PLEIAD"	ENSG00000170085	"SUMO interacting motifs containing 1"	Q8NDZ2	5	176238367-176345991	"Predicted intracellular proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 47.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.2;Inhibitory neurons: 57.4;Spermatocytes: 83.1;Theca cells: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037889, HPA037890"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA037889: AB_2675720, HPA037890: AB_2675721"	"unprognostic (1.15e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (2.32e-6)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.20e-2)"	5.3	28.0	6.8	4.0	6.2	3.8	4.3	7.0	6.8	12.0	7.5	7.1	5.8	12.2	9.9	4.3	13.4	4.0	4.1	6.0	7.3	3.9	8.7	5.0	5.3	4.7	5.0	47.0	6.5	6.0	14.1	5.1	5.3	9.6	6.9	4.6	3.7	6.5	12.1	5.4	7.5	8.5	3.9	10.2	10.2	33.5	8.2	6.8	4.0	4.4	5.5	8.4	6.4	5.9	2.8	6.9	21.6	17.2	11.1	11.3	11.2	9.6	8.7	9.8	11.2	25.7	7.3	0.1	11.5	10.7	20.0	2.5	24.2	18.1	11.9	4.8	17.9	12.7	4.7	3.3	24.5	13.7	9.3	7.4	7.1	6.4	12.1	6.9	9.3	4.6	32.6	11.5	11.5	12.5	13.2	12.3	8.2	3.3	7.5	19.2	15.2	16.6	6.8	5.1	14.3	15.0	11.0	1.7	10.6	8.3	6.1	26.4	6.6	11.6	6.2	10.6	8.4	3.1	3.5	18.9	4.3	9.2	6.9	7.2	3.7	7.0	3.3	3.5	4.0	4.4	4.0	2.6	5.2	4.1	3.3	2.7	0.4	7.3	2.8	2.6	2.9	2.7	6.8	6.2	7.0	6.8	6.0	7.3	4.7	5.0	5.3	3.9	8.2	5.9	4.9	9.6	5.6	24.2	12.6	2.9	5.9	3.2	8.6	18.1	2.1	3.0	4.0	2.8	3.4	1.8	4.2	0.4	15.0	8.9	1.9	3.8	46.5	2.9	15.6	3.6	13.2	2.5	49.1	3.6	2.9	9.2	19.9	4.9	0.0	58.2	5.3	7.2	2.2	18.5	57.4	9.9	0.0	5.7	2.0	14.4	29.8	4.2	5.4	30.9	5.7	6.1	11.3	30.7	7.7	4.7	7.8	34.6	5.7	7.1	12.0	1.9	3.0	5.3	32.9	5.6	6.3	83.1	33.8	5.9	2.6	0.8	7.7	102.8	8.9	3.1
SIN3A	"DKFZP434K2235, KIAA0700"	ENSG00000169375	"SIN3 transcription regulator family member A"	Q96ST3	15	75369379-75455842	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004506, HPA047213, HPA062123"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-1)"	19.2	12.4	10.0	19.8	10.9	42.5	18.0	21.0	11.7	21.0	12.5	19.6	13.8	25.6	16.6	19.1	24.3	17.4	14.8	9.6	13.3	15.1	16.0	18.0	25.9	11.7	12.0	30.0	15.3	22.5	12.1	20.1	10.3	19.7	16.1	24.1	16.6	20.7	16.6	21.5	16.3	19.6	8.3	22.1	16.5	29.6	14.0	43.2	27.2	18.7	26.3	20.2	16.7	10.8	31.2	63.6	55.5	36.7	27.0	28.4	32.1	22.9	35.3	33.0	35.2	35.2	41.2	67.8	23.3	34.0	45.0	54.5	81.2	34.4	35.9	55.0	42.1	64.0	46.2	27.9	20.5	61.4	52.5	34.7	26.1	38.5	39.8	34.0	30.0	47.5	51.5	73.2	27.0	36.2	60.7	39.1	54.2	41.3	26.3	60.5	73.3	41.8	23.6	56.4	43.7	43.7	56.6	25.0	31.0	53.0	38.1	47.9	26.4	40.6	54.5	27.2	34.3	49.8	85.0	70.8	24.2	61.2	23.2	2.9	4.2	5.9	6.3	3.8	9.6	7.0	8.1	8.1	5.2	7.7	8.2	7.2	7.3	8.1	7.4	3.5	7.7	5.7	10.0	10.9	21.0	11.7	9.6	13.3	11.7	12.0	10.3	8.3	14.0	10.8	26.0	35.3	32.4	13.7	35.8	39.4	23.6	21.2	60.9	19.7	36.5	25.4	13.4	17.2	30.5	27.6	31.3	23.5	29.0	17.8	5.9	15.1	10.1	35.7	30.8	32.1	17.3	24.4	19.2	12.8	11.1	24.4	15.3	42.1	29.9	30.1	26.0	17.4	13.2	20.2	18.3	19.0	10.2	21.3	31.7	5.8	23.0	19.5	10.6	27.2	18.8	16.8	24.7	16.6	24.1	14.1	14.0	20.3	33.1	29.8	13.7	9.2	33.4	33.8	13.1	34.7	24.7	42.1	42.7	37.5	53.1	21.9	34.6	21.2	19.2	19.4
SIN3B	KIAA0700	ENSG00000127511	"SIN3 transcription regulator family member B"	O75182	19	16829398-16880353	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050329	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA050329: AB_2681089"	"unprognostic (2.71e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (4.37e-4)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (1.18e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	38.6	31.7	30.1	21.7	28.4	12.6	42.0	8.6	33.3	57.2	12.7	35.9	15.0	59.3	24.1	25.9	49.9	20.4	27.3	30.1	22.7	31.6	19.8	43.6	26.8	19.8	21.8	58.0	25.5	37.8	32.3	29.0	27.0	43.9	12.3	10.0	30.9	35.2	24.7	32.9	36.4	30.6	10.3	43.0	27.2	51.7	24.8	13.2	42.8	14.9	18.1	34.0	43.7	24.5	28.1	14.7	24.4	31.5	19.7	18.1	76.8	23.3	19.2	31.6	27.9	36.4	25.7	25.0	25.5	27.2	26.7	23.6	20.4	20.9	29.1	26.2	36.8	27.0	35.6	16.7	25.9	15.8	20.8	29.9	26.9	21.3	18.2	25.1	29.1	19.7	22.2	15.0	22.4	33.7	21.7	25.5	30.4	14.6	46.6	28.4	22.4	16.6	18.0	23.5	18.0	22.5	29.6	22.5	18.4	32.5	15.9	14.7	38.6	30.5	18.5	44.6	26.5	21.3	16.8	25.0	21.1	20.6	23.1	0.1	4.2	3.9	1.0	3.8	0.6	3.5	0.9	1.1	1.3	2.7	1.1	0.8	2.0	1.2	3.4	1.5	0.3	1.5	30.1	28.4	8.6	33.3	30.1	22.7	19.8	21.8	27.0	10.3	24.8	24.5	45.4	22.4	11.9	30.7	18.9	7.9	11.6	7.4	14.2	20.3	14.4	18.4	8.3	1.5	8.6	3.7	14.6	21.9	9.5	7.0	3.9	10.6	11.4	16.3	34.6	18.8	4.9	6.9	29.9	8.6	29.2	16.0	13.7	36.2	5.1	29.9	10.8	7.0	17.6	10.1	29.8	8.4	0.0	14.6	5.5	24.2	50.7	13.9	5.4	19.7	14.6	8.0	10.3	21.6	26.3	14.5	4.0	66.5	22.0	14.2	4.2	7.5	6.9	14.5	6.6	17.5	13.7	9.7	9.2	14.4	8.1	124.9	11.7	34.5	7.3	17.9
SINHCAF	"C12orf14, FAM60A, TERA"	ENSG00000139146	"SIN3-HDAC complex associated factor"	Q9NP50	12	31280584-31327058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 150.5;Extravillous trophoblasts: 118.8;Glandular and luminal cells: 149.3;monocytes: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 600.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038167, HPA057585"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA038167: AB_10675629, HPA057585: AB_2732615"	"unprognostic (2.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.75e-2)"	16.2	11.6	1.1	22.8	2.0	25.6	26.7	2.8	2.0	24.0	10.1	24.3	21.5	51.9	18.0	25.1	36.2	15.2	8.7	1.0	1.1	36.3	7.7	16.6	34.4	2.0	1.5	28.1	22.6	22.6	24.8	26.3	1.5	26.9	25.9	4.0	25.8	30.3	3.2	24.0	19.6	33.3	1.5	17.4	19.5	17.0	1.3	50.9	14.0	3.6	33.6	34.1	23.7	1.4	27.8	29.9	128.7	26.6	8.0	12.0	238.3	10.7	10.3	25.9	36.7	91.6	74.8	95.9	94.9	3.9	26.7	48.1	105.4	48.4	51.0	92.6	42.6	61.7	21.2	66.6	28.4	105.2	54.7	13.0	82.0	21.6	102.2	45.3	61.6	98.9	88.0	39.1	11.4	17.5	173.7	71.7	600.6	81.7	19.0	159.6	62.4	80.0	57.3	67.8	180.0	113.5	26.5	54.1	71.8	280.2	24.6	64.5	58.5	6.0	36.1	2.8	46.4	40.3	50.5	156.9	17.9	42.9	34.0	29.5	12.9	19.8	21.8	15.8	24.8	59.1	30.4	25.9	27.5	48.5	35.8	29.0	3.9	50.4	24.2	71.9	15.3	29.6	1.1	2.0	2.8	2.0	1.0	1.1	2.0	1.5	1.5	1.5	1.3	1.4	31.0	76.9	35.8	0.0	26.5	0.0	0.0	0.0	0.0	0.0	52.3	48.8	0.0	0.0	56.3	46.0	0.0	75.1	37.7	0.0	82.2	70.1	0.0	150.5	37.8	21.8	0.0	0.0	0.0	43.2	118.8	14.9	0.0	149.3	11.4	48.8	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	154.5	0.0	0.0	0.0	0.0	56.0	0.0	0.0	11.1	0.0	0.0	41.1	59.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	60.5	18.6	18.3	0.0	0.0
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638101-65650918	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 95.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.5;NK-cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Nucleoplasm, Golgi apparatus, Plasma membrane"	"CAB020833: , HPA039867: AB_2676716"	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"	21.6	17.2	16.4	48.7	15.5	53.8	16.2	14.1	16.8	20.6	10.3	24.0	12.5	20.9	3.4	14.3	19.5	16.0	25.7	15.8	13.2	17.0	15.0	37.0	60.7	22.3	16.0	13.1	8.4	3.5	7.5	19.4	19.5	17.1	6.0	0.9	14.1	10.0	10.0	8.1	37.8	12.0	19.5	95.6	15.9	4.7	24.5	21.3	14.9	6.4	32.5	18.8	15.3	21.0	1.6	13.3	9.1	20.1	5.4	11.1	21.7	14.9	12.7	11.7	11.3	3.9	14.5	21.3	33.2	7.6	0.4	7.8	3.4	5.1	3.9	22.7	8.1	52.6	20.7	7.4	9.6	21.5	21.5	11.4	2.3	16.2	2.1	11.5	34.4	21.8	30.3	9.2	5.8	5.8	8.6	36.1	6.4	5.4	12.3	38.8	5.1	19.3	4.4	0.8	3.4	20.9	7.5	12.6	31.7	8.5	9.6	32.5	49.2	14.2	28.7	15.2	3.0	14.1	12.2	48.4	19.5	33.0	42.0	3.2	3.3	9.3	5.8	3.9	4.1	4.1	2.8	3.7	2.3	4.7	2.0	3.1	11.1	4.7	4.8	2.1	3.0	3.0	16.4	15.5	14.1	16.8	15.8	13.2	22.3	16.0	19.5	19.5	24.5	21.0	22.5	6.4	5.2	7.5	59.0	6.8	24.7	23.2	17.6	2.1	24.8	26.5	7.2	21.5	19.2	23.9	0.0	10.1	82.5	16.5	37.2	19.8	3.0	8.3	6.8	26.8	21.0	31.6	0.1	14.5	19.6	12.2	11.2	14.9	7.0	37.1	42.8	22.0	38.4	5.0	0.2	12.8	30.5	44.4	11.4	9.8	8.1	40.2	10.6	14.0	23.7	7.6	88.6	0.5	4.0	27.2	12.7	13.2	29.6	29.0	39.0	20.7	6.0	1.8	13.1	7.4	20.9	0.8	13.8	14.4	11.1	13.5	50.4	30.9	14.3	31.9
SIPA1L2	"KIAA1389, SPAR2"	ENSG00000116991	"Signal induced proliferation associated 1 like 2"	Q9P2F8	1	232397965-232630571	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 80.2;Inhibitory neurons: 95.9;Microglial cells: 183.6;Oligodendrocyte precursor cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 69.7;NTERA-2: 53.9;WM-115: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024181, HPA027224"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Golgi apparatus"		No	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear membrane, Nuclear bodies"	"Golgi apparatus"	"HPA024181: AB_1856886, HPA027224: AB_2672165"	"unprognostic (2.34e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.98e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.57e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.84e-3)"	"unprognostic (3.45e-3)"	12.1	3.3	8.5	6.4	7.2	5.4	9.2	9.6	11.7	10.0	0.5	19.4	3.9	4.4	2.8	20.3	4.5	8.5	31.3	9.6	16.0	7.7	6.4	16.2	3.0	44.0	21.7	11.9	3.6	4.4	8.1	18.3	44.6	8.1	18.9	14.7	8.7	4.7	7.1	9.0	9.2	7.4	14.4	9.6	5.7	7.2	18.7	2.4	8.0	9.5	3.3	12.5	14.9	9.0	0.0	7.5	69.7	0.2	0.6	0.0	29.3	1.2	2.5	3.1	2.2	2.9	0.1	5.9	13.3	26.4	2.9	1.7	13.8	2.3	2.9	0.0	12.8	0.0	7.0	0.0	5.9	1.0	7.2	3.8	9.1	0.6	6.2	0.0	15.7	25.4	0.0	0.1	1.6	3.5	7.4	0.7	53.9	0.2	10.2	0.0	0.0	3.4	8.1	11.5	3.5	11.9	23.8	0.8	9.5	15.8	1.4	0.6	5.6	8.1	0.0	17.8	2.9	6.5	0.0	0.0	10.0	6.2	46.1	0.0	0.2	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.6	0.3	0.3	0.0	0.1	8.5	7.2	9.6	11.7	9.6	16.0	44.0	21.7	44.6	14.4	18.7	9.0	53.7	6.4	1.8	22.9	0.8	8.8	9.8	8.7	15.4	23.5	10.7	8.6	62.6	12.8	10.4	3.7	52.1	4.9	4.4	29.9	0.0	7.1	11.7	19.0	21.4	22.7	7.2	0.4	80.2	0.5	7.1	15.2	5.1	47.5	1.3	16.0	1.8	3.8	10.0	5.0	95.9	29.5	14.2	16.6	7.2	9.8	0.9	19.5	14.2	183.6	6.3	12.7	1.0	104.0	21.0	1.4	39.9	1.9	0.5	13.2	9.1	0.4	7.7	35.7	0.0	21.8	23.9	6.9	24.0	45.8	7.4	14.8	2.0	11.9	23.4	23.0
SIPA1L3	"KIAA0545, SPAR3"	ENSG00000105738	"Signal induced proliferation associated 1 like 3"	O60292	19	37907208-38208369	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 93.7;Inhibitory neurons: 87.3;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 59.6"	"Low region specificity"	"Detected in all"							"HPA042072, HPA045480, HPA074988"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: "	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.96e-2)"	2.2	3.0	6.0	6.6	3.0	2.9	5.1	10.4	16.2	4.8	2.6	10.6	18.4	3.3	1.3	4.9	4.8	3.9	6.2	28.9	2.0	6.4	3.4	5.7	6.8	4.2	4.1	2.9	9.7	3.3	3.2	1.4	3.5	5.3	7.0	5.0	8.4	3.5	6.5	11.1	18.1	1.8	1.6	7.3	9.1	4.3	5.6	3.8	10.0	7.3	5.5	4.3	3.6	5.5	34.4	59.6	7.3	9.3	4.3	4.3	4.9	14.5	12.2	9.4	8.8	20.6	19.5	19.5	12.2	12.4	7.9	7.6	6.7	27.1	10.4	6.7	3.3	5.3	5.5	6.5	8.3	3.7	5.5	3.3	14.1	17.5	37.3	13.9	10.8	5.6	3.9	4.1	16.6	10.6	5.0	5.1	6.0	27.2	15.8	10.8	5.9	2.9	20.7	29.1	17.3	9.3	16.0	27.1	2.2	3.9	18.0	3.5	23.2	15.6	5.5	48.4	22.6	5.4	10.0	6.6	20.1	4.9	20.6	0.1	0.1	0.4	0.1	0.2	0.0	1.1	0.1	0.2	0.1	1.5	0.1	0.5	0.1	0.3	1.5	0.3	0.1	0.1	6.0	3.0	10.4	16.2	28.9	2.0	4.2	4.1	3.5	1.6	5.6	5.5	4.8	6.4	10.1	41.4	24.5	12.0	5.2	10.4	6.2	21.9	22.6	12.1	5.2	22.8	10.8	23.9	14.6	2.1	9.3	93.7	3.9	7.2	4.5	19.8	4.8	5.4	25.2	10.8	61.1	15.3	1.4	3.7	40.2	16.5	2.5	4.8	6.4	23.5	3.5	33.7	87.3	46.3	20.3	5.1	13.9	9.2	2.1	8.3	5.4	50.6	7.1	3.0	5.2	99.5	58.7	13.4	38.7	1.9	12.8	6.6	50.0	21.1	19.1	5.7	6.6	4.5	3.6	1.7	5.1	8.9	16.1	0.8	5.1	1.7	30.4	5.6
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884656-67918390	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 292.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	16.4	30.2	8.9	11.0	10.4	19.8	17.5	15.6	11.9	17.1	7.8	12.5	9.2	18.5	11.9	10.9	11.9	14.0	10.6	8.5	9.9	13.4	17.3	12.6	17.7	9.3	9.2	25.1	12.1	14.0	6.9	12.7	10.0	14.0	12.0	13.5	9.9	11.2	14.6	9.6	9.7	13.7	8.8	14.3	10.3	26.8	9.4	19.2	14.7	18.5	15.1	15.5	9.5	12.9	15.1	16.8	26.2	29.4	24.4	18.7	16.3	20.4	21.0	27.4	24.3	18.7	12.6	31.4	10.8	13.7	17.1	11.7	32.8	6.9	29.3	16.9	19.0	16.7	12.1	14.7	22.3	18.1	12.3	17.3	16.2	16.6	28.3	29.4	11.2	17.6	21.6	16.7	20.3	12.1	17.0	25.0	32.5	9.6	26.6	30.3	20.6	12.4	13.1	9.1	16.8	23.0	37.4	24.4	26.8	22.5	17.7	16.6	9.4	21.2	19.8	19.0	20.1	13.9	17.7	61.8	10.9	27.2	8.9	1.3	0.8	1.1	1.1	1.0	1.6	1.8	1.2	1.5	1.3	1.0	2.2	1.3	1.0	1.2	1.3	1.2	1.0	0.6	8.9	10.4	15.6	11.9	8.5	9.9	9.3	9.2	10.0	8.8	9.4	12.9	35.7	19.2	7.4	17.0	27.6	39.1	20.9	7.2	22.8	12.5	48.3	33.4	34.8	11.5	8.7	5.5	27.1	7.1	42.5	31.2	5.9	4.3	292.2	38.4	26.2	20.6	42.9	10.3	16.0	5.6	5.4	28.0	23.4	57.1	12.0	14.8	15.4	15.8	9.1	11.8	18.4	21.0	10.2	23.4	28.7	45.6	17.7	34.1	16.0	30.9	14.8	7.1	9.2	18.6	30.7	6.2	20.6	19.5	15.8	26.0	11.2	8.4	4.1	14.0	0.0	43.4	28.8	24.2	16.3	21.1	47.5	12.4	29.1	8.9	18.7	17.2
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 302.1;tongue: 218.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Cytosol"	Nucleoplasm	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	43.2	44.0	101.6	11.5	137.5	17.4	39.7	141.1	123.0	41.5	79.4	49.2	12.6	37.2	10.4	42.5	37.2	15.0	76.9	100.7	111.2	35.9	51.5	38.2	13.7	151.0	129.6	49.0	33.4	18.2	31.2	10.5	144.7	32.7	10.2	11.9	41.5	14.9	302.1	48.8	32.4	18.3	121.3	40.1	41.4	43.5	127.6	13.1	34.5	218.2	13.0	41.3	37.8	173.5	16.1	9.8	8.4	20.6	46.7	31.8	5.8	11.3	20.2	17.8	22.7	17.1	10.2	5.4	23.7	21.3	13.2	8.3	14.6	25.1	10.9	25.2	15.6	10.1	10.9	10.9	33.0	7.0	22.4	33.5	29.7	14.4	16.9	21.4	31.9	17.7	10.1	42.0	28.2	8.9	15.4	6.2	1.2	27.6	13.6	19.9	22.8	15.3	14.8	14.9	20.7	9.0	12.9	17.8	13.0	7.0	8.0	19.2	28.9	24.0	5.1	37.2	17.0	16.9	8.8	12.6	18.1	19.0	22.0	48.9	54.7	59.8	44.9	69.1	28.5	24.9	21.9	31.0	42.9	28.9	14.3	23.6	42.7	36.5	56.7	44.0	33.1	51.9	101.6	137.5	141.1	123.0	100.7	111.2	151.0	129.6	144.7	121.3	127.6	173.5	39.5	16.0	19.4	26.1	21.0	51.6	30.3	35.1	35.3	29.7	28.8	29.7	42.1	14.3	27.2	12.9	35.5	36.5	90.8	28.4	37.2	29.0	173.0	24.7	15.4	31.1	17.5	27.1	31.2	17.6	15.2	30.3	44.9	26.5	25.4	29.5	28.5	19.7	66.3	30.3	27.2	24.1	97.6	38.3	51.7	74.8	31.1	37.1	46.2	11.2	20.0	22.6	85.5	76.4	110.8	26.5	23.9	41.0	39.7	14.9	54.0	38.8	30.1	28.2	19.7	113.5	27.9	15.3	7.2	30.1	60.1	42.3	45.8	31.3	18.2	21.5
SIRT6		ENSG00000077463	"Sirtuin 6"	Q8N6T7	19	4174109-4182566	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Distal enterocytes: 199.2;Paneth cells: 129.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049729, HPA071776"	Supported		Supported	Nucleoplasm,Vesicles		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA049729: AB_2680865, HPA071776: AB_2686445"	"unprognostic (4.58e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.13e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.84e-2)"	"prognostic favorable (9.13e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.58e-4)"	8.2	12.0	10.4	7.8	10.6	10.4	8.6	10.3	15.1	10.5	8.7	23.6	10.0	10.6	2.4	12.3	9.2	3.5	10.0	10.7	10.2	13.7	11.0	8.9	7.1	11.2	10.3	7.5	14.1	5.2	13.3	4.3	10.5	12.7	7.5	1.9	9.3	5.0	8.0	11.8	14.2	2.6	9.8	15.3	9.8	6.0	12.1	4.9	10.1	2.7	3.9	9.9	9.7	10.6	25.7	16.8	8.3	10.4	6.5	6.2	12.9	12.0	8.9	10.1	8.8	11.2	9.5	16.0	12.9	8.1	9.1	15.9	4.6	12.9	1.6	30.8	10.0	6.8	9.7	10.3	14.3	17.4	25.2	7.9	10.4	10.3	6.4	7.7	8.7	15.0	15.2	35.3	5.4	19.2	23.9	18.3	14.5	9.3	15.2	18.9	7.7	18.8	9.7	11.4	11.0	18.1	11.0	10.2	24.1	3.2	10.2	23.0	12.2	10.4	10.5	36.9	17.4	45.6	25.7	18.4	20.8	28.1	12.7	5.3	13.1	12.2	10.8	16.3	6.4	9.6	7.5	8.7	14.3	10.1	6.4	6.1	11.8	5.6	13.5	11.9	12.6	8.5	10.4	10.6	10.3	15.1	10.7	10.2	11.2	10.3	10.5	9.8	12.1	10.6	9.2	12.8	7.3	5.9	13.8	10.3	10.3	32.3	9.6	12.6	6.6	6.3	3.2	7.2	18.4	5.5	18.8	24.1	7.1	199.2	13.7	32.2	1.9	6.2	7.9	11.8	26.4	9.5	8.9	26.7	24.2	9.3	19.9	9.2	5.7	5.6	13.6	6.8	24.0	13.5	10.4	29.1	18.3	11.7	10.1	2.6	11.5	15.0	5.4	1.9	27.0	15.2	14.4	3.5	6.3	32.5	129.7	8.2	10.3	9.7	28.2	14.3	11.0	13.8	0.0	7.2	11.3	7.4	9.6	13.3	12.6	25.6	10.6	7.9	30.9	11.9
SIRT7		ENSG00000187531	"Sirtuin 7"	Q9NRC8	17	81911939-81921323	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 22.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027284, HPA028246, CAB037261, HPA053669"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear speckles"	"CAB037261: AB_1079989, HPA027284: , HPA028246: , HPA053669: AB_2682224"	"unprognostic (8.15e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (3.03e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.69e-7)"	"unprognostic (4.34e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.16e-2)"	8.8	8.0	6.8	7.4	7.3	23.2	8.6	7.5	8.6	12.5	7.4	17.3	12.9	7.0	1.9	42.1	8.0	5.4	6.4	6.9	6.7	11.5	14.2	9.6	11.8	7.6	7.0	6.0	12.8	5.4	6.9	4.2	7.4	9.8	5.8	0.6	14.1	3.7	6.2	22.4	17.1	3.6	7.0	18.7	17.9	13.3	7.6	9.4	7.9	3.7	7.2	10.8	18.0	7.6	26.5	21.7	2.8	9.5	6.9	6.4	17.0	13.1	10.8	15.1	14.1	18.7	20.7	11.8	9.9	7.3	9.6	18.8	10.5	8.1	4.9	10.2	22.9	10.4	10.7	29.7	20.4	13.6	20.5	6.5	25.0	14.5	11.9	6.4	11.3	6.5	11.3	5.8	7.2	20.9	14.6	19.5	6.8	40.6	22.3	9.7	5.5	11.1	14.7	17.4	11.1	14.6	15.0	35.9	17.7	5.0	15.1	32.1	9.0	6.8	14.9	12.9	24.2	9.5	3.2	9.0	16.6	18.4	11.3	4.5	2.6	22.2	2.8	3.8	0.9	4.5	2.1	2.3	1.4	7.0	2.0	0.7	4.4	1.8	3.3	2.1	1.2	1.5	6.8	7.3	7.5	8.6	6.9	6.7	7.6	7.0	7.4	7.0	7.6	7.6	15.2	12.8	12.2	12.4	41.4	38.0	25.8	21.1	28.5	23.4	27.4	19.0	4.4	18.6	18.7	18.4	56.3	31.1	62.8	99.0	9.8	22.4	21.8	28.8	14.0	15.4	20.4	16.0	14.3	13.6	33.2	12.4	152.9	37.0	11.4	20.1	15.0	16.0	26.1	30.3	10.6	34.6	28.5	26.4	33.5	14.1	14.3	29.4	24.9	5.6	47.3	14.7	71.1	6.6	13.8	52.7	74.5	10.1	33.2	29.1	74.7	16.0	29.6	39.1	0.0	12.5	15.5	41.3	37.4	52.4	55.5	49.3	50.8	17.9	44.6	53.9
SIVA1	"CD27BP, SIVA, Siva-1, Siva-2"	ENSG00000184990	"SIVA1 apoptosis inducing factor"	O15304	14	104753147-104768494	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 506.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065398, HPA066693"			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA065398: AB_2685484, HPA066693: AB_2685703"	"unprognostic (1.86e-1)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.19e-3)"	"unprognostic (5.85e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.43e-2)"	79.8	64.3	36.0	28.4	37.7	102.2	80.8	36.1	60.4	95.9	43.3	108.3	39.8	78.5	9.0	76.1	86.2	24.2	104.6	35.0	36.8	79.6	155.7	65.1	39.6	39.0	36.5	94.4	103.9	16.0	94.2	27.5	36.5	87.8	7.1	3.1	63.2	37.0	168.8	65.5	73.8	10.5	38.3	83.3	91.1	102.7	40.8	69.7	82.9	35.5	12.7	85.4	78.0	38.9	143.3	233.6	58.9	94.8	19.4	24.7	157.8	76.5	41.5	92.2	80.3	179.8	124.1	135.9	109.6	27.5	60.3	138.4	23.2	77.2	7.9	106.6	230.9	56.5	129.5	214.6	48.4	98.8	95.3	29.9	34.5	42.1	13.5	13.6	53.8	382.9	57.7	76.1	22.2	506.6	319.6	225.9	85.9	94.1	317.9	186.6	117.8	107.8	20.7	133.3	151.6	76.2	107.3	63.1	106.4	9.4	123.5	103.0	58.6	74.4	92.8	176.4	124.8	61.0	71.0	161.9	85.6	112.3	84.7	210.7	139.5	255.0	140.4	171.6	159.5	205.1	167.3	154.6	107.5	195.3	182.3	156.1	134.0	102.7	188.2	502.3	195.3	193.9	36.0	37.7	36.1	60.4	35.0	36.8	39.0	36.5	36.5	38.3	40.8	38.9	127.0	60.9	126.7	8.1	109.3	116.5	213.0	188.9	92.8	38.7	178.1	261.1	54.6	107.2	130.2	103.0	12.5	297.4	147.9	145.0	138.9	91.2	241.3	103.3	88.9	109.6	91.1	148.5	6.3	170.9	345.1	139.8	63.7	74.3	145.1	127.9	163.1	221.0	180.6	38.7	6.3	194.0	103.7	89.7	106.5	54.1	140.8	98.0	108.5	5.6	119.6	143.9	84.5	4.5	9.9	113.2	131.8	124.1	131.3	162.4	201.4	180.2	176.5	45.3	111.7	126.2	143.1	368.9	325.2	112.8	116.9	278.4	115.2	136.3	198.7	218.8
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643421-60658259	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	5.5	0.4	0.3	0.0	0.5	0.0	1.9	0.5	1.2	15.2	1.0	0.0	0.0	0.0	0.4	1.1	0.8	0.5	0.0	0.3	0.3	0.0	0.0	1.5	0.5	0.3	0.4	0.2	0.3	47.8	19.8	0.0	0.4	13.2	0.0	0.0	51.1	0.2	119.4	0.3	0.0	0.0	0.3	0.0	0.4	1.7	0.5	9.7	1.9	46.3	0.2	1.6	0.8	0.4	15.2	3.5	0.6	28.1	17.0	20.6	0.4	4.1	10.6	4.9	4.0	0.0	8.2	0.0	2.2	0.6	2.1	4.4	10.3	6.4	2.1	0.0	17.1	2.0	1.9	6.8	0.0	0.0	0.2	15.6	4.9	2.3	0.7	36.3	0.3	1.6	5.8	0.0	142.2	2.8	0.0	0.5	0.0	0.0	8.9	0.0	71.9	0.0	5.9	16.3	2.5	0.3	5.0	0.3	6.1	0.5	3.3	0.4	13.9	6.7	5.4	7.9	6.5	0.5	0.1	0.0	1.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.2	0.3	0.3	0.3	0.4	0.4	0.3	0.5	0.4	0.8	3.2	1.5	0.0	0.0	0.1	30.7	30.8	0.6	0.0	1.0	0.8	0.9	0.0	33.9	1.8	0.0	0.2	0.0	0.1	1.9	0.0	0.2	1.1	0.1	1.6	0.0	0.0	0.0	0.8	0.4	5.7	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.5	0.0	0.0	0.6	0.0	0.3	0.0	1.9	0.0	0.8	0.0	1.0	0.1	0.2	0.0	1.2	0.0	27.4	0.0	0.1	67.1	0.2	0.0	77.3	5.1	0.0	25.0	0.1	0.1	0.3	0.1	0.1	0.0	18.3
SIX2		ENSG00000170577	"SIX homeobox 2"	Q9NPC8	2	45005182-45009452	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 21.1;skeletal muscle: 33.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 6.1;Cardiomyocytes: 3.3;Fibroblasts: 3.0;Ionocytes: 8.2;Skeletal myocytes: 8.5;Smooth muscle cells: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 48.8;LHCN-M2: 46.8;RH-30: 31.9;SCLC-21H: 54.3;U-2197: 35.3;U-698: 43.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA056958			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear membrane"	"HPA056958: AB_2683287"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.09e-6)"	"unprognostic (1.28e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.53e-9)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-5)"	"unprognostic (1.05e-1)"	10.4	0.1	0.1	0.1	0.3	0.0	1.6	0.2	0.5	11.6	0.5	0.7	0.0	1.7	0.1	0.2	0.2	0.0	1.5	0.9	0.2	0.5	0.0	0.2	0.1	0.4	1.5	0.1	6.0	2.1	12.9	0.1	1.7	6.2	0.0	0.9	21.1	1.2	33.8	0.4	0.1	0.1	0.1	0.0	9.5	0.3	0.2	3.9	0.6	15.5	0.0	1.8	8.6	0.2	0.7	0.0	0.0	4.2	13.0	48.8	0.0	0.2	2.3	1.0	0.1	0.4	0.0	0.0	2.2	0.0	0.4	0.1	4.7	8.5	0.6	0.0	2.5	0.0	16.7	0.0	0.0	0.0	4.5	2.4	0.1	10.4	0.1	0.4	1.6	0.5	0.2	0.0	46.8	1.7	0.0	2.8	0.4	0.0	10.2	0.0	31.9	0.0	0.1	2.7	54.3	0.4	7.1	0.2	0.0	0.5	0.4	4.2	0.7	0.9	2.7	35.3	0.0	1.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.5	0.9	0.2	0.4	1.5	1.7	0.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.9	0.4	6.1	0.0	0.0	1.2	0.6	3.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.4	0.0	0.0	0.0	2.2	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	0.0	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.5	0.0	8.5	3.2	0.0	0.4	0.0	0.9	0.0	0.0	0.2	0.0	0.2
SIX3	HPE2	ENSG00000138083	"SIX homeobox 3"	O95343	2	44941702-44946071	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 22.7;choroid plexus: 12.2;parathyroid gland: 9.1;pituitary gland: 27.8;retina: 25.3"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 203.9;Horizontal cells: 185.1;Muller glia cells: 392.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 68.7;SCLC-21H: 63.1;SH-SY5Y: 25.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 38.7;hypothalamus: 19.5"	HPA067988			Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA067988: AB_2685939"	"unprognostic (1.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-2)"		"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.73e-2)"	0.0	0.0	8.3	0.0	22.7	0.0	0.1	0.8	16.4	0.7	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	18.2	0.1	0.0	0.0	0.1	0.5	4.5	0.0	0.6	9.1	27.8	0.0	0.5	0.0	0.0	25.3	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	1.8	10.9	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.6	0.0	11.7	0.0	0.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	68.7	0.0	1.4	0.0	0.0	0.0	0.0	0.4	2.7	0.4	0.0	0.3	0.0	0.4	0.0	0.0	0.0	63.1	25.2	0.1	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.3	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.4	0.4	0.5	0.2	0.3	0.1	8.3	22.7	0.8	16.4	1.8	18.2	0.5	4.5	0.5	0.2	10.9	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	203.9	1.1	1.3	0.7	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.1	0.1	0.2	0.0	0.0	0.3	2.7	0.0	0.1	0.0	0.0	0.0	392.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.2	18.3	0.0	0.5	0.4	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SIX4	AREC3	ENSG00000100625	"SIX homeobox 4"	Q9UIU6	14	60709539-60724351	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 6.0;parathyroid gland: 15.1;salivary gland: 6.9;skeletal muscle: 14.4;tongue: 15.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 20.9;Endometrial ciliated cells: 36.1;Glandular and luminal cells: 37.8;Prostatic glandular cells: 23.8;Respiratory ciliated cells: 30.3;Urothelial cells: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 32.1;hTERT-RPE1: 23.3;RH-30: 30.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA031794	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA031794: AB_10602928"	"unprognostic (2.23e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.63e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.08e-1)"	0.7	0.7	1.0	0.2	0.8	0.1	1.6	2.0	2.6	2.2	6.0	0.3	0.1	0.9	0.7	0.2	2.4	0.6	0.5	1.0	1.6	0.8	0.1	0.7	0.0	2.4	1.6	1.4	1.5	15.1	2.7	0.9	2.3	2.6	0.0	0.3	6.9	0.6	14.4	0.1	0.1	0.4	1.2	0.0	1.5	0.3	1.4	1.3	1.0	15.7	0.1	1.1	0.4	1.5	32.1	2.1	1.9	7.9	7.2	8.7	14.5	7.1	10.5	2.0	3.0	1.5	10.2	0.0	4.6	3.5	2.0	11.8	8.4	5.8	4.7	2.6	6.4	0.9	3.2	2.1	2.3	3.4	0.3	4.2	2.7	1.7	9.5	23.3	1.8	0.6	6.6	0.0	10.6	7.6	0.0	0.3	5.3	0.2	13.2	2.1	30.2	0.0	3.8	17.3	5.0	0.5	4.3	6.7	1.9	2.8	9.7	0.2	6.4	6.3	14.0	4.2	6.3	2.2	0.1	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	2.0	2.6	1.0	1.6	2.4	1.6	2.3	1.2	1.4	1.5	0.1	3.2	0.5	0.0	0.1	0.4	13.9	6.9	6.8	0.5	11.9	9.7	3.3	0.0	8.3	1.8	20.9	5.0	0.3	0.1	0.0	0.2	0.1	36.1	2.9	0.9	1.8	0.0	2.6	1.1	4.1	3.2	0.0	37.8	1.3	0.1	0.4	0.3	0.3	0.0	3.2	0.0	2.0	0.0	0.3	0.0	0.3	0.7	1.8	0.0	0.0	1.6	0.0	4.0	0.1	2.9	0.0	1.5	1.3	23.8	0.0	0.3	30.3	0.4	0.0	9.7	2.5	0.4	1.3	2.2	0.6	3.1	0.9	0.1	0.0	17.2
SIX6	"OPTX2, Six9"	ENSG00000184302	"SIX homeobox 6"	O95475	14	60509146-60512850	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pituitary gland: 28.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 29.2;Horizontal cells: 48.8;Muller glia cells: 160.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.0"	"Group enriched"	"Detected in some"	18	"hypothalamus: 3.9;thalamus: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"JURKAT: 13.4;MOLT-4: 44.0"	"Region enriched"	"Detected in single"	14	"hypothalamus: 3.6"	"Region enriched"	"Detected in single"	12	"hypothalamus: 1.6"	HPA001403	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA001403: AB_1079993"					"unprognostic (2.76e-1)"				"unprognostic (6.14e-2)"			"unprognostic (8.18e-2)"			"unprognostic (5.75e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	44.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	1.3	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	1.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SKAP1	"SCAP1, SKAP55"	ENSG00000141293	"Src kinase associated phosphoprotein 1"	Q86WV1	17	48133442-48430275	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.1;granulocytes: 120.1;Late spermatids: 156.1;NK-cells: 213.1;T-cells: 147.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 29.3;HDLM-2: 16.0;HMC-1: 13.0;JURKAT: 22.2;Karpas-707: 15.7;RPMI-8226: 19.8;RPTEC TERT1: 22.6;U-266/70: 14.8;U-266/84: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002969, CAB025882, CAB055513"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB025882: , CAB055513: , HPA002969: AB_1079870"	"prognostic favorable (5.07e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.14e-4)"	1.4	6.4	0.1	11.2	0.2	6.5	8.3	0.0	0.2	10.1	0.0	3.4	2.7	3.8	17.2	1.7	13.7	3.6	0.5	0.3	0.5	11.9	3.1	5.4	28.7	0.9	0.2	0.8	5.4	13.8	9.8	0.5	0.4	1.0	4.6	0.0	6.1	6.2	0.2	0.8	5.3	1.1	1.4	12.2	4.9	9.5	0.2	35.8	1.0	0.5	26.6	6.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	29.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.1	22.2	0.0	15.7	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	19.8	22.6	0.0	0.0	0.0	1.7	0.0	0.2	0.0	7.8	0.0	0.1	0.0	0.1	0.0	0.0	14.8	11.2	0.0	0.0	0.0	0.0	12.6	0.7	1.8	171.0	0.5	144.2	15.9	139.7	155.6	0.7	54.5	121.2	135.4	3.7	121.0	1.1	0.9	268.9	126.8	0.1	0.2	0.0	0.2	0.3	0.5	0.9	0.2	0.4	1.4	0.2	0.3	3.1	3.2	10.5	1.0	27.1	2.0	0.1	0.0	2.8	0.1	9.7	5.3	0.8	0.0	3.1	9.2	0.0	0.1	107.1	0.5	46.9	0.5	58.1	12.3	1.6	2.4	1.2	9.0	7.0	2.0	0.1	1.1	7.7	14.0	120.1	0.0	7.5	28.7	0.3	0.0	1.4	1.1	0.0	5.4	3.1	156.1	1.5	3.8	1.8	12.2	2.6	1.6	213.1	0.5	1.6	1.3	0.3	0.7	31.0	0.2	0.8	2.0	1.5	0.3	6.6	0.7	1.1	46.4	9.9	0.7	1.3	0.3	147.0	1.2	0.3	0.6
SKAP2	"RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R"	ENSG00000005020	"Src kinase associated phosphoprotein 2"	O75563	7	26667068-26995239	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 313.5;Kupffer cells: 192.2;Late spermatids: 354.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 149.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005560, HPA024045"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		1000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA005560: AB_2667360, HPA024045: AB_2671416"	"unprognostic (8.52e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.51e-2)"	32.1	24.0	6.6	30.1	7.3	21.2	16.3	5.9	7.6	9.8	4.3	23.2	15.9	5.1	17.7	13.7	13.6	14.1	4.5	7.3	8.4	27.9	11.9	25.5	32.0	16.0	8.3	18.8	6.0	26.9	4.0	8.0	15.3	9.0	21.9	4.0	5.4	11.9	6.6	10.9	21.0	13.0	19.4	36.3	12.5	15.7	9.3	11.4	7.2	3.2	30.0	25.5	9.2	26.0	38.1	19.8	2.0	48.5	9.0	7.4	12.0	15.2	22.5	7.4	18.4	15.8	149.4	29.2	65.2	28.9	54.1	20.2	26.9	15.5	15.6	16.8	43.0	32.3	5.3	20.9	11.9	60.2	109.0	32.3	14.2	21.6	29.2	1.3	45.4	0.0	17.5	14.8	29.6	7.0	0.1	30.2	1.7	33.9	19.3	38.8	4.7	2.3	90.2	29.4	23.7	0.9	27.6	14.8	20.9	10.9	20.4	31.2	67.0	12.2	0.4	41.2	15.9	23.1	31.7	50.8	29.3	76.3	48.0	28.7	33.9	55.8	9.6	42.1	13.2	26.3	5.2	7.8	26.4	21.5	1.2	7.0	100.9	23.5	53.7	33.8	10.1	20.0	6.6	7.3	5.9	7.6	7.3	8.4	16.0	8.3	15.3	19.4	9.3	26.0	93.0	19.2	28.3	9.4	98.9	26.5	38.7	9.9	42.7	12.5	29.5	27.2	5.3	2.8	12.4	23.9	12.5	13.4	101.2	51.4	64.6	8.3	313.5	20.1	1.8	50.5	43.1	54.7	76.1	23.1	22.7	34.5	9.7	19.9	53.2	11.1	110.7	10.8	91.4	5.0	36.0	65.2	34.6	192.2	58.9	354.2	9.0	149.4	19.6	119.0	115.4	12.3	63.8	3.0	15.9	19.4	37.6	10.9	29.9	18.3	54.4	103.1	20.2	12.8	0.0	11.5	33.5	26.7	45.0	38.1	43.3	18.6	36.4	41.8	48.8	35.1
SKI		ENSG00000157933	"SKI proto-oncogene"	P12755	1	2228319-2310213	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Craniosynostosis, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010449, HPA066567"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB010449: AB_2187342, HPA066567: AB_2685692"	"unprognostic (3.99e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.69e-2)"	"unprognostic (5.24e-3)"	38.3	14.3	22.0	14.1	20.9	11.5	31.5	59.5	24.2	37.5	3.4	34.6	9.3	42.0	8.3	23.5	34.1	14.6	34.4	24.1	11.0	23.6	24.3	33.9	11.6	20.1	16.9	36.4	13.1	7.3	23.0	13.9	17.2	26.8	7.0	5.1	25.2	19.8	22.1	38.6	24.1	16.8	17.1	22.9	22.6	13.2	19.4	8.7	25.4	11.7	10.2	30.8	29.2	15.7	18.3	10.4	24.5	23.9	40.0	23.8	16.1	26.7	14.8	16.3	11.9	15.8	13.7	11.5	19.5	34.4	6.8	21.0	13.8	21.6	15.0	12.7	30.0	29.0	16.4	22.5	26.7	16.5	29.8	25.8	11.8	24.5	18.2	30.0	20.2	4.8	16.6	8.6	20.2	11.6	2.0	18.1	24.8	12.0	19.8	9.1	15.5	9.6	13.9	7.0	35.0	22.9	26.0	22.9	26.7	15.6	7.7	20.9	36.9	27.7	17.5	39.6	21.1	6.7	5.2	10.5	14.8	28.2	11.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	22.0	20.9	59.5	24.2	24.1	11.0	20.1	16.9	17.2	17.1	19.4	15.7	44.2	9.6	12.6	18.9	18.8	47.0	13.1	7.0	32.5	8.9	20.3	25.8	12.7	11.5	6.7	7.3	0.0	7.3	32.2	7.3	1.9	8.2	0.8	10.1	28.9	34.3	6.0	14.7	22.6	6.9	15.5	35.5	9.7	18.5	13.3	6.4	33.9	23.0	13.7	11.8	24.1	14.3	0.0	16.4	29.5	5.0	49.7	28.9	16.0	48.7	9.4	11.1	12.3	11.6	11.4	13.0	9.4	55.3	16.9	14.9	8.1	6.0	4.0	4.4	46.0	36.2	37.3	4.7	12.8	32.2	45.0	16.3	33.4	6.7	10.7	11.4
SKIDA1	"C10orf140, FLJ45187"	ENSG00000180592	"SKI/DACH domain containing 1"	Q1XH10	10	21513475-21526368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.1;Early spermatids: 17.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 26.1;AN3-CA: 6.7;BEWO: 12.1;SH-SY5Y: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039208, HPA040439"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA039208: AB_10795034, HPA040439: AB_10796122"	"unprognostic (5.36e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.45e-4)"	"unprognostic (9.97e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.93e-2)"	"unprognostic (3.38e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.20e-2)"	"unprognostic (8.52e-3)"	0.3	0.6	0.4	0.1	0.6	0.6	0.2	0.4	2.3	0.5	0.0	0.6	0.1	0.2	0.2	0.2	0.5	0.1	1.2	0.5	0.0	1.3	1.4	0.3	0.1	0.1	0.0	1.3	0.5	1.1	0.5	0.8	0.0	0.3	0.2	1.5	0.5	0.6	0.2	1.0	0.2	0.3	0.0	0.1	0.2	1.7	0.0	0.2	1.2	0.2	0.1	0.3	0.3	0.9	0.5	1.1	26.1	6.7	0.5	0.3	12.1	0.5	0.4	0.0	0.1	2.5	0.2	0.2	1.0	0.4	0.2	1.6	2.4	0.5	0.0	0.0	2.9	0.1	1.3	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.7	0.2	0.4	0.2	0.2	0.1	1.1	0.9	0.1	1.6	0.0	0.0	0.4	0.8	0.0	0.5	0.7	2.9	6.0	0.9	4.5	0.1	2.1	0.4	5.4	0.4	0.2	0.8	0.2	0.6	0.1	0.0	0.3	1.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.4	2.3	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.0	0.0	1.5	5.2	0.2	1.5	1.0	0.6	6.8	19.1	1.8	2.2	6.9	4.3	1.4	1.8	0.0	5.3	0.0	0.1	7.9	0.1	17.9	0.4	1.3	4.3	0.0	0.0	2.8	0.6	3.4	2.1	0.0	0.3	1.3	3.3	4.6	10.3	3.2	1.7	2.2	0.0	0.0	2.2	0.3	10.2	1.5	0.6	0.0	1.0	0.0	6.1	0.0	3.5	2.1	0.3	0.0	2.2	0.1	0.7	0.0	8.5	0.6	4.7	6.6	1.5	1.2	6.5	5.1	4.2	1.8	3.4	0.1	5.2	0.0	0.2
SKIL	"SNO, SnoA, SnoN"	ENSG00000136603	"SKI like proto-oncogene"	P12757	3	170357678-170396835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008472, HPA014233"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA008472: AB_1856933, HPA014233: "	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (2.94e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.34e-1)"	11.9	12.0	6.1	18.8	7.3	23.1	9.0	8.5	10.0	9.4	8.3	10.4	13.8	12.0	8.2	9.2	6.4	21.1	12.0	6.6	10.9	10.3	15.6	16.1	13.8	10.7	10.8	9.2	9.6	5.7	11.0	13.9	10.5	11.6	9.7	9.6	7.4	8.9	11.0	5.8	14.2	10.5	12.0	7.2	15.9	13.0	11.4	9.2	11.3	21.4	18.4	14.6	8.8	13.2	19.9	24.0	15.6	10.4	20.0	8.7	29.1	19.6	13.6	13.8	10.6	4.9	42.2	24.9	60.5	18.2	23.1	44.8	9.9	9.0	21.3	43.6	9.2	32.8	24.8	11.0	17.8	13.7	17.4	15.3	8.8	19.9	15.0	42.9	34.1	2.4	14.7	27.9	28.4	21.3	5.9	4.5	61.2	21.8	8.1	13.6	52.8	5.0	20.8	31.7	11.5	14.1	48.3	47.4	10.3	31.6	32.2	14.2	66.1	38.2	35.9	33.0	37.1	36.2	18.6	47.3	14.3	7.1	18.3	3.1	3.4	1.8	1.3	8.3	1.8	3.6	1.1	1.7	2.4	4.4	1.9	2.0	4.0	2.8	10.3	1.6	0.5	1.9	6.1	7.3	8.5	10.0	6.6	10.9	10.7	10.8	10.5	12.0	11.4	13.2	104.1	73.7	72.8	21.2	142.1	72.7	88.8	52.5	67.7	25.6	79.3	38.1	12.4	21.5	70.4	35.0	54.2	14.8	124.9	45.9	15.6	56.7	115.7	118.4	80.9	86.0	23.8	3.0	48.6	111.4	58.3	100.6	93.8	102.0	204.8	46.3	72.5	32.0	26.3	53.8	21.6	62.4	22.4	65.4	85.2	35.8	37.9	121.7	35.6	60.0	42.1	12.7	14.4	26.2	27.5	176.5	29.1	68.1	104.3	43.5	41.3	45.9	82.1	30.5	26.3	143.6	63.6	53.9	37.6	61.3	96.0	41.2	81.5	17.5	31.3	117.8
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959117-31969751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	21.9	33.1	0.0	5.2	0.3	4.1	21.6	0.0	0.4	26.5	0.0	25.1	10.5	22.6	9.4	23.0	25.0	0.0	22.0	0.0	0.1	24.0	54.7	22.2	3.4	0.0	0.5	24.6	25.7	2.4	39.7	2.6	0.0	31.9	2.4	2.1	22.4	3.2	20.4	20.2	31.2	5.7	0.0	40.6	27.6	16.6	0.1	4.3	27.7	5.3	2.7	23.6	20.9	0.0	0.2	12.7	13.3	0.0	16.5	11.8	27.1	10.9	11.7	13.6	13.2	0.4	0.0	0.0	26.0	25.5	13.2	11.9	0.0	30.8	9.9	14.8	15.7	0.0	0.0	0.2	0.0	0.1	0.2	28.3	17.9	0.1	0.0	12.7	0.0	19.3	0.0	13.6	0.0	0.0	0.0	0.3	20.6	0.0	0.0	0.3	0.0	0.0	11.2	0.0	0.0	0.0	23.6	0.0	17.6	11.5	0.0	15.7	12.8	16.0	7.2	18.7	0.2	42.2	35.7	12.0	20.4	0.1	0.0	0.3	0.5	0.2	1.5	1.4	1.1	0.2	0.7	0.3	1.1	0.9	0.8	0.8	0.1	0.0	2.2	0.5	0.2	0.4	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	6.4	16.0	11.3	10.1	13.3	2.8	5.0	7.9	11.4	5.0	9.3	5.1	8.5	10.0	8.8	7.3	8.4	12.6	12.7	19.7	1.9	9.5	3.1	7.7	7.9	7.9	12.6	6.5	7.2	8.6	7.9	7.4	28.1	6.3	8.2	10.8	8.6	19.4	9.2	0.0	5.0	13.2	8.2	6.3	4.1	1.5	9.3	7.8	7.2	2.8	10.2	4.9	18.6	3.0	4.8	9.4	16.0	6.0	20.2	5.9	25.5	6.9	16.5	8.3	0.0	4.1	10.2	4.7	7.5	6.6	3.7	12.4	14.4	12.3	11.0	5.2
SKP1	"EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L"	ENSG00000113558	"S-phase kinase associated protein 1"	P63208	5	134148935-134176964	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012982, HPA053745, HPA058134"	Approved		Supported	Nucleoplasm,Cytosol		No	No		880000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012982: AB_2533076, HPA053745: AB_2682245, HPA058134: AB_2683617"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.40e-1)"	430.5	566.7	442.5	194.9	463.6	363.7	559.0	471.7	648.6	455.4	486.2	529.3	230.1	441.3	490.7	401.9	437.8	330.1	650.5	470.8	492.5	588.6	442.8	346.6	305.9	465.9	457.1	525.4	266.6	776.2	501.0	394.6	474.2	420.9	350.2	484.3	366.9	550.9	1056.8	419.5	354.9	422.6	494.4	304.8	385.9	380.4	470.5	456.1	551.5	814.1	332.0	452.9	391.6	515.0	657.0	500.1	730.3	986.5	1103.6	891.8	519.2	744.6	939.1	854.0	877.1	773.0	620.0	481.9	1084.9	1009.8	974.9	356.6	738.2	1124.1	988.3	442.6	519.5	380.7	724.0	555.8	518.7	296.3	452.0	771.1	886.2	750.1	588.7	1060.4	928.4	611.2	467.4	411.8	1295.2	515.6	642.0	314.8	423.9	619.6	530.7	349.2	780.7	591.7	952.3	724.6	594.6	463.8	1010.2	254.4	726.9	942.4	738.5	454.6	705.3	547.5	338.4	578.2	766.4	254.7	459.1	717.8	762.3	555.5	608.0	1745.5	851.4	1484.9	884.6	841.7	1011.4	1202.8	1264.6	1099.9	817.8	1094.4	1495.5	1174.8	811.4	1096.1	1027.0	728.1	1416.7	2538.6	442.5	463.6	471.7	648.6	470.8	492.5	465.9	457.1	474.2	494.4	470.5	515.0	430.1	285.2	306.3	64.0	403.6	674.3	1025.7	1354.7	380.1	230.0	539.8	558.4	700.9	497.6	767.4	594.1	73.0	881.0	417.7	441.8	1696.3	644.9	593.3	511.9	405.3	410.1	356.0	617.8	66.5	376.9	749.4	561.5	270.1	439.0	336.9	433.9	340.2	376.9	471.6	223.8	65.8	402.2	1192.2	296.1	505.1	1048.6	601.4	344.8	718.6	33.7	565.4	792.8	338.8	43.7	87.0	378.1	564.0	712.8	278.2	744.7	630.0	1577.8	965.7	217.5	506.2	480.4	668.1	753.5	652.7	349.0	645.6	1347.0	511.1	500.4	410.4	837.6
SKP2	"FBL1, FBXL1, p45"	ENSG00000145604	"S-phase kinase associated protein 2"	Q13309	5	36151989-36196849	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 37.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 134.4;Extravillous trophoblasts: 227.3;Syncytiotrophoblasts: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 274.7;RH-30: 286.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013491, CAB013533, HPA051196, HPA054633"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550"	"unprognostic (2.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.72e-7)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.06e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (4.77e-15)"	"unprognostic (2.50e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.19e-1)"	4.9	4.0	3.6	5.8	3.9	11.4	4.9	4.7	4.5	5.9	3.9	6.1	6.3	4.7	4.3	8.3	5.1	2.9	2.5	3.9	3.1	2.3	9.8	4.2	7.9	3.7	3.5	5.2	3.8	2.5	4.0	37.9	3.9	4.0	6.1	4.6	4.0	3.7	2.2	5.7	6.5	4.1	3.9	5.9	4.0	2.6	3.7	12.3	3.1	1.6	8.3	4.7	5.6	5.4	25.4	14.8	35.6	54.3	15.5	20.1	274.7	31.2	25.7	89.5	48.7	83.3	22.8	43.3	10.6	20.0	13.3	28.3	53.3	46.7	71.0	19.2	46.7	23.9	51.4	47.1	6.1	44.8	11.4	18.1	12.2	16.9	8.5	7.7	24.2	40.2	37.9	9.1	31.9	16.4	58.9	26.8	51.5	23.8	24.2	53.7	286.7	28.3	7.2	28.1	45.5	46.8	94.3	27.4	14.1	32.2	22.7	33.3	8.0	31.4	36.1	13.5	24.5	12.4	13.1	50.8	15.2	61.3	21.9	9.2	6.6	13.4	4.2	6.1	6.9	5.2	4.7	4.5	14.0	6.0	6.4	4.6	1.1	6.2	3.2	3.5	4.8	4.7	3.6	3.9	4.7	4.5	3.9	3.1	3.7	3.5	3.9	3.9	3.7	5.4	4.4	22.4	8.9	11.8	8.7	3.7	2.4	7.1	12.0	8.2	3.6	4.2	1.3	1.5	1.7	1.8	10.4	134.4	7.4	2.4	1.9	2.4	0.7	5.2	6.5	6.5	3.0	14.1	22.4	2.9	227.3	11.6	7.1	2.4	2.5	20.9	1.8	11.9	35.0	0.0	13.1	6.0	4.1	9.3	3.1	0.3	4.1	5.3	1.8	12.2	7.6	2.5	9.2	11.6	29.5	2.6	3.4	6.4	10.9	1.0	3.2	1.4	6.2	6.8	0.0	11.5	4.1	1.4	6.4	19.8	4.0	83.9	5.6	11.8	9.6	1.2
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Group enriched"	"Detected in some"	7	"HEL: 91.2;JURKAT: 51.8"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	1.3	0.6	0.4	5.7	0.6	12.5	0.8	1.6	0.7	0.8	0.3	1.7	2.7	1.0	0.5	0.7	0.9	2.4	0.7	0.4	0.2	0.5	1.5	4.1	10.4	0.7	0.4	0.4	0.4	0.1	0.4	0.6	0.8	0.7	1.7	0.5	1.4	0.5	0.6	0.7	3.1	0.5	0.3	8.0	2.6	0.5	0.6	18.3	0.7	0.2	9.0	2.2	0.6	1.1	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	91.2	0.6	3.4	0.0	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	51.8	0.1	0.2	0.0	0.2	10.9	7.6	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	7.6	0.1	3.0	0.4	3.8	28.8	0.7	24.1	0.4	23.8	27.1	0.4	0.3	21.8	30.5	4.8	39.2	0.1	48.5	33.4	26.5	0.4	0.6	1.6	0.7	0.4	0.2	0.7	0.4	0.8	0.3	0.6	1.1	0.6	0.0	3.9	0.0	1.6	0.4	0.1	0.0	0.0	0.3	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.1	97.0	0.6	0.0	0.2	1.1	0.4	0.4	0.4	0.0	8.2	2.2	0.0	0.2	0.5	4.1	0.6	1.3	0.0	0.7	0.1	0.2	0.0	1.7	0.0	0.0	1.6	0.4	0.0	0.3	21.8	0.0	1.9	1.2	0.4	44.3	1.5	1.4	0.3	0.1	0.0	25.8	0.1	0.0	0.1	0.0	0.9	0.0	0.3	0.4	0.0	0.2	0.2	0.1	0.1	59.2	0.0	0.2	0.3
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692731-1712344	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 263.6;Spermatogonia: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	29.9	26.4	38.6	37.6	40.2	114.2	26.7	38.0	65.7	28.4	34.4	30.6	23.9	27.3	32.9	35.9	27.6	21.9	18.4	40.9	43.6	35.1	33.9	27.2	71.7	36.4	39.1	28.0	24.4	24.0	26.7	42.0	39.3	22.8	30.6	17.1	25.6	25.3	22.6	37.7	25.6	28.8	37.7	28.3	26.9	63.1	41.8	53.5	27.3	19.2	69.5	35.0	28.0	41.1	132.7	53.9	76.6	80.7	65.3	70.0	81.9	120.1	92.5	131.4	133.8	120.3	144.7	180.6	67.4	96.0	150.9	77.8	147.0	103.0	154.1	75.4	98.5	215.9	63.3	123.6	82.6	208.3	102.8	55.0	84.7	98.1	67.3	74.4	76.5	108.8	172.7	170.3	163.2	52.8	314.6	200.6	97.4	136.7	108.6	241.1	126.3	105.3	131.0	99.5	86.1	69.3	95.4	59.6	69.5	96.8	99.0	127.7	66.3	108.0	63.8	116.1	180.4	107.4	192.2	428.3	99.6	176.0	106.0	25.7	65.4	47.5	47.1	49.7	43.3	51.6	59.7	64.8	50.6	37.8	50.6	49.6	95.8	46.3	44.8	42.2	77.9	75.4	38.6	40.2	38.0	65.7	40.9	43.6	36.4	39.1	39.3	37.7	41.8	41.1	35.2	16.0	18.8	7.2	96.3	105.2	96.3	38.8	61.5	19.4	35.9	34.0	8.2	27.1	23.6	36.8	25.0	166.3	80.5	28.8	107.6	50.6	75.9	38.8	34.9	36.1	35.9	146.0	14.6	31.3	51.8	49.1	53.5	55.5	23.5	45.9	30.0	27.0	81.3	25.2	15.1	33.6	44.7	36.8	58.6	41.6	44.1	60.3	65.8	6.5	64.4	27.4	43.3	9.0	14.4	38.7	25.3	44.0	94.2	88.6	22.5	55.4	16.3	13.6	13.1	46.3	43.8	263.6	294.0	84.1	105.8	44.7	96.6	33.2	44.1	76.5
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	878	"kidney: 705.6"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in single"	4	"renal cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 25.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	705.6	0.4	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.4	0.2	0.6	0.5	0.6	0.4	0.2	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	38.6	0.0	0.0	0.0	0.0	209.4	0.0	13.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.2	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 22.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Excitatory neurons: 38.4;granulocytes: 17.8;Inhibitory neurons: 27.8;Intestinal goblet cells: 36.6;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.6;HHSteC: 33.6;OE19: 27.6;U-2197: 67.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031123	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.5	1.1	2.9	1.2	3.2	0.0	2.3	1.0	3.1	1.4	11.7	3.5	5.6	0.6	3.6	4.1	2.0	8.3	0.6	3.4	2.4	3.2	6.8	2.2	0.6	1.6	2.0	0.3	10.0	4.3	2.2	2.7	1.9	2.8	4.2	0.1	11.9	0.6	0.1	1.3	3.6	0.7	1.0	0.3	4.1	2.3	2.0	0.5	22.9	0.0	0.9	2.1	2.2	2.0	14.7	0.0	2.7	0.0	3.3	4.6	6.7	0.8	2.0	0.9	1.7	19.6	6.8	0.0	1.9	5.6	2.8	8.5	0.0	0.0	0.5	0.0	0.0	0.0	7.2	0.0	33.6	0.0	1.0	8.7	8.3	1.9	0.9	16.3	0.0	0.0	0.0	0.6	1.3	3.9	0.0	0.0	9.3	27.6	0.7	0.0	0.2	0.0	6.8	1.3	4.2	0.0	7.0	8.4	0.1	0.9	15.6	0.4	0.2	0.2	1.3	67.9	0.0	0.1	1.9	5.0	3.3	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.2	1.0	3.1	3.4	2.4	1.6	2.0	1.9	1.0	2.0	2.0	0.2	0.0	0.5	7.2	0.1	1.0	1.3	3.3	3.4	0.0	5.6	4.3	1.1	2.8	2.5	23.9	0.0	0.5	0.1	1.6	0.0	3.9	0.3	0.8	1.4	0.3	5.4	0.0	38.4	3.5	6.5	2.1	7.7	2.7	17.8	1.8	0.0	9.4	0.9	0.0	27.8	36.6	0.0	0.0	0.7	0.5	0.0	0.5	0.0	7.5	2.1	0.0	1.0	31.7	2.0	2.9	3.4	0.0	0.2	6.2	2.6	1.5	0.4	0.0	0.0	0.2	0.7	0.6	0.4	4.3	0.3	3.0	0.8	0.1	5.6	1.0
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684719-6713377	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 414.0"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 381.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	79	"Hep G2: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.3	2.7	4.8	0.0	7.0	0.0	0.3	4.8	8.0	0.3	2.7	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.1	5.3	7.9	0.7	414.0	0.0	0.2	6.8	6.1	0.6	0.3	0.0	0.8	0.0	5.4	0.0	0.0	1.7	38.0	0.0	0.0	0.1	0.0	0.0	4.8	3.3	0.0	2.3	8.4	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	7.0	4.8	8.0	5.3	7.9	6.8	6.1	5.4	4.8	8.4	3.9	0.4	0.0	0.0	24.8	4.8	0.5	0.6	0.6	1.2	0.6	0.1	0.1	0.9	7.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	1.9	0.0	24.0	0.3	0.5	0.1	0.4	0.0	0.1	0.0	0.9	16.8	381.0	0.0	0.0	0.2	0.0	0.0	23.2	1.1	0.4	0.6	0.3	0.0	1.9	0.0	7.0	0.0	1.5	0.1	16.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.5	0.5	2.4	2.8	1.2	0.4	0.1	1.0	7.8	0.0	0.3
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752672	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 203.0"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 414.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 55.5;SK-BR-3: 54.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.0	0.3	0.4	0.3	0.5	1.1	0.6	0.4	2.4	1.4	4.5	151.6	5.5	5.9	2.1	0.1	43.1	0.0	0.2	0.6	6.1	18.2	0.1	0.3	0.3	0.6	0.1	8.3	20.6	0.3	0.1	0.4	1.4	2.7	0.0	0.5	0.5	0.7	23.2	203.0	0.4	0.1	0.1	1.2	0.2	1.4	0.2	0.3	0.0	0.6	2.5	3.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.2	55.5	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.5	12.8	0.0	0.1	0.1	3.3	3.2	1.2	0.1	0.6	0.1	54.7	0.0	2.6	0.2	0.0	0.0	0.4	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.3	0.3	0.6	0.4	0.2	0.6	0.3	0.6	0.4	0.1	1.4	0.7	0.6	3.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	50.1	2.4	1.8	0.0	0.0	0.0	33.0	1.9	10.7	0.0	8.2	9.9	0.4	3.6	0.0	0.3	0.9	0.0	0.2	0.0	77.6	0.0	7.2	0.4	32.4	0.1	0.0	0.2	12.0	0.0	0.8	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.5	0.3	2.2	13.8	0.0	0.0	0.6	414.1	10.4	1.7	0.0	0.0	1.3	0.8	0.0	0.3	0.0	0.9	0.1	0.4	0.0	5.8	0.5
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596029-59789855	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Early spermatids: 117.3;Excitatory neurons: 150.5;Inhibitory neurons: 128.2;Late spermatids: 135.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 22.2"	HPA005911	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	6.8	1.2	3.9	1.2	4.7	4.1	5.7	3.9	2.8	3.7	2.0	1.6	3.0	1.5	6.3	2.2	5.4	34.4	1.3	0.3	11.6	3.9	4.5	4.9	2.9	0.4	2.7	9.8	1.0	1.5	1.6	2.9	1.6	2.5	1.8	2.9	1.6	1.8	7.9	2.5	3.5	0.5	6.3	10.0	2.2	1.3	4.5	1.6	3.6	4.2	4.0	3.0	4.2	0.2	3.6	0.8	0.5	10.9	18.1	0.2	8.8	8.1	4.0	3.4	0.3	6.3	5.8	2.5	16.8	3.8	0.8	1.0	1.7	6.0	2.4	0.5	10.7	12.6	0.5	5.9	14.3	0.1	8.5	3.9	1.4	10.3	7.5	1.6	7.2	0.2	13.0	6.5	3.4	5.5	3.2	0.8	1.2	3.3	0.5	0.1	2.7	9.5	16.0	3.0	1.0	0.1	0.4	6.2	0.7	0.5	2.4	0.0	8.6	3.3	15.6	0.5	11.3	0.2	10.0	10.2	0.1	1.6	0.2	1.5	0.0	4.2	3.2	5.6	1.8	3.3	3.6	1.5	4.1	3.5	5.8	0.1	3.0	8.4	2.1	3.8	2.3	1.2	1.2	5.7	3.9	1.3	0.3	2.9	0.4	2.9	0.5	1.3	4.2	15.3	28.9	21.4	13.7	28.4	10.1	7.8	9.9	16.5	24.5	1.5	3.9	135.4	90.1	16.5	46.0	10.4	0.3	29.7	0.8	23.5	53.3	117.3	2.1	25.0	22.0	0.0	2.5	150.5	67.1	0.3	36.2	7.1	9.1	10.1	4.7	9.3	14.5	3.6	8.4	128.2	27.2	6.1	32.7	6.1	135.5	6.8	24.8	3.6	14.0	14.9	1.3	37.0	63.8	82.8	28.0	1.2	10.1	26.3	8.1	1.0	0.7	14.4	6.0	6.6	14.0	18.9	4.2	4.5	61.5	12.6	0.7	35.8	80.1	1.5	3.4
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650764-59736002	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 151.3;kidney: 191.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 83.9;Distal enterocytes: 108.6;Proximal tubular cells: 252.6;Theca cells: 99.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 10.8;NTERA-2: 20.1;SuSa: 10.1;U-251 MG: 10.6;U-937: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	1.2	151.3	12.8	1.2	12.8	1.7	1.7	11.9	14.8	18.5	18.4	12.5	0.4	16.2	5.2	10.9	22.0	3.1	3.4	12.9	16.6	191.1	2.5	1.1	1.7	14.0	13.7	34.1	3.0	29.2	6.9	0.1	12.0	7.8	16.7	5.6	2.9	10.2	4.3	0.4	1.2	7.2	13.3	40.8	6.0	8.9	12.3	1.2	13.9	2.8	2.8	2.2	9.0	15.0	0.0	0.3	5.2	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.9	10.8	0.0	0.0	0.0	1.8	0.1	0.3	0.1	0.1	2.3	0.0	0.5	0.2	0.0	2.8	0.1	0.4	5.4	8.0	0.1	0.6	4.2	3.0	0.0	20.1	2.0	9.3	3.6	0.2	7.2	0.0	0.3	3.4	9.6	0.1	0.4	0.0	10.1	3.4	4.5	3.2	0.5	1.1	0.1	10.6	0.0	0.0	0.0	0.0	18.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	12.8	11.9	14.8	12.9	16.6	14.0	13.7	12.0	13.3	12.3	15.0	0.3	0.0	0.0	83.9	1.0	0.1	2.1	9.4	0.6	4.3	3.1	1.5	3.9	0.0	26.2	7.3	0.0	0.0	0.0	108.6	25.4	1.0	0.2	2.3	2.0	1.5	20.0	4.2	2.5	0.0	1.7	4.1	3.6	2.4	0.0	28.4	0.4	0.0	0.1	3.3	4.8	19.1	4.1	18.8	0.7	1.5	13.7	1.5	3.6	1.9	0.6	11.8	0.0	14.6	1.0	0.1	23.2	12.0	0.0	17.7	2.2	252.6	7.4	1.0	0.0	2.4	3.4	0.3	0.2	17.0	0.1	0.0	0.7	99.4	11.9	6.5
SLC17A9	"C20orf59, FLJ23412, VNUT"	ENSG00000101194	"Solute carrier family 17 member 9"	Q9BYT1	20	62952707-62969585	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Exocytosis, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 18.2;Gastric mucus-secreting cells: 29.0;Hepatocytes: 48.8;Hofbauer cells: 18.0;Intestinal goblet cells: 19.7;Plasma cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 35.7;CACO-2: 32.9;Hep G2: 69.5;NB-4: 39.0;RPMI-8226: 36.1;U-937: 43.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA047470			Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA047470: AB_2680060"	"unprognostic (2.65e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-3)"	"unprognostic (5.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (2.78e-15)"	"unprognostic (6.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	1.3	1.0	0.3	5.8	0.5	11.4	1.3	0.7	0.7	1.9	0.7	3.7	5.5	1.5	0.2	0.8	1.9	1.3	1.3	0.6	0.8	0.9	43.0	3.5	5.2	1.2	0.9	1.7	1.4	0.0	2.2	1.7	1.3	1.3	3.1	0.0	4.0	0.6	1.0	0.7	4.2	1.4	0.9	11.1	9.5	0.4	1.2	0.7	1.2	0.1	4.2	2.7	1.7	2.0	0.0	0.0	0.0	0.2	0.3	3.1	0.1	35.7	10.0	11.4	18.0	32.9	0.0	25.9	0.0	28.3	0.0	0.0	5.0	0.0	2.8	0.0	0.0	11.5	0.9	69.5	7.7	20.9	0.0	2.5	0.0	13.6	0.0	0.0	7.6	0.1	0.1	14.6	0.0	0.0	0.9	39.0	0.0	12.9	0.2	26.9	0.0	36.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	19.4	2.6	0.0	0.0	1.2	0.0	5.0	0.3	14.2	0.0	43.8	0.0	0.0	0.9	0.0	0.7	1.7	0.5	2.2	0.0	0.4	2.6	1.7	0.0	0.3	0.0	4.9	0.3	0.0	0.1	0.7	0.3	0.5	0.7	0.7	0.6	0.8	1.2	0.9	1.3	0.9	1.2	2.0	1.1	0.0	1.1	0.0	18.2	0.9	0.2	0.3	0.0	0.4	1.0	1.0	1.3	12.8	1.0	0.0	0.0	0.3	5.5	6.4	0.0	0.3	0.7	2.6	7.3	1.4	3.0	1.7	0.7	0.4	0.9	4.0	29.0	2.5	5.1	2.4	1.4	48.8	18.0	0.0	0.4	19.7	0.0	5.1	12.4	0.6	1.2	7.2	5.4	2.8	1.3	0.1	4.1	1.0	0.1	1.7	3.1	0.7	38.6	0.6	0.2	0.4	0.8	0.1	0.0	1.6	4.2	0.4	1.0	0.0	1.1	0.8	3.6	3.8	9.3	0.6
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718028	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.7;breast: 28.4;placenta: 24.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 65.4;Syncytiotrophoblasts: 160.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.9;BEWO: 6.2;CACO-2: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	46.7	0.6	5.0	1.9	3.3	1.2	28.4	4.7	4.3	0.5	1.0	2.6	9.1	0.5	0.1	0.7	0.5	5.7	0.7	3.4	4.4	2.2	13.8	4.1	0.8	5.2	4.2	0.9	1.7	0.1	0.1	24.1	5.4	0.3	1.8	2.2	1.1	0.1	0.9	1.6	5.6	0.4	4.4	0.5	0.5	0.5	5.7	0.2	0.4	0.8	0.4	1.0	0.4	4.0	0.3	0.9	0.2	0.8	13.9	0.3	6.2	0.1	0.2	0.2	0.6	20.2	0.4	0.2	0.1	0.1	4.6	0.4	0.6	0.5	0.8	0.0	1.0	0.1	1.1	0.8	1.8	0.2	0.1	3.4	0.4	0.1	0.8	0.3	0.0	0.3	0.1	0.6	0.0	1.6	0.1	0.5	3.0	0.7	0.1	0.3	0.1	0.2	0.2	0.2	0.9	0.1	0.3	1.9	0.5	2.6	0.2	0.2	0.6	0.4	0.4	4.1	0.4	0.1	0.1	0.6	1.4	0.2	0.5	6.8	0.8	1.0	0.4	0.6	0.3	0.8	0.4	0.4	0.2	1.3	0.5	0.5	3.3	2.2	0.7	1.0	0.2	0.3	5.0	3.3	4.7	4.3	3.4	4.4	5.2	4.2	5.4	4.4	5.7	4.0	0.2	9.6	5.1	2.3	0.0	0.0	0.5	0.0	0.6	5.3	0.2	0.1	0.4	5.7	0.0	1.8	0.0	65.4	0.1	5.7	1.9	4.4	0.3	0.1	0.0	2.6	1.2	0.0	0.4	0.0	7.4	3.2	0.0	0.1	0.0	0.3	0.0	13.1	5.1	0.0	0.9	1.6	0.0	0.6	0.0	0.7	0.3	0.9	0.0	25.3	0.0	0.8	0.0	4.5	0.3	0.4	1.0	0.0	0.1	0.4	9.3	3.0	0.0	0.2	0.0	1.7	1.6	0.0	0.3	0.0	0.0	160.6	0.2	0.1	6.5	0.4
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887344-2903575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 17.7;kidney: 11.1;liver: 14.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 163.3;Paneth cells: 124.4;Proximal enterocytes: 75.7;Proximal tubular cells: 104.0;Syncytiotrophoblasts: 80.7;Undifferentiated cells: 48.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 7.0"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.9;granulocytes: 4.0;monocytes: 7.0"	"Cell line enhanced"	"Detected in some"		"A549: 9.4;CAPAN-2: 9.4;MCF7: 18.8;OE19: 8.4;SK-MEL-30: 35.8;WM-115: 14.8"									HPA068288	Enhanced		Approved	Nucleoplasm		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA068288: AB_2685969"	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	3.2	0.6	0.5	2.2	0.6	0.2	0.7	0.5	1.7	0.7	0.5	17.7	13.4	0.8	0.4	1.2	0.4	1.7	0.3	0.6	1.0	11.1	14.9	0.6	0.4	0.9	0.9	0.4	0.3	0.0	0.3	2.3	1.1	0.8	10.2	0.3	1.8	0.1	0.1	1.1	9.7	0.7	0.8	0.7	1.6	0.5	0.8	0.1	0.3	0.0	0.1	0.7	0.9	1.1	1.2	9.4	0.3	0.5	0.0	0.0	0.9	0.5	0.4	0.0	0.2	2.2	9.4	0.0	0.8	0.0	0.6	0.5	0.0	0.3	0.0	0.4	0.1	0.0	0.8	5.8	0.7	0.0	0.1	0.1	0.3	0.0	0.6	0.4	0.3	0.5	0.0	0.9	0.0	18.8	0.0	0.4	0.2	8.4	0.3	0.3	0.0	1.0	0.8	0.0	0.1	0.3	0.9	0.4	35.8	0.2	0.0	0.9	1.9	0.0	0.7	0.3	0.2	0.0	0.0	0.2	0.2	2.6	14.8	4.0	7.0	1.2	0.2	3.9	0.1	0.0	0.1	0.2	3.9	0.0	0.0	0.1	1.6	0.4	2.9	0.0	0.6	2.4	0.5	0.6	0.5	1.7	0.6	1.0	0.9	0.9	1.1	0.8	0.8	1.1	0.6	0.0	0.5	0.0	1.3	0.5	1.1	6.3	1.2	0.0	1.2	0.9	0.4	1.5	2.7	7.3	0.0	19.5	0.4	163.3	9.8	1.7	0.1	0.1	0.3	0.7	9.1	3.2	0.4	0.8	9.8	1.4	2.6	0.5	1.3	0.0	2.9	22.7	17.7	0.0	0.1	26.2	6.1	6.3	5.5	0.2	0.3	6.4	3.6	0.0	4.6	0.0	0.0	0.0	0.1	2.4	124.4	0.0	0.0	1.0	75.7	104.0	1.0	0.0	0.0	0.0	0.6	0.1	0.4	2.1	1.1	80.7	0.9	0.8	48.5	2.5
SLC22A23	"C6orf85, FLJ22174"	ENSG00000137266	"Solute carrier family 22 member 23"	A1A5C7	6	3268962-3457050	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.8;Late spermatids: 229.3;Oligodendrocytes: 285.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014697	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	Cytosol	"HPA014697: AB_1844371"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (5.16e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.53e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (8.91e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	7.3	3.4	17.7	4.5	28.9	9.6	8.4	25.4	25.0	9.1	1.8	18.4	20.7	4.1	12.2	23.7	11.0	4.9	3.6	16.2	18.6	7.7	18.1	8.3	4.4	29.9	29.7	4.1	15.5	27.1	8.8	8.5	30.4	18.6	14.8	4.8	14.6	2.4	8.9	17.1	22.4	2.8	22.1	6.3	26.5	11.5	30.2	7.2	5.6	7.8	5.9	4.3	15.5	50.9	4.3	10.1	20.1	22.6	7.2	7.8	26.6	0.7	0.3	1.2	0.5	22.5	0.7	1.0	2.5	4.8	18.2	6.1	4.2	10.8	0.4	3.5	13.1	10.4	3.9	18.9	1.0	0.7	0.6	2.0	21.3	19.4	1.0	4.3	0.7	5.4	9.6	5.3	0.7	5.3	1.0	2.4	7.1	23.2	3.9	2.2	1.3	18.1	0.1	26.9	2.4	0.3	5.7	7.8	7.0	20.9	31.8	0.2	5.6	12.0	4.0	15.9	2.6	12.7	0.2	0.4	21.2	0.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.2	17.7	28.9	25.4	25.0	16.2	18.6	29.9	29.7	30.4	22.1	30.2	50.9	22.6	6.4	17.5	46.7	1.0	11.6	5.0	18.7	4.6	8.0	9.5	8.1	2.8	10.0	18.0	5.5	8.4	16.1	0.5	43.3	0.0	2.9	86.8	11.6	2.5	8.2	4.2	11.0	59.9	8.0	1.3	1.9	39.8	4.1	0.0	13.1	6.4	12.7	12.9	0.0	67.4	49.7	12.2	13.0	3.0	229.3	1.8	4.8	3.6	77.8	6.4	8.6	0.0	45.8	285.5	6.1	20.5	0.7	0.4	13.9	34.3	4.2	42.0	3.5	0.0	4.5	2.6	2.5	1.2	10.3	12.6	9.2	1.3	0.1	25.3	4.5
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	8	"intestine: 18.4;kidney: 45.6"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 55.9;Proximal tubular cells: 14.4"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.9;U-266/70: 3.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Not detected"	"Not detected"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA019059: AB_1857017"	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	1.1	0.4	1.0	0.9	1.0	0.1	0.9	1.2	0.9	2.8	1.0	3.8	7.6	1.6	0.5	2.2	1.5	0.5	1.0	1.0	1.0	45.6	4.0	1.3	0.7	1.1	1.0	1.8	1.1	0.8	0.5	1.0	1.0	2.4	1.5	0.2	1.0	0.6	0.2	1.9	18.4	0.7	1.0	1.5	1.2	0.1	1.1	0.3	2.4	0.1	0.8	1.1	2.3	1.0	0.5	0.2	0.1	0.6	2.0	1.1	0.4	1.2	0.3	0.2	0.7	1.1	0.7	0.2	0.4	0.8	0.0	1.7	0.4	0.1	0.3	1.1	0.9	1.1	1.2	0.1	0.4	0.1	0.4	0.4	4.9	0.4	1.5	1.9	0.6	0.6	0.1	0.4	0.3	0.2	0.0	0.5	0.0	0.4	0.1	0.3	0.3	0.4	1.6	1.9	0.2	0.5	0.1	0.0	1.3	0.5	0.5	0.5	1.4	1.1	0.7	1.0	0.4	3.1	0.1	1.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	1.2	0.9	1.0	1.0	1.1	1.0	1.0	1.0	1.1	1.0	0.6	0.0	0.5	0.0	1.7	1.5	1.4	0.5	0.6	1.1	0.9	1.1	0.3	1.5	0.3	1.8	0.0	0.3	0.5	3.8	1.9	0.2	0.0	0.2	0.8	1.0	1.8	0.4	0.3	0.0	0.1	0.8	0.0	0.9	0.0	0.5	1.1	1.2	0.2	0.0	0.3	4.0	0.0	0.9	0.8	0.0	1.5	1.0	1.8	1.0	1.1	1.2	0.0	0.0	0.0	0.4	6.0	1.2	0.2	1.5	55.9	14.4	0.1	0.2	0.0	0.8	1.0	0.0	0.2	0.7	1.6	0.4	0.8	0.6	3.9	0.9
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 183.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.3;Late spermatids: 76.9;Proximal enterocytes: 50.9;Proximal tubular cells: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"Hep G2: 158.9;SK-BR-3: 116.6"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	17.8	14.8	5.3	3.0	5.0	9.5	16.8	5.6	6.2	6.5	6.4	26.1	21.4	3.8	2.7	38.8	9.2	5.5	10.4	4.6	5.2	72.9	183.3	4.3	2.5	6.6	5.2	4.8	35.8	17.3	6.3	1.8	5.1	17.2	6.8	0.6	26.0	6.1	5.8	17.3	20.1	0.9	5.8	4.8	24.0	35.0	5.4	3.9	9.6	1.9	2.9	9.1	11.5	6.6	45.3	81.8	7.6	38.1	2.9	2.3	15.3	19.2	6.1	23.2	17.4	49.5	18.4	20.2	14.3	4.5	11.2	28.3	10.8	19.3	4.2	14.9	66.2	16.7	49.0	158.9	3.3	37.5	19.5	1.6	10.0	16.5	3.2	4.5	13.6	27.9	28.0	24.3	8.2	85.4	54.3	40.0	7.8	18.8	63.9	41.0	16.3	63.6	21.1	39.6	49.8	34.0	18.1	116.6	4.0	2.0	50.3	20.4	6.1	17.9	58.6	26.5	34.4	15.3	8.3	12.0	7.8	39.0	15.9	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.2	5.3	5.0	5.6	6.2	4.6	5.2	6.6	5.2	5.1	5.8	5.4	6.6	1.4	0.0	2.2	1.6	1.3	0.0	4.5	0.0	2.2	4.9	14.6	7.5	3.8	17.2	3.1	14.7	0.0	16.4	2.3	10.2	25.4	16.9	30.5	22.3	3.8	1.5	4.9	8.2	1.2	22.9	6.9	2.3	18.8	16.4	0.0	5.1	3.6	42.3	8.0	0.0	1.7	15.3	0.0	2.4	0.0	76.9	2.1	2.0	0.0	0.0	0.8	1.9	3.1	0.5	1.2	9.9	19.3	1.9	4.3	4.7	50.9	84.6	7.3	4.2	0.0	1.3	1.6	27.9	3.1	15.9	0.0	4.2	1.5	5.3	27.2	7.9
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563450-17590995	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 143.8;choroid plexus: 90.7;liver: 111.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 195.2;Hepatocytes: 72.8"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.8;BEWO: 8.5"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	14.4	1.0	130.1	0.3	132.1	0.1	7.2	116.5	141.1	2.5	90.7	2.9	0.3	2.9	0.2	0.3	3.8	0.9	2.8	119.4	123.3	1.9	111.5	1.2	0.3	121.7	129.2	1.2	1.1	0.2	1.5	0.1	112.5	7.8	0.1	1.9	0.5	0.4	6.2	1.2	1.9	0.5	106.5	4.8	1.5	4.2	143.8	0.3	0.6	4.0	0.1	0.8	1.4	110.7	0.3	0.6	2.2	0.4	3.8	0.0	8.5	0.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.5	0.7	0.0	0.0	0.0	0.3	1.0	0.3	0.3	0.5	1.5	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.3	0.0	0.4	0.1	0.5	2.0	0.9	1.4	2.9	0.8	0.0	0.1	0.4	0.8	0.3	0.2	0.4	0.7	1.6	2.5	1.0	0.1	0.1	0.3	0.2	0.3	0.9	1.2	0.0	1.8	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.1	132.1	116.5	141.1	119.4	123.3	121.7	129.2	112.5	106.5	143.8	110.7	1.0	28.9	10.3	195.2	0.3	0.0	0.3	0.1	0.6	0.6	0.3	0.0	1.5	5.7	7.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.6	0.4	0.9	1.7	0.0	10.7	2.0	0.0	0.3	4.7	0.0	0.7	6.3	8.5	3.6	72.8	0.3	0.0	3.0	0.3	0.0	4.1	0.3	0.6	0.9	3.9	0.0	10.3	0.1	2.2	1.0	13.0	11.5	0.0	0.0	2.6	0.1	4.3	0.1	0.8	15.8	3.4	0.0	2.7	2.5	4.8	5.9	0.0	0.1	1.8	2.6	2.6	0.0	0.2
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798281	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;pancreas: 83.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	15.8	13.6	49.1	11.0	59.8	7.5	11.2	17.9	83.1	9.0	0.0	10.0	12.9	9.6	2.1	15.2	10.4	4.1	7.7	74.2	7.9	15.1	40.2	15.1	10.1	24.5	11.1	12.7	83.4	4.0	48.7	5.0	25.4	13.9	3.0	16.1	14.4	4.3	2.0	14.2	12.2	3.7	2.4	13.9	13.5	19.1	19.1	6.3	9.4	0.5	6.2	10.3	10.3	40.2	56.2	35.7	20.4	18.6	8.3	14.8	19.4	26.3	21.3	28.0	17.7	34.9	37.1	16.8	19.2	21.6	31.9	48.8	22.4	31.1	6.3	31.9	41.4	15.4	18.2	21.9	35.8	24.7	25.0	14.9	18.6	21.4	22.6	8.8	13.0	19.3	31.8	25.3	12.7	33.9	26.3	23.5	44.8	33.9	53.7	30.9	11.2	38.9	16.8	9.2	100.3	45.3	15.0	35.9	18.7	3.1	17.4	12.5	13.0	32.1	21.5	14.8	25.0	22.1	14.3	21.5	37.8	22.2	19.3	0.0	1.6	2.5	3.7	3.3	2.2	1.3	2.3	3.9	1.8	1.0	1.3	2.3	0.9	2.0	3.4	0.5	1.3	1.6	49.1	59.8	17.9	83.1	74.2	7.9	24.5	11.1	25.4	2.4	19.1	40.2	5.7	6.4	8.6	7.8	8.4	12.6	8.7	9.5	9.1	143.2	9.1	7.5	2.5	8.6	5.0	9.2	33.3	7.1	8.8	3.9	3.9	22.0	12.4	9.5	9.0	7.0	13.1	2.5	11.8	19.3	10.3	5.1	12.8	11.2	2.5	7.2	3.3	17.6	4.3	43.7	10.0	7.6	2.0	2.8	4.6	7.7	4.7	4.1	3.6	3.7	6.6	16.0	13.4	2.5	1.4	14.1	7.8	4.9	13.7	23.8	13.0	7.1	5.8	32.0	0.0	2.8	6.7	1.8	10.4	7.4	13.4	3.1	8.2	13.7	5.9	8.8
SLC25A30		ENSG00000174032	"Solute carrier family 25 member 30"	Q5SVS4	13	45393316-45418455	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.6;skeletal muscle: 86.3;tongue: 63.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 38.8;Hepatocytes: 43.6;Proximal tubular cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045260			Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA045260: AB_10962505"	"unprognostic (9.23e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.91e-8)"	"unprognostic (2.24e-1)"	"unprognostic (5.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.19e-3)"	9.5	9.9	5.2	6.0	6.2	10.5	8.4	5.1	6.0	9.7	8.6	5.6	4.3	9.1	6.8	7.0	6.5	7.5	71.6	4.7	6.5	41.9	32.2	7.7	8.3	5.6	5.4	18.5	5.5	5.1	4.3	4.3	6.0	13.6	6.0	1.6	8.2	12.7	86.3	5.9	4.4	10.1	5.3	11.5	5.1	6.1	5.6	5.1	11.4	63.3	7.9	6.3	6.2	5.4	3.9	8.4	5.0	21.4	24.4	15.5	1.7	18.2	10.5	15.3	9.2	8.8	10.4	0.0	15.5	18.6	11.4	7.4	11.6	18.2	18.1	12.8	9.4	14.6	5.5	23.8	14.4	20.9	18.9	10.1	12.1	22.6	16.7	18.0	26.9	14.3	8.9	0.0	31.3	4.6	7.7	14.6	7.3	4.5	10.7	19.1	8.3	7.8	33.3	3.2	1.0	5.0	10.2	16.1	14.7	8.6	12.0	28.0	10.0	14.2	8.0	16.0	12.6	3.7	8.0	0.3	15.6	19.5	22.3	0.0	1.2	1.9	0.8	1.3	0.6	0.6	0.9	0.9	1.7	0.6	1.0	0.4	0.0	0.7	0.6	2.2	0.3	0.5	5.2	6.2	5.1	6.0	4.7	6.5	5.6	5.4	6.0	5.3	5.6	5.4	6.2	6.4	2.2	4.2	4.5	12.9	2.0	4.2	1.2	1.9	8.6	4.4	38.8	8.6	2.5	14.7	4.2	0.8	5.6	1.6	23.5	3.2	10.1	7.4	3.5	6.0	2.4	3.0	3.6	1.4	0.9	2.6	1.1	7.8	5.1	7.7	9.3	43.6	4.1	0.0	4.2	3.4	6.1	10.0	7.7	7.7	5.0	6.5	5.4	5.6	6.6	0.9	3.1	4.0	0.8	2.2	1.6	6.4	3.9	3.9	2.1	29.5	3.4	1.0	6.6	3.6	3.3	0.3	1.8	3.8	6.1	0.5	6.6	8.6	3.3	1.5
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024763, HPA047402"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA024763: , HPA047402: AB_2680032"	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"	13.5	7.2	3.1	12.5	3.9	14.6	11.2	4.1	4.8	8.6	2.9	7.7	6.8	10.7	7.5	7.3	9.3	11.5	9.7	4.1	4.5	9.6	17.9	8.5	16.9	4.7	4.6	9.6	8.5	8.8	11.3	10.1	4.6	8.0	7.7	1.4	6.4	7.5	9.6	6.9	7.6	10.9	4.6	12.7	7.0	6.4	4.0	8.7	7.1	9.2	12.8	15.0	7.0	5.3	33.7	11.5	10.5	18.3	21.3	23.3	10.3	27.4	39.9	30.6	31.4	14.0	19.6	73.8	25.8	29.5	17.7	20.4	22.5	22.5	47.0	45.5	16.1	53.5	8.5	18.3	37.4	26.5	23.1	23.1	17.9	34.5	51.2	8.6	32.5	19.4	33.9	25.9	30.5	13.5	45.0	21.6	17.1	39.3	23.6	33.6	16.3	50.8	20.8	12.7	28.0	17.2	13.6	22.3	48.9	10.5	19.3	18.5	22.6	36.7	24.9	44.2	36.2	19.2	19.7	76.8	31.0	38.1	27.5	0.6	3.3	1.6	6.0	3.7	7.3	7.0	6.4	6.9	4.1	4.8	6.5	6.7	0.8	5.2	4.3	3.5	5.5	5.7	3.1	3.9	4.1	4.8	4.1	4.5	4.7	4.6	4.6	4.6	4.0	5.3	28.9	3.2	3.3	10.1	46.9	23.1	16.7	6.9	32.5	9.4	10.3	6.7	10.4	11.5	5.4	5.5	6.2	11.9	20.9	4.1	7.9	9.8	4.8	8.3	14.0	22.2	11.4	16.2	30.3	9.4	13.6	19.6	27.0	9.1	8.9	8.0	20.0	15.2	10.2	8.4	25.8	7.1	8.2	7.3	11.6	4.7	9.3	16.2	10.6	24.4	9.9	7.6	15.5	25.6	46.6	10.0	3.1	8.6	56.3	14.4	4.1	9.5	2.6	8.1	19.7	13.5	14.7	22.9	17.1	32.6	25.9	14.0	27.7	9.5	7.5	15.1
SLC25A36	"FLJ10618, PNC2"	ENSG00000114120	"Solute carrier family 25 member 36"	Q96CQ1	3	140941830-140980995	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027036	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	"Mitochondria, Cytosol"	Nucleoplasm	"HPA027036: AB_1857048"	"unprognostic (4.12e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (1.55e-4)"	27.1	22.2	16.6	14.3	16.2	61.6	33.5	16.2	22.7	31.9	13.9	25.7	30.9	34.4	47.7	15.0	32.6	18.4	39.8	16.1	20.1	38.7	4.2	27.5	21.3	17.0	16.4	39.0	45.2	28.9	26.9	26.4	17.5	27.1	19.5	42.6	23.4	20.8	38.4	22.5	22.9	19.2	16.9	20.1	34.0	23.8	18.2	20.6	31.8	20.8	17.6	23.0	23.9	21.5	52.3	11.5	36.0	30.8	33.0	40.7	46.2	19.4	23.6	18.2	27.3	28.6	24.0	42.1	46.9	17.3	31.2	34.9	40.1	15.2	40.6	33.8	36.5	33.9	29.8	20.9	45.9	48.8	21.3	44.1	61.1	15.4	45.8	44.4	22.0	32.0	17.6	27.4	29.2	22.8	30.6	34.1	37.8	12.8	18.4	34.2	32.0	59.6	23.5	17.7	22.4	38.2	26.7	45.1	80.9	30.3	32.6	29.2	24.1	29.5	17.1	52.2	19.0	56.4	36.8	51.2	36.0	21.1	15.0	10.7	9.2	15.1	9.6	11.5	11.8	16.3	9.6	10.2	14.0	15.1	13.5	12.6	1.7	18.3	13.5	9.7	9.9	9.8	16.6	16.2	16.2	22.7	16.1	20.1	17.0	16.4	17.5	16.9	18.2	21.5	60.3	99.3	143.0	85.5	47.6	68.2	68.0	38.1	116.7	106.0	72.2	77.5	90.3	38.6	52.0	71.7	133.5	58.8	58.2	22.7	64.6	26.4	10.6	113.4	78.0	45.8	59.3	27.3	127.7	38.3	38.0	73.9	58.1	106.3	65.9	92.8	35.7	0.5	26.5	92.5	115.6	32.5	30.5	38.2	45.8	16.0	59.7	38.4	56.9	46.9	36.9	68.2	25.7	108.6	109.1	29.3	22.8	59.5	48.2	88.9	44.9	57.5	98.8	121.8	59.2	80.0	59.2	59.4	68.8	61.3	54.4	49.4	49.1	83.2	46.8	78.9
SLC25A44	"FLJ90431, KIAA0446"	ENSG00000160785	"Solute carrier family 25 member 44"	Q96H78	1	156193932-156212796	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 114.1;Late spermatids: 95.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 70.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065411			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA065411: AB_2685486"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (2.49e-4)"	"unprognostic (3.37e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.37e-1)"	18.3	11.6	17.5	10.4	18.7	12.8	9.5	14.4	23.1	8.8	8.5	11.2	18.2	9.5	11.2	11.9	9.2	11.2	14.1	19.5	17.2	27.7	35.3	11.4	10.4	15.8	16.9	6.8	8.8	17.2	13.4	8.3	17.4	9.4	11.5	18.2	8.7	9.3	17.6	11.1	13.0	11.5	13.6	16.6	11.4	12.4	18.0	14.6	10.4	21.2	12.4	14.8	8.4	18.3	18.3	30.5	14.6	19.5	31.0	16.7	11.6	19.2	27.9	33.8	27.5	30.1	16.4	14.4	16.3	28.6	18.3	26.6	53.9	22.5	29.8	16.6	18.0	13.1	18.8	18.4	23.8	17.2	23.2	23.6	19.3	34.3	20.6	16.3	27.8	17.5	14.0	23.0	23.6	32.7	18.1	12.2	34.6	34.6	31.2	11.5	14.8	24.6	44.2	21.2	22.8	30.7	22.3	40.0	26.1	25.6	30.1	27.8	22.7	19.6	16.4	22.0	23.1	23.4	19.2	21.5	21.6	17.8	19.8	14.2	18.2	19.3	9.3	19.1	9.6	8.2	7.4	8.9	13.4	5.4	6.0	7.3	70.5	9.4	16.1	5.8	7.3	13.5	17.5	18.7	14.4	23.1	19.5	17.2	15.8	16.9	17.4	13.6	18.0	18.3	16.4	12.8	22.4	7.5	11.1	27.8	6.2	5.5	10.8	14.4	33.0	25.4	41.1	11.5	11.5	9.2	20.9	5.2	12.0	10.4	5.9	6.0	114.1	17.9	12.3	16.6	6.0	9.5	12.0	5.6	4.0	15.6	12.2	35.4	5.1	5.3	11.7	34.0	7.5	20.2	12.4	11.7	8.2	11.3	34.4	95.6	7.2	19.1	12.4	6.5	10.1	8.2	22.6	5.5	11.6	6.2	6.1	5.7	10.2	6.6	13.8	17.1	5.2	9.0	19.7	40.7	10.8	9.6	10.3	17.6	34.1	8.2	12.8	7.3	8.5	6.9
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 58.4;Rod photoreceptor cells: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	12.2	36.5	27.4	8.9	24.8	16.4	11.8	14.1	23.2	16.3	21.9	12.1	7.2	11.6	8.9	7.5	13.5	7.6	7.1	21.1	45.5	19.1	10.2	18.8	14.1	27.8	33.3	22.5	10.6	11.8	35.1	9.0	30.1	16.8	4.1	11.6	11.3	9.2	5.9	13.0	11.2	6.0	17.7	22.6	10.0	4.8	42.2	3.4	24.8	3.6	5.6	11.6	12.1	17.4	0.7	12.4	14.3	11.1	7.1	5.2	16.1	6.7	8.4	15.6	9.4	13.6	2.5	0.1	13.1	7.4	11.3	4.4	8.0	5.2	6.1	15.7	14.4	0.0	17.5	13.5	18.6	0.0	2.2	9.5	8.4	7.5	3.4	1.4	13.3	2.7	6.4	16.8	9.3	11.6	0.6	0.3	6.5	3.5	11.7	0.5	1.6	5.7	14.2	13.6	5.4	16.9	6.8	17.0	18.3	22.0	20.4	0.3	9.9	11.8	6.9	10.4	0.9	17.8	7.4	1.8	6.2	0.0	10.1	0.0	1.0	0.0	0.7	0.4	1.1	0.2	1.2	1.0	0.6	0.1	1.9	0.8	0.0	0.0	0.1	0.0	1.7	0.9	27.4	24.8	14.1	23.2	21.1	45.5	27.8	33.3	30.1	17.7	42.2	17.4	8.8	6.4	13.4	22.2	3.9	4.6	8.9	5.0	5.2	27.2	9.6	9.9	2.5	5.7	5.6	12.9	58.4	14.5	5.6	3.2	1.9	7.5	0.6	7.1	7.0	12.4	10.2	2.7	13.4	6.0	8.8	8.1	3.6	11.6	1.3	15.4	8.2	2.2	15.2	3.3	17.2	3.2	8.2	11.4	10.5	0.7	17.1	15.1	3.6	12.2	4.2	22.8	5.2	12.1	13.3	3.4	3.9	12.4	2.2	9.0	7.0	6.0	4.4	40.8	32.9	6.4	7.7	0.2	5.3	2.4	4.7	26.0	8.2	16.4	2.6	5.3
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252234-45277846	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 92.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Paneth cells: 35.7;Proximal enterocytes: 43.4;Undifferentiated cells: 48.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046068, HPA055623"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.4	0.7	0.4	0.1	0.0	0.3	0.4	2.6	0.0	9.5	68.0	0.5	0.4	0.1	0.1	9.8	0.3	0.3	0.1	3.5	0.8	0.1	0.3	0.4	0.0	0.3	0.3	0.0	0.0	0.6	0.4	0.1	34.6	0.7	0.2	0.0	0.3	0.3	92.3	0.0	0.1	0.2	22.8	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.3	0.1	0.4	0.0	0.4	0.1	0.2	0.6	0.5	0.0	8.1	1.6	0.9	0.1	0.4	0.4	0.0	2.9	0.3	0.0	0.7	8.6	4.5	0.0	2.1	12.3	0.3	19.6	0.0	0.1	0.7	1.0	0.4	1.0	13.9	2.7	1.8	0.0	2.7	1.0	4.6	1.2	8.8	0.7	0.7	0.3	0.9	1.7	1.5	14.5	0.0	0.3	0.4	0.4	0.0	1.3	0.0	0.0	0.2	1.0	2.1	2.0	2.0	0.0	35.7	0.7	0.4	0.2	43.4	1.2	4.6	6.6	0.0	0.3	0.2	2.4	2.1	0.0	0.3	4.7	1.3	0.2	48.9	0.2
SLC29A2	"DER12, ENT2, HNP36"	ENSG00000174669	"Solute carrier family 29 member 2"	Q14542	11	66362521-66372214	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 90.8;tongue: 47.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.3;CAPAN-2: 53.5;T-47d: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018168	Approved		Uncertain	Nucleoplasm		NA	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA018168: AB_1857077"	"unprognostic (3.20e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.37e-1)"	"unprognostic (5.08e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.38e-3)"	6.7	0.9	4.2	2.5	4.3	0.8	7.4	9.8	5.6	1.9	4.2	5.7	7.8	0.9	3.1	3.3	3.6	1.4	11.9	4.1	4.0	6.9	1.5	4.4	2.8	7.4	6.9	0.7	8.7	12.9	6.1	4.1	8.2	5.2	4.1	3.1	7.2	2.4	90.8	2.8	7.4	0.3	4.1	2.1	9.4	0.5	5.9	2.3	5.4	47.3	1.9	1.2	2.6	3.7	14.2	11.4	8.2	1.8	1.2	0.3	44.3	0.6	0.0	0.4	0.6	20.2	53.5	6.1	10.4	0.1	3.1	12.9	11.4	9.7	0.0	0.5	18.6	11.7	12.4	1.5	1.3	21.9	0.4	0.7	4.3	1.5	4.1	5.2	0.5	5.1	33.0	0.0	0.0	34.5	1.6	31.9	21.8	35.1	8.1	1.3	0.3	26.4	22.2	10.4	16.1	6.6	1.0	18.4	1.2	2.4	55.2	4.1	0.0	0.3	11.2	0.4	0.0	0.3	0.8	0.5	0.9	0.5	0.7	0.0	0.0	0.0	1.3	0.0	0.4	0.2	0.7	1.7	0.3	0.7	1.7	1.7	0.1	0.0	0.0	0.6	0.1	0.5	4.2	4.3	9.8	5.6	4.1	4.0	7.4	6.9	8.2	4.1	5.9	3.7	0.6	3.2	6.3	9.4	2.2	0.6	4.7	5.4	1.2	2.5	7.6	5.8	12.3	4.3	6.5	14.7	12.5	46.4	0.7	6.0	3.9	5.0	0.1	2.1	0.5	0.9	2.4	2.1	11.2	6.7	16.5	1.7	11.2	5.4	4.5	1.8	0.4	0.9	4.4	5.0	10.8	9.2	4.1	0.8	0.4	0.0	0.0	0.5	0.0	2.8	0.9	2.3	0.0	7.5	0.8	3.5	4.7	0.4	1.5	4.7	1.6	0.5	3.8	3.7	0.0	4.4	2.1	0.4	0.5	3.5	0.0	13.5	2.1	0.4	10.6	3.4
SLC2A11	"GLUT10, GLUT11"	ENSG00000133460	"Solute carrier family 2 member 11"	Q9BYW1	22	23856703-23886309	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 298.2;Rod photoreceptor cells: 188.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 9.2"					"Low region specificity"	"Detected in all"			"HPA042960, HPA071184"	Uncertain		Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Cell Junctions"	Nucleoplasm	"HPA042960: AB_2678241, HPA071184: AB_2686355"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.77e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.29e-2)"	2.3	6.3	3.9	1.7	3.7	1.1	3.3	5.3	4.5	4.8	3.4	5.2	1.2	3.4	3.0	1.6	3.6	1.3	10.2	3.3	4.1	16.5	5.1	2.3	2.7	3.7	3.7	4.9	12.9	6.1	13.2	2.7	4.1	5.1	2.0	19.5	3.9	2.9	6.3	2.3	4.6	1.8	3.0	4.2	4.4	3.2	4.1	0.7	7.2	1.9	2.2	4.3	2.2	3.5	2.2	1.0	1.2	5.7	1.2	2.5	0.6	1.3	1.6	1.4	0.9	1.3	1.5	2.7	0.7	1.7	1.2	1.7	2.4	0.8	0.7	2.0	2.2	1.3	2.5	2.0	1.8	1.3	1.4	1.0	2.4	2.0	1.7	6.3	0.5	2.1	0.5	6.4	0.7	2.2	0.3	0.5	2.1	1.3	1.6	3.7	0.2	3.1	4.3	0.6	3.2	1.8	0.6	9.2	2.2	1.5	4.8	0.7	0.4	0.5	0.9	0.5	0.6	5.5	1.6	2.6	1.1	0.9	1.4	0.4	0.1	0.4	0.2	0.3	0.1	0.6	0.2	0.2	0.0	0.5	0.4	0.2	0.2	0.3	0.2	1.4	0.0	0.1	3.9	3.7	5.3	4.5	3.3	4.1	3.7	3.7	4.1	3.0	4.1	3.5	2.9	19.2	15.0	14.4	23.4	3.2	9.3	4.4	8.6	56.0	15.0	13.5	31.2	7.2	5.6	25.8	298.2	9.8	15.5	5.7	13.7	4.9	8.4	4.8	8.2	4.4	10.8	5.0	21.6	5.6	9.8	8.3	5.1	5.3	2.5	19.5	6.1	7.3	5.8	37.0	30.0	5.8	10.2	4.8	4.6	10.4	9.3	4.3	3.6	4.7	4.2	16.4	10.3	8.0	14.2	2.7	2.7	9.8	15.2	7.3	3.7	24.7	6.3	188.8	0.0	11.8	7.5	4.2	5.7	5.3	3.1	20.0	8.3	28.3	7.5	6.0
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.2;epididymis: 68.5;testis: 35.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.4;Early spermatids: 17.8;Excitatory neurons: 15.6;Late spermatids: 42.4;Peritubular cells: 15.1;Spermatocytes: 16.6;Spermatogonia: 10.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.3"	"Group enriched"	"Detected in many"	10	"amygdala: 14.5;basal ganglia: 10.3;cerebral cortex: 18.2;hippocampal formation: 22.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.8;HAP1: 11.2;Hep G2: 12.0;REH: 22.8;RH-30: 11.0"	"Group enriched"	"Detected in all"	4	"amygdala: 130.7;basal ganglia: 48.2;cerebral cortex: 110.9;hippocampal formation: 69.1;white matter: 34.7"	"Group enriched"	"Detected in many"	6	"amygdala: 18.5;cerebral cortex: 55.5;hippocampal formation: 43.0"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875"	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.1	2.1	14.5	0.1	10.3	0.3	0.1	0.0	18.2	0.2	0.0	0.1	0.0	0.4	68.5	0.1	0.3	0.1	7.9	22.2	0.0	0.1	0.2	0.2	0.5	0.5	0.0	0.2	0.0	0.5	0.3	0.0	0.8	0.3	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	35.2	0.0	0.0	0.2	0.0	0.1	0.0	0.2	1.5	0.4	1.3	0.1	2.0	0.2	0.2	0.3	0.0	0.0	1.3	1.4	0.5	0.5	0.0	0.1	0.0	8.8	0.3	11.2	0.0	0.3	0.0	1.2	5.9	0.5	12.0	0.2	0.2	2.3	0.0	0.0	0.6	0.0	0.2	0.9	2.9	1.7	0.1	0.2	3.9	0.1	0.4	1.8	0.4	0.0	22.8	11.0	1.4	0.0	0.3	0.0	0.7	2.8	0.0	0.0	0.1	0.0	0.8	0.1	0.3	5.1	0.3	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	14.5	10.3	0.0	18.2	22.2	0.0	0.5	0.0	0.8	0.0	0.0	1.5	0.3	0.0	0.0	2.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	17.8	0.0	0.1	0.4	0.0	0.0	15.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.4	42.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	15.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	16.6	10.7	0.0	0.1	0.1	0.1	0.0	0.0	0.0
SLC30A5	"FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1"	ENSG00000145740	"Solute carrier family 30 member 5"	Q8TAD4	5	69093949-69131069	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035373	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA035373: AB_10794630"	"unprognostic (9.81e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	25.8	25.6	9.8	21.0	10.3	19.6	30.3	11.7	15.9	29.7	17.4	26.9	24.7	25.6	38.2	19.3	24.3	24.0	24.1	9.7	10.6	29.1	29.0	21.1	24.7	10.1	11.4	22.3	33.0	35.9	24.0	27.4	10.2	29.4	24.7	18.5	30.8	24.0	16.4	27.1	23.6	22.8	9.7	21.9	26.3	16.4	10.9	20.8	37.5	16.5	23.7	23.6	19.7	12.1	37.4	29.9	26.3	46.2	69.1	53.2	82.5	58.8	53.6	36.4	55.1	26.0	45.7	50.2	70.6	41.4	63.7	38.8	38.6	46.1	61.5	60.2	43.5	55.7	35.0	43.2	55.0	34.8	58.3	35.7	57.1	38.3	46.5	50.1	36.6	34.2	34.9	57.0	46.1	46.9	46.4	71.6	29.4	25.3	33.3	35.5	33.2	89.9	53.6	34.5	46.0	36.8	47.4	45.0	84.5	36.0	43.7	76.2	33.3	23.2	29.5	58.7	58.2	49.5	67.5	37.9	46.6	62.3	58.9	11.9	5.1	8.5	4.1	5.3	4.4	6.9	6.4	6.2	6.3	4.3	5.9	4.8	4.1	4.0	5.5	9.6	4.9	2.8	9.8	10.3	11.7	15.9	9.7	10.6	10.1	11.4	10.2	9.7	10.9	12.1	17.3	19.2	21.5	14.7	26.9	18.7	27.9	27.5	19.9	15.3	28.5	20.6	29.2	18.6	23.2	25.8	22.9	42.0	35.3	19.9	29.4	22.0	6.9	28.8	35.8	19.3	13.2	29.9	29.6	27.1	80.4	24.8	34.7	23.7	41.3	15.4	21.8	19.8	22.3	8.4	30.6	27.9	32.6	17.2	18.4	9.9	24.2	16.8	14.2	19.7	21.2	14.9	15.5	22.1	23.3	19.0	16.7	22.2	51.8	34.7	16.9	21.3	27.7	24.7	26.3	17.5	21.4	11.0	14.9	26.6	21.5	51.6	23.4	20.9	23.2	28.6
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 753.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.4	0.8	0.0	0.3	0.0	0.0	19.1	2.1	0.2	66.6	6.9	0.1	16.4	34.6	0.1	1.5	69.8	9.0	0.2	0.1	0.0	16.7	1.2	753.0	0.1	0.0	0.0	1.3	7.3	0.0	2.1	4.8	0.1	1.0	0.0	0.5	90.2	16.8	0.1	2.6	4.3	0.2	0.0	0.7	2.5	2.7	0.3	2.1	33.6	0.0	7.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SLC35A4		ENSG00000176087	"Solute carrier family 35 member A4"	"L0R6Q1, Q96G79"	5	140564446-140569100	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062210			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA062210: AB_2684712"	"unprognostic (3.01e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.56e-5)"	"unprognostic (2.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.55e-1)"	45.6	62.1	34.0	39.8	37.3	23.2	42.2	38.9	35.6	36.7	29.9	51.6	45.6	38.0	31.3	69.1	39.4	33.9	72.2	31.5	36.7	58.6	53.8	46.3	42.0	39.6	38.7	32.7	44.3	59.4	24.1	33.1	38.2	41.1	47.5	19.5	66.0	33.6	138.5	64.3	44.0	36.1	36.9	47.5	46.4	45.1	38.0	44.3	44.6	94.1	44.4	42.2	41.6	34.9	43.9	134.2	57.5	124.6	77.5	43.0	92.4	60.8	45.5	84.3	91.3	186.2	57.0	115.7	80.0	65.7	105.2	55.2	0.0	107.7	59.3	155.0	96.7	91.3	109.1	1.3	74.7	91.7	83.7	65.5	92.6	83.3	71.0	38.2	74.2	73.0	83.6	136.4	80.5	98.3	110.5	62.7	43.5	74.2	92.1	82.5	93.5	129.2	69.1	79.5	66.6	91.1	79.8	157.1	84.0	50.4	131.4	52.7	69.3	78.2	52.9	70.0	78.7	57.8	127.8	53.9	54.0	127.6	91.9	16.6	65.0	37.0	56.5	83.1	54.4	29.9	45.5	52.1	75.5	32.7	53.5	49.3	24.5	63.4	79.4	28.3	33.7	83.4	34.0	37.3	38.9	35.6	31.5	36.7	39.6	38.7	38.2	36.9	38.0	34.9	13.0	12.8	22.4	4.9	17.0	10.5	23.2	20.3	15.4	13.7	21.1	15.4	30.0	32.9	21.8	16.5	4.2	32.1	13.2	56.4	45.0	33.3	71.3	9.4	11.8	18.1	25.2	19.0	3.3	35.1	50.2	16.2	24.5	15.5	21.0	14.3	25.4	25.0	32.9	13.5	3.5	27.9	20.3	24.2	13.3	127.2	12.5	18.9	17.8	5.6	27.6	28.6	44.3	3.5	5.7	39.5	26.4	12.4	15.7	22.1	33.5	39.9	10.5	10.3	32.9	11.8	15.0	9.7	17.5	20.4	11.6	30.5	17.6	18.1	38.5	28.8
SLC35B1	UGTREL1	ENSG00000121073	"Solute carrier family 35 member B1"	P78383	17	49700934-49709014	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048655, HPA057418"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"HPA048655: AB_2680481, HPA057418: AB_2683432"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.36e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.17e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (5.69e-7)"	"unprognostic (6.28e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-2)"	13.4	9.9	16.8	15.6	17.1	19.4	18.6	17.3	20.0	16.7	21.7	19.9	26.8	11.4	52.8	17.2	18.1	12.5	32.2	17.1	20.0	28.8	46.4	15.3	14.3	17.4	17.8	8.5	18.4	31.6	13.7	17.0	17.4	13.7	24.2	17.0	16.4	15.5	61.4	10.8	26.0	15.6	16.5	12.4	17.4	14.0	18.4	15.3	36.0	60.3	21.6	23.0	7.9	17.2	45.2	75.5	52.4	87.7	47.5	32.9	59.7	46.4	77.8	98.7	80.5	156.6	52.3	31.5	104.7	66.7	55.0	32.6	87.1	55.3	103.5	38.3	65.3	38.5	43.8	94.0	85.3	71.9	34.9	31.9	60.3	73.1	83.6	24.6	64.7	46.5	40.0	84.2	68.1	94.2	51.9	52.5	23.6	82.4	92.2	37.4	56.6	85.6	47.1	45.5	45.8	60.4	25.9	21.3	34.0	57.7	68.7	50.0	26.6	74.0	33.3	84.0	61.9	48.3	79.6	42.7	50.2	54.6	63.8	25.1	27.2	10.1	15.8	27.7	12.0	11.6	10.9	15.4	32.1	6.8	11.2	10.0	11.2	13.5	19.3	43.3	13.6	16.1	16.8	17.1	17.3	20.0	17.1	20.0	17.4	17.8	17.4	16.5	18.4	17.2	32.1	16.0	29.7	10.7	37.1	22.3	40.0	56.4	22.8	28.2	37.1	29.0	40.5	21.5	45.3	27.6	35.5	57.8	47.4	34.9	35.2	78.4	52.4	19.1	25.1	39.2	50.6	20.4	11.7	101.7	121.0	28.6	16.3	24.1	42.5	22.8	27.8	56.6	73.5	21.9	10.4	56.2	59.0	28.0	45.2	17.6	30.1	34.0	37.4	4.7	39.6	44.6	26.8	11.6	11.2	77.5	33.2	20.7	103.7	70.1	139.9	51.3	33.9	35.4	13.1	25.3	47.9	63.2	41.2	24.5	25.1	80.4	31.1	24.1	41.7	50.6
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA027011: AB_2672082"	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	23.2	36.3	23.1	17.2	22.3	27.1	23.2	21.3	25.2	26.4	22.6	23.9	21.3	23.1	17.4	31.8	23.2	18.2	17.2	21.8	20.6	27.7	38.3	22.8	24.0	22.6	23.1	25.5	34.9	14.9	20.3	18.2	22.3	31.2	10.1	11.3	30.3	14.0	18.3	32.7	26.4	10.4	21.2	33.6	27.7	25.0	23.4	14.4	29.2	8.2	13.4	22.4	25.6	22.8	35.9	45.1	17.5	15.0	23.9	23.2	36.3	17.6	33.7	19.7	22.6	60.9	54.6	22.5	63.2	19.9	24.7	49.0	9.3	40.5	6.7	19.6	32.5	20.2	29.5	49.0	46.6	27.6	23.6	33.6	51.0	27.4	29.8	20.8	15.2	23.7	33.3	41.5	14.2	85.0	19.8	40.7	24.3	34.1	36.7	18.9	19.7	45.3	25.8	35.1	28.1	39.6	16.4	87.1	60.9	10.4	56.0	47.8	15.7	53.2	33.7	27.5	32.0	55.6	51.5	25.2	58.0	29.7	23.9	42.7	37.9	48.0	37.5	39.9	35.4	29.7	39.0	38.8	42.4	27.9	44.5	40.3	33.5	33.4	30.8	72.9	41.1	44.1	23.1	22.3	21.3	25.2	21.8	20.6	22.6	23.1	22.3	21.2	23.4	22.8	17.0	16.0	19.1	24.5	27.6	14.4	29.0	35.5	29.0	41.3	32.4	25.4	6.7	21.5	29.2	27.6	41.7	89.5	32.6	26.9	13.7	41.3	5.9	12.8	13.0	18.4	21.0	12.4	13.6	61.8	49.2	24.0	26.0	13.9	14.7	20.3	31.8	27.5	38.7	18.5	13.6	35.1	26.4	22.8	8.2	6.7	19.3	23.6	21.4	14.0	36.4	23.4	34.0	11.1	14.2	35.0	26.9	19.2	28.8	50.0	34.8	18.3	18.7	33.6	19.7	20.1	19.0	16.1	23.6	24.8	16.6	79.2	25.9	24.8	30.2	33.1
SLC35E2B		ENSG00000189339	"Solute carrier family 35 member E2B"	P0CK96	1	1659529-1692795	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045641, HPA062711"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA045641: AB_2679402, HPA062711: AB_2684844"	"unprognostic (9.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.64e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.54e-2)"	"prognostic favorable (5.15e-4)"	21.0	29.7	38.1	20.9	35.9	17.3	25.8	30.7	38.5	35.3	31.3	30.8	31.9	31.8	34.2	20.8	29.2	19.5	19.4	38.8	27.8	27.8	26.1	22.9	32.4	28.8	29.9	39.0	30.7	20.3	43.1	20.4	29.4	30.2	22.1	42.6	29.1	22.5	29.1	29.5	34.1	30.6	26.2	40.1	28.7	10.9	31.1	34.5	30.8	14.6	28.0	26.0	26.5	33.3	13.0	17.4	58.3	49.8	42.3	40.0	16.9	15.6	35.8	16.9	19.7	12.8	33.6	22.6	24.2	33.7	20.9	16.9	23.0	14.9	16.8	28.4	20.1	30.6	37.2	21.7	31.5	24.6	26.2	35.0	31.2	21.4	30.5	47.3	35.5	40.9	31.1	30.8	19.4	9.2	32.3	29.2	19.0	11.2	18.5	28.3	15.9	29.5	29.1	13.1	50.9	46.8	26.4	31.5	50.8	23.8	38.9	34.8	33.5	29.9	12.6	11.7	8.6	25.0	19.6	35.2	22.8	45.2	16.5	1.8	3.7	2.8	7.0	3.3	7.6	3.9	5.9	8.1	2.4	3.9	6.8	5.9	5.5	4.0	2.4	7.6	6.0	5.0	38.1	35.9	30.7	38.5	38.8	27.8	28.8	29.9	29.4	26.2	31.1	33.3	8.2	12.8	28.3	9.8	19.8	7.4	7.1	14.1	18.8	35.5	12.0	8.6	17.1	34.3	24.6	3.7	77.2	14.1	26.0	28.3	0.0	5.7	1.1	9.1	14.8	16.8	25.4	21.5	12.0	6.1	9.6	18.4	30.5	6.8	23.4	13.9	25.4	22.2	10.5	30.3	12.1	24.3	18.3	31.5	8.2	3.9	30.4	13.8	12.4	9.4	21.8	12.3	29.9	14.6	12.9	6.2	17.8	26.7	28.0	9.3	38.1	3.4	23.4	66.5	6.6	16.8	12.0	8.5	16.1	16.3	9.7	8.8	23.1	10.1	26.4	8.7
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907264-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3;retina: 13.2"	"Group enriched"	"Detected in some"	17	"Astrocytes: 380.0;Excitatory neurons: 394.8;Inhibitory neurons: 503.6;Oligodendrocyte precursor cells: 1344.6"	"Cancer enriched"	"Detected in some"	4	"glioma: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 47.8;WM-115: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	1.4	1.2	17.1	0.9	19.0	0.0	0.6	6.3	21.3	1.2	0.6	4.9	0.4	1.2	3.0	0.6	1.8	0.6	3.4	16.2	11.0	0.6	0.0	0.1	0.0	8.5	12.4	0.3	0.4	0.1	0.5	0.0	8.3	1.2	0.9	13.2	0.5	1.3	0.3	0.4	1.4	1.1	9.0	0.7	1.1	0.6	12.3	0.0	0.6	0.3	0.0	0.7	0.9	16.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.0	0.9	0.0	0.0	0.4	0.0	6.1	6.9	0.0	0.0	0.3	0.0	81.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	19.0	6.3	21.3	16.2	11.0	8.5	12.4	8.3	9.0	12.3	16.4	0.9	0.0	0.0	380.0	0.1	0.4	0.1	0.0	0.0	15.8	0.1	0.0	6.9	0.0	1.3	0.0	2.1	0.0	0.3	0.0	0.0	0.0	17.9	0.0	0.2	0.2	0.0	0.0	394.8	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	16.8	503.6	0.0	0.0	0.0	0.0	38.3	0.6	0.3	14.2	27.2	0.0	27.6	0.0	1344.6	10.3	0.0	0.0	1.2	0.1	1.0	0.0	0.1	0.0	2.2	0.0	1.1	5.4	3.0	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1
SLC35F6	"ANT2BP, C2orf18, FLJ20555, TANGO9"	ENSG00000213699	"Solute carrier family 35 member F6"	Q8N357	2	26764284-26781231	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 129.9;Karpas-707: 117.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034655	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Nucleoplasm, Cytosol"	"HPA034655: AB_10696359"	"unprognostic (2.26e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.11e-4)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-2)"	18.6	20.7	9.6	7.3	10.5	4.6	16.2	10.1	9.2	14.5	8.4	10.1	7.9	11.9	7.3	22.0	10.7	7.3	13.8	9.6	11.8	19.5	17.7	11.9	6.5	13.9	12.9	8.5	10.3	21.3	10.8	9.4	12.3	11.4	5.7	5.8	14.5	8.1	12.8	21.2	10.0	10.1	10.4	10.8	11.3	5.1	13.0	5.7	16.0	9.9	7.6	12.1	13.0	11.6	24.6	43.6	12.3	32.6	41.7	19.4	20.4	14.9	20.3	16.8	15.2	27.9	44.5	6.6	23.4	18.7	42.0	29.4	18.1	26.9	11.8	11.5	10.1	7.6	16.4	23.3	129.9	7.8	36.4	29.8	26.9	18.9	62.7	7.6	19.9	9.6	14.2	117.3	16.9	40.5	10.0	7.0	7.6	17.2	10.9	8.9	35.9	10.9	44.1	20.3	9.6	12.7	22.8	37.4	25.4	10.1	14.1	8.2	19.2	21.8	24.0	30.7	15.2	23.9	32.6	12.9	23.6	13.4	21.0	12.1	18.1	8.0	11.9	25.6	7.0	4.8	8.2	10.8	11.4	3.6	5.3	7.9	11.7	13.6	30.9	7.8	5.9	9.5	9.6	10.5	10.1	9.2	9.6	11.8	13.9	12.9	12.3	10.4	13.0	11.6	39.0	12.8	10.5	11.8	5.9	17.0	13.2	10.2	7.4	17.2	17.5	10.2	13.5	28.6	11.1	33.1	6.2	24.1	12.0	21.5	7.9	34.2	1.7	13.4	29.7	20.8	9.1	0.8	6.9	38.7	22.3	25.2	12.2	22.8	1.3	11.9	31.8	25.4	51.2	15.2	7.9	11.2	8.2	61.0	16.8	1.5	18.3	28.8	28.4	4.7	19.8	19.2	11.3	9.0	10.8	48.2	14.3	12.0	5.5	18.3	21.5	57.2	9.0	11.1	26.3	17.8	20.2	3.7	7.1	14.9	25.7	38.0	10.6	16.8	11.2	11.7
SLC38A7	FLJ10815	ENSG00000103042	"Solute carrier family 38 member 7"	Q9NVC3	16	58665109-58684770	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Group enriched"	"Detected in all"	13	"Early spermatids: 271.8;Late spermatids: 753.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041777, HPA049428"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041777: AB_10796782, HPA049428: "	"unprognostic (2.16e-3)"	"unprognostic (2.30e-2)"	"unprognostic (6.23e-3)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.49e-1)"	"unprognostic (8.08e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.93e-3)"	6.0	11.4	7.5	6.0	7.8	2.6	5.3	6.0	8.9	5.1	6.1	5.1	4.3	5.5	6.2	6.5	4.0	5.6	15.9	7.9	7.4	7.3	13.6	5.4	4.3	7.7	7.6	4.6	4.8	14.1	7.2	7.5	8.1	5.5	5.9	4.7	6.2	4.6	9.4	5.3	5.5	7.4	5.8	10.3	5.4	32.8	9.8	3.6	7.8	8.3	4.6	5.4	4.9	7.0	6.9	10.9	10.8	16.5	22.0	12.9	19.3	16.2	18.7	22.7	15.6	9.9	11.0	4.5	8.9	22.9	17.9	15.9	10.2	11.7	13.3	2.8	9.4	5.1	9.3	16.5	32.9	10.6	14.0	25.9	23.6	16.1	10.3	12.3	23.5	10.4	14.9	6.3	16.7	8.0	4.3	6.3	11.7	7.5	16.0	15.2	11.6	12.1	10.0	15.4	7.9	11.3	25.7	17.0	7.0	14.4	7.6	4.2	18.7	12.3	9.3	21.8	5.0	9.7	6.7	5.2	16.8	6.3	9.3	0.1	6.8	2.0	4.0	6.6	2.2	1.3	2.4	2.9	4.5	2.5	1.9	2.1	0.5	1.8	6.4	1.7	1.8	5.5	7.5	7.8	6.0	8.9	7.9	7.4	7.7	7.6	8.1	5.8	9.8	7.0	3.3	3.2	4.4	7.8	2.0	3.8	4.0	4.4	1.2	9.8	4.7	3.2	12.8	4.3	4.8	11.0	12.5	8.4	5.0	3.7	3.9	14.0	271.8	3.5	6.8	6.2	13.1	2.1	13.3	8.5	9.5	5.1	9.7	6.0	1.3	10.7	8.2	9.3	38.6	16.8	15.5	3.1	12.2	10.1	8.2	753.3	9.6	11.6	8.8	9.4	4.0	7.1	8.2	5.0	7.6	12.8	2.7	8.6	1.8	3.7	4.8	5.9	3.8	7.1	6.6	4.8	5.1	6.9	7.6	4.6	4.3	15.3	2.7	8.6	4.9	3.2
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 48.4"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.8;Microglial cells: 362.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	8.2	9.7	7.9	6.3	7.4	4.6	7.1	0.0	21.0	10.8	0.0	4.3	3.9	11.0	3.7	3.6	9.5	8.8	4.3	15.8	0.0	8.7	2.0	7.4	8.3	0.1	0.4	7.9	4.8	5.2	1.1	12.8	1.7	19.1	4.2	5.1	3.7	6.7	1.3	7.0	4.0	7.7	1.4	18.3	5.0	9.3	9.9	10.6	48.4	3.1	7.6	6.3	2.1	5.8	7.3	27.1	46.8	13.0	9.5	21.1	24.3	34.8	16.4	16.1	8.1	38.4	26.4	10.4	51.3	19.6	12.4	10.4	28.6	31.6	19.9	5.4	21.8	11.7	37.1	34.0	10.8	45.4	4.9	12.9	5.1	17.7	20.2	56.9	37.3	10.5	34.9	14.3	26.7	7.3	12.7	14.0	53.8	44.1	18.8	28.9	16.6	27.0	74.8	12.7	17.5	24.7	34.4	65.1	18.7	81.2	11.2	26.5	36.1	28.7	33.6	19.0	18.7	4.6	3.7	6.3	24.5	19.9	29.9	41.5	4.7	3.7	7.5	4.4	6.1	12.3	6.8	6.7	6.4	15.8	6.0	7.8	0.8	21.7	3.3	32.8	7.6	2.6	7.9	7.4	0.0	21.0	15.8	0.0	0.1	0.4	1.7	1.4	9.9	5.8	72.1	3.2	12.8	40.8	42.0	25.6	12.1	51.3	13.1	23.0	16.9	23.1	7.6	5.7	33.2	36.8	8.4	49.3	60.2	4.3	1.9	17.7	28.5	13.2	48.7	75.4	15.6	26.9	170.8	11.3	66.0	35.3	11.2	16.5	13.3	25.7	26.4	2.8	24.5	8.4	78.3	5.9	26.4	20.7	27.1	16.0	19.0	31.8	7.2	362.6	16.2	17.0	20.6	49.3	49.5	24.3	2.8	18.8	21.3	20.1	4.5	14.7	9.5	20.0	13.1	41.9	29.1	61.3	33.6	7.5	20.5	23.4	35.4	30.8	6.2	7.8
SLC39A11	C17orf26	ENSG00000133195	"Solute carrier family 39 member 11"	Q8N1S5	17	72645949-73092712	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 205.3;Excitatory neurons: 107.7;Oligodendrocytes: 360.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 217.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021455			Approved	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA021455: AB_2670710"	"unprognostic (2.29e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.85e-2)"	12.6	7.8	14.0	10.8	27.8	21.2	17.4	22.5	17.2	14.9	9.5	24.0	20.3	5.5	15.7	15.5	9.1	11.0	4.9	14.1	17.9	13.4	39.4	10.9	8.8	25.7	23.7	3.4	29.3	4.7	2.9	8.7	24.0	7.7	24.1	2.3	30.3	8.0	4.5	14.2	22.8	7.3	16.9	7.9	48.2	6.8	23.9	5.5	36.1	3.5	12.4	12.5	9.3	35.3	20.5	36.8	4.3	17.2	30.7	24.8	24.4	21.6	19.0	9.7	13.0	13.7	90.7	25.4	21.5	22.1	15.4	17.2	6.2	10.9	14.8	27.6	12.8	23.8	9.9	16.3	18.3	25.4	217.5	21.2	20.3	20.1	11.6	10.6	10.1	13.1	12.6	31.0	12.4	28.9	16.3	55.1	3.5	62.4	15.6	10.9	16.3	21.5	16.0	20.9	10.2	13.8	11.6	84.7	12.7	16.8	58.4	34.9	8.5	19.0	17.7	16.3	13.4	24.9	12.2	17.9	30.8	50.6	11.1	19.3	39.9	26.0	16.7	40.4	10.9	16.7	12.5	12.5	37.9	9.8	8.8	12.1	6.6	22.6	33.1	26.8	17.1	18.1	14.0	27.8	22.5	17.2	14.1	17.9	25.7	23.7	24.0	16.9	23.9	35.3	4.9	0.0	6.3	205.3	7.6	4.5	5.3	5.6	10.2	2.6	13.7	5.5	2.3	4.3	8.6	3.7	0.0	5.6	6.9	15.8	0.0	9.4	18.5	5.6	3.6	4.0	8.4	9.9	107.7	14.1	17.4	4.7	29.0	9.5	29.9	7.9	3.6	30.1	26.3	5.0	32.1	79.0	10.2	21.0	5.6	66.7	4.1	14.4	10.6	64.6	19.6	4.1	8.2	22.6	360.3	9.1	20.5	3.4	15.1	6.0	24.8	11.5	7.8	1.6	13.1	2.6	7.1	2.0	2.9	10.3	4.4	4.9	5.4	4.4	18.3	7.5
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"intestine: 237.4;kidney: 110.0;liver: 171.1;pancreas: 306.8"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 798.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 30.6;liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	53	"CACO-2: 39.9;Hep G2: 58.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.3	0.1	0.2	5.5	0.2	0.1	0.3	0.5	0.4	0.3	0.2	73.7	237.4	0.4	0.0	0.1	0.3	6.5	0.2	0.1	0.1	110.0	171.1	0.2	0.4	0.2	0.1	0.4	306.8	0.0	0.2	0.1	0.1	0.3	45.9	6.4	0.1	0.3	0.1	0.3	219.0	2.6	0.1	0.3	1.4	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.2	0.3	0.5	0.0	0.0	0.1	0.0	39.9	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.6	0.1	0.2	0.2	58.5	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.8	0.0	0.9	0.1	0.2	0.2	0.3	0.5	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.6	0.1	0.0	0.0	0.9	0.1	0.3	0.2	15.7	0.0	3.7	116.7	0.0	0.0	171.9	19.6	0.3	0.6	0.0	0.1	0.2	25.3	2.7	0.2	20.6	0.0	0.1	0.0	0.0	0.0	0.0	2.2	138.9	0.1	0.0	0.2	112.7	0.0	1.6	1.2	1.4	0.0	1.3	0.0	0.0	0.6	0.6	0.0	0.0	0.1	7.4	192.8	0.0	0.0	0.1	798.4	169.9	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.8	0.0	168.7	0.0
SLC39A6	LIV-1	ENSG00000141424	"Solute carrier family 39 member 6"	Q13433	18	36108531-36129385	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast glandular cells: 307.0;Prostatic glandular cells: 197.9"	"Group enriched"	"Detected in all"	4	"breast cancer: 361.9;prostate cancer: 127.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042377	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 35: Glandular cells - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA042377: AB_2677968"	"unprognostic (7.60e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.50e-2)"	"unprognostic (7.63e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	27.3	25.9	23.3	21.6	28.5	11.6	147.2	28.6	26.1	34.5	48.9	13.9	9.6	56.9	56.2	17.0	63.6	24.2	14.0	20.0	28.8	28.2	16.5	18.9	17.3	28.8	33.6	43.1	37.7	86.5	23.9	31.7	30.6	129.0	13.4	50.2	30.9	114.3	12.7	51.3	8.9	30.2	28.6	15.5	16.4	19.3	26.7	18.5	37.3	16.6	28.4	52.6	16.1	34.2	43.7	54.0	127.1	75.1	131.4	96.6	33.0	116.2	137.3	76.5	88.7	30.3	47.5	47.1	57.3	113.1	53.1	104.1	112.4	109.2	115.5	105.4	40.7	20.6	69.5	44.4	83.2	69.8	49.6	88.7	236.1	116.2	100.5	69.9	11.7	38.6	10.7	92.1	108.9	67.0	69.0	15.6	30.6	24.0	30.4	70.6	72.8	61.4	84.4	145.2	132.8	116.8	143.5	41.5	200.6	52.1	56.7	32.4	18.9	184.9	30.5	35.5	59.2	85.9	90.0	35.7	64.0	48.3	99.8	29.2	13.3	31.2	16.3	19.7	19.7	16.7	13.8	14.7	16.4	17.3	12.0	17.7	10.2	18.1	19.4	33.6	17.0	14.2	23.3	28.5	28.6	26.1	20.0	28.8	28.8	33.6	30.6	28.6	26.7	34.2	13.3	38.5	18.7	8.8	22.5	45.9	58.2	79.6	59.2	41.5	307.0	132.2	19.6	10.0	66.4	42.3	33.3	6.6	36.7	4.0	1.9	53.1	21.3	37.1	76.1	12.9	25.6	4.6	13.0	37.8	56.7	45.6	9.2	73.8	23.5	18.9	8.9	11.0	20.4	23.5	23.9	7.4	38.7	20.1	30.0	18.1	37.3	26.0	67.6	1.9	25.7	38.2	10.3	34.2	36.5	39.5	1.9	47.8	24.4	197.9	2.7	13.6	44.3	41.3	39.5	40.4	38.6	43.9	27.8	32.6	74.4	23.8	23.2	23.0	5.7	69.3
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856004-62888880	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 780.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 1441.0;SiHa: 1287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		170000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"		"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	103.3	105.6	130.5	46.7	138.0	122.0	108.9	140.1	160.4	101.6	115.6	60.6	51.5	97.2	65.3	112.9	94.0	35.8	52.0	123.1	133.3	171.2	71.9	117.8	34.9	138.4	132.6	93.0	109.7	189.7	65.3	55.4	134.0	100.8	23.1	22.8	110.6	41.9	122.3	127.1	79.7	33.8	135.8	77.4	90.2	65.1	154.5	30.1	110.2	26.0	28.8	77.7	95.1	130.6	155.5	675.7	60.2	213.2	89.7	69.7	596.7	267.5	106.2	154.0	126.3	643.3	293.0	173.9	290.5	185.4	284.5	540.0	123.1	588.9	84.3	319.3	114.0	117.5	422.4	299.2	825.7	136.0	169.4	144.9	1441.0	175.3	528.8	46.2	83.6	380.7	232.9	347.4	95.1	792.6	149.8	181.3	106.9	222.5	214.2	153.8	92.7	341.8	113.9	84.0	112.5	53.5	1287.0	499.6	948.5	121.2	161.5	182.6	146.2	138.3	200.0	204.4	195.5	436.0	556.1	561.2	135.0	225.1	418.0	37.8	149.0	49.7	117.9	147.4	157.7	58.3	107.3	122.1	88.6	72.1	90.1	97.2	31.2	90.3	123.9	304.7	112.5	186.3	130.5	138.0	140.1	160.4	123.1	133.3	138.4	132.6	134.0	135.8	154.5	130.6	97.8	48.1	37.3	91.1	78.8	218.1	244.2	321.7	399.5	58.4	124.2	120.8	13.4	30.0	141.1	49.7	66.7	222.5	136.2	109.6	33.2	161.9	31.5	122.0	96.3	149.2	84.3	117.7	16.9	151.1	143.7	102.9	71.4	179.7	84.3	43.2	99.2	27.0	202.9	53.8	25.1	60.4	223.8	54.1	140.9	28.9	30.4	141.5	224.1	29.0	104.7	188.4	40.2	21.1	11.3	130.6	58.7	30.5	140.9	156.9	120.7	227.4	63.4	61.2	6.6	71.8	114.6	21.3	31.9	160.7	150.6	780.7	118.1	52.4	60.7	194.9
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560590-189583758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 489.8;Kupffer cells: 1340.2;Syncytiotrophoblasts: 2463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 326.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 509.0;CACO-2: 123.1;HEL: 430.0;HMC-1: 110.5;T-47d: 207.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	59.6	333.5	9.3	52.6	11.9	45.8	97.7	9.6	9.8	156.3	10.4	124.7	289.3	95.4	61.6	30.5	214.2	148.7	52.6	7.2	12.0	79.9	251.5	122.9	172.6	15.6	15.7	317.2	53.2	91.8	19.0	250.1	12.8	39.5	130.8	29.5	58.7	53.1	64.2	12.2	127.9	69.3	15.5	368.1	96.8	33.2	13.9	62.6	68.0	60.3	59.1	53.1	21.8	11.3	0.0	7.4	0.6	0.0	509.0	3.3	25.4	0.2	6.6	1.9	3.1	123.1	0.4	0.2	1.0	0.2	1.4	0.4	2.4	0.3	1.6	0.3	1.7	430.0	1.7	45.8	1.9	1.5	110.5	35.9	0.2	1.2	0.0	11.7	13.0	16.4	44.6	1.1	6.3	0.0	18.2	28.8	1.5	92.7	1.7	0.2	5.0	2.5	5.3	18.1	1.0	5.4	0.8	35.4	0.0	39.5	207.6	6.2	0.3	0.8	11.7	0.5	0.1	1.1	0.2	0.3	0.1	0.2	0.1	129.8	101.5	172.1	2.2	23.7	3.2	0.2	54.4	4.9	115.6	0.7	80.2	17.8	326.2	4.6	2.6	18.8	5.3	105.8	9.3	11.9	9.6	9.8	7.2	12.0	15.6	15.7	12.8	15.5	13.9	11.3	44.2	125.0	40.3	3.6	12.0	9.2	51.3	10.5	19.9	4.8	83.8	30.0	48.0	138.7	31.6	33.1	4.2	489.8	5.7	328.9	49.0	54.7	10.5	39.6	38.2	39.8	18.6	253.7	0.3	71.8	20.3	81.9	76.5	129.5	9.5	12.8	245.9	259.7	86.4	6.7	6.8	60.8	6.1	1340.2	26.8	9.2	121.2	172.7	8.8	34.7	41.7	17.5	2.1	14.6	0.2	71.5	86.2	58.6	4.1	26.2	163.0	150.0	34.4	48.4	65.7	13.7	49.1	7.4	3.9	12.5	8.1	2463.5	11.9	84.8	48.9	27.7
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 146.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 75.5;granulocytes: 67.0;Hofbauer cells: 73.7;Langerhans cells: 74.6;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 105.7;intermediate monocyte: 127.0;myeloid DC: 85.8;non-classical monocyte: 146.3;plasmacytoid DC: 85.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 85.8;monocytes: 146.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 513.8;HMC-1: 428.4;RPMI-8226: 570.9;WM-115: 532.1"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.3"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA030551: AB_10604094, HPA077244: AB_2732335"	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	61.4	16.8	5.2	34.8	5.9	58.0	50.3	5.9	7.3	40.2	6.8	23.7	8.3	28.1	4.5	34.8	30.0	28.5	34.8	5.5	7.1	15.9	146.9	46.9	26.5	6.7	6.4	24.3	13.7	3.9	4.9	14.3	7.3	14.4	11.8	0.9	35.2	7.5	15.6	34.6	20.6	25.5	6.3	20.8	20.1	4.7	11.1	23.2	76.3	13.3	28.9	30.7	28.2	8.5	289.2	0.0	16.0	0.4	52.9	76.9	0.7	22.0	93.0	31.6	54.1	0.0	61.4	165.0	9.8	52.0	16.3	161.8	47.0	28.8	63.3	1.0	0.2	257.3	93.0	0.0	106.6	513.8	428.4	231.7	0.9	306.5	3.5	22.9	89.7	75.0	299.8	154.4	123.7	0.6	108.6	328.2	24.3	0.0	5.3	221.8	3.3	570.9	76.1	0.0	38.0	0.0	62.2	1.4	263.5	1.5	24.1	77.3	48.1	1.5	81.4	209.2	62.5	0.3	0.9	41.3	187.3	183.2	532.1	15.2	105.7	23.4	19.6	127.0	22.2	9.6	13.5	26.8	85.8	7.1	10.4	10.5	9.0	3.9	146.3	85.7	26.5	60.7	5.2	5.9	5.9	7.3	5.5	7.1	6.7	6.4	7.3	6.3	11.1	8.5	19.8	16.0	49.1	1.6	6.1	46.8	7.4	30.8	48.3	0.5	8.0	14.2	3.7	28.6	26.1	1.8	0.0	0.6	11.9	0.3	0.0	75.5	1.0	1.0	3.1	33.0	0.0	38.3	0.1	6.4	5.0	33.4	2.0	3.0	67.0	2.9	14.3	61.7	73.7	0.0	0.2	0.6	16.2	21.0	74.6	1.7	9.9	47.0	30.2	8.4	10.2	0.6	3.1	8.5	0.8	9.4	0.5	12.4	22.5	14.5	0.0	0.1	4.9	0.1	65.7	15.5	22.0	0.7	1.1	13.6	17.6	0.8	11.8	12.3	1.2	3.0
SLC44A1	"CD92, CDW92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 284.9"	"Cell type enriched"	"Detected in all"	8	"Oligodendrocytes: 2444.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 285.9;ASC TERT1: 224.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		99000	"Cluster 24: B-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	16.9	13.3	112.9	12.9	204.4	11.4	26.2	166.7	138.7	16.7	79.4	50.2	22.6	15.9	32.4	18.4	15.2	20.2	12.7	116.2	136.1	21.8	38.0	18.4	9.7	204.3	167.7	14.1	15.1	23.2	5.3	23.3	205.5	11.8	49.0	14.1	9.6	25.0	9.4	21.5	27.0	17.3	161.1	9.5	35.2	3.5	150.8	13.6	43.6	20.2	15.5	21.8	15.6	284.9	29.0	23.8	6.4	7.9	285.9	224.1	20.3	23.9	61.7	15.1	20.2	25.6	74.8	38.4	12.0	90.2	17.1	56.1	19.3	34.4	25.7	34.0	15.7	47.8	15.8	32.0	19.3	9.6	23.7	125.3	27.6	29.0	26.1	38.8	48.6	19.7	1.4	77.1	17.3	40.8	38.8	10.9	35.9	51.1	22.9	8.0	24.7	29.3	20.9	66.6	30.6	12.0	33.4	36.5	33.3	37.8	36.2	28.7	41.9	15.1	13.5	16.5	17.7	59.1	41.7	28.4	29.2	20.6	20.2	1.7	3.3	0.7	0.7	1.2	0.4	1.1	0.7	0.4	2.2	2.0	0.8	0.3	0.5	5.3	0.7	0.8	0.8	0.9	112.9	204.4	166.7	138.7	116.2	136.1	204.3	167.7	205.5	161.1	150.8	284.9	48.6	35.3	26.5	83.2	22.2	70.6	36.0	28.3	75.1	10.3	76.9	27.2	10.1	67.2	19.9	106.7	235.6	53.3	7.6	296.5	3.9	17.5	2.9	59.2	40.3	45.2	157.2	20.4	174.2	36.5	12.1	64.0	84.1	175.2	100.1	16.7	48.9	170.0	21.3	6.7	108.1	160.0	14.2	46.5	46.5	6.1	110.0	48.6	74.7	81.5	91.0	9.0	13.4	257.3	2444.2	36.9	161.2	79.7	162.9	23.8	95.4	27.1	31.4	53.3	39.5	43.8	34.9	2.3	4.4	86.9	74.3	70.6	20.3	12.1	199.1	34.8
SLC45A3	"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein"	ENSG00000158715	"Solute carrier family 45 member 3"	Q96JT2	1	205657851-205680509	"Cancer-related genes, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"prostate: 306.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 19.9;granulocytes: 119.2;Oligodendrocytes: 47.1;Prostatic glandular cells: 67.2"	"Cancer enriched"	"Detected in all"	49	"prostate cancer: 539.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	382	"basophil: 40.5"	"Lineage enriched"	"Detected in single"	382	"granulocytes: 40.5"	"Cell line enriched"	"Detected in many"	29	"HMC-1: 834.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019073, HPA019075"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"HPA019073: AB_1857177, HPA019075: AB_1857179"	"unprognostic (1.80e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.33e-5)"	1.4	3.6	6.7	3.2	19.5	0.8	1.6	17.6	13.4	3.7	1.9	4.8	4.6	1.7	0.5	1.6	2.1	3.8	1.5	8.0	10.3	2.1	11.2	3.4	2.7	25.1	17.3	2.7	0.8	0.3	4.7	0.5	21.8	306.4	3.2	0.1	2.8	0.6	5.6	1.5	4.8	1.0	12.6	12.4	16.8	1.4	16.6	0.5	1.0	2.3	0.8	2.8	1.1	44.7	9.7	3.0	2.8	2.7	0.0	0.1	2.2	1.3	0.3	3.3	2.7	7.1	18.0	2.7	4.6	0.3	3.0	3.5	1.6	3.3	0.5	3.9	2.9	29.0	0.6	2.0	1.9	5.0	834.2	0.3	1.1	2.3	0.0	2.2	9.4	4.5	4.9	1.7	1.4	2.3	0.8	8.5	12.2	16.7	10.7	1.0	4.1	1.5	3.7	13.7	1.2	2.9	1.5	20.6	3.9	2.3	4.7	1.4	9.6	1.4	9.5	3.5	7.1	0.4	0.6	0.4	1.8	1.5	7.1	40.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	19.5	17.6	13.4	8.0	10.3	25.1	17.3	21.8	12.6	16.6	44.7	0.2	0.0	3.2	1.0	4.0	0.0	1.0	0.6	0.0	0.4	1.5	1.8	2.0	2.8	1.0	1.8	0.0	0.5	0.1	5.7	0.0	1.7	0.2	1.9	0.2	1.7	0.0	3.4	0.2	0.5	0.1	0.7	19.9	0.2	119.2	0.2	0.7	6.6	1.9	0.0	0.3	6.9	2.0	1.0	0.3	0.4	1.8	2.0	0.0	0.0	0.6	0.1	0.0	2.0	47.1	3.9	8.0	1.5	0.3	67.2	0.9	1.8	3.2	0.1	6.6	0.1	0.8	0.0	2.6	0.4	0.1	0.0	0.9	0.2	6.7	0.9
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 51.3;salivary gland: 54.0;thyroid gland: 60.9"	"Cell type enhanced"	"Detected in many"		"Club cells: 25.5;Collecting duct cells: 112.2;Ionocytes: 79.3;Respiratory ciliated cells: 48.1;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 70.6;Hep G2: 43.0;RT4: 30.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	2.4	6.9	4.5	0.7	3.5	0.4	3.4	2.3	3.1	10.9	5.6	0.4	0.1	0.5	2.6	16.5	1.7	1.1	0.8	2.9	1.4	51.3	0.2	2.0	1.4	2.0	2.3	0.2	0.5	0.6	4.3	0.2	2.6	5.4	0.3	0.4	54.0	7.0	5.2	12.8	0.6	0.3	0.8	0.7	2.5	5.9	4.3	1.0	60.9	0.1	1.8	3.4	5.8	1.9	11.0	15.5	1.8	7.9	5.1	1.3	21.1	5.4	3.4	2.8	1.6	1.1	14.1	0.0	6.1	1.9	6.6	70.6	8.3	16.8	0.5	0.1	3.2	0.7	7.5	43.0	3.2	4.0	13.6	0.7	6.8	3.4	3.2	2.3	7.0	9.8	1.6	9.7	2.9	7.2	0.5	0.4	12.1	13.6	20.7	2.6	10.3	3.5	16.9	30.7	0.9	4.9	2.7	17.5	0.3	5.4	6.7	7.0	12.1	2.1	7.0	0.5	2.7	0.4	0.6	0.1	0.1	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.5	3.5	2.3	3.1	2.9	1.4	2.0	2.3	2.6	0.8	4.3	1.9	0.8	0.0	0.0	1.6	0.0	0.8	2.2	16.3	8.0	0.2	4.9	4.4	1.1	0.0	25.5	112.2	0.0	0.1	0.6	0.8	0.0	0.7	5.8	2.3	0.6	0.7	0.0	0.0	0.3	0.5	0.1	0.3	5.1	4.2	0.0	0.2	1.1	0.0	0.4	0.0	0.1	0.2	79.3	0.3	0.0	2.2	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.3	3.0	1.3	0.4	0.0	3.7	0.0	0.5	48.1	0.2	26.3	0.6	5.8	3.0	4.7	3.3	0.4	0.0	0.2	0.1	0.2	5.7
SLC4A1AP	"HLC3, kanadaptin"	ENSG00000163798	"Solute carrier family 4 member 1 adaptor protein"	Q9BWU0	2	27663471-27694976	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036679	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA036679: AB_2675244"	"unprognostic (5.63e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.21e-1)"	"unprognostic (7.89e-3)"	"prognostic unfavorable (3.76e-7)"	"unprognostic (1.32e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.79e-4)"	13.7	16.6	15.3	16.1	16.2	15.8	14.5	17.9	20.9	11.8	12.7	12.3	12.6	13.4	12.4	15.1	12.7	10.4	20.6	16.4	16.2	16.0	16.2	13.9	17.4	15.7	15.6	15.5	14.4	21.1	12.7	15.7	15.7	12.9	12.9	19.8	12.9	12.0	30.6	16.4	13.3	13.2	13.3	15.0	13.9	33.9	15.6	17.1	15.3	22.1	16.9	12.6	12.0	16.4	44.6	25.4	25.1	23.6	25.3	23.2	36.8	36.1	24.8	37.2	30.3	37.4	31.7	28.0	32.7	29.1	39.2	31.0	40.6	28.0	33.2	39.2	33.2	32.2	26.2	41.5	30.7	46.6	29.5	20.9	34.8	37.1	34.8	31.2	38.4	27.1	47.5	29.7	34.7	27.1	31.5	45.4	25.4	29.3	24.7	25.9	54.9	32.4	38.5	20.4	27.2	26.8	28.1	37.9	36.0	25.2	23.0	30.1	39.3	34.5	31.3	24.2	42.7	48.5	73.8	88.4	37.4	36.8	28.2	104.8	33.4	48.9	31.6	32.6	31.8	26.1	28.6	28.0	25.8	36.7	34.5	29.1	31.9	43.7	37.6	20.8	34.9	28.0	15.3	16.2	17.9	20.9	16.4	16.2	15.7	15.6	15.7	13.3	15.6	16.4	17.1	32.1	28.9	14.7	17.3	11.9	12.3	27.1	14.8	19.9	13.3	11.0	30.1	11.5	29.1	18.4	18.8	24.5	21.0	11.4	5.9	28.4	47.2	22.0	20.3	21.9	16.3	11.8	25.5	36.9	20.3	17.4	13.3	20.4	38.6	18.5	15.4	13.9	24.4	25.2	23.7	11.5	16.2	13.9	8.2	7.9	17.4	18.9	17.8	8.4	31.5	21.6	19.6	12.5	18.2	30.5	9.3	19.2	22.1	8.7	11.5	16.1	24.4	21.1	32.9	23.3	21.7	143.4	82.4	15.7	11.9	24.4	21.8	21.5	10.1	10.8
SLC4A3	"AE3, SLC2C"	ENSG00000114923	"Solute carrier family 4 member 3"	P48751	2	219627394-219641980	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 283.1;ovary: 124.1"	"Group enriched"	"Detected in many"	9	"Cardiomyocytes: 207.1;Horizontal cells: 558.6"	"Cancer enhanced"	"Detected in all"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"myeloid DC: 1.4;plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	54	"dendritic cells: 5.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063498			Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA063498: AB_2685025"	"unprognostic (9.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (8.92e-4)"	"unprognostic (1.77e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.12e-4)"	6.3	16.7	36.1	1.0	36.6	0.4	3.9	21.2	32.1	11.4	6.3	2.9	0.7	15.3	2.7	3.2	9.3	2.3	283.1	31.7	34.5	9.3	0.3	1.6	0.9	44.1	20.7	124.1	3.9	7.7	41.4	2.7	43.1	10.4	0.2	13.0	3.8	5.3	0.9	2.0	1.1	3.7	10.6	3.3	2.7	14.2	32.7	1.0	2.5	0.6	0.6	2.6	4.7	18.0	6.9	0.2	2.3	6.8	0.4	0.4	4.9	4.1	4.2	5.4	3.8	4.8	3.8	0.0	1.6	1.5	9.3	3.8	1.2	7.3	1.6	0.0	1.0	0.0	0.1	0.1	1.1	0.1	0.3	3.1	7.0	0.0	2.1	13.4	0.0	0.0	0.3	0.0	1.6	2.3	0.0	0.0	3.8	0.2	5.5	0.0	0.0	0.0	3.7	1.5	1.3	6.7	2.7	6.9	3.7	7.2	0.7	1.7	0.0	3.4	6.0	0.0	3.3	0.0	0.0	0.0	2.7	0.0	9.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	36.1	36.6	21.2	32.1	31.7	34.5	44.1	20.7	43.1	10.6	32.7	18.0	0.3	0.0	0.0	19.2	0.2	0.3	0.7	1.5	0.0	14.4	2.2	4.8	207.1	0.0	0.8	1.8	0.0	11.4	13.5	0.0	1.9	3.0	2.3	0.9	3.5	1.8	0.0	0.0	11.5	1.7	3.0	10.4	0.0	1.4	0.0	38.3	0.0	0.0	1.8	558.6	32.7	0.0	0.0	0.3	5.6	25.6	15.2	1.1	0.0	3.7	1.3	7.6	0.0	3.5	0.6	1.1	0.0	22.6	0.0	0.4	0.0	0.3	0.2	7.5	6.6	3.9	3.5	0.6	1.2	0.0	0.9	13.8	0.1	8.7	0.0	0.1
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 528.1"	"Cell type enriched"	"Detected in many"	6	"Proximal enterocytes: 768.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 34.2"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	4.2	0.1	0.0	9.7	0.2	0.1	12.3	0.0	10.7	528.1	0.5	3.5	5.1	1.1	26.9	75.2	0.1	0.0	6.6	1.7	2.1	0.3	0.1	0.0	0.0	1.6	0.3	1.0	0.0	0.1	3.0	9.7	0.2	19.0	2.4	0.3	13.5	302.4	0.7	0.0	2.9	7.2	2.3	0.5	0.1	0.0	0.0	4.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	34.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.2	0.6	1.7	4.2	0.0	0.0	11.6	6.5	115.2	115.8	8.2	0.0	0.0	0.0	0.2	19.8	0.0	3.0	38.4	2.4	1.4	1.0	25.4	0.0	0.4	1.4	0.0	1.4	5.6	10.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	34.1	0.0	0.0	0.0	71.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	32.6	1.5	0.0	17.6	768.7	6.4	2.0	0.0	0.0	0.0	0.7	10.1	4.2	2.0	5.5	0.0	0.1	0.1	41.2	6.7
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 43.9"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocytes: 677.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 8.3;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.1	0.1	8.5	0.0	24.2	0.0	0.6	22.0	22.6	0.0	5.0	0.3	3.3	0.0	0.0	0.0	0.1	0.2	0.1	8.6	17.0	3.0	0.8	0.1	0.0	27.2	21.5	0.1	0.3	0.0	0.3	0.0	27.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	8.1	0.0	14.5	0.2	0.1	0.4	20.7	0.0	0.1	0.2	0.0	0.1	0.1	43.9	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	24.2	22.0	22.6	8.6	17.0	27.2	21.5	27.3	14.5	20.7	43.9	0.0	0.0	0.0	2.9	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.0	2.0	1.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	677.9	0.0	2.4	0.0	0.1	0.0	35.2	7.2	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.2	0.6	0.0
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667020-26723427	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 47.7;intestine: 30.1;kidney: 171.7"	"Group enriched"	"Detected in some"	23	"Proximal enterocytes: 286.0;Proximal tubular cells: 181.0"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.3;NTERA-2: 1.7;SuSa: 3.3;T-47d: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.1	0.1	0.3	0.0	0.5	0.9	0.1	0.9	0.4	0.0	0.3	0.2	4.9	0.1	47.7	0.0	0.1	0.1	4.3	0.3	0.4	171.7	1.7	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.0	0.1	0.1	0.1	0.3	30.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.2	1.7	0.3	0.0	0.0	0.0	0.3	0.0	0.5	0.8	0.1	0.7	0.1	0.0	3.3	1.2	0.2	0.2	0.2	0.1	0.2	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.9	0.4	0.3	0.4	0.2	0.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.1	3.7	0.0	0.1	0.0	2.4	9.8	0.0	1.4	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	286.0	181.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.6	4.5	3.5	0.1
SLC66A2	"FLJ22378, PQLC1"	ENSG00000122490	"Solute carrier family 66 member 2"	Q8N2U9	18	79902420-79951657	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 185.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.3;Cardiomyocytes: 10.8;Cytotrophoblasts: 14.3;dendritic cells: 9.6;Extravillous trophoblasts: 14.6;Hofbauer cells: 36.1;Syncytiotrophoblasts: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051666	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA051666: AB_2681567"	"unprognostic (6.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.70e-2)"	57.1	24.4	32.1	14.4	30.4	38.3	53.4	25.3	40.0	30.3	33.5	38.0	9.7	27.4	5.6	46.5	27.0	14.5	32.4	37.0	26.9	49.0	185.4	37.4	18.1	34.5	31.2	21.6	33.8	11.5	23.8	10.3	31.9	32.2	7.5	7.2	38.9	9.9	83.9	55.5	24.5	8.5	29.1	34.4	25.6	77.0	34.3	12.3	68.4	25.9	8.9	26.3	34.2	29.2	34.8	11.7	11.9	23.0	26.0	16.6	16.0	22.4	15.1	17.6	16.6	15.6	18.5	14.6	8.5	20.4	10.3	34.8	16.2	23.8	4.7	44.3	23.8	18.2	16.7	42.6	30.9	44.2	44.5	18.6	23.2	16.2	6.2	9.0	15.3	15.8	6.9	11.6	9.2	26.6	22.1	47.6	3.9	4.7	31.5	38.7	12.4	24.6	12.0	24.4	34.8	15.7	16.9	21.3	25.6	3.1	12.7	48.0	19.4	26.8	27.2	14.3	17.2	5.8	10.0	18.8	20.5	53.2	12.1	0.3	1.7	2.0	0.6	1.7	0.4	0.8	0.7	0.3	1.9	0.6	0.9	1.1	1.2	1.0	1.6	3.5	0.8	0.8	32.1	30.4	25.3	40.0	37.0	26.9	34.5	31.2	31.9	29.1	34.3	29.2	20.3	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	14.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	14.6	4.6	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	20.8	2.0	0.0	0.0	0.0
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816201-10940714	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 153.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 85.2;Excitatory neurons: 13.7;Inhibitory neurons: 25.8;Muller glia cells: 26.4;Oligodendrocyte precursor cells: 23.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 13.5;Hep G2: 16.0;hTCEpi: 11.9;NTERA-2: 6.7;T-47d: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.0	0.0	50.5	0.0	78.7	0.0	1.1	57.3	32.6	0.7	9.6	0.0	0.0	0.5	0.1	8.2	0.5	0.0	0.0	22.6	96.6	0.0	0.1	0.0	0.0	60.0	128.4	0.0	0.1	0.5	0.3	0.4	61.9	0.7	0.0	11.0	1.0	0.0	0.2	5.7	0.0	0.1	41.8	0.4	0.0	1.4	153.3	0.0	0.0	0.0	0.1	0.4	1.8	21.1	5.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.0	2.2	0.0	0.0	0.2	0.3	0.0	16.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.9	4.5	3.9	0.1	0.0	0.1	5.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	78.7	57.3	32.6	22.6	96.6	60.0	128.4	61.9	41.8	153.3	21.1	0.0	0.0	0.0	85.2	0.0	1.3	0.7	0.3	4.0	8.4	0.9	0.9	1.4	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	13.7	0.0	7.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.0	0.0	0.8	0.9	3.4	0.2	0.0	6.5	0.0	26.4	0.0	23.1	0.8	0.2	0.0	6.8	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.6	0.1	0.6	1.8	10.6	3.7	1.0	0.1	0.0	0.0	1.7
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 153.1"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 324.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 4.6;SuSa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.2	0.3	13.4	0.0	16.5	0.1	0.1	11.0	20.1	0.1	13.9	0.1	2.6	0.1	0.3	0.0	7.1	0.0	2.6	12.2	11.9	153.1	36.8	0.8	0.0	11.6	12.6	0.2	0.0	0.0	3.0	0.0	11.7	0.5	0.0	1.1	0.1	0.1	0.5	0.2	0.6	0.0	12.1	0.3	0.1	3.1	13.8	0.1	6.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.5	11.0	20.1	12.2	11.9	11.6	12.6	11.7	12.1	13.8	11.7	0.0	0.0	0.6	1.3	1.9	0.0	0.0	0.4	0.0	0.4	0.1	0.1	1.5	0.0	0.1	18.4	2.1	0.0	0.1	0.0	49.0	0.0	1.4	0.6	0.1	0.2	0.0	5.3	3.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	27.0	0.0	0.0	1.2	0.0	2.0	1.6	0.0	0.6	0.3	1.7	0.0	17.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.5	324.9	0.7	0.7	0.0	0.4	0.1	0.6	0.4	0.0	0.0	0.3	0.9	0.0	0.0	0.0
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.4;skin 1: 46.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.7;Distal enterocytes: 17.8;Erythroid cells: 33.1;Ionocytes: 20.3"	"Cancer enhanced"	"Detected in all"		"glioma: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 62.3;hTCEpi: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	3.9	31.0	21.7	4.9	45.5	10.8	4.6	53.2	24.2	12.1	6.3	11.0	2.3	7.4	1.1	23.1	9.5	4.8	2.1	16.1	31.3	4.3	2.3	11.6	1.1	66.3	43.5	2.9	8.2	2.8	1.7	1.4	63.6	3.9	6.3	17.2	11.5	5.5	1.1	46.6	6.0	9.1	45.6	1.9	7.4	1.1	45.9	1.4	5.3	0.6	4.3	12.3	25.1	72.4	19.7	13.7	7.1	18.0	11.2	3.7	15.6	14.7	41.0	24.3	30.1	4.8	7.5	0.3	1.6	42.9	0.0	62.3	11.0	12.5	5.0	0.1	1.8	17.1	33.9	5.8	50.3	3.8	0.7	11.3	106.6	11.9	28.5	15.3	0.6	12.3	13.0	48.5	1.0	10.4	2.9	0.1	5.4	7.4	19.1	2.2	0.0	22.9	2.3	2.2	4.4	4.2	7.4	35.3	7.0	1.7	9.1	10.3	0.2	2.8	11.0	2.4	8.0	53.1	39.2	4.4	9.2	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	45.5	53.2	24.2	16.1	31.3	66.3	43.5	63.6	45.6	45.9	72.4	1.5	0.0	2.0	5.9	1.1	7.5	0.9	3.2	8.0	30.7	2.2	0.9	0.7	4.3	2.2	1.8	16.7	0.5	0.5	17.8	0.0	3.7	5.9	4.8	0.4	0.7	0.0	33.1	2.2	8.9	1.0	0.9	1.5	2.7	0.0	0.0	0.0	0.3	0.3	1.7	1.5	2.7	20.3	0.0	1.0	0.8	1.5	0.1	3.6	0.0	1.0	1.2	0.0	3.0	16.4	4.2	3.0	1.5	1.3	2.0	9.1	1.1	12.5	11.1	6.6	0.1	10.0	0.1	0.4	8.9	12.9	0.5	0.3	1.2	2.6	3.2
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 31.8;brain: 12.7;breast: 12.7"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 40.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 1.9;HHSteC: 1.1;HSkMC: 1.6;THP-1: 3.9;U-2 OS: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	31.8	0.3	7.9	0.1	9.7	0.0	12.7	10.1	11.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	9.2	0.5	0.0	0.0	0.2	8.5	12.4	0.0	0.1	0.0	0.0	0.2	8.4	0.0	0.0	0.5	0.8	0.0	0.1	0.2	0.5	0.0	6.0	0.0	0.1	0.5	12.7	0.0	0.5	0.4	0.3	0.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	9.7	10.1	11.1	7.3	9.2	8.5	12.4	8.4	6.0	12.7	5.1	0.1	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	2.4	0.0	9.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459548-170586075	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 15.9;pituitary gland: 7.3;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 28.4;Excitatory neurons: 61.9;Horizontal cells: 28.6;Inhibitory neurons: 90.2;Oligodendrocytes: 67.4"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.2;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	0.0	2.3	8.9	0.4	8.1	0.1	0.0	5.5	8.8	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.9	15.9	0.1	0.0	0.0	0.0	15.6	6.4	0.1	0.7	0.0	7.3	0.0	14.9	0.1	0.4	6.1	0.0	0.0	0.1	0.1	0.3	0.1	4.0	0.0	0.2	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.1	0.0	0.5	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.9	8.1	5.5	8.8	7.9	15.9	15.6	6.4	14.9	4.0	8.9	7.7	0.8	3.2	2.2	4.6	0.1	0.4	0.3	0.1	0.0	28.4	0.1	0.0	1.0	0.0	2.5	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.5	1.8	0.0	61.9	0.0	0.1	0.4	0.0	0.1	2.5	0.1	0.4	0.9	0.0	28.6	90.2	0.1	0.0	0.0	1.2	0.6	2.1	0.4	3.6	6.5	0.0	1.8	0.0	9.5	67.4	0.1	1.2	2.6	0.1	0.3	0.1	0.2	3.0	4.3	0.0	0.7	0.5	0.0	0.2	0.0	0.6	0.0	0.4	0.1	0.0	0.2
SLC7A6OS	"FLJ13291, Iwr1"	ENSG00000103061	"Solute carrier family 7 member 6 opposite strand"	Q96CW6	16	68284503-68310946	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041533	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA041533: AB_10794298"	"unprognostic (1.43e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.44e-4)"	"unprognostic (2.05e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	13.9	8.8	9.6	10.1	11.2	13.9	12.0	11.7	10.8	10.1	9.1	9.8	8.2	9.0	10.1	8.3	9.6	6.1	13.4	9.1	9.6	9.1	6.1	8.5	16.0	11.1	10.7	9.5	8.9	8.1	6.7	9.4	11.2	9.0	7.7	8.8	9.2	6.9	17.0	9.0	11.3	6.8	10.2	13.2	9.5	6.7	10.4	13.0	10.2	8.7	12.3	9.3	8.9	12.5	11.3	11.4	16.4	12.3	9.4	12.8	18.2	14.4	8.1	16.7	14.4	29.3	15.9	19.4	12.6	9.3	10.4	20.0	15.6	12.1	14.5	7.4	10.0	13.1	20.1	24.2	12.1	18.7	13.8	9.9	13.5	13.9	21.7	14.6	12.5	16.6	20.7	8.6	15.2	16.9	24.3	19.1	11.8	13.0	9.7	28.4	10.1	24.3	10.4	14.8	17.3	12.6	27.4	6.1	15.7	12.7	16.5	17.2	18.5	13.0	11.2	12.7	11.3	21.0	18.6	29.2	13.4	22.4	13.8	28.5	12.8	26.3	14.3	15.1	16.6	14.2	14.4	13.3	10.3	15.1	15.5	12.1	11.6	14.8	14.2	12.7	16.2	12.7	9.6	11.2	11.7	10.8	9.1	9.6	11.1	10.7	11.2	10.2	10.4	12.5	15.8	9.6	6.3	2.9	20.6	9.2	13.0	12.4	9.6	22.9	8.3	11.0	1.4	12.8	9.3	12.9	35.5	24.1	24.7	7.0	17.6	13.0	3.0	10.8	16.2	13.6	13.8	8.0	4.8	11.2	12.4	12.7	11.2	10.5	14.0	20.5	13.9	6.2	21.5	16.8	5.2	7.8	12.2	14.1	7.4	2.5	15.8	11.9	12.4	1.0	20.2	25.5	30.9	5.0	4.8	17.0	7.3	16.1	15.7	16.9	10.0	9.8	13.9	23.5	0.0	11.4	11.0	16.7	18.5	10.2	6.7	22.0	21.6	19.7	9.5	14.2
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 117.5"	"Group enriched"	"Detected in many"	8	"Cardiomyocytes: 743.1;Excitatory neurons: 1267.5;Inhibitory neurons: 631.3;Microglial cells: 574.3;Oligodendrocyte precursor cells: 753.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 44.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 44.2;monocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"BJ: 28.9;fHDF/TERT166: 70.4;hTERT-HME1: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	6.1	4.0	25.7	7.2	25.8	2.0	1.6	0.0	28.0	4.7	0.0	9.6	5.0	19.7	5.6	5.9	5.6	6.5	117.5	30.6	11.0	17.5	3.1	5.8	3.3	1.5	19.8	2.5	1.8	0.7	0.8	11.2	0.7	18.8	4.8	5.9	1.0	27.1	0.3	1.5	5.5	23.4	2.7	7.3	3.5	0.7	19.5	2.0	0.8	0.9	1.5	8.9	2.5	24.1	3.0	2.2	2.1	0.2	3.1	6.4	0.0	28.9	11.1	9.4	6.1	0.0	4.7	0.1	2.2	70.4	10.1	1.1	0.5	4.8	9.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	3.7	0.0	10.8	19.8	4.3	0.7	0.0	0.0	0.4	12.1	0.0	0.9	0.1	1.4	0.3	4.0	7.8	14.8	0.0	3.3	0.4	3.2	0.6	0.0	0.0	0.0	9.7	0.1	0.6	9.8	8.8	0.3	0.0	3.1	1.6	0.0	0.0	1.4	1.7	1.4	0.0	8.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	44.2	0.0	11.5	0.3	0.0	1.1	25.7	25.8	0.0	28.0	30.6	11.0	1.5	19.8	0.7	2.7	19.5	24.1	10.3	3.2	2.8	39.5	3.6	1.3	0.0	0.2	1.2	79.1	0.5	5.8	743.1	2.8	0.6	35.0	4.2	0.5	0.3	0.0	0.0	0.0	1.1	2.3	52.8	15.1	0.0	3.0	1267.5	0.0	1.6	26.6	1.5	3.0	0.0	0.2	12.1	0.3	29.3	0.0	631.3	2.5	0.0	78.0	26.7	1.4	0.0	88.8	1.8	574.3	42.7	32.0	1.0	753.0	20.5	0.1	3.8	8.2	0.7	0.2	24.7	0.5	0.0	7.2	13.1	1.4	46.6	0.2	1.2	0.5	3.1	1.1	1.2	0.7	2.5	0.1
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473226-102533972	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"stomach 1: 53.8"	"Group enriched"	"Detected in some"	12	"Collecting duct cells: 25.8;Gastric mucus-secreting cells: 54.0"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.3;OE19: 6.8;RT4: 4.1"	"Group enriched"	"Detected in some"	18	"hippocampal formation: 10.6;olfactory bulb: 6.8"	"Low region specificity"	"Detected in single"			HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA036096: AB_2674939"	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.0	0.4	0.1	0.5	0.8	0.2	0.7	0.7	0.3	0.0	0.0	2.0	0.1	0.1	1.5	0.1	1.2	0.6	0.4	0.4	8.6	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	1.3	0.5	1.4	0.4	0.0	0.0	0.0	0.2	53.8	0.3	0.2	0.1	0.1	0.0	0.5	0.4	0.1	0.6	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.5	6.8	0.2	0.0	0.2	0.1	0.0	4.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.5	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.7	0.7	0.4	0.4	0.1	0.1	0.2	0.0	0.2	0.6	0.0	3.2	3.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.9	25.8	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	54.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.0	0.0	0.0	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.1	0.4	0.0	0.3	0.3
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 57.9;Exocrine glandular cells: 68.5;Inhibitory neurons: 57.2;Pancreatic endocrine cells: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.8"	"Group enriched"	"Detected in many"	5	"B-cells: 5.1;NK-cells: 11.8;T-cells: 6.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cell Junctions"		"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.8	6.0	11.2	5.2	11.7	4.6	5.7	10.9	12.8	6.2	3.2	6.2	1.1	6.8	2.3	3.4	5.6	7.6	6.2	12.5	11.1	2.5	38.7	3.6	5.9	11.4	9.1	6.7	2.4	0.3	8.5	3.9	12.7	4.1	2.7	12.8	2.4	5.0	3.0	3.0	3.7	7.7	7.0	3.6	4.9	3.6	10.0	3.6	2.9	3.5	5.6	6.5	4.9	11.2	4.9	2.1	5.2	10.5	26.0	20.7	0.0	22.0	7.8	3.2	3.0	2.5	3.0	29.3	3.7	24.3	5.1	1.4	12.2	9.3	4.8	24.7	7.5	30.2	7.5	21.8	13.5	22.5	8.8	18.7	10.8	7.7	27.3	11.1	15.3	8.3	10.1	22.1	10.7	1.7	15.3	10.8	4.4	0.1	6.4	0.0	6.0	12.2	9.0	2.4	17.5	14.9	10.0	2.3	6.0	1.4	2.6	13.4	17.6	7.5	4.3	11.6	6.9	16.8	14.2	21.7	8.7	17.5	3.0	0.0	0.1	0.0	4.9	0.0	6.4	5.1	5.1	4.1	0.9	3.0	3.1	3.8	0.0	11.8	0.1	1.6	2.4	1.8	11.2	11.7	10.9	12.8	12.5	11.1	11.4	9.1	12.7	7.0	10.0	11.2	13.9	0.0	0.5	15.0	15.6	4.8	3.4	2.0	6.2	9.7	3.1	2.8	2.5	8.6	1.1	0.0	27.1	0.5	6.5	0.2	0.0	14.1	12.1	1.1	8.6	17.8	3.0	17.2	57.9	68.5	2.3	13.2	22.4	0.9	1.3	10.3	6.1	39.5	1.4	8.4	57.2	1.1	4.1	1.3	5.3	6.9	5.6	3.4	10.6	5.6	3.9	0.7	0.0	32.6	17.6	94.7	0.3	5.3	12.0	4.9	0.0	1.4	1.1	2.3	6.6	16.5	11.5	5.8	4.2	5.6	3.8	0.3	7.9	4.8	0.3	1.3
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296284	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 41.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 49.7;Early spermatids: 21.6;NK-cells: 26.8;Proximal tubular cells: 32.8"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5;neutrophil: 9.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.8;NK-cells: 2.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.5;RPTEC TERT1: 98.8;U-937: 25.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.8	0.2	0.6	0.3	8.6	0.5	0.0	0.4	0.3	0.0	1.0	2.2	0.1	0.2	0.1	0.2	2.3	0.3	0.2	0.0	41.6	7.6	7.8	0.5	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.0	0.8	0.1	2.0	3.6	0.1	0.3	1.5	0.1	0.0	1.3	0.6	0.8	0.3	1.0	1.6	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	1.1	0.0	1.0	0.2	1.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	17.5	0.0	1.3	0.1	0.3	0.8	0.0	0.0	0.0	0.0	1.2	98.8	0.1	0.7	0.5	0.0	0.3	0.0	2.3	0.0	2.4	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	25.8	0.1	9.5	1.0	7.3	3.8	0.0	0.3	0.0	0.6	2.1	0.4	0.1	0.2	1.3	9.8	2.6	0.0	0.2	0.0	1.0	0.2	0.3	0.0	0.4	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.1	6.4	49.7	0.3	0.6	0.0	0.1	1.2	0.0	0.0	1.8	0.3	0.3	1.5	6.4	5.5	0.0	0.0	9.6	1.4	1.9	0.2	21.6	0.0	0.1	0.3	0.0	5.7	9.1	0.8	0.0	0.3	0.0	1.6	5.7	0.0	0.4	11.0	0.2	0.0	6.6	0.1	2.0	0.6	0.3	2.6	0.3	2.4	0.0	1.0	3.2	0.0	26.8	1.5	0.3	0.3	0.1	0.0	1.4	0.0	1.8	32.8	3.1	0.0	0.0	0.1	0.1	2.5	2.4	0.0	0.0	0.0	3.4	0.1	1.1	0.4
SLF1	"ANKRD32, BRCTD1, BRCTx, DKFZp564C0469, DKFZp761C121"	ENSG00000133302	"SMC5-SMC6 complex localization factor 1"	Q9BQI6	5	94618669-94739436	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 142.1;Spermatogonia: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"HeLa: 54.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040793, HPA054213"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA040793: AB_10796560, HPA054213: AB_2682419"	"unprognostic (7.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-5)"	"unprognostic (1.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-6)"	"unprognostic (3.27e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.32e-2)"	1.6	1.5	1.7	1.9	1.4	3.4	1.9	4.0	2.1	1.3	0.0	1.9	2.0	1.7	0.9	1.4	2.2	2.0	2.2	1.1	0.6	1.7	1.5	1.4	3.3	0.0	0.4	2.8	2.2	1.3	0.6	1.6	0.1	1.3	2.3	1.8	0.8	1.1	0.9	3.5	2.3	1.5	0.0	2.3	1.2	7.7	0.7	3.5	1.7	1.4	2.5	1.2	0.6	1.7	5.3	6.8	9.4	8.9	3.0	3.5	6.0	7.9	4.0	9.1	12.5	3.6	7.1	8.2	5.3	2.3	11.2	7.0	7.8	6.5	12.0	2.9	6.2	5.3	54.2	3.2	0.9	2.9	5.9	1.8	1.8	8.1	3.5	3.0	3.7	4.9	6.2	5.0	7.8	4.6	8.1	3.7	10.0	3.0	3.6	4.9	10.8	9.1	2.8	3.8	9.4	9.6	9.7	4.1	3.4	7.3	5.5	8.1	2.7	4.3	5.9	6.1	10.7	3.7	8.3	6.7	6.5	8.1	8.8	1.1	1.3	0.8	1.7	1.0	0.9	2.3	2.6	3.3	0.8	3.6	1.2	1.6	7.3	1.1	0.9	1.3	1.7	0.7	1.7	1.4	4.0	2.1	1.1	0.6	0.0	0.4	0.1	0.0	0.7	1.7	16.1	3.2	6.4	0.0	18.2	0.0	4.7	0.0	4.6	25.3	8.9	9.5	0.0	2.8	7.4	5.5	27.1	15.0	17.3	5.3	1.9	8.1	9.1	30.6	10.5	9.5	2.4	28.0	0.0	7.0	14.8	8.3	8.6	5.5	15.2	19.9	11.4	5.6	7.8	20.2	0.0	4.4	0.0	6.0	0.0	7.4	5.6	10.8	0.0	0.0	10.8	8.1	20.6	0.0	0.0	8.9	4.5	6.0	14.0	2.3	31.4	10.3	20.4	37.3	0.0	11.6	7.0	142.1	111.1	7.0	0.0	6.2	34.5	12.3	8.1	3.2
SLF2	"C10orf6, FAM178A, FLJ10512, FLJ25012"	ENSG00000119906	"SMC5-SMC6 complex localization factor 2"	Q8IX21	10	100912963-100965134	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 108.1;Peritubular cells: 105.7;Theca cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 145.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038499, HPA057568"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA038499: AB_10672520, HPA057568: AB_2683471"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	9.1	17.2	17.3	10.9	29.2	11.8	8.8	20.4	23.1	14.0	9.3	12.6	7.9	20.8	48.6	8.9	17.6	8.0	10.8	17.0	24.9	11.3	11.6	10.8	14.7	24.5	24.7	25.1	13.1	7.9	23.8	15.4	25.7	15.2	10.1	11.7	9.4	12.9	17.8	13.4	12.7	10.7	19.1	23.1	10.4	25.8	25.3	12.2	11.3	13.3	11.5	11.3	11.2	46.2	25.7	20.6	29.6	31.4	16.1	20.9	11.3	26.3	18.5	24.1	29.0	15.2	17.5	24.1	15.8	11.3	17.9	25.3	20.4	8.8	29.1	26.6	16.6	21.7	14.2	31.0	11.7	28.0	24.9	10.0	13.2	18.6	19.9	25.1	15.7	14.7	15.6	22.5	37.3	17.7	19.1	16.0	13.7	9.9	15.2	18.5	145.7	8.3	10.1	12.8	6.6	12.9	16.5	4.6	30.6	14.1	26.3	10.7	20.6	28.2	23.4	18.0	31.1	18.1	28.5	19.1	20.0	32.9	15.1	6.1	6.6	7.0	9.8	6.7	8.9	8.6	7.8	8.5	5.2	11.0	8.5	7.8	3.6	9.1	7.5	7.5	8.0	4.6	17.3	29.2	20.4	23.1	17.0	24.9	24.5	24.7	25.7	19.1	25.3	46.2	18.4	25.6	18.9	0.0	18.2	0.0	8.4	0.0	12.5	33.8	13.8	12.6	0.0	5.7	8.6	25.8	25.0	17.4	29.4	9.0	13.7	11.0	8.4	22.7	64.8	20.8	12.2	11.3	0.0	8.0	7.1	20.2	10.7	25.0	24.0	32.3	26.7	12.8	17.9	38.7	0.0	10.5	0.0	18.2	0.0	10.4	108.1	18.6	0.0	0.0	19.2	19.7	46.4	0.0	0.0	7.0	8.4	105.7	12.3	9.4	9.3	8.9	13.8	31.4	19.7	44.5	12.8	33.5	43.0	10.4	0.0	5.1	19.7	77.6	8.2	6.0
SLFN11	FLJ34922	ENSG00000172716	"Schlafen family member 11"	Q7Z7L1	17	35350305-35373701	"Predicted intracellular proteins"	"Antiviral defense, DNA damage, Immunity"	"Helicase, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.6;dendritic cells: 39.9;Endothelial cells: 38.8;Langerhans cells: 53.0;Macrophages: 47.0;Smooth muscle cells: 38.8;T-cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 118.2"					"Low region specificity"	"Detected in many"			"HPA023030, HPA062062"	Uncertain		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA023030: AB_1856613, HPA062062: AB_2684673"	"unprognostic (1.93e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.93e-10)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (6.33e-2)"	"unprognostic (8.81e-3)"	31.7	8.2	5.6	20.0	6.1	12.8	17.1	6.4	5.2	21.1	8.2	10.2	6.2	12.1	42.2	8.4	20.6	18.3	20.0	6.0	8.0	6.4	6.8	37.7	21.2	9.5	6.3	23.1	5.4	6.1	6.5	10.5	9.7	9.1	11.1	1.4	11.8	12.3	7.3	5.2	13.9	19.1	7.6	23.3	9.0	2.7	11.0	22.9	24.1	19.0	20.9	17.9	12.6	9.4	29.3	25.6	0.1	0.0	25.4	72.0	0.4	35.3	25.2	59.9	103.9	0.0	0.0	0.2	0.6	46.4	18.8	13.9	78.8	0.0	72.1	16.6	94.2	63.0	0.3	0.0	33.0	82.4	0.1	29.5	0.9	66.5	0.2	0.0	99.4	46.8	0.1	0.3	10.1	0.0	118.2	66.4	0.6	0.0	0.1	98.9	73.3	0.2	0.7	13.8	0.2	0.1	0.0	13.0	0.1	0.0	20.7	58.6	52.1	16.3	0.4	61.9	53.7	2.3	1.0	0.2	12.2	70.3	36.0	0.5	18.2	2.1	6.1	27.6	8.4	4.6	3.8	5.5	14.0	1.5	2.8	4.1	1.4	3.1	18.2	19.4	6.3	8.7	5.6	6.1	6.4	5.2	6.0	8.0	9.5	6.3	9.7	7.6	11.0	9.4	70.6	0.0	5.2	0.3	19.5	7.5	1.1	1.1	5.7	0.4	6.7	2.8	9.2	1.5	2.7	1.8	0.0	1.4	39.9	0.1	0.0	0.0	1.4	5.9	16.0	38.8	0.0	9.9	0.3	0.6	0.5	29.2	6.6	2.2	3.8	0.3	15.0	0.4	32.8	0.0	2.6	0.1	0.0	36.5	53.0	1.7	10.2	47.0	12.4	17.8	17.2	0.3	3.1	0.0	0.1	0.1	1.2	3.0	24.7	1.3	0.1	0.2	13.3	0.1	6.6	7.9	38.8	0.0	0.2	1.9	8.5	0.8	37.3	7.7	0.1	0.7
SLFN5	MGC19764	ENSG00000166750	"Schlafen family member 5"	Q08AF3	17	35243071-35273655	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 261.6;Respiratory ciliated cells: 133.0;T-cells: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 24.7;MAIT T-cell: 30.6;memory CD4 T-cell: 30.7;memory CD8 T-cell: 28.9;naive CD4 T-cell: 37.5;naive CD8 T-cell: 31.2;NK-cell: 42.3;T-reg: 68.8"	"Group enriched"	"Detected in all"	7	"NK-cells: 42.3;T-cells: 68.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 108.6;hTERT-HME1: 146.8"	"Low region specificity"	"Detected in all"							HPA017760	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"HPA017760: AB_2189993"	"unprognostic (3.43e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.48e-1)"	17.8	8.7	2.7	23.9	2.5	5.4	11.6	2.1	2.5	20.0	3.8	6.4	7.0	14.1	3.4	8.9	14.0	12.1	8.6	2.6	3.5	5.0	5.8	21.1	32.4	6.1	2.2	5.6	3.7	6.7	1.5	14.1	4.9	10.3	7.8	2.3	18.0	15.7	20.7	5.0	8.0	11.5	4.9	25.8	9.9	2.0	3.5	40.9	11.5	10.1	28.2	19.9	5.2	5.7	21.3	10.7	1.7	1.8	30.2	52.2	4.2	54.3	85.4	44.5	49.2	0.2	13.5	2.7	34.1	54.0	11.8	87.1	1.0	24.5	30.9	0.7	1.9	0.4	11.6	1.3	108.6	1.6	0.6	59.9	60.5	34.0	146.8	26.8	20.6	22.0	0.2	31.1	31.4	1.7	26.9	1.3	1.7	4.7	8.0	0.0	17.9	0.2	11.6	51.8	3.6	0.0	6.0	5.6	93.7	6.0	35.9	0.8	81.2	17.6	6.8	12.9	12.5	6.0	0.6	0.4	51.9	0.3	26.0	6.3	4.3	2.9	24.7	6.4	30.6	0.9	30.7	28.9	3.6	1.6	37.5	31.2	1.8	42.3	7.8	1.2	68.8	18.2	2.7	2.5	2.1	2.5	2.6	3.5	6.1	2.2	4.9	4.9	3.5	5.7	126.9	60.9	71.7	1.6	8.4	4.6	27.1	97.8	8.0	1.6	16.5	15.9	10.1	28.6	92.3	18.4	0.0	0.3	75.6	1.8	1.9	71.7	1.9	95.0	23.2	90.4	1.2	3.6	4.1	38.8	5.3	30.3	18.8	56.0	61.3	1.4	79.2	4.7	13.2	6.7	3.6	4.6	46.8	26.5	14.4	0.4	7.5	22.6	12.4	12.2	49.1	6.7	261.6	3.0	10.1	70.0	3.8	1.5	17.6	122.5	1.7	1.9	133.0	4.2	13.1	34.9	29.8	0.5	1.9	10.2	4.0	0.3	128.6	5.4	1.0	74.2
SLTM	"FLJ13213, Met"	ENSG00000137776	"SAFB like transcription modulator"	Q9NWH9	15	58879050-58933679	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040256, HPA040381"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA040256: AB_10674990, HPA040381: AB_2676953"	"unprognostic (2.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.24e-3)"	31.2	21.5	27.3	31.5	30.6	57.7	29.5	35.6	34.6	29.9	26.3	30.0	30.0	27.6	20.8	38.5	27.8	23.8	28.4	25.6	28.6	33.6	34.9	28.2	42.7	28.3	29.1	29.6	24.9	36.1	28.4	21.0	28.6	29.2	32.1	44.9	30.6	24.2	46.1	35.1	33.4	25.8	27.5	38.1	38.9	27.8	28.7	57.3	34.1	43.6	44.1	33.8	31.3	31.3	77.8	84.1	72.0	36.6	48.1	36.2	60.6	55.1	64.3	49.9	48.2	58.4	45.7	144.6	50.5	50.8	54.4	67.9	72.3	62.9	68.7	93.7	46.4	105.4	91.8	44.7	42.0	83.8	78.1	34.1	61.0	52.8	44.1	30.4	46.9	66.0	95.5	81.7	58.2	56.1	84.1	64.6	80.9	46.3	40.5	63.6	65.4	70.1	60.2	99.8	58.9	50.8	57.0	55.1	57.8	79.3	44.0	90.1	48.6	60.2	88.5	66.3	74.6	57.3	123.1	105.5	47.6	101.7	61.5	67.9	30.3	44.4	45.2	29.5	46.1	53.5	36.0	39.3	31.2	47.3	39.2	35.6	42.8	47.0	37.7	53.6	36.5	22.7	27.3	30.6	35.6	34.6	25.6	28.6	28.3	29.1	28.6	27.5	28.7	31.3	92.5	153.8	161.2	61.4	125.8	96.9	100.2	85.6	107.0	116.3	77.3	66.0	107.8	64.3	122.8	106.7	98.0	73.5	155.9	88.4	78.2	98.4	100.8	110.5	99.0	94.7	73.4	115.7	67.7	115.7	160.1	94.3	99.4	119.1	118.9	75.3	63.9	104.1	63.9	119.5	67.3	94.4	59.0	88.6	73.0	120.8	86.3	108.8	78.2	72.1	121.0	84.9	126.7	74.4	141.8	131.1	76.5	88.4	140.0	92.4	57.4	90.6	103.9	145.3	72.3	106.6	95.6	215.1	85.2	100.0	104.6	112.5	134.9	78.0	94.0	125.6
SLU7	9G8	ENSG00000164609	"SLU7 homolog, splicing factor"	O95391	5	160401641-160421711	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035907, HPA058120"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear speckles"	"HPA035907: AB_10671717, HPA058120: AB_2683612"	"unprognostic (3.70e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.01e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	22.1	23.2	26.2	19.5	27.2	48.6	27.4	27.7	46.6	21.1	22.3	20.8	17.0	19.9	25.9	21.9	18.0	18.7	25.8	28.3	26.7	24.4	24.4	23.3	27.3	25.6	27.2	21.3	16.4	24.6	10.9	21.1	26.0	21.2	20.9	29.4	24.7	19.7	32.6	22.6	21.5	18.2	24.6	27.9	23.4	27.2	26.6	30.4	32.2	33.0	31.3	21.5	12.1	28.9	24.5	29.6	26.0	36.2	33.4	35.1	33.1	33.9	49.3	35.9	43.8	40.1	29.1	39.5	34.2	36.6	36.9	27.0	22.9	37.7	45.2	65.1	33.0	29.4	39.0	26.2	33.7	49.8	34.9	38.1	34.3	33.8	38.1	37.7	25.7	35.3	26.7	36.0	33.2	21.5	24.7	32.1	18.6	25.2	26.5	21.4	53.4	40.4	31.6	37.8	30.9	42.7	40.1	35.6	62.2	21.6	47.7	46.4	32.7	34.5	18.2	26.1	36.3	40.1	48.8	34.9	51.2	33.1	33.4	49.9	22.2	39.2	26.7	24.9	25.5	30.0	25.2	27.2	20.2	26.1	27.2	26.7	54.2	33.9	36.5	21.6	29.4	22.8	26.2	27.2	27.7	46.6	28.3	26.7	25.6	27.2	26.0	24.6	26.6	28.9	42.7	67.3	67.8	9.8	53.7	44.7	39.9	55.5	24.5	70.2	25.7	26.3	71.4	24.3	57.1	25.8	25.0	38.1	70.9	34.1	50.9	52.2	126.2	43.0	41.6	44.1	39.5	68.8	19.8	55.8	39.7	43.0	17.9	51.3	46.3	34.7	35.3	24.6	38.4	57.2	18.3	34.7	54.9	47.3	57.3	34.3	47.8	46.9	65.8	20.6	65.8	61.6	64.9	9.0	15.2	50.5	45.3	47.4	33.1	40.0	39.8	39.5	62.0	49.4	46.0	49.6	50.1	88.9	54.6	27.4	41.5	94.1	52.0	41.9	27.8	52.5
SLX1A	GIYD1	ENSG00000132207	"SLX1 homolog A, structure-specific endonuclease subunit"	Q9BQ83	16	30193875-30197561	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 48.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047038	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA047038: AB_2679913"	"unprognostic (3.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-1)"		"unprognostic (1.26e-6)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.86e-1)"	19.8	24.0	15.0	18.1	14.9	31.1	19.2	13.7	23.5	12.2	13.1	29.5	61.5	7.2	6.1	25.8	6.8	8.1	20.7	14.4	14.1	31.0	59.4	16.8	15.3	22.4	15.6	4.1	31.5	6.5	12.9	13.6	16.8	12.0	11.3	5.3	18.2	11.1	26.3	16.8	52.2	6.2	15.0	39.4	31.9	5.5	17.5	4.8	13.4	6.3	15.9	16.3	12.7	19.2	75.9	38.8	33.3	16.3	7.0	10.0	117.1	27.4	34.2	25.3	24.4	7.0	59.4	60.3	62.9	11.9	16.0	48.7	12.8	18.4	9.3	46.3	46.8	40.9	12.1	70.0	21.2	47.6	65.8	10.7	21.4	12.2	12.2	17.4	37.9	36.6	28.9	49.8	15.1	65.3	33.3	106.8	42.5	46.8	42.0	106.8	34.2	159.5	29.6	18.0	29.7	96.0	6.0	145.3	29.5	5.1	21.6	28.2	17.3	36.4	41.4	39.6	25.4	157.6	98.3	42.7	40.8	42.8	29.0	27.7	199.5	219.4	79.3	183.6	56.2	68.1	58.9	65.1	167.1	64.0	29.0	49.7	80.8	73.6	142.6	65.8	112.2	119.3	15.0	14.9	13.7	23.5	14.4	14.1	22.4	15.6	16.8	15.0	17.5	19.2	1.5	0.0	1.1	0.0	1.7	0.6	1.3	1.7	0.0	0.6	0.4	0.3	3.1	1.5	1.3	3.7	0.0	5.9	1.4	4.4	0.0	7.2	0.6	0.3	0.1	1.4	3.6	4.6	0.0	12.0	2.3	0.8	3.1	0.2	0.0	0.3	1.4	2.5	2.8	0.0	0.0	6.3	2.0	6.9	5.5	0.1	0.9	2.1	7.2	0.0	3.3	0.2	1.0	0.0	0.0	10.5	7.8	0.0	0.5	1.0	48.3	3.6	0.5	0.3	0.0	0.2	1.6	0.4	0.5	0.0	2.3	4.1	1.9	0.1	5.0	0.7
SLX1B	"GIYD2, MGC5178"	ENSG00000181625	"SLX1 homolog B, structure-specific endonuclease subunit"	Q9BQ83	16	29454501-29458219	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.8;Erythroid cells: 12.4;Plasma cells: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 59.3"									HPA047038	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA047038: AB_2679913"	"unprognostic (2.93e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.51e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.44e-1)"	"unprognostic (5.25e-3)"	15.7	8.3	11.1	12.8	12.0	11.8	14.9	12.2	19.9	14.7	10.5	11.6	22.4	15.3	0.5	9.0	14.5	1.4	7.5	11.5	12.4	8.8	30.4	16.4	7.2	11.2	10.7	12.1	7.6	4.4	6.5	5.4	12.7	11.0	3.8	4.4	19.0	2.6	32.5	17.3	21.3	3.6	9.9	15.8	16.2	1.3	11.1	15.8	16.2	3.5	5.9	15.3	11.8	12.2	6.7	10.7	17.2	6.4	2.9	2.3	6.7	4.1	8.5	10.4	6.0	3.9	20.4	4.0	5.9	5.1	7.3	7.1	3.0	7.7	3.4	2.8	2.7	5.4	9.1	22.8	6.4	4.5	10.3	5.2	2.1	12.1	6.9	12.2	1.7	29.3	2.3	25.6	4.0	16.1	13.4	7.0	7.5	19.8	2.6	26.7	0.2	19.2	8.2	9.5	5.8	8.4	1.4	59.3	4.5	4.1	8.3	13.5	11.2	15.9	2.0	7.2	2.9	8.5	17.9	11.1	16.9	6.8	9.1	3.6	18.1	9.2	6.7	22.2	2.6	10.0	6.8	7.5	16.5	7.7	3.4	4.0	13.3	8.4	15.5	3.9	18.2	9.7	11.1	12.0	12.2	19.9	11.5	12.4	11.2	10.7	12.7	9.9	11.1	12.2	0.3	0.0	0.5	0.0	1.7	0.0	0.1	0.0	2.8	0.0	0.3	0.1	14.8	0.0	0.0	0.0	0.0	1.7	0.1	0.5	0.0	0.8	0.1	0.1	0.2	1.7	0.0	12.4	0.0	1.5	0.6	1.6	2.6	0.1	0.0	0.1	0.4	0.5	1.1	0.0	0.0	0.2	0.0	0.9	0.4	0.0	0.0	2.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.4	3.7	0.3	3.6	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.3	0.1	1.4	1.7	0.0	0.6	0.2
SLX4	"BTBD12, FANCP, KIAA1784, KIAA1987"	ENSG00000188827	"SLX4 structure-specific endonuclease subunit"	Q8IY92	16	3581181-3611606	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049421, HPA066238"	Approved		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA049421: AB_2680759, HPA066238: AB_2685642"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.28e-5)"	"unprognostic (6.52e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.74e-2)"	1.8	2.1	2.1	2.9	1.9	3.0	1.6	7.1	2.7	2.1	0.4	2.3	2.2	2.1	1.3	2.4	2.0	1.1	1.9	2.3	2.1	1.9	1.9	2.1	4.1	2.3	2.0	1.6	1.7	1.1	3.9	1.1	1.8	2.3	0.9	1.7	1.6	1.0	2.7	1.8	2.8	1.2	1.1	3.4	2.2	10.6	1.9	2.7	1.8	1.3	2.9	2.1	2.0	2.1	2.7	8.4	5.3	6.7	2.0	2.1	5.6	4.3	2.2	4.9	5.4	4.2	3.3	10.0	4.2	2.2	3.8	6.0	3.6	3.0	2.9	8.4	4.6	6.8	6.5	2.7	1.8	6.7	9.3	1.5	2.2	4.6	2.6	1.2	3.6	5.6	6.7	5.3	3.9	4.7	4.2	5.9	4.5	1.7	3.1	8.2	8.9	2.8	1.9	1.9	4.5	4.1	3.8	2.6	1.3	2.8	6.5	5.2	4.3	5.6	7.8	4.9	5.1	4.8	4.0	11.4	1.8	6.7	5.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.9	7.1	2.7	2.3	2.1	2.3	2.0	1.8	1.1	1.9	2.1	2.7	0.0	2.3	4.6	4.5	0.8	0.8	1.1	4.0	8.7	2.0	1.4	1.7	1.5	3.2	0.0	2.1	1.7	3.4	2.0	0.0	1.5	6.5	5.5	4.2	1.8	0.0	6.5	9.5	2.4	1.6	2.4	3.6	4.6	0.0	4.8	1.1	1.4	2.9	0.0	9.3	2.4	2.0	2.9	1.6	2.3	2.1	5.1	0.0	4.7	2.2	2.7	4.1	7.1	5.5	2.0	0.3	1.9	4.0	0.4	2.3	0.6	2.3	10.1	0.0	4.9	2.5	20.0	9.1	2.3	0.6	1.0	4.4	3.0	2.1	0.6
SMAD1	"JV4-1, MADH1, MADR1"	ENSG00000170365	"SMAD family member 1"	Q15797	4	145481194-145559176	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 195.9;Endothelial cells: 76.3;Late spermatids: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 46.2;non-classical monocyte: 22.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 46.2;monocytes: 22.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005389	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"CAB005389: AB_656608"	"unprognostic (8.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.15e-2)"	19.6	5.3	16.7	10.9	21.9	5.8	15.9	15.3	18.2	20.4	6.9	20.4	15.4	29.0	32.7	16.3	24.4	17.1	13.1	13.2	16.6	12.6	20.2	12.3	17.6	14.6	18.3	11.7	13.3	29.1	6.0	11.4	14.5	12.5	20.8	6.5	12.9	17.2	20.7	24.4	15.7	30.4	13.6	14.0	10.6	13.9	16.4	18.3	17.4	17.8	13.7	17.9	8.9	13.6	9.6	12.6	23.5	27.3	8.7	12.8	11.5	13.9	32.6	22.0	16.4	6.2	34.0	9.8	8.0	31.8	9.7	14.1	26.6	30.2	12.8	0.0	13.5	0.0	10.0	13.1	23.2	15.8	2.4	17.6	35.2	11.8	22.9	17.9	110.7	20.7	11.1	0.4	27.0	9.6	24.4	0.3	21.8	15.3	14.6	47.0	21.1	28.5	25.9	17.1	35.3	17.6	18.8	40.3	9.6	14.1	14.0	0.2	32.4	10.5	14.5	11.3	8.6	31.1	0.0	56.1	16.7	0.3	11.1	46.2	3.6	1.5	0.0	9.4	0.0	0.0	0.6	0.0	6.8	0.1	0.3	0.0	0.0	2.4	22.2	0.0	1.3	1.3	16.7	21.9	15.3	18.2	13.2	16.6	14.6	18.3	14.5	13.6	16.4	13.6	62.9	9.6	10.9	54.9	0.1	11.5	17.5	22.0	45.5	6.6	8.6	9.3	3.6	12.8	16.3	14.7	14.6	5.2	0.8	13.2	7.9	12.6	195.9	19.5	12.1	76.3	9.1	8.4	47.7	18.5	2.7	11.5	12.2	24.8	0.0	10.0	10.4	12.0	2.5	10.1	43.2	10.4	28.5	6.5	2.7	80.7	4.4	4.5	1.8	26.2	3.2	5.3	0.0	66.9	22.0	12.0	10.2	5.7	0.3	17.5	6.6	11.5	12.7	5.9	0.0	19.0	10.6	8.3	16.8	19.9	12.6	2.2	1.2	6.9	8.8	17.2
SMAD2	"JV18-1, MADH2, MADR2"	ENSG00000175387	"SMAD family member 2"	Q15796	18	47808957-47931146	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025507, HPA067203, CAB073546"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli, Cytosol"		"CAB025507: , CAB073546: , HPA067203: AB_2685803"	"unprognostic (1.55e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.82e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (1.91e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.28e-2)"	48.6	52.6	38.0	38.6	42.4	37.5	46.5	46.2	36.7	43.2	35.6	47.5	36.7	38.6	41.0	55.0	46.8	39.6	53.8	32.9	48.6	43.3	35.6	46.7	44.5	50.2	43.2	52.5	40.4	44.6	20.3	42.7	51.9	36.4	48.7	70.5	36.7	44.8	57.4	34.0	37.4	47.9	47.8	47.5	45.2	51.5	42.4	72.4	75.7	55.5	55.2	53.8	31.1	59.4	81.1	113.7	68.0	66.2	106.1	128.5	77.4	86.1	102.7	87.9	101.8	43.8	75.6	124.8	60.3	110.0	123.0	86.6	77.2	96.1	116.9	136.4	39.3	106.4	164.4	71.9	123.2	149.6	104.1	95.8	121.4	75.5	172.9	102.1	98.6	99.7	50.3	101.6	109.6	52.7	103.4	71.6	33.6	4.4	26.7	74.4	98.9	85.9	197.8	137.2	62.8	73.3	103.7	70.1	85.7	65.8	53.5	97.7	111.4	129.5	74.2	35.6	63.6	99.0	102.7	108.3	89.6	99.9	97.1	58.8	33.6	38.7	23.8	38.5	29.8	16.7	32.3	29.9	32.8	13.9	35.3	27.6	34.1	38.6	33.0	23.3	40.5	31.6	38.0	42.4	46.2	36.7	32.9	48.6	50.2	43.2	51.9	47.8	42.4	59.4	55.0	44.8	36.1	55.8	36.3	54.4	44.1	38.3	54.1	48.0	44.2	30.2	49.2	41.5	45.5	77.3	212.7	48.2	53.0	42.8	39.2	36.5	68.1	58.6	53.0	53.1	51.0	36.4	63.4	43.5	40.3	40.5	44.4	68.1	21.5	80.0	56.4	29.6	43.9	35.3	50.5	46.1	38.7	57.3	41.8	131.9	41.7	48.7	51.6	104.9	63.9	44.8	72.1	96.0	130.0	44.0	31.6	53.4	34.5	66.1	37.9	39.5	41.8	88.1	32.9	53.5	39.6	37.2	39.4	59.2	61.8	69.5	47.4	41.7	42.3	77.2
SMAD3	"HsT17436, JV15-2, MADH3"	ENSG00000166949	"SMAD family member 3"	P84022	15	67063763-67195173	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 162.5;Prostatic glandular cells: 149.3;Urothelial cells: 276.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008094, HPA046386, HPA067203, CAB069409"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: AB_2679647, HPA067203: AB_2685803"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.93e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-2)"	30.0	6.3	17.9	15.8	22.4	18.8	22.2	6.8	16.1	32.2	31.5	15.4	17.7	20.3	13.6	51.9	23.3	21.2	28.1	16.1	9.3	35.7	19.8	21.4	16.8	17.0	9.0	30.7	18.2	10.5	14.5	16.8	9.3	24.4	12.9	6.2	17.2	13.8	55.0	29.1	21.6	21.1	10.9	15.4	22.2	3.9	12.9	19.6	30.2	39.0	25.7	43.6	31.5	8.5	49.3	157.0	30.6	13.9	50.8	115.9	22.5	27.6	114.0	37.8	30.7	33.7	125.3	16.5	36.6	79.4	169.8	111.3	31.2	116.9	38.1	13.1	11.9	1.8	43.4	26.2	38.2	6.6	2.7	106.5	26.7	33.2	27.7	83.2	128.2	5.2	40.3	40.8	47.1	24.2	1.5	26.0	17.7	26.1	50.5	1.6	9.1	5.9	25.2	149.4	0.8	10.3	36.6	19.5	32.5	59.2	5.3	30.2	109.4	50.4	47.1	36.5	31.7	16.5	5.0	21.0	45.8	7.0	45.9	0.0	1.0	2.3	3.2	0.9	3.3	1.2	3.6	3.4	1.0	2.8	1.6	1.4	0.0	0.3	0.9	1.5	1.9	1.1	17.9	22.4	6.8	16.1	16.1	9.3	17.0	9.0	9.3	10.9	12.9	8.5	18.2	48.1	19.9	28.4	33.9	89.0	90.2	70.6	53.5	10.8	13.3	10.5	12.2	17.2	49.6	36.8	6.2	1.1	19.7	48.2	3.9	61.9	1.0	23.6	30.2	26.6	3.5	9.1	63.2	50.7	4.2	42.6	28.5	75.2	24.1	162.5	11.4	12.6	10.7	0.0	6.9	13.0	24.4	6.2	40.8	5.7	26.8	18.8	21.4	67.5	9.7	8.5	20.6	140.2	1.3	99.7	49.2	20.7	10.6	149.3	34.2	14.0	52.2	0.6	26.3	28.9	27.5	0.6	2.3	70.3	48.9	1.6	21.6	18.8	16.6	276.2
SMAD4	"DPC4, MADH4"	ENSG00000141646	"SMAD family member 4"	Q13485	18	51028394-51085045	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019154	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Centrosome	"HPA019154: AB_1853480"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.00e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.03e-3)"	"unprognostic (4.40e-2)"	"prognostic favorable (1.92e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	16.4	11.8	9.0	10.9	10.3	10.6	17.2	21.7	10.5	18.5	11.2	14.9	11.9	20.6	9.8	15.7	16.3	12.8	14.1	11.7	10.0	16.1	19.1	13.1	12.7	9.0	8.2	24.0	21.4	19.9	11.3	18.9	9.4	21.8	14.3	18.3	14.0	18.0	24.9	14.6	12.1	18.9	8.0	13.9	15.2	14.2	11.9	17.7	21.4	24.9	14.5	13.5	13.1	13.8	16.4	22.5	59.4	16.6	23.9	36.6	31.4	27.7	32.2	39.4	49.6	13.0	3.8	25.9	7.8	25.6	19.6	24.9	33.6	13.2	40.7	19.3	14.8	20.6	20.5	15.9	23.7	34.8	13.1	16.6	21.9	19.1	27.8	37.0	28.7	14.0	21.9	25.8	23.5	9.0	18.8	10.0	31.2	9.1	14.3	23.3	30.6	26.9	18.2	7.4	34.4	20.3	27.0	5.0	18.8	24.8	13.3	19.4	20.0	34.5	13.3	8.8	19.7	30.6	28.6	26.2	21.2	12.8	22.6	0.3	0.6	0.6	1.0	0.4	1.1	0.7	1.0	0.8	1.2	0.9	1.2	1.5	1.0	1.0	0.4	1.0	1.4	0.5	9.0	10.3	21.7	10.5	11.7	10.0	9.0	8.2	9.4	8.0	11.9	13.8	32.5	22.4	29.1	55.2	21.0	25.6	20.9	15.1	18.8	17.1	27.3	20.4	38.8	24.3	19.3	22.0	20.9	20.7	24.0	22.7	11.7	16.9	10.6	30.4	36.6	26.2	39.6	12.4	37.0	12.5	20.6	30.3	28.5	35.2	4.5	132.4	28.5	44.1	15.1	15.2	39.0	32.1	16.2	28.5	20.9	16.2	33.2	21.1	28.4	49.6	16.9	20.4	17.5	41.2	72.5	20.1	21.0	30.5	24.8	36.3	26.7	22.6	22.4	20.0	26.3	32.2	34.2	17.2	18.8	20.9	27.3	12.6	20.1	22.1	24.5	29.7
SMAD5	"Dwfc, JV5-1, MADH5"	ENSG00000113658	"SMAD family member 5"	Q99717	5	136132845-136188747	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 91.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 91.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058931	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA058931: AB_2683856"	"unprognostic (6.04e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.99e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.15e-1)"	18.0	13.7	11.0	10.9	17.4	10.1	17.6	33.9	15.4	18.5	10.4	14.1	12.8	25.7	14.4	16.8	16.5	14.2	15.0	7.9	14.5	15.4	20.4	13.0	11.6	13.1	13.9	29.8	13.3	21.2	7.3	24.9	12.6	17.4	16.8	15.7	13.2	16.4	14.9	27.3	11.8	20.1	13.0	14.9	14.2	11.7	15.1	11.3	17.3	21.6	13.5	14.3	15.5	18.7	36.1	30.0	35.3	31.4	37.3	57.2	37.4	48.2	34.0	32.7	48.3	134.1	25.4	39.1	39.8	38.1	33.5	32.0	42.0	56.0	51.9	16.8	26.6	25.7	32.8	24.4	31.0	15.9	26.9	43.2	32.6	50.8	34.2	32.9	40.2	19.3	25.6	26.1	35.0	14.1	13.2	16.2	21.1	12.5	14.8	27.2	68.2	23.1	18.9	37.2	31.8	33.1	42.3	11.0	41.2	42.3	24.6	19.2	46.3	48.1	30.0	35.5	48.5	29.8	37.9	48.3	31.0	19.9	37.6	91.6	12.8	29.3	14.4	8.4	11.2	14.2	8.4	9.7	13.3	14.8	2.6	8.6	2.1	20.8	10.1	15.5	2.6	5.8	11.0	17.4	33.9	15.4	7.9	14.5	13.1	13.9	12.6	13.0	15.1	18.7	95.8	41.7	32.4	34.3	24.1	46.4	38.6	31.1	79.6	29.2	36.1	46.9	38.3	42.9	36.3	31.3	20.9	19.8	25.8	19.7	23.5	24.5	25.7	32.7	80.9	57.5	99.8	17.2	27.2	26.6	12.1	63.9	41.8	38.5	8.8	62.1	53.9	61.3	14.0	52.2	36.3	36.6	22.4	33.7	21.7	24.1	70.8	21.6	21.4	52.5	20.2	50.1	25.7	45.2	57.1	31.5	21.7	72.6	40.5	48.1	10.3	43.9	32.2	27.7	46.0	87.4	58.2	23.3	23.6	66.4	50.6	11.8	18.2	68.7	30.6	35.9
SMAD6	"HsT17432, MADH6, MADH7"	ENSG00000137834	"SMAD family member 6"	O43541	15	66702236-66782849	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 30.1;lung: 27.9"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 25.1;Hepatic stellate cells: 91.4;Microglial cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 29.8;HaCaT: 18.2;HeLa: 28.6;U-2197: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061917			Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA061917: AB_2684637"	"unprognostic (1.20e-1)"	"unprognostic (7.43e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.59e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.55e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (5.45e-5)"	9.5	2.6	5.2	1.6	4.9	0.1	7.6	4.9	4.3	6.8	8.6	3.7	1.9	6.2	0.6	2.1	5.4	1.4	30.1	3.4	4.1	8.9	6.7	27.9	0.5	7.6	5.4	5.9	2.7	1.1	3.4	7.4	5.8	7.0	1.1	0.9	2.1	3.5	1.6	2.4	3.9	0.9	4.4	2.6	5.5	1.8	6.8	0.4	15.5	1.5	0.2	8.0	5.7	4.6	1.3	10.2	1.6	3.5	6.0	1.6	9.4	7.2	0.1	1.1	0.1	2.0	4.6	0.7	29.8	6.1	0.9	18.2	2.2	0.0	0.2	2.3	8.4	16.1	28.6	1.7	0.7	0.1	1.2	2.0	0.0	0.1	0.0	3.4	1.3	5.1	1.4	1.0	0.5	2.0	0.1	4.4	3.0	10.5	3.8	0.0	1.8	2.2	3.4	8.1	3.6	1.6	3.9	4.3	0.8	5.9	1.4	2.9	6.2	4.3	5.5	17.6	1.4	0.5	1.8	0.3	3.1	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	4.9	4.9	4.3	3.4	4.1	7.6	5.4	5.8	4.4	6.8	4.6	19.8	12.8	6.0	5.2	0.9	0.8	1.2	2.1	0.6	0.6	0.9	1.1	4.9	4.3	3.0	1.8	2.1	0.8	0.1	4.3	3.9	4.7	3.4	8.3	5.5	25.1	0.0	0.0	0.3	5.8	0.9	4.9	5.1	6.5	4.5	5.9	91.4	4.0	1.7	0.0	0.3	2.1	0.0	10.0	0.3	1.4	2.8	1.2	0.0	57.1	0.7	10.2	0.0	0.5	0.4	8.4	1.5	8.2	0.0	1.3	2.1	1.9	0.1	0.6	0.0	0.9	1.5	0.2	3.2	0.4	0.1	0.8	0.4	0.1	5.5	0.4
SMAD7	"MADH7, MADH8"	ENSG00000101665	"SMAD family member 7"	O15105	18	48919853-48952052	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 54.5;Distal enterocytes: 56.6;Hepatic stellate cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.1;eosinophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026212, HPA028897"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB026212: , HPA028897: AB_10600811"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (8.15e-2)"	"unprognostic (5.35e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-1)"	17.9	5.9	7.1	8.6	7.3	17.8	14.5	12.0	7.3	17.4	9.6	12.7	10.3	11.2	2.9	4.8	8.2	10.2	46.1	5.4	5.1	11.6	8.6	21.9	5.8	10.9	8.7	7.5	5.3	12.3	6.6	18.9	8.5	11.3	11.9	3.2	6.3	8.6	10.7	8.3	15.0	9.3	10.0	5.9	12.5	1.3	7.9	3.7	16.6	6.7	5.2	13.3	12.2	8.4	3.7	2.8	2.8	8.3	14.3	5.0	21.1	18.6	7.1	6.5	3.1	1.0	5.3	0.3	32.2	13.1	6.0	19.2	6.1	5.8	3.6	38.4	9.4	0.3	10.5	6.9	2.1	6.9	18.6	5.1	4.8	7.8	7.8	32.2	1.1	0.6	6.6	25.9	9.1	1.2	0.0	1.9	17.3	27.7	1.1	2.1	2.5	9.0	9.1	4.2	4.8	10.3	8.0	3.5	6.6	21.2	3.3	5.6	17.3	18.5	9.9	5.3	16.5	13.4	7.1	2.0	8.1	4.9	3.1	4.1	0.1	5.6	0.8	0.5	0.6	0.1	0.8	0.7	0.1	0.0	0.2	0.5	0.0	1.7	0.1	0.0	1.2	0.2	7.1	7.3	12.0	7.3	5.4	5.1	10.9	8.7	8.5	10.0	7.9	8.4	30.4	54.5	9.4	3.9	7.0	12.9	3.5	7.2	14.2	6.1	14.7	10.3	9.7	1.5	11.2	11.0	6.2	9.9	43.7	56.6	9.8	14.4	0.2	43.2	30.5	25.0	12.7	0.0	6.5	13.9	3.3	15.5	8.2	45.9	18.9	4.0	71.4	3.1	8.9	0.0	5.0	19.1	2.0	23.3	8.9	1.1	1.5	14.7	0.0	19.7	8.2	1.4	11.3	5.5	16.3	31.5	17.3	3.4	13.8	3.0	28.7	7.1	3.3	2.5	6.6	11.3	14.1	0.1	0.6	14.2	11.8	12.9	25.2	1.3	12.4	2.6
SMAD9	"MADH6, MADH9, SMAD8, SMAD8/9"	ENSG00000120693	"SMAD family member 9"	O15198	13	36844831-36920765	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.0;Enteroendocrine cells: 51.6;Glandular and luminal cells: 73.4;Hepatic stellate cells: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 12.9;HEK 293: 12.3;SH-SY5Y: 40.2"					"Low region specificity"	"Detected in all"			"CAB009119, HPA031162"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB009119: AB_2286517, HPA031162: AB_2673767"	"unprognostic (2.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.68e-3)"	"unprognostic (3.50e-3)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.71e-3)"	"unprognostic (4.23e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.07e-3)"	"unprognostic (3.74e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.47e-2)"	4.0	2.6	10.7	2.8	7.8	0.1	1.6	10.7	6.8	4.8	1.2	5.1	2.3	8.9	9.8	4.2	4.3	7.0	5.6	10.3	16.3	3.2	0.9	4.9	2.2	17.2	10.9	9.2	0.9	2.4	1.9	6.5	16.9	13.9	5.3	7.0	21.0	11.2	3.0	1.5	2.5	6.7	15.5	0.9	3.7	2.3	9.6	0.5	38.7	5.1	2.9	3.3	2.1	21.3	0.0	0.1	0.8	8.6	2.6	1.1	0.3	10.5	1.1	2.7	1.7	0.0	0.2	0.2	7.2	12.9	0.9	0.4	9.3	0.2	2.8	0.3	12.3	0.0	4.4	6.6	2.4	0.8	0.1	4.4	0.8	0.0	0.0	5.7	5.3	1.1	0.1	0.0	6.0	0.6	0.1	0.8	1.2	0.3	1.1	0.2	9.2	0.0	0.0	1.5	7.6	40.2	1.9	0.2	0.5	2.3	0.6	0.4	9.6	4.0	3.5	2.4	2.6	0.1	0.0	0.1	2.8	0.3	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	10.7	7.8	10.7	6.8	10.3	16.3	17.2	10.9	16.9	15.5	9.6	21.3	22.5	28.9	11.5	48.0	0.4	2.8	4.3	1.8	1.8	13.1	2.5	2.2	5.9	2.8	6.9	11.0	4.2	0.2	0.2	3.3	1.9	0.3	0.1	30.3	14.0	26.7	51.6	0.0	18.1	0.2	0.6	11.6	3.6	73.4	0.0	19.7	43.9	0.1	0.1	0.0	33.0	15.6	8.2	2.2	1.9	0.3	18.6	1.1	0.0	31.9	0.0	20.4	0.0	14.1	39.3	0.5	3.4	15.1	0.0	17.2	0.0	7.3	1.6	3.2	0.0	7.2	10.1	1.2	14.1	0.2	1.8	0.3	1.4	0.5	5.7	1.2
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 139.8;placenta: 102.1"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 1219.9;Syncytiotrophoblasts: 842.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 131.2;OE19: 163.9"	"Low region specificity"	"Detected in all"							HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	14.0	17.2	2.7	9.9	2.7	3.5	16.1	5.2	3.2	33.8	3.4	57.5	17.6	6.5	20.7	139.8	8.3	16.2	10.3	3.0	2.5	43.0	10.2	17.7	6.0	2.8	2.9	11.4	16.5	11.1	4.3	102.1	2.8	10.5	59.3	1.0	24.1	8.6	3.4	34.8	19.6	8.5	2.6	13.7	35.9	8.1	3.3	1.5	8.7	6.8	27.6	17.5	67.9	3.0	81.6	24.2	2.9	2.7	10.5	40.9	131.2	61.1	60.9	30.6	18.7	48.9	83.2	1.0	10.5	37.9	11.6	28.3	17.1	23.5	42.6	4.1	14.2	10.9	3.3	16.5	28.8	2.7	10.1	26.7	17.8	66.3	59.4	69.4	74.6	20.6	8.7	4.7	49.9	71.4	13.4	9.8	12.3	163.9	93.9	0.8	0.8	3.1	44.0	18.5	3.3	4.1	13.4	53.2	10.2	31.3	45.0	4.2	26.1	33.9	32.7	1.7	37.8	1.7	2.4	1.6	49.8	26.3	18.7	4.6	6.6	12.0	15.4	4.6	10.0	36.9	6.8	11.1	4.7	38.1	6.3	11.0	16.0	19.8	5.4	2.9	5.3	6.8	2.7	2.7	5.2	3.2	3.0	2.5	2.8	2.9	2.8	2.6	3.3	3.0	44.1	0.0	25.7	0.3	26.3	21.7	74.3	35.5	12.0	1.3	23.4	25.8	1.7	55.8	44.7	16.5	0.0	1219.9	21.7	85.0	49.0	43.6	11.7	4.8	2.3	60.9	20.4	8.6	0.6	108.7	108.0	11.4	47.9	8.7	12.7	19.7	51.4	6.7	96.8	1.7	0.5	121.5	26.4	6.3	11.2	3.2	13.1	6.1	14.2	6.5	7.9	4.1	38.1	0.0	0.5	142.5	88.1	9.8	5.7	73.7	35.0	22.6	17.4	1.7	26.3	4.8	11.1	6.2	31.3	80.7	29.7	842.5	13.8	9.8	121.7	105.2
SMAP2	SMAP1L	ENSG00000084070	"Small ArfGAP2"	Q8WU79	1	40344850-40423326	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 216.3"	"Cell type enhanced"	"Detected in all"		"B-cells: 338.4;dendritic cells: 258.0;Kupffer cells: 284.4;Macrophages: 256.8;monocytes: 291.7;Plasma cells: 224.4;T-cells: 199.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 177.1;THP-1: 302.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021466, HPA024424"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA021466: AB_2239737, HPA024424: AB_1857259"	"unprognostic (1.65e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.32e-1)"	"prognostic favorable (5.34e-5)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.24e-1)"	65.3	24.0	44.2	136.7	50.7	80.9	33.3	35.7	54.3	43.9	33.8	33.5	17.5	17.9	14.1	26.2	30.7	46.3	17.2	52.1	48.2	19.2	73.5	58.4	205.8	41.8	41.1	17.1	23.8	27.4	43.9	38.0	42.9	20.0	32.1	48.5	29.5	19.0	30.0	33.3	99.2	40.1	38.3	216.3	41.8	17.0	48.0	158.3	19.2	21.2	199.5	52.2	19.3	47.2	25.1	9.3	22.0	22.2	31.4	60.0	12.2	38.4	34.7	38.9	37.9	11.7	16.8	93.1	18.4	34.4	16.0	10.2	41.1	29.4	53.3	177.1	34.8	51.7	14.2	25.5	28.1	54.3	153.7	51.7	24.3	50.4	21.6	19.1	22.4	71.6	94.9	95.2	47.0	16.8	79.3	51.2	13.4	24.7	84.7	30.3	20.4	96.3	18.9	28.9	37.1	17.1	18.1	46.1	29.9	16.8	14.8	302.3	12.4	42.8	17.6	40.2	29.9	31.3	37.1	75.9	38.8	53.1	28.2	12.4	87.7	102.0	14.5	153.8	18.2	43.7	23.3	22.1	49.3	58.6	32.4	30.1	195.4	31.6	195.8	9.3	35.5	52.1	44.2	50.7	35.7	54.3	52.1	48.2	41.8	41.1	42.9	38.3	48.0	47.2	12.8	25.6	28.4	10.1	338.4	18.0	11.4	8.5	4.0	34.7	17.5	13.6	15.3	30.0	24.5	7.3	22.9	5.5	258.0	11.0	5.9	12.6	12.7	78.2	15.8	18.7	9.5	66.7	75.7	18.7	9.6	17.1	26.0	25.0	28.4	10.4	38.6	66.3	43.5	26.9	52.4	9.8	12.2	284.4	140.1	19.5	5.3	256.8	28.4	89.9	291.7	15.0	129.8	54.8	33.6	17.1	8.9	4.9	224.4	9.6	10.0	9.1	70.2	25.6	32.9	12.8	27.9	15.9	11.6	12.7	17.8	4.1	199.9	14.6	9.5	14.6
SMARCA1	"hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI"	ENSG00000102038	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1"	P28370	X	129446501-129523500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003335, HPA064712"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Vesicles	"HPA003335: AB_1080024, HPA064712: AB_2685332"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.03e-4)"	"unprognostic (9.26e-2)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.33e-2)"	19.0	78.6	15.7	9.0	17.8	0.3	20.6	14.0	18.1	27.9	36.0	20.9	6.7	27.2	34.7	11.3	20.1	21.4	24.5	19.9	31.6	23.9	62.1	16.3	4.6	17.0	19.0	72.6	15.8	44.6	34.8	38.0	20.3	36.7	7.0	26.7	18.5	35.4	17.3	8.1	8.4	25.9	17.1	8.9	17.3	57.7	26.7	7.9	45.3	19.8	4.2	30.0	14.0	18.1	23.5	53.5	104.8	67.9	76.3	67.1	36.6	46.8	133.2	68.6	76.7	18.3	80.9	0.0	71.8	88.7	81.1	22.1	66.6	27.5	76.4	0.1	12.9	0.2	46.9	100.0	32.6	0.0	0.1	84.2	7.8	49.0	9.3	104.3	50.4	13.1	12.4	5.7	76.1	0.0	0.6	0.2	42.6	9.0	31.0	0.0	56.7	0.2	67.4	28.3	26.0	69.8	6.6	0.9	12.1	73.1	46.9	0.6	35.7	46.0	23.3	30.3	26.4	0.0	0.0	0.2	40.7	0.0	28.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.5	0.0	0.2	0.0	0.1	15.7	17.8	14.0	18.1	19.9	31.6	17.0	19.0	20.3	17.1	26.7	18.1	23.2	96.1	55.0	24.2	1.5	23.3	35.4	28.3	47.3	26.5	34.8	24.1	80.5	12.8	47.6	40.5	45.9	56.9	1.8	0.1	29.4	30.1	3.7	32.2	80.2	25.6	16.8	3.2	29.3	12.0	15.7	64.3	23.4	42.7	2.5	84.3	22.9	67.0	15.0	92.5	43.4	2.6	14.2	3.2	9.9	18.4	142.9	3.0	28.4	22.5	5.7	47.7	0.0	41.2	17.2	14.0	0.1	125.6	0.1	24.9	0.2	34.9	41.0	13.4	65.7	40.0	49.7	11.4	23.9	17.5	11.8	58.4	2.0	82.9	2.3	29.2
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 246.5;Inhibitory neurons: 263.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 1486.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA		19000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	51.9	55.9	68.9	36.1	73.9	95.7	62.0	87.4	81.7	42.1	40.2	31.0	20.2	53.2	57.3	41.7	57.4	46.0	43.8	60.3	53.7	45.9	58.3	40.3	50.9	43.2	54.4	166.0	36.8	170.3	32.7	48.2	50.6	42.5	31.7	63.6	50.7	53.2	97.7	48.2	27.7	44.2	40.3	52.3	32.0	56.3	55.7	42.2	55.7	60.1	47.8	31.8	28.8	52.9	45.7	32.9	23.7	33.8	47.2	56.6	71.7	59.4	44.6	24.9	19.5	0.5	17.7	76.2	22.0	50.7	13.5	18.8	12.9	46.5	17.6	1486.7	20.2	208.3	88.2	16.2	18.7	88.3	118.1	37.6	17.5	24.9	46.4	44.9	40.3	35.4	7.3	255.1	43.0	19.1	22.2	72.3	23.4	26.4	12.6	97.6	30.5	69.4	57.6	40.9	15.3	14.0	36.2	8.3	14.9	34.1	16.3	55.8	49.1	40.6	19.8	25.8	27.3	22.9	31.8	33.6	43.5	32.5	11.4	26.1	5.2	15.8	10.8	7.2	10.4	12.3	10.5	11.2	6.4	9.4	13.1	10.3	14.6	9.9	10.3	12.5	12.6	5.0	68.9	73.9	87.4	81.7	60.3	53.7	43.2	54.4	50.6	40.3	55.7	52.9	83.9	73.7	70.6	246.5	57.2	58.6	18.3	55.0	82.6	57.6	103.7	74.3	95.2	31.5	54.1	106.7	37.5	99.3	102.8	32.0	31.3	30.6	38.0	44.1	61.6	69.0	37.2	41.2	216.2	22.4	24.5	65.7	19.4	45.2	48.0	27.9	36.8	62.0	31.5	35.3	263.2	31.2	48.8	54.9	34.7	22.6	76.7	57.5	49.8	142.4	45.2	53.4	43.3	120.6	100.8	18.7	15.1	86.9	71.4	13.9	26.9	18.5	88.3	37.4	13.1	58.7	40.3	42.9	14.6	66.2	52.7	88.7	74.8	56.1	28.2	12.7
SMARCA4	"BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2"	ENSG00000127616	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"	P51532	19	10960932-11079426	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 372.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004208, HPA048340"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nucleoli fibrillar center, Nucleoli rim"	"CAB004208: AB_626762, HPA048340: "	"unprognostic (2.68e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.33e-3)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.19e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.80e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.8	16.2	14.4	22.6	14.3	31.8	13.0	15.3	23.7	16.1	13.2	18.1	19.9	14.5	9.5	32.9	20.8	13.3	16.2	15.4	9.6	15.7	8.6	17.9	27.0	10.4	10.4	14.9	18.3	22.9	11.1	20.2	11.0	17.7	12.9	19.7	25.9	15.6	23.7	28.1	17.2	14.5	3.9	19.5	20.4	30.2	11.8	43.1	20.6	13.9	23.7	17.4	14.7	19.3	92.5	5.0	157.2	149.8	30.3	25.4	68.9	62.7	37.2	74.6	54.9	126.9	4.0	215.4	94.2	54.9	3.0	65.9	123.6	77.5	40.8	89.5	93.3	171.3	76.5	149.6	45.7	125.5	82.0	43.1	36.7	63.1	64.5	33.3	67.5	92.0	156.7	78.3	59.2	188.0	210.0	107.5	159.9	45.1	134.7	220.6	99.5	111.7	47.9	114.8	177.8	161.7	66.6	84.4	73.5	50.1	71.9	93.3	90.9	110.3	57.3	102.5	104.9	160.6	192.2	209.1	62.6	118.5	96.0	5.7	5.8	6.4	9.3	6.9	8.2	5.3	6.8	7.9	6.1	6.8	7.6	7.5	3.4	8.5	10.8	7.9	6.4	4.7	14.4	14.3	15.3	23.7	15.4	9.6	10.4	10.4	11.0	3.9	11.8	19.3	25.4	67.3	72.6	27.4	28.5	37.0	43.7	43.8	24.5	91.3	42.2	28.4	372.9	40.0	62.7	44.1	70.9	65.9	21.2	60.1	41.1	79.8	53.0	58.8	49.2	58.3	63.2	41.8	32.2	61.4	57.3	43.8	50.0	63.5	30.4	75.3	28.5	21.9	42.3	101.0	39.6	47.7	57.0	23.8	21.5	37.6	26.1	30.4	16.0	14.0	43.8	36.1	23.7	32.6	28.1	76.4	41.8	13.5	37.6	66.0	29.8	27.6	62.5	69.1	13.1	45.1	66.4	99.4	86.0	52.2	51.7	61.0	30.4	68.1	60.5	50.1
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513702-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 307.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB005227: AB_2191863, HPA008751: AB_1857268"	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	16.9	26.0	15.1	21.1	20.1	32.7	17.6	17.6	17.3	18.1	13.5	17.2	14.9	20.4	20.5	14.1	14.6	19.3	17.1	13.0	16.6	16.7	16.8	27.9	27.0	17.9	16.8	21.2	16.4	22.6	13.5	22.8	19.1	18.1	17.9	26.4	12.4	17.0	15.3	11.1	16.4	18.4	18.3	22.8	16.2	32.6	16.0	29.9	23.1	15.3	25.7	22.7	11.0	26.0	33.4	25.8	92.5	58.5	53.4	38.4	55.5	41.5	49.4	59.5	50.0	44.3	45.8	90.0	27.9	35.7	23.7	26.0	85.9	38.9	57.1	60.2	30.2	67.7	36.9	36.7	39.3	84.2	38.3	34.0	27.8	42.1	36.0	34.5	46.9	45.1	62.0	55.4	39.2	30.1	98.7	29.4	75.7	55.6	36.6	108.2	59.1	29.4	46.6	40.4	73.6	62.2	54.0	37.9	49.5	69.2	27.4	39.1	50.0	38.9	29.7	41.0	41.2	60.0	77.4	106.8	30.6	69.5	40.3	5.8	10.7	16.0	12.7	12.8	15.3	11.4	13.1	14.2	13.3	11.2	13.4	13.6	9.4	15.8	21.5	10.0	16.7	11.5	15.1	20.1	17.6	17.3	13.0	16.6	17.9	16.8	19.1	18.3	16.0	26.0	77.3	307.7	291.0	30.7	95.7	46.4	78.9	50.6	55.2	93.9	56.4	49.0	104.1	31.5	96.9	44.1	64.6	70.6	125.6	39.8	39.2	77.9	63.2	104.5	127.1	74.3	79.9	85.4	42.5	61.4	66.4	73.8	46.4	94.2	103.1	97.3	39.3	25.4	44.8	85.8	41.7	41.3	69.2	51.9	49.4	27.9	60.3	79.2	30.2	27.2	98.6	84.7	55.6	37.7	85.2	66.0	35.3	62.1	93.9	57.7	36.6	36.8	109.6	116.4	52.6	113.9	88.3	144.4	130.8	47.4	40.9	102.1	107.9	118.7	46.2	71.2
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 86.5;Inhibitory neurons: 82.5;Oligodendrocyte precursor cells: 86.5;Oligodendrocytes: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	10.0	9.5	7.1	11.2	7.8	7.5	15.2	12.0	8.5	10.6	7.5	9.4	9.7	14.5	12.6	10.5	10.7	10.3	7.6	7.3	8.6	11.7	9.8	9.7	16.0	7.2	7.4	14.2	8.7	11.7	11.0	14.1	7.7	11.1	12.3	14.6	8.9	10.0	7.3	20.8	9.5	11.8	7.7	11.9	10.8	12.2	8.2	18.6	15.0	6.8	14.2	11.2	9.7	9.9	15.0	18.6	59.1	38.1	16.5	26.6	30.1	26.8	24.3	21.8	20.3	18.2	23.7	37.8	17.7	23.1	19.8	12.9	42.3	22.4	30.7	29.8	18.7	27.5	20.5	27.2	24.4	41.2	28.9	27.8	17.8	27.3	34.9	27.0	33.7	33.3	46.7	15.5	32.4	12.3	69.1	21.3	40.1	19.1	9.4	40.1	33.6	19.6	24.6	18.4	33.8	49.9	20.1	32.8	28.6	36.7	17.1	26.9	32.3	27.6	29.9	17.1	20.3	21.8	34.8	45.1	25.7	21.2	34.8	2.7	1.3	0.2	2.3	1.7	2.5	2.9	2.6	2.6	2.4	2.4	2.8	3.3	0.0	4.5	1.7	2.1	2.3	1.3	7.1	7.8	12.0	8.5	7.3	8.6	7.2	7.4	7.7	7.7	8.2	9.9	19.0	12.8	11.3	56.2	16.7	11.7	6.5	12.8	25.6	20.9	15.5	13.2	12.7	4.3	24.7	9.2	16.7	13.5	20.1	7.1	1.9	12.4	2.1	27.6	32.3	17.8	9.0	25.5	86.5	10.0	11.8	19.9	17.9	17.9	24.0	29.5	13.2	13.5	10.8	18.5	82.5	12.9	14.2	14.6	5.4	3.1	14.3	13.7	3.6	47.8	12.6	8.1	17.5	86.5	99.5	15.0	6.3	18.4	16.4	7.7	4.4	15.5	26.8	18.8	6.6	21.1	16.2	25.9	34.8	18.7	9.7	9.6	17.3	26.2	12.6	5.8
SMARCAL1	"HARP, HHARP"	ENSG00000138375	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1"	Q9NZC9	2	216412414-216483053	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020337	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA020337: AB_2670410"	"unprognostic (4.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.35e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.16e-1)"	9.2	9.8	7.5	8.9	10.3	9.1	8.8	8.0	9.7	10.6	7.6	8.0	6.8	10.7	7.5	9.8	11.0	9.5	8.9	8.0	9.0	7.2	6.7	7.9	13.1	10.6	9.1	16.3	8.2	10.8	9.3	9.1	10.6	8.1	7.4	5.6	8.0	8.9	10.5	10.6	7.9	10.1	8.4	9.7	8.0	10.3	10.2	15.1	10.2	10.6	11.9	8.8	9.0	14.2	16.7	16.3	22.2	12.7	21.5	25.1	21.3	22.0	22.7	23.0	26.1	26.7	20.3	15.0	21.8	27.6	28.8	12.3	19.1	24.4	30.5	45.7	18.9	42.8	12.0	19.9	22.0	11.5	23.9	16.7	25.7	24.9	24.4	24.0	27.6	23.5	42.6	15.8	26.3	12.3	22.2	26.8	16.1	14.7	8.9	24.6	14.6	9.3	18.2	11.4	18.4	11.9	12.0	9.1	18.7	38.2	12.4	18.1	21.3	28.3	13.0	13.7	13.9	18.0	18.6	13.3	28.8	15.6	20.2	25.9	9.5	14.1	12.2	10.5	11.6	9.6	11.5	14.3	14.9	9.2	9.6	11.8	1.7	21.0	18.1	18.0	14.7	8.5	7.5	10.3	8.0	9.7	8.0	9.0	10.6	9.1	10.6	8.4	10.2	14.2	6.3	6.4	6.1	20.2	8.2	0.9	3.3	4.6	8.6	5.1	4.3	3.4	5.0	7.2	3.7	0.0	0.0	10.4	6.7	3.4	5.9	7.4	14.5	10.4	7.2	7.0	3.6	11.4	20.6	3.8	12.2	8.0	5.6	5.8	17.7	11.0	4.2	3.2	9.7	8.4	30.8	3.7	2.0	8.9	3.1	13.7	6.2	6.2	1.8	12.2	10.1	4.7	10.3	24.6	35.9	4.0	13.3	8.6	7.0	1.3	4.7	5.8	4.4	4.8	13.1	6.0	6.8	7.7	4.4	5.3	1.3	7.3	6.5	7.5	5.3	2.0
SMARCB1	"BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5, SNF5L1, Snr1"	ENSG00000099956	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	Q12824	22	23786931-23838009	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009196, HPA018248, HPA019127"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165"	"unprognostic (2.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.63e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.43e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.04e-2)"	35.9	46.4	2.3	6.9	2.5	3.3	40.3	4.1	10.0	51.5	2.7	40.9	8.1	51.4	0.4	51.0	40.4	2.2	44.0	2.3	2.3	47.0	36.9	32.3	5.8	4.3	2.7	63.1	43.9	1.2	48.0	1.2	2.7	36.6	1.1	25.3	44.1	0.6	48.1	50.1	51.7	0.6	2.2	51.7	40.4	68.3	2.3	3.5	41.3	1.8	1.5	37.5	40.9	2.9	2.4	1.6	28.2	2.6	2.7	0.7	5.8	9.2	2.7	2.7	4.3	3.4	2.6	24.2	7.9	1.2	2.9	4.4	6.9	4.6	4.5	4.1	10.5	20.1	3.2	2.1	3.0	21.7	5.6	1.6	3.4	3.2	6.9	1.4	1.4	3.0	5.6	12.9	1.7	6.1	17.6	5.0	8.6	7.2	5.7	11.0	23.1	10.8	2.3	4.5	13.4	10.1	2.2	0.6	17.9	14.8	2.2	3.3	2.2	2.4	9.8	3.8	2.7	13.8	14.3	17.7	1.8	11.3	6.8	7.1	12.8	6.4	4.4	13.4	6.4	24.4	5.5	5.7	12.0	9.2	4.5	3.0	1.1	9.8	16.8	13.3	10.4	8.1	2.3	2.5	4.1	10.0	2.3	2.3	4.3	2.7	2.7	2.2	2.3	2.9	33.6	6.4	8.6	17.0	120.2	50.2	73.3	85.1	51.2	55.4	42.9	49.1	6.1	47.1	37.4	47.8	20.9	120.6	61.8	36.6	84.1	94.6	42.6	40.9	54.9	37.4	71.8	57.8	14.1	77.1	228.1	46.2	41.8	41.1	34.8	112.2	41.0	20.3	76.1	67.3	18.4	54.6	99.7	23.0	41.7	18.9	35.8	36.5	56.9	15.9	51.2	92.4	45.3	17.1	18.1	74.7	53.1	32.0	139.6	74.4	41.9	86.4	28.5	49.6	19.7	47.7	62.8	138.9	163.3	64.5	53.0	160.1	42.0	96.8	65.4	65.1
SMARCC1	"BAF155, CRACC1, Rsc8, SRG3"	ENSG00000173473	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1"	Q92922	3	47585269-47782106	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011576, CAB016336, HPA024352, HPA026853"	Supported		Enhanced	Nucleoplasm		NA	NA		31000	"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030"	"unprognostic (3.47e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.33e-2)"	"unprognostic (4.28e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.45e-1)"	12.2	8.1	19.6	18.6	21.1	21.2	23.5	16.2	19.6	19.3	17.0	23.0	14.7	18.3	15.6	20.1	13.1	11.8	9.4	15.9	17.7	20.0	13.8	13.1	22.2	18.3	19.8	17.8	19.5	14.3	8.3	22.2	18.8	22.4	21.9	9.6	17.0	17.1	19.0	24.1	16.9	16.3	19.7	16.3	16.9	16.7	18.9	34.8	17.7	10.3	30.3	21.0	15.9	20.9	45.1	23.4	95.7	74.9	21.0	35.7	64.3	35.1	32.7	44.5	45.1	42.3	46.6	104.3	27.7	44.4	25.8	37.7	91.2	54.3	64.6	50.3	54.1	102.4	38.4	57.7	31.4	94.8	45.3	30.1	47.0	50.1	55.2	33.1	52.8	68.7	87.5	34.4	48.4	33.4	124.4	48.9	126.8	43.2	35.4	55.1	55.5	92.0	47.2	58.0	42.6	85.5	54.5	52.7	38.9	66.5	45.8	87.1	42.7	29.6	41.7	33.9	58.0	41.9	57.1	122.0	21.6	88.1	42.5	1.9	1.6	1.7	2.7	2.6	2.4	3.9	3.0	3.7	2.1	2.6	2.8	3.3	1.9	2.0	1.9	2.2	3.1	1.9	19.6	21.1	16.2	19.6	15.9	17.7	18.3	19.8	18.8	19.7	18.9	20.9	30.4	41.7	45.9	56.5	61.7	53.0	60.5	37.4	71.7	29.3	60.3	45.5	31.5	34.3	58.9	57.0	37.5	79.7	43.7	30.1	13.7	67.9	88.9	60.2	72.3	38.3	91.6	76.9	47.3	46.7	113.0	32.7	49.5	115.7	24.6	103.8	22.1	37.8	30.2	20.2	52.2	64.5	34.6	32.3	36.9	113.1	25.4	41.6	23.2	42.2	57.7	18.9	52.5	98.0	104.9	58.8	29.0	28.6	65.3	83.7	24.1	38.0	34.0	33.0	39.5	44.7	60.1	59.4	108.3	86.0	66.8	72.5	52.4	77.6	61.8	62.4
SMARCC2	"BAF170, CRACC2, Rsc8"	ENSG00000139613	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2"	Q8TAQ2	12	56162359-56189567	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004321, HPA021213, HPA061788"	Supported		Enhanced	Nucleoplasm		NA	NA		11000	"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB004321: AB_2286337, HPA021213: AB_1857275, HPA061788: AB_2684608"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	36.6	33.5	48.1	23.8	52.1	23.5	38.5	48.7	56.3	43.8	19.9	39.3	27.7	42.9	22.8	30.5	40.8	23.3	26.4	49.6	50.9	31.6	19.8	29.7	29.5	44.2	43.8	51.9	32.6	35.5	32.4	25.3	40.2	34.8	23.4	39.2	37.2	33.5	46.7	36.5	34.5	28.4	40.2	31.9	33.0	32.8	49.1	39.0	49.8	30.5	28.7	39.1	37.4	51.6	49.3	74.9	77.2	56.4	47.2	48.9	32.4	42.6	45.3	50.3	48.4	43.5	59.5	71.4	40.0	50.0	47.7	54.8	49.9	42.9	45.1	54.3	47.6	112.2	51.6	27.8	25.6	53.4	79.8	46.4	31.5	47.6	23.7	91.3	65.4	54.7	65.5	57.2	48.1	52.1	90.4	56.0	26.4	39.0	50.4	53.5	62.0	55.0	38.6	63.4	56.6	59.0	72.8	49.4	20.6	40.3	84.3	49.3	56.1	42.5	51.7	38.4	31.8	54.8	41.9	48.4	44.3	35.5	46.9	15.4	8.5	21.0	11.4	10.2	12.3	8.6	8.2	8.6	7.3	9.4	6.0	7.6	7.9	8.3	13.9	6.0	8.6	11.6	48.1	52.1	48.7	56.3	49.6	50.9	44.2	43.8	40.2	40.2	49.1	51.6	40.8	67.3	43.5	40.1	40.9	20.5	43.2	24.5	62.6	59.3	26.6	28.8	25.7	34.3	40.6	42.3	39.6	20.4	39.0	17.9	7.9	25.4	1.6	24.3	42.8	38.5	22.7	51.9	39.5	18.0	11.9	40.2	33.6	36.3	65.1	56.3	33.9	17.3	16.6	38.7	37.5	22.3	32.6	20.6	20.7	7.8	69.0	29.3	19.6	23.4	36.0	42.3	70.0	33.2	23.4	22.7	17.1	55.3	44.6	32.2	19.8	17.3	25.0	66.0	19.7	47.9	42.3	45.5	31.7	55.9	22.6	13.3	49.9	36.6	21.4	37.7
SMARCD1	"BAF60A, CRACD1, Rsc6p"	ENSG00000066117	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1"	Q96GM5	12	50085200-50100707	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis	"Chromatin regulator"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004101	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Vesicles	"HPA004101: AB_1080026"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (3.62e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	25.8	28.1	25.2	23.2	27.6	44.0	24.9	24.4	27.0	23.5	20.8	22.0	23.2	27.9	27.1	27.5	23.8	17.9	18.3	26.3	23.8	25.3	19.0	23.9	35.0	25.7	25.7	26.4	22.5	47.3	19.7	28.9	25.3	23.2	27.2	25.1	24.3	21.8	16.9	24.3	27.8	28.8	24.8	31.3	20.5	23.8	25.8	57.2	26.8	16.1	47.6	23.5	21.7	27.6	28.4	47.6	134.8	75.8	41.1	38.9	68.1	35.1	62.0	100.3	58.2	130.0	42.1	109.4	51.0	67.2	44.4	35.4	112.9	91.5	87.3	84.4	87.0	107.2	49.4	75.8	49.3	95.0	41.1	40.2	60.2	59.8	107.4	66.1	119.5	114.0	93.1	64.8	50.6	67.7	137.6	54.0	166.0	43.2	76.6	165.5	34.9	96.0	57.3	66.1	71.4	121.3	73.1	35.2	139.3	100.4	79.4	78.7	70.4	50.1	56.0	31.7	69.9	91.6	88.2	95.4	40.6	37.7	56.9	3.4	1.2	2.2	2.9	1.2	2.9	3.6	1.6	2.0	1.8	2.7	1.0	3.3	0.5	1.7	1.9	3.5	2.7	1.2	25.2	27.6	24.4	27.0	26.3	23.8	25.7	25.7	25.3	24.8	25.8	27.6	29.7	0.0	9.6	11.1	42.9	16.6	22.3	17.7	42.7	33.7	33.2	30.2	6.5	15.7	20.5	27.6	20.9	21.1	39.6	21.6	52.8	32.8	4.3	20.0	36.9	30.1	31.1	25.7	9.3	29.0	19.4	17.8	14.8	30.5	16.5	40.0	17.5	15.1	17.3	26.9	10.5	18.2	10.2	14.4	13.1	9.1	16.4	16.8	17.8	7.5	27.1	26.5	29.9	11.1	17.1	36.8	14.8	16.1	28.9	28.8	19.5	47.9	9.4	28.8	32.9	31.6	28.2	28.4	36.5	31.3	19.6	11.1	30.0	26.8	19.1	15.9
SMARCD2	"BAF60B, CRACD2, PRO2451, Rsc6p"	ENSG00000108604	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2"	Q92925	17	63832081-63843065	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059934, HPA061348"			Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA059934: AB_2684170, HPA061348: AB_2684486"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.79e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.75e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.80e-2)"	53.8	55.2	23.3	44.6	28.1	71.6	65.9	35.5	28.5	48.0	29.1	49.9	51.1	37.4	58.5	71.3	52.9	33.1	31.2	22.9	23.2	26.4	54.9	46.7	66.0	27.7	26.7	38.3	89.5	42.8	36.7	47.8	27.0	52.7	46.6	17.6	78.0	49.0	25.3	97.0	49.8	32.4	25.5	60.6	68.2	42.7	25.6	70.2	33.8	34.2	70.1	52.3	55.9	31.7	142.9	87.9	21.3	93.0	133.6	196.1	139.7	52.5	64.1	97.5	61.7	101.7	76.8	163.0	32.5	79.0	43.9	99.4	65.7	99.1	57.3	61.1	169.5	109.3	40.3	141.7	102.3	159.5	128.9	154.3	122.0	55.3	42.1	56.4	78.3	110.8	89.5	101.7	57.2	279.1	203.8	132.3	51.3	202.0	96.9	195.0	77.8	185.0	66.9	96.0	80.2	145.9	79.2	228.4	97.1	69.3	212.2	121.7	58.4	67.7	52.5	61.4	90.7	119.8	113.2	113.5	54.1	129.6	50.4	4.2	9.1	8.8	9.4	8.4	5.6	7.2	9.9	9.8	12.1	9.5	6.3	8.5	10.8	8.0	10.0	10.1	11.5	6.0	23.3	28.1	35.5	28.5	22.9	23.2	27.7	26.7	27.0	25.5	25.6	31.7	14.8	28.9	42.4	19.9	18.2	22.9	23.6	14.3	26.2	9.7	47.1	41.0	5.9	30.0	25.2	16.5	6.2	54.9	21.1	36.0	3.9	16.9	1.0	17.6	25.3	17.4	33.0	12.6	7.2	19.6	38.2	25.8	18.8	20.7	14.0	88.1	25.7	83.3	22.0	11.8	5.8	42.0	12.2	36.9	19.6	5.4	49.4	23.1	14.2	8.4	31.9	16.9	15.5	6.6	10.7	21.0	26.2	30.9	12.6	19.0	30.0	11.6	23.8	12.4	32.9	21.9	14.6	12.3	22.4	29.7	31.1	52.9	16.7	101.7	40.8	24.1
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Metabolic proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 126.4;skeletal muscle: 129.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.5;Peritubular cells: 88.4;Sertoli cells: 65.7"	"Cancer enhanced"	"Detected in all"		"glioma: 28.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.6;granulocytes: 1.9;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA063955: AB_2685159, HPA065517: AB_2685500"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	20.7	40.3	104.0	5.0	101.9	7.1	22.1	70.7	126.4	25.0	59.8	25.2	3.0	22.8	14.7	8.4	30.6	14.6	78.9	105.3	90.4	18.8	2.8	18.8	4.6	79.5	89.8	37.6	14.3	27.2	42.2	5.7	83.2	27.7	3.8	10.0	14.3	23.2	129.0	11.5	11.0	13.4	72.4	9.2	18.3	17.4	99.9	1.9	18.1	69.4	2.5	22.7	18.2	84.8	0.8	6.1	19.6	69.3	30.0	13.3	1.6	13.3	13.0	7.5	4.3	4.5	4.2	7.7	4.7	20.4	3.0	1.3	15.7	1.3	3.0	2.4	10.2	0.0	4.5	1.4	25.9	0.4	12.5	31.8	1.8	2.4	0.2	32.7	1.5	19.5	16.4	2.5	39.5	8.3	1.3	10.3	6.1	2.0	2.5	0.5	31.7	0.3	6.6	0.0	11.2	22.6	12.4	2.1	9.5	3.1	2.0	19.7	2.6	6.1	7.7	15.7	4.9	16.1	0.0	6.5	14.2	17.6	21.6	0.4	5.5	0.0	0.1	1.3	0.1	0.1	0.5	0.0	1.6	0.0	0.3	0.5	1.9	0.0	0.2	0.0	0.4	1.3	104.0	101.9	70.7	126.4	105.3	90.4	79.5	89.8	83.2	72.4	99.9	84.8	7.5	6.4	21.7	33.6	0.7	10.7	38.3	3.1	47.8	15.2	28.5	29.6	67.5	21.5	4.6	11.0	4.2	0.4	1.2	0.2	31.3	24.8	2.5	3.9	24.4	5.2	3.5	1.3	16.7	2.6	0.5	28.0	1.5	3.4	2.5	44.3	2.9	0.5	3.6	11.8	23.9	0.3	0.0	17.0	5.7	14.0	50.7	16.0	7.2	8.4	19.7	23.7	0.0	16.1	7.4	2.8	0.1	88.4	0.1	14.6	0.0	2.1	4.7	5.7	65.7	40.9	56.9	1.7	20.0	1.5	4.7	1.1	4.7	22.8	0.2	9.0
SMARCE1	BAF57	ENSG00000073584	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1"	Q969G3	17	40624962-40648654	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	Neurogenesis	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003916, CAB037318"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB037318: AB_476780, HPA003916: AB_1857279"	"unprognostic (7.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-2)"	39.4	22.2	10.5	37.8	11.9	43.2	35.6	10.6	13.3	45.9	14.3	40.2	38.9	56.2	28.3	43.6	39.0	41.4	40.1	9.2	11.7	31.2	31.5	36.1	49.6	13.7	10.7	58.6	35.4	38.3	13.3	48.4	13.2	34.2	38.5	17.5	33.6	42.1	42.5	27.7	39.3	57.4	11.7	40.5	30.9	31.5	11.2	76.1	40.8	44.7	54.2	46.8	26.2	16.5	86.5	139.6	169.1	126.5	87.7	125.5	82.8	105.9	145.4	122.1	91.0	92.7	72.7	135.9	149.6	145.3	81.0	114.5	106.1	112.3	145.1	128.3	138.0	97.2	73.4	165.2	87.8	179.8	94.5	109.3	87.6	97.7	140.6	122.1	133.4	106.5	144.2	52.2	118.2	96.5	331.6	37.1	95.4	70.8	68.6	183.3	190.2	103.7	147.5	144.9	134.6	130.0	94.5	269.4	86.6	181.5	161.5	111.4	109.7	98.1	107.6	89.7	132.6	97.7	122.8	204.5	100.0	80.9	154.9	106.3	64.4	88.2	91.7	67.8	95.0	99.8	82.4	96.1	77.9	112.3	68.3	79.3	26.5	124.7	82.2	80.3	114.7	112.2	10.5	11.9	10.6	13.3	9.2	11.7	13.7	10.7	13.2	11.7	11.2	16.5	41.4	48.1	45.1	13.1	67.5	38.1	43.0	69.5	65.4	75.8	19.7	20.2	53.0	38.6	61.5	20.2	16.7	101.8	68.7	38.7	15.6	41.5	27.1	34.9	47.0	60.4	96.5	84.1	17.1	32.3	75.7	72.4	44.9	32.1	74.0	41.3	62.8	44.0	51.6	82.4	18.8	53.5	65.1	42.9	39.6	11.8	90.4	30.9	24.9	19.7	63.2	63.3	105.0	26.7	32.7	35.7	46.7	82.4	44.2	36.5	52.8	30.5	59.3	37.1	39.5	62.7	57.0	49.7	50.9	63.3	40.1	114.8	53.8	35.3	62.5	34.3
SMC1A	"DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb"	ENSG00000072501	"Structural maintenance of chromosomes 1A"	Q14683	X	53374149-53422728	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005499, CAB025404"	Supported		Enhanced	Nucleoplasm		NA	NA		33000	"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB025404: , HPA005499: AB_1080028"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.80e-3)"	"unprognostic (9.49e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.18e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.39e-2)"	16.6	11.8	8.7	28.4	11.7	30.3	17.2	15.0	9.5	13.8	9.6	20.0	18.6	21.0	8.0	17.1	16.7	11.5	15.6	7.8	9.5	16.3	18.8	16.0	34.4	10.2	10.7	19.1	14.4	25.8	6.3	18.2	10.7	14.0	18.4	21.0	15.1	13.0	17.9	18.1	15.9	22.9	8.7	20.1	15.7	7.8	11.3	58.1	16.8	18.8	29.9	15.5	12.4	13.9	110.0	115.1	92.4	76.1	32.4	35.4	51.5	68.0	37.0	76.4	59.4	71.6	60.5	115.8	54.1	40.7	105.2	78.9	162.9	92.6	85.1	91.7	176.0	94.3	133.9	51.1	15.4	134.9	120.9	20.6	23.3	86.0	52.8	19.4	67.5	68.7	144.7	64.7	58.6	69.2	122.0	40.8	139.9	47.8	55.6	117.2	165.5	100.1	34.4	69.4	92.8	83.5	176.9	84.4	33.5	122.8	87.9	54.0	45.7	63.3	68.0	65.1	62.2	45.8	77.9	91.9	39.1	152.1	64.1	2.7	6.8	4.5	7.3	8.5	7.6	5.4	5.8	6.7	8.4	5.8	5.2	6.3	2.7	4.6	12.4	4.6	5.7	6.7	8.7	11.7	15.0	9.5	7.8	9.5	10.2	10.7	10.7	8.7	11.3	13.9	40.7	44.8	39.9	16.0	45.6	24.1	37.0	27.7	28.5	46.6	30.7	27.4	63.5	27.1	47.4	20.2	27.1	43.2	57.7	49.6	7.9	31.6	10.5	46.5	62.6	41.7	19.9	70.7	12.0	27.1	61.4	37.2	29.0	44.0	35.4	42.7	18.9	54.1	47.6	60.6	14.2	43.5	22.4	41.1	27.6	7.6	37.9	51.5	23.2	24.4	55.2	38.1	59.8	16.6	30.2	33.1	23.6	36.1	61.2	40.7	29.0	24.6	47.1	48.4	39.5	49.5	71.0	54.5	51.2	39.8	24.4	48.4	47.9	34.0	51.4	32.0
SMC1B	"bK268H5, SMC1L2"	ENSG00000077935	"Structural maintenance of chromosomes 1B"	Q8NDV3	22	45344063-45413619	"Predicted intracellular proteins"	"Cell cycle, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	98	"testis: 31.1"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 897.6;Spermatogonia: 448.5"	"Cancer enriched"	"Detected in many"	6	"cervical cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.9;EFO-21: 4.0;SiHa: 18.0;U-266/70: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001500	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA001500: AB_1080030"	"unprognostic (1.18e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.83e-9)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.98e-3)"	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.2	0.1	0.0	18.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.4	0.0	3.9	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.6	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	75.6	0.5	0.2	0.8	0.0	0.0	1.4	0.0	0.9	0.3	0.0	0.2	0.0	0.7	0.4	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	36.9	5.6	0.5	0.0	1.0	0.0	0.3	0.0	1.0	1.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.2	1.0	98.6	0.4	0.2	897.6	448.5	0.0	0.0	0.8	0.1	0.0	0.0	0.2
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141419	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.7"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	5.2	4.1	2.8	11.3	4.0	18.4	6.6	4.4	3.3	7.5	1.3	8.2	7.5	6.0	2.6	7.3	4.7	4.0	7.9	2.2	4.0	6.3	4.7	4.5	16.0	4.9	3.7	4.7	3.5	5.7	1.5	6.9	4.1	4.2	8.8	5.6	3.1	4.7	2.2	7.4	7.6	5.4	3.5	7.2	6.1	12.0	3.5	25.7	7.6	5.4	15.9	4.9	3.2	5.0	59.3	45.0	49.4	45.9	10.3	14.9	46.2	53.5	25.4	46.9	39.4	39.3	44.9	112.6	25.2	27.7	40.5	97.6	72.3	34.8	63.2	71.6	30.3	67.9	68.8	25.5	2.7	41.5	65.6	9.8	7.0	63.7	25.7	15.9	33.7	71.2	55.8	89.8	43.0	28.9	109.1	21.3	42.9	47.6	34.8	72.0	141.3	42.2	20.1	21.1	46.5	35.9	63.8	29.6	15.5	20.5	59.5	28.0	27.1	56.8	59.1	79.3	67.9	32.6	118.2	64.6	36.8	59.8	70.3	15.0	2.2	2.5	4.8	5.9	5.4	7.3	4.4	4.8	2.6	7.9	5.0	5.8	0.3	7.0	7.4	4.4	6.0	2.4	2.8	4.0	4.4	3.3	2.2	4.0	4.9	3.7	4.1	3.5	3.5	5.0	19.6	25.6	11.9	6.5	19.9	27.3	16.4	27.6	11.4	39.7	16.6	19.3	45.1	7.2	17.8	16.5	8.4	54.3	15.2	13.7	35.2	18.9	40.0	114.6	21.6	21.4	4.9	95.3	10.2	20.4	93.8	20.2	13.3	16.0	22.2	40.4	21.0	7.6	44.3	28.6	15.5	14.6	26.4	19.8	19.8	24.7	18.6	22.9	7.2	7.5	19.8	15.6	22.6	5.5	18.4	15.6	6.3	12.4	40.9	7.3	10.3	15.0	12.0	19.1	13.1	25.1	37.7	84.5	93.5	27.4	23.2	25.9	18.1	28.1	35.0	14.2
SMC3	"BAM, bamacan, CSPG6, HCAP, SMC3L1"	ENSG00000108055	"Structural maintenance of chromosomes 3"	Q9UQE7	10	110567695-110606048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Spermatocytes: 994.2;Spermatogonia: 799.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043206	Approved		Supported	Nucleoplasm		NA	NA		630000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA043206: AB_2678362"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.89e-3)"	"unprognostic (9.74e-3)"	"unprognostic (8.06e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.73e-3)"	"unprognostic (7.22e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	19.5	13.3	9.0	18.7	10.9	43.9	19.1	18.5	11.7	18.5	11.7	18.3	15.5	20.3	15.7	19.2	16.5	11.1	12.9	8.6	10.2	14.0	15.3	14.5	25.2	10.2	9.4	25.7	19.6	20.0	14.2	20.7	10.4	14.0	16.7	27.6	16.2	15.2	21.1	20.6	19.4	16.9	9.6	18.6	14.7	38.1	9.5	39.2	16.5	14.1	24.3	15.5	17.8	12.7	73.1	44.5	95.4	67.8	30.7	26.3	40.9	57.7	56.7	51.9	50.7	56.4	59.7	94.2	24.5	38.6	40.0	56.5	68.7	35.0	78.6	77.3	60.1	76.5	56.2	51.2	30.8	109.8	56.6	21.1	28.0	57.4	89.5	48.5	38.8	31.7	61.7	70.4	45.4	38.1	85.2	58.3	66.1	38.6	35.1	71.1	171.5	51.4	32.4	31.7	53.7	61.8	62.0	17.7	48.6	61.8	28.5	53.1	40.1	41.6	65.5	47.6	84.4	40.9	38.8	99.6	37.5	103.9	34.8	20.7	6.1	15.8	9.6	8.4	12.1	11.0	11.3	10.6	6.8	11.0	11.3	11.2	6.5	12.6	7.6	8.7	14.5	6.2	9.0	10.9	18.5	11.7	8.6	10.2	10.2	9.4	10.4	9.6	9.5	12.7	74.9	80.1	62.0	16.6	73.5	60.5	53.2	64.1	34.7	81.3	44.3	49.9	64.5	47.1	64.4	55.2	75.0	119.6	94.3	29.8	25.4	96.9	56.9	52.0	65.0	74.9	40.7	104.6	26.2	45.6	111.4	66.0	20.9	49.0	56.3	124.9	40.4	31.9	59.1	60.6	29.2	40.7	54.9	37.9	42.5	34.6	115.2	49.8	37.4	19.7	96.1	54.9	98.9	33.2	43.4	53.0	70.1	114.0	65.0	44.7	70.7	30.3	68.3	78.9	184.1	102.0	110.6	994.2	799.1	48.1	64.5	49.1	80.9	112.7	51.9	37.5
SMC6	"FLJ22116, SMC6L1"	ENSG00000163029	"Structural maintenance of chromosomes 6"	Q96SB8	2	17663812-17800242	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 153.4;Spermatocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035057, CAB037186, HPA042733"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB037186: AB_1080031, HPA035057: AB_2674435, HPA042733: AB_2678134"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.94e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.25e-2)"	8.4	5.2	6.8	14.7	7.6	13.3	8.5	11.4	7.7	9.5	31.9	11.9	9.0	9.4	17.4	13.2	8.7	9.4	8.6	8.0	8.4	8.9	17.2	9.0	21.6	6.2	6.9	6.9	6.1	6.0	11.6	14.2	7.4	6.7	13.3	6.8	12.4	10.8	9.4	14.7	11.4	8.7	5.3	14.9	9.8	35.2	8.4	14.3	7.7	8.8	22.6	8.6	11.4	10.6	50.6	24.8	31.9	26.6	33.6	32.2	32.2	26.4	18.6	16.7	16.2	27.9	19.4	43.9	16.6	24.2	27.9	34.4	38.5	31.0	25.7	52.3	25.2	60.3	16.2	42.1	31.3	42.3	31.2	24.3	21.4	27.0	35.1	20.5	38.9	26.4	67.5	35.4	31.9	20.8	32.8	21.7	43.3	25.3	19.7	38.7	90.0	29.9	16.2	27.7	28.0	29.9	38.4	20.0	30.0	35.1	12.7	18.7	42.7	41.3	16.5	32.5	47.2	25.0	43.5	87.9	21.0	45.7	30.0	2.2	3.8	8.2	7.8	4.2	6.6	24.8	6.0	7.1	5.1	26.4	4.3	6.0	3.1	7.5	6.7	27.7	14.4	4.1	6.8	7.6	11.4	7.7	8.0	8.4	6.2	6.9	7.4	5.3	8.4	10.6	25.6	48.1	12.5	34.9	63.7	18.2	21.6	41.5	68.3	15.2	8.4	9.3	36.5	14.3	30.8	5.5	12.5	15.2	51.5	18.9	11.7	17.0	153.4	33.0	26.3	21.9	11.3	36.6	51.1	11.7	27.5	21.0	32.1	18.2	20.8	38.6	15.7	19.3	17.6	6.7	47.9	15.7	16.2	10.0	9.1	123.7	22.4	20.1	26.6	30.0	22.0	12.5	25.7	56.3	60.5	19.7	17.2	27.4	25.3	25.1	16.0	14.5	27.2	17.4	46.0	41.2	67.8	150.0	87.9	37.4	14.2	12.4	22.2	28.9	21.2	14.9
SMCHD1	"FSHD2, KIAA0650"	ENSG00000101596	"Structural maintenance of chromosomes flexible hinge domain containing 1"	A6NHR9	18	2655726-2805017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Hydrolase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 363.7;Plasma cells: 391.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 58.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 58.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039441	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies"	"HPA039441: AB_10671042"	"unprognostic (2.99e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (1.32e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.63e-2)"	13.6	6.9	5.4	24.6	6.6	41.1	12.4	11.4	8.3	16.5	6.8	14.4	13.7	14.9	9.2	8.7	14.1	12.4	10.1	5.0	6.6	6.5	8.4	19.0	33.9	7.2	6.1	15.4	16.3	11.9	7.9	16.3	7.4	13.4	14.7	16.3	10.1	11.2	11.0	9.1	20.3	12.8	6.4	28.6	12.4	14.1	6.3	25.6	9.6	11.5	22.4	15.0	14.2	8.7	24.1	10.7	35.8	22.6	15.0	21.8	25.7	23.7	16.8	22.0	27.7	20.3	7.7	51.6	10.2	21.2	24.7	13.0	29.1	13.6	34.4	10.7	15.1	32.3	21.7	19.5	16.8	93.9	24.3	14.4	12.2	27.9	22.8	16.8	18.3	25.5	38.3	31.1	21.3	8.6	39.4	23.9	14.4	13.0	12.4	31.7	29.1	22.9	13.6	36.5	29.2	18.4	32.0	10.6	18.8	19.8	7.9	39.3	17.5	27.1	37.4	37.1	44.0	18.8	30.4	46.5	17.4	17.1	24.0	5.1	2.5	6.6	3.6	1.7	2.6	5.8	4.8	4.3	0.9	7.5	5.9	3.8	58.7	2.3	2.3	2.6	5.4	1.3	5.4	6.6	11.4	8.3	5.0	6.6	7.2	6.1	7.4	6.4	6.3	8.7	96.5	44.8	44.7	71.5	363.7	27.1	35.3	14.5	48.9	112.1	33.3	32.8	53.0	15.7	27.7	18.4	100.1	36.5	232.7	102.7	5.9	23.4	117.2	43.6	83.3	53.0	22.7	69.0	98.4	19.4	22.3	52.8	68.3	75.9	40.4	54.2	30.7	16.4	19.4	99.3	127.2	35.5	10.2	65.4	69.7	38.6	42.0	116.3	30.2	121.8	142.5	32.3	120.5	111.1	130.4	23.6	60.1	38.0	391.1	52.0	46.5	6.1	22.5	88.5	39.5	59.7	69.8	166.7	115.3	41.3	24.9	46.9	257.9	45.9	30.4	57.8
SMCR8	"DENND8A, FLJ34716"	ENSG00000176994	"SMCR8-C9orf72 complex subunit"	Q8TEV9	17	18315293-18328056	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021557, HPA024646"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA021557: AB_1857283, HPA024646: AB_1857284"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.11e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.09e-3)"	"unprognostic (7.11e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.41e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.27e-2)"	5.2	5.0	1.7	5.0	1.9	12.5	5.0	2.2	1.9	4.7	2.6	5.8	3.3	5.3	2.6	5.3	4.8	2.7	4.5	1.8	2.4	4.6	4.0	5.5	5.7	2.0	1.8	4.9	5.1	5.8	5.3	2.9	1.9	4.8	3.7	2.7	6.4	3.0	6.4	5.8	7.2	3.0	1.6	8.4	6.2	4.9	2.2	5.4	4.7	3.5	5.6	5.3	3.9	2.3	7.0	9.6	4.7	5.5	6.5	4.3	8.6	4.9	6.6	8.5	8.1	14.8	2.9	4.1	3.6	6.1	9.6	9.1	9.4	5.8	7.8	8.4	7.9	7.7	10.0	4.2	7.0	3.0	18.1	5.5	7.3	9.8	6.1	5.6	6.1	5.9	6.5	3.8	5.1	4.3	5.1	4.4	4.5	9.0	4.0	5.6	12.1	6.5	3.9	7.9	2.5	5.8	5.6	7.1	10.5	24.7	14.4	6.1	6.1	4.8	5.8	12.8	6.6	5.7	7.0	2.1	6.7	4.7	5.0	2.5	0.5	0.4	0.2	0.3	0.2	0.3	0.2	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.7	0.3	0.2	0.3	1.7	1.9	2.2	1.9	1.8	2.4	2.0	1.8	1.9	1.6	2.2	2.3	5.6	6.4	11.0	2.3	7.0	0.4	3.4	0.0	4.6	6.7	8.2	6.1	3.3	5.7	5.6	11.0	2.1	3.8	6.4	8.2	0.0	5.4	3.3	8.9	9.0	6.3	3.6	5.2	5.1	5.4	2.9	4.6	7.7	13.9	8.8	7.4	10.4	5.3	8.7	6.7	5.5	6.0	0.0	23.5	0.3	2.0	4.1	15.1	0.0	5.6	18.7	2.9	4.1	2.5	3.7	6.9	4.5	4.1	3.5	6.8	6.3	6.4	2.2	5.9	0.0	5.4	4.3	9.3	7.8	3.9	0.6	6.0	6.3	6.2	6.1	7.5
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	12.2	13.9	21.6	6.1	22.2	17.6	19.5	25.7	27.7	14.6	21.2	14.7	10.3	12.3	19.5	12.6	15.2	7.4	20.0	22.1	22.0	18.2	15.1	9.7	16.1	21.6	21.4	22.5	21.5	18.0	14.9	7.3	22.2	16.1	11.2	16.0	22.7	13.4	35.6	14.8	13.5	8.4	21.3	12.6	17.7	6.9	21.3	12.4	18.6	37.9	12.2	12.4	11.9	22.4	5.7	3.7	7.4	8.9	13.1	9.5	5.8	2.0	10.0	12.1	10.5	7.1	5.3	7.8	2.4	10.3	3.4	6.1	9.8	10.4	7.7	3.8	15.7	4.7	8.1	10.3	16.5	8.6	5.9	7.4	17.3	4.8	9.9	6.9	12.2	5.1	7.9	12.3	8.4	11.2	12.1	13.0	2.8	14.1	2.7	10.8	6.5	20.8	15.5	6.4	9.2	6.0	5.0	11.1	12.8	3.7	9.3	9.3	4.8	5.1	5.3	4.5	3.9	8.2	9.8	16.9	7.9	8.5	4.1	4.0	5.8	2.9	3.1	3.1	5.9	5.9	8.6	4.5	8.4	7.2	9.3	6.0	0.5	5.5	4.5	6.4	5.4	5.4	21.6	22.2	25.7	27.7	22.1	22.0	21.6	21.4	22.2	21.3	21.3	22.4	161.1	83.3	109.3	11.8	295.0	166.7	202.2	157.3	191.2	71.6	400.9	477.3	350.9	237.4	160.3	204.1	20.9	308.7	127.8	285.6	573.2	160.0	114.0	156.8	81.1	138.2	345.2	135.7	10.5	199.6	190.6	127.8	150.3	127.2	91.4	55.4	161.3	380.1	256.1	55.5	12.8	356.5	262.4	164.5	200.6	131.9	189.2	187.7	211.7	5.6	125.8	196.4	124.6	7.5	13.8	193.7	314.0	149.0	275.8	238.2	486.7	623.4	223.7	109.5	124.9	133.6	202.7	256.0	55.5	271.5	274.1	308.8	186.3	151.7	308.8	272.2
SMG1	"ATX, KIAA0421, LIP"	ENSG00000157106	"SMG1 nonsense mediated mRNA decay associated PI3K related kinase"	Q96Q15	16	18804860-18926408	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Nonsense-mediated mRNA decay"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006870, HPA031623, HPA073972"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006870: AB_1079725, HPA031623: AB_2673962, HPA073972: AB_2686648"	"unprognostic (6.34e-2)"	"unprognostic (5.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.32e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	12.9	8.4	11.0	16.1	11.0	39.0	19.5	42.6	12.6	13.4	11.9	14.4	11.6	14.1	15.8	14.2	12.1	10.8	13.5	12.0	7.5	14.6	17.8	11.4	21.6	7.5	6.7	18.6	13.0	15.2	10.2	11.5	9.9	12.1	15.9	20.9	12.0	10.9	53.1	42.0	13.6	13.2	1.9	15.9	12.8	14.5	12.6	29.9	18.1	35.4	19.1	15.4	13.2	16.6	42.2	27.5	25.5	18.1	28.6	29.9	18.8	19.1	18.8	20.4	22.7	24.4	15.1	57.5	26.8	26.8	21.5	23.3	29.6	16.7	32.3	37.2	18.4	26.2	25.8	31.4	23.1	35.7	19.9	17.7	27.5	42.4	50.5	20.1	29.1	30.7	41.0	31.0	22.8	22.0	24.8	20.9	27.2	15.3	15.7	28.4	34.2	19.8	17.6	32.1	23.0	17.6	29.9	19.9	20.8	20.8	15.9	22.3	37.0	30.2	20.4	19.0	28.7	15.8	21.8	37.0	20.2	27.1	18.6	31.7	2.7	4.2	6.6	3.2	3.2	4.0	4.4	4.8	2.9	7.6	5.7	5.1	8.4	2.6	7.2	5.3	4.5	1.4	11.0	11.0	42.6	12.6	12.0	7.5	7.5	6.7	9.9	1.9	12.6	16.6	83.2	76.9	85.4	58.4	98.8	193.2	73.0	26.9	112.1	52.0	71.3	40.5	48.1	32.9	67.1	27.6	75.0	21.3	97.4	65.5	3.9	21.7	20.3	88.1	81.1	66.5	39.4	44.8	81.5	23.6	19.0	57.3	90.7	140.0	39.3	66.1	37.9	46.1	24.1	42.1	75.2	41.8	36.7	48.0	112.8	24.9	29.8	82.5	39.2	68.4	61.4	20.5	72.1	48.7	87.5	34.6	76.9	26.4	82.2	94.2	43.0	15.6	45.9	44.8	46.0	118.2	63.1	49.6	32.2	107.1	204.4	30.0	97.6	37.6	46.4	95.4
SMG8	"C17orf71, FLJ10587, FLJ23205"	ENSG00000167447	"SMG8 nonsense mediated mRNA decay factor"	Q8ND04	17	59209400-59215239	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA024841	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA024841: AB_10600790"	"unprognostic (2.68e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-3)"	"unprognostic (9.91e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-3)"	"unprognostic (4.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.75e-1)"	5.9	7.0	5.0	6.4	5.3	10.9	8.5	5.7	6.8	7.4	5.5	6.0	5.9	7.4	6.9	6.5	8.5	5.1	7.5	5.3	6.4	7.1	7.7	6.3	9.5	5.2	5.7	11.2	5.2	9.4	4.1	9.2	5.8	6.6	6.0	4.6	6.3	6.9	8.3	7.3	5.4	7.2	5.7	7.4	5.9	7.5	6.2	10.2	8.1	8.4	10.1	6.7	3.9	6.3	16.2	22.6	17.4	17.5	21.4	18.0	23.5	23.1	23.5	31.7	27.3	15.5	14.1	23.8	35.2	22.1	24.6	19.2	28.3	21.4	30.6	31.5	27.0	27.3	12.2	22.2	24.6	26.8	22.6	23.6	26.2	23.2	17.2	21.0	21.1	14.7	33.5	12.2	22.0	36.2	25.9	12.4	17.1	23.3	22.0	17.3	26.0	22.5	14.9	11.5	15.4	24.9	16.2	8.9	19.3	21.7	26.9	18.7	20.5	11.9	27.0	13.0	20.8	23.7	36.3	27.3	15.2	14.0	19.8	26.7	18.6	9.6	8.7	24.2	10.2	10.0	8.1	8.3	15.0	6.2	8.0	7.3	4.7	10.2	26.4	5.0	8.3	9.0	5.0	5.3	5.7	6.8	5.3	6.4	5.2	5.7	5.8	5.7	6.2	6.3	1.0	3.2	2.6	4.6	3.8	0.6	0.3	0.9	1.8	0.8	0.7	0.4	0.9	0.0	1.8	0.0	0.0	1.0	1.2	2.4	0.0	2.7	0.3	1.6	1.9	1.8	1.8	1.3	3.4	2.8	1.0	1.6	3.1	1.6	5.7	1.5	1.1	1.0	0.8	3.3	3.7	0.5	0.0	2.4	0.0	0.0	0.9	2.4	0.0	0.0	2.3	0.6	1.0	4.5	5.0	2.9	6.3	0.7	3.6	0.2	0.8	0.6	3.5	1.1	0.0	1.6	3.0	1.2	1.3	3.1	0.6	1.4	2.3	2.1	1.5	0.3
SMIM13	C6orf228	ENSG00000224531	"Small integral membrane protein 13"	P0DJ93	6	11093834-11138733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 75.1;Syncytiotrophoblasts: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA065706	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Nuclear membrane, Golgi apparatus"		"HPA065706: AB_2685539"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.04e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.45e-2)"	4.7	4.6	15.4	3.4	16.1	2.9	3.4	21.4	23.8	4.3	5.6	4.1	3.6	5.0	3.4	4.8	2.9	4.1	6.6	16.7	18.0	4.3	9.7	3.5	3.0	17.6	16.7	4.1	3.0	6.4	4.1	12.7	19.3	4.6	3.6	17.1	3.7	4.8	11.5	4.9	3.1	5.2	15.8	2.9	3.1	3.4	20.0	3.4	3.0	14.2	3.0	4.9	3.7	19.4	9.9	8.3	12.6	10.6	12.7	14.4	13.2	26.7	11.3	13.4	14.9	11.1	3.1	12.1	35.9	8.6	13.3	8.6	26.3	9.3	24.0	7.1	19.1	12.7	9.1	8.8	16.9	23.8	2.9	17.4	25.5	13.7	18.0	10.6	14.4	11.0	18.3	5.0	25.7	5.4	10.1	14.0	5.9	6.5	7.1	13.5	23.1	17.2	8.2	7.6	29.4	16.3	5.6	18.2	32.4	17.2	4.6	9.9	20.7	20.3	15.0	8.6	18.1	9.5	33.0	17.1	4.8	9.9	31.8	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	15.4	16.1	21.4	23.8	16.7	18.0	17.6	16.7	19.3	15.8	20.0	19.4	14.3	12.8	1.5	12.4	9.1	75.1	17.1	13.7	10.8	16.4	10.6	10.3	12.7	12.8	5.2	11.0	20.9	29.3	14.4	5.7	3.9	5.2	10.3	11.8	15.6	11.4	3.6	11.8	26.8	7.4	36.6	11.9	6.1	12.0	10.8	4.2	7.9	25.6	13.5	30.3	31.4	8.1	10.2	8.1	29.4	4.3	2.8	12.0	16.0	10.3	6.3	7.6	7.2	18.6	28.0	10.5	3.1	4.1	14.6	18.8	5.8	7.8	4.6	15.2	0.0	7.7	9.8	16.8	24.8	12.7	39.5	65.1	12.9	10.4	8.7	16.2
SMIM18		ENSG00000253457	"Small integral membrane protein 18"	P0DKX4	8	30638580-30646064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;pituitary gland: 5.4;retina: 3.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.3;Excitatory neurons: 2.9;Horizontal cells: 5.0;Inhibitory neurons: 5.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 5.5;Proximal tubular cells: 4.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066648	Supported		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Centrosome	"HPA066648: AB_2685697"	"unprognostic (2.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.60e-1)"		"unprognostic (7.29e-2)"	"unprognostic (4.70e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-1)"	0.0	0.9	2.2	0.0	1.9	0.9	0.0	4.0	3.7	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	3.8	0.9	0.0	0.0	0.0	2.3	4.4	0.0	0.4	0.0	5.4	0.0	3.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	1.2	0.6	0.6	1.1	0.4	1.1	0.9	0.7	0.6	0.3	0.9	0.9	1.3	0.7	0.0	0.8	1.4	1.0	0.1	2.2	1.9	4.0	3.7	2.0	3.8	2.3	4.4	3.0	1.7	2.7	1.6	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.1	1.8	0.0	2.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.9	0.0	5.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0
SMIM2	"C13orf44, MGC5590"	ENSG00000139656	"Small integral membrane protein 2"	Q9BVW6	13	44143150-44161257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.4"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 53.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.5;OE19: 4.8"					"Low region specificity"	"Detected in single"			"HPA026891, HPA077071"	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA026891: AB_10602924, HPA077071: "	"unprognostic (4.34e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.87e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.05e-2)"	0.2	0.2	0.6	0.1	0.7	0.0	0.0	0.2	1.9	0.0	0.5	0.8	0.8	0.0	2.9	0.3	0.2	0.3	0.9	0.5	0.4	0.8	0.4	0.2	0.0	0.1	0.6	0.1	0.6	0.0	0.2	0.4	0.1	0.2	0.0	0.3	0.5	0.1	0.9	0.3	1.9	0.5	0.1	0.2	0.5	23.4	0.3	4.9	0.3	0.0	0.0	0.3	0.0	0.4	0.4	0.2	0.4	0.0	0.0	0.0	0.4	0.0	2.5	0.5	0.0	0.5	0.1	0.7	0.4	0.0	0.4	1.2	0.0	1.0	0.7	0.0	0.7	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.3	4.8	0.4	0.4	0.0	0.0	0.0	0.1	1.1	0.5	1.3	0.5	0.9	0.9	0.0	0.0	0.2	0.0	0.5	0.7	0.1	0.0	0.0	0.2	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	0.2	1.9	0.5	0.4	0.1	0.6	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0
SMIM20	"C4orf52, MITRAC7, PNX"	ENSG00000250317	"Small integral membrane protein 20"	Q8N5G0	4	25861830-25929874	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016552	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted to blood"	NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA016552: AB_1859536"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.86e-1)"	"prognostic favorable (8.97e-5)"	"unprognostic (5.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.12e-3)"	27.9	36.7	36.7	16.6	37.7	13.1	27.2	38.1	50.2	22.2	39.8	30.9	39.9	23.9	72.2	15.7	23.8	23.9	46.8	36.5	38.4	46.0	38.2	19.7	30.4	36.9	36.1	33.9	43.4	28.2	17.6	14.1	36.9	23.9	25.5	29.9	35.1	17.5	95.9	13.9	35.1	17.8	37.9	23.6	38.6	20.5	36.8	17.4	31.4	61.4	24.8	28.8	19.1	39.2	29.9	24.5	32.3	31.3	34.9	75.4	43.0	28.4	34.3	24.0	30.4	21.9	51.6	48.8	48.1	31.7	49.6	8.5	37.9	36.3	33.4	27.9	30.1	28.3	16.4	42.0	59.1	34.0	18.0	53.9	71.6	30.6	46.1	46.7	18.7	32.5	45.9	15.5	29.6	19.1	37.0	57.5	61.0	39.6	36.1	30.1	42.0	31.7	53.5	21.6	41.3	38.4	18.3	12.7	66.0	35.2	26.3	47.5	31.4	25.8	30.5	29.3	36.8	30.2	26.9	52.6	39.2	35.6	33.4	30.6	31.5	15.9	26.2	37.7	34.5	47.3	37.5	33.2	36.9	47.9	50.4	41.1	16.3	35.6	29.4	38.3	42.9	31.7	36.7	37.7	38.1	50.2	36.5	38.4	36.9	36.1	36.9	37.9	36.8	39.2	21.5	9.6	41.6	9.4	48.0	21.9	30.4	89.4	26.7	7.7	49.8	63.1	61.8	61.5	59.0	36.8	8.4	63.7	22.5	50.9	131.0	70.0	11.5	34.7	30.6	23.1	19.3	9.2	3.8	62.5	59.7	40.0	31.6	34.6	10.8	37.1	21.8	66.5	69.7	1.7	4.6	64.0	59.0	62.9	32.1	23.1	37.6	44.5	44.4	4.7	42.9	95.3	38.1	9.5	7.9	46.2	44.6	48.2	38.4	38.9	130.1	166.5	47.0	22.2	72.3	26.8	35.8	44.5	36.4	27.3	19.5	43.8	29.8	71.2	65.4	30.8
SMIM22	CASIMO1	ENSG00000267795	"Small integral membrane protein 22"	K7EJ46	16	4788397-4796491	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 193.6;pancreas: 154.3;salivary gland: 147.2;stomach 1: 201.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2005.0;Intestinal goblet cells: 1223.5;Paneth cells: 1462.9;Proximal enterocytes: 1685.8;Respiratory ciliated cells: 686.7;Undifferentiated cells: 775.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CAPAN-2: 261.7;OE19: 247.3;RT4: 89.8;SCLC-21H: 70.7;SK-BR-3: 201.2"	"Low region specificity"	"Detected in many"							HPA077331			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA077331: AB_2686834"	"unprognostic (6.55e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.69e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.73e-3)"	1.2	0.3	0.1	14.6	1.2	3.5	48.2	4.6	2.0	45.4	0.0	193.6	129.6	8.9	50.4	10.3	77.3	33.3	0.5	0.5	0.4	42.0	1.4	24.1	0.6	2.6	0.9	0.5	154.3	0.1	48.9	2.0	2.1	42.6	122.7	1.5	147.2	36.3	0.2	10.4	128.4	6.3	0.8	0.2	201.7	33.8	2.6	0.2	1.1	0.0	2.7	46.1	6.5	3.1	0.2	0.0	0.1	0.6	0.0	0.0	1.9	0.3	0.1	0.1	0.1	0.6	261.7	0.3	7.3	0.0	0.3	1.3	0.1	0.0	0.1	0.4	1.9	0.1	5.8	0.9	0.1	0.7	0.3	0.2	1.4	0.0	0.0	0.2	0.1	0.4	0.0	0.6	0.0	1.9	0.1	0.6	0.8	247.3	0.0	0.8	0.3	23.6	1.5	89.8	70.7	0.8	0.5	201.2	0.0	0.5	15.2	0.0	0.0	0.6	0.8	1.1	0.1	0.2	0.6	0.9	0.0	0.7	0.6	1.2	0.3	0.4	0.3	0.1	0.1	0.1	0.3	0.1	0.0	0.4	0.3	0.1	0.9	0.3	0.1	0.4	0.1	0.1	0.1	1.2	4.6	2.0	0.5	0.4	2.6	0.9	2.1	0.8	2.6	3.1	1.4	48.1	117.7	0.0	5.8	2.2	22.7	92.7	0.0	4.2	363.3	267.5	0.5	183.0	154.9	250.1	0.0	3.9	3.0	2005.0	25.4	259.8	40.1	430.4	26.5	4.4	470.3	0.0	0.5	381.9	0.4	4.7	438.8	258.3	18.4	0.1	0.4	0.2	0.4	1.7	0.3	1223.5	152.5	0.0	0.8	107.3	0.6	4.2	23.2	0.0	5.3	0.6	0.0	0.0	1.3	539.9	1462.9	1.2	1.0	29.5	1685.8	99.4	686.7	4.2	0.0	0.0	15.9	38.6	0.6	2.3	2.3	3.7	6.6	0.2	775.6	148.6
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480525	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"epididymis: 1580.8;intestine: 753.9;kidney: 844.8"	"Group enriched"	"Detected in many"	12	"Proximal enterocytes: 4096.4;Proximal tubular cells: 1884.8"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.7;pancreatic cancer: 37.4;renal cancer: 78.4;stomach cancer: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 154.9;HEL: 74.0;Hep G2: 117.7;MOLT-4: 113.8;OE19: 185.0;REH: 61.5;U-937: 87.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.0	4.2	2.7	5.0	91.3	0.8	4.1	6.8	0.6	5.5	30.4	753.9	0.7	1580.8	0.4	2.8	82.0	0.1	4.7	4.3	844.8	35.8	0.4	1.6	4.3	4.6	0.3	8.0	0.2	3.5	0.1	4.3	1.0	24.5	91.6	0.3	2.3	0.3	1.2	628.2	0.8	4.0	1.2	150.1	2.9	4.6	50.4	0.2	0.1	2.0	0.2	0.2	4.4	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.3	0.0	154.9	0.5	0.2	7.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.0	1.0	117.7	0.0	6.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	1.5	0.1	0.1	0.0	113.8	15.8	0.0	185.0	0.3	61.5	0.1	4.3	1.6	0.1	1.4	2.3	0.1	0.1	1.6	0.4	0.0	1.9	0.0	0.0	0.4	1.2	0.1	0.0	0.0	6.5	0.0	87.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.3	0.4	1.0	0.0	5.9	0.0	1.5	1.6	0.8	4.2	5.0	4.1	6.8	4.7	4.3	4.3	4.6	4.3	4.0	4.6	4.4	0.1	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	14.1	0.1	0.8	0.2	188.8	0.0	58.8	27.1	0.0	0.5	35.1	238.7	4.0	5.1	7.7	0.8	0.3	139.0	22.3	0.7	12.4	0.2	0.3	205.4	13.0	1.3	0.2	0.4	36.3	0.1	0.0	0.1	136.6	0.0	0.6	0.0	15.0	0.3	11.6	0.0	0.0	0.7	4.1	0.0	0.0	0.2	12.4	178.9	0.0	1.7	0.3	4096.4	1884.8	0.0	34.9	0.0	0.2	0.3	0.6	0.7	0.0	0.0	0.0	7.4	0.0	141.3	0.2
SMIM26	"LINC00493, LOC388789"	ENSG00000232388	"Small integral membrane protein 26"	A0A096LP01	20	18567347-18569563	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 252.6;Breast myoepithelial cells: 317.5;Distal tubular cells: 389.4;Proximal tubular cells: 588.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068733			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA068733: AB_2686024"	"unprognostic (1.20e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (7.84e-5)"	76.0	104.3	92.2	43.6	96.2	83.4	107.0	102.7	123.1	72.8	103.9	89.8	63.2	67.2	134.8	71.0	78.9	67.9	136.4	93.6	97.0	96.1	117.7	53.7	72.6	94.8	93.6	113.0	103.4	99.4	90.7	51.3	96.9	71.3	69.8	63.1	91.1	61.9	243.1	69.2	65.8	56.5	96.2	57.8	98.5	37.6	94.4	88.7	85.2	213.5	73.6	79.7	63.6	103.4	99.3	129.1	94.3	98.0	85.9	116.0	110.8	72.3	86.5	83.4	95.2	80.9	113.0	99.4	81.1	79.7	149.1	106.8	90.4	120.2	95.9	42.5	112.9	131.7	59.4	270.2	162.4	86.6	96.5	100.0	159.4	94.6	152.2	144.7	128.1	120.8	98.5	89.3	105.4	125.0	104.0	240.4	53.8	188.5	153.6	67.4	110.0	136.8	192.0	100.4	92.8	98.1	77.2	145.6	297.5	82.9	106.8	126.0	65.8	58.1	60.8	71.7	76.6	85.0	229.8	113.7	52.2	56.2	44.4	142.4	133.5	108.6	96.5	116.6	102.8	155.6	131.7	112.3	164.5	145.7	145.0	139.2	241.3	99.5	112.8	157.7	150.0	130.5	92.2	96.2	102.7	123.1	93.6	97.0	94.8	93.6	96.9	96.2	94.4	103.4	83.8	128.2	83.8	0.0	44.4	0.0	0.0	0.0	0.0	0.0	252.6	317.5	0.0	0.0	35.9	171.0	0.0	205.5	62.6	0.0	389.4	146.2	0.0	185.2	95.5	36.4	0.0	0.0	0.0	214.3	137.9	57.8	0.0	118.7	35.3	100.5	0.0	0.0	188.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.3	0.0	0.0	66.2	0.0	0.0	0.0	0.0	187.7	0.0	0.0	12.1	0.0	0.0	588.2	87.5	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	208.0	37.2	108.8	0.0	0.0
SMIM4	C3orf78	ENSG00000168273	"Small integral membrane protein 4"	Q8WVI0	3	52534013-52579237	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 121.9;skeletal muscle: 130.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 252.4;Distal tubular cells: 213.2;Proximal tubular cells: 215.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047771	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA047771: AB_2680150"	"unprognostic (3.76e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.89e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.25e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (6.35e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (8.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-2)"	22.6	121.9	14.6	12.9	15.3	7.4	22.1	21.8	20.5	16.0	20.5	19.1	12.3	14.3	10.4	16.3	14.5	3.7	100.3	15.3	15.5	37.3	20.2	20.3	10.5	15.6	18.2	41.5	25.7	31.6	56.4	6.1	16.9	26.2	10.4	13.9	28.9	13.6	130.3	20.1	15.0	5.0	15.0	15.8	20.4	17.3	15.4	6.6	48.6	50.2	8.7	20.2	13.3	18.0	58.7	19.0	22.9	58.5	26.5	13.7	47.0	25.9	12.0	29.2	25.3	24.6	15.4	25.1	11.6	10.9	29.4	30.2	7.6	20.9	11.8	16.9	60.1	23.6	58.2	50.2	40.1	28.4	31.6	29.6	12.7	24.6	17.7	15.8	26.8	27.0	31.9	36.4	19.9	25.4	26.4	39.4	39.1	31.9	42.4	18.1	22.2	50.1	17.0	25.2	24.9	31.4	50.6	16.5	52.6	12.9	17.0	23.6	24.0	16.0	53.1	76.4	53.5	42.3	50.6	57.3	87.9	52.2	22.5	8.1	44.1	17.3	19.1	35.8	18.8	24.6	27.3	23.9	49.7	22.7	29.1	27.0	1.6	22.5	15.2	26.5	29.6	20.0	14.6	15.3	21.8	20.5	15.3	15.5	15.6	18.2	16.9	15.0	15.4	18.0	35.4	48.1	46.3	1.3	30.3	27.1	37.3	52.2	41.5	17.6	80.9	84.1	252.4	60.1	63.1	53.3	12.5	42.9	26.6	58.3	213.2	52.9	21.9	71.9	30.6	32.8	79.3	22.1	1.9	86.1	24.7	36.0	34.1	48.9	59.5	16.9	55.6	160.4	116.4	3.3	2.1	62.9	30.5	80.8	46.7	15.1	65.0	51.1	37.4	0.0	28.5	102.8	15.5	2.5	3.2	57.8	39.9	101.2	19.7	19.7	89.5	215.6	52.1	15.3	46.0	22.8	56.8	9.8	14.2	34.8	34.5	27.6	25.8	44.3	73.5	23.6
SMIM6	"C17orf110, ELN"	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647975	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.1;kidney: 22.1;stomach 1: 33.1;testis: 26.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 565.7;Endometrial ciliated cells: 233.1;Enteroendocrine cells: 197.1;Late spermatids: 1243.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 34.2"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 11.7;CACO-2: 3.8;EFO-21: 8.7;HEL: 6.7;Hep G2: 3.6;OE19: 10.5;RPTEC TERT1: 4.2"									HPA065721	Uncertain		Approved	Nucleoplasm		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.64e-4)"	0.2	0.1	3.4	0.8	5.8	1.1	0.1	4.9	5.1	2.4	2.5	6.5	9.5	1.1	2.8	0.1	24.1	9.6	0.0	3.6	3.9	22.1	6.6	2.4	0.4	5.4	5.6	0.1	5.6	2.1	0.0	0.3	5.8	0.2	6.6	0.1	0.1	1.4	0.1	0.3	5.9	0.1	4.1	0.2	33.1	26.1	4.7	0.1	0.1	0.0	0.3	1.8	0.1	8.2	0.7	11.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	3.3	0.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	6.7	0.4	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.2	4.2	1.9	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	34.2	0.0	0.3	3.4	5.8	4.9	5.1	3.6	3.9	5.4	5.6	5.8	4.1	4.7	8.2	0.1	3.2	3.1	0.0	0.9	0.1	3.4	2.3	0.0	0.0	0.2	0.1	0.1	35.8	5.4	35.0	0.0	0.5	9.5	56.2	137.0	35.9	565.7	233.1	2.9	0.8	197.1	0.0	0.0	16.6	3.7	0.3	70.3	22.1	0.0	0.0	0.4	7.0	0.6	0.0	0.0	51.5	8.2	0.0	0.3	1243.9	6.5	1.4	0.0	0.0	1.6	0.0	0.0	0.0	4.5	55.8	129.5	1.9	0.5	2.6	32.7	24.5	38.4	0.0	6.6	0.2	0.4	5.2	2.6	0.0	0.0	4.1	0.9	0.0	4.4	9.6
SMNDC1	"SMNR, SPF30, TDRD16C"	ENSG00000119953	"Survival motor neuron domain containing 1"	O75940	10	110290730-110304938	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061214, HPA070666"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA061214: AB_2684451, HPA070666: "	"unprognostic (4.65e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.68e-3)"	"unprognostic (6.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-1)"	16.3	12.0	7.0	15.1	7.5	31.8	13.7	10.8	11.1	13.8	7.7	13.4	9.9	14.4	8.7	16.2	13.3	11.6	12.4	6.5	7.2	13.6	14.9	14.2	16.9	7.1	6.9	13.5	10.2	13.1	8.9	18.4	7.0	10.0	11.1	16.6	11.5	10.2	24.8	13.2	11.5	14.6	7.5	14.7	11.5	13.1	7.1	20.4	12.1	17.9	18.3	17.3	13.7	9.4	36.2	27.0	38.9	44.9	29.6	35.1	28.9	41.0	42.6	53.3	54.6	35.1	43.7	51.2	25.7	25.9	30.5	38.5	57.8	28.2	59.9	29.0	30.6	51.1	21.9	41.2	35.3	56.9	47.2	27.4	29.7	42.2	71.1	39.5	30.0	29.0	46.8	46.5	41.9	17.1	61.0	55.0	43.5	27.8	18.4	52.0	77.9	26.8	30.0	25.7	19.4	26.0	26.6	22.4	48.9	33.3	27.7	32.3	33.0	31.2	35.2	28.9	52.9	37.8	42.4	76.7	31.4	77.9	24.6	5.7	8.9	14.5	5.2	9.2	6.4	5.4	6.8	6.7	8.6	4.8	5.9	5.9	16.6	6.3	9.8	5.2	8.1	4.3	7.0	7.5	10.8	11.1	6.5	7.2	7.1	6.9	7.0	7.5	7.1	9.4	57.7	28.9	37.1	6.8	53.4	69.6	42.5	27.2	89.4	27.3	31.7	26.7	23.4	14.3	27.9	11.0	20.9	33.0	55.7	23.9	33.2	22.8	10.7	34.2	52.0	41.5	18.6	37.0	7.8	18.0	32.0	39.1	37.8	58.8	58.3	27.3	27.1	26.5	32.4	33.7	8.0	21.4	38.7	40.9	79.7	4.4	29.2	47.7	35.6	6.5	45.8	23.0	22.6	5.0	11.2	21.7	21.0	22.2	45.7	53.3	20.6	40.9	28.6	33.0	19.7	30.8	39.7	46.2	37.7	72.4	83.4	46.1	57.4	33.5	24.1	65.8
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 48.4;Erythroid cells: 89.7;Macrophages: 73.3;Pancreatic endocrine cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.0;myeloid DC: 2.4;neutrophil: 3.6;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;granulocytes: 3.6;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"A549: 119.6;Karpas-707: 201.7;RPTEC TERT1: 91.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA047117: AB_2679940, HPA060198: AB_2684220"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.33e-6)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	8.5	4.4	50.9	4.4	61.3	32.2	5.3	54.5	60.9	17.7	32.8	5.6	10.6	10.8	7.1	8.5	7.4	15.1	6.8	46.3	51.7	20.5	8.5	4.9	4.8	56.6	54.4	12.5	32.5	25.2	13.2	6.2	53.7	12.2	1.2	2.9	12.1	7.9	4.3	11.9	8.1	4.0	53.0	6.4	20.1	5.8	55.5	4.3	6.8	2.8	2.6	8.2	12.4	54.1	11.0	119.6	8.3	6.3	5.5	8.2	14.6	15.6	29.8	11.1	7.4	49.5	29.6	0.0	5.1	14.4	18.0	21.6	6.8	7.5	4.8	0.0	3.5	21.5	4.1	50.6	35.0	4.1	8.3	31.3	13.1	23.1	9.8	13.4	19.8	16.7	4.8	201.7	6.7	3.3	8.1	12.1	10.2	10.7	16.3	7.3	10.3	29.1	91.4	8.3	1.6	7.2	28.9	3.4	54.1	4.2	0.3	5.1	24.0	12.7	12.0	2.3	12.2	9.1	1.7	0.1	10.6	5.4	9.8	0.0	1.0	0.2	0.0	0.4	0.0	0.1	0.2	0.2	2.4	0.0	0.0	0.0	3.6	0.3	0.1	1.1	0.0	16.0	50.9	61.3	54.5	60.9	46.3	51.7	56.6	54.4	53.7	53.0	55.5	54.1	4.4	0.0	0.5	38.5	3.8	12.6	12.0	14.4	6.8	0.5	6.9	4.6	1.7	12.8	6.3	11.0	0.0	0.4	0.2	1.4	0.0	48.4	4.0	9.2	15.8	11.2	6.0	89.7	1.6	30.5	0.8	11.3	6.6	18.7	5.7	10.4	13.6	2.3	20.6	0.0	3.5	3.0	6.1	3.1	10.2	7.7	14.6	73.3	8.8	5.6	22.6	25.4	1.0	9.0	6.2	131.3	1.5	13.5	7.4	13.1	4.0	3.8	1.2	1.4	0.0	2.7	10.2	19.1	7.8	2.1	10.5	0.3	2.1	1.9	3.7	12.6
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 156.3;Distal enterocytes: 291.5;Paneth cells: 157.5;Proximal enterocytes: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"basophil: 80.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.2;hTCEpi: 36.9;OE19: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		26000000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	15.0	23.3	4.6	18.7	5.1	22.9	23.7	8.2	9.4	72.8	8.9	60.7	45.5	13.3	6.5	13.6	7.9	17.2	5.6	5.3	5.7	47.4	80.0	14.1	21.4	5.9	5.4	9.1	20.8	32.4	7.5	44.0	5.9	21.8	65.7	6.0	13.7	16.6	39.8	64.5	77.3	8.5	5.7	27.0	30.5	2.9	5.4	5.1	9.1	55.8	16.2	35.5	30.9	7.7	0.3	2.6	6.1	2.8	44.2	19.9	19.5	10.4	27.8	3.1	6.6	3.3	2.7	0.0	1.4	6.6	8.2	4.9	1.7	5.3	2.6	0.0	5.4	2.5	9.8	9.0	28.3	0.0	0.1	24.4	36.9	3.0	5.3	12.0	5.5	0.0	3.8	0.0	12.7	9.3	0.0	0.2	1.1	58.8	8.0	0.0	10.8	0.4	15.1	4.2	4.4	0.1	1.5	18.5	27.9	3.9	3.1	1.4	11.0	5.9	3.5	0.6	6.8	0.0	0.0	0.0	8.7	4.9	13.7	80.9	4.0	1.1	0.0	4.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	7.5	0.0	0.0	1.4	4.6	5.1	8.2	9.4	5.3	5.7	5.9	5.4	5.9	5.7	5.4	7.7	11.8	3.2	17.8	5.2	2.4	53.7	24.5	13.7	15.9	3.0	12.2	6.6	4.0	25.8	9.7	5.5	4.2	156.3	0.4	291.5	56.7	24.6	0.2	4.2	12.6	7.1	48.7	5.7	7.4	25.7	40.4	46.3	34.7	5.2	10.1	0.8	18.9	77.8	62.7	3.3	10.5	61.7	59.0	126.3	10.0	1.2	15.5	33.4	35.6	11.2	9.9	11.5	2.1	11.1	11.0	19.5	157.5	14.3	0.9	16.7	383.1	129.3	7.5	6.2	13.1	12.8	9.9	1.1	3.7	15.5	76.0	115.1	2.0	11.4	38.9	16.6
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 887.2;urinary bladder: 450.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 283.5;Hepatic stellate cells: 121.3;Sertoli cells: 184.1;Smooth muscle cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"		No	Yes		140000	"Cluster 30: Non-specific - Translation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Actin filaments"	"CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765"	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	54.7	19.2	10.8	25.3	12.5	4.7	42.2	10.3	13.1	100.2	7.6	887.2	30.0	251.0	7.0	65.1	132.4	20.8	152.0	9.0	9.3	35.6	15.3	38.2	5.6	11.7	12.5	34.0	25.2	3.3	9.8	17.4	11.0	150.9	29.2	15.2	16.3	177.9	95.7	38.7	151.5	127.2	10.5	54.5	231.2	12.5	12.4	2.9	26.4	26.2	2.5	450.6	91.5	10.0	73.0	21.2	7.2	27.0	11.0	17.2	58.0	106.8	49.1	85.7	58.4	29.9	22.4	32.1	9.3	59.3	17.3	10.6	7.2	62.8	40.4	10.6	58.2	33.9	18.3	36.1	9.7	51.5	57.4	14.2	5.8	114.0	18.7	29.2	74.7	12.3	37.3	25.9	59.6	64.5	5.9	11.4	8.2	36.1	90.0	20.3	20.5	34.6	34.5	23.2	11.5	12.7	33.4	15.9	15.7	7.4	18.8	8.2	118.7	62.1	58.4	59.4	79.8	24.6	32.5	18.8	91.0	19.7	200.5	0.0	1.0	0.0	0.1	0.2	0.0	1.3	0.1	0.3	0.4	0.0	1.0	0.5	0.1	0.1	0.2	0.2	0.0	0.6	10.8	12.5	10.3	13.1	9.0	9.3	11.7	12.5	11.0	10.5	12.4	10.0	94.5	6.4	3.3	23.8	2.0	65.1	33.5	16.1	19.4	46.6	18.6	26.7	39.5	5.7	6.1	9.2	283.5	13.4	2.7	12.8	9.8	14.8	1.2	4.0	52.1	62.8	29.2	0.0	0.2	20.1	68.8	35.9	18.3	7.3	0.0	11.0	121.3	2.6	6.0	5.0	1.9	29.9	14.2	6.8	14.6	1.9	22.4	4.7	14.2	7.5	1.0	31.2	1.0	4.5	2.0	73.2	11.4	48.5	2.1	21.7	5.6	18.4	2.2	54.0	184.1	18.4	116.4	5.7	7.9	9.7	69.3	21.9	3.7	16.3	27.0	14.9
SMTNL2	FLJ42461	ENSG00000188176	"Smoothelin like 2"	Q2TAL5	17	4583999-4608319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 500.8;tongue: 136.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.7;Collecting duct cells: 9.2;Distal tubular cells: 33.2;Proximal tubular cells: 35.4;Sertoli cells: 26.3;Skeletal myocytes: 8.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"CACO-2: 49.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA025706			Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Nuclear speckles"		"HPA025706: AB_1848935"	"unprognostic (8.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.73e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.89e-2)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.22e-1)"	8.3	0.1	0.9	1.5	1.1	0.0	2.5	0.8	1.6	3.4	1.0	1.2	0.2	3.9	2.3	8.0	7.2	2.1	18.2	2.5	0.7	31.8	0.2	4.7	0.2	0.9	1.0	6.7	0.6	1.1	2.3	4.9	1.0	5.0	0.5	0.1	6.1	0.9	500.8	1.5	1.2	2.5	0.7	0.8	1.0	1.3	1.0	0.2	1.4	136.2	0.1	4.5	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	49.5	0.0	0.0	0.4	0.0	0.8	0.0	2.7	0.0	0.6	0.0	2.9	0.0	0.0	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	1.3	3.2	0.0	0.0	0.0	0.1	5.4	0.0	11.4	0.0	0.0	0.0	0.0	10.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.8	1.6	2.5	0.7	0.9	1.0	1.0	0.7	1.0	0.8	0.3	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	8.7	0.0	0.6	9.2	0.0	0.8	0.0	0.0	33.2	0.1	0.1	1.8	1.3	1.3	0.0	0.0	0.1	0.0	1.5	6.1	0.0	2.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.6	0.3	1.8	1.9	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	35.4	0.0	0.0	26.3	8.2	7.6	0.0	0.5	0.1	0.0	0.5	0.3	0.1	0.2	0.3
SMUG1	"FDG, HMUDG, UNG3"	ENSG00000123415	"Single-strand-selective monofunctional uracil-DNA glycosylase 1"	Q53HV7	12	54121277-54189008	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 98.9;Syncytiotrophoblasts: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026804, HPA065892"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA026804: , HPA065892: "	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.58e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.73e-1)"	20.5	29.2	21.9	13.9	22.4	10.7	26.3	20.7	24.2	17.3	22.6	20.8	17.1	17.1	39.9	38.6	24.5	16.9	19.4	22.3	21.1	28.9	49.6	14.7	18.9	23.7	21.4	18.8	30.0	23.9	16.9	19.1	22.1	24.0	18.7	14.3	29.7	18.1	27.4	29.4	21.3	16.3	22.1	21.8	32.2	15.9	22.7	17.8	21.9	21.8	18.6	20.3	20.1	24.8	31.9	57.5	22.2	23.2	40.4	31.3	37.7	24.2	31.4	37.2	33.8	58.0	69.5	19.0	60.4	35.1	34.8	40.3	15.7	63.7	23.5	19.7	33.3	28.6	47.4	42.3	48.2	19.3	34.0	35.7	97.7	43.9	43.2	40.4	30.2	33.3	48.2	40.3	41.4	60.8	24.3	37.2	27.7	54.3	51.7	17.5	22.6	34.3	46.6	46.2	33.1	39.2	27.6	47.3	43.5	44.9	73.7	35.9	14.3	24.7	27.5	22.5	28.1	37.3	32.1	13.1	35.8	15.0	38.4	89.6	46.2	57.1	28.5	39.5	28.4	49.7	27.3	30.7	40.3	36.6	24.6	24.6	45.5	27.1	31.5	45.5	41.0	33.9	21.9	22.4	20.7	24.2	22.3	21.1	23.7	21.4	22.1	22.1	22.7	24.8	6.6	6.4	16.0	2.9	13.3	7.5	14.4	40.2	11.4	10.5	25.5	22.5	17.7	22.8	26.4	25.8	8.4	87.5	8.8	28.4	60.7	37.1	5.2	15.3	8.9	11.0	11.5	7.4	6.8	40.2	98.9	13.6	16.3	11.0	2.5	10.1	18.2	49.4	46.1	6.7	6.1	25.8	32.6	19.2	5.8	11.8	18.6	14.0	5.4	3.7	34.0	16.3	19.6	5.0	8.1	41.4	24.6	17.7	12.6	20.7	58.4	56.6	27.1	11.9	32.9	8.5	13.8	26.2	28.0	20.8	10.4	100.0	9.5	19.4	23.7	19.6
SMURF1	KIAA1625	ENSG00000198742	"SMAD specific E3 ubiquitin protein ligase 1"	Q9HCE7	7	99027440-99144108	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 100.2;Microglial cells: 89.9;Oligodendrocytes: 211.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 9.2;BJ: 15.2;EFO-21: 12.8;HDLM-2: 8.1;PC-3: 18.2;U-2 OS: 8.3;U-251 MG: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019671, HPA055245"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"HPA019671: , HPA055245: AB_2682757"	"unprognostic (2.21e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.62e-2)"	17.7	13.9	0.7	0.3	0.8	1.1	14.3	0.5	0.9	13.4	1.1	12.7	0.0	12.3	0.0	22.0	12.2	0.0	9.0	0.8	0.3	11.6	11.7	18.5	0.0	1.1	0.7	20.6	15.5	0.0	11.2	0.0	1.0	13.3	0.0	0.7	15.0	0.0	12.7	20.2	11.7	0.0	0.1	10.0	16.1	20.9	0.8	0.0	8.5	0.0	0.0	12.4	15.5	1.8	9.2	0.0	0.1	0.2	0.0	0.0	1.3	15.2	0.1	0.4	0.0	0.0	0.4	1.6	12.8	0.0	0.3	4.5	0.0	0.1	0.0	8.1	2.3	0.0	0.7	0.7	0.1	0.1	3.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.1	0.8	0.1	1.3	1.9	2.8	0.0	18.2	2.5	1.2	0.0	0.0	0.4	0.3	1.5	0.7	0.5	0.9	0.3	0.3	0.0	1.4	0.0	8.3	1.3	9.4	2.0	4.9	1.3	0.6	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.5	0.9	0.8	0.3	1.1	0.7	1.0	0.1	0.8	1.8	9.7	19.2	27.5	59.4	8.9	25.9	25.5	10.0	25.0	28.2	10.3	7.2	4.4	20.0	18.5	12.9	8.4	7.7	4.6	17.1	1.9	14.7	6.2	13.3	8.8	12.8	11.4	0.4	100.2	16.0	10.3	10.8	46.9	23.3	2.5	6.8	9.7	9.3	6.6	26.9	77.0	11.0	4.1	4.1	10.9	8.5	6.2	8.8	8.8	89.9	5.5	3.3	5.2	70.4	211.9	34.8	14.9	13.9	5.4	37.9	7.1	5.5	22.1	7.6	6.6	10.4	15.1	32.8	2.4	19.3	22.0	21.1	8.8	6.5	8.1	77.5
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 406.1;Excitatory neurons: 725.6;Inhibitory neurons: 788.3;Microglial cells: 277.3;Oligodendrocyte precursor cells: 372.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 402.2;K-562: 162.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	7.9	12.1	9.5	5.0	9.6	9.7	11.1	16.4	9.6	9.1	5.8	7.5	5.0	7.1	22.1	6.4	10.3	8.2	6.7	10.4	10.2	9.4	6.0	9.8	7.7	7.0	10.3	8.2	7.8	9.5	9.2	5.3	9.8	6.8	8.8	7.0	6.6	5.4	11.6	8.0	6.0	6.7	4.4	5.7	7.3	8.7	11.6	10.8	16.0	9.8	7.7	10.1	5.9	6.8	20.8	12.6	17.8	15.4	19.9	27.1	17.3	28.7	21.4	33.4	74.4	16.2	23.7	33.5	22.6	27.0	20.8	13.2	16.3	32.1	111.3	17.7	16.4	20.0	17.9	19.5	37.3	20.1	402.2	73.5	7.6	44.3	28.5	25.3	23.1	23.5	162.0	11.5	33.0	7.0	38.8	38.8	15.9	29.1	19.5	35.5	21.3	48.9	24.5	29.3	41.9	19.8	13.5	2.0	26.4	19.3	16.5	33.8	17.6	15.9	11.0	11.4	34.8	57.0	16.7	17.3	30.5	27.3	18.8	13.1	4.6	11.5	12.9	4.1	13.7	14.2	13.7	16.4	8.0	15.8	15.1	16.1	3.2	27.5	4.6	5.0	16.2	12.1	9.5	9.6	16.4	9.6	10.4	10.2	7.0	10.3	9.8	4.4	11.6	6.8	14.2	6.4	30.7	406.1	16.2	12.2	14.7	26.5	13.1	7.7	8.7	9.3	9.1	4.3	18.9	12.9	22.9	8.1	15.8	5.1	15.6	22.3	54.8	24.9	14.3	12.7	25.1	6.3	725.6	31.1	42.6	15.9	9.2	13.6	110.9	25.7	12.5	4.9	12.3	10.1	788.3	7.9	26.4	4.1	10.2	110.9	11.1	6.0	12.4	277.3	3.7	7.6	16.5	372.4	136.5	24.0	3.7	17.3	19.9	4.8	4.0	19.3	36.9	13.2	0.0	12.1	20.7	19.6	27.5	12.0	11.5	7.3	18.3	46.3	8.8	10.0
SMYD4	"KIAA1936, ZMYND21"	ENSG00000186532	"SET and MYND domain containing 4"	Q8IYR2	17	1779485-1830634	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030059	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA030059: AB_2191728"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	7.4	6.6	4.1	6.0	3.6	3.4	7.3	8.0	4.5	7.9	3.7	7.5	7.0	6.5	5.0	3.9	7.3	3.6	7.0	3.5	3.5	3.7	4.9	5.6	6.8	3.7	3.2	9.5	6.7	3.6	6.6	4.7	4.0	6.5	4.8	7.6	7.3	5.6	13.7	6.6	7.4	5.9	2.2	6.3	4.9	5.8	4.3	6.2	5.7	10.2	6.5	7.2	6.2	5.6	7.4	13.7	13.5	9.6	9.0	6.1	15.7	11.9	6.7	12.3	12.5	22.0	6.2	19.7	7.8	4.8	8.3	14.2	12.9	7.7	15.3	5.7	13.1	7.2	15.9	6.0	4.5	7.4	6.8	4.4	6.8	12.7	11.1	6.3	6.2	16.6	7.6	7.5	9.7	4.6	13.6	5.3	6.2	8.7	6.6	16.7	6.9	5.0	4.9	8.8	5.5	7.6	11.0	4.5	11.1	10.9	6.7	4.5	5.9	12.0	6.1	10.0	10.4	5.2	7.5	7.1	6.8	6.4	11.9	12.0	2.4	2.3	5.1	3.0	4.3	4.0	3.0	3.3	1.5	2.7	3.4	5.0	1.3	3.1	2.4	4.5	3.5	2.1	4.1	3.6	8.0	4.5	3.5	3.5	3.7	3.2	4.0	2.2	4.3	5.6	22.9	6.4	27.8	6.5	12.9	5.0	9.3	11.9	14.8	19.3	6.9	8.4	6.3	14.3	14.0	7.3	33.3	9.7	16.5	6.9	1.9	5.7	20.2	3.7	8.9	10.9	3.6	9.7	11.7	3.3	10.9	14.2	4.1	3.5	7.6	14.7	17.2	6.7	12.9	26.9	12.1	5.2	12.2	23.3	9.2	5.9	27.1	17.4	5.4	13.1	16.4	7.9	43.3	4.5	7.1	4.2	2.0	24.8	10.1	7.2	23.3	2.9	17.8	19.9	46.0	43.6	23.9	12.6	14.8	5.1	6.7	8.1	12.1	6.1	6.4	3.5
SNAI1	"SLUGH2, SNA, SNAH, SNAIL, SNAIL1"	ENSG00000124216	"Snail family transcriptional repressor 1"	O95863	20	49982980-49988886	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 30.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 191.3;Endothelial cells: 54.4;Extravillous trophoblasts: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 28.1;TIME: 39.3;WM-115: 25.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"spinal cord: 7.0"	"CAB005883, HPA056831, HPA069985, CAB078687"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB005883: AB_443967, CAB078687: AB_2665847, HPA056831: AB_2732606, HPA069985: AB_2732146"	"unprognostic (4.60e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (3.34e-3)"	"unprognostic (9.85e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.63e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (8.82e-7)"	"unprognostic (1.88e-2)"	30.3	12.0	2.5	4.4	2.3	4.5	16.8	2.7	2.8	6.1	2.7	5.1	1.0	7.0	0.7	2.7	9.6	16.5	16.0	2.2	3.8	8.3	5.2	16.7	2.1	4.5	2.7	2.4	5.1	1.3	6.5	7.2	2.6	4.1	0.8	0.3	3.9	2.4	2.3	4.6	3.3	3.1	2.4	9.7	5.9	3.9	4.2	0.8	15.4	1.3	0.7	9.4	4.6	3.0	1.2	0.9	5.4	0.7	1.6	1.0	10.9	4.7	5.8	0.9	0.6	8.9	1.4	0.7	12.6	8.4	5.6	0.1	1.6	0.0	0.5	0.1	1.1	0.6	2.0	5.4	13.6	1.5	4.3	3.1	0.3	2.0	0.0	14.3	14.0	0.7	7.0	0.2	0.0	2.0	0.1	1.6	7.2	0.8	3.8	2.5	1.4	0.8	6.4	0.0	2.3	5.6	28.1	7.1	1.2	4.6	1.4	6.5	39.3	0.0	6.8	0.0	0.1	0.2	0.1	7.5	2.3	2.1	25.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.5	2.3	2.7	2.8	2.2	3.8	4.5	2.7	2.6	2.4	4.2	3.0	191.3	0.0	5.3	0.3	11.8	5.2	2.4	0.5	5.2	0.6	18.6	37.0	4.5	2.8	3.8	0.0	0.0	8.3	29.7	2.8	0.0	1.5	3.0	5.8	18.6	54.4	1.8	0.0	0.6	0.2	79.9	31.7	5.6	8.7	1.3	1.0	17.5	0.3	8.0	3.3	0.4	4.5	2.0	6.4	40.3	0.8	5.6	35.6	5.4	0.0	1.0	0.8	0.0	0.0	0.7	4.7	1.6	14.3	2.2	1.6	1.4	0.2	1.0	0.4	6.6	7.6	17.5	1.4	3.8	7.2	4.8	14.0	12.2	7.2	3.0	0.6
SNAI2	"SLUG, SLUGH, SLUGH1, SNAIL2"	ENSG00000019549	"Snail family transcriptional repressor 2"	O43623	8	48917598-48921740	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Deafness, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 162.8;Basal prostatic cells: 119.4;Basal respiratory cells: 98.9;Endometrial stromal cells: 129.2;Melanocytes: 87.2;Suprabasal keratinocytes: 147.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 243.2;ASC TERT1: 247.8;HSkMC: 181.3;hTERT-HME1: 180.3;LHCN-M2: 228.8;U-138 MG: 206.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB011671	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB011671: AB_777968"	"unprognostic (3.52e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.83e-4)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (4.69e-8)"	"unprognostic (1.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.16e-4)"	28.2	10.6	0.5	15.7	0.8	0.4	22.9	3.6	1.4	51.1	1.7	11.6	4.3	43.0	11.3	15.8	34.4	21.8	15.0	0.8	0.5	12.4	9.6	11.1	8.1	0.8	0.5	40.8	8.0	3.6	2.3	16.2	0.6	19.8	7.6	0.1	16.8	23.2	4.6	39.8	11.5	27.5	0.4	14.2	9.4	3.7	0.6	6.9	9.5	7.7	7.9	37.8	51.3	0.5	17.7	0.6	38.5	0.4	243.2	247.8	0.1	38.6	69.0	38.1	52.3	0.0	17.4	0.0	0.0	50.1	56.7	28.9	0.4	111.8	40.2	0.0	0.8	0.0	7.2	0.1	88.5	0.1	0.1	181.3	116.8	31.9	180.3	5.4	1.3	0.0	0.0	18.5	228.8	0.3	0.0	0.1	2.3	0.0	34.7	0.0	122.2	0.2	0.1	6.8	5.1	3.8	3.3	0.1	69.2	18.9	0.2	0.2	10.6	206.6	7.4	36.6	20.9	0.0	0.1	4.2	74.9	0.0	78.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	3.6	1.4	0.8	0.5	0.8	0.5	0.6	0.4	0.6	0.5	11.7	0.0	0.0	0.0	0.1	162.8	119.4	98.9	60.9	1.9	2.1	22.0	1.2	1.5	14.0	0.0	0.0	1.7	0.3	0.0	0.0	3.0	0.6	5.2	129.2	19.5	0.0	0.0	0.6	2.3	0.5	69.9	0.0	4.8	0.0	0.0	40.0	6.8	1.7	0.0	0.5	0.0	10.2	0.8	30.7	1.7	73.7	1.9	87.2	0.0	0.0	0.0	0.0	1.0	0.0	6.1	0.0	67.4	1.4	18.4	0.0	0.0	2.4	0.2	52.6	24.7	59.2	0.2	0.4	32.3	147.9	2.2	2.3	21.8	0.0	25.0
SNAI3	"SMUC, Zfp293, ZNF293"	ENSG00000185669	"Snail family transcriptional repressor 3"	Q3KNW1	16	88677688-88686507	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 31.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 19.7;granulocytes: 9.5;Kupffer cells: 14.6;Langerhans cells: 9.3;Macrophages: 9.4;NK-cells: 17.5;Plasma cells: 14.0;T-cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"NB-4: 18.2;RPMI-8226: 28.6"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Not detected"	"Not detected"			HPA071127			Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA071127: AB_2686346"	"unprognostic (1.03e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.19e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.09e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.47e-2)"	0.7	0.5	1.5	2.4	2.4	1.8	0.4	0.0	3.3	0.6	0.0	1.2	1.5	0.6	0.3	0.6	0.8	1.0	2.4	1.9	0.0	0.7	0.8	2.2	3.9	2.1	0.0	0.5	1.7	1.5	0.7	0.1	3.7	0.8	0.3	0.3	1.2	0.2	31.3	0.6	3.7	0.2	0.0	6.9	3.3	0.9	0.0	0.8	0.9	7.3	2.6	1.4	0.5	0.0	0.3	0.9	0.3	1.3	0.0	0.0	0.6	0.3	0.0	0.0	0.1	3.5	0.3	2.3	0.5	0.0	0.8	0.8	0.3	0.2	0.0	0.4	1.2	1.1	0.1	1.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	1.5	2.1	4.3	0.0	3.2	0.2	18.2	0.4	0.3	0.4	3.9	0.3	28.6	0.0	0.4	1.7	0.2	0.7	0.0	0.2	0.4	1.2	2.2	0.3	0.1	1.0	0.2	0.0	0.7	4.2	4.0	0.3	4.9	0.5	5.2	14.1	48.5	10.2	5.3	18.8	7.8	16.7	9.8	16.7	6.1	10.0	6.4	30.9	1.1	1.5	11.9	21.4	10.9	1.5	2.4	0.0	3.3	1.9	0.0	2.1	0.0	3.7	0.0	0.0	0.0	0.3	3.2	0.0	2.0	8.5	0.5	0.1	0.4	0.0	0.2	0.4	0.5	2.0	0.0	0.7	0.0	0.0	0.0	19.7	0.0	1.9	0.1	0.0	0.6	0.0	0.4	0.0	0.4	6.4	0.4	0.5	0.2	0.5	0.1	9.5	0.0	0.4	0.1	6.9	0.0	3.7	0.1	2.0	14.6	9.3	0.3	0.0	9.4	5.4	0.0	5.3	0.1	17.5	1.0	1.9	0.1	1.1	0.4	14.0	0.1	0.0	0.2	1.0	0.9	0.0	0.7	0.4	0.0	1.5	0.2	0.3	0.1	14.0	0.0	0.3	0.1
SNAP29	"CEDNIK, SNAP-29"	ENSG00000099940	"Synaptosome associated protein 29"	O95721	22	20859007-20891214	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		"Ichthyosis, Neuropathy, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 524.1;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 220.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031823, CAB037092, HPA056492"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: AB_2683151"	"unprognostic (1.76e-1)"	"prognostic favorable (6.99e-4)"	"unprognostic (3.72e-3)"	"unprognostic (3.26e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.51e-3)"	"unprognostic (6.08e-2)"	18.3	18.0	10.8	17.1	11.5	18.9	15.9	12.8	18.0	15.3	11.7	19.9	17.4	14.5	11.1	23.1	12.8	13.7	18.9	12.0	11.4	16.8	35.8	13.9	17.0	12.6	11.7	13.6	17.3	18.7	11.0	19.1	12.4	13.5	17.8	14.4	15.8	14.1	31.2	19.0	16.6	18.1	11.2	16.8	18.6	56.5	11.0	24.1	12.3	27.4	19.7	15.6	15.7	12.5	48.4	19.4	27.1	22.3	30.0	43.5	35.0	44.8	40.3	49.5	49.5	26.8	16.7	30.1	27.9	42.2	50.0	27.8	35.8	30.4	53.2	43.5	27.3	50.0	20.9	29.2	42.7	44.6	38.8	34.6	42.2	51.9	37.2	34.0	35.1	25.5	220.8	41.5	46.2	33.1	40.7	42.9	8.9	55.9	20.2	38.9	60.6	12.1	29.1	25.5	22.0	26.2	48.0	29.9	51.0	33.3	46.8	35.3	30.7	50.1	45.5	34.6	35.6	42.4	74.0	55.3	37.5	29.8	36.7	49.0	43.7	52.4	21.7	61.5	22.7	23.7	21.2	23.7	38.0	22.6	19.3	19.8	49.0	60.0	77.9	43.6	34.5	34.6	10.8	11.5	12.8	18.0	12.0	11.4	12.6	11.7	12.4	11.2	11.0	12.5	24.4	12.8	29.0	8.8	19.0	16.7	24.5	34.7	17.6	12.4	26.4	22.5	22.5	21.5	22.9	23.9	12.5	80.1	35.9	40.0	43.0	40.3	524.1	26.3	28.2	30.1	22.1	36.4	9.6	50.0	146.0	28.4	26.5	22.3	29.2	25.0	29.6	46.5	74.4	20.2	7.2	27.6	32.6	49.4	23.1	191.7	33.2	46.7	35.6	2.8	51.4	30.6	48.4	10.6	12.1	59.4	21.4	36.5	44.1	26.7	38.8	36.8	37.4	13.2	39.5	21.9	27.9	113.5	81.1	28.2	15.5	98.2	26.5	70.3	25.3	29.7
SNAPC1	"PTFgamma, SNAP43"	ENSG00000023608	"Small nuclear RNA activating complex polypeptide 1"	Q16533	14	61762420-61796428	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 171.9;Spermatocytes: 215.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 153.7;hTERT-HME1: 153.7;U-2 OS: 207.6;U-251 MG: 146.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067076, HPA072276"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli	Nucleoplasm	"HPA067076: AB_2732757, HPA072276: AB_2732199"	"unprognostic (7.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.26e-1)"	6.2	9.0	2.7	6.4	3.6	6.0	5.9	4.9	3.4	10.1	4.1	3.5	3.6	7.0	4.9	6.0	6.4	7.7	8.3	2.7	2.9	7.0	5.2	4.8	8.1	4.3	5.7	6.1	3.6	7.9	5.8	8.7	4.5	6.8	3.0	6.6	5.2	6.9	4.4	5.2	3.2	4.8	3.0	6.8	3.2	20.0	3.0	7.1	7.2	4.7	6.9	10.0	5.2	4.6	57.6	11.0	10.7	22.8	11.7	13.6	12.7	47.4	31.4	53.3	31.4	3.9	11.5	11.9	61.5	20.3	153.7	17.7	10.6	14.3	87.3	13.0	7.6	7.1	5.7	8.1	30.8	7.5	15.2	13.1	9.5	45.0	153.7	20.7	20.7	16.2	8.0	10.6	51.4	7.4	18.3	12.0	10.3	6.4	35.9	13.9	28.3	4.4	43.9	8.8	7.6	18.3	31.3	5.5	39.0	13.2	11.0	11.7	31.8	58.4	207.6	38.2	146.6	7.0	7.8	10.5	39.7	9.5	35.3	7.7	5.0	4.5	4.4	4.3	5.7	8.4	5.4	3.8	5.2	8.8	8.8	5.7	4.9	7.0	3.8	6.9	6.5	3.6	2.7	3.6	4.9	3.4	2.7	2.9	4.3	5.7	4.5	3.0	3.0	4.6	22.6	35.3	18.3	10.1	28.0	95.3	56.2	171.9	43.3	10.2	11.5	18.0	24.6	11.5	53.6	29.5	2.1	16.8	31.2	3.4	7.9	28.6	70.7	70.1	28.7	29.3	4.2	10.7	12.8	15.9	31.5	31.1	4.1	47.6	41.8	20.2	26.7	6.9	17.3	8.4	13.3	4.0	42.7	11.7	32.6	17.1	22.1	31.6	17.8	10.3	12.4	40.4	4.1	10.6	14.6	20.3	1.9	20.3	7.9	28.8	5.6	13.3	83.9	12.6	19.7	38.3	34.7	215.0	67.7	23.5	64.5	5.6	29.0	20.6	6.8	20.8
SNAPC2	"PTFdelta, SNAP45"	ENSG00000104976	"Small nuclear RNA activating complex polypeptide 2"	Q13487	19	7920338-7923250	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049843, HPA077597"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049843: AB_2680910, HPA077597: AB_2732354"	"unprognostic (4.56e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.78e-2)"	21.2	21.6	15.4	10.4	17.7	16.7	19.6	14.7	21.4	37.1	11.0	36.1	9.7	50.7	5.7	14.3	35.0	8.3	16.6	17.1	16.0	17.2	11.9	17.1	9.1	15.6	15.2	20.7	17.8	10.1	25.5	6.5	16.4	27.0	3.8	1.8	16.6	17.2	9.0	20.5	15.2	12.4	13.8	21.4	18.7	32.6	16.3	7.6	13.1	9.7	4.9	31.7	25.1	15.3	20.6	22.9	10.8	42.0	14.7	31.1	10.0	21.4	22.6	20.5	18.5	10.6	17.4	17.6	25.8	25.0	16.4	24.7	7.7	15.9	5.9	22.7	19.7	24.5	9.6	15.4	26.6	15.4	38.7	25.5	24.0	24.3	14.9	16.6	23.5	18.1	24.5	28.3	12.7	18.1	19.9	43.6	13.9	10.4	51.8	23.4	10.7	17.6	19.1	7.1	12.7	28.7	11.0	11.8	48.6	4.8	19.2	16.6	30.9	68.8	24.5	65.2	26.8	27.4	48.1	10.8	43.1	31.6	22.2	7.0	23.8	23.5	19.0	30.8	19.2	15.7	16.1	16.5	30.1	14.5	16.6	16.9	3.5	27.7	33.4	19.9	24.0	16.4	15.4	17.7	14.7	21.4	17.1	16.0	15.6	15.2	16.4	13.8	16.3	15.3	19.8	3.2	3.7	3.3	15.4	24.3	20.0	25.1	35.9	8.6	25.8	26.2	3.2	7.2	10.7	11.0	0.0	12.2	22.9	9.8	17.6	21.2	1.9	10.7	25.0	20.7	12.0	20.2	4.1	24.5	24.2	18.5	8.6	15.0	18.4	15.4	12.5	5.2	28.6	23.5	2.6	11.9	14.2	19.6	28.0	6.0	13.7	19.2	19.6	1.0	31.3	6.0	13.4	2.0	3.0	28.9	6.6	14.3	8.4	28.5	16.7	16.1	3.0	6.1	13.1	7.3	30.1	9.5	38.6	19.0	24.3	9.9	18.4	29.2	15.5	24.1
SNAPC3	"MGC132011, MGC33124, PTFbeta, SNAP50"	ENSG00000164975	"Small nuclear RNA activating complex polypeptide 3"	Q92966	9	15422704-15465953	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 121.7;Late spermatids: 270.7;Spermatocytes: 113.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053145, HPA066031"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA053145: AB_2682055, HPA066031: AB_2685600"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.93e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.09e-2)"	4.1	6.6	5.5	4.0	5.2	1.7	3.8	10.4	7.6	6.5	4.9	5.8	4.2	5.9	5.4	5.5	5.1	3.8	7.0	7.7	5.5	4.6	3.4	4.3	4.4	5.4	5.5	7.1	4.3	4.9	5.1	6.2	6.2	4.8	5.1	11.3	4.5	3.7	7.9	5.0	5.3	4.5	4.5	4.9	4.8	5.5	6.4	3.5	4.4	6.2	3.9	5.1	5.9	8.0	4.7	5.9	12.3	4.7	9.6	10.0	7.2	7.2	3.1	4.2	4.9	2.8	2.0	3.3	2.7	4.6	5.9	2.8	6.6	3.4	5.1	15.5	7.7	11.9	13.4	4.0	4.8	2.7	8.9	6.5	6.6	2.9	3.3	17.7	7.8	7.7	3.4	5.3	9.7	1.4	3.2	8.5	3.9	3.5	15.4	6.6	1.5	1.8	7.3	2.8	13.1	9.2	2.5	2.2	1.7	10.7	5.3	5.5	6.5	7.0	2.7	3.0	9.3	6.9	9.0	4.2	4.4	3.5	3.3	4.9	14.2	7.8	7.6	24.6	7.6	15.2	7.6	7.0	11.2	16.5	10.9	10.5	1.7	7.8	32.2	9.2	12.2	8.9	5.5	5.2	10.4	7.6	7.7	5.5	5.4	5.5	6.2	4.5	6.4	8.0	13.8	19.2	11.9	31.6	21.1	9.6	14.1	18.1	8.6	19.7	9.7	6.9	39.5	7.2	16.8	20.2	31.3	12.4	14.5	21.3	13.7	17.6	121.7	15.2	14.8	18.7	15.0	19.4	56.0	9.2	17.3	15.3	11.2	14.7	17.2	22.2	20.3	14.8	16.1	35.3	63.9	15.7	38.7	25.0	10.7	270.7	33.8	16.3	19.6	26.2	21.5	13.8	18.6	46.8	46.3	12.4	27.9	30.5	18.0	9.8	36.4	28.4	23.9	19.0	13.1	11.6	32.0	113.3	27.1	9.1	11.9	9.7	13.4	34.6	17.7	11.7
SNAPC4	"FLJ13451, PTFalpha, SNAP190"	ENSG00000165684	"Small nuclear RNA activating complex polypeptide 4"	Q5SXM2	9	136375577-136400168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028939, HPA046627, HPA073243"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028939: , HPA046627: AB_10961152, HPA073243: AB_2686585"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.41e-2)"	6.3	5.3	3.5	6.0	2.9	8.5	6.6	2.0	6.3	8.0	2.7	6.2	5.7	6.7	3.0	5.8	9.8	3.9	5.8	2.9	0.5	7.6	10.8	6.5	6.9	1.7	1.1	8.0	11.3	5.9	11.2	3.7	0.9	8.0	4.1	5.4	6.6	4.6	6.3	8.2	7.2	4.5	0.1	10.1	6.0	19.7	0.9	5.2	8.6	2.4	6.0	6.7	6.4	2.2	9.2	10.5	10.6	14.8	6.7	12.9	19.4	11.7	7.8	12.0	9.5	24.3	8.2	14.0	8.2	9.3	8.3	29.0	12.9	15.0	7.1	19.9	20.3	9.5	30.3	11.6	5.9	20.2	10.8	10.3	12.4	10.4	9.8	10.4	10.8	11.3	19.8	10.1	8.4	20.6	11.7	22.7	21.9	14.5	13.7	19.0	10.7	19.9	6.9	16.4	30.4	21.2	11.7	19.1	6.2	9.1	19.7	11.6	15.4	12.3	11.2	22.3	16.9	6.3	7.9	11.2	8.6	9.3	7.3	0.0	0.5	0.4	0.7	0.3	0.3	0.5	0.3	0.3	0.1	1.5	0.2	0.1	1.0	0.7	0.1	0.5	0.2	0.1	3.5	2.9	2.0	6.3	2.9	0.5	1.7	1.1	0.9	0.1	0.9	2.2	3.6	6.4	9.0	12.1	4.8	5.4	2.8	3.9	5.7	8.2	6.0	5.0	5.9	5.7	3.8	3.7	2.1	2.6	5.9	5.4	0.0	6.2	4.1	15.1	5.6	4.1	5.3	7.0	12.2	4.5	2.0	4.1	4.6	7.1	1.3	7.0	5.7	8.1	3.2	3.3	8.5	5.0	10.2	4.2	7.7	2.5	5.0	3.4	0.0	5.6	3.2	4.4	3.1	7.1	5.5	6.8	5.8	4.9	4.6	3.7	3.6	4.3	20.3	12.2	0.0	4.2	4.4	9.5	10.0	3.0	6.8	1.4	5.7	6.2	6.1	2.9
SNAPC5	SNAP19	ENSG00000174446	"Small nuclear RNA activating complex polypeptide 5"	O75971	15	66490135-66497780	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 118.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024379	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024379: AB_2671552"	"unprognostic (4.43e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.56e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.69e-2)"	22.4	26.0	31.5	17.3	32.0	15.0	21.8	33.3	40.5	20.4	34.9	32.9	15.7	25.1	41.1	15.8	22.9	13.9	42.3	32.4	34.2	33.0	35.1	19.4	23.8	31.8	33.2	20.9	22.3	32.9	27.4	18.2	33.0	24.4	18.7	28.6	18.5	22.1	60.1	15.1	19.7	20.2	31.3	22.8	23.2	32.6	33.3	21.3	26.9	27.5	22.3	27.3	17.8	33.6	17.3	54.2	23.4	50.4	27.8	26.5	26.3	19.4	27.1	24.5	17.2	31.1	40.3	21.2	44.6	22.6	22.4	35.5	62.6	27.0	27.3	37.7	34.6	28.5	56.2	47.0	33.0	72.8	30.2	22.4	33.2	20.2	49.9	16.5	17.0	38.6	92.8	43.3	18.2	37.7	35.0	28.5	24.3	72.2	23.0	33.8	23.0	79.5	30.2	24.9	30.1	24.3	22.1	44.0	86.5	49.4	40.5	48.7	17.8	23.0	43.2	25.1	33.3	30.2	56.5	36.3	23.7	93.2	47.9	32.5	26.7	34.7	33.6	43.3	42.3	43.8	40.4	45.2	22.6	32.7	53.5	45.3	13.0	49.2	47.0	39.1	50.7	32.3	31.5	32.0	33.3	40.5	32.4	34.2	31.8	33.2	33.0	31.3	33.3	33.6	24.2	22.4	19.2	13.1	20.1	9.4	16.2	33.0	8.6	13.7	19.1	24.5	53.1	18.6	27.9	27.6	10.4	33.4	23.9	13.9	84.1	27.1	118.4	28.4	18.1	23.3	13.9	17.9	8.6	47.6	26.6	22.5	11.7	14.0	19.6	25.1	12.5	48.2	47.2	18.5	10.2	18.1	38.7	18.2	11.8	98.3	26.8	20.3	26.6	8.4	33.2	22.2	43.3	8.5	13.6	27.9	11.1	27.8	19.2	28.7	17.1	79.7	46.4	19.7	0.0	21.3	25.5	92.3	40.7	15.7	9.7	22.3	26.0	30.0	18.6	19.2
SNCAIP	SYPH1	ENSG00000064692	"Synuclein alpha interacting protein"	Q9Y6H5	5	122311354-122464219	"Disease related genes, Predicted intracellular proteins"			"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.5;ovary: 37.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Early spermatids: 68.1;Endometrial stromal cells: 56.9;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	50	"basophil: 7.6"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in some"		"AF22: 5.2;BJ hTERT+: 5.1;HBF TERT88: 3.2;OE19: 3.0;RPMI-8226: 5.2"	"Low region specificity"	"Detected in all"							HPA064687	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cytoplasmic bodies"	Nucleoplasm	"HPA064687: AB_2685324"	"unprognostic (7.28e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-1)"	3.1	1.0	2.5	2.5	7.8	0.3	1.4	7.2	3.0	17.2	10.1	1.1	1.2	19.5	1.3	0.6	5.1	2.5	1.3	2.9	2.9	1.7	0.1	1.2	2.1	4.6	5.2	37.5	0.5	0.2	1.2	2.0	4.2	1.9	1.1	0.5	0.4	2.7	0.3	1.8	0.7	12.0	3.0	5.2	1.0	4.5	5.7	1.7	0.8	1.6	1.5	4.1	2.5	4.3	0.0	0.0	5.2	0.1	0.0	0.0	0.1	2.2	5.1	0.8	0.4	0.0	0.1	0.1	0.1	2.2	0.4	0.0	2.1	0.3	3.2	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.2	0.0	0.6	0.1	0.0	0.8	0.0	0.0	0.0	0.1	2.5	3.0	0.0	0.1	0.0	5.2	0.2	0.6	0.9	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.5	0.3	0.4	0.0	0.0	0.2	0.2	0.0	0.1	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.5	7.8	7.2	3.0	2.9	2.9	4.6	5.2	4.2	3.0	5.7	4.3	6.1	0.0	0.5	84.5	0.0	1.8	3.8	0.5	1.8	0.4	0.4	1.0	0.8	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	6.1	68.1	4.6	56.9	7.1	0.0	0.0	21.8	0.0	0.1	5.6	0.0	1.4	1.3	0.1	18.9	0.2	0.3	0.0	62.8	0.0	0.0	0.8	0.4	16.6	5.3	0.6	1.8	13.1	0.0	0.5	0.0	30.7	1.9	0.4	0.7	5.7	0.0	3.0	0.0	0.3	14.9	0.0	0.0	0.5	2.3	4.1	2.1	1.8	2.7	0.1	0.4	0.1	0.2	1.5
SNF8	"Dot3, EAP30, VPS22"	ENSG00000159210	"SNF8 subunit of ESCRT-II"	Q96H20	17	48929316-48944842	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 341.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059320	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA059320: AB_2683977"	"unprognostic (7.85e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (2.81e-7)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.38e-1)"	28.7	31.7	24.6	26.0	26.9	35.2	26.6	25.8	27.1	21.5	24.7	28.4	27.6	21.3	32.1	26.9	20.3	20.5	42.7	23.9	25.7	33.0	33.1	21.9	24.8	25.9	25.9	18.5	29.7	26.1	18.3	22.0	26.1	20.1	30.7	18.1	29.6	21.5	48.6	23.7	24.4	25.8	25.6	22.7	30.0	18.4	25.5	27.8	25.5	48.5	32.5	26.7	20.5	29.2	60.9	119.3	73.2	93.3	73.7	42.4	114.0	49.9	68.1	95.0	84.8	294.6	61.5	55.3	85.5	94.3	106.0	39.8	68.0	70.1	105.4	80.1	110.7	61.6	158.7	126.1	64.2	83.8	66.6	52.7	68.9	91.0	69.2	70.5	90.4	71.7	61.4	54.7	98.2	120.7	90.8	71.4	35.6	139.1	101.3	58.9	132.8	65.8	57.1	67.4	48.0	96.3	60.1	28.1	73.5	125.2	70.9	101.3	77.2	103.6	81.1	65.3	95.1	79.6	97.5	66.0	92.1	45.1	81.5	0.9	4.4	9.2	2.5	5.0	1.3	4.4	3.5	2.8	5.0	5.4	2.3	1.9	1.9	1.6	5.7	6.2	4.7	1.1	24.6	26.9	25.8	27.1	23.9	25.7	25.9	25.9	26.1	25.6	25.5	29.2	77.4	44.8	34.4	14.7	60.0	59.8	76.5	46.4	26.2	67.9	75.0	80.9	49.0	68.6	34.4	64.4	14.6	119.6	71.3	126.4	148.7	147.8	111.9	48.3	57.6	63.5	70.8	71.8	21.4	218.4	175.7	62.8	52.5	41.7	43.1	87.5	61.8	75.2	149.1	25.2	22.7	93.2	48.8	84.4	96.2	341.1	62.7	82.7	85.4	8.4	137.9	95.1	80.3	12.1	17.6	166.6	78.7	62.1	88.6	100.0	125.4	210.1	33.7	86.7	46.0	51.9	123.3	68.0	76.3	58.6	72.5	95.1	57.7	75.0	98.9	95.9
SNIP1	PML1	ENSG00000163877	"Smad nuclear interacting protein 1"	Q8TAD8	1	37534449-37554293	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, RNA-mediated gene silencing"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036896	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA036896: AB_10670244"	"unprognostic (1.37e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.24e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.34e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	3.2	3.8	3.5	2.8	3.5	5.5	4.3	4.4	4.4	3.5	3.6	3.3	2.5	3.7	3.2	3.9	2.7	2.3	3.1	3.7	3.9	2.8	6.3	2.7	3.7	3.5	3.5	3.5	3.4	3.9	3.1	2.4	3.5	3.8	2.5	3.9	3.4	3.1	3.1	3.4	3.5	2.8	3.2	3.9	3.6	4.4	3.8	4.1	2.9	3.2	4.2	3.1	3.0	4.0	4.9	2.6	5.2	5.1	6.2	5.9	3.5	6.2	6.9	5.7	5.0	2.6	4.1	6.6	4.6	6.5	3.7	5.0	4.9	5.6	4.7	6.0	7.0	10.3	4.4	5.3	7.0	9.6	5.5	5.6	6.5	5.7	7.2	6.2	5.6	5.0	7.3	5.7	4.1	3.5	5.7	7.3	8.5	4.0	6.1	5.0	8.8	5.6	4.3	4.6	4.1	8.4	6.4	4.1	8.3	5.4	3.6	5.1	9.2	4.3	4.9	5.6	6.0	7.0	8.8	5.3	5.3	6.7	4.1	1.5	0.9	1.3	1.5	0.8	1.5	1.0	1.0	1.5	0.8	0.9	1.4	1.2	1.4	1.0	1.2	1.3	1.3	0.6	3.5	3.5	4.4	4.4	3.7	3.9	3.5	3.5	3.5	3.2	3.8	4.0	14.4	19.2	11.9	3.9	18.5	16.2	11.8	6.9	22.8	10.6	18.0	12.1	6.1	17.2	13.9	5.5	8.4	5.4	20.7	11.8	1.9	7.3	7.5	34.4	25.8	9.2	8.4	7.2	6.5	7.1	4.7	12.4	13.7	58.1	12.0	11.0	11.7	10.9	4.6	10.1	6.1	11.0	10.2	8.8	9.2	11.7	8.1	11.4	8.8	4.7	9.5	9.9	12.3	7.1	6.8	8.4	5.8	7.9	15.7	9.7	6.0	4.4	9.7	16.6	0.0	13.6	11.1	14.4	15.1	19.5	18.0	10.1	16.9	8.0	6.5	12.6
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.0;breast: 14.2;skin 1: 32.2"	"Group enriched"	"Detected in some"	22	"Breast glandular cells: 367.0;Breast myoepithelial cells: 324.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.8"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 59.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052824	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA052824: AB_2681964"	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	1.3	0.9	6.7	0.2	14.1	0.5	14.2	21.2	8.5	0.7	0.2	3.3	0.9	0.7	0.5	1.0	1.2	0.0	0.8	11.9	23.5	1.3	7.4	0.8	0.6	37.8	14.8	0.7	1.7	0.3	1.6	0.2	28.3	1.5	0.3	0.6	4.7	0.1	1.0	32.2	1.7	0.1	38.2	1.1	0.8	8.1	14.2	0.1	0.6	0.0	0.0	0.9	0.8	55.0	0.9	0.0	0.3	1.4	1.0	1.6	2.4	0.3	0.0	0.3	0.7	0.0	0.2	0.0	0.7	0.1	0.5	0.5	0.0	0.0	0.0	0.6	2.1	0.5	0.4	59.6	0.8	0.1	1.7	0.0	1.3	0.4	0.8	0.7	1.6	0.6	0.1	0.2	0.2	0.2	0.2	0.5	0.0	0.0	2.2	0.4	0.6	0.4	0.1	0.9	0.2	0.8	0.4	0.0	2.2	1.0	0.1	2.6	0.9	0.2	0.8	0.8	0.8	3.8	4.7	0.2	0.1	1.4	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.1	21.2	8.5	11.9	23.5	37.8	14.8	28.3	38.2	14.2	55.0	3.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	367.0	324.9	0.0	0.0	0.0	1.8	0.0	0.1	10.1	0.0	5.9	0.5	0.0	3.8	0.4	6.3	0.0	0.0	0.0	0.8	0.1	2.9	0.0	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	2.3	0.9	0.0	0.0
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 126.0;TIME: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	37.6	10.3	9.7	17.2	9.7	58.4	26.5	27.7	13.2	21.7	9.8	14.6	16.1	23.1	7.8	19.7	13.6	20.4	16.3	9.5	12.5	20.0	25.4	26.4	19.8	14.0	11.5	14.4	22.7	18.5	11.4	33.3	14.7	11.2	11.9	18.8	11.4	10.8	14.3	30.3	17.2	22.9	9.5	33.0	14.4	11.1	13.2	40.5	27.3	21.6	14.7	19.8	21.7	8.7	8.4	5.0	9.1	8.8	26.6	9.5	8.7	8.8	14.8	9.4	9.1	6.9	11.8	13.2	6.8	11.2	6.2	5.3	10.7	18.9	9.6	15.1	8.8	15.0	9.1	8.1	13.8	17.1	16.1	10.5	12.7	10.6	17.9	9.5	126.0	14.9	6.7	14.9	8.7	4.4	17.3	15.0	10.1	4.6	22.6	11.7	6.7	14.0	24.2	14.1	6.4	13.4	7.7	8.1	11.1	7.9	5.5	21.4	74.1	8.2	8.3	9.5	10.4	23.7	18.3	11.0	5.8	20.1	12.0	9.4	4.2	7.6	9.5	7.5	13.0	3.6	8.3	9.6	4.0	3.6	12.1	13.1	27.7	11.0	7.1	1.2	9.7	9.7	9.7	9.7	27.7	13.2	9.5	12.5	14.0	11.5	14.7	9.5	13.2	8.7	88.4	32.1	24.1	30.0	29.0	52.8	10.3	6.4	12.5	52.1	9.7	8.6	17.7	15.7	15.0	16.5	16.7	7.7	57.6	37.0	11.7	10.9	50.4	23.3	16.2	84.2	10.8	10.3	21.6	8.9	3.2	16.4	12.8	19.8	14.5	8.9	98.6	25.2	13.7	30.3	43.2	10.7	12.2	24.8	19.0	7.5	12.5	26.5	23.2	34.7	21.9	16.3	65.9	24.6	10.7	11.2	20.6	11.7	27.3	12.7	25.2	12.2	19.2	18.3	124.9	31.3	49.1	11.1	16.2	13.7	51.3	8.2	61.2	9.5	11.1	18.0
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274338-96321271	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm		NA	NA		78000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.5	21.8	11.2	38.1	11.3	58.8	38.6	16.9	12.1	31.9	25.5	29.6	29.4	41.0	20.2	29.5	39.8	25.8	26.9	9.9	11.1	28.8	29.3	29.3	43.2	13.1	10.3	53.2	34.3	52.4	19.7	39.2	12.0	31.6	34.6	67.6	35.1	33.0	47.4	30.8	30.3	38.5	12.2	36.5	30.6	40.4	9.8	73.5	37.4	38.7	52.3	30.1	21.6	14.6	97.8	107.7	144.1	106.1	63.1	57.1	131.5	67.3	80.6	119.5	112.9	197.3	69.3	169.3	101.3	83.3	178.9	74.9	264.4	88.8	130.8	94.3	139.4	221.6	169.8	106.7	40.9	171.2	92.4	58.1	53.7	133.2	112.0	61.3	97.3	98.3	198.2	112.3	68.3	82.3	158.8	49.4	182.8	77.9	102.4	185.0	139.3	107.4	43.8	145.4	159.8	150.5	107.7	88.7	65.4	165.0	86.4	100.5	86.2	98.3	117.2	101.3	96.2	101.0	134.0	207.6	66.2	109.0	106.2	16.7	4.7	6.0	7.9	5.0	8.9	5.7	6.0	9.5	5.6	6.1	5.2	7.1	4.7	7.3	6.1	5.8	6.8	5.5	11.2	11.3	16.9	12.1	9.9	11.1	13.1	10.3	12.0	12.2	9.8	14.6	47.3	44.8	53.9	21.9	57.4	29.6	27.2	35.5	38.1	79.3	40.2	42.4	35.2	54.3	46.2	51.5	104.3	43.2	64.2	43.4	5.9	42.6	29.3	42.4	48.7	44.8	46.7	54.1	21.2	46.7	36.1	37.9	52.0	48.8	25.3	79.0	40.4	49.4	35.1	87.5	21.1	40.6	34.6	31.9	33.2	18.2	57.5	35.2	17.8	16.9	45.2	79.1	73.2	17.1	16.7	46.1	30.7	55.3	68.3	34.8	47.3	17.9	50.7	135.2	65.7	54.7	45.5	77.6	56.0	38.7	33.0	44.6	71.6	53.3	49.4	30.3
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53828-57669	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 156.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 219.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041183: AB_2677353, HPA044248: AB_2678873"	"unprognostic (7.87e-2)"	"prognostic favorable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	15.2	29.3	80.7	20.6	81.4	32.7	16.1	95.2	98.3	14.0	74.4	27.2	12.9	15.9	16.3	20.1	16.0	10.4	85.3	81.7	81.0	25.0	39.2	10.8	32.6	86.3	82.7	19.8	19.7	24.6	30.7	8.7	87.0	19.8	17.5	12.4	22.9	13.8	131.6	10.9	16.5	15.1	81.8	19.0	27.6	11.0	88.0	22.5	17.7	84.5	31.2	17.2	11.9	80.1	50.1	111.2	60.7	70.8	21.2	24.9	29.5	41.4	26.5	90.7	76.1	150.4	47.5	157.3	48.3	34.2	48.6	50.4	111.8	76.2	69.2	57.3	87.8	91.6	155.3	152.9	22.4	168.9	103.9	32.1	27.0	80.8	22.4	19.6	49.6	93.5	139.2	36.5	52.2	236.5	89.5	70.0	72.8	88.4	54.5	141.9	64.6	186.9	48.6	34.7	66.2	42.9	93.4	119.8	20.7	59.0	77.5	80.8	39.3	40.0	49.6	51.8	67.2	37.6	96.9	248.2	21.3	89.5	62.3	15.1	25.5	93.3	14.9	40.3	17.9	74.3	15.1	17.9	49.6	75.1	15.9	16.3	17.2	22.5	35.9	219.7	26.1	23.2	80.7	81.4	95.2	98.3	81.7	81.0	86.3	82.7	87.0	81.8	88.0	80.1	16.5	12.8	14.3	6.8	53.4	18.6	27.2	39.5	14.8	17.9	48.1	51.9	113.0	18.6	29.3	33.1	4.2	54.6	62.3	30.9	156.5	41.6	3.0	27.3	23.8	18.9	44.0	58.5	9.9	51.4	63.3	29.3	30.1	36.9	4.5	62.3	16.4	67.5	114.5	11.8	9.8	34.5	69.2	26.4	59.8	6.5	21.5	36.2	62.2	5.6	94.3	89.0	32.0	4.5	6.5	31.0	44.8	29.7	65.9	31.5	24.0	87.6	53.2	14.5	6.6	29.4	35.7	33.7	44.8	35.8	21.9	26.1	22.4	105.0	53.5	27.7
SNRNP27	"RY1, U4/U6.U5-27K"	ENSG00000124380	"Small nuclear ribonucleoprotein U4/U6.U5 subunit 27"	Q8WVK2	2	69893956-69905575	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034541	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA034541: AB_10602408"	"unprognostic (2.24e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.89e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-1)"	31.0	33.4	25.3	23.9	26.6	43.2	26.1	28.0	40.1	19.9	21.5	18.2	17.4	23.5	24.3	19.8	19.1	21.5	39.5	27.3	27.6	23.5	24.6	19.2	32.8	23.6	26.5	21.7	18.5	32.1	16.3	30.3	25.2	23.7	20.9	25.3	21.8	19.3	62.2	19.5	20.4	24.0	26.0	22.6	18.4	14.2	25.3	31.7	26.9	71.8	27.7	24.8	13.4	30.7	27.9	16.2	52.0	31.4	44.7	49.0	41.7	38.5	45.4	54.2	42.9	34.0	31.3	29.6	30.5	31.5	56.0	15.3	34.9	16.1	67.3	33.3	34.1	34.2	14.4	42.2	40.1	43.6	57.9	36.0	38.6	35.4	30.4	44.4	42.0	41.6	49.0	46.6	72.1	15.6	59.4	73.9	38.1	30.1	16.2	46.0	42.9	31.1	60.0	18.5	53.0	41.9	28.7	30.8	42.7	39.0	28.1	35.4	24.6	37.1	51.3	53.7	58.5	28.5	29.9	45.7	33.2	52.4	71.7	43.2	25.1	38.9	23.6	23.5	25.2	37.9	25.7	23.4	22.2	32.2	27.8	27.7	13.7	32.2	25.2	40.8	30.3	25.1	25.3	26.6	28.0	40.1	27.3	27.6	23.6	26.5	25.2	26.0	25.3	30.7	45.3	54.5	39.3	6.5	57.1	49.1	40.5	47.0	44.9	31.6	53.0	32.4	60.7	47.1	36.1	62.5	14.6	49.2	69.9	40.5	74.3	57.7	37.4	37.0	44.8	42.0	38.9	82.7	14.1	55.1	70.1	50.5	18.8	44.6	60.0	24.5	56.4	78.8	57.4	23.5	11.6	52.7	22.4	57.7	46.6	12.4	51.3	48.5	37.4	8.4	50.6	41.8	68.0	4.0	7.6	70.4	42.8	57.9	60.2	34.3	33.9	63.8	47.2	31.2	39.5	32.4	45.2	76.2	61.7	33.9	46.0	52.5	51.7	20.3	37.5	37.7
SNRNP48	"C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234"	ENSG00000168566	"Small nuclear ribonucleoprotein U11/U12 subunit 48"	Q6IEG0	6	7590198-7611967	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029234	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA029234: AB_10604097"	"prognostic unfavorable (8.30e-4)"	"unprognostic (3.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.03e-1)"	5.4	3.8	4.8	5.5	5.1	10.4	6.9	8.5	6.7	7.0	4.4	5.4	5.7	6.4	4.6	4.7	5.7	4.0	7.2	4.6	5.0	6.0	7.3	4.5	7.3	5.7	4.9	7.7	5.7	3.7	3.6	5.3	5.9	5.8	5.5	7.3	5.3	4.4	9.7	6.3	6.7	5.4	4.7	6.1	5.4	2.7	5.1	7.1	5.8	7.1	5.9	5.6	5.8	5.9	10.0	7.9	16.2	30.3	8.5	12.5	10.9	11.2	10.4	12.0	13.1	16.9	8.1	23.6	11.8	9.4	11.5	12.6	20.2	12.1	18.2	18.2	19.8	17.0	24.1	32.7	8.9	20.5	10.9	8.8	18.3	13.5	10.2	14.2	10.5	20.8	24.1	3.6	16.8	5.7	33.7	29.6	21.9	17.1	8.8	35.8	13.9	31.6	10.8	8.7	25.0	6.8	21.8	5.6	19.6	29.7	10.9	7.2	11.8	15.8	7.1	9.5	19.6	5.8	34.6	14.5	5.3	16.1	28.9	0.1	0.7	0.4	0.7	0.5	1.2	0.6	0.8	0.9	0.9	1.1	0.7	1.3	2.3	1.1	0.3	1.0	0.7	0.6	4.8	5.1	8.5	6.7	4.6	5.0	5.7	4.9	5.9	4.7	5.1	5.9	18.6	19.2	10.3	8.1	15.7	35.7	20.2	13.6	12.0	18.7	12.6	14.6	32.1	15.7	17.3	9.2	20.9	16.3	22.7	19.2	11.7	18.0	2.5	18.0	14.8	20.5	11.4	17.7	20.4	20.1	15.6	18.0	8.2	19.6	24.1	16.8	20.3	23.4	15.9	5.0	18.8	18.2	0.0	15.1	22.1	2.5	17.7	14.9	8.8	13.1	21.7	15.5	19.6	14.6	23.8	12.1	17.9	16.6	11.5	21.4	27.1	20.1	8.5	17.8	6.6	20.9	23.2	16.1	17.0	11.5	34.0	16.3	18.5	11.2	17.1	20.1
SNRNP70	"RNPU1Z, RPU1, Snp1, SNRP70, U1-70K"	ENSG00000104852	"Small nuclear ribonucleoprotein U1 subunit 70"	P08621	19	49085419-49108605	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001718, HPA042050, HPA043516"	Supported		Enhanced	Nucleoplasm		NA	NA		74000	"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523"	"unprognostic (2.22e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.12e-5)"	"unprognostic (5.18e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (5.35e-5)"	77.2	106.0	30.1	41.3	28.2	49.5	79.1	29.2	46.0	108.1	29.8	90.6	39.4	96.6	21.0	103.9	95.4	13.8	88.1	28.4	32.4	83.4	96.3	81.2	43.5	28.6	28.5	107.7	95.9	28.6	104.9	26.8	27.9	107.4	21.9	18.5	92.9	23.3	104.2	95.2	90.5	20.7	24.6	106.7	94.3	72.9	28.4	45.8	103.5	16.7	33.0	81.9	94.4	34.1	178.5	224.0	142.3	101.6	56.4	34.3	155.3	125.4	81.7	136.1	118.1	140.4	103.5	203.9	127.1	89.0	123.1	152.2	176.6	128.2	101.0	137.0	468.2	185.9	103.6	164.9	29.2	209.1	125.2	48.0	35.4	99.6	67.2	64.5	103.0	107.2	195.4	65.7	84.4	175.3	218.8	338.3	175.3	102.9	167.4	254.7	133.7	124.6	87.9	113.7	112.3	136.9	158.3	96.1	94.8	94.5	98.9	132.3	147.0	101.8	190.5	86.7	223.5	164.3	156.5	263.2	84.1	135.9	95.2	0.8	2.0	1.8	1.8	1.5	1.1	4.0	1.4	0.8	2.0	1.7	2.0	1.5	0.8	4.1	1.8	1.7	1.2	0.8	30.1	28.2	29.2	46.0	28.4	32.4	28.6	28.5	27.9	24.6	28.4	34.1	86.6	19.2	63.0	198.5	107.2	139.4	166.8	78.4	93.9	108.7	97.8	109.5	31.6	55.8	66.0	75.4	89.6	179.7	97.5	89.8	46.9	108.1	23.7	101.8	141.9	84.2	118.0	76.6	81.0	105.1	208.6	92.3	110.1	123.0	55.1	111.7	61.4	97.4	125.8	114.4	99.2	121.4	77.3	58.7	97.7	21.3	130.1	77.8	69.4	74.0	75.8	82.6	76.2	110.6	151.9	116.0	80.0	110.6	112.0	177.1	95.0	77.5	59.3	109.6	124.9	102.3	101.2	109.7	108.6	92.3	130.7	176.4	96.3	115.4	119.6	154.7
SNRPA	"Mud1, U1-A, U1A"	ENSG00000077312	"Small nuclear ribonucleoprotein polypeptide A"	P09012	19	40750637-40765389	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004652, HPA046440, HPA054834"	Supported		Supported	Nucleoplasm		NA	NA		35000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004652: AB_425687, HPA046440: AB_2679668, HPA054834: AB_2682619"	"unprognostic (3.53e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.03e-1)"	"unprognostic (8.04e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (2.96e-9)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.01e-3)"	45.3	42.1	33.3	40.8	36.6	59.9	47.0	33.8	39.6	61.7	36.1	54.4	36.4	54.8	42.6	55.1	58.4	18.2	38.6	32.7	35.7	48.2	44.9	48.5	57.1	34.5	34.5	69.2	38.0	20.5	47.7	28.7	34.4	55.0	33.8	10.8	41.1	33.0	51.0	41.2	52.7	30.2	34.5	65.2	45.9	36.5	33.9	63.5	56.2	27.6	48.2	53.8	51.7	35.0	143.4	134.6	157.2	129.4	44.2	56.8	125.9	53.8	76.8	145.5	151.9	119.4	129.8	197.2	70.1	75.6	76.2	114.2	162.0	149.6	126.7	96.7	191.5	137.0	115.2	150.0	64.9	159.8	90.0	56.1	36.6	101.4	164.6	78.2	131.7	180.1	167.5	101.2	98.5	145.4	273.7	285.1	164.1	133.1	134.8	251.6	102.0	154.5	100.8	88.4	117.8	113.4	102.4	113.4	90.6	84.3	110.1	150.8	73.8	77.4	127.8	77.5	131.2	107.4	121.6	252.9	78.0	179.3	100.0	3.2	28.0	7.5	27.6	32.2	29.2	28.1	29.2	32.4	56.5	26.4	29.6	27.9	2.5	28.0	16.2	34.7	31.8	23.0	33.3	36.6	33.8	39.6	32.7	35.7	34.5	34.5	34.4	34.5	33.9	35.0	39.3	12.8	15.2	4.9	53.0	35.9	51.6	63.7	63.7	7.2	49.8	67.2	7.2	15.7	27.0	25.8	2.1	87.1	39.6	34.9	43.0	41.6	32.7	22.7	31.1	34.2	33.0	65.4	5.4	49.4	127.0	43.7	51.0	37.6	32.4	67.0	31.4	21.9	60.1	5.0	6.5	44.9	48.8	29.9	35.0	14.6	37.3	37.5	23.2	3.7	50.4	17.8	29.9	6.0	9.5	44.6	29.4	28.2	56.6	38.9	34.6	35.2	17.5	5.1	19.7	28.2	75.7	60.7	66.2	85.1	33.1	66.4	50.9	44.3	61.2	47.7
SNRPA1	"Lea1, U2A'"	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA		48000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: AB_2679394, HPA048499: AB_2680421"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favorable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	19.0	18.2	11.0	35.5	11.4	68.1	20.8	13.2	15.4	14.7	14.7	30.6	24.3	15.5	33.0	33.8	18.6	12.7	25.8	12.0	11.6	25.2	25.5	19.5	43.3	11.5	11.3	13.6	22.2	18.3	13.9	30.4	11.7	16.3	30.8	15.5	23.1	12.6	19.7	18.5	30.1	19.3	10.9	25.2	23.2	37.8	12.4	37.4	18.3	12.4	51.9	26.3	18.2	12.6	175.5	119.5	112.7	57.4	31.3	25.6	111.3	158.2	72.8	139.2	105.1	255.8	150.7	192.9	89.2	107.8	109.0	101.7	170.2	113.1	148.1	98.0	262.5	151.4	196.7	137.3	24.0	175.1	103.7	21.0	83.0	89.0	111.3	30.9	90.9	147.1	216.1	175.8	86.5	194.6	177.6	185.7	144.5	232.0	100.1	174.5	121.7	194.8	103.3	450.2	88.6	92.7	97.2	109.0	125.1	117.1	105.2	136.4	66.2	74.1	141.0	86.8	160.3	143.5	464.8	378.9	59.9	162.9	89.3	3.8	36.6	21.5	55.7	47.2	55.3	53.0	57.7	56.1	58.0	47.4	46.6	59.0	6.8	48.5	44.0	54.7	68.9	39.0	11.0	11.4	13.2	15.4	12.0	11.6	11.5	11.3	11.7	10.9	12.4	12.6	41.5	19.2	54.6	16.3	71.6	65.6	73.4	141.6	70.6	37.8	41.8	52.6	30.5	18.6	80.3	36.8	12.5	124.3	69.6	37.4	68.4	94.6	96.2	52.7	42.5	47.2	27.0	61.4	30.9	109.0	154.1	51.5	27.0	55.6	65.8	37.7	21.4	35.5	67.0	37.0	29.2	44.2	126.1	24.1	39.2	22.4	34.8	36.4	42.7	13.1	76.4	39.6	47.4	16.6	28.6	95.3	41.8	28.6	76.1	142.3	78.7	87.1	89.2	34.9	13.1	37.9	67.1	192.9	65.9	68.3	50.6	112.3	68.1	42.3	52.4	101.6
SNRPB	"COD, Sm-B/B', SmB/SmB', snRNP-B, SNRPB1"	ENSG00000125835	"Small nuclear ribonucleoprotein polypeptides B and B1"	P14678	20	2461634-2470853	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA003482, CAB009610, HPA067842"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB009610: AB_2193859, HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (2.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (5.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (9.47e-2)"	113.4	110.5	45.0	110.7	45.1	345.4	111.6	50.8	54.5	103.7	48.5	108.1	102.6	119.4	66.7	177.1	93.7	62.7	90.1	46.7	47.1	103.6	91.9	111.7	166.7	47.7	45.1	93.8	78.0	83.1	72.5	82.9	47.4	87.9	86.5	25.0	99.7	62.4	112.6	148.5	109.2	85.9	48.6	139.0	100.7	83.2	46.8	168.9	77.1	59.9	154.0	109.3	108.9	50.4	782.5	1063.7	376.7	340.4	83.8	149.1	418.7	334.6	259.8	693.8	556.2	1209.6	555.7	588.8	210.6	203.2	556.7	567.8	370.7	636.2	350.3	239.7	658.6	400.5	190.0	1148.0	290.0	560.3	236.6	171.3	237.9	564.0	252.6	132.2	389.0	491.1	561.0	414.6	288.7	543.0	897.1	916.2	825.2	405.8	520.8	531.3	379.0	711.4	266.8	407.8	405.6	442.7	414.5	554.3	503.2	162.8	524.5	612.9	266.7	404.4	340.9	360.8	764.8	345.5	938.8	877.1	137.7	623.8	419.5	167.9	166.7	133.0	202.8	210.9	170.5	210.7	178.0	179.5	226.7	210.6	144.2	167.5	87.8	166.0	221.6	237.4	241.5	266.0	45.0	45.1	50.8	54.5	46.7	47.1	47.7	45.1	47.4	48.6	46.8	50.4	197.0	44.8	69.1	4.6	206.9	478.6	335.2	309.4	150.2	46.8	156.8	151.8	17.9	112.9	167.3	93.8	12.5	365.2	251.9	163.6	144.8	347.3	17.1	98.3	143.0	202.9	142.0	170.0	6.8	295.8	647.8	155.4	89.2	128.4	144.5	215.0	83.2	60.8	294.8	30.3	6.3	239.4	203.4	102.7	308.3	20.4	159.1	158.0	190.3	6.5	189.5	68.9	265.7	6.0	8.5	404.6	171.9	123.8	176.9	421.8	119.3	143.6	98.9	57.5	157.8	169.6	228.5	329.6	308.3	181.5	423.1	373.4	210.1	306.7	293.5	433.2
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757505-34773857	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 384.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm		NA	NA		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	71.7	73.9	68.4	67.7	73.7	176.7	74.2	73.1	84.5	67.0	75.3	78.5	73.1	83.5	63.1	85.5	84.8	48.9	195.7	70.5	71.8	91.7	92.0	62.6	101.6	72.2	70.5	75.0	87.0	78.2	57.6	73.5	73.1	65.8	65.6	39.7	75.2	55.3	162.0	67.4	75.6	65.3	75.4	84.7	81.8	124.4	72.6	115.5	75.3	125.0	95.3	73.9	66.6	78.4	332.8	203.2	260.7	331.6	137.7	134.7	199.0	186.6	204.9	367.9	308.6	349.6	128.4	373.9	239.1	235.0	255.6	156.0	398.7	279.1	297.8	247.6	420.0	287.7	158.7	493.4	240.1	371.2	171.0	167.3	266.4	372.5	264.1	144.9	237.0	354.4	471.2	205.0	270.4	280.8	443.8	592.0	282.4	493.9	245.8	295.2	219.4	350.5	242.0	140.9	316.9	229.9	167.3	167.0	422.3	167.7	256.0	541.5	157.4	219.8	258.3	181.0	460.4	228.5	645.6	522.4	101.2	629.7	381.1	122.8	165.7	133.4	127.2	200.4	149.4	233.5	156.2	148.4	196.1	210.7	168.3	153.9	30.3	163.3	238.6	207.6	235.7	245.6	68.4	73.7	73.1	84.5	70.5	71.8	72.2	70.5	73.1	75.4	72.6	78.4	43.6	121.8	107.9	5.2	70.5	44.0	76.0	178.6	72.8	25.9	47.4	64.4	229.3	82.9	131.3	68.0	25.0	239.8	69.0	49.1	189.8	148.4	185.6	74.2	58.0	74.3	90.7	73.2	11.1	156.8	213.9	72.3	51.5	63.7	80.4	83.6	71.4	101.1	232.2	28.6	10.1	92.6	118.0	77.3	55.1	83.8	55.3	75.4	64.0	1.9	158.2	96.6	123.6	8.5	14.6	149.3	66.7	41.8	116.6	70.0	96.0	214.6	127.4	41.4	65.7	49.0	82.8	384.6	99.7	83.8	44.8	113.3	70.7	86.3	109.6	67.8
SNRPD3	"Sm-D3, SMD3"	ENSG00000100028	"Small nuclear ribonucleoprotein D3 polypeptide"	P62318	22	24555958-24582052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001170	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA001170: AB_1080042"	"unprognostic (3.30e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.28e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	30.5	31.1	24.7	35.2	25.7	39.2	37.5	29.6	34.8	31.8	25.7	50.5	33.2	35.5	35.5	43.5	36.7	20.2	35.3	25.0	25.8	48.0	64.9	26.9	47.7	23.7	23.9	34.3	23.7	51.2	27.0	24.7	25.5	33.8	40.7	54.1	29.7	31.9	103.7	28.8	35.7	29.5	23.6	34.3	36.5	24.7	25.0	74.4	38.9	86.2	53.3	39.5	32.3	30.7	182.5	45.7	188.6	58.5	70.1	57.7	56.1	173.1	74.8	166.1	148.1	61.4	65.8	158.7	70.1	109.2	83.0	130.7	252.1	219.3	175.5	107.9	188.8	152.4	95.4	113.9	66.2	408.0	95.7	66.5	93.8	186.3	86.6	81.8	120.6	139.8	116.2	60.5	61.5	56.8	187.0	82.6	98.9	237.8	61.9	179.5	190.7	66.6	154.5	130.0	82.2	95.6	83.4	62.7	87.7	162.7	102.3	97.5	135.5	127.0	126.3	74.3	126.2	74.3	168.2	283.7	70.1	127.1	91.4	18.5	42.9	53.9	35.6	50.2	37.6	60.5	38.4	39.2	54.2	50.7	36.6	41.3	18.6	51.1	51.1	49.7	41.1	47.4	24.7	25.7	29.6	34.8	25.0	25.8	23.7	23.9	25.5	23.6	25.0	30.7	120.0	96.1	81.8	7.5	118.2	108.6	115.3	293.1	133.1	61.1	94.2	138.8	95.9	101.5	162.9	130.6	35.5	239.5	123.1	112.6	291.6	161.9	91.0	176.6	157.7	96.8	111.0	139.4	8.1	114.8	228.8	121.0	92.2	147.9	86.2	145.3	66.0	203.3	176.4	38.7	8.7	134.2	168.9	74.5	84.8	85.1	116.2	98.1	67.6	10.3	151.0	134.3	86.5	8.0	13.4	129.4	118.2	118.5	120.7	96.8	191.7	310.5	135.2	68.9	65.7	102.8	209.6	111.1	131.4	164.9	113.7	180.3	111.9	176.2	139.0	113.3
SNRPG	Sm-G	ENSG00000143977	"Small nuclear ribonucleoprotein polypeptide G"	P62308	2	70281362-70293740	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA064152, HPA067814"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA064152: AB_2685199, HPA067814: AB_2685903"	"unprognostic (6.42e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (4.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.41e-2)"	66.9	92.0	55.9	85.9	58.0	118.0	85.1	58.4	85.7	50.4	60.2	87.9	62.1	55.2	103.0	95.5	45.6	40.5	102.2	55.3	58.3	97.1	95.5	59.8	100.7	58.9	58.0	49.2	53.1	69.5	60.4	83.8	59.5	53.7	80.3	92.7	59.2	46.0	88.3	43.5	63.2	51.6	59.1	76.6	61.1	60.1	58.4	139.9	61.2	83.8	96.9	91.4	56.3	63.1	398.0	414.3	412.2	240.0	146.5	157.1	369.0	255.4	230.5	332.8	307.2	718.7	258.1	355.1	180.6	202.2	404.9	253.9	415.1	355.7	356.7	333.2	404.5	474.0	256.6	875.4	194.0	602.3	313.6	140.2	198.1	312.8	308.8	135.0	341.5	301.1	645.3	254.8	266.9	479.0	541.5	961.8	430.4	489.9	340.2	350.4	507.9	419.0	483.9	367.1	238.1	204.4	235.9	201.1	295.8	250.7	202.1	470.1	232.9	235.3	440.2	246.3	520.4	188.1	228.3	731.8	211.1	510.0	260.9	163.1	168.5	181.1	144.2	219.2	147.4	209.1	193.4	168.8	202.5	166.0	157.8	188.9	88.1	135.8	222.4	273.0	230.1	264.8	55.9	58.0	58.4	85.7	55.3	58.3	58.9	58.0	59.5	59.1	58.4	63.1	191.7	201.9	198.9	7.2	237.0	299.1	340.3	625.6	143.4	88.8	192.3	239.1	145.7	178.7	314.8	202.3	33.3	655.3	175.7	249.1	534.1	389.6	51.0	253.2	184.7	209.1	186.6	319.4	7.4	391.5	818.7	173.3	119.3	188.4	213.3	140.7	175.3	391.8	390.8	65.6	8.7	301.5	370.2	186.6	270.8	45.4	175.8	194.0	224.1	5.6	329.1	446.1	208.1	4.5	13.8	434.1	271.6	159.1	251.9	366.1	226.5	676.1	401.8	91.4	184.1	181.3	244.4	340.7	367.4	236.6	318.2	521.5	220.2	125.9	324.1	375.1
SNRPN	"HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N, SNURF-SNRPN"	ENSG00000128739	"Small nuclear ribonucleoprotein polypeptide N"	P63162	15	24823637-24978723	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 457.8;Horizontal cells: 333.1;Proximal tubular cells: 300.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 789.5;SuSa: 505.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003482, HPA067842"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (9.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.59e-2)"	"prognostic favorable (8.93e-8)"	"unprognostic (4.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.74e-2)"	54.8	181.8	453.6	46.5	472.5	36.5	69.4	441.8	553.5	112.3	351.6	87.3	36.4	65.2	332.5	44.0	121.9	141.2	483.2	474.3	510.7	192.0	69.9	76.4	93.5	454.7	440.5	147.8	111.8	243.4	375.5	37.4	458.5	174.2	34.8	161.7	125.7	147.6	232.7	38.2	62.5	59.0	415.8	85.2	88.3	60.7	467.8	136.8	300.4	272.4	80.6	82.5	66.4	470.8	1.0	148.6	260.8	180.1	153.4	69.5	1.1	46.9	100.0	31.7	57.8	138.1	69.1	0.2	91.6	118.7	47.9	26.7	0.0	142.7	18.2	81.1	0.1	89.3	90.1	151.5	181.8	107.1	76.8	132.6	60.6	69.4	81.8	213.2	95.7	189.8	24.8	0.4	183.3	0.0	216.9	1.5	789.5	0.0	63.0	113.3	97.8	0.5	172.3	222.2	155.7	147.1	0.7	3.6	174.0	505.7	93.6	271.3	62.3	79.2	78.2	0.3	28.8	215.3	126.9	140.4	65.9	72.9	59.8	234.8	68.0	106.8	313.9	74.2	355.8	371.9	385.3	359.0	65.2	342.1	508.0	420.8	18.5	291.2	77.4	531.9	434.4	581.7	453.6	472.5	441.8	553.5	474.3	510.7	454.7	440.5	458.5	415.8	467.8	470.8	57.1	9.6	45.5	0.0	106.2	2.2	102.6	4.4	53.5	171.0	77.1	96.5	185.2	218.8	23.0	178.4	52.1	1.0	157.6	10.0	457.8	150.0	92.9	36.8	27.9	57.7	142.7	31.1	0.0	81.6	1.2	54.9	27.5	24.5	62.7	136.9	63.1	31.9	62.7	333.1	0.0	34.5	6.1	28.9	2.5	111.3	77.3	38.1	0.0	0.0	43.8	210.3	115.4	0.0	0.0	61.5	33.7	116.6	86.7	110.6	38.7	300.2	26.9	112.3	52.6	61.5	65.0	67.9	54.0	22.1	1.7	1.6	104.2	110.4	23.6	65.1
SNTB2	"D16S2531E, EST25263, SNT2B2, SNT3, SNTL"	ENSG00000168807	"Syntrophin beta 2"	Q13425	16	69187129-69309052	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.4;Muller glia cells: 214.1;Rod photoreceptor cells: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SiHa: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001394			Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA001394: AB_1080170"	"unprognostic (4.86e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-3)"	"unprognostic (6.46e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.88e-1)"	11.0	5.0	3.3	5.2	3.9	2.7	8.8	1.0	6.7	11.0	10.1	6.7	3.7	10.4	5.1	7.0	8.7	7.1	5.3	4.6	0.8	6.7	3.8	8.6	5.6	2.5	0.9	6.2	4.1	12.4	4.0	5.2	0.9	8.2	5.3	21.6	5.2	5.5	5.7	8.5	6.0	8.7	0.6	5.7	6.1	7.1	1.5	5.8	10.5	3.8	4.9	8.7	8.7	3.7	7.2	10.9	7.4	5.8	26.6	35.6	9.1	13.9	19.3	10.7	11.8	10.7	6.5	9.0	8.3	16.2	5.6	12.9	10.0	6.8	13.9	4.0	5.5	4.0	11.1	9.2	8.8	0.3	5.9	25.6	4.9	17.6	7.1	11.1	32.4	2.5	2.3	13.8	13.1	8.2	3.0	1.4	5.0	4.2	8.6	18.1	6.5	16.8	5.7	10.9	2.8	6.1	42.6	6.0	4.4	5.5	7.1	0.5	25.4	20.0	9.6	14.2	13.0	3.1	5.2	10.0	12.8	1.4	9.3	0.4	0.2	0.3	0.9	0.3	0.9	0.2	0.4	0.5	0.2	0.2	0.2	1.1	0.9	0.7	0.3	0.1	0.5	0.3	3.3	3.9	1.0	6.7	4.6	0.8	2.5	0.9	0.9	0.6	1.5	3.7	55.9	19.2	11.7	36.6	9.0	38.0	28.0	17.1	70.0	33.2	19.0	25.0	9.2	10.0	10.4	27.6	41.7	9.5	33.7	29.0	3.9	9.7	25.9	20.6	61.3	81.4	10.3	4.8	151.4	24.1	7.9	53.1	20.9	28.7	1.3	15.8	126.7	11.1	6.9	5.0	62.6	16.6	8.2	33.1	29.3	27.5	59.0	12.9	30.2	33.7	8.6	214.1	47.4	30.7	27.9	16.3	32.8	65.1	20.7	40.9	12.7	34.5	10.0	136.7	6.6	26.0	35.6	27.9	15.4	30.7	38.8	3.7	32.8	20.2	19.6	28.7
SNTG2	"G2SYN, SYN5"	ENSG00000172554	"Syntrophin gamma 2"	Q9NY99	2	950849-1367613	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 68.2;Excitatory neurons: 24.4;Horizontal cells: 90.9;Late spermatids: 44.7;Spermatocytes: 22.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HAP1: 1.7;JURKAT: 1.6;MOLT-4: 1.1;NTERA-2: 2.0;SCLC-21H: 2.0"	"Low region specificity"	"Detected in many"							"HPA065258, HPA077904"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA065258: , HPA077904: "	"unprognostic (7.52e-3)"	"unprognostic (7.52e-4)"	"unprognostic (4.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-3)"		"unprognostic (2.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.58e-3)"	"unprognostic (3.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.05e-2)"	2.0	0.3	0.6	0.0	0.7	0.0	1.8	1.0	0.6	1.0	1.1	0.5	0.1	1.2	0.2	0.5	1.2	0.2	0.4	1.7	0.7	0.1	0.0	0.3	0.0	1.7	0.9	0.2	0.9	0.0	2.9	0.0	1.3	0.6	0.2	2.1	0.5	0.0	0.4	1.1	0.6	0.7	0.4	3.2	0.3	1.8	0.7	0.2	0.7	0.9	0.1	0.8	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.0	0.6	1.7	0.7	1.7	0.9	1.3	0.4	0.7	0.6	6.8	0.0	0.0	0.7	0.4	0.9	0.1	0.0	0.6	0.8	0.2	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	68.2	0.1	0.9	7.3	0.0	0.0	24.4	0.2	0.5	0.8	0.0	0.0	0.0	3.0	0.0	0.0	0.1	90.9	10.7	0.0	0.0	0.0	1.2	44.7	0.3	0.0	1.8	9.4	0.0	0.6	0.0	1.5	1.3	0.0	0.0	4.1	0.0	0.3	0.0	0.5	0.0	4.6	0.0	0.3	0.4	22.0	5.4	0.1	0.1	0.0	0.2	0.2	0.0	0.2
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	47.1	33.3	27.6	33.6	29.5	91.2	42.7	30.6	35.9	39.2	29.1	38.4	32.6	39.0	28.4	38.4	38.3	26.7	39.5	27.0	29.0	38.7	33.6	37.1	46.2	29.5	28.6	41.4	38.6	31.3	30.3	33.0	29.8	32.2	32.1	43.3	34.0	21.9	64.8	50.7	38.5	30.9	28.6	44.6	36.6	48.5	28.4	49.0	33.9	35.9	41.9	38.8	38.0	32.9	91.0	66.6	67.0	70.8	54.5	60.6	76.5	61.3	54.6	66.8	61.2	66.0	81.0	88.3	54.5	46.1	50.8	88.2	81.8	58.9	90.3	71.1	63.5	71.8	59.1	66.7	77.7	50.5	81.0	46.8	76.1	60.0	82.8	71.5	65.8	83.7	103.9	64.7	51.9	93.1	90.7	85.4	74.2	103.1	87.8	97.3	85.5	61.7	61.4	82.6	71.2	76.5	84.7	73.6	87.3	68.1	106.6	95.5	69.9	71.6	81.7	64.9	73.9	62.9	95.5	98.7	65.5	79.8	80.9	94.5	71.0	95.6	57.5	76.9	65.5	59.2	64.5	65.9	72.6	67.0	67.6	63.9	67.8	94.5	92.1	43.2	94.5	76.1	27.6	29.5	30.6	35.9	27.0	29.0	29.5	28.6	29.8	28.6	28.4	32.9	86.5	93.0	49.3	13.1	64.2	56.5	80.4	89.1	33.6	56.0	40.1	50.0	49.9	47.1	77.9	53.3	35.5	79.4	75.4	38.0	76.3	79.0	43.5	97.2	81.3	69.9	43.6	85.0	17.9	70.1	100.1	64.9	26.5	80.5	92.3	61.5	55.6	33.7	76.4	38.7	18.6	50.8	54.9	53.6	52.0	24.0	77.9	70.7	39.2	30.0	95.6	66.7	65.9	15.6	31.9	71.3	43.8	74.1	46.3	48.9	48.8	57.3	88.1	72.2	65.7	60.9	89.5	300.5	140.7	39.7	54.3	109.0	76.8	54.4	47.9	70.9
SNX10		ENSG00000086300	"Sorting nexin 10"	Q9Y5X0	7	26291862-26374383	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 285.7;Hofbauer cells: 148.7;Kupffer cells: 215.5;Macrophages: 166.5;monocytes: 152.3;Muller glia cells: 310.5;Proximal tubular cells: 204.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 336.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 103.1;U-937: 87.3;WM-115: 297.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015605, HPA064782"	Approved		Supported	Nucleoplasm,Nucleoli,Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Microtubules"	Nucleoli	"HPA015605: AB_1857342, HPA064782: AB_2685349"	"unprognostic (6.42e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.87e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.50e-1)"	23.7	14.5	26.4	34.7	27.8	42.1	11.0	17.6	45.9	4.5	6.1	5.6	4.1	9.0	1.1	2.9	3.0	8.8	1.8	30.2	42.2	37.8	69.1	41.2	36.9	29.1	28.2	1.1	7.8	1.3	4.7	10.9	40.3	3.5	6.4	47.1	1.7	2.1	1.0	1.4	6.2	9.5	18.6	42.1	3.9	5.1	32.0	15.8	2.9	2.7	24.8	10.9	1.6	26.8	55.8	5.0	0.2	10.1	0.1	0.0	57.8	0.0	3.9	0.1	0.0	0.5	18.4	24.0	41.4	0.0	36.2	1.7	13.5	3.6	0.0	33.3	12.4	2.5	0.4	36.3	0.1	52.2	8.9	0.6	5.4	0.0	4.2	0.1	0.8	30.7	1.5	0.3	0.0	9.7	22.2	54.3	15.3	0.9	5.1	0.1	0.1	1.3	103.1	12.0	22.5	7.1	11.7	8.5	62.7	18.1	15.2	72.6	0.3	0.1	12.2	0.2	13.7	17.9	15.5	16.4	0.5	87.3	297.4	55.9	144.7	3.7	18.6	158.5	18.2	82.3	13.2	16.4	101.2	71.7	6.9	12.0	336.7	47.7	162.5	37.0	29.6	70.0	26.4	27.8	17.6	45.9	30.2	42.2	29.1	28.2	40.3	18.6	32.0	26.8	3.3	3.2	14.7	6.8	63.4	5.4	1.2	0.7	1.8	20.3	17.6	9.5	1.8	34.3	4.4	23.9	2.1	14.9	18.6	2.5	285.7	66.0	1.3	2.1	40.7	7.6	9.5	19.1	63.1	27.1	111.8	3.4	0.0	2.3	31.1	2.9	2.2	109.8	148.7	35.3	53.4	3.3	0.0	215.5	130.3	2.1	1.2	166.5	8.8	19.7	152.3	310.5	33.0	7.1	8.5	14.1	1.5	0.0	8.0	4.4	4.5	204.9	0.8	23.2	0.0	0.7	4.7	7.1	29.5	0.8	3.0	28.7	31.6	0.9	8.7	1.3
SNX20	"SLIC-1, SLIC1"	ENSG00000167208	"Sorting nexin 20"	Q7Z614	16	50666300-50681353	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.0;lymphoid tissue: 33.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 15.3;Cardiomyocytes: 16.4;dendritic cells: 23.7;Hofbauer cells: 17.6;Kupffer cells: 17.2;Langerhans cells: 25.2;Macrophages: 19.3;monocytes: 26.1;NK-cells: 24.7;T-cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.7;HMC-1: 78.5;NB-4: 48.0;RPMI-8226: 20.6;THP-1: 21.3;U-266/70: 25.7;U-937: 28.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043649	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA043649: AB_10965697"	"unprognostic (1.53e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (5.58e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.03e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.00e-6)"	"unprognostic (3.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	2.3	1.0	1.5	20.0	1.5	18.0	1.1	1.8	1.7	1.1	1.5	2.7	2.9	1.0	0.6	1.6	1.0	4.0	0.8	1.3	1.8	0.8	2.2	7.7	27.8	3.4	2.1	0.6	0.5	0.4	0.5	2.7	2.5	1.1	3.6	0.3	1.9	0.7	0.8	2.4	6.1	2.7	2.1	19.2	3.7	0.5	2.6	33.2	0.9	1.1	27.0	6.1	0.7	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.7	0.0	5.2	0.0	0.0	0.0	7.4	78.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	48.0	0.0	0.0	0.0	2.4	0.2	20.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.2	0.0	0.0	0.1	0.0	25.7	14.3	6.5	0.0	28.4	0.0	306.6	66.9	208.0	41.6	118.3	52.2	22.6	73.8	50.9	123.4	22.6	56.1	38.9	62.3	51.3	147.5	34.3	137.5	81.8	1.5	1.5	1.8	1.7	1.3	1.8	3.4	2.1	2.5	2.1	2.6	2.9	0.2	0.0	0.0	0.3	15.3	0.8	0.0	0.0	0.0	0.2	0.3	0.6	16.4	2.8	1.3	0.0	0.0	0.1	23.7	0.0	0.0	0.0	0.1	0.3	0.1	1.5	0.0	6.5	0.0	0.0	0.2	0.5	0.5	0.1	5.1	0.0	1.1	0.4	17.6	1.7	0.0	0.0	0.0	17.2	25.2	0.0	0.0	19.3	0.0	0.0	26.1	0.1	24.7	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.1	13.1	0.5	0.5	0.2	0.1	0.0	0.6	0.4	21.3	0.1	0.2	0.0
SNX22	FLJ13952	ENSG00000157734	"Sorting nexin 22"	Q96L94	15	64151715-64157481	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8;thyroid gland: 38.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;B-cells: 33.4;Erythroid cells: 136.8;Oligodendrocyte precursor cells: 95.5"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 47.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 3.3;naive B-cell: 6.1"	"Lineage enriched"	"Detected in many"	6	"B-cells: 6.1"	"Cell line enriched"	"Detected in some"	5	"Daudi: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038470			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles	Nucleoplasm	"HPA038470: AB_10673174"	"prognostic favorable (2.89e-5)"	"unprognostic (8.93e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.74e-2)"	0.4	0.4	11.2	3.7	12.5	6.5	0.5	12.0	11.6	0.6	4.7	0.4	0.5	0.2	1.9	0.3	0.2	0.3	11.9	11.2	11.1	1.0	2.9	5.7	7.2	16.8	13.1	0.1	1.7	0.0	3.2	0.2	14.4	4.2	0.2	0.0	1.4	4.5	0.1	0.2	3.4	0.2	14.4	5.4	2.3	0.4	12.9	2.5	38.7	0.0	8.6	0.5	0.3	15.4	0.0	0.4	0.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.3	0.4	17.5	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.1	1.7	0.3	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.5	2.6	0.0	0.7	0.2	0.0	1.3	0.2	0.2	3.7	0.1	0.7	0.8	0.1	3.8	0.7	0.0	0.5	0.0	0.2	1.5	0.0	0.0	0.1	1.0	0.0	0.1	3.1	1.3	3.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	1.0	6.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.4	11.2	12.5	12.0	11.6	11.2	11.1	16.8	13.1	14.4	14.4	12.9	15.4	0.7	28.9	8.8	0.0	33.4	1.5	2.3	1.3	1.2	0.9	3.2	3.2	21.0	0.0	1.4	0.0	4.2	3.3	2.0	1.5	0.0	0.6	1.6	0.5	1.6	1.0	0.0	136.8	0.1	3.8	8.6	4.1	2.6	1.3	2.5	1.9	1.4	4.3	4.6	0.0	0.3	1.2	0.0	1.9	7.4	1.7	0.6	2.5	3.6	3.7	1.9	0.5	1.0	95.5	17.7	1.3	0.6	0.4	9.5	6.2	0.6	1.6	0.5	2.0	0.0	3.1	1.9	1.4	2.1	1.3	2.8	4.0	3.0	0.3	0.8	1.6
SNX30	ATG24A	ENSG00000148158	"Sorting nexin family member 30"	Q5VWJ9	9	112750760-112881671	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.9;Oligodendrocytes: 91.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019346	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA019346: AB_2286395"	"unprognostic (1.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (4.48e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-2)"	3.5	3.6	8.0	7.3	16.5	8.4	6.8	9.7	12.3	9.1	0.0	10.2	7.1	5.5	3.4	3.8	3.1	4.7	3.0	7.9	13.5	21.2	4.6	21.3	8.6	14.5	12.9	5.7	4.6	5.2	3.0	4.5	12.2	3.4	10.3	4.0	5.0	3.5	2.0	4.8	8.2	6.5	8.6	7.0	4.2	11.9	16.1	3.8	2.6	2.1	8.1	4.0	3.2	25.8	8.2	5.0	8.5	6.8	10.5	9.6	7.2	6.9	14.2	5.7	5.4	18.1	1.9	13.6	5.7	17.9	10.2	9.6	10.4	4.1	8.8	4.4	4.9	4.2	4.6	7.3	7.5	4.2	7.2	7.8	5.6	8.8	6.5	14.4	4.9	3.4	6.7	7.5	7.8	5.7	2.8	4.9	9.4	13.2	5.2	5.9	19.9	3.5	11.1	14.2	12.6	4.0	9.0	12.3	17.6	8.7	9.2	7.4	5.6	8.4	9.0	25.0	5.9	19.6	19.5	6.3	10.8	3.9	16.9	0.0	2.0	0.6	0.2	0.7	0.6	0.0	0.3	0.4	1.6	0.2	0.2	0.2	0.2	0.3	0.8	0.2	0.6	0.7	8.0	16.5	9.7	12.3	7.9	13.5	14.5	12.9	12.2	8.6	16.1	25.8	4.4	6.4	77.9	11.4	3.5	8.2	2.0	3.1	7.4	5.9	10.5	5.5	4.3	2.8	7.6	5.5	10.4	0.6	3.6	26.2	5.9	2.6	9.1	16.2	7.5	4.8	4.8	6.6	39.0	3.2	2.1	5.3	5.6	20.1	7.0	15.6	8.9	7.7	13.4	8.4	24.1	10.8	2.0	22.4	17.0	8.1	5.6	19.8	21.4	36.5	22.3	2.4	2.1	22.6	91.2	4.4	20.3	7.9	5.8	2.5	11.9	34.2	2.3	3.1	0.0	4.7	2.8	6.6	10.0	7.3	11.1	0.4	5.7	3.7	9.6	6.3
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572889-100663415	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 6.5;urinary bladder: 16.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 81.8"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RT4: 80.7"	"Region enriched"	"Detected in single"	5	"thalamus: 2.6"	"Not detected"	"Not detected"			"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.6	0.1	1.0	0.0	1.2	0.2	0.4	0.8	3.1	0.4	0.6	0.3	0.0	0.3	0.2	6.5	0.3	1.1	1.7	1.0	1.1	0.2	0.5	0.1	0.4	0.0	0.0	0.4	0.3	0.3	0.2	0.0	0.0	1.4	0.1	0.2	1.2	0.2	0.6	0.6	0.1	0.5	0.4	0.1	0.7	4.0	0.7	0.3	0.5	0.5	3.6	16.4	1.7	1.5	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	80.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.0	1.2	0.8	3.1	1.0	1.1	0.0	0.0	0.0	0.4	0.7	1.5	0.5	0.0	0.0	6.2	0.1	0.4	3.3	0.2	9.6	0.0	0.2	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	81.8	0.2	0.1	0.4	0.0	0.0	12.8	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	19.7	0.6	0.2	0.0	1.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	1.2	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.3	3.7	0.3	0.5	9.7	0.4	0.0	0.1	0.0	0.0	6.0
SOBP	FLJ10159	ENSG00000112320	"Sine oculis binding protein homolog"	A7XYQ1	6	107490106-107661306	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 175.3;Excitatory neurons: 260.1;Granulosa cells: 149.3;Inhibitory neurons: 287.7;Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AF22: 10.5;AN3-CA: 13.9;ASC diff: 12.9;HDLM-2: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029242	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Vesicles	"HPA029242: AB_10603340"	"unprognostic (7.11e-2)"	"unprognostic (1.35e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.84e-2)"	"unprognostic (5.35e-3)"	"prognostic favorable (1.55e-5)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-3)"	4.5	6.6	12.4	1.7	14.5	0.0	3.4	9.0	16.9	6.2	0.4	14.6	1.2	5.6	2.0	2.0	4.3	2.7	10.9	15.3	8.2	3.4	1.6	2.4	0.9	6.7	9.1	10.8	1.4	3.1	9.4	2.3	6.2	8.2	1.3	5.3	10.4	2.6	16.7	1.2	3.2	3.9	6.5	1.9	4.8	4.2	9.5	2.7	4.2	5.9	1.1	11.9	4.4	11.4	0.0	0.3	10.5	13.9	12.9	4.9	1.2	0.0	0.0	0.3	0.6	0.0	0.0	5.7	0.3	0.0	0.9	0.0	7.0	0.2	0.2	9.0	6.8	0.6	0.0	6.8	1.6	3.0	0.5	5.2	0.0	5.1	0.0	1.1	4.2	2.6	0.0	0.3	0.0	2.9	1.3	0.3	2.5	0.3	0.9	3.1	1.3	0.0	0.0	0.2	3.3	5.6	1.2	0.0	0.1	0.4	0.4	2.0	0.0	3.3	1.1	5.7	0.5	2.6	0.5	3.5	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	14.5	9.0	16.9	15.3	8.2	6.7	9.1	6.2	6.5	9.5	11.4	6.0	3.2	9.8	175.3	9.2	0.5	10.3	11.4	3.4	40.4	0.5	7.4	19.4	17.2	6.1	23.9	0.0	0.2	1.8	0.2	0.0	2.5	96.2	0.6	15.8	4.4	10.8	5.3	260.1	0.2	0.7	23.6	3.1	0.4	0.0	149.3	5.3	1.4	3.0	92.5	287.7	0.1	4.1	9.6	4.1	61.4	45.1	1.8	3.6	51.5	0.1	7.6	0.0	263.9	278.8	0.4	0.0	48.9	0.2	9.3	0.0	11.9	10.9	10.1	26.3	42.8	21.0	61.2	5.6	0.6	0.9	0.1	1.3	13.3	0.2	1.0
SOCS1	"Cish1, JAB, SOCS-1, SSI-1, TIP3"	ENSG00000185338	"Suppressor of cytokine signaling 1"	O15524	16	11254408-11256204	"Cancer-related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 102.5;dendritic cells: 191.9;T-cells: 161.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 107.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010355, HPA074108"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Cytoplasmic bodies"	"CAB010355: AB_2193144, HPA074108: AB_2686661"	"unprognostic (4.50e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.31e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.67e-1)"	10.7	4.2	0.9	14.3	1.0	9.9	6.9	5.8	1.1	15.6	0.7	5.0	2.0	5.9	1.1	5.4	4.6	2.3	5.1	0.9	1.3	23.2	26.9	9.7	13.5	2.5	1.2	9.4	3.1	0.7	14.8	3.8	2.7	6.3	0.9	0.1	4.9	1.7	2.1	7.4	12.4	1.0	1.9	18.6	8.0	7.6	2.6	9.8	4.4	0.5	10.2	6.6	7.0	1.0	2.8	0.5	1.1	0.2	3.3	0.5	4.0	2.2	15.7	1.0	1.3	0.7	0.5	6.3	4.7	1.0	2.9	1.1	0.4	0.2	0.2	107.8	0.8	1.7	0.0	8.6	1.4	0.0	18.5	1.4	0.3	2.2	0.2	0.4	0.3	0.6	14.4	1.8	0.1	2.5	7.2	4.0	11.4	0.2	1.7	0.7	0.7	0.7	1.2	0.5	1.5	0.2	0.5	3.7	1.2	3.1	0.0	0.9	0.1	1.3	6.4	0.9	1.5	0.4	0.6	10.0	2.6	0.8	1.3	13.6	0.1	10.2	2.1	0.0	1.9	1.5	2.4	2.6	0.0	5.3	2.6	2.3	0.3	6.1	0.1	1.3	2.8	0.4	0.9	1.0	5.8	1.1	0.9	1.3	2.5	1.2	2.7	1.9	2.6	1.0	102.5	0.0	4.4	1.6	67.7	12.2	17.4	1.9	8.6	1.9	33.8	55.5	10.3	2.8	0.7	51.5	6.2	24.1	191.9	30.6	23.5	18.4	64.8	18.1	19.9	14.3	26.0	8.4	0.0	8.5	4.8	61.5	26.0	36.9	52.8	4.9	8.2	3.4	4.5	0.0	0.2	17.7	8.2	5.8	25.7	24.7	7.2	33.8	30.2	1.0	14.2	6.7	24.7	0.5	0.0	5.0	20.2	41.8	89.0	7.4	19.0	9.2	2.5	4.8	0.0	30.2	34.2	0.8	8.3	10.1	6.8	57.7	161.5	23.0	11.8	11.6
SOCS4	SOCS7	ENSG00000180008	"Suppressor of cytokine signaling 4"	Q8WXH5	14	55027230-55049489	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 17.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013478, HPA057961"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB013478: , HPA057961: AB_2683564"	"unprognostic (7.18e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.74e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.82e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.13e-1)"	6.6	4.9	6.1	7.9	6.7	6.8	5.7	6.7	6.7	4.7	5.6	5.2	5.3	5.8	4.2	5.1	5.2	6.6	5.6	5.9	8.7	6.3	4.9	6.7	8.9	8.1	7.1	3.8	4.1	5.5	4.5	5.7	8.2	4.8	5.6	10.8	4.5	4.5	4.9	5.1	5.3	6.0	8.1	7.6	7.0	4.3	7.0	8.0	6.9	5.1	7.6	6.5	4.2	8.8	14.2	11.0	16.2	18.9	11.0	12.2	12.0	16.4	12.1	9.9	16.0	9.6	15.2	20.8	11.3	12.4	9.7	19.1	21.4	13.5	23.1	20.8	8.8	12.8	16.3	6.1	11.1	14.3	20.9	9.9	14.4	17.6	13.0	11.5	18.5	22.0	7.4	19.2	19.3	14.6	21.9	11.6	12.7	11.7	12.0	20.3	24.5	8.5	15.2	15.0	21.1	18.5	16.6	9.8	16.8	14.8	14.0	11.2	19.3	25.5	23.9	13.1	14.0	7.4	8.3	19.6	17.2	11.8	20.2	0.9	1.2	1.2	0.8	1.3	1.3	0.8	1.0	0.8	0.9	1.1	0.6	0.6	0.7	1.8	1.8	1.2	1.0	0.5	6.1	6.7	6.7	6.7	5.9	8.7	8.1	7.1	8.2	8.1	7.0	8.8	30.7	6.4	12.4	9.8	22.3	24.0	10.8	10.7	14.8	13.6	14.7	12.3	20.2	11.5	15.8	14.7	20.9	5.2	27.5	14.7	13.7	9.4	7.4	36.8	22.5	20.9	20.4	16.8	14.3	8.7	6.2	14.8	29.0	20.6	32.9	11.8	15.0	9.4	7.4	37.0	13.6	8.3	8.2	13.3	21.8	2.6	7.2	15.6	3.6	11.2	17.3	21.0	13.4	4.5	20.4	15.6	9.6	10.1	19.4	8.1	6.7	14.6	19.7	17.4	0.0	15.8	21.5	20.7	10.9	14.7	23.2	4.9	21.7	13.7	8.1	11.5
SOCS5	"CIS6, Cish5, CISH6, KIAA0671, SOCS-5"	ENSG00000171150	"Suppressor of cytokine signaling 5"	O75159	2	46698952-46780245	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 121.0;fHDF/TERT166: 121.9;U-138 MG: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020884, CAB025510"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025510: , HPA020884: AB_1857356"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (4.52e-2)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	12.0	10.2	7.6	6.3	7.7	7.7	13.0	15.9	9.6	13.0	7.5	9.7	5.2	14.1	9.1	8.5	9.3	11.3	11.3	8.1	7.6	9.2	6.7	8.7	6.7	8.3	8.3	23.2	6.2	14.2	5.6	7.3	8.5	9.9	6.6	12.7	8.7	12.4	9.0	7.5	6.7	13.9	8.5	9.0	6.6	10.3	8.2	7.6	9.9	16.0	6.7	9.3	8.5	8.6	14.5	10.8	9.3	13.8	29.9	42.3	11.4	66.5	121.0	31.5	18.6	10.3	6.9	7.5	12.7	121.9	9.7	7.1	9.9	10.8	41.2	7.3	9.4	11.8	10.0	13.2	18.4	6.9	12.7	33.9	15.8	26.7	10.7	35.8	11.0	3.0	10.2	8.1	21.5	5.3	5.9	12.0	10.4	15.1	8.7	7.8	15.9	9.5	13.2	11.1	7.3	19.8	16.4	10.7	13.0	8.9	4.4	10.3	12.8	80.0	17.7	26.9	13.2	9.7	6.4	6.5	36.9	13.7	25.5	0.5	0.4	2.5	0.9	0.4	1.1	1.8	0.5	0.6	0.5	3.0	1.1	1.5	0.4	1.0	1.7	0.5	1.0	0.7	7.6	7.7	15.9	9.6	8.1	7.6	8.3	8.3	8.5	8.5	8.2	8.6	17.2	3.2	6.1	18.9	11.3	16.6	7.2	8.3	16.5	12.8	15.1	12.2	14.2	18.6	8.0	3.7	22.9	3.7	6.2	11.0	5.9	7.3	12.3	9.9	29.2	24.3	10.8	6.1	43.4	6.8	2.5	18.8	10.2	12.0	17.1	17.4	17.2	7.9	4.5	18.5	51.5	7.1	2.0	8.4	15.2	8.1	17.4	7.7	7.2	18.7	8.4	9.7	6.2	38.2	25.4	6.8	8.8	17.0	7.0	11.0	5.1	7.3	5.3	5.5	13.1	13.8	20.1	13.3	18.8	9.9	14.5	2.7	7.0	7.3	5.6	7.8
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659666-31668931	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1645.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 3357.9;Proximal tubular cells: 3285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA	44900000	50000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	257.6	597.1	558.0	118.4	577.4	166.4	233.5	605.2	805.1	206.6	586.6	251.0	360.3	179.5	228.4	221.1	197.1	206.0	477.3	575.1	619.9	483.2	1645.6	153.9	169.6	619.8	604.6	302.1	117.1	210.6	236.7	155.8	653.1	203.9	180.5	248.6	160.5	204.2	428.0	152.1	266.7	136.6	588.1	147.5	210.4	132.1	585.8	165.7	197.4	355.9	151.7	232.1	220.6	634.7	526.8	451.4	309.2	312.8	407.3	282.1	257.8	430.2	258.0	291.3	217.4	593.6	326.0	628.2	441.2	405.8	517.7	186.1	453.3	320.6	239.9	463.3	540.0	1008.2	579.5	866.3	267.4	451.7	363.1	294.8	240.6	406.5	225.2	327.9	331.2	469.0	704.4	773.2	357.4	860.0	489.0	454.5	466.1	830.0	475.4	413.0	622.0	981.4	579.4	320.5	335.9	281.4	805.1	419.4	438.3	279.2	484.3	393.4	387.4	222.9	489.2	304.7	322.0	583.4	1374.2	741.8	455.7	654.3	301.9	204.2	159.7	194.0	313.4	234.0	365.3	427.1	509.2	402.4	212.8	310.1	521.8	412.1	37.8	241.4	465.4	240.6	746.0	474.5	558.0	577.4	605.2	805.1	575.1	619.9	619.8	604.6	653.1	588.1	585.8	634.7	319.8	294.9	175.1	38.2	248.1	491.4	672.7	479.2	319.8	226.6	264.1	352.9	721.0	527.6	294.7	391.8	47.9	703.4	250.2	703.5	1631.7	426.3	277.0	410.7	241.2	261.0	288.4	898.8	39.7	807.3	574.9	365.8	198.8	216.3	220.0	278.9	318.1	3357.9	363.3	282.7	45.5	402.7	366.2	220.0	318.5	952.2	521.9	224.2	419.8	29.0	313.1	598.5	239.0	28.6	68.7	322.8	600.9	528.1	178.2	567.0	1158.3	3285.9	638.3	216.5	440.4	313.6	404.5	211.7	506.3	379.9	349.8	725.9	423.1	470.3	593.6	497.7
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 78.1;Inhibitory neurons: 57.4;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 32.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.3;SCLC-21H: 28.9;SH-SY5Y: 16.9"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA035388: AB_2674601, HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.3	0.9	2.3	0.6	2.5	0.0	0.1	2.4	6.6	0.4	0.0	0.3	0.1	0.7	0.0	0.8	0.3	0.7	0.2	2.6	1.7	0.2	0.1	1.0	0.2	3.8	1.2	1.2	0.6	0.0	2.0	0.4	1.9	0.4	0.2	1.2	0.4	0.1	0.1	0.3	0.6	0.1	0.7	0.4	1.3	0.7	3.8	0.0	0.6	0.1	0.0	0.4	0.3	4.4	0.3	4.2	9.3	1.5	0.0	0.8	0.4	0.9	1.1	1.2	2.9	0.3	0.4	0.6	0.3	0.2	7.3	0.0	1.0	0.0	0.7	1.1	0.1	0.8	0.0	0.1	0.0	0.4	0.2	1.5	0.0	4.4	0.0	1.0	0.0	1.5	0.4	0.2	0.7	0.7	6.5	0.0	4.3	0.0	1.0	0.6	2.2	0.0	0.2	0.0	28.9	16.9	0.0	0.0	0.2	1.1	0.0	0.4	0.2	6.8	1.5	0.5	2.2	0.3	0.1	0.1	5.4	1.5	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	2.5	2.4	6.6	2.6	1.7	3.8	1.2	1.9	0.7	3.8	4.4	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	57.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	44.2	32.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
SOS2		ENSG00000100485	"SOS Ras/Rho guanine nucleotide exchange factor 2"	Q07890	14	50117130-50231578	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004577, HPA047368, HPA052689"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"CAB004577: AB_628270, HPA047368: AB_2680014, HPA052689: AB_2681917"	"unprognostic (7.99e-2)"	"unprognostic (6.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.99e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (8.48e-8)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.57e-2)"	23.8	14.9	15.3	15.3	21.4	39.5	17.9	18.2	19.5	14.3	13.5	17.4	21.5	15.2	22.4	16.4	12.7	12.9	21.5	14.0	16.8	24.5	13.2	15.8	14.4	19.7	18.6	15.3	15.9	39.3	9.1	17.0	19.1	15.4	17.3	14.0	14.5	18.7	57.6	17.9	24.5	18.0	16.8	17.8	13.7	27.9	19.6	16.5	25.1	63.8	13.5	14.8	10.5	23.9	15.3	11.1	22.1	14.9	16.6	18.0	10.4	13.5	14.8	10.0	12.5	4.9	19.8	16.0	11.9	17.3	17.3	13.8	12.1	10.2	17.7	26.9	4.4	16.1	8.5	8.5	18.3	19.1	16.6	18.8	24.6	9.3	21.6	25.2	21.8	13.1	12.5	39.0	24.2	12.7	15.9	15.1	6.9	11.4	9.6	17.0	30.8	12.1	16.1	14.4	16.0	18.7	15.0	17.5	17.8	15.9	19.4	23.0	24.1	27.3	17.8	12.5	8.9	27.3	31.7	19.6	7.1	10.5	16.4	8.0	1.1	2.8	1.1	0.9	0.9	0.6	0.7	0.8	0.8	0.7	0.8	0.7	4.6	1.7	2.0	1.4	0.0	0.4	15.3	21.4	18.2	19.5	14.0	16.8	19.7	18.6	19.1	16.8	19.6	23.9	34.1	9.6	26.3	59.4	18.4	35.7	20.9	10.5	10.2	17.2	23.8	15.6	43.7	17.2	18.2	18.4	16.7	8.2	46.3	36.0	7.9	11.3	17.0	18.7	30.4	23.5	20.4	6.3	71.5	10.7	8.0	22.2	12.8	29.8	20.3	37.4	22.9	13.8	8.8	25.2	89.6	18.5	12.2	33.3	17.5	8.6	12.5	29.0	17.8	80.6	29.0	17.6	21.6	100.5	104.8	14.5	24.6	13.5	28.6	27.3	28.6	15.8	14.3	22.5	19.7	43.4	30.8	54.3	12.3	17.7	39.6	13.0	24.2	17.4	14.9	30.6
SOX10	"DOM, WS2E, WS4"	ENSG00000100146	"SRY-box transcription factor 10"	P56693	22	37970686-37987422	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease variant, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 194.9;salivary gland: 114.3"	"Group enriched"	"Detected in some"	14	"Breast glandular cells: 32.3;Breast myoepithelial cells: 47.8;Melanocytes: 35.6;Oligodendrocyte precursor cells: 61.3;Oligodendrocytes: 59.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	510	"SK-MEL-30: 313.9;WM-115: 432.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003171, HPA068898"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"CAB003171: AB_2195374, HPA068898: AB_2686054"																		2.9	2.7	76.9	2.5	133.7	0.1	21.7	103.1	102.8	11.8	24.9	26.6	1.5	0.8	1.2	2.7	2.5	2.2	8.8	82.7	89.0	0.5	0.5	0.1	0.0	134.7	114.0	1.2	0.8	0.0	1.8	0.0	123.3	6.8	2.6	0.5	114.3	5.8	0.6	17.0	7.1	1.9	87.3	0.3	6.1	2.7	114.2	0.0	0.9	1.5	0.0	8.4	9.5	194.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.9	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.2	0.0	0.3	0.1	0.7	0.0	432.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	133.7	103.1	102.8	82.7	89.0	134.7	114.0	123.3	87.3	114.2	194.9	0.3	0.0	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.0	32.3	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.4	0.9	0.1	35.6	0.0	0.0	0.0	0.0	61.3	59.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.7	0.0	0.9	0.0	0.2	0.0	0.0	0.0
SOX11		ENSG00000176887	"SRY-box transcription factor 11"	P35716	2	5692384-5701385	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 5.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 6.4;Breast myoepithelial cells: 8.6;Cardiomyocytes: 13.9;Inhibitory neurons: 8.4;Oligodendrocyte precursor cells: 21.6;Skeletal myocytes: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.2;NTERA-2: 23.6;REH: 17.9;RH-30: 18.2;SCLC-21H: 29.1;SH-SY5Y: 44.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000448, HPA000536, CAB056152, CAB056153"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.35e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.04e-8)"	"unprognostic (2.79e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.45e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.47e-2)"	0.0	0.0	2.3	0.0	2.8	0.0	0.0	1.3	1.9	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	5.0	0.0	0.0	0.0	0.0	2.5	2.9	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.2	3.2	0.1	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	2.3	0.0	0.0	4.4	0.0	0.0	0.0	23.6	0.0	0.0	17.9	18.2	0.7	0.0	0.0	29.1	44.0	0.0	0.3	0.0	8.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	3.3	0.6	1.2	0.0	0.0	11.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.1	2.3	2.8	1.3	1.9	1.3	5.0	2.5	2.9	2.0	3.2	4.6	3.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.1	6.4	8.6	13.9	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	5.7	0.9	0.0	0.8	1.2	0.0	0.0	0.4	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.4	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	1.0	0.0	0.5	0.0	21.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	38.8	1.1	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.0
SOX12	SOX22	ENSG00000177732	"SRY-box transcription factor 12"	O15370	20	325552-330224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 52.3;Cone photoreceptor cells: 41.7;Horizontal cells: 32.0;Rod photoreceptor cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055052, HPA061627"			Enhanced	Nucleoplasm		No	No				"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA055052: AB_2682685, HPA061627: AB_2684571"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-3)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.12e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.20e-2)"	4.0	8.2	10.1	2.4	9.1	3.0	3.8	12.3	11.4	9.7	6.7	10.6	1.8	9.9	5.1	4.8	8.5	2.1	6.7	9.2	7.5	10.4	4.8	3.9	2.6	10.2	8.1	11.7	6.5	3.7	6.8	2.3	9.2	8.1	1.2	8.5	4.1	6.1	1.1	4.4	5.3	3.7	7.1	6.1	5.4	8.9	8.3	4.0	9.8	1.3	1.7	7.2	6.4	10.6	7.9	27.1	26.0	17.7	12.3	9.0	7.8	10.6	9.2	9.5	9.4	5.5	8.0	17.5	8.0	12.3	19.9	9.2	18.9	3.5	5.4	8.8	13.3	11.3	10.9	55.3	15.8	15.7	2.9	12.4	10.9	8.0	3.2	15.4	12.6	11.8	26.9	9.0	6.2	19.2	5.4	38.4	42.3	4.4	35.3	27.7	6.6	14.2	13.5	1.0	31.7	36.9	7.1	30.9	41.0	10.6	29.4	21.7	14.3	36.5	36.0	1.0	9.5	25.5	28.8	18.1	6.8	15.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	10.1	9.1	12.3	11.4	9.2	7.5	10.2	8.1	9.2	7.1	8.3	10.6	3.8	0.0	3.2	15.3	2.6	3.4	2.5	2.7	15.4	52.3	8.5	6.2	11.3	5.7	0.8	7.3	41.7	1.4	1.6	2.3	15.6	1.3	0.9	12.1	16.2	8.6	9.1	5.5	6.5	0.4	0.4	5.3	0.5	6.6	0.0	22.8	8.9	8.7	2.3	32.0	9.2	4.5	2.0	1.3	4.5	2.0	10.2	1.7	5.4	6.5	0.8	9.9	1.0	10.6	10.1	0.4	0.8	12.4	0.8	3.3	1.1	5.1	1.2	39.1	0.0	3.2	7.6	1.3	6.9	3.9	1.1	0.7	2.9	18.4	3.9	0.5
SOX13	"ICA12, MGC117216, Sox-13"	ENSG00000143842	"SRY-box transcription factor 13"	Q9UN79	1	204073115-204127743	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.8;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 65.9;SK-BR-3: 138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051790, HPA054843"			Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA051790: AB_2681610, HPA054843: AB_2682622"	"unprognostic (4.88e-3)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (4.74e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	39.9	15.4	16.8	4.9	18.5	0.5	29.2	16.3	14.7	36.6	13.0	28.5	14.0	41.0	8.8	15.9	39.8	9.5	17.4	12.1	14.8	31.4	22.6	36.8	4.7	21.6	23.5	19.2	17.2	24.3	8.6	25.9	18.6	35.4	8.1	2.0	21.8	17.8	21.1	17.5	21.4	17.9	18.2	14.2	14.6	7.1	18.3	1.9	17.2	13.9	3.9	29.7	33.2	19.8	24.8	15.6	32.7	2.2	30.6	9.2	65.9	9.4	5.5	14.7	9.0	13.1	18.0	0.2	30.4	6.0	3.8	39.0	12.6	12.2	6.9	11.5	6.4	0.0	11.2	14.6	6.9	0.2	14.0	9.5	6.1	9.2	8.0	7.0	21.7	0.5	0.2	0.1	3.0	30.1	0.3	0.2	43.6	39.5	18.6	0.2	11.1	15.3	11.0	55.9	5.1	2.7	9.5	138.2	42.4	29.0	61.7	3.0	12.4	3.2	8.6	14.2	6.6	0.1	0.1	0.0	5.2	0.5	8.8	0.0	0.0	0.1	0.8	0.0	0.8	0.0	0.4	0.5	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.0	0.1	16.8	18.5	16.3	14.7	12.1	14.8	21.6	23.5	18.6	18.2	18.3	19.8	20.5	6.4	7.7	26.8	0.2	2.2	8.7	3.5	2.8	0.9	8.7	7.6	28.3	5.7	4.9	9.2	0.0	5.2	3.9	16.3	1.9	3.6	9.2	13.3	13.0	17.4	7.7	0.0	0.5	1.5	5.6	8.4	5.1	22.3	17.1	0.2	8.9	6.0	1.4	0.0	7.6	5.3	8.2	0.9	2.1	27.7	20.8	1.2	1.8	21.5	0.0	4.9	4.1	50.8	16.8	3.7	7.6	19.5	0.5	7.8	16.0	4.5	4.1	1.0	39.5	9.7	22.3	0.3	0.5	6.6	1.6	1.9	2.3	2.9	5.5	7.7
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box transcription factor 15"	O60248	17	7588178-7590094	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 87.4;skin 1: 48.2"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 209.2;Basal squamous epithelial cells: 447.3;Squamous epithelial cells: 388.1;Suprabasal keratinocytes: 169.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 6.7;non-classical monocyte: 10.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 10.6"	"Group enriched"	"Detected in many"	8	"A-431: 130.6;HaCaT: 142.1;HBEC3-KT: 57.8;hTCEpi: 56.6"	"Not detected"	"Not detected"							"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	2.2	0.9	15.0	0.8	14.6	2.7	3.4	17.4	23.3	21.1	11.8	12.4	0.7	8.2	1.7	87.4	11.0	1.0	8.6	14.5	15.3	1.7	1.3	1.5	0.5	14.3	15.0	15.3	1.0	0.2	7.9	0.3	14.1	12.1	0.5	5.0	14.6	7.1	2.3	48.2	3.5	1.3	14.5	1.1	4.7	2.6	14.7	1.0	2.3	1.8	2.8	10.4	32.7	15.0	130.6	3.2	1.8	1.0	0.1	0.3	9.6	1.4	0.5	1.1	1.7	2.5	0.8	0.4	1.2	0.1	0.4	142.1	0.1	57.8	0.4	3.3	3.9	0.5	1.7	0.5	0.2	0.3	2.6	0.0	56.6	0.7	11.9	3.6	0.0	2.6	2.9	0.8	0.2	0.9	0.6	1.5	3.6	0.3	0.7	1.6	1.8	1.0	2.7	0.7	0.8	2.2	1.5	0.5	0.7	5.5	1.1	1.0	1.6	1.3	2.3	1.6	4.4	0.9	1.5	1.6	4.4	1.7	3.2	0.1	2.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	10.6	1.0	0.0	0.4	15.0	14.6	17.4	23.3	14.5	15.3	14.3	15.0	14.1	14.5	14.7	15.0	0.8	0.0	0.0	2.6	0.1	209.2	51.8	72.7	447.3	13.6	6.3	13.0	4.7	0.0	20.6	1.8	14.6	1.7	0.7	0.5	1.9	0.1	0.2	0.4	4.9	3.1	1.2	0.0	8.1	0.5	2.0	10.4	0.0	0.4	0.0	1.3	1.4	0.0	0.4	10.1	7.7	0.4	10.2	1.2	19.3	1.1	31.4	0.9	26.6	1.0	1.2	50.0	0.0	4.0	2.4	0.5	0.1	36.9	4.9	21.2	0.3	0.2	16.2	9.4	32.9	7.8	7.1	0.7	10.9	388.1	169.9	1.1	1.1	0.6	0.8	73.8
SOX17		ENSG00000164736	"SRY-box transcription factor 17"	Q9H6I2	8	54457935-54460892	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 49.1"	"Group enriched"	"Detected in many"	8	"Adipocytes: 464.9;Endometrial ciliated cells: 377.3;Endothelial cells: 171.5;Glandular and luminal cells: 520.0"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 122.8;ovarian cancer: 96.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"EFO-21: 108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025594, HPA068399"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB025594: , HPA068399: AB_2685981"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.76e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.98e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.88e-1)"	49.1	1.6	2.9	1.4	2.3	0.0	32.6	2.6	3.3	20.4	1.4	8.3	0.7	18.8	1.2	3.6	23.0	7.7	19.1	2.1	2.2	5.6	1.3	9.9	0.7	2.9	2.5	4.2	1.9	0.8	2.3	5.7	2.7	6.0	0.8	0.1	3.9	1.1	10.3	5.1	5.0	4.3	2.5	13.2	5.7	3.4	2.8	0.4	5.8	5.8	0.4	8.4	9.4	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.3	2.6	3.3	2.1	2.2	2.9	2.5	2.7	2.5	2.8	2.6	464.9	0.0	0.0	0.0	0.2	13.9	0.3	0.0	0.0	0.1	0.7	1.3	2.1	1.5	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	2.6	377.3	44.5	171.5	0.0	2.7	0.0	0.2	0.1	7.7	0.0	520.0	0.0	0.0	46.8	0.1	0.1	0.0	0.0	0.0	0.0	0.9	16.6	1.8	2.5	3.5	19.6	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	7.3	5.1	3.2	6.4	0.3	13.5	0.0	4.5	0.2	0.0	3.7
SOX18		ENSG00000203883	"SRY-box transcription factor 18"	P35713	20	64047582-64049639	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 78.4"	"Group enriched"	"Detected in many"	9	"Adipocytes: 370.9;Endothelial cells: 212.4;Hepatic stellate cells: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 20.8;NB-4: 35.8;REH: 8.5;TIME: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073703			Approved	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA073703: AB_2686628"	"unprognostic (2.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.13e-3)"	"unprognostic (9.63e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.40e-2)"	51.8	14.3	8.9	3.1	6.4	0.0	43.1	6.5	6.3	19.5	1.7	16.3	3.1	38.4	0.3	12.0	29.2	3.7	78.4	4.4	5.5	21.4	5.2	29.1	3.1	10.1	8.0	8.0	8.2	1.3	6.6	5.5	9.5	17.6	0.4	0.0	12.6	1.3	13.9	12.2	17.0	1.5	6.7	22.5	15.6	5.6	9.9	0.8	29.0	3.8	0.5	19.7	21.9	5.4	0.0	0.3	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	0.2	0.3	0.0	0.0	0.5	1.0	0.0	3.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	20.8	0.0	3.7	0.0	0.0	0.7	0.0	35.8	0.1	0.0	0.3	8.5	0.0	0.6	0.0	1.4	0.6	0.6	0.3	0.0	0.5	0.0	0.5	1.8	9.6	0.1	2.6	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.4	6.5	6.3	4.4	5.5	10.1	8.0	9.5	6.7	9.9	5.4	370.9	0.0	0.6	0.3	3.7	1.0	0.2	0.0	2.2	0.9	1.9	3.0	8.8	1.5	0.0	1.8	0.0	0.0	1.6	0.1	0.0	0.3	22.1	1.0	11.9	212.4	0.0	2.7	0.0	0.0	0.0	2.5	0.0	0.7	4.5	0.0	306.6	0.6	0.1	0.0	0.0	0.0	0.0	6.0	2.2	4.8	1.2	1.3	1.8	15.9	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.2	0.0	3.6	6.5	32.4	2.5	0.9	1.1	0.3	0.7	2.3	0.0	0.3
SOX2		ENSG00000181449	"SRY-box transcription factor 2"	P48431	3	181711925-181714436	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;esophagus: 24.5"	"Group enriched"	"Detected in some"	6	"Basal squamous epithelial cells: 362.0;Muller glia cells: 383.5;Squamous epithelial cells: 229.1"	"Cancer enhanced"	"Detected in many"		"glioma: 136.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 277.0;HAP1: 118.6;NTERA-2: 226.2;U-251 MG: 54.0"	"Low region specificity"	"Detected in all"							"HPA045725, HPA062851, HPA071379, CAB079745"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: "	"unprognostic (1.80e-2)"	"unprognostic (3.18e-3)"	"unprognostic (5.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.81e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-2)"	0.3	0.9	58.0	0.5	58.5	0.0	0.2	47.1	56.6	2.1	8.6	5.5	0.4	0.1	0.2	24.5	3.1	0.2	0.5	46.5	59.0	0.0	0.1	1.8	0.0	50.5	58.9	0.3	0.1	0.0	13.6	0.0	45.2	2.5	0.4	15.0	18.4	0.3	0.1	0.6	1.4	0.2	59.8	0.0	7.9	1.9	59.2	0.4	0.1	0.1	5.3	1.3	4.8	62.2	0.1	9.0	277.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.3	0.0	0.1	0.0	0.2	0.7	118.6	3.2	0.0	0.1	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	226.2	12.4	0.5	0.0	0.6	0.0	31.0	0.4	0.5	1.2	0.0	0.0	0.1	45.7	1.7	0.1	0.0	0.0	4.2	0.0	54.0	0.0	0.0	0.0	0.2	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	58.5	47.1	56.6	46.5	59.0	50.5	58.9	45.2	59.8	59.2	62.2	0.2	0.0	6.0	0.0	0.0	0.3	35.5	28.5	362.0	4.9	0.2	0.4	0.5	0.0	48.4	3.7	0.0	0.2	0.0	1.1	0.0	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.1	1.6	19.4	0.0	1.3	0.2	0.7	0.1	0.1	0.0	0.0	0.5	38.7	0.0	0.4	0.4	0.6	0.8	3.6	0.0	0.0	383.5	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.8	0.0	0.1	52.8	13.1	0.0	0.2	1.6	3.9	0.4	229.1	0.4	0.3	0.6	0.2	0.0	7.5
SOX21	SOX25	ENSG00000125285	"SRY-box transcription factor 21"	Q9Y651	13	94709622-94712545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 9.8;esophagus: 10.3;skin 1: 15.9;stomach 1: 35.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.5;Basal squamous epithelial cells: 11.4;Gastric mucus-secreting cells: 55.5;Oligodendrocyte precursor cells: 17.1;Squamous epithelial cells: 57.1"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 79.7;NTERA-2: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048337, HPA064084"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA048337: AB_2732547, HPA064084: AB_2685187"	"unprognostic (3.33e-1)"	"prognostic favorable (7.60e-4)"		"unprognostic (7.96e-2)"	"prognostic favorable (8.79e-5)"	"unprognostic (1.54e-2)"	"unprognostic (3.87e-1)"	"unprognostic (9.02e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	0.0	0.0	9.6	0.0	9.7	0.0	0.6	7.3	9.4	0.9	2.7	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	8.6	8.7	0.0	0.0	0.1	0.0	8.1	9.8	0.0	0.0	0.0	0.2	0.0	6.8	0.5	0.0	0.0	1.4	0.0	0.0	15.9	0.0	0.0	8.7	0.0	35.1	0.1	9.8	0.0	0.0	0.0	3.3	0.3	2.2	7.8	0.0	2.4	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	6.4	12.3	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	9.7	7.3	9.4	8.6	8.7	8.1	9.8	6.8	8.7	9.8	7.8	0.0	0.0	0.0	24.5	0.0	5.4	1.1	6.6	11.4	0.0	0.0	0.0	1.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	17.1	0.3	0.0	0.0	0.0	0.1	1.6	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.1	0.4	57.1	9.1	0.0	0.0	0.0	0.0	0.9
SOX3	PHP	ENSG00000134595	"SRY-box transcription factor 3"	P41225	X	140502985-140505069	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;fallopian tube: 9.2;testis: 2.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 2.9;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 2.0;Skeletal myocytes: 3.1;Spermatogonia: 1.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;HEK 293: 8.1;NTERA-2: 17.9;SuSa: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054720, HPA075003"			Enhanced	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA054720: AB_2682584, HPA075003: AB_2686727"					"unprognostic (6.04e-2)"					"unprognostic (3.75e-1)"			"unprognostic (8.62e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.27e-3)"		0.0	0.1	1.0	0.0	1.2	0.0	0.0	0.8	1.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.7	4.9	0.0	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	2.3	3.7	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.0	0.7	4.9	1.2	1.2	0.9	1.1	3.7	1.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	7.3	0.0	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SOX30		ENSG00000039600	"SRY-box transcription factor 30"	O94993	5	157625679-157671480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 80.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 351.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.9;CACO-2: 1.3;HDLM-2: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006159, CAB009382"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB009382: AB_2195963, HPA006159: AB_1080062"	"unprognostic (3.51e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.70e-4)"	"unprognostic (2.53e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.64e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.45e-1)"	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.7	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.1	80.6	0.4	0.7	0.0	0.0	0.1	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	351.1	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	71.4	1.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	42.8	11.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0
SOX4		ENSG00000124766	"SRY-box transcription factor 4"	Q06945	6	21593751-21598619	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 73.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 1128.5;Granulosa cells: 1047.5;Ionocytes: 1320.3;Pancreatic endocrine cells: 1288.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 45.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 45.7;granulocytes: 33.3;monocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 254.1;MOLT-4: 229.9"	"Region enhanced"	"Detected in all"		"olfactory bulb: 54.2"					HPA029901	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA029901: AB_10601592"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (1.78e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.27e-2)"	11.8	4.3	4.7	9.2	5.0	24.0	17.9	8.8	6.7	21.5	2.8	11.9	12.5	57.8	15.0	5.4	13.5	20.4	6.4	4.2	6.5	16.8	6.4	19.3	5.8	3.5	5.0	51.7	10.2	3.6	4.1	6.1	4.1	14.5	14.4	6.4	17.5	6.8	3.5	8.8	11.6	17.4	4.0	5.4	17.5	9.9	7.1	73.4	8.6	6.1	7.4	21.1	7.7	4.2	8.5	24.4	60.5	254.1	22.0	5.5	98.7	3.8	7.8	4.6	4.1	16.7	16.5	2.9	100.2	6.2	3.5	25.1	32.0	17.9	3.3	36.6	66.8	2.7	11.5	11.2	3.5	9.0	2.1	9.6	18.1	2.1	7.3	64.1	72.3	138.8	0.6	0.2	5.2	20.6	229.9	21.6	45.3	12.7	23.1	99.7	5.3	0.4	44.1	78.3	78.9	141.2	35.9	41.1	14.0	74.9	20.1	30.9	55.7	7.1	23.1	1.7	18.6	1.5	0.1	71.8	2.4	30.6	28.5	33.3	19.3	2.1	0.5	11.7	0.1	7.0	0.3	0.3	8.7	6.6	2.2	1.6	0.8	7.4	22.0	45.7	2.1	4.7	4.7	5.0	8.8	6.7	4.2	6.5	3.5	5.0	4.1	4.0	7.1	4.2	235.0	198.7	50.4	0.7	36.2	112.5	129.2	660.7	676.7	99.7	586.1	676.5	297.4	423.2	457.3	154.5	12.5	74.8	104.4	247.6	66.5	1128.5	6.1	669.0	624.2	264.5	340.8	114.3	3.2	604.4	409.4	247.3	313.0	650.9	60.6	1047.5	119.2	6.8	35.5	48.8	4.6	263.0	1320.3	78.0	266.7	12.2	12.2	94.0	243.7	3.7	91.4	189.1	17.5	70.4	1.0	1288.2	153.8	11.3	40.9	151.1	76.7	132.5	162.1	31.6	6.6	234.2	439.9	4.9	236.8	400.7	93.1	30.2	36.6	69.6	299.4	272.5
SOX5	"L-SOX5, MGC35153"	ENSG00000134532	"SRY-box transcription factor 5"	P35711	12	23529504-24562544	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1531.5;Excitatory neurons: 615.9;Inhibitory neurons: 717.3;Oligodendrocyte precursor cells: 1437.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.5;naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 17.3;Daudi: 18.3;HDLM-2: 38.3;K-562: 17.0;WM-115: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060499			Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA060499: AB_2684294"	"unprognostic (9.11e-4)"	"unprognostic (4.64e-3)"	"unprognostic (3.23e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.70e-4)"	"unprognostic (6.95e-2)"	"unprognostic (4.53e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.75e-2)"	5.8	1.1	6.3	1.7	9.6	0.4	1.5	0.4	10.3	6.9	0.0	1.3	0.7	5.0	1.2	1.2	3.6	3.0	2.4	6.4	7.6	1.8	11.1	2.7	3.7	2.9	5.8	7.7	1.1	0.4	0.4	8.8	5.6	2.1	1.2	3.7	3.2	3.1	0.6	6.3	1.1	2.7	3.1	1.3	1.1	32.3	6.8	0.6	2.0	1.7	3.1	1.3	0.6	5.0	0.2	0.2	17.3	0.0	9.6	5.1	0.0	0.2	0.0	0.2	0.5	3.1	0.1	18.3	0.8	0.0	0.0	0.2	9.9	0.0	0.3	38.3	2.4	3.9	0.1	8.4	6.6	0.1	0.2	2.7	0.0	0.9	0.0	2.2	0.0	0.6	17.0	0.8	0.3	0.0	7.1	0.1	5.5	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.8	0.8	0.0	0.0	6.7	4.3	0.3	3.6	0.0	0.3	2.1	0.0	1.7	0.4	0.0	1.1	4.0	0.1	14.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	6.3	9.6	0.4	10.3	6.4	7.6	2.9	5.8	5.6	3.1	6.8	5.0	4.5	6.4	11.0	1531.5	3.7	13.3	0.1	0.0	1.8	11.9	1.0	1.3	4.0	1.5	3.1	3.7	0.0	0.1	0.0	0.0	0.0	0.2	198.7	18.7	55.7	4.0	5.4	0.4	615.9	0.0	0.2	11.3	1.5	21.2	1.3	13.3	3.6	22.0	0.3	0.0	717.3	0.0	0.0	0.8	1.9	208.6	10.2	0.8	12.4	279.2	5.7	17.9	0.0	1437.1	24.4	0.0	0.0	6.8	1.2	0.1	0.4	0.6	13.8	2.6	19.7	2.8	24.7	97.0	1.4	0.5	12.1	0.3	0.7	0.2	0.2	0.2
SOX6		ENSG00000110693	"SRY-box transcription factor 6"	P35712	11	15966449-16739591	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 308.9;Early spermatids: 256.8;Inhibitory neurons: 481.0;Oligodendrocyte precursor cells: 1687.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.7;HAP1: 4.4;hTCEpi: 5.0;SK-MEL-30: 4.9;WM-115: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001923, HPA003908"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA001923: AB_1080065, HPA003908: AB_1080063"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.89e-4)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-3)"	"prognostic favorable (6.47e-12)"	"unprognostic (9.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.04e-2)"	1.8	1.3	5.4	0.4	5.9	26.9	0.7	2.6	4.7	1.7	5.5	1.2	6.5	0.6	2.0	2.1	4.0	2.6	3.0	4.0	7.2	11.1	4.8	0.8	0.1	7.2	7.8	0.7	6.8	0.1	2.9	2.5	6.0	0.4	1.3	3.2	0.5	0.6	9.3	5.8	11.0	0.5	7.7	0.5	1.0	14.4	4.1	1.6	3.4	5.9	0.2	0.8	0.8	6.8	0.0	0.7	3.9	3.7	0.0	0.0	0.0	0.3	1.3	0.1	0.1	5.7	0.0	0.0	3.6	0.0	0.0	0.1	4.4	1.1	0.0	0.0	0.5	0.0	0.0	0.3	0.6	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	1.8	0.0	0.0	0.1	0.4	0.0	4.9	0.5	0.0	0.0	0.0	2.6	2.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	5.4	5.9	2.6	4.7	4.0	7.2	7.2	7.8	6.0	7.7	4.1	6.8	2.7	3.2	6.3	308.9	1.0	40.1	5.8	6.8	66.6	26.3	3.7	2.5	21.6	54.3	3.8	36.8	10.4	1.3	0.1	1.4	9.8	19.8	256.8	29.4	5.3	4.8	7.8	126.7	2.8	3.7	0.6	14.5	2.0	27.8	0.0	1.6	2.2	7.5	1.1	0.0	481.0	6.6	0.0	2.9	3.2	70.1	3.4	1.4	35.6	21.5	0.0	48.4	0.0	1687.9	8.9	5.5	20.3	2.2	0.1	3.2	99.8	27.1	8.3	4.3	0.0	26.2	14.6	22.1	4.5	32.7	16.1	0.5	1.1	3.0	11.8	3.7
SOX8		ENSG00000005513	"SRY-box transcription factor 8"	P57073	16	981770-986979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 127.4"	"Group enriched"	"Detected in some"	9	"Muller glia cells: 156.1;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 66.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 114.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041640, HPA058665"			Enhanced	Nucleoplasm		No	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA041640: AB_10964357, HPA058665: AB_2683792"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (6.05e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.47e-1)"	"unprognostic (9.09e-2)"	0.9	0.5	58.3	0.9	90.4	0.1	1.7	66.7	71.8	1.3	23.6	3.1	0.1	0.4	0.1	0.4	0.6	0.5	4.1	54.0	57.9	0.7	0.2	0.3	2.0	73.6	79.8	0.3	1.0	0.1	1.2	0.4	64.9	1.2	0.6	14.8	8.3	0.4	0.8	5.4	1.8	0.2	58.7	1.0	0.9	2.5	71.2	0.4	0.5	0.6	2.3	1.4	1.6	127.4	0.0	0.6	2.2	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.4	5.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	3.3	1.8	0.2	0.0	114.7	4.5	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.4	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	58.3	90.4	66.7	71.8	54.0	57.9	73.6	79.8	64.9	58.7	71.2	127.4	1.5	0.0	0.0	10.1	0.2	0.4	0.5	0.0	0.0	1.8	8.7	10.4	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.5	0.0	0.0	0.6	2.6	0.0	0.0	4.6	0.2	0.1	1.9	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.3	0.5	3.4	0.3	1.8	3.7	0.6	156.1	0.0	64.3	66.0	0.1	0.3	1.9	0.5	1.9	0.0	0.0	0.0	8.0	0.0	9.9	0.9	0.0	3.9	0.4	1.0	0.0	0.9	0.1	0.9	0.3
SOX9	"CMD1, CMPD1, SRA1"	ENSG00000125398	"SRY-box transcription factor 9"	P48436	17	72121020-72126416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.7;salivary gland: 80.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Basal squamous epithelial cells: 166.8;Breast glandular cells: 141.0;Cholangiocytes: 190.1;Gastric mucus-secreting cells: 144.8;Muller glia cells: 141.3;Squamous epithelial cells: 273.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 78.1;Hep G2: 97.0;OE19: 74.3;U-251 MG: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001758, CAB022456, CAB068240"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-2)"	3.1	2.2	54.7	4.4	50.4	0.1	28.0	42.3	58.5	7.4	46.8	17.1	19.7	2.9	0.9	13.7	7.5	13.0	15.8	50.6	49.3	12.7	3.5	3.1	1.1	73.7	72.2	0.3	38.4	0.1	10.3	0.3	48.8	24.8	17.8	15.0	80.1	10.9	2.7	23.3	15.1	1.2	56.9	0.2	40.5	30.7	51.4	0.5	20.2	1.2	4.4	1.9	6.4	49.0	31.1	19.2	38.9	78.1	3.9	1.1	0.1	4.8	4.2	8.2	4.4	27.0	40.8	0.0	2.9	1.1	43.8	31.3	0.0	18.6	7.5	0.0	2.5	0.0	4.2	97.0	0.3	0.0	0.1	0.7	1.6	9.5	9.0	47.0	0.0	0.0	0.0	0.1	11.7	0.4	0.0	0.1	1.5	74.3	29.1	0.0	31.4	0.4	35.2	2.0	1.9	1.9	4.0	4.7	0.1	21.0	16.7	0.2	0.0	15.8	42.0	8.5	66.5	0.0	0.0	0.1	11.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.4	42.3	58.5	50.6	49.3	73.7	72.2	48.8	56.9	51.4	49.0	1.1	12.8	5.6	160.0	1.9	55.4	88.2	28.9	166.8	3.0	141.0	108.2	13.6	190.1	21.1	36.8	0.0	0.3	2.8	52.1	7.9	55.3	5.1	18.4	0.9	3.2	59.7	0.0	3.1	46.7	0.0	26.0	144.8	21.7	4.5	1.9	0.0	3.4	0.2	0.0	1.5	99.0	24.4	0.0	3.4	14.5	4.4	2.3	12.4	9.4	1.0	141.3	0.0	4.5	11.1	40.8	39.1	0.4	2.8	81.1	17.7	61.0	36.4	6.8	6.6	59.9	14.5	10.2	3.1	273.5	17.8	0.1	2.8	0.1	103.8	77.2
SP1		ENSG00000185591	"Sp1 transcription factor"	P08047	12	53380176-53416446	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000330, HPA001853, HPA012292"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394"	"unprognostic (1.12e-1)"	"unprognostic (8.52e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.12e-2)"	23.6	18.6	10.7	23.1	15.1	29.9	26.2	20.3	12.5	23.7	11.6	24.8	30.9	29.8	21.0	38.6	25.5	25.6	13.4	10.6	11.7	20.7	17.0	22.8	24.2	16.4	14.0	29.8	18.6	22.1	10.7	23.7	16.2	20.8	29.8	20.4	27.5	22.0	25.2	40.1	31.2	26.4	13.0	28.0	28.6	19.4	13.5	36.7	19.6	25.8	30.2	24.2	25.3	17.6	34.2	31.3	40.5	31.2	34.7	39.4	32.1	23.1	29.0	27.2	26.9	27.9	70.3	43.9	29.3	27.1	18.3	49.2	43.6	32.9	33.0	31.3	23.8	38.5	48.2	18.3	24.3	39.4	33.1	40.3	36.4	27.0	53.9	55.1	31.0	35.5	37.6	63.8	23.1	50.2	53.9	31.9	22.4	28.0	25.0	37.8	38.5	28.5	25.7	57.8	21.0	30.5	47.7	42.9	26.8	33.5	52.3	42.6	29.5	35.3	30.3	26.4	25.3	21.3	25.4	42.5	26.3	29.9	28.2	3.1	2.6	1.6	1.3	1.7	1.6	1.4	1.3	1.3	1.5	1.5	1.4	1.5	6.9	1.0	1.9	1.8	1.1	1.0	10.7	15.1	20.3	12.5	10.6	11.7	16.4	14.0	16.2	13.0	13.5	17.6	29.7	22.4	15.0	13.1	18.5	23.8	19.9	22.4	33.6	10.6	28.3	19.4	8.2	24.3	26.8	31.3	8.4	16.2	16.6	55.8	5.9	16.1	64.1	21.8	23.4	24.7	12.6	25.2	7.7	13.8	16.3	21.5	23.9	34.7	6.3	17.2	28.2	28.4	18.2	16.8	7.2	29.8	6.1	38.6	16.1	50.3	27.4	24.5	8.8	16.9	42.2	22.7	18.6	12.5	20.4	18.8	21.0	25.9	12.0	35.4	34.8	20.8	23.9	10.8	13.1	31.4	21.0	29.4	22.1	44.2	31.3	21.3	14.8	11.7	26.2	47.7
SP100		ENSG00000067066	"SP100 nuclear antigen"	P23497	2	230415942-230545606	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 189.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 255.0"					"Low region specificity"	"Detected in all"			"HPA016707, HPA017384"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear bodies"	Nucleoplasm	"HPA016707: AB_1857398, HPA017384: AB_1857399"	"unprognostic (8.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.25e-2)"	66.3	53.1	11.0	65.5	12.3	189.2	53.8	11.3	17.9	42.4	20.7	46.1	46.1	35.1	30.8	29.4	34.9	55.9	52.9	10.9	14.0	46.0	60.9	72.4	94.3	19.6	14.3	44.3	41.1	10.5	18.3	54.5	16.7	34.9	36.1	2.5	72.7	33.0	24.3	35.7	60.4	38.7	16.2	78.8	47.9	9.2	16.5	54.2	41.0	32.1	81.6	56.1	37.1	17.1	56.9	16.9	0.8	7.5	80.8	123.2	13.3	70.3	151.0	162.4	255.0	10.6	67.9	22.9	57.0	77.0	103.0	25.9	0.8	66.6	120.7	55.2	1.9	41.8	27.9	24.0	120.0	47.3	51.4	105.6	38.8	79.8	71.4	120.2	125.1	18.9	23.9	37.9	61.7	15.9	32.0	57.6	2.4	25.6	25.6	24.4	40.7	18.2	45.9	45.3	0.4	0.7	30.0	9.5	130.3	2.8	9.1	48.3	140.3	78.7	21.4	49.4	41.8	50.3	16.0	59.8	71.6	54.8	38.1	149.7	84.4	115.8	116.3	74.9	93.9	152.0	113.0	102.4	64.6	160.5	107.5	95.3	284.6	119.8	106.0	67.0	116.0	110.1	11.0	12.3	11.3	17.9	10.9	14.0	19.6	14.3	16.7	16.2	16.5	17.1	171.9	153.8	56.6	0.3	236.6	70.7	71.2	96.5	49.5	0.6	31.2	36.7	72.3	42.9	74.4	33.1	2.1	32.9	150.6	50.5	43.0	102.9	4.7	61.6	58.3	122.7	9.0	66.9	0.6	105.5	69.4	77.9	46.4	58.9	56.8	39.3	73.5	34.5	81.0	0.0	0.7	32.5	63.1	72.9	70.9	4.8	46.6	104.1	71.2	140.5	114.3	0.2	128.8	4.5	4.8	89.7	56.9	52.6	95.6	74.2	72.8	45.4	68.4	0.8	39.5	61.2	65.9	0.8	1.1	28.4	68.2	16.1	151.5	74.0	25.2	73.7
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230165186-230225729	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 99.3"					"Low region specificity"	"Detected in all"			HPA058554			Supported	Nucleoplasm		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA058554: AB_2683754"	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"	14.0	7.3	8.4	38.5	10.3	29.8	11.8	9.4	10.8	11.6	11.5	12.6	11.9	10.5	7.9	9.2	9.6	18.0	8.1	8.1	10.3	11.9	14.8	21.0	53.7	15.3	10.9	16.5	7.9	9.7	5.3	17.5	11.6	9.6	14.0	2.0	17.0	7.6	5.7	7.8	17.6	13.4	12.1	49.8	12.9	3.1	10.9	35.7	7.4	8.4	50.1	18.9	9.3	12.3	8.3	4.4	2.7	4.7	14.2	23.6	8.3	14.8	30.8	70.3	99.3	0.2	12.7	34.5	13.8	15.8	67.0	5.1	9.0	23.0	25.7	30.5	6.0	14.9	6.2	8.9	14.5	22.1	17.1	32.7	11.8	20.8	27.4	13.2	25.3	23.6	5.3	12.1	20.6	4.9	33.0	43.5	8.6	4.2	5.1	20.1	25.4	12.8	56.2	11.1	0.5	5.7	5.7	12.7	32.7	0.9	9.6	18.5	18.8	12.9	7.9	3.2	7.5	12.9	4.6	16.2	14.4	20.6	10.7	92.2	49.7	124.4	55.2	85.8	47.8	142.8	53.5	50.5	44.1	135.8	54.1	58.7	268.6	56.9	143.4	84.4	70.7	48.5	8.4	10.3	9.4	10.8	8.1	10.3	15.3	10.9	11.6	12.1	10.9	12.3	77.8	44.8	23.8	17.3	141.7	9.9	5.2	25.7	16.5	0.4	21.6	19.3	3.7	7.2	19.6	11.0	0.0	3.8	84.0	17.0	13.7	19.9	5.2	17.2	21.3	28.6	6.7	9.7	1.1	28.5	12.7	22.8	9.2	20.1	38.0	21.2	26.4	6.2	26.9	0.0	2.1	11.4	73.2	47.4	25.8	4.2	11.8	62.3	19.6	42.2	56.7	9.7	59.8	19.6	18.2	26.0	11.6	10.1	35.7	3.5	10.7	14.4	21.0	4.9	6.6	8.6	16.2	4.8	2.3	9.8	10.1	4.7	68.8	23.5	6.1	3.0
SP140L		ENSG00000185404	"SP140 nuclear body protein like"	Q9H930	2	230327184-230403732	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA055864	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055864: AB_2682949"	"unprognostic (1.44e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.70e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (5.09e-10)"	"unprognostic (9.15e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-3)"	9.4	9.7	3.4	18.8	3.6	13.6	8.5	3.2	3.9	7.6	4.5	8.5	11.0	7.1	6.4	7.7	7.8	8.6	5.3	3.2	3.6	9.6	15.1	11.3	24.8	5.0	4.1	11.8	4.4	1.6	3.4	10.6	4.6	6.9	9.4	1.9	12.5	6.0	5.1	3.0	16.3	6.5	4.0	25.6	8.9	1.7	4.6	12.8	5.4	4.4	20.2	10.7	8.3	4.7	13.6	2.4	3.1	9.6	15.8	17.2	17.2	19.7	22.6	16.0	25.5	1.3	15.3	10.3	20.2	15.4	28.4	2.3	0.0	14.1	26.0	27.1	0.1	18.5	11.1	10.0	29.7	15.1	19.9	14.4	7.6	23.6	15.4	13.7	23.7	15.5	4.5	9.4	29.0	7.5	22.7	21.2	10.7	9.1	7.0	7.8	28.9	8.3	14.5	16.9	0.6	2.9	4.7	9.5	11.2	19.0	14.2	15.9	26.1	14.2	10.5	8.2	15.2	13.7	9.2	14.8	18.9	15.4	25.2	21.4	7.7	4.1	15.4	10.7	18.7	29.5	14.1	12.5	8.3	32.6	19.5	17.4	7.4	23.0	12.5	3.3	9.7	9.6	3.4	3.6	3.2	3.9	3.2	3.6	5.0	4.1	4.6	4.0	4.6	4.7	30.5	32.1	35.6	1.6	58.8	1.9	13.8	14.6	1.8	2.7	9.3	9.1	4.2	11.5	21.7	16.5	18.8	9.9	40.4	16.8	0.0	22.5	16.3	7.2	16.9	23.3	3.6	9.9	2.4	18.3	17.6	14.6	23.0	14.3	42.3	18.7	13.9	9.4	20.4	0.0	2.0	10.4	16.2	17.1	11.4	5.9	4.4	23.9	5.4	29.0	13.9	1.8	49.4	2.5	1.4	20.0	20.3	8.2	33.7	10.3	14.5	3.3	28.3	1.7	6.6	18.8	14.0	0.8	1.9	7.7	2.6	11.9	47.1	31.7	8.5	23.2
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	14.8	10.7	9.4	16.6	11.6	19.4	15.4	16.1	11.5	12.9	6.9	14.3	14.9	14.7	12.0	17.2	15.1	11.5	18.3	9.6	10.1	12.5	8.7	14.9	20.6	12.4	10.4	15.1	16.0	23.5	9.8	13.6	11.1	13.5	13.3	10.5	16.2	12.5	32.2	14.8	15.6	12.8	8.3	17.7	13.0	17.8	11.8	25.3	18.1	26.6	15.0	13.6	13.4	13.3	33.5	37.3	25.1	21.6	12.1	11.2	26.1	19.3	13.6	19.0	17.1	41.3	16.2	28.6	17.4	24.7	20.1	25.6	17.5	16.4	19.9	41.7	26.6	28.5	25.6	22.3	11.2	26.4	34.2	16.4	19.1	22.4	21.1	13.5	18.5	26.3	31.8	47.5	18.8	45.0	64.6	16.8	11.8	29.6	24.9	30.8	34.4	18.6	13.4	52.1	26.8	31.4	16.9	17.9	20.0	15.0	26.7	25.6	30.3	34.8	18.1	24.2	30.1	42.3	50.6	26.0	19.0	18.5	29.2	13.6	6.1	9.9	8.3	7.0	7.3	4.9	6.3	7.9	4.9	5.6	7.1	7.4	11.3	9.7	6.6	4.5	7.2	6.6	9.4	11.6	16.1	11.5	9.6	10.1	12.4	10.4	11.1	8.3	11.8	13.3	14.6	9.6	19.5	5.2	17.7	6.2	15.8	7.8	12.0	9.0	9.8	9.9	9.7	12.8	8.3	11.0	0.0	10.7	11.3	16.4	15.6	7.0	9.8	8.1	6.2	11.6	15.6	25.2	5.2	7.6	9.2	9.4	8.6	10.7	13.3	5.5	8.2	7.5	8.9	11.8	4.8	9.0	14.2	10.9	8.2	10.5	10.5	14.2	8.8	6.5	11.7	12.1	17.5	9.0	9.9	7.3	13.2	3.4	12.7	11.0	8.6	8.1	10.2	6.5	6.6	12.6	12.5	9.8	6.3	9.6	7.5	20.5	14.8	5.3	7.9	17.0
SP3	SPR-2	ENSG00000172845	"Sp3 transcription factor"	Q02447	2	173880850-173965702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004580, HPA032145, HPA032146"	Supported	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.54e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.76e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.46e-5)"	"unprognostic (2.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.69e-1)"	32.6	19.8	15.8	35.2	16.0	53.1	43.1	21.3	19.8	50.9	16.1	34.3	26.9	45.1	34.6	32.1	37.1	28.9	23.8	14.2	17.1	29.7	40.1	29.9	46.1	16.9	16.7	40.3	24.9	43.1	13.2	49.1	16.4	31.9	38.9	21.0	26.1	30.4	22.5	38.5	29.6	36.3	16.3	38.6	27.0	25.2	15.5	68.0	47.5	33.7	53.8	33.7	28.0	18.5	41.6	34.5	74.6	45.8	91.8	82.3	83.5	47.5	67.1	62.2	66.1	56.8	59.7	65.1	39.3	65.0	46.3	41.0	57.8	46.0	91.7	55.2	21.2	65.9	33.9	54.0	45.5	60.4	48.9	60.6	53.2	72.9	63.6	48.4	49.4	51.3	51.4	86.8	65.7	44.4	84.0	49.9	66.1	60.1	37.8	74.2	68.5	53.0	48.4	55.8	67.8	48.1	67.1	38.1	52.4	81.7	30.0	80.0	44.1	70.6	61.8	47.5	50.4	58.8	46.7	85.8	53.0	41.6	67.2	8.9	9.4	13.0	11.6	7.0	12.9	9.5	12.3	12.3	9.9	7.4	13.8	12.8	27.3	21.9	10.3	6.2	13.8	9.9	15.8	16.0	21.3	19.8	14.2	17.1	16.9	16.7	16.4	16.3	15.5	18.5	36.1	19.2	22.9	44.7	55.2	57.6	31.7	25.7	64.9	29.1	36.8	23.4	18.8	14.3	23.3	20.2	27.1	30.9	67.9	37.9	11.7	18.6	4.3	22.3	57.8	33.9	30.5	31.7	52.7	19.3	42.7	43.9	17.9	29.5	23.5	31.3	32.2	43.8	24.6	23.5	50.7	28.8	20.3	54.1	72.8	7.1	45.4	55.6	42.7	81.5	39.0	30.5	46.4	60.3	74.7	30.8	22.9	36.9	63.7	34.2	22.1	24.4	26.6	20.2	19.7	40.4	53.4	10.5	20.4	48.6	57.0	34.6	50.8	26.0	29.0	59.0
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428043-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: AB_2676959"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	1.9	2.5	2.1	4.5	3.2	6.8	3.6	10.0	2.5	3.7	1.4	2.0	1.7	5.5	3.0	2.2	4.3	2.5	3.8	1.7	2.8	2.9	2.1	3.5	6.5	2.4	1.8	11.3	2.3	7.2	2.5	2.0	1.9	4.0	2.4	8.9	2.2	2.7	3.6	1.9	2.4	2.9	2.1	5.9	2.9	3.8	2.7	13.5	7.8	7.6	6.8	2.9	1.7	4.4	3.6	2.2	6.7	10.6	2.1	1.4	2.0	3.4	2.2	3.6	4.7	5.5	3.5	14.1	2.3	2.0	9.6	4.2	10.0	2.9	6.9	4.6	4.5	6.5	4.6	2.1	1.5	5.4	7.7	1.4	2.4	3.8	4.3	1.8	7.1	9.6	9.5	9.2	2.9	1.3	13.8	3.7	17.5	6.4	2.7	33.1	11.6	4.6	1.2	2.2	8.8	11.0	7.1	3.0	2.5	6.6	3.6	4.0	3.2	5.7	8.3	3.5	6.5	14.0	15.0	21.0	3.4	8.7	8.1	5.7	0.8	8.9	6.9	1.0	8.2	3.7	6.4	6.6	1.0	5.9	8.2	6.9	2.1	3.9	2.1	1.8	8.4	3.8	2.1	3.2	10.0	2.5	1.7	2.8	2.4	1.8	1.9	2.1	2.7	4.4	11.0	3.2	9.0	19.6	21.8	12.6	11.6	2.5	14.2	17.5	10.0	7.5	9.7	8.6	5.7	0.0	8.4	0.9	13.1	1.6	0.0	2.2	7.0	5.4	7.0	7.8	10.7	21.9	31.0	2.2	1.3	6.3	5.6	7.9	5.1	10.8	10.8	4.6	1.8	18.5	31.3	2.2	2.0	6.0	6.4	4.8	5.6	6.0	7.2	27.2	4.5	10.3	18.6	50.3	60.2	1.7	12.3	6.8	7.1	7.7	1.2	2.0	1.6	21.0	0.0	17.3	6.9	7.3	8.4	4.8	11.1	1.5	22.2	2.8	3.1	5.3
SP5		ENSG00000204335	"Sp5 transcription factor"	Q6BEB4	2	170715337-170718078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 8.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 2.8;Cardiomyocytes: 3.1;Distal tubular cells: 3.9;Endometrial stromal cells: 7.1;Fibroblasts: 4.4;Intestinal goblet cells: 4.3;Spermatogonia: 3.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 122.1"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Low region specificity"	"Detected in some"			HPA074123			Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Nucleoplasm	"HPA074123: AB_2686664"	"unprognostic (1.16e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.77e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-8)"	"unprognostic (8.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.17e-1)"	2.5	1.2	0.5	0.2	0.5	0.0	1.4	2.2	0.3	8.8	0.5	1.5	1.0	3.7	0.4	1.2	1.2	0.2	0.2	0.2	1.4	0.2	2.1	0.5	0.2	0.3	1.4	0.4	0.4	0.3	0.1	0.2	0.2	1.7	0.2	0.0	1.5	0.2	0.2	4.6	1.4	0.1	0.0	0.0	3.1	0.8	1.8	0.1	0.1	0.0	0.8	1.5	2.2	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	27.7	0.1	0.0	0.5	0.0	0.5	1.5	0.3	0.0	0.0	3.5	0.3	0.4	0.1	122.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.0	2.3	0.0	0.0	0.0	0.1	0.0	0.1	0.3	4.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	2.2	0.3	0.2	1.4	0.3	1.4	0.2	0.0	1.8	0.2	0.2	0.0	0.0	0.3	0.0	0.8	0.1	0.0	2.8	0.0	0.2	0.3	3.1	0.0	0.0	1.8	0.0	1.5	0.1	0.3	3.9	0.0	0.2	2.3	7.1	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.0	1.3	0.0	0.0	0.0	2.5	0.2	0.0	0.4	4.3	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.4	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	3.7	0.2	0.1	0.3	0.2	0.0	1.6	0.0
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.8;skin 1: 14.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 57.5;Syncytiotrophoblasts: 98.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 11.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 92.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"		Yes	No				"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.72e-4)"	0.9	0.9	0.1	0.6	0.1	0.0	3.9	0.4	0.1	1.3	0.1	1.4	1.6	0.3	3.9	5.5	1.1	0.1	0.3	0.1	0.2	1.0	0.0	3.1	0.6	0.7	0.4	0.9	0.4	6.2	0.2	22.8	1.0	1.8	0.7	0.1	0.9	10.2	0.1	14.6	4.7	0.3	0.5	0.8	0.3	0.2	0.2	1.1	1.1	0.1	1.9	2.7	3.9	0.1	6.8	0.8	0.0	0.0	0.0	0.0	92.3	0.4	0.4	1.8	0.4	20.1	1.9	0.0	0.6	0.0	1.3	2.8	0.1	3.4	0.5	0.2	0.7	0.1	1.5	0.6	0.1	0.0	0.0	0.1	1.8	0.0	1.8	0.2	0.2	0.2	4.7	0.1	0.1	1.8	0.0	0.1	0.0	8.2	1.6	0.0	0.0	0.2	0.5	11.9	2.9	0.1	0.1	11.9	0.0	16.8	4.8	0.0	6.3	0.4	2.6	0.0	0.5	0.8	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.2	0.7	0.4	1.0	0.5	0.2	0.1	1.3	0.0	0.0	1.0	0.2	0.1	2.6	4.6	4.0	0.0	6.0	6.1	0.5	0.0	0.8	1.8	0.0	57.5	0.3	5.2	0.0	0.7	0.1	0.4	0.1	2.7	1.8	0.0	0.2	0.8	3.9	0.7	0.0	0.7	0.0	0.2	0.7	0.1	4.1	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	3.2	0.0	0.1	3.8	13.4	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.6	1.1	0.9	98.8	0.3	0.1	3.3	6.3
SP8		ENSG00000164651	"Sp8 transcription factor"	Q8IXZ3	7	20782279-20786886	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.6;prostate: 6.6"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 3.5;Inhibitory neurons: 5.3;Paneth cells: 1.2;Prostatic glandular cells: 2.9;Spermatocytes: 1.1;Spermatogonia: 1.5;Urothelial cells: 1.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;HUVEC TERT2: 6.4;NTERA-2: 12.6;PC-3: 21.6"	"Group enriched"	"Detected in many"	11	"basal ganglia: 15.3;olfactory bulb: 54.5"	"Region enriched"	"Detected in some"	11	"olfactory bulb: 29.8"	HPA054006	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA054006: AB_2682340"		"unprognostic (1.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-4)"		"unprognostic (3.46e-1)"	"unprognostic (5.49e-1)"	"unprognostic (1.73e-2)"		"unprognostic (2.42e-2)"		"unprognostic (3.38e-1)"	"unprognostic (7.44e-2)"			0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.6	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	1.2	0.0	0.0	0.0	4.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	12.6	0.1	21.6	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	2.7	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.9	0.0	4.6	0.8	2.7	3.5	0.0	0.7	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	0.0	0.0	0.0	0.0	0.2	1.0
SPAG7	"ACRP, FSA-1, MGC20134"	ENSG00000091640	"Sperm associated antigen 7"	O75391	17	4959226-4967817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 305.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024032, HPA052394"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA024032: AB_1857410, HPA052394: AB_2681810"	"unprognostic (7.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (4.66e-3)"	"unprognostic (5.51e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.72e-2)"	51.1	56.1	55.4	37.5	56.0	46.0	48.3	58.5	63.5	50.5	56.0	67.1	37.1	67.1	41.0	52.0	68.2	38.0	156.7	56.4	57.4	84.0	69.7	46.0	44.7	58.8	56.1	42.9	45.5	69.3	38.4	52.3	59.4	45.8	38.2	47.6	48.0	40.5	305.3	48.0	45.4	50.3	56.6	51.7	56.6	35.6	58.5	47.2	56.1	215.5	41.7	54.0	47.6	58.8	41.8	90.7	116.9	65.4	79.8	115.5	67.5	80.9	91.8	77.8	59.5	53.7	53.3	52.9	116.6	100.5	54.2	58.6	59.3	123.9	35.1	77.5	52.6	57.6	74.5	75.3	111.3	32.1	82.1	127.4	87.9	66.5	123.9	118.6	99.4	66.9	39.0	53.2	96.2	66.9	58.7	71.2	66.8	58.0	29.0	61.4	74.1	38.3	135.7	52.1	32.8	64.6	68.7	27.3	68.2	59.9	59.2	50.2	96.6	52.4	34.0	26.1	67.2	46.5	40.3	32.5	101.4	45.6	69.1	96.0	88.3	82.6	82.3	72.6	89.7	97.2	77.1	77.9	103.9	81.1	95.5	84.0	23.1	67.3	73.7	105.9	95.0	91.0	55.4	56.0	58.5	63.5	56.4	57.4	58.8	56.1	59.4	56.6	58.5	58.8	40.6	57.7	52.6	11.1	54.6	55.3	103.0	252.0	52.3	62.0	62.9	66.3	135.8	77.2	125.4	99.3	45.9	183.5	61.1	82.0	324.8	161.6	23.0	63.1	49.1	64.2	57.2	33.7	7.3	144.1	183.5	66.1	40.8	48.1	73.4	68.3	70.6	72.4	139.3	92.5	8.1	73.5	156.6	64.9	88.9	21.9	46.0	65.6	104.9	2.8	221.0	89.7	97.9	7.1	12.0	128.8	82.8	42.2	39.4	98.7	116.4	239.3	127.4	69.7	72.3	53.5	70.1	55.8	50.6	52.8	50.2	230.8	52.2	89.5	74.6	105.2
SPANXA1	"CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX"	ENSG00000198021	"Sperm protein associated with the nucleus, X-linked, family member A1"	Q9NS26	X	141583674-141585011	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 15.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-2 OS: 3.2"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"		Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.2	0.2	0.2	0.1	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXA2	SPANX	ENSG00000203926	"SPANX family member A2"	Q9NS26	X	141589708-141590762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	62	"testis: 20.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;GAMG: 1.3;PC-3: 1.3;U-2197: 1.5"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"		Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXB1	"CT11.2, SPANXB2, SPANXF1, SPANXF2"	ENSG00000227234	"SPANX family member B1"	Q9NS25	X	141002594-141003706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"testis: 88.8"	"Group enriched"	"Detected in some"	160	"Early spermatids: 686.8;Late spermatids: 2015.4"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.1;cervical cancer: 1.1;head and neck cancer: 2.1;lung cancer: 1.8;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 81.9;GAMG: 16.6;U-2 OS: 27.4"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (8.55e-2)"			0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.8	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.3	81.9	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	16.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	27.4	1.9	0.7	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	686.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2015.4	6.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	0.0	0.0	6.6	0.0	0.1	8.4	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXC	"CT11.3, CTp11"	ENSG00000198573	"SPANX family member C"	Q9NY87	X	141241463-141242517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"testis: 31.0"	"Group enriched"	"Detected in some"	209	"Early spermatids: 468.6;Late spermatids: 1668.9"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 11.8;U-2 OS: 6.2"									"HPA046423, HPA073647"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (3.56e-1)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	6.2	0.0	0.3	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	1.0	0.2	0.1	0.3	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	468.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1668.9	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXD	"CT11.4, SPANXE"	ENSG00000196406	"SPANX family member D"	Q9BXN6	X	141697411-141698739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	109	"testis: 23.2"	"Group enriched"	"Detected in some"	148	"Early spermatids: 491.4;Late spermatids: 1560.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 1.2;U-2 OS: 3.9"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	491.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1560.9	5.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXN2	"CT11.7, SPANX-N2"	ENSG00000268988	"SPANX family member N2"	Q5MJ10	X	143711955-143721423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 3.5"	"Group enriched"	"Detected in some"	154	"Early spermatids: 58.7;Late spermatids: 126.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045652			Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA045652: AB_2679408"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXN3	"CT11.8, SPANX-N3"	ENSG00000189252	"SPANX family member N3"	Q5MJ09	X	143508735-143517475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"testis: 48.9"	"Group enriched"	"Detected in some"	19	"Early spermatids: 456.5;Late spermatids: 271.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 1.8"									HPA045652			Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA045652: AB_2679408"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	456.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.5	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063556-32157637	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 55.2;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	5.8	5.9	9.0	7.2	12.7	9.9	6.2	10.8	12.9	8.6	1.6	7.1	7.4	7.7	5.0	6.9	6.5	6.5	3.9	9.0	10.6	5.9	9.6	6.3	9.7	10.8	11.2	9.1	5.3	6.2	4.4	6.8	10.5	6.3	7.5	6.9	4.2	5.3	7.8	7.4	8.0	7.3	11.6	7.0	6.3	9.8	10.7	14.1	8.5	10.0	9.2	7.3	4.4	13.9	17.5	12.2	19.7	19.5	12.0	14.2	17.8	9.4	13.7	9.7	8.6	16.9	14.8	30.2	8.5	13.1	14.2	12.0	19.5	9.6	11.9	20.7	11.8	33.3	6.0	20.5	11.0	23.2	22.4	7.9	12.3	12.4	11.6	11.7	21.5	9.6	27.6	10.0	10.7	7.4	37.8	19.4	20.5	19.2	7.1	19.8	27.9	19.5	13.0	10.7	27.9	29.9	16.0	13.2	15.9	16.0	8.7	15.8	18.8	10.6	16.2	9.5	11.1	14.7	29.7	23.8	11.6	19.9	13.0	1.8	3.5	3.8	1.8	4.9	2.5	2.4	2.8	2.9	3.9	1.9	2.9	3.0	5.3	3.9	3.8	1.7	4.2	2.5	9.0	12.7	10.8	12.9	9.0	10.6	10.8	11.2	10.5	11.6	10.7	13.9	15.0	9.6	4.4	26.4	12.2	9.6	5.9	7.9	11.4	15.4	11.7	6.9	8.0	8.6	7.9	5.5	22.9	9.6	21.4	11.4	0.0	6.6	4.4	16.9	11.8	11.3	10.8	10.3	38.9	8.0	7.4	8.1	9.7	13.7	10.1	16.7	7.9	12.0	9.7	10.1	55.2	10.8	10.2	17.5	9.9	8.5	8.7	17.6	1.8	36.5	21.1	7.9	18.6	59.3	62.7	10.4	9.8	10.1	12.5	8.7	10.9	7.0	13.0	14.1	0.0	11.9	11.9	16.7	21.2	11.7	13.1	8.1	13.3	10.9	10.4	7.2
SPATA12		ENSG00000186451	"Spermatogenesis associated 12"	Q7Z6I5	3	57060664-57075432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 20.5"	"Group enriched"	"Detected in some"	145	"Early spermatids: 464.2;Late spermatids: 1195.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;RH-30: 1.1"									"HPA043323, HPA075578"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA043323: AB_10796792, HPA075578: "	"unprognostic (2.31e-1)"	"unprognostic (2.18e-4)"	"unprognostic (3.47e-4)"	"unprognostic (2.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.71e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-3)"	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.2	0.2	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.3	0.2	2.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	20.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.0	1.1	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.7	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.2	0.6	2.0	0.8	0.7	0.5	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	464.2	1.0	0.1	0.6	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	1.3	0.0	1195.5	5.0	0.5	0.0	1.0	0.0	0.0	0.0	1.0	0.7	1.4	0.1	5.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	2.8	0.3	0.0	0.0	0.3	0.0	0.2	0.5
SPATA13	"ARHGEF29, FLJ31208"	ENSG00000182957	"Spermatogenesis associated 13"	Q96N96	13	23979805-24307074	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 65.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 102.6;Oligodendrocytes: 206.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 33.4;HDLM-2: 46.4"									"HPA040185, HPA041208"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA040185: AB_10795521, HPA041208: AB_10794193"	"unprognostic (8.80e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.21e-1)"	"prognostic favorable (1.16e-4)"	6.9	14.3	17.7	18.8	31.6	31.2	14.4	26.2	31.5	10.6	34.2	11.0	11.9	9.4	14.2	3.7	9.9	12.1	8.6	19.7	23.5	21.8	24.4	20.4	23.4	42.3	31.8	14.4	38.4	6.5	9.6	10.6	37.3	14.6	12.4	4.8	8.2	6.6	2.5	7.8	13.3	7.5	25.7	65.3	17.9	6.4	29.6	18.6	12.9	6.4	16.6	9.6	5.2	40.1	3.1	5.0	25.6	3.2	0.9	2.1	1.0	7.7	33.4	3.9	3.3	6.5	13.2	20.4	4.1	7.0	2.0	5.7	7.4	2.3	9.7	46.4	8.9	4.9	4.6	7.5	1.2	7.9	3.7	2.8	0.3	4.2	2.4	3.4	6.5	10.7	0.0	16.7	4.1	11.2	14.6	2.7	8.4	21.5	6.4	12.5	9.9	11.0	17.3	9.9	9.3	7.1	1.5	16.3	15.0	5.5	2.3	4.5	7.6	5.1	4.0	0.4	5.5	3.8	0.1	0.0	4.4	7.5	24.4	5.0	6.4	0.0	33.6	8.4	26.2	2.6	28.6	35.3	4.7	2.0	30.1	31.3	39.2	20.4	10.6	5.2	29.8	13.3	17.7	31.6	26.2	31.5	19.7	23.5	42.3	31.8	37.3	25.7	29.6	40.1	9.0	3.2	23.9	61.0	8.6	5.4	3.2	2.5	4.6	3.2	39.5	17.9	5.3	0.0	17.8	14.7	0.0	1.3	18.6	27.4	3.9	25.3	10.8	58.3	12.9	29.0	32.3	6.3	9.2	15.8	14.1	12.5	51.0	102.6	70.2	4.9	0.0	0.0	10.1	0.0	11.1	24.9	4.1	0.0	8.5	6.3	7.5	29.8	5.4	62.8	15.2	14.1	66.9	19.6	206.5	13.5	32.0	7.5	2.8	23.8	25.0	7.2	40.5	0.8	0.0	21.9	8.2	2.2	2.2	4.6	6.1	22.3	37.8	34.5	23.7	17.0
SPATA17	"CFAP305, FAP305, IQCH, MOT17"	ENSG00000162814	"Spermatogenesis associated 17"	Q96L03	1	217631324-217871696	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 10.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 770.1;Endometrial ciliated cells: 117.8;Late spermatids: 518.2;Respiratory ciliated cells: 150.1;Spermatocytes: 284.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030099	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli"		"HPA030099: AB_2270988"	"unprognostic (4.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.24e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.82e-1)"	0.1	0.2	0.5	0.2	0.5	1.6	0.5	0.9	0.6	0.4	2.0	0.2	0.4	0.4	3.4	0.3	4.1	0.3	0.2	0.7	0.5	0.8	0.1	0.5	0.2	1.4	1.3	0.3	0.3	2.6	0.4	0.2	1.5	0.3	0.2	1.7	0.3	0.3	2.1	0.6	0.4	0.1	0.7	0.2	0.3	10.3	0.7	0.1	0.7	0.1	0.1	0.1	0.0	0.9	0.1	0.3	0.4	0.3	0.1	0.5	0.3	0.1	0.2	0.1	0.0	0.2	0.9	0.1	0.3	0.1	0.1	0.8	0.2	0.3	0.1	0.1	0.3	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.6	0.3	0.3	0.4	0.0	0.2	0.2	0.3	0.1	0.7	0.1	0.3	0.6	0.4	0.3	0.1	0.1	0.1	0.6	0.3	1.4	0.6	0.2	0.2	0.2	0.5	0.4	0.1	0.1	0.2	0.2	0.3	0.1	0.3	0.2	0.1	0.6	0.1	0.3	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.5	0.5	0.9	0.6	0.7	0.5	1.4	1.3	1.5	0.7	0.7	0.9	0.2	3.2	0.0	10.7	0.1	0.6	0.9	6.6	0.0	0.4	2.1	1.9	2.1	0.0	18.4	3.7	20.9	0.9	0.0	0.4	5.9	2.4	770.1	117.8	3.4	0.6	1.8	0.0	5.1	0.7	0.6	1.6	0.5	3.2	0.0	2.0	0.0	0.0	0.2	0.0	3.3	1.3	12.2	0.0	0.3	518.2	8.7	0.5	1.8	2.8	0.0	4.4	0.0	5.0	1.3	0.3	0.2	6.8	0.3	1.0	0.2	10.6	150.1	18.5	0.0	2.0	2.3	284.7	8.4	0.4	1.0	0.3	0.3	2.8	0.9	0.4
SPATA2	"KIAA0757, PD1, PPP1R145, tamo"	ENSG00000158480	"Spermatogenesis associated 2"	Q9UM82	20	49903391-49915529	"Predicted intracellular proteins"	Necrosis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.2;Late spermatids: 62.5;Spermatocytes: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048581, HPA052224"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA048581: AB_2680449, HPA052224: AB_2681769"	"unprognostic (4.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-3)"	"unprognostic (8.77e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (8.33e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.57e-2)"	"unprognostic (4.38e-1)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (2.52e-1)"	3.9	5.8	19.9	3.7	21.6	12.2	3.7	17.5	20.9	3.9	8.1	7.8	7.8	5.3	3.6	5.6	4.7	3.4	6.9	21.0	16.7	5.0	5.8	4.0	3.6	17.2	19.0	4.5	8.0	5.6	7.9	3.5	16.7	5.8	6.3	6.5	5.9	3.9	13.1	5.0	7.5	3.1	17.0	11.4	5.7	14.3	21.1	3.8	8.0	7.8	3.6	4.1	3.7	21.5	7.8	9.4	6.3	5.7	7.0	5.0	10.3	4.9	7.2	16.7	7.0	29.7	6.1	5.9	10.1	4.9	8.6	14.1	4.7	8.1	8.8	8.3	4.5	3.1	5.6	19.5	6.6	8.5	12.2	5.0	9.6	8.6	5.4	5.5	3.6	8.2	10.8	6.6	4.0	16.5	8.7	21.5	9.5	10.5	11.3	6.5	6.8	6.2	5.4	6.1	6.0	6.4	9.8	29.6	7.8	4.9	7.2	7.3	5.1	11.9	9.8	9.9	7.0	16.2	13.4	6.3	9.3	4.4	5.4	0.1	1.5	1.4	1.4	1.1	1.3	1.3	1.3	1.7	1.3	2.1	1.6	1.9	2.5	1.5	0.5	0.6	1.5	1.0	19.9	21.6	17.5	20.9	21.0	16.7	17.2	19.0	16.7	17.0	21.1	21.5	5.4	9.6	2.2	2.9	7.8	7.4	6.6	4.3	12.5	7.4	11.9	8.6	4.9	10.0	2.8	0.0	8.4	11.0	8.3	34.7	3.9	6.0	45.2	11.4	4.7	6.3	26.4	1.7	6.8	8.0	13.4	5.4	9.7	9.0	4.5	5.4	10.4	7.1	4.8	6.7	5.0	22.2	2.0	4.4	5.4	62.5	5.0	3.6	5.4	1.9	7.0	5.4	4.1	2.0	8.5	8.3	16.1	5.7	6.4	7.4	20.7	4.8	6.7	7.6	6.6	5.8	6.6	41.3	16.9	7.8	7.2	30.1	6.8	10.3	18.4	8.5
SPATA20	"FLJ21347, SSP411, Tisp78"	ENSG00000006282	"Spermatogenesis associated 20"	Q8TB22	17	50543058-50555852	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 117.5"	"Group enriched"	"Detected in all"	15	"Early spermatids: 594.1;Late spermatids: 1543.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 60.1;MCF7: 59.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022023, HPA027144, HPA031442"	Enhanced		Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557"	"unprognostic (9.27e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.63e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (7.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.12e-3)"	"unprognostic (4.93e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (9.69e-5)"	10.3	36.8	25.7	7.2	24.6	4.4	10.5	25.5	33.2	16.9	30.0	14.8	10.0	18.0	9.7	10.1	13.7	12.9	33.3	24.2	27.6	18.6	17.6	8.9	6.4	26.9	28.0	21.1	22.0	17.0	11.7	6.4	27.5	17.1	6.4	3.2	17.7	11.2	18.5	8.6	10.8	8.3	26.0	14.1	22.0	117.5	33.1	2.3	22.5	18.4	3.8	14.6	10.3	24.8	8.8	39.4	4.8	25.7	7.9	22.7	6.0	14.9	24.2	9.2	7.3	29.1	12.9	9.2	38.4	13.9	8.9	7.0	1.4	6.3	4.2	14.4	5.3	7.4	9.5	60.1	27.8	2.4	17.1	33.3	8.8	4.7	13.0	17.9	11.6	2.4	0.7	16.8	5.5	59.3	0.0	2.1	3.1	19.0	18.0	4.4	6.9	2.9	35.4	39.5	4.5	11.3	13.0	12.1	17.0	5.6	21.0	1.1	19.7	9.8	22.2	5.6	3.7	31.8	14.0	0.2	14.9	1.4	6.9	0.0	5.0	1.0	1.6	4.5	1.9	2.8	1.2	1.1	8.3	1.7	1.5	1.7	0.2	7.3	3.4	1.6	0.8	3.7	25.7	24.6	25.5	33.2	24.2	27.6	26.9	28.0	27.5	26.0	33.1	24.8	12.6	6.4	5.0	17.3	14.0	10.7	15.1	13.4	25.6	5.3	13.3	17.4	32.5	20.0	13.1	23.9	4.2	17.3	9.8	32.6	27.4	35.6	594.1	13.0	13.2	11.7	37.9	6.1	10.3	39.0	10.3	23.5	66.8	23.2	17.7	38.5	10.8	26.7	34.6	11.8	9.5	28.4	16.2	23.6	14.8	1543.1	38.2	20.0	21.4	6.5	19.3	26.9	12.3	8.5	2.3	23.7	31.1	38.0	17.9	12.2	18.4	38.8	5.9	2.4	6.6	18.1	19.1	10.0	13.8	11.9	8.8	9.9	11.2	39.9	23.8	17.1
SPATA24	"CCDC161, T6441"	ENSG00000170469	"Spermatogenesis associated 24"	Q86W54	5	139396563-139404089	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 147.0"	"Group enriched"	"Detected in many"	26	"Early spermatids: 1073.6;Late spermatids: 2829.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 85.6"									HPA044000	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA044000: AB_10959668"	"unprognostic (2.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	2.9	7.1	6.1	2.9	5.4	1.8	4.1	5.5	7.1	3.3	5.8	4.6	6.5	4.1	21.0	3.4	15.0	3.8	20.6	5.9	6.6	15.0	5.1	3.1	7.2	7.8	8.0	4.2	5.3	12.5	12.7	3.1	7.0	4.9	2.9	6.5	6.6	4.0	23.0	2.9	7.1	2.9	7.6	4.0	4.3	147.0	6.2	3.1	7.3	19.2	5.4	3.9	3.2	6.1	13.4	8.4	11.6	6.3	3.3	6.5	9.2	3.3	6.3	7.0	12.0	18.7	17.2	21.0	9.5	6.4	23.5	7.3	8.7	14.6	7.4	85.6	10.4	6.5	15.7	14.4	12.7	1.4	11.1	5.7	7.1	10.2	12.6	7.7	8.3	13.3	6.5	36.1	9.3	7.4	13.8	10.1	8.5	5.4	7.1	31.6	7.5	28.9	16.3	7.2	8.8	8.0	12.8	24.2	6.0	28.0	7.0	14.5	15.3	4.1	5.3	7.7	9.5	8.7	8.9	19.4	7.6	10.8	3.4	0.0	2.1	1.5	3.0	1.6	4.1	3.5	3.1	3.5	2.4	1.9	3.4	4.8	0.1	2.0	0.6	1.4	1.5	1.5	6.1	5.4	5.5	7.1	5.9	6.6	7.8	8.0	7.0	7.6	6.2	6.1	2.2	0.0	4.1	2.6	3.4	1.7	6.4	6.4	2.8	0.3	3.8	3.4	24.7	7.2	3.7	5.5	8.4	6.0	2.3	3.0	13.7	4.6	1073.6	14.9	1.6	4.1	0.0	0.8	1.0	1.8	3.2	2.2	2.0	2.4	0.0	3.6	4.2	3.7	5.2	1.7	1.3	1.5	2.0	2.7	1.4	2829.6	14.3	2.4	1.8	0.0	1.5	3.3	7.2	0.5	0.9	2.6	3.1	13.5	1.7	3.3	6.8	36.5	20.8	1.4	26.3	3.7	4.1	75.0	18.2	2.4	1.8	4.5	3.2	8.5	3.1	5.4
SPATA2L	"C16orf76, MGC26885, tamo"	ENSG00000158792	"Spermatogenesis associated 2 like"	Q8IUW3	16	89696357-89701705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041182, HPA042453"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA041182: AB_2677352, HPA042453: AB_2678005"	"unprognostic (1.22e-1)"	"unprognostic (9.04e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.86e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.86e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.55e-1)"	6.7	5.1	5.7	2.3	6.6	5.0	4.9	4.8	8.7	3.9	5.2	6.2	5.9	6.1	0.7	5.8	6.2	2.2	4.9	8.0	4.9	10.3	13.6	7.1	1.5	4.9	3.8	5.4	14.2	2.2	16.7	1.8	3.1	5.9	0.8	0.6	5.7	1.3	1.3	7.7	7.1	1.4	2.6	6.0	6.9	4.9	4.2	1.7	7.0	0.3	0.8	3.8	3.5	6.3	7.4	5.8	2.0	9.6	1.5	1.6	10.7	4.9	2.3	2.3	1.5	11.1	6.2	2.5	6.6	1.6	3.1	12.5	1.8	2.8	0.5	2.5	19.9	1.7	2.2	15.3	5.1	1.3	5.0	1.6	3.5	3.6	1.1	2.6	2.6	2.9	7.7	1.7	1.6	34.0	4.3	8.0	5.4	7.6	7.5	9.4	1.0	7.4	3.4	2.6	11.0	7.0	5.3	5.4	6.5	0.9	14.0	5.7	6.7	2.3	8.5	0.4	2.3	4.2	2.8	2.3	6.9	4.1	4.4	2.8	4.0	5.3	5.5	6.5	3.9	3.7	3.9	4.2	4.4	4.1	3.5	3.9	13.7	2.1	4.9	4.6	3.7	4.1	5.7	6.6	4.8	8.7	8.0	4.9	4.9	3.8	3.1	2.6	4.2	6.3	5.9	3.2	0.5	2.3	10.8	15.7	18.7	7.7	5.2	9.5	11.0	6.6	0.4	7.2	3.1	11.0	0.0	8.7	18.4	27.8	1.9	13.7	7.4	7.6	3.2	6.3	23.8	0.0	13.6	13.8	5.7	6.4	9.2	9.3	4.5	2.1	6.1	5.7	7.4	3.3	7.1	7.6	14.2	6.1	13.2	1.5	2.8	9.1	8.8	2.8	4.3	6.6	8.2	2.5	1.3	12.7	21.8	2.2	8.6	12.7	32.3	10.3	1.5	8.0	0.0	9.3	7.0	2.7	2.5	2.6	19.9	24.9	10.5	4.7	9.3	11.7
SPATA33	"C16orf55, FLJ31606"	ENSG00000167523	"Spermatogenesis associated 33"	Q96N06	16	89657740-89671272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"testis: 114.0"	"Group enriched"	"Detected in all"	8	"Early spermatids: 1778.0;Late spermatids: 4200.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045648, HPA073096"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Vesicles	"HPA045648: AB_2679405, HPA073096: AB_2686570"	"unprognostic (1.05e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.03e-3)"	"unprognostic (8.82e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-1)"	3.6	4.2	7.0	2.8	7.0	3.4	4.3	6.1	8.9	5.1	9.1	5.2	5.0	4.5	8.9	5.3	12.6	2.8	4.0	7.6	6.6	11.8	6.2	5.9	2.4	6.7	7.1	3.2	5.1	3.6	9.7	1.8	6.7	6.4	2.9	6.7	4.3	2.5	2.0	4.3	9.2	2.4	5.5	5.8	5.0	114.0	6.8	3.6	8.3	1.2	2.9	4.3	4.8	6.7	11.1	11.8	13.4	5.5	3.5	3.1	4.9	7.8	2.5	10.6	4.7	11.5	10.6	1.2	3.8	5.0	8.0	15.1	6.2	3.7	8.5	2.2	9.7	2.0	17.4	16.1	1.5	2.3	4.5	3.1	5.1	7.9	3.2	4.0	2.3	11.0	12.6	1.9	7.1	14.7	7.4	6.6	7.3	7.3	9.3	14.3	7.4	4.0	6.2	3.9	13.2	7.0	17.9	3.0	4.4	6.3	13.5	3.3	2.8	7.8	10.7	6.9	5.9	4.4	7.1	4.4	8.1	14.5	3.5	2.4	1.1	2.1	1.6	1.3	2.2	2.3	1.7	2.2	0.9	0.9	1.8	1.4	1.4	3.2	1.0	2.0	1.2	1.4	7.0	7.0	6.1	8.9	7.6	6.6	6.7	7.1	6.7	5.5	6.8	6.7	14.7	6.4	9.7	4.6	10.3	7.1	8.6	16.4	8.0	18.2	14.9	14.7	6.6	15.7	13.5	29.5	64.6	4.1	10.2	16.0	23.5	15.9	1778.0	94.9	13.3	13.3	17.5	22.7	7.0	17.7	5.6	13.0	32.1	11.9	1.3	11.4	8.9	14.6	9.0	23.5	4.4	9.9	12.2	2.9	8.0	4200.3	30.4	9.5	17.8	3.7	5.8	17.0	16.5	1.0	5.1	14.2	18.9	23.7	11.1	6.7	35.6	33.4	97.8	82.5	13.1	11.8	11.4	348.5	101.2	13.5	7.1	1.4	12.8	13.9	17.1	5.5
SPATA5L1	"FLJ12286, MGC5347"	ENSG00000171763	"Spermatogenesis associated 5 like 1"	Q9BVQ7	15	45402336-45421415	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043679	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Nucleoli	"HPA043679: AB_10964179"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.57e-2)"	"unprognostic (9.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.80e-2)"	4.5	4.9	4.7	4.6	5.1	6.3	4.5	5.5	6.2	5.5	4.4	5.2	5.9	4.4	3.9	10.0	5.0	2.7	5.7	4.9	5.0	6.0	7.5	3.3	4.6	4.9	4.8	6.1	5.8	4.3	3.1	5.2	5.0	4.2	4.8	4.6	4.4	3.9	8.9	7.4	5.5	4.4	5.0	4.5	4.5	3.4	5.2	4.9	5.3	5.4	5.0	5.4	6.0	5.6	10.0	6.3	9.9	7.3	8.0	7.8	12.0	8.7	7.9	9.3	9.0	17.3	6.3	7.3	9.5	5.8	16.9	22.5	14.8	10.9	10.3	10.0	8.4	9.5	11.2	13.6	9.0	12.8	4.0	6.2	12.2	7.7	10.1	10.6	7.4	9.4	15.6	11.4	10.5	6.7	8.9	24.5	7.1	24.8	9.7	9.8	13.9	6.8	11.7	9.8	13.5	6.9	7.2	15.5	8.4	11.7	13.7	23.1	4.7	4.5	6.9	27.8	18.8	9.7	20.8	11.3	11.6	20.8	8.3	0.0	0.9	1.2	1.1	0.7	0.4	0.6	0.7	1.5	0.9	0.7	0.6	0.9	1.1	1.1	1.9	1.0	0.8	0.2	4.7	5.1	5.5	6.2	4.9	5.0	4.9	4.8	5.0	5.0	5.2	5.6	4.7	0.0	1.1	7.2	8.9	5.0	8.9	4.6	5.2	7.9	3.7	2.4	6.9	7.2	5.2	3.7	16.7	12.2	7.3	5.4	3.9	6.2	20.6	6.2	5.4	6.3	3.6	2.5	11.0	7.3	11.9	5.2	9.2	8.4	4.5	8.6	1.1	5.7	8.0	6.7	10.1	6.3	0.0	3.7	7.6	7.1	7.8	7.7	3.6	6.5	7.7	5.0	2.1	16.6	14.6	5.5	3.1	3.8	8.5	6.2	9.2	5.7	2.4	6.5	0.0	4.1	4.1	6.2	5.6	10.4	6.8	6.7	5.8	6.1	7.3	8.2
SPATA6	"FLJ10007, SRF-1, SRF1"	ENSG00000132122	"Spermatogenesis associated 6"	Q9NWH7	1	48295373-48472208	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 1475.4;Late spermatids: 4697.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 5.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 3.6;monocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 12.9;ASC TERT1: 20.9;HSkMC: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028234			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA028234: AB_2672532"	"unprognostic (1.36e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.89e-2)"	"unprognostic (5.71e-3)"	6.0	8.1	6.2	2.0	9.7	1.0	7.2	6.9	6.4	7.8	7.2	5.2	2.7	5.8	6.1	3.4	15.3	4.9	4.4	5.9	8.0	6.1	1.7	5.9	2.2	8.6	8.5	8.9	4.6	10.6	8.6	4.7	8.6	5.4	3.9	13.3	6.3	7.4	1.7	4.4	3.3	4.4	7.3	3.7	6.7	50.1	9.6	3.2	9.5	3.7	1.6	6.0	6.3	11.9	0.2	1.2	11.6	12.9	10.5	20.9	1.6	1.3	4.9	0.9	0.8	0.1	0.8	0.0	0.7	2.1	6.1	0.3	0.9	2.9	0.8	0.9	1.6	0.1	0.5	0.6	2.2	0.0	0.8	15.0	2.2	1.9	0.7	6.3	4.7	1.8	0.1	0.0	4.9	0.4	0.1	0.2	4.9	0.9	1.2	3.7	0.0	1.1	7.1	2.0	2.8	6.3	4.8	0.4	11.3	9.5	2.8	0.7	1.4	1.7	1.7	2.7	1.9	0.0	0.0	0.0	7.0	0.1	7.7	0.0	1.2	3.6	0.0	2.8	0.0	0.1	0.2	0.0	1.1	0.0	0.4	0.3	0.1	0.2	5.9	0.5	0.0	0.5	6.2	9.7	6.9	6.4	5.9	8.0	8.6	8.5	8.6	7.3	9.6	11.9	14.8	3.2	10.0	151.8	2.0	5.6	16.7	6.4	9.1	17.0	13.1	19.9	3.5	28.6	12.5	16.5	45.9	0.4	5.1	3.9	17.6	8.9	1475.4	77.3	18.9	10.5	9.6	2.1	43.9	10.2	0.6	29.8	35.2	9.0	16.5	5.0	16.1	2.4	5.1	32.0	35.0	5.7	12.2	17.9	9.2	4697.2	36.7	14.9	19.6	68.4	10.5	23.4	3.1	563.5	341.6	4.5	3.8	25.2	2.0	6.2	3.4	10.3	67.3	45.7	19.7	47.5	14.7	110.5	23.8	6.7	5.3	0.3	1.6	11.5	5.7	9.7
SPATA7	"HSD3, LCA3"	ENSG00000042317	"Spermatogenesis associated 7"	Q9P0W8	14	88384924-88470350	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.0"	"Group enriched"	"Detected in many"	9	"Early spermatids: 946.9;Late spermatids: 1152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038082, HPA038083"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA038082: AB_10671738, HPA038083: AB_10671519"	"unprognostic (2.09e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.50e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-3)"	"prognostic favorable (4.16e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.81e-2)"	5.8	6.0	8.6	1.6	10.4	1.7	6.0	28.4	9.5	7.2	6.7	5.8	2.2	6.6	7.0	2.8	8.3	5.5	5.4	8.6	10.4	9.5	5.1	4.6	1.8	8.6	9.2	12.3	7.9	7.6	11.1	2.8	8.6	6.6	3.1	10.2	4.1	4.6	5.0	5.6	3.2	4.7	8.9	3.6	5.0	57.0	9.2	3.0	12.1	4.5	1.2	5.4	4.9	11.2	2.3	3.7	5.5	7.5	8.8	16.5	6.0	5.2	9.3	5.1	3.4	1.2	4.5	2.2	2.5	5.7	3.8	2.3	2.5	4.0	4.8	3.2	1.8	0.5	1.9	2.1	12.7	3.9	0.5	7.8	6.6	2.1	3.9	16.8	9.4	5.0	1.3	2.7	4.8	2.8	2.8	3.7	1.4	2.9	4.6	3.9	5.6	1.3	8.1	1.9	3.9	4.9	5.1	6.7	5.0	6.5	6.0	4.2	4.9	3.7	4.0	5.2	2.9	2.6	2.1	1.3	6.2	1.1	2.6	0.0	1.0	0.2	2.1	1.4	2.5	1.9	1.7	1.0	2.1	0.4	1.0	1.8	0.8	0.4	0.9	2.1	0.7	1.0	8.6	10.4	28.4	9.5	8.6	10.4	8.6	9.2	8.6	8.9	9.2	11.2	7.8	12.8	7.3	38.5	1.5	2.4	7.6	9.8	7.4	10.8	6.3	8.5	12.0	7.2	8.8	3.7	20.9	2.6	5.3	1.1	9.8	11.0	946.9	22.3	13.2	6.8	16.3	1.3	113.0	7.2	3.6	11.8	4.1	4.2	1.3	19.4	7.9	4.5	5.7	15.2	91.6	4.0	12.2	17.2	2.8	1152.6	20.5	6.7	8.8	25.3	4.0	12.5	2.1	49.8	54.7	5.6	4.3	17.0	0.9	3.0	1.4	26.0	32.7	20.5	6.6	15.0	7.9	37.5	14.7	3.0	2.0	1.1	3.3	20.5	4.5	3.3
SPATS1	"FLJ25442, SPATA8, SRSP1"	ENSG00000249481	"Spermatogenesis associated serine rich 1"	Q496A3	6	44342650-44380179	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 5.9;fallopian tube: 7.6;testis: 22.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 30.9;Late spermatids: 12.1;Respiratory ciliated cells: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SK-MEL-30: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030897, HPA049722"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA030897: AB_2673647, HPA049722: AB_2680861"				"unprognostic (2.30e-3)"														0.0	0.1	0.7	0.0	0.7	0.2	0.0	0.6	0.8	0.2	0.7	0.0	0.0	0.2	5.9	0.0	7.6	0.0	0.1	0.8	0.8	0.0	0.0	0.6	0.1	1.4	2.1	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.1	22.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.4	0.1	0.0	0.1	7.9	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.7	0.7	0.6	0.8	0.8	0.8	1.4	2.1	1.2	1.3	0.7	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.9	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24 component of NDC80 kinetochore complex"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.0;lymphoid tissue: 14.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 35.0;Extravillous trophoblasts: 15.5;Hofbauer cells: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	1.9	1.7	1.3	4.8	1.5	26.0	1.2	3.9	2.1	2.1	1.7	4.7	4.5	2.7	0.8	5.0	1.3	2.3	2.7	1.6	1.5	0.8	1.6	1.6	6.3	1.1	0.8	1.3	1.1	0.4	0.4	3.2	1.3	1.6	4.3	1.2	1.3	2.0	4.0	3.9	4.1	8.1	0.5	3.1	2.9	4.3	1.4	14.7	0.9	1.1	6.5	2.5	2.0	2.4	73.6	26.9	36.9	30.1	5.0	9.7	16.6	42.3	15.7	38.6	43.6	28.4	24.6	58.2	46.0	18.5	22.8	38.8	29.0	30.3	28.7	30.9	24.9	78.5	68.9	43.2	1.1	55.5	33.7	1.9	1.1	27.8	12.8	10.0	34.7	62.3	42.8	118.3	27.6	48.7	76.4	32.9	25.5	19.8	43.9	59.8	56.7	18.6	11.2	23.8	38.4	27.2	37.0	22.4	9.6	17.5	22.0	19.8	33.2	36.8	38.3	49.6	51.2	70.5	39.8	55.6	26.9	53.9	30.5	1.9	0.4	0.4	0.5	0.5	0.4	0.8	0.9	1.5	0.2	0.7	0.9	0.6	2.2	2.0	0.5	0.5	1.7	0.3	1.3	1.5	3.9	2.1	1.6	1.5	1.1	0.8	1.3	0.5	1.4	2.4	0.2	0.0	0.5	0.3	1.5	1.1	1.2	1.3	0.0	0.0	1.0	0.4	9.0	1.5	0.8	5.5	6.2	10.0	0.9	2.8	0.0	0.2	0.3	1.0	2.2	2.2	2.4	35.0	0.3	0.0	15.5	3.5	3.6	1.8	5.7	6.5	4.6	0.7	14.0	0.0	0.3	2.6	0.0	3.0	2.5	3.0	0.6	1.0	0.0	1.0	0.0	2.1	2.1	0.5	0.3	0.3	0.0	0.4	6.3	0.3	0.7	0.6	0.2	0.6	0.0	1.3	2.4	6.9	10.8	2.1	0.3	2.1	2.2	0.5	6.6	1.2
SPCS2	KIAA0102	ENSG00000118363	"Signal peptidase complex subunit 2"	Q15005	11	74949247-74979033	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 933.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013386	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA013386: AB_1857426"	"unprognostic (2.43e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (7.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.04e-3)"	"unprognostic (9.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.62e-2)"	81.0	99.4	86.4	104.9	96.6	60.1	108.2	98.7	131.1	127.5	88.8	119.3	90.5	92.2	220.1	72.8	95.9	66.5	76.2	86.3	102.7	105.6	151.6	79.5	98.2	98.5	93.3	84.3	137.3	147.7	75.1	81.2	98.9	106.9	115.1	75.4	139.0	93.3	71.4	56.6	83.3	93.1	99.7	92.5	105.5	50.4	94.3	97.8	143.9	69.5	154.8	95.0	68.1	107.7	141.7	163.4	213.2	192.2	183.2	122.0	115.9	198.6	192.4	179.0	154.8	322.9	311.7	228.2	244.1	168.9	213.6	254.2	187.3	146.1	220.5	190.0	136.4	232.2	189.7	268.9	208.1	249.3	156.7	109.7	186.1	151.5	245.5	156.8	173.7	166.6	271.9	578.0	163.9	215.0	179.1	158.0	131.0	558.3	153.5	219.2	328.2	522.4	208.2	232.3	172.3	172.6	198.1	262.9	687.6	146.7	254.1	187.6	142.0	201.9	124.9	212.1	177.5	245.1	268.8	423.8	83.0	173.4	209.4	546.3	229.2	219.2	279.8	231.0	315.2	400.7	253.7	269.4	222.0	344.3	191.7	229.5	148.5	260.9	209.8	459.5	272.0	428.3	86.4	96.6	98.7	131.1	86.3	102.7	98.5	93.3	98.9	99.7	94.3	107.7	192.3	86.6	143.6	40.5	323.2	304.5	314.0	812.0	129.7	97.6	212.6	199.9	69.1	214.4	406.0	239.1	52.1	330.8	233.5	130.3	189.8	290.0	36.5	126.4	250.4	181.4	125.4	191.5	46.6	288.0	334.4	239.4	104.5	240.2	155.2	114.7	158.1	338.0	278.9	95.9	55.4	255.1	431.3	140.1	283.3	27.2	240.8	159.7	521.2	23.4	188.6	215.6	197.8	48.7	73.5	253.2	140.0	195.6	933.5	355.5	141.7	280.8	231.1	87.3	170.9	153.6	253.6	127.8	133.1	112.1	229.4	464.8	204.6	192.2	189.5	298.1
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 140.7;salivary gland: 114.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 94.2;Breast myoepithelial cells: 61.1;Intestinal goblet cells: 315.1;Prostatic glandular cells: 72.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 388.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 288.4;OE19: 118.0;SK-BR-3: 192.2;T-47d: 154.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"midbrain: 2.9"	HPA055707			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.4	0.1	0.5	1.4	0.5	0.1	36.6	0.8	1.1	28.0	0.0	18.4	11.6	9.0	0.5	2.2	6.3	2.4	0.4	0.5	0.2	0.1	0.1	1.1	0.0	0.3	0.4	0.1	0.6	0.0	0.2	0.0	0.2	140.7	10.2	0.0	114.8	0.1	0.3	9.3	14.3	0.6	0.1	0.1	35.4	0.3	0.5	0.0	0.1	0.0	0.0	1.0	0.3	0.5	0.0	30.9	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.4	0.3	0.4	0.0	118.0	38.6	0.1	0.0	0.3	0.3	0.3	2.1	0.2	0.0	192.2	0.0	0.0	154.0	0.0	0.0	0.0	0.5	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.8	1.1	0.5	0.2	0.3	0.4	0.2	0.1	0.5	0.5	0.8	0.0	2.2	0.7	0.3	0.1	13.3	20.7	0.0	0.0	94.2	61.1	0.3	5.7	31.7	0.0	0.0	0.0	1.4	27.1	0.0	2.6	1.1	6.2	0.7	0.6	5.4	0.0	0.8	1.2	0.0	0.4	28.1	18.7	0.0	0.2	0.4	0.0	0.0	0.0	0.6	315.1	12.2	0.0	0.2	5.5	0.0	0.9	3.6	0.0	0.0	0.0	0.0	0.0	0.2	20.2	12.3	0.0	0.1	72.7	5.7	0.0	2.9	0.0	0.0	0.0	1.2	0.1	0.2	0.0	0.0	0.3	0.8	0.0	30.0	11.5
SPDYA	"Ringo3, SPDY1, SPY1"	ENSG00000163806	"Speedy/RINGO cell cycle regulator family member A"	Q5MJ70	2	28782517-28850611	"Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"testis: 32.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 58.8;Spermatocytes: 225.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.6;THP-1: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035162, HPA066214"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA035162: AB_2674501, HPA066214: AB_2685636"	"unprognostic (3.41e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.10e-4)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.66e-13)"	"unprognostic (8.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.55e-5)"	0.8	0.9	0.2	0.2	0.2	0.6	0.7	0.2	0.3	1.8	0.0	0.8	0.5	0.7	0.0	0.9	0.9	0.5	0.8	0.3	0.0	1.7	1.4	0.7	0.5	0.0	0.0	1.4	0.8	0.0	1.4	0.2	0.0	1.7	0.0	1.0	0.7	0.0	0.3	1.6	0.9	0.0	0.0	1.8	0.8	32.5	0.1	0.0	1.2	0.0	0.0	0.7	1.0	0.1	0.4	0.2	0.7	1.6	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.4	0.3	0.3	0.5	0.0	0.4	1.0	0.1	0.0	0.1	0.2	0.4	0.3	1.0	1.3	0.0	0.5	0.7	0.1	0.0	0.1	0.2	0.3	0.0	0.3	0.2	0.6	0.3	0.2	0.1	2.6	0.2	0.1	0.1	0.3	1.2	0.4	0.5	0.3	0.5	0.3	0.8	1.0	0.3	0.7	0.3	2.5	0.1	1.2	1.0	0.6	0.6	0.3	0.7	0.7	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.5	3.2	0.5	6.5	2.6	0.3	1.0	0.4	0.6	0.8	3.7	3.8	0.6	0.0	1.4	1.8	6.2	0.1	2.1	2.1	0.0	0.7	58.8	9.9	2.7	1.4	0.0	0.4	9.0	0.5	0.2	1.9	4.1	12.2	2.5	0.8	1.8	0.1	0.4	0.0	6.0	0.0	0.0	0.3	3.1	29.1	2.5	6.7	0.0	1.9	0.8	0.1	0.0	9.0	6.0	0.8	0.3	2.2	2.9	1.2	0.5	0.1	1.6	1.4	6.6	9.0	1.7	225.0	9.6	1.8	0.1	0.5	3.8	0.5	0.5	2.1
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20008865-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 217.1;Inhibitory neurons: 220.8;Microglial cells: 187.4;Oligodendrocytes: 317.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA		9800	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	12.5	9.6	30.8	7.3	35.1	23.6	9.2	24.1	43.7	6.1	22.3	15.1	9.8	12.8	4.7	9.2	8.3	14.8	5.0	41.4	21.4	4.7	1.2	5.7	5.3	32.8	25.8	16.6	4.8	3.3	6.4	3.6	24.5	6.1	10.0	6.1	6.2	5.0	5.1	3.6	10.5	9.5	21.0	13.5	10.3	22.8	41.1	3.0	5.2	2.8	5.2	4.6	4.3	47.3	26.2	37.3	15.7	7.2	14.7	6.9	29.1	10.0	12.4	12.4	21.4	67.6	17.1	1.5	45.3	11.4	24.3	21.1	10.7	33.4	3.7	12.8	18.5	14.5	34.4	10.5	4.9	1.3	5.6	10.6	36.9	10.2	24.9	46.8	0.0	4.4	1.0	15.1	10.4	24.0	0.3	5.3	14.5	17.0	6.3	11.8	49.5	23.6	32.2	11.4	7.1	6.9	75.7	35.6	13.9	62.2	26.3	9.1	0.3	0.5	21.1	0.9	30.8	5.4	11.7	0.9	19.1	12.6	6.5	42.1	15.8	33.0	2.2	8.4	3.2	1.8	1.5	3.4	26.6	1.4	1.0	1.4	11.1	13.0	7.9	4.6	0.6	5.5	30.8	35.1	24.1	43.7	41.4	21.4	32.8	25.8	24.5	21.0	41.1	47.3	28.7	22.4	14.7	170.4	5.7	5.5	12.5	22.0	10.8	7.4	5.8	4.7	10.3	7.2	21.1	18.4	68.8	5.5	10.2	56.8	9.8	30.9	100.0	40.1	44.1	13.1	7.7	82.5	217.1	36.3	11.5	18.6	34.1	64.1	116.4	29.5	3.9	0.2	22.0	0.0	220.8	54.8	12.2	12.4	15.9	54.5	5.0	29.0	21.4	187.4	84.7	13.6	11.3	125.2	317.8	67.7	24.7	44.8	7.0	19.7	25.2	3.6	18.1	31.4	59.2	7.3	81.3	73.8	68.9	5.9	2.6	2.2	10.0	87.8	27.4	21.5
SPEN	"KIAA0929, MINT, RBM15C, SHARP"	ENSG00000065526	"Spen family transcriptional repressor"	Q96T58	1	15836095-15940456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015825, HPA050257"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015825: AB_1856823, HPA050257: AB_2681065"	"unprognostic (3.91e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.83e-1)"	15.3	8.6	11.3	11.5	14.6	23.2	14.0	22.6	12.9	13.3	4.8	12.0	8.8	14.4	8.5	13.3	15.5	8.0	10.8	10.4	14.6	9.6	11.0	14.8	12.9	14.2	12.4	21.3	17.5	16.4	10.7	11.8	11.4	11.1	9.1	15.1	12.8	9.9	20.5	17.3	13.4	9.8	8.0	12.7	11.0	10.3	12.6	16.6	15.6	19.8	13.3	13.0	13.6	20.7	25.4	20.9	26.1	19.6	25.0	15.2	13.8	12.9	16.6	13.5	11.4	19.3	19.5	35.6	15.0	25.1	15.9	36.0	24.0	22.6	21.4	32.1	68.5	44.6	20.5	12.4	11.3	37.1	20.8	11.2	15.9	20.2	28.9	12.9	15.5	26.5	47.1	35.9	11.1	14.0	30.7	14.7	11.6	14.4	15.9	29.5	25.1	21.9	7.5	22.4	20.5	19.9	36.2	17.4	14.8	11.6	6.5	18.4	28.9	12.8	15.5	24.4	18.5	21.5	15.0	39.6	12.2	29.2	17.9	7.4	1.9	1.6	1.4	1.7	0.9	1.3	1.1	1.0	0.5	3.0	0.9	1.0	8.5	1.1	1.3	2.8	0.9	0.5	11.3	14.6	22.6	12.9	10.4	14.6	14.2	12.4	11.4	8.0	12.6	20.7	55.7	80.1	85.3	68.9	69.4	104.6	44.9	18.3	90.5	67.1	35.0	27.9	52.6	30.0	43.2	5.5	52.1	12.2	52.8	44.4	3.9	18.5	7.0	90.4	67.4	51.6	31.7	47.1	57.2	17.6	15.0	45.9	41.8	146.5	62.6	34.3	20.0	32.6	15.2	95.9	66.0	27.4	8.2	34.6	69.6	4.9	27.4	53.2	21.4	64.6	56.3	28.3	68.0	51.8	88.7	23.6	34.6	35.7	74.5	46.7	16.8	7.5	29.4	53.2	19.7	85.7	56.6	59.5	45.9	89.8	101.6	15.7	52.3	33.1	32.8	56.3
SPESP1	SP-ESP	ENSG00000258484	"Sperm equatorial segment protein 1"	Q6UW49	15	68818221-68946811	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 400.4;Spermatocytes: 455.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 17.8;BJ hTERT+ SV40 Large T+ RasG12V: 18.6;HBF TERT88: 21.7;HMC-1: 13.4;OE19: 15.9;RPTEC TERT1: 26.8;SCLC-21H: 19.9;WM-115: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045936, HPA051040"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in male reproductive system"	NA	NA		52000	"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA045936: AB_2679504, HPA051040: AB_2681322"	"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.67e-2)"	2.3	3.4	1.1	0.8	1.1	0.4	2.2	1.2	1.6	1.2	1.0	1.6	1.2	1.5	6.3	2.6	1.8	3.5	3.1	1.1	1.2	2.0	1.2	1.1	0.8	1.3	1.2	3.4	1.9	4.7	1.2	12.9	1.3	3.5	1.1	2.8	1.8	2.9	1.6	1.0	0.9	1.2	1.3	1.3	1.5	73.2	1.1	0.9	1.9	1.9	0.7	2.4	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	17.8	18.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.7	5.0	0.0	0.0	0.0	0.0	6.3	0.0	13.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	2.9	0.0	0.0	3.3	15.9	0.0	0.0	1.4	0.0	26.8	0.2	19.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	31.6	1.1	1.3	0.4	0.2	1.1	0.5	0.5	0.4	0.3	0.8	0.3	0.3	0.5	0.5	0.2	0.8	0.4	0.4	0.5	1.1	1.1	1.2	1.6	1.1	1.2	1.3	1.2	1.3	1.3	1.1	1.6	5.1	0.0	0.0	0.0	0.2	1.9	3.0	23.7	1.8	1.0	2.7	4.1	4.1	1.5	4.0	7.3	4.2	92.3	0.3	0.2	1.9	2.1	400.4	3.9	3.4	3.6	1.8	0.8	0.0	2.7	7.2	5.5	0.0	2.0	0.0	1.7	2.2	1.8	7.8	0.0	0.0	0.9	6.1	2.1	3.3	90.3	21.1	1.2	5.4	0.0	1.0	5.3	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.3	0.0	3.9	6.3	5.6	46.0	3.4	4.2	455.0	88.7	1.1	2.3	62.1	0.5	11.1	0.2	1.5
SPHK2		ENSG00000063176	"Sphingosine kinase 2"	Q9NRA0	19	48619291-48630717	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 68.5;Cone photoreceptor cells: 77.2;Rod photoreceptor cells: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049062			Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA049062: "	"unprognostic (5.33e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (4.45e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.30e-4)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (1.18e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.06e-2)"	9.4	10.5	18.9	6.8	20.6	3.4	9.6	23.5	29.3	9.4	9.1	16.5	22.1	12.0	2.1	9.2	11.6	3.1	7.3	25.9	19.4	23.1	31.8	8.5	5.9	36.0	30.5	15.5	8.9	7.4	16.5	2.2	37.2	13.3	3.6	3.2	7.6	4.4	7.8	4.8	18.9	2.6	21.2	11.4	14.8	24.1	30.6	5.3	16.0	3.1	3.1	10.7	7.3	26.1	8.4	22.3	8.2	15.3	8.5	3.6	16.3	8.5	6.8	9.3	11.1	39.8	10.4	15.0	5.9	5.3	5.6	6.4	7.5	6.9	1.3	17.5	19.4	16.9	11.5	13.7	13.5	11.1	17.3	6.5	3.6	6.5	4.4	4.4	5.2	20.9	11.7	12.5	4.7	8.3	27.2	64.7	11.2	6.0	10.7	23.3	6.5	10.0	4.3	5.3	29.3	23.1	8.3	12.7	8.3	4.5	7.1	6.9	8.5	13.6	7.7	10.9	17.1	24.5	31.0	16.4	7.9	12.2	12.6	11.7	6.2	2.9	4.3	7.1	4.0	5.0	3.4	4.2	5.5	8.6	4.8	4.8	2.4	5.6	6.2	5.4	3.7	3.5	18.9	20.6	23.5	29.3	25.9	19.4	36.0	30.5	37.2	21.2	30.6	26.1	3.7	6.4	7.7	8.5	13.3	3.3	5.7	5.6	4.6	68.5	6.8	6.5	1.5	12.8	6.2	11.0	77.2	6.8	13.6	20.6	1.9	6.2	11.0	6.2	6.1	6.5	16.2	2.1	9.1	5.0	6.3	5.3	15.3	6.9	4.5	14.5	6.4	19.8	8.3	45.4	11.2	11.3	4.1	12.3	7.3	18.4	16.4	6.5	3.6	6.5	11.4	20.8	33.0	6.0	11.9	6.8	16.7	12.8	7.1	6.2	44.2	18.6	4.9	79.9	6.6	6.3	5.4	18.1	6.3	7.3	2.8	4.5	12.3	8.9	17.3	4.3
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378547	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 335.1;lung: 101.0;lymphoid tissue: 172.7"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 432.9;Kupffer cells: 411.9;Langerhans cells: 537.6;Macrophages: 453.3;monocytes: 357.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 179.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 179.7"	"Cell line enhanced"	"Detected in some"		"HEL: 90.1;HL-60: 159.7;HMC-1: 282.2;NB-4: 267.8;THP-1: 206.7;U-698: 85.3;U-937: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	36.5	19.7	12.0	107.3	13.1	335.1	17.7	14.3	19.4	7.9	15.8	15.6	21.5	7.3	2.1	9.1	19.1	21.3	13.5	11.7	16.4	10.6	15.6	101.0	65.0	31.2	20.9	5.2	7.8	3.1	7.6	28.0	24.7	10.3	10.2	1.0	14.6	6.1	5.0	13.8	29.3	21.9	19.8	172.7	17.0	3.7	26.2	15.7	8.8	8.3	32.0	29.9	7.6	30.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	72.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	0.0	159.7	282.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.7	0.0	0.0	0.2	267.8	0.2	0.0	0.0	48.7	0.2	47.5	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	206.7	0.3	0.0	0.5	0.5	0.1	0.1	0.3	85.3	0.3	117.5	0.1	14.1	19.2	179.7	0.0	27.4	0.0	3.9	0.0	0.0	16.4	2.4	0.0	0.0	83.8	0.0	34.7	0.9	0.0	7.3	12.0	13.1	14.3	19.4	11.7	16.4	31.2	20.9	24.7	19.8	26.2	30.3	2.1	3.2	1.1	10.4	72.6	10.5	0.5	0.0	1.2	1.3	2.1	5.0	2.9	4.3	0.6	5.5	0.0	2.3	6.3	0.5	19.6	0.1	7.5	0.1	0.3	5.5	4.2	39.7	3.1	0.4	3.1	2.6	1.1	0.3	33.7	0.2	7.9	3.2	432.9	0.0	3.3	0.3	0.0	411.9	537.6	27.5	1.8	453.3	10.6	36.5	357.5	7.0	8.2	3.5	1.5	0.0	0.1	0.0	21.8	0.4	0.2	2.3	0.7	1.7	13.1	1.5	1.4	5.1	9.3	0.8	9.9	4.2	4.8	1.1	0.4	0.5
SPIDR	KIAA0146	ENSG00000164808	"Scaffold protein involved in DNA repair"	Q14159	8	47260878-47736306	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 122.4;Excitatory neurons: 255.4;Inhibitory neurons: 214.4;Microglial cells: 216.4;Oligodendrocyte precursor cells: 207.6;Oligodendrocytes: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027201, HPA041582"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 64: Macrophages - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA027201: AB_10603774, HPA041582: AB_2677563"	"unprognostic (5.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.72e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.35e-2)"	21.4	16.5	17.2	16.2	17.1	15.1	19.1	20.9	19.9	19.6	16.2	16.1	11.0	16.6	14.8	23.6	18.3	20.9	12.4	17.3	15.5	13.5	15.1	19.0	16.6	16.6	15.1	23.6	18.1	11.8	17.8	18.5	16.3	18.3	14.5	18.0	17.7	10.6	13.9	20.3	13.4	11.8	13.9	20.5	17.7	10.6	15.2	12.3	19.7	4.1	12.0	17.3	16.1	15.9	16.4	24.2	16.5	28.7	19.6	24.9	15.0	22.8	18.1	16.5	25.5	13.4	39.4	31.5	22.6	19.8	16.9	8.5	18.3	17.3	23.7	9.1	15.6	21.5	23.0	25.7	21.9	16.0	13.3	15.9	13.5	13.7	19.9	20.0	12.4	19.7	16.9	11.2	19.9	38.8	30.3	40.5	19.6	38.2	6.5	15.2	10.1	2.2	22.4	55.6	9.0	19.5	35.2	25.7	12.3	17.4	23.9	33.0	20.4	12.0	17.8	17.8	13.4	12.7	25.1	21.8	14.2	22.3	12.0	4.6	10.6	3.1	9.3	6.5	9.4	7.1	4.1	5.5	8.6	6.0	4.4	3.9	4.4	7.9	7.7	1.3	8.8	5.5	17.2	17.1	20.9	19.9	17.3	15.5	16.6	15.1	16.3	13.9	15.2	15.9	25.8	35.3	33.7	122.4	22.2	10.7	16.6	17.8	30.7	11.2	20.1	18.0	19.5	12.8	18.0	12.9	18.8	17.8	15.7	8.8	7.9	8.2	8.5	18.1	20.4	21.4	11.5	12.4	255.4	8.8	11.5	21.7	26.0	21.0	12.6	20.6	10.8	8.3	11.1	13.5	214.4	9.7	10.2	33.1	11.3	7.6	14.6	27.4	8.8	216.4	24.9	8.7	15.5	207.6	141.4	7.1	10.1	14.7	16.6	15.1	6.0	4.9	26.5	12.2	6.6	17.5	16.9	21.7	29.7	27.6	8.7	16.4	15.1	10.9	12.3	18.6
SPIN1	"SPIN, TDRD24"	ENSG00000106723	"Spindlin 1"	Q9Y657	9	88388430-88478694	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Meiosis, Wnt signaling pathway"	"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 178.2;Oligodendrocytes: 220.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000162, HPA068784"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA000162: AB_1080079, HPA068784: AB_2686033"	"unprognostic (1.53e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (8.78e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.69e-6)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-1)"	23.3	26.6	42.3	17.4	44.7	14.7	35.2	30.1	46.2	59.3	35.4	29.0	19.3	61.3	76.9	27.7	50.9	31.7	29.5	45.4	42.4	44.8	20.9	26.1	15.9	32.5	38.8	55.9	21.7	41.7	28.7	33.1	34.4	37.8	25.1	34.8	24.4	42.2	6.9	24.9	22.5	46.1	35.5	19.3	21.3	35.6	44.0	31.0	41.3	14.1	17.3	27.3	31.5	39.5	68.5	32.8	54.0	46.2	36.0	42.1	63.0	67.1	62.0	75.1	54.8	24.6	38.9	37.7	38.5	82.8	48.5	102.4	40.6	61.1	85.7	39.6	24.4	18.0	67.4	26.4	33.3	41.8	19.0	35.2	62.4	50.9	71.2	74.0	43.4	47.2	23.5	0.1	85.5	46.8	71.1	18.8	89.2	56.9	30.5	93.6	58.6	12.2	68.3	47.2	76.1	57.2	79.5	49.7	30.1	62.2	38.3	32.7	41.4	49.6	52.4	74.3	48.2	15.3	24.2	32.3	60.1	38.0	47.3	7.4	2.6	4.1	3.9	2.2	4.1	2.5	2.8	4.0	5.0	1.9	3.9	4.4	0.4	2.6	2.1	2.3	2.8	3.1	42.3	44.7	30.1	46.2	45.4	42.4	32.5	38.8	34.4	35.5	44.0	39.5	26.4	51.3	15.4	139.4	13.1	40.0	26.1	23.1	47.3	22.9	45.4	31.2	35.8	42.9	22.2	44.1	25.0	28.6	17.0	29.1	25.4	24.2	178.2	56.4	73.3	24.5	41.3	19.6	136.8	18.3	44.4	39.6	22.4	68.5	34.8	74.3	26.4	17.5	33.6	25.2	173.3	23.6	30.5	35.2	21.8	123.4	33.5	22.8	21.4	89.9	13.0	38.5	13.4	123.1	220.1	25.4	17.7	44.4	9.6	34.6	20.9	47.6	22.2	15.1	26.3	28.3	38.0	25.7	54.1	37.7	44.8	24.9	16.9	37.9	21.8	28.9
SPIN2A	"DXF34, SPIN2, TDRD25"	ENSG00000147059	"Spindlin family member 2A"	Q99865	X	57134530-57137625	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.8;Cardiomyocytes: 5.0;Cone photoreceptor cells: 4.2;dendritic cells: 3.2;Rod photoreceptor cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.1;HSkMC: 3.1"									"HPA000162, HPA069835"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA000162: AB_1080079, HPA069835: AB_2686211"	"unprognostic (3.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.95e-5)"	"unprognostic (3.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.07e-3)"	1.2	0.8	1.0	0.9	1.1	0.2	1.1	1.5	1.4	1.6	0.0	1.2	0.7	1.0	0.3	0.8	1.0	0.7	0.8	0.9	1.6	1.2	0.9	0.8	1.3	1.0	0.7	1.3	1.0	0.4	1.6	0.5	1.0	1.4	0.7	0.6	0.9	0.6	0.4	1.2	1.1	0.8	0.3	1.5	1.0	0.5	1.0	0.5	1.5	0.6	0.8	1.2	1.6	1.2	0.4	0.8	2.2	0.4	0.3	0.4	0.6	0.8	0.3	0.1	0.3	0.4	0.7	0.2	0.3	1.4	0.2	0.5	0.5	0.4	0.1	0.3	0.3	0.3	3.1	0.4	0.7	0.3	0.4	3.1	0.3	0.1	0.1	1.0	0.2	0.3	0.3	1.0	0.4	0.5	0.2	1.0	0.8	0.0	0.3	0.4	0.5	0.3	0.3	0.4	1.4	0.4	0.4	0.2	0.1	0.7	0.4	0.4	0.3	1.1	0.5	0.5	0.2	1.0	0.1	0.1	0.3	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.1	1.5	1.4	0.9	1.6	1.0	0.7	1.0	0.3	1.0	1.2	0.8	0.0	0.5	0.0	0.4	0.3	0.5	0.6	0.0	5.8	0.3	0.1	5.0	0.0	0.2	0.0	4.2	0.2	3.2	0.8	1.9	0.4	0.0	0.8	1.8	1.3	0.0	0.0	0.2	0.0	0.2	1.8	0.0	0.9	1.3	1.5	1.4	0.0	0.2	1.7	0.1	0.3	0.0	0.0	0.3	0.0	2.8	0.2	0.0	0.0	0.5	0.3	2.1	0.0	0.1	0.2	0.2	0.0	0.3	0.4	0.0	0.1	0.1	4.5	0.0	0.7	1.1	0.0	0.0	0.0	0.4	0.0	0.8	2.0	0.2	0.4
SPIN2B	"SPIN-2, TDRD26"	ENSG00000186787	"Spindlin family member 2B"	Q9BPZ2	X	57118551-57121548	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA000162, HPA069835"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA000162: AB_1080079, HPA069835: AB_2686211"	"unprognostic (3.21e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.73e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (3.39e-4)"	"unprognostic (9.04e-3)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-3)"	9.7	10.4	14.1	5.5	13.4	5.0	9.7	12.5	16.3	14.5	13.8	16.2	4.5	11.5	11.2	8.1	11.2	7.4	11.2	13.2	13.8	13.4	8.5	9.0	10.2	13.1	12.6	11.7	9.2	7.4	14.8	6.5	13.2	13.6	11.7	7.8	8.1	10.4	9.5	8.7	10.2	10.8	12.3	12.8	11.2	5.2	13.4	7.0	12.7	6.5	9.0	13.8	12.4	13.8	15.6	12.1	14.1	10.8	14.7	14.9	9.3	9.9	6.8	13.1	8.8	15.7	12.8	3.3	16.8	10.3	11.9	2.4	16.7	5.3	14.1	6.4	20.1	9.3	38.5	21.1	11.9	8.1	7.1	13.7	10.7	8.8	9.3	13.7	10.9	8.9	11.6	10.9	14.8	24.0	11.9	15.6	13.4	4.6	13.8	11.2	17.5	15.2	15.0	7.6	9.3	10.0	18.0	4.7	9.9	21.8	10.3	6.0	10.5	11.2	10.6	19.6	6.3	10.8	7.6	9.5	8.6	15.2	6.5	1.6	6.5	0.8	10.4	7.8	15.4	13.3	13.3	14.6	8.1	12.2	14.7	12.2	0.4	15.6	7.2	11.4	16.9	10.0	14.1	13.4	12.5	16.3	13.2	13.8	13.1	12.6	13.2	12.3	13.4	13.8	9.1	19.2	7.3	3.3	9.5	5.4	7.6	11.3	8.0	10.1	7.9	11.3	9.7	4.3	5.5	11.0	0.0	8.8	7.2	8.7	15.6	6.7	0.1	7.7	7.1	9.5	11.5	7.8	5.8	5.1	6.0	8.4	5.1	6.6	11.4	5.6	6.4	3.0	5.1	11.8	6.6	9.1	18.3	2.6	4.2	0.9	12.2	8.6	8.8	3.7	3.8	5.3	10.3	5.0	5.2	3.7	8.1	18.8	5.9	4.7	5.5	12.0	3.4	5.6	26.3	6.3	10.1	0.1	0.6	7.7	8.9	3.0	8.2	7.4	10.6	5.3
SPIN3	TDRD27	ENSG00000204271	"Spindlin family member 3"	Q5JUX0	X	56818298-56995827	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.8;Inhibitory neurons: 23.3;Oligodendrocyte precursor cells: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.5"					"Low region specificity"	"Detected in all"			HPA000727	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA000727: AB_2196121"	"unprognostic (3.12e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.85e-4)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.98e-2)"	"prognostic favorable (6.30e-4)"	4.5	6.1	7.4	3.1	7.2	0.3	5.4	7.7	7.8	7.0	4.3	4.3	2.9	6.0	4.7	3.8	6.0	3.2	3.2	7.2	7.6	5.4	6.4	3.1	4.4	6.0	6.1	6.4	8.7	2.9	8.6	2.5	6.2	5.8	4.0	8.4	5.6	4.1	3.0	3.2	5.6	4.2	5.5	4.9	5.5	3.1	8.0	1.8	4.7	1.6	4.2	5.1	5.2	6.6	4.5	6.6	3.6	0.0	6.9	5.9	2.8	3.4	2.0	2.1	2.9	3.5	5.6	0.0	2.4	3.3	7.3	4.9	5.7	2.2	3.2	0.0	1.4	0.6	20.5	2.7	3.7	0.0	4.6	5.3	4.7	2.7	4.2	4.0	1.6	0.0	2.9	8.6	4.4	3.0	0.0	3.6	7.3	2.6	5.8	0.0	3.0	1.8	3.3	5.3	7.3	5.1	4.2	3.7	4.1	5.7	9.8	1.1	1.2	4.4	6.3	7.4	2.1	3.6	2.5	0.0	4.2	0.0	3.4	1.5	0.4	0.8	0.1	0.6	0.8	1.1	1.7	0.6	0.7	0.3	1.9	0.5	0.0	2.2	0.1	0.1	0.5	1.0	7.4	7.2	7.7	7.8	7.2	7.6	6.0	6.1	6.2	5.5	8.0	6.6	2.9	0.0	3.7	11.8	3.7	0.3	4.0	1.8	2.8	2.0	5.1	4.6	1.1	2.8	2.8	7.3	0.0	2.6	0.5	0.7	1.9	4.1	0.0	3.0	4.7	2.3	0.0	0.4	23.8	3.0	2.1	3.2	2.6	2.3	1.3	4.7	2.2	1.6	0.9	1.7	23.3	0.8	2.0	1.0	1.2	0.0	4.1	0.9	1.8	7.5	1.5	0.9	1.0	25.1	10.0	3.6	0.3	2.6	2.5	1.8	1.1	2.9	1.1	3.0	6.6	1.4	2.2	0.0	0.3	1.4	0.4	0.4	1.1	5.8	1.5	2.2
SPINK13	"HESPINTOR, LiESP6, MGC149260, SPINK5L3"	ENSG00000214510	"Serine peptidase inhibitor Kazal type 13"	Q1W4C9	5	148268180-148286255	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"epididymis: 328.8"	"Group enriched"	"Detected in some"	6	"Leydig cells: 39.7;Peritubular cells: 26.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HeLa: 574.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036456	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA036456: AB_10673496"	"unprognostic (5.22e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.43e-3)"		"unprognostic (1.25e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (4.03e-10)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.95e-2)"	0.3	1.9	0.7	0.1	1.2	0.0	0.0	0.9	1.0	0.2	0.0	1.1	0.0	0.2	328.8	0.1	0.4	0.2	0.5	0.4	0.8	0.6	0.0	0.3	0.1	1.3	0.8	0.5	0.2	0.0	0.5	0.0	1.4	1.7	0.0	1.5	0.2	31.3	0.4	0.5	0.0	0.1	0.7	0.0	1.6	1.3	1.1	0.1	0.3	0.0	0.0	1.5	0.1	2.8	0.0	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	574.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.1	0.0	1.5	0.0	0.0	0.3	30.0	0.2	0.3	0.0	22.5	0.0	0.0	0.2	1.9	0.0	0.6	1.1	0.1	0.4	0.1	0.6	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.9	1.0	0.4	0.8	1.3	0.8	1.4	0.7	1.1	2.8	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	5.0	0.6	0.0	0.0	0.0	0.0	0.1	39.7	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.4	2.8	0.0	26.7	0.1	0.5	0.0	0.1	0.0	0.6	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 980.5"	"Cell type enriched"	"Detected in some"	14	"Intestinal goblet cells: 8017.1"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	12	"HMC-1: 175.7;OE19: 480.7"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in single"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	1.4	0.6	0.0	84.2	0.0	0.6	0.1	0.7	0.3	0.0	0.1	639.5	263.4	1.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.1	0.1	0.0	0.9	2.1	0.9	0.0	0.1	0.0	980.5	92.1	0.1	0.5	0.2	0.1	638.1	42.2	0.0	0.2	1.4	0.3	0.0	0.1	0.0	0.0	0.0	17.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	11.7	27.8	1.1	0.0	0.0	175.7	0.0	0.0	0.0	0.4	0.5	0.0	0.1	4.1	0.3	0.0	3.9	0.4	2.3	0.0	480.7	0.4	0.0	0.0	0.2	0.0	0.5	0.4	1.4	15.2	3.1	0.0	0.1	14.2	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.3	0.1	1.4	0.3	0.0	1.8	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	21.7	0.1	0.0	0.0	0.0	0.0	5.5	12.5	0.1	0.0	56.5	0.0	0.2	1.0	0.1	0.0	0.6	88.2	0.0	0.0	0.0	0.0	0.0	43.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8017.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.5	0.1	0.1	106.8	0.0	0.1	0.2	541.4	0.0	0.0	129.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.1	191.5	0.2
SPINK9		ENSG00000204909	"Serine peptidase inhibitor Kazal type 9"	Q5DT21	5	148321203-148339852	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 16.0;Alveolar cells type 2: 27.9;Club cells: 14.9;granulocytes: 10.1;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 12.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.4;U-266/84: 26.9"					"Low region specificity"	"Detected in single"			HPA038288	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		24000	"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Vesicles"		"HPA038288: AB_10795400"	"unprognostic (1.84e-1)"	"unprognostic (4.87e-3)"			"unprognostic (2.88e-1)"	"unprognostic (9.02e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.90e-1)"	1.5	3.2	17.1	3.0	13.7	6.5	0.5	19.2	26.6	0.6	5.0	2.0	2.2	2.6	1.9	2.2	1.0	1.4	2.0	14.6	10.6	1.8	1.6	1.1	2.6	10.0	6.1	1.8	1.1	0.5	0.1	3.2	10.8	2.5	1.7	10.3	1.5	0.5	3.8	3.4	2.4	0.5	2.6	1.9	2.4	4.2	11.5	3.2	1.5	0.1	1.6	0.9	0.0	28.0	15.4	2.6	2.9	3.4	0.7	1.2	2.8	3.5	0.2	0.3	0.5	5.3	10.8	3.4	24.4	0.1	2.0	3.5	0.9	0.7	1.0	6.1	1.4	7.7	8.3	2.7	0.3	2.9	2.6	0.2	0.7	0.5	0.1	2.0	0.0	2.5	4.9	18.3	0.4	9.6	2.5	4.7	13.7	5.5	5.0	3.9	3.4	4.0	1.0	10.0	6.3	7.9	3.0	8.6	2.8	8.6	14.0	3.0	5.9	4.4	14.1	3.9	4.5	11.1	26.9	4.0	2.6	2.1	6.2	12.4	1.8	1.0	1.1	1.0	1.4	0.8	1.3	1.4	0.4	1.9	1.8	1.8	6.6	3.9	2.2	1.9	0.9	0.1	17.1	13.7	19.2	26.6	14.6	10.6	10.0	6.1	10.8	2.6	11.5	28.0	0.1	16.0	27.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.0	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	1.9	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.1	10.1	0.1	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	2.2	0.4	0.0	0.1	0.0	0.3	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.7	0.0	0.0	0.2
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 255.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1254.0;Distal enterocytes: 477.6;Proximal enterocytes: 514.5;Syncytiotrophoblasts: 1673.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 323.2;HaCaT: 377.6;hTCEpi: 264.0;RT4: 308.2;SK-BR-3: 558.8;T-47d: 267.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		7400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.8	0.7	0.9	16.4	1.5	1.4	34.7	5.0	1.3	42.8	6.4	108.7	159.9	13.2	78.9	255.5	33.6	38.0	1.3	0.9	2.0	79.9	3.5	47.6	6.4	2.8	3.2	2.4	69.2	132.9	31.4	144.9	2.2	52.3	89.2	0.4	162.7	31.4	0.6	148.9	138.2	4.3	1.7	6.9	88.3	1.8	3.2	9.9	34.7	0.4	45.5	57.1	90.1	2.3	124.8	1.0	0.0	0.9	0.1	0.0	323.2	2.3	3.0	4.0	2.4	195.3	202.4	0.3	141.2	0.4	3.6	377.6	30.8	181.9	2.4	1.0	10.6	5.6	3.3	10.8	2.2	21.9	93.9	0.3	264.0	3.9	16.5	3.4	14.7	12.1	2.7	1.1	0.2	96.5	0.9	16.6	37.4	207.6	17.7	12.6	0.0	24.9	179.3	308.2	79.8	3.9	9.3	558.8	15.7	56.9	267.7	16.1	0.0	0.2	2.0	1.2	0.5	1.2	24.5	0.8	0.8	16.3	1.1	0.0	19.7	14.3	0.4	15.9	0.8	8.4	3.0	1.4	32.4	6.0	1.1	0.3	25.9	5.5	18.1	4.0	0.5	7.6	0.9	1.5	5.0	1.3	0.9	2.0	2.8	3.2	2.2	1.7	3.2	2.3	0.8	57.7	14.7	0.0	7.6	76.0	96.7	220.0	55.8	0.1	96.2	63.5	0.5	105.8	207.3	134.3	0.0	1254.0	1.4	477.6	25.4	429.4	0.8	63.3	14.2	6.9	147.3	4.8	0.5	255.1	105.1	10.4	106.5	155.6	10.2	1.9	0.4	0.5	135.4	0.0	0.5	169.4	221.8	10.0	23.8	1.1	3.7	19.8	14.2	0.0	68.6	0.0	0.0	0.0	0.0	309.8	375.2	0.0	2.1	135.7	514.5	44.2	46.6	0.3	0.0	0.1	12.6	0.6	5.9	93.2	87.9	1673.8	6.6	0.1	182.7	222.3
SPIRE1	"KIAA1135, spir-1"	ENSG00000134278	"Spire type actin nucleation factor 1"	Q08AE8	18	12446512-12658134	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 151.8;Early spermatids: 167.4;Excitatory neurons: 165.2;Inhibitory neurons: 155.9;Late spermatids: 321.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 97.3;U-2197: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040737, HPA040942"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA040737: AB_10960987, HPA040942: AB_10960492"	"unprognostic (3.39e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-1)"	7.6	17.4	22.1	3.8	22.8	1.0	9.0	22.5	27.8	8.6	6.6	7.7	1.7	7.6	5.5	7.2	5.2	7.2	20.7	23.5	18.9	10.7	5.0	10.8	2.8	20.4	20.3	8.0	5.1	17.5	6.1	6.4	20.3	8.3	3.1	14.7	8.9	8.0	20.6	8.4	3.2	8.3	19.9	4.5	5.5	33.6	25.3	3.4	13.2	19.3	4.0	9.1	5.8	26.8	19.0	8.2	17.7	19.7	19.5	17.3	0.9	20.1	20.7	19.4	18.4	0.9	4.1	8.9	22.2	26.0	32.2	4.1	24.0	18.0	24.4	13.4	11.9	5.5	16.9	10.7	40.0	3.9	13.6	12.0	33.4	33.6	97.3	22.4	26.3	3.0	14.2	0.2	29.1	25.2	1.0	5.2	7.5	6.7	20.2	0.0	21.8	19.0	23.5	25.5	25.9	10.6	21.8	17.9	45.3	7.9	5.7	11.7	32.3	32.0	9.5	75.4	24.1	6.6	0.7	0.6	25.6	2.4	8.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	22.1	22.8	22.5	27.8	23.5	18.9	20.4	20.3	20.3	19.9	25.3	26.8	10.1	25.6	43.2	151.8	0.5	3.7	9.7	8.3	1.2	60.5	15.6	12.3	28.5	7.2	13.6	12.9	8.4	0.1	2.5	0.5	21.5	8.2	167.4	5.7	25.6	10.7	3.0	0.8	165.2	4.9	0.9	13.0	2.0	7.9	15.8	11.5	5.3	4.6	14.2	26.9	155.9	3.7	0.0	17.2	5.3	321.5	5.9	12.9	17.8	30.9	2.3	15.5	0.0	93.5	91.2	11.7	0.1	10.9	1.1	23.1	0.2	1.0	8.4	13.2	19.7	20.0	15.4	17.4	17.5	2.0	2.3	0.5	2.2	16.7	0.1	16.8
SPIRE2	"KIAA1832, spir-2"	ENSG00000204991	"Spire type actin nucleation factor 2"	Q8WWL2	16	89818179-89871319	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 21.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 54.9;Gastric mucus-secreting cells: 46.9;Intestinal goblet cells: 43.8;Paneth cells: 39.9;Syncytiotrophoblasts: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 29.5;T-47d: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041413, HPA049415"	Uncertain		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	"Vesicles, Intermediate filaments"	"HPA041413: AB_2677464, HPA049415: AB_2680755"	"unprognostic (2.92e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.07e-3)"	"unprognostic (6.96e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (2.10e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.95e-3)"	"unprognostic (7.21e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.59e-2)"	1.6	2.1	8.8	1.2	9.0	1.2	1.9	12.5	12.3	2.5	3.8	15.7	7.8	1.7	1.8	2.9	6.1	2.0	0.9	9.1	7.6	4.5	6.5	2.3	0.5	9.8	7.9	1.8	2.2	3.6	21.5	4.5	10.4	4.7	8.2	3.1	2.5	3.1	0.6	2.0	9.2	1.0	5.5	1.0	14.4	5.0	7.5	0.4	6.9	0.0	0.4	6.1	2.2	8.5	0.4	8.4	5.2	4.2	1.4	0.9	17.5	2.7	1.6	3.9	1.6	3.2	9.0	5.8	1.2	0.8	4.0	9.0	2.2	0.3	1.1	2.2	10.1	1.3	7.1	8.9	1.4	0.3	1.8	1.8	2.0	1.2	1.0	0.5	0.2	0.5	9.2	1.4	1.1	12.8	0.1	2.2	5.7	29.5	5.3	4.6	1.9	1.3	2.0	8.6	13.6	7.0	11.6	5.0	5.1	4.4	18.8	3.0	0.4	2.3	4.9	3.3	2.5	0.7	3.7	0.5	3.5	2.1	4.9	2.4	0.5	0.3	0.4	0.3	0.2	0.4	0.3	0.2	0.1	0.7	0.4	0.4	2.0	0.5	0.5	0.6	0.2	0.3	8.8	9.0	12.5	12.3	9.1	7.6	9.8	7.9	10.4	5.5	7.5	8.5	0.7	6.4	4.8	10.7	0.6	0.9	5.1	1.7	2.2	13.0	4.3	2.8	2.4	14.3	2.4	12.9	4.2	15.7	2.1	54.9	3.9	1.5	3.1	11.9	2.6	1.1	15.7	0.0	20.2	0.4	3.6	1.4	46.9	3.2	0.0	4.2	0.0	2.4	2.7	23.5	23.6	43.8	2.0	1.0	1.1	2.5	0.9	1.4	0.0	1.9	0.2	2.8	1.0	7.1	4.1	1.5	39.9	1.9	0.7	5.0	29.8	0.8	13.5	10.7	0.0	2.8	1.6	6.0	8.8	3.8	0.6	70.5	1.3	5.7	33.5	30.2
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;testis: 9.7;urinary bladder: 9.5"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 13.2;Pancreatic endocrine cells: 30.9;Smooth muscle cells: 10.4;Spermatogonia: 13.1;Urothelial cells: 48.6"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.9;hTEC/SVTERT24-B: 51.5;RT4: 89.2;TIME: 46.2;U-87 MG: 84.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008"	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.05e-5)"	3.0	0.4	1.1	3.1	1.8	0.1	1.6	1.1	4.0	3.0	2.5	0.4	0.9	2.2	0.3	0.3	1.1	0.9	0.2	1.2	1.8	0.5	0.1	7.3	0.1	7.6	2.9	0.3	0.0	0.0	1.5	0.3	4.2	1.6	0.5	0.0	0.3	0.1	0.1	0.3	0.9	1.4	1.6	1.9	0.9	9.7	11.8	0.2	0.3	0.0	0.0	9.5	0.9	3.1	29.8	0.8	0.1	0.1	0.5	4.0	1.4	37.7	49.9	35.8	23.7	0.5	1.7	0.5	5.0	42.7	14.7	3.9	0.0	0.7	11.2	0.1	0.1	0.0	5.8	0.2	1.7	0.0	0.6	17.7	0.6	51.5	1.7	28.9	24.4	2.0	0.7	0.6	21.5	0.1	0.2	0.0	0.7	0.4	0.8	0.0	3.8	0.0	0.1	89.2	0.0	0.0	0.9	0.2	2.6	1.2	21.6	0.0	46.2	37.4	3.9	24.6	14.3	0.2	0.3	0.1	84.6	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.1	1.1	1.8	1.1	4.0	1.2	1.8	7.6	2.9	4.2	1.6	11.8	3.1	0.2	0.0	3.7	0.3	0.0	0.1	6.5	4.5	0.0	0.0	0.3	0.1	0.5	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	8.3	0.3	1.7	0.6	2.3	1.8	0.0	0.4	9.8	0.6	1.0	0.0	5.9	1.3	0.2	0.4	0.0	13.2	0.0	0.1	0.0	0.0	0.6	0.2	0.5	0.0	5.7	0.0	0.0	0.1	0.0	0.0	0.0	1.6	30.9	0.0	0.4	0.1	2.5	0.0	0.1	0.3	0.0	0.0	5.1	10.4	0.0	13.1	0.0	0.0	0.3	0.4	0.1	0.0	48.6
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962723-14268133	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 101.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9"	"Cancer enriched"	"Detected in all"	5	"ovarian cancer: 199.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 3.3"	"Lineage enriched"	"Detected in single"	33	"T-cells: 3.3"	"Group enriched"	"Detected in some"	36	"EFO-21: 213.7;RPTEC TERT1: 604.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	28000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	54.2	16.9	25.8	18.6	33.7	0.1	19.5	26.3	22.3	43.8	7.8	31.8	31.6	36.5	15.2	17.3	63.1	101.4	30.6	28.2	28.3	12.2	2.0	49.2	1.6	25.6	33.6	23.9	4.6	0.8	10.0	41.3	26.4	16.9	46.6	63.8	7.0	8.8	0.8	8.8	28.4	46.9	14.9	8.3	28.8	2.5	34.0	1.7	5.2	1.6	1.2	51.5	12.5	21.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	9.8	0.2	0.2	213.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.0	0.1	1.7	0.0	0.1	604.1	0.1	0.1	0.2	0.0	0.0	0.0	4.1	0.0	0.1	2.6	0.2	0.7	0.5	0.3	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.8	33.7	26.3	22.3	28.2	28.3	25.6	33.6	26.4	14.9	34.0	21.8	0.2	0.0	2.3	399.9	13.5	0.0	17.3	0.0	1.2	13.5	2.0	5.5	1.9	5.7	0.0	0.0	2.1	3.4	4.8	38.9	3.9	4.3	1.5	36.1	78.9	2.5	16.7	0.0	17.0	2.0	4.2	41.2	0.5	61.5	2.5	1.8	2.5	0.2	1.9	1.7	16.8	24.0	0.0	0.3	0.0	1.3	4.4	1.0	0.0	11.2	0.5	141.9	20.6	62.4	1.6	6.8	20.6	30.1	0.9	9.0	18.4	2.1	0.7	26.8	6.6	5.8	7.0	0.4	0.8	0.6	0.0	4.9	7.8	1.1	40.9	9.4
SPPL2B	"IMP4, KIAA1532, PSL1"	ENSG00000005206	"Signal peptide peptidase like 2B"	Q8TCT7	19	2328615-2355095	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 109.1;Late spermatids: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005592, HPA039292"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	Centrosome	"CAB005592: AB_325074, HPA039292: AB_2676429"	"unprognostic (4.16e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.00e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.93e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.40e-2)"	23.1	23.2	13.7	16.7	13.6	29.1	27.4	15.5	18.6	28.4	17.4	43.4	41.6	26.4	4.4	22.5	34.0	10.7	21.6	11.8	12.1	35.9	33.0	22.2	20.7	19.2	15.6	27.2	50.7	11.0	63.8	10.4	15.5	32.5	9.2	7.1	27.2	9.8	25.3	28.9	52.6	5.9	13.2	39.1	33.9	63.5	15.1	12.0	40.5	3.1	9.9	21.9	20.9	16.4	16.6	25.9	10.9	19.5	8.8	8.9	27.8	21.1	6.1	7.6	8.1	18.2	18.4	15.7	19.4	9.9	7.1	21.7	3.6	7.3	2.3	18.4	16.0	10.4	44.7	24.9	16.5	18.6	13.1	13.1	8.2	7.2	5.2	11.9	10.7	32.2	17.3	39.0	4.7	18.4	20.2	23.6	20.4	14.7	10.5	33.4	5.8	43.9	8.3	41.0	19.4	18.3	21.2	12.8	16.7	7.1	21.3	30.8	24.3	13.8	9.7	35.3	16.9	51.0	20.1	16.7	17.3	21.4	24.5	11.5	7.7	7.4	6.2	7.7	4.4	8.2	5.6	6.0	9.4	12.5	6.9	7.7	3.3	6.4	5.4	17.0	6.0	6.4	13.7	13.6	15.5	18.6	11.8	12.1	19.2	15.6	15.5	13.2	15.1	16.4	23.6	3.2	17.2	57.1	30.8	0.0	6.5	0.0	8.0	26.1	21.6	21.5	6.0	20.0	5.0	25.8	47.9	50.6	18.8	79.5	1.9	16.6	51.4	39.3	22.2	14.4	40.7	14.5	25.3	11.5	20.8	14.2	109.1	25.5	7.0	39.9	13.2	15.1	11.8	32.0	30.3	63.2	0.0	9.4	0.0	107.7	14.9	10.8	0.0	9.4	8.0	13.2	19.6	39.7	35.2	10.4	49.9	15.8	11.5	7.3	57.8	7.9	10.9	39.4	0.0	15.0	11.7	57.0	13.5	10.8	0.0	42.8	11.0	36.4	49.8	6.0
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887382-72892158	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 85.3;Exocrine glandular cells: 81.1;Proximal tubular cells: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 8.3;intermediate monocyte: 2.4;myeloid DC: 8.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 8.9;monocytes: 8.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	25.9	50.8	26.0	7.6	27.2	0.6	20.0	27.2	61.4	14.5	39.6	36.4	23.4	13.4	36.9	19.7	26.3	11.9	44.4	26.8	30.0	44.2	99.8	15.9	3.2	27.9	31.5	12.2	63.5	38.4	10.9	6.8	29.8	26.2	32.5	3.1	31.2	16.7	43.9	9.1	22.0	11.5	27.9	9.6	42.1	7.3	28.5	2.4	20.5	25.4	5.1	25.2	13.7	28.0	47.5	130.9	0.6	20.0	51.2	18.5	31.8	21.4	31.8	16.0	15.0	84.0	48.0	34.5	25.4	26.1	80.6	43.9	58.1	35.1	13.3	10.0	43.7	51.7	30.8	87.4	19.1	8.2	13.6	16.7	38.7	17.6	19.7	32.7	42.6	25.4	54.0	6.8	21.4	100.5	3.3	31.1	10.9	139.9	118.7	0.0	82.8	20.3	85.8	73.4	8.0	14.6	39.6	89.7	31.0	16.9	40.4	9.9	52.8	17.4	42.2	30.5	38.7	7.2	16.9	2.3	25.0	17.6	31.0	0.0	8.3	0.7	0.3	2.4	0.3	0.0	0.1	0.1	8.9	0.0	0.1	0.3	0.0	0.0	0.9	0.9	0.0	2.4	26.0	27.2	27.2	61.4	26.8	30.0	27.9	31.5	29.8	27.9	28.5	28.0	13.8	12.8	7.3	0.3	1.1	8.4	23.0	14.8	20.5	0.7	22.2	16.5	46.2	38.6	10.8	42.3	0.0	18.1	0.4	85.3	21.5	56.9	0.3	12.5	4.2	16.7	11.4	6.6	0.7	81.1	10.6	13.9	26.0	6.7	4.5	8.4	17.2	62.9	42.1	1.7	0.4	39.6	12.2	6.0	7.4	1.5	9.3	9.7	14.2	1.9	20.8	13.8	0.0	0.0	0.3	43.3	50.4	5.7	1.4	33.9	71.0	91.6	11.2	0.7	6.6	8.3	8.6	0.4	10.2	17.8	6.5	4.4	1.9	8.7	57.8	15.6
SPRED1	"FLJ33903, PPP1R147"	ENSG00000166068	"Sprouty related EVH1 domain containing 1"	Q7Z699	15	38252836-38357249	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 173.7;Excitatory neurons: 163.4;Microglial cells: 199.5;Oligodendrocyte precursor cells: 277.9;Oligodendrocytes: 146.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042193, HPA061805"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA042193: AB_10794079, HPA061805: AB_2684617"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"prognostic favorable (7.08e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.21e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.81e-3)"	"unprognostic (9.27e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (7.37e-5)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (6.04e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.01e-1)"	12.7	8.2	16.0	8.8	20.3	0.7	10.9	14.7	20.6	11.5	7.1	11.4	8.2	10.9	5.7	6.1	6.9	12.8	7.3	16.5	16.3	9.1	5.6	17.4	7.1	18.9	19.6	7.9	4.5	6.8	4.0	14.0	16.2	7.2	10.9	7.5	5.6	8.6	2.6	6.1	8.4	9.5	15.6	9.0	10.3	8.2	17.9	4.4	31.1	8.0	4.9	13.2	6.8	18.3	11.0	8.2	59.0	11.3	21.4	39.0	4.8	25.1	24.7	13.1	16.2	7.6	8.7	0.1	9.0	21.7	9.5	8.6	6.2	17.3	26.2	1.5	2.0	13.0	5.2	7.3	26.3	7.1	34.6	25.5	8.5	25.5	23.4	33.6	10.7	6.5	11.7	12.1	32.2	2.9	2.6	5.2	12.0	37.6	22.0	0.0	13.3	7.3	21.2	16.9	2.9	13.0	7.2	3.5	26.7	9.3	2.8	1.7	18.2	32.0	15.7	19.7	15.4	10.1	7.1	16.7	22.5	2.8	52.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	16.0	20.3	14.7	20.6	16.5	16.3	18.9	19.6	16.2	15.6	17.9	18.3	26.4	99.3	26.9	173.7	2.5	28.3	24.6	9.4	45.5	12.6	17.2	20.8	7.2	28.6	12.6	1.8	6.2	1.3	1.5	15.7	1.9	9.5	40.3	12.0	29.4	28.2	6.7	4.6	163.4	4.9	0.9	33.0	17.3	14.8	41.8	5.4	26.7	4.1	57.8	5.0	100.0	21.2	6.1	48.2	24.6	9.6	21.8	38.7	28.4	199.5	7.3	25.4	0.0	277.9	146.9	15.1	7.8	30.5	1.6	12.7	6.6	12.8	11.4	5.2	6.6	44.4	44.1	8.0	5.0	18.1	9.7	1.4	2.4	21.4	15.3	14.7
SPRED2	"FLJ21897, FLJ31917, Spred-2"	ENSG00000198369	"Sprouty related EVH1 domain containing 2"	Q7Z698	2	65310851-65432637	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.7;Excitatory neurons: 138.5;Inhibitory neurons: 122.4;Oligodendrocyte precursor cells: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NK-cell: 1.9;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;NK-cells: 1.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038256, HPA064394"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA038256: , HPA064394: AB_2732712"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.21e-3)"	"unprognostic (5.43e-2)"	23.9	11.4	12.0	9.7	15.3	7.0	21.7	11.8	22.8	13.5	5.6	16.5	14.9	16.5	8.6	10.9	13.3	13.2	14.7	14.4	11.4	13.7	24.8	18.4	14.0	14.4	12.5	14.0	18.0	16.7	11.5	15.8	11.2	12.3	16.1	10.9	15.9	10.8	8.0	11.3	13.7	11.5	11.1	8.5	19.8	7.4	13.3	28.7	17.9	13.9	15.4	15.5	14.0	12.7	60.4	32.9	32.2	32.4	41.1	40.9	22.2	16.1	25.2	10.9	14.5	43.4	16.4	41.2	9.2	20.8	29.2	18.7	18.2	37.2	21.9	52.3	11.6	9.7	9.1	45.2	21.0	25.7	18.8	33.1	22.2	37.2	36.9	22.9	6.9	24.9	39.1	16.9	17.7	40.9	22.6	26.7	16.1	43.4	35.4	17.1	28.6	24.2	34.1	52.3	13.1	45.1	18.1	14.8	44.2	20.1	15.1	23.7	11.4	27.6	35.8	23.8	27.4	33.2	13.8	73.7	44.7	27.1	54.2	0.0	0.2	0.0	0.6	0.7	0.0	0.0	0.1	0.5	0.4	0.0	0.1	0.1	0.6	1.9	0.3	4.2	0.0	0.7	12.0	15.3	11.8	22.8	14.4	11.4	14.4	12.5	11.2	11.1	13.3	12.7	49.7	19.2	16.0	108.7	1.8	39.9	29.0	12.0	41.5	17.8	22.7	17.7	7.5	14.3	6.6	9.2	6.2	11.0	3.3	32.0	13.7	11.0	1.5	16.8	11.4	18.6	11.4	1.7	138.5	8.6	8.4	21.0	14.8	35.0	1.3	2.8	13.9	14.1	6.7	25.2	122.4	24.1	8.2	7.5	67.6	4.1	17.1	10.2	19.6	68.4	26.0	7.9	0.0	124.1	23.2	13.9	21.5	12.4	0.5	23.4	17.1	7.4	7.2	9.8	26.3	17.0	17.4	3.9	10.4	16.6	16.8	3.0	3.8	4.7	10.9	24.0
SPRED3		ENSG00000188766	"Sprouty related EVH1 domain containing 3"	Q2MJR0	19	38388421-38399587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.0;pituitary gland: 5.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 6.6;Enteroendocrine cells: 10.8;Excitatory neurons: 9.8;Inhibitory neurons: 10.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.9;TIME: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071521			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA071521: "	"unprognostic (1.09e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.71e-3)"	"unprognostic (3.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.09e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-11)"	"unprognostic (6.21e-4)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.45e-3)"	0.7	0.4	3.2	1.0	3.7	0.3	0.5	0.5	5.0	0.6	0.4	0.5	1.8	0.4	0.3	0.4	0.6	0.7	0.7	4.5	8.0	2.3	0.2	0.7	0.2	4.4	5.0	0.3	1.1	1.7	5.6	0.3	4.6	1.0	0.2	1.5	0.5	0.3	0.9	0.8	1.3	0.8	1.1	0.1	0.4	1.1	5.0	0.1	0.6	0.0	0.2	0.6	0.5	2.7	0.3	1.2	4.0	3.3	0.6	1.9	2.3	8.1	5.3	2.6	2.4	0.4	0.8	0.2	2.9	2.7	2.1	0.1	0.7	1.0	2.4	0.8	1.5	0.1	0.3	0.5	1.4	2.2	0.1	1.3	0.9	6.2	1.8	12.9	8.3	0.6	0.7	1.5	8.1	0.4	0.0	0.1	1.8	0.5	4.0	1.0	1.4	0.1	5.7	0.7	0.2	3.1	0.2	0.2	0.4	1.7	0.7	0.1	15.9	2.9	9.0	2.4	4.5	0.6	0.3	0.6	9.8	0.3	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	3.2	3.7	0.5	5.0	4.5	8.0	4.4	5.0	4.6	1.1	5.0	2.7	1.1	0.0	0.0	2.0	0.4	0.0	1.3	0.4	1.2	6.6	1.5	2.4	1.2	0.0	0.3	1.8	2.1	0.5	0.3	0.5	0.0	1.0	2.0	0.7	1.1	1.5	10.8	0.0	9.8	0.6	0.3	0.5	0.0	1.6	0.0	0.3	0.7	0.0	0.1	1.7	10.4	1.2	0.0	0.0	0.0	0.2	0.3	0.5	0.0	1.0	0.0	1.9	1.0	5.0	2.2	3.0	0.1	0.0	0.0	1.2	2.7	0.1	0.1	0.3	0.0	2.3	1.2	1.5	1.0	0.5	0.1	0.8	0.4	0.2	0.8	0.7
SPRR4		ENSG00000184148	"Small proline rich protein 4"	Q96PI1	1	152970648-152972574	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 145.4"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 54.2"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 17.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA055963	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA055963: AB_2682988"		"unprognostic (4.40e-2)"				"unprognostic (7.38e-3)"			"unprognostic (1.45e-1)"								"unprognostic (6.75e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	145.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.9	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRTN	"C1orf124, DKFZP547N043, DVC1, Spartan"	ENSG00000010072	"SprT-like N-terminal domain"	Q9H040	1	231337104-231355023	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 85.5;Rod photoreceptor cells: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025073	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA025073: AB_1847695"	"unprognostic (2.63e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.35e-2)"	4.4	3.6	2.9	5.0	3.7	11.8	5.4	3.9	3.5	4.2	3.6	3.7	4.0	4.9	4.1	5.7	3.4	4.4	4.4	2.6	3.3	4.6	5.1	3.7	6.3	3.1	3.2	3.1	2.7	4.8	2.7	7.8	3.6	3.9	3.8	4.9	3.5	3.6	8.5	5.9	3.6	4.9	3.2	5.0	4.1	14.5	3.0	7.2	5.1	5.3	6.2	4.8	3.3	4.5	13.7	11.4	10.5	11.5	9.6	6.8	12.7	12.1	10.5	13.6	11.8	13.2	11.4	12.4	12.8	10.1	5.4	19.6	15.2	12.2	14.7	10.6	26.1	7.8	11.1	9.1	10.2	13.3	11.0	9.3	12.7	15.0	12.2	6.2	13.8	11.1	19.0	11.8	13.9	7.5	14.1	7.5	10.4	15.6	10.0	12.3	13.6	14.7	12.0	10.2	13.2	12.8	13.0	9.8	13.9	4.7	17.9	19.3	10.5	11.7	11.8	17.1	19.9	9.1	10.0	17.0	9.1	11.2	20.4	8.6	4.6	9.8	5.1	6.6	5.7	4.9	5.1	5.8	4.6	3.2	6.1	6.8	9.5	6.6	4.8	4.3	5.9	3.6	2.9	3.7	3.9	3.5	2.6	3.3	3.1	3.2	3.6	3.2	3.0	4.5	14.5	16.0	4.2	8.8	19.9	32.0	11.4	9.3	27.3	22.6	11.6	13.1	5.2	10.0	11.4	3.7	85.5	12.0	25.2	10.3	9.8	8.7	20.5	16.6	13.2	16.1	12.0	12.4	12.5	9.3	10.6	12.3	12.2	9.8	26.1	11.4	13.6	7.0	9.6	15.2	11.9	7.0	12.2	9.5	12.5	8.4	9.0	10.1	7.2	8.4	15.8	13.6	34.0	10.6	21.3	12.1	7.1	7.9	10.2	10.5	11.0	8.1	16.8	73.7	13.1	14.4	13.7	51.8	21.4	20.5	28.4	15.2	20.9	11.6	8.5	14.5
SPRY1	hSPRY1	ENSG00000164056	"Sprouty RTK signaling antagonist 1"	O43609	4	123396795-123403760	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 238.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 771.3;Endothelial cells: 352.8;Fibroblasts: 222.3;Leydig cells: 448.0;Skeletal myocytes: 245.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 61.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 95.4;AN3-CA: 194.1;ASC diff: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013538, HPA051369, HPA070554"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Cytosol"	Nucleoplasm	"CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.15e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.21e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	238.1	38.4	6.5	22.3	7.9	22.7	154.3	7.6	9.0	71.9	26.6	46.6	15.7	40.9	24.1	42.5	81.2	83.8	73.1	7.5	8.4	35.6	21.5	58.3	13.0	5.5	5.4	30.0	31.8	37.4	27.3	49.6	5.8	52.0	27.5	19.0	45.2	24.7	49.9	79.8	25.2	57.7	5.6	17.0	35.1	10.2	7.6	29.2	92.7	49.9	10.1	74.4	71.0	6.0	6.3	1.8	95.4	194.1	76.5	51.6	6.4	0.4	4.9	0.3	2.0	5.8	10.3	0.0	42.4	2.9	0.4	1.2	2.6	4.6	0.7	0.1	10.0	2.2	0.0	31.0	21.7	14.2	0.1	21.1	2.5	0.7	2.1	10.5	8.1	2.2	1.7	1.9	4.7	0.7	16.4	34.8	22.8	22.6	32.0	7.1	10.3	0.2	13.2	14.5	14.5	12.3	0.1	19.4	19.6	10.1	1.9	0.0	20.2	1.2	0.2	0.4	2.9	1.0	0.1	0.2	1.4	2.6	3.2	0.1	0.4	6.5	1.1	0.2	33.1	29.8	4.0	9.2	0.1	61.2	5.7	6.4	0.4	14.2	0.1	1.7	0.0	2.0	6.5	7.9	7.6	9.0	7.5	8.4	5.5	5.4	5.8	5.6	7.6	6.0	771.3	28.9	28.3	14.4	16.2	49.6	17.3	37.3	68.9	86.2	22.8	69.6	16.9	32.9	20.6	27.6	33.3	12.7	21.6	10.4	80.3	5.0	2.5	45.9	41.9	352.8	26.5	5.7	5.0	10.9	1.7	222.3	8.2	67.4	9.5	0.2	166.3	5.9	10.1	6.7	2.2	15.0	14.2	15.3	37.9	10.5	448.0	17.1	46.2	5.6	0.7	158.3	0.0	7.5	0.3	7.0	6.3	57.9	6.1	16.8	8.1	38.7	11.7	84.5	151.2	245.0	81.6	6.2	9.6	37.0	43.3	3.1	57.3	1.8	17.9	13.5
SPRYD3	FLJ14800	ENSG00000167778	"SPRY domain containing 3"	Q8NCJ5	12	53064316-53079404	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039426, HPA039685"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	"Vesicles, Plasma membrane, Actin filaments"	"HPA039426: AB_10673358, HPA039685: AB_2676623"	"unprognostic (7.73e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.27e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.78e-15)"	"unprognostic (9.82e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.41e-1)"	32.2	29.2	70.6	18.4	77.9	6.4	30.2	35.6	84.2	33.6	38.1	32.8	18.9	38.1	36.2	31.7	45.1	20.4	42.4	79.9	60.4	29.5	22.1	23.6	17.4	61.7	55.1	43.5	50.0	43.3	60.7	14.0	61.5	34.5	17.0	39.3	43.9	40.6	21.2	27.0	23.4	31.6	43.8	24.3	35.8	11.5	58.0	13.7	34.6	23.1	20.6	36.5	30.7	67.9	28.4	43.0	5.6	11.5	45.4	22.4	7.3	42.6	22.2	16.1	10.1	7.4	23.8	18.6	34.2	53.5	19.2	26.0	7.6	32.9	10.5	19.4	11.3	11.5	25.5	16.9	34.0	22.3	20.1	20.2	51.6	23.1	34.9	31.6	33.5	9.3	10.4	45.3	28.5	62.3	16.3	11.7	3.2	23.1	30.8	7.1	9.5	38.4	20.6	22.3	9.4	8.9	37.3	34.6	18.1	3.0	31.8	16.7	46.4	18.1	17.9	40.9	29.0	24.7	24.1	5.4	53.8	19.5	22.4	29.9	16.7	47.5	32.7	28.9	30.9	14.6	22.4	26.9	15.5	11.3	18.8	22.7	25.8	17.0	32.8	7.4	13.5	28.9	70.6	77.9	35.6	84.2	79.9	60.4	61.7	55.1	61.5	43.8	58.0	67.9	13.4	3.2	10.1	4.9	13.3	5.7	19.5	12.0	13.1	46.4	11.3	8.8	20.4	17.2	10.4	18.4	8.4	6.2	8.8	9.1	11.7	30.4	0.9	21.2	10.9	17.1	11.5	2.1	14.4	36.5	14.6	22.9	15.8	16.1	10.1	5.1	18.9	9.1	11.8	43.7	13.5	13.8	10.2	11.7	5.7	2.7	16.1	10.3	10.6	3.7	15.0	38.5	16.5	4.5	5.6	28.6	9.3	33.1	19.1	20.8	10.7	15.6	18.2	23.8	19.7	11.1	20.0	4.5	3.9	12.0	9.5	4.2	14.9	5.1	7.9	16.4
SPRYD4	DKFZp686N0877	ENSG00000176422	"SPRY domain containing 4"	Q8WW59	12	56468578-56479708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 20.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 147.2;Proximal tubular cells: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053469	Uncertain		Approved	Nucleoplasm		NA	NA		7500	"Cluster 11: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA053469: AB_2682162"	"unprognostic (1.14e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.06e-3)"	"prognostic favorable (4.52e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-1)"	1.5	3.7	1.6	1.6	1.4	2.8	3.1	3.2	1.9	2.0	0.7	2.5	2.0	2.0	3.0	3.1	2.0	1.5	3.3	1.4	1.6	3.7	20.5	1.4	1.8	0.8	0.8	2.4	6.0	2.5	3.7	1.2	1.0	2.6	3.2	3.4	2.7	1.7	4.1	2.4	2.2	1.7	0.5	2.3	2.5	1.5	1.3	1.4	2.7	5.1	1.7	2.3	2.1	1.2	2.1	2.7	2.3	1.8	2.0	1.3	3.1	1.7	1.7	3.5	2.1	2.5	3.6	2.6	2.2	2.2	2.4	3.5	2.0	2.9	2.2	1.3	4.1	3.8	3.1	3.8	1.9	2.6	3.7	2.9	1.9	2.5	2.1	1.9	3.6	1.8	2.1	11.0	3.0	3.4	1.3	1.9	1.5	2.4	3.1	1.6	1.7	5.4	3.8	2.6	2.3	1.1	3.3	3.9	2.6	1.4	6.6	0.8	1.7	1.5	2.8	2.2	1.4	1.8	1.1	0.9	1.2	2.2	1.9	1.0	1.0	0.5	0.7	0.7	0.8	1.0	0.7	0.7	0.9	1.0	0.7	0.7	0.7	1.2	0.9	1.3	0.3	0.7	1.6	1.4	3.2	1.9	1.4	1.6	0.8	0.8	1.0	0.5	1.3	1.2	4.4	0.0	7.4	2.0	7.9	4.8	16.2	24.8	10.2	13.2	14.1	12.7	17.7	18.6	16.2	22.0	16.7	38.3	5.8	17.3	54.8	26.6	1.4	4.0	7.5	8.9	17.5	19.1	0.9	21.4	24.3	8.1	14.8	9.8	10.2	10.7	10.0	147.2	20.8	16.8	1.6	14.6	28.5	12.2	2.3	1.1	9.0	6.4	5.4	1.9	11.1	10.2	8.2	2.0	2.2	18.5	10.1	10.5	6.3	10.8	19.5	101.5	5.9	17.8	0.0	8.1	8.6	5.1	10.2	22.2	5.3	36.0	4.4	30.2	16.4	19.8
SPSB4	SSB-4	ENSG00000175093	"SplA/ryanodine receptor domain and SOCS box containing 4"	Q96A44	3	141051347-141148611	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 2.9;pancreas: 7.0;pituitary gland: 3.0;testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 23.6;Late spermatids: 11.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 22.1"	"Group enriched"	"Detected in some"	5	"glioma: 4.6;testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.5;NTERA-2: 3.5;RH-30: 4.2;SH-SY5Y: 3.6;U-2 OS: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062793			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA062793: AB_2732689"	"unprognostic (5.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.72e-4)"	"unprognostic (7.49e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.46e-4)"	"unprognostic (9.80e-3)"	0.3	0.3	0.5	0.0	0.9	0.0	0.1	0.8	1.2	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	2.0	0.3	0.0	0.4	0.0	2.8	2.1	0.0	7.0	0.2	3.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	1.5	1.1	0.0	2.9	1.1	0.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	12.5	0.2	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.9	0.0	3.5	0.0	0.0	0.0	4.2	0.6	0.0	0.0	1.1	3.6	0.0	0.0	0.0	2.0	0.2	0.3	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.8	1.2	0.3	2.0	2.8	2.1	1.6	1.5	1.1	0.9	0.4	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.6	0.0	0.1	0.1	0.0	0.0	2.8	0.5	0.0	3.2	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.0	5.6	0.0	0.0	5.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.4	22.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SPTBN4	"KIAA1642, SPTBN3"	ENSG00000160460	"Spectrin beta, non-erythrocytic 4"	Q9H254	19	40466241-40576464	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.1;pituitary gland: 7.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 48.6;Bipolar cells: 65.2;Cone photoreceptor cells: 56.3;Excitatory neurons: 209.5;Horizontal cells: 74.0;Inhibitory neurons: 194.8;Oligodendrocyte precursor cells: 46.3;Rod photoreceptor cells: 64.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 20.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.8;Karpas-707: 2.5;SCLC-21H: 3.9;SH-SY5Y: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054481	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Nucleoplasm	"HPA054481: AB_2682502"	"unprognostic (1.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.65e-4)"	"unprognostic (3.72e-4)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.02e-1)"	1.1	2.1	4.8	0.1	5.9	0.1	0.7	6.4	20.1	1.1	0.0	1.6	0.3	1.5	0.1	0.4	1.3	0.4	2.1	4.8	0.0	0.8	0.3	0.3	0.0	4.0	0.0	2.6	0.9	1.4	7.8	0.0	2.2	1.5	0.0	3.4	0.6	0.4	2.1	0.5	0.5	0.3	0.0	0.2	1.2	2.0	0.7	0.1	0.7	0.9	0.0	1.1	0.7	6.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.2	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.8	2.5	0.0	0.6	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.5	0.0	0.0	3.9	2.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.9	6.4	20.1	4.8	0.0	4.0	0.0	2.2	0.0	0.7	6.0	0.2	0.0	0.0	48.6	0.1	0.1	0.2	0.1	0.6	65.2	0.7	0.6	4.9	0.0	0.2	0.0	56.3	0.0	2.7	0.1	0.0	0.2	3.4	0.3	0.8	0.5	16.3	0.0	209.5	0.0	0.0	1.0	0.0	0.8	0.0	0.7	0.4	0.8	0.2	74.0	194.8	0.5	0.0	0.6	0.2	1.3	8.1	0.6	1.8	10.3	0.6	6.1	0.0	46.3	13.4	0.1	0.0	7.2	0.1	0.4	0.3	1.7	0.2	64.2	0.0	1.6	0.7	3.5	6.0	0.3	0.4	0.0	0.4	0.4	0.3	0.2
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606403-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 34.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli"		"HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	7.5	8.7	2.3	8.6	2.4	34.3	10.0	3.6	5.9	10.6	4.3	7.8	7.0	7.6	5.6	8.1	6.6	10.1	4.9	3.0	2.7	8.9	10.3	7.3	8.2	2.3	2.9	9.7	7.8	8.1	4.0	8.7	2.4	8.7	8.2	4.5	9.4	5.6	7.9	7.4	6.5	7.8	2.4	7.3	7.5	4.2	2.7	8.5	10.0	7.5	9.6	9.4	5.3	3.1	11.8	11.2	9.0	12.7	14.3	15.1	13.5	17.3	18.9	14.2	16.8	10.4	5.2	27.0	9.3	16.3	11.0	12.1	15.3	13.4	20.5	14.1	14.0	10.6	6.4	9.5	14.1	22.6	20.4	12.7	13.6	9.3	17.8	10.1	15.3	15.8	15.3	41.7	15.9	12.2	15.5	9.3	8.5	22.8	12.6	14.2	25.1	11.4	14.9	16.9	8.8	12.3	15.1	17.8	12.3	11.7	11.0	9.6	13.7	13.7	11.7	27.1	10.8	14.3	19.0	21.0	16.4	12.6	11.8	4.7	1.9	2.9	2.7	2.9	4.1	1.2	2.6	2.8	1.7	1.1	2.4	2.6	2.2	3.7	2.8	1.4	3.1	1.8	2.3	2.4	3.6	5.9	3.0	2.7	2.3	2.9	2.4	2.4	2.7	3.1	42.3	25.6	47.7	5.2	38.0	55.8	19.6	17.1	32.5	13.7	55.0	39.5	21.6	18.6	29.9	27.6	10.4	14.3	75.3	31.7	17.6	25.3	2.4	47.4	53.8	29.1	44.3	15.4	9.9	24.9	26.5	35.3	40.2	74.1	57.7	20.5	22.9	28.5	16.3	11.8	9.6	39.4	24.4	33.4	49.6	3.2	19.0	44.3	16.0	15.0	24.4	12.4	49.4	9.0	8.9	27.7	29.8	13.9	83.6	28.0	21.0	17.4	47.5	11.4	32.9	42.9	28.2	14.2	17.3	41.6	66.3	27.5	69.7	27.1	24.4	29.2
SRA1	"SRA, STRAA1"	ENSG00000213523	"Steroid receptor RNA activator 1"	Q9HD15	5	140537340-140558252	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Receptor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044598, HPA050153"	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA044598: AB_2679013, HPA050153: AB_2681033"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (8.01e-6)"	"unprognostic (9.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.38e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-1)"	12.2	34.0	8.7	7.7	9.0	9.6	9.7	15.8	12.3	10.0	9.2	12.5	5.1	8.2	6.0	9.3	9.4	5.6	12.0	9.9	9.3	12.4	25.8	15.0	6.3	8.4	8.2	14.9	7.5	4.7	22.2	5.8	8.8	12.5	4.7	7.2	14.8	6.2	14.5	9.4	11.9	5.4	8.6	17.6	14.0	22.6	8.9	5.6	12.9	2.5	5.2	9.4	8.8	9.2	9.7	22.7	11.8	12.3	5.6	7.6	16.4	16.1	9.1	10.3	10.8	41.8	5.9	8.2	11.7	6.2	5.5	6.4	2.1	12.0	4.1	12.7	13.9	7.2	25.0	16.1	12.0	13.1	9.4	14.7	6.1	5.5	2.8	9.1	4.7	13.8	7.4	12.1	6.9	29.5	10.7	20.4	3.6	5.2	18.0	11.7	10.0	7.9	5.4	11.3	8.3	9.8	9.4	8.5	11.6	4.1	10.5	14.7	7.5	9.7	5.1	8.5	13.2	15.1	10.9	8.6	12.0	16.8	6.5	16.1	26.0	20.3	10.7	23.8	9.9	15.8	10.2	10.4	25.2	14.0	8.2	9.4	43.0	13.6	23.6	15.2	19.5	26.8	8.7	9.0	15.8	12.3	9.9	9.3	8.4	8.2	8.8	8.6	8.9	9.2	43.3	6.4	49.4	13.4	46.7	52.4	68.5	126.1	38.7	23.6	57.8	48.9	71.7	57.2	86.4	33.1	8.4	103.7	56.9	87.8	113.5	102.7	104.6	59.5	33.4	39.8	38.4	35.1	15.5	148.2	117.9	48.6	64.7	43.1	68.4	21.8	42.1	69.7	93.1	15.2	17.2	71.6	107.8	61.2	71.5	150.0	25.1	82.0	67.6	7.5	90.4	59.5	42.2	9.0	11.5	186.0	78.7	29.7	113.7	82.9	83.7	131.0	84.1	23.7	26.3	26.7	76.1	77.2	30.7	62.3	45.9	179.0	47.4	66.8	49.2	142.6
SRARP	"C1orf64, ERRF, MGC24047"	ENSG00000183888	"Steroid receptor associated and regulated protein"	Q8NEQ6	1	16004236-16008807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.3;breast: 5.1;choroid plexus: 6.2"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 25.0;Distal tubular cells: 90.1"	"Group enriched"	"Detected in some"	4	"breast cancer: 7.7;endometrial cancer: 2.2;prostate cancer: 6.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	13	"Hep G2: 7.9;SK-BR-3: 13.6;T-47d: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026676	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026676: AB_1853866"	"unprognostic (8.55e-2)"	"unprognostic (1.01e-1)"		"prognostic favorable (1.68e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.41e-2)"		"unprognostic (3.49e-1)"		"unprognostic (8.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.32e-2)"	0.1	0.2	10.3	0.2	9.7	0.7	5.1	8.9	11.3	2.3	6.2	0.1	0.2	1.1	0.1	0.2	0.1	0.2	0.9	8.8	9.3	1.5	0.1	0.1	0.3	9.4	9.4	0.2	0.2	0.0	0.0	0.1	10.0	0.7	0.0	0.8	3.1	0.0	0.2	0.6	0.1	0.0	8.6	0.2	0.3	0.2	11.2	0.0	1.2	0.0	0.0	0.1	0.0	9.2	0.3	0.1	0.3	0.4	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.6	7.9	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.6	0.5	0.0	0.4	0.3	0.3	0.1	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.4	0.6	0.3	13.6	0.2	0.4	4.3	0.4	0.2	0.4	0.3	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.6	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.2	1.8	0.3	0.1	0.1	0.0	0.0	10.3	9.7	8.9	11.3	8.8	9.3	9.4	9.4	10.0	8.6	11.2	9.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	1.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 42.0;Gastric mucus-secreting cells: 43.8;Langerhans cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"A549: 110.8;HBEC3-KT: 102.6;RT4: 106.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	9.7	25.3	5.7	13.3	5.2	8.4	10.1	0.4	6.2	25.1	1.5	30.3	39.8	31.9	3.2	26.1	23.8	27.9	8.8	6.4	5.5	21.4	4.3	16.1	6.3	2.6	3.4	23.6	30.8	11.1	15.9	8.1	2.2	30.8	17.1	5.5	11.8	27.4	2.4	13.0	38.8	17.2	1.7	14.2	39.9	25.2	5.0	6.1	9.8	1.5	8.1	35.6	24.6	3.0	24.6	110.8	24.9	22.6	9.3	14.7	51.6	22.0	18.9	26.3	16.6	41.9	21.5	0.7	13.4	40.2	29.9	43.5	15.1	102.6	10.3	0.1	13.7	6.2	3.9	65.9	22.0	0.3	9.3	15.7	34.2	17.3	22.8	29.4	24.3	14.2	0.6	0.2	4.4	16.7	6.0	0.8	11.7	67.3	98.8	26.5	6.6	0.7	11.0	106.3	23.1	83.6	25.0	34.5	27.2	19.1	31.1	9.0	35.8	31.4	20.9	11.7	20.1	0.3	0.8	0.3	22.1	0.1	24.0	0.0	1.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	2.3	1.4	0.0	1.0	5.7	5.2	0.4	6.2	6.4	5.5	2.6	3.4	2.2	1.7	5.0	3.0	1.0	3.2	1.7	3.3	4.1	8.2	12.5	9.5	10.8	6.5	6.2	7.5	2.2	18.6	4.7	12.9	2.1	2.3	4.9	42.0	1.9	12.2	1.8	6.4	10.7	1.4	16.8	0.4	9.5	18.7	8.3	7.2	43.8	12.4	0.0	14.8	1.1	1.6	5.7	3.3	9.1	29.2	8.2	9.4	46.3	3.3	10.8	22.8	1.8	9.4	9.7	4.4	1.0	9.0	0.6	39.1	19.2	17.3	4.3	18.0	36.7	9.3	5.6	5.2	13.1	1.8	6.7	0.3	1.1	11.2	9.1	2.3	1.0	2.9	16.9	36.6
SRCAP	"DOMO1, EAF1, KIAA0309, SWR1"	ENSG00000080603	"Snf2 related CREBBP activator protein"	Q6ZRS2	16	30698209-30741409	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 186.4;Club cells: 145.6;Ionocytes: 179.0;Respiratory ciliated cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA028929	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA028929: AB_10601265"	"unprognostic (1.26e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.11e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.07e-1)"	15.4	11.9	3.6	18.9	4.8	30.1	10.1	7.1	4.2	12.8	1.7	13.2	15.7	15.5	6.4	13.5	14.2	10.9	12.1	2.9	3.4	9.6	7.1	11.6	15.3	5.9	4.3	16.9	19.4	20.2	9.5	12.6	3.5	12.6	11.2	12.5	18.0	13.1	24.5	16.2	16.1	15.0	0.8	18.7	16.0	20.6	7.7	20.2	14.0	19.4	13.6	11.3	9.9	6.8	29.5	60.1	36.9	35.9	28.3	19.5	37.7	24.0	21.1	26.2	20.7	27.8	21.9	65.9	29.7	30.5	16.9	27.8	37.7	27.5	21.9	42.2	88.1	42.5	56.2	24.3	11.4	49.8	48.0	20.8	13.2	40.3	29.0	12.8	27.8	21.7	65.4	36.5	19.7	34.5	42.2	17.4	37.6	10.8	27.7	57.7	28.7	36.4	7.5	34.2	34.5	36.5	26.6	31.0	8.4	12.2	35.4	26.0	44.1	37.0	26.5	21.0	31.6	39.8	36.7	45.9	29.7	23.2	28.9	0.3	0.7	2.9	0.8	1.2	0.6	0.7	0.4	0.9	0.5	1.0	0.5	0.4	2.2	0.6	0.3	0.9	0.9	0.7	3.6	4.8	7.1	4.2	2.9	3.4	5.9	4.3	3.5	0.8	7.7	6.8	3.0	3.2	3.7	8.8	9.8	24.6	1.9	186.4	13.1	7.5	3.3	1.8	2.4	4.3	145.6	1.8	8.4	2.3	5.3	54.3	0.0	1.4	1.2	4.6	3.0	3.4	11.3	7.6	8.6	3.1	1.4	4.2	19.9	4.7	2.5	3.0	2.2	3.0	2.3	8.4	8.6	17.7	179.0	1.9	14.3	0.9	2.8	3.4	10.6	8.4	3.0	1.7	6.2	4.5	10.6	1.9	39.1	1.2	11.1	3.1	3.1	0.6	118.3	5.8	0.0	5.0	14.3	5.6	6.0	7.8	58.2	2.5	8.9	2.0	25.6	3.1
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837011	"Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 202.5;SK-BR-3: 178.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710"	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	42.2	219.2	26.8	7.9	41.5	20.1	46.5	20.4	37.2	51.5	9.4	37.7	28.7	23.4	8.9	68.7	42.7	14.0	27.4	20.0	25.9	24.7	128.5	26.4	9.1	30.1	29.7	41.4	17.0	8.4	37.0	7.8	24.2	37.2	6.7	3.9	89.5	16.7	34.5	47.8	34.0	5.6	23.4	17.2	25.2	35.4	35.8	14.4	27.0	2.9	6.3	32.5	48.8	41.7	54.1	122.5	12.0	85.2	24.9	55.8	23.5	18.5	60.0	16.4	39.2	23.3	104.2	33.5	17.2	14.8	14.5	144.0	16.7	47.2	4.0	21.1	7.2	16.8	86.4	19.1	36.1	2.5	29.6	42.0	19.6	21.8	12.5	12.2	17.6	64.9	36.8	105.8	2.5	118.7	46.9	26.1	17.8	38.3	23.1	32.6	10.8	202.5	9.0	23.1	16.3	70.5	24.4	178.7	48.0	8.9	62.0	32.6	21.5	8.2	40.5	19.5	12.5	32.2	3.1	15.5	48.9	24.6	45.2	0.0	0.3	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.6	1.3	0.1	0.1	0.1	0.0	0.2	26.8	41.5	20.4	37.2	20.0	25.9	30.1	29.7	24.2	23.4	35.8	41.7	6.1	6.4	26.0	66.9	11.9	9.3	12.0	29.2	14.8	24.5	58.0	30.6	9.4	18.6	29.7	20.2	29.2	4.5	11.4	44.5	1.9	16.5	2.7	30.9	37.2	10.5	29.9	24.8	12.8	23.5	15.7	24.7	31.1	31.9	14.7	13.2	12.8	72.2	12.1	58.9	11.3	30.8	24.4	14.0	13.3	4.9	29.8	15.1	8.8	15.0	11.0	51.7	1.0	10.6	56.7	16.7	20.8	10.9	8.4	19.0	33.2	6.6	32.1	31.6	13.1	15.6	12.9	11.4	4.9	40.2	18.3	19.8	13.4	27.5	41.1	25.2
SREBF2	"bHLHd2, SREBP2"	ENSG00000198911	"Sterol regulatory element binding transcription factor 2"	Q12772	22	41833079-41907307	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031962, HPA031963"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"HPA031962: AB_10601266, HPA031963: AB_2674090"	"unprognostic (6.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.41e-3)"	"unprognostic (9.08e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.93e-3)"	22.8	80.7	50.1	31.1	58.7	32.3	24.5	22.3	60.5	26.5	2.5	47.1	40.8	34.4	60.5	82.0	27.4	25.3	53.8	51.8	32.3	33.3	36.2	43.2	35.2	38.5	37.8	35.8	45.8	51.4	30.5	24.5	38.3	33.5	31.6	21.0	49.1	22.9	34.1	58.4	35.9	30.1	16.1	26.1	53.8	20.4	37.8	25.0	23.3	33.5	36.2	29.7	39.0	45.1	65.5	45.8	119.4	111.6	68.4	90.9	66.7	21.4	71.1	24.8	50.5	54.3	84.2	115.8	29.7	52.6	91.1	109.6	68.7	141.8	17.5	32.9	75.0	58.0	79.7	54.6	113.8	85.7	37.9	85.8	78.7	65.1	80.6	56.7	49.2	64.2	60.6	135.9	26.4	83.1	62.5	64.5	75.7	81.2	34.9	71.3	68.1	189.0	103.3	67.6	48.2	36.3	49.1	89.3	91.7	69.5	56.3	150.2	53.0	33.2	61.0	15.9	25.8	98.3	54.3	91.7	32.4	64.0	51.9	0.0	4.7	1.6	4.6	3.6	3.1	7.0	2.5	3.3	5.0	4.8	2.2	2.6	0.7	1.4	3.1	6.3	1.5	4.8	50.1	58.7	22.3	60.5	51.8	32.3	38.5	37.8	38.3	16.1	37.8	45.1	14.5	44.8	43.3	100.6	35.4	16.3	13.5	52.2	30.7	41.0	36.3	23.1	30.3	37.1	38.0	58.8	10.4	25.4	23.5	67.0	3.9	20.3	15.9	25.2	10.5	16.8	49.1	14.1	72.6	44.3	22.6	16.3	42.8	59.2	12.7	43.2	8.2	34.3	14.8	57.2	75.1	39.4	52.9	10.3	14.8	7.0	31.4	16.3	7.2	67.5	18.1	18.6	20.6	90.5	129.5	38.4	30.5	27.4	29.2	27.9	26.3	4.8	30.0	18.7	19.7	13.7	20.5	8.4	13.8	55.7	28.1	36.5	19.0	43.0	40.3	30.2
SREK1	"DKFZp564B176, SFRS12, SRrp508, SRrp86"	ENSG00000153914	"Splicing regulatory glutamic acid and lysine rich protein 1"	Q8WXA9	5	66139971-66183615	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037673, HPA037674, HPA059332"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983"	"unprognostic (1.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (2.54e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.69e-2)"	5.6	6.5	6.7	4.4	6.8	20.2	5.9	8.0	8.4	7.4	9.9	6.7	4.5	8.0	5.2	5.4	7.0	4.2	4.9	6.3	7.2	4.8	6.1	6.2	5.9	6.1	6.4	6.4	8.5	6.6	8.1	5.2	6.1	5.4	4.3	9.5	7.0	3.8	4.7	9.0	7.4	3.2	6.0	7.4	6.5	4.8	7.0	5.8	8.0	3.3	4.1	5.5	5.7	7.4	5.5	6.7	8.5	5.5	3.9	7.5	9.5	6.1	3.3	3.1	3.4	9.5	6.3	8.3	7.4	4.5	4.1	7.4	4.3	5.7	5.3	6.0	10.3	7.9	18.0	7.2	3.4	7.0	8.9	4.5	5.6	3.7	4.2	6.4	5.2	4.6	7.4	5.5	3.4	5.6	7.2	16.2	4.8	2.1	3.3	10.2	4.1	6.3	5.6	9.2	10.3	7.3	5.8	2.7	5.1	6.1	7.2	8.7	5.9	5.2	3.3	7.3	6.4	6.0	4.5	8.9	5.1	11.2	5.5	4.9	2.7	2.8	2.4	2.1	2.6	3.2	2.2	2.8	2.3	3.8	2.6	2.6	2.1	3.8	1.9	3.1	2.4	1.5	6.7	6.8	8.0	8.4	6.3	7.2	6.1	6.4	6.1	6.0	7.0	7.4	72.6	93.0	143.5	70.2	67.6	66.0	84.8	69.3	58.6	64.3	64.1	51.4	80.8	60.1	98.8	46.0	116.7	84.6	72.1	59.5	37.2	59.3	46.5	91.2	124.1	83.3	77.8	65.6	71.4	55.4	86.7	80.1	72.4	107.5	97.0	80.5	55.0	68.3	50.2	67.3	73.3	64.2	79.3	54.4	50.2	62.3	83.6	55.4	42.7	40.3	62.3	63.4	53.5	98.0	85.2	54.7	41.8	76.8	70.7	83.7	49.8	32.8	112.2	89.8	46.0	92.3	87.2	78.9	62.0	49.1	69.3	120.7	63.7	85.2	62.5	91.2
SREK1IP1	"FLJ36754, P18SRP, SFRS12IP1"	ENSG00000153006	"SREK1 interacting protein 1"	Q8N9Q2	5	64718148-64768691	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 300.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045677, HPA062853"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA045677: AB_10964635, HPA062853: AB_2684881"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.60e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.99e-1)"	6.2	5.5	5.1	4.2	5.3	4.6	6.4	6.0	7.2	5.0	5.3	4.9	4.1	5.0	5.6	6.9	4.6	4.3	4.0	5.0	5.4	5.7	5.8	5.6	5.7	5.4	5.2	6.6	4.3	5.8	2.8	8.6	5.6	5.6	4.8	6.4	5.1	5.3	3.6	9.0	4.4	5.5	5.3	5.5	5.2	3.2	5.3	6.9	5.9	4.7	6.0	5.3	4.3	5.8	8.3	4.2	10.5	7.9	9.2	15.1	6.2	12.3	9.9	8.3	11.0	7.8	8.9	8.6	12.4	9.9	7.9	5.3	9.6	18.7	14.5	10.3	11.6	9.4	7.6	7.0	9.5	10.2	9.1	9.9	17.3	11.5	14.8	8.8	12.4	10.6	8.4	5.2	9.9	3.0	18.2	10.3	5.4	2.2	5.6	8.6	8.5	13.8	14.3	6.6	4.5	6.7	7.8	5.5	12.1	7.3	7.0	19.5	12.5	6.0	3.6	7.3	13.0	7.5	13.8	7.7	11.5	15.7	8.3	2.0	1.6	0.7	1.8	1.2	1.8	1.6	1.7	1.7	1.4	1.5	1.7	1.7	0.6	1.5	0.8	3.3	1.6	0.9	5.1	5.3	6.0	7.2	5.0	5.4	5.4	5.2	5.6	5.3	5.3	5.8	69.3	48.1	44.1	20.2	43.8	81.8	62.5	117.8	43.3	51.8	49.0	59.2	31.2	75.8	63.2	86.5	31.3	72.6	54.8	87.3	90.1	72.2	300.6	69.3	66.0	63.1	61.0	79.8	30.8	75.2	84.6	55.8	35.2	86.6	53.8	33.9	91.1	100.3	64.5	97.6	23.4	71.4	89.5	79.7	62.4	179.2	95.7	54.8	39.2	15.9	65.1	59.2	71.1	19.1	25.4	196.8	136.3	72.6	39.1	76.2	66.8	114.8	58.4	43.5	65.7	57.7	56.9	44.3	46.2	47.0	104.0	48.7	50.4	30.5	54.2	83.2
SRF	MCM1	ENSG00000112658	"Serum response factor"	P11831	6	43171269-43181506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.6;Enteroendocrine cells: 102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001819, CAB005416"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"CAB005416: AB_2255249, HPA001819: AB_1079928"	"unprognostic (1.44e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.97e-2)"	29.7	16.7	16.0	27.0	15.3	27.3	24.7	12.4	18.7	31.2	12.4	82.6	13.4	69.3	12.4	33.3	49.2	26.5	61.2	17.6	11.6	17.0	20.2	28.6	21.4	14.1	12.7	27.6	21.8	18.5	18.8	17.4	11.8	38.7	14.9	8.8	16.8	45.5	55.4	21.2	29.3	48.2	12.1	22.3	37.0	12.6	13.4	21.4	23.9	32.7	16.5	54.5	25.7	16.7	38.4	15.0	34.2	22.6	19.8	16.2	50.2	34.2	28.0	29.0	17.9	40.4	11.1	48.1	30.5	36.7	36.7	30.4	35.0	30.2	25.5	53.5	34.4	43.6	30.7	40.2	37.7	41.2	50.9	27.8	32.3	44.8	32.7	27.4	24.5	41.0	31.6	36.8	22.2	41.1	51.2	35.9	23.8	85.7	18.3	38.7	34.9	17.3	21.3	24.5	20.0	18.1	28.0	21.1	34.2	26.2	21.7	75.6	29.9	34.2	26.4	33.4	59.5	25.4	22.6	80.6	21.4	29.2	23.5	0.4	0.4	0.8	0.8	0.8	0.6	0.5	0.4	0.6	0.5	0.5	0.3	0.6	1.2	0.3	0.6	1.0	0.6	0.3	16.0	15.3	12.4	18.7	17.6	11.6	14.1	12.7	11.8	12.1	13.4	16.7	17.1	38.5	22.5	3.9	8.8	78.0	64.3	22.6	38.1	5.7	64.0	52.1	89.6	18.6	21.7	11.0	20.9	9.7	9.4	29.8	0.0	13.6	4.7	23.8	24.6	17.5	102.2	20.2	4.9	20.0	22.6	17.0	18.3	29.5	7.6	20.6	17.2	50.6	12.7	10.1	3.5	39.1	8.2	11.3	18.8	1.1	12.5	11.6	24.9	0.0	8.0	12.5	5.2	1.5	2.8	21.5	19.6	29.0	6.5	17.8	11.1	3.8	20.3	7.5	13.1	23.6	21.8	5.2	3.3	28.7	66.9	12.2	10.5	8.9	25.6	30.2
SRGAP2	"ARHGAP34, FNBP2, KIAA0456, SRGAP2A"	ENSG00000266028	"SLIT-ROBO Rho GTPase activating protein 2"	O75044	1	206203345-206464443	"Disease related genes, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.0"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 497.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028191, HPA028196, HPA078079"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: "	"unprognostic (2.57e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (2.70e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.18e-3)"	23.6	19.8	29.8	15.8	32.9	22.3	18.0	114.0	41.8	16.5	21.7	12.4	5.8	13.8	13.4	12.9	14.6	11.7	12.3	36.5	34.5	15.4	8.0	20.9	15.2	48.4	41.0	18.2	7.9	25.3	10.4	20.0	55.9	9.0	6.0	9.9	10.0	9.0	6.8	46.9	10.6	15.3	43.4	24.7	8.7	10.7	42.8	13.8	9.9	18.0	13.7	11.9	16.5	57.4	45.6	30.0	99.7	25.6	46.4	41.6	39.0	38.5	28.7	32.9	35.9	20.7	34.0	17.6	21.6	42.9	43.8	36.1	30.0	25.4	32.7	22.2	24.4	36.5	56.4	31.2	19.3	25.4	39.4	37.6	21.6	42.2	29.3	35.7	57.9	22.6	30.6	55.4	21.2	31.6	20.3	22.4	32.2	8.1	34.1	45.3	40.8	42.6	14.1	8.2	33.2	15.2	32.7	23.9	47.5	37.4	29.7	44.4	57.9	32.1	38.4	39.9	35.8	36.8	35.7	16.5	38.4	34.6	80.0	1.0	12.2	0.7	3.2	11.8	1.3	2.6	2.6	3.3	8.3	5.3	1.0	2.2	17.7	2.1	14.0	16.2	4.0	3.7	29.8	32.9	114.0	41.8	36.5	34.5	48.4	41.0	55.9	43.4	42.8	57.4	45.5	9.6	12.1	9.4	18.0	23.8	6.1	7.5	8.6	39.5	3.6	4.4	4.6	11.5	7.9	11.0	4.2	4.1	17.1	0.3	0.0	7.2	57.7	16.4	18.4	37.2	1.2	13.2	72.2	2.1	18.3	18.6	10.2	9.7	8.2	12.0	28.9	2.9	19.0	1.7	105.0	3.3	0.0	46.2	62.5	51.0	7.8	54.1	16.0	497.5	25.4	6.6	5.2	54.3	58.5	4.8	1.3	2.6	16.0	4.2	1.4	0.8	14.5	5.8	0.0	18.5	17.9	19.0	11.6	12.1	36.4	4.2	11.9	9.7	1.8	5.8
SRI		ENSG00000075142	Sorcin	P30626	7	88205115-88226993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 566.0"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1172.0;Extravillous trophoblasts: 1475.3;Paneth cells: 1606.5;Proximal enterocytes: 1342.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		1100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favorable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	98.7	89.5	139.1	95.9	147.8	85.2	95.9	148.0	177.1	87.0	115.0	566.0	178.0	70.4	122.4	68.3	147.8	52.3	81.3	135.9	159.7	104.6	42.3	84.2	69.3	146.6	150.6	83.2	75.8	56.7	75.3	64.5	158.3	69.9	447.2	50.3	74.4	64.6	37.6	49.2	252.2	94.2	155.5	60.3	66.3	38.9	147.3	54.6	70.5	53.0	78.2	136.8	81.3	165.7	181.7	59.5	188.5	193.8	295.0	247.0	89.3	106.5	177.5	121.5	143.3	56.2	414.0	198.9	108.3	168.0	296.6	182.8	237.6	244.5	160.2	155.9	92.2	103.4	177.6	0.1	173.8	139.0	108.5	250.5	221.2	127.0	185.1	218.2	365.4	123.7	87.8	175.8	170.4	106.3	211.7	94.5	159.4	261.2	119.3	86.1	256.8	110.9	229.2	179.0	131.5	151.5	323.0	188.0	154.7	179.7	88.0	61.4	218.1	223.4	185.6	201.5	192.9	159.6	79.2	222.4	220.7	130.5	387.8	620.5	151.3	580.6	169.8	217.3	202.4	173.0	185.9	194.9	201.0	151.9	137.7	158.5	93.3	224.3	262.2	161.1	210.4	216.7	139.1	147.8	148.0	177.1	135.9	159.7	146.6	150.6	158.3	155.5	147.3	165.7	258.8	86.6	123.7	63.6	84.4	95.1	389.6	494.2	75.1	34.9	117.2	129.5	107.1	35.8	402.0	156.3	12.5	166.0	104.7	1172.0	442.2	223.0	89.7	307.3	148.6	135.6	94.3	198.6	29.4	418.5	1475.3	175.7	80.0	172.7	135.6	131.3	106.7	40.5	147.6	47.1	22.9	471.7	276.7	79.5	117.9	34.0	172.1	103.2	104.9	15.9	172.5	195.6	113.3	40.2	34.9	380.9	1606.5	141.4	75.2	422.9	1342.4	182.2	660.4	25.9	111.7	111.9	183.9	80.8	106.3	86.9	108.3	197.4	117.9	126.8	536.9	488.1
SRM	"SPS1, SRML1"	ENSG00000116649	"Spermidine synthase"	P19623	1	11054584-11060020	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 371.7;Prostatic glandular cells: 249.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015746	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA015746: AB_1857472"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.25e-5)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.74e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.98e-2)"	77.5	69.5	53.9	54.3	54.8	31.5	64.5	45.9	71.1	58.1	45.4	56.2	19.1	68.7	16.0	63.9	57.8	18.7	89.5	57.1	52.5	43.3	77.5	53.7	44.4	49.4	58.9	60.6	190.8	15.1	53.4	26.0	51.8	50.1	19.8	10.2	52.4	28.7	127.1	54.2	40.1	40.8	49.0	70.7	57.6	33.0	57.9	24.2	34.4	48.3	38.2	74.5	48.6	47.5	149.6	212.1	69.1	232.5	134.8	144.6	107.7	224.9	114.7	315.1	168.1	263.5	87.4	284.3	127.8	197.2	98.8	114.0	222.6	181.6	104.2	140.5	337.0	180.1	225.3	302.0	197.7	305.6	157.6	145.9	129.1	306.0	266.0	73.8	134.8	183.2	298.1	234.7	155.8	326.5	261.7	266.3	150.5	136.0	405.4	194.6	71.3	466.2	112.4	58.3	132.3	126.5	116.8	248.4	182.3	53.1	87.1	153.2	113.4	204.3	161.7	357.5	257.1	185.6	201.7	429.6	142.4	406.2	241.2	0.0	5.9	0.4	7.4	6.8	10.8	12.5	7.2	9.3	7.0	11.3	8.5	10.0	0.2	5.7	3.5	11.2	8.8	2.3	53.9	54.8	45.9	71.1	57.1	52.5	49.4	58.9	51.8	49.0	57.9	47.5	68.5	0.0	4.6	4.9	115.2	95.0	92.6	6.9	18.2	27.4	75.7	165.7	31.7	28.6	4.0	29.5	20.9	78.0	44.9	23.0	76.3	20.0	4.1	11.0	97.9	54.5	27.5	67.9	13.9	43.2	198.4	91.8	36.2	16.6	26.7	102.0	35.0	50.5	96.4	30.3	23.0	39.9	6.1	41.2	41.7	14.7	71.7	39.8	67.6	10.3	22.4	44.0	29.9	15.6	9.6	30.4	10.8	53.0	371.7	249.9	3.5	86.0	2.5	18.3	0.0	70.7	66.3	14.1	75.9	47.8	113.1	36.0	49.5	108.3	43.1	95.5
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035690-40039181	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli		NA	NA		440000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	309.1	307.5	330.1	118.1	327.1	252.7	300.4	323.8	426.0	301.7	320.4	272.5	121.5	311.2	282.1	257.7	270.7	155.8	390.1	317.9	349.3	391.5	229.5	220.8	168.0	357.0	402.7	323.5	192.4	324.3	306.8	143.8	339.7	264.4	158.9	212.8	237.8	158.9	354.7	201.2	215.7	163.4	321.1	219.7	247.6	165.6	326.2	276.9	275.6	338.5	172.9	266.7	253.9	355.1	131.8	163.7	399.5	301.4	300.0	275.5	189.4	232.4	265.0	213.4	223.3	297.8	113.7	107.9	245.0	305.1	319.5	216.6	322.8	260.9	207.0	257.5	230.3	258.3	530.2	364.0	231.4	238.2	211.8	276.0	298.3	177.8	213.3	391.0	360.6	297.7	280.2	204.2	356.3	204.5	370.2	291.4	217.6	520.1	301.3	247.6	176.8	192.6	477.5	401.7	287.2	255.0	231.2	243.2	171.2	243.7	332.8	448.6	290.9	240.4	160.3	229.4	171.1	161.8	494.7	291.0	234.7	255.4	229.7	729.8	525.0	875.7	484.5	485.8	473.9	600.9	547.9	549.0	562.5	509.0	522.0	510.2	452.7	525.9	459.5	1148.0	755.1	1262.6	330.1	327.1	323.8	426.0	317.9	349.3	357.0	402.7	339.7	321.1	326.2	355.1	1378.8	461.6	415.0	83.2	577.0	667.1	861.7	1395.7	427.4	432.9	617.7	914.5	880.3	649.1	906.9	995.0	125.1	867.3	812.5	742.7	2551.3	1366.9	353.1	1215.7	729.8	957.7	554.0	619.4	39.4	1087.2	1100.4	699.1	324.7	1513.6	564.0	669.5	654.7	819.4	1022.1	348.3	56.1	676.9	1226.8	631.1	882.8	377.3	1039.8	645.8	789.8	36.5	1174.3	1262.8	619.0	39.2	76.0	1240.7	894.4	986.9	610.9	826.3	874.5	2276.2	935.5	477.3	624.5	651.9	749.3	779.9	643.1	631.5	710.3	758.8	644.1	831.9	673.2	975.0
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 379.9;Late spermatids: 599.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 61.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 61.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	8.7	6.0	6.4	18.1	8.2	41.7	14.5	10.0	14.8	12.5	6.8	31.2	25.2	12.7	9.3	23.9	8.6	11.9	8.3	8.9	3.7	16.7	16.0	12.9	19.7	4.0	4.1	8.7	23.3	14.5	9.0	14.5	4.3	9.6	35.6	25.8	16.1	10.9	20.0	26.7	23.6	14.2	2.4	17.8	18.0	44.7	5.2	19.9	8.7	12.6	24.3	31.0	16.2	11.6	104.1	39.2	54.9	82.4	30.2	39.3	69.0	62.1	60.1	57.3	60.2	109.0	34.1	139.0	51.8	39.1	65.5	51.3	110.3	74.2	100.6	96.2	79.9	73.5	42.6	93.8	26.7	111.3	34.0	25.6	39.3	66.0	84.7	44.6	72.3	76.4	157.7	55.6	48.2	36.8	111.1	80.8	45.9	62.9	42.7	77.8	67.3	84.1	56.8	169.5	117.5	42.9	65.4	59.3	42.5	55.2	33.3	70.3	54.8	52.4	41.3	37.2	78.6	33.1	78.6	128.5	20.9	124.3	48.1	61.0	4.4	30.6	8.5	5.3	12.1	8.6	11.2	11.5	5.9	6.9	9.2	10.0	50.9	11.2	7.6	3.3	14.9	6.3	6.4	8.2	10.0	14.8	8.9	3.7	4.0	4.1	4.3	2.4	5.2	11.6	26.6	9.6	25.8	18.6	40.0	42.3	119.3	91.0	67.7	36.8	25.8	22.7	28.7	14.3	51.4	22.0	37.5	54.3	33.1	51.6	29.4	55.4	379.9	29.9	40.2	29.2	46.2	46.7	74.2	68.2	53.2	25.1	46.9	54.0	7.6	44.1	13.2	41.8	21.6	10.1	50.0	50.8	32.6	16.3	19.9	599.1	22.1	20.0	16.0	24.4	31.5	16.8	32.0	30.2	29.7	100.4	47.9	24.8	68.0	117.9	50.8	59.4	33.8	92.9	6.6	17.8	48.9	197.3	100.4	126.8	41.8	39.7	43.6	33.7	90.7	162.6
SRPK2	SFRSK2	ENSG00000135250	"SRSF protein kinase 2"	P78362	7	105110704-105399308	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 108.2"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1275.7;Late spermatids: 2280.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 219.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015522, HPA020876"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	"unprognostic (9.75e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.95e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.44e-1)"	14.3	16.2	27.2	15.0	29.7	10.7	18.3	20.1	46.8	16.3	0.0	13.3	11.4	18.1	15.8	16.4	14.6	16.0	14.7	31.0	30.0	13.8	14.2	12.8	17.9	27.9	25.5	17.3	14.7	15.1	12.9	17.1	30.4	18.8	14.8	24.2	15.1	14.4	11.3	24.4	11.4	18.3	19.3	17.8	16.3	108.2	26.7	41.4	15.5	11.8	20.6	18.2	11.6	47.1	36.9	24.0	37.3	74.5	39.3	43.8	21.0	35.4	40.8	34.5	39.9	18.9	30.5	23.4	43.7	45.8	38.5	21.6	38.3	37.3	43.7	40.5	33.2	33.1	21.8	16.5	45.1	31.8	47.1	30.6	67.5	29.2	54.6	33.0	59.8	54.4	33.0	92.2	38.5	69.3	118.3	23.9	31.1	20.8	25.9	37.9	41.3	51.1	49.5	56.1	54.8	37.8	40.1	59.0	37.7	49.1	22.1	21.8	39.7	62.9	45.9	60.8	33.4	100.6	106.6	56.5	24.8	32.3	48.1	50.3	30.2	103.3	41.4	21.0	24.8	45.0	31.1	31.6	27.3	44.0	29.3	33.6	219.5	38.7	25.1	23.6	38.6	25.2	27.2	29.7	20.1	46.8	31.0	30.0	27.9	25.5	30.4	19.3	26.7	47.1	35.8	28.9	29.5	128.9	62.9	212.9	60.6	68.1	49.5	76.9	45.2	40.0	23.3	28.6	41.5	23.9	50.1	52.4	87.1	16.6	27.4	52.9	1275.7	54.3	41.9	51.8	28.8	17.2	298.1	46.3	35.6	47.3	40.8	51.6	41.2	48.9	53.6	35.9	47.6	124.5	300.9	35.2	54.9	43.0	42.9	2280.6	76.7	39.2	58.7	168.6	57.0	73.7	103.0	172.4	399.8	36.4	24.4	95.9	54.8	100.7	15.7	25.9	54.2	67.6	46.0	40.3	59.1	198.8	66.0	36.7	103.3	64.4	58.2	61.4	26.1	67.9
SRRT	"ARS2, Asr2, serrate"	ENSG00000087087	"Serrate, RNA effector molecule"	Q9BXP5	7	100875103-100888664	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 251.1;Late spermatids: 329.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042858, HPA058379"	Supported		Enhanced	Nucleoplasm		NA	NA		32000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA042858: AB_2678201, HPA058379: AB_2683697"	"unprognostic (5.83e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (4.36e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-3)"	50.1	64.6	38.8	47.2	43.2	115.2	52.4	44.1	43.8	69.9	41.8	54.7	37.7	56.8	30.3	63.4	56.5	28.7	46.3	38.8	43.2	63.0	74.7	49.4	62.3	43.2	40.1	71.3	63.0	33.0	64.1	33.2	40.7	73.6	25.2	30.8	59.3	30.6	51.1	69.6	60.4	26.8	37.7	75.0	55.3	159.9	42.0	51.0	64.2	23.6	40.6	49.6	60.0	44.7	104.3	122.5	123.6	121.2	51.6	36.8	115.2	112.9	56.6	113.0	96.7	161.3	114.5	172.7	75.6	82.0	84.6	96.1	149.6	101.0	56.0	154.0	128.3	163.3	150.3	134.7	46.4	213.6	270.4	55.2	39.0	100.8	28.8	51.3	62.1	103.8	147.1	135.6	79.4	180.9	198.7	235.6	127.5	89.0	107.4	183.1	94.9	103.4	73.6	113.0	97.6	94.4	111.0	136.5	75.4	62.9	85.9	130.7	95.2	127.1	122.7	109.4	154.8	85.5	132.8	185.2	70.6	141.4	122.6	7.7	14.6	22.2	28.3	23.0	18.3	12.2	18.7	38.8	15.7	15.5	16.0	23.0	10.9	10.4	18.1	14.2	9.7	20.9	38.8	43.2	44.1	43.8	38.8	43.2	43.2	40.1	40.7	37.7	42.0	44.7	22.7	25.6	49.2	17.3	37.6	38.5	27.8	24.1	63.7	23.3	22.4	21.8	21.5	14.3	39.2	16.5	14.6	42.7	43.2	24.4	7.9	31.7	251.1	25.6	36.2	25.9	32.9	51.9	8.6	32.0	50.4	29.2	51.5	41.7	27.1	31.3	12.8	13.1	26.5	26.9	8.5	29.1	18.3	15.0	35.9	329.5	33.8	28.4	16.0	9.4	25.1	29.4	26.8	12.5	12.7	26.3	17.9	27.8	67.2	22.8	16.0	12.2	30.5	46.0	19.7	31.7	41.7	133.3	65.8	52.4	43.5	54.2	62.8	33.9	32.3	21.4
SRSF1	"ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a"	ENSG00000136450	"Serine and arginine rich splicing factor 1"	Q07955	17	58000919-58007346	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013073, HPA061301"	Supported		Supported	Nucleoplasm		NA	NA		980000	"Cluster 27: Non-specific - Gene expression"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB013073: AB_2533079, HPA061301: AB_2684474"	"unprognostic (9.86e-2)"	"prognostic favorable (7.00e-4)"	"prognostic favorable (4.56e-5)"	"unprognostic (8.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (8.28e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.59e-2)"	71.1	81.1	44.0	84.0	47.5	54.7	62.8	52.1	50.0	78.6	53.8	76.1	69.7	79.1	70.0	84.0	73.5	42.5	61.8	43.0	45.9	71.0	71.4	60.8	107.1	44.1	45.7	78.4	58.6	73.0	69.2	64.8	45.0	70.2	77.1	60.5	67.5	57.4	71.2	57.2	73.4	59.6	47.4	72.6	69.0	38.9	46.3	104.5	72.7	51.5	119.7	69.3	73.6	50.7	211.4	157.1	264.9	153.3	72.3	67.3	164.6	187.0	102.9	177.9	167.8	195.9	180.6	352.0	121.1	129.8	134.3	178.9	298.4	192.6	325.5	196.8	176.1	263.0	202.2	220.9	83.2	292.4	169.9	56.3	90.5	164.6	168.3	84.3	145.1	131.9	291.0	166.9	181.2	162.6	370.2	258.4	246.5	191.7	160.9	349.4	216.1	217.1	176.6	177.5	192.4	206.8	142.5	128.6	139.5	142.0	180.8	220.5	139.3	158.6	197.0	122.7	258.8	149.7	217.3	333.3	150.1	272.2	193.8	23.9	48.3	32.5	38.9	64.4	38.6	35.7	30.7	37.1	71.1	24.9	32.8	33.3	22.0	48.1	45.1	40.5	36.9	45.2	44.0	47.5	52.1	50.0	43.0	45.9	44.1	45.7	45.0	47.4	46.3	50.7	74.1	35.3	48.3	66.0	89.1	133.7	130.0	53.1	96.2	62.9	73.1	58.0	31.3	41.5	48.6	44.1	31.3	70.3	68.1	57.5	70.5	68.2	57.8	44.9	59.2	66.2	65.8	93.2	33.0	60.1	116.6	74.7	53.5	59.3	59.6	92.2	44.6	46.3	59.1	52.2	51.8	76.2	52.9	54.0	73.5	34.0	84.2	52.3	55.2	36.5	60.7	43.5	80.3	56.3	59.2	61.4	84.9	60.2	73.3	102.8	76.3	56.4	43.4	83.1	105.2	87.7	89.5	74.6	58.0	86.6	137.5	60.9	69.4	57.3	93.3	120.6
SRSF10	"FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2"	ENSG00000188529	"Serine and arginine rich splicing factor 10"	O75494	1	23964347-23980927	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053805, HPA053831"	Uncertain		Supported	Nucleoplasm		NA	Yes		49000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053805: AB_2682269, HPA053831: AB_2682275"	"unprognostic (2.49e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.74e-4)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.40e-2)"	57.0	59.9	22.5	46.3	23.3	119.6	46.9	26.5	30.1	51.7	29.9	48.8	38.0	49.6	40.7	43.8	56.3	29.2	40.0	23.2	24.4	56.3	56.7	49.6	61.0	23.3	23.5	61.1	50.1	37.2	43.6	42.2	24.3	47.9	45.0	46.5	45.4	32.1	37.7	40.1	50.2	41.3	25.0	49.0	47.9	34.7	23.1	55.8	61.3	24.4	57.1	43.0	45.0	28.6	110.7	89.6	142.9	92.9	88.6	68.2	98.0	133.4	53.5	116.8	102.3	83.5	112.8	239.5	82.7	63.5	73.8	99.7	163.4	89.7	140.7	140.9	122.7	134.5	160.3	115.1	62.2	164.3	107.9	44.2	68.5	74.3	72.9	66.8	89.1	92.1	187.2	83.4	99.3	77.2	167.9	118.1	196.2	139.6	84.4	162.9	99.7	127.6	102.1	86.4	104.9	85.5	98.7	88.2	100.1	97.4	94.2	129.5	89.2	94.7	99.5	89.2	126.4	94.6	134.6	189.1	83.4	185.9	112.8	112.8	67.7	74.0	51.3	84.1	65.1	80.2	58.5	60.3	58.1	68.8	62.9	55.8	43.9	74.5	82.0	69.6	75.9	72.3	22.5	23.3	26.5	30.1	23.2	24.4	23.3	23.5	24.3	25.0	23.1	28.6	115.8	112.2	112.1	39.2	188.4	42.6	115.5	23.2	183.2	159.1	104.4	103.4	59.1	97.2	85.5	79.1	160.6	116.8	150.5	85.6	78.2	94.2	115.4	96.7	138.3	109.8	122.0	154.2	54.7	89.2	164.1	111.3	93.8	106.7	93.6	181.0	86.0	63.8	82.0	99.3	50.9	92.4	36.7	51.2	41.3	118.5	127.7	83.4	26.6	44.0	101.5	131.6	111.2	54.8	67.2	78.6	85.9	110.6	169.4	122.6	67.4	74.6	94.6	287.5	105.2	121.8	125.8	188.1	150.5	140.0	45.5	63.3	142.6	335.7	106.3	100.1
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737333	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049905	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (9.87e-4)"	106.0	106.8	27.8	95.5	29.6	184.7	92.1	29.9	34.0	83.6	37.7	100.3	86.2	88.9	64.0	129.5	89.5	42.1	78.5	29.2	32.9	83.0	115.2	95.4	111.6	30.8	28.5	85.6	88.3	48.4	81.9	66.0	30.3	78.0	71.6	53.4	90.6	52.3	91.7	96.5	113.2	49.0	31.3	121.6	94.4	49.5	30.0	94.2	102.1	36.0	100.2	80.0	94.3	36.0	318.7	239.8	289.5	207.5	70.9	58.5	300.5	197.3	146.8	225.4	207.0	257.2	216.8	478.0	143.3	188.7	164.3	279.9	293.3	229.0	230.2	202.3	489.3	357.9	246.6	311.9	79.3	404.4	210.6	65.2	51.1	186.2	54.0	91.1	179.9	212.0	373.4	209.6	183.7	251.0	460.0	440.9	339.5	186.4	340.2	455.0	310.6	360.5	156.5	225.2	247.7	350.8	227.1	196.3	120.4	154.0	238.8	301.6	187.9	206.9	271.3	139.4	330.0	278.2	219.2	552.9	187.3	318.9	177.1	2.5	40.9	10.0	26.0	53.3	26.0	23.5	17.7	26.7	67.0	19.6	20.1	19.4	4.4	35.6	33.6	49.2	24.0	33.0	27.8	29.6	29.9	34.0	29.2	32.9	30.8	28.5	30.3	31.3	30.0	36.0	271.3	118.6	105.6	57.5	396.7	460.8	439.7	205.9	540.1	151.9	291.7	277.9	86.2	148.7	141.5	88.3	91.8	339.4	548.0	233.1	156.5	199.1	203.6	176.8	181.9	204.3	266.3	366.6	51.1	157.3	579.7	233.9	196.7	257.4	218.4	241.7	116.7	125.1	251.3	99.3	55.4	246.9	132.2	143.7	480.4	162.0	159.1	273.5	282.8	63.7	226.9	153.3	196.7	55.8	87.9	189.0	288.7	127.5	492.0	384.8	250.5	128.7	97.4	188.9	118.3	286.8	242.1	272.3	296.8	489.5	443.4	316.0	469.1	185.4	329.4	459.4
SRSF3	"SFRS3, SRp20"	ENSG00000112081	"Serine and arginine rich splicing factor 3"	P84103	6	36594353-36605600	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012986, HPA056981"	Supported		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB012986: AB_2533150, HPA056981: AB_2683299"	"unprognostic (3.25e-1)"	"unprognostic (1.08e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.95e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (9.61e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.06e-2)"	97.2	62.5	39.2	93.5	40.9	172.3	90.2	43.6	44.0	72.6	42.4	89.6	54.0	76.1	62.5	97.8	78.0	40.5	70.2	40.1	43.8	83.3	75.3	68.8	118.9	40.0	40.6	84.0	58.0	62.3	49.2	74.6	41.6	58.6	95.2	45.2	57.8	64.6	76.0	66.4	73.2	89.9	43.1	67.2	74.9	59.9	44.0	164.3	60.7	48.5	147.9	97.7	72.0	45.5	357.2	232.3	401.4	308.9	151.9	117.9	247.2	248.4	206.5	408.6	312.2	275.1	248.2	593.4	174.3	273.3	266.8	275.1	533.1	395.4	433.2	279.3	327.3	357.0	175.5	312.3	184.9	485.2	289.6	105.8	131.6	267.4	295.6	130.3	315.2	354.4	438.7	244.1	300.8	277.4	601.0	457.0	424.5	414.5	241.5	527.3	384.2	355.9	292.2	291.1	308.7	291.8	276.1	267.4	385.4	284.9	271.2	513.1	207.9	208.1	303.9	211.0	380.1	238.6	381.4	822.9	178.4	443.7	295.5	85.6	179.0	57.9	145.8	176.6	166.0	129.0	136.8	154.7	350.7	113.5	136.1	140.8	17.1	190.5	125.1	206.8	184.2	305.6	39.2	40.9	43.6	44.0	40.1	43.8	40.0	40.6	41.6	43.1	44.0	45.5	648.3	201.9	238.6	47.3	337.6	469.6	425.1	308.4	225.9	146.2	371.3	388.4	227.9	198.8	258.0	125.0	54.2	495.6	574.3	245.3	363.9	357.3	176.1	216.0	295.7	346.9	332.9	345.9	24.0	324.9	816.9	373.6	226.8	251.1	396.8	275.2	243.8	182.7	359.3	99.3	23.8	409.9	191.2	262.9	559.3	321.2	211.9	356.5	334.4	45.9	366.3	368.8	334.8	38.2	51.1	290.1	301.9	172.3	256.3	401.7	259.2	274.7	164.8	154.5	203.8	497.3	448.2	374.2	290.8	312.2	445.8	526.1	415.2	184.1	427.4	285.1
SRSF5	"HRS, SFRS5, SRP40"	ENSG00000100650	"Serine and arginine rich splicing factor 5"	Q13243	14	69726900-69772005	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043484, HPA056523"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		23000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043484: AB_10797143, HPA056523: AB_2683164"	"unprognostic (2.08e-3)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.07e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	210.9	188.4	68.1	149.5	72.5	456.9	229.8	60.3	108.2	174.2	125.9	231.8	129.2	222.5	218.0	217.9	240.9	130.1	154.4	75.9	69.7	119.6	183.8	214.8	210.1	75.5	71.1	220.0	136.6	188.1	215.5	105.1	74.1	172.7	164.8	233.8	235.8	126.7	217.6	282.0	256.6	180.3	66.0	211.8	212.8	104.1	69.5	214.7	224.8	68.3	155.0	189.3	177.4	97.1	456.4	133.5	313.8	141.4	192.7	179.6	177.4	214.6	239.7	177.6	183.7	164.7	283.6	473.1	110.4	301.8	174.7	210.2	242.5	309.2	209.7	407.4	142.3	354.3	386.7	183.6	224.3	334.7	255.7	350.9	201.2	199.7	216.3	260.4	247.0	401.8	255.4	268.3	114.3	382.1	385.1	232.4	182.0	356.6	128.2	324.0	148.5	183.3	237.2	563.1	165.9	236.3	364.3	214.1	296.0	188.5	235.9	292.3	299.7	98.4	264.2	110.9	205.6	261.6	184.5	754.8	232.3	286.1	140.1	137.1	65.8	103.6	93.1	117.9	94.9	109.5	83.1	85.0	70.1	108.7	81.1	79.6	161.9	86.2	129.6	99.8	74.8	77.2	68.1	72.5	60.3	108.2	75.9	69.7	75.5	71.1	74.1	66.0	69.5	97.1	380.7	253.2	309.1	218.1	392.8	138.0	768.6	610.1	204.9	387.4	248.6	259.1	195.0	240.2	386.6	183.9	239.8	444.3	542.9	471.8	320.8	201.7	190.3	224.2	169.8	293.6	302.9	195.4	199.5	171.8	261.5	288.0	188.6	225.3	480.2	251.3	249.9	225.4	217.7	378.6	177.7	376.6	380.5	236.2	154.3	105.0	345.5	314.7	133.4	104.9	323.4	277.4	428.5	128.2	268.7	226.6	538.5	267.1	212.3	376.7	484.7	228.2	373.4	317.3	276.1	583.7	354.2	201.8	149.8	196.4	145.6	749.2	456.6	201.6	275.5	542.1
SRSF7	"9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2"	ENSG00000115875	"Serine and arginine rich splicing factor 7"	Q16629	2	38743599-38751494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043850, HPA056926"	Supported		Enhanced	Nucleoplasm		NA	NA		1300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA043850: AB_10964495, HPA056926: AB_2683277"	"unprognostic (2.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (3.24e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.44e-3)"	"prognostic unfavorable (3.18e-8)"	"unprognostic (1.02e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-3)"	68.3	44.5	30.5	59.3	31.8	132.8	53.3	32.3	36.0	37.3	33.9	55.0	30.4	43.8	40.7	65.3	45.2	24.0	37.7	32.3	33.6	47.0	49.4	50.5	72.0	30.8	30.2	34.6	33.6	36.1	30.0	50.7	30.8	38.9	52.2	25.0	37.4	34.5	41.9	37.8	46.2	52.9	33.3	45.8	50.6	54.0	30.7	87.0	34.3	27.7	90.1	68.4	40.9	34.4	271.3	229.3	304.4	197.1	91.8	71.8	213.7	225.2	96.6	222.9	177.9	272.9	202.4	436.1	150.9	148.2	206.9	149.2	385.7	277.1	266.7	274.7	240.9	264.3	154.8	281.2	78.1	329.3	185.4	43.4	92.8	153.3	295.0	94.3	187.9	180.3	388.5	171.1	191.6	298.9	421.2	289.9	331.5	313.3	208.4	367.8	253.4	248.0	168.2	257.3	207.2	201.6	215.3	190.1	156.5	189.7	172.8	295.0	163.1	134.3	210.2	116.3	317.6	186.6	297.8	658.9	159.1	339.1	189.3	23.4	71.2	27.8	59.8	103.3	65.0	63.3	46.1	60.3	142.4	40.7	51.4	59.7	6.8	65.7	61.7	85.8	53.4	77.5	30.5	31.8	32.3	36.0	32.3	33.6	30.8	30.2	30.8	33.3	30.7	34.4	445.1	80.1	208.8	31.3	453.7	259.5	460.8	255.9	220.3	122.7	226.9	367.2	67.8	87.2	177.0	64.4	118.9	313.7	730.0	214.7	156.5	195.4	173.6	104.6	193.5	245.7	178.0	153.5	96.6	132.2	478.1	264.0	258.9	130.4	320.4	273.2	150.0	85.3	241.9	121.1	82.2	222.5	140.4	123.4	242.6	45.2	138.5	289.2	152.9	65.6	222.6	253.9	239.9	74.9	100.8	149.0	179.3	109.9	337.7	309.9	192.1	94.1	116.4	225.8	118.3	317.9	408.1	286.7	287.3	163.0	243.5	250.2	652.4	186.4	242.8	344.7
SRSF8	"SFRS2B, SRP46"	ENSG00000263465	"Serine and arginine rich splicing factor 8"	Q9BRL6	11	95066919-95071225	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049905	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.99e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.75e-3)"	14.8	13.5	16.3	12.1	16.0	14.7	16.7	16.5	18.0	14.7	16.8	15.1	15.7	17.3	16.0	14.5	15.3	12.0	13.4	15.8	17.0	19.3	15.1	13.5	17.4	15.0	15.5	20.7	21.9	17.9	15.7	14.3	15.3	19.0	15.6	10.4	19.9	16.8	13.2	14.9	17.4	14.7	16.2	20.0	15.8	5.3	17.5	12.3	23.2	14.1	14.7	13.2	13.6	17.7	7.6	7.7	19.1	0.0	24.9	15.5	21.7	11.1	12.2	5.1	5.5	18.4	24.2	40.3	32.2	16.9	9.4	16.3	16.2	24.1	5.9	24.4	17.8	33.8	9.0	16.6	18.3	34.3	17.7	20.3	25.1	5.4	25.3	15.0	16.2	18.1	25.9	21.5	10.1	10.3	17.9	30.4	10.2	19.8	21.7	22.1	5.8	32.1	20.1	24.8	24.2	24.7	13.8	24.1	16.7	12.0	9.6	18.7	15.3	9.9	13.3	13.5	11.6	11.6	19.1	21.4	5.1	22.5	22.1	10.1	2.1	0.7	5.4	1.2	7.9	9.2	9.4	8.1	4.0	7.1	12.0	9.1	0.6	6.2	1.1	3.7	10.9	4.1	16.3	16.0	16.5	18.0	15.8	17.0	15.0	15.5	15.3	16.2	17.5	17.7	32.5	44.8	29.3	8.8	82.8	0.0	51.4	0.0	57.5	49.3	54.4	60.3	21.4	58.6	11.8	33.1	33.3	39.2	56.5	41.1	150.6	36.7	1.8	22.1	27.6	45.8	56.9	122.9	18.3	45.7	52.7	31.4	40.2	33.8	10.2	43.2	52.5	57.8	26.1	18.5	16.6	82.6	0.0	24.2	0.0	6.0	41.0	41.9	0.0	18.7	40.2	45.7	97.9	13.6	29.6	28.9	40.8	60.9	46.8	46.4	53.4	110.1	9.5	50.9	32.9	34.6	31.0	7.2	6.4	63.5	0.0	51.2	58.4	52.1	67.5	38.0
SRSF9	"SFRS9, SRp30c"	ENSG00000111786	"Serine and arginine rich splicing factor 9"	Q13242	12	120461672-120469748	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049849	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA049849: AB_2680911"	"unprognostic (3.80e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (9.85e-7)"	"unprognostic (9.65e-3)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	68.2	112.1	71.2	75.5	74.3	95.0	72.0	73.9	75.2	70.3	81.0	88.7	73.0	57.5	85.5	126.6	76.1	48.7	38.8	70.6	75.1	94.7	92.0	62.1	99.3	72.7	77.2	71.2	113.8	94.2	78.2	85.2	74.0	76.9	84.2	21.8	77.1	57.4	30.0	80.6	63.5	58.9	74.4	86.7	82.6	93.3	77.6	110.2	80.6	27.5	129.1	82.9	75.6	72.1	334.7	229.2	344.3	222.7	153.6	153.7	365.3	224.3	200.7	281.5	240.2	276.9	153.1	323.6	254.7	189.4	152.7	194.9	312.0	318.9	308.5	244.7	321.9	276.3	152.8	273.5	197.7	344.7	241.8	163.4	201.8	244.6	211.0	301.2	260.4	207.0	353.6	95.3	245.9	466.8	339.7	668.7	429.6	224.8	198.2	374.2	144.1	312.9	246.4	420.4	303.9	217.3	262.5	137.3	276.2	222.4	415.9	299.4	229.1	207.8	247.0	157.8	246.3	288.6	234.5	404.9	218.8	255.7	221.5	28.7	16.9	49.3	22.5	19.8	17.5	41.2	17.4	19.9	22.5	36.7	17.3	19.1	19.7	26.5	27.7	30.7	20.1	8.7	71.2	74.3	73.9	75.2	70.6	75.1	72.7	77.2	74.0	74.4	77.6	72.1	172.6	25.6	37.2	17.3	190.1	264.9	269.7	81.2	140.0	74.5	235.6	174.4	1.7	157.3	60.4	161.8	29.2	339.2	204.5	119.5	489.1	200.6	68.5	179.1	149.9	143.8	144.7	141.9	24.1	155.1	469.4	148.9	105.5	143.9	33.7	321.3	132.8	150.0	202.9	72.3	23.6	160.5	63.1	136.3	322.0	28.5	124.5	171.3	200.9	11.2	192.7	134.4	129.8	14.1	24.1	152.4	102.2	155.0	317.8	336.8	89.8	404.3	63.6	55.3	52.6	128.1	165.5	288.5	248.8	218.2	313.4	475.4	158.1	433.1	160.6	392.2
SS18	"SSXT, SYT"	ENSG00000141380	"SS18 subunit of BAF chromatin remodeling complex"	Q15532	18	26016253-26091217	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055741, HPA059539"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA055741: AB_2682901, HPA059539: AB_2684055"	"unprognostic (2.03e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.30e-1)"	29.5	46.2	21.2	27.7	24.9	23.0	33.2	23.6	22.6	32.1	26.3	28.4	18.0	32.2	39.4	34.5	33.2	29.8	29.4	21.8	23.6	36.8	41.9	26.8	35.9	25.5	24.7	47.7	23.8	52.0	30.5	36.9	24.5	35.0	23.4	24.7	29.7	31.2	11.6	41.2	27.7	31.8	23.8	28.5	26.8	25.9	22.4	33.6	45.4	17.5	38.6	38.3	31.2	29.1	52.4	37.2	90.8	43.9	69.0	65.1	45.8	62.9	57.6	55.1	53.6	24.5	43.1	90.6	49.1	75.0	49.0	67.1	50.1	62.0	67.5	58.4	23.3	45.4	56.2	39.8	55.6	69.8	66.5	81.4	71.3	68.6	74.3	53.7	43.7	26.6	34.2	45.0	76.3	53.1	28.5	39.9	17.3	51.6	35.7	33.0	70.2	44.2	57.6	60.7	38.1	57.7	96.0	43.8	27.0	64.6	45.5	40.9	51.4	114.1	22.6	26.8	63.9	80.9	58.3	64.0	53.9	47.8	62.2	27.1	13.5	19.4	16.4	19.7	19.2	17.7	15.6	17.1	15.2	15.0	16.2	18.6	5.7	24.6	20.2	8.5	18.2	16.3	21.2	24.9	23.6	22.6	21.8	23.6	25.5	24.7	24.5	23.8	22.4	29.1	28.8	28.9	23.7	43.8	45.9	8.9	27.8	13.9	40.9	28.8	29.4	26.4	16.0	22.8	18.1	23.9	16.7	70.0	34.0	25.2	21.5	30.3	52.7	44.8	31.5	27.9	24.7	26.1	50.7	26.0	48.8	30.4	22.4	32.3	36.8	60.2	22.1	34.5	27.6	87.5	42.7	25.7	6.1	25.5	10.9	51.4	33.2	22.6	5.4	65.6	19.7	51.1	22.6	90.5	118.0	34.8	15.7	41.0	42.0	24.8	19.1	24.9	30.5	29.8	39.5	23.4	31.3	29.3	20.3	37.2	13.2	85.1	34.0	30.7	16.9	24.7
SS18L1	"CREST, KIAA0693"	ENSG00000184402	"SS18L1 subunit of BAF chromatin remodeling complex"	O75177	20	62143769-62182514	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011827, HPA059046"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"CAB011827: AB_778216, HPA059046: AB_2683888"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-3)"	7.7	8.8	11.3	6.6	10.1	6.6	7.8	26.1	13.9	10.3	7.5	8.2	7.7	8.0	8.4	10.9	9.2	5.0	8.3	9.7	9.7	10.5	37.8	9.7	6.4	12.2	9.5	10.6	12.1	6.4	11.9	7.1	11.6	9.0	6.1	10.7	8.5	5.4	13.3	19.8	8.4	5.6	6.7	10.1	9.2	8.9	11.1	6.5	9.1	9.4	5.8	8.5	10.1	18.9	11.1	12.5	17.7	16.3	7.6	8.8	12.9	10.3	3.9	16.6	8.0	44.1	10.2	6.6	13.3	5.8	8.6	27.9	10.5	9.8	15.2	4.5	6.9	29.6	30.9	23.5	5.7	11.2	25.6	5.5	20.5	8.4	7.0	9.7	7.5	11.3	20.3	12.8	9.6	13.2	16.7	17.2	7.3	11.0	13.7	18.5	23.1	7.8	12.5	13.9	33.4	18.6	17.7	22.4	15.6	11.3	20.8	17.6	9.3	31.8	19.0	12.0	14.6	13.8	13.2	5.6	15.9	10.6	10.9	0.0	0.4	0.1	0.3	0.3	0.2	0.1	0.2	0.3	0.3	1.2	0.6	0.2	0.6	0.4	0.7	0.2	0.2	0.1	11.3	10.1	26.1	13.9	9.7	9.7	12.2	9.5	11.6	6.7	11.1	18.9	9.7	9.6	7.0	19.6	5.2	16.4	4.8	8.9	17.1	17.9	10.8	8.8	10.3	2.8	11.4	7.3	22.9	5.6	6.7	7.1	3.9	5.0	10.8	11.9	8.1	9.7	14.3	4.8	29.5	2.7	3.3	8.9	7.7	12.8	1.3	10.8	8.6	40.4	4.8	15.2	32.8	6.6	14.2	10.4	12.7	20.8	7.5	7.4	12.4	20.6	10.0	4.4	4.1	8.5	25.5	8.2	7.3	3.4	7.4	9.5	8.3	9.1	9.0	16.5	6.6	11.1	7.7	4.6	10.2	10.6	17.5	7.7	6.0	10.6	7.1	6.9
SS18L2	KIAA-iso	ENSG00000008324	"SS18 like 2"	Q9UHA2	3	42581840-42596934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047377	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA047377: AB_2680020"	"unprognostic (4.09e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (6.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.24e-3)"	21.0	17.1	27.6	18.5	28.6	33.9	21.9	28.8	37.1	19.8	26.7	17.5	19.0	12.6	17.8	21.2	15.7	10.4	18.7	28.2	28.4	24.5	32.4	19.6	35.4	28.2	27.8	19.1	21.6	13.5	25.1	9.9	28.3	35.9	13.6	13.7	19.1	8.6	16.2	24.9	25.6	7.4	28.4	31.6	22.7	10.1	27.8	23.6	20.4	11.0	30.2	19.4	18.5	31.5	32.3	14.0	29.0	26.4	34.9	27.8	17.3	20.6	22.4	28.7	32.2	27.1	29.1	43.3	18.2	13.6	31.6	17.9	33.9	28.0	30.9	21.7	40.5	46.9	28.9	45.3	25.4	62.5	36.2	22.1	17.7	23.7	21.9	20.6	31.4	39.1	43.2	65.4	23.1	29.3	44.8	76.4	45.9	42.7	34.2	23.6	20.6	61.2	32.3	38.2	16.2	23.0	17.6	27.2	29.8	30.2	35.8	57.4	19.5	18.0	29.0	42.8	38.0	46.5	76.3	73.5	26.3	66.1	17.0	60.4	56.4	84.9	88.4	66.0	121.0	120.3	116.3	106.2	62.1	104.3	99.5	101.1	75.8	83.0	50.9	74.5	139.2	90.4	27.6	28.6	28.8	37.1	28.2	28.4	28.2	27.8	28.3	28.4	27.8	31.5	39.3	12.8	16.7	5.5	96.3	107.1	70.1	101.5	91.0	16.2	78.6	77.8	19.3	42.9	46.1	27.6	8.4	57.1	102.9	39.2	56.7	43.4	4.3	47.0	37.9	37.0	55.1	67.3	13.6	49.2	75.8	39.0	39.8	71.9	45.7	39.6	32.5	61.0	66.8	23.5	11.2	51.1	79.3	38.6	51.2	3.7	34.5	43.0	51.6	6.5	69.3	38.1	88.6	3.0	25.8	50.6	58.9	15.8	72.4	75.6	121.4	85.2	28.2	26.8	13.1	26.4	32.5	19.4	24.7	84.5	138.1	37.4	103.2	34.5	53.7	99.2
SSB	"La, La/SSB, LARP3"	ENSG00000138385	"Small RNA binding exonuclease protection factor La"	P05455	2	169791933-169812064	"Predicted intracellular proteins"		RNA-binding	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004643, HPA017287"	Supported		Approved	Nucleoplasm		NA	NA		93000	"Cluster 42: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"CAB004643: AB_425691, HPA017287: AB_1852672"	"unprognostic (5.58e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.05e-3)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (5.99e-4)"	"prognostic unfavorable (8.30e-8)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (9.81e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (6.17e-6)"	"unprognostic (9.92e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.38e-2)"	114.1	75.6	53.7	75.8	54.9	105.3	76.0	55.5	72.8	59.3	63.3	61.7	49.2	68.6	82.0	51.6	61.0	58.1	69.0	53.8	58.0	74.5	68.5	55.9	93.3	55.5	58.3	68.9	40.2	80.0	64.6	73.6	55.6	78.2	57.1	55.2	49.9	58.8	62.3	46.6	49.3	61.5	55.3	62.7	49.8	41.1	55.2	70.2	81.7	52.9	81.2	88.4	51.2	55.2	189.0	109.3	231.2	173.5	244.9	226.0	287.8	226.8	150.8	208.2	192.7	332.9	201.7	419.8	251.7	149.8	188.9	197.9	315.3	198.6	283.9	231.2	258.4	505.9	138.0	323.4	218.6	410.8	181.5	175.1	187.1	265.0	156.8	170.6	235.4	156.1	599.0	95.5	442.4	149.5	273.6	428.2	373.3	180.7	110.5	267.9	245.7	304.6	266.3	205.6	219.8	168.0	179.9	132.4	262.9	223.4	152.5	292.0	213.9	151.1	180.1	153.8	221.9	110.3	227.3	355.9	149.2	381.4	168.2	83.4	47.3	59.9	71.9	81.6	104.2	89.8	100.9	92.1	56.8	75.8	90.5	97.0	7.9	93.8	104.5	60.6	100.9	67.2	53.7	54.9	55.5	72.8	53.8	58.0	55.5	58.3	55.6	55.3	55.2	55.2	143.0	86.6	79.9	21.9	107.9	91.6	229.2	308.7	83.6	114.7	78.1	126.7	91.9	77.2	168.9	112.2	27.1	212.4	111.6	33.6	187.9	206.6	20.3	235.3	188.4	131.5	73.0	154.2	25.4	146.7	212.4	133.5	46.9	101.2	205.0	111.4	92.8	77.0	185.7	136.3	26.8	82.7	240.1	86.8	91.4	49.7	184.2	111.7	80.0	15.0	113.4	152.7	84.5	20.1	21.5	113.2	47.8	186.9	78.7	199.2	40.2	194.9	371.1	91.4	216.9	183.7	194.8	154.4	156.7	68.5	88.4	165.4	128.4	183.3	100.0	155.9
SSBP2	HSPC116	ENSG00000145687	"Single stranded DNA binding protein 2"	P81877	5	81413021-81751797	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 281.7;Excitatory neurons: 263.4;Inhibitory neurons: 350.0;Microglial cells: 339.2;Oligodendrocytes: 340.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 136.8;MOLT-4: 132.4;REH: 196.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020834, HPA068605, HPA071780"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB020834: , HPA068605: AB_2732116, HPA071780: "	"unprognostic (4.62e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.04e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.39e-3)"	28.8	12.7	25.9	13.0	27.9	14.0	26.5	37.0	26.1	31.2	24.1	29.7	5.7	29.1	30.2	24.4	29.9	16.2	31.8	24.1	34.2	12.8	3.3	16.2	19.8	25.0	33.2	37.1	11.2	47.3	28.0	13.7	27.7	19.2	12.9	53.3	20.8	21.3	23.6	27.2	15.5	29.8	26.2	12.5	17.8	7.9	31.3	96.4	17.7	22.2	24.3	25.7	26.1	27.2	3.8	6.8	85.1	48.8	48.0	72.6	5.2	18.1	16.4	16.5	16.9	0.3	7.1	60.8	1.2	21.3	8.2	0.4	23.6	9.7	15.9	26.1	10.1	12.8	14.6	0.3	27.1	6.4	32.5	74.8	82.1	2.8	15.9	35.6	7.1	136.8	8.4	29.2	17.9	8.7	132.4	10.7	11.7	0.1	3.8	196.2	19.3	47.2	8.8	3.3	44.2	39.7	19.1	21.1	6.6	34.3	31.1	18.1	4.9	6.5	10.4	12.3	4.9	30.4	25.1	101.6	21.8	11.3	4.4	60.4	19.0	61.1	5.0	17.5	8.0	23.9	16.2	9.3	18.3	33.6	31.3	11.1	27.9	61.3	29.6	5.9	7.8	18.7	25.9	27.9	37.0	26.1	24.1	34.2	25.0	33.2	27.7	26.2	31.3	27.2	43.7	9.6	18.6	281.7	39.0	34.9	40.3	44.3	122.9	75.0	25.1	38.1	45.3	12.8	34.4	29.5	27.1	7.7	12.5	4.1	17.6	14.0	5.9	25.2	27.3	21.4	15.0	29.7	263.4	10.0	3.7	48.6	10.2	22.0	25.3	5.4	23.9	2.3	20.5	42.1	350.0	5.4	61.1	17.0	21.7	4.2	37.9	29.9	35.6	339.2	15.6	122.4	5.2	185.0	340.2	6.1	13.6	48.5	14.9	14.9	2.5	4.5	34.1	49.3	52.6	48.9	59.4	10.0	29.8	60.3	36.2	7.4	23.9	9.9	4.4	27.3
SSBP3	"CSDP, FLJ10355, SSDP, SSDP1"	ENSG00000157216	"Single stranded DNA binding protein 3"	Q9BWW4	1	54225433-54413479	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071780			Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA071780: "	"unprognostic (1.44e-2)"	"prognostic favorable (2.48e-9)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.96e-1)"	26.3	46.1	35.4	21.2	45.9	42.0	15.1	32.5	72.6	49.4	8.0	29.6	28.6	48.4	20.1	31.3	40.2	26.4	24.9	47.7	24.4	19.6	27.5	20.1	19.9	15.9	21.3	103.8	21.3	13.8	5.5	27.9	15.4	32.8	25.5	37.8	23.0	36.0	30.7	39.8	29.3	35.3	15.1	28.2	45.7	27.0	20.9	67.8	15.5	15.8	19.8	19.1	19.4	44.0	13.4	9.6	91.9	56.9	43.2	26.1	153.4	30.0	31.3	13.1	11.2	18.9	11.2	8.6	45.9	31.1	11.7	39.6	49.1	19.1	16.0	69.9	21.7	96.5	47.0	28.0	36.8	25.1	47.4	39.1	20.1	23.1	6.0	25.3	66.4	64.7	97.5	17.2	18.1	19.4	136.2	66.6	161.2	51.4	40.8	94.5	37.7	33.0	24.2	15.2	117.1	70.1	35.3	59.9	19.7	83.1	27.0	38.6	61.7	24.9	36.9	37.1	20.2	29.3	32.7	20.5	43.3	90.8	10.9	0.0	1.2	3.3	5.6	0.7	3.5	0.9	4.4	4.9	1.1	0.3	5.8	5.8	0.1	0.6	0.7	0.4	0.4	1.7	35.4	45.9	32.5	72.6	47.7	24.4	15.9	21.3	15.4	15.1	20.9	44.0	31.8	12.8	12.1	31.6	6.8	29.7	37.2	13.8	15.9	97.4	16.9	36.6	17.4	41.5	14.9	23.9	8.4	56.9	36.1	73.6	9.8	30.2	36.5	65.5	38.4	37.4	111.7	60.8	100.0	25.2	46.9	41.4	47.4	48.2	7.6	93.1	47.5	97.8	26.0	42.1	37.1	78.5	14.2	33.9	25.4	42.5	91.6	19.2	23.2	38.4	21.5	68.5	51.5	45.2	78.4	64.6	33.9	136.9	10.0	20.4	38.7	10.8	27.7	48.5	26.3	21.2	37.2	2.9	35.8	27.2	25.9	23.7	20.2	144.9	46.2	30.8
SSBP4		ENSG00000130511	"Single stranded DNA binding protein 4"	Q9BWG4	19	18418864-18434562	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071780			Approved	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA071780: "	"unprognostic (2.81e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-1)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (3.32e-2)"	"prognostic unfavorable (2.04e-10)"	"unprognostic (4.50e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.05e-2)"	52.2	42.7	74.2	18.0	87.1	14.0	44.3	32.9	97.5	87.0	88.3	51.1	17.0	72.7	5.5	28.8	101.2	6.9	51.5	78.6	56.4	75.9	31.8	50.7	12.6	44.4	46.0	69.0	38.0	6.7	129.6	12.2	31.5	57.7	4.3	5.3	27.4	21.8	41.2	24.1	43.7	6.8	38.0	79.7	38.3	41.2	68.1	6.9	45.7	8.1	4.3	48.0	48.6	40.9	37.4	32.3	27.4	53.5	5.1	20.0	38.0	51.7	11.4	11.7	12.9	12.4	41.9	33.5	45.7	11.6	13.0	42.8	7.1	9.8	4.8	35.9	80.4	59.2	37.9	28.4	20.6	27.9	106.7	16.2	7.9	7.5	2.8	16.0	38.2	66.0	120.0	16.5	3.8	60.0	74.2	91.5	22.2	19.1	84.8	49.8	22.2	35.6	17.5	12.6	49.2	82.3	8.2	26.7	75.4	5.3	27.0	64.5	45.0	19.7	51.7	121.5	31.4	23.0	7.0	23.1	53.3	85.9	42.9	0.0	5.6	0.3	12.0	14.9	7.9	14.5	9.8	10.4	7.4	11.1	5.8	10.0	0.7	5.1	26.2	4.4	5.6	4.5	74.2	87.1	32.9	97.5	78.6	56.4	44.4	46.0	31.5	38.0	68.1	40.9	54.1	6.4	18.6	21.2	43.5	17.2	35.3	23.5	26.7	11.8	39.4	36.8	6.1	18.6	21.2	53.3	25.0	20.6	83.6	13.7	25.4	13.8	10.5	99.0	69.0	53.4	59.9	24.4	43.4	21.1	44.8	51.7	27.5	31.2	37.4	49.4	37.1	12.1	34.8	42.1	29.0	17.3	34.6	41.5	38.4	29.6	58.4	39.0	19.6	16.9	23.4	41.3	70.0	10.1	6.3	12.8	12.9	51.6	19.5	36.4	6.6	19.8	96.7	16.2	39.5	23.6	48.7	20.0	58.9	17.2	14.6	18.9	79.0	80.4	21.6	34.3
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519099	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 39.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 19.3;Fibroblasts: 27.0;Leydig cells: 18.0;Peritubular cells: 15.8;Skeletal myocytes: 32.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.9;BJ: 22.7;fHDF/TERT166: 27.5;hTERT-RPE1: 23.2;U-87 MG: 27.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	Yes	NA		88000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	13.1	2.2	2.6	3.6	4.6	0.1	8.8	3.0	2.1	23.0	1.8	33.6	1.9	39.7	3.9	5.7	17.0	12.9	17.6	1.8	2.1	3.6	1.7	9.1	1.3	3.9	2.6	14.5	1.8	0.3	17.6	1.9	4.0	8.8	2.8	1.1	3.4	12.8	3.6	5.6	8.7	20.1	2.2	11.1	9.8	2.6	3.6	2.0	3.8	2.8	0.5	10.6	15.9	2.1	0.1	1.4	0.5	0.0	3.3	26.9	0.0	22.7	5.5	3.7	4.6	0.4	0.0	1.2	0.3	27.5	1.1	0.0	0.0	0.0	1.9	0.1	0.3	5.6	1.5	0.0	5.2	0.1	9.6	12.3	0.0	5.4	0.0	23.2	0.0	0.7	0.2	0.3	0.6	0.1	0.1	0.5	0.9	0.0	0.2	0.7	1.2	0.3	2.5	0.0	2.9	0.4	0.4	0.0	0.5	0.5	0.4	1.2	7.9	1.0	1.3	1.1	3.8	0.4	0.0	0.1	27.8	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.6	3.0	2.1	1.8	2.1	3.9	2.6	4.0	2.2	3.6	2.1	3.5	3.2	0.6	4.2	0.3	1.9	0.3	0.3	0.0	5.3	0.8	1.1	2.8	0.0	0.1	0.0	2.1	0.1	0.4	0.8	1.9	0.1	0.6	1.5	19.3	3.3	0.0	0.0	1.5	0.0	0.1	27.0	2.0	0.9	0.0	0.5	2.2	0.0	1.2	3.3	1.1	0.4	0.0	1.0	3.8	1.3	18.0	2.0	1.8	2.8	0.7	2.1	0.0	0.0	0.3	0.1	0.3	15.8	0.3	0.3	4.6	0.2	0.7	1.9	0.0	32.1	6.8	0.9	1.1	0.4	1.8	0.0	0.5	0.9	1.4	0.2
SSH1	"KIAA1298, SSH1L"	ENSG00000084112	"Slingshot protein phosphatase 1"	Q8WYL5	12	108778191-108857590	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 63.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019845	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA019845: AB_1857497"	"unprognostic (1.18e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.28e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.22e-2)"	6.6	5.1	5.6	5.1	5.1	7.9	5.0	9.2	5.5	5.8	7.2	7.2	2.9	5.9	4.0	5.5	5.3	5.3	7.8	5.7	5.3	6.7	5.5	11.8	4.1	5.8	5.7	5.0	4.3	5.4	5.2	5.2	5.2	5.2	4.1	5.7	3.9	4.8	11.9	4.6	5.1	5.5	5.0	7.5	4.9	3.5	5.1	3.6	5.3	6.5	4.2	6.0	5.2	5.1	9.9	12.7	8.2	6.4	15.1	12.8	7.2	12.8	26.1	11.0	9.7	6.4	4.6	4.9	8.7	29.0	18.8	9.8	4.9	20.7	8.9	9.9	4.8	11.3	6.0	4.0	8.1	5.8	28.4	17.7	7.0	10.0	22.0	27.1	10.3	5.6	2.5	3.6	29.1	5.4	6.6	8.0	5.8	3.8	10.3	4.6	9.8	6.1	4.5	17.1	6.1	8.1	11.0	2.8	24.2	11.2	3.9	4.8	8.1	19.6	8.4	11.9	7.1	7.3	7.0	5.6	10.3	4.5	63.1	1.8	0.9	2.0	1.0	1.5	0.9	0.6	0.5	0.9	0.6	0.6	0.4	0.5	2.1	0.7	1.2	0.7	0.6	0.5	5.6	5.1	9.2	5.5	5.7	5.3	5.8	5.7	5.2	5.0	5.1	5.1	34.5	9.6	16.1	26.1	6.3	9.4	20.8	23.6	19.4	12.9	6.9	6.6	25.1	11.5	12.7	14.7	16.7	6.0	18.5	8.2	5.9	8.4	2.2	10.8	17.1	52.2	5.4	7.8	27.3	8.2	4.4	14.0	13.7	16.9	20.8	12.0	29.3	15.2	12.3	11.8	35.4	5.4	0.0	23.0	20.3	5.0	6.5	21.1	12.4	55.3	33.7	7.8	14.4	14.1	14.8	12.3	2.4	12.8	13.1	21.8	4.0	6.7	9.0	19.1	6.6	17.8	18.1	1.4	7.7	13.2	8.9	2.3	17.9	7.6	7.8	13.9
SSPN	"KRAG, SPN1, SPN2"	ENSG00000123096	Sarcospan	Q14714	12	26121991-26299290	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 79.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 140.8;Leydig cells: 185.8;Peritubular cells: 267.4;Skeletal myocytes: 139.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"memory B-cell: 57.4;naive B-cell: 16.9"	"Lineage enriched"	"Detected in many"	19	"B-cells: 57.4"	"Group enriched"	"Detected in many"	4	"ASC diff: 24.4;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066432			Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear membrane"	Nucleoplasm	"HPA066432: AB_2685669"	"unprognostic (4.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (2.64e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	21.3	10.7	18.0	6.4	26.5	0.1	20.1	26.2	15.4	39.5	8.6	21.2	4.4	23.9	17.8	18.3	25.2	21.9	46.0	16.1	30.1	6.1	1.4	8.9	7.0	26.5	29.1	33.8	8.0	3.2	3.8	4.6	27.9	22.4	12.7	2.9	9.4	34.4	60.7	4.4	7.7	24.3	31.5	8.7	7.7	8.3	21.5	8.7	17.1	79.0	12.1	19.2	15.4	38.4	0.8	1.6	4.0	0.0	24.4	14.5	0.2	6.9	10.8	1.1	3.1	0.1	9.5	0.0	1.8	11.0	6.0	3.0	0.0	0.5	2.1	0.1	0.0	0.0	0.1	0.0	2.9	0.1	0.0	9.3	1.0	3.5	0.8	91.6	0.4	0.0	0.0	0.1	8.4	1.9	0.6	1.9	7.9	0.6	2.7	0.3	10.7	3.2	2.4	8.3	0.4	6.3	2.7	0.6	7.0	4.0	0.9	0.3	3.0	2.5	1.8	3.4	1.8	0.3	1.2	0.2	5.3	0.0	8.6	0.0	0.0	2.7	0.0	0.0	0.5	57.4	0.0	0.0	0.1	16.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.7	18.0	26.5	26.2	15.4	16.1	30.1	26.5	29.1	27.9	31.5	21.5	38.4	10.8	3.2	3.2	39.2	30.7	13.6	23.1	21.6	30.1	2.1	21.8	89.2	95.4	10.0	14.8	18.4	0.0	74.0	1.4	36.0	5.9	11.4	4.0	12.4	52.1	10.2	4.9	1.3	3.5	7.1	7.5	140.8	3.6	6.0	0.0	10.7	9.7	0.2	15.3	6.7	5.8	10.1	0.0	0.6	11.1	5.8	185.8	6.6	19.6	18.7	18.6	41.2	0.0	41.7	18.4	2.8	7.3	267.4	41.2	19.4	0.6	3.1	7.9	2.7	39.5	139.9	56.3	0.7	3.8	7.7	7.1	27.8	2.1	30.7	7.7	24.7
SSRP1	FACT80	ENSG00000149136	"Structure specific recognition protein 1"	Q08945	11	57325986-57335892	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002697	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		42000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002697: AB_1857509"	"unprognostic (1.67e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (4.03e-7)"	"unprognostic (3.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	52.3	42.7	37.6	62.9	39.1	78.9	53.7	37.9	46.4	61.0	37.2	64.7	48.3	64.9	47.7	67.7	68.3	37.0	47.0	39.3	41.2	48.8	43.3	51.7	76.1	38.2	38.9	74.1	74.0	60.9	57.4	57.5	37.1	46.6	66.1	36.0	55.0	49.6	140.6	67.0	55.1	58.4	38.5	52.6	59.8	45.8	42.4	87.8	54.0	63.9	91.9	58.6	56.4	40.2	353.0	332.0	308.3	226.9	95.1	105.1	150.7	188.9	181.1	321.8	229.2	230.0	255.2	424.4	196.7	166.7	204.5	264.8	493.7	293.9	402.2	297.7	276.9	271.5	233.1	250.5	149.3	455.4	195.3	106.7	175.7	331.8	456.8	149.1	213.3	320.7	376.0	207.9	222.6	237.1	463.3	400.3	406.1	186.1	201.7	386.1	520.4	412.0	151.7	249.3	321.4	271.6	267.6	226.2	286.7	157.0	275.3	177.0	162.7	218.2	287.1	298.3	328.9	240.9	259.9	431.9	185.0	251.6	294.6	0.8	4.1	4.6	8.6	5.1	8.2	8.4	7.4	9.5	6.0	10.5	8.2	11.0	1.0	7.2	5.2	10.0	9.9	5.0	37.6	39.1	37.9	46.4	39.3	41.2	38.2	38.9	37.1	38.5	42.4	40.2	31.2	76.9	91.2	4.6	51.0	74.9	78.1	52.0	55.8	27.3	38.3	39.8	26.4	44.3	78.1	29.5	25.0	115.6	31.7	29.9	13.7	92.5	83.0	40.8	47.2	52.0	28.8	106.8	10.5	99.4	116.9	45.3	32.1	33.2	41.0	55.6	33.2	39.7	57.5	25.2	9.1	45.2	32.6	37.9	45.5	158.0	42.6	34.9	28.4	8.4	42.5	26.3	40.2	6.0	8.4	69.0	32.9	44.4	72.2	80.0	32.3	25.7	101.0	18.9	19.7	53.1	66.1	58.4	108.0	75.3	76.3	67.6	43.5	46.7	78.4	70.7
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 700.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	105.4	77.3	101.9	64.1	107.4	61.0	94.8	101.9	119.7	82.1	112.6	95.9	75.1	80.4	88.3	123.3	80.6	52.7	131.5	106.2	113.3	105.5	122.4	87.9	74.3	106.6	106.6	81.9	115.0	63.4	99.9	52.0	109.0	86.8	62.7	52.1	100.6	53.6	246.7	100.2	90.8	53.8	103.4	105.9	96.1	58.9	113.2	65.1	107.8	136.3	67.7	83.6	87.2	103.9	204.6	127.6	90.2	140.3	152.1	145.4	92.2	172.8	134.1	147.6	152.5	120.8	229.7	205.4	92.1	137.0	143.7	155.0	147.4	142.5	142.8	172.8	173.9	129.3	110.7	193.8	171.5	165.6	108.4	130.7	117.8	158.4	149.8	123.2	140.1	122.6	227.9	154.1	118.6	181.4	190.8	264.5	158.5	198.9	191.5	149.5	145.5	289.8	163.7	61.8	166.1	114.0	117.1	296.3	535.3	152.0	154.6	142.0	107.8	140.8	89.2	160.9	150.7	186.5	241.2	258.1	148.0	260.1	69.9	143.4	93.0	188.6	80.0	98.9	99.3	120.7	105.9	95.9	100.2	117.7	127.6	105.1	204.1	75.3	91.7	62.9	161.5	101.0	101.9	107.4	101.9	119.7	106.2	113.3	106.6	106.6	109.0	103.4	113.2	103.9	107.5	28.9	72.7	14.7	130.6	186.2	138.9	100.0	108.1	95.9	169.6	173.7	92.4	151.5	69.2	101.2	20.9	208.6	129.9	171.2	291.6	76.3	283.0	107.8	77.6	91.5	142.0	78.8	23.3	106.6	239.4	84.4	89.7	101.0	61.5	90.6	98.6	132.7	141.1	112.7	23.8	165.8	83.4	178.4	130.0	700.2	104.7	123.3	167.2	15.9	144.8	152.3	193.6	25.6	20.1	91.9	206.7	85.7	132.5	199.6	242.8	325.8	59.0	73.4	59.2	77.6	136.6	97.1	157.4	155.9	220.4	245.3	128.1	86.2	172.1	153.2
SSX1	CT5.1	ENSG00000126752	"SSX family member 1"	Q16384	X	48255392-48267444	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 6.8"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 24.2;Spermatogonia: 30.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Daudi: 66.1;Karpas-707: 90.5;U-2197: 22.7"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "					"unprognostic (2.25e-1)"		"unprognostic (3.51e-3)"		"unprognostic (2.36e-1)"	"unprognostic (4.32e-3)"				"unprognostic (3.38e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.94e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	90.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	22.7	0.1	0.0	4.8	0.1	5.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	24.2	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX2	"CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX"	ENSG00000241476	"SSX family member 2"	Q16385	X	52696896-52707189	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 15.0"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045683, HPA071685"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX2B	CT5.2b	ENSG00000268447	"SSX family member 2B"	Q16385	X	52751132-52790305	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 29.9"	"Cell type enriched"	"Detected in single"	9	"Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.7;PC-3: 2.5;T-47d: 1.0;U-2197: 1.5"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	29.9	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.5	0.0	0.2	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.2	0.7	0.9	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX3	CT5.3	ENSG00000165584	"SSX family member 3"	Q99909	X	48346427-48356707	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 13.5"	"Group enriched"	"Detected in some"	26	"Spermatocytes: 52.7;Spermatogonia: 118.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"Karpas-707: 2.1"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "															"unprognostic (1.86e-1)"	"unprognostic (2.13e-2)"		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.7	118.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4	CT5.4	ENSG00000268009	"SSX family member 4"	O60224	X	48383516-48393347	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 2.2;Karpas-707: 5.4;U-266/70: 4.5;U-266/84: 3.3"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"		"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4B	OTTHUMT00000056510	ENSG00000269791	"SSX family member 4B"	O60224	X	48402078-48411910	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;Karpas-707: 5.4;U-266/70: 1.9;U-266/84: 9.0"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX5		ENSG00000165583	"SSX family member 5"	O60225	X	48186220-48196795	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"Spermatogonia: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"BEWO: 4.7"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA					"Cluster 28: BEWO - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "									"unprognostic (1.20e-1)"						"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"		0.0	0.0	0.6	0.0	0.4	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.6	0.3	0.5	0.4	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX7		ENSG00000187754	"SSX family member 7"	Q7RTT5	X	52644061-52654900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;RT4: 1.7"									"HPA045683, HPA071685"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																"unprognostic (1.29e-1)"		0.0	0.0	0.4	0.1	0.5	0.2	0.0	1.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.7	0.4	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.2	0.7	0.2	0.1	0.6	0.2	0.7	0.2	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"ST14 transmembrane serine protease matriptase"	Q9Y5Y6	11	130159782-130210362	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 10.0"	"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 25.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 25.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA047014, HPA056258"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		1100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902, HPA056258: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	4.3	3.9	0.8	26.7	1.2	4.3	17.7	1.8	2.9	18.6	1.2	124.7	130.7	5.7	21.8	104.5	37.1	32.6	0.9	0.9	1.1	43.2	6.3	18.5	11.9	1.8	1.7	0.6	59.2	36.5	19.1	15.1	3.1	23.1	60.1	0.0	58.7	23.6	0.3	50.2	144.8	5.4	1.1	9.1	64.9	1.0	10.0	10.5	28.6	0.0	20.9	34.8	42.5	2.7	167.2	0.2	0.0	0.6	0.0	0.0	86.4	0.0	0.0	0.0	0.0	224.2	443.0	163.6	16.7	0.0	0.1	311.4	0.0	99.3	0.0	0.1	0.2	0.1	0.1	0.9	0.0	22.0	0.8	0.0	49.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	128.5	0.3	1.1	1.7	240.4	0.9	0.2	0.0	301.2	28.8	134.2	17.8	0.4	1.5	203.1	0.4	1.6	308.3	32.0	0.1	0.4	2.7	0.7	0.7	0.2	0.3	218.5	0.3	50.4	0.5	0.0	3.6	3.4	0.0	2.2	0.1	5.0	0.0	0.0	6.2	3.6	0.0	0.0	0.5	0.0	0.3	25.0	0.0	1.2	0.8	1.2	1.8	2.9	0.9	1.1	1.8	1.7	3.1	1.1	10.0	2.7	0.2	32.1	28.6	0.0	18.2	40.9	51.5	45.2	26.2	0.0	36.5	21.5	1.2	77.2	61.6	62.5	0.0	45.6	26.1	489.4	3.9	115.8	37.8	43.9	5.7	1.7	123.4	0.8	1.0	91.8	14.6	3.2	112.1	79.6	11.4	0.2	0.4	2.1	58.1	0.0	0.4	201.0	148.5	22.7	13.2	13.9	1.8	28.0	7.2	0.0	13.6	0.0	1.0	0.0	0.1	153.4	327.2	0.7	5.9	108.7	251.9	10.0	76.4	0.0	6.6	0.0	4.9	0.2	0.3	61.3	43.9	39.7	2.9	0.0	216.9	286.8
ST6GAL2	"KIAA1877, SIAT2, St6GalII"	ENSG00000144057	"ST6 beta-galactoside alpha-2,6-sialyltransferase 2"	Q96JF0	2	106801600-106887108	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.0;thyroid gland: 28.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 58.8;Excitatory neurons: 78.7;Granulosa cells: 111.5;Inhibitory neurons: 44.8;Oligodendrocyte precursor cells: 94.0"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 16.0"	"Group enriched"	"Detected in many"	77	"amygdala: 6.9;basal ganglia: 7.4;cerebral cortex: 11.0;hippocampal formation: 10.8;thalamus: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.3;hTERT-RPE1: 6.4;NTERA-2: 4.4;PC-3: 5.9;RPMI-8226: 9.6;SCLC-21H: 6.1;U-138 MG: 7.5;U-266/70: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014459	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA014459: AB_1857528"	"unprognostic (2.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.56e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.01e-4)"	"unprognostic (4.70e-4)"	"unprognostic (4.06e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.07e-2)"	0.5	0.1	6.9	0.2	7.4	1.0	0.7	0.0	11.0	1.7	0.0	1.1	0.2	2.6	0.3	1.8	0.7	5.1	0.5	10.8	0.0	0.4	2.6	0.6	0.3	0.0	0.0	0.6	0.1	0.1	0.1	1.5	0.0	0.8	2.3	1.9	0.8	0.8	0.1	0.7	0.4	2.0	0.0	0.1	0.6	5.3	4.6	0.1	28.7	0.0	0.3	0.6	1.0	0.1	0.0	5.3	2.8	0.0	0.0	0.0	0.1	0.2	0.0	1.2	0.3	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.4	0.0	5.9	0.0	0.0	9.6	0.2	0.0	6.1	3.9	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.5	0.1	0.2	0.0	9.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.9	7.4	0.0	11.0	10.8	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	58.8	0.0	0.9	0.2	0.0	18.8	6.6	0.2	3.4	1.4	0.0	0.6	1.8	0.0	0.0	0.0	4.7	0.0	0.1	0.4	0.8	12.2	0.3	1.2	6.3	78.7	0.0	0.0	1.7	0.0	0.5	0.0	111.5	2.2	0.0	0.2	0.0	44.8	3.3	0.0	0.0	0.0	1.2	0.3	0.1	0.0	2.8	0.0	0.9	0.0	94.0	1.9	0.0	1.0	0.7	0.0	0.3	0.0	0.6	0.0	0.5	0.0	0.2	2.9	0.1	1.1	4.3	0.0	0.3	0.1	0.1	3.2	0.0
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643786	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 61.1;intestine: 195.9;stomach 1: 64.9"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 801.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 8.9;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	32	"T-cells: 8.9"	"Group enriched"	"Detected in some"	4	"K-562: 65.5;OE19: 107.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		3500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.9	0.1	6.0	12.6	5.6	2.8	2.0	5.7	9.2	61.1	4.5	155.3	62.5	5.1	3.9	24.4	3.8	18.3	3.4	5.5	6.0	0.4	0.1	5.7	1.2	6.1	6.0	0.8	0.7	0.1	0.0	2.1	6.4	6.9	195.9	1.0	26.3	0.5	1.4	0.9	75.8	5.4	5.8	14.6	64.9	3.1	6.1	0.2	0.3	0.9	2.3	3.1	4.5	5.6	0.2	2.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.4	0.2	11.9	0.0	0.0	12.4	0.0	2.9	0.0	0.0	0.0	19.5	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	65.5	0.0	0.0	0.0	0.2	0.2	0.0	107.5	0.4	0.0	0.0	0.4	0.1	0.7	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	1.3	0.9	6.0	5.6	5.7	9.2	5.5	6.0	6.1	6.0	6.4	5.8	6.1	5.6	8.6	16.0	7.5	0.7	0.3	0.1	5.7	90.2	12.0	0.1	0.1	0.0	2.0	17.2	143.4	0.0	0.0	0.3	0.0	133.3	0.0	1.4	0.3	85.1	7.6	27.2	33.0	6.7	0.4	18.2	0.1	1.3	65.7	77.6	0.0	0.3	8.6	0.0	0.3	0.0	0.3	801.0	50.8	0.0	0.0	0.9	1.5	1.1	0.0	18.7	0.0	0.0	0.0	1.5	0.3	42.8	76.1	0.0	0.0	2.4	51.6	0.0	117.4	1.2	0.0	0.3	5.3	0.4	0.1	12.8	0.1	0.1	1.8	63.3	123.1	24.5
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074746-76634603	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.0"	"Group enriched"	"Detected in many"	4	"Microglial cells: 912.5;Oligodendrocytes: 698.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 35.8;HUVEC TERT2: 45.9;SK-MEL-30: 62.3;TIME: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA054566: AB_2682526, HPA055399: AB_2682806"	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	8.8	1.4	5.8	1.8	13.3	3.1	6.4	14.3	8.4	1.9	10.4	2.0	0.7	5.9	0.5	1.9	2.7	2.5	4.4	6.9	9.0	8.7	2.0	5.2	2.0	15.2	10.6	2.3	0.9	4.4	2.1	3.1	17.2	1.1	2.4	3.9	1.1	1.6	1.6	0.8	1.4	4.5	13.3	1.4	1.5	0.3	11.3	0.9	13.3	6.5	0.7	2.6	1.6	21.0	0.2	0.0	35.8	0.0	0.6	0.0	0.0	0.0	4.2	0.6	0.4	11.9	0.1	0.6	2.4	0.3	2.3	0.1	0.0	0.4	0.3	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.6	0.0	0.0	1.1	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	2.9	0.0	1.8	1.7	0.0	0.0	0.0	2.7	8.8	0.0	0.0	62.3	8.3	0.0	0.2	20.6	0.3	2.8	0.1	3.3	0.0	0.0	0.0	0.0	8.4	5.5	0.0	6.3	2.8	0.0	2.2	0.0	2.6	0.3	0.5	2.3	3.8	1.3	1.4	3.9	0.3	4.3	0.0	0.0	1.9	5.8	13.3	14.3	8.4	6.9	9.0	15.2	10.6	17.2	13.3	11.3	21.0	59.8	3.2	1.5	174.3	5.6	0.3	0.2	0.0	0.6	3.2	0.6	1.0	1.2	0.0	0.0	3.7	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.1	4.5	23.2	0.0	0.4	107.0	0.0	0.1	2.5	3.6	0.1	0.0	0.8	66.0	0.8	1.1	0.0	101.4	0.5	0.0	9.8	0.7	0.8	0.0	3.7	5.4	912.5	3.0	12.3	1.0	23.1	698.3	0.2	3.4	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	1.1	1.3	0.2	0.7	0.1	0.4	0.1	2.0	6.9	0.3	0.1
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917041	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.0"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 67.8;Erythroid cells: 112.2;Plasma cells: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"plasmacytoid DC: 233.9"	"Lineage enriched"	"Detected in all"	9	"dendritic cells: 233.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 105.3;RPMI-8226: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"	Nucleoplasm	"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	20.9	16.9	11.2	10.6	10.4	40.0	16.6	11.9	15.2	18.1	12.7	18.6	14.9	18.5	6.3	15.2	19.3	8.6	34.2	11.5	9.9	20.5	9.0	27.7	14.0	10.6	9.8	25.1	72.0	7.4	20.8	5.3	9.6	13.6	6.6	1.0	11.8	15.3	24.4	9.7	19.4	7.5	10.4	37.2	15.1	5.4	10.2	5.9	11.3	10.2	9.4	17.9	14.7	9.7	9.5	15.9	4.1	20.1	27.4	20.8	3.0	16.3	17.6	16.2	9.4	9.1	17.0	60.2	24.0	20.2	22.8	23.0	8.2	17.2	2.7	105.3	7.2	19.3	48.8	34.2	33.3	1.6	19.1	25.6	18.0	14.4	12.9	13.1	43.2	11.4	14.0	38.9	7.8	4.4	3.8	2.2	4.6	30.7	38.9	18.3	10.5	149.6	16.5	0.5	33.8	7.8	23.6	49.8	3.0	1.3	10.3	12.2	31.3	13.1	15.2	41.3	25.8	63.5	35.0	18.8	26.2	8.4	1.9	3.7	9.0	0.3	11.1	8.0	12.3	25.1	6.9	13.3	11.3	18.6	8.6	11.9	1.1	18.9	14.5	233.9	13.3	10.2	11.2	10.4	11.9	15.2	11.5	9.9	10.6	9.8	9.6	10.4	10.2	9.7	15.0	9.6	26.5	2.3	35.5	2.2	12.2	21.1	8.6	3.1	5.2	4.8	12.2	10.0	9.9	1.8	0.0	1.1	48.1	27.0	1.9	16.1	0.2	2.5	13.8	14.8	67.8	112.2	3.7	14.1	15.6	10.7	6.6	2.6	8.2	7.1	12.1	1.9	23.0	0.0	4.9	16.6	8.2	13.3	10.0	0.6	17.4	9.2	7.2	1.9	11.2	15.0	11.3	2.0	1.0	9.3	9.1	42.9	93.9	12.8	17.1	20.6	5.1	1.9	13.1	9.2	10.9	0.3	1.5	9.3	3.1	4.5	10.2	34.0	13.0	10.6
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230176	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 184.1;Early spermatids: 131.4;Excitatory neurons: 191.5;Inhibitory neurons: 176.0;Oligodendrocyte precursor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	13.5	21.7	22.6	6.7	22.0	17.8	15.2	50.6	24.7	19.9	11.1	13.6	12.1	14.5	35.8	9.7	18.6	12.3	22.4	21.8	22.6	29.4	41.3	26.1	7.6	15.0	17.4	17.4	32.9	19.0	24.5	20.9	15.9	13.8	12.4	12.6	21.7	21.2	12.5	11.5	11.0	12.6	14.6	10.4	17.3	8.7	22.5	8.6	28.4	11.2	8.6	12.6	11.1	19.7	29.4	17.2	28.2	24.4	31.0	20.5	12.3	23.0	30.2	24.4	35.2	24.0	32.8	7.7	25.5	21.4	34.7	24.6	24.2	24.5	31.3	11.1	33.9	23.4	26.5	20.2	21.8	27.4	39.4	16.1	24.3	30.7	21.8	21.6	24.9	5.2	36.0	54.6	22.3	18.1	0.2	21.0	26.9	40.1	19.3	6.7	18.8	33.6	25.5	16.2	42.2	33.8	27.8	115.5	32.0	20.6	10.1	23.3	19.1	27.6	11.0	30.5	23.3	34.7	28.2	29.6	22.9	24.0	28.6	1.5	3.1	0.4	7.3	1.2	5.1	2.2	4.4	6.2	5.7	1.0	2.9	3.0	0.0	7.0	1.1	5.6	10.3	3.0	22.6	22.0	50.6	24.7	21.8	22.6	15.0	17.4	15.9	14.6	22.5	19.7	6.3	22.4	38.1	184.1	5.0	7.5	8.6	8.8	10.8	12.2	9.0	7.4	13.5	12.8	12.9	5.5	0.0	21.1	6.4	3.1	5.9	6.0	131.4	7.1	5.9	9.5	3.6	15.8	191.5	13.4	22.8	10.6	12.8	14.2	19.6	3.5	8.6	24.5	8.7	3.3	176.0	6.8	8.2	14.4	6.0	53.5	11.1	7.9	7.2	44.0	7.5	12.8	4.1	111.1	46.9	8.8	3.6	6.0	10.3	6.7	3.6	17.3	6.3	1.3	0.0	9.9	12.1	12.8	5.8	7.4	5.5	21.2	4.6	4.6	5.3	8.8
ST8SIA2	"HsT19690, SIAT8B, ST8SIA-II, STX"	ENSG00000140557	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2"	Q92186	15	92393881-92468728	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.4;heart muscle: 3.9"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 2.9;Cardiomyocytes: 4.3;Inhibitory neurons: 3.5;Muller glia cells: 2.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 25.8;LHCN-M2: 7.7;RH-30: 11.7;RPMI-8226: 8.9;SH-SY5Y: 5.0;WM-115: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA054518, HPA057819"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA054518: AB_2682514, HPA057819: "	"unprognostic (4.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.87e-2)"		"unprognostic (2.32e-1)"	"unprognostic (1.28e-5)"	"unprognostic (3.91e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.00e-1)"	0.0	0.3	0.6	0.0	0.6	0.0	0.4	0.6	2.2	0.8	0.0	0.1	0.0	0.4	0.8	0.0	0.0	0.2	3.9	1.5	1.2	0.1	0.0	0.0	0.0	8.4	1.9	0.0	0.0	0.0	0.2	0.0	8.2	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.4	1.8	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.2	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.2	0.0	4.1	0.0	0.0	0.0	11.7	8.9	0.0	0.0	0.6	5.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.2	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	2.2	1.5	1.2	8.4	1.9	8.2	0.1	0.4	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	1.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins, Transporters"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 439.5"	"Cell type enriched"	"Detected in many"	4	"Hepatic stellate cells: 745.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	59	"classical monocyte: 9.4;intermediate monocyte: 5.7;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	60	"dendritic cells: 2.5;monocytes: 9.4"	"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 103.1;NB-4: 146.9;TIME: 128.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		96000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	194.2	160.4	41.0	50.4	42.9	13.8	84.5	41.4	58.3	54.4	62.8	87.7	29.6	45.3	8.5	29.2	79.3	25.8	74.6	41.9	44.4	85.6	102.1	104.7	12.9	50.0	48.4	32.2	32.2	5.0	52.0	55.4	53.7	57.6	31.0	0.6	45.7	16.0	25.9	24.0	95.1	33.8	43.0	439.5	53.2	21.0	65.3	6.8	55.1	4.6	8.2	105.7	48.6	47.8	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.2	0.2	0.6	0.0	0.0	1.8	0.1	0.0	0.1	0.0	103.1	0.1	0.3	0.1	0.0	0.0	0.0	146.9	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.0	0.0	128.8	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	9.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	41.0	42.9	41.4	58.3	41.9	44.4	50.0	48.4	53.7	43.0	65.3	47.8	31.3	0.0	3.8	0.0	5.5	6.0	0.6	0.0	1.8	1.0	1.5	2.7	2.4	11.5	0.0	3.7	0.0	1.7	1.9	0.0	0.0	0.0	0.5	0.4	0.5	43.0	1.2	21.5	0.3	0.0	2.0	3.3	0.5	0.3	18.3	0.0	745.0	19.7	130.7	0.0	0.3	0.0	0.0	185.4	30.3	2.9	4.4	147.0	12.4	30.0	21.9	0.5	2.1	0.5	0.1	0.0	0.0	20.3	2.0	0.2	0.0	0.8	0.0	0.1	19.7	2.0	1.4	0.9	2.2	1.5	4.8	2.2	2.3	0.5	0.0	0.2
STAC	STAC1	ENSG00000144681	"SH3 and cysteine rich domain"	Q99469	3	36380503-36548007	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;Early spermatids: 5.2;granulocytes: 6.3;Granulosa cells: 12.5;Late spermatids: 5.3;Muller glia cells: 21.6;Smooth muscle cells: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.5;NK-cell: 1.3;T-reg: 1.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.5;NK-cells: 1.3;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 46.8;HaCaT: 34.1;SH-SY5Y: 49.1;U-251 MG: 30.3;U-87 MG: 48.1"	"Low region specificity"	"Detected in many"							HPA035143	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA035143: AB_10603892"	"unprognostic (5.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-6)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.73e-4)"	"unprognostic (8.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.94e-3)"	2.8	5.1	1.4	0.6	1.9	0.4	1.9	3.6	3.9	7.0	5.0	3.6	0.1	1.4	0.3	2.1	3.2	2.7	0.7	0.8	4.3	2.5	0.9	11.1	0.4	2.3	2.5	2.5	0.1	10.1	1.1	0.3	6.9	13.8	0.7	5.8	1.3	4.4	1.6	1.2	0.4	3.4	1.9	0.6	0.9	1.9	2.1	0.7	0.5	5.3	0.2	3.7	2.2	0.5	7.7	3.3	1.6	0.0	6.5	2.1	0.1	19.9	0.4	4.0	4.6	0.0	0.0	0.0	7.8	46.8	13.0	34.1	2.4	8.2	4.1	0.0	7.2	1.1	10.0	0.2	0.0	20.3	0.4	2.4	0.2	0.1	0.7	27.6	0.0	1.8	0.0	0.4	0.5	0.0	4.1	0.2	13.8	0.0	3.0	0.0	0.0	0.0	10.8	0.0	6.2	49.1	7.9	5.2	0.1	13.6	0.0	2.0	8.5	0.5	19.1	0.6	30.3	0.0	0.0	0.0	48.1	7.9	8.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.5	0.0	1.4	1.9	3.6	3.9	0.8	4.3	2.3	2.5	6.9	1.9	2.1	0.5	0.9	0.0	0.5	0.3	0.0	0.0	0.0	0.5	0.0	0.7	2.3	0.8	0.9	0.0	1.3	0.0	0.0	0.0	0.1	0.0	5.9	0.2	5.2	0.9	0.5	0.4	0.0	2.1	0.6	0.0	0.1	1.5	0.0	2.1	6.3	12.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.2	5.3	0.0	4.8	0.0	0.0	0.0	21.6	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.4	5.0	1.8	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0
STAC3	MGC2793	ENSG00000185482	"SH3 and cysteine rich domain 3"	Q96MF2	12	57243453-57251188	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	40	"skeletal muscle: 2315.3;tongue: 1169.0"	"Cell type enriched"	"Detected in many"	7	"Skeletal myocytes: 287.7"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.6;monocytes: 5.8"	"Cell line enriched"	"Detected in many"	23	"RH-30: 2282.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039285, HPA039527"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA039285: AB_2676427, HPA039527: AB_10673424"	"unprognostic (6.16e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (4.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-3)"	2.7	2.0	2.7	7.3	2.5	17.8	2.1	4.6	5.3	1.4	2.3	2.6	2.0	0.8	2.8	31.2	1.7	2.3	1.5	2.6	2.3	1.8	4.4	6.5	8.9	2.7	2.6	1.0	1.4	2.6	2.1	2.9	2.7	23.0	3.0	3.2	43.9	1.1	2315.3	3.4	2.6	2.5	2.1	9.1	1.7	11.9	2.6	4.1	2.1	1169.0	7.4	2.4	1.3	3.1	0.6	0.8	2.1	4.0	1.3	2.2	0.8	0.5	0.5	0.5	0.7	0.5	1.9	55.0	1.1	1.2	0.0	1.0	0.9	1.1	0.2	1.4	1.0	27.9	0.3	0.6	0.5	17.2	97.1	10.0	1.6	0.4	0.6	1.3	0.9	6.1	2.9	2.2	7.5	5.4	1.6	36.3	0.1	0.8	1.0	13.0	2282.0	2.6	1.3	1.2	1.4	1.1	1.6	1.5	0.3	0.3	0.9	48.4	1.0	0.5	0.4	1.6	0.4	2.2	1.2	9.6	1.1	32.9	0.7	0.0	4.4	0.3	0.0	5.8	0.0	0.7	0.0	0.2	3.6	0.3	0.0	0.1	0.2	0.0	2.9	1.0	0.2	1.4	2.7	2.5	4.6	5.3	2.6	2.3	2.7	2.6	2.7	2.1	2.6	3.1	0.4	0.0	0.6	1.3	1.9	1.5	0.4	1.1	0.6	7.5	1.2	1.4	0.3	1.5	0.4	0.0	2.1	1.0	2.8	0.9	0.0	0.8	13.5	1.1	0.6	0.7	2.4	0.4	3.0	1.0	0.7	0.8	1.1	0.9	5.7	1.5	1.8	1.3	39.9	1.7	2.4	1.2	4.1	37.3	16.3	8.9	1.2	24.1	0.0	0.0	26.3	1.5	0.0	1.5	1.2	0.9	1.0	0.7	0.5	1.0	1.6	0.7	2.3	2.5	0.0	287.7	1.0	3.4	1.4	0.6	0.3	1.4	1.6	0.8	1.2	0.4
STAG1	"SA-1, SA1, SCC3A"	ENSG00000118007	"Stromal antigen 1"	Q8WVM7	3	136336236-136752403	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 166.8;Microglial cells: 231.4;Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035015, HPA058653"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA035015: AB_10603117, HPA058653: AB_2683787"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.83e-2)"	13.7	9.1	7.6	12.3	8.8	15.7	15.6	17.0	8.3	16.9	9.9	13.5	9.6	19.3	10.6	10.8	13.5	10.3	10.5	6.5	8.7	12.0	10.8	11.2	14.7	9.3	7.8	21.9	12.4	13.7	5.0	17.6	9.0	10.8	14.4	13.2	11.6	12.1	15.0	13.7	11.0	16.1	8.8	11.8	10.0	8.9	7.8	22.5	15.8	15.8	15.9	12.0	11.5	11.2	34.6	17.6	29.1	25.1	21.5	36.8	15.7	37.9	48.4	35.0	33.0	30.2	14.9	26.9	23.3	39.7	28.1	23.4	31.6	17.3	47.4	33.2	14.9	28.8	25.1	16.7	16.3	50.6	27.7	23.4	19.3	25.6	28.6	20.3	27.5	28.8	18.7	52.7	22.3	29.5	33.6	16.4	19.0	23.7	13.9	29.6	31.6	35.7	19.1	24.5	14.2	22.8	40.8	16.0	17.5	15.0	22.9	21.2	23.3	40.1	29.0	36.0	33.9	39.1	28.9	59.5	24.6	17.0	26.2	4.0	3.0	4.6	4.4	3.0	4.6	6.4	3.7	4.0	2.8	4.4	4.1	3.3	8.7	5.5	3.5	4.5	4.8	2.1	7.6	8.8	17.0	8.3	6.5	8.7	9.3	7.8	9.0	8.8	7.8	11.2	44.5	25.6	24.2	95.6	42.4	40.0	31.4	18.7	38.7	43.8	24.8	26.7	10.8	22.8	23.5	16.5	39.6	29.3	39.5	42.1	11.7	20.7	2.8	23.7	59.5	34.1	18.7	29.7	161.8	22.2	26.7	33.8	23.9	39.6	22.2	30.3	31.4	21.5	18.6	28.6	166.8	27.9	8.2	16.9	22.0	4.8	49.4	25.1	16.0	231.4	27.2	25.6	42.2	223.2	188.4	27.4	17.5	32.4	53.1	27.2	24.2	13.2	14.5	68.1	26.3	67.1	36.2	54.8	50.5	27.5	36.7	31.7	39.2	16.0	23.4	24.3
STAG2	"SA-2, SA2, SCC3B"	ENSG00000101972	"Stromal antigen 2"	Q8N3U4	X	123960212-124422664	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002857	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA002857: AB_1079861"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.67e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.97e-1)"	27.9	22.9	20.7	34.2	26.3	72.8	41.5	32.6	24.1	33.3	30.4	28.8	23.8	35.7	28.3	26.8	30.1	25.2	21.5	18.0	22.6	33.7	28.5	28.6	45.0	26.2	21.9	46.0	31.7	51.9	12.0	35.8	27.8	29.8	28.2	45.5	26.5	29.6	23.3	26.1	26.5	25.8	24.2	37.4	28.5	8.0	21.2	81.4	49.3	36.0	44.3	28.4	17.6	39.6	62.6	56.9	84.5	53.0	34.9	52.3	54.4	58.0	61.8	58.5	73.2	53.8	65.1	115.0	79.6	52.3	65.5	55.6	173.6	48.8	82.5	81.9	74.7	106.6	110.8	35.7	35.6	140.7	80.0	42.2	46.4	69.5	111.4	50.2	49.7	114.2	105.4	118.9	43.1	67.8	180.6	62.9	44.5	55.8	84.4	125.9	112.0	96.1	44.9	117.3	75.7	60.6	131.2	47.7	66.9	59.2	28.9	62.2	61.5	0.3	31.1	69.4	66.6	50.9	82.2	141.6	36.8	84.3	60.3	28.2	15.2	28.0	15.0	18.9	17.8	15.0	15.6	14.6	19.1	19.0	21.3	17.5	44.5	18.8	23.1	16.5	13.5	10.0	20.7	26.3	32.6	24.1	18.0	22.6	26.2	21.9	27.8	24.2	21.2	39.6	71.1	64.1	56.6	42.4	80.9	56.2	61.5	31.5	72.3	51.0	58.0	48.4	44.9	37.1	50.6	44.1	60.5	32.2	113.4	42.9	21.5	42.3	1.1	65.1	70.4	62.3	58.1	77.0	41.8	38.2	32.7	64.5	39.8	79.3	58.1	53.6	59.3	42.2	36.0	45.4	51.9	35.0	28.5	71.4	65.0	4.2	65.9	89.9	33.8	70.3	91.4	61.2	97.9	69.4	114.0	54.9	29.3	69.2	73.8	81.4	28.0	35.7	51.4	62.9	65.7	104.0	60.3	14.8	15.4	51.0	56.1	71.4	87.2	49.5	38.9	83.6
STAG3		ENSG00000066923	"Stromal antigen 3"	Q9UJ98	7	100177563-100221488	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Chromosome partition, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 54.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 56.5;Spermatocytes: 152.6;Spermatogonia: 60.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.7;HMC-1: 54.4;U-698: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049106, HPA058330"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA049106: AB_2680634, HPA058330: AB_2683681"	"unprognostic (6.56e-4)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.31e-4)"	"unprognostic (4.26e-4)"	"unprognostic (7.48e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.07e-4)"	0.2	0.2	0.1	0.1	0.1	0.8	0.3	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.3	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.2	0.1	54.7	0.3	0.6	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	41.7	1.1	0.0	0.1	0.2	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	54.4	0.0	0.1	0.8	0.2	0.0	0.3	1.4	0.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	13.1	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.3	0.3	1.9	0.0	2.7	2.9	56.5	6.8	10.9	1.8	1.2	7.4	1.9	1.8	2.2	10.0	1.7	7.3	2.1	2.0	12.1	1.7	13.7	0.3	29.8	26.1	2.9	4.2	1.2	8.4	6.5	0.2	3.3	4.1	0.5	7.8	1.3	4.9	4.2	29.4	2.2	20.2	6.1	5.7	0.0	2.2	8.6	23.5	4.7	4.6	5.4	5.6	4.2	2.7	13.4	5.0	5.1	0.2	0.5	1.9	2.1	8.2	1.1	6.9	15.1	7.0	0.0	8.0	5.4	152.6	60.0	0.4	8.5	2.9	10.8	2.6	2.0	11.7
STAM2	Hbp	ENSG00000115145	"Signal transducing adaptor molecule 2"	O75886	2	152116801-152175763	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035528, HPA035529"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	"Nucleoplasm, Cytosol"	"HPA035528: AB_10601606, HPA035529: AB_10672868"	"unprognostic (1.53e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	9.7	9.9	7.3	7.9	8.3	3.1	12.5	7.5	8.9	10.9	8.0	10.3	9.3	10.9	8.7	9.1	12.8	9.3	9.6	6.3	7.7	14.6	11.0	10.8	8.7	7.5	7.9	11.0	8.8	12.8	6.5	10.3	7.9	12.9	10.9	11.1	11.9	8.9	5.8	10.8	9.3	10.1	8.0	8.3	11.7	12.6	7.4	8.5	14.3	7.7	8.9	10.7	6.6	9.7	8.3	7.9	7.2	8.8	18.5	22.0	7.7	16.8	19.4	10.7	13.6	7.8	7.8	10.8	13.1	24.2	9.4	8.3	8.0	15.6	17.1	13.3	6.3	7.8	5.1	11.8	21.2	11.5	14.6	16.9	14.6	20.0	26.8	15.5	11.7	7.2	5.1	7.5	22.2	8.1	6.1	8.9	4.5	6.1	11.2	4.9	8.9	5.9	16.7	14.1	3.8	5.9	9.3	8.2	14.1	8.0	11.1	10.5	15.3	23.7	7.6	18.8	10.3	6.1	6.7	6.8	17.9	9.2	13.2	16.8	3.4	4.6	1.7	4.6	1.6	1.7	1.8	1.9	2.7	2.0	1.5	1.9	8.6	2.6	7.1	3.2	2.2	1.6	7.3	8.3	7.5	8.9	6.3	7.7	7.5	7.9	7.9	8.0	7.4	9.7	17.6	25.6	33.5	39.2	10.9	13.8	12.0	16.4	15.9	10.6	17.9	11.6	30.5	7.2	28.9	16.5	16.7	7.4	14.7	22.1	23.5	13.9	147.8	37.2	25.5	15.1	8.3	13.5	43.8	14.2	14.6	22.7	27.0	22.2	27.1	14.8	17.5	16.0	16.7	1.7	39.7	20.2	20.3	20.0	13.0	64.4	15.8	16.9	14.2	32.8	19.6	14.7	8.2	51.8	61.0	21.2	18.2	15.4	10.9	14.3	13.9	14.8	55.6	11.6	26.3	18.0	16.1	54.1	20.1	13.5	13.2	20.2	9.3	18.2	13.5	16.1
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 1108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	15.6	11.6	21.7	14.6	30.6	13.3	20.2	29.7	23.8	19.3	19.3	21.5	20.7	20.6	15.5	25.4	18.3	16.9	22.3	20.6	24.5	21.9	19.0	15.7	19.3	31.3	28.0	17.7	12.2	24.3	9.3	17.3	30.4	22.1	23.2	14.6	21.5	15.6	37.4	16.7	20.4	21.3	27.9	14.9	18.2	15.8	27.1	23.2	22.6	42.8	21.6	16.8	16.0	38.6	39.0	44.0	34.0	31.6	31.1	37.2	39.1	23.3	31.7	42.1	40.3	73.7	35.9	32.2	35.8	19.8	55.7	30.0	36.6	81.7	47.6	56.6	41.3	43.3	29.1	58.1	43.4	35.8	50.0	30.1	57.6	49.6	70.7	53.5	25.1	43.7	47.9	47.8	1108.9	46.8	55.9	32.4	54.9	55.1	22.7	38.6	89.4	46.1	45.2	43.0	62.0	45.8	28.4	34.6	49.1	36.4	32.3	21.4	22.0	37.5	44.5	22.9	41.9	44.8	46.9	24.9	46.4	38.1	44.7	30.7	18.9	34.2	15.9	21.4	17.2	21.5	18.3	15.6	19.9	19.3	18.9	14.4	27.6	22.3	19.9	19.5	25.8	14.9	21.7	30.6	29.7	23.8	20.6	24.5	31.3	28.0	30.4	27.9	27.1	38.6	22.1	19.2	17.7	22.9	21.5	16.3	28.9	61.7	31.3	22.3	28.8	27.7	41.1	28.6	34.4	25.8	12.5	43.0	27.4	48.7	49.0	37.9	80.8	35.6	37.3	21.4	10.3	34.9	18.5	36.3	32.5	26.0	18.8	45.8	52.6	21.2	17.5	41.1	33.0	26.9	22.1	36.4	40.7	27.7	16.2	125.0	32.6	25.2	7.2	16.9	34.1	24.9	25.7	26.2	67.2	44.5	41.8	34.6	21.5	40.9	57.2	68.8	24.5	21.0	39.5	28.2	27.2	33.1	44.2	44.5	21.6	44.5	21.4	27.5	34.3	27.1
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558727-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 51.0"	"Group enriched"	"Detected in some"	5	"B-cells: 60.8;granulocytes: 80.8;Ionocytes: 65.1;Plasma cells: 147.2"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 88.1;naive B-cell: 107.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 185.4;U-698: 83.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.3"	"Low region specificity"	"Detected in all"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.4	0.1	0.0	15.5	0.0	5.8	0.8	0.0	0.0	0.3	0.0	2.3	1.8	0.6	1.9	0.7	0.1	1.4	0.2	0.5	0.0	9.2	0.4	1.4	40.8	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.9	2.3	0.0	1.3	2.8	0.1	0.1	8.1	0.4	0.0	16.0	2.3	2.7	0.0	6.4	0.4	0.0	51.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	24.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	83.2	0.0	24.7	0.0	5.3	0.1	24.3	0.9	0.1	1.9	88.1	2.0	0.8	1.2	107.8	7.9	0.2	1.0	38.9	0.1	5.2	0.4	4.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.7	0.0	60.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	5.5	0.0	0.0	5.8	0.0	9.8	0.0	13.0	0.1	0.0	0.6	0.0	2.5	0.3	0.0	0.0	0.1	0.0	0.0	80.8	0.0	0.4	0.0	0.8	0.0	0.2	0.1	65.1	0.3	0.7	7.1	0.3	1.2	16.0	0.0	0.2	0.0	6.2	0.0	0.3	0.0	0.0	0.4	147.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.1	0.0	4.3	0.1	0.0	0.2
STARD3	"es64, MLN64"	ENSG00000131748	"StAR related lipid transfer domain containing 3"	Q14849	17	39637090-39664201	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 260.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017021, HPA024307, HPA073948"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB017021: , HPA024307: , HPA073948: "	"unprognostic (1.11e-1)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.25e-3)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.51e-3)"	"unprognostic (3.00e-2)"	24.8	33.4	18.3	18.8	29.1	25.4	23.4	21.6	18.9	22.3	14.9	21.5	24.1	20.4	2.7	24.1	21.5	17.2	16.3	17.9	15.4	18.9	25.8	28.8	22.3	21.1	21.3	21.3	26.5	15.2	24.0	17.1	19.0	20.1	5.2	3.2	21.2	11.3	23.9	27.0	26.7	9.2	18.7	33.1	26.5	26.2	22.5	14.8	21.4	9.5	8.8	21.0	20.1	18.5	29.3	47.6	18.6	33.5	19.9	22.9	31.2	23.1	24.9	27.1	24.3	24.0	47.6	25.2	47.7	17.8	30.8	55.4	11.3	21.0	6.3	36.2	34.5	15.2	18.8	30.1	25.9	29.6	35.5	24.5	19.0	29.8	12.6	19.0	23.4	36.4	41.0	27.4	23.5	24.7	32.2	25.6	22.2	15.3	20.6	28.5	31.4	40.1	15.0	35.7	24.9	29.1	16.1	260.8	64.0	10.8	34.1	41.7	26.3	43.2	29.5	46.5	43.6	27.5	37.8	18.7	36.2	36.8	45.1	23.7	36.3	54.4	42.7	35.5	30.7	20.8	29.6	32.7	38.3	26.1	29.1	27.8	63.6	39.6	29.3	18.7	38.5	33.8	18.3	29.1	21.6	18.9	17.9	15.4	21.1	21.3	19.0	18.7	22.5	18.5	45.8	3.2	7.5	31.0	23.2	16.6	13.0	23.4	14.2	12.6	19.9	14.6	3.4	18.6	14.8	11.0	37.5	28.5	32.9	21.0	9.8	26.5	2.7	9.7	11.7	35.8	27.5	11.1	17.3	35.4	37.2	16.2	29.6	11.0	19.0	22.2	45.0	11.9	49.8	18.5	14.8	11.6	14.2	49.0	18.5	5.3	17.1	27.7	5.4	9.4	18.5	15.8	29.9	12.1	30.2	35.9	22.9	13.2	24.3	20.2	41.5	10.3	8.3	13.2	13.1	21.8	14.4	9.3	16.2	15.9	16.9	40.0	35.2	18.6	15.1	20.1
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190908460-191020960	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 533.6;BJ hTERT+ SV40 Large T+ RasG12V: 595.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		92000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	Cytosol	"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.75e-4)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	41.2	35.6	8.0	113.3	7.7	35.1	27.1	5.1	10.2	33.9	5.6	43.4	51.3	27.5	15.1	35.8	25.1	66.6	35.6	11.1	14.7	45.3	66.0	69.1	145.6	18.8	9.4	33.0	40.7	39.0	23.8	28.9	13.4	34.8	40.6	20.0	107.4	24.2	29.8	24.9	41.8	47.5	27.3	114.5	55.7	31.2	17.4	104.3	33.4	29.7	59.0	62.2	25.1	13.2	54.8	58.6	26.8	41.4	105.7	158.8	79.3	82.4	257.1	533.6	595.5	95.1	62.8	21.7	48.1	180.8	173.9	45.9	29.8	62.0	108.6	179.6	24.6	99.0	43.8	47.3	72.2	48.4	58.3	94.7	36.8	100.4	31.0	56.5	63.5	38.4	56.8	103.9	93.6	42.5	38.0	41.1	36.6	34.2	95.3	31.4	71.4	27.9	58.9	70.1	37.9	35.0	100.3	35.7	236.5	37.5	38.6	59.9	56.2	105.1	57.5	90.0	51.4	202.1	330.7	21.0	80.8	40.3	47.8	50.0	143.9	104.9	51.6	191.1	71.4	38.3	129.3	77.4	61.4	31.7	128.2	94.2	203.9	77.3	117.3	28.9	227.8	210.2	8.0	7.7	5.1	10.2	11.1	14.7	18.8	9.4	13.4	27.3	17.4	13.2	46.8	73.7	34.3	14.0	48.8	22.2	17.5	32.3	22.2	13.3	27.6	26.0	44.6	51.5	40.3	53.3	25.0	13.6	48.0	44.4	7.9	47.5	18.5	30.9	43.9	42.1	21.0	15.5	9.0	37.8	53.9	44.1	51.5	39.3	51.4	38.5	28.5	54.1	92.6	3.3	12.2	26.7	16.2	72.0	26.2	5.2	21.8	96.9	17.8	31.9	107.3	13.7	62.8	25.1	11.9	36.0	21.7	29.7	69.4	26.7	24.7	44.0	47.7	19.3	39.5	35.4	31.1	25.4	24.6	28.8	31.3	8.3	78.1	37.9	29.2	26.9
STAT3	APRF	ENSG00000168610	"Signal transducer and activator of transcription 3"	P40763	17	42313324-42388540	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Diabetes mellitus, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001671, CAB003859, HPA058603, CAB068241, CAB068242"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		55000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"CAB003859: AB_347629, CAB068241: AB_2665663, CAB068242: AB_2665662, HPA001671: AB_1080102, HPA058603: AB_2683772"	"unprognostic (1.83e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	105.6	68.1	32.4	78.5	34.5	63.2	84.4	38.7	30.2	62.6	32.4	76.9	45.9	71.6	28.2	81.6	74.0	71.7	101.2	28.6	44.6	77.2	143.1	106.0	55.3	48.4	40.7	65.4	67.3	35.3	53.3	55.6	43.4	62.9	46.5	29.9	63.5	48.2	123.9	66.8	68.1	72.1	43.9	68.0	62.3	24.6	43.0	50.5	61.9	92.1	65.2	88.6	64.3	43.1	61.5	116.0	47.4	48.2	103.7	97.6	35.4	66.5	89.7	59.6	58.3	30.3	55.8	18.5	68.2	71.2	90.3	89.2	45.8	72.6	47.7	160.6	31.4	131.2	60.4	62.4	77.3	31.8	79.0	152.1	69.8	47.4	68.9	62.2	81.1	33.4	80.1	56.4	40.1	43.8	118.7	31.3	28.5	63.4	0.0	26.6	133.8	28.1	91.3	77.2	45.2	29.8	81.4	184.9	29.2	57.2	100.5	49.1	68.7	88.9	44.9	54.8	56.5	82.9	75.3	16.4	56.1	32.8	41.6	121.1	78.4	100.0	79.5	79.9	64.4	40.2	57.5	62.6	54.3	36.6	58.7	56.5	262.6	58.3	80.8	29.3	47.9	124.5	32.4	34.5	38.7	30.2	28.6	44.6	48.4	40.7	43.4	43.9	43.0	43.1	216.0	93.0	173.7	46.0	111.6	129.5	105.3	76.8	138.3	92.6	147.1	113.0	59.7	54.3	103.2	134.3	281.5	25.2	115.1	148.9	17.6	83.2	33.5	129.3	187.0	164.7	124.0	54.3	24.2	96.8	38.2	154.0	109.1	153.9	142.0	86.3	115.3	115.7	69.1	25.2	35.8	97.8	69.2	71.0	121.7	13.7	71.7	111.7	72.9	51.5	94.1	131.3	78.2	30.7	41.7	82.9	94.5	60.9	104.6	147.9	206.4	46.3	88.5	406.7	65.7	189.5	169.7	31.5	15.3	93.4	160.1	31.2	170.2	102.3	117.5	90.6
STAT5A	"MGF, STAT5"	ENSG00000126561	"Signal transducer and activator of transcription 5A"	P42229	17	42287547-42311943	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Lactation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 78.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 101.0;HEL: 153.5;HMC-1: 85.2;K-562: 262.4;MOLT-4: 163.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB003860, HPA027873, HPA042128, HPA049883, HPA051156"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Cytosol"		"CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"prognostic favorable (5.87e-4)"	"unprognostic (3.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	78.9	40.6	4.3	28.9	5.7	52.1	48.8	5.3	4.8	19.1	5.4	24.0	8.6	17.8	5.7	9.9	19.0	13.9	13.9	3.6	7.5	13.9	8.1	23.3	37.5	8.0	7.6	22.5	12.2	2.4	10.5	7.3	7.4	15.4	9.1	1.2	15.7	13.7	23.8	18.4	22.4	14.3	6.7	29.8	14.0	4.9	7.7	24.4	13.3	13.8	27.1	24.1	15.4	8.6	3.9	4.9	0.5	0.0	35.7	17.5	0.4	2.1	8.6	4.0	2.3	0.0	3.7	0.3	9.0	8.5	0.2	0.3	0.8	0.3	1.1	101.0	0.0	153.5	9.3	1.3	15.5	13.5	85.2	36.8	2.1	1.7	2.0	0.0	12.3	2.0	262.4	0.1	2.3	0.1	163.5	64.7	1.4	2.5	0.0	4.5	1.1	13.8	1.1	2.6	0.3	0.0	10.0	3.9	17.8	0.9	2.5	13.9	7.2	8.0	2.6	3.9	0.1	0.2	0.1	0.0	1.0	25.4	2.5	9.8	15.1	7.9	10.3	18.6	14.4	8.2	18.3	15.2	18.7	6.6	18.0	15.0	18.3	17.4	24.9	6.6	14.5	12.9	4.3	5.7	5.3	4.8	3.6	7.5	8.0	7.6	7.4	6.7	7.7	8.6	14.0	0.0	10.6	2.6	18.7	7.4	3.8	4.5	5.7	2.9	35.8	24.5	29.6	5.7	3.4	5.5	0.0	1.2	17.7	5.5	5.9	5.0	0.4	7.2	5.2	21.2	0.0	33.2	0.2	13.6	2.9	15.3	5.1	11.9	22.8	6.8	6.1	3.3	21.4	0.0	1.3	4.2	0.0	24.5	41.3	3.5	32.6	31.8	8.8	5.6	41.0	3.9	8.2	2.5	5.0	9.6	8.1	41.0	12.5	12.2	1.8	14.4	8.4	0.7	6.6	13.7	10.2	0.0	0.9	4.4	7.7	1.4	29.2	7.7	6.5	7.0
STAT6	"D12S1644, IL-4-STAT"	ENSG00000166888	"Signal transducer and activator of transcription 6"	P42226	12	57095408-57132139	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001861	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoplasm	"HPA001861: AB_1080106"	"unprognostic (3.43e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (7.76e-4)"	"prognostic favorable (1.14e-4)"	76.0	84.0	22.5	68.1	24.2	40.1	67.6	19.0	25.4	85.4	29.7	91.3	79.0	81.9	49.0	93.3	82.4	66.2	50.2	22.3	21.3	68.8	75.2	83.4	78.3	22.6	20.6	93.3	48.8	52.9	18.9	45.0	22.2	81.5	71.1	3.5	70.1	68.6	14.3	108.2	99.0	80.5	21.4	111.3	78.5	15.0	24.4	81.7	57.5	20.5	91.9	96.8	81.7	22.8	60.2	55.2	13.8	24.3	153.2	138.4	39.7	53.5	103.3	49.5	37.7	26.8	78.8	145.8	78.1	106.4	0.2	82.0	18.7	89.2	38.1	70.5	4.4	32.0	57.5	32.8	93.0	39.0	97.5	213.5	75.1	67.3	55.9	145.4	91.8	45.7	23.3	19.2	69.5	21.3	44.9	41.5	20.3	81.1	12.6	50.4	1.3	49.6	95.6	92.9	0.3	1.2	46.7	35.3	45.6	19.1	53.4	90.8	68.2	0.6	30.7	51.9	0.4	0.1	1.0	35.4	48.6	39.2	67.3	12.6	19.6	11.1	6.9	19.1	6.9	8.0	6.3	6.2	14.1	6.4	5.4	5.7	34.4	6.0	15.0	6.3	6.7	26.8	22.5	24.2	19.0	25.4	22.3	21.3	22.6	20.6	22.2	21.4	24.4	22.8	27.6	48.1	60.8	5.5	45.1	29.8	44.3	33.4	31.3	1.8	23.8	21.2	15.1	27.1	43.3	49.7	0.0	2.0	38.4	80.4	15.6	38.2	8.0	35.8	33.1	32.0	33.0	26.3	13.1	36.1	10.2	36.9	80.0	51.9	58.2	27.6	38.9	41.0	36.4	0.0	1.3	40.3	24.4	73.2	51.7	17.9	59.4	54.5	21.4	26.2	66.9	3.4	42.2	0.5	1.1	45.1	63.4	50.8	10.6	49.2	80.0	27.9	53.1	1.0	26.3	20.9	31.7	1.0	1.4	37.1	32.8	6.3	31.2	29.2	42.9	62.0
STAU2	39K2	ENSG00000040341	"Staufen double-stranded RNA binding protein 2"	Q9NUL3	8	73420369-73747708	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 278.9;Inhibitory neurons: 298.3;Oligodendrocyte precursor cells: 157.8;Oligodendrocytes: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 152.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019155, CAB020836"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB020836: , HPA019155: AB_1857565"	"unprognostic (5.75e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.62e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.25e-2)"	20.2	22.7	24.8	15.8	30.5	24.6	17.8	35.0	39.6	15.3	5.5	17.6	14.9	18.2	19.0	35.1	16.6	24.2	70.6	34.8	22.8	29.5	25.7	17.3	19.3	25.3	25.6	18.2	16.1	29.6	12.5	17.6	25.0	20.9	18.6	34.6	20.5	20.8	110.6	15.0	20.8	23.4	16.2	16.7	16.3	16.8	20.7	35.0	22.9	110.0	22.0	20.8	14.2	35.3	34.7	40.7	63.5	34.5	35.5	25.2	19.3	30.4	27.5	27.1	35.4	15.6	36.0	55.1	31.5	23.9	24.3	27.2	44.5	29.2	39.1	56.1	21.2	74.7	19.4	25.5	18.6	28.4	25.8	18.1	21.6	23.2	15.1	55.8	54.8	48.2	50.5	24.2	36.8	22.6	152.7	22.5	31.4	57.5	26.8	44.9	29.6	46.3	57.6	38.1	24.0	40.2	16.4	43.1	27.4	46.8	51.2	33.3	43.4	26.3	46.0	26.2	22.7	39.4	41.7	51.8	29.3	42.3	22.1	24.4	18.0	42.8	28.6	17.9	21.5	15.7	19.0	24.3	18.4	17.9	16.6	21.7	30.8	44.4	22.8	25.1	26.0	12.8	24.8	30.5	35.0	39.6	34.8	22.8	25.3	25.6	25.0	16.2	20.7	35.3	20.4	9.6	31.1	120.8	22.5	10.6	15.4	16.7	8.6	29.1	24.6	11.8	75.7	21.5	40.7	20.2	41.7	18.4	27.1	22.5	43.0	22.7	22.0	18.6	11.6	26.2	29.9	14.7	278.9	21.7	10.0	20.2	21.4	25.5	20.3	21.8	38.2	58.0	16.1	28.6	298.3	17.6	18.3	24.1	16.8	32.2	9.0	22.5	16.0	129.3	16.9	26.9	43.3	157.8	149.9	17.6	16.5	9.4	20.2	10.9	102.1	37.6	27.6	22.2	0.0	15.8	21.8	12.5	13.8	22.1	19.2	12.2	21.6	20.5	16.1	18.5
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306894	"Enzymes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 402.5;Club cells: 152.8;Sertoli cells: 460.2;Smooth muscle cells: 255.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 163.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 163.6"	"Group enriched"	"Detected in some"	6	"HSkMC: 122.1;SiHa: 119.7;U-2197: 166.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	113.7	46.3	1.0	31.7	0.9	7.1	68.6	2.8	1.5	21.3	17.0	13.3	3.8	17.9	7.8	15.4	36.1	22.7	24.1	1.4	1.0	11.8	24.3	67.5	7.2	1.2	0.9	4.4	10.6	16.0	13.0	15.3	0.8	60.0	9.2	1.9	26.8	10.6	13.4	19.3	10.6	29.3	0.4	5.4	10.6	13.4	1.1	7.8	53.1	16.6	5.1	34.3	22.7	1.1	4.9	0.0	0.1	0.1	0.1	1.9	0.3	0.0	0.3	0.0	0.1	0.1	23.6	0.1	0.1	0.0	0.4	18.7	0.1	0.0	0.1	0.0	0.1	0.1	7.9	0.1	0.1	0.1	0.2	122.1	0.1	0.4	0.9	0.0	0.0	0.1	0.3	0.4	0.0	3.0	0.1	0.5	0.1	1.0	0.0	0.2	0.1	0.3	0.0	0.3	0.2	0.2	119.7	9.9	0.0	0.1	0.8	0.0	0.1	0.4	0.3	166.4	0.1	0.1	0.1	0.1	0.2	0.9	0.2	0.4	13.5	1.4	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	163.6	0.2	0.1	0.3	0.0	3.2	1.0	0.9	2.8	1.5	1.4	1.0	1.2	0.9	0.8	0.4	1.1	1.1	77.2	54.5	402.5	0.0	0.8	9.4	5.8	8.6	1.8	1.8	21.6	8.3	9.1	0.0	152.8	0.0	2.1	0.4	1.1	0.4	0.0	14.6	23.8	14.6	20.5	14.7	0.0	0.0	0.5	9.6	10.6	39.8	1.1	51.2	16.4	0.0	15.4	0.7	2.8	0.0	0.8	0.2	16.2	7.2	7.4	10.9	114.9	12.2	5.4	6.5	19.0	2.7	0.0	1.0	0.1	18.6	0.0	9.1	0.2	49.3	0.1	0.1	72.8	0.3	460.2	9.6	255.3	0.9	0.3	1.5	18.8	10.9	3.1	57.7	0.2	16.6
STING1	"ERIS, FLJ38577, MITA, MPYS, NET23, STING, TMEM173"	ENSG00000184584	"Stimulator of interferon response cGAMP interactor 1"	Q86WV6	5	139475533-139482935	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 25.3;Cardiomyocytes: 27.7;dendritic cells: 17.0;Hofbauer cells: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.4;EFO-21: 83.8;HDLM-2: 200.5;THP-1: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038116, HPA038534"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA038116: AB_2675841, HPA038534: AB_2676067"	"unprognostic (1.45e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.59e-8)"	"unprognostic (9.18e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.34e-1)"	38.9	9.3	4.6	18.4	5.0	16.9	26.2	4.4	5.4	32.6	12.8	16.6	6.7	25.0	6.8	21.5	36.2	11.9	35.7	4.3	4.9	17.3	5.5	48.1	15.0	5.5	4.9	21.9	5.4	3.3	11.8	12.9	5.1	20.7	11.6	0.3	24.5	15.5	7.5	15.5	19.0	18.7	5.3	37.8	11.6	3.1	6.0	12.4	20.2	8.5	27.1	21.7	28.4	4.8	2.9	0.7	0.2	0.0	4.0	12.0	0.2	15.3	64.4	7.6	24.4	0.0	18.8	0.0	83.8	49.0	1.9	10.8	0.4	22.9	4.8	200.5	3.3	13.5	6.6	0.8	7.5	4.1	0.8	16.2	1.2	4.6	5.7	12.8	27.8	1.4	3.9	58.3	33.6	0.0	2.2	24.1	0.1	0.8	4.7	0.7	6.1	18.0	9.4	7.0	5.8	0.0	6.5	5.3	16.0	0.6	0.7	73.3	17.2	1.9	1.3	6.8	5.6	0.0	20.0	0.1	0.3	56.2	11.3	16.6	60.9	0.1	56.9	40.0	29.3	0.6	57.4	47.8	55.6	0.3	40.3	35.0	5.0	90.6	17.5	19.2	65.3	60.6	4.6	5.0	4.4	5.4	4.3	4.9	5.5	4.9	5.1	5.3	6.0	4.8	25.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.8	17.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.6	8.4	0.0	0.0	0.0	0.0	0.0	0.0	67.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.8	5.8	0.0	0.0	0.0
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 340.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.23e-4)"	"prognostic unfavorable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	68.0	128.0	114.5	70.2	119.9	61.3	49.7	124.6	340.6	69.5	122.1	72.9	40.4	74.1	49.0	79.5	72.4	43.5	98.5	120.2	133.4	86.7	68.9	70.8	72.9	124.0	131.3	87.6	53.3	61.4	71.7	77.5	139.2	60.7	56.0	62.9	56.1	56.1	140.3	60.5	53.9	66.7	123.6	69.0	66.1	126.3	134.2	66.2	57.6	92.2	88.2	81.2	63.8	159.4	321.0	486.3	298.1	251.7	161.8	108.1	271.5	277.2	150.1	393.9	228.1	361.3	265.2	371.1	322.9	220.3	475.4	329.7	745.4	280.3	427.6	302.1	311.7	521.5	302.6	336.7	142.8	278.7	325.1	109.4	174.5	327.1	242.7	162.4	284.2	276.1	537.2	209.5	232.1	468.8	432.0	388.6	366.4	306.0	407.2	418.3	279.1	385.6	282.8	271.8	242.7	217.3	314.4	338.9	266.7	310.3	357.1	194.0	253.8	252.0	310.9	333.1	389.0	189.8	434.0	388.0	328.8	282.6	374.1	61.0	66.8	57.4	87.6	95.1	88.2	85.9	65.5	79.5	69.9	68.5	72.7	81.6	20.0	108.2	114.6	58.1	66.1	119.1	114.5	119.9	124.6	340.6	120.2	133.4	124.0	131.3	139.2	123.6	134.2	159.4	31.3	44.8	32.9	7.8	40.0	80.4	184.1	61.5	40.9	37.5	32.5	29.8	46.1	31.5	59.1	20.2	41.7	124.8	39.8	38.3	49.0	76.3	31.0	65.8	48.6	45.9	67.3	69.0	9.5	55.2	146.1	49.6	24.5	51.1	79.3	47.8	14.3	27.4	91.5	63.9	14.9	39.9	97.6	21.9	90.3	77.5	27.4	46.7	62.2	12.2	51.8	36.9	53.5	11.1	17.2	69.5	32.7	39.9	56.4	75.7	22.3	39.6	85.8	36.7	26.3	36.1	65.4	96.3	118.6	47.6	72.0	211.0	67.0	62.8	48.6	95.3
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042079-172188224	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5;lymphoid tissue: 45.2"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 107.7;Kupffer cells: 91.4;NK-cells: 171.0;T-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 143.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		16000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	14.9	5.7	3.1	37.1	3.6	76.5	11.4	18.4	5.6	4.5	3.5	8.5	8.4	4.9	1.7	5.6	4.7	13.2	7.6	3.1	4.0	5.9	6.2	18.4	44.1	6.2	4.4	2.5	7.2	3.1	4.1	17.2	5.8	4.4	6.9	1.2	4.7	3.5	5.0	14.2	16.0	7.8	5.4	45.2	11.1	14.0	6.4	20.6	5.3	5.5	25.0	14.9	5.2	7.0	22.2	20.2	12.7	18.8	14.7	18.1	31.5	28.4	24.0	20.2	18.9	10.6	28.6	26.8	14.6	35.6	42.3	25.4	5.7	35.1	13.5	35.0	9.3	32.1	8.2	6.1	20.2	32.7	36.4	17.4	7.5	27.4	23.1	7.5	18.3	10.4	3.0	36.2	14.7	35.7	23.5	73.4	5.0	11.3	16.1	38.2	9.9	17.7	8.2	27.6	8.3	10.2	16.4	22.5	77.9	15.6	8.2	68.7	24.8	22.3	11.3	15.8	15.5	30.2	48.4	17.1	29.4	49.8	143.3	16.7	26.5	23.4	36.5	46.3	26.9	10.0	19.3	26.3	22.5	8.1	11.0	20.0	48.9	16.9	71.8	7.1	26.7	44.0	3.1	3.6	18.4	5.6	3.1	4.0	6.2	4.4	5.8	5.4	6.4	7.0	35.8	3.2	11.2	1.6	40.5	6.6	8.4	7.2	5.7	4.3	3.3	3.7	3.8	5.7	6.1	1.8	6.2	4.1	107.7	11.8	1.9	4.5	2.5	3.5	4.6	23.9	12.0	11.8	8.5	6.2	27.2	9.3	20.9	7.1	28.4	3.6	18.2	2.3	36.3	47.1	7.9	19.9	2.0	91.4	43.8	3.2	2.8	61.3	8.8	32.8	49.8	2.1	171.0	10.1	14.4	10.7	11.8	1.5	42.8	11.7	6.5	2.0	6.1	2.2	13.1	5.1	10.2	5.3	7.8	2.6	4.1	5.1	81.4	11.4	5.3	10.7
STK11	"LKB1, PJS"	ENSG00000118046	"Serine/threonine kinase 11"	Q15831	19	1177558-1228431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.9;Late spermatids: 338.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: AB_2685847"	"unprognostic (8.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (3.69e-5)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.70e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.12e-3)"	32.1	44.2	18.8	18.2	15.5	34.1	32.3	24.8	23.5	35.4	24.7	38.7	25.6	33.6	5.5	39.7	34.9	11.8	48.4	18.3	14.7	36.4	45.5	30.5	20.5	19.2	19.4	37.9	34.2	16.1	36.8	12.6	15.2	39.3	7.7	5.7	29.7	16.1	108.2	40.2	37.7	9.6	16.3	48.3	38.1	102.4	17.6	15.0	34.3	27.7	12.9	34.4	35.0	14.9	50.0	25.8	19.9	35.9	18.6	17.0	35.5	24.0	27.7	25.1	25.4	22.5	37.1	31.9	24.8	27.8	11.2	32.3	20.1	41.9	8.2	60.2	37.8	34.8	1.7	26.4	38.1	36.6	53.5	30.5	28.9	19.4	29.2	22.3	25.2	28.1	63.1	51.1	13.9	39.3	31.9	27.7	33.0	19.6	25.1	50.0	20.0	36.1	21.1	39.7	39.8	26.6	0.0	19.7	24.2	11.4	30.3	55.2	33.7	24.6	25.0	45.2	38.7	85.3	38.1	25.7	22.6	48.1	25.5	1.7	3.3	3.9	0.4	5.5	0.3	2.3	0.8	1.4	1.6	0.7	0.7	0.6	9.9	1.4	5.7	0.8	0.6	0.5	18.8	15.5	24.8	23.5	18.3	14.7	19.2	19.4	15.2	16.3	17.6	14.9	24.5	6.4	13.7	12.7	10.5	16.7	7.4	9.5	9.6	25.5	22.0	18.4	13.7	15.7	9.0	23.9	18.8	7.5	20.1	44.4	7.9	9.4	154.9	18.0	18.1	15.7	15.0	27.3	7.9	14.0	5.3	13.2	21.9	17.8	2.5	80.3	15.4	31.6	15.2	18.5	8.5	33.1	6.1	18.3	26.4	338.7	24.5	20.7	16.0	11.2	20.4	21.2	9.2	9.0	6.5	16.7	29.3	20.7	10.2	15.1	27.5	11.0	9.3	21.0	13.1	21.5	23.7	85.5	20.1	14.6	15.5	8.8	16.6	45.2	35.4	12.6
STK16	"MPSK, PKL12"	ENSG00000115661	"Serine/threonine kinase 16"	O75716	2	219245455-219250337	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029450	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA029450: AB_10603118"	"unprognostic (1.99e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (6.09e-4)"	"unprognostic (6.21e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	15.2	24.9	17.6	11.8	17.5	15.0	16.2	16.3	20.5	14.0	19.5	20.0	17.3	13.8	20.8	22.8	18.1	13.0	19.0	16.5	16.8	26.5	43.2	14.3	17.6	17.9	17.5	14.8	30.9	22.7	19.8	9.2	16.9	20.3	13.5	7.9	20.0	10.9	14.4	17.3	17.8	9.9	17.4	21.2	24.2	27.7	18.6	20.5	19.3	8.2	14.5	17.8	14.8	16.5	14.1	18.8	15.7	13.2	40.0	40.0	17.9	17.8	23.6	14.3	14.7	21.2	31.0	8.3	24.4	32.0	23.4	14.5	18.5	30.0	7.8	20.0	19.8	17.7	15.4	19.1	34.9	17.6	20.1	40.1	48.1	20.8	57.4	29.8	17.9	18.7	23.1	21.5	26.8	27.1	19.4	38.0	14.5	25.7	10.3	18.1	17.5	24.9	32.2	16.1	12.3	14.6	5.8	25.5	39.0	11.2	27.4	36.4	13.7	20.6	14.0	16.4	17.4	25.9	12.1	19.5	22.9	18.4	18.3	1.6	7.0	5.3	4.9	3.8	5.5	7.2	6.0	9.2	6.8	6.0	6.1	7.9	4.1	14.5	3.1	5.8	7.3	8.7	17.6	17.5	16.3	20.5	16.5	16.8	17.9	17.5	16.9	17.4	18.6	16.5	11.8	6.4	5.6	3.6	22.4	9.8	18.1	32.6	24.5	7.9	31.8	31.8	9.5	24.3	19.7	7.3	16.7	24.0	23.6	27.6	68.4	40.3	87.2	21.4	13.3	14.0	25.8	36.0	2.2	58.5	25.0	15.8	17.3	12.9	8.2	17.9	12.5	43.7	28.4	13.5	2.7	38.7	16.2	27.1	17.6	70.3	15.2	17.8	21.4	0.0	38.4	22.1	44.3	4.0	6.8	33.3	44.3	13.5	27.6	18.6	58.9	80.2	19.6	19.1	0.0	11.9	19.2	43.1	9.6	28.2	11.2	12.9	22.1	33.6	34.2	20.8
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023302-132075943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 70.0;epididymis: 56.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 55.2;dendritic cells: 42.7;NK-cells: 53.5;Syncytiotrophoblasts: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 140.1;U-937: 144.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		Yes	No		360000	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: AB_2684163"	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	6.0	2.5	1.0	15.2	2.7	70.0	6.0	1.7	1.3	6.8	2.5	11.5	9.6	46.6	56.3	13.1	7.4	5.6	1.4	0.7	1.5	3.5	5.2	7.2	26.2	0.8	0.8	2.1	3.7	23.5	5.0	25.2	0.7	20.0	11.6	0.2	7.3	35.8	0.9	7.8	6.9	38.1	0.6	13.2	12.2	2.2	3.8	41.3	3.7	1.2	23.5	11.8	7.4	0.7	32.9	11.3	1.3	0.0	5.2	4.9	72.0	1.0	4.0	0.5	0.6	30.1	29.0	44.6	19.4	7.3	22.1	36.5	80.8	51.1	0.0	39.1	66.6	64.6	25.9	28.4	4.7	135.3	5.1	6.9	30.0	0.1	33.7	15.1	14.2	60.0	29.2	40.4	12.2	29.0	140.1	124.9	64.4	22.0	4.3	99.9	39.7	57.9	32.6	51.8	26.6	29.6	19.2	17.0	0.9	54.9	22.0	35.4	0.3	12.8	13.7	39.0	47.9	31.0	52.0	49.8	11.7	144.8	6.5	59.1	9.5	31.6	22.8	12.4	22.4	14.5	15.2	19.6	11.3	12.6	19.7	20.6	18.2	41.0	22.7	4.2	7.2	20.4	1.0	2.7	1.7	1.3	0.7	1.5	0.8	0.8	0.7	0.6	3.8	0.7	0.9	22.4	15.6	0.0	24.7	0.0	36.4	0.0	6.8	0.0	5.9	10.9	1.3	5.7	8.1	11.0	0.0	55.2	42.7	6.5	3.9	4.5	0.6	7.4	1.8	1.7	1.2	12.8	2.0	7.1	34.7	9.6	15.3	17.9	11.4	0.5	1.4	4.4	11.8	0.0	1.4	4.8	0.0	8.8	0.0	0.4	3.4	17.3	0.0	2.8	13.5	0.0	53.5	0.0	0.2	10.9	4.0	2.2	14.5	33.6	1.9	1.5	6.6	0.0	6.6	6.7	3.6	1.8	2.5	16.1	0.0	59.1	27.4	0.6	6.5	18.2
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051480-5500994	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0;lymphoid tissue: 19.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 108.2;Late spermatids: 39.3;Microglial cells: 27.2;Oligodendrocyte precursor cells: 169.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 27.5;HUVEC TERT2: 27.5;REH: 25.2;U-2197: 43.8;WM-115: 112.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015820			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA015820: AB_1858913"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	3.5	0.3	2.3	1.2	7.8	1.5	4.3	1.9	2.3	3.3	1.5	1.1	0.5	3.5	0.3	1.2	1.3	1.4	0.4	2.1	4.5	15.0	0.1	0.9	1.8	3.7	3.9	0.6	1.8	0.3	0.4	3.2	3.7	0.6	1.1	0.8	1.0	0.9	1.3	2.4	1.1	2.5	3.6	0.2	6.0	4.5	3.5	19.5	1.7	1.7	1.0	3.1	1.5	3.6	0.0	14.0	0.8	0.0	0.6	1.0	0.0	9.7	1.1	6.3	0.2	0.1	0.0	0.0	2.1	19.7	27.5	0.1	1.5	0.0	2.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.2	27.5	1.4	0.0	0.1	3.4	0.0	0.0	2.0	4.1	0.0	0.0	25.2	0.1	0.0	6.2	0.0	0.4	0.0	0.0	0.1	8.5	0.6	0.0	0.0	7.1	0.2	2.8	43.8	0.0	0.9	0.1	0.0	0.1	0.0	112.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.3	7.8	1.9	2.3	2.1	4.5	3.7	3.9	3.7	3.6	3.5	3.6	3.6	0.0	1.1	1.6	0.0	2.3	0.2	0.0	0.0	0.0	4.2	1.7	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	17.6	1.1	108.2	0.2	0.1	3.2	0.0	0.0	3.7	0.0	0.1	5.5	4.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	14.4	0.0	0.0	0.0	1.2	39.3	1.5	1.1	5.4	27.2	0.5	0.0	0.0	169.4	1.3	0.4	0.0	1.2	0.0	0.1	0.0	18.9	0.0	0.0	0.0	0.6	0.4	1.2	5.5	0.0	1.0	0.0	0.2	0.4	0.0	0.1
STK33		ENSG00000130413	"Serine/threonine kinase 33"	Q9BYT3	11	8391868-8594289	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 49.3;testis: 51.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 213.8;Early spermatids: 98.8;Endometrial ciliated cells: 220.9;Late spermatids: 157.0;Oligodendrocyte precursor cells: 117.6;Respiratory ciliated cells: 155.3;Spermatocytes: 148.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.1;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.0;hTERT-RPE1: 22.0;Karpas-707: 21.2;SCLC-21H: 22.9;U-251 MG: 24.3;U-266/84: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015742, HPA056855"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: AB_2683257"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.85e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.46e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-2)"	1.3	8.1	6.7	2.0	6.6	1.3	0.5	8.5	4.9	5.6	49.3	8.3	3.3	12.0	11.3	2.7	42.3	5.1	16.2	6.1	10.1	10.2	0.4	7.1	2.0	14.7	15.6	13.4	6.5	23.1	24.1	0.1	13.3	6.4	1.5	15.6	2.1	11.5	3.9	0.2	3.4	9.3	12.0	1.5	6.0	51.8	12.8	3.8	20.0	6.0	2.2	3.4	1.7	8.3	0.0	3.4	15.4	0.0	0.0	0.0	0.0	3.0	3.1	7.0	6.2	2.2	0.0	23.0	11.5	0.6	8.7	0.0	6.9	2.5	6.0	0.0	18.9	0.0	4.2	5.6	2.5	13.4	0.0	1.1	0.0	0.2	0.0	22.0	0.5	11.2	0.0	21.2	0.3	0.0	0.4	0.0	11.2	0.0	0.0	8.8	2.2	14.3	6.1	0.0	22.9	6.2	0.0	0.0	0.1	4.3	0.0	1.3	0.0	0.0	10.6	0.2	24.3	5.1	21.2	0.3	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.7	0.0	2.2	0.0	0.6	0.0	0.1	0.0	0.4	0.1	0.2	6.7	6.6	8.5	4.9	6.1	10.1	14.7	15.6	13.3	12.0	12.8	8.3	0.1	19.2	14.5	213.8	6.2	0.0	1.3	1.9	0.0	20.7	0.1	0.3	37.8	8.6	27.5	20.2	70.9	0.1	1.4	0.2	3.9	9.5	98.8	220.9	5.5	1.8	9.1	1.7	12.0	4.9	3.3	5.0	6.1	17.8	1.3	29.3	0.4	0.0	0.3	1.7	15.4	1.6	6.1	0.0	0.0	157.0	4.4	0.6	0.0	23.4	0.0	31.0	0.0	117.6	19.7	4.4	0.4	17.0	5.2	0.5	3.6	13.5	155.3	77.4	0.0	0.2	2.7	148.3	26.8	0.2	0.0	0.0	1.3	6.3	3.5	0.0
STK35	"bA550O8.2, CLIK1"	ENSG00000125834	"Serine/threonine kinase 35"	Q8TDR2	20	2101827-2177038	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"retina: 118.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 150.1;Early spermatids: 214.3;Horizontal cells: 294.4;Late spermatids: 821.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026452, HPA051673"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA026452: AB_2671861, HPA051673: AB_2681569"	"unprognostic (2.25e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.99e-2)"	9.0	11.3	9.4	6.6	8.3	8.6	7.9	6.7	13.0	7.3	5.1	10.2	7.1	9.7	5.8	15.6	8.6	7.1	10.0	9.5	8.3	6.9	8.9	8.5	6.4	6.2	10.6	8.0	9.3	7.8	9.7	6.2	7.3	8.0	8.2	118.8	8.7	6.3	6.5	11.3	9.3	7.8	5.0	8.3	8.7	18.3	15.4	6.4	8.5	5.7	7.6	8.1	8.9	8.6	23.3	19.4	14.7	25.4	6.7	9.1	17.9	9.3	11.4	12.2	12.5	25.6	17.5	15.9	7.5	11.7	19.0	34.1	17.6	21.4	13.8	6.3	8.4	15.2	7.4	28.1	8.5	13.7	6.8	7.9	18.5	19.5	16.7	11.2	11.7	15.0	14.9	12.8	8.0	10.3	17.4	19.4	27.5	18.4	12.9	14.9	13.2	10.1	11.1	22.9	24.3	11.8	16.6	29.3	15.0	17.0	14.5	13.5	10.0	20.7	14.1	10.5	14.9	11.1	15.5	10.8	11.1	14.7	9.2	0.0	0.3	0.1	0.4	0.2	0.6	0.3	0.6	0.3	0.5	0.4	0.5	0.4	0.7	0.2	0.3	0.4	0.2	0.3	9.4	8.3	6.7	13.0	9.5	8.3	6.2	10.6	7.3	5.0	15.4	8.6	8.8	12.8	9.8	4.9	6.3	11.6	4.4	7.5	13.1	111.8	10.9	9.5	12.2	2.8	9.1	3.7	150.1	7.2	7.5	15.4	1.9	6.4	214.3	15.7	7.8	9.1	6.1	12.0	11.8	6.8	11.5	11.1	11.2	12.7	9.5	8.4	7.9	10.3	5.7	294.4	11.6	7.6	10.2	6.3	4.9	821.8	6.8	5.7	7.2	11.2	4.0	124.7	5.2	9.0	11.2	10.4	9.7	6.0	8.5	6.7	8.8	3.6	10.2	96.7	0.0	10.8	7.2	15.5	14.4	12.4	11.8	5.7	6.0	4.5	10.9	6.6
STK39	"DCHT, SPAK"	ENSG00000198648	"Serine/threonine kinase 39"	Q9UEW8	2	167954020-168247595	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 159.9;Inhibitory neurons: 142.9;Oligodendrocyte precursor cells: 153.3;Oligodendrocytes: 359.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		80000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870"	"prognostic favorable (3.96e-4)"	"unprognostic (2.97e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.36e-1)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.04e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.20e-3)"	19.4	6.7	20.1	14.0	25.8	5.1	8.4	25.3	25.1	12.0	52.9	26.3	32.0	7.3	14.5	36.3	6.4	18.1	15.8	16.0	18.6	9.0	1.9	7.6	22.2	28.8	25.8	6.6	25.6	13.7	8.2	2.3	31.9	28.7	32.4	27.8	67.9	11.5	2.7	6.3	18.6	11.7	20.8	8.6	31.8	48.5	25.6	29.1	6.9	7.6	23.5	24.8	9.5	37.0	19.1	10.9	40.9	12.9	28.1	37.5	4.0	45.0	33.8	29.6	27.8	0.2	59.9	51.1	12.2	30.5	25.5	46.6	26.7	34.4	37.1	16.2	16.4	21.2	11.8	42.9	52.3	30.5	2.1	29.1	52.8	35.1	36.5	38.5	21.2	41.3	0.5	0.0	67.0	11.4	51.6	13.0	30.3	41.0	24.3	72.1	16.0	4.8	27.9	47.6	65.7	27.0	15.7	2.6	21.8	20.3	8.0	25.9	20.2	36.6	11.1	26.5	32.2	0.1	0.0	41.5	29.7	28.5	25.1	0.0	0.3	0.0	1.1	0.2	0.6	0.2	0.9	1.6	0.5	0.5	0.2	0.8	0.0	1.0	0.1	0.1	1.8	0.2	20.1	25.8	25.3	25.1	16.0	18.6	28.8	25.8	31.9	20.8	25.6	37.0	6.1	3.2	14.0	64.6	6.4	3.8	34.4	6.5	5.7	14.8	5.5	6.5	26.2	18.6	15.2	5.5	16.7	0.1	30.0	47.7	21.5	10.9	29.4	11.9	11.6	5.6	22.8	5.7	159.9	23.1	0.1	9.2	28.1	18.9	0.0	5.8	2.9	0.4	3.5	20.2	142.9	17.3	14.2	6.7	6.7	16.2	10.2	6.7	17.8	64.6	5.5	28.9	12.3	153.3	359.4	36.0	20.1	11.3	9.5	74.8	14.5	7.9	17.5	30.0	6.6	7.7	18.2	25.4	8.1	7.5	4.4	0.3	19.4	15.8	22.4	50.6
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966479-45080021	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Cell type enhanced"	"Detected in all"		"B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	10.0	8.5	6.9	33.8	8.0	57.7	9.1	6.2	10.8	7.9	9.9	11.1	10.2	8.5	7.6	9.1	6.2	11.7	4.6	7.2	8.7	6.0	9.2	15.9	43.1	8.7	7.6	7.0	6.0	5.9	4.1	10.4	9.2	6.7	13.0	7.3	7.4	8.0	3.3	11.2	13.5	9.3	8.3	30.4	12.7	9.7	7.5	33.1	7.6	4.9	41.7	15.0	6.9	10.3	27.8	18.7	23.3	16.1	13.5	16.9	16.0	23.6	35.7	39.4	35.6	52.7	14.6	66.6	20.4	16.9	33.4	28.5	24.3	31.8	49.7	30.8	13.8	48.6	27.8	36.8	23.8	63.5	66.4	13.8	25.6	36.7	39.6	19.4	14.6	44.6	23.5	37.0	19.9	21.7	47.6	42.3	13.9	17.7	12.5	30.2	25.2	31.2	14.4	18.7	10.9	13.2	35.6	20.0	27.0	17.2	18.3	39.1	18.7	29.2	28.6	34.4	27.8	48.4	41.7	73.2	28.6	29.5	22.0	80.6	19.7	54.8	34.4	19.9	34.3	26.2	32.2	32.0	18.4	26.9	33.1	28.0	101.8	28.5	38.0	10.0	34.3	22.3	6.9	8.0	6.2	10.8	7.2	8.7	8.7	7.6	9.2	8.3	7.5	10.3	26.2	16.0	24.6	18.9	372.8	55.7	49.3	33.8	28.5	27.3	22.9	17.4	7.6	14.3	25.2	42.3	52.1	24.1	341.8	23.7	9.8	16.3	5.9	19.1	25.1	32.1	25.7	46.3	76.7	17.6	30.3	29.7	34.1	25.1	133.6	114.0	26.0	22.0	61.1	43.7	38.2	20.7	28.5	109.3	606.9	5.0	22.7	154.4	133.4	85.3	367.5	20.2	278.1	34.2	48.1	21.6	27.9	17.0	336.2	32.6	23.2	13.4	26.1	69.9	13.1	25.5	29.2	44.2	42.4	20.9	53.0	19.4	414.5	48.1	19.5	45.5
STK40	"MGC4796, SgK495"	ENSG00000196182	"Serine/threonine kinase 40"	Q8N2I9	1	36339624-36385924	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 116.7;Late spermatids: 236.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 25.2;monocytes: 12.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008026	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA008026: AB_1857603"	"unprognostic (3.32e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.69e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	33.3	15.5	17.4	23.1	17.0	15.2	24.6	16.6	19.9	24.3	14.1	44.8	13.5	23.6	8.1	43.8	24.7	20.4	42.7	17.5	17.6	33.5	45.3	36.4	24.3	24.8	19.0	40.3	45.7	21.8	30.1	13.5	20.6	28.5	12.7	7.5	32.0	23.1	125.2	38.8	23.7	20.0	19.9	35.4	35.5	52.5	20.1	15.6	25.3	39.6	21.4	41.7	26.7	19.8	17.4	7.4	36.6	38.3	25.3	14.7	20.5	17.2	23.1	20.3	21.8	41.3	24.2	73.0	13.8	16.1	21.5	17.1	33.5	7.4	14.9	32.0	26.4	47.7	7.5	53.3	25.1	28.1	60.9	13.3	27.7	15.6	8.2	10.9	12.9	55.2	59.7	25.7	12.9	27.0	29.3	37.1	23.5	31.2	10.2	33.3	24.9	49.1	12.7	19.2	44.6	22.7	13.2	20.5	58.5	23.1	13.9	32.7	21.6	12.7	26.5	37.7	38.3	26.6	16.2	61.3	66.3	24.3	42.8	1.2	3.8	6.8	3.1	8.6	3.6	2.8	2.1	2.2	3.5	2.9	1.2	1.8	25.2	2.1	12.0	3.3	1.3	3.5	17.4	17.0	16.6	19.9	17.5	17.6	24.8	19.0	20.6	19.9	20.1	19.8	10.7	12.8	15.3	11.8	22.0	61.3	54.0	9.4	16.5	11.8	28.3	15.4	25.3	8.6	11.1	11.0	4.2	6.5	15.8	34.8	17.6	21.2	116.7	23.9	11.2	15.2	23.4	7.8	24.8	31.6	10.7	19.2	33.1	36.5	13.3	4.9	14.3	23.7	24.7	10.1	17.3	15.5	12.2	23.3	69.5	236.8	23.0	32.2	30.2	21.5	19.2	4.9	18.6	7.5	12.3	28.5	16.3	33.4	17.0	57.1	6.2	14.9	25.6	10.5	26.3	20.6	18.6	14.9	11.1	28.7	75.4	57.2	17.3	17.6	15.1	51.3
STN1	"bA541N10.2, FLJ22559, OBFC1"	ENSG00000107960	"STN1 subunit of CST complex"	Q9H668	10	103877569-103918184	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 37.4;Distal tubular cells: 41.1;Ductal cells: 34.6;Exocrine glandular cells: 79.2;Pancreatic endocrine cells: 62.9;Theca cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037924, HPA037925"			Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA037924: AB_10671636, HPA037925: AB_10672469"	"unprognostic (1.50e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.58e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.76e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.83e-2)"	15.7	22.2	8.8	12.2	10.1	13.5	17.1	11.3	9.4	13.3	11.5	14.5	12.0	12.0	9.8	41.0	12.2	18.3	35.0	8.2	11.1	17.9	13.1	25.2	16.0	13.1	11.0	22.2	20.9	33.6	14.9	17.1	11.5	10.2	16.4	6.4	18.7	13.3	22.4	13.3	11.0	15.4	9.9	15.3	22.2	23.4	11.5	24.5	17.6	28.9	22.8	22.5	18.5	11.2	26.8	19.7	23.8	19.6	18.6	57.6	7.6	12.6	36.5	16.4	14.6	11.4	43.6	16.7	22.2	16.1	14.7	24.8	8.7	31.0	15.3	24.1	11.9	15.3	7.0	23.5	25.6	12.7	12.9	37.2	52.1	15.9	43.9	42.9	32.0	31.2	8.5	34.9	27.3	21.7	31.5	22.0	5.5	38.7	28.5	22.7	16.4	19.2	40.5	31.3	13.7	16.1	9.3	14.9	24.4	13.4	12.5	11.0	47.1	20.4	14.1	14.5	19.4	47.3	13.1	16.6	30.4	26.4	9.0	41.7	33.2	110.3	65.1	21.3	103.4	25.5	71.9	60.4	40.2	29.6	52.3	62.6	48.8	71.3	23.7	37.1	100.2	51.5	8.8	10.1	11.3	9.4	8.2	11.1	13.1	11.0	11.5	9.9	11.5	11.2	14.7	22.4	20.9	0.0	2.3	0.0	0.0	0.0	0.0	0.0	12.7	16.9	0.0	0.0	5.0	9.2	0.0	37.4	17.2	0.0	41.1	34.6	0.0	9.2	9.9	6.4	0.0	0.0	0.0	79.2	14.0	3.9	0.0	15.4	5.1	23.8	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	13.5	0.0	0.0	0.0	0.0	62.9	0.0	0.0	1.0	0.0	0.0	12.8	7.3	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	27.0	13.3	52.4	0.0	0.0
STOX1	"C10orf24, FLJ25162"	ENSG00000165730	"Storkhead box 1"	Q6ZVD7	10	68827531-68895432	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.2;choroid plexus: 30.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 85.2;Endometrial ciliated cells: 67.4;Respiratory ciliated cells: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.6;HAP1: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037844, HPA037845"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Intracellular and membrane"	No	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA037844: AB_2675700, HPA037845: AB_10671369"	"prognostic favorable (3.37e-5)"	"unprognostic (5.53e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"prognostic favorable (2.08e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.33e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.46e-2)"	6.3	5.1	26.4	0.5	23.6	0.2	4.2	14.9	33.2	1.9	30.8	1.6	1.1	1.6	7.4	1.4	12.5	0.9	0.4	23.9	22.4	2.8	0.3	1.3	1.2	16.5	24.9	1.1	1.4	6.5	7.2	0.8	17.4	1.2	1.6	0.7	1.6	1.1	1.3	0.9	2.1	0.8	16.3	0.4	3.4	2.5	26.2	6.7	3.1	0.8	1.0	2.5	0.7	20.5	1.8	2.0	4.2	8.6	1.8	0.0	2.5	0.2	0.1	1.2	1.3	1.8	2.6	1.7	2.4	0.0	3.3	0.5	8.1	0.0	0.6	2.0	3.4	0.1	0.4	2.6	0.2	2.3	3.1	0.2	0.1	0.2	0.0	0.2	0.1	4.5	0.4	0.2	0.1	1.8	3.9	2.8	1.4	0.4	1.2	2.8	0.1	0.0	2.6	4.6	1.3	3.9	3.1	0.8	0.6	2.7	1.9	1.8	0.0	0.0	0.2	0.0	1.3	0.7	1.6	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.0	1.0	0.0	0.0	26.4	23.6	14.9	33.2	23.9	22.4	16.5	24.9	17.4	16.3	26.2	20.5	0.3	0.0	0.5	85.2	0.3	1.5	4.5	0.9	1.2	0.7	5.1	4.1	0.5	0.0	5.6	1.8	0.0	1.6	3.1	0.4	3.9	0.1	0.3	67.4	1.7	0.4	0.0	1.7	11.4	0.4	0.5	0.6	0.5	4.2	2.5	0.8	0.0	0.2	0.1	0.0	9.9	2.5	2.0	0.3	0.7	0.7	1.2	0.2	0.0	1.9	0.1	1.9	2.1	6.0	2.1	0.1	0.3	0.0	0.6	1.7	0.8	1.8	42.8	0.4	6.6	1.5	5.0	1.4	8.8	0.4	0.4	1.2	0.7	6.9	5.3	1.8
STOX2	DKFZp762K222	ENSG00000173320	"Storkhead box 2"	Q9P2F5	4	183797692-184023526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 181.7;Inhibitory neurons: 192.3;Microglial cells: 72.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;HeLa: 12.7;NTERA-2: 16.8;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049776, HPA065002"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA049776: AB_2680875, HPA065002: "	"unprognostic (9.79e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.33e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.57e-4)"	"unprognostic (8.97e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.49e-1)"	1.8	1.6	8.3	0.7	8.2	6.0	1.8	4.2	13.3	2.1	2.3	1.7	0.9	1.9	3.4	5.0	2.7	1.3	3.6	11.1	3.1	2.7	2.0	2.1	0.6	2.7	3.9	3.3	4.9	4.0	7.0	1.4	3.9	2.3	0.9	3.8	7.3	2.3	2.1	3.9	1.3	1.8	2.0	4.1	2.3	0.9	6.6	4.1	5.8	2.1	1.1	2.5	3.3	11.5	2.1	4.3	13.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.3	1.7	0.0	2.6	0.0	2.7	0.2	7.4	1.2	0.0	0.0	5.9	0.0	12.7	0.1	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.8	0.0	0.6	0.0	0.1	16.8	0.0	0.6	0.1	4.8	0.0	3.1	4.1	6.8	15.8	3.2	0.0	0.0	4.7	0.2	0.4	0.0	0.0	2.8	0.0	0.1	0.1	3.8	2.1	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	8.2	4.2	13.3	11.1	3.1	2.7	3.9	3.9	2.0	6.6	11.5	12.7	12.8	22.1	39.2	0.4	4.2	6.0	3.7	8.6	28.2	3.8	4.6	20.7	5.7	8.7	7.3	0.0	2.7	0.0	0.2	3.9	5.4	1.2	7.2	0.7	18.5	1.8	0.0	181.7	3.1	2.1	5.8	3.1	3.7	0.0	0.3	21.4	5.6	1.1	33.7	192.3	0.4	2.0	2.2	1.5	2.6	0.6	0.8	1.8	72.1	0.0	12.4	0.0	91.0	153.5	2.1	0.0	4.5	1.3	5.2	0.0	4.0	16.8	3.4	0.0	4.8	4.5	0.6	2.0	17.8	3.3	0.7	0.7	3.6	0.4	3.4
STPG1	"C1orf201, FLJ33340, MAPO2"	ENSG00000001460	"Sperm tail PG-rich repeat containing 1"	Q5TH74	1	24356999-24416934	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 27.5"	"Group enriched"	"Detected in many"	8	"Early spermatids: 282.7;Late spermatids: 660.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024301			Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA024301: AB_1845634"	"unprognostic (2.63e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (6.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (2.31e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.42e-1)"	4.6	4.1	10.0	2.1	9.2	1.1	4.0	9.2	11.5	3.3	15.7	6.4	3.5	3.8	5.4	5.0	16.8	3.2	3.2	8.6	10.5	5.5	1.6	4.9	2.1	9.9	11.2	4.2	3.9	9.2	8.8	1.0	10.0	4.3	5.3	14.6	3.4	3.2	1.3	4.5	4.4	4.9	9.4	1.8	4.0	27.5	11.6	2.7	4.5	2.5	2.7	4.0	4.2	11.1	7.9	4.7	0.6	8.5	5.9	8.5	4.5	11.5	10.8	10.6	11.0	2.1	11.6	1.0	7.6	11.9	8.9	3.3	7.3	8.0	12.2	9.4	7.2	1.4	2.4	2.2	12.2	3.9	1.9	5.1	15.9	15.4	20.2	11.2	8.5	0.0	2.9	0.0	8.1	2.9	0.0	3.3	6.9	8.3	7.7	2.1	0.0	0.3	14.3	2.6	6.9	4.6	6.2	2.5	18.1	7.0	6.2	6.9	5.8	4.0	4.5	1.6	3.4	4.9	5.0	2.8	4.3	0.4	6.3	0.0	0.0	0.5	0.6	0.6	0.1	2.2	0.5	1.9	0.3	1.7	0.5	0.7	0.0	0.0	0.1	1.3	1.2	0.8	10.0	9.2	9.2	11.5	8.6	10.5	9.9	11.2	10.0	9.4	11.6	11.1	7.6	9.6	9.6	3.9	4.1	4.6	13.0	12.0	7.4	14.9	5.5	6.0	5.3	0.0	13.5	11.0	14.6	3.9	1.6	22.9	15.6	7.5	282.7	32.1	2.3	5.0	4.8	5.7	11.0	7.1	7.8	4.1	4.1	8.5	12.0	3.2	6.8	1.7	3.7	10.1	5.9	5.9	8.2	1.6	6.7	660.7	6.5	2.4	16.0	4.7	3.0	7.1	0.0	4.0	16.1	11.3	14.0	4.5	5.0	6.2	21.0	8.4	55.9	20.0	6.6	2.4	4.8	37.0	11.3	13.0	5.5	4.5	3.7	3.1	6.3	54.2
STPG2	"C4orf37, MGC46496"	ENSG00000163116	"Sperm tail PG-rich repeat containing 2"	Q8N412	4	97184093-98143476	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9;testis: 1.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 81.6;Excitatory neurons: 34.7;Inhibitory neurons: 38.2;Microglial cells: 36.5;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 150.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059473			Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 21: Non-specific - Transcription"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Nucleoli	"HPA059473: "	"unprognostic (3.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.59e-3)"	"unprognostic (8.87e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.55e-3)"	"unprognostic (5.78e-2)"	0.0	0.1	0.5	0.0	1.3	0.0	0.2	0.7	0.5	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.1	0.0	0.3	1.0	0.6	0.2	0.1	0.1	1.1	0.9	0.1	0.2	0.2	0.4	0.2	1.2	0.1	0.1	0.9	0.1	0.1	0.0	0.2	0.1	0.0	0.9	0.1	0.1	1.9	0.7	0.1	0.4	0.0	0.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.7	0.5	0.3	1.0	1.1	0.9	1.2	0.9	0.7	1.9	0.2	0.0	0.0	81.6	0.7	0.0	0.4	0.0	0.0	0.9	0.4	0.1	0.4	0.0	0.1	0.0	6.2	0.1	0.0	0.0	3.9	0.0	1.8	0.6	0.1	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.7	0.1	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	36.5	0.0	0.8	0.0	21.1	150.4	0.2	0.0	0.0	0.1	0.1	0.3	0.8	0.0	1.8	0.0	0.0	0.0	3.2	1.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2
STPG4	"C2orf61, FLJ40172"	ENSG00000239605	"Sperm-tail PG-rich repeat containing 4"	Q8N801	2	47045538-47155308	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"testis: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047366, HPA052691"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"		Nucleoplasm	Cytosol	"HPA047366: , HPA052691: AB_2681918"	"unprognostic (6.74e-3)"	"unprognostic (5.81e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.36e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.64e-6)"	"unprognostic (5.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	14.7	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.4	0.3	0.3	0.4	0.6	0.2	0.4	0.2	0.4	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20 related adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.0;Excitatory neurons: 49.1;Inhibitory neurons: 47.5;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.43e-4)"	21.3	28.3	32.2	12.7	32.9	18.3	19.6	31.9	35.8	23.9	30.0	23.0	8.8	20.5	18.2	21.1	23.0	13.4	23.1	32.9	32.6	27.8	23.0	19.0	20.3	34.3	31.8	24.7	17.7	19.1	26.4	13.4	32.6	22.5	11.6	13.9	15.6	14.3	14.6	20.8	19.4	17.2	31.0	32.0	20.5	49.0	32.4	20.1	20.0	10.1	20.4	22.6	20.0	32.8	12.7	37.5	31.9	32.3	30.8	22.8	12.4	23.8	21.6	33.6	29.8	9.9	14.4	19.5	14.4	20.3	16.7	10.5	21.4	23.1	33.0	21.5	20.7	38.4	25.9	23.7	21.8	36.7	26.5	23.9	19.4	38.2	22.1	22.3	37.6	30.0	24.9	20.0	32.2	23.6	43.4	25.0	16.0	10.7	21.2	27.9	50.8	23.8	30.2	24.9	36.0	39.4	16.3	26.3	26.1	32.9	19.7	26.4	30.5	31.7	22.5	25.8	20.0	19.9	22.9	24.3	23.4	21.8	25.7	19.2	9.5	8.8	9.6	6.9	8.8	10.3	8.7	10.7	15.8	7.5	8.5	7.6	10.8	16.8	10.7	13.3	7.3	8.0	32.2	32.9	31.9	35.8	32.9	32.6	34.3	31.8	32.6	31.0	32.4	32.8	6.4	9.6	7.3	48.0	12.5	0.0	0.1	0.5	6.2	2.1	3.6	3.4	0.5	0.0	2.9	9.2	0.0	2.1	9.3	1.2	0.0	7.0	1.1	8.6	9.4	3.7	0.0	3.4	49.1	2.8	0.9	4.7	6.1	7.2	2.5	12.7	0.7	0.1	1.5	1.7	47.5	2.2	2.0	1.3	1.4	2.2	0.6	6.7	0.0	27.2	17.9	1.2	5.2	33.2	71.4	4.8	2.0	1.5	10.2	0.4	1.9	2.0	2.5	3.7	0.0	2.0	4.1	3.1	1.2	4.7	0.4	2.5	9.1	9.3	2.0	0.2
STRN	"PPP2R6A, STRN1"	ENSG00000115808	Striatin	O43815	2	36837698-36966536	"Cancer-related genes, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017286	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoplasm	"HPA017286: AB_1857618"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.43e-2)"	8.4	4.7	5.3	9.4	16.7	14.9	8.6	11.9	9.0	8.6	0.6	9.1	8.1	6.2	3.8	21.2	5.3	6.8	21.2	5.5	10.2	8.4	7.5	7.8	7.7	13.0	11.6	7.7	5.6	7.3	2.4	10.1	13.1	5.5	10.7	10.1	10.7	5.0	11.6	11.2	8.6	7.7	9.8	8.1	9.0	8.0	14.2	13.3	6.2	11.5	12.6	8.4	10.1	24.7	38.3	19.0	25.2	10.4	13.3	18.0	24.6	14.8	14.2	14.5	13.3	19.4	12.2	24.7	11.8	19.7	20.6	17.6	21.4	17.0	17.9	27.9	16.0	40.2	16.4	10.3	12.1	24.9	21.8	11.4	12.9	23.2	18.3	10.7	18.6	10.0	30.4	19.2	18.2	11.1	24.7	7.4	19.8	15.7	9.4	15.9	38.5	11.2	9.7	31.0	4.5	15.1	22.4	16.9	13.6	13.7	12.2	9.2	24.9	25.4	25.4	16.0	20.1	19.5	31.0	21.6	13.2	23.2	18.2	1.3	0.2	0.4	0.5	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.2	0.2	1.0	0.2	0.4	0.2	0.1	0.1	5.3	16.7	11.9	9.0	5.5	10.2	13.0	11.6	13.1	9.8	14.2	24.7	26.5	9.6	10.0	38.8	18.8	20.6	12.3	11.3	21.6	12.7	16.0	9.4	55.4	8.6	17.4	23.9	20.9	8.0	22.8	25.0	9.8	10.5	1.9	14.2	14.3	19.4	11.4	26.5	65.3	8.4	10.3	13.6	20.4	26.2	5.1	16.0	16.4	7.9	8.8	18.5	55.2	17.8	10.2	20.7	10.0	2.1	9.6	18.0	8.8	47.8	20.3	10.1	35.0	55.3	294.0	16.8	14.1	12.4	14.3	19.3	13.0	8.5	8.2	16.9	0.0	13.6	16.5	15.2	19.2	31.4	33.2	16.3	19.4	17.7	16.0	39.4
STRN3	"PPP2R6B, S/G2NA, SG2NA"	ENSG00000196792	"Striatin 3"	Q13033	14	30893799-31026401	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003392, HPA004636, CAB069925"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoplasm, Actin filaments"	"CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940"	"unprognostic (4.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (8.74e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-2)"	18.9	13.4	8.4	9.3	8.3	10.0	11.6	14.9	11.2	14.0	8.9	16.1	7.3	12.4	13.8	15.3	9.9	12.4	18.5	7.5	16.4	13.9	21.5	10.0	7.5	7.7	9.8	10.1	12.6	13.9	9.3	11.9	7.5	13.7	12.6	14.2	10.3	14.1	39.2	11.7	9.7	18.0	6.0	10.4	11.2	20.9	10.7	9.4	13.7	28.5	9.0	14.7	11.6	10.6	33.7	29.2	31.0	22.0	27.4	20.4	25.8	33.0	23.2	24.9	26.3	37.7	22.4	18.4	22.0	23.2	12.6	18.2	33.5	18.1	37.7	17.5	12.3	19.2	19.6	73.6	28.8	15.6	19.8	19.9	20.8	19.5	24.8	23.9	21.5	16.7	22.8	17.8	25.4	21.5	21.3	16.3	15.3	24.1	25.5	15.0	35.5	4.9	39.2	47.7	19.1	15.5	32.8	23.6	17.7	28.4	27.7	14.5	28.0	24.8	21.3	14.7	12.4	15.7	21.4	17.8	12.7	11.2	20.5	4.1	3.5	4.7	3.3	4.3	4.4	3.4	4.2	3.7	3.1	3.2	4.1	4.8	4.3	4.2	3.5	5.7	3.6	1.3	8.4	8.3	14.9	11.2	7.5	16.4	7.7	9.8	7.5	6.0	10.7	10.6	37.1	22.4	22.4	82.3	19.5	98.1	57.5	17.9	23.9	27.2	37.1	25.1	51.7	28.6	22.1	31.3	27.1	22.1	17.5	34.1	11.7	38.9	21.8	32.7	48.0	36.0	31.9	43.8	110.9	26.3	19.9	39.6	20.4	46.9	8.8	21.7	35.0	43.1	12.8	37.0	119.0	18.8	16.2	23.9	45.7	13.4	26.8	22.9	44.4	92.8	18.9	24.6	11.3	102.1	139.2	40.3	13.2	27.8	31.3	49.6	13.2	43.3	25.2	30.2	26.3	52.3	51.9	59.8	53.6	31.4	96.5	33.2	21.4	26.1	16.3	53.6
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	80.2	126.3	185.5	35.6	186.9	48.9	76.0	183.8	242.7	74.8	173.1	100.3	50.7	67.0	60.3	86.8	65.3	42.1	151.1	187.3	185.3	91.4	100.7	65.0	52.5	188.2	184.2	65.7	93.7	90.6	93.7	23.9	187.9	80.2	32.6	33.2	86.6	53.5	201.8	111.7	63.1	40.1	180.6	70.0	86.2	45.1	193.5	42.3	72.9	125.2	38.2	80.7	69.1	188.0	81.6	107.6	59.4	108.0	123.4	102.5	43.8	112.8	95.1	100.9	90.5	131.0	97.1	83.0	78.2	147.5	69.1	69.7	73.0	137.3	42.9	93.6	318.8	53.4	154.1	104.7	183.7	85.9	96.4	141.1	134.3	118.2	71.4	76.3	106.2	72.3	87.1	119.2	149.3	318.4	90.1	85.4	76.4	107.1	127.5	143.5	46.8	200.6	132.5	72.6	121.1	103.4	89.4	165.8	137.1	35.9	114.1	147.8	108.7	104.3	99.8	94.3	125.9	137.6	150.2	132.3	83.8	73.9	122.0	17.7	13.6	21.7	15.7	12.9	14.5	19.6	13.5	13.8	12.1	21.0	12.8	11.6	13.4	11.2	13.9	20.7	13.2	7.2	185.5	186.9	183.8	242.7	187.3	185.3	188.2	184.2	187.9	180.6	193.5	188.0	96.2	38.5	27.9	24.5	88.9	114.7	107.2	63.9	83.1	93.3	137.1	158.7	1.0	104.4	52.4	130.6	52.1	80.1	101.4	142.7	285.7	139.6	8.6	82.8	69.6	71.6	76.0	68.5	23.2	169.7	93.8	85.7	68.3	65.0	21.0	97.9	80.3	122.1	113.1	84.1	21.1	101.4	85.5	69.4	94.9	16.7	109.0	79.0	117.4	15.0	154.4	184.3	110.2	14.1	24.8	190.2	110.8	112.1	108.6	160.8	165.5	324.1	61.2	83.9	72.3	82.3	129.7	50.4	62.4	107.0	120.5	100.7	96.2	132.5	109.3	118.8
STX12	"STX13, STX14"	ENSG00000117758	"Syntaxin 12"	Q86Y82	1	27773219-27824443	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041038, HPA055300"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA041038: AB_10794261, HPA055300: AB_2682778"	"unprognostic (3.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.24e-1)"	64.2	30.1	38.1	26.6	39.0	10.8	37.0	40.8	45.6	28.8	25.4	30.7	36.3	30.9	62.9	39.2	23.9	39.8	20.9	37.3	41.7	35.2	29.1	50.0	25.6	42.0	45.3	22.1	30.3	46.5	26.6	33.3	43.6	30.7	32.5	43.2	26.9	32.1	21.4	27.0	32.8	35.9	42.2	30.5	65.5	13.4	38.4	17.3	94.7	27.1	22.2	39.1	23.4	44.6	23.2	10.9	28.8	19.0	53.9	65.0	14.8	47.9	70.3	43.1	48.5	13.5	29.5	25.2	49.6	64.6	18.5	19.0	19.2	23.9	42.9	22.2	22.8	14.4	12.0	13.7	42.2	16.1	29.0	61.3	28.7	60.6	34.5	35.3	70.3	14.3	19.1	24.6	47.7	8.5	13.7	12.3	12.1	34.3	15.3	8.7	23.1	15.5	38.1	37.5	32.3	17.6	22.4	19.3	35.2	23.3	13.1	14.0	76.2	21.9	12.5	50.0	16.6	14.5	11.2	14.3	35.1	24.1	31.2	24.6	35.7	13.7	6.1	39.4	10.6	13.6	7.3	9.7	25.2	10.8	8.1	6.8	16.5	9.2	40.6	12.4	7.9	17.4	38.1	39.0	40.8	45.6	37.3	41.7	42.0	45.3	43.6	42.2	38.4	44.6	93.0	54.5	36.3	25.1	43.6	109.4	97.2	30.7	51.2	46.2	42.0	25.7	18.9	30.0	40.8	57.0	31.3	30.0	28.3	82.8	37.2	51.9	2.0	34.7	33.1	71.1	41.3	17.7	70.9	58.4	33.5	53.2	108.6	49.4	22.8	26.7	47.8	20.4	50.6	26.9	65.7	29.5	14.2	91.4	77.7	4.2	36.1	62.3	53.4	56.2	41.3	67.9	36.0	34.7	59.1	68.4	58.6	47.4	33.9	74.9	51.3	69.7	27.4	51.2	39.5	45.7	57.5	20.0	20.1	69.9	99.2	78.0	31.6	54.0	29.9	99.9
STX5	"SED5, STX5A"	ENSG00000162236	"Syntaxin 5"	Q13190	11	62806860-62832051	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001358	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"	Nucleoplasm	"HPA001358: AB_1080119"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.22e-3)"	34.2	31.8	31.2	22.2	32.1	41.9	34.4	35.3	39.0	42.0	34.6	27.5	22.7	30.6	42.6	34.9	33.1	25.0	27.2	31.3	32.1	38.3	51.0	32.7	25.1	34.2	31.8	42.2	51.1	27.0	29.6	27.4	31.7	43.6	22.4	18.8	51.8	26.9	27.7	41.4	28.4	23.9	31.3	35.5	36.0	29.0	32.9	30.4	37.9	20.2	31.6	28.4	34.2	33.5	40.9	25.4	34.5	29.9	44.6	50.2	31.0	39.2	54.9	64.7	52.0	18.8	39.0	26.0	35.9	55.9	37.8	41.7	29.7	37.2	47.8	60.4	28.3	23.0	33.0	39.2	55.3	26.9	33.5	40.7	41.6	58.6	70.3	50.5	31.9	37.0	21.0	71.7	34.5	48.4	36.5	43.8	11.3	36.2	36.8	37.1	32.3	70.2	28.8	20.7	26.3	21.6	31.4	49.4	63.6	25.7	54.4	35.9	36.8	46.8	24.6	54.6	25.1	64.2	38.1	27.4	38.0	18.7	29.6	11.7	11.4	36.2	10.4	14.1	9.3	11.0	8.1	10.1	10.4	11.3	7.5	7.6	17.8	13.1	12.7	12.9	13.0	6.6	31.2	32.1	35.3	39.0	31.3	32.1	34.2	31.8	31.7	31.3	32.9	33.5	30.3	22.4	29.3	12.7	64.1	67.2	79.5	37.9	13.6	21.0	38.0	27.9	5.6	20.0	27.6	11.0	27.1	55.3	57.6	29.8	29.4	45.7	113.1	28.2	28.6	33.1	32.9	23.5	16.0	59.6	75.1	39.5	23.9	34.0	52.7	25.2	30.0	24.4	46.5	18.5	15.4	54.8	22.4	39.5	53.5	143.7	39.1	33.2	46.2	12.2	51.6	30.3	44.3	10.1	16.6	44.1	36.0	25.2	47.2	61.2	44.8	32.6	20.7	18.6	32.9	34.1	33.6	32.2	30.1	19.8	64.2	177.6	40.4	28.0	26.2	75.5
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	9.5	7.4	13.7	11.2	14.9	2.7	9.2	15.9	17.9	9.5	11.6	7.9	7.5	8.2	7.7	17.5	7.4	7.1	5.8	15.6	13.5	8.7	4.8	11.3	10.9	13.8	13.7	8.2	4.1	7.4	4.5	11.5	12.6	7.2	8.1	8.1	8.0	6.7	4.0	12.8	7.6	8.7	13.2	9.3	7.9	5.6	14.1	17.2	11.4	4.9	14.1	14.2	11.2	16.6	16.9	18.6	18.0	24.1	18.5	21.7	30.3	21.2	27.3	16.4	13.9	17.4	16.5	17.0	28.7	23.4	10.2	29.4	16.5	37.4	19.0	12.3	12.1	11.4	14.2	17.2	18.4	16.4	14.1	19.9	33.6	27.6	28.3	29.3	33.6	15.7	21.3	11.8	22.0	24.2	15.9	15.4	28.2	21.0	9.2	13.7	22.0	24.7	19.6	41.7	25.5	27.0	22.2	42.3	23.9	30.7	25.8	14.9	28.0	22.4	11.8	21.2	17.3	19.8	11.8	12.3	11.0	15.8	13.5	2.6	1.6	2.1	0.7	1.3	0.8	0.7	1.1	1.1	2.2	0.7	1.4	0.9	1.4	0.2	1.1	0.7	1.4	0.6	13.7	14.9	15.9	17.9	15.6	13.5	13.8	13.7	12.6	13.2	14.1	16.6	13.9	16.0	18.6	32.3	11.8	48.9	21.3	19.0	41.5	12.8	16.0	11.7	6.4	2.8	13.7	18.4	6.2	25.7	15.8	10.5	11.7	10.7	8.9	19.4	16.6	23.0	23.4	16.0	54.7	9.8	24.9	12.7	19.4	22.7	12.0	12.7	14.6	4.8	26.4	8.4	38.0	11.1	16.2	26.1	28.0	11.8	8.4	31.9	7.2	23.4	25.2	6.7	15.5	50.3	30.7	14.9	13.9	13.2	10.0	22.2	10.2	11.5	13.3	11.4	6.6	8.2	12.2	5.6	15.4	47.8	37.6	20.5	14.0	16.4	10.6	22.8
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 174.5;pituitary gland: 66.4;retina: 214.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 131.0;Cone photoreceptor cells: 156.4;Excitatory neurons: 243.2;Inhibitory neurons: 157.5;Rod photoreceptor cells: 155.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 174.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 144.1;SK-MEL-30: 131.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.47e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favorable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	27.5	28.8	22.8	7.8	33.2	1.1	21.0	38.6	174.5	21.8	0.0	15.9	5.5	24.1	7.1	10.4	32.3	11.4	24.0	48.3	12.2	14.1	3.1	32.1	6.0	48.7	0.0	25.2	24.8	15.0	66.4	14.1	33.1	10.5	8.4	214.2	15.6	10.4	9.0	11.4	9.3	21.0	0.0	10.4	13.3	9.1	6.8	5.8	20.1	9.2	7.0	15.4	16.4	27.2	13.2	27.1	25.5	28.8	56.6	48.3	23.2	45.0	22.9	26.6	23.3	1.5	15.4	13.1	24.2	29.7	74.2	4.7	22.6	28.1	32.7	29.8	15.4	17.1	69.7	4.9	28.5	1.8	14.6	36.6	15.4	70.0	33.7	42.6	32.2	43.4	17.8	19.6	45.5	24.5	12.5	5.2	21.5	21.4	35.9	7.5	12.1	31.3	22.0	0.6	144.1	69.9	72.9	37.2	131.9	22.5	5.8	5.6	47.5	30.0	15.1	59.9	17.4	40.2	73.2	17.4	59.2	18.9	28.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.9	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	22.8	33.2	38.6	174.5	48.3	12.2	48.7	0.0	33.1	0.0	6.8	27.2	24.3	25.6	70.7	34.0	1.2	11.6	10.1	8.4	12.5	131.0	10.5	8.0	15.2	1.5	9.2	3.7	156.4	2.7	1.1	0.5	7.9	13.1	2.2	8.3	14.7	28.9	45.6	4.0	243.2	8.4	5.9	18.7	3.1	7.0	5.1	5.0	26.7	1.4	4.4	84.1	157.5	10.2	8.2	2.5	5.6	2.2	20.5	3.0	10.6	45.0	0.6	27.0	0.0	61.3	39.0	5.3	0.0	44.4	1.6	10.8	0.1	8.9	15.9	155.6	13.1	9.5	11.2	40.6	16.9	2.9	7.5	24.5	2.3	17.7	0.9	7.1
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809523	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 206.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	23.2	24.3	28.7	27.0	38.6	23.9	27.6	37.9	41.6	24.7	23.8	28.5	26.1	27.1	25.6	25.1	19.6	28.0	20.5	26.9	32.8	40.3	25.0	23.1	27.9	39.5	35.2	20.9	28.1	42.0	14.2	28.1	39.7	23.8	29.1	34.4	21.6	19.4	19.3	27.2	33.4	24.1	35.6	26.1	25.2	16.3	32.2	31.6	37.1	24.0	25.3	31.1	21.5	50.2	47.1	18.1	30.6	16.1	36.3	35.1	42.9	42.9	38.9	27.9	28.2	16.8	18.3	41.7	28.4	34.7	25.8	27.4	20.9	25.3	38.8	46.7	28.9	34.5	23.8	21.9	28.7	54.2	56.0	27.4	34.5	31.5	34.0	34.8	35.2	26.2	26.0	39.3	39.0	31.7	34.8	42.9	32.6	30.9	28.4	28.4	45.1	22.8	45.7	38.4	18.4	16.9	52.3	49.6	64.6	27.6	20.1	49.9	40.2	36.3	21.4	50.8	37.1	26.3	24.8	34.1	65.2	41.0	56.4	62.7	17.1	42.7	14.2	20.8	18.4	11.3	16.6	14.5	16.6	10.8	14.0	13.7	48.1	17.9	24.9	7.7	20.4	11.9	28.7	38.6	37.9	41.6	26.9	32.8	39.5	35.2	39.7	35.6	32.2	50.2	35.9	12.8	25.2	59.1	25.6	44.0	37.4	32.5	14.2	38.2	21.8	20.2	36.4	32.9	34.5	20.2	20.9	43.7	38.7	46.5	45.0	38.1	7.3	33.6	29.3	32.9	21.0	22.7	30.0	27.4	35.4	36.2	16.8	33.9	69.7	18.7	15.4	16.1	31.5	26.9	31.4	28.3	24.4	45.5	44.2	5.4	33.5	41.7	39.2	48.7	57.3	40.5	41.2	68.9	206.2	34.5	27.3	31.6	20.0	32.9	30.4	47.5	28.7	19.3	19.7	34.2	33.6	26.4	24.7	16.1	40.3	95.5	36.7	29.6	26.8	44.8
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618923-10674318	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.1;stomach 1: 17.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Excitatory neurons: 20.6;Gastric mucus-secreting cells: 15.3;Paneth cells: 12.6;Proximal enterocytes: 10.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.2"	"Immune cell enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.7;HDLM-2: 17.5;HMC-1: 18.3;HUVEC TERT2: 25.5;TIME: 23.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	Nucleoplasm	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.4	0.3	1.2	1.8	3.0	1.1	3.9	0.0	5.2	1.9	0.0	15.9	2.4	0.5	1.2	7.3	2.2	3.5	0.1	3.6	0.0	0.6	0.3	1.3	1.4	0.0	0.0	0.3	0.3	0.0	2.4	0.7	0.0	11.6	17.1	0.9	6.7	0.9	0.1	2.8	11.2	0.6	0.0	0.9	17.5	0.2	0.0	0.2	0.4	0.0	2.5	5.1	3.3	0.3	4.8	0.2	0.0	0.6	0.0	0.0	1.3	7.3	0.7	3.5	3.4	2.6	28.7	0.3	4.7	1.8	4.5	1.4	1.6	8.0	7.4	17.5	0.4	1.0	2.4	0.2	0.0	2.2	18.3	0.4	0.4	5.1	0.3	0.5	25.5	0.2	0.3	0.3	8.1	3.1	0.2	1.3	4.2	11.8	2.0	0.1	2.0	0.3	2.5	14.6	0.9	0.1	4.5	4.9	0.0	6.7	3.5	0.6	23.8	1.0	3.8	0.5	0.8	0.0	1.0	0.2	3.5	0.2	5.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.1	12.5	0.0	0.0	0.0	0.3	1.2	3.0	0.0	5.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.2	0.0	0.0	0.3	0.8	3.1	1.2	0.6	3.3	2.0	0.7	1.5	3.3	0.0	0.0	0.1	1.8	19.6	0.0	0.5	0.2	7.3	0.5	0.4	4.2	0.8	20.6	0.2	0.6	0.2	15.3	4.5	1.3	6.3	0.0	0.0	0.0	0.0	1.6	8.9	2.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	6.2	0.0	0.5	5.9	12.6	0.0	0.9	4.7	10.6	0.0	8.8	0.4	0.0	1.2	0.2	0.2	0.8	3.1	1.0	0.3	1.9	0.0	6.9	5.5
STYX		ENSG00000198252	"Serine/threonine/tyrosine interacting protein"	Q8WUJ0	14	52730166-52774989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 117.1;Late spermatids: 92.5;Spermatocytes: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040290	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA040290: AB_10963686"	"unprognostic (5.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.89e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.84e-3)"	9.4	3.7	3.3	8.8	4.3	5.8	7.6	4.3	4.3	5.6	2.9	6.0	5.7	6.8	4.7	9.1	4.7	5.8	8.7	2.6	3.5	5.8	26.7	5.8	14.0	4.6	4.3	6.8	5.8	4.8	2.2	9.5	4.5	6.3	6.5	3.9	5.7	5.8	11.4	8.1	5.7	6.9	3.8	9.1	6.6	10.9	3.9	9.4	5.6	12.9	12.4	7.4	4.8	5.4	14.4	7.8	10.5	12.7	17.5	24.9	20.0	16.9	12.6	12.1	12.2	11.3	10.3	17.7	14.1	16.0	10.2	11.1	13.1	13.8	21.3	16.0	5.0	9.1	8.3	15.0	14.5	14.5	11.5	17.9	16.4	16.0	16.4	10.9	22.2	15.7	11.0	16.6	16.9	19.9	16.3	9.5	12.7	16.1	15.9	13.6	14.1	10.5	15.8	16.1	2.4	7.0	17.3	11.5	11.4	14.6	28.1	14.5	20.8	21.1	13.4	23.1	10.7	6.1	8.8	10.8	6.8	9.6	18.3	7.7	4.4	3.7	5.6	6.1	7.4	6.1	9.2	7.6	4.8	3.8	10.6	8.2	2.2	4.9	5.8	3.6	10.8	5.6	3.3	4.3	4.3	4.3	2.6	3.5	4.6	4.3	4.5	3.8	3.9	5.4	15.2	6.4	9.2	6.2	18.3	16.6	10.7	10.2	9.6	5.1	14.1	8.0	23.1	8.6	11.4	5.5	6.2	13.8	19.7	7.6	13.7	12.4	117.1	9.1	10.9	16.0	4.8	15.6	7.7	18.2	32.8	11.8	11.2	8.9	20.8	5.9	16.1	54.7	15.4	5.0	7.6	6.1	8.2	21.2	20.4	92.5	9.6	20.2	3.6	10.3	27.6	8.7	15.5	6.6	15.9	14.5	7.9	11.3	16.2	19.6	8.1	12.0	14.6	6.9	26.3	8.7	19.6	73.1	25.7	16.9	19.6	21.1	25.6	5.9	8.2	13.6
STYXL2	DUSP27	ENSG00000198842	"Serine/threonine/tyrosine interacting like 2"	Q5VZP5	1	167094075-167129165	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	42	"heart muscle: 63.6;skeletal muscle: 114.6;tongue: 54.1"	"Cell type enriched"	"Detected in some"	7	"Cardiomyocytes: 143.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RH-30: 14.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA012912			Approved	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.1	0.1	63.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.7	0.0	0.9	1.6	0.0	114.6	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	54.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 regulator of transcription"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 1838.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 1427.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	142.0	98.7	88.7	130.4	100.7	251.7	122.1	72.7	152.6	109.7	69.4	110.0	88.7	85.4	83.3	108.9	66.0	74.1	113.3	104.3	98.7	129.2	135.3	91.2	159.8	80.7	87.2	68.3	62.0	107.3	88.4	103.2	94.7	73.2	107.1	83.6	76.6	65.4	105.2	69.6	83.7	79.4	86.0	144.9	97.3	71.1	92.6	204.2	69.2	108.9	137.3	124.0	73.2	85.3	199.9	161.8	315.3	295.8	187.5	329.1	197.7	340.3	245.4	300.8	275.4	236.9	307.3	101.2	231.0	236.5	307.3	132.4	266.9	278.9	402.9	420.2	244.1	337.8	365.8	450.5	264.4	594.6	441.4	233.3	235.6	321.0	228.0	166.0	228.9	378.5	399.4	1427.8	269.5	178.6	566.8	942.9	207.8	235.9	326.9	247.8	409.9	645.7	303.0	178.2	170.4	141.1	526.9	244.9	251.9	198.2	272.0	544.9	238.7	324.7	351.5	275.8	261.0	556.0	1035.0	180.5	297.7	634.9	202.4	650.7	135.8	326.2	164.7	142.3	151.4	330.4	215.9	219.8	265.1	214.8	168.2	195.2	163.7	155.2	133.4	390.1	344.6	326.1	88.7	100.7	72.7	152.6	104.3	98.7	80.7	87.2	94.7	86.0	92.6	85.3	298.9	144.2	163.4	27.1	638.2	584.9	588.7	709.9	324.4	118.1	459.2	383.9	196.7	244.5	320.1	310.8	43.8	493.0	613.5	342.1	1009.5	711.4	131.6	319.0	263.7	280.2	281.4	379.5	71.5	327.2	785.0	323.6	227.9	329.9	307.5	188.6	223.1	375.4	500.5	85.8	60.9	362.9	484.2	319.0	721.3	68.1	239.9	422.5	528.3	37.5	587.5	223.7	500.5	64.3	50.4	416.3	516.6	344.6	1838.8	536.0	342.4	921.2	291.9	79.7	203.8	224.0	468.5	447.2	439.9	411.8	565.4	836.8	575.5	357.7	394.6	645.5
SUFU	"PRO1280, SUFUH, SUFUXL"	ENSG00000107882	"SUFU negative regulator of hedgehog signaling"	Q9UMX1	10	102503972-102633535	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ciliopathy, Disease variant, Joubert syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 129.2;Late spermatids: 115.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008700	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA008700: AB_1080125"	"unprognostic (1.55e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.15e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.82e-3)"	6.6	7.2	8.8	7.1	8.5	2.0	6.1	8.9	8.0	8.6	5.5	6.8	3.9	7.4	4.9	9.2	7.1	6.6	6.3	7.8	7.3	6.1	6.2	5.8	7.2	8.3	8.2	8.9	4.1	11.1	4.3	7.4	7.8	8.5	4.4	4.6	7.1	5.2	8.6	14.4	5.7	7.3	6.7	7.4	4.6	11.5	8.0	7.8	3.4	7.3	8.1	8.8	9.2	7.3	8.7	9.1	14.4	20.8	14.5	12.1	7.0	8.8	17.0	12.5	11.3	8.5	6.3	8.9	24.5	9.9	5.0	6.0	17.8	9.8	8.2	5.5	13.8	21.2	5.2	8.0	6.9	7.7	14.6	13.9	7.5	9.3	7.5	22.9	16.3	8.5	4.8	7.9	7.8	7.2	14.8	11.6	4.1	5.6	6.7	15.8	15.5	4.7	8.3	12.8	4.8	7.8	7.0	6.4	8.1	13.1	14.2	5.0	18.1	5.5	7.8	6.0	9.8	6.4	4.5	6.4	6.9	14.9	3.8	2.0	2.0	2.9	1.0	2.4	0.8	0.9	1.2	1.1	1.9	0.8	0.8	1.0	0.4	1.1	2.5	1.1	0.8	1.4	8.8	8.5	8.9	8.0	7.8	7.3	8.3	8.2	7.8	6.7	8.0	7.3	3.3	0.0	3.7	28.7	4.9	3.1	2.1	2.9	6.8	4.2	3.5	3.0	4.0	1.5	4.6	3.7	8.4	7.8	3.1	3.5	1.9	4.4	129.2	4.5	6.2	5.1	1.2	2.5	25.9	3.0	3.5	6.0	4.6	8.5	3.8	3.8	10.8	5.4	12.4	1.7	22.2	2.2	0.0	9.4	6.3	115.9	5.0	8.7	0.0	32.8	7.8	2.7	4.1	17.6	16.8	4.1	1.3	6.8	4.0	2.0	5.7	5.8	5.7	4.8	0.0	3.0	4.5	8.7	5.3	8.9	6.5	7.0	7.1	7.6	3.0	1.3
SUGP1	"DKFZp434E2216, F23858, RBP, SF4"	ENSG00000105705	"SURP and G-patch domain containing 1"	Q8IWZ8	19	19276018-19320509	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004890	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA004890: AB_1079935"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"unprognostic (5.21e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.25e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.42e-3)"	5.3	5.5	2.7	4.1	3.1	2.5	5.1	2.4	3.4	4.7	2.5	6.4	4.0	6.3	2.5	6.8	5.0	1.7	8.4	3.3	3.0	4.8	4.1	4.0	3.0	3.0	3.3	4.5	4.3	4.0	4.1	2.7	3.1	4.1	2.4	2.0	5.7	3.0	15.0	5.9	5.7	2.9	2.5	5.5	6.0	14.9	3.0	5.6	4.4	5.6	3.5	5.3	4.7	4.1	13.2	2.7	6.3	8.1	5.8	5.7	15.6	8.1	11.2	11.1	8.9	3.9	9.4	11.1	12.8	10.9	6.7	9.4	6.4	10.3	6.4	7.9	5.2	9.3	3.5	4.0	6.0	8.3	11.9	10.4	5.4	10.0	3.7	6.3	7.4	7.8	14.1	6.9	9.9	8.2	16.1	12.1	14.9	10.2	8.0	15.0	7.1	11.9	8.5	6.0	10.5	12.5	6.3	8.6	15.4	6.9	8.4	13.1	14.7	9.0	9.6	12.8	11.0	11.4	11.8	13.3	11.8	9.1	11.0	6.4	8.9	9.0	9.2	10.8	7.2	7.6	7.9	9.5	9.0	7.4	7.8	8.1	10.2	10.9	13.9	6.9	8.3	9.5	2.7	3.1	2.4	3.4	3.3	3.0	3.0	3.3	3.1	2.5	3.0	4.1	6.4	16.0	14.1	14.4	11.4	4.7	6.5	20.1	12.5	11.5	6.2	6.9	21.5	14.3	16.9	14.7	4.2	18.6	10.7	11.8	17.6	15.1	44.1	9.2	7.6	9.5	9.6	19.0	12.1	14.1	14.3	8.9	13.7	7.2	9.5	11.8	10.4	8.2	14.2	1.7	13.4	10.3	8.2	9.4	7.2	115.2	11.1	10.3	10.6	3.7	17.6	15.2	14.4	10.1	8.6	13.4	13.7	12.4	8.4	3.3	16.5	16.4	10.4	10.2	6.6	8.9	13.7	32.5	17.8	7.1	5.7	16.8	12.0	24.1	11.1	4.4
SUGP2	"KIAA0365, SFRS14"	ENSG00000064607	"SURP and G-patch domain containing 2"	Q8IX01	19	18990888-19034023	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 237.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041557, HPA061111"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA041557: AB_10794301, HPA061111: AB_2684432"	"unprognostic (1.35e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.94e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.41e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.60e-2)"	24.5	36.2	29.0	18.2	30.1	41.7	28.4	30.8	37.6	37.5	28.0	35.9	17.1	30.2	20.5	25.6	35.5	12.7	36.6	34.5	22.7	36.0	31.7	32.9	23.5	21.5	23.5	39.4	23.9	17.0	54.3	14.2	21.7	46.9	16.4	45.1	32.3	16.1	37.7	22.4	31.6	15.6	18.0	37.4	27.0	87.7	24.4	22.7	60.9	24.3	20.2	30.9	32.8	30.6	27.7	25.7	64.6	46.7	29.7	29.2	32.2	33.8	25.4	38.8	33.1	16.9	24.0	54.3	27.3	27.2	45.8	20.1	53.2	20.6	35.2	19.3	47.0	34.3	42.6	22.2	21.4	29.2	33.3	30.4	21.5	23.7	19.3	51.8	20.6	41.8	52.6	38.1	42.6	23.5	34.3	54.5	33.5	32.4	36.1	33.8	33.2	30.6	19.7	27.5	71.5	29.4	29.9	20.7	14.8	49.5	21.6	26.9	22.6	38.0	22.8	44.6	40.2	48.0	39.1	40.0	38.3	45.0	40.9	4.1	1.4	1.3	2.1	1.5	1.1	1.1	1.3	1.2	1.5	1.8	1.2	1.4	1.3	4.4	1.3	1.9	1.3	0.8	29.0	30.1	30.8	37.6	34.5	22.7	21.5	23.5	21.7	18.0	24.4	30.6	24.5	41.7	45.1	69.9	22.9	17.6	22.6	17.9	18.8	91.2	30.0	23.5	34.7	22.8	33.3	27.6	93.8	16.7	57.0	19.2	9.8	16.2	84.9	44.4	44.7	25.2	41.5	35.3	106.5	10.5	10.2	29.1	31.6	40.7	27.1	94.9	21.8	28.5	23.4	106.0	90.3	22.5	26.4	31.4	19.9	132.0	40.4	29.1	12.4	34.7	31.2	44.5	57.7	42.7	45.2	18.7	23.2	37.6	36.1	26.1	14.5	11.3	42.5	108.6	52.6	33.5	22.8	237.7	56.2	17.2	18.8	7.5	29.3	79.8	26.9	23.6
SUGT1	SGT1	ENSG00000165416	"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone"	Q9Y2Z0	13	52652709-52700909	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015942, HPA043949"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB015942: , HPA043949: AB_2678745"	"unprognostic (3.66e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.96e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-1)"	27.4	31.4	33.4	25.5	38.1	32.0	23.6	38.6	55.6	23.0	33.1	25.5	27.3	19.6	20.3	30.1	19.4	19.6	37.0	34.8	37.0	31.7	36.5	22.5	27.4	34.8	34.8	21.5	30.6	19.8	26.9	25.9	36.9	19.6	26.9	22.2	25.2	16.3	29.6	24.5	26.8	22.1	35.3	23.2	26.8	34.5	36.4	29.8	21.1	28.1	29.9	27.3	24.3	48.1	47.0	50.2	72.9	55.6	70.4	57.0	69.8	100.8	66.3	61.7	49.0	110.3	114.7	102.4	27.9	62.8	89.5	79.0	90.6	57.9	90.0	85.3	37.7	95.1	65.8	84.4	51.1	74.8	68.7	40.0	51.7	63.9	48.2	79.0	105.0	64.8	90.5	32.7	95.7	33.4	70.3	136.6	85.3	183.9	47.8	79.6	42.4	44.4	108.0	51.7	24.1	30.7	52.1	42.2	49.8	82.6	43.5	70.3	76.1	51.3	59.9	59.6	87.6	25.7	38.9	91.5	30.8	59.2	75.5	63.6	29.0	49.0	24.3	34.5	23.9	30.9	31.4	33.2	32.9	30.3	23.8	26.6	4.1	33.2	34.1	41.0	46.0	25.2	33.4	38.1	38.6	55.6	34.8	37.0	34.8	34.8	36.9	35.3	36.4	48.1	82.1	38.5	36.0	22.2	46.1	39.8	65.4	68.2	38.1	52.6	40.6	55.8	126.2	32.9	51.8	51.5	25.0	67.0	78.3	52.3	78.2	88.3	185.6	112.0	79.0	65.9	34.1	65.2	19.9	89.0	143.0	60.9	50.0	75.1	36.8	49.7	43.5	38.3	97.8	50.5	23.0	58.2	54.9	44.5	43.9	95.7	58.7	54.3	48.0	13.1	123.7	91.8	58.7	21.1	47.6	85.2	55.0	59.8	58.3	44.1	74.3	100.9	67.8	56.6	26.3	72.4	92.1	146.7	101.0	45.7	43.2	74.4	61.1	56.1	55.5	52.3
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721167-69787961	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 99.4;stomach 1: 44.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 10.7;neutrophil: 32.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	3.0	0.7	2.3	10.7	4.3	5.5	2.1	8.0	6.8	1.5	2.5	69.9	99.4	2.0	2.4	2.0	1.5	1.5	1.9	3.2	1.8	1.9	23.8	2.5	4.2	0.9	0.9	3.0	0.8	0.9	0.1	1.3	2.0	2.5	62.2	3.9	0.8	1.4	1.2	1.3	95.3	5.1	0.3	9.7	44.9	1.2	2.0	3.0	2.7	2.3	7.5	1.6	0.9	5.6	0.7	0.6	0.8	0.8	1.8	1.9	1.2	0.8	0.4	0.3	0.3	0.7	0.7	1.3	0.7	0.8	1.0	1.1	0.1	0.2	0.7	1.5	1.0	1.0	1.2	0.5	2.7	1.3	1.3	12.3	0.2	0.3	0.5	1.1	110.9	1.6	0.6	2.5	1.0	0.7	0.6	1.0	0.8	26.3	0.4	0.6	3.7	0.8	0.2	1.8	1.3	0.8	0.5	0.3	0.5	0.7	1.6	0.6	36.2	1.0	1.7	31.5	0.6	1.9	1.0	0.6	0.4	3.3	1.3	10.7	4.8	1.4	1.0	2.7	0.3	0.1	1.5	0.4	2.7	0.2	4.9	2.5	32.0	2.9	3.4	0.2	0.9	2.6	2.3	4.3	8.0	6.8	3.2	1.8	0.9	0.9	2.0	0.3	2.0	5.6	1.3	19.2	20.8	0.3	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	0.0	0.0	4.9	298.2	0.0	0.3	0.1	1.2	0.1	2.2	33.7	2.7	0.1	4.4	0.2	1.8	61.7	0.2	16.4	0.2	2.9	45.1	0.3	0.0	0.1	42.6	0.0	24.9	1.8	0.0	0.0	9.4	0.0	3.7	15.4	0.0	11.3	0.0	0.1	18.2	153.4	0.0	1.0	0.2	234.3	1.5	12.8	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.3	6.7	0.1	76.4	0.1
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin like modifier 1"	P63165	2	202206182-202238599	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.6"	"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: AB_2683285"	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	77.5	99.1	79.4	62.7	84.9	133.7	83.6	89.0	99.9	68.9	84.4	82.7	72.0	65.1	86.3	71.6	65.7	71.7	79.8	85.6	85.3	118.1	174.1	66.5	86.4	79.9	80.1	54.5	55.8	91.6	56.7	75.6	81.1	75.3	82.8	80.2	66.8	61.9	107.5	57.1	80.5	71.5	78.9	68.1	73.8	54.7	81.4	112.1	102.3	103.3	95.4	77.9	54.9	86.6	164.1	82.4	291.4	155.8	159.3	168.5	129.7	171.0	214.6	209.0	274.6	178.1	203.7	111.6	153.5	199.0	193.5	117.1	242.2	237.9	325.0	104.8	185.7	207.6	159.0	211.2	114.9	237.2	188.5	130.9	225.2	164.0	123.9	195.1	197.3	219.0	194.2	176.0	226.4	141.1	298.3	391.6	351.7	168.5	172.2	190.9	163.2	197.9	255.5	134.3	201.7	219.3	140.3	133.6	236.4	313.9	120.0	223.2	139.9	152.5	153.0	141.4	152.8	151.7	322.9	285.8	170.2	165.4	137.2	242.2	220.0	284.2	169.2	226.5	179.6	276.3	206.8	200.0	223.6	231.6	193.8	202.3	256.5	246.5	239.7	187.8	329.0	394.7	79.4	84.9	89.0	99.9	85.6	85.3	79.9	80.1	81.1	78.9	81.4	86.6	182.7	112.2	61.1	10.7	143.1	422.1	204.4	448.6	177.6	99.6	196.8	170.2	58.1	130.1	215.3	189.4	64.6	259.4	162.3	136.6	481.3	250.4	91.3	148.3	115.1	170.7	142.4	140.1	31.4	173.3	297.8	161.8	89.7	115.2	92.6	114.7	142.8	202.1	205.3	87.5	27.8	156.4	319.4	140.7	330.2	28.0	129.8	137.7	211.7	15.9	241.3	182.3	176.1	16.6	21.2	208.1	191.1	127.9	130.5	258.5	272.2	534.4	185.5	87.8	111.7	92.5	221.9	212.0	141.5	183.9	424.5	209.7	174.5	134.9	157.5	254.1
SUMO2	"SMT3B, SMT3H2"	ENSG00000188612	"Small ubiquitin like modifier 2"	P61956	17	75165586-75182959	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB037314, HPA042123, HPA048064"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear bodies"		"CAB037314: AB_796170, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (6.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (9.80e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (5.23e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.89e-3)"	198.2	205.1	176.2	203.6	186.9	229.8	174.5	214.2	239.9	219.3	168.5	190.1	161.4	205.5	158.5	240.9	186.8	134.0	156.7	185.4	193.4	205.6	185.8	171.5	214.6	175.5	177.3	231.1	161.0	130.6	146.5	130.1	177.5	158.1	143.9	205.9	160.3	122.2	229.4	182.6	169.2	154.8	187.4	174.7	205.3	182.2	187.2	271.9	149.2	152.0	228.6	188.2	205.1	191.5	742.5	299.1	1035.7	534.4	296.8	283.6	486.1	571.2	276.9	384.5	354.5	343.6	396.0	641.8	398.1	327.9	503.0	353.4	470.3	351.7	451.6	373.6	712.4	644.0	282.1	597.4	194.1	856.1	555.7	290.1	195.9	343.9	187.2	615.6	403.8	628.3	540.7	508.7	288.3	317.8	1310.8	734.0	632.8	552.5	445.5	903.2	987.1	539.5	391.9	612.0	633.4	739.0	691.1	566.8	481.4	796.9	614.6	663.0	458.1	557.2	581.7	429.4	931.3	355.4	348.1	986.8	351.2	500.6	457.3	831.1	436.4	781.2	390.9	498.9	408.8	515.7	486.8	456.8	451.6	443.6	444.0	437.1	380.1	452.3	548.3	616.0	701.6	851.5	176.2	186.9	214.2	239.9	185.4	193.4	175.5	177.3	177.5	187.4	187.2	191.5	522.1	163.5	160.6	25.5	453.3	705.4	647.4	717.6	602.2	216.4	492.1	524.1	62.3	337.5	368.2	355.0	50.1	522.8	485.0	278.1	968.5	602.7	281.8	348.6	429.0	458.5	441.9	519.9	35.7	531.7	948.9	451.1	274.2	343.5	349.0	465.0	491.2	273.4	616.3	233.9	33.0	397.9	472.0	676.9	637.0	488.6	604.9	481.5	462.4	21.5	743.4	535.4	517.0	25.1	42.6	666.5	397.3	605.2	443.0	822.3	348.7	847.5	322.6	161.3	571.9	409.5	716.6	872.2	683.2	795.2	742.7	565.2	480.3	476.1	437.0	977.2
SUMO3	"SMT3A, SMT3H1"	ENSG00000184900	"Small ubiquitin like modifier 3"	P55854	21	44805617-44818779	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB012180, HPA042123, HPA048064"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nuclear bodies"		"CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (2.77e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.81e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-2)"	68.6	58.1	58.5	56.7	64.6	118.8	63.6	50.6	75.5	55.5	55.9	55.2	55.1	52.9	50.3	57.2	52.1	44.6	74.3	64.4	71.8	64.0	59.3	61.7	68.8	53.3	59.0	57.6	49.4	44.7	38.3	49.1	58.3	46.2	45.8	72.0	66.5	47.4	106.6	51.0	58.0	39.8	54.5	61.6	56.3	28.8	68.5	63.7	54.8	73.9	57.5	50.0	53.6	50.9	226.4	88.8	131.7	80.2	105.1	147.9	86.5	152.0	177.2	211.5	173.6	133.6	137.2	78.4	234.6	165.4	122.4	53.0	96.8	123.0	166.3	110.0	106.3	322.7	78.8	123.1	113.3	184.5	172.1	126.0	139.5	123.9	89.9	87.8	109.8	164.6	188.7	215.2	173.8	293.1	220.0	127.7	254.4	223.1	174.9	239.0	8.0	217.1	120.2	111.9	98.8	153.4	136.5	196.2	126.3	48.1	190.6	218.6	172.4	99.1	151.4	151.6	172.8	155.4	234.8	198.7	77.9	265.2	138.6	2.8	123.1	52.0	78.9	130.0	79.7	84.6	74.9	76.5	133.3	77.7	88.7	81.0	14.0	70.6	122.3	162.8	91.2	157.8	58.5	64.6	50.6	75.5	64.4	71.8	53.3	59.0	58.3	54.5	68.5	50.9	83.4	64.1	50.4	5.5	76.5	96.0	121.7	127.9	74.6	72.2	99.4	88.5	59.5	67.2	66.5	95.6	20.9	122.9	98.1	95.6	166.3	121.7	63.1	36.4	51.7	101.4	59.2	113.8	14.3	112.4	107.8	76.7	52.0	37.9	29.8	63.8	92.8	116.6	200.5	62.2	13.3	91.5	81.4	143.4	172.3	114.2	72.1	137.9	97.8	10.3	280.0	132.4	111.2	3.5	6.5	148.7	112.6	72.6	58.2	150.7	129.2	130.2	33.0	60.5	59.2	43.8	68.7	90.7	77.5	82.7	77.9	136.3	78.2	43.2	99.9	145.1
SUMO4	"dJ281H8.4, IDDM5, SMT3H4"	ENSG00000177688	"Small ubiquitin like modifier 4"	Q6EEV6	6	149400262-149401278	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 11.1;Glandular and luminal cells: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"									"HPA042123, HPA048064"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear bodies"		"HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.44e-11)"	"unprognostic (4.94e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	0.5	0.3	1.0	0.3	0.7	0.7	0.3	1.7	1.2	1.1	1.2	0.4	0.2	0.2	0.1	0.6	0.5	0.2	0.8	0.5	0.7	0.8	1.3	1.0	0.5	1.9	0.9	0.9	0.4	0.0	0.8	0.3	1.2	1.0	0.2	0.7	0.4	0.1	0.2	0.4	0.3	0.1	1.0	0.6	0.3	0.6	1.5	0.1	0.6	0.0	0.2	0.6	1.1	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.5	0.2	0.2	0.4	1.0	0.7	0.2	0.6	0.6	0.9	2.2	1.0	0.5	0.2	1.1	0.2	1.0	0.7	1.7	1.2	0.5	0.7	1.9	0.9	1.2	1.0	1.5	1.6	2.0	3.2	1.5	0.0	3.1	2.9	1.8	0.9	0.0	4.3	2.5	1.8	11.1	1.5	0.9	1.8	4.2	0.7	6.4	1.3	0.0	0.7	0.1	4.5	4.0	2.7	1.8	0.8	0.0	0.9	0.4	2.9	2.0	8.4	1.3	7.2	1.4	1.6	1.1	0.0	0.0	0.5	0.0	1.3	4.7	0.9	2.1	5.1	0.0	0.0	3.9	1.7	1.0	0.0	0.0	1.1	1.2	1.2	3.5	3.5	1.0	0.4	1.0	3.9	6.6	1.8	3.6	1.9	0.8	0.5	0.9	0.3	4.3	2.7	0.4	3.9
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351476-21384019	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		27000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: AB_2680881"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	29.3	24.8	9.7	36.6	11.1	42.3	35.9	18.8	13.9	34.2	8.2	30.6	23.1	41.1	19.5	29.0	32.0	24.1	24.1	9.7	15.6	28.6	22.4	26.3	51.2	11.3	12.0	43.6	22.6	46.2	13.5	32.1	12.0	29.9	35.1	44.4	20.9	32.6	21.8	28.9	25.9	36.6	10.7	32.9	26.3	43.3	12.1	56.8	33.3	24.6	51.8	35.6	20.1	12.3	147.8	136.9	185.5	136.6	85.5	81.7	131.4	130.3	103.2	155.5	145.4	133.9	129.5	311.3	48.5	96.5	99.7	153.9	237.2	118.9	234.0	99.8	100.9	188.7	121.9	195.1	87.0	270.1	134.7	73.4	72.6	131.0	146.3	75.4	107.7	174.2	158.1	129.4	131.3	99.9	253.6	85.8	207.1	136.2	134.1	270.3	210.6	168.0	63.9	160.8	183.8	157.2	209.8	125.3	81.1	118.7	69.2	127.9	91.1	135.0	113.4	85.0	143.3	128.8	230.2	306.7	49.9	158.0	104.9	35.6	18.3	28.2	29.6	23.9	34.7	31.2	27.9	33.2	23.7	27.4	31.3	32.2	15.0	34.0	31.1	22.2	28.4	25.2	9.7	11.1	18.8	13.9	9.7	15.6	11.3	12.0	12.0	10.7	12.1	12.3	41.5	64.1	55.9	24.2	51.6	35.6	44.3	51.5	45.5	48.9	46.3	49.7	64.2	22.8	50.3	53.3	47.9	65.1	73.6	28.4	25.4	71.0	142.5	52.0	124.3	46.9	23.4	74.6	27.4	61.1	63.9	61.1	29.6	61.7	84.2	73.4	29.3	32.0	41.9	55.5	30.1	31.2	40.7	34.9	25.2	96.1	59.7	40.7	17.8	20.6	90.9	53.3	64.9	16.1	25.2	68.9	15.2	59.8	39.5	46.1	16.5	30.4	40.2	41.1	19.7	78.5	69.5	128.9	152.8	45.1	41.5	45.6	56.3	61.6	43.0	35.7
SUPT3H	"SPT3, SPT3L"	ENSG00000196284	"SPT3 homolog, SAGA and STAGA complex component"	O75486	6	44809317-45377953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"Astrocytes: 110.7;Early spermatids: 142.2;Excitatory neurons: 286.4;Inhibitory neurons: 405.2;Late spermatids: 183.4;Microglial cells: 124.6;Oligodendrocyte precursor cells: 182.9;Oligodendrocytes: 192.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024371	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA024371: AB_1857660"	"unprognostic (5.72e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (1.07e-2)"	"unprognostic (6.15e-5)"	"unprognostic (7.46e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-2)"	2.4	5.1	3.6	1.2	4.1	1.2	2.4	4.8	5.7	4.4	0.0	3.6	2.2	3.5	4.2	2.9	4.1	2.0	1.8	3.9	4.7	4.3	1.6	2.4	1.7	4.5	3.3	5.2	3.8	3.8	3.2	3.4	3.6	4.4	2.3	4.2	7.2	2.1	1.6	1.4	2.4	2.5	1.8	1.8	2.2	8.9	5.7	2.7	4.4	0.5	1.9	3.2	2.4	5.7	5.2	2.4	12.9	6.8	2.7	7.8	4.3	3.2	4.0	7.2	8.9	4.0	4.0	2.0	3.0	1.5	6.2	2.2	9.0	7.1	13.2	5.0	3.6	1.4	1.9	10.4	6.4	3.9	1.5	4.2	5.7	3.7	10.0	20.5	3.7	7.2	4.7	3.7	6.6	1.5	4.0	8.2	4.6	11.2	1.1	8.8	5.7	2.2	10.2	4.2	6.4	3.1	0.7	0.8	10.2	16.7	3.3	3.8	1.3	6.4	0.1	4.6	7.3	7.2	2.2	12.3	5.0	7.9	6.0	0.1	0.3	0.1	2.9	0.5	5.1	1.2	4.4	3.4	1.4	1.6	5.1	4.3	0.2	2.3	0.7	3.9	1.9	1.6	3.6	4.1	4.8	5.7	3.9	4.7	4.5	3.3	3.6	1.8	5.7	5.7	4.5	3.2	4.8	110.7	11.5	1.8	14.5	10.0	8.6	7.4	5.1	6.7	3.0	2.8	7.2	7.3	6.2	11.7	19.7	1.2	11.7	8.4	142.2	5.4	4.5	5.7	8.4	5.9	286.4	3.2	12.3	7.2	6.6	6.3	3.8	16.0	7.1	3.0	8.7	3.3	405.2	2.3	2.0	2.9	5.0	183.4	7.8	4.5	5.4	124.6	10.5	2.8	20.6	182.9	192.9	4.0	2.1	5.3	14.7	11.3	1.9	10.7	8.3	13.5	13.1	6.8	16.0	26.8	22.0	6.2	1.3	8.2	30.7	7.8	3.7	9.3
SUPT4H1	"Spt4, SPT4H, Supt4a, SUPT4H"	ENSG00000213246	"SPT4 homolog, DSIF elongation factor subunit"	P63272	17	58345175-58353093	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059748			Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA059748: "	"unprognostic (1.32e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (6.71e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.57e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.54e-1)"	57.2	72.4	47.0	55.4	48.6	141.9	56.0	50.3	57.9	59.4	44.2	62.3	39.1	60.4	44.5	62.6	54.9	49.0	52.2	48.5	48.0	70.4	68.4	53.3	105.2	46.2	46.0	55.2	41.2	66.2	38.8	43.7	46.2	51.8	49.9	35.2	50.1	43.2	66.4	62.0	57.3	42.6	48.0	71.9	57.6	39.6	46.5	67.8	46.7	67.5	54.8	55.2	53.5	49.1	80.1	150.3	76.3	53.5	79.4	67.1	99.0	84.7	85.0	116.2	111.9	55.2	75.0	122.5	145.5	124.8	90.3	47.0	99.8	101.8	142.8	174.6	120.8	146.0	79.4	185.4	73.8	194.5	109.5	93.8	91.6	85.5	82.8	118.6	95.4	111.5	137.3	123.9	94.3	118.7	188.6	150.8	65.7	104.0	123.4	180.8	104.1	95.5	96.6	85.6	66.7	120.4	45.1	39.1	88.5	98.2	106.0	137.1	75.4	101.9	85.8	52.4	106.9	160.7	331.7	145.3	85.1	61.7	69.2	239.7	191.2	244.7	86.7	214.3	85.0	92.6	81.0	91.9	164.4	71.6	64.8	78.5	361.7	75.2	218.4	93.6	109.8	243.1	47.0	48.6	50.3	57.9	48.5	48.0	46.2	46.0	46.2	48.0	46.5	49.1	70.6	12.8	9.1	3.9	82.6	71.5	63.0	130.2	61.5	27.7	79.0	99.7	40.3	77.2	57.3	60.7	0.0	140.3	111.0	69.1	195.6	129.1	38.5	44.7	57.2	76.5	68.6	142.3	5.5	98.5	166.3	62.7	20.9	53.4	87.1	92.6	101.4	116.0	183.2	13.5	5.4	62.1	105.8	152.6	233.8	40.8	94.8	140.8	110.3	4.7	217.5	117.6	144.1	5.5	8.2	119.3	84.0	94.4	63.3	71.3	118.4	252.0	35.7	24.7	39.5	63.0	81.5	98.8	49.8	60.4	83.7	150.2	83.5	96.6	62.0	85.1
SUPT5H	"FLJ34157, SPT5, SPT5H"	ENSG00000196235	"SPT5 homolog, DSIF elongation factor subunit"	O00267	19	39436156-39476670	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029273, CAB034370"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB034370: AB_2196394, HPA029273: AB_10603896"	"unprognostic (3.96e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (7.00e-5)"	"unprognostic (7.30e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.38e-1)"	43.3	46.2	44.7	44.9	46.6	106.1	41.7	38.2	48.3	45.3	35.3	48.1	40.3	49.7	29.6	42.7	46.2	34.6	41.2	42.7	42.6	38.8	52.1	45.4	51.6	40.4	40.6	55.9	49.5	49.3	72.6	38.2	40.7	48.5	30.0	33.0	54.7	36.1	87.2	50.0	51.3	33.7	37.5	46.7	46.9	102.1	45.1	40.2	51.1	35.6	41.4	45.0	40.2	49.1	134.1	209.5	75.2	76.4	70.7	50.4	64.8	115.4	70.5	66.0	73.2	137.9	80.1	159.7	106.4	104.7	55.0	50.8	101.9	73.5	51.6	161.6	100.3	179.2	99.7	84.5	64.0	148.5	117.4	78.9	54.6	83.9	86.2	72.2	64.0	137.3	137.9	80.4	66.2	132.5	108.5	44.5	94.0	109.8	52.3	108.8	111.0	80.5	68.3	214.1	72.7	98.1	134.0	104.6	71.7	63.3	63.6	80.1	137.6	67.1	77.8	84.1	145.5	130.9	240.8	196.0	81.8	84.1	84.7	49.0	22.1	19.0	13.7	11.5	13.9	23.0	9.6	11.5	11.1	16.2	10.6	9.0	46.3	15.3	17.2	42.6	11.4	15.6	44.7	46.6	38.2	48.3	42.7	42.6	40.4	40.6	40.7	37.5	45.1	49.1	45.1	44.8	82.7	26.4	51.9	51.6	26.8	34.1	43.3	47.4	40.2	51.9	58.8	30.0	51.6	44.1	85.5	36.5	79.6	62.6	13.7	37.4	69.9	73.2	57.2	43.8	89.2	40.4	16.6	35.1	45.3	39.1	72.9	92.2	46.2	36.0	32.5	62.5	36.7	48.8	17.6	62.4	26.4	32.2	68.9	79.1	45.1	51.4	40.9	15.0	41.2	28.4	47.4	15.1	23.1	53.5	46.3	41.3	86.5	32.8	58.1	22.9	67.9	57.6	19.7	57.3	38.1	84.4	80.4	41.0	49.6	54.0	72.6	31.0	50.4	31.2
SUPT6H	"KIAA0162, SPT6H"	ENSG00000109111	"SPT6 homolog, histone chaperone and transcription elongation factor"	Q7KZ85	17	28662198-28702679	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012416, HPA036382"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB012416: , HPA036382: AB_2675094"	"unprognostic (8.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.36e-5)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-2)"	31.2	33.5	24.6	25.4	25.8	65.3	28.3	25.0	26.8	27.0	26.8	36.6	20.0	30.6	26.8	26.5	26.6	24.7	28.8	24.0	29.0	25.6	35.8	28.9	28.4	24.0	25.2	31.2	31.4	30.8	34.3	27.8	24.3	28.7	20.9	29.2	29.1	25.6	54.5	39.2	32.2	27.3	21.6	34.4	31.3	21.4	28.7	34.0	28.9	32.6	30.3	32.1	25.6	25.6	49.4	101.3	49.8	57.1	59.1	39.3	38.2	66.2	70.3	76.3	67.8	94.7	21.5	52.1	33.6	66.5	58.7	57.5	73.6	48.1	78.4	97.6	65.4	72.9	83.2	59.4	49.4	77.2	77.9	54.6	28.4	81.2	53.6	50.3	50.8	50.3	72.9	59.7	55.1	59.1	76.9	33.4	38.7	43.2	32.4	38.7	91.2	42.7	37.6	95.9	37.8	49.9	77.6	120.5	41.6	67.9	74.2	54.2	80.6	59.8	49.4	57.5	85.3	75.4	62.2	74.4	67.5	34.4	50.5	14.7	4.5	4.4	3.7	2.9	3.9	4.5	3.1	4.1	3.7	4.5	3.1	2.8	6.8	4.3	5.0	6.2	3.1	3.1	24.6	25.8	25.0	26.8	24.0	29.0	24.0	25.2	24.3	21.6	28.7	25.6	33.9	38.5	51.0	24.2	36.5	22.4	19.2	16.8	43.3	29.5	27.4	26.0	51.6	22.8	28.4	20.2	56.3	24.4	38.4	29.5	5.9	22.1	5.4	31.0	45.3	32.6	31.0	33.0	21.6	21.3	21.3	32.7	46.4	49.1	50.5	36.6	22.9	33.9	23.7	30.3	19.7	23.1	8.2	23.0	22.4	17.8	25.7	41.8	8.8	16.9	29.9	22.0	30.9	17.6	19.4	31.9	18.7	26.7	55.7	20.0	23.4	10.5	25.7	44.4	32.9	32.4	32.0	19.8	19.1	40.1	24.3	49.8	38.3	42.0	22.9	25.7
SUPT7L	"KIAA0764, SPT7L, STAF65, STAF65gamma"	ENSG00000119760	"SPT7 like, STAGA complex subunit gamma"	O94864	2	27650809-27663840	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039565, HPA063643"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA039565: AB_10795109, HPA063643: AB_2685070"	"unprognostic (1.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (7.54e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (4.46e-7)"	"unprognostic (5.15e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.75e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.23e-3)"	31.2	35.1	31.9	22.5	32.0	35.7	27.7	32.0	37.5	34.3	38.9	30.9	22.9	31.9	25.0	25.8	32.2	20.4	36.8	31.9	33.3	33.4	37.8	29.6	27.4	31.1	31.9	39.6	31.1	22.8	46.2	27.1	32.0	34.0	25.3	55.5	24.0	22.1	30.2	20.8	32.7	28.1	30.3	41.6	29.8	20.6	31.9	26.2	36.3	27.1	24.2	29.2	29.5	35.4	33.6	28.6	41.2	31.9	36.8	30.1	49.0	32.0	30.9	28.4	30.4	37.2	36.8	29.2	32.9	34.0	40.0	35.8	37.3	35.6	27.6	33.7	36.1	39.8	43.7	42.4	48.1	32.4	37.5	42.3	43.8	42.0	44.0	52.7	37.3	35.3	45.8	34.0	37.3	23.1	28.1	52.9	27.5	33.5	25.0	26.8	44.1	37.4	36.7	31.1	32.5	42.3	28.6	29.6	54.7	52.0	20.5	27.9	28.8	39.2	29.0	19.9	30.8	60.9	47.8	60.4	30.5	39.8	27.3	30.4	14.8	13.6	18.2	15.7	20.7	10.6	14.3	19.0	20.9	17.3	17.2	16.3	3.7	22.9	14.7	14.0	17.6	13.6	31.9	32.0	32.0	37.5	31.9	33.3	31.1	31.9	32.0	30.3	31.9	35.4	15.3	22.4	17.1	33.6	15.9	8.4	13.2	19.9	13.1	18.6	12.7	11.7	21.3	12.8	21.6	22.0	41.7	34.2	25.8	12.1	21.5	18.1	12.5	19.1	18.3	18.5	10.8	11.1	31.2	14.6	29.3	17.7	21.4	14.7	19.6	20.7	15.7	15.6	25.1	15.2	32.7	12.3	12.2	12.3	11.1	3.9	13.7	17.1	3.6	14.0	13.4	19.0	16.5	17.6	33.1	13.9	8.2	15.4	25.5	8.5	10.8	20.6	24.3	24.7	19.7	15.0	16.5	29.4	22.6	15.4	8.7	42.3	19.3	22.1	13.9	11.6
SURF2		ENSG00000148291	"Surfeit 2"	Q15527	9	133356550-133361158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 105.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 448.9;Late spermatids: 992.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044340, HPA052213, HPA059710"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: "	"unprognostic (1.53e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	15.3	16.4	13.2	5.4	13.0	5.4	15.3	13.5	15.6	13.8	12.5	16.9	7.6	13.1	6.0	25.8	13.4	3.5	18.9	12.9	12.6	27.7	22.6	12.1	7.1	14.3	13.5	13.2	28.9	5.8	24.2	3.1	13.2	17.7	2.9	4.7	17.0	4.4	21.6	28.3	14.2	2.3	12.6	15.6	20.1	105.8	13.5	6.1	15.5	3.9	4.9	16.5	15.6	13.3	17.4	29.4	12.1	15.1	8.7	6.7	25.4	8.6	7.5	13.5	7.0	40.5	14.0	17.1	12.2	5.8	11.6	46.5	19.2	21.1	6.1	16.7	26.8	13.5	34.7	15.3	17.3	22.6	9.9	8.1	24.5	19.3	28.1	4.8	6.3	20.6	21.9	11.5	9.3	104.3	23.4	15.0	38.1	41.3	56.0	25.7	18.1	40.4	11.8	19.6	44.8	22.7	19.3	31.7	27.0	7.3	33.8	10.6	12.1	20.3	20.7	21.2	31.2	14.3	30.6	18.7	13.0	13.3	20.8	23.7	23.0	18.6	24.3	24.8	32.1	22.3	29.7	28.0	20.3	27.5	27.9	26.6	10.3	21.1	18.6	22.7	42.1	20.8	13.2	13.0	13.5	15.6	12.9	12.6	14.3	13.5	13.2	12.6	13.5	13.3	26.7	12.8	11.5	3.3	23.2	84.1	27.6	53.7	50.7	18.3	31.1	55.1	13.3	35.8	27.3	22.0	2.1	37.8	25.0	30.6	105.7	73.0	448.9	44.4	16.8	20.9	36.5	28.2	3.5	81.6	28.4	19.3	19.9	16.5	9.5	12.9	22.5	23.6	29.7	13.5	2.9	21.5	36.7	25.5	31.7	992.3	26.1	18.7	42.7	0.0	33.1	28.2	34.0	1.0	3.5	63.8	37.4	24.5	19.6	28.8	81.4	78.0	60.2	23.6	65.7	24.4	26.8	169.9	107.3	43.0	88.2	25.6	38.2	52.2	30.1	23.2
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328776-133336188	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	10.4	11.7	8.1	4.1	7.8	4.9	10.3	8.7	7.5	12.4	5.9	13.6	6.2	11.9	2.6	12.5	11.2	2.5	10.5	7.2	7.5	11.7	12.3	8.5	5.5	7.7	7.8	13.1	11.2	3.9	8.1	3.3	7.8	11.5	3.4	3.3	9.7	4.0	17.9	13.2	12.1	2.7	7.5	11.4	9.9	7.9	7.9	4.6	10.6	3.9	3.7	12.2	11.1	8.1	5.6	8.7	6.5	9.8	4.0	3.7	10.8	8.8	5.1	7.7	4.8	13.8	9.2	16.2	6.7	4.9	5.6	16.7	8.4	9.3	2.8	10.8	9.6	11.2	10.5	8.3	7.2	19.1	9.3	5.3	8.0	8.0	7.4	6.8	4.0	15.6	25.1	8.4	6.8	14.7	15.5	15.7	19.1	22.7	15.6	16.1	9.1	16.7	6.7	5.3	13.7	11.6	8.6	13.7	7.8	3.9	12.2	10.6	8.4	17.3	9.3	8.9	12.0	6.2	9.6	21.0	6.5	12.9	10.4	3.3	3.0	1.4	4.3	2.9	4.5	4.6	3.9	3.9	3.3	5.1	5.2	4.4	0.8	3.2	2.7	6.0	3.6	2.5	8.1	7.8	8.7	7.5	7.2	7.5	7.7	7.8	7.8	7.5	7.9	8.1	25.7	44.8	27.3	4.6	20.9	23.7	15.7	11.0	24.5	26.5	33.4	32.3	30.0	28.6	24.5	22.0	6.2	32.2	20.3	36.8	21.5	29.2	1.3	21.1	42.2	23.6	33.6	14.1	4.3	19.6	25.2	21.2	18.8	25.1	25.3	25.4	16.4	35.2	21.2	21.9	4.8	40.3	6.1	14.7	10.2	4.1	27.7	13.7	7.2	5.6	18.6	15.2	29.9	5.0	4.1	29.0	33.3	27.8	14.4	24.8	50.6	26.1	13.2	19.6	0.0	15.8	20.3	19.2	23.6	26.3	27.6	19.0	18.1	91.1	57.7	13.3
SUSD1	DKFZP761E1824	ENSG00000106868	"Sushi domain containing 1"	Q6UWL2	9	112040783-112175297	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 25.2;Kupffer cells: 31.2;NK-cells: 25.7;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 11.0;plasmacytoid DC: 44.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 44.2;granulocytes: 11.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.7;HEL: 56.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048554	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		2300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA048554: AB_2680439"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.29e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (3.63e-6)"	"unprognostic (2.14e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	7.9	8.9	3.2	8.7	3.8	14.1	4.5	0.1	4.8	5.8	2.2	8.9	7.3	3.3	3.6	2.6	4.1	6.5	5.8	3.3	9.1	12.1	3.4	9.6	8.6	3.0	7.5	1.2	4.0	9.0	4.0	15.3	8.0	4.7	9.4	3.2	5.3	5.3	1.4	1.8	8.6	8.0	3.1	8.2	10.5	4.7	7.3	5.9	4.1	2.1	5.9	12.0	2.2	2.8	2.8	18.7	12.9	0.0	9.4	6.2	41.1	11.8	15.8	16.3	20.8	37.3	24.5	0.3	13.0	20.7	1.1	8.4	4.7	2.1	12.1	50.7	3.9	56.3	13.0	25.7	11.4	14.9	17.4	7.8	1.7	9.0	0.3	11.1	38.9	8.1	31.5	2.3	10.4	3.5	2.1	9.2	4.2	46.1	3.0	12.6	3.0	0.0	3.9	9.7	4.5	10.8	6.5	1.4	0.1	7.1	2.2	16.2	29.7	0.3	6.0	1.8	0.1	0.7	0.7	1.0	11.1	5.8	3.6	6.1	2.4	11.0	2.7	2.9	0.8	0.1	0.7	1.9	1.7	0.3	0.3	1.9	0.9	3.1	5.3	44.2	0.2	2.0	3.2	3.8	0.1	4.8	3.3	9.1	3.0	7.5	8.0	3.1	7.3	2.8	3.1	0.0	4.8	1.6	3.4	0.5	1.7	1.6	0.0	0.3	2.4	1.0	2.0	1.5	4.5	12.9	0.0	9.0	24.3	7.0	0.0	7.0	1.8	6.0	5.4	2.9	4.2	3.0	25.2	7.1	10.5	5.0	8.6	7.8	5.7	4.5	7.1	0.4	16.3	0.0	21.9	4.3	2.0	31.2	6.0	1.8	0.0	21.5	0.0	13.1	19.8	0.3	25.7	38.2	1.2	11.1	3.4	1.9	1.4	2.6	2.7	2.9	5.3	1.4	0.0	4.0	3.9	0.5	0.4	1.8	0.9	8.6	6.1	1.2	6.4	9.5
SUSD6	KIAA0247	ENSG00000100647	"Sushi domain containing 6"	Q92537	14	69611596-69715144	"Predicted membrane proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030464	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Intermediate filaments"	"HPA030464: AB_10601128"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.70e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.10e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-1)"	25.3	19.3	12.0	32.9	12.4	67.2	22.2	26.7	11.6	16.2	13.1	20.9	25.4	13.0	43.1	31.8	21.0	27.5	15.6	13.5	12.8	22.2	12.2	37.1	30.4	24.5	14.5	13.5	22.1	16.6	14.4	17.0	15.3	17.8	19.0	15.6	29.7	16.7	12.3	27.3	32.8	19.7	18.2	33.6	20.9	10.7	14.2	21.7	22.4	11.5	36.2	21.7	18.1	15.5	19.4	4.9	7.0	6.4	14.0	10.2	12.8	10.7	22.6	6.0	5.8	5.9	16.7	22.6	11.8	13.5	4.8	26.4	4.0	22.1	5.6	38.9	3.0	18.4	4.1	9.8	22.6	3.0	45.6	16.6	21.5	10.1	18.7	6.5	12.4	6.9	5.7	19.6	8.4	9.5	4.5	8.1	1.4	11.3	5.0	7.7	6.2	9.1	11.5	9.8	3.0	4.7	8.8	25.4	4.0	5.1	10.4	8.3	19.4	13.8	8.1	8.8	4.4	13.5	3.2	15.7	8.9	10.3	7.4	16.3	11.6	12.3	5.5	10.2	5.5	5.3	4.8	3.4	7.6	5.0	4.6	3.4	33.0	4.1	13.7	4.3	4.6	8.8	12.0	12.4	26.7	11.6	13.5	12.8	24.5	14.5	15.3	18.2	14.2	15.5	45.6	12.8	30.0	22.2	24.6	0.0	36.0	0.0	23.3	16.7	44.2	21.5	14.0	21.5	11.2	18.4	20.9	4.3	32.9	44.3	7.9	26.7	1.0	34.7	13.3	32.8	7.3	13.9	34.6	24.6	1.7	13.1	18.8	28.4	8.8	9.7	17.9	15.9	23.5	15.2	21.1	21.9	0.0	67.4	0.0	5.1	5.3	44.3	0.0	107.7	31.6	4.3	16.5	22.1	28.4	38.7	20.4	6.8	15.1	43.0	74.1	15.2	10.9	23.7	26.3	18.3	19.0	8.4	15.4	19.7	0.0	9.2	21.2	7.6	8.5	54.6
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937007-32001038	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	12.3	11.8	6.3	18.8	6.3	45.4	15.0	11.1	8.5	11.6	6.8	14.9	16.0	15.2	12.0	14.0	11.0	12.0	10.3	5.4	5.8	16.4	18.1	12.6	33.0	5.4	5.9	11.4	11.5	19.8	6.6	18.7	5.6	13.3	16.4	26.5	10.5	12.2	8.1	13.0	15.3	14.7	5.2	18.4	15.2	27.4	6.1	38.5	18.3	11.0	30.0	15.6	9.0	7.1	46.5	40.4	37.2	42.9	21.1	26.8	38.2	44.2	38.8	53.0	63.7	30.9	25.5	100.7	33.2	27.7	45.4	40.1	56.0	25.5	85.7	35.8	54.0	69.9	32.9	22.3	24.8	111.5	68.7	18.7	28.1	53.1	40.4	32.1	33.1	47.3	68.8	135.6	46.2	16.2	133.3	64.4	21.3	32.4	24.4	78.5	95.3	81.9	31.1	44.6	47.5	37.1	71.3	22.7	43.3	25.8	66.0	91.5	24.7	41.9	38.0	50.8	69.3	73.5	98.4	122.5	30.7	67.4	38.7	0.6	0.7	1.6	1.4	1.1	1.1	2.4	1.6	1.6	0.6	1.8	1.5	2.1	1.6	1.8	0.7	1.9	1.8	0.4	6.3	6.3	11.1	8.5	5.4	5.8	5.4	5.9	5.6	5.2	6.1	7.1	44.5	41.7	45.8	43.1	50.1	58.5	50.2	21.8	31.9	77.6	54.2	36.8	32.3	27.1	32.6	35.0	108.4	61.5	65.2	24.0	17.6	28.3	16.2	52.8	55.8	45.1	29.4	93.6	71.6	21.9	53.1	35.1	31.1	54.2	15.8	41.4	38.2	42.3	32.9	62.2	69.5	31.8	10.2	42.1	58.2	13.9	26.8	47.3	24.9	45.0	73.1	45.7	38.1	75.4	71.3	27.8	15.4	25.6	66.2	62.8	21.5	26.6	29.6	80.9	13.1	47.2	38.4	121.7	128.9	48.6	71.7	69.5	52.5	52.8	35.6	66.7
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083383-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 55.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 85.0;Inhibitory neurons: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	15	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"Karpas-707: 9.1;SCLC-21H: 3.7;SH-SY5Y: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.0	1.2	4.7	0.2	31.4	0.1	0.2	11.1	32.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.0	55.7	0.0	0.0	0.0	0.0	26.1	39.5	0.5	0.1	0.0	0.4	0.0	42.2	0.1	0.1	4.3	0.3	0.2	0.0	0.0	0.2	0.2	9.1	0.0	0.5	0.1	20.2	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	8.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	31.4	11.1	32.0	0.0	55.7	26.1	39.5	42.2	9.1	20.2	10.2	0.5	0.0	0.0	5.5	0.1	0.0	0.7	0.4	0.0	5.4	0.7	0.1	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	2.5	0.6	0.4	19.8	0.0	85.0	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.7	0.0	0.1	0.0	82.6	0.6	2.0	0.6	0.3	0.8	0.0	0.2	3.6	2.8	0.0	1.0	0.0	3.0	3.1	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.1	5.6	0.0	0.2	0.4	0.2	0.7	0.0	0.1	0.0	0.2	0.8	0.2	1.5
SVBP	"CCDC23, MGC45441"	ENSG00000177868	"Small vasohibin binding protein"	Q8N300	1	42807052-42817397	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.0;Erythroid cells: 135.4;Spermatocytes: 158.0;Spermatogonia: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008507	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"	"Secreted to blood"	Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA008507: AB_2072066"	"prognostic favorable (6.33e-4)"	"unprognostic (2.68e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	34.7	15.1	36.4	13.7	37.7	43.1	29.9	39.1	49.9	30.9	33.6	29.3	11.6	24.9	26.2	17.7	27.2	15.2	24.7	37.1	38.4	25.6	19.1	17.4	23.0	38.2	37.3	36.3	12.1	22.1	30.6	20.6	37.5	20.3	15.7	22.6	15.9	15.4	28.0	17.7	19.9	19.2	38.2	22.1	19.0	52.9	37.1	48.3	19.0	23.5	23.5	23.9	24.8	40.3	25.9	12.9	75.2	26.9	30.9	48.3	37.2	21.5	18.1	28.8	29.7	22.8	20.2	29.1	23.5	28.6	22.6	18.3	14.3	23.7	35.2	53.6	23.7	54.5	12.1	43.9	25.6	41.3	35.2	31.2	37.4	16.2	15.4	29.7	29.1	56.0	46.2	14.3	35.3	12.0	41.5	50.8	40.8	23.7	14.5	30.9	55.8	19.2	29.9	25.3	45.5	40.4	26.8	14.9	31.7	76.9	11.3	120.1	22.7	25.4	28.1	19.6	35.6	14.9	19.1	20.7	16.1	27.5	24.4	60.5	40.2	76.5	26.8	40.8	23.5	56.4	46.5	32.3	39.2	59.8	42.8	37.2	70.3	37.3	43.8	33.0	115.7	24.7	36.4	37.7	39.1	49.9	37.1	38.4	38.2	37.3	37.5	38.2	37.1	40.3	46.2	9.6	6.3	0.0	25.0	0.0	33.0	0.0	23.9	6.2	33.1	53.1	0.0	28.6	9.3	20.2	2.1	53.8	20.0	19.5	54.8	51.7	149.0	32.2	34.6	32.3	18.2	135.4	0.0	24.5	66.0	36.6	14.3	18.2	11.4	22.8	42.8	45.6	70.4	6.7	0.0	19.6	0.0	51.8	0.0	61.6	42.9	48.4	0.0	0.0	70.2	33.1	29.9	0.0	0.0	43.1	21.7	53.8	16.9	21.9	20.5	43.2	7.3	15.5	59.2	28.1	28.4	158.0	153.8	21.4	0.0	61.6	21.4	24.1	23.6	31.1
SWI5	"bA395P17.9, C9orf119, SAE3"	ENSG00000175854	"SWI5 homologous recombination repair protein"		9	128275379-128316123	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"testis: 142.5"	"Group enriched"	"Detected in all"	9	"Early spermatids: 1180.8;Late spermatids: 1131.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052032	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA052032: AB_2681702"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.38e-2)"	27.5	26.5	29.0	11.2	31.3	11.0	28.2	31.3	40.8	39.2	32.7	23.5	15.9	27.5	68.8	33.3	31.7	17.8	34.9	28.7	31.9	36.4	42.3	20.6	12.5	30.4	30.8	40.8	21.2	71.4	54.5	17.6	30.4	32.8	12.7	21.1	25.6	37.1	25.2	26.0	18.6	20.3	29.7	18.0	23.0	142.5	30.4	17.1	44.0	25.6	17.7	26.4	31.5	31.6	29.2	51.4	29.7	34.8	79.2	71.8	33.7	50.6	66.7	64.2	42.6	66.6	33.5	27.7	65.7	82.6	39.5	47.8	48.1	67.5	42.6	41.4	35.7	21.0	97.5	52.9	101.9	13.6	18.6	60.8	31.7	107.4	57.8	55.9	62.5	96.8	50.5	42.8	66.5	119.9	29.6	19.6	20.3	67.8	105.3	27.1	41.0	44.4	43.6	15.2	34.0	18.9	63.0	39.8	63.0	32.9	66.2	14.5	39.0	46.4	38.0	90.9	43.3	45.6	75.0	37.0	61.8	20.9	50.7	54.3	14.2	25.8	14.5	8.7	17.0	17.6	14.1	14.4	14.7	20.2	16.7	21.6	9.0	22.2	9.1	21.4	15.6	15.3	29.0	31.3	31.3	40.8	28.7	31.9	30.4	30.8	30.4	29.7	30.4	31.6	33.8	6.4	17.4	5.2	18.0	24.5	35.1	54.0	31.3	13.7	33.6	38.9	36.2	31.5	33.5	36.8	12.5	65.7	13.7	15.7	66.5	25.5	1180.8	30.7	29.1	31.3	25.6	17.2	2.9	38.5	41.1	40.7	19.9	30.7	9.5	27.9	35.7	82.4	33.2	1.7	3.3	27.5	28.5	20.8	13.0	1131.1	43.2	31.5	37.4	2.8	23.8	50.7	20.6	4.5	7.8	29.8	27.1	31.6	17.9	34.9	68.4	84.1	29.5	21.1	32.9	25.7	31.3	93.7	44.3	33.5	21.9	117.0	18.6	32.8	23.4	36.6
SWSAP1	"C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1"	ENSG00000173928	"SWIM-type zinc finger 7 associated protein 1"	Q6NVH7	19	11374666-11376951	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052712	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 64: Macrophages - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA052712: AB_2681925"	"unprognostic (6.45e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.40e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-3)"	2.4	3.6	1.6	3.9	1.5	5.1	4.0	3.9	2.0	3.7	2.5	4.4	4.5	2.9	3.6	3.6	4.8	3.9	3.1	1.6	1.2	3.7	5.3	3.6	7.1	1.6	1.4	5.3	4.5	2.6	2.0	4.1	1.8	4.0	3.2	0.7	5.1	4.4	3.6	5.0	3.7	2.2	1.3	6.5	4.6	3.6	1.5	4.2	5.0	3.0	4.2	3.4	1.6	2.4	8.1	6.8	3.6	2.2	3.6	3.0	5.3	2.0	2.2	4.6	4.2	7.1	5.5	14.9	10.0	1.9	3.2	5.7	3.4	8.6	0.5	4.8	8.5	6.9	3.0	10.3	3.3	11.3	12.0	4.7	7.4	2.6	1.7	2.7	5.5	6.9	8.4	6.4	2.5	17.6	6.6	15.0	9.0	6.0	9.0	5.5	1.7	16.2	8.6	5.5	7.4	5.5	2.6	8.7	5.5	1.9	11.9	12.9	5.7	3.8	2.7	5.4	4.0	9.5	14.8	10.6	2.1	13.2	3.0	3.2	31.4	7.9	12.5	30.5	12.1	20.9	13.1	13.6	24.3	19.4	16.1	13.9	20.2	16.7	29.5	15.3	13.8	12.3	1.6	1.5	3.9	2.0	1.6	1.2	1.6	1.4	1.8	1.3	1.5	2.4	4.9	3.2	2.0	2.3	10.3	2.7	8.5	16.7	4.0	7.2	9.8	9.3	3.2	2.8	10.6	16.5	8.4	17.8	11.3	10.5	41.1	7.1	10.8	4.5	3.7	6.7	2.4	7.0	1.1	10.7	10.5	4.0	3.1	4.1	1.3	3.7	6.8	13.5	12.1	10.1	1.0	14.2	22.4	9.8	5.4	1.9	11.8	6.5	7.2	0.0	9.6	8.8	19.6	0.0	2.7	6.1	12.2	7.9	3.4	5.6	11.2	17.2	14.6	10.2	6.6	3.2	6.3	10.7	15.0	4.1	3.1	31.7	8.8	13.7	8.9	5.5
SYAP1	"FLJ14495, PRO3113"	ENSG00000169895	"Synapse associated protein 1"	Q96A49	X	16719612-16765340	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000175, HPA000882, HPA048047"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		13000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-3)"	15.3	25.1	5.8	11.2	6.5	25.5	12.4	7.1	7.8	13.1	11.8	14.6	17.4	9.2	8.7	11.3	11.1	13.2	9.5	6.8	7.4	16.0	29.4	9.1	10.3	7.1	6.7	10.9	11.8	15.5	7.6	8.7	7.0	12.8	13.0	7.8	10.7	8.0	12.6	10.3	15.6	9.9	6.6	7.1	13.2	6.4	7.7	7.9	11.5	7.6	10.7	10.8	8.3	8.8	29.2	24.1	17.0	32.0	22.6	25.6	7.8	22.7	16.2	18.6	18.4	22.8	23.5	22.6	32.4	22.3	37.9	16.9	21.0	29.7	24.7	14.8	41.9	9.0	25.4	21.9	16.2	15.5	13.4	17.6	13.7	32.2	27.1	21.5	26.0	6.9	19.8	12.2	25.4	34.2	8.4	16.6	19.9	16.1	26.3	9.1	21.5	22.8	27.8	18.9	17.3	21.3	42.2	29.7	23.1	22.0	39.5	13.8	20.6	23.7	12.5	48.7	18.6	13.4	12.2	26.1	23.3	7.7	19.8	7.4	7.2	9.3	9.9	7.9	8.1	9.0	8.4	9.2	7.8	7.0	8.3	8.7	12.0	10.1	11.4	6.5	10.5	6.5	5.8	6.5	7.1	7.8	6.8	7.4	7.1	6.7	7.0	6.6	7.7	8.8	60.4	64.1	75.6	14.4	96.0	64.1	107.0	69.5	37.0	20.2	116.0	78.2	74.3	88.6	92.2	79.1	22.9	66.5	273.8	164.3	111.6	119.6	214.8	219.3	84.7	53.3	106.1	45.9	13.9	132.1	83.3	65.5	72.4	176.3	210.0	38.3	71.4	216.0	49.5	23.5	16.0	107.4	63.1	70.8	241.0	296.2	42.3	171.5	67.6	8.4	55.7	49.4	64.9	11.6	26.9	183.6	159.2	54.5	185.5	80.3	148.3	164.3	169.7	21.5	59.2	56.9	68.1	15.3	21.5	42.0	52.6	150.5	156.6	48.5	118.6	104.4
SYCE1	"bA108K14.6, C10orf94, CT76"	ENSG00000171772	"Synaptonemal complex central element protein 1"	Q8N0S2	10	133553901-133569835	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 70.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 141.2;Late spermatids: 112.6;Spermatocytes: 362.8;Spermatogonia: 170.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 18.5;U-2 OS: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040208	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040208: AB_10796450"	"unprognostic (5.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"		"unprognostic (1.85e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.75e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	1.9	1.6	8.5	0.6	8.5	0.0	1.4	9.1	11.6	1.3	2.0	0.9	0.1	0.9	0.3	0.7	1.2	1.2	0.7	9.0	6.3	1.2	4.0	0.4	0.2	6.6	5.4	2.0	3.8	0.0	1.2	9.4	6.4	1.7	0.4	2.3	0.2	0.4	0.9	0.5	0.5	0.6	3.7	0.9	0.6	70.9	6.7	0.2	1.4	1.7	0.5	0.4	0.4	8.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.5	0.0	0.0	0.1	0.1	0.5	0.3	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.1	15.5	0.2	0.4	0.2	0.3	0.4	0.0	0.1	0.0	0.0	0.5	0.1	0.9	0.6	0.8	0.2	0.6	0.2	0.3	0.3	0.3	0.8	0.0	0.0	0.8	0.6	0.7	0.4	8.5	8.5	9.1	11.6	9.0	6.3	6.6	5.4	6.4	3.7	6.7	8.1	0.7	0.0	1.5	0.7	0.3	1.0	1.2	0.0	0.0	2.7	1.0	2.4	0.3	1.5	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	141.2	1.2	3.2	1.3	0.0	0.0	29.8	1.1	0.2	5.6	0.5	0.6	0.0	0.0	0.0	7.8	0.7	10.1	19.1	0.0	0.0	0.3	0.9	112.6	5.3	0.9	0.0	0.0	0.0	0.3	0.0	7.1	0.8	0.4	0.3	3.8	0.1	0.6	0.0	0.5	1.5	2.1	26.3	0.5	0.9	362.8	170.9	0.0	1.0	0.3	0.5	7.0	0.0	0.6
SYCE2	CESC1	ENSG00000161860	"Synaptonemal complex central element protein 2"	Q6PIF2	19	12898786-12919293	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 26.7"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 214.8;Spermatogonia: 72.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"NK-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 11.6;JURKAT: 10.4;MOLT-4: 11.1;SiHa: 11.7;U-266/70: 12.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042080, HPA062919"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA042080: AB_10794411, HPA062919: AB_2684905"	"unprognostic (3.00e-1)"	"prognostic favorable (3.85e-5)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (8.39e-4)"	"unprognostic (1.79e-10)"	"unprognostic (7.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-5)"	0.6	0.5	0.4	0.4	0.7	3.2	0.6	1.4	0.9	0.8	0.2	0.8	0.3	0.5	0.5	0.7	0.9	0.3	0.5	0.4	0.2	0.8	1.7	0.5	1.1	0.6	0.5	1.2	0.6	0.1	0.8	0.4	0.7	1.1	0.2	1.4	0.6	0.1	0.4	1.2	0.6	0.1	0.2	0.8	0.7	26.7	0.5	1.8	0.7	0.0	0.7	0.8	0.7	1.6	5.9	1.1	3.0	1.8	0.3	0.8	3.2	1.4	0.6	0.8	0.9	0.2	0.8	4.5	11.6	0.8	1.0	1.2	1.0	0.3	0.9	1.7	0.7	1.3	2.7	0.6	0.1	3.0	4.0	0.8	0.2	0.3	0.6	1.4	0.2	10.4	1.1	1.3	0.5	2.4	11.1	2.0	1.9	0.2	3.3	3.3	1.4	1.1	0.5	0.9	2.1	1.4	11.7	0.6	0.7	0.8	2.3	3.2	0.8	0.8	1.5	4.3	0.4	12.1	1.7	5.1	1.0	4.0	5.5	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.2	0.0	0.4	0.7	1.4	0.9	0.4	0.2	0.6	0.5	0.7	0.2	0.5	1.6	0.3	0.0	0.0	4.9	0.6	1.3	0.3	0.9	0.0	0.7	0.4	0.6	0.1	0.0	0.2	0.0	0.0	1.3	0.1	0.1	0.0	0.2	34.3	0.4	0.2	0.5	0.0	0.0	1.7	0.4	1.9	0.3	0.0	0.5	0.0	1.8	0.0	0.2	1.0	0.0	1.7	0.0	0.0	0.6	0.8	23.5	3.1	0.3	0.0	0.0	0.0	0.5	0.0	1.5	2.7	0.1	0.1	1.2	0.1	0.3	0.1	0.2	0.2	0.2	26.3	0.4	0.4	214.8	72.2	0.0	0.4	0.3	0.2	0.1	0.3	0.2
SYCE3	C22orf41	ENSG00000217442	"Synaptonemal complex central element protein 3"	A1L190	22	50551112-50562919	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"testis: 142.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 497.2;Late spermatids: 99.0;Spermatocytes: 508.0;Spermatogonia: 182.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.0;Karpas-707: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047813			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA047813: AB_2797234"	"unprognostic (2.55e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.68e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.20e-2)"	0.4	1.1	1.7	0.5	1.7	0.3	1.1	1.7	3.0	0.4	1.5	0.7	0.2	0.0	1.6	0.5	1.2	1.0	0.3	1.7	1.8	2.8	1.8	0.6	0.5	1.9	2.0	0.0	0.4	0.6	1.3	0.3	2.1	0.4	0.1	1.3	0.5	0.1	0.1	0.5	0.2	0.0	1.6	0.2	0.4	142.1	1.8	0.8	1.7	0.0	0.3	0.5	0.2	1.8	0.2	0.4	0.1	0.1	0.3	0.3	0.2	0.3	0.0	0.1	0.0	0.0	5.0	0.2	1.7	0.0	1.0	0.0	0.5	0.5	0.0	0.0	0.2	0.0	0.4	0.0	2.1	0.0	0.9	1.3	1.1	0.2	0.8	0.2	0.0	1.0	0.0	4.1	0.2	1.8	0.0	0.0	0.2	2.1	0.0	0.0	0.0	2.3	0.6	1.5	0.4	1.3	0.0	1.2	0.9	0.2	1.2	1.0	0.0	0.4	0.4	0.0	0.0	1.0	0.2	0.7	0.5	0.1	0.1	0.0	0.7	0.8	0.0	0.6	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.1	4.3	0.0	0.5	0.0	0.0	0.1	1.7	1.7	1.7	3.0	1.7	1.8	1.9	2.0	2.1	1.6	1.8	1.8	0.3	0.0	0.0	0.0	0.1	0.1	0.4	3.7	2.8	0.8	5.6	5.6	0.5	2.8	2.1	1.8	0.0	5.9	0.1	0.4	3.9	1.7	497.2	2.7	0.4	0.7	0.0	0.0	0.1	0.6	3.2	0.2	0.0	2.0	0.0	0.0	0.7	3.2	1.7	0.0	0.1	0.1	4.1	1.2	0.0	99.0	10.8	0.8	0.0	0.0	2.9	1.2	0.0	0.0	0.2	0.9	0.1	7.2	0.0	0.6	0.4	7.6	4.7	0.8	46.0	0.0	0.7	508.0	182.4	0.8	0.1	3.7	0.1	0.0	0.2	0.8
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863564-59933655	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.2"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 468.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 25.9;JURKAT: 47.2;MOLT-4: 54.4;SiHa: 92.2;T-47d: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA062401: AB_2684752, HPA065613: AB_2685519"	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	3.2	0.8	2.2	1.4	2.8	2.4	13.9	9.7	4.9	2.4	0.0	1.3	1.6	1.6	1.2	0.9	1.3	2.4	2.5	2.2	1.1	4.3	1.1	2.2	2.6	1.8	1.8	0.7	6.6	0.7	1.9	3.9	2.2	3.8	1.1	1.5	4.4	1.0	1.3	2.7	2.4	0.7	1.4	3.1	6.1	43.2	2.5	1.3	2.4	1.0	1.7	1.8	1.5	4.1	0.3	1.3	0.2	1.4	0.6	0.8	1.4	4.1	1.1	1.8	0.2	25.9	2.6	0.1	4.0	1.8	0.8	0.6	0.5	0.1	1.0	8.5	0.6	0.2	6.1	0.4	0.2	0.4	19.0	0.4	0.4	0.4	0.0	0.9	0.0	47.2	0.2	0.0	0.9	12.5	54.4	2.9	0.4	1.5	0.3	0.0	0.1	0.2	2.1	6.1	0.2	4.5	92.2	13.3	3.3	1.6	82.6	4.7	0.5	0.1	2.8	11.2	0.0	0.0	0.0	0.0	0.0	1.7	5.2	0.7	0.1	0.7	0.8	0.0	0.8	0.2	0.4	0.5	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.0	0.3	0.2	2.2	2.8	9.7	4.9	2.2	1.1	1.8	1.8	2.2	1.4	2.5	4.1	11.5	0.0	1.1	24.5	1.4	1.0	1.1	1.0	0.0	1.9	12.7	9.4	3.6	2.8	6.3	1.8	2.1	0.8	3.0	0.1	1.9	0.9	82.3	0.4	5.0	6.5	0.0	0.0	27.5	3.6	0.4	2.1	2.6	0.5	2.5	1.2	2.9	0.0	0.5	0.0	14.6	0.1	0.0	1.2	0.8	21.8	4.7	1.6	5.4	13.1	1.4	2.3	5.2	28.6	11.1	1.2	1.2	1.9	0.4	1.8	0.3	5.4	8.6	1.1	52.6	1.7	3.8	468.5	92.4	0.6	0.0	0.4	4.1	0.2	0.3	1.2
SYCP2L	"C6orf177, dJ62D2.1, NO145"	ENSG00000153157	"Synaptonemal complex protein 2 like"	Q5T4T6	6	10886831-10979320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"parathyroid gland: 68.7"	"Group enriched"	"Detected in many"	4	"Astrocytes: 21.5;dendritic cells: 9.5;Early spermatids: 17.1;Excitatory neurons: 28.5;granulocytes: 10.8;Inhibitory neurons: 23.1;Microglial cells: 13.1;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 12.4;Spermatogonia: 8.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"basophil: 1.7;eosinophil: 3.4;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	17	"dendritic cells: 4.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 13.4;HMC-1: 38.7;K-562: 10.7;NB-4: 15.3;SuSa: 8.1;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA034679			Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA034679: AB_10669729"	"unprognostic (3.25e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.57e-3)"	"unprognostic (4.23e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-2)"	0.6	0.3	0.6	0.6	0.9	0.7	0.5	0.8	1.4	0.5	0.0	0.3	0.1	0.4	2.6	0.2	0.4	0.5	1.2	0.8	0.2	1.1	0.1	1.7	0.5	0.2	0.1	0.8	1.7	68.7	0.4	1.1	0.2	0.6	0.2	0.7	0.3	0.2	0.2	0.5	0.3	0.2	0.0	0.6	0.3	3.2	0.3	0.1	1.2	0.9	0.3	0.3	0.3	1.2	0.0	1.0	1.9	0.1	0.1	0.0	5.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.5	0.2	0.2	0.1	6.4	0.0	0.0	0.0	0.0	13.4	38.7	0.0	1.0	0.0	0.0	0.3	0.0	0.4	10.7	0.1	0.0	0.1	3.4	15.3	0.7	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.7	3.5	0.0	3.5	0.0	8.1	0.1	11.4	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.1	1.7	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.6	0.9	0.8	1.4	0.8	0.2	0.2	0.1	0.2	0.0	0.3	1.2	1.1	0.0	1.3	21.5	0.3	0.1	0.0	0.2	0.0	2.1	0.3	0.0	0.4	0.0	0.1	0.0	0.0	2.9	9.5	0.0	0.0	0.2	17.1	0.1	0.4	1.4	0.0	2.1	28.5	0.2	2.0	2.9	0.0	0.4	10.8	1.5	0.0	0.0	0.5	3.3	23.1	0.0	0.0	0.0	0.5	3.2	1.2	1.0	0.0	13.1	1.0	0.6	0.0	14.1	12.4	0.6	0.0	1.5	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.6	0.3	3.1	8.7	0.0	0.0	1.4	0.6	0.1	0.0	0.1
SYDE1	"7h3, FLJ13511, SYD1"	ENSG00000105137	"Synapse defective Rho GTPase homolog 1"	Q6ZW31	19	15107401-15114985	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 140.3;Peritubular cells: 42.2;Sertoli cells: 85.5;Syncytiotrophoblasts: 134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013328	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA013328: AB_1848705"	"unprognostic (9.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.65e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (1.82e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.27e-4)"	23.3	12.6	7.8	5.7	8.0	0.0	17.6	7.4	7.8	27.6	15.7	28.6	3.8	32.9	4.6	6.6	23.2	5.7	20.8	6.9	7.2	16.3	4.9	18.1	3.5	9.7	8.0	23.5	6.0	2.5	6.7	15.4	7.9	18.2	2.5	1.4	6.1	11.5	5.4	8.6	11.7	10.8	7.8	12.9	13.5	4.7	8.5	0.9	12.4	3.8	1.4	23.9	18.8	7.3	11.2	17.4	9.0	23.9	19.9	18.2	7.1	46.9	33.7	44.4	37.5	4.1	7.0	0.0	30.3	46.5	15.2	7.0	7.0	8.1	24.6	0.3	8.0	1.6	34.2	7.6	37.7	0.1	0.1	32.1	5.9	26.6	12.0	26.8	8.2	0.0	0.0	0.1	33.6	5.9	0.0	0.0	14.7	0.3	17.3	0.0	22.4	0.2	11.1	1.8	0.3	17.8	25.9	15.9	31.6	8.7	1.9	1.2	17.5	107.3	32.8	49.6	50.4	0.1	0.3	0.2	29.3	0.1	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	8.0	7.4	7.8	6.9	7.2	9.7	8.0	7.9	7.8	8.5	7.3	18.6	3.2	1.1	3.6	0.2	2.4	0.8	1.2	1.8	0.3	0.9	3.2	4.1	1.5	0.8	1.8	0.0	7.6	0.0	0.0	0.0	4.7	10.0	0.7	13.6	15.2	0.0	0.0	0.0	0.4	140.3	16.2	0.0	0.5	0.0	12.8	20.0	0.3	3.4	1.7	0.0	0.0	0.0	1.0	2.7	19.3	29.5	0.6	14.2	6.5	0.0	20.0	0.0	1.0	0.2	1.7	0.0	42.2	0.0	0.5	0.0	6.1	0.1	0.8	85.5	10.7	30.8	3.1	0.6	0.3	2.6	134.5	0.4	7.5	0.0	0.2
SYMPK	"SPK, SYM"	ENSG00000125755	Symplekin	Q92797	19	45815410-45863194	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.6;Late spermatids: 146.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041756, HPA042449"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA041756: AB_10963544, HPA042449: AB_2678003"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.93e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.38e-2)"	18.0	17.3	15.5	29.3	17.0	27.4	18.0	12.5	19.8	24.1	11.9	22.5	22.2	25.3	20.1	19.7	23.5	18.0	17.5	14.9	14.1	19.1	21.4	20.6	34.8	18.9	15.6	23.6	19.1	20.7	32.6	25.0	17.1	23.8	14.1	15.7	24.7	16.4	38.5	25.3	22.8	16.1	11.4	28.5	22.9	41.0	16.6	30.0	24.0	18.9	22.8	20.7	19.9	22.7	57.7	101.0	40.4	29.9	39.0	46.8	67.7	44.5	32.0	45.8	51.0	45.8	51.1	101.6	30.2	51.0	25.7	46.2	55.1	49.9	40.0	79.4	62.2	58.7	68.9	47.5	43.7	64.9	65.6	36.1	29.2	49.3	55.4	31.2	47.6	52.6	79.3	64.4	39.4	54.8	61.0	70.3	34.0	50.0	23.9	64.6	46.4	62.6	31.8	102.7	46.0	57.7	55.1	35.5	36.7	40.3	48.4	89.4	53.5	37.1	58.5	28.8	66.9	84.1	173.1	81.5	42.4	42.8	61.8	1.7	3.0	1.5	2.0	2.5	1.9	2.9	1.8	3.2	2.8	4.8	1.5	1.4	3.4	2.7	5.0	5.8	1.4	2.1	15.5	17.0	12.5	19.8	14.9	14.1	18.9	15.6	17.1	11.4	16.6	22.7	14.7	0.0	7.7	34.9	30.2	20.9	18.7	15.6	18.2	21.6	17.4	15.4	7.0	22.8	12.0	25.8	35.5	35.5	20.9	32.7	54.8	21.6	141.6	24.9	29.9	23.4	36.3	26.5	24.6	17.5	34.5	17.5	41.8	27.7	12.7	35.1	26.0	31.8	18.2	21.9	27.1	38.7	10.2	27.0	25.6	146.4	19.3	24.4	14.2	19.7	47.3	11.3	32.0	29.1	28.4	20.4	25.5	21.1	19.8	21.5	30.8	14.9	15.6	27.4	19.7	17.4	20.4	35.3	34.1	14.4	21.3	57.3	21.2	21.9	38.6	20.6
SYN2	"SYNII, SYNIIa, SYNIIb"	ENSG00000157152	"Synapsin II"	Q92777	3	12004388-12192032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Schizophrenia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 96.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 338.3;Inhibitory neurons: 543.3;Oligodendrocyte precursor cells: 128.2"	"Cancer enhanced"	"Detected in many"		"glioma: 4.5"	"Group enriched"	"Detected in many"	5	"amygdala: 67.0;basal ganglia: 77.7;cerebral cortex: 96.8;hippocampal formation: 92.9;white matter: 44.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;HMC-1: 4.5;NTERA-2: 3.3;SCLC-21H: 2.7;SH-SY5Y: 11.1;SuSa: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037012, CAB079005"		Supported	Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB079005: , HPA037012: AB_2675431"	"unprognostic (1.62e-3)"	"unprognostic (1.60e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-4)"	"unprognostic (9.94e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.78e-2)"	7.0	3.1	67.0	0.4	77.7	0.1	7.1	3.8	96.8	1.4	0.0	2.3	0.4	2.0	1.0	0.3	1.2	0.4	1.0	92.9	2.9	1.5	0.0	1.1	0.0	13.4	0.0	1.5	0.5	4.1	3.4	2.8	10.8	0.5	0.5	7.8	2.4	0.2	0.9	2.5	1.6	1.8	0.0	0.6	1.8	3.6	15.3	0.1	0.2	0.4	0.0	0.3	1.3	44.9	0.0	0.2	0.0	0.0	1.8	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.1	0.2	0.0	0.0	0.0	0.0	0.2	2.7	11.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.0	77.7	3.8	96.8	92.9	2.9	13.4	0.0	10.8	0.0	15.3	44.9	43.4	0.0	0.0	7.8	0.0	0.0	0.4	0.0	0.6	13.9	0.4	2.4	1.4	0.0	0.0	0.0	6.2	1.7	0.1	0.0	0.0	0.0	0.6	0.2	0.1	4.5	0.0	0.0	338.3	0.0	0.4	0.9	0.0	0.3	0.0	0.2	0.7	0.0	0.6	13.5	543.3	0.0	0.0	1.8	0.0	1.8	0.0	0.3	0.0	4.7	0.1	2.5	0.0	128.2	8.3	0.3	0.0	0.0	0.0	0.3	0.0	2.7	0.0	3.7	0.0	0.7	0.7	4.9	6.9	0.0	0.0	0.8	0.1	0.1	0.0	0.2
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607779-85644063	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	60.5	43.2	25.1	80.2	28.0	67.3	55.6	28.1	24.8	51.4	26.0	54.1	48.0	46.1	41.7	75.8	34.0	47.8	45.6	22.8	29.9	53.1	66.7	49.4	88.1	28.9	27.4	36.2	51.9	56.9	19.5	68.5	31.0	44.9	62.7	36.0	41.4	46.5	55.9	43.5	44.0	62.1	27.7	51.3	50.0	38.7	27.6	91.0	87.3	56.0	101.9	81.5	40.8	29.0	209.5	147.5	239.9	157.1	150.8	165.3	162.8	258.6	218.1	244.4	239.9	250.4	132.6	480.0	200.0	262.8	203.1	197.4	331.1	269.0	405.4	175.9	163.9	405.4	152.8	165.2	130.3	497.6	177.7	141.8	179.6	276.4	272.1	138.4	254.9	133.2	451.5	210.0	295.1	243.5	255.2	218.9	231.5	209.4	153.2	364.7	345.5	209.9	236.2	307.1	239.5	184.6	188.5	180.8	128.6	137.2	150.8	360.9	247.4	165.8	142.7	189.8	374.2	138.0	260.5	275.4	165.4	328.7	251.4	1.8	24.7	8.8	30.6	36.2	30.0	21.9	27.1	27.5	37.7	21.2	23.4	27.7	3.0	36.1	41.1	29.0	31.6	24.6	25.1	28.0	28.1	24.8	22.8	29.9	28.9	27.4	31.0	27.7	27.6	29.0	106.9	115.4	119.5	26.4	73.0	148.2	160.9	124.4	83.6	44.5	89.0	82.8	88.9	52.9	126.7	46.0	16.7	101.3	97.2	50.4	54.8	120.7	117.6	105.1	156.2	100.7	56.7	65.6	24.0	99.6	133.3	101.8	79.5	152.1	61.4	81.6	57.5	81.4	96.9	62.2	24.3	78.0	79.3	71.1	67.1	28.7	73.7	92.9	53.4	31.9	90.7	45.1	57.7	32.2	40.9	130.0	45.7	64.3	97.4	133.0	47.7	80.7	84.6	42.2	19.7	158.6	131.8	93.7	65.8	142.4	141.6	118.1	81.6	85.8	106.7	159.8
SYNE1	"8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B"	ENSG00000131018	"Spectrin repeat containing nuclear envelope protein 1"	Q8NF91	6	152121684-152637801	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	Actin-binding	"Cancer-related genes, Disease variant, Emery-Dreifuss muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.5;choroid plexus: 182.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 550.1;Bipolar cells: 332.1;Excitatory neurons: 494.6;Inhibitory neurons: 482.6;Microglial cells: 315.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"eosinophil: 56.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 56.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 29.8;U-266/70: 29.1"	"Low region specificity"	"Detected in all"							HPA019113	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		72000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear membrane"		"HPA019113: AB_1857707"	"unprognostic (9.99e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	15.4	17.8	60.2	7.5	68.8	53.6	14.4	152.5	70.2	18.9	182.9	17.2	2.3	19.1	23.7	5.6	26.4	7.9	32.3	92.4	58.1	34.7	14.6	31.3	17.1	55.0	58.8	44.5	20.6	23.6	56.8	4.4	55.6	17.0	6.2	66.3	5.0	12.6	28.0	19.6	11.4	13.1	38.3	32.9	21.6	17.6	55.4	23.9	44.7	16.5	13.4	16.3	12.9	51.5	0.2	5.8	3.7	4.4	5.7	12.1	1.5	14.7	6.9	3.4	6.0	1.3	0.2	13.5	0.7	7.5	11.2	0.3	1.6	3.8	3.5	11.6	4.0	5.2	4.1	4.0	12.8	1.1	2.7	7.9	0.8	7.5	14.9	9.2	6.8	6.9	0.0	14.2	9.2	0.7	2.4	0.2	0.9	1.3	2.2	2.9	8.1	3.5	15.7	0.2	2.6	3.9	2.7	0.8	9.8	3.7	0.8	0.5	9.0	16.3	29.8	5.9	7.6	29.1	12.5	23.3	8.8	2.9	4.6	10.2	2.3	56.8	11.8	1.8	7.9	6.9	10.3	13.4	1.8	8.2	9.7	10.9	1.6	9.9	3.9	1.5	13.2	3.5	60.2	68.8	152.5	70.2	92.4	58.1	55.0	58.8	55.6	38.3	55.4	51.5	139.7	166.7	215.2	550.1	29.1	12.7	5.4	3.0	3.4	332.1	4.9	9.7	117.2	7.2	53.1	44.1	200.1	0.9	132.9	0.4	3.9	24.0	11.5	132.0	118.2	127.5	3.0	11.6	494.6	7.7	14.2	79.6	7.7	17.8	15.2	13.1	90.0	21.8	8.0	138.0	482.6	11.5	2.0	10.1	15.0	12.6	33.2	16.0	16.0	315.7	12.8	27.3	210.1	256.4	108.6	4.2	0.1	39.9	79.6	5.1	0.0	17.8	146.7	145.5	26.3	145.8	85.6	3.9	5.7	2.2	9.7	1.2	74.7	62.2	0.4	2.2
SYNGAP1	"KIAA1938, RASA5, SYNGAP"	ENSG00000197283	"Synaptic Ras GTPase activating protein 1"	Q96PV0	6	33419661-33453689	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Autism, Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 40.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 34.5;Horizontal cells: 38.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	135	"amygdala: 11.4;basal ganglia: 11.3;cerebral cortex: 21.0;hippocampal formation: 26.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.1;HMC-1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038373	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA038373: AB_10670779"	"unprognostic (3.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (9.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.47e-2)"	9.1	8.4	11.4	6.9	11.3	3.4	7.4	0.0	21.0	18.1	6.1	12.4	3.1	18.3	2.4	7.9	19.4	3.0	7.6	26.4	0.0	7.1	3.0	11.7	5.9	0.0	0.1	21.8	5.6	4.4	40.1	3.1	0.0	9.8	2.2	5.8	5.9	3.4	2.1	7.7	11.2	5.9	0.0	11.7	7.9	10.7	0.0	7.8	10.3	2.0	3.6	11.7	12.0	0.0	2.7	1.0	26.1	10.1	5.7	6.0	3.4	7.1	4.6	3.8	3.0	11.9	1.0	8.3	1.6	3.5	3.5	4.0	3.4	3.9	2.5	4.6	2.0	20.8	3.6	0.7	4.9	3.3	22.9	4.1	1.1	7.2	3.3	14.4	2.9	6.5	6.7	3.4	2.8	6.0	5.1	4.2	14.5	1.2	3.0	19.2	0.6	3.1	2.9	2.2	6.7	5.4	2.6	5.0	2.2	6.1	11.1	3.1	0.8	7.8	7.7	3.1	1.5	4.0	1.4	5.9	4.5	3.4	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	11.3	0.0	21.0	26.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.0	0.0	2.0	28.1	7.4	3.6	2.4	3.1	17.1	23.5	4.6	5.7	1.4	4.3	4.0	3.7	10.4	0.8	7.3	1.4	1.9	2.2	6.3	18.7	21.2	7.2	9.6	4.6	34.5	1.4	1.3	8.8	2.6	3.2	5.1	6.3	10.0	0.8	1.8	38.7	21.1	1.6	6.1	2.8	7.5	1.6	11.5	2.4	3.6	7.5	2.7	4.2	6.2	12.1	6.2	1.5	0.6	13.5	3.8	1.6	1.6	8.5	21.9	7.9	19.7	3.2	9.2	9.3	8.2	9.2	4.3	0.8	12.8	11.8	2.8	1.8
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728040	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.9;retina: 48.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.9;Inhibitory neurons: 91.5;Oligodendrocytes: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	7.6	6.9	15.0	5.3	22.8	23.8	6.5	1.1	45.9	6.2	3.5	5.6	4.0	5.1	5.1	4.6	5.0	5.2	6.4	22.1	9.8	7.4	5.7	8.0	6.3	19.5	5.6	4.8	4.8	8.4	13.8	9.8	14.8	4.5	5.4	48.4	4.7	3.7	7.7	5.1	6.3	4.9	0.0	7.9	5.0	10.2	8.7	7.1	7.3	6.4	4.8	5.5	5.4	25.9	5.5	2.9	5.0	5.7	8.9	7.1	10.3	11.3	6.2	6.8	5.7	6.1	2.6	2.0	3.8	6.9	8.9	5.0	8.9	6.8	8.4	6.8	8.1	13.8	8.7	3.5	4.8	5.6	11.7	4.1	4.9	12.0	6.1	5.8	10.8	7.3	10.6	11.6	9.0	5.5	5.5	5.1	3.4	6.4	6.0	6.1	11.1	7.4	7.5	4.3	5.6	4.5	14.0	8.4	5.6	6.9	7.8	7.2	11.2	10.0	5.3	8.2	6.4	6.0	7.8	4.4	8.0	10.7	8.7	3.4	2.9	6.9	1.2	5.2	2.0	0.1	1.9	2.0	2.5	0.3	2.2	2.2	9.1	0.5	4.7	1.4	2.6	1.1	15.0	22.8	1.1	45.9	22.1	9.8	19.5	5.6	14.8	0.0	8.7	25.9	10.2	6.4	5.4	22.9	3.9	4.8	1.9	3.1	8.0	24.8	3.8	2.5	10.0	2.8	4.0	1.8	45.9	17.7	7.0	4.8	5.9	2.0	19.9	2.4	4.7	11.9	3.0	5.0	110.9	1.3	9.8	5.3	4.1	3.6	3.8	2.2	11.0	4.2	10.1	10.1	91.5	2.0	0.0	18.6	5.7	11.3	2.8	15.7	1.8	31.9	6.5	21.8	4.1	49.3	61.0	2.8	5.3	4.5	8.6	2.7	6.2	6.5	4.6	45.4	6.6	6.1	5.8	22.1	13.3	6.7	3.3	38.0	9.9	2.8	5.4	4.3
SYT10		ENSG00000110975	"Synaptotagmin 10"	Q6XYQ8	12	33374238-33439819	"Predicted membrane proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.3;fallopian tube: 2.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.9;Distal tubular cells: 7.9;Excitatory neurons: 4.4;Inhibitory neurons: 15.4;Late spermatids: 16.2"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;K-562: 1.0;MCF7: 3.5;RT4: 1.3;SCLC-21H: 1.7"	"Region enhanced"	"Detected in all"		"olfactory bulb: 49.5"	"Low region specificity"	"Detected in all"			HPA055426			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA055426: AB_2682812"	"unprognostic (3.60e-1)"	"unprognostic (4.93e-2)"		"unprognostic (9.34e-4)"				"unprognostic (5.53e-2)"		"unprognostic (3.67e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.97e-6)"	"unprognostic (4.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.91e-1)"	0.0	0.3	0.9	0.1	1.9	0.0	0.0	0.0	0.9	0.5	0.4	0.8	0.2	0.0	0.1	0.0	2.2	0.0	0.0	0.6	5.1	0.8	0.3	0.0	0.0	4.1	1.7	0.0	0.0	0.0	0.5	0.0	4.3	0.4	0.4	0.1	0.0	0.7	0.0	0.0	0.3	0.1	2.4	0.0	0.4	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.3	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.0	0.9	0.6	5.1	4.1	1.7	4.3	2.4	6.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.5	0.0	2.5	0.0	0.0	0.1	0.0	0.0	7.9	0.0	1.5	1.8	0.3	0.1	0.0	0.0	4.4	0.0	0.0	0.3	0.0	1.0	0.0	0.8	1.4	0.0	0.0	0.0	15.4	0.2	0.0	0.0	0.0	16.2	0.3	0.0	0.0	1.0	0.0	0.6	0.0	0.5	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.7	0.2	0.0	0.0	0.3	0.2	3.7	0.0	0.0	0.1	0.0	3.2	0.1	0.1
SYT17	Syt-17	ENSG00000103528	"Synaptotagmin 17"	Q9BSW7	16	19167971-19268332	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;parathyroid gland: 25.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.8;Microglial cells: 51.5;Oligodendrocyte precursor cells: 114.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 6.2;memory B-cell: 7.8;naive B-cell: 19.0;non-classical monocyte: 20.1"	"Group enriched"	"Detected in many"	9	"B-cells: 19.0;monocytes: 20.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.2;CAPAN-2: 28.1;Daudi: 12.6;MCF7: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042059			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"		"HPA042059: AB_2677827"	"unprognostic (3.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.32e-2)"	"unprognostic (4.95e-3)"	4.8	4.8	20.8	1.4	25.7	0.3	4.3	13.4	24.4	3.1	20.2	2.6	4.2	1.0	2.7	4.4	2.2	1.0	1.7	25.8	23.3	5.9	17.4	7.8	3.3	17.8	28.6	0.6	3.0	25.3	18.8	3.8	17.7	9.2	2.8	1.7	1.6	3.3	0.3	10.0	1.9	0.8	15.8	1.3	5.9	0.4	28.2	0.6	6.8	0.6	4.7	3.4	2.6	16.0	0.1	10.4	0.1	0.1	0.3	0.7	14.2	0.0	0.0	0.1	0.0	0.4	28.1	12.6	3.4	0.0	3.8	5.0	0.7	0.4	0.0	0.0	2.1	0.0	10.9	0.2	0.0	0.0	0.1	0.9	2.5	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	21.8	0.0	0.1	1.2	8.3	5.7	0.0	1.2	1.0	3.5	6.2	2.1	1.2	4.0	11.0	0.5	6.7	10.9	2.8	0.0	0.0	7.1	0.1	0.0	2.0	0.0	11.4	0.0	0.1	0.0	0.4	0.7	0.0	0.0	6.2	0.0	7.8	0.0	0.0	2.2	19.0	0.0	0.0	0.1	0.0	20.1	0.2	0.0	0.9	20.8	25.7	13.4	24.4	25.8	23.3	17.8	28.6	17.7	15.8	28.2	16.0	0.7	6.4	9.3	90.8	8.6	3.8	12.0	3.8	7.4	1.8	7.6	4.1	1.6	2.8	7.5	22.0	0.0	6.4	0.0	4.3	27.4	4.9	0.2	2.3	0.6	2.9	21.6	5.3	18.6	0.6	15.3	2.3	2.0	2.5	0.0	0.1	3.9	23.2	4.0	1.7	20.9	10.0	34.6	4.0	4.0	0.1	1.5	3.6	12.4	51.5	6.2	12.0	0.0	114.1	1.7	3.6	9.0	0.7	0.0	6.0	0.4	0.6	5.8	0.5	0.0	6.7	1.6	0.3	3.9	3.6	9.7	4.0	0.2	0.1	4.3	8.2
SYTL2	"CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2"	ENSG00000137501	"Synaptotagmin like 2"	Q9HCH5	11	85694224-85811159	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 74.2;stomach 1: 127.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 382.2;granulocytes: 130.8;Intestinal goblet cells: 185.9;Respiratory ciliated cells: 138.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.0;MAIT T-cell: 23.7"	"Lineage enriched"	"Detected in many"	5	"T-cells: 23.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 91.1;OE19: 148.1;RH-30: 175.8;RPTEC TERT1: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039651	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane"	"HPA039651: AB_10795153"	"unprognostic (8.07e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (9.34e-4)"	"unprognostic (6.60e-3)"	"unprognostic (2.19e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (9.07e-4)"	16.7	9.6	19.3	12.9	24.6	3.3	16.0	8.7	35.7	10.7	11.9	51.7	21.6	9.1	16.3	17.0	7.6	27.8	8.4	29.0	25.1	20.2	6.9	14.8	11.1	26.4	14.0	4.8	2.7	6.4	6.1	18.2	17.9	13.6	74.2	13.3	8.9	9.8	5.1	6.8	25.0	10.2	15.6	10.4	127.7	5.1	13.8	7.1	4.7	2.7	6.8	50.9	7.4	29.1	3.5	8.0	12.2	1.0	2.8	15.4	0.2	30.3	39.4	26.3	59.2	34.7	4.5	0.7	11.1	21.3	38.0	22.3	0.8	2.7	34.5	2.4	0.2	0.0	0.2	0.3	1.8	2.7	0.5	19.6	3.8	56.8	0.8	6.2	0.2	1.0	0.4	0.4	33.6	91.1	0.1	0.9	20.6	148.1	13.6	1.3	175.8	0.1	124.2	46.8	0.3	0.6	6.7	5.4	3.0	10.2	0.6	0.5	0.1	40.8	15.6	25.9	1.5	0.2	0.0	16.1	41.9	0.5	25.7	0.0	0.0	0.0	14.0	0.0	23.7	0.0	2.8	8.4	0.0	0.1	2.3	4.1	0.0	4.6	0.1	1.0	1.1	2.6	19.3	24.6	8.7	35.7	29.0	25.1	26.4	14.0	17.9	15.6	13.8	29.1	7.5	22.4	32.5	15.3	3.0	3.6	11.7	15.8	1.8	10.4	45.4	14.0	2.3	8.6	62.1	68.0	8.4	0.7	45.6	115.2	0.0	9.1	1.2	8.0	2.2	6.4	19.2	4.0	103.9	16.9	0.4	11.5	382.2	2.3	130.8	0.8	5.0	0.5	0.5	1.7	23.2	185.9	2.0	5.9	5.0	0.9	1.8	4.6	10.6	20.6	1.6	14.0	63.8	35.7	91.9	16.5	40.6	30.1	31.6	30.7	16.3	8.6	138.4	8.1	32.9	42.1	59.8	3.6	2.6	2.2	5.7	0.4	50.1	2.3	36.7	60.9
SYTL5		ENSG00000147041	"Synaptotagmin like 5"	Q8TDW5	X	38006553-38128819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;stomach 1: 12.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 37.2;Inhibitory neurons: 92.0;Intestinal goblet cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.2;MCF7: 5.8;OE19: 8.4;SK-MEL-30: 14.8;SuSa: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026074	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Microtubules, Cytosol"	"HPA026074: AB_1857697"	"unprognostic (3.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	0.0	8.2	6.5	0.3	7.2	0.0	2.5	0.0	5.6	5.6	0.1	2.8	2.2	2.2	0.8	3.1	0.4	0.5	1.1	6.7	10.7	1.2	4.4	0.6	0.0	3.4	13.6	0.1	5.8	0.0	0.6	7.4	6.3	0.9	3.2	0.5	2.2	0.4	0.0	0.1	2.4	3.3	2.5	0.0	12.1	0.6	8.6	0.0	0.1	0.0	0.0	0.9	0.8	0.9	0.0	1.2	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	6.2	1.4	0.0	0.0	0.5	2.2	0.7	0.0	0.0	0.0	0.0	0.6	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.7	0.1	0.0	0.1	0.2	0.2	5.8	0.0	0.0	2.5	8.4	0.0	0.0	2.0	0.0	0.0	0.4	3.2	0.0	0.3	1.2	14.8	19.5	0.0	0.0	0.0	0.1	4.7	0.0	3.3	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	7.2	0.0	5.6	6.7	10.7	3.4	13.6	6.3	2.5	8.6	0.9	0.0	0.0	2.0	1.6	0.0	0.0	0.2	0.8	0.0	0.0	4.0	1.5	0.3	0.0	8.7	0.0	0.0	3.3	0.0	4.6	0.0	0.0	0.0	0.7	3.6	0.1	3.0	0.0	1.4	0.9	3.6	0.6	37.2	4.0	0.0	1.0	0.4	1.3	0.3	0.0	92.0	20.8	6.1	0.0	0.0	0.0	0.6	0.2	0.0	1.0	0.2	0.0	0.0	0.0	1.1	4.9	3.0	2.6	0.3	0.6	0.6	0.1	3.3	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	8.9	0.1	0.0	0.7	1.0
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134532	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 72.9;Plasma cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 205.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	29.2	40.3	19.3	37.1	25.6	31.0	27.6	23.2	21.4	30.7	26.7	29.2	26.1	29.1	38.8	28.4	30.6	19.7	25.3	18.6	21.2	24.5	117.5	27.0	60.9	27.9	25.6	30.9	90.9	35.0	38.2	26.2	24.6	28.5	29.0	18.7	55.9	30.3	34.2	29.3	39.4	25.9	22.8	51.2	39.4	24.3	23.4	18.3	43.4	19.0	81.1	25.8	24.8	25.9	32.4	40.6	24.0	32.5	59.8	33.8	23.8	32.8	33.5	40.9	28.8	22.2	55.0	181.0	43.8	42.4	53.8	48.8	26.4	33.3	33.6	28.4	20.0	28.6	46.8	50.2	72.3	43.3	49.6	43.3	59.0	36.1	81.0	36.4	27.0	19.0	36.4	90.1	24.3	47.9	19.1	31.2	26.1	33.6	28.0	31.9	20.3	74.0	25.7	31.5	15.6	32.0	30.4	74.1	53.3	21.0	55.4	28.2	25.9	28.3	18.6	51.2	22.4	178.1	134.2	205.9	38.1	21.8	32.3	16.8	7.4	14.0	7.4	4.7	6.5	21.9	5.2	6.9	4.4	22.6	3.7	3.9	7.0	3.5	4.7	18.4	5.3	6.6	19.3	25.6	23.2	21.4	18.6	21.2	27.9	25.6	24.6	22.8	23.4	25.9	11.5	16.0	21.4	11.1	43.5	17.6	6.9	13.8	12.0	10.7	21.0	15.5	4.0	22.8	20.8	11.0	33.3	14.5	16.4	23.1	1.9	13.6	6.6	14.2	16.2	11.3	8.4	13.2	9.6	18.9	16.5	14.2	17.9	22.1	1.3	10.1	15.0	72.9	15.1	13.5	9.5	33.6	16.2	15.3	13.2	4.1	20.5	10.8	12.4	9.4	10.5	11.0	13.4	13.0	15.8	18.2	11.7	13.2	90.5	14.9	14.0	7.7	15.1	18.7	13.1	11.9	10.7	19.3	13.2	9.7	16.1	42.8	11.7	13.6	18.6	13.8
SZRD1	"C1orf144, DKFZp566C0424"	ENSG00000055070	"SUZ RNA binding domain containing 1"	Q7Z422	1	16352575-16398145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024221	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA024221: AB_10603450"	"unprognostic (3.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.98e-6)"	"unprognostic (2.53e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.60e-2)"	52.1	57.4	43.1	50.1	47.1	82.5	45.9	43.9	41.6	48.0	40.2	58.0	44.0	68.9	25.7	66.0	50.3	41.2	65.1	38.5	41.1	48.7	48.6	48.1	56.9	51.4	45.7	59.3	36.7	69.4	28.9	46.3	45.3	46.1	38.5	20.0	38.8	41.0	120.7	48.4	50.3	58.3	44.6	51.7	49.8	22.8	50.0	56.9	44.1	68.8	51.1	59.9	43.0	43.5	126.2	94.6	127.5	89.7	106.1	121.8	42.3	126.4	161.4	145.2	112.6	95.2	108.8	109.9	137.9	168.5	80.1	68.3	115.1	140.0	106.6	189.7	100.1	126.4	96.6	75.9	96.0	124.6	118.9	123.7	113.0	160.0	105.7	102.2	128.0	93.5	115.3	100.3	134.8	121.7	122.2	93.1	90.2	92.0	106.6	123.5	135.8	129.8	98.8	57.8	101.0	105.0	111.0	70.6	161.6	52.4	73.3	80.4	145.2	98.8	116.1	156.8	127.0	55.0	65.2	131.1	111.3	166.3	135.1	37.0	46.4	68.2	44.1	65.2	43.9	58.2	37.7	41.6	36.9	67.4	34.5	37.3	51.2	41.2	78.1	28.4	52.2	65.3	43.1	47.1	43.9	41.6	38.5	41.1	51.4	45.7	45.3	44.6	50.0	43.5	42.5	19.2	23.6	7.5	48.2	45.6	51.6	47.6	39.3	21.4	41.5	32.9	44.3	52.9	28.5	40.5	2.1	56.2	49.4	74.0	70.5	64.4	21.5	31.5	44.5	45.2	47.8	27.8	7.0	53.4	79.8	42.1	31.1	53.5	36.8	31.9	35.7	55.0	72.9	43.7	7.0	47.7	46.8	48.9	45.9	55.4	36.1	47.9	44.4	10.3	78.8	30.4	77.2	7.5	12.0	68.1	47.8	35.7	35.6	63.9	62.5	50.4	18.4	18.5	39.5	31.3	56.3	28.1	20.3	43.9	58.4	84.0	44.5	39.1	49.8	68.3
SZT2	"C1orf84, FLJ10387, FLJ34502, KIAA0467, RP11-506B15.1, SZT2A, SZT2B"	ENSG00000198198	"SZT2 subunit of KICSTOR complex"	Q5T011	1	43389882-43454247	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029012	Approved		Approved	"Nucleoplasm,Vesicles,Actin filaments"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles, Actin filaments"		"HPA029012: AB_10600817"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.14e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.47e-7)"	"prognostic unfavorable (2.53e-4)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.84e-3)"	"unprognostic (8.28e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.61e-2)"	6.3	5.3	1.3	4.3	2.5	6.0	6.2	3.2	3.1	6.1	0.8	6.7	3.4	7.2	2.6	5.9	7.0	2.7	5.4	1.1	2.1	4.7	4.4	6.4	4.2	2.9	2.3	8.0	6.5	5.6	8.8	2.7	2.5	6.5	3.4	4.0	6.5	3.2	6.6	7.7	7.9	3.6	0.9	7.1	6.4	9.6	3.0	4.4	9.0	3.9	4.1	6.2	5.8	5.0	4.5	4.4	3.7	3.4	9.1	4.5	5.7	3.7	4.4	4.5	4.1	1.5	5.0	4.1	4.1	5.9	3.2	5.1	3.7	6.3	3.9	5.1	3.4	7.5	8.1	2.7	3.4	6.1	6.2	4.8	4.2	7.7	7.5	5.0	5.2	4.7	3.4	6.8	3.2	2.1	4.1	1.6	3.3	2.7	4.5	4.5	5.1	4.9	2.6	6.2	3.8	3.4	7.8	5.9	4.0	4.8	3.2	8.8	6.5	4.8	6.8	6.4	6.5	7.3	2.8	3.4	4.9	3.8	3.1	1.4	0.5	1.4	0.3	0.4	0.8	0.3	0.1	0.1	0.4	0.3	0.4	0.3	1.1	0.3	0.5	0.9	0.4	0.2	1.3	2.5	3.2	3.1	1.1	2.1	2.9	2.3	2.5	0.9	3.0	5.0	8.3	25.6	19.3	19.6	10.5	1.9	3.5	5.1	6.2	16.8	7.7	7.0	4.8	5.7	6.8	5.5	62.6	6.5	9.2	10.0	0.0	6.1	14.2	5.8	10.1	7.6	3.6	5.5	20.4	6.4	5.2	7.0	13.7	6.9	14.5	19.0	12.8	13.1	5.4	13.5	20.2	7.0	4.1	7.0	3.1	15.8	9.3	9.4	5.4	15.9	11.6	5.8	13.4	11.1	29.1	6.8	3.7	6.0	9.5	4.2	10.5	9.2	8.0	22.2	19.7	9.1	7.1	8.1	8.6	4.2	1.8	5.5	11.4	12.6	7.0	3.8
TACC2	"AZU-1, ECTACC"	ENSG00000138162	"Transforming acidic coiled-coil containing protein 2"	O95359	10	121989163-122254545	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 251.7;skeletal muscle: 387.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 210.1;Syncytiotrophoblasts: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031020, HPA031021, HPA061394"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		32000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500"	"unprognostic (3.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (2.50e-10)"	"unprognostic (7.02e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (1.61e-1)"	22.1	15.3	18.2	5.3	18.6	0.2	20.9	23.6	22.7	32.3	28.6	91.5	15.3	26.1	9.2	64.2	32.9	12.9	251.7	19.1	18.8	33.9	18.8	68.7	1.0	16.0	16.9	8.8	25.3	36.4	58.7	21.6	14.8	67.7	20.7	7.2	60.7	13.5	387.1	103.3	35.7	22.0	11.8	4.2	49.1	5.8	16.9	5.7	50.7	159.0	5.7	62.4	49.1	17.7	17.8	55.1	26.5	15.2	7.4	7.4	31.7	7.7	20.7	10.5	7.3	22.7	28.9	0.0	7.0	12.3	12.1	58.1	8.5	20.9	10.9	3.0	4.4	0.0	7.7	43.8	11.5	0.0	0.3	3.4	86.0	5.6	36.6	8.6	22.2	0.1	4.5	0.6	10.4	23.5	0.2	9.9	15.7	27.6	24.8	0.3	15.2	8.5	28.9	26.9	17.6	14.2	12.7	52.0	29.5	7.6	10.2	0.4	20.6	4.7	3.5	11.8	14.5	2.4	11.7	0.3	8.7	0.1	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	18.6	23.6	22.7	19.1	18.8	16.0	16.9	14.8	11.8	16.9	17.7	15.5	83.3	94.1	16.3	0.7	33.6	49.7	54.3	33.0	21.6	23.4	14.1	210.1	8.6	70.7	36.8	0.0	53.3	0.4	75.2	1.9	8.2	2.4	88.4	11.0	21.3	30.0	0.0	32.8	14.2	4.4	21.2	38.7	62.8	7.0	0.1	6.1	18.9	6.5	43.7	48.2	38.8	57.0	0.3	4.3	2.6	6.8	1.9	7.2	7.5	0.1	1.1	0.0	80.9	7.6	19.4	47.1	7.5	0.2	49.6	36.5	13.5	84.9	2.7	13.1	27.2	23.7	0.5	8.2	79.5	54.0	228.5	2.6	2.8	41.9	80.5
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876264	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"	5.1	8.9	9.6	6.1	10.3	19.4	9.2	9.9	12.4	7.7	8.1	8.4	7.7	9.3	7.6	8.3	8.6	5.3	8.6	10.1	9.3	11.6	26.7	6.2	10.4	7.8	8.3	11.0	6.4	10.9	6.2	8.2	8.8	7.9	9.1	17.0	8.1	7.1	9.8	8.0	8.4	7.6	9.2	6.9	7.5	10.8	9.3	13.2	7.5	10.6	10.1	6.6	5.8	11.2	15.7	14.9	27.4	16.3	8.1	10.4	16.2	8.1	9.9	13.2	11.4	13.7	12.5	29.9	15.4	9.6	10.7	11.8	22.3	14.3	10.6	18.9	21.3	9.9	11.9	22.5	12.0	28.3	17.4	7.9	16.3	8.0	19.9	9.6	11.0	22.2	35.9	17.6	10.5	10.9	34.9	22.5	41.6	25.2	16.5	29.1	12.0	37.9	18.0	20.9	17.5	30.6	14.6	18.7	17.5	25.0	25.3	29.3	8.3	10.8	12.4	11.9	17.3	24.9	36.3	56.3	7.5	12.6	10.4	2.9	12.7	13.8	20.7	12.9	22.9	20.2	22.2	23.6	20.7	20.8	27.9	22.3	2.1	27.5	10.4	13.3	23.4	24.7	9.6	10.3	9.9	12.4	10.1	9.3	7.8	8.3	8.8	9.2	9.3	11.2	2.7	9.6	2.7	7.8	8.4	6.1	4.7	3.9	6.2	7.6	4.9	4.6	10.3	2.8	4.1	3.7	8.4	6.1	4.9	4.4	5.9	3.9	4.0	4.8	4.6	4.3	7.2	13.7	9.6	4.0	7.7	4.8	6.6	4.4	5.1	6.1	3.3	20.3	4.2	1.7	10.5	6.1	0.0	5.3	5.1	1.7	4.4	2.6	1.8	3.7	6.9	6.8	4.1	7.5	17.7	3.8	1.7	3.0	7.5	6.2	5.3	7.0	4.3	6.0	0.0	6.1	4.1	5.2	12.9	7.6	5.1	7.3	7.3	1.9	5.9	4.2
TADA3	"ADA3, FLJ20221, FLJ21329, hADA3, NGG1, TADA3L"	ENSG00000171148	"Transcriptional adaptor 3"	O75528	3	9779860-9793011	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042250	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA042250: AB_10794043"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.83e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (5.47e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-3)"	32.5	60.1	51.3	36.9	51.4	34.8	32.5	48.8	57.0	37.9	43.2	44.8	31.4	44.3	23.2	34.2	44.1	32.0	47.2	51.0	54.4	41.6	50.8	34.0	46.3	54.0	53.5	56.8	29.0	35.5	45.0	22.2	50.5	49.6	27.1	18.1	35.5	40.8	59.8	28.6	33.8	32.5	52.4	38.9	39.4	54.5	56.6	32.8	39.3	40.0	37.9	41.6	31.9	48.4	48.0	49.7	78.2	44.2	67.1	61.3	167.6	50.0	83.6	64.3	80.3	50.7	55.1	52.8	59.1	107.7	84.3	28.4	43.9	65.3	29.2	66.0	53.7	118.0	60.6	55.3	95.5	44.6	185.5	62.6	83.3	91.5	65.8	85.0	43.3	75.0	80.6	63.4	80.0	136.0	43.2	44.5	73.5	62.8	47.8	22.2	39.6	67.2	66.3	47.6	30.5	88.5	42.9	23.1	81.5	43.2	80.6	106.2	62.9	88.0	70.4	47.1	70.0	50.3	61.3	92.4	126.0	76.5	74.0	62.8	44.0	126.0	58.2	68.4	30.6	33.8	40.7	48.1	49.6	30.4	35.9	39.2	51.6	53.0	88.9	31.5	54.5	55.2	51.3	51.4	48.8	57.0	51.0	54.4	54.0	53.5	50.5	52.4	56.6	48.4	26.1	12.8	12.8	22.5	37.0	16.8	88.3	66.2	32.5	28.6	43.4	45.7	8.6	41.5	30.2	33.1	14.6	47.3	59.1	80.2	66.5	65.2	93.3	28.7	32.9	24.4	35.5	41.6	9.9	64.2	53.5	34.4	32.1	22.6	47.0	31.9	35.0	43.1	65.0	25.2	10.9	63.0	44.7	50.3	25.4	75.6	36.7	48.8	32.0	6.5	92.8	96.9	146.2	5.0	10.0	67.1	68.2	42.9	31.9	43.1	64.9	70.3	25.2	29.3	72.3	33.9	42.2	86.9	81.2	32.7	16.6	36.8	50.2	41.0	52.7	53.0
TAF1	"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250"	ENSG00000147133	"TATA-box binding protein associated factor 1"	P21675	X	71366264-71532374	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dystonia, Mental retardation, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001075, CAB016283"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB016283: AB_671202, HPA001075: AB_1080179"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (6.54e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.56e-2)"	10.9	8.6	10.3	11.4	12.7	12.8	12.3	13.7	11.1	11.1	10.2	10.0	6.6	13.8	12.9	7.5	11.1	7.8	7.0	9.3	14.1	7.5	7.8	9.1	14.1	11.5	11.3	14.4	9.8	12.2	8.4	10.0	10.9	10.0	10.0	27.3	7.7	10.1	10.5	13.3	9.3	10.9	8.2	15.4	10.6	7.2	12.5	14.8	12.7	10.3	12.4	9.2	8.6	16.8	18.6	15.9	18.2	12.4	14.6	23.2	11.0	13.3	12.1	13.7	11.1	12.3	11.3	17.6	11.5	14.9	12.3	17.5	24.1	11.0	17.0	11.2	21.9	20.1	22.1	13.1	11.1	39.7	19.4	14.1	11.3	14.2	27.2	12.8	14.7	13.2	28.2	41.1	14.4	14.5	22.4	25.4	20.9	23.5	20.8	19.8	35.8	21.6	11.1	25.0	9.0	14.5	37.7	13.6	18.7	14.3	9.6	22.9	18.6	16.5	14.2	13.4	9.7	17.5	17.4	21.4	9.0	33.2	12.5	1.6	1.4	0.7	1.4	0.9	1.3	1.0	1.4	1.4	1.5	1.5	1.6	1.8	1.8	1.5	1.6	1.4	1.0	0.7	10.3	12.7	13.7	11.1	9.3	14.1	11.5	11.3	10.9	8.2	12.5	16.8	26.7	32.1	26.7	44.7	21.2	11.9	8.9	10.4	18.2	37.5	12.5	13.3	17.2	10.0	23.9	3.7	81.3	8.6	21.5	7.8	1.9	6.3	2.5	17.0	23.4	24.6	11.4	28.6	54.3	7.0	5.9	17.6	12.2	18.9	23.4	23.9	18.9	12.6	8.8	16.8	52.2	14.6	6.1	16.2	20.0	2.6	22.1	20.4	5.4	47.8	23.9	17.0	29.9	49.3	79.1	7.6	13.3	22.2	18.7	11.2	13.4	5.2	14.8	67.9	0.0	27.4	18.0	9.3	10.7	17.8	17.3	5.7	23.8	25.9	13.6	9.6
TAF10	"TAF2A, TAF2H, TAFII30"	ENSG00000166337	"TATA-box binding protein associated factor 10"	Q12962	11	6606294-6612539	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 361.8;Late spermatids: 1039.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004148, CAB022405"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB022405: , HPA004148: AB_1857736"	"unprognostic (1.69e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.10e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.24e-3)"	"unprognostic (9.03e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.38e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.80e-3)"	78.9	140.7	147.5	53.3	150.3	93.0	69.2	149.2	204.1	59.3	142.6	66.2	44.3	63.6	97.5	103.1	61.7	28.3	130.0	147.7	156.2	100.9	151.6	76.7	56.8	157.1	153.2	50.0	152.8	53.2	96.2	31.0	155.9	79.8	54.1	30.8	69.6	42.9	107.5	61.2	68.1	38.7	147.7	125.4	100.1	190.7	149.9	82.0	74.6	50.0	76.3	72.1	58.3	150.9	82.4	138.2	88.7	77.7	140.6	135.1	67.5	61.4	134.6	98.9	98.6	102.0	145.0	45.4	77.2	111.4	137.4	68.6	66.0	99.7	97.3	92.2	95.3	64.2	95.6	122.2	227.7	85.4	98.9	157.8	125.1	77.5	163.0	168.0	110.6	139.5	67.0	80.7	157.4	159.5	122.2	78.5	62.6	130.9	107.6	72.2	46.8	78.5	163.5	108.1	62.2	84.4	82.9	95.0	107.6	129.8	67.1	100.6	64.6	67.2	78.9	97.6	87.9	94.6	70.7	73.4	110.4	44.5	108.2	12.7	9.9	11.8	9.7	15.7	8.8	9.8	9.4	11.1	10.8	11.6	8.8	7.8	27.9	8.7	16.2	23.7	11.4	5.1	147.5	150.3	149.2	204.1	147.7	156.2	157.1	153.2	155.9	147.7	149.9	150.9	106.4	3.2	23.3	6.2	60.1	21.4	56.8	9.4	32.5	23.0	116.3	148.0	51.5	47.1	13.1	36.8	20.9	48.5	130.7	79.7	19.6	18.2	361.8	93.8	90.0	39.3	34.7	45.4	4.4	33.3	55.2	43.0	56.6	86.3	5.1	70.5	26.7	53.8	65.9	23.5	4.4	50.8	2.0	78.4	44.4	1039.1	24.5	91.2	26.6	9.4	36.3	84.7	53.5	2.5	9.9	30.7	68.5	19.2	89.6	85.8	55.5	43.1	14.0	27.1	0.0	36.3	50.0	108.8	33.2	75.0	29.1	53.6	65.0	124.1	44.2	88.7
TAF11	"TAF2I, TAFII28"	ENSG00000064995	"TATA-box binding protein associated factor 11"	Q15544	6	34877462-34888071	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029326, HPA049127"			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA029326: AB_2672999, HPA049127: AB_2680645"	"unprognostic (4.02e-2)"	"unprognostic (5.36e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.68e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.32e-1)"	23.2	27.9	21.3	19.5	22.4	47.1	23.0	24.8	26.5	23.9	22.0	27.8	19.3	22.6	18.4	25.8	25.1	15.5	29.5	21.4	21.0	27.5	28.5	25.5	27.1	22.0	21.7	27.9	27.2	16.7	19.8	22.6	22.0	26.2	20.6	24.8	20.9	16.9	32.6	29.0	26.5	20.7	21.1	33.8	25.1	33.4	22.3	23.7	24.4	21.6	25.4	24.9	23.1	25.6	37.2	15.4	50.2	91.4	29.5	30.8	44.5	29.5	23.1	47.2	44.8	35.9	23.0	49.5	37.8	27.3	23.1	23.4	61.5	25.1	37.7	30.3	49.6	55.7	30.7	58.8	41.3	74.9	38.6	35.8	41.2	32.2	25.2	28.8	57.6	55.0	89.0	38.1	22.6	65.6	48.1	63.4	45.9	74.3	26.0	51.6	44.9	39.7	34.4	23.0	60.6	55.3	33.9	37.9	68.6	41.5	59.4	88.6	34.6	33.3	44.6	20.1	36.9	35.2	90.5	72.4	12.2	86.3	49.9	43.6	27.8	24.5	14.3	25.8	13.8	13.8	14.9	15.4	24.1	17.1	17.4	15.6	17.5	17.6	21.7	21.5	21.4	15.9	21.3	22.4	24.8	26.5	21.4	21.0	22.0	21.7	22.0	21.1	22.3	25.6	49.9	28.9	19.5	18.3	44.9	46.0	31.4	36.1	24.5	29.0	55.1	44.3	24.0	25.8	31.3	42.3	12.5	71.9	50.4	33.5	64.6	47.9	6.6	37.4	49.7	43.8	39.5	39.5	20.8	63.2	68.9	33.5	29.6	47.7	22.2	57.8	61.1	58.8	44.2	32.0	23.7	38.4	50.8	52.2	32.2	10.6	33.8	36.5	24.9	13.1	48.5	37.8	48.4	16.6	33.6	50.8	51.2	37.2	44.0	32.9	43.5	48.9	17.1	32.9	32.9	34.0	35.5	130.9	71.2	36.3	58.4	76.8	44.3	38.2	40.6	31.2
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076003	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	37.0	17.5	22.5	23.3	24.2	49.7	22.4	23.8	26.3	25.5	14.8	26.4	16.1	21.1	21.9	33.9	12.2	27.3	30.5	19.9	24.7	34.4	32.0	18.3	15.0	25.0	24.5	7.0	17.0	25.7	8.7	33.4	25.7	25.2	27.7	9.2	15.1	17.2	66.9	18.9	17.0	34.9	28.9	12.8	20.9	17.0	27.8	12.9	28.0	48.4	24.3	34.7	9.2	25.6	74.5	19.3	28.7	42.0	80.7	75.2	47.6	172.3	72.5	68.7	69.0	30.6	16.4	28.1	64.2	115.6	40.8	30.7	50.9	62.2	102.8	48.6	11.5	28.5	43.0	31.9	63.8	50.7	41.5	67.5	73.0	115.4	62.3	36.8	59.6	25.8	55.5	26.7	93.9	42.8	26.7	13.6	57.6	34.4	39.2	20.7	51.7	11.5	80.0	63.6	29.8	37.2	84.6	54.2	63.7	50.8	18.5	35.5	78.5	112.7	43.1	80.3	95.5	32.4	88.5	36.9	119.8	26.2	171.2	2.0	2.3	2.0	0.8	1.7	0.7	0.7	0.5	0.8	0.8	0.6	0.5	0.8	4.0	0.2	1.6	1.5	1.3	0.5	22.5	24.2	23.8	26.3	19.9	24.7	25.0	24.5	25.7	28.9	27.8	25.6	46.4	19.2	24.6	1.0	10.3	70.2	10.7	12.3	8.6	5.5	14.7	10.2	63.6	10.0	20.3	7.3	0.0	16.7	21.2	35.6	13.7	16.2	55.2	29.4	24.0	21.4	31.8	9.3	4.5	20.9	30.1	20.9	11.7	48.8	14.5	5.1	25.7	37.9	18.2	6.7	3.8	30.2	18.3	28.3	37.6	6.6	9.3	26.5	14.2	1.9	14.5	13.8	5.2	3.0	3.6	31.8	21.7	12.8	9.8	21.9	25.4	31.1	16.8	7.5	6.6	23.6	20.1	10.8	18.2	10.7	82.3	54.9	13.8	6.8	17.9	29.0
TAF15	"hTAFII68, Npl3, RBP56, TAF2N"	ENSG00000270647	"TATA-box binding protein associated factor 15"	Q92804	17	35713791-35864615	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052059, HPA063647"	Supported		Enhanced	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA052059: AB_2681711, HPA063647: AB_2685072"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.99e-1)"	62.0	74.8	56.2	74.5	54.4	69.2	57.3	52.9	68.4	74.3	55.2	71.9	56.4	69.9	40.9	102.7	61.6	33.4	80.2	52.0	61.1	63.8	82.1	57.2	90.0	56.3	56.9	66.0	74.0	54.4	71.3	48.2	55.8	63.0	48.6	54.2	65.8	38.2	130.2	80.0	78.6	38.0	54.3	76.4	76.6	87.8	56.1	95.5	58.5	38.3	75.2	74.6	72.1	57.0	216.8	347.3	190.2	191.2	149.6	88.5	108.3	247.9	79.1	109.7	107.0	244.5	151.1	440.1	166.9	145.2	122.2	239.6	254.0	232.8	166.0	112.9	187.1	250.6	264.3	261.1	145.3	401.1	168.4	135.7	143.6	155.3	266.0	137.0	140.1	238.5	233.3	188.9	148.1	270.4	442.0	96.0	117.0	205.9	40.2	255.7	279.6	164.7	149.3	399.1	130.1	136.6	299.6	97.8	98.3	231.0	224.5	144.9	214.1	86.1	178.3	115.8	310.1	165.6	198.4	303.4	173.7	190.1	134.1	1.4	1.0	1.2	1.7	1.4	2.0	1.0	1.0	1.2	0.7	1.2	0.9	1.2	0.9	2.0	1.5	1.0	1.5	0.9	56.2	54.4	52.9	68.4	52.0	61.1	56.3	56.9	55.8	54.3	56.1	57.0	38.1	16.0	55.1	90.4	71.4	36.1	59.7	57.9	93.9	57.8	29.3	31.0	41.6	40.0	57.0	60.7	41.7	82.1	63.1	38.4	3.9	42.7	7.5	51.4	55.0	52.6	49.1	75.3	108.4	29.6	50.8	36.9	66.3	53.8	55.8	32.4	36.8	60.7	43.1	60.6	111.7	52.2	46.8	44.0	32.9	10.4	30.7	49.0	33.8	78.7	56.0	75.1	54.6	100.0	124.2	29.2	29.4	40.6	53.2	43.4	50.3	31.6	47.2	45.4	46.0	48.0	51.7	84.9	74.7	115.3	37.2	78.0	78.8	55.6	58.5	44.8
TAF1A	"SL1, TAFI48"	ENSG00000143498	"TATA-box binding protein associated factor, RNA polymerase I subunit A"	Q15573	1	222557902-222589933	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054334	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA054334: AB_2682453"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (7.98e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.98e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.06e-2)"	3.0	3.4	2.0	4.8	2.1	2.7	3.2	2.3	2.3	3.0	1.6	2.0	2.5	4.1	3.0	2.6	2.8	2.7	1.9	1.7	2.8	2.1	1.8	2.8	6.5	2.4	2.0	6.8	1.9	1.9	2.5	4.4	2.3	3.2	2.6	4.0	2.0	2.7	1.2	2.1	2.4	2.5	2.1	4.4	3.4	6.4	2.1	4.4	5.1	1.3	5.6	5.3	2.5	3.0	13.8	7.3	19.5	6.8	6.6	5.8	17.2	9.1	7.0	10.8	13.2	7.8	14.8	12.6	17.4	3.2	8.6	13.7	13.1	5.6	15.2	8.3	9.9	7.5	6.3	7.5	7.4	18.2	3.3	3.0	6.0	12.1	15.4	5.1	4.5	8.7	23.4	5.6	14.9	5.0	21.6	13.0	39.5	15.8	21.0	13.2	39.1	12.2	4.5	7.3	11.1	23.1	14.0	8.1	10.1	9.9	4.6	9.1	6.1	10.9	10.9	19.4	23.2	6.8	6.6	16.5	9.7	11.7	14.7	1.8	1.5	2.1	3.2	2.5	4.7	5.2	2.8	2.9	1.5	7.4	3.3	4.1	0.3	3.0	2.5	5.3	2.5	1.7	2.0	2.1	2.3	2.3	1.7	2.8	2.4	2.0	2.3	2.1	2.1	3.0	3.1	0.0	1.1	6.5	8.6	8.5	6.4	3.9	6.8	10.2	3.1	3.6	1.5	2.8	1.9	3.7	6.2	7.2	4.6	2.4	1.9	2.9	2.5	3.0	6.1	2.7	1.2	3.8	5.2	0.7	6.7	6.0	4.1	3.0	1.3	7.7	1.1	2.0	4.4	6.7	7.1	3.0	0.0	3.8	1.0	1.3	5.6	4.7	0.0	3.7	2.7	3.8	2.1	8.0	8.0	1.3	1.8	2.2	4.4	8.0	0.9	1.3	2.6	8.5	6.6	4.5	4.3	11.5	12.1	4.9	2.8	5.9	4.7	4.2	3.2	8.8
TAF1B	"RAF1B, RAFI63, SL1, TAFI63"	ENSG00000115750	"TATA-box binding protein associated factor, RNA polymerase I subunit B"	Q53T94	2	9843443-9934416	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071254			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"HPA071254: "	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (8.58e-5)"	"unprognostic (1.44e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (9.17e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-2)"	7.2	7.6	4.1	8.4	4.1	7.1	8.7	5.3	4.2	6.9	6.4	5.9	5.1	9.7	6.6	9.6	9.6	7.2	4.8	3.8	5.1	13.3	6.3	8.7	11.4	3.9	5.4	5.7	4.4	14.7	3.7	13.0	3.7	9.0	5.7	9.0	8.1	9.0	2.8	8.6	4.2	8.1	3.8	7.1	6.1	11.0	5.4	11.4	10.5	3.4	12.7	7.9	6.0	4.7	25.1	20.4	29.2	9.6	14.1	21.2	52.7	29.9	23.3	25.3	23.3	19.1	18.1	27.1	13.6	21.3	26.7	15.0	26.9	31.7	27.3	31.3	35.9	31.5	8.9	28.3	19.5	22.1	32.4	17.0	16.5	21.4	28.5	20.8	37.4	14.8	19.8	27.2	25.0	15.3	16.6	20.1	37.7	15.6	17.5	10.2	27.2	8.0	24.9	24.3	12.3	33.6	23.5	28.9	21.9	18.9	10.4	17.4	20.4	31.9	39.8	31.1	35.7	14.9	19.9	39.7	18.4	24.8	26.7	3.6	9.1	6.2	12.1	15.5	12.1	11.1	10.2	14.3	13.4	11.7	6.3	10.0	0.5	10.2	12.4	10.6	11.1	5.2	4.1	4.1	5.3	4.2	3.8	5.1	3.9	5.4	3.7	3.8	5.4	4.7	12.5	19.2	22.0	22.2	13.1	16.2	29.9	17.9	19.9	24.5	8.0	6.1	4.0	2.8	26.0	12.9	27.1	25.0	12.6	2.4	13.7	19.5	11.6	26.8	21.0	15.4	1.8	10.5	38.8	18.9	37.4	18.4	13.7	17.3	8.8	12.7	6.8	4.7	12.7	15.2	27.1	3.3	8.2	12.0	11.5	3.8	19.0	14.6	0.0	15.0	15.5	25.5	15.5	32.6	23.5	15.7	3.8	13.2	16.6	9.5	1.7	26.5	29.7	21.0	19.7	15.9	16.2	47.6	33.9	19.7	13.2	23.7	15.1	24.8	4.4	18.7
TAF1C	"MGC:39976, SL1, TAFI110, TAFI95"	ENSG00000103168	"TATA-box binding protein associated factor, RNA polymerase I subunit C"	Q15572	16	84177847-84187070	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072229			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA072229: AB_2686499"	"unprognostic (9.39e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.53e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (5.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.22e-4)"	19.4	15.8	9.8	7.2	9.9	13.5	20.6	8.1	12.9	25.9	5.4	16.0	7.9	23.5	2.2	15.9	21.4	10.1	18.3	10.9	7.7	20.6	14.8	17.0	11.1	10.5	8.7	31.7	17.9	4.2	20.6	6.2	8.6	21.7	2.9	1.8	15.3	8.3	12.3	17.8	19.3	5.3	7.3	32.2	18.7	13.8	8.9	7.4	23.7	6.7	3.6	18.5	19.1	8.9	11.8	12.7	7.5	23.6	5.7	5.9	34.3	13.8	5.3	11.5	3.7	15.0	8.3	12.7	17.3	5.0	6.1	21.2	4.3	5.4	2.6	11.4	18.2	6.8	21.0	9.7	4.8	7.6	21.8	8.9	6.9	9.1	3.7	5.0	20.4	20.7	17.9	4.1	5.6	25.4	11.3	24.9	27.8	5.1	12.2	29.2	6.1	10.5	4.7	9.5	34.0	16.8	26.3	7.8	43.0	4.6	28.9	8.1	8.9	19.2	16.5	19.2	12.0	19.6	16.9	26.7	9.8	9.2	12.4	0.0	1.3	0.4	1.5	1.3	1.8	0.9	0.6	0.9	1.5	1.1	0.7	1.3	0.0	1.5	0.5	0.6	0.9	1.2	9.8	9.9	8.1	12.9	10.9	7.7	10.5	8.7	8.6	7.3	8.9	8.9	24.9	19.2	15.8	22.5	9.2	6.5	5.1	5.2	5.2	9.3	10.2	10.2	3.0	2.8	8.2	3.7	20.9	9.4	6.5	9.9	5.9	5.1	0.5	6.9	7.4	18.7	7.2	7.4	16.5	7.1	6.7	8.4	20.9	8.8	6.3	24.6	22.9	12.9	6.6	1.7	13.0	8.2	0.0	9.8	6.3	2.5	11.8	7.3	7.2	15.9	6.3	7.8	5.2	13.6	12.5	5.2	5.1	9.1	12.1	3.9	7.6	4.0	6.1	10.4	6.6	8.3	7.8	9.9	10.6	8.7	5.3	7.4	8.0	16.8	10.2	4.4
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271"	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	10.0	9.3	2.5	18.2	3.0	16.4	12.6	5.0	6.7	7.7	1.2	9.5	13.7	14.1	9.0	9.5	7.7	15.4	7.1	2.9	3.5	6.8	6.9	8.1	20.6	2.3	0.6	13.8	20.9	5.3	4.9	18.0	2.3	9.9	12.5	8.2	10.1	7.3	8.0	11.4	13.3	9.1	0.5	11.9	11.9	5.5	1.7	10.9	10.1	7.1	13.1	13.8	7.2	7.8	18.2	8.6	17.5	17.9	14.0	47.8	29.2	27.0	11.5	18.4	13.8	28.6	38.8	32.6	34.0	15.6	12.6	44.3	21.5	25.9	21.2	10.6	7.8	34.8	55.6	20.2	16.4	31.9	25.1	19.5	25.8	16.0	35.7	35.0	23.7	22.7	24.2	50.4	22.8	5.0	25.8	66.4	12.1	16.7	9.6	23.3	19.1	30.9	22.7	17.4	10.7	19.5	10.8	38.2	16.5	19.3	32.7	12.4	28.7	26.9	30.5	44.2	28.7	22.9	26.2	32.5	11.2	36.9	10.3	44.2	16.7	28.8	17.3	12.5	17.7	39.1	24.9	19.8	12.0	39.8	28.4	24.1	42.7	18.1	10.8	26.1	18.2	5.2	2.5	3.0	5.0	6.7	2.9	3.5	2.3	0.6	2.3	0.5	1.7	7.8	106.7	89.8	95.5	20.9	246.1	244.2	252.4	66.6	255.0	86.6	129.4	130.9	26.2	134.4	105.3	29.5	39.6	176.0	162.5	94.5	45.0	95.2	19.9	144.9	184.9	121.3	110.2	98.4	41.6	146.3	170.2	147.1	125.4	245.6	104.4	257.2	63.1	54.2	69.3	69.0	38.2	148.0	24.4	103.7	153.6	16.5	128.6	112.0	80.0	24.4	102.1	34.8	89.6	35.2	44.0	110.4	87.5	67.7	162.2	269.2	71.1	101.5	67.7	78.2	72.3	187.4	123.1	49.0	71.5	251.4	203.0	160.9	182.3	119.7	174.1	356.8
TAF3	"TAF140, TAFII140"	ENSG00000165632	"TATA-box binding protein associated factor 3"	Q5VWG9	10	7818505-8016631	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066184			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nuclear membrane"	"HPA066184: AB_2685631"	"unprognostic (3.82e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (2.14e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.30e-3)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.59e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	5.4	4.9	7.1	4.8	7.9	6.9	4.5	9.9	9.0	4.7	4.8	5.1	2.8	5.2	2.2	3.0	4.3	3.3	5.9	6.1	7.6	4.0	3.7	3.9	6.1	7.9	9.0	7.0	4.3	5.2	3.1	4.5	7.9	3.5	3.5	5.3	3.6	4.4	10.7	5.2	3.8	4.2	7.2	5.5	3.7	7.5	8.2	7.0	4.3	7.6	4.6	5.0	4.2	7.2	7.9	7.2	8.0	4.3	9.0	6.2	11.1	9.2	3.5	6.8	7.7	15.6	5.8	13.4	6.9	5.4	2.8	8.4	8.9	7.9	8.5	10.9	9.8	11.5	5.0	10.0	7.7	7.8	10.1	4.2	7.8	9.5	4.6	4.3	6.5	14.5	13.0	13.5	7.8	14.9	17.7	5.5	6.1	11.5	4.2	14.2	7.6	9.0	3.9	4.9	4.3	6.1	10.0	7.2	9.4	7.8	13.1	8.1	8.1	6.1	10.7	16.3	9.1	8.0	10.3	14.4	5.9	8.8	5.6	5.8	3.9	5.7	6.0	3.4	7.1	5.2	5.4	5.9	3.2	5.6	6.7	5.8	1.5	6.2	6.6	3.1	4.9	3.9	7.1	7.9	9.9	9.0	6.1	7.6	7.9	9.0	7.9	7.2	8.2	7.2	26.2	28.9	29.5	41.1	45.2	32.0	20.7	13.3	23.3	28.6	15.3	16.5	40.1	14.3	10.5	27.6	35.5	26.6	32.0	18.0	0.0	17.0	39.6	16.7	22.9	29.9	18.7	25.2	45.1	14.7	36.8	23.2	19.9	16.7	22.1	18.0	19.6	14.5	19.8	26.9	54.4	14.6	8.2	21.3	24.2	22.0	27.4	25.3	24.9	71.2	25.7	27.0	53.5	43.2	63.9	15.0	5.9	28.6	37.7	14.1	20.5	4.5	16.3	47.8	26.3	39.3	31.0	58.9	46.2	16.4	43.0	20.0	48.6	16.4	16.5	17.6
TAF4	"TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135"	ENSG00000130699	"TATA-box binding protein associated factor 4"	O00268	20	61953469-62065810	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008599, CAB031484"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"CAB031484: AB_671207, HPA008599: AB_1080183"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.99e-2)"	5.0	5.3	1.7	2.0	1.6	2.8	5.0	3.2	2.0	6.3	0.1	6.1	2.6	6.3	0.5	6.2	5.6	0.9	5.0	1.2	0.5	6.2	7.6	5.0	1.8	1.5	1.0	9.8	6.9	1.2	4.4	1.5	1.1	5.2	0.9	1.6	4.8	1.2	8.8	6.8	6.2	1.1	0.3	6.0	5.8	10.0	1.6	2.7	5.2	1.7	1.1	5.6	5.8	2.0	6.6	6.1	3.6	4.2	1.6	1.2	7.3	3.2	1.4	5.2	2.8	20.5	5.4	5.3	8.1	1.7	3.9	8.4	3.2	3.8	2.2	4.6	4.7	12.3	7.1	9.5	1.7	5.9	10.7	0.9	3.4	2.4	2.4	1.5	2.1	6.5	10.1	4.6	0.9	7.1	16.7	7.2	5.3	4.7	8.6	15.3	8.3	5.7	1.7	6.1	6.1	5.3	9.8	10.2	3.4	2.6	6.3	7.2	2.6	6.7	9.7	6.8	6.0	6.4	6.4	8.5	4.0	3.5	4.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	1.7	1.6	3.2	2.0	1.2	0.5	1.5	1.0	1.1	0.3	1.6	2.0	5.6	6.4	14.1	13.1	4.7	7.6	3.2	4.5	4.6	8.8	8.3	4.4	7.3	5.7	4.4	5.5	2.1	5.6	6.1	11.6	0.0	5.7	21.1	7.4	5.8	7.1	3.6	10.8	16.3	3.8	5.0	5.7	8.6	11.3	1.3	7.9	6.4	12.6	5.9	15.2	17.3	9.9	12.2	11.0	5.5	7.0	9.3	7.1	3.6	15.0	10.5	3.9	5.2	17.6	22.1	6.0	10.1	10.5	4.3	8.0	9.8	4.9	7.4	9.1	6.6	5.4	6.2	8.6	13.1	7.6	9.7	8.3	7.5	5.2	9.9	5.6
TAF4B	"TAF2C2, TAFII105"	ENSG00000141384	"TATA-box binding protein associated factor 4b"	Q92750	18	26226445-26391685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 80.3;Plasma cells: 52.3;Suprabasal keratinocytes: 78.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 65.0;U-266/70: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028937	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA028937: AB_10603034"	"unprognostic (2.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (7.38e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.72e-4)"	1.5	2.0	0.4	2.8	0.4	2.8	2.7	0.3	1.9	1.2	0.0	1.6	0.4	1.4	0.3	1.0	1.3	0.7	0.4	0.3	0.2	1.5	0.1	1.0	3.1	0.9	0.1	3.1	1.2	0.6	0.2	1.7	1.1	0.8	1.4	0.3	1.1	0.8	1.3	1.5	0.8	1.2	0.0	2.5	1.8	4.6	0.2	1.8	1.7	0.7	3.2	1.5	0.6	0.8	4.3	0.7	0.3	1.1	1.6	2.6	2.1	1.3	1.5	0.7	1.3	1.1	2.3	65.0	5.0	0.3	2.5	4.8	3.7	4.0	3.4	15.5	9.9	7.5	1.9	1.0	2.3	20.5	4.4	4.3	1.5	0.5	11.6	0.6	1.4	8.1	10.2	7.9	0.3	4.2	10.7	4.1	3.5	2.5	5.1	0.0	8.1	17.3	1.0	0.3	6.1	2.8	3.9	5.7	2.7	1.6	2.0	3.6	0.9	2.7	1.6	3.7	4.8	26.2	18.0	21.8	1.3	12.8	2.4	0.0	0.3	0.0	0.1	0.5	1.0	2.3	0.7	1.0	1.0	2.0	2.0	1.6	0.0	0.6	0.2	0.3	0.1	0.6	0.4	0.4	0.3	1.9	0.3	0.2	0.9	0.1	1.1	0.0	0.2	0.8	7.2	6.4	7.2	6.2	34.0	80.3	9.5	1.7	49.5	1.5	15.0	17.9	2.8	0.0	2.5	0.0	0.0	18.6	4.1	5.8	17.6	1.2	0.7	28.9	9.7	9.0	0.0	21.7	44.8	2.0	4.3	15.5	36.7	45.0	1.3	5.4	1.1	0.0	2.4	5.0	28.3	7.0	2.0	1.6	17.9	1.6	3.4	5.9	23.2	4.7	2.6	0.2	1.0	7.5	11.7	2.2	2.5	4.1	52.3	13.9	0.8	4.0	1.0	1.2	0.0	17.6	12.1	25.4	24.8	40.8	78.8	9.7	14.5	14.5	6.2	6.7
TAF5	"TAF2D, TAFII100"	ENSG00000148835	"TATA-box binding protein associated factor 5"	Q15542	10	103367976-103389065	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.7;Spermatogonia: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006195, HPA006474"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA006195: AB_1080188, HPA006474: AB_1080185"	"unprognostic (3.09e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.36e-9)"	"prognostic favorable (7.39e-5)"	"unprognostic (2.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	2.2	1.8	2.7	2.8	2.9	4.9	2.3	5.0	3.3	2.5	2.3	3.1	2.9	2.3	1.7	2.4	2.3	1.5	2.0	2.6	2.6	1.7	2.6	1.9	4.4	2.8	2.7	3.0	2.9	1.7	2.1	3.5	2.9	2.0	3.1	3.5	2.0	2.2	3.0	2.5	2.4	2.1	2.7	3.1	2.1	11.2	2.6	7.0	2.0	3.6	4.3	2.2	2.5	3.1	9.7	4.4	10.6	19.2	5.9	4.8	12.4	6.8	7.7	9.6	12.0	8.7	5.0	23.0	3.8	3.6	5.6	9.6	18.1	3.7	12.2	8.5	15.6	10.6	5.0	8.7	2.7	20.6	11.0	2.2	2.7	5.7	6.1	3.9	7.3	10.1	15.4	11.2	6.5	6.4	16.8	26.9	12.9	12.2	5.7	14.2	12.9	7.0	2.7	2.8	7.4	8.2	4.4	3.2	4.1	10.1	3.7	8.5	4.3	5.6	7.1	6.3	12.2	6.3	8.1	14.0	3.1	24.2	3.6	0.2	0.6	0.8	0.4	0.2	0.3	0.1	0.4	0.8	0.3	1.3	1.0	0.5	0.0	0.3	0.3	0.4	1.1	0.2	2.7	2.9	5.0	3.3	2.6	2.6	2.8	2.7	2.9	2.7	2.6	3.1	5.8	6.4	2.6	3.6	6.9	14.4	4.5	1.7	6.2	6.9	3.0	2.7	2.9	1.5	2.5	1.8	6.2	5.6	8.3	2.7	3.9	2.8	19.7	1.8	3.8	5.2	2.4	11.2	4.9	2.2	9.3	5.6	2.0	2.1	8.9	4.1	2.9	2.8	3.8	1.7	5.3	2.9	4.1	2.8	6.3	14.1	1.8	3.6	1.8	3.7	4.9	1.3	4.1	3.5	5.8	1.9	3.3	2.6	14.9	4.3	3.3	1.0	0.7	7.5	0.0	7.2	6.5	48.7	52.3	5.9	14.2	6.8	8.6	3.0	4.0	3.8
TAF6	"MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85"	ENSG00000106290	"TATA-box binding protein associated factor 6"	P49848	7	100107070-100119841	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006566			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA006566: AB_1080194"	"unprognostic (5.60e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.37e-1)"	24.2	37.0	28.9	23.4	29.2	23.4	24.4	24.1	42.7	39.5	23.8	38.9	17.2	42.9	21.9	27.3	34.9	20.5	32.2	31.3	25.2	30.9	20.6	24.8	22.6	25.2	23.2	41.2	23.0	30.5	41.1	24.9	24.4	30.7	19.5	19.2	25.5	31.1	45.0	26.5	28.0	33.9	19.0	28.3	28.0	38.5	25.4	29.3	32.9	35.8	25.7	37.3	29.9	25.6	55.1	101.8	64.4	105.7	84.1	44.5	89.3	60.0	66.4	77.2	70.6	76.1	65.6	50.4	65.5	92.7	130.4	45.7	90.6	73.2	81.3	82.0	57.0	49.4	99.3	50.8	86.6	46.2	43.5	46.4	44.5	111.0	121.7	61.0	63.0	87.7	84.6	89.0	69.2	194.4	101.1	76.9	94.7	50.1	82.4	73.2	78.7	75.0	54.5	44.8	57.9	84.4	73.7	115.3	49.3	93.2	42.1	47.2	60.4	113.2	114.6	146.2	77.6	55.0	104.0	85.1	74.9	65.7	99.2	17.2	13.5	17.5	18.0	14.4	21.5	11.9	17.3	18.3	17.6	17.9	17.0	16.3	7.1	18.8	35.3	10.3	18.3	17.5	28.9	29.2	24.1	42.7	31.3	25.2	25.2	23.2	24.4	19.0	25.4	25.6	13.0	9.6	11.8	10.1	15.4	11.3	21.0	25.1	12.5	12.7	13.2	15.9	0.9	18.6	15.7	25.8	0.0	72.1	13.0	12.9	17.6	25.7	28.3	20.7	18.5	14.8	15.6	12.8	12.6	16.6	34.5	16.3	18.3	14.6	0.0	25.6	13.6	6.1	20.9	13.5	10.7	11.9	26.4	8.8	6.9	50.7	21.8	12.3	12.4	3.7	18.7	18.7	18.6	6.0	7.3	14.9	18.7	31.2	12.8	13.0	14.2	25.8	21.8	14.0	26.3	14.6	23.8	25.5	52.3	15.4	11.8	34.5	18.3	16.2	17.4	14.4
TAF6L	PAF65A	ENSG00000162227	"TATA-box binding protein associated factor 6 like"	Q9Y6J9	11	62771357-62787342	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067239	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA067239: AB_2685809"	"unprognostic (5.41e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.45e-3)"	"unprognostic (9.65e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.61e-3)"	8.6	12.0	6.0	4.3	6.3	5.7	9.1	6.0	8.8	11.2	4.1	8.9	6.7	13.0	6.2	9.9	10.3	3.9	8.1	5.1	5.2	11.8	21.2	7.5	5.3	7.2	6.0	11.0	13.0	5.2	14.9	3.4	6.9	11.1	3.3	4.0	8.5	5.1	17.4	11.8	9.8	4.8	4.8	11.8	9.4	6.7	5.7	5.3	12.7	5.0	3.9	9.6	8.6	5.9	12.6	12.3	15.8	12.6	7.0	5.8	13.1	10.5	7.1	11.6	9.0	6.9	14.3	16.9	21.0	7.5	10.7	16.7	11.2	10.5	3.6	23.3	24.4	8.9	14.4	11.8	10.0	11.4	15.6	7.7	7.6	9.3	6.1	6.0	10.0	17.2	18.9	12.2	7.4	24.5	16.7	31.8	17.1	6.4	15.8	20.4	11.2	21.4	7.9	8.9	16.8	16.7	9.9	10.5	16.2	6.6	18.5	7.9	9.3	11.7	14.6	19.2	11.9	13.3	23.1	19.7	10.4	8.6	10.9	0.7	0.7	0.9	0.6	0.8	0.7	0.8	0.4	0.4	0.9	0.7	0.9	0.6	0.2	1.1	0.3	0.9	0.3	0.2	6.0	6.3	6.0	8.8	5.1	5.2	7.2	6.0	6.9	4.8	5.7	5.9	6.1	3.2	3.0	8.8	9.3	6.1	4.7	1.5	11.4	8.7	6.8	6.0	2.8	12.8	1.8	1.8	0.0	15.0	5.0	9.8	15.6	4.8	6.0	5.3	5.0	5.6	5.3	11.6	3.5	3.1	8.9	5.0	10.2	7.2	0.0	6.9	5.7	12.1	9.8	3.3	5.2	6.9	0.0	10.9	5.5	5.0	5.3	8.0	8.8	2.8	8.9	9.9	13.4	6.0	5.1	3.4	8.5	4.9	11.8	4.6	8.5	18.1	3.2	5.5	0.0	6.8	7.0	3.2	9.6	10.7	6.3	19.4	5.7	9.9	9.4	4.3
TAF7	"TAF2F, TAFII55"	ENSG00000178913	"TATA-box binding protein associated factor 7"	Q15545	5	141260225-141320784	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006429	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA006429: AB_1080196"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.78e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-2)"	58.0	62.9	54.7	53.8	56.1	79.7	76.7	63.6	69.2	57.4	63.0	53.4	44.6	73.8	82.1	48.9	73.6	42.7	103.1	56.4	57.5	63.9	66.6	55.7	79.5	55.2	55.5	104.1	52.8	43.4	62.5	60.9	56.8	67.6	56.4	92.0	56.6	57.0	142.9	56.2	59.5	63.0	60.3	69.8	51.8	76.0	57.0	119.6	60.7	130.8	88.8	51.0	43.8	70.7	82.4	67.4	150.3	110.7	131.2	120.9	93.7	104.9	93.0	145.4	141.4	95.3	90.2	220.1	204.6	107.3	157.5	68.7	95.9	97.4	146.0	96.8	106.6	39.8	80.1	79.8	119.4	55.2	80.2	111.1	141.9	56.8	99.9	114.6	106.5	98.7	85.8	167.3	141.7	103.3	124.7	133.1	54.4	103.7	24.4	156.7	200.7	162.4	107.5	109.0	120.0	137.1	85.6	121.7	118.1	114.5	174.1	178.2	98.5	20.5	69.9	67.6	129.2	45.0	195.3	198.9	89.3	126.8	83.6	183.7	35.9	161.5	53.1	44.5	69.1	58.2	62.6	60.2	50.2	54.7	84.9	72.3	104.2	89.1	55.2	55.5	57.7	70.6	54.7	56.1	63.6	69.2	56.4	57.5	55.2	55.5	56.8	60.3	57.0	70.7	142.3	86.6	68.7	0.0	146.0	120.4	353.0	96.4	67.7	132.7	78.9	72.8	168.4	77.2	92.8	82.8	95.9	94.8	147.4	123.7	82.2	113.7	50.8	92.9	115.7	112.6	84.2	52.6	0.0	76.0	73.3	127.3	70.3	90.8	155.1	70.0	96.0	70.9	51.0	121.1	0.0	110.2	69.2	52.5	92.3	36.8	146.9	86.3	112.1	0.0	94.6	141.4	132.8	0.0	0.0	123.7	150.4	129.1	68.0	243.3	120.0	77.3	107.2	101.4	164.3	175.2	135.8	124.7	141.1	75.7	170.5	141.3	161.5	111.9	106.8	245.9
TAF7L	"CT40, TAF2Q"	ENSG00000102387	"TATA-box binding protein associated factor 7 like"	Q5H9L4	X	101268253-101293057	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 31.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.1;Late spermatids: 15.8;Spermatocytes: 39.4;Spermatogonia: 25.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SiHa: 47.9"					"Low region specificity"	"Detected in many"			"HPA001879, HPA072008"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA001879: AB_1857751, HPA072008: "	"unprognostic (1.70e-2)"	"prognostic favorable (8.71e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.12e-2)"	0.1	0.0	1.2	0.1	0.8	0.3	0.1	0.0	1.3	1.6	1.7	0.5	0.1	0.5	2.4	0.1	0.1	0.0	0.1	1.4	0.2	0.5	1.1	0.0	0.0	0.0	0.4	0.1	0.1	3.9	0.3	0.3	0.0	0.7	0.1	0.1	0.1	1.7	0.1	0.9	0.1	0.1	0.0	0.0	0.1	31.6	0.5	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.2	1.0	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.2	0.9	0.0	0.2	0.3	0.2	2.2	0.1	0.4	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.7	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	47.9	0.3	2.7	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	1.3	1.4	0.2	0.0	0.4	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.3	26.1	1.2	5.5	0.2	0.0	0.0	2.9	0.0	0.2	0.2	0.0	0.4	0.0	0.5	0.4	2.1	0.1	0.0	2.4	0.1	0.0	0.3	0.2	15.8	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	39.4	25.2	0.0	0.1	1.6	0.1	0.6	0.1	0.1
TAF8	"FLJ32821, TAF(II)43, TBN"	ENSG00000137413	"TATA-box binding protein associated factor 8"	Q7Z7C8	6	42050513-42087461	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031730, HPA031731, HPA031734"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994"	"unprognostic (7.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.46e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.26e-2)"	13.7	9.8	5.9	12.8	6.4	21.1	10.8	4.2	6.8	8.5	7.8	9.8	10.5	8.8	6.8	10.1	7.5	8.4	18.0	5.3	5.3	11.3	8.6	9.5	15.6	6.4	5.5	8.0	7.4	16.0	6.6	12.7	5.3	9.0	9.2	8.7	9.5	8.9	16.9	8.5	8.5	10.1	4.4	11.6	10.8	7.9	6.4	23.6	13.9	15.4	15.0	9.8	8.6	7.1	17.2	18.4	14.9	16.7	16.5	15.1	13.6	7.9	13.7	20.4	20.9	31.8	10.0	26.2	16.4	11.5	20.9	12.5	24.5	16.7	15.7	22.6	23.6	33.4	23.3	15.7	20.2	19.5	23.4	20.6	13.0	14.6	18.4	10.0	23.0	31.8	41.7	26.6	11.5	22.7	17.9	29.2	9.3	45.5	8.4	36.1	17.7	20.2	18.0	13.9	15.4	13.7	14.3	11.0	15.7	12.2	16.5	23.6	21.2	18.1	18.8	8.2	16.3	23.0	24.4	55.5	8.3	21.2	10.4	23.0	17.0	27.0	16.0	18.2	11.1	18.2	14.4	12.6	17.8	18.3	14.7	14.4	19.9	10.8	37.4	26.5	13.4	11.0	5.9	6.4	4.2	6.8	5.3	5.3	6.4	5.5	5.3	4.4	6.4	7.1	16.8	19.2	21.1	14.0	17.2	7.0	13.1	14.8	14.2	16.0	14.1	10.4	28.6	10.0	17.4	11.0	31.3	22.1	21.0	12.3	31.3	9.5	12.0	26.5	12.8	16.9	9.0	21.9	7.6	9.9	8.6	11.7	6.6	47.4	19.0	14.2	9.7	9.6	13.5	21.9	8.2	13.3	14.2	21.6	9.5	17.5	14.9	13.1	7.2	13.1	19.3	10.7	33.0	18.6	14.2	8.8	8.3	11.7	19.0	14.4	10.5	16.5	9.8	23.2	13.1	10.6	13.3	15.3	12.9	12.0	8.4	21.5	19.8	19.4	11.1	15.0
TAF9	"AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32"	ENSG00000273841	"TATA-box binding protein associated factor 9"	Q16594	5	69364743-69370013	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 550.8;Late spermatids: 924.3;Spermatocytes: 370.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028930, HPA053429, HPA058961, HPA072658"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA028930: AB_2672832, HPA053429: AB_2682148, HPA058961: AB_2683863, HPA072658: "	"unprognostic (1.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.38e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.79e-1)"	42.1	43.5	35.5	31.9	38.6	108.2	46.0	35.4	41.4	28.3	34.4	42.5	34.2	31.5	50.4	37.4	31.1	28.8	52.7	39.2	43.0	38.4	55.7	27.7	46.6	37.1	36.4	37.8	40.8	35.5	50.6	38.0	40.5	33.7	47.5	47.2	34.7	27.7	58.0	36.1	33.2	35.9	36.6	35.0	38.0	140.4	37.7	50.9	28.7	41.7	52.3	50.6	30.3	36.1	107.0	109.3	67.7	121.6	114.4	143.5	179.3	100.1	159.8	172.3	227.0	109.7	135.1	135.9	70.2	146.7	322.2	82.2	92.4	208.1	227.4	65.6	111.0	120.4	154.0	157.8	261.3	118.7	168.3	159.4	137.4	117.1	247.7	122.5	143.1	121.4	122.4	119.8	165.9	147.7	126.1	189.5	82.0	42.6	81.6	83.0	119.7	169.0	152.7	120.7	118.1	82.6	108.3	64.3	192.8	111.3	100.9	175.7	103.3	65.9	98.2	78.2	173.1	93.2	118.3	175.6	101.3	145.7	82.8	149.3	107.8	122.5	52.8	101.3	81.2	90.1	79.7	64.2	83.9	75.4	89.6	73.6	16.0	58.7	88.4	47.0	95.5	134.4	35.5	38.6	35.4	41.4	39.2	43.0	37.1	36.4	40.5	36.6	37.7	36.1	67.4	19.2	29.3	0.0	55.2	174.0	151.4	238.7	39.3	24.1	49.9	81.4	69.3	42.9	108.8	23.9	14.6	118.0	45.1	33.8	90.1	67.1	550.8	47.6	44.9	58.6	30.7	93.2	0.0	80.4	166.7	57.3	36.7	38.1	38.6	53.5	34.6	41.9	107.7	20.2	0.0	49.5	146.5	42.8	99.8	924.3	65.3	55.2	99.6	0.0	66.9	35.1	35.0	0.0	0.0	85.1	37.2	34.3	76.5	87.3	47.4	90.2	85.2	43.0	32.9	49.1	95.5	370.7	78.0	60.7	163.2	104.5	50.7	75.0	64.2	149.6
TAF9B	"DN-7, DN7, TAF9L, TAFII31L, TFIID-31"	ENSG00000187325	"TATA-box binding protein associated factor 9b"	Q9HBM6	X	78129748-78139650	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045275, HPA058961"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA045275: AB_10962831, HPA058961: AB_2683863"	"unprognostic (3.62e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.68e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.34e-3)"	"unprognostic (9.47e-2)"	"unprognostic (2.62e-1)"	15.7	11.4	12.8	10.4	14.0	12.0	15.6	13.7	17.5	15.5	12.9	14.5	6.5	23.1	14.2	18.2	16.1	13.5	23.1	13.7	15.1	18.2	14.0	11.0	11.5	13.5	12.4	14.4	9.7	22.9	12.0	13.1	13.4	19.8	10.0	33.6	10.1	17.2	15.4	12.3	8.1	30.7	14.5	10.7	11.0	10.4	12.8	17.0	18.9	14.0	10.7	16.5	10.3	18.0	25.6	21.8	52.7	23.3	20.2	20.5	7.9	22.5	20.7	35.6	19.8	30.7	43.3	29.2	31.2	24.5	29.0	19.8	79.5	18.5	36.9	45.7	27.6	16.0	28.7	28.2	20.1	25.4	17.0	26.3	9.8	39.1	26.7	22.5	21.8	28.7	33.4	61.1	32.0	39.1	40.3	19.8	61.9	33.4	40.4	34.3	68.6	26.9	24.6	51.2	33.3	33.1	62.3	26.7	24.7	27.2	43.3	18.2	23.3	27.4	41.6	30.2	27.4	26.2	56.8	21.3	47.6	50.5	39.3	0.8	4.1	1.2	6.6	4.4	12.5	5.6	15.1	11.5	5.2	5.2	15.1	11.3	1.9	14.2	3.3	6.5	17.7	8.7	12.8	14.0	13.7	17.5	13.7	15.1	13.5	12.4	13.4	14.5	12.8	18.0	14.9	9.6	7.8	2.9	6.6	15.6	26.7	6.1	56.3	16.1	12.2	8.8	26.6	10.0	6.2	20.2	8.4	18.1	4.5	1.4	7.9	6.8	1.0	4.7	8.2	16.4	12.6	14.1	4.0	8.6	16.4	12.9	4.1	5.0	2.5	3.0	13.2	5.6	6.9	8.4	4.0	5.4	12.2	3.5	7.9	1.7	10.5	4.9	23.2	3.7	7.6	22.9	2.1	4.5	8.9	3.9	5.0	13.9	14.1	11.7	1.0	17.6	4.1	13.6	19.7	9.3	20.4	5.9	33.5	23.0	8.8	8.5	9.9	3.0	4.4	13.2
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 153.7;HMC-1: 70.6;HUVEC TERT2: 31.2;JURKAT: 60.0;K-562: 48.9;MOLT-4: 26.3;TIME: 34.4"	"Region enriched"	"Detected in many"	5	"midbrain: 14.3"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	7.5	2.5	4.9	1.0	4.5	29.4	6.3	4.7	4.4	2.9	3.0	2.1	0.8	2.9	0.6	1.8	3.5	2.3	5.9	4.6	4.6	4.4	1.5	13.0	1.4	6.5	7.1	1.2	0.9	0.9	1.7	6.9	6.8	2.1	1.3	0.2	1.1	0.8	2.1	1.7	3.1	2.7	6.9	7.1	1.8	0.9	6.4	0.4	5.4	2.5	0.7	2.4	2.5	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	0.1	153.7	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	0.0	0.0	31.2	60.0	48.9	0.1	0.0	0.0	26.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.1	34.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.5	4.9	4.5	4.7	4.4	4.6	4.6	6.5	7.1	6.8	6.9	6.4	6.8	23.9	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.5	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.1	18.1	0.0	151.5	0.0	0.0	0.3	0.6	0.0	0.0	36.8	0.0	26.7	0.1	10.6	0.0	0.1	0.0	0.0	1.6	1.5	18.2	0.0	4.8	1.8	29.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	1.3	0.4	0.1	1.0	0.0	2.0	0.0	0.0	0.0
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747415-765012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 820.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 2870.4;neutrophil: 3726.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		29000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	139.5	80.7	108.0	121.8	128.8	464.8	121.0	129.3	119.3	101.9	105.2	99.6	116.0	68.4	66.4	330.6	79.1	100.0	95.5	108.0	113.8	111.6	136.2	109.1	107.8	135.8	119.3	77.0	107.5	49.3	53.0	88.0	130.0	91.9	78.4	34.2	132.8	60.1	120.7	132.7	101.0	60.8	124.0	152.6	132.5	40.4	120.1	109.9	140.3	107.1	115.8	160.8	142.1	148.2	331.0	405.5	115.4	218.1	235.8	136.5	338.0	242.2	313.8	238.2	194.5	176.6	694.8	179.5	323.1	324.7	181.9	345.5	185.6	263.5	122.8	238.9	372.5	310.9	146.0	616.4	250.3	498.4	449.0	112.0	210.6	159.6	129.0	170.4	331.6	224.0	413.5	294.3	224.5	318.0	296.4	601.2	183.9	478.9	326.0	243.5	131.5	656.4	437.9	185.4	284.2	100.1	224.9	466.1	243.3	102.4	220.0	383.9	434.1	107.9	99.5	86.0	232.9	122.9	132.1	223.5	238.5	440.5	444.7	1456.7	1203.5	2870.4	94.1	432.7	102.3	145.5	125.7	115.5	654.2	127.2	100.9	94.9	3726.6	112.2	457.8	267.0	192.7	1066.0	108.0	128.8	129.3	119.3	108.0	113.8	135.8	119.3	130.0	124.0	120.1	148.2	90.2	141.1	117.2	10.7	91.1	73.5	199.8	354.0	61.5	50.3	113.0	122.2	46.4	100.1	253.4	150.8	14.6	419.8	83.8	151.0	250.5	230.4	82.1	156.5	85.4	85.6	101.5	507.0	13.1	272.1	427.6	97.3	144.3	216.7	161.4	86.0	93.5	149.7	418.3	50.5	11.6	186.0	268.5	271.8	169.4	21.2	117.8	352.8	140.5	7.5	820.0	142.1	84.5	10.6	54.8	257.6	200.3	104.2	129.4	361.9	197.7	309.1	232.6	61.7	72.3	59.6	115.0	143.2	140.6	257.6	83.1	526.6	86.8	77.5	215.1	342.6
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973868-29992261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	31.4	36.0	23.4	14.7	21.2	12.7	30.8	18.0	26.1	24.8	11.9	21.8	17.3	25.9	11.1	20.8	22.6	12.0	32.6	23.0	18.9	22.7	17.6	34.0	14.4	21.0	20.0	24.1	19.5	17.4	29.4	19.4	18.9	22.5	8.5	14.3	20.5	13.3	23.4	22.4	24.4	13.3	15.3	33.8	21.8	34.8	20.8	13.2	25.4	12.7	10.5	22.4	21.6	19.0	22.2	41.8	22.4	35.1	25.8	17.1	34.2	40.0	21.1	26.4	24.4	33.6	28.7	23.8	32.8	28.8	18.0	33.9	20.4	20.0	14.1	37.5	43.3	25.8	46.2	34.8	18.7	25.5	47.5	20.0	17.1	28.1	11.2	18.5	44.7	22.4	23.5	23.6	25.8	41.0	29.8	36.0	21.5	16.4	27.6	54.2	32.5	22.2	16.6	20.5	26.1	20.8	22.8	30.2	12.1	14.4	37.5	28.5	62.9	45.0	20.7	32.4	23.6	34.2	23.7	22.1	27.6	28.8	33.7	0.3	0.7	0.4	0.7	0.7	0.8	0.5	0.7	0.6	0.4	0.6	0.4	0.3	1.2	0.5	0.4	0.8	0.9	0.6	23.4	21.2	18.0	26.1	23.0	18.9	21.0	20.0	18.9	15.3	20.8	19.0	52.0	9.6	11.5	21.9	6.3	10.7	4.6	7.5	7.4	14.6	10.5	5.7	9.8	7.2	9.1	9.2	39.6	7.8	7.6	27.0	1.9	8.5	3.9	8.7	9.5	35.3	13.1	3.4	7.9	12.0	6.2	9.7	14.3	8.9	3.8	16.0	47.2	11.8	9.8	10.1	10.7	16.8	12.2	11.2	11.1	4.4	12.5	8.2	7.2	7.5	9.0	8.4	11.3	9.0	12.7	16.1	14.8	12.8	5.9	7.4	27.2	8.0	10.0	21.4	6.6	8.7	8.7	19.7	21.6	9.1	9.7	12.0	9.2	16.0	14.7	7.4
TAPT1	FLJ90013	ENSG00000169762	"Transmembrane anterior posterior transformation 1"	Q6NXT6	4	16160505-16227410	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis"	"Developmental protein, Receptor"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7;Late spermatids: 163.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042567	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome	"Nucleoplasm, Cytosol"	"HPA042567: AB_2678055"	"unprognostic (2.34e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (9.75e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.30e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (7.07e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (9.00e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.25e-3)"	"prognostic favorable (4.18e-4)"	7.4	15.1	17.5	6.0	18.6	25.7	10.0	17.3	22.3	8.2	15.1	8.9	6.4	10.0	9.2	6.1	9.5	6.7	9.1	17.1	17.0	12.4	30.5	11.9	9.6	18.6	17.4	8.1	8.1	13.0	8.5	6.8	18.4	7.4	8.2	24.7	7.6	6.4	35.5	7.7	7.5	9.3	17.4	8.5	7.9	11.1	17.5	12.2	11.5	19.9	8.1	7.6	6.9	19.5	4.9	3.6	6.0	7.0	8.9	6.8	2.5	7.8	6.0	7.4	8.1	4.9	8.5	31.7	8.3	5.0	10.8	4.0	5.2	4.0	9.3	2.9	6.3	6.2	5.0	5.2	8.4	12.6	6.2	4.2	7.7	7.3	5.3	9.1	3.8	19.3	9.7	14.5	7.2	3.5	18.7	10.1	4.0	9.3	8.4	45.0	8.4	5.8	12.0	5.1	10.0	8.0	7.4	6.2	9.5	4.1	11.5	12.3	7.1	6.2	4.1	4.2	10.3	13.9	12.2	24.2	12.4	30.9	7.3	1.1	0.3	0.0	0.2	0.2	0.0	1.0	0.7	0.4	0.5	2.5	0.9	0.7	0.6	0.3	0.3	0.8	0.5	0.3	17.5	18.6	17.3	22.3	17.1	17.0	18.6	17.4	18.4	17.4	17.5	19.5	12.0	32.1	62.6	47.3	20.2	9.1	6.3	4.2	4.0	24.5	15.0	9.9	14.3	10.0	8.7	7.3	114.7	4.2	16.2	11.1	3.9	6.7	79.0	14.2	12.6	12.8	14.4	16.6	42.6	8.2	3.1	10.2	8.6	12.0	2.5	17.5	8.6	46.0	4.2	70.7	43.6	9.8	4.1	10.3	18.9	163.1	9.9	11.1	16.0	45.0	6.5	33.1	8.2	60.8	68.2	9.5	9.4	15.1	8.9	7.1	10.7	8.7	14.4	62.4	6.6	17.0	11.5	33.3	5.7	7.1	8.0	7.0	10.8	16.5	9.0	6.6
TARBP2	Trbp	ENSG00000139546	"TARBP2 subunit of RISC loading complex"	Q15633	12	53500921-53506431	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051181, HPA061454, CAB069406"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB069406: AB_1622301, HPA051181: AB_2681376, HPA061454: AB_2684526"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.04e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (4.75e-6)"	"unprognostic (8.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.31e-1)"	9.2	13.1	9.8	9.2	10.0	6.8	8.9	13.4	11.3	8.9	9.5	9.5	9.0	8.5	7.9	13.1	11.7	6.7	9.7	9.6	10.1	18.6	20.6	10.1	10.5	10.0	10.0	8.0	18.7	8.5	8.5	13.8	9.9	11.3	5.5	6.7	11.0	5.1	9.8	9.8	9.5	6.1	9.9	15.2	12.4	13.1	10.8	10.3	12.0	7.1	9.0	10.4	8.9	10.5	25.5	69.1	26.8	29.6	15.3	20.8	35.0	22.6	19.2	34.1	20.3	61.2	33.5	24.5	44.6	24.9	22.2	20.0	32.8	34.1	19.9	30.5	54.1	28.6	26.6	43.9	33.3	48.0	31.9	24.3	21.0	35.2	16.5	23.2	41.2	36.6	37.1	38.3	24.9	102.9	32.5	62.9	53.0	19.7	37.1	23.9	14.4	31.6	22.6	26.4	34.8	24.8	11.8	28.7	58.9	19.1	40.4	63.7	22.1	31.2	29.8	11.9	27.4	19.7	39.6	26.1	34.8	24.2	35.6	2.1	11.5	5.7	13.9	11.9	13.3	10.9	13.3	12.8	14.9	15.3	13.7	13.6	0.7	13.1	7.7	13.3	11.7	12.5	9.8	10.0	13.4	11.3	9.6	10.1	10.0	10.0	9.9	9.9	10.8	10.5	5.2	0.0	8.2	4.6	10.7	6.4	10.5	15.3	17.1	9.3	12.0	10.0	6.0	15.7	11.2	9.2	10.4	46.5	7.2	9.8	21.5	20.7	10.7	7.9	8.8	11.6	5.4	9.4	2.3	26.2	48.9	9.3	13.7	7.2	10.8	10.5	12.1	18.4	25.6	1.7	3.1	10.8	18.3	9.3	4.7	23.8	5.6	7.9	14.2	1.0	12.2	10.2	10.3	4.5	6.2	16.8	9.9	4.1	15.6	11.2	11.3	28.6	7.1	14.2	0.0	4.0	10.0	11.6	13.0	14.4	4.7	32.2	9.0	9.9	14.8	10.1
TARDBP	"ALS10, TDP-43"	ENSG00000120948	"TAR DNA binding protein"	Q13148	1	11012344-11030528	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003703, HPA017284"	Supported		Enhanced	Nucleoplasm		NA	NA		29000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB003703: AB_425904, HPA017284: AB_1857775"	"unprognostic (3.72e-3)"	"prognostic favorable (1.15e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.71e-2)"	83.4	80.1	71.9	87.1	80.6	69.7	83.3	84.7	79.0	93.9	78.1	94.5	77.4	90.9	78.8	111.1	84.1	58.7	93.0	69.4	78.5	93.8	105.5	91.6	106.5	75.5	77.2	103.5	77.2	86.7	89.1	82.7	76.4	90.1	94.5	119.9	86.6	78.8	138.9	96.1	94.5	81.2	74.8	97.4	82.4	68.2	74.7	115.1	96.6	102.9	122.9	87.6	95.8	86.0	244.7	164.4	270.4	143.5	143.9	118.2	160.3	164.7	142.3	263.6	195.5	187.9	175.6	316.3	118.1	180.6	154.3	169.2	333.1	187.6	336.0	175.1	153.8	241.2	275.2	257.9	119.4	290.5	158.9	99.5	211.4	184.5	147.9	143.8	188.6	126.7	319.0	176.4	221.7	195.0	215.6	228.6	221.0	232.2	141.7	256.9	214.4	206.2	186.0	179.1	187.9	150.8	221.3	173.7	128.8	197.1	173.8	200.9	174.8	173.8	207.8	146.3	236.9	133.3	176.2	336.3	116.2	288.2	192.0	38.0	38.0	33.7	46.7	48.6	57.4	55.2	46.9	45.4	61.7	39.6	46.3	50.5	15.4	67.2	50.0	43.1	54.3	36.4	71.9	80.6	84.7	79.0	69.4	78.5	75.5	77.2	76.4	74.8	74.7	86.0	35.5	32.1	74.4	29.4	57.6	114.6	89.9	40.8	52.3	37.6	52.0	38.6	68.0	31.5	57.0	29.5	29.2	63.2	46.3	54.2	33.2	50.8	9.7	50.7	50.0	54.9	66.3	63.5	29.5	54.2	84.5	45.2	34.7	61.7	42.3	45.8	40.0	51.7	50.1	37.0	29.8	50.1	38.7	45.9	46.3	12.3	47.2	37.8	35.6	23.4	54.3	36.2	35.0	37.2	57.2	52.9	36.1	51.6	48.8	71.7	43.2	43.9	54.4	38.8	32.9	42.8	56.9	64.9	32.8	52.4	114.5	73.5	41.3	23.6	52.6	71.3
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	9.8	16.5	11.8	10.6	11.4	10.0	10.3	11.2	12.5	9.5	10.9	10.3	8.9	8.9	13.0	13.4	11.7	7.7	20.3	11.3	11.5	14.3	25.3	8.6	14.7	12.0	11.5	11.7	8.4	17.7	9.3	8.9	12.7	8.7	11.3	14.7	9.7	9.3	31.9	11.8	9.6	10.0	10.4	12.5	12.0	11.0	11.9	12.6	11.2	31.1	15.4	9.6	9.4	12.8	33.5	27.4	18.1	27.4	19.9	18.2	34.1	15.9	17.2	30.7	30.8	22.4	30.3	48.0	34.2	12.0	21.1	33.8	44.2	36.8	23.5	29.2	38.4	22.7	25.2	22.7	19.7	31.4	33.4	16.2	30.2	23.4	31.6	19.9	20.1	26.4	40.3	32.6	21.8	40.4	27.0	26.0	22.3	46.0	40.2	27.5	23.0	59.8	20.9	15.7	25.5	29.8	24.1	52.5	38.7	25.4	42.3	48.9	11.9	17.8	18.8	14.9	27.2	31.2	39.6	36.2	26.6	36.3	17.6	30.5	15.4	30.5	21.0	27.0	21.3	28.7	20.5	21.2	25.0	25.3	19.6	20.7	2.4	33.2	29.3	16.7	31.4	18.3	11.8	11.4	11.2	12.5	11.3	11.5	12.0	11.5	12.7	10.4	11.9	12.8	6.3	3.2	12.8	6.2	13.2	3.3	5.6	10.4	5.2	15.3	6.2	4.6	22.3	11.5	11.9	7.3	20.9	24.5	8.8	8.2	11.7	11.5	1.6	9.6	12.8	7.4	4.2	11.1	9.3	9.8	14.3	8.4	13.3	11.7	22.2	11.0	6.8	22.6	13.2	15.2	9.1	12.6	6.1	7.7	5.2	2.5	8.4	8.8	3.6	2.8	12.5	7.6	9.2	6.0	9.9	11.9	3.5	7.2	9.9	4.5	8.5	8.8	9.4	16.8	6.6	10.3	8.3	18.2	12.3	7.4	4.0	14.1	10.6	15.8	12.6	4.8
TAS2R42	"hT2R55, T2R24, T2R55, TAS2R55"	ENSG00000186136	"Taste 2 receptor member 42"	Q7RTR8	12	11185993-11186937	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036149	Uncertain		Approved	"Nucleoplasm,Actin filaments,Focal adhesion sites"		NA	NA							"Nucleoplasm, Actin filaments"	"Focal adhesion sites"	"HPA036149: AB_10672080"														"unprognostic (2.45e-2)"	"unprognostic (4.17e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R5	T2R5	ENSG00000127366	"Taste 2 receptor member 5"	Q9NYW4	7	141790217-141791367	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;NK-cells: 1.0;Oligodendrocyte precursor cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 5.3"									HPA053742			Approved	"Nucleoplasm,Nucleoli,Cytoplasmic bodies"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli"	"Cytoplasmic bodies"	"HPA053742: "	"unprognostic (5.48e-3)"	"unprognostic (3.90e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.13e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.39e-2)"	1.4	0.7	1.6	0.8	1.7	0.2	1.7	2.8	1.9	3.3	0.4	1.4	0.5	1.9	2.8	1.4	2.9	0.5	1.2	1.3	1.9	1.5	1.0	1.4	0.7	1.5	1.8	3.8	1.7	0.3	2.7	0.6	1.5	1.9	0.6	1.6	1.8	0.5	1.4	4.3	1.9	0.6	1.2	1.8	1.2	1.8	1.4	0.7	1.8	0.3	0.7	1.5	2.4	2.2	0.2	0.1	0.7	0.3	0.4	1.3	0.8	0.3	0.3	0.2	0.4	1.1	0.2	0.6	0.4	0.1	0.0	0.1	0.8	0.4	0.1	0.3	0.8	0.2	0.6	1.4	0.4	0.9	0.6	1.1	5.3	0.6	1.4	1.5	0.5	0.7	1.4	0.2	0.0	0.9	0.3	2.1	0.7	0.1	0.1	0.1	0.0	1.5	0.2	0.3	1.0	0.6	0.2	0.2	0.1	0.8	0.0	0.2	0.1	0.5	0.3	0.3	0.6	0.9	0.2	0.7	0.4	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.6	1.7	2.8	1.9	1.3	1.9	1.5	1.8	1.5	1.2	1.4	2.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0
TASL	"CXorf21, FLJ11577"	ENSG00000120280	"TLR adaptor interacting with endolysosomal SLC15A4"	Q9HAI6	X	30558809-30577766	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.5;lymphoid tissue: 10.9"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"THP-1: 166.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001185	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	1.8	1.8	0.6	10.9	0.6	19.5	2.1	0.7	1.0	1.1	1.1	3.5	4.7	0.6	0.4	1.6	0.8	3.9	0.6	0.7	0.6	1.1	2.4	4.7	10.5	1.3	1.1	0.3	0.3	0.7	0.3	2.9	1.3	1.0	3.4	0.2	1.0	0.6	0.1	0.7	3.0	2.2	0.9	9.8	3.6	0.3	1.5	5.8	0.6	0.4	10.2	4.1	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	13.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	21.5	0.0	0.0	0.0	20.5	0.0	21.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.0	0.0	0.0	0.0	0.0	0.1	15.0	1.6	7.5	0.0	23.9	0.0	8.6	21.9	24.1	1.6	19.8	0.3	23.0	2.0	1.1	25.3	23.6	1.8	1.3	30.6	7.1	44.4	45.9	3.4	8.0	0.6	0.6	0.7	1.0	0.7	0.6	1.3	1.1	1.3	0.9	1.5	2.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TASOR	"C3orf63, FAM208A, KIAA1105, RAP140, se89-1, TASOR1"	ENSG00000163946	"Transcription activation suppressor"	Q9UK61	3	56620133-56683237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.0;Cardiomyocytes: 31.4;Cytotrophoblasts: 14.5;dendritic cells: 12.1;Extravillous trophoblasts: 9.9;Fibroblasts: 10.7;Hofbauer cells: 20.7;Syncytiotrophoblasts: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006735, HPA017142"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA006735: AB_1852384, HPA017142: AB_1852382"	"unprognostic (1.46e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-3)"	"unprognostic (9.31e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.74e-1)"	9.5	8.4	4.0	15.4	8.4	11.8	11.4	8.7	5.3	12.0	1.7	11.7	10.0	12.3	7.4	11.1	13.1	11.7	6.2	2.2	3.6	10.2	7.9	11.3	20.7	5.1	5.6	14.2	12.4	21.1	4.4	9.4	6.0	9.3	12.4	9.9	8.9	9.4	2.6	7.1	11.3	12.3	5.9	14.7	12.8	29.2	4.5	21.3	18.8	6.9	19.3	12.5	3.8	12.0	49.2	19.2	29.2	23.0	15.5	26.7	14.6	21.4	22.0	20.1	21.1	15.8	35.8	77.3	7.9	21.6	33.9	19.1	29.3	25.1	29.2	38.3	14.8	30.4	27.3	7.1	10.9	32.2	46.1	12.9	20.6	19.6	35.1	23.7	26.5	28.8	29.8	43.3	26.0	17.3	39.8	6.4	16.3	25.9	29.0	20.9	28.9	25.9	19.0	35.5	19.3	23.9	46.9	18.5	23.2	16.6	30.6	36.7	28.6	25.9	23.7	23.8	33.1	39.2	58.5	38.6	30.1	46.7	35.0	0.6	0.8	1.1	1.2	0.6	0.7	0.7	1.0	1.2	1.0	1.1	1.1	1.2	0.2	0.9	0.7	0.7	1.0	0.6	4.0	8.4	8.7	5.3	2.2	3.6	5.1	5.6	6.0	5.9	4.5	12.0	25.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	14.5	12.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	9.9	10.7	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	9.2	2.1	0.0	0.0	0.0
TASOR2	"bA318E3.2, C10orf18, FAM208B, FLJ20360, KIAA2006"	ENSG00000108021	"Transcription activation suppressor family member 2"	Q5VWN6	10	5684838-5763740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.0;Cardiomyocytes: 28.0;Cytotrophoblasts: 11.7;dendritic cells: 18.4;Extravillous trophoblasts: 10.5;Fibroblasts: 8.1;Hofbauer cells: 10.3;Plasma cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038042, HPA038043, HPA061547"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558"	"unprognostic (3.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.25e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.12e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.39e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.23e-2)"	9.5	8.6	3.1	12.0	4.4	14.3	12.5	19.5	8.0	13.2	9.8	10.9	6.6	13.0	15.3	9.7	10.7	10.2	9.3	2.3	9.0	8.9	10.8	8.1	17.2	2.5	5.1	12.7	10.9	14.5	10.7	12.6	3.5	9.9	11.9	14.1	9.5	10.9	12.1	8.9	9.2	13.3	1.2	10.0	10.3	24.6	4.6	14.9	16.4	14.4	17.0	17.5	8.0	10.5	38.2	31.7	19.9	34.0	25.1	29.7	28.0	31.7	20.1	26.7	33.6	33.7	22.0	77.2	19.8	31.4	16.9	29.3	57.5	32.5	43.0	15.2	38.7	36.1	24.7	22.8	25.0	26.9	20.7	22.9	35.6	43.5	36.8	17.9	31.4	29.4	59.1	17.6	30.2	25.7	35.0	9.5	24.3	24.6	20.3	25.8	27.7	27.1	16.0	34.1	24.4	27.5	31.5	28.3	22.2	22.3	37.2	20.9	31.6	33.6	36.2	65.5	43.7	21.3	21.9	67.8	16.6	26.1	18.1	1.0	1.2	0.2	1.2	1.2	1.1	1.0	0.9	1.1	0.7	1.8	0.9	1.5	0.9	4.3	0.4	1.1	1.3	0.5	3.1	4.4	19.5	8.0	2.3	9.0	2.5	5.1	3.5	1.2	4.6	10.5	19.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	11.7	18.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	10.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	7.3	2.7	0.0	0.0	0.0
TATDN1	CDA11	ENSG00000147687	"TatD DNase domain containing 1"	Q6P1N9	8	124488485-124539458	"Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023634, HPA053045"	Uncertain		Supported	Nucleoplasm		NA	NA		660000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA023634: AB_1857779, HPA053045: AB_2682024"	"unprognostic (2.19e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.12e-2)"	23.4	18.7	16.0	15.8	16.8	16.9	39.1	16.8	21.9	20.1	13.0	21.2	18.1	23.5	21.0	16.4	23.5	14.6	23.1	16.1	17.1	28.1	25.2	14.8	19.8	17.0	16.9	39.5	44.8	24.4	8.9	13.6	18.5	17.2	22.4	13.7	27.7	15.0	52.2	20.4	18.1	19.7	17.1	12.2	22.7	12.3	16.4	27.1	36.9	43.9	20.0	21.0	17.3	19.4	65.5	45.1	42.5	30.2	36.8	69.9	31.9	35.5	38.1	43.3	40.0	44.7	69.1	49.7	77.4	38.6	33.6	53.7	52.0	51.9	71.6	64.0	34.3	45.6	36.5	39.1	70.2	35.5	17.0	52.5	80.5	63.5	132.4	48.3	35.3	48.4	38.1	31.4	59.1	198.4	52.8	21.6	42.7	132.8	58.8	35.4	31.7	55.7	61.3	45.5	35.7	49.2	39.2	80.3	87.2	39.3	52.7	38.1	28.4	30.8	82.7	57.3	96.7	40.0	65.3	62.1	57.9	61.4	27.1	29.3	11.0	4.3	12.8	9.1	19.1	17.2	19.5	16.2	15.6	16.6	27.7	24.8	2.1	17.7	6.6	14.0	22.5	14.8	16.0	16.8	16.8	21.9	16.1	17.1	17.0	16.9	18.5	17.1	16.4	19.4	39.8	16.0	27.1	25.5	37.0	64.7	100.9	129.4	75.7	19.3	79.5	131.4	23.9	21.5	55.6	27.6	14.6	66.6	26.7	17.8	107.6	55.2	7.0	40.1	43.0	31.9	16.2	23.8	36.6	62.0	62.5	42.7	29.6	44.4	20.8	76.5	26.7	40.2	54.6	16.8	35.2	41.6	65.1	36.7	43.6	6.7	49.7	36.3	48.0	30.0	51.6	24.8	37.0	20.1	48.6	40.8	34.3	34.6	34.1	94.2	57.8	128.9	33.8	19.2	19.7	64.7	57.5	34.6	45.1	54.0	58.2	59.7	38.9	68.6	60.7	82.6
TATDN3		ENSG00000203705	"TatD DNase domain containing 3"	Q17R31	1	212791828-212816830	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032092	Approved		Approved	"Nucleoplasm,Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Golgi apparatus, Focal adhesion sites"	"HPA032092: AB_10671086"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.34e-3)"	"unprognostic (5.02e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.96e-3)"	13.0	11.3	10.1	10.4	12.4	12.2	10.0	10.1	12.7	6.5	9.3	8.3	6.1	7.1	13.3	7.3	7.7	7.4	19.3	10.6	12.4	16.6	10.3	8.0	12.2	12.2	10.5	8.6	9.4	18.2	8.2	7.3	12.4	6.9	7.7	17.7	8.5	6.9	29.9	6.3	7.2	7.7	10.5	11.1	11.1	10.0	10.4	11.2	11.7	24.1	10.3	8.2	5.5	15.8	12.2	11.9	10.3	15.1	16.7	26.0	23.5	12.9	14.3	10.8	13.1	3.1	17.2	27.4	12.3	12.4	6.0	7.6	13.0	18.2	11.5	17.1	17.0	13.4	10.3	6.3	19.0	33.3	16.3	20.6	12.8	14.3	37.3	11.2	16.1	37.7	28.2	21.7	11.7	5.9	28.4	10.9	13.9	14.9	7.6	16.0	19.3	49.4	11.3	6.3	21.6	18.5	14.5	25.1	30.6	19.2	26.6	19.6	10.1	7.9	10.3	16.4	13.0	19.4	32.9	44.9	20.6	26.8	12.0	26.1	37.2	60.2	12.7	59.3	11.5	39.7	15.8	15.4	45.6	31.0	12.5	14.9	42.8	13.8	64.4	74.6	16.1	22.9	10.1	12.4	10.1	12.7	10.6	12.4	12.2	10.5	12.4	10.5	10.4	15.8	9.1	6.4	16.2	17.3	18.5	4.5	8.1	14.2	3.4	16.1	8.5	8.3	36.6	8.6	8.0	3.7	18.8	14.3	39.7	3.4	41.1	18.1	12.2	10.8	7.6	8.9	10.2	6.5	35.1	16.5	17.5	10.0	6.1	7.8	7.0	10.8	5.3	7.0	18.8	15.2	43.9	5.1	12.2	27.6	8.3	4.0	5.3	20.4	14.2	17.8	31.0	17.8	8.2	23.1	53.6	12.0	6.2	4.9	9.3	6.2	7.3	26.4	12.5	29.6	6.6	8.8	9.2	24.2	17.9	6.6	4.4	9.3	11.1	11.0	5.2	7.0
TAX1BP1	"CALCOCO3, TXBP151"	ENSG00000106052	"Tax1 binding protein 1"	Q86VP1	7	27739331-27844564	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024432	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA024432: AB_1857783"	"unprognostic (1.38e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.69e-1)"	"prognostic favorable (2.80e-6)"	"unprognostic (1.76e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.03e-1)"	57.0	107.0	58.0	54.9	61.1	106.6	78.7	62.5	67.6	64.7	71.5	72.3	63.4	63.5	88.2	113.6	78.4	73.1	128.1	56.4	65.7	102.2	80.4	69.5	57.5	61.2	59.9	55.3	69.9	125.2	44.7	104.2	61.3	83.3	79.6	124.3	91.6	79.7	94.4	57.1	67.9	66.0	59.6	66.2	76.3	77.2	63.6	76.7	98.6	89.2	67.8	101.5	52.4	64.5	180.9	98.2	98.1	93.4	151.9	109.9	66.5	131.5	160.9	96.6	120.1	79.8	142.8	38.3	120.9	193.5	166.1	125.0	92.8	86.1	149.8	72.3	48.2	103.6	98.5	160.2	143.0	152.7	117.9	93.7	175.2	112.4	127.9	115.7	105.5	65.3	117.3	113.9	197.5	66.5	67.4	150.1	110.7	234.6	91.0	55.6	105.3	79.1	136.7	200.8	64.9	105.4	184.5	237.8	280.6	187.1	111.1	226.5	114.6	90.5	140.1	113.8	87.8	207.6	154.1	71.2	106.1	283.6	212.3	155.3	81.3	211.8	68.6	100.4	84.4	70.8	81.7	81.2	59.6	62.3	74.5	75.2	163.7	63.4	114.8	55.0	117.1	85.8	58.0	61.1	62.5	67.6	56.4	65.7	61.2	59.9	61.3	59.6	63.6	64.5	111.3	214.7	199.3	58.1	122.8	183.3	269.4	220.7	100.7	375.3	161.6	98.2	595.7	134.4	268.4	128.8	95.9	154.7	178.2	209.3	412.8	211.5	124.3	342.9	128.2	142.9	140.0	160.4	107.4	262.9	105.6	156.7	118.3	245.9	148.8	101.3	78.9	106.3	123.1	159.9	107.0	162.1	242.1	144.7	107.3	94.2	116.8	191.4	113.8	86.2	260.0	189.8	141.1	82.0	105.7	301.4	166.1	148.6	157.4	291.0	146.0	323.4	546.6	147.6	105.2	126.6	202.7	221.8	137.5	121.7	191.9	621.4	166.1	197.0	140.3	393.3
TBC1D12	KIAA0608	ENSG00000108239	"TBC1 domain family member 12"	O60347	10	94402541-94536332	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 110.5;Oligodendrocytes: 397.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038277, HPA038645"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear speckles"		"HPA038277: AB_10672584, HPA038645: AB_10672650"	"unprognostic (7.23e-3)"	"unprognostic (1.58e-2)"	"prognostic favorable (1.79e-5)"	"unprognostic (7.83e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.21e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-1)"	5.8	3.6	13.5	3.1	26.5	1.1	5.6	28.3	16.0	4.6	8.2	6.1	4.5	4.1	2.8	3.3	3.8	3.6	3.8	12.4	17.8	4.0	3.7	4.7	2.5	40.2	26.7	3.9	4.6	13.3	2.6	5.7	35.8	4.1	6.8	7.0	3.2	4.3	4.1	4.9	5.1	4.3	25.1	4.9	3.6	8.4	23.0	1.3	3.3	4.1	2.6	4.6	4.1	46.1	7.3	3.2	4.1	6.1	5.6	6.8	5.4	4.6	9.5	5.1	4.7	12.8	3.1	0.0	2.7	6.8	4.9	4.0	4.9	3.4	6.5	0.0	5.7	2.3	2.9	4.1	4.2	0.0	1.8	4.6	4.3	5.3	6.9	8.6	5.5	0.0	3.4	7.4	8.2	4.0	0.0	0.0	1.3	5.2	3.3	0.0	5.3	3.9	4.6	3.2	1.7	4.1	4.6	4.0	3.9	3.7	8.6	4.4	5.4	3.5	4.8	5.7	3.7	5.1	5.3	0.0	3.5	0.0	1.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	26.5	28.3	16.0	12.4	17.8	40.2	26.7	35.8	25.1	23.0	46.1	11.0	9.6	5.3	34.9	7.6	19.5	6.5	2.9	10.8	17.5	10.6	9.1	6.5	4.3	4.3	9.2	10.4	19.4	0.6	18.1	0.0	5.8	22.6	7.6	9.5	13.7	8.4	5.2	46.8	5.1	13.4	23.8	13.7	10.3	5.7	3.5	8.9	4.8	19.1	8.4	66.7	8.7	4.1	23.6	25.9	9.2	8.4	20.9	16.0	110.5	11.7	8.9	1.0	60.8	397.2	7.6	13.2	10.5	12.0	11.7	11.7	5.9	4.0	28.0	13.1	11.7	12.0	64.3	13.5	11.4	19.2	24.4	1.5	6.3	11.8	10.3
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	26.3	42.1	42.7	31.5	41.9	15.9	27.6	38.7	43.9	19.4	50.2	26.4	22.8	20.9	22.9	34.0	23.5	17.0	30.4	42.9	44.9	44.5	27.4	24.4	29.8	49.3	45.6	28.7	19.5	41.9	27.1	23.8	44.8	24.5	26.3	18.5	31.7	20.2	51.6	49.5	26.0	22.9	45.7	34.9	58.5	30.0	48.7	40.1	19.2	41.3	26.9	19.8	22.2	44.2	34.5	36.8	40.4	45.5	32.8	27.4	24.5	27.0	29.3	24.7	21.1	38.3	69.8	54.9	15.6	32.5	62.8	24.5	68.4	61.7	30.0	15.5	22.2	91.8	23.8	40.4	22.7	42.0	197.9	21.3	85.8	23.4	38.3	31.5	23.5	51.2	88.6	19.3	30.2	22.3	64.9	42.5	54.9	41.1	40.8	80.2	53.2	59.9	36.8	23.9	61.6	44.0	22.4	24.1	84.3	31.2	33.3	39.4	23.7	27.2	20.5	24.0	40.3	36.7	91.6	55.7	25.4	53.2	26.6	2.6	13.2	5.6	8.6	8.2	13.1	8.1	9.3	9.3	10.7	8.3	6.9	6.6	40.6	8.6	3.9	11.5	11.9	10.8	42.7	41.9	38.7	43.9	42.9	44.9	49.3	45.6	44.8	45.7	48.7	44.2	8.4	6.4	17.7	22.5	15.5	9.1	7.0	15.8	15.9	10.2	21.1	16.3	4.6	10.0	14.8	14.7	14.6	12.5	16.3	17.7	19.6	11.5	68.0	12.3	10.3	7.8	6.6	7.2	25.6	10.2	7.1	9.5	14.8	11.9	7.6	18.9	8.2	24.4	26.0	25.2	25.1	15.7	10.2	33.6	8.7	41.0	7.2	27.8	19.6	27.2	24.4	13.4	16.5	51.8	27.0	11.8	14.2	8.6	15.4	12.9	12.8	19.8	10.7	6.6	0.0	12.7	7.1	17.7	18.0	19.8	11.9	16.4	16.3	12.5	19.9	10.1
TBC1D19	FLJ11082	ENSG00000109680	"TBC1 domain family member 19"	Q8N5T2	4	26576437-26756223	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Excitatory neurons: 106.6;Inhibitory neurons: 95.3;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039592	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"		"HPA039592: AB_10671043"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.94e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (1.21e-7)"	"unprognostic (1.04e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.51e-1)"	3.4	5.8	5.2	2.5	4.5	1.6	4.3	5.3	5.1	7.4	10.7	4.4	1.8	7.6	7.0	2.9	7.7	7.5	5.7	4.2	6.2	17.3	2.9	4.3	2.2	7.1	6.2	8.8	3.0	14.6	5.0	3.8	7.0	5.2	3.0	9.2	3.2	6.3	3.1	2.2	1.7	8.7	4.8	2.8	3.1	4.9	5.7	17.4	7.8	5.0	2.6	4.8	3.0	6.0	2.4	1.9	8.5	5.3	11.5	18.5	2.4	11.1	8.2	4.9	4.8	4.1	5.8	5.6	9.5	15.0	15.2	1.0	4.8	5.6	4.7	1.7	2.2	1.4	6.6	1.2	6.3	3.2	1.4	9.3	4.5	9.4	5.7	19.7	6.7	7.2	5.3	0.0	77.1	0.1	6.3	3.5	3.9	3.2	9.2	4.7	8.4	0.6	18.9	2.5	8.4	3.2	5.3	1.2	5.5	6.9	2.1	1.2	6.5	6.2	1.7	4.7	2.8	1.2	3.1	2.6	22.1	1.7	6.4	1.1	0.5	1.8	4.2	0.6	5.1	1.6	3.2	4.7	0.9	2.0	2.4	2.9	0.0	4.5	0.6	1.7	1.7	1.3	5.2	4.5	5.3	5.1	4.2	6.2	7.1	6.2	7.0	4.8	5.7	6.0	6.0	3.2	4.1	66.9	8.2	3.6	5.3	7.6	7.4	7.4	5.7	5.3	6.4	1.5	2.5	20.2	14.6	4.0	18.1	1.0	5.9	4.8	11.1	15.7	18.9	6.8	9.5	2.1	106.6	3.1	2.2	9.3	6.1	9.0	8.9	9.3	7.1	1.9	1.6	5.0	95.3	2.1	10.2	2.4	2.7	3.1	9.0	2.4	10.6	42.2	0.8	7.4	13.4	102.5	72.4	2.6	0.4	9.1	5.5	1.9	0.6	19.2	17.4	19.3	0.0	9.5	11.1	25.6	8.9	3.1	4.5	1.9	14.4	13.1	1.6	2.3
TBC1D2	"Armus, PARIS1, TBC1D2A"	ENSG00000095383	"TBC1 domain family member 2"	Q9BYX2	9	98199011-98255649	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Oligodendrocytes: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 27.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 77.0;HaCaT: 98.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030871, HPA076521"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA030871: AB_10670046, HPA076521: "	"unprognostic (2.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.30e-1)"	8.8	5.3	11.1	5.7	16.0	13.1	7.8	12.3	26.0	10.8	8.5	8.6	12.6	4.4	1.5	37.4	5.5	4.0	3.7	10.6	12.9	6.4	19.8	32.0	3.8	14.9	14.9	2.9	3.0	3.5	4.4	7.2	16.4	12.0	4.4	3.4	14.7	6.1	4.3	24.3	10.1	2.8	11.4	9.4	7.0	3.4	23.3	3.0	8.1	1.4	4.9	11.7	17.3	23.9	77.0	10.8	0.5	2.5	8.2	15.9	24.3	33.2	18.4	23.8	19.6	6.9	32.8	1.3	24.7	19.6	5.2	98.1	0.7	36.8	8.3	2.6	1.4	0.7	38.0	5.4	37.6	1.7	2.9	21.7	59.8	23.6	58.7	41.5	8.6	2.1	2.4	1.0	19.0	9.9	0.4	4.6	1.6	7.4	6.2	1.2	4.8	0.2	36.0	46.7	0.9	1.4	11.3	24.4	3.4	1.7	8.1	2.6	51.7	28.8	8.6	4.8	13.6	1.6	1.5	0.6	29.0	2.9	3.2	2.1	27.5	8.4	2.5	15.3	1.8	1.2	3.8	2.2	10.0	0.8	1.6	1.9	11.9	1.2	12.3	1.3	5.5	10.8	11.1	16.0	12.3	26.0	10.6	12.9	14.9	14.9	16.4	11.4	23.3	23.9	2.9	57.7	12.5	5.2	2.4	8.3	18.5	30.4	21.6	3.3	2.7	5.6	0.7	4.3	23.3	3.7	0.0	21.5	0.9	16.2	3.9	3.3	1.8	4.6	3.7	5.0	7.7	0.4	4.6	3.2	10.9	2.4	6.1	10.3	0.0	0.6	1.1	6.1	32.0	1.7	5.4	12.6	18.3	16.2	1.8	1.2	1.8	18.3	3.6	4.7	7.5	4.4	3.1	12.1	64.9	14.4	10.7	0.7	1.7	9.2	16.4	3.2	10.8	2.4	0.0	1.8	3.4	2.1	3.0	29.8	10.9	17.4	2.4	0.7	5.7	17.1
TBC1D22A	C22orf4	ENSG00000054611	"TBC1 domain family member 22A"	Q8WUA7	22	46762617-47175699	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 252.9;Oligodendrocytes: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001173	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA001173: AB_1080212"	"unprognostic (1.62e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (5.95e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.39e-1)"	13.4	12.3	10.5	14.4	9.9	10.4	11.8	9.0	10.5	11.8	7.9	12.5	14.9	10.5	6.8	18.1	12.1	9.3	12.9	10.4	9.2	13.3	11.0	12.7	19.4	11.3	11.5	9.8	14.7	12.0	11.2	12.0	10.7	9.3	9.5	4.9	14.1	7.8	17.9	17.6	15.0	7.6	9.8	19.1	14.8	7.3	11.0	14.7	12.3	11.3	18.4	11.0	12.3	11.4	19.1	13.0	8.1	9.9	11.6	16.1	9.9	12.8	17.2	14.3	15.3	14.8	14.5	16.6	13.9	19.5	8.9	20.7	7.0	20.0	9.9	7.2	19.6	9.5	11.1	28.6	17.7	20.9	7.4	18.9	23.0	9.8	13.6	17.2	23.7	10.4	6.2	17.4	13.1	9.8	9.3	10.7	8.0	17.9	14.6	11.8	9.5	17.9	16.7	9.7	6.6	12.3	11.8	4.5	20.1	10.0	10.5	13.7	19.5	10.9	15.3	11.5	8.2	11.5	3.9	10.5	27.0	10.6	6.9	2.5	10.7	6.3	6.4	15.5	6.0	11.6	5.9	6.1	12.5	13.0	3.9	4.3	15.5	5.5	18.6	6.1	10.2	6.6	10.5	9.9	9.0	10.5	10.4	9.2	11.3	11.5	10.7	9.8	11.0	11.4	20.3	25.6	18.3	81.0	47.0	6.4	12.1	21.1	21.6	18.6	9.9	7.9	8.6	14.3	20.2	7.3	18.8	24.4	22.7	27.9	11.7	25.8	13.9	20.1	14.2	19.0	3.6	13.5	82.0	23.5	19.6	12.2	39.3	14.5	17.1	13.3	23.2	7.9	33.1	21.9	94.2	16.2	18.3	23.0	16.7	3.5	9.9	32.7	10.6	252.9	39.4	13.7	29.9	76.9	113.2	30.2	25.2	11.7	28.8	10.5	39.4	19.8	15.0	27.3	13.1	12.3	11.8	7.9	10.5	18.5	8.0	29.0	22.7	12.7	18.4	11.8
TBC1D22B	"C6orf197, dJ744I24.2, FLJ20337"	ENSG00000065491	"TBC1 domain family member 22B"	Q9NU19	6	37257772-37332970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027908, HPA027909, HPA027910"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203"	"unprognostic (9.83e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.53e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.73e-2)"	5.8	12.1	8.3	5.1	8.4	18.3	5.7	8.3	8.2	7.9	8.8	6.5	7.9	6.4	7.4	14.1	8.2	5.9	7.4	8.3	8.0	8.6	6.1	8.0	5.8	7.7	8.1	9.4	12.8	10.7	6.7	6.0	7.9	8.2	7.7	7.7	11.8	5.5	15.0	15.2	8.5	6.7	7.1	7.2	7.5	10.0	8.5	13.5	7.7	7.8	7.1	7.5	9.3	8.1	13.2	5.5	9.9	10.9	9.1	9.1	14.2	7.2	15.0	13.2	16.2	12.6	8.5	12.3	7.4	9.2	17.9	8.9	12.7	11.6	14.8	19.9	10.4	19.5	9.0	17.2	13.0	11.1	15.9	7.8	16.6	13.0	15.4	12.6	18.9	20.4	22.5	3.1	9.6	11.9	16.6	8.4	13.0	15.0	5.1	10.7	9.1	9.6	13.6	9.5	13.0	8.4	7.9	11.2	14.3	13.3	8.2	19.7	18.4	8.0	12.2	5.5	9.6	11.1	12.4	80.8	5.5	16.5	12.6	1.4	2.6	4.4	2.3	3.5	2.7	1.7	2.6	2.3	4.0	2.0	2.8	2.4	1.1	3.0	1.5	1.1	1.9	2.6	8.3	8.4	8.3	8.2	8.3	8.0	7.7	8.1	7.9	7.1	8.5	8.1	4.1	3.2	5.6	17.9	6.3	8.2	8.5	7.5	8.0	5.0	6.0	3.7	5.8	7.2	10.1	1.8	4.2	6.3	4.6	15.1	3.9	12.3	5.6	10.6	3.6	4.9	1.8	10.5	20.3	15.4	9.2	4.2	3.1	8.1	5.7	5.0	3.6	3.9	5.8	0.0	22.0	4.9	10.2	4.4	7.8	5.0	3.1	4.1	1.8	6.5	6.0	3.6	6.2	14.1	24.1	15.0	6.8	1.2	5.6	10.0	11.2	9.0	15.8	4.5	0.0	4.2	3.6	6.5	6.4	10.8	15.9	6.7	6.6	3.2	6.3	11.2
TBC1D26	MGC51025	ENSG00000214946	"TBC1 domain family member 26"	Q86UD7	17	15732247-15749192	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.5"	"Group enriched"	"Detected in some"	79	"Early spermatids: 171.9;Late spermatids: 145.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-698: 1.4"									HPA050460	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA050460: AB_2681136"	"unprognostic (3.65e-2)"	"unprognostic (2.31e-1)"		"unprognostic (7.90e-2)"	"unprognostic (3.22e-1)"			"unprognostic (1.16e-1)"		"unprognostic (3.20e-1)"			"unprognostic (5.15e-9)"	"unprognostic (9.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.16e-2)"	0.0	0.0	2.3	0.0	2.4	0.0	0.1	1.7	2.9	0.4	1.6	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	2.5	1.8	0.1	0.0	0.1	0.0	1.9	1.8	0.3	0.0	0.0	0.2	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.7	0.0	0.0	17.5	1.8	0.0	0.1	0.0	0.1	0.1	0.1	1.9	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.4	1.7	2.9	2.5	1.8	1.9	1.8	1.9	1.7	1.8	1.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	145.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D8	"AD3, GRAMD8, HBLP1, VRP"	ENSG00000204634	"TBC1 domain family member 8"	O95759	2	101007228-101252866	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 30.1;non-classical monocyte: 38.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 38.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 82.9;ASC TERT1: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015211, HPA037496"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nuclear speckles"		"CAB015211: , HPA037496: AB_2675507"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (4.25e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.73e-2)"	"unprognostic (7.98e-3)"	17.3	6.3	4.7	8.9	4.4	12.7	21.8	8.7	5.0	14.4	8.3	9.0	7.1	10.6	7.8	15.4	19.9	18.1	38.6	5.1	6.3	17.0	24.8	23.2	7.2	6.8	5.3	8.4	34.3	17.5	13.0	3.1	6.7	44.0	6.0	6.5	19.0	30.3	83.7	28.1	28.7	6.9	4.3	14.5	27.2	18.1	5.9	6.4	9.6	79.7	6.8	13.1	17.5	4.1	5.1	30.1	2.6	8.6	82.9	57.8	24.4	3.1	51.8	2.1	2.6	10.8	8.0	2.6	27.1	2.3	42.5	15.5	5.0	23.5	1.4	1.5	4.6	1.5	11.1	37.7	5.7	0.3	26.0	27.4	21.8	2.8	21.6	1.7	30.2	4.5	0.7	2.6	2.7	13.3	2.8	15.8	6.7	3.6	32.3	6.4	7.5	0.6	17.0	32.3	18.7	9.2	4.2	7.4	10.8	4.0	2.1	23.1	26.0	1.3	4.5	4.4	2.1	5.0	0.4	0.2	10.9	7.7	8.0	0.0	9.7	0.4	0.2	30.1	0.3	0.4	0.3	0.2	5.0	1.5	0.6	0.4	0.3	0.0	38.2	7.2	0.2	4.1	4.7	4.4	8.7	5.0	5.1	6.3	6.8	5.3	6.7	4.3	5.9	4.1	4.3	3.2	4.6	10.7	2.8	4.1	38.3	7.2	23.9	6.4	15.0	3.9	12.2	18.6	14.4	5.5	4.2	4.6	4.8	1.1	0.0	8.2	6.0	42.6	4.7	9.8	3.0	0.8	43.5	3.0	2.8	4.3	31.6	23.7	7.0	0.9	11.7	5.6	3.7	1.7	42.8	2.2	10.2	13.8	17.7	10.9	3.1	27.7	5.4	22.5	28.1	1.0	0.0	23.6	6.5	2.6	2.4	1.9	1.4	35.0	4.8	1.2	31.9	3.7	6.6	24.7	4.3	3.6	4.0	29.8	6.3	3.4	1.6	2.7	1.1	29.7
TBC1D9B	"GRAMD9B, KIAA0676"	ENSG00000197226	"TBC1 domain family member 9B"	Q66K14	5	179862066-179907897	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038350	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038350: AB_10673170"	"unprognostic (5.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.53e-2)"	"unprognostic (9.45e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (8.22e-2)"	54.9	61.8	53.9	20.8	62.2	22.8	46.3	58.1	51.1	39.3	38.6	34.1	22.8	38.9	12.0	43.9	34.2	23.8	30.9	51.4	50.1	44.8	55.0	31.7	23.9	60.5	59.8	39.0	46.4	27.0	29.2	17.2	61.6	33.6	12.1	9.1	37.0	25.0	45.9	44.4	34.4	21.1	63.4	39.5	35.5	20.5	57.2	13.1	36.3	18.7	15.3	35.1	35.7	65.9	42.7	64.0	27.4	62.4	69.9	49.0	66.8	51.0	47.2	50.1	48.4	43.8	41.9	29.3	60.2	57.8	56.6	39.6	28.3	115.9	9.8	98.0	39.1	26.0	47.3	27.9	41.5	35.1	85.0	50.6	42.6	39.2	18.9	22.6	48.4	55.3	17.7	28.1	39.5	104.2	22.7	24.5	20.3	17.4	36.5	38.7	22.1	27.8	35.1	66.8	40.1	30.4	48.2	54.5	54.9	11.0	45.0	48.8	57.2	71.2	31.9	34.8	45.2	16.8	23.3	22.7	68.0	41.7	51.7	5.0	7.8	5.5	6.1	9.2	4.8	6.3	4.2	4.9	9.3	5.1	3.9	3.5	0.9	4.2	9.2	9.5	4.0	7.1	53.9	62.2	58.1	51.1	51.4	50.1	60.5	59.8	61.6	63.4	57.2	65.9	24.9	22.4	19.2	20.2	19.7	16.6	10.2	14.6	15.4	27.8	23.9	21.6	9.5	12.8	14.0	27.6	8.4	19.8	20.4	28.4	13.7	21.1	2.4	18.2	20.2	21.0	18.0	17.5	32.1	18.0	23.6	21.1	21.9	27.0	11.4	30.0	24.3	35.2	30.7	62.2	23.6	23.9	10.2	33.5	15.7	8.2	32.3	28.6	16.0	15.9	21.4	17.8	24.7	14.6	27.0	25.2	24.3	28.6	16.4	15.3	24.4	22.6	13.3	18.0	26.3	26.7	16.4	11.1	18.5	25.0	15.6	14.1	17.9	57.1	20.5	13.7
TBCK	"HSPC302, MGC16169"	ENSG00000145348	"TBC1 domain containing kinase"	Q8TEA7	4	106041599-106316683	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.8;Excitatory neurons: 196.6;Inhibitory neurons: 221.1;Microglial cells: 128.4;Oligodendrocyte precursor cells: 147.2;Oligodendrocytes: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 44.0;BJ hTERT+ SV40 Large T+ RasG12V: 81.7;HBF TERT88: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039951, HPA051611"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA039951: AB_10795300, HPA051611: AB_2681550"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.81e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (8.17e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-1)"	7.4	5.2	5.6	3.0	5.3	1.3	3.4	11.0	6.1	4.5	8.3	3.2	2.3	4.3	6.0	4.2	5.3	5.6	2.8	6.1	7.0	6.3	4.4	4.1	3.0	5.2	5.3	6.4	5.8	4.8	3.9	5.5	6.0	4.7	3.1	7.6	3.6	6.0	1.6	4.1	3.3	4.7	3.5	3.6	3.5	6.1	6.9	4.7	5.5	4.3	2.6	5.2	3.0	10.1	1.4	5.9	9.0	2.7	36.7	19.1	1.1	8.1	8.9	44.0	81.7	10.9	6.4	2.3	13.0	28.0	7.0	5.4	5.7	8.1	59.3	5.1	1.8	14.1	4.5	10.3	9.7	2.7	6.3	20.9	5.9	4.1	7.1	14.5	11.1	6.0	7.2	3.8	10.2	7.7	5.2	3.7	2.0	14.4	2.0	4.1	3.7	6.8	11.1	9.0	4.4	4.1	8.2	4.0	5.6	7.6	4.8	8.5	8.3	7.7	4.3	2.4	4.4	2.5	6.1	6.8	10.1	5.6	5.0	14.1	5.1	5.1	4.7	5.7	5.6	4.8	4.9	6.4	4.8	7.9	5.6	5.2	0.4	5.2	3.8	4.4	5.5	4.0	5.6	5.3	11.0	6.1	6.1	7.0	5.2	5.3	6.0	3.5	6.9	10.1	7.7	19.2	25.2	134.8	13.9	2.3	6.4	9.0	17.1	20.7	8.2	6.9	8.2	5.7	15.5	14.7	20.9	11.5	9.0	3.5	3.9	4.3	45.7	10.2	15.9	8.9	5.4	9.2	196.6	0.9	6.6	12.5	15.3	21.1	11.4	21.5	8.6	4.6	6.8	11.8	221.1	5.7	10.2	6.2	1.6	28.2	11.1	7.7	5.4	128.4	4.6	8.1	10.3	147.2	188.8	2.2	8.0	12.8	10.4	4.3	4.8	8.0	11.9	15.3	0.0	10.6	9.6	14.5	8.2	14.2	2.4	7.4	10.6	13.9	5.5	4.5
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64452090-64502114	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA045797: AB_2679457, HPA060211: AB_2684222"	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	11.6	15.3	6.0	10.1	6.1	16.9	11.4	5.6	6.9	10.6	5.3	10.5	15.1	11.0	6.7	11.3	9.5	10.1	9.4	5.8	5.6	11.8	17.4	12.9	14.6	6.5	6.9	9.6	7.5	11.6	9.8	13.7	6.1	10.6	8.5	6.3	10.2	9.0	18.4	8.6	11.4	10.8	5.3	13.4	10.2	23.5	6.7	6.8	8.5	14.9	12.9	16.0	10.2	7.1	23.3	24.2	11.1	10.6	24.7	26.1	29.0	22.9	37.6	22.5	21.1	14.9	12.4	31.5	21.4	26.8	34.4	19.0	19.4	20.0	26.4	29.5	17.1	33.0	15.3	19.1	30.2	35.2	36.4	18.5	19.1	23.1	23.6	42.3	32.4	11.0	27.9	38.7	31.6	27.0	0.9	17.0	29.9	22.9	13.8	14.9	15.3	31.8	25.1	36.9	9.8	14.7	33.3	36.0	23.5	23.5	33.1	24.9	25.9	20.2	18.1	14.9	24.0	25.4	54.3	30.3	28.1	18.6	26.1	41.8	10.1	24.3	13.9	17.7	16.3	12.8	10.1	15.2	12.2	10.1	2.8	8.7	17.8	26.6	15.5	2.1	13.6	10.0	6.0	6.1	5.6	6.9	5.8	5.6	6.5	6.9	6.1	5.3	6.7	7.1	23.7	19.2	20.5	28.4	21.6	11.0	25.7	20.1	15.4	17.0	14.9	9.1	10.9	8.6	23.4	22.0	10.4	28.8	30.0	14.1	11.7	19.3	34.5	19.2	17.9	28.6	17.3	18.3	50.5	23.6	32.6	21.3	15.3	30.2	43.1	17.5	16.8	17.1	20.2	18.5	42.2	10.5	12.2	23.0	30.2	29.2	19.3	31.1	14.2	46.9	31.4	12.7	33.0	39.2	52.3	16.9	10.9	20.7	25.6	43.7	13.6	12.3	20.8	16.3	26.3	22.4	18.7	68.9	12.7	14.0	14.9	92.6	27.1	11.5	10.1	41.6
TBKBP1	"KIAA0775, ProSAPiP2"	ENSG00000198933	"TBK1 binding protein 1"	A7MCY6	17	47694081-47712050	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062347, HPA064856"	Approved		Approved	Nucleoplasm		NA	Yes			"Cluster 1: Neutrophils - Mixed function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA062347: AB_2684744, HPA064856: AB_2685371"	"unprognostic (2.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (8.14e-6)"	"unprognostic (5.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.59e-5)"	13.9	10.9	25.2	8.5	22.3	6.7	12.0	11.4	29.9	17.1	6.3	15.3	3.1	14.0	2.1	11.3	14.2	8.1	16.4	27.3	19.3	12.9	3.4	12.3	6.0	18.4	19.8	21.4	9.6	10.1	11.6	9.5	18.2	13.4	2.2	10.4	15.9	9.3	35.5	7.4	7.8	7.9	11.6	18.4	10.5	14.2	24.4	3.2	11.7	22.3	3.4	14.9	12.3	18.5	0.5	10.0	18.3	19.4	9.2	9.3	11.9	10.1	10.6	4.9	5.8	62.8	1.5	0.3	9.9	12.6	8.7	1.1	14.4	2.6	2.9	12.3	32.6	26.8	9.8	10.7	21.2	5.1	5.7	18.8	6.5	1.1	1.8	15.2	17.4	7.3	23.5	0.0	2.8	2.8	3.3	25.2	25.5	0.5	7.0	12.0	5.7	10.5	6.1	0.8	15.8	29.5	4.8	1.2	5.2	17.2	11.0	11.4	20.2	15.1	17.8	18.4	1.2	6.8	0.7	12.4	8.8	9.6	3.9	0.0	0.2	0.4	1.0	0.1	0.5	0.0	0.3	0.8	0.2	0.2	0.1	0.3	2.2	0.9	0.0	0.2	0.2	0.1	25.2	22.3	11.4	29.9	27.3	19.3	18.4	19.8	18.2	11.6	24.4	18.5	15.5	0.0	1.1	13.4	2.4	4.0	3.2	0.9	1.8	13.7	2.8	3.4	3.7	1.5	1.1	3.7	2.1	0.1	6.3	0.0	1.9	1.1	6.9	0.7	3.5	9.7	5.3	3.2	6.9	1.8	0.2	3.9	2.6	1.2	0.0	4.2	10.4	1.1	3.2	28.6	12.1	0.5	4.1	2.9	4.0	6.6	8.7	2.2	1.8	5.6	1.1	4.7	5.2	9.5	1.2	0.9	0.0	8.6	2.2	5.5	0.0	5.0	0.8	3.7	0.0	1.5	2.7	3.8	5.3	2.0	3.0	0.3	3.9	1.3	0.1	2.2
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 103.8;Oligodendrocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	9.3	9.1	20.0	8.7	21.3	7.2	9.7	17.4	16.7	18.1	14.2	9.4	2.8	38.4	35.3	10.2	16.6	7.1	7.3	16.7	21.1	16.6	13.6	5.8	9.0	23.8	20.2	18.0	9.2	23.9	18.7	20.7	19.7	25.4	5.3	16.5	7.3	43.2	4.6	7.5	5.0	26.6	18.6	8.4	8.1	9.7	26.7	18.4	12.0	5.2	10.2	13.5	12.7	20.0	0.1	29.6	18.5	49.2	16.8	17.4	18.4	11.3	25.0	21.3	22.2	22.4	20.2	31.6	0.8	22.7	9.1	6.7	40.7	8.9	30.9	13.0	19.6	20.0	35.6	26.5	23.7	7.2	68.6	15.6	10.1	22.3	11.8	11.7	19.9	17.2	35.8	53.5	12.5	25.6	17.8	27.2	36.7	14.2	31.5	39.3	14.5	39.3	28.9	16.9	23.4	10.6	27.2	6.8	16.9	48.2	13.3	15.6	29.1	7.5	18.3	0.8	4.6	32.6	27.8	25.1	27.2	17.4	7.1	6.3	4.7	5.7	2.2	2.9	1.8	2.2	1.7	2.0	3.5	3.6	3.1	2.9	18.7	0.3	2.0	0.3	2.9	2.1	20.0	21.3	17.4	16.7	16.7	21.1	23.8	20.2	19.7	18.6	26.7	20.0	12.6	0.0	4.5	103.8	17.3	6.5	13.2	3.8	9.1	11.8	19.1	18.0	10.1	20.0	6.8	31.3	22.9	78.1	20.4	7.9	13.7	10.7	1.0	34.4	80.7	10.3	22.8	3.8	12.5	7.8	6.0	13.1	9.7	51.1	11.4	32.5	11.4	64.3	11.3	6.7	17.1	5.4	2.0	33.0	22.8	3.2	14.3	19.7	5.4	61.8	37.5	46.6	19.6	46.3	109.7	7.5	7.9	28.6	9.5	24.1	0.2	21.8	10.0	24.5	0.0	9.4	27.9	1.4	18.0	16.5	12.4	45.0	18.8	22.3	4.9	23.7
TBL1XR1	"C21, DC42, FLJ12894, IRA1, TBLR1"	ENSG00000177565	"TBL1X receptor 1"	Q9BZK7	3	177019340-177228000	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 280.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019182	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019182: AB_1857800"	"unprognostic (4.11e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-3)"	"prognostic favorable (5.16e-5)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (3.75e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	18.8	20.3	7.2	24.4	12.7	30.2	21.7	13.9	11.8	24.9	8.5	31.0	24.6	16.9	9.2	21.2	22.4	23.2	32.6	16.0	3.3	22.3	24.5	19.6	31.3	8.1	8.5	20.9	12.1	27.3	2.9	21.0	4.9	25.6	24.4	42.7	16.1	14.8	12.9	17.1	18.7	19.4	8.6	22.9	22.3	19.1	8.4	45.5	47.1	25.3	36.3	25.3	10.3	15.0	96.8	41.2	61.1	39.7	56.2	65.8	44.2	26.1	52.3	30.3	36.3	48.9	76.2	98.9	132.9	43.6	58.4	61.2	42.9	63.2	58.7	97.5	14.5	56.2	66.8	30.3	49.7	91.0	29.6	95.3	35.9	37.3	90.6	53.8	48.5	68.5	44.8	189.9	42.8	31.0	81.7	14.0	38.1	59.8	32.2	53.9	72.6	124.6	33.1	119.5	24.8	38.7	43.3	35.9	49.8	37.3	113.0	74.3	60.5	48.9	35.3	28.8	65.6	89.8	117.6	280.7	32.9	66.2	56.1	14.3	3.7	3.8	5.6	6.2	5.9	7.5	6.9	7.3	4.6	7.3	5.9	7.4	12.9	7.4	5.5	12.4	8.3	5.3	7.2	12.7	13.9	11.8	16.0	3.3	8.1	8.5	4.9	8.6	8.4	15.0	55.1	73.7	60.7	128.0	56.5	91.5	55.1	90.6	62.0	113.6	69.2	42.2	101.9	47.1	80.3	104.8	125.1	28.9	70.0	84.7	29.4	52.2	7.4	90.9	59.0	65.5	85.3	60.4	228.9	43.8	35.1	81.8	44.4	134.5	25.3	65.9	48.5	66.6	37.8	116.1	167.6	72.6	59.0	91.1	75.0	9.0	64.0	69.4	65.8	184.6	55.8	47.6	41.2	241.8	269.4	66.7	43.7	73.0	75.1	144.9	41.5	67.3	83.9	81.6	46.0	76.3	54.4	12.9	61.4	88.1	111.8	27.5	66.0	41.6	84.6	83.6
TBL1Y	TBL1	ENSG00000092377	"Transducin beta like 1 Y-linked"	Q9BQ87	Y	6910686-7101970	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 2.9;thyroid gland: 1.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Inhibitory neurons: 2.2;Oligodendrocyte precursor cells: 1.0;Squamous epithelial cells: 5.7;Urothelial cells: 1.1"	"Cancer enriched"	"Detected in single"	6	"prostate cancer: 1.7"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-698: 12.3"									"HPA050857, HPA060073"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA050857: , HPA060073: AB_2684196"						"unprognostic (2.81e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.06e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"		"unprognostic (3.24e-2)"	0.3	0.0	0.1	0.0	1.3	0.0	0.3	0.1	0.4	0.0	0.4	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.4	0.9	0.6	0.1	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.8	0.3	0.4	0.2	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	1.6	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	1.9	0.0	2.2	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.4	0.1	0.4	0.2	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.2	3.4	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	5.7	0.0	0.3	0.0	0.0	0.0	1.1
TBP	"GTF2D1, SCA17, TFIID"	ENSG00000112592	"TATA-box binding protein"	P20226	6	170554302-170572870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009442, HPA049805"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB009442: AB_632480, HPA049805: AB_2680890"	"unprognostic (2.86e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.55e-3)"	"unprognostic (7.10e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	10.2	10.5	9.4	9.6	9.6	15.6	10.4	10.8	15.1	10.5	9.1	11.8	8.5	12.6	8.1	11.3	11.7	8.2	9.9	10.1	11.5	11.0	11.5	9.7	14.0	10.2	10.2	12.8	11.7	9.3	9.3	10.8	10.2	10.5	8.5	8.9	10.3	7.6	12.8	10.7	11.9	9.6	8.7	14.9	11.7	34.5	9.7	11.9	10.5	10.6	12.2	10.6	10.8	12.3	12.9	14.0	24.4	31.2	12.5	14.2	23.0	20.5	15.6	19.9	21.1	28.9	12.7	27.1	16.4	16.7	28.6	18.9	31.6	16.8	21.2	31.5	23.2	27.6	16.6	26.1	18.1	32.7	23.1	13.8	19.2	22.9	25.8	16.3	15.9	37.2	49.7	16.5	18.3	19.3	32.8	31.8	24.5	27.3	11.0	28.6	20.0	23.8	14.5	6.5	10.4	24.9	24.1	17.8	16.0	20.7	12.4	40.7	17.6	13.5	19.1	22.2	32.0	24.4	35.1	42.3	18.5	27.0	21.9	67.4	30.8	39.8	37.8	32.2	44.4	52.9	36.7	38.6	30.2	49.9	47.3	40.0	44.4	35.0	45.4	42.6	37.2	21.8	9.4	9.6	10.8	15.1	10.1	11.5	10.2	10.2	10.2	8.7	9.7	12.3	8.4	9.6	6.9	6.8	16.5	5.5	5.3	11.6	20.5	7.5	8.3	7.4	9.9	15.7	10.0	12.9	8.4	15.8	10.5	6.2	3.9	6.6	26.9	7.8	9.3	9.5	7.2	17.5	13.7	4.7	13.5	9.2	7.7	10.7	1.3	13.0	13.2	8.0	10.1	0.0	12.8	7.5	22.4	14.0	5.3	7.7	10.8	9.8	1.8	10.3	8.5	5.4	6.2	11.1	16.2	6.6	7.9	10.5	18.7	8.5	8.2	8.9	7.2	6.7	13.1	6.6	11.1	88.1	17.4	18.3	6.7	13.5	11.1	10.1	8.0	6.7
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 126.7"	"Group enriched"	"Detected in all"	5	"Early spermatids: 407.5;Spermatocytes: 557.4;Syncytiotrophoblasts: 244.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	12.1	11.7	16.9	12.0	18.9	37.5	10.5	19.0	23.0	10.4	12.7	11.7	13.3	12.3	8.1	11.7	13.1	11.8	11.9	19.3	19.4	9.2	13.7	9.7	21.3	14.2	12.9	12.5	8.1	10.4	11.7	14.8	14.2	12.2	14.3	15.0	9.1	12.3	6.4	9.0	12.9	11.1	11.7	12.6	11.7	126.7	20.0	19.8	16.8	9.2	16.9	15.1	9.8	16.5	16.5	19.6	43.9	28.5	32.6	33.3	24.5	29.9	31.5	39.1	51.1	23.0	13.0	49.8	20.2	24.1	43.8	21.2	28.0	32.3	46.8	38.3	35.9	87.8	11.5	25.5	33.0	46.4	32.8	20.8	32.2	43.8	47.1	30.7	37.6	43.3	129.3	33.4	28.1	37.0	39.2	27.8	49.2	23.6	25.1	26.7	26.4	19.5	23.2	14.3	56.5	56.2	17.7	23.2	37.8	36.9	10.5	18.5	34.4	22.5	32.4	50.0	33.6	27.2	31.5	32.8	37.7	30.0	27.4	133.1	31.7	81.8	62.7	33.3	69.8	67.6	53.1	67.1	29.8	60.2	50.6	59.5	74.8	52.5	38.3	35.4	60.5	64.0	16.9	18.9	19.0	23.0	19.3	19.4	14.2	12.9	14.2	11.7	20.0	16.5	35.6	6.4	12.2	10.7	43.2	70.7	27.0	46.7	46.1	22.8	29.8	34.2	12.8	28.6	21.1	7.3	18.8	40.7	59.1	16.8	29.4	29.1	407.5	20.6	17.1	40.8	71.0	51.4	35.3	25.2	69.7	30.8	36.7	14.8	40.0	13.5	22.9	11.2	24.4	15.2	25.2	26.5	48.8	14.8	43.2	75.1	21.1	38.3	32.0	22.5	21.3	23.3	42.2	27.2	27.7	31.4	24.2	18.4	35.2	39.7	17.9	28.4	28.2	12.3	19.7	27.3	35.1	557.4	72.8	36.7	65.8	244.9	50.0	11.0	24.3	37.6
TBRG1	"FLJ14621, NIAM, TB-5"	ENSG00000154144	"Transforming growth factor beta regulator 1"	Q3YBR2	11	124622836-124635926	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 21.6;HMC-1: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055645, HPA068022"			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA055645: AB_2682873, HPA068022: AB_2685942"	"unprognostic (1.64e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.13e-3)"	5.5	7.2	6.4	5.5	9.5	4.0	4.3	5.3	9.8	3.8	5.9	5.9	6.2	3.9	4.0	5.0	4.1	3.1	4.3	6.9	6.6	6.2	8.1	6.0	6.4	5.6	5.2	2.7	8.1	2.3	4.1	3.8	5.3	5.1	5.4	1.8	5.6	3.0	10.1	5.1	8.4	2.5	5.1	8.3	6.8	3.4	6.0	3.9	5.7	3.9	6.1	4.3	4.0	7.2	3.7	3.1	2.7	1.5	4.6	3.1	2.7	3.7	2.5	2.0	1.8	6.0	2.7	4.4	4.5	3.7	4.0	4.5	3.5	4.8	3.8	4.5	2.7	21.6	1.8	3.9	3.2	6.7	20.9	3.2	8.1	3.7	2.8	2.3	3.6	3.6	7.4	4.8	5.1	1.7	3.0	6.6	2.9	8.6	2.1	2.7	3.6	3.2	3.3	3.6	2.2	2.3	2.1	3.5	2.5	2.5	5.6	3.3	5.5	4.5	1.8	1.5	3.2	3.8	6.2	5.1	2.5	7.8	3.2	30.5	24.3	35.1	25.6	22.9	19.1	34.0	25.9	22.1	14.8	30.6	27.4	22.1	33.1	14.6	21.7	23.9	27.5	13.1	6.4	9.5	5.3	9.8	6.9	6.6	5.6	5.2	5.3	5.1	6.0	7.2	37.9	44.8	56.5	37.9	67.2	46.1	52.0	37.5	67.2	19.2	34.8	30.6	24.0	40.0	39.5	23.9	12.5	32.9	58.0	46.4	52.8	38.8	61.3	25.1	31.1	42.7	28.3	43.3	113.8	47.4	28.8	45.9	39.3	25.9	72.1	23.6	31.8	69.7	36.2	30.3	53.6	46.7	30.5	45.8	66.8	11.5	37.9	55.9	33.8	41.2	53.6	33.5	64.9	33.7	50.1	58.5	43.2	33.4	62.1	88.7	61.9	90.4	33.9	19.5	26.3	39.3	83.3	52.0	24.7	42.5	48.2	48.3	65.7	27.7	33.4	68.6
TBX10	"TBX13, TBX7"	ENSG00000167800	"T-box transcription factor 10"	O75333	11	67631303-67639560	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	14	"intestine: 9.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.8;Intestinal goblet cells: 103.8;Paneth cells: 20.4;Proximal enterocytes: 42.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.4;NTERA-2: 5.3;RPMI-8226: 3.6;SK-BR-3: 12.5;U-2 OS: 2.5"					"Low region specificity"	"Detected in single"			"HPA047881, HPA076197"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA047881: AB_2680199, HPA076197: "	"unprognostic (4.66e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.83e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.29e-2)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.17e-10)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.75e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.4	5.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.4	0.0	0.0	0.0	9.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	12.5	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.9	0.0	0.0	0.0	103.8	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	20.4	0.0	0.0	0.2	42.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.1
TBX15	TBX14	ENSG00000092607	"T-box transcription factor 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 46.8;skeletal muscle: 132.2;tongue: 114.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.2;Fibroblasts: 11.1;Hepatocytes: 15.3;Melanocytes: 7.2;Skeletal myocytes: 13.1;Smooth muscle cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 52.6;ASC TERT1: 22.1;BJ hTERT+ SV40 Large T+ RasG12V: 20.4;fHDF/TERT166: 28.2;HSkMC: 37.9;RH-30: 29.1;U-2197: 27.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"spinal cord: 3.3"	"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Centrosome	"HPA052245: AB_2681771, HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	29.8	0.1	0.8	0.0	1.0	0.0	16.1	0.7	1.3	0.1	2.1	0.1	0.0	0.2	0.1	1.9	0.4	0.5	3.1	0.7	0.6	1.0	46.8	0.6	2.7	0.6	0.7	0.1	0.1	0.5	1.5	0.1	0.7	1.4	0.0	0.2	6.9	0.0	132.2	9.4	0.1	0.1	0.5	0.0	0.1	0.7	0.9	0.3	1.9	114.7	1.3	0.4	0.3	0.7	1.4	0.0	0.0	0.0	52.6	22.1	0.0	4.7	6.4	12.3	20.4	0.0	0.0	0.0	2.6	28.2	0.0	0.0	0.0	0.0	4.9	0.0	0.3	0.0	1.4	0.0	0.1	0.4	0.0	37.9	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	14.1	0.0	0.0	0.2	2.3	0.0	0.2	0.0	29.1	0.4	3.0	1.4	0.6	0.0	1.6	0.0	0.6	0.6	0.0	0.6	0.0	6.6	4.0	27.3	0.2	0.4	0.2	0.0	13.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.7	1.3	0.7	0.6	0.6	0.7	0.7	0.5	0.9	0.7	3.2	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	8.2	0.1	0.0	1.2	0.0	0.0	0.3	0.0	0.0	11.1	0.0	0.1	0.0	0.0	0.0	15.3	0.1	0.0	0.2	0.0	0.0	0.0	4.0	1.1	0.0	0.1	7.2	1.9	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.1	12.5	0.2	0.4	0.0	2.0	0.0	0.3	0.1	0.0	0.0
TBX18		ENSG00000112837	"T-box transcription factor 18"	O95935	6	84687351-84764598	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.3"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 57.4;ASC diff: 39.0;ASC TERT1: 40.4;RH-30: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006807			Supported	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA006807: "	"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	10.3	2.0	1.6	0.9	3.1	0.0	6.1	1.1	3.4	1.9	4.6	0.7	0.1	1.4	0.4	3.1	1.8	1.5	6.6	1.3	1.3	0.4	0.2	0.3	1.8	1.7	1.2	2.7	0.5	0.4	1.6	1.8	1.6	0.6	0.4	0.1	1.6	1.1	1.3	4.7	1.1	0.5	1.5	0.0	0.4	1.0	2.1	0.6	1.7	1.4	0.2	4.5	2.9	1.7	0.0	57.4	0.0	0.0	39.0	40.4	0.0	23.5	11.5	17.4	16.5	0.4	0.0	0.1	0.0	9.8	0.0	3.0	0.0	13.8	14.0	0.0	23.2	0.0	0.0	0.0	5.0	0.0	23.1	17.1	1.3	12.1	25.8	0.0	20.2	0.0	30.7	0.2	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	37.3	0.0	0.3	0.0	0.2	1.2	0.0	1.0	9.0	1.4	0.0	31.0	18.2	0.0	4.8	17.6	0.0	0.3	0.0	0.0	10.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.1	3.4	1.3	1.3	1.7	1.2	1.6	1.5	2.1	1.7	1.6	0.0	0.0	0.3	0.0	5.5	0.0	0.4	0.0	0.0	0.2	0.3	2.3	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	6.9	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.4	0.0	2.1	6.1	2.3	1.2	0.1	8.8	91.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.2	0.1	0.0	1.6	16.9	0.4	3.1	0.1	4.4	0.1	0.8	0.8	0.3	0.0
TBX2		ENSG00000121068	"T-box transcription factor 2"	Q13207	17	61399843-61409466	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 62.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 134.1;Collecting duct cells: 95.6;Muller glia cells: 139.8;Sertoli cells: 170.9;Smooth muscle cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 129.3;MCF7: 78.5;SH-SY5Y: 65.4;SK-MEL-30: 49.3;WM-115: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA008586, CAB013636"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"CAB013636: , HPA008586: AB_1080222"	"unprognostic (6.18e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.34e-3)"	21.1	3.7	2.9	2.6	3.4	0.0	16.1	2.7	4.6	14.5	1.7	9.8	4.9	22.0	14.1	7.1	15.7	4.5	19.9	2.2	3.2	31.7	4.9	62.8	1.0	3.8	4.1	10.2	3.6	2.1	6.2	24.7	3.8	16.3	1.8	6.3	4.2	27.5	8.1	5.6	11.4	4.6	2.3	13.7	11.5	5.4	3.9	0.8	15.9	5.8	0.5	31.2	13.0	2.2	0.5	1.9	0.0	129.3	4.2	4.4	15.6	22.4	21.2	1.0	0.2	3.6	0.4	0.0	1.6	3.3	2.5	0.0	2.4	0.0	0.4	0.0	8.8	2.2	0.0	6.4	14.0	0.4	2.1	8.0	0.2	23.4	1.3	0.3	0.0	0.0	0.5	0.0	1.4	78.5	0.0	0.4	0.1	0.0	9.4	0.0	5.3	0.2	0.0	31.0	0.3	65.4	0.0	0.0	49.3	0.2	1.6	2.5	0.0	2.9	0.0	7.3	4.7	0.1	0.3	0.0	17.6	0.0	43.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.4	2.7	4.6	2.2	3.2	3.8	4.1	3.8	2.3	3.9	2.2	12.7	0.0	0.6	2.3	0.1	0.6	0.3	0.0	0.0	134.1	0.4	1.1	11.1	0.0	0.0	95.6	22.9	0.4	0.5	0.0	1.9	0.1	0.8	1.4	45.7	12.2	0.0	0.0	0.1	0.0	0.4	13.7	0.5	1.6	0.0	0.1	12.1	0.0	0.9	1.7	0.0	0.0	0.0	1.0	1.8	1.1	39.4	1.1	1.8	5.6	0.0	139.8	0.0	0.0	0.1	0.0	0.0	47.4	0.0	0.5	0.0	25.1	0.0	13.4	170.9	0.8	104.0	0.4	0.7	0.1	0.3	0.3	0.9	1.1	0.0	0.2
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box transcription factor 3"	O15119	12	114670255-114684175	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 178.4"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 613.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 103.0;BJ hTERT+: 97.3;RT4: 129.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA005799: AB_1857817, HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.28e-4)"	13.3	178.4	5.1	2.5	4.7	0.0	34.1	3.9	5.7	37.5	2.9	7.4	37.6	32.8	44.6	2.8	24.0	4.5	13.2	3.8	14.9	12.9	31.3	32.8	1.4	4.6	4.4	44.2	2.9	1.0	12.9	41.3	4.8	80.4	3.7	1.8	18.9	53.2	10.4	14.9	30.3	10.0	3.8	7.0	6.0	1.3	6.6	1.3	50.0	16.5	1.7	53.9	34.2	3.7	2.4	18.2	0.0	0.0	26.1	35.6	40.1	103.0	97.3	39.0	38.3	16.3	4.4	0.0	1.6	18.0	2.4	4.7	8.4	3.6	47.7	0.0	12.3	0.0	4.8	48.1	8.4	0.0	0.0	16.0	2.4	13.1	26.8	0.0	0.5	0.0	3.8	0.0	3.4	1.6	0.0	0.5	0.2	53.0	5.4	0.0	0.0	2.6	0.0	129.3	6.6	19.4	14.6	6.6	3.6	44.6	5.1	0.2	0.0	11.9	7.7	6.8	33.9	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.7	3.9	5.7	3.8	14.9	4.6	4.4	4.8	3.8	6.6	3.7	48.9	0.0	1.9	0.3	1.8	9.8	85.2	5.8	7.4	14.3	110.3	80.5	12.5	0.0	1.1	35.0	4.2	60.7	0.7	12.0	0.0	0.6	1.5	3.3	144.7	38.6	4.9	0.0	0.0	0.0	7.0	41.3	5.1	3.8	0.0	3.9	1.1	40.2	6.1	1.7	0.0	23.9	4.1	0.9	4.6	2.8	5.3	2.9	3.6	14.0	0.0	1.9	0.0	0.0	0.0	0.3	22.4	6.0	0.0	72.4	37.9	0.1	0.4	2.0	39.5	27.2	58.2	0.1	3.8	3.2	9.8	613.9	2.0	112.0	12.1	69.1
TBX5	HOS	ENSG00000089225	"T-box transcription factor 5"	Q99593	12	114353911-114408442	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 88.1;lung: 20.8;placenta: 28.7"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 104.7"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 18.9;BJ hTERT+: 41.5;BJ hTERT+ SV40 Large T+: 9.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HAP1: 16.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008786, HPA064683"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA008786: AB_10601720, HPA064683: AB_2685320"	"unprognostic (3.09e-2)"	"unprognostic (1.53e-1)"			"unprognostic (3.79e-2)"	"unprognostic (2.75e-1)"		"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-7)"	"unprognostic (2.29e-2)"	"unprognostic (1.68e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.38e-3)"	3.4	0.0	0.1	0.0	0.0	0.0	4.4	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	88.1	0.9	0.0	0.0	0.0	20.8	0.6	0.3	0.1	0.0	0.0	1.3	0.0	28.7	0.3	3.4	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	5.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.9	41.5	9.2	12.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	16.3	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.2	2.9	0.0	0.6	1.6	0.0	0.1	0.0	0.0	0.0	4.5	0.1	0.1	104.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.1	0.0	0.0	0.0	2.1	0.3	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	7.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0
TBX6		ENSG00000149922	"T-box transcription factor 6"	O95947	16	30085793-30091924	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4;Urothelial cells: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"OE19: 4.1;RT4: 6.9;U-266/70: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062498			Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA062498: AB_2732686"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.62e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.05e-3)"	"unprognostic (4.26e-2)"	1.1	1.9	3.3	0.7	3.9	0.5	1.4	3.1	4.1	3.6	2.4	1.8	1.2	1.1	0.7	13.8	1.7	0.8	1.3	3.1	3.3	3.2	1.9	1.4	0.8	3.7	3.7	1.8	4.3	1.0	1.9	0.3	3.9	3.3	0.3	1.7	2.8	1.2	2.0	3.5	1.7	0.4	3.4	2.4	4.7	1.8	4.0	0.9	2.8	0.5	1.5	4.4	7.3	4.5	0.6	0.7	0.4	0.7	1.0	0.5	0.5	0.2	0.1	0.0	0.1	0.9	2.9	1.2	1.5	0.1	0.1	0.8	0.3	0.5	0.0	0.9	0.5	0.8	1.4	0.7	0.7	0.1	1.7	0.2	0.8	0.1	0.3	0.6	0.4	2.7	0.1	2.9	0.0	2.6	0.5	0.3	0.6	4.1	0.6	2.0	0.0	2.1	0.0	6.9	0.9	1.3	0.1	0.5	0.8	0.3	1.2	1.2	0.3	0.8	0.4	0.4	0.0	6.9	1.7	0.2	0.8	1.2	0.2	1.2	0.6	0.2	0.4	0.6	0.3	0.3	0.2	0.3	0.3	1.2	0.4	0.4	0.8	0.3	0.2	0.2	0.5	0.3	3.3	3.9	3.1	4.1	3.1	3.3	3.7	3.7	3.9	3.4	4.0	4.5	1.0	0.0	0.6	2.6	2.7	1.1	3.4	4.2	4.0	1.9	1.2	1.4	0.5	0.0	3.7	1.8	8.4	1.7	0.5	0.7	0.0	0.8	0.1	0.9	0.8	1.9	0.0	3.2	0.2	1.2	0.8	1.1	3.6	1.0	0.0	1.1	0.4	0.4	0.5	0.0	0.4	1.2	4.1	0.8	1.7	0.2	0.9	1.2	0.0	1.9	0.6	1.9	2.1	0.0	2.7	3.5	1.6	1.2	0.2	3.2	2.6	0.7	3.0	3.4	6.6	2.7	1.4	2.6	3.9	6.2	1.0	2.3	0.8	0.5	1.6	9.4
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"parathyroid gland: 2.6;pituitary gland: 1.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TC2N	"C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N"	ENSG00000165929	"Tandem C2 domains, nuclear"	Q8N9U0	14	91779746-91867536	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 103.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 84.6"	"Group enriched"	"Detected in many"	47	"NK-cells: 39.2;T-cells: 84.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.1;OE19: 63.8;RT4: 37.3;SK-BR-3: 43.9;T-47d: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA027549	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nuclear bodies"		"HPA027549: AB_10603346"	"unprognostic (5.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (6.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.09e-2)"	14.3	2.3	0.1	14.2	0.7	5.1	27.7	0.2	0.5	9.5	1.4	16.5	12.1	11.4	5.1	21.6	11.8	25.2	8.5	0.2	0.3	6.9	2.9	14.4	22.0	3.1	0.5	6.5	103.0	19.8	6.9	1.5	1.6	17.2	15.2	0.5	46.5	7.8	3.1	13.7	14.5	5.8	1.4	11.1	24.9	5.9	0.7	11.5	12.5	1.2	24.5	18.4	13.9	0.7	9.2	1.5	0.0	0.0	1.6	0.0	12.2	0.0	0.2	0.0	0.0	6.5	19.1	6.0	0.4	0.1	0.2	1.0	9.0	9.0	0.0	0.1	4.7	0.0	2.4	0.0	0.0	0.0	0.0	0.2	9.3	0.0	0.5	0.0	0.0	0.5	0.1	4.7	0.0	16.3	0.0	0.0	1.3	63.8	0.0	0.1	0.0	0.0	4.3	37.3	7.0	0.0	0.8	43.9	0.0	2.4	22.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	38.4	0.1	84.6	0.7	42.0	49.0	0.1	0.2	33.6	28.7	1.3	39.2	0.2	0.2	14.8	22.5	0.1	0.7	0.2	0.5	0.2	0.3	3.1	0.5	1.6	1.4	0.7	0.7	10.0	41.7	79.6	0.7	12.4	53.4	31.3	38.1	33.6	0.4	94.3	34.3	0.9	48.6	73.1	25.8	0.0	1.0	39.6	50.2	1.9	73.3	18.5	51.4	13.6	10.9	31.8	1.7	14.4	211.7	3.6	21.2	124.4	118.6	7.0	2.5	5.7	0.6	0.3	0.0	1.8	58.5	48.8	3.0	12.7	32.7	56.8	4.0	60.5	10.3	3.1	3.5	53.5	0.5	1.6	91.7	40.0	12.8	15.6	49.1	13.6	7.5	81.0	0.1	0.0	13.2	4.5	33.8	11.8	45.4	82.5	5.5	111.0	0.1	51.7	86.8
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022456	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	52.7	46.0	44.1	56.5	47.5	81.2	62.2	44.7	58.3	55.3	42.5	49.7	47.1	55.6	45.8	53.9	52.4	42.6	35.9	42.0	46.0	59.8	90.4	46.7	98.3	47.2	44.6	61.9	68.4	80.0	28.2	49.3	47.0	59.0	50.7	49.0	56.5	54.2	42.0	49.8	46.9	52.4	47.5	49.5	52.2	36.8	44.2	72.4	124.2	41.7	112.6	54.6	41.4	55.1	161.3	157.9	138.1	145.7	99.3	121.8	100.9	122.1	147.3	143.5	160.2	91.4	131.0	392.5	136.9	147.0	152.5	120.9	182.3	116.6	212.9	225.0	88.5	293.6	71.5	139.5	309.7	116.8	122.7	88.5	308.1	137.4	606.2	121.3	128.2	132.9	191.1	334.0	135.5	75.6	245.8	83.3	229.1	265.0	47.1	185.1	48.2	72.5	204.0	107.0	129.9	95.5	101.9	91.0	356.3	132.2	129.6	132.6	110.6	106.1	96.3	120.6	114.5	201.1	134.4	260.9	184.9	133.2	152.1	82.3	64.1	78.7	103.9	63.1	98.3	213.8	107.0	96.7	81.8	174.1	93.9	99.3	23.1	97.5	60.6	116.7	153.0	73.5	44.1	47.5	44.7	58.3	42.0	46.0	47.2	44.6	47.0	47.5	44.2	55.1	94.7	89.8	106.2	24.2	253.2	135.5	128.3	98.9	257.2	77.0	129.2	124.3	23.9	82.9	109.4	99.3	89.6	115.5	143.8	61.0	168.3	121.0	86.4	126.9	145.4	92.5	87.2	330.7	17.7	109.9	125.1	118.8	111.6	124.4	98.7	75.7	66.4	160.7	87.7	57.2	20.1	96.6	118.0	89.5	134.2	191.0	134.8	124.2	117.4	17.8	132.5	166.0	170.0	22.1	29.7	121.1	71.6	132.8	341.1	146.0	72.2	207.6	110.6	104.5	78.9	102.6	130.4	94.9	103.1	237.2	150.6	112.1	154.8	108.5	88.1	148.6
TCEA2	TFIIS	ENSG00000171703	"Transcription elongation factor A2"	Q15560	20	64049836-64072347	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 173.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043836	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Centrosome	"HPA043836: AB_2678694"	"unprognostic (6.51e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.79e-1)"	32.9	31.0	63.0	9.7	62.9	8.5	32.1	58.0	105.9	45.8	32.9	43.7	6.2	42.7	13.2	14.2	42.0	16.7	40.1	63.4	61.6	39.7	56.9	23.9	12.8	70.5	61.8	55.8	19.3	31.0	57.7	17.5	71.8	39.2	3.2	12.1	22.2	25.3	41.6	24.7	21.6	14.0	54.2	30.7	25.8	91.9	62.5	15.4	38.5	14.0	6.0	38.2	31.6	62.8	17.1	18.7	29.7	50.2	26.5	15.8	11.5	16.8	20.0	31.4	15.0	11.4	30.5	19.4	38.6	21.8	18.0	45.8	12.3	15.5	6.1	12.0	21.8	7.2	37.3	29.1	38.8	8.3	9.9	24.9	13.4	8.1	10.3	43.9	21.6	24.4	12.8	35.5	9.7	41.5	34.4	41.5	18.4	22.8	44.7	32.1	21.7	51.0	17.1	12.2	28.5	48.4	18.0	12.0	46.3	9.8	34.0	21.3	30.7	56.2	28.3	31.5	10.2	40.2	28.4	10.7	50.1	9.4	11.5	1.6	1.0	3.2	2.2	1.2	0.9	7.5	1.9	1.6	1.3	2.8	3.3	2.1	0.5	2.6	1.9	2.1	3.9	1.0	63.0	62.9	58.0	105.9	63.4	61.6	70.5	61.8	71.8	54.2	62.5	62.8	43.3	0.0	3.1	20.5	34.5	22.6	38.3	17.6	38.7	54.1	44.9	64.0	31.0	30.0	11.5	71.7	27.1	27.6	13.6	0.6	107.6	35.6	123.6	30.8	44.3	40.7	19.1	5.7	21.9	16.0	13.4	43.9	13.7	21.0	2.5	62.8	47.5	47.6	17.4	65.6	19.0	2.8	16.2	16.8	23.7	173.1	51.9	20.5	62.2	7.5	18.4	123.3	10.3	8.5	17.0	24.3	2.1	49.2	14.7	31.2	11.6	115.6	16.1	37.1	26.3	43.2	48.9	126.1	39.0	13.2	20.2	20.8	18.7	42.3	3.6	25.9
TCEA3	TFIIS.H	ENSG00000204219	"Transcription elongation factor A3"	O75764	1	23380909-23424748	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 513.3"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 214.8;Hepatocytes: 205.9;Intestinal goblet cells: 376.2;Proximal tubular cells: 260.9;Undifferentiated cells: 223.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 8.4;naive CD4 T-cell: 13.6"	"Lineage enriched"	"Detected in many"	5	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.3;Hep G2: 55.1;OE19: 28.7;SiHa: 18.2;T-47d: 28.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044960, HPA055811"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA044960: AB_10964053, HPA055811: AB_2682932"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-3)"	"unprognostic (9.18e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.77e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-3)"	"unprognostic (7.37e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.58e-2)"	17.5	95.6	4.7	4.6	4.3	0.6	19.6	4.1	4.7	35.7	7.8	87.1	15.8	17.0	7.3	40.5	28.3	11.6	71.6	4.0	4.4	64.9	160.7	20.4	2.4	6.0	4.9	81.9	229.4	16.3	14.9	3.9	5.4	59.9	39.8	3.2	100.3	14.5	513.3	53.4	35.2	9.2	5.2	10.6	75.9	4.7	4.1	1.8	41.2	173.1	4.5	36.2	38.7	5.1	0.0	0.1	0.5	0.5	2.5	15.3	9.0	6.4	4.1	3.2	1.9	4.1	0.5	0.2	0.7	7.9	1.0	9.1	0.5	0.1	2.8	0.0	0.1	0.0	6.9	55.1	1.9	0.8	0.0	10.1	2.8	2.9	0.0	7.1	0.4	0.1	0.0	0.0	1.1	1.5	0.4	6.1	0.0	28.7	1.8	0.1	0.0	0.2	0.0	0.1	0.5	0.1	18.2	0.8	0.8	1.5	28.4	2.8	0.4	0.0	0.2	0.7	0.0	0.5	5.3	0.0	0.5	0.5	0.6	0.0	0.2	0.0	0.4	0.7	0.4	0.0	8.4	1.1	2.9	0.0	13.6	6.1	0.0	0.2	0.2	0.9	0.8	2.3	4.7	4.3	4.1	4.7	4.0	4.4	6.0	4.9	5.4	5.2	4.1	5.1	10.5	125.0	109.5	4.2	1.9	27.4	53.4	30.9	30.7	2.3	46.3	42.4	109.8	100.1	57.2	42.3	2.1	3.3	1.9	158.0	199.6	37.7	6.1	7.7	6.6	13.4	55.9	5.7	2.8	97.9	33.9	45.2	69.3	20.8	9.5	214.8	8.2	205.9	1.5	25.2	4.5	376.2	6.1	7.6	65.4	17.9	17.1	8.4	24.9	3.7	3.2	6.8	3.1	2.0	1.3	25.5	143.0	15.4	0.5	38.8	154.3	260.9	29.4	1.4	19.7	90.1	24.0	0.7	2.6	61.1	54.8	2.2	8.4	52.0	223.5	73.9
TCEAL1	"p21, pp21, SIIR, WEX9"	ENSG00000172465	"Transcription elongation factor A like 1"	Q15170	X	103628704-103630953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Leydig cells: 283.6;Peritubular cells: 387.8;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057345, HPA060384, HPA076762"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA057345: , HPA060384: AB_2732648, HPA076762: "	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.54e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.56e-2)"	"unprognostic (8.76e-2)"	34.9	54.7	33.9	13.8	35.6	9.9	39.4	33.6	47.1	107.9	32.6	61.1	15.2	140.8	40.3	37.8	114.3	34.8	32.2	36.0	37.8	25.1	19.0	30.5	14.1	31.7	31.4	174.8	20.3	31.9	33.9	17.8	35.2	63.3	16.8	14.7	16.1	79.3	55.1	17.3	29.2	95.0	31.4	26.2	40.3	20.1	35.8	12.2	31.9	33.6	9.8	97.9	58.3	33.6	21.8	20.6	11.4	15.8	48.2	33.2	15.2	30.2	30.3	28.9	31.2	9.1	21.1	10.0	30.4	39.3	43.9	21.2	19.2	16.0	21.4	0.0	23.9	13.6	27.2	17.8	21.7	0.1	19.7	40.9	30.4	22.4	12.3	47.7	30.1	11.4	5.1	5.5	58.7	24.1	12.1	0.3	3.8	19.3	32.9	12.4	36.8	0.1	40.4	21.3	15.7	13.2	30.6	14.4	35.4	8.3	13.5	12.7	24.0	20.9	7.7	49.3	15.7	5.4	18.6	0.3	27.4	0.1	21.3	26.8	13.2	0.8	15.3	9.4	22.5	31.9	13.7	12.9	26.4	24.9	18.2	20.8	1.4	22.6	4.0	20.9	13.2	12.8	33.9	35.6	33.6	47.1	36.0	37.8	31.7	31.4	35.2	31.4	35.8	33.6	26.5	16.0	31.2	9.4	10.4	29.7	52.7	38.4	24.5	21.8	47.3	42.8	32.9	28.6	37.2	25.8	2.1	30.0	8.9	6.2	56.7	22.9	2.5	27.5	50.0	32.2	27.6	9.1	22.1	24.6	29.8	37.4	7.7	21.9	26.6	22.7	46.1	19.7	34.7	21.9	20.4	13.2	30.5	21.0	23.1	11.7	283.6	16.5	19.6	6.5	19.7	38.6	19.6	16.6	10.3	11.7	17.5	387.8	5.1	18.4	15.0	52.8	48.0	12.3	151.2	32.6	45.3	6.0	8.5	15.5	21.3	7.3	11.3	32.5	19.4	17.6
TCEAL3	"MGC15737, WEX8"	ENSG00000196507	"Transcription elongation factor A like 3"	Q969E4	X	103607451-103629690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 165.3;Peritubular cells: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA045564, HPA058982"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (2.55e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.05e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (6.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-3)"	"unprognostic (7.19e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.64e-1)"	43.0	61.9	109.1	15.2	111.0	14.9	42.9	108.8	137.0	101.4	111.0	74.0	11.8	171.1	32.4	25.5	120.6	21.2	66.0	104.8	124.0	55.7	9.8	47.5	10.3	117.0	122.9	163.1	34.0	47.7	108.6	17.8	118.0	97.6	9.5	45.9	34.7	70.0	21.5	33.6	32.2	43.1	112.1	43.7	57.5	34.3	116.7	7.0	50.7	10.7	8.0	126.7	68.3	117.5	81.5	8.6	21.5	17.6	72.6	36.8	0.7	118.4	56.4	53.1	70.0	0.0	7.8	0.0	14.3	87.1	94.5	31.3	15.5	46.6	38.9	0.1	3.9	6.0	35.4	0.2	69.8	0.0	25.6	47.9	14.3	37.6	53.9	75.3	36.0	27.6	0.0	23.1	73.6	68.4	3.9	0.6	9.2	0.0	21.9	28.5	13.5	0.3	25.6	16.2	32.7	26.3	5.3	6.9	29.5	10.5	32.4	18.9	47.1	27.6	14.1	56.9	37.5	24.2	12.0	0.1	68.6	0.1	61.9	5.7	8.3	5.1	13.2	4.7	14.3	9.3	11.4	10.4	9.6	10.5	11.1	13.7	1.4	20.0	0.5	12.2	15.9	6.3	109.1	111.0	108.8	137.0	104.8	124.0	117.0	122.9	118.0	112.1	116.7	117.5	39.1	16.0	47.9	6.2	15.9	25.9	91.4	37.8	20.5	57.0	69.8	73.4	50.2	40.0	39.4	75.4	18.8	3.1	19.9	5.1	142.8	41.3	3.3	61.1	165.3	46.2	43.4	6.3	10.0	39.0	3.3	56.3	19.4	40.6	95.8	55.5	58.2	3.8	63.5	18.5	13.8	32.1	36.7	35.1	32.9	17.2	157.2	31.3	16.0	4.7	29.7	137.8	17.5	9.0	12.3	25.3	9.6	256.1	33.0	78.9	0.7	30.6	62.4	35.6	26.3	26.0	62.4	4.4	1.9	10.2	16.9	2.7	21.1	32.9	6.2	45.6
TCEAL5	WEX4	ENSG00000204065	"Transcription elongation factor A like 5"	Q5H9L2	X	103273691-103276750	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 67.3;choroid plexus: 35.5;pituitary gland: 62.2;retina: 23.5;testis: 60.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.4;Granulosa cells: 16.5;Late spermatids: 22.1;Muller glia cells: 75.5;Peritubular cells: 35.7"	"Cancer enhanced"	"Detected in many"		"glioma: 13.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 9.0;SH-SY5Y: 28.0"	"Low region specificity"	"Detected in all"							"HPA045564, HPA058982"	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (1.30e-3)"	"unprognostic (2.41e-1)"		"prognostic unfavorable (9.09e-4)"	"unprognostic (9.68e-2)"	"unprognostic (8.75e-4)"		"unprognostic (1.21e-1)"		"unprognostic (8.11e-2)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.03e-4)"	0.9	10.5	56.5	0.9	54.9	0.0	2.1	55.4	67.3	6.2	35.5	2.2	0.6	5.6	6.8	0.3	2.4	0.8	2.7	52.9	55.2	0.3	0.1	0.3	0.0	50.8	52.6	5.2	0.9	0.0	62.2	0.0	49.5	3.3	0.7	23.5	1.1	4.1	0.1	0.4	1.2	3.3	44.9	0.0	1.0	60.0	50.3	0.6	2.3	0.7	0.0	1.5	3.8	55.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.5	54.9	55.4	67.3	52.9	55.2	50.8	52.6	49.5	44.9	50.3	55.4	0.1	0.0	0.0	2.9	0.0	0.1	0.5	0.0	1.8	43.4	0.3	9.5	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.3	7.5	0.6	0.0	0.0	7.0	0.0	0.4	7.6	0.0	0.2	0.0	16.5	0.0	0.0	0.3	1.7	7.7	0.0	0.0	0.0	1.7	22.1	8.4	0.7	0.0	2.8	0.0	75.5	0.0	7.1	2.8	0.0	0.0	35.7	0.0	0.2	0.0	0.3	0.0	6.8	0.0	6.9	1.4	7.6	1.9	0.1	0.3	0.4	0.1	0.2	0.0	0.2
TCEAL6	WEX2	ENSG00000204071	"Transcription elongation factor A like 6"	Q6IPX3	X	102140476-102142970	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 73.4;testis: 26.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.4;Excitatory neurons: 9.1;Horizontal cells: 15.2;Inhibitory neurons: 10.4;Late spermatids: 6.7"	"Cancer enriched"	"Detected in single"	9	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045564, HPA058982"	Supported		Uncertain	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (5.43e-2)"			"unprognostic (6.54e-2)"	"unprognostic (1.87e-3)"			"unprognostic (6.69e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.18e-1)"		1.6	10.7	27.3	0.2	24.3	0.0	0.6	23.1	41.4	1.5	3.6	1.7	0.2	3.6	1.4	0.0	5.7	0.1	0.5	23.8	35.4	1.0	0.0	0.1	0.0	27.3	32.9	8.5	0.4	1.8	73.4	0.0	26.3	0.8	0.2	16.7	1.8	0.6	0.0	0.3	0.7	0.7	19.2	0.0	0.8	26.8	26.0	0.0	0.5	0.2	0.0	0.0	1.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	27.3	24.3	23.1	41.4	23.8	35.4	27.3	32.9	26.3	19.2	26.0	22.5	0.0	0.0	0.0	3.9	0.0	0.1	0.5	0.0	0.0	40.4	0.0	0.1	4.6	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.0	9.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	15.2	10.4	0.0	0.0	0.0	0.3	6.7	2.5	0.1	1.8	1.0	0.0	1.9	0.0	4.5	1.7	0.4	0.0	0.7	0.0	0.5	0.0	0.0	0.0	4.3	0.0	1.4	0.9	1.9	0.9	0.0	0.3	0.0	0.2	0.0	0.0	0.1
TCEAL7	"MGC23947, WEX5"	ENSG00000182916	"Transcription elongation factor A like 7"	Q9BRU2	X	103330229-103332326	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.9;Fibroblasts: 55.2;Horizontal cells: 48.8;Leydig cells: 43.8;Muller glia cells: 88.3;Oligodendrocytes: 46.5;Peritubular cells: 39.1;Skeletal myocytes: 48.3;Smooth muscle cells: 38.7"	"Cancer enriched"	"Detected in many"	10	"glioma: 39.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 83.8;BJ hTERT+ SV40 Large T+ RasG12V: 75.1;GAMG: 115.3;hTEC/SVTERT24-B: 83.8;LHCN-M2: 72.0;SCLC-21H: 210.1;U-87 MG: 78.9"	"Low region specificity"	"Detected in many"							"HPA051507, HPA065080"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA051507: AB_2681512, HPA065080: AB_2685419"	"unprognostic (1.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.62e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.35e-3)"	7.7	27.9	72.4	4.3	73.0	0.0	9.1	75.1	126.3	26.3	40.5	18.6	4.0	48.2	18.3	5.5	17.0	11.9	14.0	72.1	84.5	5.0	2.4	6.1	2.3	80.8	77.5	29.0	1.2	1.1	37.4	2.1	82.3	12.3	7.8	23.5	3.5	13.2	3.7	1.8	8.3	29.9	74.5	5.8	6.5	3.1	77.2	5.1	3.8	9.9	1.4	9.7	15.6	96.0	0.0	0.0	83.8	0.0	36.3	55.5	15.0	12.0	61.9	26.4	75.1	0.0	0.0	0.0	0.0	12.9	115.3	0.0	0.0	1.8	45.5	0.0	0.8	0.3	0.0	0.0	18.2	0.0	0.1	46.6	0.0	83.8	0.1	0.0	27.6	0.0	0.5	0.2	72.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	53.1	0.3	0.0	0.0	210.1	56.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	38.8	1.4	0.6	0.0	0.0	0.0	0.0	78.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	72.4	73.0	75.1	126.3	72.1	84.5	80.8	77.5	82.3	74.5	77.2	96.0	4.8	0.0	1.3	5.9	0.0	2.5	5.3	0.3	1.2	36.4	0.9	19.2	13.6	0.0	0.7	3.7	4.2	1.4	0.1	0.0	5.9	0.2	0.2	1.0	42.9	5.2	0.0	0.0	21.2	0.0	0.7	55.2	0.0	0.7	0.0	19.2	1.8	0.0	0.7	48.8	26.5	0.0	0.0	0.0	4.0	1.8	43.8	0.6	8.8	4.7	0.0	88.3	0.0	19.6	46.5	0.3	0.0	39.1	0.1	1.1	0.0	2.1	0.0	12.9	13.1	48.3	38.7	3.0	1.5	0.8	3.1	0.3	0.5	5.1	0.0	0.8
TCEAL8	"MGC45400, WEX3"	ENSG00000180964	"Transcription elongation factor A like 8"	Q8IYN2	X	103252995-103255192	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059115	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA059115: AB_2683909"	"unprognostic (1.51e-2)"	"unprognostic (4.56e-2)"	"unprognostic (9.24e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.71e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.80e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.32e-2)"	42.9	62.6	51.9	36.3	53.1	29.3	60.0	55.0	69.6	67.2	53.8	47.9	30.5	58.3	131.1	38.8	45.3	57.1	93.1	53.1	54.6	69.4	42.7	43.9	47.6	53.4	52.2	69.4	40.9	71.0	56.5	62.2	53.9	59.2	49.5	33.2	61.5	56.1	18.8	39.3	40.4	63.2	55.1	45.8	42.0	42.9	53.4	71.9	71.3	32.0	45.7	57.3	36.5	55.9	49.2	26.4	110.9	51.8	161.9	269.3	53.2	104.9	154.7	90.6	141.0	20.6	94.5	25.8	68.2	120.7	157.7	32.1	19.6	120.0	116.5	0.4	61.5	111.2	34.5	30.8	98.8	114.4	105.6	184.9	68.0	79.5	0.0	190.3	123.9	75.3	135.0	23.8	223.6	0.0	98.2	43.9	123.2	4.4	52.7	37.1	152.8	7.6	124.7	36.4	57.7	75.4	58.3	18.1	130.8	105.7	33.9	38.0	83.1	53.5	71.0	164.4	35.2	26.2	49.8	1.1	86.7	61.0	87.6	73.7	31.9	20.0	66.3	29.3	76.6	62.4	78.1	71.4	58.2	52.6	84.5	73.5	3.0	120.6	23.2	101.3	109.5	54.5	51.9	53.1	55.0	69.6	53.1	54.6	53.4	52.2	53.9	55.1	53.4	55.9	72.3	51.3	66.7	6.8	32.7	60.8	83.9	169.4	68.9	52.3	70.5	69.2	76.6	104.4	89.4	97.5	10.4	188.8	48.5	27.5	273.9	137.8	6.8	46.2	71.8	85.0	78.5	33.2	10.3	109.4	176.3	93.9	29.6	49.7	69.6	76.2	169.6	102.5	98.7	50.5	10.0	133.7	81.4	90.6	81.1	17.2	125.9	52.4	120.9	10.3	71.4	110.4	104.0	7.1	11.3	68.2	49.2	121.9	27.2	51.3	73.5	276.2	60.1	37.5	85.5	80.6	77.4	5.6	4.0	47.6	59.5	134.9	45.1	68.1	78.7	79.5
TCEAL9	"DKFZp313K1940, WBP5, WEX6"	ENSG00000185222	"Transcription elongation factor A like 9"	Q9UHQ7	X	103356489-103358462	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1165.9;Distal tubular cells: 360.0;Extravillous trophoblasts: 456.2;Syncytiotrophoblasts: 780.1;Theca cells: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 23.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA011790	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA011790: AB_2214932"	"unprognostic (1.26e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.31e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.58e-2)"	93.9	178.7	62.9	49.8	65.5	13.8	71.7	69.0	116.6	82.8	86.4	67.6	24.8	101.5	185.0	51.1	71.6	82.0	78.7	65.6	68.0	96.7	34.7	81.2	23.4	67.8	68.7	272.5	46.5	107.0	82.9	219.3	69.4	86.0	55.9	45.4	45.5	105.4	14.4	36.4	38.3	97.5	66.6	55.4	76.2	72.4	67.6	36.0	120.0	31.5	25.6	115.9	60.8	74.4	130.5	64.1	195.0	100.8	412.6	397.8	146.6	267.7	355.5	185.7	300.7	122.0	135.2	0.5	387.2	219.4	342.5	77.2	33.8	169.8	247.8	0.6	73.6	133.2	156.0	79.6	282.8	0.2	0.3	275.6	162.1	248.5	245.0	323.5	312.7	55.2	119.9	9.7	445.4	0.2	66.2	0.8	121.8	0.1	120.4	0.3	389.7	0.7	227.4	239.7	88.3	106.2	168.8	5.4	188.5	209.0	27.0	7.3	258.1	165.0	71.9	502.2	75.9	0.1	7.8	1.1	400.9	0.2	134.4	1.2	1.6	0.0	0.3	1.0	0.0	2.4	1.9	0.7	1.3	1.6	4.0	3.5	0.0	1.6	0.1	23.6	1.2	1.4	62.9	65.5	69.0	116.6	65.6	68.0	67.8	68.7	69.4	66.6	67.6	74.4	121.4	173.1	70.4	0.0	3.8	0.0	0.0	0.0	0.0	0.0	81.5	125.3	0.0	0.0	47.0	233.6	0.0	1165.9	2.1	0.0	360.0	250.1	0.0	100.6	149.7	85.3	0.0	0.0	0.0	139.8	456.2	130.2	0.0	115.6	11.4	268.5	0.0	0.0	141.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	120.8	0.0	0.0	0.9	0.0	0.0	298.6	10.2	0.0	0.0	0.0	74.1	0.0	0.0	0.0	0.0	780.1	4.9	323.7	0.0	0.0
TCEANC2	"C1orf83, FLJ32112"	ENSG00000116205	"Transcription elongation factor A N-terminal and central domain containing 2"	Q96MN5	1	54053584-54112519	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.4;Spermatocytes: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046918	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA046918: AB_2679864"	"unprognostic (2.80e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.73e-5)"	"unprognostic (8.64e-2)"	"unprognostic (7.93e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.26e-3)"	"unprognostic (8.57e-2)"	"unprognostic (7.51e-3)"	"unprognostic (2.08e-1)"	2.0	2.3	5.8	2.9	5.6	2.8	2.2	4.7	5.8	2.2	4.9	2.6	2.6	2.1	2.3	2.9	2.1	1.5	2.6	5.0	5.1	2.4	2.2	1.9	3.9	5.7	5.5	1.8	2.1	2.3	2.1	2.3	5.7	2.3	3.1	2.1	2.0	1.5	3.8	2.5	2.6	1.8	5.5	3.7	2.4	7.1	6.1	5.1	2.1	3.1	3.7	2.7	2.3	6.6	4.3	1.9	4.6	3.9	3.3	5.2	4.9	4.5	3.6	4.8	4.2	1.2	2.6	3.2	3.8	1.6	4.4	4.1	6.6	3.6	6.5	7.6	2.7	6.3	4.3	2.0	1.9	4.2	5.3	3.7	3.0	4.0	2.4	2.4	7.1	8.6	5.7	3.4	4.3	1.6	9.3	3.4	11.4	4.4	2.9	9.2	9.4	5.6	1.6	2.8	4.2	4.4	2.4	4.8	5.8	7.2	4.6	7.6	4.1	4.9	2.7	4.6	5.5	8.1	12.9	5.2	4.1	5.9	6.0	3.3	3.2	4.2	1.6	4.0	1.9	2.8	2.2	2.5	3.5	3.3	2.5	2.9	3.5	4.8	3.4	3.0	1.7	1.5	5.8	5.6	4.7	5.8	5.0	5.1	5.7	5.5	5.7	5.5	6.1	6.6	4.0	9.6	11.2	12.7	6.7	0.6	1.5	2.3	1.2	3.2	3.8	3.0	8.4	5.7	5.9	11.0	12.5	6.1	4.7	2.7	1.9	4.0	36.4	9.8	4.7	5.5	3.6	7.6	6.3	1.8	5.7	3.6	5.6	3.7	2.5	4.4	3.9	4.4	4.8	8.4	7.8	4.2	2.0	9.6	1.0	23.5	3.1	5.3	1.8	6.5	12.3	2.5	9.2	5.5	16.7	3.6	3.7	3.0	5.7	2.4	4.3	3.5	16.8	3.3	0.0	4.2	3.6	29.4	12.5	5.5	1.0	4.0	5.6	4.2	4.5	1.6
TCERG1	"CA150, TAF2S, Urn1"	ENSG00000113649	"Transcription elongation regulator 1"	O14776	5	146447311-146511961	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064854, HPA069752, HPA069808"	Supported		Enhanced	Nucleoplasm		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA064854: AB_2685370, HPA069752: AB_2686190, HPA069808: AB_2686204"	"unprognostic (2.73e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavorable (4.70e-11)"	"unprognostic (1.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.24e-3)"	11.6	8.6	6.6	15.5	6.1	28.1	12.0	7.9	10.0	11.6	4.1	12.2	10.5	13.3	6.4	13.1	12.5	7.3	10.0	6.4	5.2	9.2	6.7	10.5	17.7	5.5	5.1	13.7	9.0	8.9	11.3	12.4	5.5	10.4	10.8	16.9	10.9	8.4	23.7	13.2	11.2	10.4	4.2	12.0	11.7	10.3	5.3	19.0	10.0	13.6	17.1	12.4	12.3	8.8	51.7	37.6	56.6	39.1	15.2	23.9	72.0	38.0	30.6	42.1	48.8	61.0	53.8	89.0	27.8	31.7	30.0	44.6	70.1	48.1	63.8	52.6	56.3	58.1	43.4	37.4	16.3	87.8	43.5	16.8	28.0	40.8	43.7	23.0	37.3	73.5	69.4	31.9	32.2	36.8	76.8	49.3	56.3	29.2	42.3	74.3	66.9	58.7	26.3	40.2	36.8	45.6	42.7	44.6	28.3	34.1	47.5	43.9	42.2	36.3	42.1	31.0	60.2	32.4	38.3	116.8	33.7	73.0	41.3	0.9	5.7	2.5	5.7	8.8	6.9	5.5	6.6	7.2	9.7	5.5	6.8	6.8	0.5	9.5	11.9	4.9	6.5	5.3	6.6	6.1	7.9	10.0	6.4	5.2	5.5	5.1	5.5	4.2	5.3	8.8	35.8	54.5	49.8	50.6	49.5	44.9	49.5	35.6	54.7	54.1	32.4	33.1	35.6	14.3	39.9	23.9	62.6	48.6	42.9	20.8	1.9	31.9	3.2	23.8	62.1	37.6	28.2	77.0	100.9	33.4	60.7	43.3	56.6	44.1	37.9	57.4	21.4	17.6	30.8	35.3	91.0	36.9	24.4	28.9	30.4	7.4	28.6	36.5	24.9	42.2	33.1	20.8	35.0	73.4	76.3	44.9	25.3	24.5	61.9	60.7	13.8	7.6	33.8	38.4	19.7	53.2	51.1	73.3	60.8	66.6	45.7	43.9	42.8	43.7	47.5	62.2
TCERG1L	FLJ38950	ENSG00000176769	"Transcription elongation regulator 1 like"	Q5VWI1	10	131092391-131311721	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;retina: 6.1;thyroid gland: 14.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 69.9;Horizontal cells: 102.6"	"Cancer enriched"	"Detected in some"	14	"thyroid cancer: 20.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;RPMI-8226: 1.1;SuSa: 1.9;U-2 OS: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030816			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA030816: AB_10601721"	"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.69e-2)"		"unprognostic (1.62e-1)"	"unprognostic (4.96e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.03e-1)"	0.0	0.9	1.3	0.0	3.5	0.0	0.1	0.3	5.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	2.5	1.6	0.2	0.0	0.0	0.0	2.2	1.5	3.0	0.3	0.5	1.3	0.0	0.9	0.6	0.0	6.1	0.0	0.6	0.0	0.5	0.0	0.0	1.5	0.2	0.0	1.6	2.0	0.6	14.9	0.0	0.1	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.5	0.3	5.0	2.5	1.6	2.2	1.5	0.9	1.5	2.0	2.1	0.0	0.0	0.0	0.7	0.0	0.6	0.2	0.0	2.2	5.9	0.5	0.1	1.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	69.9	0.0	0.7	0.9	0.5	0.1	0.0	0.1	0.0	0.0	0.0	102.6	14.5	0.0	0.0	0.0	0.0	0.1	4.7	0.2	10.6	1.0	0.0	0.9	0.0	3.0	2.3	0.1	0.0	4.5	0.0	0.7	0.0	0.0	0.0	4.3	0.0	0.3	0.2	0.4	3.7	2.8	0.6	0.1	0.1	2.5	0.0	0.1
TCF12	"bHLHb20, HEB, HsT17266, HTF4, p64"	ENSG00000140262	"Transcription factor 12"	Q99081	15	56918623-57299281	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 319.8;Microglial cells: 440.3;Oligodendrocyte precursor cells: 618.3;Oligodendrocytes: 1512.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004432, HPA065827"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear speckles"		"CAB004432: AB_671267, HPA065827: AB_2685564"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (7.26e-3)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (2.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.41e-1)"	26.1	21.5	29.2	23.4	45.5	21.2	29.5	37.1	34.0	75.6	17.2	26.7	28.4	47.9	24.3	26.6	46.3	37.1	21.8	30.5	32.6	28.4	25.0	28.9	26.0	43.1	39.3	43.3	19.7	44.0	11.5	33.4	38.3	32.0	30.3	29.4	23.3	28.3	20.5	21.3	28.4	44.1	34.5	25.0	25.5	27.4	35.5	133.0	29.0	26.6	28.1	31.2	22.4	55.7	25.4	50.8	204.5	70.6	90.0	79.0	36.1	52.2	89.6	45.1	58.9	34.0	20.3	35.5	42.3	78.3	33.4	30.4	84.3	37.3	56.7	47.5	29.8	71.7	52.7	40.4	62.4	46.1	36.1	69.4	66.2	42.9	112.2	60.1	81.0	163.0	81.7	46.8	61.8	9.5	109.4	25.0	57.5	26.4	20.9	143.2	234.9	33.9	61.5	53.1	43.6	121.2	58.7	21.0	52.0	65.3	33.6	93.9	63.2	75.5	57.5	32.2	78.2	24.6	49.7	59.4	40.8	86.3	90.9	27.4	13.8	11.3	17.4	17.9	14.3	13.4	14.0	16.5	20.0	14.7	16.2	14.8	1.5	16.8	26.3	8.4	23.0	14.1	29.2	45.5	37.1	34.0	30.5	32.6	43.1	39.3	38.3	34.5	35.5	55.7	35.5	54.5	19.6	212.9	37.7	26.6	20.6	14.2	44.9	13.8	24.0	20.4	19.3	14.3	21.2	16.5	35.5	10.4	20.6	17.0	13.7	16.0	23.7	25.9	148.0	38.2	9.0	34.9	117.7	11.8	15.5	42.3	52.0	33.3	23.4	26.9	25.7	18.2	27.5	13.5	319.8	16.8	10.2	38.1	30.0	19.9	25.7	33.0	14.2	440.3	17.4	29.0	18.6	618.3	1512.7	15.9	18.4	34.6	29.1	23.4	20.0	15.3	15.9	23.3	46.0	39.9	36.5	22.2	15.0	33.6	33.8	13.0	28.4	16.5	20.1	18.2
TCF19	SC1	ENSG00000137310	"Transcription factor 19"	Q9Y242	6	31158547-31167159	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 37.0;Glandular and luminal cells: 17.6;Plasma cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 82.8;GAMG: 47.0;HEK 293: 43.3;JURKAT: 40.9;Karpas-707: 39.2;SCLC-21H: 48.5;U-138 MG: 49.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA065994			Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA065994: "	"unprognostic (1.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (3.54e-10)"	"unprognostic (3.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.21e-1)"	4.6	1.7	0.3	2.6	0.4	1.0	4.3	0.7	0.4	6.9	0.2	5.8	4.4	4.2	2.1	12.5	3.8	0.4	3.7	0.3	0.3	4.1	2.0	4.4	10.0	0.5	0.4	4.8	3.2	0.0	1.3	0.3	0.5	5.1	1.7	0.6	4.7	0.8	2.7	8.9	7.2	1.1	0.3	9.5	5.5	1.9	0.7	0.0	2.4	0.1	1.7	5.2	8.1	0.3	82.8	0.7	0.7	0.1	5.4	7.0	0.7	0.5	0.0	0.1	0.1	5.3	0.1	0.1	17.7	20.1	47.0	0.1	0.0	30.3	0.0	0.5	43.3	7.3	5.1	2.0	0.0	0.2	21.1	2.9	0.0	2.3	0.0	4.4	17.9	40.9	0.1	39.2	8.1	0.3	1.2	13.2	0.1	0.0	0.0	1.1	4.8	0.7	7.1	0.3	48.5	0.5	0.4	0.1	0.5	6.5	0.1	6.0	0.0	49.0	0.2	0.4	0.4	12.5	15.0	24.8	0.1	0.3	0.3	0.0	0.1	0.0	0.2	0.0	1.3	0.5	0.6	1.1	0.3	0.5	0.8	0.2	0.1	0.4	0.0	0.0	1.0	0.5	0.3	0.4	0.7	0.4	0.3	0.3	0.5	0.4	0.5	0.3	0.7	0.3	2.8	3.2	0.6	0.7	6.7	5.1	3.1	2.5	8.6	3.0	2.8	2.9	1.2	0.0	2.5	3.7	0.0	2.9	3.9	1.8	7.9	1.3	0.3	4.7	2.0	4.7	1.2	37.0	0.1	1.8	9.6	5.6	5.6	17.6	1.3	7.0	1.8	0.6	8.9	1.7	0.2	3.9	2.0	2.9	5.4	0.7	5.0	4.8	12.4	0.0	6.0	4.2	8.2	0.0	0.2	1.1	0.9	6.4	21.1	1.3	1.6	0.4	0.2	0.5	0.0	3.5	5.3	0.7	11.1	9.6	3.8	0.4	7.6	2.0	8.8	2.9
TCF20	"AR1, SPBP"	ENSG00000100207	"Transcription factor 20"	Q9UGU0	22	42160013-42343616	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.0;Inhibitory neurons: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017849, HPA036786"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"CAB017849: , HPA036786: AB_2675313"	"unprognostic (2.17e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.89e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.07e-3)"	"unprognostic (4.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	7.1	6.5	4.2	1.7	3.1	1.6	7.5	0.0	2.9	10.2	0.0	9.1	1.6	9.0	0.2	16.3	6.9	1.0	4.9	3.7	2.4	7.6	7.4	7.1	1.6	0.9	1.0	7.6	8.2	1.2	7.4	1.2	1.1	6.9	1.3	0.9	9.9	1.0	5.7	14.3	10.0	1.4	0.0	7.3	8.0	15.3	1.8	2.3	9.6	1.3	1.6	7.8	11.0	2.1	6.6	2.3	3.2	2.1	1.0	2.1	5.5	4.2	2.8	2.1	3.5	5.0	2.5	10.9	3.6	1.1	3.1	5.4	3.9	3.3	1.2	8.5	3.9	3.4	2.2	1.6	1.5	6.0	4.7	1.2	2.9	3.0	3.0	0.9	1.0	3.1	4.1	3.9	1.6	3.0	9.4	1.8	3.4	2.2	3.1	4.7	2.0	5.7	0.5	5.2	6.2	2.0	2.7	2.0	2.7	2.0	1.2	4.8	3.9	3.8	8.9	3.9	1.9	7.0	6.2	4.5	2.3	4.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.1	0.0	2.9	3.7	2.4	0.9	1.0	1.1	0.0	1.8	2.1	10.0	0.0	9.6	23.5	9.1	22.6	11.3	19.4	12.0	25.1	11.5	6.9	7.3	17.2	10.1	9.2	18.8	6.3	11.0	16.6	0.0	10.8	127.0	14.2	9.9	9.3	16.8	9.9	54.0	7.5	5.5	8.1	10.7	22.2	1.3	10.0	8.9	12.6	6.2	10.1	63.5	13.8	12.2	12.4	13.3	36.2	12.5	9.4	7.2	22.5	12.0	5.6	6.2	29.7	55.0	13.3	13.5	6.4	8.7	20.9	13.0	6.0	13.4	12.6	6.6	5.8	8.5	19.1	13.4	19.5	22.9	4.5	13.0	4.3	17.9	14.6
TCF3	"bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR"	ENSG00000071564	"Transcription factor 3"	P15923	19	1609290-1652615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 467.3;U-698: 597.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018351, HPA049808, HPA062476"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.25e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.07e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (4.87e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.07e-1)"	"unprognostic (8.05e-2)"	23.8	17.9	20.7	49.2	20.0	72.8	26.1	18.1	22.7	33.4	21.9	32.3	35.5	29.6	16.2	28.2	25.5	19.8	22.8	19.1	17.8	27.2	18.9	25.9	86.6	22.0	19.3	35.1	28.4	10.2	26.2	17.9	20.4	27.3	18.7	11.0	26.4	12.0	19.5	32.9	48.0	14.4	18.3	62.5	27.3	74.8	20.3	68.4	31.6	12.5	61.0	27.4	27.4	21.8	83.6	48.6	146.4	139.8	18.6	49.6	50.4	51.9	48.0	67.8	60.6	89.8	68.7	421.7	53.5	50.1	12.7	98.4	87.9	69.2	42.8	253.7	52.4	43.2	71.2	115.2	44.8	105.7	56.8	34.0	75.1	52.4	39.2	64.0	82.5	176.1	163.8	146.6	46.0	158.2	301.1	107.8	187.1	65.1	49.2	467.3	61.7	104.3	46.5	78.5	119.3	175.7	50.1	55.9	70.8	53.0	63.8	191.7	103.2	87.1	90.5	116.0	94.1	353.5	173.5	597.2	63.1	140.3	80.1	3.3	1.2	1.0	3.6	1.5	3.6	10.0	2.1	3.1	2.8	10.6	2.8	4.3	0.4	2.8	3.2	12.9	2.2	1.7	20.7	20.0	18.1	22.7	19.1	17.8	22.0	19.3	20.4	18.3	20.3	21.8	17.3	6.4	9.1	14.7	33.9	13.9	5.3	10.0	4.6	12.3	16.6	16.1	10.7	4.3	10.8	1.8	27.1	4.3	26.5	14.7	1.9	11.4	8.6	9.9	20.4	13.5	16.2	32.2	3.9	6.9	8.9	12.3	14.8	16.6	7.0	27.8	9.7	4.8	7.7	5.0	5.6	16.5	16.2	8.9	12.3	5.2	13.7	9.4	10.6	6.5	8.1	9.2	10.3	3.0	7.3	17.6	13.3	10.1	31.1	13.0	16.4	6.3	2.9	13.8	19.7	8.2	16.9	5.5	46.2	9.0	13.2	2.9	12.5	10.4	20.1	8.5
TCF4	"bHLHb19, E2-2, ITF2, SEF2-1B"	ENSG00000196628	"Transcription factor 4"	P15884	18	55222185-55664787	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Disease variant, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 820.0;Endothelial cells: 574.5;Inhibitory neurons: 1177.6;Oligodendrocyte precursor cells: 719.8;Oligodendrocytes: 573.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 65.1"	"Group enriched"	"Detected in many"	14	"memory B-cell: 173.6;naive B-cell: 146.8;plasmacytoid DC: 559.8"	"Group enriched"	"Detected in many"	33	"B-cells: 173.6;dendritic cells: 559.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 140.4;SH-SY5Y: 157.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020722, HPA025958"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"CAB020722: , HPA025958: AB_1857849"	"unprognostic (2.11e-1)"	"unprognostic (9.10e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.03e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (1.99e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.76e-3)"	"prognostic unfavorable (9.95e-4)"	20.3	9.6	3.7	12.8	12.5	9.5	11.6	65.1	26.5	28.5	0.0	7.4	5.1	23.0	2.1	9.7	13.4	17.4	17.5	29.8	0.0	4.4	4.4	15.5	14.7	5.5	1.0	25.9	5.8	8.0	6.5	28.9	3.9	6.6	7.9	14.0	6.8	10.2	6.1	6.4	5.0	24.1	2.2	13.1	6.0	15.4	2.4	9.8	13.3	16.7	14.7	13.1	7.3	14.4	0.1	4.1	36.8	11.4	8.5	14.4	0.1	18.4	40.6	13.2	17.2	23.1	3.6	28.8	0.1	41.9	2.7	4.5	17.9	17.1	9.2	140.4	13.9	12.1	0.1	0.0	4.0	5.3	2.8	19.6	5.3	18.5	0.7	9.1	45.8	1.6	19.5	22.0	11.0	0.0	7.6	0.0	10.4	0.1	2.4	41.6	14.9	65.4	0.0	0.9	12.6	157.7	0.0	1.5	0.0	11.1	1.6	1.3	49.1	48.5	17.4	2.1	14.6	16.3	32.2	25.7	11.0	5.2	15.5	0.9	7.4	0.8	0.9	8.3	0.7	173.6	0.2	0.5	20.6	146.8	0.5	0.3	1.8	11.2	7.4	559.8	0.7	11.3	3.7	12.5	65.1	26.5	29.8	0.0	5.5	1.0	3.9	2.2	2.4	14.4	820.0	6.4	13.1	501.1	217.4	117.0	37.8	34.0	80.8	293.0	6.5	23.4	35.5	4.3	32.6	22.0	83.4	1.8	446.8	0.1	0.0	1.5	103.2	17.5	201.4	574.5	5.4	34.2	503.8	7.1	1.5	296.7	1.5	12.2	13.9	105.7	316.3	6.6	39.6	25.2	1177.6	0.3	26.4	112.4	129.2	116.3	205.3	80.4	64.0	474.1	32.7	372.8	13.4	719.8	573.6	2.1	0.1	182.1	131.7	20.8	0.0	2.3	25.9	54.7	236.7	304.5	221.0	8.7	14.5	47.5	84.4	2.6	15.1	164.8	0.2	17.8
TCF7	TCF-1	ENSG00000081059	"Transcription factor 7"	P36402	5	134114681-134151865	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"lymphoid tissue: 604.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 73.0;T-cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 28.8;memory CD4 T-cell: 49.7;memory CD8 T-cell: 29.0;naive CD4 T-cell: 97.2;naive CD8 T-cell: 62.3;NK-cell: 43.0"	"Group enriched"	"Detected in many"	20	"NK-cells: 43.0;T-cells: 97.2"	"Cell line enriched"	"Detected in many"	6	"MOLT-4: 1324.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019403, HPA058863, HPA070505"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275"	"unprognostic (3.63e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.10e-2)"	4.1	5.3	2.0	56.4	1.8	16.4	4.0	1.8	1.9	3.2	21.3	5.8	16.0	3.9	41.5	3.5	43.1	6.2	2.4	3.1	1.5	4.0	5.8	5.6	94.4	5.9	2.7	1.8	9.4	2.1	6.4	3.5	2.2	5.0	6.8	1.5	8.0	3.5	1.4	4.3	20.4	1.8	3.8	34.6	11.0	3.4	2.1	604.3	6.3	1.0	70.0	9.8	2.0	2.6	0.2	7.8	8.2	29.2	3.9	16.2	11.4	2.2	4.4	0.7	0.8	61.6	19.3	0.4	14.0	13.4	32.3	1.0	13.1	3.1	0.6	3.0	12.2	0.2	7.4	46.4	0.4	0.4	1.6	1.1	0.1	12.6	0.7	5.7	1.8	218.2	7.9	0.3	1.3	0.7	1324.2	1.4	9.0	19.2	10.4	1.6	0.0	1.4	3.0	1.4	3.4	25.1	6.0	1.8	1.6	6.4	1.6	7.3	1.9	81.2	0.5	37.0	2.8	1.3	0.1	0.4	42.7	0.5	4.1	2.2	0.3	3.2	12.3	0.2	28.8	3.5	49.7	29.0	0.2	1.4	97.2	62.3	1.9	43.0	0.2	0.5	6.5	21.8	2.0	1.8	1.8	1.9	3.1	1.5	5.9	2.7	2.2	3.8	2.1	2.6	6.0	3.2	1.9	4.6	27.3	15.7	27.9	6.9	2.8	28.6	14.5	14.9	3.1	10.0	2.9	3.7	73.0	21.6	47.4	18.4	0.0	6.1	3.8	57.6	30.4	9.6	12.6	5.3	2.4	9.9	30.5	11.7	6.6	35.8	20.3	12.1	6.8	3.0	7.1	10.1	2.0	17.0	6.1	9.7	20.0	2.3	6.2	8.7	10.6	1.0	17.1	12.4	41.2	3.5	4.1	23.6	18.5	4.5	9.3	24.6	50.8	1.4	2.5	58.4	0.0	61.4	16.1	4.0	11.0	3.3	11.4	30.0	108.3	8.6	24.1	14.9
TCF7L1	TCF3	ENSG00000152284	"Transcription factor 7 like 1"	Q9HCS4	2	85133392-85310387	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 49.2;Astrocytes: 76.4;Leydig cells: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 43.3;NTERA-2: 99.0;RH-30: 44.7;T-47d: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071298			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA071298: AB_2686383"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (6.16e-5)"	"unprognostic (1.79e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.06e-4)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (5.38e-4)"	37.8	5.3	7.5	4.0	9.9	3.7	33.4	7.8	6.4	33.1	13.8	27.6	4.3	25.9	6.7	10.0	20.1	7.2	20.3	6.9	7.7	15.7	12.5	17.8	5.9	10.8	13.0	27.5	4.5	7.0	8.9	5.2	6.9	20.0	4.1	1.7	13.1	14.5	15.0	14.6	12.2	13.0	7.4	11.8	10.7	9.1	10.0	5.8	30.6	7.9	3.5	18.3	24.1	6.7	2.1	1.5	33.5	25.8	12.6	2.6	20.3	2.5	8.5	5.8	5.3	5.2	2.0	0.7	4.0	5.6	6.4	4.7	25.9	43.3	4.0	1.8	4.1	0.7	2.1	2.3	1.2	0.3	4.9	2.1	7.7	0.6	1.4	2.6	11.2	1.3	0.5	1.3	6.8	1.6	0.2	1.6	99.0	1.3	0.9	0.6	44.7	0.5	2.7	3.7	1.0	10.4	4.0	17.1	1.3	25.9	44.3	0.9	12.1	6.5	9.2	0.4	3.3	1.1	0.3	0.4	0.2	1.0	5.2	5.1	0.5	1.1	0.5	0.4	0.7	1.1	0.6	0.7	0.2	1.5	0.7	0.9	1.3	0.9	0.5	0.9	0.6	0.1	7.5	9.9	7.8	6.4	6.9	7.7	10.8	13.0	6.9	7.4	10.0	6.7	49.2	6.4	37.3	76.4	1.0	6.0	14.4	12.9	15.9	0.2	20.0	33.1	9.1	5.7	10.5	16.5	0.0	6.3	0.8	0.3	0.0	3.7	28.2	9.4	17.5	31.4	0.0	0.0	1.1	5.6	4.0	28.9	0.5	16.0	5.1	39.4	45.7	6.7	1.7	0.0	2.2	2.9	8.2	9.1	8.3	5.4	65.3	2.2	3.6	22.5	1.0	4.9	0.0	32.2	1.5	1.1	1.6	28.6	1.4	10.8	5.0	2.2	7.7	0.2	6.6	24.9	28.9	1.9	9.3	3.4	3.4	1.4	1.2	2.9	2.1	2.4
TCF7L2	"TCF-4, TCF4"	ENSG00000148737	"Transcription factor 7 like 2"	Q9NQB0	10	112950247-113167678	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"brain: 244.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 244.9"	"Group enriched"	"Detected in many"	10	"intermediate monocyte: 28.9;non-classical monocyte: 86.6"	"Lineage enriched"	"Detected in many"	14	"monocytes: 86.6"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"midbrain: 67.2;thalamus: 86.6"	"Group enriched"	"Detected in all"	5	"midbrain: 146.8;pons: 97.8;thalamus: 164.3"	"CAB013535, HPA038800"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB013535: AB_2533167, HPA038800: "	"unprognostic (1.79e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.36e-3)"	28.1	9.4	47.4	8.6	6.3	7.6	25.0	0.2	12.1	18.9	1.0	22.9	20.4	25.1	6.7	9.9	18.1	9.4	11.3	4.3	46.9	9.9	22.4	13.9	5.4	5.1	98.0	22.9	12.4	11.1	9.6	17.7	1.7	12.3	21.3	4.6	14.5	13.1	8.4	17.2	19.3	16.4	1.6	22.2	23.3	7.6	244.9	5.8	12.9	6.9	3.7	13.8	14.3	3.2	15.0	37.8	40.7	39.6	20.8	13.7	48.5	10.3	20.0	7.1	8.5	24.9	45.3	0.1	11.3	19.4	9.6	10.5	14.0	17.6	9.1	1.7	13.1	10.4	25.2	23.6	22.0	4.2	3.7	24.4	6.3	11.0	18.2	29.7	12.0	8.8	11.0	0.7	8.2	28.0	6.7	2.5	29.2	16.6	21.6	19.0	29.8	6.9	15.2	20.4	0.8	12.4	15.7	15.4	17.0	31.5	10.0	2.2	27.9	6.8	18.7	16.9	21.3	2.6	0.3	0.4	6.5	8.7	14.9	0.4	4.5	0.4	1.5	28.9	0.9	0.0	0.4	1.2	4.1	0.0	0.4	0.6	6.0	0.0	86.6	0.2	0.0	3.5	47.4	6.3	0.2	12.1	4.3	46.9	5.1	98.0	1.7	1.6	244.9	3.2	62.0	22.4	26.5	264.8	3.3	42.6	27.3	35.8	64.9	2.8	53.0	54.9	13.6	52.9	35.5	40.5	6.2	44.2	9.1	260.0	11.7	39.3	8.8	40.1	140.6	46.1	19.8	4.8	35.1	43.6	231.4	90.8	90.2	64.2	0.0	37.6	52.8	74.2	17.5	5.0	16.6	87.7	16.2	99.9	20.6	5.0	59.0	54.6	32.0	107.7	22.4	34.4	5.2	192.5	34.9	59.0	211.1	48.5	6.0	38.4	75.3	16.2	26.8	6.1	92.1	37.3	51.3	9.4	28.9	61.1	39.8	28.5	6.7	13.1	73.9	49.0
TCFL5	"bHLHe82, CHA, E2BP-1, Figlb"	ENSG00000101190	"Transcription factor like 5"	Q9UL49	20	62841005-62861822	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.3;testis: 74.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.6;Oligodendrocytes: 32.4;Spermatocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055223, HPA076419"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA055223: AB_2682745, HPA076419: "	"unprognostic (4.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.01e-2)"	7.0	4.3	48.1	4.9	56.0	4.8	7.4	48.4	73.3	7.3	35.4	7.7	3.7	6.5	7.4	6.9	6.6	5.8	6.6	42.7	44.4	5.6	5.5	4.1	6.1	51.4	54.7	9.5	5.6	9.9	4.8	5.7	52.3	5.4	4.3	8.9	5.8	6.9	5.7	13.6	4.9	6.3	53.8	5.0	4.8	74.0	49.2	11.8	18.3	7.2	6.1	7.1	5.4	62.4	23.4	6.9	14.9	17.6	31.1	31.3	13.3	14.9	20.1	28.5	15.6	16.9	14.1	11.8	16.7	13.2	15.1	25.0	15.1	16.8	24.7	8.3	12.7	9.9	20.9	25.3	12.2	14.4	11.4	11.6	24.2	8.1	16.4	12.1	12.9	17.9	11.1	4.4	13.3	28.1	63.4	18.0	9.8	19.2	21.7	34.8	25.9	16.8	7.6	6.8	21.3	11.5	26.2	10.4	41.3	10.5	17.9	26.5	14.1	22.4	14.6	19.7	17.7	11.0	8.0	9.9	13.6	17.6	12.7	0.1	0.3	0.6	0.6	0.3	0.4	0.2	0.4	0.4	0.2	0.2	0.4	0.3	0.5	0.2	0.3	0.4	0.4	0.1	48.1	56.0	48.4	73.3	42.7	44.4	51.4	54.7	52.3	53.8	49.2	62.4	8.9	0.0	1.5	4.9	3.3	10.5	1.6	1.6	0.6	10.2	4.6	5.0	4.7	5.7	1.3	7.3	6.2	0.6	3.7	1.3	1.9	1.4	23.6	2.7	6.9	6.6	2.4	1.7	10.6	1.2	0.9	5.2	1.5	2.7	0.0	7.8	3.3	3.8	1.0	8.4	7.4	2.5	2.0	4.0	6.2	9.4	7.8	2.4	3.6	3.7	2.1	12.8	1.0	10.1	32.4	1.0	1.8	7.2	0.9	1.5	1.2	2.2	1.8	6.9	0.0	4.8	4.1	64.6	8.9	2.1	14.2	0.3	2.5	5.8	2.3	1.3
TCIM	"C8orf4, hTC-1, TC-1, TC1"	ENSG00000176907	"Transcriptional and immune response regulator"	Q9NR00	8	40153482-40155310	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.5;Alveolar cells type 2: 882.5;Collecting duct cells: 200.5;Distal tubular cells: 193.7;Ductal cells: 331.6;Glandular and luminal cells: 397.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 48.5;AF22: 134.4;BJ: 51.5;BJ hTERT+: 134.4;EFO-21: 87.5;HeLa: 94.8;RPTEC TERT1: 67.2;SuSa: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027188	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 12: NES - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027188: AB_10601150"	"unprognostic (8.88e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.48e-2)"	91.5	24.2	6.2	42.9	7.4	0.0	64.0	6.0	10.8	134.1	10.6	68.7	30.9	67.7	18.3	22.3	20.3	105.2	130.8	6.5	6.5	252.6	210.0	165.4	18.0	6.5	6.6	44.6	51.5	70.3	18.9	165.1	6.9	67.7	71.1	4.5	176.0	28.3	37.7	13.2	101.4	43.5	6.9	83.3	56.1	4.8	8.6	3.8	53.9	47.9	4.1	255.3	26.2	7.8	0.0	48.5	134.4	0.0	0.0	0.0	0.3	51.5	134.4	0.2	0.6	0.7	0.0	0.0	87.5	1.0	0.5	0.1	0.0	0.0	0.5	0.1	0.0	0.0	94.8	21.4	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.3	1.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.2	67.2	0.1	0.1	0.2	0.2	4.6	0.0	50.4	0.0	0.0	43.6	0.0	1.2	0.4	0.8	1.2	1.7	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.4	6.0	10.8	6.5	6.5	6.5	6.6	6.9	6.9	8.6	7.8	209.5	99.3	882.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	124.9	62.0	0.0	0.0	77.4	200.5	0.0	12.3	1.5	0.0	193.7	331.6	0.0	152.6	90.7	103.2	0.0	0.0	0.0	111.2	26.5	13.5	0.0	397.4	26.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	102.4	0.0	0.0	0.1	0.0	0.0	2.5	8.7	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	4.5	8.1	22.7	0.0	0.0
TCL1A	TCL1	ENSG00000100721	"TCL1 family AKT coactivator A"	P56279	14	95709947-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 267.6"	"Group enriched"	"Detected in some"	4	"B-cells: 282.5;dendritic cells: 210.3"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	296	"memory B-cell: 874.7;naive B-cell: 2160.3;plasmacytoid DC: 1099.9"	"Group enriched"	"Detected in all"	350	"B-cells: 2160.3;dendritic cells: 1099.9"	"Group enriched"	"Detected in some"	142	"Daudi: 459.4;REH: 599.4;U-698: 616.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"	1.0	0.1	0.1	34.4	0.1	20.3	0.2	0.1	0.1	0.1	0.0	2.4	0.8	0.8	0.6	0.5	0.1	3.6	0.6	0.1	0.1	0.4	0.4	1.0	267.6	0.1	0.1	0.1	0.3	0.0	0.0	0.8	0.2	0.3	2.0	0.0	4.0	0.0	0.1	0.4	14.2	0.3	0.0	56.7	3.4	7.7	0.1	19.1	1.1	0.0	216.0	2.7	0.1	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	459.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.6	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	599.4	0.3	0.8	0.0	0.0	0.2	0.2	0.4	0.7	0.1	0.3	0.1	1.0	1.0	0.2	2.8	0.6	0.2	0.5	3.9	616.2	0.2	0.1	0.1	4.6	1.4	1.8	0.5	0.5	1.3	874.7	0.9	0.4	2.2	2160.3	1.5	0.5	3.3	1.3	1.6	1099.9	1.2	92.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.0	1.3	0.0	282.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	210.3	0.6	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.9	0.6	2.8	0.0	0.0	2.7	0.0	3.1	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	28.7	60.2	0.0	0.0	0.0	2.7	0.0	0.3	0.0
TCTN1	"FLJ21127, JBTS13, TECT1"	ENSG00000204852	"Tectonic family member 1"	Q2MV58	12	110614027-110663431	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 98.9;Respiratory ciliated cells: 203.7;Spermatocytes: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039687, HPA040036"	Approved		Approved	"Nucleoplasm,Vesicles,Actin filaments,Microtubules"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Actin filaments"	"Nucleoplasm, Vesicles, Microtubules"	"HPA039687: AB_10795293, HPA040036: AB_10794759"	"unprognostic (2.54e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (2.89e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (9.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.27e-2)"	8.8	14.0	5.6	2.0	5.3	1.0	8.4	9.3	7.5	10.1	18.2	7.1	1.5	9.0	10.7	4.5	15.3	5.6	17.0	5.7	4.5	19.0	9.1	8.3	2.5	4.5	5.0	12.8	10.8	15.2	26.2	4.0	4.4	10.0	0.9	3.0	9.5	6.1	10.3	5.3	4.0	3.6	3.6	4.6	6.9	21.1	5.2	1.3	17.6	1.9	0.8	7.7	7.0	7.0	11.6	11.7	6.7	17.6	24.9	18.0	4.3	6.3	16.2	5.9	4.4	1.2	2.7	2.0	6.9	18.6	7.2	6.1	4.7	4.6	5.0	4.7	8.7	0.3	4.1	3.6	8.6	1.2	1.3	14.8	7.8	7.7	7.9	34.7	3.3	3.0	7.4	2.5	9.7	9.4	0.9	2.2	4.1	3.5	16.7	2.4	2.9	14.6	16.8	1.8	5.5	11.7	13.1	1.6	5.3	5.5	22.7	16.0	4.0	8.2	2.4	3.5	6.0	4.2	2.6	2.6	11.1	1.3	9.3	0.0	2.0	0.0	0.8	3.6	2.2	4.9	1.5	2.5	3.4	9.1	2.2	1.6	6.4	1.0	1.9	4.3	0.5	2.0	5.6	5.3	9.3	7.5	5.7	4.5	4.5	5.0	4.4	3.6	5.2	7.0	6.5	3.2	18.8	25.5	24.0	13.8	28.4	38.4	18.2	10.7	22.8	19.3	13.0	24.3	26.0	16.5	31.3	30.9	5.8	1.0	9.8	24.3	82.7	98.9	29.0	11.5	18.0	1.3	15.0	4.7	8.5	30.5	8.2	9.8	3.8	27.1	9.3	6.9	11.8	3.3	12.1	4.8	32.6	3.8	12.4	18.7	17.1	7.0	23.2	7.5	1.7	30.5	0.0	12.5	9.3	4.2	2.4	28.6	9.6	20.0	0.4	42.5	203.7	34.1	6.6	16.2	18.3	96.9	30.1	8.5	11.2	18.3	4.2	38.1	4.7	16.6
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965822-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA052263: AB_2681777"	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	10.8	13.6	5.8	15.9	6.4	18.1	12.0	6.7	7.2	10.0	7.2	13.2	11.4	11.6	9.5	17.8	8.7	12.2	9.8	6.3	6.0	8.5	12.1	9.6	21.0	5.3	5.5	9.7	9.5	10.4	9.5	17.5	5.5	9.6	15.6	10.5	9.2	7.3	9.5	12.8	13.4	10.9	4.6	11.9	11.2	4.9	5.5	25.7	10.6	9.6	19.1	17.1	11.2	7.3	42.6	21.4	64.4	37.2	15.5	13.7	69.4	32.4	12.3	42.6	23.6	39.1	18.2	99.4	18.8	26.3	6.9	27.9	76.8	36.5	32.6	42.8	66.8	76.4	31.8	17.5	14.8	95.4	55.8	16.3	48.0	31.5	24.6	25.9	42.3	58.4	91.1	15.8	20.6	45.2	107.6	53.6	76.7	33.0	34.0	107.9	32.8	35.0	46.4	61.4	84.2	58.0	38.9	42.7	28.4	37.7	70.7	52.2	26.5	13.3	21.5	14.3	37.5	34.5	49.5	81.8	14.2	52.0	25.3	55.0	53.0	45.8	28.9	39.2	22.0	43.4	28.1	24.3	34.6	39.8	28.5	25.5	35.5	33.6	40.1	92.5	30.5	17.6	5.8	6.4	6.7	7.2	6.3	6.0	5.3	5.5	5.5	4.6	5.5	7.3	35.4	38.5	23.8	12.1	54.6	79.0	49.1	63.0	38.7	51.3	61.2	54.9	25.9	37.1	49.4	33.1	27.1	66.7	68.7	35.2	37.2	68.6	6.2	44.7	44.7	45.2	81.7	69.4	30.3	53.9	82.6	38.5	47.4	45.7	40.4	27.0	39.3	36.4	44.1	35.3	30.0	55.7	87.5	44.8	42.1	3.8	27.4	42.4	16.0	23.4	41.1	24.4	43.3	20.6	20.9	79.7	39.0	30.1	52.6	52.4	28.4	30.5	40.8	39.0	46.0	37.4	38.0	11.0	23.1	52.8	102.9	156.7	49.8	25.0	42.6	61.8
TDP1	"FLJ11090, SCAN1"	ENSG00000042088	"Tyrosyl-DNA phosphodiesterase 1"	Q9NUW8	14	89954939-90044764	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071317	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Plasma membrane"	"HPA071317: AB_2686388"	"unprognostic (5.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.26e-1)"	5.5	3.9	4.8	11.8	4.5	13.9	8.9	6.6	4.9	6.6	7.1	7.8	6.5	5.9	5.8	8.2	9.2	6.6	2.6	4.1	5.3	7.0	6.5	4.7	19.0	3.8	3.6	6.4	4.8	5.1	4.6	8.2	3.9	5.0	10.1	4.9	5.5	4.3	2.1	6.4	7.0	6.3	2.8	10.6	7.9	22.3	4.6	28.3	4.9	1.7	23.7	8.1	5.0	4.2	33.8	18.6	40.9	37.5	10.1	14.0	32.7	31.7	25.9	38.4	34.6	13.6	35.5	42.9	23.3	21.7	12.9	33.9	18.2	29.5	55.2	44.1	19.6	43.9	16.7	16.6	8.7	73.2	24.1	10.1	12.9	26.9	24.9	21.9	49.5	57.3	30.6	43.5	45.9	35.0	56.3	39.2	10.0	39.8	43.7	42.3	77.3	34.0	24.6	27.3	30.7	20.9	26.9	77.6	10.1	27.0	31.0	30.8	39.9	16.5	15.7	23.0	28.7	31.8	60.4	52.3	35.5	32.3	24.6	28.7	8.9	15.1	18.8	14.6	18.3	21.1	19.8	20.8	14.2	20.0	21.7	23.1	5.7	23.8	14.1	15.0	32.2	14.8	4.8	4.5	6.6	4.9	4.1	5.3	3.8	3.6	3.9	2.8	4.6	4.2	2.9	0.0	1.1	4.2	15.2	4.7	4.9	7.4	4.0	3.0	6.4	7.1	1.4	1.5	5.0	14.7	8.4	11.4	14.6	3.8	5.9	9.2	123.5	13.2	6.1	3.6	3.6	12.8	13.4	5.6	14.9	4.3	7.7	9.2	2.5	8.9	3.9	4.2	8.8	3.3	13.9	4.9	0.0	6.8	10.2	36.7	2.8	7.8	1.8	1.9	8.0	1.5	8.2	8.0	24.2	6.4	4.8	3.0	16.9	5.7	2.9	7.8	11.0	2.7	0.0	3.4	5.4	33.7	22.8	8.7	4.5	10.1	15.0	10.3	7.9	4.0
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649979-24666930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Hydrolase, Nuclease"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 183.2"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 530.9;Paneth cells: 428.1;Proximal enterocytes: 637.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 75.6;neutrophil: 228.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 228.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: AB_2686651"	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favorable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.47e-5)"	24.4	23.7	27.4	34.3	28.4	21.8	27.3	30.4	36.4	20.6	30.4	141.6	120.1	19.7	25.3	18.6	22.6	28.6	28.2	28.0	28.9	77.9	51.2	24.5	38.9	28.2	29.5	21.3	29.5	25.7	20.3	20.1	28.7	56.5	127.4	18.9	21.9	21.7	21.9	21.1	183.2	24.6	28.3	27.9	26.2	25.3	32.1	37.5	21.7	26.3	37.7	27.2	16.5	28.3	47.7	37.1	41.5	48.1	63.0	64.0	32.4	41.4	53.1	38.9	51.9	50.8	26.3	57.0	70.1	43.8	90.0	34.2	51.2	47.3	52.9	73.6	53.1	53.4	37.7	84.2	40.1	82.8	49.5	43.1	43.7	40.7	36.5	46.0	63.9	54.1	48.8	23.7	59.2	34.1	64.7	52.8	37.1	54.7	31.8	55.5	43.7	61.6	67.0	66.5	52.2	29.8	33.6	84.5	71.0	42.2	38.9	47.4	48.0	37.6	31.3	28.3	61.4	33.7	107.9	77.1	26.0	107.5	61.3	75.6	13.9	29.4	25.0	14.8	30.8	20.0	28.8	27.9	13.2	14.5	24.0	26.2	228.9	29.0	16.5	12.4	31.9	22.7	27.4	28.4	30.4	36.4	28.0	28.9	28.2	29.5	28.7	28.3	32.1	28.3	24.0	6.4	16.7	23.5	24.1	14.1	25.1	37.0	18.8	12.7	19.8	20.2	23.4	37.1	29.6	22.0	6.2	18.4	23.0	530.9	49.0	35.4	140.6	19.4	16.6	22.5	52.7	20.8	25.9	36.0	23.6	18.3	14.3	19.7	24.1	15.7	27.5	31.4	68.4	6.7	25.8	168.9	30.5	28.9	20.0	80.2	18.0	33.5	12.4	15.0	61.7	19.5	38.1	11.6	21.2	21.4	428.1	23.3	10.7	37.0	637.5	175.8	30.5	15.8	32.9	19.1	20.4	9.0	32.7	10.4	16.6	44.3	28.5	15.7	119.3	31.9
TDRD3	FLJ21007	ENSG00000083544	"Tudor domain containing 3"	Q9H7E2	13	60396457-60573878	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 169.1;granulocytes: 152.3;Inhibitory neurons: 128.9;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034925, HPA067153"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034925: AB_2240523, HPA067153: AB_2732759"	"unprognostic (8.52e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.62e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.27e-3)"	8.8	8.2	14.2	6.8	18.7	5.8	12.0	18.2	16.4	10.6	12.7	9.9	9.5	10.8	9.9	10.4	9.8	9.2	10.7	11.8	16.0	11.4	9.4	12.5	9.1	17.1	15.5	14.0	14.1	10.9	7.7	6.0	16.6	8.0	11.1	10.9	9.3	7.4	16.7	11.3	8.7	9.2	16.0	8.7	11.2	12.3	17.9	11.9	12.0	18.5	9.2	8.1	7.7	21.2	6.7	7.3	15.3	36.7	5.9	13.3	9.5	7.6	8.4	8.7	5.6	4.9	10.9	16.0	3.0	11.1	7.4	8.9	12.6	11.0	9.4	12.5	10.1	30.4	13.7	9.4	12.0	21.3	15.4	8.9	15.4	5.1	15.1	17.9	12.0	13.3	6.7	9.7	9.5	7.4	19.5	11.4	11.7	24.4	5.5	10.1	7.5	11.0	12.0	8.8	13.8	16.4	10.9	13.2	27.9	10.9	6.8	9.3	10.2	5.4	5.6	6.1	8.5	18.8	17.7	13.7	5.0	11.0	16.7	0.3	1.4	1.6	3.2	2.2	2.3	2.2	3.7	3.7	2.1	1.4	3.0	3.8	0.1	2.1	1.7	4.6	4.5	1.3	14.2	18.7	18.2	16.4	11.8	16.0	17.1	15.5	16.6	16.0	17.9	21.2	24.5	22.4	30.0	169.1	13.8	7.9	9.6	9.3	14.8	30.9	10.8	10.2	44.4	11.5	18.2	11.0	54.2	8.8	18.7	11.5	21.5	13.4	20.9	18.8	24.4	15.9	17.4	7.2	101.1	17.8	10.6	18.5	18.3	15.7	152.3	26.1	11.7	8.8	6.9	20.2	128.9	12.8	12.2	9.5	7.8	24.4	19.0	22.2	19.6	69.3	12.2	12.7	20.6	142.7	168.7	10.6	19.2	18.4	14.6	7.1	12.4	12.3	22.8	30.6	6.6	32.9	12.9	38.9	21.6	14.1	6.7	6.7	20.9	30.6	14.0	8.0
TDRD7	PCTAIRE2BP	ENSG00000196116	"Tudor domain containing 7"	Q8NHU6	9	97412096-97496125	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 63.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.7;Microglial cells: 33.7;Rod photoreceptor cells: 44.4;Spermatocytes: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 56.5;HDLM-2: 55.6;THP-1: 54.4"	"Low region specificity"	"Detected in all"							"CAB020800, HPA022250, HPA024529"	Enhanced		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Cytoplasmic bodies"	Nucleoplasm	"CAB020800: , HPA022250: , HPA024529: AB_1857869"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (2.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (4.76e-5)"	"unprognostic (4.03e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.67e-1)"	7.3	6.2	11.9	8.0	13.6	11.1	6.7	13.0	12.5	6.7	10.4	14.4	15.8	6.9	6.4	8.9	8.8	10.2	6.5	11.0	13.1	6.9	8.1	9.7	8.1	14.2	12.3	7.4	5.7	9.8	5.9	8.9	14.4	6.1	13.9	63.1	7.5	7.3	4.7	5.4	13.7	9.8	14.6	9.0	8.5	36.9	12.3	11.0	7.9	5.4	8.4	8.2	6.7	15.4	17.1	11.7	0.0	4.0	8.7	11.2	9.8	10.6	26.7	35.8	39.9	15.2	14.1	1.1	5.1	15.1	56.5	12.8	9.8	5.4	9.6	55.6	8.3	7.8	5.5	11.1	7.9	17.6	18.0	3.8	10.7	11.9	1.2	10.7	15.7	8.2	4.4	0.8	9.5	10.2	8.8	8.6	1.7	20.1	6.2	3.8	5.9	0.2	8.8	11.4	1.8	4.8	14.8	6.5	41.6	6.2	3.9	54.4	16.1	4.5	4.4	11.4	8.2	5.5	6.9	1.0	10.6	9.4	11.8	1.7	2.2	7.2	1.1	4.3	1.6	3.0	1.5	1.1	3.2	2.5	1.2	1.9	4.2	1.2	4.2	0.7	1.1	1.2	11.9	13.6	13.0	12.5	11.0	13.1	14.2	12.3	14.4	14.6	12.3	15.4	7.0	0.0	3.0	10.4	5.7	1.7	2.6	2.2	2.8	8.2	2.7	2.4	6.4	1.5	4.0	3.7	18.8	1.7	3.0	14.2	5.9	4.4	44.7	11.1	5.2	6.0	6.0	1.7	18.5	4.9	2.2	4.3	10.2	8.0	0.0	5.4	2.9	2.5	4.8	5.0	19.0	7.9	2.0	6.4	1.8	23.9	4.4	7.3	1.8	33.7	10.8	8.6	1.0	21.1	29.9	6.1	7.6	3.8	4.3	2.2	8.9	2.8	12.9	44.4	6.6	3.7	4.2	36.4	15.7	4.4	2.3	0.7	4.7	2.6	7.2	4.3
TEAD1	"AA, TCF13, TEF-1"	ENSG00000187079	"TEA domain transcription factor 1"	P28347	11	12674421-12944737	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 230.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057339, HPA062471"			Enhanced	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA057339: AB_2683413, HPA062471: AB_2684773"	"unprognostic (1.00e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.40e-3)"	"unprognostic (8.39e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.18e-2)"	29.5	12.1	11.1	8.2	11.6	0.0	17.8	8.6	8.5	23.4	30.6	36.1	7.7	26.4	7.1	29.8	19.2	18.5	31.3	14.5	14.8	17.2	13.6	15.9	4.2	15.1	12.3	21.9	15.2	27.1	14.4	33.3	10.5	18.8	13.0	10.5	10.2	20.1	67.5	13.2	11.9	27.2	13.3	7.3	16.4	8.6	15.6	4.2	17.8	72.6	5.6	33.9	14.7	12.9	62.8	52.1	43.9	58.7	59.9	62.1	65.4	89.2	76.2	71.6	69.7	53.8	54.5	0.4	23.0	120.9	32.3	37.0	53.7	35.9	115.5	0.2	17.6	0.0	107.3	18.1	55.8	0.0	4.7	51.8	18.3	50.4	68.2	58.6	15.2	3.9	26.0	0.2	111.2	13.1	0.1	0.6	17.2	14.5	23.5	0.3	64.8	33.2	48.2	37.2	26.9	31.2	90.9	43.1	59.0	63.8	20.0	4.4	32.0	107.8	76.2	84.9	59.5	8.6	17.3	12.0	41.6	0.2	69.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	11.6	8.6	8.5	14.5	14.8	15.1	12.3	10.5	13.3	15.6	12.9	37.9	89.8	21.7	230.8	0.4	99.3	32.2	19.3	39.9	12.9	16.4	20.2	75.0	31.5	33.1	49.7	12.5	24.1	0.2	11.0	1.9	16.6	6.5	80.8	97.4	33.3	46.7	0.0	101.8	12.8	52.4	46.5	18.8	142.9	0.0	57.7	25.7	39.8	3.7	1.7	108.4	13.5	10.2	1.9	16.0	7.2	23.6	1.9	24.9	91.8	0.0	31.2	0.0	121.2	69.7	34.8	8.1	24.0	1.4	69.4	6.7	29.8	53.8	17.5	6.6	73.5	46.7	3.0	22.3	29.9	54.8	12.3	2.0	45.5	10.4	54.6
TEAD2	"ETF, TEF-4, TEF4"	ENSG00000074219	"TEA domain transcription factor 2"	Q15562	19	49340595-49362457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 51.1;Early spermatids: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"memory B-cell: 1.7;naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	27	"B-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"AF22: 135.3;AN3-CA: 147.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066292, HPA069963"			Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA066292: AB_2685651, HPA069963: AB_2686222"	"unprognostic (2.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.78e-2)"	32.8	17.8	7.5	15.4	7.1	0.2	31.6	6.6	7.9	41.8	16.2	50.4	7.6	39.6	12.4	11.0	34.2	15.5	55.5	7.5	6.8	34.5	11.9	35.7	9.0	8.7	8.3	33.5	26.8	19.4	9.2	17.7	7.7	26.5	11.2	3.4	18.5	22.7	12.9	10.7	18.5	38.4	7.6	14.8	31.3	26.6	8.3	3.1	16.9	22.1	7.3	27.2	24.4	6.6	12.5	28.6	135.3	147.6	14.2	20.8	24.3	22.8	23.9	25.6	29.7	2.3	6.8	1.2	29.6	38.5	13.1	13.9	37.5	7.7	14.1	0.1	17.5	0.0	27.2	19.3	24.6	0.1	0.3	24.8	17.8	17.4	8.4	50.6	92.1	0.1	22.0	0.0	36.1	15.3	0.0	0.2	45.4	35.2	36.2	0.0	40.8	0.2	23.3	0.2	0.2	82.0	38.1	5.6	10.1	46.1	40.5	3.5	55.0	45.9	28.1	9.9	1.8	0.1	0.1	4.8	1.7	0.6	18.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	7.1	6.6	7.9	7.5	6.8	8.7	8.3	7.7	7.6	8.3	6.6	26.1	3.2	3.2	0.0	3.8	3.3	6.9	5.9	8.6	0.4	21.1	9.5	1.0	8.6	3.4	12.9	0.0	0.6	0.4	1.3	1.9	51.1	76.6	7.3	20.7	29.5	7.1	3.2	0.1	26.2	23.7	15.0	9.7	6.5	0.0	14.7	21.4	2.8	0.6	0.0	0.1	6.6	8.2	0.9	3.6	29.6	15.2	0.7	5.4	1.9	0.0	15.9	0.0	0.0	0.1	22.7	4.9	22.2	0.1	7.2	0.1	0.2	1.2	0.4	32.9	7.6	28.7	2.1	2.4	2.0	1.6	1.2	0.5	4.4	6.8	2.8
TEAD4	"EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1"	ENSG00000197905	"TEA domain transcription factor 4"	Q15561	12	2959330-3040676	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 127.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 50.3;Exocrine glandular cells: 38.3;Hepatic stellate cells: 32.2;Proximal enterocytes: 37.9;Syncytiotrophoblasts: 34.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 78.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 364.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.1"	"Low region specificity"	"Detected in all"			HPA056896	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA056896: AB_2683268"	"unprognostic (3.68e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.21e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.78e-9)"	"unprognostic (5.05e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-3)"	17.4	5.2	4.2	7.1	3.6	0.4	12.0	5.6	5.5	10.4	4.0	8.1	4.8	9.7	1.0	7.8	8.3	4.5	20.0	3.5	3.9	33.7	4.6	26.0	1.6	5.3	4.8	4.5	51.1	1.6	3.4	10.9	6.1	8.5	4.1	0.5	8.0	5.0	127.3	16.4	8.4	8.9	4.0	9.0	8.1	3.7	6.4	1.6	23.6	46.7	2.4	11.3	7.1	3.6	37.6	51.5	13.0	36.2	4.0	8.7	137.8	29.5	15.6	49.7	27.8	99.6	39.0	0.3	22.2	22.5	34.0	52.5	51.2	364.1	46.1	0.2	41.2	59.1	43.7	87.7	18.8	12.8	10.7	12.2	14.8	43.3	66.7	20.8	42.9	23.4	38.4	0.5	17.5	53.2	0.7	0.3	99.5	48.0	30.0	27.4	73.7	28.9	23.6	15.3	7.4	13.2	36.4	89.9	27.1	93.8	61.2	21.8	49.4	28.7	100.1	20.2	15.7	0.1	0.2	0.4	23.3	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.6	5.6	5.5	3.5	3.9	5.3	4.8	6.1	4.0	6.4	3.6	17.1	12.8	4.7	0.0	0.1	12.2	12.6	6.1	9.1	0.1	6.6	3.7	2.4	5.7	2.3	7.3	0.0	50.3	0.4	3.7	5.9	17.7	0.3	3.0	5.1	25.9	0.0	0.0	1.6	38.3	18.3	6.6	4.1	5.0	5.7	3.4	32.2	0.4	5.2	0.0	0.5	3.7	2.0	0.8	1.5	2.3	0.0	0.5	8.8	3.7	0.0	0.0	0.0	0.0	0.4	21.1	0.9	0.4	1.2	28.9	37.9	21.1	1.5	0.1	0.0	9.3	12.2	0.5	6.4	5.4	7.7	34.6	0.5	0.4	7.1	4.9
TECPR2	KIAA0329	ENSG00000196663	"Tectonin beta-propeller repeat containing 2"	O15040	14	102362941-102502477	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.5;Excitatory neurons: 59.1;Oligodendrocytes: 150.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 7.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA000658	Enhanced		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nucleoli, Centrosome"	"HPA000658: AB_1079191"	"unprognostic (6.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.76e-3)"	"unprognostic (3.78e-2)"	"prognostic favorable (6.53e-9)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-3)"	5.4	5.1	12.4	5.4	18.8	5.7	5.4	12.1	13.9	6.0	5.6	8.3	3.8	7.9	6.7	4.9	6.4	4.5	7.5	12.9	10.5	4.4	4.1	5.1	2.7	13.0	14.7	5.9	4.5	9.0	7.2	5.7	12.2	6.4	3.2	9.7	10.1	7.2	11.1	5.6	4.7	8.7	10.4	5.7	5.4	10.9	15.4	5.5	5.7	7.8	2.9	7.2	5.0	21.5	4.7	9.4	8.9	7.4	18.0	13.6	4.9	10.4	12.0	10.3	8.6	2.0	3.4	3.5	6.4	10.9	7.6	8.4	6.2	7.8	8.6	13.0	4.1	4.2	4.9	4.1	8.5	2.3	3.9	9.0	6.8	9.3	6.1	9.7	10.2	3.9	2.1	7.8	9.6	8.9	2.1	2.5	3.4	4.9	9.7	5.0	6.2	1.1	5.2	7.8	7.1	6.6	9.0	2.3	5.7	5.7	10.5	3.1	10.6	7.9	2.0	21.4	4.4	8.0	5.1	0.7	7.6	6.1	8.3	0.3	0.5	0.9	0.2	0.3	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.1	7.3	0.1	0.1	0.1	0.4	0.4	12.4	18.8	12.1	13.9	12.9	10.5	13.0	14.7	12.2	10.4	15.4	21.5	9.1	9.6	6.9	57.5	3.5	2.0	3.1	4.7	8.0	17.0	10.1	8.0	13.0	4.3	5.6	3.7	50.1	7.1	5.7	7.2	5.9	8.2	31.2	7.4	10.3	8.7	4.2	5.7	59.1	7.1	5.7	8.4	5.6	6.3	0.0	8.6	8.2	6.1	4.9	13.5	34.4	3.8	10.2	4.7	3.4	27.9	14.3	12.7	3.6	26.2	8.5	21.6	5.2	28.6	150.4	6.8	2.5	18.8	8.0	4.0	5.9	6.0	7.0	44.7	19.7	9.1	8.3	24.6	15.0	7.7	1.6	6.0	4.6	8.4	4.6	3.2
TEDC1	C14orf80	ENSG00000185347	"Tubulin epsilon and delta complex 1"	Q86SX3	14	105489855-105499575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 11.6;Endometrial ciliated cells: 12.0;Exocrine glandular cells: 12.7;Extravillous trophoblasts: 26.6;Hofbauer cells: 14.6;monocytes: 11.9;Pancreatic endocrine cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 66.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039049, HPA039050"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039049: AB_2676320, HPA039050: AB_10670918"	"unprognostic (8.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.73e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-3)"	5.1	1.6	5.2	4.9	5.5	6.8	4.7	4.1	7.8	4.3	0.5	5.5	5.1	3.8	1.0	6.8	4.6	1.8	4.3	5.8	3.0	4.0	5.4	4.9	5.4	7.0	3.5	2.5	3.0	1.0	5.3	1.6	4.2	4.2	1.6	0.5	4.3	2.3	2.3	8.2	5.4	1.0	3.1	6.8	5.9	4.9	3.6	4.5	5.7	0.5	3.1	3.9	4.5	5.3	17.2	38.9	9.2	13.5	0.8	1.5	24.5	13.4	5.0	15.9	14.7	14.0	31.2	25.6	27.2	2.2	6.2	43.5	3.2	14.0	3.0	29.0	16.0	6.5	22.8	13.3	0.6	12.9	17.9	0.3	4.6	10.6	3.5	2.0	6.4	23.2	10.5	31.2	2.5	66.7	26.9	29.6	11.9	14.6	41.8	21.9	13.8	17.9	4.5	14.3	25.7	15.5	13.7	15.8	9.8	2.0	26.0	12.6	7.8	10.9	18.4	33.4	22.4	17.8	8.2	15.7	13.9	14.8	18.0	0.0	0.5	0.6	0.5	0.9	0.4	0.1	0.8	1.4	0.7	0.3	0.6	0.1	0.1	0.0	0.8	2.4	0.6	0.2	5.2	5.5	4.1	7.8	5.8	3.0	7.0	3.5	4.2	3.1	3.6	5.3	4.8	3.2	2.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	5.9	5.3	0.0	0.0	0.6	1.8	0.0	8.0	10.1	0.0	3.9	11.6	0.0	12.0	3.0	4.0	0.0	0.0	0.0	12.7	26.6	3.4	0.0	7.2	0.0	8.1	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	11.9	0.0	0.0	0.0	0.0	14.7	0.0	0.0	4.7	0.0	0.0	2.0	3.6	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.0	4.2	2.5	0.0	0.0
TEDC2	"C16orf59, FLJ13909"	ENSG00000162062	"Tubulin epsilon and delta complex 2"	Q7L2K0	16	2460086-2464963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.0;testis: 5.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 12.8;Extravillous trophoblasts: 12.5;Granulosa cells: 6.7;Hofbauer cells: 4.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051394, HPA055389"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cell Junctions"		"HPA051394: AB_2681465, HPA055389: AB_2732595"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.38e-3)"	"prognostic unfavorable (2.43e-5)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (4.04e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.03e-1)"	0.3	0.8	0.8	1.7	0.9	4.0	0.4	0.4	1.4	0.7	0.2	1.0	1.5	0.4	0.0	2.3	0.3	0.1	0.8	0.8	0.6	0.6	0.8	0.5	2.2	0.7	0.6	0.4	0.6	0.2	0.8	0.9	0.8	0.6	0.7	0.2	0.6	0.2	0.3	0.9	1.4	0.3	0.4	1.2	0.8	5.0	0.9	2.2	0.4	0.0	1.4	0.4	0.8	0.6	10.2	31.3	17.7	20.8	0.3	1.2	17.7	7.9	4.7	12.5	12.1	21.9	8.2	14.0	12.6	3.4	6.8	15.3	12.9	8.0	3.0	15.6	17.4	12.7	23.2	22.9	0.4	12.3	16.3	1.1	1.0	11.0	3.0	1.0	5.8	22.8	21.9	5.2	4.4	19.7	21.6	23.2	39.2	9.7	11.5	52.0	15.1	31.3	2.7	4.4	16.6	27.2	9.1	9.5	7.1	4.7	14.0	14.2	2.2	13.2	19.2	12.8	18.2	11.4	20.1	28.3	6.7	12.3	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.2	0.4	0.1	0.8	0.9	0.4	1.4	0.8	0.6	0.7	0.6	0.8	0.4	0.9	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	0.0	0.0	0.0	0.0	0.0	12.8	0.5	0.0	1.9	2.9	0.0	1.2	1.1	0.6	0.0	0.0	0.0	1.3	12.5	1.7	0.0	1.0	0.0	6.7	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.9	0.4	2.7	0.0	0.0
TEKT3	FLJ32828	ENSG00000125409	"Tektin 3"	Q9BXF9	17	15303811-15341632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 31.0"	"Group enriched"	"Detected in some"	10	"Early spermatids: 413.1;Late spermatids: 408.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;SuSa: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027293, HPA044354, HPA073565"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA027293: , HPA044354: AB_10962623, HPA073565: "	"unprognostic (1.85e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.73e-2)"	"unprognostic (5.38e-4)"	"unprognostic (4.59e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (8.63e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.09e-4)"	"unprognostic (1.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.90e-3)"	"unprognostic (7.85e-2)"	0.3	0.2	0.7	0.3	0.6	0.1	0.5	1.4	0.9	1.2	0.6	0.3	0.3	0.5	0.6	0.1	4.9	0.4	0.2	0.4	0.4	0.3	0.2	0.8	0.1	0.9	1.0	0.9	0.7	0.2	1.0	0.3	0.5	0.4	0.2	0.6	0.5	0.1	0.1	0.7	0.4	0.2	0.5	0.2	0.2	31.0	0.4	0.1	0.7	0.0	0.1	0.2	0.4	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.1	0.1	1.5	0.0	0.2	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.7	0.3	0.0	0.1	0.0	0.0	0.7	0.6	1.4	0.9	0.4	0.4	0.9	1.0	0.5	0.5	0.4	1.1	0.7	3.2	0.5	0.7	0.1	0.3	0.1	0.7	0.0	0.7	0.5	0.5	0.7	1.5	4.7	0.0	0.0	0.3	0.2	0.5	0.0	0.1	413.1	16.3	1.7	0.7	1.8	0.0	1.2	0.0	0.5	3.9	0.0	0.5	0.0	0.7	0.4	0.1	3.8	0.0	1.1	0.0	0.0	0.0	1.4	408.9	11.1	0.3	0.0	1.0	0.0	1.7	0.0	2.0	0.8	0.0	0.1	6.4	0.0	0.2	0.7	0.1	39.1	0.2	6.6	3.2	1.4	25.9	2.6	0.0	0.1	0.0	0.1	3.4	0.0	0.2
TEN1	"C17orf106, FLJ39785"	ENSG00000257949	"TEN1 subunit of CST complex"	Q86WV5	17	75979240-76000586	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 55.1;Exocrine glandular cells: 88.9;Pancreatic endocrine cells: 89.1;Proximal tubular cells: 89.0;Suprabasal keratinocytes: 52.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA065069			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA065069: AB_2685418"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.85e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.85e-4)"	21.0	27.7	10.1	14.8	10.4	32.2	21.9	10.4	12.7	19.4	11.8	18.9	22.7	16.8	11.8	43.4	15.2	15.9	16.7	10.0	10.8	27.4	49.5	20.7	18.7	10.8	11.4	16.1	32.8	12.8	22.3	11.5	11.7	28.1	9.5	3.4	27.8	10.2	12.1	46.3	25.7	7.8	10.5	23.3	26.9	13.3	11.0	6.7	20.1	7.8	12.9	16.2	25.0	11.5	19.2	15.1	12.1	16.6	16.5	21.6	32.7	12.3	18.4	21.5	21.9	18.6	32.3	25.0	20.4	15.0	22.4	18.1	7.7	18.6	6.3	13.8	24.8	28.7	21.3	21.0	19.8	18.6	45.7	19.4	25.8	11.8	12.3	18.0	29.0	14.6	12.4	24.2	12.8	31.8	23.9	40.3	11.8	19.4	25.6	21.7	12.0	22.7	27.5	33.5	23.8	40.1	9.6	83.5	16.3	9.3	43.4	28.8	15.9	41.7	24.0	17.8	28.3	25.3	10.1	14.2	22.4	13.2	13.3	81.8	53.7	33.4	40.0	52.5	33.3	60.8	31.6	34.0	48.5	49.2	23.7	28.4	32.7	45.3	29.2	52.8	37.9	36.3	10.1	10.4	10.4	12.7	10.0	10.8	10.8	11.4	11.7	10.5	11.0	11.5	14.0	0.0	4.2	0.0	13.0	39.0	0.0	55.1	5.2	0.0	39.2	32.8	0.0	0.0	23.4	5.5	0.0	0.0	21.7	0.1	39.2	39.5	0.0	12.4	13.0	10.2	0.0	0.8	0.0	88.9	0.1	8.8	2.6	19.0	2.5	16.9	0.0	0.0	0.1	0.0	0.0	0.2	34.6	0.0	39.9	0.0	0.0	19.7	30.2	0.0	37.2	0.0	0.0	0.0	0.0	89.1	0.0	0.0	7.9	0.0	0.0	89.0	8.7	0.0	0.0	0.1	12.9	0.0	0.0	6.1	52.7	0.0	9.4	24.4	0.0	0.1
TENM3	"KIAA1455, ODZ3, Ten-M3, TEN3"	ENSG00000218336	"Teneurin transmembrane protein 3"	Q9P273	4	182143987-182803024	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"		"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8;placenta: 13.1"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 635.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;BEWO: 63.3;HDLM-2: 90.0;T-47d: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047043	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA047043: AB_2679914"	"unprognostic (5.79e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.25e-4)"	5.0	5.1	12.0	1.6	18.4	0.0	2.0	0.0	12.3	1.5	0.0	4.3	0.8	2.9	0.6	0.8	1.0	2.4	1.4	21.8	8.1	0.9	0.3	0.8	0.8	2.8	7.3	3.8	1.2	5.1	4.5	13.1	0.0	3.7	0.8	3.9	0.6	3.6	2.1	0.4	0.9	2.3	0.8	2.2	0.7	2.1	7.4	2.8	6.1	4.3	1.2	1.6	1.4	2.0	0.3	2.6	66.3	0.4	13.2	23.5	63.3	7.8	2.7	6.9	6.1	33.9	17.6	0.0	0.9	52.6	28.6	3.3	16.0	3.4	6.8	90.0	26.7	0.0	0.0	0.0	1.3	0.0	0.0	31.2	1.2	21.5	15.0	15.4	9.6	0.0	0.0	0.4	10.6	2.3	0.1	0.1	21.4	0.0	2.8	0.0	17.1	0.2	0.1	0.1	27.2	25.2	4.0	0.5	0.1	35.8	86.0	3.4	21.2	53.7	38.2	0.2	39.6	0.0	0.0	0.0	28.2	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	18.4	0.0	12.3	21.8	8.1	2.8	7.3	0.0	0.8	7.4	2.0	0.1	0.0	0.0	23.8	0.0	0.4	0.2	0.7	1.8	50.8	1.6	2.2	3.9	0.0	0.1	3.7	4.2	112.7	0.0	0.0	1.9	0.1	12.4	0.1	4.5	0.7	5.3	0.0	115.6	1.8	54.6	4.1	0.0	0.6	0.0	7.7	1.1	0.7	10.4	5.0	635.6	0.0	0.0	0.0	0.7	3.2	8.4	0.0	1.8	8.4	0.0	10.6	0.0	12.1	24.4	0.4	0.0	2.6	0.0	0.4	0.0	0.3	0.0	3.1	0.0	4.8	3.2	3.8	7.2	1.8	0.0	133.4	0.1	4.1	0.1	0.1
TENT4A	"LAK-1, PAPD7, POLK, POLS, TRF4, TRF4-1"	ENSG00000112941	"Terminal nucleotidyltransferase 4A"	Q5XG87	5	6713432-6757044	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Breast glandular cells: 13.4;Breast myoepithelial cells: 13.2;dendritic cells: 12.3;Endometrial stromal cells: 15.4;Glandular and luminal cells: 14.0;Granulosa cells: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045487, HPA046742"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA045487: AB_2679346, HPA046742: AB_2679781"	"unprognostic (1.45e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.62e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (8.55e-4)"	13.1	8.1	8.4	9.5	8.6	27.6	11.0	16.6	10.1	12.5	5.7	10.0	8.7	11.1	6.4	10.7	11.5	10.0	8.5	8.7	8.1	9.6	20.5	12.8	13.0	6.5	6.5	15.6	12.0	10.0	11.1	9.1	7.0	11.1	7.2	12.5	8.2	8.8	9.3	15.7	12.4	12.2	6.0	13.7	9.6	10.1	7.9	14.6	10.2	12.1	10.4	10.1	11.8	8.9	31.7	20.9	25.4	31.6	17.7	15.6	37.0	21.0	25.7	25.1	28.2	21.9	17.3	23.1	16.1	25.5	28.5	22.9	20.7	16.4	23.1	26.1	14.0	12.0	72.5	12.4	11.0	18.0	17.3	10.7	13.8	28.7	18.4	18.6	15.0	16.9	16.3	29.8	20.8	17.6	24.4	25.3	13.6	9.7	16.6	21.8	21.2	6.0	10.5	17.5	25.1	19.3	50.7	24.1	14.5	13.4	14.5	9.9	13.6	30.6	32.7	27.2	29.8	28.6	12.6	20.4	19.6	16.4	19.2	0.0	0.2	0.2	0.6	0.1	0.6	0.5	0.4	0.4	0.3	0.4	0.5	0.5	0.1	0.1	0.2	1.1	0.6	0.2	8.4	8.6	16.6	10.1	8.7	8.1	6.5	6.5	7.0	6.0	7.9	8.9	19.3	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	13.4	13.2	0.0	0.0	0.0	5.5	0.0	5.3	12.3	0.0	1.9	4.9	0.0	10.7	15.4	4.8	0.0	0.0	0.0	4.4	4.0	4.0	0.0	14.0	0.0	14.5	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	4.2	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	5.6	4.8	10.7	0.0	0.0
TENT5A	"C6orf37, FAM46A, FLJ20037"	ENSG00000112773	"Terminal nucleotidyltransferase 5A"	Q96IP4	6	81491439-81752774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 225.9;salivary gland: 104.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 73.1;Endometrial stromal cells: 70.6;Extravillous trophoblasts: 115.4;Glandular and luminal cells: 176.7;Syncytiotrophoblasts: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 81.9;HeLa: 86.1;HL-60: 95.6;THP-1: 162.0;U-937: 72.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051067, HPA067140"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051067: , HPA067140: AB_2685788"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.62e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (7.18e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.66e-2)"	13.5	21.3	4.3	7.9	4.6	225.9	12.2	9.0	5.8	21.3	9.9	17.2	16.4	10.2	19.7	4.4	12.0	32.3	21.7	4.0	14.0	6.4	35.9	9.1	5.2	7.8	7.1	23.6	8.3	9.4	17.4	18.7	6.1	9.9	16.9	8.7	104.4	24.8	2.1	18.7	22.2	11.1	5.0	9.9	37.8	3.7	6.7	2.9	8.8	5.1	4.3	16.6	8.8	5.3	3.5	5.0	3.3	0.2	67.9	29.8	6.2	27.0	19.2	15.7	23.5	51.0	2.6	0.3	1.0	81.9	10.0	2.9	2.4	4.2	11.5	0.0	6.2	0.1	86.1	8.0	21.2	95.6	7.1	13.2	2.4	12.3	2.1	51.2	2.0	0.8	1.4	0.0	10.6	14.7	0.0	67.2	0.9	29.2	3.8	0.0	28.8	0.1	2.1	6.2	3.3	4.4	12.1	5.2	8.3	9.9	1.2	162.0	4.5	17.9	3.8	7.6	7.6	0.4	0.3	0.3	25.3	72.7	7.8	37.3	29.9	46.3	11.5	29.6	6.8	18.2	4.3	5.7	24.2	21.0	8.1	8.0	13.8	16.9	47.3	8.5	5.6	14.0	4.3	4.6	9.0	5.8	4.0	14.0	7.8	7.1	6.1	5.0	6.7	5.3	22.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	40.8	44.2	0.0	0.0	0.0	5.5	0.0	39.9	43.1	0.0	3.9	30.5	0.0	73.1	70.6	2.9	0.0	0.0	0.0	23.4	115.4	32.7	0.0	176.7	0.0	40.9	0.0	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	26.7	0.0	0.0	5.9	0.0	0.0	3.6	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	162.0	9.4	12.6	0.0	0.0
TENT5C	"FAM46C, FLJ20202"	ENSG00000183508	"Terminal nucleotidyltransferase 5C"	Q5VWP2	1	117606048-117628389	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 89.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 41.8;Breast glandular cells: 34.0;Breast myoepithelial cells: 43.2;dendritic cells: 104.5;Plasma cells: 47.7;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.3"	"Group enriched"	"Detected in many"	17	"B-cells: 13.3;granulocytes: 29.3;T-cells: 13.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 296.2;RPMI-8226: 185.5;U-266/70: 81.7;U-266/84: 72.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054049	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA054049: AB_2682356"	"unprognostic (3.76e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.24e-3)"	"prognostic favorable (3.75e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.77e-5)"	"unprognostic (6.26e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.10e-2)"	2.8	2.4	0.9	17.0	1.0	89.1	11.6	1.1	1.6	10.9	27.4	23.8	16.0	3.2	19.1	3.6	4.8	7.8	6.9	1.4	0.9	7.5	10.3	10.5	18.8	1.6	1.6	9.0	46.8	11.2	2.6	3.8	1.1	6.6	24.8	0.1	25.8	4.1	29.4	1.2	13.0	2.9	1.9	21.7	30.2	43.5	1.0	6.2	14.3	10.9	37.3	14.1	1.9	1.3	0.2	0.1	0.1	1.3	0.1	0.0	1.3	0.6	26.9	0.5	0.2	1.7	0.2	4.9	0.3	0.8	0.3	0.3	0.1	0.5	0.2	17.6	1.6	37.9	0.2	0.0	0.1	22.4	46.8	0.0	0.1	0.4	0.0	0.1	0.1	10.0	5.2	296.2	0.0	3.8	0.1	22.8	3.8	4.5	2.4	0.1	0.1	185.5	0.3	3.7	2.2	0.2	1.7	2.4	1.8	0.6	1.9	0.2	0.5	0.3	2.1	0.1	0.4	81.7	72.8	1.9	1.7	8.1	2.4	29.3	0.0	15.9	3.4	0.0	3.1	13.3	3.3	4.4	0.1	10.4	0.4	1.9	1.6	1.1	0.0	0.3	13.7	2.9	0.9	1.0	1.1	1.6	1.4	0.9	1.6	1.6	1.1	1.9	1.0	1.3	17.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	34.0	43.2	0.0	0.0	0.0	1.8	0.0	1.9	104.5	0.0	11.7	0.8	0.0	8.3	5.4	2.9	0.0	0.0	0.0	5.2	2.2	3.2	0.0	13.7	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	47.7	0.0	0.0	9.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.2	48.4	1.0	0.0	0.0
TEP1	"p240, TLP1, TP1, TROVE1, VAULT2"	ENSG00000129566	"Telomerase associated protein 1"	Q99973	14	20365667-20413501	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 23.9;Gastric mucus-secreting cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029206			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA029206: AB_10601271"	"unprognostic (4.53e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.58e-4)"	"unprognostic (2.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.00e-1)"	9.4	7.8	3.4	12.1	4.1	5.1	8.7	3.2	4.0	7.8	6.0	17.4	28.0	6.9	7.3	6.8	7.2	10.7	6.8	3.3	4.3	6.5	6.5	11.0	15.0	6.0	5.3	6.2	6.2	13.7	5.7	6.6	5.1	7.9	17.9	5.0	8.3	6.3	10.3	7.9	15.5	9.7	3.8	14.8	9.6	2.3	5.8	10.2	8.1	5.1	15.1	7.5	7.8	5.2	9.2	4.2	4.1	4.5	26.1	9.9	7.3	6.8	6.0	4.0	5.1	8.7	10.2	8.1	4.2	17.0	7.3	9.3	3.5	13.6	6.8	7.8	3.5	9.5	9.4	5.7	7.5	8.0	16.1	14.1	11.8	6.5	5.2	17.1	15.2	6.7	3.1	5.8	14.0	5.4	4.7	5.8	1.8	28.4	3.6	12.2	10.2	2.8	13.2	13.8	1.2	1.9	5.4	12.8	4.2	11.8	6.5	4.9	20.1	15.5	10.6	4.9	1.9	12.9	6.9	5.1	3.7	6.9	5.5	3.6	2.3	0.0	1.0	2.8	1.0	1.7	0.5	1.0	0.8	2.4	0.5	0.6	4.5	0.5	2.9	5.4	0.6	0.3	3.4	4.1	3.2	4.0	3.3	4.3	6.0	5.3	5.1	3.8	5.8	5.2	3.7	9.6	14.1	13.1	8.4	2.8	4.8	3.1	2.8	0.3	3.2	2.8	3.2	8.6	5.6	1.8	2.1	2.0	14.3	23.9	1.9	4.8	0.2	2.9	4.2	5.8	4.2	2.1	1.9	5.1	2.5	3.4	25.5	4.2	10.8	2.6	8.2	4.9	6.4	0.0	2.1	12.8	0.0	10.4	4.6	1.3	5.0	10.2	5.4	16.9	12.9	2.6	7.2	4.5	3.9	6.0	12.8	3.8	8.4	5.1	21.8	3.8	12.2	2.6	0.0	5.1	6.1	0.0	0.6	2.4	1.4	1.9	5.0	2.2	8.3	4.9
TERB1	"CCDC79, FLJ35894"	ENSG00000249961	"Telomere repeat binding bouquet formation protein 1"	Q8NA31	16	66754640-66801620	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA079436			Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA079436: "	"unprognostic (2.15e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.57e-5)"	"unprognostic (6.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.81e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.14e-3)"	0.1	0.3	0.7	0.2	0.4	1.5	0.0	1.6	1.0	0.0	1.5	0.1	0.4	0.2	0.1	0.2	0.1	0.1	0.0	0.4	0.6	0.1	0.1	0.2	0.3	1.3	0.4	0.1	0.0	0.0	0.0	0.1	0.9	0.1	0.1	0.4	0.3	0.0	0.1	0.7	0.1	0.0	0.1	0.2	0.0	12.6	0.8	0.0	0.4	0.0	0.1	0.0	0.0	1.6	0.2	0.6	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.2	0.8	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.6	0.1	0.7	0.4	0.0	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.4	0.2	0.4	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.6	0.3	0.3	0.1	0.2	0.1	0.4	0.0	0.2	0.0	0.4	0.2	0.5	0.2	0.3	0.2	0.6	0.3	0.3	0.1	1.9	0.2	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.4	0.1	0.2	0.8	0.4	0.1	1.1	0.1	0.3	0.7	0.4	1.6	1.0	0.4	0.6	1.3	0.4	0.9	0.1	0.8	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TERB2	"C15orf43, MGC33951"	ENSG00000167014	"Telomere repeat binding bouquet formation protein 2"	Q8NHR7	15	44956687-44979229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA041780			Uncertain	Nucleoplasm,Nucleoli		No	NA				"Cluster 83: Testis - Spermatogenesis"			Nucleoli	Nucleoplasm	"HPA041780: AB_10796460"							"unprognostic (1.42e-3)"					"unprognostic (4.19e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TERF2	"TRBF2, TRF2"	ENSG00000132604	"Telomeric repeat binding factor 2"	Q15554	16	69355567-69408571	"Predicted intracellular proteins"	"Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001907, HPA002735, CAB010451"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898"	"unprognostic (2.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	15.2	14.4	19.8	17.2	20.6	18.5	14.1	22.7	29.1	15.3	9.1	15.5	13.4	17.9	15.1	15.0	15.4	13.7	15.1	21.8	21.0	13.0	14.8	12.6	35.6	17.6	19.9	19.2	16.7	18.3	12.4	16.1	16.8	13.3	14.4	21.0	11.9	14.1	31.9	15.9	14.0	19.1	14.5	15.8	12.6	16.4	18.4	21.0	16.6	22.1	44.7	15.6	13.4	23.3	21.6	34.4	30.5	30.8	28.5	20.9	26.0	21.5	26.9	50.1	38.7	31.7	28.6	98.2	28.6	26.7	17.9	34.0	37.8	26.4	46.7	18.6	29.3	28.8	18.2	29.1	24.2	28.6	23.0	21.5	26.2	40.2	48.7	22.2	35.0	38.4	54.8	14.2	32.8	29.2	57.0	36.4	35.1	23.6	16.7	78.5	20.2	56.8	21.6	15.8	34.4	27.0	71.4	16.1	19.6	27.5	30.6	32.8	21.5	31.3	27.4	21.9	25.9	36.8	42.1	124.9	27.1	25.5	30.8	14.9	3.5	4.3	5.9	3.3	4.3	13.0	5.6	5.0	3.7	8.4	6.3	6.2	4.2	4.6	3.5	5.0	5.0	2.8	19.8	20.6	22.7	29.1	21.8	21.0	17.6	19.9	16.8	14.5	18.4	23.3	16.2	16.0	10.2	15.0	20.9	12.5	12.8	5.0	5.7	25.3	13.4	8.5	17.2	5.7	5.1	9.2	18.8	8.3	13.0	15.5	1.9	5.3	33.4	15.5	20.8	17.9	10.2	8.6	18.3	7.5	7.7	13.5	8.6	20.5	14.0	14.9	14.3	18.2	12.5	45.4	19.9	11.6	2.0	15.4	12.3	19.5	9.3	11.0	3.6	16.9	8.9	19.3	16.5	18.6	26.5	7.9	7.3	14.3	11.2	14.8	9.5	8.4	8.3	13.9	19.7	18.8	12.1	8.8	13.1	9.6	12.9	8.3	12.1	17.0	11.1	12.8
TERF2IP	RAP1	ENSG00000166848	"TERF2 interacting protein"	Q9NYB0	16	75647773-75761872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006719, CAB018660, CAB018749"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nuclear bodies"		"CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267"	"unprognostic (3.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (6.14e-5)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.81e-1)"	"prognostic favorable (2.15e-5)"	"unprognostic (6.26e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.99e-1)"	56.3	93.4	151.5	41.2	152.0	89.7	51.9	146.3	186.2	52.7	112.3	48.3	27.2	51.6	57.6	37.6	50.7	36.7	67.0	146.2	189.9	46.7	42.9	51.8	68.2	142.8	154.1	72.8	38.2	71.8	144.4	27.5	155.3	48.0	26.9	168.6	38.3	44.8	58.3	48.0	41.8	39.1	146.0	57.7	37.7	55.0	174.0	71.9	55.2	47.3	61.9	44.5	46.4	156.5	25.1	23.2	51.2	39.7	56.9	59.2	16.0	74.6	63.9	62.0	45.8	25.7	26.9	127.2	97.0	50.6	30.6	35.6	51.1	21.3	52.5	48.1	74.1	64.9	36.6	59.1	74.4	88.6	88.7	50.7	59.3	49.8	76.8	68.2	42.2	82.6	77.2	52.2	71.9	73.7	107.2	112.5	25.9	32.4	53.3	119.9	33.0	106.0	46.4	22.7	123.9	74.7	96.8	22.4	61.8	18.5	51.7	86.0	46.6	59.1	31.3	51.4	57.9	216.2	202.5	179.2	62.2	59.6	57.1	56.4	21.9	101.3	28.7	19.8	35.8	46.8	44.2	47.9	21.0	65.7	53.9	33.8	33.2	39.7	31.2	20.3	48.6	19.8	151.5	152.0	146.3	186.2	146.2	189.9	142.8	154.1	155.3	146.0	174.0	156.5	109.1	48.1	69.3	30.7	160.8	195.5	114.3	82.5	163.4	388.8	73.6	77.0	95.2	68.6	74.2	93.8	93.8	76.8	172.7	33.4	135.0	81.7	7.8	68.5	81.8	102.3	97.8	421.4	46.7	51.1	38.9	115.7	39.3	74.6	124.9	81.4	84.3	58.1	60.7	282.7	54.5	50.1	120.1	70.8	138.5	23.6	115.5	89.3	120.9	18.7	96.6	320.2	125.7	38.2	68.2	46.3	46.9	130.5	162.8	101.7	45.1	74.7	66.9	176.2	138.1	79.0	106.2	255.1	116.2	94.3	194.4	122.3	215.0	140.7	32.2	116.4
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295068	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Intestinal goblet cells: 1.0;Plasma cells: 2.8;Spermatocytes: 1.5;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 438.0;fHDF/TERT166: 429.4;HBEC3-KT: 929.2;hTEC/SVTERT24-B: 560.1;LHCN-M2: 252.2;TIME: 799.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA					"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: AB_2682554, HPA065897: AB_2685576"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	213.2	438.0	3.2	0.0	173.9	31.7	59.4	0.3	0.1	3.0	0.2	429.4	0.1	0.1	1.0	929.2	29.1	0.0	1.7	0.1	0.0	0.4	0.1	0.5	1.2	0.0	22.9	560.1	6.8	1.3	1.5	1.8	2.9	0.2	252.2	0.4	0.2	9.4	2.9	0.1	1.3	2.1	0.0	5.4	23.9	0.5	0.2	2.1	0.1	0.0	0.2	0.0	0.1	0.3	799.9	0.0	0.0	0.0	0.0	0.9	0.5	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0
TESC	"CHP3, FLJ20607, TSC"	ENSG00000088992	Tescalcin	Q96BS2	12	117038923-117099479	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 329.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 183.0;Erythroid cells: 222.9;Exocrine glandular cells: 481.2;Gastric mucus-secreting cells: 316.0;Late spermatids: 319.3;Pancreatic endocrine cells: 215.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 261.1"	"Lineage enriched"	"Detected in all"	5	"monocytes: 261.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 398.5;NB-4: 675.1;OE19: 288.1;U-937: 221.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053200	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 24: NB-4 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Cytosol	"HPA053200: AB_2682079"	"unprognostic (4.53e-3)"	"unprognostic (5.98e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.23e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.67e-3)"	8.1	46.5	17.4	10.3	36.8	118.8	8.9	16.4	25.4	4.3	15.7	3.8	7.2	3.9	121.9	3.3	4.0	36.1	71.5	26.5	15.0	26.5	4.9	10.2	8.0	17.8	15.0	5.3	102.4	9.4	26.7	10.2	18.2	9.8	2.8	0.5	329.9	19.7	5.1	9.7	7.3	2.8	14.8	11.9	138.4	31.1	15.5	7.4	10.7	8.1	10.3	29.3	5.3	18.9	0.2	97.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	4.3	13.8	4.7	0.0	0.2	0.6	8.1	0.0	0.0	37.5	19.2	115.5	9.8	78.1	0.0	49.2	398.5	0.1	0.0	0.0	0.0	0.0	0.0	18.5	54.0	0.9	0.0	2.2	95.5	675.1	9.0	288.1	0.0	0.4	0.0	52.4	56.5	15.0	17.0	6.1	0.1	0.1	3.6	0.9	0.0	53.9	0.0	0.0	1.7	0.2	0.4	17.0	38.2	0.0	0.1	221.8	0.5	0.0	51.0	51.5	7.0	67.9	0.4	5.5	2.4	9.1	35.8	13.1	0.3	3.8	12.6	11.6	261.1	2.6	3.5	19.0	17.4	36.8	16.4	25.4	26.5	15.0	17.8	15.0	18.2	14.8	15.5	18.9	35.6	0.0	0.0	5.9	16.2	2.7	0.3	0.4	1.8	0.8	5.5	67.1	58.3	183.0	0.9	12.9	0.0	0.4	21.1	0.2	74.3	159.5	106.5	1.3	0.7	43.6	1.8	222.9	26.1	481.2	0.6	7.9	316.0	3.2	71.1	1.2	1.8	0.5	48.0	0.0	2.0	1.5	0.0	17.9	6.1	319.3	3.1	30.6	72.9	8.4	41.0	0.2	25.7	2.5	1.5	215.6	0.9	3.4	25.8	3.5	0.2	6.1	0.0	1.5	144.7	1.9	68.4	63.0	20.3	0.5	2.0	1.2	28.3	66.7	2.3	1.3
TESK2		ENSG00000070759	"Testis associated actin remodelling kinase 2"	Q96S53	1	45343883-45491163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 222.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.6;RT4: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027257: AB_10602477, HPA063869: AB_2685137"	"unprognostic (2.95e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	3.8	2.1	7.1	2.8	10.6	10.2	6.6	10.3	8.3	6.4	4.8	5.3	8.6	3.2	3.7	7.1	3.0	2.6	2.4	7.3	8.0	2.5	6.9	3.9	3.9	10.8	10.1	9.8	3.6	3.4	2.4	3.5	10.3	15.5	7.0	2.8	8.4	2.6	8.3	12.7	10.8	2.9	8.5	5.3	4.5	9.6	9.9	4.2	3.4	4.7	5.2	4.7	7.4	15.1	1.9	0.0	0.9	0.1	3.5	1.8	14.6	0.7	4.9	2.1	3.6	4.3	1.7	6.2	0.6	1.8	5.4	2.3	3.9	3.1	1.6	4.4	4.9	4.2	2.0	3.2	1.9	1.4	11.1	1.9	3.2	2.4	3.4	3.2	1.7	8.1	0.8	12.4	1.4	0.7	3.6	2.9	3.8	1.8	1.8	5.2	0.1	1.5	1.9	14.7	0.4	1.6	3.8	7.3	14.1	8.6	11.3	1.8	0.0	0.2	2.1	1.3	1.3	8.0	5.0	1.2	1.1	0.0	1.0	12.8	4.6	13.3	2.7	3.4	1.9	8.0	2.5	1.8	2.4	6.6	4.1	2.3	19.0	1.5	8.0	1.3	1.9	3.4	7.1	10.6	10.3	8.3	7.3	8.0	10.8	10.1	10.3	8.5	9.9	15.1	3.9	0.0	2.8	54.2	10.7	7.8	7.1	2.8	14.2	2.4	11.9	9.4	1.3	4.3	3.4	0.0	14.6	8.3	4.2	13.9	0.0	1.3	23.7	4.6	1.8	3.2	4.2	5.0	10.2	2.7	2.8	3.7	7.7	8.9	7.0	2.4	2.2	6.3	6.8	0.0	6.7	6.9	4.1	5.5	4.4	7.8	2.8	6.0	3.6	15.9	4.6	1.1	4.1	18.6	222.9	1.1	7.3	1.9	9.8	10.6	14.9	1.2	2.0	3.1	6.6	2.6	6.1	22.0	13.6	12.6	8.5	14.8	4.7	1.8	4.9	8.0
TESMIN	"CXCDC2, MTL5"	ENSG00000132749	"Testis expressed metallothionein like protein"	Q9Y4I5	11	68707440-68751520	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 52.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 9.6;Breast myoepithelial cells: 7.4;Endometrial ciliated cells: 31.5;Glandular and luminal cells: 27.0;Proximal tubular cells: 11.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 6.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 11.9;T-47d: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA018539			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"HPA018539: "	"unprognostic (1.99e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (3.22e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-1)"	0.3	0.5	0.7	1.0	0.7	7.4	4.3	0.6	0.6	0.7	0.6	2.5	1.4	0.7	0.7	1.6	1.7	0.4	0.2	0.5	0.8	3.1	0.4	0.4	1.3	1.2	0.7	0.8	1.1	2.1	2.3	0.3	1.2	2.3	2.9	1.5	1.9	1.1	0.0	0.6	1.4	0.4	0.5	1.3	0.9	52.5	0.7	2.1	1.1	0.1	1.1	0.4	0.9	0.5	7.2	3.1	1.3	0.1	0.0	0.0	3.5	1.6	0.8	2.2	1.0	0.9	7.1	2.9	1.6	0.3	0.0	3.4	1.0	1.4	1.7	3.0	2.5	2.1	1.0	0.0	0.0	1.5	11.9	0.0	3.8	0.1	2.2	3.0	0.7	3.4	4.5	5.4	0.3	4.8	0.8	4.2	7.3	3.3	3.1	1.9	0.4	0.8	2.6	0.1	4.4	4.7	0.0	1.5	0.0	3.7	23.8	10.0	2.7	0.2	0.5	0.2	0.1	2.1	2.0	2.8	0.1	4.2	1.9	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.7	0.7	0.6	0.6	0.5	0.8	1.2	0.7	1.2	0.5	0.7	0.5	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.6	7.4	0.0	0.0	0.6	0.0	0.0	1.8	0.7	0.0	5.9	6.3	0.0	31.5	2.6	0.3	0.0	0.0	0.0	4.0	4.7	0.3	0.0	27.0	2.5	4.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.5	0.0	0.0	11.5	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	1.1	0.2	0.0	0.0
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560337-68694487	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	0.4	0.2	0.6	0.2	1.2	0.3	0.4	4.9	0.7	0.7	0.8	0.4	0.1	0.9	0.6	0.2	0.5	0.3	0.3	0.3	0.9	0.3	0.2	0.2	0.3	0.9	1.3	0.8	0.2	0.7	0.3	1.2	1.1	0.6	0.3	1.5	1.0	0.3	0.9	0.3	0.2	0.5	1.0	0.3	0.4	0.2	1.1	2.0	0.5	0.3	0.3	0.2	0.4	2.2	0.7	0.8	8.0	9.0	0.8	0.7	17.7	0.4	1.0	0.7	1.2	5.5	0.3	0.0	0.3	0.8	0.1	0.0	20.4	0.0	0.8	0.3	3.3	2.1	0.0	4.9	1.2	1.9	1.0	1.0	0.1	0.5	0.1	1.6	0.1	3.5	12.0	1.4	0.7	0.6	3.3	1.4	11.9	0.0	1.1	3.2	2.5	0.2	0.4	0.8	2.2	3.5	0.4	0.5	1.6	7.9	1.0	1.5	0.3	0.7	1.6	0.0	0.6	0.5	0.6	3.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.4	0.3	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.6	1.2	4.9	0.7	0.3	0.9	0.9	1.3	1.1	1.0	1.1	2.2	6.3	3.2	6.2	54.5	2.5	1.1	1.8	0.4	5.2	2.5	7.0	9.5	7.2	1.5	2.6	0.0	10.4	21.0	3.0	0.2	0.0	2.7	0.8	3.6	34.2	4.8	13.8	2.5	15.6	0.4	79.9	15.4	1.5	2.9	0.0	13.6	5.7	2.5	3.9	35.3	20.6	0.3	4.1	0.0	0.3	1.7	25.7	0.8	1.8	12.2	0.4	16.1	5.2	44.7	45.3	0.6	0.0	20.7	7.3	1.4	0.0	0.9	0.8	12.5	6.6	21.9	10.7	0.5	1.5	0.8	1.1	27.9	2.6	43.7	0.6	0.4
TET2	"FLJ20032, KIAA1546"	ENSG00000168769	"Tet methylcytosine dioxygenase 2"	Q6N021	4	105145875-105279816	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 112.6;Oligodendrocytes: 128.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 55.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 55.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043135	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA043135: AB_10794177"	"unprognostic (6.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.84e-2)"	4.3	3.1	2.9	10.1	4.4	22.4	5.4	2.5	2.7	6.3	5.8	5.2	6.1	7.2	6.0	7.7	4.9	5.0	3.3	2.1	4.6	4.1	4.2	5.4	5.6	5.3	4.4	4.3	3.7	4.6	1.8	10.2	5.3	4.4	5.9	6.6	4.7	3.3	2.8	11.0	6.0	5.7	2.9	7.2	5.3	1.3	4.1	5.4	4.2	5.2	7.0	5.5	4.5	5.6	5.1	3.1	10.9	11.1	2.1	3.7	4.2	3.1	4.8	4.8	4.7	3.1	6.4	0.5	4.0	4.0	2.1	4.9	9.3	6.1	5.3	6.7	2.9	7.0	6.5	1.6	4.9	15.5	11.8	3.8	7.9	4.5	5.6	8.6	6.4	4.1	7.7	13.6	4.4	3.1	2.5	4.7	2.5	6.2	2.2	8.4	4.7	1.0	4.7	9.4	7.5	5.9	4.2	9.1	0.8	5.9	4.5	11.8	9.1	7.8	6.7	2.1	5.3	9.5	6.8	6.8	4.8	3.8	7.2	30.1	13.6	14.7	3.9	10.4	1.6	5.3	2.3	2.2	10.2	6.3	1.9	2.9	55.5	5.9	13.6	8.9	3.1	3.3	2.9	4.4	2.5	2.7	2.1	4.6	5.3	4.4	5.3	2.9	4.1	5.6	24.5	25.6	29.1	58.8	28.3	14.4	11.0	14.2	12.5	22.8	15.6	13.6	27.9	5.7	23.9	9.2	16.7	23.1	34.1	19.0	7.9	7.0	0.4	22.1	38.3	20.3	23.3	10.9	48.4	7.5	5.7	18.0	21.4	33.2	27.8	15.5	13.6	8.5	14.5	35.3	89.7	15.8	32.6	48.8	93.3	0.9	8.1	98.3	5.4	90.9	48.1	5.8	34.0	112.6	128.3	8.2	18.7	7.2	22.5	12.1	16.3	2.8	22.3	24.3	13.1	47.0	21.7	0.2	1.3	28.4	35.9	34.2	18.9	24.7	14.0	27.5
TET3	"hCG_40738, MGC22014"	ENSG00000187605	"Tet methylcytosine dioxygenase 3"	O43151	2	73984910-74108176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;skin 1: 16.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 88.5;Oligodendrocytes: 86.7;Suprabasal keratinocytes: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050845	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"HPA050845: AB_2681256"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.05e-1)"	"unprognostic (5.30e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.10e-1)"	2.2	1.6	3.7	5.2	2.4	19.7	3.0	6.3	13.7	2.5	0.0	4.1	5.4	2.0	1.4	7.6	1.9	2.5	1.2	9.3	1.7	1.6	3.9	4.1	3.7	2.0	1.5	1.5	2.6	2.0	1.5	4.6	2.2	2.5	4.3	3.6	4.2	1.1	1.2	16.2	6.0	2.1	0.6	3.8	4.3	1.6	2.7	5.8	2.3	1.3	4.1	3.4	4.0	5.8	9.0	8.0	14.5	8.9	1.2	1.3	26.4	1.8	2.4	3.4	2.7	16.6	8.1	14.9	3.5	2.4	1.6	9.4	13.0	5.2	3.6	6.7	5.2	19.2	7.0	5.6	5.1	20.2	11.3	2.0	13.3	4.2	9.9	4.3	5.3	10.3	13.4	4.8	2.0	14.6	10.0	13.0	8.1	7.7	2.7	15.4	9.1	5.2	3.8	16.5	18.1	15.5	4.0	10.3	4.9	5.7	6.6	16.1	6.7	3.7	15.4	1.8	6.8	4.2	2.0	12.7	2.4	13.9	4.9	0.1	0.4	0.2	0.0	0.4	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.2	3.7	2.4	6.3	13.7	9.3	1.7	2.0	1.5	2.2	0.6	2.7	5.8	4.2	6.4	9.0	31.3	6.4	49.5	3.5	4.2	14.8	16.3	8.0	5.8	2.9	2.8	8.0	1.8	20.9	7.0	7.3	10.5	0.0	3.5	4.7	18.8	11.9	6.6	6.0	24.8	88.5	4.4	30.1	3.4	13.7	29.6	2.5	6.2	3.6	6.1	10.1	10.1	45.7	8.0	8.2	26.9	23.2	0.8	0.6	26.9	10.6	54.4	27.1	1.5	2.1	41.7	86.7	6.2	7.7	3.0	4.8	6.2	10.3	1.5	11.9	8.6	0.0	3.8	7.7	0.5	2.6	24.4	68.2	2.5	5.5	2.3	6.9	7.0
TEX10	"bA208F1.2, FLJ20287, Ipi1"	ENSG00000136891	"Testis expressed 10"	Q9NXF1	9	100302077-100352942	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045434			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Mitochondria	"HPA045434: AB_10965650"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.28e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-3)"	"unprognostic (9.63e-3)"	9.3	7.0	4.0	8.7	4.3	12.2	9.9	7.2	4.8	9.7	5.2	7.4	5.3	11.2	8.2	9.1	10.2	8.6	6.5	4.3	4.4	6.3	6.9	6.4	14.3	3.9	4.1	11.4	5.7	8.1	5.4	18.8	4.1	7.5	6.8	5.5	6.9	7.4	16.0	12.2	6.5	8.8	4.1	7.9	6.5	22.3	4.9	22.3	8.4	11.6	13.6	10.8	8.7	5.5	26.5	28.5	36.6	41.3	13.2	23.1	56.6	32.7	33.7	41.8	38.7	29.5	30.4	74.6	17.2	21.4	38.3	35.2	52.9	42.1	48.6	30.2	23.3	40.6	17.5	25.8	28.2	59.6	29.1	20.3	23.3	42.5	44.6	20.3	23.1	26.0	46.3	23.8	54.5	41.5	44.0	38.1	75.4	51.1	33.9	42.1	62.2	22.8	30.8	17.0	32.3	27.4	17.9	29.3	29.4	22.4	12.2	17.3	23.6	27.5	24.5	37.3	30.9	16.7	30.6	29.9	28.1	26.3	29.4	18.1	7.4	2.6	9.1	8.9	9.7	12.2	9.0	9.1	9.1	12.9	9.7	11.5	1.8	10.7	6.9	5.3	11.4	7.0	4.0	4.3	7.2	4.8	4.3	4.4	3.9	4.1	4.1	4.1	4.9	5.5	8.6	3.2	9.3	10.7	14.7	22.2	10.6	8.4	20.5	7.8	10.8	8.1	15.4	0.0	13.0	9.2	12.5	53.5	9.6	3.8	3.9	7.7	13.9	11.0	15.8	10.9	5.3	11.1	24.1	8.8	15.7	14.7	5.1	21.9	17.1	13.9	5.0	7.9	9.8	8.4	23.3	5.7	2.0	4.1	8.1	11.4	8.7	8.1	17.8	18.7	7.8	3.4	7.2	21.1	23.9	7.5	5.6	7.9	7.1	9.7	3.0	4.5	5.6	6.5	0.0	14.5	14.7	33.0	33.4	12.9	22.6	46.1	10.3	12.0	6.9	9.5
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913008	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 6.7;smooth muscle: 5.3;testis: 12.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Early spermatids: 114.3;Late spermatids: 49.7;Spermatocytes: 95.4;Spermatogonia: 98.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.4;HEL: 19.3;K-562: 5.5;OE19: 4.2;SCLC-21H: 4.1"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.2"	"Low region specificity"	"Detected in many"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.2	0.4	12.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.9	0.0	8.4	1.1	0.0	1.2	3.1	19.3	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.5	0.0	0.0	0.1	0.1	0.1	3.7	4.2	0.3	0.0	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	3.6	0.2	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.1	0.4	0.7	0.3	0.3	0.6	0.7	0.2	0.4	0.2	0.1	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.3	0.1	1.3	0.5	0.0	0.0	5.7	0.0	0.0	1.2	0.0	0.0	0.0	1.7	2.5	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	49.7	1.2	0.1	0.0	1.0	0.0	1.3	0.0	0.5	0.4	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.1	13.1	0.0	0.1	95.4	98.5	0.0	0.0	0.1	0.0	4.4	0.0	0.0
TEX2	"HT008, KIAA1738, TMEM96"	ENSG00000136478	"Testis expressed 2"	Q8IWB9	17	64147227-64263260	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5;Late spermatids: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 20.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020648, HPA057116"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA020648: AB_1857908, HPA057116: AB_2683341"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (3.90e-6)"	"unprognostic (1.69e-2)"	"unprognostic (3.84e-2)"	"unprognostic (8.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.53e-3)"	"unprognostic (5.59e-3)"	16.6	24.2	38.4	7.3	46.9	18.7	19.6	38.3	39.3	17.8	31.1	13.6	10.2	14.7	11.4	17.3	13.4	16.7	27.2	37.6	46.2	18.5	33.2	14.9	6.3	43.5	46.4	15.7	29.4	31.5	11.2	9.9	43.3	16.3	13.5	23.0	19.4	17.0	45.0	15.5	10.2	14.6	40.4	12.7	13.2	53.5	44.9	8.9	40.2	41.9	6.8	10.5	11.1	44.2	32.6	15.2	9.5	19.5	44.7	26.3	11.5	44.1	49.7	39.2	27.0	14.2	7.8	11.3	11.0	55.9	24.3	15.5	17.0	53.3	44.7	16.6	11.6	76.3	9.9	27.0	16.7	22.5	12.2	19.3	29.0	26.7	54.3	27.5	19.1	18.8	21.3	13.6	29.8	36.1	20.5	10.4	5.4	25.3	26.9	12.6	85.8	16.1	22.7	14.9	14.4	24.0	21.9	55.9	24.3	52.2	26.4	19.0	22.6	36.5	21.1	28.5	25.8	14.0	20.1	7.2	14.5	21.0	33.6	0.0	3.1	0.9	1.5	1.0	1.7	0.3	1.7	1.8	2.9	0.6	1.7	1.7	0.3	3.3	2.0	20.6	1.3	1.8	38.4	46.9	38.3	39.3	37.6	46.2	43.5	46.4	43.3	40.4	44.9	44.2	8.1	3.2	8.1	27.4	3.4	8.8	6.8	5.1	16.5	4.2	17.6	13.7	33.3	8.6	6.2	12.9	6.2	2.5	14.7	10.7	1.9	4.7	53.5	6.0	10.5	8.8	12.1	15.4	41.6	8.3	2.0	7.4	16.3	4.2	3.8	12.2	8.6	30.4	12.0	10.1	35.6	11.3	6.1	11.5	3.7	52.9	6.5	9.2	7.2	17.8	2.9	7.2	1.0	33.2	39.3	6.5	4.6	12.8	10.1	7.1	7.1	8.3	8.2	17.3	0.0	12.6	7.4	22.5	8.8	14.6	8.9	1.4	3.6	9.4	10.9	5.4
TEX261	"MGC32043, TEG-261"	ENSG00000144043	"Testis expressed 261"	Q6UWH6	2	70985942-70994873	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016631	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA016631: AB_2240434"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-1)"	39.5	38.8	30.8	21.5	34.8	20.0	29.7	33.1	31.2	32.2	39.1	28.3	25.0	25.4	45.5	27.5	35.3	22.7	36.0	29.3	32.7	41.1	38.8	30.4	22.0	38.5	34.5	39.6	47.5	66.1	29.2	25.0	33.5	31.6	32.7	43.9	36.0	34.3	56.4	20.9	25.6	34.0	32.9	23.5	30.0	36.9	33.4	25.7	46.1	54.3	27.0	26.2	21.6	33.4	61.9	57.1	39.4	50.3	116.4	58.9	44.7	69.8	65.6	79.1	49.6	67.5	49.8	50.2	25.9	122.5	74.7	45.6	75.3	82.7	113.8	38.4	62.8	60.1	28.7	71.8	68.3	70.7	48.7	53.7	54.3	76.2	51.6	43.4	81.5	51.3	75.7	32.4	93.6	48.2	61.2	39.3	26.2	98.7	66.4	43.1	120.7	43.1	57.7	53.1	64.0	33.8	72.3	70.9	46.0	26.2	46.3	41.3	66.1	96.8	83.6	52.4	93.8	25.3	23.9	58.4	84.4	91.7	83.2	8.7	3.8	7.7	3.4	3.9	2.9	1.8	3.7	4.6	2.9	2.7	4.1	3.3	2.8	2.6	3.9	3.1	3.3	2.1	30.8	34.8	33.1	31.2	29.3	32.7	38.5	34.5	33.5	32.9	33.4	33.4	14.7	3.2	14.7	9.4	11.3	8.3	10.7	8.2	5.7	14.7	20.6	14.9	22.9	20.0	8.4	23.9	37.5	16.4	9.0	21.8	7.9	24.9	15.7	10.8	11.9	15.5	8.4	17.4	8.0	23.8	17.4	16.3	12.2	13.3	2.5	17.1	16.4	35.2	19.5	8.4	7.5	18.2	8.2	18.3	6.4	28.5	15.8	11.9	19.6	6.5	13.0	28.1	14.4	15.1	12.6	21.1	14.9	18.4	7.4	12.9	24.4	18.3	5.5	72.9	0.0	16.7	15.0	45.3	11.2	12.8	7.5	17.9	8.7	14.4	18.9	7.7
TEX47	"C7orf62, MGC26647"	ENSG00000164645	"Testis expressed 47"	Q8TBZ9	7	88794106-88795737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 28.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory bulb: 6.3"	"HPA023817, HPA024163"			Uncertain	Nucleoplasm,Mitochondria		NA	NA				"Cluster 78: Testis - Spermatogenesis"			"Nucleoplasm, Mitochondria"		"HPA023817: AB_1853868, HPA024163: AB_1853869"					"unprognostic (1.43e-1)"													0.0	0.0	0.5	0.0	5.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	0.6	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.2	0.0	1.3	0.5	1.3	0.6	0.7	0.7	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX49	LINC00935	ENSG00000257987	"Testis expressed 49"	A0A1B0GTD5	12	48727435-48765790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 20.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"stomach cancer: 0.6;testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066635			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 36: Testis - Spermatogenesis"			Nucleoplasm	"Nuclear bodies"	"HPA066635: "											"unprognostic (2.63e-2)"			"unprognostic (6.32e-3)"	"unprognostic (8.28e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX52		ENSG00000283297	"Testis expressed 52"	A6NCN8	12	2849046-2857039	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.0"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.8;Karpas-707: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043581			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"		Nucleoplasm	Cytosol	"HPA043581: "																		0.5	0.4	0.1	1.0	0.3	0.8	0.5	0.0	0.4	0.4	2.3	0.5	1.2	0.3	0.0	0.5	0.4	0.3	0.3	0.0	0.0	0.4	0.5	0.3	1.0	0.5	0.1	0.5	1.1	0.0	0.5	0.1	0.3	0.6	0.0	2.9	1.5	0.0	2.5	3.4	1.0	0.0	0.1	0.9	0.5	8.0	0.3	0.0	1.0	0.0	0.0	0.4	0.5	1.2	0.2	0.8	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.6	0.7	0.1	2.8	0.9	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	2.9	0.0	0.5	0.1	0.3	0.3	0.0	0.0	0.6	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.1	0.4	0.3	0.0	0.3	0.1	0.7	0.4	0.2	0.5	0.1	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.5	0.1	0.3	0.1	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 32.8;skin 1: 66.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 167.9;Cytotrophoblasts: 285.8;Extravillous trophoblasts: 260.6;Squamous epithelial cells: 147.7;Syncytiotrophoblasts: 700.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 4.1;medulla oblongata: 3.0;midbrain: 1.3;pons: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 104.7;hTCEpi: 97.3;SuSa: 97.3"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.9;pons and medulla: 1.0"	"Low region specificity"	"Detected in many"			"CAB000326, HPA056871"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB000326: AB_667767, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.5	0.4	0.4	0.1	0.3	0.1	32.8	4.1	0.4	7.5	0.2	1.1	0.5	0.3	21.8	29.9	0.4	0.2	0.9	0.3	0.1	7.4	0.1	0.5	0.4	3.0	1.3	0.4	0.2	0.6	0.4	29.6	2.1	9.8	0.5	8.1	23.5	9.3	0.5	66.7	0.8	0.1	0.5	0.1	1.4	2.2	0.5	0.2	0.5	0.1	5.1	3.5	16.6	0.6	51.8	17.8	0.1	87.9	0.4	0.0	19.7	40.2	30.3	31.7	31.4	2.1	19.3	3.2	4.9	12.0	17.5	53.2	4.3	66.1	30.9	104.7	45.2	0.4	44.5	0.0	0.0	1.7	1.5	0.0	97.3	0.1	66.6	18.3	0.0	0.9	3.3	0.1	0.3	12.2	0.0	17.2	0.5	3.3	24.7	5.9	5.0	2.2	18.8	21.8	12.5	0.3	44.1	82.7	82.3	97.3	56.0	1.7	0.0	9.9	2.7	7.1	25.3	0.1	5.1	0.8	5.1	1.7	59.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.1	0.4	0.3	0.1	3.0	1.3	2.1	0.5	0.5	0.6	0.5	0.0	0.0	0.0	0.4	130.6	45.5	50.3	167.9	25.9	98.2	65.7	2.7	0.0	30.5	31.3	2.1	285.8	0.5	1.0	7.9	2.2	5.3	1.2	0.7	2.1	1.2	0.0	0.0	0.4	260.6	4.2	0.0	1.5	0.0	0.1	0.0	0.0	20.4	80.8	0.0	0.5	46.8	0.0	6.1	3.8	0.6	0.5	124.5	0.0	0.0	4.3	0.0	0.0	0.1	3.7	0.5	0.0	1.2	58.2	0.1	0.3	21.5	4.6	0.0	0.3	4.1	6.5	16.8	147.7	138.4	700.1	0.3	0.3	0.5	46.7
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847619	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 33.3;retina: 14.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 145.7;Bipolar cells: 76.4;Horizontal cells: 437.4;Melanocytes: 106.7"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in many"	6	"cerebellum: 3.5;medulla oblongata: 3.9;midbrain: 9.0;pons: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 109.6;SH-SY5Y: 208.1"	"Region enhanced"	"Detected in many"		"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA034683: AB_10670966, HPA062942: AB_2684909"	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.1	3.4	0.0	0.0	0.0	0.0	8.2	3.5	0.1	0.1	0.0	0.1	0.0	0.0	33.3	3.9	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	3.9	9.0	0.0	0.0	0.0	0.6	0.2	10.2	0.0	0.0	14.8	6.4	0.7	0.0	8.6	0.0	0.0	0.6	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	109.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	35.5	0.1	0.2	208.1	0.0	0.8	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.1	3.9	9.0	10.2	0.6	1.1	0.2	0.2	0.0	0.0	0.0	0.0	11.7	0.0	0.0	145.7	76.4	43.0	29.7	0.9	0.0	0.0	51.5	8.4	14.9	0.1	0.0	54.8	0.0	17.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	437.4	0.0	0.0	0.0	0.0	1.5	2.0	0.0	0.5	106.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.7	0.0	11.8	0.0	0.0	0.3	1.9	0.6	31.1	4.3	4.9	0.2	0.0	0.0	0.0
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629306-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.1;skin 1: 53.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 132.4;Basal squamous epithelial cells: 120.1;Breast glandular cells: 66.1;Breast myoepithelial cells: 79.6;Cytotrophoblasts: 91.7;Extravillous trophoblasts: 59.7;Squamous epithelial cells: 81.0;Suprabasal keratinocytes: 149.3;Syncytiotrophoblasts: 105.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"BEWO: 190.6;MCF7: 169.2;SK-BR-3: 308.9;T-47d: 86.8;WM-115: 114.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 2.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329"	"unprognostic (1.74e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.8	0.3	1.3	0.2	0.6	0.1	26.1	0.5	1.5	18.3	0.5	4.0	0.2	6.2	5.2	29.1	2.6	1.0	0.3	1.7	0.7	2.0	0.0	2.6	0.1	0.9	0.8	0.3	1.0	2.6	0.8	17.0	1.2	7.1	1.2	2.7	20.7	4.4	2.1	53.3	0.3	1.1	0.5	0.1	0.7	1.0	0.6	0.7	2.3	0.1	3.0	3.9	19.2	1.0	12.8	15.8	0.1	0.2	0.0	0.0	190.6	20.1	36.4	25.0	4.5	3.2	0.3	0.0	1.3	13.3	13.3	42.7	27.3	5.5	17.0	0.1	2.8	0.0	1.7	0.0	0.0	0.0	1.7	0.3	21.4	7.4	7.2	0.0	0.0	8.1	0.2	3.2	0.0	169.2	20.8	1.2	9.5	9.9	20.7	0.1	0.0	7.0	0.0	10.1	5.1	0.1	13.6	308.9	21.8	28.3	86.8	4.6	0.2	16.2	0.4	8.6	15.4	0.1	0.0	0.1	4.0	0.1	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.5	1.5	1.7	0.7	0.9	0.8	1.2	0.5	0.6	1.0	0.7	0.0	9.5	3.9	0.3	132.4	29.9	2.4	120.1	4.1	66.1	79.6	1.0	0.0	5.6	9.2	0.0	91.7	1.5	1.7	0.0	0.3	0.3	7.8	18.7	2.0	3.0	0.0	0.0	0.0	59.7	7.4	1.5	16.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	1.7	10.2	0.3	8.2	0.0	0.0	1.6	21.4	3.7	0.0	0.3	0.0	0.0	0.0	1.0	0.6	0.0	3.8	18.6	0.0	0.0	5.2	0.0	0.0	0.5	2.1	0.0	1.8	81.0	149.3	105.6	1.3	0.0	1.0	18.5
TFAP2D	TFAP2BL1	ENSG00000008197	"Transcription factor AP-2 delta"	Q7Z6R9	6	50713526-50773033	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"brain: 6.3"	"Cell type enhanced"	"Detected in single"		"Horizontal cells: 1.7"	"Cancer enriched"	"Detected in single"	10	"lung cancer: 0.5"	"Region enriched"	"Detected in some"	5	"midbrain: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Region enriched"	"Detected in many"	4	"midbrain: 11.8"	"Region enriched"	"Detected in some"	6	"midbrain: 9.4"	HPA048962			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA048962: AB_2680573"																		0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.3	0.2	0.0	0.0	6.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFAP4	"AP-4, bHLHc41"	ENSG00000090447	"Transcription factor AP-4"	Q01664	16	4257186-4273075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 30.1;Proximal enterocytes: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001912	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Mitochondria"		"HPA001912: AB_1080251"	"unprognostic (1.61e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.97e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.30e-1)"	6.2	4.2	3.7	6.9	3.8	1.9	5.8	5.3	5.4	9.0	1.7	5.4	6.4	7.8	1.0	8.1	6.9	3.8	3.2	3.5	3.2	3.6	5.3	3.9	6.8	3.9	3.7	10.0	12.0	3.3	4.3	3.7	3.9	5.7	1.9	0.7	7.6	3.1	7.5	10.5	6.8	2.5	3.5	7.3	5.0	1.7	3.7	8.3	4.6	3.1	3.9	6.4	8.4	5.1	14.9	15.4	12.9	19.2	5.4	14.1	21.7	5.7	14.6	9.6	10.5	8.1	23.0	51.0	14.5	5.5	4.5	22.0	23.6	19.4	3.0	29.8	17.4	15.6	13.0	21.1	7.5	27.8	8.8	13.3	12.2	10.4	29.0	4.5	6.4	16.7	29.1	13.1	3.8	23.9	39.2	46.4	29.8	14.7	20.2	34.3	28.8	53.7	3.7	11.2	27.0	20.0	19.2	19.7	18.9	2.0	10.0	21.9	4.2	13.1	10.4	46.2	15.1	21.3	19.3	43.6	8.8	27.2	9.5	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.7	3.8	5.3	5.4	3.5	3.2	3.9	3.7	3.9	3.5	3.7	5.1	7.0	3.2	0.0	2.3	11.6	21.5	9.8	5.7	30.1	4.2	8.1	6.6	2.2	7.2	2.1	27.6	0.0	7.7	5.3	5.3	7.9	4.1	0.1	2.4	9.6	5.4	7.8	22.7	3.0	5.7	11.7	7.6	10.7	3.1	0.0	6.9	3.6	3.4	4.2	0.0	3.9	12.4	8.2	4.0	7.4	0.1	11.8	3.7	3.6	1.0	4.7	2.2	5.2	1.5	3.6	2.9	5.3	5.3	7.2	11.1	40.0	5.7	1.4	3.4	6.6	6.9	7.1	0.9	0.9	22.1	22.3	2.2	7.3	7.5	20.2	4.3
TFCP2	"CP2, LBP-1C, LSF, TFCP2C"	ENSG00000135457	"Transcription factor CP2"	Q12800	12	51093656-51173135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.0;Inhibitory neurons: 75.9;Microglial cells: 69.3;Oligodendrocyte precursor cells: 79.4;Oligodendrocytes: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070247			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA070247: AB_2686239"	"unprognostic (6.27e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.31e-2)"	16.7	12.9	12.4	18.5	14.7	9.8	16.9	13.9	16.4	18.4	10.1	17.0	14.9	18.0	16.1	13.5	19.6	13.5	17.7	13.2	13.1	16.1	11.3	13.5	21.0	12.4	13.0	18.6	13.8	25.0	14.2	18.8	12.6	18.5	20.3	32.1	16.3	15.0	26.7	14.3	15.1	18.1	12.6	18.5	15.2	9.1	12.8	27.3	17.1	22.1	26.0	15.5	13.4	16.9	17.3	29.5	43.0	40.4	25.2	31.3	64.1	30.7	18.6	29.8	17.4	52.4	37.6	1.5	27.9	29.4	21.9	33.8	56.0	35.2	29.4	35.5	28.3	47.4	26.6	23.8	20.3	57.9	48.4	21.3	33.3	29.4	47.8	34.0	28.4	15.1	54.1	0.1	32.0	0.0	55.2	39.5	64.0	39.9	55.3	41.2	23.6	0.4	39.2	39.4	41.1	36.0	38.8	34.6	28.1	41.7	13.0	49.0	24.3	27.1	27.9	27.8	28.4	30.8	53.3	0.1	25.8	35.3	19.5	7.4	6.1	6.6	2.3	5.4	3.8	2.8	2.4	2.6	5.6	1.8	3.1	2.4	2.1	6.9	7.2	2.2	3.8	3.3	12.4	14.7	13.9	16.4	13.2	13.1	12.4	13.0	12.6	12.6	12.8	16.9	9.3	9.6	16.4	57.8	11.0	6.6	6.9	10.7	9.1	21.6	11.5	10.5	23.8	8.6	8.7	12.9	20.9	13.2	19.6	11.4	5.9	9.2	0.8	11.0	14.1	10.2	10.8	5.9	73.0	7.7	10.5	9.7	10.7	14.6	10.8	22.5	12.5	9.3	13.7	10.1	75.9	13.2	10.2	21.1	10.8	0.7	12.2	17.0	10.6	69.3	36.8	9.8	24.7	79.4	103.6	12.2	11.0	10.9	7.3	11.1	8.7	9.4	9.2	27.3	0.0	14.0	13.1	6.7	11.3	9.9	5.3	16.7	10.7	12.2	13.4	6.4
TFDP1	"DILC, Dp-1, DP1, DRTF1"	ENSG00000198176	"Transcription factor Dp-1"	Q14186	13	113584721-113641473	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 164.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 344.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 31.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033605, HPA044754, HPA068909, HPA077304"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB033605: AB_783105, HPA044754: AB_2679074, HPA068909: AB_2686056, HPA077304: "	"unprognostic (4.28e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (5.50e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (7.57e-4)"	"prognostic favorable (6.17e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	28.2	23.5	24.3	38.6	24.0	164.0	27.2	24.5	24.4	33.5	32.5	37.8	30.5	27.6	19.4	50.1	32.8	24.6	34.3	24.1	22.8	23.2	25.9	21.8	67.1	27.5	24.4	19.3	18.4	28.5	21.3	40.6	25.3	26.1	42.4	20.2	26.1	30.8	58.2	42.8	32.3	34.3	26.6	30.8	31.3	49.6	26.8	53.4	33.1	59.0	68.3	37.5	30.1	25.7	343.2	82.5	104.4	89.5	138.4	122.7	118.5	187.8	168.7	238.1	218.6	173.3	155.9	314.6	61.3	181.3	130.3	160.3	183.0	167.1	232.2	215.9	212.8	184.4	129.2	109.8	86.8	468.3	155.7	102.1	147.3	151.3	87.4	85.0	162.7	116.2	154.1	82.6	215.5	117.7	207.0	181.4	96.6	322.7	105.0	138.9	93.0	181.1	91.3	129.1	268.2	79.3	84.8	228.8	58.7	75.1	157.9	371.7	114.4	77.2	122.9	165.6	210.8	69.5	92.4	326.4	171.9	285.2	133.2	31.9	3.0	4.6	3.1	3.8	3.4	4.4	4.1	3.7	5.9	3.6	6.3	3.2	3.8	2.3	5.5	3.0	5.3	2.5	24.3	24.0	24.5	24.4	24.1	22.8	27.5	24.4	25.3	26.6	26.8	25.7	21.4	9.6	15.8	12.7	38.8	59.8	32.1	16.1	33.6	10.3	45.6	35.2	26.6	28.6	14.7	29.5	14.6	83.2	33.8	29.8	80.3	12.3	5.5	34.4	28.2	25.8	40.2	344.3	22.5	11.9	128.0	30.8	38.7	31.0	21.0	23.3	34.6	58.7	49.2	6.7	19.5	36.1	12.2	49.1	51.2	10.7	28.6	41.1	35.6	5.6	24.8	14.7	16.5	9.5	10.2	19.0	24.2	28.2	67.3	35.7	29.4	66.5	21.0	22.5	6.6	20.0	32.7	76.7	52.7	74.6	60.0	66.6	32.1	30.3	47.4	35.8
TFDP2	Dp-2	ENSG00000114126	"Transcription factor Dp-2"	Q14188	3	141944428-142149544	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 986.1;Late spermatids: 397.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 216.4;MOLT-4: 423.3;REH: 222.7;U-698: 366.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018396, HPA070399"	Supported		Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Vesicles, Mitotic spindle"	"CAB018396: AB_2287284, HPA070399: "	"unprognostic (1.35e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (8.08e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.60e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.84e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.08e-1)"	18.8	15.1	7.8	9.2	8.9	50.3	18.9	21.2	12.7	12.1	8.2	14.8	22.7	15.3	15.9	13.7	14.7	19.4	26.0	9.0	7.0	29.5	17.3	11.8	10.5	12.5	10.6	23.3	12.4	16.7	13.0	28.4	12.4	19.4	14.0	13.2	12.3	13.7	28.5	11.9	21.3	14.4	7.4	9.5	12.4	69.9	8.2	169.7	21.6	21.3	10.6	11.2	10.2	10.0	32.8	14.7	61.6	49.4	20.3	21.9	134.0	16.3	18.8	25.5	40.2	19.2	32.2	115.8	73.7	18.7	44.6	19.5	15.8	31.2	35.8	46.9	28.5	140.4	21.5	26.0	19.6	43.1	47.8	20.6	22.8	27.8	26.9	23.5	18.3	216.4	53.5	6.8	44.3	25.4	423.3	16.1	49.6	17.2	20.0	222.7	42.2	27.0	29.4	16.5	26.9	25.0	54.5	19.5	29.0	45.3	46.7	21.9	12.0	24.2	21.9	19.8	20.7	20.7	20.5	366.5	19.4	11.4	11.6	69.3	4.0	48.0	28.0	6.9	10.9	14.7	12.8	14.9	9.8	18.7	18.6	22.2	4.4	37.4	10.0	33.7	12.8	12.5	7.8	8.9	21.2	12.7	9.0	7.0	12.5	10.6	12.4	7.4	8.2	10.0	29.7	32.1	30.6	64.0	24.2	25.1	52.1	30.4	43.3	33.0	45.1	36.8	87.6	45.8	30.7	47.8	33.3	235.4	98.5	23.1	93.9	36.8	986.1	63.9	51.1	26.8	38.6	171.9	194.6	26.4	125.2	44.0	15.8	35.8	33.5	84.8	27.8	39.8	27.8	37.0	166.7	27.1	40.7	13.5	15.4	397.5	77.0	27.0	5.4	51.5	14.9	26.1	128.8	61.9	116.6	27.2	25.7	75.2	25.2	36.3	87.5	98.4	43.1	34.5	26.3	96.7	38.6	75.4	75.6	31.3	20.0	99.2	42.9	72.4	42.0	36.0
TFDP3	"CT30, E2F-like, HCA661"	ENSG00000183434	"Transcription factor Dp family member 3"	Q5H9I0	X	133216662-133218354	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 4.2"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 23.5;Spermatogonia: 31.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077304			Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA077304: "	"unprognostic (1.57e-1)"								"unprognostic (2.17e-1)"					"unprognostic (3.22e-1)"	"unprognostic (2.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.5	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFE3	"bHLHe33, TFEA"	ENSG00000068323	"Transcription factor binding to IGHM enhancer 3"	P19532	X	49028726-49043410	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 12.5;monocytes: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA023881: AB_1857931"	"unprognostic (2.68e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (2.19e-8)"	"unprognostic (1.93e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.25e-1)"	31.3	23.6	27.8	16.8	27.3	24.1	22.9	25.8	26.9	24.1	23.3	23.6	10.8	24.7	21.1	15.6	26.2	18.5	17.2	25.7	29.4	15.1	12.6	29.2	11.8	37.2	30.9	25.8	12.4	25.1	18.4	20.8	28.7	17.2	11.5	14.8	13.4	28.3	17.0	20.5	14.7	24.7	27.5	22.5	16.8	5.9	32.2	10.7	20.0	14.0	13.2	25.0	20.5	25.6	32.8	41.5	14.6	44.6	48.6	45.1	12.5	40.6	55.8	49.7	38.2	23.3	26.8	10.2	18.0	65.7	48.6	25.5	25.4	40.2	44.8	24.4	11.8	8.3	39.6	26.2	69.0	10.0	28.3	38.5	32.3	64.4	50.1	47.8	26.3	8.4	19.8	55.9	49.2	20.6	7.5	17.2	36.3	11.0	34.1	11.9	22.2	26.6	43.1	18.0	12.4	12.4	44.8	19.0	17.9	52.5	27.6	15.0	48.5	47.1	48.7	48.0	27.3	30.1	29.7	8.0	56.1	14.0	33.2	0.0	4.8	1.8	0.6	4.7	1.1	0.5	0.9	0.5	2.2	1.0	0.6	0.5	12.5	0.4	6.3	0.5	1.3	2.6	27.8	27.3	25.8	26.9	25.7	29.4	37.2	30.9	28.7	27.5	32.2	25.6	13.8	16.0	8.8	13.7	9.8	19.8	19.7	11.2	30.1	6.8	10.9	9.4	8.1	15.7	11.8	20.2	4.2	16.0	4.4	14.3	9.8	17.7	0.7	10.9	15.3	17.5	12.5	5.2	7.5	15.8	9.4	20.2	14.3	14.8	5.7	12.0	10.8	15.0	22.3	18.5	7.2	8.2	0.0	21.7	29.4	2.2	27.4	20.5	8.8	11.2	15.5	12.0	4.1	6.0	7.7	21.4	13.7	24.5	12.9	20.2	10.6	12.1	7.0	5.6	13.1	18.5	14.3	2.2	0.8	18.9	22.0	37.1	8.6	13.9	7.5	19.6
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.2;kidney: 20.5;lymphoid tissue: 22.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 45.5;Kupffer cells: 56.3;Macrophages: 61.6;Microglial cells: 60.0;monocytes: 44.1;Proximal tubular cells: 77.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 7.1;intermediate monocyte: 2.8;memory B-cell: 3.8;myeloid DC: 6.3;naive B-cell: 2.5;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	29	"B-cells: 3.8;dendritic cells: 6.3;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;HUVEC TERT2: 11.0;THP-1: 21.5;TIME: 12.5;U-937: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	3.5	2.4	1.3	19.2	1.2	17.2	2.6	1.5	1.6	1.9	2.1	2.7	4.2	1.4	0.6	1.0	1.0	4.9	1.0	0.8	1.7	20.5	3.1	9.9	22.1	3.3	1.9	1.3	1.0	0.4	0.6	4.7	2.7	1.0	4.2	0.1	1.3	0.9	0.3	0.4	9.7	3.1	2.7	14.6	3.0	1.6	3.7	2.8	0.9	0.4	12.6	4.0	0.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	1.7	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	21.5	12.5	2.1	0.2	1.3	0.0	5.5	0.0	0.0	0.1	24.4	1.1	0.0	7.1	0.0	0.0	2.8	0.0	3.8	0.0	0.0	6.3	2.5	0.0	0.0	0.1	0.0	0.4	3.3	0.0	1.5	1.3	1.2	1.5	1.6	0.8	1.7	3.3	1.9	2.7	2.7	3.7	4.8	0.5	0.0	2.2	0.3	18.1	0.5	0.0	0.0	0.0	0.0	0.3	0.8	0.8	1.5	0.0	3.7	0.0	0.2	8.3	0.0	0.0	0.0	2.4	0.0	0.0	1.7	0.0	7.2	0.6	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	45.5	0.0	0.5	0.4	0.0	56.3	17.8	3.8	0.0	61.6	0.0	60.0	44.1	0.0	1.0	1.0	0.1	0.1	0.0	0.0	1.3	0.1	15.6	77.8	0.0	0.0	0.0	0.3	0.1	0.3	2.5	0.1	0.4	0.8	0.8	0.1	0.7	0.1
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"	Q07654	21	42311667-42315651	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 305.8;intestine: 355.3;salivary gland: 340.2;thyroid gland: 416.7"	"Cell type enriched"	"Detected in many"	10	"Intestinal goblet cells: 33890.3"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 765.0"	"Region enriched"	"Detected in single"	6	"midbrain: 1.9"	"Immune cell enriched"	"Detected in single"	9	"eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 58.7;OE19: 126.6;T-47d: 27.8;TIME: 105.0"									"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000	6500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	11.5	5.9	0.1	27.8	0.1	2.2	26.3	0.3	0.2	305.8	0.1	355.3	208.0	2.8	0.5	22.7	49.8	82.8	3.5	0.1	0.1	5.7	6.6	9.9	3.5	0.1	1.9	3.5	6.1	0.0	1.3	0.1	0.2	9.8	305.8	0.1	340.2	1.6	0.9	6.7	290.6	8.4	0.1	23.1	7.4	0.5	0.2	1.8	416.7	1.7	0.9	3.6	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.7	0.0	0.7	0.1	126.6	12.1	0.0	9.0	0.3	0.1	0.0	16.1	0.1	0.0	1.7	0.0	0.0	27.8	0.0	105.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	1.9	0.2	0.1	0.2	0.1	36.9	16.0	25.3	0.0	15.4	41.6	15.1	196.3	3.4	0.1	804.5	444.7	21.6	919.3	595.9	22.0	0.0	0.6	3.4	2188.7	0.0	9.4	0.5	29.3	1.4	322.8	770.9	0.0	0.0	67.8	0.7	21.5	71.4	11.4	59.2	2.0	170.3	5.8	2.1	5.0	0.0	33890.3	3263.2	3.4	42.4	9.0	2.5	2.8	96.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	1855.5	7.9	6.1	73.0	2788.7	0.1	453.2	0.1	0.0	1.1	28.2	1.0	0.3	4.3	38.6	0.8	14.9	0.6	1376.3	107.7
TFIP11	"DKFZP434B194, Spp382, TIP39"	ENSG00000100109	"Tuftelin interacting protein 11"	Q9UBB9	22	26491225-26512505	"Plasma proteins, Predicted intracellular proteins"	"Biomineralization, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027085			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA027085: AB_1857964"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	13.5	13.0	12.4	16.3	13.5	62.8	12.5	15.4	13.9	11.5	12.1	12.7	12.9	12.4	10.4	14.8	13.1	12.6	16.0	12.9	12.0	13.9	19.3	14.0	24.9	12.0	11.8	12.4	16.7	13.0	10.5	14.5	11.3	12.4	12.6	13.4	11.0	10.6	41.8	20.3	13.5	13.1	11.6	17.7	11.9	26.6	13.0	20.1	16.2	21.5	24.7	14.8	10.9	14.3	22.9	26.4	22.3	24.6	34.7	20.6	21.5	26.4	34.5	41.8	39.1	19.8	16.1	44.4	16.6	33.9	27.6	32.8	32.1	26.3	30.3	32.3	30.4	27.4	16.4	20.2	31.4	63.6	33.2	25.9	34.9	40.0	30.9	22.3	32.6	22.4	37.4	38.9	28.2	28.2	29.2	33.8	21.4	32.2	21.9	43.6	34.6	38.8	24.2	22.4	16.7	24.0	31.9	22.7	32.8	21.4	18.7	27.7	31.6	35.2	56.8	22.4	25.6	29.8	41.8	86.6	27.8	24.6	26.8	68.7	28.4	50.1	37.2	31.3	35.1	37.9	33.0	35.2	26.1	42.9	30.9	28.4	44.9	36.3	44.1	16.4	44.5	33.0	12.4	13.5	15.4	13.9	12.9	12.0	12.0	11.8	11.3	11.6	13.0	14.3	11.3	9.6	9.7	11.4	17.8	16.8	11.2	13.2	22.2	9.7	7.5	6.3	3.5	17.2	12.3	12.9	8.4	17.9	20.7	14.8	13.7	15.1	67.9	12.2	9.2	13.3	16.2	20.2	7.1	20.7	14.4	7.8	9.2	12.6	8.2	11.9	13.2	10.8	13.3	15.2	7.2	11.2	6.1	6.2	7.8	12.3	11.1	10.4	7.2	4.7	12.3	7.7	19.6	6.0	6.5	25.3	8.4	9.8	18.6	7.6	11.4	9.3	14.1	6.9	0.0	10.1	10.6	43.6	19.4	14.2	16.8	19.4	17.4	11.6	10.7	10.9
TFPT	"amida, FB1, INO80F"	ENSG00000105619	"TCF3 fusion partner"	P0C1Z6	19	54107020-54115657	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034958, HPA058534"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA034958: AB_10603036, HPA058534: AB_2683745"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (6.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.85e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.66e-2)"	12.1	15.8	27.4	8.9	25.2	10.4	12.8	23.1	41.3	11.7	18.6	15.7	9.7	11.7	4.3	10.0	9.9	7.2	16.1	26.5	24.7	12.0	10.5	12.3	10.7	24.1	25.0	9.5	8.7	9.2	10.9	8.4	24.3	22.2	4.1	5.0	13.1	5.4	19.4	13.2	12.2	6.1	20.9	19.1	14.1	9.1	24.0	13.5	11.2	10.6	6.4	12.3	9.4	28.0	23.5	28.5	18.2	12.9	6.7	9.5	11.8	25.1	15.5	23.9	24.5	17.8	23.6	20.5	20.2	12.8	12.5	11.2	10.8	19.6	7.8	43.5	52.2	30.7	27.5	20.8	39.6	16.1	34.7	11.2	9.5	18.8	15.7	11.5	18.7	30.8	19.3	45.8	9.2	30.2	34.3	47.2	11.0	34.1	19.8	30.6	10.0	15.4	10.0	35.9	19.2	17.4	9.2	38.4	45.1	5.6	14.0	48.9	37.8	52.4	19.3	7.5	36.9	33.8	48.2	18.5	20.7	40.4	34.4	10.5	9.2	6.4	15.4	10.7	14.6	9.4	19.4	20.1	19.0	9.3	16.2	17.2	6.5	21.4	3.9	43.3	26.0	11.2	27.4	25.2	23.1	41.3	26.5	24.7	24.1	25.0	24.3	20.9	24.0	28.0	25.3	16.0	7.2	5.2	12.2	17.0	9.8	25.5	12.0	10.9	31.4	32.3	2.5	12.8	28.6	22.0	2.1	22.4	30.3	22.5	15.6	21.0	9.6	27.1	8.2	29.5	15.6	7.8	5.0	27.6	29.1	11.3	11.2	13.3	15.2	20.8	37.9	9.6	135.7	0.0	4.1	35.7	32.6	28.1	41.0	5.5	12.2	43.5	39.2	1.0	49.7	17.8	25.7	2.5	3.6	55.9	18.4	17.0	13.1	31.9	23.0	24.8	46.4	12.4	6.6	7.8	16.5	11.0	16.0	5.8	17.3	26.1	22.8	41.1	16.1	13.0
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574054-94596242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 75.2;U-698: 97.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	No			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	10.4	9.4	5.3	8.2	5.5	6.0	12.4	5.6	8.2	10.4	6.3	8.0	10.2	8.0	11.8	6.9	9.2	6.8	5.4	4.9	5.6	10.9	30.0	7.1	12.9	5.6	5.4	12.1	10.0	8.1	8.4	10.1	5.9	7.9	9.5	6.9	7.7	7.6	4.1	7.5	9.2	6.7	5.6	9.2	9.1	6.0	5.3	14.1	13.3	4.3	11.0	9.1	6.4	6.6	16.7	7.2	11.6	10.6	17.2	13.5	14.1	15.3	14.9	14.2	13.4	18.9	15.9	26.0	14.8	10.9	8.8	10.4	20.1	11.9	14.9	20.3	7.7	20.7	8.1	18.1	21.0	75.2	13.8	14.9	9.5	8.0	22.8	11.1	13.2	18.9	21.3	8.9	13.3	10.8	20.6	38.4	15.2	26.8	8.3	17.1	11.4	15.9	18.3	7.4	15.9	8.9	11.6	24.2	43.5	19.1	10.2	39.8	12.2	5.6	14.5	8.6	12.6	20.0	11.4	97.5	14.9	26.5	15.5	14.7	5.5	10.8	9.6	6.6	14.9	9.5	11.6	10.7	8.7	7.1	16.8	12.5	1.6	12.1	8.3	7.6	13.8	6.9	5.3	5.5	5.6	8.2	4.9	5.6	5.6	5.4	5.9	5.6	5.3	6.6	7.4	12.8	6.8	8.1	12.8	2.4	9.2	15.9	6.8	4.3	7.8	7.9	5.2	8.6	11.9	7.3	2.1	15.7	12.5	5.8	9.8	11.9	1.2	10.4	8.9	7.0	5.4	3.4	7.7	9.1	17.7	12.9	6.1	6.0	11.4	7.7	7.9	21.4	11.2	1.7	6.7	7.7	8.2	8.8	7.2	1.0	14.3	7.5	8.8	8.4	11.1	7.0	7.2	12.1	10.4	8.9	6.6	8.2	10.7	10.9	10.0	17.6	15.9	4.7	26.3	6.7	8.1	11.9	12.3	8.5	3.7	10.4	11.0	9.2	9.1	9.7
TGIF1	"HPE4, TGIF"	ENSG00000177426	"TGFB induced factor homeobox 1"	Q15583	18	3411608-3459978	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 783.4;Basal respiratory cells: 419.8;Basal squamous epithelial cells: 483.2;Urothelial cells: 426.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062160			Supported	Nucleoplasm		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA062160: AB_2684701"	"unprognostic (1.11e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.60e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.48e-3)"	51.2	40.1	21.7	43.3	20.8	41.5	57.6	22.4	25.7	68.9	30.2	51.5	31.6	51.2	133.7	46.7	74.7	65.3	29.8	20.2	29.3	74.0	61.5	47.6	26.4	29.8	27.3	67.3	46.9	26.9	22.0	63.8	25.7	54.6	65.7	8.0	56.5	56.1	34.4	60.2	37.8	37.4	27.5	35.5	49.1	25.9	25.7	40.0	66.7	26.9	27.0	112.1	40.0	28.4	33.6	148.5	92.7	29.3	90.0	121.7	235.7	63.1	236.6	49.9	62.1	61.0	142.6	1.9	20.9	49.8	165.7	33.7	35.0	73.8	61.6	13.9	16.8	4.3	73.2	110.5	178.8	47.6	38.3	89.5	291.7	89.7	233.7	131.3	104.4	22.3	36.0	0.4	95.6	65.8	31.1	58.8	240.8	119.0	34.8	32.8	43.2	10.3	198.1	156.7	27.1	26.5	166.2	123.0	92.5	151.3	28.1	43.7	49.6	77.5	65.6	92.7	41.1	5.0	0.6	15.7	78.5	18.6	98.2	65.4	42.8	7.6	62.9	16.6	67.8	46.5	52.5	61.9	35.1	32.2	37.1	43.5	19.8	21.5	16.7	3.3	32.1	36.3	21.7	20.8	22.4	25.7	20.2	29.3	29.8	27.3	25.7	27.5	25.7	28.4	41.0	35.3	40.2	8.1	106.5	359.6	783.4	419.8	483.2	0.0	114.1	72.1	5.6	100.1	128.3	123.2	0.0	161.6	60.1	30.0	49.0	117.1	41.5	167.2	58.5	66.6	46.4	25.7	2.7	75.0	220.9	102.8	79.0	240.2	68.0	71.5	29.3	35.7	71.8	1.7	0.6	99.4	136.3	44.9	221.1	9.7	28.6	126.8	76.5	7.5	71.9	6.7	11.3	4.0	1.7	106.0	53.0	15.4	15.1	308.1	24.9	113.1	93.3	0.1	32.9	90.9	86.6	7.9	15.4	223.9	257.1	150.4	103.7	8.0	91.8	426.2
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: NES - Nervous system development"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Centrosome	"HPA053786: AB_2682261, HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	7.5	5.9	3.9	12.4	4.0	7.6	10.2	3.6	3.8	10.5	8.6	8.6	4.8	22.0	4.4	5.7	24.2	8.6	6.3	3.7	3.9	9.2	9.3	8.6	16.9	5.7	4.6	13.7	15.1	13.2	3.0	11.6	4.6	9.0	5.5	5.2	10.2	7.8	2.1	5.8	8.3	18.6	4.8	14.6	7.0	11.4	4.9	17.8	8.5	3.7	18.7	9.5	6.6	4.5	16.1	4.2	45.0	52.3	6.2	5.6	16.1	8.9	10.3	21.3	15.5	22.9	20.5	42.5	23.2	9.2	9.7	16.4	36.1	23.6	20.8	20.0	13.2	53.5	10.6	30.5	9.6	23.6	12.7	9.1	15.0	4.8	16.4	19.1	20.9	20.6	26.1	27.3	10.4	22.8	38.8	43.6	37.1	23.0	11.1	33.2	52.7	24.0	13.8	10.7	13.5	40.0	3.1	23.3	23.1	34.8	28.7	51.2	15.6	3.7	13.7	0.3	17.2	29.6	11.9	40.3	0.3	27.2	16.6	16.0	5.0	1.6	4.0	4.3	4.4	7.2	3.6	4.1	6.7	4.9	6.0	5.1	2.0	3.8	3.0	6.7	3.8	3.8	3.9	4.0	3.6	3.8	3.7	3.9	5.7	4.6	4.6	4.8	4.9	4.5	11.5	9.6	8.8	0.0	41.7	44.6	31.4	10.5	50.7	0.2	25.5	16.6	17.3	14.3	9.4	7.3	2.1	6.6	26.5	1.3	7.9	19.7	2.8	11.4	13.4	17.9	6.6	13.5	0.0	7.7	1.7	12.9	8.6	13.7	16.5	35.7	10.8	5.8	10.4	0.0	0.0	3.7	10.2	10.0	25.8	3.2	6.2	13.2	14.2	0.0	12.7	7.4	3.1	0.0	0.0	15.9	4.8	7.5	35.3	27.5	0.3	7.0	5.3	2.0	6.6	10.0	13.9	3.0	19.8	11.6	25.4	9.0	27.0	11.0	4.2	16.4
TGIF2LX		ENSG00000153779	"TGFB induced factor homeobox 2 like X-linked"	Q8IUE1	X	89921908-89922883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	88	"testis: 8.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 74.1;Late spermatids: 45.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SH-SY5Y: 10.9;U-2 OS: 12.4;U-266/84: 21.4"									HPA034543	Supported		Approved	Nucleoplasm		No	No				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA034543: AB_10603037"															"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	12.4	0.3	0.0	1.1	21.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328296	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	70.0	67.5	37.5	82.6	42.1	129.9	58.3	38.5	44.0	63.5	32.2	85.8	110.6	62.0	60.9	41.1	65.1	75.7	63.5	39.6	45.3	120.8	136.5	86.8	73.9	45.5	43.4	61.3	56.0	67.1	26.9	76.6	44.9	66.9	102.3	31.8	59.8	62.5	34.7	40.1	111.9	74.0	40.4	83.2	74.8	37.1	45.1	65.2	91.3	46.2	66.1	61.4	41.0	50.0	46.5	116.4	51.8	68.6	124.0	129.0	120.7	144.1	172.2	98.5	78.5	100.6	142.2	60.6	108.3	207.1	132.9	76.4	37.8	71.9	161.8	96.5	36.7	87.2	41.3	113.3	67.1	173.0	189.5	96.2	45.2	125.5	76.1	152.1	144.4	49.5	50.9	94.1	147.1	43.9	54.0	86.3	46.0	109.3	47.5	55.4	193.1	45.6	104.8	73.2	47.4	40.5	127.2	95.5	83.6	61.7	50.7	77.0	155.7	205.5	73.9	158.6	173.5	58.7	81.9	58.1	152.3	131.1	137.3	62.6	78.0	68.5	32.4	73.3	25.0	25.0	23.8	22.4	41.5	24.4	24.3	23.6	96.3	25.1	103.5	15.9	20.9	75.6	37.5	42.1	38.5	44.0	39.6	45.3	45.5	43.4	44.9	40.4	45.1	50.0	104.4	102.5	96.4	22.5	89.7	38.2	57.1	72.5	43.9	53.3	89.2	56.4	64.3	150.2	84.2	180.3	39.6	59.4	116.9	216.1	9.8	92.7	6.0	86.3	89.5	91.7	89.5	39.5	29.5	93.2	80.9	87.5	64.7	105.7	158.8	70.5	86.7	245.0	113.0	208.6	37.9	99.0	52.9	187.1	85.3	7.8	49.4	145.6	60.5	33.7	126.9	47.8	95.8	25.1	50.6	101.6	121.8	69.2	74.0	62.8	211.2	82.8	111.4	36.5	65.7	85.0	65.8	36.1	37.1	32.6	34.9	44.6	91.1	61.9	100.3	70.8
THAP1	"4833431A01Rik, DYT6, FLJ10477"	ENSG00000131931	"THAP domain containing 1"	Q9NVV9	8	42836674-42843325	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071310			Supported	Nucleoplasm		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA071310: AB_2686386"	"unprognostic (8.99e-3)"	"unprognostic (3.97e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.16e-2)"	7.3	5.7	4.9	6.9	5.1	8.3	7.4	7.3	7.5	6.2	4.9	6.2	5.9	6.9	6.2	6.3	7.3	5.1	8.8	4.9	4.7	7.0	8.7	5.4	9.5	5.2	4.8	8.2	4.6	7.9	3.8	7.0	5.3	5.7	5.4	5.7	6.2	5.7	12.4	4.0	5.8	6.8	5.2	6.3	5.0	9.4	5.2	11.5	8.6	12.5	8.4	6.5	3.7	6.4	10.5	9.3	8.5	8.2	12.7	14.3	10.2	14.2	10.8	12.8	11.7	8.0	13.2	12.8	11.3	10.5	19.0	10.7	14.0	12.0	16.2	12.4	10.3	12.5	8.1	9.4	15.6	10.4	12.7	11.3	17.7	14.1	18.2	12.4	16.5	17.1	14.1	14.7	15.1	6.4	25.1	12.1	16.8	16.9	7.4	11.2	15.2	10.2	13.9	7.8	6.9	8.1	15.5	9.7	20.2	11.2	13.5	11.6	10.0	11.2	8.3	15.0	14.3	11.9	14.0	12.2	11.2	13.6	12.4	23.8	18.6	30.8	19.9	16.7	21.6	20.4	23.1	22.1	19.9	17.8	26.9	21.5	22.0	19.3	18.0	9.8	32.5	18.8	4.9	5.1	7.3	7.5	4.9	4.7	5.2	4.8	5.3	5.2	5.2	6.4	17.2	9.6	9.4	3.6	20.1	13.5	9.4	16.6	26.7	10.5	12.3	11.4	21.5	7.2	12.6	5.5	0.0	20.5	17.5	7.7	23.5	17.5	35.6	16.1	16.2	15.5	14.3	18.3	5.2	11.3	23.8	14.5	2.6	13.3	16.5	8.6	10.4	12.1	15.2	23.5	5.3	8.8	28.5	11.6	9.2	17.9	11.5	13.4	7.2	2.8	20.2	15.6	30.9	5.5	4.9	10.6	4.0	13.9	18.5	10.8	14.1	22.9	13.1	11.0	0.0	12.9	17.0	32.6	45.8	21.1	13.8	8.1	24.6	12.8	9.6	8.2
THAP10		ENSG00000129028	"THAP domain containing 10"	Q9P2Z0	15	70881342-70892433	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.5;Early spermatids: 12.6;Spermatocytes: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"U-2197: 40.4"									"HPA041416, HPA073220"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041416: AB_10795592, HPA073220: "	"unprognostic (1.00e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.15e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.25e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.44e-3)"	1.7	2.2	4.6	1.3	5.2	0.1	1.9	6.1	7.3	2.4	2.4	2.2	2.3	2.1	1.8	1.9	3.2	1.5	4.7	3.9	5.2	3.0	2.1	1.8	1.0	5.1	5.4	3.7	1.9	5.1	1.7	1.8	5.2	3.0	1.9	10.8	1.8	3.1	2.3	1.3	1.2	2.0	5.0	0.9	2.9	3.4	6.3	0.9	3.6	2.3	0.9	2.6	1.4	5.9	7.3	12.6	7.7	9.8	4.1	5.0	0.1	13.5	6.1	11.4	13.5	2.0	9.5	0.0	8.2	3.8	14.3	11.3	16.2	3.7	10.2	0.0	8.3	2.6	6.2	0.9	2.0	0.7	5.2	1.6	5.1	6.5	6.2	7.9	5.8	0.0	0.9	0.0	8.3	5.7	0.0	2.9	11.2	5.2	5.3	0.0	9.9	0.3	5.1	5.9	8.6	8.9	9.3	3.9	6.5	7.5	4.6	6.3	4.3	7.9	5.6	40.4	9.6	3.4	4.3	0.0	5.0	0.9	11.6	0.0	0.3	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.4	4.2	0.0	0.2	0.1	4.6	5.2	6.1	7.3	3.9	5.2	5.1	5.4	5.2	5.0	6.3	5.9	3.5	0.0	0.5	0.0	0.5	1.8	4.1	2.4	1.2	17.5	2.0	2.0	6.1	1.5	2.0	11.0	0.0	0.2	0.0	2.5	9.8	3.0	12.6	5.5	1.9	2.7	3.0	0.4	3.0	1.1	0.3	2.4	1.1	1.1	0.0	2.1	1.4	1.8	1.3	1.7	4.0	1.5	8.2	0.6	1.0	7.8	2.5	0.7	0.0	0.0	0.1	5.2	0.0	1.0	4.7	0.8	5.3	4.9	1.2	2.2	0.6	6.8	5.4	4.6	0.0	1.5	2.9	19.3	2.7	2.6	1.4	0.1	0.2	1.8	2.9	4.2
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206, RONIN"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842320-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	Nucleoplasm,Cytosol		NA	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	16.6	14.4	20.5	14.9	21.1	10.2	16.3	21.4	21.3	21.9	19.2	26.7	12.3	24.5	13.0	19.5	22.4	10.1	25.1	20.7	21.7	16.1	14.9	15.4	20.8	22.1	20.8	20.9	19.3	16.9	16.4	12.3	20.6	16.1	11.1	10.9	15.7	19.6	48.1	26.1	22.1	17.2	22.5	24.8	20.8	12.6	21.1	23.5	14.9	26.4	19.0	23.9	18.4	23.1	31.3	40.2	27.4	25.9	37.5	25.7	28.7	15.5	27.0	37.1	31.9	51.9	23.6	68.0	31.7	15.9	22.3	35.6	48.6	29.0	21.1	25.4	55.3	27.1	22.5	64.1	34.2	34.9	29.4	23.6	28.4	25.6	22.4	26.8	27.7	45.9	39.5	15.4	22.9	49.1	37.7	62.6	55.1	36.9	34.7	73.6	32.7	61.4	19.0	20.2	38.2	43.1	45.4	16.4	33.2	19.6	40.1	35.2	22.3	23.4	28.4	21.3	19.2	60.9	65.9	67.5	18.3	38.2	25.8	7.6	13.6	14.7	26.3	18.4	20.7	13.8	23.6	24.2	14.3	18.8	29.9	24.0	4.1	21.3	17.5	11.3	31.5	17.9	20.5	21.1	21.4	21.3	20.7	21.7	22.1	20.8	20.6	22.5	21.1	23.1	20.4	22.4	13.1	3.3	24.4	29.2	25.0	6.6	22.8	25.6	27.4	23.6	15.1	12.8	5.3	11.0	4.2	19.6	32.8	12.5	52.8	7.6	1.2	18.6	18.0	21.3	13.2	23.8	4.6	9.5	25.9	17.4	7.1	14.3	7.6	20.3	24.3	14.0	22.4	8.4	4.6	16.2	6.1	19.6	20.0	2.2	23.6	19.1	10.6	4.7	24.5	29.8	43.3	7.1	6.1	6.5	5.9	31.2	18.9	25.0	13.5	19.8	6.1	16.9	19.7	24.2	22.2	16.1	27.4	20.9	39.1	13.5	32.5	28.6	16.5	20.2
THAP2	DKFZP564I0422	ENSG00000173451	"THAP domain containing 2"	Q9H0W7	12	71664301-71680644	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 367.4;Late spermatids: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039790	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoplasm	"HPA039790: AB_10795157"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.51e-4)"	"unprognostic (1.24e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.80e-2)"	16.1	26.1	5.7	9.1	7.1	14.8	4.2	11.6	9.2	4.8	3.1	4.1	5.7	6.3	17.0	6.5	4.6	8.6	5.2	5.5	6.3	5.6	4.4	4.7	7.9	6.7	6.0	8.6	3.8	3.4	11.1	6.8	6.6	4.7	5.7	11.3	4.7	4.1	5.0	5.7	4.3	4.4	6.9	5.1	6.4	18.2	5.7	5.4	4.6	5.7	7.1	28.2	4.1	10.8	3.9	4.9	11.2	8.6	8.2	7.2	5.6	6.0	5.5	5.7	4.8	5.1	5.1	2.7	4.0	4.0	6.9	6.8	10.9	3.4	7.4	11.5	6.0	7.8	8.6	8.0	7.4	4.8	3.4	5.1	15.1	5.4	12.0	11.9	9.0	13.2	5.7	5.6	7.9	1.3	3.9	4.7	5.7	7.9	8.2	5.5	3.8	13.3	7.1	6.0	7.9	12.4	6.6	3.8	5.8	7.8	7.1	5.4	4.0	5.9	2.8	5.1	4.1	6.9	9.4	6.2	3.4	5.7	3.6	1.4	2.2	2.2	3.7	3.0	6.0	4.1	5.1	3.6	3.0	4.8	8.1	5.5	1.9	6.4	3.7	1.4	5.5	2.1	5.7	7.1	11.6	9.2	5.5	6.3	6.7	6.0	6.6	6.9	5.7	10.8	15.1	0.0	11.0	11.1	36.2	19.6	27.7	13.7	20.5	11.5	9.9	13.6	12.4	4.3	7.9	3.7	4.2	4.0	24.4	8.1	9.8	7.7	367.4	12.2	13.5	10.6	5.4	3.4	14.8	5.4	7.3	47.1	12.8	20.2	58.3	9.4	6.1	4.3	12.3	13.5	20.8	8.1	2.0	11.3	93.2	183.7	11.5	75.2	78.2	5.6	9.9	10.2	9.2	14.1	24.3	7.0	9.4	5.7	44.3	16.7	15.6	19.2	10.5	7.5	0.0	22.2	64.1	26.1	7.2	44.8	29.5	3.0	20.0	6.7	9.5	25.7
THAP3		ENSG00000041988	"THAP domain containing 3"	Q8WTV1	1	6624866-6635586	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067114	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Mitochondria"	"HPA067114: AB_2685782"	"unprognostic (1.82e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.50e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.26e-3)"	17.4	24.7	22.1	6.5	22.3	9.6	17.9	23.1	25.8	23.4	18.9	20.1	7.9	18.8	8.3	15.7	19.4	7.7	28.4	20.9	21.3	27.0	29.0	14.1	11.5	23.7	21.8	22.3	24.0	14.0	19.7	7.4	22.2	22.9	4.5	5.1	16.5	9.9	22.8	17.0	15.1	7.0	21.0	21.6	19.2	16.8	21.9	9.7	19.9	13.4	8.6	18.9	18.2	25.0	13.6	12.8	11.2	16.3	18.2	16.3	10.8	12.0	15.6	31.2	19.4	17.1	8.4	11.9	15.7	13.2	11.6	10.5	17.9	10.7	10.8	20.6	30.1	13.7	18.5	15.5	22.8	9.8	13.6	15.3	13.4	19.7	17.2	19.0	13.6	20.5	14.1	14.9	11.7	9.7	17.2	22.2	9.7	15.8	21.7	16.2	13.6	17.3	14.3	3.2	14.7	16.7	14.6	19.9	28.6	9.3	12.8	17.4	12.4	16.5	9.9	11.4	19.0	16.7	19.3	15.9	13.9	20.9	9.5	16.6	19.4	15.2	25.2	16.2	25.7	22.1	25.0	26.8	24.4	31.0	27.3	23.1	12.0	24.7	12.9	22.2	27.1	20.9	22.1	22.3	23.1	25.8	20.9	21.3	23.7	21.8	22.2	21.0	21.9	25.0	12.1	0.0	7.5	5.5	10.8	14.0	12.0	13.2	9.1	11.1	10.4	14.2	7.2	10.0	6.9	9.2	6.2	16.0	9.7	10.7	19.6	10.5	6.5	9.2	11.8	12.8	7.7	11.0	4.6	10.4	17.5	15.8	5.6	9.0	5.7	17.6	11.7	11.6	15.5	5.0	5.8	10.4	10.2	10.9	15.9	4.7	18.6	7.1	10.6	2.8	19.2	12.2	12.3	5.0	7.9	9.8	13.1	23.3	18.1	21.5	21.1	19.3	12.3	8.8	13.1	13.8	15.8	18.2	18.0	8.7	14.8	16.4	9.3	17.7	13.0	15.6
THAP4	"CGI-36, Nb(III)"	ENSG00000176946	"THAP domain containing 4"	Q8WY91	2	241584405-241637158	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"		"DNA-binding, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044982, HPA053448"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear speckles"		"HPA044982: AB_10959786, HPA053448: AB_2682154"	"unprognostic (3.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.07e-1)"	34.3	31.8	60.3	19.0	60.4	28.1	35.6	57.7	78.5	34.5	60.2	51.1	42.1	30.9	28.7	53.1	29.0	25.0	106.5	58.9	60.7	96.7	54.0	29.3	22.0	60.0	61.4	33.2	48.4	107.0	37.7	16.1	60.3	43.7	27.1	9.0	42.1	24.1	118.8	46.8	34.9	17.3	56.3	26.5	52.0	40.8	62.7	23.4	31.9	91.6	19.0	41.5	38.9	59.8	47.6	53.4	31.5	58.9	41.5	43.1	53.7	32.1	42.5	46.6	41.4	48.6	41.1	40.5	16.4	50.1	53.8	53.4	63.8	71.4	17.6	33.3	76.9	42.5	35.7	138.7	55.0	48.6	28.5	44.8	55.4	50.2	69.2	32.5	43.9	62.4	76.9	13.1	36.4	84.5	51.1	110.1	57.1	43.9	45.2	55.9	44.1	52.6	100.2	57.0	76.4	50.1	24.7	76.9	65.1	19.4	38.7	52.3	40.0	55.5	36.6	50.7	58.3	32.4	19.9	42.6	40.2	40.4	40.9	31.0	15.7	40.3	27.4	18.0	29.4	21.6	30.3	25.5	16.4	25.0	28.6	23.3	10.2	22.7	24.1	23.2	53.6	16.1	60.3	60.4	57.7	78.5	58.9	60.7	60.0	61.4	60.3	56.3	62.7	59.8	16.6	19.2	21.7	15.7	16.4	20.0	42.1	31.9	21.1	9.9	21.2	17.1	55.9	35.8	28.3	40.5	4.2	23.4	13.2	64.6	223.0	48.0	17.7	37.5	19.6	17.7	28.8	21.5	12.2	27.8	24.6	19.9	35.2	58.9	7.0	16.6	13.6	38.0	17.7	8.4	12.8	52.3	32.6	11.4	10.6	7.7	18.0	14.2	12.4	7.5	15.3	11.1	22.6	11.1	11.5	27.6	44.2	19.5	21.3	38.1	79.0	90.0	21.3	6.8	32.9	16.3	23.3	25.3	29.1	40.0	25.9	27.5	15.1	17.5	60.2	53.4
THAP5	DKFZp313O1132	ENSG00000177683	"THAP domain containing 5"	Q7Z6K1	7	108554543-108569750	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 398.3;Late spermatids: 537.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043170, HPA051488"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA043170: AB_10964500, HPA051488: AB_2681504"	"unprognostic (2.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.79e-2)"	8.9	13.2	9.8	11.3	11.2	4.7	12.8	13.1	14.3	12.1	9.2	9.2	9.8	12.8	12.6	7.7	9.9	7.8	13.8	9.4	10.8	15.9	19.7	10.3	14.6	11.2	10.4	17.4	9.9	18.0	10.6	10.0	10.5	13.1	8.2	17.8	9.9	11.4	13.0	8.3	9.8	8.6	10.8	12.7	10.2	26.7	10.8	13.1	22.3	15.3	13.3	7.8	5.9	14.9	19.4	14.8	18.6	42.3	11.8	16.7	9.7	17.5	19.8	19.0	20.1	7.5	15.9	23.4	31.0	12.1	24.8	8.0	19.3	13.8	24.5	30.5	15.2	17.6	14.4	7.1	25.1	31.7	22.4	10.4	26.1	11.6	27.4	20.2	11.8	26.3	27.9	49.3	19.4	19.5	48.6	13.7	21.9	11.5	14.4	15.0	26.6	54.8	11.6	11.2	21.8	38.2	25.0	29.2	35.1	14.5	12.2	11.9	11.8	35.7	19.7	28.3	21.8	57.0	52.6	43.0	19.8	19.1	33.0	19.2	8.0	15.0	11.7	10.6	15.2	17.8	13.2	11.1	8.0	19.5	17.2	14.6	25.7	11.2	15.5	12.7	11.9	8.3	9.8	11.2	13.1	14.3	9.4	10.8	11.2	10.4	10.5	10.8	10.8	14.9	30.6	16.0	20.9	9.4	31.0	12.2	12.0	9.0	9.1	40.9	23.6	20.4	30.1	32.9	12.6	25.8	8.4	13.2	26.6	14.7	46.9	15.5	398.3	14.9	18.9	20.7	15.7	39.5	12.9	16.9	9.3	21.3	7.7	12.1	32.2	18.6	21.8	26.5	9.6	47.1	15.1	16.3	12.2	15.2	19.8	537.3	28.3	15.0	35.6	6.5	16.1	49.5	15.5	12.5	21.6	13.6	15.6	28.2	20.8	14.9	16.6	32.8	23.7	40.7	26.3	24.4	21.8	44.6	25.9	8.4	18.0	14.4	22.5	18.0	12.4	8.1
THAP6	MGC30052	ENSG00000174796	"THAP domain containing 6"	Q8TBB0	4	75513946-75550473	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035767	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome	Nucleoplasm	"HPA035767: AB_10696510"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-2)"	9.8	11.3	6.8	12.6	12.3	12.6	15.3	14.4	10.0	10.2	8.9	9.9	12.4	16.5	12.7	9.4	10.6	9.1	14.6	7.9	11.5	9.8	12.5	9.4	15.7	11.7	9.6	14.8	8.5	12.4	9.4	9.6	11.0	13.5	11.7	21.7	13.3	10.2	15.3	16.7	13.2	10.7	7.2	12.5	11.0	23.5	10.8	9.2	15.5	13.6	12.1	9.2	8.5	21.0	8.5	6.2	13.4	9.2	14.8	14.9	6.9	19.8	10.1	10.5	10.8	7.3	20.7	11.5	10.0	6.6	11.8	8.8	12.4	8.8	12.8	14.1	8.5	8.8	10.5	9.3	20.0	12.8	9.5	12.3	16.9	11.7	18.3	16.5	5.9	14.8	16.2	25.0	11.3	10.4	11.1	8.2	6.8	12.2	5.8	11.0	14.5	8.5	9.9	6.5	10.0	10.3	9.6	12.6	11.8	11.0	14.1	10.2	6.8	17.5	11.6	20.8	9.8	22.4	12.3	11.5	11.9	9.5	14.9	17.2	8.4	12.7	9.0	7.4	12.2	8.6	10.9	8.6	7.0	10.2	12.2	9.5	18.2	6.9	8.3	5.7	13.3	6.6	6.8	12.3	14.4	10.0	7.9	11.5	11.7	9.6	11.0	7.2	10.8	21.0	11.0	12.8	11.0	21.9	19.8	8.3	14.7	12.7	14.8	20.2	13.0	10.5	17.0	18.6	11.5	22.0	31.3	10.8	13.5	8.9	15.6	8.3	131.8	13.1	13.5	8.5	12.6	12.6	11.0	6.4	8.8	16.0	8.6	8.4	10.8	18.0	9.3	9.8	7.2	16.8	15.6	12.8	6.1	14.0	6.5	23.0	14.0	9.6	7.2	13.1	11.5	13.3	8.2	18.6	35.9	8.0	11.5	11.3	17.5	11.4	16.7	15.7	20.6	18.9	0.0	10.0	13.7	56.0	16.6	12.2	6.8	7.7	18.1	15.5	7.5	7.7
THAP7	MGC10963	ENSG00000184436	"THAP domain containing 7"	Q9BT49	22	20999104-21002196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 162.9;Spermatogonia: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 106.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003083	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Vesicles"	"HPA003083: AB_1080264"	"unprognostic (6.48e-2)"	"unprognostic (2.13e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-3)"	16.1	26.9	13.7	5.6	12.9	4.8	18.1	13.7	19.6	23.0	16.0	23.1	7.9	20.4	4.8	15.4	20.9	5.8	19.4	12.6	13.2	20.8	37.8	13.4	8.8	14.1	14.9	21.9	26.9	9.8	39.5	4.2	14.4	29.1	2.5	2.7	19.0	9.2	39.7	19.1	19.0	3.5	13.3	24.2	23.2	35.5	13.9	7.6	20.9	14.4	3.7	21.5	16.6	13.2	23.5	25.0	6.9	11.8	6.0	7.5	14.2	12.1	11.6	15.9	14.7	11.5	13.5	17.2	11.9	7.6	8.4	16.4	6.1	12.1	2.4	17.1	36.4	21.6	18.7	14.9	18.5	22.2	13.4	7.2	15.0	14.0	12.9	7.0	8.4	13.1	106.2	19.8	8.8	29.3	24.4	13.7	9.6	16.0	24.7	19.0	13.6	10.4	8.4	11.8	13.5	11.7	15.1	19.5	21.5	3.2	22.4	14.6	5.5	25.4	19.5	15.4	12.8	27.6	17.4	14.1	27.6	14.3	22.4	1.9	22.1	8.8	27.2	23.9	36.1	50.0	32.8	27.4	21.3	36.9	45.2	36.3	1.9	24.0	25.3	31.6	30.7	24.9	13.7	12.9	13.7	19.6	12.6	13.2	14.1	14.9	14.4	13.3	13.9	13.2	18.7	16.0	25.7	6.2	33.3	19.1	20.3	24.5	14.8	31.5	25.0	30.4	14.8	37.1	18.3	25.8	14.6	31.2	23.8	22.4	64.6	28.2	30.0	16.6	15.7	20.3	22.2	16.2	5.8	38.2	30.1	25.8	20.4	10.6	21.5	21.0	18.5	35.3	27.8	13.5	5.8	22.8	30.5	15.8	11.5	44.0	41.7	14.2	40.9	1.0	27.5	52.0	45.3	3.5	7.2	23.9	19.7	32.4	28.6	31.4	38.4	57.4	22.6	27.1	39.5	22.8	43.5	162.9	119.4	16.7	16.3	29.6	28.8	31.1	21.7	13.2
THAP8	FLJ32891	ENSG00000161277	"THAP domain containing 8"	Q8NA92	19	36034984-36054739	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 18.8;Spermatogonia: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA064056, HPA070139"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA064056: AB_2685184, HPA070139: AB_2686230"	"unprognostic (1.33e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (9.01e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.48e-1)"	3.3	3.2	9.1	2.5	9.8	0.9	2.7	9.4	9.6	5.0	6.3	9.5	3.7	4.7	3.4	3.7	3.8	3.5	3.5	8.3	9.7	4.1	4.6	2.8	3.1	10.1	9.8	3.5	2.8	3.7	3.4	2.8	10.2	3.6	2.4	4.6	3.0	4.3	10.2	5.2	3.5	4.4	8.9	3.4	3.6	9.7	9.7	4.0	3.1	3.3	2.2	6.6	4.0	11.2	3.3	8.2	4.4	3.7	11.6	8.0	2.8	2.7	4.8	5.5	7.8	3.6	2.3	4.5	9.7	4.5	5.7	1.5	2.5	3.3	2.1	3.2	1.6	2.8	3.0	4.3	12.7	1.6	2.7	6.2	5.0	3.8	2.6	6.2	2.6	8.2	2.4	5.3	5.8	5.5	4.1	3.4	3.9	5.6	3.1	3.9	1.4	4.2	4.5	2.9	8.1	6.1	4.6	3.9	3.3	5.7	4.1	2.2	2.3	7.3	4.5	4.5	2.2	5.2	4.5	3.3	8.0	2.6	4.7	7.1	6.5	7.9	5.2	7.6	5.9	4.1	5.5	5.4	4.7	3.0	4.1	6.1	2.7	6.2	6.6	4.5	5.8	4.1	9.1	9.8	9.4	9.6	8.3	9.7	10.1	9.8	10.2	8.9	9.7	11.2	1.4	3.2	3.7	3.6	3.4	1.1	1.2	3.2	2.8	2.2	3.0	2.4	3.7	5.7	2.9	7.3	2.1	10.2	3.5	2.1	1.9	5.7	3.0	1.5	3.9	2.5	6.6	1.3	2.7	0.5	5.5	3.8	4.1	2.7	5.7	8.8	3.9	3.5	15.8	3.3	3.3	1.3	12.2	4.4	0.8	6.1	1.8	3.2	1.8	1.9	4.4	5.2	8.2	4.5	5.5	2.6	2.7	4.1	2.5	1.2	5.3	11.7	1.2	3.0	0.0	1.7	2.9	18.8	21.5	2.3	2.3	10.5	2.5	5.8	2.2	1.0
THBD	CD141	ENSG00000178726	Thrombomodulin	P07204	20	23045633-23049672	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease variant, Hemolytic uremic syndrome, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 254.3;Endothelial cells: 200.6;Langerhans cells: 138.1;Leydig cells: 130.8;Macrophages: 130.9;Peritubular cells: 259.2;Squamous epithelial cells: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 24.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.8;granulocytes: 24.6;monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;CAPAN-2: 39.2;EFO-21: 33.5;HaCaT: 33.1;hTCEpi: 42.6;OE19: 29.8;THP-1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002425, HPA002982"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA	5550000	1300000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"CAB002425: AB_563497, HPA002982: AB_1078444"	"unprognostic (1.96e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.81e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.58e-3)"	"unprognostic (9.71e-2)"	65.4	11.4	2.0	19.6	1.8	15.5	25.5	1.6	3.2	16.7	3.4	16.5	5.5	12.6	3.1	36.8	27.5	26.5	31.0	2.4	3.0	19.7	9.7	56.7	14.5	4.1	2.7	6.9	13.2	9.9	20.4	28.5	2.8	8.0	5.9	0.2	10.8	4.6	40.7	71.4	20.0	15.6	3.0	43.6	30.8	7.6	8.5	5.1	35.5	17.5	8.0	20.8	21.0	2.4	11.5	9.9	0.3	0.0	24.3	1.4	0.2	0.2	0.0	0.0	0.0	0.0	39.2	0.0	33.5	3.4	1.7	33.1	0.0	1.8	0.0	0.0	0.1	0.1	1.0	0.0	4.7	0.0	0.2	1.1	42.6	0.7	2.8	23.0	11.0	0.0	4.2	0.0	0.9	0.8	0.0	4.2	0.1	29.8	1.6	0.0	0.0	4.9	0.2	16.2	0.7	0.0	9.4	1.2	17.4	2.9	0.0	24.8	21.7	0.1	0.6	3.2	0.0	0.0	0.0	0.0	2.0	5.8	0.8	0.0	4.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	24.6	2.0	8.7	10.8	0.0	2.0	2.0	1.8	1.6	3.2	2.4	3.0	4.1	2.7	2.8	3.0	8.5	2.4	254.3	22.4	21.4	0.0	2.0	34.3	10.4	9.5	23.3	0.1	3.9	5.3	16.8	1.5	21.3	0.0	0.0	3.2	16.9	0.0	0.0	1.8	0.9	1.9	1.8	200.6	0.0	2.7	0.3	0.2	37.1	46.1	2.6	7.2	7.6	0.2	65.3	0.8	14.9	0.0	0.7	0.4	4.1	32.4	138.1	4.9	130.8	130.9	16.0	1.0	8.1	0.0	0.0	0.0	0.0	9.0	0.0	259.2	2.3	4.5	0.0	0.3	2.5	0.0	6.6	51.4	39.0	0.2	1.0	237.3	98.6	42.4	3.2	2.8	0.1	58.2
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 32.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 47.1;Microglial cells: 15.0;T-cells: 59.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	22	"gdT-cell: 26.7;MAIT T-cell: 34.0;memory CD4 T-cell: 33.5;memory CD8 T-cell: 48.9;naive CD4 T-cell: 30.0;naive CD8 T-cell: 58.3"	"Lineage enriched"	"Detected in single"	88	"T-cells: 58.3"	"Group enriched"	"Detected in some"	4	"HDLM-2: 32.6;JURKAT: 54.1;MOLT-4: 51.6;RPMI-8226: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	0.4	0.5	0.5	3.3	3.2	1.7	0.6	0.1	2.3	0.4	0.3	0.7	1.6	0.2	0.4	0.6	0.2	1.4	0.1	0.9	0.1	0.2	0.7	1.4	7.5	0.6	0.3	0.1	0.3	0.0	0.0	0.1	0.4	0.4	0.9	0.0	0.9	0.1	0.1	0.2	2.3	0.3	0.3	3.2	1.5	0.1	0.3	32.9	0.4	0.1	4.0	1.1	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	26.7	0.1	34.0	0.1	33.5	48.9	0.2	0.2	30.0	58.3	0.6	0.1	0.2	0.2	1.7	20.3	0.5	3.2	0.1	2.3	0.9	0.1	0.6	0.3	0.4	0.3	0.3	1.9	0.5	0.0	3.0	2.9	2.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.9	0.1	0.2	0.4	0.0	1.7	47.1	0.0	0.0	0.7	5.1	0.1	1.3	0.0	1.1	0.1	0.1	0.0	0.9	0.0	0.0	0.8	0.8	0.2	0.0	1.5	7.2	15.0	1.4	0.0	0.0	0.0	9.7	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.1	1.4	0.0	59.9	0.0	0.0	0.1
THEMIS2	"C1orf38, ICB-1"	ENSG00000130775	"Thymocyte selection associated family member 2"	Q5TEJ8	1	27872543-27886685	"Predicted intracellular proteins"	"Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 215.5;lymphoid tissue: 126.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.5;Hofbauer cells: 62.6;Kupffer cells: 135.9;Langerhans cells: 59.9;Macrophages: 125.4;monocytes: 144.8;Plasma cells: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 403.3;eosinophil: 341.0;intermediate monocyte: 441.4;myeloid DC: 309.6;neutrophil: 498.1;non-classical monocyte: 454.6;plasmacytoid DC: 125.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 309.6;granulocytes: 498.1;monocytes: 454.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 135.9;U-266/70: 98.4;U-937: 62.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027513, HPA031096"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA027513: , HPA031096: AB_10599254"	"unprognostic (7.38e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.56e-3)"	"unprognostic (4.13e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.52e-3)"	30.7	10.6	10.8	72.8	13.1	215.5	12.7	13.6	14.4	7.2	12.3	14.7	10.1	5.7	3.9	8.0	10.2	23.6	6.6	11.2	16.6	9.2	19.1	45.8	47.9	22.2	14.3	3.3	5.4	2.7	4.9	18.8	19.1	5.4	10.1	0.9	11.1	3.9	3.4	4.5	28.2	15.5	15.4	126.0	12.2	22.4	17.8	16.0	11.0	4.5	29.9	26.9	6.4	24.6	9.1	0.3	3.4	0.5	11.4	15.6	1.5	1.9	20.0	28.7	40.2	1.3	2.4	12.8	1.2	6.6	15.9	1.3	5.2	1.2	4.6	1.7	1.2	18.0	0.4	2.3	22.3	23.0	27.8	7.9	0.3	14.8	0.1	1.5	11.1	1.0	24.7	135.9	2.1	6.1	0.9	20.1	11.8	0.3	1.8	4.1	12.8	23.2	8.6	0.3	0.2	5.0	0.1	0.8	26.2	2.1	0.3	20.2	6.9	1.7	0.2	5.6	0.3	98.4	6.1	0.8	32.3	62.1	0.5	41.7	403.3	341.0	71.9	441.4	66.1	41.5	53.1	60.2	309.6	21.8	45.6	48.2	498.1	61.9	454.6	125.2	56.4	380.7	10.8	13.1	13.6	14.4	11.2	16.6	22.2	14.3	19.1	15.4	17.8	24.6	2.2	3.2	20.0	0.3	42.6	3.2	1.1	2.7	0.6	0.4	1.0	0.6	0.7	2.8	8.7	0.0	0.0	0.8	87.5	0.3	0.0	0.9	2.3	4.5	1.8	6.8	10.7	6.1	6.2	8.3	1.3	1.8	1.1	6.4	13.3	7.1	3.6	1.3	62.6	0.0	0.7	0.2	36.7	135.9	59.9	5.2	0.6	125.4	17.8	6.5	144.8	0.1	54.6	0.5	14.7	8.7	0.0	0.4	57.3	3.0	0.0	0.4	3.2	0.2	0.0	21.9	2.1	1.8	2.9	0.1	1.1	2.5	21.2	3.0	0.8	5.0
THOC2	"CXorf3, dJ506G2.1, MRX12, MRX35, THO2"	ENSG00000125676	"THO complex 2"	Q8NI27	X	123600561-123733056	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047921	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA047921: AB_10960388"	"unprognostic (2.12e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.43e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	22.8	26.1	26.2	22.7	28.2	25.1	26.3	29.0	43.8	28.6	33.3	28.5	23.0	27.1	38.1	26.3	26.6	19.6	21.0	25.9	28.1	22.5	26.0	27.3	32.7	27.9	26.8	32.1	27.8	23.9	21.8	23.4	28.8	26.8	22.8	34.9	22.4	19.2	23.5	29.6	28.1	22.6	26.3	30.8	24.1	15.1	28.0	38.2	26.0	17.7	27.4	24.6	25.8	30.5	59.6	48.6	61.1	66.1	44.0	42.0	32.8	39.6	38.9	42.8	56.9	34.3	59.4	60.5	44.3	43.6	41.2	44.1	74.6	29.6	72.3	58.1	67.5	84.8	69.1	46.8	40.8	99.5	58.0	83.5	36.1	49.1	56.2	37.3	40.2	90.6	129.3	53.5	43.9	62.6	86.0	96.3	34.0	79.7	47.5	86.3	38.2	50.0	67.6	66.4	46.9	41.5	111.0	30.2	39.3	48.6	30.3	60.0	41.8	38.4	19.8	55.2	67.8	37.1	58.0	51.7	34.3	86.8	43.2	9.8	8.3	9.2	11.1	10.9	12.9	10.7	12.1	12.1	7.9	11.5	13.1	12.6	4.7	11.0	12.2	13.3	10.2	7.9	26.2	28.2	29.0	43.8	25.9	28.1	27.9	26.8	28.8	26.3	28.0	30.5	65.8	137.8	151.4	68.2	81.2	83.4	67.7	69.3	80.8	67.5	45.3	45.3	53.6	20.0	89.0	64.4	158.4	42.3	69.5	65.9	11.7	55.0	5.7	54.9	102.4	68.4	67.5	88.5	64.8	50.9	36.4	68.2	46.9	70.8	80.4	90.4	59.6	37.9	38.9	53.8	72.7	55.9	46.8	44.6	58.1	9.0	93.2	61.9	30.2	75.9	82.4	41.2	69.0	96.5	119.9	47.3	36.3	91.4	66.4	76.2	55.1	28.9	77.5	108.9	124.9	81.0	98.1	69.0	35.8	55.7	77.0	43.6	76.2	84.2	57.9	73.8
THOC3	"MGC5469, TEX1"	ENSG00000051596	"THO complex 3"	Q96J01	5	175917873-176034680	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 132.1;Early spermatids: 187.0;Squamous epithelial cells: 226.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042764, HPA044009, HPA045071"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	Vesicles	"HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-3)"	"unprognostic (6.48e-3)"	"unprognostic (8.60e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.91e-1)"	12.0	14.5	22.0	11.4	15.9	35.1	21.4	23.0	40.6	23.1	19.1	27.0	12.5	13.4	63.2	82.9	15.1	8.0	9.3	40.2	14.9	16.3	22.2	11.9	29.1	15.5	13.3	18.8	15.3	10.0	15.9	17.4	15.9	14.6	21.1	12.1	22.5	14.9	12.6	26.5	16.2	12.2	13.2	17.7	17.5	51.3	15.4	39.2	20.5	17.6	45.5	17.4	33.5	15.9	82.1	44.7	47.0	102.7	44.1	39.3	168.0	48.4	44.6	104.5	120.4	63.5	65.2	105.6	68.3	27.9	112.6	69.2	71.6	206.0	109.7	73.5	103.3	57.3	46.2	70.7	14.6	94.6	49.2	33.3	85.9	90.0	45.2	23.3	58.3	98.0	88.1	46.5	66.9	98.7	64.0	57.9	40.1	82.3	160.3	110.7	59.3	110.4	75.2	60.7	89.5	51.4	100.0	48.5	52.5	67.4	55.3	86.1	45.1	35.9	40.8	55.6	88.2	23.2	44.1	64.4	26.7	90.1	28.5	16.5	26.9	15.1	39.3	33.5	48.4	49.6	81.7	48.9	43.1	70.6	99.7	62.4	3.9	42.3	31.5	39.8	133.6	59.1	22.0	15.9	23.0	40.6	40.2	14.9	15.5	13.3	15.9	13.2	15.4	15.9	14.9	12.8	8.6	2.0	35.8	44.5	34.1	64.5	132.1	12.3	17.7	18.0	4.0	10.0	24.4	25.8	10.4	40.8	25.1	8.1	41.1	25.1	187.0	50.2	18.4	16.1	16.8	63.9	5.2	19.2	84.3	15.2	26.5	44.9	12.0	18.8	13.9	20.3	24.6	6.7	3.7	16.3	26.4	13.2	14.9	122.0	14.6	14.3	8.8	1.9	15.4	8.9	27.8	4.5	2.0	21.9	11.6	19.2	55.9	18.4	10.4	46.8	15.8	12.0	19.7	10.6	22.8	107.9	48.3	226.5	40.9	20.0	33.3	25.0	27.7	31.1
THOC5	"C22orf19, Fmip, fSAP79, KIAA0983, PK1.3"	ENSG00000100296	"THO complex 5"	Q13769	22	29505879-29555216	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048402			Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA048402: AB_2680387"	"unprognostic (1.16e-1)"	"unprognostic (3.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (6.34e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (9.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.97e-1)"	19.3	11.6	5.4	14.2	7.2	19.0	17.2	9.2	10.1	24.4	3.5	37.5	11.4	31.9	13.6	18.5	20.3	17.2	29.2	6.4	7.3	13.4	13.5	14.7	15.3	8.6	7.1	21.5	14.5	14.1	9.3	11.2	9.6	18.2	13.8	11.1	11.9	20.9	43.7	13.8	17.5	29.3	5.0	15.0	20.3	19.8	7.2	14.7	11.3	40.9	15.1	28.7	17.6	9.6	43.0	28.7	25.8	77.5	47.7	38.1	32.7	79.3	46.7	68.8	68.0	46.8	18.8	26.4	30.2	63.4	40.9	37.8	36.5	42.4	67.0	30.5	38.5	43.6	40.8	53.0	32.5	100.1	35.8	40.6	39.2	67.8	52.1	56.0	51.2	25.9	50.2	26.3	43.3	47.7	31.2	31.1	53.6	36.7	22.1	45.3	62.1	32.7	25.2	32.4	52.6	84.5	44.1	34.8	49.3	33.9	19.7	35.0	35.5	120.6	69.8	28.7	52.0	41.2	42.7	64.9	40.2	40.9	52.5	6.7	15.6	39.4	14.1	19.5	14.1	12.6	11.6	10.3	17.2	10.1	12.1	11.3	42.8	10.6	24.4	4.1	18.3	13.0	5.4	7.2	9.2	10.1	6.4	7.3	8.6	7.1	9.6	5.0	7.2	9.6	8.5	22.4	12.6	7.2	11.1	5.4	7.8	9.5	4.0	10.8	10.7	16.3	17.0	4.3	8.9	3.7	20.9	21.3	9.5	8.2	13.7	20.0	43.6	7.0	11.0	10.1	9.0	16.6	9.5	14.7	22.6	12.1	9.7	6.5	11.4	15.9	7.9	8.6	14.2	8.4	11.0	5.6	6.1	11.7	5.7	125.7	12.8	9.6	8.8	2.8	16.9	7.3	18.6	6.6	6.6	17.4	6.4	12.8	10.4	8.9	18.7	17.9	9.2	25.1	0.0	10.9	19.5	39.2	23.5	9.4	6.1	17.4	11.1	17.9	9.4	5.6
THOC6	"fSAP35, MGC2655, WDR58"	ENSG00000131652	"THO complex 6"	Q86W42	16	3024027-3027755	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Developmental protein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 107.8;Extravillous trophoblasts: 121.1;Prostatic glandular cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052953	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA052953: AB_2681997"	"unprognostic (2.07e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.43e-2)"	17.0	16.9	8.6	16.1	9.1	23.5	15.3	9.6	11.2	16.1	9.7	17.9	18.8	20.3	6.0	19.3	13.9	10.5	15.8	8.6	9.2	22.2	21.3	17.5	20.8	11.6	9.1	11.6	12.9	10.8	17.4	18.2	11.8	21.1	10.1	2.1	15.2	12.2	25.9	24.9	19.2	12.5	9.2	22.7	15.6	10.4	10.2	19.6	15.7	8.4	16.1	17.1	16.5	9.5	37.3	59.6	42.0	45.0	21.1	23.9	74.4	11.3	25.7	25.7	37.8	39.6	42.8	70.0	36.0	18.9	19.1	49.9	46.3	35.6	14.0	62.3	59.9	38.0	58.6	58.7	35.9	56.2	80.0	24.3	42.6	31.4	76.9	32.4	24.1	39.7	56.1	36.5	12.8	87.0	32.0	103.3	76.2	21.4	25.3	84.7	31.6	82.4	27.1	18.6	86.4	41.0	31.8	49.9	21.7	18.1	35.9	60.0	20.1	26.8	61.1	30.6	41.3	26.3	24.3	85.5	7.0	38.1	27.3	2.4	61.3	13.6	35.2	62.2	36.2	37.8	32.6	34.7	88.6	43.2	37.1	39.1	4.4	38.8	35.7	74.3	38.0	45.4	8.6	9.1	9.6	11.2	8.6	9.2	11.6	9.1	11.8	9.2	10.2	9.5	11.0	19.2	7.4	1.6	24.7	68.2	84.9	59.0	30.7	3.7	22.1	20.8	3.3	14.3	18.9	18.4	2.1	107.8	23.3	23.2	35.2	33.1	5.4	17.9	19.0	17.9	25.8	30.3	1.9	23.5	121.1	24.6	15.3	25.8	12.0	15.6	6.4	10.3	51.8	3.3	1.7	32.3	44.7	19.4	37.3	3.2	14.9	23.4	24.9	2.8	39.6	3.2	15.5	0.5	4.2	21.5	28.0	12.0	19.7	109.4	32.1	32.0	8.7	2.4	6.6	23.4	31.9	5.3	23.3	23.3	44.9	77.2	20.4	20.9	42.2	46.8
THRSP	"Lpgp, LPGP1, S14, SPOT14, THRP"	ENSG00000151365	"Thyroid hormone responsive"	Q92748	11	78063861-78068351	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 210.0;liver: 408.9"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 128.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 44.1"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"ASC diff: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040642	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm		"HPA040642: AB_10794878"	"unprognostic (1.19e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.69e-3)"	210.0	5.9	0.1	0.4	0.1	0.0	95.3	2.7	0.3	0.1	0.0	2.6	0.0	0.1	0.4	0.3	1.0	3.4	18.6	0.2	0.0	4.6	408.9	0.1	0.7	0.0	0.2	0.1	3.6	15.5	0.1	0.0	0.4	0.1	0.2	1.5	48.9	2.3	8.2	33.7	4.6	0.5	0.0	0.1	0.7	0.1	0.0	0.2	5.7	3.3	0.0	0.8	1.1	0.1	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.3	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	2.3	21.1	11.2	0.1	4.3	0.0	0.0	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.6	0.1	0.4	0.0	2.7	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.1	2.9	128.4	0.0	0.0	0.4	0.3	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677718	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.9;retina: 19.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 25.0;Horizontal cells: 90.9;Inhibitory neurons: 153.4;Rod photoreceptor cells: 32.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Daudi: 11.0;SCLC-21H: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051416: AB_2681477, HPA056745: AB_2683224"	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	1.9	0.0	0.8	0.0	1.2	0.0	0.7	0.6	1.2	0.2	0.1	0.1	0.0	0.2	4.1	0.3	0.9	0.2	0.5	1.2	2.3	0.9	0.1	0.1	0.0	8.2	3.3	0.0	0.0	0.3	0.6	0.2	8.9	0.7	0.0	19.7	0.4	0.2	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.3	1.6	0.8	0.7	0.1	0.0	0.2	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.6	1.2	1.2	2.3	8.2	3.3	8.9	0.6	1.6	1.6	1.1	0.0	0.0	2.6	0.0	0.1	0.7	0.0	13.6	1.6	0.1	0.9	0.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	1.9	0.0	3.7	0.5	0.2	0.8	0.0	0.0	9.5	0.0	0.0	0.2	0.0	1.4	0.0	1.7	1.8	0.0	0.0	90.9	153.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	8.4	0.0	1.8	0.0	1.5	7.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	32.2	6.6	0.3	3.3	0.5	0.5	1.4	0.0	0.0	0.0	0.4	0.0	0.1
THTPA	THTPASE	ENSG00000259431	"Thiamine triphosphatase"	Q9BU02	14	23555988-23560271	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Spermatocytes: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028876	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA028876: AB_10600731"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.70e-9)"	"unprognostic (3.47e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.40e-2)"	13.6	17.6	29.3	10.4	41.7	8.2	11.0	27.5	33.0	9.4	28.5	11.5	14.2	12.1	15.1	8.5	14.9	9.7	14.8	30.1	27.0	14.4	11.3	9.5	10.6	28.4	27.5	12.6	11.4	19.8	11.1	6.7	27.7	16.0	10.6	13.2	17.3	14.0	23.6	6.9	9.8	11.8	27.9	10.7	10.7	20.1	27.9	11.0	11.5	20.7	10.2	10.2	7.3	29.3	3.9	24.1	11.4	12.4	26.3	14.6	6.3	11.2	9.7	10.7	10.5	4.9	15.9	7.2	9.5	13.1	12.1	11.8	12.1	13.8	7.8	15.9	13.7	10.2	16.9	13.3	13.0	9.1	8.7	20.6	10.2	16.4	12.0	22.9	13.0	11.6	7.7	15.9	15.7	11.6	14.6	3.7	4.1	20.9	20.1	9.9	7.9	13.4	18.9	7.6	22.1	10.6	10.8	22.0	6.6	6.6	14.9	4.4	10.9	7.0	7.4	14.5	6.5	18.9	12.2	4.4	7.3	4.2	10.9	13.7	16.0	8.7	9.8	12.0	9.8	10.2	7.2	7.6	14.7	15.3	11.7	10.2	1.7	8.3	16.1	18.7	6.4	10.9	29.3	41.7	27.5	33.0	30.1	27.0	28.4	27.5	27.7	27.9	27.9	29.3	8.1	6.4	7.5	16.6	14.5	0.0	7.8	0.0	6.8	27.4	12.0	10.7	0.1	8.6	3.7	7.3	8.4	11.0	9.2	7.2	54.8	14.5	21.9	6.7	9.2	6.2	6.1	3.4	11.8	12.4	5.1	9.9	9.2	6.7	23.5	7.7	7.1	10.8	18.4	8.4	23.1	7.5	0.0	7.9	0.0	23.0	11.5	9.8	0.0	4.7	9.9	33.4	14.4	15.1	37.0	8.2	9.6	7.5	11.3	9.3	15.2	38.9	2.9	11.6	13.1	13.2	7.7	57.5	8.3	9.5	0.0	6.7	9.3	14.2	7.7	5.9
THUMPD2	"C2orf8, MGC2454"	ENSG00000138050	"THUMP domain containing 2"	Q9BTF0	2	39736060-39779267	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043042, HPA058025"	Approved		Uncertain	Nucleoplasm		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA043042: AB_10964424, HPA058025: "	"unprognostic (6.30e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.48e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-3)"	2.4	2.0	2.6	0.5	2.5	1.7	2.1	2.9	3.0	1.9	2.6	1.9	0.5	1.7	0.2	3.5	1.5	0.5	3.3	2.6	2.6	2.4	2.3	2.2	1.4	2.6	2.8	3.2	2.2	0.5	2.3	0.4	2.6	2.0	0.7	0.4	2.1	0.4	6.0	2.5	2.0	0.4	2.4	2.5	2.2	0.9	2.6	2.0	2.1	4.0	1.5	2.1	2.4	2.8	4.9	4.7	1.0	6.5	2.3	3.3	2.7	1.3	2.5	3.0	3.1	5.0	4.5	7.8	2.7	1.6	7.6	2.0	9.7	4.4	3.2	13.1	10.8	4.7	3.0	5.7	4.1	6.3	2.4	3.9	3.2	3.1	1.0	2.9	4.9	1.5	5.9	1.8	6.1	2.3	3.3	5.0	0.0	13.0	2.9	3.4	4.2	5.4	2.9	2.6	5.7	3.1	1.3	5.6	3.2	0.4	1.8	3.9	2.5	4.0	2.5	1.1	3.6	2.4	3.1	5.1	2.0	11.4	3.2	0.0	0.6	0.0	0.1	0.4	0.6	0.7	0.4	0.1	0.5	0.3	0.6	0.4	0.1	0.4	0.1	0.9	0.1	0.6	2.6	2.5	2.9	3.0	2.6	2.6	2.6	2.8	2.6	2.4	2.6	2.8	17.4	25.6	20.6	26.8	17.8	14.3	29.0	19.5	15.9	26.8	14.4	29.8	23.7	8.6	20.3	14.7	18.8	11.5	23.0	7.2	19.6	16.6	4.5	7.5	16.9	13.7	9.6	23.8	42.2	13.7	13.6	18.4	17.9	10.9	7.0	19.2	10.0	9.9	11.3	6.7	41.6	8.1	8.2	10.9	7.7	4.0	28.0	10.0	5.4	45.0	11.8	12.1	15.5	45.2	30.3	16.7	17.1	25.6	8.2	23.7	10.3	16.4	10.9	21.1	6.6	20.5	16.0	9.1	19.7	16.9	13.5	6.8	12.6	22.2	13.5	22.7
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119415476-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 286.8;smooth muscle: 304.7;urinary bladder: 216.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.6;Excitatory neurons: 116.0;Fibroblasts: 201.9;Inhibitory neurons: 104.1;Muller glia cells: 108.1;Proximal tubular cells: 199.9;Smooth muscle cells: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 461.3;BJ: 738.4;BJ hTERT+: 832.5;fHDF/TERT166: 1330.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	90.6	16.4	97.9	78.6	114.8	0.2	25.6	12.9	286.8	78.9	0.0	35.4	10.2	58.6	27.8	29.4	23.1	101.0	12.9	135.4	73.3	142.2	7.4	21.6	40.4	83.6	37.0	9.2	14.8	39.4	18.1	62.0	60.8	15.5	41.8	25.3	8.5	47.0	3.4	13.9	14.5	304.7	35.4	21.9	17.4	11.4	43.6	73.2	37.9	8.3	35.6	216.7	21.7	108.7	0.7	3.9	108.5	0.1	461.3	331.5	0.3	738.4	832.5	263.6	289.3	0.2	0.2	0.4	0.1	1330.6	121.9	0.9	4.3	1.1	200.7	65.1	0.0	41.5	14.4	0.0	142.7	0.0	0.2	247.5	0.0	335.6	11.6	355.2	0.3	22.6	0.0	0.6	206.5	0.1	0.6	0.1	173.9	0.0	1.4	0.5	50.7	0.3	0.1	0.2	18.1	47.9	0.1	0.4	0.2	32.9	1.0	2.1	0.0	368.6	120.9	107.3	110.1	0.3	19.7	0.4	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.9	114.8	12.9	286.8	135.4	73.3	83.6	37.0	60.8	35.4	43.6	108.7	68.2	0.0	1.8	17.3	2.1	17.7	0.3	1.7	0.0	27.2	1.6	40.0	0.9	0.0	0.0	9.2	0.0	1.9	0.2	0.0	21.5	0.9	1.0	5.1	141.6	69.2	0.0	0.0	116.0	0.0	2.6	201.9	1.5	3.2	1.3	0.0	17.5	0.1	4.0	32.0	104.1	0.0	0.0	0.0	25.0	2.7	96.3	2.7	17.8	21.5	0.0	108.1	0.0	64.3	22.7	0.4	0.0	77.5	0.1	0.3	0.0	199.9	0.0	27.5	32.9	9.3	226.6	0.3	0.6	0.2	17.6	4.0	4.5	6.2	0.0	0.6
THYN1	THY28	ENSG00000151500	"Thymocyte nuclear protein 1"	Q9P016	11	134248279-134253370	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038732, HPA038733"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA038732: AB_10697397, HPA038733: AB_2676183"	"unprognostic (5.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.48e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.01e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.61e-2)"	42.3	40.5	74.2	22.0	75.4	43.3	45.1	74.4	104.9	39.8	68.5	53.9	30.2	43.1	75.8	28.1	47.6	31.1	51.7	75.9	76.2	40.1	57.5	28.3	40.5	72.2	71.3	62.9	32.8	27.9	50.8	22.2	73.2	50.1	44.9	41.3	29.6	54.2	32.3	28.1	36.3	42.3	72.5	36.6	39.4	42.6	74.9	77.1	52.1	38.0	44.5	44.3	33.1	76.6	32.0	19.5	69.8	56.0	65.9	74.7	41.0	26.9	59.2	62.0	58.1	106.8	76.3	60.0	88.6	37.8	66.6	48.9	106.8	82.0	60.5	61.5	30.3	165.5	25.7	97.6	94.3	133.0	52.4	56.9	43.2	73.9	48.2	80.6	98.9	199.0	78.1	28.0	56.5	17.7	155.1	242.8	81.0	127.0	71.0	72.3	51.8	50.6	86.4	55.4	66.4	53.7	55.8	13.6	33.1	50.3	78.2	66.5	52.7	26.6	41.3	24.4	41.7	31.4	35.0	126.9	39.5	170.6	31.5	185.4	89.8	330.3	145.2	108.4	175.6	122.1	152.3	146.8	99.1	96.4	175.4	200.0	47.2	139.1	104.4	131.3	199.8	160.0	74.2	75.4	74.4	104.9	75.9	76.2	72.2	71.3	73.2	72.5	74.9	76.6	41.9	32.1	28.8	8.1	31.1	23.8	42.2	107.4	28.5	28.6	37.5	65.4	52.1	47.1	57.7	36.8	14.6	52.7	33.5	25.5	86.1	48.2	28.2	44.7	33.8	36.9	57.6	40.8	15.3	55.6	52.9	42.3	20.4	23.4	40.5	65.5	37.1	47.9	53.0	28.6	12.0	47.9	75.3	22.2	23.7	16.0	50.4	32.7	40.9	8.4	43.1	65.7	44.3	11.1	11.1	53.2	33.0	48.5	29.8	13.4	49.3	93.3	73.1	23.9	46.0	34.0	51.3	79.1	94.9	31.4	20.6	13.8	44.1	72.7	52.7	31.6
TIA1	TIA-1	ENSG00000116001	"TIA1 cytotoxic granule associated RNA binding protein"	P31483	2	70209444-70248660	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Apoptosis	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 172.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056961			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 51: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA056961: AB_2683289"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.51e-3)"	"unprognostic (3.37e-3)"	"prognostic favorable (6.79e-5)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.05e-7)"	"unprognostic (4.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (1.02e-5)"	27.3	34.4	20.0	34.3	23.5	28.0	47.5	27.6	29.2	63.6	25.0	42.3	35.6	68.5	70.2	26.1	50.5	36.6	27.3	20.0	21.4	46.0	33.1	32.8	49.6	22.4	21.1	73.8	41.2	29.7	49.3	36.7	22.7	43.5	39.8	68.0	42.2	35.1	24.6	40.3	45.8	41.0	21.4	51.4	37.0	19.7	21.2	67.6	47.6	25.7	35.8	36.8	39.9	29.7	21.0	22.9	117.4	66.1	32.7	55.1	56.6	36.6	25.8	34.8	34.4	31.0	31.7	47.1	30.7	27.3	20.2	33.8	57.5	20.0	48.9	44.2	25.1	48.9	43.2	74.4	26.1	49.5	26.6	41.2	29.0	20.0	21.9	82.3	65.1	37.5	38.4	41.9	49.4	17.9	91.9	78.0	95.8	30.0	27.0	110.5	63.8	48.0	53.3	40.7	71.0	60.6	43.2	50.8	36.0	60.5	30.4	36.2	53.6	42.5	44.3	20.1	36.6	34.9	36.9	86.7	24.9	62.1	57.6	13.5	5.9	8.4	5.6	5.0	5.4	7.1	5.5	5.8	8.8	5.2	5.0	5.6	2.3	8.2	3.1	4.5	7.6	3.9	20.0	23.5	27.6	29.2	20.0	21.4	22.4	21.1	22.7	21.4	21.2	29.7	45.8	83.3	63.4	91.7	44.7	25.4	31.2	25.1	38.1	52.7	46.9	40.6	30.8	28.6	54.8	20.2	47.9	31.3	40.3	23.0	0.0	31.0	21.0	31.9	70.6	40.1	52.6	42.9	95.0	27.1	34.6	40.8	36.2	34.2	55.7	106.7	33.2	30.6	21.1	35.3	94.5	31.7	32.6	29.4	28.7	9.3	36.1	32.4	16.0	57.1	44.0	31.4	28.8	152.3	172.0	30.1	23.6	35.7	38.2	32.5	24.8	14.0	58.8	51.8	26.3	25.4	45.7	30.0	19.3	26.0	24.0	24.8	43.5	44.3	31.9	29.7
TIAL1	TIAR	ENSG00000151923	"TIA1 cytotoxic granule associated RNA binding protein like 1"	Q01085	10	119571802-119597029	"Predicted intracellular proteins"	Apoptosis	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060962			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Vesicles"		"HPA060962: "	"unprognostic (1.61e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (7.81e-6)"	"unprognostic (5.54e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.32e-3)"	"unprognostic (6.48e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.26e-2)"	32.2	29.7	14.3	26.8	18.3	49.0	31.3	27.5	20.2	32.2	16.7	33.2	23.9	43.6	37.4	46.1	29.8	28.7	31.5	13.0	15.7	29.9	34.1	30.6	40.1	15.8	15.3	35.3	36.3	28.2	28.3	32.5	16.9	27.1	27.8	29.6	34.9	18.6	58.1	35.3	35.8	25.6	14.7	35.1	35.0	32.6	15.4	25.0	32.0	21.7	27.6	29.3	34.2	24.5	50.0	26.8	68.9	83.5	35.8	53.9	34.0	46.1	46.1	31.7	36.5	22.1	51.1	48.2	29.4	31.6	24.9	53.8	42.3	25.0	42.9	63.5	34.1	30.4	47.1	36.6	29.2	57.5	52.3	41.1	30.3	30.5	76.1	137.9	41.6	32.9	23.2	47.7	33.3	15.2	62.2	60.5	37.9	29.5	24.3	43.9	52.2	35.2	43.3	26.7	19.3	32.8	39.2	35.0	40.4	35.1	30.9	29.5	38.9	34.9	25.2	35.6	47.2	35.5	62.3	48.4	31.7	57.9	27.1	2.5	2.5	2.4	3.8	2.3	4.2	3.2	4.3	3.7	2.5	2.8	4.5	4.8	2.5	4.5	3.0	4.1	4.6	1.9	14.3	18.3	27.5	20.2	13.0	15.7	15.8	15.3	16.9	14.7	15.4	24.5	64.6	44.8	60.1	24.5	72.7	63.6	75.8	54.0	66.6	55.7	52.7	53.1	37.9	42.9	54.7	23.9	31.3	66.0	87.3	54.6	46.9	54.4	13.7	45.2	69.1	58.5	52.7	90.7	37.7	54.7	108.3	57.8	48.9	53.3	35.4	73.7	57.1	49.6	58.4	45.4	50.6	46.5	30.5	57.0	46.4	8.2	61.2	61.3	37.4	38.4	79.7	49.3	61.8	54.8	91.9	70.0	43.4	45.1	73.7	99.1	49.5	48.0	40.7	48.9	52.6	53.9	63.6	62.9	49.1	72.6	64.2	77.4	80.6	53.6	53.8	94.2
TIAM1		ENSG00000156299	"TIAM Rac1 associated GEF 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 207.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 207.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 245.9"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	7.2	12.7	40.3	6.6	35.2	2.8	5.4	207.9	49.2	17.8	12.5	5.1	1.7	9.9	3.2	39.7	11.0	4.6	5.5	51.8	26.5	5.5	7.9	5.8	11.1	26.7	33.4	3.3	2.2	0.3	12.9	4.3	36.1	9.0	3.1	8.6	5.6	3.3	0.9	27.2	5.0	11.1	27.5	5.2	2.4	10.5	37.3	18.7	1.9	0.8	11.1	12.1	18.5	28.6	2.9	1.0	21.7	1.3	0.4	4.9	34.5	0.0	0.0	2.7	0.9	0.2	3.9	7.6	1.5	0.5	4.0	5.1	2.5	4.4	4.3	0.6	12.0	34.7	0.7	0.2	0.5	0.0	29.1	2.2	1.5	14.7	5.9	2.6	0.0	11.3	0.0	10.9	11.1	14.7	5.4	0.2	7.1	5.3	9.4	7.0	6.8	0.0	3.3	35.5	32.6	8.1	1.5	11.4	1.3	7.5	4.7	0.1	0.2	3.1	12.5	0.0	1.5	12.3	9.9	6.6	7.2	2.6	24.2	1.5	17.4	0.0	0.5	15.3	3.1	0.1	12.5	2.4	9.6	0.0	16.2	1.0	1.0	11.3	22.0	0.5	27.8	5.9	40.3	35.2	207.9	49.2	51.8	26.5	26.7	33.4	36.1	27.5	37.3	28.6	3.7	3.2	2.3	21.2	1.7	83.7	65.6	3.0	22.8	8.9	4.9	1.9	1.1	1.5	11.8	0.0	2.1	10.1	8.0	1.3	0.0	1.8	11.7	25.2	2.2	31.4	5.4	2.7	43.9	0.7	29.7	11.4	2.0	28.4	24.1	2.0	35.0	5.5	8.1	74.0	327.3	0.4	10.2	22.9	73.4	11.3	34.5	26.3	10.6	133.0	37.3	35.2	4.1	120.6	124.6	1.8	11.6	58.3	3.2	30.8	0.0	0.5	1.2	4.6	6.6	0.9	2.1	1.3	9.8	60.2	143.3	10.7	16.3	82.6	1.2	106.7
TIAM2	STEF	ENSG00000146426	"TIAM Rac1 associated GEF 2"	Q8IVF5	6	154832697-155257723	"Metabolic proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Early spermatids: 141.5;Excitatory neurons: 74.2;Late spermatids: 347.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.4;non-classical monocyte: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 65.7;HDLM-2: 27.8;RH-30: 43.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 36.9"	"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA011134: AB_1858005, HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.4	1.2	2.8	0.9	7.1	0.4	1.2	5.4	11.8	1.1	0.0	1.2	8.3	0.8	0.6	0.6	0.8	2.2	2.2	6.1	0.0	0.3	0.3	0.5	1.2	0.4	1.0	0.3	1.3	0.1	1.4	0.5	0.0	2.0	0.8	3.3	1.3	2.7	2.5	0.6	7.9	1.1	0.4	0.7	3.0	13.3	0.8	0.6	5.5	1.7	2.0	2.0	0.7	6.1	8.3	1.5	65.7	6.1	2.9	7.9	0.4	3.2	2.2	3.3	5.5	0.7	4.8	1.1	3.1	6.3	0.9	0.5	2.4	0.0	2.3	27.8	3.3	0.0	1.1	1.9	1.8	0.2	1.7	5.4	0.2	1.1	0.2	2.5	4.7	0.5	0.2	0.1	7.5	0.5	0.7	0.7	4.1	0.1	1.3	8.4	43.3	0.3	0.2	0.2	1.1	14.5	0.1	0.3	0.2	11.9	0.3	0.6	1.5	0.2	15.5	0.4	1.5	0.2	3.6	0.2	0.0	0.3	3.9	0.0	0.0	2.1	0.0	2.0	0.0	2.0	0.1	0.1	0.3	0.7	0.0	0.0	6.4	0.4	9.5	0.0	1.2	0.1	2.8	7.1	5.4	11.8	6.1	0.0	0.4	1.0	0.0	0.4	0.8	6.1	2.9	3.2	2.6	8.8	9.6	3.1	22.5	2.8	1.8	14.3	3.3	5.3	8.3	7.2	2.1	1.8	81.3	1.8	4.3	2.2	0.0	5.3	141.5	8.3	4.9	2.7	0.0	3.6	74.2	3.1	2.6	4.4	6.1	12.1	19.7	6.8	11.0	1.5	1.9	23.5	31.4	3.9	6.1	2.2	2.2	347.4	9.9	5.2	12.4	4.7	9.8	7.6	4.1	28.6	5.1	5.9	5.8	7.9	13.3	9.6	23.9	1.0	3.3	23.9	0.0	7.0	4.3	6.7	7.3	2.1	2.6	0.4	5.0	5.3	3.9	11.6
TICAM1	"MGC35334, PRVTIRB, TICAM-1, TRIF"	ENSG00000127666	"Toll like receptor adaptor molecule 1"	Q8IUC6	19	4815932-4831712	"Disease related genes, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.9;Paneth cells: 146.3;Urothelial cells: 134.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042460, HPA055421"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA042460: AB_10806240, HPA055421: "	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (7.60e-3)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (9.86e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.48e-2)"	12.8	6.4	4.5	6.7	5.0	15.0	11.2	3.1	7.5	14.0	2.3	13.1	14.4	9.3	1.1	45.6	9.4	7.0	10.3	4.7	4.9	13.9	20.1	16.5	6.9	5.1	5.1	7.3	10.3	2.9	6.1	4.4	4.7	9.4	3.2	0.4	13.5	3.3	19.7	21.5	14.5	3.3	4.6	11.9	15.7	1.8	5.1	2.6	8.2	4.1	4.4	10.1	17.4	4.5	34.9	6.7	0.1	5.8	4.9	6.2	3.1	11.2	11.4	8.8	9.8	6.9	12.2	23.5	6.2	12.9	8.8	23.1	3.2	11.8	3.4	25.4	6.2	5.9	13.7	6.7	13.5	2.1	14.7	10.1	14.4	11.0	8.0	6.8	9.2	8.1	12.9	4.9	4.8	13.0	6.0	1.2	1.0	6.2	26.5	13.2	1.4	15.4	8.0	10.7	4.6	8.5	6.9	20.4	11.4	0.0	9.2	4.9	18.5	10.7	7.3	27.4	17.1	19.6	18.5	16.7	12.5	8.1	8.4	6.8	4.1	1.8	1.7	5.4	1.5	3.4	1.7	2.0	3.6	2.8	1.1	0.7	1.2	1.2	7.1	2.5	2.1	5.1	4.5	5.0	3.1	7.5	4.7	4.9	5.1	5.1	4.7	4.6	5.1	4.5	10.5	6.4	9.6	3.9	12.4	69.3	67.0	20.0	23.9	0.9	19.4	13.6	2.5	21.5	18.5	5.5	0.0	6.3	3.7	156.9	7.9	29.9	0.1	27.0	7.6	14.4	29.2	4.2	3.9	17.5	11.7	11.0	42.3	56.2	10.8	4.6	11.7	13.4	12.8	1.7	3.2	39.2	10.2	14.0	52.6	0.3	3.7	22.1	14.2	1.9	17.7	0.8	7.2	3.0	1.4	51.8	146.3	5.3	18.6	57.5	55.8	9.2	16.3	0.2	6.6	4.6	5.8	0.3	1.4	27.3	71.2	3.4	9.8	3.4	26.2	134.3
TICRR	"C15orf42, FLJ41618, MGC45866, SLD3, Treslin"	ENSG00000140534	"TOPBP1 interacting checkpoint and replication regulator"	Q7Z2Z1	15	89575469-89631056	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.4;esophagus: 4.2;lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 6.5;Extravillous trophoblasts: 6.0;Granulosa cells: 5.1;Spermatocytes: 5.4;Spermatogonia: 5.3;Squamous epithelial cells: 8.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046746, HPA049454"			Supported	Nucleoplasm		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA046746: AB_2732533, HPA049454: AB_2680773"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-5)"	"unprognostic (7.73e-3)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (1.64e-1)"	"unprognostic (1.31e-4)"	"unprognostic (5.87e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.54e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.59e-2)"	0.3	0.1	0.1	1.0	0.1	3.4	0.3	0.0	0.0	0.5	0.0	0.8	1.0	0.4	0.0	4.2	0.3	0.1	0.1	0.0	0.0	0.1	0.1	0.2	1.4	0.1	0.0	0.3	0.0	0.0	0.1	0.9	0.0	0.2	1.1	0.1	0.5	0.0	0.0	0.5	0.9	0.2	0.1	0.5	0.4	1.5	0.2	4.2	0.1	0.0	1.8	0.3	1.1	0.0	11.0	15.0	19.0	11.0	0.7	1.5	10.7	8.0	3.7	11.0	11.4	16.4	8.4	14.7	4.2	2.6	9.2	21.5	26.3	7.0	10.0	7.4	25.4	21.9	15.5	8.7	0.1	15.8	7.6	0.4	0.5	9.0	6.6	1.6	5.5	12.8	21.3	16.6	6.4	10.4	13.9	13.3	12.7	11.0	7.6	19.6	17.1	11.8	2.6	15.5	8.1	8.0	19.0	10.6	3.1	13.9	7.9	10.5	3.3	11.9	14.8	24.4	16.5	3.9	8.0	12.3	4.1	13.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.2	1.2	0.0	0.3	0.8	1.4	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.0	1.7	0.1	0.3	0.3	0.0	6.5	0.4	0.0	6.0	0.5	2.0	0.3	0.0	5.1	0.0	0.0	1.3	0.0	0.6	1.6	0.0	0.0	0.7	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.1	0.0	2.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	5.4	5.3	8.6	0.1	1.0	0.1	0.1	1.6	0.1
TIFA	"MGC20791, T2BP, T6BP, TIFAA"	ENSG00000145365	"TRAF interacting protein with forkhead associated domain"	Q96CG3	4	112274537-112285904	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 86.6;Syncytiotrophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 137.4;U-698: 123.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045889	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA045889: AB_10963785"	"unprognostic (2.41e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.49e-3)"	6.4	6.3	2.0	19.9	1.8	40.6	13.7	4.3	2.1	7.7	4.3	7.0	6.7	5.6	2.1	15.6	6.8	7.5	10.7	2.3	2.4	5.2	11.3	10.2	32.2	2.3	2.1	9.3	41.3	11.5	2.1	14.2	2.5	6.7	6.9	2.8	34.8	3.7	3.8	9.3	8.8	5.3	2.1	11.7	10.3	2.1	2.3	15.4	21.1	6.4	34.6	11.6	7.7	2.3	21.9	5.5	7.9	13.4	9.5	7.7	15.9	17.0	32.0	10.6	18.1	2.8	19.1	66.3	13.5	6.8	15.5	6.3	10.9	13.0	22.1	54.1	6.4	6.6	12.4	6.2	6.4	21.2	8.8	10.4	7.0	11.4	12.3	18.0	17.0	18.1	6.8	137.4	14.3	11.0	37.3	11.5	1.6	13.4	7.0	63.7	19.9	44.7	23.6	14.7	18.1	18.6	13.7	28.2	6.6	3.4	12.2	29.9	12.7	16.7	19.8	14.2	13.6	85.3	84.8	123.8	15.7	13.8	12.6	6.8	7.2	4.0	11.1	5.2	18.1	38.2	20.4	19.4	13.2	40.4	9.0	11.6	21.4	17.4	6.8	12.3	33.9	11.3	2.0	1.8	4.3	2.1	2.3	2.4	2.3	2.1	2.5	2.1	2.3	2.3	35.7	19.2	27.4	0.0	44.8	21.3	15.7	27.8	43.9	1.4	31.6	30.9	15.4	12.8	15.7	12.9	0.0	47.9	23.4	4.4	19.6	16.5	0.1	10.0	9.6	31.8	9.0	7.6	1.4	24.4	20.9	22.3	14.8	21.0	3.8	5.4	6.4	10.7	17.8	0.0	0.6	8.4	28.5	13.0	29.7	1.4	9.0	13.1	33.8	2.8	7.1	12.5	11.3	0.5	0.1	11.4	8.0	10.9	86.6	29.2	11.0	9.5	8.8	0.6	6.6	27.2	10.5	2.5	3.8	39.2	26.0	79.4	35.9	5.7	7.0	15.1
TIGD1	EEYORE	ENSG00000221944	"Tigger transposable element derived 1"	Q96MW7	2	232543883-232550557	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041717	Approved		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies"	"HPA041717: AB_2677636"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.40e-2)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (3.77e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-3)"	1.8	2.3	6.3	2.3	5.3	6.5	2.7	13.4	7.8	3.2	5.4	2.8	1.9	2.6	2.9	2.8	3.8	1.9	2.4	5.0	4.5	7.4	2.7	2.5	3.4	3.2	2.4	5.7	2.9	1.6	5.0	2.0	4.1	4.4	2.1	10.4	2.7	1.7	4.0	4.2	3.6	1.3	1.5	6.1	3.3	5.2	4.5	3.3	4.7	1.4	2.2	2.8	3.0	9.7	3.1	2.3	4.7	7.5	1.7	2.3	3.6	2.1	1.2	2.6	2.9	2.8	3.6	5.0	1.5	1.6	2.8	3.2	4.1	1.3	3.8	3.0	3.9	4.5	7.7	3.5	1.1	3.6	2.9	2.6	1.2	2.6	1.6	2.5	1.5	6.5	3.6	5.0	2.1	5.3	4.9	8.3	2.8	1.9	2.7	4.7	6.3	2.3	1.5	3.5	6.1	6.0	2.2	2.1	2.3	3.3	3.1	3.9	2.5	4.3	4.5	2.7	2.1	4.8	3.4	4.5	2.5	3.6	2.6	1.6	1.7	1.8	1.9	1.4	1.9	1.7	2.0	1.5	1.1	2.1	3.1	2.5	2.3	1.8	1.5	1.2	1.6	0.7	6.3	5.3	13.4	7.8	5.0	4.5	3.2	2.4	4.1	1.5	4.5	9.7	2.4	9.6	3.9	4.2	5.3	1.3	4.5	2.3	1.8	4.9	2.5	2.2	2.0	1.5	2.9	3.7	8.4	2.2	3.1	1.7	0.0	3.6	4.2	1.0	3.6	1.7	1.2	6.5	4.5	1.5	1.3	3.1	7.7	1.5	0.0	6.4	1.4	0.7	1.4	6.7	5.7	1.5	2.0	1.6	1.7	0.7	4.7	2.4	1.8	1.0	2.8	7.5	5.2	5.0	8.1	2.0	2.4	1.9	5.6	2.6	3.5	1.4	1.7	7.0	6.6	3.7	2.0	3.9	5.7	3.7	2.0	1.4	4.1	4.0	3.0	2.9
TIGD3		ENSG00000173825	"Tigger transposable element derived 3"	Q6B0B8	11	65354751-65357613	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5;intestine: 2.5;testis: 5.0"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 9.6;Spermatocytes: 40.5;Spermatogonia: 13.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 7.7;eosinophil: 10.9;neutrophil: 17.5"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 17.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA040016			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA040016: AB_10805600"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.48e-4)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-3)"	0.1	0.2	1.2	0.2	1.7	0.5	0.1	2.5	2.1	0.1	0.5	0.2	0.8	0.1	0.2	0.2	0.1	0.1	0.4	1.2	1.0	0.3	0.2	0.2	0.4	1.1	1.2	0.3	0.5	0.4	1.2	0.1	1.0	0.2	0.1	0.9	0.3	0.1	0.2	0.1	2.5	0.0	1.1	1.0	0.3	5.0	1.1	1.3	0.1	0.3	0.2	0.1	0.1	1.2	0.8	1.6	1.3	3.5	0.0	0.0	0.5	0.0	0.1	0.3	0.4	1.2	0.2	0.6	0.5	0.1	0.6	0.8	1.3	0.0	0.1	1.1	1.4	0.2	0.9	2.8	0.0	0.5	2.6	0.0	0.1	0.1	0.0	0.0	0.2	1.3	0.9	1.8	0.0	2.1	1.7	1.1	0.7	0.7	0.6	2.5	0.6	2.4	0.0	0.8	3.9	2.4	1.0	1.5	0.6	0.1	2.5	0.8	0.0	0.1	0.6	0.9	0.6	3.7	2.5	0.8	0.0	1.1	0.4	7.7	0.6	10.9	0.0	0.3	0.0	0.4	0.0	0.0	1.0	0.2	0.2	0.0	17.5	0.1	1.5	1.5	0.0	0.2	1.2	1.7	2.5	2.1	1.2	1.0	1.1	1.2	1.0	1.1	1.1	1.2	1.0	0.0	1.1	0.7	4.5	1.5	0.4	0.5	5.7	4.0	1.7	0.9	2.6	0.0	0.3	0.0	0.0	0.4	4.0	0.4	0.0	1.1	4.3	1.0	0.3	0.6	0.0	2.7	0.7	0.6	0.3	0.4	1.1	1.1	0.0	2.9	0.0	0.4	0.3	0.0	1.0	0.6	0.0	0.6	5.7	2.2	0.0	1.3	1.8	1.0	1.9	1.1	0.0	1.0	0.4	0.4	0.1	0.4	3.0	0.8	9.6	0.9	0.6	3.4	0.0	1.2	0.8	40.5	13.5	3.5	1.6	0.8	1.0	0.7	1.1	0.1
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779730	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 22.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 107.6;Rod photoreceptor cells: 30.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.1;U-266/70: 4.5;U-266/84: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035649, HPA073768"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"HPA035649: AB_10670956, HPA073768: "	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.2	0.3	0.6	0.2	0.7	0.0	0.4	0.6	0.7	0.8	1.3	0.2	0.3	0.7	1.2	0.1	2.0	0.2	0.3	0.5	0.9	0.7	0.1	0.4	0.1	1.1	1.2	0.5	0.2	1.5	1.2	0.1	0.8	0.4	0.2	22.1	0.7	0.3	0.4	0.4	0.2	0.2	1.0	0.2	0.3	4.9	0.8	0.3	0.7	0.8	0.1	0.2	0.1	0.8	0.4	0.4	2.0	0.8	0.1	0.2	0.2	0.0	0.4	0.2	0.4	0.3	0.9	0.7	0.1	0.1	0.9	0.4	0.8	0.3	0.3	0.7	0.1	1.0	0.6	0.2	0.1	0.4	0.2	0.0	0.3	0.3	0.2	0.4	0.1	1.5	0.3	3.1	0.2	0.2	2.0	0.2	0.9	0.3	0.3	0.3	0.4	0.0	1.3	0.1	0.9	1.0	0.1	0.2	1.9	0.9	0.5	0.1	0.0	0.2	0.4	0.3	0.4	4.5	9.4	0.4	0.6	1.1	1.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.6	0.7	0.5	0.9	1.1	1.2	0.8	1.0	0.8	0.8	0.4	0.0	1.5	8.5	0.6	0.0	0.4	0.6	0.6	7.9	0.8	0.8	0.1	0.0	0.3	1.8	12.5	0.2	0.8	0.2	0.0	0.7	107.6	6.9	0.6	0.7	1.2	0.4	6.5	1.1	0.2	0.4	1.1	1.4	0.0	0.2	0.0	0.1	0.5	1.7	6.3	0.4	0.0	0.3	0.0	14.0	0.3	0.5	0.0	5.6	0.0	14.1	0.0	5.5	2.1	0.4	1.1	0.4	0.0	0.4	0.4	2.0	9.3	30.3	0.0	1.0	0.5	8.3	3.2	0.0	0.0	0.3	0.6	0.1	0.4	0.3
TIGD6	DKFZp761E2110	ENSG00000164296	"Tigger transposable element derived 6"	Q17RP2	5	149993118-150000654	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044599	Uncertain		Approved	"Nucleoplasm,Vesicles,Actin filaments"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Actin filaments"	"HPA044599: AB_10961286"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.30e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.85e-2)"	"prognostic favorable (5.88e-4)"	"unprognostic (1.94e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.18e-1)"	2.6	3.6	2.1	1.7	2.4	1.3	4.7	2.7	2.4	2.5	2.6	2.8	2.2	2.4	5.1	1.7	3.1	2.3	2.0	2.0	2.3	3.6	2.8	2.4	1.9	2.2	2.3	3.9	3.2	11.2	2.6	2.6	2.2	4.1	2.5	3.5	3.1	3.0	1.4	2.7	2.0	2.6	2.1	2.1	2.9	4.0	2.2	2.3	3.0	2.2	2.0	2.4	1.7	2.5	2.1	5.7	3.8	8.2	10.7	8.8	5.9	6.0	6.3	4.6	4.6	3.7	3.7	1.0	5.3	7.1	5.7	3.7	3.4	4.4	5.4	4.7	2.8	1.8	3.1	2.0	9.5	2.6	4.4	9.0	8.3	5.9	7.7	5.4	3.6	4.1	2.5	4.7	5.8	5.0	3.4	1.2	1.5	2.7	4.8	3.9	4.3	2.7	4.4	3.0	2.9	3.8	4.2	6.7	9.1	4.6	7.5	4.5	4.9	3.7	2.8	4.1	4.5	3.5	1.4	2.7	5.9	2.8	5.9	0.0	2.2	1.2	1.5	2.3	1.3	1.4	2.0	1.5	1.9	1.7	4.2	2.6	0.0	3.4	1.3	1.0	2.2	1.5	2.1	2.4	2.7	2.4	2.0	2.3	2.2	2.3	2.2	2.1	2.2	2.5	3.1	12.8	2.7	1.3	2.2	2.2	6.6	2.9	2.2	6.2	5.4	3.7	5.4	4.3	4.7	3.7	0.0	5.2	2.6	2.0	7.9	5.1	1.2	2.9	3.5	2.7	3.0	0.4	1.4	4.7	2.7	3.5	7.1	3.6	3.8	4.6	3.3	1.8	4.2	3.3	1.6	2.6	6.1	1.9	1.9	2.1	4.4	2.6	3.6	2.8	4.8	6.3	1.0	4.5	5.6	4.3	1.9	3.4	3.8	5.7	3.1	7.9	3.6	6.3	0.0	2.1	3.8	20.0	8.7	2.6	1.1	3.6	2.2	6.8	2.0	4.9
TIMELESS	"hTIM, TIM, TIM1"	ENSG00000111602	"Timeless circadian regulator"	Q9UNS1	12	56416363-56449426	"Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.5;Spermatogonia: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA060655	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA060655: AB_2684338"	"unprognostic (3.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.03e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (9.47e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.01e-2)"	3.4	3.4	1.6	11.0	2.1	22.0	4.5	2.1	2.1	4.1	2.7	6.7	6.0	4.4	2.5	6.8	3.1	3.3	1.8	1.5	2.1	3.8	9.8	4.1	15.3	2.4	2.4	1.9	5.0	5.9	5.4	8.7	2.5	3.2	8.5	13.7	3.9	3.4	3.4	5.5	6.2	5.6	2.1	6.8	5.5	6.2	2.6	19.8	4.7	1.6	17.9	4.7	3.9	2.5	39.4	89.1	111.4	51.9	9.9	9.9	62.8	41.9	25.3	58.3	46.0	45.6	56.5	113.3	41.5	24.5	29.4	32.8	82.0	32.7	53.5	54.2	45.7	86.9	47.6	33.6	5.1	66.2	62.2	6.9	10.3	41.9	25.2	16.0	31.5	67.3	82.7	99.5	49.8	77.2	94.7	51.2	79.2	49.5	36.8	93.5	56.7	55.5	22.7	49.5	85.4	58.9	78.2	43.9	12.2	45.6	77.4	51.8	18.9	45.3	45.1	41.8	35.0	37.3	50.9	62.8	21.1	39.9	55.5	0.1	0.6	0.4	1.8	1.5	0.3	3.3	1.1	1.2	1.0	4.9	0.8	0.3	0.2	1.5	1.1	1.2	1.5	1.1	1.6	2.1	2.1	2.1	1.5	2.1	2.4	2.4	2.5	2.1	2.6	2.5	2.6	0.0	5.0	2.3	8.2	3.3	3.0	3.0	6.8	57.5	3.1	3.4	2.1	2.8	6.8	7.3	2.1	15.9	1.8	2.7	0.0	4.8	6.9	2.5	3.9	5.0	1.8	16.6	0.9	5.7	20.9	3.7	6.6	4.8	5.7	15.5	4.6	10.6	8.5	6.7	1.3	5.2	4.1	2.6	3.7	2.9	1.2	4.6	0.0	1.9	4.2	4.8	4.1	0.5	3.2	3.7	0.6	1.2	18.2	4.2	1.1	2.0	3.4	17.8	0.0	2.7	7.0	1.6	24.5	12.1	1.4	9.2	6.1	3.2	8.5	3.0
TIMM17A	"TIM17, TIM17A"	ENSG00000134375	"Translocase of inner mitochondrial membrane 17A"	Q99595	1	201955503-201970664	"Cancer-related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 265.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010083	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Mitochondria"		"HPA010083: AB_10602899"	"prognostic unfavorable (1.98e-5)"	"unprognostic (3.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.81e-1)"	31.4	48.3	29.3	35.4	30.6	36.8	29.3	31.2	35.8	27.4	34.9	35.2	31.4	25.7	41.1	31.9	20.9	19.0	72.2	31.3	32.5	42.2	80.6	23.7	30.9	30.2	30.6	18.5	23.4	55.8	24.8	31.3	31.0	25.0	38.0	33.3	23.0	28.4	86.1	20.9	23.9	35.3	30.5	24.9	29.1	19.7	30.7	30.3	38.2	94.9	35.8	42.8	23.2	29.4	89.1	88.9	78.5	94.9	64.5	67.2	132.5	138.4	98.0	110.5	98.4	104.8	89.7	122.5	49.7	118.6	81.1	69.2	145.3	82.4	118.3	90.4	90.7	67.7	119.1	99.7	66.7	145.5	69.5	78.0	89.8	113.2	93.9	79.5	117.4	75.4	173.1	66.7	131.7	56.9	78.9	78.3	99.6	88.3	47.0	76.5	91.4	152.6	136.2	83.1	118.0	83.2	84.6	213.5	130.7	98.7	118.5	97.0	95.2	73.6	78.7	86.7	146.4	99.9	115.9	102.3	78.4	109.2	84.2	18.5	32.0	29.2	21.7	44.5	28.6	30.3	23.5	28.1	50.1	23.6	22.4	26.2	7.7	29.7	46.7	33.6	37.0	32.2	29.3	30.6	31.2	35.8	31.3	32.5	30.2	30.6	31.0	30.5	30.7	29.4	31.7	38.5	37.2	9.4	54.7	92.2	100.2	123.3	34.1	24.1	43.2	36.2	129.5	37.1	73.0	38.6	35.5	115.2	44.2	38.8	137.0	94.5	69.7	40.1	55.2	46.0	34.0	36.6	18.1	86.0	187.0	55.9	40.2	48.1	55.2	37.9	32.9	168.0	114.8	35.3	17.4	58.1	81.4	44.0	177.7	32.0	33.5	52.8	53.4	4.7	80.4	49.4	26.8	6.6	14.9	109.4	30.4	38.4	98.6	85.0	37.2	131.8	55.8	31.7	26.3	46.6	75.3	42.6	61.5	60.6	98.9	265.6	46.2	62.9	58.3	118.1
TIMM29	"C19orf52, TIM29"	ENSG00000142444	"Translocase of inner mitochondrial membrane 29"	Q9BSF4	19	10928811-10933535	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.0;Ductal cells: 21.6;Extravillous trophoblasts: 31.4;Hofbauer cells: 22.4;Proximal tubular cells: 22.1;Syncytiotrophoblasts: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041858	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA041858: AB_10963429"	"unprognostic (8.45e-2)"	"prognostic favorable (9.93e-5)"	"unprognostic (8.99e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-3)"	"prognostic favorable (7.03e-7)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.26e-3)"	8.4	11.7	4.6	5.4	4.5	10.1	8.4	3.7	6.1	10.4	3.5	11.0	8.0	11.0	1.1	14.9	9.0	3.1	13.5	4.9	3.8	11.5	12.2	8.1	6.0	5.8	4.3	7.9	9.9	3.3	10.7	4.6	4.2	10.1	2.0	1.1	10.1	3.8	23.5	13.9	9.7	2.1	3.8	10.7	11.0	13.0	4.2	5.3	7.5	5.9	2.8	10.5	11.4	4.7	21.3	8.0	6.2	10.4	5.3	5.1	16.7	14.3	7.6	10.7	9.9	14.7	7.0	18.0	24.7	7.0	5.8	20.1	3.3	8.9	1.8	21.3	25.0	20.7	8.4	10.0	8.4	15.8	15.5	4.5	8.6	7.5	3.2	4.3	6.5	15.7	23.1	15.4	4.1	19.0	17.4	29.1	21.8	6.6	34.0	23.4	8.7	22.3	4.7	8.6	15.6	15.8	16.9	9.1	18.3	2.3	13.1	16.7	10.7	17.1	10.0	21.6	23.1	49.7	52.8	19.8	10.6	19.3	14.8	3.7	8.7	9.8	5.3	9.3	8.9	17.9	10.6	11.7	5.8	15.0	10.1	8.3	1.7	11.3	7.4	11.0	12.8	3.8	4.6	4.5	3.7	6.1	4.9	3.8	5.8	4.3	4.2	3.8	4.2	4.7	6.9	3.2	5.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	9.6	8.4	0.0	0.0	1.3	16.5	0.0	36.0	13.8	0.0	19.6	21.6	0.0	9.6	10.9	4.9	0.0	0.0	0.0	10.5	31.4	5.2	0.0	9.2	1.3	10.5	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	2.4	0.0	0.0	22.1	0.7	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	35.7	5.5	14.7	0.0	0.0
TIMM50	"TIM50, TIM50L"	ENSG00000105197	"Translocase of inner mitochondrial membrane 50"	Q3ZCQ8	19	39480412-39493785	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"	RNA-binding	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 185.5;Late spermatids: 662.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048843, HPA056448"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA048843: , HPA056448: AB_2683137"	"unprognostic (1.49e-1)"	"unprognostic (6.97e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.04e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.04e-2)"	37.3	37.2	31.2	30.4	33.7	45.4	29.7	34.3	44.2	27.7	31.5	32.2	30.4	33.2	11.2	35.8	27.9	18.5	75.7	35.0	35.0	32.9	43.9	25.7	27.7	35.0	32.8	27.4	35.3	36.2	22.7	25.2	33.0	27.4	15.4	8.9	32.0	17.5	127.0	26.6	29.6	23.0	30.6	26.2	31.8	80.5	32.9	21.6	31.7	76.6	18.2	30.9	26.1	33.1	147.2	365.3	59.6	155.1	43.8	33.4	116.8	115.8	54.2	119.6	97.4	262.6	96.6	156.5	126.0	67.9	71.9	81.6	100.9	114.8	56.4	148.7	170.8	140.3	94.5	197.3	81.5	282.8	106.6	51.9	73.2	97.2	78.7	33.9	76.4	184.5	237.8	91.3	77.2	202.9	178.4	110.5	113.7	159.2	123.3	190.8	112.5	119.3	88.1	195.5	166.3	99.4	133.6	190.0	251.8	35.7	89.1	168.0	86.4	154.7	165.6	140.1	262.7	96.1	181.1	232.8	117.9	146.7	179.2	42.5	53.7	13.4	36.3	58.5	34.9	41.8	34.1	40.0	60.5	46.4	41.4	35.7	5.9	45.2	58.1	47.0	47.8	62.1	31.2	33.7	34.3	44.2	35.0	35.0	35.0	32.8	33.0	30.6	32.9	33.1	20.0	22.4	26.0	4.6	19.3	26.0	43.6	57.4	18.8	10.4	23.8	28.7	47.6	24.3	37.6	25.8	12.5	83.8	14.7	27.4	66.5	56.3	185.5	19.8	24.2	28.6	23.4	29.6	8.7	51.8	84.4	30.9	25.0	21.5	39.3	29.5	19.2	31.3	67.1	28.6	9.3	27.5	48.8	18.8	27.7	662.8	23.3	22.3	30.2	3.7	22.1	17.4	21.6	6.6	4.9	50.9	22.2	21.1	34.6	68.0	35.7	66.0	22.1	11.4	6.6	27.2	55.7	111.5	46.5	32.3	26.7	94.5	19.9	34.1	48.1	47.6
TIMMDC1	"C3orf1, FLJ22597"	ENSG00000113845	"Translocase of inner mitochondrial membrane domain containing 1"	Q9NPL8	3	119498547-119525090	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053214, HPA055846"	Uncertain		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA053214: AB_2682081, HPA055846: AB_2682941"	"unprognostic (3.95e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (9.60e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-1)"	10.5	12.0	13.4	10.7	14.3	6.3	13.1	14.2	15.4	15.0	13.2	11.3	8.9	9.3	17.9	15.9	12.8	14.4	44.0	12.7	13.9	17.8	14.2	11.0	17.7	14.3	13.6	10.9	11.1	23.1	7.1	17.1	13.9	13.0	13.7	4.2	14.6	19.7	27.3	15.8	7.7	12.1	14.0	9.9	8.5	10.6	14.1	11.4	19.1	49.2	14.8	14.2	7.0	14.6	26.9	24.5	12.4	10.4	45.5	30.6	27.0	7.7	25.3	21.7	24.7	16.7	16.0	19.5	13.7	27.1	15.1	12.2	30.8	24.8	35.0	16.4	10.9	14.4	10.7	18.8	23.9	11.3	9.1	28.0	37.4	18.4	22.4	13.9	31.5	18.5	19.8	18.1	40.3	33.2	12.0	23.7	16.2	22.4	30.1	10.0	8.4	25.4	32.0	13.1	15.8	29.4	7.8	11.8	28.0	16.2	19.5	30.4	16.1	12.2	9.3	11.3	13.8	12.1	11.8	28.3	20.7	28.5	19.6	11.1	17.6	21.3	10.8	17.6	12.5	16.2	10.4	12.0	17.4	17.6	12.2	10.9	4.3	13.1	20.9	15.1	20.7	22.1	13.4	14.3	14.2	15.4	12.7	13.9	14.3	13.6	13.9	14.0	14.1	14.6	61.2	25.6	39.3	18.6	24.0	37.5	50.4	110.2	31.3	25.0	44.8	55.0	165.3	41.5	63.7	40.5	14.6	157.5	28.9	44.0	150.6	73.2	12.2	39.9	41.1	56.0	28.8	43.1	17.4	62.7	112.7	48.2	29.0	31.1	41.2	34.1	31.8	52.4	86.3	21.9	23.9	43.5	87.5	32.7	40.4	10.0	47.2	39.4	44.4	15.0	65.7	73.6	18.6	22.6	35.6	52.7	40.9	54.5	30.2	43.5	50.5	146.5	63.0	35.4	72.3	43.9	52.5	111.1	58.2	45.9	42.1	177.5	29.7	48.0	45.7	46.7
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: AB_2682486"	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	4.3	4.3	1.5	4.9	1.4	2.9	4.5	3.1	2.4	5.4	3.6	5.3	7.6	4.5	2.5	4.4	5.3	4.5	5.3	1.3	2.1	3.9	6.3	4.2	4.1	1.9	1.8	8.0	4.7	7.2	3.6	4.9	2.1	5.7	5.5	3.1	8.0	6.4	5.3	4.3	6.9	4.7	1.0	5.0	4.3	1.5	1.6	3.1	4.8	4.9	5.1	4.5	3.3	1.1	2.2	7.0	3.7	6.2	6.2	8.5	4.4	5.7	9.3	3.9	3.7	11.0	8.3	5.7	9.6	5.9	6.9	6.2	3.9	4.4	1.5	15.3	3.7	15.4	4.2	7.1	4.9	9.6	7.9	6.4	6.0	7.4	5.1	4.7	6.5	4.6	4.2	12.9	4.6	4.0	0.3	1.5	1.7	15.9	6.3	2.0	1.0	5.4	3.1	7.8	4.6	5.8	6.8	6.7	4.6	4.8	18.2	4.9	6.5	2.2	2.1	4.5	4.3	3.6	5.6	4.2	3.4	7.5	7.0	5.3	5.8	2.9	4.0	4.5	3.7	2.1	3.1	4.2	4.6	3.8	2.5	2.4	4.9	2.6	3.2	3.2	3.5	3.7	1.5	1.4	3.1	2.4	1.3	2.1	1.9	1.8	2.1	1.0	1.6	1.1	1.7	6.4	2.6	2.3	3.7	0.4	1.8	2.0	4.0	3.5	2.7	2.0	1.3	2.8	2.8	3.7	0.0	3.4	2.2	4.2	0.0	3.3	0.0	1.1	2.3	3.2	1.2	0.8	3.7	4.0	4.9	2.7	2.0	1.7	1.3	2.0	2.5	4.8	5.2	3.3	5.0	3.9	2.0	4.4	0.8	0.3	4.7	3.7	1.8	3.7	2.1	3.6	4.1	3.0	1.8	3.6	8.1	4.5	9.2	2.0	6.5	2.2	1.6	2.5	0.0	2.0	2.5	0.1	0.6	3.5	0.1	2.6	4.2	2.3	2.4	1.5
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69274615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 212.4;Rod photoreceptor cells: 267.6;Urothelial cells: 244.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 237.5"	"Low region specificity"	"Detected in all"							"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		580000	"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161"	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favorable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	44.4	14.9	35.1	11.6	45.3	12.0	30.2	44.5	42.6	16.9	25.7	39.0	54.4	19.8	13.1	45.8	23.8	24.4	35.8	38.0	45.4	44.7	64.8	47.6	9.7	52.6	39.9	37.0	21.9	57.9	5.3	18.4	52.6	24.8	35.1	122.0	37.1	21.9	14.1	35.0	49.6	16.1	55.0	5.7	58.3	32.1	39.9	32.5	44.9	15.1	23.1	55.3	22.3	66.3	237.5	6.4	24.4	25.8	92.9	90.3	108.5	37.3	26.7	54.9	29.0	31.8	106.6	33.0	37.0	20.3	31.4	158.3	33.2	79.3	75.9	115.3	20.7	34.5	22.5	165.2	28.9	13.8	59.1	71.3	65.2	43.1	32.4	19.6	143.6	9.9	19.7	24.7	34.3	36.0	5.5	2.3	49.5	194.5	50.0	23.1	26.9	2.9	192.0	194.2	8.3	14.9	13.3	111.2	3.4	55.7	37.0	7.9	196.3	44.3	48.3	32.4	38.6	23.0	5.2	0.9	48.0	19.6	16.1	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.8	0.1	35.1	45.3	44.5	42.6	38.0	45.4	52.6	39.9	52.6	55.0	39.9	66.3	2.9	44.8	22.8	76.4	2.3	65.1	79.1	26.3	4.6	212.4	4.6	1.3	38.5	40.0	33.1	3.7	35.5	27.9	2.7	74.4	0.0	32.5	3.5	7.1	1.7	36.4	11.5	10.5	10.1	24.3	25.6	15.5	64.2	9.9	5.7	0.2	27.5	104.9	5.6	18.5	13.4	45.0	36.7	14.6	28.9	6.7	29.2	8.2	28.4	22.5	9.0	111.1	1.0	21.6	82.5	44.2	65.8	13.9	5.2	115.4	73.4	1.9	51.3	267.6	0.0	4.9	13.1	19.6	18.0	40.6	64.1	43.2	3.2	0.2	50.3	244.5
TJP3	ZO-3	ENSG00000105289	"Tight junction protein 3"	O95049	19	3708362-3750813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.0;stomach 1: 27.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 238.7;Early spermatids: 405.1;Paneth cells: 140.4;Proximal enterocytes: 130.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 1.2;MAIT T-cell: 3.9;memory CD4 T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD4 T-cell: 3.3;naive CD8 T-cell: 1.2;T-reg: 3.8"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 44.0;CAPAN-2: 41.1;MCF7: 20.3;OE19: 37.4;SK-BR-3: 25.7;T-47d: 52.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB013244, HPA046863, HPA053337"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cell Junctions"		"CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (2.78e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.36e-8)"	"unprognostic (8.58e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.62e-3)"	0.2	0.0	0.2	4.7	0.1	0.1	4.0	0.1	0.4	6.3	7.4	34.1	43.0	1.5	2.4	25.5	13.7	6.2	0.0	0.4	0.1	5.8	7.1	5.2	0.4	0.2	0.4	0.1	6.4	7.5	1.7	1.6	0.2	4.0	13.2	0.1	20.8	5.3	0.7	7.3	37.4	0.5	0.0	0.5	27.0	2.5	0.0	0.2	6.9	0.0	2.6	4.1	6.0	0.3	0.3	8.3	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	13.0	41.1	8.2	1.3	0.0	0.1	10.4	0.6	0.0	0.0	0.5	0.2	0.0	0.7	2.9	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.3	0.0	20.3	0.0	0.3	0.9	37.4	0.2	0.1	0.0	6.2	1.4	6.8	0.2	0.2	1.6	25.7	0.0	3.3	52.2	0.2	0.0	0.1	1.0	0.1	0.0	1.7	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	3.9	0.4	3.1	2.4	0.0	0.6	3.3	1.2	0.0	0.0	0.0	0.0	3.8	1.2	0.2	0.1	0.1	0.4	0.4	0.1	0.2	0.4	0.2	0.0	0.0	0.3	0.1	9.6	13.7	0.3	1.9	0.0	7.0	21.0	0.0	0.0	20.3	6.3	0.9	34.3	42.1	31.3	0.0	32.1	0.8	238.7	19.6	21.1	405.1	31.2	1.1	0.5	12.5	0.0	0.9	23.6	4.2	0.6	52.5	13.2	4.5	0.1	0.0	7.3	2.7	0.0	0.9	50.9	24.4	0.3	0.3	36.5	1.8	0.8	3.6	0.0	0.1	0.0	0.0	0.5	1.4	21.8	140.4	1.2	0.2	6.5	130.4	8.0	86.1	0.0	0.0	0.0	3.4	4.3	4.8	8.0	0.1	40.2	4.3	0.0	62.1	25.6
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333220-61353295	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Lyase, Multifunctional enzyme, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 192.8;liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 115.9;Proximal enterocytes: 415.8;Proximal tubular cells: 91.2;Theca cells: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 133.2;RPMI-8226: 140.7;T-47d: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		6800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Nucleoplasm	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	9.5	82.8	5.9	9.4	6.0	16.6	12.1	5.8	6.6	9.5	5.7	12.5	192.8	11.0	7.6	16.3	15.4	9.2	7.6	6.4	5.1	45.5	115.8	9.0	13.6	6.8	6.3	10.3	24.0	6.7	14.0	6.1	6.2	12.2	5.7	5.6	16.2	8.9	10.9	17.8	138.0	5.2	6.5	13.0	16.6	28.2	6.0	7.5	14.7	5.6	8.0	10.9	11.0	7.2	19.9	51.3	8.5	30.0	10.7	11.4	24.2	11.7	12.4	10.4	6.9	23.1	47.1	25.0	39.3	8.5	11.0	27.7	16.3	21.8	3.5	42.5	21.7	15.7	26.2	133.2	17.9	13.4	25.0	18.2	14.5	9.9	35.4	9.4	10.7	17.1	27.2	46.7	7.9	91.8	11.9	11.9	23.8	19.2	33.8	20.0	13.8	140.7	17.1	35.0	33.0	29.6	21.0	36.4	19.3	6.0	135.4	9.2	13.0	21.0	21.6	16.6	7.0	85.8	76.5	22.9	21.3	12.3	19.7	2.6	13.4	6.5	7.1	7.8	9.6	10.3	8.3	7.1	21.2	9.7	5.8	6.2	1.2	6.5	6.5	10.1	12.9	9.7	5.9	6.0	5.8	6.6	6.4	5.1	6.8	6.3	6.2	6.5	6.0	7.2	8.0	0.0	14.5	0.0	9.5	0.0	13.8	0.0	11.4	12.8	19.1	16.0	3.8	11.5	6.8	14.7	14.6	31.2	8.3	4.8	29.4	19.6	16.2	16.4	6.6	8.0	13.3	7.8	0.0	14.6	6.2	11.2	20.4	12.1	7.6	10.8	7.5	115.9	17.1	8.4	0.0	31.6	0.0	17.2	0.0	12.0	15.2	8.2	0.0	0.0	21.2	10.0	9.2	0.0	0.0	11.2	32.9	22.6	11.0	11.1	415.8	91.2	10.9	17.8	6.6	4.7	3.6	37.5	14.1	12.6	0.0	15.2	6.5	93.6	47.6	13.4
TKT		ENSG00000163931	Transketolase	P29401	3	53224712-53256052	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 667.0"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 696.7;monocytes: 624.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 447.9;eosinophil: 274.4;intermediate monocyte: 199.0;myeloid DC: 203.8;neutrophil: 375.3;non-classical monocyte: 242.6"	"Group enriched"	"Detected in all"	9	"dendritic cells: 203.8;granulocytes: 375.3;monocytes: 447.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		NA	NA		150000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	152.2	93.2	78.0	66.2	80.0	667.0	71.9	93.2	82.3	59.7	60.5	73.2	84.2	44.7	19.2	168.5	53.7	97.2	27.4	72.3	96.9	68.2	58.1	93.4	69.2	89.2	89.9	87.7	154.0	41.4	45.6	61.2	93.8	48.8	48.8	21.7	54.9	50.9	12.8	47.0	58.1	51.6	77.4	99.8	66.1	20.2	87.9	82.9	116.1	15.2	67.4	130.9	85.5	97.2	313.0	1542.9	216.0	241.5	470.8	570.8	439.5	206.2	353.8	348.8	330.8	430.1	779.3	388.5	96.8	302.9	673.3	438.3	377.9	775.8	102.4	131.0	210.3	259.6	1022.2	655.2	573.9	321.4	168.1	416.0	437.5	418.5	213.7	949.2	444.9	323.8	188.3	164.7	144.5	381.6	338.6	358.1	737.1	603.0	367.9	201.1	98.5	726.2	550.3	520.2	139.6	103.7	383.4	605.3	365.1	656.7	188.8	437.4	335.9	107.2	164.2	320.0	401.9	94.5	190.3	235.7	234.4	321.0	203.8	51.5	447.9	274.4	17.8	199.0	22.8	39.7	25.8	20.6	203.8	21.1	26.6	20.7	375.3	30.8	242.6	34.4	36.7	312.4	78.0	80.0	93.2	82.3	72.3	96.9	89.2	89.9	93.8	77.4	87.9	97.2	79.5	134.6	125.6	46.7	92.1	79.4	384.6	325.3	287.4	41.0	99.3	80.5	14.9	75.8	149.5	62.5	29.2	349.0	69.7	139.1	80.3	197.7	6.5	87.4	79.6	81.8	52.6	150.3	16.9	269.8	249.8	80.2	168.7	95.5	62.7	123.6	75.0	83.4	256.0	37.0	23.9	149.6	142.4	696.7	110.5	8.9	157.2	333.3	76.5	17.8	624.4	88.8	46.4	17.1	39.3	193.6	81.4	106.8	109.4	337.7	141.5	219.1	99.2	46.3	52.6	35.9	102.1	16.8	30.6	409.3	67.1	413.6	78.8	427.2	276.7	413.6
TLE1	"ESG, ESG1, GRG1"	ENSG00000196781	"TLE family member 1, transcriptional corepressor"	Q04724	9	81583683-81689547	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011482, HPA071396"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB011482: AB_443210, HPA071396: AB_2686392"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.59e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (4.09e-1)"	44.9	40.1	36.1	11.8	31.8	40.0	39.0	23.1	35.5	57.4	11.7	39.3	7.7	50.1	27.1	20.3	43.0	27.3	19.3	41.2	22.1	21.4	80.7	23.5	12.7	20.7	32.3	42.0	59.9	6.3	19.1	19.3	20.2	31.0	21.6	11.1	47.5	17.4	90.7	31.8	30.2	33.3	20.1	44.7	38.2	25.8	27.6	6.6	24.9	22.5	13.5	30.2	35.5	23.3	69.9	50.6	49.7	0.2	50.3	28.3	99.6	3.9	12.4	8.6	11.3	8.8	26.2	0.0	43.1	27.6	69.0	40.9	1.0	22.3	8.3	0.2	40.0	0.0	12.0	74.8	24.5	0.0	1.3	12.4	47.2	26.2	57.1	22.6	35.1	20.0	0.3	22.4	25.8	74.2	9.8	0.4	88.6	48.0	26.1	66.9	35.2	4.9	46.1	38.2	25.2	31.0	4.8	39.6	22.2	53.3	27.9	31.4	27.6	21.7	22.5	10.5	30.8	0.5	0.3	1.6	28.0	0.2	41.0	8.4	0.0	4.6	2.1	0.0	2.9	6.6	0.2	0.9	0.6	5.8	0.0	0.2	0.0	4.3	0.1	1.7	0.0	0.6	36.1	31.8	23.1	35.5	41.2	22.1	20.7	32.3	20.2	20.1	27.6	23.3	66.6	0.0	6.5	121.5	52.4	54.6	22.3	9.8	18.8	36.6	33.5	18.4	5.7	41.5	15.8	14.7	16.7	67.2	63.5	49.5	15.6	40.8	1.7	85.9	76.2	38.2	28.8	13.9	36.5	23.8	71.9	27.5	23.9	205.8	0.0	30.1	27.1	65.3	7.8	16.8	23.5	24.0	36.7	6.4	20.5	3.6	22.7	9.6	46.2	46.9	8.1	39.5	68.0	22.6	14.5	54.8	41.0	34.3	35.1	40.5	12.2	3.0	17.1	6.0	118.3	12.8	47.4	2.2	102.4	29.3	43.8	50.8	18.6	71.4	48.6	69.4
TLE3	"ESG, ESG3, GRG3, HsT18976, KIAA1547"	ENSG00000140332	"TLE family member 3, transcriptional corepressor"	Q04726	15	70047790-70098176	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 65.1"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 49.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 49.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054116	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA054116: AB_2682386"	"unprognostic (5.57e-2)"	"prognostic favorable (2.09e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.74e-1)"	16.1	6.4	9.2	18.3	11.5	65.1	15.2	10.7	10.9	17.4	2.9	20.6	17.3	10.8	3.0	31.1	10.1	5.8	9.9	12.3	15.3	16.4	13.3	20.3	17.7	15.1	13.9	14.0	14.9	5.8	10.3	12.6	11.8	23.2	6.4	4.9	19.1	10.1	8.3	29.4	21.8	6.9	13.4	23.1	15.7	22.1	15.1	13.5	13.5	2.9	18.9	9.8	19.4	12.2	7.8	24.2	13.3	23.6	12.1	9.9	80.3	1.5	4.1	3.1	2.5	34.0	22.8	22.0	32.8	2.1	4.8	14.3	32.3	11.5	1.6	30.9	45.9	36.9	50.8	6.6	11.5	11.4	51.1	20.5	6.3	9.1	8.2	19.7	15.5	47.9	26.1	96.0	4.5	20.9	41.2	28.3	14.2	7.4	24.9	36.8	13.6	24.7	7.1	41.7	19.5	28.7	66.2	29.7	28.7	14.5	33.6	24.9	11.7	9.5	18.7	29.6	16.4	84.6	57.2	35.3	13.3	37.3	25.1	2.6	4.5	2.5	1.9	4.8	1.8	9.9	2.6	2.5	2.9	4.9	2.5	3.3	49.1	2.8	5.2	8.7	1.6	1.7	9.2	11.5	10.7	10.9	12.3	15.3	15.1	13.9	11.8	13.4	15.1	12.2	27.5	12.8	27.7	16.0	49.2	115.1	47.8	19.5	59.2	19.9	45.5	28.4	8.1	4.3	18.9	62.5	31.3	25.3	38.2	55.2	7.9	11.6	45.5	17.2	5.0	27.6	28.8	15.2	6.1	5.6	64.4	25.0	17.9	32.1	53.2	25.5	23.9	21.5	37.3	0.0	5.0	30.3	10.2	41.5	78.2	76.9	14.0	51.5	35.6	13.1	35.8	32.6	1.0	9.5	0.4	11.0	31.7	18.4	47.2	39.9	41.0	13.2	8.1	4.4	0.0	39.8	24.7	5.8	28.0	67.7	132.8	82.4	37.6	0.7	43.9	31.5
TLE4	"E(spl), ESG, GRG4"	ENSG00000106829	"TLE family member 4, transcriptional corepressor"	Q04727	9	79571773-79726882	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 818.9;Late spermatids: 1315.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 24.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 99.9;BJ hTERT+: 98.7;BJ hTERT+ SV40 Large T+: 89.4;fHDF/TERT166: 154.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065357			Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065357: AB_2685479"	"unprognostic (6.68e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.94e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.94e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	9.3	15.7	18.4	16.4	45.2	67.9	8.7	22.3	27.4	9.6	20.2	9.9	8.4	14.3	5.9	17.6	12.9	16.6	8.0	27.5	21.6	6.9	5.6	12.5	15.9	31.7	21.4	32.3	6.4	10.6	24.2	19.7	32.2	5.6	10.5	24.7	10.9	8.4	23.1	18.9	11.3	14.5	26.1	18.5	14.1	108.0	25.4	27.8	10.4	10.3	19.9	18.7	12.8	64.0	0.0	19.0	70.7	0.5	11.4	9.6	21.2	99.9	98.7	89.4	34.4	2.8	10.3	7.4	0.2	154.3	13.7	20.8	5.0	18.3	39.2	38.2	30.8	0.0	9.1	0.4	13.8	21.4	13.0	11.3	12.6	26.1	5.2	25.2	23.9	14.0	1.5	21.3	28.6	0.7	29.4	9.4	22.5	11.9	4.8	25.7	35.9	7.4	5.5	2.7	28.5	41.5	14.7	1.9	0.1	32.8	0.0	25.1	36.4	34.8	0.1	0.8	5.0	14.4	25.0	10.9	12.3	18.0	16.6	24.2	4.4	17.1	4.8	6.3	5.9	1.3	2.5	3.6	2.9	1.7	1.5	2.5	11.7	3.2	4.9	1.0	0.8	2.6	18.4	45.2	22.3	27.4	27.5	21.6	31.7	21.4	32.2	26.1	25.4	64.0	108.9	6.4	19.4	77.4	91.9	121.0	57.2	50.6	167.4	76.8	76.0	92.8	15.9	84.4	45.6	14.7	127.2	77.2	228.1	163.5	3.9	13.4	818.9	262.0	230.0	59.7	25.2	22.3	150.8	22.0	67.1	71.4	137.1	158.7	21.0	34.8	53.2	14.1	51.1	218.7	33.3	117.3	61.1	167.9	70.4	1315.5	105.6	101.7	42.7	77.8	75.3	31.0	88.6	301.6	381.0	31.7	207.6	46.6	152.7	37.8	122.0	18.1	50.4	290.2	72.3	280.7	83.9	38.3	146.0	140.0	90.8	65.0	141.0	86.8	96.0	99.9
TLE5	"AES, GRG5"	ENSG00000104964	"TLE family member 5, transcriptional modulator"	Q08117	19	3052910-3063107	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 92.3;dendritic cells: 167.1;Extravillous trophoblasts: 372.2;Hofbauer cells: 84.2;Plasma cells: 57.5;Syncytiotrophoblasts: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049499			Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA049499: AB_2680795"	"unprognostic (1.08e-1)"	"unprognostic (3.32e-3)"	"unprognostic (7.15e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.15e-1)"	"prognostic favorable (7.74e-4)"	"unprognostic (7.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.78e-3)"	237.7	357.9	325.2	93.8	320.4	99.7	214.8	341.0	435.0	304.3	209.5	466.7	82.0	336.6	80.8	282.1	315.9	90.6	504.4	319.4	327.4	266.5	239.6	283.8	145.2	341.8	301.7	284.0	234.4	174.5	276.9	94.7	349.4	314.8	90.9	82.9	287.9	197.1	550.0	231.4	233.2	109.9	279.3	325.2	274.2	109.0	345.5	210.0	315.9	313.7	120.0	361.8	285.4	326.0	120.8	138.7	101.8	180.7	122.1	140.8	78.9	155.1	211.9	192.6	173.0	57.2	120.3	195.9	169.1	200.7	69.5	100.6	122.9	226.7	112.6	292.8	56.5	68.8	141.9	109.6	217.1	99.4	85.1	152.3	182.1	93.2	89.7	226.9	191.8	100.8	245.5	80.0	169.0	120.0	221.7	119.5	89.4	85.3	140.3	251.3	123.4	135.1	241.7	247.7	258.1	283.3	152.2	174.1	163.9	55.8	138.3	134.2	266.5	161.1	106.6	152.8	143.5	4.7	0.9	265.0	151.1	165.7	151.7	38.9	6.6	18.1	130.8	10.7	100.8	62.0	169.3	134.9	12.5	74.3	220.8	149.5	4.6	41.6	9.2	28.8	242.0	89.2	325.2	320.4	341.0	435.0	319.4	327.4	341.8	301.7	349.4	279.3	345.5	326.0	92.3	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	24.5	167.1	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	372.2	27.7	0.0	0.0	0.0	0.0	0.0	0.0	84.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	94.0	27.8	0.0	0.0	0.0
TLK1	"KIAA0137, PKU-BETA"	ENSG00000198586	"Tousled like kinase 1"	Q9UKI8	2	170990823-171231314	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016043	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA016043: AB_1858027"	"unprognostic (2.13e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.36e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.53e-1)"	7.7	10.2	5.9	10.7	8.3	11.1	12.3	4.1	10.5	12.7	5.1	13.0	9.4	10.6	5.4	9.4	9.5	9.6	7.0	10.1	4.6	13.0	14.8	8.4	15.0	3.5	7.3	14.0	10.4	18.0	6.2	15.2	3.4	11.8	12.3	15.8	9.2	14.6	16.3	8.5	11.8	11.7	4.4	13.2	13.5	17.7	10.6	13.8	17.6	5.5	15.7	11.7	8.3	7.6	16.6	15.6	22.0	17.3	15.4	15.3	24.7	22.5	31.9	21.8	18.2	21.8	25.9	34.2	18.7	33.4	23.6	13.7	28.5	24.6	23.8	42.1	14.9	39.1	18.5	28.0	16.5	50.3	19.0	16.7	24.6	43.4	28.4	23.0	24.3	21.2	42.3	27.4	13.2	20.3	43.8	15.5	20.6	15.5	8.9	31.9	26.9	34.7	17.7	30.9	25.0	19.7	24.7	16.7	16.1	14.9	13.8	17.0	33.2	19.3	24.0	12.7	17.8	24.5	43.0	59.7	23.9	20.1	19.9	11.1	3.1	5.7	5.2	2.6	7.3	8.3	8.3	5.7	3.0	8.3	9.3	6.2	4.2	8.1	5.3	4.4	8.5	5.2	5.9	8.3	4.1	10.5	10.1	4.6	3.5	7.3	3.4	4.4	10.6	7.6	34.2	51.3	27.8	135.8	76.7	41.3	33.2	27.1	30.7	34.8	45.9	28.4	32.1	37.1	29.2	51.5	60.5	82.7	42.6	55.8	88.0	29.2	58.1	29.5	33.9	34.5	23.9	33.7	196.2	32.7	52.7	30.3	37.8	38.4	27.3	39.5	27.5	40.0	27.4	45.4	161.0	36.7	36.7	29.0	30.4	32.0	43.2	54.7	37.4	74.0	29.1	26.6	49.4	84.9	92.0	35.6	36.5	44.8	66.3	51.0	33.4	58.0	30.7	77.5	0.0	41.6	29.6	31.1	54.9	24.5	39.1	174.9	66.4	59.2	33.9	43.0
TLNRD1	"MESDC1, MGC99595"	ENSG00000140406	"Talin rod domain containing 1"	Q9H1K6	15	81000923-81005788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 36.8;Exocrine glandular cells: 31.5;Extravillous trophoblasts: 31.5;Glandular and luminal cells: 27.7;Hofbauer cells: 35.2;Pancreatic endocrine cells: 44.1;Proximal tubular cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 47.0;SK-MEL-30: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071716			Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytoplasmic bodies"		"HPA071716: AB_2732183"	"unprognostic (1.32e-2)"	"unprognostic (5.30e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.37e-3)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (1.47e-5)"	"unprognostic (1.68e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.82e-3)"	13.5	9.6	4.8	5.4	8.7	7.5	7.8	12.5	6.4	6.2	6.3	7.1	3.7	7.3	2.0	8.2	7.1	3.7	10.0	5.2	3.9	7.4	6.2	14.5	4.3	6.8	4.8	4.6	10.1	1.6	5.9	4.6	5.3	5.3	2.9	1.2	6.3	1.8	1.9	3.4	6.9	2.4	5.0	11.8	8.0	1.6	6.3	3.5	5.3	2.1	2.9	7.7	5.5	4.9	11.2	3.6	9.4	6.8	4.1	2.4	15.5	10.0	2.8	6.2	4.5	6.3	10.0	12.1	13.7	2.5	3.7	14.2	5.8	3.2	3.5	47.0	17.0	23.8	2.2	6.9	3.1	8.4	16.6	2.5	4.2	3.8	3.7	2.2	9.4	10.3	13.7	29.3	4.2	5.6	13.3	9.7	14.9	7.2	5.0	16.9	9.5	27.7	4.0	11.2	14.7	12.5	5.6	6.1	48.0	8.0	5.4	7.3	11.2	7.1	22.3	9.9	15.1	20.2	21.4	12.9	4.8	12.0	7.5	0.5	0.3	0.4	0.6	0.5	0.5	0.8	0.7	0.7	0.2	0.5	0.3	0.5	0.5	1.2	0.4	0.5	0.3	0.3	4.8	8.7	12.5	6.4	5.2	3.9	6.8	4.8	5.3	5.0	6.3	4.9	36.8	0.0	9.4	0.0	8.2	0.0	0.0	0.0	0.0	0.0	23.3	12.7	0.0	0.0	4.3	12.9	0.0	8.4	19.3	0.0	1.9	15.1	0.0	13.4	21.4	17.6	0.0	0.0	0.0	31.5	31.5	10.4	0.0	27.7	2.5	15.9	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	44.1	0.0	0.0	4.1	0.0	0.0	30.9	2.2	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	9.0	6.5	11.1	0.0	0.0
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
TLR5	"FLJ10052, MGC126430, MGC126431, SLEB1, TIL3"	ENSG00000187554	"Toll like receptor 5"	O60602	1	223109404-223143248	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 20.2"	"Cell type enhanced"	"Detected in many"		"Club cells: 23.3;Glandular and luminal cells: 25.6;Kupffer cells: 29.5;Microglial cells: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 30.8;intermediate monocyte: 28.1;myeloid DC: 23.4;neutrophil: 25.3;non-classical monocyte: 12.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 23.4;granulocytes: 25.3;monocytes: 30.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.1;HaCaT: 3.2;OE19: 1.8;SK-BR-3: 2.0;T-47d: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB009013			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB009013: AB_2240732"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	3.5	1.9	2.6	4.7	2.2	0.5	8.6	2.5	2.4	6.0	2.3	2.0	1.6	2.1	2.6	4.9	5.1	4.5	1.7	2.3	2.7	4.1	1.6	6.2	4.3	3.7	3.5	20.2	4.0	4.4	0.7	3.4	3.6	3.3	2.1	0.7	10.3	2.4	1.4	2.0	2.1	2.6	3.1	2.9	4.1	1.8	3.4	2.5	1.9	1.6	5.0	4.0	2.4	5.0	2.1	0.2	0.3	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.0	3.2	0.0	0.2	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.2	0.1	0.8	0.4	0.0	0.0	0.3	0.5	0.1	1.1	1.8	0.0	0.0	0.0	0.1	0.9	0.4	0.8	0.3	0.6	2.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.3	0.2	0.0	30.8	0.4	0.2	28.1	0.4	0.2	1.5	0.4	23.4	0.1	2.3	0.7	25.3	0.4	12.4	0.3	1.2	10.9	2.6	2.2	2.5	2.4	2.3	2.7	3.7	3.5	3.6	3.1	3.4	5.0	1.0	3.2	17.0	0.0	0.2	0.5	5.8	18.9	4.6	0.1	10.6	5.3	1.7	14.3	23.3	22.0	2.1	1.5	0.3	0.4	3.9	5.9	4.6	13.6	2.0	2.1	1.2	0.0	0.5	3.8	0.3	7.7	3.1	25.6	2.5	4.6	0.7	0.7	18.1	0.0	1.0	0.6	6.1	29.5	3.1	5.7	9.3	22.4	3.6	23.4	14.4	1.4	0.0	1.5	0.1	2.4	0.1	8.6	0.1	3.0	0.5	0.1	11.0	0.2	0.0	4.2	4.1	5.4	5.5	15.9	1.6	0.8	1.7	4.1	1.5	6.3
TLX2	"Enx, HOX11L1, NCX"	ENSG00000115297	"T cell leukemia homeobox 2"	O43763	2	74513463-74517148	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.0;retina: 3.1"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 20.9;Rod photoreceptor cells: 18.0;Spermatocytes: 4.3;Spermatogonia: 7.4"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"SH-SY5Y: 64.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062254			Approved	Nucleoplasm		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA062254: AB_2684727"	"unprognostic (7.30e-2)"	"unprognostic (3.03e-4)"	"unprognostic (9.54e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.40e-1)"	"unprognostic (3.92e-7)"	"unprognostic (2.51e-1)"	"unprognostic (6.86e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.18e-1)"	0.0	2.0	1.0	0.2	0.3	0.0	0.0	0.4	0.8	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.2	1.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.9	0.0	3.4	0.0	0.0	0.0	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.0	3.2	0.0	0.1	0.1	0.0	0.0	0.0	1.4	3.8	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.4	0.8	0.1	0.1	0.5	0.4	0.4	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	20.9	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	4.3	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309248-171312139	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"brain: 9.0"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 7.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Group enriched"	"Detected in many"	6	"cerebellum: 9.0;medulla oblongata: 2.3;spinal cord: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 25.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.2"	"Region enriched"	"Detected in some"	8	"cerebellum: 15.5"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130"		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	2.3	0.6	1.0	5.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TM2D1	BBP	ENSG00000162604	"TM2 domain containing 1"	Q9BX74	1	61681046-61725423	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046058, HPA055621"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Vesicles	"HPA046058: AB_2679519, HPA055621: AB_2682865"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.79e-1)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	30.9	36.3	25.4	16.5	26.0	23.2	35.8	27.3	36.5	29.4	27.6	27.7	20.5	30.3	45.3	21.4	29.9	26.0	45.4	25.2	27.0	38.8	29.3	27.4	26.5	26.7	27.0	36.4	21.8	41.6	20.4	35.7	26.8	33.3	28.5	26.2	30.1	22.5	40.9	19.8	25.0	29.3	27.1	23.9	24.4	34.9	25.9	25.1	40.6	35.3	20.3	30.1	20.7	28.4	31.3	15.0	22.8	18.2	68.1	66.2	29.2	54.5	55.2	26.4	35.0	9.7	39.0	25.3	70.9	45.9	52.7	34.8	29.2	39.7	40.5	41.3	34.4	28.2	23.0	21.8	66.7	40.9	48.0	74.2	67.0	30.5	38.0	64.4	50.5	33.6	32.7	47.7	64.7	10.1	20.9	32.0	24.9	27.5	21.4	17.9	43.1	31.5	78.4	24.3	25.4	30.9	32.5	64.1	102.6	30.5	35.1	43.2	45.3	35.3	17.8	19.8	41.9	40.0	39.4	30.8	61.3	39.4	31.8	52.8	18.7	44.9	16.1	23.7	16.6	24.2	18.6	19.7	18.6	20.1	17.2	19.9	12.2	23.3	26.8	36.4	24.3	19.4	25.4	26.0	27.3	36.5	25.2	27.0	26.7	27.0	26.8	27.1	25.9	28.4	49.5	41.7	40.2	32.3	49.0	78.3	91.9	205.2	59.2	60.3	67.7	56.6	40.5	48.6	99.9	79.1	60.5	51.2	47.4	46.5	39.2	50.3	6.5	43.3	34.7	59.2	43.9	42.1	42.3	45.3	60.0	84.3	29.0	42.2	61.5	37.6	80.7	54.2	50.3	69.0	46.9	41.3	158.7	58.7	53.8	9.9	79.9	48.1	90.7	43.1	54.1	99.2	63.8	50.3	63.4	54.2	60.4	53.0	51.4	110.0	45.9	67.6	100.0	70.1	39.5	75.3	60.0	172.1	72.5	58.6	76.4	53.5	47.3	42.0	43.0	110.1
TM2D2	BLP1	ENSG00000169490	"TM2 domain containing 2"	Q9BX73	8	38988808-38996824	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 218.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047152, HPA050547"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA047152: AB_2679957, HPA050547: AB_2681168"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (2.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-2)"	"unprognostic (8.61e-2)"	20.2	24.4	15.6	15.9	17.3	13.1	19.8	18.2	22.2	19.7	24.4	15.7	18.0	18.4	26.5	16.5	17.4	23.1	19.5	17.5	18.6	32.9	29.8	20.6	17.7	16.5	17.4	22.0	13.9	23.6	15.9	33.8	17.6	22.2	16.3	17.1	17.8	22.1	15.6	18.5	16.2	17.8	17.2	22.3	19.6	27.6	18.0	11.8	26.4	17.6	15.2	20.0	16.6	19.7	35.7	56.5	25.7	35.7	58.8	39.0	35.4	73.8	44.9	54.6	49.1	43.4	30.0	12.5	56.7	54.9	61.5	37.8	27.5	44.5	59.0	15.0	21.7	28.6	32.3	47.3	51.8	8.6	35.3	47.9	42.8	43.1	20.9	40.0	71.1	21.2	32.2	35.7	73.5	22.1	21.3	28.9	32.6	53.2	22.0	17.8	33.2	21.0	62.2	27.9	8.6	16.9	28.2	19.5	37.8	45.1	48.1	17.9	64.6	44.0	33.0	64.9	37.7	24.9	59.1	21.9	33.6	19.4	31.6	64.5	28.5	27.3	29.7	34.2	33.3	24.9	35.1	33.0	30.4	26.2	33.1	32.0	7.9	33.0	29.8	60.5	41.8	35.3	15.6	17.3	18.2	22.2	17.5	18.6	16.5	17.4	17.6	17.2	18.0	19.7	30.4	12.8	14.7	3.9	13.8	35.1	56.9	64.3	20.5	25.1	22.5	25.1	17.7	32.9	44.5	51.5	20.9	91.3	28.2	12.9	29.4	59.9	62.2	24.1	33.3	36.0	10.3	5.9	7.6	38.4	98.2	38.6	17.3	25.8	22.2	44.3	58.2	38.4	218.5	23.5	9.2	12.6	40.7	33.6	33.9	46.6	36.1	40.6	26.6	7.5	70.8	45.4	15.5	6.0	5.4	74.9	19.4	24.8	14.5	52.5	35.1	61.4	29.4	34.0	0.0	25.4	26.5	60.8	58.1	16.3	15.5	79.9	17.8	39.3	16.7	48.5
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA054064: AB_2682366"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	32.2	38.3	58.9	23.5	62.8	28.2	33.9	57.0	74.7	36.7	51.4	31.1	24.6	40.8	43.5	23.9	34.2	29.6	47.8	62.0	70.1	32.2	58.1	28.1	30.5	54.9	58.7	55.7	30.3	40.6	35.7	31.7	58.5	32.7	24.2	32.3	34.4	35.3	44.5	27.0	26.2	32.1	55.9	29.2	29.1	28.0	61.1	29.5	45.2	55.7	31.7	32.8	28.5	58.0	20.1	48.9	25.6	46.6	71.9	53.1	31.3	25.9	42.6	30.0	33.4	26.4	55.5	32.5	34.9	35.5	50.7	45.9	40.3	33.3	23.7	31.2	88.4	48.7	39.9	45.4	47.2	38.4	55.8	44.2	66.3	18.1	37.4	42.1	42.1	41.5	40.6	47.8	47.9	40.8	28.3	40.2	39.5	90.4	16.2	33.9	32.3	51.0	61.5	52.0	34.3	31.3	35.8	37.4	54.3	43.7	35.5	49.8	33.7	31.6	32.5	21.2	28.9	45.0	71.2	35.3	26.9	47.5	26.7	36.4	40.6	81.9	41.2	41.9	46.4	30.6	33.6	31.6	29.1	44.8	44.1	41.4	69.6	52.4	32.4	24.6	38.4	41.3	58.9	62.8	57.0	74.7	62.0	70.1	54.9	58.7	58.5	55.9	61.1	58.0	52.4	25.6	28.7	22.2	55.8	66.3	58.5	142.3	32.5	47.1	42.6	45.8	35.7	35.8	67.9	42.3	33.3	73.7	51.9	23.0	19.6	61.0	8.0	28.1	38.2	48.8	27.0	30.3	41.5	42.3	64.7	53.7	23.0	44.8	25.3	37.6	60.3	56.6	32.3	69.0	55.3	23.2	91.6	42.1	36.4	10.8	73.7	39.2	26.6	37.5	44.4	60.6	56.7	29.1	45.8	27.8	20.7	62.8	41.3	66.6	32.6	39.5	47.2	46.8	72.3	40.1	67.0	89.3	84.2	25.0	55.4	91.0	55.1	21.5	27.8	40.0
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins, Transporters"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 174.7;liver: 204.6"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 115.2;Hepatocytes: 275.4;Intestinal goblet cells: 143.9;Paneth cells: 285.4;Proximal enterocytes: 618.4"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 53.7;Hep G2: 96.0;OE19: 60.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	174.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	11.6	204.6	0.0	0.2	0.0	0.0	0.0	1.4	8.1	0.0	0.6	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	158.1	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	53.7	2.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	96.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.0	60.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	1.8	0.0	0.1	0.0	40.5	5.9	0.9	2.0	0.0	0.0	0.1	115.2	5.3	0.1	8.9	4.6	0.0	57.6	0.0	4.5	0.0	4.6	275.4	0.1	0.0	0.1	143.9	0.0	4.8	0.3	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	285.4	0.0	0.1	0.0	618.4	72.8	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.0	47.8	0.0
TM7SF3		ENSG00000064115	"Transmembrane 7 superfamily member 3"	Q9NS93	12	26971579-27014434	"Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 258.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 553.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057640			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA057640: "	"unprognostic (4.24e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.04e-3)"	"unprognostic (8.80e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	38.0	48.8	23.1	28.2	25.1	66.0	33.2	19.2	27.3	37.8	34.6	60.5	40.4	29.9	48.6	61.2	40.7	58.3	18.3	23.1	25.2	258.0	138.4	53.7	29.1	25.8	22.8	32.9	117.9	42.4	20.1	36.0	24.6	36.1	69.1	38.9	41.6	43.9	13.7	40.5	35.3	45.8	26.1	32.7	48.7	30.6	26.3	101.4	44.0	35.4	39.9	47.5	28.6	30.7	70.0	147.8	82.6	104.7	122.1	74.3	438.7	74.3	132.8	65.1	109.9	73.3	289.2	80.9	92.3	78.1	61.1	71.5	85.9	553.0	77.0	84.1	46.7	126.9	168.2	134.1	76.7	439.5	84.9	48.7	382.6	144.3	111.7	191.8	177.2	242.2	53.8	60.1	97.1	114.9	232.4	189.3	170.5	266.8	75.4	216.9	131.8	164.2	93.7	278.2	14.4	72.9	84.8	56.6	121.0	391.6	151.8	77.2	62.4	53.9	92.1	140.3	93.4	38.5	97.3	152.9	115.5	133.7	78.5	11.2	7.4	19.0	6.0	8.1	5.4	8.7	8.0	7.8	12.4	13.5	11.1	7.1	6.2	13.7	3.8	10.1	13.9	4.7	23.1	25.1	19.2	27.3	23.1	25.2	25.8	22.8	24.6	26.1	26.3	30.7	23.2	12.8	27.6	28.4	20.2	28.8	52.4	78.7	96.8	50.0	17.2	19.8	10.3	127.2	46.0	42.3	43.8	40.0	35.2	22.2	17.6	62.1	82.4	23.0	5.7	19.4	13.2	49.0	83.1	39.6	15.2	23.5	32.1	21.1	14.0	48.5	22.5	42.5	39.5	23.5	50.4	24.0	28.5	25.7	11.1	148.8	15.5	27.1	65.8	26.2	27.4	30.8	27.8	63.8	40.0	25.3	28.1	23.0	38.2	18.1	25.5	143.7	24.9	38.4	6.6	27.4	18.4	10.1	22.3	65.0	27.8	16.3	21.8	21.6	31.3	37.6
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.6;Late spermatids: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.4	11.9	4.4	17.9	4.6	12.5	18.0	5.4	6.7	10.8	5.1	13.0	11.0	15.8	6.9	14.3	11.4	9.9	9.2	4.4	5.1	12.1	13.5	8.9	22.0	4.8	4.7	16.8	14.8	9.5	5.3	14.0	5.0	11.8	11.8	5.7	14.4	9.9	9.6	14.4	10.1	13.0	4.9	16.1	12.8	26.7	4.5	19.1	11.6	7.6	20.0	13.9	10.8	6.2	49.1	24.1	43.0	37.3	20.1	32.6	41.3	56.3	29.8	34.2	28.5	23.4	65.4	108.1	22.7	34.0	27.0	25.2	54.6	43.0	43.0	58.1	42.6	154.3	23.3	41.3	39.6	120.2	46.7	22.6	40.0	27.1	36.4	29.5	34.5	39.4	55.1	79.9	39.7	47.2	74.9	68.4	45.6	28.4	43.0	67.7	38.3	68.9	26.2	23.8	22.5	35.2	36.8	46.3	43.4	25.7	30.3	51.3	59.3	23.5	46.0	22.9	61.2	55.8	75.8	124.7	47.3	64.0	72.3	11.7	37.0	3.5	18.4	58.8	26.1	55.6	32.4	23.5	42.3	51.7	29.8	26.1	1.3	35.3	48.4	74.8	31.3	19.4	4.4	4.6	5.4	6.7	4.4	5.1	4.8	4.7	5.0	4.9	4.5	6.2	25.7	22.4	31.2	3.3	51.2	32.9	36.3	52.0	29.6	15.4	42.9	40.5	37.6	47.1	31.7	33.1	4.2	53.8	25.6	16.4	64.6	53.2	165.6	19.0	61.4	30.0	30.5	28.8	8.8	71.0	92.3	37.9	15.3	17.9	29.1	41.6	36.0	55.6	36.4	15.2	7.3	37.5	20.3	43.3	23.4	179.2	55.6	25.4	26.6	6.5	44.4	15.8	16.5	11.6	11.0	54.9	30.6	32.0	30.0	57.8	11.9	71.7	19.0	14.3	39.5	30.4	33.7	103.9	42.1	28.5	39.6	30.5	24.1	43.7	44.0	28.9
TMA7	"CCDC72, HSPC016"	ENSG00000232112	"Translation machinery associated 7 homolog"	Q9Y2S6	3	48440257-48444208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.14e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.31e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.64e-3)"	252.5	276.8	498.7	220.7	507.8	434.6	241.9	504.6	588.9	236.5	500.2	253.3	192.8	179.4	344.5	310.5	181.7	117.9	355.4	502.2	514.7	317.6	273.2	208.0	279.3	511.7	510.0	259.6	230.3	309.8	302.0	146.6	505.9	239.6	229.3	295.4	215.9	142.7	511.6	215.1	220.4	132.7	513.0	272.9	235.5	216.0	511.9	388.3	232.4	287.4	297.7	213.3	239.3	514.5	565.0	398.8	634.2	456.6	514.0	497.1	435.6	454.1	355.7	425.1	419.3	326.3	395.9	365.2	315.3	397.8	553.6	215.5	559.8	512.5	471.6	452.6	475.5	689.4	910.3	845.8	399.0	792.2	443.0	459.7	538.2	402.6	388.8	414.2	546.0	641.1	376.6	379.0	615.3	581.2	929.4	1071.2	847.1	607.0	637.3	262.2	397.0	620.4	746.0	748.7	207.8	526.1	511.0	369.3	736.1	583.6	356.7	1156.3	412.1	358.0	650.8	560.5	902.6	626.1	1001.6	902.8	459.1	754.2	379.9	1923.2	1058.7	2195.0	1127.1	1022.5	1237.6	1412.6	1486.0	1377.1	1150.8	1172.2	1464.7	1408.1	2036.5	943.8	1028.9	1521.6	1652.1	2663.7	498.7	507.8	504.6	588.9	502.2	514.7	511.7	510.0	505.9	513.0	511.9	514.5	518.8	240.4	370.4	20.9	615.0	716.3	534.0	1308.9	618.6	219.6	866.8	1111.2	633.4	513.3	616.2	901.2	106.3	785.4	797.4	948.2	1717.8	566.9	653.6	524.8	511.4	474.5	635.3	609.1	25.8	1032.9	830.9	443.7	356.3	646.1	454.4	376.5	574.7	1098.6	854.5	119.5	25.4	985.5	695.8	652.4	790.5	1123.9	646.8	544.3	777.3	18.7	850.3	522.8	1080.3	10.1	28.3	872.9	980.3	464.6	593.9	584.6	1211.0	1438.8	466.4	321.9	355.0	393.6	448.4	547.4	689.4	805.5	898.4	440.1	757.1	351.9	937.2	572.2
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.4;stomach 1: 46.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 282.4;Pancreatic endocrine cells: 302.2;Proximal enterocytes: 374.3;Respiratory ciliated cells: 624.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 69.7;OE19: 41.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Nucleoplasm	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.6	0.1	0.2	3.1	0.4	1.5	12.7	0.5	0.3	8.9	5.6	21.6	45.4	2.1	17.5	1.2	5.1	25.5	0.1	0.3	0.0	0.3	0.6	18.9	0.2	0.2	0.2	0.1	2.3	6.0	0.1	3.2	0.2	12.2	22.7	0.2	22.8	0.2	0.1	1.8	53.4	1.1	0.0	0.1	46.0	3.8	0.2	0.1	0.7	0.0	1.1	3.2	0.5	0.2	6.9	10.8	0.0	0.3	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.1	69.7	0.0	0.3	0.0	0.2	4.4	1.1	0.0	0.0	0.1	0.1	0.0	1.8	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	1.1	0.0	0.2	2.5	41.5	3.1	0.0	0.0	2.6	0.1	0.3	0.7	0.2	0.1	2.1	0.0	1.1	0.9	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.1	157.0	162.5	0.0	1.8	0.8	22.9	46.6	2.8	0.3	57.4	17.9	0.9	102.9	282.4	22.0	2.1	39.0	1.0	173.7	0.0	121.1	32.8	107.0	6.9	2.9	38.9	8.0	1.9	166.3	3.4	3.3	188.1	88.4	5.7	11.0	0.7	0.6	2.7	3.3	2.0	101.5	26.4	0.0	1.1	32.6	0.3	1.8	1.8	0.0	1.0	0.2	0.0	0.5	0.9	302.2	180.9	0.7	0.5	103.1	374.3	2.0	624.7	1.9	0.0	0.4	9.5	1.3	1.1	2.2	1.7	16.3	1.3	1.5	125.1	55.9
TMCO6	"FLJ39769, PRO1580"	ENSG00000113119	"Transmembrane and coiled-coil domains 6"	Q96DC7	5	140639435-140645408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037473, HPA037474"	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA037473: AB_10671049, HPA037474: AB_10671050"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.20e-2)"	6.6	10.5	5.7	3.9	5.7	2.9	6.6	5.5	5.8	6.1	5.5	4.9	2.9	4.8	3.4	7.2	6.9	2.9	3.1	5.5	5.8	6.7	13.3	3.6	4.6	6.0	5.9	7.1	6.6	4.0	4.9	5.6	5.9	4.8	2.5	0.7	9.8	2.9	3.6	5.2	4.8	3.0	6.3	7.2	5.2	10.4	5.9	7.7	5.3	2.6	4.0	5.4	5.6	7.0	3.9	7.5	5.0	7.4	4.9	5.2	18.1	3.0	3.4	3.8	4.1	11.6	7.2	15.6	7.8	2.3	4.4	7.7	4.2	8.8	2.0	5.5	13.7	11.9	3.7	8.3	6.5	6.7	4.4	8.6	2.3	4.6	7.7	2.9	8.9	12.6	5.1	5.0	4.7	7.5	15.3	15.5	5.7	9.2	11.3	13.1	10.3	15.5	4.6	3.5	8.6	3.7	8.6	16.6	8.0	3.4	13.6	7.9	4.2	0.1	3.7	1.4	1.3	8.4	5.7	7.4	2.4	10.7	4.6	11.6	6.5	5.7	5.2	9.1	5.7	7.8	6.9	5.1	6.9	6.1	9.5	3.9	12.7	4.4	10.3	1.9	8.2	4.1	5.7	5.7	5.5	5.8	5.5	5.8	6.0	5.9	5.9	6.3	5.9	7.0	4.0	6.4	2.0	1.3	7.5	1.9	7.3	3.4	6.8	5.2	4.6	4.3	0.6	5.7	2.4	11.0	6.2	7.7	4.2	3.9	0.0	3.8	4.1	2.2	4.0	6.3	7.3	10.3	3.8	2.4	7.4	4.6	6.6	2.5	0.0	4.6	10.0	9.7	4.8	0.0	3.3	5.0	4.1	5.1	2.7	1.5	4.1	4.1	1.8	9.4	6.6	3.3	16.5	1.0	3.9	4.5	5.2	4.9	7.3	7.4	6.2	2.4	6.2	4.3	6.6	3.9	3.4	19.2	15.8	10.3	2.3	6.3	8.2	7.7	7.7	6.9
TMEM100	"FLJ10970, FLJ37856"	ENSG00000166292	"Transmembrane protein 100"	Q9NV29	17	55719627-55732121	"Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 192.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 57.8;Endothelial cells: 25.5;Fibroblasts: 40.7;Leydig cells: 40.7;Peritubular cells: 52.6;Sertoli cells: 32.9"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 28.9;ASC TERT1: 19.5;HHSteC: 44.8;HSkMC: 20.6;U-87 MG: 13.9;WM-115: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055936	Approved		Uncertain	Nucleoplasm		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA055936: AB_2682975"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.07e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (5.74e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (4.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.26e-3)"	40.8	5.0	5.4	3.2	5.5	0.0	27.6	4.3	9.0	15.8	6.0	14.5	6.7	3.6	36.6	6.5	8.0	7.3	18.7	5.1	7.0	1.9	7.0	192.5	1.2	5.5	7.0	26.5	2.3	0.8	11.2	54.1	6.0	10.3	11.6	0.4	8.0	24.7	9.7	4.6	13.2	5.5	4.6	6.9	30.2	2.7	8.1	1.1	7.5	14.1	0.6	11.1	8.2	4.7	0.0	0.0	5.9	0.0	28.9	19.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	44.8	0.0	0.0	20.6	0.0	1.4	0.1	0.2	0.0	0.3	1.0	0.1	0.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	8.7	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	1.9	3.9	0.0	0.8	0.0	0.1	13.9	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.5	4.3	9.0	5.1	7.0	5.5	7.0	6.0	4.6	8.1	4.7	57.8	0.0	3.6	2.3	0.1	2.5	0.3	0.0	1.2	0.7	0.4	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	4.0	25.5	0.0	0.0	0.1	0.0	0.0	40.7	1.5	0.2	1.3	0.1	7.1	15.2	0.1	0.0	1.6	0.0	0.0	0.0	4.9	0.5	40.7	0.2	7.2	1.9	0.0	0.0	0.0	17.1	0.0	0.1	0.0	52.6	0.0	0.1	0.0	3.4	0.0	0.1	32.9	10.3	15.1	0.1	0.2	0.7	2.6	0.1	0.5	0.3	0.0	0.3
TMEM101	"FLJ23987, MGC4251"	ENSG00000091947	"Transmembrane protein 101"	Q96IK0	17	44011188-44023946	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 237.2;Glandular and luminal cells: 507.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039739, HPA075651"			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA039739: AB_2676657, HPA075651: "	"unprognostic (1.40e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (5.91e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (1.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	17.2	19.8	22.6	12.9	26.8	11.5	107.0	23.2	24.0	44.4	24.2	20.6	16.9	63.5	27.6	28.0	37.9	15.9	23.1	22.2	22.7	93.9	24.1	18.7	19.4	24.2	24.0	22.7	39.2	26.4	15.4	21.6	23.2	24.0	16.9	12.1	30.1	111.8	33.3	29.0	17.4	16.1	23.5	20.4	28.8	23.6	23.9	16.5	23.0	24.9	17.7	20.4	23.0	23.4	23.5	56.0	19.7	16.2	45.7	43.9	19.6	24.1	36.1	46.5	43.8	42.0	59.5	26.1	6.5	24.9	36.0	35.3	22.9	41.5	35.2	28.5	46.1	19.5	45.7	86.2	39.3	31.7	32.8	39.4	46.5	32.8	46.3	41.8	40.8	45.0	40.7	50.1	29.2	31.7	34.6	36.6	9.1	25.4	62.6	29.8	42.8	47.4	39.1	18.7	25.3	20.2	14.6	0.5	59.6	24.9	27.3	59.9	24.7	42.1	28.5	18.8	46.9	52.1	38.0	12.0	44.3	29.7	38.2	20.1	42.8	15.3	31.2	43.4	35.7	37.3	39.6	36.4	44.9	39.8	43.2	35.7	15.9	44.1	32.9	44.0	44.6	31.1	22.6	26.8	23.2	24.0	22.2	22.7	24.2	24.0	23.2	23.5	23.9	23.4	22.1	19.2	15.4	0.0	22.8	20.6	31.6	72.0	21.6	10.4	64.2	61.2	27.3	24.3	34.5	40.5	6.2	68.5	19.6	18.5	37.2	36.6	13.1	237.2	70.8	28.2	23.4	33.2	0.0	49.8	47.3	21.1	13.7	507.4	22.9	34.4	36.0	20.6	37.6	11.8	0.0	37.3	28.5	32.4	11.8	11.1	13.1	23.8	33.8	0.0	47.7	17.7	29.9	0.0	0.0	41.8	20.7	12.4	29.4	23.4	27.7	30.2	27.1	11.7	6.6	13.2	19.8	45.8	24.7	26.9	22.6	44.6	20.9	25.6	45.7	25.2
TMEM104	"FLJ00021, FLJ20255"	ENSG00000109066	"Transmembrane protein 104"	Q8NE00	17	74776499-74839753	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044330	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Golgi apparatus"	"HPA044330: AB_10960543"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (7.46e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.75e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (8.14e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.46e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.00e-2)"	6.5	10.7	7.0	5.6	9.1	8.4	5.3	9.2	7.9	3.9	5.6	5.0	3.5	4.7	3.8	6.6	4.2	3.4	7.2	6.5	6.8	7.7	14.9	7.8	4.5	10.4	9.3	3.8	8.1	8.1	9.9	5.0	9.8	5.5	2.9	2.0	7.5	3.8	5.4	5.2	5.3	4.2	8.2	7.0	6.1	8.4	9.3	4.2	7.8	3.8	4.4	5.1	4.2	10.8	10.8	26.0	13.4	15.4	18.9	11.7	8.1	18.2	18.1	22.8	25.1	21.1	11.2	5.6	5.8	20.9	23.4	12.0	13.8	10.2	12.0	4.2	19.5	14.1	10.5	15.0	13.8	23.5	12.6	9.3	10.9	23.1	5.0	6.8	16.5	13.6	8.4	8.5	15.6	10.3	14.1	9.3	7.5	14.2	20.6	8.7	21.3	9.4	9.9	9.3	11.4	15.1	10.1	12.9	13.6	10.0	16.5	35.8	13.2	48.0	12.1	18.4	24.0	5.9	5.5	6.5	18.5	24.0	18.6	1.4	5.0	3.7	4.7	4.1	2.4	3.3	4.5	4.4	5.3	0.8	3.7	2.6	2.1	2.8	4.6	5.5	5.0	3.6	7.0	9.1	9.2	7.9	6.5	6.8	10.4	9.3	9.8	8.2	9.3	10.8	2.3	6.4	5.8	7.8	2.2	2.5	1.1	3.4	0.6	2.7	5.6	3.3	49.5	8.6	4.6	5.5	2.1	4.1	5.2	6.0	0.0	5.0	3.0	3.3	2.7	4.8	8.3	1.7	5.6	5.6	4.3	4.6	5.6	6.4	1.3	3.2	2.9	14.2	13.3	0.0	4.4	4.7	4.1	7.3	3.8	3.5	2.8	9.5	0.0	4.7	4.7	4.1	3.1	4.0	11.1	6.2	3.4	2.2	8.2	2.5	3.4	1.9	2.0	3.1	0.0	3.3	4.2	4.4	3.8	2.8	2.3	3.8	4.3	2.5	3.6	1.6
TMEM107	"JBTS29, MGC10744, MKS13"	ENSG00000179029	"Transmembrane protein 107"	Q6UX40	17	8172457-8176399	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease variant, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 110.8;Respiratory ciliated cells: 164.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052555, HPA059653"	Approved		Approved	"Nucleoplasm,Plasma membrane,Midbody ring"		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Plasma membrane"	"Midbody ring"	"HPA052555: AB_2681870, HPA059653: AB_2684096"	"unprognostic (2.87e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.49e-1)"	9.6	13.4	11.1	6.6	12.0	15.0	9.8	12.2	13.3	10.6	19.3	9.0	3.5	11.3	20.7	10.5	27.0	7.2	9.2	11.9	12.8	14.7	4.4	11.3	7.4	13.0	12.6	7.8	11.2	16.9	23.5	6.8	12.2	7.3	5.0	29.6	10.7	6.5	1.6	12.0	7.6	6.6	12.1	13.7	8.0	17.1	12.3	8.9	16.1	1.8	7.6	8.4	9.6	12.5	45.0	16.9	21.8	11.3	12.2	17.8	4.8	11.1	8.2	8.2	10.9	2.0	26.6	10.5	14.6	9.7	7.4	30.5	8.3	16.9	13.6	18.1	11.5	7.6	29.0	4.7	4.9	2.6	8.3	7.9	11.2	20.7	9.4	18.4	13.1	17.7	5.9	23.5	18.0	12.2	6.8	7.7	2.2	6.3	7.2	13.1	6.5	19.1	15.8	3.5	7.3	10.7	13.5	2.4	9.1	5.1	8.1	8.8	10.6	4.8	9.6	7.6	6.1	9.5	5.5	4.9	27.3	10.0	8.7	21.0	22.1	51.6	28.2	27.9	24.3	45.4	27.6	30.3	19.7	59.2	30.9	32.2	20.0	26.4	56.8	31.6	24.8	21.0	11.1	12.0	12.2	13.3	11.9	12.8	13.0	12.6	12.2	12.1	12.3	12.5	30.8	9.6	9.8	2.9	38.1	19.2	19.5	35.2	11.4	17.3	31.1	43.3	7.9	35.8	25.1	33.1	45.9	17.3	30.0	12.9	13.7	21.7	12.2	99.9	22.9	25.1	9.1	15.4	5.1	11.1	21.3	18.2	48.9	26.9	36.7	12.7	27.1	24.0	45.5	11.8	3.6	14.1	16.2	45.6	31.6	10.1	12.8	55.9	33.8	3.7	22.0	37.7	28.8	1.5	1.7	11.0	12.7	15.1	110.8	16.3	26.0	21.7	164.3	63.2	0.0	15.3	16.8	69.4	50.3	13.0	28.6	13.3	34.8	13.2	17.6	11.1
TMEM116	FLJ90167	ENSG00000198270	"Transmembrane protein 116"	Q8NCL8	12	111931282-112013185	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 59.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"T-cells: 19.3"	"Cell line enhanced"	"Detected in many"		"RT4: 33.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040720	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Microtubules	Nucleoplasm	"HPA040720: AB_10795623"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.12e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.19e-3)"	3.8	8.8	7.0	2.2	7.8	1.2	11.4	9.2	8.4	6.0	27.5	4.2	11.1	2.7	7.1	4.2	4.9	6.8	26.3	6.4	6.5	30.8	12.3	8.5	4.5	7.2	7.5	5.2	4.2	59.7	6.5	2.9	7.2	3.9	3.7	7.0	13.3	5.9	6.6	11.1	6.3	2.1	6.9	3.4	10.2	27.1	7.5	5.4	6.3	5.8	6.8	7.4	3.2	8.5	6.2	6.4	8.9	9.7	8.3	6.6	6.0	5.1	7.5	6.1	6.6	4.6	5.1	6.9	2.9	3.5	7.6	5.9	4.8	5.1	5.4	17.1	4.1	4.4	5.4	5.1	13.2	1.6	0.7	7.8	8.5	7.7	13.5	6.7	2.2	13.2	8.7	5.0	6.5	9.4	2.3	14.2	10.6	14.5	3.9	7.0	3.8	12.2	18.9	33.1	8.1	5.6	5.3	4.4	8.3	11.7	16.0	22.9	1.6	5.8	1.8	5.1	2.2	6.5	12.1	6.6	7.9	5.5	8.0	1.1	2.6	4.5	8.1	4.5	6.8	2.9	18.5	15.6	2.9	3.6	9.6	10.8	0.4	2.4	3.5	4.2	19.3	4.0	7.0	7.8	9.2	8.4	6.4	6.5	7.2	7.5	7.2	6.9	7.5	8.5	4.0	3.2	18.5	17.3	6.2	5.5	6.2	8.8	7.4	11.2	14.0	12.8	21.7	7.2	10.1	29.5	16.7	18.6	10.2	5.7	23.5	4.2	67.8	7.0	4.3	3.5	0.0	3.4	28.3	4.0	5.9	5.9	7.7	3.7	5.7	7.0	2.2	5.4	5.1	10.1	25.6	4.6	24.4	4.1	4.5	33.5	9.3	3.9	7.2	7.5	3.6	13.4	11.3	13.0	33.3	2.7	3.2	4.9	5.5	4.2	20.9	10.3	18.6	17.3	6.6	6.5	6.6	123.5	37.4	6.2	5.4	40.1	17.4	7.0	6.0	7.6
TMEM121B	CECR6	ENSG00000183307	"Transmembrane protein 121B"	Q9BXQ6	22	17116297-17121367	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;prostate: 6.6"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Hofbauer cells: 2.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 1.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.0;SCLC-21H: 14.2;THP-1: 11.9;U-937: 9.8"	"Low region specificity"	"Detected in all"							HPA068790	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA068790: AB_2686036"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.49e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.88e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.10e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.71e-1)"	0.3	0.6	6.4	0.9	7.5	1.0	0.7	3.5	7.6	0.2	1.5	0.2	0.2	0.3	0.9	0.3	0.3	0.2	1.2	8.7	3.9	0.3	0.1	0.3	0.1	3.8	3.3	0.2	1.1	0.1	1.6	0.7	3.3	6.6	0.2	1.3	0.4	0.2	1.3	0.5	0.2	0.3	3.6	0.7	0.2	1.9	4.9	0.1	0.1	0.4	0.1	0.3	0.2	5.1	0.0	0.0	6.0	0.8	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.1	0.3	0.0	0.8	3.2	2.1	0.0	0.1	0.2	3.0	0.0	0.3	0.1	14.2	2.1	0.0	0.0	0.3	0.8	0.0	11.9	0.6	0.6	0.2	0.2	0.0	0.2	0.4	0.9	0.0	9.8	0.3	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	6.4	7.5	3.5	7.6	8.7	3.9	3.8	3.3	3.3	3.6	4.9	5.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	1.3	0.9	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
TMEM126A	"DKFZp586C1924, OPA7"	ENSG00000171202	"Transmembrane protein 126A"	Q9H061	11	85647967-85656547	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046648	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA046648: AB_2679737"	"unprognostic (3.79e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.60e-5)"	"unprognostic (8.25e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.17e-1)"	31.9	28.0	40.3	23.1	41.5	43.8	33.5	41.4	52.3	21.8	39.5	28.0	32.6	20.0	31.2	27.2	19.8	19.9	82.1	41.4	42.3	33.1	49.0	20.5	27.3	40.7	40.6	21.0	33.9	26.3	22.2	22.8	41.5	23.5	29.3	23.9	31.3	19.5	81.6	19.4	26.0	27.6	41.1	21.0	32.8	38.5	41.4	24.2	26.6	98.7	27.8	30.5	20.1	42.4	46.7	53.2	50.9	33.0	67.2	66.7	38.0	55.9	60.1	82.3	77.6	65.9	67.5	25.4	61.3	69.2	32.0	48.9	53.8	59.5	70.7	72.5	31.0	72.5	56.9	73.7	82.4	89.0	54.8	58.0	65.8	73.1	78.0	43.5	71.6	72.2	51.1	39.0	86.2	57.5	48.6	112.3	48.1	175.1	68.4	48.3	49.5	79.2	54.5	57.0	34.3	34.7	49.4	72.9	44.7	44.5	88.1	64.4	42.8	70.4	52.7	134.6	65.3	27.5	54.4	70.4	37.0	63.6	85.2	6.6	23.9	11.6	21.2	28.1	26.0	29.8	26.4	23.8	32.9	27.3	24.4	24.1	1.9	15.1	23.4	24.7	26.4	18.7	40.3	41.5	41.4	52.3	41.4	42.3	40.7	40.6	41.5	41.1	41.4	42.4	40.5	28.9	24.3	12.7	39.6	31.7	55.3	87.9	29.6	14.8	45.8	62.1	110.8	28.6	57.5	38.6	6.2	67.8	38.5	23.6	146.8	51.0	147.8	26.8	32.8	36.7	21.7	46.1	8.6	93.2	73.3	40.8	23.4	24.2	37.4	33.6	26.7	68.5	94.6	8.4	9.0	46.6	40.7	54.4	43.3	80.6	29.5	48.4	33.8	5.6	66.3	35.1	38.1	8.5	11.8	64.5	34.8	26.7	45.4	73.4	61.8	109.4	39.7	21.9	19.7	40.0	40.9	119.0	57.9	49.4	42.1	52.9	42.1	42.2	57.1	71.2
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		170000	"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.3	0.1	4.6	0.0	3.0	0.0	0.1	6.1	6.4	0.4	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.5	2.6	6.2	3.6	0.4	0.1	0.1	17.9	5.1	0.2	0.0	0.0	0.1	0.1	10.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.7	0.1	8.7	0.3	0.1	1.9	6.5	0.0	0.2	0.0	0.1	0.1	0.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	4.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	3.0	6.1	6.4	2.6	6.2	17.9	5.1	10.2	8.7	6.5	11.1	0.1	0.0	0.0	2.6	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	6.4	0.0	0.0	1.9	0.7	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	0.2	0.5	1.2	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TMEM14A	"C6orf73, PTD011"	ENSG00000096092	"Transmembrane protein 14A"	Q9Y6G1	6	52671113-52686588	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 253.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072536	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Endoplasmic reticulum"		"HPA072536: AB_2686531"	"unprognostic (6.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.56e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.64e-1)"	20.7	46.8	51.9	13.6	52.7	10.3	24.9	52.7	78.4	25.8	72.6	25.3	38.3	27.7	36.4	36.2	31.3	25.0	16.5	53.3	62.6	51.5	106.4	18.0	19.7	55.1	50.5	39.8	36.2	22.2	24.2	16.1	55.8	36.4	25.9	31.4	21.7	21.6	4.4	13.9	35.4	26.4	52.5	13.7	40.8	17.2	55.0	15.5	28.6	8.5	23.9	24.4	26.2	55.4	253.4	37.5	27.3	77.6	73.1	56.0	23.1	50.0	68.0	45.2	69.5	57.8	63.5	30.8	54.2	63.1	94.9	93.9	61.3	83.7	75.3	125.0	50.1	45.6	57.4	95.7	24.0	23.6	54.7	50.5	57.8	49.5	11.1	59.5	61.7	38.9	9.8	85.4	54.1	51.3	46.4	26.9	16.2	165.9	64.7	36.0	38.8	24.5	88.5	48.1	141.4	68.5	55.6	44.2	97.1	33.9	68.0	44.8	45.8	62.0	83.3	24.5	81.3	40.9	37.1	46.6	87.4	14.8	50.7	23.3	0.5	16.4	38.4	0.1	24.8	54.6	48.7	40.4	19.4	36.0	36.9	39.4	2.1	11.0	0.1	35.2	66.5	30.3	51.9	52.7	52.7	78.4	53.3	62.6	55.1	50.5	55.8	52.5	55.0	55.4	28.6	25.6	17.6	13.1	23.4	48.4	61.9	183.5	56.9	20.4	71.3	72.4	17.4	54.3	90.1	51.5	8.4	56.1	27.5	22.6	64.6	108.1	1.4	31.2	33.3	37.3	33.5	32.8	50.3	140.9	150.8	62.4	50.0	26.3	25.4	46.5	38.6	138.7	47.0	5.0	45.7	53.1	77.3	7.0	56.6	2.5	43.5	10.9	88.9	16.9	4.9	27.1	16.5	15.1	15.5	74.7	25.2	50.0	18.6	48.5	77.4	152.7	85.5	13.2	6.6	38.6	60.7	4.3	41.2	139.5	38.2	15.5	30.9	22.0	51.7	69.3
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618628-152680012	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 58.3;skin 1: 58.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.6;Basal keratinocytes: 74.2;Glandular and luminal cells: 75.0;granulocytes: 101.2;monocytes: 82.1;Squamous epithelial cells: 119.2;Suprabasal keratinocytes: 194.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 6.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"basophil: 403.7;eosinophil: 305.7;neutrophil: 477.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 477.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 63.0;HMC-1: 71.1;Karpas-707: 55.6;U-266/70: 69.7;U-937: 56.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear membrane"	Nucleoplasm	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	3.1	0.5	0.3	17.2	0.7	18.6	4.3	0.6	1.7	5.7	0.5	3.1	2.6	1.6	0.7	58.3	1.4	5.1	0.8	0.4	0.7	0.6	5.9	5.1	14.3	0.8	0.6	0.2	1.0	0.3	0.8	3.8	1.1	2.0	2.6	0.2	6.9	2.3	0.4	58.5	3.6	1.8	0.7	12.4	5.9	0.2	1.0	6.2	3.6	1.9	26.4	11.6	7.9	1.0	32.1	0.1	0.3	0.1	0.5	8.7	14.1	8.0	29.1	8.5	16.2	0.4	4.2	32.5	3.3	7.6	9.3	22.8	0.0	63.0	15.5	0.1	0.1	1.8	0.5	0.0	8.9	25.7	71.1	8.3	29.7	27.1	23.4	0.0	21.4	19.7	0.1	55.6	0.7	2.3	10.1	8.0	1.6	0.1	7.8	1.2	0.1	0.2	47.5	19.4	0.1	1.2	2.2	6.2	1.0	8.4	1.0	17.8	8.6	1.2	5.1	0.7	11.1	69.7	26.0	18.1	11.7	56.6	6.6	403.7	37.8	305.7	4.9	38.2	9.2	51.6	10.9	7.9	19.6	45.1	10.7	7.4	477.5	0.8	43.7	2.5	22.5	17.2	0.3	0.7	0.6	1.7	0.4	0.7	0.8	0.6	1.1	0.7	1.0	1.0	6.5	12.8	19.3	0.0	108.6	74.2	9.0	23.6	20.5	0.1	8.8	4.8	1.7	0.0	20.9	22.0	2.1	25.0	9.8	0.9	0.0	6.4	0.1	31.9	13.4	6.7	1.2	6.6	0.5	3.7	14.5	5.2	8.2	75.0	101.2	0.1	0.7	4.6	4.5	3.3	0.3	0.7	14.2	9.8	15.7	0.2	0.6	28.2	5.4	15.9	82.1	0.1	5.2	3.5	0.1	21.5	7.1	0.0	45.7	5.4	0.0	0.3	60.5	0.7	0.0	3.0	3.6	0.1	0.5	119.2	194.4	25.9	28.6	0.5	2.6	27.2
TMEM169	FLJ34263	ENSG00000163449	"Transmembrane protein 169"	Q96HH4	2	216081866-216102783	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;retina: 3.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.4;Cone photoreceptor cells: 22.9;Excitatory neurons: 13.1;Inhibitory neurons: 13.9;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 9.3;Rod photoreceptor cells: 11.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 7.3;RPTEC TERT1: 12.3;SCLC-21H: 9.9;SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"							"HPA062462, HPA062797, HPA070657, HPA074877"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"	Centrosome	"HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: "	"unprognostic (5.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.69e-7)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	0.5	1.0	1.4	1.0	3.0	0.3	0.2	1.5	2.6	0.7	0.0	0.4	0.7	0.3	0.7	0.2	1.0	0.8	0.4	2.3	2.1	1.8	1.7	0.6	1.0	2.6	2.1	0.3	0.3	0.1	0.8	0.1	2.8	0.4	0.3	3.4	0.2	0.3	0.3	0.5	0.6	0.4	1.0	1.0	0.2	0.3	1.7	1.0	2.6	0.3	0.7	0.2	0.1	2.8	0.0	0.3	7.3	0.1	1.0	0.0	0.0	0.3	0.2	0.2	0.8	0.3	2.4	0.0	5.8	0.3	0.4	0.1	0.9	0.0	0.2	1.4	0.3	2.9	0.1	1.4	1.9	0.1	0.5	0.6	0.6	0.5	0.7	1.8	0.0	0.9	0.0	0.3	6.3	0.8	0.2	0.1	4.1	0.0	0.0	1.4	2.0	0.0	12.3	0.0	9.9	14.5	0.3	0.1	5.7	4.0	0.5	1.0	0.0	0.2	0.4	0.0	0.4	1.7	2.2	0.4	1.9	0.2	1.4	0.8	1.0	0.1	1.2	1.0	0.9	1.5	2.0	1.4	0.0	1.4	2.1	0.9	2.3	0.3	3.2	0.1	3.7	0.7	1.4	3.0	1.5	2.6	2.3	2.1	2.6	2.1	2.8	1.0	1.7	2.8	0.3	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	14.4	0.1	0.5	0.8	4.3	0.0	5.5	22.9	0.1	0.3	0.0	0.0	0.6	0.0	0.4	0.4	0.2	4.9	0.0	13.1	0.0	0.0	0.2	0.5	0.5	0.0	0.0	1.4	0.8	0.4	0.0	13.9	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.0	3.7	0.2	2.2	3.1	11.1	9.3	0.1	0.6	0.4	0.3	0.1	0.3	2.8	0.1	11.6	0.0	3.6	0.4	0.0	0.7	0.0	0.0	0.0	0.8	0.1	0.2	0.1
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.5	28.2	13.0	8.1	13.3	12.9	17.5	15.7	24.6	14.7	12.2	15.5	8.9	17.3	6.0	14.2	14.9	10.0	19.6	12.9	13.1	16.4	33.5	16.1	16.1	14.6	13.1	12.2	23.3	9.2	30.9	7.4	14.5	19.0	3.6	10.2	21.4	8.7	19.7	17.0	17.5	6.4	11.4	26.1	19.3	13.2	12.7	8.9	21.0	4.5	6.1	16.1	13.5	13.5	4.9	9.5	5.1	7.0	23.7	12.3	11.8	13.0	8.6	7.3	10.8	4.2	20.5	4.0	7.5	12.8	12.8	8.4	4.7	9.5	3.1	9.2	11.9	8.3	14.9	4.3	13.7	4.6	14.8	17.5	11.3	6.4	4.3	5.1	4.6	8.1	8.2	30.0	6.4	16.2	11.3	17.4	3.2	5.8	24.8	7.5	3.1	11.5	7.0	5.0	14.0	12.9	8.6	5.5	7.8	2.5	24.3	11.3	6.6	13.7	3.0	16.8	9.1	23.0	5.9	7.4	13.2	9.4	11.3	36.8	32.2	27.2	20.6	41.1	13.3	19.4	17.3	15.5	29.4	21.6	12.6	17.6	27.8	17.0	39.7	47.1	18.5	21.2	13.0	13.3	15.7	24.6	12.9	13.1	14.6	13.1	14.5	11.4	12.7	13.5	17.0	12.8	8.9	26.8	20.7	6.2	8.1	21.0	12.5	26.8	15.2	14.4	10.4	8.6	17.1	14.7	4.2	24.1	19.2	13.7	1.9	8.8	6.1	11.6	12.2	10.2	16.2	3.0	42.8	11.4	10.1	16.6	17.9	11.3	7.0	10.8	10.8	24.5	15.2	47.1	37.8	9.6	34.6	14.5	9.1	4.0	12.5	15.8	19.6	15.0	9.6	38.6	15.5	25.1	29.1	7.9	16.1	16.1	16.7	6.1	16.6	8.0	13.6	28.7	13.1	10.1	12.3	24.0	14.1	12.3	7.7	18.9	15.3	29.2	7.6	8.4
TMEM176B	"LR8, MS4B2"	ENSG00000106565	"Transmembrane protein 176B"	Q3YBM2	7	150791285-150801360	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 1656.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 1171.9;monocytes: 502.3;Paneth cells: 762.4;Proximal enterocytes: 922.5;Proximal tubular cells: 976.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 537.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 865.5;intermediate monocyte: 586.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 865.5"	"Group enriched"	"Detected in some"	17	"HSkMC: 642.7;THP-1: 215.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047509	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA047509: AB_2680072"	"unprognostic (5.21e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.05e-2)"	120.9	49.5	48.5	190.8	50.1	13.5	77.8	50.7	65.8	74.5	43.0	251.8	167.7	25.9	25.7	50.4	81.5	197.3	208.5	45.4	58.0	356.5	1656.5	95.6	177.5	69.2	60.1	143.1	53.6	7.3	22.7	115.0	64.5	48.9	244.9	34.1	42.5	28.3	11.0	34.7	286.6	99.0	65.0	87.0	94.5	11.1	52.2	26.1	33.6	36.1	93.7	158.6	92.4	73.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	25.7	0.4	0.8	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.6	0.8	0.2	642.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.1	0.9	0.5	0.1	0.0	0.1	1.0	11.8	0.1	0.0	1.9	1.4	0.6	0.3	0.2	0.2	0.0	215.7	0.0	0.0	3.2	0.5	0.2	0.4	0.2	0.6	0.0	0.3	0.0	5.3	865.5	50.5	2.3	586.0	3.4	2.5	0.6	0.7	164.3	0.6	0.7	0.4	8.6	0.6	309.3	7.7	0.6	498.5	48.5	50.1	50.7	65.8	45.4	58.0	69.2	60.1	64.5	65.0	52.2	73.2	22.2	3.2	9.3	14.4	16.9	12.6	0.5	0.9	5.7	156.9	52.2	74.0	73.7	190.1	14.4	375.2	2.1	0.9	2.8	419.4	166.3	95.1	18.5	6.1	14.5	19.8	128.1	13.5	0.1	34.0	1.0	243.7	14.8	2.1	54.4	61.9	22.9	1171.9	92.5	6.7	0.6	252.1	46.8	98.5	44.4	12.2	43.5	190.0	16.0	8.4	502.3	87.3	1.0	7.5	0.1	65.4	762.4	3.4	1.5	2.5	922.5	976.5	11.3	17.9	0.0	6.7	34.0	4.0	3.8	1.8	15.6	2.7	9.1	0.4	263.7	2.8
TMEM177	MGC10993	ENSG00000144120	"Transmembrane protein 177"	Q53S58	2	119679167-119686507	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 66.5;Proximal tubular cells: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036689, HPA053816"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA036689: AB_2675253, HPA053816: AB_2682272"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.05e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.90e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	3.2	8.0	6.6	4.8	7.1	1.0	6.8	7.4	7.7	5.3	3.3	10.9	16.1	6.6	9.0	5.7	10.6	3.9	8.2	6.8	4.6	13.4	25.7	3.3	5.1	4.2	6.2	7.9	5.5	8.2	12.5	3.2	4.5	5.9	9.1	7.2	6.9	5.9	12.2	6.7	13.7	5.2	3.9	4.0	6.3	7.7	6.6	4.7	5.6	7.0	5.2	5.2	4.9	6.6	22.9	19.9	17.2	16.7	4.6	4.5	8.9	8.4	10.4	24.3	18.3	50.4	12.6	37.9	20.1	7.4	19.9	13.7	27.9	28.7	14.0	18.0	51.4	19.5	11.8	56.7	10.1	12.5	13.9	12.4	20.1	19.2	12.5	9.3	15.7	22.3	30.7	4.9	13.3	19.0	21.8	24.3	44.0	16.7	29.2	19.6	16.8	22.4	24.4	11.8	33.8	19.3	10.9	23.2	26.9	15.9	17.7	21.1	12.8	12.0	28.7	9.2	16.7	4.9	3.8	23.3	4.5	15.2	22.0	0.0	2.6	2.6	8.2	2.1	8.5	6.6	6.9	8.4	4.9	8.7	16.2	10.3	0.8	7.2	1.4	5.8	7.9	5.5	6.6	7.1	7.4	7.7	6.8	4.6	4.2	6.2	4.5	3.9	6.6	6.6	2.6	3.2	0.0	3.3	3.6	2.9	12.1	13.9	1.8	13.3	8.2	9.7	13.0	11.5	10.7	5.5	14.6	11.9	2.1	8.9	66.5	16.0	2.2	4.0	6.8	5.0	2.4	3.4	4.1	14.3	9.7	5.4	5.6	2.8	0.0	10.1	1.4	30.5	6.3	11.8	4.1	7.2	8.2	1.2	1.1	2.1	7.5	1.5	14.2	0.0	4.7	9.4	5.2	5.5	2.0	12.3	6.5	12.4	3.4	9.2	22.8	47.2	5.4	21.8	0.0	2.6	6.1	6.5	6.6	5.1	2.0	2.1	4.1	21.5	14.1	4.5
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 135.5"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 32.4;Excitatory neurons: 109.1;Inhibitory neurons: 109.2;Oligodendrocyte precursor cells: 33.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 10.2;glioma: 13.2;prostate cancer: 19.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 138.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	5.9	7.6	65.4	0.6	71.3	0.2	6.2	135.5	104.1	4.1	38.6	8.9	1.9	3.6	1.5	1.8	6.3	2.7	4.5	71.7	51.3	42.7	9.9	6.7	0.5	64.7	54.9	5.9	4.6	2.3	12.9	3.2	65.5	11.6	1.7	15.7	21.9	1.6	2.8	3.3	3.2	2.4	65.7	2.6	8.6	2.2	51.5	0.5	12.3	1.9	0.5	3.9	3.0	108.0	0.0	0.0	138.7	0.1	0.1	3.3	0.2	0.6	0.1	0.0	0.3	0.0	0.3	0.0	3.7	0.0	0.0	0.3	4.5	0.0	0.5	0.3	0.1	0.0	0.0	0.4	1.1	0.1	0.0	2.6	0.3	0.0	0.4	4.3	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.2	17.7	0.2	0.1	1.7	0.0	0.0	1.0	0.2	25.7	0.6	0.0	0.6	0.3	23.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	71.3	135.5	104.1	71.7	51.3	64.7	54.9	65.5	65.7	51.5	108.0	3.2	0.0	2.0	14.7	0.0	0.4	0.5	0.6	1.8	9.1	1.1	32.4	3.9	0.0	1.3	12.9	6.2	0.3	0.1	0.8	0.0	0.2	0.4	3.0	1.2	4.3	16.1	0.0	109.1	0.2	0.0	2.6	0.0	6.5	0.0	1.4	0.7	0.5	0.2	1.7	109.2	0.4	2.0	0.0	0.4	0.1	0.0	0.2	1.8	7.5	0.0	1.1	0.0	33.7	19.3	0.4	0.3	0.0	0.0	3.7	0.5	0.7	4.3	6.1	0.0	0.9	0.6	0.2	0.5	0.1	0.6	0.5	0.1	0.5	0.4	0.3
TMEM182	FLJ30294	ENSG00000170417	"Transmembrane protein 182"	Q6ZP80	2	102736905-103019900	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	24	"heart muscle: 97.6;skeletal muscle: 150.7;tongue: 127.7"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 150.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA045861			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Vesicles"		"HPA045861: AB_2679475"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.12e-4)"	"unprognostic (5.35e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.36e-2)"	2.7	1.6	2.2	0.7	2.0	0.6	2.3	2.6	2.9	2.9	2.2	1.8	1.9	1.1	5.3	3.9	2.1	1.8	97.6	2.5	3.1	2.1	2.0	1.3	1.8	2.8	2.7	1.5	2.1	3.6	2.6	1.4	3.0	4.0	2.3	1.5	2.0	2.1	150.7	0.5	1.2	1.1	2.5	1.6	2.2	1.4	2.6	1.8	3.0	127.7	1.4	2.2	0.6	2.7	4.9	3.3	2.4	7.3	2.8	2.4	6.9	2.5	2.2	2.4	4.4	10.7	7.3	4.5	9.0	1.4	6.1	3.3	2.6	3.7	5.4	11.6	3.5	6.6	1.4	6.7	3.0	6.2	4.4	3.2	7.6	4.5	5.2	1.9	0.4	6.4	5.2	1.2	3.5	4.6	3.9	5.7	4.2	5.9	3.6	3.4	6.3	3.7	5.7	6.2	5.2	1.9	4.1	3.3	10.3	3.5	3.0	3.2	0.7	4.2	3.5	2.7	3.1	3.9	13.0	5.5	3.8	8.4	6.3	0.0	0.0	0.2	2.5	0.2	2.8	3.6	1.5	1.3	0.9	1.2	2.4	2.4	0.0	2.4	0.3	2.9	0.5	1.1	2.2	2.0	2.6	2.9	2.5	3.1	2.8	2.7	3.0	2.5	2.6	2.7	0.6	22.4	12.3	1.3	3.6	0.4	1.0	1.8	1.2	0.3	8.1	2.4	150.6	0.0	15.3	3.7	0.0	2.3	4.2	0.5	0.0	1.8	0.6	2.4	1.1	2.0	6.6	3.6	6.1	3.3	2.6	6.9	4.1	1.6	3.8	1.2	0.7	2.3	1.2	0.0	10.8	2.6	2.0	0.8	0.7	0.6	0.6	1.3	7.2	6.5	0.1	2.4	1.0	8.5	3.4	2.4	1.1	0.7	2.7	1.0	1.0	2.4	12.8	0.3	0.0	4.6	2.3	1.0	2.4	2.5	0.6	1.1	2.9	1.1	1.8	2.8
TMEM183A	C1orf37	ENSG00000163444	"Transmembrane protein 183A"	Q8IXX5	1	203007374-203024848	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072607			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA072607: AB_2686539"	"unprognostic (2.94e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (6.46e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.28e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.01e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	21.6	19.1	27.6	17.0	28.8	76.6	22.1	28.2	35.1	22.9	23.8	30.9	26.6	19.8	18.8	30.3	19.4	14.1	17.0	30.1	30.1	22.8	23.9	21.0	21.7	26.7	25.8	20.1	28.7	17.8	12.2	14.4	27.7	21.2	30.2	21.8	25.4	16.4	14.8	27.5	26.1	19.9	23.7	22.2	25.2	34.1	26.7	30.0	22.2	12.7	24.1	23.4	22.9	27.0	32.7	31.2	39.2	64.6	50.6	37.7	64.4	32.2	31.7	36.4	31.7	38.1	33.6	81.1	22.6	41.7	14.6	40.4	53.1	45.1	30.1	26.6	64.5	40.2	33.8	42.3	36.6	72.6	33.9	37.3	49.3	30.1	60.2	36.8	46.6	64.4	83.8	28.7	34.5	73.3	59.7	74.4	107.7	44.0	49.2	45.4	66.7	65.7	57.0	31.6	50.2	62.7	48.0	79.0	48.1	61.9	56.6	56.6	34.8	24.4	34.2	42.3	35.7	28.8	49.7	62.4	27.0	55.7	26.3	33.3	33.6	51.2	23.5	29.2	23.1	23.8	26.3	26.6	37.4	26.2	29.8	24.7	28.7	36.6	27.8	26.8	30.6	37.4	27.6	28.8	28.2	35.1	30.1	30.1	26.7	25.8	27.7	23.7	26.7	27.0	39.7	16.0	20.5	3.6	40.4	73.4	61.5	62.2	41.5	22.8	62.2	48.6	14.9	54.3	52.1	35.0	10.4	53.2	57.3	70.4	70.5	88.6	161.1	31.1	34.9	36.2	52.7	103.7	13.2	76.1	86.0	34.8	42.3	34.4	17.7	34.6	40.7	53.6	60.4	18.5	11.8	87.5	63.1	63.1	52.0	113.7	27.1	49.7	39.2	6.5	71.1	26.6	50.4	3.5	7.2	52.7	57.6	29.3	62.1	100.2	102.3	100.4	44.5	28.0	19.7	38.3	46.7	95.0	80.9	72.9	82.1	51.6	48.3	39.6	88.6	105.2
TMEM184A	"MGC9712, SDMG1"	ENSG00000164855	"Transmembrane protein 184A"	Q6ZMB5	7	1542235-1560821	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 94.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 65.9;Intestinal goblet cells: 40.4;Paneth cells: 41.7;Proximal enterocytes: 60.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 34.2;RT4: 37.9;SCLC-21H: 40.8;SK-BR-3: 58.4;T-47d: 53.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053790, HPA071312"	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA053790: AB_2682263, HPA071312: AB_2686387"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (5.47e-2)"	0.4	0.3	0.1	1.4	0.1	0.7	3.0	0.1	1.0	20.6	0.2	12.1	24.4	1.1	0.3	94.6	7.0	3.6	0.4	0.0	0.2	6.2	24.4	2.2	0.2	0.2	0.0	0.2	22.9	5.2	11.4	1.7	0.1	11.3	6.6	0.1	22.5	4.5	4.9	37.0	23.6	0.3	0.0	0.1	12.6	3.7	0.2	0.6	0.6	0.6	4.3	12.8	41.0	0.1	23.7	15.0	0.1	0.0	0.0	0.1	5.0	0.8	0.3	0.9	0.1	20.9	25.4	0.5	7.6	0.3	7.5	17.0	0.0	9.7	0.3	0.2	0.9	0.1	15.3	9.7	0.2	0.0	0.0	0.0	8.9	0.3	8.0	0.4	0.1	6.3	0.2	0.1	0.0	34.2	0.2	0.1	0.7	13.5	19.3	0.5	0.0	10.9	7.3	37.9	40.8	0.1	6.4	58.4	0.1	0.5	53.7	0.1	0.0	0.0	8.2	9.7	1.1	0.1	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	2.9	3.2	4.4	0.0	1.6	4.0	5.8	7.2	2.2	1.1	12.1	5.5	7.5	11.5	18.2	9.2	0.0	7.1	1.4	65.9	1.9	13.2	0.0	19.3	3.4	1.4	7.2	0.0	0.3	11.0	8.7	1.7	23.4	31.7	1.3	0.5	0.0	14.2	0.8	0.0	0.1	40.4	14.2	0.6	2.6	0.0	0.0	1.4	0.0	0.0	0.6	0.5	0.0	0.0	0.0	13.1	41.7	0.0	4.6	10.4	60.5	5.1	28.0	0.6	0.0	1.8	3.0	0.0	0.1	15.4	9.2	16.8	1.2	0.1	19.4	16.0
TMEM184B	"C22orf5, DKFZP586A1024, FM08, HS5O6A"	ENSG00000198792	"Transmembrane protein 184B"	Q9Y519	22	38219291-38273010	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 86.8;Oligodendrocytes: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024076	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA024076: AB_1858106"	"unprognostic (1.52e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.94e-6)"	"unprognostic (1.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.96e-1)"	28.6	21.9	49.5	14.0	52.3	5.8	24.9	54.5	59.6	18.6	22.1	21.0	16.9	19.4	7.2	17.3	17.1	14.5	35.7	49.6	48.2	25.9	11.4	35.9	8.4	56.8	56.0	16.2	18.4	18.9	34.3	38.4	54.8	18.8	10.8	15.2	22.6	14.4	28.7	16.0	17.6	14.0	52.9	22.0	22.4	7.5	56.7	6.2	26.1	17.4	8.2	18.4	16.5	66.9	55.8	47.5	27.5	21.9	53.6	42.6	63.4	58.8	82.9	46.9	41.5	35.1	25.2	10.6	44.9	87.6	42.4	67.2	24.9	57.8	31.6	37.9	45.0	20.9	34.0	29.5	56.3	16.6	28.0	36.1	50.2	55.4	61.5	48.5	59.5	15.9	13.5	36.2	41.5	31.6	10.6	14.1	22.4	41.2	43.4	18.1	24.8	10.6	34.8	60.6	59.3	10.5	44.2	63.6	32.0	31.7	35.2	12.0	89.2	47.7	48.4	42.5	36.2	74.5	197.9	8.5	69.2	12.1	42.0	14.2	3.3	4.7	5.3	2.3	4.6	1.4	2.9	4.0	4.5	1.1	2.1	2.5	10.9	6.2	1.6	7.0	1.0	3.2	49.5	52.3	54.5	59.6	49.6	48.2	56.8	56.0	54.8	52.9	56.7	66.9	43.4	6.4	14.8	86.8	7.5	12.4	19.8	22.3	17.6	16.4	15.9	10.5	17.1	8.6	18.7	14.7	2.1	35.0	17.8	12.5	3.9	17.3	5.6	17.4	15.5	34.6	25.9	4.6	42.6	22.2	48.3	17.4	13.3	33.8	2.5	15.3	18.2	4.4	14.7	15.2	40.7	19.7	12.2	8.5	19.7	2.4	11.8	8.4	14.2	22.5	12.2	44.4	23.7	42.3	93.1	28.3	9.8	13.5	35.6	32.9	11.1	4.3	15.9	9.0	19.7	15.3	27.0	3.3	6.1	5.3	9.7	78.4	9.3	10.2	10.1	37.0
TMEM184C	"FLJ10846, TMEM34"	ENSG00000164168	"Transmembrane protein 184C"	Q9NVA4	4	147617386-147672044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 131.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054013	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA054013: AB_2682343"	"unprognostic (5.45e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.31e-7)"	"unprognostic (4.68e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.31e-3)"	14.0	20.7	7.8	12.4	10.0	7.9	12.8	10.0	15.9	16.1	10.3	14.8	17.2	14.2	11.2	12.9	13.6	13.4	14.3	10.6	8.9	20.3	20.4	12.7	11.4	8.1	8.7	16.5	15.4	131.7	7.1	19.6	8.7	16.7	16.4	16.2	17.3	16.7	14.7	11.8	16.9	14.3	9.2	11.2	15.3	12.0	9.9	12.6	32.6	16.4	13.8	14.5	7.6	11.2	17.4	27.3	33.7	25.6	45.0	44.6	22.3	32.6	37.5	23.7	26.9	22.7	32.7	16.3	15.7	25.1	23.2	20.5	28.4	24.6	25.8	36.4	16.2	21.1	19.8	16.2	36.3	28.8	29.8	33.2	33.0	26.3	26.9	34.9	30.7	18.4	27.2	44.1	33.6	27.0	24.8	10.2	21.7	40.4	15.7	24.3	11.6	28.2	26.3	32.6	25.8	33.4	18.3	27.0	28.5	25.8	26.8	17.5	31.5	29.2	15.7	24.3	21.0	47.9	68.0	21.5	34.9	17.0	32.7	20.5	12.9	14.7	15.3	16.5	19.4	10.4	13.9	13.9	15.8	12.1	13.0	12.4	10.0	14.6	17.9	10.8	14.3	11.0	7.8	10.0	10.0	15.9	10.6	8.9	8.1	8.7	8.7	9.2	9.9	11.2	8.3	9.6	9.3	7.8	9.5	4.6	8.0	6.3	6.8	8.6	8.3	5.7	19.8	8.6	11.5	5.5	12.5	14.3	12.5	9.8	1.9	12.8	34.6	8.0	11.1	10.0	5.4	8.2	10.4	12.7	12.0	10.6	7.7	9.9	21.5	7.3	8.2	11.8	10.4	11.8	12.7	7.7	6.1	11.9	5.1	13.7	10.8	9.1	5.4	6.5	6.4	8.5	7.2	8.5	14.1	8.6	6.7	14.7	9.0	7.8	9.7	5.8	5.2	6.5	6.6	9.5	8.8	6.5	5.4	10.6	3.4	8.6	12.0	10.6	11.3	7.0
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavorable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.0	15.2	4.9	7.2	5.9	6.6	13.2	7.5	7.0	9.9	7.1	11.5	9.7	10.5	9.0	8.8	11.2	10.3	12.6	4.8	5.2	48.3	45.2	10.6	8.9	4.7	5.5	24.5	22.3	24.6	5.1	10.8	5.0	22.1	13.3	10.7	14.5	8.4	15.0	5.4	9.3	8.6	4.6	9.1	10.5	9.8	4.8	6.6	26.8	17.0	7.7	8.5	5.4	6.2	13.5	19.9	7.1	18.0	18.1	6.4	16.5	20.1	29.4	20.5	22.8	11.7	21.6	29.5	11.7	13.0	33.4	11.8	26.8	20.6	23.6	19.2	13.8	16.4	14.1	13.4	46.1	41.0	21.2	23.3	42.8	18.4	37.4	17.8	17.0	15.6	28.4	48.1	25.4	29.4	7.1	12.0	14.8	28.1	16.9	16.0	6.2	27.1	16.4	19.6	15.2	15.9	31.4	49.1	31.9	10.4	23.9	18.5	12.6	9.0	11.1	28.6	23.0	46.9	67.0	40.8	21.6	22.2	36.6	2.9	16.6	4.8	12.1	14.9	16.3	26.7	9.4	12.6	15.7	20.2	10.4	12.6	1.7	18.7	8.3	16.3	8.5	10.7	4.9	5.9	7.5	7.0	4.8	5.2	4.7	5.5	5.0	4.6	4.8	6.2	12.3	32.1	36.2	18.9	24.0	9.7	18.4	10.5	10.2	33.0	21.5	15.7	35.0	42.9	19.1	55.2	16.7	31.4	15.4	17.0	11.7	21.0	26.4	11.2	17.0	19.0	21.7	10.1	16.4	25.8	20.5	18.9	7.7	15.5	40.4	26.1	27.8	77.7	38.2	37.0	16.5	18.2	6.1	27.4	17.7	11.1	39.7	22.3	28.4	11.2	21.3	35.8	28.8	14.6	20.9	11.5	14.3	33.4	11.8	33.7	26.3	63.4	10.9	27.1	6.6	30.7	20.7	17.8	18.3	12.0	12.9	33.7	15.9	27.1	24.0	14.2
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719315-19773617	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 10.4;retina: 21.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 116.4;Endometrial stromal cells: 90.9;Excitatory neurons: 45.1;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 127.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 4.8;ASC TERT1: 4.5"					"Low region specificity"	"Detected in many"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.3	1.3	2.6	0.0	4.4	0.0	0.0	0.0	4.1	0.4	0.0	0.1	0.0	1.4	0.4	0.0	0.3	0.0	0.0	2.7	10.4	0.0	0.0	0.0	0.0	3.6	6.7	0.0	1.1	0.0	3.7	0.0	3.3	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.7	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	4.8	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.4	0.0	4.1	2.7	10.4	3.6	6.7	3.3	1.9	7.1	1.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	116.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	90.9	0.4	0.0	0.0	45.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	3.3	23.9	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	1.9	0.0	2.6	0.0	127.6	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588911-9614877	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear membrane"	Nucleoplasm	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	5.8	6.1	8.6	3.6	8.9	7.7	5.2	7.9	9.7	7.5	6.8	5.7	3.2	7.3	2.0	7.0	6.3	2.2	14.5	9.4	8.4	9.5	3.4	4.0	3.2	10.8	9.7	9.4	6.1	4.4	16.0	2.5	9.5	6.4	1.3	6.1	5.5	2.9	43.2	6.4	4.7	2.7	7.9	5.4	4.6	10.4	9.6	3.2	5.5	24.3	2.0	5.2	5.5	8.3	13.6	18.2	11.1	26.3	4.6	3.1	9.9	15.7	4.8	18.3	12.9	33.1	12.0	23.5	19.4	5.5	9.0	27.9	12.4	12.4	6.2	15.7	31.2	16.7	17.4	17.0	8.4	20.4	16.6	5.7	5.5	24.6	3.9	3.9	7.3	10.9	21.7	6.6	7.5	16.0	17.8	14.8	11.2	10.3	16.4	37.1	19.0	19.3	6.6	7.3	26.6	19.9	12.3	29.9	13.5	3.8	9.1	12.7	6.7	21.7	18.8	24.0	30.0	11.0	9.9	21.0	15.0	33.0	19.6	0.0	0.2	0.0	0.3	0.2	0.1	0.5	0.3	0.5	0.3	0.2	0.2	0.2	0.0	0.1	0.1	1.3	0.5	0.3	8.6	8.9	7.9	9.7	9.4	8.4	10.8	9.7	9.5	7.9	9.6	8.3	5.2	3.2	2.0	4.9	2.2	7.0	2.5	1.8	4.6	16.0	5.3	4.7	12.1	2.8	2.1	0.0	27.1	4.1	0.8	2.6	1.9	2.3	2.0	4.2	4.9	4.9	6.7	5.2	4.1	1.0	2.5	4.0	2.6	4.4	4.5	11.7	3.6	1.6	3.6	10.1	6.0	3.7	2.0	2.5	3.5	1.8	4.1	2.4	3.6	0.0	0.9	5.0	1.0	7.1	5.9	1.7	0.9	4.5	2.8	3.2	0.6	1.9	2.4	16.9	0.0	7.3	4.2	6.8	5.4	7.9	5.5	0.8	2.8	4.6	4.3	2.3
TMEM205	"MBC3205, UNQ501"	ENSG00000105518	"Transmembrane protein 205"	Q6UW68	19	11342776-11346518	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 405.8;Hepatocytes: 520.1;Late spermatids: 662.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"	"Nucleoplasm, Nuclear membrane"	"HPA041504: AB_10795595"	"unprognostic (2.54e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.56e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	70.3	177.5	111.5	36.8	113.2	55.2	76.0	110.7	142.9	92.8	135.4	73.8	62.3	69.5	92.6	53.7	85.2	61.1	119.7	117.2	122.4	139.2	276.9	73.9	38.9	112.8	113.1	86.8	155.0	210.0	97.4	53.6	114.0	93.2	36.4	25.9	92.4	78.7	122.2	74.3	57.2	42.2	113.6	62.6	86.3	78.8	113.6	39.3	132.1	66.0	34.1	92.4	64.0	122.7	95.5	229.7	28.5	96.2	54.1	64.5	52.6	35.2	80.9	75.9	59.4	70.0	29.5	84.7	209.3	71.6	74.5	95.6	40.5	106.6	50.5	100.7	39.2	23.0	76.5	117.7	135.9	38.9	69.8	61.3	106.7	48.7	81.0	78.5	92.3	79.9	70.4	349.8	47.0	238.8	58.6	108.9	49.9	123.0	174.5	54.3	43.4	225.9	186.9	169.0	50.2	76.7	37.3	151.1	88.1	33.1	132.2	111.3	54.0	94.3	36.2	104.4	80.2	207.0	225.3	51.5	90.4	172.2	74.0	31.8	336.5	36.7	67.2	150.0	67.9	112.7	54.7	58.5	208.2	95.8	43.9	52.2	52.6	55.8	91.0	150.9	73.7	175.8	111.5	113.2	110.7	142.9	117.2	122.4	112.8	113.1	114.0	113.6	113.6	122.7	80.5	67.3	70.5	40.1	44.1	51.5	135.9	281.3	62.0	32.5	113.3	134.4	68.5	175.8	202.3	152.6	12.5	123.7	27.7	53.7	60.7	159.2	405.8	63.2	65.8	72.4	117.6	14.5	30.8	162.7	83.0	76.4	26.0	97.0	29.2	45.4	69.3	520.1	94.4	26.9	27.3	81.4	136.3	67.5	50.0	662.3	80.8	61.2	96.0	5.6	62.1	91.9	19.6	17.6	22.2	97.7	68.6	68.1	70.7	136.7	104.1	224.6	69.3	33.1	46.0	76.3	70.9	38.1	15.6	46.4	54.0	96.7	29.8	101.6	79.3	130.9
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783540-32789201	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 6.9;retina: 18.3;testis: 3.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 572.0;Early spermatids: 129.9;Late spermatids: 302.1"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Region enriched"	"Detected in many"	4	"thalamus: 6.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"			Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA052804: AB_2681957, HPA063207: AB_2732697"	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.0	0.0	1.2	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	18.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.9	6.9	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.5	0.7	1.5	0.2	1.6	0.3	0.3	6.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	572.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	129.9	0.0	1.2	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	3.7	0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.0	0.0	302.1	2.8	0.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.1	3.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM223	MGC3196	ENSG00000168569	"Transmembrane protein 223"	A0PJW6	11	62771629-62792006	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane, Mitochondria"		"HPA014504: AB_1853881"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.14e-3)"	"unprognostic (9.75e-2)"	13.1	20.9	10.4	9.4	12.0	6.4	12.8	12.4	13.4	13.2	11.6	15.7	11.0	12.9	9.7	13.3	11.7	5.5	27.9	10.4	10.5	17.3	22.5	11.1	12.0	11.6	10.2	11.4	19.8	8.0	13.2	7.1	11.8	14.8	7.4	5.2	15.3	7.2	16.1	13.3	14.4	5.3	10.0	16.6	15.4	6.7	10.4	7.3	13.8	8.5	7.0	12.2	11.1	12.1	29.2	24.4	14.3	19.6	11.8	13.5	19.5	15.3	13.4	16.9	14.1	21.5	34.9	21.6	36.8	11.1	22.5	43.3	17.3	18.9	9.6	34.7	32.5	16.1	26.9	25.9	20.6	20.0	18.4	14.4	18.8	11.2	13.9	20.3	13.9	28.2	24.8	15.8	12.6	42.3	20.3	44.3	28.2	30.2	29.2	24.7	17.3	48.8	26.8	18.3	24.3	32.0	16.0	32.3	43.0	14.5	48.1	18.4	13.9	20.2	24.4	18.7	18.5	32.1	27.5	25.1	24.0	17.8	21.5	21.0	41.3	25.0	71.3	46.2	68.8	77.6	69.8	69.9	46.8	81.8	74.9	73.0	19.0	66.2	29.8	75.6	66.8	41.5	10.4	12.0	12.4	13.4	10.4	10.5	11.6	10.2	11.8	10.0	10.4	12.1	31.9	12.8	5.6	4.2	24.1	13.5	15.3	39.7	8.6	17.9	27.6	45.0	18.8	52.9	25.2	20.2	12.5	49.4	22.8	30.2	62.6	37.2	2.6	29.1	26.9	28.9	20.5	18.5	6.1	44.3	42.9	22.0	15.3	22.3	19.7	22.4	31.8	36.0	37.6	6.7	8.0	32.6	38.7	20.1	13.6	3.4	32.6	16.2	19.6	4.7	16.2	16.5	35.0	6.0	5.7	36.1	19.3	26.4	25.4	22.4	32.1	52.3	39.6	18.0	19.7	22.3	17.9	6.9	19.7	21.3	13.9	14.2	24.3	34.2	43.4	17.1
TMEM233	"DSPB2, IFITMD2"	ENSG00000224982	"Transmembrane protein 233"	B4DJY2	12	119593774-119643075	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 66.6;tongue: 21.2"	"Group enriched"	"Detected in some"	5	"granulocytes: 79.1;Skeletal myocytes: 77.8"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 22.2;hTERT-RPE1: 9.0;RH-30: 11.8;U-2197: 17.9;U-87 MG: 70.3"	"Not detected"	"Not detected"							"HPA047506, HPA075435"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA047506: AB_10963068, HPA075435: "	"unprognostic (1.46e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.10e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.66e-1)"	0.7	0.6	4.6	0.1	6.6	0.0	0.4	1.1	9.0	0.4	1.3	0.2	0.2	0.3	0.2	0.3	0.2	0.5	1.2	4.4	2.5	1.3	0.6	0.9	0.2	1.8	1.4	0.9	0.2	1.3	0.8	0.1	1.8	0.6	0.2	0.2	0.5	0.3	66.6	0.1	0.3	0.4	1.4	0.2	0.3	0.2	3.4	0.9	14.3	21.2	0.2	1.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	1.7	0.0	22.2	0.0	9.0	0.1	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	70.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	6.6	1.1	9.0	4.4	2.5	1.8	1.4	1.8	1.4	3.4	4.4	12.0	3.2	1.1	0.7	0.0	0.0	0.4	0.0	0.0	2.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.9	9.5	0.3	0.1	13.3	0.0	0.0	5.4	8.5	0.0	3.6	0.0	0.4	79.1	5.5	15.4	0.1	0.1	8.4	3.7	0.0	0.0	0.6	0.0	4.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.5	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	77.8	2.2	3.1	1.0	0.2	0.1	0.1	0.9	9.2	0.0	0.2
TMEM250	"bA83N9.1, C9orf69"	ENSG00000238227	"Transmembrane protein 250"	H0YL14	9	136114581-136118875	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 17.1;Extravillous trophoblasts: 21.3;Pancreatic endocrine cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066070	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA066070: AB_2685608"	"unprognostic (2.79e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.64e-1)"	14.9	14.0	18.6	11.6	18.6	4.3	13.5	14.1	20.2	12.8	10.0	20.0	16.7	14.3	7.3	29.1	12.2	6.9	17.4	19.5	12.0	16.3	21.7	13.1	11.4	15.6	13.8	13.2	13.2	8.2	11.9	10.4	16.4	14.7	8.0	2.9	14.0	8.5	28.5	20.8	17.1	7.7	13.3	16.8	15.6	13.0	16.7	8.7	11.0	10.4	8.9	19.5	15.0	16.0	24.9	46.2	17.7	26.5	24.7	22.4	54.9	29.2	20.7	17.3	12.3	26.4	35.5	18.3	33.3	31.5	27.6	62.2	12.6	20.6	5.4	78.8	24.1	15.4	48.3	18.7	34.2	28.2	19.2	20.2	38.8	18.8	19.6	22.3	27.9	18.0	35.1	18.9	15.3	57.3	34.6	22.7	39.2	43.4	49.6	14.0	24.5	30.5	19.0	17.9	30.4	23.1	31.5	21.6	26.4	10.4	19.7	42.1	31.6	30.2	13.3	39.8	32.9	11.0	11.3	10.9	30.4	19.9	29.0	4.3	2.9	1.8	6.2	4.2	4.5	1.8	4.7	5.2	3.0	1.3	2.2	4.1	3.4	3.5	4.2	1.9	2.6	2.1	18.6	18.6	14.1	20.2	19.5	12.0	15.6	13.8	16.4	13.3	16.7	16.0	11.9	6.4	7.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	12.9	11.9	0.0	0.0	1.3	14.7	0.0	17.1	15.2	0.0	3.9	13.1	0.0	9.8	12.6	6.0	0.0	0.0	0.0	10.6	21.3	5.1	0.0	7.0	2.5	14.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.8	0.0	0.0	1.3	0.0	0.0	13.2	1.5	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	7.8	5.5	11.5	0.0	0.0
TMEM254	"bA369J21.6, C10orf57, FLJ13263"	ENSG00000133678	"Transmembrane protein 254"	Q8TBM7	10	80078646-80092557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029105, HPA072613"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Nucleoplasm	"HPA029105: AB_2672909, HPA072613: AB_2732205"	"unprognostic (9.40e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.39e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.96e-2)"	15.2	11.9	7.9	11.1	8.3	9.4	26.5	7.3	8.3	16.0	7.0	22.6	16.3	10.7	62.1	39.5	28.0	14.0	5.7	8.0	7.0	14.8	52.8	9.4	10.4	8.0	8.7	13.0	19.0	16.5	4.4	15.6	8.5	43.1	22.3	11.2	16.6	14.2	4.4	72.3	15.4	10.4	8.3	7.8	15.0	15.5	7.5	15.4	14.8	2.9	14.6	12.4	22.7	9.3	14.4	13.8	20.0	17.2	27.1	29.7	33.4	13.5	9.3	9.0	9.7	10.6	43.5	11.0	22.1	16.9	9.3	15.2	8.9	11.5	10.0	17.5	16.5	3.0	3.8	14.3	11.2	12.8	13.0	20.3	48.6	8.9	7.3	20.6	7.7	9.1	7.9	22.9	9.4	29.8	10.7	9.9	11.0	12.6	43.2	13.2	2.8	9.7	13.5	11.9	8.0	12.1	12.6	31.4	13.3	14.8	45.1	9.1	12.1	7.8	12.8	12.0	8.0	15.8	24.7	0.8	17.8	13.6	6.6	57.3	25.0	13.0	18.1	28.6	22.3	21.3	20.2	18.8	20.7	14.3	33.8	22.6	2.8	17.5	31.5	23.1	27.2	20.5	7.9	8.3	7.3	8.3	8.0	7.0	8.0	8.7	8.5	8.3	7.5	9.3	4.6	9.6	9.6	17.6	7.3	8.2	5.9	9.7	5.2	7.9	22.6	17.5	4.4	12.8	13.7	9.2	16.7	40.9	3.8	9.0	21.5	15.7	10.5	37.6	10.0	5.4	8.4	5.9	17.2	8.7	37.2	7.6	11.2	10.5	5.7	12.9	5.7	33.4	19.4	16.8	16.4	23.7	8.2	10.3	5.8	7.5	9.3	8.5	3.6	4.7	15.2	15.7	12.3	8.5	14.8	10.3	15.3	11.7	5.2	15.6	19.6	23.1	40.2	13.3	13.1	2.6	7.1	36.8	8.7	20.9	24.0	22.7	6.9	11.2	18.1	8.4
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.7;ovary: 19.6"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 32.6;Skeletal myocytes: 14.6"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 25.3;NTERA-2: 9.5;RPMI-8226: 17.1;SK-MEL-30: 27.7;U-2 OS: 11.8;U-87 MG: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	4.7	3.3	7.4	1.8	5.8	0.7	3.2	4.8	9.2	11.9	1.7	2.6	0.7	1.9	1.6	2.8	3.8	1.1	1.3	3.8	27.4	1.4	0.6	3.0	3.6	22.7	48.7	19.6	0.4	1.4	3.8	0.2	33.0	1.4	2.3	1.5	1.2	1.8	1.4	2.6	2.3	0.9	19.9	1.7	1.8	0.2	36.8	8.1	0.4	2.7	3.8	1.9	8.5	11.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.2	0.0	0.1	0.3	0.0	2.9	0.0	1.9	0.7	0.7	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	25.3	0.4	0.0	0.0	0.1	9.5	0.0	0.0	0.1	0.0	17.1	0.0	0.0	5.1	0.1	0.5	0.0	27.7	0.3	0.0	0.3	0.0	0.0	11.8	0.0	5.1	0.0	5.2	3.7	29.7	0.0	0.0	0.0	0.3	0.0	2.8	0.1	1.4	0.2	0.2	1.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	7.4	5.8	4.8	9.2	3.8	27.4	22.7	48.7	33.0	19.9	36.8	11.5	0.1	3.2	0.0	1.6	0.0	0.4	0.1	0.1	0.6	1.9	0.2	1.3	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.2	0.0	0.0	4.4	0.0	0.4	0.0	0.3	0.4	0.0	1.3	0.0	4.3	0.0	0.0	1.0	0.7	1.6	0.6	1.6	5.4	1.9	3.7	0.3	0.0	32.6	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	14.6	0.6	0.1	0.1	0.0	1.3	0.1	0.4	0.0	0.0	0.0
TMEM255B	"FAM70B, MGC20579"	ENSG00000184497	"Transmembrane protein 255B"	Q8WV15	13	113759226-113816995	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.0;Endothelial cells: 81.5;granulocytes: 39.3;Hepatic stellate cells: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 28.6;HUVEC TERT2: 38.8;PC-3: 39.3;RPMI-8226: 25.1;TIME: 35.9;U-87 MG: 40.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043334	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA043334: AB_10795982"	"unprognostic (2.20e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (4.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.83e-1)"	14.2	6.1	1.3	3.7	1.3	0.7	10.6	1.1	2.2	10.1	2.1	4.0	1.6	8.4	0.3	3.9	8.1	3.6	6.6	1.6	3.7	10.1	3.4	13.2	2.4	2.1	1.3	4.3	3.1	1.6	3.5	1.0	1.7	7.0	1.4	0.4	4.2	2.2	2.9	4.2	4.8	5.0	1.4	8.2	4.3	3.3	1.9	0.8	11.2	3.9	1.8	7.5	7.1	1.5	10.3	0.0	0.6	0.0	2.8	0.0	0.1	4.8	10.7	5.5	3.5	0.4	0.2	0.2	0.1	7.7	12.5	1.5	1.1	0.7	2.3	0.1	0.9	0.3	0.4	0.0	1.4	2.9	28.6	1.8	2.3	11.7	4.6	15.7	38.8	0.6	0.1	0.2	12.0	0.2	1.5	0.9	1.0	1.6	39.3	1.8	0.8	25.1	5.4	0.5	2.2	5.1	0.2	1.5	0.1	1.0	0.6	8.2	35.9	1.6	10.3	0.6	1.7	0.0	0.0	1.9	40.6	2.7	0.3	31.2	5.4	0.7	0.0	5.5	0.0	0.9	0.0	0.0	1.5	2.8	0.0	0.0	2.7	0.0	4.0	0.0	0.0	1.4	1.3	1.3	1.1	2.2	1.6	3.7	2.1	1.3	1.7	1.4	1.9	1.5	65.0	6.4	4.8	2.3	1.9	5.9	1.2	0.9	1.2	0.9	1.1	1.7	9.1	0.0	0.2	1.8	0.0	0.1	0.3	0.0	1.9	8.2	0.8	0.3	0.8	81.5	1.2	3.2	2.7	1.7	0.1	4.7	0.0	0.2	39.3	2.3	105.0	0.7	12.9	0.0	0.1	0.2	0.0	17.4	14.6	1.1	7.8	16.3	8.8	7.5	3.4	0.5	0.0	0.0	0.6	1.3	0.1	3.0	1.4	1.7	0.0	0.1	0.5	0.8	6.6	0.9	3.6	5.1	19.1	0.2	4.7	0.0	1.8	2.1	0.3	1.0
TMEM260	"C14orf101, FLJ20392"	ENSG00000070269	"Transmembrane protein 260"	Q9NX78	14	56488354-56650606	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 39.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Excitatory neurons: 66.7;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003502	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA003502: AB_1078314"	"unprognostic (4.63e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (7.11e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.81e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-2)"	4.6	4.3	4.5	4.0	5.4	2.1	5.5	4.7	4.9	39.8	12.4	5.8	5.2	6.2	7.8	3.4	7.4	5.9	2.5	4.4	4.5	6.8	5.6	4.4	4.7	4.6	4.4	9.3	4.5	7.3	3.7	5.7	4.5	5.2	5.8	6.9	3.8	4.5	2.2	5.6	5.7	3.9	4.4	4.0	5.5	5.2	4.5	5.8	8.4	2.2	3.8	4.7	3.6	7.3	8.0	5.5	4.2	8.9	14.5	11.9	8.2	8.4	9.2	5.4	6.4	2.6	5.8	6.5	8.0	6.2	6.1	9.1	9.7	6.1	8.4	8.1	4.9	4.2	2.7	3.6	10.2	5.9	9.6	14.6	10.7	3.0	10.3	9.8	7.1	4.9	5.2	6.8	7.1	5.3	3.1	2.2	3.9	13.0	8.6	4.3	6.7	2.2	9.0	11.7	8.8	4.3	9.4	6.7	5.5	7.8	8.6	9.0	10.0	10.9	4.1	8.2	4.2	4.1	3.5	3.8	6.8	4.3	5.5	0.0	1.1	1.2	1.3	0.8	0.9	0.7	0.8	0.7	0.9	0.7	1.2	0.8	0.5	2.5	0.7	1.9	1.3	0.8	4.5	5.4	4.7	4.9	4.4	4.5	4.6	4.4	4.5	4.4	4.5	7.3	12.2	19.2	17.2	39.8	13.0	5.4	7.1	5.9	5.7	14.6	8.0	7.7	3.7	2.8	8.5	22.0	4.2	10.2	9.8	9.4	1.9	8.1	88.5	22.8	17.6	8.3	18.0	7.6	66.7	3.8	7.7	10.4	9.2	29.1	12.0	20.0	8.9	13.3	6.5	6.7	62.8	10.0	6.1	12.8	5.0	31.5	15.2	8.7	1.8	39.4	11.1	5.2	14.4	69.9	106.0	5.6	7.6	10.9	9.3	9.3	9.5	4.8	14.2	16.4	0.0	7.0	8.0	9.3	11.0	10.0	5.5	11.1	8.9	14.5	12.1	8.0
TMEM267	"C5orf28, FLJ21657"	ENSG00000151881	"Transmembrane protein 267"	Q0VDI3	5	43444252-43483893	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 38.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 20.2;Collecting duct cells: 16.5;Cytotrophoblasts: 26.3;Distal tubular cells: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059946, HPA072991"			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"HPA059946: AB_2684175, HPA072991: "	"unprognostic (8.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.77e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.40e-3)"	7.6	7.0	5.7	8.8	5.4	4.9	15.1	5.5	6.2	10.9	7.1	8.4	7.6	8.4	11.9	8.1	8.6	7.7	6.0	5.3	6.5	9.8	7.2	7.6	10.4	5.7	6.6	7.7	7.6	10.7	5.7	6.7	6.5	9.0	9.9	8.1	8.6	9.9	6.2	10.4	6.5	9.6	6.2	8.6	9.9	7.3	5.7	9.2	38.2	3.7	9.6	8.6	6.7	6.4	20.0	18.0	9.5	21.2	17.2	34.8	10.8	28.0	17.3	14.9	10.8	7.9	41.7	21.9	37.7	28.9	15.8	16.3	9.2	12.6	21.3	26.7	14.8	12.9	37.2	8.8	32.0	26.5	17.9	28.9	35.3	22.3	31.7	15.0	16.7	26.3	17.1	39.9	32.8	17.1	14.5	15.3	4.4	20.4	17.4	9.9	23.5	27.3	18.7	20.1	13.2	9.3	56.1	31.5	27.9	8.7	46.0	18.4	21.9	24.0	19.4	14.9	14.1	17.0	26.5	21.6	18.1	37.3	21.6	16.6	11.1	4.4	15.1	13.5	22.3	14.5	20.2	15.9	12.7	13.4	20.3	16.6	1.9	18.9	16.0	9.8	17.5	14.3	5.7	5.4	5.5	6.2	5.3	6.5	5.7	6.6	6.5	6.2	5.7	6.4	9.7	6.4	3.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	20.2	13.2	0.0	0.0	1.8	16.5	0.0	26.3	6.3	0.0	27.4	13.8	0.0	8.4	9.1	2.6	0.0	0.0	0.0	13.6	10.2	4.5	0.0	9.2	2.5	6.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.9	0.0	0.0	13.7	6.6	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	10.5	3.7	6.6	0.0	0.0
TMEM35B	ZMYM6NB	ENSG00000243749	"Transmembrane protein 35B"	Q8NCS4	1	34981535-34985353	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 22.4;Alveolar cells type 2: 13.4;Club cells: 6.2;granulocytes: 8.8;Respiratory ciliated cells: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 115.3;CAPAN-2: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051024	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 5: Breast - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"		"HPA051024: AB_2681316"	"unprognostic (3.34e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.07e-1)"	48.9	36.0	12.6	25.1	12.5	13.6	40.1	12.4	18.5	41.6	16.9	27.4	16.6	36.2	39.0	15.4	41.3	41.0	32.3	12.4	13.1	36.8	40.1	44.2	40.0	13.8	12.8	32.5	29.6	29.8	21.8	63.4	13.7	30.4	26.6	2.2	25.8	34.8	8.6	13.3	27.6	30.1	13.7	32.5	24.4	22.6	13.4	29.7	44.7	20.4	30.9	36.2	33.3	14.4	25.8	19.5	4.2	7.3	115.3	67.1	9.3	27.7	46.2	19.1	25.8	19.4	113.1	12.6	42.1	28.4	30.3	27.2	8.1	23.4	15.0	49.2	12.9	27.2	9.0	23.1	63.2	18.0	27.5	67.7	21.3	17.4	36.6	39.1	38.3	26.8	17.5	36.2	34.2	16.2	13.3	18.6	20.2	0.0	13.6	17.7	37.3	4.0	53.6	24.9	11.1	3.5	42.4	0.6	39.5	21.3	10.3	27.9	39.4	25.6	24.0	22.7	15.8	20.9	12.7	8.9	25.7	29.4	22.2	161.3	101.2	112.4	188.7	118.6	202.9	108.9	205.0	208.3	71.3	89.9	177.7	179.9	31.4	165.4	100.4	159.5	232.4	182.9	12.6	12.5	12.4	18.5	12.4	13.1	13.8	12.8	13.7	13.7	13.4	14.4	0.6	22.4	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	6.2	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.0	0.3	0.7	2.1	0.0	0.0	0.0	0.2	0.2	2.0	0.0	0.3	8.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	15.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0
TMEM37	"PR, PR1"	ENSG00000171227	"Transmembrane protein 37"	Q8WXS4	2	119429901-119438504	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 101.1;liver: 100.0;parathyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.9;Hepatocytes: 184.5;Muller glia cells: 146.8;Proximal enterocytes: 575.7;Proximal tubular cells: 188.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 57.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"EFO-21: 26.9;Hep G2: 74.7;RPTEC TERT1: 60.0"	"Low region specificity"	"Detected in all"							HPA053794	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA053794: AB_2682265"	"unprognostic (2.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.61e-2)"	53.1	11.1	2.1	6.6	2.0	0.7	25.6	1.8	3.6	21.9	2.5	37.3	53.5	6.4	4.8	6.8	3.4	23.2	4.8	1.5	1.8	101.1	100.0	15.4	10.2	2.5	2.1	12.7	13.3	124.7	1.0	14.9	2.3	3.9	19.0	23.6	7.0	7.6	2.4	10.5	76.1	4.8	2.5	25.7	18.1	5.1	3.7	3.0	31.1	4.2	4.9	7.0	5.6	3.2	0.0	7.3	0.7	0.3	4.3	0.4	1.0	0.2	0.1	0.0	0.1	11.4	6.4	0.0	26.9	3.4	0.6	1.7	3.0	0.0	0.0	0.0	2.9	1.0	4.0	74.7	5.9	0.0	0.1	9.7	0.0	0.0	0.0	0.2	5.9	0.0	0.2	10.9	0.0	0.7	0.0	0.8	5.4	0.1	0.2	0.0	0.1	9.9	60.0	4.9	0.9	0.4	0.3	2.9	0.0	5.0	1.2	1.7	3.8	0.0	10.4	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.1	2.0	1.8	3.6	1.5	1.8	2.5	2.1	2.3	2.5	3.7	3.2	12.2	25.6	9.6	0.0	3.2	2.0	0.3	11.1	0.0	2.4	1.8	1.5	2.1	82.9	13.6	18.4	0.0	64.9	0.1	179.9	50.9	36.1	0.3	7.7	98.8	15.1	9.1	5.3	0.0	52.3	3.8	17.9	11.7	10.3	1.3	16.4	61.8	184.5	64.6	6.7	0.0	22.0	14.2	65.5	5.0	1.9	49.7	19.5	1.8	0.0	0.6	146.8	0.0	0.0	0.6	15.3	68.1	3.8	0.0	0.1	575.7	188.1	7.6	17.4	0.0	0.9	14.8	0.0	0.8	1.0	2.8	104.1	2.4	45.3	23.3	2.3
TMEM38A	"MGC3169, TRIC-A"	ENSG00000072954	"Transmembrane protein 38A"	Q9H6F2	19	16661139-16690023	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 581.3;tongue: 260.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.7;Cone photoreceptor cells: 85.5;Excitatory neurons: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 36.9;eosinophil: 12.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 36.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.1;OE19: 15.2;U-266/70: 15.6;U-698: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048100, HPA050463"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA048100: , HPA050463: AB_2681137"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.78e-5)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.99e-10)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.96e-2)"	2.1	4.1	10.5	1.3	15.4	5.8	2.3	13.3	15.9	1.9	52.4	2.9	1.9	1.3	18.0	9.2	3.4	0.9	26.1	10.8	16.1	5.7	7.6	4.5	1.5	10.7	14.3	2.4	2.1	4.4	7.4	0.6	11.2	7.0	2.7	10.0	9.3	5.0	581.3	1.8	2.0	1.4	10.2	1.6	14.7	3.9	16.0	2.9	2.5	260.0	2.3	1.7	1.3	11.3	4.1	0.8	1.0	6.1	3.3	0.3	0.5	1.4	0.8	0.9	1.9	1.3	5.8	16.1	2.4	0.3	5.3	3.3	8.1	1.7	0.9	1.1	2.4	0.0	2.5	1.3	0.9	0.1	0.2	1.4	6.2	1.1	0.7	4.6	0.4	2.9	0.1	1.5	0.6	6.3	0.2	1.7	1.5	15.2	9.4	8.5	1.4	4.4	5.8	3.0	9.9	6.9	4.4	0.5	2.1	0.5	3.0	1.3	0.0	1.2	2.8	3.7	0.7	15.6	12.2	27.1	1.4	9.6	1.2	36.9	4.2	12.3	0.0	1.6	0.0	4.6	0.5	0.1	0.4	6.0	0.1	0.1	2.4	3.5	1.0	0.8	0.8	1.0	10.5	15.4	13.3	15.9	10.8	16.1	10.7	14.3	11.2	10.2	16.0	11.3	2.8	3.2	1.5	18.3	2.3	1.1	3.5	6.7	3.4	30.7	3.9	2.2	25.9	1.5	3.0	0.0	85.5	0.1	0.6	1.7	1.9	3.6	0.1	1.4	0.6	4.5	4.2	0.0	31.0	2.5	0.1	3.0	17.3	1.4	0.0	2.2	9.7	9.2	0.4	13.5	24.0	7.6	14.2	4.3	1.2	0.9	10.5	0.9	3.6	3.7	0.9	13.9	0.0	7.5	3.1	10.8	1.1	22.6	2.9	3.4	0.4	1.2	1.8	9.5	0.0	25.4	3.9	0.9	1.3	3.3	0.3	0.1	0.6	2.1	2.7	1.3
TMEM39A	"FLJ10902, SUSR2"	ENSG00000176142	"Transmembrane protein 39A"	Q9NV64	3	119428949-119468830	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039140	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Vesicles	"HPA039140: AB_10673303"	"unprognostic (2.16e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (9.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (4.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.41e-2)"	12.4	10.5	2.2	14.4	4.3	12.9	10.2	4.1	3.5	19.5	10.9	9.0	10.0	13.2	10.9	9.0	11.7	12.6	11.1	2.2	3.1	6.4	13.0	12.4	10.0	4.0	3.4	13.1	28.4	12.8	15.4	18.1	4.3	9.1	9.3	5.0	13.3	14.3	7.2	8.8	8.0	9.7	3.1	9.2	9.8	7.8	4.7	12.1	16.6	11.9	13.6	14.4	10.5	6.2	28.3	15.1	24.1	17.4	56.1	54.2	24.1	26.4	54.3	37.2	50.0	26.1	21.2	12.0	27.4	28.7	37.9	28.7	29.3	12.1	38.0	12.6	11.2	15.5	13.5	25.4	37.9	27.1	23.4	29.7	20.5	25.9	61.5	37.5	23.6	18.5	16.1	35.5	19.6	14.1	13.7	7.0	20.5	29.8	31.5	16.5	11.3	25.7	9.2	10.7	10.7	15.8	26.6	15.2	33.4	17.3	14.8	23.8	18.5	20.2	17.2	13.8	17.3	39.5	12.5	28.5	27.6	18.2	26.8	12.7	10.9	7.3	11.7	5.8	11.9	7.7	7.1	9.6	12.3	9.0	5.6	6.1	3.8	11.9	4.6	17.3	8.9	9.4	2.2	4.3	4.1	3.5	2.2	3.1	4.0	3.4	4.3	3.1	4.7	6.2	8.5	9.6	15.8	9.8	14.3	22.8	16.0	21.8	8.6	4.7	14.6	10.8	10.8	7.2	16.2	7.3	6.2	26.5	24.7	7.4	5.9	11.6	22.8	8.2	26.3	10.8	10.8	9.0	12.4	14.2	57.6	28.9	13.3	17.9	1.3	13.5	7.9	12.0	13.3	1.7	14.0	18.3	6.1	15.0	54.9	6.8	17.1	17.8	10.6	12.2	31.0	3.9	9.2	25.1	21.8	10.2	6.6	13.2	57.8	20.6	8.0	3.0	14.9	6.4	6.6	15.9	25.2	26.1	18.5	9.6	21.7	59.8	17.4	9.4	11.1	20.4
TMEM41A	MGC15397	ENSG00000163900	"Transmembrane protein 41A"	Q96HV5	3	185476496-185499057	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA059101, HPA059790"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059101: AB_2683905, HPA059790: AB_2684125"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (6.70e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.02e-2)"	9.0	27.2	9.6	5.4	9.3	11.0	10.2	9.7	11.0	10.0	8.9	7.9	26.4	8.7	11.2	23.6	9.2	7.6	9.9	9.0	9.4	14.7	20.5	10.6	7.4	9.4	11.6	14.1	9.7	8.7	5.7	8.4	9.2	10.2	8.9	7.5	12.0	8.3	9.8	19.9	24.1	7.4	9.8	12.5	10.3	9.3	12.1	7.8	7.0	16.4	12.6	10.8	14.6	10.9	43.6	15.4	10.1	12.5	15.6	16.8	29.6	16.3	14.3	20.2	14.6	40.5	16.7	13.4	30.5	15.3	28.5	29.4	28.1	17.5	20.4	22.6	25.8	23.3	8.6	41.2	17.5	25.3	12.5	15.7	25.6	18.3	20.9	12.7	15.6	16.8	42.1	32.4	13.0	16.8	15.6	14.5	16.8	34.1	24.1	15.5	15.6	24.6	17.4	31.4	10.1	13.1	14.1	35.8	25.7	14.4	42.8	19.6	11.4	11.9	15.0	25.2	34.5	47.2	78.0	26.5	18.2	15.1	14.6	14.0	8.2	7.2	16.3	9.4	21.0	17.5	16.7	18.1	9.3	15.6	18.2	19.8	2.8	12.2	12.2	21.7	15.3	9.2	9.6	9.3	9.7	11.0	9.0	9.4	9.4	11.6	9.2	9.8	12.1	10.9	12.1	9.6	30.5	7.2	16.7	53.0	42.8	29.5	50.7	22.4	38.2	20.6	12.6	24.3	24.9	20.2	18.8	27.5	18.3	23.3	7.9	33.4	0.7	17.7	14.5	19.8	18.6	16.4	8.1	56.0	23.5	18.0	36.2	38.0	8.8	50.2	17.2	40.9	19.6	16.8	9.8	28.3	16.2	14.2	17.3	2.8	14.3	12.5	8.8	2.8	65.9	11.4	11.3	20.1	7.6	50.3	17.0	13.5	20.9	64.2	200.8	23.2	9.6	28.6	19.7	16.8	16.5	22.1	14.3	113.0	84.7	46.0	18.5	82.6	45.6	93.4
TMEM42	MGC29956	ENSG00000169964	"Transmembrane protein 42"	Q69YG0	3	44861904-44865670	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.0;Late spermatids: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052569	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Nucleoli	"HPA052569: AB_2681871"	"prognostic favorable (5.23e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.16e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	14.8	21.8	15.4	2.2	16.5	2.1	13.6	16.2	18.0	16.9	14.8	11.4	2.4	12.3	11.3	11.4	12.9	3.5	15.1	15.4	16.5	19.7	22.8	11.5	4.7	15.8	16.2	18.5	14.1	7.3	25.8	3.8	16.2	17.5	3.5	4.3	11.7	5.1	20.7	13.2	10.1	3.8	16.4	14.2	13.6	26.4	16.2	9.4	20.2	8.8	4.2	13.6	14.1	17.0	6.0	6.1	1.8	3.5	22.4	17.7	0.2	4.9	7.0	5.9	6.0	1.4	11.9	4.1	9.3	9.8	2.6	4.1	0.4	7.5	6.1	6.3	0.1	2.6	8.1	6.7	23.7	3.0	0.2	18.4	19.3	6.2	13.7	12.7	10.3	10.3	0.1	8.4	9.2	4.8	2.7	5.0	3.3	7.4	2.4	2.1	1.0	1.0	13.3	2.4	1.9	2.3	5.9	2.0	2.5	5.7	4.4	5.2	6.8	5.2	0.6	7.6	5.5	2.8	2.2	1.2	10.4	3.6	2.4	5.8	9.0	4.7	7.6	8.7	8.4	15.4	11.6	7.2	11.5	13.0	15.7	12.7	1.7	10.7	11.9	12.6	10.0	9.7	15.4	16.5	16.2	18.0	15.4	16.5	15.8	16.2	16.2	16.4	16.2	17.0	8.0	22.4	7.7	0.0	14.0	6.1	14.4	31.5	19.4	8.9	17.5	21.2	11.3	18.6	13.0	33.1	2.1	22.5	15.1	4.5	13.7	19.9	70.0	16.0	14.0	10.5	12.0	12.0	0.0	10.2	14.0	18.3	7.1	13.0	3.8	24.7	13.2	18.5	22.7	18.5	0.0	10.2	24.4	10.6	6.0	85.6	27.4	11.7	7.2	0.0	11.2	21.5	10.3	0.0	0.0	14.3	9.3	19.5	6.2	19.1	11.7	21.7	19.9	15.8	6.6	15.4	9.0	33.8	19.9	13.0	8.9	9.7	12.8	29.2	10.7	9.4
TMEM45B	"BC016153, FLJ40787"	ENSG00000151715	"Transmembrane protein 45B"	Q96B21	11	129815848-129860003	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.5;intestine: 136.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 325.6;Paneth cells: 221.6;Proximal enterocytes: 288.7;Respiratory ciliated cells: 133.9;Undifferentiated cells: 122.2;Urothelial cells: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.0;naive CD4 T-cell: 3.6;neutrophil: 11.7"	"Group enriched"	"Detected in many"	14	"granulocytes: 11.7;T-cells: 3.6"	"Group enriched"	"Detected in some"	5	"OE19: 333.1;RT4: 133.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015474, HPA015878"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA015474: , HPA015878: AB_2205046"	"unprognostic (4.92e-3)"	"unprognostic (7.94e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	0.7	0.6	1.5	8.3	1.6	1.1	13.2	1.9	1.8	14.9	7.6	95.1	136.4	1.1	13.6	66.5	21.7	24.1	0.1	2.1	2.0	20.6	24.7	6.0	0.9	1.5	2.8	0.2	1.2	12.4	4.2	1.4	1.5	3.6	94.6	0.4	15.4	8.2	0.3	25.4	127.4	2.8	0.9	0.8	24.3	0.3	2.0	0.4	6.5	0.0	15.0	30.8	27.3	1.4	0.1	0.1	0.1	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	39.1	16.8	0.2	7.0	0.0	0.2	22.3	0.0	0.0	0.0	0.1	0.5	0.3	2.1	40.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.4	0.2	0.2	0.1	0.0	13.3	0.2	1.5	0.2	333.1	49.2	0.3	0.1	2.6	21.0	133.1	4.1	0.6	0.2	10.8	0.1	0.1	37.1	0.2	0.3	0.2	0.3	0.4	0.1	0.2	0.1	0.4	0.1	0.3	0.1	1.2	0.5	0.1	0.2	0.1	0.2	0.2	3.0	0.8	0.0	0.4	3.6	0.6	11.7	0.5	0.1	0.3	0.5	0.9	1.5	1.6	1.9	1.8	2.1	2.0	1.5	2.8	1.5	0.9	2.0	1.4	0.1	19.2	12.5	0.3	1.1	3.3	16.4	29.1	0.0	0.1	6.7	2.5	0.8	18.6	68.8	46.0	0.0	3.8	0.0	325.6	13.7	26.9	0.4	27.7	2.9	1.0	55.4	0.0	0.8	8.6	0.8	0.8	17.9	29.5	2.5	0.3	0.4	8.4	0.5	0.0	0.4	49.3	20.3	0.6	0.4	0.3	0.3	2.9	3.6	2.8	0.1	0.1	0.0	0.0	0.3	50.2	221.6	0.0	0.0	23.8	288.7	1.4	133.9	0.2	0.0	0.7	3.6	0.1	0.2	4.4	20.9	0.4	1.8	0.1	122.2	162.0
TMEM51	"C1orf72, FLJ10199"	ENSG00000171729	"Transmembrane protein 51"	Q9NW97	1	15152532-15220478	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 87.0;Exocrine glandular cells: 74.1;Pancreatic endocrine cells: 71.0;Urothelial cells: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014547, HPA019441"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA014547: AB_1858121, HPA019441: AB_2670142"	"unprognostic (1.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (7.81e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.91e-2)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.67e-3)"	5.0	20.5	8.1	8.8	8.1	0.8	5.5	18.1	10.6	16.0	7.4	19.8	22.8	5.3	7.3	17.6	11.3	21.2	5.8	8.0	7.4	36.0	4.0	14.2	4.8	9.4	8.6	21.3	45.1	12.9	7.0	10.8	8.5	15.7	10.7	0.4	10.4	15.3	1.7	8.4	20.1	7.9	8.2	7.0	30.2	2.6	8.8	2.2	4.8	3.0	5.0	30.3	18.1	9.1	42.7	22.4	12.5	3.0	2.1	4.5	0.0	4.8	20.1	14.5	19.6	29.6	46.8	0.0	15.4	3.2	20.7	40.2	4.3	15.7	8.2	0.1	11.1	1.0	1.2	29.8	17.8	0.0	39.7	1.4	13.7	18.9	20.6	9.3	13.6	1.7	6.5	0.1	7.5	14.7	0.0	0.1	2.3	33.7	8.4	5.9	8.0	7.4	37.0	43.3	1.9	37.0	4.0	16.2	40.6	7.5	2.3	4.5	9.5	15.0	13.2	6.6	15.2	0.4	0.6	0.1	14.8	0.6	18.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	8.1	8.1	18.1	10.6	8.0	7.4	9.4	8.6	8.5	8.2	8.8	9.1	2.7	0.0	2.6	19.9	1.5	18.2	53.8	9.4	15.4	0.1	9.7	6.7	3.0	34.3	10.7	49.7	0.0	6.3	0.1	20.3	5.9	87.0	0.5	10.0	1.9	10.5	19.2	0.0	0.7	74.1	0.9	10.3	26.0	15.7	0.0	0.3	8.6	0.4	48.1	0.0	8.1	18.7	57.0	31.4	19.2	0.4	2.8	22.1	14.2	23.4	13.1	0.0	0.0	11.6	0.4	71.0	27.2	13.9	0.3	53.7	14.3	12.1	11.7	0.1	32.9	1.6	30.3	0.5	3.6	20.7	21.2	1.4	1.1	1.0	15.4	117.9
TMEM52		ENSG00000178821	"Transmembrane protein 52"	Q8NDY8	1	1917590-1919279	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	5	"pancreas: 216.2;skeletal muscle: 298.9;tongue: 207.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 22.3;Hepatocytes: 25.9;Spermatocytes: 34.6;Spermatogonia: 39.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 20.5;OE19: 18.2;RPMI-8226: 37.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA079372			Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	Nucleoplasm	"HPA079372: "	"unprognostic (4.39e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.04e-5)"	"unprognostic (1.46e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.68e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	1.9	52.6	1.9	0.2	2.1	0.5	2.0	2.1	3.7	1.1	3.0	2.5	3.6	0.6	0.4	6.9	3.3	0.4	1.8	1.8	1.9	2.4	13.5	1.9	0.4	1.8	2.1	2.2	216.2	3.1	1.7	0.2	1.7	1.8	1.3	0.2	19.8	0.4	298.9	3.5	2.3	0.3	1.5	2.8	6.9	29.2	1.8	0.4	0.8	207.8	0.3	0.6	2.1	1.7	3.4	0.3	0.9	1.8	0.3	0.1	7.5	0.5	0.2	2.2	1.3	5.6	2.3	0.8	2.2	3.5	0.8	1.1	5.5	1.5	0.4	0.4	4.0	0.0	0.9	20.5	1.1	0.0	1.3	0.1	3.1	0.7	0.3	0.1	0.1	3.9	5.1	1.9	0.0	6.4	0.5	1.5	2.9	18.2	10.6	1.5	0.0	37.1	1.2	0.2	3.7	2.6	0.0	3.1	0.4	1.3	2.1	0.4	0.0	0.0	1.4	1.0	0.0	2.4	0.8	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	2.1	2.1	3.7	1.8	1.9	1.8	2.1	1.7	1.5	1.8	1.7	0.4	0.0	0.0	0.0	1.2	4.5	2.9	1.2	2.8	0.4	3.9	5.2	0.8	8.6	2.4	0.0	0.0	1.9	0.8	6.8	1.9	1.8	3.9	3.8	0.3	0.8	0.0	0.4	0.6	22.3	7.0	1.6	5.1	0.8	0.0	5.1	0.7	25.9	0.6	0.0	0.5	11.1	8.2	0.8	2.2	5.8	14.9	0.7	8.8	0.0	0.6	1.8	0.0	0.0	0.1	6.7	2.5	9.8	4.3	14.2	15.4	11.5	8.7	1.0	0.0	15.4	1.6	34.6	39.4	2.5	2.8	3.7	1.2	15.5	7.1	3.1
TMEM62	FLJ23375	ENSG00000137842	"Transmembrane protein 62"	Q0P6H9	15	43123279-43185144	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 61.0;U-266/84: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044461, HPA062359"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies"		"HPA044461: AB_2678950, HPA062359: AB_2684747"	"unprognostic (7.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.56e-2)"	"prognostic favorable (9.72e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	7.1	4.6	4.8	6.0	5.0	9.0	22.9	8.2	6.7	8.1	3.6	13.1	13.1	5.4	12.3	6.2	7.5	7.9	5.1	5.3	4.8	7.6	10.3	8.8	7.2	4.5	4.5	3.2	8.1	13.7	4.6	10.3	5.0	6.1	14.4	8.9	13.6	7.1	9.4	5.2	11.7	6.5	5.0	6.1	10.2	2.0	5.4	4.0	8.5	6.6	8.0	7.6	5.4	5.6	14.9	7.9	3.5	6.8	4.3	5.5	36.4	13.9	17.6	24.1	33.3	12.5	28.5	15.0	7.9	13.2	21.7	27.6	14.8	10.9	8.7	17.7	6.8	12.2	15.4	9.5	9.4	12.7	10.5	3.9	13.0	10.6	7.4	6.8	13.6	3.7	10.9	12.7	2.8	3.5	0.0	3.0	1.2	61.0	3.2	7.5	3.7	7.9	12.9	18.6	22.2	9.6	10.9	27.2	6.7	3.9	14.6	12.9	8.0	11.9	4.9	8.5	22.7	10.6	67.1	10.7	11.0	14.0	10.4	0.5	0.7	1.1	0.8	0.3	1.0	0.7	1.1	1.0	0.7	0.8	0.7	0.9	0.2	1.6	0.4	1.7	2.0	0.4	4.8	5.0	8.2	6.7	5.3	4.8	4.5	4.5	5.0	5.0	5.4	5.6	7.7	16.0	4.6	12.1	18.8	2.3	4.1	2.8	5.7	5.6	12.3	6.3	2.6	8.6	5.0	12.9	10.4	21.9	7.0	12.5	5.9	12.9	1.6	9.6	3.7	5.6	4.2	9.1	36.3	14.8	25.2	4.8	11.2	13.9	5.1	7.0	6.1	7.3	7.5	1.7	33.4	11.4	6.1	6.5	4.8	3.7	2.5	7.1	5.4	18.7	6.4	7.8	6.2	29.1	34.5	12.2	8.1	1.2	16.5	2.7	12.8	3.4	6.1	9.9	6.6	4.1	5.2	2.2	1.0	8.6	2.8	34.1	7.4	3.8	11.0	4.8
TMEM69	"C1orf154, FLJ21029"	ENSG00000159596	"Transmembrane protein 69"	Q5SWH9	1	45688181-45694436	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026993	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA026993: AB_10601824"	"prognostic favorable (2.24e-4)"	"unprognostic (2.47e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.66e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.41e-3)"	"unprognostic (3.65e-2)"	17.4	19.5	12.0	17.2	12.4	9.4	21.0	13.2	14.4	14.6	15.6	19.0	22.7	15.6	26.7	21.5	17.1	15.8	31.8	12.4	12.9	16.3	19.4	12.1	26.9	12.6	13.0	23.5	14.0	31.9	5.9	19.7	13.0	19.1	22.9	16.6	21.2	15.4	23.9	21.2	17.0	13.9	12.4	16.2	15.2	13.3	13.0	21.2	21.1	25.4	27.7	26.0	8.7	13.3	50.1	13.2	33.9	25.9	25.1	32.6	81.6	31.6	37.1	52.5	50.7	34.2	24.8	59.8	20.4	30.9	38.1	64.9	26.5	77.2	56.3	40.1	31.6	126.2	30.6	38.2	45.3	59.6	58.2	38.8	75.5	50.7	32.6	34.3	44.7	57.8	75.5	37.4	32.4	17.9	32.9	41.3	77.8	30.0	33.4	51.1	29.2	59.9	56.7	57.2	36.8	34.6	32.8	88.8	56.2	61.2	47.0	59.1	32.5	23.9	40.0	49.8	38.9	29.9	41.6	44.8	32.5	43.0	36.5	12.2	25.0	10.2	9.0	25.8	11.7	16.6	12.8	10.5	22.1	15.5	14.5	11.4	9.6	9.2	34.6	12.5	12.8	13.6	12.0	12.4	13.2	14.4	12.4	12.9	12.6	13.0	13.0	12.4	13.0	13.3	10.8	0.0	14.9	9.8	22.4	20.1	22.8	49.2	37.5	11.0	19.1	21.7	9.1	12.8	26.8	18.4	0.0	61.4	7.7	16.7	43.0	22.7	1.9	13.4	12.6	14.3	24.0	32.4	9.1	17.8	36.1	17.1	35.7	11.6	6.3	12.1	14.6	14.4	37.7	6.7	9.7	21.3	34.6	38.9	11.9	4.4	18.6	21.8	17.8	2.8	23.9	14.5	14.4	9.5	14.6	14.8	16.1	12.8	16.3	22.7	31.0	39.0	18.8	9.8	13.1	10.8	13.0	21.7	16.9	53.5	26.0	59.7	13.7	16.3	25.0	22.4
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 100.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	18.1	18.2	9.2	9.8	9.7	10.4	11.3	10.5	12.3	8.0	9.5	12.6	5.8	8.9	10.6	9.3	11.3	8.9	19.3	10.3	10.2	12.0	24.4	9.0	10.1	9.6	9.1	10.5	25.0	8.3	7.6	10.3	10.1	7.4	9.7	6.1	9.9	5.9	100.7	7.7	9.5	9.1	9.5	9.6	17.8	9.8	9.5	11.0	6.0	20.5	10.3	11.3	7.4	10.1	21.2	16.4	13.1	13.8	14.9	12.7	13.6	17.6	15.8	19.4	15.3	15.8	11.9	28.4	15.0	12.0	16.4	19.1	24.9	16.8	21.4	18.9	17.5	28.3	10.0	21.2	14.7	15.5	14.5	11.8	15.3	12.2	6.4	7.3	16.4	14.2	22.0	13.5	20.5	15.9	35.8	29.6	12.3	26.6	20.6	25.4	12.8	24.2	20.5	20.0	29.7	13.1	11.0	78.0	23.3	10.2	16.0	14.1	10.6	11.1	13.7	20.7	16.9	19.9	18.7	28.1	16.4	12.1	12.5	6.3	9.1	6.7	8.0	10.2	9.1	17.7	9.0	9.3	9.6	10.9	10.3	9.6	6.7	5.8	7.9	11.0	7.9	12.0	9.2	9.7	10.5	12.3	10.3	10.2	9.6	9.1	10.1	9.5	9.5	10.1	136.2	16.0	30.1	5.5	37.1	67.3	43.7	54.8	24.5	23.9	26.2	22.2	46.3	14.3	35.7	22.0	8.4	71.2	48.1	69.0	66.5	36.6	20.3	40.8	26.2	96.4	13.8	26.5	12.8	63.5	59.6	50.2	17.3	17.1	39.9	17.0	28.5	50.3	132.4	10.1	11.4	31.7	42.7	70.0	74.5	12.1	29.8	73.2	40.9	5.6	38.9	23.1	22.6	3.5	8.1	43.6	37.9	29.0	68.6	42.1	28.8	75.4	58.7	17.5	39.5	61.9	40.8	70.6	29.5	21.5	59.7	70.3	39.8	52.6	34.1	26.2
TMEM74B	"C20orf46, FLJ11190"	ENSG00000125895	"Transmembrane protein 74B"	Q9NUR3	20	1180561-1185415	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 15.6;Horizontal cells: 18.5;Inhibitory neurons: 16.3;Paneth cells: 15.6;Proximal enterocytes: 21.1;Sertoli cells: 19.7;Smooth muscle cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.3;Hep G2: 9.2;K-562: 16.8;Karpas-707: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045213	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Golgi apparatus"		"HPA045213: AB_10961999"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-4)"	"unprognostic (9.58e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (1.20e-1)"	"unprognostic (9.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.07e-3)"	5.8	2.0	17.5	1.0	16.2	0.2	4.9	10.3	19.4	1.9	8.8	4.0	18.2	2.0	0.8	4.0	7.4	3.9	11.2	13.5	16.6	4.5	4.7	27.6	2.0	19.8	13.2	1.0	2.0	7.1	10.1	17.2	18.2	3.1	1.8	3.9	6.3	15.7	5.1	9.8	23.1	2.0	10.8	2.8	4.1	4.1	17.8	0.3	4.1	2.2	1.2	1.2	2.0	11.5	0.0	4.4	2.5	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.3	0.6	0.1	0.9	0.0	2.7	0.3	3.4	0.4	0.1	0.0	4.2	1.1	0.0	9.2	0.0	0.0	1.2	0.0	0.9	0.0	0.1	0.1	0.1	0.6	16.8	7.1	0.0	0.0	0.1	0.0	3.0	1.2	0.3	0.0	0.2	0.0	0.7	0.6	0.5	1.9	0.1	0.0	0.1	0.9	0.0	0.0	1.7	0.0	2.9	0.0	0.1	2.7	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	16.2	10.3	19.4	13.5	16.6	19.8	13.2	18.2	10.8	17.8	11.5	3.7	0.0	0.0	0.7	0.1	0.3	0.7	0.9	0.6	10.5	2.2	1.0	2.3	0.0	0.2	0.0	0.0	0.2	0.2	1.0	0.0	0.5	1.0	0.2	0.1	3.3	15.6	0.0	9.7	0.2	1.8	0.8	2.6	0.1	0.0	0.5	4.6	0.8	0.0	18.5	16.3	9.9	2.0	0.6	0.7	0.7	0.0	1.4	1.8	1.9	1.0	0.5	0.0	0.0	1.1	0.9	15.6	0.0	0.1	0.7	21.1	0.6	1.2	4.0	19.7	0.4	13.3	0.2	2.7	0.2	0.9	1.4	0.2	0.3	3.9	0.3
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742499-15747982	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 24.4;kidney: 11.5;liver: 52.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 42.8;Hepatocytes: 49.3;Paneth cells: 60.2;Proximal enterocytes: 173.6;Proximal tubular cells: 53.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2;renal cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"CACO-2: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"HPA060282: AB_2684241"	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favorable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	24.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	52.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	1.6	0.0	42.8	7.9	0.0	0.0	0.0	0.0	0.0	2.4	2.7	0.0	0.2	2.9	0.0	1.5	0.1	0.0	0.0	0.4	49.3	0.1	0.0	0.0	9.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	60.2	0.0	0.0	0.0	173.6	53.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	12.5	0.0
TMEM86A	FLJ90119	ENSG00000151117	"Transmembrane protein 86A"	Q8N2M4	11	18693122-18704785	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 17.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 40.6;Theca cells: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057119	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA057119: AB_2683342"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.24e-1)"	2.8	2.7	2.6	2.2	2.2	0.3	3.2	2.1	2.8	2.3	3.8	1.5	1.4	2.2	1.0	2.3	2.6	4.0	2.9	2.1	2.6	9.5	2.6	3.5	4.7	3.1	2.7	7.1	3.4	5.4	2.2	4.3	2.5	1.6	1.8	5.7	2.7	1.4	2.9	17.6	2.0	1.9	2.7	4.9	2.1	2.3	4.0	1.6	2.1	2.5	2.5	2.3	3.6	4.5	0.0	0.2	0.6	3.1	2.7	0.0	0.1	0.6	0.5	0.5	0.5	0.0	0.4	0.0	1.2	0.6	3.0	0.3	0.2	0.1	0.3	0.2	1.9	0.2	0.1	0.0	2.1	0.0	2.8	3.8	1.2	0.1	0.2	0.7	1.7	1.8	0.6	0.0	1.3	1.7	0.0	0.0	0.2	0.5	1.6	0.0	5.1	0.0	17.5	3.8	1.0	1.3	1.0	3.2	1.4	1.1	3.9	0.4	1.9	0.5	0.2	0.1	0.1	3.2	2.7	0.0	1.1	0.0	1.1	0.0	1.9	0.1	0.2	1.4	0.5	0.0	0.2	0.4	3.4	0.1	0.4	0.8	0.0	0.1	0.5	2.0	0.5	0.8	2.6	2.2	2.1	2.8	2.1	2.6	3.1	2.7	2.5	2.7	4.0	4.5	1.9	0.0	0.0	0.3	0.0	0.1	0.8	0.4	0.0	5.2	3.5	1.8	2.2	0.0	0.7	11.0	8.4	0.5	1.4	0.6	7.9	7.8	12.2	1.1	1.9	2.1	3.5	0.0	0.5	8.0	0.3	1.7	1.1	1.0	0.0	3.0	3.9	1.6	40.6	0.0	0.8	0.8	0.0	12.7	0.8	12.1	2.1	8.3	0.0	3.7	2.3	2.6	0.0	2.0	0.1	7.4	0.1	1.9	0.4	0.6	0.0	8.3	0.4	4.8	6.6	0.4	1.2	7.8	2.6	0.2	0.3	2.3	0.7	17.4	0.2	0.4
TMEM92	FLJ33318	ENSG00000167105	"Transmembrane protein 92"	Q6UXU6	17	50271406-50281485	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.0;stomach 1: 23.0"	"Group enriched"	"Detected in many"	4	"Proximal enterocytes: 285.4;Urothelial cells: 88.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.5;CACO-2: 14.1;CAPAN-2: 10.6;EFO-21: 21.4;OE19: 16.8;SuSa: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063009, HPA069820"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA063009: AB_2684921, HPA069820: AB_2686208"	"unprognostic (3.54e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.37e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.81e-2)"	0.2	0.0	0.4	0.9	0.4	0.4	0.3	0.2	0.5	2.1	0.1	2.2	16.0	0.8	0.0	0.7	0.6	4.4	0.1	0.3	0.3	1.0	8.3	2.6	0.1	0.8	0.4	2.0	1.0	0.0	0.0	0.0	0.5	0.7	1.4	0.0	2.7	0.0	0.0	0.2	19.0	0.3	0.4	0.2	23.0	0.2	0.6	0.0	0.0	0.0	0.1	1.5	1.4	0.4	0.7	7.5	0.1	0.0	0.0	0.1	1.5	0.2	0.1	0.0	0.0	14.1	10.6	0.0	21.4	0.2	2.8	0.1	0.1	1.6	0.0	3.6	0.2	0.1	0.7	0.9	0.2	0.0	0.1	0.2	1.4	0.0	0.4	1.6	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.2	3.1	16.8	3.5	0.2	0.0	2.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.2	0.5	0.0	0.3	2.0	0.0	0.1	0.0	0.0	0.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.5	0.3	0.3	0.8	0.4	0.5	0.4	0.6	0.4	0.1	3.2	21.7	0.0	0.0	0.5	15.8	26.5	1.8	0.0	9.7	0.0	0.3	18.6	16.1	7.3	0.0	0.1	0.0	5.9	0.0	7.9	0.1	2.3	2.1	1.2	5.4	0.0	0.0	19.6	2.8	0.8	34.1	19.5	0.0	0.0	2.2	15.6	0.4	0.0	0.0	24.4	0.0	0.6	0.7	0.2	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	45.1	14.8	0.0	0.2	19.1	285.4	0.0	3.5	0.0	0.0	0.0	1.5	0.1	1.6	0.2	1.0	0.0	0.3	0.0	19.8	88.3
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500452	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 43.0;Granulosa cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: AB_2681207"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	21.3	55.9	50.3	13.9	46.4	18.4	21.7	27.7	54.9	21.9	30.5	25.1	18.8	24.4	5.4	21.1	30.7	15.8	27.8	40.7	31.5	29.7	20.2	25.6	14.1	40.1	36.8	27.7	23.7	20.3	30.1	14.2	30.5	19.9	13.6	27.7	21.1	13.2	63.4	22.9	28.2	10.7	34.8	29.7	25.0	27.1	47.1	18.0	27.4	25.8	8.6	20.5	15.3	35.8	15.3	40.7	33.6	52.6	16.1	18.8	45.6	9.2	20.0	15.4	15.4	13.7	22.6	20.6	30.3	15.9	23.6	19.9	15.8	25.6	8.8	19.4	23.1	22.0	18.4	22.9	21.2	23.7	45.2	30.9	14.5	15.0	13.4	13.9	28.1	18.3	22.6	24.4	20.7	19.1	53.3	18.8	14.4	19.3	16.2	36.2	37.2	19.2	16.0	40.7	28.1	30.5	10.2	47.4	28.7	25.3	29.8	29.3	16.0	16.5	19.0	16.5	13.8	53.2	17.2	12.2	17.2	23.8	20.8	0.1	2.6	3.0	3.5	1.6	2.6	1.0	1.6	2.5	2.5	2.5	1.3	2.2	0.7	2.4	1.4	3.3	2.1	2.9	50.3	46.4	27.7	54.9	40.7	31.5	40.1	36.8	30.5	34.8	47.1	35.8	12.8	12.8	11.1	0.0	5.8	0.0	3.3	0.0	6.2	43.0	10.9	9.1	0.0	12.8	6.2	9.2	31.3	16.1	8.8	18.0	0.0	8.1	4.7	10.1	6.8	8.2	7.3	10.7	0.0	9.5	11.0	4.4	28.1	8.6	6.3	41.5	13.9	8.9	15.4	20.2	0.0	10.5	0.0	12.4	0.0	1.9	6.8	8.9	0.0	0.0	5.6	15.2	4.1	0.0	0.0	6.0	9.1	9.1	8.1	3.3	19.6	3.4	2.9	33.6	6.6	7.5	6.0	14.9	8.8	9.7	0.0	20.1	6.9	19.0	9.3	3.1
TMEM98	DKFZP564K1964	ENSG00000006042	"Transmembrane protein 98"	Q9Y2Y6	17	32927910-32945106	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"plasmacytoid DC: 4.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 4.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 277.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040473, HPA053385"	Uncertain		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA040473: AB_10794876, HPA053385: AB_2682134"	"unprognostic (1.55e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.36e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (8.14e-4)"	"prognostic favorable (7.10e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (3.85e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	56.3	50.6	48.9	17.3	84.1	4.7	44.5	75.3	64.1	68.6	161.9	90.0	102.5	100.4	74.2	27.9	96.5	93.9	44.3	51.2	56.9	36.5	27.5	58.1	5.7	72.8	77.4	191.9	88.5	53.7	23.9	28.2	69.7	80.7	96.3	15.7	50.1	23.9	5.3	24.6	118.4	62.3	51.9	19.6	101.6	20.7	75.0	4.4	47.7	14.6	7.7	50.7	42.6	109.3	7.4	27.2	115.5	0.2	154.7	138.0	1.1	114.2	153.2	59.2	126.5	277.6	8.1	1.6	1.7	144.0	2.1	0.9	74.2	30.1	34.5	24.7	92.0	4.6	0.1	124.5	71.5	0.3	1.7	116.3	29.7	74.7	12.1	31.6	154.8	40.7	78.1	0.3	162.9	0.2	0.1	0.7	77.0	83.1	42.0	0.2	108.4	0.5	13.6	49.0	9.8	158.3	2.7	0.0	89.8	72.6	36.5	0.2	128.2	83.8	78.1	1.0	0.2	9.2	3.8	0.1	42.9	0.1	46.2	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	4.1	0.0	0.1	48.9	84.1	75.3	64.1	51.2	56.9	72.8	77.4	69.7	51.9	75.0	109.3	7.6	41.7	24.8	6.2	0.6	25.1	76.1	111.5	27.3	1.4	32.4	104.5	14.1	72.9	61.0	46.0	0.0	8.1	0.7	109.2	5.9	81.0	18.2	14.7	48.5	7.8	97.9	2.7	0.6	66.4	7.3	127.2	40.8	12.1	3.8	87.8	29.6	13.0	5.7	0.0	0.3	145.7	40.7	0.6	15.9	14.9	120.5	2.0	44.4	1.9	0.0	106.3	0.0	3.0	173.0	88.2	97.9	151.6	0.2	68.1	250.9	37.2	54.6	4.8	65.7	22.1	55.5	40.7	27.7	17.1	12.6	7.1	2.4	132.6	166.6	68.6
TMOD2	NTMOD	ENSG00000128872	"Tropomodulin 2"	Q9NZR1	15	51751597-51816363	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 63.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 101.9;Excitatory neurons: 147.3;Horizontal cells: 87.5;Inhibitory neurons: 125.9;Oligodendrocyte precursor cells: 98.0;Oligodendrocytes: 94.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 13.1;monocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041365	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA041365: AB_10794665"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (5.33e-4)"	"prognostic favorable (4.53e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.89e-1)"	6.1	5.2	30.0	5.6	43.1	0.7	4.2	9.8	63.0	8.8	0.0	12.2	2.2	5.2	3.3	3.9	6.9	4.4	6.3	48.3	17.9	2.5	1.3	3.7	4.4	16.8	12.7	5.4	2.3	4.3	6.0	2.0	21.3	4.3	4.1	15.7	3.1	8.3	2.0	3.7	5.8	5.8	9.5	3.8	3.7	2.2	18.1	4.8	4.0	3.7	4.0	4.7	7.6	27.3	1.2	0.7	2.4	5.7	11.3	12.1	0.4	6.5	2.2	4.8	5.2	0.1	0.6	5.3	0.2	5.1	5.0	3.4	10.2	5.8	1.5	0.1	5.0	0.0	1.0	0.1	1.9	2.1	0.4	7.1	7.7	0.7	1.4	6.4	1.0	13.6	0.0	0.1	6.0	0.9	4.4	0.7	1.6	0.0	1.2	3.4	1.4	0.1	0.8	1.7	37.0	9.1	6.0	0.0	1.7	3.0	1.4	0.3	2.4	12.9	1.0	8.3	4.7	0.0	0.0	0.0	4.1	14.2	6.0	0.2	5.9	8.6	2.3	2.4	0.9	2.7	1.3	1.0	1.6	1.6	1.6	0.7	13.1	1.3	10.6	1.3	0.5	1.2	30.0	43.1	9.8	63.0	48.3	17.9	16.8	12.7	21.3	9.5	18.1	27.3	13.8	0.0	4.1	101.9	7.4	4.8	3.6	1.2	3.4	26.3	3.0	3.0	7.9	0.0	1.7	11.0	22.9	0.1	1.8	0.1	7.9	3.3	30.8	0.9	4.3	13.5	23.4	0.8	147.3	1.8	0.1	12.2	1.1	0.5	0.0	3.0	12.8	0.4	4.9	87.5	125.9	0.7	2.0	7.9	4.4	19.6	11.1	9.1	1.8	53.4	29.8	12.6	3.1	98.0	94.1	2.2	0.2	5.7	2.6	1.9	1.8	1.2	2.8	19.7	6.6	13.1	5.8	6.6	4.9	6.3	7.5	0.3	6.5	1.3	0.5	1.8
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33097146	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.5"	"Cell type enhanced"	"Detected in some"		"Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	0.6	0.5	0.8	1.4	0.7	5.5	0.6	0.7	1.2	0.6	4.3	1.0	1.2	0.5	0.6	0.6	0.9	0.6	0.4	1.5	0.5	1.0	0.6	1.1	1.1	1.4	1.4	0.6	0.7	1.9	0.3	1.2	1.6	0.5	1.2	2.8	0.7	0.6	0.2	1.1	1.1	0.8	0.2	1.5	1.3	0.3	1.7	0.5	1.0	0.3	1.3	0.8	0.4	0.2	1.4	1.9	1.0	1.7	1.2	1.0	27.2	0.6	1.0	1.6	0.9	2.7	3.8	0.8	1.2	1.7	0.9	1.4	1.7	1.5	2.6	4.2	0.6	3.4	1.9	2.1	0.9	3.0	4.7	1.1	1.2	2.0	1.4	0.8	1.9	1.7	2.6	2.9	1.2	1.3	1.2	1.3	1.0	0.4	1.1	1.5	0.6	1.9	1.5	1.9	0.2	0.6	0.9	2.6	0.6	1.3	1.4	4.2	2.7	2.4	3.0	1.3	2.6	2.3	1.6	0.4	3.0	2.2	1.7	0.0	1.1	0.3	0.1	2.4	0.6	0.3	0.2	0.0	1.0	0.1	0.0	0.0	1.9	0.0	1.1	0.2	0.2	0.4	0.8	0.7	0.7	1.2	1.5	0.5	1.4	1.4	1.6	0.2	1.7	0.2	0.3	0.0	1.3	0.0	0.8	0.8	0.1	0.0	0.0	1.2	0.4	0.4	0.4	0.0	0.2	0.0	0.0	1.1	1.9	1.4	0.0	0.4	0.0	0.8	0.6	0.4	0.0	0.4	0.0	0.8	1.7	0.3	0.0	1.1	0.0	0.4	0.4	0.6	0.9	1.7	0.0	0.2	2.0	1.3	1.2	0.0	0.0	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.5	1.4	0.4	1.0	0.2	1.4	0.3	0.4	2.2	0.0	0.2	0.7	0.0	0.0	1.5	0.9	0.4	0.6	0.5	0.6	0.2
TMPRSS5	"MGC141886, MGC148044"	ENSG00000166682	"Transmembrane serine protease 5"	Q9H3S3	11	113687547-113706373	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.6;choroid plexus: 20.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 26.4;Excitatory neurons: 5.4;Horizontal cells: 5.0;Oligodendrocytes: 15.5"	"Cancer enhanced"	"Detected in some"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.0;CAPAN-2: 3.2;OE19: 2.0;WM-115: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010992			Approved	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA010992: AB_1858152"	"unprognostic (1.53e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.19e-3)"	"unprognostic (8.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.04e-3)"	1.3	0.5	28.1	0.2	34.7	1.4	2.0	24.9	39.0	0.8	20.8	0.7	0.1	0.5	0.2	0.5	0.7	0.7	1.0	28.2	27.0	1.0	1.0	0.7	0.2	34.0	29.8	0.6	0.5	0.0	1.6	0.2	33.1	0.8	0.3	1.1	9.6	0.3	2.6	2.1	0.7	0.3	28.5	0.8	0.8	2.1	32.1	0.3	0.6	0.5	0.3	0.7	1.0	50.6	0.2	0.3	2.0	1.1	0.2	0.1	0.3	0.5	0.2	0.3	0.4	1.1	3.2	0.1	1.4	0.2	0.3	0.4	0.1	0.2	0.1	0.2	0.6	0.4	0.3	0.0	0.1	0.5	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.7	0.4	0.2	0.4	0.0	0.4	0.6	0.2	2.0	0.1	0.4	0.2	0.0	0.3	0.2	0.3	0.4	0.2	0.0	1.6	0.2	0.2	0.2	0.2	0.4	0.7	0.3	0.3	0.2	0.1	0.0	0.1	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	34.7	24.9	39.0	28.2	27.0	34.0	29.8	33.1	28.5	32.1	50.6	0.2	0.0	0.0	26.4	0.2	0.3	0.2	0.0	0.0	0.5	1.0	0.9	0.5	0.0	0.1	1.8	2.1	0.0	0.2	0.2	0.0	0.3	0.1	0.3	0.2	0.3	0.0	1.3	5.4	0.9	0.0	0.3	0.0	0.4	0.0	0.4	0.4	0.2	0.1	5.0	2.8	0.0	0.0	0.0	0.3	0.3	0.3	0.1	0.0	2.8	0.1	3.2	0.0	3.5	15.5	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.1	1.3	0.0	0.5	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2
TMSB4X	"TB4X, TMSB4"	ENSG00000205542	"Thymosin beta 4 X-linked"	P62328	X	12975110-12977227	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 30742.3;Langerhans cells: 57681.0;monocytes: 48133.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033806	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Vesicles, Cytosol"		"CAB033806: AB_2256019"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	6173.6	4217.0	3255.7	5088.7	3773.0	8722.4	4452.0	3539.2	4521.9	3685.7	2999.1	4327.1	1776.8	3731.3	2877.9	2069.6	2709.3	4129.3	2652.4	3319.4	3573.5	3300.1	2360.4	6225.5	10448.1	4064.7	3620.0	2592.1	1852.6	483.2	1053.7	2450.2	4203.0	2335.6	3793.9	273.3	1886.8	2441.9	816.5	1962.4	3671.2	3340.7	4219.2	7935.5	4690.0	486.8	3591.8	6377.6	1648.7	1475.0	7233.8	5168.6	2907.2	4467.6	5980.6	4886.3	9387.7	14881.1	11264.5	12247.2	23.0	3083.9	8032.6	2344.3	4005.4	1016.1	4865.3	1417.1	2900.6	9443.7	4198.0	2564.2	1411.5	2072.7	3135.4	8343.4	80.9	1771.0	2621.8	12.9	2619.8	6994.8	14038.1	5755.3	2911.9	2781.9	2412.7	5704.5	14335.9	3714.1	230.0	22.0	8424.8	2121.5	8390.5	15083.5	3384.1	2853.1	3337.3	6352.0	3321.0	5858.5	14234.5	1720.4	994.2	422.9	4461.8	207.4	583.3	6898.2	5536.5	6961.4	11607.2	3383.5	1647.5	19441.4	3123.6	4432.5	3490.6	2774.8	5183.2	2860.5	2499.5	42940.3	34738.5	50992.6	21474.2	33907.1	18326.4	18757.1	23777.1	23343.2	31253.2	16919.4	19802.1	20330.2	35862.9	18444.5	37523.3	12797.6	34088.1	86809.5	3255.7	3773.0	3539.2	4521.9	3319.4	3573.5	4064.7	3620.0	4203.0	4219.2	3591.8	4467.6	6885.8	5253.2	4939.6	35.9	6293.8	8836.3	2708.7	10515.3	296.5	332.9	2318.3	1124.2	106.9	3484.4	8003.6	6882.2	22.9	283.0	9136.2	9016.2	2181.5	17304.6	142.1	2613.2	4698.0	9239.4	1765.0	1339.1	54.3	23029.4	511.7	4800.1	2728.9	5047.4	4380.4	4646.7	6638.0	1088.5	30742.3	62.2	81.0	4883.9	14806.8	20982.2	57681.0	343.6	3932.0	17648.1	6349.9	212.7	48133.8	86.7	20882.8	19.6	102.1	25113.5	5826.4	6035.9	2541.8	3272.5	6888.7	835.1	2596.4	99.4	5732.4	1018.2	5450.7	58.2	126.3	933.7	9528.5	454.8	12719.6	3874.8	3140.6	9064.0
TMTC1	"ARG99, FLJ31400, FLJ41625, OLF"	ENSG00000133687	"Transmembrane O-mannosyltransferase targeting cadherins 1"	Q8IUR5	12	29500840-29784759	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.0;Astrocytes: 64.6;Excitatory neurons: 186.0;Inhibitory neurons: 200.5;Skeletal myocytes: 60.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 83.0;HSkMC: 56.9;hTERT-HME1: 103.8;LHCN-M2: 58.8;RH-30: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016720	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA016720: AB_1858155"	"unprognostic (1.67e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.63e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.49e-4)"	"unprognostic (5.89e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.51e-3)"	36.7	14.1	14.5	5.2	21.0	0.2	16.8	6.7	13.5	11.9	13.3	11.9	3.1	9.0	3.0	6.8	14.3	7.1	16.5	20.0	25.0	14.7	2.4	8.7	2.7	11.4	24.0	9.3	2.6	28.0	10.7	2.8	15.8	6.9	5.9	2.6	4.5	8.8	18.5	4.0	6.4	13.2	7.9	42.4	8.3	2.4	25.1	6.9	4.7	31.2	2.1	12.1	8.2	6.3	0.0	0.0	15.3	0.0	47.7	31.6	0.1	14.7	33.1	4.3	3.4	0.0	0.2	0.1	7.4	10.0	17.6	0.0	0.5	0.2	0.2	0.3	4.6	0.0	41.5	0.7	83.0	2.1	0.0	56.9	5.6	40.3	103.8	12.2	2.2	0.0	0.0	2.2	58.8	0.0	0.0	0.0	11.1	0.2	20.8	0.0	122.4	2.1	0.0	0.3	1.2	1.2	1.7	0.0	4.1	5.4	0.0	0.8	6.2	3.7	2.4	2.3	12.5	19.6	0.0	0.0	27.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.5	21.0	6.7	13.5	20.0	25.0	11.4	24.0	15.8	7.9	25.1	6.3	105.0	3.2	0.6	64.6	0.9	3.3	1.0	6.1	11.4	12.1	1.3	10.4	32.3	0.0	2.4	3.7	0.0	0.1	0.0	0.0	0.0	0.1	29.6	7.7	16.2	57.9	0.0	0.0	186.0	0.0	0.0	17.5	2.0	7.0	0.0	4.3	54.7	5.4	0.5	0.0	200.5	0.2	0.0	17.7	4.2	7.5	8.1	4.9	10.6	30.9	0.5	0.5	0.0	9.5	5.7	0.0	0.0	18.4	0.3	4.0	0.1	0.7	6.0	1.3	46.0	60.3	24.9	2.4	1.7	1.3	2.0	1.9	1.0	21.9	0.0	0.4
TMUB1	"C7orf21, HOPS, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081085-151083493	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 191.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	33.1	53.3	26.8	25.6	24.7	23.0	34.3	25.6	38.6	34.0	19.4	52.7	47.2	33.6	8.6	54.2	32.8	14.9	50.4	24.9	24.6	56.3	131.3	41.6	26.3	29.6	25.9	37.0	93.5	20.3	68.8	20.4	27.0	51.2	8.3	5.2	44.1	14.9	84.5	47.0	56.7	9.0	24.2	53.6	66.8	25.9	29.4	17.9	51.3	20.0	12.1	40.8	38.9	23.7	88.3	77.5	18.0	93.2	11.6	14.2	67.2	35.3	29.3	30.8	34.3	67.5	104.6	58.6	73.9	17.4	39.9	58.6	20.0	31.2	6.8	108.0	74.4	24.8	74.8	104.7	29.5	31.3	84.8	22.0	25.4	25.8	6.9	23.4	22.9	59.3	159.4	77.4	14.0	141.2	104.5	134.5	77.2	51.7	48.3	64.8	22.7	108.5	32.2	67.4	65.6	73.2	28.6	43.6	47.9	10.6	34.0	42.9	28.3	39.0	28.5	49.3	59.1	121.2	72.5	41.4	89.8	58.2	50.4	4.2	3.1	23.8	5.7	4.3	5.0	5.3	8.7	6.4	3.2	11.2	8.7	4.8	5.3	3.7	2.6	4.8	12.1	2.4	26.8	24.7	25.6	38.6	24.9	24.6	29.6	25.9	27.0	24.2	29.4	23.7	24.0	6.4	3.2	7.5	51.2	26.4	25.9	26.0	31.9	15.2	45.7	34.8	9.9	28.6	15.9	22.0	14.6	93.1	50.2	136.7	35.2	73.1	11.9	15.8	11.7	21.5	41.3	23.2	4.5	109.6	60.2	18.3	52.0	29.3	15.9	23.3	25.4	51.4	44.2	20.2	5.3	85.9	46.8	30.4	61.2	5.1	12.5	32.4	32.0	6.5	44.8	28.9	70.0	2.5	7.2	96.3	109.7	16.6	67.8	39.3	191.0	37.9	6.4	16.0	39.5	9.3	21.8	22.3	15.6	39.5	36.9	94.5	52.8	25.4	84.0	37.9
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712593-57740973	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Lissencephaly, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: AB_2685116"	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (3.37e-4)"	52.9	75.1	77.7	37.3	83.0	27.0	50.5	87.4	101.9	43.6	103.3	70.0	56.4	39.4	58.2	62.8	42.7	33.2	71.5	75.0	84.1	78.7	83.4	45.0	31.5	81.7	81.5	40.9	57.7	84.9	43.1	44.0	83.5	50.1	80.8	64.7	49.6	53.8	44.7	45.1	58.3	43.1	84.3	44.9	60.9	30.6	85.5	34.9	57.1	41.3	47.6	48.2	43.8	90.6	122.7	141.4	78.5	143.4	144.8	77.2	86.6	144.2	111.8	140.0	117.9	135.3	205.6	115.1	156.6	116.3	207.1	220.0	203.5	115.4	146.3	83.3	88.9	110.2	105.7	136.8	119.3	156.6	145.5	94.8	166.5	154.8	243.2	76.3	80.6	95.3	194.4	130.9	157.7	62.7	93.0	177.1	153.8	227.7	191.5	124.7	97.9	242.5	174.4	136.4	90.3	129.3	110.2	255.7	168.3	76.7	228.5	102.2	66.7	130.5	84.8	176.1	152.1	127.9	269.5	115.3	146.6	109.3	198.3	37.8	41.5	40.0	34.6	72.4	44.0	36.8	34.4	40.9	40.6	34.9	43.1	43.8	11.2	37.8	86.0	49.7	32.0	45.0	77.7	83.0	87.4	101.9	75.0	84.1	81.7	81.5	83.5	84.3	85.5	90.6	37.9	38.5	34.0	0.0	32.0	32.1	44.9	108.2	19.9	43.4	35.8	28.1	42.6	30.0	60.8	49.7	31.3	108.0	29.9	39.5	43.0	72.4	2.0	19.6	27.4	36.8	28.8	37.6	0.0	43.5	85.6	38.6	23.0	20.7	43.1	29.9	31.8	48.7	62.0	30.3	0.0	49.6	81.4	30.8	21.4	3.6	48.7	31.9	48.0	0.0	37.8	91.1	19.6	0.0	0.0	54.5	32.0	43.6	32.5	49.0	51.4	41.1	37.4	66.7	39.5	36.3	34.5	60.7	62.2	33.6	32.7	99.6	26.6	46.6	75.2	43.6
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103121476-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 277.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 48.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"RT4: 785.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: AB_2673552"	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (7.17e-5)"	119.9	76.8	9.0	103.6	11.5	106.8	78.4	6.7	12.2	53.8	12.1	39.8	38.0	50.9	6.6	88.3	57.1	102.2	48.3	8.0	9.7	67.7	61.6	142.4	87.4	17.1	10.4	16.9	33.6	66.8	16.6	48.4	16.2	73.6	26.8	1.6	84.0	14.9	35.0	53.3	52.5	24.8	13.6	147.9	37.4	37.1	21.4	39.5	36.8	32.5	80.3	277.5	74.6	16.1	34.7	156.3	1.1	0.6	10.1	45.9	54.5	9.7	43.2	26.4	8.9	1.6	148.7	0.3	120.3	48.5	142.5	104.2	11.6	0.0	11.9	6.1	0.6	15.4	120.0	0.7	19.2	7.7	20.0	17.8	1.6	8.4	0.1	10.5	14.2	7.7	15.5	35.3	3.6	3.4	0.4	11.6	9.7	19.6	13.4	6.8	18.9	24.9	80.8	785.1	1.3	2.3	150.2	52.4	1.9	5.6	83.8	50.4	28.4	5.1	13.5	30.3	31.5	31.4	2.4	0.9	38.1	34.0	16.1	5.9	16.8	9.0	0.1	18.6	0.1	0.1	0.1	0.0	9.4	0.2	0.1	0.1	48.4	0.2	15.0	0.5	0.0	4.5	9.0	11.5	6.7	12.2	8.0	9.7	17.1	10.4	16.2	13.6	21.4	16.1	45.8	0.0	25.1	2.3	8.2	28.3	41.8	295.5	6.8	1.1	24.2	11.4	14.1	51.5	126.1	27.6	0.0	1.2	1.3	1.0	0.0	160.9	36.8	92.4	122.2	47.1	17.3	1.7	2.5	44.7	61.2	123.3	5.6	172.8	33.7	4.5	18.9	8.0	54.1	0.0	5.7	0.3	85.5	151.2	198.7	48.8	8.4	163.3	30.2	25.3	351.9	5.9	5.2	1.0	0.9	122.1	18.3	2.2	11.7	186.0	0.7	14.4	121.5	0.7	19.7	104.9	39.7	2.1	4.6	20.7	33.4	4.8	8.3	1.1	1.9	138.6
TNFAIP8	"GG2-1, MDC-3.13, SCC-S2"	ENSG00000145779	"TNF alpha induced protein 8"	O95379	5	119268692-119399688	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 211.8;Langerhans cells: 323.4;Syncytiotrophoblasts: 292.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 155.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054434, HPA057089"	Uncertain		Enhanced	Nucleoplasm		No	Yes		470000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA054434: AB_2682487, HPA057089: AB_2683331"	"prognostic favorable (2.45e-4)"	"unprognostic (6.06e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.86e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-2)"	72.4	5.1	4.2	62.3	4.1	65.5	19.3	8.9	7.0	15.9	31.2	17.8	16.1	13.3	17.1	25.3	10.5	16.6	8.5	3.9	4.0	16.4	10.1	19.1	117.8	4.9	4.1	3.5	16.8	14.8	1.6	52.5	4.8	18.9	19.0	2.4	11.2	14.4	3.3	31.6	31.3	15.5	1.7	61.1	28.6	17.5	5.1	100.0	25.3	5.6	115.9	43.6	17.8	6.6	27.7	19.0	10.0	16.1	20.5	17.2	91.2	15.0	40.4	11.1	23.0	10.2	31.6	51.0	4.7	16.7	17.6	38.4	8.3	45.4	15.7	56.6	17.9	81.4	41.1	17.6	9.9	99.6	86.4	19.1	42.0	33.7	15.9	21.2	15.4	99.9	32.0	155.2	15.5	10.7	84.5	128.9	15.0	16.0	8.9	25.6	44.1	75.8	44.5	54.8	5.1	7.8	56.6	10.9	5.5	32.1	9.4	111.4	8.1	20.2	7.8	14.1	17.9	76.0	90.0	103.3	23.3	104.8	11.9	491.9	96.1	305.0	111.0	105.1	217.3	267.2	221.9	164.7	133.6	243.5	260.8	169.7	54.6	111.4	86.7	63.8	188.4	213.0	4.2	4.1	8.9	7.0	3.9	4.0	4.9	4.1	4.8	1.7	5.1	6.6	8.9	9.6	18.7	1.6	174.9	160.5	80.9	81.9	123.5	0.2	14.4	10.8	10.3	12.8	38.3	18.4	0.0	142.6	83.6	2.7	17.6	55.4	4.4	11.8	7.8	23.2	1.2	34.5	0.8	101.0	158.8	30.1	17.9	9.5	211.8	0.7	6.4	1.9	48.9	0.0	2.3	9.9	20.3	59.4	323.4	1.4	2.1	126.0	37.4	24.4	196.6	4.3	111.2	1.0	6.8	125.7	2.7	1.9	45.6	63.9	0.9	19.8	47.2	0.4	46.0	4.0	32.9	1.1	18.0	93.1	119.2	292.7	139.0	35.2	4.3	103.6
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 86.9;smooth muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 10.3;Inhibitory neurons: 14.4;Langerhans cells: 10.8;Smooth muscle cells: 9.3;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;ASC TERT1: 87.8;HUVEC TERT2: 78.7;LHCN-M2: 74.5;TIME: 105.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA077484: AB_2732347"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (3.51e-4)"	9.4	3.8	9.2	7.1	8.3	0.8	5.7	3.5	8.2	13.7	4.3	8.6	1.6	86.9	6.0	20.4	45.6	6.2	6.3	15.3	6.6	2.7	2.4	15.5	3.9	5.5	8.5	15.9	2.4	0.8	3.0	2.0	4.8	6.8	8.6	0.3	3.9	5.4	4.7	23.1	7.9	84.8	4.3	19.9	5.8	4.4	6.6	0.9	5.4	3.5	3.2	18.6	15.1	5.6	0.1	0.4	0.1	0.2	35.0	87.8	0.4	0.3	0.1	1.0	1.6	0.1	1.0	0.1	1.5	5.0	11.2	0.1	1.2	0.8	0.4	0.1	0.7	0.0	2.4	5.9	9.1	0.3	1.9	32.5	7.1	6.7	26.8	5.8	78.7	0.1	0.1	0.1	74.5	0.9	0.0	0.6	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.1	0.1	0.1	0.9	0.5	0.6	105.5	8.0	0.5	26.5	2.3	0.4	0.0	0.1	16.7	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.6	0.3	0.2	0.2	0.0	0.0	9.2	8.3	3.5	8.2	15.3	6.6	5.5	8.5	4.8	4.3	6.6	5.6	1.2	0.0	0.5	4.6	0.0	3.3	1.1	0.4	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.3	2.3	1.7	3.9	10.3	0.0	4.5	0.4	0.0	5.8	0.0	0.1	0.0	7.1	1.8	0.3	2.9	0.0	14.4	3.3	2.0	2.9	10.8	0.7	9.0	3.5	1.8	1.0	0.6	0.1	0.0	1.0	2.6	0.1	1.5	5.3	0.1	0.4	0.0	0.1	1.3	0.2	6.6	1.6	9.3	23.7	0.8	0.3	8.4	0.0	0.1	0.1	1.5	0.5
TNFRSF10A	"Apo2, CD261, DR4, TRAILR-1, TRAILR1"	ENSG00000104689	"TNF receptor superfamily member 10a"	O00220	8	23190452-23225102	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA050958, HPA054475"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050958: AB_2681290, HPA054475: AB_2682500"	"unprognostic (3.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-1)"	5.7	2.3	2.6	9.9	2.5	9.3	5.7	2.2	2.7	4.3	2.2	7.0	6.2	2.9	1.1	8.4	4.1	8.2	3.0	2.0	2.4	3.8	5.3	6.6	13.4	3.4	2.8	0.8	2.4	2.7	0.8	7.1	3.1	2.9	7.1	0.2	4.8	2.5	1.5	4.9	6.5	3.9	2.8	6.8	6.5	0.5	3.4	6.4	3.0	2.8	14.0	10.8	5.8	2.8	18.7	33.0	1.7	0.1	1.2	6.4	0.1	3.8	2.3	1.9	5.2	25.4	31.8	42.9	41.9	2.4	9.1	34.6	29.5	47.2	3.1	10.7	0.2	22.7	20.4	14.7	16.2	12.3	20.7	11.0	38.2	41.1	35.0	5.5	21.9	1.4	35.7	14.9	8.9	14.5	0.4	7.8	22.6	33.0	20.0	0.3	0.0	31.2	24.4	39.5	0.9	1.1	9.3	23.0	0.0	6.9	12.3	9.3	31.3	0.1	0.2	1.8	0.1	17.4	26.7	32.7	0.2	3.9	0.5	2.8	6.1	5.7	5.0	2.6	13.8	15.3	16.1	10.2	6.3	19.1	15.7	9.2	0.6	6.1	2.6	0.0	20.8	6.5	2.6	2.5	2.2	2.7	2.0	2.4	3.4	2.8	3.1	2.8	3.4	2.8	21.5	3.2	8.7	0.7	22.3	23.6	20.7	9.1	21.6	0.2	8.2	7.1	1.1	7.2	15.5	11.0	0.0	0.1	3.1	10.1	0.0	10.1	0.1	8.6	1.9	16.6	2.4	1.3	0.4	4.0	0.4	2.2	10.2	23.9	7.6	0.7	2.9	5.1	3.1	0.0	0.4	7.0	8.2	2.2	12.7	0.0	0.0	8.5	3.6	9.4	4.2	0.0	2.1	1.0	0.5	20.3	7.3	0.0	14.0	11.7	4.5	2.9	5.7	0.0	0.0	0.9	1.1	0.0	0.5	25.6	27.4	0.0	12.8	0.1	9.1	27.4
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 55.3;skin 1: 107.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.2;Microglial cells: 71.2;Respiratory ciliated cells: 62.4;Suprabasal keratinocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.5;BJ hTERT+: 73.2;fHDF/TERT166: 55.9;Hep G2: 83.0;SK-MEL-30: 128.4;WM-115: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 28: Keratinocytes - Keratinization"	Mitochondria	Nucleoplasm	"HPA010135: AB_1079797"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.8	2.9	1.8	0.9	1.7	1.7	9.9	1.8	1.9	7.0	4.2	2.4	1.8	8.6	13.4	9.4	30.5	3.4	22.1	2.0	2.5	15.7	1.1	17.2	0.7	3.3	3.2	2.7	2.8	0.9	8.5	8.4	2.6	27.4	1.9	4.7	55.3	7.6	2.4	107.5	1.3	3.0	3.1	5.1	5.4	2.2	2.7	6.7	3.4	2.1	1.8	4.5	4.8	2.5	0.1	3.3	3.2	0.0	4.7	46.5	3.5	3.7	73.2	2.0	2.8	23.6	0.1	0.0	0.0	55.9	0.5	0.1	3.3	2.9	3.6	0.0	2.9	0.6	2.4	83.0	2.2	0.2	0.9	22.5	0.7	23.1	0.3	1.5	0.1	0.0	0.1	0.0	13.2	1.1	0.0	0.1	2.3	29.7	5.1	0.0	13.6	0.0	8.4	0.4	30.9	4.9	0.1	0.0	128.4	3.4	0.0	0.3	0.0	11.5	0.5	0.1	3.5	0.0	0.1	0.0	4.5	0.1	76.2	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	1.8	1.7	1.8	1.9	2.0	2.5	3.3	3.2	2.6	3.1	2.7	2.5	3.1	0.0	20.8	1.0	0.2	62.2	3.0	2.0	23.9	0.8	6.3	2.9	23.4	2.8	9.3	9.2	8.4	0.1	0.3	0.1	0.0	11.1	1.7	10.4	4.4	5.1	0.0	0.0	6.9	1.0	0.0	14.4	2.6	3.9	1.3	0.5	0.0	0.5	0.1	0.0	6.7	0.0	6.1	0.0	8.5	1.0	11.5	0.2	14.2	71.2	0.0	3.3	0.0	12.5	1.1	11.3	0.0	13.9	0.0	13.3	0.0	20.9	62.4	3.3	0.0	3.2	4.9	1.5	2.3	8.3	80.3	0.0	0.6	3.5	0.0	0.6
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6460786-6466175	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;pituitary gland: 29.9;skin 1: 25.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 34.1;Excitatory neurons: 37.5;T-cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"MAIT T-cell: 5.6;memory CD4 T-cell: 4.4;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.4;T-reg: 7.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.5;RPMI-8226: 25.7"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.4;hippocampal formation: 2.0"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"	NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	6.4	4.2	4.0	3.2	4.0	0.8	4.0	11.1	6.1	5.2	4.9	6.1	3.0	3.0	0.6	10.3	5.7	2.2	8.7	4.8	4.3	3.3	1.2	2.4	4.3	3.7	3.6	3.1	1.5	0.9	29.9	4.4	4.4	5.2	1.4	1.2	3.3	2.3	1.1	25.3	5.0	0.5	3.3	44.0	2.0	0.9	3.7	2.0	3.2	1.2	2.7	2.5	4.6	3.5	1.8	0.4	1.1	2.0	0.0	0.6	1.3	1.5	0.6	0.3	0.0	1.7	2.8	0.0	2.5	0.0	1.3	4.2	0.6	4.7	0.0	20.5	1.5	0.6	1.7	0.1	0.7	0.0	0.1	0.0	3.2	1.5	4.1	2.7	4.0	1.1	0.0	0.0	0.0	2.2	0.0	8.0	1.4	1.4	3.4	0.6	0.3	25.7	1.3	0.7	3.4	5.3	0.0	2.5	0.1	0.6	2.0	2.9	2.5	1.3	2.1	0.0	2.0	0.0	3.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.0	0.2	5.6	0.0	4.4	2.2	0.5	0.0	4.4	0.7	0.0	0.8	1.0	0.0	7.9	0.9	4.0	4.0	11.1	6.1	4.8	4.3	3.7	3.6	4.4	3.3	3.7	3.5	19.0	3.2	5.0	3.9	2.5	24.6	2.3	5.6	11.4	3.1	4.2	5.5	1.1	1.5	3.3	1.8	2.1	0.7	12.8	34.1	0.0	0.2	0.2	4.1	11.2	11.5	6.7	3.0	37.5	0.4	2.0	2.3	5.6	6.9	7.0	4.8	7.9	1.1	4.0	5.0	21.6	20.3	0.0	1.2	6.6	0.3	2.8	4.0	7.2	14.0	3.0	10.2	10.3	7.5	2.1	1.4	16.0	9.4	3.2	3.7	9.8	0.6	4.8	9.1	0.0	2.6	2.6	0.4	1.2	8.6	28.6	0.1	41.4	0.7	25.0	6.8
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784652-114806039	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 9.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 25.6;Basal squamous epithelial cells: 14.8;Endometrial ciliated cells: 15.7;Glandular and luminal cells: 28.9;Squamous epithelial cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 13.2;hTEC/SVTERT24-B: 8.6;HUVEC TERT2: 16.7;OE19: 16.0;RT4: 16.5;TIME: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"	NA	NA	1110000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	0.8	0.7	0.1	2.5	0.2	0.1	0.9	0.1	0.5	1.5	0.1	2.3	9.5	1.0	0.9	1.2	0.9	1.9	0.0	0.1	0.2	4.5	0.2	4.1	0.8	0.3	0.1	0.1	0.1	0.8	0.1	4.4	0.2	4.1	2.0	0.0	4.8	1.9	0.1	0.6	3.5	2.0	0.0	0.5	2.9	0.1	0.2	0.6	0.9	0.0	1.0	4.7	0.7	0.4	0.5	4.4	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.2	3.0	1.6	0.0	0.0	0.5	13.2	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.0	16.7	0.0	0.0	0.9	0.4	0.6	0.0	0.0	0.3	16.0	0.0	0.0	0.1	0.0	0.1	16.5	0.1	0.0	0.0	0.7	0.0	5.6	1.2	0.0	7.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.1	0.2	0.0	0.2	0.4	0.2	12.8	12.1	0.0	0.1	0.5	7.7	25.6	14.8	0.3	3.7	3.7	0.6	1.5	4.9	7.3	0.0	0.7	0.4	8.0	0.0	4.9	0.7	15.7	2.9	0.3	0.0	0.0	0.1	2.0	0.2	1.2	8.2	28.9	0.0	0.0	0.0	0.0	2.3	0.0	0.7	2.4	2.0	0.3	5.1	0.1	0.0	5.0	0.0	0.0	5.3	0.1	0.0	0.0	0.1	1.3	0.5	0.4	1.2	4.9	8.9	9.3	1.0	0.3	0.0	0.4	3.0	0.0	0.0	13.7	0.6	0.3	1.0	0.1	7.4	6.5
TNFSF4	"CD252, gp34, OX-40L, TXGP1"	ENSG00000117586	"TNF superfamily member 4"	P23510	1	173183731-173207331	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins"		Cytokine	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.5;Granulosa cells: 37.0;Macrophages: 26.4;monocytes: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 42.0;HHSteC: 17.3;HUVEC TERT2: 81.2;LHCN-M2: 67.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059579	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA059579: AB_2684071"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-7)"	"unprognostic (3.73e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.98e-2)"	1.2	2.0	1.1	2.3	1.2	0.6	0.6	1.8	1.5	1.0	0.1	1.0	0.3	0.8	0.5	0.6	0.9	1.1	1.0	1.1	0.9	0.8	0.9	1.2	2.2	1.2	1.2	1.1	1.1	0.5	1.5	0.5	1.2	1.4	1.2	1.4	0.4	0.6	0.2	0.3	0.8	0.8	0.8	1.7	0.7	4.0	1.1	3.7	0.4	0.2	1.9	1.5	0.8	1.2	0.1	0.0	0.4	1.2	2.7	14.1	0.2	4.1	0.9	0.2	0.3	0.2	0.1	0.2	0.7	42.0	0.2	0.1	0.1	0.1	0.3	0.7	0.1	0.1	0.4	1.6	17.3	0.3	0.2	6.2	0.3	2.1	0.3	1.3	81.2	1.5	0.1	0.5	67.5	0.0	0.7	0.4	0.3	0.1	0.6	2.0	0.1	0.6	0.6	0.1	0.1	0.6	0.3	0.2	0.9	1.3	0.0	0.7	0.6	0.1	0.1	0.4	0.2	0.9	1.4	0.3	0.2	7.7	4.4	0.0	0.1	0.1	0.5	0.0	0.3	0.5	0.2	0.4	0.3	0.5	0.4	0.4	0.7	1.7	0.0	1.2	0.4	2.8	1.1	1.2	1.8	1.5	1.1	0.9	1.2	1.2	1.2	0.8	1.1	1.2	0.2	0.0	0.5	8.5	0.8	0.8	0.3	0.4	0.6	0.4	0.2	0.0	1.5	1.5	0.1	1.8	0.0	0.2	2.2	0.9	0.0	0.1	5.8	0.2	0.4	1.0	0.0	0.8	3.6	0.0	0.2	3.7	0.0	0.1	0.0	37.0	0.0	1.2	0.5	0.0	5.2	0.0	0.0	0.6	2.3	2.2	0.3	26.4	1.8	0.0	8.2	1.3	2.1	2.5	4.0	0.3	0.1	1.9	0.4	0.4	0.0	0.2	0.8	0.5	0.0	0.6	3.7	0.3	0.2	0.0	0.6	0.0	2.4	0.7	0.1	0.1
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171058414-171460408	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1074.4;Excitatory neurons: 248.4;Inhibitory neurons: 360.8;Oligodendrocyte precursor cells: 374.5;Oligodendrocytes: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 65.2;HMC-1: 71.3;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	1.4	4.4	25.7	6.2	33.7	4.4	2.1	4.1	17.5	1.3	0.0	8.2	21.0	3.4	0.9	4.1	2.8	5.1	9.4	20.8	15.7	3.8	3.1	8.9	6.7	25.5	18.7	1.5	3.7	0.5	8.4	1.9	6.3	3.5	6.7	19.4	1.9	4.6	23.2	1.0	21.3	4.3	19.0	4.5	7.0	7.7	20.1	7.0	6.3	23.6	5.3	4.8	2.1	10.7	0.9	1.2	43.4	4.7	0.8	0.1	10.4	9.3	2.5	7.3	4.8	41.5	16.9	0.0	3.4	9.0	6.9	14.1	6.3	2.6	7.3	0.3	9.8	65.2	3.7	0.0	19.0	13.0	71.3	6.1	5.9	4.3	0.9	15.7	43.6	10.5	23.3	0.1	1.1	1.1	4.1	13.5	18.2	30.6	17.9	0.0	11.8	16.6	12.0	0.1	2.1	2.3	5.8	0.4	9.6	4.1	20.4	2.9	0.5	0.0	7.9	20.5	7.1	0.1	0.0	0.1	1.8	13.8	52.1	4.6	0.1	10.5	3.5	0.0	4.4	0.0	4.2	3.2	0.0	0.2	5.8	3.1	0.1	2.4	0.1	0.0	5.3	1.0	25.7	33.7	4.1	17.5	20.8	15.7	25.5	18.7	6.3	19.0	20.1	10.7	0.7	6.4	50.4	1074.4	4.9	2.5	1.6	1.3	9.1	19.2	8.4	6.5	28.6	21.5	7.1	9.2	14.6	6.3	32.5	19.6	5.9	12.1	48.6	1.1	2.5	1.6	13.2	13.5	248.4	7.7	1.3	9.1	21.4	0.3	83.5	0.4	2.5	8.1	2.9	0.0	360.8	10.3	0.0	6.5	1.9	38.0	2.5	10.4	1.8	57.1	1.6	65.0	51.5	374.5	205.5	7.1	21.6	6.4	11.7	0.7	56.2	17.3	1.8	28.7	0.0	12.4	6.2	3.1	1.0	10.3	1.6	2.5	47.4	9.9	16.6	3.2
TNIP1	"ABIN-1, KIAA0113, NAF1, VAN"	ENSG00000145901	"TNFAIP3 interacting protein 1"	Q15025	5	151029945-151093577	"Human disease related genes, Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 265.5;Proximal enterocytes: 257.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 406.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037893, HPA037894, HPA071950"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA037893: AB_10672468, HPA037894: AB_2675723, HPA071950: AB_2686476"	"prognostic favorable (5.69e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (7.45e-3)"	"unprognostic (2.94e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.84e-2)"	120.0	49.7	34.1	79.6	33.4	128.0	90.7	35.3	40.8	60.1	33.3	72.7	73.2	37.6	22.4	89.3	37.9	54.3	96.3	31.5	36.5	83.3	107.9	91.7	69.4	40.5	37.4	41.8	71.6	42.8	27.2	28.7	39.0	47.9	52.4	17.4	53.1	39.2	211.2	60.4	90.8	32.6	37.6	101.2	63.5	14.6	37.1	43.4	45.9	130.7	83.3	84.4	69.3	35.3	117.7	81.3	15.4	55.7	58.4	58.6	39.4	54.7	174.5	48.6	91.1	78.4	155.5	95.8	182.3	74.2	285.3	68.3	25.2	406.4	59.4	167.8	34.6	37.8	44.4	51.1	111.4	43.6	168.3	84.3	74.5	80.3	166.2	134.1	69.1	37.2	24.6	94.2	122.7	43.7	48.2	60.0	13.9	41.1	43.4	39.0	118.4	131.4	152.3	85.0	21.7	49.9	42.4	131.5	57.2	41.6	67.5	54.5	107.8	162.7	53.0	28.7	79.2	184.6	102.2	43.4	177.0	63.7	39.6	18.2	12.1	36.0	11.9	11.1	14.0	12.7	13.9	12.0	9.2	16.8	7.1	7.9	41.3	12.4	10.8	12.8	21.2	10.4	34.1	33.4	35.3	40.8	31.5	36.5	40.5	37.4	39.0	37.6	37.1	35.3	31.1	57.7	45.4	4.9	73.1	29.7	50.4	119.9	27.3	14.3	33.3	24.9	48.8	54.3	72.2	27.6	4.2	18.3	53.7	233.7	72.4	218.0	3.3	39.8	18.0	75.1	37.3	52.4	6.5	139.1	31.3	38.9	92.8	64.8	48.2	105.2	42.1	62.7	39.0	18.5	6.4	69.0	46.8	49.6	113.1	6.9	27.1	64.9	26.6	8.4	238.3	20.3	68.0	5.5	9.4	265.5	173.9	23.7	63.6	179.1	257.5	56.4	49.1	15.0	32.9	69.2	45.7	2.2	13.9	30.2	28.6	48.2	60.7	12.2	77.1	158.6
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756342	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	30.0	19.9	15.8	16.5	16.6	23.9	26.3	16.3	18.5	20.9	15.7	32.1	17.7	20.2	6.4	27.2	18.1	10.6	31.4	14.8	15.9	37.1	30.1	29.9	17.6	18.0	16.9	18.8	22.8	5.5	19.7	15.7	17.0	24.5	10.5	2.6	19.2	9.2	41.5	19.6	39.4	9.9	16.9	31.2	27.8	22.9	17.3	10.8	22.3	13.6	15.9	30.2	20.8	16.3	24.4	32.6	10.1	15.4	31.5	21.6	43.7	25.8	22.9	23.6	22.9	37.2	38.5	22.1	28.7	28.3	52.9	15.8	18.3	29.8	13.8	17.2	23.0	26.4	19.9	41.9	39.0	21.9	32.2	27.9	26.5	26.1	23.5	18.1	33.9	19.8	27.4	30.4	16.5	50.6	29.0	53.6	26.6	35.9	55.0	18.9	15.3	11.6	25.5	26.9	15.1	17.0	20.2	21.0	29.6	17.2	23.0	32.0	40.0	18.2	20.1	29.0	40.4	31.3	22.8	16.0	33.3	39.1	20.2	7.6	8.9	27.1	7.4	13.9	8.1	9.6	11.3	12.5	8.7	14.4	9.2	7.6	8.4	5.7	14.8	4.0	13.3	6.3	15.8	16.6	16.3	18.5	14.8	15.9	18.0	16.9	17.0	16.9	17.3	16.3	48.2	6.4	9.8	3.6	40.7	61.3	49.3	42.5	19.4	2.0	25.3	17.8	13.2	7.2	19.0	14.7	2.1	52.4	44.6	56.0	13.7	58.2	2.3	26.0	26.4	46.7	19.2	8.2	1.1	59.6	106.1	28.4	28.5	33.3	13.3	21.4	41.0	16.7	34.5	0.0	0.7	38.0	24.4	21.2	112.7	7.5	21.5	34.6	26.6	3.7	71.8	12.4	48.4	0.5	3.4	71.8	63.0	17.7	21.2	86.6	174.3	46.8	13.0	6.8	19.7	18.7	38.0	23.6	62.4	28.1	79.0	95.6	44.9	17.1	38.0	84.7
TNKS	"ARTD5, PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1"	ENSG00000173273	Tankyrase	O95271	8	9555912-9782346	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.9;Excitatory neurons: 203.2;Inhibitory neurons: 230.6;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 285.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025690	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA025690: AB_10602249"	"unprognostic (2.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.45e-3)"	"unprognostic (8.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.01e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.10e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.36e-2)"	7.3	9.3	14.2	6.5	20.5	12.2	9.9	18.5	15.8	12.1	6.9	7.5	6.0	10.5	17.5	5.9	8.2	6.2	7.0	13.4	16.8	6.1	7.5	6.6	8.5	21.5	18.5	13.1	7.5	12.5	12.6	7.9	22.2	7.8	6.8	21.0	7.1	7.7	18.4	11.4	7.8	7.1	14.7	6.5	7.2	20.3	18.3	10.5	9.7	11.8	8.6	7.9	6.9	32.2	8.8	11.5	28.8	17.4	17.8	23.7	10.7	13.4	15.1	10.7	12.0	6.9	6.9	18.9	5.4	13.2	14.3	9.2	16.5	12.5	15.4	4.9	8.6	13.3	10.7	15.6	16.0	6.9	7.9	16.9	14.8	11.1	21.6	17.3	14.6	14.5	12.7	19.6	19.9	5.8	17.5	10.4	18.9	9.7	6.7	13.9	17.8	5.5	12.8	17.8	29.1	21.4	10.5	9.9	19.3	17.3	6.6	10.2	19.7	17.4	10.6	11.9	10.0	6.7	11.8	13.3	18.7	9.5	17.1	2.4	1.1	0.9	2.0	1.1	1.0	1.9	1.6	1.9	1.4	3.2	1.8	2.2	3.5	1.5	1.4	1.8	0.8	0.7	14.2	20.5	18.5	15.8	13.4	16.8	21.5	18.5	22.2	14.7	18.3	32.2	19.7	16.0	11.7	130.9	23.1	11.5	12.8	11.4	12.0	34.1	15.8	13.6	17.0	15.7	12.0	9.2	14.6	11.2	14.9	9.2	1.9	12.4	149.9	19.9	30.6	15.5	13.8	14.5	203.2	8.5	10.9	20.3	19.9	20.9	10.1	33.7	18.9	18.0	7.1	42.1	230.6	10.8	16.2	9.4	8.5	76.3	16.8	10.3	12.4	92.8	8.4	15.1	5.2	313.1	285.7	13.4	12.8	18.0	20.7	12.8	17.2	6.9	28.1	37.0	0.0	28.7	16.6	37.7	15.4	12.9	15.5	12.3	18.1	39.5	12.2	12.8
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451100-52454041	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	36	"heart muscle: 8734.3;skeletal muscle: 21081.1;tongue: 12403.9"	"Cell type enriched"	"Detected in many"	10	"Cardiomyocytes: 3550.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 27.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 68.2;CAPAN-2: 33.5;EFO-21: 65.2;HeLa: 49.1;Hep G2: 46.1;HSkMC: 67.2;U-2 OS: 97.7"	"Region enriched"	"Detected in all"	4	"cerebral cortex: 87.0"	"Group enriched"	"Detected in some"	6	"midbrain: 7.6;spinal cord: 7.1"	"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		NA	NA		990000	"Cluster 13: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	8.4	10.9	0.7	0.8	0.8	0.7	19.1	2.7	1.1	7.7	7.3	4.0	1.1	2.8	41.7	387.3	2.8	3.3	8734.3	1.2	0.7	19.2	4.0	78.5	3.9	0.8	0.9	2.4	6.8	1.6	17.6	5.2	1.0	170.1	4.1	0.4	120.8	2.2	21081.1	18.9	3.3	0.8	0.8	2.8	5.7	10.6	0.8	4.3	14.4	12403.9	1.6	5.3	5.4	0.7	0.7	5.2	3.6	0.6	0.2	0.5	8.0	0.4	0.3	0.3	0.4	68.2	33.5	0.5	65.2	9.9	0.1	0.4	0.1	0.3	0.0	1.2	1.6	0.5	49.1	46.1	0.3	0.3	0.1	67.2	1.2	0.0	0.7	0.6	0.0	2.0	0.2	5.1	2.0	0.1	0.2	0.8	0.5	15.1	0.7	0.1	2.9	2.3	3.3	13.0	0.2	0.0	0.5	6.7	0.1	3.9	26.7	0.5	0.0	0.1	97.7	0.8	0.2	2.8	1.3	0.9	0.3	0.7	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.1	0.7	0.8	2.7	1.1	1.2	0.7	0.8	0.9	1.0	0.8	0.8	0.7	0.2	125.0	12.6	0.0	0.3	1.5	1.7	4.0	0.6	0.2	0.5	0.3	3550.1	5.7	7.9	3.7	2.1	59.0	0.1	1.6	27.4	11.8	0.7	66.4	6.7	39.8	330.7	0.4	0.0	13.0	5.1	52.7	0.5	98.8	0.0	0.8	0.7	0.7	4.9	0.0	0.0	1.7	2.0	0.0	1.4	5.8	22.4	2.6	5.4	0.0	0.1	1.2	0.0	0.0	0.0	6.5	0.3	177.6	0.1	0.8	0.5	1.3	2.8	0.1	0.0	241.8	36.0	2.1	1.0	0.1	0.9	31.1	2.8	1.3	2.0	6.8
TNNC2	"CFAP85, FAP85"	ENSG00000101470	"Troponin C2, fast skeletal type"	P02585	20	45823214-45833745	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	109	"skeletal muscle: 30416.4;tongue: 8088.6"	"Group enriched"	"Detected in many"	4	"Proximal enterocytes: 338.7;Skeletal myocytes: 1165.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.2;head and neck cancer: 22.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Hep G2: 10.0;HSkMC: 14.8;SCLC-21H: 11.3"	"Region enriched"	"Detected in some"	5	"olfactory bulb: 6.1"	"Low region specificity"	"Detected in some"			"HPA043174, HPA058481"	Enhanced		Approved	Nucleoplasm,Vesicles		No	NA		560000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA043174: AB_10806380, HPA058481: AB_2683729"	"unprognostic (1.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.12e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.03e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.13e-1)"	6.6	5.5	4.8	0.4	5.7	1.1	8.3	5.2	6.9	2.2	4.4	5.3	2.5	4.2	1.0	128.5	3.0	2.2	4.0	4.8	4.5	1.7	2.5	3.2	0.5	4.4	4.5	6.5	2.2	1.2	3.1	0.2	4.5	44.3	2.2	1.3	176.3	1.3	30416.4	10.1	7.8	1.0	4.1	1.8	2.4	4.6	4.8	6.7	5.1	8088.6	0.7	2.5	3.0	5.5	0.1	0.0	0.2	0.4	1.6	1.0	1.7	0.1	0.4	0.0	0.1	0.2	1.1	0.4	1.1	1.0	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.0	1.0	10.0	0.4	0.3	0.2	14.8	0.2	0.1	0.7	0.3	0.0	1.2	0.1	0.5	0.2	1.2	0.7	0.1	0.0	0.4	0.6	0.3	0.6	0.2	0.4	0.1	11.3	0.5	1.6	0.1	0.4	0.5	1.3	0.4	0.5	0.2	0.3	0.9	0.2	1.5	0.4	0.2	1.4	0.1	0.2	0.0	0.6	1.3	0.1	1.1	0.6	5.3	1.3	0.2	0.3	4.6	0.0	0.3	2.0	0.3	0.8	0.8	3.9	8.7	4.8	5.7	5.2	6.9	4.8	4.5	4.4	4.5	4.5	4.1	4.8	5.5	0.9	3.2	0.6	0.3	3.1	0.8	0.5	2.0	0.0	4.2	3.1	1.7	0.5	2.8	3.6	3.7	0.0	2.4	0.5	171.7	3.9	1.5	6.9	37.1	1.0	3.8	22.9	0.0	1.9	5.1	0.4	7.2	0.5	2.3	0.0	13.9	0.0	1.1	0.3	0.0	0.7	108.2	14.2	0.3	1.1	47.0	1.2	22.4	0.0	0.0	2.1	1.4	1.0	0.0	0.6	3.3	92.9	3.0	0.5	0.7	338.7	1.0	4.3	2.4	0.0	1165.3	9.5	2.5	5.5	0.1	8.4	0.1	4.7	7.2	37.0	0.7
TNNI1		ENSG00000159173	"Troponin I1, slow skeletal type"	P19237	1	201403768-201429866	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	40	"skeletal muscle: 12562.8;tongue: 3158.3"	"Group enriched"	"Detected in some"	17	"Cardiomyocytes: 74.7;Skeletal myocytes: 176.2"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.6;prostate cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RH-30: 491.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA		74000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Nucleoli	"HPA028190: AB_10600831"	"unprognostic (2.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	1.3	0.4	0.0	0.1	0.0	0.1	1.6	0.1	0.1	0.3	0.0	0.9	2.1	1.2	0.4	194.2	0.4	1.2	97.4	0.0	0.2	10.8	1.9	1.1	0.3	0.1	0.0	0.5	1.5	0.0	0.3	0.1	0.1	85.8	0.0	0.0	56.6	0.0	12562.8	2.1	2.5	0.1	0.0	0.3	1.3	0.5	0.1	1.6	1.4	3158.3	0.4	0.2	1.5	0.1	0.9	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.3	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.6	0.0	55.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.8	0.3	0.0	0.0	491.6	0.9	0.0	0.8	0.3	0.0	0.1	0.1	0.1	4.9	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	74.7	0.0	0.0	0.0	0.0	0.4	0.0	0.7	5.9	0.0	3.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	7.3	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	3.6	0.0	1.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	176.2	2.2	0.0	0.2	0.0	0.0	0.5	1.0	0.0	0.9	0.1
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132698-55149206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	29	"skeletal muscle: 21567.3;tongue: 13372.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 61.2;Basal squamous epithelial cells: 47.8;Cardiomyocytes: 51.5;Skeletal myocytes: 192.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 211.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 211.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 829.4;RH-30: 638.8"	"Region enriched"	"Detected in many"	5	"thalamus: 125.0"	"Region enhanced"	"Detected in all"		"thalamus: 23.1"	"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		79000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavorable (4.66e-4)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	5.7	1.2	42.1	0.4	45.7	3.3	5.0	44.3	55.4	1.9	36.4	2.7	1.0	1.1	1.0	593.5	8.4	1.0	256.7	43.9	38.9	1.3	2.5	8.3	0.4	36.7	41.4	1.5	2.5	2.3	8.5	6.0	38.5	200.4	0.6	0.6	171.2	0.4	21567.3	48.5	2.0	0.4	35.6	1.9	1.9	10.6	40.8	3.4	3.8	13372.6	2.0	1.7	5.8	40.8	178.4	102.3	1.0	22.4	0.0	1.7	33.3	8.0	30.1	11.1	32.7	37.9	115.8	2.6	66.5	3.2	88.8	88.5	24.0	76.0	9.4	11.8	192.2	33.6	11.8	6.7	3.7	2.7	829.4	36.6	121.3	3.4	127.0	125.7	0.5	35.1	171.7	158.6	10.3	168.0	3.4	0.3	21.4	45.0	202.1	113.9	638.8	21.2	26.5	5.8	6.6	49.3	10.7	1.3	57.9	8.5	106.3	102.7	2.9	163.6	238.9	6.5	12.4	1.2	7.0	8.8	171.8	26.4	50.9	2.4	39.4	211.5	0.3	21.7	0.3	0.2	0.3	0.3	37.4	0.4	0.3	0.4	1.9	0.6	10.2	0.9	0.1	12.2	42.1	45.7	44.3	55.4	43.9	38.9	36.7	41.4	38.5	35.6	40.8	40.8	0.0	0.0	0.0	0.7	0.3	61.2	0.6	25.1	47.8	4.5	0.5	5.3	51.5	0.0	2.8	0.0	0.0	2.2	0.0	0.5	0.0	2.1	2.1	9.7	0.3	2.6	2.4	2.7	0.4	0.0	18.0	18.8	0.0	3.4	0.0	22.1	1.4	0.0	12.9	0.0	0.7	0.3	0.0	13.2	3.8	10.7	0.3	8.9	3.6	0.0	25.8	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.7	0.0	192.0	3.5	4.3	34.1	2.5	30.4	3.6	1.6	1.2	0.8	0.2
TNNT2	"CMD1D, CMH2, CMPD2"	ENSG00000118194	"Troponin T2, cardiac type"	P45379	1	201359008-201377764	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	205	"heart muscle: 10670.6"	"Cell type enriched"	"Detected in many"	32	"Cardiomyocytes: 12561.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"RH-30: 1077.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.8"	"CAB015371, HPA015774, HPA017888"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules"		No	No		57000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli"	"Focal adhesion sites, Microtubules"	"CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.98e-2)"	2.2	4.9	12.4	0.6	13.9	0.1	11.9	11.7	20.4	2.3	11.7	1.3	0.3	3.2	0.8	7.8	1.9	3.8	10670.6	16.8	11.6	51.9	2.3	22.0	2.7	11.6	11.6	1.3	5.0	0.0	4.5	10.3	11.6	6.1	0.1	0.4	3.6	0.7	16.5	21.7	1.6	0.1	11.6	0.7	2.0	1.7	11.6	2.1	2.0	9.4	0.5	19.3	5.0	15.8	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.5	0.0	0.0	6.7	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.0	44.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	1.1	0.0	0.0	2.2	3.3	0.0	0.0	1077.7	0.0	0.7	0.4	1.1	0.8	0.1	2.0	0.0	61.2	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	13.9	11.7	20.4	16.8	11.6	11.6	11.6	11.6	11.6	11.6	15.8	0.6	3.2	3.0	0.3	0.0	3.4	1.4	1.7	1.8	3.9	0.9	1.7	12561.8	0.0	1.1	1.8	0.0	3.5	0.0	2.3	0.0	0.4	11.6	1.2	0.2	93.3	0.0	0.0	9.4	0.4	1.2	385.3	1.1	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.5	1.7	0.0	0.0	0.8	19.3	0.6	0.3	0.0	1.9	2.6	0.0	0.0	0.5	0.7	1.2	1.4	1.2	0.0	2.1	0.8	0.9	0.7	0.6	0.0	8.7	145.8	0.5	0.2	2.5	7.2	4.2	0.1	0.8	3.2	1.5
TNPO1	"IPO2, KPNB2, MIP, MIP1, TRN"	ENSG00000083312	"Transportin 1"	Q92973	5	72816312-72916733	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016325	Approved		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		130000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"CAB016325: AB_675691"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (6.55e-5)"	"unprognostic (8.93e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.49e-2)"	23.5	23.0	10.6	28.8	14.6	31.7	25.0	14.0	10.0	20.2	23.0	24.5	20.5	24.0	33.8	23.1	20.6	27.7	20.8	10.5	17.1	30.5	28.4	17.3	29.9	18.2	13.4	22.4	31.5	39.8	15.6	36.8	16.5	23.4	29.9	65.0	20.9	28.1	25.0	11.6	20.9	28.2	15.1	20.6	30.7	37.3	13.1	35.6	36.8	27.0	32.3	33.3	14.0	21.5	94.8	123.7	154.5	104.8	133.3	144.5	110.4	112.3	145.6	112.2	113.6	111.4	87.1	117.5	78.5	173.0	140.4	71.6	126.3	108.8	160.8	66.6	71.9	76.2	144.8	55.9	103.9	78.4	55.1	110.8	80.2	151.0	184.8	78.2	248.6	52.9	113.4	54.8	298.1	50.3	87.2	37.3	99.3	39.8	90.9	83.1	150.5	74.1	73.4	109.5	87.5	73.6	160.6	60.3	135.8	99.8	71.2	61.9	225.1	79.5	113.8	116.8	136.7	53.2	95.8	155.8	69.9	91.3	154.4	8.2	8.2	6.9	11.9	11.0	16.5	10.3	10.9	9.3	10.3	10.8	11.6	11.9	8.4	14.1	14.0	5.0	8.3	10.5	10.6	14.6	14.0	10.0	10.5	17.1	18.2	13.4	16.5	15.1	13.1	21.5	42.3	12.8	25.0	45.7	49.0	59.1	40.9	29.7	60.3	105.0	38.7	24.0	53.8	30.0	28.7	27.6	98.0	81.9	44.9	39.8	17.6	39.0	105.4	38.6	46.1	64.8	53.2	27.1	142.2	41.5	50.0	52.8	53.0	46.7	22.1	62.8	50.7	38.1	42.7	89.2	77.8	46.3	28.5	40.0	42.2	60.9	46.6	42.1	24.9	50.6	47.4	143.1	26.8	79.9	84.7	58.9	24.9	60.2	42.9	57.0	33.9	36.1	27.6	187.9	26.3	72.5	48.8	58.5	76.3	42.0	53.3	131.3	36.9	40.2	37.2	60.2
TNPO2	"FLJ12155, IPO3, KPNB2B, TRN2"	ENSG00000105576	"Transportin 2"	O14787	19	12699194-12724011	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046446, HPA071498"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"CAB046446: AB_10603392, HPA071498: AB_2686405"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (2.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.76e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-3)"	"unprognostic (7.63e-2)"	28.3	33.0	50.3	21.7	54.4	26.8	24.8	36.7	57.3	30.9	28.2	28.4	17.3	33.3	25.5	31.3	30.3	20.5	26.6	54.6	44.1	22.5	18.4	23.0	23.4	51.3	45.4	40.3	20.6	32.3	33.6	20.9	50.9	26.6	19.8	33.0	22.2	23.9	25.7	48.1	23.4	28.1	39.5	26.3	23.5	32.7	51.5	27.8	26.8	20.1	23.9	28.6	27.6	51.2	54.4	40.5	61.0	78.3	36.3	47.6	39.5	61.0	40.1	86.5	60.6	55.9	28.5	36.6	46.5	51.7	24.1	70.5	109.2	60.3	47.9	45.6	87.6	56.5	72.1	68.4	40.9	100.6	52.0	42.9	46.8	57.5	60.4	55.8	41.0	72.7	89.4	33.9	48.5	93.4	84.8	68.8	71.0	39.8	120.8	80.7	47.6	67.0	51.2	38.9	148.6	73.8	49.6	62.2	30.7	41.2	43.5	35.2	41.5	131.5	34.9	71.3	91.2	66.8	70.4	62.3	39.2	89.9	47.9	0.2	0.2	0.1	0.6	0.3	0.9	0.4	0.4	0.5	0.4	0.4	0.8	1.0	0.8	0.1	0.4	1.5	0.2	0.2	50.3	54.4	36.7	57.3	54.6	44.1	51.3	45.4	50.9	39.5	51.5	51.2	13.2	6.4	17.9	24.2	10.7	31.0	8.9	10.6	14.8	42.4	22.8	17.1	17.6	11.5	10.0	22.0	100.1	10.9	11.0	14.1	5.9	9.7	12.2	16.2	20.6	17.0	22.9	14.9	22.3	8.5	6.6	18.0	10.2	12.9	3.8	20.7	19.2	17.8	10.5	57.2	26.6	17.7	8.2	13.0	14.9	19.5	31.1	8.7	8.8	22.5	11.1	24.6	6.2	19.6	24.7	15.2	9.1	32.4	8.7	19.3	11.9	16.7	11.3	33.6	6.6	23.8	15.3	23.8	11.3	21.9	41.5	14.5	9.5	16.5	16.6	9.3
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 20.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: AB_2670506, HPA024251: AB_2671498"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	30.4	18.3	10.8	29.0	8.9	51.8	30.1	16.2	14.2	40.8	2.2	56.3	25.3	57.6	16.4	26.0	43.5	22.4	22.1	10.3	0.5	22.9	19.8	32.0	16.1	6.2	1.7	46.0	29.5	35.0	22.2	30.6	1.6	36.1	22.6	12.2	28.8	34.3	24.0	33.2	29.0	36.4	1.3	25.2	33.8	22.6	5.1	17.2	32.6	11.1	14.6	40.8	31.9	3.2	72.8	63.4	51.5	43.4	42.9	50.6	133.8	50.4	47.3	27.4	29.0	26.3	62.4	49.3	48.3	74.7	60.8	79.7	30.2	60.5	23.0	21.6	19.2	31.4	56.6	43.1	37.1	104.3	111.2	51.2	70.0	54.8	63.2	39.5	31.3	43.6	45.4	27.2	35.3	120.0	24.6	127.2	4.5	47.5	48.0	27.0	25.7	37.3	22.3	91.3	22.3	53.4	38.8	102.5	37.0	23.1	106.9	106.1	78.7	78.3	109.6	47.0	36.7	38.6	44.1	46.2	44.1	72.6	94.1	14.2	3.8	3.6	1.7	1.5	1.2	2.2	1.2	1.0	1.4	2.3	0.9	1.7	20.8	3.2	2.1	5.4	1.9	0.2	10.8	8.9	16.2	14.2	10.3	0.5	6.2	1.7	1.6	1.3	5.1	3.2	25.6	9.6	29.0	59.7	7.4	9.3	3.7	9.8	13.6	51.7	15.8	25.9	7.5	14.3	12.4	14.7	2.1	14.5	20.4	33.6	1.9	5.0	14.4	22.2	29.7	17.3	31.3	9.7	40.9	6.6	3.8	17.8	19.4	36.2	14.0	48.3	29.6	25.4	11.2	50.5	45.6	30.4	8.2	41.8	12.4	18.8	18.3	22.8	5.4	71.2	25.9	31.0	11.3	32.6	20.3	9.0	10.6	19.9	12.1	6.5	7.4	5.4	11.1	4.0	19.7	18.4	21.2	0.4	2.1	12.5	8.8	10.0	12.3	18.6	25.1	3.8
TNRC6A	"CAGH26, GW182, KIAA1460, TNRC6"	ENSG00000090905	"Trinucleotide repeat containing adaptor 6A"	Q8NDV7	16	24610209-24827632	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 289.3;Excitatory neurons: 283.8;Inhibitory neurons: 414.6;Oligodendrocyte precursor cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015305, HPA017869"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA015305: AB_1850454, HPA017869: AB_1850456"	"unprognostic (2.64e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.35e-2)"	17.2	21.0	5.0	6.4	3.6	6.0	14.9	10.8	7.1	17.8	6.1	17.8	5.5	23.5	11.5	11.3	17.7	6.4	11.1	3.4	6.6	10.3	13.0	12.8	7.1	6.1	4.8	20.6	19.2	13.2	22.8	6.6	6.1	14.6	6.4	7.0	14.9	8.0	14.0	13.1	15.3	8.1	2.2	9.9	15.2	6.6	7.0	8.6	17.8	6.9	7.4	13.0	13.4	7.4	10.1	13.8	16.0	8.7	13.6	17.7	9.1	16.9	13.6	12.0	13.1	10.2	8.2	10.2	7.1	17.0	12.4	11.2	20.1	14.2	18.0	10.4	10.4	10.2	16.7	14.1	11.7	10.5	6.9	18.0	7.3	15.8	10.2	14.8	16.7	6.6	15.7	6.2	15.8	11.9	8.8	6.9	23.1	4.9	6.8	17.1	12.4	9.1	9.1	9.3	7.7	10.8	11.8	7.2	6.6	12.1	8.4	6.8	15.5	15.3	10.5	7.6	12.0	13.7	11.6	16.5	14.3	6.4	11.3	0.5	0.5	0.4	0.5	0.3	0.4	1.1	0.5	0.5	0.2	1.0	0.7	0.5	0.3	0.6	0.3	1.0	0.5	0.3	5.0	3.6	10.8	7.1	3.4	6.6	6.1	4.8	6.1	2.2	7.0	7.4	51.2	38.5	60.0	289.3	45.5	34.9	17.8	21.9	39.9	97.1	42.8	41.0	75.3	51.5	32.3	46.0	118.9	22.4	49.9	38.3	17.6	23.6	17.2	38.7	65.5	45.5	55.9	34.9	283.8	24.5	15.1	50.5	33.6	42.8	39.3	76.5	60.3	115.3	21.2	176.7	414.6	36.3	22.4	56.2	26.5	11.3	69.0	28.7	30.2	138.7	36.1	42.0	50.4	265.4	234.2	28.5	36.1	81.3	44.7	26.0	42.8	19.2	29.8	81.7	19.7	52.8	60.9	41.2	30.6	38.1	28.7	8.2	39.0	36.5	35.8	17.4
TNRC6C	"FLJ20015, KIAA1582"	ENSG00000078687	"Trinucleotide repeat containing adaptor 6C"	Q9HCJ0	17	77959240-78108835	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 25.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 237.7;Oligodendrocyte precursor cells: 175.4;Oligodendrocytes: 144.9;Rod photoreceptor cells: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 15.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022007, HPA062051"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA022007: AB_2670877, HPA062051: AB_2684670"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.83e-2)"	"prognostic favorable (6.56e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.70e-2)"	5.2	3.1	9.3	4.5	10.5	3.1	5.2	18.8	11.9	5.3	0.0	4.7	2.0	5.9	4.3	2.7	5.6	4.1	6.1	10.1	8.1	2.9	3.5	3.6	5.8	8.2	7.2	7.3	4.0	3.8	7.4	1.9	6.3	5.1	2.7	25.0	5.6	4.0	10.8	3.0	4.0	4.8	2.5	5.1	3.7	8.3	7.1	17.7	4.3	7.6	5.0	4.5	4.1	18.3	4.2	4.0	7.1	7.7	3.0	2.2	0.0	6.3	5.3	4.4	3.6	4.2	1.2	0.0	2.6	4.9	3.1	0.3	5.2	0.2	2.7	3.4	5.5	15.0	1.5	4.7	2.7	3.6	7.3	1.9	2.0	1.7	4.1	2.0	9.4	14.6	2.5	7.4	4.6	5.8	34.5	1.7	3.7	1.8	3.0	4.5	14.2	2.8	1.0	6.0	8.7	16.0	7.6	9.2	3.0	3.4	6.9	5.1	7.0	9.8	3.2	5.1	7.9	5.5	0.9	4.3	2.8	5.3	7.2	15.9	0.2	1.2	1.5	0.1	1.6	0.9	1.6	1.6	0.1	0.9	1.8	2.1	0.9	2.4	0.0	0.6	0.8	0.4	9.3	10.5	18.8	11.9	10.1	8.1	8.2	7.2	6.3	2.5	7.1	18.3	43.9	28.9	27.8	63.6	24.7	22.0	9.5	4.7	26.7	123.2	28.4	17.5	30.1	30.0	7.6	9.2	237.7	0.1	36.2	8.8	1.9	7.5	9.7	12.6	26.3	25.3	39.8	21.0	125.8	6.0	0.7	36.5	8.6	13.6	22.8	13.0	40.7	21.3	2.1	74.0	112.6	8.7	8.2	10.5	14.8	7.9	51.3	6.6	16.0	33.7	7.3	33.1	41.2	175.4	144.9	9.0	5.3	42.9	15.8	11.8	6.5	5.2	5.9	138.1	0.0	35.9	27.4	36.7	20.1	12.2	14.2	0.3	47.9	14.4	7.9	5.1
TOB1	"APRO5, TOB, TROB, TROB1"	ENSG00000141232	"Transducer of ERBB2, 1"	P50616	17	50862223-50867978	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 253.3"	"Low region specificity"	"Detected in all"							HPA047839	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"HPA047839: AB_2680175"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.04e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.92e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-2)"	"unprognostic (6.97e-2)"	42.6	210.2	32.6	22.3	34.9	70.2	65.3	31.6	40.8	55.3	59.3	47.4	56.1	23.9	26.5	77.7	54.6	47.6	44.7	29.8	39.4	67.9	168.6	36.8	18.9	37.3	48.2	63.4	207.9	81.4	50.1	13.8	38.6	72.3	57.5	101.8	99.8	92.2	178.6	133.5	48.1	29.4	31.8	17.8	87.5	26.0	33.4	17.7	95.4	109.9	21.0	81.9	70.9	40.2	44.1	88.7	28.1	11.5	51.4	25.4	22.0	31.9	79.2	20.5	25.0	36.0	54.6	40.0	60.6	43.9	20.7	61.0	19.5	54.1	21.1	20.4	29.3	4.8	100.7	60.5	72.0	21.5	18.9	54.5	65.5	23.9	120.0	27.3	9.9	12.2	17.0	33.7	43.4	119.0	16.1	19.4	10.2	109.4	33.9	14.0	35.6	47.6	80.9	89.4	16.6	40.4	55.1	158.9	19.9	42.5	253.3	27.1	13.2	23.3	16.7	26.7	15.8	51.9	57.7	18.5	19.2	10.2	9.1	417.7	53.5	285.6	245.8	107.3	269.9	40.7	222.7	192.5	119.1	31.9	192.1	233.6	130.7	28.8	152.5	38.5	206.0	169.0	32.6	34.9	31.6	40.8	29.8	39.4	37.3	48.2	38.6	31.8	33.4	40.2	101.6	115.4	118.3	71.8	53.1	283.2	232.9	119.8	284.0	125.3	180.6	179.6	115.5	210.1	81.8	68.0	56.3	20.8	124.8	183.3	103.7	42.6	97.9	143.7	51.7	40.7	203.4	18.1	11.5	54.1	2.0	83.5	123.3	176.2	63.9	19.7	33.2	205.6	35.4	18.5	14.1	223.2	48.8	27.6	249.2	40.4	26.4	89.9	71.2	5.6	29.1	118.3	20.6	16.6	34.1	41.8	186.7	59.8	41.3	187.2	126.2	60.4	87.8	62.7	164.3	137.3	123.8	36.9	12.1	153.8	230.7	10.9	154.7	77.4	167.6	287.2
TOE1	hCaf1z	ENSG00000132773	"Target of EGR1, exonuclease"	Q96GM8	1	45340052-45343973	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 36.6;Spermatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053775, HPA069119"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA053775: AB_2682259, HPA069119: AB_2686090"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (9.05e-4)"	"prognostic unfavorable (6.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.71e-4)"	"prognostic favorable (9.98e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.08e-1)"	4.8	5.1	4.9	5.9	4.9	8.0	5.5	4.8	6.1	3.7	4.8	6.8	6.7	6.7	8.4	3.7	5.4	3.5	3.7	4.7	5.4	4.7	5.5	5.1	7.9	5.1	5.0	6.2	4.8	7.5	3.2	6.8	5.1	5.0	8.2	4.1	5.3	5.0	3.0	3.9	5.0	6.5	5.0	5.8	5.6	11.8	5.4	9.0	7.1	2.4	8.3	5.5	3.3	5.1	15.8	9.1	16.5	15.7	7.6	5.9	23.9	15.6	12.9	26.6	24.7	16.7	9.6	29.9	12.1	16.2	23.4	15.9	21.0	22.5	21.3	19.6	17.3	36.0	21.9	15.6	7.3	23.7	17.2	8.8	4.8	28.4	17.8	9.4	19.5	22.5	28.4	19.6	18.9	14.6	34.8	18.4	31.1	20.6	14.2	24.9	24.5	13.6	11.5	28.7	13.9	13.4	14.5	36.3	27.5	25.7	9.8	33.2	14.6	12.6	23.3	19.1	29.7	15.0	19.4	19.9	14.8	26.5	14.7	20.0	5.8	6.2	7.3	6.9	8.4	5.9	6.3	7.3	6.0	8.4	6.4	7.0	0.6	4.1	6.1	5.2	8.6	5.1	4.9	4.9	4.8	6.1	4.7	5.4	5.1	5.0	5.1	5.0	5.4	5.1	6.5	6.4	4.8	2.3	12.4	1.8	6.3	8.8	4.6	10.7	4.5	5.0	1.8	7.2	8.1	7.3	12.5	36.6	9.2	9.2	7.9	5.4	13.9	2.1	6.2	9.0	3.0	14.1	2.5	6.2	13.8	6.6	4.6	3.4	11.4	10.5	8.6	5.0	9.3	8.4	2.7	7.3	8.2	3.5	2.6	9.4	6.8	6.2	3.6	1.9	12.3	13.1	9.2	2.0	2.1	3.4	10.7	6.4	7.0	6.5	8.8	7.9	4.7	18.3	13.1	8.0	7.1	51.7	18.9	3.8	1.4	22.7	9.0	10.2	6.9	4.6
TOGARAM1	"crescerin, Crescerin-1, FAM179B, KIAA0423"	ENSG00000198718	"TOG array regulator of axonemal microtubules 1"	Q9Y4F4	14	44962190-45074431	"Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 65.7;Endometrial stromal cells: 28.6;Granulosa cells: 30.1;Respiratory ciliated cells: 38.6;Theca cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 4.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050849, HPA053559"	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA050849: AB_2681257, HPA053559: AB_2682190"	"unprognostic (2.91e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.63e-2)"	"unprognostic (6.49e-2)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.60e-1)"	4.5	6.6	9.6	2.9	13.4	3.9	5.2	10.1	13.0	6.7	9.6	4.5	2.7	6.0	5.2	4.6	10.4	4.7	8.3	11.2	8.9	7.9	4.6	3.9	3.9	7.2	8.0	7.6	6.3	8.5	7.1	5.8	8.7	5.5	3.7	16.8	4.8	6.4	12.4	4.2	3.8	5.4	7.5	4.3	4.3	6.5	9.3	8.4	9.0	12.1	3.9	5.4	4.3	19.9	3.5	5.7	5.3	1.4	12.2	14.2	3.8	4.9	10.4	9.1	10.8	2.3	3.7	3.3	5.6	7.9	4.9	6.4	9.8	3.3	10.0	3.0	3.6	2.7	2.8	2.7	8.6	4.6	2.7	8.3	5.6	5.2	8.8	10.8	7.4	1.8	1.9	3.7	9.2	5.0	5.9	2.5	1.8	5.2	4.3	2.9	12.9	2.2	8.6	12.0	5.5	2.1	5.8	8.4	9.1	5.5	6.2	3.6	5.5	6.1	4.9	7.8	3.7	3.8	3.0	3.7	3.5	0.9	5.2	4.8	0.4	1.0	0.4	0.4	0.5	0.4	0.6	0.4	0.6	0.6	0.5	0.3	0.0	0.8	0.4	0.7	0.6	0.3	9.6	13.4	10.1	13.0	11.2	8.9	7.2	8.0	8.7	7.5	9.3	19.9	15.8	16.0	14.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	15.2	10.9	0.0	0.0	20.4	16.5	0.0	11.9	13.2	0.0	1.9	10.2	0.0	65.7	28.6	6.6	0.0	0.0	0.0	5.6	8.1	8.8	0.0	16.0	10.1	30.1	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	3.8	0.0	0.0	10.4	38.6	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	9.9	6.3	34.4	0.0	0.0
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29052230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 34.9;choroid plexus: 25.2;fallopian tube: 20.1"	"Group enriched"	"Detected in some"	4	"dendritic cells: 20.1;Endometrial ciliated cells: 65.4;Respiratory ciliated cells: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;JURKAT: 1.2;NB-4: 1.3"	"Low region specificity"	"Detected in many"							"HPA037561, HPA037562, HPA075216"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Plasma membrane"		"HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: "	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.1	1.2	4.5	0.6	11.5	1.9	0.2	10.6	2.3	0.5	25.2	0.3	0.5	0.6	0.1	0.4	20.1	0.3	2.8	4.5	7.6	0.1	0.2	2.8	0.8	19.2	34.9	0.5	0.3	0.0	1.1	0.3	17.3	0.2	0.2	0.2	0.2	0.1	1.2	0.3	0.4	0.5	12.5	2.0	1.0	1.3	10.6	0.2	0.1	3.0	0.7	0.2	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.0	0.6	0.1	0.2	0.6	2.3	0.1	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.3	0.3	0.0	0.3	1.3	1.0	0.4	0.1	0.0	0.3	0.6	0.3	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.6	0.5	4.5	11.5	10.6	2.3	4.5	7.6	19.2	34.9	17.3	12.5	10.6	5.3	0.3	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	65.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.2	30.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	3.6	0.5	0.0	0.0
TONSL	"IKBR, NFKBIL2"	ENSG00000160949	"Tonsoku like, DNA repair protein"	Q96HA7	8	144428775-144444440	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024679, HPA046494"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nuclear bodies"	"HPA024679: AB_1854441, HPA046494: AB_2679673"	"unprognostic (6.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.04e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.11e-3)"	"unprognostic (7.96e-2)"	1.0	2.1	0.4	2.5	0.4	8.5	1.3	0.4	1.3	1.7	0.0	3.4	3.5	1.6	0.2	3.9	1.4	0.6	1.4	0.3	0.3	1.4	1.7	1.3	2.3	1.3	0.6	1.7	1.5	0.4	0.9	1.5	1.1	1.6	0.8	0.1	1.5	0.8	0.5	3.3	4.4	0.6	0.1	3.9	2.2	3.8	0.8	2.3	2.4	0.1	1.4	2.3	2.1	0.3	21.2	18.6	13.7	21.7	1.0	1.7	33.0	17.6	3.4	10.4	8.1	15.0	17.9	19.6	17.5	2.7	4.9	14.2	13.4	10.7	2.3	20.2	26.6	46.5	26.1	15.9	0.6	14.3	28.1	1.7	1.5	10.9	2.1	2.6	5.0	26.5	53.0	14.3	4.2	43.4	35.5	24.5	19.4	20.4	26.7	42.6	8.9	20.3	5.9	22.6	22.9	13.0	18.4	12.3	7.8	5.2	17.6	13.2	5.9	12.7	52.3	14.5	21.7	5.0	9.9	12.0	12.3	30.2	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.4	1.3	0.3	0.3	1.3	0.6	1.1	0.1	0.8	0.3	2.5	6.4	22.4	1.6	2.9	8.9	5.2	1.0	1.2	3.1	3.5	2.9	2.3	8.6	3.7	1.8	2.1	4.1	1.3	20.2	0.0	0.9	0.4	4.3	2.7	4.3	2.4	7.2	2.4	1.0	5.3	3.8	11.7	6.1	2.5	8.5	2.9	11.4	4.5	1.7	1.0	14.6	0.0	0.9	16.7	0.7	0.3	3.0	14.2	1.9	1.2	1.1	1.0	0.5	0.8	1.2	7.1	1.2	4.0	3.9	76.5	7.7	4.1	3.0	6.6	6.4	2.8	4.6	7.8	3.4	11.2	1.2	3.1	3.3	15.9	3.9
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028822-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 801.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	Yes		7600	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	37.9	36.7	17.4	49.9	18.6	74.9	27.9	21.8	25.1	26.9	25.3	36.9	42.6	27.9	34.4	36.7	22.4	37.2	19.1	18.0	18.9	39.0	47.5	40.0	59.9	18.5	18.4	24.3	28.6	26.7	22.4	50.2	18.1	31.8	37.3	25.5	26.7	24.2	21.3	26.5	42.6	23.9	18.7	38.5	36.5	18.9	18.8	58.9	37.6	20.2	60.6	42.7	28.8	19.2	105.2	71.7	131.4	108.2	52.2	61.8	129.8	92.6	81.0	105.0	94.8	190.5	127.6	296.4	96.4	48.5	112.3	98.9	159.1	147.2	153.0	64.9	81.6	378.6	54.9	139.0	135.4	165.1	124.0	69.8	76.4	102.4	166.8	94.0	111.5	98.1	167.8	98.7	120.9	233.2	235.3	119.7	106.3	104.1	131.6	197.7	123.1	157.7	121.4	95.2	108.6	75.4	145.4	88.3	95.0	94.2	98.6	146.4	109.9	84.7	71.3	78.8	100.9	62.7	75.6	338.3	113.7	91.1	82.0	12.6	9.9	16.8	6.6	10.3	8.3	10.5	7.3	7.0	9.5	10.1	7.7	6.9	19.1	6.3	13.2	18.8	9.0	5.4	17.4	18.6	21.8	25.1	18.0	18.9	18.5	18.4	18.1	18.7	18.8	19.2	116.9	118.6	201.5	66.0	117.6	245.9	338.0	90.3	153.7	98.2	90.5	75.7	49.7	78.6	170.3	99.3	60.5	192.1	137.1	194.1	74.3	94.4	10.0	151.3	167.4	115.1	91.8	486.5	86.9	65.8	175.4	121.4	84.1	259.2	78.6	119.1	67.1	131.7	99.2	72.3	77.4	126.9	69.2	101.2	109.1	12.8	59.7	151.6	72.9	74.9	95.4	88.0	78.2	87.4	90.7	119.2	169.8	69.6	234.1	162.3	94.1	136.2	68.3	87.0	85.5	135.5	130.8	116.8	54.6	129.4	214.2	801.5	111.5	123.7	117.8	237.7
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388525-40417896	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 127.8;testis: 65.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 4.2;white matter: 8.0"	"Low region specificity"	"Detected in some"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.2	2.5	0.2	20.0	0.2	42.0	5.4	0.1	0.7	5.0	1.1	17.8	18.1	3.9	0.3	29.0	1.5	2.6	1.2	0.2	0.2	1.2	2.8	4.1	40.3	0.2	0.8	1.0	0.9	0.3	0.3	15.9	0.5	1.4	19.8	0.1	4.3	0.5	0.3	15.3	17.0	7.6	0.2	9.9	8.9	65.7	1.1	127.8	1.9	0.2	42.5	6.0	9.6	0.4	212.6	275.6	343.1	158.0	16.8	33.9	76.3	283.3	151.5	255.0	224.2	130.5	157.6	339.4	140.1	96.7	152.7	326.5	266.8	113.5	339.5	182.7	177.8	224.8	167.9	216.7	1.6	318.4	228.6	7.4	9.2	179.8	181.4	55.1	136.3	216.5	247.5	225.8	279.2	72.6	372.3	209.6	143.0	152.4	108.3	310.7	531.9	141.3	61.6	133.3	201.6	144.6	229.3	281.4	89.4	198.2	236.9	143.2	90.3	167.0	233.2	195.5	276.7	128.4	154.9	290.7	94.3	214.9	285.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.1	0.1	0.0	0.0	0.1	1.4	0.1	0.0	2.4	0.4	0.2	0.2	0.1	0.7	0.2	0.2	0.2	0.8	0.5	0.2	1.1	0.4	1.0	0.0	2.0	0.3	17.4	11.7	3.7	15.0	2.2	0.0	18.7	17.1	1.3	2.8	5.8	0.0	0.0	72.9	6.1	19.8	0.0	0.8	20.3	12.7	15.8	9.3	0.0	216.8	0.2	0.0	92.4	23.3	23.0	10.0	0.0	117.5	20.7	5.4	83.5	0.0	0.1	34.2	18.3	33.9	13.2	19.1	4.7	14.1	1.8	0.0	2.6	0.0	3.1	0.0	0.1	0.3	3.5	1.9	31.3	3.1	3.4	0.1	1.8	0.0	72.3	0.5	19.5	621.2	269.6	45.1	6.1	8.9	14.8	4.3	61.0	6.9
TOP2B		ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597905-25664907	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 569.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (2.90e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.86e-7)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.93e-2)"	27.1	25.5	15.3	38.9	17.6	49.1	34.7	25.2	16.5	36.2	12.0	30.1	28.8	42.9	25.5	34.1	29.7	26.2	38.5	15.3	16.0	32.1	27.7	28.0	50.4	13.5	16.2	40.6	28.8	53.2	11.7	34.4	15.1	38.7	33.3	112.3	27.1	34.2	29.9	32.4	28.6	34.2	16.4	36.4	32.1	19.5	14.6	82.5	45.8	36.7	46.6	43.7	18.5	25.3	57.6	58.6	125.9	155.3	41.1	51.7	50.1	54.4	69.6	49.4	53.9	30.1	44.6	176.9	37.1	79.2	30.5	47.7	105.6	60.5	82.5	85.5	56.7	268.5	71.2	50.6	28.9	212.8	137.4	37.1	29.7	55.3	48.2	49.8	81.7	118.6	92.0	84.3	64.4	64.0	138.5	52.5	95.9	38.5	44.1	569.9	71.0	82.6	43.9	199.5	63.2	109.7	81.1	57.4	49.9	72.2	59.7	187.1	78.7	68.3	52.6	55.2	58.9	129.6	78.6	185.1	44.9	155.6	46.5	3.2	1.4	2.8	3.0	1.7	3.3	2.0	2.9	3.1	2.2	2.5	3.3	3.0	1.0	3.9	2.6	2.8	2.3	1.1	15.3	17.6	25.2	16.5	15.3	16.0	13.5	16.2	15.1	16.4	14.6	25.3	36.4	64.1	62.7	65.3	47.3	39.1	47.9	30.9	31.3	62.4	44.4	31.9	121.5	34.3	36.1	25.8	56.3	47.8	65.8	29.9	13.7	34.3	3.6	48.0	58.8	36.6	59.3	65.6	77.8	33.4	24.5	40.2	28.5	45.1	34.1	71.4	25.0	35.1	26.2	60.6	89.8	32.3	20.3	40.7	50.1	6.0	39.1	45.3	23.2	43.1	49.8	51.3	68.0	76.4	113.0	35.5	22.2	33.4	46.0	56.2	20.6	25.6	39.2	95.7	32.9	56.5	51.0	94.9	44.0	57.9	37.6	46.7	53.7	48.4	39.2	64.3
TOP3B		ENSG00000100038	"DNA topoisomerase III beta"	O95985	22	21957025-21982813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072114			Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA072114: "	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.11e-4)"	10.6	12.0	5.5	10.1	6.9	16.2	11.2	7.5	8.3	17.9	12.2	13.7	11.1	13.5	7.1	14.8	13.5	7.4	11.8	6.0	5.7	13.9	17.0	13.7	12.7	5.9	5.0	20.3	12.7	7.4	12.9	8.4	6.1	16.7	9.9	6.9	13.9	6.8	10.4	14.7	17.7	9.7	4.0	25.0	13.5	11.1	6.3	13.6	14.3	5.7	13.4	11.4	15.5	8.1	22.1	21.1	40.9	16.8	14.8	12.3	25.7	14.2	17.6	32.1	28.3	22.2	9.3	29.9	10.5	14.9	13.4	39.6	18.6	25.2	25.9	15.3	45.4	23.5	31.4	24.1	20.1	32.3	14.9	6.1	37.5	26.8	12.7	18.6	27.1	17.2	112.5	15.7	15.2	22.3	20.6	25.0	17.0	15.8	19.9	31.6	27.1	4.6	15.8	28.9	26.7	19.3	17.4	15.4	13.7	16.4	11.9	20.7	19.9	13.2	27.6	13.0	17.6	23.2	20.8	28.2	10.2	19.4	14.0	1.9	4.3	1.8	5.5	4.4	3.8	4.5	3.6	3.9	4.7	4.9	3.3	3.5	1.5	4.3	2.6	5.4	4.2	3.7	5.5	6.9	7.5	8.3	6.0	5.7	5.9	5.0	6.1	4.0	6.3	8.1	7.2	0.0	2.6	12.1	7.2	1.8	2.6	6.2	2.8	4.6	3.7	3.9	0.2	8.6	5.0	3.7	10.4	5.2	7.2	7.0	1.9	4.8	1.3	5.3	6.7	5.7	4.8	2.1	8.9	4.3	3.6	4.3	12.2	5.0	1.3	15.0	7.9	7.1	4.0	1.7	7.7	5.3	4.1	3.4	3.8	1.8	10.5	5.1	5.4	6.5	4.3	3.1	5.2	4.5	9.2	6.4	4.6	7.5	6.1	3.4	4.5	2.8	8.2	6.1	6.6	4.9	9.6	6.6	4.9	3.6	1.6	4.0	5.9	7.6	5.8	2.9
TOPBP1	"Dpb11, KIAA0259, TOP2BP1"	ENSG00000163781	"DNA topoisomerase II binding protein 1"	Q92547	3	133598175-133662380	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 104.1;Spermatocytes: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022451, HPA036738, HPA036739"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281"	"unprognostic (7.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.05e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (8.03e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (2.74e-3)"	"unprognostic (8.65e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.60e-1)"	7.7	4.9	3.6	13.0	4.3	33.1	10.7	5.0	4.6	6.5	3.1	9.3	8.3	8.1	5.0	8.9	5.9	6.9	6.1	4.6	3.3	5.5	7.4	7.3	19.7	3.7	3.2	7.3	7.6	6.0	3.6	12.0	3.7	6.6	11.5	8.2	7.1	5.5	6.9	11.8	9.2	8.7	3.5	10.4	8.7	22.4	3.7	29.1	7.4	7.6	18.6	8.3	7.0	4.5	44.4	27.2	43.1	35.1	8.0	10.5	32.3	33.9	26.9	41.0	52.4	37.9	27.5	80.5	29.1	24.7	49.3	50.2	62.8	22.6	62.7	48.9	28.2	75.4	38.3	23.4	7.7	81.5	57.1	12.5	13.7	40.2	23.9	15.4	28.5	46.3	47.6	55.7	32.6	30.3	79.9	43.1	35.7	50.4	23.0	53.3	53.8	58.4	14.6	30.1	40.9	45.2	41.9	22.6	35.4	41.7	37.7	74.6	19.9	43.0	38.9	43.9	37.7	33.4	53.4	150.6	25.4	42.7	38.4	1.8	0.7	2.2	0.7	0.9	1.0	0.9	0.7	0.7	0.7	0.5	0.7	0.7	0.9	1.0	0.5	1.0	1.5	0.4	3.6	4.3	5.0	4.6	4.6	3.3	3.7	3.2	3.7	3.5	3.7	4.5	17.1	22.4	21.9	10.7	22.8	12.4	8.8	7.8	20.5	15.2	14.2	14.2	10.1	12.8	19.7	11.0	2.1	20.0	33.9	11.9	9.8	12.3	69.4	8.8	16.8	16.0	7.2	42.7	24.3	13.3	19.6	14.9	16.3	13.1	7.6	34.3	7.5	9.5	11.2	3.3	19.6	13.9	6.1	16.7	8.0	104.1	10.2	18.2	8.8	11.2	27.4	10.4	28.8	16.6	13.0	14.7	11.6	9.8	37.5	10.2	6.1	6.1	8.7	9.3	13.1	20.9	12.2	81.3	43.6	22.0	11.5	14.0	23.3	17.7	14.8	10.5
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase"	Q9NS56	9	32540544-32552586	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 169.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 67.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 67.6"	"Cell line enhanced"	"Detected in all"		"HEL: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA060640: AB_2684334, HPA065661: AB_2685527"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	9.8	9.8	5.4	8.4	6.3	25.2	12.4	10.5	8.5	10.3	7.3	9.2	8.3	11.4	10.0	9.9	7.6	8.7	6.8	5.4	6.6	13.2	16.2	9.3	9.3	6.1	6.1	15.3	8.6	14.0	6.9	10.0	6.2	11.2	9.3	11.5	7.6	9.3	7.2	9.6	8.8	11.2	5.9	10.5	8.9	14.8	6.6	14.5	14.1	10.4	10.1	10.3	7.2	8.3	16.6	15.1	20.4	17.9	24.4	21.8	12.9	20.7	19.5	16.9	19.5	9.5	8.3	26.8	11.7	20.8	14.8	10.9	24.2	23.5	23.6	22.5	13.3	90.8	25.2	11.9	15.1	26.1	24.0	17.9	25.8	24.4	17.1	20.9	20.8	20.1	16.1	13.6	27.9	8.9	23.5	47.6	27.2	12.3	15.2	23.9	18.1	12.2	22.5	17.2	10.1	16.1	20.7	11.2	13.8	22.9	11.3	14.7	22.0	18.4	18.6	9.6	15.5	9.5	16.2	28.5	17.0	14.8	8.4	38.8	10.0	21.3	9.6	9.8	10.3	9.4	10.4	11.4	10.2	10.8	13.9	13.8	67.6	15.0	13.6	8.2	13.5	7.3	5.4	6.3	10.5	8.5	5.4	6.6	6.1	6.1	6.2	5.9	6.6	8.3	69.2	54.5	32.0	10.7	49.1	47.2	45.3	33.7	61.5	46.8	32.7	28.6	18.4	25.8	37.0	25.8	37.5	31.9	63.4	26.3	19.6	25.1	169.9	36.2	38.1	48.8	45.9	66.5	14.5	18.4	16.9	42.0	25.0	45.5	41.8	43.6	26.4	24.3	17.7	55.5	15.5	22.9	44.7	19.1	35.3	21.8	33.2	31.8	19.6	7.5	30.4	43.5	36.0	13.0	22.4	21.1	24.3	32.7	39.5	39.0	24.3	22.7	22.3	42.0	19.7	54.0	48.2	54.4	53.7	39.0	47.6	50.8	55.4	43.1	24.0	49.8
TOR4A	"C9orf167, FLJ20245"	ENSG00000198113	"Torsin family 4 member A"	Q9NXH8	9	137277726-137282641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 45.6;Undifferentiated cells: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 45.4;TIME: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA044913	Enhanced		Approved	Nucleoplasm		NA	NA		260000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA044913: AB_10965030"	"unprognostic (1.95e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.99e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (5.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.93e-3)"	"unprognostic (2.56e-1)"	4.4	2.9	2.2	4.9	1.9	2.8	2.4	1.9	1.9	4.8	2.0	12.4	9.6	3.6	0.8	7.5	4.2	5.2	13.0	1.6	1.8	11.7	2.9	10.9	4.1	2.8	2.3	5.1	3.8	1.9	1.9	1.9	2.5	2.3	4.3	0.0	1.6	2.5	1.4	1.7	11.0	1.3	2.6	15.4	12.5	0.6	3.2	0.8	4.2	0.7	3.0	3.8	3.8	2.3	16.7	21.6	0.2	0.6	0.2	1.7	1.7	27.0	18.5	12.3	6.5	2.7	30.8	1.6	37.4	9.7	0.9	34.0	0.1	9.0	4.2	1.4	1.4	18.2	15.4	14.8	25.9	8.0	45.4	0.9	9.3	2.5	4.8	13.9	16.8	0.1	27.8	2.1	2.1	1.8	0.0	22.0	2.6	18.0	23.9	4.4	5.8	11.3	14.7	0.1	0.8	0.2	19.7	0.1	0.5	0.5	1.6	24.7	41.7	0.6	14.6	2.9	4.6	0.2	1.2	10.5	4.6	7.3	6.0	0.5	0.7	1.3	0.1	0.7	0.2	0.2	0.1	0.0	0.5	0.4	0.0	0.0	0.4	0.2	1.2	0.0	0.2	0.3	2.2	1.9	1.9	1.9	1.6	1.8	2.8	2.3	2.5	2.6	3.2	2.3	10.5	0.0	5.9	0.0	6.2	2.7	3.0	4.9	2.2	0.1	1.9	4.6	8.1	22.8	6.3	12.9	0.0	0.2	4.1	45.6	0.0	10.4	0.1	4.6	2.4	8.4	7.2	5.2	0.0	2.2	0.2	1.9	21.4	9.6	10.2	0.0	27.8	1.0	15.0	0.0	0.0	24.7	2.0	22.0	17.7	0.1	2.5	16.2	0.0	2.8	16.1	0.7	15.5	0.0	0.0	22.9	29.4	4.1	2.4	1.7	17.9	0.6	7.5	0.6	19.7	1.5	3.1	0.0	0.7	2.2	2.4	0.0	2.9	4.3	34.7	15.4
TOX	"KIAA0808, TOX1"	ENSG00000198846	"Thymocyte selection associated high mobility group box"	O94900	8	58805412-59119147	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 52.4"	"Group enriched"	"Detected in many"	5	"Astrocytes: 316.3;Excitatory neurons: 198.3;Inhibitory neurons: 155.0;Oligodendrocyte precursor cells: 455.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 36.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.5;NK-cells: 18.4;T-cells: 36.6"	"Cell line enhanced"	"Detected in many"		"JURKAT: 75.9;MOLT-4: 149.1;SH-SY5Y: 43.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018322, HPA073241"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA018322: AB_1858199, HPA073241: AB_2686584"	"unprognostic (7.60e-4)"	"unprognostic (6.16e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.73e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	0.7	1.0	7.1	5.8	9.3	2.9	1.0	0.1	10.7	1.8	0.0	11.4	9.5	1.3	0.4	3.3	0.8	4.6	0.7	6.4	8.0	3.0	1.1	4.6	18.2	2.0	4.4	5.7	1.4	2.4	1.8	1.3	2.2	2.0	8.6	6.0	1.6	1.0	0.1	0.5	10.3	2.5	0.0	5.5	7.9	6.3	5.8	52.4	1.1	0.6	18.9	2.0	1.4	4.9	0.9	0.2	15.7	0.0	1.6	3.5	0.0	3.3	7.5	1.8	0.3	0.0	0.0	0.0	0.0	14.4	0.8	1.2	3.9	0.0	0.4	0.5	1.5	0.0	2.8	0.0	12.7	2.8	0.7	1.9	0.5	2.3	2.9	1.0	25.9	75.9	0.0	0.0	1.2	0.0	149.1	0.0	2.7	0.2	0.4	3.1	10.7	0.1	0.4	0.4	14.3	43.8	0.0	0.1	0.0	3.6	0.0	0.0	0.2	3.9	1.8	12.9	4.4	0.0	0.0	9.9	0.5	0.1	2.8	21.5	0.2	3.2	12.1	0.0	5.5	5.4	8.6	18.2	1.4	1.3	3.3	9.7	0.3	18.4	0.0	0.0	36.6	5.6	7.1	9.3	0.1	10.7	6.4	8.0	2.0	4.4	2.2	0.0	5.8	4.9	0.6	9.6	31.6	316.3	12.3	1.3	0.1	0.1	1.2	18.4	0.2	0.9	1.8	1.5	2.5	1.8	0.0	3.9	23.2	3.7	0.0	0.9	2.0	1.9	2.7	1.8	46.0	4.2	198.3	0.7	0.2	2.7	6.1	0.8	16.5	0.0	0.4	0.7	3.7	0.0	155.0	34.8	2.0	0.6	9.6	2.2	0.9	2.8	0.0	47.8	0.6	14.3	34.0	455.4	5.0	2.6	9.6	0.4	22.4	0.1	4.0	1.3	10.4	2.2	0.0	0.2	0.6	1.0	0.7	0.5	1.3	0.8	35.0	0.0	10.3	0.1
TOX2	"C20orf100, dJ1108D11.2, GCX-1"	ENSG00000124191	"TOX high mobility group box family member 2"	Q96NM4	20	43914852-44069616	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.3;Excitatory neurons: 20.5;Hepatic stellate cells: 34.2;Inhibitory neurons: 76.9;Oligodendrocyte precursor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 92.0;U-266/70: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA049900, HPA058396"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA049900: AB_2680942, HPA058396: AB_2683704"	"unprognostic (2.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.97e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (7.45e-8)"	"unprognostic (1.60e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.60e-2)"	"unprognostic (3.12e-1)"	10.0	4.0	11.2	6.2	8.2	1.8	6.8	4.9	18.4	10.2	2.3	7.6	1.3	6.2	1.1	12.8	3.6	2.9	3.6	8.3	35.7	5.1	5.2	36.4	13.3	12.3	18.8	3.1	2.0	10.1	24.6	2.6	15.9	16.7	2.4	1.9	3.8	2.7	1.5	5.1	10.2	1.6	5.8	5.7	9.7	20.8	25.9	50.2	7.4	6.4	8.1	17.6	8.9	10.6	9.9	12.5	4.9	0.9	4.7	13.3	0.1	11.5	5.3	8.1	8.9	0.0	4.0	0.0	16.8	16.6	35.2	5.1	3.2	0.3	8.4	15.5	2.7	0.0	1.1	0.0	92.0	0.1	19.4	31.0	14.0	27.0	1.6	25.8	9.4	9.5	0.0	14.5	4.6	11.3	3.2	4.5	3.0	0.3	42.2	0.0	10.1	15.4	0.0	1.2	4.3	35.8	2.4	0.0	18.0	0.5	0.0	9.2	11.3	0.0	7.5	0.3	0.1	57.4	13.5	9.0	16.9	0.1	27.0	0.0	0.2	6.5	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.7	1.1	0.0	2.6	1.2	0.1	11.2	8.2	4.9	18.4	8.3	35.7	12.3	18.8	15.9	5.8	25.9	10.6	8.0	0.0	0.6	3.9	3.4	1.0	1.0	0.7	0.0	0.8	0.2	0.1	0.8	1.5	0.1	0.0	0.0	0.0	7.3	0.3	0.0	0.1	22.3	0.3	8.9	8.9	0.0	0.0	20.5	0.2	0.1	6.7	1.5	0.3	0.0	10.7	34.2	0.5	1.5	3.3	76.9	0.6	0.0	2.9	3.6	17.3	1.8	1.2	1.8	3.7	0.2	4.6	1.0	45.2	0.5	0.1	2.2	0.7	12.1	0.5	0.0	0.1	0.0	0.1	0.0	0.4	8.7	1.3	1.8	0.2	1.3	0.3	10.5	0.1	1.8	0.3
TOX3	"CAGF9, TNRC9"	ENSG00000103460	"TOX high mobility group box family member 3"	O15405	16	52436417-52547802	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.9;retina: 17.6;stomach 1: 20.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Enteroendocrine cells: 61.7;Inhibitory neurons: 138.9;Muller glia cells: 162.1;Oligodendrocyte precursor cells: 51.8;Oligodendrocytes: 75.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 46.1;HAP1: 22.1;Hep G2: 20.8;OE19: 25.8;RT4: 97.1;SCLC-21H: 30.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040240, HPA040376"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA040240: , HPA040376: AB_10795522"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (3.08e-12)"	"unprognostic (1.19e-1)"	"unprognostic (1.31e-1)"		"prognostic favorable (3.95e-4)"	0.4	3.0	4.7	1.4	5.6	0.0	3.8	1.2	6.0	7.6	0.3	15.6	9.3	1.3	4.4	0.6	3.1	6.9	0.0	5.3	4.4	9.5	5.2	1.4	0.1	4.6	3.5	0.9	2.6	0.0	2.3	0.2	3.0	1.8	17.9	17.6	8.9	0.5	4.0	0.7	9.3	1.0	5.1	0.0	20.3	0.6	8.4	1.3	0.0	0.5	0.2	5.7	1.0	6.8	0.0	5.8	46.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	3.5	0.0	0.3	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	25.8	0.0	0.0	8.0	0.2	10.7	97.1	30.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.6	1.2	6.0	5.3	4.4	4.6	3.5	3.0	5.1	8.4	6.8	0.2	6.4	8.2	1.3	0.0	1.0	0.5	2.8	0.6	4.1	20.0	12.6	0.7	52.9	7.7	35.0	0.0	0.0	0.0	47.6	3.9	1.6	3.2	1.6	0.4	0.3	61.7	0.0	3.9	5.1	0.0	1.5	29.6	6.1	0.0	0.1	0.7	4.6	0.1	40.4	138.9	31.7	2.0	0.0	0.3	1.8	0.6	0.2	0.0	8.4	0.0	162.1	0.0	51.8	75.0	15.3	15.2	0.0	0.2	11.8	16.6	14.0	12.3	3.8	0.0	3.3	0.8	0.1	0.8	0.3	0.3	0.0	0.4	9.7	32.6	6.5
TOX4	"C14orf92, KIAA0737, LCP1"	ENSG00000092203	"TOX high mobility group box family member 4"	O94842	14	21476597-21499175	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 265.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017880, HPA027551"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA017880: AB_1845573, HPA027551: AB_10601701"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.46e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (8.05e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.94e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.48e-3)"	16.7	14.6	17.3	14.1	17.6	21.4	16.3	17.9	20.1	18.0	14.8	18.5	12.6	15.4	15.1	21.1	14.7	12.2	21.9	17.5	17.7	15.0	15.7	15.9	15.1	17.1	18.7	15.9	15.8	20.4	13.6	15.5	17.5	14.7	15.2	16.1	14.8	17.4	55.5	21.5	14.8	19.7	16.8	13.7	16.9	14.3	18.3	26.1	17.1	25.8	21.3	17.4	16.0	19.5	27.1	27.4	22.7	21.5	32.1	30.6	30.3	25.3	49.6	52.7	50.3	27.0	31.6	16.2	17.5	41.5	42.0	31.5	37.4	38.8	66.8	28.6	15.1	18.1	17.7	37.8	41.5	33.6	28.7	40.0	39.8	41.7	39.4	35.9	38.0	30.1	22.6	27.4	37.9	22.8	33.4	19.3	12.8	39.5	43.2	29.7	23.7	18.6	24.5	33.4	20.9	21.5	25.0	26.3	21.3	29.8	24.8	12.6	25.0	27.2	24.9	24.1	22.5	35.1	41.7	36.9	12.8	16.4	28.7	40.9	27.4	40.0	23.1	29.2	25.0	24.0	20.5	22.2	26.0	24.9	21.3	24.4	48.6	29.2	27.5	33.7	31.7	28.9	17.3	17.6	17.9	20.1	17.5	17.7	17.1	18.7	17.5	16.8	18.3	19.5	60.0	67.3	64.0	0.0	43.3	87.3	63.9	81.3	58.1	75.0	50.4	42.0	51.8	42.9	64.4	46.0	29.2	73.5	69.3	51.0	62.6	47.3	76.1	42.6	46.9	53.4	68.9	48.8	0.0	51.4	64.1	48.4	40.8	50.4	61.4	41.4	37.9	43.1	43.8	42.1	0.0	45.4	52.9	41.3	61.6	36.5	48.7	46.1	39.2	0.0	55.3	40.4	46.4	0.0	0.0	51.4	51.9	44.0	44.4	59.0	91.4	64.0	57.4	54.5	32.9	54.1	58.6	131.9	66.8	50.5	88.8	265.8	62.0	55.5	43.8	70.0
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876, CAB079965"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Mitochondria, Cytosol"	"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, CAB079965: , HPA051244: AB_2681403, HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	19.3	13.8	10.4	27.1	12.6	19.6	22.5	10.4	16.5	19.9	10.3	29.0	18.9	24.5	12.8	28.8	31.3	13.2	11.1	10.1	11.4	14.9	16.5	15.1	34.6	18.7	13.6	27.3	18.3	9.4	7.3	23.5	12.5	17.7	27.5	4.1	18.9	15.3	12.3	37.4	20.4	24.6	12.6	31.1	22.6	10.4	12.3	47.2	17.4	6.1	45.4	20.8	19.9	13.3	81.5	145.3	81.1	57.3	37.3	43.9	82.8	28.4	66.1	78.5	100.2	4.2	40.6	190.5	126.9	58.7	77.6	174.9	119.7	80.4	72.8	42.7	76.5	77.6	76.8	70.9	111.5	1.6	37.0	55.7	93.0	38.9	106.5	45.6	79.4	24.7	3.8	6.9	41.5	145.1	130.0	96.3	80.2	10.4	2.4	252.2	56.1	66.2	59.4	87.3	46.0	80.5	94.1	62.6	24.3	39.4	109.2	7.4	100.7	91.6	30.2	1.0	48.3	47.6	37.9	82.5	23.6	9.7	80.1	1.2	21.2	3.4	13.0	21.7	15.9	21.5	13.3	14.6	30.3	19.1	13.7	15.4	2.4	17.5	19.3	27.3	17.3	14.7	10.4	12.6	10.4	16.5	10.1	11.4	18.7	13.6	12.5	12.6	12.3	13.3	21.1	9.6	12.8	16.3	26.0	28.7	14.5	24.6	24.5	2.6	36.1	30.4	2.5	18.6	15.4	20.2	0.0	36.9	24.7	16.9	9.8	24.8	12.8	11.5	29.0	24.5	30.7	21.7	2.1	18.1	39.6	17.0	11.2	19.5	1.3	31.7	22.1	18.0	24.2	0.0	3.2	43.0	18.3	27.8	20.1	3.8	23.0	19.3	12.4	7.5	31.9	4.9	25.7	9.0	8.0	15.8	16.4	17.0	7.8	15.7	10.3	10.1	8.8	2.6	13.1	25.9	20.6	0.5	4.9	28.7	32.8	22.4	16.5	27.4	54.1	11.5
TP53BP1	"53BP1, p202, TDRD30"	ENSG00000067369	"Tumor protein p53 binding protein 1"	Q12888	15	43403061-43510728	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004083, HPA008788, HPA022133, CAB079980"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382"	"unprognostic (2.12e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.07e-1)"	"unprognostic (8.06e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.99e-2)"	"unprognostic (3.38e-2)"	6.9	11.5	17.4	10.1	16.6	11.5	10.7	19.9	14.5	17.7	21.5	9.7	6.4	16.0	15.9	6.1	14.7	10.7	8.8	15.4	26.3	9.1	4.1	8.3	8.6	13.5	16.7	16.8	7.4	22.3	24.1	12.2	15.7	12.1	10.2	22.0	10.1	12.8	7.2	9.2	6.4	16.3	9.6	8.7	7.6	21.6	23.0	15.3	17.9	11.0	12.6	11.2	8.7	12.1	13.5	22.3	63.8	40.1	25.8	31.9	15.8	22.8	33.8	31.0	39.1	19.4	15.8	14.5	19.2	39.0	66.9	32.4	46.3	27.5	36.8	38.9	15.8	27.1	40.1	11.7	16.8	30.2	37.4	24.9	19.0	41.8	31.2	51.7	37.4	24.2	26.9	12.3	36.5	9.6	23.7	14.1	41.1	24.2	13.9	25.1	23.9	9.3	22.9	31.8	57.3	26.8	33.8	14.3	8.5	48.6	29.9	16.9	27.5	33.7	22.3	27.0	20.5	9.8	22.4	33.0	27.6	14.6	17.5	1.4	0.5	1.0	1.6	0.7	1.3	1.9	1.6	1.6	1.2	1.8	1.8	1.6	0.6	0.9	0.5	1.3	1.4	0.7	17.4	16.6	19.9	14.5	15.4	26.3	13.5	16.7	15.7	9.6	23.0	12.1	11.5	22.4	22.3	53.2	17.8	6.4	10.2	10.0	13.6	32.4	17.4	13.2	14.9	5.7	20.8	29.5	47.9	13.4	11.1	7.4	9.8	14.5	38.8	47.0	44.8	16.8	41.9	8.4	66.2	7.1	11.2	23.9	14.8	26.8	26.6	47.0	15.0	3.3	10.8	47.1	81.9	15.7	12.2	3.8	6.9	17.8	23.6	9.3	1.8	17.8	4.0	11.9	7.2	62.8	50.4	7.5	5.8	17.7	17.1	11.0	2.6	8.8	60.7	51.7	13.1	35.2	20.5	33.1	36.2	14.7	5.3	18.5	17.0	29.9	13.4	8.9
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631389-189897276	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.6;skin 1: 137.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	0.5	0.3	0.3	0.6	0.3	0.4	18.0	0.9	0.5	23.5	0.3	0.3	0.1	0.3	10.5	69.6	1.0	0.3	0.6	0.5	0.5	0.3	0.4	1.9	1.0	0.4	0.6	0.1	0.3	0.0	0.5	10.8	0.7	17.4	0.2	0.0	20.8	18.0	42.4	137.3	0.2	0.3	0.2	0.2	0.4	3.4	0.4	23.1	0.3	12.4	17.7	18.6	54.4	0.4	2.3	4.6	0.0	0.1	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.6	0.1	0.2	87.1	0.0	167.3	0.0	1.4	0.0	1.9	1.3	0.4	0.0	0.0	0.3	0.2	124.0	0.2	117.3	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.3	0.2	0.0	1.0	0.3	0.0	0.2	185.1	0.2	0.1	0.2	0.0	0.0	2.5	0.9	0.2	0.3	0.2	0.1	0.2	0.0	25.3	0.3	1.1	0.5	0.1	0.8	0.6	0.0	0.2	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.9	0.5	0.5	0.5	0.4	0.6	0.7	0.2	0.4	0.4	0.2	0.0	5.3	1.0	0.9	275.4	26.8	61.9	335.2	0.0	0.9	30.1	0.7	0.0	8.5	0.0	0.0	24.9	0.1	0.1	0.0	0.2	1.8	0.0	0.1	1.1	0.0	0.0	1.3	0.2	2.8	1.4	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	4.8	0.0	2.0	0.0	11.9	0.4	0.3	0.7	8.8	14.0	0.6	0.0	0.0	0.5	1.4	1.6	0.0	1.2	1.6	5.6	0.0	0.0	2.8	0.0	0.0	5.3	0.9	0.5	2.4	173.4	283.1	8.9	0.6	0.2	0.0	15.2
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652516-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 8.0;fallopian tube: 6.7;skin 1: 6.6"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 13.0;Basal squamous epithelial cells: 16.5;Early spermatids: 21.8;Endometrial ciliated cells: 31.0;Late spermatids: 15.7;Respiratory ciliated cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.0;RH-30: 11.6;SCLC-21H: 18.0;U-698: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971"	"unprognostic (5.71e-3)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.0	0.0	0.7	0.7	0.5	0.5	0.8	4.2	0.5	1.4	8.0	0.2	0.0	0.1	0.1	3.7	6.7	0.0	0.1	0.8	0.7	0.1	0.2	0.9	1.0	2.4	2.9	0.1	0.8	0.1	0.3	0.0	1.4	2.6	0.1	0.2	2.9	0.3	0.2	6.6	0.2	0.0	1.4	0.7	0.3	0.7	0.7	1.6	0.2	0.0	1.4	0.1	2.9	1.0	2.6	0.1	0.3	7.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.9	4.0	2.6	2.0	0.0	0.9	4.3	2.7	0.9	0.0	0.8	8.7	0.2	3.9	2.6	0.0	0.0	2.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.8	1.9	15.0	2.0	0.5	0.0	0.1	0.0	11.6	0.1	0.3	3.8	18.0	8.4	0.4	0.0	0.8	0.0	10.9	9.2	0.0	2.9	7.5	0.0	5.8	3.3	0.7	18.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	4.2	0.5	0.8	0.7	2.4	2.9	1.4	1.4	0.7	1.0	0.0	0.0	1.5	0.0	1.2	3.1	3.8	13.0	16.5	0.5	0.2	2.5	1.5	0.0	7.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	21.8	31.0	0.3	0.3	2.4	3.2	0.1	0.2	0.4	0.4	0.0	0.7	0.0	0.1	0.4	0.2	0.3	0.0	0.1	0.5	2.0	0.0	1.3	15.7	0.6	0.1	1.8	0.0	0.0	0.2	0.0	2.5	0.1	0.2	0.0	0.0	6.8	0.2	0.0	0.1	35.8	0.1	0.0	0.0	2.6	0.1	0.4	1.6	2.3	0.3	0.4	0.1	0.3	0.2
TPBG	"5T4, 5T4-AG"	ENSG00000146242	"Trophoblast glycoprotein"	Q13641	6	82363206-82367420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 94.6;hTCEpi: 115.2;hTEC/SVTERT24-B: 98.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010554	Enhanced		Approved	Nucleoplasm		NA	NA		310000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA010554: AB_1858206"	"unprognostic (3.03e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.55e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.57e-2)"	19.9	2.5	1.6	3.3	20.6	0.5	17.3	0.4	5.7	24.2	0.6	8.5	3.5	15.8	2.6	26.3	14.9	6.9	9.1	0.2	4.2	10.7	1.5	7.5	1.9	8.2	11.4	6.0	8.3	4.2	14.2	6.2	9.3	15.3	3.0	0.2	20.1	7.0	2.9	15.9	8.0	6.7	3.1	9.9	9.0	3.6	3.6	4.2	15.7	1.9	3.0	35.1	20.2	3.6	17.1	27.6	8.7	21.2	35.2	40.4	17.6	84.9	94.6	16.7	22.0	3.9	26.9	0.0	9.6	39.5	51.9	37.3	10.3	44.6	13.9	0.0	14.5	11.9	13.1	0.8	29.1	0.9	9.2	25.8	115.2	98.5	34.1	12.9	4.5	0.7	2.3	0.2	3.9	37.8	0.0	0.0	12.5	8.8	22.3	0.0	19.4	0.2	24.4	25.8	4.4	16.9	20.9	28.3	0.0	16.2	49.4	3.5	10.8	15.1	15.8	33.5	19.2	0.1	0.0	0.0	71.3	1.3	17.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	20.6	0.4	5.7	0.2	4.2	8.2	11.4	9.3	3.1	3.6	3.6	16.4	12.8	6.5	2.3	0.2	67.9	78.2	120.3	68.3	1.1	44.6	24.0	2.1	21.5	62.4	55.2	0.0	42.7	0.4	9.0	0.0	35.8	8.6	29.2	38.7	25.4	1.2	0.0	21.3	45.4	82.5	48.0	14.8	68.0	0.0	3.8	11.0	0.2	3.6	1.7	0.9	20.2	75.3	0.6	11.5	6.5	12.8	2.3	17.8	7.5	0.1	2.1	0.0	2.0	3.2	38.2	17.8	6.0	0.0	51.9	1.9	0.7	29.9	0.3	32.9	55.6	47.0	13.7	11.8	25.2	31.3	65.9	3.5	9.7	10.8	78.8
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2470.8;tongue: 2005.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		170000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	340.4	588.6	446.2	269.7	480.2	334.8	274.5	476.5	541.9	314.1	446.9	425.6	421.0	240.5	220.2	764.4	248.2	216.8	819.8	481.0	462.0	609.0	536.1	308.6	253.9	459.2	460.4	269.9	238.1	496.4	236.8	287.2	467.2	272.1	435.3	625.0	377.6	273.3	2470.8	410.1	404.5	301.5	429.7	291.4	329.0	239.8	503.5	200.3	269.1	2005.8	410.4	363.8	440.6	454.4	1556.8	1350.5	706.1	1094.6	666.5	696.6	1236.3	1097.5	1184.9	1999.1	2407.5	1409.9	823.0	903.4	212.7	1069.7	1042.4	748.8	1671.0	1812.3	2189.4	1196.4	1265.1	1172.0	924.4	926.2	496.8	1351.5	924.0	764.0	739.7	1537.8	1305.0	2816.1	1233.3	451.0	615.0	336.5	1554.5	1130.0	709.6	1119.5	1741.0	1302.3	855.9	413.5	1156.1	930.7	1261.4	1061.1	497.2	830.0	953.3	977.8	542.7	1452.6	224.4	1003.2	778.2	1068.0	914.6	703.1	1631.7	653.4	285.7	1327.8	2153.1	821.2	784.9	1708.8	2304.1	2375.2	824.6	2402.3	845.7	863.3	820.0	808.0	2656.1	800.9	570.5	703.0	934.3	1387.7	2165.7	482.0	1106.3	4679.5	446.2	480.2	476.5	541.9	481.0	462.0	459.2	460.4	467.2	429.7	503.5	454.4	311.5	134.6	204.2	34.6	290.6	684.8	553.8	1756.4	414.9	284.6	294.3	303.3	552.5	391.7	673.0	389.9	110.5	1017.0	278.2	850.3	1508.5	1361.5	203.0	280.8	307.0	352.0	425.5	243.3	38.4	786.5	1824.0	386.5	408.3	343.9	362.8	364.8	276.6	547.3	937.3	297.8	33.7	567.2	1151.5	386.7	750.4	683.5	279.0	482.8	674.1	18.7	1129.8	739.6	312.0	17.1	26.7	1081.5	889.4	263.3	427.9	556.2	1595.9	1642.7	401.2	298.0	197.2	270.5	551.3	14.9	79.0	690.4	615.9	1530.4	352.9	869.2	827.0	652.5
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 50.6;vagina: 32.3"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 199.7"	"Cancer enriched"	"Detected in many"	4	"breast cancer: 7.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.6;Karpas-707: 4.7;OE19: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA044751: AB_2679073, HPA060187: AB_2684217"	"prognostic favorable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	10.6	1.9	0.5	1.8	0.6	0.0	23.3	0.6	0.7	23.3	3.5	0.5	0.3	3.0	2.8	50.6	8.4	2.9	2.0	0.4	0.7	0.4	9.0	4.4	0.9	2.2	0.7	2.2	0.6	0.1	0.2	1.2	1.0	1.2	0.3	0.4	6.1	1.3	9.1	25.1	0.7	3.0	0.6	0.7	0.5	4.8	3.6	1.5	1.3	0.4	9.0	1.0	32.3	2.0	0.9	0.2	0.3	0.0	2.0	1.7	0.0	0.0	0.0	0.1	0.1	1.1	2.2	1.3	3.4	0.1	0.6	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.5	0.0	0.0	0.0	4.7	0.2	0.4	0.0	0.0	0.6	23.4	0.3	0.0	0.0	1.7	0.0	1.8	0.0	0.0	0.2	0.5	0.0	0.7	4.1	0.6	0.0	0.1	0.3	0.0	0.3	4.3	3.7	0.4	0.1	0.0	0.1	0.0	1.5	0.0	3.8	1.2	0.5	0.1	3.0	4.0	0.4	0.0	0.6	1.5	0.7	0.0	1.1	0.0	3.8	0.9	0.5	0.6	0.6	0.7	0.4	0.7	2.2	0.7	1.0	0.6	3.6	2.0	0.9	38.5	1.7	3.6	0.9	5.6	19.9	10.5	13.6	1.3	9.8	31.1	0.8	0.0	6.4	0.0	0.0	0.4	5.3	0.2	0.0	0.3	199.7	1.2	1.1	1.0	0.0	2.7	2.8	0.6	0.2	5.5	0.5	0.2	1.3	0.3	0.0	8.4	4.8	0.0	7.9	0.3	2.0	3.5	2.7	24.4	7.2	2.5	0.0	3.7	0.6	0.2	2.1	9.5	2.1	4.5	0.1	3.0	5.6	1.7	0.2	0.2	1.0	0.2	0.0	30.7	5.3	5.1	1.1	4.3	5.8	0.3	14.4	1.2	0.2	5.7
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2 microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.0;lymphoid tissue: 70.3;testis: 30.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 90.7;Extravillous trophoblasts: 68.5;Granulosa cells: 46.6;Spermatocytes: 114.5;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.1;NK-cells: 3.6;T-cells: 8.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.9	1.4	0.9	13.0	0.9	48.0	2.7	0.8	1.0	2.3	0.5	11.6	9.4	2.4	0.2	13.2	0.9	1.8	0.8	1.1	0.6	0.7	4.2	1.9	26.6	0.6	1.0	0.5	0.4	0.4	0.2	8.3	0.7	0.7	14.2	0.5	2.0	0.5	1.4	9.8	9.4	6.8	0.6	5.2	6.2	30.7	1.3	70.3	1.0	0.8	32.3	3.4	4.1	0.9	455.1	149.1	176.4	139.1	13.8	25.2	169.8	186.1	104.5	264.0	197.7	319.1	190.4	212.4	106.7	104.5	196.8	232.7	203.7	169.0	298.8	92.3	78.8	416.3	139.7	219.6	4.2	161.9	102.8	8.7	9.1	166.0	120.0	37.9	144.6	157.1	313.8	187.8	209.7	186.2	272.2	125.3	197.1	174.0	159.3	152.5	475.5	128.2	71.2	72.8	127.5	85.7	284.6	106.3	82.0	120.9	185.1	97.3	98.3	294.1	179.7	136.5	290.0	74.4	138.6	187.3	92.2	565.1	195.8	5.1	0.0	0.4	0.4	0.0	0.2	0.6	1.4	1.7	0.5	0.2	0.3	0.5	0.2	3.6	0.1	1.0	8.1	1.0	0.9	0.9	0.8	1.0	1.1	0.6	0.6	1.0	0.7	0.6	1.3	0.9	1.0	0.0	4.2	0.0	5.9	6.9	1.5	4.3	1.2	0.9	3.0	3.4	0.9	4.3	3.8	0.0	0.0	23.3	3.8	6.4	0.0	1.2	9.3	7.3	6.6	3.9	1.2	90.7	2.9	0.4	68.5	9.2	16.3	8.4	0.0	46.6	8.9	3.0	19.5	1.7	0.9	9.8	10.2	8.0	5.5	13.1	0.9	7.6	0.0	1.0	2.1	0.4	3.1	0.5	0.5	1.8	1.4	0.0	30.8	2.5	0.9	0.0	0.7	0.4	0.0	1.1	15.4	114.5	63.1	31.2	6.1	4.7	8.2	4.2	18.4	2.9
TRA2A	"AWMS1, htra-2-alpha"	ENSG00000164548	"Transformer 2 alpha homolog"	Q13595	7	23504780-23532041	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054018	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Nucleoplasm, Vesicles"	"HPA054018: AB_2682344"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.77e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.28e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.36e-3)"	35.1	39.1	55.7	37.0	58.2	113.4	32.1	57.4	75.7	47.1	57.9	38.7	26.4	42.8	43.9	47.3	42.7	21.3	30.4	55.3	57.8	45.9	34.9	33.5	47.6	57.2	56.5	53.1	32.6	25.6	40.4	32.9	57.6	41.3	39.2	42.0	33.2	22.1	23.1	42.8	36.8	41.0	56.6	52.8	33.0	30.9	56.8	46.1	35.9	21.3	53.6	37.9	42.9	64.9	57.2	61.2	94.1	148.4	49.1	30.9	60.4	71.4	33.6	70.5	57.4	51.2	76.4	107.4	39.9	53.7	82.3	92.1	115.6	66.9	88.4	64.6	65.7	65.9	67.9	81.8	52.0	78.0	59.2	37.1	44.9	53.1	66.1	62.7	80.9	46.7	129.5	51.0	79.7	55.6	96.5	128.7	84.5	69.5	62.5	106.1	74.8	64.3	81.8	81.0	80.7	65.8	66.0	75.8	49.8	69.1	59.6	85.5	73.8	55.4	79.0	51.0	83.4	56.6	76.1	86.9	47.7	103.8	75.3	16.8	17.1	23.6	24.6	28.8	21.6	17.6	23.3	23.1	20.6	16.1	19.6	23.7	25.4	19.1	27.0	30.0	25.2	10.2	55.7	58.2	57.4	75.7	55.3	57.8	57.2	56.5	57.6	56.6	56.8	64.9	110.6	60.9	72.2	112.3	141.9	104.4	95.6	61.7	94.4	54.5	118.5	74.8	42.5	60.1	60.8	88.3	52.1	83.2	153.3	84.9	25.4	54.8	62.1	155.7	137.1	74.8	118.5	77.5	113.1	43.9	84.6	91.5	89.2	166.7	86.7	62.5	84.6	71.4	54.8	37.0	115.4	100.3	48.8	89.5	125.4	23.7	65.0	88.9	56.9	107.7	71.5	48.1	70.0	203.1	245.1	59.2	92.0	67.7	125.4	97.7	59.7	41.8	71.3	101.8	72.3	119.2	88.2	99.8	65.0	138.6	113.1	117.9	130.4	49.1	112.6	92.1
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185914558-185938103	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 444.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		62000	"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	38.2	41.3	18.1	35.2	19.1	46.3	30.2	23.0	31.1	25.2	25.7	41.7	21.5	31.3	26.3	38.7	27.1	16.0	31.7	19.6	22.3	41.6	37.5	21.5	38.7	19.8	17.2	25.5	28.3	28.9	20.3	26.3	20.4	25.8	24.9	18.5	27.0	18.4	34.1	25.5	27.0	25.2	17.4	36.2	31.1	22.4	19.5	47.6	23.2	23.2	43.9	28.7	26.8	26.3	145.0	44.2	135.0	67.8	30.3	27.3	78.2	101.5	71.1	117.5	90.2	75.3	67.6	124.5	134.4	53.2	79.5	94.1	140.9	104.5	120.9	117.5	89.6	122.0	40.1	92.7	42.4	133.3	101.1	26.5	44.3	75.1	51.0	36.5	90.4	63.5	120.4	81.6	79.6	66.4	344.9	164.1	191.3	113.0	85.5	201.1	109.4	147.5	94.3	58.9	98.0	104.0	73.3	90.1	117.8	66.5	101.1	138.0	52.7	81.3	110.8	68.2	170.1	159.6	444.0	272.0	78.0	151.0	130.6	84.1	39.2	33.0	36.3	33.1	32.8	71.2	36.1	34.0	35.3	64.0	45.0	40.9	44.0	41.3	39.6	73.2	36.4	21.5	18.1	19.1	23.0	31.1	19.6	22.3	19.8	17.2	20.4	17.4	19.5	26.3	236.3	64.1	122.0	46.4	201.7	258.4	196.9	136.6	157.1	107.8	206.0	148.2	67.2	140.2	104.0	69.9	196.0	188.9	196.6	156.2	72.4	126.8	156.9	152.7	284.5	181.6	227.6	233.4	49.7	109.5	230.7	147.2	92.2	274.6	197.6	155.9	189.9	93.0	174.6	72.3	53.7	259.8	85.5	280.7	283.1	46.6	127.7	228.1	135.2	74.0	196.9	115.5	167.9	78.4	67.0	97.5	129.1	117.4	152.1	218.3	121.2	59.1	66.7	219.5	105.2	177.0	214.7	168.2	151.5	141.3	260.7	214.9	212.6	89.4	232.4	163.7
TRABD	PP2447	ENSG00000170638	"TraB domain containing"	Q9H4I3	22	50185913-50199598	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000822	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA000822: AB_10959384"	"unprognostic (9.37e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (2.80e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.98e-3)"	19.8	20.7	7.1	27.7	6.9	60.9	18.5	10.1	10.6	23.0	5.9	24.1	18.3	16.8	3.8	40.4	18.8	11.0	21.8	7.0	6.2	26.8	40.8	26.0	32.8	8.5	6.7	18.8	72.7	7.6	21.9	8.4	6.6	29.1	6.3	3.2	29.0	9.6	29.3	23.6	30.7	5.3	6.7	36.9	27.5	20.8	7.2	16.6	24.8	5.0	15.7	22.6	27.0	6.8	62.8	40.9	14.5	24.7	7.8	9.0	35.9	21.4	14.0	17.6	14.9	26.2	29.6	38.3	20.5	10.1	13.7	38.6	18.8	38.1	3.5	27.1	87.1	22.5	71.2	46.0	30.5	45.4	42.7	14.6	22.9	12.9	17.7	10.3	17.9	37.3	27.8	61.7	7.6	70.5	32.5	51.2	21.3	21.3	38.0	87.6	19.7	83.0	13.4	61.5	16.8	28.0	18.4	66.2	31.3	6.1	28.0	47.0	19.4	14.6	36.2	19.2	24.4	73.9	14.1	46.7	18.0	31.5	23.5	16.9	30.5	51.4	21.2	26.5	20.3	13.6	19.1	19.5	32.5	6.7	12.6	15.3	40.6	32.1	16.7	68.7	29.5	22.4	7.1	6.9	10.1	10.6	7.0	6.2	8.5	6.7	6.6	6.7	7.2	6.8	22.2	9.6	19.3	12.1	80.3	42.1	57.4	48.9	33.6	32.6	38.8	30.1	12.0	17.2	31.8	33.1	18.8	25.5	151.7	66.2	27.4	52.3	20.7	17.1	25.1	27.2	18.0	17.4	11.6	62.9	54.5	27.2	77.5	32.4	27.3	31.6	12.8	24.0	46.4	43.7	12.9	55.3	46.8	46.9	59.4	8.8	32.3	69.6	42.7	9.4	111.4	22.5	117.4	14.1	15.3	80.6	67.7	32.4	133.1	125.9	55.0	28.9	19.7	32.8	19.7	20.5	23.7	49.9	31.5	34.3	45.6	30.6	84.3	31.2	71.0	92.5
TRAF1	EBI6	ENSG00000056558	"TNF receptor associated factor 1"	Q13077	9	120902393-120929173	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Langerhans cells: 319.7;monocytes: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 12.9"	"Lineage enriched"	"Detected in many"	4	"T-cells: 12.9"	"Group enriched"	"Detected in many"	6	"HDLM-2: 92.5;WM-115: 113.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001852, CAB009593"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"CAB009593: , HPA001852: AB_1080344"	"unprognostic (1.45e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (2.19e-5)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.42e-5)"	"unprognostic (1.85e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.64e-1)"	"unprognostic (9.87e-3)"	7.0	9.9	8.0	20.8	11.1	8.9	6.7	7.7	9.4	8.6	7.0	8.8	3.5	6.2	4.6	5.7	9.6	7.5	9.0	7.7	8.0	9.5	6.3	9.4	33.5	9.4	9.2	12.1	4.8	2.9	12.4	2.8	8.5	11.8	4.1	10.8	5.2	5.6	2.6	7.4	10.9	3.6	7.2	14.9	8.0	3.1	10.6	15.0	9.1	1.8	23.1	14.8	7.4	14.0	3.2	2.0	0.4	0.1	3.7	9.1	0.0	0.8	5.0	1.4	2.7	0.2	1.7	6.1	1.0	1.0	14.7	1.1	0.5	0.3	1.9	92.5	0.0	0.5	1.5	0.4	2.6	0.2	6.9	4.6	4.8	5.8	4.2	1.8	0.9	1.7	0.2	12.6	0.9	0.3	0.2	2.6	1.2	1.4	0.2	1.5	1.5	12.2	0.5	0.2	1.1	0.1	0.8	0.3	0.3	2.7	0.7	1.1	0.9	1.2	0.8	4.9	16.1	9.3	3.5	3.2	3.0	0.5	113.0	0.0	0.3	0.0	3.8	0.4	6.7	0.3	9.7	8.2	0.4	0.1	3.1	4.5	0.0	1.7	0.3	2.8	12.9	2.1	8.0	11.1	7.7	9.4	7.7	8.0	9.4	9.2	8.5	7.2	10.6	14.0	1.6	6.4	0.0	9.8	9.6	9.7	6.2	1.0	2.8	2.0	2.2	2.4	2.5	4.3	4.0	3.7	18.8	0.0	19.0	0.5	1.9	24.3	0.6	0.8	2.5	5.0	1.8	2.7	1.4	2.0	0.1	7.1	3.1	1.0	36.8	1.3	1.4	1.4	2.7	0.0	2.1	1.1	0.0	3.7	319.7	0.8	1.8	26.0	7.2	3.7	316.7	1.4	4.1	2.5	8.3	15.6	0.3	1.9	10.7	6.7	0.6	1.5	0.3	5.9	0.0	3.6	4.1	1.9	0.4	1.6	10.4	0.0	36.7	3.0	0.8	1.8
TRAF4	"CART1, MLN62, RNF83"	ENSG00000076604	"TNF receptor associated factor 4"	Q9BUZ4	17	28744005-28750956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 54.0"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 54.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009055, HPA021904, HPA052377"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB009055: AB_2209701, HPA021904: , HPA052377: AB_2681804"	"unprognostic (1.77e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.58e-3)"	10.7	19.4	16.1	11.2	17.8	31.2	19.3	15.6	19.1	10.9	18.4	28.4	47.1	9.1	4.1	28.6	14.4	20.3	5.2	15.5	15.5	45.0	60.1	22.7	18.8	18.6	17.7	12.2	32.1	4.0	14.5	16.4	17.0	31.4	22.2	3.6	46.8	6.9	1.8	15.4	38.7	5.1	15.6	19.0	35.9	15.1	16.3	13.6	29.1	0.8	20.1	36.7	11.8	23.9	41.2	62.7	85.3	41.6	12.0	13.9	131.2	27.3	22.8	28.2	37.2	50.2	50.0	62.5	38.8	29.9	19.0	61.0	39.1	61.5	11.6	20.3	58.5	22.5	111.7	58.3	45.9	10.9	25.0	26.5	59.2	33.2	39.7	25.5	22.2	29.1	60.1	5.4	26.1	67.3	34.6	22.7	65.9	80.2	14.4	52.1	38.8	30.6	80.8	115.7	53.2	61.3	42.0	181.7	84.3	73.4	69.5	17.2	15.0	17.8	37.4	20.3	39.2	8.2	21.3	80.1	14.0	17.8	81.9	5.7	0.5	1.9	1.0	1.1	2.6	9.7	1.8	1.9	2.9	9.3	1.3	1.3	0.2	1.8	0.9	54.0	1.0	1.8	16.1	17.8	15.6	19.1	15.5	15.5	18.6	17.7	17.0	15.6	16.3	23.9	9.3	22.4	28.3	28.4	59.2	137.5	185.0	58.2	122.3	3.4	134.8	100.1	0.4	44.3	66.7	20.2	6.2	107.9	88.3	121.3	43.0	78.5	53.4	102.8	22.8	20.7	84.1	4.8	0.9	109.2	136.8	20.4	83.1	133.7	7.0	10.1	8.9	38.1	13.9	8.4	1.6	81.6	61.1	2.2	71.9	12.1	3.7	16.0	39.2	3.7	7.3	23.0	5.2	37.7	19.8	128.0	125.7	1.5	36.6	219.0	155.7	33.8	68.7	2.3	0.0	9.8	34.9	5.8	22.6	57.7	78.6	124.4	31.5	14.5	93.5	346.4
TRAFD1	FLN29	ENSG00000135148	"TRAF-type zinc finger domain containing 1"	O14545	12	112125538-112153604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 117.6;Spermatocytes: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039254, HPA039266"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA039254: AB_10805358, HPA039266: AB_10795142"	"unprognostic (7.80e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (1.07e-1)"	"unprognostic (6.15e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (3.92e-5)"	17.1	14.6	15.9	30.4	21.5	30.1	20.3	21.2	18.9	21.2	24.7	40.6	16.7	16.8	15.6	32.0	15.4	17.7	22.3	15.1	17.3	15.7	13.5	26.3	37.1	22.4	20.0	18.7	11.8	15.7	11.7	19.0	23.0	22.0	20.6	18.7	19.0	19.8	12.9	35.9	20.3	25.9	20.5	31.3	17.2	29.1	20.1	32.6	13.8	11.4	40.4	29.9	21.7	30.2	23.8	26.2	41.8	40.8	28.8	27.3	22.1	27.2	38.8	36.5	29.4	29.5	21.9	27.4	22.6	28.9	15.7	49.0	42.0	26.3	24.2	47.3	40.1	44.4	37.7	16.3	50.0	27.1	67.7	34.4	43.5	27.1	35.7	37.2	32.6	16.6	50.1	16.9	23.6	41.2	31.5	39.0	35.4	27.8	31.8	43.8	25.6	46.8	24.3	89.5	36.4	27.3	57.4	55.7	15.1	30.8	35.8	38.7	22.1	17.2	12.2	17.1	14.3	40.3	36.2	29.3	18.5	21.6	19.1	323.7	96.1	226.1	45.1	86.8	30.1	56.7	43.1	40.3	50.1	60.2	39.4	36.6	188.2	70.8	93.1	33.5	63.7	101.2	15.9	21.5	21.2	18.9	15.1	17.3	22.4	20.0	23.0	20.5	20.1	30.2	10.7	19.2	13.1	6.8	12.4	12.2	7.4	18.5	30.7	7.0	14.7	11.8	10.9	5.7	18.9	12.9	25.0	20.1	8.5	15.4	5.9	21.3	1.7	9.0	14.3	11.3	15.6	9.0	8.4	20.8	15.6	15.1	15.3	7.5	12.0	10.0	7.9	5.7	14.8	15.2	12.2	10.3	30.5	11.9	9.9	3.7	11.8	14.0	7.2	7.5	117.6	9.9	19.6	10.6	28.6	25.8	15.5	12.8	8.7	22.7	13.0	6.3	10.2	10.9	0.0	5.6	8.8	75.6	36.0	22.0	15.2	26.4	14.0	10.0	9.4	14.4
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225890	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 168.9;skeletal muscle: 262.4;tongue: 202.6"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.0;Cardiomyocytes: 262.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"	Nucleoplasm	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favorable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	26.0	13.1	23.0	17.1	26.2	18.2	18.0	28.5	27.7	13.7	27.8	27.1	34.5	12.2	10.4	29.3	19.8	26.9	168.9	24.2	19.5	20.1	15.3	24.1	22.8	24.4	30.3	8.5	13.1	32.2	17.7	15.3	21.6	15.4	25.4	96.7	44.1	13.1	262.4	45.1	42.0	16.8	19.1	22.2	61.0	12.1	26.0	17.9	31.4	202.6	22.6	33.8	18.4	21.4	22.2	19.2	37.9	16.4	25.6	24.9	48.9	29.5	33.5	19.0	20.6	12.8	30.7	43.9	15.1	75.2	20.4	10.7	26.5	68.8	20.6	39.6	18.8	30.4	19.9	35.6	12.8	34.6	22.9	21.4	28.9	41.9	38.0	28.1	38.6	11.6	15.7	34.4	24.4	9.2	3.7	18.1	16.4	60.4	14.8	16.1	14.1	36.8	26.3	165.3	23.8	27.9	11.3	16.3	16.2	31.4	14.6	29.3	39.6	16.6	19.2	99.0	17.4	25.7	23.0	38.9	18.2	30.2	16.4	0.9	1.3	0.5	0.6	2.4	0.5	2.4	0.9	0.7	1.5	3.6	0.3	0.9	0.6	1.0	1.4	2.5	0.4	0.7	23.0	26.2	28.5	27.7	24.2	19.5	24.4	30.3	21.6	19.1	26.0	21.4	27.4	32.1	32.4	173.0	23.9	38.0	16.3	32.1	30.1	22.7	18.5	17.7	262.0	24.3	38.1	14.7	100.1	23.0	13.9	61.4	1.9	10.8	1.1	53.3	21.8	23.9	22.8	6.5	62.0	12.3	18.3	14.0	81.1	70.0	10.8	11.5	6.8	10.3	15.7	33.7	81.3	39.5	26.4	15.7	33.4	3.0	1.8	23.3	24.9	97.4	17.9	27.8	4.1	105.1	64.8	24.2	37.1	2.6	5.4	18.5	97.9	10.2	80.6	139.9	32.9	15.9	29.9	1.0	3.9	27.5	43.2	15.7	7.5	4.6	35.6	27.0
TRAK2	"ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98"	ENSG00000115993	"Trafficking kinesin protein 2"	O60296	2	201377207-201451500	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 157.8;Erythroid cells: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015827, HPA062163"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA015827: AB_1858238, HPA062163: AB_2684702"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (7.42e-5)"	"unprognostic (1.48e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.82e-3)"	24.1	20.3	53.2	16.4	63.7	52.2	14.8	61.2	60.9	16.1	55.6	22.4	13.4	14.3	13.0	16.7	13.9	18.7	70.9	47.3	54.0	23.7	14.1	20.7	17.3	92.9	67.6	9.7	15.4	26.6	12.4	23.7	86.8	12.8	22.8	20.1	26.4	15.2	14.8	8.1	16.1	20.4	99.9	18.1	12.2	7.8	69.7	12.4	34.9	26.8	13.6	15.7	9.0	102.2	11.6	15.5	9.4	34.3	61.6	87.4	10.6	39.2	32.8	27.4	31.9	24.4	9.8	7.1	16.3	50.6	26.4	11.2	20.0	12.9	43.5	21.4	13.0	15.5	25.6	15.9	33.8	12.3	18.4	48.4	10.8	28.8	22.2	27.5	40.4	11.0	12.4	26.9	55.8	16.6	9.6	6.9	10.6	11.3	32.7	12.1	24.9	10.6	21.9	15.6	18.6	24.0	21.0	15.5	63.6	13.6	12.4	12.4	50.2	44.2	16.6	31.0	25.7	16.2	30.2	8.3	37.2	18.2	24.4	2.6	5.5	6.2	7.8	7.0	7.3	9.3	10.1	6.7	4.3	14.2	6.9	7.3	3.4	11.1	6.5	2.3	12.6	6.0	53.2	63.7	61.2	60.9	47.3	54.0	92.9	67.6	86.8	99.9	69.7	102.2	34.0	16.0	29.8	37.5	17.8	8.3	3.4	6.3	11.4	45.4	14.4	8.8	157.8	22.8	13.4	9.2	73.0	10.3	9.3	27.9	7.9	13.9	1.9	12.7	20.9	21.0	29.5	181.0	92.3	14.7	4.8	16.9	10.7	25.7	19.6	10.3	15.0	14.3	10.6	77.4	75.6	20.6	10.2	12.9	7.7	3.8	8.1	13.2	26.6	22.5	14.2	5.1	12.3	47.7	57.0	10.7	14.5	12.8	16.8	5.7	21.7	8.9	14.9	22.1	13.1	23.2	23.3	9.4	12.8	16.2	4.1	5.6	16.6	18.7	24.5	7.2
TRANK1	"KIAA0342, LBA1"	ENSG00000168016	"Tetratricopeptide repeat and ankyrin repeat containing 1"	O15050	3	36826819-36945057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 45.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 56.5;Granulosa cells: 73.0;Inhibitory neurons: 91.8;Microglial cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 115.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 115.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 67.9;HMC-1: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035508	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA035508: AB_10671105"	"unprognostic (7.11e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.04e-3)"	"unprognostic (9.13e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.07e-3)"	7.4	4.6	1.7	14.0	2.5	10.0	6.4	5.2	7.5	24.6	0.0	14.8	11.1	18.0	5.2	3.2	45.0	9.6	6.2	1.8	2.3	3.4	9.9	8.8	18.7	1.9	0.5	15.6	2.4	3.2	6.7	5.2	1.8	16.5	13.4	1.4	6.8	6.3	1.1	2.3	16.7	8.8	3.4	13.1	8.2	2.4	3.3	17.5	6.2	2.5	20.8	16.6	10.0	0.7	1.4	1.7	0.4	0.0	4.5	17.9	0.0	1.4	9.1	3.9	8.0	0.0	7.2	67.9	2.8	5.3	13.5	0.5	0.2	1.0	0.7	3.7	0.1	11.6	4.8	0.0	5.5	3.1	26.1	5.7	3.5	3.1	0.2	1.1	5.4	7.6	9.5	9.9	2.4	0.1	8.9	1.3	0.5	0.0	1.9	2.5	0.3	1.4	1.5	3.3	0.6	0.0	7.2	1.9	0.7	0.8	1.2	3.8	3.7	3.4	1.3	0.2	1.2	9.3	2.2	15.8	0.6	2.6	0.4	7.3	2.0	11.5	14.9	2.9	10.7	10.9	12.3	15.3	1.4	17.5	11.0	10.6	115.1	8.5	3.9	0.2	11.6	3.0	1.7	2.5	5.2	7.5	1.8	2.3	1.9	0.5	1.8	3.4	3.3	0.7	5.4	16.0	7.8	18.3	18.8	0.8	1.3	1.7	6.8	4.4	1.6	2.3	3.6	1.5	4.0	3.7	2.1	1.3	16.5	40.9	0.0	3.1	0.4	6.1	15.1	5.5	5.4	12.6	56.5	1.8	1.6	7.1	18.8	8.8	6.3	73.0	5.7	17.7	5.0	0.0	91.8	16.7	0.0	6.6	0.8	0.0	4.4	7.4	5.4	52.5	8.7	1.6	26.8	23.6	13.2	3.2	16.9	6.0	21.9	1.6	16.7	0.9	5.2	0.7	0.0	2.6	5.2	0.3	0.3	2.6	0.9	0.7	21.8	3.7	4.0	1.5
TRAPPC12	"CGI-87, TTC-15, TTC15"	ENSG00000171853	"Trafficking protein particle complex 12"	Q8WVT3	2	3379675-3485094	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 96.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 293.9;Late spermatids: 504.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034799, HPA043196"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA034799: AB_10600920, HPA043196: "	"prognostic favorable (1.80e-5)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (9.15e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.18e-2)"	21.7	26.0	13.9	10.9	14.4	10.1	21.8	15.0	23.3	20.2	13.5	27.9	10.1	23.7	6.3	23.0	22.2	10.4	46.7	14.8	15.9	22.6	28.0	17.1	16.0	15.9	14.1	21.4	26.2	18.4	26.7	6.6	17.1	20.6	4.7	9.1	25.8	10.0	45.8	35.7	21.2	5.2	14.6	22.1	28.4	96.6	14.8	15.7	24.7	6.4	5.0	26.1	18.9	15.5	16.4	28.0	9.1	10.4	19.9	24.5	23.9	26.6	6.5	7.6	4.2	17.5	13.6	18.8	28.6	9.0	6.7	20.8	10.5	11.9	3.1	22.8	39.5	16.2	8.1	60.8	9.0	20.4	28.0	18.1	9.0	8.5	21.2	5.8	6.7	21.5	25.5	10.0	13.5	22.5	20.6	34.9	22.1	7.3	39.4	15.4	12.4	15.3	8.1	13.5	23.2	37.8	10.6	11.8	18.5	4.0	13.9	16.3	17.2	18.6	10.6	18.7	23.6	28.5	22.4	15.0	21.8	15.9	10.5	0.7	1.0	3.8	0.8	2.5	2.0	0.5	1.3	2.2	1.4	0.5	0.8	1.0	1.0	0.9	3.6	4.3	2.5	0.8	13.9	14.4	15.0	23.3	14.8	15.9	15.9	14.1	17.1	14.6	14.8	15.5	18.8	9.6	12.8	59.4	20.7	11.5	16.2	15.1	14.2	31.8	13.7	16.0	68.4	21.5	11.2	12.9	33.3	21.3	16.9	17.1	58.7	21.7	293.9	20.3	16.4	18.5	3.5	19.1	56.2	18.0	15.2	23.7	23.0	14.5	5.7	22.3	11.0	16.0	25.9	26.9	62.5	17.7	14.2	17.9	10.0	504.5	26.4	20.7	16.0	30.0	28.5	42.6	15.5	52.3	56.4	23.9	11.9	24.0	19.6	16.0	20.3	30.0	19.4	42.0	26.3	20.9	21.7	125.2	26.3	18.8	17.8	17.6	14.4	33.8	15.7	12.2
TRAPPC13	"C5orf44, FLJ13611, MGC48585"	ENSG00000113597	"Trafficking protein particle complex 13"	A5PLN9	5	65625004-65666233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037777	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"		"HPA037777: AB_10672464"	"unprognostic (3.66e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.25e-2)"	10.0	11.5	7.8	8.9	8.4	8.0	12.8	9.1	9.9	10.6	7.0	10.8	9.3	10.8	9.1	12.4	8.9	9.3	16.8	8.3	9.4	20.0	14.7	10.5	10.8	8.7	8.8	7.6	7.3	22.7	8.8	10.4	8.8	18.7	13.3	16.6	9.1	10.9	13.4	5.8	9.1	12.9	9.1	9.9	10.0	10.6	8.7	16.6	17.3	16.8	10.8	12.1	7.0	10.4	20.7	13.6	21.0	38.2	15.8	20.2	20.7	23.8	21.2	29.1	31.2	11.8	28.7	21.3	25.5	19.5	31.0	18.8	24.0	25.0	33.9	14.6	17.8	13.4	15.3	11.1	21.7	16.6	19.3	14.5	19.2	22.7	28.8	17.5	25.8	30.0	16.2	19.1	26.3	21.9	27.3	6.4	9.5	11.9	7.4	23.7	26.9	24.0	20.8	23.2	25.4	19.2	29.3	17.4	22.2	11.6	25.7	20.8	17.8	10.2	14.0	22.6	24.4	12.6	26.3	34.0	21.3	28.9	19.8	17.6	8.3	3.6	8.4	9.3	11.0	5.8	8.1	7.0	9.0	4.7	7.9	7.9	3.1	8.9	13.4	6.7	9.3	9.1	7.8	8.4	9.1	9.9	8.3	9.4	8.7	8.8	8.8	9.1	8.7	10.4	10.4	19.2	10.5	27.1	7.4	5.7	6.8	17.3	6.2	13.3	8.5	5.5	7.1	12.8	13.1	7.3	10.4	12.1	13.0	7.6	15.6	12.9	24.6	7.9	7.6	11.9	15.5	12.0	54.7	10.8	9.6	9.1	11.2	7.6	3.8	9.8	8.2	11.2	12.4	13.5	44.2	8.9	26.4	13.9	7.7	10.2	7.5	9.6	7.2	28.1	11.1	14.8	11.3	46.3	66.5	10.3	6.3	13.2	8.9	11.8	11.0	25.2	13.4	16.2	6.6	8.7	8.3	16.4	8.6	9.1	6.8	15.2	12.0	10.2	8.7	11.9
TRAPPC2	"hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L"	ENSG00000196459	"Trafficking protein particle complex 2"	P0DI81	X	13712244-13734635	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004665, HPA063308"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"CAB004665: AB_425678, HPA063308: AB_2684982"	"unprognostic (1.97e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (2.13e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.35e-4)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.89e-5)"	6.0	5.7	12.5	6.7	13.4	7.6	6.8	13.1	14.2	10.0	10.7	10.9	6.0	11.0	6.3	8.4	9.4	5.5	5.3	13.3	13.9	7.4	8.2	7.5	12.7	12.1	11.2	11.2	9.2	5.2	7.7	5.3	12.5	8.3	6.4	10.2	7.3	5.1	4.4	7.4	9.6	8.8	10.2	10.3	9.7	3.2	14.9	9.0	7.8	2.7	11.8	8.9	9.9	11.8	9.1	6.2	10.5	26.1	8.0	5.9	3.7	8.5	7.8	6.7	6.9	5.8	11.0	14.8	13.2	6.9	8.8	11.0	13.8	12.4	8.6	15.3	20.4	11.3	16.0	5.2	6.4	15.9	20.8	8.0	7.0	14.7	17.1	13.4	6.3	11.1	15.0	26.3	7.3	16.0	16.0	21.7	10.6	7.2	11.4	15.3	14.3	14.6	10.8	5.5	10.6	13.6	14.5	12.1	11.0	16.3	13.5	10.6	7.9	6.7	6.2	11.4	5.5	13.3	13.8	19.6	6.0	10.5	6.4	19.3	6.0	11.0	18.1	8.4	18.2	13.2	14.3	17.8	5.5	12.8	11.8	16.6	11.7	22.9	6.9	13.0	18.7	11.1	12.5	13.4	13.1	14.2	13.3	13.9	12.1	11.2	12.5	10.2	14.9	11.8	8.9	9.6	6.5	7.8	22.0	15.2	10.0	14.8	9.6	16.5	16.5	13.6	11.0	15.7	14.6	9.2	12.5	14.1	49.8	14.6	21.5	10.0	17.7	17.3	11.0	9.3	12.1	12.4	20.7	13.4	19.9	11.5	14.8	21.2	9.5	16.9	16.8	12.2	11.6	20.2	20.2	14.0	8.2	12.9	14.4	6.1	12.8	13.6	8.8	10.3	12.0	8.8	44.3	31.7	17.3	15.7	18.6	11.3	17.6	9.8	15.4	23.8	8.5	14.5	6.6	8.6	18.5	4.3	4.0	11.3	17.6	17.9	28.8	16.6	13.2	12.5
TRAPPC2B	"MIP-2A, SEDLP, SEDLP1, TRAPPC2P1"	ENSG00000256060	"Trafficking protein particle complex 2B"	P0DI82	19	57363551-57365405	"Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063308			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"HPA063308: AB_2684982"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.39e-2)"	15.0	20.6	8.3	6.8	8.8	10.6	14.2	10.6	11.5	7.9	9.5	13.0	5.0	10.6	11.0	12.5	9.8	9.8	19.5	8.5	9.5	12.5	11.0	10.4	12.3	8.4	8.6	12.8	7.3	10.8	14.9	10.8	9.0	10.1	5.7	8.6	10.9	6.7	30.2	11.6	8.6	9.2	8.2	13.3	9.5	23.2	8.9	15.2	12.2	17.0	10.7	12.4	8.5	8.6	16.9	11.9	18.0	12.0	16.2	18.9	16.2	11.5	25.9	16.6	48.6	6.4	12.5	13.0	15.3	14.9	28.3	6.1	8.4	18.5	17.8	5.9	60.8	13.0	18.7	14.6	16.7	14.3	20.9	18.9	23.1	12.6	9.4	19.1	12.5	14.5	4.1	0.1	19.5	5.0	22.1	13.0	6.0	1.2	25.3	10.7	17.0	20.2	18.8	26.7	18.8	15.4	10.9	12.5	11.1	15.9	18.7	18.1	13.9	15.8	13.7	7.7	18.6	20.5	27.8	25.4	22.7	9.1	16.0	68.4	23.5	30.8	12.0	22.2	24.6	45.1	25.3	20.2	26.5	48.5	24.4	19.5	27.7	44.1	20.9	37.9	24.6	22.4	8.3	8.8	10.6	11.5	8.5	9.5	8.4	8.6	9.0	8.2	8.9	8.6	38.9	9.6	13.1	0.0	13.2	0.0	0.0	0.0	0.0	0.0	21.7	28.2	26.1	0.0	9.9	18.4	0.0	38.1	16.3	0.0	25.4	32.9	0.0	29.3	13.4	15.4	0.0	0.0	0.0	22.1	18.3	10.3	0.0	25.7	21.5	18.2	0.0	0.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	11.9	0.0	0.0	0.0	0.0	28.7	0.0	0.0	4.4	0.0	0.0	17.0	13.1	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	91.9	11.7	32.7	0.0	0.0
TRAPPC9	"IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120"	ENSG00000167632	"Trafficking protein particle complex 9"	Q96Q05	8	139727725-140458579	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 89.5;Excitatory neurons: 121.8;Inhibitory neurons: 136.3;Late spermatids: 119.0;Microglial cells: 105.9;Oligodendrocyte precursor cells: 93.5;Oligodendrocytes: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026579			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA026579: AB_1854459"	"unprognostic (1.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.11e-6)"	"unprognostic (2.09e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.62e-1)"	8.6	13.4	10.3	6.9	11.0	11.1	8.9	10.7	12.7	10.3	12.5	11.1	8.0	11.3	5.1	12.3	12.2	5.8	15.0	10.8	10.3	13.8	11.6	9.5	8.0	13.1	14.1	10.5	11.9	27.4	20.7	7.2	13.9	11.7	6.0	14.2	11.6	8.3	33.5	11.4	10.9	7.2	10.2	11.3	12.5	9.0	11.9	11.3	12.9	17.6	6.8	11.1	10.8	13.0	9.6	16.6	7.4	20.8	15.5	9.0	4.9	6.0	9.9	3.1	5.0	6.2	11.2	11.6	14.0	11.9	4.7	12.2	10.0	9.4	3.4	16.8	6.1	18.6	9.8	6.2	11.2	4.7	14.5	8.9	9.3	2.5	7.9	11.1	12.9	13.1	6.7	10.1	5.1	27.0	29.2	6.2	2.3	31.3	14.0	12.2	2.7	19.4	11.6	11.6	19.1	10.6	9.8	4.7	10.6	7.6	15.3	6.8	7.7	4.6	7.9	10.8	4.9	14.1	10.9	7.8	9.6	10.1	7.4	15.4	3.5	2.9	4.2	3.3	4.6	2.7	2.9	3.3	3.5	4.4	2.8	3.6	5.0	4.9	3.4	4.2	2.1	3.5	10.3	11.0	10.7	12.7	10.8	10.3	13.1	14.1	13.9	10.2	11.9	13.0	5.1	3.2	8.3	89.5	9.6	2.3	4.7	3.1	5.7	14.2	5.5	4.1	13.9	5.7	5.3	11.0	20.9	10.9	5.4	15.2	9.8	6.5	47.9	8.4	3.7	6.5	30.5	3.4	121.8	6.2	4.4	5.3	29.6	10.2	8.8	7.9	4.6	9.2	7.5	28.6	136.3	14.4	10.2	10.5	3.7	119.0	5.9	10.3	10.6	105.9	5.3	13.6	11.3	93.5	170.6	5.1	6.6	7.9	11.0	3.7	13.4	19.9	15.7	13.7	6.6	9.0	5.3	3.6	6.6	8.7	3.0	14.6	10.5	8.6	12.0	5.4
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.9;Inhibitory neurons: 111.4;Microglial cells: 52.5;Oligodendrocyte precursor cells: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 144.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	3.4	5.7	1.3	5.8	2.2	13.9	2.6	1.1	3.8	7.7	0.0	3.7	3.2	6.0	2.9	8.8	5.1	3.9	1.8	0.8	0.6	2.9	1.0	2.9	7.7	0.3	0.7	7.1	1.6	3.9	3.5	2.6	0.0	5.4	3.4	2.0	2.3	3.6	1.1	6.4	4.7	3.9	0.2	7.2	4.2	6.0	1.6	10.3	2.0	1.2	5.0	7.0	8.0	0.8	13.7	9.4	10.3	13.2	4.7	10.4	14.5	10.2	16.2	11.4	9.4	0.1	7.1	12.7	2.2	15.5	15.6	16.2	13.2	12.6	9.1	144.3	1.0	13.7	8.0	0.0	3.2	25.4	42.1	4.3	17.3	10.2	4.1	10.3	0.0	8.5	0.1	4.1	5.0	3.0	6.6	42.9	11.3	10.1	9.6	11.8	0.8	4.7	6.7	16.7	8.3	4.4	6.1	0.2	1.0	5.6	5.9	34.1	4.5	6.5	7.5	10.7	2.9	1.7	9.5	13.7	4.4	22.7	0.1	1.1	0.6	4.6	1.5	0.2	1.4	0.2	1.1	1.3	0.7	0.0	0.9	1.0	2.0	1.5	0.1	0.6	1.2	0.7	1.3	2.2	1.1	3.8	0.8	0.6	0.3	0.7	0.0	0.2	1.6	0.8	2.7	3.2	1.3	37.9	3.6	8.3	2.9	3.2	6.2	9.9	4.1	2.5	1.9	1.5	5.9	5.5	0.0	3.4	20.9	8.4	0.0	1.8	2.7	3.3	16.2	5.4	3.0	0.4	96.9	1.0	0.9	11.8	11.2	1.7	12.0	14.7	6.4	0.3	2.6	8.4	111.4	2.1	4.1	4.7	10.4	3.2	14.0	8.0	3.6	52.5	7.9	4.2	12.3	80.4	3.8	1.2	2.5	22.2	7.2	1.6	1.0	0.2	8.5	0.5	26.3	4.4	7.9	10.0	7.4	23.5	7.4	1.2	18.0	4.2	3.8	4.3
TRIAP1	"HSPC132, MDM35, P53CSV, WF-1"	ENSG00000170855	"TP53 regulated inhibitor of apoptosis 1"	O43715	12	120443964-120446384	"Predicted intracellular proteins, Transporters"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053640	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA053640: AB_2682213"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.87e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.97e-2)"	21.8	24.6	16.6	18.9	16.8	32.9	28.4	17.1	23.0	16.6	18.0	24.6	19.2	14.1	20.8	22.9	17.2	15.4	19.4	16.8	17.5	21.1	66.4	16.8	24.8	16.9	16.7	12.1	52.5	14.7	12.3	29.1	17.1	20.1	30.5	8.8	25.3	15.3	60.4	27.0	18.5	20.9	17.2	16.3	19.6	13.2	16.9	25.7	15.7	39.1	27.5	24.1	15.6	18.2	56.2	75.1	67.4	46.3	57.5	88.1	161.0	71.8	51.2	62.5	51.6	63.2	30.4	110.0	59.6	59.2	25.0	37.4	79.3	118.6	65.8	49.1	88.5	66.9	48.7	167.9	85.4	113.6	49.6	91.6	146.7	61.4	87.0	62.3	131.1	59.8	109.3	27.7	92.1	70.3	86.0	152.7	96.5	67.9	60.4	70.4	63.5	114.4	81.1	62.0	66.3	43.2	82.7	28.1	64.6	105.7	93.9	65.6	74.8	40.0	60.7	40.7	44.1	70.6	120.6	118.5	61.5	86.9	71.2	26.7	47.1	18.2	41.0	52.7	48.8	35.1	39.2	39.0	59.1	31.8	48.3	43.1	4.0	49.6	36.5	53.1	37.3	45.0	16.6	16.8	17.1	23.0	16.8	17.5	16.9	16.7	17.1	17.2	16.9	18.2	25.8	3.2	15.2	3.6	30.5	51.2	28.5	108.2	44.3	10.6	35.9	44.1	12.1	45.8	36.0	7.3	6.2	128.5	29.4	16.9	66.5	48.4	8.3	22.4	27.7	34.3	22.1	23.7	3.9	50.4	91.2	23.1	15.3	16.4	17.2	34.9	24.3	63.3	52.0	3.3	2.9	22.6	40.7	23.3	27.6	5.7	16.4	19.1	39.2	1.0	48.0	15.4	44.3	3.0	4.7	43.2	20.7	18.4	19.8	37.7	30.1	49.4	25.4	9.5	19.7	18.9	27.3	34.5	31.4	45.6	71.3	75.4	28.3	47.0	39.5	28.9
TRIB2	"GS3955, TRB2"	ENSG00000071575	"Tribbles pseudokinase 2"	Q92519	2	12716889-12742734	"Enzymes, Predicted membrane proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 104.3;Muller glia cells: 100.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 48.8"	"Group enriched"	"Detected in many"	8	"B-cells: 12.2;NK-cells: 19.3;T-cells: 48.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 183.5;HEL: 185.7;K-562: 258.0;SK-MEL-30: 189.3;WM-115: 246.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001305	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"HPA001305: AB_1080371"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.31e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.13e-2)"	43.3	63.1	29.1	38.9	29.9	16.8	38.3	36.1	35.2	21.7	30.5	27.0	17.8	44.4	43.4	15.5	23.4	28.8	51.0	31.6	37.7	92.3	21.0	39.8	72.7	31.4	30.8	97.8	26.2	18.0	20.0	46.6	29.7	33.0	13.4	137.8	20.4	25.6	14.3	16.9	25.2	34.2	29.7	79.7	41.8	28.5	32.4	39.3	23.9	19.5	69.6	48.4	19.5	28.0	0.2	0.4	138.8	183.5	48.9	44.7	0.2	7.9	7.5	4.9	7.9	0.9	15.3	16.3	5.5	16.9	0.8	2.3	10.3	16.1	4.2	18.3	28.9	185.7	0.4	2.7	60.7	10.7	68.0	41.7	16.0	20.3	5.6	48.9	22.1	23.8	258.0	0.3	7.9	1.7	24.4	44.8	66.1	7.0	18.0	0.0	46.2	6.7	31.9	23.4	118.9	56.6	1.1	7.4	189.3	41.4	0.2	1.1	13.9	65.3	32.0	0.6	17.8	0.1	0.2	22.9	35.2	36.3	246.7	1.7	0.2	3.2	12.7	0.0	15.8	9.6	26.1	13.8	1.2	12.2	15.0	9.2	0.5	19.3	0.2	0.1	48.8	8.9	29.1	29.9	36.1	35.2	31.6	37.7	31.4	30.8	29.7	29.7	32.4	28.0	52.2	3.2	8.3	25.5	12.5	6.1	9.1	26.9	19.4	55.0	7.9	8.6	17.1	12.8	15.6	16.5	31.3	2.6	17.5	0.7	7.9	17.2	4.3	9.7	11.6	43.9	0.0	22.1	13.5	104.3	0.2	11.3	20.9	15.9	34.2	77.3	59.6	6.7	5.8	20.2	6.9	0.4	28.5	5.1	8.2	14.3	77.3	3.8	30.2	13.1	3.0	100.3	26.8	59.8	2.7	45.3	0.2	74.4	21.0	11.6	0.3	1.0	17.9	66.7	52.6	9.9	41.2	1.0	6.0	5.7	5.4	0.8	27.1	30.5	0.8	32.5
TRIB3	"C20orf97, dJ1103G7.3, TRB3"	ENSG00000101255	"Tribbles pseudokinase 3"	Q96RU7	20	362835-397559	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 80.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 53.1;Hepatocytes: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 630.3;hTCEpi: 401.9;hTERT-HME1: 461.8;SK-MEL-30: 615.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015272, HPA055442"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA015272: AB_1858269, HPA055442: AB_2682818"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (1.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.07e-13)"	"unprognostic (7.62e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.05e-3)"	8.0	16.4	5.6	4.0	5.4	16.1	7.8	6.0	6.7	4.4	6.5	4.4	1.3	2.9	3.0	20.5	2.2	2.6	4.0	5.1	6.5	9.9	80.5	15.4	6.5	5.5	5.5	3.2	17.3	13.3	15.2	8.4	5.6	7.8	2.2	2.7	10.4	3.0	1.8	13.6	5.3	1.8	4.4	12.1	10.2	1.4	6.7	5.6	38.2	0.5	5.9	4.8	5.3	4.4	80.9	41.6	5.1	11.9	13.7	17.9	33.7	23.9	65.8	23.0	47.5	86.7	40.0	35.3	22.2	22.5	102.3	62.6	22.6	107.7	21.4	12.4	16.2	27.5	8.9	144.2	630.3	71.5	12.7	73.3	401.9	43.5	461.8	16.2	45.1	86.1	97.3	155.2	2.3	77.3	4.2	87.0	11.8	122.8	133.0	15.2	7.1	77.1	27.0	33.3	14.7	23.0	5.6	192.2	615.5	7.2	55.7	185.6	24.6	11.7	20.6	0.3	36.2	52.3	73.9	63.5	10.5	61.4	43.6	5.1	6.4	1.4	13.2	4.9	9.4	21.0	12.3	15.3	6.7	13.8	13.7	9.8	4.4	10.2	2.6	2.8	9.7	7.8	5.6	5.4	6.0	6.7	5.1	6.5	5.5	5.5	5.6	4.4	6.7	4.4	7.9	3.2	1.5	0.3	9.3	6.8	10.9	20.3	3.4	6.8	12.7	8.3	1.6	11.5	8.5	1.8	4.2	14.1	4.0	3.4	0.0	53.1	0.0	0.2	1.6	15.8	1.2	5.7	2.2	22.7	6.4	3.9	0.0	2.6	5.1	0.5	6.8	38.4	6.4	0.0	3.1	8.8	6.1	3.3	4.4	0.0	1.8	3.0	7.2	0.0	4.2	1.0	14.4	1.0	0.6	24.0	1.9	1.5	10.0	12.2	0.0	0.1	2.9	7.0	6.6	6.5	6.9	2.4	3.1	4.0	5.4	7.1	5.7	3.5	2.2	6.7
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406835	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: AB_2678711"	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	10.2	12.1	12.7	8.9	16.0	30.7	10.4	23.9	15.2	14.7	10.1	13.6	7.7	11.5	4.5	20.7	12.7	6.1	8.7	14.4	11.6	12.2	10.2	11.8	12.2	11.6	9.9	11.9	11.9	6.7	9.8	5.6	10.8	15.4	7.1	2.0	17.1	7.0	5.0	17.1	14.6	4.6	8.6	24.1	12.9	14.9	13.2	10.1	11.0	3.1	8.7	11.7	15.6	11.0	28.3	26.3	13.8	19.1	10.2	8.4	65.1	18.1	12.1	20.5	16.4	32.2	24.0	21.1	19.7	12.2	13.5	45.1	16.8	17.4	8.6	23.6	40.5	17.5	26.7	17.6	27.6	22.2	25.6	11.3	27.2	21.3	10.6	10.5	10.2	33.9	40.7	26.4	10.7	18.2	27.1	35.1	35.3	23.9	22.9	26.3	12.5	25.8	13.4	34.0	22.9	42.0	15.1	42.2	24.7	5.6	29.9	36.8	11.6	13.0	18.3	30.6	37.9	26.9	19.3	18.9	16.1	17.7	20.9	5.2	4.5	5.6	5.5	5.3	5.9	3.7	6.4	7.1	4.4	3.5	3.6	5.1	6.2	6.2	7.5	3.5	6.4	3.9	12.7	16.0	23.9	15.2	14.4	11.6	11.6	9.9	10.8	8.6	13.2	11.0	7.8	3.2	5.8	1.6	12.1	15.8	16.3	7.4	10.8	12.1	13.3	10.7	3.6	12.8	10.4	1.8	2.1	15.7	21.6	28.1	17.6	14.8	154.2	11.2	10.2	10.1	14.4	12.6	9.8	11.0	15.5	8.5	23.4	17.1	5.7	13.4	8.9	5.7	11.8	5.0	4.7	21.7	4.1	12.6	9.3	16.5	9.6	11.0	5.4	2.8	22.0	10.3	30.9	3.0	3.2	18.3	21.1	7.5	12.8	17.4	17.8	9.9	7.3	1.6	6.6	8.4	9.1	7.3	12.4	15.8	19.5	57.3	18.9	14.9	17.6	30.1
TRIM21	"RNF81, RO52, SSA1"	ENSG00000132109	"Tripartite motif containing 21"	P19474	11	4384897-4393702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004566, HPA005673"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"CAB004566: AB_628286, HPA005673: AB_1080090"	"prognostic favorable (4.83e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.26e-6)"	"unprognostic (9.12e-3)"	14.1	13.0	6.1	21.6	6.0	27.7	11.9	5.9	8.0	11.9	7.2	17.1	20.3	12.5	13.0	12.0	14.6	12.9	13.1	5.5	6.8	16.3	17.6	23.5	23.8	8.2	6.3	20.6	11.7	6.8	7.1	14.4	7.0	11.3	18.4	2.4	19.5	12.9	5.5	11.4	19.2	17.9	7.8	32.5	15.5	3.5	7.8	21.8	10.0	8.2	23.2	16.7	10.9	7.2	13.5	15.5	7.7	7.3	15.5	23.1	10.7	16.8	31.7	64.6	71.4	7.2	37.6	20.5	7.5	25.0	66.5	18.4	13.6	25.7	20.1	34.5	14.6	31.6	8.5	6.5	34.3	37.3	29.6	22.7	14.9	13.0	9.2	23.3	40.3	17.3	10.1	21.6	21.9	11.9	19.8	26.5	6.6	14.9	8.0	13.8	10.0	10.9	25.6	12.0	0.1	3.3	13.8	14.9	19.1	12.0	5.3	24.5	36.7	15.6	12.3	8.3	6.1	11.4	9.5	13.0	14.0	29.2	11.5	105.2	132.4	311.9	89.3	139.6	78.6	50.2	76.6	81.1	109.5	57.9	67.6	71.7	354.0	78.0	130.9	36.7	100.1	175.2	6.1	6.0	5.9	8.0	5.5	6.8	8.2	6.3	7.0	7.8	7.8	7.2	8.9	9.6	6.3	0.0	6.4	2.0	6.1	7.5	11.4	0.4	2.7	3.2	2.3	12.8	9.8	5.5	0.0	6.8	11.0	12.8	7.9	11.3	0.1	3.7	4.5	7.8	2.4	8.2	0.2	8.5	9.6	5.7	10.2	5.7	12.6	8.1	9.7	8.7	9.6	1.7	0.1	7.3	0.0	11.9	2.2	1.3	4.4	9.6	1.8	1.9	20.7	2.6	22.6	1.0	0.1	9.7	4.7	7.2	4.0	4.3	10.0	4.9	7.9	0.0	13.1	4.7	5.3	0.3	0.8	4.7	1.7	9.0	10.5	4.5	6.0	3.8
TRIM22	"GPSTAF50, RNF94, STAF50"	ENSG00000132274	"Tripartite motif containing 22"	Q8IYM9	11	5689697-5737089	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 135.9;dendritic cells: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 174.6;BJ hTERT+ SV40 Large T+ RasG12V: 209.9;HSkMC: 190.6;TIME: 153.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003307, HPA003575"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA003307: AB_1080381, HPA003575: AB_1080378"	"unprognostic (1.47e-2)"	"unprognostic (5.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.16e-2)"	54.0	21.3	13.1	101.3	18.8	90.3	50.7	16.3	23.7	42.7	25.5	36.0	25.2	50.6	70.2	37.1	49.3	78.6	22.6	14.7	16.5	21.2	72.5	83.4	139.0	17.9	16.7	60.3	17.2	8.0	12.6	21.5	16.7	43.3	53.4	11.0	65.4	52.6	13.4	18.1	53.4	52.1	17.7	143.1	39.5	15.4	12.8	101.2	21.7	40.6	120.7	61.6	22.6	29.3	2.8	1.2	13.9	2.4	88.6	174.6	5.0	53.3	93.9	89.8	209.9	1.7	8.6	111.9	13.0	80.2	20.6	10.5	34.0	56.4	10.7	2.0	0.0	6.4	5.6	1.4	107.8	18.2	11.4	190.6	54.3	18.7	9.6	124.5	128.7	1.0	2.3	4.7	111.6	1.5	54.1	16.9	40.3	0.5	4.9	62.6	3.4	2.3	51.1	14.9	1.4	2.7	4.5	4.5	2.1	56.8	4.5	17.9	153.6	56.4	29.8	2.5	2.4	4.9	4.4	11.2	67.7	28.9	7.2	108.7	118.5	79.6	109.0	143.3	145.9	149.4	118.4	117.2	138.7	158.2	106.5	102.7	103.1	61.3	181.1	177.0	197.9	181.9	13.1	18.8	16.3	23.7	14.7	16.5	17.9	16.7	16.7	17.7	12.8	29.3	54.4	67.3	57.7	2.0	135.9	12.6	17.0	42.5	56.3	0.5	17.7	14.0	6.0	7.2	60.5	29.5	0.0	1.5	113.9	4.7	5.9	11.2	0.3	16.1	27.0	40.5	4.2	16.8	4.9	8.0	4.7	36.2	20.9	23.8	17.7	5.4	33.5	4.3	18.7	1.7	0.3	9.0	30.5	87.1	46.6	2.0	36.1	67.8	5.4	52.5	59.0	6.4	83.4	1.0	0.5	5.4	6.3	30.1	18.8	9.9	4.4	3.3	52.5	1.0	13.1	35.1	24.4	0.6	0.3	14.1	8.7	2.3	89.3	13.0	5.0	18.8
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460259-138589996	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"AF22: 146.5;HMC-1: 196.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic favorable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	7.5	25.7	6.0	6.9	6.8	10.6	9.1	5.8	7.0	6.4	5.2	8.1	10.0	8.8	8.4	9.0	5.7	5.3	10.4	6.0	7.1	8.0	23.1	11.4	8.0	6.8	6.4	30.0	10.8	14.2	3.8	12.3	6.3	11.7	9.2	12.2	8.3	5.2	13.9	8.6	9.7	7.6	6.2	7.2	11.6	27.3	8.2	17.3	9.1	16.4	7.8	7.5	6.1	9.0	15.0	18.1	146.5	42.7	9.6	8.9	11.4	13.7	14.4	10.5	10.2	28.7	13.6	28.7	13.2	13.2	21.5	7.9	71.9	11.4	15.4	22.1	17.7	63.1	13.1	88.9	13.1	49.8	196.8	7.9	11.8	8.8	13.9	7.3	25.0	15.4	72.6	17.1	12.7	29.2	85.2	44.8	56.3	77.6	16.0	66.5	17.3	24.2	23.6	43.9	30.3	68.8	25.5	22.6	7.5	50.6	15.5	32.3	10.7	12.1	9.9	21.4	19.1	15.6	18.2	47.8	20.1	32.1	18.0	0.3	0.6	1.0	0.5	0.6	0.1	0.2	0.4	0.3	0.5	0.3	0.4	0.5	0.9	0.6	0.3	0.3	0.7	0.2	6.0	6.8	5.8	7.0	6.0	7.1	6.8	6.4	6.3	6.2	8.2	9.0	29.0	51.3	46.9	26.1	9.5	13.9	13.4	13.8	10.8	13.6	14.7	14.4	39.7	20.0	18.8	7.3	16.7	28.4	14.9	12.2	5.9	7.1	70.4	16.7	22.9	18.9	10.1	31.3	27.9	12.4	15.2	16.0	20.4	25.2	40.4	85.2	14.3	31.9	10.3	40.4	46.6	10.9	14.2	9.5	14.9	38.7	14.0	13.8	14.2	21.5	12.2	23.3	9.2	64.3	67.1	9.5	9.5	16.1	13.7	12.2	6.8	10.6	14.5	22.4	13.1	21.5	17.6	72.8	14.7	22.2	11.8	22.2	15.8	34.6	19.4	12.8
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56836387-56914080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 23.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 23.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	16.3	20.7	9.8	19.8	10.4	47.7	13.1	9.5	23.2	14.5	11.1	19.7	19.4	12.1	8.5	20.4	18.2	9.7	11.1	9.0	11.3	11.9	29.8	25.0	17.3	10.3	9.9	14.3	16.7	13.0	10.3	9.5	10.3	9.3	17.3	11.8	15.3	7.4	12.6	29.2	20.2	12.4	11.4	41.6	17.0	9.1	12.1	18.5	10.8	7.6	19.7	12.1	14.6	9.0	77.2	37.4	9.0	30.7	66.6	55.8	0.1	29.6	59.6	69.4	59.3	36.7	41.1	74.6	59.8	28.6	75.4	44.5	44.5	39.9	38.5	64.1	35.0	48.1	29.0	41.0	57.0	58.2	33.2	25.1	65.7	36.2	76.4	32.9	46.7	50.2	12.0	43.8	35.8	51.3	65.6	41.9	5.8	63.3	71.5	46.3	30.2	47.4	40.5	59.7	17.5	16.3	23.3	37.1	69.7	5.8	50.3	46.8	31.3	32.2	23.1	50.1	31.2	24.7	51.1	12.1	31.2	39.4	13.0	4.8	3.0	1.2	1.0	2.5	1.3	2.2	0.9	1.0	3.1	1.7	0.7	1.0	23.5	1.1	1.8	2.2	2.0	1.1	9.8	10.4	9.5	23.2	9.0	11.3	10.3	9.9	10.3	11.4	12.1	9.0	27.3	35.3	19.8	7.5	12.7	18.5	8.5	10.5	13.1	9.9	12.6	11.9	7.5	20.0	16.6	9.2	29.2	5.4	15.1	54.8	0.0	19.1	3.5	44.9	20.0	32.7	18.6	11.1	4.1	21.6	10.7	16.0	32.6	72.5	3.8	23.0	32.2	30.9	14.8	3.3	8.2	28.7	6.1	27.5	24.6	2.1	9.6	29.3	14.2	8.4	28.3	5.7	11.3	12.1	0.3	32.2	54.2	9.4	17.7	21.6	20.0	8.0	18.5	22.2	6.6	13.1	9.2	0.4	0.3	24.5	30.5	15.9	11.5	45.3	25.7	25.4
TRIM26	"RNF95, ZNF173"	ENSG00000234127	"Tripartite motif containing 26"	Q12899	6	30184455-30213427	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044975, HPA050456"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA044975: AB_2679162, HPA050456: AB_2681133"	"unprognostic (1.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.82e-2)"	"prognostic favorable (3.25e-5)"	15.6	16.5	3.6	6.9	4.4	4.5	16.3	4.5	7.1	15.8	3.7	17.9	5.6	16.8	2.9	28.9	16.4	4.9	12.5	3.3	4.9	18.1	26.1	16.8	6.6	4.7	4.0	12.5	15.5	4.2	14.1	2.9	4.3	18.2	2.3	4.2	21.0	3.2	14.5	20.8	19.8	1.1	3.6	18.0	17.6	11.5	4.8	3.9	17.6	1.3	6.6	17.8	17.4	4.9	15.7	8.3	0.0	23.8	8.1	4.6	7.8	9.7	5.4	11.4	11.6	0.0	0.9	38.2	13.0	12.4	17.0	17.6	0.0	16.8	3.5	0.0	13.0	6.1	2.5	16.7	7.1	13.3	5.4	4.6	5.7	11.9	7.1	0.0	7.6	18.4	2.8	0.0	0.0	0.0	19.1	17.8	0.0	0.0	6.7	16.9	15.1	5.3	9.8	14.5	0.5	11.0	18.5	0.9	5.2	5.0	8.0	2.3	16.5	8.7	5.8	0.0	0.2	15.1	31.2	18.1	0.0	21.3	15.0	0.5	1.5	0.1	1.8	1.9	1.2	1.0	1.2	1.5	1.2	1.4	0.7	1.0	0.5	0.7	1.6	0.5	1.6	1.3	3.6	4.4	4.5	7.1	3.3	4.9	4.7	4.0	4.3	3.6	4.8	4.9	13.5	28.9	21.7	18.3	23.8	30.1	22.4	13.1	34.7	20.1	22.0	18.0	13.5	18.6	15.7	12.9	16.7	18.6	31.1	21.8	11.7	16.1	0.5	25.7	15.1	16.2	22.3	1.7	16.5	15.9	14.4	12.7	17.9	34.7	5.1	12.2	9.3	52.9	13.8	13.5	25.1	15.4	6.1	17.3	25.7	1.6	7.5	21.0	17.8	18.7	24.0	12.1	21.6	18.1	26.9	13.6	15.7	12.0	26.3	20.2	17.1	15.8	24.4	19.7	6.6	10.7	12.1	5.0	13.4	42.0	34.0	17.6	28.7	9.4	17.2	22.3
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923988	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	23.8	28.1	1.8	7.2	1.7	1.1	23.3	1.1	2.6	33.0	2.2	23.0	8.7	24.5	0.0	20.5	31.0	0.5	24.3	1.6	1.3	32.7	59.5	26.8	2.2	2.2	2.1	30.8	53.0	0.6	33.8	4.5	1.8	35.1	0.6	0.1	25.8	6.5	21.2	17.6	26.8	2.3	1.5	45.8	27.3	14.4	2.0	0.9	26.3	0.0	1.0	28.7	22.6	2.0	2.4	8.2	1.2	21.7	2.8	6.2	0.3	16.1	0.8	5.1	6.2	6.1	1.7	1.6	1.1	4.8	1.3	17.5	4.0	9.2	0.5	1.3	2.6	20.3	2.5	9.3	4.3	2.0	5.7	0.1	1.0	4.1	1.3	0.6	4.5	5.8	2.1	12.1	1.3	4.9	11.1	0.9	0.0	3.4	13.5	20.1	4.6	49.7	3.9	2.3	4.9	18.7	19.9	11.6	4.1	0.6	11.6	12.2	13.1	6.3	9.3	14.7	5.1	31.7	2.7	17.9	6.8	24.8	20.0	5.2	4.4	2.5	7.0	12.5	11.3	7.0	10.6	5.5	8.5	1.8	4.1	7.6	2.7	6.4	7.0	5.6	5.2	9.9	1.8	1.7	1.1	2.6	1.6	1.3	2.2	2.1	1.8	1.5	2.0	2.0	21.4	16.0	24.8	11.8	32.2	28.4	41.9	27.4	33.6	11.7	32.2	24.6	18.3	24.3	24.0	29.5	16.7	46.4	25.4	15.9	21.5	39.5	12.9	27.1	27.0	32.0	27.6	24.6	13.5	43.4	55.5	25.5	26.5	27.2	21.5	36.9	27.8	42.1	41.1	8.4	13.4	38.5	26.4	28.3	23.5	6.8	23.9	29.0	8.8	16.9	46.5	10.4	29.9	19.1	19.7	48.9	18.7	18.4	51.2	53.3	19.3	27.6	23.9	13.6	19.7	14.8	31.0	8.0	16.1	25.8	19.6	45.6	28.9	43.7	28.3	30.9
TRIM28	"KAP1, PPP1R157, RNF96, TF1B, TIF1B"	ENSG00000130726	"Tripartite motif containing 28"	Q13263	19	58544064-58550722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 2817.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010066, HPA064033"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		140000	"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB010066: AB_2209905, HPA064033: AB_2685179"	"unprognostic (2.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (1.20e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.28e-2)"	103.1	111.0	83.5	103.8	85.9	217.5	104.4	91.1	100.1	152.9	77.5	159.9	90.8	163.3	42.8	132.6	142.8	73.6	114.7	83.1	80.1	122.1	104.6	103.5	142.5	85.5	83.4	228.1	183.7	89.4	98.7	108.9	89.1	128.8	57.8	39.4	108.4	108.8	172.4	143.3	117.7	94.6	86.0	137.4	136.7	215.5	82.8	186.6	117.9	77.0	109.2	147.7	115.1	97.2	481.6	1080.4	491.9	365.1	218.9	186.5	616.5	321.5	291.1	311.4	237.0	732.8	375.0	562.5	196.1	270.7	492.8	317.7	590.5	480.5	163.6	281.3	2817.1	1012.8	407.6	537.7	254.4	640.9	577.5	252.4	248.2	385.9	274.9	220.1	301.3	597.7	507.1	259.4	284.8	705.0	756.5	640.8	372.8	443.6	637.5	761.9	340.9	550.2	260.8	730.6	517.1	403.4	343.9	359.3	170.7	131.9	273.2	493.1	272.4	643.1	273.2	148.6	562.5	397.7	665.7	604.7	293.0	432.9	418.6	1.9	9.7	8.2	12.8	11.1	17.2	15.9	18.0	17.4	13.7	19.1	22.8	20.5	4.3	24.9	7.9	21.2	12.4	10.1	83.5	85.9	91.1	100.1	83.1	80.1	85.5	83.4	89.1	86.0	82.8	97.2	60.8	12.8	18.6	18.3	51.0	64.2	60.2	34.7	47.3	61.8	86.6	87.5	9.5	51.5	29.0	33.1	27.1	61.2	72.4	88.3	23.5	44.8	96.9	70.7	53.3	49.7	64.6	46.7	10.3	56.3	61.6	48.3	65.7	80.2	21.6	136.3	35.7	31.9	46.9	55.5	12.6	79.4	14.2	36.5	70.7	110.6	65.9	48.3	28.4	6.5	32.8	49.8	19.6	10.6	18.2	56.3	50.0	41.3	43.5	52.1	47.3	36.3	28.7	34.1	59.2	69.3	61.6	158.7	83.1	58.0	60.7	56.1	54.5	80.9	94.1	45.6
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111286-120185529	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 600.1;skin 1: 551.2;vagina: 269.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 272.0;Basal squamous epithelial cells: 250.4;Late spermatids: 150.3;Squamous epithelial cells: 552.9;Suprabasal keratinocytes: 460.6;Urothelial cells: 159.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 399.9;HBEC3-KT: 107.5;hTCEpi: 476.0;RT4: 190.5;SiHa: 268.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"spinal cord: 4.0"	"HPA020053, HPA074841"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA020053: AB_1858280, HPA074841: "	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	2.5	1.0	0.1	0.4	0.2	0.4	41.7	0.0	0.4	133.8	1.6	3.0	1.7	2.6	4.8	600.1	17.4	3.5	0.4	0.3	0.0	1.7	1.8	3.7	0.0	1.8	0.6	0.4	1.0	0.0	8.1	30.7	1.8	31.4	2.6	0.3	131.5	23.7	2.2	551.2	1.0	1.5	2.6	0.3	1.4	2.7	0.0	19.9	0.4	0.2	107.2	55.8	269.1	0.6	34.4	2.5	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.2	0.1	0.8	25.6	0.2	3.9	0.2	0.5	399.9	0.0	107.5	0.0	0.1	0.0	0.2	25.4	0.4	0.0	0.2	0.5	0.0	476.0	0.0	2.6	0.0	0.0	0.0	0.2	0.7	0.0	4.4	0.0	0.0	0.1	11.4	0.1	0.0	0.3	0.0	0.3	190.5	1.3	5.9	268.3	35.2	0.1	0.2	1.9	0.0	0.4	0.1	2.1	0.2	0.1	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.3	0.0	1.8	0.6	1.8	2.6	0.0	0.6	0.5	0.0	1.5	3.3	0.2	272.0	106.1	76.4	250.4	0.0	9.5	58.8	1.2	1.5	39.2	0.0	0.0	41.0	0.2	11.3	0.0	5.0	28.1	8.7	0.8	3.4	2.4	0.0	0.5	4.3	7.1	5.6	1.1	3.6	1.3	0.0	0.0	0.4	5.0	0.0	0.1	2.1	12.2	0.0	30.3	150.3	0.6	1.4	23.2	1.0	0.0	0.0	0.0	0.0	0.1	57.1	11.3	0.0	0.0	66.0	0.2	0.6	64.6	0.0	0.0	0.1	4.9	0.8	2.6	552.9	460.6	24.8	2.4	0.1	3.7	159.3
TRIM33	"FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA"	ENSG00000197323	"Tripartite motif containing 33"	Q9UPN9	1	114392790-114511203	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 115.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004345	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoplasm	"HPA004345: AB_1858287"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.09e-2)"	"unprognostic (8.42e-3)"	"prognostic favorable (8.93e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	9.3	8.1	10.1	10.7	11.3	25.4	13.5	18.3	16.9	12.5	8.2	9.5	8.8	15.2	29.8	11.7	9.1	10.9	8.9	11.5	9.9	13.5	12.2	10.9	13.3	8.0	9.1	14.4	12.2	15.3	7.3	16.0	8.2	12.6	10.1	18.8	10.7	11.0	8.8	14.8	8.9	11.8	8.1	12.7	11.2	25.3	9.5	17.8	14.2	10.7	12.8	11.5	9.8	11.3	30.9	16.3	30.1	22.6	12.5	13.1	51.0	15.4	16.3	20.9	22.1	18.5	12.8	32.8	15.5	18.1	13.6	17.4	27.6	18.0	28.6	24.9	16.4	31.6	21.7	21.6	13.8	40.3	25.3	12.5	12.9	24.9	25.2	16.0	17.8	27.3	40.1	22.5	20.2	115.4	40.9	17.0	40.7	11.7	16.3	34.8	45.9	10.8	14.9	47.7	20.8	21.9	29.2	34.7	27.4	19.3	15.8	21.7	20.1	14.5	23.4	33.8	21.7	15.7	15.6	33.4	20.4	23.0	42.0	13.2	1.2	6.1	2.5	1.5	2.2	3.0	2.6	2.7	1.5	1.4	2.0	3.1	3.6	4.1	2.4	3.0	1.6	0.8	10.1	11.3	18.3	16.9	11.5	9.9	8.0	9.1	8.2	8.1	9.5	11.3	31.0	19.2	33.3	70.5	35.4	52.8	28.9	28.6	25.6	75.6	35.9	23.9	29.2	30.0	32.3	55.2	98.0	64.9	53.9	33.3	1.9	21.0	237.3	50.4	37.5	33.2	52.1	37.9	120.7	23.6	34.0	28.7	30.1	90.0	37.4	55.6	40.7	44.3	29.6	26.9	108.5	30.4	30.5	50.3	47.9	97.9	49.0	37.2	19.6	79.6	42.9	31.5	54.6	116.6	101.8	31.4	34.9	36.9	31.6	47.3	26.6	17.3	31.4	58.3	32.9	38.3	32.5	60.0	31.9	31.2	55.4	87.7	42.8	48.1	31.2	55.3
TRIM35	"HLS5, KIAA1098, MAIR"	ENSG00000104228	"Tripartite motif containing 35"	Q9UPQ4	8	27284886-27311272	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 68.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019647	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA019647: AB_1858291"	"unprognostic (7.67e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.61e-2)"	"unprognostic (9.64e-3)"	"unprognostic (9.35e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (8.79e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.86e-2)"	"prognostic favorable (5.59e-7)"	"unprognostic (1.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.92e-1)"	9.4	6.1	6.5	5.9	8.2	7.2	8.4	8.1	9.2	8.9	13.7	7.9	5.5	8.8	4.5	10.7	7.4	3.6	5.5	8.9	6.8	6.3	11.9	5.9	6.9	10.0	7.7	6.1	5.9	4.6	4.2	5.3	9.7	7.3	3.9	4.1	16.3	9.0	5.0	32.2	6.2	7.2	6.7	6.2	5.9	6.4	9.8	8.1	4.6	4.6	7.0	8.2	10.4	11.7	17.4	12.3	7.0	9.0	68.4	16.9	16.1	10.3	8.1	9.4	10.0	17.6	3.4	15.3	10.3	11.5	8.3	17.0	10.1	19.9	7.1	8.7	7.6	15.1	10.3	15.1	17.8	8.3	12.4	24.6	44.2	13.3	26.1	5.0	9.4	14.5	10.8	16.4	7.7	9.0	27.8	11.3	12.3	11.1	9.8	13.8	9.0	13.3	6.4	13.5	11.9	11.4	8.6	8.1	14.3	6.7	5.2	13.2	10.9	8.5	17.7	27.1	10.2	7.5	8.5	11.1	12.1	12.0	8.5	11.9	3.0	4.0	8.6	3.0	9.7	5.3	11.2	9.7	3.8	3.8	7.5	11.2	1.1	8.9	3.4	6.4	14.5	5.3	6.5	8.2	8.1	9.2	8.9	6.8	10.0	7.7	9.7	6.7	9.8	11.7	9.4	3.2	4.5	5.2	4.4	20.9	6.0	4.6	40.9	3.5	3.6	2.7	5.0	8.6	3.8	12.9	6.2	3.5	3.2	3.6	0.0	3.7	1.0	4.0	3.7	6.7	2.4	8.6	8.3	5.1	2.8	6.6	6.1	4.6	5.7	3.8	23.9	20.3	2.9	5.0	5.3	2.7	6.1	8.9	6.2	0.6	12.8	6.9	7.2	3.7	5.2	3.5	3.1	4.5	16.8	4.7	2.0	10.9	4.8	3.6	4.5	6.1	0.9	3.5	0.0	3.4	5.5	1.3	3.9	15.0	22.3	1.5	6.9	2.4	3.5	2.5
TRIM36	"HAPRIN, RBCC728, RNF98"	ENSG00000152503	"Tripartite motif containing 36"	Q9NQ86	5	115124762-115180546	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 44.2;testis: 174.3"	"Group enriched"	"Detected in many"	26	"Early spermatids: 2120.7;Late spermatids: 4980.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 5.8;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	48	"dendritic cells: 5.8;granulocytes: 3.2;monocytes: 6.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 24.5;SCLC-21H: 28.3;SH-SY5Y: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061321			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA061321: AB_2684479"	"unprognostic (6.36e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.33e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.82e-13)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.80e-3)"	0.5	1.3	13.2	1.6	16.7	0.5	4.4	3.9	14.2	2.4	8.7	7.5	14.1	0.9	0.6	0.3	2.2	0.5	0.2	16.1	15.7	0.3	0.4	1.8	0.3	17.0	10.5	4.7	1.6	0.2	13.4	1.1	16.1	10.0	7.5	44.2	0.5	0.6	0.2	0.6	13.8	0.8	10.2	0.5	4.6	174.3	12.7	0.7	0.2	0.4	0.4	0.4	1.3	20.0	3.6	0.9	1.6	8.4	0.2	0.1	2.0	0.7	2.8	1.5	1.7	1.2	1.7	0.0	1.4	0.1	11.9	1.1	7.9	1.5	1.1	0.6	2.7	6.0	3.3	1.7	0.3	6.0	4.8	0.1	1.4	0.7	2.0	1.9	0.1	11.2	0.2	7.9	2.3	4.6	1.6	5.4	6.7	0.6	3.8	1.3	24.5	1.9	0.9	0.1	28.3	19.6	5.3	0.5	3.2	0.8	5.8	7.4	0.7	2.3	1.8	1.7	2.7	1.2	0.8	0.0	2.5	3.4	1.1	0.0	1.2	3.2	0.0	1.3	0.0	0.0	0.0	0.0	5.8	0.1	0.0	0.0	0.3	0.0	6.5	1.2	0.0	0.6	13.2	16.7	3.9	14.2	16.1	15.7	17.0	10.5	16.1	10.2	12.7	20.0	0.4	0.0	3.4	1.0	0.1	2.3	0.6	0.2	0.6	5.0	14.8	9.3	2.3	0.0	0.5	1.8	56.3	0.0	1.8	27.6	0.0	0.4	2120.7	3.3	0.3	2.0	3.5	0.0	39.7	1.8	0.5	1.4	6.6	1.1	1.3	0.1	0.4	0.0	2.8	5.0	14.0	15.8	2.0	1.9	18.1	4980.3	14.9	6.0	8.8	29.0	3.4	6.9	0.0	2.5	53.4	1.5	20.4	12.8	0.1	12.1	28.2	0.2	5.0	76.8	6.6	2.0	2.3	136.2	26.9	1.2	1.3	0.3	0.7	0.1	8.8	0.2
TRIM42	"FLJ40097, PPP1R40, T4A1"	ENSG00000155890	"Tripartite motif containing 42"	Q8IWZ5	3	140678064-140701150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	41	"testis: 16.7"	"Group enriched"	"Detected in some"	118	"Early spermatids: 245.8;Late spermatids: 157.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003581, HPA022481"			Uncertain	Nucleoplasm,Mitochondria		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA003581: AB_1080383, HPA022481: AB_1858301"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	245.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM49D1	"TRIM49D, TRIM49D1P, TRIM49DP"	ENSG00000223417	"Tripartite motif containing 49D1"	C9J1S8	11	89911111-89921767	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	285	"basophil: 28.5"	"Lineage enriched"	"Detected in single"	285	"granulocytes: 28.5"	"Not detected"	"Not detected"											HPA072153			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"				Nucleoplasm	Cytosol	"HPA072153: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM49D2	"TRIM49D2P, TRIM49L, TRIM49L1"	ENSG00000233802	"Tripartite motif containing 49D2"	C9J1S8	11	89924064-89933063	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	186	"basophil: 18.6"	"Lineage enriched"	"Detected in single"	186	"granulocytes: 18.6"	"Not detected"	"Not detected"											HPA072153			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"				Nucleoplasm	Cytosol	"HPA072153: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM56	RNF109	ENSG00000169871	"Tripartite motif containing 56"	Q9BRZ2	7	101085481-101097967	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024358	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA024358: AB_1858308"	"unprognostic (6.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.44e-3)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.63e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.13e-4)"	13.6	11.3	12.9	14.4	13.9	6.7	12.9	11.7	12.2	14.8	12.6	11.8	11.7	13.5	13.4	12.4	14.8	7.5	9.9	10.4	11.5	12.9	10.8	17.7	15.4	17.0	13.8	19.0	10.1	9.6	8.6	8.9	14.0	14.8	9.7	2.0	14.0	13.0	11.9	15.7	14.7	8.5	12.7	21.4	12.4	3.8	14.2	12.9	12.7	6.7	12.4	12.6	13.4	16.8	16.4	20.1	8.5	10.9	19.1	19.7	10.2	13.4	11.7	21.2	19.6	9.6	23.0	19.2	14.0	11.1	29.3	18.4	3.5	12.3	14.2	19.2	5.5	12.2	28.9	7.1	17.1	21.6	26.4	12.6	17.3	13.8	22.4	20.7	11.2	12.2	21.6	23.7	14.8	22.4	18.3	24.0	8.5	8.8	16.7	16.8	13.9	12.7	11.1	16.9	0.4	0.3	14.8	40.8	11.6	10.8	9.3	14.0	21.6	29.4	26.1	22.4	14.4	11.7	12.4	14.7	14.6	17.2	23.6	1.7	1.2	1.2	1.8	0.8	1.4	1.1	1.4	1.2	0.4	1.6	1.3	1.7	3.9	4.1	1.2	1.1	0.7	0.6	12.9	13.9	11.7	12.2	10.4	11.5	17.0	13.8	14.0	12.7	14.2	16.8	62.5	73.7	82.7	3.3	45.7	5.2	82.2	6.7	28.5	3.1	30.4	27.2	21.7	108.7	32.8	51.5	2.1	41.6	45.4	51.9	3.9	61.4	2.1	60.8	53.7	80.6	29.1	43.5	0.1	48.1	25.7	40.0	33.1	42.5	15.2	129.9	114.5	48.1	19.3	10.1	0.1	40.9	4.1	48.7	4.5	5.2	132.3	33.3	1.8	8.4	60.0	20.4	141.1	2.5	3.6	56.9	45.4	94.4	24.9	79.9	76.5	11.4	51.0	4.0	65.7	76.7	38.9	5.4	7.2	15.9	3.3	29.8	44.3	64.5	41.1	60.5
TRIM60	"FLJ35882, RNF129, RNF33"	ENSG00000176979	"Tripartite motif containing 60"	Q495X7	4	165016458-165041749	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 1.5;testis: 1.5"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 5.1;Early spermatids: 3.0;Extravillous trophoblasts: 10.6;Spermatocytes: 9.6;Spermatogonia: 8.2;Syncytiotrophoblasts: 5.6"	"Cancer enriched"	"Detected in single"	103	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 14.2"	"Not detected"	"Not detected"							"HPA035809, HPA035810, HPA061496"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540"															"unprognostic (1.10e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.3	0.2	0.3	0.2	0.3	0.0	0.4	0.5	0.9	0.7	0.0	0.1	0.0	0.0	5.1	0.6	0.0	0.0	0.0	3.0	0.8	0.9	0.7	0.0	0.0	0.2	0.0	10.6	0.3	0.0	1.5	0.0	0.2	0.0	1.1	0.5	0.0	0.3	0.0	0.0	1.3	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	0.7	0.3	0.0	0.1	0.8	0.5	0.0	0.0	0.3	9.6	8.2	0.0	0.3	5.6	0.7	0.2	0.0	0.1
TRIM65		ENSG00000141569	"Tripartite motif containing 65"	Q6PJ69	17	75880335-75896951	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021575, HPA021578, HPA064820"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359"	"unprognostic (1.82e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.74e-6)"	"unprognostic (5.36e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.86e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-3)"	"unprognostic (7.50e-3)"	13.0	7.8	12.5	8.5	15.2	7.4	10.7	15.3	13.5	15.5	11.0	14.1	8.8	14.7	6.8	14.2	13.1	7.1	10.3	11.5	13.2	11.2	8.4	12.9	10.5	15.0	14.6	14.1	15.7	7.4	11.8	5.4	14.8	11.7	7.9	7.2	12.6	8.1	13.2	14.6	13.5	8.3	13.8	16.6	11.3	3.9	14.5	6.5	12.2	6.9	8.2	14.6	14.0	17.0	19.8	20.2	7.8	22.2	13.5	19.2	4.0	8.3	8.9	11.1	9.4	9.1	17.0	21.4	6.5	7.2	15.6	13.7	16.8	18.6	6.8	11.1	28.9	16.9	20.4	12.5	13.4	17.2	18.9	12.0	14.4	8.9	16.0	9.3	29.2	27.2	29.3	19.5	8.7	20.6	38.0	33.7	17.7	20.0	19.5	31.3	11.2	30.9	11.2	8.2	16.1	14.9	11.4	21.3	22.7	9.7	21.2	24.2	14.5	26.6	13.5	13.3	16.9	17.9	7.4	6.2	16.2	32.2	11.8	1.4	1.1	1.8	1.9	1.0	2.2	1.4	1.4	1.9	0.9	2.0	1.5	1.5	1.1	1.9	0.6	1.3	1.3	0.6	12.5	15.2	15.3	13.5	11.5	13.2	15.0	14.6	14.8	13.8	14.5	17.0	8.4	6.4	4.8	13.1	7.5	2.9	5.7	2.4	3.4	19.0	3.7	3.0	4.3	5.7	3.4	9.2	12.5	0.9	9.0	3.6	1.9	3.2	0.4	2.8	9.2	8.2	0.0	9.5	4.5	3.4	3.6	6.6	7.1	4.0	7.0	8.6	5.7	3.8	8.9	5.0	5.9	6.6	6.1	5.4	9.3	0.5	13.7	6.9	8.8	3.7	4.9	6.3	3.1	6.6	9.3	5.3	2.9	9.4	5.8	5.1	4.8	5.9	1.8	12.9	0.0	9.3	5.2	0.8	2.9	6.7	3.7	0.5	8.5	6.4	5.9	2.8
TRIM66	"C11orf29, KIAA0298, TIF1D"	ENSG00000166436	"Tripartite motif containing 66"	O15016	11	8612037-8682694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.7;Early spermatids: 46.0;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027420	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA027420: AB_1858316"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.79e-2)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (1.67e-1)"	"unprognostic (4.26e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.31e-1)"	4.4	5.9	4.5	4.0	5.6	2.8	4.6	2.8	4.6	3.9	5.2	4.4	3.5	3.8	8.2	5.2	4.2	3.0	2.4	3.0	5.1	4.9	10.9	3.6	5.3	4.1	5.4	3.6	8.9	3.1	9.5	1.5	4.0	4.2	4.6	3.6	4.3	3.3	3.6	11.9	5.5	3.5	3.3	5.7	5.4	17.3	5.4	4.5	6.2	3.1	5.2	4.2	4.2	3.6	5.3	4.9	2.9	10.2	6.0	4.5	3.6	3.2	3.7	2.2	2.9	6.5	9.9	5.2	2.2	2.9	2.1	7.2	3.1	2.8	2.7	6.1	2.4	5.0	9.2	3.6	2.5	4.5	3.9	7.1	2.8	1.9	6.6	2.4	2.9	13.1	2.7	5.5	2.9	5.8	2.1	3.4	1.8	2.7	4.6	3.0	2.2	2.1	3.1	6.7	2.1	2.0	4.6	3.2	2.2	2.8	4.2	1.0	2.3	4.2	3.8	2.5	2.8	2.3	3.7	6.4	2.8	4.6	2.4	0.0	0.5	0.6	0.7	0.1	0.4	0.6	0.7	0.9	0.7	0.8	0.7	1.1	0.3	0.8	1.3	1.3	0.6	0.3	4.5	5.6	2.8	4.6	3.0	5.1	4.1	5.4	4.0	3.3	5.4	3.6	3.0	3.2	5.6	47.7	4.0	1.8	2.3	3.6	2.2	8.0	5.1	5.6	1.9	4.3	5.1	5.5	12.5	3.6	3.1	4.5	0.0	3.4	46.0	5.0	4.0	3.2	6.0	5.7	14.2	3.2	1.8	2.6	5.1	3.7	1.3	6.7	5.0	9.8	2.6	11.8	17.1	4.2	0.0	5.2	2.2	27.3	1.8	3.8	0.0	13.1	5.9	4.3	3.1	9.5	22.6	3.9	3.9	2.2	3.1	1.6	8.3	2.4	5.4	9.0	13.1	6.5	2.5	14.6	7.2	3.8	1.1	1.4	3.3	8.0	4.4	1.0
TRIM68	"FLJ10369, RNF137, SS-56"	ENSG00000167333	"Tripartite motif containing 68"	Q6AZZ1	11	4598672-4608231	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023455	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Cytosol"		"HPA023455: AB_1858319"	"unprognostic (4.77e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (4.14e-6)"	"unprognostic (4.23e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"	5.1	6.5	6.6	3.7	7.0	2.1	6.4	7.2	7.2	9.6	6.3	7.1	6.6	6.5	7.2	5.0	7.6	5.1	7.2	6.6	7.0	9.7	7.4	6.6	5.2	6.6	6.9	10.1	6.2	8.9	6.3	6.2	6.8	10.7	6.2	5.8	8.3	8.1	5.9	4.8	6.0	6.0	6.8	6.8	8.0	6.5	7.3	6.5	9.6	6.6	5.8	7.0	5.3	7.2	10.2	11.2	4.5	8.2	7.2	11.6	0.0	10.9	8.0	9.9	8.9	1.4	10.3	6.9	6.5	5.6	9.3	11.6	4.5	7.7	8.4	17.2	8.8	8.4	2.9	0.0	8.3	13.7	11.4	9.1	11.1	5.7	8.6	10.2	12.6	6.3	8.0	3.7	8.9	2.4	11.3	3.7	5.4	7.1	9.2	9.0	6.4	0.3	6.3	4.4	2.4	4.3	0.0	11.0	7.1	9.0	4.8	6.8	10.3	13.1	8.8	13.3	5.0	13.7	15.9	9.9	8.9	6.0	12.5	8.6	2.5	8.9	7.9	4.8	8.8	8.5	8.8	8.9	5.6	7.6	11.1	9.0	0.3	5.7	5.5	3.8	8.7	7.4	6.6	7.0	7.2	7.2	6.6	7.0	6.6	6.9	6.8	6.8	7.3	7.2	3.2	0.0	3.6	2.9	2.8	0.8	1.4	2.7	3.4	3.3	2.6	2.4	5.4	2.8	5.9	5.5	2.1	6.1	2.7	5.3	5.9	3.2	0.9	2.6	2.2	3.4	6.7	1.3	1.7	3.3	2.7	2.9	4.6	2.8	3.8	5.9	3.6	6.0	2.2	0.0	1.6	5.2	6.1	2.1	0.6	0.4	1.8	2.0	0.0	1.9	2.7	4.1	5.2	3.5	3.0	3.3	1.9	1.9	1.8	2.0	2.4	2.5	2.4	2.8	6.6	2.0	2.6	2.9	6.6	2.0	1.0	4.4	2.8	3.9	4.7	0.6
TRIM7	"GNIP, RNF90"	ENSG00000146054	"Tripartite motif containing 7"	Q9C029	5	181193924-181205293	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 193.3;tongue: 51.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 17.8;Cardiomyocytes: 40.1;Squamous epithelial cells: 39.6;Suprabasal keratinocytes: 28.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 16.4;HDLM-2: 35.0;PC-3: 18.8;TIME: 16.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039213	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	"Nucleoplasm, Cytosol"	"HPA039213: AB_10795173"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.45e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-2)"	2.1	1.5	1.2	0.4	1.0	0.4	2.1	10.5	3.0	5.5	0.4	1.9	0.3	1.3	3.1	27.0	2.2	0.2	8.5	0.9	1.7	3.9	0.6	2.6	0.4	3.1	2.9	1.5	4.8	2.7	5.5	0.3	2.8	2.8	0.5	1.6	7.3	0.6	193.3	28.7	1.3	0.6	1.3	1.4	2.2	1.3	2.0	0.4	6.3	51.0	2.1	2.2	9.5	1.3	9.0	4.4	0.1	0.5	0.7	0.8	0.2	1.9	0.0	0.7	1.8	0.4	12.0	0.6	6.1	2.6	3.7	16.4	4.8	13.8	0.2	35.0	1.8	0.9	12.2	0.2	2.2	0.0	2.0	0.1	10.5	0.4	6.7	2.7	3.9	1.6	0.5	2.0	0.4	1.3	0.5	0.3	0.0	14.5	18.8	0.4	6.0	1.4	4.9	0.0	0.4	1.1	4.2	0.2	6.5	0.2	1.0	0.4	16.0	0.2	3.4	0.6	6.3	2.8	0.4	1.0	0.5	0.7	1.5	0.0	1.7	0.0	0.4	0.7	0.7	0.1	0.4	0.4	0.3	0.2	0.7	0.5	0.0	0.1	0.5	0.2	0.9	0.3	1.2	1.0	10.5	3.0	0.9	1.7	3.1	2.9	2.8	1.3	2.0	1.3	7.3	0.0	1.1	0.0	1.0	17.8	4.3	11.1	12.0	6.2	0.8	1.5	40.1	0.0	6.3	3.7	0.0	0.1	0.8	5.9	5.9	0.7	0.9	0.2	0.3	4.6	0.0	0.0	1.3	2.4	0.7	4.8	11.2	0.7	0.0	0.1	5.7	0.4	1.1	0.0	3.9	3.3	2.0	6.0	2.8	0.0	0.9	2.9	1.8	0.0	5.7	0.6	1.0	2.0	0.1	5.0	6.5	1.5	0.1	2.5	0.0	1.5	2.9	2.9	13.1	17.3	5.8	1.5	0.4	39.6	28.4	0.0	1.4	0.1	3.4	5.3
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214091-31231537	"Predicted intracellular proteins, Transporters"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 151.8;tongue: 43.0"	"Cell type enriched"	"Detected in many"	5	"Skeletal myocytes: 45.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.9"	"Region enriched"	"Detected in many"	7	"cerebellum: 9.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 7.2;LHCN-M2: 12.6;RH-30: 29.7;U-266/70: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	0.2	0.2	0.9	0.2	0.8	0.8	0.2	9.3	1.0	0.1	0.5	0.2	0.2	0.2	0.3	1.0	0.1	0.2	0.8	0.7	0.4	0.1	0.1	0.2	0.3	1.0	0.5	0.2	0.3	0.1	0.0	0.2	1.3	1.9	0.1	0.8	2.5	0.1	151.8	0.5	0.2	0.1	0.1	0.3	0.3	0.3	0.5	0.1	0.2	43.0	0.2	0.1	0.0	1.2	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.3	0.1	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.3	0.1	0.2	0.7	0.2	0.2	7.2	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.8	12.6	0.1	0.1	0.5	0.2	0.2	0.2	0.3	29.7	4.1	0.0	0.2	2.6	0.2	0.1	0.3	0.1	0.3	0.2	2.6	0.1	0.2	0.2	0.2	0.1	17.9	1.7	0.2	0.2	0.4	0.2	1.9	0.3	0.5	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.6	0.4	0.3	1.5	0.6	0.4	0.6	0.2	0.1	0.9	0.8	9.3	1.0	0.7	0.4	1.0	0.5	1.3	0.1	0.5	1.2	4.7	3.2	3.8	0.0	0.8	0.1	3.1	0.0	0.0	1.0	3.1	8.0	3.0	0.0	2.5	0.0	2.1	0.3	2.4	0.0	0.0	0.0	0.3	1.5	4.7	1.5	0.0	0.0	0.2	0.0	0.3	2.5	0.0	4.0	1.3	0.8	0.4	0.0	0.2	0.0	0.1	0.2	0.0	1.2	0.3	0.0	0.0	3.1	0.0	0.0	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.1	0.1	0.0	0.9	0.0	45.6	2.2	0.1	0.2	0.8	0.3	0.1	2.2	1.2	0.9	1.5
TRIM8	"GERP, RNF27"	ENSG00000171206	"Tripartite motif containing 8"	Q9BZR9	10	102644479-102658318	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023560, HPA023561"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA023560: AB_10600414, HPA023561: AB_10601861"	"unprognostic (4.32e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.36e-2)"	80.1	47.6	67.2	21.5	68.1	26.0	58.4	62.9	55.0	63.0	35.8	50.9	17.8	53.5	9.3	42.0	55.6	22.0	67.8	55.0	56.5	77.9	62.2	70.3	18.3	72.4	72.7	45.2	80.4	36.6	43.5	21.3	64.7	55.5	9.5	18.1	69.1	21.9	80.8	48.3	43.8	17.1	60.4	42.8	61.9	20.1	84.4	18.7	67.4	38.8	11.8	62.9	49.9	54.2	96.4	18.7	16.3	28.7	17.2	40.6	21.1	34.4	59.3	32.1	24.6	30.7	93.0	30.7	102.9	57.5	11.4	32.7	12.2	40.4	21.3	34.4	23.4	78.3	12.9	67.4	55.8	15.5	28.3	47.0	21.9	64.8	32.9	83.4	40.6	13.6	17.3	33.4	24.3	45.5	27.8	57.7	12.7	25.6	38.0	18.6	49.2	16.6	37.4	48.0	12.3	26.2	18.8	17.2	42.6	16.9	58.4	28.2	94.8	40.9	22.4	23.3	68.8	49.0	28.5	16.3	65.5	39.2	9.7	14.0	5.2	2.7	6.8	4.6	6.5	8.9	7.3	5.4	4.5	7.4	6.4	5.7	17.9	6.0	5.7	12.4	7.5	4.5	67.2	68.1	62.9	55.0	55.0	56.5	72.4	72.7	64.7	60.4	84.4	54.2	46.0	57.7	71.2	33.6	29.5	31.5	12.6	21.2	21.6	33.4	53.9	45.3	38.0	38.6	33.6	88.3	8.4	13.0	52.8	15.4	41.1	63.2	1.1	91.5	61.7	30.1	21.6	2.5	8.9	44.9	2.6	38.9	20.4	81.6	8.8	32.2	31.8	33.3	25.4	28.6	13.6	32.8	18.3	40.5	24.1	1.7	31.1	43.5	17.8	13.1	58.1	26.1	24.7	18.1	17.6	65.0	16.4	34.3	18.6	30.5	32.0	53.0	38.5	15.1	13.1	35.7	38.4	2.4	5.1	19.8	22.9	10.9	26.6	38.9	21.4	30.1
TRIP10	"CIP4, HSTP, STOT, STP"	ENSG00000125733	"Thyroid hormone receptor interactor 10"	Q15642	19	6737925-6751530	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 362.8"	"Cell type enhanced"	"Detected in many"		"monocytes: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 26.4"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 26.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041934, HPA072625, HPA073886"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		24000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Vesicles	Nucleoplasm	"HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244"	"unprognostic (5.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.19e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (6.73e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.93e-2)"	"unprognostic (8.83e-2)"	110.7	60.3	15.5	25.5	15.6	8.6	92.3	15.3	17.8	123.9	18.6	112.1	30.5	66.5	17.5	253.3	80.1	27.6	125.7	14.6	16.7	81.7	27.0	115.4	14.5	17.5	16.5	99.4	44.7	18.6	22.4	48.6	16.0	80.4	19.9	16.9	85.4	45.0	362.8	57.8	56.0	26.4	15.8	40.0	58.6	29.9	17.5	9.6	75.5	177.3	21.9	86.7	147.4	14.8	83.5	49.7	17.1	25.8	64.7	67.9	61.1	52.5	60.0	58.8	51.1	67.8	46.7	1.8	69.2	44.6	47.6	60.2	38.8	76.5	34.7	52.5	15.5	27.0	48.4	52.3	53.4	1.4	8.3	79.0	50.9	52.5	39.8	77.2	61.2	3.7	40.2	22.1	43.7	28.3	7.5	18.7	36.3	51.9	41.7	12.2	35.1	24.5	50.0	40.9	0.1	19.6	69.1	30.7	20.0	39.4	32.2	14.7	120.5	39.3	70.4	103.8	56.4	23.1	13.4	8.4	63.6	7.9	26.2	0.0	0.8	0.0	0.6	0.1	0.9	1.5	0.3	1.1	5.2	1.7	0.3	0.2	0.1	2.5	0.1	26.4	0.0	0.5	15.5	15.6	15.3	17.8	14.6	16.7	17.5	16.5	16.0	15.8	17.5	14.8	43.0	28.9	19.8	6.5	5.6	85.4	104.9	76.9	43.9	14.7	28.3	16.6	8.7	20.0	66.9	16.5	37.5	9.9	16.5	39.1	5.9	45.0	16.4	30.3	32.1	43.1	7.7	4.4	0.1	38.0	37.9	66.3	10.7	55.7	29.7	8.8	38.9	3.7	9.6	0.0	0.2	16.3	24.4	6.7	90.4	13.6	55.9	19.6	37.4	3.7	196.9	12.5	0.0	5.5	0.4	91.5	24.7	36.1	9.0	116.6	25.8	23.8	24.8	18.5	32.9	26.4	46.4	5.7	6.9	51.3	83.3	14.2	7.4	24.5	25.9	120.7
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: AB_2686295"	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	10.4	10.5	4.7	8.6	8.8	7.6	10.5	10.8	7.4	11.6	13.5	10.1	10.4	9.7	6.7	12.1	7.7	10.1	10.6	3.5	5.4	13.5	12.9	8.0	9.4	6.2	7.3	11.0	25.5	19.2	4.8	11.6	6.8	9.6	9.8	10.6	11.0	8.5	11.8	8.9	7.9	10.2	6.2	8.6	15.3	13.6	6.5	11.2	16.7	15.6	11.4	10.4	5.8	10.7	22.8	22.5	14.4	15.2	24.8	38.1	21.8	35.3	27.0	17.1	19.5	13.8	36.0	15.8	25.3	31.3	13.3	29.1	19.1	17.1	37.0	24.1	5.8	17.9	20.4	13.1	18.9	21.2	17.1	14.7	20.4	30.3	25.8	18.9	27.8	8.7	11.9	17.8	27.0	31.7	12.2	5.2	6.6	22.1	16.0	14.8	27.5	8.0	15.3	36.5	10.5	9.5	28.5	16.6	11.0	14.5	36.2	10.5	36.9	19.8	13.8	20.8	16.1	15.7	25.9	14.2	23.2	11.7	25.3	9.3	9.7	20.2	13.9	9.0	13.6	13.0	14.7	13.1	7.9	23.7	14.2	14.9	9.6	14.8	16.1	14.3	14.5	4.3	4.7	8.8	10.8	7.4	3.5	5.4	6.2	7.3	6.8	6.2	6.5	10.7	66.8	54.5	79.8	57.5	32.5	16.6	30.7	31.7	21.6	61.1	39.9	40.0	115.7	34.3	54.0	38.6	73.0	44.2	41.4	29.8	17.6	72.5	13.6	58.2	81.2	53.9	32.2	30.7	58.1	46.2	32.0	51.7	39.8	56.5	37.9	68.7	32.9	37.5	24.4	43.7	74.7	40.4	32.6	25.7	11.2	14.7	62.1	30.4	7.2	51.5	41.6	56.5	47.4	66.9	92.4	44.7	29.5	54.2	26.3	39.0	31.6	23.4	56.4	70.4	59.2	76.6	50.4	105.0	65.8	19.5	17.0	72.5	30.2	79.8	32.9	35.1
TRIP13	16E1BP	ENSG00000071539	"Thyroid hormone receptor interactor 13"	Q15645	5	892884-919357	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 29.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 115.4;Late spermatids: 206.9;Respiratory ciliated cells: 79.9;Spermatocytes: 86.4;Spermatogonia: 70.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005727, HPA053093"	Enhanced		Approved	Nucleoplasm		NA	NA		78000	"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA005727: AB_10603220, HPA053093: AB_2682042"	"unprognostic (1.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (2.34e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.44e-3)"	"unprognostic (1.73e-3)"	"prognostic favorable (1.39e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.34e-1)"	1.4	0.7	2.0	4.4	2.1	6.0	2.7	0.9	1.8	1.5	1.0	3.8	3.5	1.8	0.6	4.6	6.7	0.7	0.4	1.6	1.5	1.1	0.8	1.3	7.1	1.3	2.0	2.0	1.3	0.2	1.6	3.3	1.4	0.8	5.7	0.5	1.0	0.4	0.6	2.3	3.6	3.5	1.1	1.9	1.7	29.9	1.9	9.3	0.5	0.3	8.4	1.9	1.7	1.2	67.5	73.9	46.6	69.6	4.3	10.1	51.8	68.6	33.1	103.4	96.7	72.2	43.4	59.1	48.7	39.5	90.1	48.7	100.3	47.6	129.1	91.0	83.7	40.6	136.4	52.3	1.1	67.3	23.9	4.7	3.6	87.0	37.3	10.7	51.5	45.9	61.7	50.2	71.7	45.7	67.6	60.6	53.0	37.7	69.4	38.8	87.3	113.0	29.3	34.2	47.9	49.0	103.1	38.2	20.8	40.2	71.3	32.0	26.4	55.6	70.4	46.5	79.0	31.9	68.9	64.6	34.2	79.3	63.1	0.0	0.0	0.0	0.4	0.0	0.2	1.1	0.6	0.7	0.1	1.2	0.2	0.1	0.0	1.6	0.1	1.0	2.1	0.4	2.0	2.1	0.9	1.8	1.6	1.5	1.3	2.0	1.4	1.1	1.9	1.2	0.7	0.0	1.1	0.3	4.3	3.4	3.5	7.3	4.0	0.9	2.2	1.8	0.3	0.0	5.0	0.0	0.0	8.6	0.7	2.2	0.0	3.0	115.4	29.3	2.1	2.5	4.2	14.3	1.3	2.0	25.2	3.4	1.5	3.8	5.7	9.8	2.2	0.4	7.3	3.3	0.5	3.0	4.1	1.3	4.2	206.9	2.1	1.7	0.0	0.0	1.1	0.7	0.0	0.0	0.4	2.2	1.8	2.2	18.1	2.8	0.5	1.2	79.9	0.9	6.6	2.5	5.2	86.4	70.1	7.6	1.4	3.4	3.2	2.7	5.1	3.3
TRIP4	"ASC-1, HsT17391, ZC2HC5"	ENSG00000103671	"Thyroid hormone receptor interactor 4"	Q15650	15	64387748-64455303	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016605, HPA050666"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nuclear bodies"		"HPA016605: AB_1858339, HPA050666: AB_2681211"	"unprognostic (1.56e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (2.41e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.25e-1)"	14.9	12.4	13.6	13.3	14.7	15.3	17.1	14.1	20.6	13.0	14.9	17.1	17.1	13.2	11.6	19.4	14.1	11.0	15.5	13.7	14.0	27.5	14.3	15.0	16.4	14.4	14.2	13.1	16.6	20.0	13.0	16.9	14.8	12.7	19.2	16.8	13.3	12.1	8.9	18.0	17.9	16.5	14.2	16.6	15.6	12.0	14.5	19.8	25.6	9.2	18.7	17.7	14.7	15.6	18.6	27.1	23.3	16.7	18.9	24.6	21.8	19.3	24.7	32.7	31.5	22.8	40.5	13.3	6.3	29.4	26.6	25.7	38.3	22.0	30.9	27.0	10.9	19.4	19.2	24.1	33.5	21.2	35.1	30.9	28.2	25.9	27.0	18.7	28.9	19.2	22.7	16.2	30.4	21.2	13.5	21.3	13.7	32.7	14.4	20.4	17.7	22.2	31.6	35.1	12.6	19.8	17.3	20.7	35.3	43.5	26.2	31.3	25.7	23.2	15.8	15.6	27.7	13.5	25.9	13.5	19.2	21.4	29.6	70.1	22.2	54.3	20.8	29.1	17.7	16.0	19.7	21.2	20.5	16.3	16.6	17.3	30.9	21.2	42.4	16.2	23.3	16.9	13.6	14.7	14.1	20.6	13.7	14.0	14.4	14.2	14.8	14.2	14.5	15.6	12.7	22.4	13.2	15.3	10.0	8.4	9.6	23.3	2.2	11.1	7.6	7.1	10.3	7.2	18.1	12.9	12.5	22.2	20.1	15.3	13.7	25.2	20.4	21.7	10.7	13.2	11.4	9.9	32.5	27.1	26.8	10.2	10.2	16.2	19.6	12.3	10.0	4.4	21.7	15.2	25.8	8.2	24.4	12.9	7.6	3.7	11.8	15.3	14.2	22.5	27.5	10.0	27.8	18.1	30.9	33.6	10.5	12.8	6.5	6.0	13.5	44.6	26.7	17.3	6.6	9.0	15.0	19.3	21.4	5.4	6.3	24.2	14.4	12.1	8.1	7.8
TRIR	"C19orf43, fSAP18, MGC2803, TERCIR"	ENSG00000123144	"Telomerase RNA component interacting RNase"	Q9BQ61	19	12730640-12734684	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 390.7;Exocrine glandular cells: 381.0;Extravillous trophoblasts: 514.9;Proximal tubular cells: 510.1;Syncytiotrophoblasts: 579.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059965	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA059965: AB_2684182"	"unprognostic (5.57e-2)"	"unprognostic (2.73e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.02e-2)"	171.6	146.4	162.7	76.7	168.5	133.5	161.3	163.0	211.3	168.9	153.2	191.4	78.2	164.6	108.6	170.1	141.8	45.6	169.1	156.0	169.9	164.8	261.8	132.8	98.7	167.8	158.5	166.4	152.3	76.3	131.9	71.9	160.5	144.9	68.6	53.5	137.9	61.4	167.0	162.4	155.4	66.2	165.4	178.7	163.3	99.6	170.5	104.7	124.6	73.5	107.6	163.1	152.4	163.7	276.7	148.0	185.0	135.2	146.5	156.5	174.3	230.8	144.4	175.7	171.6	195.9	94.1	221.0	294.2	142.8	143.0	188.6	185.5	150.3	143.1	250.9	353.8	147.8	177.6	327.5	140.0	214.8	265.8	158.9	182.6	134.4	108.6	151.1	171.0	156.5	208.3	88.4	168.0	612.7	350.0	504.5	200.8	161.7	416.8	302.3	141.1	222.1	209.2	192.7	203.9	268.2	158.0	159.4	277.4	122.8	138.6	311.5	175.5	212.9	164.4	323.0	296.0	292.2	341.3	248.1	173.7	257.0	147.3	22.5	22.9	85.3	25.0	22.0	28.2	66.5	31.4	31.1	21.5	48.6	29.5	26.1	45.3	23.7	20.2	29.1	37.7	13.8	162.7	168.5	163.0	211.3	156.0	169.9	167.8	158.5	160.5	165.4	170.5	163.7	264.0	70.5	76.0	0.0	93.5	0.0	0.0	0.0	0.0	0.0	262.4	287.0	0.0	0.0	34.0	183.9	0.0	390.7	254.9	0.0	272.0	313.9	0.0	162.2	165.6	95.0	0.0	0.0	0.0	381.0	514.9	92.1	0.0	153.6	25.2	177.4	0.0	0.0	359.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.5	0.0	0.0	247.6	0.0	0.0	0.0	0.0	351.9	0.0	0.0	29.7	0.0	0.0	510.1	30.6	0.0	0.0	0.0	113.7	0.0	0.0	0.0	0.0	579.3	113.6	162.0	0.0	0.0
TRMO	"C9orf156, HSPC219"	ENSG00000136932	"TRNA methyltransferase O"	Q9BU70	9	97904489-97922516	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021281, HPA052197"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021281: AB_2670649, HPA052197: AB_2681758"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-2)"	"prognostic favorable (4.81e-10)"	"unprognostic (1.97e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.39e-2)"	7.5	9.4	7.4	11.3	8.5	16.4	13.6	8.1	7.8	9.0	9.3	7.2	7.0	9.1	11.8	7.8	10.4	7.5	6.6	6.8	8.2	9.9	11.3	9.2	14.6	7.8	7.7	9.0	9.7	11.6	7.8	7.5	8.2	9.5	8.1	5.5	9.6	7.7	7.3	10.3	9.3	6.4	8.0	11.9	9.3	12.0	7.5	13.8	18.4	7.8	14.0	7.1	6.5	10.2	19.4	12.1	6.5	8.0	8.1	6.7	11.2	9.7	11.0	15.3	11.6	16.9	14.0	12.1	6.4	9.7	17.1	18.0	10.6	7.6	11.8	14.6	8.4	10.0	14.8	15.3	16.7	19.4	15.8	11.7	17.0	8.5	6.9	9.2	6.9	9.5	16.0	15.3	10.7	28.1	8.3	13.3	9.1	20.7	13.4	9.8	14.5	8.7	14.5	15.5	11.5	10.1	7.1	15.4	16.6	5.5	6.8	10.5	10.6	8.4	8.5	17.7	15.0	16.3	12.6	6.1	9.0	9.8	7.7	44.4	21.1	49.4	20.4	23.4	25.4	19.4	30.8	24.6	22.6	28.8	39.7	27.9	32.4	22.9	16.1	13.1	35.1	20.1	7.4	8.5	8.1	7.8	6.8	8.2	7.8	7.7	8.2	8.0	7.5	10.2	7.5	12.8	5.3	0.0	16.7	0.0	14.6	0.0	10.2	9.1	7.3	7.6	0.0	4.3	6.8	5.5	0.0	8.9	17.5	3.5	7.9	9.1	30.6	9.3	5.4	4.9	2.4	6.9	0.0	9.6	6.9	6.0	9.2	7.1	0.0	4.1	5.3	7.3	10.8	6.7	0.0	5.6	0.0	10.7	0.0	18.3	5.0	9.7	0.0	0.0	10.7	12.1	8.2	0.0	0.0	10.3	5.7	7.2	12.0	6.1	4.9	9.9	5.8	4.9	6.6	8.6	5.2	16.7	13.3	7.8	0.0	18.3	14.6	6.6	3.9	8.1
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	22.0	19.8	16.5	16.2	15.3	21.1	21.0	14.7	22.1	24.3	14.8	20.0	11.8	22.9	6.3	22.3	23.6	8.9	17.3	15.5	14.7	18.0	22.1	17.3	23.2	16.0	14.8	28.7	25.4	10.0	17.2	11.3	16.8	23.0	10.9	6.5	17.0	11.4	28.8	23.4	21.7	12.5	14.2	30.6	18.9	16.8	16.2	11.6	19.2	10.5	15.9	22.3	22.2	17.6	38.6	25.3	26.9	46.0	26.7	34.1	38.7	42.1	20.9	45.3	39.1	27.4	30.8	47.7	53.6	22.9	23.7	34.8	45.2	37.3	20.9	31.3	62.8	38.0	68.7	46.5	48.7	77.2	43.1	48.4	48.4	47.3	44.1	28.9	33.8	35.2	83.7	14.9	28.6	42.6	31.7	83.3	64.0	24.2	57.5	52.5	34.6	65.8	28.3	38.2	63.5	28.9	26.2	53.7	44.8	19.4	21.0	42.8	38.2	65.1	25.5	39.8	75.1	25.6	53.4	44.1	30.3	80.7	34.7	1.8	18.9	0.6	8.9	15.0	8.6	12.4	9.6	8.6	18.2	12.9	11.1	8.5	3.7	5.6	9.9	10.6	6.9	10.7	16.5	15.3	14.7	22.1	15.5	14.7	16.0	14.8	16.8	14.2	16.2	17.6	15.5	12.8	13.1	8.5	47.5	24.0	27.0	16.8	22.8	8.9	16.6	20.2	8.3	11.5	9.6	12.9	2.1	21.7	19.6	16.6	5.9	17.3	22.4	7.9	11.7	17.6	7.2	13.0	12.0	14.9	22.6	14.3	17.9	9.8	29.8	19.7	6.1	10.8	47.7	8.4	9.1	14.1	4.1	80.0	51.0	47.9	14.0	57.4	17.8	10.3	64.8	6.1	12.3	2.5	7.5	12.8	6.8	12.8	24.2	29.0	7.8	14.2	9.2	12.6	13.1	17.5	16.1	21.1	20.0	20.7	20.6	15.5	24.4	14.6	22.5	20.3
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564039	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 99.5;Spermatogonia: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	4.3	3.7	2.0	3.1	2.6	2.2	4.4	2.6	2.9	1.9	1.5	3.6	4.3	2.7	3.9	3.6	5.8	3.4	2.3	1.8	2.5	4.9	9.8	2.4	4.4	2.6	2.5	3.3	5.9	3.7	2.3	3.7	2.9	4.1	3.6	2.8	3.9	2.2	3.9	3.7	4.5	2.7	2.7	3.5	4.4	9.9	2.4	4.3	6.1	2.7	4.4	2.9	2.0	4.3	8.2	5.4	10.1	5.7	6.0	8.4	7.8	9.6	3.7	5.8	4.1	4.9	9.4	10.9	3.7	5.6	5.9	4.4	10.9	5.1	8.6	13.7	5.4	8.0	4.4	7.6	5.5	19.6	7.8	5.4	14.4	5.7	14.0	3.0	6.4	10.0	17.5	9.4	4.5	9.4	16.4	3.5	6.5	13.8	5.0	9.5	10.2	7.2	8.5	6.8	6.3	5.8	5.3	28.3	9.9	8.5	9.3	7.8	4.9	6.9	7.2	5.5	11.1	7.0	12.4	10.0	4.9	10.9	4.7	2.7	3.9	2.1	1.8	3.8	1.7	3.5	3.3	3.3	5.2	5.8	3.5	3.2	4.9	3.3	3.4	3.0	3.9	1.9	2.0	2.6	2.6	2.9	1.8	2.5	2.6	2.5	2.9	2.7	2.4	4.3	7.2	3.2	10.3	8.8	8.7	8.2	5.6	8.4	10.2	4.3	12.1	8.6	6.4	11.5	6.6	11.0	4.2	16.8	6.1	10.6	43.0	13.8	46.8	33.5	12.1	7.2	7.2	2.1	5.3	19.3	16.4	6.9	8.6	21.6	8.2	11.0	8.2	32.6	8.5	5.0	4.6	11.1	12.2	8.1	4.1	17.0	6.5	5.0	5.4	1.9	8.4	8.7	5.2	3.5	19.7	14.1	11.0	7.5	10.4	4.8	19.0	31.9	20.6	5.9	13.1	5.7	8.1	99.5	55.0	10.2	9.5	17.5	5.5	8.1	10.6	6.6
TRMT10B	"bA3J10.9, FLJ31455, RG9MTD3"	ENSG00000165275	"TRNA methyltransferase 10B"	Q6PF06	9	37753803-37778972	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021800	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA021800: AB_1856214"	"unprognostic (1.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (5.49e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	5.6	6.9	7.3	5.7	8.1	6.0	6.2	10.7	8.0	8.3	5.8	8.3	4.4	7.1	4.4	5.5	7.6	4.1	4.9	6.8	7.3	6.9	6.4	4.9	7.4	7.9	7.6	9.5	7.9	3.9	6.7	3.8	7.1	8.3	3.5	7.3	6.1	4.2	4.4	10.7	7.1	4.0	6.6	8.1	6.7	3.4	7.6	4.0	7.6	2.1	4.2	7.6	7.1	9.8	4.7	5.6	7.0	6.2	4.2	3.3	3.1	4.4	3.3	4.5	3.9	3.3	4.1	8.7	3.3	3.4	2.7	5.3	3.3	5.5	4.1	3.7	5.6	7.8	14.8	3.5	7.6	8.0	5.2	3.8	5.5	4.3	7.4	5.3	4.7	10.4	6.2	3.6	3.4	3.3	8.1	6.2	6.2	5.0	6.7	8.1	2.4	4.6	4.3	4.2	9.4	9.0	3.7	4.7	4.1	4.4	5.0	5.7	4.8	3.6	5.1	5.9	4.0	4.2	6.1	6.9	2.1	6.1	7.3	3.4	2.7	1.5	3.1	2.4	3.8	3.3	2.8	3.1	1.2	4.3	3.3	3.0	2.8	2.4	1.7	2.3	1.9	1.5	7.3	8.1	10.7	8.0	6.8	7.3	7.9	7.6	7.1	6.6	7.6	9.8	13.2	3.2	8.9	30.3	20.3	7.4	11.4	8.9	15.9	16.2	13.5	16.5	7.4	14.3	8.4	3.7	6.2	16.1	11.0	7.9	11.7	11.3	2.1	7.1	14.1	12.8	13.8	13.7	25.4	12.5	8.6	14.0	13.7	9.1	14.5	17.3	13.6	8.1	8.2	16.8	27.5	14.0	8.2	10.4	9.5	0.9	14.6	12.2	10.6	19.7	15.5	15.9	25.7	37.2	45.7	10.0	6.7	23.7	9.1	14.2	11.4	9.0	7.8	13.5	26.3	13.0	11.1	4.2	5.3	9.7	7.5	12.2	16.4	12.3	10.9	9.4
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561868-101566446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	16.6	17.4	6.9	14.8	7.9	18.2	20.8	9.1	9.7	12.2	8.5	15.4	12.7	14.1	13.4	18.9	14.5	11.4	21.6	7.8	7.9	19.2	25.2	10.3	20.5	7.4	7.4	15.7	10.4	15.6	6.4	14.0	7.9	11.9	14.7	7.8	13.0	9.9	27.6	12.7	13.1	16.0	7.4	12.5	12.1	11.8	7.5	17.5	15.4	30.2	20.7	26.6	8.6	7.5	58.9	28.2	36.6	37.1	33.0	28.0	34.1	34.2	33.3	43.6	48.5	43.2	38.6	121.3	43.4	21.6	35.4	57.9	71.5	52.5	59.7	43.8	35.3	81.6	20.5	31.6	25.4	72.5	33.1	32.9	53.3	38.3	35.4	23.2	43.1	45.4	70.3	26.3	47.6	40.4	58.2	52.9	68.2	75.9	60.4	42.9	29.8	54.3	56.2	49.0	90.9	51.8	26.7	56.0	78.1	31.9	74.0	78.9	28.7	23.6	45.0	15.8	36.5	30.4	59.4	117.5	40.0	51.5	36.2	56.6	18.2	12.8	21.1	24.7	29.8	35.7	26.2	25.1	22.7	34.2	35.0	33.2	8.1	21.4	27.4	25.8	26.2	19.5	6.9	7.9	9.1	9.7	7.8	7.9	7.4	7.4	7.9	7.4	7.5	7.5	33.3	22.4	24.0	4.9	47.9	94.3	153.4	106.8	63.7	30.6	39.9	52.7	51.5	21.5	69.2	29.5	14.6	65.7	50.3	21.5	52.8	48.5	49.7	54.7	54.0	39.5	35.8	65.0	8.8	33.8	47.0	38.8	28.1	63.5	46.3	47.3	31.4	56.9	31.1	21.9	8.5	31.5	69.2	27.3	31.9	13.7	37.3	23.7	14.2	1.9	42.1	29.8	37.0	6.6	7.6	37.2	17.9	37.6	21.5	85.3	17.3	72.0	53.3	33.9	32.9	58.1	41.3	77.7	55.0	55.2	105.0	65.5	46.4	57.1	47.0	127.4
TRMT112	"HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2"	ENSG00000173113	"TRNA methyltransferase subunit 11-2"	Q9UI30	11	64316460-64317559	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039901, HPA040006"	Uncertain		Approved	Nucleoplasm,Microtubules		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	Nucleoplasm	"HPA039901: AB_10796334, HPA040006: AB_10793859"	"unprognostic (1.48e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (6.08e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.28e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.32e-2)"	159.1	273.6	158.4	109.5	159.8	149.7	152.5	161.3	182.3	182.2	172.7	143.8	68.5	173.0	140.7	167.7	167.5	90.9	138.0	157.3	175.5	176.0	164.7	129.6	170.8	165.9	169.2	238.2	145.5	109.9	182.0	112.2	170.3	137.7	65.4	64.3	116.5	96.4	159.4	146.6	110.0	105.6	163.0	146.8	129.4	130.7	169.0	152.3	142.0	81.8	153.4	145.8	150.3	177.6	411.4	590.3	203.2	298.9	238.0	195.8	199.9	195.3	245.2	231.2	188.3	308.0	401.7	320.5	575.6	204.5	353.1	338.8	367.8	430.1	157.7	373.0	340.1	359.7	503.6	708.9	264.3	282.2	225.2	227.1	401.0	205.5	409.7	241.4	239.7	218.3	298.2	394.5	220.0	1070.4	414.0	527.9	543.0	279.2	511.0	249.6	233.0	451.3	270.6	416.8	133.3	599.3	278.1	322.8	571.4	178.1	503.8	249.7	197.0	241.7	297.2	408.7	365.7	338.7	591.5	512.8	330.2	276.3	255.4	780.9	377.7	573.3	428.7	331.8	444.1	956.3	559.0	481.0	404.8	808.8	617.8	534.8	459.0	392.8	303.5	671.5	551.1	883.6	158.4	159.8	161.3	182.3	157.3	175.5	165.9	169.2	170.3	163.0	169.0	177.6	234.8	160.3	164.3	8.1	269.6	349.9	421.7	465.9	299.9	89.4	219.5	323.8	137.4	135.8	255.8	274.0	22.9	561.1	239.3	96.1	491.0	232.1	71.3	270.9	200.4	236.0	154.4	251.8	10.0	224.4	469.8	249.8	96.8	257.8	217.4	251.8	189.5	196.0	395.2	52.2	10.9	160.6	205.4	174.6	312.3	63.1	299.5	179.1	336.2	12.2	321.2	177.2	247.2	9.0	24.5	221.2	126.4	218.6	296.7	304.4	111.0	610.2	305.0	88.1	216.9	196.2	246.6	230.6	531.2	276.6	396.4	412.1	261.6	258.2	155.3	386.8
TRMT12	"FLJ20772, Trm12, TYW2"	ENSG00000183665	"TRNA methyltransferase 12 homolog"	Q53H54	8	124450820-124462150	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.1"	"Low region specificity"	"Detected in all"							HPA023939	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Mitochondria	"HPA023939: AB_1848793"	"unprognostic (2.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.99e-5)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.25e-4)"	"unprognostic (1.04e-2)"	6.0	5.8	5.0	5.4	5.1	3.1	8.7	4.3	6.7	6.5	5.5	5.7	4.6	6.5	6.1	5.6	7.6	4.4	5.9	6.5	4.8	7.6	6.0	5.9	6.5	3.6	3.9	5.0	5.1	8.6	4.7	5.4	4.1	6.9	6.5	8.1	7.7	6.1	9.7	5.3	5.0	8.2	3.4	5.5	5.7	6.4	5.5	8.3	8.8	10.0	6.7	6.7	4.3	4.9	14.8	12.6	10.3	8.1	19.0	9.7	2.5	9.1	10.6	13.1	11.2	7.7	10.0	14.9	12.3	9.4	8.5	10.1	14.7	14.9	15.4	14.8	11.2	14.4	12.8	2.6	14.8	0.0	11.2	12.1	19.6	12.9	16.2	3.8	11.1	15.4	20.4	10.1	8.2	73.1	17.2	6.1	0.0	33.9	11.5	5.4	6.9	9.9	12.1	15.7	17.3	13.8	13.4	49.5	19.5	8.7	14.1	6.1	8.9	9.1	23.8	6.8	10.4	10.4	15.6	5.8	8.2	5.0	7.5	0.4	3.5	3.8	2.3	2.9	3.0	2.1	3.2	2.5	2.8	2.8	3.9	3.9	1.3	3.1	3.3	0.8	2.1	2.4	5.0	5.1	4.3	6.7	6.5	4.8	3.6	3.9	4.1	3.4	5.5	4.9	4.9	9.6	7.5	2.0	11.2	5.2	6.1	3.5	7.4	5.6	5.5	4.7	3.9	7.2	2.2	3.7	16.7	7.3	8.4	4.2	5.9	5.6	18.6	6.3	4.9	5.7	3.0	1.7	1.5	6.2	5.4	4.5	6.6	3.6	9.5	7.7	4.2	5.4	5.1	8.4	1.8	4.4	4.1	4.1	2.5	21.0	4.1	5.2	5.4	1.0	8.1	4.0	9.2	1.0	1.2	4.3	3.9	6.0	8.4	4.8	3.9	8.2	7.6	8.2	0.0	8.2	6.5	14.2	5.8	4.7	4.3	4.9	6.3	7.9	4.9	4.6
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150498	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	8.8	8.7	6.9	12.2	9.8	5.2	14.5	9.6	9.6	11.2	6.7	9.3	11.2	13.9	11.8	8.5	9.2	7.2	8.0	6.5	9.7	8.8	8.7	7.8	18.2	8.5	9.0	13.5	11.5	12.9	6.8	10.7	8.7	10.4	11.3	21.7	9.1	8.1	13.1	14.7	10.7	10.1	7.0	14.1	10.0	9.4	8.5	11.3	12.0	6.2	14.6	9.5	10.3	14.9	17.5	10.0	16.5	11.5	8.7	16.9	18.0	18.0	7.1	13.4	11.1	11.9	7.0	28.7	21.8	14.4	8.9	15.4	30.6	14.0	23.1	29.0	24.2	17.2	23.1	11.6	15.7	30.0	15.4	11.9	15.5	25.5	33.3	8.4	12.4	21.0	36.6	17.9	13.6	6.7	24.6	15.6	23.0	16.7	19.9	26.0	25.0	15.7	11.1	13.6	10.7	17.9	16.6	15.8	21.6	16.1	9.3	26.1	13.0	17.8	11.9	15.1	24.3	22.8	20.0	34.0	20.1	23.5	7.0	0.2	5.8	3.1	10.5	6.1	13.0	19.9	11.3	10.6	7.0	18.7	16.8	14.0	2.5	7.9	5.1	12.8	8.6	5.6	6.9	9.8	9.6	9.6	6.5	9.7	8.5	9.0	8.7	7.0	8.5	14.9	13.1	25.6	17.0	34.0	29.0	9.7	14.2	14.2	19.9	38.9	10.7	7.9	11.1	12.8	22.2	14.7	29.2	14.2	18.9	8.0	13.7	10.5	20.9	14.3	21.0	15.7	20.4	11.3	23.1	6.1	10.2	13.7	11.7	8.0	21.5	18.7	17.9	11.4	7.6	28.6	32.1	9.9	18.3	10.1	7.0	6.0	24.8	10.3	10.6	25.3	14.7	16.6	41.2	33.7	97.4	8.5	9.6	18.4	9.0	12.6	13.0	10.7	20.4	44.7	19.7	16.0	13.4	47.6	21.9	12.2	11.9	7.3	21.5	15.8	13.6	10.0
TRMT1L	C1orf25	ENSG00000121486	"TRNA methyltransferase 1 like"	Q7Z2T5	1	185118101-185157072	"Metabolic proteins, Predicted intracellular proteins"	"Behavior, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.0;Spermatocytes: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026728	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA026728: AB_1845641"	"unprognostic (1.07e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.26e-1)"	6.8	8.6	7.8	8.4	9.1	5.7	7.6	9.7	9.7	7.9	9.1	7.7	8.5	7.3	9.4	6.9	10.6	7.0	12.1	7.6	8.4	13.1	14.5	7.4	10.8	8.7	8.2	11.4	5.0	12.1	7.0	8.2	8.9	7.6	7.2	8.9	5.6	8.1	20.8	4.8	7.0	6.9	9.1	10.6	7.2	27.7	8.2	10.2	10.4	18.7	11.9	7.0	5.5	12.3	12.4	22.3	15.1	11.3	21.8	20.0	21.5	11.7	10.5	15.7	16.4	20.4	23.1	13.5	28.5	8.1	24.0	15.6	25.7	15.3	15.4	16.1	11.2	13.0	15.9	20.9	15.2	19.3	20.6	9.6	20.3	16.1	16.1	16.6	17.5	17.9	34.5	18.0	18.9	10.5	14.7	11.2	24.9	25.3	4.6	17.1	21.7	21.6	15.2	13.5	13.4	12.0	22.8	22.0	16.2	34.2	22.4	10.7	16.9	14.3	11.4	9.9	15.8	28.7	41.5	21.3	9.4	16.8	14.0	24.0	10.6	21.9	7.5	14.7	8.1	12.3	9.9	9.3	13.3	18.1	12.3	9.7	12.3	12.8	19.2	5.5	14.2	9.2	7.8	9.1	9.7	9.7	7.6	8.4	8.7	8.2	8.9	9.1	8.2	12.3	8.2	12.8	15.6	24.2	18.0	2.7	8.1	11.6	7.4	8.7	6.9	6.5	29.5	11.5	15.1	16.5	8.4	16.3	10.0	8.9	27.4	12.2	73.0	22.4	8.9	11.7	6.1	29.0	19.8	6.0	9.9	12.0	10.7	8.2	8.8	14.5	11.0	25.0	13.0	3.3	19.6	9.2	12.2	17.5	6.2	25.0	12.5	13.7	1.8	20.6	16.3	9.6	6.2	18.6	36.8	7.6	10.9	12.0	10.7	5.9	9.6	23.9	44.2	8.6	0.0	11.0	9.6	103.8	32.0	9.7	2.4	11.4	10.7	13.6	8.3	5.3
TRMT2A	HTF9C	ENSG00000099899	"TRNA methyltransferase 2 homolog A"	Q8IZ69	22	20111875-20117392	"Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 131.7;Late spermatids: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 84.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001077	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA001077: AB_1079092"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.19e-3)"	"unprognostic (5.93e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.99e-8)"	"unprognostic (4.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.14e-3)"	15.7	24.0	11.2	7.6	11.4	8.2	16.8	11.4	16.8	17.7	12.0	15.3	8.7	14.7	4.4	16.3	16.0	6.4	13.8	11.3	10.6	18.0	31.4	12.9	13.1	12.2	10.9	15.5	24.2	5.8	21.8	5.5	11.9	20.7	2.7	2.4	19.1	5.6	15.6	17.1	16.3	3.6	11.1	28.1	17.2	22.8	11.7	10.2	18.7	4.8	5.2	15.3	13.8	12.9	13.8	15.4	6.1	9.9	6.0	4.4	20.9	12.3	6.4	9.7	8.8	18.5	11.7	18.7	10.2	5.9	7.4	21.0	4.5	7.2	1.4	20.3	52.2	22.7	23.3	17.0	15.8	34.9	21.2	8.2	9.0	10.3	3.8	6.7	9.9	15.4	84.5	13.1	6.8	21.7	19.5	21.6	11.2	16.2	19.9	22.8	10.6	7.4	5.7	15.1	16.0	12.2	7.9	18.9	21.5	2.6	13.6	28.7	9.3	11.5	15.4	9.3	10.6	44.3	21.6	14.6	15.2	14.7	11.9	10.2	12.2	7.4	9.8	15.3	14.4	9.7	10.3	11.7	14.3	6.3	11.1	11.1	1.5	10.6	13.5	12.7	8.4	12.3	11.2	11.4	11.4	16.8	11.3	10.6	12.2	10.9	11.9	11.1	11.7	12.9	10.8	12.8	13.8	13.4	13.4	9.8	10.2	13.9	9.6	12.5	15.9	18.0	7.4	14.3	14.1	11.0	8.4	25.0	18.3	17.0	13.7	12.3	131.7	8.9	9.5	10.9	18.6	14.5	6.9	13.0	18.9	10.8	15.8	6.6	25.4	15.8	8.9	18.6	25.0	15.2	7.4	13.4	14.2	18.9	8.9	206.4	17.7	13.7	7.2	4.7	16.9	22.7	12.3	3.5	9.0	13.0	13.4	14.3	18.1	12.1	14.4	10.5	11.9	12.8	6.6	11.8	11.2	16.4	13.7	10.4	11.2	28.5	16.6	19.2	20.0	9.7
TRMT2B	"CXorf34, FLJ12687"	ENSG00000188917	"TRNA methyltransferase 2 homolog B"	Q96GJ1	X	101009346-101052116	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003745, HPA035120, HPA040814"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA003745: AB_2667047, HPA035120: AB_10601702, HPA040814: "	"prognostic unfavorable (1.58e-5)"	"unprognostic (6.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (2.30e-7)"	"unprognostic (4.58e-2)"	"unprognostic (4.82e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.60e-2)"	5.4	6.4	3.3	7.1	3.3	7.8	6.3	3.7	4.0	6.8	5.6	7.8	6.1	4.7	4.0	8.2	5.3	5.4	9.1	3.3	3.8	8.7	6.2	6.5	10.3	4.3	3.9	6.7	6.4	14.7	5.8	3.9	4.7	6.6	9.2	2.4	9.9	5.3	15.0	6.9	9.2	5.0	3.4	10.6	8.7	2.5	4.0	14.7	8.6	14.4	11.3	5.2	6.1	3.3	22.4	18.9	3.8	8.9	8.7	4.5	11.6	11.4	15.4	12.6	18.7	20.6	17.5	19.9	22.3	10.6	25.6	13.7	17.5	16.0	15.7	17.2	10.9	12.6	15.6	9.9	7.6	22.5	19.6	5.8	9.3	18.2	8.4	8.8	24.8	21.2	13.0	18.3	11.7	22.5	28.5	11.6	5.2	27.7	14.0	22.8	18.2	19.1	9.2	12.8	5.5	7.4	19.4	14.0	11.7	10.4	9.1	10.8	14.5	15.7	9.4	14.8	10.3	11.5	18.7	18.1	12.2	25.3	12.4	14.9	10.0	18.8	15.8	8.0	17.0	18.7	18.6	15.8	9.3	20.4	21.8	18.3	5.7	18.7	9.5	10.0	16.8	14.8	3.3	3.3	3.7	4.0	3.3	3.8	4.3	3.9	4.7	3.4	4.0	3.3	3.0	6.4	6.3	22.2	10.5	2.3	5.5	4.1	6.2	0.8	3.0	1.5	10.3	1.5	5.0	14.7	2.1	6.1	5.7	5.4	7.9	4.0	0.1	3.3	1.9	4.0	6.7	5.7	17.2	3.4	3.0	3.4	6.1	2.9	13.3	6.9	3.6	4.1	3.6	1.7	18.5	6.8	2.0	5.3	0.6	0.8	3.4	3.4	1.8	18.7	5.6	4.8	14.4	9.5	11.6	5.3	4.8	3.8	4.2	3.8	5.5	5.7	6.0	1.8	0.0	5.3	3.0	0.2	3.8	6.2	1.6	5.1	8.7	4.4	6.1	5.3
TRMT44	"C4orf23, FLJ35725, METTL19, TRM44"	ENSG00000155275	"TRNA methyltransferase 44 homolog"	Q8IYL2	4	8436140-8493531	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045461	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA045461: AB_10961276"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.76e-2)"	"unprognostic (8.34e-3)"	5.8	3.5	2.0	3.9	2.5	7.1	6.9	2.6	2.8	5.1	0.7	4.9	3.6	6.2	4.4	6.6	5.4	3.4	4.6	2.2	0.9	3.2	4.2	4.2	5.0	0.9	0.6	7.6	4.5	4.2	3.2	4.9	1.2	4.8	3.2	3.7	5.5	3.8	5.9	9.0	3.6	4.4	0.6	4.0	5.3	4.9	1.3	3.7	4.5	2.6	5.2	5.0	5.6	2.6	5.2	5.1	6.4	7.5	6.5	6.3	15.2	5.9	4.2	7.6	6.7	6.8	7.0	6.9	3.1	2.3	6.4	4.1	9.3	5.4	6.7	3.7	5.9	6.9	8.9	5.1	6.0	11.4	4.9	3.9	7.7	5.8	6.3	6.4	8.1	4.8	10.2	7.2	5.0	3.2	9.5	8.3	7.4	6.5	8.5	6.9	6.9	4.9	6.6	6.0	6.9	4.7	3.8	3.4	5.5	7.2	2.9	4.7	5.2	4.6	2.5	4.4	9.3	8.4	6.0	6.2	5.1	10.7	4.7	0.1	0.3	0.0	0.6	0.3	0.3	0.2	0.5	0.6	0.5	0.5	0.7	0.2	0.0	0.2	0.6	0.4	0.0	0.1	2.0	2.5	2.6	2.8	2.2	0.9	0.9	0.6	1.2	0.6	1.3	2.6	4.4	9.6	7.3	12.7	4.9	6.8	4.2	3.1	2.8	7.8	6.8	5.1	3.3	7.2	3.2	7.3	25.0	10.2	4.1	2.6	5.9	5.0	3.8	16.2	13.0	4.7	1.8	1.7	21.3	4.5	6.2	7.5	14.8	25.6	5.1	18.8	5.0	3.8	4.6	3.3	18.4	2.0	2.0	3.1	2.4	2.8	5.9	3.7	1.8	8.4	4.1	2.6	3.1	8.5	12.3	4.5	7.2	3.8	5.3	5.3	3.0	2.7	8.1	10.8	0.0	6.3	6.5	9.2	5.8	8.2	5.8	16.3	5.2	4.8	3.8	7.6
TRMT5	"KIAA1393, TRM5"	ENSG00000126814	"TRNA methyltransferase 5"	Q32P41	14	60971441-60981170	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA000943: AB_1080388"	"unprognostic (1.58e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.82e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	7.3	5.5	3.5	4.4	3.8	4.8	9.8	6.0	4.1	6.5	3.1	6.7	5.7	7.0	7.8	7.6	7.4	5.1	4.2	3.4	4.6	6.9	6.8	5.0	6.0	2.5	3.4	9.9	6.7	10.5	3.5	7.0	2.8	6.9	6.0	5.2	7.6	4.8	7.5	6.7	4.5	7.0	3.1	4.7	5.8	17.3	4.0	6.1	7.2	7.2	5.8	6.7	3.9	3.8	49.7	12.5	17.9	25.0	15.5	23.6	19.4	18.2	14.0	19.1	15.2	9.8	28.7	25.2	19.9	13.3	14.3	22.3	22.9	26.4	25.0	25.3	11.5	18.6	8.1	10.2	25.1	33.2	9.9	18.3	25.1	17.4	25.4	17.0	17.0	21.6	24.5	8.8	28.3	18.7	17.1	16.8	16.4	19.4	20.3	5.4	41.5	21.4	16.3	16.7	22.1	21.6	20.2	20.1	16.6	15.4	33.5	19.7	16.1	22.1	26.7	15.7	17.5	5.3	10.8	11.6	15.6	7.2	21.0	0.1	3.2	0.7	2.4	5.5	3.3	4.9	3.4	3.5	3.0	4.1	3.8	3.4	0.3	1.4	5.9	5.2	4.5	2.5	3.5	3.8	6.0	4.1	3.4	4.6	2.5	3.4	2.8	3.1	4.0	3.8	7.0	6.4	10.9	3.9	4.5	6.4	19.5	15.9	9.6	5.7	6.3	10.0	8.0	1.5	19.6	11.0	4.2	12.8	5.7	3.2	1.9	7.7	221.8	8.2	17.4	9.2	5.4	10.7	5.4	7.5	12.4	12.4	9.7	8.1	6.3	12.1	8.6	7.0	10.9	3.3	6.7	8.3	8.2	6.2	7.6	50.2	11.1	6.0	7.2	3.7	4.1	12.2	1.0	9.0	6.3	8.2	4.8	7.5	4.7	8.2	3.9	11.1	14.9	5.4	13.1	14.7	9.5	23.3	12.6	11.1	4.3	19.2	5.2	14.4	7.6	10.6
TRMT6	"CGI-09, GCD10, Gcd10p, MGC5029"	ENSG00000089195	"TRNA methyltransferase 6"	Q9UJA5	20	5937228-5950558	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatogonia: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047032, HPA050408"	Approved		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions"	"HPA047032: AB_2679911, HPA050408: AB_2681117"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.70e-12)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	7.4	9.7	5.1	7.3	5.3	13.8	5.9	5.9	6.3	5.9	4.5	5.8	3.4	6.6	6.0	9.1	5.7	3.5	7.7	5.4	5.2	8.0	5.5	4.9	9.3	5.8	5.1	5.6	7.3	6.8	8.4	5.1	5.8	5.2	5.5	3.7	6.1	9.9	20.2	7.8	5.9	5.6	4.9	6.6	5.8	11.5	4.8	8.8	5.9	7.3	9.0	11.0	6.4	5.1	55.5	27.8	17.1	25.9	10.4	11.8	21.4	24.7	12.5	24.5	20.6	36.5	22.2	62.1	13.1	15.1	33.8	39.9	36.3	41.8	40.3	13.3	25.5	50.6	12.0	32.2	19.8	47.8	13.3	13.6	21.8	44.4	33.4	8.6	10.0	25.6	32.3	18.0	28.8	14.4	50.6	26.2	39.5	36.9	33.9	33.4	33.6	36.1	18.3	31.3	33.9	51.1	29.2	39.3	45.0	16.2	20.2	24.4	8.8	28.5	27.1	26.8	52.1	31.6	64.1	74.6	13.3	37.9	29.3	2.1	7.8	6.3	9.1	9.1	10.9	8.6	9.9	11.5	18.0	8.1	10.1	11.1	0.7	15.6	8.3	7.5	12.5	7.2	5.1	5.3	5.9	6.3	5.4	5.2	5.8	5.1	5.8	4.9	4.8	5.1	11.7	6.4	20.3	2.0	20.0	21.4	26.1	35.8	25.0	19.8	12.6	14.9	25.9	15.7	31.3	29.5	10.4	26.2	12.4	6.3	35.2	26.3	3.9	18.2	14.8	17.8	13.8	10.7	6.4	30.7	26.8	19.7	12.8	16.2	34.9	25.5	5.0	19.1	17.6	26.9	4.9	8.6	26.4	15.0	47.5	6.5	11.5	35.0	17.8	11.2	13.6	13.2	20.6	4.5	4.0	22.4	7.3	7.2	17.5	33.8	3.8	22.7	30.8	11.0	13.1	26.7	28.7	70.4	103.6	17.4	24.0	29.3	21.0	18.7	12.6	20.6
TRMT9B	"C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L"	ENSG00000250305	"TRNA methyltransferase 9B (putative)"	Q9P272	8	12945642-13031503	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 118.6;choroid plexus: 375.5"	"Cell type enhanced"	"Detected in some"		"Club cells: 9.9;Collecting duct cells: 14.7;Distal tubular cells: 11.7;Endometrial ciliated cells: 35.1;Glandular and luminal cells: 18.7;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 118.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.0;BJ: 8.7;fHDF/TERT166: 11.9;RPTEC TERT1: 4.0;SCLC-21H: 4.3;U-266/84: 4.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 31.1"	HPA024673	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA024673: AB_1845788"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-4)"	"unprognostic (1.06e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.77e-7)"	"unprognostic (2.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.34e-2)"	1.3	0.4	6.1	0.6	6.8	0.3	2.3	118.6	7.9	1.7	375.5	1.6	0.7	1.0	0.9	0.9	2.0	1.6	6.3	25.2	6.3	3.5	2.2	1.7	0.4	5.4	7.2	0.3	2.2	1.6	1.4	0.4	11.5	1.2	1.2	24.5	2.6	1.0	3.2	3.2	1.2	0.4	4.8	1.5	1.1	1.2	17.5	0.2	33.7	1.6	0.3	0.9	0.8	5.0	0.1	0.0	6.0	0.0	0.0	0.0	1.4	8.7	2.0	1.2	0.6	0.0	0.1	0.1	0.4	11.9	1.1	0.2	0.1	0.2	1.2	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.6	0.2	3.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.1	0.7	0.1	0.0	1.0	0.0	0.1	4.0	0.1	4.3	0.1	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.1	0.8	0.8	0.1	0.2	4.4	0.0	0.0	0.0	1.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	6.1	6.8	118.6	7.9	25.2	6.3	5.4	7.2	11.5	4.8	17.5	5.0	6.2	6.4	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	6.7	0.0	0.0	9.9	14.7	0.0	1.0	0.2	0.0	11.7	2.3	0.0	35.1	6.4	2.1	0.0	0.0	0.0	1.1	0.2	1.8	0.0	18.7	1.3	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.3	14.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0
TRNAU1AP	"FLJ20503, SECP43, TRSPAP1"	ENSG00000180098	"TRNA selenocysteine 1 associated protein 1"	Q9NX07	1	28553085-28578545	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032068, HPA032069"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA032068: AB_2674135, HPA032069: AB_10603998"	"unprognostic (4.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (4.93e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (5.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.76e-1)"	5.8	4.7	8.2	3.9	8.5	4.1	5.2	10.1	10.5	5.2	7.7	5.8	2.7	4.2	5.5	5.2	5.0	2.5	5.4	7.9	8.5	5.3	3.3	5.2	5.9	8.4	8.2	5.8	5.6	5.7	4.0	4.1	8.5	4.3	4.4	7.2	4.8	5.1	4.0	6.9	4.7	3.7	8.1	5.3	5.1	2.9	8.2	8.5	3.8	3.4	7.0	5.0	4.6	9.2	5.1	3.0	8.6	6.0	7.7	14.6	4.1	6.7	13.5	12.1	10.9	4.7	7.8	7.7	2.6	7.4	5.7	3.8	9.4	10.7	12.1	6.8	10.6	5.8	10.1	3.2	7.1	4.5	4.8	15.7	9.2	9.5	7.4	8.5	17.4	7.8	6.8	6.1	12.0	3.5	7.7	5.2	6.1	5.5	6.5	5.5	6.0	5.4	13.3	5.1	5.0	6.5	8.0	6.9	7.7	9.1	7.7	5.4	5.0	3.1	3.0	5.0	6.1	7.9	10.6	4.8	7.6	9.7	9.1	5.4	2.7	7.3	4.2	4.5	4.2	3.6	4.5	5.3	3.3	4.1	5.3	3.4	1.6	9.7	2.8	2.2	3.3	2.2	8.2	8.5	10.1	10.5	7.9	8.5	8.4	8.2	8.5	8.1	8.2	9.2	30.3	35.3	36.6	15.0	29.2	17.6	20.0	33.8	17.6	35.1	22.3	23.0	19.9	21.5	39.9	18.4	35.5	30.6	37.1	13.4	17.6	37.4	11.1	41.0	20.4	23.8	10.3	32.2	29.7	32.8	52.8	23.0	14.8	28.0	35.4	28.1	25.4	10.8	33.1	23.5	28.2	13.9	36.7	30.1	23.2	5.0	28.9	27.6	14.2	6.5	35.1	25.5	39.1	17.6	29.9	40.8	12.2	22.6	37.5	22.2	23.4	19.5	84.7	35.4	32.9	22.0	55.0	21.9	25.3	36.3	20.5	68.4	31.8	23.1	14.8	28.9
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.2;Hepatocytes: 81.7;Intestinal goblet cells: 114.8;Paneth cells: 77.1;Undifferentiated cells: 88.9"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 3.3;granulocytes: 2.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"OE19: 32.7;RT4: 60.8;SK-BR-3: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	10.8	6.1	5.8	6.1	5.4	4.6	13.5	8.5	7.0	11.5	4.8	46.1	25.3	9.9	2.5	13.1	9.2	7.4	23.0	5.9	4.5	22.8	15.4	16.0	1.8	6.2	7.4	3.3	10.1	3.7	5.6	5.3	6.9	35.7	12.9	1.3	27.3	6.2	14.0	26.6	22.9	3.4	4.2	5.5	20.6	5.4	6.6	1.0	17.3	5.3	1.9	13.7	14.4	5.1	11.9	9.0	2.1	9.5	7.7	6.6	6.6	10.0	6.0	2.7	3.7	6.1	18.7	0.4	2.7	6.8	3.6	15.7	1.3	3.0	1.0	0.2	3.4	1.9	4.0	3.7	6.6	0.3	11.7	9.3	13.6	5.3	2.6	3.3	4.6	1.0	4.9	2.1	6.9	17.4	0.8	0.9	1.0	32.7	13.3	4.1	2.0	0.6	4.6	60.8	0.8	2.2	4.1	38.6	2.2	0.7	22.6	3.7	11.8	14.4	7.8	7.9	0.2	3.9	4.3	0.4	7.9	7.4	5.3	2.2	4.3	0.7	0.3	2.5	0.2	0.5	0.2	0.2	3.3	0.5	0.3	0.3	2.8	0.5	1.0	3.1	0.2	1.4	5.8	5.4	8.5	7.0	5.9	4.5	6.2	7.4	6.9	4.2	6.6	5.1	12.8	32.1	2.6	9.8	3.5	12.5	15.3	9.9	9.1	2.0	19.0	14.6	16.7	17.2	12.3	14.7	0.0	6.6	0.2	179.2	19.6	7.9	2.9	17.5	8.2	11.7	21.7	0.0	5.4	18.5	6.8	6.0	71.4	36.2	5.7	2.9	11.4	81.7	19.9	0.0	8.5	114.8	14.2	9.8	19.0	3.1	6.8	8.5	39.2	9.4	12.8	6.7	0.0	3.5	0.9	32.9	77.1	7.2	7.6	35.5	55.3	3.8	8.9	2.6	32.9	2.2	8.5	6.1	15.7	8.4	11.5	3.4	1.9	4.1	88.9	33.1
TRPS1	"GC79, LGCR"	ENSG00000104447	"Transcriptional repressor GATA binding 1"	Q9UHF7	8	115408496-115809673	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 60.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 758.7;Breast glandular cells: 243.2;Oligodendrocyte precursor cells: 280.5;Oligodendrocytes: 294.0"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 49.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 47.4;SK-BR-3: 78.1;T-47d: 244.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060380, HPA071767"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA060380: AB_2684270, HPA071767: AB_2732185"	"unprognostic (4.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (2.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.07e-3)"	4.4	3.1	15.5	5.7	14.3	7.6	60.8	10.5	14.7	10.9	10.1	5.9	0.9	9.9	3.4	14.2	5.5	10.0	3.8	17.0	13.5	5.4	2.1	4.7	4.9	32.5	31.5	5.2	1.1	5.3	2.6	2.8	24.2	9.4	2.7	4.1	12.0	8.4	2.6	10.6	2.1	10.6	18.4	4.2	2.7	12.5	27.5	2.4	5.7	3.3	4.0	5.1	14.1	16.3	3.1	0.6	5.9	0.3	5.4	19.8	0.6	4.9	11.3	3.1	5.2	0.5	4.9	2.4	0.0	12.7	2.6	0.1	22.9	4.3	3.5	0.3	6.9	0.1	10.3	0.2	7.2	0.0	0.3	9.5	4.4	8.6	15.8	8.9	2.7	0.3	1.1	37.7	6.0	47.4	0.2	0.0	1.1	1.1	4.8	0.2	0.2	30.0	4.9	0.3	5.2	3.9	2.5	78.1	3.2	2.8	244.8	2.1	0.2	13.7	6.9	4.0	9.7	10.1	0.3	4.5	14.4	0.0	9.2	0.0	4.5	0.0	0.9	1.9	0.9	0.5	1.0	1.0	1.7	0.8	0.9	0.9	0.8	1.0	1.4	0.6	0.5	0.8	15.5	14.3	10.5	14.7	17.0	13.5	32.5	31.5	24.2	18.4	27.5	16.3	10.0	6.4	3.0	758.7	13.3	9.4	20.0	10.3	34.1	9.2	243.2	125.1	4.6	2.8	9.2	18.4	43.8	0.1	18.7	0.1	11.7	2.9	95.0	58.5	35.7	7.5	0.0	5.5	128.3	2.9	0.2	26.8	4.6	63.5	12.7	0.3	3.6	1.1	16.5	0.0	148.2	0.0	8.2	55.2	104.1	163.2	25.1	55.5	21.4	171.4	32.5	10.6	5.2	280.5	294.0	2.7	0.0	28.2	10.1	16.9	0.0	23.7	8.9	35.9	6.6	60.2	28.2	1.8	8.3	73.6	12.5	0.3	25.6	19.5	0.0	11.2
TRRAP	"PAF400, TR-AP, Tra1"	ENSG00000196367	"Transformation/transcription domain associated protein"	Q9Y4A5	7	98877933-99050831	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Autism spectrum disorder, Cancer-related genes, Deafness, Disease variant, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054376			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA054376: AB_2682467"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	6.0	8.1	3.4	7.4	3.5	11.1	6.2	10.3	3.7	8.3	5.9	7.7	5.3	8.6	3.5	6.8	8.4	4.9	6.8	3.1	2.6	6.2	6.7	7.0	9.3	1.4	2.2	10.9	8.3	10.3	14.0	6.1	1.9	7.1	5.0	7.5	7.1	5.2	7.6	11.2	8.4	6.2	0.6	8.5	7.1	11.0	2.8	15.8	8.8	7.3	8.7	7.3	7.0	5.0	24.0	27.2	27.7	23.4	12.9	13.8	13.7	10.3	13.6	15.8	15.1	21.2	10.3	32.8	15.9	19.1	30.3	12.2	29.1	14.0	17.7	19.2	28.3	20.2	20.3	11.7	9.4	36.9	14.3	12.6	8.0	25.8	21.7	10.9	20.5	29.2	35.4	59.8	14.8	44.0	45.0	13.5	21.1	14.1	16.6	32.7	16.0	25.2	7.7	26.6	21.6	27.1	26.1	16.6	8.4	22.7	8.5	15.7	22.0	21.1	30.6	28.3	24.2	24.7	30.2	47.8	14.9	18.3	21.3	2.8	0.3	0.2	0.5	0.2	0.9	0.6	0.8	0.4	0.3	0.8	0.6	0.6	1.0	0.5	0.3	1.0	0.7	0.1	3.4	3.5	10.3	3.7	3.1	2.6	1.4	2.2	1.9	0.6	2.8	5.0	12.8	16.0	14.2	30.3	16.4	15.8	4.2	8.2	13.1	15.2	13.7	10.0	10.9	5.7	9.4	14.7	27.1	8.9	15.0	7.9	0.0	7.7	3.6	16.6	20.1	11.1	12.6	12.4	43.7	6.5	5.2	11.1	11.2	24.1	5.7	26.5	8.6	11.0	8.0	21.9	45.5	10.4	8.2	10.4	7.4	5.4	8.7	12.3	8.8	29.0	9.8	6.1	6.2	36.7	42.4	8.3	5.8	8.6	25.3	7.6	6.2	5.2	8.3	9.2	0.0	12.8	12.4	14.8	8.4	18.5	21.3	10.9	17.1	12.1	10.1	7.5
TSACC	"C1orf182, SIP, SSTK-IP"	ENSG00000163467	"TSSK6 activating cochaperone"	Q96A04	1	156337314-156346995	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	299	"testis: 924.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 6594.1;Late spermatids: 20555.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"basophil: 15.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA029897			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA029897: AB_2756315"	"unprognostic (3.95e-1)"	"unprognostic (5.82e-3)"	"unprognostic (8.24e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.63e-6)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.28e-2)"	0.4	1.5	1.0	0.9	1.4	0.6	1.0	1.9	1.3	0.4	1.5	0.4	0.8	0.3	2.4	0.6	0.4	0.6	0.5	1.2	1.2	0.9	1.8	0.2	1.0	1.4	1.1	0.3	0.6	0.7	0.5	0.5	1.5	1.2	0.4	2.3	0.5	0.9	0.9	0.4	0.8	0.1	1.2	0.4	0.5	924.9	1.3	0.2	1.0	0.4	0.5	0.3	0.3	3.0	2.7	3.7	1.6	1.8	1.1	2.1	2.9	1.3	0.7	1.7	1.9	3.4	1.9	4.0	2.1	0.8	1.9	3.1	3.1	0.3	1.6	2.3	6.7	2.8	6.3	3.7	0.8	2.5	2.3	0.8	5.1	1.7	2.3	1.0	0.5	3.8	7.6	2.5	0.3	4.8	2.5	1.5	5.0	6.7	4.4	2.8	0.6	4.0	4.6	1.7	2.4	1.3	1.8	5.0	2.2	6.9	2.7	2.7	1.3	1.1	1.8	0.9	1.9	4.5	7.8	6.1	0.7	1.4	1.0	15.2	0.4	0.1	1.1	0.3	0.5	1.2	0.8	1.0	0.2	1.4	1.5	1.3	0.1	1.9	0.4	1.7	1.0	0.3	1.0	1.4	1.9	1.3	1.2	1.2	1.4	1.1	1.5	1.2	1.3	3.0	0.1	0.0	0.0	0.7	1.2	0.3	0.3	1.4	0.6	0.6	1.3	1.9	0.6	0.0	1.8	3.7	0.0	4.8	0.1	0.2	1.9	0.9	6594.1	2.4	0.4	4.7	0.0	0.4	0.5	0.6	1.7	0.2	1.1	0.9	0.0	0.4	0.0	3.7	1.1	0.0	0.4	0.7	0.0	0.8	0.0	20555.9	111.6	7.6	0.0	0.0	0.0	0.4	0.0	0.5	0.9	1.0	0.1	85.7	1.2	0.3	0.6	7.9	4.5	0.8	52.6	0.1	0.3	2124.8	93.8	1.5	0.4	2.7	0.7	0.5	0.5	0.6
TSC22D1	"MGC17597, TGFB1I4, TSC22"	ENSG00000102804	"TSC22 domain family member 1"	Q15714	13	44432143-44577147	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 44.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 17.9;granulocytes: 44.7;NK-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"HEL: 247.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077414			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nuclear bodies"		"HPA077414: AB_2686839"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.78e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.08e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (8.14e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.48e-2)"	125.9	88.8	261.8	58.9	276.9	16.5	143.1	223.1	295.7	162.3	283.4	133.0	64.9	159.4	138.5	107.6	152.0	115.6	128.2	272.4	252.1	172.1	86.9	120.3	38.6	248.0	270.8	180.1	35.4	114.1	110.3	88.0	253.9	181.5	109.1	73.7	76.1	84.7	190.8	67.6	118.2	147.6	237.8	26.7	115.0	61.8	268.6	168.6	88.3	125.7	41.4	138.1	87.3	245.4	21.7	67.7	62.1	24.6	36.3	45.7	75.5	22.4	93.9	23.1	25.8	77.1	74.9	35.4	48.6	47.9	52.6	53.8	25.1	191.2	33.4	6.5	22.2	247.3	116.9	23.4	36.1	12.8	30.1	65.0	80.2	65.6	162.0	184.8	55.6	18.6	6.9	0.2	45.5	21.0	44.9	10.3	45.3	148.8	61.6	31.1	11.6	10.6	47.7	35.5	33.5	45.3	64.3	61.8	18.6	65.1	30.8	19.5	49.6	26.4	25.8	59.1	34.9	0.6	6.6	10.2	70.0	10.6	65.7	44.7	1.9	5.8	4.6	1.9	4.4	1.3	1.4	2.1	1.8	2.0	1.5	2.2	8.6	16.7	5.1	17.9	3.4	50.0	261.8	276.9	223.1	295.7	272.4	252.1	248.0	270.8	253.9	237.8	268.6	245.4	739.9	118.6	368.2	77.7	21.4	441.9	415.0	905.0	870.2	147.8	464.9	296.5	279.9	97.2	425.3	435.9	114.7	584.7	34.9	660.8	369.8	190.8	851.5	186.0	105.0	643.0	225.0	118.9	302.4	157.0	177.2	234.3	211.0	313.8	314.2	108.2	88.9	74.5	106.5	127.9	261.0	254.0	526.9	21.1	153.3	1231.0	91.6	218.4	402.0	148.0	16.2	246.2	26.8	207.1	103.8	229.5	339.6	136.5	17.2	550.9	212.0	155.1	265.8	149.9	447.0	268.2	500.9	80.9	34.6	178.2	610.0	1170.1	65.0	80.6	273.6	445.8
TSEN15	C1orf19	ENSG00000198860	"TRNA splicing endonuclease subunit 15"	Q8WW01	1	184051651-184123978	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029237	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA029237: AB_10671361"	"unprognostic (4.54e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.72e-3)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.82e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.82e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.66e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-1)"	16.4	17.9	21.4	14.8	23.0	19.8	17.8	22.2	27.9	17.1	15.4	20.6	11.6	17.4	28.1	15.1	14.7	12.3	21.9	21.1	22.6	14.7	15.3	16.6	19.1	23.1	20.4	11.6	17.3	15.9	11.8	17.5	22.5	17.2	13.6	21.7	15.2	15.2	36.2	14.1	11.5	17.8	19.9	14.7	15.3	14.6	22.3	28.1	21.0	22.8	18.7	16.4	12.3	29.7	83.3	28.2	39.2	41.6	30.1	31.7	96.6	40.1	77.9	64.1	61.7	30.0	35.8	54.3	40.2	50.4	41.0	38.8	44.2	38.7	69.6	78.1	23.4	28.2	19.7	34.7	60.1	103.4	32.3	21.1	67.2	29.7	60.9	25.4	38.1	95.5	55.9	144.0	59.7	43.4	97.8	46.5	72.6	107.6	30.7	60.3	65.0	113.0	37.6	26.6	35.2	52.3	54.0	39.0	102.7	41.2	51.1	57.8	20.0	39.5	83.9	26.5	61.9	190.4	141.7	87.1	36.7	52.5	86.1	33.5	16.7	24.7	33.7	27.5	30.2	24.8	32.3	35.3	35.9	18.1	24.4	33.7	3.1	54.3	25.4	31.8	39.8	35.0	21.4	23.0	22.2	27.9	21.1	22.6	23.1	20.4	22.5	19.9	22.3	29.7	15.5	48.1	8.1	22.2	26.1	11.1	12.4	17.3	16.5	8.7	18.4	13.7	32.0	10.0	17.1	12.9	4.2	42.5	31.4	3.4	54.8	33.0	1.6	6.7	13.1	15.9	6.7	22.7	30.9	41.8	48.9	20.0	14.3	11.7	32.3	18.0	18.2	34.0	31.7	3.3	32.7	8.4	10.2	13.1	29.1	2.5	21.8	16.6	33.8	13.1	21.6	19.8	64.9	42.7	91.7	35.9	4.5	19.5	45.7	13.3	5.4	71.4	6.9	12.5	13.1	11.3	24.9	46.0	44.6	23.1	13.2	22.6	34.8	19.1	9.8	10.5
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484421-12541549	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (3.49e-4)"	8.9	9.4	3.4	1.1	3.9	0.3	8.9	4.4	4.8	11.5	3.7	11.5	1.4	10.9	2.6	8.6	12.0	1.8	15.5	3.5	3.7	10.2	8.5	6.0	2.2	3.6	3.5	14.2	12.1	3.2	10.9	0.9	3.6	10.0	2.3	3.4	6.7	3.2	15.9	8.3	6.9	3.2	3.3	6.6	9.7	6.7	3.9	2.6	9.0	3.8	2.2	11.5	9.7	3.8	6.2	11.8	5.5	7.4	6.3	7.7	7.6	5.8	4.3	6.6	5.1	4.2	5.2	5.5	3.3	4.0	5.8	5.8	7.8	9.4	5.4	5.5	9.8	5.1	9.1	5.7	5.4	9.3	2.1	4.9	11.2	10.1	9.7	3.3	4.7	8.8	10.7	3.4	6.5	11.9	9.6	6.1	6.5	10.5	13.5	4.6	2.3	13.5	9.9	4.8	1.5	4.5	6.7	5.0	4.8	3.1	10.1	5.1	4.5	4.2	3.9	4.7	9.7	3.1	8.6	6.2	5.6	11.8	5.4	0.6	1.9	0.0	2.7	1.6	4.4	3.7	4.6	3.8	2.3	3.2	6.2	5.1	0.4	2.5	1.7	3.4	1.6	2.6	3.4	3.9	4.4	4.8	3.5	3.7	3.6	3.5	3.6	3.3	3.9	3.8	5.5	3.2	3.3	26.1	8.9	2.9	11.2	5.6	13.1	28.1	3.7	4.3	7.0	10.0	3.8	11.0	43.8	8.8	2.6	9.2	1.9	6.2	1.6	7.1	7.4	6.2	4.2	8.4	42.8	4.2	4.3	5.7	13.7	3.7	5.1	17.7	3.6	5.0	4.6	10.1	46.4	5.2	4.1	3.5	1.7	2.8	9.0	3.6	3.6	16.9	2.4	8.0	6.2	19.1	31.8	4.5	5.0	10.1	3.8	6.2	2.3	6.9	11.1	34.1	6.6	7.9	6.3	14.0	23.0	7.1	4.8	1.9	4.6	15.3	8.4	8.0
TSEN34	"LENG5, SEN34, SEN34L"	ENSG00000170892	"TRNA splicing endonuclease subunit 34"	Q9BSV6	19	54189938-54194536	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Disease variant, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 5.0;eosinophil: 1.9;neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041111, HPA048208"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA041111: AB_10794263, HPA048208: AB_2680313"	"unprognostic (3.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (2.38e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.12e-1)"	28.5	68.2	2.2	1.3	1.8	1.3	29.5	2.4	2.4	38.8	1.8	34.7	1.1	37.1	1.9	41.0	37.8	1.5	26.3	2.1	1.7	39.1	41.3	31.5	1.3	2.2	1.7	47.9	43.0	1.8	36.0	1.3	2.0	36.2	1.3	2.0	34.0	1.9	26.7	40.5	27.7	1.2	1.3	44.1	34.3	45.0	1.7	0.5	30.9	1.8	0.7	38.9	34.2	2.2	3.3	1.7	2.5	3.1	1.3	2.0	3.9	0.6	1.0	0.9	1.7	2.1	1.1	1.1	0.0	0.9	2.5	2.5	2.6	2.3	1.4	1.1	6.2	1.0	1.1	2.0	0.5	1.1	1.1	1.9	1.1	2.0	1.3	0.9	1.3	0.0	1.7	0.9	2.4	1.4	0.4	0.2	1.5	2.9	1.1	1.4	2.6	0.7	3.4	2.4	0.1	1.7	0.0	3.5	3.0	2.5	2.6	3.1	1.1	0.2	2.8	2.7	3.4	1.4	1.9	0.9	2.6	1.3	1.2	5.0	0.6	1.9	0.2	0.5	0.4	0.1	0.3	0.1	0.3	0.4	0.4	0.2	4.8	0.0	0.3	0.4	0.0	0.2	2.2	1.8	2.4	2.4	2.1	1.7	2.2	1.7	2.0	1.3	1.7	2.2	33.1	12.8	27.7	6.8	28.2	73.5	92.0	137.7	67.2	35.4	62.9	60.8	11.8	52.9	60.9	44.1	29.2	102.5	45.4	58.8	95.9	68.7	24.0	39.4	37.0	32.5	76.8	13.7	3.8	59.7	98.2	47.5	19.9	35.3	26.6	47.7	35.7	40.6	57.8	16.8	4.9	103.7	122.1	37.0	53.6	17.2	67.7	45.0	46.2	1.0	51.8	81.9	18.6	6.0	5.9	50.4	55.9	66.5	27.6	79.8	57.8	110.5	70.0	48.9	59.2	38.7	60.8	40.1	77.2	56.7	70.2	111.0	32.8	100.3	66.5	62.3
TSEN54	"SEN54, SEN54L"	ENSG00000182173	"TRNA splicing endonuclease subunit 54"	Q7Z6J9	17	75515944-75524735	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease variant, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 78.4;granulocytes: 81.7;NK-cells: 87.6;T-cells: 70.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024543, HPA053097"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA024543: , HPA053097: AB_2682043"	"unprognostic (3.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.60e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (2.33e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (2.62e-5)"	"unprognostic (7.26e-3)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.78e-5)"	"unprognostic (8.69e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.54e-4)"	11.1	14.9	2.8	1.3	4.2	2.1	12.7	5.2	3.2	14.1	2.3	19.2	2.9	11.8	0.2	23.2	15.5	3.1	8.3	2.6	3.2	27.2	18.2	17.8	2.9	5.0	4.1	12.4	29.9	4.1	18.3	1.7	3.5	20.0	2.1	0.4	17.4	3.4	9.5	24.3	22.5	2.3	4.1	25.4	20.4	14.2	3.5	5.1	18.1	1.8	2.5	15.1	17.0	4.6	21.8	25.3	2.6	7.2	2.7	2.7	14.7	6.1	6.6	14.4	13.0	35.4	3.9	32.5	9.1	3.6	12.3	11.9	14.3	11.1	7.5	7.7	33.9	26.2	4.7	23.9	11.8	7.5	36.0	2.7	13.7	6.2	5.8	2.0	14.0	20.7	31.5	6.0	2.8	36.6	46.7	19.1	9.0	31.7	30.5	26.4	23.6	25.1	8.4	9.5	19.0	17.0	13.2	30.8	14.3	8.5	11.9	17.3	3.0	6.2	20.7	13.7	12.5	22.6	14.1	19.0	6.1	32.7	6.4	20.0	4.1	14.4	82.1	9.7	56.1	11.5	34.1	62.4	10.8	7.2	26.5	50.0	0.2	47.7	9.8	26.2	21.2	27.1	2.8	4.2	5.2	3.2	2.6	3.2	5.0	4.1	3.5	4.1	3.5	4.6	9.8	9.6	9.6	15.7	13.3	26.4	10.7	19.0	17.6	15.4	11.3	11.9	2.6	20.0	11.6	9.2	4.2	13.6	78.4	25.4	11.7	17.8	6.1	7.7	6.9	10.8	18.7	14.9	14.7	17.2	18.2	8.1	29.0	7.0	81.7	10.2	8.6	8.6	13.2	32.0	15.0	16.9	24.4	4.7	11.1	4.6	4.7	9.2	16.0	5.6	12.5	15.4	87.6	14.1	23.9	14.5	13.8	7.5	29.2	22.3	23.1	13.1	5.0	7.7	13.1	5.9	7.4	15.0	33.8	21.3	24.3	7.5	70.4	14.6	22.6	8.7
TSFM	"EF-TS, EF-Tsmt"	ENSG00000123297	"Ts translation elongation factor, mitochondrial"	P43897	12	57782761-57808071	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"RH-30: 962.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006204			Supported	Nucleoplasm,Mitochondria		NA	NA		9200	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA006204: AB_1080405"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.93e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (8.82e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	23.1	57.6	17.7	23.5	18.5	26.1	26.3	18.8	20.9	16.7	21.1	28.9	27.4	15.0	17.4	22.3	18.0	13.9	43.6	18.8	19.0	39.2	45.2	15.1	24.2	18.4	18.3	13.5	17.1	35.0	16.5	16.5	19.7	16.6	26.8	16.7	20.0	16.4	58.6	21.6	21.0	17.5	19.0	17.4	19.7	25.2	18.9	22.5	16.2	64.3	20.7	24.4	15.7	18.7	56.3	63.1	35.5	52.5	33.7	33.9	53.2	46.4	39.8	71.6	50.2	74.1	71.6	142.6	85.8	38.9	39.1	64.9	60.1	66.2	51.3	57.7	78.0	82.6	51.9	64.7	50.5	112.7	47.2	39.6	65.3	55.6	25.4	52.2	44.7	75.7	110.3	70.0	56.3	64.8	64.8	113.0	57.5	81.7	83.7	78.3	962.0	125.5	70.5	64.1	80.0	49.1	47.7	84.8	83.6	31.5	148.9	71.7	33.1	39.6	54.6	58.9	49.1	52.0	120.2	108.7	53.6	63.7	48.1	8.5	24.6	15.3	28.0	23.7	36.0	28.5	30.9	28.3	30.3	26.9	31.1	31.7	6.5	33.6	30.5	23.4	30.9	26.9	17.7	18.5	18.8	20.9	18.8	19.0	18.4	18.3	19.7	19.0	18.9	18.7	16.5	19.2	10.8	6.2	18.5	25.9	14.5	57.4	10.8	19.4	24.6	21.1	31.8	27.1	28.7	46.0	14.6	68.5	23.5	13.2	95.9	66.0	73.3	19.5	19.7	18.7	13.8	20.0	8.4	87.6	52.3	18.8	13.3	16.3	22.2	31.0	16.4	38.3	35.4	15.2	8.5	20.9	36.7	11.4	13.9	42.5	22.7	18.1	26.6	10.3	66.6	23.1	12.3	9.5	8.4	47.2	15.7	24.0	17.5	21.3	19.9	146.2	26.0	20.1	59.2	19.7	31.6	46.1	65.8	21.1	36.2	47.6	18.6	71.1	35.3	13.9
TSHZ1	"NY-CO-33, SDCCAG33, TSH1"	ENSG00000179981	"Teashirt zinc finger homeobox 1"	Q6ZSZ6	18	75210755-75289950	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 84.9;Peritubular cells: 187.3;Theca cells: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.4"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 115.6"	"Low region specificity"	"Detected in all"			HPA006982	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006982: AB_1079886"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.12e-2)"	"unprognostic (9.05e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (3.42e-3)"	12.0	7.7	16.3	7.1	14.1	3.3	12.1	23.5	21.0	17.4	6.3	18.1	13.8	11.4	9.3	10.0	15.9	10.4	10.9	17.0	10.4	12.1	8.2	8.0	7.3	18.8	11.5	35.4	7.2	9.2	9.7	29.7	19.3	8.9	9.3	7.9	12.5	11.1	9.2	10.6	13.7	9.3	20.1	9.4	8.8	6.3	15.5	12.3	8.2	6.4	5.3	10.9	11.0	14.1	5.4	7.0	2.2	12.8	18.8	8.9	2.2	24.2	22.6	4.0	7.4	3.2	12.9	10.8	3.0	21.9	4.5	4.8	2.9	6.9	1.4	44.4	23.2	8.3	14.5	4.3	4.9	20.0	9.4	9.1	7.2	3.3	6.5	6.2	10.1	12.5	4.7	19.1	6.6	5.2	14.3	11.4	0.9	6.3	7.6	12.9	6.6	12.9	7.6	3.9	15.9	12.1	6.8	8.8	6.8	0.8	2.0	10.4	7.6	8.7	5.9	6.0	3.9	6.2	15.9	8.7	8.6	16.6	8.1	0.0	0.5	0.5	2.1	0.2	1.4	0.4	1.0	1.8	0.8	0.6	1.5	2.2	0.3	1.5	0.2	0.8	0.4	0.7	16.3	14.1	23.5	21.0	17.0	10.4	18.8	11.5	19.3	20.1	15.5	14.1	60.2	12.8	14.0	34.3	7.1	17.0	5.6	4.8	27.9	40.8	12.2	12.6	24.4	25.8	7.9	3.7	2.1	4.6	25.6	25.4	3.9	7.5	1.2	12.5	33.9	34.4	16.9	6.9	24.9	10.0	2.2	28.8	4.6	18.2	7.0	22.5	21.0	20.5	6.4	11.8	27.7	15.0	10.2	10.8	30.9	5.9	64.7	14.3	8.8	30.0	11.2	17.9	24.7	84.9	21.3	2.9	14.7	187.3	10.6	7.3	29.7	18.4	9.1	12.1	26.3	21.3	12.2	1.4	4.8	33.1	13.2	3.6	18.2	83.2	17.9	5.4
TSHZ2	"C20orf17, OVC10-2, TSH2, ZABC2, ZNF218"	ENSG00000182463	"Teashirt zinc finger homeobox 2"	Q9NRE2	20	52972358-53495330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 395.6;Leydig cells: 468.2;Peritubular cells: 803.8;Theca cells: 396.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 26.7;ASC diff: 11.3;HeLa: 23.6;SiHa: 15.3;U-2197: 13.7"	"Low region specificity"	"Detected in all"							HPA038123	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA038123: AB_10670657"	"unprognostic (9.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (3.30e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.88e-8)"	"unprognostic (6.26e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.37e-7)"	"unprognostic (2.97e-3)"	21.5	14.8	3.4	4.5	4.7	0.2	10.6	2.9	4.3	9.0	0.0	7.3	2.3	6.8	16.5	8.2	8.7	12.4	3.7	5.7	8.9	3.3	12.6	2.9	3.9	5.9	8.2	18.4	3.5	5.4	2.7	1.3	5.5	5.4	2.0	1.7	12.9	13.6	1.6	5.9	2.8	8.8	10.3	5.1	6.1	4.8	8.1	2.0	5.3	2.6	3.4	7.6	5.7	7.5	0.0	0.0	1.8	26.7	11.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	6.8	0.0	0.1	0.0	0.1	0.0	5.2	1.4	0.0	23.6	0.0	0.3	0.0	0.6	4.1	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.7	4.4	15.3	0.1	0.0	0.7	0.0	0.0	0.0	0.1	2.6	13.7	0.0	0.1	0.3	0.0	2.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.4	3.0	0.2	0.6	0.1	0.0	0.1	2.4	0.5	3.4	4.7	2.9	4.3	5.7	8.9	5.9	8.2	5.5	10.3	8.1	7.5	171.4	0.0	0.6	32.7	7.0	45.4	19.9	43.8	37.0	6.7	24.4	161.5	2.8	54.3	41.6	36.8	2.1	1.3	1.3	0.1	0.0	52.2	11.1	32.7	144.4	125.7	6.6	0.0	188.2	9.8	0.5	93.3	3.1	68.9	1.3	395.6	11.7	92.1	1.2	0.0	58.1	1.9	18.3	1.3	16.6	20.3	468.2	2.8	12.4	104.9	1.9	39.0	1.0	23.6	4.9	6.8	2.7	803.8	16.0	27.5	0.8	0.4	19.9	1.9	39.5	10.9	48.2	2.6	1.8	43.9	40.5	0.8	24.2	396.9	2.6	8.2
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31149979-31349436	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 32.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.0;Excitatory neurons: 34.4;Inhibitory neurons: 84.7;Oligodendrocyte precursor cells: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.2;RH-30: 46.4;U-138 MG: 32.8;U-87 MG: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	7.0	3.6	4.6	4.8	4.5	1.1	6.2	0.0	8.6	18.8	0.3	16.1	2.2	21.5	9.2	5.7	13.0	9.3	5.7	5.7	0.4	3.2	1.3	6.3	1.2	3.1	1.0	32.8	1.5	1.3	4.6	5.7	1.5	11.6	4.0	1.8	3.3	9.5	1.9	3.0	5.5	18.4	3.9	5.4	6.7	2.7	3.1	0.8	10.2	2.3	0.5	14.8	8.8	4.9	0.0	2.0	0.7	0.0	9.4	22.2	0.0	6.0	8.8	3.7	6.6	0.0	1.2	0.0	0.0	14.8	7.0	1.0	2.7	5.3	8.2	0.0	2.2	0.0	0.0	0.0	19.4	5.2	9.1	13.0	4.5	13.7	6.8	0.0	0.0	4.4	0.0	0.0	16.9	0.9	0.0	0.0	0.7	0.0	0.0	5.9	46.4	0.0	0.0	0.0	0.0	13.8	0.1	0.0	4.7	4.4	0.0	3.6	0.0	32.8	10.3	3.4	8.8	0.0	0.0	0.0	21.2	8.8	0.9	0.0	0.9	0.0	1.1	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.3	1.9	0.0	0.1	0.0	0.3	0.3	4.6	4.5	0.0	8.6	5.7	0.4	3.1	1.0	1.5	3.9	3.1	4.9	8.3	3.2	1.1	10.1	0.2	4.8	7.3	9.2	15.4	14.0	0.8	2.4	2.1	1.5	5.1	3.7	0.0	0.4	2.5	0.0	0.0	0.4	0.2	1.3	54.0	9.0	0.0	0.4	34.4	0.6	0.3	20.2	0.0	1.3	1.3	2.6	17.2	0.2	11.6	16.8	84.7	0.0	2.0	9.7	10.4	1.1	17.7	5.0	5.4	14.0	6.4	0.2	0.0	59.3	1.9	0.6	0.0	29.3	0.3	3.8	0.0	0.1	1.3	0.2	0.0	29.7	7.8	0.3	4.0	1.7	1.7	0.8	1.7	1.0	0.0	3.2
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798153	"Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 237.3"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 506.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 168.0;ASC diff: 282.5;OE19: 188.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted to blood"	NA	NA		6200000	"Cluster 6: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (2.87e-4)"	"prognostic favorable (1.66e-4)"	"prognostic unfavorable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	96.5	12.1	4.2	8.3	4.5	2.1	80.4	6.5	5.8	147.1	27.8	23.5	37.1	46.4	20.6	62.8	67.7	14.9	34.8	6.5	2.7	41.5	237.3	15.0	2.4	4.4	3.1	47.0	16.8	6.4	14.8	30.3	5.0	44.0	14.4	4.1	33.9	24.6	9.5	60.0	32.3	41.1	1.9	6.9	28.2	9.1	3.9	4.7	37.6	5.7	5.6	41.6	99.6	4.4	3.7	168.0	19.1	18.4	282.5	36.1	34.6	5.9	32.2	12.6	12.0	22.2	48.0	0.3	32.7	21.1	53.7	68.6	10.9	42.7	3.9	35.7	5.9	8.3	43.5	63.1	53.6	3.0	11.9	37.3	46.0	22.5	18.2	24.0	15.7	6.4	19.9	1.4	11.7	81.9	0.5	6.5	24.5	188.9	7.4	5.9	18.3	28.7	29.7	29.7	16.8	28.5	32.7	25.7	15.4	15.8	34.5	2.7	4.9	35.4	28.2	86.8	14.2	1.1	0.6	1.4	16.6	8.9	6.4	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	4.2	4.5	6.5	5.8	6.5	2.7	4.4	3.1	5.0	1.9	3.9	4.4	6.2	0.0	0.5	1.0	0.5	17.3	12.1	25.8	27.9	3.5	13.6	13.2	3.2	11.5	12.1	1.8	0.0	50.0	0.1	33.2	0.0	6.7	0.2	8.1	35.6	5.8	7.8	13.5	0.5	21.7	71.8	33.0	14.8	10.6	1.3	38.7	9.7	506.3	9.9	0.0	0.1	12.4	26.4	9.1	6.4	2.0	37.3	0.8	5.4	1.9	1.6	9.2	0.0	0.0	0.0	21.3	21.2	45.1	0.1	14.6	28.6	21.9	3.0	0.6	0.0	1.0	11.3	0.4	2.0	22.3	22.6	43.8	1.6	8.6	13.8	20.1
TSN	"BCLF-1, REHF-1, TRSLN"	ENSG00000211460	Translin	Q15631	2	121737103-121767853	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059561	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		280000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA059561: AB_2684063"	"unprognostic (3.15e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (7.13e-3)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (2.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.18e-1)"	16.2	16.9	20.9	13.5	21.9	47.8	25.4	22.7	28.4	17.4	18.9	23.3	16.9	15.8	17.9	16.6	14.2	13.2	19.5	21.0	23.6	24.4	22.9	14.3	19.1	21.3	22.4	16.7	18.4	21.7	13.1	10.8	22.3	14.5	18.8	16.6	14.9	17.2	31.6	19.3	14.6	14.2	21.4	14.7	15.0	26.2	22.0	24.1	17.2	31.0	18.2	15.6	12.8	23.8	56.2	24.8	38.4	34.1	35.0	27.8	21.1	45.6	43.2	50.3	48.4	71.1	32.3	81.7	51.9	45.4	30.1	27.0	55.0	46.6	69.8	43.2	44.3	48.0	33.0	68.3	40.0	69.3	32.5	24.2	51.3	56.3	38.7	23.0	43.2	40.0	72.9	39.4	47.4	30.5	38.2	77.5	46.6	32.8	47.2	67.6	43.1	59.3	63.7	36.0	48.9	30.6	31.4	46.6	61.2	29.2	29.3	54.1	30.8	36.2	56.4	22.9	45.1	33.8	97.0	85.4	40.3	46.8	45.6	27.6	29.8	28.6	22.5	27.9	26.9	27.4	23.4	19.8	27.4	21.0	26.5	22.9	9.3	26.9	24.3	20.1	25.6	28.8	20.9	21.9	22.7	28.4	21.0	23.6	21.3	22.4	22.3	21.4	22.0	23.8	34.7	32.1	24.4	15.0	37.5	39.1	34.4	49.1	23.3	32.1	38.2	27.6	34.7	42.9	36.9	42.3	22.9	34.9	34.3	22.3	43.0	64.4	80.0	24.9	29.7	42.7	19.9	34.7	19.8	60.0	33.3	32.5	15.8	23.9	40.0	36.0	58.5	44.4	35.2	16.8	19.8	27.7	57.0	35.6	34.9	19.8	36.4	29.8	67.6	15.0	45.4	88.7	44.3	29.1	33.5	45.4	22.2	31.2	25.4	34.7	24.4	58.7	33.0	29.5	26.3	39.9	81.8	152.8	96.6	36.7	43.9	28.5	36.8	38.5	37.9	28.8
TSNAX	"C3PO, TRAX"	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528541-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 194.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		36000	"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	22.7	31.9	12.2	20.2	12.8	15.1	25.4	11.5	15.1	19.5	17.8	18.4	17.7	21.5	22.8	19.4	18.0	18.7	26.2	13.2	15.2	31.7	26.0	20.8	26.4	11.9	12.7	18.3	16.3	40.0	17.0	20.4	12.3	22.8	19.6	19.9	18.1	20.5	50.5	21.8	17.3	20.7	13.4	28.5	17.7	20.9	13.2	26.6	29.8	40.7	25.7	19.9	14.9	13.7	30.3	24.1	36.7	29.7	27.1	32.6	41.4	33.1	50.9	42.2	36.0	21.4	40.8	42.3	55.0	38.0	15.7	31.9	29.3	31.4	53.9	38.4	51.7	40.7	23.9	28.6	35.8	67.8	82.1	40.4	32.4	40.9	32.3	26.4	30.7	31.6	66.6	28.8	58.0	12.9	44.0	32.9	53.4	26.5	28.3	42.8	39.8	56.8	46.9	33.9	34.1	65.7	35.3	43.3	116.8	14.5	63.2	113.0	28.9	28.3	26.3	57.6	61.0	48.2	68.9	46.4	46.8	52.0	79.7	194.4	34.8	85.6	30.6	40.2	30.3	28.5	33.5	30.6	33.2	28.3	34.6	34.0	37.7	51.9	55.7	22.3	39.4	33.6	12.2	12.8	11.5	15.1	13.2	15.2	11.9	12.7	12.3	13.4	13.2	13.7	48.3	28.9	41.3	0.0	25.5	43.8	21.4	42.4	8.6	59.2	27.2	20.1	24.1	40.0	25.3	42.3	29.2	44.4	36.9	21.8	54.8	30.6	12.6	23.6	20.5	46.1	28.9	59.5	0.0	31.1	51.5	28.1	11.7	19.3	77.3	26.2	31.8	32.8	49.5	65.6	0.0	28.2	38.7	62.2	35.0	9.4	33.5	40.5	26.6	0.0	51.7	72.0	37.0	0.0	0.0	26.5	21.8	36.1	13.4	17.3	22.4	45.8	31.9	47.1	39.5	34.4	30.2	40.8	65.4	13.0	51.4	36.3	30.5	46.8	25.6	14.9
TSNAXIP1	TXI1	ENSG00000102904	"Translin associated factor X interacting protein 1"	Q2TAA8	16	67806765-67832148	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 8.6;testis: 21.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 99.9;Endometrial ciliated cells: 41.1;Late spermatids: 178.6;Respiratory ciliated cells: 51.9;Spermatocytes: 53.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.0;SiHa: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA053516			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA053516: AB_2682175"	"unprognostic (9.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.59e-3)"	0.5	1.0	1.1	0.4	1.3	0.1	0.5	0.8	1.8	1.4	2.8	1.0	0.0	0.9	0.9	0.2	8.6	0.4	0.3	1.3	1.2	1.2	0.8	1.3	0.1	1.8	2.2	1.5	1.2	1.3	6.4	0.1	1.7	0.9	0.1	3.5	0.3	0.4	0.2	0.3	0.3	0.4	1.2	0.3	0.5	21.5	1.3	0.2	0.7	0.0	0.1	0.6	0.5	1.0	0.5	0.1	1.1	3.0	1.4	0.4	0.4	0.1	0.7	0.2	1.0	0.3	0.3	0.4	0.4	0.1	0.3	0.6	0.3	0.4	0.6	0.1	0.4	0.0	0.4	0.0	0.4	0.7	0.0	0.3	0.4	1.4	0.2	0.2	0.0	0.6	0.2	0.1	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.8	0.3	0.0	1.3	0.3	0.8	1.0	2.0	0.0	0.2	0.3	0.8	0.0	0.3	0.1	0.0	0.3	0.1	0.5	1.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.8	1.8	1.3	1.2	1.8	2.2	1.7	1.2	1.3	1.0	0.6	0.0	2.7	9.1	0.2	0.1	0.4	2.5	0.6	2.9	1.0	1.1	12.0	0.0	4.8	5.5	4.2	0.4	0.2	0.2	0.0	0.7	99.9	41.1	2.0	1.1	0.0	0.4	7.9	0.0	0.2	1.6	0.0	1.3	0.0	1.3	0.7	0.7	0.3	3.3	4.9	0.0	10.2	0.0	0.2	178.6	2.8	0.3	0.0	3.7	0.0	3.7	0.0	3.0	1.3	0.1	0.0	1.9	0.0	0.3	0.0	2.5	51.9	10.2	6.6	0.6	1.7	53.3	8.9	0.1	0.3	0.5	0.2	1.4	0.0	0.2
TSPAN1	"NET-1, TSPAN-1"	ENSG00000117472	"Tetraspanin 1"	O60635	1	46175073-46185962	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 593.8;kidney: 244.3"	"Cell type enhanced"	"Detected in many"		"Club cells: 723.5;Distal enterocytes: 1983.8;Late spermatids: 838.1;Paneth cells: 1127.7;Respiratory ciliated cells: 1817.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 455.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	57	"plasmacytoid DC: 5.6"	"Lineage enriched"	"Detected in single"	57	"dendritic cells: 5.6"	"Cell line enhanced"	"Detected in many"		"A-431: 129.6;CAPAN-2: 216.7;HaCaT: 151.4;hTCEpi: 173.6;OE19: 257.9;RPTEC TERT1: 628.4;RT4: 308.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA011909	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA011909: AB_2668565"	"unprognostic (1.21e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.28e-6)"	"unprognostic (5.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.90e-2)"	"unprognostic (4.30e-2)"	1.9	4.3	0.5	53.2	0.7	0.0	6.2	1.7	1.1	78.2	1.4	523.3	25.4	17.7	34.7	5.5	122.4	28.9	0.9	0.5	0.5	244.3	3.9	32.1	0.4	1.2	0.6	0.4	3.1	72.0	17.3	1.1	1.1	194.7	593.8	0.0	101.0	65.9	0.8	2.5	96.7	20.8	1.0	0.7	213.1	27.3	0.6	1.9	121.9	0.1	4.9	104.9	9.9	1.8	129.6	2.0	0.0	0.0	0.2	0.0	1.8	0.1	2.7	0.1	0.0	0.0	216.7	0.0	40.2	0.3	0.2	151.4	0.0	111.2	0.1	0.0	0.0	0.0	1.1	7.6	0.0	0.0	0.2	0.0	173.6	0.7	60.9	3.6	0.3	1.3	0.0	0.0	1.6	4.9	0.0	0.5	0.1	257.9	8.1	0.1	0.1	1.6	628.4	308.2	1.9	0.0	0.3	13.0	0.5	0.5	9.0	0.1	1.4	0.0	0.7	0.4	0.7	1.5	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.5	0.7	1.7	1.1	0.5	0.5	1.2	0.6	1.1	1.0	0.6	1.8	2.5	25.6	29.5	0.3	7.4	1.0	194.4	499.9	4.0	0.0	14.5	11.0	0.7	11.5	723.5	579.4	0.0	0.3	0.2	1983.8	46.9	61.3	141.3	268.3	14.1	4.5	201.8	0.0	1.2	525.1	0.1	6.0	223.3	144.3	11.4	0.0	1.4	3.6	0.3	0.0	1.3	648.1	242.1	0.3	0.3	838.1	5.0	5.3	5.4	1.0	1.6	0.0	0.0	0.5	1.6	484.4	1127.7	1.9	0.7	211.7	505.4	477.8	1817.6	0.0	0.0	0.4	54.1	4.7	2.6	2.9	1.3	0.0	7.4	0.0	275.9	517.0
TSPAN13	"NET-6, TM4SF13"	ENSG00000106537	"Tetraspanin 13"	O95857	7	16753755-16784536	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 303.4;Alveolar cells type 1: 496.8;Cytotrophoblasts: 293.7;Intestinal goblet cells: 404.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 99.6;plasmacytoid DC: 231.7"	"Group enriched"	"Detected in many"	42	"B-cells: 99.6;dendritic cells: 231.7"	"Cell line enhanced"	"Detected in many"		"OE19: 484.5;SCLC-21H: 215.3;SK-BR-3: 314.0;T-47d: 587.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007426	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA007426: AB_10603137"	"unprognostic (3.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (5.69e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (2.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-1)"	65.6	81.1	32.1	29.1	37.2	26.1	76.3	20.5	95.8	60.7	17.0	83.5	88.9	20.0	36.9	19.7	19.9	55.5	23.9	36.2	67.1	7.8	47.4	185.5	56.2	24.1	28.3	3.1	95.8	14.1	83.6	67.1	28.7	51.1	99.9	19.4	168.0	35.8	9.3	16.6	77.3	20.3	19.8	26.3	108.0	8.9	27.1	20.4	35.1	13.7	47.2	41.0	16.1	29.3	47.4	38.6	47.8	50.9	6.0	0.2	13.2	99.0	16.1	2.6	4.9	137.4	70.9	1.4	24.7	35.8	12.3	71.2	56.2	83.2	21.6	1.4	60.3	20.3	15.3	14.8	13.3	1.9	4.0	5.6	35.4	5.2	5.9	27.4	30.1	20.7	67.0	0.4	2.9	135.4	2.8	2.6	33.4	484.5	46.5	54.0	0.2	48.5	153.1	90.1	215.3	32.5	18.0	314.0	4.8	68.1	587.9	5.2	2.9	1.4	17.0	1.5	33.1	28.4	0.8	1.0	44.2	0.8	69.1	0.6	0.0	0.2	0.0	0.0	0.1	47.9	0.1	0.0	1.1	99.6	0.0	0.1	3.9	3.6	0.1	231.7	0.0	5.6	32.1	37.2	20.5	95.8	36.2	67.1	24.1	28.3	28.7	19.8	27.1	29.3	303.4	496.8	82.5	10.1	94.0	42.6	84.9	96.0	31.9	78.2	141.7	46.7	19.1	41.5	137.6	29.5	8.4	293.7	131.6	95.4	7.9	68.0	1.6	27.8	6.5	97.9	107.7	60.2	79.3	203.9	109.3	22.5	89.2	67.1	9.5	1.0	7.5	26.3	40.8	15.2	56.8	404.6	122.1	18.9	22.6	2.5	0.6	9.4	32.0	9.4	61.3	3.5	2.1	23.6	7.6	109.1	88.8	0.7	49.9	127.4	99.8	0.9	63.2	8.1	32.9	2.2	22.0	1.7	19.5	39.4	39.6	201.1	8.9	6.1	125.3	173.6
TSPAN2	"FLJ12082, TSN2, TSPAN-2"	ENSG00000134198	"Tetraspanin 2"	O60636	1	115048011-115089503	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.4;intestine: 55.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 35.3;Enteroendocrine cells: 39.4;NK-cells: 40.2;Prostatic glandular cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 109.0;neutrophil: 109.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 109.8;NK-cells: 86.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 58.8;hTERT-RPE1: 16.9;U-937: 26.9"	"Region enhanced"	"Detected in all"		"white matter: 842.5"	"Low region specificity"	"Detected in many"			"HPA015640, HPA073306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA015640: AB_1858405, HPA073306: "	"unprognostic (4.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (9.73e-6)"	"unprognostic (6.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.48e-7)"	"unprognostic (5.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.80e-3)"	7.2	1.8	3.5	10.1	1.9	20.8	4.5	0.9	1.4	10.7	1.3	55.4	5.4	47.4	7.5	14.6	22.2	7.4	7.4	1.0	3.6	8.4	0.8	6.5	1.4	5.4	4.1	2.9	2.9	10.2	2.1	3.0	5.7	15.4	12.0	2.0	3.0	28.3	2.8	2.0	11.0	42.7	2.1	3.8	13.8	1.1	5.7	2.7	2.7	5.2	1.1	24.7	8.0	1.2	15.1	0.3	1.2	0.0	0.0	0.2	0.1	2.1	1.0	2.4	3.8	3.1	9.5	0.0	58.8	3.5	3.3	2.2	1.9	0.0	2.7	3.1	1.2	0.5	1.1	0.0	0.2	0.1	0.0	0.0	0.4	0.7	0.0	16.9	0.1	11.1	0.0	0.9	0.0	0.8	8.2	1.3	13.8	3.2	1.6	0.1	0.8	0.0	0.4	5.8	3.0	4.5	3.5	1.6	0.2	8.2	0.3	0.6	0.2	0.2	5.7	0.4	14.1	12.5	0.4	0.1	0.1	26.9	6.9	109.0	9.1	55.8	17.4	0.2	5.6	0.6	20.5	22.6	4.1	0.3	3.4	17.0	109.8	86.2	0.1	3.8	3.3	13.1	3.5	1.9	0.9	1.4	1.0	3.6	5.4	4.1	5.7	2.1	5.7	1.2	18.7	0.0	0.6	0.3	1.4	8.0	23.2	10.9	1.8	2.5	1.5	7.6	9.6	0.0	4.4	11.0	0.0	1.4	19.9	0.1	0.0	35.3	12.2	14.3	0.9	16.3	39.4	3.0	2.8	2.4	4.3	4.0	0.5	16.3	0.0	2.0	6.4	0.0	0.7	0.0	5.4	1.3	4.1	0.6	3.7	4.6	0.6	3.0	3.6	2.8	2.7	0.0	40.2	1.5	0.2	10.9	0.0	3.0	3.3	30.0	0.0	1.3	10.7	0.4	6.6	1.4	16.2	0.1	0.9	0.2	2.7	0.3	17.2	0.1	1.4	21.6
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 705.9;Muller glia cells: 508.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"memory B-cell: 481.0;naive B-cell: 488.1;plasmacytoid DC: 313.2"	"Group enriched"	"Detected in all"	5	"B-cells: 488.1;dendritic cells: 313.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	333.8	143.9	257.2	87.3	248.9	33.3	143.3	253.4	292.4	138.2	288.7	364.2	342.1	130.9	432.8	78.4	249.8	186.2	108.8	247.8	296.3	211.3	87.4	202.1	88.0	250.0	267.7	148.1	140.2	283.4	189.7	111.6	260.2	96.2	386.3	418.6	152.2	187.3	429.1	78.3	349.2	128.3	266.7	84.8	221.2	84.8	282.5	71.6	200.3	374.4	106.9	170.1	67.4	281.3	130.6	347.6	282.8	179.3	484.7	295.8	93.3	203.7	220.2	245.1	265.7	213.5	264.7	126.9	294.8	211.6	234.0	289.0	271.2	139.5	182.9	143.4	410.4	91.0	252.5	204.4	234.5	118.4	64.3	280.9	165.5	135.8	120.1	372.6	304.8	83.1	98.0	109.2	243.3	49.5	105.7	112.1	200.5	414.7	152.4	130.8	351.0	135.3	408.0	73.0	255.0	282.1	139.8	116.9	393.7	269.3	125.0	220.8	292.1	225.7	88.4	138.0	290.7	237.4	346.6	67.1	200.1	173.5	131.9	8.8	51.3	10.4	32.6	69.6	34.1	481.0	16.5	23.9	99.2	488.1	42.6	39.3	4.8	60.3	77.1	313.2	4.6	95.2	257.2	248.9	253.4	292.4	247.8	296.3	250.0	267.7	260.2	266.7	282.5	281.3	76.1	112.2	213.4	69.5	83.8	34.7	77.5	114.6	36.5	247.7	43.6	32.3	98.2	108.7	169.0	68.0	183.5	89.9	41.3	705.9	25.4	250.2	28.5	86.1	63.4	57.6	91.3	19.4	47.8	354.0	35.6	90.8	85.1	41.7	23.4	88.6	53.6	29.5	65.4	127.9	54.3	290.4	97.6	58.0	27.5	57.9	64.3	38.2	72.9	29.0	35.1	508.9	36.0	116.6	32.7	245.1	410.7	51.6	81.2	220.1	364.3	65.5	201.7	185.1	26.3	44.8	189.0	108.0	64.6	34.2	34.2	75.9	19.4	149.5	205.2	381.4
TSPAN31	SAS	ENSG00000135452	"Tetraspanin 31"	Q12999	12	57738013-57750219	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	4	"glioma: 54.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030758, HPA057489"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA030758: , HPA057489: AB_2683447"	"unprognostic (2.66e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (4.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (9.91e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.58e-1)"	24.5	29.7	9.0	11.2	10.8	5.5	23.1	10.8	15.6	26.2	11.8	20.5	16.4	26.2	13.2	20.4	25.8	20.9	26.7	9.5	10.3	26.7	20.9	22.8	11.8	11.2	10.2	25.6	25.2	32.7	24.4	12.5	11.0	22.1	10.7	29.7	25.6	13.5	21.0	18.6	18.5	8.4	11.1	20.8	23.0	8.0	9.9	9.8	30.2	21.2	8.7	21.0	20.1	13.0	9.5	23.4	21.1	5.4	44.3	24.0	13.5	15.8	11.7	4.6	5.1	16.7	46.4	7.6	32.7	29.0	9.4	17.5	5.7	26.7	10.7	23.1	15.4	10.7	18.7	6.6	45.2	10.6	17.9	29.6	30.2	13.7	30.3	22.1	14.6	4.6	7.5	19.9	19.6	19.4	9.2	5.9	4.3	18.3	7.0	10.5	139.8	20.0	15.7	19.0	6.6	16.7	15.6	21.3	10.5	4.5	41.1	15.8	27.6	11.3	9.5	5.6	7.4	28.9	8.1	4.1	32.7	6.3	19.2	25.4	26.3	16.4	35.8	28.6	34.8	31.1	28.5	30.7	27.6	31.0	28.3	26.2	5.8	35.4	42.0	58.3	22.1	33.0	9.0	10.8	10.8	15.6	9.5	10.3	11.2	10.2	11.0	11.1	9.9	13.0	37.1	48.1	32.4	8.1	23.8	11.2	46.4	37.4	22.2	43.2	32.0	27.4	5.1	20.0	31.4	31.3	41.7	20.9	29.8	19.9	9.8	37.6	1.2	18.5	32.5	26.7	26.5	8.2	9.1	39.0	15.2	31.7	11.7	20.4	45.0	28.9	22.1	21.6	22.4	21.9	9.1	21.6	32.6	18.0	16.4	1.8	25.7	24.2	32.0	8.4	21.6	62.7	35.0	11.1	13.3	37.6	20.3	17.3	18.4	30.5	30.6	18.1	27.9	60.4	19.7	22.3	31.9	9.2	7.7	16.1	12.6	24.5	20.4	35.3	19.4	31.8
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318204	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 19.9;heart muscle: 11.4;lymphoid tissue: 5.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 44.6;Erythroid cells: 20.6;granulocytes: 30.4;Langerhans cells: 19.6;NK-cells: 87.6;T-cells: 21.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HEL: 15.0;HL-60: 6.6;NB-4: 5.3;THP-1: 5.6;U-937: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024135	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"	0.5	0.5	0.2	1.6	0.2	19.9	0.3	0.5	0.2	1.1	0.0	0.5	0.3	0.7	0.2	0.4	0.5	1.4	11.4	0.2	0.3	0.2	0.4	2.0	5.5	0.5	0.3	0.5	0.0	0.0	0.0	0.3	0.3	0.2	0.3	0.2	0.9	0.5	0.3	0.6	0.5	0.0	0.1	3.5	0.9	0.2	0.2	0.9	0.2	0.2	2.4	0.7	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	15.0	0.0	0.1	0.6	6.6	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	8.9	0.0	40.5	31.8	4.2	25.8	40.9	16.5	2.4	9.1	22.7	32.2	1.1	7.2	27.1	17.3	58.6	46.0	1.6	13.2	21.7	0.2	0.2	0.5	0.2	0.2	0.3	0.5	0.3	0.3	0.1	0.2	0.5	0.5	0.0	6.7	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.2	0.1	15.9	0.0	0.6	0.0	0.0	0.1	44.6	0.0	0.0	0.0	0.8	0.1	0.3	0.8	0.0	20.6	0.0	0.0	0.3	1.3	0.5	0.0	30.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	6.5	19.6	4.1	0.9	13.6	1.8	1.0	14.4	0.2	87.6	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.2	1.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	21.9	0.0	0.0	0.1
TSPAN9	NET-5	ENSG00000011105	"Tetraspanin 9"	O75954	12	3077355-3286564	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 128.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 68.7;Extravillous trophoblasts: 105.1;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 96.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 213.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.1"	HPA014002	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA014002: AB_2304038"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	25.4	12.9	11.0	7.1	12.1	0.6	25.0	96.6	13.5	29.6	9.7	18.0	7.9	32.3	11.5	15.4	23.2	35.2	128.8	6.9	12.6	45.8	54.8	35.8	5.4	12.3	13.0	35.3	13.1	28.1	8.6	58.7	14.5	27.6	6.2	14.8	18.0	24.4	16.8	27.9	12.3	23.6	8.6	20.6	13.4	5.1	17.1	19.1	18.4	12.4	7.1	18.4	22.3	7.6	1.5	12.7	20.1	16.1	19.2	15.5	48.3	26.7	82.3	20.1	26.1	30.6	11.6	0.8	23.9	14.6	19.7	3.1	9.5	9.6	11.8	5.0	9.3	36.3	8.5	20.6	42.2	0.2	3.0	17.7	7.4	40.4	16.9	50.4	55.7	1.1	1.0	1.1	17.6	16.7	0.0	0.8	25.5	7.8	7.4	9.9	213.0	3.1	61.7	7.4	36.8	22.6	18.8	36.6	16.4	45.9	13.7	0.2	27.2	8.5	28.8	14.8	25.7	0.2	0.6	0.3	20.3	0.5	10.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	1.2	11.0	12.1	96.6	13.5	6.9	12.6	12.3	13.0	14.5	8.6	17.1	7.6	60.1	0.0	4.1	10.4	0.8	19.2	13.3	22.4	13.1	68.7	19.8	9.0	50.1	11.5	6.5	12.9	2.1	53.1	0.2	1.7	5.9	21.1	3.0	2.3	24.9	43.1	6.0	5.3	16.8	9.1	105.1	22.2	2.0	5.7	0.0	13.0	41.0	36.7	6.2	33.7	45.5	2.3	2.0	3.2	3.5	4.1	17.4	7.1	12.4	30.9	0.8	4.0	0.0	9.0	2.0	9.9	0.6	17.3	1.4	13.8	2.4	22.4	2.5	4.7	19.7	1.4	20.9	1.3	3.4	9.7	11.9	80.7	1.5	6.4	2.5	10.5
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116267760-116279930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031970	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favorable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	26.5	73.8	51.1	17.1	56.4	34.4	23.4	35.2	78.2	22.5	25.5	30.8	24.4	28.4	33.0	34.0	31.4	20.5	43.3	64.9	38.1	50.4	40.9	21.4	21.4	25.9	22.2	34.9	33.3	63.9	40.1	16.0	26.0	42.0	17.7	26.1	30.2	33.9	114.9	29.4	30.0	24.3	17.1	29.5	35.5	28.9	34.6	22.3	39.6	91.9	25.6	31.4	22.7	44.5	22.2	21.5	27.3	50.3	47.2	30.9	22.7	35.2	34.7	31.3	35.8	27.7	15.9	47.3	43.0	40.8	28.2	38.5	21.6	59.8	33.2	19.4	56.0	19.1	29.9	50.8	29.8	31.9	11.2	36.2	46.0	32.5	31.2	32.9	30.3	20.7	34.3	36.1	44.2	48.9	21.5	18.9	13.6	21.3	19.8	19.1	23.5	26.3	54.9	42.9	23.7	23.6	29.2	38.8	18.0	30.6	51.0	39.1	37.3	21.2	18.7	17.2	38.7	19.8	22.7	25.2	35.1	20.3	14.1	121.0	30.1	51.5	40.5	51.0	61.4	46.4	52.4	45.4	26.1	52.2	51.1	50.0	24.1	33.2	57.7	44.9	44.8	34.0	51.1	56.4	35.2	78.2	64.9	38.1	25.9	22.2	26.0	17.1	34.6	44.5	29.4	35.3	45.9	15.7	65.2	166.1	100.6	37.6	70.6	81.0	91.7	47.5	100.0	61.5	40.5	104.8	27.1	54.8	54.2	49.3	154.6	40.8	33.0	40.5	42.0	40.4	74.6	49.7	65.4	43.9	25.5	63.1	41.3	34.9	31.7	67.5	73.9	81.3	42.4	38.7	50.5	59.3	46.8	82.1	116.0	20.2	75.5	40.2	87.2	22.5	38.3	82.6	42.2	15.6	20.2	48.8	52.5	95.5	24.1	77.0	60.3	218.9	41.4	58.1	131.5	87.6	63.5	61.9	39.8	55.5	162.0	59.7	69.1	101.3	70.2	75.8
TSPYL6		ENSG00000178021	"TSPY like 6"	Q8N831	2	54253178-54256229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 21.5"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 33.9;Spermatogonia: 22.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	69	"K-562: 8.3"									"HPA034699, HPA034700"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA034699: AB_2674288, HPA034700: AB_10670159"	"unprognostic (8.21e-2)"				"unprognostic (4.25e-1)"			"unprognostic (1.06e-2)"		"unprognostic (1.00e-1)"			"unprognostic (5.54e-6)"	"unprognostic (4.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-1)"		0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.7	0.1	0.3	0.3	0.0	0.4	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	33.9	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSR1	FLJ10534	ENSG00000167721	"TSR1 ribosome maturation factor"	Q2NL82	17	2322396-2336657	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024434, HPA053087"	Approved		Approved	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA024434: AB_1858413, HPA053087: AB_2682040"	"unprognostic (1.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.95e-3)"	"unprognostic (9.80e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.46e-3)"	18.2	10.9	11.7	17.2	12.1	15.5	17.3	11.2	12.2	10.5	11.5	13.0	9.4	14.8	12.2	20.1	12.3	10.8	17.2	11.5	11.4	12.3	14.8	10.1	15.9	11.7	11.8	15.2	19.9	16.1	8.3	14.6	11.9	13.4	14.6	14.0	12.8	13.9	49.4	19.6	9.4	18.4	12.6	11.0	11.8	18.1	12.4	15.3	11.8	30.7	19.2	22.2	11.8	12.1	80.2	85.1	39.6	77.6	31.6	36.9	80.4	65.5	36.3	39.8	30.6	138.2	33.4	85.5	54.6	52.2	36.4	70.3	86.5	76.8	50.7	39.1	97.3	63.9	66.4	65.5	44.0	59.4	42.3	37.4	48.1	76.6	87.2	43.5	39.5	45.5	84.1	46.5	49.1	49.8	56.6	29.3	94.0	60.0	50.6	59.6	55.1	57.6	49.1	52.5	27.7	61.7	57.6	43.4	45.7	37.6	40.4	26.0	43.9	54.6	43.3	65.7	122.8	33.3	45.7	49.7	53.5	67.3	67.3	1.9	7.1	1.5	8.3	10.5	11.0	7.1	6.8	7.7	11.5	8.7	7.4	9.0	1.3	6.5	11.5	4.8	9.1	6.3	11.7	12.1	11.2	12.2	11.5	11.4	11.7	11.8	11.9	12.6	12.4	12.1	13.5	32.1	29.3	7.2	21.5	34.4	42.8	18.1	31.3	16.2	18.3	13.7	17.6	12.8	30.7	14.7	18.8	29.9	17.3	7.8	3.9	27.7	68.2	18.0	32.6	20.8	10.3	30.5	7.7	16.5	39.7	24.0	18.3	24.8	43.1	24.4	12.5	13.2	16.0	18.5	6.7	12.0	10.2	12.4	10.2	73.6	13.1	14.4	16.0	3.7	18.2	12.6	10.3	3.0	6.4	23.3	5.8	12.0	23.2	35.8	4.8	11.4	21.9	19.7	19.7	36.4	27.7	29.7	47.7	42.2	41.2	24.2	16.1	25.4	15.7	33.1
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2 ribosome maturation factor"	Q969E8	X	54440404-54448032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	35.2	45.1	50.9	11.2	49.9	11.9	35.6	43.4	59.4	36.8	39.3	42.2	10.2	34.9	23.0	34.6	32.2	7.7	45.5	46.2	52.9	43.8	36.7	30.4	12.6	48.9	48.0	34.6	30.2	25.0	47.1	14.6	47.3	33.3	13.3	27.4	32.6	16.9	51.7	40.7	31.3	13.2	50.3	32.4	38.8	16.5	50.6	14.9	41.1	18.6	15.8	36.3	35.0	47.8	24.1	26.6	23.9	20.6	19.9	13.0	18.7	22.4	17.5	19.6	17.3	26.2	24.1	23.5	15.8	18.2	35.7	24.9	47.9	28.3	24.8	29.8	26.8	19.3	20.8	19.6	12.5	32.7	19.4	12.9	18.0	26.4	27.1	19.7	13.8	22.9	20.5	16.9	19.3	37.9	27.4	29.9	34.6	23.6	33.0	26.5	38.2	19.6	20.6	18.3	25.9	20.5	42.1	19.9	28.0	38.0	45.4	14.7	21.0	16.2	27.1	38.0	19.9	19.8	32.3	29.7	24.4	27.5	23.2	29.7	16.6	32.0	36.3	23.1	30.0	44.8	34.0	33.6	15.1	46.3	42.6	32.3	10.4	29.7	26.0	16.7	40.8	24.9	50.9	49.9	43.4	59.4	46.2	52.9	48.9	48.0	47.3	50.3	50.6	47.8	39.1	25.6	30.2	1.6	39.8	32.8	43.0	42.7	26.7	61.6	27.4	28.6	49.0	28.6	38.6	35.0	27.1	98.5	36.0	26.3	125.2	43.9	1.2	17.7	23.7	35.6	18.1	18.1	5.7	32.9	71.5	33.8	16.8	22.9	45.0	20.3	31.8	25.2	46.6	57.2	5.6	35.5	61.1	18.2	31.4	2.8	34.8	24.6	40.9	6.5	48.6	85.6	44.3	2.5	6.5	38.1	29.5	45.1	22.3	36.7	32.6	64.6	33.8	67.0	46.0	29.8	38.0	20.5	43.3	25.4	31.7	75.9	37.8	36.2	30.9	33.9
TSSC4		ENSG00000184281	"Tumor suppressing subtransferable candidate 4"	Q9Y5U2	11	2400488-2403878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041801, HPA058763"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041801: AB_10793934, HPA058763: AB_2683811"	"unprognostic (1.98e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.38e-2)"	34.9	26.0	25.2	16.5	27.1	42.5	30.9	26.5	32.5	33.5	22.4	44.4	17.6	43.1	6.4	33.5	36.7	16.0	38.7	24.8	25.1	35.0	46.8	31.8	21.2	26.8	26.5	31.1	28.4	9.6	31.3	11.9	25.6	39.6	6.0	5.9	25.1	19.3	62.3	39.3	29.2	13.1	25.7	39.1	31.5	72.7	27.6	17.1	29.7	16.6	10.5	39.6	29.4	28.0	48.1	62.4	18.9	29.8	15.4	11.1	35.8	31.9	21.8	38.0	26.1	46.8	60.2	34.9	27.6	24.8	42.6	46.6	21.5	37.5	7.1	40.7	66.7	20.3	34.7	47.3	43.0	35.9	40.5	27.3	51.9	24.2	22.7	16.2	27.2	33.7	47.0	37.5	18.0	64.7	41.9	61.9	54.4	35.7	74.3	46.6	17.2	30.6	19.0	42.0	48.7	49.2	28.3	59.8	38.5	9.7	31.4	40.8	36.1	49.4	26.0	47.3	37.2	73.8	70.3	29.1	42.9	35.4	53.1	105.4	64.9	69.6	64.2	58.7	68.9	64.1	63.6	66.6	67.3	87.2	56.6	53.3	64.0	70.5	65.5	65.0	74.9	57.6	25.2	27.1	26.5	32.5	24.8	25.1	26.8	26.5	25.6	25.7	27.6	28.0	56.4	19.2	17.8	8.1	33.8	67.3	56.3	59.0	18.2	35.3	36.0	36.2	20.5	31.5	34.0	12.9	12.5	50.9	44.3	72.7	50.9	55.0	88.1	31.6	31.9	42.4	57.3	52.8	4.0	50.5	45.9	32.4	29.6	31.6	17.2	33.4	37.5	32.0	39.0	28.6	4.1	44.9	63.1	29.8	34.9	178.8	44.4	32.3	32.0	6.5	53.4	43.7	57.7	5.5	6.8	62.3	53.9	33.8	27.9	71.9	58.2	46.7	20.9	40.6	39.5	43.3	45.6	129.3	73.1	27.9	82.3	82.1	38.2	38.9	46.9	55.8
TSSK3	"SPOGA3, STK22C"	ENSG00000162526	"Testis specific serine kinase 3"	Q96PN8	1	32351521-32364312	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 12.7;testis: 34.0"	"Group enriched"	"Detected in some"	67	"Early spermatids: 335.4;Late spermatids: 1251.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037516			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA037516: AB_2675517"	"unprognostic (5.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-3)"	2.3	2.7	0.1	2.5	0.2	12.7	2.0	2.2	0.4	2.9	0.3	2.1	3.4	2.3	0.0	1.3	2.7	1.8	1.5	0.1	0.0	1.9	2.7	2.7	3.8	0.5	0.0	3.0	2.1	0.0	1.7	0.7	0.2	2.1	0.0	4.3	2.4	0.0	3.0	4.7	4.0	0.1	0.0	4.3	2.2	34.0	0.2	0.0	2.3	0.0	0.0	1.7	2.3	0.5	2.4	2.8	6.0	3.6	0.0	0.8	5.2	0.6	0.9	0.0	0.0	0.5	1.3	1.4	0.8	0.0	1.0	3.5	0.0	0.0	0.0	3.6	6.8	2.8	14.1	4.3	3.3	1.3	3.2	0.1	0.7	0.0	1.0	6.7	0.0	4.5	3.5	5.5	0.0	0.7	1.5	1.5	1.1	0.5	1.6	2.1	1.6	4.7	0.0	2.4	1.7	3.8	0.8	3.0	3.9	4.5	1.8	2.4	2.4	2.1	2.9	3.0	2.4	7.6	3.3	1.9	3.5	4.3	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	0.4	0.1	0.0	0.5	0.0	0.2	0.0	0.2	0.5	0.4	0.0	0.5	0.7	0.3	0.1	0.4	0.3	0.0	0.2	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.3	335.4	0.4	0.6	0.5	0.0	0.0	0.0	0.7	0.1	0.3	0.0	0.5	0.0	1.4	0.7	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	1251.0	9.3	0.3	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.3	0.1	9.4	0.0	0.2	0.7	0.8	0.8	1.2	6.6	0.2	0.2	11.7	3.7	0.0	0.0	0.3	0.2	0.5	0.3	0.3
TSTD2	"C9orf97, PP4189"	ENSG00000136925	"Thiosulfate sulfurtransferase like domain containing 2"	Q5T7W7	9	97600080-97633368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022537, HPA024241, HPA064304"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA022537: AB_1845850, HPA024241: AB_1845851, HPA064304: AB_2685238"	"unprognostic (7.24e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.75e-4)"	"unprognostic (2.21e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-1)"	5.9	5.6	3.4	5.3	4.2	2.5	8.1	4.0	5.1	8.5	3.5	7.0	4.7	8.2	7.4	6.1	7.3	7.1	9.9	3.2	4.1	8.0	9.5	7.3	6.5	3.7	4.3	7.3	10.3	10.1	4.6	7.6	4.1	7.6	7.3	10.3	6.7	8.2	9.1	6.0	4.3	8.6	4.2	6.1	6.2	8.0	4.2	8.9	10.4	12.9	8.1	7.5	3.8	5.5	13.6	10.7	17.3	11.3	11.1	9.2	15.1	8.7	10.7	12.0	12.3	10.9	4.7	14.4	4.1	11.6	14.5	19.0	15.3	9.3	13.3	10.0	6.7	10.1	12.6	8.8	14.4	15.0	13.3	12.3	15.4	11.8	21.0	11.2	9.5	15.0	18.0	10.7	10.6	7.6	17.7	8.2	13.5	17.8	10.6	14.5	24.9	7.7	8.9	6.6	12.3	9.7	11.3	8.0	10.4	13.4	6.1	8.3	9.8	11.1	10.1	12.5	10.0	15.8	21.2	7.5	8.8	7.3	7.7	4.3	2.9	3.9	4.4	5.0	7.3	4.1	4.3	5.4	4.8	4.5	4.8	4.7	1.0	8.6	4.0	2.0	2.6	3.9	3.4	4.2	4.0	5.1	3.2	4.1	3.7	4.3	4.1	4.2	4.2	5.5	11.4	19.2	15.3	23.8	11.7	1.7	4.3	5.7	7.4	27.8	11.1	9.9	17.5	11.5	16.9	1.8	25.0	7.6	12.3	11.1	17.6	8.7	17.9	11.3	17.2	7.8	19.2	12.4	26.0	7.5	3.9	11.3	10.2	10.6	20.8	8.5	5.0	13.4	5.3	21.9	31.5	5.3	4.1	5.4	3.1	9.6	8.1	5.9	5.4	15.0	6.5	13.0	7.2	36.7	36.4	9.2	6.5	10.5	9.5	5.2	4.5	8.9	16.2	23.9	19.7	13.9	9.4	18.8	24.8	7.6	4.1	10.9	9.3	7.6	6.3	3.8
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243481-43288258	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 20.7;pituitary gland: 9.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Bipolar cells: 6.6;Excitatory neurons: 12.1;Inhibitory neurons: 13.0;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 12.4"	"Group enriched"	"Detected in some"	4	"glioma: 3.0;liver cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 20.3;SH-SY5Y: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA031735: AB_2674019, HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	0.0	1.3	11.8	0.2	10.6	0.0	0.0	3.8	20.7	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.1	12.0	1.1	0.4	1.9	0.0	0.1	5.0	2.2	0.0	0.2	0.3	9.2	0.0	3.5	0.1	0.1	3.0	0.0	0.1	0.0	0.0	2.8	0.0	0.5	0.1	0.1	0.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	20.3	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	10.6	3.8	20.7	12.0	1.1	5.0	2.2	3.5	0.5	6.0	11.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	12.1	0.2	0.0	0.1	0.0	0.0	0.0	2.2	0.4	2.5	0.1	5.0	13.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	2.8	0.0	1.4	0.0	12.1	12.4	0.0	1.1	0.0	0.0	0.0	3.8	3.5	0.0	0.5	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0
TTC12	"FLJ13859, FLJ20535, TPARM"	ENSG00000149292	"Tetratricopeptide repeat domain 12"	Q9H892	11	113314579-113383544	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 158.8;Late spermatids: 210.5;Respiratory ciliated cells: 62.0;Spermatocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 26.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038542, HPA038543, HPA061364"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038542: AB_2676072, HPA038543: AB_10674686, HPA061364: AB_2684492"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (3.14e-4)"	"prognostic favorable (2.48e-5)"	"unprognostic (2.11e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.33e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.03e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (5.95e-5)"	"unprognostic (3.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.35e-2)"	4.1	8.3	4.5	3.7	4.5	2.0	11.0	4.7	4.7	6.8	15.7	5.4	3.8	6.8	12.1	4.3	17.7	5.3	7.5	3.4	5.5	9.3	5.7	5.7	6.5	7.4	6.7	8.7	5.5	24.4	12.6	4.6	5.3	10.3	6.6	11.3	7.8	11.6	4.0	5.8	4.9	4.1	5.2	4.9	5.3	51.9	5.8	4.5	16.2	6.6	7.7	5.7	4.7	5.9	5.6	3.7	8.3	9.0	6.0	7.3	4.9	5.0	9.4	6.5	6.3	4.2	15.8	3.0	7.3	0.2	5.3	12.0	0.0	24.2	9.8	3.4	4.0	1.2	11.8	6.5	12.0	0.0	2.0	8.1	9.7	0.0	14.3	12.8	4.7	0.0	5.1	2.0	12.0	7.3	0.0	1.1	5.3	19.4	6.3	0.0	1.3	5.4	12.1	4.2	7.2	10.0	26.4	9.3	5.3	11.3	16.9	3.4	1.7	1.2	5.9	5.2	9.0	1.7	3.0	0.1	5.6	0.5	0.0	0.0	1.0	1.5	1.7	1.0	2.6	2.3	2.2	1.8	2.0	3.3	2.5	2.5	1.5	1.4	0.9	1.6	0.9	1.2	4.5	4.5	4.7	4.7	3.4	5.5	7.4	6.7	5.3	5.2	5.8	5.9	2.3	0.0	5.4	31.6	6.6	1.3	4.9	9.0	5.2	7.5	4.0	4.1	7.5	7.2	14.4	5.5	2.1	6.8	4.2	3.0	5.9	6.3	158.8	24.6	3.7	2.4	4.8	1.7	10.9	4.9	2.0	3.8	2.0	4.8	2.5	5.2	0.4	2.7	2.6	1.7	3.1	3.3	4.1	1.0	1.3	210.5	3.4	1.7	1.8	9.4	1.6	6.0	5.2	7.1	11.7	3.8	3.5	3.8	4.9	2.5	3.9	8.9	62.0	9.1	6.6	3.6	4.3	84.7	7.5	3.6	1.7	2.7	3.8	4.9	4.6	2.6
TTC13	FLJ22584	ENSG00000143643	"Tetratricopeptide repeat domain 13"	Q8NBP0	1	230906243-230978875	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 42.7;Excitatory neurons: 70.9;Inhibitory neurons: 76.7;Microglial cells: 56.2;Oligodendrocyte precursor cells: 41.7;Oligodendrocytes: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018022, HPA051558"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA018022: AB_2211524, HPA051558: AB_2681534"	"unprognostic (2.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.10e-2)"	"prognostic favorable (7.66e-4)"	"unprognostic (2.60e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.60e-11)"	"unprognostic (4.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.54e-3)"	7.8	5.1	7.4	11.7	9.4	11.6	7.0	7.9	7.9	7.1	4.8	11.2	8.0	5.9	6.5	6.0	6.5	6.1	6.5	7.3	9.2	6.4	7.9	9.9	19.6	7.3	6.7	5.6	10.5	6.8	9.2	7.5	7.5	6.3	15.9	11.8	6.7	5.1	11.4	9.8	12.2	6.1	7.7	20.3	12.2	2.9	8.4	10.2	6.8	6.2	14.8	6.5	6.7	9.5	12.4	12.4	12.0	23.5	11.0	7.1	24.5	17.7	13.9	9.8	11.0	18.4	13.2	22.7	15.9	10.8	9.7	19.4	8.0	6.6	6.5	25.6	23.3	6.8	13.7	12.5	11.6	14.1	6.0	6.3	11.4	9.2	8.5	9.8	17.5	9.7	7.3	12.9	9.1	6.5	7.5	13.5	13.5	41.1	15.2	12.0	17.2	31.9	10.2	8.5	16.5	14.2	13.5	13.8	24.2	5.2	14.8	18.1	9.0	11.5	1.6	15.7	31.9	15.8	27.9	6.8	11.3	8.8	19.2	5.7	5.5	4.9	6.6	4.1	4.5	2.8	4.5	5.3	7.7	2.2	3.5	4.4	1.9	7.9	5.3	4.9	3.9	4.2	7.4	9.4	7.9	7.9	7.3	9.2	7.3	6.7	7.5	7.7	8.4	9.5	7.2	6.4	7.4	42.7	18.9	3.3	1.0	1.8	1.2	6.1	3.4	2.4	3.0	1.5	4.0	1.8	6.2	4.3	21.8	6.6	1.9	5.6	1.7	1.7	2.4	5.4	6.1	11.6	70.9	8.6	5.1	5.2	14.3	3.0	9.5	4.6	1.8	5.0	5.0	11.8	76.7	11.3	8.2	7.8	6.6	2.3	2.8	8.9	1.8	56.2	7.2	4.5	17.5	41.7	70.6	4.1	8.7	6.8	13.6	1.9	2.6	1.2	1.3	10.8	6.6	5.5	4.9	3.1	3.5	3.8	2.7	1.6	16.9	2.1	9.4	1.6
TTC14	"FLJ00166, KIAA1980"	ENSG00000163728	"Tetratricopeptide repeat domain 14"	Q96N46	3	180602163-180617828	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009295	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA009295: AB_1858425"	"unprognostic (2.72e-1)"	"unprognostic (4.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.33e-3)"	25.9	23.3	18.2	28.5	20.1	30.7	27.7	13.7	22.7	40.6	27.9	33.7	23.4	35.2	43.7	17.9	38.7	19.5	25.0	20.2	16.2	36.8	21.6	28.0	41.3	17.8	16.2	56.1	35.3	27.3	57.9	21.5	17.1	36.3	22.0	68.6	22.0	23.8	13.7	22.2	31.2	19.7	15.9	33.4	28.0	20.5	16.6	24.1	49.4	7.2	28.9	29.6	32.4	25.2	18.6	15.2	22.7	12.9	29.6	25.9	21.4	26.1	21.0	18.8	30.8	20.3	24.3	27.9	27.4	18.9	43.0	26.2	21.3	13.9	25.4	52.0	21.5	26.5	37.0	46.2	21.8	28.7	23.3	32.9	26.3	18.9	9.4	31.1	15.2	35.2	11.3	5.4	21.1	5.4	21.9	2.1	16.1	23.0	29.6	25.5	14.0	29.9	10.6	14.0	19.4	18.8	24.8	12.5	25.8	22.7	47.0	26.9	24.3	37.6	19.3	17.4	48.7	40.2	66.2	62.0	18.4	35.1	16.7	23.8	9.4	10.6	10.6	10.4	12.7	14.7	11.0	10.6	7.1	10.7	13.3	10.9	7.5	13.9	14.6	17.6	10.7	6.3	18.2	20.1	13.7	22.7	20.2	16.2	17.8	16.2	17.1	15.9	16.6	25.2	33.8	9.6	35.6	135.2	82.1	17.7	33.5	33.6	23.9	98.2	25.8	15.9	14.0	41.5	38.9	66.2	116.7	33.4	114.3	27.8	3.9	28.4	6.2	19.0	41.7	38.7	39.0	41.8	173.1	32.7	19.6	41.8	30.5	19.6	59.6	112.6	45.0	30.4	24.5	80.8	169.9	24.8	30.5	31.7	23.0	11.0	92.6	37.5	30.2	111.5	61.0	49.8	121.5	120.1	160.0	31.9	38.9	81.3	61.5	23.9	42.7	9.4	40.7	123.5	85.5	47.1	40.2	59.6	29.9	16.8	15.3	24.6	68.8	72.2	23.4	23.1
TTC21A	"IFT139A, STI2"	ENSG00000168026	"Tetratricopeptide repeat domain 21A"	Q8NDW8	3	39107704-39138903	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 21.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.3;Late spermatids: 84.7;Respiratory ciliated cells: 56.0;Spermatocytes: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035510, HPA035511"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA035510: AB_2674659, HPA035511: AB_10671514"	"unprognostic (1.85e-3)"	"unprognostic (6.95e-3)"	"unprognostic (7.74e-3)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.58e-5)"	"unprognostic (2.29e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.91e-4)"	0.1	0.1	0.6	0.4	0.6	0.1	0.2	0.4	1.1	0.2	1.8	0.1	0.2	0.3	0.0	0.1	1.0	0.1	0.1	0.5	0.6	0.1	0.1	0.2	0.3	0.7	0.9	0.3	1.1	0.2	0.1	0.1	0.6	0.2	0.1	0.4	0.3	0.1	0.1	0.2	0.1	0.0	0.5	0.2	0.1	21.2	0.5	0.2	0.2	0.1	0.3	0.1	0.1	0.6	0.1	0.3	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.3	0.0	0.3	0.3	0.2	0.2	0.2	0.0	0.4	0.2	0.0	0.2	0.0	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.8	0.3	0.0	0.8	0.0	0.2	0.0	0.1	0.7	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.4	1.1	0.5	0.6	0.7	0.9	0.6	0.5	0.5	0.6	3.7	0.0	3.0	20.2	10.4	0.6	4.4	4.0	0.6	5.3	2.6	2.4	6.4	4.3	5.4	1.8	8.4	1.7	1.8	2.5	0.0	2.1	82.3	24.0	3.6	3.0	4.2	0.4	15.0	1.8	1.7	2.1	4.1	5.2	1.3	3.2	5.0	1.3	1.6	5.0	13.3	2.5	0.0	2.2	0.9	84.7	7.2	1.6	3.6	4.7	2.6	3.4	0.0	5.0	3.2	1.7	2.0	6.0	3.7	2.1	2.3	1.2	56.0	15.3	6.6	7.8	2.7	59.8	3.4	0.1	0.6	3.7	1.3	2.1	2.4	2.3
TTC24		ENSG00000187862	"Tetratricopeptide repeat domain 24"	A2A3L6	1	156579723-156587719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"lymphoid tissue: 21.2"	"Group enriched"	"Detected in some"	5	"B-cells: 4.6;dendritic cells: 3.6;Erythroid cells: 1.3;NK-cells: 2.1;Skeletal myocytes: 1.7;T-cells: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NK-cell: 3.7;plasmacytoid DC: 12.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.4;NK-cells: 3.7"	"Cell line enhanced"	"Detected in some"		"JURKAT: 10.3;MOLT-4: 3.8;REH: 11.9;U-698: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029799			Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA029799: AB_10601684"	"unprognostic (2.43e-3)"	"unprognostic (5.61e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.48e-6)"	"unprognostic (6.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-1)"	"unprognostic (7.96e-2)"	"unprognostic (4.87e-9)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.76e-4)"	0.1	0.0	0.0	1.9	0.1	1.8	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	5.9	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.2	0.0	0.0	3.0	0.4	0.1	0.0	21.2	0.1	0.0	5.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.0	3.8	0.7	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.0	1.1	0.1	1.7	0.2	1.8	0.2	3.7	0.0	12.4	0.0	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	45.8	29.3	28.1	27.1	25.0	26.4	43.1	36.3	35.3	59.3	45.7	34.6	24.7	38.9	58.6	27.9	34.9	35.4	28.0	38.9	15.5	37.7	31.7	24.4	29.4	10.0	11.1	60.6	42.9	39.1	35.6	29.0	11.8	51.2	36.3	63.0	50.0	41.4	27.7	30.7	30.3	34.6	6.7	27.3	40.9	27.4	15.3	38.0	64.8	30.6	29.2	30.6	9.4	21.4	72.9	25.4	115.3	22.2	108.9	156.8	40.0	77.5	96.0	34.2	46.1	34.0	35.8	62.3	26.6	130.9	32.1	23.3	35.3	47.9	48.2	66.3	25.0	125.6	38.0	44.1	39.6	70.9	39.1	81.9	28.8	35.0	31.0	68.8	51.6	54.1	77.3	71.1	65.2	56.0	69.4	18.8	33.3	48.0	42.6	91.6	55.3	33.2	39.4	55.3	87.7	67.6	97.2	55.2	49.1	26.5	62.2	27.3	68.3	49.2	19.5	61.2	30.4	71.1	55.1	60.6	80.7	69.9	37.9	4.8	6.2	6.8	11.5	6.4	17.1	13.0	13.3	15.8	10.8	15.1	23.2	14.4	1.0	12.8	8.6	17.3	10.0	4.8	28.1	25.0	36.3	35.3	38.9	15.5	10.0	11.1	11.8	6.7	15.3	21.4	78.3	125.0	142.7	161.3	144.8	65.9	94.8	102.7	86.0	347.7	175.8	140.1	134.7	68.6	118.2	75.4	227.2	50.1	129.5	67.8	166.3	91.1	192.7	115.0	217.4	78.9	190.2	65.4	424.5	75.3	93.5	171.0	131.5	132.0	64.6	256.8	99.6	94.4	61.4	329.7	396.0	163.1	99.7	95.2	83.7	192.4	210.0	86.8	211.7	111.5	87.4	196.5	93.7	321.7	261.9	73.3	96.5	261.1	167.6	121.4	72.8	96.1	108.6	233.9	52.6	245.8	127.9	400.0	258.4	91.7	62.8	52.7	109.7	204.1	148.1	103.9
TTC30A	"FAP259, FLJ13946, IFT70A"	ENSG00000197557	"Tetratricopeptide repeat domain 30A"	Q86WT1	2	177612999-177618742	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.1;Respiratory ciliated cells: 29.0;Spermatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (7.75e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.67e-3)"	"unprognostic (6.07e-2)"	2.1	1.8	1.9	1.2	2.1	0.4	4.2	1.9	1.9	2.9	4.0	2.6	1.7	3.2	7.9	1.6	6.3	2.2	3.4	1.8	2.2	5.0	2.9	2.5	1.2	2.4	2.6	2.5	3.3	5.6	2.1	0.9	2.6	2.9	2.5	8.2	3.2	2.8	1.5	1.1	1.7	2.7	2.6	1.2	2.8	9.9	2.2	1.7	7.2	1.2	1.3	1.2	0.6	2.6	5.1	2.9	2.8	0.0	5.7	4.7	2.1	2.4	7.1	4.3	4.5	0.9	3.6	1.1	4.6	4.3	5.8	4.2	1.9	5.4	4.7	0.3	1.6	1.0	1.4	1.3	2.3	1.2	1.1	2.9	3.5	2.4	0.9	4.1	2.0	2.5	0.7	0.5	3.0	2.6	4.0	2.4	1.6	1.8	1.0	2.5	7.5	0.5	5.4	1.3	9.2	6.2	2.2	4.2	2.6	6.6	2.4	1.3	1.8	2.6	1.5	2.9	2.0	1.9	1.9	0.3	6.6	0.1	2.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.1	0.5	0.2	0.1	0.0	0.3	0.1	0.2	0.2	1.9	2.1	1.9	1.9	1.8	2.2	2.4	2.6	2.6	2.6	2.2	2.6	2.3	9.6	3.1	1.6	1.2	0.8	0.8	3.6	1.8	3.0	3.8	2.4	3.6	2.8	4.7	7.3	2.1	1.0	0.4	5.0	1.9	5.5	50.1	10.8	3.1	2.0	7.2	0.4	1.2	4.0	0.7	3.2	1.5	1.6	0.0	2.8	3.6	3.8	0.8	16.8	1.6	2.5	8.2	0.6	0.4	10.9	2.1	0.8	1.8	0.0	0.3	10.6	0.0	0.5	1.0	2.9	1.0	2.2	1.2	1.1	1.7	4.7	29.0	11.7	0.0	4.1	2.1	51.7	4.3	2.8	0.4	0.3	0.9	4.1	1.9	0.3
TTC30B	"fleer, FLJ30990, IFT70B"	ENSG00000196659	"Tetratricopeptide repeat domain 30B"	Q8N4P2	2	177548998-177552796	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 43.3;Spermatocytes: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Centrosome	"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (5.76e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.65e-1)"	1.7	1.6	1.7	1.8	1.8	0.8	5.3	1.8	1.8	3.4	3.3	3.3	2.6	3.3	6.8	2.0	10.3	2.1	1.7	1.6	1.7	4.9	2.5	3.2	2.2	2.3	2.6	3.4	2.4	5.1	1.6	1.7	2.1	2.8	3.0	5.2	3.7	3.2	0.4	2.4	2.9	2.5	2.5	2.3	3.9	7.0	2.0	3.2	8.2	0.5	2.4	1.9	0.8	2.6	2.5	3.7	4.7	0.9	4.1	4.8	3.2	1.4	4.5	3.9	4.1	2.1	6.1	0.9	3.9	2.8	4.5	6.0	5.7	6.2	3.7	1.4	2.8	1.7	2.2	1.8	3.5	2.2	2.9	4.0	5.7	3.8	2.9	4.7	3.1	4.5	2.3	0.8	2.3	4.2	4.4	3.4	2.2	3.3	0.9	3.4	4.1	1.0	5.9	2.7	11.4	6.2	1.8	4.1	2.9	6.4	4.2	4.2	2.7	2.1	1.1	2.8	1.2	2.1	2.6	0.3	4.9	0.9	3.7	2.7	1.4	1.2	0.6	1.3	0.4	0.5	0.4	0.7	1.6	1.4	0.8	0.8	0.8	0.9	1.0	1.1	0.4	0.7	1.7	1.8	1.8	1.8	1.6	1.7	2.3	2.6	2.1	2.5	2.0	2.6	1.8	3.2	4.6	1.3	2.8	0.6	0.6	5.0	2.8	2.2	3.1	2.8	1.4	5.7	7.9	0.0	2.1	2.5	0.4	4.8	5.9	4.8	10.8	12.8	3.7	2.5	1.2	1.3	0.7	2.7	1.1	3.3	5.1	1.9	1.3	3.2	2.5	2.8	1.2	5.0	0.8	2.4	6.1	1.3	0.6	6.6	1.5	1.3	1.8	1.9	1.4	7.2	4.1	1.5	1.1	2.6	0.5	2.2	4.1	0.6	2.6	5.3	43.3	11.5	0.0	2.7	1.8	24.5	3.7	2.3	0.9	0.5	1.3	5.4	1.8	0.2
TTC31	FLJ12788	ENSG00000115282	"Tetratricopeptide repeat domain 31"	Q49AM3	2	74483073-74494559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041783	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA041783: AB_10794306"	"unprognostic (2.38e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (2.64e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.56e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (2.49e-4)"	6.4	4.8	3.5	8.4	3.9	9.0	4.8	3.4	4.3	5.4	3.8	7.9	11.1	5.9	4.5	6.1	5.9	5.9	5.7	3.3	3.6	6.0	18.7	6.8	9.8	4.3	3.8	6.3	7.9	9.2	3.2	9.2	3.9	5.2	8.2	4.8	4.7	4.5	3.7	8.8	9.9	7.4	3.8	8.2	7.5	3.2	3.8	9.7	4.8	3.9	10.6	5.7	4.6	4.5	16.0	13.1	11.7	6.3	7.3	17.0	12.9	11.2	11.4	16.2	11.9	11.3	13.0	20.6	6.4	9.5	14.2	11.8	9.5	10.5	11.0	23.0	8.3	22.4	12.9	24.9	11.0	10.1	21.5	11.5	13.7	14.0	9.8	14.3	11.0	12.0	15.0	11.5	12.0	13.7	17.4	9.2	7.6	12.2	7.9	13.7	24.0	11.5	11.5	11.8	5.6	16.5	7.9	12.4	10.2	7.4	9.7	6.2	17.6	12.5	18.7	9.5	12.6	13.6	10.8	14.1	13.5	12.5	11.4	4.9	8.3	6.1	6.5	8.1	7.2	7.0	4.9	6.2	8.1	4.7	4.6	5.4	0.8	6.6	8.7	4.4	7.3	7.4	3.5	3.9	3.4	4.3	3.3	3.6	4.3	3.8	3.9	3.8	3.8	4.5	5.4	16.0	9.2	7.2	10.8	2.8	4.1	5.2	4.6	11.1	5.2	5.0	3.5	14.3	7.8	9.2	39.6	8.3	9.8	7.8	1.9	5.8	4.6	3.8	8.0	6.7	6.1	13.3	3.0	5.5	5.3	6.0	7.1	5.9	19.0	8.8	4.6	20.8	8.3	5.0	3.4	5.9	6.1	7.9	3.5	5.0	6.2	7.5	3.6	10.3	13.2	9.2	19.6	2.5	4.4	5.9	9.4	5.7	9.6	3.1	13.9	6.0	4.3	23.6	6.6	7.3	5.3	8.3	10.0	4.2	3.3	8.1	9.8	8.2	6.5	3.8
TTC32		ENSG00000183891	"Tetratricopeptide repeat domain 32"	Q5I0X7	2	19896631-19901983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036024	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA036024: AB_10673493"	"unprognostic (2.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.92e-3)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (5.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.27e-2)"	11.8	8.8	8.7	12.3	10.5	34.7	16.6	13.6	17.2	12.3	8.6	11.7	12.2	13.9	26.0	7.4	11.9	6.7	7.1	8.8	9.1	11.4	12.3	10.0	15.5	10.6	10.0	16.5	8.6	8.2	11.3	8.5	11.3	16.0	10.2	33.0	11.1	9.3	22.5	13.8	13.1	8.0	9.5	15.6	11.4	12.5	9.7	19.7	12.4	7.7	10.1	11.3	11.2	14.2	22.5	14.4	12.8	9.6	5.6	12.3	2.7	4.8	8.0	7.7	5.0	7.3	25.6	14.5	2.7	5.1	9.6	14.6	5.6	15.4	4.9	21.3	23.3	14.8	20.4	12.8	12.1	14.2	25.5	11.7	9.6	8.6	20.4	6.5	7.5	23.3	27.1	28.5	6.4	6.8	10.7	21.7	9.6	8.4	24.1	12.6	8.5	24.1	21.6	8.6	20.6	19.1	16.1	8.5	18.2	14.1	11.9	5.5	5.6	11.6	12.4	11.5	6.6	29.8	27.3	24.0	17.9	13.9	6.7	9.2	7.6	23.1	7.3	5.7	8.7	12.2	11.6	7.8	7.2	11.9	15.8	12.2	28.0	6.7	6.9	5.0	15.6	4.9	8.7	10.5	13.6	17.2	8.8	9.1	10.6	10.0	11.3	9.5	9.7	14.2	23.2	9.6	14.4	8.5	24.7	18.9	33.4	36.0	34.7	66.9	27.4	39.0	15.8	15.7	26.4	12.9	14.6	14.6	13.7	10.0	45.0	12.2	27.2	25.8	6.1	16.2	28.3	34.0	7.1	24.8	8.7	19.6	14.8	13.2	8.8	7.2	7.5	24.1	9.1	42.1	8.6	19.9	32.6	8.8	8.9	7.2	19.9	17.4	7.2	5.6	14.6	67.8	11.3	9.5	22.0	14.6	12.9	9.8	12.3	15.8	13.7	28.5	48.7	39.2	13.1	21.1	21.3	113.2	38.7	22.4	26.1	9.6	21.6	9.0	11.7	26.7
TTC33	OSRF	ENSG00000113638	"Tetratricopeptide repeat domain 33"	Q6PID6	5	40512333-40755963	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038252, HPA038253"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA038252: AB_10674551, HPA038253: AB_10671739"	"unprognostic (2.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.28e-3)"	6.9	5.9	6.6	3.3	7.2	0.8	5.7	10.0	9.7	5.8	5.3	6.3	4.3	6.2	4.7	4.2	5.6	4.6	6.3	7.5	6.6	7.5	7.7	5.1	4.3	6.3	6.5	6.7	4.8	8.9	4.4	4.1	6.3	5.9	4.2	11.6	5.3	5.6	15.5	3.8	4.8	5.0	5.6	4.6	5.2	4.5	7.3	6.7	6.0	14.8	4.1	5.4	5.2	6.9	3.6	3.2	6.1	6.8	5.0	7.1	2.9	4.7	5.6	4.8	5.1	1.7	3.5	11.0	2.8	4.3	5.2	1.6	5.2	2.7	8.5	10.3	4.9	2.4	13.5	4.3	5.5	6.5	3.1	4.4	5.6	4.8	5.0	8.4	7.2	7.3	5.8	8.3	6.4	1.0	12.5	9.3	1.9	2.8	3.5	11.1	11.5	7.9	8.2	2.1	4.5	6.2	11.0	6.4	8.1	5.0	4.3	8.7	5.5	5.5	4.6	4.3	4.6	6.0	6.7	5.8	5.1	10.1	4.9	7.1	1.8	3.2	2.0	4.4	2.2	2.1	2.3	2.1	1.9	2.2	2.5	2.2	2.5	2.3	6.6	1.0	2.2	1.9	6.6	7.2	10.0	9.7	7.5	6.6	6.3	6.5	6.3	5.6	7.3	6.9	12.9	16.0	7.4	9.8	13.1	14.4	5.6	8.6	11.4	12.3	8.6	6.0	18.2	7.2	6.2	7.3	6.2	5.9	8.8	6.9	19.6	8.2	22.4	9.1	11.5	11.0	3.0	9.5	23.7	6.3	4.2	12.6	6.1	6.8	12.7	8.9	13.9	9.4	5.1	5.0	27.5	8.0	10.2	7.5	15.4	8.4	14.0	7.5	10.6	15.9	14.3	19.2	2.1	23.6	35.1	8.0	8.4	13.9	11.8	6.8	6.8	12.6	13.7	23.5	13.1	9.9	13.4	28.1	22.1	6.3	18.3	2.6	14.6	5.0	6.2	4.5
TTC36	HBP21	ENSG00000172425	"Tetratricopeptide repeat domain 36"	A6NLP5	11	118527472-118531197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 171.5"	"Group enriched"	"Detected in many"	13	"Hepatocytes: 492.9;Proximal enterocytes: 185.5;Proximal tubular cells: 172.9"	"Group enriched"	"Detected in some"	7	"breast cancer: 5.0;liver cancer: 12.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SK-BR-3: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038731	Enhanced		Uncertain	Nucleoplasm		NA	NA		100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA038731: AB_10672651"	"unprognostic (1.57e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.81e-5)"	"unprognostic (6.32e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.38e-2)"	"unprognostic (5.77e-7)"	"unprognostic (5.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-3)"	8.0	1.3	0.8	0.1	0.8	0.0	11.1	0.8	0.7	0.3	0.7	0.5	5.9	0.4	18.5	0.5	0.5	0.1	1.0	0.3	0.6	8.9	171.5	0.3	0.1	1.1	0.7	0.6	1.2	0.0	1.6	0.1	0.6	1.0	0.0	0.3	0.9	0.0	1.4	0.5	4.1	0.0	0.6	0.2	0.7	0.8	0.6	0.0	0.7	0.4	0.0	0.5	0.3	1.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.2	0.7	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.0	0.8	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.8	0.8	0.7	0.3	0.6	1.1	0.7	0.6	0.6	0.6	1.0	0.3	0.0	0.0	0.3	2.4	0.3	0.6	0.2	0.6	0.1	21.2	11.3	0.3	11.5	0.1	12.9	0.0	1.5	0.1	0.8	17.6	0.2	0.1	1.2	0.6	1.1	2.4	16.4	0.2	0.5	0.2	0.3	2.0	1.7	0.0	0.4	9.7	492.9	0.1	0.0	0.3	9.3	0.0	14.2	0.3	0.2	0.3	0.9	0.0	0.0	0.6	1.1	0.0	0.0	0.1	0.2	7.6	0.0	0.3	1.9	185.5	172.9	0.2	0.8	0.0	0.2	0.2	0.3	0.3	0.3	0.1	2.1	1.1	0.4	11.7	1.3
TTC37	"KIAA0372, THES"	ENSG00000198677	"Tetratricopeptide repeat domain 37"	Q6PGP7	5	95461755-95554977	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037905	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA037905: AB_10673034"	"unprognostic (5.99e-2)"	"unprognostic (7.65e-3)"	"prognostic favorable (2.62e-4)"	"unprognostic (8.48e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.30e-3)"	"unprognostic (6.88e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.98e-2)"	"unprognostic (7.90e-3)"	23.6	24.2	10.6	17.9	13.1	10.5	25.7	21.4	15.4	23.8	14.8	20.2	21.4	22.8	19.7	19.9	16.9	18.4	24.3	12.3	11.7	27.5	23.2	17.1	20.5	15.0	12.2	22.6	26.7	46.1	20.2	25.9	15.9	27.2	22.1	21.8	20.7	21.4	34.5	32.7	19.2	22.2	12.7	19.4	26.2	7.8	13.3	25.8	26.2	30.9	21.5	17.0	16.7	18.5	33.1	34.6	43.0	14.9	70.3	94.9	38.2	61.8	49.6	39.3	58.6	37.1	23.6	58.0	39.7	59.0	41.0	31.7	54.5	74.5	65.4	34.0	44.6	39.1	68.8	24.6	60.1	25.7	27.1	63.6	37.3	50.1	69.5	60.3	63.0	19.0	31.2	37.1	75.1	19.0	33.5	20.6	24.3	15.1	28.2	28.1	60.0	61.5	43.2	25.7	53.5	41.8	50.8	24.8	57.0	35.7	38.8	21.7	87.4	53.3	30.5	42.5	47.9	35.4	48.3	53.0	54.0	36.9	70.0	6.1	6.4	2.4	10.1	7.8	12.2	10.3	9.8	8.5	8.1	10.0	10.0	10.6	0.2	9.3	8.0	16.2	9.7	4.4	10.6	13.1	21.4	15.4	12.3	11.7	15.0	12.2	15.9	12.7	13.3	18.5	51.4	76.9	56.1	68.6	38.5	19.5	20.4	26.5	8.6	57.8	33.2	31.8	84.9	25.8	40.9	27.6	50.1	32.5	52.0	22.4	15.6	41.5	2.4	44.8	70.9	39.9	32.5	20.2	146.8	40.5	41.8	43.4	42.8	57.3	41.1	64.6	32.9	36.0	26.9	58.9	130.6	34.3	16.2	28.8	16.7	4.3	62.4	32.2	8.8	68.4	55.4	21.0	41.2	99.5	145.0	38.1	20.2	64.7	41.1	19.0	32.2	30.7	38.2	33.6	39.5	55.1	39.5	10.5	10.0	30.9	32.8	19.8	34.8	52.3	34.2	18.2
TTC39C	"C18orf17, FLJ33761, HsT2697"	ENSG00000168234	"Tetratricopeptide repeat domain 39C"	Q8N584	18	23992773-24135610	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 143.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.8;Hepatocytes: 169.3;Late spermatids: 320.0;Rod photoreceptor cells: 241.5"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 19.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 115.9"	"Lineage enriched"	"Detected in all"	4	"T-cells: 115.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065705, HPA065713"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA065705: AB_2685538, HPA065713: AB_2685542"	"prognostic favorable (1.48e-4)"	"unprognostic (6.37e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (2.32e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.48e-3)"	21.1	30.5	6.7	12.3	6.4	36.3	18.9	3.2	26.2	20.1	10.8	10.9	9.1	15.6	7.4	16.0	18.6	23.6	7.2	19.9	4.5	6.1	94.2	15.1	19.0	1.6	2.5	10.2	15.8	1.9	20.1	2.7	0.6	20.0	7.4	143.2	25.2	5.4	10.2	56.1	13.4	8.3	2.1	13.2	12.8	33.3	3.6	15.4	7.1	1.6	21.3	13.3	19.6	5.3	12.6	10.4	6.1	3.7	38.3	39.8	22.9	16.4	39.0	13.9	13.5	1.3	6.8	19.7	16.8	30.4	11.1	15.8	12.3	16.5	10.9	28.7	13.1	6.6	50.6	26.3	7.7	31.4	15.3	33.4	21.8	8.4	11.7	26.9	1.1	14.6	0.1	0.2	8.7	10.7	4.9	10.0	14.5	5.5	25.1	28.1	9.5	7.8	14.7	19.7	15.9	12.4	34.5	10.6	11.4	6.5	8.2	10.6	8.3	11.8	9.6	8.7	8.7	0.4	0.1	32.0	16.0	32.9	8.3	2.4	5.4	0.2	32.8	6.1	84.0	16.4	71.7	40.3	7.8	10.0	30.0	25.0	1.5	18.5	5.2	27.8	115.9	13.1	6.7	6.4	3.2	26.2	19.9	4.5	1.6	2.5	0.6	2.1	3.6	5.3	6.9	0.0	3.4	13.7	23.0	46.0	17.1	10.1	30.1	14.7	28.6	24.1	3.0	64.3	5.0	7.3	45.9	0.7	52.0	2.0	0.0	14.2	149.8	72.9	34.9	7.0	4.2	20.6	114.3	11.5	15.2	16.5	15.8	30.0	2.5	11.5	4.6	169.3	12.6	13.5	80.3	9.4	18.3	26.6	44.5	320.0	11.1	21.5	14.2	20.6	18.9	27.8	38.1	41.7	2.3	8.9	1.5	7.9	7.1	20.8	11.4	1.3	16.7	241.5	0.0	5.2	6.7	42.4	8.0	26.8	86.1	0.5	95.9	9.2	9.0	20.1
TTC5	Strap	ENSG00000136319	"Tetratricopeptide repeat domain 5"	Q8N0Z6	14	20256558-20305960	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045008, HPA054198"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA045008: AB_10960209, HPA054198: AB_2682414"	"unprognostic (2.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.54e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.07e-2)"	2.1	2.8	2.8	1.8	2.8	2.9	3.8	2.2	3.1	3.1	4.8	2.2	2.1	3.1	3.2	2.2	5.7	2.2	1.8	2.6	3.1	3.5	1.4	2.5	3.2	2.1	2.7	3.0	1.9	6.1	2.1	2.4	2.1	3.8	2.3	2.6	2.3	3.0	0.7	3.4	1.6	2.9	2.1	2.4	2.4	2.5	4.3	2.6	4.9	2.3	3.1	2.3	1.7	2.2	3.4	5.4	6.5	0.7	4.7	6.8	3.5	4.3	5.0	6.4	6.6	2.4	7.6	7.2	2.7	4.5	3.3	2.8	6.4	3.0	9.8	6.3	2.4	5.9	2.2	4.3	4.8	11.0	3.5	4.2	6.7	5.6	7.2	5.8	6.3	5.1	4.3	3.5	6.3	4.6	6.5	4.6	5.5	5.6	5.2	3.4	4.8	5.2	5.6	3.5	2.2	4.3	4.9	5.1	3.0	2.6	4.0	5.3	6.6	2.5	4.1	3.4	2.3	5.0	4.7	8.9	2.0	4.6	6.0	1.3	2.0	2.9	2.7	2.0	2.3	2.7	2.0	2.2	2.2	3.0	2.1	2.5	0.8	3.0	2.9	1.6	2.7	2.0	2.8	2.8	2.2	3.1	2.6	3.1	2.1	2.7	2.1	2.1	4.3	2.2	13.9	12.8	7.2	6.5	15.2	6.4	9.4	21.5	13.6	15.5	9.4	12.8	4.3	12.8	9.8	18.4	16.7	20.4	12.2	2.3	11.7	10.6	1.6	27.7	13.4	12.3	9.0	6.7	18.2	6.5	12.4	12.5	8.6	7.9	12.0	16.0	10.8	6.4	15.4	5.0	12.4	6.9	18.3	11.2	6.8	3.4	10.2	10.5	7.2	6.5	11.5	12.4	19.6	11.6	8.7	6.4	5.0	9.8	7.8	4.6	8.6	13.1	32.8	19.4	6.6	14.1	11.6	26.6	36.1	8.8	8.7	4.7	12.7	14.6	8.3	5.3
TTC9B	FLJ30373	ENSG00000174521	"Tetratricopeptide repeat domain 9B"	Q8N6N2	19	40216058-40218399	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"brain: 110.8;choroid plexus: 32.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.1;Excitatory neurons: 39.3;Horizontal cells: 18.5;Inhibitory neurons: 19.7;Oligodendrocyte precursor cells: 27.2"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042496	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria	"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA042496: AB_10795506"	"unprognostic (2.31e-1)"	"unprognostic (1.39e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.24e-2)"	0.0	0.6	73.9	0.3	74.7	0.0	0.0	49.7	110.8	0.0	32.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	84.2	60.6	0.2	0.0	0.0	0.0	45.1	46.3	0.0	0.0	0.0	0.9	0.0	46.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.1	43.0	0.0	0.2	0.3	60.4	0.0	0.0	0.0	0.0	0.0	0.1	69.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	26.8	1.4	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.4	0.1	0.0	0.3	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	73.9	74.7	49.7	110.8	84.2	60.6	45.1	46.3	46.4	43.0	60.4	69.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	39.1	0.2	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.8	0.2	0.2	1.8	0.0	39.3	0.5	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	18.5	19.7	0.1	0.0	0.0	0.0	1.0	0.3	0.0	0.0	4.7	0.0	1.7	0.0	27.2	5.0	0.1	1.2	0.7	0.0	0.1	0.0	0.0	1.2	8.4	0.0	0.0	0.1	7.0	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1
TTC9C	MGC29649	ENSG00000162222	"Tetratricopeptide repeat domain 9C"	Q8N5M4	11	62728069-62740293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055169	Approved		Approved	Nucleoplasm		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA055169: AB_2682724"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.67e-7)"	"prognostic favorable (4.15e-5)"	"unprognostic (7.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-2)"	12.9	14.1	17.0	18.2	17.5	5.6	14.8	18.9	21.7	13.7	15.9	16.0	20.4	15.3	17.3	14.4	18.4	15.1	11.3	18.2	17.7	15.0	13.4	12.4	25.9	18.7	17.6	26.2	13.3	9.4	11.9	19.3	19.1	12.1	15.5	9.9	14.9	14.2	16.2	19.9	15.4	15.6	17.4	19.7	15.4	14.0	17.8	25.1	19.3	13.7	23.9	15.9	11.5	18.4	47.4	39.4	32.8	31.5	46.6	54.3	24.4	48.7	49.7	57.1	47.6	35.0	45.0	35.7	88.1	33.5	50.7	41.2	49.8	14.8	44.9	93.0	24.8	39.3	57.1	43.0	51.1	26.9	41.1	35.8	31.4	46.3	47.1	42.5	43.3	42.0	29.3	34.3	54.2	33.9	42.5	55.2	27.4	38.5	31.5	32.5	42.3	54.0	36.6	18.0	28.3	23.3	41.3	35.3	57.1	29.1	46.5	24.8	36.9	56.5	33.3	64.0	34.1	36.4	58.6	40.1	31.3	20.2	30.5	70.1	39.1	40.5	22.4	36.4	17.6	42.3	24.1	22.9	33.9	37.9	23.6	21.7	25.1	29.9	24.3	33.9	39.5	24.7	17.0	17.5	18.9	21.7	18.2	17.7	18.7	17.6	19.1	17.4	17.8	18.4	14.5	16.0	10.9	7.8	27.0	29.6	13.3	14.2	25.0	17.5	13.8	13.8	9.3	10.0	17.3	18.4	8.4	35.0	21.8	17.0	27.4	24.0	23.3	14.0	14.4	19.6	6.0	14.1	18.0	14.9	41.9	18.5	7.7	10.9	8.2	22.6	13.6	9.9	38.5	28.6	13.5	15.8	18.3	27.1	20.6	20.4	28.3	18.8	16.0	4.7	40.5	13.5	35.0	7.5	9.8	19.7	15.3	27.4	22.4	21.3	25.9	27.0	18.2	16.0	32.9	10.2	17.0	32.4	31.8	21.2	33.2	23.8	21.5	19.6	17.7	19.6
TTF1		ENSG00000125482	"Transcription termination factor 1"	Q15361	9	132375548-132406851	"Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"DNA replication inhibitor, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054837	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Nucleoli"		"HPA054837: AB_2682621"	"unprognostic (7.07e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.71e-2)"	8.0	5.0	7.0	6.2	7.7	16.7	9.6	9.0	8.3	7.4	6.7	9.6	4.7	8.5	9.0	6.4	7.3	5.3	13.3	6.9	7.3	6.6	4.2	7.0	10.5	7.0	7.1	8.6	6.6	7.0	5.0	6.5	7.1	7.9	6.6	8.6	6.1	7.4	13.6	7.1	6.5	7.1	6.8	7.9	6.5	9.6	7.1	18.9	10.4	10.3	10.0	7.9	6.9	8.3	12.5	11.5	16.4	14.8	9.0	11.5	14.7	14.1	10.7	16.2	12.0	11.8	13.2	20.9	11.5	10.6	18.3	29.7	18.5	10.8	17.1	13.9	12.6	9.6	17.2	9.5	9.1	25.6	14.9	7.1	12.0	13.8	10.5	13.1	14.0	34.1	19.3	17.5	12.7	19.0	59.8	15.5	30.0	22.3	16.8	37.1	22.8	24.9	13.1	10.1	14.4	24.8	19.8	14.4	10.7	15.3	17.9	13.7	13.2	25.0	15.8	21.8	16.8	8.2	24.8	25.0	14.7	20.6	25.1	17.0	5.8	12.0	6.6	6.0	8.6	13.6	8.4	7.8	3.6	12.2	9.3	7.0	20.9	8.2	7.4	11.2	9.6	3.3	7.0	7.7	9.0	8.3	6.9	7.3	7.0	7.1	7.1	6.8	7.1	8.3	26.8	25.6	21.6	12.7	35.4	9.8	21.9	26.9	7.4	27.2	11.8	15.5	40.1	25.8	18.3	18.4	60.5	23.8	33.2	14.8	19.6	28.5	22.9	26.2	21.4	29.5	12.1	68.0	12.4	21.2	22.8	17.5	15.3	16.8	22.8	28.8	27.5	8.3	18.7	30.3	10.6	15.4	20.3	22.0	12.1	6.8	23.6	17.4	1.8	14.0	30.1	20.3	41.2	9.5	19.2	25.3	18.6	25.9	14.3	22.8	16.5	19.3	29.2	55.0	26.3	21.9	24.1	47.4	61.8	7.5	8.5	25.2	28.2	16.8	19.7	24.5
TTI1	"KIAA0406, smg-10"	ENSG00000101407	"TELO2 interacting protein 1"	O43156	20	37983007-38033461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034230, HPA068338"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	Nucleoplasm	"CAB034230: AB_1564322, HPA068338: AB_2685975"	"unprognostic (7.14e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (3.30e-5)"	"unprognostic (1.11e-1)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	6.8	9.5	7.4	9.1	7.7	8.7	8.9	7.5	8.0	8.5	8.1	7.7	6.2	9.7	9.8	7.3	10.0	6.0	8.2	7.3	8.0	8.5	12.0	7.5	11.8	7.4	7.2	11.8	13.9	11.0	10.0	10.9	7.5	9.4	10.6	10.0	10.1	11.1	16.0	8.0	7.5	10.0	6.8	9.3	8.7	11.0	7.6	13.8	12.1	10.2	12.8	9.0	7.4	10.3	21.7	31.6	34.3	13.1	13.7	19.0	36.7	24.1	14.1	35.2	29.8	74.3	27.5	35.5	24.5	13.8	39.1	33.7	38.8	50.5	34.5	14.3	15.2	48.9	31.3	38.6	15.5	39.4	22.0	14.6	32.6	35.0	21.1	13.5	26.5	37.1	52.3	23.6	26.9	22.3	53.7	27.3	33.7	33.7	32.9	34.7	55.2	41.6	13.4	23.0	31.1	27.7	36.9	64.5	8.6	35.1	36.6	18.8	17.6	47.0	31.2	25.3	24.9	20.4	19.1	39.5	27.5	25.5	24.8	13.8	8.2	15.0	9.3	9.5	10.4	7.9	7.1	9.2	10.8	7.7	10.5	8.5	5.1	9.6	6.1	5.2	9.9	7.9	7.4	7.7	7.5	8.0	7.3	8.0	7.4	7.2	7.5	6.8	7.6	10.3	6.1	9.6	11.6	16.3	9.2	3.1	3.6	5.1	4.0	8.5	5.0	5.0	12.3	7.2	8.3	3.7	10.4	15.1	5.9	3.4	1.9	5.7	8.9	5.1	6.8	6.9	3.0	9.9	15.9	3.2	10.7	7.0	5.1	5.2	2.5	16.8	3.3	8.4	5.5	8.4	14.6	4.4	4.1	1.6	2.0	3.9	6.5	5.0	3.6	14.0	7.5	5.9	6.2	15.6	25.4	3.9	5.3	6.8	10.5	6.0	3.9	5.0	15.8	9.1	0.0	5.3	5.5	14.5	12.9	4.2	3.0	14.4	8.9	8.2	6.3	4.4
TTL	MGC46235	ENSG00000114999	"Tubulin tyrosine ligase"	Q8NG68	2	112482156-112541739	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA066819			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"HPA066819: AB_2685728"	"unprognostic (1.05e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.95e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	1.0	0.8	2.3	0.9	3.0	1.8	0.6	1.6	3.0	0.6	0.1	0.8	0.6	1.0	0.8	1.1	0.5	1.1	1.6	2.4	1.7	0.8	0.6	1.3	1.0	1.5	1.9	0.6	0.8	0.8	0.3	1.2	1.6	0.6	0.8	1.4	0.4	0.7	3.7	1.4	0.6	1.3	0.8	0.9	0.6	0.6	2.7	1.0	0.9	3.8	0.8	1.0	0.4	3.5	2.9	2.2	2.7	6.2	3.2	4.6	1.1	4.9	4.0	5.1	4.4	2.7	1.0	2.7	2.7	4.2	3.3	2.0	4.8	2.5	6.2	1.9	2.7	2.3	3.1	3.4	1.4	3.2	1.1	2.1	1.7	7.5	4.0	2.3	4.4	1.8	3.8	2.1	4.1	1.5	2.8	1.8	2.4	0.8	4.4	3.0	3.1	1.5	1.6	2.2	5.8	4.0	3.8	1.2	6.7	1.8	1.3	1.8	4.4	6.0	4.4	4.8	3.7	1.1	2.5	2.2	6.7	2.4	2.6	0.6	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.0	2.3	3.0	1.6	3.0	2.4	1.7	1.5	1.9	1.6	0.8	2.7	3.5	14.0	12.8	6.4	19.2	7.0	20.3	4.9	8.3	4.6	15.6	6.4	6.0	39.1	2.8	6.7	12.9	12.5	3.2	10.6	8.0	0.0	7.2	12.2	8.3	28.3	18.5	11.3	16.2	34.1	9.6	2.4	12.6	2.6	10.8	0.0	11.7	15.7	10.4	11.4	8.4	24.0	5.8	16.2	24.2	19.2	5.1	3.1	17.0	7.2	20.6	17.2	9.8	8.2	24.6	72.8	9.4	5.2	5.7	9.1	6.6	2.4	6.0	4.2	20.2	6.6	15.4	12.2	4.5	5.0	6.5	18.0	1.2	7.6	7.7	6.1	4.1
TTLL9	"C20orf125, dJ310O13.1"	ENSG00000131044	"Tubulin tyrosine ligase like 9"	Q3SXZ7	20	31870702-31944963	"Cancer-related genes, Predicted intracellular proteins"		Ligase	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 4.4;choroid plexus: 10.3;epididymis: 2.6;fallopian tube: 6.2;testis: 5.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 20.8;Early spermatids: 39.3;Endometrial ciliated cells: 25.8;Late spermatids: 69.8;Oligodendrocytes: 28.0;Respiratory ciliated cells: 50.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041772, HPA055676"	Uncertain		Uncertain	Nucleoplasm,Microtubules		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Microtubules"		"HPA041772: AB_10959904, HPA055676: AB_2682881"	"unprognostic (8.77e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.05e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.23e-2)"	0.1	0.1	2.0	0.0	2.1	0.0	0.2	2.2	2.2	0.9	10.3	0.0	0.0	0.1	2.6	0.0	6.2	0.1	0.0	2.5	2.3	0.7	0.0	1.1	0.1	3.8	4.4	0.1	0.2	0.6	0.9	0.0	3.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	3.0	0.2	0.0	5.0	2.4	0.0	0.6	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.1	2.2	2.2	2.5	2.3	3.8	4.4	3.0	3.0	2.4	2.6	0.2	12.8	20.8	13.1	0.1	0.1	1.1	1.1	0.0	1.8	0.4	0.6	0.9	0.0	8.1	0.0	4.2	0.1	0.1	0.0	0.0	0.2	39.3	25.8	0.7	1.1	0.0	0.0	5.6	0.0	0.0	1.6	0.0	0.8	7.6	0.8	0.4	0.1	0.0	5.0	7.8	0.2	2.0	0.6	0.5	69.8	1.5	3.5	0.0	1.0	0.8	0.4	0.0	15.1	28.0	0.1	0.0	1.2	0.0	0.5	0.0	0.2	50.2	0.8	0.0	0.8	0.7	13.8	1.2	0.0	0.1	0.0	2.7	0.4	0.0	0.4
TTYH1		ENSG00000167614	"Tweety family member 1"	Q9H313	19	54415219-54436904	"Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 80.9;choroid plexus: 35.6;testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 257.6;Bipolar cells: 138.6;Muller glia cells: 653.4;Oligodendrocytes: 97.5;Rod photoreceptor cells: 155.3"	"Cancer enriched"	"Detected in many"	15	"glioma: 63.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;AN3-CA: 11.7;U-2 OS: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005725, HPA023617, HPA050655"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"HPA005725: , HPA023617: AB_10600836, HPA050655: AB_2681204"	"prognostic favorable (3.64e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.60e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.09e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.69e-1)"	0.9	0.9	64.3	0.0	67.9	0.0	3.5	64.0	80.9	4.0	35.6	10.0	0.2	1.6	0.0	1.1	10.4	0.2	3.6	57.6	59.7	1.2	0.7	0.2	0.0	69.4	66.5	1.5	19.4	0.0	17.7	0.0	63.5	3.5	0.0	3.2	3.6	0.4	3.3	5.9	2.6	0.0	67.6	1.4	2.5	53.4	69.3	0.0	0.3	0.0	0.0	1.7	4.2	66.8	0.1	0.0	7.9	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.3	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.1	2.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.3	67.9	64.0	80.9	57.6	59.7	69.4	66.5	63.5	67.6	69.3	66.8	0.4	3.2	0.6	257.6	0.4	0.8	1.2	0.6	0.0	138.6	44.3	42.2	1.3	4.3	3.0	0.0	20.9	0.9	1.3	0.2	0.0	30.4	3.9	0.3	0.9	2.8	1.2	0.0	26.4	0.6	0.7	1.5	0.0	0.7	0.0	13.7	0.7	0.1	0.3	10.1	3.3	0.0	0.0	0.0	1.5	4.8	1.8	0.3	23.2	19.7	0.3	653.4	0.0	48.2	97.5	2.2	0.0	0.7	0.1	1.9	0.4	0.7	2.8	155.3	6.6	2.3	7.8	2.2	5.1	0.0	0.9	4.2	0.6	0.5	0.3	1.9
TUBD1	"FLJ12709, TUBD"	ENSG00000108423	"Tubulin delta 1"	Q9UJT1	17	59859479-59892945	"FDA approved drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 83.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004609, HPA023980, HPA027090"	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 13: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"		"CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457"	"unprognostic (1.92e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (2.86e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (4.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.83e-2)"	4.4	4.4	5.8	4.9	6.9	3.9	7.0	9.2	7.4	7.5	5.0	7.5	3.8	5.5	9.1	10.6	6.5	4.6	6.0	5.9	6.3	6.2	5.9	5.1	6.7	6.7	6.9	9.0	7.8	5.9	6.9	4.2	7.0	7.8	4.7	5.6	7.0	6.2	6.5	6.8	4.8	4.3	6.3	5.8	6.4	5.5	6.2	8.2	7.3	7.7	8.3	6.4	8.3	8.9	11.7	15.8	12.2	12.8	6.8	4.9	9.7	9.1	5.3	11.7	9.5	17.0	7.5	10.5	15.0	2.1	7.9	9.7	17.4	5.4	11.1	6.1	21.2	12.6	12.4	20.4	3.6	7.6	6.4	2.7	8.3	10.1	3.5	4.0	9.4	10.3	27.5	7.1	4.0	83.1	15.6	8.5	10.8	13.0	6.9	16.1	17.9	16.2	5.0	4.8	11.3	6.8	6.4	4.9	6.5	14.5	11.8	7.2	3.0	8.4	18.3	5.9	9.8	8.3	13.7	16.2	4.0	8.3	7.5	6.5	8.4	16.3	11.4	5.8	13.2	11.7	14.0	12.1	5.9	8.9	18.1	14.8	8.8	10.1	6.5	9.9	16.7	7.1	5.8	6.9	9.2	7.4	5.9	6.3	6.7	6.9	7.0	6.3	6.2	8.9	8.3	12.8	36.1	10.7	16.9	15.7	14.4	9.1	10.8	7.6	10.9	11.3	5.3	5.7	17.6	3.7	6.2	6.3	9.4	3.2	11.7	5.7	1.7	9.2	8.5	9.4	10.3	13.9	9.2	4.8	7.4	9.6	4.1	16.3	11.4	9.9	8.9	3.8	4.0	3.3	9.5	5.5	8.2	4.7	7.1	0.8	5.6	6.9	7.2	9.4	6.0	10.3	13.4	8.5	18.4	3.7	7.5	8.2	10.9	12.5	3.6	3.6	9.4	8.6	6.6	13.3	9.6	14.7	24.2	10.6	16.9	4.0	16.2	2.6	4.9	6.8
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278635-133312337	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.0	22.2	14.4	20.9	15.4	35.0	13.4	13.5	19.3	15.7	18.2	18.2	22.1	16.0	10.5	17.3	30.3	14.9	20.4	14.8	14.1	19.3	16.4	17.3	20.9	17.1	15.2	26.8	28.3	26.0	3.5	15.8	17.5	17.8	13.3	11.8	28.2	17.1	33.2	22.5	22.1	14.9	13.0	21.9	20.4	21.7	15.0	20.7	19.0	24.4	14.4	15.9	5.8	14.5	64.2	84.2	30.7	35.6	28.3	29.8	42.9	47.5	66.5	50.0	49.5	97.0	45.9	42.1	27.7	48.6	21.6	47.2	35.8	32.3	22.8	50.5	75.7	24.6	46.7	52.3	35.5	63.4	57.0	31.3	29.9	46.5	58.0	55.3	33.3	29.9	36.4	45.6	41.2	79.9	41.4	56.3	30.4	37.2	64.6	32.7	32.9	19.5	32.7	40.8	20.6	43.0	33.0	40.1	36.1	17.9	23.6	38.3	45.6	30.9	27.6	38.0	47.9	43.7	25.9	53.8	102.3	27.3	19.8	6.4	22.5	15.9	15.3	23.2	14.8	11.4	13.3	14.6	27.6	12.3	14.0	15.4	13.8	27.7	25.8	11.7	18.3	19.0	14.4	15.4	13.5	19.3	14.8	14.1	17.1	15.2	17.5	13.0	15.0	14.5	29.1	48.1	38.5	18.9	36.7	13.9	27.4	30.2	23.3	45.7	25.9	25.3	33.9	22.8	38.8	40.5	31.3	41.4	40.1	34.8	23.5	34.5	25.9	78.0	41.6	26.4	29.3	28.0	17.5	37.1	32.9	35.9	38.7	37.1	39.9	49.5	28.9	27.5	44.4	38.7	15.9	36.2	8.2	42.7	25.5	28.6	33.8	51.6	14.2	15.9	75.0	39.3	62.8	9.5	20.1	37.3	33.5	35.3	37.2	28.6	37.3	53.4	112.2	74.8	32.9	39.9	32.1	74.3	65.3	29.0	13.8	42.5	35.7	50.4	36.0	30.3
TULP3	TUBL3	ENSG00000078246	"TUB like protein 3"	O75386	12	2877223-2941138	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015285, HPA018496"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA015285: AB_1858460, HPA018496: AB_2669889"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.19e-2)"	21.0	17.1	13.6	7.5	14.2	2.6	18.3	19.2	16.1	33.3	15.8	21.6	5.4	23.2	11.7	17.8	24.3	12.1	17.7	13.8	13.2	17.3	9.0	13.5	6.1	16.3	14.8	37.7	9.6	13.3	12.3	13.7	13.8	15.4	8.2	12.7	13.0	13.9	10.4	25.7	10.5	18.2	14.5	9.4	15.5	13.0	14.4	9.4	15.5	9.7	8.1	16.7	24.1	17.1	22.6	18.8	35.0	29.1	34.3	51.0	32.9	34.5	57.5	36.4	40.2	24.0	20.4	16.7	5.1	51.2	31.2	18.5	21.1	22.2	42.0	21.7	15.4	10.0	23.4	15.5	44.3	10.8	11.1	30.1	25.7	55.3	74.9	44.6	28.6	20.8	9.7	15.1	31.0	20.3	16.1	9.4	47.4	17.8	13.7	16.8	34.2	6.3	22.9	18.7	8.8	23.4	30.1	17.8	19.9	63.4	22.2	10.5	23.0	26.6	32.0	54.7	33.9	4.7	6.0	14.3	26.9	5.9	41.5	0.0	0.9	0.3	2.1	0.8	3.5	1.6	1.7	2.2	0.7	1.8	2.0	2.8	0.4	2.7	0.5	1.6	3.3	1.0	13.6	14.2	19.2	16.1	13.8	13.2	16.3	14.8	13.8	14.5	14.4	17.1	12.9	6.4	10.5	70.5	6.2	20.3	16.9	14.8	26.2	6.1	9.9	12.2	8.0	18.6	15.9	1.8	2.1	9.4	6.0	4.6	23.5	17.3	5.8	35.1	33.5	15.2	3.6	6.1	6.0	7.3	10.6	31.7	6.6	14.6	0.0	11.5	24.3	5.5	5.3	40.4	10.8	4.0	14.2	2.5	8.6	3.6	40.7	5.4	19.6	14.0	6.7	50.7	12.3	10.1	34.9	11.1	2.4	24.8	8.3	23.3	3.2	21.9	47.4	10.0	39.5	22.3	26.3	38.0	50.8	22.2	20.2	11.6	6.5	13.3	6.4	13.2
TUSC1	"CCDC89B, TSG-9"	ENSG00000198680	"Tumor suppressor candidate 1"	Q2TAM9	9	25676389-25678440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051426	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA051426: AB_2681481"	"unprognostic (9.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	16.1	10.6	8.5	2.8	8.5	1.7	14.8	7.0	9.3	13.6	9.5	14.3	5.3	18.3	6.2	9.1	15.9	2.8	12.2	8.7	8.9	13.1	10.9	9.8	1.6	9.6	10.5	13.2	9.8	5.6	9.0	3.8	8.2	11.7	3.7	2.8	10.8	6.1	8.3	13.1	9.1	5.5	9.0	6.8	11.5	21.8	8.6	3.2	11.9	4.7	2.0	12.7	10.7	10.4	10.0	2.1	2.1	0.0	7.0	5.8	0.1	7.5	0.0	2.8	3.4	0.1	3.5	0.0	2.2	8.9	7.6	0.0	5.3	9.4	1.7	0.0	10.3	38.6	11.2	0.0	3.4	0.0	0.0	7.1	13.0	3.1	7.3	0.0	3.1	0.0	0.0	0.1	3.3	5.0	0.0	0.1	1.8	8.0	9.5	0.0	1.4	0.1	3.9	4.6	0.7	16.8	9.3	7.6	8.2	4.1	6.7	10.8	6.6	0.0	13.6	0.1	0.0	0.0	0.0	0.0	8.8	2.6	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	8.5	8.5	7.0	9.3	8.7	8.9	9.6	10.5	8.2	9.0	8.6	10.4	46.5	12.8	6.4	2.3	2.1	60.8	46.1	14.7	47.3	24.8	45.4	55.0	12.2	20.0	5.9	16.5	4.2	29.5	2.4	14.8	66.5	7.9	85.7	11.0	26.6	24.4	13.1	4.8	7.3	12.4	13.8	33.0	7.1	17.2	0.0	15.7	22.9	18.5	9.7	21.9	7.6	11.8	10.2	4.8	13.0	16.2	30.7	5.2	28.4	3.7	1.2	42.9	0.0	4.0	9.3	8.1	9.5	21.8	0.5	45.5	8.1	23.1	3.5	14.3	32.9	52.8	36.9	164.0	12.8	16.8	37.8	29.0	1.3	16.3	14.3	19.8
TUT1	"FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TENT1, TUTase"	ENSG00000149016	"Terminal uridylyl transferase 1, U6 snRNA-specific"	Q9H6E5	11	62575045-62591637	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.5;Early spermatids: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA069055, HPA071838"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA069055: AB_2686075, HPA071838: AB_2686456"	"unprognostic (3.81e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-3)"	10.5	10.7	9.1	7.4	10.1	6.0	11.8	9.1	9.9	10.4	8.1	8.9	8.8	9.9	5.8	9.3	11.2	6.1	9.5	8.8	8.6	10.7	22.2	8.3	11.8	10.5	9.3	11.2	19.4	7.6	10.6	6.2	10.1	12.7	4.0	5.4	11.7	7.3	20.4	12.8	10.2	4.6	9.4	12.7	12.6	13.6	9.8	10.2	12.3	7.6	7.9	10.4	9.2	12.0	12.5	16.0	10.7	15.4	12.6	7.3	14.0	12.7	8.3	11.2	9.7	14.0	24.9	19.5	30.1	6.6	14.3	23.7	19.8	15.9	5.7	15.1	10.5	20.3	15.8	14.1	14.3	14.8	9.3	10.3	16.6	13.7	21.1	10.5	10.8	26.2	32.1	20.7	9.6	28.8	21.1	33.3	12.4	8.4	19.1	23.7	16.6	50.9	10.6	6.9	18.2	24.6	10.4	19.6	17.5	8.9	27.2	14.2	10.1	12.9	11.3	15.2	10.1	36.1	32.9	24.6	14.8	11.5	10.7	6.0	5.9	7.0	9.9	7.2	13.7	9.2	9.5	8.1	7.9	11.6	14.3	11.7	3.5	11.0	5.6	9.3	9.2	7.7	9.1	10.1	9.1	9.9	8.8	8.6	10.5	9.3	10.1	9.4	9.8	12.0	32.5	0.0	6.7	7.5	7.5	2.7	5.2	7.2	4.0	8.4	5.9	5.2	4.2	18.6	7.1	11.0	6.2	12.8	6.0	4.4	5.9	8.5	34.3	5.7	3.1	15.0	7.2	3.2	3.9	7.4	7.8	5.1	7.7	4.1	2.5	5.5	18.2	17.8	5.9	1.7	4.6	9.1	6.1	5.0	2.2	16.4	7.2	4.3	10.6	1.0	4.0	9.8	14.4	4.0	5.4	5.6	3.6	3.4	4.9	7.1	8.4	7.1	13.1	8.4	0.0	4.1	4.1	10.0	16.3	3.1	2.3	14.0	5.6	5.6	7.0	3.1
TUT7	"FLJ13409, KIAA1711, PAPD6, TENT3B, ZCCHC6"	ENSG00000083223	"Terminal uridylyl transferase 7"	Q5VYS8	9	86287733-86354454	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 80.3;Endometrial stromal cells: 61.1;Glandular and luminal cells: 206.7;Syncytiotrophoblasts: 92.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 114.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 114.6;monocytes: 47.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	12.5	9.4	4.8	16.0	6.4	22.6	18.7	5.9	10.0	12.8	10.9	12.1	11.0	9.1	8.9	24.7	8.8	11.3	8.2	5.1	7.9	7.5	38.4	16.5	19.1	9.0	6.3	8.7	13.1	8.7	8.2	14.3	7.8	20.8	11.8	7.7	14.2	7.2	13.6	33.7	12.3	7.8	5.1	20.6	13.6	11.6	9.2	15.1	8.6	9.3	19.2	13.4	16.0	9.0	16.2	17.2	9.8	14.3	22.4	36.0	12.2	21.6	20.5	9.1	10.6	7.8	13.7	22.8	18.9	14.0	9.5	27.3	11.8	12.0	13.5	27.1	6.0	16.5	18.4	13.7	19.3	19.1	21.8	23.5	22.7	14.5	16.2	13.7	15.0	12.3	15.9	24.0	24.6	14.9	16.0	11.0	7.5	25.1	11.1	8.0	17.5	10.1	15.3	31.4	7.2	5.7	13.1	15.5	7.4	11.6	6.4	7.8	24.8	8.7	10.5	15.7	14.8	27.4	23.3	16.5	20.7	10.8	11.8	35.4	19.4	20.5	15.0	24.7	12.5	11.6	8.2	10.7	11.9	12.2	9.5	10.1	114.6	12.8	47.8	5.5	8.8	8.9	4.8	6.4	5.9	10.0	5.1	7.9	9.0	6.3	7.8	5.1	9.2	9.0	28.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	34.2	16.4	0.0	0.0	0.0	9.2	0.0	22.4	36.6	0.0	5.9	29.6	0.0	80.3	61.1	7.2	0.0	0.0	0.0	17.9	17.4	5.6	0.0	206.7	0.0	36.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	12.4	0.0	0.0	0.0	0.0	27.8	0.0	0.0	13.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	92.5	14.8	30.9	0.0	0.0
TWIST2	"bHLHa39, Dermo-1, DERMO1"	ENSG00000233608	"Twist family bHLH transcription factor 2"	Q8WVJ9	2	238848032-238910534	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 83.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 95.4;Fibroblasts: 58.9;Leydig cells: 48.1;Peritubular cells: 39.1;Theca cells: 23.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	24	"eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 80.0;ASC TERT1: 50.5;BJ: 69.3;BJ hTERT+: 212.4;fHDF/TERT166: 97.4;U-2197: 81.3"	"Low region specificity"	"Detected in single"							HPA062870			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Nucleoli	"HPA062870: AB_2684888"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.83e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-9)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.48e-2)"	59.7	4.0	0.3	1.4	0.3	0.4	43.3	0.3	0.5	83.0	0.6	22.9	0.3	31.3	0.7	10.1	30.4	1.7	10.8	0.4	0.3	1.8	0.7	9.3	0.3	0.4	0.8	39.9	1.8	0.1	8.3	3.1	0.4	25.7	1.1	0.0	7.9	3.7	1.8	33.5	8.9	2.9	0.4	2.3	10.3	1.9	0.3	0.1	8.2	1.0	0.4	21.3	54.2	0.5	0.1	4.5	0.4	0.0	80.0	50.5	0.1	69.3	212.4	31.0	46.4	0.0	0.0	0.0	2.1	97.4	2.5	0.5	0.7	5.4	22.5	0.0	7.3	0.0	4.0	0.2	13.7	0.0	1.6	11.8	2.9	15.0	12.5	3.7	4.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.7	0.0	0.9	11.8	1.2	2.2	81.3	0.8	0.0	0.0	0.0	0.3	2.1	4.3	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.4	0.3	0.4	0.8	0.4	0.4	0.3	0.5	2.5	0.0	2.6	0.0	0.1	2.0	16.0	0.0	7.4	0.0	0.5	0.4	0.6	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.4	3.6	95.4	1.3	0.0	0.0	4.4	0.0	1.9	58.9	0.0	2.1	1.3	0.5	2.9	0.1	2.2	0.0	0.2	0.0	0.0	0.0	3.6	1.2	48.1	0.8	1.8	12.2	0.4	0.0	8.2	0.5	0.1	0.1	0.0	39.1	0.0	20.5	0.0	0.0	0.0	0.0	0.0	1.1	9.6	0.5	3.3	0.2	1.7	1.6	1.6	23.2	0.0	3.7
TXLNA	DKFZp451J0118	ENSG00000084652	"Taxilin alpha"	P40222	1	32179675-32198285	"Cancer-related genes, Predicted intracellular proteins"	Exocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045383, HPA072477"	Supported		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Nucleoplasm, Centrosome"	"HPA045383: AB_10967649, HPA072477: AB_2686525"	"prognostic favorable (6.24e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (5.53e-4)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (3.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.69e-5)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (7.21e-7)"	"unprognostic (3.94e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	26.1	35.8	20.6	20.7	22.0	16.5	20.3	20.6	21.3	30.7	27.5	32.2	16.9	35.4	22.7	30.7	30.5	18.7	22.2	20.4	22.8	30.0	45.6	23.1	22.0	25.3	23.6	29.0	29.2	32.5	31.7	16.7	22.1	30.1	17.9	12.6	23.2	21.7	21.8	31.3	24.4	27.8	21.5	28.5	26.5	29.4	23.9	19.3	27.0	14.5	27.0	28.6	24.3	22.7	45.1	37.7	38.5	43.5	48.8	63.8	31.1	62.7	49.6	59.3	56.6	42.4	47.4	51.1	24.9	61.2	19.5	49.5	53.0	41.2	53.7	58.8	41.0	80.8	57.6	55.8	51.7	59.4	61.4	64.3	54.2	62.8	29.6	43.6	47.6	60.8	33.5	51.3	49.2	25.0	43.8	38.1	56.1	32.0	34.3	50.8	58.3	45.1	40.6	56.4	40.1	41.3	65.1	40.8	68.5	46.9	37.8	35.6	49.9	62.3	53.5	83.3	81.1	75.8	63.0	45.7	64.5	79.5	58.9	11.0	8.8	4.6	12.9	9.8	11.0	6.8	8.8	9.7	6.9	7.4	7.6	8.3	1.4	14.2	13.3	14.3	7.0	10.6	20.6	22.0	20.6	21.3	20.4	22.8	25.3	23.6	22.1	21.5	23.9	22.7	26.2	22.4	21.4	13.4	13.4	8.8	11.3	14.1	17.1	16.0	26.4	24.6	9.5	11.5	16.8	14.7	39.6	10.8	18.9	15.0	1.9	17.4	14.4	26.9	44.7	23.6	26.3	12.4	9.7	16.4	14.3	27.7	23.9	27.4	13.3	20.2	16.1	32.2	18.2	26.9	9.6	18.1	12.2	11.0	10.0	16.8	23.9	15.9	5.4	7.5	20.9	13.3	10.3	9.5	12.9	22.4	7.2	20.7	19.8	12.4	8.3	12.7	24.1	26.1	13.1	33.6	25.8	34.3	23.8	21.2	12.1	6.8	15.5	23.2	14.7	7.7
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243810-110256507	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1058.8"	"Cell type enriched"	"Detected in all"	4	"monocytes: 15775.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1642.2;granulocytes: 1355.4"	"Cell line enhanced"	"Detected in all"		"OE19: 3836.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	144.2	127.7	149.9	145.4	155.3	367.5	218.6	154.5	225.4	153.9	140.5	455.2	349.3	130.9	168.4	1058.8	240.7	142.1	90.8	156.2	161.7	430.6	436.0	158.4	131.6	163.3	156.2	83.8	119.1	73.0	61.2	105.8	163.0	113.6	435.0	46.2	391.7	128.9	84.8	240.1	332.2	140.3	158.1	105.4	222.7	36.6	156.4	261.3	93.8	76.4	208.3	218.1	230.8	164.8	672.9	920.0	238.7	265.6	601.0	782.3	352.7	792.5	756.2	555.6	419.4	606.8	785.6	598.9	331.5	754.7	1181.3	1464.8	351.0	1081.1	544.6	887.6	778.5	298.2	804.7	1061.8	684.7	747.2	864.2	556.2	703.5	809.0	607.8	504.7	498.7	369.7	515.9	553.1	775.4	557.1	621.9	1119.7	505.4	3836.3	1110.5	256.6	810.3	696.3	721.7	479.4	520.9	183.7	860.0	687.5	572.7	458.6	661.2	508.6	587.9	556.4	357.3	1050.2	1006.1	271.4	872.5	512.7	804.8	654.4	789.5	484.8	311.2	1355.4	169.2	195.5	165.2	154.2	237.7	207.3	475.7	75.9	87.4	129.3	1212.7	195.0	131.6	1642.2	337.0	279.2	149.9	155.3	154.5	225.4	156.2	161.7	163.3	156.2	163.0	158.1	156.4	164.8	458.7	391.0	298.2	12.4	165.9	1304.5	1072.4	3654.4	435.4	38.0	514.2	752.8	108.5	418.9	1810.0	263.0	20.9	637.2	443.0	1297.7	972.4	1172.8	31.2	1560.7	1465.0	587.0	556.4	388.4	18.2	1341.7	993.1	526.8	662.1	775.9	268.6	247.1	216.0	842.8	571.8	28.6	18.3	1111.2	2191.1	286.1	1752.9	31.6	403.2	682.7	763.1	10.3	15775.8	86.3	128.8	7.5	21.9	1994.7	1227.7	285.5	388.5	2151.2	1439.2	3670.6	1516.8	34.8	144.7	211.8	557.8	10.6	76.3	2725.7	1491.0	468.2	266.6	879.4	1621.8	1742.1
TXNL4A	"DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD"	ENSG00000141759	"Thioredoxin like 4A"	P83876	18	79970813-80033949	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"		Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 360.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041324			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA041324: AB_2677410"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	61.1	79.1	88.1	39.9	92.5	59.6	52.1	96.0	98.7	37.2	94.9	53.5	32.8	35.7	50.3	69.4	38.1	24.1	88.6	95.0	98.4	87.7	97.1	48.2	53.4	89.4	95.8	32.6	86.0	42.2	95.5	31.6	94.1	53.9	33.2	36.5	55.0	25.3	88.5	59.3	48.0	25.6	93.1	67.8	60.5	88.0	91.6	52.4	51.1	61.3	45.6	46.1	45.5	99.3	98.5	129.3	113.0	108.1	90.3	94.7	99.8	104.3	83.5	138.7	124.9	121.2	68.0	118.8	37.8	100.3	94.1	81.4	137.1	121.5	91.2	139.7	173.7	85.6	196.1	288.7	115.4	247.6	134.1	88.6	105.5	98.7	125.6	87.9	132.4	145.0	76.2	168.0	97.8	177.1	177.0	166.3	88.6	74.3	276.9	106.2	75.7	245.4	137.7	152.7	172.1	125.0	51.6	151.8	200.5	96.9	74.6	145.0	62.9	121.3	149.5	55.7	129.4	74.0	302.3	198.6	113.4	185.7	113.9	10.6	10.3	9.0	14.7	12.7	9.9	15.8	11.8	11.6	14.5	17.6	11.7	14.0	8.2	15.6	13.1	31.3	17.3	6.1	88.1	92.5	96.0	98.7	95.0	98.4	89.4	95.8	94.1	93.1	91.6	99.3	81.0	19.2	42.6	14.0	89.2	87.2	76.9	73.6	64.3	35.7	131.9	139.7	80.3	65.8	62.3	66.2	35.5	107.8	104.8	53.6	360.0	123.4	259.3	98.5	66.0	65.2	56.3	94.1	25.3	125.2	156.9	69.8	71.4	88.1	11.4	84.1	47.2	97.4	126.0	45.4	22.5	88.4	59.0	66.4	76.9	245.5	42.0	89.5	94.3	14.0	87.2	81.5	60.8	21.1	34.8	144.5	54.9	45.1	177.9	177.2	48.6	271.8	41.9	51.3	46.0	61.2	100.8	84.6	74.2	147.6	109.8	96.7	78.7	112.6	71.1	119.4
TXNL4B	"Dim2, DLP, FLJ20511"	ENSG00000140830	"Thioredoxin like 4B"	Q9NX01	16	72044289-72094431	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065865			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA065865: AB_2685571"	"unprognostic (1.45e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	9.5	7.2	8.8	9.5	11.1	14.3	9.6	10.7	12.2	8.1	9.9	7.4	10.1	7.7	7.6	9.1	10.1	8.7	8.6	9.5	10.1	8.3	16.2	6.7	11.3	10.7	10.1	20.9	9.1	7.6	8.4	7.5	10.8	7.3	8.2	6.7	8.7	7.4	9.0	8.0	8.5	6.4	10.4	7.4	7.9	15.6	10.5	11.7	8.1	8.3	9.7	7.3	6.9	15.5	14.3	20.8	11.2	15.9	8.2	9.7	25.0	18.1	14.7	31.0	23.3	21.4	12.7	20.6	12.8	9.4	14.5	19.3	20.1	10.9	24.0	10.3	18.9	19.0	16.8	32.7	17.4	22.8	15.9	10.1	7.3	27.5	26.1	12.0	13.5	22.6	46.5	12.2	14.8	26.7	27.6	20.5	20.9	9.0	19.1	28.3	14.2	28.3	11.5	10.6	25.9	22.2	17.0	8.0	24.6	8.6	18.7	14.5	12.9	14.9	21.6	12.5	17.2	23.9	41.8	86.0	16.7	15.4	15.2	25.4	8.8	12.3	7.6	9.8	11.9	9.7	7.9	6.7	7.8	7.1	10.8	10.8	12.6	4.9	14.0	8.5	9.9	9.1	8.8	11.1	10.7	12.2	9.5	10.1	10.7	10.1	10.8	10.4	10.5	15.5	7.1	3.2	8.3	7.5	13.1	8.5	7.7	5.4	9.6	3.7	9.8	10.4	2.0	7.2	5.5	5.5	2.1	13.5	8.9	7.4	5.9	10.7	1.6	10.5	9.7	10.1	9.0	10.8	3.3	10.1	17.5	7.9	7.7	12.5	9.5	16.0	10.8	13.3	12.0	10.1	3.3	9.5	0.0	9.2	4.6	4.5	11.8	9.3	7.2	2.8	10.8	4.5	8.2	7.5	5.8	7.6	3.3	9.1	7.9	7.7	11.6	16.2	7.2	5.1	0.0	8.2	6.7	8.2	8.8	9.6	8.2	19.4	9.7	10.2	9.1	7.2
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350307	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 459.7;Prostatic glandular cells: 557.4;Urothelial cells: 488.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 1452.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		6100000	"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	47.1	148.1	22.5	40.6	21.1	64.7	28.0	20.9	22.6	28.0	37.3	50.9	58.4	47.9	21.0	30.7	39.0	55.9	65.8	21.1	29.8	37.9	46.5	63.0	34.4	55.2	26.7	34.1	19.0	33.8	21.2	39.1	33.3	41.0	45.6	20.1	20.8	60.6	67.8	12.4	39.4	51.6	22.9	27.8	52.1	37.8	24.6	42.8	30.4	64.0	34.1	141.6	30.1	25.7	228.4	1032.6	118.1	111.3	553.5	308.0	409.8	412.4	259.3	182.7	186.8	110.5	329.4	169.3	187.0	1452.6	682.1	77.7	235.7	158.6	214.1	82.7	101.8	143.1	765.8	468.0	885.7	226.3	149.9	176.9	159.8	403.7	128.1	557.1	634.0	227.9	200.5	77.5	276.8	109.1	233.4	102.7	114.4	453.0	1053.1	227.3	82.1	146.5	211.2	123.1	182.6	110.6	333.3	519.1	325.2	222.6	123.2	131.4	854.5	89.3	183.7	201.3	341.2	84.8	179.9	254.5	186.8	122.5	538.0	109.4	29.9	69.7	23.6	39.0	26.9	21.3	21.6	23.9	39.5	14.5	19.1	16.7	102.6	24.4	48.4	25.2	19.8	27.6	22.5	21.1	20.9	22.6	21.1	29.8	55.2	26.7	33.3	22.9	24.6	25.7	26.0	64.1	67.5	50.3	27.6	104.0	459.7	41.3	40.9	28.1	19.4	16.3	66.2	32.9	79.3	16.5	22.9	26.1	40.4	93.4	41.1	79.6	45.0	100.9	36.8	116.2	20.4	46.3	48.2	80.7	34.3	90.1	69.8	119.6	53.2	35.2	49.2	68.2	42.0	28.6	56.7	18.8	44.7	43.5	100.5	19.1	68.0	62.2	19.6	49.6	51.9	24.8	26.8	29.1	55.3	197.7	40.5	29.3	28.4	557.4	24.6	37.5	105.5	20.9	0.0	43.4	84.0	14.4	33.8	24.3	72.9	51.3	28.5	98.4	33.0	488.0
TXNRD3	"TGR, TR2, TR2IT1, TRXR3, TXNRD3IT1, TXNRD3NB, TXNRD3NT1"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126571779-126655124	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 20.4"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	4.9	4.0	2.4	2.2	2.4	1.1	6.1	3.4	1.9	4.7	3.1	2.4	1.3	5.1	5.9	4.8	3.6	3.6	3.1	1.8	3.3	5.7	8.7	4.2	1.1	2.8	3.0	6.7	6.3	8.2	1.7	2.9	2.8	3.8	3.0	1.9	3.7	4.1	5.6	3.2	1.4	4.9	3.0	2.6	3.6	20.4	3.0	4.6	6.1	5.8	1.4	3.2	1.9	2.8	16.0	3.8	4.9	8.3	8.7	13.1	2.7	6.7	5.8	5.4	7.4	7.6	8.7	0.0	8.5	9.7	3.4	6.4	6.3	7.1	6.4	0.0	5.1	1.5	3.7	5.9	7.8	6.4	0.6	13.1	5.9	1.8	12.1	7.0	3.8	5.2	3.7	0.0	9.0	12.2	1.4	3.4	7.3	4.3	3.4	0.5	4.2	2.6	6.0	8.0	8.9	5.1	19.9	5.7	10.3	3.7	8.0	2.6	6.9	6.8	1.8	9.3	3.3	4.0	1.9	0.0	3.5	2.2	5.6	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	2.4	2.4	3.4	1.9	1.8	3.3	2.8	3.0	2.8	3.0	3.0	2.8	1.3	3.2	7.2	14.4	0.4	1.0	5.7	1.6	6.2	2.0	2.9	2.4	4.1	4.3	3.0	3.7	2.1	9.4	0.1	0.5	3.9	5.1	18.2	1.5	4.0	1.7	4.2	3.0	7.5	3.8	5.4	5.3	4.1	1.0	5.7	6.1	2.9	8.0	2.9	0.0	5.8	2.4	0.0	0.8	0.7	4.0	4.7	1.0	0.0	3.7	0.0	3.2	0.0	11.1	4.7	3.8	0.3	8.6	0.1	5.5	0.1	4.5	3.3	0.9	0.0	5.7	2.8	71.5	18.2	6.1	0.6	7.3	0.6	6.6	1.5	3.2
TYSND1	"MGC34695, NET41"	ENSG00000156521	"Trypsin like peroxisomal matrix peptidase 1"	Q2T9J0	10	70137981-70146700	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 120.7;Late spermatids: 227.4;Spermatocytes: 124.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 27.5;PC-3: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030304	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	Cytosol	"HPA030304: AB_10670560"	"unprognostic (4.75e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	5.7	6.0	1.4	1.9	1.3	0.9	5.4	1.7	1.8	5.8	1.1	4.9	3.3	4.1	0.6	11.8	4.5	0.6	2.9	1.0	0.9	5.2	6.4	2.8	1.8	2.1	0.7	4.2	6.2	1.3	3.4	1.3	0.8	5.7	0.6	0.2	5.7	1.5	3.2	11.4	5.0	0.3	0.6	5.4	3.9	14.2	0.9	1.2	4.6	0.5	0.9	4.8	6.5	1.4	16.0	10.2	0.8	6.2	1.0	0.9	3.7	2.2	1.4	2.0	1.8	6.2	9.6	13.8	6.0	0.5	0.6	27.5	1.0	3.9	0.4	8.9	9.5	0.7	2.9	3.3	2.4	1.2	0.1	2.0	7.6	1.7	3.1	1.2	1.4	4.9	0.1	4.3	0.8	6.3	5.3	5.6	3.3	3.5	41.7	8.9	2.6	6.2	0.9	2.6	7.4	3.8	6.7	14.8	6.1	0.2	9.4	1.1	2.6	2.5	1.7	4.8	8.7	14.9	9.9	7.0	2.9	6.2	1.8	0.0	0.8	0.7	3.8	1.2	2.4	3.0	2.2	2.8	0.9	3.3	3.0	2.6	0.3	2.0	0.7	0.7	2.6	1.4	1.4	1.3	1.7	1.8	1.0	0.9	2.1	0.7	0.8	0.6	0.9	1.4	6.1	9.6	5.3	4.9	12.6	14.3	14.5	13.3	14.8	6.9	14.8	16.9	4.2	27.1	7.8	11.0	0.0	35.2	15.5	14.6	17.6	7.8	120.7	5.5	6.8	6.3	14.3	5.0	6.7	9.5	9.8	7.5	5.1	6.3	13.4	9.3	6.8	16.5	12.1	0.0	6.0	12.1	16.2	10.7	6.6	227.4	9.3	8.2	12.4	6.5	6.1	7.0	12.3	11.6	5.5	5.5	11.6	7.9	7.5	14.5	19.2	16.5	3.9	4.4	6.6	6.9	6.1	124.7	12.5	22.4	18.5	16.7	14.0	10.6	21.0	8.8
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 57.8;Oligodendrocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	7.7	10.8	5.5	8.1	5.9	9.1	10.0	6.6	7.6	13.0	8.8	9.0	9.5	9.2	9.7	6.6	10.1	7.1	7.9	5.6	6.4	8.8	12.0	7.2	9.8	6.4	5.8	12.2	7.3	13.1	6.9	8.4	6.1	9.8	10.7	9.0	7.1	9.5	15.6	7.9	7.8	9.2	5.6	7.7	7.7	8.1	5.7	10.4	12.8	8.4	9.4	8.5	8.7	7.3	16.3	20.5	12.1	24.9	17.4	12.0	13.8	16.8	12.9	12.9	12.0	23.3	20.2	28.1	25.2	15.4	18.6	18.4	24.9	20.3	18.4	22.1	24.1	11.9	17.1	15.6	17.7	27.7	15.1	12.4	20.3	17.5	27.0	10.6	13.0	20.9	32.3	16.0	15.6	15.7	18.1	23.4	21.1	27.2	18.8	19.7	16.6	34.8	17.4	16.4	18.2	18.3	20.4	38.4	17.6	22.7	26.6	19.6	14.0	15.0	10.8	11.8	23.3	16.1	25.7	33.2	12.1	25.9	20.8	2.4	7.4	3.9	8.5	7.7	11.2	8.3	8.8	9.5	8.8	9.8	10.8	11.7	1.8	11.1	10.0	6.7	6.8	6.2	5.5	5.9	6.6	7.6	5.6	6.4	6.4	5.8	6.1	5.6	5.7	7.3	10.0	6.4	15.3	39.2	18.2	10.5	5.3	10.0	17.1	12.0	11.4	11.7	9.5	10.0	7.6	11.0	4.2	18.6	11.7	7.8	0.0	7.8	7.3	10.9	18.0	8.8	4.8	12.6	57.8	6.9	13.1	11.0	12.8	10.9	34.2	9.1	6.1	14.2	7.7	3.3	53.4	12.3	12.2	7.1	11.2	4.5	8.4	10.3	8.8	43.1	10.0	6.8	10.3	50.3	58.7	7.1	4.0	8.2	18.0	6.2	4.9	2.4	9.6	11.5	19.7	11.2	10.4	23.9	23.4	15.6	16.9	15.2	17.1	10.2	11.4	3.3
TYW1B	"LINC00069, MGC87315, NCRNA00069, RSAFD2"	ENSG00000277149	"TRNA-yW synthesizing protein 1 homolog B"	Q6NUM6	7	72558744-72828200	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.9;Excitatory neurons: 47.4;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (2.61e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.96e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.33e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	2.3	1.8	2.4	1.3	2.3	2.9	2.5	2.0	2.6	4.1	6.9	1.8	1.0	2.4	2.9	2.0	2.3	0.9	1.5	2.5	2.3	1.8	4.5	1.6	1.7	1.8	1.4	5.3	2.0	1.7	2.1	1.8	1.9	2.6	2.4	2.5	1.8	2.7	3.4	2.6	1.7	1.3	1.5	1.9	2.0	2.9	1.8	2.4	3.4	1.1	2.5	2.6	3.1	3.1	2.4	2.5	1.0	2.0	1.5	0.5	1.1	1.2	0.5	1.0	1.1	8.0	4.1	7.4	0.7	0.8	1.0	1.1	1.9	0.8	1.2	8.0	2.3	0.7	1.2	4.7	0.8	7.6	2.0	3.6	0.5	1.2	0.8	0.6	0.7	1.6	10.3	7.5	1.0	1.0	2.5	3.8	1.8	3.1	4.5	1.4	5.4	2.7	1.1	0.8	1.7	0.9	1.5	8.2	4.5	3.1	2.1	2.6	3.1	1.8	4.1	9.4	1.4	6.5	8.4	8.2	0.5	2.1	9.5	3.0	1.9	3.3	1.5	0.8	1.3	4.7	0.9	0.9	0.7	2.3	1.1	1.4	2.2	1.2	0.8	2.9	1.0	0.6	2.4	2.3	2.0	2.6	2.5	2.3	1.8	1.4	1.9	1.5	1.8	3.1	3.5	0.0	2.0	21.9	7.2	0.0	1.8	0.0	2.2	4.3	3.4	3.4	5.3	2.8	0.6	0.0	10.4	4.8	5.4	2.1	0.0	2.9	4.9	3.6	7.6	3.2	0.0	3.2	47.4	0.7	1.7	3.3	4.6	5.3	1.3	2.0	1.8	2.7	3.1	1.7	27.7	2.9	0.0	1.0	0.0	1.1	0.9	3.0	0.0	15.0	3.2	0.9	2.1	23.1	41.4	0.8	2.3	0.7	5.8	2.2	2.0	0.7	1.5	8.0	0.0	6.9	5.2	5.6	5.2	5.4	0.0	1.9	5.1	5.4	2.2	1.1
U2AF1	"RN, RNU2AF1, U2AF35, U2AFBP"	ENSG00000160201	"U2 small nuclear RNA auxiliary factor 1"	Q01081	21	43092956-43107570	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 492.9;Basal respiratory cells: 406.9;Ionocytes: 266.5;Langerhans cells: 374.7;Suprabasal keratinocytes: 433.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 607.7"	"Low region specificity"	"Detected in all"							"HPA044833, HPA052083"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.29e-4)"	"unprognostic (4.81e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-2)"	62.9	47.6	36.8	31.1	39.9	85.9	58.7	39.8	46.9	57.6	38.0	79.3	25.8	68.9	27.8	64.3	60.8	18.7	43.0	37.7	41.1	42.8	48.0	57.3	45.2	39.3	40.2	69.3	41.8	32.7	60.1	34.6	38.5	48.0	26.8	28.9	49.1	40.8	74.9	47.5	57.2	35.8	38.3	65.4	58.2	54.4	38.8	61.8	62.6	24.8	55.9	60.7	50.7	40.8	101.1	27.7	250.5	71.3	28.7	38.8	248.1	88.2	82.4	105.4	115.3	486.0	59.8	20.8	35.1	54.3	125.6	33.0	161.1	36.3	104.9	114.6	134.0	607.7	61.2	117.9	77.0	264.0	115.2	45.5	90.6	177.1	100.6	43.5	62.8	238.0	105.8	113.4	97.2	324.4	271.1	358.1	287.6	123.4	108.3	485.1	166.9	211.9	99.8	15.4	125.9	77.6	212.6	98.6	147.6	36.5	125.5	147.5	12.1	79.2	59.6	82.0	236.3	191.4	178.3	48.8	80.3	333.6	118.6	211.9	141.0	153.1	101.2	140.4	106.7	140.2	112.7	95.5	150.4	134.2	112.9	109.1	213.1	93.1	196.9	240.7	149.3	188.7	36.8	39.9	39.8	46.9	37.7	41.1	39.3	40.2	38.5	38.3	38.8	40.8	9.5	19.2	18.1	3.9	37.8	492.9	32.5	406.9	86.6	23.9	5.7	2.8	5.0	17.2	153.5	1.8	43.8	19.5	15.3	16.5	1.9	5.2	3.1	4.2	4.4	51.7	18.2	45.0	5.2	6.0	20.7	51.8	44.4	4.2	28.4	3.8	31.8	16.2	23.2	18.5	4.6	17.0	266.5	33.0	374.7	4.1	18.3	30.6	202.7	4.7	19.3	13.0	27.8	3.0	6.2	4.8	17.0	22.6	60.3	31.1	43.2	3.1	107.6	60.7	6.6	39.1	110.7	16.4	18.9	79.8	433.6	23.8	46.6	1.3	20.2	39.1
U2AF1L4	"MGC33901, U2AF1L3, U2af26"	ENSG00000161265	"U2 small nuclear RNA auxiliary factor 1 like 4"	Q8WU68	19	35742464-35745445	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052083, HPA061644"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA052083: AB_2681720, HPA061644: AB_2684574"	"prognostic favorable (2.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.58e-5)"	"unprognostic (3.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.67e-2)"	"prognostic favorable (8.58e-5)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (1.06e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.05e-4)"	2.6	3.7	8.9	1.5	9.9	1.7	2.2	8.6	12.6	3.5	7.1	5.5	1.6	3.5	0.0	2.3	3.9	0.5	11.4	9.5	9.9	4.3	2.4	2.4	0.4	9.8	9.3	4.4	2.2	5.4	5.4	1.8	9.6	3.7	0.6	4.6	1.8	3.0	9.1	1.5	2.6	2.1	8.8	2.5	3.5	8.5	9.2	2.6	2.8	6.9	0.9	4.1	2.5	9.9	4.1	13.7	2.2	3.3	0.4	1.6	3.0	3.3	3.4	8.3	8.2	5.1	3.3	1.7	6.6	7.7	7.7	1.9	6.7	5.4	5.1	10.7	1.5	2.3	3.4	5.9	10.2	2.6	5.5	2.0	2.1	3.4	2.0	3.0	1.6	5.2	4.4	4.6	5.5	8.5	8.0	2.5	3.1	8.9	2.7	2.2	3.0	0.0	1.9	0.6	4.5	4.1	5.0	3.7	1.2	4.4	3.7	4.9	2.9	5.3	2.2	1.4	5.5	5.4	7.0	3.5	4.1	5.9	6.6	0.0	2.0	1.7	2.9	4.0	2.9	8.4	5.7	5.5	2.4	6.8	8.1	7.8	2.3	0.9	2.7	9.0	10.2	3.3	8.9	9.9	8.6	12.6	9.5	9.9	9.8	9.3	9.6	8.8	9.2	9.9	12.0	19.2	25.4	7.8	40.9	10.3	14.3	34.7	10.2	26.9	19.8	18.9	4.7	8.6	16.5	9.2	14.6	14.9	35.2	20.1	27.4	11.1	13.9	6.5	8.9	11.9	12.6	7.8	6.5	12.6	9.4	13.6	12.2	7.8	36.6	10.3	10.4	18.3	19.2	20.2	7.1	13.4	48.8	18.5	36.3	15.6	15.5	18.4	30.2	1.9	27.9	12.3	30.9	4.5	7.7	9.5	22.5	12.4	38.4	12.0	23.6	26.6	12.7	29.3	13.1	15.2	16.7	36.7	16.0	9.3	8.8	29.6	39.1	12.6	10.7	12.7
U2AF1L5		ENSG00000275895	"U2 small nuclear RNA auxiliary factor 1 like 5"	P0DN76	21	6484623-6499261	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.0;Club cells: 14.2;granulocytes: 30.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044833, HPA052083"	Supported		Uncertain	Nucleoplasm		NA	NA		28000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (6.54e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.39e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.20e-2)"	48.0	41.4	34.1	50.7	33.1	71.5	47.4	33.0	42.7	40.8	29.2	45.3	44.2	43.2	54.4	39.6	47.4	26.1	39.8	33.3	34.7	47.7	44.4	32.0	55.4	35.1	32.9	58.1	47.6	34.9	41.7	52.8	35.0	34.2	54.1	48.7	31.8	31.0	40.1	41.5	36.4	47.5	35.4	52.3	34.3	39.6	33.7	86.5	49.4	39.0	80.9	55.6	19.9	36.2	195.0	186.6	156.9	128.0	107.5	76.0	80.6	118.0	103.5	164.3	88.2	83.2	88.6	571.9	105.2	149.3	191.6	143.2	275.3	223.6	195.6	143.0	266.8	226.8	170.8	311.9	178.1	401.0	125.5	61.1	64.6	91.6	121.6	77.5	179.7	58.4	479.7	186.2	150.5	85.4	216.3	131.2	212.7	250.6	76.2	277.6	91.4	108.7	167.9	274.8	164.7	124.3	70.3	139.5	91.0	63.8	78.1	222.5	234.7	121.5	217.1	51.1	86.7	184.5	212.6	538.1	105.0	260.3	176.3	175.4	197.4	182.8	147.0	189.1	162.2	210.7	176.6	172.2	207.3	236.6	188.1	165.4	348.0	169.9	127.9	297.9	246.3	235.8	34.1	33.1	33.0	42.7	33.3	34.7	35.1	32.9	35.0	35.4	33.7	36.2	2.6	12.8	18.0	0.0	0.8	0.0	4.2	0.0	0.0	0.2	4.7	2.7	0.0	2.8	14.2	0.0	0.0	1.4	3.2	0.4	1.9	4.8	0.7	2.8	3.1	2.9	2.4	0.0	0.0	7.1	1.9	7.5	0.0	3.6	30.3	3.8	1.4	1.2	1.1	0.0	0.0	1.5	0.0	0.8	0.0	0.2	0.3	2.9	0.0	0.0	2.9	0.5	1.0	0.0	0.0	6.4	2.1	1.2	0.9	3.8	1.5	1.7	10.2	0.4	0.0	1.8	1.5	1.9	2.0	0.0	0.0	2.1	2.0	3.9	1.4	2.0
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674716	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		73000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555"	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	74.2	80.9	70.3	101.9	73.0	147.7	70.2	74.6	82.4	92.1	75.4	83.7	85.1	87.4	56.7	98.2	82.8	54.0	69.3	70.3	70.8	79.4	80.2	74.2	119.3	76.2	71.5	98.3	75.0	70.1	93.7	63.6	73.0	74.9	54.0	46.0	72.0	65.9	67.3	80.0	92.3	62.1	72.0	115.7	75.4	81.8	72.1	132.5	78.9	45.9	93.7	78.2	80.7	82.4	244.5	394.0	235.9	191.1	108.3	109.8	249.3	191.9	174.1	314.2	305.3	231.3	222.3	284.5	149.5	164.9	160.5	193.0	299.3	268.3	149.1	218.0	501.9	245.2	176.1	221.5	176.7	287.4	263.5	148.8	161.0	239.5	166.8	120.0	190.8	195.9	293.1	181.3	169.9	239.2	388.0	261.1	260.4	217.1	307.2	414.5	149.7	233.0	189.7	290.0	270.6	211.0	208.6	197.1	125.7	134.6	190.5	296.9	161.5	279.7	203.7	130.0	415.9	165.0	239.3	344.5	124.3	279.5	245.2	0.1	1.1	0.8	1.3	1.5	1.0	0.8	1.1	0.9	1.0	1.1	0.8	0.8	2.1	0.6	1.2	1.8	1.1	0.9	70.3	73.0	74.6	82.4	70.3	70.8	76.2	71.5	73.0	72.0	72.1	82.4	31.0	3.2	9.1	10.4	46.0	45.4	41.4	34.8	57.5	41.8	29.7	21.3	2.7	24.3	20.6	27.6	31.3	58.5	34.1	44.0	19.6	33.0	6.4	33.8	36.0	31.4	45.5	32.6	6.8	23.8	63.0	29.4	51.0	40.9	34.3	30.4	27.5	26.8	37.6	35.3	7.6	42.4	30.5	22.0	32.3	8.4	44.4	31.6	19.6	11.2	37.4	25.3	30.9	4.0	12.0	31.8	29.3	34.3	62.4	41.9	31.9	21.3	15.3	52.0	0.0	26.1	46.6	22.5	32.0	53.5	39.2	71.8	42.7	30.8	43.6	44.9
U2SURP	"fSAPa, SR140"	ENSG00000163714	"U2 snRNP associated SURP domain containing"	O15042	3	142964497-143060725	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037545, HPA037546, HPA061407"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506"	"unprognostic (2.01e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (8.86e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.12e-1)"	"prognostic favorable (6.78e-4)"	22.1	18.2	16.6	19.3	17.1	57.6	23.4	21.9	25.1	25.0	15.9	21.3	12.9	22.6	20.8	21.5	23.9	12.3	18.1	16.2	16.8	23.2	24.3	18.8	29.9	16.4	16.1	31.7	25.2	22.5	21.5	17.8	16.6	19.8	20.1	51.8	18.5	14.5	27.4	21.9	22.0	17.5	15.1	25.7	19.9	20.4	16.2	31.3	22.5	17.7	26.1	20.9	21.9	20.8	165.4	54.2	59.7	40.1	30.9	28.3	103.9	72.8	46.4	82.2	61.2	72.7	49.7	189.2	76.0	47.5	157.0	58.2	124.0	66.1	93.2	51.8	88.0	205.1	49.9	58.3	31.7	202.1	75.3	34.4	32.0	64.3	81.9	36.4	45.4	118.5	129.5	59.1	39.0	46.3	100.4	86.8	96.7	52.8	50.4	101.9	116.2	79.0	40.8	102.8	76.5	44.5	146.1	48.2	87.1	61.2	85.3	84.8	49.5	44.1	52.2	35.1	118.0	69.4	97.5	319.8	34.9	72.1	63.1	40.2	32.7	33.3	40.9	31.7	35.1	60.1	37.1	37.0	27.0	60.7	42.4	36.6	33.3	35.5	48.2	53.9	40.5	21.6	16.6	17.1	21.9	25.1	16.2	16.8	16.4	16.1	16.6	15.1	16.2	20.8	124.4	118.6	129.4	116.2	94.8	60.8	85.7	140.5	68.9	124.2	64.4	90.3	123.8	52.9	115.6	62.5	66.7	78.9	109.9	50.0	52.8	77.2	35.1	91.5	129.4	96.4	55.2	126.0	71.7	79.8	83.7	103.8	58.1	99.1	98.1	165.5	62.8	58.5	61.3	92.5	80.7	74.7	85.5	60.2	54.6	22.0	108.7	78.4	51.6	63.7	115.9	98.1	110.2	104.5	145.8	89.6	55.7	79.7	108.7	81.9	48.0	60.6	100.2	125.4	78.9	122.8	139.4	243.6	235.6	76.9	64.8	79.1	98.6	111.6	80.7	78.4
UACA	"FLJ10128, KIAA1561"	ENSG00000137831	"Uveal autoantigen with coiled-coil domains and ankyrin repeats"	Q9BZF9	15	70654554-70763558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 142.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 293.0;Cardiomyocytes: 175.1;Endothelial cells: 177.4;Microglial cells: 184.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 244.5;BJ hTERT+: 148.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041412, HPA043503, HPA056006"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: "	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (1.03e-4)"	37.7	17.9	10.5	7.8	13.1	1.0	33.0	11.0	12.9	25.1	24.2	14.6	22.2	22.1	21.5	28.9	21.6	32.2	28.0	9.4	11.8	30.8	17.3	30.7	8.0	13.3	12.8	31.2	12.7	12.5	11.5	28.6	13.0	21.6	15.4	11.9	25.3	18.4	142.0	19.4	22.3	16.0	12.1	30.0	15.9	16.1	14.2	4.6	35.6	106.0	6.7	13.2	25.4	14.7	42.7	34.8	15.2	20.2	29.9	127.9	0.1	244.5	148.4	62.7	53.8	58.5	61.5	29.2	65.6	61.4	18.4	48.1	34.4	19.4	78.3	0.1	15.3	16.4	27.9	12.3	38.8	0.4	6.0	60.8	10.7	37.1	28.1	103.3	67.7	6.9	4.1	0.1	78.7	14.0	0.1	2.6	12.7	19.3	18.0	0.0	109.6	0.2	30.3	14.4	4.0	7.6	46.5	7.1	48.9	30.3	13.4	4.9	130.5	3.6	24.8	20.6	39.1	2.3	8.8	0.2	31.4	4.4	27.4	0.1	0.9	0.0	0.0	1.7	0.0	0.5	0.0	0.0	0.8	1.2	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3	10.5	13.1	11.0	12.9	9.4	11.8	13.3	12.8	13.0	12.1	14.2	14.7	293.0	6.4	6.4	31.6	5.4	11.3	14.6	13.7	10.2	6.3	22.2	33.3	175.1	18.6	19.2	49.7	4.2	1.0	2.1	66.5	3.9	49.0	21.0	75.3	46.3	177.4	9.1	3.0	0.9	48.7	1.9	81.6	33.6	53.0	15.2	34.9	47.5	18.8	9.6	25.2	0.7	33.1	6.1	24.3	8.6	15.2	125.2	15.8	30.2	184.6	9.5	49.4	2.1	6.0	62.0	78.8	35.7	141.1	0.8	21.8	45.3	5.0	61.9	4.2	52.6	53.5	96.2	46.4	35.2	16.4	13.1	1.0	2.9	62.7	24.2	10.9
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 678.4;U-251 MG: 463.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	Yes		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	96.0	43.7	12.2	33.7	13.2	51.5	58.8	13.5	14.9	37.1	16.1	65.6	43.9	18.6	29.1	33.9	33.1	39.8	45.1	13.4	13.6	27.0	172.6	36.0	14.1	11.5	16.9	39.9	68.6	12.0	28.9	22.3	11.8	33.3	66.3	20.4	76.6	31.2	41.2	25.0	56.0	24.6	11.6	13.8	55.8	90.9	13.9	11.8	24.4	45.2	22.2	77.9	37.4	11.0	204.6	14.6	39.2	31.5	185.7	147.8	26.8	292.4	107.1	220.7	178.5	38.6	93.5	8.0	64.3	225.8	79.6	35.0	44.7	85.5	359.9	32.4	66.6	36.0	43.8	75.6	87.1	61.8	23.5	69.0	39.8	242.4	678.4	100.6	137.5	62.6	206.1	81.3	298.9	37.4	36.0	40.0	29.2	207.6	64.4	31.9	76.2	99.8	34.8	23.7	41.9	43.4	128.0	78.4	70.4	45.6	38.9	70.0	235.2	110.6	102.5	281.2	463.5	135.0	51.0	67.0	63.4	28.5	71.3	1.4	2.2	11.7	16.7	2.1	20.4	10.7	10.0	17.3	4.6	11.1	9.4	12.0	2.2	8.6	1.2	7.7	5.5	7.2	12.2	13.2	13.5	14.9	13.4	13.6	11.5	16.9	11.8	11.6	13.9	11.0	58.1	6.4	30.2	15.0	42.5	134.7	163.0	47.2	47.8	11.8	59.1	42.7	30.0	27.1	57.4	16.5	8.4	27.2	82.9	94.8	72.4	27.1	78.2	28.6	58.0	35.7	54.9	13.9	12.4	64.7	63.9	195.8	45.9	40.7	33.7	21.3	22.5	98.4	14.5	6.7	12.4	139.4	40.7	10.1	82.2	20.1	50.7	24.6	85.4	3.7	18.2	16.6	41.2	8.0	6.1	73.0	74.5	41.3	152.8	94.6	88.4	26.9	56.0	13.9	19.7	59.4	88.6	212.0	125.9	43.2	81.8	97.7	50.5	18.8	70.4	141.7
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Supported	Nucleoplasm		NA	NA		14000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.21e-2)"	98.4	157.9	102.9	98.3	113.2	94.3	98.6	103.4	115.5	127.9	133.9	101.1	71.3	127.1	64.3	155.3	119.3	64.9	117.4	106.2	102.0	131.2	114.7	109.5	105.0	106.9	104.2	136.5	89.0	107.5	135.2	67.4	109.3	103.2	68.5	95.6	119.5	78.9	201.1	119.5	100.4	117.4	94.4	131.9	98.6	98.7	110.0	119.7	160.1	114.1	110.8	101.1	124.8	121.3	269.1	273.2	307.7	471.9	207.4	186.8	135.0	175.1	187.1	248.6	200.5	219.3	201.3	201.6	111.8	357.0	361.5	254.9	392.9	375.7	180.9	163.4	391.7	126.1	295.2	180.0	145.1	215.2	258.8	177.4	193.2	362.7	279.4	176.7	330.2	236.1	138.9	173.7	250.4	343.4	203.3	188.5	329.6	163.2	417.1	233.1	215.3	343.7	198.7	287.0	197.4	148.1	520.8	250.9	116.9	329.9	349.5	130.3	241.6	183.1	210.7	266.4	166.1	117.6	132.8	286.3	189.4	150.8	224.9	31.0	39.7	40.7	39.4	51.1	34.0	39.8	31.8	35.0	43.2	29.9	24.7	31.1	44.8	38.1	49.7	29.3	40.3	39.9	102.9	113.2	103.4	115.5	106.2	102.0	106.9	104.2	109.3	94.4	110.0	121.3	37.2	51.3	34.7	45.1	37.1	33.6	38.6	55.7	26.2	24.9	48.3	39.6	51.4	51.5	50.0	82.8	16.7	46.3	34.2	133.1	35.2	77.5	29.6	84.9	56.3	40.9	57.5	33.2	27.1	90.8	68.7	45.0	74.9	97.5	18.3	60.3	43.5	51.2	60.0	11.8	35.5	78.6	30.5	49.0	37.8	61.6	42.3	51.4	19.6	31.9	57.7	20.7	13.4	32.2	46.5	147.9	74.7	65.8	44.0	55.2	82.2	61.6	56.4	25.1	39.5	38.8	56.6	10.5	34.0	51.3	42.1	71.1	34.6	56.8	68.2	55.4
UBA2	"FLJ13058, HRIHFB2115, SAE2"	ENSG00000126261	"Ubiquitin like modifier activating enzyme 2"	Q9UBT2	19	34428352-34471251	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 269.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041436	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041436: AB_2677479"	"unprognostic (2.37e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.39e-3)"	"unprognostic (8.72e-3)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-1)"	91.3	36.8	35.9	37.1	37.1	54.9	67.7	44.6	53.1	52.4	35.1	41.6	27.4	55.3	34.8	43.6	47.9	35.7	43.3	36.4	39.3	36.5	36.0	45.3	57.2	36.9	39.1	51.7	40.4	40.8	38.5	60.6	36.5	33.6	35.1	47.2	34.4	34.3	109.4	54.5	37.0	43.0	36.9	32.4	38.6	91.8	38.3	68.5	41.8	57.8	54.8	45.7	46.1	40.7	122.9	175.7	176.2	73.4	93.5	75.8	72.0	93.5	80.0	118.2	130.9	151.7	72.7	227.4	140.3	76.7	73.4	48.8	188.8	72.9	165.4	164.0	126.7	241.6	84.6	152.9	120.3	194.6	100.7	55.3	90.8	83.8	146.2	79.2	94.2	96.2	244.0	125.4	105.0	122.7	151.1	107.4	132.3	190.4	59.9	118.1	121.3	101.9	83.9	126.1	149.0	146.1	85.8	77.3	133.2	113.9	55.7	234.4	61.2	131.9	92.1	85.3	169.6	130.7	200.8	223.1	83.5	146.4	118.8	8.8	4.8	8.1	7.3	4.9	9.9	8.5	9.5	11.1	5.8	8.2	11.5	9.3	0.6	8.0	6.4	10.2	8.0	3.8	35.9	37.1	44.6	53.1	36.4	39.3	36.9	39.1	36.5	36.9	38.3	40.7	58.9	25.6	35.3	25.5	62.1	87.1	72.5	36.4	59.7	90.6	36.3	33.1	36.2	31.5	32.7	18.4	41.7	75.4	53.3	15.9	33.2	49.8	22.1	29.7	47.8	55.9	46.0	60.3	50.8	42.0	95.9	56.4	44.4	36.2	38.7	52.5	25.0	25.0	46.7	47.1	48.9	32.8	24.4	34.9	45.4	23.9	43.5	40.4	76.5	33.7	51.9	50.2	41.2	41.7	56.7	39.6	23.9	53.0	74.5	93.5	19.0	32.0	29.7	42.0	269.5	69.0	206.5	223.9	198.3	57.9	92.9	92.8	58.6	49.9	45.4	73.6
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 383.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473"	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	34.3	32.3	83.7	39.4	225.9	39.1	43.4	138.0	136.2	32.1	32.1	34.5	28.8	35.8	41.0	33.9	27.5	29.7	66.6	109.7	198.7	33.9	31.2	32.2	49.6	240.4	162.7	30.0	19.3	45.6	22.9	41.7	245.4	36.6	35.8	62.0	44.9	32.2	41.5	45.0	30.3	39.8	131.0	38.9	26.4	23.7	197.1	44.8	27.1	34.7	49.8	39.4	26.6	383.0	76.6	31.4	75.8	47.1	69.0	90.9	56.1	65.9	74.4	70.4	70.2	39.2	52.2	55.2	18.6	72.5	71.3	42.1	59.1	76.5	80.2	105.0	38.5	77.0	57.7	39.6	53.8	77.1	62.4	72.0	49.8	67.9	54.9	86.7	92.3	45.2	31.9	45.6	94.0	26.8	49.5	49.7	67.5	95.4	26.9	39.6	55.9	53.0	113.2	94.6	32.8	46.2	70.3	51.0	58.4	80.9	34.3	73.3	71.4	53.0	46.9	70.6	93.3	53.2	91.8	67.3	54.5	84.3	69.7	87.9	45.7	71.0	24.3	54.0	28.1	33.6	32.2	30.3	40.1	29.7	29.6	30.5	40.9	39.8	57.1	20.1	40.8	53.0	83.7	225.9	138.0	136.2	109.7	198.7	240.4	162.7	245.4	131.0	197.1	383.0	21.9	35.3	31.4	35.9	35.5	33.8	29.2	66.2	31.9	22.9	21.6	17.9	68.5	14.3	44.5	35.0	39.6	74.5	19.8	15.8	19.6	37.1	15.2	25.1	21.2	26.9	18.6	30.7	44.6	23.6	57.2	28.3	22.4	25.6	42.4	26.0	22.9	17.2	34.1	33.7	62.8	16.3	97.6	37.1	49.6	10.3	40.4	39.6	30.2	44.0	60.6	29.1	24.7	53.3	76.7	31.5	11.7	38.0	28.3	23.7	16.7	36.9	47.3	48.9	26.3	22.2	31.0	34.2	32.1	34.9	42.8	56.8	34.0	24.3	17.5	32.5
UBA52	"CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40"	ENSG00000221983	"Ubiquitin A-52 residue ribosomal protein fusion product 1"	P62987	19	18571730-18577550	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 11928.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041344, HPA049132, HPA056624"	Supported		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196"	"unprognostic (1.98e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (9.35e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.23e-1)"	1161.5	955.0	823.8	793.2	845.7	2181.5	1115.4	815.0	1021.1	1262.7	808.6	984.4	531.1	938.2	966.2	1196.8	984.5	610.9	989.3	803.8	848.5	931.1	927.4	888.7	1469.5	861.9	825.6	1622.0	1664.8	844.0	758.0	720.8	858.2	917.0	789.6	235.6	1061.1	615.4	1629.9	1444.0	916.6	712.9	883.0	1239.2	989.5	755.3	853.4	1487.1	748.6	1196.7	1674.0	995.3	1107.5	875.5	1680.6	1304.1	961.2	1612.8	2437.7	2298.9	2376.3	1260.7	1738.5	2044.2	1618.9	2381.2	1521.6	2403.4	1268.0	2092.8	803.0	1103.3	1881.9	2242.7	1918.7	650.0	2938.0	1320.1	1942.1	2733.4	1770.8	2898.3	1616.2	2684.2	3008.4	1406.4	2024.7	1778.7	2083.2	1508.8	2131.5	3231.7	1769.8	2786.9	2336.4	2584.2	2162.6	3166.1	2800.9	1899.3	958.6	2769.6	2001.7	2497.0	1246.1	1505.9	914.3	2187.0	2300.9	1424.6	970.6	3681.4	1562.7	1017.6	850.0	2172.8	2271.9	1973.0	2863.7	2412.2	1386.0	3245.8	1412.8	962.6	2155.2	1163.1	1761.2	1764.2	2401.7	3126.7	2616.4	2119.8	2320.3	3025.4	2946.4	2445.0	1168.8	1864.5	1629.2	2469.2	2250.9	4829.5	823.8	845.7	815.0	1021.1	803.8	848.5	861.9	825.6	858.2	883.0	853.4	875.5	831.5	464.8	673.1	15.0	2198.0	1898.4	2027.9	1544.8	1365.8	117.9	1444.5	1279.9	332.3	1109.5	886.1	654.7	68.8	2020.5	1806.7	1264.6	1571.0	1437.7	3146.5	772.1	1337.9	1108.6	1106.6	2241.7	10.8	2271.5	2803.3	1060.1	672.2	1194.9	805.8	1061.9	1385.3	1919.9	2574.7	104.3	12.4	1812.7	710.1	3200.4	2894.6	11928.8	1875.2	2003.3	1250.4	8.4	3379.8	599.1	2276.1	11.1	23.1	1799.4	1853.6	1034.7	1202.4	2110.3	1645.1	2688.2	510.4	219.1	696.8	1483.1	2041.1	629.9	674.5	1939.2	2239.4	2282.9	1892.0	1285.6	1783.6	2426.6
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701155	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		12000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	6.7	6.6	5.9	9.9	8.0	17.1	8.3	7.5	7.5	10.6	4.9	7.1	8.1	6.8	6.2	11.4	5.7	8.0	5.3	5.6	7.9	6.3	10.7	7.8	12.4	9.7	8.0	7.7	6.2	7.9	12.0	9.8	10.0	7.7	8.4	14.4	6.7	5.5	5.2	8.4	8.6	8.7	8.4	10.2	9.4	10.0	8.7	10.4	7.9	6.5	13.6	10.2	10.6	16.0	34.4	18.8	30.5	24.0	14.8	17.4	20.6	69.5	27.1	31.1	36.2	19.8	45.1	43.4	24.2	28.7	31.8	19.8	31.9	34.6	46.6	50.0	8.9	27.8	30.7	18.7	12.6	49.3	20.4	12.5	10.9	40.3	24.3	21.2	27.8	21.9	67.2	25.0	37.2	13.0	51.5	11.2	18.0	24.3	22.6	30.0	62.6	16.1	25.3	38.3	14.9	18.8	39.2	27.5	13.0	25.3	18.4	13.0	40.6	28.6	31.9	23.6	30.8	17.8	15.0	43.0	50.9	13.5	28.1	6.4	1.8	2.9	2.4	2.3	2.7	3.0	2.8	3.2	2.2	3.0	2.0	2.4	1.3	5.7	2.6	3.1	2.5	1.4	5.9	8.0	7.5	7.5	5.6	7.9	9.7	8.0	10.0	8.4	8.7	16.0	34.6	25.6	21.7	54.5	46.5	70.1	65.2	43.0	37.5	45.8	30.8	17.0	13.5	10.0	34.6	16.5	54.2	29.2	45.0	34.7	3.9	24.6	2.3	28.6	24.8	39.0	32.3	23.8	66.3	17.1	17.8	26.6	39.8	45.3	31.0	62.3	20.0	20.9	23.2	33.7	78.1	27.0	28.5	29.9	54.0	5.8	21.5	31.4	24.9	37.5	34.6	14.6	26.8	77.9	115.7	53.3	36.6	19.9	44.8	87.0	21.2	15.9	34.9	39.9	19.7	28.0	24.0	57.7	43.9	30.9	46.2	58.8	37.6	40.4	22.8	149.0
UBA7	"D8, UBA1B, UBE1L, UBE2"	ENSG00000182179	"Ubiquitin like modifier activating enzyme 7"	P41226	3	49805209-49813953	"Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 52.5;granulocytes: 83.0;Proximal enterocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 56.7;HEL: 55.7;HMC-1: 103.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB015444, HPA058182"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		370000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB015444: AB_793598, HPA058182: AB_2683631"	"prognostic favorable (1.55e-4)"	"unprognostic (7.07e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.61e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.11e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.48e-4)"	21.6	21.4	10.1	32.7	10.6	40.2	20.7	10.4	12.1	25.6	10.4	29.0	43.4	22.5	15.6	18.7	23.8	27.7	17.9	9.8	10.5	25.6	23.0	35.4	51.2	13.7	11.1	32.8	17.2	2.9	14.1	19.4	12.1	34.8	26.1	1.2	42.3	22.4	9.1	20.5	48.6	20.6	12.3	65.6	27.5	5.8	12.2	39.8	31.8	10.3	33.6	23.1	23.3	13.8	11.6	0.1	0.9	0.3	30.2	31.7	3.5	6.1	27.0	42.7	56.7	0.0	23.9	0.4	4.8	22.4	18.3	6.2	0.1	10.9	3.7	29.9	0.1	55.7	0.6	3.5	22.3	5.3	103.7	49.0	0.7	16.9	1.0	29.6	21.7	2.0	0.1	3.4	10.0	0.3	11.6	13.7	0.1	0.0	1.2	14.6	1.0	1.9	8.8	22.3	0.0	0.9	7.4	10.7	3.8	0.6	1.1	36.8	9.7	8.3	1.1	3.7	2.4	0.1	0.2	0.3	23.2	19.8	2.0	20.7	22.5	38.5	16.4	32.9	14.3	17.1	15.0	14.5	21.3	18.1	13.4	12.4	6.8	17.1	27.6	7.6	15.9	22.0	10.1	10.6	10.4	12.1	9.8	10.5	13.7	11.1	12.1	12.3	12.2	13.8	17.3	32.1	20.3	11.4	28.0	3.8	6.3	10.5	6.8	0.2	9.2	9.1	6.9	17.2	16.6	12.9	0.0	5.2	15.5	28.7	0.0	9.5	6.9	5.8	3.0	13.5	9.5	8.0	0.2	7.8	3.5	11.8	52.5	6.5	83.0	13.2	16.1	7.6	21.6	0.0	0.1	21.7	8.2	20.1	6.4	34.1	11.1	32.5	0.0	15.0	16.8	2.4	19.6	1.0	0.1	5.2	21.7	11.3	14.1	4.4	51.8	5.6	12.8	1.2	6.6	5.8	8.1	0.9	0.3	7.3	4.7	2.9	17.7	6.9	20.2	6.6
UBALD1	FAM100A	ENSG00000153443	"UBA like domain containing 1"	Q8TB05	16	4608883-4615027	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 110.3;Late spermatids: 129.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066771	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA066771: AB_2685717"	"unprognostic (7.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.63e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-2)"	25.5	28.4	21.7	11.1	20.0	26.2	24.6	23.9	39.5	29.9	7.4	44.3	14.2	38.6	2.6	32.8	32.0	6.2	39.8	23.3	16.4	39.2	70.6	29.9	8.7	16.2	14.2	29.2	30.1	5.1	25.0	10.6	14.5	39.6	2.3	4.8	23.7	9.5	51.1	31.4	25.5	6.8	10.6	29.3	34.9	29.1	16.8	5.5	35.4	8.6	4.4	33.5	27.5	24.2	13.5	38.2	8.9	14.2	6.0	7.6	39.4	19.7	8.2	7.6	11.0	18.6	15.5	19.8	21.6	6.3	5.7	36.5	5.7	20.4	2.1	42.4	57.4	18.7	42.8	29.6	12.1	11.8	30.8	10.8	14.9	11.6	5.7	8.7	8.3	15.0	28.7	20.4	3.0	66.0	19.5	63.6	33.3	12.0	33.4	27.9	11.1	65.6	6.7	19.0	25.7	23.7	23.5	35.9	33.1	5.1	23.2	18.9	24.4	15.2	17.2	61.5	13.0	38.8	34.2	22.9	6.2	15.8	8.1	0.9	1.6	8.7	1.6	2.5	1.0	1.3	1.3	1.7	1.9	1.2	1.3	1.4	2.7	1.1	3.3	1.2	1.7	1.3	21.7	20.0	23.9	39.5	23.3	16.4	16.2	14.2	14.5	10.6	16.8	24.2	12.0	9.6	8.2	3.3	14.3	110.3	55.8	32.7	29.6	9.7	23.7	20.6	4.2	15.7	17.9	18.4	4.2	65.8	15.1	26.4	31.3	21.1	37.6	29.1	16.2	16.8	84.6	26.1	6.2	23.6	60.1	16.2	43.3	28.7	10.8	13.6	16.1	32.4	23.6	10.1	6.1	34.4	28.5	14.7	25.9	129.1	16.1	14.5	21.4	1.9	19.4	13.0	23.7	3.5	8.1	22.4	19.0	19.9	22.2	37.6	24.4	57.0	7.3	11.5	46.0	15.2	25.1	18.6	14.6	20.2	102.9	107.8	15.9	14.0	22.0	33.1
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 18.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 5.9;Erythroid cells: 3.8;T-cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.9;MAIT T-cell: 22.9;memory CD4 T-cell: 28.2;memory CD8 T-cell: 24.8;naive CD4 T-cell: 32.2;naive CD8 T-cell: 24.0;T-reg: 27.9"	"Lineage enriched"	"Detected in many"	12	"T-cells: 32.2"	"Group enriched"	"Detected in some"	7	"HEL: 23.0;JURKAT: 39.0;MOLT-4: 47.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	0.4	0.6	0.0	5.2	0.0	2.5	0.2	0.0	0.1	0.5	0.1	0.8	1.6	0.5	0.0	0.4	0.4	2.0	0.4	0.0	0.1	0.4	0.7	1.7	11.1	0.2	0.0	0.3	0.1	0.0	0.1	0.2	0.1	0.4	0.9	0.0	0.9	0.1	0.2	0.3	2.4	0.1	0.1	4.4	1.9	0.1	0.0	18.9	0.5	0.1	5.1	1.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	23.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.4	0.0	0.0	0.0	47.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.9	0.0	22.9	0.1	28.2	24.8	0.0	0.0	32.2	24.0	0.5	2.5	0.1	0.1	27.9	10.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.8	0.0	0.0	0.2	0.3	1.0	0.0	0.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	3.8	0.0	0.0	0.0	0.4	1.1	0.5	1.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.3	0.0	20.5	0.0	0.0	0.0
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655722-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0;lymphoid tissue: 15.6;placenta: 13.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 54.9;Inhibitory neurons: 166.3;Langerhans cells: 51.2;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 122.2;HMC-1: 88.9;hTEC/SVTERT24-B: 72.9;REH: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038606, HPA038607"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		23000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA038605: AB_10669648, HPA038606: , HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	3.4	0.7	1.1	4.8	1.5	6.7	1.1	15.0	1.9	3.0	0.1	1.2	1.3	1.0	0.2	1.1	0.5	1.9	0.9	1.2	5.5	1.7	1.3	4.6	5.7	10.3	7.1	0.2	0.6	0.4	0.3	13.8	10.2	0.7	1.4	1.9	0.7	0.7	1.1	3.4	1.7	1.9	1.2	15.6	1.4	1.2	2.8	15.1	2.3	0.3	3.2	4.4	0.5	1.4	13.1	31.5	5.6	7.5	2.4	4.4	29.1	45.6	25.1	18.1	13.9	12.5	6.8	5.3	3.5	24.3	17.2	6.4	0.1	16.3	28.7	0.2	0.9	122.2	1.0	10.8	6.7	15.0	88.9	3.9	1.0	72.9	26.9	19.7	12.4	5.3	0.1	0.1	17.8	0.5	18.5	9.6	2.5	13.3	7.4	73.3	3.3	0.7	28.6	10.9	12.7	0.2	12.1	0.9	10.1	11.7	0.2	4.0	32.3	23.4	12.6	13.9	19.1	1.0	0.0	15.1	12.4	20.6	43.4	0.0	1.3	9.9	1.8	6.3	1.9	0.3	2.3	1.7	1.7	1.1	2.6	1.4	2.7	6.4	11.1	0.2	4.7	1.8	1.1	1.5	15.0	1.9	1.2	5.5	10.3	7.1	10.2	1.2	2.8	1.4	2.2	0.0	4.7	9.1	4.6	7.1	4.2	3.4	2.8	1.8	1.2	1.3	1.1	0.0	2.0	3.7	0.0	32.5	10.0	0.6	0.0	8.4	2.4	0.6	4.0	4.5	0.0	1.7	24.8	9.7	54.9	4.9	2.0	1.5	12.7	11.5	5.0	0.6	35.7	11.8	166.3	0.5	4.1	26.0	51.2	3.9	0.0	26.5	1.8	30.0	9.1	0.2	17.5	26.2	2.7	26.3	0.3	0.4	11.4	4.7	0.2	0.6	2.5	1.1	0.0	3.8	3.4	0.1	0.8	2.4	6.0	47.6	16.8	0.1	0.4	3.1
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559732	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 151.3"	"Group enriched"	"Detected in many"	7	"Ductal cells: 534.8;Exocrine glandular cells: 273.8;monocytes: 151.9;Pancreatic endocrine cells: 510.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"Hep G2: 63.9;RT4: 52.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	4.2	0.4	0.3	35.6	0.4	0.0	8.6	0.3	0.7	1.7	0.3	13.3	4.2	1.9	1.2	8.3	4.7	0.9	0.6	0.3	0.3	23.2	25.4	10.9	87.5	0.4	0.3	1.2	27.3	1.7	1.4	0.0	0.3	11.9	19.0	0.0	14.6	1.3	0.4	1.8	31.1	1.2	0.3	22.9	27.1	0.8	0.3	90.2	3.0	0.1	151.3	25.8	1.7	0.3	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	63.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	52.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.9	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.7	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.2	3.2	3.1	0.0	0.7	0.1	0.1	2.3	16.5	0.0	1.9	1.9	0.0	21.5	13.3	0.0	0.0	0.0	0.1	6.9	1.9	534.8	0.0	0.3	0.2	7.1	3.6	0.0	0.0	273.8	0.0	2.2	13.3	0.2	0.0	0.0	0.7	0.3	0.1	0.0	0.0	5.2	6.1	0.3	0.0	0.0	0.0	1.2	0.0	0.0	151.9	0.0	0.0	0.0	0.0	510.6	8.3	0.0	0.0	0.5	49.1	1.1	9.7	0.0	0.0	0.0	3.4	0.0	0.0	2.2	0.0	0.0	0.2	0.0	11.1	0.1
UBE2A	"HHR6A, HR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574536-119591083	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 508.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (2.27e-3)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	40.0	27.4	30.1	39.1	30.6	29.8	29.4	34.1	38.8	34.1	27.1	52.3	37.5	32.0	38.2	53.4	27.3	32.6	63.2	29.6	32.2	41.0	30.1	32.9	46.9	34.4	32.5	20.1	29.2	39.2	18.9	56.8	34.4	31.0	45.0	27.1	30.9	33.0	71.9	30.7	39.1	43.0	32.1	26.8	30.5	17.6	32.1	46.1	30.5	55.0	50.4	46.9	32.8	35.1	129.5	104.1	60.8	54.1	103.0	125.6	63.9	122.6	106.3	141.8	130.3	50.8	84.0	96.4	126.4	133.9	240.6	86.4	86.3	65.7	128.6	142.3	60.6	42.7	71.9	47.1	96.6	105.9	72.1	86.9	90.1	134.0	58.3	98.1	99.4	86.5	57.0	83.6	160.1	134.5	166.6	99.9	106.3	125.7	126.9	84.2	64.0	91.6	113.1	76.6	48.9	51.3	171.2	75.0	93.7	73.2	65.8	92.6	101.5	92.4	42.0	184.3	142.5	83.6	147.1	92.4	99.1	136.3	74.6	46.8	58.5	92.5	43.0	92.1	34.8	52.6	37.9	38.5	74.6	48.7	23.7	33.9	78.0	35.0	101.1	58.5	56.8	51.1	30.1	30.6	34.1	38.8	29.6	32.2	34.4	32.5	34.4	32.1	32.1	35.1	67.5	102.5	40.9	12.7	79.1	124.8	91.6	129.4	51.8	17.2	60.7	43.9	66.7	44.3	80.7	40.5	31.3	179.8	93.0	168.6	101.8	95.4	51.7	75.6	55.3	62.9	45.5	70.4	9.9	102.1	176.2	67.7	37.8	63.0	57.0	35.7	46.4	35.5	131.3	8.4	9.4	49.7	103.7	59.1	183.9	15.3	37.0	97.3	83.6	15.9	129.0	49.8	41.2	14.6	18.0	137.6	132.5	40.6	92.2	98.2	85.6	125.2	107.7	35.0	46.0	56.3	101.1	44.1	32.1	74.6	127.9	508.5	94.8	36.6	54.5	120.3
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371469-134392108	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 265.8"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 723.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 444.6"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 444.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	52.5	74.2	31.5	50.0	33.1	84.4	44.2	36.3	53.2	38.3	30.2	48.0	40.7	53.6	34.8	70.5	37.3	51.0	118.4	34.3	34.8	50.6	56.6	44.9	47.1	29.5	31.0	44.4	53.7	25.8	39.9	48.4	31.0	32.9	42.0	29.2	39.7	23.2	265.8	43.1	46.4	43.3	30.3	43.7	39.6	49.2	32.9	29.3	41.2	99.8	48.1	42.8	43.2	36.7	109.4	27.9	58.2	55.0	50.0	54.1	92.7	80.2	43.5	51.4	60.9	85.6	70.9	58.7	94.1	52.3	138.7	42.7	45.8	60.4	56.0	94.5	47.6	32.1	75.9	92.8	58.2	38.8	63.7	46.5	80.2	47.4	39.3	68.1	44.1	48.8	61.1	103.5	46.8	63.4	62.5	102.1	24.9	32.6	26.7	61.6	63.8	83.8	46.6	82.9	77.6	60.1	62.9	29.3	147.9	62.5	63.0	106.0	87.6	57.8	40.8	78.9	89.4	86.1	129.4	87.0	65.2	72.8	59.4	236.7	58.3	174.0	46.9	68.3	42.9	49.7	58.8	48.1	42.6	47.9	69.9	60.6	444.6	53.0	78.9	48.0	77.5	64.1	31.5	33.1	36.3	53.2	34.3	34.8	29.5	31.0	31.0	30.3	32.9	36.7	187.5	73.7	61.6	40.1	176.5	364.7	321.2	215.1	175.8	77.8	169.9	156.5	315.8	147.3	113.7	75.4	81.3	144.5	182.0	183.1	172.1	173.8	233.2	139.8	102.2	149.7	131.8	261.2	103.0	169.5	123.0	183.3	113.2	167.8	116.8	81.7	115.3	97.4	119.4	87.5	84.2	141.0	181.0	131.5	323.9	315.4	155.0	184.2	227.7	49.6	190.6	150.0	113.3	44.7	68.4	210.6	195.2	113.2	162.5	343.9	153.4	170.7	111.7	91.3	151.2	154.9	262.9	223.5	201.7	145.5	369.7	723.5	192.0	140.4	105.7	488.1
UBE2E1	UbcH6	ENSG00000170142	"Ubiquitin conjugating enzyme E2 E1"	P51965	3	23805955-23891640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030445, CAB073413"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB073413: , HPA030445: AB_10669599"	"unprognostic (7.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.91e-3)"	"unprognostic (7.13e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (9.97e-7)"	"unprognostic (3.69e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	68.6	54.9	84.5	67.1	91.0	123.2	89.5	91.5	121.1	74.7	83.9	76.9	50.6	66.6	68.3	80.9	63.5	61.8	62.6	82.4	94.1	69.3	71.2	71.2	102.4	92.5	88.7	79.3	53.9	103.7	34.4	96.1	93.8	71.3	79.0	73.1	64.6	73.6	89.4	63.8	51.4	77.5	93.2	73.8	60.9	51.7	87.2	98.5	61.4	94.9	108.1	92.5	65.1	101.8	199.3	101.7	202.1	99.1	129.2	170.3	151.5	141.0	256.8	172.7	234.0	80.1	235.8	182.6	121.2	166.3	146.8	65.6	232.5	208.6	228.2	202.2	201.4	235.5	75.8	97.3	177.0	260.2	138.8	172.6	162.8	230.4	324.9	207.1	278.6	118.9	177.2	210.8	136.0	86.7	188.6	235.8	268.0	117.8	255.3	201.6	80.7	531.0	262.0	129.3	54.3	176.0	146.7	131.5	215.5	202.5	146.4	329.1	183.1	132.2	144.2	85.9	109.5	154.9	99.8	363.6	152.2	231.9	110.9	1.7	4.2	3.7	1.8	4.7	2.9	3.0	2.4	1.8	3.8	2.8	3.2	2.0	1.5	4.3	2.8	4.0	2.0	2.1	84.5	91.0	91.5	121.1	82.4	94.1	92.5	88.7	93.8	93.2	87.2	101.8	30.7	44.8	28.9	66.3	52.7	72.3	62.6	89.0	59.2	31.3	37.9	24.9	68.2	31.5	59.5	18.4	4.2	97.3	27.9	56.7	56.7	90.4	25.6	37.0	28.7	58.4	46.3	41.0	47.1	78.0	99.4	43.2	25.5	32.7	40.6	40.2	43.5	22.5	98.8	20.2	50.6	37.9	150.5	69.4	156.5	55.3	40.7	61.5	97.8	127.4	98.9	81.6	36.0	90.5	102.8	71.8	61.9	48.5	40.8	78.0	21.5	43.4	60.1	27.7	52.6	47.1	63.0	35.4	59.5	61.7	90.2	72.1	35.7	27.6	52.2	72.6
UBE2E2	"FLJ25157, UbcH8"	ENSG00000182247	"Ubiquitin conjugating enzyme E2 E2"	Q96LR5	3	23203020-23591794	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 652.7;Inhibitory neurons: 399.4;Microglial cells: 402.8;Oligodendrocyte precursor cells: 513.2;Oligodendrocytes: 845.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 41.7;intermediate monocyte: 50.3;memory B-cell: 35.1;myeloid DC: 57.6;naive B-cell: 40.1;non-classical monocyte: 54.4;plasmacytoid DC: 74.0"	"Group enriched"	"Detected in all"	6	"B-cells: 40.1;dendritic cells: 74.0;monocytes: 54.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003303, HPA028872, HPA030445, CAB073417"	Approved		Approved	Nucleoplasm		No	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599"	"unprognostic (2.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.68e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.19e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.11e-3)"	23.9	8.9	14.3	10.6	17.2	7.0	18.3	14.5	28.1	22.9	9.4	18.2	4.6	18.2	25.7	17.4	13.7	15.4	19.9	20.2	16.8	17.1	13.4	17.8	16.4	13.2	12.8	16.2	7.0	13.5	12.0	7.4	14.4	14.7	4.8	16.6	11.9	13.3	16.0	16.8	8.3	18.9	12.6	14.3	11.6	15.1	13.7	18.1	13.9	12.4	12.6	16.2	17.8	28.4	36.7	12.9	33.3	0.6	29.0	32.1	30.3	22.6	38.2	20.8	29.0	3.6	29.2	31.7	15.1	19.9	28.5	3.5	24.5	35.2	26.5	0.2	24.6	0.0	15.3	4.3	20.8	0.0	24.5	25.6	36.2	30.0	50.0	21.1	20.2	24.5	1.9	32.4	19.0	5.9	16.8	7.2	23.7	20.7	18.6	34.9	13.0	36.8	20.4	0.8	8.5	17.7	24.8	14.4	0.4	23.8	30.7	20.9	17.8	20.4	29.1	13.8	25.7	31.2	10.9	49.4	19.2	14.2	5.8	0.1	41.7	0.2	0.7	50.3	0.9	35.1	1.4	0.6	57.6	40.1	9.1	3.5	1.1	2.5	54.4	74.0	0.7	15.7	14.3	17.2	14.5	28.1	20.2	16.8	13.2	12.8	14.4	12.6	13.7	28.4	13.3	22.4	9.8	159.3	48.4	25.6	12.2	77.2	34.7	24.0	31.3	27.1	38.2	15.7	28.1	31.3	16.7	34.8	24.2	0.9	68.4	12.0	24.2	9.6	30.8	24.6	1.8	8.2	652.7	29.2	43.1	42.1	5.6	18.8	0.0	38.5	14.6	41.4	47.7	32.0	399.4	1.1	67.1	47.3	73.9	16.0	39.4	49.2	78.2	402.8	40.5	14.8	1.0	513.2	845.2	13.9	1.2	53.0	32.8	64.6	0.0	152.7	17.3	3.6	32.9	14.9	67.3	36.3	91.0	44.1	42.3	38.6	4.6	15.1	0.7	8.6
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 210.2"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 286.0;Late spermatids: 248.3;Suprabasal keratinocytes: 239.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"		"HPA045681: AB_2679417, HPA050551: AB_2681171"	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	21.0	19.1	15.8	25.4	21.4	31.5	20.1	21.0	24.3	25.2	11.6	39.7	22.5	22.7	14.7	52.2	16.3	16.0	37.9	16.1	18.7	27.0	30.3	15.6	38.8	21.5	19.2	15.6	18.4	21.5	9.7	18.9	21.7	22.6	24.2	17.5	21.0	20.8	210.2	28.0	23.6	27.2	20.3	20.7	21.8	23.2	21.0	24.9	16.1	84.1	46.4	24.5	32.1	26.5	54.5	57.8	52.7	38.9	42.2	44.3	74.9	51.7	41.4	48.2	42.1	40.0	27.0	84.5	52.8	51.2	39.4	57.2	66.3	48.1	77.2	44.8	53.9	31.7	28.6	45.9	41.3	46.5	57.4	38.0	70.3	45.8	66.1	33.8	65.6	55.8	56.5	88.9	40.1	24.3	59.4	42.5	58.2	40.1	29.6	76.1	27.9	78.1	56.4	35.1	22.7	42.3	48.9	41.8	41.6	77.4	41.1	29.9	49.6	48.1	36.8	57.0	58.7	34.3	43.8	118.9	36.9	42.8	37.7	13.3	15.8	39.0	22.2	16.8	29.9	34.1	28.3	29.1	20.2	24.4	28.3	28.9	28.1	32.5	18.6	14.8	28.9	21.8	15.8	21.4	21.0	24.3	16.1	18.7	21.5	19.2	21.7	20.3	21.0	26.5	28.3	22.4	14.4	31.3	70.6	286.0	36.5	47.8	111.5	18.8	47.0	31.0	67.6	27.1	32.2	25.8	6.2	47.0	47.8	41.4	82.2	30.9	139.5	36.7	25.7	35.5	38.4	26.5	47.9	26.7	59.6	31.1	32.6	39.9	21.0	13.9	31.1	62.3	48.1	15.2	46.3	38.3	44.7	36.5	81.1	248.3	19.6	35.7	67.6	30.9	43.1	28.7	36.0	36.2	84.4	43.0	30.4	21.1	154.3	65.7	40.4	75.6	35.4	17.1	6.6	25.9	43.5	70.8	50.8	85.3	239.7	66.8	58.2	13.8	30.1	54.0
UBE2I	UBC9	ENSG00000103275	"Ubiquitin conjugating enzyme E2 I"	P63279	16	1308880-1327018	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003909, CAB009021, CAB079920"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		130000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"CAB009021: AB_2210610, CAB079920: AB_2809487, HPA003909: AB_1858529"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.15e-3)"	62.5	76.3	42.5	60.3	44.0	81.6	62.0	46.1	49.3	64.7	37.1	63.8	45.1	72.7	48.7	74.2	67.3	34.3	68.2	45.2	45.2	63.4	40.8	53.1	76.0	39.3	42.3	93.1	49.1	72.0	61.6	58.1	40.2	53.4	47.3	31.7	56.4	46.7	58.0	68.0	61.1	53.8	42.2	71.9	52.9	47.6	47.1	110.3	53.2	57.0	89.3	66.6	63.1	42.1	121.3	161.1	269.0	157.7	112.7	135.8	114.4	170.0	121.7	154.3	152.9	191.8	190.1	208.2	137.7	148.1	140.7	142.4	193.2	159.2	197.9	151.2	133.4	130.6	136.6	188.4	178.6	194.9	148.0	127.1	100.7	152.1	180.0	149.0	170.0	169.9	190.3	124.3	148.0	254.4	349.6	193.0	219.0	136.0	118.5	434.0	170.9	238.4	145.7	106.6	150.3	159.8	149.3	164.1	177.7	152.8	167.5	234.4	139.4	149.2	172.6	134.0	155.5	132.1	170.4	423.4	85.3	142.9	164.7	278.7	214.3	327.1	165.9	256.6	200.9	297.8	167.8	170.3	214.7	241.1	148.2	149.6	149.5	202.6	249.5	186.3	196.5	260.9	42.5	44.0	46.1	49.3	45.2	45.2	39.3	42.3	40.2	42.2	47.1	42.1	109.5	51.3	67.0	16.3	172.8	178.6	186.4	275.6	97.3	64.6	101.9	105.7	89.1	84.4	140.9	62.5	50.1	312.8	153.9	77.4	105.7	211.9	64.4	66.6	100.6	118.3	102.3	127.4	17.2	148.2	293.1	134.4	55.5	104.6	109.5	149.7	94.2	43.7	213.5	47.1	16.8	97.1	162.8	104.8	182.1	37.8	129.8	124.8	128.1	15.9	220.2	104.7	209.1	16.6	26.7	212.3	91.8	107.6	144.1	294.8	90.4	117.7	65.7	63.1	78.9	82.1	185.4	139.6	145.7	158.4	206.7	418.1	144.7	134.9	134.7	304.5
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 544.4"									"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		5800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	41.5	46.0	63.7	37.1	64.8	54.4	33.9	65.0	72.0	35.5	54.4	45.5	39.6	35.0	41.0	49.1	38.5	34.0	51.5	65.4	65.3	40.1	40.9	33.9	48.8	67.8	64.7	33.9	30.3	43.2	31.2	42.7	66.8	39.1	45.6	28.1	33.9	36.8	63.5	36.2	40.7	48.6	62.3	37.6	37.5	28.5	66.7	51.9	36.4	53.1	52.5	46.8	32.3	65.5	121.9	68.9	98.3	77.4	105.1	93.1	56.6	100.0	113.6	125.8	118.7	79.0	57.0	114.2	49.0	133.5	94.7	101.4	132.1	108.6	124.3	114.4	142.9	132.1	63.3	94.8	70.0	190.9	91.0	82.7	93.1	91.2	65.7	90.6	143.4	69.4	544.4	59.3	137.9	89.6	100.0	137.6	72.8	134.8	71.6	80.5	147.6	31.2	118.8	96.2	88.0	65.4	79.9	99.1	95.6	89.4	61.7	104.0	103.8	88.6	113.5	75.5	103.6	57.3	99.7	103.7	120.0	87.5	86.0	84.4	87.8	105.7	84.9	102.2	79.7	77.3	79.9	91.6	109.2	73.6	69.0	82.9	73.2	81.2	89.0	106.3	106.1	141.1	63.7	64.8	65.0	72.0	65.4	65.3	67.8	64.7	66.8	62.3	66.7	65.5	102.6	109.0	83.9	26.1	110.7	125.5	171.6	318.5	51.2	54.5	76.9	72.8	64.9	101.5	180.3	71.7	16.7	312.1	159.0	215.1	197.6	288.2	79.9	133.1	104.6	125.9	126.0	173.0	25.6	385.0	406.5	102.6	60.1	124.9	129.3	79.3	109.6	159.8	298.5	69.0	24.3	153.1	193.3	126.9	159.7	61.1	87.3	140.9	126.3	19.7	257.9	98.4	200.8	22.6	30.4	432.1	222.1	103.8	98.4	186.7	213.5	257.2	173.9	45.5	105.2	81.0	205.4	202.8	121.2	87.6	129.7	372.1	130.1	133.7	154.0	208.4
UBE2L5	UBE2L5P	ENSG00000236444	"Ubiquitin conjugating enzyme E2 L5"	A0A1B0GUS4	13	30422488-30429758	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Ligase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"testis: 46.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA045609, HPA062415"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (2.09e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.50e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.44e-2)"	"unprognostic (8.75e-2)"	0.5	0.2	0.2	0.2	0.1	0.3	0.4	0.4	0.4	0.4	0.0	0.3	0.2	0.8	0.2	0.2	0.5	0.1	0.2	0.2	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.2	0.2	0.4	0.7	0.2	0.4	0.0	0.2	0.2	46.5	0.0	0.2	0.2	0.0	0.2	0.3	0.3	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.4	0.5	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.2	0.0	0.4	0.2	0.3	0.2	0.7	0.2	0.6	0.2	0.3	0.3	0.4	0.2	0.3	0.4	0.4	0.3	0.3	0.4	0.7	0.2	0.1	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558954	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 1197.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No		49000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	46.3	66.1	133.2	39.2	138.8	82.2	42.8	116.7	199.7	48.9	104.0	72.5	41.7	48.1	36.3	61.8	51.3	30.9	111.0	141.2	129.3	63.2	45.6	46.3	43.4	123.5	124.4	46.0	47.5	84.5	69.7	45.0	127.7	48.3	32.5	49.7	48.5	46.1	174.0	56.6	41.6	39.5	111.9	49.3	55.8	81.0	124.4	51.7	44.3	104.5	43.7	58.3	45.8	139.1	161.8	272.1	119.3	124.8	61.7	71.9	112.2	166.0	117.4	97.8	82.8	162.7	109.7	161.9	135.5	93.4	198.1	105.9	130.1	138.6	69.2	207.3	1197.4	235.5	163.7	113.7	154.4	197.3	192.9	82.1	107.1	145.9	167.3	102.6	117.8	146.3	119.6	179.4	127.3	158.2	177.2	223.7	87.1	155.1	306.5	171.7	106.7	204.5	111.6	166.8	239.5	205.5	133.1	149.7	163.3	41.6	94.4	188.4	105.2	333.4	80.5	110.6	281.3	262.3	411.9	169.6	206.0	177.6	220.5	6.7	3.6	4.2	3.0	2.6	2.2	2.8	3.2	3.2	2.8	3.8	3.3	2.2	10.1	1.7	2.7	6.7	2.9	1.9	133.2	138.8	116.7	199.7	141.2	129.3	123.5	124.4	127.7	111.9	124.4	139.1	75.1	6.4	13.0	14.7	32.7	40.4	36.3	15.9	6.2	100.0	74.5	81.3	38.5	20.0	11.6	18.4	20.9	21.0	72.9	63.9	7.9	17.3	25.7	89.6	68.0	40.1	41.2	39.8	22.9	30.6	22.4	38.9	21.9	63.3	19.7	103.3	28.5	38.0	35.4	109.4	20.8	43.8	20.3	27.0	33.5	34.0	17.4	42.5	35.6	15.9	21.1	142.3	14.4	8.5	17.9	41.8	21.4	13.9	35.4	59.1	37.9	33.9	18.6	81.1	26.3	41.5	55.4	27.1	7.9	17.0	56.8	52.5	41.0	156.1	41.6	56.2
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93441947	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 2532.0;Late spermatids: 8141.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: AB_2679163"	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	52.4	48.6	46.4	62.1	49.9	69.9	41.6	40.3	51.6	35.8	26.8	55.9	42.5	44.0	38.3	60.4	37.3	33.5	57.6	50.8	53.2	54.4	45.5	38.2	80.0	45.2	43.9	31.3	30.6	40.4	32.6	49.5	52.2	46.0	44.0	50.3	36.0	34.5	83.0	41.3	42.3	42.7	44.3	42.9	41.0	186.9	44.3	79.4	29.0	70.3	73.8	76.4	38.6	44.4	190.3	133.2	221.1	142.6	82.9	81.4	154.5	259.4	135.6	201.0	167.3	239.8	80.0	380.2	57.3	151.1	133.8	147.7	245.2	188.7	189.7	323.3	128.4	258.0	66.6	214.2	106.4	311.9	165.1	86.3	75.2	120.8	148.9	143.1	157.3	146.9	292.8	58.0	210.9	155.3	310.4	286.2	288.9	165.9	189.4	237.3	179.9	186.6	170.1	280.9	214.9	195.6	136.1	158.5	130.0	118.7	207.5	188.0	165.8	135.7	114.6	124.1	189.9	99.5	289.4	324.0	53.5	162.5	170.2	133.7	89.5	101.3	99.3	123.3	116.8	174.0	124.8	124.1	119.6	144.7	109.3	104.9	27.7	106.0	141.7	89.6	198.6	202.5	46.4	49.9	40.3	51.6	50.8	53.2	45.2	43.9	52.2	44.3	44.3	44.4	87.5	38.5	45.8	24.8	151.4	322.2	231.3	219.1	92.2	72.1	84.3	60.5	74.6	60.1	112.2	90.1	27.1	236.0	104.3	76.3	191.7	141.4	2532.0	79.7	79.0	95.3	74.7	75.9	44.6	99.0	226.0	100.9	49.5	96.5	93.8	68.3	55.3	55.3	165.6	87.5	49.0	78.6	187.2	67.8	216.3	8141.3	93.8	97.0	147.7	33.7	152.9	111.9	79.3	38.7	42.1	135.5	83.8	86.1	113.3	218.2	61.2	171.3	88.9	57.6	46.0	101.9	146.2	338.4	227.6	142.2	322.5	284.7	128.2	86.4	94.9	260.3
UBE2O	E2-230K	ENSG00000175931	"Ubiquitin conjugating enzyme E2 O"	Q9C0C9	17	76389456-76453152	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.7;Inhibitory neurons: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023605	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		No	No		220000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear bodies"	Nucleoplasm	"HPA023605: AB_2671257"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (6.84e-8)"	"unprognostic (3.54e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.34e-9)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	9.1	9.7	12.9	10.1	14.0	21.2	9.7	8.0	24.9	12.8	1.4	10.7	9.4	11.5	7.0	12.8	11.0	6.5	20.3	15.4	11.7	8.4	10.5	8.7	13.1	21.7	9.0	15.1	17.4	10.9	18.2	9.1	21.7	11.6	5.3	10.5	12.9	8.7	28.3	16.1	10.6	7.1	4.4	13.9	11.0	16.6	11.6	12.0	16.1	13.4	8.6	10.8	12.5	14.5	25.8	29.2	29.1	35.5	17.7	11.3	25.2	11.8	12.8	18.9	18.3	25.6	12.7	36.4	8.3	14.8	29.7	25.2	34.2	20.4	13.2	10.5	42.2	36.9	20.6	42.9	14.7	22.6	22.0	11.4	16.2	18.1	15.3	16.2	25.7	19.9	31.5	31.4	9.6	21.3	44.7	26.0	27.0	15.5	38.9	43.3	37.6	40.2	8.5	22.1	43.0	38.5	17.4	43.9	23.6	26.3	25.4	16.1	15.4	21.9	20.5	18.8	19.9	25.8	9.2	30.8	24.1	18.8	14.6	0.0	0.7	1.0	1.4	0.3	0.8	0.9	0.9	0.7	0.4	1.6	0.7	1.1	0.1	0.5	0.4	1.5	0.9	0.8	12.9	14.0	8.0	24.9	15.4	11.7	21.7	9.0	21.7	4.4	11.6	14.5	7.9	3.2	7.7	24.8	19.6	8.7	6.1	7.2	13.1	45.8	9.7	9.1	23.2	5.7	7.3	7.3	41.7	6.4	15.2	6.5	0.0	6.0	1.8	8.6	13.7	8.3	23.4	33.2	54.7	9.4	7.4	8.3	17.9	10.1	7.0	18.9	7.1	8.5	8.1	45.4	63.0	9.3	2.0	5.3	11.0	1.8	9.6	11.6	5.4	19.7	10.0	7.3	18.6	27.2	24.7	7.2	5.7	7.9	22.9	9.8	5.2	3.3	5.6	23.8	6.6	12.2	10.9	19.6	23.2	12.9	12.4	5.2	14.7	13.3	8.7	6.2
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA063368: AB_2684996"	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (1.04e-2)"	25.4	23.1	36.1	19.0	37.0	32.2	22.4	34.5	43.3	21.2	35.2	24.3	18.7	21.8	27.2	27.4	23.7	19.9	25.9	37.3	38.0	28.8	31.6	25.0	29.5	36.0	36.0	23.1	31.8	28.3	31.3	23.9	37.5	21.2	28.2	25.9	22.5	20.9	26.3	26.7	25.5	24.4	35.5	32.3	26.8	34.6	38.2	29.8	23.0	25.8	35.2	25.7	22.2	36.2	39.0	33.0	45.6	35.0	45.8	46.9	39.4	38.0	57.0	47.3	38.0	37.3	40.4	47.5	53.3	52.8	39.5	33.0	54.3	43.6	40.5	48.7	34.3	37.8	29.6	36.4	57.5	62.1	58.3	45.5	56.7	38.5	44.1	51.3	61.8	43.3	32.4	57.1	61.3	60.4	38.1	45.6	62.5	92.3	55.5	43.4	31.8	50.3	52.4	40.6	46.2	64.6	38.1	70.6	64.5	77.5	43.3	93.2	43.3	30.5	34.1	36.5	41.2	69.3	55.2	62.1	34.2	43.2	47.1	3.9	1.3	2.9	2.1	1.6	2.0	1.4	2.0	2.7	1.2	1.5	2.2	2.5	2.0	2.3	1.3	2.4	3.1	0.8	36.1	37.0	34.5	43.3	37.3	38.0	36.0	36.0	37.5	35.5	38.2	36.2	40.8	32.1	26.5	9.8	24.7	16.2	18.0	15.9	15.4	41.2	27.3	32.5	29.4	27.1	18.4	16.5	4.2	19.8	45.2	33.4	11.7	14.5	4.5	24.8	20.9	32.8	33.6	12.0	12.2	21.0	18.2	23.3	14.3	24.9	10.8	31.9	35.3	38.3	27.5	60.6	11.7	29.2	22.4	48.0	19.7	7.3	17.7	27.9	14.2	10.3	30.9	42.8	39.1	7.1	11.7	26.2	18.5	19.2	22.1	29.5	29.6	19.7	29.0	23.1	13.1	20.1	21.2	34.1	29.2	18.1	19.0	19.6	26.5	36.3	25.7	31.4
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448859-6496723	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.1;heart muscle: 16.8;retina: 28.3;skeletal muscle: 54.5;tongue: 13.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Cardiomyocytes: 27.6;Excitatory neurons: 47.8;Granulosa cells: 45.5;Horizontal cells: 45.4;Inhibitory neurons: 35.3;Rod photoreceptor cells: 63.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 29.7;PC-3: 24.6;SCLC-21H: 23.1;U-266/70: 54.4;U-266/84: 52.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Plasma membrane"	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favorable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	1.2	1.4	14.3	0.4	14.6	0.0	1.1	16.5	26.1	2.1	1.8	5.3	0.3	0.8	1.0	0.4	0.7	0.4	16.8	17.9	11.4	3.4	1.2	0.1	0.1	12.0	7.9	2.6	0.6	0.1	3.2	0.0	11.6	3.5	0.3	28.3	0.8	5.5	54.5	1.5	1.4	0.7	5.6	0.2	2.9	0.7	10.1	0.3	1.2	13.9	0.2	0.3	1.3	17.7	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.7	0.0	5.3	0.0	0.0	0.3	0.0	24.6	0.1	0.0	11.5	0.0	0.0	23.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	54.4	52.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	14.6	16.5	26.1	17.9	11.4	12.0	7.9	11.6	5.6	10.1	17.7	0.2	0.0	0.0	5.5	0.3	1.3	0.5	0.5	0.0	30.0	0.4	1.0	27.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	5.9	0.0	0.0	0.2	0.4	1.0	5.4	0.0	47.8	0.2	0.0	3.6	1.1	0.1	0.0	45.5	0.0	1.0	0.1	45.4	35.3	0.0	0.0	0.3	0.3	0.3	4.1	0.1	0.0	2.8	0.0	9.4	0.0	12.1	5.4	0.1	0.0	6.8	1.8	0.9	0.0	0.2	0.0	63.6	0.0	3.2	1.4	0.1	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0
UBE2R2	"CDC34B, FLJ20419, MGC10481, UBC3B"	ENSG00000107341	"Ubiquitin conjugating enzyme E2 R2"	Q712K3	9	33817160-33920399	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061000, HPA074334"			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA061000: AB_2684408, HPA074334: "	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.82e-3)"	"unprognostic (4.61e-3)"	"unprognostic (3.05e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.43e-1)"	32.0	20.6	25.4	20.2	27.3	15.4	27.1	24.8	28.0	30.8	20.8	31.4	28.0	28.5	16.3	29.2	23.9	18.6	32.4	24.8	24.6	22.1	33.3	28.2	21.7	27.2	25.8	30.1	53.4	14.5	15.0	23.9	26.7	20.9	19.6	25.0	21.5	18.4	63.1	34.5	24.8	25.9	24.5	23.1	22.1	44.8	25.0	30.1	18.3	44.8	25.4	26.6	28.7	30.2	41.2	42.0	78.7	35.0	42.0	68.2	25.1	34.7	46.5	38.7	38.3	34.0	28.7	33.9	14.4	47.2	28.3	17.8	41.5	38.5	41.8	58.3	22.7	28.7	43.7	43.3	60.1	34.6	31.0	58.4	55.6	31.8	59.2	61.5	65.8	39.8	28.0	35.0	38.7	22.6	68.0	91.4	46.2	33.1	34.7	63.2	24.0	17.6	41.1	28.9	37.6	45.4	40.1	35.2	27.0	49.5	31.3	41.9	50.3	37.8	35.4	26.8	32.9	23.5	23.0	46.5	36.0	19.7	83.5	22.6	10.9	6.3	2.8	11.1	1.7	4.6	2.6	2.2	6.1	4.8	2.5	2.3	31.7	7.4	18.7	3.7	3.3	4.0	25.4	27.3	24.8	28.0	24.8	24.6	27.2	25.8	26.7	24.5	25.0	30.2	73.7	22.4	30.7	39.8	38.6	105.5	46.3	26.1	32.5	65.8	57.8	60.8	134.8	57.2	26.8	22.0	14.6	69.5	46.4	64.7	15.6	49.7	311.1	65.7	84.9	74.9	72.0	36.6	67.8	69.4	82.0	57.4	25.5	81.8	13.3	99.2	84.9	88.3	76.6	60.6	67.0	55.4	32.6	123.5	112.2	257.4	67.1	110.6	35.6	40.3	116.4	124.3	42.2	45.2	127.8	84.7	49.1	76.0	24.0	83.9	79.1	59.8	25.0	31.2	59.2	48.3	55.6	94.4	64.6	41.8	120.5	82.8	34.9	68.0	48.7	121.2
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407788	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 115.9;testis: 158.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 341.4;dendritic cells: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	Nucleoplasm	"CAB015228: , HPA057150: AB_2683351"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	16.3	17.6	17.1	21.8	17.3	115.9	11.0	15.7	23.7	16.8	10.9	18.5	11.4	17.2	5.5	37.1	15.1	13.1	24.8	25.2	23.8	13.0	11.5	16.2	35.7	17.0	16.5	14.8	7.7	6.8	28.8	13.6	22.2	15.1	9.3	9.4	12.0	6.2	15.5	12.0	16.2	15.0	16.7	25.7	17.6	158.3	18.9	47.8	10.3	5.7	30.9	16.2	17.8	21.3	532.9	279.4	241.3	193.8	15.3	21.6	42.9	419.3	126.1	253.2	229.1	191.1	183.6	508.6	169.5	106.4	304.5	152.9	243.6	109.5	111.4	402.0	810.5	305.8	162.8	62.5	45.1	370.0	286.0	23.8	30.2	186.7	179.1	55.0	100.6	272.7	310.0	347.0	161.3	139.5	503.2	191.3	605.3	147.2	470.6	437.4	185.5	185.8	69.2	111.5	609.3	330.0	534.5	131.2	248.6	72.6	93.8	198.1	155.9	151.9	432.8	130.7	1013.5	277.1	734.4	617.0	159.2	257.5	562.7	0.5	0.8	1.3	0.7	0.6	0.5	2.5	1.0	1.0	0.6	0.6	1.0	0.5	2.4	0.2	0.4	1.3	0.4	0.1	17.1	17.3	15.7	23.7	25.2	23.8	17.0	16.5	22.2	16.7	18.9	21.3	308.0	0.0	3.4	5.9	161.3	162.6	151.2	31.5	81.4	59.3	235.9	341.4	3.1	8.6	9.9	20.2	54.2	87.8	432.7	59.2	15.6	42.8	127.5	89.3	68.2	72.5	92.6	166.5	8.7	30.5	247.9	99.3	44.9	68.0	18.4	200.9	31.8	10.6	65.5	32.0	11.0	69.1	38.7	26.8	125.3	52.2	17.4	131.7	74.7	3.7	36.7	91.1	21.6	7.5	13.5	82.3	44.1	12.4	100.6	82.9	20.4	18.4	9.7	75.7	13.1	125.2	186.7	196.9	174.0	74.1	115.9	59.8	233.3	64.6	55.8	121.1
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.5;Erythroid cells: 134.3;Extravillous trophoblasts: 103.4;Spermatocytes: 114.1;Spermatogonia: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	2.3	3.7	6.6	10.4	6.5	28.7	4.5	5.8	13.7	4.1	5.0	13.1	8.7	4.5	4.4	10.6	3.3	2.5	11.3	6.8	7.4	3.5	3.2	3.0	19.0	6.5	6.6	1.0	0.7	4.4	3.0	10.1	6.9	2.1	15.5	2.5	2.7	3.1	17.2	5.3	8.2	9.4	6.0	6.2	4.7	19.3	6.7	47.1	2.9	13.0	18.6	6.3	5.0	6.1	123.3	111.6	167.1	79.8	15.4	27.9	94.2	130.2	72.8	146.0	102.6	79.9	147.1	140.4	50.0	47.0	108.4	98.6	154.1	76.7	131.2	128.1	87.2	85.6	54.0	93.8	6.9	105.2	102.0	9.8	18.1	114.0	47.2	34.3	85.8	157.4	111.0	114.0	116.4	113.3	190.8	135.1	65.4	126.9	57.4	145.0	176.2	122.9	57.1	58.1	131.3	132.8	90.2	112.1	44.8	49.8	117.1	64.6	41.8	65.7	104.6	116.1	159.6	57.8	120.1	182.9	64.5	107.0	139.1	0.0	0.7	1.7	3.3	2.3	2.5	8.5	4.5	3.3	1.7	6.6	6.4	7.1	0.0	1.2	8.9	3.4	10.8	2.4	6.6	6.5	5.8	13.7	6.8	7.4	6.5	6.6	6.9	6.0	6.7	6.1	1.9	0.0	2.2	1.3	13.3	14.3	10.4	29.9	2.8	6.4	6.3	8.6	12.8	0.0	12.1	5.5	0.0	74.5	5.4	10.1	5.9	10.9	24.4	15.7	7.6	5.3	1.2	134.3	8.3	7.5	103.4	11.8	10.7	6.7	8.8	32.2	3.9	2.4	27.7	10.1	6.1	14.4	32.6	1.9	5.4	8.2	3.1	5.8	3.6	1.9	2.6	1.6	0.0	1.0	1.4	10.3	2.9	4.1	32.1	5.2	3.3	12.2	16.2	1.2	6.6	0.8	11.3	114.1	113.1	15.5	10.9	22.4	9.3	12.1	30.5	11.3
UBE2V1	"CROC-1, CROC1, UBE2V, UEV-1, UEV1A"	ENSG00000244687	"Ubiquitin conjugating enzyme E2 V1"	Q13404	20	50081124-50115959	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 74.0;Erythroid cells: 80.1;Plasma cells: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA052535, HPA053186"			Enhanced	Nucleoplasm		NA	NA		1100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA052535: AB_2681863, HPA053186: AB_2682073"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (4.58e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	61.2	57.8	50.1	56.9	54.9	51.3	51.3	43.1	72.2	51.2	44.2	70.7	58.4	45.4	53.2	71.9	46.6	48.0	66.7	55.8	48.8	58.9	78.2	59.3	68.4	45.2	44.5	44.2	64.7	61.1	37.4	66.3	46.3	53.5	61.2	47.2	55.6	55.0	87.9	65.9	51.9	73.5	38.3	55.5	56.7	40.9	48.9	60.8	49.9	70.8	89.1	67.8	53.6	48.6	155.0	94.1	174.3	104.8	141.6	238.7	97.3	172.6	168.0	356.3	169.9	466.6	112.8	148.8	155.9	223.8	155.1	134.5	129.5	235.4	307.1	105.0	81.2	146.0	66.2	212.2	125.9	178.3	113.2	192.4	140.4	176.1	115.1	199.6	243.5	120.4	185.2	88.4	200.9	102.7	162.9	143.8	121.9	204.5	164.7	89.0	196.8	136.4	248.7	109.9	101.8	123.2	174.4	301.0	136.7	173.2	115.0	161.2	215.1	196.5	182.3	165.7	140.8	85.7	118.5	119.0	213.9	92.2	139.4	120.7	162.3	146.5	219.9	161.5	221.9	149.2	178.9	210.7	165.3	134.1	180.3	197.2	55.8	233.6	147.9	130.4	189.5	351.7	50.1	54.9	43.1	72.2	55.8	48.8	45.2	44.5	46.3	38.3	48.9	48.6	18.9	51.3	30.9	0.0	39.1	5.9	5.0	18.4	74.0	4.6	10.6	7.9	9.2	7.2	36.3	11.0	6.2	6.4	24.6	10.7	23.5	11.5	19.1	36.3	32.0	18.4	10.2	80.1	0.0	11.3	5.7	21.2	38.2	36.1	36.6	4.8	16.8	14.5	7.0	0.0	0.0	5.2	8.2	17.8	5.9	19.8	7.8	29.6	8.8	0.0	18.4	3.0	12.3	0.0	0.0	16.1	15.4	4.9	79.4	2.8	7.7	27.2	47.8	5.4	6.6	6.9	14.8	12.9	6.7	67.8	8.5	7.1	41.1	5.4	4.9	5.1
UBE2V2	"DDVit-1, DDVIT1, EDAF-1, EDPF-1, EDPF1, MMS2, UEV-2, UEV2"	ENSG00000169139	"Ubiquitin conjugating enzyme E2 V2"	Q15819	8	48008415-48064708	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052535, HPA053186"			Supported	Nucleoplasm		NA	NA		800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA052535: AB_2681863, HPA053186: AB_2682073"	"unprognostic (3.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.62e-2)"	36.6	42.9	40.0	32.1	44.0	23.0	35.5	38.3	50.3	28.2	33.5	43.7	35.1	32.9	26.7	49.0	26.2	27.5	25.3	45.7	47.0	35.8	60.8	23.3	39.2	44.4	42.2	24.4	21.4	36.9	36.0	31.4	45.2	34.0	36.1	52.1	23.2	30.8	56.3	25.4	33.0	38.3	39.6	23.7	32.8	34.3	46.4	52.1	37.2	56.0	39.7	41.7	31.7	38.6	112.7	63.9	140.0	78.0	75.4	83.6	49.4	114.8	80.1	113.8	99.2	80.9	85.3	136.9	65.7	110.5	97.4	66.1	128.6	107.8	152.1	47.2	89.8	123.6	74.4	68.8	94.0	68.2	35.7	79.5	109.9	91.7	145.6	86.1	97.6	115.8	154.0	83.0	145.3	85.7	218.3	131.6	130.3	166.7	42.2	108.3	61.8	67.6	122.7	90.0	152.9	99.4	96.7	85.1	107.5	103.8	143.0	89.7	54.1	95.8	87.8	86.6	108.7	82.3	151.5	175.8	124.3	118.7	104.0	73.9	70.5	74.4	58.9	84.9	71.6	77.4	72.6	72.8	87.2	76.1	72.2	81.7	45.1	110.6	85.0	73.3	104.6	94.2	40.0	44.0	38.3	50.3	45.7	47.0	44.4	42.2	45.2	39.6	46.4	38.6	52.4	48.1	34.7	20.2	53.1	45.2	75.5	172.5	36.5	87.1	40.9	51.8	58.9	35.8	89.0	51.5	16.7	93.3	39.9	29.9	129.1	81.9	51.6	46.7	58.3	45.4	32.3	57.0	41.6	88.3	149.6	67.9	30.5	36.9	50.8	55.5	32.2	50.8	90.4	80.8	38.1	49.2	109.9	35.4	53.1	34.6	56.2	51.6	37.4	20.6	76.0	110.8	56.7	21.1	28.4	83.6	56.0	73.4	46.7	95.9	51.9	130.2	71.4	65.2	59.2	48.3	122.1	134.7	82.2	46.8	57.1	149.7	47.2	76.2	59.3	75.0
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908407-48929056	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favorable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	33.5	45.9	37.4	37.8	40.6	33.4	36.0	37.7	44.5	41.2	32.8	37.6	34.6	39.8	60.3	45.3	44.4	34.6	33.8	40.0	40.7	40.2	33.1	34.9	44.9	39.2	37.9	36.2	34.5	46.8	31.4	42.6	42.6	39.1	40.4	38.4	38.5	47.0	29.9	43.9	35.7	49.3	35.7	41.9	35.8	28.0	40.7	45.2	50.2	28.8	59.3	45.8	39.1	57.8	101.2	122.4	45.1	43.0	111.8	107.7	61.6	107.6	131.1	126.1	120.7	153.8	84.8	81.6	150.5	133.1	158.0	64.0	57.1	100.7	159.7	271.7	61.8	73.9	80.3	96.8	128.8	53.0	76.3	92.4	109.5	103.1	132.3	134.7	94.0	38.1	55.2	103.0	137.4	160.8	57.5	52.4	42.1	122.4	105.7	45.7	114.6	46.6	98.7	97.6	46.4	70.1	73.2	38.8	76.5	100.7	107.7	41.4	111.2	187.2	89.9	62.0	89.4	77.8	79.5	47.6	91.8	38.2	83.2	5.2	7.7	5.7	8.3	9.9	6.8	6.2	7.3	8.4	5.4	8.6	6.9	7.6	7.3	5.4	9.5	6.8	8.2	6.4	37.4	40.6	37.7	44.5	40.0	40.7	39.2	37.9	42.6	35.7	40.7	57.8	36.6	25.6	19.2	17.9	32.7	52.8	50.3	47.1	27.3	56.4	40.6	32.9	37.9	21.5	25.8	36.8	41.7	34.2	40.0	42.1	21.5	44.2	1.6	48.8	40.8	44.0	48.6	23.4	22.5	54.7	32.7	35.1	20.9	59.5	6.3	37.6	37.5	25.8	24.8	43.7	20.8	35.9	20.3	28.1	54.0	5.1	28.0	35.6	30.2	12.2	48.6	31.6	26.8	13.6	52.7	75.8	25.6	29.0	23.7	89.5	34.7	27.5	42.1	34.4	32.9	25.8	39.3	21.6	26.0	35.9	57.0	42.8	30.7	50.4	30.8	66.7
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	29.1	29.0	28.0	27.6	30.3	32.4	32.6	42.8	41.7	33.5	14.0	33.5	22.9	32.9	29.5	32.9	29.9	24.5	40.6	31.0	28.2	32.6	42.2	24.9	33.3	22.3	23.6	37.1	27.2	38.4	15.3	28.4	24.0	31.8	28.9	32.8	23.3	28.4	109.2	26.8	29.5	30.9	19.9	26.9	26.1	45.6	28.1	41.7	41.5	92.0	34.2	32.8	20.0	29.2	55.9	33.6	77.7	46.1	45.0	56.4	38.4	84.8	54.8	59.9	55.6	76.0	27.6	103.4	61.2	68.2	57.8	51.2	106.8	62.2	75.2	54.1	32.7	85.8	49.0	43.1	65.5	107.0	60.2	60.6	56.2	58.3	71.6	60.0	47.6	87.0	89.0	71.1	95.1	32.3	84.0	29.1	50.3	62.1	46.6	88.6	117.8	45.6	51.7	91.1	80.0	59.6	72.1	72.1	102.1	51.3	57.9	56.7	59.2	102.1	84.7	52.1	64.5	77.5	103.4	139.5	60.4	56.6	55.3	14.4	12.7	17.2	17.0	11.2	19.9	17.3	18.5	20.8	16.7	22.8	20.8	18.7	2.2	29.6	22.3	15.2	15.8	9.7	28.0	30.3	42.8	41.7	31.0	28.2	22.3	23.6	24.0	19.9	28.1	29.2	56.6	96.1	80.5	112.6	74.7	71.1	83.8	40.6	84.2	82.7	59.5	42.3	175.3	42.9	58.7	38.6	56.3	52.3	74.3	43.3	19.6	51.6	139.4	53.6	75.2	58.7	68.7	64.3	187.7	49.6	49.6	64.1	52.5	63.8	62.8	84.1	44.3	58.6	46.0	80.8	196.3	55.0	12.2	60.9	41.1	61.6	56.8	64.4	53.4	87.1	53.3	54.5	54.6	126.2	124.4	59.8	41.5	64.7	95.7	102.8	51.4	50.3	59.4	59.2	78.9	119.0	80.5	146.1	88.3	78.3	90.6	74.0	63.3	65.7	52.6	98.6
UBE3C	"KIAA0010, KIAA10"	ENSG00000009335	"Ubiquitin protein ligase E3C"	Q15386	7	157138916-157269370	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039915	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA039915: AB_10795264"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.01e-3)"	"unprognostic (8.64e-2)"	"prognostic favorable (9.18e-6)"	"unprognostic (9.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-2)"	25.7	17.4	12.0	21.5	13.2	16.2	21.7	17.5	14.1	18.4	18.8	22.3	20.0	19.4	13.4	28.3	18.5	19.1	28.5	13.2	14.1	20.3	22.9	19.0	20.9	14.6	13.4	20.0	22.4	36.2	11.1	17.5	14.9	19.9	23.2	20.2	22.7	22.7	65.6	20.8	20.8	29.2	12.7	18.0	20.9	26.2	14.8	18.6	17.3	58.5	22.8	28.1	17.0	15.0	68.8	53.3	33.5	67.3	58.8	61.3	37.1	74.0	63.4	61.1	61.3	48.3	55.7	36.8	64.0	82.1	79.6	42.4	52.6	68.3	72.0	67.6	48.3	37.6	35.6	35.0	58.4	56.9	52.8	54.8	61.6	68.0	55.9	46.4	72.2	30.3	55.7	39.9	87.6	59.8	56.2	35.9	53.3	61.1	63.6	31.9	37.7	75.9	63.2	74.1	53.5	55.2	72.8	61.9	54.5	37.2	32.0	39.3	65.3	76.6	16.5	190.0	93.3	39.7	42.9	37.0	87.7	83.0	89.5	0.3	1.8	1.1	2.2	2.3	3.0	1.1	2.4	2.4	2.0	1.2	2.2	2.7	0.6	2.1	2.5	1.8	2.8	1.5	12.0	13.2	17.5	14.1	13.2	14.1	14.6	13.4	14.9	12.7	14.8	15.0	23.8	22.4	19.7	52.2	14.2	27.5	17.3	19.0	17.6	34.7	22.4	16.9	33.7	22.8	14.2	25.8	66.7	14.9	25.3	27.3	9.8	20.3	11.6	21.6	27.4	23.4	24.5	14.9	98.9	17.7	17.4	19.6	27.0	24.5	9.5	23.0	23.6	48.3	15.4	32.0	100.7	21.8	12.2	27.6	15.2	10.1	15.5	20.6	5.4	52.5	22.0	9.9	26.8	81.4	96.2	27.5	13.4	25.6	17.5	31.5	20.6	19.1	19.8	39.9	0.0	23.1	21.4	26.6	27.3	37.5	33.2	15.1	20.9	22.3	26.2	28.1
UBFD1	"FLJ38870, FLJ42145, UBPH"	ENSG00000103353	"Ubiquitin family domain containing 1"	O14562	16	23557721-23574389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051746			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA051746: AB_2681587"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.45e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.06e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.46e-1)"	12.8	20.7	18.8	11.9	18.3	10.8	12.7	16.6	19.0	13.7	25.0	13.6	7.4	17.1	18.3	13.1	17.3	12.0	20.7	18.4	24.3	15.5	17.0	9.9	12.4	20.1	21.2	17.4	13.5	25.2	19.6	18.0	26.2	15.4	11.7	10.7	12.4	15.2	81.2	10.6	9.6	18.8	16.5	11.1	10.7	26.0	21.9	21.0	17.7	39.0	15.7	13.4	11.1	16.7	17.1	40.0	55.0	40.0	62.3	76.9	48.8	45.8	44.2	42.3	39.1	29.9	30.1	39.3	68.5	66.9	28.5	23.6	88.4	36.1	53.9	57.1	47.3	20.8	34.0	66.3	33.2	21.9	34.7	55.1	26.5	41.3	38.4	64.9	41.4	31.1	47.6	20.7	47.1	37.4	30.9	39.5	118.0	29.2	17.2	53.6	33.7	33.0	39.5	14.9	53.5	47.6	17.6	34.3	31.8	52.7	47.1	31.6	43.1	23.3	26.1	25.7	27.2	25.0	29.8	23.6	43.0	25.3	36.6	0.0	0.5	0.5	1.4	0.7	0.7	0.6	0.9	1.3	1.1	1.3	0.5	0.8	0.0	1.2	0.3	1.5	0.8	0.4	18.8	18.3	16.6	19.0	18.4	24.3	20.1	21.2	26.2	16.5	21.9	16.7	10.0	6.4	2.6	10.1	6.8	8.8	10.2	10.3	13.1	11.6	16.5	13.8	35.1	8.6	6.6	20.2	22.9	19.2	14.9	8.1	15.6	13.0	49.3	20.7	29.4	11.6	7.2	10.3	14.6	11.5	27.2	17.2	7.1	20.6	0.0	26.4	5.3	19.0	13.4	6.7	12.3	10.2	2.0	6.6	5.1	76.1	18.6	6.6	10.6	7.5	10.7	11.0	6.2	5.0	9.8	8.8	8.9	9.8	9.8	20.4	4.8	18.3	8.8	14.9	26.3	17.1	19.2	21.3	21.7	14.0	14.2	36.0	8.3	22.2	9.3	14.8
UBL4A	"DXS254E, GDX, GET5, MDY2, TMA24, UBL4"	ENSG00000102178	"Ubiquitin like 4A"	P11441	X	154483717-154486615	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003617	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		11000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA003617: AB_1080450"	"unprognostic (2.75e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (4.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.50e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-2)"	18.3	29.6	31.2	11.3	32.5	11.2	17.1	28.8	38.3	21.2	25.8	27.1	17.7	19.0	18.0	29.1	17.9	11.4	47.8	32.4	30.0	20.0	28.1	17.7	16.1	31.0	29.7	15.8	36.9	20.9	16.0	13.5	31.7	20.9	12.4	6.4	27.8	20.2	97.9	24.8	19.5	11.9	30.4	18.9	23.1	4.5	32.0	17.3	15.8	72.1	17.0	25.8	21.5	34.0	84.8	50.9	15.3	42.1	31.3	31.3	51.0	35.0	26.3	37.2	39.5	50.3	32.6	64.1	107.8	33.7	31.5	31.5	76.9	40.4	20.2	42.6	46.5	46.3	46.6	29.6	38.9	55.8	48.1	24.0	45.9	24.8	42.8	36.1	27.0	46.5	51.9	31.4	30.1	66.2	49.9	52.3	17.8	74.4	82.0	44.5	44.5	68.4	31.0	34.2	29.3	44.2	19.4	66.7	59.0	18.2	30.8	40.3	27.3	37.6	42.5	61.1	77.9	60.8	67.8	115.8	39.6	92.4	44.5	94.7	22.0	22.1	33.2	18.9	46.4	20.4	31.2	35.5	21.7	16.3	26.5	30.0	7.1	34.1	16.7	12.7	34.0	41.9	31.2	32.5	28.8	38.3	32.4	30.0	31.0	29.7	31.7	30.4	32.0	34.0	17.6	3.2	6.7	3.9	12.3	9.6	11.7	13.2	4.0	19.4	16.7	24.5	32.5	15.7	9.2	16.5	4.2	32.5	25.2	21.8	43.0	25.3	0.3	5.7	11.9	14.2	8.5	29.0	8.7	32.2	47.4	14.5	9.2	7.7	9.5	16.8	13.2	18.9	24.2	18.5	6.3	17.2	14.2	13.8	10.2	1.0	12.5	31.7	28.4	1.9	20.3	17.2	38.1	5.5	4.9	30.2	11.4	18.8	19.5	16.7	24.6	25.1	4.7	11.4	0.0	13.2	24.9	0.1	5.7	21.9	12.1	13.0	16.2	7.2	17.4	7.8
UBL7	"BMSC-UbP, MGC14421"	ENSG00000138629	"Ubiquitin like 7"	Q96S82	15	74445977-74461182	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 175.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040423, HPA041897"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA040423: AB_10673442, HPA041897: AB_2677732"	"unprognostic (4.21e-2)"	"prognostic favorable (6.37e-5)"	"unprognostic (2.93e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.43e-2)"	33.8	38.4	27.0	13.5	28.9	15.9	32.9	26.7	35.0	34.0	23.9	48.1	15.0	36.8	15.4	37.8	30.3	10.6	67.9	29.4	26.9	38.1	32.0	29.7	21.4	28.2	27.3	31.1	44.7	25.0	30.3	15.6	29.2	36.4	16.5	13.1	34.2	16.3	114.6	54.3	36.9	18.4	25.5	48.2	43.5	55.8	25.9	27.3	37.0	37.8	29.6	38.7	33.1	29.0	18.7	20.3	31.6	42.3	32.4	42.1	21.8	29.8	36.0	37.6	46.6	24.7	26.4	27.2	31.1	35.9	48.6	29.4	88.4	40.4	36.5	36.0	55.6	35.8	32.2	45.3	31.7	22.4	29.1	32.9	35.5	32.1	43.0	32.3	32.0	60.8	30.9	39.3	39.3	26.2	28.1	35.3	75.7	31.2	24.6	29.4	25.0	60.5	32.6	21.2	31.1	61.8	28.8	26.8	40.1	44.1	28.6	36.7	18.8	34.6	20.4	17.4	37.5	39.8	82.1	30.5	22.7	40.3	30.6	32.9	51.6	59.7	35.1	58.5	33.7	50.5	35.3	37.1	70.6	55.3	33.9	40.6	65.3	55.5	55.5	151.5	65.6	52.1	27.0	28.9	26.7	35.0	29.4	26.9	28.2	27.3	29.2	25.5	25.9	29.0	17.3	32.1	18.2	3.9	35.4	15.8	24.1	35.6	26.7	5.8	24.9	23.9	29.9	18.6	20.0	14.7	8.4	71.1	36.8	25.5	58.7	37.3	75.3	12.7	13.0	20.7	23.4	45.8	5.7	34.7	66.9	20.7	22.4	13.5	19.0	21.5	22.5	16.3	41.9	5.0	3.8	26.9	20.3	38.3	31.4	175.8	24.5	31.4	21.4	5.6	82.6	18.2	23.7	4.0	4.5	29.5	27.6	21.1	51.6	19.5	48.9	44.6	16.1	9.0	19.7	13.5	50.5	59.2	31.1	29.8	25.1	68.4	23.0	19.6	28.0	25.2
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263290-159286036	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	19.0	16.3	8.8	24.5	9.4	23.3	20.5	9.6	14.1	19.9	6.4	15.7	12.6	23.6	17.2	21.1	15.1	17.1	16.4	10.0	10.5	19.2	18.3	22.4	33.7	10.3	9.5	15.8	14.9	19.7	5.6	23.6	10.2	17.5	16.9	18.2	14.2	19.6	10.9	15.5	12.7	22.8	9.6	26.7	15.8	30.5	10.7	36.4	16.6	13.8	37.3	21.3	11.7	10.7	39.9	28.6	57.9	64.1	58.9	54.5	34.1	42.5	64.6	42.8	56.6	23.5	27.1	35.7	46.1	53.7	60.9	29.7	36.3	81.8	74.3	71.3	35.7	27.3	23.8	21.9	74.0	62.7	41.1	48.1	76.8	38.9	77.2	34.0	41.4	36.4	38.4	47.0	60.8	12.9	33.5	22.9	41.7	20.0	17.1	42.3	56.5	42.8	44.4	30.4	30.4	42.9	42.7	29.0	115.8	34.6	30.2	45.6	44.2	44.0	37.8	22.8	54.9	36.9	39.8	53.5	46.1	43.9	66.1	47.6	10.8	27.5	25.5	22.4	28.4	18.5	23.9	26.7	14.2	16.7	26.9	29.1	30.8	42.8	24.5	17.8	28.3	13.6	8.8	9.4	9.6	14.1	10.0	10.5	10.3	9.5	10.2	9.6	10.7	10.7	31.9	12.8	41.6	12.7	43.0	15.9	10.3	43.0	35.3	12.7	22.5	14.4	16.8	10.0	34.4	14.7	4.2	31.8	36.8	13.2	35.2	23.0	8.5	23.2	32.1	24.2	10.7	30.1	26.3	24.9	18.7	27.1	29.6	17.4	45.0	16.9	28.5	15.6	39.0	20.2	25.0	14.6	18.3	40.0	16.4	4.2	20.5	33.1	17.8	14.0	30.9	17.6	32.0	22.6	25.6	22.5	10.1	24.8	39.3	13.2	8.8	34.5	37.4	13.1	19.7	18.8	26.2	74.0	61.5	51.8	20.6	17.8	40.8	30.7	14.5	10.1
UBN1		ENSG00000118900	"Ubinuclein 1"	Q9NPG3	16	4846665-4882401	"Predicted intracellular proteins"	"Host-virus interaction"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 14.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 14.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061029, HPA069036, HPA069045"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA061029: AB_2684420, HPA069036: , HPA069045: AB_2686072"	"unprognostic (8.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.89e-2)"	14.7	12.3	8.3	14.5	7.9	48.9	12.9	10.5	8.3	14.9	12.4	13.9	14.7	12.4	6.5	25.0	11.9	11.8	20.8	9.1	5.9	10.5	13.6	13.5	15.4	6.6	6.9	13.3	14.1	12.2	10.1	11.5	5.8	11.6	14.3	20.1	15.7	9.6	22.9	15.8	14.6	13.8	6.2	21.5	12.7	37.4	8.0	22.5	11.4	19.5	15.5	11.6	16.5	8.0	21.0	26.0	29.5	29.3	25.3	23.6	23.7	25.7	24.5	29.6	28.4	21.7	24.4	39.2	23.1	25.3	32.1	27.2	38.2	23.6	25.0	38.4	19.0	32.2	35.0	17.1	24.3	39.4	33.6	15.8	30.6	34.4	36.7	22.5	39.3	38.3	53.6	32.5	22.0	30.1	43.6	18.0	25.1	21.8	19.3	67.5	36.6	37.5	15.5	24.0	39.9	22.0	44.7	36.4	22.3	21.8	36.0	34.6	39.7	31.3	29.5	102.5	32.4	30.4	34.7	77.5	18.5	24.5	53.9	1.7	1.2	0.9	1.4	1.1	1.0	0.9	1.0	1.3	0.8	1.0	1.1	0.7	14.2	1.0	0.9	1.7	0.9	0.9	8.3	7.9	10.5	8.3	9.1	5.9	6.6	6.9	5.8	6.2	8.0	8.0	31.2	9.6	15.9	17.3	31.9	18.0	22.0	7.5	30.1	59.9	23.6	20.3	25.5	22.8	9.8	9.2	110.5	28.1	51.3	41.1	7.9	16.7	46.2	39.2	36.8	36.4	30.9	32.4	17.9	18.2	23.3	22.9	29.6	29.8	7.6	27.9	28.5	31.0	23.2	50.5	16.8	27.4	8.2	33.2	21.5	57.8	29.2	37.0	26.6	30.0	28.9	27.9	61.8	19.6	20.3	27.7	33.4	22.6	44.0	33.4	27.4	13.3	16.4	100.8	13.1	26.8	21.8	153.8	128.4	30.9	22.3	29.1	40.4	35.2	26.8	27.3
UBN2	"FLJ25778, KIAA2030"	ENSG00000157741	"Ubinuclein 2"	Q6ZU65	7	139230356-139308236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 140.7;Late spermatids: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"basophil: 8.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019743, HPA020122, HPA020124"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202"	"unprognostic (1.96e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.05e-2)"	3.4	4.6	4.2	2.4	2.9	5.9	4.7	12.2	5.9	5.6	2.0	4.2	2.4	4.7	6.8	4.3	5.3	2.7	3.8	3.4	5.0	3.4	4.4	3.6	2.6	1.8	1.7	6.2	6.6	4.0	8.4	3.0	1.1	4.6	3.3	13.5	5.0	3.0	7.3	9.7	3.8	3.0	0.1	3.5	3.9	14.5	2.5	3.3	5.8	4.8	2.5	4.1	5.1	8.0	3.3	3.1	4.9	6.1	3.8	3.5	3.7	1.8	2.7	1.6	2.0	3.7	3.2	5.5	3.4	2.3	4.2	3.0	6.3	1.5	2.9	2.8	3.7	4.2	5.8	4.1	2.2	8.2	3.1	2.4	4.3	2.2	3.4	3.0	3.3	2.9	9.9	4.1	2.1	5.0	5.9	9.4	6.9	3.3	2.2	3.4	4.6	3.9	2.3	2.4	8.0	5.8	5.7	3.9	2.7	4.5	2.5	5.4	3.7	2.0	2.3	3.1	2.4	4.8	5.8	9.5	3.4	4.9	3.0	8.5	0.6	0.0	0.3	0.2	0.2	0.5	0.3	0.3	0.2	0.6	0.4	0.3	0.5	1.9	0.2	0.7	0.2	0.1	4.2	2.9	12.2	5.9	3.4	5.0	1.8	1.7	1.1	0.1	2.5	8.0	21.0	6.4	23.6	58.1	11.7	23.3	18.6	9.9	15.4	54.0	23.2	13.6	27.2	21.5	15.0	22.0	93.8	9.0	21.8	16.5	7.9	8.0	140.7	58.3	38.2	17.7	23.4	24.8	97.5	6.9	8.9	20.2	14.3	68.8	11.4	28.7	17.5	22.6	7.1	45.4	95.1	16.7	10.2	11.5	17.9	178.6	22.4	15.4	8.8	53.4	19.0	23.6	16.5	79.4	84.9	9.2	14.0	21.4	16.2	41.5	15.7	11.0	36.5	58.2	19.7	37.6	22.8	44.6	31.6	20.9	28.8	14.6	14.3	27.2	13.5	28.4
UBOX5	"KIAA0860, RNF37, Ubce7ip5, UIP5"	ENSG00000185019	"U-box domain containing 5"	O94941	20	3107573-3160196	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028871	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA028871: AB_10603140"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.80e-5)"	"unprognostic (4.02e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.33e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-2)"	4.5	4.4	4.3	2.7	5.1	6.9	4.5	5.5	5.1	4.8	2.4	6.2	2.8	5.9	2.7	4.4	4.8	2.6	3.8	4.5	3.8	4.4	3.5	3.7	3.7	3.8	3.7	5.0	6.1	5.4	4.4	3.4	3.5	5.2	2.9	3.8	4.8	4.4	11.2	7.6	4.2	4.1	3.2	4.3	4.7	4.8	3.9	3.8	3.8	6.8	3.0	5.6	4.2	6.1	6.1	6.1	4.8	3.1	6.3	3.5	2.6	4.9	4.7	6.1	6.0	5.8	5.2	4.8	2.0	4.2	7.0	8.5	3.2	7.8	3.6	1.4	2.7	7.9	2.1	5.4	5.0	3.9	2.9	4.5	5.6	4.9	6.2	5.0	3.9	3.7	6.7	4.4	3.5	4.5	7.0	5.0	3.7	6.3	3.7	4.7	5.8	3.3	3.8	6.7	5.9	5.7	3.4	18.8	4.0	3.7	8.1	2.5	4.3	4.0	2.7	4.6	4.4	5.9	9.4	4.2	2.1	3.5	3.0	7.9	5.1	9.4	4.4	5.1	5.0	6.3	5.2	3.6	5.5	4.8	5.3	5.1	8.1	5.2	5.3	3.7	5.6	4.6	4.3	5.1	5.5	5.1	4.5	3.8	3.8	3.7	3.5	3.2	3.9	6.1	2.4	12.8	6.0	6.8	3.6	1.9	4.1	3.4	0.6	6.6	2.8	2.0	1.1	1.5	3.1	0.0	6.2	6.9	1.9	5.6	0.0	4.0	1.4	2.5	2.5	3.6	10.2	0.4	9.6	4.2	4.4	3.5	5.1	2.7	2.5	4.5	4.6	4.3	4.9	6.7	8.5	4.9	6.1	5.0	3.2	1.9	6.8	3.5	3.6	3.7	6.6	4.5	4.1	4.5	10.4	3.9	3.4	3.8	2.3	5.8	4.7	5.2	2.7	5.2	6.6	5.2	2.8	10.2	5.2	1.6	2.4	10.1	3.1	3.8	5.3	5.9
UBP1	LBP-1a	ENSG00000153560	"Upstream binding protein 1"	Q9NZI7	3	33388336-33441371	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003967			Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003967: AB_10601829"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (4.64e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.88e-2)"	23.6	21.4	18.6	31.2	20.8	24.5	24.4	24.3	22.9	23.9	14.2	34.7	29.7	28.7	26.8	29.6	23.2	24.4	31.3	21.2	19.9	23.4	32.4	30.5	44.1	15.0	16.6	29.2	31.0	24.6	22.9	22.2	15.5	25.7	34.6	28.5	23.5	39.5	23.0	26.5	28.7	37.0	17.0	32.6	27.0	16.9	20.0	43.6	26.5	27.6	43.8	35.6	23.0	18.4	48.9	58.6	44.3	74.0	66.1	48.0	21.6	57.7	64.0	67.8	68.4	57.1	42.5	91.2	33.1	85.2	48.6	33.1	133.3	67.6	82.9	50.2	40.7	97.9	57.0	68.7	46.2	71.8	40.5	40.0	54.4	65.7	66.3	55.5	82.5	49.6	90.7	49.0	66.1	46.5	57.5	42.5	105.4	38.6	59.7	59.8	32.4	84.7	47.9	72.8	30.5	36.3	45.9	78.8	50.3	58.5	59.6	86.2	68.8	59.4	45.7	67.8	81.1	38.8	74.9	92.4	51.4	82.7	45.0	3.5	1.6	1.7	2.1	1.7	2.0	1.1	2.1	2.1	2.5	0.8	2.4	2.0	0.4	2.2	2.4	2.0	1.4	1.6	18.6	20.8	24.3	22.9	21.2	19.9	15.0	16.6	15.5	17.0	20.0	18.4	18.0	6.4	20.9	29.7	15.4	25.5	9.7	13.6	19.9	24.6	35.3	17.8	29.3	18.6	10.0	11.0	14.6	7.9	22.2	30.0	3.9	11.8	1.6	12.8	23.5	23.5	12.1	21.7	58.3	14.5	9.4	15.8	17.9	18.4	2.5	27.2	21.4	41.6	14.8	23.5	50.9	27.8	10.2	27.3	27.6	3.5	9.9	25.5	26.6	29.0	27.3	7.7	20.6	34.2	35.5	14.3	17.1	17.7	15.7	17.1	17.3	10.9	8.1	17.8	13.1	15.6	19.7	14.3	13.8	26.8	31.1	5.5	20.5	24.9	28.4	13.2
UBQLN1	"DA41, DSK2, PLIC-1, XDRP1"	ENSG00000135018	"Ubiquilin 1"	Q9UMX0	9	83659968-83707958	"Plasma proteins, Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037256, HPA054143"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB037256: AB_1858556, HPA054143: AB_2682398"	"unprognostic (4.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.07e-5)"	"unprognostic (3.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.29e-2)"	50.1	49.8	43.0	43.6	46.4	84.9	42.3	42.2	46.7	40.7	30.6	44.2	39.3	43.1	38.8	50.8	36.9	37.0	63.0	50.1	50.2	55.2	74.0	39.0	51.1	46.7	47.2	36.1	50.5	72.2	28.6	50.4	50.7	45.4	41.3	55.8	34.5	46.8	125.8	42.4	39.6	47.1	43.6	37.7	42.4	42.0	46.3	69.4	45.3	72.9	65.1	53.3	35.2	57.0	154.5	137.8	101.9	77.9	83.4	89.3	164.0	140.8	125.4	147.7	111.3	56.8	105.5	153.9	86.6	120.0	137.0	172.0	141.8	101.7	152.7	79.7	66.0	95.1	97.9	90.3	111.7	116.6	98.3	74.7	127.1	124.1	172.4	92.8	112.8	72.6	102.7	105.7	124.6	91.0	160.8	66.6	132.6	147.5	126.3	117.6	113.7	80.4	98.7	65.0	90.4	101.2	130.9	131.7	102.0	100.2	64.6	84.2	111.8	92.2	84.9	154.2	143.6	146.1	222.0	74.7	139.4	85.1	114.1	34.9	21.2	22.6	19.8	31.4	19.3	19.0	16.9	18.2	24.2	19.6	16.9	18.5	22.7	31.8	30.7	10.5	24.2	20.5	43.0	46.4	42.2	46.7	50.1	50.2	46.7	47.2	50.7	43.6	46.3	57.0	39.5	35.3	42.2	29.4	53.9	103.2	66.2	43.0	42.7	58.4	41.2	28.3	76.7	31.5	46.8	22.0	20.9	59.9	38.9	49.9	19.6	55.1	37.9	47.7	50.9	42.8	51.4	51.8	61.9	53.5	86.9	42.2	32.1	74.9	50.1	33.6	25.7	73.4	52.1	75.7	58.7	41.5	42.7	51.2	87.5	18.3	24.5	52.4	42.7	41.2	46.5	31.0	39.1	33.2	67.9	70.4	36.5	27.8	56.2	68.8	48.9	39.6	33.4	34.1	39.5	33.4	42.9	74.1	50.5	45.2	92.5	164.3	47.7	28.9	41.1	84.0
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035299-156053798	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA061797: AB_2684613"	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	18.9	19.4	39.9	14.6	47.9	9.1	19.1	34.3	52.5	31.6	27.3	24.5	13.6	24.3	15.3	33.7	26.7	11.5	26.7	40.8	40.2	25.7	31.7	20.8	15.0	38.1	38.3	21.1	32.2	25.6	11.3	15.5	37.7	25.4	15.5	18.3	23.3	19.6	59.7	27.0	18.8	22.9	37.1	20.2	28.2	19.8	40.0	14.1	17.7	39.5	17.0	26.1	26.0	39.8	45.9	54.1	50.8	50.1	34.1	21.0	50.0	37.8	20.7	37.2	27.8	49.0	40.5	77.7	33.9	34.7	20.1	50.2	51.8	40.8	35.2	65.9	54.9	42.8	31.5	47.7	21.9	46.4	77.3	15.9	51.6	51.3	41.5	32.6	44.8	24.4	81.4	42.1	34.0	56.3	51.4	46.5	69.8	117.2	49.8	64.8	37.4	76.9	30.2	45.7	37.3	108.0	38.0	93.2	38.7	49.0	90.1	50.4	43.7	34.3	44.9	35.3	41.4	92.7	79.4	83.2	21.0	45.9	49.1	9.7	0.7	0.4	1.5	0.7	1.9	1.1	1.1	1.6	0.5	0.8	0.8	1.2	0.0	1.2	0.1	1.2	1.0	0.7	39.9	47.9	34.3	52.5	40.8	40.2	38.1	38.3	37.7	37.1	40.0	39.8	8.6	6.4	5.3	9.8	8.4	13.4	9.4	9.1	18.2	6.8	17.2	9.9	4.3	17.2	8.5	23.9	6.2	8.1	8.1	9.6	3.9	11.6	0.8	5.0	10.2	9.3	10.7	6.3	5.9	10.9	9.1	7.4	7.1	8.9	1.3	13.4	11.7	22.7	9.9	6.7	6.6	10.8	8.2	8.4	7.2	4.9	6.5	8.3	17.8	9.4	15.6	7.3	5.2	4.5	9.2	13.1	6.9	9.1	13.0	25.3	8.2	12.1	5.4	6.0	0.0	10.7	7.8	4.9	5.6	21.0	14.6	8.2	7.7	4.8	15.0	14.3
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.9;Inhibitory neurons: 108.8;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 127.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038838, HPA038839"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA038838: AB_10673120, HPA038839: "	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	9.1	7.9	12.5	8.8	29.4	24.9	9.3	11.7	17.4	9.9	4.8	8.6	7.8	10.7	7.4	5.8	8.0	8.6	13.7	11.6	31.5	9.2	7.1	8.6	10.9	24.2	18.3	7.7	9.5	14.3	6.6	10.5	21.6	10.0	8.0	14.3	6.3	10.5	12.0	5.6	7.8	9.6	8.5	9.5	7.2	10.1	21.2	13.3	12.6	14.0	8.7	9.1	5.8	48.6	7.4	10.2	11.6	9.6	17.1	14.7	10.7	17.6	19.4	15.9	19.2	13.3	5.5	8.6	10.1	18.4	18.9	12.4	17.1	15.5	18.1	18.0	8.4	33.1	20.4	6.3	12.3	23.0	14.4	15.3	8.4	18.8	14.8	14.6	17.0	16.7	19.6	12.3	18.7	4.5	12.7	6.8	6.5	18.9	10.6	16.4	15.7	6.4	14.9	16.6	12.0	10.3	22.7	12.0	7.7	13.1	10.9	12.2	24.3	17.9	11.1	16.7	18.0	14.6	26.4	23.6	12.2	14.6	16.6	3.7	1.5	2.5	2.4	1.8	2.9	1.9	2.6	2.9	1.4	2.3	2.6	3.2	2.9	3.2	1.7	2.2	1.9	0.9	12.5	29.4	11.7	17.4	11.6	31.5	24.2	18.3	21.6	8.5	21.2	48.6	46.4	48.1	30.7	73.1	28.9	10.6	11.6	9.3	17.1	27.5	15.4	10.8	28.0	12.8	19.1	9.2	27.1	14.7	35.8	12.8	0.0	10.8	16.8	13.4	27.4	24.5	14.4	23.8	108.9	14.4	7.7	25.6	20.9	18.2	28.5	22.8	17.2	9.9	8.1	32.0	108.8	10.9	14.2	16.4	10.6	16.9	16.1	17.1	8.8	73.1	15.6	13.5	23.7	102.1	127.6	10.3	8.2	20.7	33.2	7.7	12.3	9.2	15.7	38.8	13.1	34.7	36.5	27.0	17.8	8.6	7.2	36.9	31.4	16.5	10.6	9.8
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564029-42693505	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.5;Inhibitory neurons: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	11.0	10.7	8.5	12.7	10.1	17.9	12.9	14.1	11.1	10.3	11.3	12.7	14.4	10.9	11.2	9.5	9.4	8.6	11.2	9.0	8.8	12.1	17.2	11.9	12.7	9.0	8.7	12.2	15.6	15.0	8.8	11.7	9.3	10.5	13.8	29.7	12.0	10.0	22.8	12.2	13.8	10.6	8.6	15.3	12.2	6.2	9.1	13.5	13.3	22.3	11.5	10.8	10.4	14.2	18.5	9.0	10.4	16.4	20.9	20.0	14.0	13.8	14.9	12.0	12.4	13.2	7.4	12.5	10.7	15.0	13.9	18.1	15.1	11.8	15.2	17.1	10.6	20.0	13.3	17.3	17.0	19.6	13.1	14.1	12.7	12.0	12.9	14.8	13.7	17.9	23.7	15.4	11.7	14.9	15.4	17.1	9.5	36.2	8.7	13.6	15.5	19.0	13.8	15.7	12.4	9.8	14.0	13.3	13.9	15.7	13.0	18.7	19.8	10.8	8.4	13.5	10.1	14.1	13.4	18.9	5.7	14.5	6.8	17.7	7.1	15.2	6.5	7.3	5.4	5.2	4.2	5.1	5.5	5.2	4.3	4.8	38.5	5.9	9.8	4.1	5.3	3.4	8.5	10.1	14.1	11.1	9.0	8.8	9.0	8.7	9.3	8.6	9.1	14.2	33.5	16.0	24.6	82.6	33.9	16.6	18.1	14.9	28.5	43.0	20.4	15.9	39.3	30.0	22.1	20.2	60.5	17.4	46.6	51.6	17.6	18.5	12.4	27.5	30.8	24.8	12.6	75.1	138.5	15.3	13.4	26.5	34.1	32.9	20.3	31.3	21.8	35.0	13.2	63.9	142.7	22.5	14.2	26.7	28.6	3.9	25.4	26.1	19.6	87.1	43.0	23.5	32.0	123.1	131.4	15.0	29.1	24.0	50.6	22.8	37.2	11.7	27.9	53.5	39.5	30.0	27.2	11.2	10.9	28.1	16.2	17.2	44.0	24.0	21.5	22.7
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3"	Q6ZT12	2	169827454-170084131	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 71.2;tongue: 87.1"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 305.1;Inhibitory neurons: 302.0;Oligodendrocyte precursor cells: 232.2;Oligodendrocytes: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	14.2	12.4	4.4	7.7	5.8	7.4	9.2	5.9	8.5	10.9	2.8	8.8	8.1	10.1	6.9	12.8	8.4	9.3	29.4	8.0	3.3	15.2	21.0	8.8	7.2	2.4	2.7	10.2	11.9	21.5	2.1	8.7	3.3	13.1	8.5	21.2	11.5	10.3	71.2	9.2	7.5	11.1	3.2	8.8	9.3	9.7	3.4	9.5	17.9	87.1	7.3	11.0	2.3	8.4	14.8	12.4	12.9	17.1	25.0	19.7	10.8	26.1	15.0	14.7	11.8	19.1	9.1	16.7	22.2	20.5	12.0	19.0	15.5	13.2	18.2	17.4	13.4	61.1	12.6	20.3	12.4	20.4	18.9	11.9	12.1	19.3	12.9	11.7	14.8	8.3	32.4	17.6	25.6	14.0	13.3	10.0	10.1	14.9	10.2	12.6	21.1	17.8	10.5	20.5	25.1	13.7	18.4	16.7	10.6	10.2	10.9	11.4	18.9	22.1	9.0	17.5	16.7	14.2	11.9	15.1	18.2	11.8	12.5	0.0	0.6	0.5	0.9	0.6	1.3	0.6	0.5	0.8	0.9	0.3	0.9	1.2	0.6	0.8	0.5	0.7	1.0	0.4	4.4	5.8	5.9	8.5	8.0	3.3	2.4	2.7	3.3	3.2	3.4	8.4	19.0	44.8	26.9	162.6	16.3	25.9	12.4	14.8	20.5	46.3	15.8	8.9	109.7	17.2	20.0	12.9	81.3	19.7	22.9	17.1	3.9	8.7	7.6	16.8	21.9	26.4	16.7	24.4	305.1	11.0	8.4	22.2	23.4	22.0	16.5	22.7	30.4	39.0	10.2	63.9	302.0	11.3	22.4	20.9	18.7	10.2	25.7	18.7	16.0	110.5	18.7	61.7	14.4	232.2	288.0	10.7	15.0	19.2	21.3	20.9	15.3	10.0	13.4	51.5	26.3	29.0	21.8	12.4	8.6	22.9	29.0	23.0	18.1	17.3	13.2	17.2
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074510-19210266	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 271.0;Suprabasal keratinocytes: 252.9;Urothelial cells: 236.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 39.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		15000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	56.2	62.8	48.2	23.0	46.0	79.8	49.8	38.7	48.4	57.4	47.6	69.6	20.9	61.7	35.7	55.4	52.3	29.6	58.7	45.8	46.0	74.7	82.7	71.9	25.7	51.5	46.4	75.3	53.5	35.5	70.7	27.5	54.9	67.2	22.7	44.6	48.0	27.0	129.1	161.9	59.7	26.0	35.2	62.8	70.6	105.3	45.9	34.6	56.5	45.0	25.7	90.0	59.2	44.7	61.4	60.7	53.5	39.7	97.6	50.0	46.2	46.5	48.8	49.5	44.7	97.2	51.3	36.6	42.3	61.7	43.3	40.8	42.3	46.3	46.0	30.6	37.5	83.8	63.3	64.1	68.6	51.9	53.4	45.0	57.9	100.8	96.3	48.1	54.9	63.7	58.5	32.9	47.6	43.6	24.7	62.9	43.5	124.3	33.6	34.0	41.7	31.0	44.7	35.2	37.7	37.4	55.0	31.1	39.9	48.6	21.7	40.4	85.9	57.4	36.1	69.0	52.8	38.8	25.2	41.5	39.3	79.3	50.3	39.8	28.7	4.7	4.9	5.9	4.2	7.4	4.4	2.9	14.2	4.0	3.9	3.7	15.4	4.4	2.1	6.5	3.4	8.3	48.2	46.0	38.7	48.4	45.8	46.0	51.5	46.4	54.9	35.2	45.9	44.7	28.1	35.3	37.6	85.5	30.3	271.0	124.6	28.9	28.5	57.5	22.1	23.9	19.1	37.1	30.4	31.3	152.2	24.7	34.2	31.6	13.7	41.3	21.4	39.8	32.0	30.8	17.5	48.4	58.9	40.9	17.0	32.2	44.9	50.4	19.6	32.9	31.1	94.1	63.2	79.1	61.8	29.2	12.2	43.0	48.7	28.7	30.7	46.4	49.8	34.7	64.4	28.8	21.6	51.8	44.5	61.0	16.7	35.7	26.4	59.1	57.9	135.6	39.1	48.5	19.7	28.3	30.1	44.8	21.0	28.0	252.9	33.9	32.7	34.5	20.1	236.5
UBR5	"DD5, EDD, EDD1, HYD, KIAA0896"	ENSG00000104517	"Ubiquitin protein ligase E3 component n-recognin 5"	O95071	8	102252273-102412759	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 239.9;Excitatory neurons: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053688			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA053688: AB_2682230"	"unprognostic (3.79e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.54e-3)"	"unprognostic (8.29e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.45e-1)"	33.0	18.3	16.6	22.4	19.4	36.5	30.9	26.5	24.0	25.6	23.4	33.3	14.9	29.6	23.7	27.5	26.1	17.3	25.8	17.3	16.0	17.5	17.7	29.8	33.6	16.0	16.1	32.2	25.7	30.4	24.4	17.8	15.7	20.0	17.0	45.4	26.1	20.7	50.1	35.6	27.2	17.2	13.7	24.2	25.0	43.9	16.6	43.0	21.0	29.6	28.6	28.2	26.4	18.9	64.5	28.4	53.2	27.5	51.8	52.2	48.9	47.4	41.9	36.6	31.7	28.3	42.1	127.1	39.8	44.5	23.7	38.2	46.2	41.1	51.1	55.3	22.7	106.5	39.7	52.2	46.1	33.7	56.3	60.1	40.4	37.5	64.5	41.5	44.6	35.6	52.3	70.2	34.8	58.0	85.3	40.3	40.1	61.8	31.6	49.3	31.6	60.9	33.5	62.3	39.1	32.5	33.4	31.8	34.3	46.1	51.4	35.1	44.6	38.5	44.9	35.1	33.5	37.3	38.7	129.5	38.0	51.2	32.0	1.8	1.5	2.4	2.4	1.5	2.4	2.1	2.5	2.5	1.8	1.7	2.0	3.0	3.0	1.1	2.7	1.6	3.4	1.0	16.6	19.4	26.5	24.0	17.3	16.0	16.0	16.1	15.7	13.7	16.6	18.9	51.4	25.6	31.7	239.9	44.8	52.3	41.2	26.3	55.8	52.0	37.3	29.6	39.8	8.6	49.9	31.3	68.8	27.7	36.2	20.9	9.8	18.8	38.6	47.5	47.0	40.1	33.4	33.2	214.2	15.0	18.9	43.7	37.8	69.0	29.8	64.3	22.9	19.0	17.0	57.2	191.7	19.5	26.4	31.4	52.6	23.6	39.7	43.7	44.4	129.3	43.5	31.3	26.8	196.6	174.0	21.4	18.3	36.5	65.9	45.2	18.3	9.0	46.5	44.8	13.1	66.3	48.4	59.4	30.2	46.8	61.1	69.6	46.9	30.8	19.5	53.5
UBR7	C14orf130	ENSG00000012963	"Ubiquitin protein ligase E3 component n-recognin 7"	Q8N806	14	93207241-93229215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 300.9;Late spermatids: 372.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000861	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA000861: AB_1078321"	"unprognostic (9.60e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.12e-5)"	"unprognostic (1.14e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.94e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	12.7	10.4	16.9	13.2	19.1	21.1	19.1	16.3	20.2	17.6	17.7	16.9	11.8	14.4	14.0	13.0	14.4	13.1	22.0	18.8	15.9	16.6	15.1	12.7	22.2	15.3	16.1	17.6	22.9	25.7	8.9	10.3	16.0	14.6	18.3	24.3	12.7	15.3	17.5	15.7	13.2	15.3	17.1	14.1	14.2	19.0	17.3	34.0	16.8	25.9	27.3	13.6	10.9	18.8	26.1	33.0	52.2	44.2	24.2	24.0	18.6	54.0	38.6	57.1	43.9	23.5	28.2	60.9	42.6	28.3	26.0	30.7	55.8	30.1	60.7	46.4	29.2	45.7	33.1	23.7	11.2	65.7	47.5	15.5	20.7	33.8	21.2	21.7	33.1	54.8	41.5	60.5	57.7	77.3	104.5	35.7	24.1	69.4	61.9	81.9	92.9	33.6	20.6	42.0	65.3	45.4	39.5	32.1	16.3	31.1	58.4	44.6	24.0	43.1	23.0	37.0	56.3	69.0	103.4	61.1	37.0	49.8	38.7	34.5	11.3	18.2	17.8	14.2	19.5	26.4	16.4	16.4	11.4	20.4	13.6	15.1	16.6	18.1	18.3	15.0	26.7	13.4	16.9	19.1	16.3	20.2	18.8	15.9	15.3	16.1	16.0	17.1	17.3	18.8	13.8	16.0	6.4	9.4	16.1	19.9	8.3	8.0	6.8	6.1	11.6	11.0	19.7	11.5	8.5	11.0	10.4	12.3	15.1	15.6	11.7	9.9	300.9	8.2	8.5	11.0	5.4	20.2	16.3	12.9	15.2	12.0	9.7	9.1	5.1	8.8	12.8	11.3	14.0	3.3	12.7	8.4	12.2	10.7	10.9	372.2	9.3	9.0	14.2	7.5	9.3	13.5	13.4	10.6	13.9	8.9	5.4	12.4	26.0	4.7	10.3	9.3	5.5	13.9	6.6	11.2	10.1	38.7	23.2	10.7	13.5	6.6	12.4	6.2	12.4	6.0
UBXN1	"2B28, LOC51035, SAKS1, UBXD10"	ENSG00000162191	"UBX domain protein 1"	Q04323	11	62676498-62679117	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012669, HPA076932"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		45000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol	Nucleoplasm	"HPA012669: AB_1853149, HPA076932: "	"unprognostic (1.76e-3)"	"unprognostic (8.72e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.94e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.42e-1)"	138.3	103.0	88.9	67.1	94.0	63.7	121.3	91.5	102.9	133.5	86.1	130.6	71.9	113.2	44.3	99.6	112.4	54.4	106.4	85.8	88.5	95.1	72.8	81.9	108.0	96.5	90.1	147.8	120.3	58.9	75.8	52.2	93.9	89.4	37.9	28.0	79.0	56.1	284.3	128.6	93.3	48.3	91.2	111.7	116.6	113.5	91.1	107.6	96.8	105.3	82.2	113.2	103.8	94.7	86.2	137.7	101.3	142.5	137.7	147.0	87.7	73.4	136.6	139.4	94.6	99.0	109.7	135.7	131.3	100.1	123.7	119.2	81.6	128.3	64.5	124.3	99.5	95.6	118.9	136.4	269.1	150.7	102.6	191.7	195.1	123.5	188.5	149.4	132.1	170.3	148.0	86.4	88.5	196.6	117.8	280.3	5.2	67.4	88.9	86.6	107.9	135.3	114.1	85.8	98.6	165.5	68.8	108.3	330.0	43.2	150.5	188.0	128.6	111.8	84.0	113.4	84.6	109.0	89.3	123.8	129.7	64.9	103.7	158.0	320.2	160.7	273.9	346.7	350.2	534.6	415.2	323.7	346.2	533.5	494.7	365.8	173.5	303.8	440.6	276.8	562.3	559.0	88.9	94.0	91.5	102.9	85.8	88.5	96.5	90.1	93.9	91.2	91.1	94.7	183.1	93.0	116.4	16.6	222.8	264.0	176.5	240.7	142.3	61.7	202.9	190.2	86.4	137.2	160.7	75.4	45.9	172.9	194.1	162.0	156.5	191.1	184.1	91.2	119.0	194.9	126.2	144.9	9.2	184.7	195.2	124.1	78.0	81.4	162.7	146.6	180.2	77.0	216.3	30.3	9.1	156.5	187.2	325.2	352.2	245.8	208.8	196.2	183.2	8.4	307.5	153.5	244.1	7.5	17.8	203.8	235.9	143.3	93.0	192.7	335.9	259.7	132.7	57.4	197.2	171.3	300.3	257.6	220.6	130.2	302.8	324.7	226.9	147.0	161.4	235.0
UBXN2B	p37	ENSG00000215114	"UBX domain protein 2B"	Q14CS0	8	58411359-58451501	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 42.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.8;monocytes: 12.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045278	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA045278: AB_10963578"	"unprognostic (1.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.42e-2)"	7.9	9.1	10.3	12.0	11.4	15.4	11.0	14.0	12.5	6.6	9.2	8.7	7.7	8.1	10.8	5.8	8.5	8.6	9.8	11.9	9.0	15.7	18.8	9.7	9.1	11.2	8.9	9.0	8.8	16.1	7.9	7.6	11.2	9.5	9.2	13.4	12.9	8.5	9.0	6.4	7.8	9.8	9.6	10.1	8.2	9.5	9.8	11.9	14.2	11.0	9.4	8.9	4.3	12.8	11.1	20.2	16.9	20.9	3.0	1.5	11.7	6.7	12.3	8.2	10.6	8.8	20.4	13.0	13.4	8.3	22.2	9.9	25.1	12.1	11.5	10.0	12.7	16.2	17.0	11.0	12.6	14.5	15.1	5.4	19.0	3.8	18.9	19.5	10.2	19.7	11.4	23.8	7.4	11.3	26.0	16.0	22.1	38.6	4.8	14.5	7.5	8.9	26.4	16.8	6.2	25.4	11.6	11.7	19.7	16.5	23.7	17.3	2.3	6.3	13.4	13.7	14.0	12.4	13.3	18.0	20.6	13.6	8.5	15.8	11.9	18.0	4.3	11.0	4.2	3.4	4.1	3.6	5.9	3.3	4.9	4.3	42.8	5.4	12.9	2.9	5.3	5.3	10.3	11.4	14.0	12.5	11.9	9.0	11.2	8.9	11.2	9.6	9.8	12.8	4.0	9.6	8.7	27.7	11.4	5.7	10.6	10.3	4.0	16.0	13.7	11.7	18.4	10.0	9.0	11.0	22.9	15.9	10.4	15.9	9.8	11.2	35.8	8.6	9.3	4.7	12.0	13.5	55.3	11.1	17.6	9.5	10.7	11.8	23.5	13.3	4.6	17.1	23.0	11.8	62.4	9.6	14.2	32.4	12.4	61.8	10.5	27.5	8.8	21.5	26.0	13.6	15.5	43.2	41.4	10.8	8.2	14.7	8.4	10.4	15.5	29.7	8.9	25.6	0.0	13.9	8.5	20.4	17.8	9.3	6.7	8.6	10.9	8.6	9.1	10.4
UBXN7	"KIAA0794, UBXD7"	ENSG00000163960	"UBX domain protein 7"	O94888	3	196347662-196432430	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048441, HPA049442"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA048441: AB_2680394, HPA049442: AB_2680769"	"unprognostic (8.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	6.5	7.5	5.3	7.5	7.5	21.7	8.2	17.5	7.1	8.3	7.4	6.9	5.5	10.1	8.1	6.6	8.4	5.7	4.9	5.4	9.3	6.8	6.4	6.7	9.0	6.3	7.3	12.8	7.4	10.8	7.3	9.5	6.9	7.3	6.8	18.1	6.6	6.7	5.0	10.7	6.3	7.9	5.8	8.9	6.6	11.9	7.6	13.9	8.1	7.0	8.7	6.2	7.0	10.9	25.2	7.7	29.8	15.8	15.2	26.6	13.0	20.3	13.4	11.4	10.4	19.9	10.5	23.0	41.6	13.7	15.4	20.0	22.5	12.0	21.2	9.5	13.8	36.9	16.5	11.3	11.6	18.8	11.5	16.0	13.5	16.0	20.0	20.4	18.7	17.2	17.8	15.5	13.5	10.8	19.6	9.9	17.3	10.2	9.7	22.7	22.3	15.8	9.4	10.9	20.0	15.4	32.6	9.0	15.7	23.7	24.2	15.7	23.5	13.0	11.6	11.8	21.7	21.6	31.3	33.5	12.0	21.0	9.9	9.9	4.7	7.0	4.4	3.7	4.0	6.9	3.8	2.9	5.0	5.9	6.5	5.9	8.4	6.2	5.4	2.2	6.6	2.5	5.3	7.5	17.5	7.1	5.4	9.3	6.3	7.3	6.9	5.8	7.6	10.9	27.1	44.8	18.8	29.7	31.4	47.3	14.3	16.2	40.5	38.0	22.2	16.0	16.8	12.8	21.1	20.2	70.9	18.0	32.9	14.8	5.9	10.8	38.3	47.8	46.3	27.8	46.5	34.0	35.3	10.0	10.5	30.7	18.8	35.1	8.8	46.0	21.8	12.0	12.5	32.0	41.3	15.9	12.2	25.4	41.0	24.7	29.8	24.7	23.2	27.2	28.4	21.5	33.0	36.7	47.8	12.2	11.8	28.2	34.3	31.7	13.3	11.7	30.5	46.5	32.9	37.3	25.6	34.7	23.8	38.6	54.7	18.9	29.8	33.2	15.8	25.3
UBXN8	"D8S2298E, REP8, UBXD6"	ENSG00000104691	"UBX domain protein 8"	O00124	8	30729131-30767006	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 79.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 167.4;Granulosa cells: 191.2;Hepatocytes: 65.7;Late spermatids: 180.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017725, HPA077538"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	"Nucleoplasm, Nucleoli"	"HPA017725: AB_1847462, HPA077538: AB_2686844"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.13e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.25e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-2)"	10.2	17.3	17.0	7.1	12.0	8.8	14.1	12.2	16.1	10.4	0.0	12.5	13.1	10.4	49.9	10.7	13.2	13.5	4.9	13.3	5.4	22.1	44.1	8.7	8.1	10.3	4.2	79.9	33.0	20.5	2.8	15.6	10.6	16.3	16.3	11.6	8.5	18.6	3.7	16.9	12.1	10.8	1.7	11.1	12.4	37.1	9.2	14.3	25.9	5.4	9.7	10.4	3.3	12.7	16.4	17.0	11.7	12.2	17.9	25.2	14.3	29.5	17.2	15.2	19.6	27.6	6.1	26.8	23.2	24.5	25.9	14.8	3.1	16.8	24.6	23.9	27.2	77.0	14.0	33.0	27.3	18.1	41.8	20.2	17.4	25.6	12.7	13.6	14.1	12.8	71.9	21.8	35.5	16.1	18.6	14.6	22.9	52.2	12.9	21.4	10.9	18.3	27.7	22.4	6.4	17.7	8.3	26.0	52.1	14.1	16.8	30.4	17.3	17.0	7.8	8.2	28.3	8.8	29.2	19.7	15.0	29.0	25.5	0.0	4.6	0.6	6.2	4.9	5.4	4.7	3.3	5.8	5.2	1.9	3.0	5.5	0.8	2.8	2.4	6.5	3.2	2.7	17.0	12.0	12.2	16.1	13.3	5.4	10.3	4.2	10.6	1.7	9.2	12.7	20.5	3.2	8.2	5.5	5.2	0.0	5.4	0.0	8.0	2.5	7.5	7.6	4.3	17.2	3.1	14.7	20.9	23.8	10.7	7.5	7.9	9.7	167.4	9.1	18.6	12.4	8.5	12.8	5.4	5.3	20.2	22.8	9.7	11.3	14.0	191.2	21.4	65.7	22.0	11.8	7.8	9.7	0.0	16.7	0.0	180.4	14.3	8.9	0.0	6.5	11.6	8.1	12.3	4.5	16.3	3.1	6.0	9.8	6.7	4.9	6.9	25.4	0.7	2.2	6.6	8.7	10.4	16.1	24.2	13.0	0.0	15.2	6.6	27.1	11.8	4.4
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 692.7;pituitary gland: 285.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 115.8;Distal tubular cells: 258.2;Excitatory neurons: 147.1;Horizontal cells: 146.4;Inhibitory neurons: 118.4;Spermatogonia: 88.4"	"Cancer enhanced"	"Detected in all"		"glioma: 129.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1142.2;SCLC-21H: 1160.6;U-251 MG: 1162.6;U-266/84: 1138.4;U-87 MG: 1209.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	30.1	104.4	211.4	19.2	188.8	0.6	13.6	83.4	342.7	18.9	0.0	49.0	9.0	13.2	3.3	3.3	9.7	12.3	26.9	229.7	692.7	62.7	1.6	8.2	12.9	255.7	205.2	35.6	11.6	0.6	285.4	2.5	446.7	12.3	6.9	38.3	3.7	5.8	27.5	4.7	18.9	9.2	122.2	2.7	14.5	16.5	150.3	4.1	9.8	7.7	7.3	31.7	29.1	231.2	3.3	712.8	146.8	0.4	18.9	19.7	0.4	681.4	352.8	236.0	243.4	149.0	0.9	0.0	1142.2	384.4	356.7	1.1	262.8	0.6	116.4	1.5	97.0	0.0	6.9	0.2	529.3	0.1	1.2	127.4	3.0	197.9	0.0	413.7	2.0	0.0	0.0	2.3	122.6	0.6	1.0	12.3	435.3	0.0	714.1	0.1	297.2	0.7	386.3	0.3	1160.6	765.7	5.1	2.8	1.8	165.4	0.8	5.0	3.3	16.8	5.2	0.4	1162.6	583.1	1138.4	3.1	1209.3	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	211.4	188.8	83.4	342.7	229.7	692.7	255.7	205.2	446.7	122.2	150.3	231.2	0.8	0.0	3.1	29.0	2.1	1.7	1.1	1.5	1.2	25.6	0.3	0.6	3.1	0.0	3.5	115.8	8.4	3.6	0.0	0.1	258.2	4.3	3.5	0.9	9.8	3.9	4.2	0.8	147.1	0.8	0.8	35.4	1.1	0.5	2.5	46.3	8.9	0.6	4.7	146.4	118.4	0.0	4.1	0.6	3.4	6.0	37.0	2.3	3.6	35.6	0.6	21.6	0.0	55.8	54.6	3.0	0.0	17.3	9.2	3.7	0.0	17.1	7.4	61.3	0.0	3.6	35.7	10.4	88.4	0.3	1.6	1.5	1.3	20.0	0.2	1.0
UCHL3		ENSG00000118939	"Ubiquitin C-terminal hydrolase L3"	P15374	13	75549480-75606020	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019678, CAB037139, CAB037208"	Approved		Supported	Nucleoplasm,Cytosol		No	No		700000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583"	"unprognostic (4.16e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-2)"	"unprognostic (6.46e-3)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.26e-2)"	20.7	56.9	20.6	20.2	24.2	33.5	34.2	20.3	25.2	15.3	17.2	35.4	21.6	12.4	63.2	58.0	13.0	17.7	29.3	21.7	20.5	32.2	50.9	15.0	21.3	18.6	18.9	7.4	30.9	23.9	22.9	24.6	18.5	19.5	39.5	9.7	27.2	18.2	53.9	48.6	19.9	25.1	18.9	15.9	25.1	43.3	20.5	25.7	44.4	40.6	34.6	44.3	26.6	21.0	196.0	31.9	26.9	18.8	49.9	58.6	78.6	72.3	70.3	90.7	100.5	177.5	92.1	100.4	50.2	75.7	70.2	105.8	64.1	175.3	137.1	53.8	55.9	62.2	50.7	114.9	71.6	150.4	45.7	52.6	118.7	71.7	114.2	38.4	90.1	79.6	70.0	27.9	138.9	70.2	62.4	100.2	40.3	229.0	95.1	49.5	42.9	66.3	108.4	77.9	81.0	23.8	40.8	78.3	34.5	58.2	45.7	42.0	70.8	39.6	47.9	42.7	98.2	39.5	45.5	117.1	80.4	161.3	29.0	57.6	68.7	49.3	29.9	134.4	39.6	51.5	54.1	43.0	99.5	51.5	53.0	49.5	15.6	62.7	117.9	134.9	71.8	50.1	20.6	24.2	20.3	25.2	21.7	20.5	18.6	18.9	18.5	18.9	20.5	21.0	18.2	9.6	23.4	9.1	20.3	76.3	80.4	197.5	35.9	9.3	48.8	66.2	27.2	28.6	88.2	46.0	2.1	105.2	32.9	39.0	92.0	146.2	198.2	35.4	17.4	26.6	24.0	24.4	22.5	143.1	163.6	25.1	23.9	36.2	24.1	19.3	13.9	45.7	88.0	16.8	22.3	54.6	81.4	28.8	28.8	43.5	16.8	32.8	26.6	18.7	33.3	17.3	22.6	22.6	24.9	153.1	44.3	11.7	33.3	133.1	40.4	119.6	48.0	8.9	19.7	24.5	73.5	159.3	36.8	64.8	79.1	169.0	22.1	47.6	60.8	96.2
UCHL5	"CGI-70, INO80R, UCH37"	ENSG00000116750	"Ubiquitin C-terminal hydrolase L5"	Q9Y5K5	1	193012250-193060080	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005908, HPA006069"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		18000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA005908: AB_1858585, HPA006069: "	"unprognostic (3.66e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.44e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (4.33e-2)"	19.9	19.0	11.0	22.5	12.1	24.6	22.7	20.3	15.8	13.6	5.5	23.3	24.7	14.8	17.5	32.2	11.3	15.5	30.5	13.3	12.3	27.2	37.9	15.9	29.1	11.8	11.5	16.4	33.1	20.3	9.7	23.1	12.8	21.4	24.0	37.7	26.0	16.0	39.7	21.3	24.2	18.1	12.9	18.0	17.8	13.4	10.7	24.8	19.2	36.8	32.6	19.1	14.3	14.1	136.6	74.0	61.7	65.5	37.1	37.8	76.4	80.1	40.4	74.8	65.8	71.4	94.9	104.7	72.5	44.4	43.2	85.5	84.1	99.5	100.9	110.0	61.9	126.0	97.5	97.3	57.6	198.5	67.8	33.9	44.5	106.1	91.2	33.6	76.4	100.3	285.1	86.2	67.3	105.9	146.2	70.1	57.7	89.1	46.9	84.5	68.3	216.4	70.8	81.0	61.2	76.7	72.7	97.3	110.4	64.9	82.2	95.8	49.9	71.9	21.4	70.0	125.0	62.8	105.2	117.5	40.2	119.5	123.6	60.9	31.7	41.6	53.3	40.1	59.5	43.8	48.0	51.2	39.0	37.4	51.0	57.1	19.5	75.2	45.0	41.3	51.3	44.8	11.0	12.1	20.3	15.8	13.3	12.3	11.8	11.5	12.8	12.9	10.7	14.1	33.9	9.6	30.2	12.7	28.6	24.3	13.5	27.9	18.8	20.6	19.4	16.6	79.5	21.5	28.5	27.6	43.8	35.8	45.7	18.9	45.0	26.3	2.8	13.0	15.4	21.4	10.8	39.7	35.4	28.3	34.5	22.8	20.9	16.0	56.3	21.4	17.9	24.6	28.0	25.2	33.2	20.2	16.2	18.8	20.7	3.8	14.9	25.0	17.8	19.7	23.4	27.4	75.2	18.1	29.6	25.3	10.6	17.3	58.5	21.8	30.2	39.9	21.1	43.5	19.7	19.6	34.9	22.1	16.8	32.7	30.0	25.2	34.5	31.9	23.2	12.4
UCK1	"FLJ12255, URK1"	ENSG00000130717	"Uridine-cytidine kinase 1"	Q9HA47	9	131523801-131531264	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050969, HPA070526"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA050969: AB_2681294, HPA070526: "	"unprognostic (2.20e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	21.5	25.3	40.3	10.2	41.2	16.4	20.4	40.5	45.2	21.2	37.0	26.0	11.8	20.2	18.7	21.2	19.9	12.2	28.1	38.1	39.2	29.3	52.7	17.2	15.1	41.6	41.4	22.2	29.8	22.6	24.2	14.3	40.0	26.9	9.3	13.5	25.6	17.3	43.9	19.1	18.0	11.2	40.7	20.9	24.9	20.4	42.1	17.5	23.4	26.8	11.5	20.9	17.2	40.9	13.9	30.0	33.9	43.8	23.6	16.7	28.9	22.0	32.1	37.0	28.0	30.1	12.4	15.0	12.9	26.4	28.9	26.3	31.9	28.0	15.8	27.7	29.8	14.0	46.3	19.2	33.6	23.2	19.9	18.8	25.8	29.9	21.6	22.4	23.0	36.3	17.9	11.2	27.6	55.2	31.9	11.8	40.4	27.0	29.6	30.1	52.5	25.1	24.1	13.0	45.7	28.9	31.8	23.9	34.3	15.4	46.6	13.5	17.1	40.9	20.7	25.7	21.7	22.7	31.3	19.4	20.3	16.0	29.1	2.1	5.5	9.0	7.3	7.2	9.8	7.4	8.5	6.4	5.2	8.0	11.3	5.6	3.6	7.0	2.6	5.9	12.0	5.6	40.3	41.2	40.5	45.2	38.1	39.2	41.6	41.4	40.0	40.7	42.1	40.9	13.6	16.0	5.0	7.8	12.4	14.3	10.3	9.9	12.5	18.0	16.2	20.1	14.0	4.3	6.2	14.7	8.4	33.8	12.0	20.4	29.4	22.7	21.9	9.0	10.2	14.3	12.1	3.0	4.7	26.2	17.5	15.7	6.6	9.2	2.5	16.2	13.2	20.5	26.4	26.9	6.1	11.6	16.2	10.0	13.4	33.3	17.7	14.0	16.0	4.7	20.4	22.0	9.2	2.0	6.0	18.6	12.3	19.9	8.0	14.3	21.1	31.6	3.1	13.1	19.7	12.4	17.2	32.8	33.4	11.8	12.5	25.7	10.0	14.9	14.8	8.5
UCK2	UMPK	ENSG00000143179	"Uridine-cytidine kinase 2"	Q9BZX2	1	165827614-165911618	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057128			Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA057128: AB_2683346"	"unprognostic (5.37e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-3)"	"prognostic unfavorable (9.22e-8)"	"prognostic unfavorable (4.98e-4)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.12e-13)"	"unprognostic (2.49e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.83e-1)"	12.8	6.0	5.9	9.2	6.0	11.8	15.3	8.9	7.7	8.3	2.5	14.5	13.9	8.0	15.2	17.4	7.5	5.0	9.2	7.2	7.1	7.0	10.6	9.9	8.5	8.0	8.9	5.5	16.0	4.8	7.4	28.0	9.9	6.8	14.1	3.7	13.1	8.4	17.0	13.9	13.2	8.5	5.7	5.9	11.2	6.0	6.2	17.7	5.2	10.8	10.6	14.2	9.9	6.0	66.1	67.7	36.6	34.4	20.2	32.9	49.3	63.4	59.7	86.7	92.2	70.6	75.3	32.3	43.5	57.6	35.2	46.3	88.6	106.2	72.3	51.3	40.8	40.2	52.3	81.8	56.2	72.1	29.2	35.0	52.1	176.6	111.7	21.5	60.8	73.6	95.3	43.0	78.1	54.1	63.6	49.4	103.4	104.7	54.5	27.8	37.6	112.5	43.5	37.6	51.5	58.3	47.2	104.4	48.8	83.3	62.5	65.9	32.9	41.4	52.1	50.3	71.9	49.8	84.9	116.0	36.7	50.1	33.3	0.8	5.9	0.1	1.5	3.7	3.6	3.3	1.6	2.5	15.1	4.4	0.1	1.4	0.1	3.8	4.2	13.9	2.2	1.9	5.9	6.0	8.9	7.7	7.2	7.1	8.0	8.9	9.9	5.7	6.2	6.0	10.2	0.0	1.1	10.7	6.6	22.9	29.6	18.3	19.9	4.2	22.4	26.2	5.7	8.6	8.8	9.2	0.0	4.4	12.9	41.5	7.9	14.7	110.4	8.7	12.1	22.3	6.7	10.7	32.8	22.2	60.1	12.4	17.3	11.4	0.0	15.4	5.0	5.8	13.0	0.0	33.1	16.1	14.2	4.1	10.2	56.2	6.5	7.9	10.6	30.0	13.5	4.5	9.2	19.6	23.3	54.8	16.1	3.4	25.8	33.0	31.4	6.7	4.5	4.6	0.0	23.0	15.3	5.6	12.0	26.9	29.7	26.4	4.1	5.4	20.4	22.3
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000277-74009085	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	80	"skeletal muscle: 393.2;tongue: 263.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Late spermatids: 14.0;NK-cells: 6.2;Skeletal myocytes: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 15.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	1.2	1.7	2.5	1.3	2.6	2.2	1.3	3.9	3.0	1.4	2.3	1.7	0.7	1.4	2.0	2.9	1.5	0.8	2.4	2.7	2.1	1.7	1.3	1.4	1.3	2.4	2.1	1.1	1.1	0.9	2.7	0.5	2.3	1.8	0.7	4.0	3.7	0.7	393.2	1.4	1.7	0.8	1.8	3.1	1.2	3.9	2.4	1.6	2.6	263.1	0.7	1.4	0.9	2.8	0.2	1.8	1.7	1.5	0.7	0.3	0.3	0.5	0.4	0.4	0.2	0.4	0.4	0.9	0.2	0.3	0.2	1.9	0.7	0.3	0.7	15.8	0.5	0.3	2.4	0.2	0.5	1.1	1.4	0.4	1.1	1.1	0.1	0.3	0.5	0.9	0.4	1.2	0.6	1.0	0.7	1.4	0.9	1.4	1.1	1.4	3.6	0.5	0.9	0.5	0.9	1.0	0.4	0.7	0.6	0.3	0.2	1.0	0.3	0.2	1.1	0.6	1.1	1.4	1.5	0.7	0.2	1.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.5	2.6	3.9	3.0	2.7	2.1	2.4	2.1	2.3	1.8	2.4	2.8	0.8	0.0	0.0	1.6	0.8	0.1	0.1	0.5	0.6	2.3	1.0	1.1	0.7	0.0	1.1	0.0	0.0	0.3	2.0	0.3	0.0	0.3	15.4	1.2	1.1	0.6	0.0	0.4	1.6	0.5	0.2	0.4	0.0	0.8	0.0	0.7	1.1	0.3	0.7	0.0	1.6	0.5	2.0	0.8	0.0	14.0	0.0	0.6	0.0	1.0	0.7	0.8	6.2	0.5	0.6	0.4	0.1	0.7	0.5	0.2	0.3	0.1	3.0	2.1	0.0	6.5	0.5	1.5	0.8	0.4	0.3	0.3	1.5	0.3	0.6	0.1
UEVLD	"Attp, UEV3"	ENSG00000151116	"UEV and lactate/malate dehyrogenase domains"	Q8IX04	11	18529609-18588747	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047134	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA047134: AB_10960698"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (5.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	10.1	8.4	5.3	8.8	7.9	4.5	11.8	6.5	6.7	11.5	6.3	13.4	11.1	8.8	8.7	10.7	8.8	9.4	9.2	5.7	6.4	12.3	9.0	9.0	7.0	8.1	7.1	8.0	7.2	9.9	4.2	9.4	8.5	10.4	14.1	9.7	7.5	9.5	11.0	14.8	10.0	11.0	6.6	6.9	9.8	5.3	7.0	7.6	10.9	10.5	8.6	10.2	6.9	11.1	16.2	19.6	8.9	8.6	28.2	25.1	8.3	17.5	24.3	22.7	21.6	8.1	4.6	5.0	9.4	20.7	19.8	24.8	8.2	18.1	25.8	14.6	10.7	7.5	8.8	9.1	12.7	11.5	10.4	17.4	18.3	11.2	15.5	15.9	21.2	0.4	5.7	4.7	29.3	12.3	0.3	3.7	2.4	24.9	19.8	1.8	20.7	6.2	26.9	25.4	3.7	7.9	19.1	23.8	15.1	11.0	19.1	6.8	16.2	20.7	11.1	34.0	17.2	0.9	11.3	1.1	17.7	8.7	21.3	4.6	4.9	3.1	4.2	5.1	4.0	2.6	3.1	3.5	3.4	2.7	1.8	2.6	6.5	5.2	4.2	4.2	2.3	2.4	5.3	7.9	6.5	6.7	5.7	6.4	8.1	7.1	8.5	6.6	7.0	11.1	10.3	16.0	19.3	18.9	4.5	6.2	6.3	9.9	8.6	9.3	11.2	6.3	10.1	5.7	12.4	23.9	10.4	8.4	9.4	27.3	3.9	10.8	3.3	13.6	12.4	11.6	9.1	4.8	14.7	13.3	7.4	8.7	10.7	12.9	6.3	11.6	13.6	13.5	12.5	15.2	14.4	15.4	18.3	18.6	10.3	2.0	8.1	11.0	7.2	20.6	11.9	13.3	11.3	25.1	34.3	14.5	10.3	18.4	3.4	8.3	12.8	12.8	23.9	11.1	13.1	10.2	8.7	7.1	7.2	10.1	9.2	7.7	6.6	11.7	15.7	7.6
UFD1	UFD1L	ENSG00000070010	"Ubiquitin recognition factor in ER associated degradation 1"	Q92890	22	19449911-19479202	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 121.1;Ductal cells: 115.7;Exocrine glandular cells: 142.2;Extravillous trophoblasts: 107.3;Pancreatic endocrine cells: 149.9;Syncytiotrophoblasts: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 782.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030286, HPA030287"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA030286: , HPA030287: AB_10601830"	"unprognostic (2.52e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.50e-8)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	43.8	39.8	23.6	36.8	26.3	64.8	37.8	27.6	29.8	33.9	25.7	42.5	32.1	46.8	54.4	48.4	31.4	29.3	44.8	24.6	28.6	36.7	51.9	37.2	43.4	28.9	26.7	31.8	39.3	44.7	31.7	35.3	29.5	32.1	38.4	21.7	38.1	30.1	98.3	42.5	35.7	39.5	27.2	38.6	40.8	53.3	27.1	61.6	34.9	42.5	47.5	40.2	37.0	29.7	187.5	132.4	110.6	168.5	89.0	62.0	86.0	150.2	148.8	202.9	187.1	147.8	78.8	129.2	114.1	126.7	93.3	157.5	131.5	132.1	175.1	239.8	138.0	136.5	88.3	119.4	84.4	218.6	177.7	57.4	133.0	173.2	84.4	59.1	164.7	67.9	782.0	240.5	125.1	268.5	142.0	133.4	79.8	232.2	111.9	170.1	262.0	50.1	126.6	172.5	90.5	102.2	118.2	126.0	123.3	114.2	75.9	103.5	180.9	169.6	230.8	143.2	164.1	102.9	221.7	168.8	142.5	110.3	158.6	150.9	90.6	158.1	107.0	140.3	103.7	87.7	122.5	112.4	81.0	82.6	104.6	102.9	167.1	105.7	140.7	113.1	224.5	129.5	23.6	26.3	27.6	29.8	24.6	28.6	28.9	26.7	29.5	27.2	27.1	29.7	68.3	25.6	34.5	0.0	16.4	0.0	0.0	0.0	0.0	0.0	39.7	55.2	0.0	0.0	16.7	27.6	0.0	121.1	44.9	0.0	84.1	115.7	0.0	43.1	36.9	32.6	0.0	0.0	0.0	142.2	107.3	25.4	0.0	44.9	27.8	36.0	0.0	0.0	88.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	149.9	0.0	0.0	7.5	0.0	0.0	81.0	27.7	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	170.3	26.3	61.5	0.0	0.0
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399537-185425979	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	21.2	24.9	19.9	9.5	21.7	5.7	24.3	25.2	24.1	21.6	29.6	19.5	13.0	19.9	28.1	25.8	17.7	15.6	32.1	20.4	21.9	37.3	24.1	17.1	11.9	20.4	20.2	31.4	19.7	23.8	10.0	14.0	20.9	19.8	15.3	56.4	20.3	19.2	48.5	21.6	12.0	20.2	20.7	14.5	17.5	21.0	21.3	14.3	25.9	40.6	16.1	16.2	10.1	25.3	17.5	11.9	28.8	24.3	25.8	25.6	15.3	20.3	20.5	19.3	19.3	18.4	23.2	17.9	9.0	19.7	14.7	16.1	20.4	32.2	17.4	21.8	12.4	11.8	13.0	23.3	30.2	15.3	12.3	14.7	26.8	16.5	16.7	26.7	35.7	21.9	24.8	34.3	28.2	16.3	22.0	16.4	8.7	11.8	16.7	20.2	11.5	20.4	31.9	11.4	18.6	14.8	11.3	25.6	23.1	17.6	15.4	13.6	27.3	9.5	16.8	7.5	17.2	34.6	14.8	9.5	30.5	11.0	25.3	10.8	12.3	7.6	21.2	10.4	25.7	22.0	21.7	24.1	14.1	15.4	23.2	22.9	0.7	21.5	11.1	19.9	20.6	12.5	19.9	21.7	25.2	24.1	20.4	21.9	20.4	20.2	20.9	20.7	21.3	25.3	33.8	6.4	23.9	14.7	30.1	22.0	28.7	35.1	33.0	47.6	20.9	25.5	27.0	15.7	31.1	20.2	66.7	26.0	23.4	8.3	111.6	28.3	190.5	16.4	28.9	24.1	19.3	24.0	12.2	33.1	29.7	34.2	20.4	19.2	29.7	21.9	21.8	17.3	27.2	18.5	17.8	18.6	28.5	22.1	18.8	52.9	35.4	18.5	35.6	12.2	17.3	71.8	21.6	23.6	33.2	19.7	14.6	42.2	53.0	15.4	22.2	100.9	23.7	87.9	65.7	31.8	38.9	89.3	56.7	22.6	18.9	41.9	27.1	35.6	14.8	19.6
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.7"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 345.5;Hepatocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 509.6;Hep G2: 595.9;U-2197: 375.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		1300000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	48.5	27.8	6.2	29.5	7.3	2.4	32.0	9.4	9.2	31.5	18.1	96.5	45.3	29.1	10.6	34.1	29.6	40.5	16.0	5.9	8.3	37.5	137.7	19.0	13.3	7.4	7.7	30.0	33.7	23.1	7.8	38.4	8.0	35.6	73.3	14.3	16.8	14.0	6.7	9.9	41.1	23.5	7.6	11.5	47.4	6.8	8.4	10.3	27.8	9.5	14.5	54.4	17.1	9.7	36.0	509.6	58.4	76.2	181.5	185.3	51.3	102.7	113.8	94.5	84.8	76.2	115.5	25.4	63.0	133.3	94.5	33.5	56.0	29.5	95.8	32.1	13.0	26.2	65.4	595.9	72.7	34.1	25.3	64.4	14.9	160.2	49.8	78.9	59.3	20.9	34.1	17.3	67.9	89.8	29.4	34.4	53.1	194.0	46.4	48.3	95.0	22.0	53.7	120.0	31.2	46.7	69.2	37.9	45.3	41.4	21.0	27.0	85.9	97.9	49.1	375.8	54.2	42.1	33.3	23.3	86.9	25.8	56.6	30.0	20.9	19.7	23.2	18.4	37.8	18.8	18.8	24.9	19.0	18.4	16.1	19.4	3.8	42.3	11.2	22.5	13.5	18.8	6.2	7.3	9.4	9.2	5.9	8.3	7.4	7.7	8.0	7.6	8.4	9.7	19.1	25.6	27.6	4.6	14.1	116.1	73.4	19.5	43.9	7.5	115.8	62.0	8.9	24.3	25.4	20.2	14.6	21.3	12.9	207.8	70.5	54.7	1.1	78.3	53.8	25.4	113.3	9.1	10.6	345.5	78.8	145.7	184.0	64.8	35.5	11.1	20.7	231.3	17.8	10.1	12.6	114.5	12.2	20.2	33.3	1.6	33.2	12.7	30.2	7.5	19.9	7.3	9.2	46.3	12.8	195.8	112.2	29.0	21.3	127.3	81.4	79.6	65.7	9.2	32.9	39.0	57.5	6.5	5.5	102.2	40.1	29.0	11.7	12.4	152.4	86.4
UGP2	"SVUGP2, UGP1, UGPP1"	ENSG00000169764	"UDP-glucose pyrophosphorylase 2"	Q16851	2	63840952-63891562	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 858.6;tongue: 756.1"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 849.9;Hepatocytes: 559.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 417.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034696, HPA034697, HPA064836"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA		13000000	"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Centrosome, Mitochondria"	Nucleoplasm	"HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365"	"unprognostic (1.00e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.44e-2)"	267.3	72.0	79.8	65.8	89.3	40.1	119.7	72.7	109.8	65.9	78.8	177.9	66.0	75.2	50.6	97.5	68.9	60.7	232.5	87.9	81.4	105.4	858.6	65.4	65.7	77.7	77.0	47.0	74.4	113.3	49.8	137.8	77.6	57.4	159.3	36.8	92.9	66.2	498.0	59.1	67.6	78.5	73.2	50.8	69.5	38.3	83.3	106.2	64.5	756.1	73.7	88.4	63.7	91.8	122.3	77.6	63.1	42.0	176.1	222.4	220.6	129.1	116.1	82.7	89.4	170.0	104.5	149.5	48.3	165.6	79.9	57.4	73.4	102.6	137.0	99.2	35.7	86.5	50.4	117.9	87.0	79.1	73.9	148.1	175.8	76.1	80.3	108.4	119.4	38.9	48.2	58.1	327.8	56.7	104.6	75.2	122.9	207.7	50.1	80.4	117.9	84.5	147.4	77.7	36.5	29.6	103.3	149.8	64.3	162.6	51.7	59.2	144.3	84.4	125.9	113.8	90.5	101.3	51.4	174.9	99.2	122.7	225.7	417.1	33.0	53.1	48.0	40.7	51.8	33.0	53.6	50.1	27.9	31.8	57.6	53.6	45.4	70.0	39.5	29.7	127.2	62.0	79.8	89.3	72.7	109.8	87.9	81.4	77.7	77.0	77.6	73.2	83.3	91.8	73.4	28.9	54.0	107.4	65.3	75.8	87.8	245.9	34.7	49.6	360.6	87.1	264.3	104.4	171.6	47.8	64.6	414.3	81.1	849.9	242.6	140.6	91.5	53.0	106.3	69.8	44.5	56.0	86.1	103.6	445.5	159.3	79.0	49.5	67.8	42.4	63.5	559.4	120.9	87.5	78.4	179.8	144.5	102.4	90.2	86.1	79.2	89.1	96.0	62.8	139.7	58.8	154.5	37.2	79.3	91.6	313.9	77.5	60.7	81.2	176.2	284.4	139.3	57.3	72.3	50.5	129.2	84.9	54.9	50.9	57.8	472.8	143.1	90.6	189.5	109.1
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035021-36071358	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 14.7;skin 1: 10.3"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0"	"Low region specificity"	"Detected in many"							HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.0	0.8	0.0	0.0	0.0	6.5	1.1	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	2.6	0.6	0.0	0.0	1.0	1.1	0.0	0.0	0.1	0.9	0.2	1.2	0.4	0.0	0.1	0.1	0.0	0.1	10.3	0.0	0.0	0.1	1.2	0.1	2.9	0.6	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.3	0.4	0.0	1.3	0.0	0.5	6.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.4	0.0	5.3	0.0	0.0	29.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.2	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.0	1.1	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	1.1	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529631	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077624			Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA077624: "	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	26.8	23.3	21.2	23.3	24.6	40.3	19.3	18.1	21.2	15.1	16.6	19.2	19.1	11.7	14.1	13.3	14.4	13.7	11.6	26.0	28.3	31.2	38.1	17.5	30.8	24.9	28.5	11.9	11.0	27.8	7.8	17.1	28.3	16.2	19.6	10.5	13.5	18.5	25.8	11.9	23.4	10.8	19.8	25.4	20.0	12.2	26.1	24.6	19.4	25.9	28.9	18.1	10.5	19.4	61.9	28.4	14.6	35.8	40.7	31.9	32.7	79.7	43.2	63.9	45.7	18.6	37.8	50.2	67.8	60.0	31.2	34.9	28.2	44.1	102.4	69.1	20.4	49.8	34.3	16.9	31.3	73.4	55.5	33.0	45.8	63.2	59.9	44.6	37.4	34.2	44.1	67.7	111.4	26.0	39.3	19.4	19.4	46.1	37.8	24.9	64.9	41.9	42.6	62.8	26.4	24.3	70.5	64.6	52.2	19.9	56.0	81.0	58.5	72.7	41.0	50.8	112.6	69.2	103.5	58.0	60.5	35.3	67.3	3.6	2.0	2.4	4.8	5.3	4.9	3.2	3.5	4.0	2.3	3.6	3.5	4.0	1.3	3.7	6.1	2.6	3.1	2.6	21.2	24.6	18.1	21.2	26.0	28.3	24.9	28.5	28.3	19.8	26.1	19.4	37.6	19.2	41.2	20.9	75.6	29.4	33.7	38.5	34.7	24.4	39.4	20.2	35.1	40.0	53.8	53.3	12.5	26.2	81.0	53.9	56.7	27.6	55.6	35.1	35.7	33.4	33.5	51.6	37.0	23.2	38.1	25.5	43.3	44.4	45.7	23.3	31.1	85.1	30.0	23.5	27.4	34.1	48.8	73.5	47.5	58.4	21.5	60.0	28.4	33.7	58.0	14.6	74.2	20.6	29.5	40.4	33.0	19.5	47.2	59.9	60.8	62.2	50.9	23.0	0.0	29.2	27.8	25.1	29.6	45.2	24.6	22.4	69.4	31.4	39.3	58.3
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 27.0;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 49.7;Plasma cells: 21.0;Squamous epithelial cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.8;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 450.9;REH: 1004.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	1.0	0.9	2.1	9.6	2.7	27.0	1.7	2.1	2.3	1.6	1.8	2.9	3.7	1.0	0.1	6.5	0.4	0.8	0.5	2.0	2.2	0.6	0.9	1.3	15.8	2.8	2.8	0.3	0.6	0.2	0.2	2.1	2.7	0.6	2.6	0.4	1.5	0.2	1.2	3.4	3.9	1.9	1.9	3.7	3.3	5.2	3.5	67.2	0.3	0.3	10.3	1.6	2.5	4.6	111.3	78.7	116.6	83.4	3.3	13.3	18.5	88.3	42.0	89.9	86.8	94.6	54.9	62.7	21.1	39.4	32.7	54.1	81.2	47.7	63.0	102.7	92.2	54.3	74.3	102.4	1.3	135.1	78.9	6.5	3.5	48.9	12.6	14.1	27.2	97.2	79.3	70.5	54.5	86.7	450.9	82.5	52.5	40.0	84.3	1004.5	259.7	45.4	24.9	80.1	86.0	68.5	69.2	37.7	12.1	18.8	68.2	127.6	34.2	94.6	76.7	124.3	108.3	29.8	33.1	183.5	54.8	129.7	123.3	0.3	0.2	0.1	0.6	0.0	0.0	0.2	0.8	1.0	1.3	0.1	0.2	0.8	0.8	0.5	0.2	4.8	2.3	0.6	2.1	2.7	2.1	2.3	2.0	2.2	2.8	2.8	2.7	1.9	3.5	4.6	0.2	0.0	0.0	1.6	2.1	0.0	0.8	0.0	3.4	2.5	4.4	2.8	4.3	1.5	0.6	0.0	0.0	6.6	6.9	2.6	0.0	2.2	2.9	1.3	1.8	2.2	0.0	49.7	0.4	0.4	7.8	4.7	8.6	2.4	0.0	10.4	0.4	0.7	8.9	3.3	0.4	2.3	0.0	1.9	0.0	1.8	0.6	3.8	0.0	0.0	2.0	0.6	1.0	3.0	1.3	4.2	1.9	0.4	21.0	0.6	1.4	0.2	0.7	0.7	0.0	1.2	6.1	6.1	11.9	15.8	0.0	1.4	3.7	1.5	8.3	1.3
UHRF1BP1	"C6orf107, dJ349A12.1, FLJ20302, ICBP90"	ENSG00000065060	"UHRF1 binding protein 1"	Q6BDS2	6	34792015-34883138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032099, HPA032100"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA032099: AB_10696057, HPA032100: AB_10671087"	"unprognostic (2.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.58e-2)"	"unprognostic (4.39e-3)"	"unprognostic (9.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.24e-2)"	4.3	4.4	2.8	4.3	2.8	14.2	3.6	7.1	3.2	2.7	4.6	3.1	3.2	3.3	2.4	3.2	2.8	2.5	6.8	2.4	3.4	3.7	3.9	4.2	4.9	3.5	3.7	3.3	8.0	8.5	3.0	5.3	3.9	3.6	3.9	7.5	5.9	2.9	14.3	3.1	3.6	3.9	3.5	4.4	4.0	12.0	3.5	5.8	6.0	7.5	4.2	3.5	2.4	3.8	12.9	9.1	7.9	25.9	4.1	3.0	14.3	7.4	5.0	7.1	10.0	18.2	3.4	19.4	7.9	7.7	12.3	9.6	29.2	4.2	9.6	10.0	9.4	17.2	8.7	15.2	16.7	15.7	10.3	6.8	12.0	5.7	12.0	6.6	9.1	16.6	29.3	7.5	3.1	12.3	12.2	10.2	3.6	9.3	6.3	7.3	12.7	11.8	9.6	11.8	9.5	9.7	18.7	9.7	24.7	8.1	18.5	20.3	5.6	3.5	12.7	5.5	8.2	11.1	18.6	12.0	1.9	21.5	8.8	0.1	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1	0.4	1.3	0.1	0.1	0.2	2.8	2.8	7.1	3.2	2.4	3.4	3.5	3.7	3.9	3.5	3.5	3.8	5.1	16.0	6.3	16.0	5.0	1.0	3.0	3.9	5.7	10.1	5.2	2.9	16.8	4.3	9.1	0.0	20.9	6.9	3.7	3.0	1.9	5.4	10.0	5.8	4.9	6.3	9.5	6.7	20.8	5.8	3.8	4.9	10.2	11.5	1.3	14.3	15.0	6.0	15.6	5.0	39.3	4.9	10.2	19.0	6.0	18.2	5.6	11.9	0.0	22.5	9.4	4.6	4.1	25.6	14.1	7.2	3.3	2.6	11.4	9.9	4.1	3.9	5.1	10.8	13.1	7.5	5.4	16.4	10.8	8.3	2.8	4.9	3.9	4.0	3.8	8.5
UHRF1BP1L	KIAA0701	ENSG00000111647	"UHRF1 binding protein 1 like"	A0JNW5	12	100028455-100142874	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039671, HPA075150"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Cytosol"	"HPA039671: AB_10794201, HPA075150: "	"unprognostic (4.80e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.94e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-2)"	8.7	10.9	6.2	10.2	7.7	32.9	8.8	11.0	11.5	7.2	9.9	8.3	8.4	7.5	7.0	7.0	6.3	8.9	7.9	13.2	6.2	12.3	24.6	7.7	9.2	4.9	5.4	7.5	3.8	13.6	5.2	9.0	4.8	9.0	7.9	14.6	6.4	8.0	19.8	5.9	7.1	8.8	4.6	9.2	6.0	14.0	3.7	8.4	10.9	14.6	7.0	10.1	5.2	9.2	18.6	19.7	10.8	11.2	16.4	23.1	21.6	28.3	28.4	22.4	16.3	14.8	6.2	16.0	7.2	29.1	13.1	6.9	20.4	9.7	21.5	42.7	10.0	10.7	14.1	17.3	15.1	20.4	16.8	13.1	8.0	27.0	18.6	20.7	16.0	11.0	8.6	16.2	22.1	10.3	13.1	17.5	18.7	6.3	17.7	14.7	19.2	15.7	11.4	32.2	18.3	11.4	21.4	24.5	8.5	9.2	21.9	23.0	12.7	24.6	13.2	21.5	20.1	19.1	35.2	22.3	12.4	15.1	15.2	21.6	11.4	7.8	3.6	12.3	5.3	5.5	4.0	4.1	12.8	4.5	3.4	4.2	33.9	5.9	10.9	7.6	5.2	5.4	6.2	7.7	11.0	11.5	13.2	6.2	4.9	5.4	4.8	4.6	3.7	9.2	10.6	28.9	8.7	27.1	18.2	12.7	17.2	5.0	19.9	11.9	9.3	7.5	15.7	1.5	12.6	9.2	4.2	4.7	15.0	10.9	5.9	6.0	35.1	15.7	23.7	8.6	5.4	9.4	75.2	5.9	8.9	24.7	7.7	9.9	24.1	6.3	5.3	18.5	11.2	15.2	54.2	2.1	4.1	23.3	21.4	5.3	7.2	29.5	10.6	45.0	25.7	8.3	8.2	37.2	29.5	5.9	7.4	7.9	12.5	18.5	8.9	14.9	21.8	12.0	0.0	23.3	15.1	24.1	19.1	14.9	11.6	10.9	15.7	8.3	5.7	11.9
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA026633: AB_2732431, HPA026697: AB_2732432"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	10.0	8.1	8.2	9.9	10.3	44.6	9.7	14.9	10.4	12.9	10.4	11.6	6.2	12.9	10.0	8.3	9.9	7.9	7.2	8.7	9.2	8.1	7.9	7.8	17.3	9.4	8.6	12.4	10.7	9.7	5.4	12.1	9.4	15.3	9.2	9.2	8.5	12.6	11.0	7.7	8.5	14.0	8.8	10.4	8.3	8.4	10.0	21.2	8.1	11.9	16.6	11.4	10.1	14.3	18.1	18.8	26.7	11.9	21.4	30.7	20.5	43.9	23.4	23.7	41.2	12.4	12.0	26.9	9.2	19.2	21.8	11.9	24.6	22.5	36.0	53.6	14.9	46.3	36.2	19.7	17.8	19.3	16.1	13.5	14.1	18.4	44.5	44.4	93.2	25.4	5.1	24.0	56.0	5.9	37.0	79.2	10.8	24.8	14.8	43.1	12.4	8.7	17.2	11.3	24.8	9.4	16.6	11.0	25.6	32.1	14.0	41.9	78.6	25.2	10.0	11.0	34.4	7.2	23.2	30.4	12.4	18.2	10.2	4.0	0.5	2.7	1.2	0.5	0.8	1.8	1.8	1.0	0.3	2.9	1.0	1.2	0.5	0.6	0.9	1.2	1.9	0.6	8.2	10.3	14.9	10.4	8.7	9.2	9.4	8.6	9.4	8.8	10.0	14.3	27.5	6.4	14.4	24.2	33.9	21.5	10.2	6.2	12.0	22.0	13.8	13.1	59.0	4.3	8.4	12.9	31.3	13.2	31.3	9.1	1.9	5.2	23.6	12.8	22.9	24.1	7.1	34.9	44.2	4.0	9.9	16.0	20.9	24.5	17.7	27.8	12.8	14.6	10.7	28.6	53.3	14.8	4.1	12.6	9.3	8.1	19.3	15.6	21.4	51.5	12.5	6.4	16.5	46.8	78.6	6.2	14.4	14.7	30.1	16.0	10.2	7.3	6.3	34.8	13.1	14.4	18.8	46.2	23.4	16.1	19.0	5.9	29.0	13.7	12.6	9.8
UIMC1	RAP80	ENSG00000087206	"Ubiquitin interaction motif containing 1"	Q96RL1	5	176905005-177022633	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 132.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 64.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 64.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037503, HPA037504"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA037503: AB_10671373, HPA037504: AB_10671760"	"unprognostic (2.96e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.51e-2)"	"unprognostic (5.52e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.44e-1)"	28.2	24.6	15.8	14.0	15.9	60.2	27.2	22.3	19.1	31.1	19.1	32.5	9.5	29.4	11.2	18.8	26.6	10.8	27.1	15.1	15.4	21.9	18.6	26.4	22.8	14.0	14.4	35.8	27.2	9.1	19.6	12.7	14.4	23.0	12.4	15.0	17.1	13.3	32.6	23.8	23.3	18.9	12.6	31.4	22.5	62.3	14.9	27.6	23.5	12.0	22.0	29.2	23.8	17.6	27.6	26.6	26.9	33.1	25.8	22.7	38.3	28.1	31.4	35.5	37.0	30.6	30.7	79.1	33.8	23.3	37.8	21.1	27.9	62.7	41.8	91.4	25.4	35.4	30.9	25.7	28.5	43.8	22.7	15.9	29.0	27.0	74.0	26.9	41.6	47.1	30.9	26.1	26.6	25.7	43.1	29.4	19.6	22.2	16.2	39.5	38.8	46.1	38.0	17.4	29.1	23.2	62.3	20.1	30.4	28.3	17.5	24.2	31.6	20.1	20.3	17.7	37.6	39.1	49.8	50.8	19.6	43.2	22.1	15.8	11.8	33.0	9.0	7.0	9.4	11.8	10.3	8.9	7.4	13.9	10.0	8.3	64.5	14.5	4.5	9.5	14.7	6.5	15.8	15.9	22.3	19.1	15.1	15.4	14.0	14.4	14.4	12.6	14.9	17.6	24.8	12.8	21.0	36.9	31.3	10.5	18.0	11.8	23.3	19.3	10.9	11.8	20.6	8.6	17.3	9.2	14.6	13.9	22.5	7.8	7.9	13.7	27.4	19.4	23.1	17.0	13.1	47.8	59.5	12.9	12.7	17.1	12.2	22.8	18.3	20.6	13.2	8.8	9.9	16.8	53.3	7.9	8.2	14.8	14.1	13.2	15.5	19.8	1.8	44.0	18.0	8.9	19.6	43.7	51.1	17.0	9.1	12.4	24.2	12.9	8.1	8.9	19.2	33.7	13.1	17.7	18.8	132.1	73.8	13.2	11.9	6.8	23.0	35.4	8.7	13.9
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962130	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 352.3;Excitatory neurons: 108.6;Inhibitory neurons: 99.2;Late spermatids: 405.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	2.7	3.1	1.6	2.9	2.1	8.5	2.5	0.4	1.7	8.5	16.9	1.6	1.2	6.6	4.5	1.5	9.0	1.9	8.6	2.3	2.5	3.9	2.1	3.5	3.0	6.9	7.6	2.1	2.0	8.0	2.9	2.7	3.9	2.2	1.7	6.0	1.7	2.4	0.4	2.1	2.0	3.5	5.6	2.0	2.4	23.4	2.5	3.0	4.9	0.4	2.7	1.9	3.7	2.1	8.3	2.9	2.8	3.8	1.1	1.7	4.8	2.7	2.7	3.2	3.0	1.0	2.3	9.5	1.6	6.3	3.5	4.1	3.7	2.1	2.9	1.5	1.0	2.1	5.7	3.3	4.1	6.5	1.8	1.6	2.3	16.1	3.2	4.4	2.2	6.4	2.1	7.5	2.3	6.4	8.1	4.9	3.4	2.1	3.4	1.7	9.1	4.5	7.2	7.6	1.6	10.3	3.1	1.3	2.8	1.8	3.1	2.0	6.6	2.0	2.4	14.2	2.5	4.5	9.0	3.9	11.5	6.3	2.5	3.7	3.7	4.0	5.0	4.3	4.1	3.7	5.3	4.5	3.3	4.7	4.0	5.7	6.6	1.8	2.3	3.3	7.7	3.0	1.6	2.1	0.4	1.7	2.3	2.5	6.9	7.6	3.9	5.6	2.5	2.1	6.4	9.6	6.9	84.9	11.2	2.0	3.0	4.0	5.2	5.6	5.7	4.6	14.8	4.3	5.1	3.7	54.2	3.1	9.9	2.0	0.0	3.4	352.3	45.3	27.4	6.0	1.8	2.1	108.6	2.4	4.1	8.7	10.2	7.5	1.3	49.6	1.8	6.6	7.3	11.8	99.2	1.2	2.0	3.1	4.0	405.2	6.5	6.9	0.0	80.6	5.9	10.4	3.1	49.8	62.0	3.0	0.7	4.1	5.1	0.9	1.1	5.9	47.3	26.7	6.6	4.4	10.5	38.9	9.6	3.3	3.7	4.2	10.8	3.6	1.9	1.2
UMAD1	"RPA3-AS1, RPA3OS"	ENSG00000219545	"UBAP1-MVB12-associated (UMA) domain containing 1"	C9J7I0	7	7640711-7968020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.7;Inhibitory neurons: 114.3;Microglial cells: 79.6;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044806	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044806: AB_10961141"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.08e-3)"	"unprognostic (9.24e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.87e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.73e-8)"	"unprognostic (6.66e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.58e-1)"	9.2	16.5	5.5	11.2	5.8	9.5	10.3	5.6	6.2	10.1	7.0	12.8	15.4	10.3	11.4	8.9	10.2	10.7	13.7	4.9	8.3	17.2	14.3	12.0	15.7	6.9	7.3	13.6	36.1	29.7	10.3	9.2	7.5	18.9	11.6	11.5	20.6	11.7	11.3	7.0	16.6	9.8	6.1	10.3	23.0	5.8	7.0	18.4	24.6	10.5	13.4	12.3	8.4	7.1	24.7	17.9	9.0	10.5	12.7	14.9	10.3	14.9	17.2	11.5	17.4	7.6	17.9	13.4	15.4	9.4	46.3	15.7	10.4	15.0	14.3	10.1	8.1	7.3	12.4	8.9	14.2	13.6	16.3	14.2	18.6	16.6	12.7	13.5	7.1	17.2	15.1	40.0	15.4	19.9	12.4	7.4	16.2	16.5	14.8	13.6	21.3	21.3	20.9	11.1	3.6	14.8	21.0	26.7	21.6	26.5	20.8	16.3	7.8	11.7	27.2	23.3	15.2	28.6	34.2	15.5	26.4	19.2	36.8	51.8	16.0	43.5	19.3	21.5	23.9	28.8	27.2	24.2	13.8	26.0	31.8	23.8	46.1	18.5	24.1	16.3	38.7	17.9	5.5	5.8	5.6	6.2	4.9	8.3	6.9	7.3	7.5	6.1	7.0	7.1	12.1	25.6	11.9	58.8	22.8	0.0	27.7	0.0	12.0	6.5	13.8	12.3	10.9	11.5	9.9	14.7	14.6	16.7	7.7	7.6	39.2	8.4	7.1	9.7	7.6	7.1	6.1	6.7	96.7	14.5	23.6	11.4	33.1	10.6	15.2	3.8	6.4	9.5	16.8	15.2	114.3	13.3	0.0	13.2	0.0	3.7	13.4	12.9	0.0	79.6	8.9	11.4	16.5	80.9	119.3	10.4	9.0	7.9	28.4	19.3	16.8	34.2	9.5	9.8	26.3	12.0	9.6	4.8	5.0	12.6	0.0	21.2	17.0	7.6	7.7	21.2
UNC13B	"hmunc13, Munc13-2, UNC13, Unc13h2"	ENSG00000198722	"Unc-13 homolog B"	O14795	9	35161992-35405338	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Alveolar cells type 2: 80.7;Cone photoreceptor cells: 95.9;Excitatory neurons: 60.4;Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024493, HPA062300"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments"		Yes	No				"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Nucleoplasm, Golgi apparatus, Intermediate filaments"	"HPA024493: AB_1858618, HPA062300: AB_2684742"	"unprognostic (9.73e-3)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (6.56e-2)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (7.64e-2)"	"prognostic favorable (6.59e-5)"	"unprognostic (3.80e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.34e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.80e-2)"	12.6	12.8	10.5	5.6	13.3	1.0	10.3	6.6	14.5	12.5	15.7	22.2	11.6	10.1	7.7	17.5	10.4	11.5	13.6	11.4	7.2	21.8	12.8	38.9	1.8	8.3	9.5	7.3	21.3	15.0	11.5	6.0	7.8	22.6	25.0	41.2	17.8	23.3	24.2	12.3	13.4	11.9	7.3	4.7	17.9	15.6	10.6	3.0	12.2	10.4	5.0	10.2	12.7	9.0	9.8	12.8	13.9	22.6	26.3	14.6	11.8	15.7	7.1	11.4	15.3	10.7	4.5	0.0	7.0	20.6	20.1	4.7	35.4	18.2	14.5	0.0	11.3	5.9	36.6	13.9	12.7	2.2	6.4	11.6	14.0	18.0	18.5	18.2	37.3	15.8	13.5	8.1	13.5	7.5	2.1	0.2	12.6	30.2	13.3	0.1	8.6	3.4	15.5	12.6	14.9	15.7	11.0	6.8	11.4	23.0	11.6	7.5	34.5	7.8	7.2	12.3	12.2	12.7	16.2	0.0	8.5	18.4	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	13.3	6.6	14.5	11.4	7.2	8.3	9.5	7.8	7.3	10.6	9.0	6.7	57.7	80.7	28.7	0.8	3.1	1.1	2.1	3.4	42.3	7.3	4.4	11.4	18.6	16.7	9.2	95.9	3.7	0.1	24.4	3.9	6.0	6.9	8.2	5.1	8.5	24.6	1.7	60.4	12.2	2.1	4.8	16.3	13.9	2.5	8.7	5.7	12.5	4.9	6.7	17.7	31.9	0.0	2.4	3.0	12.3	2.1	3.7	7.2	73.1	0.1	5.7	0.0	42.3	36.7	7.8	11.9	3.0	4.2	11.7	10.5	7.8	10.0	40.8	6.6	8.4	6.5	8.7	7.5	14.3	7.4	2.9	1.0	5.7	19.5	5.7
UNC79	KIAA1409	ENSG00000133958	"Unc-79 homolog, NALCN channel complex subunit"	Q9P2D8	14	93333219-93707876	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;pituitary gland: 11.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 524.0;Inhibitory neurons: 463.6;Oligodendrocyte precursor cells: 270.4;Oligodendrocytes: 202.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 4.3;SCLC-21H: 3.0;SH-SY5Y: 1.9;U-937: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071881			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"HPA071881: AB_2732189"	"unprognostic (8.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.70e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.73e-3)"	"unprognostic (8.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.47e-2)"	0.0	0.7	2.2	0.0	2.8	0.0	0.0	5.1	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.1	1.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.2	11.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	2.5	0.4	0.0	0.1	0.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.3	0.0	0.0	0.1	0.1	3.0	1.9	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	5.1	4.7	2.1	1.9	0.0	0.1	0.0	0.0	0.4	2.3	0.3	0.0	0.0	89.8	0.4	0.3	0.3	0.5	0.0	41.9	0.3	0.3	2.8	0.0	0.1	0.0	10.4	0.1	0.3	0.7	0.0	0.3	36.9	4.8	0.9	0.6	0.0	0.4	524.0	0.2	0.1	0.6	1.1	0.8	0.0	0.3	0.4	0.2	0.3	40.4	463.6	0.3	0.0	0.6	0.4	16.4	0.6	0.4	0.0	23.4	0.1	2.1	0.0	270.4	202.6	0.4	0.1	0.4	0.0	0.3	0.6	1.9	0.9	5.7	0.0	0.5	0.8	3.4	2.5	0.2	0.3	0.7	0.2	0.5	0.2	0.3
UNC93B1	UNC93	ENSG00000110057	"Unc-93 homolog B1, TLR signaling regulator"	Q9H1C4	11	67991100-68004982	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 76.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 96.2;Kupffer cells: 78.3;Macrophages: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 128.9;RPMI-8226: 368.2;SK-BR-3: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038716, HPA038717, HPA042803"	Approved		Approved	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176"	"unprognostic (3.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-3)"	"unprognostic (5.23e-3)"	18.7	17.7	4.9	19.9	5.6	19.9	15.4	5.0	7.5	19.0	6.4	20.2	22.5	7.7	0.8	20.5	15.7	9.8	7.3	4.9	5.0	16.4	15.3	29.5	29.5	10.7	6.5	6.2	17.1	2.6	6.7	6.4	8.1	16.4	3.1	0.1	27.9	8.8	3.5	16.3	35.8	3.1	7.9	76.7	20.6	1.7	6.8	3.5	14.8	1.5	7.3	20.6	15.0	10.2	18.9	34.1	2.5	13.8	7.2	2.7	28.2	8.3	7.7	13.0	11.8	2.8	128.9	40.9	30.8	4.0	11.0	44.9	1.0	7.0	0.4	14.1	9.3	4.2	11.1	6.4	11.2	30.0	22.7	6.0	7.6	3.8	1.5	5.0	2.6	6.4	3.0	19.3	2.0	18.7	0.2	23.9	6.2	46.8	16.7	24.5	0.0	368.2	11.8	10.7	3.9	5.5	14.0	95.6	19.3	1.0	35.4	39.0	9.2	8.6	12.2	12.8	0.8	13.2	18.8	7.0	16.0	30.7	10.5	0.1	3.8	6.6	0.1	7.2	0.2	2.5	0.2	0.2	5.1	2.7	0.0	0.0	3.2	2.1	7.7	14.8	0.0	1.2	4.9	5.6	5.0	7.5	4.9	5.0	10.7	6.5	8.1	7.9	6.8	10.2	12.5	9.6	9.1	4.6	45.3	4.0	21.9	12.5	9.1	0.0	16.4	13.1	1.8	40.0	21.0	16.5	0.0	10.3	63.3	23.2	1.9	36.8	0.8	32.0	5.9	10.0	4.2	3.0	1.1	23.4	47.8	8.0	20.9	17.2	7.0	9.3	10.0	5.4	96.2	5.0	0.1	17.2	14.2	78.3	28.4	0.1	4.4	85.3	23.2	13.1	57.5	4.7	8.2	0.0	0.7	49.7	25.6	4.1	33.8	27.0	31.7	6.9	57.3	0.5	0.0	8.3	9.8	0.2	1.1	12.9	6.5	7.3	10.5	2.1	23.1	37.7
UNCX	Uncx4.1	ENSG00000164853	"UNC homeobox"	A6NJT0	7	1232872-1237326	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 17.5"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"NB-4: 98.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.2"	"Region enriched"	"Detected in single"	8	"cerebellum: 7.5"	HPA063294			Approved	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA063294: AB_2684977"					"unprognostic (1.15e-1)"										"unprognostic (9.71e-2)"			0.0	0.0	0.7	0.0	0.1	0.0	0.0	17.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.4	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	17.5	0.5	0.0	2.8	2.2	3.0	3.2	0.6	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UPF1	"HUPF1, KIAA0221, NORF1, pNORF1, RENT1, smg-2"	ENSG00000005007	"UPF1 RNA helicase and ATPase"	Q92900	19	18831959-18868230	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Nonsense-mediated mRNA decay"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019587, HPA020857"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		19000	"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019587: AB_1856174, HPA020857: AB_1856175"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (2.94e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.71e-3)"	"prognostic favorable (2.97e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-2)"	22.7	21.2	11.6	22.2	13.2	26.1	21.2	13.9	14.3	23.4	8.9	23.2	21.6	24.4	8.1	24.1	20.6	17.7	17.5	11.8	11.6	16.3	17.3	21.6	25.8	15.8	12.7	22.5	42.2	35.1	18.6	22.3	11.4	21.1	10.7	10.1	36.7	22.3	31.3	29.3	21.7	13.8	13.3	24.8	23.8	30.9	12.6	27.0	23.0	19.6	16.5	23.5	23.1	15.3	61.2	39.8	27.4	32.8	41.5	27.1	89.7	50.6	31.1	48.0	37.4	76.9	54.0	54.5	65.4	32.0	25.5	60.0	38.7	55.2	18.2	29.2	76.5	59.9	37.2	49.8	35.7	67.2	34.7	30.3	39.3	37.4	40.3	27.5	30.8	46.6	76.6	51.4	25.8	66.5	78.5	42.2	45.7	42.2	96.0	62.1	44.2	51.4	21.1	54.3	57.8	44.6	46.4	52.2	27.3	21.8	31.4	42.7	43.9	42.6	29.6	52.8	57.3	33.0	27.4	83.7	30.3	64.0	48.0	0.0	0.6	1.1	0.2	0.3	0.2	0.1	0.3	0.0	0.4	0.3	0.2	0.1	1.7	1.0	0.8	0.2	0.2	0.3	11.6	13.2	13.9	14.3	11.8	11.6	15.8	12.7	11.4	13.3	12.6	15.3	24.2	22.4	13.6	10.1	14.8	15.7	13.3	10.0	10.2	30.8	24.7	24.5	14.5	12.8	11.0	27.6	14.6	16.4	18.7	32.5	0.0	11.1	13.5	46.5	27.8	19.4	21.6	8.8	9.9	9.8	13.7	15.8	29.0	65.9	0.0	24.4	13.9	24.1	14.4	37.0	9.5	27.4	10.2	19.1	12.2	7.9	14.6	19.5	12.4	10.3	11.8	19.5	13.4	9.0	11.4	16.6	16.6	19.2	18.9	22.2	17.5	10.5	29.0	18.5	13.1	15.6	15.0	26.8	18.4	20.1	18.6	20.5	16.5	20.5	22.8	27.2
UPF3A	"HUPF3A, RENT3A, UPF3"	ENSG00000169062	"UPF3A regulator of nonsense mediated mRNA decay"	Q9H1J1	13	114281601-114305817	"Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 480.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018325, HPA061316"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA018325: AB_1858638, HPA061316: AB_2684477"	"unprognostic (9.08e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.44e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.71e-4)"	17.5	20.0	13.7	15.1	14.6	18.0	16.4	19.6	19.7	17.6	10.2	17.4	18.1	18.7	8.3	13.3	18.4	11.7	12.9	12.9	16.9	14.5	10.3	12.1	17.0	16.4	14.6	15.5	19.7	13.7	17.1	11.2	17.3	16.4	11.1	11.6	16.5	14.5	23.8	15.6	15.9	11.3	13.2	16.3	16.7	46.3	14.3	17.9	30.2	7.5	10.8	15.4	14.3	17.5	55.9	15.9	35.3	31.7	16.4	28.1	22.3	42.0	30.0	26.4	29.1	24.4	19.4	54.0	11.9	19.6	17.8	29.3	17.2	14.1	32.6	39.8	33.7	47.0	50.9	27.1	28.3	81.7	20.3	19.1	28.1	17.8	20.5	27.7	21.2	14.0	29.0	24.7	26.6	16.7	33.8	22.1	46.7	36.8	15.9	43.2	19.8	31.7	23.4	17.5	39.1	43.3	33.6	51.3	31.3	23.6	37.6	72.7	27.5	27.8	46.0	15.5	26.6	53.4	39.3	74.5	51.7	46.7	23.3	3.0	5.6	4.8	6.8	4.7	5.2	13.2	7.0	7.2	6.5	9.7	7.1	6.7	0.9	11.9	6.1	16.9	10.8	4.3	13.7	14.6	19.6	19.7	12.9	16.9	16.4	14.6	17.3	13.2	14.3	17.5	104.8	67.3	61.5	88.5	64.2	68.7	57.8	57.2	76.8	85.3	80.6	84.3	22.8	52.9	60.8	58.8	83.4	65.0	75.3	32.1	103.7	54.3	205.8	148.7	101.2	78.1	57.5	51.9	84.7	71.2	45.2	69.7	42.8	65.4	55.6	57.7	63.9	72.6	45.7	79.1	114.7	50.5	79.3	44.9	46.1	96.8	100.6	53.8	55.2	59.0	51.1	74.2	83.4	188.5	130.9	52.6	34.0	87.6	81.1	59.1	36.0	69.8	96.0	72.3	85.5	77.5	56.4	480.3	172.4	82.4	71.9	40.5	64.3	111.8	62.2	46.7
UPF3B	"HUPF3B, MRX62, MRX82, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.9	8.1	17.0	10.2	17.2	13.6	9.5	21.1	30.0	11.9	16.3	11.8	11.8	11.7	10.5	12.7	9.9	6.9	7.5	16.5	20.0	11.4	12.4	9.0	15.4	17.5	17.3	13.3	8.1	11.3	12.9	8.8	17.4	10.8	10.5	22.0	8.8	9.0	12.9	15.5	10.0	9.3	16.0	11.3	8.6	15.7	17.8	14.7	11.5	10.9	15.6	10.5	11.7	18.6	29.2	17.3	35.1	28.8	15.7	10.3	22.5	27.4	15.3	20.9	18.3	32.7	20.4	51.9	22.6	11.5	29.9	27.1	45.9	16.6	26.5	29.9	33.9	48.3	57.9	17.2	17.9	52.7	23.0	8.7	12.4	35.8	43.3	19.0	19.7	30.5	47.4	41.8	17.6	35.9	36.8	65.6	67.7	37.1	46.8	35.9	40.2	38.2	17.3	14.5	46.7	32.1	55.6	22.4	42.4	36.2	11.9	30.4	17.3	21.6	16.6	34.9	58.6	23.1	27.5	69.5	17.5	76.1	25.7	8.1	4.4	6.5	5.9	4.8	4.8	12.5	5.6	4.8	3.3	13.7	6.3	6.4	4.9	7.7	5.6	8.7	7.4	2.2	17.0	17.2	21.1	30.0	16.5	20.0	17.5	17.3	17.4	16.0	17.8	18.6	26.3	32.1	25.7	31.6	47.4	37.7	31.1	31.6	47.8	50.7	26.4	28.2	19.0	17.2	38.7	25.8	56.3	39.0	46.1	33.5	5.9	31.6	157.3	26.1	23.5	31.1	27.6	52.2	30.6	26.4	48.2	25.5	23.0	33.8	58.9	32.8	23.2	22.9	28.5	28.6	39.5	35.5	26.4	19.1	43.3	31.7	30.4	28.2	24.9	27.2	44.9	32.6	56.7	33.7	45.4	21.5	33.6	32.7	32.5	33.8	30.4	16.5	35.2	99.0	13.1	34.4	42.0	65.8	41.4	38.8	38.1	64.3	39.9	28.1	37.6	25.0
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108736	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 250.1;Extravillous trophoblasts: 260.3;Macrophages: 199.5;Paneth cells: 260.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 62.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"hTERT-HME1: 362.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.4	9.4	3.8	7.5	4.4	12.5	10.0	3.0	5.8	16.8	2.0	9.8	4.3	3.9	0.8	66.9	5.7	5.9	8.9	3.1	3.9	39.8	11.9	18.8	3.7	4.2	2.8	1.9	4.6	5.0	7.4	3.8	3.7	4.9	5.3	0.5	14.2	1.1	3.7	3.1	6.5	3.4	1.3	20.3	4.1	2.2	4.4	1.2	8.0	0.9	6.6	9.1	31.2	3.7	19.5	26.0	2.4	5.2	8.9	4.0	29.7	7.9	15.5	14.5	17.5	10.8	9.9	0.0	2.5	9.7	89.9	13.9	5.2	46.1	9.4	4.1	4.5	0.8	4.8	4.6	7.4	0.9	1.3	5.0	21.8	6.4	362.8	5.9	9.1	0.4	1.5	13.5	7.6	2.3	0.0	2.9	9.4	4.2	20.7	0.0	4.8	6.0	33.7	11.5	2.3	1.6	10.2	3.0	63.4	29.3	2.4	0.9	12.4	29.6	22.9	7.3	22.6	21.4	34.7	3.7	29.6	3.0	77.8	11.5	16.0	12.2	11.8	12.1	8.9	0.2	7.8	8.7	6.5	0.6	8.1	8.1	6.2	5.4	14.8	0.5	8.4	10.9	3.8	4.4	3.0	5.8	3.1	3.9	4.2	2.8	3.7	1.3	4.4	3.7	107.4	19.2	58.5	5.2	19.1	46.8	26.3	104.4	19.4	27.6	9.0	16.1	11.6	24.3	51.0	11.0	33.3	15.1	122.9	250.1	70.5	50.5	1.0	42.1	22.4	108.1	13.1	4.4	16.5	40.5	260.3	34.1	5.1	91.1	25.9	3.8	72.5	17.5	110.0	16.8	29.4	35.0	85.5	130.5	118.1	2.4	5.3	199.5	87.2	1.0	61.4	13.3	71.1	4.0	3.6	117.9	260.8	2.2	30.3	30.4	42.8	23.3	11.9	29.2	6.6	21.1	32.2	0.3	9.5	42.9	29.8	78.7	71.0	1.5	29.1	34.9
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 45.8;liver: 23.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Distal tubular cells: 13.7;Excitatory neurons: 32.5;Inhibitory neurons: 20.8;Oligodendrocyte precursor cells: 27.6;Proximal tubular cells: 82.1"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Mitochondria"	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	0.0	0.1	3.3	0.0	2.9	0.0	0.0	1.8	3.0	0.1	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	3.7	1.9	45.8	23.9	0.0	0.1	1.3	1.3	0.3	0.1	0.0	0.2	0.0	1.1	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.1	0.0	1.4	0.0	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	2.9	1.8	3.0	3.7	1.9	1.3	1.3	1.1	1.4	1.6	2.4	0.0	0.0	0.0	24.2	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	13.7	0.0	0.1	0.2	0.1	0.1	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	8.2	0.0	0.0	20.8	0.0	0.0	0.9	0.0	0.1	0.3	0.5	0.0	2.8	0.0	0.1	0.0	27.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	82.1	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1
UPRT	"DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3"	ENSG00000094841	"Uracil phosphoribosyltransferase homolog"	Q96BW1	X	75156388-75304885	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000805	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA000805: AB_1080482"	"unprognostic (3.12e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.53e-3)"	6.2	10.9	7.2	6.3	7.4	13.4	7.9	7.4	8.7	8.1	8.1	7.6	10.9	5.9	8.9	7.9	7.2	6.1	9.3	7.1	8.2	11.4	8.6	7.6	8.9	7.2	8.3	6.1	6.5	14.0	7.0	5.8	7.9	9.2	7.9	6.4	8.7	6.0	8.9	5.6	8.1	6.5	7.4	7.3	10.3	1.9	8.1	8.9	10.2	10.8	8.2	6.9	4.7	8.1	11.6	7.6	8.9	8.1	9.4	9.9	8.4	8.0	9.2	8.4	9.6	7.2	7.7	16.3	6.6	8.5	15.1	4.8	20.7	6.8	13.9	14.3	8.0	10.2	7.8	9.1	9.0	20.2	20.1	7.5	5.0	11.2	6.1	13.4	15.1	13.1	12.1	15.7	22.6	4.8	22.7	12.4	17.8	8.6	13.0	10.7	22.8	8.1	21.9	6.4	0.6	9.2	11.0	11.4	11.4	15.7	5.3	12.6	12.6	10.6	6.3	19.4	6.8	10.7	36.5	15.8	11.2	21.9	6.9	6.9	7.3	9.2	7.7	10.6	9.0	8.2	7.6	8.0	10.9	7.0	9.4	8.3	1.4	14.4	17.9	5.2	13.5	7.1	7.2	7.4	7.4	8.7	7.1	8.2	7.2	8.3	7.9	7.4	8.1	8.1	8.5	6.4	5.0	8.1	8.0	6.2	8.7	10.0	3.4	8.5	5.3	3.8	6.6	5.7	11.2	9.2	0.0	8.4	8.1	5.3	27.4	8.8	2.0	4.8	4.1	8.6	6.0	4.6	8.8	6.0	15.1	5.2	5.1	4.1	24.1	5.2	11.7	6.0	11.6	10.1	8.8	5.3	22.4	16.1	8.8	1.8	4.4	10.8	14.2	3.7	7.8	9.4	13.4	13.0	8.4	5.6	3.2	3.4	9.8	5.5	8.4	15.4	6.1	7.2	6.6	4.8	7.1	0.7	2.4	4.2	6.0	12.2	12.1	6.5	7.2	7.4
UQCC1	"BFZB, C20orf44, CBP3, FLJ10850, UQCC"	ENSG00000101019	"Ubiquinol-cytochrome c reductase complex assembly factor 1"	Q9NVA1	20	35302566-35412031	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 64.6;Inhibitory neurons: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034875	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA034875: AB_10603226"	"unprognostic (9.66e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.45e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.34e-2)"	19.4	30.0	22.0	13.8	24.3	4.6	16.5	21.9	27.7	20.1	20.9	26.0	18.9	18.6	22.9	18.8	20.6	12.6	55.3	22.4	23.0	28.6	27.1	15.8	17.9	24.1	23.5	19.8	15.9	37.2	23.9	14.9	26.6	19.7	25.8	29.5	18.7	18.4	106.8	16.3	19.3	18.5	19.9	19.7	23.0	17.6	22.9	21.2	22.3	105.7	21.9	20.1	18.0	22.8	20.2	28.6	33.5	32.2	34.1	38.4	4.8	38.5	43.3	70.7	48.1	97.7	39.4	66.6	68.5	26.1	60.7	53.5	60.0	70.0	52.6	19.0	24.2	89.2	41.3	80.3	22.7	54.2	25.6	37.6	72.3	37.9	48.8	51.2	24.6	53.5	39.9	23.9	50.0	26.8	58.6	29.2	25.4	42.0	61.5	31.4	50.0	37.9	67.6	26.2	46.4	28.7	32.9	148.9	34.0	28.1	23.9	34.6	23.5	46.2	28.8	25.9	34.6	30.1	37.2	26.5	79.7	31.1	36.8	28.6	10.2	14.2	14.8	14.3	18.3	12.3	13.7	14.7	16.0	15.7	16.7	14.7	0.3	22.3	10.2	14.4	14.2	12.6	22.0	24.3	21.9	27.7	22.4	23.0	24.1	23.5	26.6	19.9	22.9	22.8	7.0	0.0	7.8	51.6	7.0	6.4	9.3	18.1	6.8	20.7	7.8	5.8	44.0	10.0	11.8	16.5	8.4	22.9	5.3	13.9	60.7	18.2	15.1	10.5	8.5	10.5	12.0	5.2	64.6	13.1	15.7	9.2	7.7	6.9	8.2	17.5	6.1	14.2	11.6	18.5	68.9	9.1	18.3	6.6	3.9	8.6	10.5	5.8	14.2	33.7	13.2	16.7	10.3	44.2	50.3	19.1	6.6	12.0	5.0	8.4	10.9	19.4	14.8	22.8	6.6	9.6	11.9	24.6	18.2	6.2	5.3	17.4	6.2	19.7	13.2	9.6
UQCC3	"C11orf83, UNQ655"	ENSG00000204922	"Ubiquinol-cytochrome c reductase complex assembly factor 3"	Q6UW78	11	62670273-62673686	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"ATP synthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 209.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046851	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA046851: AB_2679839"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.70e-3)"	"unprognostic (7.84e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.36e-1)"	7.5	12.2	7.4	3.7	7.5	5.7	7.5	8.2	9.7	7.6	9.3	9.9	8.1	6.5	1.7	12.3	6.1	1.2	10.2	7.1	7.1	10.7	11.9	4.7	4.2	7.6	7.3	6.5	9.0	3.5	6.7	2.2	7.7	9.4	1.9	3.9	11.5	3.3	15.7	9.0	8.3	1.5	7.0	7.4	9.6	3.4	7.4	2.4	6.3	5.0	1.6	6.3	8.1	8.1	26.9	52.9	7.7	12.0	4.7	4.6	6.5	10.4	3.5	7.7	7.6	31.4	22.8	17.4	21.1	3.6	10.4	26.1	7.4	12.3	2.4	8.8	27.4	9.8	28.7	20.3	6.3	16.0	7.6	4.4	10.3	6.8	7.6	4.8	6.0	8.1	21.3	12.2	4.3	82.4	15.7	39.2	8.6	10.6	29.8	17.9	11.7	31.1	6.1	13.2	15.5	15.7	11.5	41.7	16.2	2.4	39.7	14.9	7.9	16.8	19.7	17.6	23.6	18.7	11.0	18.3	13.8	13.7	12.3	14.6	25.0	20.1	21.3	19.1	20.4	30.8	21.1	19.0	20.0	29.9	19.2	15.3	11.0	19.6	17.2	26.7	25.8	20.0	7.4	7.5	8.2	9.7	7.1	7.1	7.6	7.3	7.7	7.0	7.4	8.1	49.0	44.8	25.0	3.6	32.3	0.0	42.2	0.0	47.3	21.8	77.5	86.4	35.8	70.1	16.1	64.4	16.7	53.1	22.9	65.2	140.8	56.6	1.7	50.3	40.6	32.9	35.2	32.2	2.4	78.4	53.1	32.4	54.6	41.1	5.1	28.0	44.6	125.4	54.8	18.5	4.2	75.2	0.0	39.7	0.0	3.7	48.4	29.2	0.0	7.5	47.2	59.7	66.9	5.0	5.2	67.4	66.9	36.1	38.4	85.1	209.3	170.6	12.4	37.0	39.5	28.3	31.8	4.2	32.0	91.0	0.0	29.0	25.3	35.1	79.0	57.0
URI1	"C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI"	ENSG00000105176	"URI1 prefoldin like chaperone"	O94763	19	29923644-30016612	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Protein phosphatase inhibitor, Repressor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 499.7;Late spermatids: 514.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071709	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA071709: AB_2686434"	"unprognostic (4.22e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	25.0	30.6	29.7	24.8	39.6	36.4	36.7	57.8	40.7	27.9	21.0	26.1	23.5	34.2	32.3	28.5	30.2	25.1	28.1	25.0	36.8	25.6	30.5	22.9	39.9	35.9	32.3	44.1	21.9	31.4	11.0	24.1	34.5	37.7	32.1	32.4	27.2	30.4	52.8	44.9	23.4	22.8	28.4	30.0	25.0	51.6	30.9	31.7	55.4	36.2	37.3	24.8	10.7	45.6	64.8	85.9	39.5	61.7	27.5	39.8	66.5	41.3	34.4	29.5	33.7	45.4	41.5	99.7	79.4	48.2	23.4	44.6	84.8	52.7	66.5	69.7	48.5	90.8	44.3	59.7	39.7	88.5	37.3	35.1	70.6	25.7	95.7	31.7	22.1	58.2	109.7	27.2	37.4	55.3	58.0	37.1	37.1	83.4	26.2	56.7	73.2	40.5	19.4	75.3	63.4	49.7	47.1	56.3	62.2	41.7	23.5	54.8	29.1	72.1	63.9	35.6	63.3	74.4	86.2	67.7	35.5	76.5	44.4	3.4	1.3	1.8	2.9	1.4	2.5	1.9	2.6	3.0	1.1	4.5	3.1	3.1	0.1	2.2	1.4	1.6	2.2	0.8	29.7	39.6	57.8	40.7	25.0	36.8	35.9	32.3	34.5	28.4	30.9	45.6	51.6	44.8	38.8	59.1	48.6	57.0	95.3	19.4	40.5	60.6	67.6	68.1	52.8	48.6	28.2	40.5	25.0	19.2	84.4	21.7	105.7	16.9	499.7	48.5	82.8	32.5	28.9	38.5	79.9	27.8	28.7	45.6	41.3	41.8	30.9	54.5	31.8	50.9	15.4	52.2	122.3	36.5	18.3	33.6	24.0	514.0	43.8	32.9	32.0	74.9	25.0	58.5	70.0	137.7	178.4	19.4	23.7	41.3	53.3	123.9	19.4	85.2	38.8	59.8	13.1	82.3	48.5	72.2	52.2	44.8	73.6	13.1	74.2	91.6	37.0	94.3
URM1	"C9orf74, MGC2668"	ENSG00000167118	"Ubiquitin related modifier 1"	Q9BTM9	9	128371361-128392016	"Predicted intracellular proteins"	"tRNA processing, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053645, HPA065160"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Nucleoplasm	"HPA053645: AB_2682215, HPA065160: AB_2685423"	"unprognostic (7.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.04e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.43e-6)"	"unprognostic (1.77e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.17e-2)"	20.1	23.8	35.5	16.3	40.3	26.2	20.0	37.7	37.8	21.2	28.1	22.0	20.2	21.2	15.1	22.0	18.8	11.2	31.1	33.8	35.9	26.8	24.6	17.6	21.7	40.3	41.2	19.5	30.0	18.9	17.9	14.7	38.0	22.7	16.5	12.4	17.2	14.1	25.2	20.9	20.8	16.8	35.7	28.0	23.2	12.5	38.6	23.6	19.3	25.5	20.7	21.9	18.7	42.4	17.9	36.6	34.5	21.6	31.2	29.9	29.9	17.8	27.8	40.1	27.4	28.5	32.7	41.6	14.2	37.8	26.0	63.8	40.3	38.7	20.7	27.7	27.5	37.2	53.4	32.9	28.7	40.8	30.9	40.5	33.3	31.4	28.2	30.6	49.0	44.7	43.9	26.2	29.5	39.9	54.7	54.9	39.5	71.5	41.0	44.5	41.8	48.6	33.5	16.3	27.6	37.6	31.5	51.3	41.4	18.5	50.7	32.2	32.1	31.6	30.0	30.3	30.0	25.2	54.2	39.8	31.4	33.6	38.7	6.1	14.1	10.0	14.5	18.3	12.2	11.7	12.7	13.6	16.8	12.3	12.4	13.5	3.5	12.2	17.6	12.2	15.7	12.6	35.5	40.3	37.7	37.8	33.8	35.9	40.3	41.2	38.0	35.7	38.6	42.4	49.9	16.0	24.5	13.7	36.8	22.7	32.9	60.0	16.5	19.2	37.1	32.9	22.4	25.8	26.1	27.6	14.6	84.1	37.1	57.3	70.5	69.2	2.5	21.5	31.6	47.4	22.2	53.0	12.6	112.2	85.1	32.1	35.7	19.8	37.4	34.6	38.9	23.1	81.6	10.1	13.3	53.3	28.5	42.6	27.7	4.2	31.1	31.6	53.4	4.7	70.5	32.2	59.8	15.1	38.7	89.5	49.3	31.2	29.4	38.4	90.4	51.4	17.4	14.4	19.7	26.3	32.6	24.1	27.1	29.4	23.9	71.7	37.4	48.1	66.7	31.7
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45010950-45015575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 806.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 420.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440"	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	51.7	120.1	72.0	25.5	73.9	199.0	48.2	72.0	79.3	40.8	77.2	49.3	29.2	46.9	54.7	34.2	49.2	30.8	70.6	73.1	74.5	58.0	100.9	34.8	35.2	72.1	73.4	51.1	45.1	115.0	42.6	39.4	73.6	35.1	30.1	24.7	61.4	44.2	75.9	31.7	30.7	54.7	72.9	37.8	38.5	44.8	73.6	44.0	54.0	83.8	36.1	40.3	32.7	73.8	66.0	42.5	67.0	89.1	113.4	107.7	31.8	87.4	209.8	163.9	125.2	59.9	32.3	46.4	82.3	122.8	116.3	31.1	127.2	153.6	116.9	42.9	133.4	245.4	95.4	200.7	132.4	79.0	42.6	115.1	97.6	154.1	132.3	121.8	208.9	92.9	420.8	48.5	157.6	53.5	49.9	62.9	104.1	51.5	145.9	76.5	96.5	69.9	141.7	54.4	73.9	57.3	89.1	63.9	134.3	73.7	50.8	77.6	137.5	96.9	71.6	34.2	130.5	49.4	60.1	38.1	141.0	117.6	47.2	72.3	111.9	65.5	57.4	81.5	58.8	84.9	69.2	56.7	149.7	81.9	63.6	58.0	20.1	87.4	50.9	102.3	88.7	122.1	72.0	73.9	72.0	79.3	73.1	74.5	72.1	73.4	73.6	72.9	73.6	73.8	25.8	44.8	38.0	7.8	25.4	22.9	35.8	101.4	43.9	27.3	31.0	37.1	74.4	41.5	45.3	27.6	16.7	98.6	22.1	21.4	90.1	73.5	8.1	20.3	30.7	42.7	18.0	806.8	9.4	63.7	54.6	57.1	17.3	21.2	52.6	20.4	38.6	98.5	101.8	13.5	6.7	20.2	73.2	37.9	29.4	16.2	79.6	38.5	48.0	5.6	103.6	89.7	24.7	7.1	7.3	51.2	23.7	56.1	36.8	15.9	32.7	134.5	32.9	25.3	39.5	29.4	75.0	37.3	42.3	31.6	24.7	49.8	23.3	72.7	20.9	29.1
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823258	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		69000	"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	27.9	41.3	54.1	13.4	55.3	67.5	26.9	40.6	64.5	15.9	33.0	29.9	20.9	21.4	56.9	24.9	19.3	15.6	73.2	56.3	45.8	40.7	59.7	20.5	18.8	41.6	48.1	22.5	32.9	30.0	29.9	11.3	43.5	27.4	16.5	26.2	29.6	19.1	83.8	23.0	24.2	18.1	40.2	28.0	29.6	31.2	51.8	18.6	32.5	80.0	19.1	27.3	17.0	47.8	45.5	56.3	29.8	74.9	38.5	42.2	51.9	51.4	94.5	39.0	34.6	22.9	54.0	58.4	24.7	72.9	24.3	23.5	18.5	43.1	31.3	78.1	39.9	125.3	27.9	40.1	67.3	50.7	29.7	59.3	20.7	25.8	66.0	47.5	34.4	48.5	24.4	54.1	63.5	65.2	51.2	72.8	37.7	31.8	54.0	33.1	34.1	37.3	53.9	28.2	26.2	46.8	51.6	41.8	80.7	30.8	40.4	59.1	33.8	52.3	19.6	38.1	48.2	50.7	36.8	40.6	75.6	23.1	26.3	4.9	31.9	4.6	30.1	33.1	33.9	30.1	29.3	38.6	53.5	37.5	38.1	29.6	2.1	53.6	31.9	25.3	29.8	38.1	54.1	55.3	40.6	64.5	56.3	45.8	41.6	48.1	43.5	40.2	51.8	47.8	19.0	19.2	23.1	20.5	34.3	9.3	12.0	31.8	9.6	49.3	36.2	39.5	70.5	40.0	28.6	36.8	45.9	60.8	36.3	19.1	101.8	59.7	57.0	11.2	25.5	22.2	14.5	231.5	23.9	59.6	47.4	33.3	23.9	16.9	11.4	112.3	28.2	53.4	79.3	47.1	25.2	25.6	40.7	47.8	20.8	123.7	35.8	31.6	62.2	9.4	58.7	77.0	69.0	13.6	29.6	42.7	15.8	40.6	46.9	27.3	52.9	142.6	20.4	42.3	6.6	22.8	36.7	55.7	100.9	28.5	12.8	20.0	37.8	55.0	38.8	21.3
USB1	"C16orf57, FLJ13154, HVSL1, Mpn1"	ENSG00000103005	"U6 snRNA biogenesis phosphodiesterase 1"	Q9BQ65	16	57999546-58021618	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041791, HPA059854"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA041791: AB_10793933, HPA059854: AB_2684143"	"unprognostic (2.79e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (6.69e-7)"	"unprognostic (4.30e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.04e-2)"	21.5	27.5	24.0	27.6	23.4	30.9	14.8	22.4	26.2	15.6	20.9	22.8	14.3	19.0	16.3	17.4	15.7	14.7	27.7	23.6	25.8	19.0	29.9	20.5	20.2	26.5	24.9	11.8	17.6	14.7	13.4	16.6	26.3	17.2	18.6	6.7	14.1	18.4	15.6	15.2	18.1	24.8	23.8	25.7	19.4	20.2	25.7	18.4	19.1	13.0	20.8	28.1	15.4	23.5	53.2	109.2	36.5	69.7	46.4	32.5	57.6	43.9	58.2	68.6	48.3	70.9	31.0	32.5	56.6	65.3	61.0	38.6	58.2	93.6	97.6	31.9	32.9	40.5	43.0	103.8	52.7	54.2	114.1	46.6	54.7	87.2	50.8	45.4	76.1	69.7	55.4	15.4	58.2	56.0	50.1	62.3	60.6	47.7	88.5	49.3	32.9	53.8	49.1	63.4	17.6	41.6	114.8	29.8	27.6	57.6	14.8	54.5	82.6	40.2	59.0	43.3	60.5	23.4	37.3	58.9	48.3	51.1	50.0	112.3	58.4	86.8	57.1	67.8	37.4	19.5	33.2	43.7	54.8	13.4	20.3	36.7	162.2	45.5	95.5	23.8	45.1	32.4	24.0	23.4	22.4	26.2	23.6	25.8	26.5	24.9	26.3	23.8	25.7	23.5	12.9	0.0	9.2	6.2	12.2	18.1	17.7	22.8	13.1	3.2	15.2	13.0	13.0	14.3	12.4	9.2	4.2	29.3	33.2	30.2	11.7	39.5	1.3	9.5	10.7	13.5	12.6	9.0	10.4	46.2	55.3	13.3	14.3	9.7	16.5	6.3	17.5	13.0	42.0	6.7	6.2	15.9	28.5	19.8	16.4	1.4	8.1	26.5	14.2	5.6	37.2	11.5	48.4	2.5	5.2	49.7	20.0	11.7	16.4	14.7	18.3	16.2	9.7	3.6	6.6	7.7	15.3	12.6	22.5	10.9	13.1	20.5	24.3	13.0	10.2	15.2
USF1	"bHLHb11, MLTFI, UEF"	ENSG00000158773	"Upstream transcription factor 1"	P22415	1	161039251-161045977	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001480, HPA036233, HPA036535"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"CAB001480: AB_2213986, HPA036233: AB_2675012, HPA036535: AB_2675178"	"unprognostic (3.66e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (8.70e-4)"	"unprognostic (1.59e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (6.01e-12)"	"unprognostic (1.24e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.08e-1)"	"prognostic favorable (1.95e-5)"	15.3	18.2	26.3	18.9	26.2	17.5	13.9	26.2	27.2	14.8	25.7	18.4	18.5	14.3	14.2	13.8	16.8	14.6	18.4	26.5	26.6	15.7	21.0	18.4	27.8	26.0	25.5	16.7	11.4	20.5	11.4	18.1	26.4	15.1	18.3	17.0	14.0	18.2	32.7	15.3	19.6	18.1	26.0	30.5	14.9	7.6	28.2	36.0	12.9	29.4	32.7	20.7	13.7	26.9	17.2	25.5	29.9	35.0	39.4	22.3	39.9	14.0	30.3	42.9	33.3	17.9	21.2	22.1	29.0	23.5	18.6	21.0	35.6	22.3	24.0	20.6	21.2	19.1	20.9	18.9	23.0	26.7	25.4	18.3	22.0	31.1	25.1	27.3	40.7	36.8	31.7	23.1	27.2	20.1	41.5	29.2	61.8	37.0	32.9	35.6	23.3	26.9	21.0	26.8	16.9	32.3	25.5	32.8	18.1	42.9	27.5	85.5	24.0	21.5	13.5	13.2	23.1	19.5	26.6	34.3	18.3	25.9	16.7	2.5	2.6	1.4	1.9	2.1	1.1	1.5	1.1	1.3	2.6	1.7	1.2	1.2	4.1	0.9	2.1	2.7	1.3	1.3	26.3	26.2	26.2	27.2	26.5	26.6	26.0	25.5	26.4	26.0	28.2	26.9	13.1	6.4	6.9	3.6	18.0	2.3	0.6	3.1	9.1	3.3	2.7	3.9	1.0	0.0	3.2	3.7	2.1	2.2	14.5	7.1	1.9	2.1	0.4	5.5	8.1	6.0	3.0	5.0	6.3	1.3	4.4	4.6	14.8	5.6	11.4	4.0	1.1	0.4	3.1	5.0	5.4	3.4	6.1	2.1	3.5	0.2	0.3	12.4	5.4	4.7	4.7	1.6	4.1	4.0	5.8	2.3	7.1	0.0	20.0	1.6	7.3	3.1	7.9	3.5	6.6	3.3	4.9	0.5	0.4	8.5	1.8	3.4	9.3	7.7	4.9	1.9
USF2	"bHLHb12, FIP"	ENSG00000105698	"Upstream transcription factor 2, c-fos interacting"	Q15853	19	35268962-35279821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029764, HPA046567"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	Vesicles	"HPA029764: AB_2673190, HPA046567: AB_2679702"	"unprognostic (6.10e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.07e-2)"	"prognostic favorable (5.12e-5)"	"unprognostic (7.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.28e-4)"	126.7	132.5	188.9	130.4	191.7	177.7	105.4	190.2	192.9	109.3	147.9	120.8	105.3	104.4	51.5	104.6	104.1	66.3	196.6	181.0	180.3	97.8	185.2	102.2	154.9	192.9	185.4	164.5	121.1	109.4	149.1	63.5	187.2	99.8	54.1	90.4	97.9	57.2	359.3	122.0	112.7	52.4	186.4	160.5	104.1	51.7	191.7	101.3	125.8	195.1	96.7	100.2	99.9	183.2	189.2	190.2	93.6	91.1	161.7	81.5	89.2	101.0	119.7	90.4	69.3	87.3	95.5	183.7	157.6	86.3	96.4	56.5	88.6	79.6	45.4	306.4	135.8	107.5	111.1	143.1	97.8	182.5	177.5	71.7	108.3	58.6	89.1	151.3	62.2	119.6	135.3	260.0	70.5	218.8	200.7	69.8	78.7	171.3	61.1	190.9	123.2	171.2	74.8	119.5	159.3	120.7	188.2	200.4	346.7	80.7	81.8	142.4	107.4	150.0	101.0	99.5	134.4	260.0	286.6	199.7	139.4	114.8	201.0	44.5	8.3	11.1	6.8	11.2	8.2	10.2	7.0	9.0	13.4	13.5	6.3	6.0	7.8	11.7	6.9	50.6	13.8	7.7	188.9	191.7	190.2	192.9	181.0	180.3	192.9	185.4	187.2	186.4	191.7	183.2	58.2	6.4	22.4	29.7	72.5	23.7	23.7	18.7	20.5	66.0	42.2	38.4	71.6	35.8	15.5	31.3	33.3	24.2	108.1	50.7	56.7	33.5	1.1	25.6	31.3	36.5	52.1	37.2	19.7	57.8	38.5	32.7	30.5	34.0	20.3	45.7	38.6	50.5	107.0	94.2	16.9	33.6	20.3	66.8	42.9	3.4	32.0	91.9	26.6	28.1	37.8	118.9	35.0	12.1	19.5	36.0	37.1	31.2	63.8	23.1	58.1	51.7	11.0	53.9	13.1	40.9	35.8	9.0	10.6	34.3	24.7	17.5	56.2	52.0	33.0	35.6
USF3	KIAA2018	ENSG00000176542	"Upstream transcription factor family member 3"	Q68DE3	3	113648385-113696646	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029243, HPA029245"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Centrosome	"HPA029243: AB_10611114, HPA029245: AB_10600443"	"unprognostic (2.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.55e-2)"	7.1	4.9	5.6	3.0	5.9	10.2	6.7	8.8	8.0	5.5	7.5	7.5	2.8	5.3	7.8	6.8	6.2	2.4	7.0	6.2	5.3	8.2	16.4	5.9	5.3	5.4	5.4	5.8	8.5	6.0	6.7	2.8	5.6	5.9	3.9	5.6	6.4	2.7	18.7	7.4	8.3	2.4	5.2	8.7	7.5	4.8	5.3	6.7	6.2	8.5	4.6	6.0	6.1	6.8	4.6	3.4	4.1	3.9	9.8	3.7	2.8	1.8	2.9	1.7	1.6	3.2	1.9	8.0	3.2	4.6	2.8	2.8	4.5	3.6	3.3	2.7	1.9	5.7	2.2	5.3	2.9	10.5	6.2	5.5	6.4	3.2	3.6	2.6	4.2	5.9	2.7	4.1	3.7	6.4	5.9	5.8	3.0	6.1	3.4	2.5	3.2	3.2	6.3	6.3	1.9	3.0	4.3	2.4	5.5	2.8	3.3	7.7	5.7	2.7	6.0	1.5	2.6	4.8	2.9	9.2	3.1	4.3	2.0	2.2	1.0	1.7	1.3	1.3	1.0	1.0	0.9	1.0	0.8	2.3	1.1	1.2	3.2	1.2	1.8	2.3	0.5	0.7	5.6	5.9	8.8	8.0	6.2	5.3	5.4	5.4	5.6	5.2	5.3	6.8	27.1	22.4	15.1	0.0	30.1	0.0	11.2	0.0	15.9	19.5	19.7	12.6	0.0	14.3	6.2	25.8	14.6	8.1	42.7	13.1	25.4	8.4	6.7	28.3	18.6	15.6	6.1	17.0	0.0	11.8	4.2	13.3	18.3	22.8	5.1	6.7	20.3	46.3	7.8	13.5	0.0	10.2	0.0	22.6	0.0	10.9	13.1	17.0	0.0	0.0	16.4	12.4	29.9	0.0	0.0	12.5	12.4	13.9	17.5	18.4	23.6	29.2	12.4	18.8	6.6	27.6	13.8	13.1	6.0	15.8	0.0	14.5	20.0	12.2	10.9	19.5
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 302.7;Spermatogonia: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028387: AB_2672578, HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	13.8	10.6	12.4	21.0	14.7	53.2	23.9	20.2	15.4	16.2	11.8	19.0	17.1	20.7	16.8	17.9	16.7	11.9	12.2	11.5	13.4	14.1	13.5	16.0	32.3	12.8	13.0	26.0	16.0	18.2	10.0	14.4	13.7	16.7	20.7	34.5	14.7	15.9	11.9	19.3	17.2	17.0	14.2	19.4	16.9	51.5	12.9	48.1	20.2	16.0	31.7	13.9	11.9	17.3	85.6	25.5	96.8	53.2	21.3	25.5	57.0	79.7	52.1	93.3	101.2	41.4	39.3	151.3	57.0	43.1	83.6	48.0	80.3	53.0	128.5	79.5	63.5	124.5	82.1	42.7	23.2	132.5	60.9	13.7	33.8	84.1	62.8	25.1	44.9	100.1	92.7	125.3	66.2	38.0	136.9	50.9	88.2	48.5	52.4	131.9	166.3	93.9	34.9	60.1	103.4	58.6	89.3	70.1	86.8	64.2	41.3	79.7	32.1	72.7	80.7	109.3	112.9	52.2	78.1	171.1	49.5	104.0	67.0	22.6	9.9	26.0	12.7	10.5	16.9	15.6	15.3	13.5	12.3	11.2	14.4	12.2	17.4	17.9	14.9	12.4	15.3	10.3	12.4	14.7	20.2	15.4	11.5	13.4	12.8	13.0	13.7	14.2	12.9	17.3	35.8	48.1	31.8	6.2	58.7	62.2	34.7	32.9	75.7	49.6	41.5	46.2	34.9	24.3	34.9	16.5	22.9	43.7	52.4	22.7	19.6	34.1	173.9	37.2	32.3	39.7	8.4	85.2	10.3	34.1	59.2	43.9	15.8	33.2	27.8	41.4	30.0	18.4	31.0	35.3	11.2	33.3	30.5	27.2	38.8	81.1	50.1	34.7	26.6	7.5	56.0	49.5	62.8	10.6	17.2	27.5	12.7	41.0	63.7	56.8	22.7	17.3	41.9	86.6	52.6	59.7	42.0	302.7	206.7	73.8	64.4	33.0	59.7	21.2	39.5	35.8
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699986-84779922	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 742.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 742.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	24.8	21.7	19.6	29.4	20.3	29.5	23.4	22.1	22.9	21.0	17.8	31.2	29.5	25.9	23.9	29.1	27.0	18.5	25.4	20.8	20.7	28.8	33.8	18.7	36.7	18.8	18.7	27.1	23.0	41.5	6.0	40.3	19.0	28.3	26.4	52.5	21.0	25.9	46.6	25.7	27.4	31.0	19.8	32.6	23.8	22.0	20.4	29.1	27.4	39.5	37.7	32.1	10.1	21.6	63.6	72.9	78.5	104.7	31.4	50.2	111.5	58.0	60.1	96.9	51.5	106.9	54.9	102.9	65.2	61.1	47.7	69.8	108.2	89.7	139.0	41.3	63.3	63.2	37.3	92.2	39.4	95.0	37.9	30.0	74.8	95.6	112.3	57.5	76.4	68.5	153.4	22.7	73.1	129.4	92.4	96.8	102.5	71.8	56.7	119.9	44.5	55.0	81.9	48.4	73.0	48.6	130.5	48.7	54.0	72.3	108.4	76.8	55.7	66.9	60.2	39.4	62.2	38.8	53.7	272.3	44.5	64.6	73.2	29.0	77.3	15.6	46.1	61.9	58.0	60.6	148.0	53.9	92.6	59.7	82.9	49.6	742.4	65.9	58.6	30.7	57.3	97.3	19.6	20.3	22.1	22.9	20.8	20.7	18.8	18.7	19.0	19.8	20.4	21.6	21.3	54.5	50.0	26.4	51.5	51.5	46.1	25.8	54.1	25.1	27.6	28.6	66.6	25.8	45.2	27.6	29.2	106.9	38.1	25.8	31.3	29.0	63.3	31.0	35.8	30.4	28.9	42.5	39.3	25.1	73.4	40.1	35.7	42.1	58.0	38.7	21.0	37.2	31.4	20.2	38.9	28.1	16.2	34.8	33.4	116.6	23.6	40.6	24.9	41.2	52.6	23.7	32.0	49.8	35.8	23.6	23.9	22.6	50.8	48.6	30.4	45.0	90.7	52.7	26.3	58.4	34.3	35.0	29.5	54.5	49.6	60.9	42.5	33.6	40.6	45.2
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232866-47248328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 203.6;Horizontal cells: 139.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favorable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	25.5	32.8	117.7	23.7	118.7	11.2	26.8	41.5	116.3	51.2	30.0	33.9	11.5	47.0	23.6	18.2	49.9	24.5	45.5	113.1	148.1	33.3	12.7	30.9	30.1	69.8	78.3	76.4	27.1	36.6	103.7	24.9	93.9	33.4	14.1	84.8	21.4	38.7	32.4	18.5	25.5	35.9	65.4	29.3	24.9	46.2	122.8	42.6	52.2	29.6	28.9	36.9	31.7	79.8	45.6	70.7	117.6	81.0	43.4	28.5	33.0	34.0	52.5	65.6	73.3	67.4	36.7	29.9	26.1	60.5	70.5	53.5	94.7	24.0	56.4	47.1	73.5	34.7	52.9	61.4	50.7	39.2	70.7	42.1	9.8	69.1	29.3	37.3	26.7	68.9	26.6	3.9	51.8	70.0	77.8	43.4	89.2	24.3	62.5	86.1	114.3	25.1	32.4	60.9	66.8	114.4	62.6	12.4	37.7	73.9	26.0	23.0	28.2	56.0	58.0	79.3	39.6	54.3	36.2	51.3	34.3	48.8	50.8	63.9	9.1	19.9	55.4	19.6	48.3	53.1	24.5	54.3	11.9	53.1	36.6	76.3	5.5	56.4	24.3	53.2	35.0	46.0	117.7	118.7	41.5	116.3	113.1	148.1	69.8	78.3	93.9	65.4	122.8	79.8	13.6	22.4	17.7	25.8	53.5	13.6	42.2	30.9	21.6	203.6	13.0	23.5	24.2	7.2	31.5	33.1	56.3	20.9	52.2	9.4	50.9	18.3	26.4	28.2	26.3	22.5	35.4	18.3	43.3	10.2	15.0	41.3	22.4	28.3	45.7	56.6	22.1	8.2	13.4	139.7	63.7	8.7	28.5	12.0	16.3	41.0	29.5	17.9	28.4	19.7	17.5	96.2	23.7	25.1	24.8	12.5	7.9	42.2	48.1	18.6	4.7	15.2	46.4	63.4	26.3	57.2	40.2	18.3	87.8	11.9	6.5	16.3	44.6	34.2	8.9	26.0
USP12	USP12L1	ENSG00000152484	"Ubiquitin specific peptidase 12"	O75317	13	27066156-27171811	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, HPA059492"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA007288: AB_1080531, HPA059492: "	"unprognostic (6.72e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.73e-1)"	20.4	13.6	21.0	20.9	22.0	75.7	15.3	21.6	26.7	13.1	15.5	35.6	18.2	13.2	15.1	17.0	13.5	17.9	14.4	23.7	22.2	24.8	34.9	23.6	29.4	18.9	24.8	14.7	15.3	16.5	13.8	17.7	19.5	14.0	25.5	38.0	10.2	12.1	13.1	24.0	24.3	18.6	21.0	17.2	17.7	15.5	22.2	12.2	16.1	15.9	26.4	21.8	13.5	21.8	24.9	15.3	28.6	14.9	18.8	23.8	10.2	34.1	23.9	18.5	13.7	27.7	37.8	35.1	16.6	27.0	44.9	15.0	18.9	19.8	39.4	57.0	16.1	54.3	19.2	19.6	23.6	31.8	36.5	14.9	28.3	21.0	23.9	23.4	43.3	23.8	18.4	16.5	38.9	14.4	19.6	42.0	20.5	31.5	26.7	22.1	36.5	8.3	36.3	17.3	31.5	19.0	29.3	24.2	28.2	35.5	11.4	30.4	51.6	19.3	18.6	41.6	31.4	12.6	15.0	24.6	32.4	18.5	22.0	0.0	0.5	2.2	0.5	0.5	0.9	1.2	0.9	0.8	0.6	1.6	0.6	0.6	0.5	0.9	0.8	1.1	1.4	0.4	21.0	22.0	21.6	26.7	23.7	22.2	18.9	24.8	19.5	21.0	22.2	21.8	54.2	28.9	29.9	19.6	42.1	91.6	29.4	7.0	34.7	23.8	30.6	24.0	23.4	17.2	9.1	23.9	39.6	15.4	26.5	47.0	29.4	12.8	19.2	29.1	26.4	42.0	20.9	60.6	37.0	16.3	7.0	34.2	23.9	68.9	13.3	15.7	21.4	23.3	14.0	28.6	29.0	27.5	10.2	20.8	153.8	10.7	7.8	47.8	39.2	42.2	33.6	13.8	9.2	43.7	65.0	24.4	37.4	6.4	37.1	34.0	34.3	21.3	12.2	32.1	32.9	114.7	42.8	2.7	12.9	23.1	79.0	10.9	27.2	9.3	24.1	40.6
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179653032-179804366	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 149.2;tongue: 108.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 93.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.2	11.9	3.9	2.8	13.6	1.5	5.3	8.6	12.0	3.3	0.0	2.9	1.2	5.7	3.4	4.0	3.4	4.5	42.5	3.7	4.7	3.0	4.6	5.4	3.6	11.3	10.5	12.5	4.1	4.0	5.8	2.6	12.7	4.3	2.2	7.1	6.2	2.7	149.2	2.2	1.9	6.3	6.4	2.1	1.7	6.0	8.1	2.4	9.7	108.9	3.5	3.5	2.2	34.4	27.6	11.3	20.0	14.8	8.9	14.1	11.6	18.6	17.4	23.7	18.8	17.1	9.6	35.6	18.0	17.2	27.6	2.6	21.4	9.1	26.4	93.3	14.8	9.0	23.6	14.4	6.3	26.5	1.1	10.5	3.0	18.8	18.5	9.1	16.6	11.9	4.7	43.0	15.7	15.0	22.5	3.0	17.9	1.3	13.1	29.3	20.2	27.4	11.7	7.9	13.0	14.5	14.1	16.9	7.2	5.4	37.0	12.7	24.1	28.6	27.6	23.7	64.1	29.5	21.2	78.3	13.0	15.0	27.2	0.1	0.3	0.0	2.6	0.5	15.6	3.2	1.8	3.8	1.5	0.9	1.2	1.3	0.0	0.0	0.7	4.5	0.7	1.3	3.9	13.6	8.6	12.0	3.7	4.7	11.3	10.5	12.7	6.4	8.1	34.4	45.0	9.6	35.9	14.0	5.3	2.5	1.9	1.4	0.6	13.7	7.1	5.2	208.5	5.7	5.4	1.8	6.2	10.7	5.6	1.4	15.6	1.1	2.6	13.9	11.4	10.1	9.6	5.5	23.2	4.4	2.4	12.0	4.1	2.5	2.5	35.5	22.1	7.6	4.3	16.8	52.2	2.9	0.0	4.8	3.5	3.6	9.3	5.0	14.2	16.9	1.7	7.0	3.1	36.2	42.5	1.0	12.2	9.4	4.5	4.4	0.1	2.7	3.7	10.2	13.1	17.8	12.0	6.1	2.8	4.8	1.6	5.1	4.1	58.8	4.5	1.4
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 176.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 297.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	29.0	21.6	4.5	29.4	4.8	176.2	22.9	12.3	6.7	17.6	10.2	18.0	13.8	14.6	9.2	19.7	17.8	13.7	19.8	5.2	5.5	14.9	27.2	31.5	33.3	6.0	5.4	26.7	19.7	14.9	13.9	18.4	5.7	14.3	16.7	45.8	19.7	8.3	35.5	29.9	24.6	12.6	4.6	44.3	18.8	30.2	5.5	26.5	17.1	14.8	24.9	18.1	19.4	8.0	18.3	16.5	14.2	17.7	25.7	25.1	27.0	29.0	21.2	22.3	16.1	19.6	21.6	15.5	16.6	17.8	10.1	18.5	18.4	23.1	27.6	18.5	15.0	25.2	15.1	14.1	18.8	35.6	61.8	15.0	19.2	27.2	20.7	20.7	26.1	16.3	80.8	36.0	20.0	23.5	26.4	19.3	25.4	16.5	24.0	17.2	19.1	32.3	17.9	22.8	17.9	8.9	30.9	21.6	17.3	17.4	34.7	18.8	37.2	21.2	22.2	32.0	18.2	16.4	24.0	21.9	25.7	26.7	23.5	163.4	60.0	64.3	13.5	31.1	14.9	28.5	19.6	14.0	23.7	20.5	23.5	13.8	297.9	14.7	26.8	26.6	58.8	26.1	4.5	4.8	12.3	6.7	5.2	5.5	6.0	5.4	5.7	4.6	5.5	8.0	57.1	38.5	36.4	68.6	130.3	58.8	40.8	26.2	40.5	54.9	32.3	28.1	74.9	21.5	48.9	23.9	110.5	31.7	142.5	50.2	11.7	36.4	172.2	26.3	46.5	45.4	42.0	248.3	124.8	41.5	43.3	52.5	57.6	38.9	88.6	53.5	21.0	45.3	46.2	42.1	104.2	33.2	12.2	101.3	97.6	172.0	61.8	120.6	53.4	135.9	195.8	25.6	90.6	100.0	108.8	55.1	47.6	29.3	94.3	36.0	30.9	25.9	31.9	151.5	39.5	66.1	60.5	83.7	43.3	49.3	77.0	65.8	130.0	27.0	29.5	60.8
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 514.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	27.0	23.0	18.8	23.4	23.2	29.3	27.4	21.3	20.4	22.7	19.1	24.6	25.1	25.2	25.2	25.2	19.9	20.4	29.3	17.5	20.5	22.1	30.7	20.9	27.9	20.5	20.8	22.3	26.0	34.3	16.7	24.2	21.7	25.7	26.4	42.3	24.7	23.6	34.7	19.9	22.8	22.6	20.2	21.9	23.4	25.7	20.3	30.0	33.8	37.5	32.3	27.1	14.1	27.5	59.9	23.4	36.5	33.0	25.4	41.5	34.2	56.9	37.9	38.5	36.4	29.5	38.3	60.5	16.8	54.8	58.7	26.5	45.6	41.5	50.1	58.6	48.4	80.9	27.3	33.1	37.6	80.3	43.0	35.9	42.9	50.3	46.4	28.7	37.5	33.9	67.7	103.8	45.3	27.3	49.7	29.3	39.2	48.4	29.9	33.0	89.7	69.6	31.7	42.5	39.4	41.9	36.8	58.1	51.1	24.9	40.2	54.2	38.0	44.8	55.7	41.8	59.3	87.8	129.3	62.5	46.8	57.3	45.6	37.4	24.1	33.6	36.3	24.9	28.6	40.7	34.1	33.6	23.1	46.0	36.9	35.8	23.5	31.5	34.0	36.2	38.9	17.2	18.8	23.2	21.3	20.4	17.5	20.5	20.5	20.8	21.7	20.2	20.3	27.5	60.3	86.6	91.9	27.4	114.4	57.2	132.5	68.9	55.2	161.0	65.8	58.7	84.2	64.3	83.1	53.3	89.6	81.7	108.2	90.2	133.1	77.9	514.9	85.9	82.6	55.0	82.6	40.8	18.2	119.9	79.7	68.3	55.0	107.7	141.8	61.5	45.7	86.2	59.9	72.3	27.6	100.4	44.7	62.0	53.1	117.0	87.7	69.4	62.2	25.3	117.3	94.1	96.8	28.1	47.3	94.0	99.2	86.9	106.8	100.1	74.8	91.8	94.1	183.5	59.2	133.4	83.2	100.4	82.4	68.4	64.4	162.0	105.3	72.8	90.6	141.9
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881828	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 95.9;K-562: 60.2;MOLT-4: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	8.1	12.0	8.7	13.5	8.0	22.6	8.3	4.8	8.7	12.5	2.5	13.6	8.2	12.5	4.2	7.9	12.1	7.7	7.5	7.8	10.6	7.6	7.4	8.4	18.3	10.2	9.1	13.5	10.9	8.4	18.4	6.7	10.0	14.8	4.9	6.7	11.4	13.2	10.9	12.1	12.5	8.2	5.4	13.9	9.9	10.0	8.9	32.3	18.7	7.5	11.8	14.9	10.1	6.5	6.0	5.8	10.0	13.4	12.8	10.8	14.1	9.5	7.9	7.1	4.9	4.7	6.5	8.1	8.0	9.3	8.0	14.7	6.0	6.7	2.9	43.4	7.9	14.9	17.0	3.3	8.8	14.2	10.6	9.6	9.8	9.3	7.0	12.4	7.7	95.9	60.2	9.9	4.4	15.9	56.4	33.6	7.9	12.7	13.6	9.4	11.2	14.0	5.5	6.5	2.2	11.0	11.0	13.9	9.1	5.9	14.4	19.9	11.5	7.8	3.5	10.5	6.3	9.7	15.3	5.7	15.5	18.6	7.4	1.0	1.9	5.4	8.6	1.5	9.1	3.7	8.7	8.3	2.6	3.4	9.8	8.9	2.8	10.0	1.5	2.1	11.5	6.3	8.7	8.0	4.8	8.7	7.8	10.6	10.2	9.1	10.0	5.4	8.9	6.5	3.0	9.6	6.9	16.3	9.2	2.8	2.2	2.5	4.0	7.8	6.4	8.0	7.7	4.3	3.0	1.8	4.2	5.9	9.4	6.2	3.9	2.4	2.1	4.1	6.3	4.3	8.4	12.8	17.0	4.0	2.5	4.6	8.2	5.7	1.3	6.8	6.4	6.1	3.3	10.1	21.1	4.6	4.1	1.6	3.8	3.3	6.2	6.0	3.6	11.2	3.1	5.3	11.3	9.5	14.3	2.7	5.0	4.9	6.7	3.0	4.1	2.9	5.0	6.3	0.0	4.3	5.7	12.1	6.0	4.8	2.0	6.2	19.3	2.9	5.2	1.6
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.35e-5)"	12.2	15.3	19.6	11.9	20.7	15.0	14.3	18.5	22.8	19.4	18.3	17.6	13.6	18.2	12.0	16.4	28.0	12.0	13.0	19.4	18.4	14.5	10.8	13.1	16.1	19.2	19.7	23.2	16.4	17.1	15.7	13.2	18.7	17.7	11.0	12.9	16.5	20.3	20.9	20.8	15.9	12.6	17.3	17.8	16.4	14.2	20.1	18.4	18.5	17.7	14.0	17.6	16.8	22.1	12.5	20.6	26.9	26.2	21.1	17.5	16.5	9.1	14.6	24.2	18.9	19.4	23.3	16.0	14.6	11.2	15.1	20.7	17.6	17.5	13.2	30.8	30.0	19.3	34.1	15.3	15.2	17.4	13.4	14.8	23.0	16.6	23.9	27.1	17.3	35.0	28.4	21.6	15.6	22.6	30.7	26.9	25.2	24.3	26.1	28.8	9.0	26.5	14.4	14.9	24.2	31.5	17.2	17.2	13.9	20.1	37.3	27.5	10.1	16.9	14.8	11.9	15.3	42.9	36.5	23.9	15.3	14.7	15.5	15.2	10.0	17.1	12.6	6.4	14.6	11.0	11.5	13.2	10.8	11.3	13.1	12.3	8.4	13.3	7.6	10.8	12.3	11.0	19.6	20.7	18.5	22.8	19.4	18.4	19.2	19.7	18.7	17.3	20.1	22.1	4.5	0.0	3.7	5.2	6.5	1.5	1.8	2.4	16.5	5.0	4.9	4.1	3.9	8.6	2.9	1.8	6.2	4.9	3.6	3.6	1.9	2.0	1.0	6.3	5.7	4.4	5.4	10.7	2.4	2.3	2.3	5.1	9.2	3.7	2.5	4.5	5.3	2.1	2.2	0.0	2.7	4.0	4.1	4.8	0.8	1.0	5.0	2.1	1.8	1.9	1.2	3.3	5.2	2.0	4.6	2.0	2.4	4.1	7.8	2.7	3.5	2.5	9.5	5.2	6.6	2.0	5.2	5.3	3.2	10.7	1.4	3.1	5.6	3.1	4.1	1.5
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215364	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 552.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785"	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	16.6	8.2	13.4	14.2	13.3	56.7	13.4	25.3	13.6	9.4	13.2	12.0	8.3	10.7	9.2	9.4	9.9	9.0	12.7	12.6	14.7	15.7	15.3	10.6	22.1	13.5	13.1	16.5	11.4	20.3	12.8	9.6	14.6	10.2	13.3	17.2	12.8	9.6	47.9	13.6	12.6	9.8	12.8	18.6	12.3	8.4	13.6	21.9	9.2	36.6	20.9	10.4	9.2	14.2	32.5	17.4	21.3	11.6	27.2	23.5	24.6	14.0	17.5	19.6	20.3	25.0	11.1	25.9	15.1	26.1	40.1	25.6	28.5	23.6	30.5	27.2	17.4	51.5	40.2	29.6	16.1	36.0	38.6	21.0	20.6	30.0	33.7	19.0	18.2	25.7	48.5	10.6	26.6	7.6	21.9	19.1	31.4	15.5	21.0	22.3	27.1	11.3	34.6	21.4	18.7	13.1	23.8	16.8	21.1	32.3	11.7	17.5	24.7	17.9	17.3	21.7	22.6	13.2	10.6	33.2	16.9	29.4	16.3	5.4	1.3	1.7	2.8	1.1	1.7	3.0	2.2	2.2	1.2	3.4	1.9	2.5	1.4	2.3	1.5	6.9	1.3	0.7	13.4	13.3	25.3	13.6	12.6	14.7	13.5	13.1	14.6	12.8	13.6	14.2	20.4	16.0	20.0	92.4	27.7	14.9	8.4	5.6	9.1	14.0	13.4	10.2	37.7	10.0	13.0	12.9	73.0	4.2	42.6	11.1	0.0	10.3	0.7	11.9	15.1	16.1	17.3	37.4	84.5	10.2	7.8	11.9	21.4	15.0	12.7	18.2	12.1	11.9	9.7	38.7	100.4	16.2	8.2	19.2	18.8	2.5	11.8	18.6	10.6	87.1	19.6	7.0	15.5	552.4	115.2	11.8	11.4	7.9	18.1	12.7	8.3	5.9	10.0	16.9	6.6	18.0	13.5	7.7	7.1	13.9	17.2	1.5	21.8	9.8	16.0	12.1
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"Spermatogonia: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000424, HPA027310, HPA079124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000424: , HPA027310: , HPA079124: "	"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27 X-linked"	A6NNY8	X	49879484-49882558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.5;Bipolar cells: 15.8;Cytotrophoblasts: 44.5;Syncytiotrophoblasts: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA077264: AB_2686831"	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.6	2.5	6.0	1.3	6.2	0.5	2.0	8.0	5.8	3.0	3.1	3.2	1.0	3.9	2.9	1.6	3.5	1.6	1.8	5.3	14.4	2.7	1.8	2.7	1.7	4.9	8.4	6.3	2.6	3.0	7.3	11.7	5.9	3.0	1.4	3.8	1.6	2.8	4.4	2.1	2.1	2.8	3.6	1.8	2.4	1.3	10.5	2.6	2.4	2.1	1.7	3.0	2.2	4.4	1.6	3.8	4.2	4.8	3.8	3.1	3.6	1.6	2.6	1.8	1.4	6.9	1.6	0.9	1.6	4.2	6.0	2.6	6.0	4.0	2.6	2.0	3.1	1.6	1.1	6.2	2.6	0.5	3.4	4.4	2.7	2.6	2.6	4.4	2.5	4.2	3.4	1.5	2.9	3.7	2.5	1.2	4.8	2.7	2.7	2.7	3.7	0.3	2.9	1.4	1.1	3.2	3.4	3.0	4.0	12.9	3.5	1.1	1.9	2.1	4.3	3.8	0.7	1.6	0.4	0.6	2.5	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	6.2	8.0	5.8	5.3	14.4	4.9	8.4	5.9	3.6	10.5	4.4	3.5	19.2	15.5	0.7	2.5	2.9	4.5	0.3	2.2	15.8	1.9	2.7	2.6	0.0	7.5	0.0	0.0	44.5	1.4	1.7	5.9	1.5	0.1	2.1	4.1	5.2	4.2	0.0	2.9	0.7	3.6	2.7	1.1	2.1	2.5	4.0	2.5	1.9	4.0	5.0	3.3	1.3	0.0	0.6	1.0	0.3	2.1	1.2	0.0	0.0	1.5	8.3	0.0	3.5	0.8	1.2	0.5	3.4	0.5	3.3	0.5	2.9	13.2	2.5	6.6	2.5	2.6	0.2	1.3	0.9	2.3	26.1	2.0	8.8	1.6	1.7
USP28	KIAA1515	ENSG00000048028	"Ubiquitin specific peptidase 28"	Q96RU2	11	113797874-113875570	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.7;skeletal muscle: 68.3;tongue: 66.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 152.2;Excitatory neurons: 57.0;NK-cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 20.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006778, HPA006779"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies"	"HPA006778: AB_1080520, HPA006779: AB_1080517"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.03e-2)"	5.8	6.7	3.2	9.5	4.3	5.8	10.4	20.1	9.5	21.1	0.6	10.4	9.6	11.5	11.3	9.6	9.8	7.7	62.7	4.6	1.8	9.9	11.3	7.5	15.6	2.1	1.7	14.1	8.2	15.5	7.4	8.0	3.4	11.3	11.7	27.1	12.0	14.2	68.3	7.0	10.4	13.1	1.2	13.8	9.2	9.2	1.9	9.0	10.1	66.5	15.5	9.8	8.4	5.3	18.3	20.2	26.7	35.4	21.3	20.9	18.8	13.2	18.0	17.5	29.7	30.2	25.6	24.2	29.3	18.0	40.1	35.1	37.9	24.8	24.1	27.1	17.2	12.9	13.8	16.3	13.0	16.8	12.4	12.6	18.5	20.2	23.8	25.4	32.0	11.9	22.7	15.3	18.5	9.3	12.9	27.1	32.0	33.6	14.4	31.3	37.1	29.4	19.3	17.8	11.6	12.6	31.4	10.7	10.1	82.7	25.8	5.8	17.1	19.2	28.3	17.8	13.8	10.4	15.9	20.1	1.9	32.1	12.8	0.2	5.0	3.4	23.2	3.7	12.1	15.5	5.7	16.8	6.4	12.3	3.8	13.1	1.4	28.6	6.4	1.9	9.2	10.3	3.2	4.3	20.1	9.5	4.6	1.8	2.1	1.7	3.4	1.2	1.9	5.3	7.3	9.6	8.8	18.3	17.8	1.7	7.3	9.9	13.6	18.7	9.7	9.8	152.2	5.7	9.9	5.5	18.8	4.4	32.1	3.3	5.9	6.7	1.7	6.6	11.6	7.9	4.9	2.5	57.0	3.9	4.7	12.2	11.7	8.7	1.3	18.9	7.5	8.8	4.4	5.0	34.1	9.6	4.1	6.5	2.5	2.0	6.8	7.4	1.8	10.3	8.2	10.3	73.2	29.1	21.3	3.5	5.3	13.9	21.7	7.1	7.3	7.1	14.6	21.5	6.6	10.3	11.0	15.8	11.4	7.7	2.0	1.1	18.6	9.0	8.9	5.8
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 36.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 15: RT4 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	12.7	8.2	5.8	5.4	7.0	21.4	11.2	36.4	5.9	11.7	15.4	13.4	6.5	12.9	4.7	10.9	10.9	5.4	6.0	5.3	6.3	10.1	8.2	13.2	6.5	6.9	6.9	16.2	18.9	3.1	6.2	2.7	7.6	10.4	5.6	6.3	12.4	6.0	10.0	14.6	13.9	4.5	5.3	17.6	15.7	5.3	8.6	7.4	9.1	3.6	6.4	12.4	11.9	7.5	10.4	21.0	12.1	8.1	5.5	7.6	8.2	6.7	9.6	7.1	5.8	6.6	13.1	8.7	15.3	9.3	3.6	12.0	11.6	11.1	5.6	12.2	5.8	10.4	8.6	9.8	6.8	6.4	11.4	11.3	7.8	7.7	10.6	8.9	12.4	17.3	9.5	9.0	3.3	5.2	11.0	8.8	16.2	13.7	5.3	22.2	8.4	11.3	4.5	23.8	9.6	9.5	3.3	13.0	6.7	7.8	5.5	9.5	13.4	7.2	16.9	3.3	10.3	9.3	24.4	18.2	7.4	13.8	7.5	120.0	84.7	12.7	24.8	66.0	28.4	34.1	34.3	26.0	59.8	34.8	34.0	25.2	169.1	19.8	65.4	13.1	28.1	45.2	5.8	7.0	36.4	5.9	5.3	6.3	6.9	6.9	7.6	5.3	8.6	7.5	23.6	38.5	69.2	76.7	63.4	52.6	34.3	24.8	23.3	31.4	27.9	20.3	9.2	25.8	41.4	16.5	12.5	19.8	48.4	37.6	41.1	41.0	21.6	37.8	32.8	26.0	43.8	15.8	11.2	37.2	57.3	28.3	39.8	74.6	27.1	64.5	11.4	24.0	24.8	13.5	40.0	35.4	30.5	78.4	109.6	77.4	15.8	74.5	42.7	75.9	101.8	25.9	41.2	80.4	40.6	39.8	35.6	18.4	69.7	40.6	33.2	28.3	33.3	17.9	13.1	25.3	34.5	14.8	40.3	33.9	59.0	34.1	64.6	40.1	40.6	37.6
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	40.7	31.2	31.5	24.6	40.4	34.5	34.3	52.0	49.7	24.2	37.3	24.3	25.4	28.0	26.8	21.6	22.5	26.3	21.7	35.4	31.8	31.1	25.4	26.2	28.1	28.6	24.9	29.3	19.5	35.0	20.9	28.0	30.8	28.8	25.2	49.1	25.2	22.9	18.0	24.3	26.9	24.1	22.3	26.0	24.4	25.4	28.6	27.1	30.4	20.7	26.0	22.9	20.0	55.5	42.4	18.8	64.1	44.2	90.0	78.3	54.8	45.3	42.9	54.0	60.1	25.4	35.5	31.4	41.2	44.3	88.2	32.1	47.4	31.1	65.7	28.8	36.6	111.1	44.6	22.2	56.0	37.8	26.8	58.3	23.9	52.4	37.9	51.9	48.7	28.0	43.9	26.3	41.2	16.1	34.9	38.0	62.2	32.6	37.2	33.0	67.7	22.2	51.0	41.1	53.8	41.2	31.9	41.5	64.2	54.3	23.1	41.2	41.2	49.4	34.4	50.1	43.2	21.0	28.4	30.4	37.3	44.5	25.4	67.3	22.5	31.8	21.0	22.6	21.7	20.5	20.6	21.7	17.5	22.3	24.5	21.9	30.5	19.2	30.1	18.4	20.7	16.7	31.5	40.4	52.0	49.7	35.4	31.8	28.6	24.9	30.8	22.3	28.6	55.5	40.2	44.8	40.9	66.3	35.1	17.2	18.8	21.2	32.5	56.7	25.7	22.1	39.9	22.8	25.5	35.0	58.4	25.1	48.8	35.9	9.8	20.8	4.3	54.8	37.8	31.8	35.5	50.9	149.3	15.4	19.0	39.6	43.3	54.6	23.4	43.1	28.2	23.1	19.0	62.2	159.0	28.6	22.4	30.8	20.7	5.5	35.8	35.1	23.2	75.9	38.7	31.4	37.0	98.0	138.5	19.6	27.8	32.0	42.4	22.9	33.2	25.6	37.3	44.5	19.7	34.9	35.6	39.8	30.1	28.4	16.3	11.9	41.0	39.2	24.8	21.8
USP34	"KIAA0570, KIAA0729"	ENSG00000115464	"Ubiquitin specific peptidase 34"	Q70CQ2	2	61187463-61471087	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025815, HPA070764"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA025815: AB_1858681, HPA070764: AB_2686308"	"unprognostic (4.04e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.01e-2)"	32.2	36.0	49.9	21.7	53.9	37.7	35.6	57.7	58.3	36.1	59.9	47.0	14.8	38.4	54.4	35.8	33.3	21.1	33.7	49.7	53.5	43.3	34.8	36.4	44.1	52.1	51.8	43.4	32.4	35.1	45.0	17.4	52.3	38.6	26.8	77.5	27.2	32.4	53.9	41.4	40.8	27.9	50.3	45.8	36.3	45.1	54.5	47.8	32.2	36.8	45.1	36.9	32.8	56.8	43.6	29.9	38.9	40.3	71.8	48.1	32.4	26.3	37.1	23.0	21.7	43.0	16.3	102.2	27.0	56.9	24.3	23.4	30.9	34.4	42.6	36.7	24.4	61.6	29.5	69.6	60.2	46.1	37.8	52.9	43.6	41.9	62.1	55.7	49.0	28.8	42.7	32.2	51.5	40.6	30.6	66.6	26.3	43.9	23.9	32.4	46.5	27.7	67.9	52.2	31.9	34.0	40.5	30.1	48.3	49.4	16.0	33.2	43.6	36.1	48.2	21.5	34.7	37.0	19.7	103.6	33.8	42.5	31.7	2.1	1.2	1.6	3.8	1.1	3.5	2.6	2.6	2.9	1.0	3.1	2.9	3.9	1.8	3.1	2.8	3.2	2.5	1.4	49.9	53.9	57.7	58.3	49.7	53.5	52.1	51.8	52.3	50.3	54.5	56.8	64.5	64.1	68.3	193.6	82.8	61.1	54.2	40.3	46.7	139.7	54.0	46.6	46.0	48.6	54.6	33.1	250.2	33.5	87.3	46.0	9.8	41.4	133.5	59.9	66.9	59.3	48.6	53.2	256.6	33.6	23.8	53.0	73.9	70.6	32.3	78.0	31.8	38.9	21.6	107.7	240.4	37.8	59.0	45.4	48.6	138.0	56.8	56.0	40.9	212.7	55.2	60.0	87.6	232.2	310.0	49.9	41.1	67.0	69.9	79.9	38.3	23.4	44.1	178.1	26.3	78.2	63.9	95.8	115.9	53.1	61.4	53.4	70.5	74.7	35.6	69.9
USP35	KIAA1372	ENSG00000118369	"Ubiquitin specific peptidase 35"	Q9P2H5	11	78188812-78215232	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 39.1;Granulosa cells: 30.8;Late spermatids: 121.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055213, HPA058592"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA055213: AB_2682740, HPA058592: AB_2683766"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	6.1	19.8	8.0	3.6	7.4	2.5	5.1	5.1	8.0	9.2	7.4	7.6	3.5	6.7	3.2	6.0	6.4	3.5	10.2	8.3	7.1	6.2	16.8	7.0	3.3	9.0	8.2	7.4	5.9	12.4	13.4	4.7	9.4	5.9	1.9	2.1	3.9	3.2	4.1	3.0	4.5	4.7	3.9	4.9	4.6	4.5	8.3	6.2	8.7	4.0	2.6	6.6	7.7	6.4	2.2	3.3	5.7	6.1	9.7	8.7	3.9	5.0	5.8	5.8	4.0	8.4	4.7	1.7	5.0	9.5	6.2	5.8	3.8	7.8	3.4	12.8	2.0	2.9	9.8	5.0	7.4	1.8	8.3	7.4	5.1	12.1	3.5	11.4	7.2	6.5	4.1	4.2	4.6	2.0	4.7	7.6	1.7	6.2	5.3	2.9	5.2	2.0	4.5	4.1	2.8	5.9	3.9	5.1	1.9	8.1	4.3	1.6	8.9	10.6	5.9	12.8	2.7	5.7	2.0	2.7	3.1	2.0	6.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	7.4	5.1	8.0	8.3	7.1	9.0	8.2	9.4	3.9	8.3	6.4	1.3	0.0	1.8	5.9	1.2	0.8	0.2	0.7	3.4	0.8	1.0	0.6	3.5	0.0	0.3	0.0	6.2	0.7	1.0	1.2	0.0	1.1	39.1	1.3	2.7	1.9	0.0	0.4	5.2	2.0	1.6	2.0	5.1	1.2	0.0	30.8	1.4	2.7	1.6	0.0	4.8	0.9	0.0	0.6	0.8	121.6	1.5	1.4	1.8	2.8	2.7	0.4	0.0	3.5	2.8	2.0	0.1	3.0	0.8	0.3	0.8	1.0	0.5	0.6	6.6	0.7	1.3	1.2	2.4	4.1	1.0	0.3	2.9	2.1	1.3	0.2
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568351	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 119.4;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	2.7	4.1	3.5	4.4	4.7	11.8	4.7	8.5	4.9	3.6	1.9	3.0	2.9	4.2	7.5	3.9	3.3	3.5	2.3	3.3	4.0	2.9	3.8	3.0	6.0	3.8	4.0	5.9	3.0	4.0	1.4	4.0	4.0	3.6	3.5	9.1	3.9	3.0	2.9	3.9	3.3	3.2	2.5	3.8	3.4	12.7	3.4	6.3	5.0	4.2	4.9	3.6	2.2	8.3	9.6	6.9	14.2	11.0	3.6	4.4	12.1	7.1	5.1	12.2	13.6	13.1	7.4	8.7	7.5	5.6	9.3	8.9	15.7	8.0	13.4	12.0	8.3	23.5	13.6	8.7	4.1	15.6	11.3	2.4	4.7	12.9	9.2	4.5	5.3	15.0	17.3	16.2	7.8	7.2	20.1	10.6	12.2	6.2	5.9	16.0	21.3	8.0	4.2	11.2	15.5	8.4	11.5	5.6	7.2	13.6	6.4	10.8	6.8	13.7	12.0	7.7	9.5	11.0	10.4	17.6	7.4	11.2	9.5	4.2	2.0	3.8	3.1	2.3	3.2	2.5	2.6	2.7	2.1	3.2	4.0	2.6	1.6	3.2	2.2	2.9	3.6	1.2	3.5	4.7	8.5	4.9	3.3	4.0	3.8	4.0	4.0	2.5	3.4	8.3	12.8	0.0	11.0	34.3	16.5	19.5	7.0	7.1	22.2	14.7	14.4	10.2	4.9	4.3	9.6	7.3	27.1	8.4	13.4	5.5	0.0	5.8	119.4	13.3	11.8	14.2	10.3	16.6	47.4	2.3	6.6	13.2	9.2	16.4	5.1	16.2	12.5	11.0	7.8	15.2	40.0	8.9	4.1	8.5	22.9	145.5	9.9	17.2	21.4	27.2	10.2	9.1	10.3	35.2	60.5	4.9	7.4	9.8	14.6	12.1	7.1	4.2	11.1	19.9	6.6	12.7	21.6	60.8	31.4	13.6	20.6	7.3	19.7	10.9	7.6	7.1
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223874	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 65.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: AB_2675419, HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	6.5	4.4	2.5	6.2	4.3	21.6	4.6	4.3	2.9	6.2	4.3	8.0	7.9	5.5	2.3	7.0	4.3	5.2	6.8	2.2	2.4	7.0	13.2	6.3	6.4	5.9	3.8	3.7	8.2	7.7	3.3	8.1	4.9	5.5	5.7	4.5	5.8	5.6	36.6	5.9	7.2	5.7	4.9	7.4	6.3	6.8	3.2	9.3	7.4	21.3	5.8	6.8	3.9	6.8	8.5	7.9	6.6	11.3	8.4	8.2	5.1	13.0	12.5	11.8	10.1	23.1	11.7	10.5	9.2	11.5	7.8	6.5	15.9	13.5	10.2	26.0	10.5	9.7	8.5	4.7	11.3	19.4	9.4	10.2	11.1	12.0	9.5	8.3	12.2	11.9	21.5	31.5	7.9	13.3	25.6	3.7	6.1	17.7	15.3	16.7	10.2	10.1	7.2	9.2	13.8	12.3	10.5	17.3	10.9	4.9	10.8	7.6	14.6	10.8	9.1	9.6	14.1	35.7	65.3	18.6	10.9	14.4	9.3	13.4	4.5	9.7	5.7	4.6	7.0	4.6	4.9	4.9	6.6	4.5	4.8	4.2	4.3	10.1	4.9	2.7	7.9	4.3	2.5	4.3	4.3	2.9	2.2	2.4	5.9	3.8	4.9	4.9	3.2	6.8	21.5	22.4	19.8	13.7	19.5	53.5	21.0	6.2	25.6	7.4	20.8	13.7	18.4	10.0	12.2	0.0	12.5	12.8	22.2	35.5	1.9	8.3	36.4	20.7	26.1	15.3	30.6	31.5	19.6	7.7	7.1	13.4	26.0	52.1	3.8	9.9	17.9	38.4	10.6	8.4	15.9	20.2	4.1	17.0	16.6	20.3	6.8	21.9	12.4	9.4	10.1	15.1	12.3	18.6	22.8	10.2	13.4	9.4	38.6	16.8	17.0	18.5	10.9	8.9	13.1	15.0	14.1	11.3	4.7	31.5	59.1	26.7	23.2	11.0	17.6	45.4
USP39	"CGI-21, SAD1, SNRNP65"	ENSG00000168883	"Ubiquitin specific peptidase 39"	Q53GS9	2	85602856-85649283	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034823, HPA077350"	Supported	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA034823: AB_10602488, HPA077350: "	"unprognostic (1.10e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.46e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (1.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (4.05e-7)"	"unprognostic (3.95e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-1)"	22.6	16.1	18.1	19.8	18.7	40.8	21.3	19.0	20.6	22.2	22.7	24.2	17.1	23.5	26.1	22.7	19.5	12.7	22.7	17.9	19.5	21.7	18.5	21.4	26.5	18.9	18.4	20.1	17.2	21.8	14.3	26.9	18.9	18.7	22.7	22.0	19.0	21.2	55.2	23.8	19.5	21.3	18.9	20.9	20.6	15.6	18.8	41.0	19.8	42.6	32.2	24.7	20.6	19.8	71.0	70.0	70.0	77.5	49.7	38.7	79.5	59.2	54.6	84.1	74.5	113.9	49.8	83.0	53.4	54.6	62.3	50.6	135.7	62.5	105.8	83.9	86.4	103.4	39.1	100.6	49.0	127.4	67.5	27.9	49.3	65.1	57.8	39.3	68.1	85.3	129.8	47.2	62.8	81.4	125.2	94.8	92.8	84.9	64.2	114.1	150.0	63.1	45.0	53.8	65.1	53.7	36.4	58.9	51.4	56.7	39.5	60.5	43.9	51.7	65.0	62.7	97.2	42.0	83.0	87.7	44.9	130.5	63.6	51.1	35.8	44.5	40.2	42.4	46.6	34.7	41.8	41.7	40.6	37.0	40.4	37.0	23.1	40.4	41.6	32.0	53.4	43.6	18.1	18.7	19.0	20.6	17.9	19.5	18.9	18.4	18.9	18.9	18.8	19.8	18.4	19.2	25.2	19.9	17.5	20.5	16.7	17.9	22.2	8.5	14.1	14.0	17.3	11.5	19.9	12.9	8.4	54.1	17.8	14.8	21.5	21.1	26.1	9.8	15.4	17.1	12.1	18.3	13.9	18.8	31.8	17.1	9.7	11.7	17.1	16.3	17.5	14.2	25.6	5.0	18.2	13.4	24.4	11.9	14.7	13.0	19.3	17.6	19.6	17.8	26.4	15.3	12.3	16.1	33.1	19.2	8.5	18.8	14.0	16.0	11.2	14.6	15.6	11.6	0.0	13.0	17.7	19.5	17.1	15.5	16.2	35.7	21.3	12.7	15.7	16.3
USP42	FLJ12697	ENSG00000106346	"Ubiquitin specific peptidase 42"	Q9H9J4	7	6104884-6161564	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.1;Spermatocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006939, HPA064800"			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA006939: , HPA064800: AB_2685355"	"unprognostic (1.48e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.66e-1)"	3.8	3.0	3.1	3.2	3.0	13.4	3.9	5.8	4.4	4.3	2.4	4.5	4.5	4.9	3.6	3.7	4.3	3.4	3.2	3.0	3.0	3.9	4.0	4.1	3.8	2.8	3.1	4.9	3.8	4.7	3.8	3.3	2.7	3.8	3.4	5.8	3.5	3.1	4.3	5.4	4.3	4.1	2.9	4.4	3.6	15.2	3.2	5.7	4.0	3.4	3.2	4.0	3.8	3.2	10.2	7.4	13.1	12.9	7.4	5.5	9.0	5.4	6.9	6.2	6.1	5.3	5.2	12.0	3.4	6.7	9.2	9.3	11.1	5.9	6.7	2.9	8.6	5.6	6.1	5.5	6.3	13.0	6.1	6.4	6.8	6.7	8.5	5.7	7.7	10.0	21.7	7.9	4.1	9.1	7.9	14.6	14.8	5.2	5.6	14.9	10.2	8.2	5.9	5.3	10.0	17.7	6.9	14.0	4.3	12.0	6.5	6.6	6.5	5.5	20.5	7.0	6.5	7.0	6.3	10.3	4.6	7.8	11.0	0.6	0.3	0.9	0.5	0.6	0.7	0.4	0.6	0.3	0.3	0.2	0.4	1.0	0.3	0.5	0.3	0.6	0.5	0.2	3.1	3.0	5.8	4.4	3.0	3.0	2.8	3.1	2.7	2.9	3.2	3.2	13.7	12.8	7.0	19.6	16.1	40.5	18.2	5.2	26.7	18.7	17.4	10.8	10.5	8.6	6.8	1.8	22.9	8.3	16.4	20.7	0.0	10.4	89.1	27.1	15.3	14.4	10.7	10.8	26.1	10.4	8.4	13.4	15.3	25.6	9.5	13.4	12.8	9.8	8.2	21.9	26.2	18.1	8.2	9.1	19.9	42.5	14.3	12.4	10.6	18.7	7.7	10.1	12.3	18.6	26.2	12.0	7.7	12.8	21.7	22.3	12.4	5.7	10.6	18.7	13.1	16.2	14.9	72.4	37.0	23.1	41.5	26.8	19.2	6.4	14.4	15.3
USP43	FLJ30626	ENSG00000154914	"Ubiquitin specific peptidase 43"	Q70EL4	17	9644698-9729687	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 37.9;Excitatory neurons: 35.5;Glandular and luminal cells: 52.5;Oligodendrocyte precursor cells: 73.4;Syncytiotrophoblasts: 73.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 11.7;SK-BR-3: 8.1;T-47d: 9.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA023389, HPA027762, HPA027763"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA023389: AB_1858691, HPA027762: AB_10603001, HPA027763: "	"unprognostic (1.39e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.49e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.28e-1)"	0.3	0.2	2.6	0.6	3.4	0.7	1.9	0.8	4.1	2.9	2.9	3.5	4.2	1.9	1.0	6.5	4.2	1.2	0.0	3.3	1.4	4.0	9.1	3.2	0.1	2.5	4.6	0.1	5.0	1.1	3.5	8.3	2.5	9.8	3.2	1.4	4.3	2.2	0.0	2.2	3.5	0.2	2.1	0.3	2.1	3.2	2.3	0.3	1.7	0.0	0.7	1.1	2.4	2.5	5.6	1.4	0.0	0.5	0.0	0.0	11.7	0.1	0.2	0.6	1.6	2.8	4.5	0.0	1.8	0.2	2.5	6.8	0.6	5.3	0.6	3.6	1.8	0.3	3.0	1.0	0.1	0.5	0.0	0.0	6.8	0.3	2.8	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.9	4.6	0.7	4.8	0.3	3.6	0.0	0.8	4.1	3.0	0.7	0.0	2.4	8.1	1.0	3.7	9.9	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	3.4	0.8	4.1	3.3	1.4	2.5	4.6	2.5	2.1	2.3	2.5	0.0	3.2	3.1	1.6	0.3	4.7	7.8	4.6	5.2	0.5	7.0	2.4	0.6	4.3	7.4	11.0	6.2	26.2	0.6	14.3	1.9	4.4	1.1	37.9	4.2	0.5	2.4	3.2	35.5	4.7	23.7	0.8	7.7	52.5	0.0	0.9	0.4	15.6	2.7	0.0	4.0	8.3	2.0	0.9	0.3	1.1	0.0	0.6	5.4	0.0	0.3	8.4	0.0	73.4	1.2	11.3	3.5	0.0	0.2	10.6	8.7	1.8	30.2	1.5	0.0	0.0	1.0	1.5	0.3	12.3	3.3	73.2	0.7	0.0	9.7	11.8
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432325-99521728	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 53.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.1;Inhibitory neurons: 44.4;Oligodendrocytes: 39.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 53.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	6.1	4.4	5.2	4.9	5.8	4.4	4.6	53.5	9.4	4.3	3.8	5.3	7.3	5.1	4.8	5.3	4.0	6.2	6.2	5.8	6.3	6.3	4.2	3.7	7.4	6.0	7.7	4.5	4.0	4.5	3.6	5.2	8.2	5.1	6.7	6.7	4.0	4.2	6.0	6.3	5.8	4.5	5.3	4.6	4.4	3.3	6.2	3.1	5.3	5.5	5.2	4.3	3.8	9.0	5.9	4.0	8.1	11.2	14.3	13.5	8.7	10.3	11.1	10.1	14.7	8.2	6.4	15.2	7.3	10.3	11.9	7.7	12.1	9.8	13.9	12.2	12.0	15.2	8.4	6.7	11.4	14.2	8.3	15.3	7.6	9.2	15.5	10.7	15.4	13.8	37.2	14.8	9.6	5.5	4.5	13.3	12.8	9.1	8.9	6.8	5.9	8.9	13.8	6.8	11.3	9.2	7.0	9.1	7.8	10.0	4.9	6.8	15.5	5.5	7.1	8.1	15.5	6.3	6.2	29.1	9.8	13.1	10.1	2.9	1.4	0.4	3.2	0.8	4.2	5.3	2.7	4.0	2.4	6.7	1.9	1.9	0.3	1.9	2.0	3.6	2.6	1.0	5.2	5.8	53.5	9.4	5.8	6.3	6.0	7.7	8.2	5.3	6.2	9.0	13.3	3.2	5.8	22.5	13.3	2.3	9.6	6.8	4.6	10.3	4.4	4.6	9.4	4.3	4.7	3.7	18.8	6.4	7.3	5.9	5.9	4.3	15.7	10.1	10.3	7.6	2.4	4.2	47.1	2.5	6.6	7.1	9.7	4.3	2.5	5.8	6.8	4.5	4.0	10.1	44.4	2.9	10.2	4.8	2.6	10.2	13.1	4.6	3.6	22.5	10.0	5.4	2.1	32.6	39.4	5.0	3.1	8.6	6.5	8.6	8.3	15.8	10.4	7.4	0.0	6.3	6.7	1.9	7.5	5.2	2.8	7.4	7.1	5.8	7.3	6.9
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	25.8	47.5	18.7	26.6	24.5	43.5	26.4	31.0	26.4	26.9	21.6	24.4	21.7	25.3	20.4	23.0	22.3	18.9	21.6	19.3	20.4	18.2	23.8	23.1	35.1	20.1	20.4	31.1	24.6	25.2	26.9	27.3	21.7	23.5	26.0	57.0	31.2	18.6	23.1	29.5	28.7	22.9	18.5	36.0	32.5	20.6	20.8	26.9	28.6	19.5	34.5	23.1	24.6	36.0	43.9	20.5	47.0	34.0	40.1	49.0	46.4	54.0	36.5	35.3	46.6	19.1	43.2	49.1	35.6	48.8	27.5	39.2	59.0	43.4	53.6	48.3	42.1	104.3	75.7	34.5	35.5	53.0	53.7	39.8	36.6	36.1	39.7	48.1	106.1	36.2	83.8	133.2	44.0	21.9	44.2	68.5	29.7	44.5	36.8	61.3	47.2	57.3	40.7	36.2	57.1	35.6	50.4	45.7	122.7	62.3	23.4	63.0	76.1	37.7	30.9	46.7	31.8	105.6	81.7	48.1	36.3	64.5	56.6	82.1	19.5	35.0	12.2	9.4	13.9	28.6	17.8	17.9	21.1	29.8	20.5	13.1	16.8	12.2	10.9	15.3	21.4	12.6	18.7	24.5	31.0	26.4	19.3	20.4	20.1	20.4	21.7	18.5	20.8	36.0	37.9	54.5	42.1	32.0	55.4	22.2	25.1	30.3	33.0	86.5	22.2	24.5	65.3	21.5	24.4	20.2	62.6	61.4	48.3	17.8	25.4	28.5	71.4	33.3	48.5	32.5	21.7	88.1	66.4	20.0	56.3	42.0	33.1	41.4	49.9	200.4	27.5	22.1	29.2	50.5	74.2	31.3	32.6	22.6	28.1	47.7	34.8	34.4	58.7	52.5	55.9	30.7	36.0	54.3	112.3	23.8	16.4	51.6	150.1	20.7	24.1	20.2	27.3	69.2	32.9	51.7	39.8	52.7	47.4	35.1	25.7	32.6	41.8	54.8	31.6	21.6
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852148-6866632	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	27.1	37.9	23.7	26.7	26.1	22.8	19.5	15.5	38.0	24.1	2.4	31.3	25.3	31.5	17.4	38.2	25.9	18.5	33.0	25.3	33.6	20.1	23.1	20.5	29.2	31.0	31.3	19.4	17.8	41.4	27.8	25.4	38.8	26.5	22.2	15.7	20.0	29.6	66.7	48.1	26.1	35.5	15.0	21.2	22.9	40.9	28.9	36.5	26.7	42.5	29.4	29.8	24.2	29.0	88.1	135.7	88.4	100.4	59.0	53.9	113.4	93.0	70.9	109.2	78.8	129.4	84.9	105.7	47.6	98.5	86.5	75.2	98.6	92.7	69.5	198.6	84.0	97.1	105.5	71.0	45.8	88.5	97.2	55.6	52.9	94.8	64.9	72.9	94.8	41.7	85.4	40.9	91.1	97.4	132.9	44.4	172.8	89.3	56.5	103.4	115.5	73.5	62.9	84.5	48.5	97.4	63.5	96.3	41.1	110.6	38.3	72.4	92.4	91.5	109.1	70.4	117.6	49.0	124.5	163.8	102.1	55.3	91.3	5.4	19.3	8.3	24.3	25.1	23.1	15.0	21.7	20.8	28.4	13.9	20.1	20.9	1.3	17.6	24.4	20.5	19.9	27.7	23.7	26.1	15.5	38.0	25.3	33.6	31.0	31.3	38.8	15.0	28.9	29.0	11.3	9.6	13.1	7.5	14.0	11.6	11.4	18.0	8.6	18.7	13.1	10.8	9.5	17.2	11.5	22.0	60.5	45.9	14.8	21.5	11.7	28.1	14.7	10.6	14.7	15.3	16.7	19.4	11.5	20.5	30.7	16.6	10.2	13.7	14.7	29.6	11.4	22.2	28.4	40.4	11.9	19.3	14.2	13.0	7.4	19.2	23.0	10.9	16.0	9.4	32.4	16.0	13.4	6.0	11.9	20.2	17.4	33.8	14.1	10.3	22.5	18.5	7.9	16.2	32.9	13.3	17.2	51.7	25.6	17.6	15.5	52.8	15.4	27.6	27.5	7.9
USP7	HAUSP	ENSG00000187555	"Ubiquitin specific peptidase 7"	Q93009	16	8892097-8975328	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	"Developmental protein, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 282.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008108, HPA015641, CAB079904"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		16000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700"	"unprognostic (6.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.94e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.56e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.69e-1)"	22.3	16.1	17.6	27.0	19.8	54.6	20.5	20.5	20.7	20.1	15.1	33.1	21.8	21.5	10.1	29.6	19.0	19.9	23.8	21.4	18.1	19.5	25.1	19.3	39.9	16.9	20.1	19.8	26.7	34.8	13.9	23.7	17.5	20.7	32.5	21.7	18.7	18.7	45.2	25.4	25.9	25.7	18.7	24.2	25.5	58.8	18.8	51.1	22.8	41.0	44.9	26.3	17.7	20.8	39.9	73.5	62.2	46.9	34.9	42.9	42.9	53.6	44.7	48.1	40.4	66.6	46.7	94.6	33.8	61.0	27.7	48.8	95.2	61.9	79.6	63.1	38.1	78.4	49.5	132.9	49.0	87.6	48.8	37.3	37.7	52.6	61.0	37.0	69.7	139.8	77.7	101.5	49.6	75.4	130.8	16.9	43.9	49.8	41.4	114.5	69.7	86.2	33.4	77.9	58.8	35.5	59.4	55.3	28.7	62.3	55.0	39.4	60.4	52.1	54.1	80.3	40.4	49.1	134.3	145.1	48.5	49.6	43.5	5.2	2.1	2.8	4.5	2.2	5.7	4.0	4.1	5.3	2.2	4.9	4.9	4.3	3.4	2.8	6.1	6.5	5.1	1.1	17.6	19.8	20.5	20.7	21.4	18.1	16.9	20.1	17.5	18.7	18.8	20.8	40.4	35.3	54.5	22.2	38.0	46.5	23.1	17.9	22.8	51.1	29.7	28.8	74.3	21.5	36.4	29.5	25.0	21.9	51.4	39.8	5.9	22.5	282.4	38.5	50.9	35.8	42.2	46.5	31.4	33.4	14.5	34.4	31.1	57.6	26.6	47.8	25.0	37.5	19.8	43.7	34.9	49.3	10.2	29.2	31.0	112.2	25.4	43.8	19.6	21.5	36.3	29.2	24.7	24.1	30.2	35.6	39.0	34.6	46.8	34.1	31.3	13.7	37.8	44.2	6.6	58.4	39.4	33.8	39.4	41.3	50.0	21.1	40.4	47.6	54.8	35.0
UTP11	"CGI-94, UTP11L"	ENSG00000183520	"UTP11 small subunit processome component"	Q9Y3A2	1	38009258-38024820	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 111.4;tongue: 85.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 60.2;Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 72.6;Syncytiotrophoblasts: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045830	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045830: AB_10969917"	"unprognostic (1.95e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.44e-8)"	"unprognostic (3.51e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (1.42e-8)"	"unprognostic (1.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	15.4	18.7	11.0	15.4	11.9	16.7	13.6	11.9	15.9	11.4	10.6	18.4	11.3	15.9	13.4	18.4	12.3	12.9	19.9	11.7	11.6	12.3	17.0	11.4	14.9	12.9	12.3	11.0	15.6	12.0	7.3	14.8	12.4	13.7	13.3	7.0	14.1	12.8	111.4	14.6	9.9	19.7	12.0	10.7	14.0	15.1	11.9	13.5	11.0	85.5	17.5	19.7	11.0	14.7	37.6	22.9	38.5	36.8	27.8	37.8	34.6	41.5	39.4	55.4	50.4	32.8	44.9	62.6	37.9	34.2	27.2	31.6	44.2	37.2	68.8	47.3	39.9	72.6	27.9	28.8	37.9	72.7	45.3	35.3	23.7	61.4	53.3	34.1	44.6	47.6	84.1	32.5	63.5	26.6	56.9	75.4	92.1	41.9	29.1	49.7	80.8	57.3	36.5	36.2	49.8	41.5	36.1	30.7	67.8	40.1	28.1	44.5	33.2	36.8	45.0	40.8	80.0	31.0	65.8	52.6	49.3	79.3	46.5	18.1	27.6	15.2	23.1	30.6	24.3	15.0	18.3	19.3	27.6	17.5	16.3	20.3	8.3	32.2	36.5	26.3	23.4	20.5	11.0	11.9	11.9	15.9	11.7	11.6	12.9	12.3	12.4	12.0	11.9	14.7	37.9	35.3	43.6	0.0	5.7	0.0	0.0	0.0	0.0	0.0	29.8	27.6	0.0	0.0	21.1	25.8	0.0	54.2	23.6	0.0	39.2	60.2	0.0	23.6	43.5	31.4	0.0	0.0	0.0	67.4	51.7	23.4	0.0	24.8	25.2	19.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	19.1	0.0	0.0	0.0	0.0	72.6	0.0	0.0	3.5	0.0	0.0	49.4	25.5	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	77.8	10.5	39.1	0.0	0.0
UTP18	"CGI-48, WDR50"	ENSG00000011260	"UTP18 small subunit processome component"	Q9Y5J1	17	51260546-51297936	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.6;Late spermatids: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052378	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear membrane"	"HPA052378: AB_2681805"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.47e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.93e-2)"	17.9	20.1	12.6	24.9	13.7	40.0	25.8	19.1	15.7	18.8	14.2	17.5	17.8	15.7	15.8	21.0	17.5	12.8	10.2	13.2	13.8	21.8	22.3	17.3	33.1	13.0	12.3	23.8	21.3	23.3	20.4	26.3	13.6	16.2	18.7	17.5	17.4	14.2	24.4	32.3	16.5	12.9	13.0	24.5	18.1	58.7	13.2	27.7	24.4	16.2	34.4	24.8	18.0	15.6	90.5	87.7	54.6	50.3	35.1	52.2	142.2	48.9	40.2	83.5	79.7	55.4	49.3	113.5	67.8	36.6	89.0	48.1	89.7	52.0	123.3	74.8	117.0	119.4	52.6	97.3	48.0	127.9	56.4	33.9	39.5	71.1	57.0	42.1	50.7	55.6	98.7	50.6	63.5	56.1	115.6	86.9	78.5	127.5	91.8	103.2	124.2	89.4	61.3	59.1	60.7	76.9	56.7	66.6	114.7	67.4	82.3	64.4	44.7	85.3	71.8	71.1	102.9	97.4	192.5	131.5	53.0	87.6	62.4	19.0	48.2	27.9	40.2	46.9	49.9	54.1	50.7	49.2	55.9	52.4	53.6	51.1	8.2	40.0	49.0	35.0	56.8	56.2	12.6	13.7	19.1	15.7	13.2	13.8	13.0	12.3	13.6	13.0	13.2	15.6	20.6	16.0	23.4	11.8	37.4	60.2	62.9	40.6	33.0	15.6	19.6	17.9	4.4	20.0	25.2	14.7	14.6	66.7	27.4	11.4	39.2	38.4	190.6	26.3	27.3	25.1	16.1	20.8	18.5	46.9	71.2	24.5	14.3	24.1	31.7	19.6	8.9	17.1	62.8	10.1	18.0	20.7	34.6	37.7	26.1	182.0	26.8	33.3	23.2	15.0	42.2	21.3	25.7	17.6	24.6	34.2	16.3	22.2	24.2	50.2	13.8	37.5	38.8	11.8	13.1	24.8	35.7	140.2	104.5	27.7	52.7	79.6	30.4	30.8	25.3	48.1
UTRN	"DMDL, DRP, DRP1"	ENSG00000152818	Utrophin	P46939	6	144285701-144853034	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 410.3;Early spermatids: 527.1;Late spermatids: 332.1;Microglial cells: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 219.4;HUVEC TERT2: 157.0;TIME: 203.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016348, HPA018894"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		4200	"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"CAB016348: AB_628424, HPA018894: AB_10600839"	"unprognostic (3.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.61e-5)"	"unprognostic (6.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	52.6	17.4	26.8	25.8	40.5	56.6	40.5	32.7	18.3	40.4	35.6	33.8	17.0	29.8	16.8	27.9	43.5	31.2	24.8	18.4	67.9	30.9	25.3	49.3	34.9	48.6	52.1	37.2	52.1	69.4	7.9	45.8	49.7	39.7	31.7	11.0	26.0	26.1	14.0	27.5	22.3	25.9	40.0	71.5	27.2	59.2	48.8	43.2	68.4	38.9	35.8	25.2	16.0	31.0	27.2	22.6	39.3	51.0	66.5	60.5	23.4	39.0	37.8	31.1	45.2	86.1	9.8	8.4	33.6	88.4	36.6	15.6	219.4	32.9	44.6	90.6	25.5	32.2	24.9	51.6	26.3	36.1	0.7	35.5	6.8	46.2	24.1	29.3	157.0	25.1	2.0	22.7	44.1	18.1	28.7	15.5	15.9	16.6	23.9	25.7	70.2	0.8	35.9	0.7	49.7	0.9	60.8	8.4	23.5	59.5	33.3	48.2	203.6	29.8	37.0	15.5	37.6	17.7	25.3	1.3	18.2	21.5	49.5	41.2	40.9	23.2	39.5	120.8	28.3	25.7	24.9	33.0	17.2	35.7	21.8	22.8	34.5	37.6	173.9	50.4	22.2	13.9	26.8	40.5	32.7	18.3	18.4	67.9	48.6	52.1	49.7	40.0	48.8	31.0	267.0	410.3	138.7	148.2	101.2	29.4	31.7	17.2	40.9	6.5	47.4	32.1	56.0	28.6	111.0	31.3	0.0	94.4	175.1	10.9	0.0	25.3	527.1	61.2	51.5	171.8	31.2	19.8	61.2	32.0	6.9	51.6	76.5	87.5	29.7	22.8	83.6	15.6	22.3	60.6	161.4	16.9	8.2	109.7	45.9	332.1	23.9	97.6	39.2	425.3	79.8	29.1	171.0	68.9	4.1	28.1	9.3	33.4	70.3	25.4	3.6	7.1	87.3	4.3	144.7	151.0	157.8	6.6	6.6	33.7	45.5	129.3	108.0	32.0	22.3	19.2
UTY	"KDM6AL, KDM6C"	ENSG00000183878	"Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked"	O14607	Y	13248379-13480673	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 66.7;Inhibitory neurons: 65.2;Oligodendrocytes: 65.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 20.6;SK-MEL-30: 14.9;U-266/84: 16.4;U-698: 20.2"	"Low region specificity"	"Detected in all"							"HPA000568, HPA001165"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Nucleoli rim"	"HPA000568: AB_1858705, HPA001165: AB_1080541"			"unprognostic (7.52e-2)"		"unprognostic (6.60e-2)"	"unprognostic (4.04e-6)"	"unprognostic (6.47e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-2)"		"unprognostic (9.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-2)"	3.6	3.5	0.9	2.4	1.5	6.8	3.5	2.0	2.2	0.0	1.6	2.9	2.5	0.0	9.4	4.1	0.0	3.5	2.9	0.9	1.2	3.1	4.1	4.2	2.1	2.1	1.1	0.0	3.4	2.9	4.0	3.4	2.1	8.1	6.2	4.5	4.3	6.2	5.7	5.1	6.3	0.0	1.3	3.4	2.9	3.8	1.4	0.0	3.8	5.2	6.0	3.6	0.0	3.2	0.0	2.5	0.0	0.0	0.0	0.0	8.7	4.5	7.7	5.0	7.5	0.0	0.0	12.4	0.0	5.1	0.0	0.0	0.0	0.0	6.9	6.9	0.0	20.6	0.0	0.0	6.4	0.0	0.0	7.8	7.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	5.5	0.0	7.1	0.1	0.0	0.0	0.0	0.0	3.1	5.6	5.4	8.3	4.9	0.0	0.0	0.0	14.9	8.5	0.0	4.4	5.9	8.7	0.0	0.0	3.1	13.5	16.4	20.2	0.8	0.0	0.0	1.8	1.7	3.8	2.6	1.9	3.7	2.9	2.6	2.1	1.8	3.2	3.6	2.7	3.9	5.8	2.2	2.9	3.2	1.1	0.9	1.5	2.0	2.2	0.9	1.2	2.1	1.1	2.1	1.3	1.4	3.2	0.0	16.0	25.3	58.4	35.4	11.3	18.4	8.2	44.3	35.2	0.0	0.0	6.1	5.7	10.7	18.4	64.6	10.0	8.0	3.0	0.0	4.8	0.4	0.0	0.0	9.0	1.8	19.6	66.7	0.0	3.7	9.3	37.8	0.0	16.4	0.0	12.5	2.1	3.0	37.0	65.2	3.3	2.0	14.2	14.5	2.0	10.8	12.7	8.8	54.4	18.1	12.8	25.7	57.8	65.8	1.5	2.2	11.7	23.2	14.0	2.9	2.6	10.7	37.4	0.0	4.7	5.0	4.0	6.8	33.2	15.3	13.3	25.1	0.0	2.9	21.3
UVSSA	KIAA1530	ENSG00000163945	"UV stimulated scaffold protein A"	Q2YD98	4	1345691-1395989	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050824, HPA053496"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA050824: AB_2681251, HPA053496: AB_2682170"	"unprognostic (6.40e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.85e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.76e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (6.87e-4)"	4.2	4.3	3.5	5.5	4.1	8.0	4.4	3.4	5.1	4.5	5.5	4.7	5.5	5.0	6.0	4.2	6.4	3.4	2.9	3.3	3.1	3.2	3.9	6.0	3.8	5.7	3.9	5.5	6.7	2.6	9.3	2.8	4.7	4.1	3.5	4.7	5.7	2.7	4.6	9.2	5.3	2.5	3.0	5.6	5.5	9.4	5.4	3.8	7.1	1.5	3.4	4.7	4.5	7.5	3.7	4.1	6.1	5.7	7.0	9.0	4.6	3.4	2.9	3.0	2.6	3.4	7.5	2.7	6.5	3.4	7.9	4.4	3.8	3.9	2.6	3.7	1.6	6.4	7.9	4.0	2.7	3.9	7.6	2.6	7.8	3.4	4.4	3.4	5.0	4.6	6.2	8.9	3.7	2.1	5.8	8.1	6.0	2.9	5.2	5.0	3.1	3.4	2.7	5.4	4.4	5.8	2.6	3.0	3.8	5.3	8.0	2.2	9.5	11.4	2.8	4.2	5.9	13.4	9.0	6.1	8.5	4.4	6.9	0.1	0.6	0.9	0.6	0.5	0.3	0.4	0.5	0.5	1.0	0.4	0.4	0.3	1.0	3.3	0.8	0.8	0.2	0.5	3.5	4.1	3.4	5.1	3.3	3.1	5.7	3.9	4.7	3.0	5.4	7.5	20.7	6.4	26.2	16.3	11.5	5.5	5.2	3.4	5.7	18.2	13.7	10.7	3.6	7.2	8.8	16.5	41.7	3.4	17.1	10.3	3.9	8.0	7.6	23.7	23.1	9.1	6.0	7.4	6.9	8.5	2.9	10.3	21.9	20.1	8.8	16.7	5.3	12.5	6.8	30.3	9.3	10.9	8.2	10.8	6.3	7.3	5.3	13.4	5.4	14.0	7.6	9.0	7.2	5.5	16.5	10.1	6.7	3.8	12.6	5.0	10.7	4.8	23.6	25.3	0.0	13.1	11.4	23.2	9.4	8.0	6.1	3.7	12.0	12.8	6.5	4.5
UXT	"ART-27, STAP1"	ENSG00000126756	"Ubiquitously expressed prefoldin like chaperone"	Q9UBK9	X	47651796-47659180	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Chaperone, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050499, HPA058400"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Centriolar satellite"	"HPA050499: AB_2681146, HPA058400: AB_2683706"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.09e-3)"	124.7	148.6	82.1	78.8	84.9	212.0	127.1	85.6	111.7	121.8	86.5	112.3	77.2	93.6	123.6	116.6	103.3	66.7	144.6	80.1	85.1	134.2	135.1	97.8	148.7	87.1	82.5	184.6	182.3	90.5	107.0	65.3	88.4	119.7	99.7	42.8	121.6	65.9	130.7	143.6	113.8	68.2	87.7	139.5	131.7	46.3	83.7	166.9	96.3	95.2	143.0	109.6	111.9	91.1	192.0	208.6	87.4	116.0	194.3	233.4	152.3	119.2	178.5	203.6	191.7	182.1	178.1	217.3	86.4	173.5	188.0	151.8	123.5	163.8	145.3	143.7	240.8	111.6	220.8	182.4	224.2	246.6	208.1	162.9	207.5	168.6	183.8	142.2	165.9	185.6	122.2	205.1	174.8	211.5	170.7	342.1	125.4	174.7	231.2	149.5	177.2	300.9	168.1	141.4	82.1	107.1	133.1	146.7	197.8	157.7	170.4	227.2	122.4	140.7	153.2	196.2	136.7	161.7	154.5	200.7	179.8	270.1	145.1	110.1	159.7	123.4	169.5	166.1	229.8	262.7	242.6	184.2	213.3	245.2	303.2	255.4	100.7	172.1	156.9	270.3	248.2	247.9	82.1	84.9	85.6	111.7	80.1	85.1	87.1	82.5	88.4	87.7	83.7	91.1	108.3	73.7	79.5	5.5	276.8	214.9	274.3	247.9	212.3	27.3	242.1	239.6	100.7	165.8	141.4	97.5	16.7	189.4	207.2	212.1	315.0	161.2	73.5	122.3	125.2	129.6	187.2	170.0	4.0	318.9	212.6	127.6	78.0	114.0	154.1	161.4	193.5	242.4	246.5	10.1	4.3	331.9	126.1	248.0	277.4	185.2	210.3	179.8	197.5	1.9	316.0	108.2	212.1	3.5	7.7	189.3	338.0	196.0	198.3	256.4	297.8	466.1	138.0	28.6	144.7	224.3	145.2	78.7	85.6	183.3	203.7	213.7	240.5	185.5	328.5	286.0
VAMP5		ENSG00000168899	"Vesicle associated membrane protein 5"	O95183	2	85584431-85593406	"Predicted membrane proteins"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 487.9;Endothelial cells: 337.8;Hepatic stellate cells: 486.2;Kupffer cells: 340.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 364.7;LHCN-M2: 428.9;TIME: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035082	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		130000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA035082: AB_10610564"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.28e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (9.61e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.60e-1)"	134.0	117.4	71.0	59.9	74.1	41.2	118.4	72.9	89.1	78.6	66.8	76.4	23.3	79.4	33.2	45.3	84.3	58.0	114.7	69.4	76.1	90.0	79.3	134.6	92.7	79.1	71.4	52.8	29.0	14.7	31.9	74.1	74.2	72.8	20.5	2.9	36.9	36.7	217.3	44.5	54.1	77.2	73.8	97.5	54.0	11.4	78.0	50.9	63.8	199.6	41.2	87.1	69.7	71.7	0.8	0.2	2.4	0.0	89.3	155.8	2.4	98.5	155.9	95.5	104.5	39.5	15.1	0.3	2.3	172.2	50.7	1.1	0.0	2.4	42.2	142.9	2.8	1.9	2.5	56.1	187.2	4.5	0.9	108.4	9.6	40.1	1.1	138.9	364.7	61.7	0.4	0.3	428.9	14.5	63.1	13.8	0.1	27.2	0.6	92.4	0.4	2.7	2.7	3.6	0.2	3.4	0.6	27.4	0.5	2.2	3.2	5.1	250.0	2.3	6.7	7.5	0.2	0.1	3.1	2.4	110.5	5.4	65.9	59.1	222.6	176.5	180.5	503.8	171.7	60.7	136.1	135.2	79.0	54.5	102.4	125.1	70.2	94.4	424.9	86.4	248.7	283.0	71.0	74.1	72.9	89.1	69.4	76.1	79.1	71.4	74.2	73.8	78.0	71.7	487.9	19.2	21.2	3.6	43.9	60.8	39.8	104.1	39.3	0.8	14.9	27.3	84.4	71.4	70.1	44.1	0.0	22.9	64.5	38.8	29.4	29.9	1.8	7.7	64.7	337.8	12.6	35.6	0.1	49.1	7.2	148.0	9.7	7.9	44.4	22.2	486.2	198.6	80.3	3.3	0.2	20.5	36.7	340.8	91.5	10.2	192.6	147.8	275.7	4.7	136.0	17.5	112.3	0.5	1.6	44.2	51.9	165.1	68.4	64.7	126.5	91.2	50.6	1.0	59.2	152.2	83.9	5.5	6.6	19.8	45.3	21.6	88.5	19.2	7.8	49.4
VAMP8	EDB	ENSG00000118640	"Vesicle associated membrane protein 8"	Q9BV40	2	85561562-85582031	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 873.4;NB-4: 1362.5;U-937: 912.8"	"Low region specificity"	"Detected in all"							"HPA006882, HPA007215, CAB037132, CAB037147"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		220000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: "	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (8.07e-9)"	"prognostic favorable (1.59e-6)"	74.0	34.7	26.9	148.4	28.2	299.7	225.1	28.7	53.8	121.8	51.6	250.6	229.9	30.6	144.5	303.1	166.1	119.2	24.6	26.5	29.9	280.1	247.4	266.5	212.4	35.6	31.6	10.4	182.5	270.3	33.7	265.7	34.3	107.7	300.9	4.4	322.5	90.4	24.3	210.2	252.1	71.4	31.9	175.9	228.4	23.4	35.5	173.5	126.0	27.3	311.7	198.0	150.0	36.5	255.0	33.2	2.6	2.3	2.4	1.4	241.6	0.7	0.3	0.2	0.3	191.2	225.2	56.8	174.4	1.2	17.9	175.2	2.4	451.6	0.6	232.3	173.7	290.3	104.4	220.7	3.3	873.4	287.1	2.3	317.5	0.3	72.3	1.2	58.2	1.2	214.9	11.6	103.8	363.9	0.8	1362.5	3.2	315.9	26.0	5.2	8.9	381.7	516.9	384.3	8.4	2.9	120.9	628.3	19.4	126.3	231.4	665.4	113.9	0.3	15.3	2.9	2.7	3.0	151.1	340.0	2.6	912.8	1.1	601.3	868.6	328.4	469.3	740.3	455.6	519.3	537.0	463.3	787.3	508.3	423.2	442.0	52.4	556.3	460.0	2135.6	665.3	1536.0	26.9	28.2	28.7	53.8	26.5	29.9	35.6	31.6	34.3	31.9	35.5	36.5	39.4	371.8	283.2	1.3	147.7	259.1	303.3	800.9	164.4	1.2	289.7	251.7	6.3	356.0	662.1	366.0	0.0	980.8	447.1	832.3	765.0	630.7	28.0	231.3	22.8	46.1	129.1	147.4	0.1	730.0	460.4	35.6	188.6	212.9	269.4	3.3	163.1	314.8	1191.1	0.0	0.1	391.8	545.3	1000.4	488.7	49.1	9.3	537.2	352.2	2.8	686.1	7.9	375.9	0.0	0.5	865.5	843.2	7.5	103.0	302.7	1184.0	1046.8	600.5	2.0	46.0	21.4	56.5	48.0	8.3	239.8	329.7	877.8	219.5	13.8	299.4	602.0
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383538	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 58.7;Fibroblasts: 104.2;Leydig cells: 50.1;Peritubular cells: 60.9;Sertoli cells: 98.6;Smooth muscle cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 21.8;MCF7: 18.4;U-2197: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"	NA	Yes		2000000000		"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: AB_2732418"	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	55.7	15.5	1.5	5.8	2.3	2.7	31.5	0.8	2.3	48.1	3.0	12.1	3.4	30.3	0.0	34.1	24.6	7.3	30.5	1.1	0.5	56.1	31.8	44.9	2.8	6.3	5.5	40.0	10.3	0.0	12.8	10.4	1.7	17.9	0.0	0.3	15.9	0.0	6.9	38.8	11.2	0.0	1.6	13.0	13.4	16.8	4.6	0.0	26.8	0.0	0.0	26.5	38.9	2.7	4.2	0.0	0.6	0.5	0.2	0.2	12.6	21.8	0.1	0.0	0.0	1.9	5.5	0.0	4.5	0.3	2.6	0.3	0.0	0.0	0.0	13.7	2.2	0.9	15.9	14.9	0.6	0.0	0.4	7.9	0.0	0.3	0.0	3.1	0.0	0.1	3.1	0.8	0.0	18.4	1.0	5.3	2.2	0.4	2.4	1.0	0.0	0.0	0.0	0.1	1.4	9.3	6.5	13.5	0.6	2.2	6.8	2.5	0.0	17.5	12.5	78.4	4.6	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.3	0.8	2.3	1.1	0.5	6.3	5.5	1.7	1.6	4.6	2.7	10.0	6.4	13.1	5.5	1.4	9.6	7.8	4.2	9.1	0.5	21.9	10.9	16.2	32.9	6.4	23.9	0.0	5.4	2.8	1.5	7.9	13.1	1.1	12.1	58.7	4.6	0.0	0.0	1.1	2.9	7.2	104.2	16.8	20.5	3.8	4.6	2.9	15.3	3.4	0.0	0.9	2.0	2.0	0.6	21.7	2.8	50.1	2.0	14.2	2.8	0.0	18.3	0.0	0.5	0.3	28.3	1.2	60.9	0.8	6.4	0.2	12.3	2.7	0.7	98.6	12.6	80.9	0.8	4.1	3.7	7.5	10.0	3.5	2.3	0.8	4.9
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"brain: 8.4"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 7.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 3.1;WM-115: 2.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 5.6;hypothalamus: 3.2;olfactory bulb: 1.5"	"Low region specificity"	"Detected in some"			HPA028946	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli rim"	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.0	0.0	1.6	0.0	4.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.4	0.0	2.8	0.2	8.4	0.1	0.2	0.0	0.0	2.3	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35053928-35072668	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 540.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		34000000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	59.8	88.4	56.8	33.7	59.0	52.0	54.2	58.9	58.0	57.8	72.0	51.8	33.8	59.0	51.6	84.9	49.4	35.3	117.5	60.4	66.2	59.1	87.5	57.2	42.5	64.4	62.0	46.1	61.2	65.7	57.3	46.0	68.2	54.5	36.5	26.3	63.2	58.9	176.0	64.0	51.8	42.5	62.3	64.1	62.5	45.1	63.7	59.6	49.7	135.3	53.3	57.9	55.3	69.8	167.6	223.8	124.6	57.5	187.4	135.3	98.3	153.8	215.0	244.1	197.6	160.0	60.1	140.8	137.2	242.9	173.1	69.5	253.1	230.7	227.6	146.2	126.0	95.3	216.5	238.0	146.5	92.4	106.2	148.5	136.4	239.2	115.6	104.4	276.2	56.3	97.6	71.4	219.2	154.7	114.3	234.9	152.2	82.7	219.1	80.7	111.8	72.8	204.1	175.7	65.7	84.1	100.4	81.2	45.1	152.2	71.5	60.3	215.5	77.5	112.5	63.7	118.6	41.9	116.5	104.3	139.5	67.0	105.4	142.0	62.7	75.0	58.8	70.0	62.4	59.2	59.0	65.6	75.3	53.0	42.3	44.4	71.1	67.1	80.4	49.8	91.2	111.8	56.8	59.0	58.9	58.0	60.4	66.2	64.4	62.0	68.2	62.3	63.7	69.8	86.5	80.1	73.7	22.9	124.3	77.0	120.8	147.6	111.5	86.6	66.0	47.2	220.4	47.1	115.1	55.2	118.9	276.8	91.0	111.9	74.3	188.6	43.6	97.8	85.6	127.7	84.2	137.0	27.4	187.5	164.7	109.7	133.5	105.8	62.1	106.2	111.0	126.0	133.1	74.0	27.7	108.3	89.5	57.9	65.6	47.0	83.9	81.5	76.5	16.9	159.6	88.7	54.6	18.6	31.4	247.9	69.0	86.9	267.6	118.3	77.2	113.4	102.5	90.0	138.1	74.1	154.9	144.5	118.7	126.2	90.6	540.6	105.4	129.6	96.4	135.6
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 235.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 141.7;Proximal enterocytes: 88.7;Undifferentiated cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"classical monocyte: 3.5;eosinophil: 1.9;intermediate monocyte: 6.5;myeloid DC: 5.1;neutrophil: 6.5;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.5;monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 55.5;HDLM-2: 80.0;U-937: 85.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.1"	"Region enhanced"	"Detected in some"		"spinal cord: 4.3"	"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.6	13.7	0.2	13.3	0.2	8.2	11.3	0.2	0.4	5.0	0.9	40.4	56.0	1.6	0.4	13.6	1.8	8.5	1.2	0.2	0.7	21.0	1.1	7.7	5.3	0.7	0.4	0.5	2.1	235.9	11.1	2.9	0.6	1.9	35.3	0.2	6.1	1.8	2.8	22.1	55.0	3.8	0.1	2.6	7.4	1.0	1.4	1.5	2.2	0.6	7.2	10.4	7.6	0.3	15.0	2.6	0.1	0.1	12.0	16.4	0.2	17.7	8.6	15.0	12.9	10.6	12.1	3.5	17.4	13.6	10.7	27.1	0.5	55.5	6.4	80.0	4.0	6.3	3.1	0.9	8.1	12.2	20.3	23.6	30.5	16.4	26.0	22.3	1.2	1.3	1.8	3.9	7.0	9.2	0.3	6.0	0.2	34.8	19.1	0.3	0.0	9.9	13.3	13.5	6.2	0.2	14.7	42.6	5.9	0.1	47.6	6.7	1.0	28.8	7.3	8.2	10.2	2.2	0.1	3.0	8.6	85.3	7.7	0.1	3.5	1.9	0.0	6.5	0.1	0.5	0.3	0.0	5.1	0.0	0.1	0.0	6.5	0.2	6.7	0.4	0.7	1.5	0.2	0.2	0.2	0.4	0.2	0.7	0.7	0.4	0.6	0.1	1.4	0.3	0.4	12.8	20.1	0.3	1.4	36.1	9.0	8.5	24.5	0.5	21.2	13.7	1.7	0.0	9.2	7.3	0.0	0.2	0.9	141.7	7.9	3.5	0.2	11.9	0.5	1.3	21.7	0.0	0.4	10.9	0.1	5.3	14.3	4.7	7.0	0.2	0.0	0.3	3.4	0.0	0.3	32.8	2.0	7.3	43.4	0.0	0.0	21.2	8.8	1.0	10.4	0.2	0.0	0.5	0.1	22.4	43.3	0.4	10.9	8.3	88.7	32.0	9.0	0.2	0.0	1.1	2.2	0.7	0.3	23.4	40.6	0.3	2.8	0.0	72.4	11.6
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.2;kidney: 27.0;lung: 29.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 266.0;Alveolar cells type 2: 175.9;Distal tubular cells: 46.9;Early spermatids: 64.5;Late spermatids: 84.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.3;renal cancer: 4.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 92.0;hTERT-RPE1: 96.7;HUVEC TERT2: 245.1;TIME: 147.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.4	20.2	0.2	0.1	0.3	2.2	1.9	0.8	0.1	3.1	11.1	0.8	0.7	0.3	17.6	0.0	5.4	0.9	0.2	0.7	0.4	27.0	0.5	29.4	0.0	2.7	1.1	0.2	13.1	2.1	17.1	1.3	2.9	1.4	0.8	0.4	2.5	2.8	0.1	1.5	0.1	0.2	0.4	4.0	0.9	2.9	0.4	0.1	2.0	0.1	0.0	0.4	0.3	0.2	7.3	0.8	16.0	0.0	9.2	33.8	0.0	41.9	92.0	12.2	17.7	1.1	6.4	0.0	16.0	45.3	1.9	0.3	0.5	1.0	67.2	0.2	0.0	7.3	0.8	0.0	2.9	0.0	0.1	9.9	0.7	51.9	10.3	96.7	245.1	0.0	2.5	0.0	33.4	0.9	0.0	0.0	6.6	1.9	6.2	0.0	1.2	0.0	6.1	3.6	0.6	0.0	1.3	1.9	17.0	0.2	70.7	0.1	147.2	48.0	1.6	16.8	58.0	0.0	0.0	0.0	38.6	0.0	11.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.7	0.2	0.3	0.8	0.1	0.7	0.4	2.7	1.1	2.9	0.4	0.4	0.2	0.1	266.0	175.9	1.6	0.5	1.8	0.2	0.0	0.0	0.2	4.5	3.7	0.5	22.8	14.3	31.3	2.1	1.8	0.2	1.2	46.9	6.9	64.5	11.1	0.5	0.9	0.0	0.0	2.8	10.1	0.1	0.9	0.0	4.4	0.0	0.8	0.0	0.0	0.2	0.0	3.3	0.4	0.0	0.0	0.3	84.7	1.5	2.3	28.4	0.0	0.7	1.5	0.0	0.0	0.9	1.8	3.2	0.4	0.0	0.3	0.0	28.7	8.1	0.5	0.0	0.1	1.3	0.3	0.9	0.0	0.4	0.0	0.6	0.9	0.8	0.2
VEZF1	"DB1, ZNF161"	ENSG00000136451	"Vascular endothelial zinc finger 1"	Q14119	17	57971547-57988259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027520, HPA048315"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA027520: AB_10602680, HPA048315: AB_2680353"	"unprognostic (7.24e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (6.14e-5)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.03e-2)"	22.1	29.1	20.8	18.7	33.4	56.6	24.0	26.7	23.9	30.9	26.0	40.7	19.1	37.6	16.0	24.8	37.7	25.0	29.2	20.4	25.9	26.2	16.6	28.5	21.9	32.1	28.6	32.1	25.7	24.8	20.5	26.3	31.0	29.3	23.1	70.5	27.5	27.2	65.7	16.0	24.3	33.0	24.3	23.9	26.0	18.9	27.5	34.9	37.4	44.5	20.2	32.7	24.2	47.3	42.5	48.1	93.8	30.1	22.9	32.4	28.9	35.1	50.9	44.7	41.0	22.9	44.4	20.6	55.3	40.3	41.6	23.7	38.1	40.7	60.3	58.2	23.7	41.7	39.5	25.6	27.1	36.0	33.6	23.0	47.6	29.9	52.1	59.3	42.2	29.5	30.9	28.9	44.2	15.3	58.0	20.0	30.5	38.4	48.7	43.4	68.9	16.9	25.6	40.9	36.6	63.2	32.3	15.3	51.8	39.3	90.3	33.1	40.2	59.7	59.3	37.5	56.1	30.9	26.3	33.9	40.5	30.4	76.3	31.6	15.2	30.1	17.9	19.0	18.0	12.8	13.8	19.3	18.6	14.3	18.0	16.2	25.2	30.7	33.9	17.2	14.3	16.4	20.8	33.4	26.7	23.9	20.4	25.9	32.1	28.6	31.0	24.3	27.5	47.3	44.4	83.3	60.9	29.0	32.2	36.2	39.5	25.8	70.0	73.6	42.6	37.6	111.0	40.0	41.5	25.8	66.7	16.3	49.5	24.9	25.4	36.2	28.9	73.5	41.4	44.6	49.0	23.8	8.1	36.5	19.2	48.6	23.4	64.3	57.0	44.4	34.2	18.3	22.6	33.7	14.5	29.7	24.4	34.9	48.5	36.6	36.1	36.5	42.7	19.7	39.4	44.5	34.0	43.2	81.9	30.9	21.1	27.8	20.2	48.3	21.1	23.8	63.0	65.7	52.6	102.8	60.5	42.1	24.5	36.0	21.0	19.8	34.3	21.8	26.7	35.3
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302799	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.93e-5)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	7.3	9.9	7.7	5.8	8.0	3.3	8.9	11.3	9.9	9.2	3.1	7.6	5.8	8.2	9.6	6.6	7.7	7.4	9.5	8.5	8.6	6.9	6.2	7.8	6.4	4.4	5.7	11.2	9.0	8.6	13.4	9.4	5.7	9.6	6.3	20.3	5.4	7.6	23.8	10.3	5.9	7.1	4.0	4.1	5.6	4.5	6.9	6.6	18.9	21.2	6.4	7.5	8.5	7.1	14.4	12.9	18.0	9.5	14.7	9.2	6.8	10.3	13.3	8.7	12.9	4.8	6.6	18.6	6.5	8.8	4.3	7.4	13.3	9.2	15.2	12.6	7.3	7.2	3.3	5.2	7.5	14.2	4.1	12.7	15.6	7.6	21.9	19.0	17.1	8.9	4.2	7.0	7.6	4.0	12.4	6.7	9.2	4.5	13.1	11.1	8.4	6.0	23.8	10.3	12.1	10.6	10.1	14.9	4.9	15.8	18.4	2.4	13.9	7.2	2.8	3.5	5.8	6.8	11.4	16.3	2.8	5.1	3.8	0.2	1.5	0.5	1.5	1.6	2.1	2.5	2.2	0.9	2.0	1.8	1.0	0.9	0.1	1.1	0.4	0.8	1.8	0.5	7.7	8.0	11.3	9.9	8.5	8.6	4.4	5.7	5.7	4.0	6.9	7.1	36.5	70.5	49.3	88.8	31.1	77.8	58.1	37.5	63.2	67.9	46.3	28.6	49.0	37.1	44.5	33.1	85.5	39.6	26.3	40.0	9.8	50.1	16.5	30.1	48.4	44.6	38.4	22.1	151.8	45.2	22.3	31.0	27.5	53.8	29.2	59.9	47.8	36.7	21.6	62.2	149.1	36.1	30.5	27.1	37.5	11.4	32.6	23.2	37.4	74.9	25.2	24.1	14.4	101.0	98.4	76.4	39.4	33.1	40.5	54.6	33.0	21.5	33.1	146.6	6.6	39.0	37.3	39.4	21.3	57.8	72.5	110.7	29.1	32.7	24.9	71.7
VGLL1	"TDU, TONDU"	ENSG00000102243	"Vestigial like family member 1"	Q99990	X	136532215-136556807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 203.9"	"Group enriched"	"Detected in some"	11	"Cytotrophoblasts: 1282.0;Extravillous trophoblasts: 582.3;Syncytiotrophoblasts: 1788.6"	"Group enriched"	"Detected in many"	4	"ovarian cancer: 13.7;urothelial cancer: 47.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 130.7;BEWO: 189.5;CAPAN-2: 72.7;RT4: 328.6;SK-BR-3: 328.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042403, HPA064616"	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA042403: AB_2677980, HPA064616: AB_2685300"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (4.54e-4)"		"unprognostic (5.16e-2)"		"unprognostic (1.80e-1)"	"unprognostic (4.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.37e-2)"		"unprognostic (5.53e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-2)"	0.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.4	1.5	1.3	0.6	0.1	0.0	0.0	6.6	0.1	2.1	0.0	0.0	0.0	0.1	1.5	0.0	1.4	203.9	0.0	1.4	0.0	0.0	5.1	6.7	0.0	0.2	0.2	0.0	0.0	0.1	0.9	0.1	0.1	0.2	0.0	0.0	1.1	22.7	1.6	0.0	130.7	0.0	0.0	0.1	0.0	0.0	189.5	0.0	0.0	0.0	0.0	18.1	72.7	0.0	0.0	0.0	0.0	5.9	0.0	7.5	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.3	0.4	0.1	2.1	0.0	0.1	0.0	0.1	0.0	328.6	0.2	0.2	0.0	328.7	0.3	13.2	5.6	0.4	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.4	0.0	0.0	0.0	0.0	2.3	1.7	0.0	0.0	4.9	1.8	0.2	0.0	16.6	36.8	0.0	1282.0	0.1	0.0	0.0	2.1	0.0	3.3	0.1	2.7	0.0	0.0	0.0	0.2	582.3	5.8	0.0	2.0	1.3	0.0	0.0	0.0	108.2	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.3	0.0	0.1	8.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1788.6	0.0	0.0	0.0	30.5
VGLL4	KIAA0121	ENSG00000144560	"Vestigial like family member 4"	Q14135	3	11556069-11771350	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038225, HPA038614"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA038225: AB_10674549, HPA038614: AB_2676115"	"unprognostic (1.21e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.26e-1)"	36.2	44.2	29.3	16.8	28.9	14.7	37.2	21.8	31.2	54.2	73.1	31.6	25.4	50.6	21.3	37.0	45.7	35.8	31.1	33.0	26.1	34.8	15.8	33.0	20.0	30.1	27.2	78.0	25.2	37.2	25.3	25.1	26.1	31.5	17.9	19.8	43.8	22.9	18.9	39.7	25.7	31.1	22.3	21.1	27.0	24.5	30.2	29.6	45.8	12.6	21.9	35.2	46.1	30.2	26.6	17.1	38.8	9.9	55.0	28.5	97.4	16.7	33.0	12.8	14.0	15.2	26.0	33.0	36.1	26.1	25.1	18.1	20.4	29.9	9.2	20.8	32.5	27.1	15.7	22.6	43.2	27.9	23.0	36.0	61.8	16.1	25.4	72.6	51.8	33.1	10.4	5.1	20.1	23.1	27.3	31.0	25.0	37.1	24.7	43.5	25.9	44.3	33.3	39.0	20.6	50.0	16.8	21.7	43.1	29.8	21.3	26.0	27.1	33.1	18.5	22.3	39.0	9.9	28.9	72.7	37.4	44.9	64.0	20.2	3.9	0.8	10.2	2.3	7.0	5.9	6.0	9.0	5.1	3.8	6.9	8.5	2.5	5.6	9.2	4.2	3.3	6.1	29.3	28.9	21.8	31.2	33.0	26.1	30.1	27.2	26.1	22.3	30.2	30.2	76.8	32.1	20.8	92.4	21.3	64.5	61.8	101.8	82.6	43.1	63.1	68.6	4.1	61.5	53.3	44.1	148.0	74.0	22.6	23.8	62.6	73.3	15.6	63.8	44.4	78.4	34.6	29.9	108.9	35.8	80.6	59.5	35.2	67.5	14.5	66.5	69.3	17.2	33.1	74.0	75.5	34.1	105.8	20.2	43.6	16.1	73.3	21.1	44.4	50.6	23.1	95.3	32.0	111.6	60.8	54.5	35.3	90.7	14.7	101.7	36.2	27.1	61.7	55.3	32.9	58.9	59.0	8.7	28.3	78.2	76.1	44.7	26.8	66.0	41.3	77.7
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141778-10153667	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031631, HPA031632, HPA068954"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA031631: AB_2673968, HPA031632: AB_2673969, HPA068954: "	"prognostic unfavorable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	14.0	13.7	11.5	21.1	11.0	27.9	14.7	13.6	12.1	11.8	6.7	14.8	15.7	14.1	9.8	12.3	13.4	11.5	7.9	11.8	14.9	12.6	14.1	11.8	29.6	9.4	9.4	12.6	12.7	11.7	9.0	14.1	9.3	14.0	15.7	8.9	14.5	10.2	11.4	14.2	17.2	12.8	9.6	22.5	16.0	13.4	16.6	23.4	15.8	7.7	29.7	12.5	10.9	12.5	19.5	18.2	39.9	24.6	36.0	27.7	146.5	16.8	24.0	21.1	24.5	21.5	23.7	67.9	22.2	23.0	29.9	16.4	37.2	23.6	25.7	33.0	33.7	52.7	30.5	30.6	34.3	47.3	41.3	28.1	26.3	28.0	35.1	28.4	24.6	42.5	48.3	50.3	21.1	35.0	45.5	40.9	26.7	21.1	23.4	57.3	34.6	34.6	25.5	48.7	15.0	49.4	35.0	18.7	21.0	23.9	37.0	59.1	21.3	20.8	27.7	19.6	26.8	35.7	78.1	105.6	23.2	55.3	19.4	4.6	3.2	2.3	2.6	2.2	1.9	2.5	1.8	2.2	2.0	3.3	1.7	1.8	5.6	3.0	2.0	2.3	1.7	1.2	11.5	11.0	13.6	12.1	11.8	14.9	9.4	9.4	9.3	9.6	16.6	12.5	12.4	12.8	12.5	9.1	38.7	14.7	17.8	14.3	24.5	14.7	10.7	6.1	6.1	20.0	9.6	16.5	18.8	16.8	21.9	10.7	7.9	11.8	9.6	13.1	26.1	14.8	14.4	30.5	15.9	5.1	18.7	12.8	20.9	19.9	5.1	18.4	18.9	14.3	14.9	18.5	14.2	11.3	16.2	27.1	45.8	7.3	14.0	32.3	12.4	7.5	31.9	9.1	28.8	12.1	14.9	10.7	11.7	11.3	33.3	23.8	12.3	9.5	9.7	15.3	6.6	17.4	11.9	15.4	24.0	26.7	20.5	17.2	23.5	21.4	10.2	25.9
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 61.9;stomach 1: 97.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 221.7;Gastric mucus-secreting cells: 192.7;Paneth cells: 139.0;Proximal enterocytes: 165.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.0;OE19: 78.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA035675, HPA035676"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA035675: AB_10671223, HPA035676: "	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (1.35e-4)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	5.4	3.7	8.7	11.0	9.0	12.6	6.4	6.6	10.6	9.5	6.4	46.8	61.9	5.7	1.5	7.2	6.7	15.7	6.4	8.6	7.8	5.3	1.4	7.7	9.8	8.3	8.4	6.8	3.4	1.2	5.1	4.1	8.0	16.0	26.6	1.2	5.7	4.0	1.2	9.1	61.7	4.1	8.0	11.8	97.5	5.4	8.2	10.2	7.4	1.4	6.3	17.5	7.4	7.2	8.2	0.1	0.2	0.4	2.8	2.2	0.8	2.3	1.9	2.3	2.2	6.1	25.0	3.9	3.5	1.6	0.0	1.9	1.8	0.2	0.5	0.8	0.0	7.3	0.1	0.6	3.4	7.7	9.5	3.3	2.2	2.2	0.0	0.0	4.5	16.1	7.3	2.3	2.6	0.1	12.4	8.7	0.2	78.4	0.0	4.8	0.0	2.0	0.8	9.8	0.1	0.3	0.0	0.5	1.8	0.0	0.7	12.4	2.8	1.0	0.3	3.0	0.0	1.4	3.1	1.2	0.6	10.9	5.0	0.0	3.2	0.0	6.8	2.0	7.4	3.5	4.4	3.9	2.1	4.6	5.6	4.2	0.1	3.4	1.4	3.8	5.8	4.1	8.7	9.0	6.6	10.6	8.6	7.8	8.3	8.4	8.0	8.0	8.2	7.2	4.9	9.6	7.4	10.4	7.2	2.3	5.7	25.5	6.8	0.9	3.3	2.9	1.9	8.6	46.1	0.0	0.0	3.0	13.3	221.7	0.0	3.4	6.2	1.5	2.7	4.5	9.6	6.1	5.5	16.9	3.4	6.7	192.7	1.5	8.2	6.1	5.3	0.3	2.4	1.7	3.0	64.4	14.2	1.9	2.4	19.9	3.7	4.0	1.8	3.7	4.2	28.1	7.2	2.5	1.2	38.7	139.0	2.6	4.4	6.2	165.6	1.6	40.5	0.8	0.0	4.3	7.1	5.4	3.4	3.1	1.4	1.0	8.1	5.6	50.5	33.4
VIRMA	"DKFZP434I116, fSAP121, KIAA1429"	ENSG00000164944	"Vir like m6A methyltransferase associated"	Q69YN4	8	94487689-94553529	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 26.4;Endometrial stromal cells: 32.2;Granulosa cells: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031530	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	Nucleoplasm	"HPA031530: AB_10600818"	"unprognostic (2.51e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.87e-2)"	12.5	7.8	6.9	11.6	8.5	27.3	17.5	11.5	7.2	13.1	7.1	9.9	8.1	13.7	8.6	9.7	11.4	8.9	9.9	6.1	7.4	10.8	12.5	10.7	14.4	7.1	7.2	16.7	10.3	14.8	6.3	13.2	7.2	10.7	11.7	12.3	9.5	10.3	8.7	9.7	9.1	13.9	7.2	11.4	11.6	16.5	7.3	20.0	13.3	9.3	15.2	10.5	8.0	9.2	40.5	25.2	26.8	14.9	32.4	42.5	17.1	27.5	27.9	29.4	29.9	17.9	33.2	43.6	25.5	36.1	23.0	25.9	36.2	33.5	42.9	38.7	20.0	52.0	19.6	17.6	23.6	25.9	17.9	32.8	13.4	35.4	33.7	30.1	37.5	28.2	54.0	26.6	30.0	23.8	50.7	14.6	17.5	41.4	19.1	29.9	24.4	24.3	19.1	27.6	20.9	28.9	21.6	5.5	23.8	26.3	31.2	20.7	37.3	26.9	15.9	23.1	25.7	20.8	27.8	51.0	26.4	33.7	26.2	14.2	5.0	8.7	6.7	6.4	10.7	6.6	7.4	9.1	5.2	5.0	9.0	7.9	6.0	9.5	13.8	3.3	6.9	5.8	6.9	8.5	11.5	7.2	6.1	7.4	7.1	7.2	7.2	7.2	7.3	9.2	24.2	25.6	21.5	0.0	6.3	0.0	0.0	0.0	0.0	0.0	16.9	16.4	0.0	0.0	14.9	7.3	0.0	26.4	20.0	0.0	7.9	14.4	0.0	23.8	32.2	9.8	0.0	0.0	0.0	12.2	23.7	10.6	0.0	22.4	5.1	28.5	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	14.7	0.0	0.0	5.2	0.0	0.0	6.9	8.7	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	16.8	9.9	25.0	0.0	0.0
VN1R1	"V1RL1, VNR19I1, ZVNH1, ZVNR1"	ENSG00000178201	"Vomeronasal 1 receptor 1"	Q9GZP7	19	57454790-57457142	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 8.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.5;Cone photoreceptor cells: 2.1;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 2.5;Rod photoreceptor cells: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;U-266/70: 2.5;U-266/84: 3.3"					"Not detected"	"Not detected"			HPA062209			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles	Nucleoplasm	"HPA062209: "	"unprognostic (7.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.59e-5)"	0.5	1.0	2.2	0.2	2.4	0.3	0.7	4.5	2.4	0.6	1.8	1.2	0.0	0.5	2.2	0.6	0.8	0.3	2.0	2.3	1.9	1.2	1.0	0.8	0.4	1.8	1.9	1.2	0.6	1.1	3.4	0.6	1.4	1.3	0.3	8.2	0.9	0.6	2.3	1.7	0.7	0.3	1.3	1.1	0.5	1.3	1.9	0.4	1.7	2.7	0.3	0.9	0.6	2.2	0.2	0.0	0.8	0.9	0.0	0.2	0.4	0.2	0.3	0.2	0.8	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.3	0.0	2.9	0.4	0.0	0.3	0.1	0.2	0.5	0.3	0.3	0.0	0.1	0.4	0.1	0.3	0.1	0.4	0.4	0.1	0.2	0.9	0.2	0.0	0.3	0.2	0.5	0.4	0.2	0.5	1.5	0.6	0.0	0.2	0.0	0.4	0.4	0.3	0.0	0.6	0.1	0.1	0.3	2.5	3.3	0.2	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	4.5	2.4	2.3	1.9	1.8	1.9	1.4	1.3	1.9	2.2	0.4	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	4.5	0.2	0.0	0.3	0.0	0.6	0.0	2.1	0.2	1.4	0.0	0.0	0.3	0.0	0.2	0.1	0.6	0.0	0.4	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.3	0.1	6.7	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.1	0.0	2.5	0.3	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	4.4	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.2
VPS13D	"FLJ10619, KIAA0453"	ENSG00000048707	"Vacuolar protein sorting 13 homolog D"	Q5THJ4	1	12230030-12512047	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 181.4;Inhibitory neurons: 149.2;Late spermatids: 208.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027332, HPA051621"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"	Cytosol	"HPA027332: AB_2672223, HPA051621: AB_2681555"	"unprognostic (2.97e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"prognostic favorable (7.42e-12)"	"unprognostic (5.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.31e-2)"	10.9	6.9	14.3	4.4	17.2	5.0	10.3	14.5	17.9	13.7	18.1	12.2	3.8	8.1	8.7	12.6	8.9	5.3	21.9	15.8	14.5	10.5	10.4	8.8	6.4	14.6	16.5	8.9	10.9	13.4	7.7	5.3	14.3	17.4	6.4	14.1	10.8	9.3	18.1	24.7	8.7	6.0	13.4	9.3	11.1	6.1	17.8	6.6	15.5	15.3	6.2	9.6	10.6	16.6	9.3	5.2	5.8	4.4	15.1	11.9	2.7	4.4	7.7	7.4	7.0	3.5	6.4	8.7	5.4	12.6	6.2	8.3	10.1	8.7	10.3	4.7	3.4	7.4	8.1	2.8	6.3	10.8	3.7	10.1	11.9	9.5	9.3	9.2	12.0	8.2	15.5	4.3	6.9	4.3	6.4	4.2	2.3	5.0	6.5	5.5	6.9	2.6	5.3	5.4	2.8	3.8	12.9	9.4	9.0	5.4	8.1	3.6	13.1	4.6	4.7	12.0	3.7	3.8	3.3	13.4	5.2	7.5	7.1	3.2	0.7	0.5	1.1	0.7	1.2	0.9	1.2	0.8	0.6	1.6	1.1	0.9	0.9	0.7	0.5	1.5	0.6	0.3	14.3	17.2	14.5	17.9	15.8	14.5	14.6	16.5	14.3	13.4	17.8	16.6	28.9	19.2	23.4	111.0	19.8	21.7	45.1	23.2	19.9	38.1	18.8	12.8	68.0	14.3	35.7	18.4	73.0	8.4	20.3	24.7	3.9	9.1	83.1	20.6	23.5	23.0	14.4	9.4	181.4	14.4	7.2	19.4	28.1	48.1	12.6	26.3	17.9	21.2	11.5	47.1	149.2	15.1	18.3	17.3	15.5	208.7	23.0	17.5	12.4	79.6	16.7	23.0	17.5	78.4	107.4	17.0	11.2	21.8	11.8	32.0	18.2	9.8	32.0	34.1	46.0	23.4	46.5	18.8	12.3	38.2	31.4	14.8	21.4	20.3	15.5	37.3
VPS33A		ENSG00000139719	"VPS33A core subunit of CORVET and HOPS complexes"	Q96AX1	12	122229564-122266494	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038701			Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038701: AB_10673473"	"unprognostic (3.98e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (9.11e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (4.63e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.09e-2)"	4.9	6.8	7.1	6.0	7.5	7.0	6.0	8.4	9.3	4.4	7.0	6.8	5.7	5.1	7.6	5.0	5.9	4.1	4.8	7.3	8.2	4.5	6.0	5.3	8.1	7.3	7.1	5.9	5.4	6.1	9.2	8.5	7.8	4.9	5.5	10.5	4.5	4.9	9.0	7.0	5.9	6.5	6.7	6.9	5.6	8.1	7.6	9.6	4.3	6.1	6.8	5.4	4.2	8.9	13.2	17.1	17.3	6.9	13.3	10.2	20.0	11.9	12.9	20.4	12.7	28.2	6.4	14.6	9.8	8.0	14.2	11.1	31.6	12.6	17.5	19.9	16.9	15.1	11.5	24.8	17.0	20.6	15.6	11.4	10.4	14.5	11.5	16.8	13.5	16.0	34.3	7.3	13.3	14.7	10.1	21.2	25.2	10.8	18.5	17.2	16.0	17.5	8.7	13.6	12.6	19.0	25.0	7.4	22.7	17.8	31.6	13.8	8.8	9.2	14.5	17.4	11.0	23.1	54.2	23.4	14.5	13.1	12.8	29.6	11.5	19.0	11.3	12.6	10.3	12.0	12.7	12.2	12.1	8.9	9.0	10.5	9.4	13.6	15.2	7.6	18.6	10.9	7.1	7.5	8.4	9.3	7.3	8.2	7.3	7.1	7.8	6.7	7.6	8.9	5.7	9.6	3.9	6.8	14.0	3.2	4.0	8.1	3.4	18.1	5.4	4.8	7.3	5.7	6.8	7.3	10.4	21.7	11.3	10.1	3.9	15.0	23.0	5.9	6.5	6.6	18.0	12.2	13.8	12.6	21.4	7.0	8.2	5.2	14.5	10.2	9.7	10.2	21.2	3.3	13.9	7.7	6.1	11.5	5.3	13.1	8.1	13.4	3.6	10.3	20.7	12.1	15.5	8.5	15.3	15.0	8.8	11.3	12.6	2.5	8.5	11.3	12.6	17.7	19.7	5.4	6.2	38.8	31.4	7.0	3.0	21.6	13.4	10.0	8.2	2.9
VPS37C	FLJ20847	ENSG00000167987	"VPS37C subunit of ESCRT-I"	A5D8V6	11	61130257-61161615	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 1.4;eosinophil: 1.7;intermediate monocyte: 2.6;myeloid DC: 1.0;neutrophil: 3.8;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.0;granulocytes: 3.8;monocytes: 2.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043348	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	Nucleoplasm	"HPA043348: AB_10794658"	"unprognostic (1.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-1)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.37e-7)"	"unprognostic (1.99e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.05e-2)"	14.1	13.8	11.5	13.2	10.9	10.3	14.0	10.0	12.2	14.3	11.9	17.7	17.1	15.9	5.2	22.0	12.5	11.2	15.8	12.6	9.9	16.8	10.7	14.5	8.1	11.9	11.6	14.1	24.1	11.9	20.1	14.1	10.5	20.9	10.5	22.7	23.3	14.6	23.6	22.2	15.5	14.5	9.6	13.3	27.7	15.3	12.0	6.2	12.1	11.8	10.0	18.3	15.9	11.4	33.8	13.1	16.7	16.1	8.0	16.6	37.2	16.4	44.0	23.9	16.2	15.7	15.6	8.8	22.5	22.5	19.7	18.5	15.2	17.3	12.3	19.2	11.4	11.2	9.0	17.8	25.7	9.0	13.7	15.0	26.3	20.6	25.7	14.3	15.8	6.0	29.6	14.6	16.4	41.1	2.0	13.7	20.6	14.7	18.8	3.1	7.2	21.4	18.9	17.2	10.3	25.1	16.4	52.2	28.8	14.0	49.5	22.2	12.1	23.9	17.2	24.4	20.8	6.9	10.0	7.2	21.6	11.1	16.5	0.4	1.4	1.7	0.3	2.6	0.4	0.5	0.2	0.4	1.0	0.5	0.3	0.1	3.8	0.2	2.4	0.1	0.2	0.7	11.5	10.9	10.0	12.2	12.6	9.9	11.9	11.6	10.5	9.6	12.0	11.4	6.3	16.0	6.0	5.9	4.1	12.5	14.3	9.4	10.2	5.8	14.9	9.3	7.5	12.8	10.0	12.9	10.4	30.6	1.2	15.6	11.7	17.4	8.9	5.0	4.0	11.2	16.3	4.2	8.9	19.8	20.9	10.6	13.7	6.8	0.0	5.1	7.1	6.7	17.3	25.2	7.1	18.3	8.2	13.7	11.4	6.5	7.8	13.9	7.2	13.1	12.3	11.5	2.1	4.5	8.3	21.7	11.3	13.5	2.2	17.7	19.0	7.2	12.2	41.7	0.0	6.7	9.2	12.9	16.7	8.4	19.9	35.2	2.9	7.4	10.6	14.5
VPS54	"HCC8, PPP1R164"	ENSG00000143952	"VPS54 subunit of GARP complex"	Q9P1Q0	2	63892146-64019428	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 81.8;Microglial cells: 76.8;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055894, HPA067981, HPA070582"			Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Nucleoplasm	"HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.91e-2)"	11.7	11.5	8.1	10.6	9.7	15.0	14.5	13.5	9.6	13.5	10.9	11.6	13.0	14.4	12.3	10.8	12.4	10.4	8.4	7.8	8.5	16.0	14.4	13.1	11.1	8.8	8.7	14.6	17.0	28.3	13.0	13.5	8.9	17.4	13.4	17.3	36.8	12.8	9.3	10.9	12.2	12.8	8.5	12.9	14.4	13.4	8.5	13.2	17.7	9.9	11.2	10.9	9.8	11.0	23.3	11.9	22.5	17.4	15.7	17.1	16.6	14.3	21.4	15.0	14.9	22.0	14.9	15.8	10.5	20.1	22.3	10.7	22.1	12.9	27.1	23.0	15.9	14.7	10.0	38.9	15.0	10.3	6.2	16.3	19.8	10.5	22.7	18.0	23.0	11.3	16.6	13.4	19.4	10.1	10.9	11.5	13.8	22.9	9.1	10.8	21.8	9.0	17.1	13.1	13.1	19.6	12.8	16.3	17.8	17.3	11.9	20.6	16.8	19.3	15.3	11.8	23.9	30.8	8.7	20.4	14.3	20.5	16.4	1.0	0.7	0.3	0.5	0.6	0.5	0.6	0.4	0.5	0.4	0.7	0.6	0.5	0.6	0.7	0.5	0.6	0.9	0.2	8.1	9.7	13.5	9.6	7.8	8.5	8.8	8.7	8.9	8.5	8.5	11.0	16.6	16.0	22.3	62.7	5.2	11.1	8.7	6.4	3.4	20.9	11.8	9.8	14.3	15.7	14.2	1.8	12.5	6.5	6.4	11.1	1.9	6.8	53.9	9.3	16.6	13.4	13.2	2.1	71.6	13.2	6.8	11.8	15.8	11.0	2.5	15.2	10.8	15.4	8.1	23.5	81.8	17.4	2.0	9.8	9.3	37.4	18.6	12.2	5.4	76.8	9.6	9.4	3.1	105.6	108.9	11.3	12.8	12.4	7.7	17.3	11.6	9.9	10.6	16.2	19.7	13.4	12.8	14.9	8.3	9.4	10.4	5.5	7.5	15.9	12.9	13.8
VPS9D1	"ATP-BL, C16orf7"	ENSG00000075399	"VPS9 domain containing 1"	Q9Y2B5	16	89707134-89720898	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.2;Inhibitory neurons: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"neutrophil: 18.0"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 18.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007847, HPA023620"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA007847: AB_1845582, HPA023620: AB_1845583"	"unprognostic (7.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.63e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.03e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.91e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.13e-3)"	12.9	26.9	23.8	16.2	26.3	13.2	10.5	15.8	39.2	13.2	16.5	14.6	13.5	11.0	4.4	33.3	12.0	7.4	15.8	25.4	19.3	23.1	30.4	16.1	9.3	25.4	19.5	10.8	12.6	12.5	31.6	5.4	25.7	15.3	3.8	5.7	15.3	6.1	11.6	12.7	17.2	4.9	15.4	29.1	12.8	18.8	21.3	3.5	17.3	5.5	5.1	11.2	15.9	23.6	6.2	9.3	10.2	10.8	10.2	9.9	8.5	11.3	11.7	9.6	4.7	8.0	13.6	6.3	7.1	12.6	5.4	14.1	0.9	6.4	2.7	5.7	15.0	4.5	8.7	10.0	7.7	2.6	10.5	10.9	5.8	11.6	2.7	15.5	6.7	5.8	11.5	3.8	6.5	28.1	4.8	10.0	3.8	4.9	10.4	11.8	8.5	3.8	7.7	9.8	8.4	8.8	14.5	5.3	11.6	3.1	24.0	11.0	10.5	12.4	15.5	10.2	6.9	17.4	5.9	5.4	18.0	6.8	10.6	2.2	0.6	0.3	0.3	0.5	0.1	0.2	0.1	0.1	0.3	0.4	0.4	0.2	18.0	0.2	0.3	0.0	0.2	0.2	23.8	26.3	15.8	39.2	25.4	19.3	25.4	19.5	25.7	15.4	21.3	23.6	3.5	6.4	5.1	30.0	3.6	2.0	2.0	5.4	5.7	13.3	6.5	5.5	8.8	2.8	6.4	9.2	10.4	3.0	6.1	11.6	7.9	4.9	13.5	5.8	6.8	3.1	10.8	1.7	43.2	7.8	2.3	5.3	8.2	9.3	4.5	8.7	9.7	9.6	4.8	8.4	41.9	3.9	2.0	8.5	8.3	21.7	6.2	12.6	3.6	4.7	3.7	6.6	3.1	16.1	17.5	6.2	5.1	6.0	3.9	1.8	13.5	6.1	4.6	12.8	0.0	5.2	5.8	12.3	4.7	7.5	3.8	3.0	4.5	8.6	7.2	2.8
VRK1		ENSG00000100749	"VRK serine/threonine kinase 1"	Q99986	14	96797304-96954846	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.4;testis: 37.1"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 198.9;Spermatogonia: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	5.9	5.2	5.9	12.8	7.1	50.4	11.5	6.0	7.9	5.2	4.3	10.8	6.5	6.5	6.9	8.9	9.2	4.4	5.2	5.9	5.1	4.9	5.5	4.9	27.1	5.3	5.5	6.0	3.2	5.4	3.1	7.6	5.4	5.0	12.3	4.4	4.3	5.0	4.7	7.4	7.2	6.7	4.8	11.3	6.5	37.1	5.9	35.5	5.9	4.6	27.9	7.7	5.4	7.0	52.4	27.0	78.5	30.2	9.2	14.9	44.8	42.8	34.4	67.1	65.4	36.0	54.7	139.2	22.4	24.3	39.2	56.5	75.5	54.4	90.5	73.4	36.4	90.5	18.7	39.3	10.2	168.5	49.2	8.5	9.7	50.4	32.6	12.8	47.0	104.8	76.6	79.0	56.9	65.5	137.1	76.5	47.8	39.9	59.3	124.5	134.2	48.6	32.3	59.3	53.2	28.0	34.2	36.4	30.8	36.0	39.3	66.6	24.4	27.9	22.8	47.7	37.3	37.7	53.5	124.8	44.7	74.6	34.8	42.7	12.3	26.2	21.5	15.5	29.0	31.3	24.9	26.4	15.7	32.7	27.1	27.3	6.5	45.6	15.2	21.4	34.9	19.4	5.9	7.1	6.0	7.9	5.9	5.1	5.3	5.5	5.4	4.8	5.9	7.0	15.3	3.2	4.6	6.8	30.6	16.8	13.8	23.3	6.2	12.4	9.3	11.3	11.8	12.8	16.7	14.7	8.4	34.8	24.8	6.3	11.7	13.5	21.3	21.1	8.3	12.4	3.0	76.2	42.0	19.4	48.3	11.4	14.8	10.8	28.5	20.0	7.1	3.3	19.2	10.1	36.2	10.4	20.3	11.8	14.9	11.5	5.6	12.0	12.4	19.7	14.2	6.2	27.8	12.1	19.8	10.3	2.2	9.8	25.4	6.1	3.0	11.2	37.6	9.6	19.7	14.3	15.1	198.9	110.9	14.1	13.9	15.1	26.8	9.2	18.1	10.4
VRK3		ENSG00000105053	"VRK serine/threonine kinase 3"	Q8IV63	19	49976468-50025946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 135.6"	"Group enriched"	"Detected in all"	7	"Early spermatids: 557.6;Late spermatids: 1646.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA056489: AB_2683150"	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.66e-4)"	17.4	23.3	25.9	17.6	26.6	23.6	17.7	26.1	28.6	17.9	30.2	21.9	25.8	15.9	19.5	17.6	33.2	20.9	17.5	25.4	27.9	36.5	35.6	16.9	28.5	27.6	31.1	21.2	22.1	15.9	20.6	16.9	30.4	20.2	22.0	64.8	21.9	15.4	26.9	16.8	32.9	14.1	25.2	26.0	21.6	135.6	27.9	35.6	19.7	17.4	25.7	18.0	16.8	29.3	31.0	31.3	22.6	24.5	29.2	26.9	23.3	21.7	25.7	31.6	34.5	16.8	33.7	37.1	15.2	21.2	22.1	22.5	21.3	18.6	25.5	32.6	43.5	28.9	20.4	29.4	21.9	36.7	48.7	24.2	27.3	18.3	19.2	28.4	26.5	39.9	35.8	53.7	23.2	13.0	49.7	24.5	12.2	54.6	26.7	39.3	23.9	47.6	27.2	32.2	25.3	12.3	21.5	26.0	24.7	20.0	23.9	38.5	20.2	32.2	18.6	13.1	17.1	34.3	47.4	19.6	25.8	22.3	22.5	110.0	42.8	81.1	53.7	46.1	43.3	58.9	48.7	51.9	47.9	53.3	49.2	45.3	112.5	82.7	55.1	45.4	76.1	48.4	25.9	26.6	26.1	28.6	25.4	27.9	27.6	31.1	30.4	25.2	27.9	29.3	19.6	6.4	28.6	10.1	26.6	6.6	16.0	27.2	6.8	34.3	17.9	14.5	8.4	24.3	29.8	14.7	143.9	43.8	27.9	49.9	31.3	31.0	557.6	50.7	12.0	16.0	22.2	38.7	13.9	32.7	38.6	15.5	18.8	26.8	18.3	24.1	28.5	44.5	34.8	32.0	15.9	35.4	34.6	25.4	9.3	1646.8	22.1	22.9	14.2	6.5	40.6	33.2	41.2	10.1	15.3	34.2	67.9	25.9	18.6	20.6	87.5	91.4	71.8	116.0	13.1	12.0	15.2	142.8	52.6	10.5	10.9	57.3	28.0	24.9	36.0	30.1
VRTN	"C14orf115, FLJ10811, vertnin"	ENSG00000133980	"Vertebrae development associated"	Q9H8Y1	14	74303069-74360008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.5;testis: 1.7"	"Cell type enhanced"	"Detected in single"		"Spermatocytes: 2.7"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 15.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"NTERA-2: 50.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001460	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA001460: AB_1078318"			"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"				"unprognostic (1.37e-1)"		"unprognostic (5.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.78e-2)"		"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"			0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	1.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0
VSIG10L		ENSG00000186806	"V-set and immunoglobulin domain containing 10 like"	Q86VR7	19	51331536-51342124	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 20.3;esophagus: 62.3;salivary gland: 23.5;vagina: 22.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 10.1;Melanocytes: 5.4;Sertoli cells: 6.6;Squamous epithelial cells: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 4.7;OE19: 11.0;T-47d: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA060453, HPA066745"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA060453: AB_2684280, HPA066745: AB_2685712"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (2.40e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.90e-4)"	"unprognostic (1.42e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.19e-3)"	0.2	0.1	0.1	0.0	0.4	0.1	0.8	0.8	0.5	20.3	0.0	0.1	0.0	0.0	0.0	62.3	0.1	0.3	0.1	0.1	0.7	0.1	0.7	0.1	0.1	0.5	1.0	0.2	0.0	0.0	0.1	0.0	0.8	1.2	0.0	0.0	23.5	0.1	0.1	10.6	0.2	0.0	0.1	0.1	0.1	0.3	0.6	0.1	0.1	0.0	6.3	0.2	22.3	0.7	0.0	0.9	0.0	0.3	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.3	0.7	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.1	0.2	4.7	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.4	1.3	0.0	0.4	0.0	0.1	0.6	11.0	0.4	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	8.4	0.0	0.0	0.0	0.1	0.7	0.0	1.1	0.7	0.1	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.5	0.1	0.7	0.5	1.0	0.8	0.1	0.6	0.7	1.2	0.0	0.5	1.3	0.8	0.6	1.1	0.6	1.8	1.6	2.2	1.8	0.9	0.0	0.1	0.0	0.0	0.4	0.2	0.9	0.0	1.1	0.2	0.0	0.3	0.5	1.2	0.0	0.6	0.0	0.9	1.6	1.1	0.2	1.3	1.0	1.4	1.2	4.5	10.1	1.0	0.5	0.0	3.2	0.9	0.7	2.1	2.4	5.4	1.0	1.1	1.4	0.0	0.0	0.9	0.4	1.3	4.1	0.1	1.0	1.6	0.9	0.0	0.6	6.6	1.5	1.2	0.5	2.6	6.1	0.4	0.5	0.4	2.2	0.7	0.7
VSIG2	"CTH, CTXL"	ENSG00000019102	"V-set and immunoglobulin domain containing 2"	Q96IQ7	11	124747474-124752255	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"stomach 1: 619.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 514.3;Gastric mucus-secreting cells: 623.4;Intestinal goblet cells: 285.6;Pancreatic endocrine cells: 260.2;Paneth cells: 509.9;Undifferentiated cells: 207.0;Urothelial cells: 285.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 87.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"OE19: 429.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035919, HPA050147"	Enhanced		Approved	Nucleoplasm		NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA035919: AB_10669981, HPA050147: AB_2681032"	"unprognostic (1.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.36e-2)"	6.5	0.8	3.1	7.0	6.4	3.4	9.5	0.8	7.1	29.7	0.2	136.2	6.2	4.9	0.4	26.4	17.5	26.5	5.3	2.8	1.5	6.3	3.0	45.7	0.9	1.7	3.6	1.1	2.0	1.9	1.7	6.0	2.0	58.2	137.8	0.6	31.8	4.3	2.3	1.5	2.8	4.7	1.1	1.6	619.2	0.9	3.1	0.2	43.7	2.5	2.5	84.5	9.3	3.6	0.4	0.1	4.8	3.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.9	1.5	2.4	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.3	16.6	0.0	7.9	0.7	0.5	3.0	0.1	0.0	0.0	0.0	0.3	2.8	0.3	0.3	0.6	0.0	1.6	0.1	0.1	0.6	429.0	3.7	0.4	3.6	0.1	0.1	69.2	0.3	0.9	0.1	4.6	0.0	0.7	0.4	2.4	4.1	1.8	1.1	0.3	0.8	0.3	0.0	0.0	0.6	1.7	0.9	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.4	0.0	0.6	0.4	0.1	0.3	0.2	0.0	0.7	0.9	3.1	6.4	0.8	7.1	2.8	1.5	1.7	3.6	2.0	1.1	3.1	3.6	4.6	125.0	51.6	0.0	1.5	0.8	19.2	25.3	2.8	1.5	31.5	18.4	0.7	82.9	99.3	3.7	0.0	0.0	0.6	514.3	1.9	14.6	0.0	12.1	1.8	5.0	66.8	0.0	0.2	90.9	0.1	0.9	623.4	18.3	1.3	0.1	3.9	0.2	0.1	0.0	0.1	285.6	20.3	0.3	2.7	0.0	1.5	2.4	3.6	1.0	0.0	0.0	0.0	0.0	0.1	260.2	509.9	0.0	0.7	61.6	1.3	0.1	36.7	0.0	0.0	0.3	6.2	0.2	0.7	0.7	0.4	0.0	2.2	0.3	207.0	285.3
VSIR	"B7-H5, B7H5, C10orf54, Dies1, GI24, PD-1H, SISP1, VISTA"	ENSG00000107738	"V-set immunoregulatory receptor"	Q9H7M9	10	71747556-71773520	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 90.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 217.1;Cytotrophoblasts: 324.4;Extravillous trophoblasts: 293.4;Syncytiotrophoblasts: 677.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1006.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 63.1;HaCaT: 48.0;HMC-1: 78.6;U-937: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007968			Approved	Nucleoplasm		NA	NA		320000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA007968: AB_1845518"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.37e-3)"	"unprognostic (3.29e-1)"	40.8	8.0	32.9	31.6	33.6	81.4	28.6	31.4	38.3	18.7	25.0	18.9	21.2	23.8	3.5	23.7	24.5	12.7	28.2	29.9	33.6	8.3	4.8	34.7	25.7	39.3	34.4	17.6	6.3	2.8	5.5	23.6	33.4	15.5	8.3	0.7	12.2	9.7	7.6	15.3	25.3	15.9	33.0	90.3	14.5	3.6	36.7	10.7	12.3	12.9	20.6	19.6	20.7	30.4	8.2	15.7	0.0	0.2	8.1	6.7	7.4	2.9	18.8	3.7	6.1	6.5	63.1	0.5	3.9	27.1	0.0	48.0	0.0	1.8	1.0	0.3	0.1	10.7	3.1	0.6	11.2	1.8	78.6	5.6	1.8	0.5	0.3	5.3	1.3	1.4	0.2	5.9	2.3	0.3	1.9	13.5	0.0	12.3	3.1	0.1	0.8	3.8	0.0	3.8	0.0	0.3	4.1	3.0	3.0	0.9	0.2	23.0	4.2	0.0	0.0	12.7	0.0	4.4	2.3	0.1	0.4	71.5	0.2	237.3	400.9	768.1	75.4	371.8	99.5	15.0	75.2	71.7	220.3	16.8	68.6	69.2	1006.0	56.8	435.5	58.0	82.9	472.3	32.9	33.6	31.4	38.3	29.9	33.6	39.3	34.4	33.4	33.0	36.7	30.4	217.1	28.9	6.8	0.0	15.6	0.0	0.0	0.0	0.0	0.0	10.5	15.5	0.0	0.0	6.2	11.0	0.0	324.4	51.6	0.0	0.0	41.3	0.0	1.9	8.1	33.0	0.0	0.0	0.0	10.6	293.4	32.5	0.0	1.7	31.5	0.3	0.0	0.0	71.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.5	0.0	0.0	67.7	0.0	0.0	0.0	0.0	59.8	0.0	0.0	12.6	0.0	0.0	14.5	3.6	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	677.7	34.7	5.1	0.0	0.0
VSTM4	"C10orf72, FLJ31737"	ENSG00000165633	"V-set and transmembrane domain containing 4"	Q8IW00	10	49014236-49115522	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Granulosa cells: 96.9;Late spermatids: 140.6;Sertoli cells: 59.2;Theca cells: 44.7"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 22.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 8.6;RH-30: 9.3;SH-SY5Y: 7.9;U-138 MG: 10.6;U-2197: 24.0;U-87 MG: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017279	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA017279: AB_10959519"	"unprognostic (8.46e-2)"	"unprognostic (5.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.25e-4)"	18.7	41.5	7.1	3.2	9.0	0.3	9.8	8.0	6.6	22.3	7.7	7.8	2.5	12.3	7.4	7.8	8.5	10.5	12.3	6.2	7.6	12.3	3.9	10.9	3.5	8.9	9.3	35.2	1.5	26.8	5.1	10.4	9.2	13.5	5.6	2.3	3.4	11.7	5.6	4.9	4.9	11.4	8.6	2.3	5.6	9.4	8.4	6.5	27.8	5.9	4.6	12.0	7.5	9.4	0.0	0.0	3.1	0.1	1.3	0.7	0.1	2.6	4.1	0.9	0.2	0.0	0.1	0.1	0.1	6.1	3.4	0.1	0.2	0.0	0.4	3.2	1.4	0.2	0.1	0.1	0.1	0.1	0.0	4.7	0.0	4.2	0.0	0.0	0.0	0.8	8.6	0.1	0.8	0.1	0.0	0.2	0.6	0.0	0.0	0.0	9.3	5.0	0.0	0.1	0.1	7.9	0.1	0.0	0.0	0.4	0.1	0.3	0.0	10.6	1.2	24.0	0.1	0.0	6.8	0.0	11.6	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.3	0.1	0.1	0.0	0.0	7.1	9.0	8.0	6.6	6.2	7.6	8.9	9.3	9.2	8.6	8.4	9.4	9.4	3.2	17.5	17.3	1.3	6.5	1.6	0.1	0.6	5.4	1.2	1.1	16.7	0.0	9.4	0.0	2.1	0.4	3.7	0.2	1.9	0.1	88.5	0.8	10.7	6.2	0.0	0.0	11.1	0.0	0.3	29.7	0.0	0.7	12.6	96.9	5.3	5.0	0.7	5.0	7.0	0.0	0.0	2.2	11.1	140.6	9.6	2.9	7.2	4.7	1.0	9.1	2.1	20.1	33.3	0.2	0.1	14.7	0.7	0.8	0.0	9.4	3.8	2.9	59.2	20.6	37.7	1.3	4.4	0.4	4.3	0.4	2.0	44.7	0.0	0.7
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224685	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		220000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	22.2	20.9	16.6	25.7	19.0	30.6	31.6	20.2	20.3	23.2	12.5	34.9	38.2	23.4	25.4	39.1	27.3	23.0	33.9	18.9	18.9	34.5	45.4	21.5	33.4	17.4	18.1	21.0	19.3	28.3	9.9	32.1	17.8	22.5	39.9	29.2	18.2	19.6	55.7	30.7	37.0	26.3	21.1	23.1	23.5	18.3	18.2	45.4	27.6	58.3	39.1	35.8	20.3	22.2	56.5	47.5	75.8	116.8	65.3	71.4	52.3	124.7	74.0	111.6	105.8	80.9	43.0	91.2	82.1	112.6	84.6	70.2	81.5	85.1	153.4	62.3	71.7	99.2	46.2	97.0	48.2	155.6	55.2	59.4	97.7	111.8	71.7	59.8	72.4	69.7	93.7	44.5	94.5	82.1	101.8	80.7	57.0	72.1	53.8	92.1	60.8	55.8	86.4	61.5	79.0	61.5	70.1	53.3	63.7	62.9	57.8	104.4	53.0	50.0	69.6	84.7	90.8	43.5	80.9	103.8	32.7	85.5	77.8	222.4	90.0	151.9	64.3	114.5	83.5	85.6	72.8	76.0	90.9	84.8	79.8	80.4	56.0	97.5	120.3	55.9	79.0	121.5	16.6	19.0	20.2	20.3	18.9	18.9	17.4	18.1	17.8	21.1	18.2	22.2	16.7	22.4	20.3	22.5	25.8	25.2	19.2	25.5	25.6	9.7	16.5	18.3	47.8	12.8	24.5	16.5	0.0	32.7	23.9	40.2	17.6	31.5	4.5	30.7	30.4	17.5	21.6	23.1	40.1	28.0	36.4	25.4	16.8	28.0	12.6	18.1	11.4	24.7	27.9	11.8	38.7	24.7	14.2	20.9	14.3	2.2	11.8	20.0	8.8	40.3	28.0	23.9	35.0	25.6	48.7	30.1	18.3	12.4	16.4	17.2	30.0	31.6	36.6	12.6	6.6	16.8	18.4	23.6	24.9	28.8	31.0	31.7	23.8	25.3	25.9	18.8
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 22.3;testis: 30.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 467.1;Late spermatids: 995.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 7.1"	"Low region specificity"	"Detected in all"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA036700: AB_2675261, HPA036701: AB_10673505"	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	1.4	0.0	1.1	0.0	0.0	0.9	0.7	0.6	5.0	0.1	0.0	0.2	0.0	0.0	22.3	0.0	0.0	1.3	1.5	0.1	0.0	2.5	0.0	7.0	5.8	0.2	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.1	30.0	1.2	0.7	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.9	0.7	1.3	1.5	7.0	5.8	3.7	4.8	1.2	2.7	0.3	0.0	1.1	11.8	0.1	0.3	1.7	2.2	0.0	1.0	0.1	0.3	0.9	0.0	12.1	1.8	31.3	0.0	0.0	0.8	0.0	0.0	467.1	53.8	0.6	0.6	1.8	0.0	1.9	0.4	0.2	0.8	4.6	1.6	0.0	0.1	1.1	0.0	0.2	0.0	1.0	2.8	6.1	0.0	0.8	995.9	4.7	0.7	0.0	3.7	0.6	0.7	0.0	1.5	0.7	0.2	2.7	5.7	0.2	0.4	0.2	0.0	124.5	0.5	0.0	0.5	1.0	17.6	6.0	0.0	0.4	0.0	0.1	0.2	1.0	0.8
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115404-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"granulocytes: 563.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 57.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 57.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 59.7;HEL: 44.1;HHSteC: 32.1;HUVEC TERT2: 39.5;RPTEC TERT1: 43.0"					"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 45: Intestine - Brush border"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	17.2	24.9	18.7	12.8	16.1	3.1	24.2	12.8	19.4	22.4	14.3	37.9	26.5	13.9	25.3	15.0	15.0	31.1	6.8	16.9	44.0	21.7	6.4	30.8	12.2	21.3	25.6	10.2	20.7	4.4	37.4	10.2	27.9	17.8	43.3	11.9	30.0	19.2	4.3	28.5	36.6	16.0	17.0	8.3	28.2	9.6	47.1	8.0	11.5	12.3	14.6	22.8	12.6	16.2	0.0	0.6	7.6	0.5	7.9	7.4	2.8	1.1	0.6	0.6	0.3	0.4	59.7	0.0	7.2	1.3	10.3	0.4	1.5	13.6	0.0	20.9	0.2	44.1	10.5	1.4	32.1	0.6	19.8	21.8	1.5	1.3	4.4	2.9	39.5	5.8	2.4	7.3	2.4	0.2	0.9	0.7	11.9	0.0	1.5	0.0	26.2	0.3	43.0	0.5	6.7	0.7	1.1	0.4	2.1	17.3	5.4	1.9	1.0	0.2	5.5	0.3	0.0	2.7	2.5	0.0	24.1	0.9	0.4	57.8	7.9	0.9	4.7	5.5	1.1	7.1	5.0	2.7	8.0	3.8	6.3	4.1	0.6	8.1	9.3	4.3	12.7	6.1	18.7	16.1	12.8	19.4	16.9	44.0	21.3	25.6	27.9	17.0	47.1	16.2	5.0	9.6	28.3	4.6	1.3	17.2	14.6	14.9	4.6	3.8	12.6	8.8	2.6	5.7	33.2	33.1	2.1	7.9	2.0	25.0	9.8	27.8	50.6	11.5	4.8	4.3	15.0	3.4	4.0	28.1	2.5	11.4	17.3	7.6	563.0	3.8	3.9	3.2	35.7	32.0	17.1	22.3	30.5	6.6	7.2	6.0	2.8	6.7	5.4	1.9	3.6	14.3	3.1	8.0	2.6	17.7	16.8	0.4	2.5	6.5	50.6	15.1	59.1	1.4	0.0	9.5	5.7	0.7	4.1	4.8	12.5	1.9	9.4	5.9	23.7	13.6
VWA5B2	"DKFZp761K032, LOC90113"	ENSG00000145198	"Von Willebrand factor A domain containing 5B2"	Q8N398	3	184230429-184242329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 40.7;brain: 16.4"	"Group enriched"	"Detected in some"	7	"Enteroendocrine cells: 112.4;Excitatory neurons: 39.2;Inhibitory neurons: 29.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9;pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 31.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 22.9"	"HPA036823, HPA036824, HPA061412"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Nucleoplasm	"HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507"	"unprognostic (3.92e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-1)"	0.0	40.7	7.8	0.0	1.7	0.1	0.0	0.7	16.4	0.5	0.0	0.4	1.8	0.2	0.1	0.0	1.3	0.0	0.0	6.5	0.7	0.2	0.0	0.1	0.0	7.4	0.5	0.4	5.6	1.4	8.3	0.0	5.0	0.5	0.3	0.2	0.6	2.4	0.0	0.0	1.1	0.0	0.0	0.0	2.8	1.0	2.6	0.0	0.3	0.0	0.0	0.1	0.1	2.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	1.9	0.3	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.3	0.0	0.0	31.7	2.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.1	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	1.7	0.7	16.4	6.5	0.7	7.4	0.5	5.0	0.0	2.6	2.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	7.6	0.1	0.1	112.4	0.0	39.2	0.2	0.0	0.0	6.1	0.8	0.0	0.2	1.1	0.0	0.2	3.3	29.2	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	1.7	0.2	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295316	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.3;ovary: 7.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.2;Cone photoreceptor cells: 29.2;Hepatocytes: 16.4;Rod photoreceptor cells: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.2;Hep G2: 26.3;HSkMC: 13.4;REH: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2200000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: AB_2676963, HPA043921: AB_2678731"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.8	1.1	0.6	0.1	0.9	1.6	1.5	0.3	1.6	2.9	0.0	0.6	0.3	1.3	0.6	0.9	3.5	0.6	0.8	0.7	0.7	0.5	14.3	0.3	0.2	0.5	1.2	7.9	0.3	0.1	0.6	2.4	0.4	1.0	0.4	0.8	0.9	0.5	0.7	0.7	0.4	0.4	0.0	0.4	0.4	1.8	0.5	2.5	0.8	0.4	0.1	0.6	1.2	0.2	0.0	0.1	1.5	0.2	0.2	1.8	0.6	0.2	2.0	0.0	0.3	7.2	0.0	0.5	0.0	0.4	0.1	0.0	2.3	0.0	0.1	0.4	0.0	0.8	0.0	26.3	1.2	0.0	0.3	13.4	0.6	0.7	0.0	0.1	2.3	3.3	0.2	0.3	0.3	0.1	5.5	0.0	2.2	0.0	0.0	14.0	0.2	0.0	0.1	0.1	0.6	1.0	0.0	0.1	0.7	2.4	0.9	0.0	0.8	0.3	0.3	0.5	0.2	0.2	0.6	1.2	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.3	1.6	0.7	0.7	0.5	1.2	0.4	0.0	0.5	0.2	2.1	3.2	1.7	19.2	0.3	1.8	1.8	3.8	3.4	3.6	1.7	0.5	1.0	1.5	2.3	0.0	29.2	1.0	0.5	0.2	0.0	0.1	0.5	2.9	1.0	5.5	1.8	6.1	7.5	0.5	5.0	2.6	0.0	1.8	3.8	6.5	2.5	16.4	1.2	0.0	5.8	0.1	2.0	3.5	2.4	0.8	6.8	2.6	1.8	2.8	2.3	2.3	1.0	2.5	1.4	0.0	0.0	1.9	0.4	1.1	0.1	0.3	5.4	21.1	0.0	0.9	1.1	1.1	3.4	1.3	2.3	4.4	0.9	7.7	0.3	0.7
WAC	"BM-016, FLJ31290, MGC10753, PRO1741, Wwp4"	ENSG00000095787	"WW domain containing adaptor with coiled-coil"	Q9BTA9	10	28532493-28623112	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036528, HPA042609, HPA074604"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA036528: AB_10670839, HPA042609: AB_2678076, HPA074604: "	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (9.27e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.36e-1)"	53.2	39.9	18.4	30.8	24.3	51.6	48.9	45.2	22.0	49.4	17.9	66.3	27.3	50.3	16.7	45.9	47.1	23.7	44.8	19.6	20.5	38.1	35.9	50.4	31.6	19.2	21.9	53.1	39.5	34.0	36.9	31.6	19.6	40.6	23.2	34.5	44.2	25.6	55.1	50.2	47.4	25.0	19.1	45.6	45.8	37.3	21.8	45.8	43.7	34.0	28.4	54.9	46.7	26.3	72.4	45.2	65.5	51.1	40.7	31.4	59.9	58.2	33.1	60.9	50.5	68.7	73.2	71.8	42.8	46.6	44.6	63.1	51.5	46.8	55.1	92.1	54.0	89.0	40.6	41.2	51.2	39.9	66.7	33.0	57.7	65.6	46.7	38.4	44.4	65.8	76.8	69.9	38.4	60.0	87.8	24.6	41.9	48.1	21.4	71.8	109.3	56.2	29.3	36.1	60.1	56.8	50.7	57.4	78.2	40.6	45.8	56.1	47.9	38.5	64.3	40.1	52.8	40.8	44.4	82.6	47.8	70.5	38.8	13.7	10.7	9.2	10.5	15.0	10.5	12.7	8.7	12.7	11.2	12.3	10.3	9.2	13.0	13.4	14.3	7.3	9.2	8.5	18.4	24.3	45.2	22.0	19.6	20.5	19.2	21.9	19.6	19.1	21.8	26.3	110.8	93.0	75.1	114.6	94.1	176.0	94.6	44.2	105.9	114.5	95.8	78.9	109.6	81.5	52.9	40.5	95.9	59.2	115.7	77.1	31.3	47.0	99.8	92.9	107.4	92.8	69.5	97.8	117.8	47.6	61.5	86.4	58.6	142.4	55.8	94.1	75.3	61.4	53.6	107.7	107.1	86.2	44.7	111.5	154.8	123.6	83.0	107.2	76.5	138.7	92.1	68.4	87.6	142.7	180.9	55.0	68.5	82.8	86.0	128.5	73.2	59.4	45.5	92.4	59.2	113.5	85.1	85.9	59.2	80.5	184.1	99.1	100.4	83.4	71.6	134.5
WAPL	"FOE, KIAA0261, WAPAL"	ENSG00000062650	"WAPL cohesin release factor"	Q7Z5K2	10	86435256-86521792	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037874, HPA037875, HPA066141"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: "	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.78e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	15.4	13.2	8.4	19.6	9.9	27.1	16.6	11.9	9.2	12.8	7.8	15.4	15.2	14.8	8.7	15.9	11.7	13.1	10.3	7.5	8.3	16.8	22.6	16.5	25.0	8.2	8.5	13.7	14.4	16.9	4.9	18.4	8.3	13.0	15.2	36.0	11.2	11.7	20.9	17.9	16.0	14.8	8.9	19.0	16.5	35.1	9.0	33.7	17.9	22.5	27.7	17.9	9.2	10.4	42.6	19.6	33.5	44.4	26.1	27.6	29.6	36.4	44.2	30.3	32.4	42.9	36.6	64.3	24.1	32.5	26.7	39.1	38.3	31.3	46.3	42.1	25.3	38.9	30.9	47.4	29.7	79.8	43.1	21.9	35.7	38.9	64.9	34.5	34.6	36.8	41.7	37.6	35.2	36.3	49.9	29.6	29.9	26.4	19.5	35.2	27.1	25.6	26.3	37.2	13.1	25.2	32.3	21.4	40.9	33.2	47.1	41.9	33.5	29.1	34.4	25.8	48.6	36.8	54.9	66.9	26.7	55.8	20.9	15.0	3.5	7.7	3.4	4.1	4.9	3.9	4.5	4.7	4.8	4.0	5.1	4.0	5.5	3.2	7.4	3.6	6.1	2.4	8.4	9.9	11.9	9.2	7.5	8.3	8.2	8.5	8.3	8.9	9.0	10.4	38.3	83.3	54.8	0.0	48.3	0.0	57.4	0.0	35.3	49.1	41.3	27.9	0.0	20.0	21.1	16.5	20.9	42.8	62.4	17.4	21.5	60.8	86.8	36.7	44.4	33.9	18.2	94.1	0.0	52.5	28.3	30.0	37.8	52.2	25.2	40.3	32.5	47.6	40.4	55.5	0.0	21.5	0.0	56.5	0.0	42.0	32.0	58.3	0.0	0.0	81.0	48.7	55.6	0.0	0.0	52.1	27.5	32.4	50.5	56.6	25.0	35.5	13.8	113.4	65.7	70.3	33.6	153.4	90.2	48.4	0.0	76.1	51.4	35.2	24.8	74.1
WASHC4	"KIAA1033, SWIP"	ENSG00000136051	"WASH complex subunit 4"	Q2M389	12	105107324-105169130	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Endometrial stromal cells: 48.3;Hofbauer cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045666, HPA046737"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045666: AB_2679411, HPA046737: AB_2679778"	"unprognostic (2.68e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	22.4	21.1	9.4	30.9	13.8	23.8	20.8	13.8	12.2	20.7	11.8	16.1	15.3	20.1	19.9	15.1	13.1	22.6	14.3	9.1	13.8	23.5	29.7	20.2	44.0	17.8	13.0	22.8	18.3	20.4	8.5	30.5	18.4	19.2	18.4	15.4	16.1	15.8	12.2	31.2	18.4	19.8	15.2	32.9	17.9	12.1	14.5	18.0	22.1	14.2	39.5	17.6	12.6	22.1	24.0	28.2	24.6	18.2	56.3	56.6	29.5	36.5	41.5	41.7	38.0	20.2	13.5	53.4	19.8	61.0	26.5	21.9	21.5	22.3	33.5	19.2	15.3	11.1	25.6	16.8	38.4	30.9	20.5	45.7	25.7	37.3	30.4	45.1	68.7	18.1	22.1	18.6	45.9	12.1	17.1	32.6	30.1	16.8	23.5	32.7	32.8	16.6	55.6	27.5	15.4	19.0	37.7	26.4	37.9	31.0	19.6	32.9	84.1	49.8	13.6	32.1	23.9	23.3	23.9	42.7	35.4	26.1	51.4	21.3	15.1	9.2	3.0	18.4	4.4	16.2	4.7	4.1	11.9	12.9	4.9	4.7	16.7	8.0	34.2	5.8	3.5	6.9	9.4	13.8	13.8	12.2	9.1	13.8	17.8	13.0	18.4	15.2	14.5	22.1	37.5	35.3	24.3	0.0	25.3	0.0	0.0	0.0	0.0	0.0	16.4	11.0	0.0	0.0	11.8	44.1	0.0	24.1	17.5	0.0	19.6	25.8	0.0	23.8	48.3	18.0	0.0	0.0	0.0	22.1	28.0	14.6	0.0	31.7	26.5	30.7	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	24.2	0.0	0.0	5.2	0.0	0.0	41.8	17.5	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	32.0	8.9	29.1	0.0	0.0
WASHC5	"KIAA0196, SPG8"	ENSG00000164961	"WASH complex subunit 5"	Q12768	8	125024260-125091819	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.8;Exocrine glandular cells: 17.2;Hofbauer cells: 21.8;Proximal tubular cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034216, CAB034219, HPA064649, HPA070916"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322"	"unprognostic (1.98e-3)"	"unprognostic (3.75e-2)"	"unprognostic (8.40e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (2.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	18.1	18.6	10.5	18.5	16.9	21.3	19.6	14.9	13.2	17.2	16.5	18.5	18.1	16.2	15.7	16.6	13.3	17.8	16.1	11.1	12.5	22.9	18.5	17.1	19.6	14.7	13.7	15.6	13.0	24.8	9.5	21.2	14.6	17.4	20.1	11.4	14.3	16.1	15.9	13.6	14.7	20.2	14.0	19.3	16.1	9.5	13.8	21.8	23.3	18.5	21.0	21.1	10.3	24.7	40.0	45.4	24.9	30.6	55.3	58.8	16.3	42.0	63.6	43.0	45.8	17.0	42.1	36.1	29.1	54.1	25.3	30.6	40.2	37.7	56.8	47.5	23.1	48.1	26.5	22.8	53.8	14.8	46.6	58.7	25.1	35.5	31.2	33.2	49.9	30.9	28.3	35.6	53.0	87.6	44.3	11.8	23.7	66.7	46.7	29.8	22.4	36.7	33.2	48.5	13.1	26.3	48.8	109.2	39.5	25.8	47.3	25.5	44.7	23.6	51.9	39.4	37.7	31.7	31.2	31.7	62.4	27.5	33.4	10.4	17.0	12.5	13.5	20.9	14.3	9.5	12.8	13.9	19.7	10.6	10.1	14.3	5.8	17.2	29.3	7.2	16.9	13.0	10.5	16.9	14.9	13.2	11.1	12.5	14.7	13.7	14.6	14.0	13.8	24.7	10.9	3.2	19.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	14.4	9.3	0.0	0.0	5.0	11.0	0.0	13.4	6.9	0.0	5.9	12.2	0.0	9.9	13.5	4.9	0.0	0.0	0.0	17.2	11.0	5.4	0.0	14.8	8.8	11.1	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	16.2	0.0	0.0	1.9	0.0	0.0	17.2	4.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	12.3	3.8	9.6	0.0	0.0
WBP11	"BUG13, CFAP90, FAP90, NPWBP, PPP1R165, SIPP1"	ENSG00000084463	"WW domain binding protein 11"	Q9Y2W2	12	14784582-14803486	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA039710, HPA040037, HPA046403, HPA049126"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA039710: AB_2676638, HPA040037: AB_10796115, HPA046403: AB_2679654, HPA049126: AB_2680644"	"unprognostic (4.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (5.67e-3)"	"unprognostic (3.30e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	22.3	23.4	14.2	22.4	15.3	65.7	20.8	14.3	17.1	17.8	14.3	19.4	16.1	22.4	17.4	19.8	24.1	18.2	31.2	14.6	19.0	20.0	23.1	20.4	27.4	14.5	17.6	24.8	21.0	25.0	13.3	25.1	14.4	21.8	22.2	21.3	21.3	18.0	38.8	23.3	18.8	22.2	13.5	22.9	18.8	39.0	16.8	26.0	24.3	32.9	29.6	21.5	16.8	14.9	52.1	45.3	53.0	102.4	34.7	32.9	95.6	41.8	35.0	62.3	62.3	83.9	63.2	64.1	26.7	38.0	53.0	42.4	82.3	55.3	76.5	114.6	54.5	94.3	48.1	52.0	34.8	89.6	50.1	32.2	43.7	69.8	52.0	33.6	50.2	59.5	61.3	33.7	50.1	50.1	84.0	48.7	171.9	35.4	29.0	70.7	84.3	40.6	45.3	70.8	28.3	57.6	55.8	46.3	44.9	123.8	24.6	58.2	37.8	43.7	66.1	38.9	72.8	29.2	43.8	116.6	45.7	43.6	59.3	12.3	14.0	12.7	18.8	19.4	20.8	18.3	18.1	19.1	13.2	16.9	20.9	19.6	8.7	19.2	20.6	9.6	21.3	13.7	14.2	15.3	14.3	17.1	14.6	19.0	14.5	17.6	14.4	13.5	16.8	14.9	56.8	57.7	61.0	10.1	79.3	54.9	86.9	49.7	41.5	43.7	53.5	40.6	108.6	54.3	60.7	36.8	47.9	57.8	87.2	36.6	43.0	62.5	98.5	70.1	66.8	52.5	39.5	72.6	17.5	59.5	93.3	62.2	32.6	56.7	106.3	41.0	45.0	48.6	46.6	43.7	16.2	37.8	32.6	44.3	42.1	58.4	45.4	56.7	35.6	9.4	104.6	49.6	74.2	13.0	23.0	52.8	22.3	32.7	64.0	64.1	34.0	53.8	78.7	54.1	59.2	79.3	81.3	207.5	140.4	43.5	55.7	75.9	84.8	42.9	42.6	68.1
WBP1L	"C10orf26, FLJ20154, OPAL1"	ENSG00000166272	"WW domain binding protein 1 like"	Q9NX94	10	102743948-102834516	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037635, HPA038371"	Uncertain		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Microtubules	Nucleoplasm	"HPA037635: AB_10672462, HPA038371: AB_2675980"	"unprognostic (3.28e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (5.35e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.53e-1)"	34.9	43.2	21.3	22.3	23.1	5.0	25.8	20.7	20.1	26.4	28.7	27.7	15.2	27.4	18.9	21.1	29.4	25.1	24.1	19.8	22.4	20.8	42.1	24.5	21.4	32.0	23.9	26.5	15.5	41.7	22.9	23.5	23.6	26.9	15.0	5.7	22.6	22.4	54.6	37.5	19.9	26.2	25.9	21.3	25.7	14.2	24.7	33.7	41.1	49.0	18.9	24.5	20.5	22.6	21.0	26.8	14.5	24.5	47.0	37.9	29.5	21.0	56.7	20.5	25.8	18.3	31.9	18.1	27.8	32.5	16.5	22.7	10.7	18.2	15.5	18.3	11.3	36.6	11.6	13.3	30.3	17.8	41.7	41.2	32.0	26.4	20.3	47.0	40.5	21.6	18.1	22.0	35.6	27.5	21.7	19.8	11.0	16.1	12.9	42.9	38.3	11.7	18.2	20.4	3.4	13.9	11.5	11.6	24.1	26.0	47.2	19.5	30.4	19.6	20.1	22.3	19.1	40.6	22.9	13.0	27.7	33.6	8.8	7.8	12.2	16.2	8.7	14.8	7.0	6.5	7.3	8.4	8.7	6.1	6.5	6.9	15.2	12.9	19.4	5.4	8.2	10.6	21.3	23.1	20.7	20.1	19.8	22.4	32.0	23.9	23.6	25.9	24.7	22.6	13.3	22.4	19.0	29.4	12.2	8.2	8.0	17.0	11.4	6.4	25.0	15.4	15.7	12.8	17.8	12.9	0.0	33.9	17.2	26.4	1.9	14.2	2.0	9.7	11.0	20.4	9.1	11.1	24.6	25.3	14.6	29.3	16.8	12.7	38.1	16.4	27.1	56.2	27.7	13.5	26.4	14.6	14.2	46.6	13.1	1.8	13.1	28.8	10.6	40.3	28.9	9.8	29.9	19.1	26.3	24.6	13.7	19.5	9.0	29.9	18.3	8.9	20.5	3.8	19.7	16.6	17.7	4.4	5.8	11.3	11.8	40.0	14.4	8.9	12.2	11.3
WBP2	"GRAMD6, WBP-2"	ENSG00000132471	"WW domain binding protein 2"	Q969T9	17	75845699-75856507	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 321.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065682, HPA068819"	Approved		Supported	Nucleoplasm,Cytosol		No	No		440000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA065682: AB_2685530, HPA068819: AB_2686042"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.76e-1)"	113.2	223.6	239.5	57.1	238.6	82.7	114.1	225.1	340.9	103.2	163.6	109.7	65.2	84.6	44.3	94.7	106.1	62.8	183.1	243.0	242.2	125.7	184.4	118.1	60.9	293.9	256.8	113.9	134.5	100.7	116.0	55.4	286.4	103.5	39.0	129.7	137.7	73.5	250.2	131.3	85.7	52.0	226.4	112.5	123.2	95.4	259.8	49.2	83.8	91.9	51.8	97.8	94.7	256.6	104.6	119.9	43.4	52.5	88.0	87.2	57.9	32.7	102.1	74.3	91.8	59.7	104.2	52.9	81.9	47.0	232.2	61.0	45.2	100.9	66.3	40.1	90.4	97.7	66.4	97.6	182.2	40.8	161.6	96.4	94.6	89.4	120.8	127.0	143.8	82.1	68.2	156.7	60.2	107.3	85.8	85.8	37.3	70.8	78.8	57.8	85.4	101.5	109.7	62.3	72.6	114.8	58.5	99.9	163.1	76.3	134.9	102.1	84.3	75.8	66.1	73.6	52.3	145.4	109.6	38.8	212.5	38.3	54.9	239.9	85.0	288.7	53.8	102.6	59.1	68.9	59.5	54.6	54.8	55.3	55.8	47.5	308.9	57.4	136.4	42.0	77.4	93.2	239.5	238.6	225.1	340.9	243.0	242.2	293.9	256.8	286.4	226.4	259.8	256.6	73.5	83.3	79.0	34.9	62.7	60.9	127.2	85.9	30.1	109.7	75.2	53.3	73.2	55.8	59.9	53.3	75.0	64.9	45.9	65.9	162.4	124.3	264.5	41.5	21.7	63.4	33.6	124.0	23.6	188.6	65.1	43.5	34.1	44.3	67.0	40.0	54.3	61.9	138.4	112.7	23.4	48.9	71.2	65.5	71.2	321.1	59.4	90.2	60.5	23.4	90.8	104.8	52.5	21.1	38.6	126.5	72.6	53.8	35.6	120.2	88.4	100.7	44.8	120.7	26.3	43.8	44.9	45.5	25.7	24.8	80.0	184.7	51.7	62.5	27.1	95.6
WBP4	"FBP21, MGC117310"	ENSG00000120688	"WW domain binding protein 4"	O75554	13	41061509-41084006	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038965, HPA058738"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA038965: AB_10672836, HPA058738: AB_2683803"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.65e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.52e-1)"	17.5	16.0	16.1	9.8	16.8	15.6	13.4	16.5	23.9	12.0	13.2	13.2	11.2	18.5	16.0	11.2	11.1	9.3	23.1	16.1	18.1	12.3	16.3	10.4	11.8	16.3	16.6	13.2	8.7	12.4	8.2	11.5	16.4	14.0	9.1	16.5	8.1	14.7	41.0	11.3	11.5	14.8	15.7	9.8	9.3	12.2	16.5	14.7	11.2	29.8	11.6	11.3	11.0	18.6	15.0	9.8	26.7	17.3	17.1	25.9	16.2	33.3	23.4	25.9	19.7	15.5	15.7	21.4	13.0	23.6	31.2	20.6	10.2	16.7	33.0	22.3	14.3	30.2	10.0	16.0	26.3	19.1	18.8	21.3	25.0	18.8	26.5	21.1	22.0	20.3	16.4	9.1	27.5	12.6	27.3	20.6	16.3	23.2	8.0	25.3	16.5	8.4	23.6	14.6	6.1	14.7	10.6	11.3	16.1	21.5	9.4	29.3	19.3	16.0	14.7	22.2	19.5	6.0	7.0	14.7	19.7	13.7	22.2	19.2	13.0	12.4	10.6	12.0	9.7	14.2	13.6	11.5	11.0	12.6	14.4	14.3	27.3	12.5	21.8	18.5	14.4	6.1	16.1	16.8	16.5	23.9	16.1	18.1	16.3	16.6	16.4	15.7	16.5	18.6	42.4	51.3	29.3	21.2	23.9	54.4	60.3	54.8	33.0	46.8	33.5	37.5	110.0	40.0	32.5	25.8	33.3	55.6	23.0	32.3	76.3	52.3	11.9	32.9	58.4	46.9	37.8	111.7	17.0	42.0	61.1	52.2	15.8	44.5	45.7	27.5	38.2	63.1	40.9	45.4	16.6	28.1	18.3	26.7	47.1	9.7	47.8	33.0	32.0	10.3	60.4	63.8	28.8	17.1	33.3	50.3	33.2	52.6	16.8	60.9	33.8	70.6	23.6	49.2	26.3	55.3	66.7	87.5	103.9	29.7	44.9	49.9	22.3	31.9	27.6	40.9
WDFY4	"C10orf64, Em:AC060234.3, FLJ45748, KIAA1607"	ENSG00000128815	"WDFY family member 4"	Q6ZS81	10	48684876-48982956	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 28.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 44.7;dendritic cells: 29.9;Early spermatids: 47.2;Langerhans cells: 30.6;Macrophages: 24.6;Microglial cells: 81.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 14.3;myeloid DC: 11.3;naive B-cell: 21.2;neutrophil: 10.2;plasmacytoid DC: 32.5"	"Group enriched"	"Detected in many"	7	"B-cells: 21.2;dendritic cells: 32.5;granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 61.0;HDLM-2: 56.3;HL-60: 21.5;THP-1: 18.9;U-698: 25.6;U-937: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040634	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA040634: AB_10795491"	"unprognostic (6.20e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.38e-4)"	"unprognostic (9.41e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.76e-2)"	1.9	0.7	3.2	12.1	3.4	11.7	1.4	4.2	4.8	1.1	3.2	1.9	1.5	0.8	1.9	1.4	0.7	3.2	0.6	3.2	4.2	0.8	1.3	5.2	28.5	6.0	4.9	0.6	1.0	0.4	0.3	1.2	6.2	0.8	1.9	0.1	1.3	0.6	0.7	2.6	7.4	1.7	5.9	17.3	2.3	3.7	6.3	12.3	0.6	0.4	23.9	3.1	0.3	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	56.3	0.0	6.5	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	25.0	0.0	0.0	3.0	0.0	0.0	2.8	0.0	14.3	0.0	0.1	11.3	21.2	0.0	0.0	10.2	0.0	1.3	32.5	0.0	1.1	3.2	3.4	4.2	4.8	3.2	4.2	6.0	4.9	6.2	5.9	6.3	9.3	0.2	0.0	1.1	2.0	44.7	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.3	0.0	0.6	1.8	0.0	0.1	29.9	0.0	1.9	0.0	47.2	0.0	0.1	0.3	0.0	0.4	0.7	0.0	0.2	1.1	0.0	0.0	5.7	0.0	0.0	0.0	13.0	0.0	0.4	0.1	0.0	12.9	30.6	17.7	0.3	24.6	1.8	81.5	16.4	0.0	0.0	1.0	0.5	0.0	0.0	0.4	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	2.9	0.5	0.2	0.3	0.3	1.5	0.0	0.3	0.1
WDHD1	"AND-1, CHTF4, CTF4"	ENSG00000198554	"WD repeat and HMG-box DNA binding protein 1"	O75717	14	54938949-55027105	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 15.5;Spermatocytes: 15.0;Spermatogonia: 19.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 23.5"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000632, HPA001122"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA000632: , HPA001122: AB_1080589"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.33e-4)"	"unprognostic (5.52e-3)"	"unprognostic (7.28e-3)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	1.3	0.8	0.5	3.8	1.0	7.2	2.2	0.9	0.9	1.2	0.1	2.8	1.8	2.1	0.6	2.4	1.6	1.3	0.9	0.7	0.2	1.1	1.2	1.3	5.5	0.2	0.2	1.4	0.9	1.5	0.3	2.8	0.2	1.0	4.0	1.8	0.7	0.8	0.6	2.0	1.7	2.6	0.3	1.7	1.6	5.3	0.4	8.0	0.9	0.8	6.7	1.7	1.1	0.9	39.6	24.7	48.4	21.4	4.6	11.2	28.1	37.5	16.1	29.6	36.0	16.6	25.9	44.9	18.6	10.8	21.4	32.8	72.9	21.5	61.7	30.0	12.7	29.8	23.7	16.2	1.9	56.7	21.8	5.9	3.8	36.6	14.3	7.1	19.6	28.8	37.8	22.0	28.7	21.7	53.5	11.1	38.6	21.1	25.7	49.5	69.7	17.3	8.4	26.0	28.1	19.8	39.8	10.0	12.8	35.1	26.8	11.3	12.8	37.3	43.9	27.5	32.1	6.5	14.4	58.8	17.1	27.4	30.0	1.7	0.3	0.6	0.9	0.2	1.2	1.2	1.0	1.3	0.5	1.8	1.3	1.8	0.4	2.0	0.4	0.7	1.6	0.6	0.5	1.0	0.9	0.9	0.7	0.2	0.2	0.2	0.2	0.3	0.4	0.9	2.3	0.0	2.0	3.9	5.1	3.8	2.2	3.5	3.4	2.9	1.8	1.9	1.7	0.0	4.0	3.7	0.0	8.7	3.6	1.8	0.0	1.8	0.8	1.9	3.1	2.0	0.0	15.5	10.3	1.0	8.4	3.4	2.6	2.5	0.0	12.4	0.7	0.9	4.1	3.3	6.5	2.4	6.1	2.1	1.2	1.1	0.0	2.4	1.8	5.6	1.4	1.4	2.1	4.5	10.1	1.1	0.3	3.0	7.8	0.6	0.5	6.2	3.5	3.1	0.0	2.4	3.0	15.0	19.3	6.1	2.4	2.6	3.6	2.8	5.2	1.7
WDR13		ENSG00000101940	"WD repeat domain 13"	Q9H1Z4	X	48590042-48608869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000913	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA000913: AB_1858795"	"unprognostic (5.03e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.65e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.54e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.32e-2)"	67.2	76.7	84.2	27.7	81.1	34.6	63.8	68.2	95.2	71.6	85.0	71.6	43.8	71.5	73.7	54.6	67.1	33.4	150.3	85.7	70.4	91.9	106.3	60.8	23.4	73.0	70.2	93.1	189.2	36.9	80.1	29.5	70.5	67.5	26.3	28.2	75.7	45.3	105.2	56.9	54.4	37.5	69.4	58.6	76.6	22.9	74.5	18.7	64.8	83.0	19.6	59.5	56.3	78.5	41.6	59.4	29.3	90.8	39.3	57.4	22.4	28.1	50.7	31.9	29.0	35.5	64.8	28.7	26.3	57.8	25.7	35.0	14.6	61.6	11.3	34.2	26.2	19.7	72.2	65.3	89.3	17.1	51.4	54.7	86.4	45.3	82.7	55.6	44.4	16.3	19.8	35.5	44.9	59.4	23.7	29.9	21.2	18.0	46.6	22.4	31.0	52.3	56.7	32.6	33.9	41.9	31.8	65.2	66.9	20.4	41.9	32.6	74.0	33.0	48.8	52.8	27.5	41.0	16.6	11.0	48.9	25.3	46.5	75.5	42.4	24.7	20.9	47.4	16.7	32.7	21.8	19.9	39.1	25.0	17.4	19.6	29.9	33.0	57.2	24.6	27.0	31.1	84.2	81.1	68.2	95.2	85.7	70.4	73.0	70.2	70.5	69.4	74.5	78.5	61.1	44.8	41.7	19.9	22.3	35.1	72.8	69.1	37.5	45.5	39.2	35.8	79.7	68.6	49.9	20.2	54.2	44.2	19.9	75.5	103.7	89.0	6.1	75.9	36.1	54.0	50.4	31.2	7.8	119.2	34.5	50.5	62.2	53.0	30.4	46.2	65.3	50.2	42.6	33.7	6.6	58.3	50.8	35.4	30.6	20.8	51.6	34.9	58.7	15.0	42.1	68.9	22.6	7.1	14.0	96.8	75.0	43.2	28.3	48.3	90.2	140.7	74.3	55.6	46.0	51.2	59.6	11.2	21.0	29.7	29.8	70.7	21.4	56.2	59.8	65.8
WDR18	Ipi3	ENSG00000065268	"WD repeat domain 18"	Q9BV38	19	984332-998438	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 162.0;Proximal tubular cells: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050193, HPA050200"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA050193: AB_2681047, HPA050200: AB_2681049"	"unprognostic (7.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	14.8	21.7	12.3	12.0	12.6	11.3	15.3	12.7	18.3	14.0	11.5	16.4	11.6	14.8	3.3	26.0	13.9	4.9	20.6	12.6	11.6	25.1	31.7	12.7	8.8	13.6	12.1	13.7	18.3	8.3	18.9	10.2	13.1	16.4	4.2	7.1	16.0	9.3	23.7	21.5	14.6	4.1	11.8	18.2	15.8	17.7	13.0	8.4	15.6	8.8	6.7	15.2	15.6	13.4	58.3	55.2	16.7	28.2	15.7	14.4	68.0	25.6	14.3	30.5	22.6	62.8	19.6	68.9	29.8	37.2	3.6	46.6	45.4	53.3	11.8	36.1	75.3	33.3	34.1	79.8	36.7	71.7	30.1	18.5	28.1	18.2	42.5	15.5	28.3	32.7	74.9	25.7	11.4	62.3	53.2	102.9	96.1	39.7	35.8	99.1	39.8	107.0	19.4	35.8	63.7	60.4	24.3	20.0	26.5	11.5	47.5	42.6	28.8	34.3	41.7	67.8	40.7	83.0	74.9	33.7	29.6	44.3	37.0	11.5	77.5	18.9	53.4	84.8	52.8	56.6	53.7	58.0	117.8	69.7	53.2	48.4	3.6	57.1	70.8	74.6	65.2	66.7	12.3	12.6	12.7	18.3	12.6	11.6	13.6	12.1	13.1	11.8	13.0	13.4	20.8	9.6	13.0	10.4	19.5	19.4	28.4	57.9	25.0	28.6	23.1	22.6	13.6	15.7	31.1	31.3	22.9	90.3	14.5	22.4	70.5	73.2	35.6	18.0	17.4	24.6	32.3	20.8	9.8	54.4	162.0	22.3	23.0	18.9	16.5	47.7	23.6	43.0	46.0	26.9	7.9	33.0	44.7	19.2	17.2	38.2	15.5	19.2	16.0	5.6	47.7	32.2	23.7	1.5	6.0	47.8	23.9	16.1	30.0	27.9	28.8	207.8	27.2	24.8	13.1	16.2	31.7	36.5	30.6	29.8	20.3	60.1	18.7	43.7	48.3	24.2
WDR19	"DYF-2, FAP66, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182504-39285810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 61.8;Inhibitory neurons: 82.5;Respiratory ciliated cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.3;ASC TERT1: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favorable (2.70e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	7.5	8.0	3.1	5.3	2.5	3.7	9.2	5.3	3.8	10.5	10.8	6.8	1.9	16.0	13.3	3.9	20.3	8.4	4.2	2.3	2.5	8.8	6.3	8.8	4.7	5.3	3.6	17.9	5.4	8.1	9.1	6.2	2.9	7.7	4.2	13.0	5.7	8.4	2.3	5.5	4.7	9.1	3.5	4.6	6.2	14.0	2.7	6.9	16.7	2.4	4.9	6.2	6.8	3.6	6.1	5.2	10.3	12.1	45.3	47.0	4.7	7.5	17.2	8.1	10.6	2.8	6.5	10.4	4.1	7.8	17.2	4.0	10.9	5.4	8.6	0.5	8.5	2.2	10.3	6.1	16.1	9.6	2.6	30.5	11.1	11.9	7.2	24.6	10.7	11.0	8.7	9.1	9.9	2.1	7.7	8.1	3.5	3.7	5.6	8.2	10.4	4.2	7.0	2.9	11.5	10.4	10.2	2.4	6.1	13.1	5.5	3.6	7.9	7.9	5.3	17.5	7.8	7.2	7.6	7.6	11.9	3.3	3.7	0.1	0.3	0.2	0.3	0.5	0.3	0.8	0.5	0.6	0.3	1.2	0.5	0.6	0.3	0.8	0.5	0.1	0.3	0.2	3.1	2.5	5.3	3.8	2.3	2.5	5.3	3.6	2.9	3.5	2.7	3.6	5.5	12.8	9.3	26.1	5.4	4.8	4.9	4.6	2.2	10.1	7.3	7.4	4.5	2.8	9.4	18.4	10.4	1.2	1.8	0.7	0.0	5.5	5.1	32.3	14.6	6.7	2.4	4.0	61.8	3.6	3.2	10.8	2.0	12.0	2.5	13.4	4.2	10.0	3.2	25.2	82.5	2.0	12.2	3.2	3.6	3.4	16.4	3.0	1.8	19.7	1.8	6.7	1.0	18.1	19.7	2.9	0.2	18.8	3.9	3.0	0.3	4.0	46.6	21.7	0.0	10.9	7.9	33.8	10.2	3.9	4.7	1.4	2.9	13.1	1.1	1.9
WDR25	"C14orf67, MGC4645"	ENSG00000176473	"WD repeat domain 25"	Q64LD2	14	100376418-100530303	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003113	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA003113: AB_2215263"	"unprognostic (5.31e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.36e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.62e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.51e-2)"	6.4	10.0	7.6	2.5	7.8	4.1	6.5	8.0	9.5	8.1	8.1	6.7	3.2	7.9	4.2	4.5	6.8	3.0	6.6	7.4	7.5	7.0	8.6	5.8	3.6	7.6	7.6	6.6	12.9	3.5	11.3	3.3	8.5	7.9	2.5	4.5	5.7	3.6	10.7	5.7	4.8	2.7	7.0	5.7	6.5	7.4	7.3	5.6	9.1	4.5	2.3	7.9	5.4	7.8	3.5	6.1	4.2	15.6	6.7	6.2	3.5	6.4	10.2	7.3	7.4	2.9	6.5	5.1	7.9	5.0	2.0	6.2	4.0	7.8	3.8	5.0	2.9	3.4	6.9	4.9	12.2	4.0	3.8	9.3	9.2	5.3	7.9	6.4	5.3	5.9	4.2	7.3	4.8	13.5	6.0	4.4	3.2	4.2	10.7	4.3	5.9	3.6	5.6	2.8	9.8	10.3	5.2	1.9	9.0	4.0	7.2	1.4	9.2	2.8	3.2	10.8	3.7	4.9	2.6	2.5	9.7	3.0	5.4	34.0	16.4	24.6	8.6	14.6	8.7	13.0	11.1	9.1	14.3	8.5	11.7	8.6	8.7	5.6	16.3	11.0	12.0	12.2	7.6	7.8	8.0	9.5	7.4	7.5	7.6	7.6	8.5	7.0	7.3	7.8	7.1	0.0	6.4	12.1	5.1	3.2	4.3	8.6	0.6	8.8	5.5	6.1	2.6	0.0	6.9	3.7	10.4	8.4	6.7	6.3	9.8	12.7	9.2	13.8	6.7	8.8	5.4	11.0	17.8	33.6	4.7	6.2	8.2	8.5	3.8	3.9	5.0	8.7	6.9	5.0	16.9	9.0	14.2	5.6	4.0	6.3	6.8	3.7	5.4	16.9	5.4	14.0	5.2	14.6	19.1	13.3	3.8	11.3	6.3	3.3	7.5	17.9	11.8	16.2	13.1	4.5	7.2	15.6	17.0	2.8	3.0	7.0	5.0	9.2	7.1	3.0
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385146-224437033	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028538, HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427"	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	33.7	28.3	21.9	32.1	21.3	88.9	26.7	20.0	22.0	28.9	27.5	28.9	21.2	26.5	20.8	52.1	22.7	27.1	28.0	23.4	22.8	23.7	35.4	35.1	33.8	21.5	22.0	24.3	24.4	26.4	20.6	35.6	20.2	26.1	25.4	31.5	28.7	25.0	57.1	40.9	26.5	28.6	18.8	38.2	26.7	37.4	22.1	36.0	26.0	45.0	33.2	32.6	31.5	21.9	49.7	28.0	54.6	29.7	76.8	74.6	47.6	58.4	86.4	51.7	48.0	39.0	46.8	51.9	74.4	86.3	21.7	40.6	40.2	47.2	76.1	55.3	53.6	36.2	31.5	31.0	74.7	40.3	68.6	70.8	58.4	55.0	52.1	72.6	80.8	31.7	52.7	51.4	62.4	24.8	42.4	34.7	65.7	41.5	32.0	42.6	66.1	44.2	55.1	48.3	29.5	56.0	64.8	94.9	74.9	55.5	117.5	67.0	88.7	47.7	28.7	41.5	71.3	66.8	33.6	35.2	53.3	26.1	66.8	2.1	1.0	2.1	1.4	1.4	0.8	0.8	0.8	1.0	0.9	0.6	0.7	1.0	4.8	1.5	2.4	1.0	1.1	0.8	21.9	21.3	20.0	22.0	23.4	22.8	21.5	22.0	20.2	18.8	22.1	21.9	32.6	105.8	54.2	55.2	34.4	111.4	29.6	30.9	43.3	24.6	54.1	30.5	49.2	40.0	48.2	35.0	31.3	30.4	54.3	34.8	5.9	22.2	243.3	60.6	35.2	44.2	35.4	53.7	63.4	23.8	15.7	37.9	26.5	71.0	48.1	34.1	41.4	44.2	53.4	38.7	61.3	44.4	40.7	133.4	96.4	102.1	37.0	74.5	46.2	67.5	45.7	16.3	32.0	63.3	70.0	34.2	26.2	28.2	33.0	49.0	19.2	22.8	55.4	24.2	19.7	35.2	41.4	37.1	25.8	63.9	122.3	68.3	45.1	37.9	25.0	63.7
WDR27	MGC43690	ENSG00000184465	"WD repeat domain 27"	A2RRH5	6	169457212-169702067	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.1;Excitatory neurons: 57.2;Inhibitory neurons: 52.6;Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037497, HPA037498"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA037497: AB_10671503, HPA037498: AB_2675509"	"unprognostic (2.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (3.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	5.1	4.5	2.8	3.1	2.2	2.6	6.7	3.1	3.1	9.5	5.9	6.7	3.4	8.1	4.8	6.3	9.9	3.3	3.5	2.3	2.0	5.0	4.4	4.7	4.1	2.4	2.5	10.9	6.1	3.1	5.1	3.0	2.2	6.8	3.6	2.5	6.2	2.0	4.1	4.7	6.1	2.2	1.7	4.8	5.8	10.5	2.7	3.5	10.0	0.8	3.0	6.4	8.0	2.0	3.8	6.5	17.6	6.4	4.2	8.3	4.4	5.8	1.6	3.5	4.1	6.1	4.8	3.1	3.5	1.8	5.0	8.5	3.1	4.4	5.1	4.0	6.0	6.7	13.4	6.1	2.5	3.3	1.0	4.3	4.1	4.4	3.3	6.5	6.5	7.3	15.6	6.1	4.6	4.9	2.1	12.3	4.6	2.8	3.3	5.0	3.6	5.6	3.3	3.5	7.3	7.5	3.8	3.6	2.1	4.7	4.3	6.1	5.6	4.6	3.7	4.3	5.1	5.8	2.2	7.5	4.2	7.7	4.7	0.0	0.1	0.3	0.3	0.1	0.8	0.3	0.4	0.4	0.1	0.8	1.6	0.2	0.0	0.1	0.1	0.4	0.4	0.3	2.8	2.2	3.1	3.1	2.3	2.0	2.4	2.5	2.2	1.7	2.7	2.0	7.0	9.6	3.9	44.1	6.6	2.2	5.6	6.7	8.0	13.5	8.5	9.0	4.3	7.2	5.4	12.9	6.2	5.2	3.2	3.2	0.0	2.3	28.3	26.9	15.5	7.2	4.2	7.8	57.2	1.5	2.8	7.3	11.2	6.2	3.8	13.7	9.3	4.1	2.2	21.9	52.6	4.7	2.0	2.4	2.5	10.3	8.1	3.4	3.6	38.4	1.4	5.9	4.1	51.3	47.4	2.1	5.7	9.8	4.8	4.3	4.2	2.1	25.7	12.7	0.0	5.2	6.3	21.7	10.7	8.1	1.1	1.9	5.4	6.3	7.0	5.4
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	9.1	6.3	2.2	8.4	2.8	2.9	9.3	2.8	2.6	7.3	7.4	5.9	5.4	6.7	4.2	6.6	7.4	3.1	4.4	2.6	3.1	5.9	11.2	4.5	7.1	2.2	2.7	7.6	5.1	9.2	3.0	6.2	2.2	5.8	7.7	4.3	4.4	4.9	10.3	5.0	4.9	8.0	2.3	6.2	6.6	11.7	2.7	8.5	6.0	7.4	11.8	9.4	4.3	2.7	35.6	22.2	21.7	33.5	23.0	18.8	24.9	24.1	15.9	27.8	24.3	23.8	11.6	42.4	32.4	18.2	17.7	23.1	55.0	28.4	44.4	34.3	28.1	39.7	22.7	19.0	19.1	74.8	20.0	18.5	19.8	35.4	53.3	16.3	27.2	29.1	49.7	20.2	24.2	20.4	35.9	15.5	78.7	30.7	34.7	33.9	75.5	32.5	13.8	23.4	33.4	30.1	27.8	33.6	39.6	29.6	13.5	29.9	24.0	20.9	33.1	38.4	54.9	29.3	36.8	64.5	30.5	47.2	55.0	0.1	6.8	0.6	9.3	7.1	12.0	9.3	8.4	11.0	13.5	8.6	12.9	11.9	0.6	9.6	8.1	7.4	12.4	7.4	2.2	2.8	2.8	2.6	2.6	3.1	2.2	2.7	2.2	2.3	2.7	2.7	11.4	9.6	14.3	5.9	13.1	20.9	21.9	13.1	15.4	11.3	11.2	9.7	14.9	8.6	23.4	7.3	6.2	10.7	8.6	4.6	9.8	12.8	33.2	11.7	20.4	13.2	3.6	10.7	12.4	13.8	9.9	14.9	8.2	7.5	16.4	11.9	8.9	27.4	7.9	15.2	12.5	6.4	14.2	7.3	5.7	43.6	12.5	7.1	10.6	5.6	8.2	7.4	10.3	13.0	7.5	12.3	4.1	11.7	10.9	31.4	3.0	7.4	17.6	7.3	13.1	23.0	13.8	52.3	50.8	21.7	22.4	5.1	10.6	31.1	9.8	15.4
WDR33	"FLJ11294, NET14, WDC146"	ENSG00000136709	"WD repeat domain 33"	Q9C0J8	2	127701027-127811187	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026897, HPA046527"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA026897: AB_1858803, HPA046527: AB_2679686"	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-2)"	20.2	16.1	16.2	18.5	16.9	17.3	20.4	35.0	19.0	24.5	19.8	21.9	14.7	19.9	14.4	20.9	21.6	11.8	20.0	16.2	17.0	19.9	27.9	18.9	22.0	15.0	16.5	27.8	20.1	19.1	23.0	16.8	16.3	22.1	15.1	24.5	19.3	12.9	21.2	26.6	22.2	15.0	14.2	27.8	18.5	20.6	16.6	30.9	24.2	21.3	23.9	19.9	22.9	20.0	40.3	22.3	38.2	31.2	22.3	22.9	39.0	36.0	28.5	37.3	35.2	52.1	30.3	50.5	39.0	24.0	34.4	31.8	43.6	30.5	48.6	46.5	26.0	48.9	28.2	56.6	25.1	59.7	35.1	22.4	31.7	35.9	30.3	26.7	32.4	45.0	41.5	44.4	26.6	25.1	62.3	43.7	46.5	25.9	24.6	43.1	38.6	40.4	21.5	51.6	35.5	27.5	32.3	29.6	26.0	35.7	23.0	34.4	29.8	29.3	42.6	33.0	31.1	42.8	70.5	96.4	23.9	23.4	27.8	35.7	20.6	35.1	24.9	22.7	25.8	30.5	25.2	24.2	27.4	28.3	26.6	25.7	14.1	34.7	25.0	19.7	34.4	18.5	16.2	16.9	35.0	19.0	16.2	17.0	15.0	16.5	16.3	14.2	16.6	20.0	63.0	35.3	45.0	47.3	77.9	110.0	77.3	83.8	51.2	50.7	41.3	41.4	46.5	64.3	51.5	36.8	64.6	80.7	74.7	31.4	46.9	48.1	42.4	38.3	39.8	55.0	39.4	35.9	66.2	44.8	87.9	49.3	40.8	47.4	64.7	49.8	43.2	72.5	49.5	60.6	68.9	36.6	75.3	42.0	82.0	25.2	50.4	50.8	76.5	45.0	69.2	32.2	64.9	73.4	83.5	38.9	37.0	50.4	110.1	51.2	42.3	56.7	35.6	61.3	46.0	48.8	71.3	113.3	81.2	53.7	115.8	110.5	79.2	59.7	43.2	65.5
WDR4	"TRM82, TRMT82"	ENSG00000160193	"WD repeat domain 4"	P57081	21	42843094-42879568	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 25.8;Prostatic glandular cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017381	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA017381: AB_1858807"	"unprognostic (3.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.48e-7)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.46e-2)"	5.1	4.7	4.0	7.2	3.9	6.7	3.9	3.8	4.8	4.3	3.4	3.8	5.0	5.1	1.9	9.1	4.1	1.8	3.5	3.8	3.4	4.8	6.0	3.8	9.3	4.3	3.9	4.3	5.6	2.9	2.3	4.1	4.4	3.4	3.1	1.6	3.6	2.6	6.7	5.0	4.0	3.3	3.9	5.4	3.6	4.7	4.0	5.3	4.1	3.2	7.3	5.7	5.0	4.5	35.7	48.5	12.9	18.5	6.9	8.2	30.7	20.2	7.3	16.9	10.7	48.9	18.1	58.8	11.5	14.5	24.5	19.3	44.7	25.5	11.8	19.2	42.0	59.7	52.0	41.9	13.3	36.8	14.5	4.7	11.2	22.9	16.4	6.3	22.1	20.9	72.6	22.0	14.8	29.4	38.5	20.9	32.3	26.4	47.0	41.6	7.8	58.4	12.8	21.2	30.4	19.5	21.2	31.1	10.2	4.1	20.4	28.2	16.4	25.9	17.3	12.1	41.0	28.9	21.6	48.1	12.5	57.2	31.1	0.0	3.9	0.2	2.4	6.8	3.6	5.4	3.4	3.1	7.1	4.9	3.4	3.5	0.0	3.6	4.2	3.5	4.4	3.5	4.0	3.9	3.8	4.8	3.8	3.4	4.3	3.9	4.4	3.9	4.0	4.5	3.6	0.0	4.8	5.5	10.3	8.5	12.7	7.3	4.0	4.1	5.3	4.6	2.5	0.0	3.2	0.0	2.1	16.3	5.5	5.9	0.0	7.4	4.8	2.8	5.8	5.2	5.4	8.4	4.8	6.7	25.8	4.7	6.1	3.4	10.2	5.4	3.6	7.0	12.5	3.3	4.5	6.0	4.1	3.5	4.0	3.8	2.8	4.7	7.2	2.8	1.9	3.8	2.1	1.5	5.1	6.9	1.0	3.0	15.3	24.6	3.5	6.8	2.1	4.6	6.6	2.7	6.1	10.4	8.4	7.5	10.9	11.5	3.6	8.2	7.7	10.7
WDR41	FLJ10904	ENSG00000164253	"WD repeat domain 41"	Q9HAD4	5	77425970-77620611	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043124	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA043124: AB_10793990"	"unprognostic (1.81e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.15e-3)"	"unprognostic (6.11e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.90e-3)"	16.3	9.4	13.5	13.7	15.1	19.3	15.7	13.3	18.3	13.4	8.5	12.8	8.9	10.9	12.3	19.6	16.6	11.7	17.1	13.8	13.7	12.9	14.8	14.0	15.2	15.0	13.6	7.6	21.0	13.8	6.9	11.4	14.8	11.3	13.1	20.6	12.1	10.9	21.4	12.1	8.8	19.1	12.4	11.8	11.3	27.6	14.0	11.7	22.4	21.0	17.2	14.8	10.8	17.0	17.7	29.8	42.6	62.1	41.9	60.1	32.2	55.5	59.6	26.3	47.5	28.1	28.7	54.1	24.6	53.1	44.4	22.3	31.6	77.8	27.6	65.5	37.1	21.6	32.0	24.7	63.7	46.1	50.0	38.5	96.1	30.1	63.1	28.3	42.0	29.6	21.7	56.8	42.2	39.1	24.7	29.7	15.4	17.8	11.7	58.1	56.1	38.7	27.9	14.8	23.5	29.7	48.2	31.0	47.9	49.9	29.4	57.8	38.2	34.3	28.0	19.1	41.3	51.3	44.8	96.7	48.1	20.7	59.4	25.4	28.5	50.1	11.3	33.8	10.9	19.0	6.5	10.2	51.0	13.3	4.4	8.0	13.7	31.8	38.5	23.2	5.8	16.5	13.5	15.1	13.3	18.3	13.8	13.7	15.0	13.6	14.8	12.4	14.0	17.0	10.2	38.5	12.3	63.3	12.6	12.0	25.2	31.0	14.2	34.8	11.6	12.3	17.3	12.8	16.5	18.4	20.9	8.8	16.4	4.4	37.2	22.7	178.8	17.7	25.6	11.3	6.0	13.5	41.3	20.9	25.5	23.7	9.2	8.3	15.8	11.7	8.9	11.5	26.3	23.5	46.7	8.5	14.2	20.2	29.5	87.5	9.6	23.9	17.8	36.5	16.4	14.9	15.5	56.8	78.9	15.2	7.4	8.2	25.6	26.8	5.0	18.7	17.0	19.2	6.6	12.7	22.3	56.4	44.5	23.9	14.2	6.3	11.4	35.5	10.9	28.0
WDR45B	"WDR45L, WIPI3"	ENSG00000141580	"WD repeat domain 45B"	Q5MNZ6	17	82614562-82648553	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 462.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017886			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA017886: AB_1858810"	"unprognostic (1.91e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-2)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.23e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.93e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.02e-1)"	39.4	44.5	50.7	22.4	56.1	58.7	37.6	52.4	50.4	35.6	41.4	33.6	30.8	37.9	30.1	59.3	43.6	36.8	37.0	48.9	50.9	37.3	32.4	32.9	23.3	53.0	51.7	50.1	46.1	46.2	36.8	25.5	50.7	37.5	25.9	30.9	46.6	28.5	24.4	46.9	34.4	27.5	54.3	28.6	39.9	50.0	54.6	23.8	32.1	26.8	25.8	39.8	40.1	60.3	100.5	65.1	56.0	54.6	53.8	44.4	63.0	71.1	77.7	106.4	93.5	78.7	53.8	27.9	44.8	64.2	76.9	52.4	52.8	58.5	101.4	18.6	93.7	55.4	40.5	67.8	64.1	42.8	42.8	50.9	61.7	62.1	57.3	52.1	88.2	38.0	41.6	27.8	63.0	66.8	31.3	37.6	72.3	86.8	78.2	36.6	92.0	28.1	65.0	99.3	68.3	100.9	66.9	74.7	90.7	67.6	86.9	39.2	63.6	120.0	94.4	81.5	135.8	66.5	29.7	40.5	76.8	42.9	87.0	34.2	27.5	33.9	16.4	27.6	16.6	13.4	12.5	13.7	22.2	12.8	10.9	10.5	21.9	13.9	22.8	10.9	11.3	19.3	50.7	56.1	52.4	50.4	48.9	50.9	53.0	51.7	50.7	54.3	54.6	60.3	62.1	32.1	47.3	17.0	51.5	59.9	48.6	71.5	48.3	39.7	76.3	54.0	21.2	60.1	84.4	42.3	12.5	54.4	49.6	85.6	88.0	128.8	152.7	145.2	72.5	56.1	47.4	14.5	16.9	137.7	77.3	44.9	43.3	177.1	73.5	32.7	47.2	71.5	45.8	45.4	20.0	68.0	67.1	62.0	42.5	462.7	57.2	72.8	56.9	15.9	57.8	66.2	44.3	13.0	24.6	157.6	55.4	48.2	24.8	72.8	58.3	71.5	91.1	34.9	32.9	44.6	53.2	94.5	171.6	53.8	72.5	108.1	46.7	37.0	68.3	101.0
WDR47	KIAA0893	ENSG00000085433	"WD repeat domain 47"	O94967	1	108970214-109042113	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 93.6;Suprabasal keratinocytes: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027287, HPA027289"	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 28: Keratinocytes - Keratinization"	"Actin filaments"	Nucleoplasm	"HPA027287: AB_10599416, HPA027289: AB_10601862"	"unprognostic (8.55e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.05e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.39e-3)"	"unprognostic (7.90e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.09e-2)"	7.8	7.1	22.6	5.5	26.6	12.2	6.3	14.1	27.3	8.8	1.5	8.0	3.7	9.3	5.7	14.4	8.5	7.3	8.1	27.7	17.9	7.6	3.5	7.0	5.6	13.4	11.0	7.5	5.9	9.2	5.3	6.5	14.6	7.3	5.3	37.0	5.8	7.0	17.0	22.9	4.5	10.2	10.9	5.7	6.0	22.7	16.7	7.7	6.2	15.3	7.5	7.5	8.9	19.5	15.6	4.7	8.8	10.9	17.0	14.8	4.7	17.4	10.7	11.4	12.7	4.6	2.3	7.0	9.0	16.7	8.4	17.1	12.5	7.6	15.0	13.1	7.0	5.8	9.9	5.3	9.7	9.2	8.3	9.2	12.4	17.9	8.5	13.8	13.7	8.1	3.5	9.5	19.4	9.3	8.9	7.2	3.7	5.0	9.1	12.5	22.3	3.9	19.0	13.3	15.3	14.0	15.2	8.1	12.5	9.4	3.7	9.3	23.5	15.1	7.0	26.7	14.5	6.1	5.4	5.5	17.6	9.0	23.0	18.0	5.4	7.1	3.3	5.7	3.1	2.4	3.1	3.5	5.8	3.4	2.8	2.5	22.0	2.7	5.9	6.3	5.5	2.6	22.6	26.6	14.1	27.3	27.7	17.9	13.4	11.0	14.6	10.9	16.7	19.5	16.5	12.8	6.5	33.3	13.8	93.6	5.1	7.7	62.0	15.3	11.1	12.6	18.9	10.0	8.0	7.3	45.9	2.4	25.1	2.7	5.9	3.5	33.2	20.5	9.3	12.1	3.0	1.7	46.2	0.9	2.1	10.7	8.2	10.4	2.5	5.6	7.1	2.0	4.4	11.8	39.1	1.0	4.1	5.5	28.4	41.4	8.4	13.9	24.9	19.7	6.3	13.2	8.2	15.1	26.5	3.9	0.9	15.1	14.9	2.4	2.4	5.5	18.9	32.3	6.6	13.5	16.5	32.2	28.9	52.1	104.4	4.9	18.9	3.3	2.1	4.1
WDR49	FLJ33620	ENSG00000174776	"WD repeat domain 49"	Q8IV35	3	167478684-167653983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 31.3;choroid plexus: 29.3;fallopian tube: 10.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 79.0;Endometrial ciliated cells: 43.4;Respiratory ciliated cells: 47.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.7;myeloid DC: 2.2;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 2.9;monocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;NTERA-2: 3.0;THP-1: 14.5;U-937: 7.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 9.5"	"HPA036225, HPA036226"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA036225: AB_10696652, HPA036226: AB_2675007"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-3)"		"unprognostic (2.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-2)"		"unprognostic (5.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-9)"	"unprognostic (1.79e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.07e-1)"	0.1	0.1	10.2	0.4	8.2	2.0	0.1	16.6	3.4	0.3	29.3	0.1	2.0	0.4	0.0	0.9	10.0	0.2	2.1	7.0	15.6	0.3	0.0	1.9	0.3	30.1	27.0	0.1	0.3	0.0	0.5	0.0	23.8	0.2	0.1	0.0	0.2	0.0	0.0	0.1	4.6	0.1	31.3	0.4	0.2	0.6	15.5	0.4	0.0	0.2	0.3	0.2	0.2	23.4	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	2.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.5	10.2	8.2	16.6	3.4	7.0	15.6	30.1	27.0	23.8	31.3	15.5	23.4	0.2	0.0	0.6	79.0	0.1	0.0	0.9	1.7	9.1	0.0	0.1	0.1	1.1	0.0	10.9	0.0	0.0	0.0	1.6	0.1	0.0	0.1	2.4	43.4	0.3	0.2	0.0	1.7	4.5	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	4.1	1.6	2.5	0.8	0.0	1.8	0.0	0.0	4.0	0.0	0.0	2.5	3.0	0.0	0.0	0.0	0.1	0.4	3.3	0.0	47.7	0.0	6.6	0.3	0.6	0.1	0.2	1.0	0.1	0.0	0.1	0.0	0.2	0.8
WDR5	"CFAP89, SWD3"	ENSG00000196363	"WD repeat domain 5"	P61964	9	134135365-134159968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 152.7;Spermatocytes: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047182			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA047182: AB_2679971"	"unprognostic (9.28e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.26e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.88e-2)"	17.5	18.4	17.4	13.9	18.2	20.3	16.7	20.1	21.0	17.1	17.3	19.3	17.6	18.7	8.9	24.9	18.9	8.3	19.5	17.8	18.0	18.6	34.0	15.4	16.2	15.9	16.9	21.9	27.7	13.5	25.4	14.7	16.5	18.9	13.7	9.1	18.1	12.7	33.9	22.2	19.4	13.5	15.0	20.0	20.6	38.7	18.4	17.8	17.7	18.2	18.0	18.4	16.3	17.9	43.6	52.4	49.0	56.1	26.1	28.7	77.4	43.0	28.3	57.5	39.1	61.3	34.9	68.8	26.7	35.2	50.5	105.9	66.9	44.1	46.6	46.4	45.6	39.7	85.6	49.9	27.9	90.0	40.2	27.7	41.0	43.1	52.6	23.7	38.7	67.5	75.3	37.6	40.5	116.1	77.4	73.6	62.3	98.3	65.2	83.4	99.2	65.2	28.3	42.0	81.7	42.5	64.8	50.2	29.7	32.5	69.1	78.3	33.9	58.7	53.8	54.5	70.5	19.6	40.0	74.0	34.1	60.4	48.2	0.9	9.3	1.6	6.7	6.0	6.6	4.6	6.6	6.9	10.0	5.8	6.8	5.4	0.8	4.9	5.1	8.3	6.4	7.1	17.4	18.2	20.1	21.0	17.8	18.0	15.9	16.9	16.5	15.0	18.4	17.9	8.2	9.6	8.6	10.7	11.8	11.9	14.9	7.0	16.5	9.6	13.6	12.8	9.5	11.5	5.0	5.5	22.9	27.4	8.9	9.1	9.8	14.7	152.7	8.6	14.4	9.6	6.6	17.5	16.4	20.9	42.5	12.2	15.3	10.0	8.9	17.6	5.3	21.9	19.1	8.4	16.6	13.7	8.2	6.3	9.8	41.4	11.5	10.9	5.4	11.2	10.0	6.8	10.3	10.1	14.3	16.7	9.7	11.7	26.6	30.4	17.6	10.2	3.9	7.4	6.6	9.7	10.9	99.9	42.3	25.6	16.3	17.8	9.7	32.5	22.2	18.0
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: "	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	9.9	9.2	5.2	9.5	5.4	12.9	9.2	6.2	5.6	7.6	6.8	10.6	9.3	7.8	4.3	13.4	7.4	6.1	7.7	5.4	5.8	9.4	12.3	8.8	10.1	6.4	5.6	7.5	11.1	6.1	9.0	7.6	6.0	8.8	10.3	4.0	10.5	5.4	9.1	11.0	11.0	6.4	5.4	12.6	10.5	4.9	5.7	7.8	7.4	6.0	10.6	8.9	7.9	5.9	13.2	18.0	8.5	34.4	12.8	10.1	23.7	12.9	15.5	13.3	15.2	31.1	17.7	12.3	16.8	16.6	24.3	16.1	11.5	22.4	10.2	11.6	9.6	14.1	15.9	12.7	12.2	14.8	25.5	12.2	12.7	18.3	9.6	9.2	14.4	13.7	9.9	9.3	14.9	19.2	14.0	13.3	8.9	18.9	15.2	11.6	12.2	11.6	15.9	19.7	8.3	11.1	17.7	51.3	20.2	10.4	36.3	15.8	13.0	17.5	9.0	20.3	17.6	15.6	12.9	9.6	22.7	19.5	10.6	6.4	10.2	7.8	11.3	16.6	11.7	8.5	10.5	9.8	9.9	7.3	8.3	8.5	9.0	10.3	14.2	7.2	12.6	10.0	5.2	5.4	6.2	5.6	5.4	5.8	6.4	5.6	6.0	5.4	5.7	5.9	17.1	9.6	16.7	5.9	16.9	14.5	10.9	9.1	9.6	13.5	15.5	10.3	5.3	5.7	16.2	18.4	12.5	21.6	28.9	31.9	21.5	20.2	29.3	20.6	13.1	12.9	14.9	13.9	7.2	28.2	42.8	12.6	25.0	13.9	19.7	16.4	12.5	14.9	20.8	23.5	7.0	22.6	8.2	16.1	13.9	9.7	9.6	18.3	8.8	1.0	20.5	5.7	23.7	4.5	6.5	27.2	39.3	7.5	23.0	15.6	24.9	20.8	17.2	8.3	13.1	13.0	14.1	7.9	9.8	15.1	13.4	23.3	21.0	14.2	26.0	16.4
WDR61	REC14	ENSG00000140395	"WD repeat domain 61"	Q9GZS3	15	78277835-78299703	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039932, HPA040065"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA039932: AB_10796336, HPA040065: AB_10793926"	"unprognostic (1.08e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.74e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (2.03e-10)"	"unprognostic (1.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.09e-2)"	38.8	52.7	34.5	29.6	36.5	61.5	59.9	50.4	63.0	40.8	31.1	39.5	36.2	34.9	115.7	40.1	46.6	28.6	41.0	40.8	40.4	60.8	50.9	34.6	37.4	41.5	41.2	34.6	41.3	55.6	49.9	35.5	40.0	46.0	43.5	49.4	39.5	37.4	45.4	52.1	30.4	41.4	38.2	29.9	33.5	49.0	37.0	48.5	56.8	38.2	46.0	41.4	32.4	61.5	39.3	92.4	74.3	77.4	74.1	61.6	56.1	60.9	68.6	76.6	73.6	87.9	67.9	80.7	72.6	69.8	119.2	78.2	165.8	71.5	58.3	53.9	123.8	66.2	79.9	84.6	62.6	99.2	63.3	52.8	50.5	30.8	24.0	52.7	82.7	80.0	113.1	78.8	92.5	116.6	82.3	81.6	54.3	98.5	76.2	74.7	59.7	89.1	81.3	112.3	103.7	56.2	88.0	90.9	323.7	76.9	56.0	124.2	58.2	53.7	66.0	38.2	103.6	69.3	113.7	113.0	80.5	153.3	112.6	39.0	91.2	33.6	59.6	100.0	65.0	66.4	59.7	62.1	134.2	53.5	62.2	68.6	7.7	72.4	86.0	71.6	72.7	89.1	34.5	36.5	50.4	63.0	40.8	40.4	41.5	41.2	40.0	38.2	37.0	61.5	38.7	35.3	44.7	20.5	26.7	49.1	61.5	105.0	31.9	57.2	44.8	47.2	25.8	28.6	57.5	38.6	47.9	106.1	29.2	23.2	125.2	62.5	32.2	41.5	38.6	42.2	23.4	37.6	34.6	55.6	78.1	51.0	20.4	29.1	47.5	49.1	40.0	47.0	66.1	43.7	36.8	38.0	93.6	37.0	47.2	12.4	50.1	37.0	58.7	12.2	61.1	81.9	42.2	17.1	33.1	41.0	28.5	50.8	36.4	51.6	35.4	132.7	70.1	50.7	6.6	37.8	90.2	122.4	60.2	38.3	58.7	92.4	31.7	59.4	52.4	57.7
WDR7	"KIAA0541, TRAG"	ENSG00000091157	"WD repeat domain 7"	Q9Y4E6	18	56651343-57029811	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 99.6;Excitatory neurons: 268.8;Inhibitory neurons: 223.0;Microglial cells: 111.5;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 244.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042074, HPA051057"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA042074: AB_2677833, HPA051057: AB_2732563"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.70e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (4.80e-2)"	"unprognostic (4.52e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	5.9	7.6	13.2	5.9	14.2	7.2	4.9	7.0	19.8	4.8	3.1	5.4	4.1	4.8	5.3	4.4	4.2	5.3	5.9	16.2	11.1	5.3	7.4	5.0	7.4	14.6	8.8	4.2	4.2	9.2	8.4	4.7	14.7	7.5	4.9	18.8	4.2	5.7	8.2	4.3	4.3	5.6	7.8	6.2	4.9	4.6	9.6	10.3	9.1	9.6	5.8	5.0	4.5	16.0	4.7	7.7	8.7	4.9	13.5	7.8	2.2	9.2	7.8	7.4	8.8	3.1	2.9	13.0	3.6	8.3	6.3	4.9	8.8	7.2	9.2	15.1	5.4	12.3	5.8	2.8	8.1	18.7	15.0	6.7	5.9	9.9	6.6	6.1	9.3	6.1	6.0	17.5	9.3	4.6	13.0	5.5	3.7	2.4	5.1	5.8	6.7	6.3	5.7	8.4	11.3	5.6	6.5	3.1	4.3	7.4	4.9	5.2	8.3	10.5	5.3	3.2	5.0	17.4	14.2	13.9	8.6	9.3	7.2	4.0	3.0	5.5	3.6	4.4	4.5	2.4	4.0	3.7	3.6	2.2	4.2	3.8	2.6	4.6	5.5	1.7	5.2	2.0	13.2	14.2	7.0	19.8	16.2	11.1	14.6	8.8	14.7	7.8	9.6	16.0	8.7	3.2	4.8	99.6	7.5	2.9	1.9	2.3	2.8	24.5	3.4	2.4	12.5	5.7	6.8	0.0	31.3	2.0	7.7	5.8	3.9	3.2	21.0	4.4	6.0	6.6	8.4	8.2	268.8	3.6	1.2	6.3	7.7	3.9	10.8	9.0	9.3	8.9	5.8	26.9	223.0	2.7	0.0	16.2	2.8	7.0	5.6	11.3	0.0	111.5	8.8	7.1	10.3	146.3	244.7	2.6	2.6	8.2	10.1	2.6	4.5	3.2	5.7	26.3	6.6	10.7	5.8	2.0	1.7	5.8	2.4	0.7	9.9	9.3	4.1	1.6
WDR74	"FLJ10439, Nsa1"	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 565.6;choroid plexus: 711.0"	"Cell type enriched"	"Detected in all"	5	"Early spermatids: 616.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	21.3	21.8	352.4	20.5	274.3	127.1	21.2	485.9	291.6	19.5	711.0	19.6	17.1	20.8	14.6	25.8	22.3	11.4	23.1	251.8	208.5	21.5	28.5	14.9	30.6	220.8	221.4	25.6	30.9	15.1	11.4	18.3	292.3	19.5	16.4	33.7	25.0	13.7	59.3	31.2	17.7	17.0	305.3	30.1	22.0	15.4	244.7	62.3	28.4	25.3	23.9	24.8	18.9	565.6	64.2	76.2	28.8	49.4	22.9	31.4	85.9	35.8	37.5	73.6	49.1	108.8	77.0	111.6	97.6	28.5	59.0	84.1	88.8	69.0	56.8	72.7	64.2	55.5	84.1	97.5	65.9	112.3	36.0	30.9	75.7	47.8	153.9	24.8	36.1	80.5	126.1	32.5	33.7	120.6	106.7	178.7	117.1	70.9	96.7	108.9	49.9	193.6	52.7	35.6	65.7	72.1	40.8	84.1	115.4	27.8	58.8	83.1	28.0	44.4	52.4	98.3	88.2	81.0	120.3	137.1	47.5	68.3	57.2	40.1	140.9	11.7	40.2	61.4	49.7	66.0	42.1	38.6	105.0	121.5	56.8	52.0	51.0	93.2	44.9	154.3	52.4	47.8	352.4	274.3	485.9	291.6	251.8	208.5	220.8	221.4	292.3	305.3	244.7	565.6	36.8	38.5	67.9	1.6	112.5	104.5	47.2	45.7	60.9	15.2	37.6	57.0	2.0	40.0	108.7	16.5	16.7	55.2	57.9	32.0	43.0	42.8	616.0	22.4	34.0	41.7	41.0	26.5	3.6	40.5	53.8	39.1	65.2	32.4	43.6	23.5	20.7	34.0	37.9	3.3	3.0	32.1	20.3	33.1	69.2	97.1	32.9	45.0	30.2	1.0	22.4	15.4	45.3	2.0	2.8	39.8	24.2	21.4	74.3	50.3	44.8	54.0	32.0	11.4	19.7	53.0	89.3	19.4	31.4	50.3	109.3	34.8	66.3	30.4	41.5	39.8
WDR77	"MEP50, p44"	ENSG00000116455	"WD repeat domain 77"	Q9BQA1	1	111439890-111449256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 104.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026437, HPA026448, HPA027271"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004"	"unprognostic (1.84e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (5.14e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (7.88e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.23e-2)"	16.5	23.5	13.5	18.2	13.6	10.3	14.1	13.0	13.5	14.2	13.3	17.0	14.9	20.1	17.7	27.3	104.9	12.4	29.6	15.1	14.6	19.5	22.7	13.8	28.4	14.1	15.2	12.6	17.5	18.2	14.2	18.5	14.2	17.4	24.1	11.4	19.4	14.7	42.2	13.6	16.3	19.2	13.4	22.5	21.2	14.1	15.1	20.5	13.6	32.9	36.2	24.6	16.7	14.1	70.0	58.6	56.0	46.2	32.5	19.6	76.6	51.8	27.6	76.4	50.1	86.0	25.5	118.8	48.6	44.0	49.1	49.4	101.2	96.9	91.1	46.9	80.0	70.9	67.4	125.2	36.9	71.7	114.6	23.8	68.6	75.4	47.6	20.5	51.7	51.9	96.3	30.1	74.5	86.0	94.0	38.8	109.7	64.5	99.4	92.2	88.2	44.9	68.9	118.7	45.6	33.4	45.5	54.7	42.3	70.6	45.1	50.5	38.7	42.3	86.4	82.6	111.1	25.4	34.1	106.3	54.6	81.1	126.5	17.6	24.6	6.6	27.5	38.2	31.2	53.6	30.0	31.5	54.5	42.3	31.2	29.4	3.6	58.5	35.6	34.1	27.8	27.1	13.5	13.6	13.0	13.5	15.1	14.6	14.1	15.2	14.2	13.4	15.1	14.1	11.1	12.8	11.4	8.1	29.6	20.8	27.9	34.8	10.8	11.5	13.2	11.7	22.2	10.0	17.7	18.4	25.0	56.1	19.4	7.0	25.4	30.6	4.8	42.1	18.2	15.3	15.7	18.1	6.0	13.6	57.0	12.9	26.5	40.9	15.8	21.2	8.2	15.6	47.4	8.4	7.2	14.4	20.3	20.3	8.0	4.1	7.5	18.9	5.4	7.5	16.0	9.7	13.4	7.1	5.8	22.1	7.8	9.1	20.1	28.2	8.8	29.3	34.2	9.2	13.1	10.6	18.3	22.3	24.8	26.1	18.5	45.6	15.3	36.0	22.5	23.5
WDR81	"CAMRQ2, FLJ33817, PPP1R166, SORF-2"	ENSG00000167716	"WD repeat domain 81"	Q562E7	17	1716523-1738599	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023044, HPA063703"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Vesicles, Cytosol"	"HPA023044: AB_1858822, HPA063703: "	"unprognostic (1.00e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.90e-3)"	"unprognostic (6.10e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.60e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (3.26e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.90e-2)"	17.7	16.2	4.5	4.6	5.4	4.9	16.9	4.6	6.3	18.2	6.6	11.5	4.8	18.9	2.4	9.9	17.4	1.6	10.9	4.3	4.4	11.9	32.8	13.7	5.6	5.9	5.1	21.4	11.0	2.4	13.1	3.9	5.3	16.0	1.7	0.8	11.0	5.9	18.2	18.4	17.8	5.1	4.7	24.3	11.0	7.5	6.1	6.6	10.5	2.1	4.2	15.4	13.7	6.4	0.7	12.3	1.7	9.1	12.4	7.0	9.2	0.9	0.2	0.6	0.0	1.8	4.4	4.9	6.5	5.4	6.2	12.2	6.3	8.4	0.4	9.5	12.8	0.3	8.8	5.9	22.1	4.1	7.6	17.8	8.8	5.9	4.1	1.9	5.0	3.7	1.0	6.3	7.6	6.8	1.3	7.6	3.9	4.2	9.4	6.4	2.9	6.8	3.7	2.0	2.2	5.0	4.3	3.4	15.4	0.1	6.0	6.1	6.8	4.8	5.4	7.9	6.7	0.5	1.3	3.1	7.7	5.9	2.4	0.0	1.4	2.8	1.1	2.3	1.3	1.3	1.2	1.2	1.8	1.0	0.8	1.1	0.3	2.1	2.3	3.3	1.2	1.1	4.5	5.4	4.6	6.3	4.3	4.4	5.9	5.1	5.3	4.7	6.1	6.4	6.3	12.8	10.3	6.5	4.2	2.5	2.9	4.4	8.6	4.5	4.8	5.3	3.6	4.3	3.8	0.0	4.2	2.5	9.9	6.8	1.9	3.1	0.7	2.1	6.2	5.4	1.2	14.3	5.3	4.5	1.9	8.2	6.6	2.9	4.5	6.2	4.6	27.7	23.8	5.0	5.3	4.6	10.2	22.3	4.5	1.2	16.4	15.3	0.0	9.4	7.5	2.5	9.2	5.0	7.6	4.8	4.8	15.1	5.3	2.9	8.7	20.1	6.4	1.8	19.7	5.9	4.5	0.7	2.0	3.4	1.7	2.3	4.7	5.8	4.4	1.7
WDR83	MORG1	ENSG00000123154	"WD repeat domain 83"	Q9BRX9	19	12666802-12675832	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042629, HPA042838"	Uncertain		Approved	"Nucleoplasm,Vesicles,Centriolar satellite"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Centriolar satellite"	"HPA042629: AB_10794763, HPA042838: AB_10794173"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.56e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (3.12e-4)"	5.2	6.7	7.5	3.4	8.1	5.3	5.2	8.0	9.3	6.0	7.1	7.1	2.6	6.2	2.0	4.2	6.8	2.9	7.2	7.5	7.9	6.9	4.8	4.6	5.0	7.8	7.8	6.5	6.3	5.6	5.7	2.7	7.7	5.9	1.4	2.5	8.1	3.3	4.2	6.5	4.6	1.9	7.5	5.3	6.9	10.0	7.8	6.8	5.8	2.9	3.1	5.7	4.5	8.2	6.8	11.0	6.2	8.1	11.0	4.4	4.9	6.1	5.8	7.3	7.5	13.4	5.7	10.0	8.7	5.6	4.2	7.0	7.3	9.6	1.3	10.2	16.0	8.0	7.6	8.0	9.3	11.3	8.4	8.0	7.6	6.0	4.9	5.1	7.2	21.6	7.2	0.8	3.4	25.6	16.4	9.2	4.8	8.0	18.8	10.9	7.7	9.3	7.1	8.0	12.6	8.6	6.4	9.0	5.3	3.5	5.1	11.2	4.0	8.0	2.4	6.2	6.1	24.7	17.7	4.9	12.7	8.7	4.6	5.6	13.4	5.7	10.2	12.4	12.2	9.7	10.2	10.2	14.0	10.8	9.8	12.8	6.7	21.9	6.4	23.5	12.2	10.8	7.5	8.1	8.0	9.3	7.5	7.9	7.8	7.8	7.7	7.5	7.8	8.2	10.8	0.0	14.4	4.2	13.5	15.4	12.1	15.9	11.4	21.1	10.1	9.8	4.4	17.2	12.0	18.4	12.5	12.4	22.3	9.0	17.6	15.6	17.8	12.2	7.3	12.0	9.6	16.2	7.2	17.5	13.9	9.9	9.2	6.1	14.0	12.4	8.6	9.2	13.2	20.2	7.1	7.8	16.2	11.6	19.2	61.9	15.8	9.6	16.0	1.9	17.8	18.2	24.7	4.5	4.4	13.5	5.8	18.0	11.6	15.4	13.6	33.7	18.4	22.7	19.7	8.1	11.3	25.8	17.6	8.3	16.1	9.0	12.4	10.1	9.6	14.6
WDR88	PQWD	ENSG00000166359	"WD repeat domain 88"	Q6ZMY6	19	33132090-33175799	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 8.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 31.3;Late spermatids: 15.9;Spermatocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041916, HPA050336"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA041916: AB_10804121, HPA050336: AB_2681093"	"unprognostic (1.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.33e-4)"	"unprognostic (5.14e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.67e-2)"	0.2	0.4	0.4	0.9	0.9	0.9	0.1	0.9	0.8	0.1	0.0	0.1	0.6	0.3	0.0	0.6	0.2	0.5	0.9	0.6	0.2	0.3	0.1	0.2	1.2	0.3	0.2	0.7	0.8	0.0	0.2	0.2	0.3	0.3	0.0	1.5	0.8	0.0	0.2	0.7	0.7	0.0	0.2	0.6	0.3	8.9	0.4	0.0	1.0	0.0	0.0	0.2	0.0	0.4	0.5	1.1	0.7	1.3	0.3	0.0	1.0	0.4	0.0	0.1	0.0	0.5	1.1	1.3	0.6	0.0	0.8	0.4	0.0	0.1	0.0	2.8	0.4	1.3	1.0	0.2	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.9	1.4	0.0	1.7	0.5	0.6	0.5	0.4	0.4	1.1	0.4	0.2	0.0	0.6	1.9	1.9	1.3	0.6	0.3	0.9	1.6	1.0	0.7	0.3	1.0	0.6	0.2	1.2	0.9	0.7	0.2	2.1	0.5	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.9	0.9	0.8	0.6	0.2	0.3	0.2	0.3	0.2	0.4	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	15.9	0.3	0.0	0.0	1.9	0.0	0.0	0.0	2.5	4.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WDR92	"FLJ31741, Monad"	ENSG00000243667	"WD repeat domain 92"	Q96MX6	2	68122936-68157549	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 47.9;Respiratory ciliated cells: 40.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035335, HPA035336"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA035335: AB_10959456, HPA035336: AB_10964348"	"unprognostic (3.55e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.61e-1)"	"unprognostic (3.56e-3)"	"unprognostic (9.86e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.15e-2)"	6.0	7.0	4.9	6.6	6.4	3.6	8.6	7.6	5.5	5.4	10.4	6.1	6.3	7.4	16.0	7.0	11.1	5.3	9.0	5.0	4.9	5.5	5.2	5.8	9.7	5.7	7.2	6.9	4.3	7.2	4.7	5.7	4.6	8.1	8.0	6.9	6.4	6.8	11.4	10.5	5.3	7.5	5.2	8.2	5.9	8.0	4.7	8.1	8.3	9.1	8.9	5.0	5.1	5.5	15.3	9.4	12.0	12.6	14.5	14.7	10.3	11.6	10.1	12.1	12.8	7.0	12.5	16.5	3.7	10.3	16.5	15.0	13.0	8.8	15.6	11.2	13.8	16.9	13.1	8.0	7.0	18.5	5.2	9.4	11.5	10.0	8.6	12.9	11.7	15.2	11.3	11.1	14.3	7.3	13.2	18.6	12.2	12.8	12.9	15.9	15.3	14.1	12.5	8.6	12.4	10.6	8.6	15.5	9.6	11.8	11.9	12.1	13.6	18.4	7.4	11.6	10.1	7.6	11.6	11.6	17.3	17.6	9.3	0.7	2.3	1.7	3.2	2.5	4.2	5.3	3.4	3.8	2.7	4.9	4.0	5.0	1.0	6.3	1.8	5.1	4.0	2.1	4.9	6.4	7.6	5.5	5.0	4.9	5.7	7.2	4.6	5.2	4.7	5.5	7.8	3.2	10.9	5.9	5.2	3.4	4.7	6.5	2.2	28.7	5.6	5.6	3.1	1.5	11.1	5.5	47.9	13.6	12.2	1.3	1.9	6.7	5.8	26.3	6.8	7.4	0.0	7.0	17.9	6.5	9.2	5.7	1.5	4.3	13.3	9.7	8.2	6.3	7.3	11.8	16.4	3.3	4.1	3.5	1.2	2.8	7.8	3.5	1.8	8.4	7.2	12.0	6.2	14.1	11.6	6.2	2.9	9.4	2.0	3.3	3.7	6.7	40.2	21.9	6.6	9.0	5.9	26.0	15.2	1.8	4.1	5.1	3.6	9.4	6.0	2.1
WDSUB1	"FLJ36175, UBOX6, WDSAM1"	ENSG00000196151	"WD repeat, sterile alpha motif and U-box domain containing 1"	Q8N9V3	2	159235798-159286703	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036840, HPA058172"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036840: AB_10670926, HPA058172: AB_2683628"	"unprognostic (1.37e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (2.56e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.76e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.87e-2)"	6.7	10.9	9.1	4.6	10.2	10.6	12.0	10.7	12.0	7.8	11.7	6.7	4.9	8.2	17.5	7.5	9.8	5.9	10.1	8.9	9.3	23.5	6.9	9.0	7.9	9.7	9.3	13.5	10.6	13.9	9.1	9.7	9.8	9.1	7.6	11.1	10.4	6.8	6.7	6.9	5.8	6.6	8.9	8.6	7.4	6.7	9.4	7.0	17.3	6.5	5.8	6.2	6.3	11.7	8.4	6.3	5.4	9.0	10.1	11.4	19.1	6.7	13.0	11.4	20.4	13.7	13.6	11.7	6.9	9.9	20.3	5.2	15.9	5.9	16.1	4.5	13.4	12.1	6.8	14.0	12.2	10.2	15.6	6.7	21.5	14.4	12.0	22.2	9.8	14.9	16.0	8.5	11.1	8.8	7.3	18.5	7.5	14.3	13.6	11.3	8.3	6.2	13.6	12.2	10.3	6.8	7.0	8.6	15.9	26.0	6.7	17.3	4.1	8.2	6.2	11.8	6.5	4.2	7.7	10.7	14.4	12.6	5.3	3.9	11.1	3.5	14.3	8.6	10.9	11.8	5.6	9.1	12.2	9.9	6.7	8.0	0.8	20.8	7.9	11.6	3.3	7.8	9.1	10.2	10.7	12.0	8.9	9.3	9.7	9.3	9.8	8.9	9.4	11.7	8.2	12.8	6.8	28.4	10.7	5.4	8.7	13.0	11.4	6.9	9.3	8.0	11.3	10.0	11.3	20.2	2.1	25.4	11.2	5.1	35.2	9.5	4.5	13.7	6.9	7.0	5.4	6.7	42.4	3.6	9.2	9.9	10.2	16.1	12.0	13.2	6.4	2.0	17.3	5.0	52.0	4.5	12.2	14.8	4.8	2.9	12.8	10.2	5.4	29.0	9.2	6.6	14.4	31.7	34.6	4.0	7.0	11.3	3.8	6.8	6.9	23.7	15.0	9.7	0.0	12.0	7.8	10.1	22.5	11.1	6.3	23.0	9.1	12.7	7.1	7.3
WEE2	"FLJ16107, WEE1B"	ENSG00000214102	"WEE2 oocyte meiosis inhibiting kinase"	P0C1S8	7	141708353-141731271	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 1.9;Proximal tubular cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA					"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	0.6	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WIPI1	"ATG18, ATG18A, FLJ10055, WIPI49"	ENSG00000070540	"WD repeat domain, phosphoinositide interacting 1"	Q5MNZ9	17	68420948-68457513	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 127.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 165.7;Syncytiotrophoblasts: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 114.1;eosinophil: 223.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 224.3;HHSteC: 216.7;HSkMC: 180.8;SK-MEL-30: 183.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007493, CAB037230"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB037230: AB_1841265, HPA007493: AB_1848642"	"unprognostic (2.83e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.32e-3)"	"unprognostic (6.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-3)"	31.3	18.8	11.2	14.1	11.2	26.6	30.5	12.5	15.1	33.1	19.1	36.4	12.8	15.3	14.4	14.8	12.6	23.3	78.4	10.6	12.9	33.3	18.7	26.2	8.7	12.5	12.0	11.2	29.8	25.2	17.8	62.4	12.5	17.4	38.5	8.2	55.0	18.3	127.2	21.9	14.8	18.8	11.4	12.5	29.3	9.6	15.5	5.9	21.1	97.5	16.7	22.0	14.4	11.9	4.9	9.8	8.6	12.5	224.3	167.2	49.0	36.3	163.5	13.7	43.6	7.2	7.3	3.0	16.0	74.2	47.9	3.7	3.3	22.1	23.9	4.4	4.6	34.7	3.2	42.6	216.7	2.4	48.5	180.8	39.5	54.2	72.0	44.2	61.3	5.3	2.5	82.0	41.1	29.9	0.5	7.1	1.8	12.7	15.0	0.4	30.3	35.7	20.2	16.7	2.4	11.4	7.7	103.8	183.4	44.4	54.8	9.5	61.2	65.4	10.1	31.0	8.6	78.2	92.0	10.5	98.9	16.5	29.7	114.1	18.4	223.6	11.9	22.7	5.3	4.4	3.1	11.7	9.0	1.4	0.2	5.6	39.0	10.7	24.7	6.3	2.7	15.0	11.2	11.2	12.5	15.1	10.6	12.9	12.5	12.0	12.5	11.4	15.5	11.9	26.2	9.6	11.5	12.7	13.3	7.8	11.9	45.6	0.6	15.0	24.1	8.9	7.3	28.6	48.5	16.5	2.1	44.0	18.3	30.2	31.3	31.2	6.3	26.3	19.9	17.2	12.0	56.6	9.4	57.2	165.7	41.2	25.5	40.0	7.0	12.3	33.9	11.7	35.6	10.1	8.2	67.6	44.7	18.2	14.5	5.2	46.3	37.1	42.7	20.6	34.2	10.6	20.6	6.0	12.2	28.8	20.1	42.2	83.3	55.3	8.5	71.8	49.6	15.7	26.3	10.1	24.1	5.0	5.1	3.3	6.8	125.1	13.6	27.8	28.2	36.7
WIPI2	"ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984"	ENSG00000157954	"WD repeat domain, phosphoinositide interacting 2"	Q9Y4P8	7	5190196-5233840	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 255.9;Spermatocytes: 233.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019852, HPA021488"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA019852: AB_1846589, HPA021488: AB_1846591"	"unprognostic (5.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (1.96e-3)"	"unprognostic (9.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (4.96e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (9.78e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.05e-6)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.98e-2)"	31.1	30.9	38.8	22.9	40.7	47.0	30.8	35.2	41.8	27.3	37.1	33.9	24.7	32.1	26.3	35.8	29.0	23.2	38.0	42.8	38.6	32.2	35.7	26.4	30.2	36.3	39.1	28.2	37.1	38.2	30.6	32.8	38.7	28.7	20.2	19.1	43.5	28.2	41.3	47.1	26.7	26.8	37.0	29.6	33.6	53.8	38.7	36.8	27.4	45.0	29.2	27.1	30.0	39.8	67.5	42.1	40.4	69.4	60.7	63.3	62.0	58.7	66.9	61.2	64.2	41.2	60.9	47.7	43.9	73.8	76.0	48.2	41.2	47.8	47.4	24.9	64.1	32.7	39.7	45.8	59.9	51.8	34.4	66.9	56.4	69.7	38.3	60.9	86.3	64.3	94.2	41.9	56.2	69.9	39.6	90.0	84.3	35.9	61.1	64.3	57.7	79.5	40.4	32.3	50.3	75.4	43.0	72.8	52.4	67.3	44.8	97.2	69.2	38.9	80.9	65.6	44.4	75.0	75.2	54.7	63.4	59.3	58.8	0.4	4.7	13.6	4.4	6.0	2.8	5.7	5.8	8.0	4.2	6.2	7.5	4.7	9.1	2.6	4.2	6.4	9.0	2.2	38.8	40.7	35.2	41.8	42.8	38.6	36.3	39.1	38.7	37.0	38.7	39.8	40.2	38.5	31.5	16.3	51.6	54.9	39.5	13.9	39.3	71.5	49.4	50.5	37.0	42.9	17.6	18.4	62.6	89.4	62.7	42.6	72.4	43.0	195.8	50.0	38.1	37.9	39.5	125.0	19.7	41.8	96.6	43.1	34.7	48.0	31.1	54.8	54.7	60.4	69.1	47.1	19.6	42.6	18.3	61.4	44.8	255.9	42.6	55.9	44.4	20.6	64.5	89.5	44.3	13.6	23.5	55.6	37.0	56.1	67.7	97.7	48.7	80.6	26.4	52.8	52.6	39.7	39.4	233.0	117.3	49.8	71.0	150.8	46.8	44.1	43.0	69.8
WIZ	ZNF803	ENSG00000011451	"WIZ zinc finger"	O95785	19	15419978-15449956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: AB_2671308"	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	13.9	13.7	22.2	10.2	18.0	7.5	13.2	11.1	28.2	13.5	8.3	15.8	9.6	18.7	3.6	12.2	13.4	6.6	18.7	21.4	12.2	13.3	12.3	9.9	6.6	14.0	15.4	14.0	19.7	9.3	7.9	6.7	13.7	12.0	3.5	3.6	10.4	10.3	14.4	13.7	10.2	8.3	12.2	9.5	15.8	21.3	17.7	6.6	9.1	7.3	4.0	16.0	11.6	15.7	23.0	13.1	22.6	28.0	32.2	13.4	17.0	23.2	10.8	19.8	13.4	14.1	43.0	18.8	36.7	22.9	12.1	20.3	12.5	17.3	5.0	13.8	21.3	14.6	13.5	11.3	21.2	15.2	19.9	23.8	22.9	14.7	16.4	12.3	18.3	14.4	22.5	16.8	13.8	48.4	30.2	15.9	28.7	23.8	38.2	27.7	10.4	19.9	13.2	18.5	31.0	36.4	20.2	19.5	15.7	8.3	21.4	16.0	29.2	45.4	16.7	36.0	32.0	22.8	15.6	21.2	18.0	19.1	31.5	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.2	0.1	0.5	1.0	0.3	0.2	0.1	22.2	18.0	11.1	28.2	21.4	12.2	14.0	15.4	13.7	12.2	17.7	15.7	11.3	12.8	6.9	6.5	4.1	15.8	7.2	7.8	5.7	9.4	16.2	17.8	10.9	8.6	5.6	12.9	0.0	7.1	8.4	8.4	3.9	14.9	9.0	6.3	15.3	14.9	6.7	3.0	3.2	20.0	9.9	10.3	9.2	12.1	1.3	17.3	14.3	14.7	7.8	6.7	3.2	9.0	4.1	11.3	7.2	10.0	15.8	8.7	7.2	3.7	6.7	8.5	2.1	2.0	2.8	19.1	3.9	19.2	3.1	14.1	6.2	5.3	2.5	7.4	13.1	9.5	12.7	34.8	21.9	9.3	20.3	7.4	5.4	16.8	10.0	12.8
WNT2B	"WNT13, XWNT2"	ENSG00000134245	"Wnt family member 2B"	Q93097	1	112466541-112530165	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Leydig cells: 80.2;Peritubular cells: 197.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.4;HSkMC: 8.0;SuSa: 3.4;TIME: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047274, HPA066368"			Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	Nucleoplasm	"HPA047274: AB_2732539, HPA066368: AB_2685664"	"unprognostic (2.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.65e-4)"	"unprognostic (5.41e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-2)"	4.5	1.9	2.0	1.5	4.9	0.1	2.8	2.1	2.8	8.2	2.0	5.6	3.0	4.9	2.8	5.8	4.7	2.8	4.3	1.9	1.7	2.4	1.0	6.3	0.8	1.8	1.7	10.9	1.8	0.6	2.3	4.8	1.9	6.1	5.3	5.5	2.2	13.9	1.6	11.1	5.2	2.2	1.4	1.7	3.8	3.8	1.8	0.2	1.9	0.8	0.7	5.6	9.1	2.3	0.4	0.3	2.2	0.5	2.2	4.4	0.4	1.0	1.0	0.2	0.4	0.2	0.5	1.1	0.2	1.1	0.2	1.4	0.7	0.3	0.2	0.0	0.4	0.1	0.8	0.3	1.8	0.2	0.5	8.0	0.8	0.4	0.1	1.3	1.2	0.3	0.1	0.2	0.2	0.3	0.1	0.1	0.3	0.0	0.3	0.1	0.3	0.0	1.5	0.3	0.3	0.3	0.7	0.1	0.7	3.4	0.0	0.2	3.5	0.3	1.4	0.8	0.3	0.1	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.0	4.9	2.1	2.8	1.9	1.7	1.8	1.7	1.9	1.4	1.8	2.3	7.6	12.8	3.3	2.0	2.0	10.1	1.8	6.1	5.2	14.1	2.1	0.9	6.5	1.5	3.9	1.8	27.1	2.1	2.4	3.5	0.0	0.8	5.6	2.6	3.6	10.2	8.4	2.1	5.5	1.4	0.8	17.7	1.1	6.8	2.5	2.8	6.1	0.2	1.1	5.0	6.2	2.2	4.1	2.1	8.2	3.4	80.2	4.0	3.6	30.9	2.2	9.8	0.0	11.6	7.1	2.0	4.8	197.5	2.5	4.4	2.9	0.9	4.6	27.6	0.0	9.7	2.7	5.9	5.5	26.4	13.9	1.9	1.9	2.0	1.5	2.6
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257"	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	4.1	3.7	3.4	4.5	3.5	7.6	4.0	3.4	3.5	4.3	5.0	4.2	2.7	4.5	2.3	4.5	14.5	3.0	4.2	3.4	3.5	4.0	3.6	4.1	6.9	3.9	5.0	3.3	4.5	3.1	4.1	3.4	3.8	3.0	3.5	3.4	3.6	3.0	6.2	4.4	4.7	3.9	4.0	6.9	4.3	5.2	3.5	8.0	3.5	4.5	6.5	3.8	3.6	4.0	22.7	40.6	28.9	29.5	9.2	8.0	16.5	14.3	14.9	45.6	42.1	24.2	13.2	23.3	15.0	13.1	18.7	24.0	33.8	24.5	35.2	14.4	41.4	12.0	22.6	20.5	7.9	8.1	14.7	6.8	9.3	39.9	8.9	6.8	28.8	27.4	12.0	7.7	18.7	21.1	27.0	22.2	15.4	16.7	20.5	35.0	19.3	14.0	17.2	7.7	13.3	19.4	23.1	11.9	12.1	14.0	16.7	10.3	10.1	17.4	19.0	0.1	36.6	5.3	15.9	13.1	16.8	15.2	21.4	29.4	5.8	5.0	5.3	6.3	6.1	3.0	4.2	6.2	5.3	4.2	3.8	4.2	2.5	5.0	2.8	7.4	8.9	3.8	3.4	3.5	3.4	3.5	3.4	3.5	3.9	5.0	3.8	4.0	3.5	4.0	4.6	3.2	3.4	2.3	7.0	3.8	5.2	12.9	2.8	5.6	4.1	4.6	3.6	2.8	7.0	11.0	6.2	12.3	9.2	4.5	3.9	10.1	3.9	22.4	3.4	5.8	3.0	10.8	2.0	10.4	17.0	4.4	4.1	4.1	1.3	7.3	5.3	4.6	7.7	1.7	2.1	5.6	18.3	7.2	3.1	1.9	2.5	5.4	3.6	1.0	8.7	7.2	12.3	5.0	2.8	6.9	3.7	2.2	8.8	2.2	5.2	6.5	51.0	6.3	0.0	6.4	6.3	13.3	6.7	3.5	4.5	4.1	5.7	5.8	7.2	2.9
WRNIP1	"bA420G6.2, CFAP93, FAP93, FLJ22526, WHIP"	ENSG00000124535	"WRN helicase interacting protein 1"	Q96S55	6	2765393-2786952	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031752, HPA031753"	Enhanced		Approved	Nucleoplasm		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA031752: AB_10603004, HPA031753: AB_2674028"	"unprognostic (5.52e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	23.7	31.1	45.6	22.6	47.0	49.0	28.8	47.8	46.8	29.2	46.2	29.7	23.6	26.7	37.1	48.3	35.6	24.6	39.5	47.8	46.7	35.7	33.0	30.3	34.7	44.4	44.8	30.1	43.9	46.4	43.1	43.3	43.5	28.5	29.1	45.8	46.1	26.8	44.0	37.2	27.4	23.8	43.6	28.7	29.1	31.5	47.4	43.9	39.0	76.3	34.7	32.1	31.7	45.1	86.8	42.7	42.5	70.1	44.1	37.7	56.5	38.9	54.2	69.8	69.2	67.8	39.4	77.4	103.1	50.4	75.6	65.9	70.2	78.1	67.8	77.9	77.5	80.9	50.3	107.4	50.1	51.4	53.8	38.7	62.7	64.4	69.5	48.5	89.8	71.8	62.8	27.2	51.6	84.5	76.7	92.7	36.5	59.3	52.5	60.3	62.2	78.4	75.3	52.5	127.8	36.5	45.9	46.1	93.7	66.7	59.4	57.1	49.4	52.1	39.4	45.8	95.8	34.8	65.3	59.8	20.4	55.0	72.1	9.4	1.6	2.3	4.0	1.8	1.2	2.3	2.7	2.8	1.3	1.3	3.1	3.0	0.7	2.6	0.9	2.6	4.2	1.4	45.6	47.0	47.8	46.8	47.8	46.7	44.4	44.8	43.5	43.6	47.4	45.1	16.4	19.2	14.6	14.0	12.4	32.5	13.4	20.1	23.9	24.8	22.3	19.4	23.7	24.3	12.3	11.0	8.4	30.4	11.8	29.6	3.9	14.5	45.0	21.9	19.7	20.9	39.7	26.1	23.5	13.5	25.6	15.1	11.7	17.5	9.5	12.7	28.2	25.0	12.4	8.4	20.8	21.2	24.4	16.2	17.9	13.4	22.4	12.4	21.4	23.4	15.0	20.0	10.3	26.2	23.0	18.0	16.3	22.2	10.2	18.5	14.8	13.7	24.1	17.4	6.6	19.9	17.8	22.1	23.9	32.4	32.1	25.4	12.5	20.5	25.0	16.3
WSCD1	KIAA0523	ENSG00000179314	"WSC domain containing 1"	Q658N2	17	6057807-6124427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.4;Late spermatids: 99.6;Oligodendrocyte precursor cells: 110.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 40.0;HUVEC TERT2: 24.7;OE19: 26.4;PC-3: 24.8;RH-30: 50.5;SCLC-21H: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015919	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA015919: AB_2216211"	"unprognostic (1.50e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	2.2	2.2	19.7	1.0	21.7	0.0	1.8	29.5	19.8	1.1	6.8	6.8	3.4	1.2	0.2	0.6	1.0	0.9	2.0	18.1	19.1	5.9	0.5	1.4	1.3	29.4	23.8	0.5	1.5	0.9	3.5	4.8	24.9	0.6	3.8	5.7	1.2	0.7	11.4	1.3	4.3	1.3	22.2	13.6	1.3	11.2	22.9	1.1	0.9	3.8	0.9	0.8	0.8	26.7	0.0	5.8	40.0	3.2	0.2	0.0	2.1	4.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.4	10.0	0.3	0.0	0.0	13.6	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.5	0.0	24.7	0.1	0.0	0.9	1.2	0.8	0.0	0.0	13.3	26.4	24.8	0.0	50.5	1.6	8.4	2.1	15.5	0.0	0.2	0.0	0.0	4.1	0.0	0.3	0.1	0.0	1.4	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	21.7	29.5	19.8	18.1	19.1	29.4	23.8	24.9	22.2	22.9	26.7	7.7	0.0	0.0	11.8	0.1	0.4	0.0	0.0	0.6	24.1	0.2	0.1	3.8	0.0	0.0	1.8	0.0	0.7	0.1	22.4	1.9	0.3	73.4	0.1	0.0	5.9	0.0	0.0	2.7	0.2	0.1	0.2	0.0	0.0	0.0	0.7	10.0	0.4	1.2	1.7	12.5	3.3	0.0	0.8	0.4	99.6	0.6	0.0	1.8	4.7	0.0	9.8	0.0	110.1	20.6	0.2	6.5	0.0	0.0	0.0	21.5	1.4	0.0	3.5	0.0	6.0	0.7	0.4	3.3	0.1	0.6	0.0	0.3	0.1	5.8	0.1
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129288-108250537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7;thyroid gland: 16.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.7;Excitatory neurons: 30.1;Horizontal cells: 21.9;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 9.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"RT4: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA013346: AB_1858865, HPA048133: AB_2797236"	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	0.9	0.7	8.9	0.1	14.3	0.0	0.8	36.7	13.9	3.5	0.3	3.3	0.3	10.1	2.1	1.0	2.6	0.1	0.4	17.9	4.2	1.0	0.0	0.3	0.1	0.6	2.4	0.3	1.4	0.0	1.4	0.2	2.2	4.2	0.3	11.9	0.3	13.5	0.2	0.8	0.7	6.8	2.7	0.1	1.9	0.2	10.0	0.0	16.8	0.4	0.1	2.5	1.3	7.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.4	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.9	14.3	36.7	13.9	17.9	4.2	0.6	2.4	2.2	2.7	10.0	7.2	0.8	0.0	0.0	5.9	0.6	0.1	0.0	0.1	0.0	43.7	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	30.1	0.0	0.0	1.6	3.1	0.0	0.0	0.0	0.7	0.0	0.0	21.9	27.7	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	2.8	0.0	0.3	0.0	9.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"WT1 transcription factor"	P19544	11	32387775-32435564	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 67.6;fallopian tube: 52.3;ovary: 45.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Endometrial stromal cells: 70.1;Endothelial cells: 16.3;Granulosa cells: 9.3;Late spermatids: 9.3"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.7;HMC-1: 29.9;K-562: 19.6;NB-4: 37.2;THP-1: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279"	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	26.5	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.1	18.4	0.0	0.7	0.0	67.6	5.3	0.0	52.3	1.3	4.5	0.1	0.0	16.3	0.1	0.8	0.0	0.2	0.1	45.8	0.1	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	33.1	0.0	19.0	0.2	24.2	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	8.4	20.7	0.0	1.2	4.7	10.8	29.9	0.0	0.0	3.4	0.0	0.0	0.0	0.7	19.6	0.0	2.0	0.0	11.2	37.2	0.8	0.0	6.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	2.1	19.6	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	20.2	0.0	1.0	0.0	0.0	0.0	0.0	3.6	2.2	70.1	16.3	0.0	0.0	0.1	0.0	0.5	7.3	0.0	1.4	0.0	9.3	1.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	9.3	8.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	2.3	0.0	0.0	6.6	0.0	2.0	4.5	1.0	0.0	0.0	0.8	0.5	0.4	0.0	0.1
WWTR1	"DKFZp586I1419, TAZ"	ENSG00000018408	"WW domain containing transcription regulator 1"	Q9GZV5	3	149517235-149736714	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 229.3;Endothelial cells: 221.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 212.1;RPTEC TERT1: 151.1;SK-MEL-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007415, CAB017483, CAB068248"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602"	"unprognostic (1.85e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.01e-3)"	41.6	13.8	19.2	22.4	20.8	0.2	37.2	18.9	19.6	41.8	32.6	74.9	8.0	42.1	13.4	35.8	33.7	39.6	36.4	20.7	53.9	45.9	19.0	41.2	7.2	52.6	39.9	43.9	31.8	14.1	13.6	44.0	35.9	34.5	13.5	4.2	27.6	32.1	13.2	24.8	21.6	43.7	37.1	19.5	32.7	7.2	23.0	4.7	31.6	15.0	6.1	59.2	34.3	41.0	58.9	80.5	40.6	48.7	48.6	86.8	43.0	32.6	57.5	17.7	17.8	46.7	53.2	0.1	212.1	45.0	53.3	36.1	28.4	28.5	17.9	22.0	19.3	0.0	18.6	37.8	27.3	0.0	0.1	45.3	7.4	61.8	26.6	65.4	136.3	0.0	0.0	0.2	61.7	9.2	0.2	0.2	8.2	0.2	96.6	0.0	50.6	0.4	151.1	9.4	0.0	0.4	21.1	17.2	160.2	31.5	26.5	1.6	94.2	29.0	16.2	24.8	67.4	0.6	0.5	0.8	66.8	0.1	78.8	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.1	19.2	20.8	18.9	19.6	20.7	53.9	52.6	39.9	35.9	37.1	23.0	41.0	125.7	64.1	89.7	60.4	1.1	51.7	229.3	34.6	60.9	2.2	58.1	56.8	46.8	141.5	87.8	49.7	4.2	12.2	2.0	0.5	7.9	72.0	21.9	136.3	89.1	221.2	0.0	3.2	8.7	27.1	82.3	77.9	10.2	144.4	7.6	45.0	111.4	21.9	4.1	0.0	6.1	1.2	10.2	6.0	32.3	7.9	57.8	4.6	30.2	94.6	2.1	11.0	0.0	7.5	12.7	45.8	0.0	126.4	2.9	86.7	1.2	59.8	53.9	2.0	59.2	76.1	58.0	2.2	0.8	46.3	35.5	14.8	6.5	48.4	2.4	93.5
XAB2	"HCNP, HCRN, NTC90, SYF1"	ENSG00000076924	"XPA binding protein 2"	Q9HCS7	19	7619525-7629545	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 159.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048751			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Vesicles	"HPA048751: AB_2680512"	"unprognostic (1.13e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (1.99e-3)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.80e-3)"	29.4	23.6	17.7	15.1	19.9	44.5	30.6	19.6	24.8	37.0	16.9	28.3	17.5	33.8	6.9	25.4	32.0	11.8	24.3	17.8	17.9	27.7	27.8	27.2	20.7	19.9	18.0	45.8	35.9	13.4	27.1	15.4	20.2	32.7	5.4	9.0	31.1	17.5	35.6	39.0	27.6	9.3	18.6	34.5	30.9	37.7	18.3	21.1	34.7	13.3	10.6	29.1	29.6	25.5	39.8	35.7	21.2	27.9	21.9	16.3	41.2	22.8	26.5	39.6	40.0	46.4	25.4	26.7	44.1	21.3	28.9	34.2	30.2	33.2	10.0	47.1	39.0	35.5	30.2	41.3	28.3	47.5	30.8	28.8	27.0	28.0	20.2	21.3	24.2	56.4	32.4	69.0	12.4	44.0	44.9	73.8	48.3	24.8	69.6	49.3	26.8	47.0	15.8	30.7	30.2	34.4	25.9	25.1	23.2	13.8	32.0	41.6	24.1	18.1	29.5	41.3	39.0	117.7	75.0	39.0	31.0	40.1	27.4	8.8	10.0	9.3	11.8	10.2	11.3	10.1	11.0	9.1	8.0	12.2	13.1	10.0	6.4	8.3	13.9	6.9	14.2	12.1	17.7	19.9	19.6	24.8	17.8	17.9	19.9	18.0	20.2	18.6	18.3	25.5	18.3	0.0	1.8	3.9	22.9	19.6	16.2	28.1	14.2	14.1	89.4	54.4	1.4	25.8	20.1	47.8	12.5	46.0	24.8	28.3	35.2	19.8	39.9	24.7	13.3	16.4	18.6	14.1	2.3	34.4	26.4	16.7	33.6	32.3	19.7	27.7	17.5	46.4	19.8	3.3	2.5	21.2	24.4	19.2	11.0	19.1	28.3	18.3	26.6	3.7	26.5	13.9	23.7	1.0	3.7	15.1	12.4	21.8	19.4	12.2	28.9	159.5	13.4	14.2	39.5	15.9	21.6	36.1	57.3	14.6	17.8	65.9	20.6	17.8	23.9	14.3
XAF1	"BIRC4BP, HSXIAPAF1, XIAPAF1"	ENSG00000132530	"XIAP associated factor 1"	Q6GPH4	17	6755447-6775647	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 174.2;Endothelial cells: 90.4;Microglial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 81.8;BJ hTERT+ SV40 Large T+ RasG12V: 83.8;HHSteC: 35.3"	"Low region specificity"	"Detected in all"							HPA057302	Approved		Supported	Nucleoplasm,Mitochondria		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Mitochondria"		"HPA057302: AB_2683405"	"unprognostic (6.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.09e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.08e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.73e-7)"	"unprognostic (2.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.15e-3)"	31.9	12.8	28.3	29.7	29.8	33.4	24.2	27.7	39.6	42.3	23.8	17.5	26.8	26.5	13.0	17.0	22.5	34.0	30.9	27.5	29.2	23.5	63.6	35.8	29.7	37.5	28.4	52.9	2.9	2.9	14.3	25.9	30.8	24.9	16.8	4.8	47.6	11.2	14.1	18.4	25.4	24.3	31.9	63.4	23.6	9.2	31.5	23.8	18.2	13.5	15.5	17.3	22.1	27.5	5.2	0.3	0.7	1.4	6.7	15.1	0.7	7.1	26.3	81.8	83.8	0.7	7.5	1.3	2.0	10.2	28.9	3.1	0.0	1.3	9.3	11.4	0.3	1.9	0.9	1.0	35.3	1.2	8.0	6.9	0.0	11.3	0.3	0.4	6.9	25.5	0.7	26.1	2.6	0.4	6.3	22.1	0.6	0.2	2.2	11.3	0.4	0.5	0.2	4.9	0.5	0.6	3.6	0.5	14.3	0.6	0.8	30.4	0.7	1.1	0.8	2.3	0.5	3.9	1.4	0.5	2.6	18.4	2.2	17.4	9.6	4.3	7.8	12.7	5.7	3.6	6.0	5.6	8.0	4.6	3.8	4.0	10.6	8.0	12.5	0.8	9.9	5.6	28.3	29.8	27.7	39.6	27.5	29.2	37.5	28.4	30.8	31.9	31.5	27.5	174.2	60.9	29.9	14.0	25.7	5.2	5.7	5.5	13.1	0.5	4.1	10.3	2.7	8.6	30.0	0.0	0.0	0.4	37.1	12.4	0.0	1.3	4.0	18.9	68.4	90.4	1.8	10.7	0.3	1.9	5.1	29.8	27.5	10.4	48.7	44.4	33.5	20.1	15.9	0.0	0.3	9.2	0.0	21.3	11.2	2.6	36.4	54.4	5.4	103.0	44.5	1.1	70.0	1.5	0.6	10.1	2.7	27.4	11.4	2.5	11.4	0.3	24.3	0.4	19.7	27.3	19.0	0.2	0.8	11.8	2.7	0.4	35.1	47.3	9.2	5.6
XAGE1A	"CT12.1a, GAGED2, XAGE-1, XAGE1"	ENSG00000204379	"X antigen family member 1A"	Q9HD64	X	52495808-52500812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"testis: 94.5"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 1443.3;NB-4: 1484.7;THP-1: 1390.5;U-2 OS: 1014.9;U-266/70: 649.2;U-266/84: 1967.0;U-937: 1201.1"									HPA046363			Approved	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA046363: "																		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	94.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	5.7	235.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.0	6.5	2.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	1443.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	319.6	1.9	0.0	0.0	1.3	1484.7	0.2	0.0	0.0	0.7	0.0	5.3	0.0	0.0	0.6	156.7	0.0	2.6	3.7	0.0	96.1	1390.5	1.5	0.0	1014.9	0.3	187.7	649.2	1967.0	3.3	0.7	1201.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
XAGE1B	"CT12.1b, CT12.1c, CT12.1d, XAGE1C, XAGE1D, XAGE1E"	ENSG00000204382	"X antigen family member 1B"	Q9HD64	X	52512077-52520803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 37.8"	"Cell type enhanced"	"Detected in some"		"Spermatocytes: 1.5;Spermatogonia: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 81.1;NB-4: 95.0;THP-1: 89.4;U-2 OS: 70.5;U-266/84: 143.5;U-937: 69.5"									HPA046363			Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA046363: "																		0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	37.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	23.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.2	0.0	95.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	9.3	0.0	0.7	0.4	0.0	6.2	89.4	0.0	0.0	70.5	0.0	13.3	38.3	143.5	0.0	0.0	69.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
XAGE5	"CT12.5, GAGED5, XAGE-5"	ENSG00000171405	"X antigen family member 5"	Q8WWM1	X	52812204-52818301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Spermatocytes: 3.8;Spermatogonia: 9.0;Syncytiotrophoblasts: 1.9"	"Cancer enriched"	"Detected in single"	4	"liver cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"U-2 OS: 22.0"									"HPA052507, HPA055941"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA052507: AB_2681855, HPA055941: AB_2682978"															"unprognostic (1.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414742	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 42.2;intestine: 49.5;liver: 68.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 262.1;Distal enterocytes: 143.5;Hepatocytes: 46.9;Paneth cells: 48.8;Proximal enterocytes: 96.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 8.2;HBEC3-KT: 20.0;hTERT-HME1: 31.0;U-251 MG: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		77000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Nucleoli	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (8.73e-6)"	0.2	0.0	0.0	4.8	0.0	0.1	42.2	0.3	0.0	0.3	0.4	11.1	44.9	0.9	2.3	9.8	0.1	4.5	0.0	0.0	0.0	0.2	68.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.1	1.3	9.5	0.1	3.6	0.1	0.5	1.1	49.5	0.7	0.0	0.0	3.2	0.1	0.0	0.2	0.3	0.0	2.3	2.7	2.0	0.1	2.0	0.4	0.0	0.0	0.0	0.1	0.1	8.2	4.7	1.0	1.4	0.3	2.3	0.1	1.6	0.3	0.8	4.2	0.0	20.0	1.0	1.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	1.8	1.1	31.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.4	1.2	0.2	0.0	1.4	4.5	5.7	5.2	0.0	0.1	0.1	0.3	0.0	1.7	0.0	0.0	0.0	3.8	2.4	0.2	8.9	2.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	2.4	0.0	0.2	0.5	6.0	5.5	2.8	0.3	262.1	6.5	0.4	2.8	3.6	0.0	0.0	0.3	1.1	143.5	0.0	3.9	0.3	7.9	2.8	0.3	11.9	0.0	0.2	8.2	0.6	0.2	2.0	37.0	0.0	0.0	1.4	46.9	0.0	0.0	0.2	8.4	2.0	1.9	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	48.8	0.0	0.0	2.2	96.8	0.0	1.0	0.7	0.0	0.3	0.7	0.0	0.2	1.2	0.1	0.4	0.7	0.2	22.2	16.9
XIAP	"API3, BIRC4, hILP, ILP-1"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913976	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: AB_2677993"	"prognostic unfavorable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	9.2	7.7	6.5	9.2	7.5	8.3	9.7	6.8	7.0	9.6	12.9	12.4	10.1	8.4	10.0	11.5	7.4	8.6	7.8	5.8	8.2	11.8	12.1	8.5	10.4	7.6	8.1	7.5	8.3	18.4	6.3	8.6	7.3	8.5	10.1	21.4	8.6	7.4	10.3	8.8	10.1	7.4	8.5	10.4	10.2	4.2	8.1	8.9	14.9	11.9	8.6	9.6	6.1	10.3	15.8	13.2	10.2	8.8	11.8	15.0	13.3	16.9	12.4	8.9	7.7	5.9	17.9	14.7	24.3	14.4	17.1	5.6	15.3	10.5	16.3	15.5	8.3	9.9	11.1	9.2	14.9	18.1	19.7	10.4	16.0	14.9	19.0	10.2	12.7	10.8	15.9	16.4	17.6	16.5	10.2	8.8	8.4	15.6	10.3	10.8	11.9	15.6	13.4	22.6	6.8	10.0	22.9	13.0	13.5	9.0	8.0	8.7	15.7	0.5	6.0	27.0	18.9	13.8	14.9	15.8	18.3	12.7	11.5	9.3	1.8	2.6	3.3	1.5	3.0	3.1	2.4	3.6	1.0	4.0	2.7	1.9	5.6	2.4	2.9	2.9	1.8	1.5	6.5	7.5	6.8	7.0	5.8	8.2	7.6	8.1	7.3	8.5	8.1	10.3	50.0	80.1	91.6	26.4	42.1	26.6	36.3	35.0	28.5	72.1	29.7	19.9	44.5	44.3	55.2	53.3	95.9	17.9	41.7	122.9	27.4	36.0	2.7	38.4	44.9	55.0	47.4	23.5	30.0	54.0	30.0	38.4	39.8	50.4	60.7	30.9	64.2	85.8	29.0	75.7	34.9	62.2	26.4	43.6	33.0	4.1	42.6	44.2	8.8	29.0	45.8	45.8	55.6	32.6	41.9	65.4	53.5	51.6	39.5	53.0	59.2	59.8	50.6	133.7	65.7	43.6	34.9	15.2	21.0	30.8	35.5	38.0	40.8	30.0	48.0	68.1
XIRP1	"CMYA1, DKFZp451D042, Xin"	ENSG00000168334	"Xin actin binding repeat containing 1"	Q702N8	3	39183210-39192596	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 682.0;skeletal muscle: 383.4"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 850.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Region enhanced"	"Detected in some"		"cerebellum: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 4.4;LHCN-M2: 1.1;RH-30: 3.0"	"Not detected"	"Not detected"							"HPA016750, HPA018458, CAB026391"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885"	"unprognostic (2.19e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-5)"	"unprognostic (2.08e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.86e-4)"	"unprognostic (4.12e-2)"	1.1	0.3	0.0	1.2	0.0	0.0	0.2	2.0	0.3	0.0	0.1	0.7	0.0	0.2	0.0	5.6	0.0	1.0	682.0	1.1	0.1	0.1	0.1	1.7	0.0	0.6	0.2	0.1	1.2	0.0	0.5	0.7	0.2	3.4	0.0	0.0	5.1	0.0	383.4	0.5	0.5	0.4	0.2	0.6	0.3	0.0	0.1	0.5	0.2	96.4	0.0	3.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	1.1	0.1	0.6	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	850.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888480-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 202.3;skeletal muscle: 1034.1;tongue: 543.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 1907.2"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;HUVEC TERT2: 4.2;U-2197: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Nucleoplasm	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	202.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.9	0.0	0.0	8.0	0.0	1034.1	1.2	0.1	0.0	0.0	0.5	0.1	3.0	0.0	0.1	0.3	543.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1907.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	10.1	0.0	0.0	1.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	23.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.4	5.8	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685791-37732130	"Blood group antigen proteins, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Blood group antigen"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;intestine: 12.2;stomach 1: 11.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 26.7;Erythroid cells: 63.5;Gastric mucus-secreting cells: 17.9;Proximal enterocytes: 21.5;Undifferentiated cells: 14.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 6.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	53	"basophil: 10.2;eosinophil: 5.8"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"HEL: 44.4;HL-60: 23.2;K-562: 29.1;NB-4: 21.1;RPMI-8226: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.2	2.1	2.5	1.4	2.5	14.2	0.7	2.3	3.0	1.2	0.2	12.2	10.8	0.7	0.5	2.0	3.8	0.9	4.3	3.2	4.9	0.9	0.8	1.0	0.2	1.6	0.9	0.7	4.9	0.7	1.3	0.7	2.0	1.5	11.2	2.1	1.2	0.9	5.4	0.7	10.6	1.8	0.5	0.5	11.5	1.4	2.8	0.2	0.9	5.8	0.5	1.1	0.8	1.4	17.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	14.7	0.3	0.0	0.8	2.7	15.4	0.1	0.0	0.0	4.2	44.4	2.4	0.0	0.0	23.2	3.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	29.1	10.9	0.1	1.7	0.2	21.1	5.5	0.7	5.6	0.0	0.0	20.2	0.0	1.1	4.1	0.1	0.8	1.4	0.1	0.9	2.1	5.6	0.0	0.0	0.8	0.0	2.4	9.3	16.5	0.0	0.2	12.1	0.1	10.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	2.5	2.5	2.3	3.0	3.2	4.9	1.6	0.9	2.0	0.5	2.8	1.4	0.0	0.0	1.1	2.6	0.8	0.4	0.4	0.1	1.2	0.7	1.1	0.8	7.9	0.0	0.1	0.0	6.2	0.3	0.1	26.7	0.0	0.0	1.2	4.0	0.1	0.3	6.1	63.5	11.0	3.1	0.1	0.6	17.9	0.9	0.0	0.1	0.0	0.9	0.1	3.3	12.6	10.9	2.0	0.3	0.0	0.4	0.0	0.2	1.8	1.9	0.0	0.0	0.0	4.5	1.2	1.1	9.2	0.7	2.2	0.9	21.5	0.1	1.7	1.4	0.0	0.7	1.3	10.2	6.1	3.8	1.1	0.0	0.3	0.1	14.7	1.5
XPA	"XP1, XPAC"	ENSG00000136936	"XPA, DNA damage recognition and repair factor"	P23025	9	97674909-97697340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000155, HPA056856"	Supported		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"CAB000155: , HPA056856: AB_2683258"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.55e-3)"	"prognostic favorable (4.28e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.17e-1)"	15.1	13.4	9.9	9.5	10.3	9.1	13.4	12.0	15.4	13.9	10.8	23.0	15.8	14.0	11.0	14.9	13.1	9.7	9.9	9.7	10.8	18.4	18.8	11.3	14.0	10.2	10.0	13.0	11.8	18.7	9.9	9.7	9.8	14.8	9.9	10.6	12.5	12.7	19.5	12.5	13.1	12.0	9.7	12.5	21.6	5.2	10.7	11.0	23.6	8.6	17.2	15.4	13.5	10.6	35.5	8.2	11.9	14.8	14.3	13.7	8.2	9.4	14.9	16.9	11.4	21.4	28.9	19.9	8.9	10.5	11.3	17.4	9.6	11.4	14.1	13.7	19.2	15.7	17.7	12.0	15.5	18.7	18.2	12.0	12.0	7.9	8.0	11.4	19.1	16.1	22.0	15.2	9.4	11.0	24.4	22.5	8.2	33.5	13.5	24.6	25.4	17.0	27.0	13.7	16.7	16.7	13.4	10.3	12.7	9.0	14.9	11.1	12.0	5.9	14.8	23.4	20.6	26.5	22.7	12.3	14.6	13.2	11.8	12.8	21.6	22.6	25.5	23.0	30.1	34.4	27.9	25.0	23.0	40.5	33.5	29.0	2.6	35.2	29.7	39.8	33.1	19.6	9.9	10.3	12.0	15.4	9.7	10.8	10.2	10.0	9.8	9.7	10.7	10.6	32.4	25.6	37.8	49.0	36.1	17.3	23.3	39.3	31.9	101.4	24.8	31.9	36.2	45.8	39.7	22.0	81.3	32.1	47.2	10.6	121.3	36.3	1.7	22.5	29.1	30.4	22.3	11.1	49.3	38.3	9.7	31.3	22.4	17.2	30.9	28.0	28.2	48.7	36.0	84.1	63.5	24.6	30.5	27.7	20.7	4.0	44.1	24.5	14.2	40.3	49.6	87.0	64.9	74.9	96.0	29.3	19.2	47.4	26.2	18.9	32.1	55.5	28.6	97.5	32.9	38.3	39.4	18.2	17.9	28.5	18.8	14.0	34.9	36.4	24.2	23.5
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178621	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167"	"unprognostic (7.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (4.14e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.62e-2)"	"prognostic favorable (2.46e-4)"	22.9	17.2	14.3	16.4	17.3	10.2	22.9	15.6	14.6	27.2	15.2	20.1	19.0	24.9	17.6	16.1	25.3	16.6	13.1	12.9	17.3	24.8	24.2	20.7	24.5	16.8	17.4	34.6	21.6	24.0	25.8	15.6	17.4	22.9	15.6	15.2	18.5	23.6	21.3	31.9	24.0	17.5	15.2	24.2	17.4	12.4	16.0	21.2	26.7	9.8	21.7	22.9	20.3	18.3	14.3	33.8	36.7	22.6	51.0	35.8	124.8	33.6	88.7	29.9	22.3	11.8	14.7	46.6	14.5	37.5	14.7	15.6	23.6	49.3	23.6	21.5	24.7	24.9	35.7	21.7	45.0	16.8	42.2	50.1	56.4	39.7	77.4	34.2	34.5	19.0	31.2	22.5	32.5	27.2	17.9	16.3	23.5	20.4	21.2	19.3	17.9	33.7	36.2	36.9	8.8	29.9	36.1	27.2	23.5	54.6	29.9	13.8	57.1	11.2	32.1	18.4	15.4	54.5	46.4	25.4	26.5	19.4	41.6	41.4	20.2	26.8	23.2	16.6	22.7	27.1	26.7	23.5	17.9	25.0	28.3	20.8	73.1	24.3	23.3	17.4	24.7	16.9	14.3	17.3	15.6	14.6	12.9	17.3	16.8	17.4	17.4	15.2	16.0	18.3	26.0	60.9	63.2	16.6	39.9	13.8	20.4	25.5	59.2	35.6	19.0	25.9	11.8	31.5	47.7	16.5	39.6	42.5	38.9	13.4	35.2	19.3	2.3	32.2	44.8	29.9	16.3	20.8	18.0	19.2	20.3	29.2	15.3	25.5	47.4	25.0	22.9	40.5	18.2	26.9	22.0	13.9	20.3	23.9	14.9	2.7	30.7	19.6	8.8	15.0	40.1	24.9	54.6	17.1	27.5	19.5	15.0	28.2	29.1	18.9	32.7	66.1	55.0	51.0	26.3	43.3	27.7	28.7	54.9	21.4	11.1	32.0	42.3	26.3	18.1	10.5
XPO1	"CRM-1, CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61476032-61538741	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		410000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	33.2	29.8	30.1	48.7	31.4	25.8	39.2	35.7	44.3	37.9	31.6	34.9	24.7	52.5	37.0	35.1	45.9	32.0	36.0	27.9	33.7	30.8	41.7	31.9	65.3	28.9	30.5	58.9	26.2	38.5	22.0	52.1	30.4	34.2	42.0	52.0	19.9	34.9	37.5	34.2	33.2	48.6	30.9	43.4	31.9	54.5	32.8	73.6	38.8	47.2	60.9	38.6	22.4	38.9	169.1	152.9	194.1	135.8	91.4	107.9	145.5	166.6	109.2	192.9	151.8	217.3	114.7	256.0	117.4	127.1	186.3	125.0	307.9	126.5	268.6	151.6	110.7	242.8	136.2	148.4	55.4	234.6	145.4	62.9	103.8	149.4	145.9	126.0	149.5	108.7	285.5	127.7	164.9	97.8	212.6	100.4	213.1	189.9	111.5	175.6	208.0	148.1	103.0	124.9	152.8	77.5	174.2	142.8	87.1	185.6	108.6	110.8	98.9	153.7	178.7	137.2	175.0	102.8	203.2	347.0	96.8	214.0	151.0	3.3	1.4	2.2	1.8	2.2	1.9	1.1	1.0	1.8	2.1	0.7	1.0	1.0	0.6	2.7	1.2	1.6	1.2	1.2	30.1	31.4	35.7	44.3	27.9	33.7	28.9	30.5	30.4	30.9	32.8	38.9	42.0	41.7	43.2	114.3	55.3	52.1	32.1	45.5	78.6	67.5	40.2	38.6	64.5	38.6	38.7	31.3	95.9	54.1	56.6	27.3	13.7	29.7	4.2	58.6	79.7	47.7	45.1	73.2	87.9	26.1	49.3	49.9	42.3	68.6	41.8	100.4	41.4	55.8	57.2	72.3	101.3	34.2	40.7	55.3	58.4	11.9	33.5	63.9	37.4	68.4	64.2	33.4	61.8	83.4	102.5	32.3	20.9	30.9	57.2	55.6	21.0	22.2	56.9	101.7	19.7	50.5	55.7	65.9	91.6	83.3	56.8	30.1	54.5	54.4	46.2	47.7
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 72.8;Inhibitory neurons: 70.8;Oligodendrocytes: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"		"HPA053768: AB_2682254"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	4.3	3.6	3.1	5.7	4.3	10.2	6.1	5.6	3.8	4.4	4.5	4.7	3.7	6.1	4.1	4.8	4.1	3.5	10.7	3.0	3.5	5.1	4.1	6.0	7.3	3.7	3.6	6.1	4.2	6.5	3.0	5.2	3.8	5.4	5.7	13.5	3.7	3.9	44.1	5.6	3.8	5.6	3.8	5.8	4.6	5.8	3.7	7.1	6.5	16.7	7.0	4.6	3.7	5.6	10.1	7.5	12.0	11.5	5.7	9.9	12.4	11.2	8.2	13.0	10.7	15.3	12.4	22.0	5.9	10.8	9.8	16.2	28.0	15.2	24.0	15.1	8.0	35.0	9.5	10.3	8.6	31.0	11.0	9.8	9.4	13.1	24.7	7.6	15.9	12.5	16.8	7.1	12.4	8.3	14.9	13.6	13.6	21.2	6.9	16.3	19.8	9.2	9.0	12.1	13.6	9.4	9.7	13.9	11.5	12.0	8.2	16.8	13.2	9.1	7.1	11.3	16.1	4.7	7.4	17.9	4.5	19.5	13.9	1.5	0.7	0.8	1.1	0.8	1.3	1.0	1.0	1.0	1.0	0.8	1.2	1.2	0.0	1.1	2.5	0.7	1.0	0.4	3.1	4.3	5.6	3.8	3.0	3.5	3.7	3.6	3.8	3.8	3.7	5.6	10.0	12.8	12.5	36.6	24.0	8.3	10.7	12.1	11.4	17.0	8.5	6.1	22.2	10.0	5.6	9.2	64.6	8.3	11.4	4.7	0.0	5.4	10.4	6.1	11.9	9.5	1.2	10.9	72.8	4.1	7.4	9.8	18.3	7.7	15.2	11.9	12.1	10.5	10.8	10.1	70.8	7.5	6.1	10.0	8.0	8.2	17.4	9.5	12.4	44.0	11.6	5.4	10.3	58.8	82.5	5.4	3.6	8.2	21.3	11.8	3.4	5.4	6.3	21.4	32.9	11.6	10.0	14.2	18.8	14.7	11.2	12.9	18.6	7.1	9.6	10.4
XPO5	KIAA1291	ENSG00000124571	"Exportin 5"	Q9HAV4	6	43522334-43576038	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012357, HPA018402, HPA023959, HPA029909"	Enhanced		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245"	"unprognostic (6.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (6.16e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (4.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.66e-3)"	7.3	8.0	4.6	9.1	5.3	8.3	8.5	5.1	5.8	7.6	4.1	7.2	6.3	8.0	9.1	12.0	6.9	5.8	7.0	4.7	4.7	7.4	6.7	6.5	8.7	4.8	4.6	6.3	14.0	11.1	6.5	7.6	4.5	7.9	8.8	11.7	8.1	7.1	11.2	12.3	6.4	9.7	4.2	6.9	8.3	23.7	5.2	12.0	13.1	6.0	11.2	11.2	7.9	4.7	48.8	28.5	46.7	94.4	23.7	19.9	43.3	24.8	17.3	47.9	34.4	79.1	16.5	65.6	31.4	23.7	45.1	40.8	78.4	36.2	53.5	48.0	61.9	63.6	34.5	57.8	34.0	71.0	32.6	14.5	36.8	50.4	78.0	17.2	34.6	46.0	138.5	50.2	32.6	59.5	53.9	35.1	50.1	132.3	28.7	57.9	49.5	49.2	27.6	37.6	95.7	39.7	34.5	31.5	44.7	40.6	36.3	56.1	29.2	35.2	41.9	34.0	52.8	31.8	37.1	126.3	12.6	60.7	38.4	0.0	4.3	3.1	4.8	5.4	4.4	2.8	4.3	5.3	4.9	2.4	3.4	4.6	0.4	7.1	10.8	1.4	4.7	4.0	4.6	5.3	5.1	5.8	4.7	4.7	4.8	4.6	4.5	4.2	5.2	4.7	4.7	6.4	3.3	21.2	6.0	8.9	6.8	4.6	5.2	11.3	7.0	7.4	6.5	2.8	3.5	11.0	8.4	5.5	8.4	3.6	1.9	6.7	12.3	7.1	10.9	6.6	14.4	9.4	31.7	7.7	6.5	7.5	10.2	7.5	11.4	13.4	2.5	4.6	6.2	21.9	35.2	5.9	2.0	5.3	2.5	13.5	4.1	4.9	1.8	25.3	5.1	4.5	13.4	26.7	32.0	6.6	2.2	8.2	10.8	13.0	4.1	4.7	5.5	14.3	0.0	10.0	7.3	26.9	23.5	10.2	7.1	4.4	5.4	11.5	7.2	5.8
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097976-28211965	"Metabolic proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 202.1"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 202.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (8.80e-4)"	48.0	48.3	70.0	55.9	73.7	92.0	39.9	61.7	87.0	43.7	63.9	47.0	21.8	42.3	18.8	57.0	44.8	24.5	36.2	72.2	72.0	47.2	62.1	70.9	62.9	76.1	69.2	36.6	43.2	26.9	56.6	25.7	73.6	48.6	27.4	35.2	44.9	20.1	29.9	52.9	63.0	26.8	67.8	160.6	42.8	100.3	72.9	51.1	50.5	13.7	44.9	44.9	46.0	77.8	82.9	63.3	54.8	58.8	37.2	58.8	57.9	97.0	98.0	124.8	124.8	89.1	61.7	59.8	78.6	99.8	63.3	53.8	131.6	83.9	151.5	115.3	72.1	67.6	90.0	101.6	87.9	95.4	70.8	46.3	61.2	111.1	108.9	53.5	73.1	63.4	118.0	31.0	86.0	101.1	116.2	116.1	88.1	43.6	55.4	101.0	64.3	101.2	46.8	45.2	103.3	55.0	52.9	88.3	47.8	60.8	62.7	63.3	75.4	104.1	64.4	87.2	84.8	63.0	83.8	89.8	78.7	98.4	89.1	21.1	9.9	32.9	14.2	11.4	15.4	20.7	16.5	15.8	7.3	15.7	18.1	22.6	202.1	10.7	17.6	9.5	14.7	8.4	70.0	73.7	61.7	87.0	72.2	72.0	76.1	69.2	73.6	67.8	72.9	77.8	9.6	9.6	14.2	27.4	20.2	18.6	11.4	12.6	5.2	20.8	15.0	14.6	8.0	5.7	12.6	23.9	31.3	11.5	30.2	28.5	7.9	14.1	39.2	12.7	21.5	11.6	23.5	10.3	51.2	19.2	17.3	13.3	12.2	32.8	2.5	34.6	9.3	16.7	23.4	21.9	55.4	20.6	10.2	27.9	15.8	44.8	10.8	22.6	7.2	43.1	28.6	8.3	23.7	59.3	90.3	23.4	13.5	8.6	16.5	22.4	13.3	7.1	10.3	28.1	6.6	13.5	12.2	31.6	26.5	18.0	21.3	8.3	27.0	9.5	21.2	15.4
XPOT	XPO3	ENSG00000184575	"Exportin for tRNA"	O43592	12	64404392-64451125	"Predicted intracellular proteins, Transporters"	Transport	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048067, HPA057602"			Enhanced	Nucleoplasm,Cytosol		NA	NA		9800	"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA048067: AB_2680246, HPA057602: AB_2683481"	"unprognostic (4.53e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (2.41e-12)"	"unprognostic (2.72e-1)"	"unprognostic (3.68e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.79e-4)"	19.5	15.9	18.5	21.0	22.4	32.2	15.5	20.4	21.7	15.8	24.6	12.6	10.7	14.5	19.3	18.8	12.2	12.6	10.8	18.3	22.0	13.6	20.9	15.9	21.2	21.5	21.7	11.6	31.5	26.3	13.8	19.3	22.3	14.9	14.5	33.1	20.2	13.0	14.7	18.0	10.9	16.9	20.6	15.8	15.5	18.9	21.5	21.7	50.4	13.1	22.8	17.4	16.4	24.3	76.3	51.9	51.5	64.9	76.2	80.9	94.1	99.4	83.3	65.5	59.2	52.0	25.4	153.9	69.3	126.9	69.8	56.0	99.1	77.2	94.7	96.6	52.3	85.8	46.6	46.0	134.5	159.2	74.1	57.8	194.5	73.2	223.7	84.6	59.3	112.7	145.0	299.0	70.3	93.8	88.6	63.5	98.5	53.8	91.8	69.5	61.9	116.5	36.2	44.2	57.2	66.9	58.3	66.3	146.4	49.9	117.4	157.3	62.4	51.1	51.4	74.4	78.9	186.4	154.2	118.3	114.0	122.3	84.5	6.7	7.4	10.2	9.9	7.3	13.3	7.1	11.2	10.4	9.9	5.0	10.0	8.7	2.2	11.2	6.9	3.4	10.2	6.8	18.5	22.4	20.4	21.7	18.3	22.0	21.5	21.7	22.3	20.6	21.5	24.3	17.9	12.8	9.1	39.2	13.4	19.6	19.0	16.3	14.2	16.8	16.8	10.2	11.3	12.8	14.3	14.7	12.5	24.4	17.3	7.6	17.6	9.4	7.3	16.0	32.1	18.1	11.4	15.8	25.9	13.0	20.5	19.0	9.2	13.1	24.7	13.0	19.6	33.6	14.4	13.5	34.8	11.1	8.2	21.9	21.7	5.3	20.2	15.7	21.4	23.4	11.4	80.3	10.3	18.1	29.6	15.2	6.6	20.3	22.6	26.1	5.4	13.4	15.8	25.4	13.1	14.5	16.2	12.4	17.1	21.6	22.4	17.0	18.4	10.8	12.9	18.7
XRCC1	RCC	ENSG00000073050	"X-ray repair cross complementing 1"	P18887	19	43543311-43580473	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005427, HPA006717"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"CAB005427: AB_2215661, HPA006717: AB_1858896"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.07e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.69e-2)"	18.5	16.4	15.3	18.0	15.6	24.4	17.9	18.5	17.1	23.6	13.5	20.4	14.6	23.5	16.2	16.1	23.2	14.4	15.5	14.6	15.6	15.7	10.8	16.2	22.9	15.7	15.2	32.0	19.6	17.6	32.3	16.6	14.0	16.2	11.4	16.7	16.3	15.6	19.5	21.0	15.7	17.3	13.5	20.1	18.5	23.9	16.6	29.0	20.6	15.7	20.9	18.6	18.0	15.6	57.4	51.4	54.4	48.2	23.6	24.6	27.0	28.4	36.0	42.5	46.3	32.0	40.4	44.1	39.1	28.9	39.1	30.0	33.2	36.8	24.7	46.4	33.9	57.5	49.4	36.1	23.2	34.5	42.9	27.3	24.8	53.5	26.4	48.8	37.2	49.1	35.9	42.5	37.3	48.9	57.5	52.5	18.5	44.2	21.3	57.0	35.4	25.8	34.3	44.1	44.5	26.5	41.6	35.3	20.7	26.8	33.9	67.4	23.3	55.7	40.4	16.3	39.9	44.2	44.2	32.0	42.8	28.0	58.7	18.6	13.1	15.6	10.8	11.9	12.3	11.7	13.8	14.6	11.6	10.5	11.3	10.9	15.1	10.4	7.9	9.1	14.5	11.7	15.3	15.6	18.5	17.1	14.6	15.6	15.7	15.2	14.0	13.5	16.6	15.6	10.2	16.0	9.8	5.9	13.4	6.1	7.1	17.5	12.5	12.6	10.2	9.0	7.6	7.2	14.7	7.3	6.2	29.8	12.5	9.1	19.6	15.4	32.2	18.7	13.3	12.2	13.7	15.4	8.2	11.6	19.2	13.3	8.2	13.7	19.7	22.0	11.4	7.1	21.0	5.0	9.2	15.3	10.2	18.0	10.1	19.5	10.2	12.6	14.2	3.7	14.3	8.6	8.2	4.5	8.1	12.2	9.7	12.8	17.7	4.1	9.2	16.9	39.0	12.7	6.6	9.6	17.7	21.4	14.1	10.8	7.1	20.0	14.6	16.4	13.7	4.7
XRCC2	FANCU	ENSG00000196584	"X-ray repair cross complementing 2"	O43543	7	152644776-152676141	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 14.1;Extravillous trophoblasts: 21.2;Granulosa cells: 20.2;Spermatocytes: 31.3;Spermatogonia: 19.1;Syncytiotrophoblasts: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065153			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Vesicles"		"HPA065153: AB_2685422"	"unprognostic (9.31e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.36e-5)"	"unprognostic (9.98e-3)"	"unprognostic (5.82e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-15)"	"unprognostic (4.52e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.73e-2)"	0.2	0.2	0.9	2.3	0.6	5.3	1.5	1.6	2.8	0.3	0.0	1.1	1.7	1.1	0.9	1.0	0.5	0.4	1.0	0.6	1.9	0.4	0.4	0.5	2.9	0.6	0.6	1.0	0.0	0.6	0.0	2.1	1.4	0.7	1.7	1.9	0.2	0.4	0.1	1.9	1.5	0.5	1.1	1.0	1.0	3.0	1.0	3.6	0.6	0.0	2.5	0.5	0.1	1.9	16.5	10.4	18.3	15.8	1.1	1.8	15.0	11.8	3.9	8.2	10.3	14.7	12.8	24.8	9.5	3.5	13.7	13.7	12.8	7.1	19.3	8.9	17.3	16.8	15.5	10.0	0.3	27.3	9.3	0.9	1.1	15.6	3.6	2.0	3.8	15.5	34.2	22.8	8.3	12.6	32.4	21.2	21.6	10.8	12.9	22.8	19.3	15.3	3.1	10.3	16.7	18.1	11.7	7.6	5.0	11.3	5.4	8.3	4.2	17.2	6.9	13.3	23.0	8.8	14.5	19.0	11.0	20.9	20.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.6	1.6	2.8	0.6	1.9	0.6	0.6	1.4	1.1	1.0	1.9	0.2	0.0	1.1	1.6	1.9	1.3	1.0	1.0	0.0	4.9	0.8	0.4	2.9	0.0	1.4	1.8	0.0	11.2	0.4	0.9	0.0	1.1	11.7	0.9	1.9	1.1	0.0	14.1	2.3	0.2	21.2	2.5	3.1	1.4	0.0	20.2	1.1	0.2	2.4	0.0	2.0	1.7	2.0	0.6	0.8	4.9	0.9	0.8	0.0	0.0	0.6	1.1	3.1	4.5	2.0	0.5	0.1	1.2	6.1	0.6	0.3	0.3	0.1	2.3	0.0	1.9	1.8	31.3	19.1	2.7	1.4	12.6	2.2	1.2	2.3	1.0
XRCC3		ENSG00000126215	"X-ray repair cross complementing 3"	O43542	14	103697609-103715504	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA062422, HPA068953"			Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA062422: AB_2684757, HPA068953: AB_2686062"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (6.75e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.53e-4)"	"unprognostic (2.93e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.52e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.72e-2)"	9.8	6.0	8.7	8.7	12.5	31.9	9.3	7.2	10.3	13.7	11.9	11.1	6.9	10.4	1.7	13.9	10.9	6.6	8.3	6.6	5.8	7.9	7.7	12.1	15.4	13.6	9.7	12.7	9.8	1.7	8.6	5.2	9.7	13.4	7.5	4.5	12.7	3.3	12.4	39.0	12.6	2.8	7.7	21.3	9.1	13.8	9.7	10.0	10.5	2.5	11.0	9.6	12.4	14.3	32.4	58.4	31.5	38.5	2.8	7.9	57.0	35.5	11.6	48.9	52.3	32.4	50.3	51.8	29.5	7.5	38.4	50.3	34.6	52.4	29.9	31.3	36.1	50.6	31.6	30.4	4.9	45.3	30.8	6.0	5.2	43.2	26.7	10.4	20.2	51.3	31.8	30.4	25.2	70.7	79.6	35.8	26.4	47.1	42.0	63.7	45.7	19.8	10.5	44.2	31.1	25.7	41.3	21.7	14.3	17.4	34.6	35.0	17.5	25.1	28.9	80.0	38.8	26.2	25.8	63.7	15.6	36.9	38.4	0.7	0.5	0.9	1.0	0.9	1.0	1.1	0.8	0.8	0.5	0.9	0.8	0.5	0.3	0.7	0.7	0.4	0.6	1.3	8.7	12.5	7.2	10.3	6.6	5.8	13.6	9.7	9.7	7.7	9.7	14.3	2.2	0.0	0.0	2.6	2.5	1.5	1.9	2.1	1.8	1.7	3.2	3.6	0.2	2.8	2.5	0.0	2.1	10.2	1.8	6.9	1.9	1.5	0.7	1.9	2.2	2.0	1.2	7.4	2.6	1.8	6.1	1.2	0.5	2.0	0.0	4.7	0.4	0.3	4.4	3.3	1.0	7.4	0.0	0.0	2.0	1.8	0.3	1.5	0.0	1.0	1.5	1.7	2.1	1.5	1.4	1.7	2.6	1.2	4.4	1.6	0.7	0.2	1.7	2.3	0.0	2.6	1.2	3.1	5.8	2.8	1.3	3.1	2.0	4.2	8.3	1.2
XRCC4		ENSG00000152422	"X-ray repair cross complementing 4"	Q13426	5	83077498-83353787	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 80.8;Pancreatic endocrine cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 61.6"	"Low region specificity"	"Detected in all"							"HPA006801, HPA051538"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA006801: AB_1858899, HPA051538: AB_2681526"	"prognostic unfavorable (1.80e-5)"	"unprognostic (3.05e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.91e-2)"	4.4	4.2	2.8	6.0	3.1	4.4	6.1	3.1	3.9	3.1	2.5	5.9	7.6	3.5	3.2	3.8	3.9	5.2	7.9	3.2	3.3	7.2	5.4	4.7	8.5	3.2	3.1	2.3	2.5	2.4	2.1	5.4	3.2	3.9	5.7	2.3	3.4	4.3	2.6	3.3	5.1	3.9	3.3	4.8	4.3	8.8	3.0	10.3	4.3	2.4	9.0	5.5	2.9	3.4	15.1	11.7	14.1	12.5	7.8	11.3	13.2	13.7	11.2	14.8	17.3	10.0	21.8	20.9	10.3	11.0	21.2	12.8	9.4	30.7	24.2	10.0	11.8	11.1	8.3	12.4	5.2	12.5	17.2	7.9	14.3	19.3	10.8	15.6	12.4	13.8	8.2	9.8	17.6	12.1	23.1	16.0	7.9	8.8	17.2	19.0	61.6	20.7	14.1	6.8	9.2	11.8	8.9	6.5	18.4	11.8	13.2	19.5	7.8	8.2	17.6	8.9	19.0	7.8	12.3	26.6	14.8	22.2	13.5	17.6	17.3	12.4	5.9	25.8	6.1	9.3	6.2	6.5	13.6	8.8	8.3	6.8	16.5	15.2	25.4	10.1	7.7	9.1	2.8	3.1	3.1	3.9	3.2	3.3	3.2	3.1	3.2	3.3	3.0	3.4	10.4	16.0	5.5	39.8	13.0	5.4	13.2	28.0	5.2	4.7	5.5	5.0	15.3	8.6	19.2	5.5	0.0	17.4	12.9	7.6	15.6	17.4	10.2	14.8	12.6	8.9	0.0	6.3	16.6	28.4	38.9	11.6	11.2	10.0	10.8	11.9	11.4	5.5	19.1	1.7	18.7	7.8	22.4	20.7	12.1	5.9	7.8	20.5	8.8	30.9	25.1	7.8	14.4	53.3	80.8	65.7	6.7	7.2	11.3	4.4	7.2	26.5	16.9	4.5	0.0	4.6	11.9	33.1	25.3	7.1	4.4	11.9	12.6	8.0	6.2	8.2
XRCC5	"KARP-1, KU80, Ku86, KUB2"	ENSG00000079246	"X-ray repair cross complementing 5"	P13010	2	216107464-216206303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004468, HPA025813, HPA064685"	Supported		Enhanced	Nucleoplasm		NA	NA		940000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322"	"unprognostic (4.23e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.07e-3)"	"unprognostic (3.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.01e-2)"	79.6	74.0	52.8	102.4	58.4	112.0	114.6	56.0	69.9	96.4	38.1	91.0	82.2	103.3	85.3	96.8	95.8	83.2	77.1	58.1	56.4	100.2	140.6	76.6	127.8	52.4	50.7	104.0	71.7	118.4	61.4	87.1	54.4	84.7	106.6	102.0	71.6	91.3	103.1	91.6	82.3	100.1	59.1	83.9	77.0	69.5	51.0	176.8	129.2	92.7	140.9	131.7	72.7	65.6	234.4	194.9	427.0	230.5	185.5	210.9	256.6	269.9	279.2	307.1	328.5	421.0	225.7	225.6	214.8	239.1	269.2	203.5	425.2	329.5	469.7	215.0	291.0	488.5	282.9	398.0	229.2	437.1	230.0	193.5	172.1	361.2	156.6	218.4	368.0	272.1	314.4	199.7	405.9	225.9	496.7	221.7	498.0	236.0	170.6	429.8	376.7	186.5	331.9	262.6	372.6	314.6	217.8	159.9	201.1	428.5	196.7	325.8	264.2	287.3	241.5	190.6	312.3	240.0	311.4	493.6	223.4	339.5	290.0	253.2	172.7	175.0	153.6	177.1	165.3	121.2	148.1	157.0	168.0	121.6	147.6	149.1	192.7	172.9	217.4	102.1	167.5	330.4	52.8	58.4	56.0	69.9	58.1	56.4	52.4	50.7	54.4	59.1	51.0	65.6	129.0	105.8	126.3	65.6	131.0	113.7	174.0	242.4	90.5	136.7	93.6	87.1	163.0	105.8	190.0	101.2	45.9	210.5	141.6	79.8	97.8	304.3	103.0	147.4	175.4	142.4	133.3	159.4	73.9	235.8	238.8	134.1	74.5	159.1	146.7	140.2	82.8	222.5	157.3	89.2	82.4	90.7	173.0	100.5	85.3	30.0	101.5	130.7	69.4	108.7	310.9	142.0	138.0	93.0	111.4	247.9	70.3	129.4	132.5	137.4	82.8	139.9	160.1	114.0	111.7	142.9	161.3	252.2	179.2	114.7	120.3	165.5	149.7	165.3	112.0	161.2
XRCC6	"D22S671, D22S731, G22P1, KU70, ML8"	ENSG00000196419	"X-ray repair cross complementing 6"	P12956	22	41621163-41664048	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 579.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004254, HPA047549, HPA062226"	Enhanced		Enhanced	Nucleoplasm		No	No		700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716"	"unprognostic (5.55e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.95e-2)"	143.7	183.4	84.9	153.4	89.3	218.2	143.3	87.8	100.8	152.1	87.2	159.5	136.8	153.8	111.3	192.1	151.4	105.5	176.1	89.2	94.7	136.9	142.4	133.2	196.6	89.5	86.8	169.8	119.0	156.5	122.6	155.0	92.2	132.7	164.9	115.6	130.8	144.4	273.0	168.3	142.8	161.0	93.5	143.1	138.6	231.2	87.9	224.1	137.8	184.3	222.2	162.6	142.0	96.4	554.6	388.0	527.9	455.5	313.5	279.5	413.8	394.7	464.6	794.9	656.4	570.4	335.7	886.2	319.8	478.1	357.4	400.6	739.2	486.8	803.2	493.4	921.2	478.8	435.2	559.5	281.5	1142.2	520.5	252.7	323.1	501.2	275.0	319.8	505.6	371.6	470.2	360.1	523.1	589.9	589.0	390.6	482.1	1138.4	452.1	660.0	562.3	695.6	440.4	404.4	243.3	174.6	644.1	328.2	455.7	392.9	382.2	439.0	366.2	394.3	546.2	354.0	522.4	354.0	671.9	896.1	369.4	441.3	476.4	146.0	264.3	227.6	243.6	296.5	258.4	256.5	269.5	269.2	324.1	246.9	293.2	262.5	69.2	253.2	307.0	191.7	325.9	600.8	84.9	89.3	87.8	100.8	89.2	94.7	89.5	86.8	92.2	93.5	87.9	96.4	96.6	96.1	142.5	18.6	132.6	124.0	201.0	219.0	83.1	107.1	80.1	83.4	89.4	115.8	160.4	82.8	62.6	422.3	104.9	97.3	166.3	205.4	119.6	86.1	87.0	117.0	98.6	125.4	24.5	182.7	317.2	123.9	73.4	105.9	119.7	156.4	70.3	103.7	170.2	87.5	29.5	114.7	166.8	98.1	116.7	62.9	126.8	110.4	88.9	17.8	182.8	149.7	89.6	26.2	30.5	150.9	106.6	126.7	116.0	112.0	113.7	140.3	112.6	103.6	164.3	102.4	127.4	579.8	314.4	91.5	102.1	362.2	136.9	150.6	166.8	137.5
XRN2		ENSG00000088930	"5'-3' exoribonuclease 2"	Q9H0D6	20	21303331-21389825	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047118, HPA050485"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA047118: AB_2679941, HPA050485: AB_2681141"	"unprognostic (9.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.54e-5)"	"unprognostic (7.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.31e-1)"	36.1	36.1	14.7	42.6	17.2	73.3	42.9	18.5	15.8	33.4	21.1	29.9	24.3	37.0	31.3	25.9	33.2	35.8	24.8	13.6	16.5	34.8	42.7	34.4	43.2	16.5	15.5	36.7	32.8	45.2	18.7	37.4	17.0	28.4	32.4	24.8	27.0	33.6	38.2	24.3	24.8	39.4	16.1	36.1	24.9	29.9	16.1	46.8	41.2	26.5	45.8	46.5	23.1	18.3	91.9	106.7	115.1	88.7	84.1	102.7	113.7	82.3	107.1	107.2	124.1	71.8	102.2	89.7	47.8	86.8	146.1	106.0	131.0	138.7	136.6	40.8	66.0	116.0	37.7	136.5	73.9	105.7	96.8	98.0	68.7	118.5	103.1	95.3	93.6	84.5	94.9	74.7	101.0	71.7	156.5	69.6	89.8	88.8	71.1	113.1	195.4	76.9	91.0	95.6	88.9	115.2	96.0	116.6	89.9	88.6	65.5	123.9	87.0	107.0	79.8	24.8	105.4	65.3	90.0	95.0	41.5	48.5	82.5	36.0	68.6	49.2	34.6	54.8	46.4	30.5	37.7	38.1	61.1	30.9	39.8	38.7	69.2	43.9	71.8	26.2	49.2	54.3	14.7	17.2	18.5	15.8	13.6	16.5	16.5	15.5	17.0	16.1	16.1	18.3	118.6	60.9	112.2	29.7	72.4	63.6	90.8	81.2	64.9	44.9	85.0	75.2	58.7	52.9	94.4	40.5	41.7	106.2	99.1	36.6	27.4	123.8	157.6	119.5	128.5	99.9	59.5	62.6	45.7	120.9	96.8	80.1	39.8	113.7	83.5	92.0	41.0	70.4	105.4	50.5	48.9	52.6	67.1	129.6	57.9	26.8	57.8	111.2	60.5	49.6	165.9	55.1	85.5	46.8	67.6	96.1	53.7	55.7	77.1	91.6	45.1	80.6	102.7	49.7	59.2	120.1	108.1	104.1	116.6	65.6	67.2	105.2	83.5	99.4	68.1	89.7
XRRA1	FLJ00225	ENSG00000166435	"X-ray radiation resistance associated 1"	Q6P2D8	11	74807739-74949200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 19.4"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 139.7;Spermatocytes: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 36.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA039263			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies"	"HPA039263: AB_2676419"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.27e-1)"	3.4	3.8	2.3	1.1	2.9	1.6	3.4	2.4	2.5	5.1	1.9	4.5	2.6	4.8	3.8	4.1	4.4	2.9	4.4	2.1	2.7	4.2	5.0	3.8	1.9	2.6	2.7	4.9	4.5	3.2	4.2	2.4	2.7	5.0	2.3	2.3	5.5	3.0	6.0	3.6	2.9	4.8	2.3	4.2	3.8	19.4	3.2	2.6	7.1	11.6	2.7	4.6	3.9	4.3	5.4	3.0	0.7	4.9	7.5	4.9	2.1	2.3	2.5	1.3	1.3	1.6	2.8	2.2	8.3	2.5	11.1	4.3	6.1	3.0	2.8	8.8	0.5	1.9	2.0	3.1	2.2	1.2	0.9	4.7	3.4	5.6	36.1	10.5	2.7	7.2	5.1	5.0	6.5	2.0	2.0	2.8	1.7	6.5	2.7	0.9	3.9	1.7	1.1	4.1	4.7	3.9	10.7	4.5	14.2	2.3	2.8	5.6	1.8	7.8	5.0	5.7	2.2	7.0	6.7	6.1	1.8	1.1	2.7	1.4	2.0	1.9	2.9	2.5	3.2	1.6	2.1	2.2	1.7	1.5	2.1	2.0	3.3	1.0	1.7	1.2	4.4	1.5	2.3	2.9	2.4	2.5	2.1	2.7	2.6	2.7	2.7	2.3	3.2	4.3	22.8	9.6	8.8	40.5	27.7	11.0	10.4	15.7	10.8	56.7	18.3	15.0	5.9	8.6	12.3	22.0	139.7	12.3	15.1	13.9	15.6	8.2	51.9	18.7	19.5	13.8	12.1	9.0	38.4	8.0	10.6	16.0	11.2	13.6	12.0	14.7	15.0	14.0	7.8	48.8	39.1	16.3	8.2	10.3	11.0	78.9	29.8	8.9	28.4	30.0	7.7	19.9	25.7	36.7	55.5	6.5	16.2	30.5	29.8	10.5	17.6	22.1	22.5	76.6	26.3	23.4	13.9	125.2	37.7	6.5	7.5	10.9	21.1	7.1	18.4	7.8
YAF2		ENSG00000015153	"YY1 associated factor 2"	Q8IY57	12	42157104-42238349	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 1187.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026867	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA026867: AB_1858911"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.20e-2)"	11.5	9.5	9.7	8.1	10.5	10.8	10.0	13.9	12.0	10.3	4.3	8.1	5.9	9.4	8.7	6.9	8.8	8.6	36.6	11.6	10.4	9.5	18.0	8.1	12.5	9.2	9.1	9.0	6.3	7.8	8.6	9.0	10.3	8.2	7.3	14.2	6.6	8.4	29.4	6.3	7.9	10.3	9.9	10.6	6.9	7.3	10.1	13.5	11.1	21.1	10.0	10.0	8.9	12.6	13.5	10.6	15.3	12.1	19.1	16.9	9.9	19.1	17.1	15.5	15.1	14.4	10.7	8.6	14.0	16.6	6.2	11.5	15.0	10.7	21.7	20.5	14.9	18.0	4.6	6.8	11.0	17.6	11.1	12.1	14.9	12.8	25.3	15.7	16.3	8.3	17.2	20.1	20.1	5.6	20.4	21.2	3.9	16.0	14.1	15.0	16.6	13.9	20.1	10.1	11.6	14.6	16.0	18.3	14.8	6.9	12.4	13.0	14.4	13.6	12.1	16.7	9.5	16.6	26.4	31.7	15.0	82.3	6.8	43.2	15.6	28.9	18.2	18.9	18.6	20.6	17.6	20.9	12.5	24.2	13.4	14.5	56.6	27.1	17.2	19.3	26.5	9.7	9.7	10.5	13.9	12.0	11.6	10.4	9.2	9.1	10.3	9.9	10.1	12.6	41.9	22.4	13.4	68.2	41.1	58.1	40.8	31.0	33.0	75.0	45.2	35.1	1187.5	31.5	27.6	20.2	85.5	40.1	71.2	22.7	62.6	32.2	33.6	27.7	43.1	61.7	38.9	36.2	105.5	45.5	22.4	49.7	18.3	37.0	70.5	88.4	50.7	104.7	27.8	144.7	89.4	33.1	46.8	44.7	61.3	15.9	58.1	37.6	42.7	83.4	48.8	94.6	84.5	97.0	57.8	35.3	26.8	76.8	44.6	37.2	29.9	66.0	20.1	99.7	105.2	44.8	63.8	38.0	38.2	30.5	51.1	45.3	58.7	36.2	27.5	32.7
YAP1	YAP65	ENSG00000137693	"Yes1 associated transcriptional regulator"	P46937	11	102110447-102233424	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009370, HPA038884, HPA038885, CAB069915, HPA070359"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB009370: AB_2273277, CAB069915: AB_922796, HPA038884: , HPA038885: AB_2676255, HPA070359: AB_2732154"	"unprognostic (9.56e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (9.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-2)"	57.2	27.8	19.1	25.9	19.1	0.3	42.7	18.6	17.1	62.5	44.3	41.5	27.2	78.1	45.9	74.7	65.6	49.3	48.1	15.9	22.1	39.3	33.5	45.7	13.0	31.8	30.2	93.1	22.3	37.0	9.9	83.1	21.8	59.2	30.1	12.9	40.6	83.7	48.3	44.2	27.4	100.5	27.3	14.7	31.6	15.0	27.0	13.8	85.9	58.2	22.7	60.9	52.6	20.2	56.9	52.1	141.5	69.6	151.1	143.1	118.7	130.4	147.8	124.2	101.5	130.2	134.9	0.0	105.4	171.6	92.1	98.0	71.0	186.4	130.6	16.8	25.5	0.1	67.3	89.5	115.3	0.1	2.5	115.2	119.4	136.6	220.2	138.4	39.4	6.7	0.0	0.1	142.1	27.2	2.6	0.4	66.8	135.9	49.3	0.1	79.7	0.3	90.9	99.5	0.4	4.7	153.6	57.2	43.5	129.1	103.2	0.8	43.4	175.4	68.8	89.6	55.7	0.1	0.2	0.8	51.0	0.2	130.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	19.1	18.6	17.1	15.9	22.1	31.8	30.2	21.8	27.3	27.0	20.2	28.4	35.3	69.4	145.3	1.5	113.7	47.8	43.5	71.2	0.4	48.1	43.8	39.2	62.9	37.2	92.0	0.0	91.4	0.4	16.2	11.7	27.6	6.7	61.8	53.3	28.9	7.3	0.0	1.5	18.3	20.3	49.0	23.9	85.1	0.0	127.2	26.0	45.2	10.6	0.0	1.6	13.1	14.2	1.6	21.5	4.6	37.9	2.2	44.4	60.0	1.0	27.6	0.0	5.0	0.7	25.2	16.3	40.6	0.1	66.0	27.2	26.1	41.6	1.2	39.5	21.6	62.0	2.5	5.3	59.5	123.2	61.6	2.1	15.9	27.8	65.6
YBEY	C21orf57	ENSG00000182362	"YbeY metalloendoribonuclease"	P58557	21	46286342-46297751	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 78.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 376.6;Late spermatids: 276.0;Spermatocytes: 273.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016593, HPA018162"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA016593: AB_1845698, HPA018162: AB_1845699"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.81e-1)"	"unprognostic (2.78e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-3)"	12.0	13.0	13.8	5.4	15.1	5.9	13.4	15.5	17.8	12.1	12.9	14.5	11.5	10.0	14.4	9.7	10.1	8.7	15.9	13.3	14.6	14.0	18.3	7.8	11.4	15.0	14.5	12.6	17.1	11.8	11.8	6.0	15.2	12.8	12.1	7.5	13.7	8.1	16.5	16.1	16.1	4.2	14.6	11.0	11.1	78.8	14.4	10.9	9.4	12.8	14.3	8.9	9.2	16.7	24.4	21.1	17.7	21.5	13.2	50.0	17.2	16.4	24.3	15.8	19.2	11.2	4.0	30.7	13.9	17.0	8.4	7.9	7.7	7.5	14.3	29.3	29.9	8.9	13.9	4.4	37.7	10.1	1.0	34.8	31.9	12.5	25.9	20.7	10.5	15.2	21.6	36.0	18.6	20.7	19.9	13.2	51.5	9.3	21.7	41.4	8.4	59.6	32.5	11.2	13.0	22.6	22.3	10.0	46.6	5.8	5.1	8.8	12.8	15.1	5.6	12.2	10.8	44.4	85.2	53.8	27.5	11.1	9.3	27.7	9.1	7.3	13.2	10.4	13.2	32.7	16.3	16.9	10.5	24.9	15.8	18.2	3.2	21.3	12.5	24.1	26.6	10.3	13.8	15.1	15.5	17.8	13.3	14.6	15.0	14.5	15.2	14.6	14.4	16.7	16.9	3.2	7.4	12.1	35.2	46.3	38.4	49.6	45.5	14.4	44.7	46.1	21.6	21.5	23.1	18.4	8.4	17.5	33.3	45.1	64.6	36.4	376.6	31.4	31.2	22.3	32.0	13.7	7.9	77.2	27.9	27.6	28.5	17.9	11.4	20.5	26.4	50.5	25.2	16.8	13.5	55.5	30.5	37.8	45.8	276.0	40.7	24.6	39.2	7.5	27.7	21.3	40.2	11.6	18.4	47.9	58.4	24.5	36.9	28.1	103.4	65.6	20.6	20.8	6.6	21.1	19.5	273.7	31.8	31.2	60.5	9.6	30.2	32.5	55.6	36.8
YDJC		ENSG00000161179	"YdjC chitooligosaccharide deacetylase homolog"	A8MPS7	22	21628089-21630064	"Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA061005			Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA061005: AB_2684412"	"unprognostic (5.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (9.84e-4)"	"unprognostic (9.35e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.60e-2)"	"prognostic favorable (8.98e-5)"	2.2	4.1	4.3	1.2	4.2	0.7	2.8	3.8	7.5	3.5	3.7	4.4	1.9	4.0	1.6	7.2	4.4	0.3	2.8	4.3	3.9	8.0	6.6	2.8	0.5	4.7	4.1	3.8	9.7	1.4	3.3	0.5	4.3	4.9	1.2	0.4	4.6	1.5	2.0	5.7	4.9	0.8	4.1	5.0	5.6	3.2	4.1	0.6	6.1	0.0	2.6	4.6	4.3	4.7	8.3	1.5	0.1	1.2	2.4	1.8	8.8	3.5	2.5	2.7	3.7	0.7	3.5	7.4	12.6	0.9	1.9	6.8	5.0	8.3	4.5	6.5	23.8	9.7	1.5	12.3	4.2	18.7	8.5	3.5	13.1	2.4	21.1	2.6	5.9	10.0	82.4	1.5	2.3	10.5	6.7	30.5	3.0	23.8	13.8	4.7	0.0	8.2	15.4	4.5	11.0	6.1	3.1	6.3	6.3	1.6	6.7	10.3	4.9	0.9	8.9	1.9	4.3	12.8	7.4	5.7	1.0	6.0	1.6	8.1	14.4	12.4	9.4	14.5	9.9	18.3	13.6	10.1	18.0	18.4	11.4	10.4	5.3	22.3	9.4	11.2	15.3	11.1	4.3	4.2	3.8	7.5	4.3	3.9	4.7	4.1	4.3	4.1	4.1	4.7	11.8	6.4	8.2	1.0	39.4	25.0	54.1	35.0	22.2	5.8	27.1	28.2	3.6	18.6	15.3	44.1	0.0	43.1	30.3	24.9	39.2	57.7	25.3	15.2	10.1	13.0	16.2	19.1	5.4	42.8	69.1	11.6	15.8	15.8	12.0	27.9	5.0	15.0	30.2	3.3	4.6	33.5	22.4	15.7	22.9	4.8	10.5	16.3	14.2	1.9	53.9	8.6	27.8	1.5	5.3	51.4	44.5	6.8	21.1	88.9	52.0	68.3	11.3	5.6	19.7	3.7	10.7	27.7	26.3	26.6	22.7	23.1	28.9	32.6	38.9	45.7
YEATS2	"FLJ10201, FLJ12841, FLJ13308, KIAA1197"	ENSG00000163872	"YEATS domain containing 2"	Q9ULM3	3	183697797-183812624	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 95.6;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 71.9;Oligodendrocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045891	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA045891: AB_10961271"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.33e-3)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (6.90e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.08e-2)"	7.4	4.8	5.4	8.9	7.4	14.5	7.9	8.1	8.8	8.5	0.0	9.1	5.4	9.0	4.7	8.2	10.3	6.5	6.6	6.4	5.2	6.1	3.4	10.0	12.9	2.4	3.7	15.1	5.4	9.9	8.6	11.2	3.0	8.2	6.8	15.6	8.0	7.3	5.5	8.5	7.0	11.9	1.9	8.9	5.8	8.0	4.2	16.9	9.7	4.8	11.8	8.7	8.4	7.0	38.1	11.3	32.4	14.5	15.5	22.8	35.8	22.1	17.0	32.1	37.5	27.8	13.3	34.7	39.8	19.5	49.9	23.9	31.8	21.2	32.7	28.5	18.8	35.0	12.2	13.7	23.9	26.3	19.4	15.6	16.3	23.1	27.8	32.1	33.1	35.2	14.0	28.3	24.5	10.2	38.3	20.2	29.3	13.8	22.0	53.5	30.5	42.0	12.9	16.6	31.3	22.3	16.4	55.4	29.2	27.1	27.5	17.8	28.2	29.5	21.3	15.1	25.0	26.9	22.6	57.6	22.9	25.8	21.3	0.1	4.6	1.2	1.9	2.0	1.3	1.9	1.7	1.4	1.6	1.3	1.3	1.5	8.5	1.3	7.1	2.1	0.7	1.8	5.4	7.4	8.1	8.8	6.4	5.2	2.4	3.7	3.0	1.9	4.2	7.0	13.8	35.3	2.3	41.4	7.0	2.0	3.3	7.0	8.6	19.5	5.6	7.5	10.1	5.7	5.9	5.5	10.4	4.8	7.4	4.4	0.0	5.7	2.4	10.5	18.3	15.3	8.5	6.3	95.6	4.0	9.7	9.2	7.1	9.8	7.0	42.1	7.5	3.0	7.1	13.5	62.1	6.0	6.1	8.7	6.7	3.3	9.9	10.1	1.8	40.3	6.6	5.8	5.2	71.9	80.0	7.1	3.1	9.4	9.5	5.3	4.7	1.0	11.2	15.8	0.0	10.1	10.4	3.1	12.3	8.7	3.4	2.1	8.8	9.7	4.8	2.8
YEATS4	"GAS41, NuBI-1, YAF9"	ENSG00000127337	"YEATS domain containing 4"	O95619	12	69359710-69390870	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Spermatocytes: 364.9;Spermatogonia: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072532			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"HPA072532: AB_2686530"	"unprognostic (7.23e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.05e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.77e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	9.4	11.8	5.6	10.4	6.1	45.8	17.8	9.4	8.2	10.1	9.5	12.3	13.3	10.3	14.9	11.6	12.2	8.3	11.1	6.1	6.2	15.3	14.9	8.9	22.5	6.2	5.9	9.9	17.3	11.1	10.1	10.9	6.3	10.8	13.7	20.1	12.0	9.6	14.3	11.3	13.6	8.4	6.4	10.9	11.0	37.1	5.9	25.9	13.8	19.5	20.4	11.3	9.5	8.0	54.3	27.0	52.1	32.5	11.8	18.9	41.3	32.0	33.7	54.7	45.6	31.1	15.4	108.1	30.5	17.3	28.2	40.8	41.6	32.3	53.2	54.2	45.4	63.0	20.5	37.6	16.5	92.4	53.3	14.0	40.3	29.1	43.1	27.9	31.7	90.1	53.4	127.9	26.8	27.5	130.4	99.8	72.5	36.0	37.6	68.9	49.0	53.6	30.9	47.7	57.6	39.4	33.0	31.4	54.9	32.2	60.5	52.9	18.9	22.5	22.9	63.4	39.4	34.2	44.5	120.2	24.4	43.7	40.1	9.3	13.1	26.4	21.1	19.2	24.0	22.7	29.5	22.2	17.9	21.2	34.8	30.3	6.0	21.6	28.4	14.9	31.8	21.2	5.6	6.1	9.4	8.2	6.1	6.2	6.2	5.9	6.3	6.4	5.9	8.0	14.5	6.4	25.8	11.4	29.0	29.7	36.1	36.3	17.6	25.5	29.5	25.7	23.4	14.3	24.4	11.0	12.5	51.2	24.9	16.8	46.9	31.4	8.0	27.2	10.6	16.3	17.6	50.9	13.6	38.9	58.0	17.4	13.3	19.9	19.0	21.8	12.5	17.0	37.6	18.5	15.5	26.4	22.4	15.1	24.3	14.6	18.6	19.8	12.4	6.5	44.1	26.5	20.6	10.1	18.4	33.2	17.3	24.0	18.3	37.0	23.7	35.2	26.1	28.2	19.7	26.4	18.6	364.9	109.1	26.5	32.0	23.5	33.0	30.7	34.3	34.9
YIPF1	"DJ167A19.1, FinGER1"	ENSG00000058799	"Yip1 domain family member 1"	Q9Y548	1	53851719-53889798	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.0;Syncytiotrophoblasts: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014716, HPA073931"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA014716: AB_1847686, HPA073931: "	"unprognostic (4.94e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.96e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.35e-1)"	7.1	9.2	5.3	6.2	5.6	5.7	8.5	5.8	15.2	6.7	6.9	7.9	6.9	4.1	7.6	9.0	6.3	5.5	6.6	5.9	6.3	11.1	13.5	7.7	7.1	6.7	5.8	7.0	6.8	7.0	6.2	9.7	6.8	11.3	9.2	7.2	11.7	4.8	14.6	9.4	6.9	6.0	6.2	8.2	8.7	7.2	6.0	8.8	22.1	10.4	10.7	7.7	7.1	6.4	11.0	6.4	10.1	7.1	11.9	13.1	9.0	7.7	12.0	14.0	18.3	7.1	3.3	3.8	12.9	9.2	21.6	13.2	12.9	17.0	14.4	27.4	10.3	8.9	6.4	11.6	15.9	10.0	8.1	13.3	15.8	11.3	13.5	12.0	15.0	13.2	9.6	10.0	14.0	9.2	10.8	14.2	7.7	12.7	10.4	6.6	9.3	15.4	11.5	5.8	4.5	5.6	7.4	13.8	35.4	31.0	21.4	11.1	7.1	5.7	5.8	10.4	6.8	20.1	24.7	7.0	9.3	8.1	5.0	19.1	18.4	20.2	11.8	16.5	11.0	10.4	10.0	12.1	16.6	13.8	9.5	9.2	38.3	11.0	23.3	11.5	24.3	16.5	5.3	5.6	5.8	15.2	5.9	6.3	6.7	5.8	6.8	6.2	6.0	6.4	11.6	6.4	12.6	9.8	9.0	8.5	17.6	19.2	9.6	6.6	20.0	12.4	9.6	24.3	24.0	9.2	0.0	80.0	8.5	14.6	11.7	28.3	30.5	11.4	10.9	10.9	9.6	12.2	9.8	32.6	28.4	9.9	9.7	14.7	9.5	6.3	11.7	20.8	39.7	10.1	8.2	27.5	30.5	19.4	7.7	54.9	5.9	18.9	10.6	11.2	20.2	16.5	21.6	8.5	11.5	32.5	10.8	9.4	28.1	33.2	12.3	17.7	19.7	6.5	0.0	5.6	17.7	22.2	20.9	12.3	10.9	129.6	10.8	17.7	10.8	29.0
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511832-43516985	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 494.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	72.3	120.2	78.9	43.3	79.9	46.4	70.0	79.5	92.0	74.0	102.6	74.3	65.2	72.1	100.5	80.3	69.7	63.3	87.6	80.2	78.9	78.2	105.4	68.9	42.6	80.5	79.2	75.6	152.0	110.0	91.9	77.8	81.2	76.3	62.1	49.8	118.6	61.1	82.8	70.0	66.1	57.5	78.3	67.2	106.1	48.0	81.6	46.0	74.3	83.4	46.5	69.1	67.3	80.8	95.0	66.2	95.3	185.4	208.3	168.5	56.1	111.9	174.6	91.8	115.7	79.1	67.6	37.8	84.4	208.6	78.4	93.4	71.0	110.2	59.4	69.9	95.7	61.2	91.8	153.2	163.2	64.7	85.9	169.0	141.2	77.9	78.3	154.4	141.1	61.1	67.8	88.2	111.5	146.9	47.5	82.3	49.7	494.4	71.1	42.6	43.0	103.2	164.3	101.4	76.7	109.0	50.3	66.9	122.2	72.8	111.4	133.5	133.5	103.1	53.4	57.0	78.8	102.5	88.8	74.3	73.2	53.5	71.5	147.2	84.8	128.7	60.0	82.2	52.3	46.1	53.7	54.1	78.7	48.5	42.7	48.5	316.0	65.5	83.2	70.3	79.8	78.2	78.9	79.9	79.5	92.0	80.2	78.9	80.5	79.2	81.2	78.3	81.6	80.8	77.8	35.3	33.6	12.7	41.4	40.7	63.8	121.7	63.2	54.6	62.8	49.4	31.7	82.9	86.5	55.2	37.5	192.2	41.1	109.7	49.0	149.6	38.1	63.5	60.5	78.9	107.1	42.1	12.1	101.8	209.5	78.2	59.7	67.9	40.6	77.9	74.6	71.0	99.3	58.9	14.7	117.6	101.7	49.1	31.2	79.0	69.9	49.6	65.8	14.0	72.4	115.0	42.2	15.1	17.7	117.5	108.8	67.0	111.6	71.4	129.1	74.9	51.2	63.5	32.9	45.5	64.4	44.0	40.8	52.8	35.5	264.1	34.9	101.9	80.0	81.6
YIPF5	"FinGER5, SMAP-5"	ENSG00000145817	"Yip1 domain family member 5"	Q969M3	5	144158162-144170714	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 236.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042338, HPA073622"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Golgi apparatus, Vesicles"	Nucleoplasm	"HPA042338: AB_2677953, HPA073622: AB_2686618"	"prognostic unfavorable (7.83e-5)"	"unprognostic (1.13e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.12e-5)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.49e-2)"	22.2	20.4	8.3	17.7	9.8	21.0	24.1	9.8	11.0	24.7	16.3	25.8	30.5	20.2	21.2	28.6	20.3	21.4	18.1	9.5	12.5	25.4	31.7	20.3	18.9	9.7	10.3	20.6	32.0	25.7	17.0	30.2	11.5	18.3	26.0	20.6	26.2	19.2	9.3	17.7	27.3	28.5	10.3	15.5	22.7	20.9	10.3	16.1	22.6	14.5	23.9	24.0	14.3	12.0	43.2	28.2	36.0	28.6	84.4	90.5	32.9	143.6	96.9	63.2	101.5	45.3	44.0	23.5	67.3	156.9	72.5	38.7	34.7	70.5	84.8	32.9	30.2	17.4	44.9	46.7	68.0	39.3	27.7	69.1	64.3	56.8	46.3	108.9	61.0	25.6	18.8	38.5	86.4	22.5	19.4	22.2	23.3	27.5	30.7	20.3	53.4	39.3	39.4	37.7	24.4	30.0	49.7	26.4	66.5	36.2	54.9	25.5	236.7	74.0	35.8	72.5	57.2	34.7	61.8	29.9	70.7	36.9	55.2	48.9	34.5	48.7	47.2	47.4	53.1	37.9	47.1	52.4	41.2	36.4	49.0	46.3	26.0	41.0	44.7	45.0	62.8	40.6	8.3	9.8	9.8	11.0	9.5	12.5	9.7	10.3	11.5	10.3	10.3	12.0	43.5	38.5	27.4	8.5	35.6	29.4	24.5	49.4	26.2	40.6	33.4	29.6	21.8	31.5	35.9	20.2	33.3	56.7	40.5	33.0	31.3	43.7	14.9	31.4	49.8	44.1	14.8	20.0	19.7	68.3	77.1	51.9	33.6	31.2	36.8	34.1	30.4	34.7	36.5	33.7	16.9	50.1	22.4	34.0	24.4	7.3	35.4	28.7	30.2	6.5	38.3	54.9	27.8	13.6	16.2	60.5	35.5	33.8	70.0	23.4	56.0	36.1	50.6	53.8	39.5	31.8	45.4	83.9	56.0	33.4	26.0	67.5	42.0	41.1	27.4	24.5
YJU2	"CCDC94, FLJ10374"	ENSG00000105248	"YJU2 splicing factor homolog"	Q9BW85	19	4247080-4269088	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.7;Distal tubular cells: 23.5;Ductal cells: 23.5;Exocrine glandular cells: 32.9;Extravillous trophoblasts: 23.3;Pancreatic endocrine cells: 21.9;Syncytiotrophoblasts: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043606, HPA055675"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA043606: AB_10963431, HPA055675: AB_2682880"	"unprognostic (1.75e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.32e-4)"	"prognostic favorable (8.04e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.46e-3)"	15.6	17.0	16.9	11.0	19.1	44.3	16.7	18.9	22.3	14.9	14.3	16.2	13.3	18.5	7.6	20.1	15.4	7.3	16.3	16.8	16.6	19.1	20.4	12.5	15.2	20.0	17.6	18.4	23.8	11.8	11.3	10.0	18.2	17.6	7.6	8.0	16.3	8.7	23.4	23.5	17.8	7.1	17.1	20.4	19.4	15.4	18.0	12.6	17.4	13.9	10.7	16.4	14.7	21.4	30.7	29.1	16.0	12.9	9.3	12.3	16.3	12.2	15.3	22.2	24.4	26.2	18.3	35.5	13.5	18.3	19.1	22.8	26.1	28.8	15.4	20.6	25.8	22.9	19.4	31.0	13.7	30.1	30.6	13.1	17.0	19.6	28.8	13.5	18.2	16.9	33.0	40.1	9.3	42.2	31.9	18.7	38.3	13.9	22.0	18.4	13.5	31.6	21.1	29.7	22.9	23.9	10.8	23.3	21.8	9.2	16.8	27.9	20.5	15.7	16.4	31.8	30.5	43.2	33.0	35.2	21.9	31.6	17.1	21.3	19.6	31.0	25.7	25.5	23.2	31.0	24.6	23.8	24.0	33.1	29.0	24.2	12.1	23.4	19.3	25.0	33.4	18.9	16.9	19.1	18.9	22.3	16.8	16.6	20.0	17.6	18.2	17.1	18.0	21.4	11.2	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	9.4	9.0	0.0	0.0	0.0	9.2	0.0	29.7	10.1	0.0	23.5	23.5	0.0	7.6	7.7	7.0	0.0	0.0	0.0	32.9	23.3	4.4	0.0	11.6	0.0	10.4	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	18.6	0.0	0.0	0.0	0.0	21.9	0.0	0.0	1.7	0.0	0.0	19.6	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	45.7	4.7	11.9	0.0	0.0
YLPM1	"C14orf170, PPP1R169, ZAP"	ENSG00000119596	"YLP motif containing 1"	P49750	14	74763316-74859435	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048070, HPA061123"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA048070: AB_2680247, HPA061123: AB_2684435"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.63e-2)"	"prognostic favorable (6.08e-7)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	13.3	13.0	12.5	10.4	12.8	17.6	13.8	18.1	15.6	18.0	2.8	12.9	7.0	16.1	12.9	12.7	15.9	8.5	11.4	10.9	16.4	10.6	8.5	11.2	13.1	9.5	10.0	22.1	13.1	12.1	15.6	11.2	9.3	14.0	9.2	17.6	15.0	10.3	15.0	15.3	13.4	9.4	4.8	13.4	11.9	18.5	12.3	14.9	16.8	7.4	11.9	14.0	15.0	12.8	28.3	28.9	31.8	7.1	25.2	20.8	18.0	18.3	18.7	18.9	18.9	25.8	19.6	40.9	13.4	20.8	13.7	26.1	28.6	19.6	30.2	24.6	17.3	29.4	19.8	20.0	12.2	22.3	21.9	19.0	13.5	20.9	16.5	23.3	25.3	22.9	24.1	18.9	23.5	29.9	26.4	24.4	20.0	19.2	26.1	40.5	31.8	14.3	16.5	37.2	24.2	23.8	29.4	20.2	8.3	21.8	22.9	17.4	37.0	22.6	28.3	15.6	23.9	23.3	24.8	43.6	19.3	17.3	17.2	0.3	1.4	1.5	1.5	1.6	1.7	1.9	1.3	1.3	1.1	1.9	1.8	1.8	1.0	2.3	1.5	3.4	1.1	1.4	12.5	12.8	18.1	15.6	10.9	16.4	9.5	10.0	9.3	4.8	12.3	12.8	26.8	25.6	34.3	54.2	32.7	19.9	11.2	13.3	27.9	42.0	27.7	25.3	45.9	14.3	25.0	9.2	41.7	19.7	32.4	15.7	1.9	15.7	35.4	26.8	36.0	29.7	20.4	23.5	86.7	15.5	13.5	24.4	23.0	28.6	17.7	54.1	21.8	16.8	19.1	52.2	84.3	18.9	12.2	22.6	12.3	17.7	33.8	19.5	5.4	51.5	28.6	24.6	32.0	68.9	76.5	18.0	13.3	48.5	30.3	18.9	14.0	14.7	33.0	30.8	19.7	35.5	24.8	62.8	49.0	29.2	23.3	15.7	29.3	32.5	21.6	13.2
YOD1	"DKFZp451J1719, DUBA8, OTUD2"	ENSG00000180667	"YOD1 deubiquitinase"	Q5VVQ6	1	207043849-207052980	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Unfolded protein response"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.6"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 70.9;Glandular and luminal cells: 118.8;Late spermatids: 103.3;Urothelial cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 86.3;K-562: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028400, HPA028439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		110000	"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA028400: AB_10599854, HPA028439: AB_10600994"	"unprognostic (3.69e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.87e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.62e-1)"	3.0	4.5	3.5	4.3	3.8	58.6	5.4	3.7	5.5	5.2	3.9	3.9	4.2	3.7	2.9	24.6	2.6	2.8	4.4	4.0	3.4	4.7	5.4	8.5	4.7	5.5	3.6	2.9	3.2	1.6	2.7	5.7	4.4	3.0	3.9	7.6	6.6	2.7	4.8	15.6	4.8	2.5	3.6	5.7	8.8	3.8	5.0	9.9	5.3	4.1	7.6	4.6	10.9	9.9	11.8	6.1	9.5	5.7	3.3	4.4	18.5	7.6	5.9	5.7	5.7	11.7	11.9	6.1	3.0	4.7	2.7	12.6	0.1	9.3	6.4	4.9	10.3	86.3	27.6	5.6	3.1	11.5	29.2	3.1	7.1	4.6	17.7	6.7	5.0	12.5	61.1	0.0	5.0	0.1	10.1	6.3	9.1	4.9	13.5	5.1	0.4	4.5	5.7	13.0	5.0	11.0	12.5	14.4	16.7	8.4	5.1	8.1	2.4	4.8	12.6	4.0	10.0	9.5	0.6	9.0	5.7	0.0	3.3	1.0	0.3	0.5	0.2	0.3	0.3	0.0	0.3	0.2	0.3	0.1	0.3	0.4	0.7	0.3	0.2	0.1	0.2	0.2	3.5	3.8	3.7	5.5	4.0	3.4	5.5	3.6	4.4	3.6	5.0	9.9	6.8	41.7	12.2	20.5	3.3	31.6	29.4	8.1	21.1	8.0	6.2	3.8	7.0	2.8	10.0	1.8	4.2	2.7	8.2	39.4	1.9	4.1	35.4	50.5	19.0	6.7	8.9	70.9	8.5	10.5	3.2	5.5	36.2	118.8	8.2	6.1	2.9	8.6	2.8	11.8	6.4	5.0	12.2	10.0	12.5	103.3	1.5	8.3	14.2	6.5	5.2	4.9	6.2	6.0	16.4	24.4	67.8	2.2	4.8	38.2	7.8	7.0	21.6	17.9	6.6	3.6	6.0	10.9	4.6	33.9	40.2	1.8	6.9	9.0	7.5	86.5
YPEL5	CGI-127	ENSG00000119801	"Yippee like 5"	P62699	2	30146941-30160533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 438.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 548.0;Plasma cells: 545.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042809	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA042809: AB_2678179"	"unprognostic (7.22e-3)"	"unprognostic (6.50e-3)"	"unprognostic (9.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.67e-3)"	65.2	67.0	61.5	44.9	65.6	438.1	55.2	58.0	81.2	61.3	68.2	70.3	40.5	51.4	84.3	55.6	51.3	64.0	56.7	66.0	64.7	87.4	64.4	61.1	62.7	64.0	57.2	60.3	44.8	101.5	45.6	64.6	63.0	68.8	45.5	77.2	63.3	95.5	54.1	51.9	44.4	65.1	61.8	58.9	49.4	71.4	60.8	77.2	61.8	48.7	62.8	78.1	47.0	61.6	35.9	18.1	42.5	20.9	113.3	109.4	35.0	50.7	152.6	28.5	43.3	16.3	36.7	21.4	32.7	100.7	65.0	19.1	9.9	50.5	40.2	94.1	19.1	11.0	8.0	26.0	98.3	3.7	24.9	114.1	100.7	53.0	67.6	122.5	53.8	13.5	15.5	36.8	77.2	18.5	11.3	26.3	23.9	41.2	22.7	7.0	56.8	20.9	96.4	69.6	16.7	51.1	24.6	24.4	65.2	77.1	27.3	20.5	70.6	77.4	29.5	21.2	14.2	86.5	34.9	28.7	55.1	9.9	31.7	229.3	82.4	190.7	53.3	95.4	54.7	89.9	65.8	64.2	78.0	74.0	62.2	55.8	306.9	56.5	149.5	152.9	95.8	146.6	61.5	65.6	58.0	81.2	66.0	64.7	64.0	57.2	63.0	61.8	60.8	61.6	83.8	83.3	90.5	13.4	398.6	134.0	162.9	184.8	122.3	70.7	142.5	105.5	73.2	47.1	119.3	101.2	47.9	172.8	300.4	104.1	138.9	90.9	253.9	178.0	71.0	74.3	208.9	93.7	30.9	78.8	140.4	84.2	126.9	213.7	81.3	46.4	56.0	43.3	103.3	63.9	25.9	94.5	114.0	132.1	168.7	548.0	57.8	214.9	170.7	15.9	321.0	103.4	50.4	19.6	28.3	110.2	108.6	82.8	545.7	143.3	84.8	137.0	101.4	63.5	52.6	87.4	114.9	133.8	78.0	97.4	142.6	408.0	358.5	53.5	46.8	281.2
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350090	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (7.29e-5)"	43.0	27.0	22.4	19.5	26.5	116.6	43.8	31.9	25.0	52.6	18.6	40.0	15.6	43.6	22.7	48.0	42.3	15.3	34.1	20.9	26.0	38.2	33.1	40.6	28.4	23.6	23.6	68.6	44.5	20.3	41.2	23.8	24.8	37.9	19.6	38.5	42.1	17.6	47.2	51.3	40.5	17.2	23.2	41.9	36.3	31.3	23.1	30.3	42.1	16.7	26.7	37.3	50.5	32.7	31.8	18.4	37.1	22.2	21.7	18.8	30.4	33.8	21.3	20.6	21.5	22.9	27.9	50.8	27.0	17.2	16.7	23.3	35.1	29.4	33.1	38.2	21.3	38.8	27.3	25.6	22.1	41.5	29.0	17.8	31.3	18.5	44.0	26.6	22.6	24.7	37.5	29.0	30.7	23.9	48.9	37.1	27.6	30.4	18.0	42.4	41.6	22.8	32.6	35.6	31.9	24.8	29.5	31.5	25.9	34.3	24.6	28.8	24.1	23.5	24.9	16.4	22.5	30.1	21.8	53.7	15.9	26.6	22.0	69.3	20.3	40.4	24.1	12.7	19.0	36.1	19.6	19.8	12.2	44.8	26.9	22.9	105.4	20.8	27.0	39.3	20.3	9.7	22.4	26.5	31.9	25.0	20.9	26.0	23.6	23.6	24.8	23.2	23.1	32.7	104.6	112.2	129.5	54.9	104.7	119.9	103.6	76.2	88.8	105.8	112.8	107.2	92.6	85.8	125.1	73.5	70.9	73.6	136.8	58.1	52.8	70.2	98.5	131.9	135.3	92.2	85.8	74.7	43.8	57.2	124.8	81.3	54.0	254.8	94.7	86.2	63.5	85.6	43.2	90.9	49.4	77.9	63.1	61.0	75.9	22.0	74.6	84.5	64.0	56.2	67.0	99.2	96.8	59.3	110.1	81.6	56.0	67.7	103.2	121.6	42.0	44.0	113.2	138.4	52.6	122.0	98.8	139.2	95.9	127.1	134.5	119.0	122.0	59.5	66.9	119.8
YTHDC2	"DKFZp564A186, FLJ10053, FLJ2194"	ENSG00000047188	"YTH domain containing 2"	Q9H6S0	5	113513694-113595285	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.8;Inhibitory neurons: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037364, HPA072678"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytoplasmic bodies"	"HPA037364: AB_10672788, HPA072678: AB_2686548"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.82e-3)"	"unprognostic (3.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (4.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	8.4	9.7	5.2	11.3	5.8	9.9	10.1	8.8	6.6	8.9	7.8	8.7	9.3	9.2	8.6	9.4	8.3	8.0	7.6	6.1	5.1	8.5	12.6	7.4	13.8	5.3	5.8	11.0	8.7	15.5	8.7	6.9	5.3	8.1	10.0	18.3	8.9	7.4	11.5	11.3	10.1	7.9	5.1	11.4	9.2	14.8	4.7	10.2	9.2	10.9	12.9	9.8	8.9	7.1	16.0	14.2	18.1	30.7	9.8	12.9	19.7	12.1	13.4	15.2	23.6	10.0	8.8	29.1	8.5	10.2	19.5	15.3	22.0	27.2	19.8	12.6	19.9	15.8	25.8	13.6	14.5	12.8	13.4	10.6	10.3	9.6	17.4	14.3	21.5	13.0	15.8	13.0	13.6	5.3	17.8	9.1	8.4	4.7	9.2	7.4	15.6	22.7	12.7	20.9	14.4	12.0	16.3	11.7	12.7	11.3	16.6	11.4	18.8	23.2	8.1	12.1	16.7	13.3	18.0	18.0	13.3	14.4	10.1	0.0	2.8	2.9	2.8	1.9	3.3	7.3	3.2	3.0	2.4	5.1	3.4	2.9	1.0	4.3	3.3	3.6	2.6	1.2	5.2	5.8	8.8	6.6	6.1	5.1	5.3	5.8	5.3	5.1	4.7	7.1	27.4	28.9	32.8	61.0	39.6	13.3	21.8	14.7	15.9	59.9	17.6	17.7	17.7	14.3	25.3	12.9	83.4	13.7	34.0	12.3	0.0	17.8	47.5	15.5	24.5	24.0	7.2	16.6	129.8	18.6	8.3	22.4	34.1	17.2	12.6	69.0	20.0	25.7	17.3	52.2	146.3	14.2	20.3	30.0	13.2	44.2	19.9	26.8	12.4	95.5	23.9	21.4	16.5	94.5	97.6	18.0	7.8	14.7	20.0	14.4	16.0	17.8	24.9	88.9	26.3	34.0	26.6	93.8	37.8	19.2	14.3	18.1	33.0	33.4	16.7	18.5
YWHAQ	"14-3-3, HS1"	ENSG00000134308	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta"	P27348	2	9583967-9630997	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007925, CAB010286"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		49000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"CAB010286: AB_2218221, HPA007925: AB_1844340"	"unprognostic (2.65e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (1.53e-1)"	"unprognostic (5.78e-3)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (4.90e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.39e-3)"	144.6	141.0	190.8	106.1	223.2	178.4	153.6	216.5	239.1	177.0	149.4	161.2	119.4	184.3	141.6	187.3	136.5	122.6	218.7	205.1	229.7	140.0	116.3	119.3	132.0	218.6	203.8	163.2	201.5	131.9	112.9	123.2	212.4	161.1	133.0	143.6	120.2	140.2	53.5	121.5	116.2	177.4	203.9	89.8	127.5	144.6	205.7	148.2	137.6	62.1	141.1	144.4	161.8	280.5	316.1	465.2	412.0	400.3	316.6	434.5	385.7	421.6	412.3	432.5	360.2	352.9	269.3	404.4	214.0	608.5	451.3	288.5	462.8	459.7	553.6	1003.0	374.8	378.8	268.9	379.9	241.1	369.1	219.7	295.8	264.5	473.6	305.9	394.9	493.5	285.6	378.5	236.8	539.3	219.3	658.2	374.4	700.7	351.9	527.5	473.0	533.3	497.4	478.8	276.9	390.1	659.9	384.1	392.2	317.3	343.8	244.4	187.0	453.9	539.6	380.7	473.4	654.4	239.3	351.4	526.6	461.8	378.9	458.8	99.5	102.7	120.5	207.8	137.8	255.6	151.9	192.8	223.5	144.2	147.8	103.6	170.1	31.1	252.0	137.0	73.1	208.4	344.1	190.8	223.2	216.5	239.1	205.1	229.7	218.6	203.8	212.4	203.9	205.7	280.5	186.6	51.3	67.3	26.1	144.0	316.7	366.5	339.0	143.4	201.4	198.4	153.7	82.6	90.1	143.4	136.1	27.1	261.6	189.9	209.9	416.7	371.5	281.9	132.9	175.8	191.0	187.1	179.2	57.3	283.7	615.3	242.0	115.2	131.6	125.0	152.5	84.9	97.9	215.3	572.0	45.1	129.2	270.6	111.9	228.3	360.5	174.0	132.3	295.3	30.0	195.0	229.2	155.5	39.7	186.6	261.2	150.9	250.5	187.9	323.7	135.9	278.8	111.7	105.8	197.2	191.5	312.7	432.2	205.8	252.1	355.3	238.6	217.7	252.9	186.5	457.3
YY1	"DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1"	ENSG00000100811	"YY1 transcription factor"	P25490	14	100238298-100282788	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001119, CAB009392"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"CAB009392: AB_2218501, HPA001119: AB_1858930"	"unprognostic (7.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (6.75e-3)"	"unprognostic (8.31e-3)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-1)"	27.2	26.2	20.9	28.9	22.1	56.4	27.0	27.0	24.2	24.6	18.5	30.7	27.9	24.8	34.0	28.9	21.7	22.7	22.8	22.7	20.2	32.9	46.8	24.0	36.0	20.4	20.4	21.6	24.4	32.5	17.4	34.2	20.3	25.2	28.7	20.1	25.1	23.6	36.8	29.0	29.7	24.8	20.1	31.9	26.2	23.8	21.5	52.3	37.2	27.2	38.2	31.9	21.0	26.2	62.0	30.7	64.2	51.5	51.8	65.9	68.1	60.0	55.1	64.7	66.0	38.6	97.7	94.0	82.3	54.5	37.1	64.0	72.6	64.1	88.3	70.8	60.9	86.8	34.6	50.0	48.4	103.8	73.2	38.7	76.4	45.4	61.4	58.6	63.9	67.3	69.9	61.8	63.7	74.5	113.5	61.8	68.7	98.0	56.0	93.9	88.9	50.7	75.8	58.3	68.2	53.3	79.2	57.8	85.1	54.0	86.6	100.1	57.4	39.4	48.3	97.6	53.8	68.3	72.0	126.6	56.4	68.6	52.5	4.8	5.7	11.9	4.3	4.8	5.6	5.3	5.7	5.9	4.9	8.3	5.4	5.4	9.8	9.5	3.8	5.3	7.7	2.7	20.9	22.1	27.0	24.2	22.7	20.2	20.4	20.4	20.3	20.1	21.5	26.2	116.0	54.5	66.8	23.8	102.4	238.0	101.1	49.9	211.7	80.5	129.8	98.2	91.5	92.9	50.0	68.0	81.3	118.6	147.4	122.8	72.4	68.7	10.3	118.7	133.8	115.7	110.1	125.4	28.2	82.0	123.6	106.7	58.1	153.6	71.7	99.4	103.5	119.4	81.3	127.9	26.5	108.8	48.8	111.8	225.8	15.7	94.8	121.6	76.5	30.0	117.8	82.0	114.4	20.6	40.7	80.0	95.5	100.8	125.0	168.9	90.0	104.6	47.6	74.9	92.1	106.5	124.3	86.0	67.0	192.1	243.1	175.5	124.8	124.1	118.7	153.5
Z82206.1		ENSG00000225528	"Novel protein similar to translation machinery associated 7 homolog (S. cerevisiae) TMA7"		22	39960397-39964718	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;lymphoid tissue: 4.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 7.9;granulocytes: 3.8;Proximal tubular cells: 3.2;T-cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"K-562: 12.5"									HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (8.48e-4)"	"unprognostic (2.95e-6)"	"unprognostic (3.67e-1)"	"unprognostic (5.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (6.95e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.41e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.77e-2)"	"unprognostic (6.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.58e-3)"	0.1	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.1	0.1	0.1	0.0	4.3	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	12.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.1	2.7	2.9	1.3	2.5	2.3	3.5	3.2	1.6	2.0	3.6	4.4	2.4	1.3	1.2	1.7	2.6	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.9	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0
ZADH2	MGC45594	ENSG00000180011	"Zinc binding alcohol dehydrogenase domain containing 2"	Q8N4Q0	18	75195113-75209139	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021468, HPA053646"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA021468: AB_1858932, HPA053646: AB_2682216"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.79e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.23e-1)"	17.7	12.9	15.6	11.8	17.8	20.7	22.2	19.2	22.0	18.8	14.0	26.3	19.0	15.5	24.8	20.0	17.9	15.8	34.3	17.0	12.9	24.2	32.5	16.3	19.3	16.8	13.9	23.9	26.6	24.7	21.5	36.6	18.3	17.1	28.7	30.6	23.8	18.2	44.9	22.0	26.0	15.2	16.5	16.1	21.3	7.0	15.5	23.3	27.8	40.7	20.6	16.6	16.9	16.8	21.7	14.1	14.8	30.4	22.6	29.0	16.3	38.5	44.6	14.8	18.5	8.7	30.0	15.2	6.0	38.3	17.4	28.7	18.5	32.6	10.4	94.6	27.1	34.1	32.7	17.0	16.0	58.0	33.2	32.2	31.9	11.9	27.2	27.5	30.9	35.2	18.6	54.0	28.6	25.5	14.6	28.6	3.8	20.9	31.9	31.0	23.7	50.2	28.9	36.2	27.2	22.4	21.4	21.7	24.5	10.4	21.8	28.4	27.7	28.9	22.0	9.2	12.4	8.8	41.2	10.5	19.1	49.5	23.8	1.7	3.4	8.9	3.2	2.9	2.3	2.1	2.6	2.9	2.3	1.5	1.4	2.2	1.7	1.7	3.8	1.7	3.2	1.8	15.6	17.8	19.2	22.0	17.0	12.9	16.8	13.9	18.3	16.5	15.5	16.8	41.5	35.3	17.9	12.4	7.5	9.7	18.7	13.9	9.6	59.0	15.3	10.8	56.3	20.0	12.5	27.6	6.2	8.4	15.9	24.8	19.6	12.3	0.5	8.5	39.0	24.1	23.4	9.9	16.6	21.1	8.1	26.4	12.8	11.1	7.0	42.6	23.6	25.0	16.4	25.2	14.1	25.1	14.2	20.2	19.1	2.1	36.7	18.3	12.4	12.2	23.9	21.3	13.4	20.6	14.9	15.5	21.9	63.2	6.2	18.5	35.2	19.0	8.1	40.9	19.7	25.5	12.3	0.4	4.9	23.7	11.1	6.7	11.0	73.0	27.2	20.9
ZBED1	"ALTE, DREF, hDREF, KIAA0785, TRAMP"	ENSG00000214717	"Zinc finger BED-type containing 1"	O96006	X	2486414-2500976	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 91.0"					"Low region specificity"	"Detected in all"			HPA077591	Approved		Approved	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Centrosome"	"Nuclear membrane"	"HPA077591: AB_2686847"	"unprognostic (7.66e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.27e-1)"	20.4	35.8	16.4	11.8	17.7	7.2	16.8	20.0	16.1	16.9	11.3	16.4	18.9	18.0	5.3	12.2	13.0	12.9	32.5	14.4	17.1	13.9	32.5	12.2	12.5	25.1	21.7	13.1	21.4	11.3	10.4	9.9	22.8	15.4	11.5	8.1	16.8	10.5	70.9	22.3	20.4	9.3	21.3	15.5	14.7	7.8	20.9	11.3	12.1	37.4	9.3	13.1	12.9	16.2	11.6	28.3	20.2	22.4	12.6	13.3	91.0	16.1	17.5	9.3	10.7	36.4	10.0	22.8	18.1	21.5	25.5	5.4	19.5	16.7	6.9	27.0	26.0	17.0	23.4	31.3	16.5	10.6	34.1	19.7	12.8	9.8	7.3	13.8	22.1	15.2	21.9	7.3	18.2	8.2	17.7	8.5	49.9	7.4	16.6	14.0	20.0	10.8	15.6	22.2	24.0	23.6	13.7	36.2	25.6	22.6	10.0	22.3	30.7	19.9	10.5	11.0	17.7	8.7	0.1	37.4	8.1	14.8	11.5	2.2	11.8	10.3	10.6	11.7	9.3	8.4	6.1	5.9	13.3	11.2	5.7	4.9	12.5	5.5	9.8	9.7	6.4	11.7	16.4	17.7	20.0	16.1	14.4	17.1	25.1	21.7	22.8	21.3	20.9	16.2	12.9	12.8	11.7	0.0	20.7	15.2	17.6	14.1	29.6	55.5	12.9	12.4	27.8	40.0	9.2	25.8	14.6	15.9	18.7	23.3	11.7	22.8	0.4	23.0	18.2	17.5	15.5	7.6	0.0	23.4	18.0	22.6	8.2	28.5	14.7	37.1	18.5	37.3	18.0	10.1	0.0	19.4	10.2	22.2	24.9	1.3	19.9	19.5	8.8	0.0	23.0	20.5	34.0	0.0	0.0	22.7	17.3	23.0	8.8	19.7	25.5	18.1	15.8	23.5	6.6	23.7	19.2	0.7	2.6	15.8	11.2	38.0	14.4	29.5	23.2	12.9
ZBED3	MGC15435	ENSG00000132846	"Zinc finger BED-type containing 3"	Q96IU2	5	77072072-77087285	"Predicted intracellular proteins, Predicted secreted proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.7;JURKAT: 31.0;MOLT-4: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055995	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Secreted to blood"	NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA055995: AB_2683000"	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.82e-2)"	"unprognostic (8.64e-3)"	"unprognostic (3.63e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.08e-1)"	10.3	3.3	9.3	1.9	14.2	2.6	8.8	9.4	10.8	6.7	7.5	4.2	3.9	10.2	7.4	2.4	7.0	3.5	4.6	7.8	9.2	10.0	10.7	5.0	1.9	16.0	12.2	7.9	7.6	8.4	3.9	2.4	10.9	5.1	4.3	3.8	6.0	6.6	2.7	2.6	3.3	8.7	9.9	3.6	6.4	1.9	13.5	4.8	11.2	3.8	1.9	3.0	3.7	17.1	5.2	4.2	5.4	29.7	22.1	1.5	0.3	1.7	5.0	2.6	6.9	9.1	2.4	0.0	10.9	3.4	1.1	0.6	2.9	1.8	2.3	1.7	5.8	4.0	9.1	10.4	13.1	5.5	1.5	24.6	6.8	1.3	5.1	4.2	8.3	31.0	0.0	11.0	1.6	5.2	29.4	0.8	3.5	1.4	2.5	12.1	10.3	1.7	12.3	2.0	5.9	12.4	6.1	5.0	8.7	2.1	7.5	3.8	3.3	2.3	4.5	5.1	7.0	8.0	8.2	11.5	3.6	10.4	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	9.3	14.2	9.4	10.8	7.8	9.2	16.0	12.2	10.9	9.9	13.5	17.1	10.5	0.0	2.8	8.1	1.7	1.3	3.8	0.3	4.0	8.4	13.5	13.6	10.7	12.8	2.0	12.9	12.5	1.5	2.0	3.1	17.6	4.1	3.3	16.5	13.5	11.7	16.2	5.0	3.3	6.0	0.3	9.3	11.7	12.5	1.3	20.2	12.1	31.8	9.6	3.3	8.5	5.3	0.0	13.6	4.9	2.2	17.7	9.0	7.2	5.6	5.1	13.8	3.1	16.1	18.3	2.7	3.4	11.3	1.4	5.6	1.9	17.2	0.1	17.0	0.0	21.4	7.7	1.5	3.4	2.2	1.4	0.3	1.2	25.6	7.1	1.8
ZBED4	KIAA0637	ENSG00000100426	"Zinc finger BED-type containing 4"	O75132	22	49853844-49890080	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045341	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA045341: AB_2679295"	"unprognostic (3.82e-2)"	"unprognostic (6.39e-2)"	"unprognostic (7.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.20e-2)"	3.6	2.6	2.3	5.3	2.1	11.0	3.4	5.6	2.3	3.1	1.3	5.7	5.3	3.5	2.7	6.5	3.3	3.5	3.3	2.2	1.6	3.7	4.7	4.2	6.6	2.2	1.9	3.6	5.3	3.0	3.3	3.9	2.1	3.4	4.8	4.7	3.8	2.1	4.5	5.0	5.3	3.2	1.2	5.1	4.5	3.8	2.2	10.9	3.3	3.2	5.5	4.0	3.5	4.0	14.9	13.1	24.5	19.5	7.4	8.1	15.2	8.6	7.1	9.3	8.6	13.5	6.5	29.3	5.9	9.2	9.7	16.7	17.4	11.1	9.9	11.6	21.2	16.8	13.2	12.8	10.7	36.0	23.2	7.6	16.5	10.2	15.4	9.3	12.6	28.0	18.2	13.7	11.1	11.9	30.0	17.1	13.4	12.9	9.1	35.5	22.1	17.8	9.9	14.9	12.9	25.7	8.5	24.9	17.3	15.2	11.8	20.3	14.7	12.7	19.9	7.5	12.3	13.5	9.0	26.5	7.7	15.9	15.2	0.4	0.4	0.7	0.8	0.6	1.6	0.6	0.8	0.9	1.0	0.4	1.0	0.8	0.2	2.9	0.6	1.0	0.6	0.6	2.3	2.1	5.6	2.3	2.2	1.6	2.2	1.9	2.1	1.2	2.2	4.0	4.9	0.0	6.5	11.4	7.2	5.1	5.1	5.0	4.0	7.9	6.3	6.1	7.2	7.2	8.6	5.5	14.6	3.6	23.5	8.7	3.9	9.2	4.8	10.0	10.1	6.6	12.6	12.8	14.7	7.1	6.4	5.1	7.7	10.1	0.0	10.1	5.3	6.9	6.8	13.5	14.7	9.5	4.1	12.6	5.2	4.6	3.1	7.3	0.0	16.9	8.5	2.5	16.5	12.1	16.6	13.3	8.5	4.1	12.5	9.2	3.8	2.9	6.2	9.9	6.6	5.8	7.1	4.8	6.4	6.7	3.8	3.3	17.2	7.4	11.0	6.8
ZBED5	Buster1	ENSG00000236287	"Zinc finger BED-type containing 5"	Q49AG3	11	10812074-10858796	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048472, HPA050994"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA048472: AB_2680408, HPA050994: AB_2681300"	"unprognostic (7.74e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.05e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (5.69e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.87e-4)"	26.4	22.0	16.9	36.6	22.5	34.1	32.7	35.3	20.0	39.4	23.3	33.1	25.6	45.6	35.7	26.4	38.5	25.8	32.5	16.8	18.0	33.1	15.7	31.5	57.1	20.1	18.5	45.1	28.8	35.0	30.5	27.9	21.1	36.3	29.9	50.8	29.6	21.9	33.3	51.4	36.5	28.9	19.5	42.9	28.5	21.3	18.7	49.7	40.1	29.1	45.4	30.7	31.7	32.7	46.8	36.7	63.1	41.2	33.8	52.0	32.7	37.4	38.2	24.8	24.5	27.0	99.6	50.7	27.5	28.0	34.5	56.8	39.8	39.3	33.1	49.8	35.5	13.4	89.3	15.6	27.5	42.3	17.1	36.0	55.3	18.8	41.0	44.3	31.0	25.3	35.0	56.0	36.0	23.6	41.9	46.2	34.1	33.3	47.8	62.8	34.3	27.4	29.2	64.6	30.9	54.4	38.4	49.1	30.6	35.3	46.8	23.1	31.1	53.2	38.4	35.9	26.6	27.9	36.8	39.8	46.0	29.5	41.2	1.1	8.7	8.0	11.0	9.6	14.3	20.6	13.1	14.1	12.2	21.2	17.0	17.2	7.3	17.8	11.6	15.8	12.3	8.5	16.9	22.5	35.3	20.0	16.8	18.0	20.1	18.5	21.1	19.5	18.7	32.7	17.1	57.7	33.0	32.0	44.6	34.7	46.1	25.0	34.7	32.8	15.9	11.8	38.8	20.0	39.4	22.0	29.2	17.1	13.6	12.3	23.5	22.2	6.9	13.9	29.4	22.7	27.6	8.8	18.1	16.2	8.5	27.3	15.3	14.0	8.8	25.8	20.7	6.2	12.1	28.6	22.3	15.6	26.4	15.7	19.8	7.9	27.4	19.3	16.0	16.9	18.1	21.6	14.4	25.6	40.9	18.3	13.1	27.4	26.6	25.3	12.5	14.5	42.7	35.8	19.7	41.2	25.2	43.4	22.2	25.9	35.7	12.4	22.6	18.7	16.7	28.5
ZBED6		ENSG00000257315	"Zinc finger BED-type containing 6"	P86452	1	203795714-203854999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA068807			Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Centriolar satellite"	"HPA068807: AB_2686040"	"unprognostic (1.79e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.28e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.47e-2)"	5.0	4.3	3.4	3.6	7.9	3.0	3.7	6.7	4.5	6.4	8.9	3.3	6.0	5.9	3.2	3.9	4.0	4.4	2.7	2.8	5.6	4.5	5.7	3.7	4.0	5.8	5.7	6.9	7.0	3.9	3.2	6.0	5.9	3.2	3.8	5.6	4.6	4.1	4.3	4.9	3.6	3.8	2.5	5.0	4.9	2.5	6.8	5.3	5.0	6.2	4.3	3.4	3.7	11.9	4.4	7.2	10.2	5.0	7.6	16.8	4.1	6.2	15.2	4.4	4.9	1.7	4.4	3.0	1.3	10.3	2.6	7.0	3.3	5.2	7.1	8.3	2.7	6.2	7.7	1.4	3.8	4.7	4.4	9.2	2.4	5.8	6.3	9.7	12.2	3.8	7.6	8.7	6.5	3.0	3.2	3.4	2.4	2.1	2.7	2.5	9.1	3.3	2.5	7.3	2.1	10.2	7.4	6.6	2.8	8.7	10.7	5.0	21.4	6.7	6.3	3.2	4.4	4.9	2.0	0.9	7.7	2.4	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	3.4	7.9	6.7	4.5	2.8	5.6	5.8	5.7	5.9	2.5	6.8	11.9	1.5	9.6	6.3	0.0	8.9	15.9	35.3	11.3	6.8	15.0	0.4	0.5	2.5	8.6	15.2	0.0	31.3	14.5	5.4	15.7	0.0	0.1	1.0	2.2	3.0	14.5	18.5	12.0	0.0	0.0	13.9	16.0	11.2	2.3	33.0	1.1	10.0	4.6	6.0	11.8	0.0	14.0	8.2	9.3	19.6	1.0	19.9	8.9	14.2	0.0	5.8	14.7	15.5	0.0	0.0	0.1	14.5	15.1	3.8	43.0	35.1	0.1	11.0	21.1	26.3	37.3	15.2	6.5	8.2	5.6	17.0	34.9	12.0	1.5	14.2	56.9
ZBED8	"Buster3, C5orf54"	ENSG00000221886	"Zinc finger BED-type containing 8"	Q8IZ13	5	160393148-160400054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 12.6;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA045445, HPA055817"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA045445: AB_10959608, HPA055817: AB_2682933"	"unprognostic (1.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.47e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.96e-3)"	2.6	4.6	5.4	1.1	6.9	0.2	3.9	10.7	7.3	7.5	5.3	5.0	1.6	6.1	7.8	2.1	5.4	2.5	4.2	5.0	6.0	4.1	1.8	2.4	1.6	5.6	5.8	10.9	3.1	3.2	9.9	4.6	5.8	4.7	1.9	8.8	5.0	4.8	2.6	2.8	2.0	3.8	6.0	2.4	2.7	4.3	5.6	2.1	5.6	3.1	1.8	4.9	4.3	9.0	5.7	4.4	10.8	9.6	8.5	6.2	4.4	4.8	4.5	5.8	8.8	4.0	4.4	4.7	9.1	1.6	13.7	6.0	6.2	2.8	7.7	4.8	6.2	3.0	6.7	5.2	3.1	1.9	3.6	2.4	5.8	4.3	2.8	5.3	3.0	4.0	2.1	4.4	6.2	2.3	1.8	3.2	2.6	2.3	4.7	2.3	12.5	3.1	2.7	1.6	11.1	3.7	6.4	1.8	5.5	4.3	4.2	2.0	2.1	8.7	5.7	2.7	4.1	4.0	7.2	1.2	6.2	2.9	8.7	0.0	0.7	0.3	0.7	0.5	0.4	0.2	0.6	0.5	0.9	0.1	0.4	0.3	0.0	1.1	1.0	0.8	0.0	0.4	5.4	6.9	10.7	7.3	5.0	6.0	5.6	5.8	5.8	6.0	5.6	9.0	1.4	0.0	0.5	4.2	0.2	0.0	1.0	0.0	1.8	5.7	1.6	1.3	3.3	0.0	0.6	1.8	2.1	4.0	0.1	0.5	1.9	1.4	1.3	2.6	3.0	1.7	0.0	1.7	4.0	0.4	1.6	3.4	1.1	1.3	0.0	7.2	1.1	0.2	1.5	3.3	5.5	0.7	0.0	0.9	0.0	0.4	6.5	0.6	0.0	1.0	1.1	6.1	0.0	4.5	12.6	0.7	0.7	5.7	0.4	0.7	0.4	1.2	5.1	4.1	13.1	2.4	3.2	3.8	5.1	0.8	0.0	1.4	0.3	2.1	0.7	0.3
ZBED9	"Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452"	ENSG00000232040	"Zinc finger BED-type containing 9"	Q6R2W3	6	28570535-28616212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 27.2;Spermatocytes: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.7;hTCEpi: 4.4;K-562: 8.3;U-266/84: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA007246: AB_1080727"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.96e-2)"	"unprognostic (9.46e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.21e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	0.1	0.5	0.8	0.1	0.6	0.1	0.9	1.6	0.8	0.8	0.1	0.4	0.2	0.6	3.1	0.2	1.2	0.2	0.3	0.6	0.6	0.8	1.2	0.5	0.1	0.2	0.3	1.6	0.8	0.9	0.7	0.6	0.3	1.4	0.5	1.5	0.7	1.9	0.0	0.2	0.2	0.3	0.1	0.0	0.3	8.7	0.4	0.4	1.7	0.0	0.1	0.2	0.3	0.4	1.1	1.2	1.2	0.0	0.0	0.0	1.3	0.2	0.0	0.2	0.7	0.0	0.7	0.0	4.7	0.1	2.4	0.6	0.0	1.3	0.2	0.0	3.0	0.2	0.8	1.1	0.7	0.0	0.0	0.6	4.4	0.1	2.1	0.7	0.0	0.0	8.3	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.6	0.4	0.5	0.0	1.3	1.3	1.2	2.8	0.0	1.2	0.0	1.6	0.0	0.3	0.0	0.0	1.3	0.0	0.8	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.6	1.6	0.8	0.6	0.6	0.2	0.3	0.3	0.1	0.4	0.4	0.0	0.0	3.2	0.3	0.2	0.0	0.9	0.0	2.2	1.6	1.5	0.8	1.9	2.8	0.6	0.0	2.1	2.8	0.0	1.0	1.9	1.7	27.2	1.1	0.3	0.3	1.2	0.0	5.2	1.3	1.5	0.3	0.0	1.1	0.0	1.7	0.0	1.9	0.4	0.0	5.7	1.4	0.0	0.0	0.0	5.4	2.5	0.1	0.0	0.0	0.1	1.1	0.0	1.0	0.2	0.4	0.8	0.0	0.0	0.9	0.5	0.6	0.7	1.5	0.0	0.2	0.2	24.9	3.5	1.3	0.0	1.0	0.0	0.2	1.2	0.6
ZBTB1	"KIAA0997, ZNF909"	ENSG00000126804	"Zinc finger and BTB domain containing 1"	Q9Y2K1	14	64503712-64533690	"Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA repair, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050516, HPA054552, HPA075151"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA050516: AB_2681153, HPA054552: , HPA075151: "	"unprognostic (4.09e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.11e-3)"	"unprognostic (9.43e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.65e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.27e-2)"	24.0	15.2	14.2	28.9	17.1	83.1	25.8	15.8	16.6	21.1	17.8	21.4	16.9	20.5	26.9	15.9	24.8	21.2	16.9	15.0	14.2	17.9	22.1	22.3	44.1	16.5	15.6	21.5	17.8	20.8	18.0	24.0	16.8	24.2	22.2	20.8	18.5	17.9	22.6	34.7	23.9	19.3	16.3	34.8	21.0	12.4	17.7	38.5	27.9	21.3	35.8	21.9	20.2	19.8	56.2	18.4	40.5	25.4	41.1	49.3	41.5	23.8	35.4	22.0	27.9	17.9	38.7	53.5	23.2	33.8	17.2	38.4	19.9	23.6	30.0	79.7	13.5	26.1	35.9	15.1	25.8	21.9	36.7	63.7	40.6	15.3	22.6	48.3	25.8	33.8	13.1	35.7	41.2	42.5	38.0	22.0	16.9	28.8	27.5	33.7	25.0	20.7	38.3	67.1	28.2	22.6	38.9	29.0	32.7	39.0	27.9	27.9	34.4	36.6	24.7	17.7	16.7	44.6	20.6	59.6	36.9	20.6	24.5	42.5	13.6	23.1	18.8	13.1	21.4	14.8	16.6	20.9	14.6	14.3	16.8	20.8	10.4	19.9	19.1	9.1	25.6	16.4	14.2	17.1	15.8	16.6	15.0	14.2	16.5	15.6	16.8	16.3	17.7	19.8	19.8	16.0	12.7	65.6	56.9	31.7	17.0	29.7	40.9	11.5	14.4	13.7	11.9	8.6	22.3	9.2	12.5	8.0	115.7	9.2	9.8	13.2	83.0	40.0	41.5	24.7	22.1	20.8	40.6	8.6	13.7	26.5	19.9	30.2	28.5	18.8	19.2	8.4	15.2	6.7	58.1	12.1	30.5	23.0	73.5	38.0	15.8	50.5	30.2	58.1	13.8	7.7	22.6	40.2	96.3	16.2	8.3	18.4	48.3	15.2	6.0	6.6	27.8	8.4	6.6	20.4	27.9	2.2	4.5	23.7	24.2	7.8	78.7	23.5	10.9	19.2
ZBTB10	"FLJ12752, RINZF"	ENSG00000205189	"Zinc finger and BTB domain containing 10"	Q96DT7	8	80485619-80526265	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 142.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021554, HPA050569"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA021554: AB_1858937, HPA050569: AB_2681179"	"unprognostic (7.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.40e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.63e-2)"	7.9	7.9	4.1	4.8	5.2	23.7	8.2	12.1	4.4	8.7	3.9	6.9	2.0	11.2	6.1	3.7	11.8	7.4	7.5	3.3	5.1	10.2	18.5	6.2	5.3	4.9	4.4	12.7	14.0	7.1	3.5	17.8	5.0	14.1	7.8	7.3	7.6	6.3	5.4	1.9	2.2	8.9	4.3	7.0	4.6	11.2	4.7	8.6	10.1	8.0	3.4	5.5	3.3	5.7	0.0	4.2	21.1	10.7	9.1	6.9	28.5	3.9	0.0	3.0	3.0	9.2	3.4	12.7	11.0	5.8	9.2	0.9	16.7	5.3	3.5	0.0	26.8	6.5	2.8	7.3	5.3	2.2	2.9	6.5	4.6	3.7	10.6	2.5	7.7	10.5	5.9	24.2	2.5	6.7	12.6	5.5	5.3	1.3	6.6	14.7	11.1	4.5	8.4	12.5	12.6	14.6	5.2	48.5	14.8	23.6	9.4	9.1	9.9	7.3	13.5	0.1	3.6	7.0	3.7	14.0	2.8	0.0	9.1	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.4	0.3	0.3	0.0	0.5	0.2	0.9	0.0	0.0	4.1	5.2	12.1	4.4	3.3	5.1	4.9	4.4	5.0	4.3	4.7	5.7	37.1	25.6	17.0	18.9	55.3	28.4	21.1	8.1	44.3	13.4	48.8	39.8	36.1	25.8	11.8	12.9	16.7	38.3	34.1	38.9	3.9	13.1	83.7	82.4	60.6	34.5	60.4	3.0	12.8	6.9	41.0	29.3	40.8	142.6	9.5	37.0	16.8	31.7	13.3	32.0	11.1	43.0	20.3	21.3	79.6	29.7	19.3	32.0	49.8	13.1	11.2	20.8	8.2	19.6	13.4	8.3	14.8	21.1	24.5	82.1	0.4	14.5	19.4	10.6	26.3	46.6	49.5	14.6	10.6	13.6	12.6	105.2	28.4	19.6	34.7	19.6
ZBTB11	"ZNF-U69274, ZNF913"	ENSG00000066422	"Zinc finger and BTB domain containing 11"	O95625	3	101648889-101677132	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015328, HPA024138"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015328: AB_1858938, HPA024138: AB_1858939"	"unprognostic (3.25e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.86e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.09e-1)"	7.3	7.2	6.1	10.6	7.0	38.0	10.0	11.8	10.3	8.2	5.9	6.7	8.3	9.8	7.2	7.6	6.8	7.4	5.6	6.9	5.9	7.3	9.6	8.2	13.5	5.6	6.0	10.4	9.6	9.9	5.5	9.2	6.2	8.1	7.6	12.4	9.2	6.7	9.1	12.4	7.2	7.1	6.6	13.1	7.8	10.5	6.3	13.7	8.4	10.0	12.7	8.6	6.8	10.0	14.8	16.5	10.7	14.0	16.7	16.3	18.7	14.4	14.2	13.0	14.3	15.0	10.0	18.1	11.4	11.0	11.6	18.0	16.3	16.4	23.3	18.8	11.3	40.1	15.8	14.1	12.8	28.8	14.2	13.1	20.8	12.1	27.8	11.6	13.0	20.6	23.7	21.2	14.1	18.4	25.5	12.8	10.1	15.7	24.0	20.6	16.7	22.1	12.2	17.4	31.0	11.4	18.7	15.0	19.1	6.5	19.1	15.3	14.7	19.6	14.2	8.2	14.5	24.2	21.7	33.4	12.2	18.6	13.9	6.7	3.7	4.2	3.6	4.6	4.7	2.9	3.1	4.0	4.6	3.8	3.5	3.0	2.4	3.0	7.3	2.7	3.8	2.8	6.1	7.0	11.8	10.3	6.9	5.9	5.6	6.0	6.2	6.6	6.3	10.0	19.0	32.1	20.8	12.7	28.2	46.4	20.0	8.4	51.8	14.2	21.4	17.4	12.1	10.0	19.3	1.8	33.3	10.2	40.3	14.0	0.0	6.6	3.2	44.7	50.4	20.1	20.2	12.4	32.7	5.5	7.5	19.4	15.8	70.2	8.8	13.7	13.2	10.3	7.9	21.9	28.2	14.5	14.2	23.0	24.4	3.9	8.4	25.9	19.6	12.2	20.3	12.0	21.6	15.1	27.6	7.6	4.4	14.3	32.6	18.3	8.2	6.2	20.1	22.8	6.6	25.0	19.1	25.5	21.8	50.0	49.0	16.8	34.1	14.3	14.2	24.1
ZBTB12	"C6orf46, D6S59E, G10, NG35"	ENSG00000204366	"Zinc finger and BTB domain containing 12"	Q9Y330	6	31899613-31902086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 4.6;Erythroid cells: 2.5;Horizontal cells: 3.3;Oligodendrocytes: 2.2;Rod photoreceptor cells: 1.7;Squamous epithelial cells: 1.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.5;HEK 293: 3.1;NTERA-2: 2.5;REH: 4.6;U-266/84: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047161, HPA070639"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA047161: AB_2679962, HPA070639: "	"unprognostic (2.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.39e-2)"	"unprognostic (8.98e-3)"	1.8	2.8	0.6	0.0	0.6	0.0	1.9	0.5	0.7	5.7	0.0	2.7	0.0	5.0	0.0	2.7	4.1	0.1	1.7	0.5	0.3	1.9	1.3	1.5	0.0	0.7	0.7	6.4	2.1	0.0	2.2	0.0	0.6	3.2	0.0	0.0	2.4	0.0	2.0	1.5	2.4	0.0	0.6	2.4	2.1	2.3	0.7	0.0	2.5	0.0	0.0	4.2	3.1	1.1	1.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.1	1.1	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.5	0.2	2.5	0.0	1.2	4.6	0.3	0.2	0.0	0.0	1.1	1.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.1	1.4	3.1	0.6	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	0.7	0.5	0.3	0.7	0.7	0.6	0.6	0.7	1.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.8	0.3	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.4	0.0	2.5	0.4	0.0	0.0	0.2	0.5	0.2	0.0	1.0	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	1.7	0.0	0.3	1.1	0.0	0.0	1.5	0.0	0.0	0.2	0.5	0.1	0.1
ZBTB14	"ZFP161, ZNF478"	ENSG00000198081	"Zinc finger and BTB domain containing 14"	O43829	18	5289019-5297053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050758, HPA070819"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA050758: AB_2681226, HPA070819: AB_2686316"	"unprognostic (5.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.72e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.90e-2)"	10.3	8.6	9.3	14.7	10.5	9.6	12.5	11.4	12.2	9.6	7.4	10.4	8.7	9.9	16.4	12.4	10.6	12.0	8.6	8.7	9.6	11.2	13.4	11.1	24.7	9.5	10.3	15.6	14.4	12.0	4.8	9.1	9.6	9.8	10.0	7.3	12.2	12.1	8.5	14.0	9.3	8.7	10.2	16.2	11.9	5.9	9.5	21.8	15.5	8.4	21.8	9.6	5.2	11.4	9.0	11.8	15.1	11.2	11.0	14.5	10.0	8.8	13.0	12.0	10.5	11.3	11.5	31.2	7.6	10.7	13.9	8.2	11.2	13.2	12.2	6.0	6.0	12.4	11.1	10.5	7.8	15.8	14.4	11.6	10.9	8.5	7.9	13.0	19.2	22.3	8.1	10.1	12.4	9.9	23.8	10.5	13.4	11.1	6.0	14.0	9.7	9.2	10.0	10.8	13.3	13.0	13.4	8.8	14.3	15.0	10.5	17.9	10.7	15.6	12.8	12.2	13.3	6.4	6.9	19.9	16.4	13.3	14.0	9.8	5.5	14.1	8.7	7.8	8.6	7.5	11.0	10.0	8.2	10.4	11.6	11.1	1.2	7.6	7.5	6.1	7.6	7.3	9.3	10.5	11.4	12.2	8.7	9.6	9.5	10.3	9.6	10.2	9.5	11.4	8.8	6.4	6.7	5.9	8.5	2.4	1.6	2.9	5.2	7.4	5.6	4.3	3.6	1.5	2.2	5.5	0.0	5.3	6.3	5.5	5.9	4.9	0.8	4.3	5.5	7.4	1.2	9.1	2.9	3.3	5.5	4.6	0.5	3.7	15.9	6.0	11.7	6.9	7.1	5.0	3.1	5.1	8.2	7.5	4.5	2.8	5.9	6.3	1.8	1.0	7.8	10.8	6.2	2.5	6.6	3.5	4.0	5.7	2.2	2.4	5.7	5.5	2.5	5.9	0.0	6.0	5.7	1.0	9.3	4.2	3.0	2.2	8.8	5.1	5.2	1.5
ZBTB18	"C2H2-171, RP58, TAZ-1, ZNF238"	ENSG00000179456	"Zinc finger and BTB domain containing 18"	Q99592	1	244048939-244057476	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 172.8;skeletal muscle: 85.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.8;Muller glia cells: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 217.5"	"HPA024656, HPA074019"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA024656: , HPA074019: "	"unprognostic (3.48e-3)"	"unprognostic (9.17e-3)"	"unprognostic (3.69e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (6.83e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-3)"	"prognostic favorable (6.78e-6)"	9.8	6.3	36.2	14.9	45.4	28.2	9.0	172.8	57.5	7.4	20.3	9.2	13.2	7.2	18.5	5.8	8.6	7.4	12.2	66.1	13.5	11.9	19.0	10.0	18.2	18.0	18.1	7.2	24.6	6.2	4.9	9.4	24.7	10.1	10.8	42.2	10.6	11.5	85.5	8.3	14.6	6.1	19.0	20.2	11.4	22.3	18.9	41.9	8.4	37.5	15.7	10.0	5.4	29.8	23.7	8.2	31.2	1.2	4.0	4.1	21.7	13.0	9.6	20.5	12.4	6.3	18.7	17.9	1.2	25.2	6.6	2.4	20.1	6.4	25.5	6.4	17.7	3.0	3.1	3.0	6.3	3.8	9.1	3.5	5.3	12.3	7.7	24.7	22.5	19.3	2.3	7.5	24.5	0.3	31.4	15.2	16.1	7.3	3.6	9.1	21.2	5.1	13.1	8.0	45.8	44.6	5.4	0.2	14.8	13.0	0.4	27.2	33.7	10.5	12.9	6.5	28.0	3.2	0.4	7.0	10.6	11.6	21.6	0.1	0.2	1.3	0.1	0.3	0.1	0.6	0.2	0.2	0.3	0.9	0.5	0.3	2.3	0.1	0.6	0.9	0.2	0.1	36.2	45.4	172.8	57.5	66.1	13.5	18.0	18.1	24.7	19.0	18.9	29.8	18.5	9.6	18.5	37.2	16.2	11.2	3.3	5.0	8.0	6.1	32.6	6.1	22.2	8.6	10.0	18.4	12.5	1.5	8.2	10.5	0.0	4.5	3.8	18.2	3.3	15.3	19.3	0.0	51.8	5.1	2.0	3.8	10.7	11.0	6.3	5.1	12.8	44.3	6.1	6.7	19.8	16.1	18.3	25.4	26.7	5.0	2.1	16.1	3.6	15.0	13.9	52.1	2.1	21.6	20.8	8.5	7.9	4.9	2.2	5.2	6.6	12.0	17.4	27.6	13.1	10.9	6.2	9.8	7.7	8.7	19.7	1.0	7.2	1.7	14.8	4.2
ZBTB2	"bA351K16.2, KIAA1483, ZNF437"	ENSG00000181472	"Zinc finger and BTB domain containing 2"	Q8N680	6	151364115-151391559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023136, HPA023137, HPA023458, HPA023487"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945"	"unprognostic (1.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.73e-2)"	8.4	4.8	4.8	8.5	5.1	16.1	8.5	6.0	6.3	6.9	4.5	8.0	7.5	8.5	6.9	5.9	7.7	7.9	6.0	5.2	5.1	6.9	9.4	9.7	14.4	5.4	5.3	13.3	8.3	7.1	3.0	8.7	5.4	6.1	9.0	3.2	7.1	5.9	9.1	6.9	8.2	9.4	5.0	9.3	7.4	6.7	5.2	20.8	29.7	9.7	12.6	11.0	5.4	6.6	15.3	10.9	16.3	12.4	17.1	17.9	17.4	23.6	33.9	29.2	27.7	21.1	12.2	38.9	12.8	23.9	29.5	17.8	26.5	28.7	36.1	17.7	19.7	17.5	12.6	32.2	25.3	47.9	20.8	19.0	16.9	26.8	32.6	16.6	17.4	18.1	32.5	22.2	20.8	34.2	26.1	22.3	19.8	18.8	16.4	24.6	15.4	15.6	22.2	22.7	18.1	12.6	18.6	24.2	18.8	16.3	16.3	28.4	14.4	24.5	26.8	11.3	31.8	29.4	32.9	43.2	10.1	25.7	17.8	18.7	6.5	16.8	11.3	7.1	14.2	6.3	10.2	13.5	7.1	4.5	8.4	10.4	7.3	8.9	12.9	2.9	9.2	7.1	4.8	5.1	6.0	6.3	5.2	5.1	5.4	5.3	5.4	5.0	5.2	6.6	13.3	9.6	4.6	4.6	13.2	15.7	11.4	5.8	42.7	3.0	14.4	7.4	8.8	5.7	9.1	0.0	0.0	5.9	18.0	4.6	13.7	4.8	9.4	18.7	14.2	12.7	9.0	8.2	5.6	2.9	19.6	9.9	6.6	29.5	9.5	4.9	5.7	3.3	7.5	1.7	4.4	6.3	18.3	8.8	17.4	10.5	8.7	10.8	10.6	1.0	4.4	3.1	12.3	5.5	11.1	5.0	2.0	4.1	11.1	14.8	5.8	5.3	7.1	2.3	6.6	6.2	10.8	4.1	6.7	23.8	18.3	12.4	16.3	3.7	7.3	9.6
ZBTB20	"DKFZp566F123, DPZF, ODA-8S, ZNF288"	ENSG00000181722	"Zinc finger and BTB domain containing 20"	Q9HC78	3	114314500-115147288	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1998.0;Microglial cells: 855.4;Oligodendrocyte precursor cells: 1908.5;Oligodendrocytes: 2090.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015551, HPA016815"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"		"HPA015551: AB_2669217, HPA016815: AB_1858947"	"unprognostic (1.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.81e-1)"	4.1	3.9	24.5	1.1	43.8	2.5	3.4	66.5	43.7	3.4	5.7	1.7	0.8	3.6	9.6	1.2	2.4	2.3	3.5	65.9	30.9	5.2	5.4	1.8	1.8	43.8	42.6	6.8	3.4	2.3	1.4	1.0	32.9	5.4	1.4	8.5	3.0	4.9	7.9	2.3	0.8	2.9	29.9	2.5	1.7	15.8	39.4	1.9	5.0	8.9	1.7	1.6	0.7	41.1	1.4	2.7	1.0	2.8	4.2	1.8	0.0	1.3	2.5	0.8	0.6	1.7	0.5	0.4	3.7	3.2	0.8	0.0	4.0	0.6	0.7	0.3	0.1	0.4	1.7	1.3	0.8	0.1	0.0	1.8	0.2	1.4	0.4	2.4	0.8	0.2	0.1	0.6	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	3.4	0.0	2.9	0.0	0.3	0.7	0.5	0.0	0.9	0.1	0.0	0.3	4.8	1.0	3.5	0.2	1.8	0.9	0.0	0.1	1.7	0.2	1.3	9.7	1.5	6.4	6.8	2.3	4.6	20.4	6.4	6.4	1.9	11.3	8.3	6.8	3.5	5.3	4.6	4.9	3.6	3.5	24.5	43.8	66.5	43.7	65.9	30.9	43.8	42.6	32.9	29.9	39.4	41.1	278.1	160.3	122.6	1998.0	115.4	25.7	38.2	11.3	22.2	123.6	103.7	81.8	48.5	108.7	25.2	294.3	60.5	0.2	56.1	10.3	49.0	231.4	450.3	109.8	628.3	106.4	31.8	20.4	72.3	82.9	0.6	174.5	36.7	170.5	80.6	194.5	56.0	106.0	4.3	80.8	462.3	14.5	40.7	20.4	28.5	111.1	105.6	36.0	32.0	855.4	29.3	127.7	36.0	1908.5	2090.4	107.8	10.5	120.7	58.4	28.0	19.2	198.4	36.4	108.6	85.5	301.2	124.6	6.9	8.7	14.2	18.5	0.5	67.4	140.7	17.2	25.0
ZBTB21	"KIAA1227, ZNF295"	ENSG00000173276	"Zinc finger and BTB domain containing 21"	Q9ULJ3	21	41986831-42010387	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 41.2"	"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 60.4;U-266/84: 57.0"	"Low region specificity"	"Detected in all"							"HPA024655, HPA031757, HPA031758"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032"	"unprognostic (1.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.02e-1)"	8.9	35.6	3.2	6.0	3.6	41.2	8.1	4.6	5.6	7.9	2.2	5.7	4.0	13.7	7.1	6.5	6.6	11.9	4.6	3.9	7.2	6.5	11.2	6.9	5.1	5.3	7.2	8.5	9.4	14.0	4.8	6.9	5.0	7.8	4.9	14.2	4.1	4.2	2.5	8.8	4.7	8.5	2.2	6.5	6.5	12.2	5.3	6.4	9.5	3.1	5.4	9.6	5.1	5.4	12.8	10.0	9.6	10.9	13.3	10.2	9.3	11.6	16.6	10.9	16.5	12.0	6.2	22.5	5.1	11.6	19.6	9.5	14.1	8.2	17.6	11.9	13.9	2.6	10.3	7.3	10.2	8.9	5.2	5.9	17.2	15.2	19.9	4.8	6.2	12.2	15.1	38.0	7.8	18.6	24.0	4.3	9.5	9.3	12.3	10.1	10.7	26.4	4.8	10.1	13.6	7.9	16.1	23.8	11.2	4.8	8.5	4.2	7.0	16.0	8.9	11.3	11.5	60.4	57.0	20.9	21.0	14.5	10.6	0.1	2.4	1.2	1.6	2.8	1.9	2.6	1.8	1.3	2.4	1.9	2.6	1.9	2.3	0.5	3.2	2.1	1.3	1.2	3.2	3.6	4.6	5.6	3.9	7.2	5.3	7.2	5.0	2.2	5.3	5.4	19.0	6.4	41.1	8.1	24.7	60.0	32.9	6.2	26.2	14.5	15.6	15.9	4.9	12.8	12.4	7.3	2.1	6.7	20.8	7.1	11.7	5.4	14.0	20.8	34.8	19.6	4.2	2.1	13.8	5.0	5.5	31.9	10.2	27.1	16.5	6.7	9.3	20.4	6.1	32.0	15.5	10.2	10.2	6.3	24.8	5.3	4.1	14.5	35.6	5.6	7.2	10.1	5.2	4.5	8.1	3.9	6.0	10.5	20.3	24.7	5.4	4.8	13.5	13.6	6.6	36.1	21.0	21.5	14.1	19.3	63.2	9.7	20.8	7.3	5.6	20.9
ZBTB22	"BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A"	ENSG00000236104	"Zinc finger and BTB domain containing 22"	O15209	6	33314406-33317942	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043848			Approved	Nucleoplasm		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA043848: AB_10961146"	"unprognostic (1.32e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.54e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.32e-3)"	10.2	15.1	1.2	2.6	1.2	2.1	11.3	1.1	3.5	15.6	0.7	10.4	4.7	15.6	8.5	13.3	12.6	1.7	10.6	1.2	0.9	11.9	10.1	12.0	1.1	2.1	1.3	14.9	12.2	11.6	10.5	2.3	1.4	12.1	4.2	5.7	12.0	3.8	8.6	19.2	11.6	3.0	1.5	13.7	11.8	6.1	1.0	5.3	15.1	3.9	3.9	12.0	13.2	1.4	0.3	0.3	8.5	4.4	8.3	3.3	3.5	7.5	7.3	7.1	4.6	0.1	1.9	1.9	5.6	12.5	9.1	0.6	0.3	4.6	5.2	11.7	2.8	7.5	4.4	4.1	0.0	0.0	2.8	10.8	10.0	0.3	2.6	9.8	0.7	6.3	2.9	7.8	2.6	4.7	4.6	6.7	0.0	0.4	2.2	0.5	0.1	4.2	6.3	0.4	9.7	0.6	0.7	0.4	4.3	5.0	0.7	0.4	10.7	3.9	4.5	0.2	0.2	4.3	4.5	1.9	5.6	1.1	4.3	0.8	0.2	0.8	0.3	0.3	0.1	0.5	0.4	0.2	0.2	0.3	0.7	0.1	0.3	0.1	0.2	0.4	0.1	0.2	1.2	1.2	1.1	3.5	1.2	0.9	2.1	1.3	1.4	1.5	1.0	1.4	9.4	0.0	5.0	2.6	7.3	6.4	16.3	6.0	8.6	20.1	9.9	7.6	4.3	4.3	4.9	7.3	8.4	6.3	3.3	9.8	23.5	11.0	1.6	8.3	5.2	7.7	7.7	4.0	2.8	7.1	4.6	6.7	5.6	6.9	3.8	6.5	7.9	2.0	5.3	20.2	2.8	8.7	12.2	4.4	4.0	1.8	9.3	5.3	1.8	3.7	12.1	18.2	8.2	3.5	2.6	6.5	8.6	6.4	4.0	10.9	7.6	8.3	6.0	21.2	13.1	10.0	7.6	2.2	2.0	8.1	7.4	10.1	4.9	8.0	5.8	11.8
ZBTB24	"BIF1, KIAA0441, PATZ2, ZNF450"	ENSG00000112365	"Zinc finger and BTB domain containing 24"	O43167	6	109462594-109483219	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017872, HPA049003"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Centrosome"		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Cytokinetic bridge, Centrosome"	"HPA017872: AB_2669673, HPA049003: AB_2680596"	"unprognostic (8.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.77e-2)"	3.1	2.2	1.5	5.4	2.4	8.9	4.6	2.4	2.4	4.0	1.0	3.5	3.6	3.1	3.2	3.0	2.9	2.5	2.2	1.6	1.9	3.9	2.6	3.9	8.7	1.5	1.2	3.4	3.5	7.4	1.8	3.2	1.6	3.5	3.8	10.1	4.4	3.3	3.2	4.7	3.7	2.8	1.3	5.5	4.1	4.3	1.6	6.9	4.9	2.9	7.3	3.5	2.7	2.9	4.7	4.8	4.3	10.8	6.8	6.9	7.0	5.3	7.3	6.5	7.4	6.7	3.6	20.0	6.7	6.7	7.8	6.0	10.9	8.3	9.8	12.4	10.7	16.2	6.5	5.1	5.0	13.3	8.0	7.0	6.7	6.6	11.4	4.6	5.5	9.3	13.8	11.0	6.8	8.0	19.2	9.0	10.7	4.7	5.3	11.9	6.1	8.3	8.0	8.0	7.3	6.4	6.8	7.1	16.9	5.9	5.0	14.5	5.4	5.3	5.3	4.4	11.5	5.3	4.4	20.2	7.0	10.4	9.0	0.1	0.6	0.9	0.7	0.6	0.4	3.4	1.5	0.9	0.7	2.8	1.9	1.1	0.4	1.3	0.8	1.1	2.9	0.5	1.5	2.4	2.4	2.4	1.6	1.9	1.5	1.2	1.6	1.3	1.6	2.9	8.4	12.8	9.1	2.6	32.8	10.1	11.2	5.3	7.4	21.7	8.6	7.4	3.8	7.2	5.2	3.7	31.3	8.5	16.8	4.5	3.9	6.6	1.4	7.3	14.3	6.6	9.6	12.0	3.3	9.1	9.9	8.6	12.8	10.7	9.5	14.1	3.6	7.3	7.7	10.1	2.8	11.0	6.1	12.5	12.1	1.8	7.2	10.3	8.8	5.6	20.5	10.0	14.4	1.0	5.4	6.4	5.1	6.4	16.8	8.2	7.4	6.4	6.0	65.2	0.0	13.2	7.4	6.2	27.8	9.3	9.7	7.8	17.8	15.0	8.5	7.3
ZBTB25	"C14orf51, KUP, ZNF46"	ENSG00000089775	"Zinc finger and BTB domain containing 25"	P24278	14	64449106-64505213	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054699	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA054699: AB_2682579"	"unprognostic (1.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.32e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-1)"	6.6	6.1	6.5	8.3	7.9	7.6	6.1	8.8	8.5	7.3	6.5	7.4	3.6	6.1	8.3	4.1	8.4	5.4	11.0	7.1	6.2	4.8	6.9	6.9	11.1	8.7	7.3	8.0	6.7	6.2	9.0	4.3	8.0	6.7	4.9	11.1	4.7	4.8	11.2	7.7	7.8	5.6	7.3	8.4	5.1	6.4	8.8	12.7	8.8	8.9	11.1	7.6	6.5	11.0	20.2	8.7	5.6	5.4	8.0	10.0	11.2	3.4	6.1	5.5	7.2	4.0	13.8	14.9	3.9	5.7	6.9	18.1	5.7	5.7	6.7	15.6	1.8	3.4	14.1	1.9	9.2	2.3	7.6	12.8	5.5	5.4	10.7	11.7	5.1	14.0	2.1	23.7	6.6	8.7	8.5	3.5	2.9	7.1	8.9	6.5	6.2	6.4	6.3	9.4	5.5	6.0	7.1	5.3	4.5	5.2	6.8	1.8	5.5	7.5	11.2	3.5	5.2	20.9	5.1	6.7	11.1	3.0	5.7	3.8	2.4	1.6	6.5	1.6	8.6	6.6	9.3	6.4	1.7	3.9	10.7	10.8	2.4	7.0	1.4	2.9	8.9	7.5	6.5	7.9	8.8	8.5	7.1	6.2	8.7	7.3	8.0	7.3	8.8	11.0	7.2	6.4	13.0	15.3	25.1	7.9	8.4	13.9	12.5	19.4	7.1	7.6	19.2	8.6	7.8	7.3	18.8	7.1	19.3	2.3	9.8	8.5	47.9	15.6	9.4	8.7	3.5	14.1	23.1	6.6	9.8	10.8	6.1	7.6	6.3	11.9	7.1	10.9	10.8	8.4	28.1	2.6	8.2	11.1	19.1	54.1	13.4	12.6	17.8	15.9	10.5	7.5	27.8	26.7	37.0	7.2	3.7	10.9	19.3	6.3	3.8	7.7	15.4	22.4	0.0	12.5	10.2	11.9	11.8	7.7	8.4	4.0	33.2	8.7	4.6	5.9
ZBTB33	"kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348"	ENSG00000177485	"Zinc finger and BTB domain containing 33"	Q86T24	X	120250752-120258398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000755, CAB001980, HPA005732"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166"	"unprognostic (9.14e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.59e-2)"	6.4	7.0	6.4	8.5	7.0	19.5	15.4	7.1	9.0	6.8	4.7	6.8	7.7	6.2	9.4	9.9	8.2	7.3	4.9	6.4	9.2	6.4	19.0	8.7	13.2	7.3	8.7	9.7	8.4	13.7	4.8	8.8	8.5	7.4	6.5	5.7	10.4	6.0	5.4	18.8	6.4	4.8	8.4	11.5	8.6	5.7	9.3	16.2	10.2	7.7	12.8	8.0	4.8	9.7	13.6	12.9	19.6	18.1	15.9	17.8	23.4	10.3	13.5	11.7	14.5	9.0	11.7	19.5	18.8	10.4	15.7	20.7	31.9	15.7	15.3	22.0	21.6	20.3	20.3	12.7	11.6	21.2	22.7	12.7	19.9	11.2	17.6	17.1	20.9	18.7	13.5	23.2	14.6	15.6	19.2	14.1	24.3	20.9	15.3	21.9	14.9	32.0	12.5	22.2	35.6	15.2	20.9	21.3	25.3	14.9	11.5	29.6	19.6	9.5	6.9	14.3	18.5	12.7	13.1	24.7	12.6	29.4	11.9	11.5	4.2	5.6	2.9	6.4	5.0	2.4	3.8	3.9	6.2	2.2	4.6	3.4	0.9	4.0	4.2	6.7	3.5	3.6	6.4	7.0	7.1	9.0	6.4	9.2	7.3	8.7	8.5	8.4	9.3	9.7	15.7	16.0	7.0	3.9	7.9	12.7	7.8	5.1	12.5	4.5	11.5	13.1	5.2	8.6	11.9	1.8	0.0	7.7	21.7	5.3	1.9	5.5	0.1	12.9	8.7	8.5	8.4	10.3	3.4	6.7	8.7	7.9	7.1	10.3	0.0	16.0	7.9	16.6	7.6	3.3	4.6	7.0	6.1	12.8	10.3	0.4	4.4	8.2	3.6	3.7	14.6	7.0	14.4	5.0	4.6	6.9	5.7	2.6	5.4	9.5	6.8	4.0	15.3	1.6	6.6	6.9	4.1	5.0	10.0	12.7	13.1	9.3	8.7	11.2	6.0	11.9
ZBTB34	"KIAA1993, MGC24652, ZNF918"	ENSG00000177125	"Zinc finger and BTB domain containing 34"	Q8NCN2	9	126860665-126885878	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023893	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA023893: AB_2219180"	"unprognostic (2.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-3)"	"unprognostic (6.59e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.01e-2)"	3.8	2.7	4.9	4.3	6.1	14.7	3.7	7.6	5.3	3.1	2.8	3.5	3.0	3.6	3.1	3.2	3.2	3.9	3.1	4.2	4.8	3.3	2.9	5.3	4.8	5.9	6.2	3.6	3.2	3.7	3.5	6.7	5.6	3.0	2.9	12.7	4.4	2.9	3.3	4.1	3.7	3.1	5.4	5.4	3.8	3.0	6.0	4.8	3.5	4.8	4.6	3.3	3.1	6.8	2.6	3.5	9.9	4.1	7.6	7.6	13.8	3.1	4.6	3.6	4.0	8.3	4.8	5.0	3.3	3.3	3.3	7.9	12.1	3.1	3.6	5.2	5.0	5.7	9.8	4.4	5.3	7.9	9.1	6.7	4.9	4.2	4.8	4.7	4.8	8.6	12.3	3.9	3.4	3.7	5.1	6.6	8.7	4.9	2.6	9.5	11.5	5.2	4.7	3.8	3.1	10.7	4.1	3.6	5.6	8.9	3.6	11.6	5.2	3.3	6.0	4.7	3.4	6.8	8.5	4.2	3.0	6.4	3.2	0.7	0.3	1.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.1	1.4	0.4	0.2	0.3	0.0	0.1	4.9	6.1	7.6	5.3	4.2	4.8	5.9	6.2	5.6	5.4	6.0	6.8	5.6	3.2	4.6	5.2	1.3	5.4	2.5	1.6	2.8	6.8	5.9	3.9	2.2	2.8	3.5	1.8	6.2	3.8	3.8	5.6	1.9	2.4	8.4	2.1	4.0	5.4	1.8	3.0	6.9	1.6	3.1	4.7	4.1	4.8	0.0	3.7	6.8	4.1	7.8	8.4	8.1	4.1	2.0	13.6	8.4	31.8	6.8	7.2	5.4	7.5	8.3	2.1	2.1	7.1	12.4	3.2	5.0	0.7	1.7	4.4	4.0	2.5	2.3	12.7	0.0	4.5	5.6	4.0	2.5	3.8	8.2	3.3	2.2	2.1	2.4	4.7
ZBTB37	"MGC2629, ZNF908"	ENSG00000185278	"Zinc finger and BTB domain containing 37"	Q5TC79	1	173868082-173903549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 12.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.2;Late spermatids: 67.0;Rod photoreceptor cells: 60.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023438	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA023438: AB_1858954"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.96e-2)"	3.0	1.6	4.6	2.6	7.5	5.7	2.6	6.3	4.6	2.8	2.1	1.9	1.8	2.1	2.3	1.4	2.1	1.6	2.0	4.4	4.6	2.2	2.1	2.7	3.8	8.6	6.3	3.3	2.0	1.8	2.6	2.1	9.2	2.3	1.6	10.8	2.0	1.4	1.8	3.2	2.3	1.8	4.4	3.8	2.3	9.3	6.4	3.2	2.7	2.2	3.0	2.0	2.3	12.7	1.7	2.5	3.8	1.6	2.3	1.8	4.2	1.5	1.1	2.7	1.9	3.2	2.1	4.6	3.1	2.4	1.4	2.1	3.2	1.7	2.2	2.6	2.0	6.4	3.0	1.6	1.3	3.8	3.9	1.7	1.1	4.0	2.6	1.6	1.4	3.2	5.7	3.0	2.8	1.2	2.6	0.9	3.6	1.3	0.6	1.7	3.3	1.5	1.5	4.2	2.8	3.5	2.1	2.9	2.8	4.0	4.2	3.9	2.5	3.5	3.7	1.7	2.4	5.3	4.2	7.3	2.3	2.1	2.1	0.1	0.4	1.4	1.1	0.4	0.4	0.2	0.5	0.7	0.2	0.6	0.2	0.6	2.3	0.9	0.4	0.9	0.4	0.3	4.6	7.5	6.3	4.6	4.4	4.6	8.6	6.3	9.2	4.4	6.4	12.7	8.5	6.4	6.3	2.0	9.7	2.9	3.7	3.6	4.0	27.2	5.7	2.8	9.2	12.8	4.2	11.0	33.3	8.3	11.9	4.6	7.9	3.6	60.2	9.1	8.8	6.8	3.5	5.7	1.6	3.8	3.9	7.4	5.1	7.6	2.5	16.9	11.0	4.7	5.0	18.5	2.1	3.9	0.0	15.4	5.5	67.0	8.7	10.0	10.6	2.8	10.6	10.3	18.6	3.5	5.3	2.8	2.7	13.2	5.7	4.3	4.7	5.4	10.6	60.1	6.6	9.5	10.8	23.2	13.2	3.2	5.8	9.2	9.3	11.6	3.6	3.4
ZBTB38	"CIBZ, FLJ35036, PPP1R171, ZNF921"	ENSG00000177311	"Zinc finger and BTB domain containing 38"	Q8NAP3	3	141324213-141449792	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 284.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 261.2;RPMI-8226: 395.1;U-266/70: 259.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014865, HPA059378"			Enhanced	Nucleoplasm		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA014865: AB_2732412, HPA059378: AB_2683998"	"unprognostic (1.78e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.04e-1)"	27.1	42.3	7.7	30.4	14.4	11.3	25.4	34.1	18.1	47.8	11.9	39.1	28.8	65.5	20.3	26.8	32.3	47.3	42.1	9.8	9.6	34.1	24.2	31.7	34.4	11.8	12.8	38.2	33.6	53.5	8.3	34.8	13.9	28.1	40.8	39.0	33.0	33.9	55.1	16.7	31.5	56.0	8.0	23.9	29.2	30.1	14.0	14.3	38.0	31.0	38.7	35.0	11.6	28.3	56.4	82.0	9.3	18.7	84.8	79.4	12.5	89.0	106.7	84.6	122.8	43.0	32.4	1.9	36.1	78.1	65.7	15.5	10.8	75.4	191.5	54.5	15.2	15.8	74.4	25.2	94.0	1.0	22.4	60.1	43.8	89.9	180.6	137.8	65.6	1.5	16.9	261.2	96.9	6.0	1.0	3.5	9.7	15.7	10.1	1.1	27.5	395.1	54.3	34.3	3.6	13.7	130.7	12.4	46.0	16.4	26.8	13.8	159.5	68.5	17.5	134.9	42.2	259.7	163.4	19.8	116.7	1.8	38.5	27.9	5.5	15.2	25.9	8.2	19.3	16.6	16.7	26.4	8.1	7.2	12.9	21.0	6.3	24.1	7.2	3.9	24.4	11.5	7.7	14.4	34.1	18.1	9.8	9.6	11.8	12.8	13.9	8.0	14.0	28.3	70.7	76.9	64.6	38.2	48.0	20.4	33.8	36.3	24.5	89.8	44.0	41.1	114.8	64.3	61.2	58.8	75.0	32.6	66.5	57.8	29.4	39.3	284.2	63.4	107.9	81.2	36.0	17.7	115.4	31.8	17.0	59.3	35.2	125.9	68.9	40.0	59.3	34.9	32.6	141.3	107.9	37.0	24.4	23.4	43.1	118.6	70.5	37.9	39.2	65.6	70.8	59.3	55.6	56.8	105.3	69.6	37.0	103.0	221.9	36.8	38.9	51.1	46.6	73.3	118.3	71.9	106.9	9.4	11.4	19.0	18.6	124.9	88.4	35.6	82.5	43.5
ZBTB4	"KAISO-L1, KIAA1538, ZNF903"	ENSG00000174282	"Zinc finger and BTB domain containing 4"	Q9P1Z0	17	7459366-7484263	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008980, HPA064763"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB008980: , HPA064763: AB_2685347"	"unprognostic (2.23e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.65e-9)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.04e-3)"	34.8	36.1	22.1	7.4	20.6	3.0	31.4	19.9	23.1	41.9	11.7	47.2	6.3	40.3	16.2	26.4	40.5	9.6	38.8	21.2	21.0	24.1	7.8	30.0	8.3	27.1	21.7	48.4	23.1	36.1	28.6	10.8	27.0	33.1	6.6	23.1	28.0	21.4	32.4	27.2	23.0	16.4	19.7	22.1	27.3	15.9	23.3	9.5	43.9	14.8	9.0	42.3	33.9	21.5	10.7	14.4	3.6	6.9	37.1	19.1	6.5	14.7	21.0	13.0	12.9	4.8	5.1	1.1	11.4	28.0	9.5	16.7	3.6	20.6	9.5	17.0	6.2	5.3	12.3	3.4	10.4	1.0	12.2	13.4	21.1	12.5	15.9	30.6	11.5	4.0	1.8	3.4	14.5	7.1	3.7	2.2	1.5	4.3	6.8	6.8	6.2	1.6	15.9	8.9	2.1	5.3	6.5	4.6	6.9	6.3	8.6	2.4	16.1	14.6	5.7	13.9	12.3	6.1	4.5	0.7	15.7	3.3	7.7	0.4	0.3	0.5	1.0	0.5	1.0	0.5	0.8	0.8	0.2	0.5	1.0	1.0	0.2	0.6	1.7	0.4	0.4	0.6	22.1	20.6	19.9	23.1	21.2	21.0	27.1	21.7	27.0	19.7	23.3	21.5	27.4	51.3	53.1	33.6	14.6	30.7	16.3	18.4	18.8	86.6	23.6	20.6	92.6	20.0	24.8	20.2	68.8	10.3	24.5	4.6	3.9	14.4	40.8	21.1	25.2	26.1	17.4	9.5	36.9	14.4	2.2	24.8	7.1	26.0	13.9	25.7	23.9	8.1	13.5	74.0	37.3	10.1	14.2	30.0	34.6	57.0	51.9	18.6	17.8	15.9	12.0	27.0	24.7	21.6	26.7	19.0	5.3	70.0	9.5	16.2	8.2	11.2	32.2	39.9	32.9	37.8	27.4	7.3	4.3	17.3	23.4	5.2	21.1	16.3	9.0	14.7
ZBTB40	"KIAA0478, ZNF923"	ENSG00000184677	"Zinc finger and BTB domain containing 40"	Q9NUA8	1	22428838-22531157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042386			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA042386: AB_10794649"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.78e-8)"	"unprognostic (8.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.34e-2)"	9.1	15.2	6.7	10.9	8.1	8.9	8.1	7.6	7.0	9.7	10.0	10.0	7.8	9.7	7.1	6.4	10.0	8.5	7.5	6.8	7.2	7.4	6.3	8.6	14.2	8.1	8.4	10.7	12.3	8.8	10.6	5.9	7.8	10.1	8.3	12.5	8.2	7.0	10.4	8.3	14.5	7.0	9.9	17.4	9.9	7.3	7.7	9.9	9.5	7.8	15.0	9.6	6.7	9.9	8.6	10.0	15.7	16.6	11.1	9.7	15.2	7.1	8.2	11.4	12.6	8.9	10.8	10.3	8.9	8.6	8.9	10.6	15.6	7.7	13.5	13.3	13.1	22.1	20.0	10.3	9.6	12.4	20.5	7.9	11.1	14.5	10.9	8.5	9.6	13.7	23.5	0.1	9.0	6.4	8.4	16.1	9.7	7.0	8.0	14.7	11.9	11.5	5.4	9.2	12.7	10.8	14.4	10.4	6.1	10.1	19.1	10.2	12.0	13.3	11.2	14.6	7.3	6.5	9.7	9.8	8.0	15.1	9.6	1.0	0.5	0.3	1.0	1.2	1.3	0.8	0.8	0.8	0.8	1.1	0.8	1.0	0.1	2.9	0.5	0.5	1.4	0.4	6.7	8.1	7.6	7.0	6.8	7.2	8.1	8.4	7.8	9.9	7.7	9.9	7.6	12.8	16.7	12.1	12.2	5.7	3.1	4.2	8.0	15.0	7.0	5.0	11.8	8.6	11.7	1.8	31.3	4.6	11.0	3.6	1.9	5.2	4.6	8.9	10.8	8.0	16.2	3.4	15.0	7.4	4.5	7.0	6.6	6.0	16.4	21.1	4.2	3.4	4.8	11.8	20.1	5.1	8.2	5.7	5.7	6.7	5.9	8.1	14.2	25.3	4.1	5.6	13.4	18.6	24.1	6.4	8.2	6.8	12.4	4.8	4.7	2.6	8.8	22.7	13.1	11.9	9.6	7.2	8.2	6.9	4.1	2.9	13.3	13.5	5.8	3.5
ZBTB41	"DKFZp686C06120, FLJ36199, FRBZ1, ZNF924"	ENSG00000177888	"Zinc finger and BTB domain containing 41"	Q5SVQ8	1	197153682-197201293	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034841, HPA034842"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA034841: AB_2674355, HPA034842: AB_10669995"	"unprognostic (2.36e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.01e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.58e-1)"	3.5	4.7	5.0	3.0	4.7	1.3	7.0	6.6	5.8	5.2	2.2	3.2	3.2	4.2	4.7	3.4	3.7	4.3	3.2	4.6	5.8	5.3	4.4	3.4	3.9	5.5	6.1	6.8	4.0	4.8	3.9	3.3	5.6	4.2	3.5	7.0	3.9	3.4	3.6	3.5	2.9	3.2	6.0	4.4	4.3	3.8	5.8	5.2	7.5	4.7	3.3	3.9	2.4	6.9	8.1	4.6	5.8	4.7	9.0	13.6	4.6	4.8	7.8	4.9	4.6	2.9	6.7	3.0	6.8	10.9	3.0	6.5	4.1	4.1	7.7	2.7	2.4	2.4	6.0	2.6	8.0	4.8	2.3	5.6	10.6	5.0	8.6	10.0	3.4	3.4	5.7	3.5	12.8	3.9	3.6	2.7	2.3	5.6	1.6	2.5	8.1	5.4	6.0	4.5	8.3	7.4	8.6	14.9	9.3	4.2	11.4	3.6	5.6	9.7	5.6	7.8	6.3	4.0	2.2	3.2	4.6	1.7	13.8	0.3	0.1	0.1	0.2	0.1	0.4	0.4	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.4	0.1	0.1	0.2	0.1	5.0	4.7	6.6	5.8	4.6	5.8	5.5	6.1	5.6	6.0	5.8	6.9	11.6	19.2	8.9	21.2	9.4	7.5	6.9	5.8	11.4	13.6	17.5	10.7	14.7	10.0	10.0	16.5	2.1	4.3	10.6	4.2	1.9	6.3	3.2	14.5	18.0	8.2	13.1	1.7	32.1	5.7	4.0	13.3	7.7	11.3	1.3	18.5	6.8	9.2	4.4	25.2	27.9	7.3	2.0	7.3	5.2	4.6	15.5	8.1	12.4	13.1	9.3	28.5	11.3	19.6	41.0	6.8	2.9	12.0	6.3	9.4	4.3	10.4	12.8	9.1	6.6	13.3	12.7	7.0	4.9	10.8	10.1	3.4	7.7	16.0	7.0	6.0
ZBTB42	ZNF925	ENSG00000179627	"Zinc finger and BTB domain containing 42"	B2RXF5	14	104800596-104804712	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 11.7;Exocrine glandular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"eosinophil: 5.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.3;MCF7: 33.7;T-47d: 26.9"	"Not detected"	"Not detected"							HPA066961	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA066961: AB_2685756"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.99e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (2.30e-9)"	"unprognostic (1.34e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-3)"	"unprognostic (5.45e-2)"	2.3	3.5	1.1	1.7	1.1	0.3	3.3	1.0	0.9	1.7	1.5	3.0	3.2	2.2	1.8	4.8	4.5	1.8	4.5	0.9	1.2	4.1	5.5	4.3	1.4	1.8	1.4	1.1	11.5	2.2	1.0	1.1	1.3	6.2	1.8	0.4	6.3	3.3	6.5	2.6	2.9	1.4	1.4	2.2	6.5	2.4	1.2	1.4	4.7	2.6	1.3	2.3	2.2	1.0	1.3	4.4	1.3	5.3	1.0	1.1	5.4	1.9	2.0	3.4	3.0	2.8	5.1	0.4	3.7	1.9	2.3	5.8	1.1	1.8	0.5	19.3	1.3	1.8	2.3	3.3	1.6	0.4	10.3	2.0	2.1	1.4	0.7	2.4	1.5	3.8	3.0	2.9	0.6	33.7	3.6	2.8	0.8	8.9	4.0	5.0	0.3	2.7	2.5	8.6	5.9	2.5	1.5	7.9	3.4	1.2	26.9	2.1	2.4	1.3	3.0	0.3	0.6	3.1	1.8	0.3	4.3	1.8	2.8	0.0	0.1	5.4	0.3	0.0	0.5	0.4	0.4	0.1	0.0	0.4	0.3	0.4	0.0	0.1	0.0	0.4	0.3	0.2	1.1	1.1	1.0	0.9	0.9	1.2	1.8	1.4	1.3	1.4	1.2	1.0	3.1	3.2	11.7	0.3	1.2	0.4	5.0	1.9	1.2	0.3	8.1	3.4	4.4	5.7	8.2	0.0	0.0	1.2	1.1	4.3	3.9	4.2	2.6	2.3	1.2	2.6	5.4	4.4	0.0	13.5	1.9	1.1	3.1	3.9	0.0	2.3	2.5	7.3	1.1	0.0	0.0	6.4	2.0	2.5	0.6	0.9	0.6	0.9	1.8	0.0	0.8	2.8	5.2	0.5	0.0	7.5	3.2	0.4	0.7	6.9	3.4	4.3	3.1	0.4	0.0	1.5	1.6	8.4	3.4	3.4	0.1	0.8	1.8	0.5	4.9	5.1
ZBTB43	"FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B"	ENSG00000169155	"Zinc finger and BTB domain containing 43"	O43298	9	126805006-126838210	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016825	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA016825: AB_1858959"	"unprognostic (1.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.14e-1)"	"unprognostic (5.41e-3)"	"prognostic favorable (8.73e-4)"	"unprognostic (6.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.13e-2)"	5.3	5.4	4.5	4.7	5.3	60.6	5.9	6.3	6.8	5.0	9.0	4.6	5.2	5.7	4.4	9.5	4.1	5.3	10.6	4.7	4.9	3.9	7.9	8.3	5.6	4.1	5.1	6.1	4.9	9.5	4.6	5.2	4.5	4.4	5.8	9.3	6.0	3.5	32.8	14.4	4.8	5.0	3.5	5.0	7.0	16.2	5.0	5.9	5.3	20.2	6.4	5.1	6.4	6.3	6.3	4.7	8.5	7.8	7.0	9.9	8.7	8.0	8.0	6.3	5.6	11.0	4.3	8.7	3.9	8.4	12.4	18.4	7.5	8.0	7.8	7.6	5.0	6.0	14.6	4.9	9.6	8.6	11.0	12.1	20.2	10.2	25.0	6.0	4.9	7.1	10.6	19.8	9.4	6.8	7.5	5.4	7.8	6.7	8.0	6.3	27.4	7.1	6.8	7.2	7.5	6.9	8.5	8.5	7.8	7.6	7.6	5.4	4.7	7.6	7.1	8.4	7.0	21.0	16.4	3.3	9.4	7.0	6.3	12.0	4.5	3.9	7.0	4.3	6.8	4.2	3.8	4.1	3.7	3.3	4.1	4.8	2.5	6.7	3.5	2.0	6.1	3.3	4.5	5.3	6.3	6.8	4.7	4.9	4.1	5.1	4.5	3.5	5.0	6.3	16.5	35.3	44.7	34.0	23.4	84.9	68.2	37.5	30.7	42.2	36.0	19.9	42.7	27.1	46.1	27.6	108.4	18.2	30.6	80.2	1.9	31.1	91.2	51.7	35.0	25.1	11.4	21.4	44.2	18.5	12.3	27.7	78.5	133.6	31.0	23.7	17.5	25.3	14.7	26.9	40.5	21.6	40.7	21.7	74.1	45.3	17.7	46.4	24.9	12.2	18.3	29.3	21.6	25.6	37.3	43.4	51.5	14.3	27.2	54.9	33.5	7.9	27.7	55.7	13.1	39.4	29.3	49.7	73.1	70.8	117.3	52.0	31.8	22.4	25.6	141.7
ZBTB44	"BTBD15, HSPC063, ZNF851"	ENSG00000196323	"Zinc finger and BTB domain containing 44"	Q8NCP5	11	130226677-130314917	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052589	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA052589: AB_2681874"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.03e-2)"	"unprognostic (7.60e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.34e-1)"	"unprognostic (8.45e-3)"	"unprognostic (6.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.78e-2)"	13.0	11.2	14.0	10.5	16.4	12.8	15.6	21.3	13.8	12.6	9.1	11.3	8.8	12.0	17.5	11.5	14.6	8.7	11.3	13.2	12.2	25.4	14.1	11.5	15.7	10.4	13.6	15.8	11.4	16.0	8.2	12.6	10.8	10.6	9.8	16.7	14.2	11.6	36.9	14.6	10.9	9.4	11.1	14.3	10.4	36.9	15.0	25.3	13.4	31.4	16.4	12.3	12.0	16.5	14.0	9.1	13.6	12.4	18.9	18.4	14.9	8.3	14.7	7.5	9.4	15.7	42.5	44.0	42.8	14.0	18.4	14.0	19.1	18.0	12.7	37.8	11.6	65.3	10.2	9.7	11.2	34.2	47.2	12.3	19.2	12.8	27.8	15.9	11.5	26.3	18.6	63.8	8.5	11.1	33.4	24.2	12.0	21.1	13.6	21.8	12.1	15.0	21.4	14.2	28.4	12.1	24.4	16.3	6.5	12.9	29.8	26.9	12.8	15.3	13.5	6.9	9.5	12.2	19.4	40.0	4.0	42.4	14.1	0.7	0.7	0.9	2.0	0.8	1.3	1.1	1.2	1.2	0.8	1.3	1.0	1.2	2.0	1.5	0.6	1.6	1.6	0.4	14.0	16.4	21.3	13.8	13.2	12.2	10.4	13.6	10.8	11.1	15.0	16.5	32.6	25.6	39.4	33.0	42.9	72.1	33.9	33.8	46.7	44.4	56.6	41.4	49.3	40.0	28.6	77.3	58.4	34.0	61.6	18.3	19.6	26.6	56.5	47.9	38.7	33.8	19.3	55.2	50.5	20.4	18.6	40.2	16.3	85.3	10.2	56.6	38.6	43.4	14.9	20.2	48.5	26.8	24.4	42.5	29.9	58.3	73.7	30.0	23.2	39.4	33.6	23.2	104.0	64.3	125.7	21.4	16.9	79.0	27.1	51.7	27.7	69.7	30.5	37.6	39.5	64.4	26.5	103.4	61.6	39.8	82.1	26.8	40.2	42.3	33.1	40.9
ZBTB46	"BTBD4, BZEL, FLJ13502, RINZF, ZNF340"	ENSG00000130584	"Zinc finger and BTB domain containing 46"	Q86UZ6	20	63743668-63832038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 28.6;Excitatory neurons: 26.0;Hepatic stellate cells: 28.9;Microglial cells: 45.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013997, HPA048051"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA013997: AB_1858961, HPA048051: "	"unprognostic (1.11e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (3.87e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.12e-1)"	8.4	5.0	5.1	2.2	4.7	1.2	7.5	13.9	5.5	8.0	4.3	2.5	1.2	7.2	4.5	2.1	7.7	2.5	10.7	4.3	5.5	9.1	4.7	5.8	3.5	4.3	3.5	12.2	3.2	2.2	10.0	4.1	3.9	4.5	0.7	4.1	2.9	2.6	3.7	2.4	3.4	1.8	3.4	16.6	2.7	3.9	5.1	1.3	9.8	3.7	1.2	3.5	3.4	3.0	1.6	0.6	6.9	1.9	0.4	0.8	3.6	0.4	2.7	0.4	0.2	1.8	4.7	0.2	7.2	0.1	1.5	1.2	0.4	0.1	0.4	0.5	1.7	0.3	1.0	3.3	1.8	0.5	1.0	0.4	0.1	0.1	0.0	0.8	0.8	0.2	2.4	0.5	1.5	4.1	0.1	9.7	1.0	1.9	2.4	1.8	2.4	2.9	0.5	1.1	7.2	1.7	0.7	3.9	0.5	3.8	4.0	5.7	0.1	4.1	2.4	1.7	0.6	1.2	3.3	0.4	0.2	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	4.7	13.9	5.5	4.3	5.5	4.3	3.5	3.9	3.4	5.1	3.0	28.6	0.0	1.1	14.4	0.8	0.4	1.3	2.0	1.2	4.7	2.6	2.0	10.8	1.5	2.8	1.8	18.8	4.3	0.6	1.0	0.0	1.6	0.6	1.5	11.2	14.5	1.2	4.0	26.0	0.6	0.9	5.1	0.0	1.6	2.5	0.1	28.9	0.3	3.0	1.7	6.9	0.0	4.1	3.8	14.6	2.3	8.1	4.2	1.8	45.0	1.7	3.9	0.0	12.1	2.0	2.3	0.1	8.6	0.5	2.6	0.2	1.3	1.7	10.1	0.0	2.2	8.0	0.7	1.9	0.3	0.4	3.7	0.5	13.4	0.2	2.0
ZBTB47	"DKFZp434N0615, KIAA1190, ZNF651"	ENSG00000114853	"Zinc finger and BTB domain containing 47"	Q9UFB7	3	42653697-42667580	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.9;Inhibitory neurons: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5;fHDF/TERT166: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074057	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA074057: AB_2686657"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.86e-2)"	"unprognostic (8.99e-2)"	"prognostic favorable (7.96e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.10e-2)"	23.2	13.7	74.4	9.3	69.3	2.7	17.9	52.6	65.3	21.5	32.9	29.3	3.9	23.0	4.5	11.5	15.2	11.4	70.3	61.0	54.0	9.4	6.2	14.0	2.7	70.5	63.8	15.3	13.4	9.9	12.3	6.2	58.2	23.5	3.3	6.5	17.4	14.5	112.5	16.4	11.2	14.8	59.9	7.2	18.7	9.1	70.8	2.0	19.4	63.1	1.8	23.7	15.9	81.2	6.7	5.9	3.6	2.4	55.5	20.7	1.2	15.1	12.7	6.5	4.7	1.3	2.7	0.1	6.4	30.9	2.5	1.6	0.9	5.9	1.2	0.0	7.2	3.7	18.9	1.6	17.5	0.1	5.3	23.5	10.4	8.5	7.1	17.0	7.3	0.0	3.9	4.8	12.9	1.7	0.2	0.5	2.1	0.2	3.5	5.0	6.7	1.9	3.4	1.3	4.0	6.7	7.3	1.2	6.0	1.5	8.3	8.6	17.3	14.1	8.2	13.9	6.4	0.2	0.0	0.0	13.1	4.8	4.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.1	74.4	69.3	52.6	65.3	61.0	54.0	70.5	63.8	58.2	59.9	70.8	81.2	1.8	0.0	1.1	21.9	0.0	4.0	1.5	3.6	3.4	6.4	0.8	0.9	10.5	0.0	1.8	1.8	0.0	0.1	1.6	0.1	0.0	0.7	10.0	0.5	4.5	2.1	0.0	0.0	7.8	1.3	0.2	6.4	4.6	1.2	4.5	2.9	2.2	0.7	1.4	0.0	11.8	0.3	2.0	1.9	4.1	2.5	3.4	2.0	8.8	8.4	0.8	7.7	0.0	9.0	11.5	0.6	1.2	3.0	1.9	2.0	0.0	0.6	1.1	1.9	0.0	7.8	4.4	0.0	0.2	1.3	3.1	0.1	0.4	5.9	0.0	1.1
ZBTB48	"HKR3, TZAP, ZNF855"	ENSG00000204859	"Zinc finger and BTB domain containing 48"	P10074	1	6579994-6589280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030417	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030417: AB_10603145"	"unprognostic (6.66e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.15e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.19e-6)"	"unprognostic (7.73e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	10.1	10.9	6.7	13.3	7.3	14.2	10.8	6.9	8.6	15.4	9.3	10.7	11.8	11.0	11.9	11.9	13.1	11.2	8.5	7.2	7.2	11.5	21.2	11.1	14.1	7.1	7.7	16.5	11.6	13.3	11.9	10.5	7.2	15.5	12.4	6.9	11.5	10.0	10.2	14.1	11.5	10.6	6.5	16.0	12.4	25.5	7.8	16.9	14.2	14.2	15.0	12.0	13.0	8.5	6.5	7.2	12.1	17.8	13.0	10.1	6.1	6.3	7.5	12.2	12.8	8.1	14.8	20.8	11.1	5.7	8.1	12.4	18.3	12.8	9.3	21.6	16.5	17.0	24.1	7.9	15.1	28.0	45.2	10.0	9.5	11.9	18.9	16.1	8.9	16.0	17.5	13.2	9.0	12.0	14.0	20.0	9.2	12.7	12.9	15.5	11.3	23.4	10.6	5.3	23.4	10.7	9.7	22.3	15.1	12.1	12.7	22.2	9.9	8.3	5.3	9.1	8.3	14.7	13.8	33.2	7.7	22.0	5.1	20.0	10.5	42.3	8.3	6.5	8.5	9.1	6.5	8.1	11.5	10.5	8.7	7.8	14.6	10.6	10.7	7.7	5.9	8.4	6.7	7.3	6.9	8.6	7.2	7.2	7.1	7.7	7.2	6.5	7.8	8.5	7.7	3.2	12.3	10.4	13.0	4.7	9.3	13.3	3.4	8.0	7.8	8.0	5.8	11.5	10.0	11.0	6.2	6.1	12.5	15.1	11.7	4.7	61.8	10.1	7.1	6.1	15.5	3.4	7.5	3.6	5.1	6.8	23.4	6.5	26.6	10.1	7.1	15.1	10.8	10.1	6.6	15.5	14.2	7.6	5.4	19.1	8.7	11.2	5.4	4.7	9.2	11.1	9.2	4.0	5.5	3.1	14.6	5.7	6.6	5.6	22.6	12.6	18.3	7.8	19.7	10.5	8.2	34.5	14.8	5.3	5.5	5.1	9.9	13.6	10.0	6.5
ZBTB49	"FLJ38559, ZNF509"	ENSG00000168826	"Zinc finger and BTB domain containing 49"	Q6ZSB9	4	4290251-4321786	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024450	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Microtubules, Cytosol"	"HPA024450: AB_1859311"	"unprognostic (4.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.54e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.88e-5)"	2.3	1.8	0.8	2.2	0.7	5.1	2.4	1.0	1.6	2.4	1.1	2.1	1.6	2.2	2.4	1.8	1.9	1.9	2.3	0.8	0.8	1.8	1.9	2.4	3.0	0.9	0.7	3.7	2.9	2.1	3.1	2.0	1.2	2.8	1.6	3.4	2.2	2.2	2.9	2.2	1.9	2.3	0.4	3.5	1.7	4.0	1.0	2.0	2.9	2.1	3.0	2.4	2.1	2.3	1.4	2.2	2.7	4.6	3.6	3.7	3.2	1.6	3.2	3.6	2.8	1.9	2.6	4.9	1.7	1.9	4.4	2.3	4.8	2.8	3.7	1.6	1.9	5.7	1.5	2.8	2.8	3.5	2.0	2.4	2.3	3.3	2.1	2.0	3.6	5.2	3.0	2.6	3.4	2.2	6.9	6.7	4.7	2.0	3.0	4.1	3.6	3.1	1.4	2.4	3.3	3.2	3.7	1.4	3.7	3.6	2.0	3.3	3.6	3.2	1.4	2.0	3.7	3.1	3.3	4.3	2.3	2.9	3.2	2.9	2.0	9.8	4.6	2.1	3.8	1.6	2.6	4.5	1.5	2.4	2.9	3.4	4.6	2.8	1.8	0.3	2.6	1.5	0.8	0.7	1.0	1.6	0.8	0.8	0.9	0.7	1.2	0.4	1.0	2.3	3.1	0.0	1.1	3.9	5.3	2.5	1.9	1.8	2.2	2.9	2.2	3.4	1.9	1.5	2.1	1.8	4.2	2.0	5.8	0.8	0.0	1.9	2.7	1.2	2.7	3.1	1.2	3.6	11.5	2.6	1.5	3.1	2.0	1.3	1.3	5.4	3.9	2.2	1.8	1.7	12.5	1.8	2.0	3.1	2.4	0.7	1.5	2.7	3.6	4.7	4.5	1.7	9.2	11.6	10.0	1.1	2.9	2.2	6.6	2.1	1.8	0.9	1.3	8.2	0.0	2.2	2.1	9.7	5.5	1.7	2.6	1.5	6.3	4.6	1.6	1.2
ZBTB5	KIAA0354	ENSG00000168795	"Zinc finger and BTB domain containing 5"	O15062	9	37438102-37465450	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021521	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA021521: AB_2670736"	"unprognostic (2.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.81e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.80e-1)"	4.9	6.2	4.9	5.6	5.8	13.6	7.4	5.9	5.0	6.3	5.0	6.1	6.3	6.3	7.7	17.8	5.9	5.4	5.5	4.7	5.0	7.4	12.9	7.9	9.0	5.7	5.3	8.4	8.4	7.6	4.7	6.2	5.5	7.2	5.8	9.2	7.8	6.7	5.2	11.9	7.2	5.3	5.0	7.2	7.2	8.8	5.2	9.5	10.3	7.2	12.1	5.6	9.3	7.8	9.3	10.5	26.6	16.6	6.7	4.7	11.4	7.5	5.8	9.0	7.4	7.8	6.7	18.8	7.9	5.6	6.6	11.1	17.5	6.2	6.9	13.9	9.1	6.9	28.7	9.1	6.5	8.6	5.8	4.5	15.5	4.5	9.5	10.2	10.2	14.8	16.6	15.6	6.8	5.9	18.2	6.3	6.8	10.0	5.3	16.3	12.8	7.2	8.7	8.2	12.2	21.9	7.3	11.7	5.8	13.3	18.7	8.3	7.0	6.3	17.3	3.7	7.2	8.3	9.8	16.3	5.8	7.3	6.8	0.1	0.4	0.0	0.6	0.2	0.7	0.9	0.5	0.5	0.8	0.7	0.8	0.9	0.0	0.3	0.0	0.2	0.5	0.3	4.9	5.8	5.9	5.0	4.7	5.0	5.7	5.3	5.5	5.0	5.2	7.8	4.0	16.0	6.5	12.7	5.1	14.3	8.8	5.0	11.4	2.0	8.4	6.6	3.2	7.2	9.3	1.8	6.2	3.9	3.7	6.5	0.0	4.0	2.2	7.3	4.2	5.6	8.4	2.1	8.9	3.2	2.2	4.2	5.1	7.3	1.3	6.6	3.6	8.6	2.4	13.5	9.1	5.2	4.1	1.9	4.8	5.3	4.1	3.4	3.6	10.3	3.7	3.3	1.0	13.6	15.5	4.1	3.7	3.8	4.2	12.6	3.1	3.5	6.0	5.1	0.0	5.4	4.0	7.5	7.9	17.9	18.2	5.7	2.7	4.4	5.1	8.2
ZBTB6	"ZID, ZNF482"	ENSG00000186130	"Zinc finger and BTB domain containing 6"	Q15916	9	122908056-122913323	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054111, HPA076894"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Mitochondria	"HPA054111: AB_2682384, HPA076894: AB_2686818"	"unprognostic (9.74e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.84e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.31e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.92e-2)"	4.2	4.4	3.4	7.0	3.9	3.2	6.8	5.2	5.8	5.4	2.8	5.3	5.9	6.3	4.0	4.9	5.0	4.0	5.5	3.4	3.6	4.8	4.2	4.5	9.7	3.5	3.6	7.2	4.5	6.6	2.3	4.5	3.8	4.9	4.8	7.3	4.5	4.7	6.7	5.0	5.8	4.7	4.1	6.7	5.5	5.5	3.5	7.3	7.5	7.0	9.2	5.3	2.6	5.3	5.1	5.9	9.3	8.5	9.6	9.2	9.4	8.4	10.3	8.3	7.3	6.1	6.3	8.1	5.1	7.6	7.4	22.8	9.8	10.3	10.3	11.5	7.8	8.6	11.9	5.7	9.5	11.4	14.9	7.6	15.5	7.6	12.5	10.2	7.7	10.1	9.2	9.7	12.1	9.6	11.6	7.7	11.7	15.0	9.9	6.1	25.6	11.4	8.7	8.3	11.7	15.2	13.0	12.6	8.2	9.8	15.8	7.4	7.9	9.0	7.0	9.2	9.8	17.0	21.7	2.2	10.5	7.7	9.3	10.6	1.5	2.3	1.2	1.7	1.7	1.4	1.7	1.2	1.6	1.0	2.4	2.2	2.0	2.5	2.9	0.9	2.0	1.7	3.4	3.9	5.2	5.8	3.4	3.6	3.5	3.6	3.8	4.1	3.5	5.3	5.3	6.4	3.6	3.6	6.8	2.2	3.1	2.9	3.4	8.0	4.1	2.9	3.5	7.2	6.9	1.8	10.4	2.3	7.2	3.5	0.0	2.7	9.1	4.4	7.6	4.4	3.0	2.1	4.6	2.5	1.3	5.4	4.1	3.7	7.6	5.0	6.1	3.1	2.4	6.7	5.1	3.9	4.1	7.6	4.0	4.4	3.1	4.1	1.8	3.7	4.3	8.8	2.1	6.6	6.8	2.9	2.5	7.9	3.7	4.1	2.9	4.2	5.3	10.6	6.6	5.1	5.2	6.0	5.1	4.9	2.7	1.9	5.8	5.0	3.4	3.2
ZBTB7A	"DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A"	ENSG00000178951	"Zinc finger and BTB domain containing 7A"	O95365	19	4043303-4066899	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037214, CAB037285, HPA046387"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 47: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB037214: AB_609875, CAB037285: AB_609874, HPA046387: AB_2679648"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (6.50e-6)"	"unprognostic (7.54e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.34e-6)"	"prognostic favorable (1.79e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.36e-2)"	15.2	13.2	23.0	8.7	23.1	12.8	12.9	12.0	58.3	16.6	1.7	22.5	16.3	20.0	3.3	39.1	15.4	5.8	14.0	29.4	13.7	9.8	15.0	13.7	6.6	19.8	13.7	12.0	9.5	8.9	13.4	4.9	19.0	13.5	6.4	8.1	16.2	7.3	33.7	25.9	17.5	4.8	6.8	13.3	18.9	4.4	25.0	5.7	12.7	10.4	5.6	18.9	21.2	28.1	26.5	13.5	2.1	7.5	16.5	17.2	9.3	19.2	11.0	5.0	5.2	4.9	10.7	12.4	12.4	13.7	6.9	23.1	2.7	8.9	4.3	23.4	13.2	7.1	10.2	6.3	11.7	10.1	25.2	9.5	14.5	6.9	7.1	10.6	5.7	5.5	14.4	10.2	5.7	18.3	13.1	7.6	5.5	11.8	16.9	9.8	6.3	12.4	8.0	11.7	9.8	7.4	11.6	24.8	11.5	1.8	13.9	17.9	18.0	19.2	9.3	26.6	24.4	23.6	10.6	6.9	24.7	10.3	12.3	0.7	0.9	0.3	0.7	1.1	0.5	1.1	0.3	0.5	0.2	0.6	0.3	0.6	1.5	1.2	1.0	0.7	0.3	0.2	23.0	23.1	12.0	58.3	29.4	13.7	19.8	13.7	19.0	6.8	25.0	28.1	76.3	41.7	32.8	27.4	73.1	88.5	69.7	26.5	175.2	104.7	73.5	57.4	26.6	104.4	27.7	42.3	54.2	22.6	93.7	185.8	27.4	20.9	5.5	66.4	63.8	64.5	47.9	118.0	39.0	20.2	10.7	54.1	77.5	67.6	26.6	21.6	72.8	67.9	23.6	159.9	35.5	115.6	8.2	72.9	80.7	7.7	44.1	74.3	37.4	25.3	52.1	32.7	76.2	17.6	34.2	33.1	98.0	49.2	71.6	83.6	68.0	19.9	31.0	72.8	32.9	80.0	60.2	3.8	1.8	181.1	113.9	53.8	74.9	36.5	136.3	113.0
ZBTB7B	"c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B"	ENSG00000160685	"Zinc finger and BTB domain containing 7B"	O15156	1	155002630-155018522	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.2;Proximal enterocytes: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006811, HPA025820"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA006811: AB_1859046, HPA025820: AB_1859045"	"unprognostic (5.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.53e-2)"	24.9	35.3	12.9	18.1	15.8	30.0	27.9	15.8	12.9	25.3	11.7	55.4	61.9	16.1	6.4	95.4	17.9	11.0	25.2	11.2	13.6	19.7	48.4	25.0	16.2	18.3	17.5	12.7	29.9	15.6	20.0	9.0	17.3	30.5	18.6	6.5	40.2	12.8	40.6	111.9	71.2	9.9	15.8	31.6	37.7	6.1	17.7	9.0	25.5	17.6	15.2	20.4	44.4	17.9	16.5	29.0	2.5	8.8	12.7	7.2	34.7	11.1	13.1	11.4	13.2	19.5	23.4	7.2	19.5	12.6	9.1	24.5	8.1	15.7	2.4	39.4	9.1	12.0	51.4	13.1	18.6	9.2	31.7	9.4	54.8	15.6	19.3	15.3	9.1	1.1	17.3	32.2	6.7	31.2	0.2	20.7	8.7	26.4	23.8	6.8	1.9	45.6	17.2	16.9	16.1	16.5	21.4	56.5	8.9	10.6	35.2	30.7	7.7	7.4	12.9	14.8	9.5	38.1	25.1	7.6	17.3	30.3	8.6	0.4	1.5	1.3	0.6	1.4	0.2	0.6	0.7	0.3	0.9	0.7	0.6	0.2	2.3	0.7	1.2	0.0	1.0	2.5	12.9	15.8	15.8	12.9	11.2	13.6	18.3	17.5	17.3	15.8	17.7	17.9	6.5	9.6	0.0	11.1	8.5	35.2	9.3	8.8	29.6	13.6	35.2	15.6	2.6	18.6	7.1	5.5	2.1	11.9	6.9	135.2	11.7	13.3	4.3	15.4	6.7	5.6	6.7	6.1	1.0	15.1	14.6	4.9	27.5	21.3	5.7	2.8	6.1	29.9	14.8	16.8	1.1	32.7	14.2	28.7	40.3	8.3	9.0	20.7	16.0	4.7	25.8	5.4	11.3	0.0	8.6	16.8	57.7	7.2	6.8	24.9	158.5	10.0	4.2	10.3	0.0	3.2	5.7	0.5	1.2	51.7	53.6	27.5	11.3	4.4	38.5	24.4
ZBTB8B	"DKFZp547H154, RP1-27O5.1, ZNF916B"	ENSG00000273274	"Zinc finger and BTB domain containing 8B"	Q8NAP8	1	32465072-32496686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Langerhans cells: 4.7;Oligodendrocyte precursor cells: 9.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RT4: 1.0"									"HPA055553, HPA071427"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA055553: AB_2682848, HPA071427: "	"unprognostic (8.32e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.83e-5)"	"unprognostic (1.86e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.67e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.88e-3)"	0.0	0.1	1.6	0.1	1.1	0.4	0.1	0.8	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.0	1.9	0.0	0.0	0.0	0.1	1.2	1.9	0.1	0.1	0.1	0.6	0.1	1.1	0.1	0.0	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.1	0.0	0.2	1.8	0.0	0.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.9	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	1.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.2	0.1	0.0	1.6	1.1	0.8	1.2	1.0	1.9	1.2	1.9	1.1	0.4	1.8	0.8	0.4	0.0	1.8	0.3	0.2	1.7	1.1	0.1	0.0	2.6	0.3	0.5	0.8	0.0	0.7	0.0	6.2	1.9	1.4	0.3	0.0	0.0	2.1	0.5	1.6	0.7	0.0	0.0	0.8	0.0	1.3	0.8	0.0	0.5	3.8	2.8	0.7	0.2	0.4	3.3	2.2	0.0	0.0	0.3	4.7	2.1	0.6	0.7	1.8	1.9	0.0	1.4	1.0	9.0	0.4	0.0	0.0	0.0	0.3	0.9	0.0	0.1	1.5	2.4	0.0	1.6	0.7	2.2	1.5	0.0	0.6	0.3	0.7	0.9	0.0	0.9
ZBTB9	"MGC23166, ZNF919"	ENSG00000213588	"Zinc finger and BTB domain containing 9"	Q96C00	6	33453970-33457544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.5;Ionocytes: 6.1;Respiratory ciliated cells: 4.3;Suprabasal keratinocytes: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 11.6;BEWO: 11.3;GAMG: 16.5;HMC-1: 14.2;U-698: 12.0"	"Low region specificity"	"Detected in all"							"HPA036767, HPA058171"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA036767: AB_10696787, HPA058171: "	"unprognostic (1.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.85e-4)"	"unprognostic (4.20e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.95e-1)"	2.8	3.9	0.9	1.5	1.0	1.7	2.3	0.8	1.6	2.5	8.6	2.4	2.3	2.6	1.7	3.8	2.5	0.6	3.0	1.9	0.7	4.4	3.2	2.4	1.9	1.2	0.9	3.0	2.9	0.6	10.0	0.5	0.6	2.4	1.4	1.9	2.9	0.1	1.8	3.8	2.7	0.8	0.2	3.5	2.7	7.4	0.4	0.2	2.2	1.0	3.3	2.5	2.2	0.9	1.0	0.3	11.6	2.9	2.1	0.1	11.3	0.6	0.2	0.2	0.1	3.0	0.8	2.7	1.8	0.3	16.5	1.2	4.8	2.4	1.3	3.1	2.0	9.0	2.3	0.0	0.0	2.3	14.2	0.5	0.9	3.3	2.6	0.6	0.1	1.5	3.2	1.8	2.6	1.6	0.6	0.9	4.3	0.5	0.7	5.6	3.0	2.7	2.2	2.3	1.8	1.1	3.3	0.3	1.1	1.1	1.6	0.4	1.9	0.9	1.3	1.3	1.2	0.7	3.5	12.0	0.9	2.9	0.3	5.2	1.1	0.4	2.8	0.8	1.2	0.4	1.2	2.6	1.5	0.8	2.5	1.9	0.8	1.3	1.7	0.3	2.2	0.6	0.9	1.0	0.8	1.6	1.9	0.7	1.2	0.9	0.6	0.2	0.4	0.9	0.1	0.0	0.0	1.3	2.1	4.5	0.0	1.9	1.8	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.3	0.4	0.1	0.6	1.8	1.3	1.2	1.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.7	6.1	0.0	1.2	1.1	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.6	0.0	0.2	0.1	4.3	0.0	0.0	0.0	0.7	0.1	0.1	0.8	3.7	0.0	0.7	0.1	1.0	0.0
ZC3H12A	"FLJ23231, MCPIP1, Regnase-1"	ENSG00000163874	"Zinc finger CCCH-type containing 12A"	Q5D1E8	1	37474580-37484377	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 136.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 300.7;Basal squamous epithelial cells: 242.4;Langerhans cells: 232.8;Squamous epithelial cells: 217.6;Suprabasal keratinocytes: 225.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 48.8;RT4: 61.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA032052, HPA032053"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Cytoplasmic bodies"	Nucleoplasm	"HPA032052: AB_10603241, HPA032053: AB_2674128"	"unprognostic (2.35e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.51e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (5.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.77e-2)"	28.9	28.0	2.4	17.3	2.3	136.3	15.1	3.6	4.1	9.1	2.7	16.3	14.1	6.6	4.6	45.4	14.3	36.0	12.1	2.5	3.8	15.7	23.3	40.0	13.6	4.1	3.7	6.0	12.4	2.5	9.2	3.7	4.1	29.5	7.9	0.3	22.9	5.2	10.8	51.5	20.1	5.7	3.0	15.5	23.5	5.2	3.7	5.7	6.5	3.2	15.5	39.0	21.4	2.8	7.8	5.5	0.6	3.5	2.7	4.0	6.2	5.5	48.8	3.5	4.5	6.1	17.2	8.7	22.8	5.3	37.8	16.8	2.2	35.4	2.0	17.8	3.2	2.3	20.9	9.7	3.9	4.6	3.5	8.6	17.8	30.0	5.3	7.9	3.9	4.4	4.3	14.1	3.1	9.4	3.5	8.3	4.2	10.4	4.8	5.2	2.2	5.1	8.8	61.2	1.6	1.1	11.0	17.4	1.3	5.3	6.0	5.1	4.1	10.3	5.7	7.7	8.5	11.2	4.5	6.6	23.5	9.7	2.0	1.2	1.4	4.0	3.1	1.4	3.3	3.1	1.3	1.9	1.7	3.9	0.7	1.5	5.6	3.5	1.2	1.5	2.0	1.7	2.4	2.3	3.6	4.1	2.5	3.8	4.1	3.7	4.1	3.0	3.7	2.8	19.1	16.0	36.2	1.6	56.9	195.9	149.8	300.7	242.4	0.4	93.6	69.8	4.2	61.5	117.6	11.0	0.0	3.7	78.1	71.5	0.0	79.5	16.9	67.6	20.8	32.2	63.9	0.4	0.1	73.9	10.0	41.0	66.3	102.2	42.6	5.0	5.3	11.4	9.7	0.0	0.1	77.3	69.2	10.5	232.8	2.7	0.9	71.2	48.0	1.0	14.0	0.9	9.2	0.5	0.9	55.4	73.2	1.2	52.1	127.9	59.5	0.6	58.4	4.5	6.6	52.7	36.1	1.6	1.3	217.6	225.2	11.8	76.6	9.5	62.2	81.9
ZC3H12D	"C6orf95, dJ281H8.1, MCPIP4"	ENSG00000178199	"Zinc finger CCCH-type containing 12D"	A2A288	6	149446795-149485014	"Disease related genes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.6;intestine: 4.7;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 14.6;Distal enterocytes: 7.7;Kupffer cells: 12.4;Macrophages: 7.4;Proximal enterocytes: 7.5;T-cells: 17.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036897	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytoplasmic bodies"		"HPA036897: AB_10672104"	"unprognostic (2.89e-2)"	"unprognostic (3.91e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.47e-6)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.52e-2)"	0.7	0.4	1.0	7.2	0.5	3.6	0.4	0.4	0.9	0.3	0.3	1.5	2.8	0.2	0.2	0.3	0.3	0.6	0.3	0.8	0.9	0.6	0.3	0.8	9.8	1.0	0.5	0.3	0.1	0.0	0.2	0.3	0.8	0.3	1.4	0.5	0.7	0.3	0.4	1.1	4.7	0.5	0.4	5.8	0.8	0.3	0.9	1.1	0.5	0.0	12.6	1.0	0.2	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.1	8.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	34.3	0.2	0.3	1.2	2.7	0.0	2.8	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.1	0.0	2.5	0.0	0.0	0.0	7.1	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	4.6	0.0	0.2	0.1	0.1	0.1	0.1	0.2	2.9	0.4	2.5	0.1	0.7	0.8	0.1	0.1	0.5	0.2	1.4	1.5	0.7	0.8	1.3	0.9	0.2	0.5	0.3	1.4	0.4	3.5	0.8	1.0	0.5	0.4	0.9	0.8	0.9	1.0	0.5	0.8	0.4	0.9	0.9	1.0	3.2	3.9	1.3	14.6	0.4	0.5	0.0	0.0	0.7	0.3	0.3	1.4	1.5	0.6	0.0	4.2	0.0	3.7	7.7	1.9	0.0	0.4	0.4	0.4	1.3	0.0	0.4	1.2	0.4	0.0	0.7	0.5	0.6	0.0	0.2	1.4	0.3	3.7	0.0	0.7	1.1	0.0	12.4	4.4	0.5	0.0	7.4	1.8	1.0	1.6	0.8	0.0	0.0	0.7	0.3	0.8	0.0	4.6	0.4	7.5	1.6	0.0	1.1	0.0	0.9	0.4	0.2	0.4	0.1	1.4	0.0	17.4	0.0	2.6	0.4
ZC3H3	"KIAA0150, ZC3HDC3"	ENSG00000014164	"Zinc finger CCCH-type containing 3"	Q8IXZ2	8	143437659-143541447	"Predicted intracellular proteins"	"mRNA transport, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023658, HPA050577"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA023658: AB_1858973, HPA050577: "	"unprognostic (1.15e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (4.38e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"unprognostic (2.18e-1)"	16.4	12.7	6.0	5.6	6.1	17.2	14.4	6.3	9.4	11.8	2.7	13.4	11.7	12.3	1.0	14.6	11.3	2.2	11.4	6.6	3.6	25.0	45.9	14.5	5.0	6.3	4.7	12.0	10.5	2.9	8.2	3.6	6.4	12.1	1.5	1.9	11.0	3.5	21.1	16.9	21.5	2.6	3.7	19.1	11.8	19.4	6.2	5.3	14.0	2.9	2.5	12.2	12.0	6.8	11.3	16.1	5.1	12.4	3.1	3.6	13.7	6.4	4.5	8.0	6.5	8.8	10.3	8.0	11.2	5.3	4.3	12.9	4.1	6.6	1.7	16.7	14.2	10.0	10.6	14.2	7.6	5.0	8.9	8.0	6.1	6.6	4.7	3.7	5.9	7.6	17.1	14.5	3.3	29.3	24.1	9.7	9.4	9.2	26.0	13.9	4.1	25.6	5.9	6.8	13.1	8.7	12.4	10.9	7.1	2.6	17.5	9.4	8.2	7.0	21.1	15.4	11.3	13.2	9.4	6.8	9.1	11.6	7.8	6.5	4.6	6.3	3.9	5.5	4.5	3.2	4.6	4.8	3.7	2.7	5.8	4.8	9.1	2.2	3.6	3.2	3.4	5.4	6.0	6.1	6.3	9.4	6.6	3.6	6.3	4.7	6.4	3.7	6.2	6.8	6.9	0.0	2.3	10.7	8.4	7.0	3.4	4.5	5.7	7.3	5.1	3.4	1.4	4.3	3.4	5.5	8.4	7.9	4.0	14.2	1.9	6.5	8.8	5.6	6.1	5.5	10.7	12.8	9.8	7.3	9.4	5.4	20.4	7.2	5.7	28.1	5.0	13.2	8.5	5.0	9.9	11.2	6.1	9.8	6.0	7.9	5.3	10.9	3.6	6.5	6.4	6.1	7.2	4.0	10.5	7.6	2.3	5.7	8.4	4.4	16.7	11.2	3.5	7.5	13.1	4.0	5.8	22.8	14.8	6.3	8.7	12.3	7.2	3.8	9.0	5.5
ZC3H4	"C19orf7, KIAA1064"	ENSG00000130749	"Zinc finger CCCH-type containing 4"	Q9UPT8	19	47064187-47113776	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040934, HPA041068"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA040934: AB_10795495, HPA041068: AB_10796567"	"unprognostic (8.02e-3)"	"unprognostic (3.68e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.23e-4)"	8.0	7.7	11.6	8.3	11.6	5.6	8.1	11.9	9.8	9.7	3.3	10.3	6.7	11.5	3.2	11.5	9.1	3.7	8.7	9.6	8.3	8.4	10.4	6.9	9.0	11.5	11.1	10.6	10.8	4.8	9.8	3.8	9.7	9.1	4.0	5.2	8.3	4.7	10.5	10.4	10.3	4.7	9.3	12.5	9.0	11.2	11.2	9.6	9.4	5.3	6.3	9.6	8.8	11.0	14.4	22.2	13.5	19.3	7.4	4.6	13.7	11.3	6.4	10.4	7.0	15.9	15.8	30.3	8.2	7.7	6.4	24.5	5.9	16.1	6.6	18.8	9.6	21.6	13.9	12.2	6.4	20.7	22.1	7.8	4.4	9.6	7.6	5.6	8.6	18.4	21.2	11.2	6.9	25.2	23.6	34.9	20.1	9.7	7.4	36.5	11.6	13.7	8.0	23.2	16.4	23.1	17.3	14.3	8.6	6.5	15.0	16.6	15.2	14.1	13.7	9.1	16.1	14.5	12.7	26.4	11.0	16.6	20.5	2.6	0.9	1.5	2.2	1.6	2.3	2.1	1.9	2.3	1.2	1.9	1.7	1.9	2.7	2.3	1.6	3.0	1.3	0.6	11.6	11.6	11.9	9.8	9.6	8.3	11.5	11.1	9.7	9.3	11.2	11.0	19.4	3.2	13.1	10.7	16.6	22.3	6.2	8.4	6.8	23.8	18.0	10.0	12.8	28.6	11.7	20.2	14.6	6.6	14.7	20.0	9.8	10.8	18.0	13.0	16.0	14.7	19.2	20.0	8.8	11.6	7.4	12.7	9.7	18.2	12.6	17.5	19.2	16.5	12.9	16.8	9.9	18.4	8.2	28.3	20.0	6.8	16.8	18.9	7.2	13.1	23.3	14.3	17.5	12.5	17.6	10.9	14.6	9.8	8.2	9.7	15.1	11.5	12.6	23.8	6.6	16.0	13.8	15.6	9.8	14.7	22.4	8.6	16.1	9.8	17.1	7.5
ZC3H6	"FLJ41410, FLJ45877, KIAA2035, ZC3HDC6"	ENSG00000188177	"Zinc finger CCCH-type containing 6"	P61129	2	112275597-112340063	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036019, HPA036020, HPA076065"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA036019: AB_10673228, HPA036020: AB_2674904, HPA076065: AB_2732300"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.99e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.45e-2)"	3.9	2.5	3.1	1.8	4.4	1.7	3.3	5.5	4.1	3.2	0.0	3.0	1.4	2.9	3.4	1.8	3.6	1.8	2.9	2.6	3.1	2.1	1.8	2.4	2.9	3.1	3.3	6.1	2.3	3.0	3.4	1.7	3.0	2.4	1.7	9.4	2.8	2.1	5.8	4.4	2.6	1.8	2.9	3.1	2.2	2.9	3.0	3.8	3.7	5.7	2.6	2.9	2.9	5.4	1.1	0.4	2.3	2.2	2.1	4.1	0.7	1.2	1.9	0.7	1.5	0.2	1.4	1.7	0.9	0.7	2.0	0.6	0.7	0.3	1.0	2.0	0.2	0.3	0.5	0.0	1.9	0.4	0.4	1.6	3.3	0.8	5.5	3.4	1.2	2.2	0.4	3.0	1.7	1.0	1.0	0.6	1.5	0.7	0.5	0.6	0.1	1.6	1.0	0.2	1.7	2.3	1.1	0.6	1.2	1.2	0.7	0.6	1.8	1.1	0.1	1.3	0.5	3.1	0.9	1.5	2.2	1.1	3.0	0.5	0.6	0.8	0.9	0.4	1.0	1.3	1.3	1.0	0.6	1.7	1.4	1.2	1.2	0.6	1.3	1.0	1.2	0.4	3.1	4.4	5.5	4.1	2.6	3.1	3.1	3.3	3.0	2.9	3.0	5.4	33.3	38.5	32.0	33.3	24.4	17.3	30.0	12.1	33.0	69.3	31.9	33.4	68.7	20.0	20.6	22.0	54.2	21.1	17.5	7.8	29.4	13.1	16.8	39.3	16.0	27.7	16.2	14.5	46.7	14.8	7.3	31.7	7.7	16.2	26.6	41.2	25.7	16.7	12.4	114.4	62.2	13.5	6.1	19.5	14.2	12.4	46.3	16.2	5.4	29.0	21.1	47.6	30.9	43.7	114.4	16.0	10.4	36.1	12.2	30.7	12.1	22.3	30.6	89.5	32.9	50.8	31.0	75.2	46.4	13.7	18.5	7.9	28.6	26.9	12.9	20.6
ZC3H8	"Fliz1, ZC3HDC8"	ENSG00000144161	"Zinc finger CCCH-type containing 8"	Q8N5P1	2	112211529-112255136	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034803, HPA034804"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA034803: AB_2674338, HPA034804: AB_10670284"	"unprognostic (2.45e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.49e-2)"	"unprognostic (8.02e-3)"	"unprognostic (4.88e-3)"	3.6	3.9	4.7	5.7	4.8	6.2	8.0	6.5	6.2	5.4	3.1	4.6	5.2	4.6	4.4	8.6	5.1	2.6	8.6	5.0	4.7	5.7	5.9	2.9	8.5	4.5	4.1	6.0	9.0	11.2	6.6	3.7	4.5	5.6	6.0	5.9	7.1	3.9	11.0	7.6	4.6	4.4	4.0	6.1	4.4	9.0	4.1	9.1	7.2	11.0	8.6	4.9	6.1	4.8	22.1	10.5	13.2	13.7	7.4	8.0	20.6	6.8	5.8	9.5	7.9	25.3	8.3	45.6	12.4	4.8	13.3	13.1	19.4	13.7	12.5	16.2	9.0	30.3	11.8	12.9	11.7	28.6	13.4	10.0	27.0	18.4	28.4	7.0	7.2	27.3	39.2	12.2	7.5	14.6	31.0	25.7	12.2	23.1	29.2	21.2	22.5	18.8	8.7	9.7	19.8	15.4	12.9	13.7	29.9	11.5	10.9	15.1	9.6	12.3	15.9	8.8	17.4	21.9	27.9	44.4	8.8	23.4	4.9	2.7	2.5	0.8	4.0	2.0	8.4	5.9	4.2	4.3	2.5	6.1	7.1	5.9	1.4	7.2	2.6	4.1	4.7	2.4	4.7	4.8	6.5	6.2	5.0	4.7	4.5	4.1	4.5	4.0	4.1	4.8	15.5	9.6	15.2	17.0	35.6	12.6	18.2	16.6	30.7	50.2	28.7	28.6	35.4	12.8	22.8	7.3	41.7	18.1	38.7	13.4	27.4	15.2	30.9	25.5	28.0	15.4	14.9	19.8	35.8	18.6	16.8	16.4	12.2	15.1	35.4	20.2	13.6	11.3	11.4	38.7	46.2	27.4	22.4	15.7	7.8	40.6	22.1	13.7	1.8	12.2	18.1	16.1	43.3	41.2	27.8	19.5	11.3	20.3	14.3	21.2	12.7	24.3	17.4	53.5	13.1	20.9	16.2	60.9	39.0	34.3	17.8	14.2	31.6	24.4	24.0	12.5
ZC3HC1	NIPA	ENSG00000091732	"Zinc finger C3HC-type containing 1"	Q86WB0	7	130018287-130051451	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019089, HPA024023"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019089: AB_1858976, HPA024023: AB_1858977"	"unprognostic (7.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.53e-1)"	8.4	12.4	11.2	7.3	11.3	4.7	8.4	10.9	11.4	9.1	11.9	9.5	5.4	9.3	8.6	7.4	8.3	5.7	16.5	11.1	12.1	11.8	14.1	6.3	10.6	11.4	11.5	9.3	7.5	11.6	7.5	8.4	11.4	8.3	7.2	5.8	7.1	7.0	32.7	6.3	7.6	11.5	11.4	12.5	8.7	15.6	12.1	10.4	7.4	29.1	10.6	9.1	7.6	11.8	15.2	24.8	30.3	35.1	17.2	15.5	20.6	19.5	23.5	36.5	36.3	29.7	25.5	34.2	13.7	24.4	48.5	13.4	40.1	29.2	35.0	22.7	34.2	24.1	21.4	29.1	27.7	27.4	22.9	18.4	21.2	38.1	24.2	20.1	39.5	28.9	73.7	11.7	35.5	26.5	33.2	51.9	62.5	26.0	28.0	31.0	23.6	29.5	37.0	10.7	19.3	34.3	27.5	39.4	30.7	42.9	17.3	28.6	17.6	24.2	11.5	20.5	32.8	22.9	36.8	44.7	37.8	34.9	41.2	34.5	24.6	23.8	26.0	29.4	29.5	39.3	26.6	27.5	31.2	37.1	35.2	27.7	2.0	29.5	28.3	18.6	30.8	24.6	11.2	11.3	10.9	11.4	11.1	12.1	11.4	11.5	11.4	11.4	12.1	11.8	5.2	6.4	2.3	12.4	8.8	1.5	5.4	16.0	11.4	6.1	4.3	5.8	13.5	4.3	7.5	7.3	0.0	19.2	4.8	2.3	17.6	12.8	3.3	3.1	5.5	8.6	3.6	5.2	13.8	9.7	16.9	8.1	4.1	2.6	4.5	12.4	11.4	9.1	9.0	6.7	15.7	4.2	16.2	5.0	3.0	5.2	8.7	4.3	1.8	9.4	11.6	6.9	9.2	11.6	12.4	8.9	7.7	6.4	9.1	2.3	2.6	22.1	8.9	5.9	0.0	7.4	8.3	42.0	22.9	5.0	1.7	7.4	7.0	9.4	4.9	2.2
ZCCHC10	FLJ20094	ENSG00000155329	"Zinc finger CCHC-type containing 10"	Q8TBK6	5	132996985-133026604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038944	Approved		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"	Nucleoplasm	"HPA038944: AB_10673601"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.89e-3)"	15.8	14.5	8.5	18.6	8.9	38.1	16.1	11.4	12.5	12.3	10.4	25.8	19.2	14.8	13.9	23.4	12.4	14.0	17.3	8.3	10.5	16.5	21.9	13.1	29.4	8.4	9.7	12.7	15.1	14.1	12.3	19.7	8.7	11.1	22.4	18.9	14.9	10.2	24.8	13.5	18.3	14.2	7.6	16.8	17.7	21.2	9.6	24.1	11.4	24.0	28.4	21.1	14.3	9.6	28.0	29.4	37.7	30.5	18.2	15.9	48.3	29.1	21.1	35.2	40.1	74.2	33.6	75.1	43.5	18.3	28.9	35.3	46.3	35.9	38.5	46.3	62.0	45.0	35.4	54.4	26.4	36.8	50.5	14.0	41.0	21.8	35.5	19.8	35.2	37.6	47.7	41.3	25.9	36.1	62.7	45.1	40.5	29.7	30.5	54.1	43.5	33.8	32.8	40.8	28.7	24.1	46.6	18.2	55.0	50.5	40.9	50.4	37.6	30.7	37.0	20.2	43.5	35.4	60.6	107.9	24.7	69.6	36.7	49.8	65.6	41.6	44.4	61.7	47.0	102.3	54.1	54.0	66.5	122.4	47.4	48.5	34.7	59.9	66.2	58.3	70.2	48.4	8.5	8.9	11.4	12.5	8.3	10.5	8.4	9.7	8.7	7.6	9.6	9.6	47.4	28.9	37.5	11.8	76.2	33.3	37.5	48.9	26.2	28.2	33.3	22.7	55.7	50.1	42.6	12.9	8.4	46.8	43.6	72.1	33.2	38.6	7.3	39.1	28.8	39.9	37.8	40.4	13.6	67.2	56.7	37.2	27.5	30.9	33.0	29.0	39.7	65.2	47.0	28.6	13.8	57.9	67.1	54.4	61.9	6.3	24.5	37.2	35.6	15.0	48.8	24.3	53.5	16.6	14.4	54.5	77.6	29.7	30.6	31.0	47.4	90.5	42.9	27.9	13.1	34.0	33.0	60.3	72.8	31.5	37.8	61.6	45.2	24.1	52.2	50.6
ZCCHC2	"C18orf49, FLJ20222, FLJ20281, KIAA1744"	ENSG00000141664	"Zinc finger CCHC-type containing 2"	Q9C0B9	18	62523025-62587709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 143.8;Late spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040943	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA040943: AB_10795496"	"unprognostic (9.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	10.7	5.5	6.2	5.8	6.6	26.5	9.1	9.3	8.2	6.7	6.0	7.1	6.7	6.3	5.9	5.5	7.8	8.6	8.5	5.5	6.9	5.5	23.3	10.2	7.0	7.2	6.8	8.0	6.2	5.8	8.0	8.1	6.7	7.3	5.4	10.0	37.2	5.3	12.2	11.6	7.5	5.8	5.3	9.0	6.4	12.0	6.6	7.6	7.3	7.3	6.3	7.9	6.5	11.5	8.0	6.8	5.8	11.5	17.1	7.3	10.9	4.5	6.7	10.5	10.4	3.7	4.8	22.4	5.8	7.4	8.6	13.2	18.6	9.9	4.3	15.5	8.8	5.9	15.6	25.2	5.9	11.4	8.3	7.2	12.6	6.7	12.3	7.6	19.9	9.9	6.4	7.3	3.5	6.5	7.5	4.8	3.7	5.8	6.7	9.7	6.1	0.1	7.3	8.0	7.2	4.5	7.5	16.8	6.6	10.2	5.9	8.9	8.6	10.3	7.0	4.1	6.5	2.8	5.8	9.4	7.6	4.7	3.9	0.0	0.3	0.8	0.5	0.5	0.4	0.1	0.3	0.4	0.1	0.4	0.6	0.4	1.5	0.2	0.1	0.3	0.4	0.1	6.2	6.6	9.3	8.2	5.5	6.9	7.2	6.8	6.7	5.3	6.6	11.5	23.1	25.6	18.8	28.1	10.8	26.6	16.9	7.5	10.8	33.1	15.2	13.2	18.8	20.0	12.4	16.5	54.2	7.4	33.6	10.2	3.9	6.8	143.8	24.1	12.3	28.8	12.6	8.2	48.5	6.2	10.9	9.7	10.2	27.5	2.5	4.4	17.5	35.4	14.1	43.7	33.9	15.5	2.0	44.4	22.0	158.6	8.1	30.6	7.2	29.0	11.9	7.7	9.2	37.2	51.7	5.1	9.1	7.9	10.7	16.5	8.4	5.3	10.8	19.5	6.6	15.6	15.0	16.3	15.2	15.3	18.5	6.8	22.6	5.6	11.5	12.2
ZCCHC24	"C10orf56, FLJ90798, Z3CXXC8"	ENSG00000165424	"Zinc finger CCHC-type containing 24"	Q8N2G6	10	79382325-79445624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 148.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 66.0;Hepatic stellate cells: 64.2;Hepatocytes: 59.2;Leydig cells: 68.6;Oligodendrocyte precursor cells: 184.5;Oligodendrocytes: 130.6;Peritubular cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 135.0;ASC TERT1: 115.1;BJ hTERT+: 91.6;HSkMC: 120.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038348	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria	Nucleoplasm	"HPA038348: AB_10669538"	"unprognostic (3.47e-3)"	"unprognostic (8.70e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.35e-6)"	"unprognostic (1.84e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.95e-3)"	40.4	11.9	119.7	13.8	147.7	2.6	32.5	112.0	109.7	42.3	44.8	67.7	6.2	42.8	8.9	14.0	34.1	23.8	35.7	89.4	101.0	8.7	33.1	22.7	7.5	134.9	145.8	26.4	8.4	4.0	9.4	16.1	120.3	32.2	8.9	3.7	12.0	27.2	58.0	13.7	18.2	36.1	119.7	10.9	25.5	8.9	136.8	2.7	18.4	26.5	4.3	43.2	22.9	148.0	3.3	3.1	10.4	9.0	135.0	115.1	2.5	24.6	91.6	14.2	16.5	2.6	0.1	0.1	13.1	49.5	5.0	0.3	1.7	0.6	11.9	6.2	6.5	1.3	7.2	3.1	35.1	3.8	2.0	120.5	1.3	12.8	3.5	42.1	2.9	0.9	4.8	5.3	12.3	1.1	0.1	14.9	2.5	0.6	30.1	0.6	12.3	2.2	1.7	4.0	0.3	12.9	7.7	0.9	31.5	9.7	3.5	7.0	2.0	13.6	12.4	37.4	8.5	9.2	6.5	0.1	27.9	4.9	49.4	0.0	0.6	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.1	0.1	119.7	147.7	112.0	109.7	89.4	101.0	134.9	145.8	120.3	119.7	136.8	148.0	36.2	0.0	2.6	29.0	1.4	7.6	1.4	1.5	1.8	0.1	5.6	5.7	20.2	5.7	1.2	0.0	0.0	0.6	4.5	0.3	0.0	0.8	2.0	2.3	66.0	29.5	0.0	4.4	0.3	0.8	0.9	40.9	5.1	2.6	1.3	4.1	64.2	59.2	10.7	0.0	0.5	0.4	0.0	17.1	14.5	4.8	68.6	7.4	16.0	30.0	5.6	16.7	1.0	184.5	130.6	0.9	0.1	65.5	5.0	2.9	0.0	1.8	1.2	1.1	13.1	38.7	24.0	0.7	1.7	1.4	4.5	1.5	3.6	8.9	0.1	1.3
ZCCHC8	DKFZp434E2220	ENSG00000033030	"Zinc finger CCHC-type containing 8"	Q6NZY4	12	122471599-122501073	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 43.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037483, HPA037484"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA037483: AB_10671502, HPA037484: AB_10672485"	"unprognostic (1.96e-3)"	"unprognostic (8.48e-2)"	"unprognostic (5.55e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (8.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.48e-2)"	10.2	8.2	3.6	8.9	4.0	43.7	9.9	7.5	4.8	10.8	5.5	9.3	9.0	9.8	8.8	9.8	10.2	6.5	6.3	3.4	3.5	7.9	10.3	8.5	10.5	4.2	3.6	11.5	9.4	8.9	8.9	8.1	3.9	7.9	8.1	10.8	9.7	6.6	16.8	11.8	10.4	7.5	3.0	11.0	10.7	12.1	3.9	10.7	10.8	8.7	11.8	8.9	9.6	5.5	14.8	14.4	21.7	21.0	8.4	10.8	25.2	18.0	11.3	21.5	16.1	13.9	13.0	26.6	10.9	7.6	12.5	17.4	23.1	9.8	19.6	20.9	14.0	17.5	21.0	11.5	19.8	30.5	16.9	9.4	15.7	12.9	18.2	19.2	10.9	26.8	24.3	17.0	11.3	8.4	20.7	23.9	18.5	10.0	15.3	24.2	17.8	21.4	10.5	9.3	15.6	17.2	20.5	9.5	23.0	21.1	20.0	20.3	12.2	14.3	15.3	14.2	17.7	18.2	11.6	36.6	7.8	19.6	8.6	5.5	3.4	2.2	3.5	3.6	3.6	4.5	4.1	4.3	2.8	4.0	4.6	3.8	2.9	4.3	4.3	2.9	5.7	2.5	3.6	4.0	7.5	4.8	3.4	3.5	4.2	3.6	3.9	3.0	3.9	5.5	21.6	32.1	22.6	20.5	26.8	20.5	27.2	13.5	27.3	30.5	23.1	21.5	9.4	21.5	27.0	9.2	125.1	17.4	32.6	13.3	1.9	11.8	78.5	30.7	40.6	21.0	19.6	48.2	21.7	9.5	17.6	22.8	26.0	41.4	19.0	22.5	10.4	17.9	12.8	15.2	24.6	15.5	14.2	15.6	20.2	48.1	14.9	22.4	16.0	26.2	23.5	12.4	21.6	27.6	25.3	14.1	12.2	14.7	29.6	21.3	18.8	6.6	20.4	72.7	6.6	33.6	21.0	34.4	17.1	24.0	25.7	32.3	26.2	19.0	17.3	22.9
ZCCHC9	"DKFZp761J139, PPP1R41"	ENSG00000131732	"Zinc finger CCHC-type containing 9"	Q8N567	5	81301587-81313297	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038404	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA038404: AB_10672744"	"unprognostic (1.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-1)"	13.4	12.3	8.7	15.9	8.6	10.8	13.5	9.7	13.4	15.5	9.8	15.2	14.9	15.5	16.3	14.6	12.6	14.3	11.2	8.6	9.2	17.9	33.3	11.2	19.0	8.9	9.0	17.2	11.8	13.0	13.8	19.1	9.0	15.5	14.9	14.0	10.5	11.0	14.9	16.3	18.7	14.6	8.5	13.3	12.9	14.9	9.4	17.7	12.6	11.6	18.2	16.3	13.5	9.1	26.6	18.5	44.5	23.7	37.5	35.3	59.7	39.2	46.3	29.5	40.8	41.0	35.8	24.6	15.8	19.8	51.1	19.4	35.6	35.8	46.9	55.3	33.5	25.4	21.0	48.4	44.2	32.6	20.3	27.6	30.7	25.3	62.7	22.9	25.3	26.5	43.1	23.4	30.8	36.3	54.0	48.7	32.4	14.9	23.7	31.9	57.0	36.4	23.4	26.5	21.6	20.5	31.1	18.4	146.5	32.1	23.0	51.7	17.6	18.5	22.6	33.2	43.4	33.2	36.5	37.7	32.7	46.7	40.3	12.6	10.8	11.3	10.5	14.9	13.2	12.8	14.0	12.8	13.3	11.1	13.3	13.8	10.6	10.8	13.6	15.1	17.4	6.5	8.7	8.6	9.7	13.4	8.6	9.2	8.9	9.0	9.0	8.5	9.4	9.1	15.9	9.6	18.6	10.4	18.2	9.1	12.5	25.8	14.2	18.0	14.5	17.1	12.3	37.1	19.3	31.3	14.6	28.0	17.3	15.0	31.3	22.4	68.4	22.6	31.5	17.9	7.8	12.8	15.0	20.4	53.8	23.9	14.8	18.8	13.3	13.3	29.6	61.7	36.7	26.9	19.3	23.3	16.2	14.2	16.5	19.1	32.6	19.9	3.6	13.1	33.2	22.0	35.0	12.1	14.2	30.2	27.4	29.0	17.6	13.8	44.8	67.1	28.1	28.2	19.7	16.2	18.8	75.6	38.2	14.0	9.2	23.0	19.8	22.3	21.6	12.6
ZDBF2	"FLJ45338, KIAA1571"	ENSG00000204186	"Zinc finger DBF-type containing 2"	Q9HCK1	2	206274663-206314427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.0;Granulosa cells: 44.4;Inhibitory neurons: 56.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039121, HPA050311"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"HPA039121: AB_2676357, HPA050311: AB_2681081"	"unprognostic (8.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.73e-3)"	"unprognostic (7.59e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.40e-1)"	2.3	4.1	1.8	0.9	3.5	0.6	1.6	3.4	1.8	3.0	7.8	2.4	0.4	2.6	1.7	1.1	3.2	1.2	2.3	2.3	3.8	1.4	1.5	1.3	1.1	1.2	1.4	9.5	5.0	1.5	8.0	2.3	1.1	1.8	0.6	5.5	1.7	1.4	2.7	1.1	1.7	1.3	0.4	1.4	2.0	1.7	3.5	0.9	2.0	1.5	0.9	1.7	2.0	0.4	1.4	0.2	4.4	0.8	1.7	1.4	6.9	1.4	1.5	0.7	0.9	0.4	1.2	0.0	0.6	1.5	2.6	0.3	3.0	1.1	1.3	1.4	2.9	0.0	3.4	0.1	2.2	1.3	2.9	1.4	1.9	1.4	2.7	5.1	2.1	1.1	0.2	1.9	2.1	0.2	0.4	0.0	6.2	0.1	1.6	0.0	4.6	0.0	0.8	0.6	2.4	5.6	2.6	0.0	2.5	10.0	0.1	0.0	2.6	0.7	2.3	0.5	1.1	4.1	1.1	0.2	3.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	3.5	3.4	1.8	2.3	3.8	1.2	1.4	1.1	0.4	3.5	0.4	6.9	3.2	3.9	15.7	19.3	4.0	1.9	3.1	7.4	26.9	4.4	3.3	9.2	1.5	4.4	11.0	14.6	5.2	9.7	0.6	0.0	2.8	4.1	1.9	7.5	5.1	7.8	0.8	75.0	2.2	6.9	11.7	4.6	0.6	12.7	44.4	3.3	3.4	0.5	8.4	56.5	1.3	4.1	0.3	4.2	5.1	4.4	2.3	1.8	18.7	0.1	8.7	0.0	26.2	3.1	1.2	0.5	5.3	23.4	3.5	1.0	2.3	10.6	18.1	0.0	19.2	9.2	4.4	9.0	6.0	3.3	9.0	13.5	24.5	0.5	0.8
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type palmitoyltransferase 12"	Q96GR4	9	128720870-128724127	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 224.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA059339: AB_2683985"	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	18.8	23.9	7.8	15.5	7.7	41.3	19.3	7.5	9.9	16.8	8.4	40.5	26.3	12.9	7.1	67.8	12.0	14.1	13.7	7.4	8.8	30.6	52.3	23.3	20.0	9.6	7.8	7.4	67.1	9.8	11.3	16.3	8.4	26.6	13.7	0.5	43.2	12.5	15.6	42.4	36.8	6.3	8.4	31.7	49.2	24.7	10.5	12.4	16.2	4.1	13.7	18.7	30.5	9.7	53.5	127.6	6.0	31.3	17.6	12.1	59.4	32.8	28.8	34.5	22.9	109.6	61.5	37.3	29.6	25.5	62.9	139.8	13.0	65.0	3.8	65.0	31.7	20.1	92.7	49.1	34.7	33.1	87.1	19.9	44.7	29.6	11.0	17.7	25.6	65.6	18.8	93.6	7.1	187.3	45.9	66.2	26.8	118.8	107.6	21.0	21.0	108.4	28.7	43.4	42.1	30.4	46.2	64.1	18.3	9.6	98.9	35.6	27.5	0.1	36.9	25.9	45.8	58.1	106.8	17.3	61.3	38.4	41.4	231.1	122.3	385.6	105.1	123.9	91.2	94.6	95.9	101.5	100.1	111.0	99.2	91.4	269.5	90.5	150.0	244.7	130.9	101.0	7.8	7.7	7.5	9.9	7.4	8.8	9.6	7.8	8.4	8.4	10.5	9.7	10.0	16.0	12.0	1.3	31.8	16.2	43.3	94.0	10.8	1.2	55.5	30.4	14.8	77.2	59.0	46.0	0.0	183.9	39.1	171.0	13.7	106.8	73.2	20.7	11.5	21.1	51.2	51.1	0.6	200.0	224.0	14.2	38.7	52.5	18.4	13.7	35.7	55.3	137.0	0.0	0.5	108.5	67.1	62.2	20.9	30.0	9.6	46.5	42.7	6.5	115.3	18.4	81.4	0.5	2.0	133.8	167.7	7.2	43.3	56.5	186.0	48.5	20.1	2.0	6.6	5.4	16.3	36.0	18.6	55.2	28.1	134.1	34.1	22.0	110.0	77.5
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type palmitoyltransferase 16"	Q969W1	10	97446170-97457370	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	15.6	14.9	17.8	10.2	18.5	6.8	16.3	20.3	21.9	15.0	16.4	17.1	14.3	16.4	18.5	19.9	12.2	9.9	22.1	18.1	16.5	25.1	30.3	20.8	11.3	17.2	17.8	15.9	22.8	25.5	16.7	21.6	16.4	18.3	17.3	17.4	24.2	12.1	25.8	13.1	14.7	16.6	16.1	14.5	24.1	17.3	18.8	12.6	16.0	27.9	15.1	17.1	15.3	16.7	50.7	57.4	37.9	47.1	58.7	40.4	38.7	54.6	72.1	61.2	58.4	45.7	43.6	44.4	60.1	79.8	53.4	58.0	48.2	76.7	54.2	43.7	56.0	28.5	39.8	44.3	47.4	34.0	39.7	45.7	49.8	71.6	51.3	66.3	63.9	40.4	23.1	32.8	79.0	48.4	51.8	46.0	29.9	45.8	49.5	34.0	38.6	40.9	51.9	23.2	18.4	25.9	33.2	33.7	30.6	37.7	44.6	32.9	39.6	38.2	35.0	25.0	64.7	29.2	53.0	26.9	44.1	51.7	20.7	0.3	11.1	11.1	7.2	11.9	8.1	9.0	12.5	11.5	15.7	10.6	10.0	10.1	0.5	14.5	11.8	12.0	11.1	6.8	17.8	18.5	20.3	21.9	18.1	16.5	17.2	17.8	16.4	16.1	18.8	16.7	6.2	19.2	23.1	3.9	9.0	5.2	18.9	31.8	14.8	15.8	13.6	9.3	10.1	14.3	27.6	12.9	4.2	39.8	10.3	11.5	25.4	35.5	24.8	7.0	13.3	11.3	7.2	11.6	8.2	32.3	67.2	13.7	10.2	10.9	7.0	13.3	7.5	19.5	24.6	13.5	9.2	18.9	28.5	7.3	5.9	7.6	8.7	9.3	3.6	9.4	18.4	14.9	15.5	11.1	8.4	31.5	12.1	3.8	17.1	20.0	18.9	22.2	8.3	13.0	6.6	5.2	12.2	20.1	12.9	13.8	4.3	37.9	7.2	10.9	20.9	19.3
ZDHHC23	MGC42530	ENSG00000184307	"Zinc finger DHHC-type palmitoyltransferase 23"	Q8IYP9	3	113947901-113965401	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 26.7;Excitatory neurons: 72.2;Late spermatids: 41.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 5.4;basal ganglia: 7.3;cerebral cortex: 9.4;hippocampal formation: 7.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016808	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA016808: AB_1859002"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.48e-7)"	"unprognostic (2.58e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.90e-4)"	"unprognostic (3.29e-3)"	1.1	1.0	5.4	3.0	7.3	1.2	2.6	0.0	9.4	1.4	13.2	9.4	7.3	1.2	1.5	1.5	2.4	1.6	1.0	7.4	0.0	5.5	4.0	3.2	2.8	0.0	0.0	0.9	4.8	7.4	3.2	0.9	0.0	2.5	11.5	3.6	6.6	1.8	1.2	3.8	6.8	1.3	0.0	2.4	6.2	12.2	0.0	1.2	6.1	0.9	3.8	1.9	1.5	0.8	17.8	4.4	0.5	10.1	1.5	0.3	14.8	6.9	2.1	1.3	2.0	7.1	11.6	8.1	5.9	4.0	11.0	11.4	13.0	1.9	2.2	4.9	6.0	7.5	7.0	4.4	0.5	8.5	6.7	0.3	2.2	0.3	0.8	1.6	1.1	8.5	0.0	4.6	0.2	10.2	7.0	0.5	3.1	18.2	4.9	1.2	5.8	6.8	7.0	8.6	17.6	4.4	5.3	17.5	3.3	3.9	10.5	2.7	0.3	4.8	9.6	1.0	3.1	5.2	7.3	13.2	4.1	5.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	5.4	7.3	0.0	9.4	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.3	0.0	1.5	12.1	10.5	3.1	2.0	2.3	0.6	2.1	4.8	4.2	1.4	7.2	2.2	16.5	8.4	0.9	2.7	21.8	0.0	2.1	26.7	13.6	1.6	2.8	13.8	0.4	72.2	1.9	1.6	1.0	9.2	8.5	0.0	3.2	4.2	6.4	0.4	0.0	4.0	12.7	0.0	0.3	2.2	41.0	1.2	1.3	3.6	2.8	1.0	4.2	0.0	2.5	5.4	0.7	8.3	0.0	2.3	3.9	10.9	4.4	8.7	0.9	0.0	1.7	0.7	18.2	2.9	2.1	2.7	0.3	1.3	0.9	12.6	1.7
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type palmitoyltransferase 5"	Q9C0B5	11	57667747-57701182	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	29.0	21.7	8.3	27.2	7.8	29.2	25.8	8.3	9.5	27.0	11.0	36.4	29.6	22.3	24.1	60.9	25.0	27.9	27.9	7.5	9.2	28.2	36.7	29.0	24.4	8.5	8.9	20.7	31.6	45.3	12.6	36.7	8.7	28.0	34.4	35.9	35.0	26.7	40.9	45.2	31.0	29.0	6.9	25.5	30.2	36.2	10.9	30.6	36.9	45.5	35.0	42.3	28.7	8.9	80.3	86.2	33.7	34.7	74.9	57.4	64.9	72.8	89.8	61.8	46.3	52.3	97.0	53.4	91.9	89.5	53.1	110.1	53.6	88.9	55.4	66.5	24.4	45.8	40.1	49.3	81.5	85.9	73.7	81.3	79.3	88.8	92.9	51.1	71.0	45.6	61.5	66.2	79.7	48.4	49.1	29.3	41.1	61.0	52.2	47.8	66.6	67.1	74.8	115.2	25.3	30.7	67.6	77.0	78.5	45.4	81.9	52.6	80.7	76.5	40.7	82.9	52.2	48.2	63.0	45.9	59.1	44.4	68.0	11.6	5.2	7.1	6.9	6.8	8.3	5.8	6.7	6.0	5.4	5.7	6.7	6.9	6.9	5.0	8.1	9.0	7.0	6.8	8.3	7.8	8.3	9.5	7.5	9.2	8.5	8.9	8.7	6.9	10.9	8.9	28.8	16.0	10.5	14.7	13.4	16.2	12.7	13.7	16.5	21.4	20.4	15.2	21.6	12.8	19.8	12.9	37.5	10.1	20.3	41.3	3.9	14.4	21.3	19.9	22.1	17.1	11.5	10.8	16.4	18.2	9.9	15.5	15.8	35.5	19.7	24.9	16.1	15.1	13.0	13.5	17.9	17.5	18.3	16.3	10.2	9.8	11.8	18.4	1.8	14.0	16.0	14.0	17.5	17.6	14.7	26.0	20.8	7.5	12.4	15.1	22.9	11.4	17.4	47.7	0.0	18.4	18.5	13.3	7.1	31.5	19.9	18.6	15.9	16.8	19.7	20.5
ZDHHC8	"KIAA1292, ZNF378"	ENSG00000099904	"Zinc finger DHHC-type palmitoyltransferase 8"	Q9ULC8	22	20129456-20148007	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003422	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003422: AB_1080640"	"unprognostic (1.00e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.34e-3)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.57e-2)"	31.6	31.2	13.8	18.6	15.1	10.7	30.4	11.3	26.4	32.6	0.0	22.8	12.1	31.2	7.5	29.3	27.7	13.0	31.6	13.9	7.0	30.4	36.1	31.0	17.1	12.2	10.0	34.6	35.6	14.4	41.3	16.9	9.9	28.1	7.0	7.4	27.6	15.4	23.6	32.2	24.7	13.1	6.6	35.7	26.4	14.9	12.3	13.7	37.3	10.3	11.7	25.3	30.9	12.8	30.0	18.7	29.3	38.7	42.0	25.0	26.3	55.1	37.3	36.6	32.6	9.8	15.2	0.1	22.3	46.0	19.8	40.2	15.5	42.2	18.0	43.2	59.4	14.5	57.2	23.0	34.5	0.0	19.5	43.7	27.9	28.2	23.6	22.5	41.4	21.0	101.4	22.8	33.0	14.7	17.8	39.1	14.9	13.2	29.4	37.8	25.6	10.9	15.6	35.9	46.9	23.7	22.4	10.7	26.6	13.1	0.7	20.4	48.0	82.5	59.8	46.8	25.0	32.6	11.5	11.7	24.2	18.7	24.8	1.3	0.4	0.1	0.8	0.5	0.4	0.2	0.2	0.4	0.1	0.5	0.4	0.5	0.0	0.4	0.2	1.3	0.7	0.2	13.8	15.1	11.3	26.4	13.9	7.0	12.2	10.0	9.9	6.6	12.3	12.8	17.4	3.2	3.1	17.6	3.7	9.1	3.8	3.6	5.7	11.9	8.2	8.1	7.1	4.3	3.5	11.0	14.6	3.6	9.2	4.3	1.9	5.2	0.5	4.3	15.7	11.5	4.2	0.8	16.6	4.5	8.5	9.3	10.2	8.7	5.7	8.7	10.4	9.8	4.9	13.5	9.9	5.9	10.2	5.0	5.0	2.1	10.8	5.7	5.4	9.4	3.7	7.4	1.0	13.0	13.3	7.7	5.4	14.7	2.7	7.6	2.7	2.1	1.5	10.8	6.6	10.5	6.8	1.4	3.8	5.5	9.8	3.4	4.2	8.0	5.0	3.4
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 113.1;TIME: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686, CAB079943"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Nucleoli	"CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	26.6	8.6	16.4	12.9	16.2	8.6	16.8	14.0	20.1	33.2	9.9	49.2	6.0	38.7	13.4	11.7	18.6	20.0	34.8	15.2	22.8	7.5	10.4	16.0	9.6	21.1	19.2	9.3	3.8	3.4	7.9	17.5	21.2	14.5	12.3	14.8	8.0	26.9	54.4	7.0	11.8	39.9	16.8	8.1	18.1	10.1	18.2	29.9	11.2	60.5	9.7	24.4	16.4	18.5	0.1	11.1	35.1	43.9	58.4	113.1	0.0	32.7	44.9	6.6	9.3	0.2	0.1	11.3	15.6	39.6	9.3	0.0	14.9	0.0	11.8	19.1	7.9	0.0	7.0	6.3	44.4	9.8	0.3	53.4	0.1	19.6	17.6	21.4	54.9	9.5	7.5	14.4	42.7	0.1	33.7	6.2	2.3	0.0	6.6	11.6	66.0	5.1	12.9	0.0	0.9	15.6	11.1	0.0	0.0	7.2	0.0	6.7	87.7	40.8	9.4	10.0	16.7	9.1	6.3	12.8	10.9	0.0	4.2	4.9	0.0	5.4	2.4	0.0	3.2	4.1	3.2	1.7	1.3	3.1	6.8	3.5	8.5	6.6	0.0	3.1	5.0	1.6	16.4	16.2	14.0	20.1	15.2	22.8	21.1	19.2	21.2	16.8	18.2	18.5	104.4	0.0	7.7	212.9	34.6	11.2	3.0	2.0	0.6	42.7	1.4	2.8	106.3	1.5	3.6	1.8	45.9	0.3	22.0	0.0	0.0	2.1	110.1	7.2	287.8	110.6	0.0	12.2	276.1	2.7	0.5	66.1	2.0	6.5	1.3	17.0	49.6	13.4	1.2	10.1	261.9	0.0	0.0	3.8	25.6	141.8	30.7	6.3	26.6	479.7	10.7	7.2	7.2	968.6	7.3	2.5	0.0	102.0	33.2	3.7	0.0	1.6	1.5	43.4	78.9	99.2	74.2	17.4	15.7	1.1	8.7	0.7	36.2	12.0	0.0	3.8
ZEB2	"KIAA0569, SIP-1, SIP1, ZFHX1B"	ENSG00000169554	"Zinc finger E-box binding homeobox 2"	O60315	2	144364364-144521057	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Epilepsy, Hirschsprung disease, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 363.7"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 662.9;Inhibitory neurons: 539.3;Oligodendrocytes: 1489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 154.0;THP-1: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003456	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA003456: AB_10603840"	"unprognostic (1.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.04e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.32e-2)"	61.3	45.2	185.6	56.8	258.3	127.5	29.5	138.3	165.5	52.4	3.0	24.5	21.9	29.6	9.6	27.9	20.3	43.9	45.7	132.5	155.4	18.2	23.3	41.2	43.2	238.3	214.5	70.5	5.7	6.7	3.3	62.1	222.8	18.5	29.9	35.5	9.6	22.7	20.8	12.8	25.9	33.3	183.2	69.4	18.0	16.2	249.6	10.6	13.3	18.8	24.2	46.6	24.1	363.7	1.6	2.0	83.4	0.1	98.9	49.7	0.3	35.1	35.1	38.5	37.1	0.0	0.8	6.6	0.1	37.4	10.6	0.4	14.5	0.1	47.6	37.6	11.2	154.0	6.3	0.2	23.0	26.4	113.2	42.1	0.9	48.9	22.9	33.7	29.4	0.0	43.0	4.1	45.2	0.2	0.4	79.9	12.3	0.0	1.9	44.1	63.5	0.2	0.4	0.6	0.7	22.1	4.2	0.2	97.3	27.5	0.2	181.4	45.9	42.9	0.7	87.5	11.0	47.1	0.3	7.5	66.7	78.4	122.6	27.8	47.7	12.2	21.0	42.6	1.9	9.2	2.7	10.7	27.0	9.4	1.9	7.7	15.2	7.3	43.9	21.5	0.6	19.0	185.6	258.3	138.3	165.5	132.5	155.4	238.3	214.5	222.8	183.2	249.6	363.7	32.6	6.4	19.2	121.8	92.4	24.9	1.2	0.6	3.4	158.6	2.2	4.3	71.0	1.5	10.1	5.5	4.2	1.7	426.2	0.1	1.9	0.7	2.2	2.1	84.7	29.2	0.0	127.0	228.2	0.8	2.0	123.0	13.3	2.5	157.5	99.3	79.2	4.6	144.5	662.9	539.3	0.0	0.0	435.0	276.3	7.2	120.5	435.0	103.2	343.8	233.6	69.3	223.5	381.0	1489.6	0.2	1.1	66.5	132.3	1.8	0.0	10.3	4.0	11.9	184.1	185.0	198.7	2.9	11.3	3.4	19.6	4.7	136.7	108.8	0.4	2.2
ZFAND2B	AIRAPL	ENSG00000158552	"Zinc finger AN1-type containing 2B"	Q8WV99	2	219195237-219209651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 144.0;Proximal enterocytes: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035159, HPA035160"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA035159: AB_2674499, HPA035160: AB_10670697"	"unprognostic (3.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.77e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.38e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-2)"	"unprognostic (7.02e-2)"	28.5	26.6	33.2	20.7	34.3	38.2	28.3	34.4	43.7	38.2	27.4	41.6	41.5	29.7	18.1	48.8	28.5	20.0	28.1	33.3	34.0	44.1	64.5	32.3	28.4	37.2	33.3	29.0	40.7	26.8	36.2	17.4	34.3	31.3	25.0	10.8	27.7	17.6	34.3	42.5	45.4	15.9	33.1	45.9	37.4	15.6	34.3	37.9	49.8	15.5	23.3	33.0	35.5	37.5	23.0	14.4	17.2	23.7	17.6	18.5	23.5	22.8	26.3	32.1	31.7	34.8	18.9	16.5	23.0	39.2	26.0	15.5	15.4	28.9	25.5	27.8	25.2	41.8	25.6	30.3	36.3	22.9	45.3	15.3	62.2	31.9	75.0	17.7	21.2	40.0	25.0	38.9	31.9	40.0	37.9	47.9	8.9	31.7	17.5	22.4	8.3	31.6	29.6	17.7	33.7	16.3	10.9	17.3	24.8	19.3	15.4	47.3	22.5	32.2	29.5	37.2	33.3	20.2	6.6	34.1	31.5	44.2	25.6	30.8	34.8	48.6	49.1	46.0	42.5	43.6	44.2	48.0	26.7	53.0	39.9	48.9	58.3	53.5	38.3	33.5	51.6	44.3	33.2	34.3	34.4	43.7	33.3	34.0	37.2	33.3	34.3	33.1	34.3	37.5	30.4	22.4	21.2	17.6	43.5	27.1	26.3	34.0	19.9	14.9	37.1	33.7	12.7	44.3	24.5	20.2	14.6	26.9	52.4	144.0	56.7	44.1	4.9	14.6	17.7	26.4	40.2	15.2	17.8	66.0	24.3	19.6	42.3	20.7	32.4	11.6	23.6	39.4	34.9	8.4	16.1	67.5	36.7	32.4	31.3	7.8	32.0	35.6	35.6	5.6	24.4	21.5	44.3	6.0	15.3	60.3	101.1	29.7	39.5	25.1	170.6	79.5	13.8	17.2	26.3	15.9	28.7	6.2	22.9	27.6	36.1	51.3	46.7	27.8	54.4	28.8
ZFAND3	"FLJ13222, TEX27"	ENSG00000156639	"Zinc finger AN1-type containing 3"	Q9H8U3	6	37819727-38154624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 821.8;Late spermatids: 3021.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016755	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA016755: AB_1859011"	"unprognostic (3.32e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.41e-2)"	"unprognostic (4.33e-1)"	44.2	42.3	36.6	31.7	38.0	42.6	36.4	36.8	36.4	42.6	33.2	50.3	39.3	41.2	35.3	37.4	33.4	36.3	51.1	37.0	41.4	47.7	53.3	37.8	28.1	46.2	40.8	32.3	39.0	56.6	33.8	48.8	41.5	35.3	32.1	39.4	32.8	46.1	137.8	33.8	39.5	46.9	39.2	31.6	42.0	113.0	38.2	39.7	52.0	67.3	29.3	49.3	31.2	42.9	59.1	33.8	116.8	82.8	72.4	75.9	42.5	88.6	115.6	87.3	92.8	68.4	33.4	24.6	71.8	106.8	96.2	39.5	48.3	73.4	122.3	102.2	30.6	75.6	17.3	65.3	171.0	29.5	59.4	96.1	93.7	91.7	157.0	101.6	76.8	56.9	37.3	48.1	68.4	50.6	50.2	27.0	33.4	84.5	38.4	52.4	48.4	29.6	79.5	94.0	74.2	63.2	54.6	43.6	151.5	98.1	70.2	61.5	81.5	87.2	66.2	47.5	58.8	47.3	47.7	74.2	32.4	47.1	91.9	0.5	1.7	6.1	1.5	1.7	1.1	1.3	1.1	1.2	0.9	1.9	0.9	1.5	6.0	1.6	1.3	2.9	1.5	0.9	36.6	38.0	36.8	36.4	37.0	41.4	46.2	40.8	41.5	39.2	38.2	42.9	25.4	22.4	11.5	241.0	27.0	27.3	30.9	20.0	52.9	25.8	19.8	19.4	23.0	25.8	11.6	47.8	22.9	35.0	23.2	55.2	74.3	27.3	821.8	25.4	26.6	28.1	16.2	22.5	332.7	29.3	33.1	27.2	31.6	33.2	5.1	33.9	27.5	48.8	33.8	30.3	262.9	30.5	6.1	43.7	44.3	3021.1	38.8	49.2	14.2	283.9	32.9	47.4	34.0	276.0	316.4	38.9	29.1	55.3	28.3	52.3	57.6	38.2	17.2	21.6	32.9	32.9	31.2	63.5	54.1	41.3	30.1	86.1	31.2	21.1	21.5	61.2
ZFAND5	"ZA20D2, ZFAND5A, ZNF216"	ENSG00000107372	"Zinc finger AN1-type containing 5"	O76080	9	72351413-72365235	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 591.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 450.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018129, HPA077824"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA018129: AB_1859012, HPA077824: "	"unprognostic (1.97e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.86e-2)"	"unprognostic (7.03e-2)"	312.2	187.7	99.9	55.3	112.7	145.7	150.0	105.5	136.0	97.6	70.9	88.1	39.4	91.0	115.7	99.8	120.6	87.3	117.7	103.9	107.8	114.9	204.7	108.5	46.9	93.9	113.3	250.4	73.6	69.1	138.8	79.2	105.6	76.8	49.2	50.7	69.8	121.4	591.1	75.4	69.0	94.9	100.5	60.4	95.5	88.5	105.9	52.3	79.2	273.9	59.1	108.9	87.1	110.8	115.9	113.0	138.8	59.4	156.5	77.3	104.3	131.9	178.9	71.1	55.1	14.5	112.6	60.4	81.3	194.5	105.2	122.4	305.1	50.4	103.4	450.1	43.1	53.5	57.7	70.1	120.4	74.7	71.1	99.0	87.6	72.7	79.2	156.3	122.1	60.4	49.8	82.1	82.6	31.3	96.3	38.8	178.9	107.2	74.3	74.1	72.4	70.5	218.4	109.3	101.2	86.4	85.2	91.2	117.2	142.1	42.1	64.3	97.1	57.4	71.7	104.7	90.9	113.9	110.3	38.1	77.2	49.1	146.3	39.0	35.9	37.3	11.2	52.1	12.0	17.0	14.6	14.1	33.6	15.1	13.2	12.2	27.7	19.2	81.6	6.2	11.2	23.9	99.9	112.7	105.5	136.0	103.9	107.8	93.9	113.3	105.6	100.5	105.9	110.8	370.7	176.3	192.1	102.8	125.8	339.2	573.2	130.6	376.7	93.9	267.0	207.1	322.6	92.9	132.6	132.4	75.0	145.1	118.6	213.3	148.7	145.8	91.8	257.1	291.9	195.3	136.7	155.6	45.7	142.6	164.8	270.8	145.2	527.6	109.2	116.1	97.5	308.3	198.0	40.4	38.6	119.8	126.1	290.6	320.1	44.5	118.4	470.1	208.1	31.9	268.8	84.2	53.5	38.7	67.2	185.9	221.3	93.3	149.3	329.9	87.2	127.1	109.2	70.6	85.5	674.9	285.2	148.7	116.4	298.1	291.2	226.3	165.5	102.9	109.4	528.2
ZFAND6	"AWP1, ZA20D3, ZFAND5B"	ENSG00000086666	"Zinc finger AN1-type containing 6"	Q6FIF0	15	80059568-80138393	"Predicted intracellular proteins"	"Apoptosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 496.7;Late spermatids: 598.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034845, HPA052746, HPA077824"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA034845: AB_10671234, HPA052746: , HPA077824: "	"unprognostic (2.04e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.48e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (8.20e-4)"	63.2	70.2	41.3	48.4	43.1	79.9	65.4	54.5	48.8	47.8	48.7	61.5	54.8	58.2	66.2	54.9	54.9	49.8	90.5	42.1	50.1	76.3	123.5	55.7	73.2	50.6	46.4	40.8	42.1	60.6	41.2	50.6	47.7	56.3	61.1	74.2	52.9	50.6	128.5	44.0	53.9	59.8	53.7	60.9	59.6	135.9	44.0	50.9	100.9	109.8	75.5	55.2	43.1	57.2	78.9	161.0	116.9	67.3	118.0	93.4	110.3	91.7	127.2	78.7	107.0	56.6	133.6	87.5	115.7	94.3	76.6	63.1	125.9	92.3	83.8	52.8	107.2	207.1	72.7	78.5	138.2	74.7	131.9	83.3	117.8	87.3	117.7	108.3	120.0	74.4	84.5	66.8	87.3	83.3	59.5	74.0	73.6	70.3	53.4	48.1	102.6	200.8	196.3	129.4	23.9	68.8	79.2	91.0	238.4	144.5	89.1	106.7	111.5	82.1	66.5	53.2	89.8	88.9	189.1	102.6	85.0	127.1	58.6	505.1	90.0	290.1	93.6	118.9	82.5	226.4	84.7	91.2	103.1	174.4	88.2	98.4	216.3	85.0	167.1	89.5	91.2	135.7	41.3	43.1	54.5	48.8	42.1	50.1	50.6	46.4	47.7	53.7	44.0	57.2	60.5	54.5	86.8	76.0	122.5	149.5	141.3	236.1	46.7	40.3	96.2	60.1	92.7	85.8	147.8	75.4	41.7	125.3	101.1	95.9	199.6	103.7	496.7	102.0	57.0	75.0	82.6	97.2	18.1	98.3	130.8	75.0	69.8	135.3	105.1	57.0	72.8	154.6	144.2	32.0	27.7	88.6	203.4	96.1	173.5	598.2	53.1	109.8	124.5	78.7	167.2	101.3	91.6	61.9	73.9	126.5	107.6	62.8	92.7	174.1	64.8	278.8	168.3	89.9	92.1	70.0	98.6	230.6	173.3	62.8	169.3	392.8	87.0	67.6	67.3	183.4
ZFAT	"KIAA1485, ZFAT1, ZNF406"	ENSG00000066827	"Zinc finger and AT-hook domain containing"	Q9P243	8	134477788-134713049	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 31.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.5;dendritic cells: 35.6;Early spermatids: 49.3;Late spermatids: 53.0;Syncytiotrophoblasts: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	24	"plasmacytoid DC: 34.5"	"Lineage enriched"	"Detected in many"	24	"dendritic cells: 34.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020989, HPA063592"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"	Nucleoplasm	"HPA020989: AB_2670552, HPA063592: AB_2685051"	"unprognostic (2.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-3)"	"unprognostic (5.91e-3)"	"unprognostic (2.45e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (6.27e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.33e-1)"	2.2	1.4	0.8	2.8	0.9	1.2	2.1	0.5	1.4	1.8	1.7	4.7	2.3	2.5	2.0	2.6	2.0	1.2	2.2	1.0	0.9	9.7	1.5	2.2	3.7	1.3	0.6	2.1	2.3	2.7	1.5	31.1	0.8	2.2	1.7	2.7	1.8	2.1	7.5	1.9	2.1	2.6	0.5	2.5	1.9	2.3	0.7	3.2	1.6	4.3	2.9	2.8	1.8	0.7	4.1	6.5	2.3	2.9	4.4	4.3	2.1	4.4	3.8	3.9	4.0	4.5	5.2	4.7	3.8	4.6	2.3	3.2	4.7	5.6	5.1	3.9	6.0	8.7	5.7	3.3	3.4	4.9	4.3	3.5	2.8	4.3	5.7	3.6	4.9	1.7	3.4	8.4	3.4	5.6	5.1	0.8	3.2	4.2	3.9	3.1	3.0	2.0	3.8	6.2	2.8	2.1	4.5	3.4	3.7	2.6	2.8	4.6	5.4	2.3	3.4	3.3	5.0	3.0	4.4	4.5	2.8	3.6	4.9	1.1	0.6	1.4	0.4	0.8	0.4	0.9	0.4	0.7	0.5	1.1	0.6	0.4	1.0	0.1	0.5	34.5	0.3	0.9	0.8	0.9	0.5	1.4	1.0	0.9	1.3	0.6	0.8	0.5	0.7	0.7	3.5	3.2	3.3	14.4	7.0	1.5	1.2	1.0	1.8	5.3	4.0	1.4	2.0	1.5	3.1	1.8	4.2	74.5	35.6	1.5	0.0	2.1	49.3	2.6	5.0	2.8	0.0	0.8	24.4	1.5	17.2	2.7	3.6	3.1	2.5	2.9	0.7	1.4	8.4	1.7	18.9	1.4	0.0	3.8	2.1	53.0	3.4	4.2	8.8	14.0	3.5	2.1	4.1	9.5	12.6	3.3	0.5	2.6	17.0	1.6	1.1	12.2	1.1	6.0	0.0	3.7	2.5	2.9	5.5	1.9	1.7	126.7	3.6	3.2	1.3	1.5
ZFC3H1	"CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2"	ENSG00000133858	"Zinc finger C3H1-type containing"	O60293	12	71609599-71667725	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007072, HPA007151"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA007072: AB_1846134, HPA007151: AB_1846133"	"unprognostic (3.90e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	9.6	12.3	4.1	10.1	5.1	18.5	8.1	8.1	6.2	9.5	5.3	10.6	6.2	8.7	10.5	10.4	9.2	7.3	7.8	4.2	6.0	7.9	5.5	12.1	14.5	4.5	4.2	11.0	8.0	7.6	8.0	8.0	4.5	8.3	8.9	13.4	8.1	8.2	7.7	9.1	11.1	6.3	2.9	10.9	10.1	12.4	5.0	13.2	9.0	5.6	12.0	9.8	9.5	6.2	16.1	15.7	12.6	8.6	14.4	26.5	7.6	12.9	18.6	17.8	17.7	15.1	9.2	21.2	7.3	15.0	7.9	19.2	15.3	7.4	23.8	20.8	13.0	21.6	27.6	7.3	8.6	22.0	10.5	15.2	14.6	13.1	6.1	25.4	18.2	17.1	19.6	9.8	17.0	5.0	15.5	8.2	11.5	7.2	9.6	14.0	13.7	15.9	13.5	12.4	8.3	8.3	13.4	8.1	8.0	12.0	21.0	14.4	16.7	12.2	7.4	6.9	6.9	17.3	10.5	15.2	12.6	15.8	7.7	60.5	20.9	27.1	15.0	10.7	12.1	21.7	13.3	10.4	9.3	29.9	13.1	11.2	60.7	11.7	20.3	27.1	11.9	3.5	4.1	5.1	8.1	6.2	4.2	6.0	4.5	4.2	4.5	2.9	5.0	6.2	33.5	35.3	25.5	37.2	50.1	47.9	85.8	20.6	46.7	32.8	28.4	17.1	18.4	7.2	30.5	14.7	22.9	14.6	60.2	35.7	1.9	20.5	97.6	33.2	46.0	35.8	20.9	24.8	56.9	16.9	14.5	40.2	52.0	66.5	48.8	32.7	23.9	12.0	17.5	58.9	58.1	32.1	18.3	17.8	47.0	65.2	32.0	49.7	10.6	55.3	39.3	14.7	37.0	62.4	68.6	28.5	36.4	23.0	54.0	45.1	32.1	8.4	22.9	33.0	26.3	39.9	37.5	51.7	30.8	79.3	40.9	11.5	44.9	29.2	28.7	93.4
ZFHX2	"KIAA1056, KIAA1762, ZFH-5, ZNF409"	ENSG00000136367	"Zinc finger homeobox 2"	Q9C0A1	14	23520857-23556192	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9;testis: 7.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Early spermatids: 38.9;Excitatory neurons: 31.0;Inhibitory neurons: 20.0;Late spermatids: 19.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 20.8;Spermatocytes: 16.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.8;SuSa: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000720, HPA005146"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA000720: AB_10603462, HPA005146: AB_1859250"	"unprognostic (7.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.08e-4)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.75e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.90e-2)"	0.5	0.7	1.8	0.5	6.3	0.1	0.4	11.9	5.3	0.4	0.0	0.7	0.1	0.7	0.4	0.2	2.2	0.4	0.3	3.2	0.0	1.3	0.2	0.5	0.3	1.5	0.1	0.5	0.4	1.7	3.4	0.2	0.2	0.6	0.2	3.1	0.4	1.2	0.7	0.5	0.3	0.6	0.0	0.2	0.4	7.3	0.9	0.2	0.7	0.5	0.2	0.3	0.2	2.3	0.1	3.1	2.4	4.8	1.6	0.2	0.1	0.7	0.2	0.3	1.2	0.3	0.2	0.2	0.3	0.0	0.3	0.1	1.2	0.1	0.5	2.2	0.8	2.5	0.0	0.6	0.2	0.4	1.7	0.3	0.1	0.5	0.1	1.3	0.3	2.1	0.4	0.4	0.1	0.8	0.3	0.3	2.9	0.3	0.7	1.4	0.0	0.0	1.3	1.2	2.7	1.7	0.4	0.6	0.1	3.6	1.0	0.6	0.1	0.0	1.2	0.7	0.3	0.3	1.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	6.3	11.9	5.3	3.2	0.0	1.5	0.1	0.2	0.0	0.9	2.3	0.5	0.0	1.1	22.5	0.7	0.1	0.6	1.1	0.0	9.0	2.2	2.3	2.5	0.0	2.4	1.8	0.0	0.3	0.1	0.6	1.9	2.8	38.9	12.2	0.6	1.1	6.7	0.0	31.0	2.4	0.0	1.4	2.0	2.5	0.0	3.2	0.7	0.2	1.0	8.4	20.0	0.7	2.0	1.0	1.9	19.1	0.6	0.8	0.0	4.7	1.0	2.7	0.0	27.2	20.8	1.2	1.2	0.4	0.1	1.4	0.4	1.4	9.8	3.8	0.0	2.5	1.3	16.5	1.2	0.7	0.0	0.3	0.4	0.2	0.6	0.3
ZFHX3	"ATBF1, C16orf47, FLJ26184, ZNF927"	ENSG00000140836	"Zinc finger homeobox 3"	Q15911	16	72782885-73891871	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"brain: 501.8"	"Cell type enhanced"	"Detected in all"		"Microglial cells: 285.8;Smooth muscle cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebral cortex: 501.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059353	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA059353: AB_2683987"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.15e-2)"	6.0	4.3	5.9	1.9	5.8	0.9	3.6	2.8	501.8	5.2	7.1	6.0	1.5	4.7	4.0	2.0	3.6	4.2	3.5	68.3	12.1	3.2	3.1	4.3	1.2	72.3	13.7	2.8	4.0	9.7	3.9	6.2	49.5	6.9	2.6	4.5	4.0	6.4	9.9	2.6	2.6	4.1	11.3	3.1	3.6	1.8	12.5	1.3	7.4	10.7	0.7	6.8	3.5	56.5	5.0	9.2	14.7	12.3	5.3	6.7	15.1	3.9	4.3	2.5	2.8	10.6	2.9	2.3	5.5	7.5	3.4	3.5	9.4	4.7	3.4	9.3	2.3	0.4	13.1	15.1	4.9	1.6	3.5	2.5	2.8	7.3	6.5	2.3	4.7	1.0	1.1	0.6	6.3	10.9	0.5	3.1	2.4	2.7	1.5	7.0	4.0	0.8	4.0	8.8	10.9	3.9	6.9	2.1	4.8	6.7	3.0	0.7	10.3	6.0	7.0	6.5	4.9	4.7	1.7	1.6	2.9	1.4	4.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	5.9	5.8	2.8	501.8	68.3	12.1	72.3	13.7	49.5	11.3	12.5	56.5	13.6	70.5	26.7	109.7	8.6	17.0	55.6	13.1	37.0	122.0	24.5	20.6	23.7	47.1	34.8	47.8	22.9	47.4	5.2	11.0	5.9	23.0	2.6	94.6	33.1	40.3	26.9	7.4	22.0	23.4	19.4	68.8	25.5	154.6	21.0	20.7	44.6	37.5	67.0	23.5	8.7	23.2	22.4	84.2	142.6	2.8	10.5	72.9	21.4	285.8	40.8	13.9	3.1	83.9	18.5	20.7	22.4	19.9	2.2	77.5	6.9	7.4	29.3	34.1	124.9	153.7	177.3	3.7	16.8	29.5	17.2	62.1	7.7	12.4	31.0	43.8
ZFHX4	"FLJ20980, ZFH4"	ENSG00000091656	"Zinc finger homeobox 4"	Q86UP3	8	76681239-76867281	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 358.5;Bipolar cells: 87.2;Oligodendrocyte precursor cells: 234.2;Oligodendrocytes: 222.6;Skeletal myocytes: 120.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 16.8;TIME: 33.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023837	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA023837: AB_1859013"	"unprognostic (2.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.63e-3)"	"unprognostic (6.14e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.15e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.20e-7)"	"unprognostic (3.50e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.50e-4)"	"unprognostic (5.89e-4)"	3.0	3.6	7.5	0.5	12.0	0.0	2.1	0.9	9.3	3.2	0.0	3.2	0.0	0.8	3.2	0.3	0.6	0.9	0.4	6.0	18.9	0.3	2.8	0.1	0.3	11.3	23.3	1.9	0.2	0.2	2.8	0.1	17.7	1.0	0.5	2.2	0.6	5.5	2.8	0.4	0.3	1.1	7.0	0.1	0.8	6.7	15.3	0.6	0.3	3.1	0.0	2.7	2.6	15.0	0.0	2.2	3.8	0.0	7.2	8.7	0.0	3.3	4.6	3.8	3.9	0.0	0.0	0.0	5.8	5.7	1.7	0.4	7.8	1.0	7.6	0.0	10.3	0.1	0.0	0.0	1.9	0.0	0.5	16.8	0.4	9.5	3.0	6.5	0.7	0.0	0.1	0.3	7.0	0.0	0.0	0.0	0.6	0.4	7.1	0.0	6.8	0.0	5.8	0.0	0.0	6.5	0.0	0.8	0.0	0.0	0.9	0.0	33.4	3.7	5.6	10.6	7.4	10.9	1.2	0.0	1.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	12.0	0.9	9.3	6.0	18.9	11.3	23.3	17.7	7.0	15.3	15.0	5.4	0.0	1.5	358.5	0.3	0.5	0.1	1.0	2.2	87.2	2.4	2.2	4.0	42.9	0.3	5.5	2.1	0.1	0.2	0.0	0.0	0.1	70.0	0.0	1.1	2.0	0.0	0.0	13.7	0.0	0.0	37.5	0.0	0.0	0.0	0.1	1.1	30.5	0.4	5.0	12.6	0.2	0.0	0.6	1.8	24.3	13.7	0.7	0.0	29.0	0.0	15.0	0.0	234.2	222.6	0.0	0.0	21.4	0.1	0.3	0.0	0.3	0.3	5.8	0.0	120.6	8.1	12.4	2.3	1.2	1.1	0.0	0.6	10.0	0.0	0.9
ZFP1	"FLJ34243, ZNF475"	ENSG00000184517	"ZFP1 zinc finger protein"	Q6P2D0	16	75148494-75172236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044916, HPA062910"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA044916: AB_2679144, HPA062910: AB_2684902"	"unprognostic (1.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.24e-5)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (5.55e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-1)"	4.2	3.3	3.7	1.7	4.4	1.8	3.9	4.4	5.1	4.8	1.7	5.4	1.7	5.7	2.2	2.7	4.8	2.7	3.6	4.6	3.4	3.7	11.1	3.5	3.1	3.3	3.0	5.1	2.1	4.6	3.8	3.0	3.3	2.9	2.0	5.8	2.2	3.1	5.8	2.7	3.0	4.0	3.7	2.5	3.0	4.2	3.7	8.2	4.8	4.3	3.2	4.7	3.6	5.3	3.1	6.6	9.1	8.2	5.1	6.7	3.6	3.7	4.4	8.2	9.8	5.3	2.4	13.1	4.2	3.0	3.2	3.8	8.1	5.6	9.5	7.2	4.9	4.8	2.4	4.0	4.4	4.7	14.8	4.5	5.5	6.1	7.9	8.6	5.4	12.3	5.6	2.7	6.4	11.9	16.4	4.6	2.8	2.6	2.5	15.1	4.0	4.2	3.6	2.8	9.0	7.2	9.0	2.7	3.5	2.3	6.0	3.9	3.7	7.4	7.9	3.4	4.3	11.2	11.5	28.6	3.6	6.7	5.8	1.1	0.7	0.2	1.5	1.2	1.6	1.2	1.1	1.7	0.7	1.6	1.4	1.5	0.0	1.9	0.5	0.3	1.7	0.9	3.7	4.4	4.4	5.1	4.6	3.4	3.3	3.0	3.3	3.7	3.7	5.3	5.4	6.4	4.8	6.8	5.1	5.4	2.5	2.3	5.7	6.9	3.8	3.4	4.2	1.5	2.0	1.8	0.0	2.9	7.6	1.0	1.9	3.6	4.6	2.9	7.5	5.3	7.2	4.6	9.5	2.3	2.7	5.9	0.0	3.9	1.3	5.1	3.9	11.7	2.0	13.5	8.5	0.9	0.0	4.1	2.7	5.2	3.4	1.8	1.8	7.5	3.6	6.8	4.1	7.1	11.7	1.6	1.0	4.1	2.7	2.3	0.8	3.6	2.6	3.8	0.0	5.6	8.2	15.9	8.8	5.0	5.8	4.1	5.5	4.7	1.8	2.4
ZFP28	"KIAA1431, mkr5"	ENSG00000196867	"ZFP28 zinc finger protein"	Q8NHY6	19	56538948-56556808	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028879	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA028879: AB_10603841"	"unprognostic (5.02e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.32e-4)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-1)"	4.2	4.2	6.7	2.3	7.0	1.3	4.4	8.0	7.8	5.4	5.0	4.8	1.9	6.4	4.8	2.9	4.6	3.9	4.6	7.7	7.4	4.2	0.9	4.3	2.6	6.9	6.9	10.7	3.5	6.2	6.1	3.8	7.8	4.9	2.2	11.0	3.2	4.6	2.9	3.5	2.7	5.1	6.0	3.8	3.2	7.5	6.8	3.4	5.3	3.9	2.7	4.6	4.3	8.4	0.0	1.7	7.9	2.4	2.6	2.5	4.1	5.2	5.0	4.1	6.7	0.0	1.1	0.0	2.6	6.2	7.9	0.2	3.9	1.7	6.2	0.0	6.7	5.4	0.3	0.0	7.4	0.2	6.0	6.9	2.2	6.2	0.1	8.1	0.8	2.8	1.1	0.1	5.3	0.0	2.7	1.0	3.6	0.0	1.7	4.2	10.3	0.0	5.5	3.4	0.0	7.2	0.0	0.3	1.2	7.2	3.0	5.4	2.0	3.8	4.1	0.4	6.4	0.1	0.2	0.5	0.1	0.1	0.4	0.0	0.1	1.4	0.1	0.1	0.8	0.6	0.8	0.6	0.4	1.1	0.6	0.5	0.1	0.8	0.1	0.5	1.3	0.3	6.7	7.0	8.0	7.8	7.7	7.4	6.9	6.9	7.8	6.0	6.8	8.4	5.1	9.6	3.6	6.2	1.0	5.7	2.8	2.0	4.0	7.6	3.3	2.5	5.6	1.5	2.1	5.5	4.2	0.8	1.2	0.6	7.9	2.7	4.2	2.7	3.5	4.3	2.4	1.7	6.7	0.8	0.8	3.5	1.1	3.6	3.8	3.8	2.2	0.5	0.7	10.1	6.7	0.4	4.1	0.3	3.1	2.0	4.1	1.6	5.4	3.7	1.7	6.0	0.0	6.0	8.1	1.1	1.8	4.9	0.2	3.1	0.1	2.7	2.5	5.9	0.0	6.7	4.6	9.7	5.7	2.1	3.8	0.7	3.0	3.9	0.8	1.8
ZFP3	"FLJ30726, ZNF752"	ENSG00000180787	"ZFP3 zinc finger protein"	Q96NJ6	17	5078467-5096374	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 5.8;SH-SY5Y: 6.0;SiHa: 5.5"	"Low region specificity"	"Detected in all"							"HPA053085, HPA057290"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA053085: AB_2682039, HPA057290: AB_2683400"	"unprognostic (3.71e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.69e-7)"	"unprognostic (8.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.29e-3)"	2.6	2.6	2.9	3.9	3.7	0.9	4.7	6.4	4.4	3.3	6.7	4.8	7.1	3.4	3.3	2.7	5.8	2.5	6.8	3.2	3.4	5.2	1.2	3.8	5.3	3.9	3.9	4.9	4.6	9.4	2.1	2.7	3.4	3.9	5.7	8.0	6.0	3.7	6.8	3.5	6.1	3.2	3.2	5.1	4.4	3.1	3.9	5.0	5.8	9.7	6.2	2.8	2.3	3.7	0.0	1.0	0.2	0.0	0.9	0.4	0.0	2.2	0.0	1.7	1.9	4.5	2.0	0.0	3.1	2.2	0.8	4.5	0.0	0.0	0.9	0.0	0.1	0.1	1.9	0.0	3.0	0.0	5.8	1.5	0.0	1.2	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	3.2	0.4	0.0	0.6	1.5	2.7	2.7	2.7	6.0	5.5	4.5	2.9	1.0	2.7	4.4	0.0	0.0	0.8	1.5	3.2	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.8	0.6	1.0	0.9	0.6	0.8	0.6	0.9	0.5	2.1	1.5	1.1	0.0	0.7	0.8	0.3	0.6	0.7	2.9	3.7	6.4	4.4	3.2	3.4	3.9	3.9	3.4	3.2	3.9	3.7	1.8	0.0	4.2	1.6	2.1	0.3	0.4	0.9	1.2	4.1	1.6	1.4	7.8	1.5	2.1	1.8	8.4	1.2	2.4	3.1	0.0	1.7	1.8	3.1	2.7	1.8	0.0	0.8	3.0	1.1	0.4	1.8	4.6	0.8	1.3	2.9	4.2	0.1	1.7	3.3	4.5	2.2	0.0	2.5	0.2	0.5	1.5	1.2	0.0	0.0	0.9	2.8	2.1	4.5	3.1	0.6	1.0	1.2	1.8	0.6	2.6	1.4	11.0	6.0	0.0	3.0	1.5	7.1	3.8	2.3	0.1	0.8	1.6	2.9	2.5	0.5
ZFP37	ZNF906	ENSG00000136866	"ZFP37 zinc finger protein"	Q9Y6Q3	9	113038377-113056759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 15.5;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA049112	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Vesicles"		"HPA049112: AB_2680637"	"unprognostic (3.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.54e-3)"	"prognostic favorable (1.96e-4)"	"unprognostic (7.84e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.07e-1)"	1.6	1.7	2.2	1.3	2.9	0.2	2.8	4.4	2.5	3.0	0.5	1.6	0.8	4.5	1.8	1.2	2.5	1.3	1.5	1.9	2.7	2.3	0.6	1.3	1.2	2.3	2.2	7.1	1.3	2.9	3.8	1.3	2.5	2.5	1.0	6.3	0.9	1.8	1.4	1.2	1.1	2.5	2.5	2.0	1.2	2.2	3.3	1.2	2.9	1.9	1.3	1.8	1.6	4.0	0.6	1.7	7.2	6.0	3.9	7.5	3.7	2.3	3.4	2.5	2.1	0.0	1.7	4.2	1.8	2.4	3.3	1.5	0.0	0.9	3.9	5.2	0.8	0.2	3.5	1.9	2.1	0.0	0.8	2.1	0.7	3.0	5.8	6.1	1.4	0.0	0.4	3.6	5.2	0.0	0.0	0.0	7.4	4.4	0.0	0.0	10.0	0.6	1.9	0.0	6.1	5.8	7.1	1.5	1.4	3.5	6.0	0.0	0.6	5.8	2.5	6.9	3.5	1.4	2.9	0.0	4.5	0.1	3.6	0.1	0.0	0.0	0.9	0.2	0.7	0.9	0.8	0.9	0.3	0.4	0.6	0.9	0.1	0.7	0.0	0.0	2.4	0.3	2.2	2.9	4.4	2.5	1.9	2.7	2.3	2.2	2.5	2.5	3.3	4.0	3.4	0.0	0.5	5.5	2.1	0.3	0.9	1.3	2.2	10.3	1.4	2.8	8.0	0.0	0.5	0.0	6.2	0.8	1.6	0.1	3.9	1.6	1.0	0.6	4.9	3.2	1.2	0.0	9.2	0.9	1.6	3.8	2.6	0.6	5.7	2.5	2.5	1.3	0.5	6.7	15.5	0.6	4.1	0.3	0.3	0.2	2.1	0.8	0.0	3.7	0.5	3.4	3.1	23.6	29.7	0.4	1.3	2.2	1.1	0.5	0.1	3.1	0.4	6.0	6.6	6.4	4.2	5.6	3.2	2.7	0.0	0.1	1.3	2.6	0.3	0.4
ZFP41	"FLJ00028, FLJ38705, ZNF753"	ENSG00000181638	"ZFP41 zinc finger protein"	Q8N8Y5	8	143246821-143262705	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: AB_2683082"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (4.92e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.20e-1)"	2.9	3.5	5.4	2.3	6.6	1.5	2.8	2.8	6.9	3.6	0.0	3.8	3.4	4.2	1.4	2.9	4.1	1.9	3.1	4.9	6.6	3.9	3.4	2.2	2.6	7.8	5.6	5.3	3.5	4.0	5.3	1.1	5.7	3.7	1.5	2.4	4.8	2.6	3.2	4.9	3.6	2.0	2.4	3.2	3.6	6.3	8.2	2.4	4.1	1.8	2.1	3.4	3.0	9.7	6.7	10.5	4.5	6.0	5.1	3.9	5.3	4.0	2.1	7.6	5.2	5.2	5.5	3.7	5.8	5.2	7.7	5.4	4.9	5.2	3.7	5.9	6.0	4.7	5.6	4.1	7.1	1.8	2.8	4.1	7.2	4.9	7.2	5.2	3.6	2.6	10.1	3.5	3.6	12.0	5.0	2.0	6.7	8.2	10.3	2.6	3.7	1.3	3.3	6.0	5.7	7.8	11.2	3.0	5.9	3.8	7.7	3.6	3.8	5.7	10.2	4.5	6.4	5.6	4.6	1.7	5.1	4.5	7.7	0.0	0.1	0.0	0.3	0.2	0.5	0.1	0.2	0.2	0.1	0.2	0.4	0.3	0.0	0.1	0.0	0.9	0.2	0.2	5.4	6.6	2.8	6.9	4.9	6.6	7.8	5.6	5.7	2.4	8.2	9.7	1.6	0.0	2.0	2.9	2.3	1.1	0.7	0.8	0.6	2.5	2.3	1.9	3.2	5.7	1.1	3.7	6.2	0.3	0.8	3.7	1.9	1.9	1.5	1.8	2.3	1.6	3.0	0.8	2.2	0.9	1.1	1.6	2.6	1.2	0.0	2.7	2.5	3.9	1.2	6.7	3.4	2.4	2.0	2.2	0.5	2.6	1.2	1.5	1.8	1.0	0.9	2.5	2.1	1.5	4.4	1.6	4.1	2.2	1.6	0.5	3.4	1.4	3.2	2.0	0.0	1.6	1.9	7.9	3.7	1.8	0.3	0.3	0.9	1.6	3.4	0.4
ZFP62	"FLJ34231, ZET, ZNF755"	ENSG00000196670	"ZFP62 zinc finger protein"	Q8NB50	5	180847611-180861285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048629	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Actin filaments"		"HPA048629: AB_2680467"	"unprognostic (2.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.49e-2)"	"unprognostic (7.11e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-2)"	"unprognostic (2.29e-3)"	7.8	7.1	8.1	12.6	8.9	4.5	13.8	12.8	10.5	12.1	7.0	14.2	13.4	13.6	15.0	13.1	15.4	9.6	9.4	7.5	10.3	11.4	6.6	9.5	18.7	8.4	7.5	19.7	11.2	13.7	8.6	9.8	7.9	12.9	17.2	18.3	11.6	11.4	14.2	15.7	13.5	10.4	5.8	13.9	16.0	8.9	7.8	24.9	23.6	14.1	20.2	10.8	11.2	11.0	13.7	10.5	21.2	28.4	14.9	13.5	26.4	13.8	10.4	11.0	15.3	24.9	33.5	34.2	21.7	6.2	12.9	20.0	10.2	24.7	16.6	58.2	19.0	19.3	30.8	8.4	10.2	17.2	11.0	10.6	20.0	11.5	20.8	17.1	10.2	19.6	16.0	18.0	15.2	31.8	25.2	9.5	14.8	12.5	24.6	22.2	22.3	19.3	9.3	24.4	28.1	19.1	20.1	15.3	15.1	15.0	23.0	15.4	14.6	17.0	14.8	8.3	14.0	18.7	23.4	16.8	14.1	22.9	13.5	6.9	2.1	2.6	2.5	2.9	4.8	4.4	3.4	3.6	2.2	4.8	6.1	5.5	1.0	3.4	3.5	2.5	3.7	2.9	8.1	8.9	12.8	10.5	7.5	10.3	8.4	7.5	7.9	5.8	7.8	11.0	10.5	9.6	11.0	5.5	12.2	7.1	8.9	10.8	11.4	8.2	9.4	11.9	11.4	8.6	7.2	0.0	2.1	6.2	6.8	12.9	15.6	9.7	24.3	9.5	5.8	8.3	10.3	12.4	9.1	16.5	6.7	6.7	7.1	7.9	8.8	16.3	9.7	5.0	6.4	1.7	9.3	17.6	8.2	5.9	4.0	28.0	17.1	5.4	5.4	6.5	7.8	11.4	9.2	9.0	10.1	14.9	7.8	11.7	11.8	8.3	15.3	9.8	6.6	13.1	13.1	7.4	8.2	30.0	14.8	7.2	4.7	5.6	9.9	11.0	15.8	8.5
ZFP64	"dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338"	ENSG00000020256	"ZFP64 zinc finger protein"	Q9NTW7	20	52051663-52204308	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035112, HPA058387"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA035112: AB_10672859, HPA058387: AB_2683702"	"unprognostic (3.86e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (4.68e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	4.2	4.8	5.8	5.7	5.5	5.3	4.6	5.2	5.5	5.7	3.0	6.3	6.6	5.7	4.2	7.0	6.7	5.3	4.8	5.1	3.4	4.7	5.2	4.5	6.6	4.7	3.4	7.8	5.6	7.2	4.7	4.3	4.6	6.3	5.7	5.0	5.8	5.7	5.4	11.2	5.9	5.5	2.6	5.7	5.9	6.6	4.5	7.3	6.8	4.5	5.3	5.6	6.1	5.6	35.1	19.6	14.7	35.1	7.2	13.0	21.0	11.9	17.3	25.5	21.1	18.8	14.3	15.5	23.2	21.5	21.1	46.2	12.0	26.6	15.6	6.6	37.5	9.3	35.0	20.1	19.9	10.4	6.6	11.3	39.4	13.0	14.8	13.0	17.6	16.4	11.2	19.5	6.4	14.6	14.5	8.9	14.8	19.0	15.1	15.9	7.6	15.6	12.1	13.9	15.2	18.0	23.1	28.6	22.5	12.0	19.2	12.3	11.6	18.0	26.1	19.7	7.7	21.1	20.6	12.6	17.2	10.3	12.2	5.1	3.3	8.1	4.5	1.8	3.3	5.1	3.4	3.6	4.2	3.2	3.8	3.7	1.8	5.3	4.8	4.1	3.3	2.8	5.8	5.5	5.2	5.5	5.1	3.4	4.7	3.4	4.6	2.6	4.5	5.6	4.7	3.2	3.3	7.2	5.4	8.7	4.3	5.4	19.9	5.1	5.1	3.9	4.0	4.3	2.5	0.0	2.1	4.3	6.2	7.5	7.9	8.2	7.4	3.9	4.4	4.2	6.7	5.5	18.0	5.8	8.5	5.9	9.7	3.9	7.0	5.2	9.3	6.1	4.0	1.7	15.5	9.5	8.2	4.1	4.2	9.1	6.5	2.9	3.6	14.0	4.0	2.7	7.2	15.6	18.6	5.4	6.0	7.2	11.6	3.5	5.3	4.9	4.0	4.7	6.6	3.8	5.5	19.7	2.9	11.3	13.4	1.2	5.8	3.9	9.0	2.6
ZFP69	"FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A"	ENSG00000187815	"ZFP69 zinc finger protein"	Q49AA0	1	40477290-40496343	"Predicted intracellular proteins, Transcription factors"	"Lipid metabolism, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	5	"THP-1: 58.2"	"Not detected"	"Not detected"							"HPA027808, HPA054942"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA027808: AB_10601031, HPA054942: AB_2682644"	"unprognostic (1.07e-2)"	"unprognostic (6.00e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (7.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.81e-1)"	2.0	1.3	2.8	2.3	3.1	1.9	2.0	2.6	2.8	2.4	2.0	2.7	1.9	2.4	2.2	2.0	2.3	1.7	1.8	2.5	2.6	2.2	2.0	2.3	2.9	2.9	2.8	2.6	2.4	2.5	1.3	2.2	2.8	2.5	1.9	2.0	1.7	2.3	0.5	2.8	2.4	2.6	2.6	3.1	2.1	3.6	2.8	3.0	2.1	0.8	2.9	2.7	2.1	3.2	5.4	0.0	3.1	4.1	3.8	3.9	5.3	2.9	3.4	4.4	5.0	2.8	4.2	9.6	3.7	4.6	5.7	4.3	6.0	2.5	5.0	8.7	4.1	7.2	5.3	4.8	3.0	0.1	7.4	4.0	6.2	2.9	4.5	1.4	2.6	0.2	4.2	0.1	2.5	2.8	7.5	9.1	5.9	0.5	0.1	4.1	11.0	4.5	2.4	4.0	4.1	6.5	4.9	4.5	8.3	4.8	0.1	58.2	1.1	2.0	4.0	5.6	0.3	0.2	7.6	5.9	3.7	1.5	5.6	0.0	0.1	0.0	0.5	0.1	0.6	0.3	0.4	0.6	0.2	0.2	0.2	0.6	0.0	1.9	0.1	0.0	0.2	0.2	2.8	3.1	2.6	2.8	2.5	2.6	2.9	2.8	2.8	2.6	2.8	3.2	1.5	6.4	0.0	2.3	2.4	1.0	0.4	0.2	4.0	1.4	0.6	0.6	1.5	0.0	0.1	0.0	0.0	1.2	1.8	0.7	1.9	1.5	15.1	0.8	1.4	2.2	0.0	2.1	2.7	1.3	1.8	1.5	1.1	0.6	0.0	2.6	0.7	1.1	1.3	0.0	2.7	0.9	2.0	1.0	1.9	3.5	1.2	1.4	1.8	2.8	2.4	1.5	2.1	6.6	5.4	1.1	0.3	1.9	3.6	0.4	0.3	0.5	0.8	0.9	0.0	1.4	1.4	4.1	4.6	1.5	0.4	0.3	1.9	1.5	1.3	0.3
ZFP69B	"FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B"	ENSG00000187801	"ZFP69 zinc finger protein B"	Q9UJL9	1	40450102-40463718	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.2;Inhibitory neurons: 7.9;Oligodendrocyte precursor cells: 11.1;Spermatogonia: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044289	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA044289: AB_10962717"	"unprognostic (2.01e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.05e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-5)"	"unprognostic (1.64e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.89e-1)"	0.4	0.5	1.7	1.7	1.4	0.4	0.9	0.0	2.9	0.9	0.0	0.9	0.9	1.4	0.7	0.7	0.5	1.1	0.6	1.3	0.5	0.4	0.8	0.5	1.4	0.2	0.5	0.6	1.0	0.7	0.5	0.4	1.0	0.6	1.0	1.5	0.4	0.6	0.4	0.5	0.6	1.0	0.0	0.8	0.9	1.4	1.0	1.9	0.9	0.3	1.9	1.2	0.3	1.2	3.6	1.5	6.1	14.8	2.2	5.8	1.7	3.5	3.2	1.5	2.9	1.6	2.3	6.9	3.3	3.0	3.0	1.3	3.1	3.0	3.4	6.0	1.3	2.8	3.5	5.2	1.5	0.4	4.4	1.3	4.9	5.4	7.1	1.5	2.1	9.0	7.5	6.9	4.6	2.5	9.4	0.6	8.1	1.3	1.5	5.3	5.9	3.3	3.0	3.5	8.0	8.4	5.6	4.6	2.4	3.4	2.4	8.0	4.6	4.9	10.4	4.6	5.0	10.4	10.6	14.8	6.5	0.9	5.2	0.0	0.1	0.3	0.9	0.7	1.2	0.6	0.6	0.5	0.4	0.6	1.2	1.0	0.0	0.6	0.2	0.1	1.4	0.3	1.7	1.4	0.0	2.9	1.3	0.5	0.2	0.5	1.0	0.0	1.0	1.2	1.1	0.0	0.0	1.3	2.4	0.3	0.6	0.3	0.0	3.4	0.8	0.6	0.7	0.0	0.2	1.8	0.0	0.6	1.0	0.1	0.0	1.2	0.0	0.8	1.6	1.3	0.0	0.4	10.2	0.2	1.4	0.7	1.1	0.5	0.0	3.2	1.1	0.1	1.1	0.0	7.9	0.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	1.0	1.1	0.9	3.1	11.1	1.8	1.1	0.3	0.4	2.4	0.3	0.2	0.2	0.1	2.2	0.0	0.9	1.3	1.8	5.7	0.3	0.1	0.0	1.5	0.9	0.4	0.2
ZFP82	"KIAA1948, MGC45380, ZNF545"	ENSG00000181007	"ZFP82 zinc finger protein"	Q8N141	19	36383120-36418644	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051669, HPA060470"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA051669: AB_2732568, HPA060470: AB_2684290"	"unprognostic (1.52e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.14e-4)"	"unprognostic (9.63e-2)"	"unprognostic (9.17e-4)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.91e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.05e-1)"	2.1	2.1	4.5	1.3	4.8	0.7	2.7	6.4	6.8	3.6	3.4	2.7	0.7	3.1	4.2	0.9	3.0	1.9	2.6	4.5	4.7	2.3	0.6	1.5	2.6	3.9	4.3	4.4	1.2	2.7	3.1	2.4	3.9	2.7	1.1	5.1	1.4	1.8	0.8	0.9	1.7	2.2	3.9	2.7	1.3	2.5	4.3	2.9	4.1	1.1	2.6	3.0	2.3	4.8	0.1	2.8	8.6	7.3	2.0	2.8	2.7	2.9	3.2	5.0	6.3	1.3	1.0	7.0	5.5	3.2	4.8	0.3	0.0	0.8	6.1	4.6	4.0	7.2	1.5	1.6	4.9	0.0	5.7	3.8	1.1	3.4	0.9	0.0	2.2	9.8	0.1	0.1	5.3	0.0	12.2	0.1	4.8	0.0	1.2	8.8	5.2	1.5	2.8	3.9	0.4	8.6	0.0	0.6	4.0	6.4	1.7	4.1	0.5	2.1	2.8	4.3	5.6	5.6	3.7	10.0	0.1	0.1	4.6	0.2	0.5	0.7	2.7	0.5	2.6	4.8	2.6	3.0	1.3	4.3	4.0	3.6	0.4	2.5	0.6	1.6	1.7	1.5	4.5	4.8	6.4	6.8	4.5	4.7	3.9	4.3	3.9	3.9	4.3	4.8	3.6	0.0	6.4	7.5	9.0	1.0	2.3	2.4	1.8	20.3	3.7	3.6	4.6	1.5	3.4	5.5	22.9	7.8	3.5	0.1	9.8	6.0	11.2	2.2	4.6	5.9	3.0	1.7	16.4	1.4	5.9	5.5	0.5	1.7	6.3	11.4	3.3	0.6	4.4	33.7	19.0	0.3	6.1	2.6	3.4	2.5	5.9	3.5	5.4	6.5	1.4	7.9	3.1	21.1	22.1	1.1	0.2	7.5	3.2	1.9	0.4	4.8	6.1	11.8	19.7	4.7	5.0	17.5	9.1	0.6	0.6	1.4	5.7	7.6	0.9	1.2
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein, atypical E3 ubiquitin ligase"	Q96JP5	11	58579063-58621550	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 243.7;Late spermatids: 179.3;Spermatocytes: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024037, CAB025417, HPA065325"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"		"CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	25.0	22.0	27.8	23.0	32.3	59.2	21.9	28.0	33.4	22.0	16.0	28.9	25.9	22.4	17.6	24.4	19.9	21.5	29.8	22.9	26.9	25.1	30.7	21.3	24.8	26.5	28.8	20.2	22.8	29.8	15.3	20.3	27.1	19.3	33.5	29.8	20.2	22.6	53.2	25.7	29.0	24.4	28.8	24.3	21.1	86.4	28.4	36.7	25.9	45.3	26.2	27.5	20.4	32.8	65.4	36.3	42.0	43.3	39.6	47.5	23.1	52.3	98.3	59.6	50.7	19.9	67.1	77.5	50.6	66.9	59.4	56.7	43.2	56.0	77.9	41.3	24.3	51.2	36.5	21.9	44.9	65.3	80.9	41.8	53.8	83.9	97.3	49.4	60.0	51.5	51.4	71.4	77.7	21.7	56.8	36.1	22.2	37.6	35.4	43.4	71.0	51.8	43.8	60.9	45.1	35.9	67.2	61.0	86.8	22.7	68.2	48.5	67.8	74.8	51.4	114.0	59.3	41.0	32.3	62.9	66.2	36.1	78.1	1.3	1.4	1.0	1.5	1.2	0.8	1.3	0.9	0.9	1.4	1.1	0.9	1.2	1.5	1.0	1.3	2.0	0.8	0.8	27.8	32.3	28.0	33.4	22.9	26.9	26.5	28.8	27.1	28.8	28.4	32.8	24.6	25.6	33.6	0.0	29.1	60.2	26.1	20.6	44.3	31.9	25.4	17.9	45.7	38.6	20.6	18.4	16.7	12.1	31.7	46.2	13.7	23.7	243.7	30.1	33.7	28.8	25.2	46.7	0.0	31.2	11.4	31.3	23.9	40.9	50.6	32.5	27.5	51.3	16.6	35.3	0.0	27.6	12.2	45.3	55.9	179.3	30.7	36.5	23.2	0.0	36.4	21.1	25.7	0.0	0.0	29.5	18.6	27.1	26.2	35.0	34.6	26.7	24.2	22.4	19.7	34.7	27.6	140.9	41.1	53.7	66.5	13.8	24.2	17.9	39.1	43.4
ZFPM1	"FOG, FOG1, ZC2HC11A, ZNF89A"	ENSG00000179588	"Zinc finger protein, FOG family member 1"	Q8IX07	16	88453280-88537031	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 35.3;Muller glia cells: 58.0;Theca cells: 37.4"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 12.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 19.3;K-562: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046603	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA046603: AB_2679718"	"unprognostic (1.29e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.49e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (4.24e-4)"	2.1	2.5	4.8	1.9	2.4	9.2	1.9	5.7	5.8	2.3	4.2	1.7	12.4	2.2	1.0	1.8	4.0	1.5	4.8	5.8	2.1	3.7	8.6	2.1	2.7	3.5	3.2	2.2	10.4	1.4	5.6	0.8	2.6	3.2	0.8	0.7	2.8	1.3	1.6	3.7	6.8	0.2	1.6	4.9	13.7	5.7	3.3	1.5	4.0	0.3	1.2	2.3	2.0	1.6	1.4	3.8	2.8	5.9	0.5	0.1	11.9	4.0	0.5	1.3	0.4	12.1	1.5	5.9	3.0	0.6	1.4	9.5	0.1	3.3	0.3	4.6	2.5	19.3	8.1	10.7	2.1	1.1	6.2	1.3	2.1	1.4	0.5	1.4	1.3	1.6	29.2	0.4	1.0	7.3	6.9	7.0	1.9	9.3	3.2	2.0	1.3	2.9	1.3	4.8	7.7	12.8	4.9	0.3	3.9	1.4	3.1	3.1	4.8	4.9	3.1	2.2	0.8	1.4	1.0	0.5	1.4	2.3	4.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	2.4	5.7	5.8	5.8	2.1	3.5	3.2	2.6	1.6	3.3	1.6	16.7	3.2	2.2	12.4	4.8	0.9	6.1	0.7	0.0	20.7	13.5	25.8	17.2	5.7	0.4	1.8	29.2	0.4	27.5	10.8	1.9	1.3	0.7	24.1	23.7	6.3	6.0	4.8	6.8	5.1	0.2	10.9	14.3	20.1	0.0	16.0	5.0	8.8	0.9	35.3	8.0	6.7	0.0	5.3	1.2	1.1	0.9	7.5	1.8	8.4	1.6	58.0	2.1	5.5	13.4	2.9	6.2	1.5	9.5	1.4	1.3	1.3	0.4	23.9	0.0	16.1	12.4	0.7	1.0	1.9	1.4	0.3	9.6	37.4	5.2	2.1
ZFPM2	"FOG2, hFOG-2, ZC2HC11B, ZNF89B"	ENSG00000169946	"Zinc finger protein, FOG family member 2"	Q8WW38	8	104590733-105804539	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Gonadal differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.2;ovary: 33.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 115.2;Excitatory neurons: 524.4;Inhibitory neurons: 159.8;Microglial cells: 152.7;Oligodendrocyte precursor cells: 689.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 64.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.4;BJ hTERT+: 14.2;HHSteC: 9.9;hTEC/SVTERT24-B: 5.7;HUVEC TERT2: 10.9;K-562: 6.0;TIME: 6.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 39.4"	HPA004094	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA004094: AB_1859058"	"unprognostic (4.48e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-6)"	"unprognostic (4.10e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.61e-2)"	12.2	2.8	7.4	1.5	3.1	0.0	4.5	64.2	12.7	6.5	0.0	4.3	0.5	10.7	2.3	4.5	12.3	5.8	10.2	16.4	3.5	1.1	2.7	3.8	2.7	11.9	5.7	33.3	0.7	0.4	1.1	4.2	12.3	0.9	2.1	1.1	1.0	1.9	18.0	1.6	1.9	17.8	0.2	2.9	2.8	4.3	6.3	1.3	6.8	17.2	1.5	7.0	4.9	3.4	0.0	0.0	6.4	0.0	5.4	1.7	0.0	0.5	14.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	4.9	1.6	0.0	0.0	9.9	0.0	0.0	0.5	0.0	5.7	0.0	1.9	10.9	0.0	6.0	0.0	1.3	0.0	1.4	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	4.3	0.0	6.5	0.3	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	3.1	64.2	12.7	16.4	3.5	11.9	5.7	12.3	0.2	6.3	3.4	10.0	0.0	0.6	115.2	0.1	3.6	0.3	0.0	0.6	2.9	0.1	0.3	21.3	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	55.2	0.6	9.8	7.9	0.0	0.0	524.4	0.0	0.1	17.1	1.1	1.5	0.0	24.6	7.1	0.0	0.3	8.4	159.8	0.2	0.0	0.0	1.7	34.0	23.9	0.3	1.8	152.7	0.6	0.1	0.0	689.7	10.0	0.1	0.0	13.5	0.0	0.6	0.0	0.0	0.0	0.7	6.6	22.5	8.1	0.9	2.2	0.1	2.8	0.4	0.2	1.4	0.2	0.4
ZFR	"SPG71, ZFR1"	ENSG00000056097	"Zinc finger RNA binding protein"	Q96KR1	5	32354350-32444740	"Predicted intracellular proteins"		"Developmental protein, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016666	Supported		Approved	Nucleoplasm		NA	NA		8100	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA016666: AB_1859060"	"unprognostic (7.45e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	26.6	28.3	32.2	21.8	36.4	30.9	26.8	32.5	37.6	26.6	23.9	22.1	18.5	27.9	21.7	26.0	27.9	23.6	34.4	34.4	32.2	29.5	24.9	19.5	26.7	31.8	32.2	38.4	26.0	31.3	14.2	35.5	32.2	26.2	22.5	36.7	27.7	24.7	42.4	16.1	21.0	27.4	33.0	22.6	21.2	30.2	32.6	31.6	34.1	41.3	26.3	28.7	17.3	36.8	45.1	65.8	75.4	47.2	81.4	59.3	65.8	68.0	57.3	70.5	50.3	65.9	39.0	65.7	43.2	66.8	92.0	34.4	99.0	48.1	98.4	62.4	55.3	80.5	66.9	65.3	71.2	83.7	63.6	56.7	59.1	74.7	135.8	63.9	53.9	31.9	82.0	53.9	73.1	34.0	73.7	35.4	55.5	47.3	48.7	59.2	101.3	36.1	52.7	73.1	41.9	44.2	101.1	58.2	60.8	53.1	36.1	102.0	61.4	69.5	65.0	51.9	57.4	26.7	50.3	72.6	51.4	66.2	86.2	35.3	15.5	19.8	15.6	24.2	18.1	16.6	14.9	16.1	17.3	13.1	14.2	14.3	10.1	22.9	24.9	9.1	15.1	13.2	32.2	36.4	32.5	37.6	34.4	32.2	31.8	32.2	32.2	33.0	32.6	36.8	48.0	51.3	55.4	80.0	55.1	26.0	70.6	47.0	61.5	61.2	39.4	34.9	108.7	34.3	63.7	31.3	22.9	40.1	51.4	28.3	49.0	51.7	53.1	47.7	62.1	51.6	39.5	36.6	109.5	35.9	31.3	66.0	34.1	48.6	76.5	50.4	40.4	35.8	32.7	77.4	98.5	26.1	52.9	35.8	31.3	35.6	53.1	47.3	30.2	74.0	53.9	70.8	52.5	117.6	171.4	44.9	39.6	60.9	52.3	69.8	28.7	45.6	56.3	55.4	39.5	81.2	70.9	118.5	71.8	53.1	24.6	55.5	50.1	65.3	34.1	55.7
ZFR2	KIAA1086	ENSG00000105278	"Zinc finger RNA binding protein 2"	Q9UPR6	19	3804024-3869038	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.0;pituitary gland: 26.1;retina: 10.9;testis: 13.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.7;Cone photoreceptor cells: 27.1;Early spermatids: 25.3;Excitatory neurons: 39.3;Horizontal cells: 32.0;Inhibitory neurons: 42.7;Rod photoreceptor cells: 38.5;Spermatocytes: 29.4"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 16.3;NTERA-2: 31.7;SiHa: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043275, HPA055678"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA043275: , HPA055678: AB_2682883"	"unprognostic (1.74e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.60e-3)"	"unprognostic (5.47e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.18e-2)"	0.2	2.5	9.6	0.4	9.5	0.2	0.1	0.3	17.0	0.3	0.0	0.5	0.0	0.1	0.0	0.1	0.7	0.1	0.3	7.9	10.9	0.2	0.1	0.3	0.2	3.9	3.0	0.1	0.4	2.5	26.1	0.0	4.0	0.4	0.1	10.9	0.1	0.1	0.1	0.2	0.3	0.0	1.3	0.3	0.3	13.4	8.0	0.0	0.3	0.0	0.2	0.1	0.2	5.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.5	0.8	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	31.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.1	0.5	6.9	0.0	0.4	1.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	1.0	0.0	0.0	1.1	0.0	1.2	0.0	0.7	0.5	0.0	0.2	1.0	0.8	0.2	0.4	0.0	0.0	0.2	0.3	9.6	9.5	0.3	17.0	7.9	10.9	3.9	3.0	4.0	1.3	8.0	5.3	0.2	0.0	1.1	2.9	0.2	1.0	0.5	0.1	0.0	33.7	0.2	1.0	1.6	0.0	0.0	0.0	27.1	0.0	1.1	0.0	0.0	0.5	25.3	0.7	0.2	0.5	0.0	0.0	39.3	0.2	0.1	0.2	1.1	0.2	1.3	0.3	0.0	0.1	0.1	32.0	42.7	0.2	0.0	0.0	0.4	11.0	0.9	0.2	1.8	1.9	0.1	4.4	1.0	16.1	4.5	0.2	0.0	0.0	0.3	0.4	0.0	0.3	1.5	38.5	0.0	0.6	0.2	29.4	15.9	0.0	0.1	0.0	1.5	0.1	0.0	0.4
ZFX	ZNF926	ENSG00000005889	"Zinc finger protein X-linked"	P17010	X	24149173-24216255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001748, HPA003877, HPA071863"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.22e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.95e-2)"	13.2	6.8	9.8	8.8	13.4	29.5	10.5	21.2	10.8	12.6	8.4	9.9	6.8	15.6	9.7	7.3	12.5	6.9	8.8	7.1	12.9	8.0	10.2	8.6	11.6	10.7	13.4	17.3	9.9	15.4	6.0	13.7	9.4	14.8	6.1	10.3	7.4	11.3	15.1	8.0	8.1	14.5	9.8	12.3	8.0	4.7	12.4	17.3	10.7	12.5	10.0	9.1	11.3	14.3	13.8	17.6	19.3	20.9	23.4	16.4	9.2	12.9	11.9	13.5	14.6	11.4	9.4	15.0	17.1	19.5	31.3	17.5	19.4	23.3	18.1	15.4	26.9	14.4	63.3	6.2	9.8	18.2	24.4	14.3	7.4	27.1	34.1	15.3	17.2	9.4	16.5	16.9	9.7	6.6	14.2	12.5	10.3	6.0	13.7	18.8	15.4	13.9	8.8	21.4	9.6	14.4	37.9	14.5	11.8	11.7	9.6	10.0	18.3	12.6	7.4	18.3	8.9	9.5	13.7	15.3	9.3	7.7	14.4	9.6	6.5	10.2	6.9	7.6	7.2	5.9	6.5	7.1	7.1	9.4	6.5	6.1	11.8	6.8	7.0	4.8	4.1	5.5	9.8	13.4	21.2	10.8	7.1	12.9	10.7	13.4	9.4	9.8	12.4	14.3	35.4	19.2	12.0	38.2	37.7	22.0	18.1	14.5	19.4	19.1	29.6	17.5	16.6	30.0	19.9	7.3	20.9	56.6	60.7	21.0	5.9	14.4	2.0	29.2	48.1	26.2	20.4	16.4	32.4	16.1	13.6	29.2	16.3	30.6	27.9	39.9	24.7	26.6	17.1	15.2	33.6	16.6	4.1	24.3	26.2	5.7	35.8	31.2	30.2	47.8	28.8	15.7	22.6	49.8	52.6	14.8	17.1	35.7	34.1	21.6	14.8	11.5	15.4	22.7	32.9	47.3	36.2	18.2	27.1	15.1	20.9	20.7	34.0	29.8	14.5	20.5
ZFY	ZNF911	ENSG00000067646	"Zinc finger protein Y-linked"	P08048	Y	2935281-2982506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.7;Late spermatids: 88.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001748, HPA071863"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA071863: AB_2686463"			"unprognostic (1.07e-1)"		"unprognostic (7.43e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"		"unprognostic (2.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.91e-1)"		"unprognostic (2.54e-2)"	2.6	1.7	0.6	2.5	0.8	8.0	2.1	3.3	2.1	0.0	1.0	2.3	2.7	0.0	3.0	4.6	0.0	3.1	1.9	0.6	1.0	1.7	4.4	1.7	1.3	0.8	0.9	0.0	2.6	1.9	1.6	3.8	0.9	5.0	5.0	2.3	2.7	4.0	3.4	1.8	4.2	0.0	0.7	2.2	2.5	7.2	0.6	0.0	2.8	7.4	3.7	3.2	0.0	1.2	0.0	5.9	0.0	0.0	0.0	0.0	9.3	13.6	13.5	11.5	10.7	0.0	0.0	10.0	0.0	14.6	0.0	0.0	0.0	0.0	14.7	15.5	0.0	19.2	0.2	7.6	9.6	0.0	0.0	10.6	9.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	12.8	0.0	8.5	0.0	4.9	0.0	0.0	0.0	8.1	5.2	7.6	17.7	9.8	0.0	0.0	0.0	13.4	6.4	0.0	6.5	11.7	11.3	0.0	0.1	7.3	6.7	0.0	17.5	1.8	0.0	0.0	0.0	2.7	2.2	2.3	1.8	3.1	2.0	2.5	1.3	2.8	2.4	2.7	1.4	1.5	2.9	1.5	2.0	1.6	1.8	0.6	0.8	3.3	2.1	0.6	1.0	0.8	0.9	0.9	0.7	0.6	1.2	0.0	9.6	10.5	7.2	14.7	11.1	10.6	6.8	10.2	12.4	0.0	0.0	7.6	7.2	10.3	1.8	8.4	5.0	8.0	1.0	0.0	4.4	35.7	0.0	0.0	5.8	1.8	11.1	14.1	0.0	2.8	7.8	11.7	0.0	7.0	0.0	10.0	3.7	3.4	13.5	11.3	1.9	2.0	11.3	12.6	88.9	9.9	10.5	3.6	6.5	8.0	12.1	18.6	7.5	6.7	1.3	0.0	10.9	12.2	11.7	1.9	3.3	7.5	8.6	13.1	6.5	5.9	20.3	7.7	12.8	9.5	3.7	12.7	0.1	2.4	12.0
ZFYVE27	"FLJ32919, SPG33"	ENSG00000155256	"Zinc finger FYVE-type containing 27"	Q5T4F4	10	97737121-97760907	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037523, HPA069876"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA037523: AB_10672351, HPA069876: AB_2686218"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (7.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (7.80e-4)"	14.4	27.9	33.1	12.9	32.1	23.2	15.8	29.2	35.9	20.6	34.8	25.6	24.8	16.5	22.9	16.5	20.3	12.1	17.8	35.5	33.6	28.3	32.6	17.7	16.1	32.6	31.4	25.9	23.7	19.2	38.3	9.5	33.2	22.0	16.3	28.4	18.9	10.3	12.8	18.2	30.6	8.5	29.1	29.1	19.8	23.0	33.5	12.7	20.4	5.9	13.1	16.8	17.0	32.4	17.7	21.4	12.6	28.1	14.1	9.8	17.2	17.7	18.5	20.3	19.7	19.1	35.9	27.2	19.8	12.8	25.9	38.8	18.4	17.2	10.6	28.3	18.6	12.9	23.1	18.1	18.1	20.9	24.9	16.0	20.4	19.9	15.2	32.4	11.5	22.5	19.6	17.9	15.3	13.8	16.9	39.4	10.3	15.3	16.4	19.2	12.7	13.0	19.5	10.8	10.1	19.7	11.9	9.9	47.2	11.5	21.8	20.5	12.4	10.2	11.9	15.6	34.2	20.6	18.6	14.3	25.3	26.5	11.9	4.8	5.8	9.3	9.6	6.2	8.2	7.1	6.6	7.9	5.4	6.7	7.5	8.3	8.2	6.8	9.2	5.6	9.5	8.3	33.1	32.1	29.2	35.9	35.5	33.6	32.6	31.4	33.2	29.1	33.5	32.4	10.0	3.2	11.4	14.0	22.1	8.2	12.8	11.3	18.8	29.9	11.1	8.9	7.2	14.3	9.7	14.7	58.4	7.4	21.2	33.9	7.9	14.9	5.2	14.3	7.8	11.0	20.3	14.3	33.6	16.0	5.7	10.1	19.4	11.4	14.0	17.3	10.8	10.9	8.2	37.0	35.2	15.6	14.2	8.8	5.7	1.5	9.6	11.0	10.6	16.9	11.2	14.8	15.5	12.5	20.2	13.9	26.1	9.1	13.4	13.8	35.5	8.6	16.6	43.7	19.7	6.7	9.9	8.9	7.6	10.4	5.5	13.5	17.9	10.9	14.7	17.7
ZFYVE28	"KIAA1643, lst-2"	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418651	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.9;Inhibitory neurons: 93.2;NK-cells: 48.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 12.6;NB-4: 14.2;U-266/70: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: AB_2683477"	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	5.5	8.7	4.6	3.1	7.5	2.1	5.4	49.9	18.0	5.5	0.5	8.0	6.1	4.8	1.6	4.7	5.4	3.4	3.9	7.3	0.3	8.7	6.5	6.2	4.0	9.4	6.9	4.5	5.0	4.3	10.8	1.0	7.4	4.0	2.8	4.0	5.5	2.8	2.9	5.4	8.8	1.5	1.0	6.7	7.2	8.1	5.0	2.6	7.7	1.8	2.0	4.8	4.6	6.2	0.9	1.2	0.2	4.2	2.4	0.8	0.2	2.1	3.5	1.1	0.3	0.1	7.6	0.0	2.2	3.7	2.9	4.4	1.4	0.3	0.7	11.7	1.5	0.3	5.3	0.3	4.8	0.8	12.6	3.3	0.7	1.3	0.1	7.7	3.5	1.1	2.2	9.2	1.0	2.6	0.1	14.2	0.2	2.4	9.3	0.0	0.0	4.7	1.7	0.6	6.6	0.5	2.1	0.1	1.2	0.1	2.8	0.3	0.6	2.0	0.1	6.2	0.2	14.8	11.7	0.2	6.0	2.8	2.0	0.4	0.2	0.0	1.9	0.0	0.8	0.4	1.0	1.3	0.3	1.8	1.3	1.4	0.0	0.2	0.1	0.1	1.9	0.5	4.6	7.5	49.9	18.0	7.3	0.3	9.4	6.9	7.4	1.0	5.0	6.2	12.2	0.0	1.7	41.4	3.7	5.9	3.4	2.1	5.7	12.2	7.6	6.2	3.4	7.2	2.9	11.0	18.8	0.3	25.4	32.3	7.9	3.4	29.1	5.1	4.8	8.0	2.4	1.3	133.9	2.3	0.3	3.6	11.7	6.3	8.9	2.6	5.3	3.7	1.9	8.4	93.2	7.8	2.0	2.2	33.0	8.9	1.5	5.1	7.2	32.8	4.0	1.6	48.4	23.6	36.4	2.6	16.8	2.2	9.8	1.7	18.1	4.2	3.0	17.8	0.0	2.3	3.0	3.1	8.0	6.2	4.8	0.3	31.6	8.2	6.6	5.4
ZG16B	"HRPE773, JCLN2, PRO1567"	ENSG00000162078	"Zymogen granule protein 16B"	Q96DA0	16	2830169-2839585	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	717	"salivary gland: 63926.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 194.0;Basal respiratory cells: 181.6;Breast glandular cells: 154.9;Club cells: 343.9;Intestinal goblet cells: 232.2;Prostatic glandular cells: 398.1;Urothelial cells: 357.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 47.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.3;intermediate monocyte: 11.4;non-classical monocyte: 7.4"	"Lineage enriched"	"Detected in many"	7	"monocytes: 11.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 27.1;OE19: 57.5;SK-BR-3: 24.1;T-47d: 22.2"	"Not detected"	"Not detected"							"HPA041125, HPA053549"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		690000	"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"HPA041125: AB_10794264, HPA053549: AB_2682184"	"unprognostic (5.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (3.48e-6)"	"unprognostic (1.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.33e-2)"	2.5	13.2	0.0	3.9	0.0	4.6	33.1	0.0	0.1	33.0	0.0	13.6	11.5	0.6	1.5	25.3	4.4	34.4	9.0	0.0	0.0	2.6	8.2	3.3	0.3	0.0	0.8	10.3	46.6	30.4	6.0	4.8	0.1	89.1	17.8	0.0	63926.2	7.1	6.1	47.7	9.6	0.4	0.0	4.2	33.2	4.4	0.0	0.2	2.9	0.1	5.9	11.2	16.3	0.0	0.0	1.1	0.0	0.0	0.3	1.9	0.2	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.3	0.0	0.2	2.1	0.0	4.4	0.0	0.0	0.0	9.0	2.8	2.4	1.6	0.0	0.0	0.1	0.2	0.0	1.2	0.1	0.0	0.0	0.2	3.6	0.2	27.1	0.0	0.4	0.1	57.5	5.0	0.0	0.0	8.6	0.2	6.3	0.0	0.0	0.1	24.1	0.0	0.1	22.2	0.0	3.1	0.1	0.5	1.9	0.1	0.0	0.5	0.3	0.3	6.5	0.3	1.7	6.3	0.0	0.0	11.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.4	1.2	7.4	0.0	0.5	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	9.1	194.0	181.6	0.0	0.0	154.9	82.5	0.0	70.1	343.9	1.8	0.0	0.1	2.0	107.1	0.0	5.9	7.7	3.5	1.6	2.8	58.2	0.4	0.0	28.1	3.2	1.8	21.9	13.0	5.7	1.7	0.7	0.1	14.6	0.0	0.0	232.2	140.4	4.6	0.5	5.7	0.0	4.4	83.6	0.0	5.6	0.0	0.0	0.0	0.0	46.4	65.3	0.0	0.0	398.1	12.5	0.0	74.7	0.0	0.0	0.0	19.2	1.4	0.6	9.5	24.0	0.3	2.5	21.3	76.7	357.4
ZGLP1	"GATAD3, GLP-1, GLP1"	ENSG00000220201	"Zinc finger GATA like protein 1"	P0C6A0	19	10304803-10309880	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 9.5;Hofbauer cells: 12.7;Kupffer cells: 20.0;Macrophages: 12.6;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 32.8;U-937: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049855	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA049855: AB_2680916"	"unprognostic (1.73e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-4)"	"unprognostic (2.82e-2)"	"unprognostic (6.57e-7)"	"unprognostic (6.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-4)"	1.9	1.5	5.0	1.0	5.2	0.5	2.3	4.6	10.7	4.0	4.3	2.4	1.0	2.5	0.4	1.9	3.3	0.8	1.7	5.3	4.4	7.8	6.4	2.2	1.7	4.2	4.0	5.2	3.3	0.5	8.3	0.9	4.0	6.8	0.2	0.5	2.5	1.0	1.2	2.1	2.6	0.2	3.7	5.0	1.9	5.0	4.4	0.4	9.2	0.4	0.7	2.6	2.7	4.8	0.5	1.2	1.7	0.6	1.1	0.5	4.3	0.9	0.3	0.8	1.8	1.2	0.4	1.9	0.9	0.3	0.8	1.8	1.2	0.4	0.3	1.6	5.5	1.8	2.0	0.7	0.7	0.0	0.5	0.9	2.5	0.8	0.5	0.7	0.2	1.4	1.8	1.3	1.1	2.0	0.2	32.8	2.7	0.4	2.0	1.8	0.8	0.8	0.7	0.8	1.4	1.6	0.4	0.3	1.6	0.4	2.5	0.6	0.6	2.5	2.9	2.4	0.3	6.2	7.9	0.9	0.4	8.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.2	4.6	10.7	5.3	4.4	4.2	4.0	4.0	3.7	4.4	4.8	1.1	0.0	1.8	4.6	0.5	0.9	0.6	1.2	0.0	1.6	2.0	2.4	0.8	0.0	1.2	1.8	0.0	0.5	0.8	0.9	0.0	0.6	0.8	0.9	1.3	1.1	0.0	0.4	9.5	0.0	0.4	0.6	0.0	0.9	0.0	2.7	0.7	1.2	12.7	6.7	6.9	0.7	0.0	20.0	7.9	1.3	0.9	12.6	3.6	2.8	7.8	1.7	0.0	1.5	1.6	0.3	1.5	0.7	0.1	0.9	0.4	0.4	1.5	1.5	0.0	0.5	0.8	2.2	16.3	0.3	0.9	0.1	0.6	0.8	1.6	0.0
ZGPAT	"dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP"	ENSG00000197114	"Zinc finger CCCH-type and G-patch domain containing"	Q8N5A5	20	63707465-63736142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 123.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 14.2;Gastric mucus-secreting cells: 13.7;Plasma cells: 26.9;Squamous epithelial cells: 11.1;T-cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056705			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA056705: AB_2683213"	"unprognostic (4.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.58e-2)"	"prognostic favorable (6.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-3)"	14.5	17.0	5.3	8.8	5.8	14.8	14.6	5.4	8.9	15.7	7.5	18.0	10.0	16.1	3.4	16.6	14.2	5.5	16.0	5.6	4.7	22.2	123.5	13.0	11.5	7.6	5.4	11.9	14.0	8.4	14.4	6.5	5.9	14.9	3.0	1.4	13.7	6.7	16.7	19.0	14.8	4.9	4.1	20.3	15.3	20.2	5.7	9.5	13.8	4.3	4.1	15.9	15.0	7.4	15.3	19.3	7.4	12.0	6.0	4.2	17.1	15.5	10.1	24.0	10.0	41.6	20.4	15.6	28.9	8.8	23.3	27.4	5.0	18.3	3.0	10.7	13.3	14.8	16.9	43.3	11.7	9.4	25.2	10.7	15.3	9.9	3.9	6.5	13.2	18.5	16.5	13.9	8.0	15.3	22.6	22.1	12.1	22.3	24.0	23.9	5.7	15.7	13.5	14.0	14.0	17.4	22.1	24.7	14.2	3.7	16.9	26.0	15.2	37.2	13.3	14.3	20.1	13.9	24.3	22.2	23.5	9.3	17.0	8.6	21.0	26.5	28.3	21.5	28.1	19.2	24.6	26.3	19.7	16.2	23.9	24.7	21.8	26.4	18.4	28.2	26.2	18.6	5.3	5.8	5.4	8.9	5.6	4.7	7.6	5.4	5.9	4.1	5.7	7.4	0.3	3.2	3.4	4.6	8.0	0.0	0.0	0.1	14.2	1.0	0.2	0.3	0.3	0.0	1.3	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.1	0.4	1.1	2.1	1.8	6.3	7.4	0.2	0.3	3.3	13.7	0.6	2.5	0.5	0.4	2.3	0.2	0.0	5.8	0.2	0.0	1.3	0.0	0.0	0.0	5.4	1.8	8.4	0.0	0.2	0.0	5.5	4.6	0.4	0.1	0.0	26.9	0.2	0.3	0.5	0.1	1.1	0.0	0.5	1.4	0.3	0.1	11.1	0.3	0.3	8.9	0.5	0.2	0.1
ZHX1		ENSG00000165156	"Zinc fingers and homeoboxes 1"	Q9UKY1	8	123248451-123275541	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 146.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055357			Supported	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA055357: AB_2682793"	"unprognostic (4.36e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (8.73e-3)"	"unprognostic (5.61e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.76e-2)"	28.2	14.8	24.5	12.1	24.3	13.5	18.7	27.0	28.1	20.8	21.3	15.6	18.4	17.4	15.2	37.0	18.5	15.1	15.2	23.3	31.9	22.9	39.5	14.4	12.6	25.4	27.7	20.8	17.2	22.8	12.7	14.3	26.5	17.9	14.8	35.0	17.4	18.6	15.5	27.8	19.3	19.2	23.1	15.8	14.8	10.1	24.1	19.8	37.7	19.4	15.0	19.8	17.9	29.4	29.7	13.2	18.0	21.3	34.3	28.3	11.6	35.3	19.6	25.6	29.6	23.5	12.4	44.7	46.1	42.8	11.4	19.6	51.3	32.5	32.4	89.5	26.5	72.6	29.1	14.2	23.3	26.9	33.3	21.4	36.9	35.1	30.0	21.9	20.5	21.2	86.0	34.1	38.3	89.7	62.0	12.1	4.8	62.1	27.7	31.3	16.2	32.0	22.9	66.0	86.3	32.1	40.3	113.6	14.1	10.5	45.4	30.6	19.3	40.1	53.4	32.6	23.8	32.1	95.1	49.6	27.2	49.7	11.2	1.5	3.6	3.6	3.8	6.4	4.8	3.3	4.8	3.5	4.9	3.9	4.5	4.8	1.3	6.5	14.0	2.7	5.7	2.9	24.5	24.3	27.0	28.1	23.3	31.9	25.4	27.7	26.5	23.1	24.1	29.4	35.0	25.6	25.7	0.0	15.7	37.1	28.0	19.7	47.3	46.3	28.8	27.1	30.7	25.8	26.8	20.2	47.9	10.4	22.8	33.5	31.3	16.6	10.9	13.0	52.5	30.8	43.3	19.8	0.0	22.3	6.6	33.0	19.4	13.8	28.5	19.1	28.9	71.5	15.0	146.4	0.0	23.1	14.2	24.2	19.0	21.7	46.6	19.4	26.6	0.0	20.5	46.3	27.8	0.0	0.0	16.7	25.8	64.3	15.3	21.2	35.8	33.2	21.4	34.3	39.5	34.4	38.0	38.5	27.6	84.4	62.5	9.6	20.0	27.0	22.8	29.2
ZHX1-C8orf76		ENSG00000259305	"ZHX1-C8orf76 readthrough"	Q96EF9	8	123226189-123274284	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 26.0"									HPA023708	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.49e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.64e-11)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-2)"	2.7	2.4	1.4	1.1	1.8	8.5	2.5	2.1	1.8	2.3	1.3	1.8	2.0	1.8	1.8	2.8	2.1	1.1	2.5	1.3	1.4	2.3	2.6	2.9	2.4	1.8	1.7	2.3	1.6	1.1	3.6	1.7	1.6	2.5	2.4	2.9	2.5	1.3	4.1	2.5	1.9	1.6	1.2	3.0	1.8	1.4	1.9	2.2	2.1	1.9	2.7	1.9	2.3	2.3	3.4	4.3	3.1	2.2	1.9	2.1	2.0	1.5	1.5	3.6	2.7	3.5	2.6	2.0	1.3	2.5	2.1	2.2	3.5	1.9	5.4	3.5	7.3	5.9	3.1	4.2	1.9	1.2	3.1	2.8	2.8	2.9	1.8	1.5	4.2	5.9	4.9	2.8	3.2	10.6	5.0	3.9	0.8	6.8	4.7	3.9	2.0	2.8	2.5	3.4	4.8	3.4	3.0	26.0	1.6	1.7	3.9	1.1	0.3	1.5	3.0	2.5	3.4	3.9	5.2	4.3	2.1	3.2	1.1	1.7	2.9	4.8	2.0	4.1	1.9	2.7	2.6	1.8	2.5	2.9	2.1	1.8	1.0	2.7	2.9	2.3	4.9	2.0	1.4	1.8	2.1	1.8	1.3	1.4	1.8	1.7	1.6	1.2	1.9	2.3	2.5	0.0	1.1	4.6	2.0	3.1	5.3	2.5	0.0	0.4	2.2	2.0	1.1	1.5	2.7	3.7	0.0	1.9	5.2	0.9	1.9	1.8	1.4	1.0	1.0	1.7	3.0	0.0	2.0	1.8	2.6	1.8	0.0	0.8	0.0	1.7	2.2	0.8	2.7	10.1	2.8	2.2	4.1	1.3	2.1	1.4	0.9	2.0	1.8	0.0	2.4	0.9	3.1	4.5	4.9	2.2	0.5	1.2	0.7	2.9	1.6	1.3	4.3	1.4	0.0	1.6	1.4	2.7	2.5	0.4	1.4	1.0	1.3	0.8	1.4	7.0
ZHX2	KIAA0854	ENSG00000178764	"Zinc fingers and homeoboxes 2"	Q9Y6X8	8	122781655-122974510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 252.1;Microglial cells: 81.5;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 176.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 49.3;REH: 53.1;U-698: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006769, HPA006996"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA006769: AB_10669919, HPA006996: AB_10670555"	"unprognostic (8.28e-2)"	"unprognostic (3.80e-3)"	"unprognostic (6.48e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.61e-3)"	"unprognostic (3.04e-1)"	11.6	11.7	18.5	14.0	25.7	6.8	11.5	19.4	19.5	15.2	10.0	8.8	5.4	14.7	7.0	9.7	15.1	12.3	20.6	18.7	18.6	10.2	15.0	13.8	27.6	23.0	21.4	27.6	17.7	7.7	12.0	6.4	21.8	15.1	6.5	11.7	13.3	9.7	33.8	9.3	12.0	11.5	19.2	15.8	7.9	2.8	21.8	14.2	13.7	21.9	23.2	13.0	10.7	31.3	5.7	2.7	14.9	3.0	7.1	2.2	0.0	3.2	9.9	3.5	4.6	0.6	18.0	49.3	13.0	10.7	2.7	4.7	10.1	6.3	3.8	22.8	7.0	22.3	3.3	17.5	7.9	5.5	7.0	6.4	7.4	3.3	17.2	16.6	4.2	8.9	0.8	16.7	4.2	16.2	5.2	5.1	8.7	2.9	3.7	53.1	8.1	4.1	17.2	13.5	6.6	3.7	12.9	38.8	6.8	9.9	6.6	12.6	6.9	2.8	7.3	3.4	7.0	4.5	0.1	48.4	2.8	4.3	4.7	13.0	1.0	5.5	6.5	1.3	6.8	11.6	4.7	6.3	1.2	10.0	6.8	5.7	5.2	7.0	2.1	5.4	5.2	3.5	18.5	25.7	19.4	19.5	18.7	18.6	23.0	21.4	21.8	19.2	21.8	31.3	6.0	6.4	4.6	252.1	24.8	5.5	5.1	3.4	8.6	1.8	12.0	6.2	11.2	12.8	2.7	9.2	0.0	0.5	19.5	3.5	3.9	10.7	7.7	4.2	9.1	7.1	4.2	1.7	4.4	6.2	0.4	15.4	5.6	11.8	8.2	3.0	5.7	11.5	1.9	5.0	23.5	5.0	8.2	5.5	18.0	2.6	10.5	5.5	10.6	81.5	4.1	12.6	8.2	200.6	176.9	6.2	3.9	19.5	16.6	13.0	4.9	5.2	2.8	0.8	0.0	21.4	9.8	0.6	0.1	8.3	8.8	1.4	16.1	4.2	4.0	10.2
ZHX3	"KIAA0395, TIX1"	ENSG00000174306	"Zinc fingers and homeoboxes 3"	Q9H4I2	20	41178448-41317672	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 370.5;Early spermatids: 106.3;Excitatory neurons: 99.0;Inhibitory neurons: 96.5;Oligodendrocyte precursor cells: 139.7;Oligodendrocytes: 142.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046498			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA046498: AB_2679676"	"unprognostic (6.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.53e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (7.52e-4)"	"prognostic unfavorable (1.84e-5)"	14.4	15.4	33.8	6.5	32.8	3.4	13.3	31.6	27.4	11.6	16.4	19.8	8.6	15.8	5.7	13.6	15.7	8.4	12.2	30.2	27.7	26.4	17.2	11.6	4.5	37.6	32.1	16.3	11.9	15.4	7.8	4.9	29.9	10.6	8.0	10.8	5.7	11.9	28.5	11.0	11.4	12.1	29.4	4.3	15.5	35.0	36.0	7.0	19.0	20.1	4.8	18.1	11.0	28.6	22.5	6.3	6.6	14.2	52.6	56.3	7.6	31.0	35.4	28.3	19.1	11.4	2.9	15.6	14.7	58.5	7.6	7.0	7.9	39.2	30.0	4.3	7.1	6.6	8.6	8.8	21.6	7.6	7.9	34.6	18.7	21.3	27.3	19.2	12.3	11.7	6.2	10.6	38.3	45.0	11.9	4.5	2.9	10.4	23.0	5.8	18.6	6.2	38.6	6.7	23.0	8.3	20.7	12.0	7.4	5.7	11.6	10.5	19.9	70.2	10.8	25.0	15.5	12.2	8.0	6.9	28.9	11.0	11.4	0.1	0.1	0.4	0.2	0.1	0.4	0.6	0.2	0.1	0.2	0.6	0.4	0.3	0.1	0.6	0.2	0.1	0.2	0.1	33.8	32.8	31.6	27.4	30.2	27.7	37.6	32.1	29.9	29.4	36.0	28.6	29.8	19.2	16.4	370.5	4.7	2.9	3.9	2.6	2.8	19.5	6.3	4.7	12.7	17.2	5.8	22.0	4.2	0.6	3.8	5.5	11.7	3.7	106.3	12.3	33.2	15.1	14.9	3.8	99.0	2.7	2.7	20.5	6.6	26.3	1.3	3.7	16.4	31.6	3.0	40.4	96.5	5.6	4.1	3.5	1.7	32.3	18.6	3.5	1.8	52.5	1.9	28.6	1.0	139.7	142.4	4.6	1.3	24.5	2.7	2.6	12.6	27.0	3.2	7.1	26.3	41.2	10.9	11.0	5.2	6.3	3.7	0.4	2.7	19.7	4.7	2.3
ZIC1	"ZIC, ZNF201"	ENSG00000152977	"Zic family member 1"	Q15915	3	147393422-147510293	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 616.8"	"Group enriched"	"Detected in some"	4	"Microglial cells: 25.3;Skeletal myocytes: 61.0"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 616.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 174.0;MCF7: 43.9;U-2197: 28.5"	"Region enhanced"	"Detected in all"		"cerebellum: 207.4"	"Region enriched"	"Detected in all"	8	"cerebellum: 638.1"	HPA004098	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA004098: AB_1859065"	"unprognostic (1.33e-2)"			"unprognostic (1.82e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.19e-1)"		"unprognostic (5.01e-1)"	"unprognostic (2.61e-7)"	"unprognostic (2.95e-3)"	"unprognostic (1.67e-2)"		"unprognostic (3.01e-1)"	3.4	0.7	25.0	0.0	50.7	0.0	0.2	616.8	30.3	0.0	39.0	0.1	0.2	0.0	1.8	0.2	0.0	0.1	0.1	13.6	39.5	0.1	12.8	0.1	0.1	66.8	55.3	0.2	0.1	0.0	2.4	0.0	67.3	0.0	0.1	10.7	0.5	0.0	6.9	2.5	0.8	0.0	23.8	0.0	0.2	0.3	112.1	0.0	0.0	0.8	0.0	0.0	0.0	44.8	0.0	0.0	174.0	0.0	17.9	19.6	9.8	11.4	13.5	12.1	9.9	0.0	0.0	0.0	9.1	0.9	9.2	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.4	0.0	0.7	0.0	0.0	3.1	0.0	10.9	43.9	0.0	0.0	0.5	0.9	0.0	0.0	17.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	17.9	0.0	28.5	11.0	0.0	0.0	0.0	13.5	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	50.7	616.8	30.3	13.6	39.5	66.8	55.3	67.3	23.8	112.1	44.8	0.2	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.9	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.0	25.3	0.0	4.3	0.0	2.0	9.5	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	61.0	0.3	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ZIC3	"HTX, HTX1, ZNF203"	ENSG00000156925	"Zic family member 3"	O60481	X	137566127-137577691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.8;choroid plexus: 4.0;retina: 2.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 4.7;Muller glia cells: 9.6;Rod photoreceptor cells: 1.3;Spermatocytes: 2.0;Spermatogonia: 3.7"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	35	"AF22: 38.8;NTERA-2: 42.8;SuSa: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052936, HPA069523"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA052936: AB_2681993, HPA069523: AB_2732136"					"unprognostic (3.55e-5)"					"unprognostic (3.82e-1)"		"unprognostic (1.95e-1)"			"unprognostic (3.31e-1)"			0.0	0.0	2.9	0.0	3.9	0.1	0.0	13.8	3.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	4.5	0.0	0.0	0.0	0.0	3.5	3.7	0.0	0.0	0.0	0.7	0.0	4.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	42.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	24.8	0.6	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.9	13.8	3.5	1.8	4.5	3.5	3.7	4.0	2.3	4.3	3.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.7	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406809	"Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 68.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.0;Late spermatids: 13.5;Microglial cells: 6.5;Muller glia cells: 5.5;Oligodendrocytes: 6.9;Skeletal myocytes: 6.2"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Region enriched"	"Detected in all"	4	"cerebellum: 68.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.5;ASC diff: 4.7;BEWO: 3.5;MCF7: 4.7;SH-SY5Y: 4.9;U-2197: 3.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"cerebellum: 67.3"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030194: AB_2673367"	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.6	0.0	1.9	0.0	6.6	0.0	0.0	68.5	4.7	0.0	5.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.7	5.5	0.0	0.3	0.0	0.0	10.6	5.8	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	4.8	0.0	0.0	1.3	1.2	0.1	0.0	2.7	0.0	0.0	0.5	10.5	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	16.5	0.0	4.7	1.9	3.5	1.8	0.4	0.2	0.5	0.0	0.0	0.0	2.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.1	0.0	3.9	1.8	0.0	0.0	0.0	1.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.6	68.5	4.7	1.7	5.5	10.6	5.8	9.0	2.7	10.5	15.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	6.5	0.0	5.5	0.0	0.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.2	0.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZIC5		ENSG00000139800	"Zic family member 5"	Q96T25	13	99962964-99971909	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.1;choroid plexus: 8.1"	"Group enriched"	"Detected in some"	7	"Astrocytes: 20.5;Microglial cells: 15.0;Spermatocytes: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 22.0;HEK 293: 12.7;NTERA-2: 15.1;SCLC-21H: 85.5"	"Group enriched"	"Detected in all"	5	"basal ganglia: 18.9;cerebellum: 18.4;thalamus: 5.3"	"Region enriched"	"Detected in all"	7	"cerebellum: 39.7"	HPA074045			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Vesicles"		"HPA074045: "	"unprognostic (2.78e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.38e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.87e-2)"		"unprognostic (1.13e-1)"	"unprognostic (3.12e-2)"		"unprognostic (4.94e-2)"	0.0	0.0	2.8	0.0	3.5	0.0	0.0	17.1	11.2	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	2.8	2.1	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	2.2	22.0	1.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.0	2.1	0.0	3.1	0.0	1.1	0.0	4.5	0.0	0.0	4.0	12.7	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.9	3.3	0.0	0.0	1.7	0.0	1.7	15.1	0.0	0.3	1.9	0.8	0.0	0.0	0.0	85.5	0.0	2.4	2.0	0.0	1.6	0.0	2.8	0.0	1.2	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.5	17.1	11.2	3.9	2.1	2.8	2.1	3.0	1.8	3.1	2.6	0.1	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.0	0.0	1.9	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZKSCAN1	"KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33"	ENSG00000106261	"Zinc finger with KRAB and SCAN domains 1"	P17029	7	100015572-100041689	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 272.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006672	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Mitochondria"	"HPA006672: AB_1080707"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.09e-3)"	12.0	18.4	20.2	11.6	29.1	8.7	22.7	17.2	22.1	16.4	7.4	21.5	18.2	15.5	17.1	18.8	21.7	13.9	10.1	14.4	23.8	13.3	52.8	10.9	11.7	21.3	23.2	19.0	26.1	16.5	10.9	11.0	23.4	23.0	23.5	15.8	25.3	10.8	10.4	32.6	16.9	13.7	13.9	13.5	32.6	11.1	24.1	14.2	11.9	8.8	11.9	12.2	17.4	37.5	17.0	12.3	31.8	34.6	32.0	38.7	12.0	18.6	22.5	10.9	11.0	7.4	15.7	19.1	23.0	20.9	19.1	13.7	18.4	16.1	20.6	18.4	11.3	15.5	15.8	19.3	18.0	29.9	17.7	26.1	25.1	14.7	49.0	29.5	24.4	22.2	36.2	16.3	21.7	22.4	28.4	17.6	12.8	31.6	15.2	16.7	16.2	17.3	18.2	26.4	36.8	44.0	28.9	37.4	32.4	17.8	19.1	19.6	36.8	23.7	23.0	27.9	18.9	18.7	35.3	19.5	16.2	20.8	31.7	16.0	4.0	4.1	5.0	3.1	4.9	3.8	3.9	4.9	5.8	4.8	5.3	3.9	4.2	8.8	9.0	3.9	3.5	3.8	20.2	29.1	17.2	22.1	14.4	23.8	21.3	23.2	23.4	13.9	24.1	37.5	45.3	25.6	55.4	57.5	37.0	15.0	45.7	43.4	71.7	93.9	77.6	38.7	42.8	140.2	61.4	46.0	150.1	41.1	40.1	84.8	15.6	55.9	46.5	89.2	90.9	52.2	220.9	24.6	70.1	43.8	15.3	47.9	103.5	68.0	35.4	120.5	44.6	140.8	19.8	89.2	77.7	99.2	77.3	32.7	18.6	18.4	51.3	31.2	40.9	62.8	45.8	61.2	34.0	102.1	272.5	46.6	81.3	53.4	27.1	93.1	70.4	32.4	153.6	70.1	19.7	87.4	43.9	32.8	16.7	62.9	21.5	65.9	32.3	74.0	114.4	62.0
ZKSCAN2	"FLJ23199, ZNF694, ZSCAN34"	ENSG00000155592	"Zinc finger with KRAB and SCAN domains 2"	Q63HK3	16	25236001-25257845	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Cone photoreceptor cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049141	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus"	"HPA049141: AB_2680652"	"unprognostic (2.71e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.28e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.70e-6)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.03e-2)"	1.2	1.3	2.2	0.9	2.0	1.9	1.7	2.0	1.9	2.1	0.7	1.3	0.6	2.3	1.2	0.6	1.7	1.0	1.9	2.1	2.6	1.5	1.6	1.2	1.2	2.0	2.2	3.8	1.1	2.9	1.6	1.6	2.3	1.6	1.0	4.1	1.2	1.7	3.2	0.6	1.0	1.9	1.8	1.1	1.1	4.2	3.0	2.4	2.1	4.6	1.1	1.2	0.9	2.4	2.0	1.9	8.6	5.4	3.4	3.2	3.5	2.1	3.2	3.1	3.0	5.0	1.4	6.5	2.2	2.5	3.4	1.4	5.8	2.8	3.7	3.6	3.9	3.8	3.4	7.7	4.5	3.1	1.9	4.3	3.3	2.9	4.9	3.2	2.4	4.6	7.0	3.1	2.9	2.0	7.7	3.3	4.7	0.7	1.8	9.0	6.3	1.4	2.5	2.8	6.8	6.8	2.6	2.3	2.3	4.1	2.8	5.0	2.4	5.0	3.3	2.0	3.3	4.1	3.6	7.5	1.7	2.5	3.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.1	2.2	2.0	2.0	1.9	2.1	2.6	2.0	2.2	2.3	1.8	3.0	2.4	1.2	16.0	2.3	4.2	2.4	0.8	2.7	1.3	0.6	7.4	2.0	1.9	3.8	0.0	0.6	1.8	14.6	3.4	1.5	1.1	0.0	1.6	4.4	2.4	3.9	2.1	4.9	0.4	3.3	0.9	2.1	2.5	0.5	2.9	1.3	7.2	0.7	3.2	1.6	6.7	4.9	1.7	2.0	2.4	1.5	2.1	5.0	1.3	1.8	2.8	1.7	4.1	2.1	1.5	4.1	2.2	0.8	3.8	4.1	2.5	1.1	1.4	2.3	8.9	0.0	3.6	1.9	11.4	8.2	1.0	0.6	4.1	1.5	3.9	1.3	1.4
ZKSCAN3	"ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35"	ENSG00000189298	"Zinc finger with KRAB and SCAN domains 3"	Q9BRR0	6	28349947-28369172	"Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA009637, HPA060116"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA009637: AB_2668244, HPA060116: AB_2732641"	"unprognostic (2.71e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.42e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.50e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (7.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.10e-3)"	2.2	2.6	1.5	2.1	1.7	1.1	3.9	3.0	2.3	3.9	2.5	3.4	2.2	3.5	4.5	2.4	3.6	1.9	2.4	1.8	1.6	3.3	2.8	3.1	3.0	1.7	1.6	5.6	2.3	4.7	2.6	4.0	1.8	4.1	3.9	3.8	2.4	4.3	2.5	3.8	2.3	4.7	1.3	3.4	4.1	2.4	1.9	4.3	4.3	2.5	3.9	2.8	2.7	2.6	3.0	1.8	6.9	12.4	6.2	4.3	2.5	2.6	2.8	4.4	5.8	2.4	1.7	4.6	6.0	2.8	4.7	4.1	7.6	3.4	4.4	4.3	3.2	6.1	4.9	3.9	4.3	6.0	1.9	3.8	3.0	4.8	4.1	5.2	7.0	5.8	15.7	2.9	5.3	0.9	3.1	5.9	3.1	1.7	1.8	8.7	5.4	6.7	4.6	2.1	5.5	6.1	4.6	2.4	4.1	8.9	3.5	6.1	4.2	4.6	3.0	3.0	3.4	3.8	6.2	4.2	1.5	7.9	3.2	1.9	1.2	5.1	2.2	2.1	2.3	2.2	1.5	1.7	1.7	2.1	1.4	2.3	1.4	1.6	1.3	2.0	2.2	1.1	1.5	1.7	3.0	2.3	1.8	1.6	1.7	1.6	1.8	1.3	1.9	2.6	1.7	0.0	3.4	4.9	1.2	0.5	0.5	0.8	1.2	1.5	1.9	1.8	2.1	0.0	0.5	3.7	8.4	2.6	0.8	1.0	0.0	1.3	0.6	1.3	2.3	3.0	0.0	3.8	6.6	1.0	1.9	1.7	0.5	1.4	2.5	3.5	3.9	2.3	2.0	0.0	7.2	1.5	4.1	3.8	1.0	2.9	2.8	1.1	0.0	1.9	2.7	2.4	2.1	5.0	4.6	1.6	0.5	1.5	0.7	0.6	1.7	1.9	3.5	2.3	0.0	2.1	1.8	0.9	1.1	1.8	0.3	1.0	2.0	2.7	2.6	0.4
ZKSCAN4	"FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36"	ENSG00000187626	"Zinc finger with KRAB and SCAN domains 4"	Q969J2	6	28241697-28252269	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009637	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA009637: AB_2668244"	"unprognostic (4.29e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.90e-6)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.73e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	2.7	2.7	1.6	1.9	1.6	1.0	2.6	2.7	2.0	3.5	1.6	2.9	2.0	3.5	2.0	2.5	2.6	1.4	2.2	1.6	1.6	2.7	3.0	2.0	3.4	1.6	1.5	3.2	2.3	2.3	2.1	2.1	1.7	2.7	2.0	2.2	2.9	1.9	1.6	2.9	3.6	1.5	1.5	8.6	2.5	8.9	1.6	4.1	2.4	1.6	3.3	2.9	2.8	1.9	1.4	1.0	2.8	4.7	3.2	3.1	2.6	1.8	2.9	2.6	2.9	1.6	1.2	3.9	3.3	2.1	1.6	1.6	2.9	2.3	2.7	1.8	3.1	3.3	2.5	2.2	2.2	6.6	2.9	3.4	2.8	2.3	2.3	3.3	2.7	3.4	3.1	0.8	2.2	1.4	4.4	6.9	2.2	0.6	1.9	3.4	3.9	2.5	1.6	1.1	4.3	3.1	1.5	2.0	3.3	2.5	1.7	3.0	2.2	2.9	1.7	1.7	1.8	2.5	2.6	1.8	1.0	6.5	1.7	2.8	1.9	2.2	1.9	1.6	2.2	1.8	1.8	1.8	3.2	1.7	2.7	2.6	2.5	2.4	1.9	4.2	1.8	1.4	1.6	1.6	2.7	2.0	1.6	1.6	1.6	1.5	1.7	1.5	1.6	1.9	1.7	0.0	0.5	2.6	2.2	0.4	0.5	1.0	1.2	1.1	1.5	1.4	1.3	2.8	2.7	1.8	2.1	3.9	3.9	2.2	0.0	2.7	9.8	1.3	3.2	2.2	3.5	3.8	7.9	2.0	2.8	2.5	3.1	1.4	2.5	4.2	2.5	1.0	4.5	1.7	6.5	1.5	0.0	10.7	1.8	6.9	2.8	2.9	1.8	7.5	2.6	2.2	3.1	2.5	3.9	1.7	4.9	3.8	1.3	0.4	2.3	1.7	0.4	1.7	0.0	1.6	1.6	27.4	2.4	1.6	0.3	1.1	2.1	3.5	2.3	0.3
ZKSCAN8	"LD5-1, ZNF192, ZSCAN40"	ENSG00000198315	"Zinc finger with KRAB and SCAN domains 8"	Q15776	6	28141883-28159460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA003483: AB_1080686"	"unprognostic (2.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.80e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.33e-3)"	11.0	7.7	4.5	8.1	6.2	14.8	11.5	8.9	7.2	11.2	7.4	11.8	6.6	15.9	13.3	5.6	11.1	7.6	7.6	4.5	5.6	7.7	7.3	9.2	10.5	5.5	5.1	17.6	9.9	12.9	8.4	9.4	6.1	10.3	8.4	17.6	9.0	11.6	8.1	7.9	10.7	10.7	5.0	10.8	9.2	9.1	5.2	13.1	10.6	8.9	10.9	10.2	7.9	9.2	9.0	5.6	26.1	25.4	15.8	14.9	8.2	9.7	18.3	12.6	15.7	6.3	5.3	19.4	15.7	9.4	10.5	7.4	16.7	6.2	17.9	11.2	14.1	17.7	11.7	13.6	14.4	21.8	12.7	15.4	10.4	12.9	19.2	21.5	12.5	16.9	27.9	7.1	12.9	4.4	15.5	18.2	9.5	2.1	6.4	17.0	16.5	15.2	8.6	10.9	19.5	24.7	11.6	5.3	11.9	14.3	5.9	11.7	10.9	18.1	10.5	6.1	13.2	17.3	13.2	15.6	5.1	14.8	9.9	2.2	0.5	0.6	1.0	1.2	1.1	0.5	0.6	0.4	0.4	1.7	1.0	0.8	0.1	1.1	2.1	0.7	0.6	0.6	4.5	6.2	8.9	7.2	4.5	5.6	5.5	5.1	6.1	5.0	5.2	9.2	6.9	3.2	9.3	11.8	9.8	4.8	2.6	3.8	14.8	9.5	8.5	5.1	8.0	7.2	5.0	7.3	6.2	4.2	11.0	2.0	0.0	3.1	3.7	5.9	10.0	8.8	7.2	9.4	11.1	2.9	2.0	9.5	4.6	7.4	5.1	12.7	8.6	10.2	4.1	6.7	12.5	4.6	4.1	11.1	6.8	5.2	9.0	6.0	1.8	15.9	5.9	6.5	4.1	26.7	17.1	3.0	2.4	9.1	9.0	4.3	2.3	3.5	6.1	9.2	0.0	9.9	7.3	11.9	8.6	8.5	2.8	2.3	7.1	7.4	3.7	1.9
ZMAT1	KIAA1789	ENSG00000166432	"Zinc finger matrin-type 1"	Q5H9K5	X	101882288-101932079	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 190.3;Oligodendrocyte precursor cells: 111.1;Oligodendrocytes: 112.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.2;U-266/70: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012827	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA012827: AB_1859070"	"unprognostic (9.30e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.20e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.09e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.38e-2)"	6.4	9.3	11.1	2.8	11.5	6.3	7.5	10.5	15.1	8.0	10.6	7.3	1.8	5.5	21.2	2.4	10.0	2.1	7.9	10.7	10.7	18.3	9.7	5.7	6.6	11.5	10.9	15.2	10.3	4.3	34.8	0.7	11.0	10.7	1.3	9.4	6.7	3.7	2.6	3.0	7.5	1.3	11.1	13.8	5.8	6.7	10.9	3.2	25.0	1.5	2.6	6.0	4.8	12.1	0.2	0.0	1.0	1.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	1.2	1.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.2	0.7	1.9	0.0	8.2	0.6	0.0	0.1	0.1	1.3	0.0	0.1	1.5	0.0	0.1	2.3	0.0	0.4	1.1	0.7	0.0	0.1	1.1	1.4	2.1	2.0	0.6	0.0	0.0	0.1	4.1	0.3	0.0	0.4	2.0	0.6	0.8	0.3	0.5	0.2	0.1	0.4	0.6	0.3	0.4	0.0	0.9	0.4	0.3	0.2	0.1	0.1	0.9	0.2	0.1	11.1	11.5	10.5	15.1	10.7	10.7	11.5	10.9	11.0	11.1	10.9	12.1	18.9	16.0	31.2	190.3	30.2	4.1	7.6	0.2	7.4	38.1	18.2	12.3	25.4	11.5	14.4	14.7	43.8	0.1	16.5	0.6	3.9	5.0	14.9	28.2	3.7	16.8	10.3	6.9	30.7	2.7	0.0	10.3	2.0	21.6	15.8	51.5	13.6	10.6	3.3	16.8	32.8	2.8	0.0	9.7	11.1	9.7	1.8	11.7	7.2	71.2	10.7	25.8	10.3	111.1	112.8	1.5	1.6	1.2	7.4	6.1	2.7	5.7	13.0	57.5	0.0	27.5	9.0	22.4	10.2	3.2	2.8	0.1	16.3	5.4	2.6	4.3
ZMAT2	"FLJ31121, hSNU23, Snu23"	ENSG00000146007	"Zinc finger matrin-type 2"	Q96NC0	5	140698680-140706686	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036518	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Mitochondria"		"HPA036518: AB_10671960"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (2.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.38e-3)"	"unprognostic (6.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.84e-2)"	51.5	53.2	65.8	41.6	76.0	73.0	59.2	61.8	85.6	49.3	63.3	52.1	35.2	49.7	53.0	67.1	51.5	34.0	41.2	70.6	68.7	60.7	57.8	41.7	55.2	65.2	69.0	49.1	38.8	78.1	44.9	47.3	66.0	42.2	56.7	46.9	49.4	46.7	81.7	59.9	45.6	48.2	63.3	55.4	48.8	28.9	68.0	69.2	44.1	79.5	69.4	50.2	51.2	69.8	78.2	128.0	81.5	138.5	128.8	85.8	109.5	79.2	84.9	107.0	114.9	195.5	127.7	87.0	126.2	136.7	121.6	72.9	116.7	158.0	136.4	96.2	99.9	70.6	151.0	138.3	82.1	168.5	89.0	100.0	119.1	111.2	128.0	106.6	90.9	138.1	81.0	93.5	100.6	117.2	135.1	115.4	61.4	54.7	79.5	93.0	96.4	96.9	92.5	110.3	96.8	73.0	112.5	109.8	124.5	115.5	151.6	144.6	77.4	92.5	50.8	48.3	123.4	60.0	130.9	97.5	100.7	114.5	73.7	63.7	37.2	59.9	30.7	29.9	38.7	29.6	33.3	32.3	27.0	27.6	30.6	33.6	96.9	29.3	31.9	28.8	34.8	30.2	65.8	76.0	61.8	85.6	70.6	68.7	65.2	69.0	66.0	63.3	68.0	69.8	44.1	51.3	81.3	9.1	63.8	56.7	76.9	70.8	50.1	30.5	52.4	56.8	87.1	72.9	73.6	69.9	6.2	132.5	66.8	81.0	117.4	80.9	10.8	80.8	69.5	60.0	68.8	170.9	12.8	67.4	126.3	54.5	43.8	70.5	82.8	47.3	51.0	92.7	82.6	16.8	9.7	55.7	44.7	95.8	61.1	11.2	56.5	68.9	58.7	10.3	135.4	82.4	95.8	5.5	9.2	70.9	86.9	57.9	55.3	71.6	68.6	168.0	96.8	22.4	52.6	56.4	58.2	60.1	73.5	68.0	63.2	207.6	71.9	38.0	59.2	87.5
ZMAT3	"FLJ12296, MGC10613, PAG608, WIG-1, WIG1"	ENSG00000172667	"Zinc finger matrin-type 3"	Q9HA38	3	178960121-179072215	"Predicted intracellular proteins"	"Apoptosis, DNA damage, Growth regulation, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HSkMC: 76.0;LHCN-M2: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027569, HPA028671, HPA054356"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA027569: AB_2732438, HPA028671: AB_2672725, HPA054356: AB_2682460"	"unprognostic (3.53e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.46e-2)"	5.2	7.9	9.9	5.2	10.9	3.4	5.9	4.4	14.5	5.8	3.4	6.3	3.4	5.2	6.2	6.8	5.8	8.9	6.1	12.1	11.0	6.3	12.6	5.9	7.4	10.5	12.1	4.4	4.1	8.8	4.9	5.6	11.9	5.9	8.5	6.1	4.3	7.7	3.1	6.1	3.4	11.2	9.9	6.9	5.1	4.1	12.5	10.2	7.5	4.4	6.4	6.1	3.7	11.7	5.9	4.0	12.8	8.4	57.4	64.2	28.3	23.1	33.9	3.3	4.3	5.1	3.5	24.2	11.1	36.2	5.1	5.4	4.6	24.6	7.6	20.7	7.0	10.7	7.8	16.2	45.7	11.7	16.0	76.0	45.2	8.1	16.7	51.2	48.5	6.8	5.7	3.3	87.7	5.8	9.3	2.1	5.7	8.3	3.3	10.7	11.1	5.2	19.2	11.3	3.0	12.7	7.1	6.4	7.7	23.8	8.0	4.9	53.2	49.9	19.2	8.3	11.0	3.2	2.9	10.2	29.6	1.7	34.9	2.1	0.7	1.7	1.8	0.6	1.0	0.9	1.3	1.4	0.7	1.8	2.2	1.5	0.8	1.6	1.4	0.8	1.0	0.6	9.9	10.9	4.4	14.5	12.1	11.0	10.5	12.1	11.9	9.9	12.5	11.7	11.2	54.5	105.8	38.2	24.6	39.6	10.6	26.1	34.1	19.5	22.2	22.9	21.0	24.3	53.8	35.0	25.0	10.7	25.1	14.0	7.9	16.1	1.1	12.0	15.7	14.6	20.9	14.5	40.7	20.7	2.9	28.2	19.9	12.2	39.8	19.8	17.2	32.1	18.2	62.2	36.7	9.5	30.5	40.2	16.6	2.2	20.2	24.4	51.6	41.2	49.7	15.5	32.0	87.4	18.9	28.6	11.9	29.0	11.1	17.3	14.0	20.2	45.1	11.1	39.5	25.0	23.8	9.5	13.1	25.2	36.7	4.4	29.8	42.8	10.4	11.1
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.5;retina: 4.4;thyroid gland: 16.3"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 220.9;Inhibitory neurons: 507.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	86	"NK-cell: 8.6"	"Lineage enriched"	"Detected in single"	86	"NK-cells: 8.6"	"Group enriched"	"Detected in some"	5	"AF22: 22.5;U-2197: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA069813: AB_2686206, HPA071585: AB_2686423"	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.79e-3)"	0.0	0.7	3.2	0.1	7.5	0.0	0.1	1.6	15.0	1.4	0.0	0.7	0.0	0.3	0.1	0.0	0.1	0.1	0.4	6.2	2.7	0.3	0.0	0.0	0.1	15.5	4.5	0.4	0.1	0.0	1.8	0.1	15.4	0.6	0.2	4.4	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.3	0.1	1.4	11.1	0.3	16.3	0.0	0.1	0.0	0.0	4.1	0.0	1.3	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.7	3.6	0.0	0.0	0.0	0.6	14.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	3.2	7.5	1.6	15.0	6.2	2.7	15.5	4.5	15.4	0.3	11.1	4.1	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	8.5	0.1	0.0	0.9	2.8	0.0	0.0	6.2	0.0	1.0	0.0	1.9	0.0	19.7	0.0	0.1	0.0	1.8	0.0	220.9	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	507.5	0.0	0.0	0.0	0.0	55.2	2.8	0.0	0.0	7.5	0.0	1.3	42.2	13.0	4.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.1	0.1
ZMAT5	"SNRNP20, ZC3H19"	ENSG00000100319	"Zinc finger matrin-type 5"	Q9UDW3	22	29730956-29767011	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004858	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004858: AB_1080657"	"unprognostic (2.14e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-3)"	"unprognostic (6.04e-3)"	"unprognostic (5.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.10e-2)"	14.3	26.0	25.8	10.6	26.4	14.2	14.5	26.5	34.9	17.1	25.9	19.6	12.2	18.0	19.8	21.1	20.5	10.0	25.5	25.3	26.0	21.3	26.8	13.7	15.0	27.5	26.5	16.2	20.4	23.0	10.6	8.4	25.5	19.2	7.2	7.8	18.2	16.6	37.1	18.1	14.4	13.8	26.0	19.9	20.1	10.6	27.2	17.8	19.1	24.5	12.2	19.0	15.8	26.8	17.9	22.1	19.3	37.5	23.7	26.2	8.7	19.4	23.9	28.5	34.7	19.4	11.0	12.2	18.9	20.8	22.0	16.5	16.5	19.9	18.6	39.2	36.3	46.9	10.8	36.3	43.8	21.6	14.8	22.7	30.2	36.5	22.2	24.2	30.4	19.0	12.3	25.9	23.8	26.7	31.0	22.5	7.2	34.7	25.9	37.1	34.2	32.6	22.8	10.9	14.8	27.4	18.1	22.4	27.9	10.9	33.7	30.0	19.4	38.8	19.4	26.4	29.2	24.0	20.5	20.4	29.9	25.6	27.9	48.1	84.6	95.3	46.1	94.6	47.3	61.6	47.7	48.6	73.9	60.3	41.8	49.1	69.5	60.8	94.7	57.6	61.0	65.3	25.8	26.4	26.5	34.9	25.3	26.0	27.5	26.5	25.5	26.0	27.2	26.8	17.0	16.0	20.8	6.2	14.6	9.6	21.0	32.0	10.2	12.7	16.2	22.6	1.4	17.2	20.4	14.7	18.8	21.5	11.3	16.4	33.2	35.3	0.9	13.8	14.3	15.2	14.4	8.6	3.7	27.3	18.1	15.9	13.3	10.4	33.7	13.0	15.0	17.1	45.1	5.0	5.1	19.4	24.4	21.4	17.9	3.0	15.8	22.1	12.4	3.7	27.7	26.0	34.0	6.0	6.5	31.7	18.1	21.8	14.9	12.4	27.8	40.0	19.3	21.4	32.9	15.1	40.0	11.0	22.8	14.0	11.8	14.1	18.0	18.2	14.4	18.9
ZMIZ1	"FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10"	ENSG00000108175	"Zinc finger MIZ-type containing 1"	Q9ULJ6	10	79068966-79316519	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 259.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 176.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045144, HPA071156"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045144: AB_10962360, HPA071156: "	"unprognostic (4.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.63e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.90e-2)"	"prognostic favorable (3.64e-7)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.34e-2)"	34.0	24.4	24.5	19.2	27.1	26.6	27.7	25.1	30.1	44.7	5.2	28.1	19.2	51.5	18.8	37.5	26.5	25.9	31.8	25.8	27.5	17.2	8.7	26.5	17.5	34.5	36.0	48.5	23.3	19.2	12.5	21.7	29.9	19.5	14.5	14.6	28.4	28.8	34.6	33.7	22.2	26.9	27.2	44.8	27.6	4.5	33.9	16.4	37.3	17.0	18.2	28.4	31.0	23.1	24.0	29.3	54.8	23.6	55.8	16.0	19.1	22.4	40.2	15.6	8.8	8.7	10.8	12.2	17.8	52.8	40.9	33.0	9.2	16.6	8.4	26.5	5.1	43.5	11.1	25.9	39.2	24.3	88.1	21.0	18.2	22.3	15.9	98.4	25.3	10.2	16.9	62.9	13.3	45.4	24.4	37.6	16.2	13.8	44.0	107.5	10.3	12.3	11.6	20.0	56.8	82.8	14.8	176.2	46.8	19.4	56.5	23.4	35.5	58.7	23.5	29.9	29.2	11.5	21.9	0.2	77.0	42.7	11.5	1.3	2.1	1.6	1.2	3.6	0.8	0.5	0.8	0.7	2.6	0.2	0.3	0.6	3.0	3.4	3.0	2.5	1.0	1.2	24.5	27.1	25.1	30.1	25.8	27.5	34.5	36.0	29.9	27.2	33.9	23.1	49.3	38.5	26.0	64.9	14.5	22.8	8.4	14.9	15.4	49.8	27.1	18.0	54.4	20.0	15.8	16.5	0.0	7.1	14.7	39.1	7.9	22.1	47.2	17.9	75.3	49.9	13.8	25.7	23.1	24.1	5.6	36.2	38.7	33.2	50.6	16.8	56.4	9.6	37.9	63.9	16.4	14.5	14.2	34.9	86.0	259.7	28.3	52.4	24.9	46.9	27.2	12.9	4.1	92.5	45.5	19.3	22.5	23.7	14.2	13.0	19.7	8.1	14.7	3.4	19.7	24.7	32.6	1.8	3.2	40.8	23.7	3.6	12.1	14.3	14.8	12.7
ZMIZ2	"DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7"	ENSG00000122515	"Zinc finger MIZ-type containing 2"	Q8NF64	7	44748581-44769881	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 70.1;Late spermatids: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040716	Supported		Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Mitochondria	"HPA040716: AB_10805826"	"unprognostic (2.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.15e-3)"	20.2	27.4	19.2	23.1	20.5	19.3	21.3	0.0	26.9	22.2	0.0	22.9	20.8	23.6	9.4	25.1	26.1	12.4	27.8	20.4	0.3	30.4	17.4	28.3	22.8	4.1	3.5	25.3	34.3	17.0	36.3	9.3	1.4	26.2	10.2	6.5	29.4	18.2	20.8	29.7	26.9	9.8	0.3	33.5	23.2	31.7	6.4	17.6	39.6	9.1	16.5	23.1	21.8	13.3	33.1	37.4	17.1	33.3	11.4	7.6	18.1	16.6	15.6	13.9	16.7	21.4	50.5	22.6	25.3	17.5	34.7	44.4	10.6	18.9	8.4	53.3	20.1	9.1	36.8	17.0	23.3	13.2	19.2	11.6	11.4	21.9	14.3	12.4	26.3	24.2	27.0	49.7	20.9	31.8	29.3	36.3	32.4	24.8	35.5	36.6	9.4	29.6	16.1	25.0	60.6	40.0	22.3	43.3	9.9	16.0	41.4	20.2	39.4	13.3	28.5	36.2	38.6	71.4	24.4	17.3	25.7	23.0	55.4	0.3	0.6	0.2	0.8	0.8	0.5	1.0	0.4	0.6	0.6	1.8	0.2	0.3	0.2	1.1	0.4	1.5	0.4	0.3	19.2	20.5	0.0	26.9	20.4	0.3	4.1	3.5	1.4	0.3	6.4	13.3	16.9	12.8	16.9	23.5	22.0	10.1	4.3	11.1	10.8	14.1	18.9	18.4	17.5	7.2	14.7	23.9	14.6	8.2	16.5	18.6	1.9	17.5	26.2	19.3	12.7	12.7	19.9	6.9	17.8	15.7	2.3	11.8	34.7	27.8	14.5	22.3	13.6	16.4	11.2	11.8	14.7	19.6	14.2	14.5	70.1	88.8	13.4	19.9	14.2	14.0	24.8	5.4	10.3	8.5	21.0	24.4	14.2	18.0	15.9	9.3	14.2	8.4	19.7	7.5	6.6	12.2	11.7	4.4	4.2	16.8	18.5	7.3	12.9	13.4	21.2	9.8
ZMYM2	"FIM, MYM, RAMP, ZNF198"	ENSG00000121741	"Zinc finger MYM-type containing 2"	Q9UBW7	13	19958677-20091829	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 305.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031765	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Endoplasmic reticulum"		"HPA031765: AB_10601927"	"unprognostic (2.96e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.80e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.07e-4)"	14.3	17.3	6.2	12.3	9.2	26.5	17.0	6.3	10.4	17.5	10.1	13.8	14.3	15.0	12.4	16.4	14.6	15.9	18.1	6.6	8.4	17.3	14.5	13.2	14.8	6.1	7.1	16.4	16.8	17.7	8.4	14.7	7.3	19.2	13.8	25.4	14.0	16.8	13.7	12.7	12.2	15.2	3.3	14.3	17.2	49.3	8.5	20.9	24.6	20.6	18.8	17.6	9.8	13.1	14.9	13.1	50.2	22.0	21.0	23.2	23.7	15.4	24.2	19.1	23.4	20.4	29.4	35.5	13.6	21.3	18.5	23.8	38.2	16.3	25.7	14.2	10.5	63.5	19.4	10.5	21.4	54.8	18.5	22.5	30.1	15.2	16.0	30.2	33.5	35.8	24.7	24.8	27.4	21.4	51.8	16.4	46.5	45.4	8.2	58.4	54.7	16.7	14.5	21.2	58.3	56.6	29.1	21.0	27.6	33.3	28.1	37.6	19.5	9.6	14.8	12.0	8.1	19.3	16.3	36.4	8.2	12.3	23.4	0.1	2.7	2.2	2.7	3.0	3.4	2.7	3.6	2.7	3.2	2.0	3.7	3.3	3.8	3.0	2.7	3.3	2.8	1.9	6.2	9.2	6.3	10.4	6.6	8.4	6.1	7.1	7.3	3.3	8.5	13.1	40.1	44.8	39.3	140.7	85.3	55.1	47.1	51.4	55.2	112.8	43.8	34.0	36.8	25.8	58.5	51.5	112.6	13.6	71.2	24.4	5.9	23.8	105.8	45.4	53.1	38.5	55.8	32.8	218.4	17.8	15.3	43.0	49.5	59.1	46.3	61.2	42.1	34.4	21.6	72.3	179.5	28.4	44.7	57.5	101.8	174.6	55.9	53.6	33.8	124.6	40.0	34.9	41.2	225.7	305.6	35.3	41.4	41.0	42.1	51.3	27.4	16.1	51.7	106.6	32.9	45.2	38.3	94.9	54.9	55.1	44.6	11.4	68.0	37.3	29.6	82.6
ZMYM3	"DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261"	ENSG00000147130	"Zinc finger MYM-type containing 3"	Q14202	X	71239624-71255146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 38.8;Theca cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003211, HPA075255"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA003211: AB_1080661, HPA075255: AB_2732287"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.18e-4)"	"unprognostic (5.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.30e-3)"	10.0	29.2	19.5	8.6	18.9	7.1	10.2	10.7	18.2	17.3	9.5	15.5	7.1	15.9	18.6	9.9	19.2	9.9	9.6	17.8	20.4	13.2	13.6	11.0	12.1	12.8	14.4	37.1	10.8	11.6	18.1	7.9	14.2	15.5	7.8	13.3	11.6	17.1	10.8	11.4	12.0	14.6	13.0	15.5	12.2	20.5	25.9	16.0	15.8	5.7	10.9	13.3	13.3	13.7	15.4	27.9	66.2	35.2	18.8	18.9	16.7	14.0	20.8	29.7	27.8	31.1	22.9	39.0	34.1	25.3	26.8	14.2	57.1	21.2	22.3	13.1	30.6	33.9	25.6	27.9	8.7	31.9	20.3	22.3	12.1	21.6	13.4	52.8	25.2	30.8	39.7	20.9	22.0	25.5	38.6	40.6	65.9	19.0	24.2	47.7	20.3	28.7	22.0	18.6	31.5	21.7	23.8	14.7	13.7	47.8	21.7	20.7	19.5	14.6	26.7	21.5	12.8	18.9	12.1	32.9	17.6	42.9	16.4	6.1	5.2	4.3	4.2	4.8	4.8	7.1	4.8	3.9	4.8	6.6	4.0	4.0	0.3	4.9	4.2	10.1	4.8	4.0	19.5	18.9	10.7	18.2	17.8	20.4	12.8	14.4	14.2	13.0	25.9	13.7	5.6	12.8	11.9	14.7	6.9	3.8	2.7	12.2	6.8	12.9	9.2	10.0	10.6	7.2	15.0	31.3	10.4	8.5	4.7	3.3	1.9	6.7	1.1	12.0	8.5	7.5	4.8	7.6	15.8	8.9	7.0	7.0	6.6	9.4	2.5	38.8	8.9	15.3	9.8	13.5	17.3	9.2	6.1	11.9	6.7	4.0	13.7	6.6	3.6	6.5	11.2	9.5	7.2	7.1	12.3	5.5	8.8	23.3	4.9	1.9	4.5	15.1	12.0	7.7	6.6	5.3	9.9	1.5	4.0	9.3	3.8	4.2	5.2	40.0	7.1	2.0
ZMYM4	"KIAA0425, MYM, ZNF198L3, ZNF262"	ENSG00000146463	"Zinc finger MYM-type containing 4"	Q5VZL5	1	35268709-35422058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 127.9;Inhibitory neurons: 136.5;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051301, HPA054802"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA051301: AB_2681431, HPA054802: AB_2682605"	"unprognostic (8.95e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (9.75e-9)"	"unprognostic (9.76e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.21e-1)"	12.1	11.4	13.3	12.5	14.3	13.6	17.2	23.9	15.2	17.2	12.0	11.8	8.9	16.3	15.5	12.7	14.8	13.5	11.2	11.8	14.9	13.3	12.8	12.1	14.4	12.8	13.3	21.7	13.9	18.1	9.3	17.2	14.0	15.0	11.5	24.6	12.2	13.6	14.9	10.9	9.2	13.7	13.8	14.8	13.7	34.2	14.0	20.9	18.4	15.3	17.0	14.6	9.9	16.0	28.1	22.6	67.7	35.0	19.2	41.4	24.9	32.7	49.1	39.1	50.7	24.6	27.6	52.0	19.6	41.3	19.1	17.8	47.3	24.4	56.2	29.5	27.8	63.5	25.0	21.4	35.5	54.7	28.1	31.3	21.1	38.3	35.9	32.4	44.0	28.5	70.0	14.1	47.9	17.4	47.4	32.0	56.3	15.0	19.9	52.4	43.4	26.1	28.7	37.2	39.1	37.5	39.1	29.4	45.7	42.3	23.2	41.4	53.7	36.4	37.8	16.3	35.9	15.3	29.9	40.0	26.2	41.4	35.7	1.8	3.6	2.7	3.1	5.1	2.9	3.2	2.8	2.7	3.5	2.4	2.7	2.6	0.7	6.6	7.1	7.0	2.4	1.9	13.3	14.3	23.9	15.2	11.8	14.9	12.8	13.3	14.0	13.8	14.0	16.0	33.6	12.8	21.9	94.3	17.4	11.5	16.6	14.4	17.1	30.7	31.8	29.1	32.0	25.8	20.8	27.6	31.3	14.7	20.6	6.6	5.9	22.7	59.8	25.0	45.1	22.8	22.3	22.5	127.9	23.7	12.5	27.0	21.9	33.7	14.5	49.1	18.5	16.1	13.1	23.5	136.5	14.7	14.2	23.1	12.5	91.9	26.4	21.4	5.4	109.6	27.5	22.5	26.8	174.4	132.6	19.9	8.1	23.0	13.9	22.7	5.5	11.8	21.6	33.0	19.7	33.4	29.0	34.4	13.3	13.8	11.4	14.1	13.9	45.5	14.0	22.7
ZMYM5	"MYM, ZNF198L1, ZNF237"	ENSG00000132950	"Zinc finger MYM-type containing 5"	Q9UJ78	13	19823482-19863649	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015544, HPA020879"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Golgi apparatus"	"HPA015544: , HPA020879: AB_2670524"	"unprognostic (4.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	7.0	7.8	2.6	7.1	3.6	12.2	7.9	3.5	3.4	6.7	3.9	5.9	6.2	7.6	8.6	7.6	5.4	9.2	5.4	2.2	2.9	6.6	6.9	6.7	10.3	3.9	3.2	6.7	5.4	5.5	4.8	7.1	3.5	8.2	6.2	9.0	5.7	5.5	6.2	7.8	6.6	6.9	2.9	7.5	7.3	23.4	3.3	10.1	8.6	7.7	8.9	7.2	5.8	5.0	8.5	4.4	9.6	7.7	6.5	10.3	3.6	7.8	12.2	12.5	10.3	10.6	16.5	11.8	8.4	11.2	15.5	7.9	7.1	9.3	14.0	9.5	5.7	22.1	7.9	7.4	21.0	15.9	11.4	12.5	11.0	6.8	12.7	12.8	12.7	7.6	9.0	10.0	12.0	21.4	11.9	16.4	5.2	11.0	6.4	13.2	12.3	4.6	10.5	9.4	9.0	8.2	10.1	8.2	27.4	10.2	12.7	13.7	10.6	6.8	5.1	9.2	5.8	15.9	7.7	17.6	6.8	6.9	11.2	16.1	5.4	8.6	8.7	5.2	9.3	9.9	9.9	8.5	5.7	8.6	7.7	8.2	10.7	8.0	7.4	7.8	8.9	4.2	2.6	3.6	3.5	3.4	2.2	2.9	3.9	3.2	3.5	2.9	3.3	5.0	34.1	28.9	17.3	33.0	35.7	24.3	20.8	20.3	43.9	29.7	27.4	26.8	16.2	22.8	18.9	11.0	18.8	17.9	32.4	10.7	7.9	15.5	16.0	24.0	24.0	21.3	27.6	22.3	36.2	10.5	9.6	24.4	19.9	25.4	33.6	19.6	15.0	7.9	11.4	28.6	35.8	11.9	24.4	12.9	24.0	20.8	22.7	23.9	21.4	26.2	17.0	15.2	16.5	30.7	52.9	14.2	16.9	18.4	20.7	16.8	10.7	11.2	10.4	30.3	32.9	27.2	24.7	92.7	51.1	56.5	21.7	8.3	38.3	15.5	11.4	32.9
ZMYM6	"Buster2, MYM, ZBED7, ZNF198L4, ZNF258"	ENSG00000163867	"Zinc finger MYM-type containing 6"	O95789	1	34986165-35031945	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011004, HPA071865"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA011004: AB_1859075, HPA071865: AB_2686464"	"prognostic favorable (1.30e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.11e-6)"	"unprognostic (1.77e-3)"	"unprognostic (4.83e-3)"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.29e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.84e-3)"	5.7	7.5	3.2	8.4	4.5	15.2	6.9	5.2	4.6	5.3	3.3	6.2	6.4	7.1	8.5	6.9	4.8	6.4	6.8	3.3	4.0	6.8	4.6	6.4	9.5	3.8	3.7	9.2	5.0	7.6	6.8	4.9	4.4	6.5	7.5	9.2	5.2	5.4	3.5	8.2	7.1	6.6	3.2	10.6	7.3	9.6	4.5	8.2	9.4	4.8	8.6	5.5	4.9	5.4	8.3	4.8	7.9	8.0	9.3	10.8	5.1	7.5	10.7	7.8	8.6	3.4	8.9	11.3	7.2	10.4	5.8	7.7	9.2	7.3	9.8	7.7	5.4	9.6	6.4	4.4	8.1	14.7	11.8	9.9	9.9	9.3	7.2	5.8	9.2	9.5	15.9	12.2	8.3	3.0	6.5	10.0	7.7	4.8	7.6	8.9	10.9	6.5	7.2	6.1	8.4	8.4	8.1	7.8	9.5	8.0	5.2	7.9	9.7	10.0	8.0	11.0	10.6	7.6	13.0	8.5	10.5	13.6	8.9	3.0	5.5	5.7	5.3	4.6	4.6	4.6	3.6	3.0	5.0	5.5	5.2	3.5	3.1	4.0	5.9	7.7	4.3	2.6	3.2	4.5	5.2	4.6	3.3	4.0	3.8	3.7	4.4	3.2	4.5	5.4	9.2	12.8	16.5	30.0	11.1	6.0	5.5	7.2	10.2	12.0	7.8	6.1	15.7	8.6	7.9	16.5	20.9	3.9	13.5	8.9	5.9	5.1	2.0	5.6	7.7	6.9	3.6	3.4	34.4	5.6	3.3	8.0	13.3	7.1	10.1	10.6	5.0	8.8	7.8	13.5	37.9	8.0	6.1	20.6	15.7	1.8	8.4	15.6	1.8	30.9	19.0	8.5	15.5	22.6	41.4	5.8	7.4	11.3	7.0	4.0	7.5	7.3	8.3	20.9	13.1	8.0	12.0	24.7	18.8	9.0	6.5	5.3	8.5	8.6	8.2	5.7
ZMYND11	BS69	ENSG00000015171	"Zinc finger MYND-type containing 11"	Q15326	10	134465-254637	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015816			Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA015816: AB_1845427"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (4.76e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.42e-1)"	41.7	37.1	50.7	26.3	58.8	11.3	45.8	60.0	64.6	47.4	38.5	54.8	29.9	55.0	46.6	42.8	39.8	35.6	58.0	50.7	54.8	51.1	34.9	39.0	26.3	54.1	52.8	55.3	46.4	99.7	27.7	34.8	54.8	52.8	33.8	43.2	46.1	56.0	58.1	33.1	30.9	50.9	52.4	32.7	39.2	33.1	54.1	23.8	88.0	64.7	24.8	46.7	31.1	59.1	64.0	64.6	53.8	42.9	57.3	55.0	33.3	63.0	35.8	43.7	40.5	39.2	62.3	0.1	19.8	78.4	13.8	38.3	28.9	44.2	55.8	25.1	25.1	71.8	33.4	42.3	64.6	19.5	38.8	38.4	60.6	42.3	38.3	56.8	55.6	32.8	19.5	44.7	76.0	75.4	29.3	27.3	17.4	69.3	10.7	28.4	34.4	34.5	58.0	72.7	24.3	44.3	72.3	83.3	34.1	29.4	74.9	37.8	72.2	43.4	15.8	89.2	48.8	37.0	48.4	4.6	44.2	36.1	30.3	15.6	2.3	19.5	11.9	3.5	10.4	5.2	8.3	11.9	3.8	3.1	9.2	9.1	1.0	14.7	1.7	4.5	8.9	5.0	50.7	58.8	60.0	64.6	50.7	54.8	54.1	52.8	54.8	52.4	54.1	59.1	51.2	60.9	51.4	90.8	25.3	25.9	27.0	17.5	34.1	37.5	46.3	33.8	103.0	31.5	31.9	33.1	12.5	15.2	39.4	14.6	50.9	29.3	28.6	27.0	50.3	45.7	25.9	25.0	110.8	31.8	4.6	45.7	27.5	37.1	46.2	42.1	35.3	28.1	14.4	20.2	118.0	26.2	16.2	25.1	14.9	27.1	39.1	21.7	24.9	94.6	13.9	62.5	34.0	128.2	131.5	28.1	14.5	56.1	31.1	44.1	19.1	41.9	23.7	22.0	13.1	56.9	49.8	26.8	25.6	32.2	27.8	12.4	32.6	28.5	22.1	29.8
ZMYND8	"PRKCBP1, RACK7"	ENSG00000101040	"Zinc finger MYND-type containing 8"	Q9ULU4	20	47209214-47356889	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020949	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA020949: AB_1857223"	"prognostic unfavorable (2.56e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (7.06e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	13.1	32.7	25.4	10.5	21.3	26.0	14.7	26.2	36.2	11.9	47.8	14.1	11.0	9.8	33.3	16.0	15.9	12.3	12.5	35.5	29.5	18.5	10.9	11.1	12.8	30.5	22.9	13.6	12.3	11.6	25.9	11.8	33.0	11.8	14.5	20.1	14.6	14.6	15.3	19.9	16.2	8.7	9.4	18.3	20.0	14.2	25.2	14.6	11.0	11.0	12.8	14.5	14.9	37.3	27.6	17.2	90.5	36.6	15.2	21.3	59.4	21.7	17.8	22.3	22.8	107.7	26.0	26.5	34.4	16.3	27.1	18.7	39.4	96.0	33.3	11.4	14.9	110.4	6.3	95.9	55.4	11.9	55.9	20.9	43.4	24.8	94.1	40.4	61.0	9.5	90.6	17.7	41.0	32.1	4.4	45.4	85.9	20.3	24.3	55.8	15.0	22.9	30.4	49.6	38.0	14.3	10.3	32.4	44.4	70.3	17.0	22.6	143.6	23.9	16.6	23.3	20.2	12.5	25.2	23.2	80.8	18.3	80.3	34.8	7.4	10.4	8.7	7.5	8.7	15.3	8.8	9.0	4.7	18.3	11.4	11.8	19.8	16.3	6.8	16.5	9.3	4.3	25.4	21.3	26.2	36.2	35.5	29.5	30.5	22.9	33.0	9.4	25.2	37.3	48.2	44.8	78.5	94.0	36.6	8.8	32.2	44.6	15.9	108.1	29.3	20.7	23.7	28.6	74.3	90.1	160.6	23.1	36.2	64.0	15.6	36.5	13.6	111.3	29.8	31.7	56.3	112.9	153.8	28.7	42.0	24.2	41.8	124.4	32.2	44.8	30.7	16.1	21.9	85.8	113.5	49.2	42.7	48.8	12.8	21.9	27.7	31.8	10.6	49.6	25.0	24.4	40.2	89.0	138.7	47.1	42.3	26.7	29.7	23.9	56.8	12.0	82.3	50.0	32.9	33.4	27.5	6.3	29.9	19.2	8.4	66.5	34.2	39.3	32.1	24.2
ZNF10	KOX1	ENSG00000256223	"Zinc finger protein 10"	P21506	12	133130575-133159465	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 45.5;Excitatory neurons: 46.0;Inhibitory neurons: 48.4;Oligodendrocyte precursor cells: 54.3;Oligodendrocytes: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003204	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA003204: AB_1080663"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.13e-3)"	6.7	14.3	4.9	3.7	5.6	8.6	12.3	8.8	7.6	14.4	6.2	10.9	3.7	15.0	23.4	6.0	12.1	10.3	8.3	5.8	8.0	10.9	10.6	7.6	5.9	4.7	6.8	22.4	13.2	17.3	45.3	5.2	5.6	15.1	6.2	13.1	8.0	12.7	4.9	8.8	7.1	8.6	5.4	6.0	10.5	15.3	7.8	7.7	21.2	6.3	5.8	10.7	8.8	7.1	3.8	2.2	10.8	0.0	11.5	4.8	6.5	4.4	3.9	5.3	3.6	3.9	2.4	0.0	6.0	4.4	2.9	1.7	6.8	3.6	3.9	0.0	6.6	8.0	10.5	4.4	3.5	5.0	2.6	5.0	3.3	5.7	6.3	7.9	4.4	6.3	6.0	0.0	6.3	1.2	12.0	10.6	11.1	2.1	4.4	9.9	6.8	5.4	4.2	7.9	10.7	7.0	8.7	1.4	3.7	4.9	6.6	5.0	4.3	3.9	3.6	3.7	3.7	0.2	0.0	12.8	1.2	1.7	3.7	0.9	0.5	1.4	2.9	0.6	3.2	3.1	3.4	4.1	1.4	3.0	6.5	3.3	0.5	6.3	0.4	3.4	0.9	1.8	4.9	5.6	8.8	7.6	5.8	8.0	4.7	6.8	5.6	5.4	7.8	7.1	6.8	0.0	9.0	39.2	39.6	3.8	5.3	3.9	45.5	15.9	9.9	9.4	7.7	4.3	7.1	0.0	31.3	4.5	9.1	1.8	1.9	2.3	24.6	11.9	7.6	5.0	12.6	5.0	46.0	1.4	2.0	15.5	21.4	11.7	10.8	5.0	1.4	4.9	2.5	5.0	48.4	3.9	6.1	3.8	4.6	6.3	2.8	9.0	3.6	21.5	1.5	9.1	2.1	54.3	45.4	1.0	2.1	6.8	16.3	2.6	2.2	2.5	2.7	16.2	0.0	6.3	14.3	20.4	15.4	21.4	3.8	3.8	21.9	6.0	3.3	1.6
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491141	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 392.5;tongue: 465.5"	"Cell type enriched"	"Detected in all"	9	"Cardiomyocytes: 1836.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 29.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 161.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA054267: AB_2682431"	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	32.4	11.2	20.8	14.3	29.8	24.4	17.9	19.0	28.1	18.0	109.2	19.7	10.0	15.9	17.3	18.5	12.7	17.2	175.6	23.3	22.6	16.5	8.7	20.9	17.5	23.6	29.1	15.9	10.3	17.8	10.3	12.9	22.5	20.9	13.9	22.0	12.9	14.7	392.5	11.7	13.3	23.0	20.8	17.1	12.8	14.3	27.4	15.6	13.2	465.5	18.6	14.6	9.1	27.7	27.2	15.1	29.0	33.5	86.8	68.5	16.1	21.7	22.2	19.6	20.5	33.9	7.8	17.8	19.0	27.7	22.8	31.8	28.3	23.4	29.5	29.0	13.1	34.7	37.9	13.6	23.2	43.1	20.2	55.4	17.8	28.0	32.6	19.5	32.3	23.2	43.0	2.7	36.9	11.9	16.2	13.3	11.0	26.1	15.1	15.2	54.3	10.8	12.1	31.5	16.5	10.2	45.0	22.8	28.7	23.4	20.0	30.0	42.2	20.8	32.5	26.1	32.3	14.8	32.2	76.5	18.4	33.6	37.6	86.8	63.8	27.1	15.6	52.3	13.5	21.8	13.0	13.3	35.6	26.8	11.3	10.6	161.0	12.5	66.8	36.0	13.0	18.0	20.8	29.8	19.0	28.1	23.3	22.6	23.6	29.1	22.5	20.8	27.4	27.7	58.0	134.6	107.7	46.0	49.6	38.5	57.9	41.9	44.3	58.5	50.9	46.0	1836.4	62.9	57.0	29.5	95.9	37.9	67.2	31.7	41.1	43.2	197.2	75.2	67.1	69.9	40.2	50.5	73.3	42.4	39.3	141.7	31.1	37.5	44.9	49.5	62.8	40.1	53.5	35.3	62.9	32.6	32.6	132.7	43.4	105.2	37.6	89.8	65.8	47.8	124.3	53.6	66.9	31.2	34.2	65.7	26.9	92.6	50.7	74.8	39.7	41.5	161.1	79.9	46.0	151.2	70.0	62.3	38.1	49.8	29.8	30.6	46.0	85.9	36.6	68.2
ZNF114	MGC17986	ENSG00000178150	"Zinc finger protein 114"	Q8NC26	19	48270081-48287608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 5.9"	"Cell type enhanced"	"Detected in some"		"Spermatogonia: 4.4;Syncytiotrophoblasts: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.2;Hep G2: 27.8;NTERA-2: 13.8;REH: 14.6"									"HPA025019, HPA029553"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA025019: AB_1859080, HPA029553: AB_10603005"	"unprognostic (1.82e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.63e-1)"	0.8	0.4	1.8	0.7	1.6	0.8	0.6	2.1	2.1	1.1	0.8	0.3	0.3	1.1	0.7	0.5	0.9	0.5	0.7	1.7	1.8	0.5	0.2	0.7	0.6	1.4	1.8	0.4	0.8	1.6	0.4	1.4	1.2	0.4	0.2	0.6	0.4	0.5	0.5	1.0	0.1	0.2	0.6	0.6	0.1	0.9	1.8	0.2	5.9	0.4	0.6	0.2	0.3	2.3	3.8	5.9	6.9	0.2	0.0	0.0	22.2	0.4	0.0	2.1	2.8	2.2	5.6	0.0	6.4	0.3	2.4	7.4	9.5	0.1	2.5	0.1	0.6	0.3	1.4	27.8	1.5	3.7	0.5	0.4	0.7	1.1	0.0	0.5	0.1	0.4	0.7	0.0	0.2	10.9	0.3	11.6	13.8	10.3	0.9	14.6	0.0	0.0	0.2	2.7	2.7	3.1	3.7	0.1	3.7	4.2	1.4	7.0	0.9	0.5	2.2	1.7	0.6	0.2	0.2	0.0	0.2	1.8	0.5	1.8	0.3	0.3	0.2	0.2	0.1	0.4	0.2	0.1	0.7	1.2	0.1	0.1	2.0	0.7	0.2	1.0	0.1	0.1	1.8	1.6	2.1	2.1	1.7	1.8	1.4	1.8	1.2	0.6	1.8	2.3	2.3	3.2	1.8	0.7	0.2	0.4	1.3	0.5	0.0	1.2	0.3	0.4	0.5	0.0	2.6	0.0	0.0	2.1	0.2	0.0	1.9	0.5	2.6	3.3	1.6	1.4	0.0	1.3	0.2	0.6	2.5	0.6	0.0	3.9	0.0	0.9	2.2	0.8	1.8	0.0	0.9	0.0	0.0	0.3	2.0	0.8	1.2	0.6	0.0	0.0	0.2	1.3	0.0	2.0	0.2	0.3	0.0	0.7	0.1	0.9	0.0	0.4	0.8	0.7	0.0	0.9	0.6	0.8	4.4	0.0	0.1	15.3	0.5	0.7	0.1	1.1
ZNF12	"GIOT-3, KOX3, ZNF325"	ENSG00000164631	"Zinc finger protein 12"	P17014	7	6688433-6706947	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 8.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063402			Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Centrosome	"HPA063402: AB_2685005"	"unprognostic (2.68e-1)"	"unprognostic (6.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.89e-3)"	"unprognostic (5.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.46e-3)"	9.2	8.7	9.0	8.2	8.7	8.5	13.6	12.5	8.9	12.1	10.3	9.7	10.0	13.8	13.8	10.4	10.3	9.2	8.9	8.3	8.2	9.7	10.2	8.5	13.4	9.0	9.1	14.3	9.0	18.5	8.7	13.3	9.4	11.3	10.4	15.3	10.0	12.1	6.7	10.5	11.2	9.8	8.3	13.3	10.2	5.2	9.7	12.3	13.9	10.0	13.4	9.8	10.0	9.2	16.5	7.7	15.0	18.9	15.1	15.2	14.4	10.2	18.3	12.8	13.3	10.5	9.4	12.5	6.9	12.7	28.8	19.3	12.5	9.9	19.4	4.7	9.4	12.6	11.9	10.6	14.1	20.2	13.1	16.7	21.6	9.2	14.8	19.0	9.4	9.9	20.3	11.2	17.1	13.1	7.8	18.6	18.2	5.2	11.7	10.2	21.5	7.7	10.4	16.2	13.7	24.2	11.8	21.2	12.4	18.7	13.5	22.7	9.4	14.3	18.0	11.5	13.7	10.6	7.3	12.6	11.7	13.4	19.4	8.8	0.5	0.7	1.4	0.4	1.9	1.1	1.1	1.6	0.5	1.1	1.5	1.9	0.5	1.2	0.4	1.1	1.0	0.2	9.0	8.7	12.5	8.9	8.3	8.2	9.0	9.1	9.4	8.3	9.7	9.2	15.1	9.6	8.9	16.3	14.1	26.9	16.3	8.0	11.4	27.9	16.3	15.1	17.2	12.8	10.7	3.7	16.7	11.7	15.3	8.3	1.9	8.7	1.2	10.4	15.8	13.9	7.7	12.4	15.9	6.8	9.0	14.9	6.6	12.7	11.4	27.3	15.4	10.3	10.1	37.0	16.7	11.9	2.0	13.0	10.9	2.7	22.4	8.4	5.4	18.7	11.3	20.9	15.5	9.5	19.9	9.1	8.8	22.6	11.6	13.3	10.1	7.0	12.6	18.9	26.3	17.6	16.7	12.7	7.8	16.7	22.4	8.6	11.2	23.9	12.1	18.1
ZNF121	"D19S204, ZHC32, ZNF20"	ENSG00000197961	"Zinc finger protein 121"	P58317	19	9560329-9584504	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 68.2;RT4: 72.3"	"Low region specificity"	"Detected in all"							HPA054961	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 24: NB-4 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Centrosome"	Nucleoli	"HPA054961: AB_2682651"	"unprognostic (3.06e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.91e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.80e-3)"	"prognostic favorable (6.59e-5)"	"unprognostic (9.36e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (8.75e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.75e-5)"	7.0	4.8	5.5	5.2	5.9	14.3	7.2	8.8	6.4	5.3	8.2	5.5	3.6	4.7	5.6	9.3	5.4	4.0	6.1	5.7	6.7	8.0	8.5	7.5	6.2	6.0	5.1	4.6	6.3	8.7	6.7	4.2	6.3	7.1	5.8	7.2	6.7	3.5	4.4	10.8	6.4	4.8	5.3	7.4	5.7	3.6	6.3	6.0	5.6	3.2	6.8	5.3	7.0	9.5	14.9	8.7	10.3	23.7	4.6	5.4	16.4	5.3	5.3	7.3	10.0	17.7	6.6	16.1	13.3	4.6	4.1	13.6	18.8	15.0	9.2	8.4	32.4	43.2	29.2	15.7	6.1	26.0	25.6	7.2	11.2	7.2	16.3	6.1	5.4	17.4	16.9	27.7	5.4	11.8	17.9	68.2	27.1	5.2	13.9	10.9	13.0	11.8	8.0	72.3	19.6	10.2	7.6	10.6	6.2	20.7	7.8	8.2	6.1	21.7	12.0	7.6	12.1	26.6	17.6	18.4	6.0	14.4	9.1	1.6	1.5	0.9	2.1	1.9	2.8	1.5	2.0	1.9	1.6	2.3	2.3	2.6	1.2	3.1	2.0	2.0	2.0	0.9	5.5	5.9	8.8	6.4	5.7	6.7	6.0	5.1	6.3	5.3	6.3	9.5	16.0	6.4	10.5	3.9	14.7	22.6	36.9	15.6	10.8	7.3	12.7	11.7	11.2	5.7	15.7	9.2	12.5	12.3	25.8	5.6	7.9	11.4	1.5	12.3	16.9	11.8	13.7	11.6	6.2	5.3	11.3	11.7	11.7	18.3	15.2	16.7	10.8	9.9	5.3	6.7	5.3	10.2	8.2	10.4	13.8	0.6	6.2	9.7	8.8	1.0	6.9	3.1	12.3	7.5	6.7	11.4	5.6	8.2	12.6	26.2	4.1	5.3	11.0	7.8	6.6	17.0	10.3	11.0	12.5	21.3	31.7	10.5	14.5	11.9	14.6	35.9
ZNF124	"HZF-16, HZF16"	ENSG00000196418	"Zinc finger protein 124"	Q15973	1	247121975-247172016	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.3;salivary gland: 42.6"	"Group enriched"	"Detected in many"	16	"Early spermatids: 343.2;Late spermatids: 1250.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA031127	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 4: Stomach - Digestion"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA031127: AB_10602685"	"unprognostic (3.97e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (1.03e-4)"	2.4	2.3	0.9	4.1	2.8	6.0	3.5	14.3	5.2	2.6	0.4	7.0	6.3	4.3	3.9	2.0	2.2	3.5	2.0	2.5	4.4	4.6	3.2	4.0	6.1	2.5	2.9	3.2	3.4	1.5	1.0	4.3	1.9	2.9	6.9	4.8	42.6	2.4	1.8	4.3	5.9	3.5	0.5	5.5	4.4	3.9	3.3	6.7	3.7	1.4	6.3	3.3	1.9	6.6	5.8	4.3	12.0	15.8	4.4	2.5	29.9	5.8	3.5	6.0	6.0	6.5	5.1	11.6	6.8	4.7	4.0	6.2	14.4	4.6	8.6	0.7	3.8	10.0	5.6	14.0	4.3	18.5	11.3	3.5	3.7	5.9	5.7	2.9	8.8	13.4	14.6	8.0	7.5	5.1	18.9	11.8	31.1	11.1	9.9	19.9	9.7	8.2	5.7	17.0	18.5	18.9	8.7	6.7	6.0	14.0	4.8	28.8	10.0	4.5	6.8	5.0	10.7	6.8	9.0	16.8	1.9	18.6	9.6	8.1	7.9	9.2	5.8	9.1	8.2	9.3	7.4	7.1	11.2	5.1	9.9	9.8	1.8	9.5	14.5	8.7	6.2	5.5	0.9	2.8	14.3	5.2	2.5	4.4	2.5	2.9	1.9	0.5	3.3	6.6	8.2	16.0	8.9	5.5	14.9	3.6	5.8	10.2	6.2	3.7	4.1	6.5	4.6	7.2	11.2	3.7	4.2	3.6	13.8	8.6	1.9	5.3	343.2	7.2	6.8	8.9	7.8	5.5	13.5	5.0	6.6	4.5	13.3	7.9	11.4	10.7	3.3	0.7	7.9	0.0	47.8	5.1	12.2	26.8	5.3	1250.3	12.2	16.7	7.2	18.7	10.5	2.3	5.2	25.6	12.7	5.0	10.6	12.0	9.3	6.8	7.7	6.2	4.5	5.6	6.6	9.3	5.1	8.8	12.3	3.7	1.6	1.4	10.6	4.7	9.0	5.5
ZNF131	"pHZ-10, ZBTB35"	ENSG00000172262	"Zinc finger protein 131"	P52739	5	43065176-43192021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007023, HPA027748, HPA074630"	Approved		Enhanced	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Intermediate filaments"	"HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705"	"unprognostic (1.23e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.46e-2)"	13.2	13.5	12.5	13.9	12.8	28.4	19.5	17.3	21.7	13.8	10.0	13.2	10.0	17.6	9.6	14.4	12.6	12.9	9.6	12.8	12.4	12.0	14.3	11.4	20.3	11.4	11.9	15.9	12.2	11.7	10.7	16.9	11.9	12.6	13.2	14.7	10.4	9.0	15.8	18.2	12.0	15.9	11.3	15.9	11.6	32.6	12.3	26.7	11.8	17.1	17.5	15.0	13.3	14.2	25.4	15.2	32.4	43.2	30.1	20.6	27.3	32.8	26.6	31.9	26.9	24.0	22.2	50.8	25.9	22.1	29.7	17.7	38.9	20.8	44.9	24.8	34.1	31.4	92.2	18.0	27.7	55.0	24.7	18.8	38.2	23.5	38.3	22.8	24.7	39.0	40.7	52.7	36.8	24.5	53.9	68.8	21.5	23.4	24.9	35.3	49.4	39.9	27.1	24.4	20.0	29.4	83.5	39.8	43.2	21.7	22.3	51.6	18.5	39.8	37.3	20.5	31.1	21.1	32.5	58.4	21.0	71.2	27.1	10.4	8.2	5.8	19.1	9.5	19.2	13.1	18.5	18.5	11.9	16.8	22.3	18.3	3.9	17.2	6.6	11.3	14.9	10.0	12.5	12.8	17.3	21.7	12.8	12.4	11.4	11.9	11.9	11.3	12.3	14.2	42.5	22.4	21.9	28.7	44.7	49.6	51.4	24.1	53.5	52.1	32.3	29.7	17.5	22.8	19.4	9.2	52.1	27.0	53.3	28.0	31.3	15.3	52.9	30.0	47.7	32.8	31.2	39.1	31.2	11.8	25.0	32.4	23.0	49.7	24.1	39.4	24.7	13.3	16.4	38.7	33.6	29.7	20.3	25.8	35.4	19.5	20.5	30.9	21.4	14.0	27.5	29.0	49.4	38.7	24.2	17.9	24.7	21.1	27.8	38.5	34.9	13.1	15.7	70.0	26.3	57.0	43.2	109.6	80.3	45.9	65.5	25.4	59.3	37.3	38.7	35.6
ZNF133	"pHZ-13, pHZ-66, ZNF150"	ENSG00000125846	"Zinc finger protein 133"	P52736	20	18288283-18316996	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 37.1;Inhibitory neurons: 42.0;Oligodendrocyte precursor cells: 32.6;Oligodendrocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001493	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA001493: AB_1080666"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.46e-6)"	"unprognostic (6.01e-3)"	"unprognostic (8.60e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (2.20e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.52e-1)"	12.3	13.1	16.8	4.6	17.1	4.3	14.5	19.0	19.0	17.1	20.5	15.7	5.2	13.3	16.5	14.8	14.1	7.7	11.1	16.9	17.7	18.1	13.0	10.9	5.7	16.1	16.4	17.6	16.0	11.4	21.2	8.7	16.7	18.7	6.8	10.5	12.9	8.8	14.0	16.7	10.3	10.5	15.5	15.5	12.9	10.2	16.9	7.1	17.4	9.8	5.9	14.1	15.1	17.8	10.0	10.8	8.3	12.0	19.9	13.7	17.6	9.2	13.5	11.5	16.6	8.7	11.5	2.6	5.4	10.9	13.2	21.4	8.1	24.1	10.8	2.9	5.6	6.8	9.9	19.4	14.9	5.8	1.0	13.4	16.3	9.6	28.0	15.6	11.2	11.0	8.1	2.8	10.0	10.0	7.2	9.5	6.9	11.9	10.6	6.2	11.4	6.4	11.3	6.8	11.7	11.9	7.1	18.9	13.3	11.5	7.4	15.7	8.0	12.1	5.8	8.6	9.2	9.1	9.8	0.9	3.7	3.9	7.0	1.5	3.1	2.4	5.9	2.2	3.9	3.2	5.0	4.0	3.9	3.4	3.8	4.6	1.0	8.7	3.5	2.1	4.0	2.7	16.8	17.1	19.0	19.0	16.9	17.7	16.1	16.4	16.7	15.5	16.9	17.8	3.7	6.4	9.2	18.6	2.5	2.2	2.7	7.3	3.4	7.5	4.6	7.4	7.9	5.7	5.7	1.8	4.2	5.0	0.8	2.2	3.9	4.5	14.7	5.1	7.7	4.7	1.2	3.2	37.1	2.3	3.2	5.3	5.1	4.5	7.0	7.1	5.3	4.2	4.7	3.3	42.0	4.6	2.0	3.8	0.9	25.0	7.8	2.2	0.0	21.5	1.4	3.1	4.1	32.6	31.8	3.7	1.5	4.5	2.3	3.3	2.5	3.4	5.0	5.0	0.0	4.4	3.6	6.1	2.6	3.0	3.1	2.3	1.9	3.7	3.3	3.0
ZNF134	pHZ-15	ENSG00000213762	"Zinc finger protein 134"	P52741	19	57614233-57624724	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA009064	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA009064: AB_1080668"	"unprognostic (3.60e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.88e-1)"	"unprognostic (4.29e-2)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	4.6	5.4	4.9	4.7	5.2	12.5	7.5	8.7	5.3	5.7	4.0	6.5	3.5	5.5	6.0	5.3	6.5	4.5	6.0	4.9	5.5	5.6	4.9	5.8	7.5	3.9	4.0	7.6	3.8	12.0	5.7	7.9	3.7	7.3	4.5	10.6	5.4	8.3	6.3	7.1	4.9	6.0	3.6	7.1	6.0	6.6	5.5	11.1	8.3	7.2	8.5	6.1	4.1	4.7	2.5	6.6	15.5	8.4	6.8	9.1	7.7	6.8	11.1	9.8	4.9	2.2	2.9	5.0	4.7	8.5	7.5	2.1	7.2	12.6	16.8	0.1	33.2	15.8	7.0	6.2	9.9	10.6	11.2	12.3	12.1	7.4	16.7	12.9	6.6	8.2	2.1	5.7	14.8	3.7	21.0	4.4	21.8	1.6	13.6	12.2	22.5	7.9	7.3	21.5	12.4	14.5	11.3	4.9	7.2	17.0	6.9	8.4	8.7	14.7	6.3	3.5	9.0	15.3	21.8	6.9	7.7	1.8	9.9	2.3	4.2	7.4	6.3	3.0	8.3	9.5	6.5	6.7	4.6	8.3	7.5	7.5	3.4	11.9	3.4	3.5	4.4	5.5	4.9	5.2	8.7	5.3	4.9	5.5	3.9	4.0	3.7	3.6	5.5	4.7	6.0	9.6	4.1	1.0	14.4	5.4	12.7	4.4	8.6	8.4	9.8	8.0	11.2	11.5	5.6	3.7	12.5	8.2	11.1	1.2	7.9	7.8	1.7	6.0	7.8	8.3	1.2	13.0	1.0	3.7	4.3	6.2	1.1	7.3	6.3	10.6	9.7	4.1	5.3	8.4	0.9	4.0	6.1	5.1	3.2	1.5	7.2	4.4	3.6	0.0	7.0	11.3	9.2	1.0	1.6	3.8	2.6	14.7	5.0	9.3	2.8	4.6	5.1	11.9	6.6	6.6	8.5	2.2	15.2	6.7	7.7	16.3	8.8	8.0	3.6	13.8
ZNF14	"GIOT-4, KOX6"	ENSG00000105708	"Zinc finger protein 14"	P17017	19	19710472-19733112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049863	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA049863: AB_2680921"	"unprognostic (1.04e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (8.09e-6)"	"unprognostic (1.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.17e-2)"	"unprognostic (9.05e-3)"	3.0	2.6	3.4	3.3	3.7	8.3	7.3	7.1	4.4	5.6	1.4	3.1	2.2	5.2	5.2	2.7	5.1	2.8	3.8	2.8	3.6	4.7	0.8	2.7	6.8	2.3	3.2	8.7	3.2	7.6	3.3	4.2	2.8	5.4	2.8	4.8	3.8	5.1	2.0	3.6	3.1	3.4	2.3	5.3	4.1	3.5	3.8	4.9	7.8	4.4	6.5	3.6	3.2	5.0	2.8	2.7	4.7	6.1	3.1	3.4	5.6	2.9	4.0	4.2	4.5	2.7	2.1	7.6	4.7	3.0	2.4	2.8	4.9	2.9	5.2	1.9	5.6	3.5	2.0	3.5	3.7	0.1	5.2	3.3	3.0	2.9	2.5	5.5	2.6	3.7	4.2	3.5	4.2	4.7	6.6	4.1	6.1	5.3	8.1	3.4	7.6	3.6	3.0	5.6	4.6	3.3	0.0	3.3	4.7	4.0	4.6	7.3	1.7	3.6	1.0	4.3	3.8	2.7	3.5	6.5	0.2	3.9	2.2	22.4	2.7	9.4	13.3	4.7	21.0	14.9	18.1	16.6	3.8	12.0	24.8	19.9	6.1	10.1	5.8	4.4	12.7	9.1	3.4	3.7	7.1	4.4	2.8	3.6	2.3	3.2	2.8	2.3	3.8	5.0	3.6	0.0	3.7	11.4	8.5	2.4	4.4	1.5	3.4	4.6	3.2	3.4	2.8	0.0	1.4	3.7	0.0	3.4	5.3	0.4	3.9	1.7	0.6	1.5	2.1	3.4	3.0	4.8	9.7	1.3	1.5	3.5	2.6	2.5	1.3	4.7	3.3	0.2	1.8	6.7	12.5	1.4	4.1	0.8	1.4	0.9	1.8	1.8	3.6	11.2	0.3	3.8	4.1	12.5	13.7	0.8	2.5	3.8	2.8	2.2	1.0	3.0	2.9	5.7	6.6	3.2	2.9	3.4	3.0	1.5	1.4	2.2	9.5	2.2	1.3	2.5
ZNF140	pHZ-39	ENSG00000196387	"Zinc finger protein 140"	P52738	12	133080474-133107526	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003655, HPA048332"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA003655: , HPA048332: AB_2680362"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.67e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.13e-3)"	6.6	8.4	8.5	3.8	7.5	3.0	11.0	8.9	8.5	9.8	7.8	7.0	7.4	11.2	8.4	6.2	10.0	7.9	5.7	6.9	6.7	8.2	8.2	5.7	7.1	6.9	6.5	11.5	9.8	9.4	11.7	6.9	6.7	8.6	5.4	11.1	8.0	7.4	5.5	7.3	6.5	7.2	6.9	6.6	7.2	9.0	7.4	9.1	12.8	4.6	6.5	7.4	7.9	9.0	5.8	6.0	9.3	0.1	7.6	12.7	12.0	7.0	4.5	6.0	6.2	2.9	2.9	3.5	7.9	6.9	7.3	5.2	8.4	5.1	5.0	0.4	11.5	9.4	4.9	5.7	10.8	7.7	13.3	13.4	11.6	6.9	16.2	12.3	7.0	9.0	4.4	4.4	10.5	9.0	13.1	12.0	10.0	3.5	3.3	11.5	1.1	7.7	7.7	12.9	10.8	13.7	11.3	7.5	8.3	5.9	11.8	14.6	11.0	0.2	6.5	5.1	5.2	2.7	0.1	6.8	0.6	7.0	5.8	11.0	7.3	19.1	13.1	11.4	18.9	18.0	15.4	15.8	12.6	15.1	22.3	17.9	11.5	19.2	7.5	7.3	19.4	10.9	8.5	7.5	8.9	8.5	6.9	6.7	6.9	6.5	6.7	6.9	7.4	9.0	11.1	0.0	16.4	7.5	13.5	7.1	12.0	7.9	12.5	7.6	10.9	9.5	7.2	5.7	15.3	0.0	10.4	8.8	7.4	5.4	13.7	9.5	16.0	11.1	10.2	8.1	13.8	4.2	13.4	5.8	7.9	8.9	12.8	10.8	7.6	9.7	7.5	4.4	5.8	6.7	13.8	6.6	16.2	7.2	6.4	5.2	9.0	5.5	8.8	12.2	4.2	7.4	7.2	18.6	15.0	6.8	9.1	8.2	5.5	9.7	5.4	7.4	9.7	7.2	0.0	10.0	8.5	16.5	13.4	8.5	6.0	14.9	11.3	9.9	6.2	10.2
ZNF142	"KIAA0236, pHZ-49"	ENSG00000115568	"Zinc finger protein 142"	P52746	2	218633329-218659655	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049594	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA049594: AB_2680829"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-1)"	"unprognostic (8.20e-3)"	"unprognostic (9.08e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.63e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	6.0	5.7	5.0	5.0	5.5	8.0	6.0	5.5	6.9	6.4	1.2	8.0	2.6	7.5	2.5	6.7	6.7	3.6	7.0	5.5	3.6	6.3	4.5	5.4	5.3	4.5	3.9	6.2	7.5	4.9	8.3	3.2	4.2	6.8	3.1	6.4	6.3	4.3	10.3	7.0	6.5	4.9	2.6	7.3	7.0	4.8	4.7	6.0	6.9	6.6	4.9	7.3	5.8	5.1	6.3	9.7	9.0	10.7	8.5	6.3	8.5	7.1	4.2	9.7	7.4	19.3	5.0	8.3	6.1	6.4	8.1	11.4	17.6	11.7	6.6	12.0	16.5	12.9	20.7	12.3	6.8	16.8	11.8	4.3	11.0	11.5	11.3	5.3	8.2	9.2	17.0	15.7	5.0	13.7	11.7	9.6	11.8	3.9	8.8	17.7	5.1	8.1	7.3	11.3	12.3	9.3	5.3	10.4	4.0	8.5	6.0	6.1	12.2	9.2	9.7	7.8	11.0	10.5	7.1	13.4	5.9	7.9	9.5	0.9	0.7	0.8	1.0	0.1	0.4	0.7	0.6	0.6	0.6	0.3	0.7	0.5	0.4	0.3	0.2	0.8	0.6	0.6	5.0	5.5	5.5	6.9	5.5	3.6	4.5	3.9	4.2	2.6	4.7	5.1	3.5	3.2	0.5	4.9	6.0	5.9	2.0	1.7	5.7	3.5	3.8	3.4	5.3	4.3	2.7	3.7	6.2	2.2	4.0	4.1	0.0	3.2	2.7	2.7	4.3	3.2	0.0	2.1	7.0	3.8	2.2	3.8	6.6	5.2	1.3	5.2	4.2	3.1	3.0	1.7	6.7	3.0	4.1	4.7	3.2	4.8	3.7	4.1	3.6	4.7	3.1	2.3	8.2	3.0	6.7	4.1	3.5	3.8	8.5	2.8	3.4	2.2	1.0	2.7	6.6	3.9	2.9	5.5	5.5	6.6	6.1	1.1	6.3	4.1	4.3	2.3
ZNF143	"pHZ-1, SBF, STAF"	ENSG00000166478	"Zinc finger protein 143"	P52747	11	9460319-9528524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003263, HPA003264, HPA074818"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus, Vesicles"	"HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.72e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (4.87e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.55e-2)"	9.0	6.1	8.6	11.4	10.1	18.6	9.6	17.3	9.9	10.0	10.8	9.7	9.5	10.5	14.4	9.8	10.1	8.4	9.3	7.9	9.3	8.6	9.6	9.1	15.7	9.9	8.8	13.7	7.7	7.9	7.1	10.4	11.2	8.7	9.9	16.1	8.9	8.0	17.3	10.2	8.2	9.5	9.8	11.1	7.7	16.9	9.0	18.9	14.6	11.5	14.1	11.2	8.4	14.9	20.0	18.8	23.4	15.2	18.9	17.4	21.5	21.8	17.3	16.4	17.9	26.7	24.3	19.6	9.7	17.7	14.0	22.5	23.1	17.3	24.5	20.0	27.7	18.5	27.7	18.7	15.6	25.9	17.8	15.3	20.4	22.2	19.4	21.4	16.3	17.9	20.5	23.3	18.3	17.1	24.1	10.6	26.3	23.0	19.9	21.4	21.2	12.3	14.7	24.0	16.1	15.8	24.0	16.0	14.3	20.6	14.9	14.6	15.6	21.4	15.3	15.1	19.6	11.5	21.6	33.4	13.8	14.8	12.5	39.1	24.6	57.3	28.0	24.9	25.0	23.0	24.6	22.9	20.9	18.2	22.8	19.6	45.1	19.4	28.2	10.1	29.7	19.6	8.6	10.1	17.3	9.9	7.9	9.3	9.9	8.8	11.2	9.8	9.0	14.9	17.9	6.4	12.1	6.2	14.7	26.6	34.1	12.1	17.6	9.3	8.7	13.2	15.5	7.2	10.3	5.5	8.4	10.0	17.1	10.1	3.9	12.5	20.3	18.7	14.9	13.0	6.6	25.4	8.1	11.5	16.2	14.5	9.7	16.3	14.0	7.7	6.8	7.6	9.9	5.0	7.4	6.9	14.2	8.3	22.0	10.0	11.8	15.8	10.6	12.2	16.3	15.5	17.5	7.5	9.8	14.1	7.7	6.8	15.4	20.1	6.3	7.7	15.0	14.3	59.2	18.3	16.7	50.5	21.3	12.8	23.4	18.3	18.1	7.3	7.9	26.9
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225669-125375325	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	8.9	7.5	5.6	9.4	8.9	7.9	12.1	12.9	7.8	12.6	0.0	10.8	7.6	13.9	10.2	10.3	12.4	9.5	15.5	4.5	16.4	12.9	11.7	10.3	12.3	4.2	6.5	17.4	9.5	15.8	4.7	9.7	4.2	11.1	11.5	13.1	10.0	11.1	11.1	5.8	8.9	13.7	2.3	11.9	9.8	10.5	14.5	16.9	30.0	12.0	14.4	10.6	6.1	8.3	30.6	19.8	21.1	18.9	18.4	19.7	16.0	27.2	31.5	29.9	28.4	19.1	16.6	24.4	18.5	40.3	24.1	24.4	23.2	20.5	42.4	10.9	8.9	30.1	23.3	9.8	13.6	20.9	29.1	16.1	21.0	28.0	29.4	19.7	20.7	17.7	15.0	20.2	22.3	23.9	26.1	7.7	13.6	20.6	16.8	18.6	23.2	13.9	17.1	33.6	18.2	15.3	36.2	18.2	29.7	11.7	22.7	20.8	26.6	22.6	24.1	28.5	17.5	17.4	21.5	36.6	16.9	13.1	21.3	4.4	15.3	32.0	21.8	14.5	22.5	24.5	19.2	20.9	13.0	22.2	27.9	22.0	51.4	33.2	23.4	11.3	19.6	20.1	5.6	8.9	12.9	7.8	4.5	16.4	4.2	6.5	4.2	2.3	14.5	8.3	54.7	93.0	41.3	92.7	56.7	35.6	26.0	36.2	48.9	68.0	37.0	35.7	75.2	24.3	43.0	33.1	39.6	28.7	53.7	34.7	25.4	37.5	82.0	28.8	54.3	51.6	47.9	32.0	166.7	37.4	24.3	44.5	31.1	38.1	50.6	75.7	37.9	41.0	31.1	75.7	170.3	34.4	26.4	37.1	21.2	135.2	48.1	41.2	17.8	143.4	50.1	45.7	59.8	154.3	151.4	33.7	25.6	59.0	35.8	36.6	28.2	43.9	27.5	39.4	32.9	63.4	60.7	24.4	24.2	32.5	38.4	31.6	52.0	42.0	33.6	35.6
ZNF154	pHZ-92	ENSG00000179909	"Zinc finger protein 154"	Q13106	19	57697367-57709194	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 11.8;granulocytes: 10.8;Oligodendrocyte precursor cells: 10.6;Rod photoreceptor cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;HSkMC: 2.9;MOLT-4: 4.4;NTERA-2: 2.9;SuSa: 6.1"					"Low region specificity"	"Detected in all"			HPA076284	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA076284: "	"unprognostic (3.32e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.20e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.35e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.11e-1)"	1.3	2.8	2.4	3.2	2.8	1.2	2.1	6.4	2.8	1.4	4.9	3.6	1.1	0.8	1.5	2.1	0.9	2.0	2.9	2.6	2.8	2.2	0.7	1.6	4.9	1.6	2.2	1.4	1.4	3.6	5.1	3.1	1.2	2.2	1.3	4.6	2.4	3.5	1.6	0.8	2.5	1.4	0.9	4.6	1.2	0.9	3.1	6.1	5.8	1.5	4.4	2.4	0.8	1.5	0.1	0.2	5.2	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.1	0.2	0.3	0.1	1.3	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.8	0.1	1.8	0.3	0.4	2.9	0.0	0.3	0.0	1.8	0.1	0.2	0.2	0.3	1.2	0.1	4.4	0.2	2.9	0.1	0.1	0.2	0.1	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.0	6.1	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0.3	0.1	0.2	0.0	0.2	0.0	0.8	0.1	2.0	0.2	0.0	0.6	0.4	0.2	0.4	0.1	1.0	0.3	0.3	0.6	0.5	0.0	0.5	0.0	0.2	2.4	2.8	6.4	2.8	2.6	2.8	1.6	2.2	1.2	0.9	3.1	1.5	2.0	0.0	1.9	11.8	7.5	0.4	1.5	0.5	0.6	8.1	1.9	2.2	4.2	1.5	1.0	1.8	8.4	0.2	5.5	0.1	0.0	2.5	0.0	0.5	1.4	2.7	0.0	0.4	7.3	0.2	0.2	1.2	2.0	0.8	10.8	2.2	3.6	0.2	1.6	8.4	7.2	0.0	2.0	0.6	1.7	0.2	0.3	1.2	0.0	1.9	0.7	3.4	4.1	10.6	1.4	0.1	0.0	1.5	2.5	1.3	0.0	0.2	1.3	10.3	0.0	1.5	3.6	0.6	1.1	0.5	0.4	0.3	2.6	0.3	0.0	2.0
ZNF155	pHZ-96	ENSG00000204920	"Zinc finger protein 155"	Q12901	19	43967862-43998326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.5;Excitatory neurons: 22.0;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003220	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA003220: AB_1080675"	"unprognostic (2.71e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.98e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.57e-2)"	4.1	5.6	4.1	3.3	4.8	2.9	5.5	7.2	5.1	4.6	4.3	4.0	3.3	4.7	6.1	3.6	3.7	3.6	6.0	4.0	4.7	5.2	6.5	4.4	4.4	4.1	3.9	6.1	3.0	8.2	4.5	4.4	4.3	5.1	4.6	8.6	3.8	4.6	3.2	5.4	4.0	5.8	3.8	6.0	5.2	3.3	4.4	6.6	7.8	3.5	4.3	4.0	2.9	5.5	5.1	4.2	10.4	9.5	5.6	6.5	3.0	4.1	3.9	2.8	4.1	2.8	2.5	0.0	5.1	6.4	4.0	3.9	3.5	8.7	4.7	5.7	8.7	10.8	9.8	3.1	5.8	3.9	6.0	9.2	7.0	5.8	8.5	8.2	6.6	0.2	0.2	0.1	7.8	4.5	4.9	3.9	6.4	2.1	3.7	0.0	11.1	3.8	7.5	16.3	7.0	9.3	10.1	0.6	4.0	9.1	6.7	9.3	5.0	6.3	9.2	4.1	6.0	11.5	9.1	0.0	5.3	0.7	5.9	8.1	2.7	9.8	6.5	2.9	6.3	4.0	4.5	7.0	4.1	5.2	5.5	5.0	2.4	5.5	2.2	2.4	4.2	4.2	4.1	4.8	7.2	5.1	4.0	4.7	4.1	3.9	4.3	3.8	4.4	5.5	2.4	0.0	1.3	23.5	2.7	1.5	1.1	2.2	1.2	3.6	2.4	2.2	0.4	1.5	1.9	0.0	0.0	1.8	1.8	2.3	1.9	1.8	0.5	0.8	1.3	2.6	0.0	0.8	22.0	1.5	0.6	2.0	2.0	1.2	1.3	3.2	2.5	1.5	1.6	6.7	16.1	1.3	2.0	0.8	1.3	0.9	2.8	1.3	1.8	9.4	0.9	4.2	1.0	24.6	24.1	0.9	0.8	5.7	1.0	1.2	1.9	1.9	0.8	3.2	0.0	2.2	2.4	1.3	1.4	1.4	1.3	1.1	2.2	3.0	1.5	1.0
ZNF16	KOX9	ENSG00000170631	"Zinc finger protein 16"	P17020	8	144930358-144950888	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035782, HPA061835"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"HPA035782: AB_10603243, HPA061835: AB_2684621"	"unprognostic (4.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (2.39e-4)"	"unprognostic (7.53e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.17e-3)"	4.6	3.6	4.6	2.4	4.7	2.6	6.3	4.4	5.0	6.0	5.9	6.5	4.7	6.2	6.9	5.9	7.1	5.7	4.4	4.5	4.4	5.3	3.9	3.7	3.2	4.2	4.2	11.0	7.5	8.6	4.0	3.9	4.3	5.4	4.7	5.1	4.6	5.6	8.3	9.3	4.8	5.5	4.5	3.4	5.0	7.5	4.8	4.4	7.0	8.3	3.9	5.7	6.0	4.6	4.5	3.9	7.7	4.2	6.4	9.0	5.5	4.0	8.9	8.0	7.2	3.1	4.5	7.1	5.2	5.2	4.3	3.5	5.4	8.9	7.2	3.1	4.5	8.2	4.4	4.5	10.7	3.0	4.6	10.9	8.8	5.1	13.2	7.9	4.4	5.3	5.7	4.7	6.4	6.2	6.1	3.0	4.7	6.9	8.8	7.5	4.5	4.5	6.8	6.7	6.4	4.7	8.5	5.1	6.9	5.8	9.5	5.6	4.7	3.6	7.5	4.3	4.5	3.4	3.1	6.4	4.1	4.0	5.8	2.6	3.0	2.2	4.9	2.9	5.6	2.8	3.8	4.5	4.8	4.4	3.8	3.5	0.4	9.2	3.0	2.5	5.8	3.2	4.6	4.7	4.4	5.0	4.5	4.4	4.2	4.2	4.3	4.5	4.8	4.6	3.6	3.2	4.4	4.9	3.4	2.7	6.9	6.8	5.2	11.4	4.3	2.9	3.7	5.7	3.1	9.2	12.5	5.9	7.0	3.2	1.9	7.3	10.3	2.0	3.5	3.7	4.2	3.0	6.8	4.4	3.6	3.8	5.1	3.9	7.0	9.4	5.0	4.5	3.6	6.7	6.3	5.6	6.1	3.5	2.4	3.7	6.2	2.1	1.8	6.5	5.4	6.2	7.2	6.6	7.2	3.6	4.9	6.4	3.2	4.2	10.6	4.8	3.4	25.1	0.0	3.4	4.0	13.6	18.1	4.5	4.5	5.5	5.1	6.6	5.4	5.5
ZNF169	MGC51961	ENSG00000175787	"Zinc finger protein 169"	Q14929	9	94259298-94301829	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.4;Inhibitory neurons: 16.7;NK-cells: 15.5;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041769, HPA061185"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Vesicles, Cytosol"	"HPA041769: AB_2677662, HPA061185: "	"unprognostic (1.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.27e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.45e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-4)"	3.0	2.7	3.8	4.4	4.4	3.2	3.9	4.3	4.8	5.4	3.4	4.3	2.9	3.9	4.2	2.6	4.8	1.7	2.6	3.8	2.4	3.7	2.1	3.2	6.0	3.7	2.6	5.4	3.3	2.3	2.7	2.1	3.8	4.2	5.5	4.2	3.9	2.6	4.6	5.2	5.7	2.8	1.8	6.1	4.1	2.6	3.5	3.8	4.8	1.8	5.1	4.0	4.1	5.7	3.0	2.6	2.8	4.9	1.5	3.4	3.1	1.1	2.0	2.2	2.3	1.8	4.3	7.3	1.4	1.7	2.2	5.8	5.7	2.7	2.9	4.0	6.3	5.1	6.5	3.3	1.8	7.8	5.0	3.0	2.9	1.8	2.8	2.8	2.7	6.8	4.6	2.1	2.8	2.9	3.7	4.4	4.6	6.2	3.2	3.1	2.0	2.3	1.9	2.5	2.9	3.5	1.9	3.5	1.4	2.7	2.2	3.2	3.1	2.0	2.6	2.6	2.2	3.9	1.5	1.4	1.9	5.2	1.9	2.2	3.0	3.2	2.4	3.4	3.1	3.0	2.9	1.7	2.1	4.0	3.0	4.1	2.5	3.3	2.6	2.0	3.1	1.7	3.8	4.4	4.3	4.8	3.8	2.4	3.7	2.6	3.8	1.8	3.5	5.7	2.0	3.2	0.5	10.4	8.0	0.3	2.2	1.3	1.2	4.8	1.0	1.3	1.2	1.5	2.6	1.8	4.2	0.5	3.9	2.5	0.0	1.1	1.0	0.6	1.4	2.3	1.2	3.8	18.4	0.9	0.8	1.8	2.6	0.5	0.0	6.3	2.5	0.8	0.7	5.0	16.7	4.1	0.0	4.4	1.6	1.0	5.9	4.1	0.0	7.5	7.8	2.3	15.5	14.1	19.9	1.2	3.1	3.4	2.6	2.6	4.3	1.0	2.4	4.5	0.0	2.9	1.7	5.2	3.6	0.7	0.4	0.4	4.7	3.7	2.1	2.4
ZNF18	"HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38"	ENSG00000154957	"Zinc finger protein 18"	P17022	17	11977439-11997475	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.0;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006144	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA006144: AB_1080683"	"unprognostic (2.99e-3)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (5.12e-6)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (1.52e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.53e-3)"	7.2	5.7	7.9	5.8	8.6	13.7	6.1	7.7	11.2	6.7	7.4	6.0	5.0	5.3	6.3	7.5	5.7	5.5	5.9	7.9	8.3	5.8	12.4	5.1	8.8	8.4	8.0	5.7	6.0	4.3	7.7	4.0	8.8	8.4	6.7	4.9	5.2	5.1	7.3	9.7	6.6	5.8	7.6	10.2	5.3	14.1	8.1	8.5	6.2	4.6	8.0	6.3	6.6	9.8	3.0	6.1	6.4	9.7	11.9	10.5	3.4	4.3	7.5	5.5	5.9	2.9	5.0	10.3	6.3	4.7	4.8	6.1	5.4	6.8	5.9	7.8	4.5	6.1	6.9	4.0	8.4	3.4	7.8	8.7	10.8	4.2	7.6	6.3	8.4	12.0	3.6	4.7	7.6	3.1	11.5	6.9	4.8	10.9	2.8	9.4	6.5	4.6	8.0	3.6	2.5	5.4	7.3	3.6	5.9	37.2	5.1	3.2	6.7	6.5	3.2	2.9	3.3	5.2	4.1	5.1	7.5	7.9	7.8	10.5	5.9	6.9	10.3	5.9	9.6	9.0	9.3	9.7	5.8	7.2	10.0	10.3	19.1	7.7	8.2	8.6	11.1	6.1	7.9	8.6	7.7	11.2	7.9	8.3	8.4	8.0	8.8	7.6	8.1	9.8	2.5	0.0	2.0	10.1	3.8	2.0	1.7	4.2	4.6	2.0	2.0	1.4	1.6	2.8	2.1	1.8	2.1	2.4	3.5	2.5	1.9	3.1	23.0	1.8	2.8	1.9	1.2	5.2	7.4	0.9	2.2	2.7	2.0	1.8	2.5	5.1	2.5	3.7	4.3	1.7	8.4	4.2	6.1	3.8	1.8	27.3	3.4	3.2	1.8	8.4	3.4	2.0	5.2	7.5	9.3	2.1	5.0	3.4	2.3	1.6	3.9	3.1	2.5	1.2	0.0	2.5	2.3	9.6	4.9	5.0	2.3	1.5	4.7	2.8	3.1	1.1
ZNF180	HHZ168	ENSG00000167384	"Zinc finger protein 180"	Q9UJW8	19	44474428-44500524	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028979, HPA028980"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA028979: AB_10600328, HPA028980: AB_10611524"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.38e-3)"	2.8	2.8	1.7	2.4	1.8	2.7	4.5	2.3	2.2	3.2	2.4	2.9	2.4	3.5	2.6	2.7	4.1	1.6	2.4	1.8	1.8	2.9	3.3	3.0	3.2	1.8	2.0	4.7	3.3	8.1	2.4	2.7	1.9	5.2	3.4	4.7	2.4	3.0	2.6	3.0	3.0	3.2	1.8	3.2	3.1	2.8	1.8	3.9	4.5	2.2	4.0	2.7	2.8	2.2	7.0	2.0	9.1	6.5	2.1	3.9	5.5	4.0	4.3	6.3	7.4	3.6	0.9	0.6	3.1	5.5	4.5	2.2	5.5	8.0	7.8	8.0	3.3	7.7	1.6	2.7	2.0	11.7	4.8	3.8	3.3	3.8	4.8	5.8	4.4	3.4	3.7	5.6	4.4	1.3	6.2	4.1	6.0	6.5	4.4	3.7	4.9	5.2	6.1	11.4	7.5	6.4	7.1	6.8	3.3	5.8	3.6	9.8	3.5	10.8	4.3	1.4	5.7	1.5	5.7	3.2	2.4	5.0	5.6	2.1	1.1	2.3	1.1	0.6	1.6	1.8	1.7	2.0	1.7	1.7	1.9	1.8	0.3	1.7	1.2	0.4	4.6	1.3	1.7	1.8	2.3	2.2	1.8	1.8	1.8	2.0	1.9	1.8	1.8	2.2	3.4	6.4	1.5	4.2	4.3	2.5	2.2	2.4	4.0	6.7	3.2	2.4	4.5	2.8	4.1	1.8	4.2	5.5	4.2	3.5	7.9	4.2	5.8	3.0	4.7	2.8	4.2	8.2	5.7	4.2	4.0	3.5	4.1	2.9	1.3	5.7	5.3	3.7	3.4	1.7	5.8	4.9	6.1	4.6	1.1	1.3	2.8	2.6	5.4	8.4	5.4	6.0	7.2	6.6	9.0	3.9	5.7	4.5	1.7	2.2	4.3	3.5	4.3	4.4	6.6	4.3	3.5	2.7	4.6	2.5	1.3	3.1	4.0	3.5	4.0	1.7
ZNF181	"HHZ181, MGC44316"	ENSG00000197841	"Zinc finger protein 181"	Q2M3W8	19	34734155-34745378	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043701, HPA062305"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA043701: AB_10960859, HPA062305: AB_2684743"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.34e-2)"	"prognostic favorable (5.45e-4)"	7.5	8.9	10.4	5.9	12.5	3.6	10.4	13.8	13.2	8.8	10.3	9.4	9.7	9.0	6.3	6.5	9.0	7.2	13.8	10.0	11.2	9.2	14.6	8.1	7.8	11.6	11.3	18.2	11.8	13.2	6.8	5.5	11.1	8.5	7.0	17.7	8.0	10.6	22.8	5.1	8.8	8.1	11.2	9.8	7.6	7.1	10.8	8.8	10.5	23.7	9.1	7.8	5.8	14.1	4.4	7.0	8.5	11.2	13.4	10.5	2.7	5.3	9.4	5.7	6.5	5.0	4.6	6.8	14.8	8.2	7.6	4.1	5.9	5.8	4.3	14.5	6.0	12.9	9.1	7.0	15.8	7.6	4.3	8.1	9.2	4.0	7.8	14.4	5.5	15.0	10.6	0.1	11.4	3.0	15.1	5.4	5.4	10.0	5.7	10.3	10.7	8.9	7.5	5.1	5.9	10.8	11.6	3.2	12.4	7.0	6.7	12.1	7.2	14.6	7.3	3.6	5.8	10.2	16.4	5.7	5.8	2.0	7.5	3.0	4.1	6.6	8.3	5.6	8.5	8.8	11.0	11.3	6.0	15.2	17.1	12.3	0.7	10.9	16.1	6.6	7.6	6.3	10.4	12.5	13.8	13.2	10.0	11.2	11.6	11.3	11.1	11.2	10.8	14.1	11.5	16.0	5.3	8.5	5.7	1.7	3.7	4.0	3.4	15.9	6.5	9.0	40.8	2.8	9.4	5.5	4.2	3.6	3.1	5.3	17.6	6.3	3.3	4.6	7.3	8.9	4.2	1.7	6.8	4.9	1.0	11.2	5.6	4.0	2.5	13.1	7.5	8.5	3.8	13.5	7.8	6.5	4.1	5.4	2.0	2.5	9.3	3.3	5.4	2.8	3.0	16.1	15.5	8.0	11.7	2.6	4.6	12.0	2.6	2.7	6.9	8.0	14.5	15.5	0.0	22.3	14.6	18.9	8.9	3.2	0.9	1.1	6.2	13.1	4.4	1.5
ZNF182	"HHZ150, KOX14, Zfp182, ZNF21"	ENSG00000147118	"Zinc finger protein 182"	P17025	X	47974851-48003989	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059574	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA059574: AB_2684068"	"unprognostic (1.86e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.88e-3)"	"unprognostic (6.88e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (1.01e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.59e-2)"	"prognostic favorable (1.55e-7)"	4.5	4.2	4.3	4.0	4.5	5.0	4.5	6.0	5.8	6.5	4.6	4.8	2.9	4.6	4.6	3.0	5.4	3.2	3.6	4.0	4.4	6.3	5.3	4.5	6.6	4.6	4.3	6.3	6.5	4.4	7.7	3.4	4.7	5.7	3.4	6.7	4.2	3.6	3.0	3.7	5.7	2.9	4.1	8.4	4.6	2.8	4.7	7.6	8.8	3.6	6.2	4.6	4.4	5.3	3.6	4.8	5.8	5.6	3.2	3.6	2.2	4.5	5.3	6.4	7.7	3.7	4.7	9.2	3.2	2.9	6.1	4.3	9.7	2.6	7.7	6.6	5.6	4.6	6.3	4.7	4.0	8.6	7.2	3.2	5.5	5.5	6.5	7.7	3.9	8.9	4.0	6.7	6.0	2.7	6.7	15.2	9.2	2.4	5.4	5.7	11.0	10.2	5.6	2.4	5.4	7.3	7.3	2.3	4.3	12.6	5.9	7.5	3.9	5.1	5.5	7.6	3.8	8.7	7.6	7.1	3.5	7.2	3.4	1.8	1.9	4.2	3.3	1.9	3.8	4.4	3.0	3.1	2.4	2.9	4.6	3.9	4.2	3.0	5.5	1.8	3.2	2.5	4.3	4.5	6.0	5.8	4.0	4.4	4.6	4.3	4.7	4.1	4.7	5.3	3.5	12.8	7.0	6.2	5.8	0.3	1.0	1.3	3.4	6.7	2.3	2.0	4.4	5.7	2.4	1.8	2.1	2.1	4.7	0.6	0.0	2.8	0.2	3.6	4.1	3.5	7.7	7.8	6.6	1.8	1.4	2.5	1.1	2.5	0.0	10.3	4.2	2.5	1.7	1.7	7.4	4.1	2.0	3.7	0.7	0.4	2.5	4.0	3.6	4.7	4.9	3.8	6.2	5.0	8.0	2.7	3.0	1.9	6.0	1.1	0.9	2.1	4.4	2.9	0.0	4.0	4.5	2.8	3.2	1.7	1.1	0.8	3.8	6.5	2.5	1.1
ZNF184		ENSG00000096654	"Zinc finger protein 184"	Q99676	6	27450743-27473118	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA003226, HPA064793"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003226: AB_2218705, HPA064793: AB_2732722"	"unprognostic (8.86e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.99e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (4.41e-5)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.79e-3)"	2.8	3.1	2.4	4.3	4.6	8.8	5.4	1.2	8.4	6.1	0.0	4.4	3.4	5.4	4.1	3.8	4.5	4.0	2.8	6.4	0.6	7.0	3.6	4.1	6.3	0.4	0.3	6.0	2.7	5.9	4.1	3.0	0.3	4.3	4.5	4.4	3.5	4.3	2.9	5.7	3.6	4.3	0.6	4.6	4.4	8.3	0.3	10.2	5.6	5.0	6.6	4.5	2.9	2.7	6.4	2.0	10.8	19.7	7.6	5.6	3.6	6.2	8.3	7.1	10.9	3.6	3.7	11.7	10.3	4.0	4.8	3.9	9.7	4.0	10.3	11.4	6.0	14.0	7.3	5.1	4.0	16.9	9.7	4.1	6.0	5.2	5.4	8.4	7.8	17.8	10.9	21.1	11.9	3.2	27.3	14.3	6.3	3.5	4.5	35.4	15.2	17.5	4.9	5.9	18.4	8.9	7.0	6.0	9.2	5.3	7.0	14.4	5.3	10.8	7.1	4.9	7.2	9.6	17.4	21.8	2.4	19.4	10.9	2.1	2.7	8.0	7.9	3.7	10.9	7.4	8.3	7.7	4.1	6.9	6.3	7.9	1.4	7.0	2.9	2.5	10.4	3.9	2.4	4.6	1.2	8.4	6.4	0.6	0.4	0.3	0.3	0.6	0.3	2.7	5.4	6.4	8.1	2.0	9.8	4.1	3.8	2.5	6.8	2.5	5.1	5.5	3.5	2.8	6.4	1.8	2.1	4.3	17.5	2.1	7.9	2.7	36.9	7.9	3.7	5.1	7.1	3.4	10.3	3.0	3.0	4.5	2.0	5.0	5.1	7.4	3.9	1.5	2.8	10.1	3.4	5.1	2.0	3.8	3.8	12.6	3.4	3.6	1.8	5.6	3.0	3.3	9.2	4.0	4.2	2.5	2.1	3.8	6.5	4.6	1.6	4.5	6.3	4.8	0.0	5.2	6.8	12.8	5.9	4.3	4.4	2.9	12.5	4.6	4.4	4.5
ZNF195		ENSG00000005801	"Zinc finger protein 195"	O14628	11	3339261-3379222	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA030605	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA030605: AB_10602686"	"unprognostic (2.30e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.24e-4)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.79e-7)"	9.3	10.1	12.1	6.6	12.0	10.8	13.7	13.1	16.0	12.3	11.8	11.1	9.4	8.5	15.6	9.1	8.5	7.1	7.7	12.1	13.7	13.0	13.1	8.7	11.3	13.9	12.5	6.8	13.1	6.2	10.2	6.4	13.7	13.7	12.1	14.1	10.3	6.2	11.8	8.3	12.4	7.5	11.9	16.5	10.3	4.9	12.8	17.1	10.2	9.5	11.0	10.3	9.2	13.4	15.8	18.6	32.0	38.2	9.9	11.8	37.7	16.7	14.1	16.4	22.6	19.4	24.3	26.7	11.1	10.8	24.2	21.1	34.5	20.0	24.6	14.2	28.4	18.3	15.6	19.1	12.5	32.3	28.7	14.7	17.9	13.4	21.7	12.1	21.7	35.0	32.8	17.3	17.9	12.7	37.6	25.1	66.4	18.4	19.1	35.8	20.4	14.2	27.4	38.3	47.8	49.5	18.5	21.2	15.9	27.8	10.7	29.0	17.2	9.1	14.2	11.6	14.0	14.9	25.5	43.8	7.7	23.6	13.8	2.4	11.6	14.7	15.4	13.0	20.0	18.8	19.0	19.5	17.3	17.8	17.9	20.3	1.8	18.7	11.6	14.5	28.4	11.3	12.1	12.0	13.1	16.0	12.1	13.7	13.9	12.5	13.7	11.9	12.8	13.4	13.8	16.0	21.9	15.0	16.6	12.1	16.9	18.6	14.2	15.3	9.7	12.8	18.3	11.5	20.8	7.3	10.4	9.7	17.3	9.0	9.8	25.1	3.3	10.3	18.7	12.7	20.4	12.0	19.8	18.9	10.5	12.0	23.4	13.3	6.3	33.9	8.2	7.5	10.9	18.5	24.3	14.0	14.2	12.3	8.4	0.8	5.9	8.8	7.2	6.5	9.8	17.9	15.5	20.1	27.9	25.3	13.5	5.7	16.9	13.6	10.0	12.5	15.6	13.7	0.0	12.6	12.3	12.3	9.6	12.4	6.8	4.0	15.9	15.2	15.8	17.5
ZNF197	"D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41"	ENSG00000186448	"Zinc finger protein 197"	O14709	3	44584888-44648471	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA054567	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA054567: AB_2682527"	"unprognostic (1.06e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.85e-2)"	6.2	5.8	2.8	1.9	3.0	1.1	5.7	4.6	3.0	6.3	2.1	7.2	2.1	6.3	2.7	4.5	6.1	2.2	5.4	2.8	3.3	5.6	6.3	4.6	2.4	3.1	3.0	7.4	5.9	3.3	7.4	2.7	2.9	6.0	2.4	5.7	5.2	2.9	11.6	4.8	5.0	2.7	2.7	4.8	5.2	5.7	3.1	3.2	7.6	4.2	2.3	6.9	5.6	3.5	2.6	1.2	10.4	3.4	5.5	6.4	0.4	5.0	6.5	4.3	4.6	2.1	2.3	2.1	3.1	4.0	2.6	1.7	4.8	4.0	4.4	0.4	1.2	9.0	4.0	1.7	5.7	6.8	2.4	6.7	5.2	4.9	7.3	5.6	3.2	2.8	6.1	3.7	6.3	0.6	3.9	4.9	7.2	2.8	3.4	1.5	7.3	2.9	3.9	2.6	4.2	7.3	4.5	2.3	6.0	5.5	6.2	6.8	3.1	4.5	3.6	7.0	4.2	4.9	5.6	1.4	3.5	2.3	4.5	0.4	0.7	0.5	0.7	0.3	0.6	0.5	0.6	0.6	1.0	1.7	0.7	0.4	0.3	1.3	4.7	1.7	0.8	0.3	2.8	3.0	4.6	3.0	2.8	3.3	3.1	3.0	2.9	2.7	3.1	3.5	7.3	16.0	8.7	13.1	3.8	2.5	4.6	4.1	5.7	12.4	4.5	3.9	12.3	1.5	9.7	0.0	8.4	1.1	5.7	7.2	1.9	7.4	16.7	4.6	8.0	5.4	6.1	3.0	13.5	8.9	0.7	6.2	3.6	4.5	3.8	10.9	6.8	7.6	4.6	16.8	17.1	6.5	2.0	5.1	3.4	4.5	5.6	5.1	5.4	12.2	8.5	13.2	7.2	14.6	20.1	6.8	5.2	5.3	5.4	5.0	6.4	4.5	4.6	8.5	6.6	6.6	6.4	11.2	5.7	3.3	3.4	0.4	4.6	13.5	5.1	3.6
ZNF2	"A1-5, Zfp661, ZNF661"	ENSG00000275111	"Zinc finger protein 2"	Q9BSG1	2	95165432-95184317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041358	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041358: AB_10795539"	"unprognostic (1.18e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	2.1	2.6	2.3	2.3	2.5	0.7	2.5	2.7	2.9	3.2	2.0	2.4	2.1	2.4	3.2	2.3	2.9	1.5	3.1	2.2	2.2	2.7	1.9	2.4	3.1	2.3	2.3	3.9	2.1	3.8	1.9	2.2	2.4	2.6	1.7	3.0	2.3	3.2	3.4	2.9	1.8	2.6	2.1	2.9	2.5	3.0	2.3	3.2	3.1	3.6	3.2	2.3	1.8	3.0	4.1	3.7	4.5	7.6	6.2	5.1	2.8	4.0	5.7	6.1	7.7	3.9	2.5	2.2	3.0	4.1	4.3	3.0	5.1	3.2	6.1	5.8	4.0	5.8	2.9	4.9	5.1	2.8	3.4	4.4	4.3	5.5	7.8	6.3	5.1	4.6	3.9	1.9	5.9	3.1	4.2	4.1	1.8	3.3	4.9	4.1	7.4	3.3	3.4	2.3	4.0	5.2	4.1	5.7	4.9	3.8	3.6	4.4	4.0	7.0	4.2	5.4	3.6	3.4	3.3	3.0	4.4	3.7	5.2	5.6	3.4	12.9	6.3	4.8	4.4	5.4	4.9	5.5	4.0	5.1	6.3	6.2	2.6	3.5	4.0	3.1	6.2	4.0	2.3	2.5	2.7	2.9	2.2	2.2	2.3	2.3	2.4	2.1	2.3	3.0	2.1	0.0	1.7	3.3	2.0	1.0	0.7	1.1	1.8	3.3	2.3	1.5	2.6	5.7	2.1	1.8	0.0	1.8	2.9	0.8	5.9	1.8	2.7	1.3	2.0	1.9	0.0	1.3	7.7	2.0	1.4	2.1	1.5	1.2	1.3	4.7	2.5	1.6	2.5	1.7	6.2	0.7	0.0	2.5	1.2	0.8	2.1	2.2	0.0	3.7	0.5	4.2	4.1	7.1	5.7	0.9	0.5	3.0	1.4	0.9	1.5	2.8	2.5	2.7	6.6	1.6	2.0	5.5	7.5	0.9	1.1	1.6	1.6	2.8	1.1	0.7
ZNF20	KOX13	ENSG00000132010	"Zinc finger protein 20"	P17024	19	12092843-12140355	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 42.1;Late spermatids: 66.3;Respiratory ciliated cells: 29.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 22.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 22.9;NK-cells: 6.8"	"Low cell line specificity"	"Detected in many"											HPA020887	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA020887: AB_2218842"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.08e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.21e-3)"	0.8	1.2	0.9	1.6	0.9	2.7	3.0	2.1	1.3	1.3	2.3	2.0	0.7	1.2	3.1	2.0	4.9	1.2	0.8	0.9	0.7	1.8	0.8	1.6	2.1	0.9	1.1	1.8	2.1	1.8	1.2	0.9	0.9	1.3	1.8	1.9	2.2	1.5	0.3	2.4	1.4	1.0	0.8	1.3	2.1	6.1	0.7	1.5	3.4	1.1	1.3	1.5	1.2	1.3	2.4	0.0	3.1	6.8	1.2	2.4	2.4	1.6	3.3	1.7	2.4	0.8	0.9	1.8	1.9	2.2	1.7	1.4	1.6	0.5	2.0	1.7	0.6	0.4	2.4	0.8	0.7	0.0	2.2	1.9	3.3	0.8	1.0	2.0	1.3	3.7	1.0	0.3	3.9	0.9	3.0	2.2	5.4	1.2	1.7	2.0	1.6	1.0	2.1	5.4	1.2	3.2	1.6	1.4	2.9	3.0	2.3	3.0	0.0	4.1	1.3	4.3	1.1	3.4	2.0	2.2	0.4	0.0	1.6	16.3	2.5	6.5	1.4	1.3	1.2	1.6	1.4	1.6	1.3	2.6	1.3	1.1	22.9	6.8	1.9	1.7	3.2	1.2	0.9	0.9	2.1	1.3	0.9	0.7	0.9	1.1	0.9	0.8	0.7	1.3	0.4	0.0	0.0	0.0	1.0	0.1	0.8	2.3	1.8	0.6	1.8	1.1	0.8	1.5	1.5	1.8	2.1	1.0	0.9	1.9	1.9	2.1	42.1	10.3	0.7	0.7	4.2	1.7	0.0	2.4	1.3	0.5	3.6	1.4	2.5	0.8	0.4	2.3	1.7	0.0	0.0	2.1	0.0	0.8	1.0	66.3	0.6	1.0	0.0	0.0	1.4	0.4	1.0	0.0	0.0	2.7	2.1	0.0	1.5	1.7	2.9	2.9	29.7	1.4	0.0	0.4	1.0	10.8	1.7	1.8	0.6	1.1	1.2	0.3	1.7	1.6
ZNF205	"Zfp13, ZNF210"	ENSG00000122386	"Zinc finger protein 205"	O95201	16	3112560-3120517	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001791	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA001791: AB_1080688"	"unprognostic (8.46e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.71e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.17e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.19e-3)"	10.0	10.4	7.0	4.0	6.7	1.9	10.1	18.0	9.9	12.2	4.6	11.4	8.0	13.0	2.0	10.7	11.1	6.2	12.7	6.7	6.1	12.0	14.0	9.2	3.0	7.0	6.8	14.4	16.3	6.8	10.7	5.5	6.7	14.0	3.2	4.0	10.6	5.3	20.4	14.3	7.7	4.5	4.8	7.6	11.9	3.8	6.8	1.6	11.5	6.8	1.6	9.9	10.7	7.7	11.0	14.3	12.2	19.6	4.7	6.2	16.5	9.0	9.3	11.5	14.1	7.6	10.2	0.4	11.4	5.6	7.4	16.5	10.8	9.3	5.5	2.9	22.1	4.5	21.2	9.0	10.6	0.5	2.5	7.0	14.4	11.1	7.5	11.9	13.4	0.2	9.9	8.1	5.8	18.6	0.2	0.5	12.8	7.2	11.3	0.7	15.1	9.9	6.8	6.3	17.1	14.9	9.3	19.9	13.1	6.3	13.9	3.9	7.8	11.5	13.2	11.3	13.0	0.2	8.6	0.5	5.0	0.6	9.8	0.0	0.1	0.4	0.5	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.5	0.0	0.8	0.0	0.0	0.3	0.1	7.0	6.7	18.0	9.9	6.7	6.1	7.0	6.8	6.7	4.8	6.8	7.7	12.7	0.0	0.0	4.6	1.4	5.7	3.8	4.3	8.0	7.8	8.4	9.8	1.5	14.3	2.3	5.5	4.2	9.7	0.3	12.7	5.9	13.1	0.8	7.5	7.8	9.9	10.3	0.8	3.2	13.7	13.8	7.5	10.2	7.3	4.5	20.1	12.1	8.6	8.9	6.7	4.3	14.6	2.0	4.4	4.2	1.5	17.1	3.7	5.4	3.7	4.2	9.6	0.0	3.5	6.7	14.0	7.7	19.5	0.1	3.8	19.5	15.3	1.9	8.4	26.3	9.1	9.8	1.7	2.1	7.5	5.5	4.8	0.4	15.0	13.0	2.1
ZNF207	BuGZ	ENSG00000010244	"Zinc finger protein 207"	O43670	17	32350132-32381885	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017013, HPA063908"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA017013: AB_1859124, HPA063908: AB_2685149"	"unprognostic (8.40e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.30e-8)"	"unprognostic (2.68e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.17e-8)"	"unprognostic (1.28e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	71.8	65.5	36.8	74.0	40.2	239.5	67.8	50.3	45.3	72.0	44.4	68.7	55.1	70.6	72.0	111.1	62.3	58.5	60.5	38.6	37.7	63.2	63.4	72.3	101.0	39.3	37.2	71.7	55.3	72.0	61.3	78.7	40.7	57.2	81.3	61.9	71.6	56.4	84.5	76.3	63.6	77.8	40.7	69.3	63.6	66.3	39.4	103.8	63.0	62.1	128.6	93.2	78.2	48.0	169.9	203.5	215.8	122.4	113.0	121.3	172.6	165.5	231.9	230.1	205.3	195.2	157.3	231.5	124.8	204.6	178.5	170.6	282.1	200.6	258.1	120.0	188.9	237.9	183.8	202.9	118.2	305.0	209.4	141.3	118.3	162.0	89.6	129.4	215.9	115.5	245.9	173.2	223.9	154.6	245.2	142.5	187.1	160.8	114.8	217.5	193.5	217.0	191.5	324.9	150.6	167.7	155.8	113.2	148.1	183.9	204.8	178.7	154.1	129.4	153.4	132.5	227.8	146.7	235.6	369.5	110.6	141.9	204.9	110.5	75.7	78.1	67.6	84.8	70.2	59.7	61.7	62.7	99.8	44.7	50.8	59.1	38.6	83.9	92.5	47.1	86.9	90.6	36.8	40.2	50.3	45.3	38.6	37.7	39.3	37.2	40.7	40.7	39.4	48.0	119.3	80.1	114.7	135.8	131.1	149.4	195.5	120.8	149.1	134.2	108.8	64.1	32.9	65.8	146.1	64.4	225.2	123.3	191.1	118.2	54.8	94.9	62.0	101.9	116.9	110.1	115.9	125.1	171.2	105.7	175.5	101.3	124.9	144.2	75.3	152.8	85.3	58.4	98.7	101.0	163.0	95.2	93.6	98.8	130.2	26.1	107.2	133.1	55.2	123.7	175.8	55.0	168.9	215.7	257.4	146.5	91.2	97.8	144.9	160.3	101.7	57.7	115.0	141.0	124.9	146.3	145.6	136.3	113.5	175.9	148.5	178.7	143.8	90.0	109.9	250.3
ZNF212	C2H2-150	ENSG00000170260	"Zinc finger protein 212"	Q9UDV6	7	149239651-149255606	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049807, HPA054178"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA049807: AB_2680891, HPA054178: AB_2682406"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.55e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.59e-1)"	5.4	8.3	6.7	4.8	6.9	12.2	6.7	7.2	6.9	9.9	6.7	7.1	9.2	8.1	6.2	14.7	7.4	4.1	5.9	6.4	6.5	7.4	10.2	4.8	8.0	7.1	6.8	9.1	7.9	6.4	6.4	6.2	6.9	8.7	4.8	4.5	8.6	6.2	6.2	10.9	9.7	5.1	6.7	10.7	7.0	12.5	6.8	9.5	7.7	4.7	8.0	6.9	9.6	7.2	10.7	10.4	12.5	15.9	8.7	7.0	13.8	6.3	9.5	11.2	11.2	8.9	13.3	14.0	9.7	6.4	9.0	9.6	9.3	10.4	9.2	10.8	16.7	7.7	8.1	7.5	6.6	12.8	9.2	8.0	11.7	7.7	8.1	7.0	6.7	16.9	14.3	10.5	6.5	15.2	23.2	26.0	16.6	8.4	12.5	15.6	8.6	15.3	7.0	8.9	12.5	20.5	9.7	9.4	9.6	7.5	5.6	13.5	5.7	11.3	3.1	14.5	11.7	24.1	11.3	12.6	14.8	11.5	10.4	0.0	3.5	7.6	5.0	2.9	5.0	4.1	3.7	4.2	4.4	3.9	6.4	5.5	1.9	8.2	3.7	3.9	5.9	2.1	6.7	6.9	7.2	6.9	6.4	6.5	7.1	6.8	6.9	6.7	6.8	7.2	3.7	6.4	3.3	5.9	5.4	9.7	3.1	3.2	4.0	7.3	5.4	4.7	3.0	5.7	2.2	0.0	4.2	9.6	2.9	5.5	3.9	5.9	1.8	5.9	3.5	4.2	6.7	5.2	6.8	4.0	10.0	4.0	2.6	5.7	2.5	7.1	4.2	5.8	4.2	10.1	6.5	5.5	8.2	5.6	2.3	0.8	6.2	2.9	1.8	5.6	6.1	6.0	6.2	6.0	7.7	4.6	1.2	6.0	4.0	3.8	11.1	3.8	4.5	8.3	13.1	4.2	3.1	13.8	22.1	4.4	8.7	15.1	5.4	5.8	5.3	4.0
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142804	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.7;Late spermatids: 58.3;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: AB_2683225"	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	4.3	6.7	5.0	3.6	4.9	3.9	4.6	5.7	6.2	5.1	0.9	5.7	5.5	6.5	1.7	6.9	5.1	3.2	5.6	4.9	3.3	4.6	2.5	3.5	5.7	7.1	4.6	6.5	7.2	4.9	6.7	2.1	4.7	5.7	1.2	4.3	10.4	3.0	11.5	10.0	6.8	2.3	3.4	4.9	5.7	17.9	5.1	2.5	5.2	1.2	0.9	5.7	5.2	5.4	3.6	11.1	4.9	11.3	4.7	3.8	6.0	6.4	2.6	3.3	3.9	3.6	7.2	4.3	6.2	4.2	4.9	8.4	2.2	7.1	1.3	9.2	8.3	2.4	13.4	7.0	8.8	7.5	7.8	3.7	8.7	4.4	1.8	2.5	2.5	8.2	8.0	9.4	2.2	15.1	7.0	9.1	8.3	3.8	8.4	9.4	5.7	8.1	2.6	2.4	10.0	8.5	9.7	5.7	4.7	3.1	7.5	12.8	6.3	6.8	6.2	7.7	4.5	5.2	5.4	6.4	2.7	9.9	5.3	0.0	0.5	1.3	1.2	0.9	1.1	0.9	1.2	0.8	0.5	1.5	1.5	1.1	1.3	1.6	0.7	1.2	0.7	0.8	5.0	4.9	5.7	6.2	4.9	3.3	7.1	4.6	4.7	3.4	5.1	5.4	4.1	0.0	1.1	3.6	1.9	1.9	1.5	2.1	2.8	5.3	4.8	4.2	4.4	1.5	1.7	0.0	2.1	1.8	3.4	10.2	1.9	4.0	22.7	3.0	3.1	3.4	2.4	2.1	3.2	4.9	2.0	3.9	4.6	4.4	4.5	4.8	4.6	1.4	3.2	8.4	3.5	6.0	0.0	5.1	1.7	58.3	6.5	3.6	0.0	1.0	4.4	5.6	5.2	0.5	4.6	5.2	4.2	7.2	1.3	2.1	14.6	2.5	1.5	5.2	19.7	3.9	4.1	9.5	4.5	4.8	2.0	1.4	2.3	3.5	6.6	1.8
ZNF214		ENSG00000149050	"Zinc finger protein 214"	Q9UL59	11	6997085-7020346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 6.6;Endometrial ciliated cells: 6.6;Excitatory neurons: 10.5;Respiratory ciliated cells: 10.4;Spermatocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 3.5"									HPA055391	Uncertain		Approved	Nucleoplasm,Midbody		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Midbody	"HPA055391: AB_2682804"	"unprognostic (3.01e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.77e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.53e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-2)"	0.6	1.0	1.0	0.2	1.2	0.0	2.1	0.8	1.5	2.3	1.8	1.2	0.5	2.3	2.7	0.5	3.9	0.8	0.8	0.9	1.1	2.4	1.2	1.2	0.2	1.8	1.7	4.2	1.0	2.5	1.3	0.1	1.1	2.0	1.1	5.3	0.9	2.1	0.4	0.4	0.6	1.7	1.2	0.2	0.7	3.1	1.0	0.2	3.4	0.5	0.2	1.4	1.3	1.4	0.4	0.8	3.3	0.0	0.6	2.2	0.8	1.3	3.5	1.7	1.9	0.0	2.4	0.1	0.4	0.9	1.1	0.5	0.3	0.9	1.9	0.0	0.9	0.0	0.5	0.2	1.2	0.0	0.1	0.6	2.2	0.0	1.9	2.3	1.5	0.0	0.2	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	2.6	1.3	0.1	0.1	1.3	0.5	0.0	0.2	1.1	1.4	3.0	0.0	0.0	0.0	0.0	1.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.5	0.9	1.1	1.8	1.7	1.1	1.2	1.0	1.4	0.5	0.0	1.5	4.6	0.1	0.0	2.0	1.6	0.6	2.5	1.1	1.5	0.9	1.5	2.7	0.0	0.0	0.1	0.0	0.4	1.9	2.1	6.6	6.6	2.0	0.6	2.4	0.0	10.5	0.9	0.4	1.5	0.0	0.9	0.0	1.2	0.0	0.4	0.1	3.3	5.5	1.7	0.0	0.0	0.5	1.0	0.6	0.2	0.0	2.8	0.0	3.0	0.0	4.0	2.9	1.1	0.1	0.4	0.0	0.6	0.8	3.3	10.4	3.6	0.0	0.8	0.9	10.4	3.3	0.9	0.1	0.0	0.2	0.8	0.9	0.4
ZNF215	"ZKSCAN11, ZSCAN43"	ENSG00000149054	"Zinc finger protein 215"	Q9UL58	11	6926404-7001004	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 13.7;Inhibitory neurons: 8.5;Plasma cells: 27.5;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-698: 19.8"					"Low region specificity"	"Detected in many"			"HPA047243, HPA051010"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA047243: , HPA051010: AB_2681308"	"unprognostic (2.18e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	0.4	0.4	0.4	1.3	0.4	0.7	1.3	0.2	0.5	0.8	0.1	2.0	2.2	0.7	0.6	0.9	0.4	0.5	0.4	0.4	0.5	1.0	0.3	0.5	3.4	0.5	0.4	0.8	2.2	0.0	0.2	0.2	0.4	0.8	2.6	0.4	1.4	0.4	0.2	0.5	1.9	0.5	0.2	1.6	0.8	1.5	0.6	1.2	0.8	0.1	4.2	1.1	0.7	0.3	2.9	1.1	1.8	0.2	1.2	1.7	6.4	7.0	5.7	3.6	6.5	0.2	0.0	10.1	2.1	3.2	4.3	3.1	4.8	6.4	6.3	0.0	7.5	0.0	0.3	0.0	1.2	6.5	0.0	3.2	3.1	0.1	7.0	1.4	5.3	0.1	11.5	3.1	1.3	0.0	0.1	0.0	8.9	0.0	1.6	0.0	0.0	1.3	0.1	5.3	0.0	0.2	0.0	2.4	0.0	4.4	0.1	2.4	2.8	2.0	5.8	2.4	0.0	0.3	0.1	19.8	4.8	0.0	1.9	1.5	0.4	0.1	0.1	0.2	0.0	0.6	0.1	0.3	0.4	0.5	0.3	0.1	0.6	0.2	0.1	0.7	0.2	0.3	0.4	0.4	0.2	0.5	0.4	0.5	0.5	0.4	0.4	0.2	0.6	0.3	0.2	0.0	0.0	0.3	2.5	0.4	1.7	1.0	1.8	0.6	0.7	0.3	0.2	0.0	0.9	7.3	6.2	0.4	0.1	0.9	1.9	0.1	0.3	0.8	1.8	0.6	1.2	2.5	13.7	1.8	2.6	1.1	0.0	0.9	1.3	0.6	0.0	0.9	0.4	3.3	8.5	3.5	0.0	0.3	0.0	0.3	0.0	0.8	1.8	3.7	0.0	0.1	0.0	1.5	0.4	0.3	0.8	0.0	27.5	0.6	2.0	1.1	0.4	0.0	0.0	0.2	0.7	5.6	9.1	2.3	0.3	0.0	0.8	2.2	2.2	0.8
ZNF219		ENSG00000165804	"Zinc finger protein 219"	Q9P2Y4	14	21090077-21104722	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030761, HPA056168"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA030761: AB_2673598, HPA056168: AB_2683052"	"unprognostic (9.82e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.35e-2)"	44.2	77.1	15.2	7.4	10.7	4.5	35.5	32.0	17.9	33.9	14.3	83.3	22.4	41.6	9.4	49.2	29.6	5.4	42.0	22.0	14.8	20.6	17.1	32.8	2.5	20.7	25.7	30.7	24.7	12.4	23.5	6.5	20.3	38.3	10.3	11.0	28.2	21.7	34.0	45.6	33.1	9.3	13.6	13.1	33.3	11.9	17.8	10.9	32.3	5.9	3.6	44.7	36.1	9.1	8.1	26.6	33.6	49.5	4.5	4.3	48.1	9.8	15.0	4.9	7.7	15.5	17.7	12.0	7.2	3.7	5.4	59.1	10.8	31.4	3.4	24.6	11.5	7.1	42.2	32.7	2.8	1.5	10.9	6.6	25.9	8.0	14.7	6.5	6.0	11.0	6.9	3.5	2.7	22.4	16.2	11.3	47.5	15.3	5.7	33.7	5.6	3.1	3.8	44.0	38.2	34.4	13.5	7.9	7.8	6.7	9.5	4.2	1.2	6.0	26.4	14.7	4.0	6.1	4.2	2.7	3.8	6.0	11.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.4	0.0	0.0	15.2	10.7	32.0	17.9	22.0	14.8	20.7	25.7	20.3	13.6	17.8	9.1	5.6	3.2	10.7	12.7	1.8	14.8	13.3	13.5	11.4	36.6	14.4	19.6	7.6	10.0	4.3	3.7	27.1	9.6	3.4	33.0	1.9	10.3	9.2	2.5	1.9	6.3	7.8	8.2	3.5	11.3	1.0	6.0	5.1	4.6	14.7	35.1	9.3	8.0	7.4	11.8	4.9	17.4	10.2	7.5	11.8	5.6	9.9	5.9	8.8	7.5	0.8	33.0	1.0	13.6	2.5	7.8	10.0	12.4	3.9	12.0	23.6	6.8	4.3	27.4	13.1	9.3	14.7	8.9	8.7	13.5	15.6	12.4	5.2	6.3	26.6	12.7
ZNF22	"HKR-T1, KOX15, Zfp422, ZNF422"	ENSG00000165512	"Zinc finger protein 22"	P17026	10	45000923-45005326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 184.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016736, HPA054893"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA016736: AB_1859133, HPA054893: AB_2682632"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.31e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.11e-5)"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.39e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-2)"	28.3	13.5	19.8	21.9	21.3	25.7	41.1	20.5	26.1	22.8	18.1	21.0	18.9	30.6	23.5	10.9	25.7	17.6	23.9	19.1	21.0	25.2	38.7	23.1	36.1	25.1	20.7	35.8	39.6	13.3	8.6	40.0	21.5	22.8	21.6	19.2	22.7	19.6	21.1	8.4	18.2	23.9	21.4	27.1	22.8	9.0	20.9	70.4	23.9	25.7	35.1	18.1	10.9	22.9	46.7	7.4	63.3	39.3	32.1	23.2	0.5	21.6	44.5	54.7	58.8	25.5	38.6	48.4	33.5	32.5	12.0	7.8	62.1	23.2	77.3	30.3	1.1	50.3	11.3	0.3	68.8	98.5	17.0	41.6	33.3	22.3	0.9	0.5	87.7	127.8	67.8	84.9	43.7	1.4	184.0	148.5	38.0	26.8	12.9	133.8	87.8	69.4	43.0	39.2	60.5	52.7	19.3	38.8	32.3	57.5	8.4	96.7	48.4	39.2	72.2	27.2	73.3	48.0	51.0	46.4	24.4	3.6	42.6	28.2	28.1	37.6	51.7	27.5	62.5	42.2	33.6	53.8	37.8	54.4	45.3	56.6	2.9	70.8	18.3	64.7	21.1	38.1	19.8	21.3	20.5	26.1	19.1	21.0	25.1	20.7	21.5	21.4	20.9	22.9	69.3	28.9	27.4	5.9	45.7	19.2	65.5	34.1	42.1	33.6	51.2	68.6	9.9	68.6	25.2	33.1	10.4	71.7	48.0	7.0	56.7	58.7	6.3	22.1	48.7	72.9	40.0	67.5	5.0	43.3	55.8	49.5	21.4	25.4	33.5	59.1	91.8	58.6	49.3	38.7	7.6	37.2	38.7	28.7	28.4	3.6	44.4	32.7	19.6	4.7	61.4	57.2	89.6	7.5	11.3	35.7	15.1	51.1	31.9	57.9	6.9	54.6	28.4	32.7	32.9	77.1	48.4	40.1	37.1	23.9	13.2	53.2	36.4	58.7	34.7	27.6
ZNF222		ENSG00000159885	"Zinc finger protein 222"	Q9UK12	19	44025342-44033110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004086	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies"	"HPA004086: AB_2273259"	"unprognostic (1.91e-3)"	"unprognostic (3.41e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.75e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (5.56e-7)"	"unprognostic (2.19e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-3)"	2.8	4.1	3.7	3.0	3.7	5.3	4.5	6.0	5.3	3.2	3.6	2.5	1.6	2.8	3.9	1.9	2.9	3.4	4.3	3.6	4.5	3.8	2.8	3.2	4.4	4.3	4.5	4.7	3.1	3.7	5.1	3.1	4.4	3.5	2.7	6.8	2.6	3.3	2.3	2.6	2.7	3.2	3.4	4.6	3.1	9.1	4.2	5.8	4.1	2.3	4.3	3.8	2.0	4.9	3.8	4.5	7.4	6.7	5.5	5.5	0.3	4.1	7.3	4.7	7.4	2.1	2.4	1.2	6.1	4.4	5.5	1.3	5.2	3.6	5.9	4.9	4.7	6.4	6.5	3.8	7.0	0.2	5.2	4.2	5.4	3.9	6.5	7.4	4.5	5.2	1.2	2.4	5.9	0.5	4.3	2.4	4.5	1.8	1.7	0.1	7.7	2.1	3.8	12.1	4.0	9.0	6.4	1.2	5.4	6.3	1.6	6.2	3.3	5.1	4.9	2.9	5.0	10.6	9.1	0.1	2.7	0.1	5.8	7.7	2.4	5.0	5.9	1.6	4.8	4.7	5.4	5.7	2.5	5.9	6.2	4.6	4.8	4.9	2.0	2.9	4.2	2.8	3.7	3.7	6.0	5.3	3.6	4.5	4.3	4.5	4.4	3.4	4.2	4.9	2.1	0.0	1.5	1.0	1.9	2.5	1.9	2.3	0.0	5.3	2.1	2.0	1.9	0.0	1.8	5.5	0.0	1.8	3.1	0.8	7.9	2.4	78.5	1.6	1.7	2.4	3.0	4.8	3.7	1.2	1.1	3.0	1.5	2.7	4.5	3.5	3.3	1.1	2.3	6.7	4.2	2.1	6.1	1.3	1.5	6.9	1.8	1.5	1.8	1.0	1.7	6.3	3.1	3.5	3.6	0.8	0.4	2.2	1.5	0.8	1.1	1.3	0.3	2.8	0.0	2.8	3.0	9.9	3.5	0.7	1.7	1.1	3.7	3.5	1.2	1.1
ZNF223		ENSG00000178386	"Zinc finger protein 223"	Q9UK11	19	44051367-44067999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 23.4"									"HPA067823, HPA079175"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 64: Macrophages - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Mitochondria	"HPA067823: AB_2685906, HPA079175: "	"unprognostic (6.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-4)"	3.2	3.8	2.9	3.5	2.8	2.0	5.5	3.9	3.7	3.6	2.3	4.5	4.0	3.3	5.9	3.0	3.9	3.8	4.9	2.4	3.3	3.9	2.6	3.9	3.6	2.8	2.7	4.0	2.8	4.9	4.1	5.5	3.0	6.5	5.7	4.5	3.6	4.8	2.1	4.9	4.4	3.9	2.5	4.9	4.9	3.2	3.4	2.7	6.3	1.6	4.3	3.9	3.0	3.0	2.8	1.5	5.9	1.4	3.8	4.7	0.1	4.2	4.6	3.7	5.3	2.8	4.6	0.0	3.9	3.3	2.2	2.6	0.0	4.7	3.9	0.1	4.5	5.6	5.0	3.9	2.8	0.3	0.1	4.6	3.7	3.1	3.0	5.2	4.2	0.1	0.2	0.0	4.2	2.2	0.0	2.1	4.4	1.9	2.1	0.0	2.4	1.3	4.5	23.4	3.6	8.5	7.3	0.9	2.9	7.5	4.1	5.2	4.2	3.5	3.3	1.9	1.6	2.7	5.0	0.0	1.5	0.1	3.4	15.0	4.9	7.8	2.4	5.9	3.5	3.2	3.8	1.9	5.4	3.3	7.4	3.2	0.4	6.2	2.7	6.6	3.6	2.4	2.9	2.8	3.9	3.7	2.4	3.3	2.8	2.7	3.0	2.5	3.4	3.0	2.4	0.0	1.1	4.2	1.3	0.0	0.6	0.0	1.2	3.6	1.7	1.4	0.9	2.8	0.0	1.8	2.1	2.1	0.9	2.2	3.9	2.3	3.8	1.4	1.0	1.8	0.0	3.0	6.1	0.5	0.8	1.8	2.0	1.5	0.0	1.8	3.3	0.4	1.7	3.3	5.0	2.8	0.0	2.4	0.0	1.0	1.5	1.3	0.0	1.9	1.7	1.2	3.1	4.5	3.4	1.4	1.5	1.9	0.3	0.6	2.3	1.1	0.7	1.6	0.0	0.7	1.4	1.9	2.1	1.9	0.0	1.0	0.7	1.3	1.7	0.7
ZNF224	"BMZF-2, KOX22, ZNF255, ZNF27"	ENSG00000267680	"Zinc finger protein 224"	Q9NZL3	19	44094339-44109886	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA054045	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane"	Nucleoplasm	"HPA054045: AB_2682354"	"unprognostic (1.01e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.40e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.25e-4)"	"unprognostic (9.61e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.53e-7)"	15.5	15.4	12.5	17.6	14.2	9.6	17.0	15.9	13.9	16.2	16.0	15.0	18.1	17.8	23.1	9.4	16.1	13.8	12.5	12.3	13.3	14.3	15.8	16.3	22.4	13.1	13.2	20.6	14.7	14.1	19.5	14.8	13.7	17.1	21.2	17.8	15.6	15.7	7.5	24.6	22.2	13.3	12.6	27.2	16.0	6.4	13.4	18.3	19.8	5.9	22.6	12.7	13.0	16.7	8.5	13.9	14.7	12.1	14.4	15.0	12.0	10.5	15.6	7.1	16.2	7.0	6.6	10.2	11.3	13.9	5.4	9.5	8.1	9.0	9.4	10.5	16.4	19.7	26.5	7.3	7.6	14.3	22.0	18.6	16.0	8.8	13.1	22.6	13.1	10.1	6.1	12.0	12.0	2.2	12.6	17.2	6.4	4.7	9.5	7.4	15.9	6.3	10.8	26.9	7.5	17.1	14.4	6.2	5.0	14.4	6.1	18.5	13.8	15.7	10.1	7.1	7.4	16.2	16.3	5.8	8.4	11.0	7.4	49.6	9.1	22.0	18.4	6.3	20.3	16.9	15.5	18.7	9.7	17.8	19.5	15.1	6.9	16.7	13.7	8.7	19.5	10.4	12.5	14.2	15.9	13.9	12.3	13.3	13.1	13.2	13.7	12.6	13.4	16.7	16.0	22.4	14.6	16.3	26.2	5.6	7.3	14.7	10.8	26.8	9.1	5.7	4.7	18.6	11.3	25.8	18.8	13.1	30.4	14.5	1.9	8.1	14.5	7.9	9.9	12.2	9.6	12.0	26.2	5.3	8.1	12.4	8.6	8.2	21.0	20.5	16.1	7.6	7.3	26.9	23.4	11.2	20.3	13.9	8.9	4.4	16.1	10.4	5.4	14.0	19.8	11.8	47.4	14.1	29.0	8.6	13.3	13.9	12.1	10.4	29.8	3.3	7.4	22.1	13.1	10.9	9.3	5.4	4.1	6.8	6.8	8.2	27.3	19.9	11.0	9.3
ZNF225		ENSG00000256294	"Zinc finger protein 225"	Q9UK10	19	44112181-44134822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.1"									HPA073778			Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA073778: AB_2686634"	"unprognostic (1.52e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.03e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.82e-2)"	"unprognostic (7.18e-3)"	"unprognostic (5.67e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.60e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.17e-4)"	2.2	3.2	4.3	2.7	5.6	2.3	8.0	5.5	5.3	4.1	4.4	2.5	2.4	3.4	2.5	2.1	3.2	2.8	3.2	4.1	4.9	3.0	2.7	2.7	3.7	4.8	5.0	5.2	1.9	4.5	2.5	3.3	4.7	3.3	2.4	7.0	3.0	3.5	2.5	3.1	2.2	2.5	4.4	4.0	3.0	12.8	4.9	5.3	4.1	2.4	3.9	2.6	2.0	7.0	2.6	4.2	5.4	6.3	7.9	7.0	1.2	4.2	6.4	4.9	6.3	2.6	1.6	1.1	3.2	4.6	2.8	2.2	5.0	3.1	4.3	2.6	4.8	7.7	5.4	2.4	4.6	4.7	6.8	6.6	3.7	4.4	7.1	8.3	4.8	3.4	2.3	1.3	4.2	0.8	3.4	3.3	4.8	1.9	4.3	2.8	7.4	2.5	4.8	5.2	3.2	5.6	7.6	18.1	2.3	5.5	2.0	8.0	4.9	4.5	4.7	2.2	2.8	5.9	3.8	0.8	2.1	2.8	4.1	11.6	3.2	5.2	3.4	4.6	3.3	3.3	2.5	2.6	4.4	5.3	4.7	3.5	0.7	4.4	1.9	2.0	3.8	2.4	4.3	5.6	5.5	5.3	4.1	4.9	4.8	5.0	4.7	4.4	4.9	7.0	1.5	0.0	1.7	3.9	2.7	0.3	0.7	0.5	1.2	4.3	1.3	1.0	1.6	1.5	1.5	1.8	0.0	2.3	6.0	1.0	3.9	1.3	9.7	0.7	1.9	2.0	1.2	4.4	3.4	1.3	1.1	2.1	2.6	0.7	0.0	3.8	2.9	1.8	1.5	6.7	3.4	1.0	0.0	3.5	1.1	2.0	2.8	1.3	0.0	0.0	1.3	3.0	3.1	2.5	5.8	1.3	1.9	1.9	1.4	0.4	1.5	1.2	1.7	4.3	0.0	2.3	1.6	4.1	2.2	0.5	0.4	0.3	2.1	3.4	0.9	0.5
ZNF232	ZSCAN11	ENSG00000167840	"Zinc finger protein 232"	Q9UNY5	17	5105541-5123116	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 18.1;Spermatogonia: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027309, HPA028611"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA027309: AB_10603464, HPA028611: AB_2672700"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.12e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (6.55e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.61e-3)"	1.8	1.2	3.0	1.1	3.5	0.4	1.9	3.4	4.3	2.7	3.1	2.7	1.0	2.4	2.4	1.6	2.3	1.3	2.0	3.1	3.5	2.3	2.1	1.5	1.9	3.6	3.1	3.4	2.8	1.9	1.6	1.5	3.5	2.1	1.3	2.3	1.9	1.3	2.0	1.4	1.8	1.9	3.1	1.9	2.2	2.6	3.5	1.6	2.4	1.8	1.4	1.8	1.8	4.2	5.8	4.3	6.9	7.0	2.4	1.0	3.7	2.8	1.4	2.7	3.7	6.7	1.4	11.5	3.4	1.0	4.0	3.9	4.9	2.8	1.6	4.6	7.4	2.0	10.0	6.0	3.5	0.0	3.4	1.9	3.0	2.9	2.5	1.9	2.0	13.7	10.0	4.1	3.3	2.8	10.1	4.0	13.5	4.9	4.6	8.5	4.4	7.8	2.2	0.8	7.2	4.7	5.4	2.1	4.6	5.2	1.1	2.8	3.2	2.7	4.6	2.1	5.5	5.5	9.3	3.0	6.9	0.3	4.6	1.3	1.9	1.9	4.2	2.0	5.2	12.5	4.7	5.8	3.9	11.4	7.0	6.5	0.1	5.7	1.2	7.4	4.3	3.5	3.0	3.5	3.4	4.3	3.1	3.5	3.6	3.1	3.5	3.1	3.5	4.2	4.2	0.0	2.6	2.0	5.2	4.2	2.9	4.0	5.7	5.7	3.8	6.6	5.6	0.0	3.9	5.5	0.0	3.9	3.5	3.1	3.9	7.0	8.6	5.5	6.8	5.2	1.2	2.1	3.4	4.0	5.0	3.4	1.5	2.2	0.0	4.0	3.6	3.9	6.1	0.0	3.3	2.4	0.0	3.8	1.3	6.9	3.7	2.9	0.0	3.7	1.8	4.2	0.0	3.0	8.1	3.7	7.6	5.3	1.4	4.1	2.6	3.2	6.5	3.9	0.0	4.4	4.4	18.1	21.7	3.3	4.7	2.1	3.2	3.4	3.8	1.8
ZNF233	FLJ38032	ENSG00000159915	"Zinc finger protein 233"	A6NK53	19	44259880-44275317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 40.9;Spermatocytes: 38.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 6.9;U-266/84: 7.6"									HPA020975	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020975: AB_1859145"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-3)"	"unprognostic (6.88e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.71e-4)"	"unprognostic (1.55e-1)"	0.4	1.1	1.8	1.1	1.9	1.8	1.5	3.4	3.1	0.7	0.4	3.0	0.9	0.4	1.6	0.6	1.3	0.9	3.2	1.5	1.8	1.3	0.5	0.6	1.3	1.2	0.1	0.5	0.8	1.7	3.1	1.3	1.5	2.7	1.3	4.9	0.9	1.0	1.7	1.6	1.0	0.4	0.3	1.3	1.1	14.2	0.9	1.5	1.9	0.6	0.6	0.8	0.4	2.5	0.4	1.8	2.0	1.9	2.2	0.4	0.5	0.7	0.6	0.7	1.2	1.5	2.1	0.6	1.9	0.6	1.1	0.6	0.0	0.5	0.8	0.3	2.4	1.0	2.5	1.7	1.5	0.7	0.8	0.5	0.3	0.5	1.3	2.9	0.9	0.7	0.8	3.8	0.1	0.7	0.6	0.5	2.1	0.4	0.3	1.2	0.2	0.8	0.4	1.2	2.8	4.4	0.7	0.5	1.3	3.7	3.5	1.0	0.3	0.6	0.4	0.4	0.4	6.9	7.6	1.2	3.0	0.5	0.9	1.5	0.3	0.2	0.5	0.3	0.4	0.9	0.4	0.3	0.1	1.3	0.6	0.7	0.7	1.1	0.3	1.3	0.7	0.1	1.8	1.9	3.4	3.1	1.5	1.8	1.2	0.1	1.5	0.3	0.9	2.5	0.5	0.0	0.5	2.6	0.4	0.0	0.2	0.2	0.0	3.7	1.1	0.4	4.6	0.0	0.3	0.0	0.0	0.5	0.2	0.3	0.0	0.6	40.9	1.3	0.3	0.9	1.2	0.4	9.0	0.0	0.1	0.6	0.5	0.5	0.0	0.7	0.0	0.0	0.6	0.0	7.9	0.2	2.0	0.0	0.0	8.5	0.6	0.1	0.0	1.0	0.0	1.9	0.0	4.5	5.7	0.1	0.1	0.7	0.0	0.5	0.8	0.0	0.4	4.0	0.0	0.6	0.4	38.6	1.9	0.0	0.0	0.0	0.3	1.1	0.4	0.1
ZNF235	"ANF270, HZF6, ZFP93, ZNF270"	ENSG00000159917	"Zinc finger protein 235"	Q14590	19	44228729-44305046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 8.3;Oligodendrocytes: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045582	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA045582: AB_10963792"	"unprognostic (2.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.38e-2)"	2.0	1.3	2.6	2.1	2.8	0.7	2.7	2.9	3.5	1.9	2.6	2.5	1.7	2.0	2.1	1.6	2.2	1.6	2.4	3.0	2.5	2.2	1.8	2.2	2.8	2.7	3.1	2.6	1.8	2.7	1.9	2.4	2.8	2.4	2.0	3.1	1.7	2.5	2.6	1.4	2.0	2.3	2.6	2.7	1.5	2.4	2.8	4.5	2.3	3.0	3.3	1.7	1.4	4.0	1.6	2.6	4.7	5.1	3.7	2.2	1.6	1.0	3.1	1.8	2.1	1.6	2.8	2.9	2.5	1.9	2.8	1.5	4.4	2.1	2.2	0.0	5.3	5.8	4.0	2.4	3.0	3.5	3.6	2.1	2.7	2.0	2.4	2.9	2.9	4.9	1.3	0.0	1.8	1.4	5.4	0.7	6.0	2.8	1.5	2.7	4.7	2.4	3.2	4.0	3.6	10.1	2.7	3.2	2.4	4.9	2.4	4.1	3.6	1.8	2.4	0.5	1.1	6.0	6.4	1.9	1.4	1.0	2.8	20.7	3.5	3.5	6.3	3.1	4.2	6.9	4.6	5.3	2.7	10.1	6.8	5.8	1.8	6.2	3.0	8.1	3.7	2.4	2.6	2.8	2.9	3.5	3.0	2.5	2.7	3.1	2.8	2.6	2.8	4.0	3.5	0.0	0.0	6.2	5.6	0.5	0.5	1.5	4.6	1.7	1.5	1.5	2.3	1.5	0.7	0.0	6.2	1.5	2.5	1.3	0.0	1.4	1.5	1.7	1.8	2.4	0.0	5.2	8.3	0.0	0.4	1.4	2.0	1.2	2.5	2.5	1.8	1.4	1.4	1.7	6.7	1.1	0.0	2.2	0.9	0.3	0.6	2.2	1.8	1.0	1.4	1.1	3.1	5.0	9.2	0.6	3.6	3.4	3.2	0.6	2.0	0.9	0.9	1.6	0.0	1.8	2.0	2.3	5.6	1.8	0.6	1.5	4.1	1.3	0.8	0.2
ZNF236		ENSG00000130856	"Zinc finger protein 236"	Q9UL36	18	76822557-76972901	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008600	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA008600: AB_1080696"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.88e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.95e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	2.5	2.2	3.2	2.2	5.3	4.9	2.4	9.2	4.4	3.0	0.0	2.8	1.9	3.2	2.8	2.5	2.9	2.0	2.3	3.4	4.3	2.0	2.1	2.1	2.6	2.3	3.5	4.3	2.8	3.1	3.6	2.2	2.6	2.6	1.5	2.4	2.7	2.3	2.5	4.1	2.5	2.1	1.4	2.3	2.8	6.8	3.5	4.1	2.6	3.1	2.4	2.6	2.9	5.7	2.5	2.4	4.7	3.4	3.7	3.4	1.9	1.8	2.6	2.9	2.4	2.3	2.3	3.6	0.9	2.5	3.2	4.6	3.0	2.8	2.5	3.8	3.1	3.4	3.9	2.8	2.1	5.7	3.7	3.4	3.1	2.8	4.4	3.4	3.0	5.5	3.3	2.9	3.1	2.2	6.9	3.2	2.5	0.6	2.6	4.3	4.9	2.4	2.4	3.8	2.6	2.8	3.6	2.2	2.5	2.2	2.5	3.9	3.2	5.3	2.0	1.3	2.9	2.0	3.0	4.4	3.6	3.0	3.9	0.7	2.0	3.9	3.1	1.9	3.0	5.9	2.3	2.1	1.4	4.4	2.6	2.7	2.1	1.9	1.8	2.8	2.7	0.9	3.2	5.3	9.2	4.4	3.4	4.3	2.3	3.5	2.6	1.4	3.5	5.7	9.3	9.6	7.9	39.5	11.9	7.1	8.5	5.4	10.8	15.3	8.0	7.6	9.5	12.8	6.7	7.3	10.4	8.4	12.9	5.6	1.9	5.4	6.9	10.8	12.6	9.3	6.0	12.8	37.7	3.9	7.2	8.8	9.2	10.5	1.3	15.8	10.0	6.8	6.0	25.2	25.3	5.0	6.1	7.2	7.2	6.0	10.5	8.7	7.2	16.9	8.4	9.7	9.2	41.7	39.7	4.7	3.1	7.2	9.1	6.8	5.9	3.0	10.9	15.9	6.6	14.2	10.4	26.7	26.2	8.8	8.4	6.0	12.4	7.8	5.7	6.3
ZNF239	"HOK-2, MOK2"	ENSG00000196793	"Zinc finger protein 239"	Q16600	10	43556344-43574618	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 49.2;Late spermatids: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 2.8;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 24.4;T-47d: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030843, HPA046679"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA030843: AB_2673632, HPA046679: AB_10960498"	"unprognostic (1.74e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-7)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.90e-3)"	"unprognostic (4.13e-2)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	2.5	2.3	4.3	1.9	4.3	0.3	5.3	4.1	4.9	3.8	3.1	3.3	1.3	4.4	2.1	1.1	4.3	1.4	1.4	4.1	4.0	6.2	1.5	1.4	2.9	3.8	3.8	3.9	5.0	4.3	4.5	0.9	3.7	5.2	2.7	1.5	1.9	4.5	2.9	0.7	2.0	4.9	3.9	1.5	2.5	8.2	4.2	1.7	3.2	2.7	2.6	4.3	1.7	4.3	0.0	4.3	5.0	4.9	6.8	5.2	0.0	8.9	1.0	10.6	9.3	11.1	9.7	0.0	3.3	4.9	3.9	0.3	0.0	0.5	13.5	0.1	7.2	0.0	8.0	0.0	5.3	0.0	3.2	5.7	0.2	8.3	0.0	3.2	0.4	0.0	14.7	0.0	8.8	4.9	1.4	1.5	24.4	4.8	5.0	0.0	0.0	0.3	8.8	3.9	9.3	12.7	4.0	0.1	0.6	6.9	19.1	6.1	1.1	0.0	10.8	0.3	11.6	1.2	8.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.5	0.0	3.7	2.6	3.5	2.4	0.0	2.8	6.4	3.8	0.0	0.4	0.0	0.0	2.0	1.4	4.3	4.3	4.1	4.9	4.1	4.0	3.8	3.8	3.7	3.9	4.2	4.3	0.5	0.0	0.5	3.6	1.4	0.0	1.7	0.3	4.0	3.1	1.8	2.4	0.7	0.0	1.3	3.7	0.0	0.3	0.2	0.2	1.9	2.0	49.2	0.5	2.2	0.3	0.0	0.4	5.6	0.4	1.2	1.6	1.5	0.7	0.0	2.1	0.4	0.2	0.4	0.0	6.7	0.9	0.0	0.0	0.3	16.4	0.3	0.2	0.0	1.0	0.6	1.3	3.1	7.5	4.3	0.9	0.2	1.5	0.1	0.9	0.0	1.5	0.0	0.5	0.0	1.9	1.6	6.1	8.2	0.4	0.0	0.1	0.8	2.8	1.1	0.2
ZNF24	"KOX17, Zfp191, ZNF191, ZSCAN3"	ENSG00000172466	"Zinc finger protein 24"	P17028	18	35332227-35345482	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024062, CAB025642"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB025642: , HPA024062: AB_1859150"	"unprognostic (1.19e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (5.25e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-3)"	19.4	21.9	32.1	22.4	40.0	25.0	35.3	34.9	34.8	21.6	29.7	19.7	20.5	23.8	22.2	17.8	18.2	18.1	20.9	28.7	33.1	23.8	30.9	21.5	28.8	36.4	36.8	26.1	25.8	32.3	12.5	23.4	37.3	25.5	21.4	38.0	23.7	18.3	23.7	15.4	21.4	18.2	33.4	25.6	25.1	19.9	33.4	34.0	33.3	27.6	26.4	19.2	12.6	54.4	19.3	19.1	60.0	31.5	24.9	26.7	16.9	25.9	29.1	31.3	35.7	12.4	15.5	43.7	28.4	21.7	25.0	34.8	44.7	24.3	53.5	40.1	24.3	31.3	40.2	26.7	26.2	66.9	48.6	22.6	41.0	28.0	30.2	36.0	30.2	27.2	48.2	27.6	32.8	22.8	51.3	28.5	31.2	12.8	12.8	38.0	38.8	35.1	31.5	44.0	51.0	43.7	31.6	29.2	54.7	31.0	27.4	50.3	25.7	44.8	20.1	10.8	26.1	69.7	60.6	44.4	25.0	27.0	41.8	30.2	21.0	24.8	24.4	20.3	23.5	30.5	24.1	20.8	19.3	30.2	23.0	21.4	40.9	22.4	30.3	29.7	20.0	15.2	32.1	40.0	34.9	34.8	28.7	33.1	36.4	36.8	37.3	33.4	33.4	54.4	49.0	57.7	63.0	30.0	66.1	32.9	65.9	44.2	29.0	57.2	62.6	55.4	46.9	52.9	60.7	25.8	43.8	41.4	52.7	37.7	27.4	46.4	126.1	47.6	37.6	50.2	55.6	43.1	26.9	41.1	33.6	47.5	29.6	41.1	43.6	40.0	42.8	48.3	35.3	79.1	26.4	39.2	44.7	38.2	25.4	33.8	54.3	38.6	23.2	33.7	43.1	101.3	56.7	33.2	71.7	42.3	37.8	50.0	34.0	67.2	29.8	30.4	59.1	85.5	46.0	50.1	53.9	59.0	51.6	32.7	32.5	70.7	45.6	50.9	32.2	76.5
ZNF248	bA162G10.3	ENSG00000198105	"Zinc finger protein 248"	Q8NDW4	10	37776526-37858106	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 110.0;Excitatory neurons: 145.0;Inhibitory neurons: 135.1;Oligodendrocyte precursor cells: 101.6;Oligodendrocytes: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018237, HPA018287, HPA018455"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA018237: AB_2669815, HPA018287: AB_2669829, HPA018455: AB_2669869"	"unprognostic (6.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.50e-4)"	"prognostic favorable (1.04e-4)"	"unprognostic (6.37e-3)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.22e-4)"	"prognostic unfavorable (6.71e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.68e-3)"	5.2	7.1	12.8	6.7	12.8	0.8	7.8	21.0	16.7	15.9	7.6	17.6	5.5	15.2	14.1	5.8	12.2	6.6	7.9	12.7	11.7	8.2	6.0	6.2	6.7	10.3	10.9	15.5	6.8	12.3	18.9	6.5	10.7	12.2	8.9	17.1	6.8	16.1	8.5	7.3	7.9	10.8	8.5	7.9	7.7	7.0	12.8	5.5	13.4	9.7	6.5	9.5	9.7	17.5	7.0	5.8	1.2	16.1	11.3	9.4	7.0	7.1	3.6	7.2	7.7	7.2	8.7	9.2	6.1	5.0	5.5	8.7	9.4	5.0	6.2	16.2	10.3	11.5	12.9	8.8	5.6	9.6	7.5	3.8	9.4	3.8	3.1	14.3	6.6	9.9	5.1	6.5	10.7	3.4	9.7	6.2	4.9	4.6	31.1	8.9	16.2	6.6	8.9	3.4	6.7	12.7	6.1	3.3	4.2	9.8	8.8	2.7	6.5	6.5	6.8	5.2	4.3	10.1	11.6	7.7	8.7	12.5	3.2	0.8	1.3	1.2	4.0	0.9	4.5	4.2	3.5	3.5	2.9	5.1	6.0	5.3	0.2	3.4	1.2	2.6	2.0	2.2	12.8	12.8	21.0	16.7	12.7	11.7	10.3	10.9	10.7	8.5	12.8	17.5	7.1	12.8	14.4	110.0	10.0	2.0	7.6	4.4	10.2	47.4	6.7	7.6	24.4	8.6	7.2	5.5	47.9	6.3	7.7	4.0	7.9	4.1	1.0	15.7	15.4	8.3	5.4	7.2	145.0	1.6	3.1	11.1	6.1	24.7	5.1	26.3	5.0	4.1	4.3	42.1	135.1	4.4	0.0	1.6	2.9	1.8	9.9	3.3	1.8	52.5	4.0	16.1	6.2	101.6	106.8	3.8	5.9	12.0	8.2	4.8	4.2	4.4	5.2	36.9	0.0	17.0	14.2	9.0	10.5	5.9	2.7	2.6	6.4	17.1	5.1	4.2
ZNF25	"FLJ31890, KOX19, Zfp9"	ENSG00000175395	"Zinc finger protein 25"	P17030	10	37949573-37976647	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 44.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030190	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA030190: AB_10602687"	"unprognostic (9.42e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.61e-1)"	10.2	10.1	12.3	3.5	12.5	2.6	8.2	12.5	19.1	9.7	4.1	12.3	2.2	9.9	6.1	5.4	9.2	6.1	10.0	12.5	15.9	5.7	3.0	6.4	4.8	11.9	10.9	11.1	5.4	7.6	14.3	4.7	12.4	7.3	4.4	10.6	4.6	8.9	22.3	4.8	5.3	8.9	9.8	6.5	5.8	4.7	14.6	4.6	6.0	21.5	4.3	8.8	7.1	12.6	1.6	3.0	3.3	6.7	12.1	9.2	0.6	3.6	4.9	2.8	4.2	0.5	2.3	3.1	1.0	6.4	1.0	0.4	0.9	1.5	4.5	7.3	1.6	5.0	0.0	1.0	7.7	3.3	3.1	6.5	6.6	3.1	3.6	11.1	4.9	4.0	0.4	2.3	6.9	1.0	1.1	2.6	0.6	0.6	2.2	1.2	3.7	0.6	3.3	0.6	1.2	7.6	1.2	0.2	4.7	1.2	2.9	5.3	7.1	4.3	0.8	7.1	2.2	2.8	1.4	1.3	8.2	6.3	2.9	1.3	1.5	3.4	1.6	2.5	1.7	1.0	1.4	1.3	1.9	1.3	1.8	1.5	0.2	1.0	5.2	0.3	1.2	1.2	12.3	12.5	12.5	19.1	12.5	15.9	11.9	10.9	12.4	9.8	14.6	12.6	10.0	3.2	3.2	17.9	4.8	3.4	2.5	2.5	3.4	17.3	3.8	3.6	23.6	4.3	2.9	7.3	6.2	1.2	3.5	1.0	1.9	2.0	27.9	2.4	7.0	7.6	0.0	2.1	46.7	2.5	0.5	10.6	4.1	2.7	8.2	8.2	10.4	2.9	5.7	16.8	44.6	1.2	4.1	13.2	6.8	41.9	12.2	9.5	3.6	14.0	8.1	13.7	5.2	38.2	36.7	1.8	0.3	16.1	1.5	2.6	1.3	3.1	8.1	7.1	0.0	11.4	10.4	4.4	6.4	2.4	4.0	0.3	5.2	4.8	0.8	1.3
ZNF251		ENSG00000198169	"Zinc finger protein 251"	Q9BRH9	8	144720907-144756417	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.6;Excitatory neurons: 49.1;Inhibitory neurons: 50.2;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018290	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA018290: AB_1859153"	"unprognostic (1.16e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.42e-9)"	"unprognostic (5.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-3)"	16.6	10.4	12.5	6.2	12.3	3.5	16.6	17.4	12.9	21.3	10.4	17.5	6.8	17.5	24.4	9.8	18.1	10.5	23.4	12.7	12.4	15.8	11.4	10.5	12.2	11.8	12.0	20.0	14.5	12.2	22.6	8.8	11.6	17.8	11.4	17.5	12.2	13.5	10.1	13.1	15.7	12.6	10.9	14.9	13.2	14.1	12.9	11.2	28.0	8.6	11.1	16.6	15.5	12.6	9.9	6.0	23.0	10.8	13.5	17.7	8.7	9.9	14.9	11.3	15.8	2.5	11.6	14.6	9.0	12.9	6.3	13.5	6.8	6.1	15.3	4.1	5.0	11.1	25.1	6.8	7.8	4.1	5.9	13.4	9.1	6.9	13.2	22.0	9.2	10.3	7.4	4.1	13.3	4.7	12.3	2.4	6.9	7.3	10.5	12.7	3.3	5.9	7.6	5.5	10.7	13.9	9.5	4.8	11.0	10.4	12.2	9.6	7.4	9.4	14.4	16.4	8.7	4.4	1.3	8.5	10.5	6.0	7.5	0.0	0.3	1.0	0.9	0.5	1.5	1.3	1.4	1.4	0.7	1.0	1.9	1.4	0.0	1.2	0.5	0.7	1.6	0.8	12.5	12.3	17.4	12.9	12.7	12.4	11.8	12.0	11.6	10.9	12.9	12.6	9.3	0.0	5.3	31.6	4.8	2.2	3.8	1.7	5.7	5.5	4.0	4.1	3.9	1.5	8.9	1.8	6.2	2.0	3.1	1.0	5.9	1.6	20.2	4.5	7.1	7.7	1.2	3.8	49.1	1.5	1.4	5.6	6.6	5.0	1.3	6.8	1.8	0.9	1.6	5.0	50.2	2.1	0.0	3.0	3.0	9.5	7.8	2.0	1.8	22.5	2.9	2.8	3.1	37.7	40.7	2.0	1.8	4.5	5.7	3.0	2.0	3.2	5.3	5.9	13.1	5.2	6.1	11.9	10.3	3.9	3.1	1.4	5.0	5.4	1.9	2.0
ZNF256	BMZF-3	ENSG00000152454	"Zinc finger protein 256"	Q9Y2P7	19	57940833-57947706	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 32.8"									HPA055390	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA055390: AB_2682803"	"unprognostic (2.47e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.32e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.83e-2)"	"unprognostic (6.39e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.28e-3)"	3.5	2.5	2.3	2.3	2.6	10.8	5.6	5.6	3.3	2.9	2.4	3.3	2.3	3.5	4.4	2.7	3.9	1.9	6.0	2.5	1.9	3.1	1.8	3.2	4.9	1.6	1.8	5.5	2.1	4.4	2.8	4.6	1.6	3.8	2.9	9.1	3.3	4.0	3.6	7.1	3.5	3.5	1.6	4.6	2.6	4.3	1.7	5.4	3.9	4.2	5.3	3.1	2.8	2.3	3.9	1.3	9.6	9.7	2.0	3.3	8.3	3.3	3.5	5.2	3.5	0.8	2.1	0.0	2.9	4.3	8.0	0.5	2.2	7.4	8.5	0.0	32.8	9.5	0.0	2.6	3.7	0.0	7.4	6.5	2.0	3.8	0.0	5.4	3.2	9.1	0.7	0.0	5.3	0.9	13.2	0.0	11.6	0.4	8.2	4.2	12.0	5.9	3.8	16.8	4.8	6.9	0.0	3.0	2.4	11.8	7.2	3.0	1.3	10.7	6.3	0.0	6.5	4.4	4.7	16.9	0.3	0.0	4.7	1.3	1.0	1.3	3.3	3.4	6.1	4.7	5.6	5.0	4.2	5.6	5.4	6.4	0.5	3.9	3.6	2.0	4.9	2.2	2.3	2.6	5.6	3.3	2.5	1.9	1.6	1.8	1.6	1.6	1.7	2.3	2.4	0.0	0.0	2.0	4.0	2.7	4.8	3.5	2.2	4.5	2.4	1.4	3.2	1.5	1.7	1.8	0.0	3.1	2.2	0.4	3.9	3.5	0.2	1.2	1.1	2.7	1.2	5.2	1.6	0.8	1.7	2.0	1.1	1.3	0.0	2.2	0.7	0.7	1.4	1.7	1.4	0.9	8.2	0.8	1.0	0.3	1.8	0.8	0.0	1.0	1.7	3.8	1.0	3.5	0.6	0.8	0.3	0.4	0.3	2.7	0.8	0.9	3.4	7.2	0.0	2.6	2.1	4.9	8.7	1.6	3.4	2.6	3.1	2.3	1.2	3.7
ZNF260	"ozrf1, Zfp260"	ENSG00000254004	"Zinc finger protein 260"	Q3ZCT1	19	36510687-36528271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028806	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA028806: AB_10795285"	"unprognostic (1.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.89e-3)"	4.5	5.0	4.9	4.1	5.7	1.7	7.9	5.5	5.8	6.7	4.4	3.9	4.1	7.2	5.2	5.1	5.3	5.4	5.0	4.5	5.5	7.4	5.8	4.9	6.3	5.2	5.5	8.4	3.9	11.7	3.2	6.8	5.3	6.6	4.6	8.9	4.8	4.7	2.4	6.8	4.2	5.2	5.2	5.9	5.5	3.1	5.6	7.6	9.7	4.1	6.7	6.1	3.4	6.9	11.2	11.2	25.1	19.1	7.7	11.5	10.9	9.6	10.1	8.6	11.0	5.1	6.2	7.3	15.2	7.8	6.6	4.1	12.8	5.9	13.2	9.7	5.6	10.8	8.6	5.8	10.7	5.5	8.7	10.6	9.8	8.9	13.7	12.5	11.7	10.7	8.7	7.9	17.4	6.1	20.6	3.6	15.9	7.0	4.8	13.5	15.5	5.5	9.8	19.6	18.1	19.9	21.3	11.4	8.0	15.3	9.5	10.5	10.2	15.0	15.5	8.9	8.7	10.0	20.4	16.7	0.4	5.9	20.7	4.6	1.3	1.4	1.7	1.2	1.8	2.4	2.3	1.4	1.5	2.9	3.1	2.4	0.6	1.9	1.9	1.0	2.2	1.4	4.9	5.7	5.5	5.8	4.5	5.5	5.2	5.5	5.3	5.2	5.6	6.9	10.9	9.6	6.2	9.4	14.1	10.3	8.2	7.2	18.2	7.9	12.3	9.8	8.9	1.5	11.1	0.0	8.4	6.4	8.9	2.7	5.9	8.2	18.0	9.3	12.7	9.7	12.0	10.7	13.2	4.4	7.0	9.3	7.7	9.2	8.2	15.9	10.8	4.0	4.6	21.9	13.4	5.1	12.2	5.7	3.3	4.1	5.9	5.4	1.8	9.4	6.0	7.9	5.2	24.1	27.7	6.6	3.5	8.2	3.7	7.1	3.4	8.3	6.3	7.9	6.6	6.4	9.1	8.0	3.8	16.2	13.1	4.1	10.4	9.2	4.6	11.9
ZNF263	"FPM315, ZKSCAN12, ZSCAN44"	ENSG00000006194	"Zinc finger protein 263"	O14978	16	3263800-3301401	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035085, HPA035086"	Approved		Supported	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Mitotic spindle"	"HPA035085: AB_10671099, HPA035086: AB_10603244"	"unprognostic (2.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.98e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.66e-1)"	20.8	18.3	18.3	16.8	18.1	19.1	24.1	20.4	22.5	20.2	20.3	20.1	14.5	22.9	23.2	15.4	24.5	16.7	15.1	19.1	17.7	20.4	17.6	19.4	22.6	20.1	17.6	29.2	21.5	30.7	23.4	20.4	17.2	21.4	17.0	24.6	20.2	20.2	17.3	24.0	19.3	18.7	16.6	23.2	22.0	18.1	18.2	22.3	20.0	13.7	21.5	19.5	17.5	20.5	19.7	25.1	27.6	40.8	22.7	28.8	36.6	26.1	38.6	30.0	32.2	27.5	30.3	74.2	26.5	33.6	28.6	25.7	38.6	26.4	29.9	41.6	41.3	31.4	35.6	25.6	25.7	48.8	38.5	34.0	53.3	27.6	40.0	33.5	26.2	44.5	37.9	47.4	24.8	25.5	43.9	37.2	55.7	23.2	19.2	70.4	29.8	57.6	20.7	18.4	40.6	43.8	27.9	30.0	30.9	32.5	32.8	57.7	30.1	31.4	30.9	23.3	25.4	50.8	60.8	88.0	12.9	23.6	23.8	1.4	2.5	6.4	3.5	2.4	4.0	2.5	4.2	4.7	3.5	4.4	5.4	3.8	3.0	4.5	3.4	2.9	3.1	1.9	18.3	18.1	20.4	22.5	19.1	17.7	20.1	17.6	17.2	16.6	18.2	20.5	15.9	0.0	11.5	8.8	16.6	17.5	17.1	3.7	16.5	12.5	13.9	12.8	4.6	15.7	5.0	1.8	0.0	11.5	16.1	8.7	7.9	10.2	60.9	10.5	8.8	12.8	13.2	6.3	7.9	10.0	11.1	11.9	11.2	13.5	7.0	14.3	10.0	7.1	9.1	3.3	6.7	12.1	10.2	9.4	14.3	35.1	8.1	9.5	16.0	7.5	8.4	9.8	19.6	8.0	7.8	10.3	6.0	7.9	11.8	16.3	7.5	6.3	5.7	9.0	13.1	17.5	17.3	13.0	11.1	14.3	20.6	11.1	15.0	15.2	12.3	13.6
ZNF264	KIAA0412	ENSG00000083844	"Zinc finger protein 264"	O43296	19	57191500-57222846	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA046330			Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA046330: "	"unprognostic (2.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.19e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.65e-2)"	6.1	4.3	5.5	6.4	7.3	8.2	6.0	8.5	6.5	5.6	9.8	4.0	4.7	5.9	4.9	4.8	5.9	4.1	3.3	5.3	6.4	4.9	5.2	5.3	7.0	12.1	6.6	8.8	8.1	6.5	4.9	6.7	6.5	5.2	4.5	8.8	5.1	5.1	3.9	6.8	5.3	5.2	5.9	8.2	7.3	9.9	7.6	7.9	7.3	4.0	7.0	4.5	4.4	12.8	9.9	6.9	7.8	6.2	5.4	7.5	3.2	5.7	8.8	7.6	13.6	4.8	7.8	3.2	3.9	7.9	6.4	10.3	0.0	7.8	10.9	0.1	27.7	13.3	11.9	3.8	6.3	2.6	12.0	7.9	4.2	9.5	21.7	6.4	7.4	7.6	0.2	0.2	7.0	0.1	11.1	3.3	5.1	2.8	17.2	4.1	10.0	10.5	5.7	13.6	8.6	5.9	11.5	3.5	4.4	6.5	6.3	6.3	10.6	10.1	8.7	3.1	8.2	13.8	17.6	10.1	7.5	0.1	4.3	0.9	1.0	4.3	1.8	1.5	1.2	4.2	2.7	1.8	1.3	1.8	3.4	3.2	0.9	2.4	1.5	1.8	2.1	1.1	5.5	7.3	8.5	6.5	5.3	6.4	12.1	6.6	6.5	5.9	7.6	12.8	17.2	16.0	18.4	15.7	18.4	1.5	10.9	1.3	9.1	22.1	19.7	12.1	8.8	31.5	7.5	16.5	31.3	7.3	17.5	11.2	7.9	10.1	33.3	29.5	12.5	22.1	16.2	11.4	20.5	15.8	9.2	14.2	7.7	17.5	8.2	13.1	24.3	15.1	13.3	32.0	18.5	11.4	4.1	22.9	0.9	19.0	9.9	14.1	0.0	18.7	13.2	10.9	21.6	15.1	27.1	14.6	5.4	15.8	15.1	16.6	9.3	10.2	6.3	21.0	26.3	17.9	13.3	22.8	18.8	13.4	1.3	4.9	16.7	11.6	10.0	16.7
ZNF266	HZF1	ENSG00000174652	"Zinc finger protein 266"	Q14584	19	9412461-9435571	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 74.2"	"Low region specificity"	"Detected in all"							"HPA026836, HPA054110"	Uncertain		Supported	"Nucleoplasm,Vesicles,Rods & Rings"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Rods & Rings"	"HPA026836: AB_2672018, HPA054110: AB_2682383"	"unprognostic (2.50e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.60e-2)"	"prognostic favorable (3.94e-6)"	"unprognostic (1.72e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.00e-3)"	"prognostic favorable (3.03e-5)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (9.15e-5)"	21.0	17.6	8.7	12.7	9.1	17.5	22.8	10.5	10.7	26.3	10.1	22.8	10.2	20.6	53.3	17.5	21.7	9.7	15.3	8.4	8.9	16.3	15.4	21.8	23.8	8.9	8.9	24.2	15.1	15.7	20.1	15.0	9.0	31.5	15.9	12.6	19.0	14.6	11.4	25.1	29.4	14.0	8.8	44.1	19.4	16.7	9.1	27.6	26.3	8.6	27.9	20.0	20.3	9.9	21.5	5.4	13.0	26.6	10.8	15.3	10.3	19.4	18.9	19.1	27.5	10.1	7.1	22.5	12.6	10.7	7.4	6.3	19.3	10.8	22.1	6.8	29.6	27.1	21.8	13.9	9.2	16.9	17.3	16.4	16.0	9.6	14.3	15.5	14.2	25.7	18.0	0.0	16.7	2.1	25.8	74.2	16.6	9.9	16.5	9.6	16.4	16.9	13.6	22.2	13.0	19.5	10.5	11.0	14.0	14.0	8.8	14.2	13.7	16.6	6.9	23.1	11.8	32.1	55.6	28.0	4.5	14.8	11.3	4.0	3.5	4.9	9.6	4.1	6.8	4.8	5.7	7.4	2.9	5.3	7.5	8.1	2.0	11.1	5.4	2.7	7.5	4.8	8.7	9.1	10.5	10.7	8.4	8.9	8.9	8.9	9.0	8.8	9.1	9.9	8.8	0.0	14.3	10.4	15.3	4.0	5.9	5.3	11.4	8.0	9.0	8.8	5.5	4.3	8.7	3.7	12.5	4.8	22.4	7.2	3.9	5.5	0.7	5.0	5.4	7.5	9.5	14.3	12.5	3.7	3.3	6.6	11.2	6.5	12.0	12.9	10.8	3.1	4.8	8.4	12.0	7.1	6.1	11.4	7.2	1.4	6.2	9.1	5.4	14.0	11.3	4.2	20.6	14.1	15.1	4.7	5.2	4.5	10.5	5.6	7.6	1.4	6.6	9.5	6.6	7.2	6.2	5.5	8.7	6.4	4.7	4.7	17.1	6.5	7.4	6.4
ZNF267	HZF2	ENSG00000185947	"Zinc finger protein 267"	Q14586	16	31873807-31917357	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.1;Macrophages: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003866	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA003866: AB_1080698"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.64e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.34e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.21e-2)"	6.3	3.7	3.2	18.6	3.8	27.4	7.3	3.4	11.6	5.5	5.4	6.1	7.1	6.7	3.1	7.1	6.0	10.0	4.4	2.9	4.4	5.0	6.6	9.3	17.9	4.6	4.4	6.2	4.8	4.5	2.3	10.0	4.8	5.2	7.1	2.5	5.3	3.9	6.1	4.0	5.9	5.9	4.2	13.2	6.8	9.8	6.4	11.4	5.9	6.6	18.4	13.6	4.4	5.5	8.8	10.0	8.8	7.0	6.2	7.2	26.9	7.0	11.7	9.6	14.7	17.9	13.7	15.6	12.6	5.7	9.6	11.3	14.4	11.4	18.5	23.6	12.1	15.8	5.6	16.1	5.6	17.0	35.3	10.3	7.7	13.6	9.7	7.0	14.0	11.8	25.9	35.9	13.2	12.2	11.4	11.3	8.2	6.8	5.8	11.4	24.8	13.7	10.9	38.8	2.8	4.3	10.8	9.6	10.3	15.3	5.7	23.6	16.8	9.3	8.5	8.2	12.0	20.1	12.3	15.7	12.3	13.6	5.7	36.6	24.0	33.4	12.4	23.4	18.6	21.2	16.2	12.5	18.8	15.9	12.6	15.2	75.3	16.5	27.5	11.3	20.3	12.3	3.2	3.8	3.4	11.6	2.9	4.4	4.6	4.4	4.8	4.2	6.4	5.5	23.7	9.6	8.0	3.6	37.0	31.9	39.6	15.2	13.1	4.5	12.3	12.2	5.6	8.6	14.0	3.7	0.0	14.1	27.2	5.4	7.9	19.1	23.3	34.8	10.3	33.5	7.7	10.9	7.1	20.0	10.4	17.2	13.7	31.4	60.3	5.4	7.5	2.8	21.5	11.8	3.7	7.0	14.2	25.3	131.1	8.8	5.9	82.2	14.2	15.0	68.5	5.0	22.6	9.5	7.7	49.7	8.0	3.4	19.9	30.1	4.2	12.4	26.2	3.9	0.0	10.8	12.2	20.7	29.6	33.1	25.6	8.3	47.6	5.9	5.6	48.9
ZNF273	HZF9	ENSG00000198039	"Zinc finger protein 273"	Q14593	7	64870172-64930966	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 4.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.0;Inhibitory neurons: 51.2;Respiratory ciliated cells: 82.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.9"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA077549			Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA077549: AB_2732352"	"unprognostic (7.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.02e-5)"	"unprognostic (2.54e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.85e-2)"	0.4	0.1	0.2	0.2	0.2	2.4	1.2	1.0	0.7	0.8	0.1	0.2	0.3	0.6	0.1	0.5	0.8	0.1	0.2	0.2	0.2	0.2	0.1	0.4	1.1	0.5	0.4	0.9	0.3	0.2	0.0	0.5	0.3	0.4	0.4	0.4	0.4	0.3	0.3	4.0	0.1	0.2	0.3	0.4	0.2	2.1	0.2	1.2	1.5	0.3	1.0	0.4	0.6	0.3	1.8	1.3	2.8	4.1	0.4	0.9	2.3	0.8	0.5	1.2	2.2	2.0	1.6	4.7	2.4	0.4	2.2	0.6	5.6	1.1	1.0	2.3	2.1	2.5	0.6	0.7	0.2	2.4	1.7	0.7	0.7	2.0	1.8	0.8	1.1	6.9	6.7	1.8	1.4	1.6	5.3	2.7	5.7	1.0	2.0	5.5	4.2	2.8	0.6	1.1	2.6	2.7	2.2	1.1	1.3	5.4	2.1	3.5	0.5	1.4	1.5	1.0	1.7	1.7	2.4	6.8	0.3	2.4	1.0	2.0	0.2	1.2	0.3	0.3	0.6	1.2	0.7	0.5	0.6	1.0	0.5	0.9	0.4	0.2	0.2	0.6	0.8	0.3	0.2	0.2	1.0	0.7	0.2	0.2	0.5	0.4	0.3	0.3	0.2	0.3	8.2	3.2	2.3	22.5	12.9	25.0	6.2	8.8	6.8	5.5	7.6	4.7	4.3	1.5	11.1	1.8	0.0	6.8	4.9	0.5	7.9	3.4	25.0	27.1	4.7	7.1	0.0	30.7	44.0	2.9	13.1	7.8	3.6	4.4	3.8	13.4	6.4	1.1	3.6	5.0	51.2	2.0	8.2	3.1	3.5	13.5	6.2	4.1	5.4	15.0	3.9	3.6	7.2	20.1	11.6	2.6	6.1	3.4	2.8	3.6	0.6	1.6	82.0	3.2	0.0	4.8	4.4	21.6	11.4	9.7	18.9	2.9	7.2	5.2	3.5	3.1
ZNF274	"ZKSCAN19, ZSCAN51"	ENSG00000171606	"Zinc finger protein 274"	Q96GC6	19	58183029-58213562	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 77.1"					"Low region specificity"	"Detected in all"			HPA028880	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Centrosome	"HPA028880: AB_10601929"	"unprognostic (2.38e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.58e-3)"	12.0	11.5	10.1	9.9	11.1	13.1	13.0	13.5	10.3	11.3	15.2	14.4	8.6	10.2	13.6	14.9	14.5	8.8	18.0	9.6	9.5	16.4	19.2	13.1	14.0	10.8	10.5	21.7	8.7	21.7	14.4	9.4	11.0	12.9	7.5	17.3	10.3	10.7	17.7	15.1	14.8	8.9	10.0	17.3	11.4	14.4	10.7	11.5	18.9	14.6	14.3	12.7	11.8	14.5	18.5	12.3	20.9	8.5	12.9	19.1	20.3	14.3	7.9	15.9	14.1	7.5	13.1	6.2	9.4	9.3	16.9	5.1	10.1	20.3	21.8	12.7	77.1	29.5	12.8	12.1	20.8	20.9	46.1	15.0	25.7	19.6	37.2	16.6	12.8	9.7	22.5	26.8	12.0	12.0	11.5	19.1	20.0	10.6	12.2	26.0	5.3	26.8	11.9	7.4	13.6	6.1	19.6	8.6	16.9	15.7	20.4	39.4	12.5	8.5	12.8	10.0	16.9	12.5	14.1	20.9	3.8	23.3	18.4	23.0	7.3	36.9	13.5	8.0	21.1	20.5	17.7	19.7	10.3	26.3	26.1	18.5	26.1	22.1	13.4	5.0	24.4	13.2	10.1	11.1	13.5	10.3	9.6	9.5	10.8	10.5	11.0	10.0	10.7	14.5	15.2	16.0	19.6	17.6	33.5	10.5	40.1	12.8	8.0	32.6	10.2	8.3	14.5	15.7	14.1	18.4	43.8	11.3	12.7	10.4	1.9	13.5	18.5	8.3	8.1	13.9	6.6	10.8	4.4	5.6	11.7	9.2	13.7	11.9	29.2	11.2	13.2	9.9	7.1	20.2	3.7	9.0	4.1	13.0	15.9	10.7	12.2	11.9	7.2	10.3	10.4	22.3	18.6	16.6	21.0	12.3	17.9	12.0	7.8	26.7	18.0	10.3	12.4	67.0	19.7	14.1	16.6	21.6	14.6	8.8	12.1	16.7	23.7	5.5	8.3	25.5
ZNF276	"CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477"	ENSG00000158805	"Zinc finger protein 276"	Q8N554	16	89720400-89740925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 63.5;NK-cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021309, HPA022255"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"HPA021309: AB_1859024, HPA022255: AB_1859025"	"unprognostic (1.45e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-3)"	9.9	12.5	13.3	11.0	14.2	21.0	10.4	13.5	15.9	12.5	9.3	13.0	10.7	10.0	3.5	19.1	14.5	5.3	10.0	12.4	11.8	13.5	14.3	12.0	16.9	15.2	13.2	16.0	13.6	4.4	14.6	4.8	14.0	13.4	5.7	3.8	11.7	4.2	10.6	17.6	19.6	4.5	11.0	26.8	12.0	9.3	14.4	8.1	12.8	4.6	10.6	10.8	14.4	19.7	6.6	5.5	4.8	11.8	3.7	5.4	7.9	5.2	3.0	4.6	1.7	7.4	7.4	8.4	4.6	5.2	2.1	12.1	6.0	5.6	3.1	5.4	25.8	7.9	12.0	3.1	6.8	7.7	9.7	7.3	7.2	6.2	4.7	4.5	5.9	7.7	13.9	7.8	1.9	9.9	9.1	19.3	3.2	7.1	10.6	14.4	5.5	6.0	5.5	3.9	11.5	10.0	9.4	8.8	6.0	2.8	11.8	11.0	7.6	6.3	9.1	5.2	4.3	24.4	8.5	4.7	6.2	14.5	7.2	3.8	1.2	1.5	6.6	1.1	3.3	1.2	3.7	5.4	0.7	1.7	3.7	4.9	3.1	3.8	1.0	1.2	2.7	2.0	13.3	14.2	13.5	15.9	12.4	11.8	15.2	13.2	14.0	11.0	14.4	19.7	17.1	9.6	13.3	15.7	20.8	11.5	8.3	11.2	14.8	15.8	13.9	11.7	2.6	12.8	10.7	11.0	20.9	4.6	63.5	16.8	1.9	7.6	1.9	11.5	14.7	13.6	7.2	13.5	17.6	6.6	3.9	9.5	15.8	14.4	12.6	14.3	20.0	11.5	9.0	6.7	14.6	14.5	2.0	9.8	9.8	2.3	11.5	19.7	8.8	18.7	13.5	9.7	89.6	25.1	30.6	9.2	13.2	10.5	25.4	12.9	19.8	3.4	10.1	21.6	13.1	12.3	8.7	17.0	9.7	15.5	16.1	4.0	39.0	24.0	15.7	11.0
ZNF277	"NRIF4, ZNF277P"	ENSG00000198839	"Zinc finger protein 277"	Q9NRM2	7	112206695-112343934	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027307	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Plasma membrane"	"HPA027307: AB_1859164"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (9.47e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	7.5	6.8	3.9	5.4	4.9	6.1	8.9	4.2	7.2	6.1	3.8	7.1	5.9	6.7	3.1	7.1	6.0	6.4	8.0	4.5	3.7	9.5	11.6	7.0	6.8	4.7	3.8	7.1	11.3	7.1	4.6	4.6	4.6	5.6	6.9	4.5	7.1	4.4	6.5	8.3	5.6	6.0	3.8	5.8	7.8	5.4	4.7	7.9	9.4	3.4	6.3	8.2	7.0	7.1	7.6	4.5	7.5	9.3	10.2	28.1	5.6	7.4	7.9	3.5	6.3	6.8	6.8	12.6	13.3	6.1	7.2	5.0	5.7	7.3	9.4	10.2	3.6	6.6	6.1	5.8	6.3	12.1	5.2	17.1	10.8	8.6	5.7	11.1	10.7	13.2	7.9	13.3	6.4	8.8	15.2	20.6	5.1	6.5	5.0	7.4	8.2	11.4	9.5	5.6	5.3	13.8	9.7	12.0	11.9	8.1	3.4	10.2	14.9	5.4	3.1	12.0	4.8	11.5	14.6	14.8	3.9	11.5	6.6	9.3	4.6	6.4	5.7	8.1	8.5	8.7	8.0	8.2	3.7	9.6	9.6	8.1	6.6	7.4	7.2	5.9	9.4	3.7	3.9	4.9	4.2	7.2	4.5	3.7	4.7	3.8	4.6	3.8	4.7	7.1	13.0	38.5	24.6	77.1	25.7	20.6	18.2	35.7	26.2	10.0	19.0	17.5	12.8	27.1	24.1	5.5	2.1	12.3	19.6	12.4	27.4	25.9	46.4	13.6	15.6	17.9	18.5	11.1	51.9	31.0	18.3	15.7	12.8	16.3	7.6	21.4	16.4	19.2	21.7	32.0	43.4	22.5	34.6	46.9	34.8	8.6	17.1	29.1	12.4	43.1	50.6	6.6	37.0	47.7	70.5	24.6	22.9	25.2	13.2	17.5	27.0	34.5	12.7	12.0	19.7	17.1	23.7	32.8	10.4	19.1	24.3	13.8	25.8	28.1	22.4	21.5
ZNF280A	"3'OY11.1, SUHW1, ZNF280, ZNF636"	ENSG00000169548	"Zinc finger protein 280A"	P59817	22	22513736-22520270	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"adrenal gland: 1.4"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 1.8;Spermatogonia: 1.2;Syncytiotrophoblasts: 5.1;Theca cells: 1.9"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7;testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;K-562: 8.2;SK-MEL-30: 2.1"									HPA044475			Approved	Nucleoplasm		NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA044475: AB_10960420"			"unprognostic (7.53e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-2)"		"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.65e-3)"			"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"			0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.2	0.3	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.0	0.0	5.1	0.0	1.9	0.0	0.0
ZNF280B	"5'OY11.1, SUHW2, ZNF279, ZNF632"	ENSG00000275004	"Zinc finger protein 280B"	Q86YH2	22	22484421-22508742	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 13.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 135.6;Late spermatids: 99.3;Spermatocytes: 104.2;Spermatogonia: 161.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 20.9;U-2 OS: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059519	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA059519: AB_2684050"	"unprognostic (7.32e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.80e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.34e-2)"	0.1	1.6	2.4	0.6	2.4	0.3	0.2	1.5	3.2	0.4	0.1	0.3	0.2	1.1	1.0	0.2	0.8	0.4	0.5	2.3	4.0	0.2	0.1	0.2	1.0	2.3	2.8	2.1	0.6	1.2	1.3	0.2	2.3	0.9	0.4	3.3	0.2	1.0	0.3	0.3	0.4	0.8	1.6	0.9	0.4	13.4	3.6	0.8	1.9	0.2	0.9	0.2	0.1	2.2	0.0	2.5	3.2	0.0	0.0	0.0	3.7	0.5	0.0	0.0	0.0	1.8	1.1	3.2	3.1	0.1	3.0	0.0	2.8	0.3	0.0	0.0	3.8	4.0	0.6	3.6	2.4	2.5	4.4	1.2	0.0	2.7	0.0	0.5	2.7	3.1	20.9	1.4	1.0	0.0	3.0	1.7	2.4	1.5	0.5	3.0	0.0	0.2	0.8	0.0	2.0	2.2	0.0	0.0	1.1	2.6	0.0	1.9	1.0	4.4	9.8	1.0	0.1	1.7	1.9	1.9	3.0	2.1	0.2	12.9	1.6	2.9	2.6	2.5	4.2	2.8	3.2	2.5	1.5	2.8	3.8	4.5	4.1	5.2	5.4	2.4	2.6	1.8	2.4	2.4	1.5	3.2	2.3	4.0	2.3	2.8	2.3	1.6	3.6	2.2	0.1	0.0	0.6	3.9	5.3	0.1	0.6	0.4	0.0	7.1	0.9	1.3	2.6	2.8	0.6	0.0	4.2	0.3	0.8	0.3	0.0	2.8	135.6	3.4	2.4	1.8	3.0	0.4	12.7	3.7	0.3	1.3	1.1	3.9	0.0	11.4	1.4	0.2	3.0	5.0	14.6	0.7	0.0	0.8	1.9	99.3	2.5	2.6	5.4	1.0	1.9	6.9	5.2	7.5	4.2	2.3	0.1	7.2	0.7	0.8	0.0	4.4	0.0	8.0	6.6	2.3	0.5	104.2	161.7	0.0	0.0	0.3	2.3	17.2	1.6	0.1
ZNF280C	"FLJ20095, SUHW3, ZNF633, ZPET"	ENSG00000056277	"Zinc finger protein 280C"	Q8ND82	X	130202707-130268899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.4"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 20.1;Spermatocytes: 27.5;Spermatogonia: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051494, HPA055788"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA051494: AB_2681506, HPA055788: AB_2682921"	"unprognostic (2.97e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.98e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.16e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.27e-8)"	"unprognostic (1.71e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.85e-2)"	1.6	1.4	0.6	1.7	1.3	2.6	1.6	1.5	1.3	2.9	0.3	1.5	1.3	2.7	5.1	1.4	1.5	1.8	0.9	0.7	1.3	1.1	1.2	1.5	2.3	0.5	0.8	1.8	1.3	1.7	1.6	1.8	0.7	1.5	1.4	1.8	1.2	1.2	1.3	1.6	1.4	1.8	0.5	1.7	1.1	9.4	0.8	2.2	1.6	1.1	2.6	1.6	1.6	1.1	3.3	4.1	10.7	9.6	3.1	4.3	4.0	3.1	4.0	3.2	4.8	2.5	5.2	7.8	12.0	2.2	6.3	3.2	7.5	2.4	5.7	6.9	2.1	3.4	3.2	1.9	2.5	11.1	3.0	3.2	1.1	4.6	4.7	3.2	3.7	5.0	1.7	4.6	3.8	4.2	6.0	4.5	6.2	4.9	3.4	8.2	3.6	3.0	3.4	5.2	5.2	7.1	3.0	1.7	3.4	4.3	1.9	3.7	3.7	3.5	2.9	5.8	8.2	1.9	1.3	4.3	3.3	9.9	3.3	1.0	0.5	0.6	1.0	0.8	1.7	1.4	1.2	1.2	0.7	1.0	0.9	1.3	0.2	1.8	1.1	0.8	1.8	0.4	0.6	1.3	1.5	1.3	0.7	1.3	0.5	0.8	0.7	0.5	0.8	1.1	3.1	3.2	3.6	8.8	6.8	0.9	2.1	1.3	3.4	2.4	2.1	3.2	1.3	0.0	1.4	1.8	2.1	2.0	8.1	1.2	0.0	1.3	0.3	2.9	7.4	2.8	4.8	3.4	13.1	1.8	1.7	2.9	5.1	3.6	0.0	7.4	3.6	2.7	1.6	5.0	11.2	0.9	4.1	3.2	1.0	0.3	3.4	2.4	0.0	9.4	4.3	0.9	0.0	20.1	11.8	1.1	1.8	3.0	3.2	2.1	1.0	2.1	3.2	3.1	6.6	3.8	3.2	27.5	33.8	4.3	1.6	0.8	4.3	5.0	2.3	2.5
ZNF280D	"FLJ20086, SUHW4, ZNF634"	ENSG00000137871	"Zinc finger protein 280D"	Q6N043	15	56630176-56734086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 176.6;Oligodendrocyte precursor cells: 200.1;Oligodendrocytes: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA030233	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"	"Golgi apparatus, Centrosome"	"HPA030233: AB_10602590"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.72e-2)"	11.3	11.4	3.4	8.7	3.9	23.1	15.4	9.0	4.6	18.0	4.8	10.2	7.5	20.1	8.1	8.4	12.4	9.6	9.2	3.6	3.8	10.3	13.2	10.1	10.0	3.1	3.0	23.7	13.7	11.1	4.5	11.5	3.6	10.6	11.5	12.4	10.5	9.9	12.6	6.6	9.5	15.1	4.0	10.3	10.3	7.8	3.5	35.9	11.5	11.6	9.9	10.9	8.5	9.8	13.4	7.4	13.6	20.9	13.3	18.7	9.9	20.2	14.3	8.2	9.3	5.4	13.6	22.7	8.4	14.5	7.9	10.0	6.7	5.3	9.9	11.6	4.1	2.4	12.5	8.2	13.3	20.4	6.6	12.8	7.6	5.6	8.0	20.6	18.3	23.0	11.9	25.7	13.0	9.6	14.4	2.3	0.0	15.6	5.8	4.3	22.2	16.1	10.1	15.4	11.2	20.0	16.9	10.5	6.7	0.7	11.4	19.9	16.2	12.1	18.2	11.3	16.1	13.2	21.6	0.0	13.7	31.0	13.2	7.8	2.6	3.5	2.1	2.2	2.0	3.4	1.9	1.7	3.6	3.2	2.0	2.4	0.4	1.8	2.0	3.6	1.9	1.0	3.4	3.9	9.0	4.6	3.6	3.8	3.1	3.0	3.6	4.0	3.5	9.8	32.4	9.6	18.9	176.6	31.1	11.1	18.3	12.9	42.7	79.8	20.5	20.7	37.9	22.8	14.6	3.7	83.4	23.0	25.5	12.2	7.9	12.0	18.3	14.3	33.0	36.5	32.3	27.5	107.2	14.0	21.5	37.5	26.0	14.2	17.7	37.8	34.2	31.1	36.6	69.0	151.3	25.7	16.2	35.6	18.1	49.5	33.2	22.9	16.0	91.8	27.0	24.9	28.8	200.1	293.3	10.5	10.4	21.1	41.4	21.1	26.8	14.2	12.8	84.5	6.6	47.4	30.8	49.4	33.8	26.8	13.9	13.3	21.4	27.7	22.2	16.3
ZNF281	ZBP-99	ENSG00000162702	"Zinc finger protein 281"	Q9Y2X9	1	200404940-200410056	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051228	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA051228: AB_2681396"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.71e-3)"	"unprognostic (8.30e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.26e-2)"	"unprognostic (4.86e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.83e-1)"	7.7	3.3	6.3	10.7	12.0	33.5	7.9	10.8	9.8	6.9	4.2	4.6	5.4	7.0	3.9	3.2	4.3	10.1	4.2	7.1	7.6	7.1	21.6	7.5	11.3	8.8	8.9	5.7	5.7	5.6	2.6	8.9	8.3	4.7	4.3	10.7	5.5	4.3	5.7	2.7	4.1	9.0	7.0	9.7	5.1	9.6	8.6	12.6	5.1	7.9	11.7	7.9	2.0	20.7	19.9	19.8	27.2	12.5	10.8	14.5	22.2	21.0	33.3	21.0	19.6	19.7	15.7	29.0	11.6	24.2	24.4	13.4	29.6	19.7	24.9	30.6	17.5	23.6	15.6	20.4	11.6	21.3	12.9	14.1	21.9	22.6	24.5	26.2	19.1	15.6	33.9	4.6	21.5	9.8	22.5	13.8	61.1	6.3	17.1	20.6	18.8	17.2	21.7	10.3	9.2	24.4	21.1	13.8	18.6	42.4	27.0	15.4	25.7	38.1	28.2	8.7	22.3	16.8	17.8	37.0	20.2	16.8	20.5	15.2	8.1	30.3	9.9	8.5	9.7	10.7	8.3	10.4	8.0	9.1	13.6	11.9	38.1	8.1	8.3	8.3	10.9	3.4	6.3	12.0	10.8	9.8	7.1	7.6	8.8	8.9	8.3	7.0	8.6	20.7	30.2	64.1	40.3	7.2	35.1	48.2	26.2	24.0	37.5	55.1	46.3	26.9	14.5	28.6	25.9	27.6	29.2	15.4	24.6	13.8	13.7	22.1	2.6	21.6	37.1	38.9	26.8	22.9	16.0	10.5	31.0	21.2	11.2	41.4	6.3	16.3	30.0	76.9	19.6	18.5	19.6	11.4	8.2	52.1	25.8	3.6	9.9	43.5	23.2	15.0	30.6	15.5	26.8	22.6	59.4	17.8	13.3	7.9	31.7	25.4	10.9	20.3	20.5	37.0	13.1	21.1	32.9	50.1	42.4	18.9	22.7	12.3	29.5	14.2	12.9	20.4
ZNF282	HUB1	ENSG00000170265	"Zinc finger protein 282"	Q9UDV7	7	149195546-149226238	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.6;Late spermatids: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024374	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA024374: AB_1851322"	"unprognostic (1.79e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.11e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	10.4	10.1	8.8	6.6	8.2	11.0	11.0	10.3	9.0	15.1	5.7	13.6	9.9	14.3	2.5	15.6	12.4	6.0	12.3	7.9	7.2	10.4	13.1	8.8	6.8	8.3	8.0	14.0	17.0	6.8	9.9	8.0	7.4	18.3	4.0	3.7	12.7	7.0	16.9	17.0	10.8	5.7	6.9	12.6	12.5	5.3	8.0	7.2	11.4	9.1	4.7	14.0	12.1	8.8	20.6	20.3	11.5	27.7	10.0	11.6	17.0	18.4	13.4	15.8	15.7	18.8	21.9	20.7	27.1	11.6	14.0	22.2	13.6	17.6	6.0	31.3	49.1	17.2	13.1	16.0	15.0	22.0	18.8	13.6	23.4	15.2	16.5	11.9	16.7	13.6	33.8	15.6	8.6	24.6	46.4	33.0	37.3	12.0	25.3	29.9	11.2	28.8	8.7	19.6	26.1	25.1	20.3	24.2	16.9	6.1	15.6	21.3	20.9	22.5	5.1	27.2	27.0	22.4	14.4	15.5	18.8	19.0	19.7	0.0	0.5	1.1	0.5	0.5	0.6	0.2	0.7	0.6	0.3	1.7	0.3	0.4	0.5	0.6	0.6	0.7	1.0	0.3	8.8	8.2	10.3	9.0	7.9	7.2	8.3	8.0	7.4	6.9	8.0	8.8	8.2	3.2	4.5	5.2	3.9	7.1	2.7	4.7	5.2	11.4	9.0	8.3	4.8	7.2	3.6	1.8	4.2	11.7	3.8	10.2	0.0	4.9	31.6	7.0	6.2	6.8	13.1	3.0	6.1	4.4	5.4	5.4	4.6	9.3	5.7	13.3	7.5	8.7	6.0	15.2	6.7	11.5	2.0	6.8	2.7	32.6	6.2	4.5	1.8	9.4	4.2	6.9	3.1	6.0	9.3	6.3	11.9	5.7	4.4	4.9	9.9	3.2	2.9	7.7	13.1	7.5	6.3	11.8	1.3	6.0	6.5	5.1	5.3	9.6	10.1	4.4
ZNF283		ENSG00000167637	"Zinc finger protein 283"	Q8N7M2	19	43827321-43852017	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Oligodendrocytes: 20.4;Rod photoreceptor cells: 42.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 22.4"					"Low region specificity"	"Detected in all"			HPA072977			Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA072977: AB_2686563"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.49e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.63e-2)"	2.4	2.8	2.3	2.1	3.5	0.8	4.8	7.0	2.9	3.0	1.5	2.6	2.9	3.3	4.2	2.9	3.4	2.9	4.0	3.3	2.9	2.4	1.9	2.0	2.8	3.2	3.6	4.9	2.0	4.3	3.9	3.2	3.3	3.6	3.6	8.4	3.2	2.8	2.2	4.4	3.2	2.9	1.9	3.2	3.4	1.7	3.2	2.7	3.8	4.6	3.0	2.4	2.9	6.2	6.4	3.7	4.5	9.0	4.4	6.8	3.8	3.8	5.4	4.5	6.4	3.8	3.2	0.0	3.1	5.6	5.2	5.6	6.5	4.8	6.7	1.4	7.5	6.6	9.6	2.6	3.5	3.3	3.7	5.7	6.6	5.5	4.6	5.7	4.5	1.9	6.8	1.5	5.8	2.5	2.1	2.5	4.4	3.3	2.9	0.0	3.5	1.9	3.7	9.0	5.4	7.1	7.2	4.9	3.7	4.5	2.7	5.6	3.8	6.1	22.4	3.5	4.9	5.0	4.9	0.3	3.0	0.3	4.9	2.2	0.9	0.9	1.4	1.1	1.9	1.1	1.7	0.9	0.8	0.8	1.8	1.0	0.9	1.2	0.9	0.6	1.8	0.6	2.3	3.5	7.0	2.9	3.3	2.9	3.2	3.6	3.3	1.9	3.2	6.2	4.0	9.6	14.1	9.1	2.5	2.4	2.5	1.2	4.0	9.3	3.3	2.2	5.0	1.5	6.3	0.0	22.9	2.9	2.0	2.3	7.9	2.8	1.4	2.5	5.1	4.0	6.0	2.1	14.1	1.8	2.3	5.6	3.1	2.8	3.8	5.6	6.4	1.0	2.4	6.7	14.3	4.1	4.1	1.9	1.4	0.7	2.5	3.0	1.8	5.6	4.6	3.4	2.1	14.6	20.4	2.5	4.8	3.4	2.4	2.5	2.9	1.5	2.5	42.7	0.0	5.7	4.8	2.9	3.6	3.8	1.6	2.9	2.5	5.9	4.0	2.6
ZNF292	"bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16"	ENSG00000188994	"Zinc finger protein 292"	O60281	6	87152833-87265943	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032154, HPA050618"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA032154: AB_10601930, HPA050618: AB_2681190"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.36e-2)"	6.8	6.3	4.4	7.8	4.6	25.4	9.6	17.8	8.7	8.7	1.8	7.3	7.9	10.3	9.5	6.6	6.2	6.7	6.2	3.9	3.1	6.3	6.4	5.7	10.9	3.2	2.5	13.7	6.9	13.8	8.5	8.8	3.8	8.2	6.8	26.4	8.3	7.2	5.5	8.6	8.8	6.4	2.2	8.0	8.1	6.2	3.7	14.3	9.6	5.6	9.1	7.1	7.3	10.3	8.3	4.7	16.1	14.2	9.0	8.1	16.8	6.4	8.1	7.4	10.1	8.2	5.7	12.8	9.0	8.4	10.4	8.4	10.1	9.6	15.9	29.3	7.6	17.3	6.4	6.8	6.7	14.0	7.6	8.1	9.2	7.3	9.4	11.8	6.9	13.6	12.8	19.1	8.1	4.6	8.1	12.0	8.1	2.9	4.4	16.9	15.9	4.9	6.2	17.8	11.9	16.8	8.0	5.3	6.1	9.2	5.4	16.0	7.8	9.8	6.8	7.2	10.1	17.5	12.3	8.6	10.8	11.8	7.2	60.3	16.9	20.0	15.7	5.4	14.8	46.6	16.8	17.3	8.0	42.8	18.7	16.1	83.6	11.2	5.7	25.0	18.3	8.3	4.4	4.6	17.8	8.7	3.9	3.1	3.2	2.5	3.8	2.2	3.7	10.3	64.2	60.9	72.4	147.2	99.0	66.2	31.2	46.1	70.0	167.7	48.0	47.9	76.8	48.6	51.8	25.8	123.0	27.0	89.9	64.9	9.8	122.3	44.4	119.3	89.6	55.6	47.3	43.5	176.6	38.5	36.6	52.3	66.3	203.1	29.1	135.6	40.0	19.0	26.8	186.7	225.7	52.7	40.7	29.2	53.1	12.4	60.0	46.3	32.0	124.6	53.0	62.5	65.9	210.6	209.8	52.2	49.5	66.2	90.8	49.4	72.5	14.5	50.1	99.4	32.9	84.6	59.5	56.3	34.1	36.7	51.4	211.8	90.8	66.8	44.5	58.5
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076587	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.3;Basal squamous epithelial cells: 94.4;Plasma cells: 48.2;Squamous epithelial cells: 107.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;SK-BR-3: 15.6;U-698: 28.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Centrosome	"HPA046940: AB_2679871, HPA049576: AB_2680821"	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"	0.6	1.1	1.4	2.2	1.2	5.3	1.7	3.3	1.9	1.3	0.4	2.5	3.0	0.5	0.1	9.2	1.4	0.2	0.4	1.4	1.0	1.5	0.7	1.3	2.8	1.2	1.1	0.7	0.7	0.1	3.3	0.1	1.2	2.4	0.3	0.5	5.1	0.4	0.5	6.0	4.2	0.1	1.1	5.9	2.7	2.3	1.0	0.4	1.2	0.1	1.4	1.5	3.2	0.9	4.6	2.9	0.1	0.6	0.0	0.2	2.5	0.6	0.0	0.3	0.2	4.7	1.6	24.0	2.7	0.1	0.0	8.3	1.2	1.8	0.0	5.2	6.3	7.2	1.4	4.8	1.2	3.9	7.2	0.9	0.9	0.9	0.0	0.1	0.7	0.4	5.2	8.0	0.0	6.5	0.3	6.8	2.7	2.8	6.3	13.5	0.0	14.8	0.5	1.6	4.4	0.4	3.0	15.6	0.1	0.4	3.4	8.1	1.5	0.0	2.4	0.1	0.0	8.6	9.3	28.7	0.2	5.0	0.1	59.7	10.7	17.2	8.3	18.3	9.7	82.6	4.3	9.3	26.0	62.8	1.8	4.7	5.1	45.9	18.5	78.5	4.4	8.7	1.4	1.2	3.3	1.9	1.4	1.0	1.2	1.1	1.2	1.1	1.0	0.9	2.4	0.0	0.6	2.3	53.3	12.1	13.9	1.5	94.4	1.4	20.5	13.3	1.2	0.0	2.6	3.7	4.2	0.4	31.9	18.5	0.0	1.8	0.5	6.1	1.0	2.0	5.3	3.0	0.4	0.9	3.6	1.3	21.9	4.5	8.9	0.5	1.4	0.2	3.5	0.0	0.3	32.1	6.1	2.9	19.1	0.5	0.0	7.6	3.6	0.0	24.9	0.4	12.3	0.0	0.5	1.2	36.1	1.2	48.2	6.4	23.4	0.2	3.9	1.6	0.0	0.8	3.2	1.1	14.2	107.3	10.1	0.8	18.5	0.2	28.9	6.2
ZNF3	"A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113"	ENSG00000166526	"Zinc finger protein 3"	P17036	7	100064033-100082548	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003719	Supported	Supported	Approved	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003719: AB_1080701"	"unprognostic (5.92e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.73e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.65e-1)"	"unprognostic (2.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (2.20e-4)"	13.3	11.1	18.5	9.9	21.1	27.1	19.8	20.4	20.6	17.7	20.0	16.9	20.3	21.3	22.2	13.5	36.5	11.9	11.8	18.7	19.0	15.1	18.6	12.3	12.9	21.3	21.0	21.7	16.0	19.2	13.0	11.7	21.4	14.9	18.4	14.9	14.3	15.7	18.3	13.9	21.0	14.2	20.3	13.9	16.6	8.8	19.9	18.6	18.5	19.5	15.5	14.3	13.8	26.1	13.2	14.1	39.1	54.9	18.8	14.5	23.1	16.8	18.5	23.8	20.4	18.4	19.0	19.2	28.8	15.7	19.6	17.2	29.3	18.2	19.8	20.1	23.7	15.5	20.8	26.6	22.4	28.7	13.6	18.5	21.5	16.8	37.3	26.4	21.4	27.6	44.9	29.3	22.0	36.1	67.3	28.9	54.9	24.2	25.7	27.7	31.4	49.0	22.8	25.9	40.9	60.5	20.1	57.2	26.1	37.1	16.5	27.1	17.5	29.5	21.8	22.0	22.0	39.9	47.3	38.1	14.8	24.6	29.3	13.1	10.2	19.5	14.2	9.8	16.6	13.4	11.8	14.7	10.5	15.5	13.6	14.9	3.9	18.6	14.5	11.8	12.7	10.1	18.5	21.1	20.4	20.6	18.7	19.0	21.3	21.0	21.4	20.3	19.9	26.1	13.5	12.8	31.9	8.1	16.9	7.6	10.0	8.1	12.0	18.7	15.1	12.2	10.5	14.3	13.2	3.7	16.7	12.5	12.6	17.0	7.9	19.3	2.7	42.3	16.1	17.4	26.3	26.1	5.8	11.1	7.6	16.4	15.8	13.0	15.2	28.5	14.6	14.5	6.6	18.5	6.2	20.0	10.2	12.6	5.9	1.8	15.2	7.8	3.6	2.8	11.5	16.5	30.9	9.0	20.4	16.1	18.1	15.1	11.6	12.7	32.5	13.5	32.1	19.5	6.6	9.3	12.1	16.2	17.0	9.9	8.9	10.4	11.1	14.0	20.1	8.2
ZNF30	"DKFZp686N19164, FLJ20562, KOX28"	ENSG00000168661	"Zinc finger protein 30"	P17039	19	34926903-34945170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 15.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 15.4;Horizontal cells: 13.5;Inhibitory neurons: 13.2;Oligodendrocytes: 15.6;Rod photoreceptor cells: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA030400	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA030400: AB_10603245"	"unprognostic (3.04e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.10e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-2)"	2.1	2.9	5.1	1.4	5.4	0.5	2.6	8.0	6.0	2.5	2.7	2.5	2.0	2.1	1.5	1.8	3.0	1.2	2.6	4.5	4.2	2.9	3.6	2.7	2.6	4.4	4.2	2.4	3.7	3.0	3.3	1.5	4.8	3.3	2.0	15.6	2.3	2.2	2.7	2.6	2.4	2.3	4.2	3.7	2.3	2.5	4.5	1.8	2.1	2.8	2.4	2.2	2.2	5.7	3.4	7.3	3.1	7.8	5.3	3.3	0.1	3.2	2.2	2.9	3.2	5.3	1.1	0.0	4.2	2.2	1.1	2.0	9.0	4.6	3.6	0.0	4.3	2.4	4.2	4.1	2.5	3.3	2.2	2.9	4.0	2.7	3.9	1.1	4.6	6.5	8.0	0.0	4.6	2.5	2.4	1.4	4.3	8.2	3.8	3.1	2.4	0.7	2.2	2.9	4.0	5.8	0.0	0.1	2.9	3.2	3.0	0.8	3.4	6.1	3.2	2.2	4.4	2.1	11.1	0.9	1.2	0.0	3.6	1.8	0.1	0.1	3.1	0.3	3.1	2.2	2.5	1.4	0.9	1.3	4.7	4.9	0.0	4.7	0.0	0.8	2.7	1.3	5.1	5.4	8.0	6.0	4.5	4.2	4.4	4.2	4.8	4.2	4.5	5.7	3.6	0.0	1.1	8.8	1.3	0.4	0.4	0.5	1.8	6.4	1.2	0.9	3.6	0.0	0.4	1.8	6.2	0.1	2.6	0.1	3.9	1.1	0.6	1.0	2.5	3.6	1.2	6.1	15.4	1.3	0.5	1.4	2.0	0.9	5.7	2.4	5.0	1.0	0.8	13.5	13.2	1.2	0.0	1.9	0.3	0.8	2.1	0.5	1.8	3.7	0.3	4.4	6.2	9.0	15.6	1.0	0.7	2.2	1.0	0.5	0.5	1.4	2.5	11.5	0.0	1.4	1.5	2.7	2.6	1.2	0.1	0.0	2.3	2.1	1.5	0.4
ZNF300		ENSG00000145908	"Zinc finger protein 300"	Q96RE9	5	150894392-150904983	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 13.3;Granulosa cells: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 36.1"					"Low region specificity"	"Detected in all"			"HPA028975, HPA051777"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nucleoli, Nucleoli rim, Nuclear bodies"	"HPA028975: AB_2672851, HPA051777: AB_2681606"	"unprognostic (5.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.85e-3)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (3.62e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.50e-2)"	3.6	1.0	2.3	2.6	3.2	2.7	4.5	3.8	2.8	6.5	2.3	3.6	2.7	7.4	2.3	5.1	4.4	3.3	3.2	2.3	2.9	7.4	1.2	2.4	3.0	3.0	3.1	10.2	5.5	0.8	2.4	1.5	3.1	5.4	2.7	9.1	2.8	2.3	0.9	4.4	3.8	4.0	2.6	3.9	4.7	6.4	2.9	2.8	6.9	1.5	2.9	4.5	4.9	3.5	2.1	4.7	28.2	0.0	2.4	5.8	0.0	7.1	5.6	6.1	8.7	2.4	3.5	0.0	6.1	5.9	18.3	4.2	0.0	16.2	9.5	0.0	9.3	0.0	36.1	3.9	5.0	0.2	0.1	8.9	5.0	12.7	14.7	8.6	10.4	0.1	0.0	15.1	6.1	0.0	0.0	1.5	27.2	0.0	0.0	0.0	4.1	8.5	4.4	5.3	15.9	26.2	16.7	14.3	9.8	17.1	9.4	0.0	4.6	8.1	3.4	5.9	12.9	0.5	0.2	0.0	0.8	0.1	17.1	0.0	0.1	0.3	0.1	0.4	0.0	0.2	0.2	0.0	0.3	1.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.2	2.3	3.2	3.8	2.8	2.3	2.9	3.0	3.1	3.1	2.6	2.9	3.5	2.0	0.0	0.5	0.3	1.8	1.5	3.1	2.3	7.4	4.0	2.3	1.7	0.6	1.5	2.7	7.3	0.0	0.7	1.9	0.3	1.9	2.5	3.2	1.8	5.3	2.3	3.0	4.0	0.8	1.6	2.2	3.8	13.3	1.9	0.0	11.5	1.8	0.2	0.5	0.0	1.9	1.4	2.0	1.0	1.2	0.9	2.5	0.8	0.0	5.6	1.5	3.3	3.1	5.5	6.7	1.8	0.1	1.2	0.3	2.0	0.6	1.8	0.8	4.3	6.6	4.1	2.8	7.2	3.7	5.9	2.3	0.8	1.2	2.7	1.8	3.0
ZNF317		ENSG00000130803	"Zinc finger protein 317"	Q96PQ6	19	9140397-9163424	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042075, HPA048625"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA042075: AB_10796471, HPA048625: AB_2680464"	"unprognostic (3.81e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.70e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.42e-3)"	15.8	17.5	21.3	10.2	22.0	26.2	14.7	22.4	34.1	15.1	22.3	17.4	11.2	16.4	11.5	17.4	15.5	8.3	16.1	21.4	21.8	22.2	21.1	14.2	14.2	21.4	21.6	16.4	19.6	12.4	15.8	9.1	21.3	17.8	10.4	12.9	13.6	9.6	14.6	22.8	17.9	10.3	21.3	24.7	18.3	6.7	21.9	15.0	14.5	12.7	15.3	17.7	15.1	22.7	17.4	14.6	15.7	21.0	15.7	14.9	13.6	14.3	22.3	19.2	23.2	16.6	9.2	29.5	17.9	15.3	22.8	17.2	25.7	24.7	24.8	24.4	34.5	26.6	13.3	18.4	20.9	27.8	26.0	17.9	32.2	21.9	38.1	16.6	17.0	25.8	24.8	33.6	19.6	14.6	34.8	88.3	29.0	18.4	30.9	24.4	19.8	23.6	17.0	29.4	27.0	18.6	19.9	17.4	22.7	13.7	13.1	28.7	15.1	13.6	12.3	31.2	19.3	42.0	42.8	33.3	13.1	24.2	17.8	19.4	14.8	16.1	13.0	15.5	20.5	20.8	17.3	15.2	15.0	16.4	16.4	17.9	9.0	22.8	13.4	13.6	22.5	14.2	21.3	22.0	22.4	34.1	21.4	21.8	21.4	21.6	21.3	21.3	21.9	22.7	5.7	9.6	13.4	6.8	11.8	7.4	7.1	4.4	6.2	8.3	8.9	6.7	7.3	7.2	9.4	5.5	6.2	5.6	12.6	9.5	3.9	5.3	0.7	8.9	9.0	7.6	7.2	9.1	6.1	6.4	5.2	7.9	12.2	13.1	13.9	8.1	6.4	10.1	8.0	8.4	7.4	8.6	6.1	15.9	6.2	1.4	3.7	10.1	5.4	7.5	8.1	4.6	8.2	10.6	9.3	8.5	4.7	3.8	10.5	9.5	5.8	9.8	9.4	5.3	0.0	5.7	5.4	2.4	1.0	7.0	6.5	10.9	10.3	7.7	9.6	11.7
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369647	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 82.9;Spermatogonia: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"B-cells: 2.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"	8.1	6.4	6.4	12.4	5.5	11.4	7.9	11.7	8.8	14.2	1.9	9.3	7.2	11.5	10.6	6.4	9.7	7.0	7.0	6.3	5.3	6.4	8.1	7.5	25.6	3.7	4.6	11.9	8.2	10.8	7.3	8.0	3.6	9.7	8.0	21.2	7.5	8.1	8.5	12.0	9.7	9.0	3.1	14.4	6.3	26.2	4.8	13.3	12.5	6.3	25.0	8.9	10.0	6.9	26.4	6.2	18.0	29.9	15.4	13.7	9.3	11.6	14.3	12.8	11.1	6.6	3.2	41.5	6.4	14.4	15.0	11.4	20.0	9.5	16.6	11.8	10.7	11.4	8.1	10.7	7.7	20.2	9.2	8.8	9.8	10.8	9.6	10.8	10.2	11.3	15.6	19.3	13.8	9.0	6.4	12.8	8.1	42.9	5.9	7.6	17.9	6.4	7.1	5.9	16.6	10.2	8.6	7.2	9.0	13.8	9.1	27.6	10.6	17.9	9.2	12.2	11.4	12.4	10.9	28.2	5.6	15.1	10.2	0.0	0.3	0.0	0.5	0.2	0.1	0.6	0.4	0.3	0.3	2.1	0.3	0.3	0.1	0.3	0.1	0.3	0.5	0.2	6.4	5.5	11.7	8.8	6.3	5.3	3.7	4.6	3.6	3.1	4.8	6.9	7.8	9.6	14.5	10.7	29.9	9.7	4.4	5.6	12.0	18.1	6.5	6.9	9.5	8.6	6.4	9.2	8.4	5.8	6.8	5.2	3.9	5.2	30.7	9.2	13.3	7.8	5.4	8.2	19.9	4.7	4.4	10.4	5.1	6.3	6.3	20.6	11.7	19.4	6.6	25.2	18.9	5.1	6.1	11.1	7.2	16.5	6.2	10.7	3.6	4.7	9.7	9.4	16.5	15.6	17.5	4.2	8.2	9.8	5.1	3.0	11.4	3.9	6.8	11.8	26.3	13.6	8.7	82.9	46.3	9.0	5.1	1.8	8.8	8.9	8.3	2.0
ZNF319	"KIAA1388, Zfp319"	ENSG00000166188	"Zinc finger protein 319"	Q9P2F9	16	57994676-58000672	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052584	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA052584: AB_2681873"	"unprognostic (1.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.87e-5)"	"unprognostic (8.69e-2)"	"unprognostic (3.72e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.80e-2)"	3.8	4.5	4.0	3.6	4.2	11.8	3.6	5.2	4.7	5.1	2.1	5.1	3.1	6.5	2.3	3.0	4.8	1.9	5.2	3.9	4.5	3.6	3.4	3.7	4.1	5.0	4.5	5.8	5.2	6.1	3.8	2.6	4.9	4.0	1.7	2.2	3.8	3.8	5.1	4.2	4.0	3.5	3.7	6.6	3.7	3.8	5.0	3.9	6.4	5.1	2.9	5.8	3.2	4.3	4.5	10.8	6.1	8.7	5.5	6.9	4.8	6.2	6.7	6.6	3.1	5.5	2.9	6.8	10.7	5.2	4.9	4.4	5.4	6.6	4.2	2.9	4.2	3.3	6.4	5.7	10.8	3.9	10.2	8.9	8.1	4.8	11.6	6.2	3.9	5.7	6.2	1.2	5.7	4.3	8.1	5.8	3.7	2.2	10.5	11.5	3.4	7.6	4.1	11.4	4.1	4.4	9.1	4.3	4.3	4.6	1.5	5.8	6.4	5.1	3.1	2.7	4.6	5.6	3.2	6.0	4.0	3.8	5.8	0.0	1.0	3.4	2.1	0.7	1.2	0.5	1.0	1.4	1.1	0.5	0.7	1.1	1.9	0.7	0.6	0.4	0.9	1.4	4.0	4.2	5.2	4.7	3.9	4.5	5.0	4.5	4.9	3.7	5.0	4.3	2.7	3.2	3.4	1.6	1.2	0.9	0.5	2.4	1.2	2.0	1.9	2.4	5.3	5.7	1.6	0.0	0.0	1.6	4.1	1.6	3.9	2.4	0.3	3.2	2.9	2.2	4.9	0.4	0.9	3.0	1.0	2.1	0.0	2.7	1.3	3.3	3.9	2.2	2.3	0.0	1.2	1.5	0.0	7.6	1.0	0.1	3.1	1.8	0.0	1.9	4.3	3.2	10.3	4.0	1.7	2.7	0.5	3.4	1.0	0.8	2.0	1.3	3.7	3.1	0.0	2.4	1.4	2.8	1.1	0.8	1.3	0.3	2.8	3.2	1.2	0.2
ZNF32	"KOX30, Zfp637, ZNF637"	ENSG00000169740	"Zinc finger protein 32"	P17041	10	43643860-43648881	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039148			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies"	Nucleoplasm	"HPA039148: AB_2676365"	"unprognostic (1.05e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.15e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.90e-3)"	"prognostic favorable (3.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (6.66e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	33.2	33.2	69.4	13.2	71.9	8.3	45.9	71.0	101.5	46.0	69.0	56.7	12.7	42.9	57.5	23.1	40.0	23.4	60.0	69.0	70.8	49.9	32.4	26.5	22.1	71.3	71.0	52.8	48.1	47.7	45.1	16.6	70.4	48.5	23.4	40.8	31.0	38.1	84.3	31.5	29.6	36.8	70.1	36.0	37.8	16.2	70.9	32.8	41.9	72.9	25.9	41.2	32.9	73.3	25.0	21.8	32.3	48.9	58.1	62.1	10.6	21.9	65.5	39.9	35.8	14.8	12.5	0.1	37.7	46.7	18.8	14.5	20.7	21.2	29.2	27.5	23.0	6.6	13.2	17.2	54.4	0.7	19.7	64.1	48.0	24.7	29.7	38.2	30.6	86.8	19.5	0.0	50.9	22.8	25.2	22.8	25.2	25.2	11.3	38.5	36.3	5.7	40.8	9.7	41.2	36.7	18.1	13.3	35.4	35.3	49.0	23.0	13.1	22.3	26.8	16.4	5.4	14.3	40.2	0.1	8.0	15.9	21.1	14.0	13.9	18.2	36.5	12.9	36.8	26.0	29.2	41.1	22.9	27.2	37.0	41.6	1.1	50.4	11.6	19.3	22.8	20.7	69.4	71.9	71.0	101.5	69.0	70.8	71.3	71.0	70.4	70.1	70.9	73.3	26.1	9.6	14.3	14.0	18.8	11.0	24.4	28.6	33.0	23.2	41.4	57.8	11.7	22.8	16.9	18.4	8.4	18.0	31.9	7.5	105.7	44.7	2.3	16.2	25.6	23.8	27.7	16.8	9.7	47.4	17.1	27.3	16.3	11.5	30.4	34.1	25.7	25.5	29.4	16.8	11.1	16.0	22.4	22.3	10.1	2.1	42.3	19.0	17.8	9.4	15.8	52.7	58.7	16.6	23.0	28.4	10.3	54.5	9.5	36.2	10.0	53.1	12.6	24.1	32.9	38.3	34.2	17.0	14.3	26.4	15.3	6.7	27.1	33.0	17.9	17.9
ZNF320	"DKFZp686G16228, ZFPL"	ENSG00000182986	"Zinc finger protein 320"	A2RRD8	19	52860851-52897693	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 105.9;U-266/84: 56.1"									"HPA043696, HPA062474"	Uncertain		Uncertain	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cytoplasmic bodies"	"HPA043696: AB_10793951, HPA062474: AB_2732685"	"unprognostic (3.33e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.47e-4)"	"unprognostic (8.90e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.75e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.61e-3)"	4.9	6.3	4.5	6.6	5.8	5.0	10.4	8.9	5.5	8.9	5.1	9.0	6.9	10.0	9.8	5.1	10.5	7.3	7.2	4.9	4.9	10.7	1.5	5.9	6.7	4.5	3.9	13.4	6.8	12.3	6.5	11.1	4.7	10.3	9.7	13.0	6.3	8.0	7.0	9.1	5.3	7.8	2.5	7.5	7.8	5.3	4.7	6.3	10.8	3.6	6.4	9.5	7.1	7.3	11.2	0.5	16.8	28.1	3.8	6.2	19.8	8.0	7.3	10.5	12.7	6.7	3.8	12.5	10.3	6.9	9.3	3.1	0.1	5.7	7.4	0.1	3.6	12.6	16.6	0.1	7.8	0.8	14.2	10.7	4.8	12.2	2.6	4.8	7.8	5.5	12.9	0.8	7.7	0.0	16.1	9.8	20.4	0.2	9.5	12.0	15.3	14.1	10.2	105.9	13.3	26.4	0.3	7.0	2.9	23.3	10.0	1.3	9.0	4.4	11.0	2.7	12.2	14.1	56.1	9.3	0.3	0.2	9.8	3.2	2.1	1.8	3.2	2.6	2.9	2.2	1.8	2.4	2.5	3.2	3.4	3.5	3.5	7.9	2.4	3.7	2.0	2.5	4.5	5.8	8.9	5.5	4.9	4.9	4.5	3.9	4.7	2.5	4.7	7.3	0.6	3.2	1.7	13.7	2.8	1.9	5.8	3.4	1.2	8.3	0.2	0.1	13.2	14.3	5.9	1.8	10.4	10.5	2.9	9.0	0.0	0.3	6.7	1.9	1.0	4.5	10.7	4.2	10.2	0.0	6.3	5.0	6.1	2.8	1.3	0.6	6.8	0.8	4.3	16.8	10.1	9.0	4.1	3.2	3.9	2.7	4.4	1.6	3.6	3.7	2.4	5.6	9.2	17.6	12.4	0.1	6.3	2.6	0.5	9.4	4.1	0.2	4.4	12.4	0.0	9.2	3.2	5.6	5.8	5.3	4.3	7.7	1.8	0.4	7.3	7.5
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: AB_2678346, HPA046692: AB_2679755"	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	7.8	12.0	11.0	7.8	11.9	1.3	12.8	12.1	12.4	15.4	10.9	8.8	9.3	15.5	13.3	8.6	11.4	9.8	7.7	10.2	12.0	11.8	9.3	9.9	9.9	11.8	11.5	17.9	8.2	17.7	7.1	11.2	12.4	14.9	10.9	14.3	8.7	13.9	6.6	6.0	8.1	10.5	12.0	11.7	9.1	11.1	11.6	10.1	15.3	12.8	9.7	10.8	7.4	15.0	9.3	6.8	26.2	31.0	17.3	22.5	9.7	12.3	16.1	16.6	20.1	13.3	5.5	11.0	28.5	10.6	20.8	11.5	19.7	7.4	20.8	17.3	18.0	19.5	8.7	13.2	19.5	0.0	17.3	14.1	27.0	10.7	12.3	20.8	14.4	13.5	23.3	11.7	18.3	5.2	14.1	16.9	7.8	8.5	8.4	15.4	18.6	16.0	10.1	14.5	21.3	22.7	14.5	13.6	25.9	12.8	12.5	12.8	14.4	27.8	11.0	11.4	12.4	12.2	25.8	10.8	5.8	2.9	28.4	3.3	8.4	10.8	10.5	7.2	7.6	11.2	5.3	6.9	6.9	9.0	6.1	9.1	8.0	17.8	11.9	7.8	4.5	5.1	11.0	11.9	12.1	12.4	10.2	12.0	11.8	11.5	12.4	12.0	11.6	15.0	24.8	6.4	10.5	3.9	18.0	4.0	17.3	4.8	14.8	32.1	23.9	31.2	5.8	12.8	11.1	9.2	8.4	12.5	16.1	9.9	35.2	17.7	4.1	14.2	32.6	20.1	19.7	7.2	5.3	10.2	11.3	21.9	10.2	15.7	13.3	30.0	18.2	7.6	13.3	47.1	7.0	14.1	8.2	8.9	5.3	3.7	30.1	11.7	8.8	6.5	12.7	26.7	10.3	11.1	10.3	16.1	12.8	26.4	11.8	26.4	10.2	13.3	8.1	13.9	32.9	20.6	22.2	26.0	15.7	12.0	6.5	9.6	9.1	37.7	10.0	24.9
ZNF324	"ZF5128, ZNF324A"	ENSG00000083812	"Zinc finger protein 324"	O75467	19	58467045-58475436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 37.0;Horizontal cells: 33.7;Rod photoreceptor cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 54.2"									HPA039774	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA039774: AB_10673149"	"unprognostic (8.60e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.74e-5)"	"unprognostic (6.39e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (3.56e-1)"	3.4	3.9	4.8	3.4	4.9	6.7	3.7	6.3	6.0	4.6	2.8	4.1	4.3	5.0	3.2	5.9	5.2	2.9	3.4	5.1	4.2	3.1	5.7	3.2	3.1	4.7	3.9	5.8	7.0	4.4	6.6	2.9	3.8	4.6	2.2	3.0	4.7	4.2	3.0	6.6	3.9	3.3	2.9	3.9	4.4	4.4	3.4	6.8	4.8	2.6	2.9	4.4	3.8	4.8	7.8	8.9	5.0	10.1	5.3	5.0	7.2	6.3	6.4	5.6	5.0	8.5	4.2	11.2	5.9	4.3	7.6	9.3	6.4	6.6	2.1	10.5	54.2	6.9	6.7	3.6	4.5	12.3	9.2	3.9	8.5	7.1	3.3	5.1	3.7	7.9	11.4	7.1	6.0	6.0	12.5	6.6	5.4	6.4	12.9	13.9	6.5	7.3	3.8	15.5	11.8	9.5	6.5	10.8	3.8	3.6	4.9	10.1	6.4	17.6	3.9	6.4	11.2	10.4	12.0	5.8	9.5	6.7	6.5	2.3	5.3	8.9	10.5	5.9	11.5	5.8	8.0	11.6	3.8	6.2	12.1	9.7	15.6	7.3	4.5	7.0	8.8	4.2	4.8	4.9	6.3	6.0	5.1	4.2	4.7	3.9	3.8	2.9	3.4	4.8	4.8	0.0	1.7	5.2	8.4	9.1	5.5	3.1	2.2	37.0	10.3	7.5	7.5	2.8	3.8	0.0	25.0	4.8	6.9	9.9	0.0	4.9	1.2	6.3	6.3	5.5	7.8	6.5	5.6	4.1	3.8	6.0	6.6	3.6	1.3	11.3	7.5	3.6	2.9	33.7	6.3	7.9	6.1	2.4	3.7	1.6	12.8	3.2	3.6	7.5	4.1	15.8	7.2	4.5	6.7	4.2	12.4	14.7	5.6	8.0	9.0	2.3	5.8	57.2	6.6	11.7	8.5	19.4	15.8	4.8	13.4	6.7	7.6	11.2	6.3	3.8
ZNF326	"FLJ20403, ZAN75, Zfp326, ZIRD"	ENSG00000162664	"Zinc finger protein 326"	Q5BKZ1	1	89995110-90035533	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 52.6"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 373.2;Rod photoreceptor cells: 458.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028450, HPA028461, HPA028466"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 79: Retina - Phototransduction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677"	"prognostic favorable (9.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.84e-4)"	11.0	9.5	5.9	5.5	7.2	21.0	11.1	8.9	6.7	13.5	6.8	12.8	8.8	12.5	7.4	15.3	11.0	5.3	10.4	7.1	5.2	12.2	12.8	8.5	6.9	7.3	6.5	17.2	17.0	4.5	10.3	6.2	7.3	9.3	8.5	52.6	13.4	3.9	9.8	10.2	12.6	5.0	6.7	8.0	10.3	6.9	5.8	5.3	10.9	2.4	6.0	9.6	12.4	10.2	9.2	6.9	17.9	7.1	6.1	4.3	16.4	11.1	4.5	6.6	5.0	7.2	8.1	13.3	5.7	5.6	6.3	9.5	10.8	7.2	8.8	5.9	7.2	10.6	14.3	7.0	2.4	12.6	6.1	4.3	4.3	6.8	5.7	8.5	4.6	7.8	11.7	5.8	7.1	4.0	13.3	9.6	11.2	6.1	8.0	11.1	11.1	3.0	6.2	15.5	11.3	10.9	10.1	10.6	5.0	10.2	7.8	4.2	8.0	9.3	7.7	8.3	8.4	7.2	3.8	8.8	2.7	10.1	5.3	1.0	1.1	1.2	0.9	1.4	0.8	0.9	0.8	0.9	0.7	1.5	0.8	1.0	0.8	2.0	1.5	1.7	0.6	0.4	5.9	7.2	8.9	6.7	7.1	5.2	7.3	6.5	7.3	6.7	5.8	10.2	43.0	22.4	50.9	48.0	40.5	65.1	61.5	43.3	37.0	140.8	35.3	39.0	39.2	28.6	43.4	23.9	373.2	46.4	46.7	81.6	19.6	54.2	5.1	45.0	50.3	43.5	70.3	66.9	29.1	54.8	85.3	35.6	35.2	48.9	51.8	68.4	29.6	35.1	26.1	69.0	35.1	47.8	38.7	19.4	38.2	7.3	43.2	34.0	39.2	28.1	40.9	57.0	28.8	58.8	61.3	47.7	70.6	33.8	33.0	53.8	61.0	19.6	44.6	458.4	26.3	45.0	53.6	58.5	35.8	53.2	45.3	49.4	31.6	71.0	50.0	82.0
ZNF329	FLJ12586	ENSG00000181894	"Zinc finger protein 329"	Q86UD4	19	58126248-58155110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044373, HPA077958"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA044373: AB_10966569, HPA077958: "	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.53e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-3)"	"prognostic favorable (8.58e-9)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.52e-1)"	3.9	3.9	4.4	2.7	5.0	6.4	6.0	6.4	6.0	5.1	5.4	4.5	1.6	5.2	5.2	2.9	5.2	2.8	4.5	4.8	4.5	6.0	4.9	3.5	3.9	4.3	4.4	5.5	3.1	9.0	5.3	4.1	4.8	5.0	3.0	8.5	3.4	4.4	1.4	4.4	3.6	4.9	3.6	4.6	3.5	7.7	4.3	5.8	5.7	3.2	4.0	4.7	3.9	5.7	3.6	1.9	8.6	15.3	6.6	6.9	0.1	4.9	10.2	4.8	3.5	1.0	2.8	2.3	2.5	8.8	3.1	1.2	1.3	6.7	5.9	1.8	11.7	7.7	2.5	2.8	6.5	4.6	6.9	7.4	7.1	5.0	10.3	8.1	6.9	5.5	1.8	10.0	7.4	1.0	7.9	2.8	6.5	2.0	6.3	4.4	8.4	2.4	5.6	7.4	5.6	5.4	7.0	0.9	3.9	10.9	8.7	2.5	3.7	13.3	3.6	1.1	0.0	5.7	18.5	5.8	2.8	0.1	7.8	3.1	0.9	4.1	1.4	1.0	2.5	4.1	2.7	2.4	1.2	4.8	4.4	2.6	2.8	3.5	0.7	3.0	1.3	1.4	4.4	5.0	6.4	6.0	4.8	4.5	4.3	4.4	4.8	3.6	4.3	5.7	4.2	3.2	0.5	7.2	5.2	1.7	2.1	1.7	2.8	12.5	3.4	3.2	6.9	7.2	2.8	3.7	6.2	2.2	3.4	0.9	1.9	2.9	2.2	4.6	5.1	4.6	2.4	5.2	14.5	1.6	1.2	3.1	1.5	3.5	2.5	6.2	3.9	3.7	1.5	8.4	13.5	1.6	0.0	2.1	2.1	2.0	2.8	1.7	0.0	4.7	0.5	5.7	5.2	11.6	9.5	0.9	1.3	1.5	1.0	1.9	0.9	2.5	2.0	10.0	0.0	3.9	3.6	7.6	6.7	1.3	1.6	1.5	4.4	4.0	1.3	1.7
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 154.0;Early spermatids: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015705, HPA056325"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA015705: AB_1859199, HPA056325: AB_2683101"	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.66e-6)"	"prognostic favorable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	29.1	26.8	11.9	20.3	12.6	35.5	22.8	14.3	15.7	23.1	15.0	30.9	18.5	26.0	17.6	25.2	25.6	19.8	100.3	11.0	12.8	26.0	51.7	25.1	28.6	13.3	12.6	25.1	26.9	23.9	15.5	20.2	13.2	21.0	22.7	25.0	48.1	20.1	67.1	19.0	21.2	32.1	12.9	23.2	22.8	26.3	13.1	21.5	37.4	43.4	26.7	23.4	18.7	14.6	20.7	24.8	29.5	23.4	51.7	46.1	41.3	54.0	31.1	34.1	32.1	33.5	38.6	87.6	32.4	34.3	19.3	16.1	52.6	35.0	51.7	40.8	34.4	40.7	39.2	47.6	55.2	103.8	31.6	46.6	40.3	32.0	46.4	41.4	36.1	53.1	84.3	57.9	43.8	46.4	80.9	48.6	26.3	63.2	46.7	65.0	42.2	55.9	36.7	22.6	51.1	23.8	19.0	42.9	55.7	33.0	21.5	28.1	38.7	43.3	29.4	26.3	39.1	96.1	74.7	83.2	36.2	63.8	31.6	16.3	27.4	16.7	15.9	22.7	22.3	21.6	20.1	20.7	28.9	17.7	21.6	20.0	4.1	20.1	18.8	19.6	25.9	16.3	11.9	12.6	14.3	15.7	11.0	12.8	13.3	12.6	13.2	12.9	13.1	14.6	32.5	54.5	32.4	8.1	31.9	49.2	53.9	22.3	35.3	63.0	21.5	29.1	154.0	27.1	26.2	9.2	14.6	38.2	29.8	21.2	58.7	32.7	197.7	34.9	58.2	31.5	16.8	29.6	13.0	51.0	37.9	35.3	18.8	26.9	22.9	25.7	32.5	70.6	73.5	16.8	13.4	25.7	20.3	56.2	36.0	50.5	39.1	48.2	46.2	20.6	38.1	38.4	14.4	11.6	17.3	43.5	27.8	28.6	27.4	43.6	26.0	78.3	20.3	26.1	13.1	42.4	34.9	46.2	17.7	33.6	51.6	34.3	29.7	38.4	26.9	56.6
ZNF331	"RITA, ZNF361, ZNF463"	ENSG00000130844	"Zinc finger protein 331"	Q9NQX6	19	53519527-53580269	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 284.5;dendritic cells: 298.4;granulocytes: 241.9;Langerhans cells: 245.5;Macrophages: 241.4;T-cells: 303.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 79.7;RT4: 63.4"					"Low region specificity"	"Detected in all"			HPA063157			Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA063157: AB_2684951"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.24e-1)"	"unprognostic (8.16e-2)"	"unprognostic (7.62e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.69e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (6.74e-2)"	52.6	124.7	14.3	18.5	13.5	46.3	19.2	55.9	25.1	22.6	23.6	14.8	4.8	20.2	10.7	7.5	46.6	22.6	39.0	13.7	21.2	13.7	12.3	43.4	10.3	24.1	23.0	119.4	21.0	17.0	74.7	54.5	17.8	24.3	8.4	41.2	11.0	22.4	18.8	14.4	10.8	14.2	11.6	10.6	15.3	20.0	22.6	12.2	16.6	9.3	8.7	28.8	16.5	14.7	0.2	11.3	22.5	26.0	15.0	10.7	38.3	16.2	13.7	12.0	21.4	11.8	5.7	7.9	4.2	9.4	5.4	6.6	16.4	12.1	21.4	0.1	79.7	11.8	18.8	7.5	10.9	6.8	15.4	12.4	6.9	13.2	4.8	6.2	5.6	13.9	0.5	3.0	11.4	7.6	16.5	15.1	9.5	0.2	15.5	20.2	13.5	9.6	5.9	63.4	14.3	15.7	7.1	18.8	4.5	43.2	4.1	6.7	5.6	17.0	15.1	10.0	11.1	37.7	28.2	17.8	0.2	1.0	13.9	0.8	5.7	8.2	9.6	4.7	15.2	8.9	10.5	9.7	4.3	10.3	15.6	10.2	0.7	6.1	9.8	4.8	11.7	5.9	14.3	13.5	55.9	25.1	13.7	21.2	24.1	23.0	17.8	11.6	22.6	14.7	37.4	19.2	56.2	13.1	284.5	44.7	21.1	10.9	95.6	56.2	28.6	44.7	20.5	35.8	15.2	77.3	29.2	38.2	298.4	1.6	9.8	4.0	125.7	51.0	18.9	36.8	23.4	7.4	36.3	4.0	33.7	96.7	52.5	79.3	241.9	14.5	13.6	3.8	62.1	30.3	39.9	4.8	14.2	46.8	245.5	84.8	24.2	241.4	46.2	15.0	5.9	33.8	11.3	17.6	24.9	2.4	2.7	19.5	141.7	15.9	3.9	4.4	12.4	38.3	0.0	44.0	151.4	39.2	23.5	15.8	50.6	44.5	303.9	14.0	5.2	12.3
ZNF333	KIAA1806	ENSG00000160961	"Zinc finger protein 333"	Q96JL9	19	14689801-14733746	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA043973, HPA054680"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043973: AB_10961277, HPA054680: AB_2682571"	"unprognostic (8.16e-2)"	"unprognostic (2.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.32e-5)"	"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.06e-3)"	6.3	3.8	4.5	3.7	5.0	6.3	5.2	5.9	5.4	6.8	3.5	6.1	1.9	6.4	4.6	2.3	6.7	2.9	3.5	4.5	4.3	3.2	2.2	4.2	3.5	4.8	4.7	7.3	4.3	3.1	3.0	3.4	5.1	4.3	2.5	5.6	3.0	3.6	7.8	3.6	3.7	5.2	4.6	6.8	3.6	3.8	4.9	3.5	3.3	4.1	3.0	5.7	4.7	6.6	1.2	0.8	4.6	6.1	6.6	6.2	1.8	2.7	4.0	2.5	3.6	0.1	0.9	1.8	3.3	3.5	0.6	1.0	1.2	0.9	3.6	4.9	1.3	8.5	1.9	1.8	5.5	3.2	4.6	5.4	3.2	2.1	6.6	3.3	3.6	2.2	1.5	3.9	3.2	0.5	1.7	8.1	1.7	2.8	1.5	3.1	2.6	1.9	2.4	1.4	2.5	5.1	2.6	0.3	4.9	1.8	1.1	5.5	5.8	4.1	1.9	6.9	3.0	1.7	0.9	1.7	4.3	5.8	5.0	8.6	3.4	5.3	3.5	4.5	4.6	2.3	3.0	2.9	4.3	2.2	3.5	3.3	6.4	13.8	4.6	2.7	3.2	2.2	4.5	5.0	5.9	5.4	4.5	4.3	4.8	4.7	5.1	4.6	4.9	6.6	8.8	6.4	8.7	9.1	6.6	3.1	5.4	1.6	6.2	12.7	4.5	5.6	3.7	0.0	2.7	3.7	4.2	3.0	4.7	2.2	1.9	2.7	5.8	2.3	9.0	7.5	2.4	3.4	12.6	3.0	3.0	9.1	3.1	3.1	16.5	12.0	5.0	2.2	5.1	8.4	15.7	1.0	4.1	9.1	6.0	3.7	9.9	8.0	1.8	11.2	9.5	5.5	12.3	13.6	22.9	2.3	2.1	9.1	4.1	4.1	2.0	2.1	3.5	17.4	13.1	10.8	9.8	11.9	7.3	2.6	2.7	1.4	5.5	4.3	2.3	3.5
ZNF334	bA179N14.1	ENSG00000198185	"Zinc finger protein 334"	Q9HCZ1	20	46499630-46513559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 43.1;Inhibitory neurons: 29.1;Oligodendrocyte precursor cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 15.5;BEWO: 19.4;NTERA-2: 10.4;SCLC-21H: 12.9;SuSa: 22.0"	"Low region specificity"	"Detected in all"							HPA050022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA050022: AB_2680994"	"unprognostic (3.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.71e-3)"	3.5	7.9	9.3	0.9	9.8	1.4	6.9	15.1	10.3	7.9	10.2	3.7	2.0	6.7	9.3	2.1	9.5	4.1	2.5	8.2	10.5	6.9	5.5	3.4	1.4	11.6	10.6	15.8	8.9	1.7	16.1	5.1	9.7	12.6	2.3	15.7	6.4	5.8	0.9	2.0	3.6	3.3	9.3	3.2	5.2	7.7	10.7	2.9	12.3	1.7	1.1	5.1	5.5	10.2	0.1	0.0	15.5	0.1	1.0	0.1	19.4	1.4	0.1	1.2	0.1	0.0	4.0	0.0	0.0	0.4	4.8	0.0	0.0	0.3	0.6	0.0	3.3	5.1	0.1	5.7	4.1	0.1	0.0	4.9	0.0	1.3	0.0	0.7	0.1	0.1	3.5	0.0	0.1	0.0	0.0	9.1	10.4	2.6	1.3	0.0	0.0	0.1	4.2	3.9	12.9	7.3	0.0	0.4	0.2	22.0	0.1	4.5	0.0	0.2	6.9	0.1	0.0	1.2	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	9.3	9.8	15.1	10.3	8.2	10.5	11.6	10.6	9.7	9.3	10.7	10.2	1.2	9.6	4.5	43.1	0.2	0.1	3.5	1.1	2.8	11.0	5.6	4.3	1.9	1.5	5.5	3.7	2.1	4.1	0.0	0.4	5.9	4.5	0.6	2.5	6.2	1.7	0.0	2.1	15.7	1.3	3.7	3.9	7.7	1.3	2.5	11.1	2.2	0.9	1.7	10.1	29.1	1.2	0.0	0.0	0.3	1.4	2.8	1.2	0.0	3.7	0.0	7.8	0.0	33.2	7.5	1.7	0.3	1.9	0.2	2.2	0.6	3.4	7.9	12.3	0.0	5.1	2.4	5.7	7.5	1.4	0.0	1.0	0.2	6.5	1.8	1.6
ZNF335	"bA465L10.2, NIF-1"	ENSG00000198026	"Zinc finger protein 335"	Q9H4Z2	20	45948660-45972203	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063999, HPA071230"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA063999: AB_2685170, HPA071230: AB_2686369"	"unprognostic (1.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (4.48e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (7.04e-4)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (4.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.88e-3)"	12.8	12.1	8.2	11.6	8.4	29.6	13.2	11.8	10.0	14.7	5.4	13.2	10.3	13.9	4.2	14.2	14.1	6.5	9.6	8.6	6.4	11.6	12.1	13.1	14.4	6.9	6.4	17.9	15.2	8.3	17.4	6.4	6.9	16.1	5.7	4.8	13.0	7.4	14.6	20.8	17.6	6.7	5.4	22.1	14.4	13.8	6.9	13.3	17.8	7.7	10.2	12.5	12.7	8.7	12.6	12.6	11.0	11.9	5.7	7.2	23.2	11.0	7.6	10.7	7.7	27.3	13.8	15.0	16.0	10.9	9.8	17.7	10.7	16.6	4.9	10.3	14.6	12.6	20.0	14.6	8.8	16.4	20.5	11.6	13.8	14.1	10.0	7.7	9.3	15.5	12.0	19.6	7.5	25.7	19.4	15.8	7.5	8.4	20.4	15.8	7.3	12.7	9.5	19.5	11.0	9.7	16.4	22.7	11.6	6.5	17.2	13.4	9.8	23.0	10.0	14.8	15.2	22.7	12.6	15.4	18.6	10.0	12.9	1.2	1.7	2.4	3.3	2.2	1.6	1.4	1.6	2.2	1.7	1.5	1.3	1.5	1.7	4.2	1.8	1.2	1.8	2.0	8.2	8.4	11.8	10.0	8.6	6.4	6.9	6.4	6.9	5.4	6.9	8.7	16.9	12.8	15.0	16.6	17.3	18.7	12.1	5.3	14.8	19.3	13.7	14.2	3.8	5.7	5.9	1.8	27.1	8.1	21.5	22.7	0.0	4.4	32.1	10.0	12.3	10.9	21.5	5.7	14.8	5.9	8.5	9.5	22.4	15.4	7.0	15.2	7.1	5.1	6.1	13.5	12.4	11.7	6.1	10.0	11.3	24.8	7.5	14.5	8.8	9.4	6.7	6.0	21.6	7.1	12.4	7.9	12.7	5.3	18.5	10.5	14.6	2.7	4.6	11.6	0.0	21.7	10.3	3.8	7.2	12.9	22.4	11.9	23.1	7.8	12.3	12.8
ZNF34	KOX32	ENSG00000196378	"Zinc finger protein 34"	Q8IZ26	8	144772224-144787345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA053925, HPA060755, HPA066805"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA053925: AB_2682311, HPA060755: AB_2684354, HPA066805: AB_2685725"	"unprognostic (2.54e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	9.3	4.2	8.5	2.8	9.3	3.3	8.6	12.8	10.5	10.4	8.1	10.2	2.2	9.1	4.7	3.8	10.0	3.6	5.8	8.6	9.4	6.0	5.0	5.5	3.9	9.0	9.0	10.8	5.1	6.2	9.7	4.7	9.6	7.5	3.6	12.4	4.5	7.3	6.3	8.1	5.6	6.6	8.4	4.9	5.6	6.4	9.0	5.4	8.2	6.4	3.0	9.1	7.4	10.9	2.1	3.0	5.7	4.7	4.7	4.8	1.4	1.8	4.1	4.6	3.8	0.8	3.3	3.1	3.4	4.9	2.6	2.0	3.4	3.9	3.6	2.9	2.8	6.3	5.4	2.7	4.3	1.8	3.4	4.8	4.4	3.5	7.7	5.0	3.2	2.0	4.2	2.6	4.1	5.0	3.8	2.7	3.9	4.7	3.3	3.3	2.1	4.1	2.6	2.2	5.6	4.0	4.1	3.0	3.1	3.6	3.2	2.3	2.0	4.3	3.9	3.4	3.9	3.4	1.2	3.9	3.1	2.7	5.1	8.2	6.7	12.9	6.6	6.5	5.7	7.2	6.2	7.8	10.2	7.4	4.3	6.5	1.0	6.1	16.3	4.8	5.1	4.8	8.5	9.3	12.8	10.5	8.6	9.4	9.0	9.0	9.6	8.4	9.0	10.9	17.2	6.4	5.1	3.3	5.5	3.7	2.8	3.9	5.2	7.8	4.6	9.1	3.0	1.5	3.9	0.0	0.0	2.7	2.4	1.4	5.9	3.0	10.6	3.2	7.7	7.9	0.0	1.7	4.8	1.3	3.1	6.7	1.1	4.9	5.1	3.8	2.9	2.1	1.8	13.5	6.2	1.7	6.1	1.2	4.5	7.9	7.2	4.1	3.6	2.8	8.2	6.2	2.1	3.0	8.2	1.1	3.2	4.9	2.7	2.0	2.8	2.3	1.1	9.1	6.6	8.5	7.5	16.4	9.9	8.4	4.8	2.3	4.9	4.2	2.3	0.9
ZNF341	dJ553F4.3	ENSG00000131061	"Zinc finger protein 341"	Q9BYN7	20	33731657-33792269	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023240, HPA024607, HPA067108"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780"	"unprognostic (1.74e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.31e-2)"	"prognostic favorable (3.93e-4)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.17e-5)"	"unprognostic (4.84e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.67e-3)"	"unprognostic (3.68e-2)"	1.2	0.9	1.0	1.9	1.1	2.4	0.9	0.8	2.2	1.1	0.0	1.5	1.4	1.3	1.0	1.3	1.3	0.9	1.0	1.6	0.2	0.6	0.6	1.1	1.9	0.3	0.1	1.3	1.6	0.9	0.6	1.4	0.4	1.3	1.1	0.7	1.5	1.0	3.3	2.1	1.0	1.2	0.2	1.9	1.4	1.5	0.5	1.8	0.9	3.3	1.2	1.2	1.1	1.3	2.4	6.4	2.2	4.7	2.1	1.7	9.5	2.3	1.2	1.9	1.2	4.6	5.4	3.7	3.8	1.7	2.2	3.7	2.4	4.1	0.8	3.3	2.2	3.6	3.6	3.7	1.2	2.1	4.3	1.4	3.0	1.6	1.0	1.7	2.3	3.4	1.9	1.7	2.0	2.9	1.9	1.6	3.0	3.5	3.1	2.4	1.4	2.1	1.3	5.2	1.9	2.1	6.1	5.6	1.4	1.7	5.0	1.7	2.9	3.4	1.4	2.5	2.2	1.3	1.9	3.4	3.3	1.7	2.4	2.6	1.3	2.9	1.1	1.8	1.0	2.2	0.8	0.7	1.0	1.2	0.5	1.5	2.5	1.3	1.2	0.7	0.6	0.9	1.0	1.1	0.8	2.2	1.6	0.2	0.3	0.1	0.4	0.2	0.5	1.3	1.8	3.2	5.1	5.5	2.9	0.4	1.0	1.5	0.6	2.2	1.9	1.4	2.7	2.8	4.7	1.8	2.1	2.6	0.9	7.0	0.0	1.5	0.6	1.6	1.4	1.4	1.2	0.8	11.3	1.4	3.3	1.6	6.6	2.1	2.5	1.8	1.4	1.0	1.4	1.7	8.0	2.0	2.0	1.6	2.0	0.1	0.6	2.4	0.0	3.7	1.2	0.6	2.1	6.0	7.7	1.7	2.5	0.4	2.6	2.5	4.2	0.4	4.6	2.3	0.0	1.9	1.1	1.6	2.4	1.6	1.0	2.1	1.9	1.5	2.4	2.5
ZNF343	MGC10715	ENSG00000088876	"Zinc finger protein 343"	Q6P1L6	20	2481817-2524702	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 14.0;Inhibitory neurons: 14.2;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA030587, HPA052438"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA030587: AB_10603246, HPA052438: AB_2681833"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (9.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.88e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (4.53e-5)"	"unprognostic (1.65e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.53e-2)"	6.8	4.4	4.3	5.2	3.9	1.9	8.1	6.6	6.8	7.4	3.9	7.5	4.1	8.0	10.3	5.6	6.6	4.3	4.2	4.6	4.8	5.5	4.7	5.2	5.3	3.2	3.4	7.9	4.5	8.7	4.7	6.2	3.5	5.8	5.9	6.2	5.5	6.1	7.9	8.0	4.2	7.7	2.3	5.8	4.9	4.4	4.4	5.6	6.4	8.9	6.2	6.7	6.2	5.8	11.7	14.5	8.7	10.5	10.1	10.0	3.4	8.7	9.3	10.2	10.1	8.2	6.8	18.1	3.6	8.3	10.7	12.4	13.8	15.7	13.0	4.4	7.6	9.9	6.9	18.0	9.2	6.8	4.0	10.3	15.0	13.2	20.6	11.2	10.1	11.5	13.9	7.6	10.0	4.7	13.1	5.8	9.0	10.5	13.8	11.1	12.3	10.1	6.3	5.8	10.7	16.6	10.5	17.1	10.6	7.1	6.1	6.1	7.5	13.6	6.7	10.8	10.1	15.4	28.3	8.1	3.2	8.7	8.7	0.5	2.2	2.7	2.9	2.3	3.5	4.0	3.9	2.4	2.3	4.8	4.0	4.7	1.7	1.3	2.1	3.6	3.4	2.1	4.3	3.9	6.6	6.8	4.6	4.8	3.2	3.4	3.5	2.3	4.4	5.8	2.0	3.2	1.5	6.2	4.0	2.0	1.6	0.9	5.2	4.1	1.8	1.5	1.9	1.5	2.3	1.8	0.0	2.4	2.2	1.6	1.9	2.2	0.9	0.9	3.3	2.2	3.0	0.8	14.0	0.9	1.3	3.6	2.0	1.2	1.3	2.2	1.8	3.6	1.4	8.4	14.2	2.2	4.1	1.3	1.2	0.2	4.1	1.4	1.8	2.8	1.4	2.6	1.0	13.6	8.9	2.5	0.8	3.0	2.3	2.1	1.8	3.4	1.0	2.9	0.0	2.2	3.9	4.2	3.5	4.5	2.3	0.8	1.9	2.0	2.5	1.7
ZNF346	"JAZ, Zfp346"	ENSG00000113761	"Zinc finger protein 346"	Q9UL40	5	177022696-177081189	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.0;Excitatory neurons: 36.7;Inhibitory neurons: 35.1;Oligodendrocyte precursor cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018485	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA018485: AB_1859213"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-2)"	"unprognostic (5.71e-3)"	"prognostic unfavorable (9.54e-5)"	"unprognostic (9.85e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.88e-7)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (5.11e-2)"	"unprognostic (7.86e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.44e-2)"	5.9	8.1	8.5	5.0	8.4	6.4	6.3	13.5	10.0	9.7	6.5	7.6	4.6	8.4	7.7	8.5	8.4	4.6	6.9	8.2	7.7	8.1	7.3	5.3	7.8	5.7	5.8	13.4	8.0	7.2	10.4	5.0	5.3	8.3	5.1	11.1	6.5	7.1	8.1	7.7	6.1	9.0	4.5	8.1	6.2	9.7	8.6	10.1	10.4	6.5	9.5	7.4	7.8	7.2	6.5	11.7	18.7	25.4	9.6	8.7	16.1	11.3	11.5	17.8	19.7	14.8	9.8	17.1	12.5	10.8	15.3	8.5	17.7	18.0	16.9	54.3	14.1	11.1	13.7	13.2	11.5	18.0	10.2	9.7	10.1	16.9	12.3	10.5	20.8	18.4	13.4	10.2	8.2	21.8	25.2	9.6	8.2	8.1	19.0	25.6	12.9	7.8	12.4	7.6	24.0	10.3	13.9	10.3	8.9	9.0	14.5	10.0	11.0	14.4	11.5	10.0	12.3	9.6	10.6	18.5	5.7	16.1	11.8	0.8	4.0	6.6	8.2	4.0	5.3	5.3	5.8	5.4	4.2	8.4	7.2	7.4	4.2	18.3	4.0	3.9	6.4	4.9	8.5	8.4	13.5	10.0	8.2	7.7	5.7	5.8	5.3	4.5	8.6	7.2	5.2	0.0	6.0	31.0	7.1	2.9	2.9	4.3	8.0	11.4	4.3	5.3	4.1	7.2	3.2	5.5	6.2	9.5	3.3	2.6	9.8	6.0	2.4	3.6	7.5	7.7	4.8	15.2	36.7	5.8	5.8	5.9	1.5	3.2	2.5	9.6	4.2	2.9	5.7	8.4	35.1	4.1	8.2	2.9	1.7	5.4	5.0	3.1	3.6	12.2	3.5	7.8	1.0	29.1	20.9	4.0	2.2	6.4	8.6	1.0	4.7	4.1	1.1	6.0	0.0	6.1	5.8	12.9	10.9	5.5	4.8	3.3	6.7	10.1	3.2	1.4
ZNF35	"HF.10, HF10, Zfp105"	ENSG00000169981	"Zinc finger protein 35"	P13682	3	44648732-44660791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051859, HPA054738"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051859: AB_2681642, HPA054738: AB_2682588"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.91e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.30e-1)"	3.9	2.7	2.2	1.6	2.4	1.9	3.1	2.9	2.5	3.1	1.4	4.1	1.3	4.3	2.8	3.9	2.8	1.7	4.0	2.3	2.4	3.5	2.0	2.8	1.4	2.3	2.5	2.3	2.8	2.0	3.5	1.4	2.4	3.4	1.6	2.5	3.1	2.1	3.8	3.3	2.9	3.2	2.1	3.1	3.2	7.1	2.3	1.3	3.1	2.3	2.4	3.6	3.3	2.9	3.2	2.4	6.2	8.0	4.0	3.2	1.1	3.9	5.4	6.7	6.4	4.3	1.4	2.8	1.7	5.4	2.9	2.2	0.3	5.6	6.9	0.1	2.2	9.3	4.3	0.2	3.6	9.3	6.8	3.3	4.1	6.0	5.3	3.3	5.4	0.0	6.3	2.6	7.4	1.9	0.2	3.0	13.9	2.3	6.7	0.1	6.6	4.9	3.6	9.0	3.4	8.8	4.9	3.0	0.8	5.1	8.0	5.7	5.7	7.1	5.2	3.9	7.8	7.1	11.8	1.6	6.1	4.5	5.6	0.0	1.7	0.7	0.9	1.9	0.6	1.5	0.2	1.0	1.8	1.9	0.4	0.5	0.1	2.3	1.8	0.7	0.1	1.0	2.2	2.4	2.9	2.5	2.3	2.4	2.3	2.5	2.4	2.1	2.3	2.9	6.6	6.4	8.7	6.8	5.3	2.8	3.9	3.0	1.8	4.9	4.8	3.4	3.2	2.8	3.3	1.8	0.0	0.3	3.7	2.8	1.9	8.1	10.2	2.2	4.2	9.3	2.4	3.8	7.5	8.7	0.1	5.8	2.6	3.5	0.0	5.7	5.0	1.5	3.8	6.7	8.5	2.4	10.2	2.8	1.4	6.5	1.2	3.2	1.8	4.7	3.6	4.4	7.2	8.0	11.2	10.3	3.3	4.5	4.0	4.3	2.0	3.8	3.4	6.4	0.0	4.8	5.5	30.7	11.7	3.0	2.8	0.4	2.6	5.7	3.0	3.3
ZNF350	"ZBRK1, ZFQR"	ENSG00000256683	"Zinc finger protein 350"	Q9GZX5	19	51964340-51986856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"prostate cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA001521	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA001521: AB_1080705"	"unprognostic (7.26e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.64e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.30e-2)"	"prognostic favorable (2.54e-4)"	6.6	4.4	5.8	5.4	7.3	26.2	13.8	8.6	6.7	5.5	4.1	6.6	5.4	6.4	8.2	4.7	5.8	5.2	5.1	6.4	6.5	7.0	5.3	6.3	9.7	6.0	5.7	8.3	4.5	9.2	4.8	9.3	6.1	27.5	9.1	9.7	6.4	6.3	4.5	7.5	6.1	5.8	5.8	9.0	7.3	6.3	6.5	9.0	9.8	5.9	9.1	6.2	5.2	7.2	0.8	4.4	5.6	6.8	7.5	6.7	1.1	4.6	6.5	4.8	9.5	0.0	3.5	2.1	3.6	5.5	8.8	5.8	4.9	6.5	6.6	0.0	10.5	8.6	7.5	3.9	6.3	2.2	10.1	9.5	9.9	6.4	6.6	9.4	5.5	3.5	2.3	0.1	5.8	2.8	8.5	10.2	3.7	0.5	6.8	4.0	8.0	6.9	7.6	11.9	4.7	6.3	0.0	6.0	5.0	7.9	9.8	7.7	5.9	5.2	3.7	3.1	4.7	1.6	2.8	2.7	1.0	0.1	5.6	65.3	11.2	26.9	16.2	12.7	16.4	16.8	15.3	15.6	13.6	17.2	17.7	14.2	30.8	21.5	16.2	8.8	13.4	8.1	5.8	7.3	8.6	6.7	6.4	6.5	6.0	5.7	6.1	5.8	6.5	7.2	9.1	0.0	7.3	4.6	13.1	5.9	11.0	11.1	5.7	9.9	6.0	5.3	6.6	2.8	10.7	9.2	12.5	12.2	12.9	5.1	7.9	6.7	13.0	4.5	4.7	8.0	7.3	2.5	4.2	5.3	9.9	7.1	3.6	6.7	12.0	9.7	6.4	3.1	7.8	6.7	4.1	5.9	16.2	9.5	12.0	3.4	11.1	10.8	12.4	6.5	11.6	7.9	23.7	4.0	9.1	6.0	5.7	6.0	7.5	14.5	7.6	3.9	7.8	13.1	0.0	7.2	8.4	10.2	5.7	3.5	7.0	23.1	15.1	6.8	3.8	13.4
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178711512-178730659	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 49.6"	"Low region specificity"	"Detected in all"							HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: AB_2681706"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favorable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	8.3	5.3	7.8	7.7	7.6	9.4	8.3	7.4	9.3	9.5	6.8	12.4	4.3	8.6	7.6	6.9	8.8	5.8	7.7	7.8	6.9	11.7	4.8	8.1	8.4	7.1	7.3	7.6	11.1	8.1	6.5	8.5	7.3	9.7	5.8	8.5	6.3	8.4	7.5	7.5	8.2	8.0	6.7	12.6	7.9	10.5	7.7	8.4	10.8	8.1	8.8	9.9	8.3	7.9	7.6	5.8	12.0	31.9	20.4	16.4	49.6	8.6	11.4	11.7	12.5	8.7	12.5	10.1	11.1	7.9	21.5	14.9	4.5	37.6	17.8	13.7	13.8	3.1	8.0	1.1	15.4	0.0	8.3	12.9	22.9	10.3	20.8	15.1	11.3	13.5	2.5	0.0	17.2	15.4	15.5	10.2	10.5	7.0	15.0	11.6	2.1	6.5	10.9	7.6	13.1	14.3	10.9	12.3	17.0	15.7	10.1	14.9	8.8	13.2	8.6	7.5	7.4	3.3	7.2	6.3	0.5	2.3	16.9	4.5	6.0	15.6	4.9	4.0	6.1	5.4	4.3	5.5	5.4	3.5	4.8	3.6	15.8	6.1	4.1	2.0	4.4	3.6	7.8	7.6	7.4	9.3	7.8	6.9	7.1	7.3	7.3	6.7	7.7	7.9	10.7	12.8	7.4	8.8	7.5	5.0	11.7	14.1	4.0	9.0	8.2	9.3	6.6	4.3	11.3	7.3	14.6	12.8	12.6	3.7	13.7	11.3	18.8	5.9	9.0	9.0	4.8	7.8	18.6	7.6	14.6	9.5	3.6	5.7	6.3	14.3	4.6	1.5	8.9	6.7	10.9	2.7	8.2	7.7	8.2	4.7	6.8	8.2	10.6	10.3	7.6	9.2	16.5	12.5	13.3	7.2	1.4	10.5	3.2	10.7	4.1	17.0	9.5	10.5	6.6	10.1	9.4	36.2	12.0	4.8	5.5	12.2	9.2	10.9	4.3	7.7
ZNF354B	"FLJ25008, KID2"	ENSG00000178338	"Zinc finger protein 354B"	Q96LW1	5	178859953-178888122	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"brain: 142.5;choroid plexus: 99.2"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029056	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA029056: AB_10603006"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.24e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (2.88e-4)"	"unprognostic (6.72e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.15e-3)"	11.6	6.3	50.1	6.0	55.6	4.3	12.0	81.0	142.5	10.8	99.2	10.1	6.3	9.7	5.5	6.4	9.0	5.5	5.7	41.0	33.5	8.4	6.0	7.7	7.8	80.5	33.1	9.3	10.0	6.8	8.1	14.0	58.4	10.0	5.4	11.1	8.1	7.5	4.8	7.5	7.9	6.5	35.6	9.1	8.0	5.2	55.9	6.8	11.6	5.5	6.8	8.4	8.7	72.3	5.2	4.0	7.4	16.9	7.2	6.9	18.9	6.4	5.8	6.1	7.0	5.1	9.1	0.0	6.7	5.7	8.4	10.6	9.4	10.8	7.4	0.0	7.7	6.0	15.6	3.8	6.2	0.1	4.1	6.4	6.4	5.0	7.6	9.3	5.5	8.9	5.0	0.0	6.6	5.8	9.8	13.5	3.9	2.5	5.4	9.1	4.0	5.8	5.3	6.2	8.3	8.6	7.7	6.8	4.9	7.2	6.0	10.4	6.5	10.7	9.6	3.9	4.8	3.7	5.7	0.2	0.7	0.0	5.7	2.0	1.8	0.7	3.1	1.1	2.8	2.6	2.1	1.7	1.6	3.8	2.6	2.7	0.5	1.3	1.2	2.0	2.0	0.9	50.1	55.6	81.0	142.5	41.0	33.5	80.5	33.1	58.4	35.6	55.9	72.3	21.5	9.6	4.8	3.3	4.0	4.6	6.9	2.4	4.6	6.8	5.3	6.5	6.9	4.3	6.2	7.3	8.4	20.4	5.3	1.0	0.0	4.6	1.2	2.8	8.7	10.1	0.0	2.1	6.0	2.3	6.7	8.0	6.1	3.7	0.0	7.7	8.9	2.0	4.9	11.8	5.7	2.4	0.0	3.5	4.9	0.1	5.0	4.4	0.0	4.7	3.2	3.5	12.3	4.0	6.5	2.1	0.8	5.3	2.6	5.8	1.7	2.4	5.2	6.5	0.0	9.8	7.0	10.4	11.1	3.3	5.4	34.6	5.6	7.8	1.8	3.9
ZNF354C	KID3	ENSG00000177932	"Zinc finger protein 354C"	Q86Y25	5	179060373-179083977	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 16.8;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.8"	"Low region specificity"	"Detected in all"							"HPA030904, HPA068570"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA030904: AB_10603842, HPA068570: "	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.56e-4)"	"unprognostic (4.76e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.83e-1)"	3.2	2.2	2.7	2.4	3.7	0.6	4.0	6.1	2.9	3.6	1.8	3.1	1.2	5.1	1.8	2.0	3.6	2.6	2.8	2.3	2.6	2.1	1.4	2.6	3.4	3.0	3.5	7.0	2.0	3.1	1.2	3.2	3.2	3.5	1.6	6.4	2.1	3.3	2.2	1.9	2.0	3.8	2.9	3.3	2.0	2.2	3.4	4.4	4.7	4.3	3.4	2.5	2.3	4.4	1.0	1.4	11.1	17.8	5.6	9.0	0.0	5.0	4.3	5.4	6.1	0.0	2.2	0.0	5.9	5.4	9.0	3.4	0.0	1.7	10.2	0.0	0.1	0.0	0.5	0.0	5.3	0.0	2.4	6.8	1.6	5.4	0.0	1.7	2.6	0.0	0.1	0.0	6.5	0.6	10.6	0.0	7.7	0.8	0.0	0.0	0.0	0.0	2.0	0.4	6.7	11.2	7.8	0.1	5.2	4.7	4.6	4.2	3.3	0.0	7.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.1	0.1	0.5	0.2	0.5	0.3	0.7	0.5	0.2	0.3	0.7	0.6	0.0	0.3	0.6	0.0	0.5	0.3	2.7	3.7	6.1	2.9	2.3	2.6	3.0	3.5	3.2	2.9	3.4	4.4	6.4	3.2	3.1	10.4	2.6	0.9	0.6	1.4	2.8	10.5	1.7	3.0	6.1	4.3	2.3	0.0	0.0	2.2	2.2	0.1	0.0	1.3	0.4	1.3	5.5	4.3	0.0	2.1	8.0	0.9	1.4	5.1	0.5	1.3	1.3	7.4	4.6	0.9	1.7	16.8	2.5	0.5	2.0	1.6	2.2	0.4	3.1	1.7	1.8	4.7	0.6	5.4	1.0	17.6	16.2	0.7	0.1	5.7	0.7	0.6	0.2	0.6	1.3	5.0	6.6	7.0	3.9	2.3	1.3	2.2	0.9	0.5	2.2	4.3	0.7	0.3
ZNF358	"FLJ10390, ZFEND"	ENSG00000198816	"Zinc finger protein 358"	Q9NW07	19	7515292-7521025	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.5;Granulosa cells: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030887, HPA063624"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 47: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA030887: AB_10602688, HPA063624: AB_2685064"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.52e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.60e-2)"	70.6	57.4	82.5	12.0	73.1	2.2	58.4	64.8	109.9	75.5	47.5	107.9	29.5	69.8	28.0	31.9	62.1	31.9	109.4	79.3	70.9	52.8	67.0	50.6	10.5	77.8	81.7	88.6	50.5	49.6	60.9	18.3	69.7	78.6	18.3	11.8	51.3	43.8	175.5	38.8	47.9	37.4	68.3	39.6	67.9	12.6	88.4	14.1	59.9	147.0	7.9	88.4	54.3	79.7	32.5	21.4	39.7	63.3	83.2	91.8	33.9	12.0	78.2	53.7	47.0	9.4	22.6	0.0	45.7	64.8	8.5	12.4	16.5	30.8	17.2	0.1	35.0	6.2	24.9	13.3	91.0	0.9	0.3	80.3	57.2	25.4	22.0	80.0	57.1	0.0	16.7	0.0	48.2	16.0	0.1	23.5	40.9	13.4	37.4	35.8	21.2	3.5	28.2	13.8	43.8	87.1	15.1	12.5	43.8	25.5	9.5	16.9	27.1	34.4	24.8	51.6	18.4	41.8	24.8	0.1	31.7	0.0	48.6	1.5	0.5	0.4	0.6	0.5	0.4	0.1	0.1	0.3	0.2	0.7	0.4	0.7	0.0	0.2	0.1	0.4	0.0	0.2	82.5	73.1	64.8	109.9	79.3	70.9	77.8	81.7	69.7	68.3	88.4	79.7	29.5	9.6	11.1	11.8	4.6	7.8	11.8	7.1	2.2	20.8	32.8	37.1	126.5	20.0	5.5	16.5	14.6	3.3	6.5	38.8	5.9	13.0	3.8	9.4	28.2	22.1	36.5	0.8	5.8	16.8	5.1	29.2	8.6	14.2	14.7	178.1	32.5	43.0	10.9	50.5	8.5	27.8	8.2	21.1	10.8	7.7	37.9	13.3	5.4	7.5	3.8	48.8	1.0	8.5	14.9	16.0	21.7	37.2	3.4	11.3	48.3	30.7	3.3	20.7	13.1	22.1	27.6	0.7	1.2	3.2	3.7	3.0	3.6	23.9	24.7	12.8
ZNF362	"FLJ25476, lin-29, RN"	ENSG00000160094	"Zinc finger protein 362"	Q5T0B9	1	33256492-33300719	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059239	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA059239: AB_2683955"	"unprognostic (8.31e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.66e-1)"	15.7	12.0	18.4	8.5	17.2	6.7	15.5	17.2	23.1	19.5	8.5	18.9	7.3	22.0	10.2	12.6	16.3	9.1	20.2	16.9	15.6	15.4	8.9	12.6	9.4	18.3	15.4	17.0	13.5	11.9	17.7	11.3	14.3	20.1	5.5	6.3	16.4	13.3	19.7	17.7	11.6	11.7	12.7	16.2	13.7	7.6	18.0	12.2	16.3	11.3	6.7	18.6	15.0	15.8	6.3	10.3	43.7	17.4	11.3	7.9	27.8	8.6	10.3	10.7	11.3	10.6	21.2	3.0	17.1	11.2	3.3	20.6	10.2	5.0	4.5	18.0	7.5	16.1	6.1	13.2	10.1	7.3	12.3	16.9	12.2	4.7	4.1	10.8	14.8	21.2	1.6	5.5	8.3	15.7	23.9	12.9	23.9	3.9	8.4	39.4	10.4	1.5	8.6	10.2	15.4	46.4	24.8	7.8	39.9	18.5	7.7	19.9	21.0	6.5	8.2	15.2	5.6	15.8	15.3	3.4	5.1	6.7	19.4	1.9	1.9	2.6	1.8	1.7	1.3	1.1	1.3	1.6	1.4	2.9	1.2	1.2	1.4	1.7	2.0	3.5	1.1	1.3	18.4	17.2	17.2	23.1	16.9	15.6	18.3	15.4	14.3	12.7	18.0	15.8	15.6	9.6	12.4	13.1	9.2	10.1	4.7	6.2	20.5	12.8	11.0	11.2	25.5	5.7	7.9	11.0	0.0	11.7	16.6	2.6	1.9	6.6	2.5	5.2	12.0	13.9	1.8	3.4	14.3	7.3	5.9	11.8	3.6	7.6	10.1	15.3	18.2	6.9	10.2	8.4	17.7	4.4	6.1	13.9	5.0	8.0	13.7	11.2	8.8	19.7	9.9	9.2	10.3	26.7	14.3	4.3	10.7	21.4	7.5	1.9	7.3	11.4	2.4	4.9	6.6	12.4	16.7	1.2	5.0	11.4	9.5	3.6	10.6	7.7	6.1	2.9
ZNF366	FLJ39796	ENSG00000178175	"Zinc finger protein 366"	Q8N895	5	72439903-72507410	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.0;Cone photoreceptor cells: 31.3;Endothelial cells: 18.3;Langerhans cells: 9.3;Microglial cells: 54.4;monocytes: 14.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"myeloid DC: 10.4"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 10.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.3;TIME: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023128, HPA023526, HPA074074"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA023128: AB_1859223, HPA023526: AB_1859224, HPA074074: "	"unprognostic (3.49e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.29e-2)"	5.8	0.8	6.1	3.4	5.0	0.1	3.2	4.5	5.6	2.8	2.4	1.4	1.5	3.1	0.7	1.8	2.4	2.3	3.8	4.1	4.6	2.1	1.0	2.6	5.0	5.8	5.5	0.8	0.7	1.1	0.4	8.9	6.0	0.9	1.5	0.5	0.8	1.5	5.0	2.2	1.9	3.9	4.1	6.4	1.4	0.5	7.1	3.1	2.2	5.6	4.0	1.7	1.0	4.5	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.5	6.1	5.0	4.5	5.6	4.1	4.6	5.8	5.5	6.0	4.1	7.1	4.5	19.0	0.0	0.6	0.0	0.1	0.5	0.4	0.0	0.6	0.4	0.1	0.3	1.6	0.0	0.6	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	18.3	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.4	0.5	0.0	0.3	0.0	0.0	4.6	9.3	0.5	0.3	2.4	0.0	54.4	14.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	1.2	0.7	0.0	0.0	0.2	0.3	0.1	0.3	0.1	0.0	0.0
ZNF367	FLJ33970	ENSG00000165244	"Zinc finger protein 367"	Q7RTV3	9	96385941-96418370	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA015319, HPA015785"	Uncertain		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA015319: AB_2669185, HPA015785: AB_2217750"	"unprognostic (5.91e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.76e-3)"	"unprognostic (1.60e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.88e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.28e-1)"	1.4	0.6	0.7	3.7	1.3	26.1	1.7	1.4	1.3	1.1	0.2	3.0	2.9	1.1	0.1	2.4	0.7	1.0	2.1	0.7	1.0	3.0	10.8	1.1	4.6	1.5	1.4	1.0	1.4	1.6	0.3	1.9	1.4	1.2	3.3	1.3	0.7	0.4	1.5	3.5	3.0	2.4	0.9	1.3	2.1	6.1	1.3	8.7	1.1	2.7	4.7	1.5	1.2	2.7	25.4	10.3	9.9	8.9	3.8	5.3	13.4	34.6	20.4	16.9	20.0	6.4	17.5	19.2	14.4	16.5	12.6	30.5	11.6	12.6	19.9	21.2	10.0	14.0	19.1	5.3	0.0	19.8	16.5	0.9	0.8	13.7	6.9	3.7	6.3	13.3	13.0	45.4	21.7	16.9	30.4	16.1	6.7	27.9	16.7	15.3	49.9	11.7	4.9	16.8	17.4	12.0	15.3	18.1	10.6	8.0	9.4	17.3	5.7	27.6	15.8	25.6	26.6	17.6	32.0	7.8	16.7	17.0	23.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.7	1.3	1.4	1.3	0.7	1.0	1.5	1.4	1.4	0.9	1.3	2.7	1.1	0.0	0.0	2.9	3.8	9.9	1.3	0.4	10.8	0.7	2.2	2.3	2.6	0.0	0.9	0.0	0.0	3.2	2.5	2.4	0.0	0.5	0.7	0.6	1.1	2.0	0.0	22.3	5.1	1.2	4.2	1.7	2.6	1.8	0.0	4.7	1.1	3.8	1.9	0.0	5.3	3.6	0.0	2.1	2.6	0.8	0.6	8.3	3.6	2.8	0.1	0.6	1.0	3.0	7.9	0.7	0.5	0.7	9.6	0.6	0.9	2.5	0.0	1.5	6.6	2.0	3.6	10.3	1.7	10.9	6.5	0.8	5.0	0.3	5.6	1.1
ZNF383	"FLJ35863, Zfp383"	ENSG00000188283	"Zinc finger protein 383"	Q8NA42	19	37217926-37248738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063945	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA063945: AB_2685158"	"unprognostic (1.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.27e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (3.71e-4)"	3.6	3.2	2.5	3.4	4.4	3.5	5.1	8.5	3.4	4.1	1.5	3.3	3.5	3.8	3.6	3.6	3.7	2.9	4.9	2.7	3.5	4.4	3.2	3.5	6.1	3.7	3.1	5.8	2.9	4.4	2.8	3.2	3.8	4.1	3.5	5.4	4.0	3.9	7.4	5.4	3.4	3.8	2.0	5.1	3.9	3.9	3.7	5.7	5.3	9.0	6.0	3.4	3.4	7.1	2.9	6.8	4.6	7.1	5.7	5.8	3.1	4.1	5.6	4.0	5.9	3.1	3.6	4.0	5.9	3.9	3.8	3.0	3.6	5.5	5.9	5.4	4.2	5.7	5.2	2.6	6.1	6.9	6.2	7.1	4.6	3.9	7.6	5.1	3.7	5.5	3.2	2.1	5.0	1.4	6.3	3.2	4.2	5.8	1.9	4.4	8.4	3.7	3.6	8.2	5.2	4.1	6.6	3.8	5.7	5.8	4.6	4.1	2.3	5.0	3.5	3.7	4.0	6.5	6.4	7.9	0.7	3.2	4.7	3.7	3.2	5.3	5.8	3.9	8.2	8.0	5.4	7.1	3.3	10.7	8.6	6.9	3.5	4.8	4.9	3.1	6.0	3.9	2.5	4.4	8.5	3.4	2.7	3.5	3.7	3.1	3.8	2.0	3.7	7.1	7.2	3.2	4.4	7.5	10.2	2.7	4.0	3.4	5.7	9.8	3.7	5.2	12.8	7.2	2.5	1.8	14.6	3.8	7.5	3.8	1.9	3.5	8.9	3.6	5.4	5.1	2.4	11.0	7.4	3.6	4.8	5.8	4.6	3.7	5.7	7.8	6.4	2.2	3.8	15.2	8.7	3.8	2.0	6.3	3.5	3.0	6.5	4.5	8.8	4.7	5.5	6.2	10.3	9.5	10.4	2.7	3.6	7.5	3.8	5.1	5.8	3.9	2.5	9.9	13.1	9.9	6.1	5.8	5.2	3.9	3.3	4.9	8.5	6.6	4.8	4.1
ZNF384	"CAGH1A, CIZ, NMP4, NP, TNRC1"	ENSG00000126746	"Zinc finger protein 384"	Q8TF68	12	6666477-6689572	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004051	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA004051: AB_1859228"	"unprognostic (1.90e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.13e-2)"	31.4	33.2	21.9	36.2	23.2	59.9	30.7	26.9	26.4	39.8	22.9	35.1	35.1	40.6	25.1	27.9	35.8	26.1	25.9	22.5	23.8	28.9	26.3	28.6	36.0	23.5	22.3	46.3	29.8	34.7	32.6	32.5	22.3	31.9	32.7	30.2	29.9	30.0	36.7	32.1	36.8	37.8	20.8	40.2	30.9	31.7	22.8	46.7	38.4	32.3	37.6	36.7	30.8	25.4	35.4	66.2	79.9	53.7	55.2	38.9	107.1	50.0	46.4	47.3	50.3	73.3	73.6	82.9	18.5	56.4	68.5	46.6	59.8	45.9	53.6	150.8	54.0	94.9	93.0	38.6	38.9	91.2	67.5	43.0	43.6	58.3	90.1	88.9	41.5	57.4	50.6	27.9	52.4	54.8	82.6	58.3	155.0	64.1	28.7	81.0	85.4	32.2	41.9	93.6	24.8	80.4	51.8	68.4	44.1	133.5	18.0	74.5	51.9	51.6	71.4	40.9	59.6	38.5	39.6	149.9	51.0	32.4	60.0	3.7	8.5	15.4	16.4	9.8	13.4	9.7	10.7	13.4	11.5	8.0	10.2	11.6	14.4	17.0	15.3	7.6	14.5	8.3	21.9	23.2	26.9	26.4	22.5	23.8	23.5	22.3	22.3	20.8	22.8	25.4	19.2	0.0	8.7	17.3	12.5	7.9	2.6	4.4	12.0	6.0	11.1	11.9	2.6	10.0	4.7	1.8	10.4	6.7	17.9	16.5	0.0	4.6	4.3	10.2	12.9	10.7	3.6	8.0	10.3	5.0	6.8	8.2	12.8	13.5	5.7	14.7	8.9	8.3	7.0	0.0	10.4	11.8	2.0	16.6	6.0	2.7	8.4	8.6	5.4	6.5	9.9	6.1	7.2	9.0	11.8	6.8	14.4	8.6	11.4	4.8	10.6	4.3	5.6	7.8	0.0	9.3	9.3	7.1	6.5	10.7	9.8	7.3	13.2	9.0	13.4	4.6
ZNF385A	"DKFZp586G1122, Hzf, ZFP385, ZNF385"	ENSG00000161642	"Zinc finger protein 385A"	Q96PM9	12	54369133-54391298	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 159.3;retina: 250.6;skin 1: 159.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 212.8;Cone photoreceptor cells: 171.0;Horizontal cells: 144.7;Muller glia cells: 142.6;Rod photoreceptor cells: 209.7;Syncytiotrophoblasts: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 29.2;intermediate monocyte: 32.8;myeloid DC: 31.9;non-classical monocyte: 25.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 31.9;monocytes: 32.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 89.5;HBEC3-KT: 85.7;HEL: 109.5;hTCEpi: 94.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039799			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA039799: AB_10795117"	"unprognostic (8.56e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.75e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.07e-3)"	43.3	10.1	76.8	28.6	87.9	32.8	22.2	96.9	86.3	29.2	57.7	13.8	7.2	7.6	16.6	99.5	9.7	14.2	13.7	60.2	89.8	10.2	6.4	19.1	15.3	105.5	111.9	5.3	3.3	26.6	26.7	19.4	93.9	34.9	8.0	250.6	28.1	15.0	21.9	159.8	15.8	14.2	95.1	24.8	10.4	2.4	159.3	12.1	40.8	23.3	20.3	38.8	55.8	65.1	2.5	10.7	15.9	20.0	17.9	12.0	43.6	2.1	8.1	8.3	7.1	21.8	7.8	5.9	7.2	4.4	6.7	89.5	6.1	85.7	2.8	5.8	8.5	109.5	6.6	4.3	8.0	1.6	73.4	10.7	94.8	9.3	23.5	20.3	5.2	15.0	53.6	0.5	3.8	49.9	5.4	15.9	9.2	10.1	8.3	19.5	1.3	21.7	6.5	71.0	7.0	31.6	0.8	59.7	4.5	18.3	71.0	45.5	5.3	4.4	10.2	5.4	5.6	1.7	0.5	5.3	18.6	5.0	11.8	3.0	29.2	0.0	0.0	32.8	0.0	1.3	0.0	0.0	31.9	1.3	0.0	0.4	2.2	0.1	25.7	3.0	0.1	16.5	76.8	87.9	96.9	86.3	60.2	89.8	105.5	111.9	93.9	95.1	159.3	65.1	8.3	0.0	0.0	12.1	7.3	36.2	21.3	76.5	49.5	212.8	16.7	13.8	3.2	1.5	20.4	9.2	171.0	63.9	2.5	0.2	9.8	3.4	0.5	13.3	9.8	8.8	4.8	9.2	5.4	0.6	9.4	29.6	3.6	2.2	1.3	4.8	4.6	1.3	56.4	144.7	13.5	0.1	12.2	71.6	54.7	0.5	14.9	78.0	8.8	6.5	49.4	142.6	3.1	3.5	0.9	1.8	0.1	9.1	2.0	13.1	0.0	2.8	12.1	209.7	0.0	4.0	12.3	2.6	3.6	68.3	66.1	108.9	2.2	0.2	0.1	29.7
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99473877-99504857	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 97.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Approved		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favorable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.09e-4)"	13.3	9.6	8.6	10.3	9.5	97.0	12.5	16.4	8.3	11.9	8.8	12.5	10.3	10.4	6.9	12.6	12.5	7.3	12.2	7.7	9.0	10.4	10.1	13.3	13.6	9.8	9.1	13.9	9.7	7.7	9.4	8.1	9.0	13.5	8.6	5.4	10.2	7.7	12.2	15.4	14.3	7.8	8.5	19.2	11.5	10.6	9.4	12.8	10.2	9.6	11.3	11.9	12.2	10.6	10.3	10.2	6.6	14.0	10.4	7.1	13.1	8.5	11.6	9.9	9.7	11.0	11.0	12.4	12.2	9.2	13.5	9.6	9.2	11.2	9.8	9.1	12.0	12.2	12.0	12.1	8.3	17.4	20.0	9.4	9.6	9.6	10.2	7.3	11.6	10.5	17.6	24.0	9.3	19.6	18.3	28.8	15.0	12.9	12.0	10.2	7.3	22.1	11.0	14.7	7.8	16.5	10.2	24.6	16.9	16.5	6.4	21.8	11.9	11.7	12.0	17.4	10.9	19.7	22.1	20.0	8.5	17.4	12.9	56.8	20.6	36.6	31.7	25.5	33.2	24.5	31.8	34.3	22.6	23.6	38.5	30.8	37.8	36.8	26.8	32.8	37.7	24.6	8.6	9.5	16.4	8.3	7.7	9.0	9.8	9.1	9.0	8.5	9.4	10.6	29.3	16.0	19.7	5.2	37.1	35.6	36.1	16.4	16.5	9.7	20.6	14.6	11.4	8.6	16.6	11.0	12.5	15.8	56.7	26.3	17.6	15.7	10.4	17.3	12.9	22.2	20.8	31.5	4.6	14.1	18.2	17.5	25.0	24.4	58.9	17.1	17.5	12.3	18.9	15.2	5.0	16.9	8.2	25.5	29.6	2.9	15.5	29.3	28.4	1.9	19.3	13.6	45.3	7.1	5.6	16.4	20.8	13.5	31.8	29.2	29.7	11.7	19.4	11.7	13.1	22.6	19.7	41.9	30.6	21.5	35.5	29.7	54.3	24.6	18.6	65.6
ZNF395	"DKFZp434K1210, HDBP2, PBF, PRF-1"	ENSG00000186918	"Zinc finger protein 395"	Q9H8N7	8	28345590-28402701	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 140.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049382, HPA076275"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA049382: , HPA076275: "	"unprognostic (1.28e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (9.35e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.42e-2)"	33.0	18.5	21.9	14.4	22.1	37.5	30.5	14.9	20.8	23.1	27.6	25.7	20.9	17.4	13.9	47.6	27.2	14.5	27.2	18.3	17.3	23.4	37.0	19.7	21.3	25.7	18.5	53.6	47.5	17.7	16.4	33.9	19.3	23.7	13.9	27.1	38.8	17.5	16.3	42.9	24.7	9.5	19.4	21.8	26.2	10.9	26.7	18.9	18.6	13.9	25.2	26.3	29.3	20.7	140.0	19.4	17.9	48.7	13.9	19.6	52.6	16.2	28.4	13.2	30.6	31.0	24.0	66.1	56.2	25.7	30.5	29.3	16.1	40.6	25.6	11.0	12.7	16.4	3.8	6.5	14.2	7.3	6.6	34.9	55.3	2.3	34.3	37.5	6.5	21.2	16.9	14.2	18.3	23.7	31.6	21.7	28.1	33.9	22.7	29.3	19.7	22.1	30.6	26.4	48.1	50.9	3.8	10.3	26.5	15.8	18.9	16.3	1.5	26.6	32.9	15.1	6.6	17.4	9.6	42.9	72.8	13.6	21.5	10.0	4.3	11.5	4.6	0.8	4.4	11.4	5.5	5.6	1.6	13.7	7.1	4.8	1.9	3.7	0.7	6.2	2.4	2.2	21.9	22.1	14.9	20.8	18.3	17.3	25.7	18.5	19.3	19.4	26.7	20.7	14.8	32.1	22.7	45.7	24.7	16.8	17.2	33.0	45.5	10.3	19.1	16.0	12.4	12.8	20.5	9.2	14.6	17.1	9.3	18.4	3.9	22.5	0.6	18.0	9.9	15.1	27.2	8.6	15.9	24.1	21.6	15.8	11.2	21.8	11.4	11.9	26.0	32.4	5.8	6.7	10.8	21.7	6.1	16.8	6.0	1.5	24.8	5.6	10.6	17.8	7.1	17.4	7.2	15.6	18.3	23.7	8.5	18.0	9.0	14.8	21.9	7.6	19.1	10.2	26.3	25.8	11.6	1.1	3.2	29.2	11.5	6.3	7.9	4.9	27.2	9.7
ZNF398	"KIAA1339, P51, P71, ZER6"	ENSG00000197024	"Zinc finger protein 398"	Q8TD17	7	149126416-149183042	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 32.3;Inhibitory neurons: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073151			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA073151: "	"unprognostic (4.11e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.97e-2)"	"unprognostic (9.27e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.89e-1)"	3.9	3.3	1.6	3.6	1.8	7.6	4.4	6.3	3.7	4.9	0.6	4.4	3.7	4.1	4.3	6.4	4.3	3.0	3.3	1.6	2.2	3.5	3.6	3.8	4.7	0.1	0.4	4.4	4.5	5.0	4.9	3.8	0.2	4.8	3.6	7.6	4.8	5.1	4.4	6.8	3.7	4.0	0.0	4.5	4.5	8.5	1.8	5.3	3.6	4.5	5.6	4.8	5.0	2.5	9.8	9.5	7.1	13.8	10.4	7.4	8.4	5.8	8.6	7.3	8.2	7.9	5.0	12.5	6.8	10.6	6.5	8.0	12.0	8.2	5.3	7.3	14.4	8.3	7.2	5.3	7.3	9.8	8.1	8.3	12.1	8.2	8.4	5.4	5.2	4.9	11.9	4.7	8.3	13.9	13.6	10.3	47.1	9.4	8.9	10.3	7.9	9.1	5.7	19.0	9.8	10.9	9.2	11.2	5.7	7.7	6.8	10.6	6.2	7.4	1.9	13.3	7.6	12.7	6.6	9.6	9.6	8.0	7.4	2.4	0.6	2.3	1.1	0.7	1.4	1.0	0.8	1.2	0.5	0.8	1.2	1.3	1.2	0.7	0.6	0.7	1.1	0.4	1.6	1.8	6.3	3.7	1.6	2.2	0.1	0.4	0.2	0.0	1.8	2.5	3.9	6.4	4.6	19.2	6.6	7.8	4.5	4.0	5.7	8.8	5.6	3.7	5.9	0.0	5.5	5.5	6.2	4.2	7.7	4.4	0.0	3.9	23.5	7.0	8.6	5.9	1.8	8.6	32.3	2.8	4.9	5.1	12.2	7.5	4.5	7.1	3.9	2.8	3.7	3.3	31.3	3.7	2.0	5.0	3.3	25.2	7.2	3.9	8.8	21.5	4.8	4.5	3.1	20.6	28.6	4.6	2.1	9.1	10.9	6.6	3.8	3.1	6.9	11.6	0.0	6.4	4.5	21.4	13.5	10.1	8.5	3.1	5.2	4.7	3.8	9.9
ZNF407	"FLJ13839, FLJ20307, KIAA1703"	ENSG00000215421	"Zinc finger protein 407"	Q9C0G0	18	74597870-75065671	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 96.9;Excitatory neurons: 111.0;Inhibitory neurons: 100.2;Microglial cells: 113.4;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028255, HPA041673"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"		"HPA028255: AB_10603466, HPA041673: AB_2677610"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.04e-4)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.79e-5)"	"unprognostic (8.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	2.4	1.9	2.9	3.1	3.5	5.3	2.9	8.0	2.8	2.7	8.6	2.8	2.2	3.7	1.9	2.5	2.7	2.1	3.2	2.3	2.9	2.4	2.2	2.4	3.3	3.6	3.0	4.8	2.2	3.9	1.5	2.7	4.1	2.8	2.2	2.9	2.4	2.8	3.9	2.3	2.4	3.1	2.9	3.4	2.3	4.0	3.2	5.5	3.6	3.6	3.0	2.4	2.0	4.1	3.9	4.0	4.4	4.1	3.2	4.7	3.2	5.1	4.4	3.7	4.0	1.7	2.2	5.6	1.5	7.1	2.5	4.5	4.2	5.5	5.4	9.3	2.6	7.1	5.5	3.2	2.9	10.9	6.0	4.3	2.4	5.9	5.1	3.5	5.6	3.9	4.1	8.0	5.7	3.1	5.3	1.5	2.6	1.4	3.6	5.4	5.8	4.4	2.6	7.2	4.2	4.0	4.7	2.9	3.6	3.2	3.4	4.6	7.9	8.3	3.5	2.3	4.1	2.8	6.2	5.7	3.0	4.6	5.0	1.6	0.7	0.9	1.0	0.9	1.0	0.8	0.8	0.6	0.3	0.8	0.9	1.1	2.2	1.1	0.6	1.3	0.2	0.4	2.9	3.5	8.0	2.8	2.3	2.9	3.6	3.0	4.1	2.9	3.2	4.1	16.5	6.4	6.3	96.9	10.6	3.2	5.0	3.0	2.8	11.2	6.3	6.0	19.4	2.8	4.9	5.5	6.2	4.2	11.4	6.9	0.0	4.3	4.6	8.6	15.3	10.0	4.2	3.4	111.0	2.9	2.7	7.6	17.3	14.4	1.3	10.2	3.3	5.5	3.2	5.0	100.2	5.7	2.0	5.3	2.8	3.3	5.3	7.6	5.4	113.4	6.1	6.2	8.2	122.6	130.5	4.8	6.0	4.5	11.1	4.4	4.3	2.6	6.2	13.2	6.6	10.8	8.1	9.0	12.8	5.6	4.1	5.2	10.1	12.1	6.0	3.9
ZNF41	"MGC8941, MRX89"	ENSG00000147124	"Zinc finger protein 41"	P51814	X	47445879-47482946	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 12.6;Inhibitory neurons: 18.6;Microglial cells: 17.8;Oligodendrocytes: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA069102	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA069102: AB_2686086"	"unprognostic (9.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.87e-2)"	"prognostic favorable (8.32e-4)"	"unprognostic (3.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	4.2	3.2	3.6	6.2	3.9	1.4	6.3	5.5	5.1	6.1	4.4	6.0	4.2	5.1	3.5	4.5	4.2	4.3	9.8	3.6	3.9	5.2	4.9	5.3	6.3	3.7	3.9	5.1	3.8	8.7	3.4	4.9	3.9	4.9	7.0	9.6	4.4	4.6	19.1	4.7	4.3	5.4	3.0	6.2	5.5	2.2	4.4	7.5	7.0	16.2	7.4	5.3	3.0	4.8	6.3	6.8	5.5	14.0	6.6	7.3	3.8	8.5	7.0	7.2	8.2	3.9	6.7	8.9	4.6	11.2	9.2	9.7	12.5	5.9	9.0	14.3	4.7	2.2	9.4	2.4	4.5	9.0	7.8	5.3	7.3	8.2	10.6	6.5	6.6	7.4	6.5	9.5	9.1	9.4	9.4	4.9	9.3	5.7	10.4	8.7	7.2	9.3	5.5	10.5	7.6	7.7	12.5	9.6	4.8	6.4	10.1	4.9	10.0	7.6	5.9	15.5	6.1	6.9	10.0	9.4	6.5	17.8	8.2	0.8	2.7	2.8	3.5	3.3	4.1	2.5	3.0	3.8	3.6	4.2	3.4	3.2	0.7	3.5	1.7	2.4	2.8	2.3	3.6	3.9	5.5	5.1	3.6	3.9	3.7	3.9	3.9	3.0	4.4	4.8	3.1	3.2	3.9	9.4	3.4	0.6	2.1	1.1	4.0	3.8	1.5	1.1	4.6	0.0	1.3	0.0	0.0	0.3	2.1	2.0	1.9	1.5	0.1	1.4	2.2	2.3	0.0	3.8	12.6	1.4	0.8	3.1	3.6	2.2	1.3	1.7	3.9	1.7	1.1	0.0	18.6	1.4	2.0	1.3	1.0	0.2	0.9	2.7	1.8	17.8	1.0	1.6	2.1	8.5	16.3	1.7	2.5	0.7	5.7	1.5	2.0	0.8	2.0	3.7	0.0	1.6	2.2	1.6	1.7	4.1	0.1	0.8	4.0	2.3	1.7	2.5
ZNF414	"MGC15716, Zfp414"	ENSG00000133250	"Zinc finger protein 414"	Q96IQ9	19	8509678-8514167	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 93.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 40.5"	"Low region specificity"	"Detected in all"							HPA053769	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA053769: AB_2682255"	"unprognostic (7.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.26e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.67e-6)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (8.71e-4)"	14.3	19.6	5.6	5.2	6.3	9.1	15.9	5.0	12.3	22.3	0.5	16.8	7.9	23.2	1.3	18.3	17.2	1.8	16.7	5.7	4.8	17.2	20.9	11.4	6.3	7.1	5.6	22.4	14.9	3.4	21.3	3.7	6.3	23.9	1.1	2.1	15.0	4.4	18.1	21.9	15.6	1.8	3.5	19.3	14.5	20.6	6.6	4.3	22.5	2.7	1.9	17.2	18.0	11.1	9.2	7.8	4.2	6.8	1.1	2.6	9.2	6.9	2.6	4.4	3.9	6.9	4.4	12.5	19.3	2.1	3.2	12.5	1.4	5.6	0.6	11.4	31.0	7.9	7.2	8.3	5.9	7.0	10.3	4.8	4.0	3.6	1.3	2.4	1.9	7.8	10.7	18.0	2.7	11.3	15.7	40.5	12.5	2.4	22.0	18.1	2.2	12.8	3.1	7.5	14.4	22.3	7.5	5.7	6.6	0.8	10.8	8.1	7.1	12.8	6.5	18.7	8.9	26.0	11.8	10.0	10.2	5.8	7.1	1.4	0.5	0.3	0.6	0.4	0.3	0.8	0.9	0.9	0.5	0.8	0.8	0.8	1.6	0.8	0.7	1.2	0.4	0.4	5.6	6.3	5.0	12.3	5.7	4.8	7.1	5.6	6.3	3.5	6.6	11.1	9.7	0.0	1.1	4.2	11.8	11.9	13.5	6.9	26.2	18.3	12.1	14.7	2.1	11.5	2.5	3.7	10.4	28.8	15.8	14.3	15.6	3.9	27.1	5.7	9.2	8.2	22.2	9.2	3.6	5.3	22.8	11.8	17.3	8.0	4.5	15.0	13.2	10.9	13.1	11.8	3.6	14.6	2.0	12.7	7.6	93.4	20.5	11.6	8.8	3.7	8.8	20.4	11.3	4.0	6.5	4.6	16.0	16.1	9.3	9.1	16.2	17.6	1.4	21.9	13.1	11.5	10.0	21.3	38.3	18.0	12.1	31.5	12.8	19.0	13.2	9.8
ZNF417	MGC34079	ENSG00000173480	"Zinc finger protein 417"	Q8TAU3	19	57900296-57916610	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 57.4"									"HPA042125, HPA043288, HPA056213"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.34e-1)"	"unprognostic (7.65e-3)"	"unprognostic (5.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-2)"	"unprognostic (8.75e-2)"	"prognostic favorable (3.48e-4)"	7.7	9.7	29.5	9.7	29.9	15.7	21.3	37.9	38.0	18.4	31.9	10.5	9.4	13.4	48.9	8.3	13.0	15.0	11.2	28.9	33.5	11.7	14.9	10.5	19.0	28.7	29.1	12.1	8.4	15.4	10.5	10.0	28.8	15.8	13.4	25.8	12.6	17.4	7.3	29.0	10.7	10.4	25.3	17.8	14.5	9.5	31.3	21.6	21.1	6.3	22.3	9.3	4.9	35.6	7.1	10.8	17.2	11.9	17.0	16.2	14.6	8.8	12.7	8.0	6.7	11.6	4.1	15.1	4.8	12.9	6.1	4.9	10.9	11.9	22.4	2.6	57.4	16.2	26.5	10.7	11.5	15.0	16.7	11.9	11.9	7.9	10.5	14.9	10.3	12.0	5.1	0.9	16.7	6.9	16.3	7.2	9.9	4.9	10.6	12.8	20.7	10.8	8.6	32.1	15.7	10.2	11.6	7.8	3.0	17.7	8.3	12.0	7.1	20.2	8.6	4.6	8.9	16.1	27.8	12.5	8.7	6.0	9.8	5.9	2.0	5.1	2.6	2.4	3.3	2.6	3.0	2.6	1.5	3.6	4.0	3.0	3.3	2.1	1.7	3.3	2.7	1.5	29.5	29.9	37.9	38.0	28.9	33.5	28.7	29.1	28.8	25.3	31.3	35.6	1.5	6.4	1.1	5.5	1.7	0.8	1.2	0.7	1.8	4.0	2.5	1.9	3.0	2.8	4.8	0.0	0.0	1.0	1.5	1.7	0.0	1.2	0.5	1.2	1.2	2.6	6.0	6.1	3.9	1.4	0.8	2.0	2.0	1.6	4.5	2.0	2.9	2.2	1.0	1.7	3.8	2.1	0.0	2.5	1.5	0.1	2.5	1.7	0.0	1.9	1.0	0.9	2.1	2.5	5.7	0.4	0.5	1.5	5.0	1.4	1.5	1.5	2.2	3.9	6.6	1.9	1.7	1.3	2.1	1.0	1.3	0.8	2.0	1.2	1.7	1.6
ZNF418	"FLJ31551, KIAA1956"	ENSG00000196724	"Zinc finger protein 418"	Q8TF45	19	57921882-57935402	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 9.1;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 11.1;SuSa: 7.6;T-47d: 6.9"									"HPA043800, HPA053762, HPA072145"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (4.41e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.36e-3)"	2.2	2.8	4.9	2.4	5.7	2.0	5.9	10.3	5.0	3.2	0.2	4.5	1.0	4.1	5.3	2.0	4.7	2.4	8.7	4.5	5.6	4.1	2.3	2.6	5.2	2.6	3.3	6.2	4.5	6.2	5.3	5.7	2.5	4.7	1.5	12.4	3.5	5.6	3.3	9.0	2.5	4.0	1.4	5.1	3.5	4.4	4.9	4.6	6.7	4.9	4.5	3.6	2.9	9.2	0.3	1.3	11.1	3.6	1.7	3.6	1.2	3.4	1.1	2.5	0.2	0.2	1.2	0.4	2.3	1.7	3.3	1.0	0.0	2.8	3.0	0.3	1.0	0.2	0.7	0.1	1.0	0.3	2.3	3.0	0.8	3.1	0.0	0.0	0.5	1.0	0.9	0.8	2.1	0.4	0.6	0.4	5.7	0.1	0.4	0.5	0.8	4.0	2.1	1.4	0.2	0.5	0.1	2.0	0.1	7.6	6.9	1.2	0.0	0.7	0.5	0.4	0.6	1.8	4.7	2.9	0.3	1.3	2.2	1.3	0.5	0.5	0.1	1.3	0.4	3.2	1.1	0.7	1.0	5.5	1.8	0.5	0.6	4.3	0.5	1.8	0.0	0.8	4.9	5.7	10.3	5.0	4.5	5.6	2.6	3.3	2.5	1.4	4.9	9.2	1.7	0.0	0.6	4.2	2.9	0.4	0.8	0.4	0.6	4.3	1.8	1.4	9.1	1.5	1.0	0.0	4.2	1.0	0.8	0.0	1.9	1.2	0.1	1.8	0.9	1.9	0.0	2.5	4.1	0.6	0.6	1.9	1.1	1.1	5.7	2.5	2.5	0.8	0.8	3.3	3.5	0.0	0.0	0.3	0.7	0.9	0.3	0.6	0.0	1.9	0.2	4.3	1.0	4.0	6.3	0.2	1.2	1.5	0.1	1.1	0.0	1.1	5.6	5.9	13.1	0.7	1.3	2.6	5.6	0.7	0.4	0.8	0.7	0.3	0.2	0.8
ZNF419	"ZAPHIR, ZNF419A"	ENSG00000105136	"Zinc finger protein 419"	Q96HQ0	19	57487711-57496098	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 31.9"									"HPA003152, HPA003274"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA003152: AB_1080716, HPA003274: AB_1080714"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.55e-5)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (2.53e-5)"	6.0	8.7	10.0	4.6	10.1	3.0	6.2	10.7	12.6	4.8	9.9	6.3	3.8	5.3	9.7	4.7	6.2	3.5	8.2	10.0	10.1	8.1	6.6	7.0	7.4	9.4	8.9	7.8	4.6	9.1	13.4	6.1	8.8	8.9	3.6	11.1	6.4	6.3	10.4	7.4	6.2	4.0	8.9	10.6	5.3	5.3	10.2	8.0	10.8	7.8	8.9	5.4	4.6	10.1	5.4	6.0	10.3	10.5	4.7	7.1	8.9	6.4	8.8	5.8	31.9	3.8	3.4	1.8	5.1	4.5	5.2	1.6	4.9	13.3	8.0	0.5	22.4	8.3	9.1	4.2	16.8	6.5	6.0	9.7	19.3	5.8	13.8	12.0	6.4	8.0	0.9	1.3	7.3	0.9	10.9	6.7	6.8	0.7	7.9	10.1	9.9	7.6	6.3	11.5	8.4	9.4	6.5	6.0	6.2	8.8	5.3	9.7	6.6	7.0	7.7	2.5	5.6	15.2	18.0	4.5	5.6	3.5	5.7	4.5	2.7	6.1	5.2	3.3	8.9	14.3	8.9	6.6	4.7	15.8	13.8	7.4	3.2	9.7	2.7	3.4	6.5	4.4	10.0	10.1	10.7	12.6	10.0	10.1	9.4	8.9	8.8	8.9	10.2	10.1	3.1	0.0	5.3	3.6	7.2	4.1	5.7	4.9	2.8	8.1	4.3	5.2	5.3	4.3	5.2	7.3	6.2	5.0	4.2	1.3	0.0	5.8	0.3	2.0	2.1	4.8	1.2	2.5	3.3	1.8	2.4	3.7	0.5	1.7	4.5	7.4	5.7	4.6	3.2	10.1	2.8	1.8	8.2	3.2	1.7	0.5	1.8	1.8	5.4	0.0	4.1	6.8	7.2	3.5	1.9	2.5	2.8	5.7	1.6	9.0	2.0	1.9	1.8	9.5	6.6	2.9	3.3	4.9	10.4	2.1	3.8	8.3	4.8	4.2	1.8	5.6
ZNF420	FLJ32191	ENSG00000197050	"Zinc finger protein 420"	Q8TAQ5	19	37007857-37130368	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA059675	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA059675: AB_2684101"	"unprognostic (1.00e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.40e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (7.94e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (2.42e-1)"	"unprognostic (7.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.63e-2)"	3.0	4.2	4.9	2.5	5.2	1.6	5.6	6.7	6.2	5.0	5.0	3.9	2.5	4.5	3.9	3.0	5.1	2.7	3.3	4.9	5.0	4.2	3.3	2.8	4.2	4.5	4.8	8.0	3.2	6.3	3.4	3.3	5.5	4.2	2.5	7.3	3.4	4.0	5.5	3.4	2.7	4.1	5.0	4.4	3.1	9.8	4.9	5.7	6.6	6.5	4.6	3.4	3.2	5.4	0.0	6.8	6.4	6.7	5.8	3.8	3.2	4.2	4.1	4.7	7.1	1.5	1.4	3.3	8.1	2.9	2.9	1.2	6.6	2.1	5.5	10.8	5.0	7.5	3.6	2.8	6.0	6.3	3.2	4.0	4.5	5.1	3.5	5.4	2.7	5.6	4.1	0.3	5.5	2.3	10.7	2.4	7.4	2.7	4.1	6.1	12.9	6.8	2.7	4.5	8.7	9.7	6.1	2.5	3.4	4.5	4.0	4.9	3.1	5.0	7.7	4.6	4.9	9.9	12.9	8.2	0.0	1.3	4.4	2.1	2.9	6.8	9.9	4.0	10.6	9.8	11.0	10.4	5.6	13.7	11.1	12.3	0.5	12.3	4.3	3.0	14.3	5.9	4.9	5.2	6.7	6.2	4.9	5.0	4.5	4.8	5.5	5.0	4.9	5.4	7.1	12.8	8.6	11.1	11.0	9.9	3.3	4.0	7.4	18.7	7.4	6.3	6.1	4.3	6.6	3.7	0.0	9.2	6.2	2.1	7.9	4.1	31.4	4.6	4.1	6.7	6.0	4.2	32.8	1.3	4.1	7.0	0.5	2.9	12.7	15.3	10.0	4.2	4.2	16.8	24.2	2.8	8.2	3.8	2.3	34.5	9.6	3.5	7.2	26.2	2.8	5.9	12.3	28.1	26.4	1.9	2.9	9.4	5.9	4.2	2.7	5.3	10.7	9.0	26.3	10.5	6.5	15.5	7.4	6.4	8.7	4.0	10.4	6.6	4.3	2.6
ZNF423	"Ebfaz, hOAZ, JBTS19, KIAA0760, NPHP14, OAZ, Zfp104"	ENSG00000102935	"Zinc finger protein 423"	Q2M1K9	16	49487524-49857919	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4;skeletal muscle: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.4;Late spermatids: 115.7;Microglial cells: 53.4;Oligodendrocyte precursor cells: 38.7;Peritubular cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 62.6;NTERA-2: 33.2;REH: 27.5;SCLC-21H: 35.1;SH-SY5Y: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015258, HPA065820"			Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA015258: , HPA065820: AB_2685563"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.84e-2)"	9.1	2.9	13.5	2.3	9.6	0.3	6.7	14.0	10.2	6.3	1.0	4.3	1.3	5.4	3.4	4.7	9.3	5.8	7.8	9.7	11.0	2.0	0.7	2.9	1.9	14.9	30.4	7.6	3.4	3.0	4.0	4.2	11.8	6.0	2.7	3.6	2.8	9.5	27.5	2.0	2.6	6.5	8.6	1.4	2.0	4.5	26.3	1.8	4.3	14.7	1.2	3.9	5.4	7.8	0.0	0.0	62.6	3.3	5.1	0.6	7.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	1.4	0.0	0.0	1.9	0.5	0.0	3.6	0.1	0.2	0.0	0.0	4.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	8.8	0.4	33.2	0.0	0.0	27.5	0.1	0.0	0.0	1.7	35.1	87.7	0.0	0.1	0.0	17.6	0.0	0.0	0.0	0.0	1.0	16.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.5	9.6	14.0	10.2	9.7	11.0	14.9	30.4	11.8	8.6	26.3	7.8	12.7	0.0	0.0	75.4	0.0	2.7	0.3	0.1	1.2	9.8	0.6	0.6	2.6	0.0	0.0	0.0	0.0	0.5	0.1	2.3	1.9	0.2	23.5	2.7	7.6	11.4	0.0	0.0	10.9	0.2	0.7	15.8	0.0	0.6	0.0	1.6	15.4	0.9	0.7	0.0	7.4	1.0	0.0	0.3	5.1	115.7	27.7	0.4	1.8	53.4	0.0	11.7	0.0	38.7	5.1	0.2	0.4	54.5	0.2	0.1	0.2	0.6	0.0	1.1	0.0	4.5	6.4	0.8	1.9	0.1	1.7	0.3	0.3	5.5	0.7	0.1
ZNF425		ENSG00000204947	"Zinc finger protein 425"	Q6IV72	7	149102784-149126324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 8.5;Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA020087	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA020087: AB_2670358"	"unprognostic (4.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-4)"	"unprognostic (9.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.21e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.25e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.58e-2)"	0.8	1.2	3.1	0.9	3.1	0.6	1.7	3.3	3.2	2.1	2.1	2.1	1.0	2.4	2.1	2.1	2.3	1.0	0.8	3.0	2.7	2.2	1.0	1.0	0.8	2.8	2.8	3.8	1.5	2.3	1.4	0.7	2.8	1.9	0.8	1.4	1.8	2.2	3.8	2.5	0.9	1.7	2.6	1.0	1.6	1.3	2.9	1.6	1.9	1.9	1.2	1.9	1.5	2.8	1.4	1.7	3.6	3.1	5.3	1.5	2.0	2.0	3.4	1.1	1.2	0.4	1.8	1.6	2.8	1.6	1.4	1.9	0.6	1.0	0.4	1.1	1.4	1.9	2.4	0.8	3.0	0.9	0.8	3.1	1.7	1.1	2.0	3.0	0.5	2.4	1.4	1.5	3.7	6.6	2.5	2.9	8.6	2.0	3.3	2.7	1.8	0.9	2.4	1.9	1.6	3.0	1.9	2.4	4.5	2.3	1.6	2.6	0.7	2.3	0.3	2.7	0.5	3.2	2.1	1.2	1.9	0.6	1.9	2.1	0.6	1.4	1.8	0.7	2.3	1.4	1.5	1.2	0.6	1.8	2.1	2.3	1.6	3.2	0.4	2.1	2.0	0.8	3.1	3.1	3.3	3.2	3.0	2.7	2.8	2.8	2.8	2.6	2.9	2.8	0.4	0.0	2.0	5.2	1.9	0.3	0.8	0.7	2.2	3.4	1.8	1.5	1.8	0.0	1.2	3.7	0.0	0.8	0.3	0.5	5.9	1.6	0.9	1.4	2.2	0.6	1.2	3.0	7.5	0.5	0.8	1.5	4.6	1.2	0.0	3.4	0.4	0.6	0.4	6.7	8.5	0.7	2.0	0.0	0.2	0.3	4.4	0.6	0.0	7.5	1.8	4.7	0.0	9.0	10.7	0.6	0.6	5.3	1.3	1.0	0.7	1.1	2.4	1.2	0.0	2.3	1.5	3.5	3.5	2.8	0.3	1.0	1.4	3.0	0.8	0.5
ZNF426	MGC2663	ENSG00000130818	"Zinc finger protein 426"	Q9BUY5	19	9523223-9538645	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029342	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA029342: AB_10603007"	"unprognostic (3.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.05e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.41e-3)"	"prognostic favorable (2.57e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.81e-4)"	5.1	3.3	3.1	3.9	4.0	5.7	6.9	5.4	3.4	5.5	4.9	4.1	2.8	7.6	4.5	20.6	5.8	4.3	5.4	3.2	2.9	4.3	2.2	5.1	4.1	3.4	3.4	9.2	4.3	6.3	2.4	5.6	3.4	5.9	3.8	5.1	4.0	5.3	3.7	4.1	2.9	7.8	2.9	4.7	3.7	4.8	3.8	5.7	6.7	5.5	5.7	4.7	5.8	6.0	5.7	1.8	11.2	11.8	7.4	9.7	6.2	7.1	10.8	9.4	11.4	2.4	2.5	5.7	5.6	6.9	6.6	4.8	11.7	8.4	14.0	2.7	9.0	23.7	9.5	4.3	6.7	0.7	7.4	12.4	7.1	10.5	15.0	10.2	10.2	9.7	9.6	0.5	9.1	0.3	13.7	11.4	14.0	1.3	4.4	7.4	13.9	5.9	5.1	14.7	6.3	8.5	12.1	4.3	9.7	9.5	6.0	5.5	8.3	13.2	7.7	6.0	7.7	6.4	9.7	4.8	1.9	0.3	9.6	10.0	3.2	6.1	8.8	4.5	7.8	7.6	6.8	8.7	3.8	6.5	10.0	9.3	6.7	7.8	6.3	3.4	7.1	3.4	3.1	4.0	5.4	3.4	3.2	2.9	3.4	3.4	3.4	2.9	3.8	6.0	15.0	28.9	26.5	3.3	13.2	3.4	15.6	3.2	12.5	24.8	17.1	14.6	10.1	5.7	12.4	7.3	20.9	12.8	13.4	3.8	21.5	10.9	33.5	11.5	14.2	16.4	3.6	12.6	5.4	4.2	10.2	12.4	5.1	15.5	28.4	22.4	14.3	3.0	7.6	37.0	3.9	4.2	12.2	8.9	1.6	8.2	17.1	8.2	3.6	5.6	11.2	20.1	15.5	4.5	4.7	6.9	5.1	22.2	6.7	13.3	4.7	5.4	14.6	22.0	6.6	17.9	13.2	12.2	11.8	14.7	2.8	14.2	12.1	12.3	6.3	17.9
ZNF429		ENSG00000197013	"Zinc finger protein 429"	Q86V71	19	21496682-21556270	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004139			Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA004139: AB_2667147"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.96e-8)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.48e-1)"	2.8	4.7	5.1	2.8	4.7	2.4	5.2	7.4	6.1	4.2	6.4	3.2	2.6	3.3	6.1	2.1	4.9	2.8	2.1	4.5	3.3	5.4	5.6	3.3	4.9	4.2	3.1	6.8	5.1	5.4	3.5	3.6	4.4	4.3	4.1	5.4	3.6	2.9	2.2	6.8	3.1	2.2	2.1	5.9	4.4	4.5	4.4	5.7	7.8	2.2	3.5	2.2	2.6	7.3	0.3	0.6	3.7	5.2	2.7	2.4	4.0	2.0	1.5	2.7	3.6	0.4	2.7	3.5	5.6	1.3	2.4	1.3	2.1	0.9	4.9	0.9	2.7	0.8	0.9	1.3	1.5	3.6	1.4	2.5	1.2	1.7	0.6	2.5	0.2	4.9	5.5	0.9	4.4	2.4	8.5	3.4	4.1	0.1	1.3	4.1	2.1	1.8	3.2	4.2	6.5	2.9	0.3	0.2	1.6	7.1	4.9	3.2	0.6	0.4	0.9	3.5	1.7	0.7	3.0	4.4	0.2	0.4	1.4	8.9	1.3	6.7	3.5	1.7	3.8	5.5	4.8	4.7	1.2	4.9	6.7	6.2	6.9	7.1	2.2	1.9	3.2	1.9	5.1	4.7	7.4	6.1	4.5	3.3	4.2	3.1	4.4	2.1	4.4	7.3	6.1	28.9	13.6	14.7	13.6	2.8	6.5	3.8	8.6	15.9	8.6	8.0	6.0	18.6	10.8	7.3	6.2	9.1	5.1	3.8	21.5	8.7	39.2	9.6	8.7	7.7	6.7	10.1	17.5	4.9	6.9	9.5	9.2	7.8	3.8	19.0	7.1	8.5	3.4	3.3	20.8	5.1	8.2	3.1	4.0	7.6	11.5	5.4	5.4	12.2	4.5	11.4	23.7	20.6	20.4	4.4	6.1	6.0	3.7	5.0	10.9	13.6	12.2	8.1	19.7	6.0	7.5	14.0	17.3	9.4	2.0	6.8	10.3	37.2	5.8	4.6
ZNF432	KIAA0798	ENSG00000256087	"Zinc finger protein 432"	O94892	19	52031378-52095738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 26.9;Rod photoreceptor cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA052082, HPA060274, HPA065606"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA052082: AB_2681719, HPA060274: AB_2684238, HPA065606: AB_2685518"	"unprognostic (1.62e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.41e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.49e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (4.11e-5)"	6.3	13.4	3.2	3.7	3.9	8.0	6.5	5.7	3.7	6.5	8.8	5.5	5.2	7.0	8.7	6.6	6.0	3.5	6.0	3.4	5.5	5.1	4.1	5.6	4.3	3.9	3.7	6.8	18.0	5.6	12.4	4.4	3.9	11.8	4.3	24.6	7.1	4.5	4.1	7.8	5.2	4.3	2.9	4.4	6.4	7.2	4.3	4.0	6.7	4.4	4.1	5.0	6.5	4.8	4.6	3.7	8.2	13.0	5.6	7.2	2.8	5.2	3.9	3.7	5.9	3.2	2.7	3.1	1.6	5.6	4.0	3.4	4.8	4.5	6.4	3.2	11.8	9.5	9.2	6.0	2.6	0.0	8.5	7.3	3.6	5.4	7.9	7.1	4.9	3.7	2.6	14.0	6.8	2.6	9.3	5.2	3.0	2.4	6.3	4.9	9.5	5.4	5.5	22.2	4.8	5.0	8.1	4.4	2.6	5.8	3.9	3.7	7.0	3.1	4.7	3.7	5.5	7.2	10.7	7.5	7.2	0.8	6.1	0.9	1.1	1.3	1.4	1.3	1.0	1.9	0.8	0.8	0.9	1.2	1.5	1.1	1.0	0.6	0.6	0.6	1.2	0.8	3.2	3.9	5.7	3.7	3.4	5.5	3.9	3.7	3.9	2.9	4.3	4.8	6.2	16.0	10.0	8.1	8.0	2.0	3.3	3.4	3.4	9.8	3.8	3.2	6.0	2.8	11.6	9.2	16.7	2.7	6.4	3.7	3.9	3.5	14.7	11.9	6.4	5.7	10.2	2.5	9.4	1.6	5.8	5.8	6.6	9.0	12.6	7.8	3.9	1.3	2.3	26.9	6.7	4.9	4.1	4.1	1.3	12.4	3.7	3.2	3.6	9.4	3.8	7.7	10.3	9.0	6.9	2.1	5.2	4.5	4.0	3.6	2.0	2.7	11.6	30.7	6.6	7.1	6.4	10.0	8.4	2.2	2.3	4.9	6.5	4.2	3.1	3.3
ZNF436	"KIAA1710, Zfp46"	ENSG00000125945	"Zinc finger protein 436"	Q9C0F3	1	23359448-23369836	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.8;HSkMC: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043817	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"HPA043817: AB_10794774"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.51e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.75e-3)"	10.0	14.8	4.8	2.3	5.2	1.4	9.8	5.5	5.4	9.8	4.5	8.5	3.1	9.9	8.0	16.5	6.9	5.5	8.3	5.5	5.3	4.0	3.7	4.2	2.7	6.3	5.2	15.4	6.9	5.3	4.4	4.2	5.6	9.5	3.1	4.6	14.6	5.1	6.5	12.6	5.6	6.2	5.6	7.0	6.1	7.9	5.4	3.5	9.0	6.2	3.6	10.4	10.2	5.9	3.8	2.4	8.6	4.5	9.1	18.8	4.1	3.4	4.6	4.3	5.0	1.4	3.3	2.6	3.8	4.9	2.8	4.8	15.0	5.7	4.6	3.2	3.3	2.8	5.3	2.2	3.6	1.2	1.9	34.9	8.0	3.6	4.1	7.8	6.2	3.1	3.4	1.8	4.5	1.8	2.9	2.1	0.3	1.7	3.8	3.8	3.6	2.5	3.4	9.5	3.9	4.9	9.6	4.7	3.7	2.9	2.6	1.4	5.0	3.7	2.7	2.9	1.9	2.8	3.6	2.1	2.9	2.3	2.9	0.0	0.7	0.7	0.7	0.8	0.7	0.4	0.5	0.8	1.1	0.5	0.8	0.7	0.5	2.6	0.8	0.1	0.9	0.6	4.8	5.2	5.5	5.4	5.5	5.3	6.3	5.2	5.6	5.6	5.4	5.9	7.8	0.0	0.5	2.6	2.0	5.2	1.6	1.9	22.2	4.1	6.9	5.0	6.4	1.5	1.6	5.5	6.2	3.8	2.6	3.5	0.0	2.9	2.3	5.0	8.5	14.0	3.6	1.7	4.2	4.9	1.8	9.6	2.0	7.8	0.0	9.4	3.3	3.1	2.1	10.1	3.3	4.6	2.0	1.9	3.8	1.5	9.9	2.1	5.4	0.0	4.5	9.3	2.1	2.5	3.1	3.6	5.9	11.7	2.1	3.3	4.0	2.8	2.4	2.4	0.0	4.5	4.5	5.5	6.9	22.1	9.7	2.9	2.4	7.9	3.1	2.0
ZNF438	bA330O11.1	ENSG00000183621	"Zinc finger protein 438"	Q7Z4V0	10	30820207-31031937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Excitatory neurons: 55.3;Inhibitory neurons: 74.7;Microglial cells: 76.8;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;U-937: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039843	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA039843: AB_10795159"	"unprognostic (1.69e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.50e-2)"	11.9	3.6	5.5	6.4	5.7	5.5	7.4	5.1	7.3	8.5	5.7	11.3	3.8	9.2	6.6	4.6	8.2	5.6	11.0	5.6	5.8	4.4	5.4	8.4	4.0	5.3	5.2	5.9	3.1	3.7	4.9	4.0	5.5	5.4	4.1	4.5	6.2	5.6	24.6	6.8	5.3	8.7	5.3	10.3	6.0	8.4	6.3	7.8	9.7	17.4	3.1	9.3	6.8	6.5	3.7	3.7	3.1	2.7	18.0	12.5	1.7	2.9	4.2	4.5	5.6	0.2	4.4	5.0	3.3	5.2	4.2	1.0	1.6	2.2	6.3	11.6	1.2	2.2	2.0	0.2	10.1	1.7	2.3	6.0	3.7	6.4	3.6	4.1	19.0	5.8	4.3	3.5	6.2	2.7	5.9	9.7	0.3	2.7	1.5	2.6	4.5	2.9	6.4	0.9	2.3	2.5	1.4	0.6	2.1	2.0	1.4	16.2	7.9	2.0	3.5	6.1	3.6	0.8	1.5	0.1	4.0	25.3	1.5	1.3	7.2	3.3	2.0	6.9	1.5	1.0	1.5	2.7	2.2	3.7	3.1	1.7	13.1	3.9	4.3	2.8	3.6	3.5	5.5	5.7	5.1	7.3	5.6	5.8	5.3	5.2	5.5	5.3	6.3	6.5	7.8	3.2	4.8	111.3	3.2	1.0	2.0	1.7	5.2	5.5	2.1	2.2	13.0	5.7	4.2	3.7	6.2	3.5	2.0	1.8	7.9	3.6	25.2	2.7	5.6	6.1	0.0	2.5	55.3	4.2	4.6	9.1	7.1	2.4	12.6	4.1	6.4	1.8	6.9	3.3	74.7	2.6	0.0	12.9	3.5	9.6	4.1	36.3	0.0	76.8	7.3	2.4	7.2	137.2	86.9	3.7	0.8	8.2	3.6	1.3	2.5	3.9	3.9	5.3	6.6	17.0	6.7	12.8	8.0	6.0	2.4	1.6	4.2	2.4	2.3	1.8
ZNF439	DKFZp571K0837	ENSG00000171291	"Zinc finger protein 439"	Q8NDP4	19	11848726-11883750	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;Rod photoreceptor cells: 49.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 26.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.4;U-138 MG: 15.6"									HPA047845	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.83e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.19e-3)"	"unprognostic (8.26e-3)"	"unprognostic (7.54e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"unprognostic (9.66e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.29e-2)"	2.6	3.5	3.8	3.5	4.7	4.2	5.7	8.2	5.2	4.2	4.3	5.0	1.1	5.2	5.0	3.2	4.0	2.4	3.5	4.0	4.0	6.3	1.3	5.1	7.3	4.5	4.1	8.1	4.1	16.5	10.1	5.2	5.0	6.2	3.8	14.7	5.3	4.4	0.8	8.0	8.0	2.6	4.0	9.4	3.9	5.7	4.1	10.0	7.3	1.1	7.6	5.6	4.8	6.7	0.1	0.0	4.2	12.2	0.4	0.3	0.0	5.2	1.8	6.2	4.2	3.0	0.2	4.5	2.2	2.9	1.8	0.1	0.0	0.4	7.2	0.0	0.1	4.4	0.0	1.8	1.2	0.0	4.2	1.2	0.3	1.3	0.0	2.7	0.0	4.2	0.8	0.0	0.4	0.4	6.2	15.4	5.1	0.0	1.2	7.3	1.2	0.0	4.6	2.6	7.5	8.0	0.0	0.1	5.6	4.3	3.2	10.0	0.0	15.6	1.4	1.3	3.1	6.0	10.1	10.1	0.2	0.0	4.3	26.1	0.6	5.7	1.7	1.6	2.3	8.9	3.0	1.7	2.8	8.6	5.4	3.1	1.6	2.2	3.5	2.7	1.4	1.9	3.8	4.7	8.2	5.2	4.0	4.0	4.5	4.1	5.0	4.0	4.1	6.7	3.1	3.2	10.4	15.0	23.9	0.5	2.5	1.6	3.4	26.2	3.9	4.6	3.5	11.5	6.8	0.0	52.1	32.8	8.3	9.2	3.9	8.2	4.5	6.5	5.1	4.6	6.1	3.0	19.2	1.8	22.2	3.8	4.1	4.4	29.8	11.2	6.1	0.2	4.2	16.8	8.7	2.3	2.0	1.9	3.1	3.8	4.4	2.7	5.4	14.0	2.4	10.4	25.7	31.7	28.3	3.0	6.0	7.9	4.1	2.1	6.5	2.1	5.8	49.9	13.1	1.8	5.9	21.7	5.8	1.1	1.8	13.5	7.4	2.8	3.1	1.3
ZNF44	"KOX7, ZNF504, ZNF55, ZNF58"	ENSG00000197857	"Zinc finger protein 44"	P15621	19	12224686-12294883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 95.9;Early spermatids: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003146	Supported		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Microtubules, Cytosol"	"HPA003146: AB_1080723"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.65e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.56e-3)"	"unprognostic (7.30e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.69e-2)"	"prognostic favorable (9.21e-6)"	6.9	5.7	2.5	2.7	2.7	9.6	6.8	3.8	3.1	7.5	3.8	6.9	3.3	5.4	5.2	6.8	6.3	2.1	5.2	2.5	2.7	12.1	11.0	6.1	4.4	2.8	2.7	9.4	6.8	4.0	7.1	2.7	2.8	7.4	4.9	5.0	5.7	3.1	3.5	7.9	7.4	2.6	2.3	9.4	5.0	9.7	2.8	3.2	6.7	2.4	4.2	7.0	6.9	3.4	3.0	0.9	1.8	4.3	2.1	1.9	9.6	4.2	1.7	6.5	5.9	4.2	1.7	3.0	5.0	3.4	1.9	3.2	3.0	2.6	5.6	0.0	2.7	2.9	4.4	11.3	2.9	0.0	7.4	2.5	3.9	4.1	4.9	2.6	2.6	3.8	1.9	0.6	4.2	3.2	4.6	5.7	1.8	3.0	5.2	3.2	4.7	3.8	3.7	7.1	2.6	2.9	5.4	2.2	1.4	6.2	4.5	4.6	2.8	8.3	2.3	8.3	3.7	6.5	7.5	2.8	0.2	2.7	2.4	11.9	1.7	15.8	7.3	3.2	8.5	4.2	7.9	7.9	1.3	3.4	8.4	8.4	5.6	11.5	3.2	3.2	6.1	3.4	2.5	2.7	3.8	3.1	2.5	2.7	2.8	2.7	2.8	2.3	2.8	3.4	14.6	28.9	19.9	16.6	16.1	9.1	6.6	8.2	8.0	16.1	10.6	8.3	16.9	17.2	13.9	64.4	37.5	17.2	21.5	17.9	95.9	9.9	113.1	21.1	11.6	11.8	15.6	6.5	13.8	9.3	6.8	8.3	6.1	25.1	24.1	14.4	11.0	12.4	8.5	16.8	16.1	12.9	10.2	11.1	8.7	34.1	14.0	10.9	10.6	25.3	8.8	9.8	27.8	17.6	21.7	9.6	13.0	6.0	13.7	6.2	17.1	13.6	24.8	36.7	19.7	11.6	9.8	36.5	24.8	16.4	11.6	8.6	19.2	8.4	12.9	9.6
ZNF440	FLJ37933	ENSG00000171295	"Zinc finger protein 440"	Q8IYI8	19	11814273-11835216	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 44.8;Respiratory ciliated cells: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 12.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"RT4: 25.5"									HPA047845	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (2.48e-1)"	"unprognostic (8.96e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.13e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.57e-4)"	"prognostic favorable (1.18e-4)"	"unprognostic (9.81e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.88e-4)"	3.8	3.9	2.8	3.4	2.5	6.9	6.8	6.3	3.6	6.1	7.4	10.0	5.6	4.4	4.8	9.8	14.5	4.3	3.3	5.0	1.8	4.7	3.7	6.9	4.2	3.7	5.3	3.8	5.5	16.4	2.8	9.7	3.1	6.3	11.1	7.1	7.1	4.3	4.3	15.6	7.1	3.5	1.2	4.3	8.6	6.4	2.4	8.0	4.1	2.2	5.2	11.6	7.1	4.8	6.7	0.0	7.3	8.9	5.4	4.8	19.4	4.6	3.8	5.5	4.7	7.0	5.7	3.7	4.4	4.2	2.7	8.2	3.8	8.9	7.6	0.3	2.5	5.2	4.8	5.6	2.7	0.1	11.5	2.7	5.8	3.4	0.9	3.9	3.1	5.0	19.9	0.3	6.4	2.8	4.7	6.9	5.6	2.3	5.8	3.9	9.5	1.6	4.0	25.5	4.2	3.3	7.2	3.0	5.3	7.8	12.9	10.3	3.3	12.5	2.6	9.2	4.1	6.7	5.2	4.9	5.8	3.3	4.6	12.6	1.4	1.9	1.1	0.9	1.4	1.0	1.4	1.3	1.8	1.1	1.0	1.6	2.5	3.0	2.9	1.1	1.8	0.8	2.8	2.5	6.3	3.6	5.0	1.8	3.7	5.3	3.1	1.2	2.4	4.8	3.9	16.0	7.9	7.2	2.5	2.9	7.6	5.2	8.0	5.5	3.4	2.7	3.0	1.5	14.6	9.2	35.5	31.1	5.8	25.1	3.9	3.6	16.7	44.8	3.8	4.2	6.7	2.1	10.4	3.6	20.7	3.1	15.3	11.9	10.8	3.3	4.2	1.7	4.5	6.7	6.7	12.7	2.0	5.0	2.8	5.7	2.8	3.0	3.6	2.8	2.2	2.0	4.1	10.6	5.8	5.8	15.9	1.9	2.5	5.7	20.8	2.1	74.1	13.1	0.0	3.9	4.1	9.7	3.5	9.0	4.8	29.8	4.6	1.1	12.1	9.8
ZNF443	ZK1	ENSG00000180855	"Zinc finger protein 443"	Q9Y2A4	19	12429706-12441021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.3"									"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (5.64e-3)"	"unprognostic (1.51e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.38e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.74e-7)"	"unprognostic (3.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (3.91e-4)"	1.4	1.7	3.2	1.4	3.3	0.6	4.2	3.6	3.8	2.9	2.5	2.8	2.0	2.7	3.1	2.6	2.6	2.1	1.8	2.9	3.1	3.8	3.2	1.6	1.8	3.2	3.3	2.3	2.6	2.8	1.9	3.2	3.0	3.1	3.3	3.3	2.9	3.2	1.1	3.8	2.2	1.8	3.1	1.6	2.4	1.8	3.4	4.0	2.4	1.7	2.2	2.8	2.8	2.9	3.1	1.4	5.4	4.9	1.6	1.3	7.4	2.2	1.6	3.0	2.8	3.0	0.9	3.7	3.9	1.8	1.2	1.8	3.6	2.3	2.5	0.0	1.8	1.5	1.9	7.0	0.4	3.5	4.1	1.2	1.4	1.5	0.7	2.0	1.7	4.5	2.6	0.0	3.3	3.8	13.3	4.8	4.6	3.1	4.6	1.5	5.7	4.5	3.6	11.6	2.6	4.2	3.7	2.0	0.5	3.0	0.0	4.3	1.2	5.9	2.4	3.2	2.2	2.2	3.6	2.3	0.8	3.5	1.2	2.5	0.6	0.9	1.0	0.3	3.7	2.1	2.2	2.2	1.1	1.7	1.9	1.4	0.4	1.6	0.2	0.6	1.8	1.0	3.2	3.3	3.6	3.8	2.9	3.1	3.2	3.3	3.0	3.1	3.4	2.9	3.5	0.0	0.5	10.7	2.4	1.0	1.5	1.2	2.2	1.2	2.8	2.3	2.3	2.8	1.4	0.0	4.2	7.7	2.6	1.8	1.9	2.7	6.3	2.9	1.2	2.8	3.0	1.7	8.9	1.2	1.2	1.4	1.1	3.4	0.0	3.7	1.4	1.6	1.3	1.7	8.1	2.1	2.0	0.9	1.5	2.7	0.6	1.0	0.0	3.7	0.1	3.0	5.2	8.5	5.0	1.1	2.8	2.2	0.6	0.6	1.7	2.2	2.3	2.2	0.0	1.0	1.7	5.0	6.6	3.0	2.6	1.6	2.1	1.2	2.6	0.7
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 118.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA056895: AB_2683267, HPA065203: AB_2685431"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.87e-4)"	13.2	23.4	33.8	6.3	31.4	3.2	15.8	28.3	36.3	24.1	31.3	32.5	11.4	24.9	7.7	16.5	26.1	9.3	23.9	30.5	30.2	23.7	64.3	18.1	5.7	38.6	32.4	26.0	46.4	7.8	29.3	4.8	31.4	35.2	4.2	5.7	21.6	19.6	18.6	14.6	19.0	5.9	29.1	17.7	32.0	21.3	32.6	16.0	28.8	7.0	4.4	25.8	17.7	32.1	11.3	21.1	19.0	16.7	8.0	8.1	12.5	14.0	9.2	11.7	12.6	23.1	12.4	19.7	12.2	8.1	5.9	10.3	11.8	9.5	4.9	17.3	118.4	19.6	15.3	42.4	13.0	8.7	17.4	9.5	8.5	9.5	7.3	17.6	10.6	24.1	25.7	8.6	8.3	14.6	28.4	24.4	20.5	22.3	38.2	32.7	12.3	10.7	13.0	10.2	20.4	28.0	7.1	23.2	11.2	10.3	23.2	15.7	14.4	20.8	18.2	4.6	15.6	20.5	18.9	15.1	13.1	11.8	13.9	1.9	1.1	2.4	2.3	0.9	2.5	1.2	4.0	4.0	1.2	2.3	4.0	2.7	0.1	2.2	0.6	2.1	2.9	1.4	33.8	31.4	28.3	36.3	30.5	30.2	38.6	32.4	31.4	29.1	32.6	32.1	12.2	3.2	18.1	26.1	11.0	3.1	17.4	15.3	5.2	17.9	13.9	11.8	13.9	28.6	17.6	11.0	8.4	18.8	5.6	15.6	9.8	26.4	28.6	16.2	8.9	15.1	29.3	6.1	10.0	21.9	9.7	10.0	20.9	9.2	10.2	16.8	18.5	38.9	10.7	20.2	10.0	28.0	20.3	7.2	6.1	39.2	12.2	5.5	16.0	5.6	13.6	17.7	12.3	14.6	19.0	18.3	9.9	12.0	8.6	13.5	18.7	26.9	18.3	13.4	26.3	8.5	12.6	13.6	25.6	3.4	5.3	12.4	11.2	43.4	22.9	11.0
ZNF445	"ZKSCAN15, ZNF168, ZSCAN47"	ENSG00000185219	"Zinc finger protein 445"	P59923	3	44431705-44477670	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006678	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA006678: AB_10603329"	"unprognostic (7.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.05e-1)"	4.2	3.0	2.3	1.8	2.5	1.3	3.9	4.3	2.4	6.0	1.1	4.7	1.4	5.1	2.0	2.7	5.0	1.6	3.6	2.4	2.4	3.3	4.9	4.1	1.9	2.1	2.1	7.0	4.4	2.8	5.0	2.0	2.2	4.4	1.7	4.2	3.6	2.1	4.4	3.7	3.5	2.2	1.7	3.9	3.9	3.1	2.2	3.3	3.8	2.7	2.1	4.1	4.4	2.9	1.9	2.1	6.4	5.1	3.5	3.6	2.9	2.5	2.1	3.7	3.7	3.2	1.6	3.3	1.5	2.6	2.3	1.5	4.4	1.7	4.5	3.6	1.6	6.1	4.7	3.2	2.2	7.8	4.9	2.5	2.1	4.2	2.6	3.1	2.6	4.6	4.8	2.4	3.0	1.2	7.5	5.2	4.4	1.2	1.9	3.3	4.0	1.6	2.0	3.8	3.2	3.9	3.9	2.0	1.0	4.7	3.7	3.4	3.2	5.2	4.6	3.2	3.2	1.9	1.5	2.7	1.9	3.8	3.2	1.0	0.3	0.6	0.3	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.3	0.2	1.0	0.5	0.8	0.3	0.1	0.1	2.3	2.5	4.3	2.4	2.4	2.4	2.1	2.1	2.2	1.7	2.2	2.9	11.7	12.8	17.4	19.2	8.4	4.1	4.4	2.9	9.6	36.0	4.8	4.4	11.1	5.7	7.6	11.0	37.5	4.1	15.7	3.8	1.9	5.8	2.5	6.3	14.1	9.7	7.2	10.3	21.7	8.4	1.7	9.0	7.1	6.8	11.4	26.6	13.2	10.1	5.7	28.6	24.3	6.3	2.0	16.4	4.7	2.2	9.3	10.5	0.0	9.4	11.6	10.1	22.6	11.6	19.5	4.9	6.0	9.8	9.5	5.6	4.3	2.8	9.6	28.4	13.1	14.5	10.6	6.7	6.9	5.6	2.6	1.4	9.8	9.3	7.2	3.8
ZNF449	"FLJ23614, ZSCAN19"	ENSG00000173275	"Zinc finger protein 449"	Q6P9G9	X	135344796-135363413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 15.8;Inhibitory neurons: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018079	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA018079: AB_1859277"	"unprognostic (5.51e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.61e-2)"	"unprognostic (4.22e-2)"	7.3	10.3	2.9	4.4	3.2	1.4	6.1	2.6	4.0	5.6	2.7	5.5	3.2	6.4	5.3	3.6	4.4	5.3	5.3	3.2	3.4	3.8	3.5	5.0	3.9	3.2	2.9	4.5	8.3	5.8	4.2	6.8	3.1	5.6	3.4	4.9	4.8	4.3	5.2	3.6	3.7	4.8	2.8	6.1	4.9	2.8	3.8	2.8	7.0	5.5	3.4	4.5	4.7	3.1	2.7	3.8	7.7	6.3	6.8	13.5	3.7	5.1	3.9	3.2	7.8	1.3	3.6	1.7	6.4	4.0	4.3	3.1	5.4	2.3	5.1	2.3	4.6	2.2	4.3	2.0	5.2	1.8	3.2	5.3	6.6	2.7	7.9	4.5	6.2	4.2	2.2	1.8	9.2	1.5	2.3	2.0	2.7	2.6	4.2	1.9	5.1	2.5	4.7	1.6	1.8	4.5	1.2	3.7	3.8	4.9	2.7	2.0	6.1	7.4	2.7	5.0	4.6	1.4	1.8	1.3	2.9	3.0	4.8	0.7	1.2	1.7	1.2	1.5	2.4	0.7	1.1	1.7	1.1	0.4	1.1	1.1	0.3	2.6	3.3	0.7	1.1	1.0	2.9	3.2	2.6	4.0	3.2	3.4	3.2	2.9	3.1	2.8	3.8	3.1	6.7	0.0	2.2	7.8	2.4	0.9	0.9	1.1	1.2	6.0	2.5	2.5	10.2	1.5	1.3	1.8	0.0	2.5	1.3	0.8	0.0	1.7	0.3	1.2	3.4	6.4	3.0	0.8	15.8	0.6	2.1	3.7	3.1	1.1	1.3	6.4	6.8	0.6	4.2	10.1	12.5	0.8	0.0	3.2	1.9	0.5	5.3	2.4	3.6	8.4	5.0	3.9	0.0	9.5	7.2	1.2	1.4	4.1	1.1	1.1	0.6	0.6	2.2	2.8	0.0	2.4	4.0	2.8	2.3	1.0	2.3	1.2	1.9	11.5	0.6	0.6
ZNF45	ZNF13	ENSG00000124459	"Zinc finger protein 45"	Q02386	19	43912624-43935282	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038611, HPA075124"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA038611: AB_10669544, HPA075124: AB_2686735"	"unprognostic (1.67e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.31e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.68e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.82e-2)"	4.8	5.5	3.0	5.1	3.7	6.3	7.1	6.3	3.4	6.7	3.7	5.2	5.6	7.1	5.5	4.6	6.5	5.1	4.6	3.1	4.9	5.8	5.8	5.9	7.3	3.7	3.4	9.0	4.0	9.7	5.0	5.3	3.2	6.7	6.1	8.5	4.9	5.8	6.5	5.9	5.3	6.0	3.2	7.3	5.0	3.6	3.8	10.7	7.4	5.8	7.1	5.1	3.9	4.5	9.2	12.1	16.9	15.1	8.0	7.0	5.9	11.7	12.7	12.0	18.2	5.9	3.7	13.3	7.0	7.3	9.2	5.2	12.9	8.5	15.0	11.2	13.7	19.7	10.6	5.3	7.4	19.5	12.8	7.1	8.4	8.8	7.7	11.9	9.7	4.5	6.3	5.2	13.0	4.2	11.6	4.9	19.8	8.6	5.1	9.4	16.8	4.8	7.3	20.1	11.6	19.0	16.4	6.6	5.8	10.8	6.9	12.7	10.1	13.3	19.4	5.6	10.8	21.1	37.1	14.5	5.6	7.5	15.7	3.4	3.7	5.7	5.6	3.4	8.4	5.8	5.4	6.0	4.9	4.1	7.4	5.0	1.1	6.3	4.7	3.2	6.1	4.2	3.0	3.7	6.3	3.4	3.1	4.9	3.7	3.4	3.2	3.2	3.8	4.5	2.9	3.2	1.7	7.5	4.2	1.5	0.8	2.2	3.4	1.8	3.1	2.0	3.3	1.5	3.6	0.0	6.2	2.0	5.1	2.4	0.0	2.3	0.2	2.4	1.9	2.4	2.4	3.4	5.0	1.5	1.1	2.3	3.6	2.6	0.0	3.2	1.8	2.1	2.9	3.3	4.9	3.2	2.0	2.8	1.6	0.6	1.8	2.5	1.8	10.3	2.4	1.6	1.0	8.0	9.0	1.2	0.7	4.9	1.5	1.7	2.6	1.9	4.1	2.4	19.7	2.4	1.9	1.1	2.1	3.9	1.6	1.2	3.7	2.4	2.1	1.5
ZNF451	"COASTER, dJ417I1.1, KIAA0576, KIAA1702"	ENSG00000112200	"Zinc finger protein 451"	Q9Y4E5	6	57086844-57170305	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 247.3;Late spermatids: 412.7;Oligodendrocytes: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028838			Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA028838: AB_10603330"	"unprognostic (5.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.13e-3)"	"unprognostic (6.17e-2)"	12.2	15.0	11.1	10.8	17.9	70.3	13.4	28.7	15.8	11.9	5.4	10.7	8.2	12.9	14.8	10.7	9.7	10.3	9.2	10.4	11.8	11.1	12.9	12.6	16.0	13.9	12.2	12.3	8.9	14.2	10.0	15.0	13.8	13.7	9.8	17.2	10.6	10.2	8.9	11.7	9.4	11.5	10.3	14.7	11.8	29.0	13.7	16.3	15.6	11.3	13.9	10.7	9.4	24.4	17.8	10.6	23.0	14.4	21.6	27.3	22.1	19.5	23.8	22.3	24.0	20.9	8.5	19.1	12.7	20.8	26.4	16.6	22.6	21.9	36.3	15.5	16.7	50.5	17.6	20.3	16.5	28.3	20.7	19.3	21.0	24.7	31.1	16.7	22.6	26.8	69.6	17.9	19.4	12.5	34.5	24.1	12.6	13.3	10.6	23.5	29.1	17.9	15.1	29.0	27.3	18.4	20.7	13.6	22.7	27.1	16.4	26.4	14.7	22.5	23.2	29.5	22.5	17.7	32.2	39.1	19.7	34.1	11.4	33.5	10.1	10.5	11.0	8.9	11.1	10.7	9.1	6.8	11.1	14.8	12.3	9.6	5.0	8.8	9.7	14.6	7.9	7.8	11.1	17.9	28.7	15.8	10.4	11.8	13.9	12.2	13.8	10.3	13.7	24.4	47.6	25.6	34.5	67.6	40.6	56.3	14.9	19.3	40.5	55.7	31.7	25.1	25.1	25.8	24.5	31.3	75.0	40.8	62.0	21.1	9.8	15.1	247.3	33.4	51.3	37.0	36.7	124.6	87.6	14.0	30.5	44.5	34.1	35.1	43.0	71.3	45.0	32.6	18.3	48.8	84.8	23.4	14.2	36.0	43.4	412.7	37.6	33.4	33.8	47.8	28.7	26.5	24.7	82.0	212.2	18.9	13.0	41.3	38.2	25.9	19.8	14.6	35.2	68.6	6.6	37.6	36.8	48.0	32.0	32.7	42.8	13.1	40.6	44.9	23.1	22.8
ZNF460	"HZF8, ZNF272"	ENSG00000197714	"Zinc finger protein 460"	Q14592	19	57280051-57294069	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 21.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.5"									"HPA053004, HPA066506"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA053004: AB_2682012, HPA066506: AB_2685681"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.10e-2)"	1.9	4.9	5.1	0.7	7.9	6.0	1.6	7.9	6.2	1.4	3.6	0.9	0.3	1.0	0.8	1.3	1.0	1.0	1.4	3.4	4.6	1.1	1.5	1.3	0.9	7.8	6.8	2.3	1.0	1.3	1.7	1.4	9.2	1.1	0.6	2.6	1.3	1.1	1.5	1.9	0.7	1.1	4.8	1.4	0.9	1.8	5.2	1.0	1.4	1.3	1.0	1.1	1.3	19.7	1.2	1.9	1.5	2.1	1.5	1.3	3.8	0.8	1.2	0.9	2.8	2.4	0.7	1.9	0.9	1.0	0.8	0.8	2.0	1.0	1.6	1.4	3.9	1.8	1.6	1.2	1.7	3.2	2.0	0.7	1.8	2.5	2.8	0.7	0.6	2.0	1.8	13.5	1.1	0.9	1.9	0.5	2.1	1.0	1.8	1.4	2.1	0.9	0.6	2.4	1.9	1.0	2.1	1.1	1.2	1.0	0.9	2.2	0.9	2.8	3.3	0.4	1.7	5.7	2.7	3.1	1.0	1.2	0.9	0.0	0.5	1.0	0.7	1.1	0.8	0.8	0.5	0.4	0.1	2.2	1.2	0.5	1.2	0.8	0.7	0.0	1.1	0.7	5.1	7.9	7.9	6.2	3.4	4.6	7.8	6.8	9.2	4.8	5.2	19.7	7.9	3.2	1.5	3.9	11.6	3.1	3.6	0.7	22.2	4.3	4.1	2.8	5.9	1.5	2.0	0.0	0.0	1.4	6.6	1.3	0.0	1.5	3.4	7.0	9.5	4.9	0.0	11.2	6.2	0.4	2.0	7.3	10.2	13.1	0.0	4.7	7.1	2.0	1.1	8.4	5.9	1.2	4.1	1.9	2.2	0.7	1.8	3.3	1.8	1.9	4.0	2.4	4.1	2.5	13.3	1.7	0.2	1.5	16.3	3.0	0.7	0.8	2.4	3.2	0.0	8.1	8.4	3.6	1.4	21.5	2.4	2.6	7.8	3.6	1.3	4.4
ZNF461	"GIOT-1, MGC33911"	ENSG00000197808	"Zinc finger protein 461"	Q8TAF7	19	36636618-36666853	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Alveolar cells type 2: 23.8;Early spermatids: 43.5;granulocytes: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA021139	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA021139: AB_10961418"	"unprognostic (8.37e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.11e-1)"	"unprognostic (7.01e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.11e-3)"	2.2	3.6	3.5	2.0	3.4	3.0	3.0	6.2	5.2	2.0	1.7	2.2	0.5	3.3	2.5	2.1	3.0	2.0	2.3	3.5	3.4	2.7	2.0	2.0	3.2	2.3	2.6	4.4	1.3	3.2	3.0	3.4	2.6	2.8	1.9	6.6	1.6	2.2	2.2	3.0	1.9	3.2	2.4	3.5	2.5	3.7	3.5	2.5	4.1	2.1	3.2	2.0	2.0	3.7	2.9	4.7	3.5	4.8	2.6	4.9	2.4	2.9	3.0	4.2	5.8	0.8	1.4	0.4	6.2	3.8	4.2	0.6	2.5	3.0	4.6	5.6	3.4	4.9	0.7	1.9	4.1	3.7	5.5	3.5	5.6	1.5	4.3	5.6	2.6	2.4	0.2	0.5	4.3	2.7	6.1	1.7	2.3	0.4	2.1	0.4	3.6	1.0	1.8	6.3	4.6	6.1	0.3	2.1	3.8	3.5	2.2	1.5	3.2	2.5	3.4	2.1	3.7	7.6	12.2	1.6	0.0	0.8	3.6	0.8	0.5	0.5	1.3	1.1	1.7	1.5	2.1	2.8	1.2	2.0	1.6	1.3	0.1	1.4	0.2	0.5	2.0	0.9	3.5	3.4	6.2	5.2	3.5	3.4	2.3	2.6	2.6	2.4	3.5	3.7	2.3	28.9	23.8	8.1	4.1	3.3	2.0	2.3	4.6	5.4	4.7	2.5	2.2	7.2	12.9	3.7	0.0	2.5	2.6	0.9	1.9	1.7	43.5	4.6	2.9	5.2	3.0	0.8	16.3	0.9	2.9	6.2	1.5	4.6	33.5	3.1	2.9	1.2	1.7	3.3	14.0	1.1	0.0	2.5	3.2	8.3	0.9	3.2	0.0	4.7	0.9	1.6	1.0	9.0	12.4	0.8	0.5	1.9	1.2	2.3	0.8	1.8	9.9	3.6	0.0	4.9	3.9	10.2	4.0	3.1	3.4	2.9	6.1	1.9	1.3	1.8
ZNF462	"DKFZP762N2316, KIAA1803, Zfp462"	ENSG00000148143	"Zinc finger protein 462"	Q96JM2	9	106863166-107013634	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.9;Oligodendrocyte precursor cells: 486.5;Oligodendrocytes: 152.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022283	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA022283: AB_2220602"	"unprognostic (4.22e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (2.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-2)"	3.4	8.4	10.6	1.9	16.6	0.1	3.8	13.9	14.2	8.0	6.2	4.9	1.0	4.2	1.8	7.8	5.2	2.9	5.8	8.6	16.4	3.9	1.6	3.0	0.8	14.7	16.0	7.4	1.1	6.1	4.1	3.1	17.6	6.8	3.8	8.2	7.7	4.1	13.2	6.7	2.2	6.7	10.0	2.9	1.7	5.9	16.0	2.0	7.2	5.8	1.3	3.9	6.2	15.9	4.8	12.6	22.5	14.0	6.9	4.9	3.2	3.2	4.0	2.8	3.0	14.8	5.7	0.1	8.3	2.9	13.8	7.6	14.9	12.4	3.5	0.1	2.1	0.0	5.3	0.1	2.6	3.4	0.4	4.6	6.0	6.8	18.0	7.4	1.3	6.0	0.0	6.7	7.3	8.2	2.7	0.1	16.0	0.0	10.0	0.0	15.4	0.3	7.8	4.4	10.6	12.3	6.3	0.1	4.7	13.7	11.2	0.1	1.3	3.8	13.2	8.1	9.8	0.0	0.1	0.1	5.8	0.3	13.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	10.6	16.6	13.9	14.2	8.6	16.4	14.7	16.0	17.6	10.0	16.0	15.9	25.6	22.4	29.1	114.9	0.9	33.6	10.8	10.6	44.9	60.7	21.6	18.7	27.7	25.8	10.3	7.3	31.3	14.4	0.2	14.7	5.9	7.9	63.1	7.6	25.5	23.3	16.8	2.1	18.4	2.6	7.3	14.1	4.1	10.1	17.1	18.7	40.4	0.0	1.8	18.5	91.6	15.5	12.2	0.8	4.2	16.8	14.6	1.3	12.4	15.9	2.0	19.8	0.0	486.5	152.2	7.7	5.3	27.1	0.0	15.1	6.3	17.4	15.2	39.4	26.3	21.5	22.1	1.3	24.7	24.0	11.5	3.1	1.1	22.0	17.5	6.6
ZNF469	"KIAA1858, Zfp469"	ENSG00000225614	"Zinc finger protein 469"	Q96JG9	16	88382959-88440757	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 7.5;Excitatory neurons: 9.4;Granulosa cells: 9.3;Inhibitory neurons: 8.3;Oligodendrocyte precursor cells: 16.6;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;BJ hTERT+: 4.6;HeLa: 4.7;SiHa: 4.9;THP-1: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA077792			Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Cell Junctions"	"HPA077792: "	"unprognostic (1.80e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.71e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.17e-3)"	"unprognostic (7.08e-3)"	"unprognostic (5.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.71e-7)"	"unprognostic (2.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.34e-2)"	0.9	0.5	3.2	0.9	1.1	0.1	0.5	0.3	2.0	1.4	0.0	0.3	0.2	1.6	0.0	0.1	0.7	0.9	0.4	3.4	0.4	0.1	0.1	0.3	0.6	2.2	1.6	2.2	0.4	0.1	0.1	0.3	1.3	0.8	0.0	0.0	0.4	0.3	0.7	0.3	0.4	0.8	1.0	0.8	0.4	0.2	1.3	0.4	0.1	0.1	0.2	0.9	0.4	1.2	0.0	4.3	0.1	0.0	0.6	0.9	0.0	2.6	4.6	0.6	0.0	0.0	0.1	0.0	0.1	3.6	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.7	0.0	2.9	0.1	0.1	1.0	0.0	1.0	0.0	0.7	2.7	0.0	0.0	0.0	0.7	0.4	0.0	0.6	0.5	0.0	3.4	0.3	0.0	0.0	0.0	0.0	0.0	2.1	4.9	0.0	0.0	0.0	0.9	6.4	3.3	3.6	0.9	2.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	1.1	0.3	2.0	3.4	0.4	2.2	1.6	1.3	1.0	1.3	1.2	0.3	0.0	1.8	2.0	0.8	0.3	0.6	1.1	0.0	0.5	2.1	1.1	7.5	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.2	0.6	1.1	2.3	0.0	0.0	9.4	0.0	0.1	3.9	0.0	0.1	0.0	9.3	2.9	0.0	3.1	3.3	8.3	0.0	0.0	1.4	0.6	0.2	0.0	1.9	0.0	1.9	1.6	0.6	2.1	16.6	0.8	0.7	0.0	1.5	0.2	1.1	0.0	0.2	1.1	0.1	6.6	1.3	4.8	0.1	0.7	0.0	0.1	0.1	0.5	1.7	0.0	0.3
ZNF470	"CZF-1, FLJ26175"	ENSG00000197016	"Zinc finger protein 470"	Q6ECI4	19	56567468-56588911	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.0"					"Low region specificity"	"Detected in all"			HPA029000	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear bodies"		"HPA029000: AB_10603843"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.88e-3)"	2.0	3.0	8.2	1.0	8.2	0.4	1.9	9.0	12.2	3.0	5.8	3.8	0.9	2.8	3.0	1.8	2.3	1.5	3.6	8.5	8.5	4.4	3.2	1.8	1.4	8.4	8.6	2.6	2.0	2.3	5.3	1.6	8.6	3.7	1.1	12.3	1.7	2.4	1.3	1.8	2.0	1.9	7.7	2.1	2.3	4.6	8.6	1.9	2.5	1.1	1.7	3.5	2.3	8.7	0.0	1.6	5.4	2.3	2.8	2.6	4.5	2.6	1.2	2.0	3.8	0.3	1.3	0.0	1.6	2.9	3.5	0.1	2.3	1.2	2.4	0.0	11.0	4.8	0.1	0.4	2.7	1.0	5.4	3.2	1.8	2.3	0.6	2.1	1.2	0.2	0.0	0.1	3.0	0.0	1.1	1.8	4.4	0.0	0.6	0.2	3.8	0.9	2.2	3.3	2.0	5.1	0.0	0.4	0.7	3.7	1.8	3.0	1.2	0.2	2.2	1.8	3.5	1.7	2.5	0.2	0.0	3.2	0.9	0.5	0.2	0.9	0.6	0.1	1.2	0.7	0.6	0.3	0.4	0.8	0.8	0.8	0.6	0.7	0.3	0.6	0.4	0.3	8.2	8.2	9.0	12.2	8.5	8.5	8.4	8.6	8.6	7.7	8.6	8.7	3.4	3.2	3.6	10.4	1.1	1.0	1.4	1.0	1.2	8.6	2.1	2.0	7.4	2.8	1.7	0.0	10.4	1.1	0.8	0.7	1.9	2.6	2.1	2.1	3.1	4.2	0.0	2.1	10.1	0.6	0.9	3.1	0.5	1.9	7.0	4.1	3.6	2.4	1.2	11.8	9.6	0.8	0.0	0.6	2.1	1.7	2.1	1.6	1.8	2.8	1.8	4.2	1.0	6.6	11.9	1.2	1.5	3.0	0.4	1.9	2.1	2.7	1.5	7.1	6.6	3.9	2.6	7.4	13.4	1.5	0.6	0.3	1.4	2.5	1.9	0.9
ZNF471	"KIAA1396, Z1971, Zfp78"	ENSG00000196263	"Zinc finger protein 471"	Q9BX82	19	56507850-56530221	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.8;Oligodendrocytes: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HSkMC: 8.5;hTERT-RPE1: 12.6;SuSa: 9.0"					"Low region specificity"	"Detected in all"			HPA066695	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA066695: AB_2685704"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.47e-4)"	"unprognostic (9.36e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-3)"	5.7	6.3	13.6	2.4	16.1	2.8	7.1	14.0	14.8	10.3	7.4	8.9	1.8	13.3	15.9	4.8	10.5	6.8	5.7	13.4	16.6	5.3	2.4	5.6	3.0	14.8	13.1	22.4	3.6	10.4	8.4	6.2	13.7	8.2	4.5	28.5	6.0	7.5	4.9	9.5	3.2	7.9	9.9	4.4	4.5	8.5	14.7	2.7	9.8	6.3	2.0	7.0	7.6	25.5	0.4	0.5	4.8	0.6	4.1	4.5	0.5	4.5	1.6	2.1	1.8	0.6	0.6	0.6	3.0	5.0	4.0	0.3	0.6	0.4	2.0	1.0	1.8	3.6	1.3	0.5	4.0	1.0	3.1	8.5	1.6	2.6	0.2	12.6	0.2	0.5	1.1	1.3	2.3	0.5	0.4	0.6	1.1	0.3	1.9	0.4	3.1	0.4	3.5	3.7	0.6	2.9	0.4	0.1	0.2	9.0	0.6	0.7	0.7	7.6	3.2	0.6	3.5	1.0	1.1	0.3	0.6	0.5	0.4	1.5	0.4	0.3	0.6	0.3	0.4	0.4	0.5	0.4	0.2	0.9	0.5	0.7	1.8	1.0	0.4	0.5	0.3	0.1	13.6	16.1	14.0	14.8	13.4	16.6	14.8	13.1	13.7	9.9	14.7	25.5	5.7	19.2	18.4	24.8	0.6	0.6	2.4	1.6	2.2	11.2	4.1	4.6	10.9	2.8	7.8	5.5	6.2	1.0	1.7	0.9	3.9	2.1	10.2	8.2	5.9	6.0	1.2	0.4	15.0	1.0	0.4	4.6	1.5	6.7	2.5	8.4	5.0	0.8	0.5	6.7	14.4	0.9	0.0	0.6	0.3	3.6	5.0	1.9	1.8	5.6	0.6	7.9	2.1	20.1	32.3	0.7	0.2	7.2	0.0	2.5	0.5	1.6	11.9	9.5	6.6	7.9	6.7	9.9	8.2	1.6	0.6	0.8	0.9	3.6	1.2	1.6
ZNF473	"DKFZP434N043, HZFP100, KIAA1141"	ENSG00000142528	"Zinc finger protein 473"	Q8WTR7	19	50025714-50053414	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 42.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.9;Late spermatids: 23.3;Spermatocytes: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004191, HPA073309"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA004191: AB_2667168, HPA073309: AB_2686594"	"unprognostic (7.47e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.27e-1)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.31e-3)"	"unprognostic (6.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	3.8	2.9	4.0	2.9	4.9	4.2	4.6	5.7	7.6	3.6	9.0	3.1	2.8	3.7	4.0	3.6	7.3	3.2	2.9	4.4	5.0	3.5	3.3	3.5	3.5	5.2	5.8	4.4	4.6	4.3	5.4	3.0	4.8	4.7	3.0	6.2	2.4	3.9	4.1	3.7	2.4	4.9	4.7	6.7	3.1	42.4	5.4	4.1	4.5	4.6	4.5	3.2	2.4	6.8	14.4	9.6	14.7	12.4	5.7	6.6	8.3	13.2	7.9	18.4	17.2	18.4	9.5	22.2	5.0	7.7	6.8	10.8	18.4	8.8	23.4	15.6	18.0	22.5	8.8	9.3	6.6	16.3	13.1	6.8	16.1	19.3	25.2	7.6	6.2	13.1	32.1	19.3	9.4	6.2	13.0	7.8	10.4	22.4	15.1	15.8	20.5	9.8	6.1	15.6	12.1	13.9	18.6	10.1	8.9	10.0	9.4	14.7	3.0	25.7	13.1	5.2	13.4	8.9	22.8	18.4	6.1	12.7	21.0	2.0	5.0	2.9	6.3	7.3	6.6	11.7	6.3	7.7	5.0	10.0	7.8	10.0	4.4	2.5	3.4	5.3	3.9	4.2	4.0	4.9	5.7	7.6	4.4	5.0	5.2	5.8	4.8	4.7	5.4	6.8	2.8	0.0	1.7	0.3	4.6	4.6	2.9	1.9	6.8	0.7	2.9	2.8	2.2	0.0	1.7	0.0	0.0	2.3	1.5	2.3	3.9	2.4	88.9	5.6	5.1	3.8	1.8	5.2	3.1	3.2	3.2	3.5	7.7	4.0	0.0	3.8	6.8	1.7	2.2	0.0	3.1	3.7	2.0	1.3	1.7	23.3	3.7	2.0	1.8	1.9	3.2	1.7	2.1	1.5	2.8	3.4	3.0	3.8	4.1	4.1	1.6	1.7	10.4	4.3	13.1	3.5	2.7	64.7	20.5	4.8	4.7	1.9	3.5	3.5	2.4	2.1
ZNF480	MGC32104	ENSG00000198464	"Zinc finger protein 480"	Q8WV37	19	52297169-52325922	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042218	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA042218: AB_10794791"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (4.22e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.82e-3)"	7.6	7.3	4.8	10.4	5.9	9.5	6.6	7.7	6.9	7.5	5.3	10.4	9.8	6.0	3.3	6.5	5.6	4.5	11.1	4.8	6.0	8.7	8.6	6.2	12.6	6.0	5.1	6.9	4.5	7.4	5.9	5.7	6.0	6.2	10.1	10.4	7.2	5.2	10.8	5.5	8.2	6.0	4.2	9.8	9.1	3.3	5.9	15.2	7.2	14.9	15.5	11.1	5.4	8.3	7.2	28.4	18.2	21.2	21.1	19.7	14.1	18.3	26.7	12.8	14.9	12.9	10.0	36.0	11.2	15.1	23.4	15.3	19.9	18.5	18.5	0.3	33.1	37.0	15.2	12.5	20.3	52.7	29.0	18.1	23.4	17.8	20.7	26.7	18.8	31.0	27.0	12.0	29.0	11.7	48.3	10.5	13.7	23.7	22.8	24.5	19.5	30.0	18.8	51.0	17.2	15.0	26.6	18.9	7.4	37.3	15.7	38.1	32.4	12.7	15.8	7.3	28.6	28.4	56.9	74.3	5.7	28.2	23.1	10.1	9.6	11.2	12.6	9.4	14.5	19.7	12.8	15.1	11.9	19.1	12.0	16.3	3.6	17.8	11.4	19.3	15.9	7.8	4.8	5.9	7.7	6.9	4.8	6.0	6.0	5.1	6.0	4.2	5.9	8.3	13.1	35.3	11.8	8.5	20.1	5.5	15.3	22.1	5.7	4.7	6.7	6.1	43.0	8.6	18.2	3.7	2.1	8.7	17.8	11.7	17.6	18.6	2.5	12.7	11.9	17.0	12.6	14.9	1.7	27.6	16.8	11.1	9.7	14.1	12.6	15.4	14.3	15.4	17.6	6.7	4.7	18.0	20.3	15.8	14.3	2.4	9.0	12.3	7.2	6.5	19.0	6.1	26.8	9.5	10.2	36.3	11.8	8.2	9.2	25.4	13.5	24.2	16.8	7.4	0.0	10.6	12.0	1.9	6.1	10.5	8.4	14.8	19.7	12.1	16.1	22.6
ZNF484	"BA526D8.4, FLJ33884"	ENSG00000127081	"Zinc finger protein 484"	Q5JVG2	9	92844182-92878038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.7;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA028973	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028973: AB_10610703"	"unprognostic (5.52e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.84e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.77e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.51e-1)"	2.0	2.2	1.9	2.0	2.7	4.1	2.2	9.7	3.3	2.5	0.0	1.6	1.2	2.4	1.7	1.3	2.1	1.6	1.6	1.8	3.4	2.4	1.9	2.0	2.4	2.8	2.8	3.1	1.3	3.6	2.1	2.8	3.1	2.3	1.8	5.3	1.5	2.0	1.1	1.3	1.5	2.1	2.7	2.9	2.1	1.7	3.5	2.6	3.1	2.3	2.8	2.1	1.8	4.0	3.1	3.6	4.7	3.0	2.4	3.0	0.0	2.4	3.8	4.2	4.4	1.2	2.2	2.5	2.1	1.9	2.9	5.0	3.5	3.7	4.4	4.2	1.5	2.2	3.1	2.4	3.7	1.9	3.7	3.3	2.7	4.7	4.9	3.2	3.9	2.8	2.4	10.6	4.5	2.9	2.7	0.8	4.0	3.4	1.7	2.2	5.8	1.9	2.3	3.4	3.2	3.0	4.3	1.2	2.4	3.5	0.2	1.5	3.7	3.7	3.7	2.0	1.8	3.9	2.1	1.5	2.4	1.5	3.1	0.6	1.2	2.8	2.4	1.8	3.1	1.8	2.6	2.1	1.1	2.6	3.4	3.2	0.7	2.4	1.6	1.3	2.2	1.5	1.9	2.7	9.7	3.3	1.8	3.4	2.8	2.8	3.1	2.7	3.5	4.0	6.2	0.0	1.5	9.8	13.2	0.1	0.7	1.1	6.8	5.0	1.6	0.9	2.2	0.0	4.7	1.8	0.0	1.2	6.3	0.9	1.9	1.3	0.7	1.3	4.4	4.9	0.0	3.4	17.7	0.4	1.2	4.3	5.6	1.3	2.5	3.6	0.7	0.6	0.8	5.0	22.6	1.4	4.1	0.6	0.4	0.9	0.6	2.7	0.0	12.2	1.2	3.1	5.2	27.2	19.1	0.7	1.6	1.5	5.8	0.6	0.9	1.5	4.1	3.8	0.0	3.7	4.8	0.8	0.7	3.9	0.1	0.7	9.3	3.3	0.7	0.6
ZNF487	"KRBO1, ZNF487P"	ENSG00000243660	"Zinc finger protein 487"		10	43436841-43483181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 191.2;Endometrial ciliated cells: 65.7;Late spermatids: 289.9;Respiratory ciliated cells: 73.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037820			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA037820: AB_10697083"	"unprognostic (1.97e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.97e-4)"	"unprognostic (5.85e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.92e-2)"	2.9	2.1	2.1	2.0	2.1	4.3	2.8	2.0	6.3	3.2	4.5	2.6	2.4	3.8	2.1	2.1	6.0	3.7	2.1	2.3	1.9	2.3	2.2	3.0	2.4	7.5	6.0	4.2	1.6	3.6	2.4	1.9	5.0	2.3	1.9	8.9	1.5	2.7	1.2	2.1	2.5	3.0	4.7	2.4	2.3	28.2	2.2	3.6	3.3	1.6	2.2	3.3	2.1	3.8	1.7	1.6	2.0	2.1	2.4	4.8	0.6	2.7	4.7	2.5	2.7	2.6	4.7	4.3	0.4	3.4	2.4	2.7	0.6	1.0	2.4	0.5	0.9	1.4	0.4	1.5	3.1	1.4	1.7	5.0	2.3	4.2	3.0	5.2	0.9	0.9	0.7	0.6	1.9	3.0	2.9	1.1	0.4	0.8	0.9	1.5	0.7	1.8	5.7	1.9	1.7	1.3	2.4	1.3	1.1	1.2	2.2	1.6	1.5	2.4	1.5	1.4	0.7	0.3	1.1	4.7	5.6	2.0	0.9	1.8	3.0	4.5	3.3	2.2	2.6	1.9	2.4	2.9	3.9	2.5	1.9	2.3	10.4	2.9	1.2	2.9	1.6	2.1	2.1	2.1	2.0	6.3	2.3	1.9	7.5	6.0	5.0	4.7	2.2	3.8	4.0	22.4	4.8	11.8	6.2	1.8	6.3	6.6	3.4	5.4	6.6	7.7	3.3	7.2	8.3	5.5	8.4	1.4	9.8	6.1	11.7	4.5	191.2	65.7	6.5	5.3	7.8	1.3	19.4	2.1	4.0	5.4	5.6	6.3	0.0	3.4	3.3	2.7	3.3	6.7	21.1	4.4	10.2	5.6	3.1	289.9	4.7	6.3	1.8	0.0	7.3	12.6	2.1	6.0	7.1	2.1	3.9	6.8	3.6	3.2	13.0	12.7	73.5	18.7	0.0	6.3	5.1	16.7	7.5	1.9	2.8	1.6	5.6	3.8	3.5	6.1
ZNF488	FLJ32104	ENSG00000265763	"Zinc finger protein 488"	Q96MN9	10	47365496-47384293	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.4;intestine: 22.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 7.0;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 20.1;Proximal enterocytes: 21.5;Syncytiotrophoblasts: 36.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 46.9;HDLM-2: 70.1;RT4: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035957, HPA035958"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"HPA035957: AB_10672234, HPA035958: AB_2674887"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-5)"	"unprognostic (2.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.18e-2)"	0.2	0.1	10.2	0.1	22.2	0.0	0.8	23.6	18.1	0.3	3.1	0.6	22.4	0.1	1.6	0.9	0.1	0.2	0.1	18.0	14.8	1.1	0.0	0.2	0.0	29.4	26.4	0.3	0.0	0.0	0.8	3.4	26.8	0.3	0.6	2.6	0.4	0.1	0.0	1.7	11.2	0.1	20.4	0.0	0.3	0.8	23.2	0.3	0.1	0.1	0.6	0.5	0.5	34.4	4.9	13.7	2.3	0.7	0.0	0.0	0.2	0.5	0.6	0.8	0.8	5.3	12.7	0.3	0.8	0.0	5.3	46.9	1.2	5.2	0.7	70.1	1.4	0.2	1.5	0.4	0.0	0.1	0.7	0.0	12.2	0.5	1.3	0.2	0.0	2.7	0.0	0.0	0.0	0.2	0.5	0.2	3.5	10.3	1.3	0.0	5.8	0.0	0.3	38.2	11.1	2.0	3.3	0.5	0.0	5.1	1.1	0.1	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	22.2	23.6	18.1	18.0	14.8	29.4	26.4	26.8	20.4	23.2	34.4	0.2	0.0	0.0	1.0	0.0	0.6	0.9	0.4	0.0	1.8	0.2	0.4	0.6	0.0	0.2	0.0	0.0	7.0	0.0	0.8	5.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	1.9	0.2	0.5	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	10.1	20.1	0.6	0.0	0.0	0.0	1.1	21.5	0.2	0.0	0.5	0.0	0.2	0.6	0.1	1.5	0.0	0.1	36.1	0.0	0.1	1.5	0.4
ZNF496	"MGC15548, ZKSCAN17, ZSCAN49"	ENSG00000162714	"Zinc finger protein 496"	Q96IT1	1	247297412-247331846	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025824			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA025824: "	"unprognostic (1.88e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.55e-1)"	8.6	6.0	7.8	5.4	8.1	6.8	8.1	6.8	8.2	13.6	6.3	11.6	3.8	14.3	5.5	5.6	14.7	7.8	9.0	7.0	7.4	8.7	3.6	8.5	6.9	7.4	7.5	18.7	15.4	11.3	6.4	9.9	7.0	9.4	5.6	5.7	7.8	8.4	15.6	5.8	6.8	11.5	6.9	9.2	9.0	10.8	8.2	23.8	12.3	13.7	5.4	9.2	8.0	8.4	20.8	18.7	19.4	23.7	7.5	19.1	24.2	9.5	23.5	20.9	18.8	10.3	18.9	5.9	16.1	15.6	7.8	17.4	20.1	18.3	20.8	16.0	4.8	19.2	13.1	11.8	20.3	23.5	9.5	20.4	19.0	16.2	38.9	23.2	25.1	27.3	34.6	14.5	13.1	13.3	23.4	16.2	39.0	9.2	27.5	22.0	21.2	8.1	12.8	24.8	16.5	36.4	12.7	14.3	19.0	17.6	14.9	28.7	17.4	15.1	21.4	6.9	30.2	16.1	13.8	16.8	6.3	1.6	16.8	0.0	0.4	0.1	0.8	0.3	1.2	0.3	0.3	0.9	1.1	0.4	0.7	2.1	0.1	1.1	0.4	0.7	0.1	0.8	7.8	8.1	6.8	8.2	7.0	7.4	7.4	7.5	7.0	6.9	8.2	8.4	9.2	0.0	3.2	16.3	3.3	3.7	4.4	5.0	8.0	7.4	7.0	7.5	8.3	5.7	4.7	1.8	2.1	4.8	2.4	1.2	1.9	4.4	11.2	4.9	7.5	7.5	4.9	3.0	13.0	6.0	5.8	6.8	7.1	6.5	3.8	13.7	7.1	2.3	6.0	3.3	16.9	2.5	2.0	5.1	3.6	40.0	5.6	4.0	3.6	9.4	3.4	1.7	5.2	18.6	10.8	4.9	2.6	7.2	7.5	7.5	0.8	3.0	3.9	7.3	6.6	9.7	6.2	15.9	10.8	2.4	3.4	4.2	4.7	7.5	4.3	4.3
ZNF497	FLJ44773	ENSG00000174586	"Zinc finger protein 497"	Q6ZNH5	19	58354357-58362848	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Respiratory ciliated cells: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.2"									HPA047872	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Cell Junctions"	"HPA047872: AB_2680196"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.24e-1)"	0.7	1.4	2.3	1.8	3.3	1.6	1.8	6.4	3.2	2.6	3.7	1.0	1.3	2.3	1.9	2.1	5.7	1.2	1.4	2.7	0.9	3.5	3.1	1.8	2.5	1.6	1.7	2.5	2.5	1.4	4.5	0.9	0.9	2.4	0.8	1.8	2.7	1.1	0.7	2.7	1.2	0.4	0.8	2.3	1.6	1.6	1.6	0.5	3.7	0.0	0.4	0.9	1.7	3.9	2.0	6.8	6.0	5.8	0.2	0.1	7.9	3.7	0.0	0.0	0.0	0.5	2.2	4.0	1.9	0.0	3.3	0.9	0.7	0.4	0.0	4.2	20.2	3.6	2.2	1.2	0.3	1.5	9.2	0.5	0.9	0.1	0.7	6.6	0.0	9.8	3.1	0.6	0.1	7.1	5.1	5.1	3.7	1.7	2.1	12.6	4.4	2.1	0.6	1.6	4.6	6.6	2.0	5.9	3.3	3.0	8.1	4.1	0.6	6.6	3.4	0.6	1.2	8.7	11.1	3.5	1.8	4.1	3.6	1.3	1.1	0.3	0.8	0.4	0.9	1.3	1.0	1.0	1.0	1.5	0.9	1.7	0.3	0.8	0.3	1.8	1.2	0.7	2.3	3.3	6.4	3.2	2.7	0.9	1.6	1.7	0.9	0.8	1.6	3.9	0.3	6.4	0.5	3.9	0.9	0.3	0.4	1.0	1.2	1.4	2.1	1.3	0.7	0.0	1.0	0.0	0.0	2.0	0.1	0.5	1.9	1.4	1.7	3.6	0.6	0.6	0.0	1.3	3.1	0.2	0.5	0.5	1.5	1.2	0.0	1.9	0.0	1.9	0.5	0.0	3.0	1.4	0.0	0.0	0.4	0.9	0.0	0.2	0.0	1.9	0.1	1.3	0.0	3.0	3.5	0.3	1.2	0.0	0.7	0.3	0.4	0.7	5.2	1.6	0.0	0.4	0.4	0.3	1.7	0.8	0.3	0.3	0.5	0.3	1.2	0.1
ZNF500	"KIAA0557, ZKSCAN18, ZSCAN50"	ENSG00000103199	"Zinc finger protein 500"	O60304	16	4748239-4767624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA035498, HPA057963"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA035498: AB_10602356, HPA057963: AB_2683565"	"unprognostic (3.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.41e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.19e-2)"	4.1	3.2	1.7	2.5	1.9	2.2	4.1	4.4	3.1	5.4	1.8	4.7	2.8	6.0	1.6	3.2	4.9	1.9	3.0	2.4	1.1	3.0	2.7	3.1	3.1	2.3	1.7	6.6	3.6	2.6	4.0	2.2	1.1	4.8	1.7	1.7	4.2	2.6	3.3	4.5	3.5	1.5	0.5	4.7	3.6	3.8	1.4	2.4	4.6	1.4	2.2	4.8	4.4	3.0	1.8	7.2	2.3	6.2	2.7	2.4	10.7	5.2	5.7	6.4	4.3	3.2	3.4	3.8	4.4	2.8	2.3	4.0	4.5	2.7	4.6	2.8	7.4	3.1	10.8	4.4	3.8	2.3	3.3	2.9	6.5	2.9	5.3	6.2	3.6	4.8	4.7	5.9	2.5	4.0	4.7	4.0	3.0	1.4	2.6	8.1	5.6	7.6	2.1	2.0	8.7	5.7	4.5	6.6	2.0	1.6	4.3	3.6	4.1	6.0	4.4	6.7	2.5	5.6	4.1	3.4	1.8	1.9	3.8	1.3	1.0	1.5	1.5	1.0	1.2	2.1	0.9	1.1	0.5	1.9	1.5	1.9	1.1	1.2	0.7	2.6	1.7	1.0	1.7	1.9	4.4	3.1	2.4	1.1	2.3	1.7	1.1	0.5	1.4	3.0	4.8	12.8	2.7	5.5	5.8	2.4	3.2	3.6	1.8	19.1	3.7	3.0	5.3	5.7	3.0	7.3	25.0	6.8	10.1	4.6	1.9	4.6	8.9	5.1	6.4	5.5	8.4	5.7	8.8	3.1	4.4	5.9	4.6	2.9	7.0	12.0	12.1	4.1	3.3	18.5	6.3	6.8	4.1	4.8	3.8	1.8	11.5	3.4	1.8	3.7	8.4	11.1	6.2	6.0	5.9	3.5	2.3	11.3	4.3	5.2	7.3	3.3	6.6	20.8	0.0	8.0	4.8	13.2	8.8	1.7	2.3	4.5	5.0	9.8	5.5	1.8
ZNF503	"FLJ45745, MGC2555, Nlz2"	ENSG00000165655	"Zinc finger protein 503"	Q96F45	10	75397830-75401764	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 255.0;Squamous epithelial cells: 189.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 115.1;PC-3: 149.2;U-87 MG: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026848	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA026848: AB_10610704"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.63e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.63e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (3.50e-4)"	"prognostic favorable (1.97e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	14.5	39.9	6.1	3.1	10.1	2.0	9.2	3.8	5.2	34.5	1.0	17.7	8.1	44.1	10.3	20.1	23.8	2.4	9.0	7.4	5.5	25.6	7.1	14.2	1.5	12.0	9.2	46.3	25.4	4.6	4.8	3.3	7.6	17.5	1.8	1.4	9.5	17.6	3.6	5.3	8.5	7.7	10.0	8.0	16.3	2.4	8.1	1.1	7.8	2.1	1.0	13.8	18.2	6.5	5.2	4.9	1.1	6.3	10.6	7.1	1.6	4.6	2.8	1.9	1.7	7.5	20.4	0.0	13.4	4.6	1.1	9.4	0.7	4.9	1.4	0.0	115.1	0.0	12.4	24.8	8.5	6.1	12.9	19.1	4.8	3.5	2.0	16.6	0.5	0.5	0.1	0.2	2.6	2.7	0.2	18.8	0.1	3.8	149.2	0.0	5.6	0.1	2.8	4.1	4.1	5.2	8.5	0.6	27.1	1.0	1.0	4.2	3.9	14.6	16.3	30.7	13.0	0.0	0.0	0.0	44.9	27.2	11.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	10.1	3.8	5.2	7.4	5.5	12.0	9.2	7.6	10.0	8.1	6.5	27.2	38.5	11.6	2.3	1.7	27.1	35.6	15.0	255.0	23.7	7.7	42.3	20.4	10.0	10.1	40.5	20.9	0.5	2.1	0.8	58.7	45.9	0.1	53.2	72.2	41.0	3.6	5.3	12.6	34.7	0.3	60.1	18.3	48.1	6.3	2.7	44.6	10.3	13.5	6.7	3.2	6.7	10.2	27.4	30.5	2.0	59.7	30.7	24.9	13.1	8.2	7.7	0.0	4.0	0.7	33.2	1.5	49.2	3.9	19.7	13.4	32.5	1.7	26.3	39.5	10.2	78.1	0.2	6.0	189.3	13.9	0.3	4.0	24.5	9.7	14.3
ZNF510	KIAA0972	ENSG00000081386	"Zinc finger protein 510"	Q9Y2H8	9	96754553-96778129	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 21.5;Inhibitory neurons: 22.7;Oligodendrocytes: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049139	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA049139: AB_2680651"	"unprognostic (2.70e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.18e-2)"	3.6	3.8	4.8	3.3	4.7	2.3	4.8	8.3	6.1	5.2	2.4	3.9	2.6	4.7	3.5	2.7	4.0	2.7	3.6	4.9	5.2	3.8	3.8	3.3	4.3	3.6	4.2	5.7	5.1	5.0	4.6	3.1	3.7	4.3	3.3	11.7	3.3	4.3	4.3	3.4	2.9	4.1	4.0	4.2	3.4	3.3	5.2	5.5	4.7	4.8	4.7	3.7	3.2	5.2	4.2	4.3	8.1	7.2	6.7	6.3	4.0	3.7	6.5	6.1	6.4	3.7	2.7	5.7	2.2	3.7	5.8	8.7	3.2	3.3	5.8	6.5	3.7	6.0	7.0	2.5	3.5	3.5	5.2	4.3	5.8	4.5	6.9	6.5	5.3	8.2	6.8	4.5	7.8	3.9	9.3	5.2	6.6	5.9	3.6	5.6	14.4	2.4	4.3	3.2	9.9	7.8	7.0	3.9	3.8	5.4	3.1	6.2	4.1	4.4	4.5	5.6	5.9	8.8	9.8	3.5	2.7	2.0	4.6	0.4	0.2	0.6	0.7	0.3	1.2	0.9	1.2	0.9	0.2	1.0	1.3	0.9	0.1	1.4	0.8	0.3	0.8	0.4	4.8	4.7	8.3	6.1	4.9	5.2	3.6	4.2	3.7	4.0	5.2	5.2	5.5	3.2	3.2	13.4	4.5	1.7	1.6	1.7	0.6	11.0	2.6	2.5	5.1	1.5	2.9	3.7	2.1	2.2	3.2	1.4	1.9	2.2	5.7	3.5	6.3	4.2	1.2	4.0	21.5	2.6	1.4	5.7	2.0	4.0	1.3	5.7	3.6	1.3	2.0	16.8	22.7	2.1	2.0	2.5	0.5	6.9	5.9	2.2	5.4	10.3	2.0	4.5	8.2	18.1	20.5	1.8	2.8	4.1	3.1	2.0	1.0	1.9	3.2	6.5	6.6	4.6	3.3	3.6	5.6	1.8	1.4	0.8	4.6	4.3	1.5	1.1
ZNF511	"MGC30006, Zfp511"	ENSG00000198546	"Zinc finger protein 511"	Q8NB15	10	133308914-133313162	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035360	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA035360: AB_10601931"	"unprognostic (3.35e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.52e-2)"	12.7	11.6	15.9	8.7	16.2	17.1	11.3	15.5	17.2	15.8	17.5	19.7	16.1	15.7	10.7	10.8	15.4	9.4	21.2	15.4	15.4	10.4	21.3	11.4	12.6	16.7	15.9	20.4	15.5	14.7	12.7	8.7	15.7	16.1	12.8	5.8	16.7	10.7	49.1	7.9	13.2	11.1	16.4	12.5	12.5	9.6	16.8	11.4	10.9	31.9	9.7	13.6	12.5	16.5	54.1	54.0	30.3	43.8	25.6	21.6	32.6	25.2	39.3	53.3	44.4	88.0	50.9	48.2	24.4	29.5	33.9	48.8	41.9	36.0	23.2	38.8	92.1	29.1	22.1	53.4	21.0	57.5	52.1	22.0	19.2	43.7	26.5	30.6	24.3	22.7	40.0	22.4	18.6	71.2	27.5	76.1	37.3	50.2	74.6	37.1	37.1	12.4	28.3	18.6	16.9	37.0	16.8	30.0	38.2	18.7	23.2	33.1	23.3	23.1	35.4	26.5	68.5	31.3	36.4	66.1	37.5	26.8	12.9	40.2	61.1	68.6	45.4	52.6	35.6	66.6	37.0	46.6	61.0	51.8	41.6	40.8	8.5	41.0	51.1	65.9	36.2	47.3	15.9	16.2	15.5	17.2	15.4	15.4	16.7	15.9	15.7	16.4	16.8	16.5	16.3	16.0	14.5	7.5	33.6	29.6	45.6	40.7	39.3	19.5	37.3	52.6	23.6	25.8	21.9	22.0	8.4	61.2	36.7	33.3	70.5	39.5	29.5	18.5	22.4	20.9	53.4	40.2	10.7	41.2	62.9	34.0	20.4	15.2	78.1	40.6	20.3	54.4	47.4	21.9	7.6	128.8	22.4	33.9	38.0	8.8	41.7	39.9	16.0	5.6	64.3	27.4	41.2	3.5	12.3	38.6	44.0	30.5	40.4	43.0	60.8	72.1	23.2	23.6	26.3	27.3	34.5	58.1	48.0	36.3	35.9	28.2	33.0	38.6	65.9	41.5
ZNF511-PRAP1		ENSG00000283496	"ZNF511-PRAP1 readthrough"		10	133309410-133352529	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	13	"intestine: 9.2;kidney: 8.4;liver: 30.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;RPMI-8226: 1.0"									"HPA035360, HPA038713, HPA052451"	Supported		Uncertain	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839"																		0.2	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	6.2	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	30.4	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	9.2	0.0	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.1	0.1	1.0	0.0	0.1	0.0	0.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF512	KIAA1805	ENSG00000243943	"Zinc finger protein 512"	Q96ME7	2	27582969-27623217	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031430	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA031430: AB_10603844"	"prognostic favorable (9.79e-4)"	"unprognostic (4.19e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (7.75e-3)"	"prognostic favorable (5.08e-9)"	"unprognostic (6.08e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (1.10e-2)"	"unprognostic (8.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-2)"	"unprognostic (5.60e-3)"	11.3	13.1	8.8	10.7	9.4	6.1	16.6	9.1	12.6	19.5	8.1	16.5	7.8	25.0	14.9	8.3	21.4	10.9	13.1	9.1	12.5	12.4	7.0	13.8	16.9	8.6	10.3	34.3	7.7	20.1	13.6	13.0	9.1	18.1	12.0	26.4	11.1	19.2	7.4	7.2	12.9	16.9	8.7	17.0	11.0	13.2	11.5	27.0	20.5	10.5	17.5	16.4	13.0	11.1	26.2	22.8	46.2	20.6	22.4	25.2	0.0	12.7	17.9	23.6	27.7	17.7	16.2	22.8	14.0	14.6	19.6	8.7	41.3	12.0	25.0	21.2	33.0	47.9	18.4	27.0	17.3	31.4	20.8	23.2	12.9	18.4	5.3	18.9	37.9	39.3	42.0	16.2	35.0	3.3	3.3	24.0	32.1	17.2	0.0	52.2	65.0	19.8	16.8	7.2	45.0	44.8	12.0	7.6	36.0	21.9	9.3	17.8	31.5	8.3	20.0	8.6	16.8	16.2	12.1	38.9	12.5	38.4	17.3	24.5	5.5	9.8	10.2	6.7	14.1	12.4	12.9	15.0	8.2	11.1	17.1	14.6	1.7	22.1	5.5	5.9	9.8	10.8	8.8	9.4	9.1	12.6	9.1	12.5	8.6	10.3	9.1	8.7	11.5	11.1	8.9	9.6	14.2	16.6	10.0	3.8	10.4	4.3	6.8	22.8	8.1	7.6	15.6	7.2	7.8	18.4	16.7	1.6	9.7	2.2	9.8	6.8	11.9	5.2	12.7	11.5	9.0	14.7	22.5	1.9	1.1	11.6	8.2	5.2	6.3	25.5	11.7	4.4	5.3	18.5	28.9	6.3	6.1	7.2	7.1	5.7	14.9	6.2	1.8	23.4	8.9	17.0	9.2	25.1	27.2	4.6	3.3	17.3	9.0	5.8	2.3	4.2	8.9	15.7	19.7	14.6	13.4	8.3	9.0	6.6	3.0	1.2	10.3	13.6	5.0	6.9
ZNF512B	"GM632, MGC149845, MGC149846"	ENSG00000196700	"Zinc finger protein 512B"	Q96KM6	20	63956704-63969930	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.4;Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006688, HPA008731"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006688: AB_10963053, HPA008731: "	"unprognostic (7.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.19e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.99e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.72e-2)"	8.6	11.4	8.4	5.5	8.4	5.9	10.4	4.8	11.4	12.9	0.9	10.9	4.4	13.8	2.8	17.2	12.2	5.9	9.6	8.8	7.0	12.4	21.3	8.4	6.2	5.1	5.5	14.2	15.0	9.1	20.8	7.9	4.5	13.0	1.4	4.5	12.6	7.7	12.1	14.4	7.2	5.9	2.9	10.3	10.3	10.2	6.3	8.3	19.7	5.2	4.1	11.4	10.9	5.8	10.2	16.8	18.6	19.8	8.1	5.9	17.0	14.4	11.2	42.3	13.8	33.1	16.8	6.6	34.5	12.6	7.8	12.8	14.1	21.4	10.1	11.0	20.3	16.4	26.4	31.9	12.9	8.9	18.9	12.5	17.3	14.7	8.4	11.1	13.3	29.4	23.1	9.9	8.5	24.3	43.6	19.2	12.9	12.9	21.8	19.8	1.7	20.1	7.6	16.9	27.2	15.8	11.9	19.4	9.8	8.8	40.9	21.4	18.8	40.4	6.2	10.3	12.6	23.6	12.1	18.3	14.5	0.1	17.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.4	8.4	4.8	11.4	8.8	7.0	5.1	5.5	4.5	2.9	6.3	5.8	6.7	3.2	5.6	1.6	3.1	5.4	3.5	5.3	4.6	22.4	10.3	9.5	2.9	5.7	6.5	1.8	22.9	7.8	6.1	0.1	1.9	3.7	0.1	5.2	12.0	5.8	6.0	3.4	1.1	6.1	2.9	6.7	3.6	9.6	0.0	14.0	8.6	19.4	3.9	13.5	1.4	0.8	8.2	1.9	2.5	1.3	6.5	1.7	5.4	1.0	2.3	7.3	4.1	1.5	0.6	3.2	0.2	6.8	5.2	3.5	2.2	5.7	2.6	10.6	0.0	8.7	5.6	6.5	4.1	11.1	7.0	5.1	3.6	14.3	1.2	2.8
ZNF514	FLJ14457	ENSG00000144026	"Zinc finger protein 514"	Q96K75	2	95145000-95165413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028974	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA028974: AB_10603845"	"unprognostic (8.79e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.79e-2)"	9.3	9.3	13.5	5.9	13.5	2.5	13.2	14.5	14.4	18.3	12.6	14.1	10.2	15.7	26.8	7.8	14.5	5.9	9.6	13.9	13.1	14.2	6.6	9.0	8.7	13.5	12.7	23.3	10.2	12.7	17.2	8.1	14.3	14.8	9.9	29.9	11.7	11.3	14.4	15.0	9.8	10.5	10.9	10.1	10.8	11.2	13.8	10.1	17.9	13.3	8.2	11.4	13.0	15.9	16.7	5.5	16.0	11.5	11.1	15.0	12.2	6.6	7.2	11.0	11.2	9.3	6.5	2.8	3.3	7.1	16.8	10.7	8.6	6.3	12.2	5.5	11.1	3.2	8.8	7.6	4.6	1.9	8.3	8.9	18.9	6.9	4.7	16.4	5.1	9.5	9.3	3.4	8.9	8.2	5.0	10.3	5.3	5.4	6.0	8.5	5.8	6.1	7.1	6.6	14.8	11.2	7.1	3.5	7.6	21.6	6.3	6.4	5.9	7.9	9.9	2.7	5.6	8.5	6.9	4.9	8.2	3.7	5.2	12.7	4.3	8.4	3.9	2.3	4.7	6.8	5.1	3.7	4.2	7.0	8.5	7.0	1.4	6.1	2.6	3.5	6.2	4.2	13.5	13.5	14.5	14.4	13.9	13.1	13.5	12.7	14.3	10.9	13.8	15.9	8.0	9.6	7.9	20.2	4.6	5.6	9.9	8.0	2.2	13.9	9.4	11.9	14.0	12.8	6.7	0.0	18.8	6.3	4.9	6.3	27.4	6.6	44.1	7.1	7.9	8.0	9.6	7.0	22.8	5.2	3.5	7.2	4.6	5.3	1.3	27.9	7.1	9.4	8.3	15.2	22.3	10.6	10.2	5.1	2.2	43.2	10.5	5.4	7.2	13.1	5.9	12.9	8.2	15.1	34.3	4.9	5.1	7.5	3.1	10.0	10.3	18.2	10.3	31.5	6.6	7.9	8.0	20.6	12.5	3.8	6.3	3.7	4.7	8.2	8.7	10.7
ZNF516	"HsT287, KIAA0222"	ENSG00000101493	"Zinc finger protein 516"	Q92618	18	76357682-76495242	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.1;Early spermatids: 77.4;Endometrial stromal cells: 78.9;Langerhans cells: 69.7;Oligodendrocyte precursor cells: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"THP-1: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015792	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA015792: AB_1859314"	"prognostic favorable (7.09e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.63e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (5.87e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	5.8	7.6	19.6	4.5	18.5	24.5	6.4	9.4	11.2	32.2	2.3	8.4	6.2	32.2	8.5	9.0	23.6	5.1	5.3	18.1	21.9	4.6	6.2	7.6	3.0	16.8	18.2	22.8	6.8	9.5	11.3	3.0	10.8	9.7	2.6	16.2	6.4	17.3	14.2	10.1	6.2	11.8	10.7	6.8	6.3	34.4	18.8	4.4	6.4	5.9	2.8	10.3	15.3	6.8	2.4	2.7	18.8	25.0	5.3	8.0	2.4	14.6	12.1	3.1	5.7	5.5	8.9	12.7	3.0	15.5	7.7	5.2	10.4	14.0	2.0	0.0	8.0	1.2	0.0	11.7	13.2	8.5	8.3	15.4	5.9	6.3	6.7	4.2	3.5	5.2	0.0	0.0	3.0	5.2	0.2	14.4	9.5	1.5	0.7	5.7	1.9	6.6	4.7	11.1	18.9	11.3	0.2	0.0	15.3	7.3	3.1	33.2	2.3	7.1	12.4	0.2	1.5	0.1	0.4	9.9	4.2	5.8	18.6	2.5	1.8	2.9	0.0	1.2	0.4	0.0	0.1	0.0	1.2	0.3	0.4	0.2	10.2	0.7	1.4	0.8	0.0	0.4	19.6	18.5	9.4	11.2	18.1	21.9	16.8	18.2	10.8	10.7	18.8	6.8	9.6	9.6	10.1	75.1	5.0	19.5	17.9	12.7	9.1	15.0	8.6	8.1	8.5	5.7	8.8	1.8	31.3	0.3	6.1	4.2	3.9	5.8	77.4	33.1	78.9	9.8	12.6	3.0	19.8	2.9	0.4	15.6	4.6	47.7	1.3	10.4	7.9	11.4	8.4	3.3	37.3	5.2	6.1	20.0	69.7	43.5	30.4	14.2	12.4	30.0	20.9	8.4	9.2	73.9	0.7	5.5	4.5	35.0	0.6	11.8	7.4	5.4	15.3	30.3	13.1	16.1	15.5	3.7	33.1	7.0	20.2	0.5	2.8	21.5	4.5	20.8
ZNF517		ENSG00000197363	"Zinc finger protein 517"	Q6ZMY9	8	144798876-144811169	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055337			Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA055337: AB_2682788"	"unprognostic (9.54e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.66e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.57e-2)"	2.9	5.9	2.4	2.1	2.0	1.0	3.2	1.9	3.2	5.5	0.4	4.8	2.2	6.8	0.4	3.3	5.5	2.0	3.2	3.2	0.7	4.2	3.6	2.6	2.3	1.8	1.6	7.2	3.5	1.8	5.0	1.4	2.2	5.0	0.3	2.2	4.2	1.0	6.3	6.3	3.4	0.6	0.9	3.4	3.7	4.0	2.0	1.1	4.8	0.8	0.9	4.9	4.0	2.3	1.7	3.2	5.2	5.1	0.8	1.5	2.7	1.4	0.4	0.3	0.2	1.0	1.9	0.9	3.6	0.5	2.2	1.7	0.2	0.6	0.7	3.8	1.4	2.2	2.0	11.7	1.9	0.5	2.2	1.1	1.3	0.2	1.0	2.9	1.2	2.7	2.6	1.4	0.9	2.8	2.3	1.3	3.6	3.5	3.5	3.2	1.6	0.8	0.5	2.1	2.3	6.6	4.3	1.7	1.7	2.5	4.2	2.0	1.5	3.5	5.3	1.8	1.6	2.2	0.4	0.7	3.7	0.9	2.9	0.1	0.3	0.0	0.5	0.7	0.3	1.4	0.4	0.3	0.3	0.1	0.3	0.3	0.1	0.3	0.4	0.1	0.6	0.4	2.4	2.0	1.9	3.2	3.2	0.7	1.8	1.6	2.2	0.9	2.0	2.3	1.8	0.0	0.5	1.3	1.2	0.5	5.8	0.9	0.6	3.9	1.6	1.3	3.3	2.8	1.1	0.0	8.4	0.8	1.2	0.8	1.9	0.8	1.3	1.8	1.5	1.5	1.2	0.8	0.9	0.5	0.7	1.7	1.1	1.3	0.0	2.2	2.2	2.3	1.5	3.3	1.3	1.5	2.0	2.2	0.5	0.0	0.9	1.4	0.0	1.0	0.5	2.5	4.1	1.5	0.6	0.9	0.3	1.2	0.9	1.6	1.3	3.3	0.8	3.6	0.0	1.8	1.5	4.3	3.0	0.9	1.1	0.4	1.5	2.2	0.9	4.1
ZNF518A	"KIAA0335, ZNF518"	ENSG00000177853	"Zinc finger protein 518A"	Q6AHZ1	10	96129715-96205288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029049			Approved	Nucleoplasm		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029049: AB_2672885"	"unprognostic (1.48e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-2)"	"unprognostic (6.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.16e-3)"	4.1	3.2	3.8	4.4	4.5	7.6	7.3	5.7	4.7	4.3	2.1	7.1	5.0	5.6	7.8	4.3	4.3	4.1	3.4	3.5	5.1	5.1	4.6	4.5	6.1	5.0	4.5	7.4	4.5	4.0	4.1	4.4	5.4	4.8	7.0	9.3	4.1	4.2	1.9	6.0	6.4	4.4	4.5	5.4	6.7	16.1	4.7	8.1	7.7	2.3	6.1	3.8	2.8	6.8	4.2	9.4	10.3	0.0	5.1	5.8	12.4	4.4	2.5	4.7	4.8	8.9	10.0	15.5	4.1	2.8	6.7	5.9	11.8	4.2	4.3	7.1	6.3	23.2	3.2	14.5	4.5	25.3	13.5	3.8	10.1	4.9	7.8	3.4	5.7	17.8	20.1	10.1	4.7	4.2	15.0	15.3	15.9	4.7	0.6	16.7	11.8	6.2	5.6	8.5	3.0	7.2	6.2	5.8	4.5	17.0	6.9	16.0	3.7	2.2	8.5	3.0	4.8	9.3	24.9	8.8	1.5	19.0	2.4	9.8	2.6	3.2	1.8	2.8	2.7	2.5	2.1	1.8	1.7	2.2	3.0	2.1	2.5	2.3	5.3	2.9	2.5	1.4	3.8	4.5	5.7	4.7	3.5	5.1	5.0	4.5	5.4	4.5	4.7	6.8	31.1	57.7	28.2	136.8	26.1	0.0	17.1	0.0	13.1	65.0	32.5	21.2	26.5	30.0	14.9	40.5	43.8	49.1	31.6	51.0	19.6	24.1	23.6	42.6	38.8	24.0	61.2	17.1	63.9	25.5	30.8	21.6	32.6	41.3	9.5	57.9	35.3	28.3	28.1	75.7	90.5	35.8	0.0	32.8	0.0	15.0	35.1	31.3	0.0	81.5	48.7	29.1	47.4	150.3	173.0	32.9	52.4	25.2	18.3	20.8	39.5	20.4	10.2	56.9	19.7	33.8	23.2	73.1	131.2	16.2	0.0	43.8	23.3	40.9	35.2	17.6
ZNF518B	KIAA1729	ENSG00000178163	"Zinc finger protein 518B"	Q9C0D4	4	10439880-10457426	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031215, HPA031216"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA031215: AB_10600200, HPA031216: AB_10601449"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.11e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.89e-3)"	6.3	4.4	4.7	6.4	5.2	3.9	7.0	7.8	4.7	3.7	4.9	3.9	3.7	4.9	3.6	4.2	2.9	4.3	6.4	5.6	6.4	3.3	2.2	4.3	6.7	2.5	4.0	7.8	1.5	3.7	2.9	7.0	3.6	6.9	2.9	7.0	7.4	7.1	6.0	3.7	5.0	5.6	3.9	6.7	3.5	9.0	7.7	8.6	7.9	8.7	8.7	4.2	3.7	4.0	8.2	5.5	20.8	6.1	2.7	3.9	0.1	9.1	2.3	5.7	6.6	0.0	0.0	0.1	9.2	13.7	16.1	0.2	4.8	10.4	12.6	0.0	8.8	26.2	0.0	0.0	11.9	0.0	11.2	11.7	6.0	9.0	0.0	11.6	19.6	19.3	28.9	0.0	4.7	0.0	18.2	0.6	20.4	4.1	12.5	15.5	8.6	3.0	0.3	11.2	15.5	4.6	4.3	0.0	2.8	16.6	3.4	7.0	14.9	0.0	18.7	0.1	8.8	10.7	8.5	15.1	1.1	1.4	1.1	2.2	2.0	9.6	2.1	1.9	2.6	7.9	3.3	2.4	3.5	3.5	3.4	3.2	4.9	5.0	4.7	1.2	2.6	1.7	4.7	5.2	7.8	4.7	5.6	6.4	2.5	4.0	3.6	3.9	7.7	4.0	15.7	3.2	6.3	4.2	12.1	15.9	22.8	8.0	8.6	9.6	5.7	5.1	26.3	4.3	9.5	0.0	10.4	8.9	3.7	3.6	3.9	2.5	13.1	5.0	9.2	13.1	1.2	4.6	12.1	4.0	9.3	11.9	4.6	10.2	16.5	22.5	12.8	1.8	9.2	11.8	10.6	3.5	14.2	10.2	8.0	20.8	16.1	7.3	1.8	7.5	6.5	6.1	6.2	4.5	3.5	1.6	3.3	21.4	5.3	20.0	6.2	1.3	6.7	10.3	0.0	6.7	8.6	13.7	11.2	6.8	14.2	9.2	8.1	19.7	4.3	19.5
ZNF521	"EHZF, Evi3"	ENSG00000198795	"Zinc finger protein 521"	Q96K83	18	25061924-25352190	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 95.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.1;Microglial cells: 53.4;Oligodendrocyte precursor cells: 221.7;Oligodendrocytes: 104.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 95.9"	"Group enriched"	"Detected in some"	6	"basophil: 11.4;plasmacytoid DC: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 8.8;granulocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"AF22: 67.6;fHDF/TERT166: 32.7;HUVEC TERT2: 46.9;THP-1: 38.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 49.7"	"HPA023056, HPA023849"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA023056: AB_1859315, HPA023849: AB_1859316"	"unprognostic (8.80e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.52e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.82e-4)"	13.4	11.9	8.8	3.1	10.5	2.3	11.4	95.9	9.5	10.8	29.9	4.7	1.7	15.3	4.3	3.9	9.0	10.6	9.1	6.0	14.7	3.2	1.2	6.3	3.8	17.4	14.3	20.5	1.2	1.1	7.6	8.6	21.2	2.6	3.6	5.7	9.0	3.0	3.7	6.1	4.4	13.6	12.4	21.0	2.7	3.6	10.8	4.3	6.8	6.0	2.8	5.8	6.8	13.5	0.1	0.0	67.6	0.1	10.6	18.4	0.2	10.0	14.3	3.4	2.1	0.0	0.1	0.0	0.0	32.7	0.0	0.3	0.0	0.0	2.8	0.0	4.0	14.0	0.6	0.5	1.9	0.0	20.2	23.0	0.0	0.3	0.0	0.0	46.9	16.4	0.3	0.1	6.0	0.0	9.2	0.0	4.7	0.0	0.0	0.0	15.2	1.1	0.0	0.0	8.7	5.5	0.8	0.0	0.0	6.1	0.0	38.9	26.9	26.5	2.0	8.0	1.5	0.1	0.0	0.3	10.0	0.0	22.2	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	8.8	0.0	0.1	8.8	10.5	95.9	9.5	6.0	14.7	17.4	14.3	21.2	12.4	10.8	13.5	19.0	0.0	3.0	170.1	0.3	3.7	0.1	0.0	1.2	42.4	8.0	10.9	11.9	0.0	0.6	0.0	2.1	0.1	1.7	0.0	0.0	0.0	2.1	0.5	3.3	28.6	1.2	13.9	16.5	0.0	0.0	21.4	0.0	0.2	13.3	4.7	20.3	0.0	0.1	15.2	22.7	0.1	0.0	0.6	5.5	3.3	9.9	0.9	14.2	53.4	0.1	0.7	0.0	221.7	104.6	0.0	0.0	7.9	0.1	0.2	0.0	4.0	1.5	3.0	0.0	13.7	6.0	0.1	6.1	0.8	4.4	0.1	0.8	17.2	0.0	0.2
ZNF524	MGC23143	ENSG00000171443	"Zinc finger protein 524"	Q96C55	19	55600022-55603138	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 96.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050981	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA050981: AB_2681298"	"unprognostic (6.69e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.59e-2)"	"prognostic favorable (4.98e-8)"	22.5	19.4	14.0	7.7	14.4	9.9	22.2	14.0	18.9	18.8	13.1	22.5	14.9	18.2	3.4	26.7	17.6	6.1	23.5	12.2	12.2	20.9	28.6	18.0	9.6	15.9	14.4	16.4	67.9	7.2	18.5	4.4	14.7	21.8	3.8	1.7	24.6	5.4	45.5	37.2	19.4	2.7	14.0	27.7	34.5	6.9	13.9	6.1	20.4	10.9	3.7	19.9	19.6	16.2	12.1	11.3	1.7	7.5	5.3	10.6	12.4	7.4	4.3	4.6	4.7	3.4	13.1	6.1	4.4	4.0	2.6	9.2	1.1	5.6	0.6	18.9	29.2	7.5	6.7	5.9	12.3	4.7	9.2	8.7	13.4	3.8	3.9	4.7	8.8	7.3	7.4	11.4	2.6	6.7	4.7	10.1	2.0	11.1	13.3	6.2	3.9	18.5	5.9	6.4	8.0	5.4	7.6	10.1	8.6	1.2	4.8	15.3	7.9	4.0	6.9	7.6	9.5	5.2	6.9	2.8	10.3	12.0	5.3	15.0	23.9	20.1	13.4	21.2	12.4	11.9	13.7	12.9	18.6	14.4	16.0	8.9	14.6	12.4	14.1	5.6	22.1	15.2	14.0	14.4	14.0	18.9	12.2	12.2	15.9	14.4	14.7	14.0	13.9	16.2	38.5	6.4	14.1	1.6	19.4	25.2	17.2	25.5	23.9	8.5	36.3	42.4	10.1	20.0	16.1	7.3	6.2	22.0	17.8	73.0	17.6	25.0	2.4	16.9	13.4	27.1	23.4	9.4	1.8	53.6	19.5	14.8	34.7	14.5	10.2	12.0	40.4	22.9	38.1	6.7	1.7	62.9	6.1	75.8	27.8	7.5	18.0	37.7	30.2	4.7	46.6	10.1	34.0	1.5	5.8	33.4	56.9	21.8	14.5	18.2	96.1	38.1	8.8	8.4	19.7	14.4	17.6	1.1	6.1	30.9	35.7	25.6	23.4	18.5	46.1	20.5
ZNF526	"KIAA1951, MGC4267"	ENSG00000167625	"Zinc finger protein 526"	Q8TF50	19	42220312-42228201	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 33.3;granulocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023070, HPA056609"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA023070: AB_2671057, HPA056609: AB_2683189"	"unprognostic (2.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.84e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.30e-1)"	3.4	2.5	2.1	2.8	2.3	3.8	3.1	4.3	2.6	3.9	2.0	3.3	3.3	3.6	2.3	3.1	3.5	1.9	2.8	2.0	2.1	2.3	2.8	2.6	4.0	2.4	2.2	4.5	3.5	3.9	3.0	3.0	2.3	3.3	2.1	2.0	4.6	3.3	5.1	5.2	3.1	2.4	1.6	3.6	3.1	3.5	2.4	4.2	2.8	4.0	3.6	3.5	3.4	3.4	7.8	24.8	7.1	6.4	8.0	7.7	6.2	8.9	8.2	9.2	10.1	13.0	5.5	12.6	6.3	9.5	4.2	5.7	7.7	9.7	5.7	7.5	9.2	12.6	12.0	12.5	7.5	8.1	7.8	7.6	7.7	9.2	9.6	5.7	5.8	6.7	12.3	7.8	5.9	10.8	8.2	5.2	4.7	6.8	8.7	9.4	8.7	5.7	4.2	14.0	7.3	6.4	10.2	10.1	7.2	5.4	4.1	14.4	7.8	11.3	7.7	4.8	11.2	9.3	5.9	8.5	7.5	7.8	9.5	1.8	3.6	1.4	4.5	3.6	6.9	4.7	3.5	4.1	2.8	4.4	4.2	5.3	0.7	3.4	5.3	4.2	3.9	3.3	2.1	2.3	4.3	2.6	2.0	2.1	2.4	2.2	2.3	1.6	2.4	3.4	3.0	22.4	33.3	2.0	6.9	5.5	4.4	2.8	4.0	7.4	3.1	2.4	3.2	0.0	17.1	3.7	14.6	8.0	3.2	5.7	3.9	4.1	5.8	1.7	4.0	7.1	13.8	9.5	1.4	3.0	8.3	7.4	4.6	2.3	25.2	4.9	3.6	2.6	4.6	6.7	1.5	4.2	2.0	6.8	1.8	6.3	7.2	7.0	0.0	1.9	5.8	4.1	11.3	1.0	1.4	2.9	2.8	3.0	6.1	4.6	7.8	2.8	9.2	9.6	0.0	5.7	3.6	9.9	10.1	1.9	5.1	10.3	6.7	3.7	5.7	2.6
ZNF529	KIAA1615	ENSG00000186020	"Zinc finger protein 529"	Q6P280	19	36534774-36605276	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.6;Horizontal cells: 75.7;Inhibitory neurons: 45.7;Oligodendrocytes: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA031311	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA031311: AB_10604158"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.84e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.61e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.39e-5)"	5.7	5.8	8.1	5.1	11.5	10.1	6.0	9.6	10.4	6.2	6.5	5.1	3.1	6.9	5.5	3.3	8.0	3.8	7.3	7.1	9.8	5.9	4.4	5.8	7.4	8.9	9.5	8.9	3.6	6.0	5.7	4.8	9.8	5.1	3.0	20.1	4.2	3.4	5.4	6.6	5.1	4.5	9.0	6.0	3.9	9.2	9.1	6.3	5.7	5.5	6.4	4.7	5.2	14.9	4.0	8.1	11.5	12.3	5.4	6.6	4.5	6.1	3.3	3.4	8.6	4.1	3.1	10.7	7.7	4.9	4.4	1.5	8.7	3.9	6.2	14.4	9.7	13.1	7.6	3.0	6.4	9.9	7.9	8.0	5.0	4.6	6.7	5.8	2.9	8.1	5.5	0.7	7.1	1.1	10.0	3.4	7.5	0.2	3.3	2.9	6.9	4.9	3.0	10.6	5.1	10.4	8.5	2.7	2.6	4.4	3.5	6.0	7.0	7.4	5.3	6.1	7.6	13.2	8.5	9.0	0.2	3.3	5.7	4.7	1.1	1.5	2.3	0.6	3.1	2.9	2.5	2.4	1.2	2.2	2.8	2.2	0.5	2.1	0.7	1.4	3.1	1.2	8.1	11.5	9.6	10.4	7.1	9.8	8.9	9.5	9.8	9.0	9.1	14.9	10.0	3.2	3.3	23.8	14.1	9.8	5.3	2.9	10.2	19.0	12.3	8.1	14.7	5.7	5.7	7.3	25.0	3.6	11.0	1.4	5.9	3.5	4.5	10.1	8.0	10.0	3.0	14.1	46.6	1.6	2.8	7.9	5.1	9.9	2.5	15.2	7.9	6.9	4.0	75.7	45.7	3.5	4.1	5.1	8.4	2.3	6.5	4.3	5.4	19.7	3.1	7.8	6.2	36.2	61.5	2.2	2.5	6.8	7.2	7.0	1.4	4.5	8.8	22.4	0.0	9.1	7.5	18.0	10.3	8.2	9.1	3.3	11.2	9.9	2.8	6.5
ZNF532	FLJ10697	ENSG00000074657	"Zinc finger protein 532"	Q9HCE3	18	58862600-58986480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.1;Excitatory neurons: 86.9;Inhibitory neurons: 90.9;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 178.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015322	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA015322: AB_2304947"	"unprognostic (3.43e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (4.24e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (5.76e-4)"	24.0	12.5	33.5	15.7	53.1	1.4	17.9	73.9	39.8	30.3	12.4	25.9	7.2	65.1	20.1	22.3	26.2	24.5	36.0	34.3	45.0	14.1	4.2	19.9	14.2	55.2	44.2	52.8	6.8	16.3	15.7	26.4	56.6	48.0	13.3	25.7	15.8	34.1	61.1	16.5	12.0	41.4	33.8	17.0	12.8	24.2	46.1	11.9	24.7	49.8	17.4	23.0	21.3	84.8	21.3	30.0	118.8	63.4	18.5	42.2	5.8	37.6	35.2	26.0	23.4	10.2	23.0	26.5	28.3	47.2	12.9	34.1	1.0	29.7	26.7	19.5	25.0	0.0	51.8	0.6	24.5	0.2	0.2	33.1	54.5	27.2	49.5	34.4	28.8	0.0	0.3	31.9	30.8	0.0	0.2	0.3	63.0	1.0	19.9	0.6	31.6	4.2	18.1	2.8	27.1	70.3	24.2	2.6	40.8	78.8	30.3	17.3	22.0	70.7	50.1	0.5	30.7	0.4	21.7	7.3	24.0	0.0	55.2	0.0	0.3	0.0	0.4	1.1	0.1	3.7	0.2	0.2	0.7	1.6	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.4	33.5	53.1	73.9	39.8	34.3	45.0	55.2	44.2	56.6	33.8	46.1	84.8	16.6	12.8	12.2	90.1	13.2	10.6	12.5	8.0	12.0	28.8	9.3	8.8	17.0	5.7	10.1	1.8	27.1	2.0	1.4	0.3	0.0	4.9	4.9	8.3	48.3	24.2	4.2	0.0	86.9	0.5	2.7	17.9	3.1	10.0	0.0	15.8	14.6	0.1	4.4	35.3	90.9	0.2	4.1	9.1	14.3	3.5	11.5	9.2	8.8	53.4	5.2	22.1	0.0	130.2	178.2	6.0	1.4	18.0	8.6	33.5	0.0	1.6	8.8	9.7	13.1	15.5	24.2	5.5	17.2	8.9	9.2	3.4	4.3	5.0	0.3	11.9
ZNF536	KIAA0390	ENSG00000198597	"Zinc finger protein 536"	O15090	19	30228290-30713538	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 80.7"	"Group enriched"	"Detected in some"	9	"Inhibitory neurons: 506.0;Oligodendrocytes: 794.4"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 5.0;HAP1: 11.0;SH-SY5Y: 29.5;U-937: 7.5;WM-115: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077341			Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"		"HPA077341: AB_2732340"	"unprognostic (1.98e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.68e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.46e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.45e-1)"	0.4	2.6	20.7	0.7	43.1	0.0	0.2	28.1	33.2	1.6	17.7	3.6	1.0	0.5	0.3	3.1	0.3	0.3	2.2	18.1	20.2	0.1	0.0	0.2	0.0	36.7	31.2	0.1	0.2	0.3	4.2	0.0	33.9	2.1	1.6	13.7	0.4	0.8	0.4	0.3	1.9	0.3	19.9	0.5	1.1	2.2	36.1	0.0	3.2	0.8	0.0	2.1	1.1	80.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	11.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	29.5	0.0	0.0	1.9	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	7.5	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	43.1	28.1	33.2	18.1	20.2	36.7	31.2	33.9	19.9	36.1	80.7	0.0	0.0	0.0	11.1	0.0	0.4	0.2	0.0	0.0	33.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.8	0.0	0.0	2.4	0.0	0.0	4.3	0.0	0.0	0.0	2.3	0.0	0.0	0.7	70.7	506.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	13.1	0.0	48.6	0.0	46.8	794.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	9.7	0.0	9.1	1.6	0.3	0.6	0.1	0.3	0.0	0.1	0.0	0.0	0.3
ZNF540	DKFZp547B0714	ENSG00000171817	"Zinc finger protein 540"	Q8NDQ6	19	37551406-37614179	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 25.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.3;Excitatory neurons: 47.7;Inhibitory neurons: 56.5;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 27.7;Rod photoreceptor cells: 22.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0"									HPA003444	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA003444: AB_1080732"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-4)"	"unprognostic (4.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-4)"	"unprognostic (4.24e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.88e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (8.08e-2)"	"unprognostic (8.33e-5)"	1.6	4.9	10.5	2.3	10.2	0.6	3.1	14.4	11.2	5.0	6.8	4.4	2.1	3.3	4.8	1.6	3.9	1.8	5.3	9.4	12.3	5.0	2.2	2.6	3.8	8.2	8.9	8.5	2.5	5.3	14.7	1.1	8.6	5.5	1.8	25.8	3.5	4.6	2.0	3.2	4.2	1.8	7.9	4.7	3.2	2.9	11.4	2.1	7.9	1.6	3.4	3.6	3.4	9.1	0.1	0.0	1.1	1.3	3.0	1.8	0.1	0.4	0.4	0.5	0.9	0.1	0.0	0.5	0.1	1.1	0.3	0.4	0.8	0.4	0.4	1.7	1.2	0.4	0.8	0.0	0.8	0.5	0.9	0.9	1.1	0.3	0.0	0.2	0.0	2.4	0.2	0.0	0.7	0.0	0.8	0.3	0.4	0.1	0.2	0.7	0.7	0.4	0.2	0.1	1.2	1.4	0.4	0.1	0.1	0.8	0.6	0.5	0.0	0.4	1.4	0.5	0.4	1.6	1.0	1.3	0.0	0.2	0.2	0.0	0.0	0.8	2.7	0.0	2.6	1.9	2.7	3.0	0.1	2.2	4.4	4.8	0.1	2.4	0.0	0.2	3.1	1.2	10.5	10.2	14.4	11.2	9.4	12.3	8.2	8.9	8.6	7.9	11.4	9.1	2.3	3.2	2.6	15.3	6.3	1.7	1.3	0.8	3.4	23.3	2.4	2.2	10.4	0.0	1.7	1.8	6.2	0.3	3.3	0.2	7.9	0.3	18.6	1.1	1.0	2.2	0.0	0.0	47.7	0.4	0.4	2.8	1.5	0.6	3.8	1.7	2.2	1.1	0.8	18.5	56.5	0.3	0.0	0.8	1.0	5.5	2.5	1.0	3.6	11.2	0.5	5.5	8.2	23.1	27.7	0.2	1.1	5.7	2.5	0.4	2.3	2.7	0.4	22.3	6.6	3.1	2.9	5.7	3.3	1.8	1.3	0.1	3.9	1.2	0.3	0.2
ZNF541	DKFZp434I1930	ENSG00000118156	"Zinc finger protein 541"	Q9H0D2	19	47520685-47555856	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 21.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 25.5;Late spermatids: 12.2;Proximal tubular cells: 19.1;Spermatocytes: 37.3;Spermatogonia: 11.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 1.5;SiHa: 5.0;U-87 MG: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058541, HPA076453"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA058541: AB_2683748, HPA076453: AB_2732310"	"unprognostic (4.49e-2)"	"prognostic favorable (2.94e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.92e-5)"	"unprognostic (7.98e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-2)"	1.0	3.1	0.3	0.1	0.3	0.1	0.6	0.2	0.8	0.1	0.0	0.8	0.1	0.3	0.0	0.0	0.2	0.2	0.9	0.5	0.0	0.7	0.1	0.1	0.2	0.4	0.1	2.3	0.1	0.1	0.6	0.3	0.4	0.1	0.1	0.5	0.1	0.1	0.5	0.4	0.3	0.2	0.0	0.5	0.1	21.9	0.2	0.1	0.5	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.5	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.8	0.5	0.0	0.4	0.1	0.4	0.0	0.2	0.2	4.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.5	0.3	1.8	0.0	0.0	1.8	2.1	0.0	0.3	0.0	0.0	0.0	25.5	0.0	0.1	1.6	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.3	0.0	2.0	6.1	0.4	0.0	0.0	1.5	0.1	0.0	0.0	0.0	12.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.5	19.1	0.0	0.8	0.0	0.0	0.1	37.3	11.7	0.0	0.1	0.0	0.4	0.5	0.0	0.0
ZNF543	DKFZp434H055	ENSG00000178229	"Zinc finger protein 543"	Q08ER8	19	57320472-57330770	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 12.5;Late spermatids: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA046330			Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA046330: "	"unprognostic (9.20e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.71e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.84e-2)"	1.6	1.5	1.9	1.4	1.7	1.8	2.6	4.9	2.0	1.7	0.2	1.4	0.7	1.9	1.6	2.0	2.2	1.5	1.4	1.4	2.2	1.6	1.1	1.7	2.4	1.2	1.6	4.8	1.9	3.1	1.8	2.8	1.4	2.0	1.0	2.7	1.7	2.2	1.8	2.4	1.1	1.9	0.8	2.5	1.6	3.2	1.7	3.2	2.6	1.9	2.4	1.5	1.3	2.0	2.3	3.0	2.8	4.4	2.4	2.1	3.3	1.3	2.4	2.5	4.4	0.9	1.3	3.6	1.8	1.9	1.6	1.3	2.4	2.5	3.3	1.6	6.5	3.5	3.4	2.8	2.6	3.5	2.3	2.3	2.6	1.9	4.1	2.1	1.9	4.2	1.9	0.7	1.8	0.3	4.0	1.1	2.5	0.2	2.3	3.8	4.1	3.9	1.6	5.6	5.1	3.6	3.9	1.5	2.6	2.4	1.8	3.2	1.8	3.6	2.5	0.7	2.5	5.3	3.8	4.1	1.8	1.5	1.9	0.9	1.4	3.1	1.5	1.4	1.8	2.3	1.6	2.2	1.5	2.3	1.9	1.9	1.5	2.1	1.5	1.0	0.9	1.5	1.9	1.7	4.9	2.0	1.4	2.2	1.2	1.6	1.4	0.8	1.7	2.0	4.1	3.2	0.5	0.7	4.2	2.7	1.3	1.9	3.4	4.5	2.3	1.3	1.9	5.7	2.4	0.0	6.2	3.1	4.8	0.5	5.9	1.6	12.5	3.5	2.4	3.8	0.0	1.3	4.4	0.4	1.5	1.7	0.5	4.4	2.5	4.9	2.9	0.8	1.7	6.7	5.3	1.3	8.2	1.6	1.2	15.2	1.5	1.3	1.8	5.6	0.2	3.8	0.0	4.0	2.5	0.2	0.3	2.2	3.2	1.9	0.6	0.9	0.5	6.3	6.6	2.4	2.9	3.3	2.4	4.4	2.6	2.2	2.6	3.3	1.3	1.5
ZNF544	AF020591	ENSG00000198131	"Zinc finger protein 544"	Q6NX49	19	58228594-58277495	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 164.2"					"Low region specificity"	"Detected in all"			HPA002732	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA002732: AB_1080735"	"unprognostic (5.28e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (3.61e-3)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (4.94e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.49e-1)"	8.2	10.4	13.0	6.9	14.3	9.9	15.7	24.7	14.0	13.4	24.2	10.3	5.4	11.7	38.7	11.2	25.3	10.1	18.7	15.2	12.5	11.7	9.7	9.0	14.0	13.3	14.2	15.4	13.3	26.2	12.9	12.7	11.5	12.2	10.5	22.8	10.8	11.6	3.7	14.6	7.9	13.1	12.9	10.2	12.0	24.8	13.0	19.3	21.1	8.5	15.8	10.1	8.4	13.3	49.6	18.2	12.8	13.5	12.8	23.1	29.7	23.3	9.9	42.0	29.5	14.4	19.5	65.8	11.1	27.0	0.0	16.1	15.2	50.1	59.4	29.7	164.2	49.3	38.6	6.9	35.7	30.2	36.1	15.7	71.9	28.7	76.2	41.4	36.6	0.4	28.0	0.0	24.0	15.6	64.0	19.3	29.5	10.0	8.9	21.3	13.8	50.7	26.9	73.3	68.8	0.1	26.6	13.1	8.9	21.7	19.4	18.8	32.0	7.0	25.5	7.5	24.9	56.2	118.2	0.2	0.0	0.1	18.7	4.4	2.3	15.4	8.0	4.6	7.5	11.7	7.0	10.2	5.9	13.4	8.6	11.9	2.9	17.2	1.0	9.7	6.4	5.8	13.0	14.3	24.7	14.0	15.2	12.5	13.3	14.2	11.5	12.9	13.0	13.3	9.8	6.4	11.3	15.0	14.3	5.9	11.8	11.9	8.6	25.2	12.6	13.0	12.3	17.2	17.7	7.3	45.9	15.7	9.6	3.9	19.6	7.7	43.7	17.6	8.0	9.5	11.5	21.5	21.5	4.5	10.4	5.8	9.7	9.0	10.8	18.9	11.0	9.3	13.6	21.9	23.5	7.9	10.2	4.1	3.3	62.7	5.6	5.0	8.8	9.4	2.9	18.6	20.6	26.7	8.8	9.4	1.9	3.8	15.2	12.9	7.0	12.4	16.3	34.4	19.7	7.4	8.1	55.9	28.0	13.1	7.7	11.8	12.4	11.1	8.6	11.7
ZNF546	"MGC43537, ZNF49"	ENSG00000187187	"Zinc finger protein 546"	Q86UE3	19	39984134-40021038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 13.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Oligodendrocytes: 20.1;Spermatocytes: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA030838			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030838: AB_10603332"	"unprognostic (4.38e-6)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.58e-5)"	1.9	2.8	1.1	0.7	1.8	0.5	1.9	1.8	1.5	2.2	1.6	2.1	0.4	1.7	0.9	1.0	2.2	0.5	2.4	1.3	1.0	2.3	3.7	1.3	0.9	1.6	1.3	2.9	1.9	1.2	2.8	0.8	1.8	2.1	0.5	2.4	1.4	1.1	2.5	1.0	1.8	1.4	0.9	3.2	1.5	13.5	1.4	1.0	2.4	1.4	1.1	2.0	1.7	2.8	0.1	2.2	0.8	1.2	1.9	1.1	0.1	0.8	1.2	0.8	1.3	0.1	0.3	1.1	0.9	0.6	0.3	0.0	0.4	0.1	1.3	1.0	1.5	1.4	1.7	0.7	1.0	1.5	0.9	1.1	0.4	0.5	1.3	1.1	1.2	2.0	1.7	2.9	1.0	0.3	0.5	0.3	0.2	0.1	0.2	0.7	0.8	0.5	0.5	0.2	0.5	0.7	0.5	0.0	0.5	0.8	0.3	0.7	0.5	0.3	0.6	0.1	0.5	1.9	2.2	0.2	0.6	0.5	0.4	0.7	0.4	0.8	1.0	0.7	0.7	0.8	0.7	0.6	0.8	0.6	1.3	1.2	0.3	0.8	0.3	0.2	0.9	0.3	1.1	1.8	1.8	1.5	1.3	1.0	1.6	1.3	1.8	0.9	1.4	2.8	3.1	0.0	4.6	7.8	3.9	0.5	1.0	0.8	2.8	8.4	2.4	1.9	6.8	2.8	1.1	3.7	12.5	1.4	4.1	0.6	1.9	1.4	36.0	2.5	4.5	4.0	0.0	1.7	9.9	0.4	0.2	4.9	0.5	1.5	0.0	6.3	4.6	3.0	1.8	1.7	11.7	0.5	2.0	1.9	0.5	7.4	4.4	2.0	0.0	8.4	1.5	4.8	3.1	8.5	20.1	0.3	0.4	4.1	1.9	0.8	2.4	3.5	4.1	7.9	0.0	6.2	2.6	57.8	5.4	1.0	0.0	0.3	2.3	4.8	0.6	0.7
ZNF548	FLJ32932	ENSG00000188785	"Zinc finger protein 548"	Q8NEK5	19	57389850-57402992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 55.6"									HPA066042	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 2: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA066042: AB_2685602"	"prognostic favorable (7.85e-4)"	"unprognostic (4.61e-2)"	"unprognostic (5.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (5.85e-2)"	13.8	6.8	5.2	16.9	5.4	26.3	12.3	11.6	11.2	8.2	6.6	10.0	6.8	10.8	6.9	8.1	10.2	11.3	11.1	7.2	5.5	6.5	6.8	12.0	23.8	4.8	5.0	11.8	6.9	8.6	7.1	8.4	4.5	7.8	8.2	12.6	7.1	7.1	7.6	10.3	14.6	11.6	3.6	18.9	7.2	6.5	5.3	13.4	11.8	5.5	17.9	8.4	7.7	7.2	7.5	6.8	12.1	8.7	5.7	6.2	2.5	5.4	8.0	8.4	14.0	1.7	20.5	7.4	3.4	4.3	5.6	3.3	5.1	5.9	7.6	3.5	17.4	7.7	55.6	8.8	4.1	8.1	16.3	7.2	8.5	8.0	11.7	8.1	4.2	15.1	0.5	0.1	7.6	2.0	12.8	3.1	3.4	0.2	7.6	15.6	13.3	10.1	4.4	12.7	7.5	9.1	6.6	3.5	4.0	10.2	7.6	6.1	6.9	10.0	9.7	3.3	9.8	18.7	13.1	10.3	6.9	4.5	10.1	1.3	1.5	2.6	4.0	1.7	5.6	3.9	3.7	5.2	3.1	8.4	5.5	5.8	1.4	5.1	2.2	2.6	7.0	2.6	5.2	5.4	11.6	11.2	7.2	5.5	4.8	5.0	4.5	3.6	5.3	7.2	10.2	3.2	6.7	4.6	9.5	6.6	4.9	4.3	4.6	5.0	9.1	7.1	5.7	7.2	4.0	7.3	6.2	4.4	8.9	1.9	3.9	4.4	12.7	5.3	4.4	9.1	6.0	1.7	3.0	2.4	2.9	5.9	2.0	4.5	9.5	7.6	11.0	8.4	4.2	1.7	3.9	3.8	4.1	4.8	2.9	5.1	5.6	4.3	0.0	1.9	3.2	6.3	8.2	4.0	4.6	2.5	1.1	4.1	8.8	3.5	3.3	2.7	5.8	9.4	0.0	7.7	7.8	11.7	7.1	4.5	5.7	4.4	9.4	4.2	2.3	2.2
ZNF549	FLJ34917	ENSG00000121406	"Zinc finger protein 549"	Q6P9A3	19	57527325-57557542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Rod photoreceptor cells: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.2"	"Group enriched"	"Detected in all"	4	"B-cells: 4.5;NK-cells: 11.2;T-cells: 4.6"	"Low cell line specificity"	"Detected in many"											HPA039511	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA039511: AB_10671998"	"unprognostic (6.27e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.01e-4)"	"unprognostic (4.03e-3)"	"unprognostic (2.51e-8)"	"unprognostic (2.88e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.89e-3)"	"unprognostic (9.11e-3)"	2.5	3.3	4.3	3.4	4.3	3.6	4.3	9.9	4.1	2.9	3.3	3.3	1.9	3.3	3.9	2.0	4.1	2.7	3.5	4.6	3.6	3.9	1.3	3.3	5.0	2.9	2.8	5.6	2.4	5.5	4.9	3.7	2.7	4.2	2.3	11.8	3.0	3.3	3.0	3.9	3.3	3.2	2.0	5.6	2.9	4.0	3.6	5.9	4.7	2.4	5.3	3.3	2.4	4.5	1.5	2.0	7.9	6.6	2.4	1.9	1.9	3.8	4.5	3.6	17.5	2.1	1.4	2.2	2.6	3.5	4.5	0.9	2.5	5.5	5.9	0.2	14.7	10.2	1.9	3.1	3.3	8.6	7.0	3.4	4.2	3.7	5.1	5.2	2.3	5.7	0.1	0.3	6.6	0.9	9.8	3.6	6.8	0.2	5.3	6.8	6.6	4.7	1.4	3.9	3.3	5.7	0.1	0.5	4.4	6.6	4.5	6.7	1.9	6.9	4.7	0.3	5.5	3.7	11.6	7.0	1.1	2.9	6.4	0.6	0.8	1.5	2.4	0.7	3.2	2.2	3.3	3.8	1.5	4.5	4.6	3.0	0.5	11.2	1.2	1.4	2.2	1.9	4.3	4.3	9.9	4.1	4.6	3.6	2.9	2.8	2.7	2.0	3.6	4.5	2.2	0.0	2.8	5.9	7.0	1.7	1.7	1.3	0.6	7.5	2.2	1.7	3.2	4.3	0.8	1.8	14.6	1.6	5.6	0.4	3.9	1.4	0.6	2.2	2.3	3.6	3.6	5.7	9.8	0.7	0.8	2.2	1.1	1.9	6.3	6.1	3.9	0.6	1.5	8.4	7.9	0.5	0.0	3.2	0.4	0.4	3.1	2.3	5.4	6.5	1.5	3.9	7.2	8.0	4.1	0.7	1.8	2.2	1.3	1.8	0.7	0.8	5.8	14.8	6.6	2.6	2.3	1.2	4.7	0.6	1.6	1.1	4.0	2.3	0.9	1.2
ZNF551	DKFZp686H1038	ENSG00000204519	"Zinc finger protein 551"	Q7Z340	19	57681969-57717301	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 6.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038187			Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA038187: AB_2675884"	"unprognostic (1.96e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.68e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.83e-3)"	"prognostic favorable (1.32e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.54e-1)"	1.9	2.3	0.9	3.4	1.0	7.9	4.0	6.4	1.1	2.3	2.9	2.4	2.2	1.9	1.8	2.2	2.9	1.7	2.2	1.1	0.7	2.4	1.7	1.9	5.0	0.6	0.9	3.3	2.5	3.3	6.3	2.6	0.4	2.7	2.5	4.9	2.5	2.4	2.0	3.7	2.4	2.4	0.7	3.6	2.7	4.3	1.1	5.1	6.1	1.8	4.9	2.6	1.6	1.2	3.9	8.4	10.2	7.5	1.9	2.4	10.8	4.6	3.2	6.3	2.9	7.2	3.7	7.0	2.9	3.4	4.6	4.3	6.9	10.4	9.7	0.0	30.3	12.4	0.3	3.2	1.8	8.8	10.8	4.1	3.8	6.4	5.8	3.5	2.6	7.2	8.6	0.0	5.6	3.6	18.3	3.4	21.6	7.4	13.5	11.4	17.7	9.3	2.5	22.0	9.9	8.1	6.9	4.3	3.5	9.7	5.5	11.5	3.2	7.2	7.4	2.4	8.6	7.3	17.0	15.7	1.3	4.3	6.9	1.2	1.2	1.3	1.8	1.9	3.3	3.8	2.7	2.9	2.8	2.8	4.3	4.1	0.6	3.1	1.0	2.2	2.3	2.3	0.9	1.0	6.4	1.1	1.1	0.7	0.6	0.9	0.4	0.7	1.1	1.2	2.2	6.4	3.9	2.6	5.4	5.2	6.3	2.6	1.8	7.7	4.7	2.8	1.8	2.8	6.3	1.8	8.4	4.1	4.5	2.3	1.9	3.1	13.8	2.0	3.3	3.3	2.4	11.2	1.1	1.0	3.0	2.8	2.0	3.8	1.3	6.0	4.6	2.4	2.6	3.3	1.4	4.1	4.1	4.4	2.1	4.1	3.4	2.4	1.8	1.0	1.7	2.7	3.1	2.0	0.9	1.9	1.7	4.9	3.3	5.0	1.6	0.7	4.5	13.8	0.0	2.3	2.4	8.7	12.8	4.6	7.1	2.9	4.8	3.3	4.7	7.6
ZNF552	FLJ21603	ENSG00000178935	"Zinc finger protein 552"	Q9H707	19	57803841-57814913	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"breast cancer: 23.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 25.3"	"Cell line enhanced"	"Detected in all"		"BEWO: 30.3;RT4: 42.5;T-47d: 69.6"					"Low region specificity"	"Detected in all"			"HPA043800, HPA053762, HPA072145"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"prognostic favorable (4.57e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (9.03e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.36e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-3)"	3.0	2.3	3.0	4.7	3.1	8.1	26.0	14.9	6.5	9.8	9.3	9.4	7.1	5.0	5.4	5.5	5.6	8.7	2.9	3.4	3.0	7.1	4.7	6.0	5.3	2.8	2.0	4.2	4.2	6.0	2.5	6.5	2.3	12.4	12.1	4.0	17.5	6.9	4.9	9.7	7.3	3.0	0.5	6.0	13.9	3.0	3.5	5.0	4.1	2.7	5.5	14.7	5.8	3.4	5.6	3.2	3.7	5.9	3.0	1.5	30.3	2.0	2.4	4.5	2.5	9.6	8.8	7.6	3.8	3.6	1.0	4.8	7.6	5.0	5.4	3.4	15.1	2.6	8.4	7.1	7.1	8.5	3.4	3.3	10.9	3.1	3.2	2.8	6.0	8.0	5.5	2.5	3.0	5.0	3.7	2.5	5.2	6.9	7.3	7.6	4.7	8.0	13.4	42.5	4.9	3.5	10.2	22.6	5.1	10.4	69.6	3.5	4.5	3.8	4.2	2.5	3.5	11.0	8.1	6.1	3.1	6.4	2.2	2.1	3.3	7.4	2.7	3.3	2.5	3.7	3.4	4.3	1.7	3.7	4.5	3.8	25.3	2.4	1.4	2.3	3.0	2.4	3.0	3.1	14.9	6.5	3.4	3.0	2.8	2.0	2.3	0.5	3.5	3.4	2.9	12.8	3.1	4.2	7.8	2.5	14.8	9.7	8.0	6.2	19.4	9.8	3.1	18.6	15.0	20.2	2.1	22.1	5.3	9.4	25.4	6.9	5.7	20.2	4.9	3.7	8.4	6.1	7.7	1.8	5.2	3.8	19.4	15.0	8.8	14.2	7.1	4.2	5.2	3.3	8.1	14.5	14.2	2.4	3.1	1.5	2.8	3.6	1.8	1.9	3.1	2.3	2.1	4.5	5.1	3.1	13.4	2.2	4.8	8.3	15.6	4.8	20.5	12.7	6.6	2.9	3.5	3.8	4.6	7.0	2.7	21.3	7.1	5.4	9.3	14.2
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819868-2836735	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"							"Not detected"	"Not detected"			"HPA060247, HPA063358"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Nucleoli	"HPA060247: AB_2684230, HPA063358: AB_2684995"	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favorable (5.00e-4)"	2.0	2.0	2.9	0.6	2.8	0.5	2.5	2.7	4.0	3.0	1.5	2.6	1.3	2.6	1.2	2.5	2.3	0.6	3.3	2.7	2.8	2.9	3.1	1.4	0.6	2.9	2.4	3.7	3.1	1.5	2.9	1.1	2.9	2.7	0.8	2.5	2.7	0.9	5.2	3.5	2.3	0.6	1.8	1.9	2.5	2.5	3.5	0.9	2.6	2.1	0.7	2.7	2.6	2.4	1.2	0.2	0.9	1.3	0.7	0.9	1.3	0.7	0.6	1.0	0.7	0.1	0.3	1.5	0.6	0.4	1.1	0.7	0.2	0.7	0.8	0.0	0.5	0.5	0.8	0.4	0.6	0.2	0.5	0.7	1.0	0.4	0.7	0.9	0.3	1.1	1.1	0.8	0.5	0.6	1.1	0.3	0.7	0.2	0.1	1.3	0.6	0.3	0.5	1.1	1.5	1.8	0.5	0.3	1.1	0.9	0.4	0.8	0.2	0.4	0.4	0.6	0.4	2.3	2.8	0.4	0.6	0.7	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.2	0.0	0.6	0.3	0.1	0.1	0.2	0.2	0.9	0.1	0.2	2.9	2.8	2.7	4.0	2.7	2.8	2.9	2.4	2.9	1.8	3.5	2.4	2.2	12.8	12.5	2.9	3.5	1.3	2.8	1.0	4.0	4.9	2.3	2.2	4.6	1.5	4.6	0.0	8.4	2.8	1.5	3.4	3.9	2.6	0.8	2.1	1.9	3.1	3.6	3.4	4.0	1.4	1.3	3.4	1.5	2.7	0.0	4.4	3.3	2.9	1.5	3.3	4.8	2.0	2.0	2.4	2.5	0.7	3.1	1.6	0.0	1.0	1.4	4.7	5.2	3.5	2.7	1.7	1.0	2.6	3.3	3.3	5.9	3.0	5.5	4.9	0.0	3.8	2.3	7.0	12.2	2.7	1.4	8.8	2.7	3.7	2.2	2.1
ZNF556	FLJ11637	ENSG00000172000	"Zinc finger protein 556"	Q9HAH1	19	2867335-2883445	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.8;fallopian tube: 2.0;ovary: 5.3;skeletal muscle: 2.4;tongue: 3.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 7.9;granulocytes: 7.6;Skeletal myocytes: 7.5;Theca cells: 12.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 14.9"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 14.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.0;HBEC3-KT: 8.5;Hep G2: 13.4;RH-30: 19.3;THP-1: 7.1"									HPA060593			Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 52: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA060593: AB_2684328"	"unprognostic (1.36e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.23e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.54e-3)"	0.0	0.0	0.4	0.1	0.3	0.5	0.2	1.8	0.4	0.1	0.2	0.0	0.0	0.4	0.3	0.7	2.0	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.1	0.3	0.2	5.3	0.5	0.4	0.0	0.1	0.3	0.2	0.0	0.2	0.3	0.0	2.4	0.3	0.1	0.1	0.0	0.2	0.1	0.6	0.3	0.2	0.1	3.4	0.1	0.0	0.0	0.8	2.1	0.3	0.0	3.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	8.0	0.1	2.7	1.3	0.2	0.0	0.1	0.0	8.5	0.0	0.1	0.1	0.1	3.4	13.4	0.1	0.1	4.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	2.5	0.1	0.1	0.2	0.0	0.2	0.1	0.0	19.3	1.7	0.0	0.3	0.1	3.1	0.0	0.3	0.0	0.1	4.0	7.1	0.0	0.1	0.1	5.1	0.1	2.3	4.5	0.1	0.2	0.2	0.1	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	1.0	0.5	0.1	14.9	0.1	0.2	0.4	0.3	1.8	0.4	0.3	0.1	0.3	0.2	0.3	0.0	0.3	0.8	0.6	3.2	7.9	0.0	0.3	0.4	2.9	1.5	4.6	2.7	1.1	2.2	0.4	0.0	5.6	3.7	2.1	0.5	1.9	0.1	0.0	0.1	2.1	2.2	4.1	1.0	0.0	0.0	0.5	0.0	0.3	2.7	0.0	4.5	7.6	1.0	1.1	0.2	0.2	3.3	0.6	0.0	0.0	1.3	1.4	0.0	0.6	1.8	0.0	1.0	0.4	0.5	0.0	0.5	0.4	0.1	0.2	0.4	0.3	2.2	0.0	0.7	4.6	5.4	0.0	7.5	1.5	5.0	5.0	4.8	0.1	0.3	1.3	12.9	0.1	2.0
ZNF557	MGC4054	ENSG00000130544	"Zinc finger protein 557"	Q8N988	19	7069703-7087968	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003151, HPA029291"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"		"HPA003151: AB_1859344, HPA029291: AB_10602357"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (2.56e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.51e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.81e-3)"	1.5	1.9	1.2	1.8	1.5	3.9	1.9	3.1	1.7	1.6	1.5	1.5	1.1	1.7	1.6	1.7	1.9	1.3	1.2	1.3	1.0	1.8	2.2	1.4	2.6	1.4	1.1	2.4	1.8	1.7	1.5	1.5	1.5	1.5	1.4	1.9	1.4	1.4	1.4	2.0	1.7	1.6	0.9	2.3	1.8	2.1	1.4	2.4	2.1	1.0	2.5	1.6	1.5	3.1	2.1	2.2	2.3	5.0	3.1	2.1	1.9	2.1	2.2	2.3	2.8	2.8	1.3	4.4	3.6	2.3	1.8	2.9	4.0	2.3	2.3	4.0	2.6	5.6	4.7	1.5	2.1	6.0	5.9	3.0	2.3	2.4	3.7	2.3	2.0	3.8	2.2	6.7	3.1	3.0	5.0	2.1	2.2	2.0	3.0	3.6	3.6	2.4	1.7	4.9	2.7	3.2	3.1	2.4	2.3	2.0	1.9	3.1	3.9	2.2	1.7	5.0	2.3	6.8	5.8	3.9	2.4	3.1	2.0	5.6	3.1	3.8	4.6	2.9	4.7	4.1	5.0	4.0	3.1	5.4	5.8	4.9	3.5	5.9	2.7	5.7	4.3	1.7	1.2	1.5	3.1	1.7	1.3	1.0	1.4	1.1	1.5	0.9	1.4	3.1	5.5	3.2	4.4	5.2	8.3	1.5	6.9	2.7	2.2	9.4	6.1	5.8	5.4	7.2	6.1	7.3	0.0	5.9	5.8	5.4	15.6	6.2	0.9	3.4	8.9	6.9	5.4	6.1	9.2	6.2	4.2	5.6	4.6	4.6	8.2	9.4	8.6	3.8	6.1	16.8	8.9	5.8	2.0	9.8	2.9	0.5	4.4	6.0	0.0	5.6	9.0	6.1	14.4	3.5	8.8	6.1	6.2	5.7	5.9	6.8	6.1	8.1	4.3	6.8	0.0	7.8	6.7	23.2	19.9	3.6	1.3	5.7	7.7	6.7	5.5	6.9
ZNF559	MGC13105	ENSG00000188321	"Zinc finger protein 559"	Q9BR84	19	9323772-9351162	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA059632, HPA065485"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA059632: AB_2684089, HPA065485: AB_2685497"	"unprognostic (1.35e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (6.99e-4)"	"unprognostic (7.28e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	14.8	14.2	12.5	9.2	13.7	4.0	16.8	19.7	14.0	23.5	17.8	16.7	6.4	22.4	21.5	7.4	23.1	9.9	19.7	12.4	12.9	19.1	11.1	12.4	16.0	12.7	12.3	32.7	10.6	22.2	25.9	12.1	12.4	20.5	11.0	20.4	12.3	12.9	4.7	10.7	14.8	19.1	11.8	22.1	12.9	16.3	13.7	22.7	19.7	10.6	13.1	17.0	15.6	19.4	15.4	8.3	15.6	19.3	9.2	8.3	4.2	9.3	18.6	13.3	11.4	3.8	1.8	12.4	10.8	13.7	18.4	5.4	9.5	8.8	16.9	19.9	13.5	16.2	14.0	5.7	16.0	15.0	18.3	17.3	15.6	14.7	18.7	11.4	11.3	18.8	12.7	42.8	8.7	0.0	20.4	46.8	25.4	2.6	13.4	10.0	18.8	16.7	8.1	21.5	17.8	14.7	17.9	2.9	22.6	22.9	12.7	11.5	9.6	24.6	5.6	20.1	14.2	3.5	0.1	12.6	4.6	9.4	16.0	40.7	4.8	11.4	12.1	4.7	16.4	17.4	13.0	13.3	7.7	17.0	21.0	17.2	2.7	20.9	6.5	6.4	12.6	9.0	12.5	13.7	19.7	14.0	12.4	12.9	12.7	12.3	12.4	11.8	13.7	19.4	9.8	3.2	3.3	0.0	12.9	3.8	6.7	6.2	5.7	30.2	7.0	7.1	8.8	10.0	5.1	3.7	27.1	7.0	12.4	2.2	1.9	7.3	9.1	6.1	8.3	11.0	3.0	3.0	0.0	3.2	5.3	9.8	1.5	3.8	2.5	17.8	12.8	2.7	4.9	26.9	0.0	4.0	2.0	7.0	3.7	2.9	12.8	4.7	3.6	0.0	7.7	17.3	29.9	0.0	0.0	3.2	3.0	13.5	1.8	4.6	2.2	3.4	5.7	27.2	6.6	14.1	10.1	27.0	40.4	2.9	3.0	2.9	10.0	8.5	4.1	2.8
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466355-9498616	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 2.0;testis: 6.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 79.2;Late spermatids: 20.1"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.5;HMC-1: 4.8;NTERA-2: 19.7;SuSa: 9.2"									"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear speckles"	"HPA045439: AB_2732520, HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.8	2.5	0.0	1.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	1.1	20.5	0.0	0.0	1.4	0.0	4.8	2.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	79.2	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	20.1	0.3	0.2	0.0	0.0	0.0	0.2	0.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	9.5	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF561	MGC45408	ENSG00000171469	"Zinc finger protein 561"	Q8N587	19	9604680-9621236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA055332, HPA062397"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA055332: AB_2682786, HPA062397: AB_2684751"	"unprognostic (6.68e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.63e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (9.21e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.27e-3)"	"unprognostic (2.85e-3)"	8.9	8.8	4.6	8.4	5.5	10.2	17.2	7.2	7.6	13.5	5.3	10.3	8.0	17.9	12.0	16.3	18.5	12.9	9.8	5.7	5.6	12.5	11.2	11.2	10.8	6.2	5.8	20.1	10.4	13.6	7.6	10.5	6.2	17.4	12.8	7.3	9.7	17.6	9.1	14.3	8.5	26.0	4.9	9.7	10.6	6.3	5.8	14.5	15.4	14.6	12.5	18.6	12.1	6.1	14.4	5.7	31.8	24.3	26.2	30.9	28.0	18.9	25.2	23.2	26.1	10.7	6.1	13.2	13.5	19.1	13.3	8.2	21.6	36.1	24.2	18.5	23.3	16.9	12.2	18.9	15.7	20.9	16.0	20.5	55.4	17.4	22.4	36.3	29.7	9.6	19.3	17.4	29.0	6.9	9.4	23.3	25.6	12.3	18.1	11.1	15.8	13.5	20.3	51.7	19.7	19.6	0.4	10.9	14.7	30.1	14.6	14.6	9.3	24.8	8.8	17.2	17.9	20.2	30.2	17.7	12.2	5.6	16.8	4.0	5.1	5.8	4.9	5.1	6.2	2.8	3.9	4.4	4.1	3.9	5.4	4.0	3.4	1.7	2.7	3.6	4.0	3.4	4.6	5.5	7.2	7.6	5.7	5.6	6.2	5.8	6.2	4.9	5.8	6.1	8.2	0.0	7.0	5.9	7.9	13.8	25.2	31.9	16.5	9.4	11.5	16.5	9.8	11.5	17.9	14.7	6.2	8.0	11.0	7.3	3.9	11.1	6.9	11.1	12.1	8.9	11.4	11.6	10.0	6.5	8.5	7.7	12.2	9.0	7.6	25.5	10.8	8.2	10.9	10.1	10.5	7.7	16.2	12.8	5.8	9.7	11.5	8.3	3.6	6.5	12.2	6.3	17.5	17.6	12.0	8.6	6.8	13.2	6.2	10.9	9.8	8.5	30.3	11.9	6.6	9.1	10.4	8.2	10.6	23.6	22.4	6.4	10.2	16.2	7.7	25.9
ZNF562	FLJ20079	ENSG00000171466	"Zinc finger protein 562"	Q6V9R5	19	9641807-9675100	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA055332, HPA062397"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA055332: AB_2682786, HPA062397: AB_2684751"	"unprognostic (2.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.02e-2)"	"prognostic favorable (4.17e-4)"	"unprognostic (4.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.13e-3)"	5.9	4.6	6.1	6.4	6.7	7.5	11.6	12.6	6.3	6.1	5.2	8.3	5.0	7.9	4.3	14.0	5.4	6.4	5.6	4.5	6.3	5.5	6.9	5.7	5.9	5.9	5.3	6.1	6.0	5.8	4.7	6.2	5.6	6.3	7.5	5.7	6.7	6.4	3.0	6.0	5.3	8.0	5.5	7.2	5.8	3.5	6.7	5.4	5.9	5.2	7.4	9.0	7.1	10.2	12.7	10.5	15.2	29.0	7.9	7.3	0.7	13.6	9.4	14.1	15.4	8.2	7.2	12.9	13.1	10.4	11.4	10.1	19.7	15.2	17.5	14.4	12.1	46.3	10.9	8.2	9.2	16.6	33.1	12.9	10.5	17.5	28.1	7.8	15.4	10.3	22.8	22.0	14.0	6.2	16.7	4.1	19.8	8.9	6.8	6.5	17.5	6.3	6.6	34.8	16.0	10.0	20.1	7.7	9.3	12.0	11.3	13.6	13.5	24.9	9.7	11.4	17.7	17.7	45.3	21.1	3.5	1.1	13.2	3.3	2.7	3.1	2.4	3.9	3.6	3.1	2.1	1.7	3.5	2.3	2.4	3.0	1.2	3.0	4.5	2.1	2.3	1.3	6.1	6.7	12.6	6.3	4.5	6.3	5.9	5.3	5.6	5.5	6.7	10.2	14.7	9.6	18.5	8.5	11.3	6.4	40.0	11.6	12.0	30.6	23.9	14.4	9.4	30.0	17.7	25.8	73.0	14.9	11.9	32.2	19.6	19.6	7.5	20.1	17.6	18.1	23.9	23.8	19.4	8.6	18.5	12.7	19.4	29.7	12.7	22.1	23.2	13.6	11.9	28.6	18.0	16.9	12.2	31.5	8.9	12.2	12.2	16.7	7.2	18.7	21.3	12.4	20.6	24.6	22.2	24.7	20.9	13.5	6.1	45.1	9.6	9.1	15.6	31.2	0.0	17.4	12.8	13.5	11.4	14.6	10.1	19.4	11.9	13.7	18.1	67.1
ZNF565	FLJ36991	ENSG00000196357	"Zinc finger protein 565"	Q8N9K5	19	36182276-36246257	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.3;Late spermatids: 16.1;Oligodendrocytes: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 16.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.3"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044123	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"		"HPA044123: AB_10794395"	"unprognostic (1.51e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (6.08e-3)"	"unprognostic (7.97e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.93e-4)"	2.9	2.6	4.6	2.0	7.0	3.7	3.4	5.7	5.8	2.8	2.5	2.5	2.1	3.2	3.0	2.4	3.1	2.2	2.3	4.9	5.5	2.5	3.0	2.2	2.3	6.9	6.3	5.0	2.5	2.9	2.7	2.2	6.4	3.1	2.7	3.5	3.7	2.5	4.2	3.1	2.0	2.9	4.4	2.2	3.0	6.8	5.6	2.2	3.1	4.6	2.8	2.7	2.5	12.1	2.7	4.1	4.7	3.2	7.2	4.9	1.3	2.8	4.5	3.3	5.6	2.2	2.4	2.2	3.4	3.6	1.5	1.6	2.4	2.0	5.3	3.7	0.9	3.8	3.6	3.2	3.0	2.7	2.5	5.4	5.8	2.1	5.5	3.5	3.9	2.5	2.6	2.6	4.0	3.6	3.2	0.7	1.8	6.4	1.8	2.5	2.8	2.0	3.3	3.8	3.5	3.7	2.3	2.5	2.6	2.9	1.6	2.7	3.3	4.3	2.6	3.4	3.9	0.8	1.3	1.4	4.4	2.1	2.2	16.3	2.7	4.3	2.7	2.7	3.0	2.1	3.2	2.7	3.1	2.0	3.6	2.7	1.2	3.1	3.3	1.6	1.8	1.9	4.6	7.0	5.7	5.8	4.9	5.5	6.9	6.3	6.4	4.4	5.6	12.1	3.3	3.2	1.1	5.9	1.6	2.2	7.1	2.3	4.6	4.2	2.0	1.8	2.9	0.0	1.0	1.8	6.2	1.4	1.9	1.1	0.0	2.5	23.3	2.6	3.8	3.4	1.2	0.0	10.2	2.9	2.1	3.8	7.1	3.9	0.0	3.7	2.9	1.1	1.6	1.7	12.4	0.9	2.0	2.7	0.6	16.1	5.3	1.6	0.0	5.6	1.7	2.9	6.2	5.5	21.2	2.6	0.4	2.6	1.5	5.2	1.6	1.6	3.2	4.6	6.6	7.7	3.3	10.8	8.1	2.7	1.4	2.1	2.8	2.5	1.8	4.3
ZNF566	"FLJ14779, MGC12515"	ENSG00000186017	"Zinc finger protein 566"	Q969W8	19	36445119-36489902	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023456	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA023456: AB_2221143"	"unprognostic (1.68e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (3.89e-3)"	"unprognostic (5.71e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.56e-2)"	"unprognostic (8.19e-4)"	"unprognostic (7.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.47e-3)"	4.1	5.0	5.0	3.6	5.0	3.2	4.2	7.9	6.6	4.5	4.5	4.7	3.2	4.6	4.4	2.8	5.0	2.9	4.7	4.5	5.0	3.9	5.7	3.7	4.2	4.6	4.7	6.3	3.9	4.7	5.0	2.6	4.9	4.0	2.6	5.5	3.0	3.1	4.7	3.8	4.0	4.1	4.5	4.4	3.7	2.4	5.1	3.4	4.7	6.0	4.3	4.2	3.6	5.9	3.7	9.1	10.3	11.5	7.6	7.6	7.1	7.3	6.2	9.0	9.5	3.8	1.5	7.3	7.7	4.6	4.0	2.6	9.5	2.5	10.1	11.7	7.1	7.3	6.2	3.2	5.4	7.9	8.5	6.6	3.8	4.8	7.3	4.2	3.5	7.5	10.8	0.1	6.3	6.0	10.3	3.8	12.5	6.7	4.0	6.7	8.2	4.9	2.7	7.3	9.7	14.4	8.9	4.9	7.0	4.9	4.4	10.7	3.7	7.8	10.8	3.2	7.0	2.8	8.4	10.0	0.3	5.0	10.5	6.5	1.1	1.6	3.9	1.2	6.5	6.5	5.0	4.9	2.3	5.3	6.0	6.1	1.0	4.0	1.3	1.6	5.6	2.5	5.0	5.0	7.9	6.6	4.5	5.0	4.6	4.7	4.9	4.5	5.1	5.9	7.6	9.6	7.7	14.0	9.3	3.3	4.2	4.4	7.4	22.3	4.5	3.0	10.2	4.3	7.4	5.5	35.5	6.7	8.4	1.6	11.7	4.5	4.1	4.2	8.1	8.1	3.0	8.0	24.0	2.5	3.2	10.5	3.1	4.0	2.5	10.6	10.0	4.3	4.4	32.0	26.9	4.5	6.1	3.2	3.9	0.6	8.4	3.5	10.6	11.2	2.5	8.6	8.2	14.1	20.7	2.3	4.7	14.7	5.2	5.1	2.8	6.8	4.0	22.2	19.7	12.2	9.6	11.4	5.7	5.7	3.3	1.9	9.3	9.6	4.9	2.8
ZNF567	MGC45586	ENSG00000189042	"Zinc finger protein 567"	Q8N184	19	36687612-36727701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 86.7;Late spermatids: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA023937	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA023937: AB_1859351"	"unprognostic (4.39e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.03e-2)"	3.3	3.7	2.7	2.9	2.7	3.4	5.8	5.1	4.1	4.1	3.3	3.4	2.3	5.1	4.2	3.1	3.9	3.2	3.1	2.8	3.0	3.3	4.8	3.4	4.7	2.1	2.6	4.6	2.6	5.5	4.8	5.6	2.3	5.2	2.8	4.9	3.6	5.0	2.3	3.3	3.0	4.5	2.5	4.5	3.3	9.5	3.2	6.6	4.8	3.1	4.9	4.2	3.5	3.0	7.1	5.5	9.8	8.7	5.5	5.4	9.3	5.1	7.8	5.7	9.1	3.1	2.5	4.4	6.0	4.6	4.2	1.8	9.1	5.3	7.7	8.8	4.7	8.4	6.0	3.0	5.0	10.8	6.2	8.4	6.2	5.4	10.5	7.4	6.7	8.9	3.3	2.3	6.9	4.5	13.9	4.1	9.4	4.8	4.3	6.8	13.5	6.4	3.8	10.7	7.3	7.8	9.5	4.7	4.9	10.9	5.9	7.2	4.2	7.5	7.6	3.8	5.8	8.8	7.8	14.9	0.0	4.3	6.7	5.0	1.8	5.8	5.7	1.5	4.8	5.7	6.2	5.4	3.2	7.0	6.0	6.1	0.9	6.8	1.6	2.2	5.5	2.5	2.7	2.7	5.1	4.1	2.8	3.0	2.1	2.6	2.3	2.5	3.2	3.0	15.5	6.4	6.9	4.6	15.3	11.7	12.5	7.4	7.4	9.0	13.4	14.7	5.8	5.7	8.8	9.2	10.4	15.3	13.3	3.8	3.9	8.6	86.7	13.4	7.8	9.9	4.2	11.6	12.8	5.1	13.5	7.7	8.2	11.1	17.2	11.7	12.8	6.5	7.5	11.8	11.2	4.6	4.1	5.1	3.7	153.0	9.9	4.7	7.2	11.2	6.7	8.1	14.4	8.5	11.9	4.4	6.2	15.1	5.9	13.1	3.7	6.7	4.8	6.1	6.6	11.5	10.1	42.2	13.4	6.1	17.6	27.5	13.2	12.2	4.4	13.3
ZNF568	DKFZp686B0797	ENSG00000198453	"Zinc finger protein 568"	Q3ZCX4	19	36916329-36998700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 40.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA024541, HPA052061"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA024541: , HPA052061: AB_2681713"	"unprognostic (3.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.83e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.05e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.98e-3)"	4.1	6.5	5.5	3.6	5.4	3.7	5.6	12.4	6.4	6.3	7.3	4.5	2.4	7.3	4.9	3.4	5.9	3.4	5.2	5.4	8.4	4.5	3.3	4.2	4.1	5.9	6.9	9.3	4.4	8.3	5.3	5.2	5.8	4.9	2.9	11.8	4.8	5.4	5.5	4.1	3.2	5.9	3.9	6.1	4.3	6.0	6.9	4.8	7.7	5.7	4.5	4.4	4.1	9.9	0.2	5.0	8.4	2.5	7.8	8.8	2.6	7.4	7.4	6.0	8.1	0.6	2.9	0.3	8.3	9.3	4.3	1.4	0.1	4.3	6.3	1.1	6.5	2.8	0.9	1.0	10.1	0.4	6.5	10.7	5.1	6.1	0.2	7.3	2.9	3.7	0.3	0.8	9.2	0.2	1.6	1.3	6.9	0.0	0.3	0.7	6.7	2.6	5.7	11.0	8.2	10.7	0.3	0.2	6.2	8.3	6.7	1.1	4.7	3.5	11.9	6.1	4.8	9.0	13.1	6.0	0.2	0.2	12.5	19.6	1.7	6.4	7.1	1.3	6.3	9.0	6.8	5.9	2.9	6.9	8.4	6.4	1.4	7.4	2.1	2.7	6.4	3.0	5.5	5.4	12.4	6.4	5.4	8.4	5.9	6.9	5.8	3.9	6.9	9.9	7.7	3.2	7.0	12.7	7.5	5.1	3.4	4.5	2.8	18.9	5.7	6.5	6.6	10.0	3.1	9.2	14.6	5.0	6.3	0.5	3.9	7.1	28.9	5.1	7.1	7.4	0.0	1.3	22.4	3.7	4.1	7.8	2.6	3.8	16.5	13.9	6.4	1.4	3.5	40.4	22.6	1.4	14.2	2.5	3.4	19.5	6.5	3.5	1.8	10.3	3.5	9.4	12.3	25.6	25.7	2.8	0.3	9.8	3.4	3.9	0.7	5.1	5.2	17.0	6.6	13.6	6.6	18.1	12.6	3.4	4.1	2.9	7.9	7.2	1.0	2.6
ZNF569	"FLJ32053, ZAP1, Zfp74"	ENSG00000196437	"Zinc finger protein 569"	Q5MCW4	19	37411155-37469275	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 137.7;Late spermatids: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052994	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA052994: AB_2682007"	"unprognostic (1.40e-1)"	"unprognostic (3.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.00e-1)"	"unprognostic (5.08e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.41e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	3.3	4.1	4.0	2.8	4.1	4.6	3.5	7.2	4.5	3.3	4.0	2.2	1.7	3.8	4.7	2.2	3.3	2.3	4.3	3.3	5.9	3.5	3.3	2.5	4.0	3.6	4.8	5.6	1.8	4.5	3.3	3.0	4.2	2.9	1.8	13.7	2.3	2.8	4.4	3.2	1.8	3.4	3.6	3.4	2.3	10.9	5.8	5.1	5.6	4.7	3.2	2.2	1.8	6.5	3.3	6.2	7.6	12.2	6.0	5.5	3.7	5.9	3.4	6.1	6.5	2.3	1.5	4.0	8.4	4.5	6.0	1.2	8.4	2.0	6.6	9.0	5.1	10.3	1.8	3.8	3.6	1.9	4.0	3.8	1.4	6.3	0.2	6.3	5.2	11.7	3.3	0.8	8.7	2.0	12.0	4.1	8.0	0.2	4.4	8.1	9.6	4.1	4.4	3.3	6.4	9.8	0.2	1.3	3.4	7.1	5.3	8.1	5.3	4.9	10.1	3.9	9.6	10.2	18.6	15.0	0.2	4.2	7.8	3.7	1.8	5.9	6.4	2.6	5.5	4.6	5.7	6.1	2.2	5.4	8.0	6.5	1.8	4.8	3.3	2.4	6.1	2.4	4.0	4.1	7.2	4.5	3.3	5.9	3.6	4.8	4.2	3.6	5.8	6.5	5.1	0.0	1.7	14.0	7.8	1.7	1.7	2.0	2.8	16.1	3.5	4.2	16.3	0.0	5.2	1.8	31.3	3.2	8.1	0.5	1.9	1.5	137.7	5.1	3.9	6.5	0.0	2.1	14.5	2.0	4.0	4.0	1.5	2.3	2.5	5.3	5.3	2.5	2.9	3.3	17.4	0.4	0.0	3.8	3.9	41.8	4.7	4.0	0.0	8.4	3.0	9.3	8.2	20.6	23.4	1.6	0.4	7.5	2.4	0.9	1.0	4.7	5.3	30.2	0.0	6.9	6.3	32.3	13.1	3.4	2.0	0.8	9.1	4.2	0.7	0.9
ZNF570	FLJ30791	ENSG00000171827	"Zinc finger protein 570"	Q96NI8	19	37467585-37488652	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.0;Horizontal cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028881	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA028881: AB_10603938"	"unprognostic (2.93e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.59e-2)"	"prognostic favorable (4.06e-5)"	"unprognostic (5.30e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.20e-3)"	2.1	2.4	2.4	1.7	2.9	2.2	2.9	3.3	3.0	2.1	1.8	1.6	1.9	2.5	2.1	2.3	2.0	2.2	2.5	2.5	3.0	2.8	1.8	2.0	2.7	2.8	3.0	3.4	1.6	4.0	1.8	2.1	2.7	2.9	1.2	3.1	2.3	2.1	2.0	1.8	1.5	2.3	2.7	2.4	2.1	6.0	2.7	2.4	3.2	2.8	2.4	1.9	1.3	3.4	1.5	2.0	2.7	8.3	3.6	4.4	1.3	2.9	1.5	2.7	3.6	0.0	0.6	0.3	3.9	2.1	1.6	0.3	2.4	1.8	3.2	1.6	1.7	2.0	0.2	0.9	2.5	0.1	4.2	3.8	1.7	1.8	0.0	2.5	2.6	3.2	0.3	0.1	2.9	0.5	4.8	1.5	1.7	0.1	0.8	0.8	2.8	1.6	2.2	2.3	2.5	5.2	0.0	0.0	1.0	3.3	1.6	2.2	1.4	1.1	2.1	1.8	2.1	4.4	4.2	2.1	0.0	0.2	2.2	0.7	0.7	0.9	1.3	1.3	1.0	1.6	2.1	0.9	0.7	1.4	1.7	1.8	1.4	1.8	0.5	0.7	1.3	0.9	2.4	2.9	3.3	3.0	2.5	3.0	2.8	3.0	2.7	2.7	2.7	3.4	7.9	6.4	0.5	1.6	5.5	1.7	1.7	0.7	4.6	6.4	5.7	6.0	13.7	5.7	2.8	1.8	10.4	2.6	11.4	1.3	9.8	5.5	56.0	6.5	6.6	7.4	6.0	3.0	2.1	3.8	6.7	6.7	1.1	3.9	6.3	5.7	8.2	2.2	3.3	32.0	2.0	1.7	0.0	2.5	0.7	9.0	5.0	3.5	5.4	0.0	2.5	5.4	8.2	2.5	2.9	2.9	1.1	9.8	2.6	1.8	1.6	3.6	3.4	7.2	0.0	6.7	7.6	11.0	6.6	4.8	0.4	1.4	7.9	4.4	2.1	1.1
ZNF571	HSPC059	ENSG00000180479	"Zinc finger protein 571"	Q7Z3V5	19	37554782-37594792	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 77.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.9;Oligodendrocytes: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA054762			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA054762: "	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.03e-4)"	"unprognostic (5.77e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-4)"	4.1	7.5	8.9	3.6	8.4	8.5	14.5	9.4	11.1	6.4	8.1	3.4	2.2	6.1	9.9	4.1	6.7	5.0	4.2	7.2	9.0	7.4	3.5	3.9	5.5	7.2	8.1	8.3	3.2	12.0	8.9	5.5	7.1	8.0	3.5	28.9	3.3	4.6	4.1	8.5	2.9	4.8	4.5	5.5	3.9	10.6	7.0	6.2	77.4	3.9	6.0	4.5	4.0	9.9	2.5	1.4	8.6	12.5	6.3	6.4	2.8	3.8	6.0	8.9	11.0	2.7	2.4	13.6	11.6	3.9	6.3	3.3	2.8	4.1	14.8	3.0	10.9	7.3	4.4	1.6	7.2	2.7	7.9	3.5	7.2	8.6	7.8	6.3	1.8	12.1	3.5	1.1	7.3	2.4	13.8	3.0	21.7	4.0	4.8	6.8	4.1	7.2	12.4	16.3	18.5	12.9	8.9	2.9	4.5	17.1	13.3	1.9	1.1	4.1	5.2	4.5	9.8	10.5	23.4	18.5	0.6	1.2	9.1	1.6	0.7	4.4	5.2	1.2	4.8	7.6	5.0	5.3	2.3	7.7	6.0	6.6	1.2	3.2	1.1	3.5	3.8	2.7	8.9	8.4	9.4	11.1	7.2	9.0	7.2	8.1	7.1	4.5	7.0	9.9	5.5	0.0	2.0	5.2	6.6	1.8	1.2	1.9	5.2	9.5	3.5	3.2	1.6	1.5	4.6	5.5	10.4	2.4	11.9	0.8	3.9	2.3	20.9	3.1	3.1	6.0	1.2	4.8	8.6	1.6	1.8	3.1	2.0	2.4	15.2	5.1	4.6	0.8	1.7	13.5	9.7	1.9	6.1	1.3	2.1	4.3	4.4	1.7	5.4	5.6	0.6	4.9	5.2	17.1	23.9	1.0	1.0	2.6	3.5	1.9	1.1	2.8	4.0	16.0	13.1	4.9	4.2	10.3	6.2	2.9	2.6	1.2	8.7	4.1	1.7	0.5
ZNF574	FLJ22059	ENSG00000105732	"Zinc finger protein 574"	Q6ZN55	19	42068477-42081552	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 40.9;Spermatocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023196, HPA057274"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA023196: AB_2671105, HPA057274: AB_2683392"	"unprognostic (3.90e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	8.1	5.4	6.8	4.6	6.1	11.1	7.9	9.5	7.7	8.4	4.3	9.5	6.7	10.3	2.7	9.6	8.8	5.1	6.8	6.2	6.2	5.5	5.4	5.6	6.5	6.9	5.8	9.6	7.9	6.1	6.5	5.0	5.8	7.5	2.8	4.1	8.1	6.7	9.3	12.8	7.5	3.7	5.6	8.4	7.2	27.1	6.3	6.3	6.0	6.4	4.2	8.2	7.5	6.3	15.0	41.1	9.0	11.4	8.1	8.0	9.7	11.0	9.6	14.2	13.6	16.2	10.1	21.4	9.7	9.1	7.5	8.9	10.4	14.1	5.6	11.4	17.6	20.5	10.1	14.0	8.6	12.6	13.5	9.5	13.9	13.2	11.1	8.7	7.9	11.8	17.1	13.3	10.1	31.2	15.2	10.9	16.1	13.5	16.2	20.7	8.6	9.3	7.4	19.7	14.9	12.8	11.3	24.0	7.3	6.2	11.0	20.5	9.5	19.2	14.9	5.8	16.4	14.3	9.3	15.7	10.6	11.9	11.0	12.3	10.5	16.7	16.2	7.8	17.6	17.3	12.1	17.8	12.5	12.8	12.6	11.9	13.3	10.9	11.2	11.1	10.3	12.9	6.8	6.1	9.5	7.7	6.2	6.2	6.9	5.8	5.8	5.6	6.3	6.3	6.0	0.0	3.3	1.3	11.3	29.3	15.1	6.1	40.9	7.5	11.0	7.6	4.3	4.3	6.0	1.8	2.1	7.9	6.3	5.8	1.9	6.9	25.3	6.1	5.7	7.6	3.5	8.6	1.4	5.1	6.7	6.6	7.7	5.7	12.7	5.4	6.8	3.1	5.1	3.3	1.7	7.6	6.1	2.5	11.0	15.7	5.6	3.0	8.8	1.0	7.5	3.9	4.1	1.5	0.9	4.3	8.5	8.6	8.1	10.6	6.4	4.3	5.2	9.8	6.6	8.8	8.0	35.5	20.5	22.1	22.7	4.8	10.6	3.8	7.9	9.6
ZNF575	FLJ32567	ENSG00000176472	"Zinc finger protein 575"	Q86XF7	19	43525497-43536130	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 18.9;Paneth cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051865	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA051865: AB_2681643"	"unprognostic (1.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.53e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.87e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.75e-1)"	2.8	1.6	1.5	1.1	2.2	0.6	2.1	2.5	4.4	3.0	0.0	4.5	1.6	2.9	1.0	1.6	2.3	0.7	2.3	2.1	0.0	2.1	2.1	1.6	1.1	0.9	0.2	3.1	1.5	0.5	3.2	0.4	0.9	2.1	2.0	0.6	1.7	1.0	4.6	2.0	2.2	0.8	0.0	2.1	1.5	0.8	1.1	1.1	2.1	0.5	0.6	2.2	2.3	1.5	1.9	1.7	0.4	0.5	2.4	2.0	0.1	1.2	0.8	0.4	0.6	0.4	0.7	0.4	0.8	0.9	0.2	1.0	0.0	0.2	0.2	2.7	0.3	1.4	0.7	0.3	0.5	0.6	1.7	1.2	0.7	0.6	0.1	1.3	0.3	2.6	0.5	2.6	0.7	1.3	7.7	0.2	0.1	1.3	0.8	4.1	0.0	1.0	0.4	1.1	0.3	0.6	0.9	1.2	1.3	0.3	0.3	0.7	1.3	2.3	1.5	0.5	0.9	1.3	2.2	1.2	1.4	1.7	2.4	0.0	0.4	0.3	1.4	0.2	0.5	0.7	1.3	1.4	0.6	1.8	2.1	1.5	0.4	3.3	0.2	0.9	1.4	0.7	1.5	2.2	2.5	4.4	2.1	0.0	0.9	0.2	0.9	0.0	1.1	1.5	1.5	6.4	1.1	1.6	1.3	0.1	0.6	1.2	1.8	1.2	1.1	1.9	2.0	0.0	0.9	0.0	4.2	1.3	1.9	18.9	3.9	0.4	0.1	0.5	1.6	1.8	1.2	1.3	0.9	0.6	0.9	3.5	1.1	1.1	0.0	1.5	2.5	2.3	1.6	0.0	1.1	2.3	0.0	2.7	1.0	0.4	2.5	1.8	1.8	0.0	0.8	0.8	4.1	0.0	1.3	0.2	8.7	3.4	2.6	0.3	2.0	2.5	0.2	0.1	0.0	2.0	2.6	0.1	1.1	2.6	1.7	0.3	3.1	0.7	2.7	0.5
ZNF576	MGC2508	ENSG00000124444	"Zinc finger protein 576"	Q9H609	19	43596392-43601157	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050064	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA050064: AB_2681003"	"unprognostic (1.28e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.60e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.34e-3)"	10.3	13.9	10.3	7.1	11.2	3.4	10.5	12.5	12.5	10.7	6.0	12.4	9.4	11.4	4.8	11.1	9.8	7.9	11.7	10.1	9.8	12.0	18.7	6.8	8.4	11.3	11.5	11.8	9.4	8.7	15.0	5.1	11.3	15.1	4.8	5.3	10.7	6.8	14.0	9.0	9.7	5.5	9.9	9.3	10.2	13.6	12.1	7.6	9.1	10.7	5.2	11.9	10.1	11.2	21.9	24.9	9.1	11.6	11.7	10.5	8.1	17.8	11.6	17.5	19.4	12.2	16.2	14.3	19.7	13.4	10.2	8.6	13.0	12.6	4.7	15.6	22.3	10.5	16.7	15.4	9.9	14.2	18.8	9.1	15.4	15.3	6.0	8.7	12.6	12.3	13.3	18.0	13.2	21.4	20.0	6.3	6.4	18.0	21.0	16.7	8.0	14.1	10.5	19.2	16.7	10.5	11.7	23.3	9.3	6.5	11.0	16.2	13.2	23.3	13.1	10.5	26.5	9.4	11.4	10.0	20.1	16.4	20.6	10.5	15.2	16.2	17.2	15.4	15.5	28.2	17.2	14.6	15.9	18.6	18.5	14.6	8.5	19.3	15.6	25.4	18.9	11.5	10.3	11.2	12.5	12.5	10.1	9.8	11.3	11.5	11.3	9.9	12.1	11.2	12.7	6.4	7.3	1.3	11.3	10.6	8.7	17.1	11.4	23.2	15.1	20.1	13.1	10.0	12.7	14.7	31.3	13.7	11.0	16.8	21.5	18.9	34.2	8.6	12.5	13.5	11.4	8.6	3.4	18.9	20.3	13.4	6.6	7.9	9.5	42.0	14.6	20.3	15.4	23.5	3.1	11.9	6.1	6.3	9.2	96.2	13.4	6.6	19.6	0.0	11.1	24.8	12.3	4.0	3.7	19.3	13.0	15.4	9.6	18.0	30.6	32.4	10.7	33.4	6.6	11.3	11.3	28.4	19.4	11.8	12.4	5.7	8.7	14.7	16.0	10.9
ZNF577	MGC4400	ENSG00000161551	"Zinc finger protein 577"	Q9BSK1	19	51804816-51890950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 39.2;Early spermatids: 56.3;Late spermatids: 60.6;Oligodendrocytes: 50.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041499, HPA046761"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA041499: AB_2677516, HPA046761: AB_2679791"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (2.03e-4)"	9.4	7.2	11.9	5.4	15.0	4.2	12.2	14.2	13.2	14.3	8.0	14.5	4.6	11.7	7.1	6.8	12.7	8.0	12.2	11.5	16.1	13.6	6.8	7.9	5.5	14.0	12.3	27.1	8.8	14.9	8.4	9.3	13.3	18.4	6.6	16.9	12.0	11.3	7.2	20.6	9.0	7.2	10.2	12.7	8.9	18.8	13.5	7.7	18.7	9.1	5.7	11.1	9.3	21.0	1.6	0.1	7.8	9.5	13.1	14.1	0.0	9.3	3.4	3.5	7.1	1.0	1.3	1.6	0.9	4.3	5.2	2.5	3.1	1.9	1.9	0.0	9.0	15.6	0.2	1.4	10.2	3.4	5.1	11.1	5.8	5.2	1.5	10.9	1.8	0.0	3.5	0.1	4.5	0.0	9.7	4.4	9.0	0.0	0.2	4.2	3.9	2.9	5.8	3.4	3.2	1.6	2.3	1.1	8.0	7.9	1.6	3.7	1.2	6.4	8.8	1.8	3.4	6.3	0.0	2.0	1.7	0.6	10.6	4.4	1.6	3.7	0.9	2.5	2.7	7.2	1.8	2.2	1.8	3.5	2.2	1.4	0.6	3.3	2.0	2.0	0.9	1.1	11.9	15.0	14.2	13.2	11.5	16.1	14.0	12.3	13.3	10.2	13.5	21.0	8.8	0.0	2.6	14.4	4.0	4.5	3.7	4.0	2.2	12.2	8.1	7.9	8.5	4.3	3.0	18.4	10.4	7.2	4.8	2.7	39.2	4.3	56.3	7.2	7.4	6.6	3.0	2.1	20.1	1.1	5.4	6.3	4.1	5.6	5.1	9.8	7.1	1.8	5.7	6.7	19.3	4.7	2.0	2.2	3.7	60.6	8.1	6.7	0.0	9.4	4.0	15.2	1.0	26.2	50.1	1.2	1.9	12.8	0.9	5.9	5.1	4.9	3.0	9.9	0.0	6.9	7.6	12.3	14.0	4.2	5.3	4.5	2.5	4.2	4.4	3.0
ZNF579	FLJ35453	ENSG00000218891	"Zinc finger protein 579"	Q8NAF0	19	55576774-55580848	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HEK 293: 43.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062812	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA062812: AB_2684873"	"unprognostic (1.76e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.95e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (5.27e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.08e-3)"	11.5	9.1	8.7	3.3	7.8	4.5	9.3	17.1	10.0	10.0	5.3	11.6	4.5	14.7	6.8	6.7	12.7	7.9	14.3	8.5	9.2	18.4	11.8	10.1	4.7	12.3	11.1	13.5	15.3	3.3	12.6	2.5	10.6	12.0	2.6	6.7	8.4	4.5	33.4	6.6	8.8	4.1	7.5	8.8	20.9	3.7	9.3	3.0	16.7	13.4	2.1	9.9	6.5	9.5	7.9	15.9	8.6	8.8	13.1	9.6	11.0	15.3	4.2	8.4	8.5	5.4	9.3	13.1	6.1	8.9	2.7	7.6	5.2	8.3	8.8	2.6	43.9	8.3	32.5	10.1	13.2	4.9	6.5	24.0	8.9	6.4	6.7	18.8	4.7	4.6	16.6	4.2	17.0	10.4	7.3	6.7	7.8	4.3	24.6	12.4	7.8	5.5	11.4	14.9	10.4	14.6	10.2	7.6	7.8	16.7	4.0	7.0	10.9	11.0	10.6	3.4	9.7	11.6	10.3	7.2	5.6	7.8	5.7	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	8.7	7.8	17.1	10.0	8.5	9.2	12.3	11.1	10.6	7.5	9.3	9.5	10.3	3.2	6.7	4.2	4.7	3.3	7.9	1.7	6.2	13.3	8.9	8.0	5.2	18.6	1.5	5.5	12.5	0.7	4.5	4.3	3.9	6.0	0.0	8.6	7.6	6.8	11.4	2.5	2.7	4.8	0.6	5.3	15.3	9.8	4.5	17.2	13.6	7.2	5.1	15.2	3.4	7.1	0.0	5.7	2.8	0.5	8.4	3.8	3.6	3.7	1.8	15.9	3.1	2.5	3.6	6.6	2.0	12.4	2.5	9.4	2.1	11.1	3.0	8.9	13.1	4.7	9.2	0.9	0.9	3.7	3.3	0.4	3.5	13.6	6.1	9.3
ZNF580		ENSG00000213015	"Zinc finger protein 580"	Q9UK33	19	55635016-55643470	"Predicted intracellular proteins, Transcription factors"	"Chemotaxis, Inflammatory response, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 279.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054058	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA054058: AB_2682360"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.46e-3)"	32.0	46.1	53.1	18.2	49.4	12.9	33.9	47.6	62.0	48.3	47.7	55.3	13.1	59.0	24.0	25.9	48.0	5.4	35.9	52.0	54.4	53.2	17.8	33.4	17.5	53.6	50.8	56.6	43.7	26.5	68.6	8.5	48.5	60.0	9.8	12.4	35.8	20.6	19.3	31.1	39.6	18.1	44.3	44.6	42.0	17.6	48.9	14.5	65.6	5.5	14.3	49.2	33.8	46.6	17.6	31.2	27.0	17.6	29.2	16.4	11.3	24.5	25.6	33.3	39.9	5.5	15.6	13.1	6.6	31.2	7.3	15.1	18.2	19.3	25.1	43.4	279.2	23.6	32.7	14.6	38.6	11.1	53.7	35.4	20.5	15.9	29.6	43.8	23.1	29.9	26.1	32.1	27.8	5.1	50.5	15.9	14.4	10.9	43.0	51.1	10.4	53.1	38.0	19.2	30.2	39.3	15.2	15.0	22.4	14.6	13.3	11.4	30.5	18.0	29.4	13.3	13.2	72.3	22.8	29.7	9.9	17.0	17.9	4.6	3.4	11.5	1.1	5.1	1.2	8.4	2.6	2.5	3.7	12.3	3.1	2.7	5.9	3.1	9.9	4.0	2.2	1.7	53.1	49.4	47.6	62.0	52.0	54.4	53.6	50.8	48.5	44.3	48.9	46.6	41.4	9.6	9.7	18.3	39.7	18.6	44.0	32.6	57.5	33.4	51.0	61.2	10.0	37.1	16.3	57.0	4.2	25.3	36.5	25.1	76.3	47.0	3.5	16.1	46.2	36.6	67.4	21.0	9.9	56.0	20.2	36.6	31.6	16.1	19.1	42.8	48.2	11.9	25.9	20.2	10.8	27.2	18.3	31.4	31.1	8.7	59.4	29.2	39.2	11.2	39.1	44.2	28.8	11.6	13.5	45.7	30.9	70.7	49.7	37.6	49.2	78.2	7.6	22.8	39.5	28.5	48.6	11.3	12.9	49.2	16.9	19.0	22.7	70.5	29.8	35.8
ZNF582	FLJ30927	ENSG00000018869	"Zinc finger protein 582"	Q96NG8	19	56375846-56393545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 13.7;Muller glia cells: 13.2;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028858	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA028858: AB_10603247"	"unprognostic (1.19e-3)"	"unprognostic (9.86e-4)"	"unprognostic (3.88e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.02e-7)"	"unprognostic (3.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.00e-3)"	2.3	4.5	5.8	2.2	6.8	1.6	3.3	7.5	8.6	3.2	6.2	3.1	1.1	4.1	6.9	2.5	3.1	3.3	4.4	5.8	7.0	4.0	2.5	2.7	4.8	6.5	6.2	5.1	2.1	3.8	5.0	2.9	6.3	4.3	1.3	10.5	2.1	2.7	1.8	3.0	2.0	2.3	6.2	4.1	1.9	5.1	6.2	2.6	7.4	1.6	1.9	3.0	2.1	7.3	0.0	1.3	6.9	1.4	1.6	1.7	0.0	2.9	3.0	1.8	1.4	0.0	0.4	0.0	1.8	1.6	4.0	0.0	0.9	0.4	1.3	0.0	28.3	7.0	0.0	0.5	2.9	1.8	5.4	6.1	1.5	1.1	0.0	1.8	1.1	0.7	1.6	0.0	1.1	0.0	4.1	4.5	3.9	0.1	0.0	1.9	2.3	2.5	1.5	3.9	0.0	4.5	0.0	0.9	0.0	5.1	3.1	3.8	1.2	3.6	7.4	0.9	3.9	6.0	7.0	4.4	0.2	0.4	2.1	2.9	1.4	4.2	2.8	2.3	4.2	4.3	3.4	2.8	2.3	3.2	2.4	3.1	0.4	7.6	1.7	2.3	1.1	1.9	5.8	6.8	7.5	8.6	5.8	7.0	6.5	6.2	6.3	6.2	6.2	7.3	4.9	0.0	0.0	4.2	4.0	1.3	2.4	2.3	1.2	4.4	2.5	2.8	3.5	1.5	2.1	7.3	2.1	2.7	2.9	0.2	13.7	2.5	1.0	2.8	1.7	4.6	0.0	0.4	4.5	0.6	0.7	2.6	1.1	1.9	8.2	3.2	4.6	2.4	2.8	1.7	4.9	0.5	6.1	1.0	2.0	0.9	2.1	2.3	3.6	0.0	1.6	13.2	5.2	7.1	9.2	1.4	0.3	4.1	0.1	4.2	0.7	4.9	2.2	5.5	13.1	3.5	2.8	2.8	7.9	0.9	1.0	3.6	2.7	4.5	0.6	2.3
ZNF585B	"FLJ14928, SZFP41, Zfp27"	ENSG00000245680	"Zinc finger protein 585B"	Q52M93	19	37181579-37218153	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA075556			Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytoplasmic bodies"		"HPA075556: AB_2686757"	"unprognostic (9.53e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-3)"	3.2	4.2	4.6	2.2	4.7	1.1	4.3	5.3	5.7	5.0	4.6	4.7	2.9	5.7	6.2	2.9	4.5	3.4	3.8	4.3	5.7	4.3	3.3	2.9	3.9	4.2	5.6	6.6	3.1	7.5	6.3	4.0	5.0	4.3	3.7	8.4	3.2	5.6	2.6	3.1	3.9	4.4	4.0	5.2	4.2	4.1	4.7	4.5	6.6	4.0	4.5	4.5	3.7	5.1	2.0	3.4	3.0	6.8	5.7	8.9	1.8	3.2	4.8	5.5	8.2	2.2	2.6	0.1	6.1	4.1	3.7	0.4	0.0	3.2	6.5	4.3	1.9	2.9	4.6	1.3	5.3	0.0	5.9	7.0	2.5	5.8	2.1	4.1	2.2	0.4	0.0	0.1	3.2	1.4	5.6	2.0	3.9	1.0	1.2	0.0	2.0	0.0	1.7	8.7	5.3	3.7	0.0	0.1	1.4	4.3	2.6	3.2	1.8	0.4	1.1	4.5	3.6	4.4	7.6	6.3	0.2	0.1	5.8	1.9	0.5	1.4	1.5	1.1	1.7	1.3	1.4	1.3	0.7	1.3	1.7	2.1	1.0	1.0	1.9	0.5	1.2	0.9	4.6	4.7	5.3	5.7	4.3	5.7	4.2	5.6	5.0	4.0	4.7	5.1	3.7	6.4	5.6	16.3	5.4	1.7	1.6	2.6	3.4	7.0	5.2	3.9	5.8	4.3	8.3	12.9	2.1	3.0	3.0	3.6	1.9	3.2	16.7	3.6	4.2	5.5	0.0	4.6	17.5	1.9	2.5	3.9	4.6	3.9	7.0	4.7	4.2	2.5	3.4	3.3	19.5	2.6	8.2	3.8	0.9	7.3	4.1	3.3	1.8	13.1	1.0	3.2	2.1	20.6	28.4	2.5	2.0	6.8	1.3	2.0	2.8	3.4	7.0	4.1	0.0	4.2	3.8	5.3	4.9	7.0	1.6	3.1	4.6	4.3	2.0	2.2
ZNF587	"FLJ14710, FLJ20813, UBF-fl, ZF6"	ENSG00000198466	"Zinc finger protein 587"	Q96SQ5	19	57849859-57865117	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"RT4: 41.5"									"HPA042125, HPA043288, HPA056213"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069"	"unprognostic (1.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.84e-3)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-3)"	5.0	5.1	3.9	6.4	3.6	6.8	10.1	4.5	5.3	6.4	5.9	8.5	8.2	5.9	5.6	6.1	6.0	3.7	6.0	3.7	3.8	6.5	6.2	6.2	5.4	2.9	2.9	7.1	9.1	4.9	11.5	8.0	2.9	9.6	13.1	11.4	12.1	6.5	4.5	5.9	7.9	5.5	2.1	6.1	8.9	4.4	3.3	5.4	7.7	4.1	6.8	6.2	7.3	4.7	8.6	7.8	7.0	5.7	7.5	10.9	10.5	7.5	9.5	11.2	9.8	11.2	5.7	5.7	3.9	5.9	4.4	5.1	10.1	11.1	20.8	5.3	21.5	11.1	28.6	8.0	4.3	11.1	10.6	10.8	5.1	11.0	10.4	8.6	12.1	7.8	14.1	7.5	8.4	3.6	6.7	4.1	2.1	2.2	7.1	5.3	6.6	3.8	6.7	41.5	11.1	5.2	8.7	7.9	2.7	9.2	6.8	6.3	5.7	8.3	5.1	2.1	10.7	12.0	9.8	6.0	3.8	4.7	5.0	1.4	0.5	0.4	0.4	0.4	0.4	0.5	0.5	0.4	0.5	0.7	0.4	0.7	1.2	0.5	0.4	0.4	0.7	0.3	3.9	3.6	4.5	5.3	3.7	3.8	2.9	2.9	2.9	2.1	3.3	4.7	6.9	3.2	6.8	13.1	8.4	9.2	13.6	7.3	1.8	20.0	10.4	5.8	7.1	30.0	9.6	7.3	31.3	10.8	7.4	12.2	11.7	9.1	9.5	16.9	10.0	7.8	23.4	3.8	19.9	3.7	9.8	7.3	19.4	22.6	12.7	18.3	12.5	9.4	6.5	20.2	19.3	18.2	4.1	7.1	5.5	1.3	4.7	7.0	0.0	10.3	7.2	7.6	7.2	17.6	14.1	7.6	15.9	9.1	8.7	13.4	14.8	8.5	13.3	24.7	0.0	9.2	6.3	4.2	6.7	5.4	6.7	10.1	8.7	9.5	15.5	15.4
ZNF587B		ENSG00000269343	"Zinc finger protein 587B"	E7ETH6	19	57819721-57846238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 36.2"									"HPA043800, HPA053762, HPA072145"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (4.13e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.70e-2)"	3.6	3.1	1.2	3.4	1.6	9.4	5.3	4.0	1.1	2.5	3.4	4.0	5.7	3.2	2.5	3.8	3.2	2.6	3.1	1.3	0.8	4.0	6.6	3.8	4.8	0.7	0.7	3.3	5.6	3.0	3.0	3.0	0.4	4.0	4.4	2.0	6.0	2.3	9.9	6.9	5.6	2.2	0.1	6.4	4.7	5.3	1.3	2.8	4.0	2.0	5.0	3.7	2.9	0.8	5.6	16.3	6.0	13.0	1.5	1.7	7.0	4.5	3.5	4.4	3.0	9.6	8.9	11.9	2.4	6.1	2.4	4.7	5.9	14.1	10.5	2.0	13.8	8.8	15.3	10.1	5.2	15.4	8.3	5.0	2.7	6.8	7.1	1.2	3.7	8.5	10.3	5.5	2.8	6.2	7.2	2.6	15.7	5.2	7.2	5.9	6.5	5.6	5.3	36.2	3.7	6.2	5.0	6.6	4.3	9.4	9.1	5.5	5.1	6.0	6.9	1.4	6.6	7.7	6.6	9.1	4.9	4.5	6.7	2.0	1.8	0.8	1.1	1.6	1.2	1.2	1.2	1.3	1.1	1.2	1.6	1.5	3.0	1.1	0.9	1.2	1.0	1.8	1.2	1.6	4.0	1.1	1.3	0.8	0.7	0.7	0.4	0.1	1.3	0.8	1.7	6.4	1.5	6.5	3.4	3.2	3.4	2.4	1.2	4.2	2.2	0.6	2.7	4.3	5.4	0.0	0.0	3.5	3.9	1.3	1.9	3.9	4.6	3.1	2.2	2.8	4.2	1.3	11.6	2.0	3.3	2.8	3.1	3.3	0.0	5.8	5.7	3.4	1.4	3.3	12.2	3.7	4.1	2.2	1.0	0.9	0.6	1.9	1.8	4.7	1.8	0.8	2.1	11.1	4.6	2.1	1.4	0.7	2.2	2.9	1.4	3.3	3.2	3.6	6.6	2.3	2.5	4.2	5.8	1.3	3.8	2.5	2.2	4.4	2.4	3.1
ZNF589	SZF1	ENSG00000164048	"Zinc finger protein 589"	Q86UQ0	3	48241100-48299253	"Predicted intracellular proteins, Transcription factors"		"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 20.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HAP1: 44.1;NTERA-2: 71.1"									HPA003145	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA003145: AB_1080738"	"unprognostic (2.49e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.01e-5)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.64e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.19e-2)"	7.2	8.5	9.6	6.7	9.7	5.8	6.9	14.9	11.2	11.2	2.3	8.3	3.8	7.6	20.1	10.2	8.8	4.6	6.2	11.0	9.3	7.1	3.7	10.1	12.3	7.9	7.9	13.6	6.5	5.9	7.8	3.0	7.7	18.3	6.6	14.8	6.6	15.7	6.1	9.8	16.1	6.0	7.2	24.1	7.9	6.6	8.9	8.1	16.6	4.2	12.2	8.5	10.7	10.2	4.5	3.2	12.7	10.8	15.8	8.7	16.1	4.6	3.5	5.2	6.9	6.8	6.0	17.8	3.3	4.7	4.0	3.9	44.1	11.2	4.2	11.5	10.5	22.5	14.9	5.4	2.9	5.4	5.6	2.8	7.5	6.4	4.3	5.7	9.0	13.7	15.4	4.5	2.8	4.5	6.8	4.1	71.1	4.3	6.6	3.3	4.6	6.8	4.0	4.4	4.9	9.1	3.4	3.7	13.7	18.8	6.0	8.0	14.0	3.0	5.8	7.2	3.5	8.9	12.0	14.6	4.0	12.6	9.3	1.2	2.2	1.6	2.8	2.0	3.5	3.1	3.4	3.8	2.3	1.9	3.8	3.8	1.2	1.2	2.8	10.9	3.1	1.9	9.6	9.7	14.9	11.2	11.0	9.3	7.9	7.9	7.7	7.2	8.9	10.2	2.0	0.0	5.4	4.2	5.5	1.1	1.4	0.9	3.4	15.3	2.4	1.5	4.1	0.0	2.8	9.2	20.9	2.2	13.7	1.3	3.9	1.4	1.5	7.3	3.5	2.7	1.8	2.1	9.8	1.0	1.2	4.3	1.5	11.7	0.0	3.9	2.5	1.0	3.3	1.7	11.5	2.5	0.0	5.5	3.0	2.0	2.1	7.3	1.8	3.7	3.7	5.3	1.0	9.5	11.0	1.0	1.7	4.5	5.3	1.5	1.4	1.6	2.4	13.1	6.6	4.1	3.0	1.4	3.1	2.9	1.3	0.0	4.4	7.0	2.5	0.9
ZNF592	"CAMOS, KIAA0211, SCAR5"	ENSG00000166716	"Zinc finger protein 592"	Q92610	15	84748592-84806445	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020332, HPA021600"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA020332: AB_1859365, HPA021600: AB_1859364"	"unprognostic (2.83e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.04e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.90e-1)"	"unprognostic (2.62e-1)"	9.7	8.7	9.4	6.7	10.0	11.1	9.6	10.4	9.4	9.7	7.4	9.4	7.9	9.1	7.9	7.4	9.8	4.9	9.6	9.8	9.0	8.7	10.9	9.0	9.5	11.5	10.1	11.8	10.9	9.1	7.9	5.9	10.2	8.7	7.1	7.5	7.5	6.5	18.2	10.1	10.7	6.8	9.3	11.2	8.1	8.0	10.2	11.4	8.8	14.5	9.4	8.5	8.3	10.6	7.7	12.8	11.6	6.5	12.7	8.5	12.8	5.3	7.5	8.6	6.8	12.2	8.9	11.1	6.7	11.9	7.4	13.9	18.0	7.6	6.0	9.0	10.8	12.9	12.9	11.0	7.8	10.6	9.9	9.4	10.6	6.7	11.0	10.2	7.6	7.7	13.0	6.8	9.1	12.0	7.2	13.0	10.6	7.3	5.0	10.3	10.4	9.8	9.2	15.4	10.5	11.4	12.1	10.7	9.0	16.1	6.0	22.3	10.8	12.7	7.4	7.1	10.2	7.8	9.0	11.8	8.0	15.5	7.5	0.0	1.2	0.9	1.2	1.4	0.4	1.5	0.7	1.2	1.3	1.4	1.0	0.9	2.6	1.0	1.3	1.0	0.8	0.8	9.4	10.0	10.4	9.4	9.8	9.0	11.5	10.1	10.2	9.3	10.2	10.6	9.2	9.6	10.5	23.8	15.2	8.4	4.2	8.2	6.2	9.0	14.3	8.8	5.3	8.6	7.5	3.7	8.4	5.6	9.6	18.8	0.0	8.4	7.8	24.7	10.8	9.8	7.8	12.0	21.7	8.1	8.9	8.7	13.7	40.3	3.8	10.2	10.4	16.7	11.3	3.3	20.7	10.8	4.1	21.1	9.8	11.8	4.7	14.6	7.2	28.1	14.9	3.7	11.3	10.1	29.9	9.8	11.1	9.8	16.9	5.6	16.2	6.3	8.4	8.5	6.6	13.1	9.2	13.2	12.4	8.9	7.1	4.8	11.6	8.1	11.4	5.1
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169908-26170873	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA054363: AB_2682462, HPA059387: AB_2684001"	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	35.8	31.8	20.0	12.6	21.0	20.3	30.7	21.4	25.6	18.1	20.6	23.6	13.0	22.7	6.6	32.5	23.0	6.1	37.9	20.3	23.0	40.2	63.9	21.8	10.1	21.1	22.3	32.1	61.5	16.4	25.7	9.3	22.7	31.3	6.2	2.5	24.3	7.6	101.3	32.4	21.1	7.0	20.6	28.2	39.0	16.3	20.8	4.6	28.0	21.9	8.3	25.5	20.7	21.5	76.0	41.3	13.1	48.4	13.3	17.3	72.2	32.8	16.5	37.3	36.3	62.8	44.4	87.2	58.9	21.0	29.7	48.3	47.2	43.5	13.5	53.1	150.6	59.6	33.6	98.3	56.6	82.5	50.0	31.4	41.8	41.8	43.7	15.5	32.3	20.6	91.4	32.7	23.1	58.1	34.1	154.7	53.0	72.7	143.0	42.0	23.6	89.8	27.7	32.8	35.7	39.4	39.8	98.4	132.1	10.7	41.0	46.3	33.6	35.7	42.0	75.8	62.4	64.1	71.3	97.2	42.2	171.1	46.9	0.5	41.3	0.6	35.6	69.1	33.0	64.2	48.7	34.9	57.5	63.3	36.1	34.6	1.9	44.6	70.9	70.4	58.4	39.3	20.0	21.0	21.4	25.6	20.3	23.0	21.1	22.3	22.7	20.6	20.8	21.5	38.9	12.8	57.9	2.6	56.8	171.3	180.9	67.7	128.1	18.0	116.1	142.0	6.0	88.6	50.6	60.7	2.1	114.5	29.8	86.1	103.7	102.2	6.7	70.7	62.6	45.1	109.8	26.5	2.5	147.0	158.5	49.7	75.4	83.4	50.9	62.2	40.7	201.5	79.4	3.3	3.2	156.7	36.7	59.9	52.3	14.3	32.3	37.3	49.8	0.0	47.2	20.9	21.6	2.0	2.1	130.8	61.6	23.3	94.9	197.2	71.7	218.0	27.8	16.7	13.1	65.1	57.7	39.0	52.2	111.6	168.4	222.6	28.8	68.0	128.4	185.3
ZNF594	KIAA1871	ENSG00000180626	"Zinc finger protein 594"	Q96JF6	17	5179535-5191868	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.8;Horizontal cells: 15.2;Inhibitory neurons: 15.7;Oligodendrocytes: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060283, HPA067178, HPA069360, HPA074493, HPA077596"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: "	"unprognostic (6.67e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-5)"	"unprognostic (4.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.99e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.59e-2)"	1.8	3.3	2.8	4.2	3.9	0.7	4.9	6.0	3.8	4.4	4.5	3.9	1.6	5.1	4.2	1.9	4.4	2.2	2.9	3.0	2.7	4.2	2.2	2.2	6.2	3.8	2.8	10.7	3.3	5.4	6.2	3.2	3.1	5.1	2.7	11.7	3.8	4.3	4.0	2.1	4.0	3.0	2.0	5.1	2.9	4.5	3.4	5.1	5.6	2.9	5.9	3.6	2.9	6.8	5.8	2.5	10.5	8.3	1.6	1.8	8.9	3.8	1.9	6.6	6.2	7.3	2.1	13.1	5.9	3.0	4.9	6.2	6.8	0.2	8.3	7.0	6.9	4.2	10.2	3.7	2.4	0.0	4.0	1.4	1.1	4.0	0.0	1.7	0.7	7.5	1.7	3.2	2.2	5.7	3.6	1.8	4.9	0.9	3.5	7.6	8.9	1.7	1.9	1.5	6.2	8.4	2.8	1.5	5.8	4.6	3.4	3.1	0.1	0.1	3.7	3.4	2.7	2.0	4.5	3.0	0.6	0.0	4.1	0.2	0.4	0.5	1.4	0.5	1.0	1.6	1.5	1.4	0.4	2.5	2.3	1.6	0.2	1.3	0.5	2.2	2.4	0.6	2.8	3.9	6.0	3.8	3.0	2.7	3.8	2.8	3.1	2.0	3.4	6.8	1.8	6.4	3.9	14.0	3.6	1.1	1.3	0.4	1.2	9.5	2.5	2.2	5.5	4.3	2.8	5.5	6.2	1.4	1.3	0.7	7.9	1.6	0.8	0.8	3.1	2.1	1.2	2.5	17.8	1.1	0.7	2.7	1.5	0.8	3.8	9.9	3.9	0.7	1.1	15.2	15.7	1.5	0.0	1.4	0.6	4.3	3.4	1.2	0.0	8.4	1.5	7.7	3.1	14.6	20.3	0.7	1.5	2.6	0.8	0.9	0.6	1.0	5.0	9.2	0.0	3.3	2.4	2.5	4.1	0.9	0.3	0.3	1.8	5.2	1.3	0.5
ZNF597	"FLJ33071, HIT-4"	ENSG00000167981	"Zinc finger protein 597"	Q96LX8	16	3432414-3443504	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA001556	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA001556: AB_1080740"	"unprognostic (1.98e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.75e-3)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.99e-3)"	1.6	1.9	1.1	1.5	1.1	1.9	1.7	1.0	1.3	1.4	0.8	1.1	1.2	1.5	2.1	1.1	1.4	1.9	1.3	1.0	1.5	1.3	1.7	2.4	2.1	0.9	1.1	2.0	1.6	1.4	1.3	2.3	1.0	1.4	1.0	2.3	1.1	1.2	0.7	1.3	1.3	1.2	1.0	1.8	1.2	3.9	1.4	1.5	2.0	1.1	1.8	1.6	0.9	1.2	0.0	1.2	1.5	3.7	1.1	1.7	5.9	1.8	2.2	1.7	2.1	0.0	2.3	3.1	1.7	2.0	1.3	1.0	3.5	1.6	2.2	1.9	1.4	5.3	3.6	2.2	1.6	3.2	3.1	2.2	2.5	1.9	2.1	1.7	4.7	1.6	1.1	2.0	2.0	1.0	2.3	3.3	5.0	1.4	0.0	1.4	4.5	2.1	1.4	4.9	2.0	2.8	3.5	1.8	1.4	4.1	1.5	4.7	3.1	2.8	1.4	0.0	1.7	2.6	2.9	0.4	0.0	1.8	1.7	3.1	0.8	8.8	0.9	1.7	1.5	0.9	0.7	0.8	0.8	0.7	1.2	0.9	0.2	0.7	0.8	0.4	1.2	0.6	1.1	1.1	1.0	1.3	1.0	1.5	0.9	1.1	1.0	1.0	1.4	1.2	8.3	25.6	2.6	0.0	4.3	0.1	1.8	0.3	2.8	2.1	4.3	3.8	1.9	1.5	5.2	1.8	0.0	1.2	3.6	1.4	0.0	1.1	8.1	3.8	2.1	4.2	2.4	0.4	2.9	1.0	1.8	2.6	1.5	4.5	3.8	3.0	2.5	1.4	1.2	0.0	1.9	2.1	0.0	1.0	0.7	4.1	1.2	2.7	0.0	4.7	3.0	1.8	0.0	1.0	2.0	1.8	1.0	2.2	2.1	2.4	0.7	1.3	0.9	3.1	6.6	2.7	2.6	5.3	8.0	1.9	0.4	1.5	3.3	1.1	2.4	2.3
ZNF599	FLJ30663	ENSG00000153896	"Zinc finger protein 599"	Q96NL3	19	34758073-34773229	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 33.2;Early spermatids: 81.4;Late spermatids: 30.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA014701	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA014701: AB_1859371"	"unprognostic (3.52e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.35e-3)"	"unprognostic (9.20e-2)"	"unprognostic (5.16e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.12e-3)"	4.4	5.9	5.8	2.3	6.7	1.2	5.6	6.8	6.0	8.1	8.1	6.3	2.5	7.6	11.9	3.9	8.6	2.4	4.7	5.5	6.4	9.5	4.7	4.7	3.3	6.4	6.6	7.4	4.8	9.8	11.0	3.1	6.3	9.5	2.8	4.7	5.9	4.8	3.6	4.4	4.3	3.6	6.2	5.0	4.8	14.0	6.6	4.2	11.1	5.0	2.7	6.0	6.1	7.3	4.8	2.4	4.6	3.4	5.2	6.9	2.6	1.7	4.5	4.1	4.7	2.0	3.1	0.5	4.3	3.1	3.8	2.3	3.4	2.3	4.9	0.5	4.2	3.6	4.9	5.7	4.1	0.8	3.5	6.5	3.1	1.9	2.0	6.7	4.7	8.3	6.2	0.4	6.0	1.9	9.1	3.8	2.0	6.5	0.1	4.6	4.5	3.0	5.1	1.1	5.8	8.4	5.6	1.0	3.2	3.0	2.8	0.4	2.6	3.2	4.4	3.0	1.9	5.1	5.6	0.4	2.5	0.1	3.8	1.9	0.6	3.5	3.4	1.4	2.3	1.0	3.5	1.9	1.0	2.2	3.5	3.2	0.3	3.5	3.2	2.2	2.8	1.6	5.8	6.7	6.8	6.0	5.5	6.4	6.4	6.6	6.3	6.2	6.6	7.3	5.8	0.0	3.7	5.2	2.5	3.1	7.6	5.5	6.8	4.2	10.2	11.2	4.4	1.5	8.3	18.4	2.1	7.9	5.2	1.1	33.2	4.6	81.4	25.4	6.4	5.3	1.2	3.8	0.7	2.3	4.5	8.3	1.5	4.1	0.0	6.6	5.0	4.0	3.8	0.0	3.5	3.3	4.1	1.0	1.9	30.8	10.2	1.2	5.4	0.0	0.9	14.4	4.1	9.5	8.1	3.1	0.9	4.9	4.8	5.5	2.9	15.3	22.7	2.7	6.6	5.7	5.7	26.2	7.5	4.8	1.6	1.9	3.9	7.2	3.2	6.0
ZNF605		ENSG00000196458	"Zinc finger protein 605"	Q86T29	12	132918306-132956306	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA061970, HPA062655"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA061970: AB_2684649, HPA062655: AB_2684820"	"unprognostic (2.38e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.16e-6)"	"unprognostic (3.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.53e-2)"	"unprognostic (9.06e-3)"	2.9	4.1	5.7	2.5	5.7	1.4	5.2	7.3	6.8	4.6	6.6	5.1	2.8	4.3	5.4	3.5	4.6	2.7	4.4	5.6	4.7	4.7	4.3	2.9	3.2	5.4	5.0	5.4	3.9	6.2	6.7	3.3	5.5	5.2	2.8	8.4	4.5	3.8	4.2	5.0	4.2	3.2	4.3	3.9	4.0	2.1	5.4	4.0	6.9	5.2	2.9	4.4	4.2	6.4	4.8	3.8	9.7	9.2	5.2	10.7	7.2	6.5	3.7	2.9	2.1	0.6	0.6	2.0	3.4	5.6	3.6	2.6	4.2	1.6	3.6	1.6	7.2	9.2	3.4	3.0	3.9	3.9	9.7	6.8	7.0	2.0	4.4	9.0	2.2	4.7	1.4	0.1	7.4	1.3	5.1	5.4	7.5	1.3	5.2	4.7	6.3	1.4	5.0	8.1	6.2	7.1	2.9	1.7	4.5	5.7	10.6	11.1	4.4	3.6	5.8	5.4	2.6	0.0	0.0	1.6	0.1	3.2	2.2	0.4	0.2	0.2	0.2	0.1	0.1	0.5	0.2	0.3	0.1	0.3	0.5	0.3	0.3	0.3	0.1	0.2	0.0	0.1	5.7	5.7	7.3	6.8	5.6	4.7	5.4	5.0	5.5	4.3	5.4	6.4	8.4	19.2	33.5	21.9	9.3	3.4	8.1	3.3	18.8	33.6	10.5	11.2	22.5	15.7	25.1	9.2	29.2	7.5	5.0	7.3	9.8	7.2	2.2	8.1	15.0	12.7	6.1	7.6	24.9	3.3	3.6	12.6	15.3	7.1	10.1	20.2	13.6	4.9	3.9	40.4	25.2	10.1	6.1	7.3	2.7	2.5	15.8	6.1	0.0	11.2	8.9	16.4	13.4	28.1	15.8	7.5	4.5	13.5	5.8	9.5	5.8	5.2	13.7	35.2	13.1	16.2	11.5	6.8	7.9	9.4	4.5	5.6	10.8	23.0	7.1	6.2
ZNF606	"FLJ14260, KIAA1852, ZNF328"	ENSG00000166704	"Zinc finger protein 606"	Q8WXB4	19	57977053-58003349	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 25.0;Rod photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041712, HPA043584"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041712: AB_10960410, HPA043584: AB_2678565"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.01e-2)"	"prognostic favorable (4.75e-6)"	4.4	5.3	7.3	5.0	9.2	4.0	8.0	10.5	8.1	8.3	11.8	5.7	5.6	8.1	8.9	5.0	10.0	3.5	5.7	6.8	7.2	9.7	5.7	5.3	8.1	8.4	9.1	10.4	6.4	9.3	11.3	4.3	8.2	8.9	4.5	10.0	7.9	6.0	3.9	7.2	8.4	3.5	8.1	9.0	6.7	7.6	7.8	8.5	13.3	2.8	6.6	6.3	6.0	12.1	1.7	3.1	13.1	10.9	3.9	5.4	9.4	4.0	1.4	3.9	2.4	4.1	4.7	2.7	3.1	2.7	4.2	4.0	1.7	3.9	5.2	0.0	23.5	6.6	1.3	3.7	3.0	0.0	5.1	6.4	1.9	3.4	1.9	6.1	2.8	7.7	3.4	0.1	5.0	1.6	9.0	1.5	7.9	2.1	5.8	9.9	4.8	4.0	4.2	8.2	12.1	8.0	7.2	0.2	3.0	6.3	6.3	6.3	3.3	3.1	4.4	1.1	1.3	7.8	9.1	1.9	0.2	0.7	4.1	10.2	2.3	6.5	2.2	2.0	3.2	6.5	3.6	2.7	2.1	7.4	6.4	3.7	6.2	5.5	2.3	6.5	2.6	1.8	7.3	9.2	10.5	8.1	6.8	7.2	8.4	9.1	8.2	8.1	7.8	12.1	4.3	6.4	7.8	9.1	9.6	1.0	3.5	2.5	5.2	15.4	3.5	2.9	10.8	2.8	5.6	12.9	25.0	3.2	6.2	1.7	3.9	4.0	2.8	8.6	4.6	5.9	0.0	9.0	8.4	1.6	1.1	3.9	6.1	2.2	5.1	14.4	5.3	2.6	2.0	11.8	9.8	2.4	4.1	0.8	3.0	1.2	8.1	2.5	0.0	7.5	2.2	8.6	10.3	10.1	12.9	2.2	2.4	3.4	3.0	4.1	4.2	2.2	22.6	29.2	6.6	2.9	4.6	12.3	12.7	3.1	2.0	3.4	4.4	6.8	2.2	3.2
ZNF607	"FLJ14802, MGC13071"	ENSG00000198182	"Zinc finger protein 607"	Q96SK3	19	37696371-37719761	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.0;Late spermatids: 26.7;Smooth muscle cells: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA049465, HPA055018"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA049465: AB_2680778, HPA055018: AB_2682674"	"unprognostic (6.70e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.43e-3)"	"unprognostic (3.86e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.23e-5)"	1.8	2.9	4.6	1.5	5.4	0.5	3.3	5.5	4.8	3.3	4.2	3.1	1.7	3.4	3.3	3.1	4.6	1.8	2.9	4.1	4.6	3.3	0.8	2.1	2.7	6.4	4.6	5.1	2.8	5.3	5.5	2.7	4.9	3.3	2.0	5.0	2.3	2.5	2.0	3.5	2.7	2.3	4.7	3.1	2.4	9.0	5.1	2.8	4.0	2.0	3.3	3.0	3.1	6.5	5.1	5.3	8.0	8.4	4.3	4.9	5.6	3.7	3.6	3.3	5.9	8.0	2.8	7.1	5.2	3.9	4.4	2.4	7.9	2.8	5.0	3.7	8.1	3.5	4.6	4.4	3.5	0.1	2.1	3.2	5.3	4.1	3.8	4.8	1.7	4.7	7.3	0.0	3.7	4.4	7.1	3.9	9.4	3.6	2.1	3.2	12.3	1.9	3.5	6.6	2.3	7.0	0.2	2.1	0.6	5.8	5.7	0.6	0.4	2.4	1.7	2.9	4.2	6.9	8.0	9.8	0.0	0.0	3.2	0.0	0.2	1.6	1.3	0.2	0.9	3.0	2.2	2.8	0.8	2.0	1.9	2.3	0.0	2.4	0.3	1.6	0.8	0.8	4.6	5.4	5.5	4.8	4.1	4.6	6.4	4.6	4.9	4.7	5.1	6.5	1.3	3.2	0.5	4.9	3.0	1.3	0.8	1.5	2.8	2.7	2.1	2.5	4.1	2.8	1.9	1.8	2.1	2.5	1.1	1.2	0.0	1.7	33.0	3.2	1.5	1.3	0.0	0.4	5.5	1.2	2.3	1.6	2.6	1.6	0.0	3.2	1.8	0.2	1.4	1.7	7.1	1.9	0.0	0.6	0.4	26.7	0.9	0.7	3.6	1.0	0.6	1.2	2.1	3.0	10.6	0.7	0.5	1.9	0.6	1.2	1.0	1.2	7.2	1.5	0.0	1.1	13.9	5.4	5.2	2.9	1.1	0.8	1.4	1.6	1.5	0.9
ZNF608	"DKFZp434M098, KIAA1281, NY-REN-36"	ENSG00000168916	"Zinc finger protein 608"	Q9ULD9	5	124636913-124748807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 105.4;Inhibitory neurons: 141.2;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 209.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.5;naive B-cell: 1.6"	"Group enriched"	"Detected in many"	4	"B-cells: 1.6;granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"AF22: 61.0;AN3-CA: 39.2;REH: 110.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005545, HPA076984"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Mitochondria	"HPA005545: AB_1080742, HPA076984: "	"unprognostic (3.82e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (3.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.56e-2)"	6.1	9.9	10.4	4.2	14.0	1.4	6.7	12.1	10.4	7.4	4.1	5.6	11.1	4.8	2.7	3.5	9.1	6.9	9.0	11.7	12.8	5.3	2.7	10.7	8.0	14.7	12.4	6.3	8.4	3.7	4.4	3.1	12.4	5.6	7.2	23.6	5.7	4.5	6.4	3.3	6.6	4.2	9.2	2.8	6.7	9.4	12.4	4.8	9.2	3.2	8.0	3.1	4.4	17.1	0.2	1.1	61.0	39.2	8.9	14.5	0.0	0.0	1.6	0.3	3.6	6.6	18.6	20.8	20.2	0.0	9.8	0.8	4.2	3.9	0.3	0.0	9.9	0.0	0.1	0.3	13.7	0.0	1.9	14.6	11.0	1.9	1.7	9.1	13.2	0.1	2.0	0.4	3.3	0.1	0.0	0.0	25.9	0.5	0.8	110.6	5.4	0.1	8.7	0.9	9.2	32.0	0.0	0.7	14.1	34.5	3.5	1.8	3.5	12.3	22.9	0.3	3.9	9.7	10.2	36.9	3.1	0.6	17.7	2.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	10.4	14.0	12.1	10.4	11.7	12.8	14.7	12.4	12.4	9.2	12.4	17.1	25.2	32.1	35.3	105.4	7.4	1.3	10.4	5.5	31.3	35.8	8.6	7.7	20.1	18.6	36.2	14.7	39.6	0.8	1.5	13.0	3.9	16.7	16.9	30.6	3.0	23.4	40.0	1.3	17.0	8.7	3.8	9.9	11.7	16.8	0.0	7.3	11.4	2.0	0.8	42.1	141.2	6.1	4.1	0.3	2.2	8.8	2.1	1.3	7.2	28.1	2.1	31.2	0.0	219.2	209.9	6.2	7.3	1.5	3.7	3.5	8.1	8.4	13.2	36.7	0.0	13.2	7.7	19.2	7.2	11.8	0.9	0.4	1.5	19.1	9.8	2.5
ZNF609	KIAA0295	ENSG00000180357	"Zinc finger protein 609"	O15014	15	64460742-64686068	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 123.4;Cone photoreceptor cells: 141.8;Excitatory neurons: 142.1;Microglial cells: 139.6;Oligodendrocytes: 208.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040742, HPA040832"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA040742: AB_10963581, HPA040832: AB_10960400"	"unprognostic (2.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	9.5	8.3	11.3	8.3	10.1	5.5	8.5	13.0	9.6	11.3	8.8	12.0	8.7	12.0	4.5	7.8	11.9	7.2	8.1	11.2	12.6	6.7	7.1	10.9	8.7	10.6	10.4	20.5	7.2	14.1	8.4	11.9	7.4	10.3	7.8	20.5	9.7	9.5	7.2	9.6	8.7	11.1	8.3	9.8	8.2	22.0	10.1	18.0	9.0	9.9	8.3	11.3	10.8	12.1	11.1	27.6	29.1	11.2	11.0	13.8	9.9	14.2	18.8	17.5	17.5	17.1	17.2	19.0	11.7	16.9	23.9	23.2	43.1	19.6	18.2	22.2	9.2	34.7	16.0	8.4	20.2	20.2	22.3	14.1	17.6	18.3	35.8	25.3	32.8	15.9	55.6	12.0	14.5	10.1	15.7	8.5	22.1	14.8	7.7	14.3	26.5	10.0	12.7	19.7	23.6	18.0	19.5	21.9	13.1	27.7	10.9	14.0	33.0	16.2	25.8	8.4	17.9	13.3	16.1	16.6	10.1	21.6	13.4	1.3	0.4	0.6	0.5	0.1	0.3	0.2	0.3	0.4	0.1	0.2	0.8	0.8	0.5	1.1	0.2	0.5	0.2	0.2	11.3	10.1	13.0	9.6	11.2	12.6	10.6	10.4	7.4	8.3	10.1	12.1	14.6	12.8	25.4	123.4	8.8	18.0	16.2	10.5	8.0	35.8	12.6	11.8	20.1	24.3	20.3	18.4	141.8	19.1	13.9	12.2	3.9	13.8	22.6	42.2	21.9	18.4	18.6	11.1	142.1	14.6	14.7	13.6	13.7	16.1	10.1	19.4	18.9	14.6	10.0	45.4	116.5	11.9	4.1	30.5	18.3	12.7	18.0	16.4	14.2	139.6	19.1	17.3	19.6	108.6	208.0	13.2	13.5	13.9	10.5	22.9	9.9	3.9	33.8	54.9	19.7	14.4	16.9	48.3	17.0	9.3	17.3	31.2	17.0	20.8	11.2	20.1
ZNF610	FLJ36040	ENSG00000167554	"Zinc finger protein 610"	Q8N9Z0	19	52336243-52367778	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.6;Late spermatids: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.0"									"HPA055771, HPA078134"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA055771: AB_2682914, HPA078134: AB_2732372"	"unprognostic (1.13e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.73e-3)"	1.2	2.7	4.9	0.8	5.5	0.3	3.2	5.6	7.4	3.8	4.6	1.7	0.7	2.9	6.7	1.1	4.3	2.6	2.6	4.9	5.9	3.6	0.4	1.9	1.5	5.3	6.2	8.2	1.4	4.0	2.4	2.7	5.9	4.5	1.5	6.2	1.2	2.6	1.1	0.7	0.9	2.5	5.0	2.4	1.5	12.1	5.5	3.1	4.6	1.5	1.1	1.8	1.2	5.9	0.1	0.0	5.0	4.2	3.5	2.8	4.2	1.5	3.5	0.9	3.0	0.0	0.3	0.4	3.1	0.7	6.6	0.1	0.0	0.0	2.1	0.1	2.3	0.1	0.3	0.2	5.1	0.0	1.0	3.8	0.1	0.9	0.2	2.5	3.0	2.8	0.2	0.1	5.0	1.0	2.9	0.8	5.7	0.0	0.3	1.9	3.9	0.5	2.3	3.7	6.4	3.9	0.0	0.3	1.6	7.4	3.0	2.3	2.3	0.2	1.5	0.0	2.0	0.1	11.0	0.0	0.0	0.1	2.0	1.7	0.2	0.5	1.1	0.0	1.7	1.0	0.9	0.8	0.5	1.1	1.6	0.7	0.4	1.2	0.0	0.6	1.3	0.7	4.9	5.5	5.6	7.4	4.9	5.9	5.3	6.2	5.9	5.0	5.5	5.9	0.9	0.0	0.5	4.2	0.5	0.0	0.6	0.5	1.2	3.1	1.3	1.8	3.1	2.8	2.1	3.7	4.2	1.3	0.3	0.2	5.9	1.9	35.6	3.0	1.0	1.5	0.0	1.7	3.8	0.0	1.6	1.2	0.5	1.7	2.5	4.4	0.7	0.0	0.6	0.0	5.5	0.3	0.0	0.3	0.0	10.0	0.9	0.2	1.8	0.0	0.0	4.3	0.0	5.5	7.5	0.2	0.1	1.2	0.1	0.7	0.3	0.8	2.3	2.5	6.6	0.4	1.2	5.7	3.6	0.1	0.3	0.7	0.6	1.6	0.5	0.5
ZNF613	FLJ13590	ENSG00000176024	"Zinc finger protein 613"	Q6PF04	19	51927147-51948759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 19.4"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 10.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA026833	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA026833: AB_1859377"	"unprognostic (1.10e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.78e-3)"	"prognostic favorable (1.92e-6)"	3.2	3.2	3.4	2.6	3.8	1.4	7.0	4.6	4.2	3.1	3.2	5.2	2.2	3.5	3.8	3.4	3.2	2.8	3.5	3.5	5.1	4.9	2.9	3.8	4.2	4.0	4.2	3.8	2.5	6.0	3.2	6.6	3.9	19.4	5.0	7.2	2.9	4.0	2.7	3.6	2.9	4.1	3.5	4.3	2.8	2.8	4.0	5.6	4.3	3.5	4.2	3.6	2.8	4.2	2.9	3.8	6.2	6.3	5.5	5.7	1.5	5.0	7.8	6.4	8.1	1.3	3.5	2.7	2.6	6.1	5.8	3.2	6.3	6.1	6.9	0.1	8.2	5.4	2.8	3.7	5.5	0.3	7.2	4.6	7.1	6.2	5.0	7.7	7.1	6.2	2.5	0.0	6.6	0.5	8.9	4.1	4.5	1.3	5.9	4.7	7.0	2.8	6.5	9.9	4.2	4.0	8.0	5.8	4.6	9.8	6.3	6.4	4.6	2.7	5.3	2.2	5.3	5.5	0.0	4.9	0.1	0.0	8.5	5.7	5.2	10.5	7.1	5.3	6.5	6.0	7.4	8.3	7.0	9.0	7.6	9.9	5.4	7.7	9.4	3.5	7.7	5.4	3.4	3.8	4.6	4.2	3.5	5.1	4.0	4.2	3.9	3.5	4.0	4.2	2.0	3.2	2.6	2.0	0.9	0.5	0.6	0.8	0.6	2.4	1.6	1.0	4.6	1.5	2.7	3.7	0.0	6.1	1.5	1.9	3.9	2.5	2.3	1.2	1.2	3.0	1.2	0.0	2.4	2.2	1.7	1.2	1.5	1.6	1.3	4.9	3.3	1.5	3.2	0.0	2.0	3.7	6.1	1.6	1.5	1.2	1.2	1.2	0.0	4.7	3.0	2.3	3.1	4.5	4.6	1.8	2.1	1.5	0.5	1.6	1.0	1.4	0.5	4.0	0.0	1.6	1.5	1.9	2.1	1.5	0.6	7.1	1.4	2.3	2.1	0.7
ZNF614	FLJ21941	ENSG00000142556	"Zinc finger protein 614"	Q8N883	19	52012765-52030240	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Late spermatids: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA021197	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021197: AB_1859380"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.15e-3)"	4.1	3.6	4.0	3.3	4.6	6.3	5.6	8.2	5.3	4.2	2.4	3.0	2.5	5.3	3.9	3.4	4.2	3.3	4.0	3.7	4.8	3.8	2.3	3.5	4.3	4.5	4.6	7.5	1.8	5.0	3.3	6.9	4.3	8.9	3.0	8.7	3.0	4.7	4.0	4.3	2.9	4.9	4.1	4.5	3.2	6.9	5.2	5.9	8.0	5.0	4.4	3.9	2.1	6.4	4.8	3.5	8.8	11.5	6.2	6.9	1.1	6.4	4.5	5.8	7.0	4.4	2.7	12.1	3.4	5.5	5.4	2.0	13.3	8.5	8.6	3.2	18.8	18.2	6.6	9.0	5.1	3.8	8.8	5.4	4.6	5.9	8.2	5.8	6.9	10.5	9.9	2.6	7.9	1.9	16.0	7.6	10.2	0.7	6.3	10.5	17.0	10.0	6.0	12.0	11.6	7.1	3.8	4.7	3.9	10.8	6.3	9.6	7.1	5.7	7.9	3.2	7.6	5.2	8.7	18.3	5.5	5.2	7.6	2.3	2.4	1.6	3.2	3.2	3.9	3.0	2.9	3.1	3.0	2.8	4.1	2.6	1.7	5.7	2.8	1.7	3.2	1.8	4.0	4.6	8.2	5.3	3.7	4.8	4.5	4.6	4.3	4.1	5.2	6.4	5.2	0.0	2.2	3.6	4.8	3.2	5.3	2.4	4.6	6.8	4.2	4.2	5.8	4.3	4.9	5.5	4.2	6.1	6.5	1.7	0.0	2.9	47.9	2.8	6.1	5.8	5.4	7.4	6.6	0.9	7.1	3.7	5.6	3.7	7.0	5.0	8.2	1.6	2.3	16.8	6.7	2.4	2.0	4.1	2.3	34.9	4.1	3.2	1.8	4.7	2.2	5.1	10.3	6.0	9.2	1.4	0.7	7.2	5.4	4.6	1.8	2.0	0.9	5.6	0.0	7.1	5.7	2.2	5.0	4.4	2.7	14.4	4.1	2.7	2.2	5.1
ZNF618	"KIAA1952, NEDD10"	ENSG00000157657	"Zinc finger protein 618"	Q5T7W0	9	113876282-114056591	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 33.0;REH: 31.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023116, HPA061732"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA023116: AB_10964204, HPA061732: AB_2684596"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.22e-7)"	"unprognostic (4.57e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.51e-2)"	3.3	4.6	2.5	2.1	2.4	2.7	3.7	4.5	2.3	5.8	4.5	1.8	2.2	6.4	2.9	2.3	5.4	4.0	2.0	1.8	3.1	7.3	5.5	3.5	1.2	3.4	2.9	9.6	5.5	6.9	3.9	2.1	2.9	3.0	1.6	1.9	3.4	2.8	2.3	2.2	1.6	4.5	2.1	3.9	4.2	2.5	3.7	3.5	5.4	1.8	1.1	2.0	2.6	2.1	7.4	22.5	33.0	14.4	7.8	9.1	1.6	4.8	7.9	9.5	8.4	0.2	5.2	4.1	4.5	8.4	2.7	0.2	16.6	8.3	3.7	0.1	6.6	0.0	1.7	0.1	5.8	4.4	7.4	8.8	3.3	10.1	2.2	8.6	24.2	0.5	0.0	0.0	4.3	12.1	0.2	5.6	16.4	0.6	4.9	31.8	19.2	0.1	10.2	8.1	10.2	24.2	13.7	8.7	8.7	9.4	0.7	8.9	19.8	12.6	9.9	7.1	5.9	0.0	0.0	0.0	0.9	6.6	9.0	1.6	0.4	0.2	0.3	0.2	0.1	0.0	0.0	0.3	1.4	0.5	0.2	0.2	0.0	1.1	0.3	1.7	0.0	0.4	2.5	2.4	4.5	2.3	1.8	3.1	3.4	2.9	2.9	2.1	3.7	2.1	9.1	3.2	13.2	4.9	2.1	2.0	4.8	3.7	12.0	14.9	12.6	17.1	2.7	24.3	4.2	11.0	4.2	0.2	3.1	0.5	7.9	16.0	7.6	7.4	22.8	10.0	2.4	7.6	14.6	8.2	0.1	12.7	10.7	12.2	21.0	26.9	11.0	10.9	3.4	58.9	30.6	2.1	2.0	5.4	8.5	4.8	15.2	7.2	0.0	38.4	12.1	10.1	4.1	24.1	8.7	9.7	1.9	15.4	0.4	1.8	0.1	10.8	2.3	1.6	26.3	10.1	19.2	0.4	11.4	3.6	3.7	0.3	2.0	40.0	2.8	1.9
ZNF619	FLJ90764	ENSG00000177873	"Zinc finger protein 619"	Q8N2I2	3	40477113-40491053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045094	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA045094: AB_10959900"	"unprognostic (7.16e-2)"	"unprognostic (5.94e-1)"	"unprognostic (8.38e-3)"	"unprognostic (5.42e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-3)"	"unprognostic (8.28e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.38e-2)"	1.7	1.6	2.3	2.0	3.5	3.1	2.9	3.0	2.8	2.0	2.5	2.0	2.3	2.0	2.1	1.4	2.5	1.3	1.8	2.2	2.6	2.2	2.4	2.0	2.4	3.0	3.0	2.6	2.5	3.1	1.2	2.0	3.0	2.1	2.6	4.1	2.7	2.2	2.5	2.4	2.0	2.3	2.2	2.9	2.4	1.1	3.0	1.5	3.0	2.2	2.9	1.7	1.5	4.6	1.9	2.5	2.9	2.8	4.5	4.3	1.3	2.7	3.1	4.5	3.9	0.9	2.6	0.2	1.4	2.2	2.2	2.1	3.2	5.0	4.8	3.6	1.1	6.1	2.2	1.4	4.6	4.2	5.0	3.4	3.9	4.7	6.6	3.9	3.8	0.2	3.9	2.9	2.9	2.3	0.1	2.1	1.6	2.2	2.8	1.2	3.0	3.3	2.1	4.2	2.1	2.2	2.4	4.1	2.0	2.9	3.4	2.7	3.6	3.3	2.7	2.0	2.8	1.6	2.2	0.2	2.1	2.6	3.7	0.8	0.7	1.1	0.7	0.9	0.7	0.7	0.6	0.8	1.0	0.8	0.6	0.9	0.8	1.3	1.0	0.6	1.2	0.7	2.3	3.5	3.0	2.8	2.2	2.6	3.0	3.0	3.0	2.2	3.0	4.6	1.5	0.0	1.1	1.0	2.3	0.3	0.8	0.6	1.2	3.6	1.0	1.0	1.3	0.0	0.3	3.7	2.1	1.4	1.0	0.7	0.0	1.4	0.1	1.4	1.6	1.6	0.0	2.1	0.5	1.5	0.9	1.2	1.5	1.1	0.0	2.4	1.8	0.9	1.1	0.0	1.0	1.3	0.0	1.6	0.4	0.0	1.2	1.2	0.0	2.8	1.6	2.5	2.1	1.0	2.3	0.6	0.2	0.4	1.7	0.5	1.6	1.3	1.0	3.6	0.0	2.0	1.1	1.2	1.4	1.7	0.1	0.4	1.5	2.5	0.8	0.6
ZNF622	"MGC17552, MGC2485, ZPR9"	ENSG00000173545	"Zinc finger protein 622"	Q969S3	5	16451519-16465800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036514, HPA036515"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli, Golgi apparatus"	"HPA036514: AB_2675167, HPA036515: AB_10672224"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	19.5	13.5	20.3	13.8	21.4	36.0	18.4	17.2	21.8	16.7	14.4	21.5	16.9	17.8	17.2	17.9	15.3	12.1	56.9	18.1	19.6	14.6	22.0	16.6	17.8	18.7	20.7	15.6	54.3	15.6	15.1	16.9	20.3	15.5	20.7	10.8	18.3	12.7	41.7	25.6	20.3	12.5	19.1	15.5	22.4	20.5	19.4	16.0	15.5	25.2	15.7	17.5	17.0	22.1	25.7	55.2	16.9	35.2	40.4	34.3	61.4	45.2	33.9	36.0	45.6	66.0	23.2	30.0	59.6	36.0	48.4	33.3	27.5	35.3	28.9	40.6	37.3	27.4	92.8	47.7	58.1	53.8	31.5	53.3	43.7	33.6	31.5	28.0	25.6	17.6	37.6	28.9	40.1	43.2	28.4	52.3	30.0	24.2	53.8	22.1	20.6	25.8	33.6	38.0	23.4	26.2	63.1	46.8	78.2	29.4	26.0	41.1	35.3	40.0	30.5	39.3	29.1	41.3	39.7	41.9	34.9	45.8	28.5	89.3	65.6	88.6	73.8	71.3	77.8	85.4	73.7	82.0	73.3	81.9	84.2	70.3	87.9	67.9	79.6	59.2	85.0	82.6	20.3	21.4	17.2	21.8	18.1	19.6	18.7	20.7	20.3	19.1	19.4	22.1	14.8	22.4	24.2	2.9	33.2	60.7	43.1	48.6	34.1	22.8	19.8	16.4	73.8	24.3	34.4	14.7	10.4	64.0	39.5	77.5	27.4	55.2	111.5	35.0	36.8	22.3	98.7	20.0	7.6	66.7	57.2	34.1	31.1	71.3	52.0	13.3	15.0	25.1	50.0	16.8	7.9	60.6	48.8	19.3	35.1	62.8	18.0	29.7	33.8	4.7	43.3	22.6	37.0	6.6	9.0	51.2	127.1	19.9	26.6	28.3	84.5	39.2	29.7	19.3	19.7	31.7	46.9	63.2	37.8	21.8	43.2	40.6	41.6	20.5	55.5	33.5
ZNF623	KIAA0628	ENSG00000183309	"Zinc finger protein 623"	O75123	8	143636019-143656418	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"PC-3: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044372	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044372: AB_10966790"	"unprognostic (1.06e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.03e-2)"	5.8	5.0	2.5	1.8	2.3	0.6	5.5	1.8	3.0	7.4	1.2	7.4	2.3	7.0	1.7	6.2	6.6	1.5	6.0	2.6	2.7	5.2	5.7	5.2	2.3	2.2	2.1	8.5	5.4	2.8	5.9	1.8	2.5	5.9	2.0	1.7	6.0	1.3	7.2	7.8	6.4	2.1	1.5	6.8	5.4	7.2	2.7	2.1	5.2	1.8	1.9	7.6	6.5	2.3	3.0	6.9	2.6	2.5	4.1	8.0	2.5	2.9	3.8	4.7	3.3	2.4	2.5	1.8	3.6	6.5	3.2	1.9	3.0	1.9	3.7	5.1	2.3	7.5	7.3	2.2	3.2	1.7	2.1	3.3	3.8	2.0	8.7	5.1	3.3	4.9	6.1	3.3	3.4	6.6	5.8	2.4	3.4	3.7	18.3	4.0	2.3	2.8	2.6	4.0	6.4	6.2	11.9	2.4	4.0	2.6	5.4	5.2	1.5	4.4	1.5	1.8	2.4	1.9	2.3	2.8	3.2	2.8	3.6	1.1	0.2	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.4	0.2	0.5	0.5	0.4	0.2	2.5	2.3	1.8	3.0	2.6	2.7	2.2	2.1	2.5	1.5	2.7	2.3	4.6	6.4	3.9	3.9	5.8	1.7	3.1	1.6	7.4	5.9	4.4	4.2	10.3	7.2	1.5	7.3	6.2	5.9	4.7	5.8	3.9	5.9	5.4	3.0	8.1	5.8	5.4	9.9	7.5	3.8	6.0	5.6	4.6	5.0	1.3	9.2	7.1	6.6	5.8	15.2	5.3	5.3	2.0	6.6	2.4	4.5	8.4	4.6	3.6	4.7	8.3	7.2	7.2	5.5	5.4	4.4	2.3	13.9	2.8	4.5	5.4	3.9	1.3	7.0	19.7	8.2	5.1	10.8	13.9	6.2	2.6	4.8	5.8	5.8	5.2	1.7
ZNF625		ENSG00000257591	"Zinc finger protein 625"	Q96I27	19	12142090-12156734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 10.4;Rod photoreceptor cells: 9.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA074014			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria	Nucleoplasm	"HPA074014: AB_2686652"	"unprognostic (7.88e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.62e-1)"	1.2	2.2	2.2	0.8	2.1	1.2	2.4	5.0	6.3	2.2	1.8	2.1	0.8	2.2	2.9	1.3	2.0	0.9	1.9	2.1	3.0	4.0	1.0	1.4	1.2	2.4	2.4	2.1	1.8	1.4	3.5	1.7	2.4	2.8	0.8	8.8	1.8	1.5	0.5	2.1	1.4	1.6	2.4	2.4	1.4	1.6	3.2	0.9	2.8	0.8	1.1	2.1	1.6	2.6	0.7	0.0	5.5	8.7	2.2	1.5	0.9	2.2	2.8	3.2	3.6	0.1	0.1	0.0	4.1	1.6	2.3	0.4	0.0	2.9	2.9	0.0	1.6	2.7	0.0	2.6	0.9	0.1	3.5	1.1	1.2	3.1	1.1	2.3	2.7	0.2	0.0	0.0	4.9	1.9	0.0	1.2	6.6	0.0	1.8	0.2	4.5	0.0	2.7	7.5	3.5	2.4	0.0	0.1	2.0	6.4	3.6	0.2	1.6	7.3	3.5	5.9	3.1	6.1	5.1	0.0	2.0	0.0	2.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.4	0.1	2.2	2.1	5.0	6.3	2.1	3.0	2.4	2.4	2.4	2.4	3.2	2.6	2.1	3.2	1.5	0.0	0.5	0.4	0.5	1.0	1.2	5.0	2.0	2.2	0.1	2.8	0.4	1.8	10.4	4.1	0.5	0.5	3.9	3.4	0.1	1.9	3.5	2.5	1.2	0.0	0.0	3.1	3.9	1.3	0.0	1.5	0.0	4.9	6.4	0.8	1.5	5.0	0.0	0.6	2.0	4.1	2.0	1.3	0.6	0.5	0.0	0.0	1.7	5.1	7.2	0.0	0.0	3.6	1.9	1.5	1.6	0.7	0.3	2.7	2.5	9.5	0.0	1.8	1.7	2.9	6.6	0.3	0.9	1.2	0.4	2.0	1.0	0.3
ZNF626		ENSG00000188171	"Zinc finger protein 626"	Q68DY1	19	20619939-20661596	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 19.8"									HPA045631	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA045631: AB_2679397"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.31e-1)"	7.4	8.9	3.0	5.4	4.7	3.8	16.1	4.8	4.5	8.4	4.8	3.7	1.6	11.2	7.8	6.3	12.2	9.3	10.0	3.0	3.8	11.0	5.7	5.2	12.2	2.5	3.4	25.9	7.2	21.4	3.6	7.3	2.7	11.0	3.2	7.5	7.0	9.7	4.6	9.3	2.4	9.4	3.1	7.0	8.0	5.0	3.8	8.6	23.7	5.9	9.7	14.8	4.1	5.8	0.1	0.0	5.9	0.4	6.8	8.7	0.3	6.5	0.6	9.1	7.9	0.1	0.1	0.5	3.0	8.3	10.7	1.1	0.0	0.2	11.6	0.1	0.2	0.0	0.2	2.3	12.1	0.1	0.0	16.6	2.6	5.5	2.8	0.1	4.3	0.1	4.1	0.6	9.6	0.1	0.4	1.1	12.0	0.0	2.9	5.7	4.1	2.1	8.4	6.4	1.6	10.6	0.1	0.7	6.0	10.6	13.7	0.1	0.1	4.2	0.2	16.4	0.5	9.0	19.8	8.6	0.1	0.1	0.5	0.9	1.1	6.3	7.2	1.1	6.8	8.4	7.6	8.2	3.2	10.5	7.0	6.3	11.2	9.8	4.8	4.2	3.8	3.8	3.0	4.7	4.8	4.5	3.0	3.8	2.5	3.4	2.7	3.1	3.8	5.8	14.0	3.2	8.2	26.4	18.5	9.4	13.7	4.2	10.2	11.1	18.2	18.8	9.8	12.8	6.7	27.6	10.4	17.5	11.1	1.4	31.3	8.7	1.3	19.3	15.0	11.6	2.4	1.7	29.3	9.5	24.9	13.9	6.1	20.8	7.0	19.7	17.2	7.4	11.0	13.5	27.6	1.3	6.1	4.7	9.8	1.7	18.6	5.1	5.4	15.9	2.9	16.2	19.6	37.7	43.0	9.1	0.4	15.4	3.9	17.2	0.1	30.8	12.3	9.5	13.1	11.4	11.9	10.1	16.2	6.1	12.6	43.4	12.3	39.8	0.8	15.5
ZNF627	FLJ90365	ENSG00000198551	"Zinc finger protein 627"	Q7L945	19	11559374-11619161	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA049770, HPA073463"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"HPA049770: AB_2680871, HPA073463: AB_2686606"	"unprognostic (1.81e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.89e-3)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-1)"	"unprognostic (6.39e-3)"	5.6	4.1	5.7	4.3	5.9	7.6	11.1	7.4	6.8	8.3	6.0	5.9	5.7	10.6	8.7	4.6	12.2	5.0	5.2	5.6	5.9	9.6	7.1	6.1	6.8	6.1	6.0	13.1	7.5	8.9	5.8	6.3	5.9	8.0	6.8	8.3	5.9	6.5	4.0	5.5	5.0	6.2	6.2	6.6	6.0	8.0	6.3	9.3	13.1	5.6	5.6	6.4	5.6	7.9	6.0	5.2	15.0	18.8	6.7	6.9	8.5	8.4	10.0	9.5	9.5	3.9	4.0	4.6	8.4	6.6	4.8	5.1	6.0	8.2	10.5	8.3	2.8	12.8	2.8	7.6	12.5	6.9	6.9	8.4	11.6	6.2	14.3	14.5	10.6	10.9	11.9	6.0	12.5	12.3	11.3	6.9	11.3	4.0	10.4	12.6	11.3	6.3	10.8	9.2	20.8	15.5	11.5	6.1	12.6	12.7	11.1	19.6	9.2	10.0	4.8	6.2	5.9	8.6	9.0	4.8	4.6	11.3	8.4	14.2	4.5	7.4	4.6	4.9	5.3	9.0	5.6	5.8	7.2	5.8	7.4	6.7	2.4	7.3	4.8	2.7	3.2	4.2	5.7	5.9	7.4	6.8	5.6	5.9	6.1	6.0	5.9	6.2	6.3	7.9	2.9	12.8	5.9	6.2	11.2	1.3	3.4	4.0	6.2	4.5	6.2	5.8	15.0	7.2	3.1	9.2	4.2	5.2	5.4	3.7	17.6	5.4	7.9	7.0	4.9	4.3	5.3	8.0	4.5	2.6	4.3	4.3	10.2	3.7	1.3	6.1	6.1	6.1	3.2	6.7	4.8	3.2	10.2	4.4	4.4	4.0	5.3	3.1	0.0	3.7	3.2	4.9	3.1	6.6	7.3	4.1	3.1	5.3	6.7	4.9	3.5	7.3	11.6	5.8	0.0	3.1	4.7	15.5	4.4	3.6	2.7	4.7	4.8	3.1	4.3	3.3
ZNF628	"ZEC, Zfp628"	ENSG00000197483	"Zinc finger protein 628"	Q5EBL2	19	55476617-55484487	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 35.4;Late spermatids: 119.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044451	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA044451: AB_10962507"	"unprognostic (8.70e-2)"	"unprognostic (5.08e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.58e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.49e-2)"	"unprognostic (4.88e-3)"	4.8	4.6	1.1	1.6	0.8	3.1	5.0	0.5	1.9	4.8	0.1	6.3	2.2	6.5	0.4	5.0	5.1	0.4	4.9	1.4	0.2	4.2	4.7	4.5	1.1	0.8	0.3	5.2	4.8	0.7	5.4	0.7	0.2	5.2	0.3	0.2	4.9	1.0	13.8	8.2	4.7	0.7	0.0	5.3	4.9	23.1	0.5	0.7	4.8	0.7	0.3	5.2	4.5	0.7	7.0	4.3	1.0	2.9	0.5	1.2	7.9	4.7	0.9	1.6	1.3	2.7	3.0	6.4	4.4	0.9	1.3	4.0	0.5	2.6	0.2	6.6	16.7	4.5	4.1	2.4	1.8	3.6	11.3	1.0	1.8	1.2	0.7	0.8	1.2	3.8	6.8	3.5	0.6	4.5	5.0	2.5	4.4	2.1	8.7	9.5	1.4	6.3	1.4	4.3	5.1	5.6	3.6	4.0	6.1	0.3	4.0	5.5	2.7	3.0	4.3	2.9	4.9	7.9	7.4	4.8	3.8	2.6	2.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.1	0.8	0.5	1.9	1.4	0.2	0.8	0.3	0.2	0.0	0.5	0.7	3.0	0.0	1.1	0.7	8.3	5.0	7.6	2.5	12.0	4.7	5.9	2.7	2.2	5.7	1.8	3.7	4.2	3.2	3.7	9.4	9.8	2.6	35.4	6.5	3.5	3.9	7.2	6.1	0.7	3.6	3.5	2.8	5.1	9.1	13.4	3.9	3.6	3.3	3.1	5.0	0.7	5.7	2.0	3.8	3.1	119.7	5.6	4.2	3.6	0.0	2.5	4.4	5.2	1.0	0.7	4.9	4.1	4.5	5.7	4.1	4.5	3.3	2.0	2.6	13.1	4.6	3.4	8.9	5.5	6.4	4.5	5.5	5.8	3.6	6.7	5.2
ZNF629	"KIAA0326, ZNF65"	ENSG00000102870	"Zinc finger protein 629"	Q9UEG4	16	30778456-30787205	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019550, HPA056051"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus"	"HPA019550: AB_1859386, HPA056051: AB_2683020"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (4.57e-10)"	"unprognostic (8.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.70e-2)"	5.6	9.0	5.6	3.0	6.0	4.1	5.7	7.1	5.9	6.5	4.3	6.8	5.5	8.0	4.3	5.1	6.6	3.6	12.6	5.9	6.1	7.8	4.3	5.3	1.9	6.2	6.7	6.8	5.9	15.0	6.6	3.6	5.6	6.3	4.5	7.8	6.5	6.0	9.7	8.6	5.3	6.8	5.0	4.0	7.3	4.1	7.0	3.9	5.9	9.6	2.3	6.5	5.1	5.5	9.8	15.8	23.9	18.5	11.5	10.6	3.6	10.8	15.6	16.6	14.0	9.7	8.8	1.8	10.2	17.6	5.2	11.4	11.7	14.3	11.0	0.4	17.6	13.6	14.0	10.2	12.3	4.8	8.0	17.7	10.5	10.3	8.6	13.0	8.9	0.8	20.2	0.4	14.6	20.8	7.2	6.3	12.6	4.7	6.4	24.3	18.4	0.8	13.9	15.9	22.6	25.3	10.5	19.4	2.6	7.8	14.6	17.4	10.8	15.5	10.1	10.6	8.3	0.3	0.1	0.5	10.2	11.9	5.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.3	0.1	0.6	0.0	0.1	5.6	6.0	7.1	5.9	5.9	6.1	6.2	6.7	5.6	5.0	7.0	5.5	4.9	19.2	9.4	5.9	2.6	1.9	3.4	4.3	5.7	16.7	4.2	3.4	28.3	4.3	6.5	9.2	4.2	1.3	1.6	5.4	1.9	8.7	1.7	5.1	9.5	8.0	11.5	4.6	2.4	8.0	0.6	5.3	7.1	5.3	2.5	10.7	8.2	4.7	4.4	16.8	3.7	7.9	6.1	5.2	3.0	4.7	9.3	2.6	1.8	1.0	7.7	13.4	1.0	4.5	3.4	10.9	5.0	4.5	3.0	4.8	5.1	4.3	5.9	12.4	0.0	6.7	5.6	4.6	1.5	3.8	1.8	0.5	1.4	8.3	9.0	3.8
ZNF630	"BC037316, dJ54B20.2, FLJ20573, MGC138344"	ENSG00000221994	"Zinc finger protein 630"	Q2M218	X	47983356-48071658	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 5.0;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 5.3"					"Low region specificity"	"Detected in all"			"HPA001053, HPA068130"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA001053: AB_2666183, HPA068130: AB_2685961"	"unprognostic (1.03e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.86e-3)"	"unprognostic (5.83e-2)"	"unprognostic (9.06e-3)"	"unprognostic (8.68e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.51e-5)"	1.9	2.2	3.8	1.5	4.0	0.9	2.8	5.0	4.8	3.6	4.1	2.5	1.8	2.6	2.8	2.1	2.6	2.5	2.7	3.6	3.8	2.4	1.4	2.1	1.8	4.0	4.1	4.7	3.2	4.2	2.6	1.6	4.2	3.8	2.5	3.7	2.3	2.8	1.0	1.9	1.8	2.4	3.8	2.3	2.9	0.7	4.2	0.9	3.7	1.2	1.5	3.0	2.7	4.6	1.0	0.7	0.2	0.0	0.1	0.0	0.0	1.4	0.5	1.1	0.6	2.3	4.0	0.1	0.8	1.4	1.6	1.8	0.0	0.8	0.9	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	1.0	4.0	2.3	0.0	2.6	0.7	0.0	0.0	4.2	2.5	4.3	0.0	0.0	1.5	3.5	1.2	0.5	1.0	0.0	1.7	2.2	2.3	1.8	5.3	3.7	1.4	3.2	4.3	0.9	1.3	0.0	1.8	1.8	0.0	0.0	3.7	0.0	0.0	0.1	3.3	2.3	0.8	2.0	0.8	0.3	0.9	1.0	0.7	0.7	1.5	0.6	0.9	1.0	0.9	0.7	0.3	0.4	0.5	0.9	3.8	4.0	5.0	4.8	3.6	3.8	4.0	4.1	4.2	3.8	4.2	4.6	0.8	0.0	0.0	2.6	1.4	0.1	1.0	0.8	3.4	2.5	1.6	1.3	1.6	0.0	0.8	1.8	0.0	0.1	0.4	0.9	1.9	1.4	0.0	1.2	1.9	1.2	4.2	0.8	2.2	1.1	0.9	1.4	1.1	1.3	0.0	4.0	1.8	0.3	0.9	0.0	2.6	1.6	0.0	0.0	0.0	0.2	0.3	0.7	0.0	1.0	1.3	0.7	0.0	5.0	3.2	1.0	0.6	0.4	1.0	0.9	1.1	0.7	0.5	1.0	6.6	1.4	1.4	0.2	0.4	1.7	0.3	0.3	1.1	4.0	1.0	0.8
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 342.3;Oligodendrocytes: 619.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: AB_2683426"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.73e-5)"	21.1	22.1	35.7	21.6	48.9	28.2	24.6	77.6	52.3	23.0	37.7	22.0	15.6	29.2	18.4	19.8	22.1	19.1	41.0	35.7	41.3	24.2	30.9	21.2	25.0	41.9	36.8	37.3	21.9	27.9	24.9	23.2	41.9	22.2	19.5	48.6	21.0	19.5	51.5	16.8	19.0	22.9	34.8	23.1	21.8	29.7	38.9	30.9	29.8	33.7	22.6	21.3	17.1	82.5	36.2	51.0	77.0	36.1	44.4	48.3	59.2	40.4	46.6	33.6	30.0	49.2	34.6	59.2	36.6	37.1	52.3	29.9	72.1	41.4	48.7	60.5	40.1	77.8	54.8	45.4	38.3	72.0	50.6	30.8	39.5	36.1	66.7	47.8	52.5	39.2	79.4	33.8	49.6	36.1	50.9	52.9	66.7	54.1	32.4	43.0	116.5	41.7	36.0	54.3	59.0	38.7	49.8	34.7	52.8	76.3	32.3	43.7	54.3	41.4	60.0	31.1	41.2	27.6	45.7	57.4	34.8	46.3	45.8	64.1	17.0	33.5	18.1	16.3	17.2	25.4	17.1	17.2	14.0	26.0	22.5	16.7	29.1	21.5	24.1	17.7	16.0	10.8	35.7	48.9	77.6	52.3	35.7	41.3	41.9	36.8	41.9	34.8	38.9	82.5	63.1	67.3	112.4	227.9	63.9	31.7	56.8	40.8	46.1	111.5	36.8	35.4	107.0	27.1	59.0	40.5	123.0	42.5	46.7	39.2	19.6	43.0	15.7	54.2	63.7	65.9	38.4	57.2	286.9	40.9	29.0	83.5	50.0	59.2	79.1	112.8	38.6	48.6	32.5	67.3	268.4	34.2	32.6	41.9	33.3	15.8	75.2	49.6	23.2	225.8	71.6	56.4	56.7	342.3	619.5	39.6	35.7	63.9	50.5	60.0	38.1	21.6	74.7	104.0	32.9	98.3	73.1	110.1	78.3	37.4	30.3	50.2	56.1	74.0	36.8	58.9
ZNF639	"ANC-2H01, ZASC1"	ENSG00000121864	"Zinc finger protein 639"	Q9UID6	3	179323031-179338583	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049023, HPA052163"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA049023: AB_2680603, HPA052163: AB_2681747"	"unprognostic (5.64e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (7.74e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	20.8	19.5	16.5	18.0	17.5	59.2	28.0	22.1	19.3	27.6	15.0	26.6	17.4	31.5	25.6	20.9	26.0	19.8	27.4	16.4	16.6	25.1	23.9	21.9	26.6	16.4	16.8	32.7	24.6	38.6	18.2	22.5	15.9	26.3	22.1	40.0	24.5	27.0	27.3	16.9	18.6	31.0	16.8	23.7	20.6	19.1	17.3	26.6	41.4	30.3	24.6	21.5	18.3	18.0	81.3	18.7	35.5	43.9	31.7	38.4	35.2	37.8	56.4	61.0	54.8	31.7	31.3	94.2	56.4	46.6	74.1	30.1	55.2	50.5	76.0	86.7	43.1	96.1	26.8	31.8	55.0	76.1	34.5	31.1	51.9	31.3	72.5	45.7	42.1	61.3	59.4	48.6	48.6	41.2	79.5	33.7	59.9	56.9	43.5	75.4	37.1	112.1	37.8	32.4	65.3	39.9	37.9	41.1	49.2	29.8	104.9	59.4	34.5	41.3	43.7	33.1	98.7	19.7	19.0	174.2	30.3	58.5	28.9	2.5	1.1	1.2	1.6	0.7	1.5	1.8	2.6	2.6	0.9	2.0	2.2	2.2	0.7	2.2	0.5	0.3	2.4	0.8	16.5	17.5	22.1	19.3	16.4	16.6	16.4	16.8	15.9	16.8	17.3	18.0	16.9	19.2	11.7	9.4	24.2	20.9	34.0	7.0	32.5	21.5	21.6	13.2	19.4	10.0	8.8	14.7	54.2	14.7	18.3	8.6	33.2	12.2	29.8	21.6	22.4	19.4	18.7	29.0	8.7	10.0	11.3	21.8	11.2	30.3	10.1	18.5	18.5	17.0	9.9	16.8	10.6	15.6	6.1	13.2	17.2	8.8	24.5	13.8	14.2	4.7	13.5	19.6	13.4	8.5	9.6	11.5	9.4	24.0	27.5	36.1	11.2	22.2	7.2	44.9	26.3	27.1	22.7	29.9	21.3	29.9	17.5	3.4	23.2	19.8	12.2	24.9
ZNF641	FLJ31295	ENSG00000167528	"Zinc finger protein 641"	Q96N77	12	48337180-48351414	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035189	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA035189: AB_10603333"	"unprognostic (1.79e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (7.82e-3)"	"prognostic favorable (3.91e-4)"	"prognostic favorable (8.30e-5)"	"unprognostic (3.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.85e-3)"	9.0	22.9	8.3	10.7	9.0	6.9	7.8	8.9	9.5	11.3	4.2	8.2	9.4	14.1	10.1	6.6	10.7	9.9	9.1	7.6	9.5	9.2	9.9	10.9	12.5	10.0	10.1	19.6	12.1	14.1	9.8	14.8	9.8	8.8	8.0	16.9	7.4	9.2	16.6	6.2	7.5	13.3	9.1	12.6	9.3	11.9	10.9	14.7	14.7	17.3	12.9	10.7	7.1	9.5	3.2	5.4	8.3	13.9	8.0	2.2	6.1	8.1	5.5	4.3	2.8	9.1	9.1	6.2	11.4	7.3	8.1	5.3	3.1	5.3	1.4	14.2	5.2	10.2	9.9	2.6	7.4	11.0	14.2	3.5	7.9	2.9	6.7	6.9	3.8	7.9	10.4	6.1	3.9	4.1	5.1	4.7	1.8	3.4	2.3	3.4	8.0	5.0	7.0	16.6	3.4	5.2	9.4	4.0	5.9	7.2	10.2	11.2	1.5	4.7	7.5	4.6	3.9	6.6	6.5	4.8	2.8	12.8	4.7	1.6	2.9	7.2	2.7	2.7	1.6	0.4	1.5	2.5	3.1	0.6	1.4	2.6	6.5	4.5	4.0	1.3	0.7	2.4	8.3	9.0	8.9	9.5	7.6	9.5	10.0	10.1	9.8	9.1	10.9	9.5	8.4	6.4	16.1	19.2	9.9	3.1	13.5	4.4	14.2	14.7	7.9	5.6	9.1	11.5	5.7	7.3	10.4	1.4	12.7	4.3	7.9	8.8	2.2	3.8	8.7	9.2	5.4	7.4	16.8	10.4	0.9	12.8	4.6	5.0	3.8	33.0	15.7	8.6	7.6	18.5	38.7	1.7	0.0	18.3	13.5	2.7	15.5	12.3	0.0	15.0	15.3	16.9	27.8	10.1	4.7	7.2	1.3	24.0	3.7	5.9	4.8	5.1	5.0	18.4	19.7	9.3	17.9	5.2	6.0	6.2	2.3	0.5	11.8	45.3	2.7	5.2
ZNF646	KIAA0296	ENSG00000167395	"Zinc finger protein 646"	O15015	16	31074422-31084196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.8;Spermatocytes: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042364, HPA066468"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042364: AB_10794796, HPA066468: AB_2732746"	"unprognostic (1.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.66e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.23e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	5.6	4.1	4.4	6.7	4.9	9.2	5.0	6.9	5.9	5.8	1.6	5.0	6.4	6.5	2.5	5.2	5.5	3.5	4.8	3.7	2.9	4.9	4.3	4.7	7.1	6.2	4.7	6.2	5.6	4.4	5.0	4.0	4.9	5.4	2.8	1.6	6.2	4.0	7.9	8.0	6.4	3.2	3.5	8.0	5.5	25.7	5.8	8.6	5.1	3.7	5.1	5.4	4.9	6.3	7.8	15.8	10.2	8.0	7.1	5.5	13.7	8.3	8.8	9.8	9.0	11.6	7.1	15.0	13.0	7.1	6.5	10.2	8.5	9.2	3.7	17.2	8.1	11.1	15.6	9.7	7.4	14.4	16.7	7.1	8.1	10.6	6.0	7.6	5.9	12.5	18.2	8.5	7.5	12.2	16.0	9.9	13.8	3.5	8.1	25.5	20.2	15.3	3.1	7.3	14.7	14.9	9.5	10.0	4.9	4.4	8.4	12.5	12.1	12.3	7.0	8.2	7.8	14.2	14.1	14.9	11.2	15.5	9.8	9.8	4.5	13.2	5.1	4.2	2.6	3.9	2.4	2.1	4.6	4.4	2.7	3.0	25.1	4.8	2.8	6.6	2.6	2.1	4.4	4.9	6.9	5.9	3.7	2.9	6.2	4.7	4.9	3.5	5.8	6.3	4.7	3.2	1.3	3.6	4.2	3.3	1.0	2.6	2.8	3.6	3.4	3.4	1.7	1.5	2.2	1.8	4.2	1.9	6.6	6.6	1.9	4.1	24.8	3.0	3.7	3.4	6.0	2.1	2.2	3.5	2.1	2.5	5.6	4.9	1.3	5.1	1.8	1.9	4.9	1.7	2.1	3.4	4.1	4.7	2.8	6.6	2.8	6.4	0.0	7.5	3.7	3.6	4.1	2.0	3.1	4.4	7.6	4.5	2.3	2.4	5.8	2.2	2.7	1.1	0.0	3.5	2.3	16.2	7.0	2.9	4.0	2.5	4.9	2.8	3.7	1.9
ZNF652	KIAA0924	ENSG00000198740	"Zinc finger protein 652"	Q9Y2D9	17	49289206-49362473	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 18.0"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044408	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044408: AB_2678932"	"unprognostic (1.33e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.30e-2)"	2.1	2.3	4.6	2.8	11.4	3.7	9.6	6.7	4.7	3.2	1.5	2.8	2.6	2.1	2.0	2.0	2.1	2.2	1.6	3.6	6.2	2.5	4.0	2.8	2.9	10.7	8.2	2.8	2.4	3.6	1.0	2.6	11.4	3.3	2.9	4.5	4.4	2.4	10.5	6.6	2.1	2.7	5.2	4.6	3.4	3.7	7.9	3.4	3.6	2.5	3.0	2.1	1.1	18.0	4.3	2.9	3.2	4.1	4.3	2.3	4.3	1.6	2.6	1.8	2.1	6.8	2.7	9.7	5.0	3.3	1.4	3.0	2.9	3.1	2.9	3.3	2.6	3.5	5.0	4.7	1.6	2.9	5.3	3.2	2.8	1.6	2.9	1.8	2.2	4.8	2.7	8.1	1.8	6.0	4.3	1.6	3.2	2.5	2.1	3.4	6.6	4.6	2.4	5.7	5.9	4.0	2.8	3.9	4.2	4.8	7.1	4.1	3.6	5.9	4.4	2.6	2.6	10.3	7.6	6.3	3.2	2.6	2.2	7.7	3.0	3.2	2.6	2.6	3.5	1.9	1.9	2.0	2.1	2.6	1.8	1.9	5.9	2.1	3.4	1.9	0.9	2.5	4.6	11.4	6.7	4.7	3.6	6.2	10.7	8.2	11.4	5.2	7.9	18.0	28.8	19.2	19.8	37.5	38.6	16.4	14.2	7.8	18.8	56.5	63.7	50.2	16.6	21.5	15.2	29.5	64.6	24.0	60.6	22.7	13.7	18.6	19.2	56.6	45.1	24.3	12.1	22.3	49.2	19.6	18.2	24.4	16.8	59.1	5.1	24.0	29.6	41.6	12.8	43.7	70.9	20.4	14.2	41.6	32.4	17.3	48.4	25.1	26.6	65.6	37.0	30.1	45.3	76.9	152.6	18.4	18.5	44.4	21.9	24.6	17.9	12.4	21.3	47.1	0.0	30.0	22.8	60.4	29.9	15.6	24.3	13.4	33.7	27.7	24.0	12.6
ZNF653	Zip67	ENSG00000161914	"Zinc finger protein 653"	Q96CK0	19	11483427-11505839	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.1;Late spermatids: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023631, HPA023635"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA023631: AB_2671269, HPA023635: AB_10603940"	"unprognostic (1.21e-1)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (8.37e-4)"	"prognostic favorable (4.15e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (8.74e-4)"	4.5	8.1	12.9	4.4	13.4	3.7	5.3	20.5	16.9	5.9	11.6	6.8	3.3	5.9	1.7	5.4	6.4	4.1	5.6	14.8	14.3	9.5	8.5	4.8	4.3	12.1	12.3	6.4	8.3	5.4	8.8	3.4	12.2	8.5	2.1	3.5	5.5	3.1	7.6	7.7	6.5	3.8	10.8	5.8	7.5	25.3	12.9	6.2	8.9	3.7	2.6	6.3	5.9	13.6	11.7	9.5	7.1	6.4	1.9	1.4	5.2	4.3	3.7	6.2	5.6	6.5	5.0	8.0	5.4	4.8	6.5	5.2	5.5	4.3	3.1	8.6	7.2	5.2	6.4	7.7	2.0	6.9	8.8	4.2	5.5	5.8	4.7	5.9	4.7	7.0	7.5	11.8	3.5	16.3	9.5	15.6	7.8	6.5	7.7	8.3	4.7	10.5	6.8	9.6	8.3	12.2	2.9	5.0	5.8	3.1	4.8	4.4	6.0	8.8	5.9	10.1	10.6	15.6	24.9	6.1	7.8	9.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	12.9	13.4	20.5	16.9	14.8	14.3	12.1	12.3	12.2	10.8	12.9	13.6	2.5	0.0	0.0	2.6	2.7	3.2	4.0	0.8	1.2	4.4	3.1	3.0	1.8	1.5	0.5	1.8	6.2	1.4	2.5	5.2	0.0	4.5	15.1	4.9	1.7	1.9	4.8	6.1	3.8	5.2	1.3	1.6	2.6	3.1	4.5	3.0	3.6	3.6	0.9	1.7	3.5	4.1	0.0	1.6	0.5	26.7	1.8	1.1	0.0	2.8	3.9	4.9	0.0	2.0	1.5	4.5	0.8	2.2	1.0	2.5	2.0	2.7	1.1	4.1	0.0	2.6	3.1	9.1	4.7	1.3	2.7	1.6	1.5	2.6	3.3	2.2
ZNF654	"FLJ10997, FLJ21142"	ENSG00000175105	"Zinc finger protein 654"		3	88059255-88144660	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036172, HPA036173, HPA049262, HPA077939"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364"	"unprognostic (2.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.89e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.72e-3)"	"prognostic unfavorable (9.97e-6)"	"unprognostic (1.29e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.50e-2)"	5.0	3.7	2.6	4.1	2.7	8.1	5.5	4.9	3.3	5.1	1.8	4.4	4.5	4.6	4.7	5.6	3.4	4.8	3.4	2.4	3.2	4.8	7.0	4.5	6.1	2.8	3.1	6.4	4.1	4.3	1.2	5.0	3.3	5.5	4.2	11.7	4.6	4.1	3.0	6.5	4.8	4.1	3.2	4.9	4.7	6.0	2.7	7.6	5.9	4.9	5.7	5.1	2.3	3.9	7.2	3.0	5.0	6.9	9.9	8.6	4.6	9.3	8.4	6.1	8.4	4.4	4.3	11.3	6.2	7.4	4.4	4.7	5.3	8.6	11.8	7.0	3.0	7.0	3.9	3.2	7.5	8.0	7.6	8.4	7.4	6.7	7.8	12.1	8.1	6.6	4.9	9.0	13.6	5.3	8.0	6.5	2.7	5.7	4.8	5.7	3.4	5.4	5.4	9.0	3.7	3.3	6.8	5.2	17.0	6.0	7.3	5.7	9.5	13.6	8.7	51.8	6.6	10.1	7.6	7.9	10.8	7.5	8.6	9.7	1.2	1.8	1.7	1.2	2.0	1.1	1.8	2.4	1.5	1.7	2.2	1.5	1.7	4.0	1.0	0.7	1.4	1.0	2.6	2.7	4.9	3.3	2.4	3.2	2.8	3.1	3.3	3.2	2.7	3.9	18.2	9.6	13.1	10.1	12.8	22.4	10.1	7.9	9.1	14.0	17.4	10.2	11.8	5.7	10.8	5.5	12.5	4.8	14.5	11.9	1.9	7.6	1.4	9.4	16.0	12.4	5.3	5.2	11.7	5.3	4.2	11.7	5.1	12.2	15.8	14.5	8.9	14.0	6.3	16.8	11.3	7.1	10.2	12.3	19.5	1.5	7.5	14.8	8.8	7.5	10.9	9.9	9.2	9.0	13.3	8.4	8.2	12.4	9.2	12.0	9.0	6.0	10.7	14.3	6.6	13.9	11.5	12.1	10.4	11.4	18.6	8.2	14.0	9.0	7.8	14.4
ZNF655	"VIK, VIK-1"	ENSG00000197343	"Zinc finger protein 655"	Q8N720	7	99558406-99576453	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029534, HPA050750"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA029534: AB_10603008, HPA050750: AB_2681225"	"prognostic favorable (7.12e-4)"	"unprognostic (3.03e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.12e-1)"	11.6	11.9	7.0	14.3	6.2	8.9	12.8	8.3	7.8	13.2	5.9	15.5	15.9	10.1	11.0	26.9	11.5	10.2	8.4	6.3	6.1	13.8	14.9	15.3	19.7	5.0	5.5	13.9	21.1	14.4	8.2	12.5	6.4	11.4	11.8	8.5	16.7	11.3	12.7	18.4	13.8	11.7	5.1	14.2	18.0	7.4	6.3	22.6	11.8	13.5	17.3	18.8	14.9	9.6	40.5	35.9	16.5	23.9	15.8	25.4	12.4	24.0	45.8	40.7	37.8	20.1	37.0	31.8	0.4	33.2	52.0	25.2	18.0	29.6	40.6	34.5	23.6	18.9	16.0	27.8	24.1	38.1	35.9	21.1	32.8	35.8	50.6	21.4	17.3	26.4	54.4	39.7	24.4	0.1	53.9	36.6	21.1	0.1	0.0	19.9	14.0	52.9	25.9	42.8	17.4	37.6	25.1	0.7	27.2	24.0	12.2	20.2	13.3	24.3	60.2	43.4	43.6	47.3	72.7	63.4	23.5	18.2	39.9	147.8	43.2	74.4	47.8	47.2	45.1	32.7	44.1	55.7	40.3	31.3	35.0	43.8	50.3	37.0	55.2	23.3	61.3	55.4	7.0	6.2	8.3	7.8	6.3	6.1	5.0	5.5	6.4	5.1	6.3	9.6	19.5	96.1	82.8	51.2	53.2	44.7	46.5	36.5	42.1	48.8	34.4	25.1	36.1	31.5	44.3	23.9	41.7	31.6	76.3	46.3	33.2	31.6	12.8	25.8	33.9	20.4	41.5	12.8	53.4	36.2	42.7	32.7	37.2	33.0	18.9	70.8	19.2	24.6	37.4	50.5	57.4	40.4	18.3	63.4	31.6	9.7	25.4	56.0	23.2	44.0	59.2	24.9	106.1	61.3	75.3	48.2	55.2	25.2	55.4	44.5	48.1	41.1	26.0	45.8	13.1	39.9	31.7	39.0	29.8	55.6	48.9	73.6	62.5	30.0	28.1	64.0
ZNF658	"DKFZp572C163, FLJ32813, MGC35232"	ENSG00000274349	"Zinc finger protein 658"	Q5TYW1	9	66856426-66932141	"Predicted intracellular proteins, Transcription factors"	"Ribosome biogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	11	"neutrophil: 28.0"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 28.0"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA047730, HPA048668"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA047730: AB_2680136, HPA048668: AB_2680487"	"unprognostic (9.54e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.18e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	2.6	2.7	2.4	2.0	2.8	2.0	5.4	4.7	3.0	3.6	2.9	2.5	2.1	3.6	2.7	3.5	4.0	1.8	4.4	2.7	2.8	3.7	2.4	3.0	2.7	1.4	1.8	6.3	3.3	5.0	2.4	1.8	1.4	4.0	2.6	5.4	4.1	3.4	5.0	8.1	1.8	2.8	0.9	3.5	2.7	3.5	3.2	2.8	4.5	4.4	3.1	2.5	2.0	2.3	2.3	3.9	3.7	7.0	3.7	4.4	2.8	1.8	3.3	2.4	2.7	0.3	1.7	5.3	1.9	1.7	2.6	6.1	3.0	3.5	2.6	0.2	1.9	0.8	3.5	0.8	4.1	3.3	1.8	3.5	7.8	2.4	3.4	5.0	4.8	3.4	1.1	1.0	3.1	1.3	2.7	1.7	3.1	1.6	6.6	0.2	5.9	1.9	2.6	5.9	5.4	3.2	2.8	1.5	2.7	3.9	2.2	8.4	1.1	3.1	4.0	2.8	2.2	0.6	3.2	1.3	1.4	1.2	3.3	0.8	0.7	2.3	0.9	0.6	0.1	0.8	1.3	1.1	0.3	1.6	1.8	1.0	28.0	2.4	0.6	0.6	0.7	0.2	2.4	2.8	4.7	3.0	2.7	2.8	1.4	1.8	1.4	0.9	3.2	2.3	3.9	3.2	3.2	3.3	2.7	0.9	1.3	1.9	9.6	7.3	2.6	3.8	3.5	2.8	2.4	0.0	0.0	2.7	0.3	0.8	15.6	1.4	0.8	2.3	2.8	2.7	0.0	0.4	6.5	0.7	1.1	2.2	1.5	1.3	1.3	5.8	1.4	2.3	1.8	10.1	7.8	1.8	2.0	2.4	0.3	1.2	3.1	0.8	0.0	1.9	0.2	5.1	0.0	4.0	4.5	0.8	0.3	5.3	2.0	0.9	1.3	4.6	7.5	4.3	0.0	3.9	2.0	3.2	2.9	5.4	2.0	1.0	1.3	3.5	1.4	1.8
ZNF664	"DKFZp761B128, ZFOC1, ZNF176"	ENSG00000179195	"Zinc finger protein 664"	Q8N3J9	12	123971845-124015439	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 151.6;Late spermatids: 301.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047846			Approved	Nucleoplasm		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA047846: AB_2680179"	"unprognostic (4.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.90e-2)"	"unprognostic (8.12e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.85e-2)"	52.4	30.3	68.1	25.4	80.4	12.8	42.4	78.6	104.9	44.5	63.6	51.0	78.5	38.6	71.0	28.2	56.2	33.6	48.7	62.0	69.8	60.0	44.8	43.9	23.9	79.8	79.7	30.1	60.3	127.2	38.3	36.4	78.2	42.7	58.8	71.0	55.5	38.4	50.6	17.6	82.1	29.7	81.1	24.8	43.3	20.0	75.6	33.6	91.7	56.9	28.9	30.8	27.6	84.1	87.5	60.0	93.9	98.6	71.9	54.4	79.8	50.1	67.2	50.6	41.3	75.1	46.7	85.4	59.4	68.1	36.6	74.8	135.7	61.5	93.1	72.7	98.6	132.9	79.1	64.2	86.5	81.2	70.2	34.7	134.6	52.8	85.8	119.1	81.8	82.3	82.9	35.0	45.5	67.4	80.5	37.0	88.1	85.6	129.7	69.5	91.4	51.9	110.5	141.9	193.9	140.7	86.0	90.4	85.6	77.9	161.6	42.6	54.0	43.6	70.5	62.5	52.5	48.0	64.2	65.8	75.8	55.9	68.7	0.0	0.2	0.2	1.0	0.1	1.5	0.7	0.8	0.8	0.4	1.0	0.9	0.8	0.1	0.6	0.0	0.3	1.5	0.6	68.1	80.4	78.6	104.9	62.0	69.8	79.8	79.7	78.2	81.1	75.6	84.1	15.2	25.6	57.8	0.0	16.7	12.6	14.5	18.6	33.0	28.4	39.3	21.2	58.7	28.6	36.1	20.2	20.9	9.9	8.9	72.5	29.4	35.0	151.6	52.7	19.7	20.3	43.8	22.7	0.0	31.6	8.8	22.1	37.2	38.0	13.3	26.7	23.6	43.5	12.3	32.0	0.0	60.3	32.6	15.1	10.5	301.5	23.3	10.3	21.4	0.0	6.8	29.3	9.2	0.0	0.0	43.0	42.8	17.3	38.6	32.0	94.0	30.5	74.1	30.4	19.7	19.2	24.8	32.9	24.5	32.5	8.8	10.0	14.5	22.4	57.5	20.1
ZNF667	FLJ14011	ENSG00000198046	"Zinc finger protein 667"	Q5HYK9	19	56439325-56478065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 24.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.6;Excitatory neurons: 29.2;Horizontal cells: 32.0;Rod photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.0;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 12.3;hTERT-RPE1: 17.5;U-138 MG: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030731, HPA046673"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA030731: AB_2673584, HPA046673: AB_2679746"	"unprognostic (6.10e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.81e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.26e-3)"	"unprognostic (8.55e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.34e-3)"	"unprognostic (3.54e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.55e-2)"	2.3	5.4	11.0	1.2	12.1	5.2	4.9	6.7	11.9	4.7	5.2	3.5	1.1	4.6	7.9	1.6	4.9	3.1	3.3	13.7	11.3	5.0	1.1	1.4	1.9	6.6	7.6	7.5	2.4	5.2	24.2	2.2	7.6	4.7	0.5	9.4	3.2	2.9	1.6	2.6	1.3	3.7	5.7	1.8	1.6	4.3	9.5	2.6	8.9	1.7	1.3	3.8	2.8	9.2	0.1	0.2	10.4	0.1	0.0	0.0	0.2	4.6	3.4	3.9	3.1	0.2	0.1	0.6	6.0	1.6	6.0	0.1	0.0	0.1	6.0	0.0	2.3	12.3	0.1	0.2	3.0	7.3	5.4	6.6	0.1	0.8	0.0	17.5	0.0	0.4	0.1	0.2	3.1	0.2	0.1	0.2	7.6	0.1	2.0	0.1	3.9	8.6	3.9	0.6	0.3	5.9	0.2	0.1	0.0	9.2	2.8	0.0	0.0	14.7	4.0	0.2	7.9	0.2	6.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.2	0.2	0.2	3.0	0.8	1.9	0.2	2.7	0.0	1.1	0.1	0.4	11.0	12.1	6.7	11.9	13.7	11.3	6.6	7.6	7.6	5.7	9.5	9.2	4.3	0.0	0.0	10.4	2.9	3.3	6.8	0.5	6.2	30.6	6.0	9.4	6.4	1.5	2.9	5.5	25.0	0.3	1.8	0.1	0.0	3.6	3.0	10.3	8.9	4.0	1.2	3.0	29.2	0.2	0.0	7.4	0.0	5.6	9.5	18.1	2.9	0.2	0.2	32.0	24.4	0.1	0.0	0.0	1.2	2.5	5.3	0.8	3.6	6.5	0.1	8.4	1.0	22.6	23.9	0.4	0.1	7.2	0.5	8.1	0.0	1.4	3.7	29.2	0.0	11.7	5.0	13.6	14.0	1.0	4.1	0.1	1.1	16.7	0.3	2.6
ZNF668	FLJ13479	ENSG00000167394	"Zinc finger protein 668"	Q96K58	16	31060843-31074240	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043048	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA043048: AB_10962503"	"unprognostic (2.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.20e-3)"	"unprognostic (6.73e-5)"	"unprognostic (4.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (6.24e-4)"	"unprognostic (1.72e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.83e-3)"	"unprognostic (7.25e-2)"	5.6	6.6	4.4	3.4	4.1	7.9	4.7	4.7	6.6	5.5	1.7	5.6	4.4	6.9	0.7	6.4	4.6	2.3	5.7	4.5	3.2	4.4	4.8	4.4	2.6	5.1	3.6	3.8	3.9	2.3	4.9	3.6	4.8	6.3	1.3	0.8	4.6	2.4	6.1	7.3	4.8	3.4	3.2	6.0	4.8	7.5	4.0	3.0	4.1	1.7	1.6	6.2	5.2	4.0	5.2	17.2	3.8	9.4	3.9	4.1	13.0	14.6	10.3	7.1	5.9	8.0	7.0	8.3	11.2	8.4	4.5	9.2	2.6	7.8	1.8	10.6	11.1	5.1	11.4	12.8	4.8	8.2	12.3	5.1	3.2	12.1	2.4	2.3	5.1	8.9	9.7	4.9	12.8	17.2	17.3	17.2	13.6	3.6	14.4	22.4	28.5	12.0	3.7	11.2	13.3	15.7	9.3	12.5	4.7	1.5	9.6	11.5	8.9	17.5	7.2	13.4	6.2	8.4	15.1	12.1	11.7	8.3	11.4	8.7	4.2	7.9	11.1	3.9	7.3	4.3	3.2	6.7	6.2	3.0	3.4	4.4	1.5	7.8	3.4	3.3	3.5	5.1	4.4	4.1	4.7	6.6	4.5	3.2	5.1	3.6	4.8	3.2	4.0	4.0	3.4	0.0	3.6	3.6	4.6	8.4	2.4	5.3	7.4	3.5	4.5	3.7	0.6	4.3	3.8	0.0	0.0	6.5	5.9	6.3	7.9	8.9	44.7	3.8	4.7	4.3	4.8	4.6	3.7	4.8	11.4	6.4	4.1	8.1	4.5	4.7	3.6	2.8	6.8	11.8	3.7	3.7	4.1	3.8	7.1	15.3	6.2	9.3	3.6	2.8	5.5	5.1	12.3	1.0	4.2	7.5	4.9	15.1	4.5	4.0	7.5	5.8	1.7	2.1	0.0	9.0	5.5	5.9	12.8	8.8	8.8	7.0	7.4	5.0	4.6	2.2
ZNF670	MGC12466	ENSG00000277462	"Zinc finger protein 670"	Q9BS34	1	247034637-247078811	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA003142	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA003142: AB_1859404"	"unprognostic (2.11e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.05e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-2)"	2.2	1.5	0.8	1.1	0.9	0.5	2.3	2.8	1.2	1.5	0.3	1.5	1.0	2.3	0.6	1.2	1.6	1.3	1.1	0.9	0.8	1.7	1.7	1.5	1.5	0.5	0.8	2.1	1.8	1.6	1.0	0.7	0.5	1.3	1.3	2.1	1.5	1.1	1.0	1.5	1.5	1.7	0.5	1.4	2.0	2.3	0.9	1.9	1.4	1.4	1.7	1.7	1.5	0.8	2.7	1.7	5.7	6.9	1.3	1.9	12.0	3.1	2.0	3.7	3.6	2.4	2.5	4.5	6.2	1.9	2.2	2.1	6.3	2.4	6.8	3.1	0.7	4.1	1.4	3.4	1.1	4.6	2.6	1.2	2.5	2.3	4.9	0.6	2.4	3.8	5.4	1.9	3.9	1.1	5.7	2.4	9.8	5.5	3.6	5.7	7.5	3.9	2.2	5.7	6.7	5.4	4.5	1.8	2.6	3.0	1.9	9.3	1.7	2.5	2.4	1.8	3.6	3.8	6.8	8.0	0.9	3.4	3.0	0.0	0.6	0.5	1.2	0.7	0.6	2.1	1.1	1.3	1.3	1.5	1.8	1.3	0.3	1.0	0.4	0.7	0.9	0.6	0.8	0.9	2.8	1.2	0.9	0.8	0.5	0.8	0.5	0.5	0.9	0.8	4.2	3.2	1.7	0.0	2.5	24.2	9.3	6.1	3.4	4.1	5.0	4.8	0.9	4.3	5.1	5.5	0.0	2.3	2.7	0.4	5.9	5.2	8.9	11.9	2.6	5.2	0.0	3.8	0.0	2.9	8.3	6.3	1.5	13.4	0.0	2.0	5.7	2.9	2.5	6.7	0.0	1.8	8.2	1.6	10.2	2.0	1.8	1.5	7.2	0.0	2.0	3.0	1.0	0.0	0.0	3.5	1.8	1.5	0.9	5.2	1.0	3.6	4.7	1.5	0.0	9.3	4.0	3.2	4.0	2.3	11.2	0.8	1.4	2.2	1.8	3.6
ZNF671	FLJ23506	ENSG00000083814	"Zinc finger protein 671"	Q8TAW3	19	57719751-57727624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.1"					"Low region specificity"	"Detected in all"			"HPA046099, HPA056043"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA046099: AB_10962484, HPA056043: "	"prognostic favorable (2.20e-4)"	"unprognostic (4.16e-3)"	"unprognostic (6.02e-2)"	"unprognostic (5.91e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.22e-1)"	2.9	6.8	6.8	3.7	7.1	4.4	4.3	11.0	7.7	3.4	7.1	6.5	1.8	2.5	5.3	2.0	4.5	2.8	6.8	6.6	7.7	6.0	2.8	4.0	7.9	6.7	7.1	3.3	3.4	9.4	9.7	4.0	6.8	5.8	2.3	8.3	3.8	5.8	7.7	2.2	6.4	2.7	7.3	13.5	2.7	6.4	7.8	13.7	8.3	6.9	8.5	4.8	2.0	7.4	0.1	0.2	2.2	0.0	0.4	0.1	0.0	2.5	1.4	4.8	1.7	0.3	0.4	5.2	0.8	3.6	1.5	0.1	1.9	2.1	5.6	5.7	3.6	0.1	0.8	0.0	4.2	0.0	7.3	6.2	1.5	3.0	1.7	5.6	0.7	5.4	0.8	2.5	4.4	0.1	10.1	0.1	3.2	0.0	5.1	3.9	6.8	3.2	1.8	0.2	0.2	0.0	0.0	0.1	3.5	5.4	1.4	7.3	0.0	0.5	2.6	0.0	1.9	4.5	0.1	2.8	0.5	1.2	1.6	19.4	10.5	19.3	8.0	9.5	21.4	22.7	17.0	14.1	14.9	30.4	24.2	19.7	7.3	20.9	15.1	13.7	18.9	15.0	6.8	7.1	11.0	7.7	6.6	7.7	6.7	7.1	6.8	7.3	7.8	7.4	1.1	0.0	0.6	5.9	5.2	0.6	0.7	0.9	0.0	5.8	1.3	1.0	5.4	4.3	1.2	3.7	0.0	2.3	2.0	0.0	1.9	3.7	0.2	0.8	0.4	1.7	0.0	3.4	3.4	0.0	1.1	0.7	0.0	0.7	2.5	2.9	1.1	1.2	3.8	6.7	4.1	0.2	6.1	2.7	0.8	0.7	0.0	2.3	1.8	2.8	1.9	8.4	6.2	4.0	2.8	0.3	0.1	0.4	3.8	0.5	0.9	1.6	0.9	7.8	0.0	0.2	1.6	7.0	5.0	0.4	0.4	0.8	4.1	0.6	0.5	0.1
ZNF672	FLJ22301	ENSG00000171161	"Zinc finger protein 672"	Q499Z4	1	248838210-248849517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055779, HPA062506"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA055779: AB_2682917, HPA062506: AB_2684786"	"unprognostic (1.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (7.42e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.79e-5)"	13.4	14.8	13.4	11.7	14.8	13.5	13.1	17.9	14.1	13.3	14.6	16.1	11.3	14.3	7.7	19.1	14.9	7.8	30.2	12.8	13.4	22.3	26.1	17.0	14.8	17.2	14.8	11.1	18.0	16.2	17.1	9.3	14.8	24.0	8.4	10.7	17.6	8.2	49.5	17.9	16.8	8.1	14.0	19.8	16.9	16.0	14.9	15.8	20.2	35.7	14.0	16.8	13.7	15.8	19.4	21.5	17.2	19.5	9.4	6.6	33.0	17.8	9.7	12.7	13.6	11.8	19.7	22.0	18.1	11.7	9.6	18.8	9.4	13.3	8.0	32.5	5.3	33.7	20.0	16.0	12.0	14.6	24.4	7.4	10.7	16.6	11.5	10.2	11.7	15.2	41.5	17.6	8.8	13.8	26.8	14.5	20.0	22.3	36.5	49.1	16.3	17.4	12.9	15.6	25.5	22.2	16.0	24.0	15.9	10.2	13.8	30.1	10.0	17.5	10.5	11.6	37.3	52.8	22.2	13.2	16.0	25.1	14.5	9.2	16.3	11.9	8.8	15.9	7.2	11.9	6.3	8.8	24.3	15.0	6.7	6.3	9.2	12.7	15.4	13.6	7.8	14.0	13.4	14.8	17.9	14.1	12.8	13.4	17.2	14.8	14.8	14.0	14.9	15.8	10.7	3.2	15.2	5.9	22.3	13.0	28.2	10.1	6.8	22.0	12.8	9.8	20.2	14.3	8.1	16.5	12.5	32.0	22.0	19.5	21.5	18.3	7.8	9.5	5.7	12.0	18.0	17.0	2.2	10.7	19.9	10.0	10.2	8.9	28.0	12.5	7.5	17.2	16.8	10.1	4.0	17.6	8.2	16.4	16.9	14.6	5.6	20.6	12.4	1.9	17.8	19.5	20.6	2.5	5.2	14.6	19.7	5.7	9.6	21.1	26.5	15.8	9.0	30.5	6.6	17.5	11.7	32.4	23.4	5.5	14.6	71.3	13.5	10.6	16.9	22.5
ZNF674	"MRX92, ZNF673B"	ENSG00000251192	"Zinc finger protein 674"	Q2M3X9	X	46497727-46545457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 13.5;Inhibitory neurons: 11.4;Oligodendrocytes: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA031026, HPA065295"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA031026: AB_10602690, HPA065295: AB_2685456"	"unprognostic (6.11e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.41e-5)"	"unprognostic (2.74e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.25e-4)"	"unprognostic (8.45e-4)"	1.0	1.2	1.7	1.1	1.9	1.0	1.4	3.0	2.0	1.4	1.1	1.2	1.1	1.6	1.6	0.9	1.0	1.2	1.3	1.7	1.9	1.4	2.2	1.0	1.5	1.6	1.4	1.7	2.0	1.4	1.3	1.2	2.0	2.0	1.3	3.9	1.1	1.3	1.4	1.3	1.1	1.7	1.3	1.4	0.9	0.9	1.7	1.5	1.7	1.1	1.2	1.1	1.2	2.5	1.7	2.2	2.1	2.7	1.9	1.9	2.1	1.8	2.5	2.3	2.4	1.4	1.4	1.9	1.1	3.1	4.1	1.6	2.9	2.2	2.6	1.6	1.8	0.8	2.5	1.2	2.5	2.1	3.3	1.8	3.4	1.7	5.6	2.4	1.7	3.2	1.0	2.8	2.1	1.1	2.1	0.9	3.4	0.5	2.1	1.0	3.6	2.2	1.5	0.7	0.8	1.8	2.7	0.9	5.7	5.9	2.3	1.5	1.6	2.9	3.3	1.8	1.7	3.3	3.2	0.8	1.2	1.0	3.0	0.9	0.6	0.9	0.5	1.1	0.5	0.7	0.7	0.4	0.6	0.3	0.5	0.6	1.7	0.5	0.2	0.7	0.6	0.6	1.7	1.9	3.0	2.0	1.7	1.9	1.6	1.4	2.0	1.3	1.7	2.5	2.7	9.6	1.8	5.2	1.3	1.9	3.1	0.5	1.2	6.6	1.1	1.3	4.4	0.0	2.9	1.8	0.0	0.8	2.3	1.5	0.0	0.9	0.0	1.5	2.2	3.4	0.0	0.8	9.3	0.5	0.7	2.0	3.1	1.9	2.5	1.9	3.6	2.1	1.0	13.5	11.4	1.0	0.0	1.9	2.2	0.5	0.3	1.4	0.0	5.6	2.0	2.5	2.1	9.5	12.3	1.3	1.4	1.9	2.3	2.6	1.1	0.9	2.7	5.8	0.0	3.2	1.5	1.3	4.2	1.1	1.7	0.4	1.9	1.2	0.9	2.2
ZNF677	MGC48625	ENSG00000197928	"Zinc finger protein 677"	Q86XU0	19	53235381-53254898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 602.9;Late spermatids: 408.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 30.4;SuSa: 25.5"									HPA023106	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Centrosome	"HPA023106: AB_1859409"	"unprognostic (2.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.87e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.70e-8)"	"unprognostic (6.57e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.17e-2)"	9.1	6.4	4.7	5.6	5.9	5.6	11.0	9.9	5.3	7.0	4.7	6.9	3.5	10.2	4.3	5.6	11.1	7.4	11.4	4.8	4.8	6.5	2.8	6.3	6.5	5.2	4.6	16.1	5.3	9.7	4.8	9.1	4.9	10.2	4.0	11.7	7.9	7.0	5.3	9.1	3.4	9.3	4.9	8.9	5.4	44.8	4.8	9.3	11.9	7.0	6.2	7.9	5.7	7.9	0.4	0.4	17.5	0.6	5.9	9.0	3.2	11.8	8.8	11.9	10.6	0.0	0.6	0.1	8.5	10.3	15.0	1.1	0.1	9.1	3.5	0.3	6.2	0.5	1.0	0.3	14.6	0.2	11.7	15.7	0.1	11.4	0.2	0.4	5.3	0.2	0.2	0.6	8.1	0.4	10.2	0.2	30.4	0.1	4.0	0.2	0.0	0.2	3.3	4.7	0.3	16.7	0.3	4.4	0.2	25.5	0.6	0.5	3.4	18.6	0.4	0.3	7.8	0.4	0.1	0.4	0.3	0.5	0.1	18.3	2.8	9.0	6.6	3.9	9.4	15.7	9.4	7.2	8.4	23.3	19.8	13.0	3.0	15.7	2.6	20.0	6.6	5.1	4.7	5.9	9.9	5.3	4.8	4.8	5.2	4.6	4.9	4.9	4.8	7.9	27.6	25.6	2.8	9.8	10.0	11.5	25.9	15.7	5.7	24.4	14.2	20.4	19.3	11.5	14.8	20.2	14.6	12.6	7.1	0.7	35.2	15.0	602.9	8.2	12.5	24.3	0.0	12.2	4.0	6.9	21.9	20.6	3.1	11.1	14.0	19.9	31.1	0.3	7.7	28.6	4.7	2.8	12.2	7.2	12.1	408.1	27.4	7.2	14.2	5.6	7.2	21.1	12.3	20.6	10.8	7.5	0.7	17.3	1.8	36.2	1.4	3.3	7.4	18.6	19.7	19.2	22.0	45.3	38.7	7.0	14.6	11.8	8.2	19.7	2.4	27.8
ZNF680	FLJ90430	ENSG00000173041	"Zinc finger protein 680"	Q8NEM1	7	64519878-64563075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 116.9;Oligodendrocytes: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA003173			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA003173: AB_1080744"	"unprognostic (1.65e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.05e-3)"	5.9	13.7	8.8	3.8	10.6	2.4	13.1	15.0	15.5	6.1	3.3	3.8	2.8	4.9	5.7	3.6	5.0	5.3	11.3	8.5	9.4	8.4	20.1	4.9	6.5	9.3	10.4	10.9	4.8	3.7	4.0	4.6	9.7	10.1	5.1	4.8	4.2	5.4	11.6	5.8	3.3	4.5	9.6	6.7	6.3	4.2	10.1	6.6	24.9	15.2	5.4	4.5	4.1	12.4	5.6	3.2	12.8	15.3	6.2	6.9	8.0	4.4	3.6	7.9	9.8	4.4	10.6	10.6	10.7	4.2	9.0	3.8	10.5	4.9	12.9	2.0	7.4	8.1	6.7	4.0	2.6	10.8	7.1	4.6	5.8	7.0	7.9	9.9	7.5	14.6	14.8	0.0	11.1	4.4	16.8	17.1	15.0	5.0	3.9	13.0	12.7	32.1	10.8	17.6	10.1	13.8	13.5	12.7	4.9	23.5	12.7	4.6	4.0	9.6	4.8	4.5	7.8	9.1	12.3	29.9	0.5	9.8	8.6	2.8	0.5	0.6	1.5	0.7	1.2	2.2	2.1	1.8	0.9	1.5	2.2	2.1	0.2	4.6	0.6	0.7	0.6	0.8	8.8	10.6	15.0	15.5	8.5	9.4	9.3	10.4	9.7	9.6	10.1	12.4	10.2	12.8	5.1	116.9	15.4	4.2	10.7	9.4	19.9	12.5	17.5	9.5	13.3	14.3	11.6	25.8	4.2	12.0	11.5	2.8	9.8	8.9	0.9	8.9	9.1	11.0	0.0	7.2	57.7	9.1	10.7	13.4	11.7	6.4	7.0	34.0	23.9	21.5	5.3	1.7	60.5	4.4	16.2	10.1	6.4	2.4	27.7	6.2	7.2	41.2	7.3	23.8	23.7	59.8	89.2	5.8	3.1	22.2	6.3	9.5	3.1	7.1	6.8	9.3	19.7	15.2	9.7	13.7	15.1	6.5	5.3	7.1	11.2	16.5	5.3	9.4
ZNF684	MGC27466	ENSG00000117010	"Zinc finger protein 684"	Q5T5D7	1	40531573-40548167	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 36.0"					"Low region specificity"	"Detected in all"			HPA059153	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA059153: AB_2683932"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.67e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.10e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.96e-2)"	"prognostic favorable (4.89e-10)"	"unprognostic (4.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.52e-2)"	2.4	3.7	1.7	2.2	2.6	6.4	3.0	2.0	3.3	1.7	2.2	2.8	2.3	2.4	2.8	1.7	1.7	2.4	7.7	1.5	1.8	6.9	12.4	2.5	3.3	2.3	2.2	2.6	2.6	3.3	1.2	1.5	2.6	1.8	3.4	2.1	2.5	1.4	3.3	2.9	1.9	2.3	1.4	3.1	3.2	3.2	2.3	3.4	3.8	2.8	2.7	1.7	1.4	3.9	2.9	0.9	3.6	4.8	3.2	4.8	2.1	2.6	2.5	3.2	5.4	1.7	3.7	5.0	2.1	1.7	2.1	3.5	3.6	2.7	4.9	4.4	6.3	5.4	3.2	4.9	1.7	5.7	5.7	3.0	1.0	3.8	1.5	1.8	4.6	4.0	2.9	6.9	4.5	0.9	8.6	6.6	8.8	1.3	2.8	4.1	10.3	3.6	4.7	2.5	2.5	4.4	4.7	4.5	5.2	4.7	2.0	36.0	2.8	2.9	6.3	3.1	5.1	5.8	4.8	5.9	2.6	5.9	4.8	4.1	1.9	1.0	3.0	4.1	1.6	3.5	2.0	1.7	1.2	1.5	1.3	2.6	1.0	1.9	2.2	1.9	2.6	1.3	1.7	2.6	2.0	3.3	1.5	1.8	2.3	2.2	2.6	1.4	2.3	3.9	4.9	6.4	3.2	10.4	6.8	2.3	1.6	2.2	4.6	3.4	2.0	2.8	13.0	5.7	2.9	7.3	0.0	1.2	7.2	3.2	17.6	5.7	6.5	1.6	3.2	5.0	1.2	4.2	7.8	14.7	2.5	4.2	1.5	1.8	2.5	4.6	4.2	15.8	4.8	3.3	7.9	2.2	4.1	4.2	2.3	3.7	2.5	4.2	8.8	5.6	6.3	4.3	4.1	12.5	16.1	6.4	2.0	3.0	3.2	1.0	1.1	17.3	4.3	2.6	0.0	5.8	4.8	8.7	4.6	1.7	1.3	0.0	5.9	5.3	3.2	1.5
ZNF687	KIAA1441	ENSG00000143373	"Zinc finger protein 687"	Q8N1G0	1	151281618-151292176	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.5"	"Group enriched"	"Detected in many"	8	"granulocytes: 13.5;monocytes: 4.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021193, HPA023948"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021193: AB_1859415, HPA023948: AB_2671380"	"unprognostic (2.23e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.54e-2)"	"unprognostic (7.99e-2)"	8.5	10.9	9.0	8.2	9.9	31.2	8.7	12.6	10.2	9.9	6.9	10.7	8.6	10.5	5.5	11.0	9.7	7.0	8.9	8.5	8.4	10.2	9.7	8.6	10.1	10.5	9.6	11.7	16.0	14.1	13.0	7.1	9.5	11.3	5.7	9.4	12.0	8.6	10.9	12.3	11.3	6.1	8.9	14.4	10.8	14.5	9.7	9.3	10.8	6.9	7.5	10.4	8.7	10.5	14.8	21.5	20.4	12.6	11.3	9.5	26.3	7.6	12.9	13.8	13.1	18.1	19.6	12.6	18.7	12.3	14.7	22.3	18.1	15.2	6.1	17.3	18.3	11.9	18.8	20.1	12.1	14.3	16.7	14.7	15.3	11.6	12.1	12.3	9.4	13.4	19.5	22.6	7.8	44.8	19.2	16.8	27.6	19.8	16.5	16.9	16.1	22.8	11.6	22.1	18.5	27.7	20.8	24.6	19.7	19.2	32.2	30.1	9.2	11.0	12.1	13.9	11.6	26.2	24.1	31.3	14.0	9.4	14.2	0.5	1.8	13.5	0.5	2.3	0.5	1.0	0.5	0.4	0.9	1.1	0.7	0.8	8.8	0.4	4.5	0.8	0.4	1.2	9.0	9.9	12.6	10.2	8.5	8.4	10.5	9.6	9.5	8.9	9.7	10.5	4.3	3.2	4.6	3.6	5.8	4.7	2.8	4.9	5.7	6.7	6.0	5.5	1.4	10.0	3.5	1.8	10.4	6.7	3.8	9.3	3.9	5.5	3.1	4.3	3.7	4.4	2.4	3.0	1.6	6.0	5.3	4.2	7.7	5.3	0.0	8.5	2.9	4.5	5.3	8.4	1.9	5.6	8.2	5.2	4.1	2.8	6.2	5.8	0.0	2.8	6.0	5.2	5.2	3.0	1.7	7.3	3.5	7.2	5.8	4.7	10.2	4.1	3.4	10.8	13.1	4.4	3.9	6.9	6.8	4.3	3.4	9.4	4.3	6.5	7.3	5.1
ZNF688		ENSG00000229809	"Zinc finger protein 688"	P0C7X2	16	30569672-30572734	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 180.3;Late spermatids: 576.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048922	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA048922: AB_2680557"	"prognostic favorable (5.90e-4)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.58e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.14e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.03e-2)"	8.7	8.4	17.6	9.8	17.5	11.4	5.1	20.5	19.1	6.7	16.4	9.7	14.6	7.8	5.6	5.6	10.4	4.2	7.0	16.5	15.8	8.2	8.3	7.5	9.5	17.5	16.9	9.1	12.3	9.7	8.4	3.3	17.2	7.5	6.4	5.6	10.1	6.9	25.6	9.0	11.6	5.8	16.2	12.0	10.1	13.6	18.1	8.2	5.1	9.7	5.4	6.6	5.7	20.2	10.4	9.5	7.3	8.1	13.3	5.2	3.1	6.7	8.2	5.0	4.0	2.5	15.1	6.2	12.8	6.9	6.0	8.6	2.2	3.6	4.7	16.7	6.4	3.8	3.7	2.7	6.3	4.3	17.9	8.7	8.2	5.3	6.0	7.7	4.7	7.7	3.9	12.0	5.3	13.5	14.9	9.9	3.3	8.6	4.9	13.3	3.8	9.2	8.2	3.2	12.1	13.2	2.4	14.1	15.3	2.0	15.6	7.8	5.4	5.5	4.0	5.2	4.7	20.5	13.2	5.7	12.2	4.3	9.7	12.0	4.6	11.0	6.2	4.2	5.4	6.5	6.6	6.8	4.2	7.6	5.7	5.0	5.3	20.4	6.5	7.4	11.2	3.3	17.6	17.5	20.5	19.1	16.5	15.8	17.5	16.9	17.2	16.2	18.1	20.2	16.3	6.4	3.1	5.9	22.8	6.4	10.5	12.6	16.5	19.8	20.3	22.7	11.2	22.8	10.2	16.5	18.8	7.5	26.0	38.6	49.0	24.8	180.3	25.4	9.5	14.0	20.4	11.2	5.1	31.2	9.6	15.6	17.9	9.0	5.1	12.1	20.7	22.6	24.4	21.9	5.1	27.7	12.2	33.1	12.0	576.6	19.9	17.4	17.8	1.9	28.3	31.2	30.9	9.0	10.3	21.8	37.2	19.9	16.7	10.1	59.2	54.1	38.4	27.4	6.6	17.2	20.2	34.5	8.5	11.2	7.1	4.7	23.2	15.1	23.6	8.5
ZNF689	"FLJ90415, TIPUH1"	ENSG00000156853	"Zinc finger protein 689"	Q96CS4	16	30602558-30624012	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 19.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.0;Late spermatids: 52.0;Spermatocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054095, HPA055385"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA054095: AB_2682377, HPA055385: AB_2682801"	"unprognostic (5.62e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	3.5	3.5	3.4	3.5	3.5	6.6	10.2	3.4	3.7	4.3	2.4	4.5	4.8	5.4	2.7	2.3	4.1	2.9	3.7	3.3	3.4	3.2	4.3	3.5	4.1	3.4	3.3	5.4	4.8	7.1	3.5	3.2	3.1	3.6	3.1	2.8	3.4	4.7	5.1	2.6	4.3	4.1	3.3	4.7	3.8	19.5	3.4	5.9	3.9	5.5	4.0	4.2	3.0	3.6	4.6	8.1	11.1	11.6	4.7	4.6	5.5	5.6	8.2	9.0	8.7	9.5	3.5	13.2	8.6	5.0	6.5	3.5	14.0	6.1	7.1	10.9	23.6	11.2	7.1	14.7	5.0	11.1	8.2	4.4	5.7	6.2	6.1	4.9	6.4	12.0	13.4	7.4	5.8	6.9	20.6	10.4	12.6	3.6	8.2	25.7	10.7	11.9	3.8	4.5	13.8	8.4	4.1	7.4	6.4	5.5	7.7	9.6	5.0	11.6	4.9	5.6	7.8	13.6	16.8	15.7	4.2	12.0	11.5	0.1	6.2	2.5	5.1	9.3	3.7	3.8	4.2	5.2	8.9	2.9	3.6	3.5	0.4	8.8	10.3	3.2	4.5	4.4	3.4	3.5	3.4	3.7	3.3	3.4	3.4	3.3	3.1	3.3	3.4	3.6	10.5	3.2	2.0	1.3	8.4	1.7	4.9	2.6	1.8	10.0	25.4	20.7	4.7	11.5	1.2	1.8	6.2	4.3	10.2	5.9	0.0	6.2	53.0	2.3	5.7	8.6	6.0	6.1	2.4	6.9	3.2	6.3	3.6	3.3	14.0	8.0	8.6	6.9	5.1	10.1	2.7	6.5	6.1	8.6	4.3	52.0	8.1	6.6	0.0	3.7	6.9	5.8	8.2	2.0	3.0	5.2	4.8	10.5	6.6	5.5	7.9	4.3	1.5	6.1	0.0	11.5	5.8	87.7	8.9	2.1	1.0	0.8	8.8	6.6	6.6	3.0
ZNF69	Cos5	ENSG00000198429	"Zinc finger protein 69"	Q9UC07	19	11887782-11914329	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Late spermatids: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 12.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.8"									HPA047845	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (1.08e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.97e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.83e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.93e-2)"	2.6	5.0	2.0	2.7	1.8	2.6	3.3	2.1	2.1	5.1	8.2	7.8	2.2	2.7	2.5	0.9	5.5	4.4	2.6	2.4	2.1	9.4	8.8	3.2	2.2	3.1	2.8	6.9	7.5	14.6	2.0	2.4	2.8	4.8	8.0	1.4	4.1	2.2	1.0	1.3	3.5	1.2	1.3	2.2	9.0	4.8	2.0	3.6	3.3	0.9	1.9	3.8	2.1	2.1	5.6	0.1	13.8	8.0	1.5	0.1	4.8	8.2	5.7	4.4	5.5	3.7	2.2	3.5	4.7	4.7	3.5	0.1	0.1	3.1	4.6	0.1	0.1	1.6	0.2	8.0	1.1	0.0	3.3	2.2	0.0	1.6	0.2	2.1	0.1	4.9	0.0	0.2	9.2	0.1	4.3	0.8	8.6	0.5	0.0	0.1	3.1	0.1	10.4	3.9	1.3	3.9	0.0	0.2	1.8	6.6	7.3	2.3	0.4	3.6	2.4	3.7	4.6	3.7	3.6	0.1	0.1	0.0	11.3	12.6	1.5	1.1	1.7	1.5	1.7	0.8	1.2	0.7	1.7	0.5	3.2	3.3	0.7	2.5	0.9	1.2	1.0	1.5	2.0	1.8	2.1	2.1	2.4	2.1	3.1	2.8	2.8	1.3	2.0	2.1	1.4	3.2	10.9	11.8	0.6	0.3	1.3	2.5	1.2	0.7	2.6	2.3	2.4	18.6	4.9	5.5	0.0	3.6	1.1	2.9	3.9	6.8	8.8	6.5	2.4	2.6	0.0	10.7	11.4	3.5	3.2	1.6	13.3	2.4	7.6	8.3	5.0	11.9	2.8	0.0	5.6	5.7	0.0	3.1	1.2	24.2	2.5	2.6	5.4	8.4	0.9	0.9	0.0	14.6	6.0	10.1	3.7	1.9	1.6	1.2	2.0	11.3	3.9	0.2	13.1	0.9	1.8	4.3	4.3	0.5	0.1	1.9	1.4	2.1	4.9	2.8
ZNF691	Zfp691	ENSG00000164011	"Zinc finger protein 691"	Q5VV52	1	42846573-42852477	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062527	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA062527: AB_2684791"	"unprognostic (4.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (7.33e-6)"	"unprognostic (1.40e-3)"	"unprognostic (2.65e-3)"	"unprognostic (5.12e-2)"	"prognostic favorable (6.25e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	5.9	9.8	11.0	8.8	11.9	2.3	11.2	11.4	14.4	11.1	11.7	9.7	6.5	9.9	15.1	6.1	9.9	6.1	9.1	10.6	11.7	11.6	18.2	7.3	13.0	12.3	11.5	13.0	8.9	13.6	9.2	9.3	12.1	10.5	7.2	11.3	9.8	11.0	8.0	9.5	7.5	9.5	11.1	12.1	7.7	6.7	12.3	15.5	12.1	9.9	12.7	9.0	7.0	12.6	6.6	9.1	18.1	15.0	16.0	12.2	2.3	7.7	9.3	12.4	12.3	6.5	9.5	16.2	11.8	7.3	6.2	11.5	17.6	10.3	10.6	29.3	17.8	17.0	27.2	11.7	11.9	6.6	3.5	10.6	12.3	15.6	12.7	15.1	12.8	15.8	16.8	6.9	12.3	5.3	19.8	8.7	27.1	7.2	6.8	13.2	22.8	11.2	11.6	6.2	13.0	12.9	7.9	14.2	13.3	26.9	7.8	22.2	6.7	12.3	12.8	7.0	8.6	16.5	14.0	4.7	8.6	7.8	10.6	24.5	12.7	19.2	12.9	11.5	17.0	17.2	17.4	17.8	12.7	23.4	16.8	16.6	6.9	21.3	12.4	14.1	23.1	14.8	11.0	11.9	11.4	14.4	10.6	11.7	12.3	11.5	12.1	11.1	12.3	12.6	3.6	6.4	2.7	2.6	4.1	1.8	2.7	4.1	2.8	2.5	4.5	5.6	6.5	10.0	2.7	5.5	4.2	6.5	1.4	1.4	7.9	5.5	6.8	1.2	3.3	5.1	3.0	3.0	2.0	3.8	5.3	4.3	3.1	1.2	5.1	5.3	5.0	7.6	6.8	1.7	2.3	2.8	6.1	4.1	1.2	3.2	7.2	3.0	1.8	3.7	3.1	6.4	5.2	5.0	4.1	2.3	3.2	7.2	2.3	3.2	3.5	9.6	3.2	4.2	0.0	2.3	3.2	10.4	7.4	3.1	0.9	3.3	3.3	5.3	2.4	1.2
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	13.0	16.5	35.1	4.7	36.3	7.5	16.3	36.3	48.5	26.6	34.1	20.1	5.1	17.1	8.2	23.2	25.3	4.9	18.0	35.0	34.7	27.0	21.7	12.5	6.2	36.5	35.5	27.6	28.2	7.4	29.1	4.2	37.7	34.9	3.6	8.5	17.8	5.3	17.7	18.7	16.6	3.8	34.1	23.5	19.7	38.9	35.7	7.0	24.7	4.7	4.4	21.3	20.8	36.8	7.1	6.4	6.1	14.7	4.7	2.5	26.4	6.1	1.9	6.2	4.0	8.2	9.8	8.8	11.7	2.3	2.5	9.5	9.1	8.8	3.9	12.6	5.7	9.9	17.8	2.2	3.5	11.4	8.3	3.2	10.2	6.8	17.5	5.8	5.9	11.1	21.1	6.2	2.9	3.8	5.9	23.7	12.2	17.1	13.1	19.3	3.6	16.9	11.9	4.5	11.7	8.8	6.3	10.1	12.2	2.3	13.1	18.5	4.5	2.7	5.0	2.7	8.0	17.0	11.3	5.8	6.2	14.9	4.7	0.0	1.5	1.4	3.6	1.1	3.3	3.0	2.9	4.0	3.1	2.3	4.1	3.0	3.3	8.1	1.0	2.5	3.5	2.0	35.1	36.3	36.3	48.5	35.0	34.7	36.5	35.5	37.7	34.1	35.7	36.8	7.8	9.6	8.6	27.1	10.7	9.6	12.5	19.0	11.4	15.3	16.8	18.7	5.4	7.2	10.8	11.0	22.9	12.8	10.3	10.0	5.9	7.6	14.3	6.1	7.0	6.7	8.3	22.7	20.6	4.0	10.4	8.1	15.8	6.8	5.7	15.9	2.9	6.2	6.5	11.8	19.7	12.3	12.2	6.0	5.5	7.8	10.2	5.4	16.0	10.3	6.1	8.3	9.2	8.5	23.5	5.7	5.2	7.2	6.6	17.3	11.6	4.1	10.8	13.6	0.0	8.4	8.0	52.7	15.4	11.0	8.0	6.2	11.3	9.5	14.3	10.0
ZNF696	FLJ14129	ENSG00000185730	"Zinc finger protein 696"	Q9H7X3	8	143289676-143299952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA057855, HPA072473"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA057855: AB_2683545, HPA072473: AB_2686524"	"unprognostic (3.23e-2)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (3.52e-5)"	"unprognostic (2.58e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.76e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (6.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.09e-3)"	4.0	3.3	3.9	3.3	3.7	3.5	3.2	5.9	6.1	3.4	0.0	3.3	6.0	4.5	2.5	2.6	3.4	2.1	2.8	4.2	2.5	3.3	4.6	2.8	3.8	5.6	3.0	4.7	5.0	4.3	3.2	2.7	5.0	3.1	1.9	3.6	5.7	2.3	3.9	6.6	3.7	2.3	0.9	4.0	3.3	3.5	3.4	2.1	3.7	2.4	3.0	3.7	2.8	4.9	8.2	7.4	7.8	8.8	3.2	2.5	14.9	6.3	2.4	4.4	2.7	4.3	6.3	0.7	8.2	2.5	2.5	5.8	8.5	3.8	4.5	9.1	17.9	10.8	8.8	6.7	3.4	4.5	13.5	2.4	6.1	3.0	6.8	3.3	2.2	6.4	22.2	5.3	3.1	17.3	4.6	8.8	10.2	9.7	17.1	9.8	4.4	8.1	3.0	6.3	11.6	16.1	9.3	6.7	8.2	5.3	10.3	8.1	4.5	6.2	13.4	5.5	10.9	9.7	7.3	10.0	4.2	9.2	7.5	1.2	2.0	1.7	2.9	1.1	3.0	2.4	2.1	3.1	2.1	3.2	3.9	3.5	1.2	3.5	2.0	3.8	0.7	1.9	3.9	3.7	5.9	6.1	4.2	2.5	5.6	3.0	5.0	0.9	3.4	4.9	2.2	0.0	0.0	3.6	3.0	2.9	2.3	0.6	0.0	5.3	1.5	1.3	2.8	2.8	0.3	3.7	6.2	1.7	1.8	2.1	3.9	2.4	1.2	0.8	2.3	2.5	0.0	1.3	3.4	2.0	1.8	1.9	2.0	1.0	0.0	2.9	2.2	2.2	1.2	3.3	3.9	1.0	2.0	0.9	0.7	2.4	4.1	0.7	1.8	1.0	0.9	1.8	6.2	4.5	3.1	1.5	0.3	1.2	2.3	1.7	2.7	1.9	0.3	4.5	6.6	1.7	2.2	3.0	5.7	1.1	2.0	0.4	2.5	2.7	2.0	0.6
ZNF697	MGC45731	ENSG00000143067	"Zinc finger protein 697"	Q5TEC3	1	119619377-119648266	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.0;Syncytiotrophoblasts: 19.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 14.4"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3;cerebral cortex: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 42.8;WM-115: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049933	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA049933: AB_2680958"	"unprognostic (2.57e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (6.20e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.36e-1)"	4.1	2.9	0.9	1.4	3.3	1.0	3.4	0.0	3.2	1.5	0.0	1.3	1.7	2.2	2.3	0.8	1.4	1.5	4.3	1.5	0.0	7.5	3.1	4.4	0.6	0.0	0.0	2.0	2.8	4.9	2.8	6.9	0.0	4.2	1.4	0.9	5.4	1.0	2.1	1.6	1.5	1.2	0.0	1.4	1.8	3.1	0.2	0.5	3.2	1.9	0.4	2.0	1.0	0.0	2.0	1.0	4.9	1.6	6.4	7.0	6.6	8.8	12.2	5.1	4.6	3.1	0.4	0.0	2.9	4.9	4.0	2.2	3.8	8.7	11.9	0.0	3.8	3.3	2.0	5.9	12.2	2.2	2.2	11.9	2.4	11.4	24.2	5.6	10.1	2.8	3.0	0.4	2.3	1.5	0.0	1.6	26.1	1.8	2.9	0.0	11.8	0.2	2.4	4.5	1.1	6.8	2.0	2.1	42.8	15.4	1.0	3.1	23.4	8.4	10.7	6.0	15.4	1.2	2.0	0.0	11.9	2.3	42.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	3.3	0.0	3.2	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.5	1.3	0.1	2.2	1.5	2.5	0.6	0.8	1.7	0.6	8.8	1.5	1.9	1.8	0.0	7.9	0.0	0.7	3.9	1.8	1.6	1.1	2.6	3.5	2.4	0.0	17.0	0.9	2.3	4.3	1.5	1.8	0.0	5.5	3.3	4.2	2.6	0.0	6.9	2.1	4.1	3.7	12.0	3.6	4.7	3.1	5.4	4.7	2.7	1.1	0.0	8.0	0.6	2.1	3.3	6.4	0.0	3.7	1.8	6.4	0.4	0.9	6.6	0.5	5.4	1.3	1.5	0.4	1.8	19.8	0.1	5.3	1.8	0.9
ZNF700	DKFZp434I1610	ENSG00000196757	"Zinc finger protein 700"	Q9H0M5	19	11925068-11950773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA047845	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (8.63e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (9.02e-2)"	"unprognostic (7.44e-2)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (8.38e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (2.53e-5)"	12.1	12.2	4.2	6.5	4.3	17.0	12.4	5.8	5.3	12.7	4.9	15.1	6.1	9.3	8.6	13.7	10.3	4.7	7.7	4.1	4.2	19.4	21.0	13.9	10.4	4.4	4.5	13.9	19.1	7.9	11.2	5.0	4.6	13.8	10.8	9.6	12.2	4.6	5.2	16.6	18.0	4.7	4.2	23.4	14.1	11.3	4.5	8.4	12.3	3.1	11.2	11.6	13.8	4.9	8.0	0.4	8.4	8.7	5.2	5.7	8.5	8.4	7.2	7.4	9.7	6.6	3.9	10.6	7.2	5.4	5.0	6.2	6.9	6.1	10.2	6.0	3.6	11.0	8.2	5.9	4.4	15.6	15.5	4.7	7.1	6.3	7.1	5.0	4.7	6.9	12.4	23.0	10.8	6.5	8.7	14.3	8.6	4.8	7.7	7.3	11.1	8.2	10.5	9.2	4.9	5.9	7.6	5.0	10.1	7.6	8.7	17.7	6.8	18.9	4.9	13.0	9.8	15.9	9.0	10.9	5.0	12.7	6.3	4.8	2.3	4.7	3.2	2.5	3.7	3.2	2.6	4.0	3.2	1.9	2.5	3.2	3.7	3.2	4.4	2.1	3.4	1.9	4.2	4.3	5.8	5.3	4.1	4.2	4.4	4.5	4.6	4.2	4.5	4.9	5.4	9.6	14.1	12.1	7.6	3.1	1.7	2.2	3.4	2.3	5.0	3.9	4.1	8.6	7.4	1.8	2.1	5.2	7.4	9.4	1.9	5.8	0.6	2.2	2.9	5.1	3.0	3.8	15.0	4.5	4.6	2.7	8.2	2.6	16.4	6.5	6.1	7.3	4.5	0.0	13.4	7.7	6.1	7.8	5.0	1.5	4.4	6.8	5.4	30.0	3.9	2.4	9.2	13.0	17.9	5.3	9.7	1.9	3.0	1.9	5.5	2.1	3.7	4.8	0.0	2.6	5.5	11.5	6.8	3.0	1.7	3.7	6.5	3.0	9.1	1.4
ZNF701	FLJ10891	ENSG00000167562	"Zinc finger protein 701"	Q9NV72	19	52555457-52587174	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 28.6"									HPA005532	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centriolar satellite"	"HPA005532: AB_1080746"	"unprognostic (1.21e-1)"	"unprognostic (4.98e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.40e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.46e-4)"	"unprognostic (3.75e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.17e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.89e-5)"	5.1	4.1	3.9	6.4	5.6	10.1	7.9	6.7	4.5	5.7	7.4	5.6	5.0	5.7	7.2	4.3	6.2	5.0	5.7	4.8	4.2	6.3	2.7	5.7	8.0	5.3	4.4	6.2	4.7	6.2	4.4	7.6	6.0	6.5	6.7	6.3	5.8	4.7	5.7	7.3	6.4	4.7	3.2	7.3	6.4	6.1	4.9	9.3	9.4	5.7	7.1	5.5	5.7	8.3	2.3	0.3	5.0	8.9	5.5	6.5	9.2	5.9	5.8	7.8	8.1	4.6	5.5	11.0	3.3	4.6	7.6	3.5	2.3	6.3	8.3	0.4	6.6	3.0	9.3	1.1	5.6	0.4	14.1	6.8	5.0	6.0	10.1	4.0	7.4	5.8	15.0	1.4	7.2	1.8	11.3	5.2	4.8	2.9	8.0	11.8	6.6	4.6	6.2	28.6	4.9	5.4	3.9	10.1	3.1	10.1	12.9	6.2	7.3	6.2	3.1	3.0	10.7	1.1	7.1	14.4	0.2	12.4	10.1	21.6	9.0	18.1	9.3	9.8	7.9	9.2	7.3	8.2	6.7	9.0	8.5	9.1	23.0	14.2	7.7	6.6	9.1	7.0	3.9	5.6	6.7	4.5	4.8	4.2	5.3	4.4	6.0	3.2	4.9	8.3	7.2	0.0	6.1	4.6	11.1	2.2	6.7	6.0	0.6	5.4	6.3	7.6	4.8	4.3	7.7	14.7	14.6	13.5	13.8	8.9	3.9	6.8	2.3	9.2	7.8	7.3	2.4	5.2	2.1	3.9	9.7	5.5	5.6	9.7	2.5	13.6	6.4	0.6	5.3	3.3	2.4	6.2	8.2	5.5	8.2	1.2	6.2	6.8	3.6	3.7	9.9	3.8	15.5	3.5	5.9	5.5	8.8	3.8	3.0	8.2	13.1	3.7	9.7	6.0	0.0	3.7	7.0	3.8	10.8	3.0	3.7	23.5	9.9	7.2	3.8	11.7
ZNF704	"FLJ16218, Gig1"	ENSG00000164684	"Zinc finger protein 704"	Q6ZNC4	8	80628451-80874781	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 170.8;Oligodendrocyte precursor cells: 299.6;Oligodendrocytes: 342.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 72.8;RH-30: 46.0;SH-SY5Y: 58.4;SK-BR-3: 72.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024285, HPA024302"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA024285: AB_2219847, HPA024302: AB_1859427"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (4.02e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.90e-2)"	9.9	5.3	14.6	1.8	18.3	0.7	8.5	27.5	12.0	18.7	0.0	7.3	2.8	16.9	7.2	3.0	13.3	6.3	12.2	12.0	9.7	9.2	3.7	7.5	1.4	14.4	14.4	19.8	20.0	13.8	2.2	5.1	12.8	10.2	6.1	2.5	14.9	8.3	6.5	5.0	4.7	7.2	10.7	3.2	5.2	4.4	14.3	6.9	6.0	7.9	1.1	6.4	7.6	29.9	0.0	2.6	11.5	0.1	0.0	0.0	15.7	0.1	0.0	0.1	0.0	1.3	1.9	0.1	4.5	0.0	0.9	72.8	1.1	2.0	0.0	0.0	12.1	4.3	5.7	9.8	0.0	0.8	0.3	0.4	0.1	0.0	0.3	0.1	4.7	0.6	0.0	0.4	0.1	7.6	11.2	0.2	1.0	6.3	1.1	7.7	46.0	0.2	0.0	25.4	14.5	58.4	2.3	72.2	21.3	3.8	11.6	1.6	0.2	0.0	11.8	0.2	2.5	0.1	0.1	0.3	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.6	18.3	27.5	12.0	12.0	9.7	14.4	14.4	12.8	10.7	14.3	29.9	31.6	51.3	25.9	63.0	0.4	18.5	25.5	4.8	16.5	21.3	28.6	23.4	35.0	21.5	16.5	25.8	0.0	8.8	1.1	20.7	5.9	21.6	20.0	25.5	52.6	21.9	13.8	3.8	112.8	24.5	6.5	40.1	10.7	35.9	27.8	28.7	30.0	10.6	3.2	20.2	170.8	24.7	8.2	5.7	15.7	46.8	32.9	3.6	32.0	56.2	0.0	17.0	0.0	299.6	342.4	9.4	26.5	25.6	0.2	34.7	17.9	18.1	12.8	3.1	13.1	45.1	29.5	1.8	4.2	5.4	5.1	2.9	3.4	60.3	26.2	36.2
ZNF707		ENSG00000181135	"Zinc finger protein 707"	Q96C28	8	143684452-143713898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 19.7;NK-cells: 12.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA044991	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA044991: AB_10961134"	"unprognostic (5.12e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (1.73e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.23e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.08e-2)"	3.3	3.3	1.0	1.8	1.1	1.7	3.4	0.7	1.3	4.0	1.3	3.5	1.5	3.8	1.8	3.7	3.3	1.3	3.0	0.9	0.9	4.9	3.4	3.9	2.6	1.0	0.9	2.9	4.2	1.7	3.7	1.1	0.9	4.1	0.8	0.9	3.8	1.1	1.8	5.9	4.2	1.0	0.7	8.0	3.5	7.4	1.1	2.1	4.5	1.4	1.8	3.6	3.5	1.3	1.7	2.2	2.4	2.6	2.4	2.2	2.4	2.5	1.7	2.7	1.3	1.5	2.4	1.6	2.7	1.6	1.2	2.1	2.5	2.9	1.7	3.3	0.9	4.3	5.7	2.3	1.6	1.1	2.0	2.3	3.3	3.6	2.2	2.3	2.4	2.0	2.0	1.6	0.7	3.6	4.5	1.3	0.1	1.8	3.8	3.0	1.5	1.6	1.4	1.5	1.8	2.1	3.3	2.3	3.0	1.6	3.0	2.3	3.8	1.6	5.5	2.0	3.8	3.3	1.4	0.7	2.3	2.4	1.2	0.3	0.2	0.4	0.5	0.1	0.4	0.2	0.3	0.3	0.2	0.1	0.2	0.3	0.3	0.9	0.1	0.3	0.4	0.2	1.0	1.1	0.7	1.3	0.9	0.9	1.0	0.9	0.9	0.7	1.1	1.3	2.4	0.0	1.5	2.9	3.6	2.8	2.7	2.4	5.2	2.7	2.2	1.8	1.9	0.0	2.0	3.7	0.0	2.1	5.6	2.8	3.9	1.9	19.7	1.4	1.8	1.5	0.0	0.4	1.9	1.3	2.5	1.6	2.0	2.5	1.3	3.6	3.3	1.1	1.9	1.7	1.2	1.8	0.0	3.5	4.3	5.3	1.2	2.4	0.0	1.9	5.2	0.6	12.3	1.0	1.2	1.7	2.1	2.2	4.3	2.2	1.9	0.9	1.6	3.4	6.6	1.0	1.5	4.3	3.1	2.3	3.1	2.6	4.8	2.6	1.6	2.2
ZNF709	FLJ38281	ENSG00000242852	"Zinc finger protein 709"	Q8N972	19	12461184-12513854	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 15.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 39.8;Excitatory neurons: 14.5;Inhibitory neurons: 14.8;Late spermatids: 35.7;Oligodendrocyte precursor cells: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA045573, HPA053153"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA045573: AB_2679370, HPA053153: AB_2682060"	"unprognostic (2.27e-1)"	"unprognostic (7.40e-4)"	"unprognostic (3.53e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.58e-4)"	"unprognostic (6.76e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.53e-5)"	1.0	0.9	1.8	0.8	2.0	0.5	1.6	2.7	2.5	1.6	1.5	0.9	0.0	1.4	1.6	0.6	2.1	0.6	1.0	2.1	2.4	1.6	0.4	0.8	0.8	3.2	2.2	2.7	1.2	2.3	1.6	1.0	1.7	1.7	0.5	3.1	1.1	1.3	0.9	0.8	0.8	1.1	1.8	1.3	0.8	15.3	2.9	2.1	2.9	1.0	1.2	0.9	1.2	1.6	1.1	0.0	3.6	4.4	0.6	1.0	0.6	1.1	1.3	1.2	1.3	1.0	0.1	1.1	0.7	1.2	0.3	0.8	2.0	0.8	1.4	0.3	0.5	1.0	0.7	0.7	1.4	0.2	1.6	0.5	0.3	0.7	0.0	1.7	0.8	1.4	0.6	0.1	1.5	2.1	2.6	1.3	1.3	0.4	1.1	1.3	3.5	3.5	1.2	1.8	1.6	2.3	0.0	0.1	0.5	1.6	0.8	0.6	0.0	1.8	0.4	0.8	0.8	2.0	3.0	1.6	0.0	0.0	0.9	2.7	0.1	0.0	0.9	0.0	1.4	0.9	1.5	0.9	0.4	0.9	2.0	1.4	0.0	2.5	0.6	0.6	0.9	0.4	1.8	2.0	2.7	2.5	2.1	2.4	3.2	2.2	1.7	1.8	2.9	1.6	0.7	0.0	0.5	8.5	1.3	0.4	0.2	0.3	0.0	0.8	0.8	0.4	0.5	0.0	0.8	1.8	0.0	0.4	0.5	0.4	0.0	0.4	39.8	1.5	0.6	0.6	0.0	0.8	14.5	0.4	0.3	0.4	0.5	0.5	0.0	2.3	1.4	0.4	0.5	0.0	14.8	0.5	0.0	1.3	0.4	35.7	0.9	0.5	0.0	7.5	0.1	1.5	0.0	17.6	8.2	0.3	0.1	0.7	0.6	0.4	0.1	1.2	1.0	2.3	6.6	0.6	1.0	6.8	3.3	0.6	0.6	0.3	0.5	0.4	0.3	0.2
ZNF71	"Cos26, EZFIT"	ENSG00000197951	"Zinc finger protein 71"	Q9NQZ8	19	56595300-56626481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.6"									HPA018124	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoli	Nucleoplasm	"HPA018124: AB_1848339"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.03e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.97e-3)"	3.3	2.1	3.1	2.0	2.9	1.1	3.1	2.4	4.8	3.3	0.0	3.9	1.3	4.3	1.3	2.5	3.1	1.9	3.9	4.9	2.0	2.4	0.9	2.4	3.0	1.9	2.5	3.6	2.5	2.4	2.9	2.1	1.7	3.1	1.1	3.3	2.5	2.7	3.5	2.8	2.2	2.5	1.0	2.7	2.5	3.2	2.0	3.2	2.3	2.7	1.5	3.5	2.7	2.3	3.1	7.9	9.1	8.7	3.1	3.3	5.7	3.2	3.9	3.6	4.0	1.5	1.4	3.3	3.2	3.5	3.3	1.1	2.0	3.5	2.1	0.0	20.6	5.4	0.9	3.0	3.7	6.4	4.3	4.7	3.4	3.1	2.6	4.0	4.6	7.2	2.3	0.0	3.4	0.0	12.5	2.3	9.0	0.0	7.9	4.8	6.9	3.0	2.1	5.8	9.0	10.5	2.9	4.5	4.4	3.7	3.4	6.3	5.3	10.5	5.1	2.6	6.4	2.2	3.0	5.0	3.0	3.8	3.1	2.9	1.7	3.5	4.3	1.4	4.5	3.2	3.3	3.6	2.8	3.5	3.4	3.6	0.6	6.1	2.6	2.3	3.7	2.6	3.1	2.9	2.4	4.8	4.9	2.0	1.9	2.5	1.7	1.0	2.0	2.3	8.9	3.2	1.7	3.9	4.5	2.9	2.8	3.8	2.8	9.3	4.8	4.3	3.9	4.3	2.0	7.3	4.2	4.9	5.5	0.6	3.9	10.1	2.7	2.5	3.5	9.8	2.4	2.5	7.4	4.9	6.8	4.6	1.5	2.1	0.0	7.8	3.6	1.0	5.7	11.8	6.6	2.1	4.1	2.4	5.2	3.6	6.2	3.5	3.6	1.9	4.2	3.4	12.3	5.0	4.8	6.3	1.9	5.7	1.4	2.4	1.0	5.8	0.9	8.1	0.0	5.1	6.3	7.4	10.7	2.3	4.3	1.5	5.5	5.5	2.3	1.4
ZNF710	"DKFZp547K1113, FLJ00306, FLJ37393"	ENSG00000140548	"Zinc finger protein 710"	Q8N1W2	15	90001324-90082206	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 44.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.8;Microglial cells: 149.9;Oligodendrocytes: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;granulocytes: 1.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 44.8"					"Low region specificity"	"Detected in all"			"HPA030226, HPA030227, HPA030228"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899"	"unprognostic (6.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.65e-2)"	3.6	4.3	12.0	14.7	13.0	8.7	5.4	6.4	11.2	6.3	3.1	8.3	9.1	5.3	5.0	17.1	5.2	7.0	10.0	6.9	8.8	5.7	5.3	9.8	10.0	12.2	13.6	4.8	44.2	3.3	4.5	5.7	12.9	7.5	6.9	1.2	9.6	4.3	33.4	12.6	8.0	3.4	10.4	14.2	10.2	1.7	12.4	5.6	6.2	1.5	6.5	7.7	9.2	11.5	9.2	10.7	20.1	7.6	2.7	4.0	10.5	9.4	8.8	6.8	8.6	7.7	8.3	9.3	4.3	9.1	6.4	6.2	5.1	13.5	3.8	6.0	9.4	17.1	4.6	13.1	5.5	5.0	25.6	6.6	7.2	14.6	7.9	3.2	11.8	10.0	5.8	6.2	2.6	23.7	11.1	13.9	15.8	11.3	6.9	13.5	4.5	10.2	2.7	11.4	18.3	12.3	12.5	44.8	6.4	5.2	9.6	17.2	17.1	13.9	6.8	4.2	7.4	5.0	2.7	9.0	10.6	14.6	7.4	0.0	1.6	1.2	0.2	3.5	0.2	0.1	0.1	0.2	1.2	0.1	0.4	0.4	1.9	0.2	5.7	1.4	0.5	0.7	12.0	13.0	6.4	11.2	6.9	8.8	12.2	13.6	12.9	10.4	12.4	11.5	1.7	3.2	8.2	38.8	2.7	5.4	4.7	2.8	1.8	1.4	7.1	3.6	12.1	4.3	6.3	11.0	2.1	2.3	6.8	7.7	0.0	3.6	0.8	4.0	4.1	4.3	4.8	2.5	10.2	6.1	3.0	3.1	7.1	6.2	1.3	2.1	5.7	1.6	11.6	3.3	12.0	8.1	0.0	15.8	33.5	5.5	2.5	15.7	1.8	149.9	13.3	1.4	2.1	22.1	36.4	10.1	11.5	3.0	3.8	8.5	2.3	0.8	3.6	0.9	6.6	1.6	3.0	0.3	2.5	4.3	7.5	2.3	2.5	2.0	6.5	13.7
ZNF711	"CMPX1, dJ75N13.1, MRX65, MRX97, Zfp711, ZNF4, ZNF5, ZNF6"	ENSG00000147180	"Zinc finger protein 711"	Q9Y462	X	85243991-85273362	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 37.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AF22: 34.4;HAP1: 50.3;HEK 293: 46.0;Karpas-707: 30.7;MOLT-4: 28.4;RH-30: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030654	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA030654: AB_10670561"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (9.11e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.62e-3)"	1.4	15.1	6.3	1.6	8.0	7.2	5.7	6.7	7.9	5.8	1.7	3.6	3.1	9.2	2.8	2.6	4.6	4.1	3.8	7.7	7.6	5.1	0.5	1.8	2.4	5.7	6.3	9.4	4.9	1.4	10.9	7.7	5.2	4.0	1.7	5.7	4.1	2.6	1.6	12.2	4.6	3.3	6.5	5.0	2.7	37.3	7.5	16.3	4.9	1.5	2.5	3.0	3.2	5.5	0.0	3.3	34.4	27.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	7.5	3.0	0.1	1.2	0.5	5.5	0.7	50.3	0.0	0.0	0.0	46.0	16.5	0.9	1.9	1.3	0.0	0.4	3.2	0.3	0.0	6.3	0.0	0.3	15.6	5.1	30.7	6.1	1.7	28.4	0.0	16.7	3.1	0.7	0.0	41.9	0.0	0.0	2.5	10.0	25.8	0.1	0.9	0.0	20.0	4.6	4.5	0.1	0.0	11.1	0.1	0.0	11.4	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	8.0	6.7	7.9	7.7	7.6	5.7	6.3	5.2	6.5	7.5	5.5	1.8	3.2	1.1	14.0	3.6	12.0	7.6	2.7	18.2	9.0	18.1	17.4	6.6	1.5	1.8	1.8	0.0	0.3	1.0	0.3	5.9	2.1	2.7	2.9	18.8	4.2	18.5	5.9	19.0	0.5	0.1	8.1	1.1	4.2	0.0	15.2	3.6	0.1	0.3	3.3	21.3	2.3	2.0	0.6	3.2	5.7	3.1	0.9	5.4	11.2	0.1	7.8	0.0	38.2	12.0	0.6	1.9	3.8	2.2	3.0	0.9	2.7	1.2	1.4	0.0	8.7	8.1	13.0	23.6	10.9	9.1	0.3	0.9	12.6	2.6	2.9
ZNF717	"X17, ZNF838"	ENSG00000227124	"Zinc finger protein 717"		3	75678660-75785583	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 47.7"									HPA044549	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA044549: AB_10964630"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.60e-6)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	5.1	5.7	7.6	3.3	9.6	2.8	7.3	7.7	9.5	5.7	4.4	5.1	5.7	5.9	15.4	5.4	7.2	4.5	5.9	7.2	8.1	9.9	7.9	4.6	4.8	9.0	8.5	7.9	8.9	8.3	9.3	5.0	9.2	6.7	6.6	7.8	7.2	4.7	4.2	9.9	5.2	4.2	8.5	7.1	7.4	8.2	8.7	4.7	9.3	4.4	7.1	5.8	5.4	12.3	11.4	5.8	5.2	3.6	6.1	8.5	3.9	3.5	5.2	5.1	5.9	9.4	9.8	5.2	4.6	6.0	5.0	6.3	6.8	4.5	4.2	0.5	7.0	8.6	9.4	0.9	15.9	0.5	8.6	10.4	4.8	12.8	17.4	4.3	0.7	0.5	47.7	11.6	5.7	1.8	0.6	17.1	5.2	8.9	6.3	7.7	4.5	27.0	7.6	3.8	4.2	17.4	3.5	6.6	14.6	5.1	16.8	4.6	1.6	9.3	10.9	6.4	1.4	12.0	19.9	5.2	4.7	1.3	6.0	1.3	2.6	5.1	2.1	3.8	1.2	5.1	3.3	2.0	2.7	6.1	6.3	3.7	0.7	3.0	3.8	4.1	1.1	2.0	7.6	9.6	7.7	9.5	7.2	8.1	9.0	8.5	9.2	8.5	8.7	12.3	6.6	3.2	3.1	28.1	6.0	3.2	4.2	3.4	5.2	8.5	9.1	8.3	5.6	8.6	4.2	7.3	2.1	5.2	5.8	2.2	11.7	4.6	5.0	3.4	4.8	5.1	5.3	7.4	21.7	4.4	1.8	5.7	4.6	2.6	8.9	11.4	7.9	8.2	7.3	10.1	27.2	7.0	4.1	5.7	4.1	2.1	2.5	4.5	1.8	16.9	5.0	5.2	5.2	25.6	35.4	3.9	2.0	3.0	0.7	5.1	6.3	17.5	6.3	8.1	0.0	5.1	5.3	11.1	8.6	7.0	4.4	3.4	3.1	7.9	5.0	3.9
ZNF720		ENSG00000197302	"Zinc finger protein 720"	Q7Z2F6	16	31713229-31794869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA041570	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041570: AB_10795126"	"unprognostic (5.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-3)"	"unprognostic (8.72e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.47e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-2)"	6.0	6.9	5.9	6.8	5.7	6.5	7.2	10.8	6.4	5.1	5.9	7.3	4.1	6.2	9.4	7.8	7.0	5.9	4.6	5.7	6.3	8.7	6.7	6.1	11.0	6.8	7.3	4.4	7.2	7.2	7.3	9.2	7.7	7.9	7.9	6.1	5.8	7.0	6.3	10.0	5.3	6.1	6.6	8.2	8.3	8.2	6.5	7.4	7.7	4.4	10.8	6.2	5.7	6.3	15.1	10.5	12.6	10.7	10.9	16.5	12.4	15.9	10.1	7.6	10.1	7.9	15.8	7.3	27.2	5.3	11.2	10.2	12.7	6.2	11.3	32.7	6.6	4.1	5.7	21.8	16.4	8.8	21.6	11.1	16.7	5.3	7.3	15.1	14.3	17.4	13.8	9.4	8.3	24.5	8.9	11.6	12.5	10.4	8.2	17.0	5.7	11.5	8.5	9.4	5.6	8.6	15.9	6.8	15.4	19.9	13.5	17.3	9.5	5.5	4.3	11.1	4.9	15.5	18.3	21.0	4.9	13.3	8.8	21.2	6.7	33.7	18.6	7.6	14.3	19.9	13.0	17.2	7.4	20.3	12.2	15.1	8.8	20.2	8.5	12.9	18.1	6.8	5.9	5.7	10.8	6.4	5.7	6.3	6.8	7.3	7.7	6.6	6.5	6.3	19.4	16.0	21.0	25.8	19.8	9.1	16.9	23.4	6.8	25.6	15.0	18.4	12.2	5.7	19.4	5.5	6.2	35.4	24.5	10.3	23.5	16.9	7.3	20.6	19.2	21.5	17.4	9.9	32.0	13.5	12.3	16.4	15.3	20.1	21.5	25.8	15.7	10.6	16.8	23.5	28.7	13.5	22.4	9.5	14.5	4.1	13.4	13.0	10.6	24.4	14.5	18.1	40.2	40.2	31.0	19.0	10.8	18.4	13.9	28.4	7.2	15.7	19.5	9.8	32.9	21.3	15.3	28.2	19.3	9.4	11.5	71.0	20.9	25.7	10.6	24.3
ZNF727	ZNF727P	ENSG00000214652	"Zinc finger protein 727"	A8MUV8	7	64045434-64085339	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.2;Excitatory neurons: 13.3;Inhibitory neurons: 7.7;Microglial cells: 9.4;Oligodendrocyte precursor cells: 34.2;Oligodendrocytes: 27.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"T-47d: 7.2"									"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA051027: , HPA061215: AB_2684452"	"unprognostic (5.87e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.73e-4)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-2)"	"unprognostic (8.61e-2)"	1.2	0.7	2.0	0.3	2.4	0.1	2.4	2.9	1.9	1.5	0.0	0.7	0.3	1.9	2.7	0.6	1.6	0.6	0.7	2.2	2.1	1.1	0.1	0.8	0.5	2.1	2.3	3.3	0.8	1.1	1.0	0.0	2.0	2.0	0.6	3.6	1.0	1.1	0.6	1.4	0.3	1.2	1.4	0.7	0.6	1.9	3.4	0.4	3.1	0.9	0.3	0.7	0.9	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.9	7.2	0.0	0.0	0.1	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.0	2.4	2.9	1.9	2.2	2.1	2.1	2.3	2.0	1.4	3.4	2.7	1.3	0.0	0.0	7.2	0.1	0.0	0.3	0.0	0.6	2.2	0.5	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.9	0.2	2.1	0.4	2.1	0.6	0.0	0.0	13.3	0.0	0.0	0.9	0.0	0.2	0.0	1.5	0.0	0.1	0.0	1.7	7.7	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	9.4	0.0	0.4	0.0	34.2	27.0	0.2	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.5	0.0	1.3	0.9	0.6	1.7	0.7	0.0	0.0	0.0	1.6	0.0	0.0
ZNF736		ENSG00000234444	"Zinc finger protein 736"	B4DX44	7	64307459-64356634	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 48.9;Inhibitory neurons: 45.8;Late spermatids: 70.1;Oligodendrocyte precursor cells: 42.7;Rod photoreceptor cells: 43.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051027: , HPA061215: AB_2684452"	"unprognostic (2.41e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (4.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (2.26e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.22e-3)"	"prognostic favorable (8.65e-4)"	3.0	2.0	1.8	2.8	2.2	7.7	3.6	1.6	3.0	3.6	0.5	2.4	1.2	2.9	2.6	2.1	3.3	1.7	2.1	1.9	1.2	3.1	1.4	3.0	4.2	0.7	0.9	5.0	3.0	1.7	2.9	1.7	0.7	2.7	1.8	12.4	3.1	1.4	1.6	4.7	3.6	1.7	0.3	3.9	2.5	7.5	1.8	4.1	3.9	2.6	4.1	2.5	3.0	2.3	0.5	0.2	4.6	15.9	1.5	2.4	4.6	2.3	0.1	3.5	5.3	1.2	2.5	12.7	3.7	2.1	4.0	1.9	3.4	0.8	5.6	0.3	3.3	5.4	1.5	0.2	1.7	2.4	7.1	2.1	1.0	3.7	0.0	1.5	0.4	7.1	6.5	2.9	4.1	3.1	8.3	12.7	8.5	0.1	1.1	6.8	7.8	6.0	4.1	7.3	5.1	7.2	6.0	4.1	1.5	8.4	9.6	9.1	0.3	5.2	3.6	1.3	3.2	3.1	5.0	15.2	0.1	2.6	0.1	0.4	0.5	1.1	0.4	0.6	0.3	1.8	0.6	0.4	0.7	1.4	0.6	0.5	0.2	0.1	0.6	1.2	0.4	0.3	1.8	2.2	1.6	3.0	1.9	1.2	0.7	0.9	0.7	0.3	1.8	2.3	7.0	6.4	5.4	28.7	27.1	3.8	2.4	3.5	10.2	12.8	8.6	5.3	3.6	8.6	5.6	5.5	12.5	3.6	8.0	2.2	5.9	4.0	48.9	8.6	7.1	5.9	1.2	18.3	40.7	2.2	3.0	5.2	4.6	13.3	0.0	15.2	6.1	2.7	3.7	8.4	45.8	5.6	6.1	8.1	7.1	70.1	2.5	8.9	3.6	19.7	4.4	7.4	1.0	42.7	41.2	2.1	2.5	3.0	5.4	2.6	1.4	3.9	4.5	43.6	0.0	4.2	5.6	8.2	7.5	9.9	4.0	2.7	9.1	9.6	3.8	2.1
ZNF74	"Cos52, Zfp520, ZNF520"	ENSG00000185252	"Zinc finger protein 74"	Q16587	22	20394115-20408461	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 47.9"									HPA003354	Approved		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Actin filaments"	"HPA003354: AB_1080747"	"unprognostic (1.40e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.44e-3)"	1.7	2.4	5.0	1.2	5.1	0.6	2.1	4.4	5.2	4.5	3.9	4.3	1.3	4.7	1.9	3.2	3.1	0.8	2.3	5.1	5.2	2.8	2.4	1.9	1.5	4.8	4.8	4.4	4.2	2.7	5.4	1.5	4.8	3.6	1.4	1.7	2.9	3.0	4.7	2.9	2.2	2.4	4.4	2.6	3.1	1.3	5.2	2.5	2.5	2.4	1.1	3.9	3.0	5.2	4.3	4.1	10.4	15.8	2.9	2.8	8.2	4.0	2.9	4.8	4.5	5.7	2.0	0.1	5.6	3.2	1.6	5.2	7.8	5.1	2.7	2.8	17.8	4.9	2.0	8.1	4.8	10.7	5.1	3.1	8.6	3.7	4.2	3.6	4.8	9.3	47.9	0.1	3.4	7.1	10.2	6.6	11.6	8.9	7.2	14.0	6.1	1.6	3.1	4.6	22.8	14.1	4.4	7.9	9.3	5.2	3.6	5.1	3.4	4.6	9.5	5.8	3.0	5.2	6.2	0.1	1.1	6.1	4.0	0.0	1.2	0.9	2.0	1.0	1.6	1.1	1.5	2.4	1.9	1.0	1.8	1.7	0.0	3.8	0.7	1.3	1.4	1.9	5.0	5.1	4.4	5.2	5.1	5.2	4.8	4.8	4.8	4.4	5.2	5.2	1.4	3.2	2.0	3.6	2.1	1.5	1.9	1.6	2.8	5.1	3.6	3.0	3.1	2.8	2.5	0.0	2.1	3.1	3.8	0.9	3.9	3.8	0.5	2.3	3.7	1.7	4.2	2.1	8.5	2.4	4.6	3.5	3.1	2.0	0.0	5.6	2.5	1.7	2.2	3.3	8.8	2.3	2.0	0.6	0.3	0.3	7.2	1.0	0.0	2.8	1.6	2.6	3.1	6.0	6.6	2.5	1.0	4.9	0.9	4.0	1.5	1.7	0.6	2.1	6.6	2.7	3.2	4.3	3.0	1.8	1.0	1.1	2.7	4.4	2.8	1.1
ZNF740	Zfp740	ENSG00000139651	"Zinc finger protein 740"	Q8NDX6	12	53180704-53195142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035691	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA035691: AB_10669777"	"unprognostic (2.31e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.19e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (4.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.89e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-2)"	5.6	5.6	6.9	6.1	7.3	3.1	6.0	8.0	6.8	6.7	6.8	6.2	4.8	6.6	6.4	6.4	6.8	3.2	4.3	6.4	6.9	6.4	5.8	5.0	8.8	7.2	7.2	7.6	6.6	7.9	4.3	4.1	7.1	6.2	5.1	5.6	6.3	6.5	4.8	6.0	8.4	5.3	6.8	10.1	5.5	3.1	7.1	11.7	6.9	6.0	9.3	5.3	5.0	7.3	5.7	7.5	13.0	8.4	12.9	9.5	4.8	5.8	10.9	9.2	8.0	6.4	8.8	13.0	8.5	6.7	4.5	9.0	9.5	6.9	9.3	9.9	10.1	14.5	10.5	5.7	9.4	13.3	8.7	12.1	13.5	7.3	11.0	15.2	7.6	13.4	9.7	26.1	4.8	6.5	10.6	7.2	6.4	5.3	8.8	10.6	10.0	21.5	5.2	7.8	10.0	11.1	9.9	8.2	9.8	6.1	11.9	13.6	6.8	4.8	6.6	5.5	4.3	12.4	5.7	7.0	7.4	7.4	6.1	1.1	0.2	0.4	0.4	0.1	0.3	0.5	0.4	0.6	0.2	0.5	0.5	0.5	0.0	1.3	0.1	0.4	0.6	0.2	6.9	7.3	8.0	6.8	6.4	6.9	7.2	7.2	7.1	6.8	7.1	7.3	5.2	3.2	9.3	4.6	7.7	6.1	2.3	2.8	5.2	8.5	5.1	4.7	6.3	5.7	2.8	1.8	6.2	3.3	7.1	5.0	1.9	4.2	1.3	6.8	8.8	5.7	8.4	1.7	6.0	4.6	2.0	5.1	2.0	5.1	7.6	8.1	6.1	5.3	3.3	5.0	6.1	5.5	2.0	6.6	3.1	1.5	6.2	4.4	1.8	5.6	5.9	5.7	10.3	10.1	6.7	4.9	6.4	6.0	8.5	4.5	5.1	4.5	5.5	7.5	19.7	6.7	7.0	2.5	3.3	5.6	4.5	2.5	6.6	7.0	6.2	3.5
ZNF746	"FLJ31413, PARIS"	ENSG00000181220	"Zinc finger protein 746"	Q6NUN9	7	149472696-149497817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 2.0;neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020272	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 2: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA020272: AB_2670398"	"unprognostic (2.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.32e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (4.22e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (7.47e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.06e-1)"	7.9	8.1	8.2	6.4	7.8	21.5	7.4	8.2	9.6	8.9	4.6	8.2	4.1	8.9	3.6	7.0	8.5	4.1	6.5	10.0	7.7	7.0	9.5	8.5	7.1	9.7	6.8	7.9	7.9	6.0	10.6	5.7	9.3	8.5	3.0	4.8	6.8	3.9	6.4	8.4	7.8	4.3	5.8	15.8	7.4	16.2	7.9	7.4	7.5	4.1	4.5	8.6	7.4	6.9	9.4	14.7	7.6	21.0	8.5	7.3	11.6	9.4	7.6	7.3	6.3	9.4	6.9	13.4	13.3	8.2	10.7	10.1	10.0	10.6	4.4	17.0	14.0	6.5	7.7	13.2	10.3	12.7	16.7	8.1	12.7	6.0	6.6	6.6	7.7	10.8	20.2	10.0	9.4	14.3	29.1	17.2	18.9	5.8	10.1	19.1	7.1	11.8	7.1	11.1	10.8	14.9	12.4	13.5	8.9	4.5	6.3	15.6	10.9	9.2	3.3	16.0	13.9	18.5	9.4	10.7	12.1	10.1	16.6	2.0	0.7	0.8	0.4	0.4	0.4	0.2	0.6	1.0	0.4	0.3	0.7	0.5	6.9	0.4	0.4	0.6	1.1	0.3	8.2	7.8	8.2	9.6	10.0	7.7	9.7	6.8	9.3	5.8	7.9	6.9	6.4	0.0	7.2	8.8	7.6	3.6	5.2	2.6	4.6	15.4	5.4	4.2	7.1	4.3	4.1	11.0	4.2	7.0	11.0	4.3	0.0	3.5	10.9	4.3	8.8	5.7	6.0	17.2	13.8	2.4	6.9	6.6	9.7	4.4	6.3	6.2	5.0	7.4	8.3	26.9	12.8	4.3	4.1	14.2	4.0	16.0	6.2	7.7	3.6	7.5	9.1	7.6	8.2	6.0	8.2	4.1	3.1	6.8	4.9	6.6	2.3	4.2	4.3	11.1	0.0	8.0	5.5	18.3	9.7	6.0	3.4	8.8	8.4	10.1	3.9	5.3
ZNF749	FLJ16360	ENSG00000186230	"Zinc finger protein 749"	O43361	19	57435325-57447101	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 27.9;Excitatory neurons: 24.2;Inhibitory neurons: 21.1;Melanocytes: 23.2;Oligodendrocyte precursor cells: 18.1;Squamous epithelial cells: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 24.0"									"HPA042082, HPA042091, HPA056001"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear membrane"		"HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: AB_2683005"	"unprognostic (2.54e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.27e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.05e-5)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-1)"	1.3	1.2	1.6	1.8	1.4	1.4	1.7	3.6	1.5	1.1	1.0	1.0	1.5	1.3	0.9	1.4	1.6	0.9	1.0	1.6	1.2	1.1	1.6	1.0	1.8	0.8	1.1	1.7	1.1	1.5	1.1	1.3	1.1	1.2	0.9	4.0	1.5	0.9	1.3	2.2	1.2	1.1	0.3	1.6	1.2	1.3	1.2	1.9	1.3	0.4	1.6	1.3	1.3	1.7	2.8	6.2	5.5	5.9	1.3	1.3	2.3	1.6	1.1	2.6	4.6	2.5	2.0	5.4	1.5	1.6	1.9	2.1	4.9	4.2	3.8	2.3	24.0	4.6	6.5	3.0	1.9	5.6	3.0	1.9	4.6	3.1	7.7	2.5	1.3	5.6	4.7	6.4	2.0	1.3	6.6	2.4	5.6	1.8	8.8	6.9	7.8	4.2	1.4	6.5	5.7	4.7	3.2	2.0	1.5	4.2	2.9	1.8	1.5	5.0	3.7	1.7	4.8	5.0	6.8	5.8	2.8	2.4	3.2	0.2	0.4	0.1	0.6	0.9	0.9	0.9	1.1	0.8	1.1	0.8	1.2	0.8	0.2	0.6	0.4	0.5	0.8	0.8	1.6	1.4	3.6	1.5	1.6	1.2	0.8	1.1	1.1	0.3	1.2	1.7	1.1	3.2	1.1	7.2	6.7	2.4	1.3	2.9	27.9	1.2	4.0	2.9	0.5	7.2	3.2	0.0	0.0	0.9	2.3	0.4	3.9	1.1	1.0	7.1	1.4	2.3	3.0	8.8	24.2	0.4	0.6	2.5	10.7	3.5	0.0	1.2	1.1	4.0	0.8	3.3	21.1	1.7	2.0	0.8	1.6	0.1	0.6	1.9	23.2	5.6	0.7	0.2	0.0	18.1	10.6	0.8	0.3	0.0	11.6	0.9	3.8	8.1	3.4	0.8	6.6	1.8	2.0	1.2	1.8	35.9	3.1	0.8	4.3	0.3	1.1	1.1
ZNF75A	FLJ31529	ENSG00000162086	"Zinc finger protein 75a"	Q96N20	16	3305406-3318852	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA001665	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA001665: AB_1080751"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.79e-3)"	"unprognostic (6.32e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.75e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.97e-3)"	5.4	7.3	8.3	8.5	8.6	7.7	10.1	11.0	11.6	8.3	9.3	6.9	6.7	8.6	16.7	5.4	11.5	5.6	8.3	8.4	8.4	9.4	9.1	7.7	13.4	8.8	8.0	14.5	7.9	15.4	8.1	8.1	8.9	11.3	10.0	16.9	6.9	7.7	7.8	9.9	7.7	7.1	8.0	11.0	7.8	11.0	8.8	12.4	10.7	7.4	12.3	5.6	4.9	9.7	7.4	8.8	18.5	8.4	9.3	9.6	17.6	10.6	5.4	9.6	11.4	0.0	10.0	12.3	7.9	8.2	13.0	5.0	10.2	6.1	15.8	4.8	12.6	23.5	10.4	0.9	6.2	16.4	21.3	9.7	8.7	9.0	8.9	10.4	8.1	9.9	15.0	18.8	14.3	9.9	26.3	9.5	30.1	7.4	8.1	49.4	10.0	14.5	10.9	11.7	16.5	11.8	16.3	6.9	9.0	23.1	22.5	19.2	9.9	6.3	17.8	7.0	10.0	13.2	10.9	31.1	2.4	17.2	11.9	29.5	11.7	29.3	22.2	11.9	27.4	33.7	26.1	23.8	9.5	44.1	39.4	29.0	8.8	34.5	17.3	25.8	23.5	6.4	8.3	8.6	11.0	11.6	8.4	8.4	8.8	8.0	8.9	8.0	8.8	9.7	14.5	22.4	14.0	22.5	40.5	4.1	30.6	17.5	6.8	40.4	12.0	9.1	13.3	14.3	15.9	16.5	33.3	19.4	23.8	10.7	5.9	22.0	3.5	8.6	16.7	15.7	6.0	12.4	20.4	10.2	9.4	12.4	13.3	8.4	13.9	27.0	16.8	11.5	10.7	48.8	18.0	10.8	12.2	11.7	5.4	3.6	23.3	12.5	8.8	14.0	19.8	26.8	58.7	27.6	28.7	13.7	8.5	26.7	12.7	24.1	28.6	7.8	12.9	66.5	26.3	19.7	15.4	53.0	48.3	8.3	3.4	15.7	27.1	16.0	13.5	14.5
ZNF75D	"D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28"	ENSG00000186376	"Zinc finger protein 75D"	P51815	X	135248920-135344109	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 202.9;Late spermatids: 378.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA004705	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA004705: AB_1080749"	"unprognostic (1.56e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.42e-5)"	6.3	14.5	4.8	5.6	4.9	6.9	6.3	4.7	5.3	7.1	5.6	6.7	4.8	6.2	7.5	5.2	7.0	4.7	5.5	4.6	5.6	8.4	11.0	6.7	8.4	5.2	4.9	6.8	9.8	7.1	6.9	5.0	5.4	10.2	5.5	6.7	6.4	5.9	5.1	6.8	8.2	4.9	4.9	13.9	7.5	2.2	5.2	8.6	9.3	3.9	7.2	6.0	5.8	5.3	3.3	4.3	4.6	7.4	7.7	9.3	7.0	5.5	7.5	4.4	9.4	2.6	4.1	3.5	7.9	4.7	8.5	4.5	15.2	2.5	4.2	3.3	4.0	2.4	8.6	3.5	3.3	4.1	6.6	4.6	5.9	2.7	3.4	5.5	4.6	4.4	2.1	5.4	3.9	8.0	5.0	7.5	2.2	6.7	5.8	4.7	4.6	3.1	5.0	4.5	1.5	5.2	3.1	5.2	0.9	4.9	1.8	5.9	4.8	4.2	1.0	7.1	5.3	2.7	4.1	2.5	2.6	4.5	2.7	2.7	1.0	2.0	2.3	0.8	2.1	1.4	2.5	2.7	0.9	1.6	3.1	2.8	1.1	2.8	0.8	0.8	3.4	1.5	4.8	4.9	4.7	5.3	4.6	5.6	5.2	4.9	5.4	4.9	5.2	5.3	6.4	6.4	12.9	23.5	7.5	1.8	1.3	1.4	2.8	4.9	3.9	2.0	4.7	1.5	5.0	0.0	6.2	2.4	8.4	3.7	1.9	2.0	202.9	9.2	4.8	7.1	1.8	0.8	18.5	4.0	1.5	4.2	6.1	4.9	6.3	4.9	5.7	5.3	2.4	5.0	21.8	5.0	6.1	2.9	1.6	378.3	6.5	3.8	0.0	28.1	3.9	4.1	6.2	18.6	21.4	3.1	2.8	3.4	5.0	2.3	3.3	3.7	5.1	5.1	0.0	3.4	3.5	7.6	3.1	3.4	1.4	1.8	7.1	10.2	3.6	2.3
ZNF76	"D6S229E, Zfp523, ZNF523"	ENSG00000065029	"Zinc finger protein 76"	P36508	6	35258909-35295985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030090, HPA030091"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA030090: AB_10603334, HPA030091: AB_10602593"	"unprognostic (8.29e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.66e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.20e-3)"	15.7	33.0	17.9	11.7	18.3	10.0	18.2	17.5	18.6	22.4	20.7	21.2	12.6	17.4	18.5	15.5	20.9	9.9	30.3	17.4	17.7	27.5	25.6	17.7	17.5	18.8	18.2	30.9	23.4	21.5	45.2	11.0	18.2	27.8	10.4	22.9	21.3	14.5	54.7	13.1	23.1	10.7	17.2	33.7	20.3	24.7	18.6	15.3	39.1	31.7	14.6	20.2	18.0	18.3	10.7	9.6	20.7	23.0	8.6	13.2	14.8	9.0	15.1	14.9	11.9	7.3	14.0	23.1	13.1	13.5	14.2	5.9	17.5	13.6	8.6	34.5	26.7	22.2	15.7	11.6	17.1	11.2	12.6	16.2	8.5	17.2	16.0	9.1	13.7	23.1	16.6	23.7	13.7	23.5	19.1	13.1	10.2	8.5	9.2	18.1	10.7	21.4	13.5	14.7	32.5	11.9	11.0	13.9	27.3	6.8	20.8	36.1	10.6	10.4	8.9	7.2	13.2	23.8	17.8	21.6	9.0	17.4	28.0	5.2	7.2	6.3	16.8	9.5	13.2	10.9	12.1	12.0	8.2	10.4	12.6	13.2	2.2	10.8	10.9	4.1	10.3	10.3	17.9	18.3	17.5	18.6	17.4	17.7	18.8	18.2	18.2	17.2	18.6	18.3	9.6	16.0	9.6	16.3	19.3	5.7	8.3	10.2	15.9	28.5	14.0	10.2	20.3	8.6	9.7	9.2	50.1	23.7	11.6	13.4	21.5	12.5	20.6	9.2	7.7	10.5	12.1	6.9	19.7	15.5	12.4	10.0	7.7	10.1	12.7	19.5	10.0	8.7	11.3	30.3	22.0	13.9	8.2	7.2	6.9	13.4	11.1	7.6	5.4	21.5	6.1	15.3	16.5	24.1	23.9	7.6	13.1	6.0	16.1	6.8	12.1	12.5	9.2	31.2	19.7	8.8	10.2	21.9	10.4	8.7	6.3	22.7	12.6	14.8	10.1	7.9
ZNF763	ZNF440L	ENSG00000197054	"Zinc finger protein 763"	Q0D2J5	19	11965037-11980617	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 10.4;Microglial cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 5.2"									HPA047845	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (4.09e-3)"	"unprognostic (6.15e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.36e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.07e-6)"	"unprognostic (1.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.89e-3)"	3.8	3.1	2.5	2.2	2.9	1.9	4.3	3.1	3.0	3.2	2.1	3.4	2.3	3.5	2.9	1.9	3.6	1.7	4.0	2.2	2.3	5.9	2.4	2.9	3.6	2.7	2.5	6.0	4.5	4.8	2.8	3.1	2.8	3.6	3.0	6.9	3.3	2.3	2.0	2.8	4.4	2.2	2.2	5.3	3.5	4.7	2.5	4.3	4.9	1.5	3.4	3.5	2.8	3.9	0.2	0.0	1.7	1.8	1.0	0.3	5.2	1.6	1.0	1.2	0.9	0.5	0.3	1.5	1.2	1.2	0.4	0.5	0.0	0.7	0.4	0.3	0.0	0.7	0.1	0.1	0.2	0.9	1.8	2.5	1.1	0.3	0.1	0.4	0.2	2.4	0.3	0.6	0.8	0.1	2.0	0.5	0.5	0.1	0.2	0.1	0.0	0.6	2.4	1.6	0.3	0.5	0.1	0.1	0.3	3.0	3.1	0.7	0.2	1.7	0.1	1.3	0.3	2.3	3.3	0.5	0.4	0.4	0.3	8.5	1.4	4.4	2.2	1.9	1.7	2.2	2.0	3.1	2.5	7.6	2.2	2.6	7.4	3.8	4.1	1.9	1.2	1.6	2.5	2.9	3.1	3.0	2.2	2.3	2.7	2.5	2.8	2.2	2.5	3.9	1.1	3.2	4.8	6.2	2.1	0.1	0.4	0.4	2.2	2.5	1.1	0.6	1.1	0.0	2.7	0.0	10.4	5.7	2.1	0.6	1.9	0.9	5.3	0.7	0.6	0.7	1.2	0.0	4.9	0.4	1.7	1.4	1.1	0.7	1.3	4.3	0.4	0.7	1.4	0.0	4.0	1.9	0.0	1.9	0.2	0.8	1.5	1.2	0.0	7.5	1.1	3.3	3.1	4.0	6.0	0.5	0.5	1.9	0.1	0.3	2.1	1.6	1.9	6.6	0.0	0.9	0.8	4.0	1.6	0.6	0.0	1.8	0.9	1.3	0.9	0.2
ZNF768	FLJ23436	ENSG00000169957	"Zinc finger protein 768"	Q9H5H4	16	30524004-30526821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024630, HPA066512"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA024630: AB_1859446, HPA066512: AB_2685683"	"unprognostic (2.33e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (9.30e-6)"	"unprognostic (4.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-1)"	"prognostic favorable (6.46e-4)"	22.3	23.2	31.4	9.9	32.9	13.3	22.6	30.6	35.0	28.7	28.3	42.6	29.8	30.8	9.9	22.8	27.5	10.1	49.3	27.8	27.7	34.8	38.5	19.0	7.3	32.3	31.9	28.9	25.7	30.2	27.2	11.3	30.3	30.3	17.0	13.7	25.6	21.1	93.8	28.2	31.1	13.4	28.5	22.1	30.9	39.3	33.0	6.0	23.7	53.1	7.4	34.9	23.0	29.9	27.1	33.3	37.0	36.1	17.6	20.3	29.1	20.2	22.5	32.7	28.4	21.3	36.8	17.1	30.1	14.2	26.3	35.4	24.8	24.1	19.4	38.5	52.6	40.0	24.0	30.0	44.1	26.8	121.3	17.9	52.5	25.1	32.4	30.2	21.9	6.7	47.4	28.0	17.1	74.9	10.0	64.7	34.8	22.0	27.1	50.7	24.7	42.5	23.9	14.0	43.6	48.4	11.5	59.9	77.3	15.9	59.3	66.5	14.9	34.2	25.9	19.4	22.8	41.3	32.4	21.1	28.5	41.4	35.2	0.0	0.4	1.0	0.0	0.6	0.1	1.1	0.1	0.0	0.6	0.4	0.1	0.0	0.5	0.6	0.1	0.5	0.0	0.2	31.4	32.9	30.6	35.0	27.8	27.7	32.3	31.9	30.3	28.5	33.0	29.9	9.7	9.6	1.9	8.8	4.1	5.5	6.7	9.5	6.8	13.3	15.4	12.6	7.6	14.3	5.5	16.5	2.1	7.2	2.0	50.4	11.7	12.2	18.4	10.9	9.9	9.2	18.0	3.8	2.6	16.2	8.0	6.5	10.7	13.3	3.8	15.5	14.6	17.9	12.7	21.9	3.4	29.1	8.2	8.1	7.7	7.4	10.8	6.1	5.4	4.7	6.8	16.5	0.0	4.0	4.5	11.6	38.2	13.2	2.2	7.9	38.9	17.0	7.4	12.7	6.6	11.8	10.5	15.2	5.1	10.0	5.7	3.6	2.1	14.1	31.3	5.3
ZNF77	pT1	ENSG00000175691	"Zinc finger protein 77"	Q15935	19	2933218-2944971	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA023397	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoli	Nucleoplasm	"HPA023397: AB_1859447"	"unprognostic (1.17e-2)"	"prognostic favorable (8.49e-4)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.65e-5)"	"unprognostic (2.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-6)"	"unprognostic (2.06e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.93e-3)"	"unprognostic (2.65e-3)"	"unprognostic (3.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.79e-3)"	2.7	2.7	2.3	1.2	2.3	2.2	4.6	4.6	2.6	3.5	2.0	2.5	1.4	3.0	2.8	3.1	2.9	1.4	2.6	2.1	2.2	3.4	2.7	2.8	2.5	2.2	2.2	3.4	3.0	3.3	3.1	2.9	2.3	2.8	2.1	4.0	2.6	2.1	2.6	3.2	2.1	2.9	2.1	2.6	3.2	3.6	2.2	3.4	3.0	4.1	3.4	2.6	2.9	2.7	4.3	2.1	9.4	5.5	1.9	2.5	4.2	2.5	3.8	5.0	5.9	6.5	1.7	4.8	2.1	2.8	2.7	3.4	6.1	4.1	8.3	0.7	4.7	5.9	3.4	7.3	4.8	0.2	4.6	3.9	5.6	3.9	5.7	6.2	7.0	9.2	7.7	0.0	3.4	4.7	7.2	4.2	2.1	3.7	2.8	8.1	7.3	3.3	4.1	6.5	3.8	7.2	3.9	3.6	4.6	4.5	3.5	10.0	3.5	2.1	2.7	6.0	4.7	4.8	4.9	2.2	5.4	0.1	3.9	0.0	1.6	0.8	3.0	1.7	3.5	3.7	3.1	3.2	2.2	3.5	2.3	3.4	0.1	2.4	1.8	1.7	1.6	1.9	2.3	2.3	4.6	2.6	2.1	2.2	2.2	2.2	2.3	2.1	2.2	2.7	4.2	3.2	3.9	3.6	2.2	11.6	4.7	3.3	14.2	2.8	4.6	5.3	2.2	1.5	3.4	1.8	2.1	3.6	5.7	1.9	0.0	2.1	2.1	3.3	3.6	3.7	7.2	1.3	2.9	1.8	3.0	2.9	4.6	4.0	2.5	4.0	4.2	2.2	1.7	0.0	3.2	2.5	2.0	1.6	2.8	0.3	2.8	1.7	1.8	0.0	0.7	3.3	4.1	1.0	2.6	2.4	1.9	1.5	2.0	2.8	1.5	1.4	2.0	5.6	0.0	2.5	2.3	9.7	8.1	6.8	10.9	6.2	3.3	5.4	3.4	1.8
ZNF771	DSC43	ENSG00000179965	"Zinc finger protein 771"	Q7L3S4	16	30407414-30431108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 35.6;REH: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030730, HPA046672, HPA059398"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-5)"	"unprognostic (3.53e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.99e-3)"	4.6	7.2	9.4	1.5	9.9	1.2	4.8	8.6	15.7	7.8	1.9	10.6	1.3	13.3	2.0	4.4	9.9	1.4	6.9	10.7	8.7	7.8	13.2	3.2	0.9	8.4	6.8	10.8	4.9	2.9	8.1	0.5	6.6	9.5	1.4	1.8	4.0	3.7	12.6	3.8	4.7	2.9	4.7	2.5	6.2	3.7	8.4	1.0	5.2	1.5	1.1	10.2	5.4	8.9	4.5	5.2	6.7	5.6	9.3	4.0	5.2	6.3	3.1	3.9	4.1	2.1	2.2	5.2	10.4	3.1	4.8	3.2	6.9	2.8	4.0	1.9	35.6	4.4	3.6	6.8	4.8	2.3	4.9	6.0	2.2	4.9	3.0	4.2	4.0	5.4	10.9	3.1	3.3	8.1	5.4	7.0	5.3	2.7	3.9	23.7	5.1	3.4	2.3	1.8	10.6	6.7	3.4	3.1	4.8	3.4	3.8	2.6	3.8	6.7	8.0	3.9	4.6	4.6	5.4	2.8	4.5	4.9	4.4	0.8	0.7	0.5	1.8	1.4	2.6	1.4	2.2	2.2	1.7	3.3	3.1	2.0	1.0	1.2	0.3	2.3	2.6	1.6	9.4	9.9	8.6	15.7	10.7	8.7	8.4	6.8	6.6	4.7	8.4	8.9	5.4	3.2	0.5	6.2	3.7	5.1	11.5	1.8	22.2	12.0	9.1	15.7	7.1	20.0	1.5	5.5	10.4	5.5	7.2	7.8	33.2	6.2	1.6	4.5	12.3	7.6	4.2	4.4	8.6	4.4	3.3	12.4	5.6	9.0	1.3	12.6	13.2	19.1	3.5	11.8	9.4	10.0	0.0	1.6	2.4	2.2	25.1	3.2	5.4	5.6	1.3	15.9	2.1	5.5	5.4	2.5	5.1	29.7	4.4	15.5	8.6	29.4	0.7	8.0	13.1	15.2	12.0	1.2	1.8	8.5	6.7	3.6	5.1	9.5	10.0	4.3
ZNF773	"MGC4728, ZNF419B"	ENSG00000152439	"Zinc finger protein 773"	Q6PK81	19	57499915-57518404	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003152	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA003152: AB_1080716"	"unprognostic (6.53e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.50e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.71e-3)"	4.0	4.4	4.6	3.1	4.1	6.6	6.0	6.7	5.1	2.9	3.2	3.6	4.5	3.3	5.6	2.8	4.3	2.8	3.3	4.2	4.8	4.1	2.4	3.8	4.8	4.0	4.1	6.0	2.4	6.9	4.4	4.5	3.5	4.8	3.6	5.1	3.8	3.8	4.5	5.2	3.5	3.8	2.5	5.7	3.6	4.4	3.9	5.3	6.1	3.2	5.5	3.2	2.7	5.0	2.3	4.3	7.0	9.7	4.9	6.4	0.4	7.1	10.0	6.1	24.8	4.3	3.6	4.5	3.7	4.3	4.6	1.8	3.6	7.6	9.0	0.2	22.8	8.0	0.6	2.7	8.9	5.9	6.2	14.0	9.9	4.5	15.8	7.8	4.4	8.2	0.3	0.8	7.8	0.6	11.3	4.3	7.7	1.2	12.8	6.4	11.6	6.9	4.3	8.7	7.4	9.4	1.3	3.2	6.9	6.6	5.4	10.7	3.7	9.5	4.3	2.5	7.5	10.9	12.7	7.3	3.8	5.7	8.3	30.4	6.4	10.7	10.6	5.0	17.7	15.3	13.2	11.7	8.8	19.2	21.4	17.2	2.8	13.0	4.4	9.3	10.1	7.9	4.6	4.1	6.7	5.1	4.2	4.8	4.0	4.1	3.5	2.5	3.9	5.0	3.2	0.0	2.6	2.9	6.6	1.0	2.7	1.8	1.8	5.2	2.0	2.0	1.3	2.8	3.9	0.0	6.2	3.0	2.3	0.0	3.9	2.4	0.6	1.3	1.7	3.4	0.0	2.1	6.2	0.7	0.9	2.0	1.5	1.0	1.3	3.9	3.6	0.9	0.9	6.7	5.1	0.9	4.1	1.6	1.2	0.3	1.2	1.5	1.8	0.0	1.7	4.2	3.1	3.5	3.6	1.1	1.7	3.8	2.1	2.3	1.0	0.8	0.8	7.5	13.1	2.3	2.6	4.5	7.7	2.0	0.6	2.9	5.3	4.8	0.9	2.3
ZNF776	FLJ38288	ENSG00000152443	"Zinc finger protein 776"	Q68DI1	19	57746815-57758148	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA046653, HPA068553"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA046653: AB_10961126, HPA068553: AB_2686002"	"unprognostic (6.73e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (3.99e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.86e-2)"	4.4	6.5	4.5	5.2	5.5	17.2	9.1	10.6	6.3	6.6	5.4	6.4	6.4	5.0	21.6	5.0	7.0	4.0	7.2	5.4	4.9	7.7	6.8	6.3	8.3	4.4	3.8	8.3	4.7	10.8	8.3	7.7	4.7	8.5	6.7	20.7	7.8	7.7	9.1	6.4	5.9	4.2	3.7	8.2	7.6	6.6	4.4	12.6	9.3	10.3	8.2	5.5	5.3	8.2	6.2	5.3	16.7	11.2	2.6	8.2	7.2	5.0	8.3	8.7	5.6	3.2	6.8	7.2	4.4	4.6	4.6	4.1	8.8	8.7	13.8	6.5	32.1	9.8	12.6	3.7	6.2	5.5	7.5	9.5	7.1	5.8	6.2	9.2	6.7	11.6	6.6	5.0	11.2	2.9	18.2	4.9	9.7	2.8	11.0	11.6	12.7	8.3	6.4	20.0	18.7	13.7	9.3	7.7	5.5	9.0	7.9	7.7	6.2	9.2	4.9	0.8	7.6	13.8	16.8	12.1	5.5	5.1	7.7	6.6	1.8	8.9	1.1	1.3	2.7	2.4	1.9	2.4	1.7	3.7	2.8	2.2	4.6	5.6	1.7	1.9	1.8	1.6	4.5	5.5	10.6	6.3	5.4	4.9	4.4	3.8	4.7	3.7	4.4	8.2	3.3	3.2	4.1	7.2	7.1	2.7	4.1	3.9	1.8	8.7	7.7	5.3	12.3	11.5	3.2	9.2	2.1	3.1	2.5	3.9	5.9	3.3	1.4	8.3	3.7	6.5	8.4	8.6	7.1	1.3	2.3	2.8	4.1	6.9	3.8	6.9	10.4	8.1	3.5	11.8	7.7	4.1	6.1	6.0	1.8	0.6	1.2	3.6	0.0	6.5	3.1	12.0	5.2	8.0	9.1	2.5	2.1	4.9	3.9	4.1	3.9	2.8	6.0	7.5	0.0	2.6	3.9	2.9	4.8	3.1	1.7	2.9	3.3	2.9	3.2	5.5
ZNF777	KIAA1285	ENSG00000196453	"Zinc finger protein 777"	Q9ULD5	7	149431363-149461062	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003252	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003252: AB_1080755"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.23e-2)"	"unprognostic (5.72e-2)"	7.5	6.6	5.9	4.4	5.4	7.9	7.7	5.8	7.0	8.7	2.3	9.0	4.5	10.4	3.3	6.2	8.4	3.6	7.1	6.0	6.3	6.2	7.3	5.3	5.1	5.9	5.3	10.0	7.5	6.4	8.5	4.9	5.1	8.9	3.3	3.4	7.5	5.2	13.9	11.7	6.3	5.2	4.7	6.7	7.3	6.7	5.9	5.7	7.3	7.0	3.9	9.0	7.9	5.5	14.9	18.0	11.9	17.3	8.7	7.0	15.3	9.4	9.9	12.5	10.8	11.3	9.3	9.4	18.5	10.7	7.7	9.7	11.7	14.3	6.8	15.3	17.8	9.2	5.0	11.4	14.7	13.2	12.9	8.3	16.1	10.1	14.6	6.6	6.8	12.4	30.2	0.0	7.2	19.2	27.9	18.0	14.5	6.6	10.5	22.7	6.1	19.8	7.7	11.4	12.9	18.1	16.2	16.5	15.7	4.3	7.8	21.7	10.7	10.4	4.1	20.8	15.5	8.6	8.2	4.4	7.8	9.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	5.4	5.8	7.0	6.0	6.3	5.9	5.3	5.1	4.7	5.9	5.5	4.0	0.0	1.7	5.9	3.8	1.1	1.4	0.3	2.8	6.5	3.9	5.5	2.9	2.8	0.1	1.8	6.2	2.0	4.2	3.1	0.0	1.2	2.6	2.9	4.8	2.9	1.8	6.6	6.9	1.0	3.8	2.8	2.0	4.5	0.0	8.2	2.9	5.7	1.6	1.7	6.7	3.1	0.0	2.2	1.3	3.8	2.8	2.0	0.0	4.7	0.2	5.5	2.1	3.0	3.5	1.1	3.1	3.4	1.6	2.4	1.4	1.6	0.8	5.5	0.0	5.2	3.7	1.5	4.6	2.5	1.8	3.8	3.5	6.6	2.8	1.0
ZNF778	FLJ31875	ENSG00000170100	"Zinc finger protein 778"	Q96MU6	16	89217703-89237141	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA052057, HPA057151"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear bodies"	Nucleoplasm	"HPA052057: AB_2681710, HPA057151: AB_2683352"	"unprognostic (3.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.53e-7)"	"unprognostic (2.51e-1)"	"unprognostic (2.85e-7)"	"unprognostic (3.22e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.63e-2)"	2.1	2.2	2.3	1.9	2.5	1.6	2.5	3.7	2.8	2.1	2.4	2.3	1.1	2.2	1.7	2.0	2.1	1.5	2.3	2.4	2.0	3.2	2.1	2.1	1.8	2.4	2.8	2.1	5.0	8.1	2.5	1.4	4.5	2.3	1.9	3.9	2.5	2.9	3.8	3.2	1.7	2.6	2.0	2.3	2.4	5.2	2.7	2.0	3.1	4.3	2.6	2.1	1.7	2.8	4.2	2.3	6.8	5.6	4.2	3.5	8.4	3.3	5.2	4.7	2.8	6.7	2.8	2.2	6.4	4.2	2.5	4.0	9.4	4.6	7.9	0.8	8.4	5.8	4.6	3.2	2.4	1.7	3.2	3.0	3.3	6.2	4.6	3.0	4.2	3.7	6.5	1.1	4.1	10.5	3.5	2.4	9.9	3.4	3.9	9.7	15.6	0.6	2.4	3.8	14.0	10.1	8.2	4.1	2.6	6.2	10.8	3.2	4.4	5.3	3.7	3.5	4.0	4.0	6.0	4.6	7.3	3.3	3.3	10.9	1.2	3.1	3.0	1.9	1.7	0.9	1.5	1.4	1.5	1.2	1.1	1.9	0.3	1.4	2.1	0.5	1.8	1.4	2.3	2.5	3.7	2.8	2.4	2.0	2.4	2.8	4.5	2.0	2.7	2.8	2.9	12.8	4.4	3.6	2.2	1.7	2.8	1.8	9.1	8.6	4.5	4.6	5.1	2.8	2.8	5.5	14.6	2.4	8.4	1.3	0.0	3.3	16.4	4.2	4.6	4.7	3.0	6.1	6.3	5.6	2.2	3.1	5.6	7.7	0.0	5.2	4.6	5.5	2.5	21.9	5.7	2.9	2.0	5.0	0.7	35.3	2.5	6.2	1.8	1.0	4.3	4.3	11.3	2.0	5.9	3.2	1.8	3.0	9.6	5.4	3.4	3.5	0.5	10.5	13.1	11.7	3.4	15.1	12.7	8.2	1.6	2.3	4.7	3.0	2.0	3.3
ZNF780A	ZNF780	ENSG00000197782	"Zinc finger protein 780A"	O75290	19	40069152-40090938	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 48.9;Hepatocytes: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (1.92e-1)"	"unprognostic (9.25e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.30e-4)"	2.4	3.1	1.5	3.2	1.6	1.4	2.5	2.8	2.1	2.6	1.9	2.6	1.9	2.6	3.5	3.6	2.5	2.2	2.2	1.5	1.3	2.6	4.3	2.4	4.2	1.2	1.1	2.7	3.9	3.7	2.8	2.4	1.3	2.7	1.9	3.7	3.5	3.0	1.5	2.7	3.4	1.5	0.6	4.2	3.0	1.8	1.2	2.7	3.7	1.8	4.0	2.6	2.9	1.8	3.4	6.4	4.1	3.8	3.6	3.3	2.9	3.9	3.1	3.1	4.8	4.2	2.3	3.1	2.5	1.9	3.1	2.8	2.6	2.2	3.5	5.3	3.6	4.8	5.5	4.0	3.2	5.0	3.8	3.4	2.4	3.2	2.6	4.2	3.3	3.3	5.5	5.0	2.7	2.0	2.0	1.6	3.3	3.3	2.0	1.6	7.2	1.8	2.6	7.0	2.5	4.8	5.8	2.2	2.5	3.6	2.7	6.0	2.5	3.8	5.1	3.5	3.2	4.9	4.6	3.0	2.4	3.4	2.6	1.4	2.4	4.0	1.6	2.3	2.3	1.8	1.8	1.5	2.1	1.4	2.5	2.1	2.1	1.6	3.8	1.6	2.1	1.1	1.5	1.6	2.8	2.1	1.5	1.3	1.2	1.1	1.3	0.6	1.2	1.8	8.5	9.6	10.2	6.2	8.1	3.8	4.5	15.2	6.2	5.8	9.4	5.7	4.0	8.6	11.6	9.2	2.1	5.9	7.0	7.0	9.8	14.5	25.0	4.1	5.5	8.4	3.5	3.4	7.8	48.9	8.5	6.0	2.0	4.5	16.5	4.2	12.8	37.7	15.0	5.0	5.7	7.4	4.1	25.4	11.5	3.6	4.4	11.4	12.4	9.4	12.0	3.9	17.5	4.0	6.5	32.6	7.1	5.3	5.8	3.2	14.1	21.7	13.5	7.3	6.6	4.4	5.1	9.8	4.0	5.2	2.6	5.9	11.8	5.7	7.6	3.4
ZNF780B	ZNF779	ENSG00000128000	"Zinc finger protein 780B"	Q9Y6R6	19	40028260-40056231	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Excitatory neurons: 56.5;Inhibitory neurons: 59.6;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (3.28e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-3)"	2.3	2.9	0.8	1.8	1.8	1.0	2.7	4.6	1.9	4.1	2.8	4.2	1.1	3.7	3.6	2.1	4.1	1.4	5.2	1.1	1.1	2.8	2.9	2.5	3.2	0.6	0.3	6.3	2.8	2.6	7.8	2.0	1.1	4.0	2.3	14.1	3.4	2.8	3.1	1.7	3.2	2.4	0.5	3.3	3.0	2.4	1.2	3.3	5.8	2.1	3.1	3.9	3.4	2.4	2.0	2.5	5.0	2.4	2.0	1.1	0.0	2.6	1.7	2.8	3.8	5.0	1.5	5.7	2.3	2.4	2.1	1.3	3.2	1.4	2.9	4.6	1.6	4.5	6.2	2.9	1.6	6.1	3.1	2.5	0.6	3.9	1.7	2.2	2.1	2.5	4.7	7.4	2.3	0.5	1.8	0.7	4.0	1.7	2.5	3.1	8.7	1.7	1.2	12.2	3.9	5.0	4.7	1.4	1.2	2.7	1.7	2.3	4.1	1.7	6.4	4.3	3.6	5.6	7.8	3.9	2.3	2.6	1.7	0.0	1.3	0.6	1.1	1.2	1.1	1.0	1.3	1.3	1.0	1.6	1.9	1.7	0.1	1.1	0.8	2.5	0.9	0.6	0.8	1.8	4.6	1.9	1.1	1.1	0.6	0.3	1.1	0.5	1.2	2.4	5.3	9.6	9.6	53.8	11.2	1.9	2.7	4.9	1.2	25.6	3.8	5.2	13.1	7.2	7.9	9.2	33.3	1.8	13.0	2.5	3.9	5.6	8.9	2.7	7.0	6.2	10.3	4.6	56.5	10.0	1.5	5.6	5.1	2.7	7.6	8.1	10.0	5.0	3.7	10.1	59.6	4.2	12.2	5.8	5.8	1.8	3.7	4.7	5.4	38.4	7.6	6.2	4.1	56.3	78.0	6.8	4.2	3.0	4.5	1.7	3.5	3.4	4.8	34.7	6.6	5.5	5.3	2.4	2.8	2.8	3.0	0.7	8.0	3.4	4.4	2.0
ZNF781	FLJ37549	ENSG00000196381	"Zinc finger protein 781"	Q8N8C0	19	37667751-37692315	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.1;Late spermatids: 65.7;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;ASC diff: 2.3;HSkMC: 2.1;SH-SY5Y: 2.2;U-266/84: 2.8"	"Low region specificity"	"Detected in all"							HPA062512	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA062512: AB_2684788"	"unprognostic (3.01e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	1.5	1.6	3.1	0.5	3.5	0.0	1.0	5.7	3.2	2.3	2.4	2.5	0.3	2.2	1.3	0.5	2.0	0.7	1.8	2.8	3.0	1.3	0.3	1.0	1.0	2.6	3.0	3.1	0.5	1.1	3.9	1.4	2.5	1.6	0.8	3.8	0.5	1.4	0.3	0.5	1.2	2.5	2.1	2.1	1.0	1.3	3.1	0.5	1.9	0.5	0.7	1.8	1.2	3.1	0.0	0.0	0.9	2.3	2.3	0.5	0.5	0.8	0.0	0.8	0.5	0.1	0.0	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	2.1	0.0	0.6	0.0	0.3	0.2	0.1	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.6	0.0	0.3	0.6	0.0	2.2	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.5	0.7	0.0	0.2	0.7	0.9	0.0	0.0	0.0	0.0	0.2	0.2	3.1	3.5	5.7	3.2	2.8	3.0	2.6	3.0	2.5	2.1	3.1	3.1	10.4	0.0	0.6	13.7	2.8	0.5	0.5	0.5	1.2	6.3	2.0	1.0	14.9	2.8	0.1	0.0	20.9	7.5	2.5	0.0	0.0	0.8	71.1	0.4	2.6	5.5	7.8	0.8	18.0	0.0	3.1	4.7	0.5	0.1	3.8	5.3	10.4	0.1	3.9	3.3	22.2	0.0	2.0	1.6	0.4	65.7	4.7	0.5	1.8	3.7	0.1	5.3	11.3	42.3	19.9	0.1	0.0	6.8	0.5	0.2	0.0	0.5	0.5	8.5	13.1	1.5	6.4	17.4	5.1	0.1	0.0	1.4	2.2	2.4	0.0	0.2
ZNF782	FLJ16636	ENSG00000196597	"Zinc finger protein 782"	Q6ZMW2	9	96816269-96875623	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"Astrocytes: 96.3;Excitatory neurons: 105.1;Inhibitory neurons: 126.8;Microglial cells: 70.3;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 166.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 9.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA011013	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Mitochondria"		"HPA011013: AB_1080758"	"unprognostic (5.51e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.63e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.95e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.39e-2)"	1.6	1.6	2.1	2.3	1.3	1.3	3.0	9.3	3.0	2.4	0.1	2.0	2.3	2.9	3.5	1.6	2.4	1.8	1.1	1.5	1.0	2.6	1.7	1.4	2.6	0.9	0.7	3.3	4.6	3.2	1.8	2.0	1.4	3.0	2.8	9.0	2.2	2.3	2.2	3.9	2.8	2.1	0.1	2.2	2.7	6.1	1.5	3.2	3.2	2.0	3.0	1.6	1.9	3.4	2.1	1.7	4.2	5.9	1.0	1.0	2.5	1.8	1.5	2.4	1.8	1.8	3.3	3.7	2.3	1.4	3.5	3.6	2.9	1.1	2.8	4.2	1.7	3.2	3.8	1.8	1.4	5.3	3.2	0.6	2.5	2.6	1.6	1.9	1.3	5.7	4.8	5.0	2.0	3.6	4.7	2.4	3.0	3.4	2.7	5.4	4.9	1.3	2.2	1.1	3.8	2.7	2.5	1.6	1.8	2.7	2.8	2.5	2.0	3.5	2.6	3.8	2.1	4.9	3.5	2.2	2.2	2.0	2.7	0.0	0.2	0.0	0.3	0.1	0.5	0.1	0.1	0.2	0.0	0.4	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.0	2.1	1.3	9.3	3.0	1.5	1.0	0.9	0.7	1.4	0.1	1.5	3.4	3.4	0.0	4.1	96.3	3.3	1.9	1.4	0.6	4.0	5.9	2.3	2.2	1.6	1.5	0.3	1.8	8.4	0.9	5.1	1.7	0.0	1.4	7.5	2.9	3.9	3.6	0.0	7.4	105.1	1.7	0.4	2.3	2.0	5.2	5.7	6.0	3.6	1.1	1.2	3.3	126.8	1.9	0.0	0.6	0.7	9.2	1.8	1.7	0.0	70.3	4.0	1.7	1.0	117.1	166.0	1.0	0.3	3.0	4.6	1.9	2.4	1.8	1.2	7.6	0.0	5.0	3.1	10.6	2.3	2.1	1.0	0.7	2.9	3.3	1.1	2.0
ZNF784	MGC75238	ENSG00000179922	"Zinc finger protein 784"	Q8NCA9	19	55620741-55624566	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 42.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059676	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA059676: AB_2684102"	"unprognostic (4.67e-2)"	"unprognostic (8.13e-2)"	"unprognostic (4.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.44e-2)"	"unprognostic (4.74e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.02e-4)"	4.5	8.5	3.0	3.0	2.9	6.2	5.3	4.3	3.9	8.6	2.2	12.8	8.3	10.7	3.8	7.2	9.2	2.7	13.9	2.8	2.2	7.8	11.5	4.8	3.5	3.6	2.7	11.8	11.3	4.2	7.7	2.6	2.5	11.2	3.3	4.4	6.7	3.7	42.8	6.7	10.2	3.6	2.3	9.1	8.9	5.4	2.9	2.0	7.4	16.0	2.8	10.6	6.6	3.6	4.6	6.4	5.8	3.1	2.2	2.9	5.5	4.7	2.9	2.6	3.5	3.2	5.0	5.5	4.0	3.3	2.0	2.5	1.7	4.1	1.8	3.0	16.7	5.1	5.1	4.1	4.4	4.2	5.3	4.0	4.4	2.2	2.8	4.2	1.7	7.7	6.1	5.5	4.0	4.4	3.3	4.8	5.7	3.5	13.7	6.2	3.9	6.2	4.8	11.5	6.5	8.7	7.7	3.6	2.2	3.8	3.9	7.4	5.4	3.0	2.9	1.9	3.9	6.3	2.8	3.2	4.6	3.1	2.6	0.0	0.4	0.6	0.1	0.4	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.2	0.2	0.3	0.3	0.2	0.0	0.1	3.0	2.9	4.3	3.9	2.8	2.2	3.6	2.7	2.5	2.3	2.9	3.6	1.9	0.0	7.4	1.6	3.4	0.9	4.7	1.5	2.8	4.7	2.2	3.2	12.3	8.6	1.9	0.0	2.1	5.5	1.3	10.9	3.9	4.0	2.1	2.7	2.5	2.3	5.4	4.4	0.5	4.1	2.4	3.2	1.5	3.2	2.5	5.5	3.9	6.8	3.5	8.4	0.6	6.2	6.1	3.5	1.0	0.1	4.1	2.4	0.0	1.0	4.5	4.2	0.0	1.5	1.1	4.5	7.4	2.6	2.3	2.1	11.2	5.2	2.2	11.0	13.1	2.9	2.7	0.6	2.3	1.8	1.3	10.1	2.0	7.7	5.5	3.7
ZNF786	DKFZp762I137	ENSG00000197362	"Zinc finger protein 786"	Q8N393	7	149069641-149090782	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.8;Horizontal cells: 18.5;Inhibitory neurons: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021518, HPA053459"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA021518: AB_2670734, HPA053459: AB_2682159"	"unprognostic (3.13e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (2.01e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.47e-2)"	2.0	2.2	2.9	2.8	2.6	1.5	2.6	3.9	4.3	3.5	1.1	3.1	2.0	3.3	2.4	3.8	3.1	2.0	2.0	2.8	2.6	2.9	3.1	1.9	3.8	1.6	1.7	3.2	2.6	2.3	3.8	1.6	1.5	3.7	1.4	1.9	3.0	2.2	2.0	5.6	3.1	1.9	0.9	3.9	2.3	1.6	2.8	3.5	2.9	2.3	2.8	3.3	3.5	2.8	4.5	8.1	6.1	10.4	3.7	1.5	8.7	2.7	2.8	2.9	2.3	4.3	4.0	6.3	6.3	1.9	5.1	5.0	3.8	3.6	1.9	6.9	5.9	3.2	5.1	5.4	3.1	6.3	4.1	2.2	4.0	3.6	2.6	3.0	2.7	4.5	5.6	3.5	2.7	13.9	10.7	10.5	11.4	4.1	6.0	7.7	3.0	4.1	2.4	6.1	7.3	11.5	6.6	6.1	5.0	3.8	3.9	3.0	3.6	3.4	2.0	6.0	3.9	12.7	10.0	3.5	5.7	3.9	3.8	1.8	3.4	2.9	10.4	4.7	8.8	6.4	7.5	9.4	4.3	5.9	9.7	8.3	1.1	8.5	4.0	3.7	5.0	5.0	2.9	2.6	3.9	4.3	2.8	2.6	1.6	1.7	1.5	0.9	2.8	2.8	2.4	0.0	1.1	3.6	3.5	2.7	2.6	4.2	2.8	10.1	2.3	1.3	2.7	1.5	1.6	3.7	2.1	2.4	5.9	2.0	3.9	4.1	0.4	0.9	2.1	3.1	4.8	0.8	18.8	1.5	2.5	2.6	6.6	1.1	4.5	4.5	1.8	2.4	2.2	18.5	15.8	1.6	2.0	1.9	2.6	0.4	3.1	2.1	0.0	3.7	3.6	2.8	13.4	7.1	5.4	1.8	3.3	4.1	2.9	1.4	1.7	2.5	2.3	6.0	0.0	3.3	2.5	4.9	8.3	2.3	1.7	1.9	6.0	1.8	2.7	1.7
ZNF787		ENSG00000142409	"Zinc finger protein 787"	Q6DD87	19	56087366-56121295	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 110.5;Endometrial ciliated cells: 87.6;Rod photoreceptor cells: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 102.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035140	Supported		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Mitochondria"	"HPA035140: AB_10602358"	"unprognostic (1.97e-2)"	"unprognostic (5.86e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-3)"	18.3	24.4	13.4	10.2	13.9	27.0	16.6	12.7	15.4	18.2	11.1	24.0	15.7	19.9	3.9	20.8	22.3	3.0	26.9	12.1	11.4	17.6	43.9	17.9	7.3	15.2	13.1	16.1	34.1	5.9	15.9	4.4	12.6	21.2	4.7	7.6	19.0	7.7	42.2	18.0	19.9	4.0	11.9	27.7	23.2	16.1	15.4	5.6	16.5	9.7	4.4	20.8	16.6	13.8	29.2	28.1	9.0	18.9	2.5	5.6	23.3	14.7	5.7	9.8	11.1	16.7	17.6	20.7	1.0	6.2	8.8	22.7	5.7	11.9	4.4	27.5	102.6	32.9	14.6	25.6	14.1	31.8	27.8	7.4	11.6	8.2	14.2	6.1	7.4	11.6	39.9	22.5	5.8	18.2	19.8	40.0	28.4	26.7	52.3	24.6	13.1	26.7	10.2	19.1	34.2	33.3	15.6	30.2	29.4	5.0	18.6	44.5	16.0	36.8	26.6	15.7	41.2	47.4	37.4	20.3	21.4	21.0	17.6	0.6	0.8	1.1	0.4	0.6	0.6	1.0	0.3	0.3	0.8	1.4	0.5	0.2	1.8	0.5	0.6	2.2	0.5	0.3	13.4	13.9	12.7	15.4	12.1	11.4	15.2	13.1	12.6	11.9	15.4	13.8	29.5	12.8	2.7	5.5	11.2	6.1	11.5	5.0	7.4	52.1	19.2	16.9	12.0	11.5	5.5	11.0	110.5	3.3	20.0	29.7	1.9	6.6	2.0	87.6	17.2	16.2	9.1	4.0	5.1	16.7	4.6	10.1	8.6	48.2	5.7	23.2	11.7	33.4	8.9	35.3	4.2	19.8	8.2	11.0	7.8	3.4	5.0	16.4	1.8	6.5	8.9	44.5	7.2	4.5	6.1	13.1	19.5	4.5	7.1	11.3	12.8	5.8	4.0	71.3	6.6	16.0	13.0	3.8	12.1	4.8	7.2	1.9	9.2	55.8	20.6	12.4
ZNF789		ENSG00000198556	"Zinc finger protein 789"	Q5FWF6	7	99472890-99503650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029500, HPA050793"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA029500: AB_10603009, HPA050793: AB_2681240"	"unprognostic (6.84e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.38e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (5.31e-6)"	5.2	5.7	8.2	4.7	8.3	7.6	5.5	11.0	9.9	7.7	8.1	8.7	8.5	6.1	7.2	5.0	7.1	2.6	4.6	8.3	8.7	9.8	8.8	4.9	6.2	8.4	8.7	7.9	7.6	3.3	11.8	2.6	8.8	16.4	7.3	11.7	6.1	4.3	5.7	7.3	9.8	3.7	8.0	10.7	6.1	13.4	8.5	4.5	8.4	2.9	5.8	5.1	5.2	9.2	12.0	3.8	6.1	11.0	1.9	1.8	8.4	5.8	2.2	3.7	7.9	6.0	7.7	8.6	4.8	2.7	3.7	5.0	3.2	3.3	5.0	4.0	6.0	6.6	10.3	11.8	3.1	4.3	14.5	2.1	2.8	7.2	3.5	2.2	3.9	11.1	10.2	7.7	3.3	11.6	5.7	12.0	6.1	5.7	5.6	7.0	6.2	9.4	4.9	3.4	5.9	6.6	4.2	11.8	7.3	3.4	3.0	7.5	6.1	6.4	8.0	9.9	5.9	5.0	7.6	11.9	10.8	8.2	6.9	2.0	1.5	1.5	2.3	1.0	2.7	2.3	3.0	2.6	5.2	3.6	6.0	3.7	0.3	4.2	1.3	13.5	5.1	1.8	8.2	8.3	11.0	9.9	8.3	8.7	8.4	8.7	8.8	8.0	8.5	9.2	8.2	0.0	6.3	11.8	9.5	5.5	4.2	4.0	4.6	18.3	6.3	6.7	2.4	1.5	4.6	1.8	14.6	4.4	14.0	6.3	1.9	3.8	33.9	5.2	4.8	7.2	5.4	8.6	10.4	5.4	3.2	4.7	9.2	5.6	3.8	11.8	1.8	3.5	6.9	6.7	12.7	6.3	4.1	3.1	6.5	8.4	3.4	4.6	7.2	10.3	3.8	12.0	5.2	12.5	10.6	4.3	5.4	4.5	6.1	2.7	5.2	4.6	4.9	14.7	0.0	6.5	4.8	20.8	4.8	6.7	5.3	2.2	6.9	8.5	6.6	3.4
ZNF79	pT7	ENSG00000196152	"Zinc finger protein 79"	Q15937	9	127424374-127445372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 5.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028977	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028977: AB_10602359"	"unprognostic (4.56e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (6.83e-5)"	"unprognostic (2.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.42e-5)"	"unprognostic (4.53e-3)"	"prognostic favorable (6.04e-7)"	"unprognostic (6.09e-3)"	"unprognostic (5.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.32e-1)"	2.6	3.6	2.1	3.3	2.7	3.4	3.6	5.6	2.5	3.1	2.6	3.6	2.6	3.5	4.4	2.9	4.0	2.0	3.2	2.0	2.7	2.9	3.3	2.9	4.1	2.8	2.3	3.8	2.9	4.9	2.6	3.0	2.2	3.5	3.5	3.1	3.4	3.4	4.7	3.6	2.8	3.7	1.6	3.7	3.0	6.2	2.4	5.5	3.8	5.2	4.7	4.3	2.2	2.9	2.5	5.0	6.5	3.9	7.1	4.2	18.2	6.1	7.4	7.2	8.2	5.3	2.3	5.4	2.4	4.6	9.5	7.7	4.9	7.5	5.7	5.4	3.2	3.7	8.4	6.0	8.4	8.9	5.7	4.2	8.3	8.9	7.2	4.6	7.5	6.1	6.4	7.9	6.9	5.5	7.0	3.3	5.2	6.2	6.4	5.7	9.0	7.7	3.1	3.6	7.4	5.0	11.7	5.9	3.5	5.6	7.9	5.0	5.3	4.6	4.2	4.6	4.8	10.5	24.1	6.8	5.9	2.7	7.8	2.2	3.3	5.1	6.0	4.1	6.7	5.1	3.9	7.6	4.7	5.8	5.2	5.7	4.5	7.2	2.8	4.9	5.5	3.6	2.1	2.7	5.6	2.5	2.0	2.7	2.8	2.3	2.2	1.6	2.4	2.9	0.8	0.0	0.5	2.6	2.4	1.5	1.2	0.8	1.8	0.8	1.0	0.9	2.5	2.8	1.7	0.0	0.0	2.0	0.9	0.9	1.9	2.0	4.5	0.4	1.9	1.1	0.0	4.8	3.1	0.6	0.6	1.2	2.6	0.5	0.0	1.1	1.1	1.2	2.1	1.7	3.2	0.5	0.0	0.8	1.2	4.7	0.6	0.6	0.0	1.0	0.1	0.9	2.1	4.0	2.9	0.5	0.3	1.9	3.0	0.7	0.9	1.0	0.7	1.2	0.0	0.4	1.3	5.8	1.6	2.3	1.0	2.6	1.5	1.3	1.1	0.9
ZNF791	FLJ90396	ENSG00000173875	"Zinc finger protein 791"	Q3KP31	19	12610918-12633840	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021537	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021537: AB_2670741"	"unprognostic (1.95e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.73e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.86e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (1.39e-5)"	8.3	5.9	4.9	7.4	5.7	13.3	9.3	11.6	6.1	8.6	6.7	7.2	5.7	8.2	7.6	6.9	7.8	5.1	6.3	4.7	6.4	6.3	6.7	8.6	8.6	6.0	6.2	10.2	7.2	9.6	7.3	6.5	5.8	7.2	6.4	13.6	7.3	6.7	6.9	8.6	7.8	5.7	4.8	7.8	6.7	2.7	5.4	5.2	12.1	8.2	10.1	8.2	8.1	8.3	7.2	4.0	7.6	7.7	8.6	11.3	6.4	9.7	10.1	5.8	8.3	5.0	4.5	1.6	9.1	9.8	3.8	6.7	7.1	8.7	10.6	4.8	7.7	7.6	10.0	6.9	6.9	9.7	6.7	9.9	9.6	8.5	11.4	10.4	7.3	4.4	8.6	11.2	7.2	10.9	6.2	3.5	8.2	4.3	11.9	4.4	13.0	6.2	5.9	14.3	8.5	10.3	7.9	6.6	8.5	8.9	6.5	8.1	7.5	13.2	5.3	11.8	7.3	15.6	22.8	5.0	8.9	6.8	8.3	9.9	2.6	4.7	5.5	1.9	5.5	6.2	4.8	5.6	2.4	8.6	5.4	6.6	4.6	9.2	3.5	8.3	4.2	2.2	4.9	5.7	11.6	6.1	4.7	6.4	6.0	6.2	5.8	4.8	5.4	8.3	34.2	12.8	28.2	4.9	56.1	29.2	31.2	18.1	35.9	75.5	28.3	25.7	21.8	27.1	22.6	18.4	98.0	30.5	56.7	29.0	19.6	23.8	5.5	35.6	29.3	41.2	37.1	16.8	9.1	17.6	19.4	31.6	15.8	34.2	9.5	58.7	48.9	26.5	14.0	35.3	9.4	26.3	16.2	21.8	33.5	3.9	39.1	24.9	14.2	1.0	19.8	36.2	49.4	3.0	10.9	26.3	15.4	39.1	69.5	37.6	33.0	13.3	27.9	98.0	39.5	34.8	34.6	13.4	12.7	22.1	27.7	39.1	41.5	33.2	24.1	36.8
ZNF792	FLJ38451	ENSG00000180884	"Zinc finger protein 792"	Q3KQV3	19	34956354-34964229	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 7.0;Endothelial cells: 7.5;Hepatic stellate cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 12.8;HMC-1: 16.1;HUVEC TERT2: 11.0;OE19: 9.7;SH-SY5Y: 10.2"					"Low region specificity"	"Detected in many"			"HPA035157, HPA035158"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA035157: AB_2674497, HPA035158: AB_10603010"	"unprognostic (1.31e-1)"	"unprognostic (7.31e-2)"	"prognostic favorable (2.72e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.77e-3)"	3.8	1.3	1.1	2.2	1.6	1.3	3.6	3.6	1.3	2.4	1.1	1.9	2.1	2.2	1.9	1.0	2.6	1.7	2.0	0.9	1.2	1.6	1.3	4.1	3.8	1.2	1.4	2.3	1.8	2.8	1.1	3.4	1.2	1.8	2.3	2.5	2.2	2.2	1.2	1.5	2.4	2.6	0.9	3.6	2.5	0.9	1.3	4.0	1.9	2.1	2.8	2.3	1.4	0.9	1.1	3.8	1.8	2.7	1.8	1.4	0.0	1.1	2.0	1.3	1.6	1.5	1.8	1.6	3.4	1.5	0.6	0.7	2.6	2.0	2.0	4.6	0.6	12.8	1.1	2.9	1.3	1.1	16.1	1.6	0.6	1.1	0.5	2.3	11.0	1.1	3.4	0.0	2.2	0.9	4.5	1.1	1.3	9.7	0.8	2.9	0.0	0.2	1.0	3.5	0.9	10.2	1.0	1.0	1.3	1.6	1.2	3.4	4.5	1.9	2.4	0.8	1.2	0.3	1.0	0.9	2.1	0.2	0.9	5.4	0.5	4.1	1.9	0.4	2.3	1.3	3.0	2.7	0.7	0.9	3.3	2.8	0.1	3.0	0.3	0.1	3.2	1.7	1.1	1.6	3.6	1.3	0.9	1.2	1.2	1.4	1.2	0.9	1.3	0.9	7.0	0.0	1.1	0.7	2.1	0.5	0.1	0.6	0.6	0.8	1.2	0.9	2.0	0.0	0.2	0.0	2.1	0.1	2.9	0.7	0.0	1.8	0.2	0.7	0.7	7.5	1.8	3.4	0.3	2.6	0.4	1.0	2.0	0.8	1.3	1.4	6.4	0.6	1.5	0.0	0.6	1.7	0.0	3.5	1.4	0.4	1.5	1.6	0.0	1.0	1.6	0.5	2.1	2.5	0.3	2.7	1.0	0.0	1.6	0.2	0.5	0.5	0.2	1.8	0.0	0.9	0.6	0.0	1.5	0.4	0.4	0.1	3.0	0.7	1.4	0.1
ZNF793		ENSG00000188227	"Zinc finger protein 793"	Q6ZN11	19	37506939-37548762	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 31.3;Early spermatids: 39.6;Horizontal cells: 48.8;Rod photoreceptor cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.6;RT4: 10.0;U-266/70: 18.4;U-266/84: 12.7"					"Low region specificity"	"Detected in all"			HPA034781	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA034781: AB_10602784"	"unprognostic (4.80e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.03e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.12e-3)"	1.8	4.4	6.1	2.4	5.7	1.2	3.6	10.0	5.9	4.9	4.3	3.7	1.8	5.3	3.8	3.3	4.6	2.5	4.2	5.5	5.5	5.3	0.8	2.1	3.7	4.4	4.4	8.1	2.5	6.0	9.2	2.7	4.2	4.6	3.3	14.7	2.8	3.2	2.4	6.4	2.5	3.3	3.2	3.6	3.0	9.0	5.3	2.8	6.5	2.3	2.8	3.7	4.5	6.0	0.1	0.2	4.5	11.6	0.9	0.9	0.3	3.7	0.2	0.7	0.4	0.2	1.5	3.4	5.6	1.9	1.0	0.5	0.3	2.9	0.3	0.8	4.2	0.4	0.4	0.3	2.4	0.2	2.9	3.5	2.2	0.7	0.1	0.3	0.1	0.4	0.1	0.5	0.5	3.2	0.4	0.4	7.3	0.0	0.2	0.1	0.1	0.8	3.3	10.0	3.4	6.8	0.1	0.1	0.0	8.2	6.7	0.3	0.4	0.1	1.8	0.2	3.5	18.4	12.7	0.2	0.0	0.2	0.6	4.0	0.6	0.5	0.6	0.2	0.9	0.9	1.1	1.0	0.4	1.4	0.7	0.9	1.6	1.6	0.2	0.9	1.0	0.7	6.1	5.7	10.0	5.9	5.5	5.5	4.4	4.4	4.2	3.2	5.3	6.0	6.5	3.2	5.8	24.2	4.0	3.3	3.8	2.6	6.2	29.1	5.0	5.8	9.7	7.2	5.0	12.9	31.3	5.5	2.9	1.7	3.9	3.6	39.6	5.0	8.7	7.0	9.0	2.1	14.9	1.5	4.1	4.6	1.1	3.9	2.5	21.5	6.4	0.5	0.9	48.8	16.3	2.9	0.0	0.3	3.4	11.2	5.0	0.9	0.0	2.8	1.5	13.6	8.2	19.6	16.7	2.0	1.0	10.1	1.1	2.8	1.0	2.7	5.7	33.6	0.0	8.7	5.3	6.0	6.9	4.0	3.3	1.9	4.0	12.7	3.7	1.9
ZNF799	"HIT-40, MGC71805, ZNF842"	ENSG00000196466	"Zinc finger protein 799"	Q96GE5	19	12390016-12401271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (2.96e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.02e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.47e-5)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-3)"	2.9	3.0	2.4	1.5	2.5	1.6	3.8	3.5	2.6	3.4	2.3	2.5	2.1	2.9	2.0	1.8	3.9	2.1	2.0	2.5	2.3	3.4	3.8	2.9	2.6	2.7	2.4	4.4	2.2	2.4	1.1	4.7	2.5	2.6	2.6	1.6	2.2	2.2	1.8	2.4	2.5	2.4	2.4	2.9	2.0	2.7	2.8	3.1	2.0	2.3	2.3	2.7	2.6	2.9	3.0	2.4	3.0	7.2	1.6	1.5	6.0	1.6	2.2	3.9	3.7	4.6	1.2	3.8	2.8	1.9	1.9	2.1	2.4	2.8	3.7	0.0	2.2	3.0	2.0	7.5	0.5	2.3	5.3	1.8	1.7	2.8	2.2	1.2	1.9	3.6	3.1	0.0	2.5	4.2	4.8	3.3	1.6	3.9	6.1	0.5	4.5	3.9	4.0	7.2	1.9	2.2	2.9	0.7	0.9	2.2	3.2	4.2	1.8	4.0	2.3	4.8	1.8	2.6	4.4	3.0	0.4	2.4	1.7	3.1	2.6	2.9	3.9	2.6	4.5	4.7	3.6	5.7	2.1	4.4	3.4	2.7	2.5	2.8	1.6	2.7	4.5	2.3	2.4	2.5	3.5	2.6	2.5	2.3	2.7	2.4	2.5	2.4	2.8	2.9	7.5	6.4	1.5	5.2	3.8	2.4	3.1	1.4	4.6	1.8	5.6	4.3	5.4	1.5	2.0	3.7	0.0	15.2	3.0	3.2	5.9	4.6	8.6	8.0	2.4	7.3	4.2	0.8	5.4	1.3	2.9	2.9	2.6	8.5	3.8	2.9	3.3	1.4	4.4	0.0	4.0	5.7	6.1	1.2	2.6	2.3	2.5	2.2	0.0	10.3	2.1	1.3	6.2	8.0	4.7	2.5	2.3	1.2	2.0	2.1	3.6	2.9	4.7	3.1	13.1	2.8	4.6	4.5	5.6	4.0	1.4	4.5	3.7	1.9	4.0	2.6
ZNF8	"HF.18, Zfp128"	ENSG00000278129	"Zinc finger protein 8"	P17098	19	58278955-58302791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034797, HPA034798"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA034797: AB_10696364, HPA034798: AB_10602785"	"unprognostic (1.41e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.56e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.28e-2)"	1.5	1.8	2.3	1.1	1.8	3.6	1.6	4.6	3.2	1.5	1.0	1.7	1.1	1.8	1.5	1.6	1.7	1.1	2.2	2.8	1.5	1.9	1.1	2.1	1.4	1.7	1.7	1.8	1.6	2.0	2.3	1.5	1.7	1.6	1.1	4.0	1.7	1.3	0.9	2.5	1.7	1.4	0.9	1.8	1.6	1.4	2.1	2.1	1.8	1.4	1.3	1.6	1.6	2.8	1.8	2.6	3.7	6.9	2.3	1.9	3.1	0.9	1.4	0.9	1.0	2.8	1.3	2.3	1.1	1.5	0.8	1.6	2.7	3.0	1.2	1.8	11.4	4.5	6.0	2.5	2.1	1.5	3.5	3.7	1.8	1.6	3.1	2.7	1.7	3.7	2.4	0.9	1.9	2.1	3.5	2.0	3.3	1.3	1.8	3.9	3.5	1.6	1.8	6.3	6.5	3.5	2.8	1.9	0.9	2.8	1.9	2.8	2.5	6.9	1.7	1.0	1.9	3.4	2.9	3.0	1.1	0.0	1.8	1.4	0.7	0.4	0.4	0.3	0.5	0.4	0.3	0.3	0.4	0.5	0.3	0.4	1.3	0.5	0.3	0.3	0.2	0.7	2.3	1.8	4.6	3.2	2.8	1.5	1.7	1.7	1.7	0.9	2.1	2.8	4.2	0.0	4.1	2.3	2.3	0.0	2.9	0.0	2.8	11.0	2.5	2.3	3.1	0.0	1.8	5.5	12.5	2.1	1.2	1.4	3.9	4.0	4.0	4.7	5.3	4.5	5.4	10.3	4.2	2.3	1.6	2.8	4.1	3.9	1.3	5.9	6.8	1.7	2.5	11.8	4.3	2.1	0.0	1.9	0.0	0.9	4.1	2.4	0.0	1.9	3.0	3.5	2.1	3.0	3.3	3.1	0.5	1.9	1.7	4.4	1.0	2.5	2.2	10.2	6.6	6.6	2.6	8.0	3.4	2.8	0.0	2.6	3.4	5.1	1.9	2.8
ZNF80	pT17	ENSG00000174255	"Zinc finger protein 80"	P51504	3	114234631-114237578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"lymphoid tissue: 3.1"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 3.2;granulocytes: 1.3;NK-cells: 2.1;Plasma cells: 1.4;T-cells: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.2"	"Not detected"	"Not detected"											HPA065484	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"		"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA065484: AB_2685496"	"unprognostic (6.27e-3)"	"unprognostic (3.00e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-5)"	"unprognostic (5.36e-1)"	"unprognostic (6.52e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.69e-12)"	"unprognostic (1.85e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-2)"	0.1	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.7	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.7	0.0	0.4	0.0	5.2	0.1	0.1	0.0
ZNF805		ENSG00000204524	"Zinc finger protein 805"	Q5CZA5	19	57240632-57262728	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA046330, HPA058895"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA046330: , HPA058895: AB_2683846"	"unprognostic (2.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.68e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.64e-1)"	1.5	1.9	2.6	1.5	3.0	6.7	2.0	2.6	2.5	1.6	3.3	1.3	1.0	1.7	1.6	1.1	1.4	1.2	1.5	2.1	2.7	1.3	1.9	1.6	1.5	3.1	3.1	2.1	1.3	2.2	1.3	1.8	2.7	1.3	1.6	2.7	1.4	1.5	1.8	2.0	1.1	1.8	2.5	2.1	1.5	2.2	3.2	1.6	1.7	2.1	2.0	1.3	1.1	3.7	1.3	1.8	2.1	3.0	3.9	2.7	2.6	1.2	2.6	2.1	4.2	1.9	1.1	2.5	0.9	2.9	1.4	0.8	2.1	2.3	3.5	1.3	5.3	2.6	1.8	2.2	3.0	2.5	2.3	3.1	2.6	2.7	4.7	1.9	1.9	2.7	0.9	3.5	1.7	0.9	2.9	1.3	1.6	1.2	2.1	1.3	3.9	2.1	1.6	3.9	1.7	1.9	3.2	1.9	2.1	2.5	1.2	2.5	2.2	3.3	2.1	1.3	1.6	3.2	2.4	2.4	2.0	1.3	1.6	1.0	0.8	2.4	1.6	0.4	1.8	1.5	1.3	2.0	0.8	0.7	1.3	1.4	0.9	2.8	0.6	0.8	1.6	0.9	2.6	3.0	2.6	2.5	2.1	2.7	3.1	3.1	2.7	2.5	3.2	3.7	4.1	3.2	0.5	7.2	2.3	1.7	2.2	1.3	2.8	6.3	2.1	2.2	2.0	0.0	0.7	1.8	8.4	1.1	3.5	0.7	1.9	1.6	5.3	2.8	4.2	2.3	1.2	3.2	7.4	1.1	1.6	2.9	2.0	2.7	4.5	2.6	2.9	0.6	0.9	3.3	7.1	1.1	0.0	0.8	0.4	0.8	1.2	1.9	0.0	10.3	0.0	2.5	2.1	7.5	9.7	1.4	0.2	0.7	3.9	2.1	0.9	0.8	1.6	5.4	0.0	4.4	3.7	7.8	2.8	1.8	1.1	2.3	2.7	5.1	0.7	2.4
ZNF814		ENSG00000204514	"Zinc finger protein 814"	B7Z6K7	19	57848731-57889074	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 32.5;U-266/84: 33.4"									"HPA043800, HPA053762, HPA072145"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (3.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.78e-4)"	"unprognostic (5.05e-3)"	"unprognostic (2.41e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.54e-5)"	6.4	14.5	9.2	4.5	7.8	10.4	8.1	24.8	8.3	5.5	7.3	7.6	6.6	5.2	6.9	5.2	8.5	4.5	12.9	9.2	5.2	14.5	13.4	6.3	8.7	6.3	5.2	7.4	7.2	9.7	14.2	4.9	5.7	12.6	4.8	13.8	8.7	5.5	10.0	9.5	9.2	4.0	1.2	13.0	5.4	11.2	6.6	9.5	14.7	5.7	8.1	6.3	5.4	7.1	1.6	4.0	11.6	16.6	1.2	1.1	3.0	4.1	2.7	4.4	0.6	2.0	1.6	8.9	2.7	3.8	4.5	1.3	0.7	8.8	5.4	1.6	7.9	6.6	7.0	2.4	4.8	7.8	8.2	7.3	7.9	1.6	1.7	7.8	1.1	3.6	1.8	3.6	7.3	1.7	25.2	3.6	32.5	0.9	5.1	3.1	1.3	15.6	3.8	6.2	4.7	11.8	1.4	3.2	6.1	23.5	8.0	2.5	2.5	10.3	3.5	2.4	2.2	10.1	33.4	22.5	2.6	4.3	12.9	4.6	8.2	9.7	5.4	9.7	14.0	37.4	14.2	11.7	11.9	38.7	22.4	18.5	5.4	24.8	6.0	27.9	4.2	7.4	9.2	7.8	24.8	8.3	9.2	5.2	6.3	5.2	5.7	1.2	6.6	7.1	6.2	0.0	1.5	4.6	15.6	6.8	10.5	7.3	4.0	22.7	11.5	9.8	12.9	21.5	10.1	12.9	47.9	13.2	10.8	5.0	17.6	8.0	46.5	13.9	6.6	7.6	4.9	5.9	10.9	1.4	18.6	5.5	6.1	20.4	16.5	12.6	14.6	15.3	13.0	20.2	12.3	8.7	14.2	2.8	7.9	19.5	4.1	6.5	10.6	4.7	5.9	9.4	13.4	7.5	10.1	1.7	17.8	7.2	5.9	8.4	10.5	44.0	8.4	35.9	19.7	5.7	6.6	14.1	10.9	3.5	13.1	11.6	9.2	8.9	22.1	12.6
ZNF816-ZNF321P	ZNF816-ZNF321	ENSG00000221874	"ZNF816-ZNF321P readthrough"		19	52928475-52962823	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 9.8;Syncytiotrophoblasts: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RT4: 9.0"									HPA051271	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA051271: AB_2681415"												"unprognostic (4.18e-2)"						0.2	0.1	0.0	0.3	0.0	0.4	0.8	0.0	0.2	0.7	0.0	0.9	0.0	0.5	0.0	0.2	0.8	0.3	0.2	0.0	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.5	0.3	0.2	0.2	0.8	0.0	1.7	1.5	0.0	0.4	0.7	0.0	0.2	0.2	0.0	0.0	0.3	1.0	0.1	0.0	0.2	0.2	0.0	0.4	0.6	0.4	0.0	0.3	0.0	0.8	0.2	0.5	0.1	0.5	0.0	0.3	0.5	0.5	0.0	0.3	0.9	0.3	0.4	0.8	0.1	0.8	0.1	0.0	0.5	1.1	0.4	0.1	1.1	0.6	0.0	0.2	0.5	0.0	0.8	0.0	0.3	0.4	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.1	0.0	0.2	9.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.6	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	0.8	0.0	3.8	0.0	3.4	0.0	1.5	2.4	0.6	4.3	0.0	0.0	0.0	9.8	1.2	4.4	3.9	3.6	1.9	7.3	1.9	1.0	0.0	3.0	0.7	3.6	5.7	1.1	6.6	7.4	4.5	1.5	1.4	0.3	3.7	0.0	0.3	3.6	0.0	1.6	0.0	1.1	0.3	1.8	0.0	1.0	2.9	0.0	4.1	1.0	0.6	3.5	2.5	0.7	1.0	2.7	1.9	1.1	0.0	0.0	0.0	1.3	1.1	1.3	1.6	2.0	0.0	11.2	1.6	1.0	3.0	5.9
ZNF821		ENSG00000102984	"Zinc finger protein 821"	O75541	16	71859680-71895336	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 21.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 143.0;Spermatocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 9.5;naive B-cell: 13.4;T-reg: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 13.4;T-cells: 5.6"	"Cell line enhanced"	"Detected in many"		"AF22: 13.2;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036372, HPA042742"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"		"HPA036372: AB_10669790, HPA042742: AB_2678140"	"unprognostic (3.16e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (2.83e-2)"	"prognostic favorable (6.32e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-1)"	2.1	2.8	5.4	1.5	5.7	2.5	3.3	9.8	6.0	6.0	2.9	2.8	1.4	4.4	7.5	2.6	3.1	2.6	2.8	5.7	6.7	4.0	1.8	2.9	4.4	5.2	5.0	4.9	2.3	4.1	8.9	1.7	5.3	4.2	3.4	9.3	3.3	3.3	3.6	5.3	4.3	1.9	4.7	3.9	2.5	21.2	5.8	3.3	4.2	4.1	5.4	2.0	4.2	4.8	1.1	0.9	13.2	6.4	2.6	3.3	2.2	1.4	3.0	2.9	4.6	1.9	0.8	2.5	2.3	2.6	3.2	1.9	4.4	2.0	3.5	3.9	5.0	0.5	0.8	0.8	1.6	0.9	2.8	2.9	3.2	2.0	1.2	5.0	2.3	0.6	1.7	1.8	3.2	3.3	1.5	0.9	5.2	3.9	0.6	6.0	2.8	4.5	3.3	0.4	13.2	6.3	1.8	1.1	1.5	5.6	4.5	3.0	4.5	3.1	3.2	1.1	0.9	4.4	2.4	10.2	1.0	2.5	3.0	0.0	0.5	0.4	2.0	0.0	1.8	9.5	2.1	1.5	0.9	13.4	1.3	0.5	0.4	1.0	0.5	0.0	5.6	0.8	5.4	5.7	9.8	6.0	5.7	6.7	5.2	5.0	5.3	4.7	5.8	4.8	7.4	0.0	4.2	13.7	28.7	8.0	8.7	7.2	23.3	41.8	15.2	12.4	1.2	11.5	4.9	16.5	45.9	5.8	11.8	23.5	21.5	9.7	143.0	8.5	11.5	8.4	23.4	6.1	28.3	4.8	5.2	7.7	29.0	14.8	9.5	13.5	12.5	1.8	7.9	32.0	30.4	11.3	6.1	10.6	13.4	57.4	12.5	10.3	3.6	8.4	3.7	25.8	9.2	22.1	13.7	6.2	16.7	12.4	22.6	8.0	42.8	10.8	4.7	51.6	13.1	6.3	9.2	79.4	20.8	16.1	7.5	6.2	15.4	6.3	7.7	4.3
ZNF827		ENSG00000151612	"Zinc finger protein 827"	Q17R98	4	145757627-145938823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 96.3;Excitatory neurons: 77.5;Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 96.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021166	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA021166: AB_2670608"	"unprognostic (2.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.88e-2)"	2.9	7.1	2.4	3.2	5.5	2.2	4.5	9.1	4.3	5.7	0.0	6.4	5.2	8.1	2.9	2.2	6.1	3.7	4.8	3.0	2.4	4.7	0.6	2.7	3.8	2.3	2.2	7.4	3.0	7.0	8.3	1.3	1.0	15.8	3.9	1.3	10.7	4.8	7.9	2.8	6.4	6.0	0.8	4.0	3.8	3.5	2.2	7.3	7.7	5.3	4.4	6.5	3.8	4.0	4.4	3.5	12.8	7.3	5.2	5.4	0.0	7.7	7.6	5.7	4.2	1.3	10.5	0.6	2.0	12.9	4.4	2.2	6.9	4.9	4.6	7.3	2.5	3.9	4.8	3.7	4.1	3.1	0.0	8.1	4.3	4.6	11.7	10.9	9.2	2.1	0.4	5.6	4.8	0.0	3.0	0.0	5.1	0.0	7.5	10.6	6.0	1.9	5.1	4.7	10.5	9.0	6.0	9.4	13.3	5.6	5.5	0.1	17.8	13.9	10.9	1.0	8.1	4.6	0.1	3.4	4.7	11.7	49.2	2.9	0.0	0.0	1.8	0.0	0.9	1.6	0.9	1.8	0.0	1.2	0.9	1.7	0.0	1.9	0.0	1.5	0.0	0.6	2.4	5.5	9.1	4.3	3.0	2.4	2.3	2.2	1.0	0.8	2.2	4.0	7.3	12.8	19.8	96.3	12.3	6.4	8.3	16.2	22.8	12.7	19.2	19.2	22.4	2.8	16.9	23.9	10.4	2.3	10.3	14.9	3.9	12.1	17.1	11.9	10.8	8.7	25.8	5.9	77.5	7.1	0.5	7.8	14.3	14.6	2.5	17.4	8.2	1.3	1.3	18.5	64.3	18.6	10.2	1.2	0.8	7.8	9.0	1.2	1.8	8.4	0.7	4.7	8.2	174.9	96.6	14.2	9.5	17.0	13.7	30.7	20.1	12.3	19.3	1.5	6.6	20.6	7.1	2.1	5.0	5.8	4.8	1.4	9.4	18.7	19.5	11.6
ZNF829	DKFZp779O175	ENSG00000185869	"Zinc finger protein 829"	Q3KNS6	19	36888124-36916291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 10.4"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 278.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 13.0"					"Low region specificity"	"Detected in all"			HPA073073			Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA073073: AB_2686567"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.44e-4)"	"unprognostic (1.32e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.92e-4)"	1.1	0.9	0.7	1.2	0.6	1.1	2.0	1.9	1.0	1.1	0.1	0.9	0.9	1.6	1.0	0.9	1.3	0.9	1.2	0.6	0.7	1.2	0.8	1.0	1.5	0.3	0.5	2.4	0.9	1.9	0.5	1.5	0.4	1.3	0.7	1.9	1.1	1.2	0.5	1.8	0.7	1.4	0.3	1.5	0.9	10.4	0.8	1.5	1.7	0.8	1.4	1.0	0.9	0.9	0.0	0.8	2.9	0.1	1.5	2.2	1.2	3.3	1.9	3.9	5.5	0.0	0.5	0.1	3.9	2.1	3.7	0.6	0.0	2.3	4.6	0.0	4.1	1.6	0.1	0.1	1.6	0.0	4.2	2.3	2.1	4.3	0.0	1.3	0.4	1.2	0.0	0.1	3.9	0.7	0.7	0.8	5.1	0.0	0.0	0.0	3.7	1.5	1.1	4.5	3.2	4.7	0.1	0.0	2.8	3.8	3.0	0.2	1.1	2.4	3.4	3.3	3.4	7.9	13.0	5.0	0.0	0.0	6.1	1.4	0.2	0.9	0.9	0.1	1.4	0.8	1.0	1.4	0.3	1.2	1.4	1.5	0.4	0.7	0.2	0.5	1.0	0.3	0.7	0.6	1.9	1.0	0.6	0.7	0.3	0.5	0.4	0.3	0.8	0.9	3.0	0.0	3.4	2.0	4.7	1.5	1.9	1.2	1.2	6.8	2.5	2.0	5.6	2.8	3.7	3.7	4.2	4.0	5.5	0.6	0.0	2.7	278.1	3.1	4.4	3.7	0.0	1.3	4.2	1.0	2.5	3.9	0.5	3.1	1.3	5.5	2.9	0.6	1.5	11.8	3.8	1.0	0.0	1.0	4.6	58.9	5.9	1.4	3.6	1.0	1.7	2.6	5.2	6.0	4.1	0.8	0.1	7.2	1.3	1.9	0.3	1.3	1.6	11.1	0.0	5.9	4.6	10.6	11.2	1.1	2.7	4.2	3.8	3.1	0.5	1.1
ZNF83	"FLJ11015, HPF1, ZNF816B"	ENSG00000167766	"Zinc finger protein 83"	P51522	19	52594060-52690496	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA025970	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA025970: AB_1859463"	"unprognostic (6.38e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (3.38e-3)"	"unprognostic (3.67e-1)"	"prognostic unfavorable (9.20e-4)"	"prognostic favorable (9.06e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (2.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (6.92e-6)"	42.7	54.4	35.4	24.7	49.8	30.1	45.6	53.3	47.7	82.9	35.5	55.6	14.9	50.8	92.0	28.7	88.2	28.2	36.5	33.9	40.8	99.3	13.1	42.8	36.2	43.7	38.0	100.8	36.5	26.1	77.3	30.0	44.8	81.2	24.2	67.4	33.3	40.5	9.8	30.8	40.4	29.3	36.8	48.9	34.2	22.1	40.2	19.1	71.5	8.9	29.6	50.2	61.0	51.0	19.6	1.0	27.0	19.6	23.7	47.4	15.0	29.9	20.4	17.6	23.7	7.2	16.5	20.2	14.9	20.3	13.0	8.6	16.3	20.1	24.5	2.7	18.4	16.5	18.9	9.3	19.5	12.3	23.1	38.4	24.2	14.7	73.0	61.8	19.9	22.6	19.3	15.7	29.2	13.2	17.4	20.5	7.4	3.4	18.3	17.3	23.2	13.5	45.0	39.1	15.2	12.5	19.2	18.6	7.7	42.9	19.8	12.7	27.0	17.7	10.7	8.5	31.1	1.4	18.3	27.5	1.0	12.8	14.2	4.1	3.0	7.5	5.7	3.2	6.1	5.7	7.0	7.5	3.6	9.3	6.0	6.7	2.7	10.9	4.7	2.5	3.8	3.2	35.4	49.8	53.3	47.7	33.9	40.8	43.7	38.0	44.8	36.8	40.2	51.0	28.1	35.3	20.0	53.8	20.3	10.3	52.9	23.6	11.4	25.2	23.1	20.7	15.4	12.8	38.1	40.5	35.5	48.4	22.6	10.6	19.6	21.2	24.5	35.2	30.7	28.9	10.8	14.1	26.9	6.9	20.8	32.9	16.3	47.4	37.2	130.5	23.2	1.1	13.5	48.8	57.2	11.3	18.3	5.7	15.8	17.3	42.6	12.0	30.2	46.9	14.6	16.6	37.0	56.8	80.0	10.7	18.5	34.6	9.9	90.8	8.2	23.9	34.9	38.3	6.6	43.3	21.4	15.4	15.8	6.4	9.7	64.0	26.0	62.5	8.8	116.2
ZNF830	"CCDC16, MGC20398, OMCG1"	ENSG00000198783	"Zinc finger protein 830"	Q96NB3	17	34961540-34963777	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024754, HPA027211"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024754: AB_1859464, HPA027211: AB_1859465"	"unprognostic (2.87e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.01e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (8.63e-2)"	8.0	7.0	5.9	9.5	6.3	11.1	8.4	7.9	7.2	7.9	6.3	8.3	8.6	9.4	6.8	8.7	8.9	6.8	7.0	5.9	6.1	9.0	10.4	6.5	13.9	5.9	6.0	12.8	8.2	8.0	5.5	7.8	6.1	8.1	6.4	6.3	7.8	6.7	8.0	8.5	10.6	6.5	5.8	14.7	8.9	10.1	6.1	13.7	9.0	8.5	11.8	9.4	7.5	7.4	7.9	15.2	13.5	12.5	14.1	10.9	9.3	9.5	9.6	12.2	12.0	11.5	10.5	14.3	8.5	9.3	12.7	18.2	14.5	8.6	13.7	8.7	19.7	16.9	15.5	14.5	14.3	25.4	23.2	10.7	19.9	10.2	19.7	12.3	11.1	17.4	24.6	20.5	11.1	6.1	23.2	28.5	8.9	10.6	7.4	15.4	18.3	19.1	11.3	10.6	15.9	13.6	9.3	5.7	15.4	12.9	13.2	27.5	11.7	12.8	9.4	9.5	16.7	22.6	18.5	19.1	11.0	13.4	11.7	30.8	12.3	40.7	16.2	12.1	16.2	13.1	17.3	18.0	13.5	13.0	26.2	20.9	11.6	15.8	8.7	14.4	16.9	12.3	5.9	6.3	7.9	7.2	5.9	6.1	5.9	6.0	6.1	5.8	6.1	7.4	27.6	38.5	21.3	4.2	35.3	24.0	45.3	26.7	25.0	19.9	23.3	18.7	8.3	17.2	30.9	12.9	14.6	24.5	45.8	25.7	35.2	19.0	7.1	14.1	27.3	23.6	18.5	20.2	5.1	13.1	16.7	23.2	23.0	17.3	17.1	20.4	15.4	10.6	14.4	10.1	4.8	21.1	22.4	11.5	16.7	3.8	26.8	15.8	21.4	6.5	18.3	20.4	51.5	4.5	11.6	13.4	25.3	27.4	21.3	27.7	26.5	22.4	15.4	31.8	26.3	27.2	22.6	44.8	46.4	18.6	24.2	26.7	36.3	22.6	28.2	34.3
ZNF839	C14orf131	ENSG00000022976	"Zinc finger protein 839"	A8K0R7	14	102317377-102342702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020434	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA020434: AB_10669862"	"unprognostic (7.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.10e-3)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.40e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	7.6	9.3	9.7	6.8	8.9	11.5	13.7	6.2	9.5	9.2	7.9	7.8	7.1	8.1	9.3	7.2	17.0	6.8	8.7	8.9	11.0	11.3	14.6	6.1	10.8	8.7	8.6	10.9	12.1	10.8	9.2	5.6	8.1	9.0	8.1	8.0	10.5	9.5	18.5	19.4	9.8	5.2	6.7	15.1	8.0	31.3	9.3	12.2	11.2	12.1	8.8	7.0	6.0	8.7	13.5	12.1	15.4	27.8	7.0	11.8	26.2	10.3	8.4	12.6	10.3	4.6	11.2	13.8	8.3	7.0	5.2	13.0	10.0	25.9	9.7	18.6	19.1	9.6	12.7	7.7	6.3	9.1	8.1	9.5	18.9	24.4	22.6	19.1	17.0	19.3	21.0	17.6	17.9	25.1	13.9	14.6	20.6	7.3	12.0	29.7	9.4	8.8	11.2	10.9	8.2	25.7	8.5	10.7	9.6	14.5	24.5	14.7	6.7	8.1	7.3	11.3	9.3	17.3	13.5	16.2	6.3	10.7	13.6	0.0	0.2	0.7	0.6	0.6	0.7	0.5	0.4	0.4	0.3	0.4	0.7	0.6	1.0	0.1	0.1	0.6	0.6	0.1	9.7	8.9	6.2	9.5	8.9	11.0	8.7	8.6	8.1	6.7	9.3	8.7	4.6	0.0	10.0	12.1	4.1	3.1	2.6	2.2	2.8	7.6	6.7	7.1	1.9	7.2	3.7	11.0	8.4	6.3	6.5	3.3	11.7	2.9	27.4	6.1	4.3	3.5	1.2	7.4	7.9	2.8	3.1	4.0	5.6	4.5	3.8	10.6	4.6	4.7	3.1	3.3	7.8	5.7	4.1	2.2	1.5	3.8	5.0	3.5	3.6	3.7	1.9	6.9	1.0	5.0	8.2	2.8	1.6	4.1	4.5	2.5	5.3	7.0	7.9	9.6	0.0	3.6	3.3	19.9	11.6	3.7	2.6	5.6	4.5	5.7	5.4	1.5
ZNF84	HPF2	ENSG00000198040	"Zinc finger protein 84"	P51523	12	133037292-133063304	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA028860	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA028860: AB_10604102"	"unprognostic (2.39e-1)"	"unprognostic (5.11e-3)"	"unprognostic (3.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (5.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.30e-3)"	11.1	11.1	14.6	8.9	16.2	9.3	16.6	18.3	30.2	15.7	16.6	13.9	7.5	18.0	23.0	8.6	15.8	11.3	11.2	14.7	15.3	16.6	13.1	10.5	13.7	13.8	14.9	20.8	12.7	13.5	23.1	11.6	15.4	17.0	12.0	24.7	11.9	12.2	10.3	12.3	11.6	13.3	13.8	13.6	11.3	14.0	14.9	14.9	18.2	11.7	14.4	13.5	12.2	22.4	18.4	14.3	38.0	25.0	16.1	25.3	33.1	16.5	14.2	12.0	11.5	8.7	5.5	22.0	14.4	14.3	14.6	8.2	15.4	13.4	18.7	6.2	26.0	32.8	18.2	12.4	19.8	35.8	14.0	17.9	16.1	18.3	19.7	38.9	18.9	15.4	16.8	10.8	30.8	10.8	24.8	33.6	51.5	6.9	11.7	34.4	17.7	15.2	16.8	39.5	31.7	34.5	31.8	9.6	13.9	21.3	31.5	21.0	23.2	13.6	15.2	12.8	11.7	5.2	0.0	50.2	7.9	27.8	17.8	1.5	3.5	4.4	8.1	5.2	12.2	9.5	9.0	10.4	5.9	7.9	11.9	9.8	0.8	10.1	3.8	7.4	5.4	5.0	14.6	16.2	18.3	30.2	14.7	15.3	13.8	14.9	15.4	13.8	14.9	22.4	16.6	9.6	9.6	27.4	21.8	3.1	13.4	2.7	17.6	18.6	14.0	14.4	24.1	10.0	8.1	16.5	6.2	10.3	11.7	3.2	3.9	13.4	14.9	15.5	15.4	16.1	9.6	20.8	33.7	7.1	5.6	16.3	7.1	9.6	13.9	23.2	15.7	8.6	10.5	20.2	36.2	9.6	0.0	7.3	2.4	15.2	13.4	8.6	1.8	14.0	5.1	14.6	17.5	45.2	47.5	9.7	9.1	15.1	9.1	12.9	5.4	11.2	17.6	17.3	13.1	16.9	14.3	13.1	24.2	11.5	2.7	6.4	14.2	12.0	7.5	9.3
ZNF843	MGC46336	ENSG00000176723	"Zinc finger protein 843"	Q8N446	16	31432593-31443160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 4.6;Cardiomyocytes: 5.3;Prostatic glandular cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;EFO-21: 1.8;HMC-1: 1.6"									"HPA030911, HPA030912, HPA077945"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nuclear speckles"	"HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: "	"unprognostic (9.27e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.43e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.86e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.93e-3)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-5)"	"unprognostic (1.17e-1)"	0.6	0.5	1.5	0.3	1.2	0.3	0.6	2.5	1.3	1.0	0.0	0.4	0.2	1.0	0.7	0.4	1.1	0.7	1.7	1.6	1.9	0.6	0.4	0.3	0.3	1.1	1.4	3.0	2.1	0.9	1.5	0.4	0.9	0.6	0.1	1.1	1.5	0.8	2.2	0.9	0.3	0.5	1.1	0.4	0.4	0.5	1.8	0.2	1.0	0.8	0.2	0.5	0.6	0.9	0.1	0.3	0.2	1.2	2.3	0.6	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.0	1.8	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.2	1.6	1.2	0.3	0.0	0.1	0.8	0.0	0.2	0.2	0.2	0.6	0.8	0.1	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.8	0.0	0.2	0.1	0.1	0.0	0.1	0.4	1.0	0.2	0.2	0.7	0.1	0.4	0.2	0.2	0.7	0.1	0.2	0.1	0.4	0.7	1.7	0.1	0.2	0.1	1.0	1.5	1.2	2.5	1.3	1.6	1.9	1.1	1.4	0.9	1.1	1.8	0.9	0.5	0.0	0.5	2.9	0.3	0.8	4.6	0.1	0.0	2.2	0.9	1.3	5.3	0.0	0.7	0.0	2.1	0.3	0.1	0.3	0.0	0.3	0.2	0.4	2.0	1.0	1.2	0.0	1.4	0.2	0.1	1.4	0.0	0.4	1.3	1.4	1.8	0.3	0.6	0.0	1.7	0.0	0.0	0.3	2.1	0.0	1.5	0.9	0.0	0.0	0.1	1.4	2.1	1.0	1.3	0.1	0.1	1.5	0.1	3.6	0.0	0.4	0.0	1.9	0.0	2.8	1.3	0.4	0.7	0.1	1.4	0.3	1.2	0.8	0.1	1.9
ZNF85	"HPF4, HTF1"	ENSG00000105750	"Zinc finger protein 85"	Q03923	19	20923222-20950697	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 128.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA044760	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA044760: AB_10960412"	"unprognostic (1.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.01e-4)"	"prognostic favorable (6.45e-6)"	"unprognostic (2.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.90e-3)"	"unprognostic (6.01e-2)"	2.7	4.9	0.9	2.0	0.9	5.0	5.2	3.4	1.1	2.6	0.3	1.9	0.4	2.4	1.6	2.8	2.4	1.6	1.8	0.9	0.9	2.5	0.9	1.8	5.8	1.1	1.1	6.6	8.1	2.1	1.4	3.6	1.1	2.4	2.6	1.1	2.9	1.6	0.7	2.9	2.2	2.3	0.7	3.6	5.6	11.5	1.0	5.4	7.8	0.3	6.0	2.2	2.7	1.4	0.9	0.6	12.6	12.5	3.5	3.2	9.0	8.1	3.6	12.5	12.7	0.1	4.9	13.8	9.1	3.4	5.6	1.1	0.2	7.9	13.2	0.5	6.4	2.1	0.9	0.9	0.9	0.1	3.1	1.6	2.3	5.8	6.9	2.6	3.6	12.5	0.2	4.2	6.6	1.8	20.9	7.5	11.0	0.0	11.4	9.9	17.6	6.9	4.0	5.3	10.3	5.4	0.2	0.3	2.6	10.7	5.2	9.7	3.0	7.2	1.3	15.7	10.4	5.4	15.3	13.2	0.2	0.0	5.1	0.4	0.7	2.8	1.8	2.3	1.5	5.4	2.2	1.3	1.7	3.6	2.6	2.1	2.1	5.3	1.3	2.0	2.8	1.4	0.9	0.9	3.4	1.1	0.9	0.9	1.1	1.1	1.1	0.7	1.0	1.4	5.4	3.2	1.7	2.0	8.5	0.8	2.2	1.5	1.8	4.7	4.5	4.4	3.4	1.5	2.0	5.5	0.0	9.9	8.5	1.0	1.9	6.9	128.4	2.4	4.1	8.3	0.0	9.0	3.4	6.1	14.2	5.0	3.6	3.9	12.0	10.3	5.7	0.3	8.8	3.3	4.8	2.6	4.1	1.9	3.3	24.1	3.1	4.3	5.4	6.5	5.0	3.7	5.2	9.0	5.3	3.5	2.1	3.8	3.8	2.4	0.1	3.9	2.6	2.0	19.7	2.5	5.3	23.2	13.6	3.1	1.4	7.5	4.7	6.5	1.3	3.3
ZNF850	ZNF850P	ENSG00000267041	"Zinc finger protein 850"	A8MQ14	19	36714383-36772825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 15.2;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029299	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA029299: AB_2672987"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.37e-3)"	0.8	0.6	0.7	1.0	0.6	5.1	0.9	2.4	1.0	0.7	0.9	0.7	0.6	0.7	0.3	1.0	0.7	0.8	1.6	1.5	0.7	0.6	0.9	0.7	1.5	0.9	0.7	1.2	0.6	1.0	0.5	3.1	0.8	0.9	1.0	1.0	0.7	0.7	0.4	1.2	0.6	0.8	0.3	1.1	0.7	2.6	0.7	0.7	0.7	0.5	0.8	0.5	0.5	1.4	0.3	1.7	3.7	6.0	0.8	0.2	7.0	2.2	1.3	1.5	1.8	1.3	0.4	1.2	5.1	0.4	7.6	1.1	2.6	0.5	2.7	0.8	2.3	15.2	0.3	1.2	1.0	1.8	8.6	1.0	0.1	2.3	0.0	0.5	1.3	1.8	4.4	0.8	3.6	0.8	2.7	1.7	11.9	0.6	1.0	1.7	7.8	1.1	0.7	7.5	2.4	3.8	3.5	0.2	0.5	5.0	1.5	3.3	2.9	3.6	5.9	2.1	3.7	1.4	2.7	3.2	0.0	0.9	5.6	1.8	1.2	0.9	1.3	1.3	1.7	2.7	1.6	1.1	1.1	1.7	1.8	2.0	1.9	1.3	1.5	1.2	1.2	2.2	0.7	0.6	2.4	1.0	1.5	0.7	0.9	0.7	0.8	0.3	0.7	1.4	2.4	0.0	0.0	0.7	1.7	2.2	1.3	0.5	1.8	1.1	1.9	1.5	5.1	1.5	0.2	3.7	0.0	4.4	1.3	0.3	0.0	1.0	8.0	1.6	1.5	2.9	0.0	5.7	1.3	0.7	5.4	3.0	0.5	2.4	0.0	3.6	7.1	2.1	1.3	5.0	1.0	3.5	2.0	2.2	2.1	3.3	1.2	0.8	3.6	1.9	0.5	1.2	2.1	3.0	3.7	0.6	0.4	0.4	0.7	0.8	0.1	0.7	0.2	0.5	0.0	2.5	1.6	5.9	5.7	1.1	3.4	2.9	1.1	1.7	0.8	0.9
ZNF860		ENSG00000197385	"Zinc finger protein 860"	A6NHJ4	3	31981750-31991723	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 14.0;Extravillous trophoblasts: 3.8;Respiratory ciliated cells: 4.3;Syncytiotrophoblasts: 4.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"memory B-cell: 7.0;naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	56	"B-cells: 7.0"	"Cell line enriched"	"Detected in many"	4	"BEWO: 44.8"									HPA063386	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063386: AB_2684999"	"unprognostic (1.19e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.75e-3)"	0.3	0.2	0.2	1.4	0.2	0.1	1.4	0.0	0.2	1.5	0.5	0.6	0.2	0.9	2.3	1.7	1.0	0.6	0.2	0.4	0.3	1.0	0.0	0.7	3.1	0.1	0.6	0.6	0.1	0.0	1.4	1.3	0.3	2.8	0.8	0.7	1.4	1.2	0.1	1.2	1.2	0.7	0.0	1.6	0.6	1.0	0.3	0.4	0.9	0.2	4.2	1.1	0.8	0.1	3.0	0.9	0.0	2.3	0.0	0.1	44.8	0.2	0.1	0.2	0.3	3.0	3.5	3.3	3.3	0.0	1.4	2.8	1.0	4.5	0.3	0.0	0.4	0.0	4.4	1.5	0.0	0.0	0.0	0.2	2.0	0.3	8.6	0.3	0.8	0.0	0.0	0.0	0.4	2.6	0.0	0.0	1.2	8.1	4.7	0.0	0.0	0.1	10.2	1.2	0.2	0.0	0.6	5.3	0.0	2.1	4.0	0.0	1.7	0.3	3.5	0.0	0.3	0.0	0.0	5.2	0.4	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.4	0.3	0.1	0.6	0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.0	14.0	0.9	0.5	0.7	0.6	0.6	1.9	0.8	0.6	0.0	3.1	0.0	0.0	1.7	0.1	0.2	0.0	0.1	0.1	1.2	0.7	1.1	3.5	0.0	1.6	0.5	3.8	0.7	1.5	1.6	0.0	0.0	0.4	0.0	0.3	0.0	1.7	0.5	2.0	0.0	0.5	0.3	0.6	0.3	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.3	0.2	0.4	0.7	0.8	0.5	1.2	4.3	0.0	0.0	0.2	0.7	0.1	0.2	2.4	0.3	4.2	0.4	0.0	0.5	0.6
ZNF865		ENSG00000261221	"Zinc finger protein 865"	P0CJ78	19	55605647-55617269	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 34.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068079	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoli	Nucleoplasm	"HPA068079: AB_2685947"	"unprognostic (3.98e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.72e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.41e-3)"	8.9	7.8	5.4	2.9	4.8	4.2	8.4	5.7	6.4	10.4	0.2	12.9	3.7	12.4	0.9	7.4	10.1	0.7	15.5	5.2	2.1	8.5	8.1	8.6	2.4	5.5	4.2	11.0	9.9	3.7	10.5	1.6	3.8	11.5	1.0	1.6	8.5	2.1	34.9	11.4	9.4	1.3	2.1	13.0	9.3	4.1	5.2	3.0	10.6	6.2	1.3	10.7	8.1	5.2	7.4	5.9	2.5	4.1	2.7	2.1	6.9	5.2	2.9	2.8	2.7	1.9	4.7	8.5	5.8	3.8	1.4	6.1	1.6	3.2	1.1	8.5	19.4	4.9	3.8	2.6	4.3	5.7	9.3	3.1	4.9	3.4	2.0	2.5	1.9	5.2	9.6	5.7	1.8	3.5	8.9	6.1	5.7	4.3	10.3	13.8	4.0	5.4	3.3	5.0	6.0	9.7	7.2	4.3	4.6	1.3	3.4	8.8	5.6	4.2	10.1	3.9	6.6	11.9	11.0	4.4	5.2	4.3	6.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	4.8	5.7	6.4	5.2	2.1	5.5	4.2	3.8	2.1	5.2	5.2	7.2	0.0	0.0	3.9	6.3	4.1	1.3	3.1	8.0	5.3	5.4	3.7	20.5	4.3	1.3	14.7	0.0	2.6	3.4	8.3	5.9	3.7	2.3	3.0	3.5	5.4	6.0	3.0	3.2	4.5	3.2	5.2	8.6	3.6	0.0	6.9	7.1	6.7	4.7	10.1	3.0	5.6	4.1	5.3	5.8	5.2	5.3	5.1	5.4	1.0	4.0	4.5	3.1	4.0	2.7	6.1	1.8	10.1	4.5	1.4	5.8	4.0	1.6	3.3	6.6	4.3	6.4	1.3	1.2	4.5	4.3	2.6	5.7	5.6	6.1	1.1
ZNF875	HKR1	ENSG00000181666	"Zinc finger protein 875"	P10072	19	37312837-37369365	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 141.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.1;Cardiomyocytes: 19.8;Cytotrophoblasts: 11.0;Extravillous trophoblasts: 5.7;Hofbauer cells: 7.3;Syncytiotrophoblasts: 9.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036126, HPA044855"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Mitochondria"		"HPA036126: AB_10670708, HPA044855: AB_2679113"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.92e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (4.41e-4)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	18.9	37.4	29.0	10.8	26.2	14.8	25.9	36.8	30.9	24.1	46.5	22.6	8.3	20.4	23.9	17.4	23.9	14.4	31.9	28.0	30.3	34.0	18.3	18.7	16.7	25.4	26.5	28.1	20.0	31.8	36.5	18.3	26.4	39.4	14.0	141.0	27.1	19.2	21.3	28.4	19.4	17.4	19.3	27.9	21.1	30.4	28.7	19.2	37.9	18.1	18.9	21.7	22.0	30.2	7.8	19.7	24.9	32.3	18.0	15.1	17.2	13.2	20.0	23.7	25.8	10.0	9.1	27.8	31.4	14.0	11.1	6.6	16.5	17.7	24.9	14.5	28.4	9.8	26.9	10.4	23.3	8.6	23.9	23.4	21.5	16.4	35.4	23.8	14.8	19.9	1.9	1.6	17.6	16.0	20.0	17.7	51.0	13.9	11.3	13.7	10.7	10.9	21.2	31.9	32.1	42.5	13.1	16.7	16.9	36.2	24.1	17.4	13.6	18.8	13.1	14.2	21.0	34.9	40.4	29.8	2.2	10.7	21.3	12.8	4.5	7.4	7.6	5.8	14.9	11.1	10.6	11.5	6.9	12.6	14.3	12.0	4.1	11.4	4.0	8.4	13.9	6.8	29.0	26.2	36.8	30.9	28.0	30.3	25.4	26.5	26.4	19.3	28.7	30.2	5.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	11.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	9.9	0.4	0.0	0.0	0.0
ZNF878		ENSG00000257446	"Zinc finger protein 878"	C9JN71	19	12043805-12052961	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 1.0;Cytotrophoblasts: 1.2;Spermatogonia: 1.2;Syncytiotrophoblasts: 1.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2"									HPA052735	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Nucleoli	"HPA052735: AB_2681932"	"unprognostic (3.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.62e-2)"	0.3	0.3	0.1	0.2	0.0	1.3	0.2	0.7	0.4	0.4	0.1	0.3	0.1	0.3	0.2	0.3	0.3	0.2	0.2	0.1	0.1	1.1	0.2	0.4	0.2	0.2	0.2	0.5	0.5	0.1	0.2	0.7	0.2	0.3	0.2	0.4	0.3	0.0	0.1	0.1	0.3	0.2	0.2	0.3	0.3	1.0	0.3	0.2	0.3	0.1	0.1	0.3	0.2	0.0	1.5	0.0	0.8	3.2	0.0	0.0	2.0	0.5	0.2	0.6	0.8	1.3	0.2	0.7	0.7	0.2	0.9	0.4	0.3	0.5	0.5	0.0	0.5	0.9	0.0	1.7	0.0	0.6	1.6	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	1.6	0.9	1.8	0.0	0.2	1.2	1.6	0.0	1.1	1.2	0.8	0.1	0.0	0.0	0.1	1.7	1.7	2.1	0.0	0.9	0.7	0.7	0.9	0.6	2.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.1	0.1	0.2	0.2	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	1.0	0.8	0.0	0.0	0.0	0.0	1.2	0.3	0.1	0.0	0.3	0.1	0.2	0.2	0.4	0.0	0.0	0.2	0.2	0.9	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.3	0.4	1.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0
ZNF879	DKFZp686E2433	ENSG00000234284	"Zinc finger protein 879"	B4DU55	5	179023804-179035064	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 12.5;Spermatocytes: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.9;BEWO: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068608	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA068608: AB_2686010"	"unprognostic (3.20e-2)"	"unprognostic (5.24e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.83e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.04e-2)"	"unprognostic (5.69e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.17e-3)"	2.3	1.5	2.7	2.1	3.8	0.8	2.7	4.0	3.4	2.3	2.9	2.2	1.2	2.7	2.2	2.0	2.3	1.6	2.7	2.7	2.9	2.3	1.4	2.0	3.0	3.5	3.3	3.9	1.7	2.5	2.6	2.8	3.1	2.6	1.2	7.1	2.2	3.2	2.2	3.5	1.9	2.3	3.1	3.2	1.7	6.2	2.8	3.4	3.8	3.1	3.5	1.9	1.8	4.6	0.0	3.6	3.2	9.9	3.0	2.3	10.5	1.8	2.6	4.2	5.2	3.3	1.8	2.7	2.5	1.7	4.9	1.5	0.0	2.0	3.4	0.0	0.3	0.0	2.3	0.6	4.8	0.0	4.9	2.3	1.9	2.3	1.2	1.9	1.5	2.6	0.5	0.0	3.5	1.8	3.1	1.0	3.5	1.3	0.9	2.8	1.1	0.3	3.1	2.9	1.3	3.3	3.4	0.5	4.6	4.8	4.8	3.0	1.5	1.9	3.5	2.2	0.4	0.0	0.0	4.1	0.0	0.0	2.6	14.0	3.8	3.9	4.9	3.4	4.9	4.1	4.3	4.0	3.5	4.0	6.6	5.1	0.1	5.4	3.3	2.4	6.0	3.0	2.7	3.8	4.0	3.4	2.7	2.9	3.5	3.3	3.1	3.1	2.8	4.6	1.8	6.4	1.1	2.9	3.1	0.5	1.7	1.3	0.0	8.7	1.2	0.6	2.2	5.7	1.1	5.5	12.5	3.6	5.6	0.7	5.9	1.7	6.0	0.6	1.2	2.5	1.2	0.4	1.7	0.8	2.0	2.5	2.0	0.8	2.5	4.0	1.8	0.9	2.2	10.1	1.8	0.3	2.0	1.6	1.9	3.4	1.5	1.2	0.0	1.0	1.4	3.1	8.2	2.5	2.4	0.8	0.1	2.2	1.0	1.7	1.4	1.6	1.5	5.6	6.6	4.6	2.4	13.3	9.8	0.6	1.1	4.2	2.2	2.2	0.7	1.1
ZNF880		ENSG00000221923	"Zinc finger protein 880"	Q6PDB4	19	52369917-52385795	"Predicted intracellular proteins, Transcription factors"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 38.9"									HPA077316			Approved	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"HPA077316: AB_2686833"	"unprognostic (2.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (4.33e-8)"	"unprognostic (4.14e-2)"	"unprognostic (4.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.60e-3)"	12.5	11.0	8.6	10.9	10.4	17.7	13.5	23.7	10.6	11.9	7.0	11.6	5.7	13.1	11.2	6.3	12.1	10.7	17.5	8.7	9.2	15.1	3.6	11.2	14.7	11.2	11.2	18.4	7.2	5.3	10.4	10.0	12.0	17.1	8.8	16.0	10.8	13.0	7.1	11.2	10.0	11.9	9.4	14.4	9.5	9.9	11.4	15.3	18.1	7.9	14.3	13.5	8.8	12.7	0.3	1.6	19.1	16.0	10.8	29.1	21.9	13.5	13.9	9.2	17.7	0.4	9.1	0.3	4.8	22.2	19.1	3.2	0.1	12.5	14.5	0.3	24.2	0.6	1.0	0.0	12.7	0.5	16.7	23.1	15.6	16.7	0.0	1.1	14.7	1.7	1.7	0.7	18.4	1.3	2.0	1.2	27.6	0.0	3.3	1.4	38.9	1.4	25.8	20.8	14.9	18.8	0.1	4.0	5.9	35.2	0.7	4.3	11.8	0.6	0.4	4.2	12.7	0.8	8.0	0.6	0.4	0.4	26.8	80.3	12.9	31.9	25.1	12.9	32.4	50.3	31.8	27.2	20.9	53.4	37.9	33.0	5.2	26.2	15.2	41.2	37.2	17.5	8.6	10.4	23.7	10.6	8.7	9.2	11.2	11.2	12.0	9.4	11.4	12.7	13.3	12.8	3.9	4.2	15.2	5.9	22.6	22.6	10.8	15.9	7.2	9.7	13.1	4.3	20.4	20.2	12.5	9.9	12.4	2.2	29.4	18.8	12.8	19.2	10.6	10.8	0.0	5.9	3.5	14.8	14.8	11.9	5.6	13.5	10.1	6.0	9.3	1.5	7.0	23.5	4.2	6.2	18.3	4.9	9.8	5.3	13.7	8.2	8.8	1.9	13.9	12.1	32.0	4.5	5.8	20.8	7.9	6.4	2.8	23.3	2.3	8.4	11.3	16.7	19.7	12.3	14.0	4.6	10.1	4.3	7.1	14.4	13.5	5.2	4.0	23.5
ZNF891		ENSG00000214029	"Zinc finger protein 891"	A8MT65	12	133104779-133130274	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 31.4;Early spermatids: 70.4;Horizontal cells: 40.4;Rod photoreceptor cells: 32.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA040301	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA040301: AB_10795380"	"unprognostic (3.05e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.72e-1)"	"unprognostic (7.51e-3)"	"unprognostic (5.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (2.07e-3)"	"unprognostic (6.68e-2)"	0.9	1.7	1.4	1.0	1.6	1.3	2.0	3.8	1.7	1.3	1.1	0.9	0.8	2.1	1.4	1.2	1.3	0.9	0.8	1.6	1.1	1.2	0.8	0.9	1.3	1.4	1.3	2.3	0.9	1.3	1.4	1.0	1.2	1.1	1.1	4.7	1.1	1.1	1.0	1.7	0.9	1.5	1.0	1.2	1.0	4.2	1.4	1.3	1.8	1.4	1.3	0.8	0.9	2.8	1.1	1.4	4.1	0.1	1.4	1.9	3.5	0.8	1.2	2.2	1.7	0.9	0.6	0.1	1.1	1.2	2.6	1.6	3.0	1.8	1.6	0.0	2.3	3.7	3.7	1.2	1.4	2.3	1.9	1.4	0.9	2.0	2.0	2.0	1.4	3.0	2.4	0.3	2.2	0.8	3.4	2.6	3.5	2.2	2.0	3.4	3.8	2.4	1.0	2.2	3.5	1.5	3.0	0.6	1.0	3.0	2.9	1.3	0.8	2.0	2.4	1.5	1.5	0.2	0.1	3.4	0.5	0.9	1.5	0.5	0.3	0.6	0.9	0.3	0.7	1.1	0.7	0.9	0.3	1.3	1.3	1.3	0.4	1.0	0.3	0.6	0.9	0.4	1.4	1.6	3.8	1.7	1.6	1.1	1.4	1.3	1.2	1.0	1.4	2.8	6.4	3.2	5.3	2.0	14.3	1.8	5.9	2.3	2.8	31.4	3.2	3.9	5.7	5.7	6.7	11.0	29.2	3.4	5.2	1.1	0.0	3.9	70.4	6.6	11.9	5.9	6.7	4.0	2.8	1.9	2.3	6.2	3.6	5.6	1.3	16.7	6.8	2.0	2.0	40.4	3.4	2.4	0.0	2.8	0.8	10.0	5.3	4.3	1.8	1.9	2.7	10.6	10.3	3.5	3.6	1.8	2.1	6.0	2.7	3.7	2.4	2.2	9.5	32.4	19.7	11.2	8.4	14.2	14.1	3.0	1.7	2.3	6.5	8.9	3.2	2.4
ZNF90	HTF9	ENSG00000213988	"Zinc finger protein 90"	Q03938	19	20077994-20127076	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 217.1;Langerhans cells: 329.2;Smooth muscle cells: 451.1;Suprabasal keratinocytes: 280.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 10.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.5;NB-4: 7.9;NTERA-2: 17.0;SuSa: 10.5;U-2197: 7.0"									HPA003227	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA003227: AB_1859471"	"unprognostic (4.52e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.93e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-3)"	"unprognostic (4.95e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.60e-2)"	0.3	0.2	0.1	0.6	0.3	0.6	0.5	1.0	0.2	0.8	0.2	0.5	0.2	0.9	0.6	0.4	0.8	0.3	0.3	0.1	0.2	0.5	0.1	0.7	1.2	0.3	0.2	1.5	0.9	1.8	0.3	1.2	0.3	0.6	0.7	0.0	0.3	1.4	0.2	1.1	0.6	0.6	0.1	0.5	0.8	0.6	0.3	0.8	1.9	0.0	0.8	1.0	0.7	0.4	0.0	0.0	3.7	9.5	0.0	0.0	0.0	0.9	0.3	3.3	4.0	3.2	2.3	1.3	1.7	0.6	2.5	1.1	0.0	0.5	5.7	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	3.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	7.9	17.0	0.0	0.0	0.0	3.1	0.4	2.3	3.3	0.0	3.9	0.0	1.4	0.2	10.5	1.8	0.0	0.0	1.0	0.0	7.0	3.7	0.0	1.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.2	0.1	0.2	0.3	0.2	0.3	0.1	0.3	0.4	2.2	6.4	8.4	1.0	31.7	217.1	112.5	32.7	2.8	0.6	7.8	6.6	1.9	50.1	16.7	7.3	2.1	87.5	25.1	4.8	17.6	2.3	8.2	1.9	4.9	28.8	8.5	26.7	0.5	2.0	99.1	27.6	1.5	4.5	1.3	9.3	54.3	57.1	47.8	0.0	0.7	16.9	14.2	107.1	329.2	24.2	60.9	14.9	124.5	5.6	34.6	2.2	44.3	1.5	2.9	1.2	12.3	34.6	1.8	87.8	8.4	14.0	8.6	2.5	19.7	45.2	451.1	8.6	16.7	1.9	280.3	81.5	40.1	16.0	19.0	66.4
ZNF92	"HPF12, TF12"	ENSG00000146757	"Zinc finger protein 92"	Q03936	7	65373799-65401136	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003173			Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA003173: AB_1080744"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (5.48e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.50e-3)"	2.7	4.5	2.9	5.5	3.5	16.5	10.4	5.8	4.9	5.1	1.4	4.1	4.0	3.5	4.5	5.5	3.3	4.0	2.9	2.8	3.4	3.5	3.2	3.2	10.9	3.6	3.5	5.5	3.6	4.9	2.0	3.7	3.8	3.6	4.5	3.0	2.7	3.3	2.7	3.1	4.5	2.4	4.2	6.7	5.1	5.2	3.5	10.2	6.0	4.2	9.6	3.8	2.4	4.9	7.6	5.0	21.7	21.6	5.4	6.6	10.4	6.1	4.6	6.6	9.6	9.3	10.9	29.3	11.6	3.4	10.0	7.3	17.2	4.2	10.7	11.1	11.4	13.1	2.7	9.3	2.0	16.2	12.1	5.6	3.6	6.1	4.7	8.9	8.3	15.4	17.3	11.7	9.7	2.2	23.7	17.6	29.3	7.9	6.9	21.3	12.8	9.9	7.3	15.1	18.5	14.0	9.4	14.6	7.0	20.7	10.3	21.5	6.1	7.7	6.9	4.6	8.8	7.4	6.9	41.8	5.1	12.6	6.9	4.7	1.3	3.5	2.1	1.8	4.4	8.5	3.2	3.2	1.9	7.1	3.8	4.1	1.1	7.7	2.5	1.9	5.0	1.7	2.9	3.5	5.8	4.9	2.8	3.4	3.6	3.5	3.8	4.2	3.5	4.9	13.9	9.6	1.1	3.9	44.9	5.6	7.2	3.1	8.6	8.2	15.9	11.6	5.2	5.7	6.2	5.5	0.0	6.5	35.4	4.6	11.7	7.9	1.3	5.8	11.2	9.3	7.2	13.5	7.7	4.7	5.4	9.6	6.6	11.9	11.4	17.0	9.3	2.2	4.5	5.0	11.1	8.2	6.1	6.3	3.8	2.2	7.2	11.7	5.4	3.7	10.8	11.8	14.4	12.1	12.3	6.4	7.4	6.4	17.6	6.7	2.4	5.0	2.1	5.0	0.0	11.1	10.2	25.1	24.8	5.1	3.8	4.9	23.2	16.4	6.2	7.1
ZNHIT1	"CG1I, H_DJ0747G18.14, ZNFN4A1"	ENSG00000106400	"Zinc finger HIT-type containing 1"	O43257	7	101218165-101224190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 905.3;Proximal tubular cells: 889.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019043	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA019043: AB_1859481"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.52e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.26e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.24e-3)"	67.1	58.3	142.9	34.3	149.3	59.5	53.7	153.0	173.5	51.9	149.9	65.4	66.8	38.4	54.1	45.4	60.8	46.5	67.6	141.2	146.9	82.3	199.3	38.1	48.5	152.3	148.5	32.5	62.3	77.8	45.0	44.1	149.5	49.1	43.2	21.0	73.6	52.8	90.8	46.3	58.0	39.8	148.5	48.7	62.8	20.7	148.6	55.8	49.2	70.0	38.8	44.8	39.1	158.1	100.1	92.5	61.8	128.6	114.4	147.4	63.0	113.8	112.8	111.2	111.2	97.6	120.9	70.1	154.6	132.7	87.8	80.2	56.5	159.8	49.1	76.7	221.5	37.8	83.0	116.6	142.7	75.4	82.9	137.8	190.5	97.6	49.8	94.0	166.4	102.4	121.4	126.8	99.9	280.8	145.0	411.2	121.8	151.5	239.7	73.5	47.7	222.1	154.4	46.6	79.6	176.0	79.8	166.2	197.7	70.5	44.6	99.8	121.8	109.0	94.0	190.6	91.0	95.8	136.8	95.3	101.7	142.5	138.7	231.5	214.5	220.2	121.3	202.7	126.5	130.9	133.6	124.4	186.6	142.4	107.9	114.7	181.3	121.4	205.5	202.3	195.2	234.5	142.9	149.3	153.0	173.5	141.2	146.9	152.3	148.5	149.5	148.5	148.6	158.1	203.1	93.0	81.8	6.8	85.3	100.7	121.1	214.6	76.2	30.8	146.0	163.3	77.6	183.0	139.4	191.3	16.7	204.4	115.8	358.1	361.9	200.5	30.5	177.2	153.2	158.5	241.4	195.5	4.6	254.5	199.9	124.7	121.3	169.9	78.6	110.4	174.9	905.3	205.9	11.8	5.0	315.6	166.8	205.4	133.7	59.9	135.2	126.3	129.9	5.6	222.1	89.9	176.1	5.0	17.3	271.4	389.9	124.8	119.4	89.4	432.8	889.4	139.4	37.4	151.2	71.7	150.1	70.6	42.0	109.1	116.5	163.5	104.5	153.8	287.1	138.8
ZNRF2	RNF202	ENSG00000180233	"Zinc and ring finger 2"	Q8NHG8	7	30284597-30367689	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072244	Approved		Uncertain	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center"	"HPA072244: AB_2732197"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.64e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (8.71e-4)"	"unprognostic (8.67e-2)"	7.4	6.5	4.8	11.5	5.3	13.0	9.6	5.5	4.2	5.1	14.5	18.9	13.2	8.4	10.7	10.4	4.4	9.4	5.1	4.3	4.0	22.0	21.5	7.4	15.3	7.4	6.6	3.7	10.3	9.1	5.0	9.3	6.0	5.7	16.2	4.7	9.2	5.3	5.7	10.0	15.2	9.5	7.5	10.8	15.0	24.0	7.9	8.9	11.7	6.2	13.2	11.2	4.2	8.4	13.2	4.7	3.8	3.4	4.4	3.0	19.8	4.9	5.1	5.4	7.2	2.4	21.5	13.8	12.6	4.1	14.0	12.5	12.7	8.5	5.7	13.4	11.5	8.6	9.7	6.4	2.3	6.7	15.6	4.6	14.0	3.7	9.1	5.6	4.6	10.5	10.7	26.6	5.9	5.1	13.6	17.5	8.9	13.2	5.9	11.7	8.2	23.8	16.4	28.0	13.0	12.3	9.9	41.2	8.5	22.2	11.1	26.5	5.1	5.2	8.9	5.0	10.5	44.9	41.5	18.1	5.7	14.3	7.8	0.2	0.3	0.4	0.3	0.3	0.5	0.4	0.4	0.5	0.3	0.2	0.2	0.4	0.5	0.3	0.4	2.2	1.0	0.2	4.8	5.3	5.5	4.2	4.3	4.0	7.4	6.6	6.0	7.5	7.9	8.4	11.3	9.6	8.4	19.9	13.9	15.9	7.4	4.8	8.6	11.3	26.5	10.4	3.6	14.3	5.0	16.5	41.7	10.1	40.8	60.0	7.9	4.9	5.2	32.7	7.6	6.6	31.3	6.1	54.4	10.3	11.4	5.1	14.3	43.7	3.8	4.7	8.2	41.6	10.7	1.7	32.3	14.0	0.0	23.3	16.2	10.1	2.8	23.1	12.4	119.9	13.1	5.1	4.1	41.7	39.7	7.4	19.5	2.2	11.5	8.5	22.6	32.3	5.8	5.8	6.6	7.7	9.8	18.3	7.0	7.9	18.9	11.5	17.6	7.6	23.4	14.3
ZPLD1		ENSG00000170044	"Zona pellucida like domain containing 1"	Q8TCW7	3	102099244-102479841	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.6;gallbladder: 2.2;retina: 2.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 4.3;Ductal cells: 3.6;Early spermatids: 2.8;Late spermatids: 5.9;Muller glia cells: 16.0;Pancreatic endocrine cells: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 6.5"	"Region enriched"	"Detected in single"	7	"olfactory bulb: 2.8"	"Low region specificity"	"Detected in many"			HPA077519			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA077519: AB_2732349"	"unprognostic (2.49e-1)"	"unprognostic (2.83e-3)"		"unprognostic (6.38e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.89e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.2	1.1	0.2	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.1	2.2	0.0	0.1	0.3	0.5	0.0	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	1.1	0.2	0.1	0.3	1.6	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.8	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.5	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZRANB1	TRABID	ENSG00000019995	"Zinc finger RANBP2-type containing 1"	Q9UGI0	10	124942123-124988189	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029239, HPA029240, HPA029241"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205"	"unprognostic (2.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.53e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-2)"	13.9	21.1	17.9	6.6	18.7	22.5	13.1	26.7	21.8	14.4	18.8	13.8	5.1	14.4	12.4	10.5	10.8	9.7	18.4	18.1	17.8	10.9	24.8	10.6	8.2	17.7	17.8	19.3	8.8	16.8	8.7	10.6	17.8	11.2	8.8	17.5	9.0	13.6	52.9	15.0	7.7	15.2	18.0	8.7	8.3	19.7	18.3	13.6	10.1	46.4	10.7	10.3	11.7	19.4	15.1	8.6	17.8	13.1	27.1	22.7	7.5	14.5	39.6	27.1	31.3	12.8	11.7	15.7	10.6	18.4	8.8	10.7	22.8	10.7	36.2	16.8	11.3	9.0	9.7	13.8	57.6	13.6	6.6	25.2	30.8	19.9	42.2	37.7	17.3	14.2	1.3	12.7	14.8	12.1	16.2	11.9	6.5	8.2	9.1	13.7	12.7	7.2	12.0	10.9	9.1	15.2	12.3	9.4	16.4	16.7	10.4	11.5	12.9	11.5	11.8	9.7	18.3	13.4	12.5	18.1	13.1	9.5	5.8	0.9	0.4	1.2	0.8	0.1	0.6	0.9	0.9	0.7	0.3	1.3	1.5	1.2	1.7	1.3	0.2	0.5	0.9	0.3	17.9	18.7	26.7	21.8	18.1	17.8	17.7	17.8	17.8	18.0	18.3	19.4	28.6	19.2	25.3	61.7	17.9	24.6	22.8	10.7	22.2	36.9	29.0	21.2	22.9	15.7	17.3	18.4	50.1	12.3	26.3	16.2	0.0	13.1	80.2	29.4	38.6	21.7	26.8	25.7	58.2	11.6	9.8	21.4	14.3	38.5	26.0	34.3	14.6	43.8	12.5	37.0	58.5	19.0	4.1	16.7	22.4	30.3	23.9	24.3	16.0	52.5	13.2	24.2	19.6	56.3	76.0	19.3	11.5	23.0	21.0	31.4	11.9	10.5	19.2	26.0	13.1	34.6	27.6	28.8	19.1	20.5	27.8	27.5	21.4	23.7	13.1	31.1
ZRANB2	"ZIS, ZIS1, ZIS2, ZNF265"	ENSG00000132485	"Zinc finger RANBP2-type containing 2"	O95218	1	71063291-71081289	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053960, HPA061949, HPA063298"	Supported		Enhanced	Nucleoplasm		NA	Yes		13000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979"	"unprognostic (2.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (4.25e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (1.57e-8)"	"unprognostic (3.96e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-3)"	41.0	39.4	29.7	45.3	31.1	60.0	52.6	36.9	47.0	45.0	36.8	40.8	35.5	70.7	67.6	29.3	45.4	29.6	42.7	30.7	29.1	35.3	30.2	40.4	62.5	32.0	27.7	56.7	33.8	33.2	64.5	36.3	31.6	44.2	42.9	62.1	39.5	38.0	58.9	43.4	37.9	50.1	29.3	42.6	35.6	50.4	30.3	47.6	48.5	38.9	49.3	37.9	35.2	38.8	86.8	31.1	122.3	73.0	46.5	79.8	71.0	103.2	55.6	89.2	113.2	58.7	55.5	177.6	89.0	64.2	82.7	53.5	111.1	63.9	133.4	127.5	79.9	154.5	127.3	50.0	70.8	171.5	62.7	61.7	80.3	86.1	73.5	98.1	76.3	90.3	165.1	93.6	69.6	29.3	145.0	58.4	128.7	52.9	59.6	159.8	92.3	108.4	60.5	72.6	93.8	58.3	88.7	58.8	91.4	63.7	74.7	76.8	102.5	65.9	62.1	51.9	103.8	75.7	100.6	193.8	96.4	160.3	94.6	99.1	33.4	32.1	44.5	32.3	51.2	68.8	47.5	44.0	26.8	63.1	61.2	48.7	30.7	48.2	33.8	73.4	49.6	31.2	29.7	31.1	36.9	47.0	30.7	29.1	32.0	27.7	31.6	29.3	30.3	38.8	86.9	99.3	154.5	83.6	109.8	50.6	94.4	66.1	59.7	166.5	61.4	66.5	99.9	50.1	68.4	49.7	129.3	55.1	136.9	85.8	49.0	60.2	190.3	79.9	123.5	63.5	73.0	87.1	135.3	68.2	50.4	92.6	62.7	85.7	87.4	132.8	50.7	41.8	45.4	213.7	114.7	64.5	54.9	34.5	39.7	46.2	185.4	55.7	48.0	73.1	74.8	116.6	139.0	90.5	131.9	69.2	76.5	115.5	127.5	54.8	41.2	41.1	76.5	202.2	118.3	88.1	99.2	218.7	113.0	55.3	46.5	63.5	89.6	96.4	55.1	68.5
ZRANB3	"AH2, DKFZP434B1727"	ENSG00000121988	"Zinc finger RANBP2-type containing 3"	Q5FWF4	2	135136916-135531218	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.9;Excitatory neurons: 69.4;Inhibitory neurons: 46.2;Oligodendrocytes: 67.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035234			Supported	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA035234: AB_2674530"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.52e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.88e-2)"	0.8	1.4	0.5	0.9	0.7	1.1	0.8	0.2	0.8	1.0	0.2	0.7	0.5	0.9	0.5	0.7	0.9	0.7	0.9	0.6	0.3	0.7	1.1	0.6	0.6	0.1	0.1	1.5	1.3	0.6	1.4	0.5	0.2	0.9	0.4	1.5	0.7	0.5	2.0	0.8	0.6	0.4	0.1	0.8	0.7	3.2	0.3	0.8	1.0	0.6	0.4	0.8	0.8	0.7	0.9	0.9	1.7	1.1	0.8	1.5	1.5	1.3	0.9	0.9	1.1	1.5	0.7	2.8	1.3	1.0	0.6	0.9	2.4	1.1	1.6	2.5	1.8	3.2	0.4	3.5	0.6	2.5	0.6	1.3	1.0	1.3	3.2	1.5	1.3	1.6	3.1	1.3	0.7	1.3	1.5	1.4	1.1	0.8	1.1	1.8	1.3	1.0	1.3	0.6	1.8	2.3	1.1	0.5	0.9	1.6	0.9	1.1	1.0	0.7	0.6	0.4	0.8	1.1	1.4	2.6	1.0	1.7	1.0	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.5	0.7	0.2	0.8	0.6	0.3	0.1	0.1	0.2	0.1	0.3	0.7	1.7	3.2	1.5	34.9	7.3	1.3	4.5	4.5	8.0	5.8	2.8	2.3	3.3	2.8	4.3	0.0	8.4	5.7	2.0	0.5	0.0	2.0	16.9	3.2	5.0	1.9	1.8	10.1	69.4	0.9	8.3	4.7	1.5	3.5	0.0	9.1	1.8	8.9	2.5	5.0	46.2	1.2	4.1	0.8	1.5	4.5	3.1	2.3	0.0	26.2	2.9	2.7	2.1	24.6	67.0	1.4	1.7	2.2	4.7	2.1	0.4	4.5	1.6	7.5	0.0	8.3	3.4	14.1	10.3	4.8	2.3	3.8	3.9	10.8	2.6	3.0
ZSCAN10	ZNF206	ENSG00000130182	"Zinc finger and SCAN domain containing 10"	Q96SZ4	16	3088890-3099295	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"brain: 1.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Cytotrophoblasts: 1.9"	"Cancer enriched"	"Detected in single"	207	"testis cancer: 19.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"NTERA-2: 56.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076826			Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Centrosome	"HPA076826: "	"unprognostic (4.37e-2)"	"unprognostic (5.13e-2)"		"unprognostic (9.15e-2)"	"unprognostic (6.65e-3)"	"unprognostic (6.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.24e-2)"		"unprognostic (1.15e-1)"		"unprognostic (1.72e-1)"	"unprognostic (1.85e-11)"	"unprognostic (5.98e-2)"	"unprognostic (2.92e-2)"		"unprognostic (1.79e-2)"	0.0	0.0	0.3	0.0	0.6	0.2	0.0	0.9	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	56.8	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	5.8	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.3	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.9	0.7	0.3	0.9	0.4	0.2	0.5	0.1	0.5	1.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0
ZSCAN12	"dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96"	ENSG00000158691	"Zinc finger and SCAN domain containing 12"	O43309	6	28378955-28399734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006637, HPA007018"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA006637: AB_1080646, HPA007018: "	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.35e-4)"	"unprognostic (1.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	2.4	2.3	1.8	2.6	2.0	2.2	5.6	3.6	2.5	3.6	1.6	2.9	2.5	4.3	3.6	1.8	3.0	2.3	2.4	1.8	2.2	2.9	1.6	2.9	4.7	1.7	2.1	5.5	3.2	4.0	2.0	3.6	1.6	4.3	2.9	6.8	3.1	3.7	0.9	1.8	2.7	3.6	1.6	3.9	2.9	4.1	2.2	5.1	5.1	1.7	4.1	3.1	2.9	2.0	5.5	1.8	8.1	0.1	4.1	3.2	5.7	3.7	5.1	5.5	7.6	1.2	2.0	5.3	6.8	2.6	2.8	2.4	0.0	4.6	5.6	0.0	6.6	7.6	5.6	3.8	3.8	2.7	1.8	4.2	4.3	5.5	9.9	6.0	1.5	0.0	11.4	1.1	3.5	0.6	0.0	6.1	5.1	0.5	0.9	9.2	7.3	1.4	4.1	3.5	9.8	10.0	1.9	4.3	6.4	8.0	1.7	6.7	1.5	2.2	4.6	1.7	3.0	3.1	3.4	1.0	1.9	0.7	3.4	2.4	0.7	1.5	1.5	0.4	1.4	1.8	1.1	1.8	1.0	2.7	1.8	1.6	0.2	1.8	0.8	0.9	0.9	0.8	1.8	2.0	3.6	2.5	1.8	2.2	1.7	2.1	1.6	1.6	2.2	2.0	2.1	6.4	5.1	4.6	4.0	0.4	1.1	0.9	0.6	6.1	2.6	2.5	3.2	1.5	6.5	0.0	4.2	1.5	3.6	0.3	1.9	1.7	31.8	0.6	2.4	1.9	1.2	2.1	6.9	2.6	1.0	2.7	1.5	0.9	1.3	5.5	3.3	1.0	1.0	6.7	7.0	1.2	0.0	1.3	1.1	9.7	1.8	1.1	1.8	1.0	1.8	4.9	2.1	10.1	6.2	1.3	0.3	3.4	2.4	1.5	1.5	1.2	0.6	6.0	6.6	1.7	2.4	12.6	3.9	1.2	0.3	0.5	1.5	4.2	2.1	0.7
ZSCAN16	"dJ265C24.3, FLJ22191, ZNF392, ZNF435"	ENSG00000196812	"Zinc finger and SCAN domain containing 16"	Q9H4T2	6	28124609-28130082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 69.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007290	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA007290: AB_1080721"	"unprognostic (1.50e-1)"	"prognostic favorable (5.73e-4)"	"unprognostic (3.29e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (3.41e-5)"	3.2	3.9	5.3	5.5	6.4	3.2	7.0	7.7	7.6	3.9	5.2	7.1	8.6	3.9	7.1	3.6	4.1	4.0	3.0	5.6	6.6	5.4	4.4	4.9	8.3	6.4	5.9	2.5	4.9	6.9	3.2	2.2	6.4	4.7	9.0	7.2	6.6	5.8	3.2	6.9	8.4	4.7	5.5	7.4	7.0	2.2	6.1	8.0	4.6	2.7	9.1	4.2	2.7	9.1	0.1	8.8	11.1	8.2	3.0	0.7	9.1	3.0	6.4	7.8	8.4	6.1	5.7	8.8	8.0	2.8	5.4	6.8	7.8	4.4	7.4	12.8	10.8	9.1	7.4	8.7	4.8	6.8	7.4	1.0	7.3	6.6	3.6	8.3	14.7	0.2	1.3	7.3	2.1	10.0	0.0	10.7	2.3	7.4	5.3	10.9	8.4	12.2	9.3	12.6	15.0	16.5	1.5	9.2	10.9	7.2	12.2	3.2	4.6	2.9	6.7	4.4	7.9	3.7	12.5	2.4	1.3	3.4	1.6	69.0	8.6	10.2	13.8	11.8	17.7	19.3	12.0	10.6	9.0	14.6	14.5	11.8	15.6	17.7	11.6	19.6	14.7	8.6	5.3	6.4	7.7	7.6	5.6	6.6	6.4	5.9	6.4	5.5	6.1	9.1	5.6	6.4	2.6	0.3	5.6	1.8	0.8	4.9	1.2	3.8	5.2	5.6	1.6	10.0	7.5	7.3	4.2	2.2	12.6	4.7	5.9	12.8	3.3	4.2	0.8	4.0	1.8	8.2	1.4	12.6	1.2	1.4	4.6	3.3	2.5	4.8	4.2	2.0	2.1	1.7	1.1	6.0	14.2	3.8	1.3	1.5	0.6	4.3	1.8	1.0	6.1	5.6	11.3	3.5	3.7	9.6	6.1	3.4	4.2	1.3	10.3	8.3	7.7	6.6	0.0	1.7	3.7	1.7	6.3	2.7	1.3	1.8	6.1	2.2	7.0	1.1
ZSCAN18	"FLJ12895, ZNF447"	ENSG00000121413	"Zinc finger and SCAN domain containing 18"	Q8TBC5	19	58083838-58118427	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 128.4;SCLC-21H: 59.3;U-266/84: 46.6"	"Low region specificity"	"Detected in all"							HPA024318	Supported		Approved	Nucleoplasm		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA024318: AB_1859494"	"unprognostic (1.85e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.59e-1)"	"prognostic favorable (3.95e-7)"	"unprognostic (3.68e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.04e-2)"	29.5	31.2	74.2	8.3	74.5	5.8	32.8	56.3	74.7	53.0	61.8	60.0	9.9	63.1	20.8	21.3	66.3	14.9	55.7	71.6	78.0	56.1	14.4	28.8	9.4	71.9	70.0	63.5	22.9	27.9	82.8	14.9	68.8	46.3	6.2	36.9	23.8	28.9	23.7	29.0	28.9	18.8	63.2	28.1	32.4	42.5	79.8	10.3	60.8	13.2	6.7	49.5	34.6	67.3	0.2	1.7	14.4	35.2	1.7	1.9	32.4	9.5	0.2	12.8	2.3	0.0	8.7	3.8	18.8	13.6	14.4	0.2	1.2	7.7	12.4	0.1	128.4	0.4	0.1	0.2	25.7	0.0	25.8	23.1	0.4	9.5	0.0	17.1	0.9	9.3	0.2	1.4	18.1	0.0	18.9	7.2	22.6	0.0	0.0	21.8	0.0	1.5	11.8	29.1	59.3	13.8	0.0	0.5	0.1	12.5	39.5	0.0	0.0	0.6	15.0	15.4	0.1	15.2	46.6	0.1	0.0	0.2	10.5	1.0	0.2	1.3	0.1	0.1	0.8	0.6	0.6	0.6	0.3	1.4	0.9	0.8	1.4	0.8	0.2	0.8	0.0	0.3	74.2	74.5	56.3	74.7	71.6	78.0	71.9	70.0	68.8	63.2	79.8	67.3	30.6	16.0	26.9	31.0	24.9	12.1	51.2	6.7	7.4	77.5	22.5	25.0	44.3	25.8	26.2	42.3	33.3	45.9	10.1	3.7	15.6	25.1	52.3	46.9	26.8	33.2	26.5	3.4	29.5	5.8	8.6	28.5	11.7	24.0	23.5	39.8	33.5	4.1	9.0	112.7	26.4	14.7	10.2	3.2	6.4	75.9	40.0	6.0	10.6	13.1	6.0	73.0	25.7	21.6	40.7	5.9	13.1	58.6	3.6	38.4	7.3	11.1	36.7	110.5	19.7	32.6	30.1	30.0	27.9	6.5	12.1	65.7	15.8	39.3	10.5	32.6
ZSCAN2	"FLJ20595, ZFP29, ZNF854"	ENSG00000176371	"Zinc finger and SCAN domain containing 2"	Q7Z7L9	15	84600986-84627796	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.0;Proximal tubular cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007296, HPA024331"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA007296: , HPA024331: AB_1859497"	"unprognostic (4.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.24e-1)"	"prognostic favorable (7.46e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.16e-5)"	7.6	5.8	3.0	4.2	3.9	8.7	7.2	4.8	3.6	6.7	2.3	4.5	3.1	6.4	2.3	2.3	4.0	3.5	6.0	3.2	4.1	7.5	8.8	3.0	4.1	3.2	3.3	6.0	16.6	4.1	4.1	2.1	3.8	5.2	2.9	6.2	6.8	3.0	8.2	2.6	4.4	3.3	2.8	5.9	8.1	11.8	3.7	10.1	4.1	3.1	3.1	4.6	3.5	4.8	2.2	13.4	9.0	14.6	5.7	3.5	8.5	2.5	6.2	5.3	6.4	10.4	5.2	4.9	6.9	3.5	9.8	5.6	6.9	5.0	4.6	10.4	13.0	6.2	8.4	22.0	4.9	3.9	4.4	5.6	4.9	7.0	6.6	7.0	15.5	24.0	8.4	3.9	5.6	6.7	16.8	9.6	16.9	4.5	7.9	16.8	5.6	9.2	5.3	16.7	13.5	23.1	7.6	4.1	11.7	14.5	9.1	9.8	10.8	6.3	12.4	3.2	3.3	6.3	9.5	16.8	4.3	8.7	3.7	6.4	5.8	5.0	5.7	6.4	2.8	3.9	5.2	4.3	6.6	3.5	3.8	4.3	3.1	5.6	8.4	5.9	7.8	3.9	3.0	3.9	4.8	3.6	3.2	4.1	3.2	3.3	3.8	2.8	3.7	4.8	9.1	0.0	2.0	1.6	3.9	0.9	1.2	2.6	2.2	3.1	3.5	3.2	2.5	4.3	1.7	7.3	2.1	1.6	2.5	1.3	5.9	6.9	18.0	5.7	3.3	3.0	3.0	3.0	1.6	8.6	5.1	2.3	4.6	6.9	1.3	8.0	1.1	7.5	3.6	0.0	1.6	3.2	4.1	2.8	2.3	12.3	0.9	2.9	1.8	1.0	5.5	2.3	2.1	4.0	2.5	9.9	4.2	1.5	11.1	2.6	1.9	22.6	1.8	3.1	6.6	2.3	3.9	7.1	8.2	0.9	0.4	1.4	3.7	3.6	2.6	1.5
ZSCAN20	"KOX29, ZNF31, ZNF360"	ENSG00000121903	"Zinc finger and SCAN domain containing 20"	P17040	1	33472645-33496507	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017933	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA017933: AB_1859028"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-3)"	"unprognostic (9.28e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.77e-6)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.74e-2)"	0.8	0.8	1.4	0.7	1.7	0.2	1.3	2.3	1.4	1.2	1.6	1.1	2.7	1.4	0.9	0.9	1.2	0.7	1.9	1.1	1.2	1.1	0.5	0.9	0.6	1.7	1.6	2.3	0.9	2.5	0.9	1.2	1.9	1.2	1.3	1.5	1.0	1.5	1.1	0.8	1.2	1.5	1.1	0.9	1.2	1.7	1.8	1.2	1.3	2.0	1.0	1.0	0.7	2.4	2.4	1.7	4.0	2.7	3.1	3.1	2.6	2.9	2.9	3.8	3.1	1.8	3.0	1.7	1.5	3.0	2.2	2.9	3.3	1.5	3.9	0.0	3.7	3.6	4.2	1.5	2.9	2.0	1.2	2.2	2.7	4.0	3.3	3.5	3.0	2.9	2.4	2.2	3.4	0.8	1.6	1.2	3.3	2.2	1.0	1.7	4.6	0.7	2.1	2.0	1.5	2.3	2.2	2.4	3.2	5.2	1.6	2.2	2.7	3.3	2.3	3.1	4.2	2.9	2.0	0.8	3.5	0.6	2.2	0.0	0.5	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.4	0.1	0.4	0.6	0.1	0.2	0.2	0.2	0.2	0.1	1.4	1.7	2.3	1.4	1.1	1.2	1.7	1.6	1.9	1.1	1.8	2.4	0.8	0.0	1.3	1.3	0.2	0.0	0.6	0.7	1.8	1.8	0.5	0.4	2.2	2.8	0.4	0.0	4.2	0.9	0.1	1.0	0.0	0.8	15.9	0.4	1.2	0.9	1.2	2.7	2.6	0.2	0.8	1.7	2.6	0.4	1.3	2.8	1.8	0.4	0.6	0.0	2.7	0.7	0.0	1.2	0.0	2.6	1.2	0.3	0.0	4.7	2.0	1.0	1.0	4.0	3.7	0.9	1.6	1.9	0.4	0.5	0.4	0.5	0.9	1.9	0.0	1.4	1.2	3.2	1.5	1.0	0.0	0.3	0.8	0.9	0.4	0.5
ZSCAN25	"FLJ32468, ZNF498"	ENSG00000197037	"Zinc finger and SCAN domain containing 25"	Q6NSZ9	7	99616946-99632408	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 34.6;Excitatory neurons: 48.1;Inhibitory neurons: 44.9;Microglial cells: 32.8;Oligodendrocyte precursor cells: 47.7;Oligodendrocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055127, HPA057173"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA055127: AB_2682706, HPA057173: AB_2683360"	"unprognostic (2.21e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.97e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.82e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.19e-3)"	4.2	4.0	2.8	4.8	2.7	6.4	5.0	3.3	3.1	4.9	3.1	4.4	3.3	5.1	2.3	4.7	5.1	3.3	3.0	2.6	2.5	3.9	3.3	3.8	6.0	2.8	2.3	7.7	4.5	5.7	3.1	4.1	2.5	4.7	3.6	2.7	4.5	5.4	4.5	6.1	4.1	4.8	2.2	5.1	3.9	5.3	2.8	9.5	4.6	3.9	5.3	4.3	4.3	3.1	7.6	3.5	10.0	11.5	4.3	3.3	9.8	8.2	6.9	9.3	9.6	9.3	6.1	10.6	9.3	6.9	8.5	9.7	11.0	9.5	11.5	6.1	9.4	7.1	5.8	8.1	7.4	16.6	6.3	5.2	11.7	7.4	7.7	3.7	6.0	11.7	20.4	8.3	6.6	8.4	24.0	23.4	18.4	4.2	8.3	10.0	10.3	11.4	4.0	10.3	6.8	16.8	10.8	16.2	11.7	11.8	4.5	11.2	4.3	14.4	11.6	8.3	14.0	7.4	12.8	18.2	7.8	10.2	21.6	3.5	2.4	3.2	4.3	2.6	5.3	1.9	3.0	4.2	1.9	1.6	5.0	5.1	2.9	2.8	2.4	1.6	4.7	3.3	2.8	2.7	3.3	3.1	2.6	2.5	2.8	2.3	2.5	2.2	2.8	3.1	3.9	0.0	6.2	34.6	4.6	3.4	1.8	2.6	2.8	4.9	4.0	4.4	4.2	2.8	1.5	1.8	8.4	4.3	5.1	5.2	1.9	2.9	5.2	2.3	4.6	3.9	2.4	5.5	48.1	2.8	3.4	3.3	3.6	3.5	5.1	4.5	4.2	3.6	3.6	5.0	44.9	4.4	6.1	6.0	1.4	2.7	3.7	2.0	1.8	32.8	3.9	2.3	4.1	47.7	44.4	2.1	3.1	6.0	5.5	3.0	3.7	2.4	2.5	4.7	6.6	4.0	3.9	10.0	7.6	4.0	2.3	1.9	6.2	4.7	3.7	1.7
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267058-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA027521: AB_2672314"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (1.68e-4)"	9.9	11.1	18.5	10.3	19.1	6.8	15.1	24.3	23.0	20.2	14.4	16.2	8.9	18.9	13.5	9.6	14.3	12.7	13.0	19.5	20.4	12.1	9.9	10.3	11.0	19.0	17.9	30.2	11.9	14.0	16.4	9.3	18.6	17.1	10.0	26.6	10.2	18.1	11.9	9.9	11.6	16.3	17.3	17.5	10.9	7.8	18.7	11.4	14.4	10.4	12.2	13.6	12.2	22.4	8.1	6.6	18.8	16.2	19.0	18.5	4.2	16.2	15.0	19.9	19.8	4.9	5.7	4.6	22.9	10.1	15.1	5.7	8.6	11.3	21.5	9.8	9.6	12.2	10.6	9.9	13.2	10.1	7.1	15.5	10.7	15.4	14.0	25.8	20.5	7.0	10.2	9.2	16.0	6.7	10.9	13.3	5.6	4.3	10.5	10.7	16.1	7.8	17.2	7.9	13.6	10.3	9.6	4.0	13.2	15.2	6.5	6.9	13.7	16.3	11.7	5.8	19.2	9.9	14.5	8.7	5.8	11.0	14.3	17.9	7.9	14.0	16.1	6.4	19.0	16.3	16.0	17.6	12.5	19.9	19.4	16.0	5.8	22.5	5.5	6.0	15.6	12.5	18.5	19.1	24.3	23.0	19.5	20.4	19.0	17.9	18.6	17.3	18.7	22.4	8.8	0.0	5.6	15.3	9.2	0.0	2.7	0.0	4.0	8.9	4.7	8.3	10.4	2.8	6.2	0.0	4.2	4.9	9.2	1.8	3.9	5.6	5.9	3.8	7.8	7.0	6.7	7.8	23.5	5.0	2.8	8.1	2.0	3.1	6.3	11.1	4.6	1.8	5.9	1.7	26.1	2.6	0.0	5.1	0.0	2.5	9.0	4.3	0.0	8.4	2.3	12.8	14.4	30.7	28.8	3.6	4.0	13.2	3.5	2.2	4.9	4.6	1.5	9.6	19.7	7.7	7.5	7.5	8.7	2.9	0.0	1.4	7.2	8.1	3.4	0.8
ZSCAN29	"FLJ35867, Zfp690, ZNF690"	ENSG00000140265	"Zinc finger and SCAN domain containing 29"	Q8IWY8	15	43358172-43371025	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007241, HPA011109"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Actin filaments"	"HPA007241: AB_10600420, HPA011109: AB_10611525"	"unprognostic (3.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.43e-2)"	6.3	5.6	7.9	8.6	10.1	5.6	6.8	8.1	7.4	7.2	8.1	7.6	8.8	8.9	5.2	7.2	6.4	6.0	5.5	6.6	7.4	5.7	6.9	6.9	10.7	9.3	9.7	7.4	11.4	7.7	5.5	8.1	8.9	6.8	7.6	13.6	8.5	6.5	9.7	5.8	9.9	6.4	7.7	9.0	8.8	17.3	8.5	10.7	7.2	8.5	10.4	6.6	6.0	10.3	11.7	12.5	28.9	17.9	10.0	10.5	15.6	9.0	13.9	15.6	16.2	19.7	8.1	11.4	14.7	11.1	12.6	33.7	21.5	11.0	13.9	29.6	11.8	25.1	20.5	15.5	11.1	17.3	21.2	9.3	19.0	10.6	14.9	11.0	8.0	17.3	23.7	13.5	12.7	7.4	16.7	14.2	14.5	17.1	9.6	25.7	16.1	14.0	9.1	13.9	20.6	22.2	13.9	22.5	10.4	14.5	15.8	26.6	9.1	18.3	14.4	14.0	16.4	25.8	38.4	21.6	10.7	16.9	14.1	0.4	0.3	3.1	0.4	0.4	0.3	0.8	0.4	0.3	0.4	0.5	0.2	0.6	0.7	1.0	0.3	0.3	0.8	0.3	7.9	10.1	8.1	7.4	6.6	7.4	9.3	9.7	8.9	7.7	8.5	10.3	3.5	6.4	7.9	6.8	5.8	3.6	2.6	3.7	4.6	10.8	4.8	4.8	7.8	4.3	7.8	7.3	27.1	5.1	7.1	11.0	0.0	5.4	81.7	5.0	8.2	4.9	6.1	1.3	6.4	7.1	4.4	5.8	9.7	7.8	0.0	6.5	3.9	7.2	5.8	13.5	5.2	8.1	4.1	10.6	3.7	20.7	6.8	4.8	5.4	9.4	6.7	5.5	10.3	10.1	10.2	8.7	5.0	6.0	3.3	3.9	7.7	2.6	5.2	18.0	0.0	4.9	3.8	12.0	6.7	4.4	3.1	3.8	4.2	2.8	7.0	2.4
ZSCAN30	"ZNF397OS, ZNF917"	ENSG00000186814	"Zinc finger and SCAN domain containing 30"	Q86W11	18	35251058-35290245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA007289	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA007289: AB_1079726"	"unprognostic (6.02e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-3)"	"unprognostic (7.02e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.44e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.36e-1)"	9.2	14.1	12.1	7.9	14.4	7.5	10.1	26.1	16.2	12.3	9.3	11.2	8.6	10.7	10.9	7.1	11.7	7.3	17.5	11.0	15.8	12.1	8.4	9.2	11.0	12.9	9.6	11.1	10.7	13.1	16.7	8.1	12.6	11.3	6.8	28.0	9.3	7.0	16.9	9.9	11.2	7.6	7.7	12.9	9.3	10.0	14.5	11.1	14.6	8.7	7.9	9.7	9.1	26.9	6.2	1.7	13.4	18.2	9.1	17.8	9.3	11.9	15.9	6.7	13.1	5.1	7.6	11.3	7.7	12.5	11.5	4.1	6.5	12.4	18.0	11.5	3.7	7.1	8.9	3.6	9.3	5.9	6.8	11.6	9.6	17.9	15.5	17.5	13.2	15.7	12.1	12.8	18.0	2.8	9.1	10.5	8.9	1.8	5.7	13.6	4.6	8.4	10.4	4.2	19.4	9.9	11.7	3.7	4.8	14.1	5.8	8.3	15.5	24.6	5.2	3.8	4.6	23.4	10.7	10.0	18.4	6.8	13.9	1.4	0.6	2.3	2.1	0.8	1.3	2.5	2.0	1.2	1.1	3.3	2.3	2.6	2.3	2.0	1.0	2.6	2.0	1.2	12.1	14.4	26.1	16.2	11.0	15.8	12.9	9.6	12.6	7.7	14.5	26.9	8.4	9.6	8.7	22.2	7.5	1.8	2.0	3.2	13.6	30.5	4.8	5.5	15.5	10.0	9.1	1.8	20.9	3.3	6.4	3.4	5.9	5.2	9.3	7.0	11.9	10.7	7.2	7.8	21.8	3.4	1.5	6.0	7.7	6.5	8.8	18.8	10.0	5.2	2.6	20.2	18.4	4.0	2.0	4.7	1.7	9.0	5.9	3.3	0.0	23.4	2.3	12.2	7.2	26.2	52.1	3.1	4.0	7.9	3.3	2.0	5.9	4.5	6.2	19.3	0.0	10.3	6.3	13.5	5.3	4.2	1.0	1.8	5.3	15.4	3.1	1.6
ZSCAN31	"ZNF310P, ZNF323"	ENSG00000235109	"Zinc finger and SCAN domain containing 31"	Q96LW9	6	28324693-28356271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 138.5;Late spermatids: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.5;EFO-21: 40.1;TIME: 31.0;U-2 OS: 47.6"					"Low region specificity"	"Detected in all"			HPA007124	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA007124: AB_1080703"	"unprognostic (1.11e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (2.19e-5)"	"unprognostic (8.43e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	5.3	3.4	10.5	2.5	12.9	4.7	13.0	24.1	18.3	8.1	4.4	9.9	4.1	19.2	9.5	11.3	7.9	18.7	7.9	15.5	8.7	6.2	5.6	10.7	2.5	14.0	10.8	19.7	7.2	4.4	6.2	3.0	14.6	8.3	6.1	8.2	6.4	9.3	9.6	13.4	4.4	12.6	11.7	2.7	16.9	20.9	12.7	4.6	13.5	8.0	4.1	5.7	6.3	21.2	2.0	2.7	4.1	19.1	0.7	0.9	6.0	0.9	1.2	0.9	0.8	2.5	29.5	0.5	40.1	1.4	5.9	6.2	2.1	1.8	0.6	3.6	1.7	6.5	16.0	4.5	1.7	14.0	8.3	0.7	16.2	1.1	1.7	1.9	28.0	5.4	7.7	4.9	4.3	2.9	2.4	3.4	1.3	1.4	12.1	6.2	3.7	3.7	2.8	2.5	13.6	3.7	26.3	16.6	3.9	3.0	8.4	4.7	31.0	6.1	47.6	1.2	2.2	2.1	3.3	0.5	0.7	6.7	1.4	17.6	0.3	0.6	1.3	0.2	1.2	1.2	1.1	1.0	0.3	1.0	0.8	1.2	0.2	1.3	0.3	1.8	0.2	0.3	10.5	12.9	24.1	18.3	15.5	8.7	14.0	10.8	14.6	11.7	12.7	21.2	7.0	28.9	3.3	15.7	0.5	0.8	2.4	7.5	14.8	8.9	3.3	2.8	7.6	2.8	11.6	3.7	0.0	1.9	1.8	4.9	7.9	2.9	138.5	6.6	1.5	7.4	6.0	0.8	27.9	8.1	0.9	4.1	10.2	5.8	2.5	2.2	1.8	4.8	0.7	1.7	11.7	2.5	16.2	0.8	1.2	65.0	3.7	0.7	1.8	4.7	0.7	7.2	1.0	4.0	18.5	4.8	2.6	5.3	2.0	1.4	1.2	8.1	3.9	5.9	6.6	2.7	3.4	11.2	4.5	6.8	2.3	0.8	1.1	2.3	3.3	1.5
ZSCAN32	"FLJ20417, ZNF434"	ENSG00000140987	"Zinc finger and SCAN domain containing 32"	Q9NX65	16	3382081-3401065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005758	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA005758: AB_1080720"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.71e-2)"	4.8	5.9	8.9	5.6	9.4	3.6	5.9	8.6	10.9	6.2	10.0	6.6	7.8	6.0	4.4	4.9	6.9	5.0	5.3	8.6	10.1	5.9	5.5	6.0	8.6	9.6	9.6	8.2	7.4	7.6	8.4	5.4	9.5	6.5	5.7	11.6	4.9	7.0	4.6	6.1	5.4	5.5	8.8	6.9	5.9	7.4	9.6	10.1	7.2	3.3	9.1	6.1	5.2	11.4	6.0	10.1	12.7	15.3	10.1	10.0	9.5	7.1	12.6	10.3	9.9	5.2	8.8	19.4	7.5	10.6	6.8	6.4	10.6	10.6	12.0	13.0	7.6	16.7	9.1	7.1	12.7	11.9	12.1	10.0	17.1	10.2	17.3	11.2	10.6	21.3	16.5	7.5	13.5	7.5	16.4	8.1	13.8	10.6	5.1	16.0	13.1	18.6	8.9	6.4	11.2	8.6	14.4	8.8	7.8	8.1	10.1	14.7	12.8	8.9	8.4	7.3	8.6	12.4	14.8	25.1	2.5	9.4	13.6	4.1	5.4	7.3	9.7	4.2	8.3	8.3	6.7	6.2	4.9	6.7	9.3	9.0	6.0	15.0	13.1	5.0	9.5	6.2	8.9	9.4	8.6	10.9	8.6	10.1	9.6	9.6	9.5	8.8	9.6	11.4	3.9	19.2	5.3	3.3	5.1	2.3	2.2	1.7	1.8	4.6	3.0	3.4	0.9	5.7	6.2	1.8	8.4	4.9	3.6	2.7	11.7	5.6	1.6	3.5	3.8	3.9	0.0	6.1	4.8	6.2	2.7	2.8	1.5	2.2	5.1	4.6	2.5	3.4	3.0	8.4	4.4	3.3	2.0	5.1	1.8	1.4	4.4	5.1	1.8	9.4	6.2	6.0	9.2	8.0	7.7	5.8	3.2	5.3	3.6	3.9	3.1	3.7	1.7	4.2	0.0	4.1	2.9	15.9	15.9	2.9	2.8	2.6	5.6	6.5	3.1	1.5
ZSCAN9	"PRD51, ZNF193"	ENSG00000137185	"Zinc finger and SCAN domain containing 9"	O15535	6	28224886-28233487	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA054512, HPA059951"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA054512: AB_2682511, HPA059951: AB_2684176"	"unprognostic (1.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.14e-3)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.74e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.16e-5)"	9.7	11.2	11.3	8.9	12.6	10.7	13.9	15.0	13.8	14.5	14.4	13.4	9.2	14.2	13.4	7.9	11.4	9.4	11.8	11.1	12.6	15.2	9.3	10.1	8.6	12.4	12.5	14.3	12.1	11.5	14.2	11.2	12.9	14.6	14.8	17.4	11.6	11.8	9.1	6.4	12.9	11.7	12.2	16.3	11.8	20.9	12.6	4.4	13.2	7.9	10.3	12.0	10.3	13.4	11.2	7.7	25.7	30.9	9.8	10.6	8.9	13.5	11.3	12.9	14.4	7.1	5.5	0.1	19.9	8.5	12.5	7.7	12.3	12.5	14.6	7.5	10.6	17.1	16.8	13.1	12.4	20.4	13.1	9.1	19.1	10.9	16.6	19.5	16.9	0.0	25.8	9.3	19.2	6.5	0.1	33.4	9.5	5.0	8.6	10.5	17.9	11.7	16.3	15.4	22.3	30.0	11.8	8.8	16.3	19.1	10.9	13.8	13.9	26.2	18.0	6.3	23.2	20.8	22.5	4.5	5.4	24.6	15.4	4.3	3.5	5.1	3.5	1.8	2.9	4.7	1.2	2.7	5.0	4.0	0.4	0.7	1.3	11.7	0.9	2.6	0.9	2.2	11.3	12.6	15.0	13.8	11.1	12.6	12.4	12.5	12.9	12.2	12.6	13.4	6.1	9.6	3.6	5.9	4.4	0.9	5.3	8.0	0.6	7.3	5.5	4.3	5.1	12.8	10.2	3.7	0.0	5.1	5.3	3.8	1.9	8.5	21.5	2.5	4.9	6.5	5.4	4.0	4.5	6.4	3.1	5.3	2.0	3.6	5.7	7.3	5.7	2.4	5.4	6.7	4.7	6.9	4.1	5.3	4.6	5.1	3.7	5.0	3.6	10.3	3.1	4.8	4.1	8.0	10.0	6.1	6.1	4.9	3.6	3.5	4.9	3.8	4.8	6.6	6.6	5.0	5.3	23.7	15.8	3.1	1.1	12.0	2.3	5.8	6.7	2.5
ZSWIM9	"C19orf68, LOC374920"	ENSG00000185453	"Zinc finger SWIM-type containing 9"	Q86XI8	19	48170680-48197620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 6.1;Granulosa cells: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061028	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA061028: AB_2684419"	"unprognostic (1.59e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.03e-1)"	3.8	2.4	17.0	2.2	15.6	2.4	3.2	10.1	14.4	5.3	7.4	6.9	2.2	6.1	0.8	4.1	4.9	1.2	5.3	13.6	13.3	2.9	2.6	3.0	2.5	18.2	14.8	5.6	4.6	2.6	3.6	1.7	13.3	4.2	1.3	1.6	3.5	2.5	9.1	5.4	4.0	2.2	12.5	3.6	3.9	4.0	13.8	1.9	4.3	2.8	1.4	6.1	4.7	14.2	9.5	10.4	6.1	4.5	3.9	2.2	5.5	7.2	3.8	3.3	3.8	1.7	3.0	7.6	3.4	3.3	4.1	7.8	2.0	4.4	3.6	11.5	7.6	4.8	7.0	4.4	4.2	4.4	3.9	2.3	3.5	4.8	5.7	5.9	3.4	6.0	1.2	4.0	2.1	5.1	4.8	18.5	3.8	8.9	6.6	8.9	5.5	2.1	2.3	7.7	4.2	5.2	10.0	3.1	5.0	3.7	4.3	6.6	8.6	3.9	7.1	3.3	7.9	6.5	7.0	4.5	2.3	6.2	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	15.6	10.1	14.4	13.6	13.3	18.2	14.8	13.3	12.5	13.8	14.2	6.1	3.2	3.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.3	5.5	0.0	0.0	0.6	3.7	0.0	5.6	2.2	0.0	3.9	4.1	0.0	3.2	5.6	2.4	0.0	0.0	0.0	5.8	2.8	2.4	0.0	5.5	2.5	11.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.7	0.0	0.0	2.4	0.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.7	1.7	5.8	0.0	0.0
ZUP1	"C6orf113, dJ412I7.3, ZUFSP"	ENSG00000153975	"Zinc finger containing ubiquitin peptidase 1"	Q96AP4	6	116635618-116668794	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 10.4;dendritic cells: 12.8;monocytes: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044426	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA044426: AB_10960887"	"unprognostic (2.28e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.27e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.92e-3)"	4.4	4.5	4.2	6.2	4.7	13.5	5.6	7.2	6.3	4.0	3.0	5.1	10.5	3.6	4.1	5.6	3.1	5.5	2.7	4.3	4.6	4.6	4.3	5.0	8.7	4.4	4.4	2.5	5.7	4.2	3.9	5.3	4.6	5.0	5.7	6.0	3.8	4.0	3.1	5.5	7.1	4.1	4.5	6.0	4.7	6.1	4.7	7.5	4.6	3.3	8.7	6.1	4.1	5.9	6.6	6.3	13.9	26.2	7.9	10.3	10.4	14.0	13.3	13.5	16.3	11.5	7.3	23.3	11.6	8.9	15.2	10.3	15.8	10.1	17.9	14.0	18.1	18.0	9.5	20.0	12.3	21.1	21.3	9.2	15.7	11.0	18.7	10.0	12.5	17.4	32.1	11.6	17.9	10.7	10.2	16.0	10.3	9.9	6.8	13.9	12.1	9.6	15.0	6.6	12.1	14.0	10.0	8.3	8.6	11.8	4.9	15.9	10.7	8.6	5.8	5.3	11.9	10.7	14.9	24.0	7.7	12.8	12.8	19.5	7.5	7.6	7.0	8.9	8.2	9.5	7.9	8.1	10.1	10.4	8.6	6.4	2.9	8.3	11.0	6.9	11.7	6.5	4.2	4.7	7.2	6.3	4.3	4.6	4.4	4.4	4.6	4.5	4.7	5.9	6.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	5.3	5.2	0.0	0.0	0.0	1.8	0.0	10.4	12.8	0.0	9.8	9.7	0.0	7.4	8.7	2.2	0.0	0.0	0.0	8.0	8.3	2.2	0.0	8.4	0.0	10.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	12.4	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	9.3	4.4	6.0	0.0	0.0
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357227-56361273	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.6;lymphoid tissue: 43.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	2.6	2.5	1.2	15.7	1.3	41.6	6.5	1.1	1.8	3.9	1.0	18.8	13.7	3.2	1.7	12.4	2.8	2.4	1.5	1.5	1.2	4.4	4.8	2.9	26.5	1.2	1.3	1.5	2.4	5.4	0.8	10.8	1.2	2.5	22.4	0.5	3.3	1.4	0.3	10.8	14.8	6.8	1.2	5.0	12.5	26.1	1.6	43.5	3.9	0.7	33.0	5.0	4.3	1.4	199.8	154.8	107.9	120.9	7.5	10.8	88.1	143.1	108.0	169.6	153.4	275.4	116.1	102.0	53.2	49.6	79.1	99.9	153.2	108.3	156.7	259.9	80.2	101.6	120.8	129.4	0.7	169.6	131.0	5.1	6.8	157.7	64.9	20.8	86.8	134.2	140.2	121.4	151.1	160.1	150.7	108.3	77.0	135.9	188.7	151.7	209.5	54.0	53.5	87.5	99.8	61.2	135.2	304.2	35.3	62.2	197.3	163.4	47.4	73.6	189.4	76.9	223.2	105.8	55.3	176.0	103.8	210.0	94.7	0.0	0.8	0.7	2.4	3.0	0.3	1.6	5.3	3.6	1.4	0.3	6.3	3.6	0.0	3.5	2.3	1.1	17.0	3.1	1.2	1.3	1.1	1.8	1.5	1.2	1.2	1.3	1.2	1.2	1.6	1.4	0.9	3.2	1.7	0.3	11.1	18.4	6.0	20.2	4.6	2.0	9.4	5.5	1.4	2.8	7.3	5.5	0.0	73.7	3.3	17.9	0.0	9.7	74.0	7.0	4.3	5.7	0.0	133.0	1.3	13.3	108.6	10.3	16.8	8.0	0.0	27.6	7.9	3.5	49.4	0.0	0.3	22.8	14.2	8.5	8.8	208.8	5.0	9.2	7.2	0.0	2.6	1.3	0.0	0.0	0.6	8.6	16.4	2.6	42.4	1.9	8.7	6.0	2.5	0.9	0.0	1.4	10.6	121.0	100.3	24.5	8.2	23.1	7.9	6.5	39.4	8.4
ZXDA	ZNF896	ENSG00000198205	"Zinc finger X-linked duplicated A"	P98168	X	57905430-57910458	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA043789	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA043789: AB_2678673"	"unprognostic (1.53e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.85e-3)"	"unprognostic (6.50e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-2)"	2.2	2.0	1.7	1.7	2.6	2.9	2.5	4.4	2.0	2.5	0.1	1.7	1.4	2.8	2.1	1.4	3.1	1.9	2.1	1.6	1.8	2.1	1.8	1.9	2.9	2.3	2.0	4.5	2.4	2.7	1.1	1.0	2.3	2.8	1.5	1.8	1.7	2.4	3.1	1.6	1.4	2.1	1.9	3.2	2.5	0.9	2.1	2.2	3.0	3.0	2.5	1.7	1.2	3.9	1.8	1.6	0.5	2.0	2.1	2.9	1.2	1.1	2.0	1.3	1.5	0.3	1.3	4.2	2.5	2.7	1.5	1.7	1.9	2.2	1.3	3.0	3.0	0.5	1.4	0.0	3.1	0.0	0.2	2.4	4.6	2.0	4.3	2.5	2.5	2.4	0.6	0.1	3.0	1.5	1.9	1.0	2.1	0.3	1.3	2.0	1.5	1.1	1.4	1.6	0.2	1.7	2.3	1.6	1.8	2.6	2.1	1.5	1.7	2.2	4.7	0.6	1.1	0.0	0.0	2.2	1.6	1.8	1.4	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.2	0.0	1.7	2.6	4.4	2.0	1.6	1.8	2.3	2.0	2.3	1.9	2.1	3.9	4.1	0.0	0.5	1.0	5.6	9.3	4.2	1.5	8.0	2.8	1.6	1.4	2.3	2.8	1.4	1.8	4.2	0.9	1.7	0.6	0.0	1.6	0.0	1.5	1.6	3.3	1.2	0.0	2.6	0.8	0.7	2.8	3.6	1.9	1.3	1.5	0.7	0.7	1.1	3.3	3.7	1.4	2.0	1.9	2.9	0.0	2.5	1.3	3.6	3.7	0.7	1.9	0.0	2.5	5.8	0.9	0.8	1.2	4.7	2.2	0.5	1.6	1.2	2.4	0.0	2.9	2.4	0.0	0.4	1.4	6.5	0.8	3.2	1.4	1.1	2.8
ZXDB	ZNF905	ENSG00000198455	"Zinc finger X-linked duplicated B"	P98169	X	57592011-57597477	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 31.7;Suprabasal keratinocytes: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 34.8"									HPA043789	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA043789: AB_2678673"	"unprognostic (1.87e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.61e-3)"	"unprognostic (4.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.36e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.87e-3)"	3.6	3.1	3.7	3.4	3.6	8.2	4.8	4.6	4.0	4.5	2.8	3.6	2.8	5.2	3.1	3.3	5.5	4.2	3.6	3.5	4.2	3.6	14.5	3.4	4.8	3.9	3.9	5.8	6.0	6.1	2.3	2.6	4.1	4.9	3.7	3.3	3.3	4.3	4.2	4.7	3.4	5.7	3.8	4.1	4.1	1.5	3.6	3.3	5.3	4.8	4.5	4.3	2.7	4.2	5.5	6.4	4.1	5.5	6.8	6.7	5.6	3.9	4.8	3.1	3.2	2.7	4.0	4.8	5.6	7.0	4.9	6.1	11.9	20.5	6.0	11.7	6.4	2.6	8.3	7.3	8.8	4.5	2.9	5.9	34.8	8.0	21.4	6.8	9.4	5.2	3.0	5.0	8.4	3.9	4.0	3.7	16.5	2.2	8.0	5.0	14.9	2.7	4.2	8.7	3.5	6.5	7.7	5.6	6.1	9.2	5.8	4.9	8.3	6.7	12.9	5.8	3.9	0.0	2.1	6.4	4.8	3.9	3.1	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.2	0.4	0.2	0.0	0.1	0.1	0.2	0.2	0.1	3.7	3.6	4.6	4.0	3.5	4.2	3.9	3.9	4.1	3.8	3.6	4.2	4.6	6.4	2.6	1.0	6.4	31.7	11.4	3.7	12.5	3.5	10.6	4.8	6.1	8.6	3.5	1.8	0.0	2.4	7.3	2.8	3.9	2.9	0.0	9.8	6.1	5.6	0.0	4.0	2.8	3.7	1.6	6.0	7.1	14.5	0.0	4.4	3.9	12.0	1.1	6.7	3.7	7.8	0.0	2.2	8.1	0.2	5.0	2.7	7.2	1.9	1.4	1.0	2.1	4.0	3.6	4.0	1.7	5.7	7.3	17.1	2.2	2.9	3.5	3.5	0.0	7.1	4.6	0.2	0.2	9.7	38.1	2.9	4.8	1.8	4.6	16.1
ZYG11A	ZYG11	ENSG00000203995	"Zyg-11 family member A, cell cycle regulator"	Q6WRX3	1	52842511-52894998	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.9;testis: 3.8;thyroid gland: 2.3"	"Cell type enhanced"	"Detected in some"		"Prostatic glandular cells: 2.5;Spermatocytes: 3.5;Spermatogonia: 7.9"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 11.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 12.5;hTEC/SVTERT24-B: 10.4;K-562: 10.7;SiHa: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030378, HPA030379"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA030378: AB_10604159, HPA030379: AB_2673451"	"unprognostic (7.94e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.06e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.00e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	0.3	0.1	0.1	0.5	0.8	0.2	0.2	0.5	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.3	2.9	1.2	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.7	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	3.8	0.2	0.3	2.3	0.0	0.7	0.1	0.4	0.4	0.0	2.0	0.3	0.0	0.0	0.0	4.5	1.2	1.4	5.8	4.7	0.1	0.0	0.0	3.0	1.8	0.0	0.1	3.8	0.1	6.8	0.3	7.5	0.0	12.5	0.0	2.7	0.0	0.9	0.0	0.3	10.4	0.0	0.3	1.3	0.0	10.7	5.6	0.2	5.6	0.0	5.6	1.4	0.0	1.0	0.0	1.2	4.9	3.5	0.2	1.4	2.1	10.8	0.4	0.0	4.3	6.0	3.0	0.0	0.0	0.1	0.0	0.0	2.7	4.9	0.0	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.6	0.5	1.6	0.5	0.7	0.0	0.1	0.0	0.0	1.1	0.3	0.4	0.0	0.0	0.3	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.5	0.0	0.1	0.4	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.0	0.9	2.5	0.0	1.3	0.2	1.3	0.0	0.6	0.3	3.5	7.9	1.5	0.1	0.3	0.1	0.0	0.1	0.3
ZZEF1	"FLJ10821, KIAA0399, ZZZ4"	ENSG00000074755	"Zinc finger ZZ-type and EF-hand domain containing 1"	O43149	17	4004445-4143030	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031778, HPA031790"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA		1100000	"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Mitochondria	"HPA031778: AB_10599831, HPA031790: AB_10600999"	"unprognostic (4.48e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.46e-2)"	10.2	10.6	6.4	10.1	6.7	20.8	9.7	7.4	7.3	8.4	18.3	19.2	15.5	9.9	5.7	11.1	9.1	6.4	11.0	7.1	6.0	7.6	9.0	11.3	10.1	8.0	6.9	10.1	14.2	12.1	11.2	6.0	7.8	10.1	14.6	11.2	9.1	7.4	22.2	12.1	27.5	8.8	5.8	14.2	12.0	8.0	8.5	15.1	10.7	13.3	9.7	10.9	8.1	7.5	13.1	20.1	7.1	9.7	17.4	9.8	8.5	11.1	13.9	12.7	12.3	10.0	4.5	12.4	7.3	15.0	8.4	14.6	14.4	7.6	12.9	14.5	15.0	12.0	16.4	6.5	11.8	10.2	22.6	12.6	10.0	12.5	14.7	6.6	16.6	12.3	8.8	12.2	8.0	8.9	12.7	6.0	4.3	12.5	7.6	14.0	8.6	5.4	7.1	13.2	5.6	8.2	12.6	7.7	10.8	7.0	7.6	7.7	19.7	11.1	5.6	14.1	14.7	5.4	3.0	6.3	11.1	8.9	10.5	0.7	0.6	0.6	0.8	0.9	1.0	0.4	0.5	0.5	0.5	0.3	0.3	0.6	1.0	0.2	1.0	0.4	0.4	0.4	6.4	6.7	7.4	7.3	7.1	6.0	8.0	6.9	7.8	5.8	8.5	7.5	19.3	57.7	54.8	39.8	23.5	7.1	5.4	6.6	13.1	30.6	12.6	10.3	22.8	18.6	30.0	9.2	98.0	8.3	23.7	93.4	0.0	7.3	48.9	18.8	17.4	19.2	13.2	12.4	50.3	11.2	6.4	21.6	46.4	25.6	26.5	21.8	23.2	15.2	11.9	40.4	55.3	38.5	12.2	30.5	10.6	26.8	14.9	29.0	12.4	22.5	20.4	15.8	19.6	35.2	53.6	14.9	34.3	9.8	27.8	9.5	115.2	4.8	22.7	50.3	6.6	23.7	15.2	12.0	11.8	16.4	10.1	8.9	31.1	18.0	28.6	9.3
ZZZ3	"ATAC1, DKFZP564I052"	ENSG00000036549	"Zinc finger ZZ-type containing 3"	Q8IYH5	1	77562416-77683419	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 73.8;Excitatory neurons: 102.1;Inhibitory neurons: 100.7;Microglial cells: 77.8;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 280.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053663, HPA054913, HPA066197"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635"	"unprognostic (1.30e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.38e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (2.91e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.43e-1)"	8.9	12.2	6.3	10.2	10.8	9.7	17.1	5.6	6.9	13.0	2.6	9.6	9.0	13.0	9.2	9.8	11.2	8.6	11.1	5.3	7.5	14.5	16.7	8.2	12.8	5.7	7.2	16.9	9.7	13.9	6.0	10.5	8.0	11.9	9.5	11.3	10.4	12.2	8.7	10.8	8.1	12.0	7.1	9.8	10.4	6.5	7.9	14.3	19.8	10.2	12.4	10.4	6.5	16.0	27.9	12.4	22.4	17.9	21.3	30.3	26.0	32.6	27.9	27.7	31.3	15.5	12.9	34.8	29.3	27.2	32.3	24.3	29.3	22.2	44.4	25.9	26.9	41.1	26.9	19.8	33.2	45.5	12.0	26.0	34.2	31.0	63.4	30.1	31.2	24.2	41.4	24.0	27.3	13.1	22.0	13.7	35.1	15.9	29.5	25.9	40.3	17.1	22.5	26.1	30.0	26.5	19.2	23.0	60.6	16.4	13.0	25.7	24.9	23.7	29.9	40.2	44.6	20.3	30.8	36.7	27.2	39.2	19.3	0.1	4.3	5.3	6.1	4.5	9.6	7.3	7.6	7.7	7.4	9.0	9.5	8.6	0.8	7.8	5.0	4.9	10.4	5.1	6.3	10.8	5.6	6.9	5.3	7.5	5.7	7.2	8.0	7.1	7.9	16.0	11.3	0.0	0.0	73.8	22.2	17.2	13.6	10.9	27.9	18.1	0.0	0.0	0.0	15.7	5.6	0.0	8.4	13.3	14.3	6.9	0.0	0.0	5.1	0.0	0.0	10.5	19.8	17.4	102.1	0.0	12.3	11.0	16.3	0.0	0.0	0.0	15.0	15.1	14.1	16.8	100.7	14.1	6.1	13.2	11.8	3.9	16.8	8.2	12.4	77.8	7.5	16.1	17.5	141.8	280.3	0.0	14.0	19.5	14.9	18.7	10.1	0.0	4.2	19.7	6.6	29.6	11.4	7.8	9.7	28.1	19.6	8.5	14.2	0.0	14.2	14.2